PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Tsai, WB; Long, Y; Park, JR; Chang, JT; Liu, H; Rodriguez-Canales, J; Savaraj, N; Feun, LG; Davies, MA; Wistuba, II; Kuo, MT				Tsai, W-B; Long, Y.; Park, J-R; Chang, J. T.; Liu, H.; Rodriguez-Canales, J.; Savaraj, N.; Feun, L. G.; Davies, M. A.; Wistuba, I. I.; Kuo, M. T.			Gas6/Axl is the sensor of arginine-auxotrophic response in targeted chemotherapy with arginine-depleting agents	ONCOGENE			English	Article							RECEPTOR TYROSINE KINASES; CHRONIC MYELOID-LEUKEMIA; QUALITY-OF-LIFE; AXL KINASE; ARGININOSUCCINATE SYNTHETASE; BREAST-CANCER; PROTEIN-S; TRANSLATION INITIATION; DEIMINASE RESISTANCE; DEGRADING ENZYMES	Many human malignancies lack de novo biosynthesis of arginine (Arg) as the key enzyme argininosuccinate synthetase 1 (ASS1) is silenced. These tumors acquire ectopic Arg for survival, and depleting this source by Arg-depleting recombinant enzyme ADI-PEG20 results in cell death. Mechanisms underlying Arg auxotrophy in these tumors and how they respond to Arg-auxotrophic stress are poorly understood. Here, we report that an immediate-early event of Arg-auxotrophic response involves reactive oxygen species-mediated secretion of Gas6, which interacts with its receptor Axl and activates the downstream Ras/PI3K/Akt growth signal leading to accumulation of c-Myc by protein stabilization. Arg-auxotrophic challenge also transcriptionally upregulates c-Myc expression, which provides a feedback mechanism to enhance Axl expression. c-Myc is a positive regulator of ASS1, but elevated ASS1 provides a feedback mechanism to suppress c-Myc and Axl. Our results revealed multiple inter-regulatory pathways in Arg-auxotrophic response, consisting of Axl, c-Myc and ASS1, which regulate Arg homeostasis and ADI-PEG20 sensitivity. These pathways provide potential targets for improving the efficacy of treating Arg-auxotrophic tumors using Arg-deprivation strategies.	[Tsai, W-B; Long, Y.; Liu, H.; Rodriguez-Canales, J.; Wistuba, I. I.; Kuo, M. T.] Univ Texas MD Anderson Canc Ctr, Dept Translat Mol Pathol, 2130 West Holcombe Blvd,Life Sci Plaza LSP9,4206, Houston, TX 77030 USA; [Park, J-R] Kangwon Natl Univ, Dept Thorac & Cardiovasc Surg, Gangwon, South Korea; [Chang, J. T.] Univ Texas Hlth Sci Ctr Houston, Dept Integrat Biol & Pharmacol, Houston, TX 77030 USA; [Savaraj, N.] Univ Miami, Sylvester Comprehens Canc Ctr, VA Med Ctr, Miami, FL USA; [Feun, L. G.] Univ Miami, Sylvester Comprehens Canc Ctr, Miami, FL USA; [Davies, M. A.] Univ Texas MD Anderson Canc Ctr, Dept Melanoma Med Oncol, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; Kangwon National University; University of Texas System; University of Texas Health Science Center Houston; University of Miami; University of Miami; University of Texas System; UTMD Anderson Cancer Center	Kuo, MT (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Translat Mol Pathol, 2130 West Holcombe Blvd,Life Sci Plaza LSP9,4206, Houston, TX 77030 USA.	tkuo@mdanderson.org	Liu, Hui/AAJ-4339-2020	Liu, Hui/0000-0002-7669-9386	NIH/NCI Grant [R01 CA149260, P30CA16672]; NATIONAL CANCER INSTITUTE [R01CA152197, P30CA016672, R01CA149260] Funding Source: NIH RePORTER; Veterans Affairs [I01BX003328] Funding Source: NIH RePORTER	NIH/NCI Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Veterans Affairs(US Department of Veterans Affairs)	We thank Drs Bor-Wen Wu and John S Bomalaski (Polaris Pharmacologies) for ADI-PEG20 and anti-ASS1 antibody, Drs RM Melillo, S Jakob and WB Ou for recombinant DNAs. This research was supported in part by the NIH/NCI Grants R01 CA149260 (to MTK) and P30CA16672 (MD Anderson Core).	AMATI B, 1993, CELL, V72, P233, DOI 10.1016/0092-8674(93)90663-B; BEAUDET AL, 1986, ADV HUM GENET, V15, P291; Byers LA, 2013, CLIN CANCER RES, V19, P279, DOI 10.1158/1078-0432.CCR-12-1558; Chardin P, 1999, CELL, V97, P153, DOI 10.1016/S0092-8674(00)80724-2; Cirone P, 2014, CANCER CHEMOTH PHARM, V73, P525, DOI 10.1007/s00280-014-2376-1; Conacci-Sorrell Maralice, 2014, Cold Spring Harb Perspect Med, V4, pa014357, DOI 10.1101/cshperspect.a014357; Ekman C, 2010, J THROMB HAEMOST, V8, P838, DOI 10.1111/j.1538-7836.2010.03752.x; Erez A, 2013, GENET MED, V15, P251, DOI 10.1038/gim.2012.166; Erez A, 2011, NAT MED, V17, P1619, DOI 10.1038/nm.2544; Feneyrolles C, 2014, MOL CANCER THER, V13, P2141, DOI 10.1158/1535-7163.MCT-13-1083; Feun LG, 2012, BRIT J CANCER, V106, P1481, DOI 10.1038/bjc.2012.106; Feun Lynn, 2006, Expert Opin Investig Drugs, V15, P815, DOI 10.1517/13543784.15.7.815; Giles KM, 2013, MOL CANCER THER, V12, P2541, DOI 10.1158/1535-7163.MCT-13-0170; Gjerdrum C, 2010, P NATL ACAD SCI USA, V107, P1124, DOI 10.1073/pnas.0909333107; Goodwin BL, 2008, BIOCHEM BIOPH RES CO, V370, P254, DOI 10.1016/j.bbrc.2008.03.089; Graham DK, 2014, NAT REV CANCER, V14, P769, DOI 10.1038/nrc3847; GRIFFIN JH, 1992, BLOOD, V79, P3203; Haines RJ, 2012, J BIOL CHEM, V287, P26168, DOI 10.1074/jbc.M112.378794; Hara K, 1998, J BIOL CHEM, V273, P14484, DOI 10.1074/jbc.273.23.14484; Holbrook AM, 2005, ARCH INTERN MED, V165, P1095, DOI 10.1001/archinte.165.10.1095; Holland SJ, 2010, CANCER RES, V70, P1544, DOI 10.1158/0008-5472.CAN-09-2997; Huang Z, 2014, MOL CELL ENDOCRINOL, V388, P20, DOI 10.1016/j.mce.2014.02.005; Jackson RJ, 2010, NAT REV MOL CELL BIO, V11, P113, DOI 10.1038/nrm2838; Johannessen CM, 2010, NATURE, V468, P968, DOI 10.1038/nature09627; Khoury HJ, 2012, BLOOD, V119, P3403, DOI 10.1182/blood-2011-11-390120; Kilberg MS, 2012, ADV NUTR, V3, P295, DOI 10.3945/an.112.001891; Kimball SR, 2010, J BIOL CHEM, V285, P29027, DOI 10.1074/jbc.R110.137208; Kimball SR, 1998, J BIOL CHEM, V273, P30945, DOI 10.1074/jbc.273.47.30945; Kodigepalli KM, 2015, FEBS LETT, V589, P3, DOI 10.1016/j.febslet.2014.11.036; Konishi A, 2004, J BIOL CHEM, V279, P28766, DOI 10.1074/jbc.M401977200; KRETZNER L, 1992, NATURE, V359, P426, DOI 10.1038/359426a0; Kuo MT, 2010, ONCOTARGET, V1, P246, DOI 10.18632/oncotarget.135; Laurance S, 2012, ADV NUTR, V3, P196, DOI 10.3945/an.111.001826; Lemke G, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a009076; Long Y, 2013, MOL CANCER THER, V12, P2581, DOI 10.1158/1535-7163.MCT-13-0302; Nagata K, 1996, J BIOL CHEM, V271, P30022, DOI 10.1074/jbc.271.47.30022; Neel BG, 2003, TRENDS BIOCHEM SCI, V28, P284, DOI 10.1016/S0968-0004(03)00091-4; Nickel W, 2010, CURR OPIN BIOTECH, V21, P621, DOI 10.1016/j.copbio.2010.06.004; Paccez JD, 2014, INT J CANCER, V134, P1024, DOI 10.1002/ijc.28246; Phillips MM, 2013, CANCER RES TREAT, V45, P251, DOI 10.4143/crt.2013.45.4.251; Qiu FM, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2004761; Rahl PB, 2010, CELL, V141, P432, DOI 10.1016/j.cell.2010.03.030; Rochlitz C, 1999, LEUKEMIA, V13, P1352, DOI 10.1038/sj.leu.2401484; Saenz JB, 2009, NAT CHEM BIOL, V5, P157, DOI 10.1038/nchembio.144; Sasaki T, 2006, EMBO J, V25, P80, DOI 10.1038/sj.emboj.7600912; Sasaki T, 2002, J BIOL CHEM, V277, P44164, DOI 10.1074/jbc.M207340200; Segawa K, 2014, CELL CYCLE, V13, P2990, DOI 10.4161/15384101.2014.962865; Shan JX, 2012, J BIOL CHEM, V287, P36393, DOI 10.1074/jbc.M112.399600; STITT TN, 1995, CELL, V80, P661, DOI 10.1016/0092-8674(95)90520-0; Suh CH, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3088; Suzuki J, 2014, METHOD ENZYMOL, V544, P381, DOI 10.1016/B978-0-12-417158-9.00015-7; Syed N, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2012.197; Trask PC, 2013, LEUKEMIA RES, V37, P9, DOI 10.1016/j.leukres.2012.09.013; Trask PC, 2012, LEUKEMIA RES, V36, P438, DOI 10.1016/j.leukres.2011.10.011; Tsai WB, 2012, CANCER RES, V72, P2622, DOI 10.1158/0008-5472.CAN-11-3605; Tsai WB, 2009, MOL CANCER THER, V8, P3223, DOI 10.1158/1535-7163.MCT-09-0794; Verma A, 2011, MOL CANCER THER, V10, P1763, DOI 10.1158/1535-7163.MCT-11-0116; Walz S, 2014, NATURE, V511, P483, DOI 10.1038/nature13473; Wiese KE, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a014290; Wu XL, 2014, ONCOTARGET, V5, P9546, DOI 10.18632/oncotarget.2542; Ye X, 2010, ONCOGENE, V29, P5254, DOI 10.1038/onc.2010.268; Zhang YX, 2008, CANCER RES, V68, P1905, DOI 10.1158/0008-5472.CAN-07-2661; Zhang ZF, 2012, NAT GENET, V44, P852, DOI 10.1038/ng.2330	63	14	15	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 31	2016	35	13					1632	1642		10.1038/onc.2015.237	http://dx.doi.org/10.1038/onc.2015.237			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DH8RP	26096933	Green Accepted			2022-12-26	WOS:000373064200003
J	Deschamps, CL; Connors, KE; Klein, MS; Johnsen, VL; Shearer, J; Vogel, HJ; Devaney, JM; Gordish-Dressman, H; Many, GM; Barfield, W; Hoffman, EP; Kraus, WE; Hittel, DS				Deschamps, Chelsea L.; Connors, Kimberly E.; Klein, Matthias S.; Johnsen, Virginia L.; Shearer, Jane; Vogel, Hans J.; Devaney, Joseph M.; Gordish-Dressman, Heather; Many, Gina M.; Barfield, Whitney; Hoffman, Eric P.; Kraus, William E.; Hittel, Dustin S.			The ACTN3 R577X Polymorphism Is Associated with Cardiometabolic Fitness in Healthy Young Adults	PLOS ONE			English	Article							SERUM METABOLITE PROFILE; ALPHA-ACTININ-3 DEFICIENCY; FUNCTIONAL SYMPATHOLYSIS; MUSCLE; EXERCISE; PERFORMANCE; GENOTYPE; GENES; MOUSE; WOMEN	Homozygosity for a premature stop codon (X) in the ACTN3 "sprinter" gene is common in humans despite the fact that it reduces muscle size, strength and power. Because of the close relationship between skeletal muscle function and cardiometabolic health we examined the influence of ACTN3 R577X polymorphism over cardiovascular and metabolic characteristics of young adults (n = 98 males, n = 102 females; 23+/-4.2 years) from our Assessing Inherent Markers for Metabolic syndrome in the Young (AIMMY) study. Both males and females with the RR vs XX genotype achieved higher mean VO2 peak scores (47.8+/-1.5 vs 43.2+/-1.8 ml/O-2/min, p = 0.002) and exhibited higher resting systolic (115+/-2 vs 105+/-mmHg, p = 0.027) and diastolic (69+/-3 vs 59+/-3 mmHg, p = 0.005) blood pressure suggesting a role for ACTN3 in the maintenance of vascular tone. We subsequently identified the expression of alpha-actinin 3 protein in pulmonary artery smooth muscle, which may explain the genotype-specific differences in cardiovascular adaptation to acute exercise. In addition, we utilized targeted serum metabolomics to distinguish between RR and XX genotypes, suggesting an additional role for the ACTN3 R577X polymorphism in human metabolism. Taken together, these results identify significant cardiometabolic effects associated with possessing one or more functional copies of the ACTN3 gene.	[Shearer, Jane; Vogel, Hans J.; Hittel, Dustin S.] Univ Calgary, Cumming Sch Med, Dept Biochem & Mol Biol, Calgary, AB T2N 1N4, Canada; [Deschamps, Chelsea L.; Connors, Kimberly E.; Klein, Matthias S.; Johnsen, Virginia L.; Shearer, Jane] Univ Calgary, Fac Kinesiol, Calgary, AB T2N 1N4, Canada; [Devaney, Joseph M.; Gordish-Dressman, Heather; Many, Gina M.; Barfield, Whitney; Hoffman, Eric P.] Childrens Natl Med Ctr, Washington, DC 20010 USA; [Kraus, William E.] Duke Univ, Durham, NC USA	University of Calgary; University of Calgary; Children's National Health System; Duke University	Hittel, DS (corresponding author), Univ Calgary, Cumming Sch Med, Dept Biochem & Mol Biol, 2500 Univ Dr, Calgary, AB T2N 1N4, Canada.	dhhittel@ucalgary.ca	Klein, Matthias S/H-6893-2013; Klein, Matthias S./AAD-6495-2021	Klein, Matthias S/0000-0001-7455-5381; Klein, Matthias S./0000-0001-7455-5381; Many, Gina/0000-0003-4779-1690; Hoffman, Eric/0000-0001-6470-5139	Eresman Family; BURNCO Foundations; DC-Baltimore Research Center on Child Health Disparities [2P20MD000198-06]; Clark Charitable Foundation, Inc.; National Institute on Minority Health and Health Disparities [P20MD000198] Funding Source: NIH RePORTER	Eresman Family; BURNCO Foundations; DC-Baltimore Research Center on Child Health Disparities; Clark Charitable Foundation, Inc.; National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	DSH was funded by philanthropic donations from the Eresman Family, BURNCO Foundations as well as Jay and Karen Westman. The AIMMY Study was funded by a grant from the DC-Baltimore Research Center on Child Health Disparities (2P20MD000198-06) and the Clark Charitable Foundation, Inc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmetov II, 2010, BRIT J SPORT MED, V44, P649, DOI 10.1136/bjsm.2008.051540; Alfred T, 2011, HUM MUTAT, V32, P1008, DOI 10.1002/humu.21526; Amorim CEG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115449; BRUCE RA, 1973, AM HEART J, V85, P546, DOI 10.1016/0002-8703(73)90502-4; Clarkson PM, 2005, J APPL PHYSIOL, V99, P154, DOI 10.1152/japplphysiol.01139.2004; Cole LK, 2012, BBA-MOL CELL BIOL L, V1821, P754, DOI 10.1016/j.bbalip.2011.09.009; Connors KE, 2014, CIRC-CARDIOVASC GENE, V7, P576, DOI 10.1161/CIRCGENETICS.114.000534; Eynon N, 2013, SPORTS MED, V43, P803, DOI 10.1007/s40279-013-0059-4; Fiuza-Luces C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017558; Friedlander SM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052282; Gioli-Pereira L, 2014, BMC CARDIOVASC DISOR, V14, DOI [10.1186/1471-2261-14-32, 10.1186/1471-2261-14-90]; Gomez-Gallego F, 2009, INT J SPORTS MED, V30, P66, DOI 10.1055/s-2008-1038677; Grealy R, 2013, J SCI MED SPORT, V16, P365, DOI 10.1016/j.jsams.2012.08.013; Head SI, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1004862; Heinonen I, 2014, EXP PHYSIOL, V99, P344, DOI 10.1113/expphysiol.2013.076927; Hernan MA, 2011, INT J EPIDEMIOL, V40, P780, DOI 10.1093/ije/dyr041; Hittel DS, 2005, J APPL PHYSIOL, V98, P168, DOI 10.1152/japplphysiol.00331.2004; Hochrein J, 2012, J PROTEOME RES, V11, P6242, DOI 10.1021/pr3009034; Karlos A, 2013, APPL PHYSIOL NUTR ME, V38, P188, DOI 10.1139/apnm-2012-0231; Kim MS, 2014, NATURE, V509, P575, DOI 10.1038/nature13302; Klein MS, 2014, J PROTEOME RES, V13, P5063, DOI 10.1021/pr500659r; KUSHMERICK MJ, 1992, AM J PHYSIOL, V263, pC598, DOI 10.1152/ajpcell.1992.263.3.C598; Lands WEM, 2000, BBA-MOL CELL BIOL L, V1483, P1, DOI 10.1016/S1388-1981(99)00177-8; Livak KJ, 1999, GENET ANAL-BIOMOL E, V14, P143, DOI 10.1016/S1050-3862(98)00019-9; Ma F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054685; MacArthur DG, 2008, HUM MOL GENET, V17, P1076, DOI 10.1093/hmg/ddm380; Many GM, 2016, J STRENGTH COND RES, V30, P1137, DOI 10.1519/JSC.0000000000000871; Mills MA, 2001, HUM MOL GENET, V10, P1335, DOI 10.1093/hmg/10.13.1335; North KN, 1999, NAT GENET, V21, P353, DOI 10.1038/7675; Olofsson KE, 2008, BIOCHEM BIOPH RES CO, V370, P348, DOI 10.1016/j.bbrc.2008.03.087; Pereira A, 2013, BMC GERIATR, V13, DOI 10.1186/1471-2318-13-131; Reinehr T, 2015, EUR J NUTR, V54, P173, DOI 10.1007/s00394-014-0698-8; Reiner A, 2003, BIOINFORMATICS, V19, P368, DOI 10.1093/bioinformatics/btf877; Sankararaman S, 2014, NATURE, V507, P354, DOI 10.1038/nature12961; Schadock I, 2015, GENET TEST MOL BIOMA, V19, P253, DOI 10.1089/gtmb.2014.0299; Seto JT, 2011, EXP GERONTOL, V46, P292, DOI 10.1016/j.exger.2010.11.006; Shah BN, 2013, HEART, V99, P1793, DOI 10.1136/heartjnl-2013-304003; Silva MSM, 2015, INT J SPORT PHYSIOL, V10, P636, DOI 10.1123/ijspp.2014-0205; Slentz CA, 2004, ARCH INTERN MED, V164, P31, DOI 10.1001/archinte.164.1.31; Sprouse C, 2014, DIABETES, V63, P363, DOI 10.2337/db13-1150; Thomas GD, 2015, AUTON NEUROSCI-BASIC, V188, P64, DOI 10.1016/j.autneu.2014.10.019; Wahl S, 2012, OBESITY FACTS, V5, P660, DOI 10.1159/000343204; Watts R, 2014, BIOCHEM CELL BIOL, V92, P226, DOI 10.1139/bcb-2014-0004; Wishart DS, 2007, NUCLEIC ACIDS RES, V35, pD521, DOI 10.1093/nar/gkl923; Xu Y, 2002, BBA-MOL CELL BIOL L, V1582, P81, DOI 10.1016/S1388-1981(02)00140-3; Yang N, 2011, BONE, V49, P790, DOI 10.1016/j.bone.2011.07.009; Zempo H, 2011, GENET TEST MOL BIOMA, V15, P639, DOI 10.1089/gtmb.2011.0005	48	25	27	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2015	10	6							e0130644	10.1371/journal.pone.0130644	http://dx.doi.org/10.1371/journal.pone.0130644			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4OM	26107372	Green Published, Green Submitted, gold			2022-12-26	WOS:000356932500115
J	Guha, M; Bankura, B; Ghosh, S; Pattanayak, AK; Ghosh, S; Pal, DK; Puri, A; Kundu, AK; Das, M				Guha, Manalee; Bankura, Biswabandhu; Ghosh, Sudakshina; Pattanayak, Arup Kumar; Ghosh, Saurabh; Pal, Dilip Kumar; Puri, Anurag; Kundu, Anup Kumar; Das, Madhusudan			Polymorphisms in CaSR and CLDN14 Genes Associated with Increased Risk of Kidney Stone Disease in Patients from the Eastern Part of India	PLOS ONE			English	Article							VITAMIN-D-RECEPTOR; CALCIUM-SENSING RECEPTOR; CA2+-SENSING RECEPTOR; UROLITHIASIS; HOMEOSTASIS; EXPRESSION; HAPLOTYPES; VARIANTS; DENSITY; INDEXES	Kidney stone disease (KSD) is a major clinical problem imposing a large burden for both healthcare and economy globally. In India, the prevalence of kidney stone disease is rapidly increasing. This study aimed to evaluate the association between genetic defects in vitamin D receptor (VDR), calcium sensing receptor (CaSR) and claudin 14 (CLDN14) genes and kidney stone disease in patients from eastern India. We enrolled 200 consecutive kidney stone patients (age 18-60 years) (cases) and their corresponding sex and age matched 200 normal individuals (controls). To identify genetic variants responsible for KSD, we performed sequence analysis of VDR, CaSR and CLDN14 genes. Four non-synonymous (rs1801725, rs1042636, rs1801726 and rs2228570), one synonymous (rs219780) and three intronic single nucleotide polymorphisms (SNPs) (rs731236, rs219777 and rs219778) were identified. Genotype and allele frequency analysis of these SNPs revealed that, rs1801725 (Ala986Ser), rs1042636 (Arg990Gly) of CaSR gene and rs219778, rs219780 (Thr229Thr) of CLDN14 gene were significantly associated with KSD. Serum calcium levels were significantly higher in subjects carrying 986Ser allele and calcium excretion was higher in subjects bearing 990Gly allele. In conclusion, rs1801725, rs1042636, rs219778 and rs219780 SNPs were associated with kidney stone risk in patients from the eastern part of India.	[Guha, Manalee; Bankura, Biswabandhu; Ghosh, Sudakshina; Pattanayak, Arup Kumar; Das, Madhusudan] Univ Calcutta, Dept Zool, Kolkata, W Bengal, India; [Ghosh, Saurabh] Indian Stat Inst, Human Genet Unit, Kolkata, W Bengal, India; [Pal, Dilip Kumar; Puri, Anurag; Kundu, Anup Kumar] Inst Post Grad Med Educ & Res, Dept Urol, Kolkata, W Bengal, India	University of Calcutta; Indian Statistical Institute; Indian Statistical Institute Kolkata; Institute of Post Graduate Medical Education & Research (IPGMER), Kolkata	Das, M (corresponding author), Univ Calcutta, Dept Zool, Kolkata, W Bengal, India.	madhuzoo@yahoo.com		das, madhusudan/0000-0003-3748-892X				Bollerslev J, 2004, CALCIFIED TISSUE INT, V74, P12, DOI 10.1007/s00223-002-0066-1; Brown EM, 1995, J AM SOC NEPHROL, V6, P1530; Brown EM, 1997, BONE, V20, P303, DOI 10.1016/S8756-3282(97)00002-1; Bushinsky DA, 1998, J AM SOC NEPHROL, V9, P917; Bushinsky DA, 2006, CURR OPIN NEPHROL HY, V15, P403, DOI 10.1097/01.mnh.0000232881.35469.a9; Chandak GR, 2002, J MED GENET, V39, P347, DOI 10.1136/jmg.39.5.347; Cole DEC, 1999, LANCET, V353, P112, DOI 10.1016/S0140-6736(98)06434-4; Devuyst O, 2007, KIDNEY INT, V72, P1065, DOI 10.1038/sj.ki.5002441; Dimke H, 2013, AM J PHYSIOL-RENAL, V304, pF761, DOI 10.1152/ajprenal.00263.2012; Ferreira LG, 2010, NEPHRON CLIN PRACT, V114, pC135, DOI 10.1159/000254386; Gambaro G, 2011, URINARY TRACT STONE DISEASE, P9, DOI 10.1007/978-1-84800-362-0_2; Gong YF, 2014, J AM SOC NEPHROL, V25, P745, DOI 10.1681/ASN.2013050553; Gunzel D, 2013, PHYSIOL REV, V93, P525, DOI 10.1152/physrev.00019.2012; Gunes S, 2006, UROL RES, V34, P47, DOI 10.1007/s00240-005-0033-1; Hamilton DC, 2009, ANN HUM GENET, V73, P176, DOI 10.1111/j.1469-1809.2008.00492.x; Harding B, 2006, CLIN ENDOCRINOL, V65, P598, DOI 10.1111/j.1365-2265.2006.02634.x; Heilberg IP, 2013, ADV CHRONIC KIDNEY D, V20, P165, DOI 10.1053/j.ackd.2012.12.001; Krause G, 2008, BBA-BIOMEMBRANES, V1778, P631, DOI 10.1016/j.bbamem.2007.10.018; Laaksonen MML, 2009, J NUTRIGENET NUTRIGE, V2, P55, DOI 10.1159/000204960; Lin YW, 2011, UROL INT, V86, P249, DOI 10.1159/000323949; Mittal RD, 2010, INDIAN J CLIN BIOCHE, V25, P119, DOI 10.1007/s12291-010-0023-0; Mossetti G, 2004, NEPHROL DIAL TRANSPL, V19, P2259, DOI 10.1093/ndt/gfh273; O'Seaghdha CM, 2010, HUM MOL GENET, V19, P4296, DOI 10.1093/hmg/ddq342; Ozkaya O, 2003, EUR UROL, V44, P150, DOI 10.1016/S0302-2838(03)00206-9; Purcell S, 2003, BIOINFORMATICS, V19, P149, DOI 10.1093/bioinformatics/19.1.149; RAJAGOPAL G, 1984, INDIAN J EXP BIOL, V22, P391; Scillitani A, 2007, J CLIN ENDOCR METAB, V92, P277, DOI 10.1210/jc.2006-0857; Seo IY, 2010, UROLOGY, V75, P923, DOI 10.1016/j.urology.2009.10.006; Seyhan S, 2007, INT J UROL, V14, P1060, DOI 10.1111/j.1442-2042.2007.01899.x; Tabassum Rubina, 2008, Genomic Med, V2, P93, DOI 10.1007/s11568-009-9031-7; Thorleifsson G, 2009, NAT GENET, V41, P926, DOI 10.1038/ng.404; Vezzoli G, 2007, KIDNEY INT, V71, P1155, DOI 10.1038/sj.ki.5002156; Vezzoli G, 2012, CURR OPIN NEPHROL HY, V21, P355, DOI 10.1097/MNH.0b013e3283542290; Yao JJ, 2005, J AM SOC NEPHROL, V16, P1300, DOI 10.1681/ASN.2004110991	34	41	44	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2015	10	6							e0130790	10.1371/journal.pone.0130790	http://dx.doi.org/10.1371/journal.pone.0130790			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4OM	26107257	Green Published, Green Submitted, gold			2022-12-26	WOS:000356932500124
J	Kress, D; van Bokhorst, E; Lentink, D				Kress, Daniel; van Bokhorst, Evelien; Lentink, David			How Lovebirds Maneuver Rapidly Using Super-Fast Head Saccades and Image Feature Stabilization	PLOS ONE			English	Article							PIGEON COLUMBA-LIVIA; OPTOCOLLIC REFLEX OCR; EYE-MOVEMENTS; OPTIC FLOW; SELECTIVE ATTENTION; PULSE EMISSION; VISUAL CONTROL; GAZE REFLEXES; FLIGHT; MOTION	Diurnal flying animals such as birds depend primarily on vision to coordinate their flight path during goal-directed flight tasks. To extract the spatial structure of the surrounding environment, birds are thought to use retinal image motion (optical flow) that is primarily induced by motion of their head. It is unclear what gaze behaviors birds perform to support visuomotor control during rapid maneuvering flight in which they continuously switch between flight modes. To analyze this, we measured the gaze behavior of rapidly turning lovebirds in a goal-directed task: take-off and fly away from a perch, turn on a dime, and fly back and land on the same perch. High-speed flight recordings revealed that rapidly turning lovebirds perform a remarkable stereotypical gaze behavior with peak saccadic head turns up to 2700 degrees per second, as fast as insects, enabled by fast neck muscles. In between saccades, gaze orientation is held constant. By comparing saccade and wingbeat phase, we find that these super-fast saccades are coordinated with the downstroke when the lateral visual field is occluded by the wings. Lovebirds thus maximize visual perception by overlying behaviors that impair vision, which helps coordinate maneuvers. Before the turn, lovebirds keep a high contrast edge in their visual midline. Similarly, before landing, the lovebirds stabilize the center of the perch in their visual midline. The perch on which the birds land swings, like a branch in the wind, and we find that retinal size of the perch is the most parsimonious visual cue to initiate landing. Our observations show that rapidly maneuvering birds use precisely timed stereotypic gaze behaviors consisting of rapid head turns and frontal feature stabilization, which facilitates optical flow based flight control. Similar gaze behaviors have been reported for visually navigating humans. This finding can inspire more effective vision-based autopilots for drones.	[Kress, Daniel; van Bokhorst, Evelien; Lentink, David] Stanford Univ, Dept Mech Engn, Stanford, CA 94305 USA; [van Bokhorst, Evelien] City Univ London, Dept Mech Engn & Aeronaut, London EC1V 0HB, England; [Lentink, David] Wageningen Univ, Expt Zool Grp, NL-6700 AP Wageningen, Netherlands	Stanford University; City University London; Wageningen University & Research	Kress, D (corresponding author), Stanford Univ, Dept Mech Engn, Stanford, CA 94305 USA.	dkress@stanford.edu		Lentink, David/0000-0003-4717-6815	Human Frontier Science Program [RGP0003/2013]; Office of Naval Research Multidisciplinary University Research Initiatives Program [N00014-10-1-0951]	Human Frontier Science Program(Human Frontier Science Program); Office of Naval Research Multidisciplinary University Research Initiatives Program	Human Frontier Science Program, grant RGP0003/2013, http://www.hfsp.org/funded DK and DL. The Office of Naval Research Multidisciplinary University Research Initiatives Program, grant N00014-10-1-0951, http://www.onr.navy.mil/Science-Technology/Directorates/office-research-discoveryinvention/Sponsored-Research/University-Research-Initiatives/MURI.aspx funded DL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler DL, 2012, J EXP BIOL, V215, P4070, DOI 10.1242/jeb.075044; Baird E, 2013, P NATL ACAD SCI USA, V110, P18686, DOI 10.1073/pnas.1314311110; BALOH RW, 1975, NEUROLOGY, V25, P1065, DOI 10.1212/WNL.25.11.1065; Bhagavatula PS, 2011, CURR BIOL, V21, P1794, DOI 10.1016/j.cub.2011.09.009; BILO D, 1978, NATURWISSENSCHAFTEN, V65, P161, DOI 10.1007/BF00440356; Bilo D, 1994, COURSE CONTROL FLIGH, P227; Bilo D, 1985, BIONA REPORT, V3, P445; Boeddeker N, 2010, P ROY SOC B-BIOL SCI, V277, P1899, DOI 10.1098/rspb.2009.2326; BORST A, 1988, NATURWISSENSCHAFTEN, V75, P265, DOI 10.1007/BF00378023; BROOKS B, 1973, VISION RES, V13, P1387, DOI 10.1016/0042-6989(73)90216-2; BURR DC, 1994, NATURE, V371, P511, DOI 10.1038/371511a0; Censi A, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002891; Coimbra JP, 2014, J COMP NEUROL, V522, P3363, DOI 10.1002/cne.23637; COLLEWIJN H, 1977, J PHYSIOL-LONDON, V266, P471, DOI 10.1113/jphysiol.1977.sp011778; Crawford JD, 1999, J NEUROPHYSIOL, V81, P1760, DOI 10.1152/jn.1999.81.4.1760; DAVIES MNO, 1990, NATURWISSENSCHAFTEN, V77, P142, DOI 10.1007/BF01134481; Demery ZP, 2011, P ROY SOC B-BIOL SCI, V278, P3687, DOI 10.1098/rspb.2011.0374; DIERINGER N, 1982, EXP BRAIN RES, V47, P394; EASTER SS, 1974, J COMP PHYSIOL, V92, P37, DOI 10.1007/BF00696525; Eckmeier D, 2013, FRONT INTEGR NEUROSC, V7, DOI 10.3389/fnint.2013.00068; Eckmeier D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003956; Egelhaaf M, 2014, FRONT NEURAL CIRCUIT, V8, DOI 10.3389/fncir.2014.00127; Egelhaaf M, 2012, FRONT NEURAL CIRCUIT, V6, DOI 10.3389/fncir.2012.00108; Eilers PHC, 2003, ANAL CHEM, V75, P3631, DOI 10.1021/ac034173t; ELLINGTON CP, 1984, PHILOS T ROY SOC B, V305, P41, DOI 10.1098/rstb.1984.0051; ERICHSEN JT, 1989, BRAIN BEHAV EVOLUT, V33, P268, DOI 10.1159/000115935; EVINGER C, 1978, J PHYSIOL-LONDON, V285, P209, DOI 10.1113/jphysiol.1978.sp012568; Frost B, 1994, ANAL MOTION VISUAL S, P248; FROST BJ, 1990, VISION RES, V30, P1677, DOI 10.1016/0042-6989(90)90152-B; Geurten BRH, 2010, J EXP BIOL, V213, P2461, DOI 10.1242/jeb.036079; Gibson J.J, 1950, PERCEPTION VISUAL WO, Vxii, P242; GIOANNI H, 1988, EXP BRAIN RES, V69, P583, DOI 10.1007/BF00247311; GIOANNI H, 1988, EXP BRAIN RES, V69, P567, DOI 10.1007/BF00247310; Gioanni H, 1999, EUR J NEUROSCI, V11, P155, DOI 10.1046/j.1460-9568.1999.00424.x; Gioanni H, 2012, J NEUROPHYSIOL, V107, P704, DOI 10.1152/jn.00684.2011; Goller B, 2014, P NATL ACAD SCI USA, V111, P18375, DOI 10.1073/pnas.1415975111; GREEN PR, 1992, VISION RES, V32, P2229, DOI 10.1016/0042-6989(92)90087-Y; GREEN PR, 1994, J COMP PHYSIOL A, V174, P249; Guitton D, 1987, J NEUROPHYSIOL, V58; Hedrick TL, 2004, J EXP BIOL, V207, P1689, DOI 10.1242/jeb.00933; Hedrick TL, 2009, SCIENCE, V324, P252, DOI 10.1126/science.1168431; HIKIDA RS, 1974, TISSUE CELL, V6, P411, DOI 10.1016/0040-8166(74)90035-4; Holderied MW, 2003, P ROY SOC B-BIOL SCI, V270, P2293, DOI 10.1098/rspb.2003.2487; Huang YY, 2008, FRONT BIOSCI-LANDMRK, V13, P1899, DOI 10.2741/2810; JENNI L, 1981, Journal fuer Ornithologie, V122, P37, DOI 10.1007/BF01643442; JONES G, 1994, FUNCT ECOL, V8, P450, DOI 10.2307/2390068; Kane SA, 2015, J EXP BIOL, V218, P212, DOI 10.1242/jeb.108597; Knudsen EI, 2007, ANNU REV NEUROSCI, V30, P57, DOI 10.1146/annurev.neuro.30.051606.094256; KOENDERINK JJ, 1986, VISION RES, V26, P161, DOI 10.1016/0042-6989(86)90078-7; Kress D, 2014, J EXP BIOL, V217, P3209, DOI 10.1242/jeb.097436; Kress D, 2012, J EXP BIOL, V215, P1523, DOI 10.1242/jeb.066910; Kruyt JW, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2014.0585; Land MF, 1999, J COMP PHYSIOL A, V185, P341, DOI 10.1007/s003590050393; Land MF, 1999, J COMP PHYSIOL A, V184, P265, DOI 10.1007/s003590050324; Land MF, 2015, J COMP PHYSIOL A, V201, P195, DOI 10.1007/s00359-014-0964-5; LEE DN, 1993, J EXP BIOL, V180, P85; Lindemann JP, 2008, BIOL CYBERN, V98, P213, DOI 10.1007/s00422-007-0205-x; Lisney TJ, 2011, VISION RES, V51, P1324, DOI 10.1016/j.visres.2011.04.009; Martin GR, 2007, J ORNITHOL, V148, pS547, DOI 10.1007/s10336-007-0213-6; Martin GR, 2009, J VISION, V9, DOI 10.1167/9.11.14; MARTINOYA C, 1983, BEHAV BRAIN RES, V8, P375, DOI 10.1016/0166-4328(83)90182-1; Maurice M, 2006, J EXP BIOL, V209, P292, DOI 10.1242/jeb.02005; McArthur KL, 2011, J NEUROPHYSIOL, V105, P1689, DOI 10.1152/jn.00981.2010; Mitkus M, 2014, J COMP PHYSIOL A, V200, P371, DOI 10.1007/s00359-014-0894-2; Muijres FT, 2014, SCIENCE, V344, P172, DOI 10.1126/science.1248955; Ott M, 2001, EXP BRAIN RES, V139, P173, DOI 10.1007/s002210100774; POTTS WK, 1984, NATURE, V309, P344, DOI 10.1038/309344a0; Raudies F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038446; Ros IG, 2011, P NATL ACAD SCI USA, V108, P19990, DOI 10.1073/pnas.1107519108; Rothkopf CA, 2009, VISUAL NEUROSCI, V26, P81, DOI 10.1017/S0952523808080978; Rubene D, 2010, J EXP BIOL, V213, P3357, DOI 10.1242/jeb.042424; Schwarz JS, 2013, FRONT SYST NEUROSCI, V7, DOI 10.3389/fnsys.2013.00091; Sridharan D, 2014, P NATL ACAD SCI USA, V111, pE2056, DOI 10.1073/pnas.1316824111; STITT CL, 1976, J COMP PHYSIOL PSYCH, V90, P601, DOI 10.1037/h0077222; SUTHERS RA, 1972, J EXP BIOL, V56, P37; Tammero LF, 2002, J EXP BIOL, V205, P327; Theriault DH, 2014, J EXP BIOL, V217, P1843, DOI 10.1242/jeb.100529; TOBALSKE BW, 1995, J EXP BIOL, V198, P1259; TOBALSKE BW, 1994, J EXP BIOL, V187, P1; TOMLINSON RD, 1990, J NEUROPHYSIOL, V64, P1873, DOI 10.1152/jn.1990.64.6.1873; van Breugel F, 2012, J EXP BIOL, V215, P1783, DOI 10.1242/jeb.066498; Van Hateren JH, 1999, J EXP BIOL, V202, P1491; Voss J, 2009, J EXP BIOL, V212, P1568, DOI 10.1242/jeb.024950; WAGNER H, 1982, NATURE, V297, P147, DOI 10.1038/297147a0; Wallman J, 1993, EYE MOVEMENTS HEAD M, P245; Warrick DR, 2002, INTEGR COMP BIOL, V42, P141, DOI 10.1093/icb/42.1.141; WOHLSCHLAGER A, 1993, J COMP PSYCHOL, V107, P313, DOI 10.1037/0735-7036.107.3.313; Wylie DR, 2013, FRONT BEHAV NEUROSCI, V7, DOI 10.3389/fnbeh.2013.00004; Wylie DRW, 1999, J NEUROPHYSIOL, V81, P267, DOI 10.1152/jn.1999.81.1.267; Xiao Q, 2013, EUR J NEUROSCI, V37, P1103, DOI 10.1111/ejn.12115; Yang Y, 2008, NAT NEUROSCI, V11, P595, DOI 10.1038/nn.2107; Yang Y, 2008, J NEUROSCI, V28, P10772, DOI 10.1523/JNEUROSCI.2468-08.2008; Yorzinski JL, 2013, J EXP BIOL, V216, P3035, DOI 10.1242/jeb.087338; Zweers G, 1994, PERCEPTION MOTOR CON, P354	94	18	18	1	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2015	10	6							e0129287	10.1371/journal.pone.0129287	http://dx.doi.org/10.1371/journal.pone.0129287			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4OM	26107413	Green Published, Green Submitted, gold			2022-12-26	WOS:000356932500046
J	Chen, YQ; Bekhash, A; Kovatich, AJ; Hooke, JA; Liu, JF; Kvecher, L; Fantacone-Campbell, JL; Mitchell, EP; Rui, H; Mural, RJ; Shriver, CD; Hu, H				Chen, Yaqin; Bekhash, Anthony; Kovatich, Albert J.; Hooke, Jeffrey A.; Liu, Jianfang; Kvecher, Leonid; Fantacone-Campbell, J. Leigh; Mitchell, Edith P.; Rui, Hallgeir; Mural, Richard J.; Shriver, Craig D.; Hu, Hai			Positive Association of Fibroadenomatoid Change with HER2-Negative Invasive Breast Cancer: A Co-Occurrence Study	PLOS ONE			English	Article							SCLEROSING LOBULAR HYPERPLASIA; RISK-FACTORS; FIBROCYSTIC DISEASE; WOMEN; PATHOLOGY; EPIDEMIOLOGY; MASTOPATHY; CONSENSUS; FEATURES; COHORT	Background Risk assessment of a benign breast disease/lesion (BBD) for invasive breast cancer (IBC) is typically done through a longitudinal study. For an infrequently-reported BBD, the shortage of occurrence data alone is a limiting factor to conducting such a study. Here we present an approach based on co-occurrence analysis, to help address this issue. We focus on fibroadenomatoid change (FAC), an under-studied BBD, as our preliminary analysis has suggested its previously unknown significant co-occurrence with IBC. Methods A cohort of 1667 female patients enrolled in the Clinical Breast Care Project was identified. A single experienced breast pathologist reviewed all pathology slides for each case and recorded all observed lesions, including FAC. Fibroadenoma (FA) was studied for comparison since FAC had been speculated to be an immature FA. FA and Fibrocystic Changes (FCC) were used for method validation since they have been comprehensively studied. Six common IBC and BBD risk/protective factors were also studied. Co-occurrence analyses were performed using logistic regression models. Results Common risk/protective factors were associated with FA, FCC, and IBC in ways consistent with the literature in general, and they were associated with FAC, FA, and FCC in distinct patterns. Age was associated with FAC in a bell-shape curve so that middle-aged women were more likely to have FAC. We report for the first time that FAC is positively associated with IBC with odds ratio (OR) depending on BMI (OR = 6.78, 95% CI = 3.43-13.42 at BMI<25 kg/m(2); OR = 2.13, 95% CI = 1.20-3.80 at BMI>25 kg/m(2)). This association is only significant with HER2-negative IBC subtypes. Conclusions We conclude that FAC is a candidate risk factor for HER2-negative IBCs, and it is a distinct disease from FA. Co-occurrence analysis can be used for initial assessment of the risk for IBC from a BBD, which is vital to the study of infrequently-reported BBDs.	[Chen, Yaqin; Bekhash, Anthony; Liu, Jianfang; Kvecher, Leonid; Mural, Richard J.; Hu, Hai] Windber Res Inst, Biomed Informat, Windber, PA 15963 USA; [Kovatich, Albert J.; Hooke, Jeffrey A.; Fantacone-Campbell, J. Leigh] Henry M Jackson Fdn Adv Mil Med, Clin Breast Care Project, Rockville, MD USA; [Mitchell, Edith P.; Rui, Hallgeir] Thomas Jefferson Univ, Kimmel Canc Ctr, Philadelphia, PA 19107 USA; [Shriver, Craig D.] Walter Reed Natl Mil Med Ctr, Murtha Canc Ctr, Clin Breast Care Project, Bethesda, MD USA	Windber Research Institute; Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc; Jefferson University; Walter Reed National Military Medical Center	Hu, H (corresponding author), Windber Res Inst, Biomed Informat, Windber, PA 15963 USA.	h.hu@wriwindber.org		Kovatich, Albert/0000-0002-5169-4087; Hu, Hai/0000-0001-5345-8371	United States Department of Defense through the Henry M. Jackson Foundation for the Advancement of Military Medicine [W81XWH-12-2-0050]; Promise Grant from Komen for the Cure [KG091116]	United States Department of Defense through the Henry M. Jackson Foundation for the Advancement of Military Medicine; Promise Grant from Komen for the Cure	This work was supported by grant No. W81XWH-12-2-0050 from the United States Department of Defense through the Henry M. Jackson Foundation for the Advancement of Military Medicine. This work was also partially supported by Promise Grant No. KG091116 from Komen for the Cure. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baquet CR, 2008, J NATL MED ASSOC, V100, P480, DOI 10.1016/S0027-9684(15)31294-3; Bekhash A, 2011, 34 SAN ANT BREAST CA; Ben Hassouna Jamel, 2007, Tunis Med, V85, P891; BERKOWITZ GS, 1985, J NATL CANCER I, V75, P43; BRINTON LA, 1981, AM J EPIDEMIOL, V113, P203, DOI 10.1093/oxfordjournals.aje.a113089; Chen Y, 2012, 35 SAN ANT BREAST CA; Cheraghi Z, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051446; COLE P, 1978, AM J EPIDEMIOL, V108, P112, DOI 10.1093/oxfordjournals.aje.a112594; DUPONT WD, 1985, NEW ENGL J MED, V312, P146, DOI 10.1056/NEJM198501173120303; DUPONT WD, 1994, NEW ENGL J MED, V331, P10, DOI 10.1056/NEJM199407073310103; Fitzgibbons PL, 1998, ARCH PATHOL LAB MED, V122, P1053; Gaudet MM, 2014, CANCER CAUSE CONTROL, V25, P737, DOI 10.1007/s10552-014-0376-4; Goehring C, 1997, EPIDEMIOL REV, V19, P310, DOI 10.1093/oxfordjournals.epirev.a017960; Goldhirsch A, 2011, ANN ONCOL, V22, P1736, DOI 10.1093/annonc/mdr304; GOLINGER RC, 1978, SURG GYNECOL OBSTET, V146, P273; HAAGENSEN C D, 1956, Trans N Engl Obstet Gynecol Soc, V10, P141; HANSON CA, 1987, PATHOLOGY, V19, P393, DOI 10.3109/00313028709103889; Hu H, 2011, J BIOMED INFORM, V44, P1004, DOI 10.1016/j.jbi.2011.08.003; Hutter RVP, 1986, ARCH PATHOL LAB MED, V110, P171; Kamal M, 1998, AM J ROENTGENOL, V171, P1331, DOI 10.2214/ajr.171.5.9798874; KOVI J, 1984, HUM PATHOL, V15, P336, DOI 10.1016/S0046-8177(84)80031-3; LONDON SJ, 1992, JAMA-J AM MED ASSOC, V267, P941, DOI 10.1001/jama.267.7.941; LOVE SM, 1982, NEW ENGL J MED, V307, P1010, DOI 10.1056/NEJM198210143071611; Maskery SM, 2008, J BIOMED INFORM, V41, P242, DOI 10.1016/j.jbi.2007.12.005; Maskery SM, 2006, IEEE T INF TECHNOL B, V10, P497, DOI 10.1109/TITB.2005.863863; ORY H, 1976, NEW ENGL J MED, V294, P419, DOI 10.1056/NEJM197602192940804; PAGE DL, 1978, J NATL CANCER I, V61, P1055; PARAZZINI F, 1984, AM J EPIDEMIOL, V120, P115, DOI 10.1093/oxfordjournals.aje.a113860; PICK PW, 1984, ARCH PATHOL LAB MED, V108, P590; POULTON TB, 1995, AM J ROENTGENOL, V165, P291, DOI 10.2214/ajr.165.2.7618542; Raab SS, 2005, ARCH PATHOL LAB MED, V129, P459; Rosen P. P., 2001, ROSENS BREAST PATHOL; Shabtai M, 2001, ISRAEL MED ASSOC J, V3, P813; STERNS EE, 1992, CAN J SURG, V35, P41; Tan P E, 1991, Malays J Pathol, V13, P101; Worsham MJ, 2007, BREAST J, V13, P115, DOI 10.1111/j.1524-4741.2007.00388.x; Worsham MJ, 2009, BREAST CANCER RES TR, V118, P1, DOI 10.1007/s10549-008-0198-8; YU H, 1992, AM J EPIDEMIOL, V135, P247, DOI 10.1093/oxfordjournals.aje.a116278	38	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2015	10	6							e0129500	10.1371/journal.pone.0129500	http://dx.doi.org/10.1371/journal.pone.0129500			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL3FM	26098961	Green Published, Green Submitted, gold			2022-12-26	WOS:000356835800031
J	Hur, KH; Mueller, JD				Hur, Kwang-Ho; Mueller, Joachim D.			Quantitative Brightness Analysis of Fluorescence Intensity Fluctuations in E. Coli	PLOS ONE			English	Article							PROTEIN INTERACTIONS; CORRELATION SPECTROSCOPY; CUMULANT ANALYSIS; LIVING CELLS; COPY NUMBER; IN-VIVO; EXPRESSION; QUANTIFICATION; MOLECULES; DYNAMICS	The brightness measured by fluorescence fluctuation spectroscopy specifies the average stoichiometry of a labeled protein in a sample. Here we extended brightness analysis, which has been mainly applied in eukaryotic cells, to prokaryotic cells with E. coli serving as a model system. The small size of the E. coli cell introduces unique challenges for applying brightness analysis that are addressed in this work. Photobleaching leads to a depletion of fluorophores and a reduction of the brightness of protein complexes. In addition, the E. coli cell and the point spread function of the instrument only partially overlap, which influences intensity fluctuations. To address these challenges we developed MSQ analysis, which is based on the mean Q-value of segmented photon count data, and combined it with the analysis of axial scans through the E. coli cell. The MSQ method recovers brightness, concentration, and diffusion time of soluble proteins in E. coli. We applied MSQ to measure the brightness of EGFP in E. coli and compared it to solution measurements. We further used MSQ analysis to determine the oligomeric state of nuclear transport factor 2 labeled with EGFP expressed in E. coli cells. The results obtained demonstrate the feasibility of quantifying the stoichiometry of proteins by brightness analysis in a prokaryotic cell.	[Hur, Kwang-Ho; Mueller, Joachim D.] Univ Minnesota, Sch Phys & Astron, Minneapolis, MN 55455 USA; [Mueller, Joachim D.] Univ Minnesota, Dept Biomed Engn, Minneapolis, MN USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Mueller, JD (corresponding author), Univ Minnesota, Sch Phys & Astron, Minneapolis, MN 55455 USA.	mueller@physics.umn.edu		Mueller, Joachim/0000-0002-8822-5313	National Institutes of Health [R01GM064589]; National Science Foundation [PHY-0957728]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM064589] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by National Institutes of Health (http://www.nih.gov/) (R01GM064589) and the National Science Foundation (http://www.nsf.gov/) (PHY-0957728). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cai L, 2006, NATURE, V440, P358, DOI 10.1038/nature04599; Chaillan-Huntington C, 2001, J MOL BIOL, V314, P465, DOI 10.1006/jmbi.2001.5136; Chen Y, 2003, P NATL ACAD SCI USA, V100, P15492, DOI 10.1073/pnas.2533045100; Chen Y, 2002, BIOPHYS J, V82, P133, DOI 10.1016/S0006-3495(02)75380-0; Chen Y, 2007, P NATL ACAD SCI USA, V104, P3147, DOI 10.1073/pnas.0606557104; Cluzel P, 2000, SCIENCE, V287, P1652, DOI 10.1126/science.287.5458.1652; Coffman VC, 2012, TRENDS BIOCHEM SCI, V37, P499, DOI 10.1016/j.tibs.2012.08.002; Digman MA, 2005, BIOPHYS J, V89, P1317, DOI 10.1529/biophysj.105.062836; Digman MA, 2008, BIOPHYS J, V94, P2320, DOI 10.1529/biophysj.107.114645; Elowitz MB, 1999, J BACTERIOL, V181, P197, DOI 10.1128/JB.181.1.197-203.1999; Ferguson ML, 2012, P NATL ACAD SCI USA, V109, P155, DOI 10.1073/pnas.1110541108; Ferguson ML, 2011, ANAL BIOCHEM, V419, P250, DOI 10.1016/j.ab.2011.08.017; Fogarty KH, 2011, BIOPHYS J, V100, P1587, DOI 10.1016/j.bpj.2011.02.008; Gennerich A, 2000, BIOPHYS J, V79, P3294, DOI 10.1016/S0006-3495(00)76561-1; Humpolickova J, 2006, BIOPHYS J, V91, pL23, DOI 10.1529/biophysj.106.089474; Hur KH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097440; Le TT, 2005, P NATL ACAD SCI USA, V102, P9160, DOI 10.1073/pnas.0503311102; Lill Y, 2012, PHYS REV E, V86, DOI 10.1103/PhysRevE.86.021907; Macdonald PJ, 2012, ANAL BIOCHEM, V421, P291, DOI 10.1016/j.ab.2011.10.040; Macdonald PJ, 2010, BIOPHYS J, V99, P979, DOI 10.1016/j.bpj.2010.05.017; Meacci G, 2006, PHYS BIOL, V3, P255, DOI 10.1088/1478-3975/3/4/003; Muller JD, 2004, BIOPHYS J, V86, P3981, DOI 10.1529/biophysj.103.037887; Nayak CR, 2011, BIOPHYS J, V101, P2284, DOI 10.1016/j.bpj.2011.09.032; Patterson GH, 1997, BIOPHYS J, V73, P2782, DOI 10.1016/S0006-3495(97)78307-3; Ries J, 2012, BIOESSAYS, V34, P361, DOI 10.1002/bies.201100111; Ries J, 2009, BIOPHYS J, V96, P1999, DOI 10.1016/j.bpj.2008.12.3888; Rosenfeld N, 2006, BIOPHYS J, V91, P759, DOI 10.1529/biophysj.105.073098; Saffarian S, 2003, BIOPHYS J, V84, P2030, DOI 10.1016/S0006-3495(03)75011-5; Sanchez-Andres A, 2005, BIOPHYS J, V89, P3531, DOI 10.1529/biophysj.105.067082; Skinner JP, 2005, BIOPHYS J, V89, P1288, DOI 10.1529/biophysj.105.060749; Slaughter BD, 2007, P NATL ACAD SCI USA, V104, P20320, DOI 10.1073/pnas.0710336105; Smith EM, 2014, BIOPHYS J, V107, P66, DOI 10.1016/j.bpj.2014.04.055; Smith EM, 2012, EUR BIOPHYS J BIOPHY, V41, P341, DOI 10.1007/s00249-012-0792-x; Teng SW, 2010, BIOPHYS J, V98, P2024, DOI 10.1016/j.bpj.2010.01.031; van Kempen GMP, 2000, CYTOMETRY, V39, P300, DOI 10.1002/(SICI)1097-0320(20000401)39:4<300::AID-CYTO8>3.3.CO;2-F; Wu B, 2005, BIOPHYS J, V89, P2721, DOI 10.1529/biophysj.105.063685	36	10	10	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2015	10	6							e0130063	10.1371/journal.pone.0130063	http://dx.doi.org/10.1371/journal.pone.0130063			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL3FM	26099032	Green Published, gold, Green Submitted			2022-12-26	WOS:000356835800053
J	Menager, J; Gorin, JB; Maurel, C; Drujont, L; Gouard, S; Louvet, C; Cherel, M; Faivre-Chauvet, A; Morgenstern, A; Bruchertseifer, F; Davodeau, F; Gaschet, J; Guilloux, Y				Menager, Jeremie; Gorin, Jean-Baptiste; Maurel, Catherine; Drujont, Lucile; Gouard, Sebastien; Louvet, Cedric; Cherel, Michel; Faivre-Chauvet, Alain; Morgenstern, Alfred; Bruchertseifer, Frank; Davodeau, Francois; Gaschet, Joelle; Guilloux, Yannick			Combining alpha-Radioimmunotherapy and Adoptive T Cell Therapy to Potentiate Tumor Destruction	PLOS ONE			English	Article							MULTIPLE-MYELOMA; MURINE MODEL; CANCER-IMMUNOTHERAPY; IONIZING-RADIATION; RADIOTHERAPY; IRRADIATION; LYMPHOCYTES; COMBINATION; RESPONSES; LYMPHOMAS	Ionizing radiation induces direct and indirect killing of cancer cells and for long has been considered as immunosuppressive. However, this concept has evolved over the past few years with the demonstration that irradiation can increase tumor immunogenicity and can actually favor the implementation of an immune response against tumor cells. Adoptive T-cell transfer (ACT) is also used to treat cancer and several studies have shown that the efficacy of this immunotherapy was enhanced when combined with radiation therapy. alpha-Radioimmunotherapy (alpha-RIT) is a type of internal radiotherapy which is currently under development to treat disseminated tumors. alpha-particles are indeed highly efficient to destroy small cluster of cancer cells with minimal impact on surrounding healthy tissues. We thus hypothesized that, in the setting of alpha-RIT, an immunotherapy like ACT, could benefit from the immune context induced by irradiation. Hence, we decided to further investigate the possibilities to promote an efficient and long-lasting anti-tumor response by combining alpha-RIT and ACT. To perform such study we set up a multiple myeloma murine model which express the tumor antigen CD138 and ovalbumine (OVA). Then we evaluated the therapeutic efficacy in the mice treated with alpha-RIT, using an anti-CD138 antibody coupled to bismuth- 213, followed by an adoptive transfer of OVA-specific CD8(+) T cells (OT-I CD8(+) T cells). We observed a significant tumor growth control and an improved survival in the animals treated with the combined treatment. These results demonstrate the efficacy of combining alpha-RIT and ACT in the MM model we established.	[Menager, Jeremie; Gorin, Jean-Baptiste; Maurel, Catherine; Gouard, Sebastien; Cherel, Michel; Faivre-Chauvet, Alain; Davodeau, Francois; Gaschet, Joelle; Guilloux, Yannick] CRCNA UMR 892 INSERM, Nantes, France; [Menager, Jeremie; Gorin, Jean-Baptiste; Maurel, Catherine; Gouard, Sebastien; Cherel, Michel; Faivre-Chauvet, Alain; Davodeau, Francois; Gaschet, Joelle; Guilloux, Yannick] 6299 CNRS, Nantes, France; [Menager, Jeremie; Gorin, Jean-Baptiste; Maurel, Catherine; Gouard, Sebastien; Cherel, Michel; Faivre-Chauvet, Alain; Davodeau, Francois; Gaschet, Joelle; Guilloux, Yannick] Univ Nantes, Nantes, France; [Drujont, Lucile; Louvet, Cedric] INSERM UMR 1064 ITUN, Nantes, France; [Cherel, Michel] Inst Cancerol Ouest, St Herblain, France; [Faivre-Chauvet, Alain] CHU Nantes, Dept Nucl Med, F-44035 Nantes 01, France; [Morgenstern, Alfred; Bruchertseifer, Frank] European Commiss, Joint Res Ctr, Inst Transuranium Elements, Karlsruhe, Germany	Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); Nantes Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Institut de Cancerologie de l'Ouest (ICO); Nantes Universite; CHU de Nantes; European Commission Joint Research Centre; EC JRC Institute for Transuranium Elements (ITU)	Guilloux, Y (corresponding author), CRCNA UMR 892 INSERM, Nantes, France.	yannick.guilloux@univ-nantes.fr	Chérel, Michel/F-8298-2013; guilloux, yannick/L-4801-2015; François, Davodeau/GLU-4061-2022; Faivre-Chauvet, Alain/L-9923-2015; Davodeau, Francois/M-1888-2015; Gaschet, Joelle/F-6761-2013; Gouard, Sébastien/L-5465-2015	François, Davodeau/0000-0001-8181-0192; Faivre-Chauvet, Alain/0000-0003-3849-0087; Gaschet, Joelle/0000-0003-2154-1255; Gouard, Sébastien/0000-0002-0973-5420; MENAGER, Jeremie/0000-0002-4032-5884	Labex IGO project [ANR-11-LABX-0016-01]; Labex IRON project - "Investissements d'Avenir" French Government program [ANR-11-LABX-0018-01]; La Ligue Contre le Cancer; Pays de la Loire Council "Nucleaire pour la Sante" (NucSan); French Ministry of Research and Higher Education; European Commission	Labex IGO project; Labex IRON project - "Investissements d'Avenir" French Government program(French National Research Agency (ANR)); La Ligue Contre le Cancer(Ligue nationale contre le cancer); Pays de la Loire Council "Nucleaire pour la Sante" (NucSan); French Ministry of Research and Higher Education; European Commission(European CommissionEuropean Commission Joint Research Centre)	This work has been carried out thanks to the support of the Labex IGO project (no ANR-11-LABX-0016-01) and the Labex IRON project (no ANR-11-LABX-0018-01) funded by the "Investissements d'Avenir" French Government program, managed by the French National Research Agency (ANR). This work was also supported by grants from La Ligue Contre le Cancer, and from the Pays de la Loire Council "Nucleaire pour la Sante" (NucSan). J-B. G. and J. M. are supported by grants from the French Ministry of Research and Higher Education. A. M. and F. B. are supported by the European Commission. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alatrash G, 2013, EXPERT OPIN DRUG SAF, V12, P631, DOI 10.1517/14740338.2013.795944; Apetoh L, 2007, NAT MED, V13, P1050, DOI 10.1038/nm1622; Baidoo KE, 2013, CLIN CANCER RES, V19, P530, DOI 10.1158/1078-0432.CCR-12-0298; Begg AC, 2011, NAT REV CANCER, V11, P239, DOI 10.1038/nrc3007; Bernier J, 2004, NAT REV CANCER, V4, P737, DOI 10.1038/nrc1451; Brenner D, 2008, CRIT REV ONCOL HEMAT, V66, P52, DOI 10.1016/j.critrevonc.2008.01.002; Burnette BC, 2011, CANCER RES, V71, P2488, DOI 10.1158/0008-5472.CAN-10-2820; CAMERON RB, 1990, J EXP MED, V171, P249, DOI 10.1084/jem.171.1.249; Chakraborty M, 2003, J IMMUNOL, V170, P6338, DOI 10.4049/jimmunol.170.12.6338; Chakravarty PK, 1999, CANCER RES, V59, P6028; Cherel M, 2006, Q J NUCL MED MOL IM, V50, P322; Cherel M, 2013, J NUCL MED, V54, P1597, DOI 10.2967/jnumed.112.111997; Delaney G, 2005, CANCER-AM CANCER SOC, V104, P1129, DOI 10.1002/cncr.21324; Demaria S, 2004, INT J RADIAT ONCOL, V58, P862, DOI 10.1016/j.ijrobp.2003.09.012; Demaria S, 2012, FRONT ONCOL, V2, DOI 10.3389/fonc.2012.00095; Formenti SC, 2013, JNCI-J NATL CANCER I, V105, P256, DOI 10.1093/jnci/djs629; Ganss R, 2002, CANCER RES, V62, P1462; Garnett CT, 2004, CANCER RES, V64, P7985, DOI 10.1158/0008-5472.CAN-04-1525; Garrett IR, 1997, BONE, V20, P515, DOI 10.1016/S8756-3282(97)00056-2; Gorin JB, 2014, NEOPLASIA, V16, P319, DOI 10.1016/j.neo.2014.04.002; Guilloux Y, 2001, CANCER RES, V61, P1107; Keisari Y, 2014, CANCER IMMUNOL IMMUN, V63, P1, DOI 10.1007/s00262-013-1462-2; Kitson SL, 2013, CURR RADIOPHARM, V6, P57, DOI 10.2174/1874471011306020001; Kowolik CM, 2006, CANCER RES, V66, P10995, DOI 10.1158/0008-5472.CAN-06-0160; Kroemer G, 2013, ANNU REV IMMUNOL, V31, P51, DOI 10.1146/annurev-immunol-032712-100008; Kroemer G, 2012, ONCOIMMUNOLOGY, V1, DOI 10.4161/onci.20074; Mothersill C, 2004, NAT REV CANCER, V4, P158, DOI 10.1038/nrc1277; Mulford DA, 2005, J NUCL MED, V46, p199S; Navarro-Teulon I, 2013, IMMUNOTHERAPY-UK, V5, P467, DOI [10.2217/IMT.13.34, 10.2217/imt.13.34]; Newcomb EW, 2006, CLIN CANCER RES, V12, P4730, DOI 10.1158/1078-0432.CCR-06-0593; Onishi M, 1996, EXP HEMATOL, V24, P324; Prise KM, 2009, NAT REV CANCER, V9, P351, DOI 10.1038/nrc2603; RADL J, 1988, AM J PATHOL, V132, P593; Rosenberg SA, 2008, NAT REV CANCER, V8, P299, DOI 10.1038/nrc2355; Rosenberg SA, 2011, CLIN CANCER RES, V17, P4550, DOI 10.1158/1078-0432.CCR-11-0116; Singh H, 2007, CANCER RES, V67, P2872, DOI 10.1158/0008-5472.CAN-06-2283; Stroncek DF, 2013, J IMMUNOTHER CANCER, V1, DOI 10.1186/2051-1426-1-4; Supiot S, 2007, CANCER RADIOTHER, V11, P252, DOI 10.1016/j.canrad.2007.05.001; Supiot S, 2005, CLIN CANCER RES, V11, p7047S, DOI 10.1158/1078-0432.CCR-1004-0021; Tomblyn M, 2012, CANCER CONTROL, V19, P196, DOI 10.1177/107327481201900304; Tomblyn MB, 2013, CANCER CONTROL, V20, P60, DOI 10.1177/107327481302000109; Vacchelli E, 2013, ONCOIMMUNOLOGY, V2, DOI 10.4161/onci.25595; Walter RB, 2010, CANCER BIOTHER RADIO, V25, P125, DOI 10.1089/cbr.2010.0759; Wulbrand C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064730	44	23	24	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2015	10	6							e0130249	10.1371/journal.pone.0130249	http://dx.doi.org/10.1371/journal.pone.0130249			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL3FM	26098691	Green Submitted, Green Published, gold			2022-12-26	WOS:000356835800059
J	Niu, HX; Peng, JX; Bai, CX; Liu, X; Hu, LN; Luo, YP; Wang, BX; Zhang, Y; Chen, JZ; Yu, HJ; Xian, QY; Zhu, BD				Niu, Hongxia; Peng, Jinxiu; Bai, Chunxiang; Liu, Xun; Hu, Lina; Luo, Yanping; Wang, Bingxiang; Zhang, Ying; Chen, Jianzhu; Yu, Hongjuan; Xian, Qiaoyang; Zhu, Bingdong			Multi-Stage Tuberculosis Subunit Vaccine Candidate LT69 Provides High Protection against Mycobacterium tuberculosis Infection in Mice	PLOS ONE			English	Article							T-CELL DIFFERENTIATION; EFFICIENT PROTECTION; MEMORY; BCG; IMMUNITY	Effective tuberculosis (TB) vaccine should target tubercle bacilli with various metabolic states and confer long-term protective immunity. In this study, we constructed a novel multistage TB subunit vaccine based on fusion protein ESAT6-Ag85B-MPT64(190-198)-Mtb8.4-HspX (LT69 for short) which combined early expressed antigens and latency-associated antigen. The fusion protein was mixed with an adjuvant being composed of N, N'-dimethyl-N, N'-dioctadecylammonium bromide (DDA) and polyriboinosinic polyribocytidylic acid (PolyI:C) to construct subunit vaccine, whose immunogenicity and protective ability were evaluated in C57BL/6 mice. The results showed that LT69 had strong immunogenicity and high protective effect against Mycobacterium tuberculosis (M. tuberculosis) H37Rv aerosol challenge. Low-dose (2 mu g) of LT69 generated long-term immune memory responses and provided effective protection, which was even higher than traditional vaccine BCG did at 30 weeks post the last vaccination. In conclusion, multistage subunit vaccine LT69 showed high and long-term protection against M. tuberculosis infection in mice, whose effect could be enhanced by using a relative low dosage of antigen.	[Niu, Hongxia; Peng, Jinxiu; Bai, Chunxiang; Liu, Xun; Luo, Yanping; Yu, Hongjuan; Zhu, Bingdong] Lanzhou Univ, Sch Basic Med Sci, Gansu Prov Key Lab Evidence Based Med & Clin Tran, Lanzhou 730000, Peoples R China; [Niu, Hongxia; Peng, Jinxiu; Bai, Chunxiang; Liu, Xun; Luo, Yanping; Yu, Hongjuan; Zhu, Bingdong] Lanzhou Univ, Sch Basic Med Sci, Lanzhou Ctr TB Res, Lanzhou 730000, Peoples R China; [Niu, Hongxia; Peng, Jinxiu; Bai, Chunxiang; Liu, Xun; Zhu, Bingdong] Lanzhou Univ, Sch Basic Med Sci, Inst Pathogen Biol, Lanzhou 730000, Peoples R China; [Hu, Lina; Wang, Bingxiang] Lanzhou Inst Biol Prod, Lanzhou, Peoples R China; [Zhang, Ying] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Mol Microbiol & Immunol, Baltimore, MD USA; [Chen, Jianzhu] MIT, Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA; [Chen, Jianzhu] MIT, Dept Biol, Cambridge, MA 02139 USA; [Xian, Qiaoyang] Wuhan Univ, ABSL Lab 3, Wuhan 430072, Peoples R China	Lanzhou University; Lanzhou University; Lanzhou University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Wuhan University	Zhu, BD (corresponding author), Lanzhou Univ, Sch Basic Med Sci, Gansu Prov Key Lab Evidence Based Med & Clin Tran, Lanzhou 730000, Peoples R China.	bdzhu@lzu.edu.cn			National Major Science and Technology Projects [2012ZX10003-008-006]; National Natural Science Foundation of China [31470895, 81072499]; Doctoral Fund from Ministry of Education of China [20120211110038]	National Major Science and Technology Projects; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Doctoral Fund from Ministry of Education of China	This work was supported by the National Major Science and Technology Projects [2012ZX10003-008-006; http://www.nmp.gov.cn]; the National Natural Science Foundation of China [31470895; 81072499; http://www.nsfc.gov.cn] and Doctoral Fund from Ministry of Education of China [20120211110038; http://www.cutech.edu.cn/cn/index.htm]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aagaard C, 2011, NAT MED, V17, P189, DOI 10.1038/nm.2285; Andersen P, 2005, NAT REV MICROBIOL, V3, P656, DOI 10.1038/nrmicro1211; Badovinac VP, 2002, NAT IMMUNOL, V3, P619, DOI 10.1038/ni804; Billeskov R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072185; Billeskov R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039909; BRETSCHER PA, 1994, IMMUNOBIOLOGY, V191, P548, DOI 10.1016/S0171-2985(11)80461-4; Castiglioni P, 2004, VACCINE, V23, P699, DOI 10.1016/j.vaccine.2004.06.028; Cooper AM, 2009, ANNU REV IMMUNOL, V27, P393, DOI 10.1146/annurev.immunol.021908.132703; Dietrich J, 2005, J IMMUNOL, V174, P6332, DOI 10.4049/jimmunol.174.10.6332; Doherty TM, 2007, EXPERT OPIN BIOL TH, V7, P1539, DOI 10.1517/14712598.7.10.1539; Eurosurveillance editorial team, 2013, EURO SURVEILL, V18, P20615; Hel Z, 2000, NAT MED, V6, P1140, DOI 10.1038/80481; Kaech SM, 2001, NAT IMMUNOL, V2, P415, DOI 10.1038/87720; Kaech SM, 2002, NAT REV IMMUNOL, V2, P251, DOI 10.1038/nri778; Kaufmann SHE, 2005, TRENDS IMMUNOL, V26, P660, DOI 10.1016/j.it.2005.09.012; Kaveh DA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021566; Knudsen NPH, 2014, P NATL ACAD SCI USA, V111, P1096, DOI 10.1073/pnas.1314973111; McShane H, 2005, TUBERCULOSIS, V85, P47, DOI 10.1016/j.tube.2004.09.015; Mercado R, 2000, J IMMUNOL, V165, P6833, DOI 10.4049/jimmunol.165.12.6833; Niu HX, 2011, VACCINE, V29, P9451, DOI 10.1016/j.vaccine.2011.10.032; Pope C, 2001, J IMMUNOL, V166, P3402, DOI 10.4049/jimmunol.166.5.3402; Sallusto F, 2010, IMMUNITY, V33, P451, DOI 10.1016/j.immuni.2010.10.008; Shen CH, 2010, P NATL ACAD SCI USA, V107, P22587, DOI 10.1073/pnas.1016350108; Simpson S, 2001, SCIENCE, V293, P233, DOI 10.1126/science.293.5528.233; Sterne JAC, 1998, INT J TUBERC LUNG D, V2, P200; Vogelzang A, 2014, J INFECT DIS, V210, P1928, DOI 10.1093/infdis/jiu347; Xin Q, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072745; Zaph C, 2004, NAT MED, V10, P1104, DOI 10.1038/nm1108; Zhang Y, 2007, CLIN PHARMACOL THER, V82, P595, DOI 10.1038/sj.clpt.6100362	29	15	20	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2015	10	6							e0130641	10.1371/journal.pone.0130641	http://dx.doi.org/10.1371/journal.pone.0130641			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL3FM	26098302	gold, Green Published, Green Submitted			2022-12-26	WOS:000356835800088
J	Arribas, R; Diaz-Paniagua, C; Caut, S; Gomez-Mestre, I				Arribas, Rosa; Diaz-Paniagua, Carmen; Caut, Stephane; Gomez-Mestre, Ivan			Stable Isotopes Reveal Trophic Partitioning and Trophic Plasticity of a Larval Amphibian Guild	PLOS ONE			English	Article							FALSE DISCOVERY RATE; INVASIVE CRAYFISH; PROCAMBARUS-CLARKII; NICHE WIDTH; FOOD WEBS; COMMUNITY; PREDATOR; COMPETITION; CONSUMERS; IMPACT	Temporary ponds are highly variable systems where resource availability and community structure change extensively over time, and consequently the food web is highly dynamic. Amphibians play a critical role both as consumers and prey in aquatic communities and yet there is still little information on the trophic status of most amphibians. More importantly, little is known about the extent to which they can alter their trophic ecology in response to changing conditions. We experimentally investigated the effects of increased amphibian density, presence of intraguild competitors, and presence of native and invasive predators (either free or caged) on the trophic status of a Mediterranean amphibian guild, using stable isotopes. We observed variations in delta C-13 and delta N-15 isotopic values among amphibian species and treatments and differences in their food sources. Macrophytes were the most important food resource for spadefoot toad tadpoles (Pelobates cultripes) and relatively important for all anurans within the guild. High density and presence of P. cultripes tadpoles markedly reduced macrophyte biomass, forcing tadpoles to increase their feeding on detritus, algae and zooplankton, resulting in lower delta C-13 values. Native dytiscid predators only changed the isotopic signature of newts whereas invasive red swamp crayfish had an enormous impact on environmental conditions and greatly affected the isotopic values of amphibians. Crayfish forced tadpoles to increase detritus ingestion or other resources depleted in delta C-13. We found that the opportunistic amphibian feeding was greatly conditioned by intra-and interspecific competition whereas non-consumptive predator effects were negligible. Determining the trophic plasticity of amphibians can help us understand natural and anthropogenic changes in aquatic ecosystems and assess amphibians' ability to adjust to different environmental conditions.	[Arribas, Rosa; Diaz-Paniagua, Carmen; Gomez-Mestre, Ivan] CSIC, Donana Biol Stn, Dept Wetland Ecol, Ecol Evolut & Dev Grp, E-41080 Seville, Spain; [Caut, Stephane] CSIC, Dept Ethol & Conservat Biodivers, Donana Biol Stn, E-41080 Seville, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD)	Gomez-Mestre, I (corresponding author), CSIC, Donana Biol Stn, Dept Wetland Ecol, Ecol Evolut & Dev Grp, E-41080 Seville, Spain.	igmestre@ebd.csic.es	Gomez-Mestre, Ivan/F-8226-2014; Díaz-Paniagua, Carmen/L-8931-2014	Gomez-Mestre, Ivan/0000-0003-0094-8195; Díaz-Paniagua, Carmen/0000-0002-6717-0173; Arribas Ramos, Rosa/0000-0002-2417-6049	Plan Nacional I+D from Ministerio de Ciencia e Innovacion [CGL2009-11123, CGL2012-4044]; Spanish Severo Ochoa Program [SEV-2012-0262]; Spanish Ministry of Economy and Competitivity [BES2010-042243]	Plan Nacional I+D from Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)); Spanish Severo Ochoa Program(Spanish Government); Spanish Ministry of Economy and Competitivity(Spanish Government)	Funding for this study was provided by grants CGL2009-11123 and CGL2012-4044 from Plan Nacional I+D from Ministerio de Ciencia e Innovacion, from the Spanish Severo Ochoa Program (SEV-2012-0262), and dissertation grant BES2010-042243 awarded to RA by the Spanish Ministry of Economy and Competitivity.	Ackermann M, 2004, EVOLUTION, V58, P2599; Altig R, 2007, FRESHWATER BIOL, V52, P386, DOI 10.1111/j.1365-2427.2006.01694.x; Anastacio PM, 2005, FRESHWATER BIOL, V50, P697, DOI 10.1111/j.1365-2427.2005.01343.x; ANHOLT BR, 1995, ECOLOGY, V76, P2230, DOI 10.2307/1941696; Arribas R, 2014, FRESHWATER BIOL, V59, P1996, DOI 10.1111/fwb.12402; Beaudoin CP, 2001, FRESHWATER BIOL, V46, P465, DOI 10.1046/j.1365-2427.2001.00688.x; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bolnick DI, 2010, P ROY SOC B-BIOL SCI, V277, P1789, DOI 10.1098/rspb.2010.0018; BOON PI, 1994, AQUAT BOT, V48, P99, DOI 10.1016/0304-3770(94)90077-9; Caut S, 2013, OECOLOGIA, V173, P95, DOI 10.1007/s00442-012-2428-3; Caut S, 2009, J APPL ECOL, V46, P443, DOI 10.1111/j.1365-2664.2009.01620.x; Chouinard A, 1998, J FISH BIOL, V53, P1231, DOI 10.1111/j.1095-8649.1998.tb00244.x; Costa ZJ, 2013, OECOLOGIA, V173, P1481, DOI 10.1007/s00442-013-2702-z; Cruz MJ, 2005, AMPHIBIA-REPTILIA, V26, P293, DOI 10.1163/156853805774408577; DIAZ-PANIAGUA C, 1988, Amphibia-Reptilia, V9, P15, DOI 10.1163/156853888X00161; DIAZ-PANIAGUA C, 1985, Amphibia-Reptilia, V6, P307, DOI 10.1163/156853885X00317; Diaz-Paniagua C, 2005, SERIE TECNICA ORGANI, P181; Diaz-Panigua C., 1987, REV ESP HERPETOL, V2, P189; DIAZPANIAGUA C, 1990, HERPETOL J, V1, P447; Ficetola Gentile Francesco, 2011, Pianura, V27, P124; Frederich B, 2010, COPEIA, P218, DOI 10.1643/CE-09-031; Garcia LV, 2003, TRENDS ECOL EVOL, V18, P553, DOI 10.1016/j.tree.2003.08.011; Geiger W, 2005, BIOL INVASIONS, V7, P49, DOI 10.1007/s10530-004-9635-8; Gherardi F, 2007, FRESHWATER BIOL, V52, P1249, DOI 10.1111/j.1365-2427.2007.01760.x; Gillespie JH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053041; Gomez-Mestre I, 2011, P ROY SOC B-BIOL SCI, V278, P3364, DOI 10.1098/rspb.2010.2762; Gosner K. L., 1960, Herpetologica, V16, P183; Harris D, 2001, SOIL SCI SOC AM J, V65, P1853, DOI 10.2136/sssaj2001.1853; Hoff KV, 1999, TADPOLES, P215; Karlsson J, 2004, FRESHWATER BIOL, V49, P526, DOI 10.1111/j.1365-2427.2004.01208.x; Layman CA, 2007, ECOL LETT, V10, P937, DOI 10.1111/j.1461-0248.2007.01087.x; Newsome SD, 2007, FRONT ECOL ENVIRON, V5, P429, DOI 10.1890/060150.1; Nunes AL, 2013, OECOLOGIA, V171, P115, DOI 10.1007/s00442-012-2389-6; PAINE RT, 1980, J ANIM ECOL, V49, P667; Parnell AC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009672; Peacor SD, 1997, ECOLOGY, V78, P1146, DOI 10.1890/0012-9658(1997)078[1146:TMIIIA]2.0.CO;2; Peacor SD, 2000, ECOLOGY, V81, P1998, DOI 10.2307/177288; Pfennig DW, 2006, ECOLOGY, V87, P769, DOI 10.1890/05-0787; Polis G. A., 1995, FOOD WEBS INTEGRATIO, P435; POLIS GA, 1994, AUST J ECOL, V19, P121; Polo-Cavia N, 2010, ANIM BEHAV, V80, P461, DOI 10.1016/j.anbehav.2010.06.004; Post DM, 2002, ECOLOGY, V83, P703, DOI 10.2307/3071875; R Core Team, 2021, R LANGUAGE ENV STAT; Relyea RA, 2005, ECOLOGY, V86, P1723, DOI 10.1890/04-1920; Relyea RA, 2000, ECOLOGY, V81, P2278, DOI 10.1890/0012-9658(2000)081[2278:TMIEIL]2.0.CO;2; Richardson JML, 2001, BEHAV ECOL, V12, P51, DOI 10.1093/oxfordjournals.beheco.a000378; Richter-Boix A, 2013, BIOL INVASIONS, V15, P799, DOI 10.1007/s10530-012-0328-4; Schabenberger O., 2007, GROWING FAST SAS 9 2, P1; Schiesari L, 2009, FRESHWATER BIOL, V54, P572, DOI 10.1111/j.1365-2427.2008.02134.x; Schindler DE, 1997, OECOLOGIA, V110, P592, DOI 10.1007/s004420050200; Schriever TA, 2013, FRESHWATER BIOL, V58, P223, DOI 10.1111/fwb.12044; Tomanova S, 2006, HYDROBIOLOGIA, V556, P251, DOI 10.1007/s10750-005-1255-5; Trakimas G, 2011, HYDROBIOLOGIA, V675, P87, DOI 10.1007/s10750-011-0804-3; Turner TF, 2012, FRESHW SCI, V31, P825, DOI 10.1899/11-063.1; Vander Zanden MJ, 1999, ECOLOGY, V80, P1395; Vander Zanden MJ, 1999, AM NAT, V154, P406, DOI 10.1086/303250; Verhoeven KJF, 2005, OIKOS, V108, P643, DOI 10.1111/j.0030-1299.2005.13727.x; Wallace JB, 1996, ANNU REV ENTOMOL, V41, P115, DOI 10.1146/annurev.en.41.010196.000555; WASSERSUG R, 1980, University of Kansas Museum of Natural History Miscellaneous Publication, P1; Wells K.D., 2007, ECOLOGY BEHAV AMPHIB, DOI 10.7208/chicago/9780226893334.001.0001; Whiles MR, 2006, FRONT ECOL ENVIRON, V4, P27, DOI 10.1890/1540-9295(2006)004[0027:TEOAPD]2.0.CO;2	61	28	28	0	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2015	10	6							e0130897	10.1371/journal.pone.0130897	http://dx.doi.org/10.1371/journal.pone.0130897			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL3FE	26091281	Green Published, Green Submitted, gold			2022-12-26	WOS:000356835000157
J	Patel, DE; Cumberland, PM; Walters, BC; Russell-Eggitt, I; Rahi, JS				Patel, Dipesh E.; Cumberland, Phillippa M.; Walters, Bronwen C.; Russell-Eggitt, Isabelle; Rahi, Jugnoo S.		OPTIC Study Grp	Study of Optimal Perimetric Testing in Children (OPTIC): Feasibility, Reliability and Repeatability of Perimetry in Children	PLOS ONE			English	Article							VISUAL-FIELD EXAMINATION; AUTOMATED STATIC PERIMETRY; AGED 5-8 YEARS; 10-YEAR-OLD CHILDREN; THRESHOLD STRATEGY; KINETIC PERIMETRY; NORMATIVE VALUES; SENSITIVITY; 4-YEAR-OLD; MANIFEST	Purpose To investigate feasibility, reliability and repeatability of perimetry in children. Methods A prospective, observational study recruiting 154 children aged 5-15 years, without an ophthalmic condition that affects the visual field (controls), identified consecutively between May 2012 and November 2013 from hospital eye clinics. Perimetry was undertaken in a single sitting, with standardised protocols, in a randomised order using the Humphrey static (SITA 24-2 FAST), Goldmann and Octopus kinetic perimeters. Data collected included test duration, subjective experience and test quality (incorporating examiner ratings on comprehension of instructions, fatigue, response to visual and auditory stimuli, concentration and co-operation) to assess feasibility and reliability. Testing was repeated within 6 months to assess repeatability. Results Overall feasibility was very high (Goldmann= 96.1%, Octopus= 89% and Humphrey= 100% completed the tests). Examiner rated reliability was 'good' in 125 (81.2%) children for Goldmann, 100 (64.9%) for Octopus and 98 (63.6%) for Humphrey perimetry. Goldmann perimetry was the most reliable method in children under 9 years of age. Reliability improved with increasing age (multinomial logistic regression (Goldmann, Octopus and Humphrey), p<0.001). No significant differences were found for any of the three test strategies when examining initial and follow-up data outputs (Bland-Altman plots, n= 43), suggesting good test repeatability, although the sample size may preclude detection of a small learning effect. Conclusions Feasibility and reliability of formal perimetry in children improves with age. By the age of 9 years, all the strategies used here were highly feasible and reliable. Clinical assessment of the visual field is achievable in children as young as 5 years, and should be considered where visual field loss is suspected. Since Goldmann perimetry is the most effective strategy in children aged 5-8 years and this perimeter is no longer available, further research is required on a suitable alternative for this age group.	[Patel, Dipesh E.; Cumberland, Phillippa M.; Rahi, Jugnoo S.] UCL Inst Child Hlth, Life Course Epidemiol & Biostat Sect, London, England; [Patel, Dipesh E.; Cumberland, Phillippa M.; Walters, Bronwen C.; Russell-Eggitt, Isabelle; Rahi, Jugnoo S.] Ulverscroft Vis Res Grp, London, England; [Patel, Dipesh E.; Rahi, Jugnoo S.] Moorfields Eye Hosp NHS Fdn Trust, London, England; [Patel, Dipesh E.; Walters, Bronwen C.; Rahi, Jugnoo S.] Great Ormond St Hosp Children NHS Fdn Trust, London, England; [Rahi, Jugnoo S.] UCL, Inst Ophthalmol, London, England	University of London; University College London; University of London; University College London; Moorfields Eye Hospital NHS Foundation Trust; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; University of London; University College London	Rahi, JS (corresponding author), UCL Inst Child Hlth, Life Course Epidemiol & Biostat Sect, London, England.	j.rahi@ucl.ac.uk	Borja, Mario Cortina/A-3847-2009; Liasis, Alki/AAV-5869-2020	Borja, Mario Cortina/0000-0003-0627-2624; Liasis, Alki/0000-0003-3223-5202; Garway-Heath, David/0000-0003-2907-6992; Rahi, Jugnoo/0000-0002-5718-9209; Patel, Dipesh/0000-0001-9100-1399; Khaw, Sir Peng Tee/0000-0002-8087-2268	Guide Dogs for the Blind Association [OR2009-04e]; Department of Health's NIHR Biomedical Research Centres; Ulverscroft Foundation; NIHR Biomedical Research Centre at Moorfields Eye Hospital NHS Foundation Trust; UCL Institute of Ophthalmology; MRC [G0400546] Funding Source: UKRI; Medical Research Council [G0400546B, G0400546] Funding Source: researchfish; National Institute for Health Research [NF-SI-0514-10170, NF-SI-0512-10101] Funding Source: researchfish; Fight for Sight [1495/96] Funding Source: researchfish	Guide Dogs for the Blind Association; Department of Health's NIHR Biomedical Research Centres(National Institute for Health Research (NIHR)); Ulverscroft Foundation; NIHR Biomedical Research Centre at Moorfields Eye Hospital NHS Foundation Trust; UCL Institute of Ophthalmology; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); Fight for Sight	This research was supported by The Guide Dogs for the Blind Association (Grant: OR2009-04e, http://www.guidedogs.org.uk/). This work was undertaken at UCL Institute of Child Health/Great Ormond Street Hospital and Moorfields Eye Hospital/UCL Institute of Ophthalmology, both of which receive a proportion of funding from the Department of Health's NIHR Biomedical Research Centres funding scheme. Phillippa Cumberland is supported by the Ulverscroft Foundation and Jugnoo Rahi receives a proportion of her funding from the NIHR Biomedical Research Centre at Moorfields Eye Hospital NHS Foundation Trust and UCL Institute of Ophthalmology. The funders and sponsors had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. An Octopus perimeter was loaned to Great Ormond Street Hospital by Haag-Streit (AG, Switzerland) for use in this study.	Akar Y, 2008, OPHTHALMOLOGICA, V222, P329, DOI 10.1159/000144101; Aslam TM, 2011, BRIT J OPHTHALMOL, V95, P921, DOI 10.1136/bjo.2010.198135; Bengtsson B, 2000, ACTA OPHTHALMOL SCAN, V78, P519, DOI 10.1034/j.1600-0420.2000.078005519.x; Bengtsson B, 1998, ACTA OPHTHALMOL SCAN, V76, P268, DOI 10.1034/j.1600-0420.1998.760303.x; Bjerre A, 2014, NEURO-OPHTHALMOLOGY, V38, P189, DOI 10.3109/01658107.2014.902971; Donahue SP, 2001, J AAPOS, V5, P114, DOI 10.1067/mpa.2001.113840; Garway-Heath DF, 2006, OPHTHALMOLOGY, V113, P1479, DOI 10.1016/j.ophtha.2006.05.052; Harbert MJ, 2012, J NEURO-ONCOL, V107, P545, DOI 10.1007/s11060-011-0774-3; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Henson D, 2000, VISUAL FIELDS; Koenraads Y, 2015, JAMA OPHTHALMOL, V133, P319, DOI 10.1001/jamaophthalmol.2014.5257; MARRAFFA M, 1995, DOC OPHTHALMOL, V89, P383, DOI 10.1007/BF01203713; Martin L, 2005, ACTA OPHTHALMOL SCAN, V83, P670, DOI 10.1111/j.1600-0420.2005.00569.x; MAYER DL, 1988, INVEST OPHTH VIS SCI, V29, P452; Morales J, 2001, OPHTHALMOLOGY, V108, P157, DOI 10.1016/S0161-6420(00)00415-2; Murray IC, 2009, OPHTHALMOLOGY, V116, P2017, DOI 10.1016/j.ophtha.2009.03.015; MUTLUKAN E, 1993, EYE, V7, P554, DOI 10.1038/eye.1993.121; Myers VS, 1999, ARCH OPHTHALMOL-CHIC, V117, P94; Patel DE, 2015, OPHTHALMOLO IN PRESS; Patel DE, KINETICF FRAMEWORK A; QUINN GE, 1991, J PEDIATR OPHTHALMOL, V28, P314; Saunders LJ, 2015, JAMA OPHTHALMOL, V133, P74, DOI 10.1001/jamaophthalmol.2014.4237; Tschopp C, 1998, VISION RES, V38, P2211, DOI 10.1016/S0042-6989(97)00369-6; Tschopp C, 1998, VISION RES, V38, P2203, DOI 10.1016/S0042-6989(97)00368-4; Tschopp C, 1999, VISION RES, V39, P1107, DOI 10.1016/S0042-6989(98)00180-1; Wabbels BK, 2005, ACTA OPHTHALMOL SCAN, V83, P664, DOI 10.1111/j.1600-0420.2005.00526.x; Walters BC, 2012, OPHTHAL EPIDEMIOL, V19, P358, DOI 10.3109/09286586.2012.718027; Werner E.B., 1991, MANUAL VISUAL FIELDS; Wilscher S, 2010, GRAEF ARCH CLIN EXP, V248, P1493, DOI 10.1007/s00417-010-1342-9; WILSON M, 1991, J PEDIATR OPHTHALMOL, V28, P151	30	35	35	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2015	10	6							e0130895	10.1371/journal.pone.0130895	http://dx.doi.org/10.1371/journal.pone.0130895			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL3FE	26091102	Green Published, Green Submitted, gold			2022-12-26	WOS:000356835000156
J	Ruiz, N; de Abreu, LA; Parizi, LF; Kim, TK; Mulenga, A; Braz, GRC; Vaz, ID; Logullo, C				Ruiz, Newton; de Abreu, Leonardo Araujo; Parizi, Luis Fernando; Kim, Tae Kwon; Mulenga, Albert; Cardoso Braz, Gloria Regina; Vaz, Itabajara da Silva, Jr.; Logullo, Carlos			Non-Invasive Delivery of dsRNA into De-Waxed Tick Eggs by Electroporation	PLOS ONE			English	Article							DOUBLE-STRANDED-RNA; GLUCOSE-METABOLISM; GENE-TRANSFER; INTERFERENCE; EXPRESSION; EMBRYOGENESIS; TRANSFECTION; TOOL	RNA interference-mediated gene silencing was shown to be an efficient tool for validation of targets that may become anti-tick vaccine components. Here, we demonstrate the application of this approach in the validation of components of molecular signaling cascades, such as the Protein Kinase B (AKT) / Glycogen Synthase Kinase (GSK) axis during tick embryogenesis. It was shown that heptane and hypochlorite treatment of tick eggs can remove wax, affecting corium integrity and but not embryo development. Evidence of AKT and GSK dsRNA delivery into de-waxed eggs of via electroporation is provided. Primers designed to amplify part of the dsRNA delivered into the electroporated eggs dsRNA confirmed its entry in eggs. In addition, it was shown that electroporation is able to deliver the fluorescent stain, 4', 6-diamidino-2-phenylindole (DAPI). To confirm gene silencing, a second set of primers was designed outside the dsRNA sequence of target gene. In this assay, the suppression of AKT and GSK transcripts (approximately 50% reduction in both genes) was demonstrated in 7-day-old eggs. Interestingly, silencing of GSK in 7-day-old eggs caused 25% reduction in hatching. Additionally, the effect of silencing AKT and GSK on embryo energy metabolism was evaluated. As expected, knockdown of AKT, which down regulates GSK, the suppressor of glycogen synthesis, decreased glycogen content in electroporated eggs. These data demonstrate that electroporation of de-waxed R. microplus eggs could be used for gene silencing in tick embryos, and improve the knowledge about arthropod embryogenesis.	[Ruiz, Newton; Logullo, Carlos] Univ Estadual Norte Fluminense, Unidade Expt Anim, Campos Dos Goytacazes, RJ, Brazil; [Ruiz, Newton; Logullo, Carlos] Univ Estadual Norte Fluminense, Lab Quim & Funcao Proteinas, Campos Dos Goytacazes, RJ, Brazil; [de Abreu, Leonardo Araujo] NUPEM UFRJ, Nucl Ecol Desenvolvimento Socio Ambiental Macae, Lab Integrado Bioquim Hatisaburo Masuda, Macae, RJ, Brazil; [Parizi, Luis Fernando; Vaz, Itabajara da Silva, Jr.] Univ Fed Rio Grande do Sul, Ctr Biotecnol, Porto Alegre, RS, Brazil; [Kim, Tae Kwon; Mulenga, Albert] Texas A&M Univ, Coll Vet Med, Dept Vet Pathobiol, College Stn, TX 77843 USA; [Cardoso Braz, Gloria Regina] Univ Fed Rio de Janeiro, Inst Quim, Dept Bioquim, Illha Fundao, RJ, Brazil; [de Abreu, Leonardo Araujo; Cardoso Braz, Gloria Regina; Vaz, Itabajara da Silva, Jr.; Logullo, Carlos] INCT EM, Rio De Janeiro, RJ, Brazil	Universidade Estadual do Norte Fluminense; Universidade Estadual do Norte Fluminense; Universidade Federal do Rio Grande do Sul; Texas A&M University System; Texas A&M University College Station; Universidade Federal do Rio de Janeiro	Logullo, C (corresponding author), Univ Estadual Norte Fluminense, Unidade Expt Anim, Campos Dos Goytacazes, RJ, Brazil.	carloslogullo@yahoo.com.br	Mulenga, Albert/Q-5556-2019; Silva Vaz Jr., Itabajara/A-5943-2009; Parizi, Luis/AAQ-4137-2021	Silva Vaz Jr., Itabajara/0000-0003-0309-9328; Ruiz, Newton/0000-0003-3255-9952; ARAUJO DE ABREU, LEONARDO/0000-0003-0659-8931	Conselho Nacional de Desenvolvimento Cientifico (CNPq, INCT de Entomologia Molecular); Fundacao de Coordenacao de Aperfeicoamento do Pessoal de Nivel Superior (CAPES); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)	Conselho Nacional de Desenvolvimento Cientifico (CNPq, INCT de Entomologia Molecular)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)Fundacao de Apoio a Pesquisa do Distrito Federal (FAPDF)); Fundacao de Coordenacao de Aperfeicoamento do Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ))	This work was supported by grants from Conselho Nacional de Desenvolvimento Cientifico (CNPq, INCT de Entomologia Molecular), Fundacao de Coordenacao de Aperfeicoamento do Pessoal de Nivel Superior (CAPES)and Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ). The funders had no role in study design, data colletion and analysis, decision to publish, or preparation of the manuscript.	Ando T, 2013, DEVELOPMENT, V140, P454, DOI 10.1242/dev.085241; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Buttrick GJ, 2008, J CELL BIOL, V180, P537, DOI 10.1083/jcb.200705085; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; de Abreu LA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098966; de Abreu LA, 2013, BBA-GEN SUBJECTS, V1830, P2574, DOI 10.1016/j.bbagen.2012.12.016; de Abreu LA, 2009, COMP BIOCHEM PHYS B, V153, P185, DOI 10.1016/j.cbpb.2009.02.016; de la Fuente J, 2007, TRENDS PARASITOL, V23, P427, DOI 10.1016/j.pt.2007.07.002; Fabres A, 2010, PARASITOLOGY, V137, P1537, DOI 10.1017/S0031182010000284; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Fraga A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065125; Ghartey-Tagoe EB, 2006, INT J PHARMACEUT, V315, P122, DOI 10.1016/j.ijpharm.2006.02.022; Grisi L, 2014, REV BRAS PARASITOL V, V23, P150, DOI 10.1590/S1984-29612014042; Hamatani T, 2004, HUM MOL GENET, V13, P2263, DOI 10.1093/hmg/ddh241; Henschel A, 2004, NUCLEIC ACIDS RES, V32, pW113, DOI 10.1093/nar/gkh408; Karim S, 2010, BMC BIOTECHNOL, V10, DOI 10.1186/1472-6750-10-1; Kocan KM, 2011, JOVE-J VIS EXP, DOI 10.3791/2474; Leber SM, 1996, METHOD CELL BIOL, V51, P161, DOI 10.1016/S0091-679X(08)60628-7; Logullo C, 2009, VET PARASITOL, V161, P261, DOI 10.1016/j.vetpar.2009.01.029; MILLER JF, 1988, P NATL ACAD SCI USA, V85, P856, DOI 10.1073/pnas.85.3.856; Moraes J, 2007, COMP BIOCHEM PHYS A, V146, P528, DOI 10.1016/j.cbpa.2006.05.009; Naito Y, 2005, NUCLEIC ACIDS RES, V33, pW589, DOI 10.1093/nar/gki419; NEUMANN E, 1982, EMBO J, V1, P841, DOI 10.1002/j.1460-2075.1982.tb01257.x; Nijhof AM, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-112; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Saleh MC, 2006, NAT CELL BIOL, V8, P793, DOI 10.1038/ncb1439; Souza-Ferreira PS, 2014, INSECT BIOCHEM MOLEC, V51, P101, DOI 10.1016/j.ibmb.2013.12.004; Tadros W, 2007, DEV CELL, V12, P847, DOI 10.1016/j.devcel.2007.05.009; Thomas JL, 2003, J INSECT SCI, V3, DOI 10.1093/jis/3.1.17; Vastenhouw NL, 2006, NATURE, V442, P882, DOI 10.1038/442882a; Vital W, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-25; Walser CB, 2011, CURR OPIN GENET DEV, V21, P431, DOI 10.1016/j.gde.2011.03.003; WONG TK, 1982, BIOCHEM BIOPH RES CO, V107, P584, DOI 10.1016/0006-291X(82)91531-5; Yuan TF, 2007, CYTOTECHNOLOGY, V54, P71, DOI 10.1007/s10616-007-9082-3; Zawadzki JL, 2012, PARASITOLOGY, V139, P613, DOI 10.1017/S0031182012000121	35	5	5	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2015	10	6							e0130008	10.1371/journal.pone.0130008	http://dx.doi.org/10.1371/journal.pone.0130008			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL3FE	26091260	Green Published, gold, Green Submitted			2022-12-26	WOS:000356835000082
J	Pera, T; Hegde, A; Deshpande, DA; Morgan, SJ; Tiegs, BC; Theriot, BS; Choi, YH; Walker, JKL; Penn, RB				Pera, Tonio; Hegde, Akhil; Deshpande, Deepak A.; Morgan, Sarah J.; Tiegs, Brian C.; Theriot, Barbara S.; Choi, Yeon H.; Walker, Julia K. L.; Penn, Raymond B.			Specificity of arrestin subtypes in regulating airway smooth muscle G protein-coupled receptor signaling and function	FASEB JOURNAL			English	Article						asthma; desensitization; beta-2-adrenoceptor; M3 mAChR	BETA-ARRESTINS; BETA(2)-ADRENERGIC RECEPTOR; COOPERATIVE REGULATION; AGONISTS; KINASES; ASTHMA; MICE; BETA-ARRESTIN1; RESPONSIVENESS; SALMETEROL	Arrestins have been shown to regulate numerous G protein-coupled receptors (GPCRs) in studies employing receptor/arrestin overexpression in artificial cell systems. Which arrestin isoforms regulate which GPCRs in primary cell types is poorly understood. We sought to determine the effect of beta-arrestin-1 or beta-arrestin-2 inhibition or gene ablation on signaling and function of multiple GPCRs endogenously expressed in airway smooth muscle (ASM). In vitro [second messenger (calcium, cAMP generation)], ex vivo (ASM tension generation in suspended airway), and in vivo (invasive airway resistance) analyses were performed on human ASM cells and murine airways/whole animal subject to beta-arrestin-1 or -2 knockdown or knockout (KO). In both human and murine model systems, knockdown or KO of beta-arrestin-2 relative to control missense small interfering RNA or wild-type mice selectively increased (40-60%) beta(2)-adrenoceptor signaling and function. beta-arrestin-1 knockdown or KO had no effect on signaling and function of beta(2)-adrenoceptor or numerous procontractile GPCRs, but selectively inhibited M3 muscarinic acetylcholine receptor signaling (similar to 50%) and function (similar to 25% ex vivo, >50% in vivo) without affecting EC50 values. Arrestin subtypes differentially regulate ASM GPCRs and beta-arrestin-1 inhibition represents a novel approach to managing bronchospasm in obstructive lung diseases.	[Pera, Tonio; Deshpande, Deepak A.; Morgan, Sarah J.; Tiegs, Brian C.; Penn, Raymond B.] Thomas Jefferson Univ, Ctr Translat Med, Jane & Leonard Korman Lung Ctr, Dept Med,Div Pulm & Crit Care Med, Philadelphia, PA 19107 USA; [Hegde, Akhil; Theriot, Barbara S.; Choi, Yeon H.; Walker, Julia K. L.] Duke Univ, Med Ctr, Div Pulm Allergy & Crit Care Med, Durham, NC USA	Jefferson University; Duke University	Penn, RB (corresponding author), Thomas Jefferson Univ, Dept Med, Rm 543 Jefferson Alumni Hall,1020 Locust St, Philadelphia, PA 19107 USA.	juliakl.walker@duke.edu; raymond.penn@jefferson.edu	Walker, Julia/R-7585-2017		U.S. National Institutes of Health (NIH) National Heart, Lung, and Blood Institute [HL093103]; NIH National Institute of Allergy and Infectious Diseases [AI110007]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL093103, R01HL058506] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI110007] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG041265] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIH National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Funding for this study was provided by U.S. National Institutes of Health (NIH) National Heart, Lung, and Blood Institute Grant HL093103 (to R.B.P. and J.K.L.W.) and NIH National Institute of Allergy and Infectious Diseases Grant AI110007 (to R.B.P. and J.K.L.W.). The authors declare no conflicts of interest.	Abisheganaden J, 1998, AM J MED, V104, P494; An SS, 2007, EUR RESPIR J, V29, P834, DOI 10.1183/09031936.00112606; ATTRAMADAL H, 1992, J BIOL CHEM, V267, P17882; BHAGAT R, 1995, CHEST, V108, P1235, DOI 10.1378/chest.108.5.1235; Billington CK, 2005, BIOCHEMISTRY-US, V44, P14595, DOI 10.1021/bi0510734; Billington CK, 2003, RESP RES, V4; Bohn LM, 1999, SCIENCE, V286, P2495, DOI 10.1126/science.286.5449.2495; Buckley J, 2011, THORAX, V66, P1029, DOI 10.1136/thx.2010.158568; Canning BJ, 2001, RESP PHYSIOL, V125, P113, DOI 10.1016/S0034-5687(00)00208-5; Carr R, 2014, J BIOL CHEM, V289, P35668, DOI 10.1074/jbc.M114.618819; CHEUNG D, 1992, NEW ENGL J MED, V327, P1198, DOI 10.1056/NEJM199210223271703; Conner DA, 1997, CIRC RES, V81, P1021; Deshpande DA, 2008, FASEB J, V22, P2134, DOI 10.1096/fj.07-102459; Deshpande DA, 2007, FASEB J, V21, P2335, DOI 10.1096/fj.06-8060com; Deshpande DA, 2006, CELL SIGNAL, V18, P2105, DOI 10.1016/j.cellsig.2006.04.008; Deshpande DA, 2014, FASEB J, V28, P956, DOI 10.1096/fj.13-240226; Deshpande DA, 2010, NAT MED, V16, P1299, DOI 10.1038/nm.2237; DeWire SM, 2007, ANNU REV PHYSIOL, V69, P483, DOI 10.1146/annurev.physiol.69.022405.154749; Drotar DE, 1998, ANN ALLERG ASTHMA IM, V80, P31, DOI 10.1016/S1081-1206(10)62935-3; Gosens R, 2003, AM J RESP CELL MOL, V28, P257, DOI 10.1165/rcmb.2002-0128OC; Gosens R, 2007, AM J PHYSIOL-LUNG C, V293, pL1348, DOI 10.1152/ajplung.00346.2007; Gosens R, 2006, AM J PHYSIOL-LUNG C, V291, pL523, DOI 10.1152/ajplung.00013.2006; Guo MH, 2005, BIOCHEMISTRY-US, V44, P13771, DOI 10.1021/bi051255y; Gurevich VV, 2006, PHARMACOL THERAPEUT, V110, P465, DOI 10.1016/j.pharmthera.2005.09.008; Hegde A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116458; Israel E, 2004, LANCET, V364, P1505, DOI 10.1016/S0140-6736(04)17273-5; Jokic R, 2001, CHEST, V119, P370, DOI 10.1378/chest.119.2.370; KONG GH, 1994, J BIOL CHEM, V269, P13084; Kotlikoff MI, 1996, ANNU REV PHYSIOL, V58, P115, DOI 10.1146/annurev.ph.58.030196.000555; Krupnick JG, 1998, ANNU REV PHARMACOL, V38, P289, DOI 10.1146/annurev.pharmtox.38.1.289; LEVITT RC, 1988, FASEB J, V2, P2605, DOI 10.1096/fasebj.2.10.3384240; Lin R, 2012, BRIT J PHARMACOL, V165, P2365, DOI 10.1111/j.1476-5381.2011.01725.x; Lipworth B, 1998, AM J MED, V104, P431, DOI 10.1016/S0002-9343(98)00086-2; Luttrell LM, 2002, J CELL SCI, V115, P455; Morgan SJ, 2014, J BIOL CHEM, V289, P23065, DOI 10.1074/jbc.M114.557652; MURRAY RK, 1993, AM J PHYSIOL, V264, pC485, DOI 10.1152/ajpcell.1993.264.2.C485; Nobles KN, 2007, J BIOL CHEM, V282, P21370, DOI 10.1074/jbc.M611483200; Oakley RH, 2000, J BIOL CHEM, V275, P17201, DOI 10.1074/jbc.M910348199; PANETTIERI RA, 1989, AM J PHYSIOL, V256, pC329, DOI 10.1152/ajpcell.1989.256.2.C329; Penn RB, 2008, N-S ARCH PHARMACOL, V378, P149, DOI 10.1007/s00210-008-0263-1; Penn Raymond B, 2014, Handb Exp Pharmacol, V219, P387, DOI 10.1007/978-3-642-41199-1_20; Penn RB, 1998, AM J RESP CELL MOL, V19, P338, DOI 10.1165/ajrcmb.19.2.3025; Penn RB, 2001, J BIOL CHEM, V276, P32648, DOI 10.1074/jbc.M104143200; Penn RB, 2000, TRENDS CARDIOVAS MED, V10, P81, DOI 10.1016/S1050-1738(00)00053-0; Peters SP, 1999, AM J MED, V107, P283; Shenoy SK, 2011, TRENDS PHARMACOL SCI, V32, P521, DOI 10.1016/j.tips.2011.05.002; Stephens NL, 2001, LUNG, V179, P333, DOI 10.1007/s004080000073; SterneMarr R, 1995, VITAM HORM, V51, P193, DOI 10.1016/S0083-6729(08)61039-0; Tilley SL, 2003, AM J PHYSIOL-LUNG C, V284, pL599, DOI 10.1152/ajplung.00324.2002; Wang WCH, 2009, P NATL ACAD SCI USA, V106, P15007, DOI 10.1073/pnas.0906034106; WIDDOP S, 1993, AM J RESP CELL MOL, V9, P541, DOI 10.1165/ajrcmb/9.5.541; Yan HD, 2011, FASEB J, V25, P389, DOI 10.1096/fj.10-164798	52	15	16	0	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2015	29	10					4227	4235		10.1096/fj.15-273094	http://dx.doi.org/10.1096/fj.15-273094			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CR5FY	26103985	Green Published			2022-12-26	WOS:000361367300012
J	Mohan, R; Mao, YP; Zhang, SG; Zhang, YW; Xu, CR; Gradwohl, G; Tang, XQ				Mohan, Ramkumar; Mao, Yiping; Zhang, Shungang; Zhang, Yu-Wei; Xu, Cheng-Ran; Gradwohl, Gerard; Tang, Xiaoqing			Differentially Expressed MicroRNA-483 Confers Distinct Functions in Pancreatic beta- and alpha-Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR-II; GLUCAGON-SECRETION; CYTOKINE SIGNALING-3; INSULIN-RESISTANCE; GLUCOSE-HOMEOSTASIS; DIABETES-MELLITUS; APOPTOSIS; PROLIFERATION; SUPPRESSOR; SOCS-3	Insulin secreted from pancreatic beta-cells and glucagon secreted from pancreatic alpha-cells are the two major hormones working in the pancreas in an opposing manner to regulate and maintain a normal glucose homeostasis. How microRNAs (miRNAs), a population of non-coding RNAs so far demonstrated to be differentially expressed in various types of cells, regulate gene expression in pancreatic beta-cells and its closely associated alpha-cells is not completely clear. In this study, miRNA profiling was performed and compared between pancreatic beta-cells and their partner alpha-cells. One novel miRNA, miR-483, was identified for its highly differential expression in pancreatic beta-cells when compared to its expression in alpha-cells. Overexpression of miR-483 in beta-cells increased insulin transcription and secretion by targeting SOCS3, a member of suppressor of cytokine signaling family. In contrast, overexpression of miR-483 decreased glucagon transcription and secretion in alpha-cells. Moreover, overexpressed miR-483 protected against proinflammatory cytokine-induced apoptosis in beta-cells. This correlates with a higher expression level of miR-483 and the expanded beta-cell mass observed in the islets of prediabetic db/db mice. Together, our data suggest that miR-483 has opposite effects in alpha- and beta-cells by targeting SOCS3, and the imbalance of miR-483 and its targets may play a crucial role in diabetes pathogenesis.	[Mohan, Ramkumar; Mao, Yiping; Zhang, Shungang; Tang, Xiaoqing] Michigan Technol Univ, Dept Biol Sci, Houghton, MI 49931 USA; [Zhang, Yu-Wei; Xu, Cheng-Ran] Peking Univ, Coll Life Sci, Peking Tsinghua Ctr Life Sci, Beijing 100871, Peoples R China; [Gradwohl, Gerard] Univ Strasbourg, Inst Genet & Mol & Cellular Biol, Dept Dev & Stem cells, F-67404 Illkirch Graffenstaden, France	Michigan Technological University; Peking University; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Tang, XQ (corresponding author), Michigan Technol Univ, Dept Biol Sci, 1400 Townsend Dr, Houghton, MI 49931 USA.	xtang2@mtu.edu	Gradwohl, Gérard/AFM-9024-2022; Mohan, Ramkumar/J-9037-2019; Regan, Clinton/E-6250-2012; Gradwohl, Gérard/H-8543-2014	Gradwohl, Gérard/0000-0002-6730-2615; Mohan, Ramkumar/0000-0002-1308-1642; Gradwohl, Gérard/0000-0002-6730-2615; Zhang, Shungang/0000-0002-6668-7453	National Institutes of Health [DK084166]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R15DK103197, R03DK084166] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grant DK084166 (to X. T.). The authors declare that they have no conflicts of interest with the contents of this article.	Barbagallo D, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-62; Baroukh N, 2007, J BIOL CHEM, V282, P19575, DOI 10.1074/jbc.M611841200; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bernal-Mizrachi E, 2014, DIABETES, V63, P819, DOI 10.2337/db13-1146; Breckenridge SM, 2007, DIABETES, V56, P2442, DOI 10.2337/db07-0751; Brissova M, 2004, DIABETES, V53, P1318, DOI 10.2337/diabetes.53.5.1318; Broderick JA, 2011, GENE THER, V18, P1104, DOI 10.1038/gt.2011.50; Butler AE, 2003, DIABETES, V52, P102, DOI 10.2337/diabetes.52.1.102; Cabrera O, 2006, P NATL ACAD SCI USA, V103, P2334, DOI 10.1073/pnas.0510790103; Cantley J, 2007, DIABETOLOGIA, V50, P1248, DOI 10.1007/s00125-007-0637-9; Cooperberg BA, 2010, DIABETES, V59, P2936, DOI 10.2337/db10-0728; Cornu M, 2009, DIABETES, V58, P1816, DOI 10.2337/db09-0063; D'Alessio D, 2011, DIABETES OBES METAB, V13, P126, DOI 10.1111/j.1463-1326.2011.01449.x; de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078; Deng SP, 2004, DIABETES, V53, P624, DOI 10.2337/diabetes.53.3.624; Devedjian JC, 2000, J CLIN INVEST, V105, P731, DOI 10.1172/JCI5656; Diao JY, 2005, J BIOL CHEM, V280, P33487, DOI 10.1074/jbc.M506276200; Emanuelli B, 2004, DIABETES, V53, pS97, DOI 10.2337/diabetes.53.suppl_3.S97; Emanuelli B, 2001, J BIOL CHEM, V276, P47944, DOI 10.1074/jbc.M104602200; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Guay C, 2011, TRANSL RES, V157, P253, DOI 10.1016/j.trsl.2011.01.009; Heit JJ, 2006, ANNU REV CELL DEV BI, V22, P311, DOI 10.1146/annurev.cellbio.22.010305.104425; Herrera PL, 2000, DEVELOPMENT, V127, P2317; Hill DJ, 2000, ENDOCRINOLOGY, V141, P1151, DOI 10.1210/en.141.3.1151; Hope KM, 2004, DIABETES, V53, P1488, DOI 10.2337/diabetes.53.6.1488; Jorgensen SB, 2013, DIABETES, V62, P56, DOI 10.2337/db12-0443; Karlsen AE, 2001, P NATL ACAD SCI USA, V98, P12191, DOI 10.1073/pnas.211445998; Kassem SA, 2000, DIABETES, V49, P1325, DOI 10.2337/diabetes.49.8.1325; Kawamori D, 2009, CELL METAB, V9, P350, DOI 10.1016/j.cmet.2009.02.007; Kim DH, 2008, P NATL ACAD SCI USA, V105, P16230, DOI 10.1073/pnas.0808830105; Klein D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055064; Kulkarni RN, 2005, REV ENDOCR METAB DIS, V6, P199, DOI 10.1007/s11154-005-3051-y; Kulkarni RN, 2012, DIABETES, V61, P2205, DOI 10.2337/db12-0018; Latreille M, 2014, J CLIN INVEST, V124, P2722, DOI 10.1172/JCI73066; Laubner K, 2005, DIABETES, V54, P3410, DOI 10.2337/diabetes.54.12.3410; Lindberg K, 2005, J MOL ENDOCRINOL, V35, P231, DOI 10.1677/jme.1.01840; Liu MZ, 2013, GENE DEV, V27, P2543, DOI 10.1101/gad.224170.113; Liu Z, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016096; Lovis P, 2008, BIOL CHEM, V389, P305, DOI 10.1515/BC.2008.026; Ma N, 2011, MOL CELL ENDOCRINOL, V333, P96, DOI 10.1016/j.mce.2010.11.027; Mandrup-Poulsen T, 2001, DIABETES, V50, pS58, DOI 10.2337/diabetes.50.2007.S58; Mao YP, 2013, PHARMACOL RES, V75, P37, DOI 10.1016/j.phrs.2013.06.005; MIYAZAKI JI, 1990, ENDOCRINOLOGY, V127, P126, DOI 10.1210/endo-127-1-126; Montanya E, 2009, METHODS MOL BIOL, V560, P137, DOI 10.1007/978-1-59745-448-3_11; Monteys AM, 2010, RNA, V16, P495, DOI 10.1261/rna.1731910; Petrik J, 1998, ENDOCRINOLOGY, V139, P2994, DOI 10.1210/en.139.6.2994; Piccand J, 2014, DIABETES, V63, P203, DOI 10.2337/db13-0384; Place RF, 2008, P NATL ACAD SCI USA, V105, P1608, DOI 10.1073/pnas.0707594105; Porte D, 2001, DIABETES, V50, pS160, DOI 10.2337/diabetes.50.2007.S160; Poy MN, 2009, P NATL ACAD SCI USA, V106, P5813, DOI 10.1073/pnas.0810550106; Ravier MA, 2005, DIABETES, V54, P1789, DOI 10.2337/diabetes.54.6.1789; Ronn SG, 2002, MOL ENDOCRINOL, V16, P2124, DOI 10.1210/me.2002-0082; Rui LY, 2002, J BIOL CHEM, V277, P42394, DOI 10.1074/jbc.C200444200; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Shi H, 2004, J BIOL CHEM, V279, P34733, DOI 10.1074/jbc.M403886200; Shin C, 2010, MOL CELL, V38, P789, DOI 10.1016/j.molcel.2010.06.005; Tang XQ, 2007, RNA, V13, P1803, DOI 10.1261/rna.498607; Tang XQ, 2009, RNA, V15, P287, DOI 10.1261/rna.1211209; Trajkovski M, 2011, NATURE, V474, P649, DOI 10.1038/nature10112; Ueki K, 2004, MOL CELL BIOL, V24, P5434, DOI 10.1128/MCB.24.12.5434-5446.2004; Ueki K, 2004, P NATL ACAD SCI USA, V101, P10422, DOI 10.1073/pnas.0402511101; Wang Q, 2002, DIABETOLOGIA, V45, P1263, DOI 10.1007/s00125-002-0828-3; Wang WX, 2008, J NEUROSCI, V28, P1213, DOI 10.1523/JNEUROSCI.5065-07.2008; Wang Y, 2013, DIABETES, V62, P887, DOI 10.2337/db12-0451; Xu CR, 2014, EMBO J, V33, P2157, DOI 10.15252/embj.201488671; Yoon KH, 2003, J CLIN ENDOCR METAB, V88, P2300, DOI 10.1210/jc.2002-020735; Zhou HR, 2004, DIABETES, V53, P1482, DOI 10.2337/diabetes.53.6.1482	67	29	32	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 7	2015	290	32					19955	19966		10.1074/jbc.M115.650705	http://dx.doi.org/10.1074/jbc.M115.650705			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CO7TL	26109062	Green Published, hybrid			2022-12-26	WOS:000359364600050
J	Costa, DC; de Assis, GMP; Silva, FAD; Araujo, FC; de Souza, JC; Hirano, ZMB; Kano, FS; de Sousa, TN; Carvalho, LH; de Brito, CFA				Costa, Daniela Camargos; Pereira de Assis, Gabriela Maria; de Souza Silva, Flavia Alessandra; Araujo, Flavia Carolina; de Souza Junior, Julio Cesar; Braga Hirano, Zelinda Maria; Kano, Flora Satiko; de Sousa, Tais Nobrega; Carvalho, Luzia Helena; Alves de Brito, Cristiana Ferreira			Plasmodium simium, a Plasmodium vivax-Related Malaria Parasite: Genetic Variability of Duffy Binding Protein II and the Duffy Antigen/Receptor for Chemokines	PLOS ONE			English	Article							INHIBITORY ANTIBODIES; EPIDEMIOLOGIC ASPECTS; NATURAL-SELECTION; HOWLER MONKEYS; LIGAND DOMAIN; SAO-PAULO; RECEPTOR; TRANSMISSION; RESISTANCE; ANTIGEN	Plasmodium simium is a parasite from New World monkeys that is most closely related to the human malaria parasite Plasmodium vivax; it also naturally infects humans. The blood-stage infection of P. vivax depends on Duffy binding protein II (PvDBPII) and its cognate receptor on erythrocytes, the Duffy antigen receptor for chemokines (hDARC), but there is no information on the P. simium erythrocytic invasion pathway. The genes encoding P. simium DBP (PsDBPII) and simian DARC (sDARC) were sequenced from Southern brown howler monkeys (Alouatta guariba clamitans) naturally infected with P. simium because P. simium may also depend on the DBPII/DARC interaction. The sequences of DBP binding domains from P. vivax and P. simium were highly similar. However, the genetic variability of PsDBPII was lower than that of PvDBPII. Phylogenetic analyses demonstrated that these genes were strictly related and clustered in the same clade of the evolutionary tree. DARC from A. clamitans was also sequenced and contained three new non-synonymous substitutions. None of these substitutions were located in the N-terminal domain of DARC, which interacts directly with DBPII. The interaction between sDARC and PvDBPII was evaluated using a cytoadherence assay of COS7 cells expressing PvDBPII on their surfaces. Inhibitory binding assays in vitro demonstrated that antibodies from monkey sera blocked the interaction between COS-7 cells expressing PvDBPII and hDARC-positive erythrocytes. Taken together, phylogenetic analyses reinforced the hypothesis that the host switch from humans to monkeys may have occurred very recently in evolution, which sheds light on the evolutionary history of new world plasmodia. Further invasion studies would confirm whether P. simium depends on DBP/DARC to trigger internalization into red blood cells.	[Costa, Daniela Camargos; Pereira de Assis, Gabriela Maria; de Souza Silva, Flavia Alessandra; Araujo, Flavia Carolina; Kano, Flora Satiko; de Sousa, Tais Nobrega; Carvalho, Luzia Helena; Alves de Brito, Cristiana Ferreira] Fiocruz Minas, Ctr Pesquisas Rene Rachou, Lab Malaria, Belo Horizonte, MG, Brazil; [de Souza Junior, Julio Cesar; Braga Hirano, Zelinda Maria] Univ Reg Blumenau, FURB, Blumenau, SC, Brazil; [de Souza Junior, Julio Cesar; Braga Hirano, Zelinda Maria] CEPESBI Ctr Pesquisas Biol Indaial, Indaial, SC, Brazil	Fundacao Oswaldo Cruz; Universidade Regional de Blumenau (FURB)	de Brito, CFA (corresponding author), Fiocruz Minas, Ctr Pesquisas Rene Rachou, Lab Malaria, Belo Horizonte, MG, Brazil.	cristiana@cpqrr.fiocruz.br	Kano, Flora S./AAS-3215-2020; Brito, cristiana F/D-4145-2011; Kano, Flora/N-7749-2017; carvalho, luzia H/C-4087-2013; Carvalho, Luzia H/AAW-3461-2021; de Sousa, Tais Nobrega/AAG-6225-2019; Hirano, Zelinda/AAR-3949-2020	Brito, cristiana F/0000-0002-8888-5477; Kano, Flora/0000-0002-2364-9772; de Sousa, Tais Nobrega/0000-0002-6874-9427; Hirano, Zelinda/0000-0003-2903-5509; Maira Pereira de Assis, Gabriela/0000-0002-1288-4689	FAPEMIG	FAPEMIG(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG))	The authors received funding from FAPEMIG for this work. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JH, 2001, TRENDS PARASITOL, V17, P297, DOI 10.1016/S1471-4922(01)01948-1; ADAMS JH, 1992, P NATL ACAD SCI USA, V89, P7085, DOI 10.1073/pnas.89.15.7085; Ayala FJ, 1999, PARASSITOLOGIA, VOL 41, NOS 1-3, SEPTEMBER 1999, P55; Batchelor JD, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003869; Batchelor JD, 2011, NAT STRUCT MOL BIOL, V18, P908, DOI 10.1038/nsmb.2088; Baum J, 2003, GENETICS, V163, P1327; CARRERIBRUNO GC, 1995, REV SAUDE PUBL, V29, P142, DOI 10.1590/S0034-89101995000200010; Ceravolo IP, 2008, SCAND J IMMUNOL, V67, P270, DOI 10.1111/j.1365-3083.2007.02059.x; Ceravolo IP, 2009, CLIN EXP IMMUNOL, V156, P502, DOI 10.1111/j.1365-2249.2009.03931.x; Cerutti C, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-33; Chitnis CE, 1996, J EXP MED, V184, P1531, DOI 10.1084/jem.184.4.1531; CHITNIS CE, 1994, J EXP MED, V180, P497, DOI 10.1084/jem.180.2.497; Chitnis CE, 2008, TRENDS PARASITOL, V24, P29, DOI 10.1016/j.pt.2007.10.004; Chootong P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035769; COATNEY GR, 1971, PRIMATE MALARIAS; Cole-Tobian J, 2003, MOL BIOCHEM PARASIT, V127, P121, DOI 10.1016/S0166-6851(02)00327-4; COLLINS WE, 1969, J PARASITOL, V55, P814, DOI 10.2307/3277221; Costa DC, 2014, MEM I OSWALDO CRUZ, V109, P641, DOI 10.1590/0074-0276130578; Culleton R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029137; Culleton R, 2009, J INFECT DIS, V200, P1465, DOI 10.1086/644510; Curado I, 1997, MEM I OSWALDO CRUZ, V92, P235, DOI 10.1590/S0074-02761997000200017; da FONSECA FLAVIO, 1951, MEM INST OSWALDO CRUZ, V49, P543, DOI 10.1590/S0074-02761951000100008; de Sousa TN, 2014, MEM I OSWALDO CRUZ, V109, P608, DOI 10.1590/0074-0276130592; DEANE LM, 1966, B WORLD HEALTH ORGAN, V35, P805; DEANE LM, 1992, MEM I OSWALDO CRUZ, V87, P1, DOI 10.1590/S0074-02761992000700001; Deane M, 1968, J I MED TROP SAO PAU, V10, P287; Demogines A, 2012, MOL BIOL EVOL, V29, P445, DOI 10.1093/molbev/msr204; Escalante AA, 2005, P NATL ACAD SCI USA, V102, P1980, DOI 10.1073/pnas.0409652102; ESCALANTE AA, 1994, P NATL ACAD SCI USA, V91, P11373, DOI 10.1073/pnas.91.24.11373; Fraser T, 1997, INFECT IMMUN, V65, P2772, DOI 10.1128/IAI.65.7.2772-2777.1997; GOLDMAN IF, 1993, MOL BIOCHEM PARASIT, V57, P177, DOI 10.1016/0166-6851(93)90257-X; HAYNES JD, 1988, J EXP MED, V167, P1873, DOI 10.1084/jem.167.6.1873; Jia XL, 2002, J IMMUNOL, V169, P3200, DOI 10.4049/jimmunol.169.6.3200; Oliveira TYK, 2012, IMMUNOGENETICS, V64, P497, DOI 10.1007/s00251-012-0608-2; King CL, 2008, P NATL ACAD SCI USA, V105, P8363, DOI 10.1073/pnas.0800371105; Leclerc MC, 2004, PARASITOLOGY, V129, P677, DOI 10.1017/S0031182004006146; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lim CS, 2005, P NATL ACAD SCI USA, V102, P15523, DOI 10.1073/pnas.0507413102; Liu WM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4346; de Alvarenga DAM, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0606-6; Michon P, 2000, INFECT IMMUN, V68, P3164, DOI 10.1128/IAI.68.6.3164-3171.2000; Michon PA, 1998, AM J TROP MED HYG, V59, P597, DOI 10.4269/ajtmh.1998.59.597; MILLER LH, 1975, SCIENCE, V189, P561, DOI 10.1126/science.1145213; MILLER LH, 1976, NEW ENGL J MED, V295, P302, DOI 10.1056/NEJM197608052950602; Mu JB, 2005, MOL BIOL EVOL, V22, P1686, DOI 10.1093/molbev/msi160; Ntumngia FB, 2012, INT J PARASITOL, V42, P1055, DOI 10.1016/j.ijpara.2012.09.006; Perelman P, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001342; Singh B, 2004, LANCET, V363, P1017, DOI 10.1016/S0140-6736(04)15836-4; Singh SK, 2006, NATURE, V439, P741, DOI 10.1038/nature04443; Sousa TN, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-334; Souza-Silva FA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093782; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tazi L, 2011, INFECT GENET EVOL, V11, P209, DOI 10.1016/j.meegid.2010.08.007; Tournamille C, 2005, MOL BIOCHEM PARASIT, V144, P100, DOI 10.1016/j.molbiopara.2005.04.016; VanBuskirk KM, 2004, J INFECT DIS, V190, P1556, DOI 10.1086/424852; WANDERLEY DMV, 1994, REV SAUDE PUBL, V28, P192, DOI 10.1590/S0034-89101994000300005; WATERS AP, 1993, MOL BIOL EVOL, V10, P914; WERTHEIMER SP, 1989, EXP PARASITOL, V69, P340, DOI 10.1016/0014-4894(89)90083-0; Wijeyesakere SJ, 2007, PROTEIN J, V26, P165, DOI 10.1007/s10930-006-9058-8; Yamasaki T, 2011, J MED PRIMATOL, V40, P392, DOI 10.1111/j.1600-0684.2011.00498.x	60	12	12	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2015	10	6							e0131339	10.1371/journal.pone.0131339	http://dx.doi.org/10.1371/journal.pone.0131339			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4OM	26107662	Green Submitted, Green Published, gold			2022-12-26	WOS:000356932500159
J	Ji, XX; Bao, NR; An, KN; Amadio, PC; Steinmann, SP; Zhao, CF				Ji, Xiaoxi; Bao, Nirong; An, Kai-Nan; Amadio, Peter C.; Steinmann, Scott P.; Zhao, Chunfeng			A Canine Non-Weight-Bearing Model with Radial Neurectomy for Rotator Cuff Repair	PLOS ONE			English	Article							FLEXOR TENDON REPAIR; SINGLE-ROW; IN-VIVO; FUNCTIONAL OUTCOMES; NATURAL-HISTORY; FELT GRAFT; BONE; SUTURE; AUGMENTATION; LUBRICIN	Background The major concern of using a large animal model to study rotator cuff repair is the high rate of repair retears. The purpose of this study was to test a non-weight-bearing (NWB) canine model for rotator cuff repair research. Methods First, in the in vitro study, 18 shoulders were randomized to 3 groups. 1) Full-width transections repaired with modified Mason-Allen sutures using 3-0 polyglactin suture, 2) Group 1 repaired using number 2 (#2) polyester braid and long-chain polyethylene suture, and 3) Partial-width transections leaving the superior 2 mm infraspinatus tendon intact without repair. In the in vivo study of 6 dogs, the infraspinatus tendon was partially transected as the same as the in vitro group 3. A radial neurectomy was performed to prevent weight bearing. The operated limb was slung in a custom-made jacket for 6 weeks. Results In the in vitro study, mean ultimate tensile load and stiffness in Group 2 were significantly higher than Group 1 and 3 (p<0.05). In the in vivo study, gross inspection and histology showed that the preserved superior 2-mm portion of the infraspinatus tendon remained intact with normal structure. Conclusions Based on the biomechanical and histological findings, this canine NWB model may be an appropriate and useful model for studies of rotator cuff repair.	[Ji, Xiaoxi; Bao, Nirong; An, Kai-Nan; Amadio, Peter C.; Steinmann, Scott P.; Zhao, Chunfeng] Mayo Clin, Div Orthoped Res, Biomech Lab, Rochester, MN 55905 USA; [Ji, Xiaoxi] Shanghai Jiao Tong Univ, Shanghai Peoples Hosp 1, Ctr Trauma, Shanghai 200080, Peoples R China	Mayo Clinic; Shanghai Jiao Tong University	Zhao, CF (corresponding author), Mayo Clin, Div Orthoped Res, Biomech Lab, Rochester, MN 55905 USA.	zhao.chunfeng@mayo.edu			National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health [AR57745]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR057745] Funding Source: NIH RePORTER	National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	Research reported in this publication was supported by the National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health under award number AR57745. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JE, 2006, ARTHROSCOPY, V22, P700, DOI 10.1016/j.arthro.2006.03.016; Aoki M, 2004, J BIOMED MATER RES B, V71B, P252, DOI 10.1002/jbm.b.30084; Aoki M, 2001, J SHOULDER ELB SURG, V10, P123, DOI 10.1067/mse.2001.111963; Bey MJ, 2011, J ORTHOP RES, V29, P822, DOI 10.1002/jor.21315; Boyer MI, 2002, J HAND SURG-AM, V27A, P594, DOI 10.1053/jhsu.2002.33708; Burkhart SS, 1997, ARTHROSCOPY, V13, P720, DOI 10.1016/S0749-8063(97)90006-2; Carpenter JE, 1999, CLIN ORTHOP RELAT R, pS296; Cummins CA, 2003, J SHOULDER ELB SURG, V12, P128, DOI 10.1067/mse.2003.21; Dejardin LM, 2001, AM J SPORT MED, V29, P175, DOI 10.1177/03635465010290021001; Derwin KA, 2007, J SHOULDER ELB SURG, V16, p140S, DOI 10.1016/j.jse.2007.04.002; Derwin KA, 2010, TISSUE ENG PART B-RE, V16, P21, DOI [10.1089/ten.teb.2009.0209, 10.1089/ten.TEB.2009.0209]; Derwin KA, 2009, J BONE JOINT SURG AM, V91A, P1159, DOI 10.2106/JBJS.H.00775; Galatz LM, 2004, J BONE JOINT SURG AM, V86A, P219, DOI 10.2106/00004623-200402000-00002; Gerber C, 1999, J BONE JOINT SURG AM, V81A, P1281, DOI 10.2106/00004623-199909000-00009; GERBER C, 1994, J BONE JOINT SURG BR, V76B, P371, DOI 10.1302/0301-620X.76B3.8175836; Gimbel JA, 2007, J BIOMECH, V40, P561, DOI 10.1016/j.jbiomech.2006.02.010; Goutallier D, 2003, J SHOULDER ELB SURG, V12, P550, DOI 10.1016/S1058-2746(03)00211-8; Iannotti JP, 2013, J BONE JOINT SURG AM, V95A, P965, DOI 10.2106/JBJS.L.00708; Inoue N, 2002, J ORTHOPAED RES, V20, P957, DOI 10.1016/S0736-0266(02)00037-2; Kim DH, 2006, AM J SPORT MED, V34, P407, DOI 10.1177/0363546505281238; Kim KC, 2013, J BONE JOINT SURG AM, V95A, P536, DOI 10.2106/JBJS.L.00397; Kimura A, 2003, J BONE JOINT SURG BR, V85B, P282, DOI 10.1302/0301-620X.85B2.12823; Lim JK, 2004, ARTHROSCOPY, V20, P899, DOI 10.1016/j.arthro.2004.06.035; Longo UG, 2012, MED SPORT SCI, V57, P1, DOI 10.1159/000328868; Ma CB, 2006, J BONE JOINT SURG AM, V88A, P403, DOI 10.2106/JBJS.D.02887; Martinek V, 2002, J BONE JOINT SURG AM, V84A, P1123, DOI 10.2106/00004623-200207000-00005; Mazzocca AD, 2005, AM J SPORT MED, V33, P1861, DOI 10.1177/0363546505279575; Meyer DC, 2005, J ORTHOP RES, V23, P254, DOI 10.1016/j.orthres.2004.06.010; Oguma H, 2001, J ORTHOP RES, V19, P873, DOI 10.1016/S0736-0266(01)00021-3; Rees JD, 2006, RHEUMATOLOGY, V45, P508, DOI 10.1093/rheumatology/kel046; Rodeo SA, 2007, J BONE JOINT SURG AM, V89A, P2485, DOI 10.2106/JBJS.C.01627; Safran O, 2011, AM J SPORT MED, V39, P710, DOI 10.1177/0363546510393944; Schlegel TF, 2007, J SHOULDER ELB SURG, V16, P115, DOI 10.1016/j.jse.2006.05.002; Smith MJ, 2012, ARTHROSCOPY, V28, P169, DOI 10.1016/j.arthro.2011.08.296; Sun YL, 2013, J BONE JOINT SURG AM, V95A, P273, DOI 10.2106/JBJS.K.01522; Tien YC, 2004, J BONE JOINT SURG BR, V86B, P1072, DOI 10.1302/0301-620X.86B7.14578; Yamaguchi K, 2001, J SHOULDER ELB SURG, V10, P199, DOI 10.1067/mse.2001.113086; Zhao CF, 2002, J BONE JOINT SURG AM, V84A, P78, DOI 10.2106/00004623-200201000-00012; Zhao CF, 2013, J ORTHOP RES, V31, P969, DOI 10.1002/jor.22305; Zhao CF, 2010, J BONE JOINT SURG AM, V92A, P1453, DOI 10.2106/JBJS.I.00765; Zhao CF, 2009, J BONE JOINT SURG AM, V91A, P2673, DOI 10.2106/JBJS.H.01695	41	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2015	10	6							e0130576	10.1371/journal.pone.0130576	http://dx.doi.org/10.1371/journal.pone.0130576			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4OM	26107616	Green Submitted, Green Published, gold			2022-12-26	WOS:000356932500107
J	Schotte, H; Schluter, B; Schmidt, H; Gaubitz, M; Drynda, S; Kekow, J; Willeke, P				Schotte, Heiko; Schlueter, Bernhard; Schmidt, Hartmut; Gaubitz, Markus; Drynda, Susanne; Kekow, Joern; Willeke, Peter			Putative IL-10 Low Producer Genotypes Are Associated with a Favourable Etanercept Response in Patients with Rheumatoid Arthritis	PLOS ONE			English	Article							INTERLEUKIN-10 PROMOTER POLYMORPHISM; SYSTEMIC-LUPUS-ERYTHEMATOSUS; MICROSATELLITE POLYMORPHISMS; HAPLOTYPE RECONSTRUCTION; CYTOKINE PRODUCTION; AMERICAN-COLLEGE; GENE PROMOTER; B-CELLS; DISEASE; CRITERIA	Outcome predictors of biologic therapeutic drugs like TNF inhibitors are of interest since side effects like serious infections or malignancy cannot be completely ruled out. Response rates are heterogeneous. The present study addressed the question whether in patients with rheumatoid arthritis (RA) interleukin-10 (IL-10) promoter genotypes with potential relevance for IL-10 production capacity are associated with response to long-term treatment with etanercept. Caucasian RA patients that, according to the EULAR criteria, responded well (n = 25), moderately (n = 17) or not (n = 8) to etanercept therapy (median 36 months, range 4-52), and 160 matched controls were genotyped for the IL-10 promoter SNPs -2849 G>A (rs6703630), -1082 G>A (rs1800896), -819 C>T (rs1800871) and -592 C>A (rs1800872). Haplotypes were reconstructed via mathematic model and tested for associations with disease susceptibility and therapy response. We identified the four predominant haplotypes AGCC, GATA, GGCC, and GACC in almost equal distribution. Patients that responded well carried the putative IL-10 low producer allele -2849 A or the haplotypes AGCC and GATA (RR 2.1 and 4.0, respectively; 95% CI 1.1-4.0 and 1.1-14.8), whereas an unfavourable response was associated with carriage of the putative high producer haplotype GGCC (RR 1.9, 95% CI 1.1-3.3). No significant associations of alleles or haplotypes with disease susceptibility were observed. In RA, a low IL-10 production which is genetically determined rather by haplotypes than by SNPs may favour the response to etanercept treatment. Iatrogenic blockade of TNF may reveal proinflammatory effects of its endogeneous antagonist IL-10. Further studies are needed to correlate these genetic findings to direct cytokine measurements.	[Schotte, Heiko] Franziskus Hosp Harderberg, Niels Stensen Kliniken, Georgsmarienhutte, Germany; [Schlueter, Bernhard; Schmidt, Hartmut] Univ Klinikum Munster, Ctr Lab Med, Munster, Germany; [Gaubitz, Markus] Akad Manuelle Med, Rheumatol, Munster, Germany; [Drynda, Susanne; Kekow, Joern] Univ Magdeburg, Klin Rheumatol, Vogelsang Gommern, Germany; [Willeke, Peter] Univ Klinikum Munster, Med Klin D, Munster, Germany	University of Munster; University of Munster	Schotte, H (corresponding author), Franziskus Hosp Harderberg, Niels Stensen Kliniken, Georgsmarienhutte, Germany.	h.schotte@uni-muenster.de						Aaltonen KJ, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0043508, 10.1371/journal.pone.0030275]; Aletaha D, 2010, ANN RHEUM DIS, V69, P1580, DOI [10.1136/ard.2010.138461, 10.1002/art.27584]; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; ASSMANN G, 1992, AM J CARDIOL, V70, P733, DOI 10.1016/0002-9149(92)90550-I; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; CHERNOFF AE, 1995, J IMMUNOL, V154, P5492; Cui J, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003394; CUSH JJ, 1995, ARTHRITIS RHEUM-US, V38, P96, DOI 10.1002/art.1780380115; de Jong BA, 2002, HUM IMMUNOL, V63, P281, DOI 10.1016/S0198-8859(02)00369-5; Edwards-Smith CJ, 1999, HEPATOLOGY, V30, P526, DOI 10.1002/hep.510300207; Eskdale J, 1999, GENES IMMUN, V1, P151, DOI 10.1038/sj.gene.6363656; Eskdale J, 1998, LANCET, V352, P1282, DOI 10.1016/S0140-6736(05)70489-X; Higuchi R., 1989, PCR TECHNOLOGY PRINC; Lard LR, 2003, ARTHRITIS RHEUM-US, V48, P1841, DOI 10.1002/art.11160; Lazarus M, 1997, J RHEUMATOL, V24, P2314; Mirkov MU, 2013, ANN RHEUM DIS, V72, P1375, DOI 10.1136/annrheumdis-2012-202405; Moore KW, 2001, ANNU REV IMMUNOL, V19, P683, DOI 10.1146/annurev.immunol.19.1.683; Perez L, 1995, ARTHRITIS RHEUM, V38, P1771, DOI 10.1002/art.1780381210; Prajapati R, 2011, PHARMACOGENOMICS, V12, P1571, DOI [10.2217/PGS.11.114, 10.2217/pgs.11.114]; PREVOO MLL, 1995, ARTHRITIS RHEUM, V38, P44, DOI 10.1002/art.1780380107; Ramiro S, 2014, ANN RHEUM DIS, V73, P529, DOI 10.1136/annrheumdis-2013-204575; Reparon-Schuijt CC, 1998, ARTHRITIS RHEUM, V41, P2211, DOI 10.1002/1529-0131(199812)41:12<2211::AID-ART17>3.0.CO;2-O; Reparon-Schuijt CC, 2001, ARTHRITIS RHEUM, V44, P41, DOI 10.1002/1529-0131(200101)44:1<41::AID-ANR6>3.0.CO;2-0; Rigby WFC, 2007, NAT CLIN PRACT RHEUM, V3, P227, DOI 10.1038/ncprheum0438; Rood MJ, 1999, ANN RHEUM DIS, V58, P85, DOI 10.1136/ard.58.2.85; Schotte H, 2005, ANN RHEUM DIS, V64, P575, DOI 10.1136/ard.2004.027672; Schotte H, 2014, LUPUS, V23, P378, DOI 10.1177/0961203314522334; Schulze-Tanzil G, 2009, CURR GENE THER, V9, P306, DOI 10.2174/156652309788921044; SHAM PC, 1995, ANN HUM GENET, V59, P97, DOI 10.1111/j.1469-1809.1995.tb01608.x; Shrivastava AK, 2015, ALLERGOL IMMUNOPATH, V43, P81, DOI 10.1016/j.aller.2013.11.003; Stephens M, 2003, AM J HUM GENET, V73, P1162, DOI 10.1086/379378; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Striz I, 2014, CLIN SCI, V126, P593, DOI 10.1042/CS20130497; Thye T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005420; Turner DM, 1997, EUR J IMMUNOGENET, V24, P1, DOI 10.1111/j.1365-2370.1997.tb00001.x; Van Roon JAG, 2003, J RHEUMATOL, V30, P648; vanGestel AM, 1996, ARTHRITIS RHEUM, V39, P34, DOI 10.1002/art.1780390105; WANIDWORANUN C, 1993, J IMMUNOL, V151, P6853; Westendorp RGJ, 2001, NAT MED, V7, P873, DOI 10.1038/90868; Westendorp RGJ, 1997, LANCET, V349, P170, DOI 10.1016/S0140-6736(96)06413-6	40	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2015	10	6							e0130907	10.1371/journal.pone.0130907	http://dx.doi.org/10.1371/journal.pone.0130907			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4OM	26107717	gold, Green Published, Green Submitted			2022-12-26	WOS:000356932500129
J	Rim, Y; Choi, A; McPherson, DD; Kim, H				Rim, Yonghoon; Choi, Ahnryul; McPherson, David D.; Kim, Hyunggun			Personalized Computational Modeling of Mitral Valve Prolapse: Virtual Leaflet Resection	PLOS ONE			English	Article							FINITE-ELEMENT; CHORDAE TENDINEAE; DYNAMIC SIMULATION; REPAIR; POSTERIOR; REPLACEMENT; REGURGITATION; DURABILITY; SUTURES; DISEASE	Posterior leaflet prolapse following chordal elongation or rupture is one of the primary valvular diseases in patients with degenerative mitral valves (MVs). Quadrangular resection followed by ring annuloplasty is a reliable and reproducible surgical repair technique for treatment of posterior leaflet prolapse. Virtual MV repair simulation of leaflet resection in association with patient-specific 3D echocardiographic data can provide quantitative biomechanical and physiologic characteristics of pre- and post-resection MV function. We have developed a solid personalized computational simulation protocol to perform virtual MV repair using standard clinical guidelines of posterior leaflet resection with annuloplasty ring implantation. A virtual MV model was created using 3D echocardiographic data of a patient with posterior chordal rupture and severe mitral regurgitation. A quadrangle-shaped leaflet portion in the prolapsed posterior leaflet was removed, and virtual plication and suturing were performed. An annuloplasty ring of proper size was reconstructed and virtual ring annuloplasty was performed by superimposing the ring and the mitral annulus. Following the quadrangular resection and ring annuloplasty simulations, patient-specific annular motion and physiologic transvalvular pressure gradient were implemented and dynamic finite element simulation of MV function was performed. The pre-resection MV demonstrated a substantial lack of leaflet coaptation which directly correlated with the severe mitral regurgitation. Excessive stress concentration was found along the free marginal edge of the posterior leaflet involving the chordal rupture. Following the virtual resection and ring annuloplasty, the severity of the posterior leaflet prolapse markedly decreased. Excessive stress concentration disappeared over both anterior and posterior leaflets, and complete leaflet coaptation was effectively restored. This novel personalized virtual MV repair strategy has great potential to help with preoperative selection of the patient-specific optimal MV repair techniques, allow innovative surgical planning to expect improved efficacy of MV repair with more predictable outcomes, and ultimately provide more effective medical care for the patient.	[Rim, Yonghoon; Choi, Ahnryul; McPherson, David D.; Kim, Hyunggun] Univ Texas Hlth Sci Ctr Houston, Dept Internal Med, Div Cardiovasc Med, Houston, TX 77030 USA	University of Texas System; University of Texas Health Science Center Houston	Kim, H (corresponding author), Univ Texas Hlth Sci Ctr Houston, Dept Internal Med, Div Cardiovasc Med, Houston, TX 77030 USA.	Hyunggun.Kim@uth.tmc.edu			National Institutes of Health [R01 HL109597]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL109597] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the National Institutes of Health (R01 HL109597). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams DH, 2010, EUR HEART J, V31, P1958, DOI 10.1093/eurheartj/ehq222; Bortolotti U, 2012, ANN THORAC SURG, V93, P684, DOI 10.1016/j.athoracsur.2011.09.015; Braunberger E, 2001, CIRCULATION, V104, pI8; Carpentier A, 2011, CARPENTIERS RECONSTR; Chandran KB, 2014, ANN BIOMED IN PRESS; Choi A, 2014, BIO-MED MATER ENG, V24, P341, DOI 10.3233/BME-130816; David TE, 2005, J THORAC CARDIOV SUR, V130, P1242, DOI 10.1016/j.jtcvs.2005.06.046; David TE, 2013, J THORAC CARDIOV SUR, V145, P1563, DOI 10.1016/j.jtcvs.2012.05.030; Filsoufi F, 2007, SEMIN THORAC CARDIOV, V19, P103, DOI 10.1053/j.semtcvs.2007.04.003; George KM, 2009, J HEART VALVE DIS, V18, P119; Gillinov AM, 1998, J THORAC CARDIOV SUR, V116, P734, DOI 10.1016/S0022-5223(98)00450-4; Grande-Allen KJ, 2005, J THORAC CARDIOV SUR, V130, P783, DOI 10.1016/j.jtcvs.2005.04.019; Guy TS, 2012, ANNU REV MED, V63, P277, DOI 10.1146/annurev-med-022811-091602; Holubec T, 2013, ANN CARDIOTHORAC SUR, V2, P809, DOI 10.3978/j.issn.2225-319X.2013.10.08; Kim HG, 2008, ANN BIOMED ENG, V36, P262, DOI 10.1007/s10439-007-9409-4; Kim H, 2007, ANN BIOMED ENG, V35, P30, DOI 10.1007/s10439-006-9203-8; LAM JHC, 1970, CIRCULATION, V41, P449, DOI 10.1161/01.CIR.41.3.449; Lange R, 2010, ANN THORAC SURG, V89, P1163, DOI 10.1016/j.athoracsur.2009.12.057; Lim KH, 2005, J HEART VALVE DIS, V14, P386; Mansi T, 2012, MED IMAGE ANAL, V16, P1330, DOI 10.1016/j.media.2012.05.009; May-Newman K, 1998, J BIOMECH ENG-T ASME, V120, P38, DOI 10.1115/1.2834305; MAYNEWMAN K, 1995, AM J PHYSIOL-HEART C, V269, pH1319, DOI 10.1152/ajpheart.1995.269.4.H1319; Mohty D, 2001, CIRCULATION, V104, pI1; Nguyen TC, 2008, J THORAC CARDIOV SUR, V136, P557, DOI 10.1016/j.jtcvs.2007.12.087; Obase K, 2015, J AM SOC ECHOCARDIOG, V28, P449, DOI 10.1016/j.echo.2015.01.015; Padala M, 2009, ANN THORAC SURG, V88, P1499, DOI 10.1016/j.athoracsur.2009.06.042; Park Kwon-Jae, 2013, Korean J Thorac Cardiovasc Surg, V46, P124, DOI 10.5090/kjtcs.2013.46.2.124; Perier P., 2005, MULTIMED MAN CARDIOT, V2005; Prot V, 2010, J MECH BEHAV BIOMED, V3, P167, DOI 10.1016/j.jmbbm.2009.05.004; Rim Y, 2014, BIOMED ENG ONLINE, V13, DOI 10.1186/1475-925X-13-31; Rim Y, 2014, ANN BIOMED ENG, V42, P139, DOI 10.1007/s10439-013-0908-1; Rim Y, 2013, J BIOMECH, V46, P1104, DOI 10.1016/j.jbiomech.2013.01.014; Rim Y, 2013, JACC-CARDIOVASC IMAG, V6, P263, DOI 10.1016/j.jcmg.2012.10.017; Sakamoto Y, 2005, ANN THORAC SURG, V79, P475, DOI 10.1016/j.athoracsur.2004.07.046; Seeburger J, 2009, ANN THORAC SURG, V87, P1715, DOI 10.1016/j.athoracsur.2009.03.003; Sonne C, 2009, EUR J ECHOCARDIOGR, V10, P287, DOI 10.1093/ejechocard/jen237; Stevanella M, 2001, CARDIOVASC ENG TECHN, V2, P66; Stevanella M, 2011, J BIOMECH, V44, P2229, DOI 10.1016/j.jbiomech.2011.06.005; Stevanella M, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.4000107; Tenenholtz NA, 2011, IEEE INT C INT ROBOT, P1327, DOI 10.1109/IROS.2011.6048851; Verma S, 2009, NEW ENGL J MED, V361, P2261, DOI 10.1056/NEJMct0806111; Votta E, 2007, ANN THORAC SURG, V84, P92, DOI 10.1016/j.athoracsur.2007.03.040; Wang Q, 2013, ANN BIOMED ENG, V41, P142, DOI 10.1007/s10439-012-0620-6; Xu C, 2010, AM J PHYSIOL-HEART C, V299, pH1790, DOI 10.1152/ajpheart.00370.2010	44	20	20	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2015	10	6							e0130906	10.1371/journal.pone.0130906	http://dx.doi.org/10.1371/journal.pone.0130906			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4DD	26103002	Green Submitted, Green Published, gold			2022-12-26	WOS:000356901900068
J	Zhang, J; Li, L; Baldwin, AS; Friedman, AD; Paz-Priel, I				Zhang, Jing; Li, Li; Baldwin, Albert S., Jr.; Friedman, Alan D.; Paz-Priel, Ido			Loss of IKK beta but Not NF-kappa B p65 Skews Differentiation towards Myeloid over Erythroid Commitment and Increases Myeloid Progenitor Self-Renewal and Functional Long-Term Hematopoietic Stem Cells	PLOS ONE			English	Article							MYELOGENOUS LEUKEMIA STEM; C/EBP-ALPHA; LIVER DEGENERATION; KINASE-ALPHA; MICE LACKING; CANCER; PU.1; TRANSCRIPTION; INFLAMMATION; APOPTOSIS	NF-kappa B is an important regulator of both differentiation and function of lineage-committed hematopoietic cells. Targeted deletion of I kappa B kinase (IKK) beta results in altered cytokine signaling and marked neutrophilia. To investigate the role of IKK beta in regulation of hematopoiesis, we employed Mx1-Cre mediated IKK beta conditional knockout mice. As previously reported, deletion of IKK beta in hematopoietic cells results in neutrophilia, and we now also noted decreased monocytes and modest anemia. Granulocyte-macrophage progenitors (GMPs) accumulated markedly in bone marrow of IKK beta deleted mice whereas the proportion and number of megakaryocyte-erythrocyte progenitors (MEP) decreased. Accordingly, we found a significantly reduced frequency of proerythroblasts and basophilic and polychromatic erythroblasts, and IKK beta-deficient bone marrow cells yielded a significantly decreased number of BFU-E compared to wild type. These changes are associated with elevated expression of C/EBP alpha, Gfi1, and PU.1 and diminished Gata1, Klf1, and SCL/Tal1 in IKK beta deficient Lineage-Sca1(+)c-Kit(+) (LSK) cells. In contrast, no effect on erythropoiesis or expression of lineage-related transcription factors was found in marrow lacking NF-kappa B p65. Bone marrow from IKK beta knockout mice has elevated numbers of phenotypic long and short term hematopoietic stem cells (HSC). A similar increase was observed when IKK beta was deleted after marrow transplantation into a wild type host, indicating cell autonomous expansion. Myeloid progenitors from IKK beta-but not p65-deleted mice demonstrate increased serial replating in colony-forming assays, indicating increased cell autonomous self-renewal capacity. In addition, in a competitive repopulation assay deletion of IKK beta resulted in a stable advantage of bone marrow derived from IKK beta knockout mice. In summary, loss of IKK beta resulted in significant effects on hematopoiesis not seen upon NF-kappa B p65 deletion. These include increased myeloid and reduced erythroid transcription factors, skewing differentiation towards myeloid over erythroid differentiation, increased progenitor self-renewal, and increased number of functional long term HSCs. These data inform ongoing efforts to develop IKK inhibitors for clinical use.	[Zhang, Jing; Li, Li; Friedman, Alan D.; Paz-Priel, Ido] Johns Hopkins Univ, Sch Med, Div Pediat Oncol, Baltimore, MD 21218 USA; [Baldwin, Albert S., Jr.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Baldwin, Albert S., Jr.] Univ N Carolina, Dept Biol, Chapel Hill, NC 27599 USA	Johns Hopkins University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Paz-Priel, I (corresponding author), Johns Hopkins Univ, Sch Med, Div Pediat Oncol, Baltimore, MD 21218 USA.	ipazpri1@jhmi.edu			Children Cancer Foundation; Mitchell Foundation; Cleveland Foundation New Investigator Research Award; National Institutes of Health [U01 HL099775]; Samuel Waxman Cancer Research Foundation; Giant Food Pediatric Cancer Research Foundation; National Cancer Institute [P30 CA006973]; NATIONAL CANCER INSTITUTE [P30CA006973] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL099775] Funding Source: NIH RePORTER	Children Cancer Foundation; Mitchell Foundation; Cleveland Foundation New Investigator Research Award; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Samuel Waxman Cancer Research Foundation; Giant Food Pediatric Cancer Research Foundation; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This research was supported by grants from the Children Cancer Foundation (to I.P-P.), the Mitchell Foundation (to I.P-P.), the Cleveland Foundation New Investigator Research Award (to I.PP.), National Institutes of Health grants U01 HL099775 (to A.D.F.), the Samuel Waxman Cancer Research Foundation (to A.D.F. and A.S.B.), and the Giant Food Pediatric Cancer Research Foundation, and National Cancer Institute P30 CA006973. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BEG AA, 1995, NATURE, V376, P167, DOI 10.1038/376167a0; Campbell CJV, 2010, BLOOD, V116, P1433, DOI 10.1182/blood-2009-12-258095; Chaturvedi MM, 2011, ONCOGENE, V30, P1615, DOI 10.1038/onc.2010.566; Comb WC, 2011, ONCOGENE, V30, P1727, DOI 10.1038/onc.2010.553; Comb WC, 2012, MOL CELL, V45, P719, DOI 10.1016/j.molcel.2012.01.010; Criollo A, 2010, EMBO J, V29, P619, DOI 10.1038/emboj.2009.364; Dan HC, 2007, CANCER RES, V67, P6263, DOI 10.1158/0008-5472.CAN-07-1232; Dooher JE, 2011, MOL CANCER RES, V9, P1395, DOI 10.1158/1541-7786.MCR-11-0072; Eaves CJ, 2015, BLOOD, V125, P2605, DOI 10.1182/blood-2014-12-570200; Friedman AD, 2015, INT J HEMATOL, V101, P330, DOI 10.1007/s12185-015-1764-6; Golde WT, 2005, LAB ANIMAL, V34, P39, DOI 10.1038/laban1005-39; Greten FR, 2007, CELL, V130, P918, DOI 10.1016/j.cell.2007.07.009; Greten FR, 2004, CELL, V118, P285, DOI 10.1016/j.cell.2004.07.013; Guzman ML, 2005, BLOOD, V105, P4163, DOI 10.1182/blood-2004-10-4135; Guzman ML, 2001, BLOOD, V98, P2301, DOI 10.1182/blood.V98.8.2301; Guzman ML, 2007, BLOOD, V110, P4427, DOI 10.1182/blood-2007-05-090621; Hirai H, 2006, NAT IMMUNOL, V7, P732, DOI 10.1038/ni1354; Hoberg JE, 2004, MOL CELL, V16, P245, DOI 10.1016/j.molcel.2004.10.010; Hodge D, 2006, BLOOD, V107, P3359, DOI 10.1182/blood-2005-07-2888; Hsieh MY, 2014, BLOOD, V123, P2401, DOI 10.1182/blood-2014-01-547943; Hsu LC, 2011, NAT IMMUNOL, V12, P144, DOI 10.1038/ni.1976; Iwasaki H, 2007, ONCOGENE, V26, P6687, DOI 10.1038/sj.onc.1210754; Jia CH, 2013, CELL DEATH DIFFER, V20, P248, DOI 10.1038/cdd.2012.115; Kagoya Y, 2014, J CLIN INVEST, V124, P528, DOI 10.1172/JCI68101; Kassouf MT, 2010, GENOME RES, V20, P1064, DOI 10.1101/gr.104935.110; Lamberti C, 2001, J BIOL CHEM, V276, P42276, DOI 10.1074/jbc.M104227200; Li QT, 1999, SCIENCE, V284, P321, DOI 10.1126/science.284.5412.321; Li ZW, 2003, J IMMUNOL, V170, P4630, DOI 10.4049/jimmunol.170.9.4630; Liu JJ, 2012, EXP HEMATOL, V40, P330, DOI 10.1016/j.exphem.2011.12.002; Liu Y, 2006, BLOOD, V108, P123, DOI 10.1182/blood-2005-11-4458; Mankan AK, 2011, P NATL ACAD SCI USA, V108, P6567, DOI 10.1073/pnas.1018331108; Mousallem T, 2014, BLOOD, V124, P2046, DOI 10.1182/blood-2014-04-571265; Naugler WE, 2008, CURR OPIN GENET DEV, V18, P19, DOI 10.1016/j.gde.2008.01.020; Nerlov C, 1998, GENE DEV, V12, P2403, DOI 10.1101/gad.12.15.2403; Opferman JT, 2005, SCIENCE, V307, P1101, DOI 10.1126/science.1106114; Pannicke U, 2013, NEW ENGL J MED, V369, P2504, DOI 10.1056/NEJMoa1309199; Paz-Priel I, 2005, MOL CANCER RES, V3, P585, DOI 10.1158/1541-7786.MCR-05-0111; Paz-Priel I, 2011, BLOOD, V117, P4085, DOI 10.1182/blood-2010-07-294470; PEVNY L, 1991, NATURE, V349, P257, DOI 10.1038/349257a0; Purton LE, 2007, CELL STEM CELL, V1, P263, DOI 10.1016/j.stem.2007.08.016; Rajasekhar VK, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1159; Rekhtman N, 2003, MOL CELL BIOL, V23, P7460, DOI 10.1128/MCB.23.21.7460-7474.2003; Sakurai H, 1999, J BIOL CHEM, V274, P30353, DOI 10.1074/jbc.274.43.30353; SCHLICK E, 1985, J BIOL RESP MODIF, V4, P628; Shostak K, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2886; Staudt LM, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000109; Stein SJ, 2013, BLOOD, V121, P5015, DOI 10.1182/blood-2013-02-486142; Steinbrecher KA, 2008, J IMMUNOL, V180, P2588, DOI 10.4049/jimmunol.180.4.2588; Stopka T, 2005, EMBO J, V24, P3712, DOI 10.1038/sj.emboj.7600834; Tripic T, 2009, BLOOD, V113, P2191, DOI 10.1182/blood-2008-07-169417; Wang DH, 2009, J IMMUNOL, V182, P5757, DOI 10.4049/jimmunol.0803861; Yan J, 2013, CELL, V152, P304, DOI 10.1016/j.cell.2012.12.021; Zhang P, 1999, P NATL ACAD SCI USA, V96, P8705, DOI 10.1073/pnas.96.15.8705; Zhong HH, 2002, MOL CELL, V9, P625, DOI 10.1016/S1097-2765(02)00477-X; Ziegelbauer K, 2005, BRIT J PHARMACOL, V145, P178, DOI 10.1038/sj.bjp.0706176	55	14	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2015	10	6							e0130441	10.1371/journal.pone.0130441	http://dx.doi.org/10.1371/journal.pone.0130441			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4DD	26102347	Green Published, Green Submitted, gold			2022-12-26	WOS:000356901900042
J	Carstensen, TBW; Fink, P; Oernboel, E; Kasch, H; Jensen, TS; Frostholm, L				Carstensen, Tina Birgitte Wisbech; Fink, Per; Oernboel, Eva; Kasch, Helge; Jensen, Troels Staehelin; Frostholm, Lisbeth			Sick Leave within 5 Years of Whiplash Trauma Predicts Recovery: A Prospective Cohort and Register-Based Study	PLOS ONE			English	Article							NECK PAIN INTENSITY; PROGNOSTIC-FACTORS; RISK-FACTORS; FOLLOW-UP; INJURY; DISABILITY; DISORDERS	Background 10-22% of individuals sustaining whiplash trauma develop persistent symptoms resulting in reduced working ability and decreased quality of life, but it is poorly understood why some people do not recover. Various collision and post-collision risk factors have been studied, but little is known about pre-collision risk factors. In particular, the impact of sickness and socioeconomic factors before the collision on recovery is sparsely explored. The aim of this study was to examine if welfare payments received within five years pre-collision predict neck pain and negative change in provisional situation one year post-collision. Methods and Findings 719 individuals with acute whiplash trauma consecutively recruited from emergency departments or primary care after car accidents in Denmark completed questionnaires on socio-demographic and health factors immediately after the collision. After 12 months, a visual analogue scale on neck pain intensity was completed. 3595 matched controls in the general population were sampled, and national public register data on social benefits and any other welfare payments were obtained for participants with acute whiplash trauma and controls from five years pre-collision to 15 months after. Participants with acute whiplash trauma who had received sickness benefit for more than 12 weeks pre-collision had increased odds for negative change in future provisional situation (Odds Ratio (OR) (95% Confidence Interval (CI) = 3.8 (2.1; 7.1)) and future neck pain (OR (95% CI) = 3.3 (1.8; 6.3)), controlling for other known risk factors. Participants with acute whiplash trauma had weaker attachment to labour market (more weeks of sick leave (chi(2)(2) = 36.7, p < 0.001) and unemployment (chi(2)(2) = 12.5, p = 0.002)) pre-collision compared with controls. Experiencing a whiplash trauma raised the odds for future negative change in provisional situation (OR (95% CI) = 3.1 (2.3; 4.4)) compared with controls. Conclusions Sick leave before the collision strongly predicted prolonged recovery following whiplash trauma. Participants with acute whiplash trauma had weaker attachment to labour market pre-collision compared with the general population. Neck pain at inclusion predicted future neck pain. Acute whiplash trauma may trigger pre-existing vulnerabilities increasing risk of developing whiplash-associated disorders.	[Carstensen, Tina Birgitte Wisbech; Fink, Per; Oernboel, Eva; Frostholm, Lisbeth] Aarhus Univ Hosp, Res Clin Funct Disorders & Psychosomat, DK-8000 Aarhus, Denmark; [Kasch, Helge] Aarhus Univ Hosp, Dept Neurol, DK-8000 Aarhus, Denmark; [Jensen, Troels Staehelin] Aarhus Univ Hosp, Danish Pain Res Ctr, DK-8000 Aarhus, Denmark	Aarhus University; Aarhus University; Aarhus University	Carstensen, TBW (corresponding author), Aarhus Univ Hosp, Res Clin Funct Disorders & Psychosomat, DK-8000 Aarhus, Denmark.	tinacars@rm.dk	Frostholm, lisbeth/AAE-5217-2019; Kasch, Helge/H-1325-2012; Jensen, Troels Staehelin/A-3418-2009; Kasch, Helge/Q-3170-2019; Fink, Per/AAA-2297-2021	Kasch, Helge/0000-0002-9302-4946; Jensen, Troels Staehelin/0000-0002-3487-6380; Kasch, Helge/0000-0002-9302-4946; Fink, Per/0000-0003-2921-4099; Carstensen, Tina/0000-0001-5086-4331; frostholm, lisbeth/0000-0002-9683-7416	trade organisation of Insurance and Pensions in Denmark; Health Insurance Foundation; Research Foundation of Aarhus University; Tryg Foundation; Illum Foundation; Lippmann Foundation; Foundation of The Family Hede Nielsen; Danish Rheumatism Association	trade organisation of Insurance and Pensions in Denmark; Health Insurance Foundation; Research Foundation of Aarhus University; Tryg Foundation; Illum Foundation; Lippmann Foundation; Foundation of The Family Hede Nielsen; Danish Rheumatism Association	This study was supported by the trade organisation of Insurance and Pensions in Denmark, The Health Insurance Foundation, The Research Foundation of Aarhus University, The Tryg Foundation, The Illum Foundation, The Lippmann Foundation, The Foundation of The Family Hede Nielsen, and The Danish Rheumatism Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No information about results or participation in the project was given to the participants' insurance company.	Aasvang EK, 2010, ANESTHESIOLOGY, V112, P957, DOI 10.1097/ALN.0b013e3181d31ff8; Atherton K, 2006, EMERG MED J, V23, P195, DOI 10.1136/emj.2005.027102; Berglund A, 2006, PAIN, V125, P244, DOI 10.1016/j.pain.2006.05.026; Buitenhuis J, 2009, SPINE, V34, P262, DOI 10.1097/BRS.0b013e3181913d07; Carstensen TBW, 2012, EUR J PAIN, V16, P49, DOI 10.1016/j.ejpain.2011.06.002; Carstensen TBW, 2008, PAIN, V139, P248, DOI 10.1016/j.pain.2008.04.008; Cassidy JD, 2000, NEW ENGL J MED, V342, P1179, DOI 10.1056/NEJM200004203421606; Collins SL, 1997, PAIN, V72, P95, DOI 10.1016/S0304-3959(97)00005-5; Diatchenko L, 2006, PAIN, V123, P226, DOI 10.1016/j.pain.2006.04.015; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Harrell FE, 2001, REGRESSION MODELING; Hjollund NH, 2007, SCAND J PUBLIC HEALT, V35, P497, DOI 10.1080/14034940701271882; Hogg-Johnson S, 2009, J MANIP PHYSIOL THER, V32, pS46, DOI 10.1016/j.jmpt.2008.11.010; Holm LW, 2007, CLIN J PAIN, V23, P591, DOI 10.1097/AJP.0b013e318100181f; Holm LW, 2006, SPINE, V31, pE98, DOI 10.1097/01.brs.0000199901.52053.87; Hosmer DW, 2001, APPL LOGISTIC REGRES; Jensen M., 1993, HDB PAIN ASSESSMENT, P15; JENSEN MP, 1986, PAIN, V27, P117, DOI 10.1016/0304-3959(86)90228-9; Johansen MK, 1999, PAIN, V83, P229, DOI 10.1016/S0304-3959(99)00106-2; Kasch H, 2008, EUR J NEUROL, V15, P1222, DOI 10.1111/j.1468-1331.2008.02301.x; Kasch H, 2005, EUR J PAIN, V9, P561, DOI 10.1016/j.ejpain.2004.11.011; Kasch H, 2001, CEPHALALGIA, V21, P189, DOI 10.1046/j.1468-2982.2001.00179.x; Kongsted A, 2008, EUR J PAIN, V12, P455, DOI 10.1016/j.ejpain.2007.07.008; Kongsted A, 2008, CLIN REHABIL, V22, P469, DOI 10.1177/0269215507082141; Kongsted A, 2007, SPINE, V32, P618, DOI 10.1097/01.brs.0000257535.77691.bd; Lankester BJA, 2006, EUR SPINE J, V15, P902, DOI 10.1007/s00586-005-0936-0; Leth-Petersen S, 2009, J HEALTH ECON, V28, P996, DOI 10.1016/j.jhealeco.2009.06.013; McLean SA, 2011, J PAIN, V12, P101, DOI 10.1016/j.jpain.2010.05.008; Myrtveit SM, 2013, J PSYCHOSOM RES, V74, P393, DOI 10.1016/j.jpsychores.2013.02.004; Nikolajsen L, 2006, ACTA ANAESTH SCAND, V50, P495, DOI 10.1111/j.1399-6576.2006.00976.x; Nikolajsen L, 2004, ACTA ANAESTH SCAND, V48, P111, DOI 10.1111/j.1399-6576.2004.00271.x; Peduzzi P, 1996, J CLIN EPIDEMIOL, V49, P1373, DOI 10.1016/S0895-4356(96)00236-3; Spitzer WO, 1995, SPINE S8, V20, P1, DOI DOI 10.1097/00007632-199504151-00001; STATA, 2003, 114905 STATA; Sterling M, 2011, SPINE, V36, pS330, DOI 10.1097/BRS.0b013e3182388523; Steyerberg EW, 2000, STAT MED, V19, P1059, DOI 10.1002/(SICI)1097-0258(20000430)19:8<1059::AID-SIM412>3.0.CO;2-0; VANHOUWELINGEN JC, 1990, STAT MED, V9, P1303, DOI 10.1002/sim.4780091109; Walton D, 2009, DISABIL REHABIL, V31, P943, DOI 10.1080/09638280802404128; Walton DM, 2013, J ORTHOP SPORT PHYS, V43, P31, DOI 10.2519/jospt.2013.4507; Walton DM, 2009, J ORTHOP SPORT PHYS, V39, P334, DOI 10.2519/jospt.2009.2765	40	19	20	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2015	10	6							e0130298	10.1371/journal.pone.0130298	http://dx.doi.org/10.1371/journal.pone.0130298			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL3FM	26098860	gold, Green Submitted, Green Published			2022-12-26	WOS:000356835800061
J	Spronk, HMH; Braunschweig, T; Rossaint, R; Wust, DC; van Oerle, R; Lauritzen, B; Tolba, R; Grottke, O				Spronk, Henri M. H.; Braunschweig, Till; Rossaint, Rolf; Wuest, Dirk C.; van Oerle, Rene; Lauritzen, Brian; Tolba, Rene; Grottke, Oliver			Recombinant Factor VIIa Reduces Bleeding after Blunt Liver Injury in a Pig Model of Dilutional Coagulopathy under Severe Hypothermia	PLOS ONE			English	Article							PROTHROMBIN COMPLEX CONCENTRATE; DECREASES BLOOD-LOSS; HIGH-DOSE FACTOR; MAJOR TRAUMA; FACTOR-X; COAGULATION; MANAGEMENT; TIME; THROMBELASTOGRAPHY; IDENTIFICATION	Background Recombinant factor VIIa (rFVIIa) is registered for use in haemophilia with inhibitors and other rare bleeding disorders, but has also been used in various other clinical conditions to terminate life-threatening bleeding. Underlying conditions (e.g. coagulopathy) and dosing may affect treatment efficacy. The objective of the present study was to evaluate the impact of increasing doses of rFVIIa on blood loss and coagulation assays in haemodiluted and hypothermic pigs undergoing blunt liver injury. Methods A grade III blunt liver injury was induced in 28 pigs after 70% haemodilution and cooling to 32.6-33.4 degrees C. Ten minutes after trauma, animals randomly received placebo or 90, 180 or 360 mu g/kg rFVIIa. Global coagulation parameters, thromboelastometry (TEM) and plasma thrombin generation (TG) were determined at different time points during the observation period of 120 minutes. Results Total blood loss was significantly lower following 90 mu g/ kg rFVIIa (1206 [1138-1470] mL) relative to placebo (2677 [2337-3068] mL; p<0.05), with no increased effect with higher dose levels of rFVIIa. Following trauma and haemodilution, coagulation was impaired relative to baseline in both TEM and TG analysis. At 60 and 120 minutes after trauma, TEM variables improved in the rFVIIa-treated animals compared with the placebo group. Similarly, rFVIIa improved coagulation kinetics in TG. As was observed with blood loss, no significant effect between different rFVIIa dose levels was found in TEM or TG. Macro- and microscopic post-mortem examination did not reveal any signs of thromboembolic events. Conclusion Early administration of 90 mu g/kg rFVIIa reduced blood loss in pigs undergoing blunt liver injury even after severe haemodilution and hypothermia, with no further effect of higher dose levels. Coagulation assays showed impaired coagulation in coagulopathic animals, with a dose-independent improvement in animals treated with rFVIIa.	[Spronk, Henri M. H.; van Oerle, Rene] Maastricht Univ, Cardiovasc Res Inst Maastricht, Dept Internal Med, Lab Clin Thrombosis & Haemostasis, NL-6200 MD Maastricht, Netherlands; [Braunschweig, Till] RWTH Aachen Univ Hosp, Dept Pathol, Aachen, Germany; [Rossaint, Rolf; Wuest, Dirk C.; Grottke, Oliver] RWTH Aachen Univ Hosp, Dept Anaesthesiol, Aachen, Germany; [Lauritzen, Brian] Novo Nordisk AS, Malov, Denmark; [Tolba, Rene] RWTH Aachen Univ Hosp, Inst Lab Anim Sci, Aachen, Germany	Maastricht University; RWTH Aachen University; RWTH Aachen University Hospital; RWTH Aachen University; RWTH Aachen University Hospital; Novo Nordisk; RWTH Aachen University; RWTH Aachen University Hospital	Grottke, O (corresponding author), RWTH Aachen Univ Hosp, Dept Anaesthesiol, Aachen, Germany.	ogrottke@ukaachen.de	Braunschweig, Till/AAO-5725-2020; Grottke, Oliver/F-1508-2018	Braunschweig, Till/0000-0001-9166-2912; Spronk, Henri/0000-0002-3858-334X; Grottke, Oliver/0000-0002-0722-3122	START program of the Faculty of Medicine at RWTH Aachen	START program of the Faculty of Medicine at RWTH Aachen	This research was supported by the START program of the Faculty of Medicine at RWTH Aachen and rFVIIa was provided by Novo Nordisk (Denmark, provision of NovoSeven in 2009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BOM VJJ, 1990, BIOCHEM J, V265, P327, DOI 10.1042/bj2650327; Brohi K, 2003, J TRAUMA, V54, P1127, DOI 10.1097/01.TA.0000069184.82147.06; Brohi K, 2007, CURR OPIN CRIT CARE, V13, P680, DOI 10.1097/MCC.0b013e3282f1e78f; Caballo C, 2012, BLOOD TRANSFUS, V10, P1; Darlington DN, 2012, INT J BURNS TRAUMA, V2, P42; Dusel CH, 2004, BLOOD COAGUL FIBRIN, V15, P405, DOI 10.1097/01.mbc.0000114437.81125.2b; Fenger-Eriksen C, 2009, J THROMB HAEMOST, V7, P1099, DOI 10.1111/j.1538-7836.2009.03460.x; Grottke O, 2010, BRIT J ANAESTH, V105, P789, DOI 10.1093/bja/aeq263; Grottke O, 2010, EUR SURG RES, V44, P65, DOI 10.1159/000265053; Grottke O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064100; Grottke O, 2012, CURR OPIN CRIT CARE, V18, P641, DOI 10.1097/MCC.0b013e328358e254; Grottke O, 2011, BLOOD, V118, P1943, DOI 10.1182/blood-2011-03-343046; Grottke O, 2010, CRIT CARE, V14, DOI 10.1186/cc8960; Hauser CJ, 2010, J TRAUMA, V69, P489, DOI 10.1097/TA.0b013e3181edf36e; Hedner U, 1999, THROMB HAEMOSTASIS, V82, P531; Hedner U, 2006, SEMIN THROMB HEMOST, V32, P77, DOI 10.1055/s-2006-939557; Hess JR, 2008, J TRAUMA, V65, P748, DOI 10.1097/TA.0b013e3181877a9c; Howes DW, 2007, J TRAUMA, V62, P311, DOI 10.1097/01.ta.0000229704.06991.9d; Jeroukhimov I, 2002, J TRAUMA, V53, P1053, DOI 10.1097/00005373-200212000-00004; Kheirabadi BS, 2007, J TRAUMA, V62, P1352, DOI 10.1097/TA.0b013e318047b805; Klemcke HG, 2005, J TRAUMA, V59, P155, DOI 10.1097/01.TA.0000174557.89804.A2; Knudsen T, 2011, FRONT BIOSCI-LANDMRK, V16, P3196, DOI 10.2741/3906; Loeffen R, 2012, J THROMB HAEMOST, V10, P2544, DOI 10.1111/jth.12012; MacLeod JBA, 2003, J TRAUMA, V55, P39, DOI 10.1097/01.TA.0000075338.21177.EF; Martini WZ, 2008, J TRAUMA, V65, P535, DOI 10.1097/TA.0b013e31818379a6; McMullin NR, 2008, SHOCK, V29, P703, DOI 10.1097/SHK.0b013e31815dbcbf; Mitrophanov AY, 2011, THROMB RES, V128, P381, DOI 10.1016/j.thromres.2011.05.013; Mitterlechner T, 2011, J THROMB HAEMOST, V9, P729, DOI 10.1111/j.1538-7836.2011.04211.x; Monroe DM, 1997, BRIT J HAEMATOL, V99, P542, DOI 10.1046/j.1365-2141.1997.4463256.x; Schochl H, 2010, CRIT CARE, V14, DOI 10.1186/cc8948; Schreiber MA, 2002, J TRAUMA, V53, P252, DOI 10.1097/00005373-200208000-00011; Spahn DR, 2013, CRIT CARE, V17, DOI 10.1186/cc12685; Stinger HK, 2008, J TRAUMA, V64, pS79, DOI 10.1097/TA.0b013e318160a57b; Viuff D, 2008, BRIT J ANAESTH, V101, P324, DOI 10.1093/bja/aen175	35	5	5	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2015	10	6							e0113979	10.1371/journal.pone.0113979	http://dx.doi.org/10.1371/journal.pone.0113979			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL3FM	26098426	Green Submitted, Green Published, gold			2022-12-26	WOS:000356835800001
J	Zhao, X; Xu, MM; Wei, RR; Liu, Y				Zhao, Xin; Xu, Mengmeng; Wei, Rongrong; Liu, Yang			Expression of OsCAS (Calcium-Sensing Receptor) in an Arabidopsis Mutant Increases Drought Tolerance	PLOS ONE			English	Article							CHLOROPHYLL FLUORESCENCE; ELECTRON-TRANSPORT; PHOTOSYSTEM-II; GAS-EXCHANGE; WHEAT LEAVES; PHOTOSYNTHESIS; STRESS; LIMITATIONS; PARAMETERS; RESPONSES	The calcium-sensing receptor (CaS), which is localized in the chloroplasts, is a crucial regulator of extracellular calcium-induced stomatal closure in Arabidopsis. It has homologs in Oryza sativa and other plants. These sequences all have a rhodanese-like protein domain, which has been demonstrated to be associated with specific stress conditions. In this study, we cloned the Oryza sativa calcium-sensing receptor gene (OsCAS) and demonstrated that OsCAS could sense an increase of extracellular Ca2+ concentration and mediate an increase in cytosolic Ca2+ concentration. The OsCAS gene was transformed into an Arabidopsis CaSknockout mutant (Salk) and overexpressed in the transgenic plants. OsCAS promoted stomatal closure. We screened homozygous transgenic Arabidopsisplants and determined physiological indices such as the oxidative damage biomarker malondialdehyde (MDA), relative membrane permeability (RMP), proline content, and chlorophyll fluorescence parameters, after 21 days of drought treatment. Our results revealed lower RMP and MDA contents and a higher Proline content in transgenic Arabidopsis plants after drought stress, whereas the opposite was observed in Salk plants. With respect to chlorophyll fluorescence, the electron transport rate and effective PSII quantum yield decreased in all lines under drought stress; however, in the transgenic plants these two parameters changed fewer and were higher than those in wild-type and Salk plants. The quantum yield of regulated energy dissipation and nonregulated energy dissipation in PSII were higher in Salk plants, whereas these values were lower in the transgenic plants than in the wild type under drought stress. The above results suggest that the transgenic plants showed better resistance to drought stress by decreasing damage to the cell membrane, increasing the amount of osmoprotectants, and maintaining a relatively high photosynthetic capacity. In conclusion, OsCAS is an extracellular calcium-sensing receptor that helps to compensate for the absence of CaS in Arabidopsis and increases the drought stress tolerance of transgenic plants.	[Zhao, Xin; Xu, Mengmeng; Wei, Rongrong; Liu, Yang] Capital Normal Univ, Coll Life Sci, Beijing, Peoples R China	Capital Normal University	Zhao, X (corresponding author), Capital Normal Univ, Coll Life Sci, Beijing, Peoples R China.	Zhaox0521@126.com			National Nature Science Foundation of China [30900771]; Beijing Natural Science Foundation [5102006]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Natural Science Foundation(Beijing Natural Science Foundation)	Grant Number: 30900771, National Nature Science Foundation of China (http://www.nsfc.gov.cn/), Grant Number: 5102006, and Beijing Natural Science Foundation (http://www.bjnsf.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BATES LS, 1973, PLANT SOIL, V39, P205, DOI 10.1007/BF00018060; BLUM A, 1981, CROP SCI, V21, P43, DOI 10.2135/cropsci1981.0011183X002100010013x; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Cavender-Bares J, 2004, ADV PHOTO RESPIRAT, V19, P737; CHAVES MM, 1991, J EXP BOT, V42, P1, DOI 10.1093/jxb/42.1.1; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Dias MC, 2010, PHOTOSYNTHETICA, V48, P96, DOI 10.1007/s11099-010-0013-8; Ding SH, 2012, BBA-BIOENERGETICS, V1817, P1979, DOI 10.1016/j.bbabio.2012.06.003; Farooq M, 2009, SUSTAINABLE AGRICULTURE, P153, DOI 10.1051/agro:2008021; Flexas J, 2002, ANN BOT-LONDON, V89, P183, DOI 10.1093/aob/mcf027; Grassi G, 2005, PLANT CELL ENVIRON, V28, P834, DOI 10.1111/j.1365-3040.2005.01333.x; Guarini JM, 2009, PHOTOSYNTHETICA, V47, P206, DOI 10.1007/s11099-009-0034-3; Han SC, 2003, NATURE, V425, P196, DOI 10.1038/nature01932; Kalaji HM, 2012, J PHOTOCH PHOTOBIO B, V112, P1, DOI 10.1016/j.jphotobiol.2012.03.009; Kalaji HM, 2011, OMICS, V15, P925, DOI 10.1089/omi.2011.0070; Kramer DM, 2004, PHOTOSYNTH RES, V79, P209, DOI 10.1023/B:PRES.0000015391.99477.0d; Massacci A, 2008, PLANT PHYSIOL BIOCH, V46, P189, DOI 10.1016/j.plaphy.2007.10.006; Misra A.N., 2012, BIOPHYSICS, V49, P322, DOI [10.4319/lo.2004.49.2.0322, DOI 10.4319/LO.2004.49.2.0322]; Murchie EH, 2013, J EXP BOT, V64, P3983, DOI 10.1093/jxb/ert208; MURRAY MG, 1980, NUCLEIC ACIDS RES, V8, P4321, DOI 10.1093/nar/8.19.4321; Neill SJ, 2002, J EXP BOT, V53, P1237, DOI 10.1093/jexbot/53.372.1237; Nomura H, 2008, PLANT J, V53, P988, DOI 10.1111/j.1365-313X.2007.03390.x; Papageorgiou GC, 2011, J PHOTOCH PHOTOBIO B, V104, P258, DOI 10.1016/j.jphotobiol.2011.03.008; Pei ZM, 1997, PLANT CELL, V9, P409, DOI 10.1105/tpc.9.3.409; Pompelli MF, 2010, BIOMASS BIOENERG, V34, P1207, DOI 10.1016/j.biombioe.2010.03.011; Shao HB, 2008, CR BIOL, V331, P215, DOI 10.1016/j.crvi.2008.01.002; Sui Y, 2013, BIOTECHNOLOGY B, V8, P015; Tang LL, 2013, PLANT PHYSIOL BIOCH, V71, P22, DOI 10.1016/j.plaphy.2013.06.024; Vainonen JP, 2008, FEBS J, V275, P1767, DOI 10.1111/j.1742-4658.2008.06335.x; Van Norman JM, 2009, WIRES SYST BIOL MED, V1, P372, DOI 10.1002/wsbm.25; Wei R, 2013, J ANHUI AGR SCI, P4747; Xing W, 2010, PLANT PHYSIOL BIOCH, V48, P873, DOI 10.1016/j.plaphy.2010.08.006; Zhao JS, 2007, PLANT CELL REP, V26, P1521, DOI 10.1007/s00299-007-0362-3; Zivcak M, 2014, J PHOTOCH PHOTOBIO B, V137, P107, DOI 10.1016/j.jphotobiol.2014.01.007; Zivcak M, 2013, PHOTOSYNTH RES, V117, P529, DOI 10.1007/s11120-013-9885-3	35	19	21	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2015	10	6							e0131272	10.1371/journal.pone.0131272	http://dx.doi.org/10.1371/journal.pone.0131272			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL3FM	26098425	Green Submitted, gold, Green Published			2022-12-26	WOS:000356835800166
J	Bernardes, NE; Takeda, AAS; Dreyer, TR; Freitas, FZ; Bertolini, MC; Fontes, MRM				Bernardes, Natalia E.; Takeda, Agnes A. S.; Dreyer, Thiago R.; Freitas, Fernanda Z.; Bertolini, Maria Celia; Fontes, Marcos R. M.			Structure of Importin-a from a Filamentous Fungus in Complex with a Classical Nuclear Localization Signal	PLOS ONE			English	Article							CRYSTALLOGRAPHIC ANALYSIS; BINDING-SITE; BIOPHYSICAL CHARACTERIZATION; CRYSTAL-STRUCTURE; SEQUENCE-BINDING; PROTEIN IMPORT; ALPHA; TRANSPORT; RECOGNITION; PHOSPHORYLATION	Neurospora crassa is a filamentous fungus that has been extensively studied as a model organism for eukaryotic biology, providing fundamental insights into cellular processes such as cell signaling, growth and differentiation. To advance in the study of this multicellular organism, an understanding of the specific mechanisms for protein transport into the cell nucleus is essential. Importin-alpha (Imp-alpha) is the receptor for cargo proteins that contain specific nuclear localization signals (NLSs) that play a key role in the classical nuclear import pathway. Structures of Imp-a from different organisms (yeast, rice, mouse, and human) have been determined, revealing that this receptor possesses a conserved structural scaffold. However, recent studies have demonstrated that the Imp alpha mechanism of action may vary significantly for different organisms or for different isoforms from the same organism. Therefore, structural, functional, and biophysical characterization of different Impa proteins is necessary to understand the selectivity of nuclear transport. Here, we determined the first crystal structure of an Impa from a filamentous fungus which is also the highest resolution Impa structure already solved to date (1.75 angstrom). In addition, we performed calorimetric analysis to determine the affinity and thermodynamic parameters of the interaction between Impa and the classical SV40 NLS peptide. The comparison of these data with previous studies on Impa proteins led us to demonstrate that N. crassa Imp-alpha possess specific features that are distinct from mammalian Imp-alpha but exhibit important similarities to rice Imp-alpha, particularly at the minor NLS binding site.	[Bernardes, Natalia E.; Takeda, Agnes A. S.; Dreyer, Thiago R.; Fontes, Marcos R. M.] Univ Estadual Paulista, UNESP, Inst Biociencias, Dept Fis & Biofis, Botucatu, SP, Brazil; [Freitas, Fernanda Z.; Bertolini, Maria Celia] Univ Estadual Paulista, UNESP, Inst Quim, Dept Bioquim & Tecnol Quim, Araraquara, SP, Brazil	Universidade Estadual Paulista; Universidade Estadual Paulista	Fontes, MRM (corresponding author), Univ Estadual Paulista, UNESP, Inst Biociencias, Dept Fis & Biofis, Botucatu, SP, Brazil.	fontes@ibb.unesp.br	Takeda, Agnes/AAH-3413-2020; Zanolli Freitas, Fernanda/ABB-9297-2021; Zanolli Freitas, Fernanda/J-9425-2012; Bertolini, Maria Celia/D-3654-2012; Dreyer, Thiago/B-9752-2019; Fontes, Marcos Roberto/B-1941-2009	Takeda, Agnes/0000-0001-5000-6652; Zanolli Freitas, Fernanda/0000-0002-8810-2970; Zanolli Freitas, Fernanda/0000-0002-8810-2970; Bertolini, Maria Celia/0000-0001-5319-2710; Dreyer, Thiago/0000-0002-2780-1428; Fontes, Marcos Roberto/0000-0002-4634-6221; Bernardes, Natalia/0000-0002-6498-0429	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (www.fapesp.br: MRMF, MCB, NEB), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (www.cnpq.br: MRMF and MCB), and Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (www.capes.br: AAST).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Bernardes NE, 2014, ACTA CRYSTALLOGR F, V70, P501, DOI 10.1107/S2053230X14005068; Catimel B, 2001, J BIOL CHEM, V276, P34189, DOI 10.1074/jbc.M103531200; Chang CW, 2014, MOL PLANT, V7, P1061, DOI 10.1093/mp/ssu014; Chang CW, 2012, PLANT CELL, V24, P5074, DOI 10.1105/tpc.112.104422; Chen MH, 2005, J BIOL CHEM, V280, P10599, DOI 10.1074/jbc.M413194200; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chook YM, 1999, NATURE, V399, P230, DOI 10.1038/20375; Conti E, 1998, CELL, V94, P193, DOI 10.1016/S0092-8674(00)81419-1; Conti E, 2000, STRUCTURE, V8, P329, DOI 10.1016/S0969-2126(00)00107-6; Cupertino FB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044258; Cutress ML, 2008, J CELL SCI, V121, P957, DOI 10.1242/jcs.022103; de Barros AC, 2012, ACTA CRYSTALLOGR D, V68, P743, DOI 10.1107/S0907444912010281; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; DINGWALL C, 1991, TRENDS BIOCHEM SCI, V16, P478, DOI 10.1016/0968-0004(91)90184-W; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Falces J, 2010, BIOCHEMISTRY-US, V49, P9756, DOI 10.1021/bi101179g; Fang XD, 2001, DEVELOPMENT, V128, P3349; Fontes MRM, 2003, BIOCHEM J, V375, P339, DOI 10.1042/BJ20030510; Fontes MRM, 2003, J BIOL CHEM, V278, P27981, DOI 10.1074/jbc.M303275200; Fontes MRM, 2000, J MOL BIOL, V297, P1183, DOI 10.1006/jmbi.2000.3642; Freitas FZ, 2008, PROTEOMICS, V8, P2052, DOI 10.1002/pmic.200700921; Galagan JE, 2003, NATURE, V422, P859, DOI 10.1038/nature01554; Ge Q, 2011, J BIOL CHEM, V286, P28119, DOI 10.1074/jbc.M111.237016; Giesecke A, 2010, J BIOL CHEM, V285, P17628, DOI 10.1074/jbc.M110.102343; Goldfarb DS, 2004, TRENDS CELL BIOL, V14, P505, DOI 10.1016/j.tcb.2004.07.016; Goncalves RD, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.007963; KABSCH W, 1976, ACTA CRYSTALLOGR A, V32, P922, DOI 10.1107/S0567739476001873; Knudsen NO, 2009, DNA REPAIR, V8, P682, DOI 10.1016/j.dnarep.2009.03.005; Kobe B, 1999, NAT STRUCT BIOL, V6, P388, DOI 10.1038/7625; Kohler M, 1997, FEBS LETT, V417, P104, DOI 10.1016/S0014-5793(97)01265-9; Kohler M, 1999, EXP NEPHROL, V7, P290; Kosugi S, 2008, CHEM BIOL, V15, P940, DOI 10.1016/j.chembiol.2008.07.019; Kosugi S, 2009, J BIOL CHEM, V284, P478, DOI 10.1074/jbc.M807017200; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lott K, 2011, J BIOL CHEM, V286, P28160, DOI 10.1074/jbc.M111.228007; Marfori M, 2012, TRAFFIC, V13, P532, DOI 10.1111/j.1600-0854.2012.01329.x; Marfori M, 2011, BBA-MOL CELL RES, V1813, P1562, DOI 10.1016/j.bbamcr.2010.10.013; Mason DA, 2002, GENETICS, V161, P157; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pumroy RA, 2012, J BIOL CHEM, V287, P2022, DOI 10.1074/jbc.M111.315838; REXACH M, 1995, CELL, V83, P683, DOI 10.1016/0092-8674(95)90181-7; Rona G, 2013, ACTA CRYSTALLOGR D, V69, P2495, DOI 10.1107/S0907444913023354; Sekimoto T, 1997, EMBO J, V16, P7067, DOI 10.1093/emboj/16.23.7067; Stewart M, 2007, NAT REV MOL CELL BIO, V8, P195, DOI 10.1038/nrm2114; Stinnett SM, 2007, MOL MICROBIOL, V63, P242, DOI 10.1111/j.1365-2958.2006.05506.x; Takeda AAS, 2013, PROTEIN PEPTIDE LETT, V20, P8; Takeda AAS, 2011, J MOL BIOL, V412, P226, DOI 10.1016/j.jmb.2011.07.038; Tarendeau F, 2007, NAT STRUCT MOL BIOL, V14, P229, DOI 10.1038/nsmb1212; Trowitzsch S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7011; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Wirthmueller L, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00149; Yang SNY, 2010, J BIOL CHEM, V285, P19935, DOI 10.1074/jbc.M109.079574	55	11	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2015	10	6							e0128687	10.1371/journal.pone.0128687	http://dx.doi.org/10.1371/journal.pone.0128687			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL3FE	26091498	Green Published, gold, Green Submitted			2022-12-26	WOS:000356835000027
J	Bittner, LM; Westphal, K; Narberhaus, F				Bittner, Lisa-Marie; Westphal, Kai; Narberhaus, Franz			Conditional Proteolysis of the Membrane Protein YfgM by the FtsH Protease Depends on a Novel N-terminal Degron	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							END RULE PATHWAY; TRANSCRIPTION FACTOR SIGMA(32); AMINO-ACID STARVATION; ESCHERICHIA-COLI FTSH; INORGANIC POLYPHOSPHATE; TURNOVER ELEMENT; REGULATED DEGRADATION; LENGTH RECOGNITION; STRINGENT RESPONSE; RCS PHOSPHORELAY	Regulated proteolysis efficiently and rapidly adapts the bacterial proteome to changing environmental conditions. Many protease substrates contain recognition motifs, so-called degrons, that direct them to the appropriate protease. Here we describe an entirely new degron identified in the cytoplasmic N-terminal end of the membrane-anchored protein YfgM of Escherichia coli. YfgM is stable during exponential growth and degraded in stationary phase by the essential FtsH protease. The alarmone (p) ppGpp, but not the previously described YfgM interactors RcsB and PpiD, influence YfgM degradation. By scanning mutagenesis, we define individual amino acids responsible for turnover of YfgM and find that the degron does not at all comply with the known N-end rule pathway. The YfgM degron is a distinct module that facilitates FtsH-mediated degradation when fused to the N terminus of another monotopic membrane protein but not to that of a cytoplasmic protein. Several lines of evidence suggest that stress-induced degradation of YfgM relieves the response regulator RcsB and thereby permits cellular protection by the Rcs phosphorelay system. On the basis of these and other results in the literature, we propose a model for how the membrane-spanning YfgM protein serves as connector between the stress responses in the periplasm and cytoplasm.	[Bittner, Lisa-Marie; Westphal, Kai; Narberhaus, Franz] Ruhr Univ Bochum, Microbial Biol, D-44801 Bochum, Germany	Ruhr University Bochum	Narberhaus, F (corresponding author), Ruhr Univ Bochum, Lehrstuhl Biol Mikroorganismen, Fak Biol & Biotechnol, Univ Str 150, D-44801 Bochum, Germany.	franz.narberhaus@rub.de		Narberhaus, Franz/0000-0002-8552-5310	German Research Foundation grant in the Collaborative Research Center [SFB642]	German Research Foundation grant in the Collaborative Research Center	This work was supported by German Research Foundation grant in the Collaborative Research Center SFB642 "GTP- and ATP-dependent membrane processes" (to F. N.). The authors declare that they have no conflicts of interest with the contents of this article.	AIBA H, 1981, J BIOL CHEM, V256, P1905; Akiyama Y, 1996, FEBS LETT, V399, P26, DOI 10.1016/S0014-5793(96)01283-5; Akiyama Y, 1996, J BIOL CHEM, V271, P31196, DOI 10.1074/jbc.271.49.31196; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Baker TA, 2006, TRENDS BIOCHEM SCI, V31, P647, DOI 10.1016/j.tibs.2006.10.006; Battesti A, 2011, ANNU REV MICROBIOL, V65, P189, DOI 10.1146/annurev-micro-090110-102946; Bieniossek C, 2009, P NATL ACAD SCI USA, V106, P21579, DOI 10.1073/pnas.0910708106; Brown MRW, 2008, TRENDS BIOCHEM SCI, V33, P284, DOI 10.1016/j.tibs.2008.04.005; Carballes F, 1999, MOL MICROBIOL, V34, P442, DOI 10.1046/j.1365-2958.1999.01605.x; Castanie-Cornet MP, 2010, NUCLEIC ACIDS RES, V38, P3546, DOI 10.1093/nar/gkq097; Chiba S, 2002, J BACTERIOL, V184, P4775, DOI 10.1128/JB.184.17.4775-4782.2002; Chiba S, 2000, EMBO REP, V1, P47, DOI 10.1093/embo-reports/kvd005; Dalebroux ZD, 2012, NAT REV MICROBIOL, V10, P203, DOI 10.1038/nrmicro2720; Davalos-Garcia M, 2001, J BACTERIOL, V183, P5870, DOI 10.1128/JB.183.20.5870-5876.2001; Dougan DA, 2010, MOL MICROBIOL, V76, P545, DOI 10.1111/j.1365-2958.2010.07120.x; Dougan DA, 2002, CELL MOL LIFE SCI, V59, P1607, DOI 10.1007/PL00012487; Erbse A, 2006, NATURE, V439, P753, DOI 10.1038/nature04412; Flynn JM, 2001, P NATL ACAD SCI USA, V98, P10584, DOI 10.1073/pnas.191375298; Fuhrer F, 2007, J MOL BIOL, V372, P485, DOI 10.1016/j.jmb.2007.06.083; Fuhrer F, 2006, MOL MICROBIOL, V59, P1025, DOI 10.1111/j.1365-2958.2005.04994.x; Gamer J, 1996, EMBO J, V15, P607, DOI 10.1002/j.1460-2075.1996.tb00393.x; Gottesman S, 1998, GENE DEV, V12, P1338, DOI 10.1101/gad.12.9.1338; Gotzke H, 2015, MOL CELL PROTEOMICS, V14, P216, DOI 10.1074/mcp.M114.043216; Gotzke H, 2014, J BIOL CHEM, V289, P19089, DOI 10.1074/jbc.M113.541672; Griffith KL, 2004, MOL MICROBIOL, V51, P1801, DOI 10.1046/j.1365-2958.2003.03952.x; Guisbert E, 2004, GENE DEV, V18, P2812, DOI 10.1101/gad.1219204; Gur Eyal, 2013, Subcell Biochem, V66, P3, DOI 10.1007/978-94-007-5940-4_1; Gur E, 2011, NAT REV MICROBIOL, V9, P839, DOI 10.1038/nrmicro2669; HENGGEARONIS R, 1993, J BACTERIOL, V175, P259, DOI 10.1128/JB.175.1.259-265.1993; Herman C, 1998, GENE DEV, V12, P1348, DOI 10.1101/gad.12.9.1348; Herman C, 2003, MOL CELL, V11, P659, DOI 10.1016/S1097-2765(03)00068-6; HERMAN C, 1995, P NATL ACAD SCI USA, V92, P3516, DOI 10.1073/pnas.92.8.3516; Horikoshi M, 2004, J BACTERIOL, V186, P7474, DOI 10.1128/JB.186.22.7474-7480.2004; Hoskins JR, 2002, P NATL ACAD SCI USA, V99, P11037, DOI 10.1073/pnas.172378899; Humbard MA, 2013, J BIOL CHEM, V288, P28913, DOI 10.1074/jbc.M113.492108; Jain V, 2006, J MICROBIOL, V44, P1; Johnson MD, 2011, J BACTERIOL, V193, P3653, DOI 10.1128/JB.05040-11; Karimova G, 2012, J BACTERIOL, V194, P5576, DOI 10.1128/JB.00774-12; Keiler KC, 1996, SCIENCE, V271, P990, DOI 10.1126/science.271.5251.990; Kihara A, 1998, J MOL BIOL, V279, P175, DOI 10.1006/jmbi.1998.1781; Kobiler O, 2002, P NATL ACAD SCI USA, V99, P14964, DOI 10.1073/pnas.222172499; Komenda J, 2007, PLANT CELL, V19, P2839, DOI 10.1105/tpc.107.053868; Kornberg A, 1999, ANNU REV BIOCHEM, V68, P89, DOI 10.1146/annurev.biochem.68.1.89; Krin E, 2010, RES MICROBIOL, V161, P363, DOI 10.1016/j.resmic.2010.04.002; Kuroda A, 2006, BIOSCI BIOTECH BIOCH, V70, P325, DOI 10.1271/bbb.70.325; Kuroda A, 1997, J BIOL CHEM, V272, P21240, DOI 10.1074/jbc.272.34.21240; Kuroda A, 2001, SCIENCE, V293, P705, DOI 10.1126/science.1061315; Landini P, 2014, ENV MICROBIOL REP, V6, P1, DOI 10.1111/1758-2229.12112; Langklotz S, 2012, BBA-MOL CELL RES, V1823, P40, DOI 10.1016/j.bbamcr.2011.08.015; Langklotz S, 2011, MOL MICROBIOL, V80, P1313, DOI 10.1111/j.1365-2958.2011.07646.x; Lasserre JP, 2006, ELECTROPHORESIS, V27, P3306, DOI 10.1002/elps.200500912; Maddalo G, 2011, J PROTEOME RES, V10, P1848, DOI 10.1021/pr101105c; Majdalani N, 2005, ANNU REV MICROBIOL, V59, P379, DOI 10.1146/annurev.micro.59.050405.101230; Majdalani N, 2002, MOL MICROBIOL, V46, P813, DOI 10.1046/j.1365-2958.2002.03203.x; Mogk A, 2007, TRENDS CELL BIOL, V17, P165, DOI 10.1016/j.tcb.2007.02.001; Obrist M, 2005, J BACTERIOL, V187, P3807, DOI 10.1128/JB.187.11.3807-3813.2005; Obrist M, 2009, FEMS MICROBIOL LETT, V290, P199, DOI 10.1111/j.1574-6968.2008.01423.x; Obrist M, 2007, MICROBIOL-SGM, V153, P2560, DOI 10.1099/mic.0.2007/007047-0; Ogura T, 1999, MOL MICROBIOL, V31, P833, DOI 10.1046/j.1365-2958.1999.01221.x; Okuno T, 2006, GENES CELLS, V11, P261, DOI 10.1111/j.1365-2443.2006.00940.x; Peterson CN, 2006, J BACTERIOL, V188, P3175, DOI 10.1128/JB.188.9.3175-3181.2006; Rao NN, 1996, J BACTERIOL, V178, P1394, DOI 10.1128/jb.178.5.1394-1400.1996; Sachelaru I, 2014, J BIOL CHEM, V289, P21706, DOI 10.1074/jbc.M114.577916; Sambrook J., 2001, MOL CLONING LAB MANU; Sauer RT, 2011, ANNU REV BIOCHEM, V80, P587, DOI 10.1146/annurev-biochem-060408-172623; Sauer RT, 2004, CELL, V119, P9, DOI 10.1016/j.cell.2004.09.020; Schakermann M, 2013, J BACTERIOL, V195, P1912, DOI 10.1128/JB.02134-12; Shah IM, 2006, J MOL BIOL, V357, P718, DOI 10.1016/j.jmb.2005.12.088; Shiba T, 2000, BIOCHEMISTRY-MOSCOW+, V65, P315; Shotland Y, 2000, J MOL BIOL, V299, P953, DOI 10.1006/jmbi.2000.3767; Singh S, 2011, J BACTERIOL, V193, P6436, DOI 10.1128/JB.05942-11; Sledjeski DD, 1996, J BACTERIOL, V178, P1204, DOI 10.1128/jb.178.4.1204-1206.1996; Slominska M, 1999, VIROLOGY, V262, P431, DOI 10.1006/viro.1999.9907; Sriram SM, 2011, NAT REV MOL CELL BIO, V12, P735, DOI 10.1038/nrm3217; Tatsuta T, 1998, MOL MICROBIOL, V30, P583, DOI 10.1046/j.1365-2958.1998.01091.x; TOMOYASU T, 1995, EMBO J, V14, P2551, DOI 10.1002/j.1460-2075.1995.tb07253.x; Traxler MF, 2008, MOL MICROBIOL, V68, P1128, DOI 10.1111/j.1365-2958.2008.06229.x; Westphal K, 2012, J BIOL CHEM, V287, P42962, DOI 10.1074/jbc.M112.388470; Wilms I, 2011, MOL MICROBIOL, V80, P492, DOI 10.1111/j.1365-2958.2011.07589.x; Wu J, 2009, J CELL PHYSIOL, V220, P297, DOI 10.1002/jcp.21797; XIAO H, 1991, J BIOL CHEM, V266, P5980; Yamada-Inagawa T, 2003, J BIOL CHEM, V278, P50182, DOI 10.1074/jbc.M308327200	83	18	18	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 31	2015	290	31					19367	19378		10.1074/jbc.M115.648550	http://dx.doi.org/10.1074/jbc.M115.648550			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CN9PK	26092727	Green Published, hybrid			2022-12-26	WOS:000358781100047
J	Ibeawuchi, SRC; Agbor, LN; Quelle, FW; Sigmund, CD				Ibeawuchi, Stella-Rita C.; Agbor, Larry N.; Quelle, Frederick W.; Sigmund, Curt D.			Hypertension-causing Mutations in Cullin3 Protein Impair RhoA Protein Ubiquitination and Augment the Association with Substrate Adaptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DISEASE-CAUSING MUTATIONS; VASCULAR SMOOTH-MUSCLE; KELCH-LIKE 3; LIGASE COMPLEX; DEGRADATION; KINASE; NEDD8; WNK4; MECHANISM; SUBUNIT	Cullin/Ring ubiquitin ligases regulate protein turnover by promoting the ubiquitination of substrate proteins, targeting them for proteasomal degradation. It has been shown previously that mutations in Cullin3 (Cul3) causing deletion of 57 amino acids encoded by exon 9 (Cul3 Delta 9) cause hypertension. Moreover, RhoA activity contributes to vascular constriction and hypertension. We show that ubiquitination and degradation of RhoA is dependent on Cul3 in HEK293T cells in which Cul3 expression is ablated by either siRNA or by CRISPR-Cas9 genome editing. The latter was used to generate a Cul3-null cell line (HEK293T(Cul3KO)). When expressed in these cells, Cul3 Delta 9 supported reduced ubiquitin ligase activity toward RhoA compared with equivalent levels of wild-type Cul3 (Cul3WT). Consistent with its reduced activity, binding of Cul3 Delta 9 to the E3 ubiquitin ligase Rbx1 and neddylation of Cul3 Delta 9 were impaired significantly compared with Cul3WT. Conversely, Cul3 Delta 9 bound to substrate adaptor proteins more efficiently than Cul3WT. Cul3 Delta 9 also forms unstable dimers with Cul3WT, disrupting dimers of Cul3WT complexes that are required for efficient ubiquitination of some substrates. Indeed, coexpression of Cul3WT and Cul3 Delta 9 in HEK293T(Cul3KO) cells resulted in a decrease in the active form of Cul3WT. We conclude that Cul3 Delta 9-associated ubiquitin ligase activity toward RhoA is impaired and suggest that Cul3 Delta 9 mutations may act dominantly by sequestering substrate adaptors and disrupting Cul3WT complexes.	[Ibeawuchi, Stella-Rita C.; Agbor, Larry N.; Quelle, Frederick W.; Sigmund, Curt D.] Univ Iowa, Dept Pharmacol, Iowa City, IA 52242 USA	University of Iowa	Sigmund, CD (corresponding author), Univ Iowa, Dept Pharmacol, Iowa City, IA 52242 USA.	curt-sigmund@uiowa.edu	Regan, Clinton/E-6250-2012; Sigmund, Curt D./W-1611-2019	Sigmund, Curt D./0000-0002-1453-0921; Quelle, Frederick/0000-0002-1184-6170	National Institutes of Health [HL048058, HL062984, HL084207]; American Heart Association [14PRE18420033]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL048058, P01HL084207, P01HL062984, R01HL125603, R37HL048058] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM067795] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants HL048058, HL062984, and HL084207 (to C. D. S.). This work was also supported by American Heart Association Grant 14PRE18420033 (to S. R. I.). The authors declare that they have no conflicts of interest with the contents of this article.	Ahn J, 2011, BIOCHEMISTRY-US, V50, P1359, DOI 10.1021/bi101749s; Berthold J, 2008, EXP CELL RES, V314, P3453, DOI 10.1016/j.yexcr.2008.09.005; Boyden LM, 2012, NATURE, V482, P98, DOI 10.1038/nature10814; Budzyn K, 2006, TRENDS PHARMACOL SCI, V27, P97, DOI 10.1016/j.tips.2005.12.002; Chen YZ, 2009, MOL CELL, V35, P841, DOI 10.1016/j.molcel.2009.09.004; Choo Yeun Su, 2009, J Vis Exp, DOI 10.3791/1293; Choo YY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041350; COSO OA, 1995, CELL, V81, P1137, DOI 10.1016/S0092-8674(05)80018-2; Friedman AD, 2003, J BIOL CHEM, V278, P26851, DOI 10.1074/jbc.M210039200; Furukawa M, 2000, MOL CELL BIOL, V20, P8185, DOI 10.1128/MCB.20.21.8185-8197.2000; Hao B, 2007, MOL CELL, V26, P131, DOI 10.1016/j.molcel.2007.02.022; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; HIRATA K, 1992, J BIOL CHEM, V267, P8719; Hori T, 1999, ONCOGENE, V18, P6829, DOI 10.1038/sj.onc.1203093; Loirand G, 2010, NAT REV CARDIOL, V7, P637, DOI 10.1038/nrcardio.2010.136; Masumoto A, 2001, HYPERTENSION, V38, P1307, DOI 10.1161/hy1201.096541; McCormick JA, 2014, J CLIN INVEST, V124, P4723, DOI 10.1172/JCI76126; McMahon M, 2006, J BIOL CHEM, V281, P24756, DOI 10.1074/jbc.M601119200; Oberg EA, 2012, J BIOL CHEM, V287, P43378, DOI 10.1074/jbc.M112.420281; Ohh M, 2002, EMBO REP, V3, P177, DOI 10.1093/embo-reports/kvf028; Ohta A, 2013, BIOCHEM J, V451, P111, DOI 10.1042/BJ20121903; Ohta T, 1999, MOL CELL, V3, P535, DOI 10.1016/S1097-2765(00)80482-7; Pelham CJ, 2012, CELL METAB, V16, P462, DOI 10.1016/j.cmet.2012.08.011; Pintard L, 2004, EMBO J, V23, P1681, DOI 10.1038/sj.emboj.7600186; QIU RG, 1995, P NATL ACAD SCI USA, V92, P11781, DOI 10.1073/pnas.92.25.11781; Scott DC, 2010, MOL CELL, V39, P784, DOI 10.1016/j.molcel.2010.08.030; Seol JH, 1999, GENE DEV, V13, P1614, DOI 10.1101/gad.13.12.1614; Shibata S, 2013, P NATL ACAD SCI USA, V110, P7838, DOI 10.1073/pnas.1304592110; Skaar JR, 2007, CANCER RES, V67, P2006, DOI 10.1158/0008-5472.CAN-06-3241; Tang X, 2007, CELL, V129, P1165, DOI 10.1016/j.cell.2007.04.042; Uehata M, 1997, NATURE, V389, P990, DOI 10.1038/40187; Wakabayashi M, 2013, CELL REP, V3, P858, DOI 10.1016/j.celrep.2013.02.024; Wilkins A, 2004, GENE DEV, V18, P856, DOI 10.1101/gad.1177904; Wirth A, 2008, NAT MED, V14, P64, DOI 10.1038/nm1666; Wu GJ, 2013, FEBS LETT, V587, P1717, DOI 10.1016/j.febslet.2013.04.032; Wu JT, 2005, NAT CELL BIOL, V7, P1014, DOI 10.1038/ncb1301; Wu K, 2000, J BIOL CHEM, V275, P32317, DOI 10.1074/jbc.M004847200; Xu L, 2003, NATURE, V425, P316, DOI 10.1038/nature01985; Yu HT, 1998, SCIENCE, V279, P1219, DOI 10.1126/science.279.5354.1219; Zheng N, 2002, NATURE, V416, P703, DOI 10.1038/416703a; Zhou CS, 2001, BMC BIOCHEM, V2, DOI 10.1186/1471-2091-2-7; Zhuang M, 2009, MOL CELL, V36, P39, DOI 10.1016/j.molcel.2009.09.022	42	44	44	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 31	2015	290	31					19208	19217		10.1074/jbc.M115.645358	http://dx.doi.org/10.1074/jbc.M115.645358			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CN9PK	26100637	Green Published, hybrid			2022-12-26	WOS:000358781100035
J	Cooper, PS; Garrett, PM; Rennie, JL; Karayanidis, F				Cooper, Patrick S.; Garrett, Paul M.; Rennie, Jaime L.; Karayanidis, Frini			Task Uncertainty Can Account for Mixing and Switch Costs in Task-Switching	PLOS ONE			English	Article							COGNITIVE CONTROL; ADVANCE PREPARATION; NEURAL MECHANISMS; COMPONENTS	Cognitive control is required in situations that involve uncertainty or change, such as when resolving conflict, selecting responses and switching tasks. Recently, it has been suggested that cognitive control can be conceptualised as a mechanism which prioritises goal-relevant information to deal with uncertainty. This hypothesis has been supported using a paradigm that requires conflict resolution. In this study, we examine whether cognitive control during task switching is also consistent with this notion. We used information theory to quantify the level of uncertainty in different trial types during a cued task-switching paradigm. We test the hypothesis that differences in uncertainty between task repeat and task switch trials can account for typical behavioural effects in task-switching. Increasing uncertainty was associated with less efficient performance (i.e., slower and less accurate), particularly on switch trials and trials that afford little opportunity for advance preparation. Interestingly, both mixing and switch costs were associated with a common episodic control process. These results support the notion that cognitive control may be conceptualised as an information processor that serves to resolve uncertainty in the environment.	[Cooper, Patrick S.; Garrett, Paul M.; Rennie, Jaime L.; Karayanidis, Frini] Univ Newcastle, Funct Neuroimaging Lab, Sch Psychol, Callaghan, NSW 2308, Australia; [Cooper, Patrick S.; Rennie, Jaime L.; Karayanidis, Frini] Univ Newcastle, Prior Res Ctr Translat Neurosci & Mental Hlth, Callaghan, NSW 2308, Australia	University of Newcastle; University of Newcastle	Karayanidis, F (corresponding author), Univ Newcastle, Funct Neuroimaging Lab, Sch Psychol, Callaghan, NSW 2308, Australia.	Frini.Karayanidis@newcastle.edu.au	Karayanidis, Frini/I-9269-2012; Garrett, Paul/ABB-2184-2020	Karayanidis, Frini/0000-0002-3317-9954; Garrett, Paul/0000-0002-8200-8377; Cooper, Patrick/0000-0002-0222-8514	Australian Research Council [DP120100340]	Australian Research Council(Australian Research Council)	This work was supported by the Australian Research Council Discovery Project (DP120100340). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen PA, 2004, J GERONTOL B-PSYCHOL, V59, pP210, DOI 10.1093/geronb/59.5.P210; Altmann EM, 2005, PSYCHON B REV, V12, P535, DOI 10.3758/BF03193801; Barcelo F, 2006, J COGNITIVE NEUROSCI, V18, P1734, DOI 10.1162/jocn.2006.18.10.1734; Barcelo F, 2008, FRONT HUM NEUROSCI, V1, DOI 10.3389/neuro.09.013.2007; Botvinick MM, 2001, PSYCHOL REV, V108, P624, DOI 10.1037//0033-295X.108.3.624; Braver TS, 2012, TRENDS COGN SCI, V16, P106, DOI 10.1016/j.tics.2011.12.010; Braver TS, 2009, P NATL ACAD SCI USA, V106, P7351, DOI 10.1073/pnas.0808187106; Braver TS, 2003, NEURON, V39, P713, DOI 10.1016/S0896-6273(03)00466-5; Braverman A, 2010, PSYCHOL RES-PSYCH FO, V74, P568, DOI 10.1007/s00426-010-0279-2; Cole MW, 2013, COGN AFFECT BEHAV NE, V13, P1, DOI 10.3758/s13415-012-0125-7; Dosenbach NUF, 2008, TRENDS COGN SCI, V12, P99, DOI 10.1016/j.tics.2008.01.001; Fan J, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00680; Fan J, 2014, J COGNITIVE NEUROSCI, V26, P1490, DOI 10.1162/jocn_a_00554; Fan J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003522; Goffaux P, 2006, BIOL PSYCHOL, V72, P278, DOI 10.1016/j.biopsycho.2005.11.009; Grange JA, 2010, PSYCHOL RES-PSYCH FO, V74, P481, DOI 10.1007/s00426-009-0270-y; Jamadar S, BRAIN MAPPI IN PRESS; Jost K, 2008, COGN AFFECT BEHAV NE, V8, P74, DOI 10.3758/CABN.8.1.74; Karayanidis F., 2014, TASK SWITCHING COGNI, P200, DOI DOI 10.1093/ACPROF:OSOBL/9780199921959.003.0009; Karayanidis F, 2010, FRONT PSYCHOL, V1, DOI 10.3389/fpsyg.2010.00025; Karayanidis F, 2011, PSYCHOPHYSIOLOGY, V48, P559, DOI 10.1111/j.1469-8986.2010.01115.x; Karayanidis F, 2009, COGN AFFECT BEHAV NE, V9, P202, DOI 10.3758/CABN.9.2.202; Kiesel A, 2007, PSYCHOL RES-PSYCH FO, V71, P117, DOI 10.1007/s00426-005-0004-8; Koechlin E, 2007, TRENDS COGN SCI, V11, P229, DOI 10.1016/j.tics.2007.04.005; Kray J, 2002, BRAIN COGNITION, V49, P363, DOI 10.1006/brcg.2001.1505; Kray J, 2006, BRAIN RES, V1105, P83, DOI 10.1016/j.brainres.2005.11.016; Mackie MA, 2013, BRAIN COGNITION, V82, P301, DOI 10.1016/j.bandc.2013.05.004; Mayr U, 2003, J EXP PSYCHOL LEARN, V29, P362, DOI 10.1037/0278-7393.29.3.362; Mayr U, 2000, J EXP PSYCHOL LEARN, V26, P1124, DOI 10.1037/0278-7393.26.5.1124; McMillen T, 2006, J MATH PSYCHOL, V50, P30, DOI 10.1016/j.jmp.2005.10.003; Meiran N, 2000, COGNITIVE PSYCHOL, V41, P211, DOI 10.1006/cogp.2000.0736; Meiran N, 2005, MEM COGNITION, V33, P1272, DOI 10.3758/BF03193228; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Miyake A, 2000, COGNITIVE PSYCHOL, V41, P49, DOI 10.1006/cogp.1999.0734; Nessler D, 2012, BIOL PSYCHOL, V91, P245, DOI 10.1016/j.biopsycho.2012.07.005; Petersen SE, 2012, ANNU REV NEUROSCI, V35, P73, DOI 10.1146/annurev-neuro-062111-150525; Ruge H, 2005, NEUROPSYCHOLOGIA, V43, P340, DOI 10.1016/j.neuropsychologia.2004.06.014; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; Terry CP, 2012, EXP AGING RES, V38, P87, DOI 10.1080/0361073X.2012.637008; Whitson LR, 2012, ACTA PSYCHOL, V139, P124, DOI 10.1016/j.actpsy.2011.09.004	40	13	14	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2015	10	6							e0131556	10.1371/journal.pone.0131556	http://dx.doi.org/10.1371/journal.pone.0131556			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CL4OM	26107646	gold, Green Published			2022-12-26	WOS:000356932500168
J	Hotchkin, CF; Parks, SE; Weiss, DJ				Hotchkin, Cara F.; Parks, Susan E.; Weiss, Daniel J.			Noise-Induced Frequency Modifications of Tamarin Vocalizations: Implications for Noise Compensation in Nonhuman Primates	PLOS ONE			English	Article							SAGUINUS-OEDIPUS; ACOUSTIC COMMUNICATION; CALLING BEHAVIOR; PERCEPTION; MODULATION; AMPLITUDE; LOUDNESS; FEATURES	Previous research suggests that nonhuman primates have limited flexibility in the frequency content of their vocalizations, particularly when compared to human speech. Consistent with this notion, several nonhuman primate species have demonstrated noise-induced changes in call amplitude and duration, with no evidence of changes to spectral content. This experiment used broad-and narrow-band noise playbacks to investigate the vocal control of two call types produced by cotton-top tamarins (Saguinus Oedipus). In 'combination long calls' (CLCs), peak fundamental frequency and the distribution of energy between low and high frequency harmonics (spectral tilt) changed in response to increased noise amplitude and bandwidth. In chirps, peak and maximum components of the fundamental frequency increased with increasing noise level, with no changes to spectral tilt. Other modifications included the Lombard effect and increases in chirp duration. These results provide the first evidence for noise-induced frequency changes in nonhuman primate vocalizations and suggest that future investigations of vocal plasticity in primates should include spectral parameters.	[Hotchkin, Cara F.] Penn State Univ, Intercoll Grad Degree Program Ecol, University Pk, PA 16802 USA; [Parks, Susan E.] Syracuse Univ, Dept Biol, Syracuse, NY 13244 USA; [Weiss, Daniel J.] Penn State Univ, Dept Psychol, University Pk, PA 16802 USA; [Weiss, Daniel J.] Penn State Univ, Program Linguist, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Syracuse University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Hotchkin, CF (corresponding author), Naval Facil Engn Command Atlantic, Marine Resources Branch, Norfolk, VA 23511 USA.	hotchkin.cara@gmail.com	Parks, Susan E/D-2675-2014	Parks, Susan E/0000-0001-6663-627X	National Institutes of Health [R01 HD067250]; DoD; Air Force Office of Scientific Research; National Defense Science and Engineering Graduate (NDSEG) Fellowship [32 CFR 168a]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD067250] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DoD(United States Department of Defense); Air Force Office of Scientific Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); National Defense Science and Engineering Graduate (NDSEG) Fellowship; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This project was funded by the National Institutes of Health [grant number R01 HD067250 to DJW] (www.nih.gov). Support for C. Hotchkin was provided by government support under and awarded by DoD, Air Force Office of Scientific Research, National Defense Science and Engineering Graduate (NDSEG) Fellowship, 32 CFR 168a (https://ndseg.asee.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amador A, 2013, J NEUROSCI, V33, P11136, DOI 10.1523/JNEUROSCI.5906-12.2013; [Anonymous], 2007, MATLAB; BAUERS K, 1990, AM J PRIMATOL, V21, P53, DOI 10.1002/ajp.1350210106; Bioacoustics Research Program, 2011, RAV PRO INT SOIUND A; Brumm H, 2005, ADV STUD BEHAV, V35, P151, DOI 10.1016/S0065-3454(05)35004-2; Brumm H, 2004, J EXP BIOL, V207, P443, DOI 10.1242/jeb.00768; Brumm H, 2011, BEHAVIOUR, V148, P1173, DOI 10.1163/000579511X605759; Brumm H, 2009, ANIM BEHAV, V78, P741, DOI 10.1016/j.anbehav.2009.07.004; CLEVELAND J, 1982, Z TIERPSYCHOL, V58, P231; EGAN J J, 1972, Journal of Auditory Research, V12, P318; Egnor SER, 2006, AM J PRIMATOL, V68, P1183, DOI 10.1002/ajp.20317; Eliades SJ, 2012, J NEUROSCI, V32, P10737, DOI 10.1523/JNEUROSCI.3448-11.2012; FITCH H, 1989, J ACOUST SOC AM, V86, P2017, DOI 10.1121/1.398582; Ghazanfar AA, 2002, ANIM BEHAV, V64, P427, DOI 10.1006/anbe.2002.3074; Ghazanfar AA, 2001, J COMP PHYSIOL A, V187, P27, DOI 10.1007/s003590000173; Ghazanfar AA, 2012, CURR BIOL, V22, P1176, DOI 10.1016/j.cub.2012.04.055; Hage SR, 2006, EUR J NEUROSCI, V23, P3297, DOI 10.1111/j.1460-9568.2006.04835.x; Hage SR, 2014, J EXP BIOL, V217, P2440, DOI 10.1242/jeb.102855; Hage SR, 2013, P NATL ACAD SCI USA, V110, P4063, DOI 10.1073/pnas.1211533110; Hotchkin C, 2013, BIOL REV, V88, P809, DOI 10.1111/brv.12026; Hotchkin CF, 2013, P M AC, V19; Janik VM, 1997, ADV STUD BEHAV, V26, P59, DOI 10.1016/S0065-3454(08)60377-0; Jordan K, 2004, INT J PRIMATOL, V25, P465, DOI 10.1023/B:IJOP.0000019162.31244.88; Lu YY, 2009, SPEECH COMMUN, V51, P1253, DOI 10.1016/j.specom.2009.07.002; MCCONNELL PB, 1986, BEHAVIOUR, V97, P273, DOI 10.1163/156853986X00649; Miller CT, 2004, J COMP PHYSIOL A, V190, P7, DOI 10.1007/s00359-003-0468-1; Moynihan M, 1970, OSME BEHAV PATTERNS; Nemeth E, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2798; Nemeth E, 2010, AM NAT, V176, P465, DOI 10.1086/656275; Nonaka S, 1997, NEUROSCI RES, V29, P283, DOI 10.1016/S0168-0102(97)00097-7; Owren MJ, 2011, AM J PRIMATOL, V73, P530, DOI 10.1002/ajp.20913; Parks SE, 2003, THESIS; Patricelli GL, 2006, AUK, V123, P639, DOI 10.1642/0004-8038(2006)123[639:ACIUNC]2.0.CO;2; PICK HL, 1989, J ACOUST SOC AM, V85, P894, DOI 10.1121/1.397561; Potvin DA, 2013, BEHAV ECOL, V24, P1363, DOI 10.1093/beheco/art075; Rabin LA., 2003, INT J COMP PSYCHOL, V16, P172; Egnor SER, 2006, J EXP BIOL, V209, P3652, DOI 10.1242/jeb.02420; Roy S, 2011, J EXP BIOL, V214, P3619, DOI 10.1242/jeb.056101; Savage A, 1996, AM J PRIMATOL, V38, P85, DOI 10.1002/(SICI)1098-2345(1996)38:1<85::AID-AJP7>3.0.CO;2-P; Schopf C, 2013, THESIS; SINNOTT JM, 1975, J ACOUST SOC AM, V58, P412, DOI 10.1121/1.380685; Stowe LM, 2013, J ACOUST SOC AM, V134, P640, DOI 10.1121/1.4807645; Sundberg J, 2006, J ACOUST SOC AM, V120, P453, DOI 10.1121/1.2208451; Tressler J, 2009, J COMP PHYSIOL A, V195, P923, DOI 10.1007/s00359-009-0468-x; Tyack P., 2013, ANIMAL COMMUNICATION, P251; VANSUMMERS W, 1988, J ACOUST SOC AM, V84, P917, DOI 10.1121/1.396660; Weiss DJ, 2014, BEHAV BRAIN SCI, V37, DOI 10.1017/S0140525X13004226; Weiss DJ, 2002, ANIM BEHAV, V64, P415, DOI 10.1006/anbe.2002.3083; Weiss DJ, 2001, J COMP PSYCHOL, V115, P258, DOI 10.1037/0735-7036.115.3.258; ZWISLOCKI JJ, 1969, J ACOUST SOC AM, V46, P431, DOI 10.1121/1.1911708	50	18	18	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2015	10	6							e0130211	10.1371/journal.pone.0130211	http://dx.doi.org/10.1371/journal.pone.0130211			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4OM	26107515	Green Published, Green Submitted, gold			2022-12-26	WOS:000356932500086
J	Legaard, KR; Sader, SA; Simons-Legaard, EM				Legaard, Kasey R.; Sader, Steven A.; Simons-Legaard, Erin M.			Evaluating the Impact of Abrupt Changes in Forest Policy and Management Practices on Landscape Dynamics: Analysis of a Landsat Image Time Series in the Atlantic Northern Forest	PLOS ONE			English	Article							UNITED-STATES; ROBUST PCA; HARVEST; PATTERNS; COVER; DISTURBANCE; PROGRAM; LEGACIES; REGIMES; TRENDS	Sustainable forest management is based on functional relationships between management actions, landscape conditions, and forest values. Changes in management practices make it fundamentally more difficult to study these relationships because the impacts of current practices are difficult to disentangle from the persistent influences of past practices. Within the Atlantic Northern Forest of Maine, U.S.A., forest policy and management practices changed abruptly in the early 1990s. During the 1970s-1980s, a severe insect outbreak stimulated salvage clearcutting of large contiguous tracts of spruce-fir forest. Following clearcut regulation in 1991, management practices shifted abruptly to near complete dependence on partial harvesting. Using a time series of Landsat satellite imagery (1973-2010) we assessed cumulative landscape change caused by these very different management regimes. We modeled predominant temporal patterns of harvesting and segmented a large study area into groups of landscape units with similar harvest histories. Time series of landscape composition and configuration metrics averaged within groups revealed differences in landscape dynamics caused by differences in management history. In some groups (24% of landscape units), salvage caused rapid loss and subdivision of intact mature forest. Persistent landscape change was created by large salvage clearcuts (often averaging > 100 ha) and conversion of spruce-fir to deciduous and mixed forest. In groups that were little affected by salvage (56% of landscape units), contemporary partial harvesting caused loss and subdivision of intact mature forest at even greater rates. Patch shape complexity and edge density reached high levels even where cumulative harvest area was relatively low. Contemporary practices introduced more numerous and much smaller patches of stand-replacing disturbance (typically averaging <15 ha) and a correspondingly large amount of edge. Management regimes impacted different areas to different degrees, producing different trajectories of landscape change that should be recognized when studying the impact of policy and management practices on forest ecology.	[Legaard, Kasey R.; Sader, Steven A.; Simons-Legaard, Erin M.] Univ Maine, Sch Forest Resources, Orono, ME 04469 USA	University of Maine System; University of Maine Orono	Legaard, KR (corresponding author), Univ Maine, Sch Forest Resources, Orono, ME 04469 USA.	kasey.legaard@maine.edu		Simons-Legaard, Erin/0000-0002-9815-2285; Legaard, Kasey/0000-0003-2874-8734	USDA Forest Service; Agenda 20/20 Program; Northeastern States Research Cooperative (NSRC)	USDA Forest Service(United States Department of Agriculture (USDA)United States Forest Service); Agenda 20/20 Program; Northeastern States Research Cooperative (NSRC)	This work was partially funded by the USDA Forest Service, Agenda 20/20 Program (project entitled "Predicting responses of forest landscape change on wildlife umbrella species: Modeling future effects of alternative forest harvesting scenarios on vertebrate diversity across multiple spatial scales on commercial forestlands in Maine") and the Northeastern States Research Cooperative (NSRC http://nsrcforest.org; project entitled "Developing and testing a third party landscape forest sustainability and biodiversity monitoring system"). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2005, MCCSFCP20051; Baumann M, 2012, REMOTE SENS ENVIRON, V124, P174, DOI 10.1016/j.rse.2012.05.001; Bergen KM, 2008, PHOTOGRAMM ENG REM S, V74, P787, DOI 10.14358/PERS.74.6.787; Brys G, 2004, J COMPUT GRAPH STAT, V13, P996, DOI 10.1198/106186004X12632; CARD DH, 1982, PHOTOGRAMM ENG REM S, V48, P431; Cohen WB, 2010, REMOTE SENS ENVIRON, V114, P2911, DOI 10.1016/j.rse.2010.07.010; Cohen WB, 2004, BIOSCIENCE, V54, P535, DOI 10.1641/0006-3568(2004)054[0535:LRIEAO]2.0.CO;2; Cubbage FW, 2006, FOREST POLICY ECON, V9, P261, DOI 10.1016/j.forpol.2005.07.008; DeBell D.S., 1997, CREATING FORESTRY 21; EBERHARDT LL, 1991, ECOL MONOGR, V61, P53, DOI 10.2307/1942999; Ellefson PV, 2007, FOREST POLICY ECON, V9, P620, DOI 10.1016/j.forpol.2006.05.001; Everitt B. S, 2011, CLUSTER ANAL, DOI DOI 10.1002/9780470977811; Ewers RM, 2006, BIOL REV, V81, P117, DOI 10.1017/S1464793105006949; Fuller AK, 2005, J WILDLIFE MANAGE, V69, P710, DOI 10.2193/0022-541X(2005)069[0710:IOPTHO]2.0.CO;2; Healey SP, 2008, ECOSYSTEMS, V11, P1106, DOI 10.1007/s10021-008-9182-8; Hepinstall JA, 1999, U MAINE TECHNICAL B, V173; Homyack JA, 2007, J WILDLIFE MANAGE, V71, P4, DOI 10.2193/2005-481; Hubert M, 2004, BIOINFORMATICS, V20, P1728, DOI 10.1093/bioinformatics/bth158; Hubert M, 2009, COMPUT STAT DATA AN, V53, P2264, DOI 10.1016/j.csda.2008.05.027; Irland LC, 1988, U MAINE B, V819; Jackson ST, 2010, TRENDS ECOL EVOL, V25, P153, DOI 10.1016/j.tree.2009.10.001; James PMA, 2007, ECOSYSTEMS, V10, P1261, DOI 10.1007/s10021-007-9095-y; Jin SM, 2005, REMOTE SENS ENVIRON, V94, P364, DOI 10.1016/j.rse.2004.10.012; Jin SM, 2006, FOREST ECOL MANAG, V228, P177, DOI 10.1016/j.foreco.2006.03.009; Kennedy RE, 2012, REMOTE SENS ENVIRON, V122, P117, DOI 10.1016/j.rse.2011.09.024; Lorimer CG, 2003, FOREST ECOL MANAG, V185, P41, DOI 10.1016/S0378-1127(03)00245-7; Maine Forest Service, 1994, SILV ACT REP; Maine Forest Service, 2000, SILV ACT REP; McCaskill GL, 2011, RESOURCE B; MCGARIGAL K, 1995, ECOL MONOGR, V65, P235, DOI 10.2307/2937059; McGarigal K., 2012, TECH REP; McRoberts RE, 2005, J FOREST, V103, P304; PICKETT S T A, 1989, P110; Preisendorfer R.W., 1988, DEV ATMOS SCI, V17; Price B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074333; Radford JQ, 2005, BIOL CONSERV, V124, P317, DOI 10.1016/j.biocon.2005.01.039; Robinson L, 2006, THESIS U MAINE; Sader SA, 2006, FOREST CHRON, V82, P203, DOI 10.5558/tfc82203-2; SADER SA, 1992, INT J REMOTE SENS, V13, P3055, DOI 10.1080/01431169208904102; Sader SA, 2003, FOREST SCI, V49, P341; Sader SA, 2008, FOREST ECOL MANAG, V255, P3846, DOI 10.1016/j.foreco.2008.03.047; Schrott GR, 2005, ECOL APPL, V15, P493, DOI 10.1890/04-0416; Seymour R.S., 1995, REGIONAL SILVICULTUR, V3, P31; Seymour Robert S., 1999, P22, DOI 10.1017/CBO9780511613029.004; SEYMOUR RS, 1992, FOR SCI, V40, P217; Simons E.M., 2009, DISSERTATION; Small C, 2013, INT J APPL EARTH OBS, V22, P40, DOI 10.1016/j.jag.2012.02.009; Sturtevant BR, 2014, FOREST ECOL MANAG, V313, P199, DOI 10.1016/j.foreco.2013.10.039; Thomas NE, 2011, REMOTE SENS ENVIRON, V115, P19, DOI 10.1016/j.rse.2010.07.009; Verboven S, 2010, WILEY INTERDISCIP RE, V2, P509, DOI 10.1002/wics.96; WARD JH, 1963, J AM STAT ASSOC, V58, P236, DOI 10.2307/2282967; Wilson EH, 2002, REMOTE SENS ENVIRON, V80, P385, DOI 10.1016/S0034-4257(01)00318-2; With K.A., 2007, TEMPORAL DIMENSIONS, P43; Zhu ZL, 2000, PHOTOGRAMM ENG REM S, V66, P1425	54	17	17	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2015	10	6							e0130428	10.1371/journal.pone.0130428	http://dx.doi.org/10.1371/journal.pone.0130428			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4OM	26106893	Green Published, Green Submitted, gold			2022-12-26	WOS:000356932500102
J	Snow, RW; Kibuchi, E; Karuri, SW; Sang, G; Gitonga, CW; Mwandawiro, C; Bejon, P; Noor, AM				Snow, Robert W.; Kibuchi, Eliud; Karuri, Stella W.; Sang, Gilbert; Gitonga, Caroline W.; Mwandawiro, Charles; Bejon, Philip; Noor, Abdisalan M.			Changing Malaria Prevalence on the Kenyan Coast since 1974: Climate, Drugs and Vector Control	PLOS ONE			English	Article								Background Progress toward reducing the malaria burden in Africa has been measured, or modeled, using datasets with relatively short time-windows. These restricted temporal analyses may miss the wider context of longer-term cycles of malaria risk and hence may lead to incorrect inferences regarding the impact of intervention. Methods 1147 age-corrected Plasmodium falciparum parasite prevalence (PfPR(2-10)) surveys among rural communities along the Kenyan coast were assembled from 1974 to 2014. A Bayesian conditional autoregressive generalized linear mixed model was used to interpolate to 279 small areas for each of the 41 years since 1974. Best-fit polynomial splined curves of changing PfPR(2-10) were compared to a sequence of plausible explanatory variables related to rainfall, drug resistance and insecticide-treated bed net (ITN) use. Results P. falciparum parasite prevalence initially rose from 1974 to 1987, dipped in 1991-92 but remained high until 1998. From 1998 onwards prevalence began to decline until 2011, then began to rise through to 2014. This major decline occurred before ITNs were widely distributed and variation in rainfall coincided with some, but not all, short-term transmission cycles. Emerging resistance to chloroquine and introduction of sulfadoxine/pyrimethamine provided plausible explanations for the rise and fall of malaria transmission along the Kenyan coast. Conclusions Progress towards elimination might not be as predictable as we would like, where natural and extrinsic cycles of transmission confound evaluations of the effect of interventions. Deciding where a country lies on an elimination pathway requires careful empiric observation of the long-term epidemiology of malaria transmission.	[Snow, Robert W.; Kibuchi, Eliud; Karuri, Stella W.; Sang, Gilbert; Gitonga, Caroline W.; Noor, Abdisalan M.] Wellcome Trust Res Programme, Kenya Med Res Inst, Spatial Hlth Metr Grp, Nairobi, Kenya; [Snow, Robert W.; Bejon, Philip; Noor, Abdisalan M.] Univ Oxford, Nuffield Dept Clin Med, Ctr Trop Med & Global Hlth, Oxford, England; [Mwandawiro, Charles] Kenya Govt Med Res Ctr, Eastern & South Africa Ctr Int Parasite Control, Nairobi, Kenya; [Bejon, Philip] KEMRI Wellcome Trust programme, Ctr Geog Med Coast, Kilifi, Kenya	Kenya Medical Research Institute; University of Oxford; Kenya Medical Research Institute	Snow, RW (corresponding author), Wellcome Trust Res Programme, Kenya Med Res Inst, Spatial Hlth Metr Grp, Nairobi, Kenya.	rsnow@kemri-wellcome.org	Snow, Robert William/AFR-1436-2022	Snow, Robert William/0000-0003-3725-6088	Wellcome Trust [095127, 079080, 103602, 092654]; Wellcome Trust Strategic Award for Capacity Building [084538]; UK Department for International Development [ITDCZE47]; MRC [G1002624] Funding Source: UKRI; Medical Research Council [G1002624] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); Wellcome Trust Strategic Award for Capacity Building; UK Department for International Development; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	RWS is a Wellcome Trust Principal Fellow (# 079080 & # 103602); AMN is supported by the Wellcome Trust as an Intermediate Fellow (# 095127); and SWK is supported by a Wellcome Trust Strategic Award for Capacity Building (# 084538). Funding from the UK Department for International Development to the INFORM project supports EK and GK (# ITDCZE47). RWS, EK, SWK, GS, PB and AMN acknowledge Wellcome Trust support to the Kenya Major Overseas Programme (# 092654). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.		0	43	44	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2015	10	6							e0128792	10.1371/journal.pone.0128792	http://dx.doi.org/10.1371/journal.pone.0128792			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4OM	26107772	gold, Green Submitted, Green Accepted, Green Published			2022-12-26	WOS:000356932500029
J	Dong, X; Yi, H; Lee, J; Nou, IS; Han, CT; Hur, Y				Dong, Xiangshu; Yi, Hankuil; Lee, Jeongyeo; Nou, Ill-Sup; Han, Ching-Tack; Hur, Yoonkang			Global Gene-Expression Analysis to Identify Differentially Expressed Genes Critical for the Heat Stress Response in Brassica rapa	PLOS ONE			English	Article							ARABIDOPSIS TRANSCRIPTION FACTOR; GENOME-WIDE ANALYSIS; CHINESE-CABBAGE; ABIOTIC STRESS; OXIDATIVE STRESS; SHOCK PROTEINS; ACQUIRED THERMOTOLERANCE; REACTIVE OXYGEN; MOLECULAR-MECHANISMS; FACTOR DREB2A	Genome-wide dissection of the heat stress response (HSR) is necessary to overcome problems in crop production caused by global warming. To identify HSR genes, we profiled gene expression in two Chinese cabbage inbred lines with different thermotolerances, Chiifu and Kenshin. Many genes exhibited >2-fold changes in expression upon exposure to 0.5-4 h at 45 degrees C (high temperature, HT): 5.2% (2,142 genes) in Chiifu and 3.7% (1,535 genes) in Kenshin. The most enriched GO (Gene Ontology) items included 'response to heat', 'response to reactive oxygen species (ROS)', 'response to temperature stimulus', 'response to abiotic stimulus', and 'MAPKKK cascade'. In both lines, the genes most highly induced by HT encoded small heat shock proteins (Hsps) and heat shock factor (Hsf)-like proteins such as HsfB2A (Bra029292), whereas high-molecular weight Hsps were constitutively expressed. Other upstream HSR components were also up-regulated: ROS-scavenging genes like glutathione peroxidase 2 (BrGPX2, Bra022853), protein kinases, and phosphatases. Among heat stress (HS) marker genes in Arabidopsis, only exportin 1A (XPO1A) (Bra008580, Bra006382) can be applied to B. rapafor basal thermotolerance (BT) and short-term acquired thermotolerance (SAT) gene. CYP707A3 (Bra025083, Bra021965), which is involved in the dehydration response in Arabidopsis, was associated with membrane leakage in both lines following HS. Although many transcription factors (TF) genes, including DREB2A (Bra005852), were involved in HS tolerance in both lines, Bra024224(MYB41) and Bra021735(a bZIP/AIR1[Anthocyanin-Impaired-Response-1]) were specific to Kenshin. Several candidate TFs involved in thermotolerance were confirmed as HSR genes by real-time PCR, and these assignments were further supported by promoter analysis. Although some of our findings are similar to those obtained using other plant species, clear differences in Brassica rapa reveal a distinct HSR in this species. Our data could also provide a springboard for developing molecular markers of HS and for engineering HS tolerant B. rapa.	[Dong, Xiangshu; Yi, Hankuil; Lee, Jeongyeo; Hur, Yoonkang] Chungnam Natl Univ, Dept Biol, Coll Biol Sci & Biotechnol, Taejon, South Korea; [Nou, Ill-Sup] Sunchon Natl Univ, Dept Hort, Sunchon, Jeonnam, South Korea; [Han, Ching-Tack] Sogang Univ, Dept Life Sci, Seoul, South Korea	Chungnam National University; Sunchon National University; Sogang University	Han, CT (corresponding author), Sogang Univ, Dept Life Sci, Seoul, South Korea.	cthan@sogang.ac.kr; ykhur@cnu.ac.kr		Dong, Xiangshu/0000-0002-6640-0731; Hur, Yoonkang/0000-0002-2325-2249	Golden Seed Project (Center for Horticultural Seed Development) [213003-04-2-CG100, 213003-04-2-SB230]; Ministry of Agriculture, Food and Rural Affairs (MAFRA); Ministry of Oceans and Fisheries (MOF); Rural Development Administration (RDA); Korea Forest Service (KFS); Next-Generation BioGreen21 Program, RDA, Korea [PJ008118]	Golden Seed Project (Center for Horticultural Seed Development); Ministry of Agriculture, Food and Rural Affairs (MAFRA); Ministry of Oceans and Fisheries (MOF); Rural Development Administration (RDA)(Rural Development Administration (RDA), Republic of Korea); Korea Forest Service (KFS); Next-Generation BioGreen21 Program, RDA, Korea	This research was supported by two research grants: (1) Golden Seed Project (Center for Horticultural Seed Development, nos. 213003-04-2-CG100 and 213003-04-2-SB230), Ministry of Agriculture, Food and Rural Affairs (MAFRA), Ministry of Oceans and Fisheries (MOF), Rural Development Administration (RDA), and Korea Forest Service (KFS), and (2) a grant from the Next-Generation BioGreen21 Program (PJ008118), RDA, Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AL-Quraan NA, 2010, PLANT PHYSIOL BIOCH, V48, P697, DOI 10.1016/j.plaphy.2010.04.011; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Baniwal SK, 2007, J BIOL CHEM, V282, P3605, DOI 10.1074/jbc.M609545200; Baniwal SK, 2004, J BIOSCIENCES, V29, P471, DOI 10.1007/BF02712120; Bita CE, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00273; Bita CE, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-384; Bokszczanin KL, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00315; Charng YY, 2007, PLANT PHYSIOL, V143, P251, DOI 10.1104/pp.106.091322; Charng YY, 2006, PLANT PHYSIOL, V140, P1297, DOI 10.1104/pp.105.074898; Ciftci-Yilmaz S, 2007, J BIOL CHEM, V282, P9260, DOI 10.1074/jbc.M611093200; Davletova S, 2005, PLANT CELL, V17, P268, DOI 10.1105/tpc.104.026971; Davletova S, 2005, PLANT PHYSIOL, V139, P847, DOI 10.1104/pp.105.068254; Du Z, 2010, NUCLEIC ACIDS RES, V38, pW64, DOI 10.1093/nar/gkq310; Ernst J, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-191; Fragkostefanakis S, 2015, PLANT CELL ENVIRON, V38, P1881, DOI 10.1111/pce.12396; Frank G, 2009, J EXP BOT, V60, P3891, DOI 10.1093/jxb/erp234; Gill SS, 2010, PLANT PHYSIOL BIOCH, V48, P909, DOI 10.1016/j.plaphy.2010.08.016; Gilroy S, 2014, TRENDS PLANT SCI, V19, P623, DOI 10.1016/j.tplants.2014.06.013; Gollery M, 2007, TRENDS PLANT SCI, V12, P492, DOI 10.1016/j.tplants.2007.08.018; Haralampidis K, 2002, PLANT PHYSIOL, V129, P1138, DOI 10.1104/pp.004044; Hasanuzzaman M, 2013, INT J MOL SCI, V14, P9643, DOI 10.3390/ijms14059643; Higo K, 1999, NUCLEIC ACIDS RES, V27, P297, DOI 10.1093/nar/27.1.297; Hobo T, 1999, P NATL ACAD SCI USA, V96, P15348, DOI 10.1073/pnas.96.26.15348; Hossain M. M., 1989, Memoirs of the College of Agriculture, Kyoto University, P21; Hu WH, 2009, PLANT SCI, V176, P583, DOI 10.1016/j.plantsci.2009.01.016; Hua J, 2009, CURR OPIN PLANT BIOL, V12, P568, DOI 10.1016/j.pbi.2009.07.012; Hwang I, 2014, GENOMICS, V104, P194, DOI 10.1016/j.ygeno.2014.07.008; Jia LX, 2014, PLANT SIGNAL BEHAV, V9, DOI 10.4161/psb.28887; Jiang YQ, 2009, MOL GENET GENOMICS, V282, P503, DOI 10.1007/s00438-009-0481-3; Jung HJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106069; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Kaplan B, 2006, PLANT CELL, V18, P2733, DOI 10.1105/tpc.106.042713; Kayum MA, 2015, MOL GENET GENOMICS, V290, P79, DOI 10.1007/s00438-014-0898-1; Khalturin K, 2009, TRENDS GENET, V25, P404, DOI 10.1016/j.tig.2009.07.006; Kim S, 2004, PLANT J, V40, P75, DOI 10.1111/j.1365-313X.2004.02192.x; Kosma DK, 2014, PLANT J, V80, P216, DOI 10.1111/tpj.12624; Kotak S, 2007, CURR OPIN PLANT BIOL, V10, P310, DOI 10.1016/j.pbi.2007.04.011; Koussevitzky S, 2008, J BIOL CHEM, V283, P34197, DOI 10.1074/jbc.M806337200; Kugler A, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-140; Larkindale J, 2008, PLANT PHYSIOL, V146, P748, DOI 10.1104/pp.107.112060; Lee J, 2013, GENES GENOM, V35, P273, DOI 10.1007/s13258-013-0088-2; Lee J, 2010, GENES GENOM, V32, P247, DOI 10.1007/s13258-010-0004-y; Lee SC, 2012, PLANT PHYSIOL BIOCH, V61, P142, DOI 10.1016/j.plaphy.2012.09.016; Lee SC, 2008, MOL CELLS, V26, P595; Li SJ, 2010, MOL CELLS, V29, P475, DOI 10.1007/s10059-010-0059-2; Lim CJ, 2006, J PLANT RES, V119, P373, DOI 10.1007/s10265-006-0285-z; Lin MY, 2014, PLANT PHYSIOL, V164, P2045, DOI 10.1104/pp.113.229609; Lindlof A, 2009, BIOINFORMATICS, V25, P1345, DOI 10.1093/bioinformatics/btp172; Liu HC, 2011, PLANT CELL ENVIRON, V34, P738, DOI 10.1111/j.1365-3040.2011.02278.x; Luhua S, 2008, PLANT PHYSIOL, V148, P280, DOI 10.1104/pp.108.124875; Ma SS, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-4-r49; Ma SS, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003840; Miller G, 2006, ANN BOT-LONDON, V98, P279, DOI 10.1093/aob/mcl107; Mishra SK, 2002, GENE DEV, V16, P1555, DOI 10.1101/gad.228802; Mittler R, 2006, TRENDS PLANT SCI, V11, P15, DOI 10.1016/j.tplants.2005.11.002; Mittler R, 2012, TRENDS BIOCHEM SCI, V37, P118, DOI 10.1016/j.tibs.2011.11.007; Mittler R, 2010, ANNU REV PLANT BIOL, V61, P443, DOI 10.1146/annurev-arplant-042809-112116; Morito D, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00048; Myouga F, 2008, PLANT CELL, V20, P3148, DOI 10.1105/tpc.108.061341; Nakashima K, 2006, PLANT MOL BIOL, V60, P51, DOI 10.1007/s11103-005-2418-5; Narusaka Y, 2003, PLANT J, V34, P137, DOI 10.1046/j.1365-313X.2003.01708.x; Nover L, 2001, CELL STRESS CHAPERON, V6, P177, DOI 10.1379/1466-1268(2001)006<0177:AATHST>2.0.CO;2; Okamoto M, 2009, PLANT PHYSIOL, V149, P825, DOI 10.1104/pp.108.130823; Qu AL, 2013, BIOCHEM BIOPH RES CO, V432, P203, DOI 10.1016/j.bbrc.2013.01.104; Rapacz M, 2002, ANN BOT-LONDON, V89, P543, DOI 10.1093/aob/mcf090; Rensink Willem Albert, 2005, Functional & Integrative Genomics, V5, P201, DOI 10.1007/s10142-005-0141-6; RIEPING M, 1992, MOL GEN GENET, V231, P226, DOI 10.1007/BF00279795; Rizhsky L, 2004, PLANT PHYSIOL, V134, P1683, DOI 10.1104/pp.103.033431; Saidi Y, 2011, NEW PHYTOL, V190, P556, DOI 10.1111/j.1469-8137.2010.03571.x; Sakuma Y, 2006, PLANT CELL, V18, P1292, DOI 10.1105/tpc.105.035881; Sakuma Y, 2006, P NATL ACAD SCI USA, V103, P18822, DOI 10.1073/pnas.0605639103; Scharf KD, 2012, BBA-GENE REGUL MECH, V1819, P104, DOI 10.1016/j.bbagrm.2011.10.002; Schramm F, 2008, PLANT J, V53, P264, DOI 10.1111/j.1365-313X.2007.03334.x; Seo PJ, 2010, PLANT SIGNAL BEHAV, V5, P481, DOI 10.4161/psb.11083; Seo PJ, 2010, BIOCHEM J, V427, P359, DOI 10.1042/BJ20091762; Sgobba A, 2015, PHYSIOL PLANTARUM, V153, P68, DOI 10.1111/ppl.12220; Song LL, 2006, PLANT SCI, V171, P449, DOI 10.1016/j.plantsci.2006.05.002; Song LH, 2013, PHYSIOL PLANTARUM, V148, P322, DOI 10.1111/ppl.12013; Song XM, 2014, MOL GENET GENOMICS, V289, P77, DOI 10.1007/s00438-013-0791-3; Song XM, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-573; Srivastava R, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00059; Suzuki M, 2005, PLANT PHYSIOL, V139, P437, DOI 10.1104/pp.104.058412; Umezawa T, 2006, PLANT J, V46, P171, DOI 10.1111/j.1365-313X.2006.02683.X; Van Oosten MJ, 2013, PLANT MOL BIOL, V83, P405, DOI 10.1007/s11103-013-0099-z; VIERLING E, 1991, ANNU REV PLANT PHYS, V42, P579, DOI 10.1146/annurev.pp.42.060191.003051; Volkov RA, 2006, PLANT MOL BIOL, V61, P733, DOI 10.1007/s11103-006-0045-4; von Koskull-Doring P, 2007, TRENDS PLANT SCI, V12, P452, DOI 10.1016/j.tplants.2007.08.014; Wang L, 2014, PLANT PHYSIOL, V164, P2184, DOI 10.1104/pp.113.229369; Wang WX, 2004, TRENDS PLANT SCI, V9, P244, DOI 10.1016/j.tplants.2004.03.006; Wang Z, 2014, ACTA PHYSIOL PLANT, V36, P3217, DOI 10.1007/s11738-014-1688-4; Wilson RA, 2014, J ENVIRON BIOL, V35, P383; Xu XM, 2010, J CELL SCI, V123, P1644, DOI 10.1242/jcs.063222; YAMAGISHI H, 1994, SCI HORTIC-AMSTERDAM, V58, P283, DOI 10.1016/0304-4238(94)90098-1; Yeh CH, 2012, PLANT SCI, V195, P10, DOI 10.1016/j.plantsci.2012.06.004; Zheng Y, 2012, ANN BOT-LONDON, V110, P743, DOI 10.1093/aob/mcs133	95	25	28	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2015	10	6							e0130451	10.1371/journal.pone.0130451	http://dx.doi.org/10.1371/journal.pone.0130451			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4DD	26102990	Green Published, gold, Green Submitted			2022-12-26	WOS:000356901900044
J	Stoianov, AM; Robson, DL; Hetherington, AM; Sawyez, CG; Borradaile, NM				Stoianov, Alexandra M.; Robson, Debra L.; Hetherington, Alexandra M.; Sawyez, Cynthia G.; Borradaile, Nica M.			Elongation Factor 1A-1 Is a Mediator of Hepatocyte Lipotoxicity Partly through Its Canonical Function in Protein Synthesis	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; FATTY LIVER-DISEASE; INDUCED HEPATIC LIPOTOXICITY; BETA-CELL APOPTOSIS; ER STRESS; CHEMICAL CHAPERONES; FACTOR EF-1-ALPHA; NATURAL-PRODUCTS; SKELETAL-MUSCLE; UP-REGULATION	Elongation factor 1A-1 (eEF1A-1) has non-canonical functions in regulation of the actin cytoskeleton and apoptosis. It was previously identified through a promoter-trap screen as a mediator of fatty acid-induced cell death (lipotoxicity), and was found to participate in this process downstream of ER stress. Since ER stress is implicated in the pathogenesis of nonalcoholic fatty liver disease (NAFLD), we investigated the mechanism of action of eEF1A-1 in hepatocyte lipotoxicity. HepG2 cells were exposed to excess fatty acids, followed by assessments of ER stress, subcellular localization of eEF1A-1, and cell death. A specific inhibitor of eEF1A-1 elongation activity, didemnin B, was used to determine whether its function in protein synthesis is involved in lipotoxicity. Within 6 h, eEF1A-1 protein was modestly induced by high palmitate, and partially re-localized from its predominant location at the ER to polymerized actin at the cell periphery. This early induction and subcellular redistribution of eEF1A-1 coincided with the onset of ER stress, and was later followed by cell death. Didemnin B did not prevent the initiation of ER stress by high palmitate, as indicated by eIF2 alpha phosphorylation. However, consistent with sustained inhibition of eEF1A-1-dependent elongation activity, didemnin B prevented the recovery of protein synthesis and increase in GRP78 protein that are normally associated with later phases of the response to ongoing ER stress. This resulted in decreased palmitate-induced cell death. Our data implicate eEF1A-1, and its function in protein synthesis, in hepatocyte lipotoxicity.	[Stoianov, Alexandra M.; Robson, Debra L.; Hetherington, Alexandra M.; Sawyez, Cynthia G.; Borradaile, Nica M.] Univ Western Ontario, Schulich Sch Med & Dent, Dept Physiol & Pharmacol, London, ON N6A 5C1, Canada; [Sawyez, Cynthia G.] Univ Western Ontario, Dept Med, London, ON N6A 5C1, Canada; [Sawyez, Cynthia G.] Univ Western Ontario, Robarts Res Inst, London, ON N6A 5C1, Canada	Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario)	Borradaile, NM (corresponding author), Univ Western Ontario, Schulich Sch Med & Dent, Dept Physiol & Pharmacol, London, ON N6A 5C1, Canada.	nica.borradaile@schulich.uwo.ca			Canadian Institutes of Health Research [MOP 115038]; Canadian Lipoprotein Conference	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Lipoprotein Conference	This work was supported by grants from the Canadian Institutes of Health Research (MOP 115038, http://www.cihr-irsc.gc.ca/e/193.html) and the Canadian Lipoprotein Conference (http://www.lipoprotein.ca/) to NB.	Akazawa Y, 2010, J HEPATOL, V52, P586, DOI 10.1016/j.jhep.2010.01.003; Al-Maghrebi M, 2005, MOL CELL BIOCHEM, V273, P177, DOI 10.1007/s11010-005-0552-7; Alkhouri N, 2011, EXPERT REV GASTROENT, V5, P201, DOI [10.1586/EGH.11.6, 10.1586/egh.11.6]; Borradaile NM, 2006, J LIPID RES, V47, P2726, DOI 10.1194/jlr.M600299-JLR200; Borradaile NM, 2006, MOL BIOL CELL, V17, P770, DOI 10.1091/mbc.E05-08-0742; Bouchoux J, 2011, BIOL CELL, V103, P499, DOI 10.1042/BC20110024; Brasaemle DL, 2012, J BIOL CHEM, V287, P2273, DOI 10.1074/jbc.R111.309088; Brookheart RT, 2009, CELL METAB, V10, P9, DOI 10.1016/j.cmet.2009.03.011; Cao J, 2012, MOL CELL BIOCHEM, V364, P115, DOI 10.1007/s11010-011-1211-9; Cao SS, 2013, EXPERT OPIN THER TAR, V17, P437, DOI 10.1517/14728222.2013.756471; Cazanave SC, 2009, J BIOL CHEM, V284, P26591, DOI 10.1074/jbc.M109.022491; Chen E, 2000, EXP CELL RES, V259, P140, DOI 10.1006/excr.2000.4952; Chen XQ, 2010, J PROTEOME RES, V9, P885, DOI 10.1021/pr900784c; Das SK, 2010, J LIPID RES, V51, P2121, DOI 10.1194/jlr.M004275; Ding YB, 2012, ACTA BIOCH BIOPH SIN, V44, P394, DOI 10.1093/abbs/gms008; Doyle A, 2011, J STRUCT BIOL, V176, P370, DOI 10.1016/j.jsb.2011.09.004; Egnatchik RA, 2014, MOL METAB, V3, P544, DOI 10.1016/j.molmet.2014.05.004; Flamment M, 2012, TRENDS ENDOCRIN MET, V23, P381, DOI 10.1016/j.tem.2012.06.003; Gentile CL, 2011, AM J PHYSIOL-REG I, V301, pR1710, DOI 10.1152/ajpregu.00677.2010; Grassi G, 2007, BIOCHIMIE, V89, P1544, DOI 10.1016/j.biochi.2007.07.007; Gross SR, 2005, NAT STRUCT MOL BIOL, V12, P772, DOI 10.1038/nsmb979; Guan BJ, 2014, J BIOL CHEM, V289, P12593, DOI 10.1074/jbc.M113.543215; HAYASHI Y, 1989, J BIOCHEM-TOKYO, V106, P560, DOI 10.1093/oxfordjournals.jbchem.a122895; Itagaki K, 2012, J BIOL CHEM, V287, P16037, DOI 10.1074/jbc.M111.308122; Karaskov E, 2006, ENDOCRINOLOGY, V147, P3398, DOI 10.1210/en.2005-1494; Krokowski D, 2013, J BIOL CHEM, V288, P17202, DOI 10.1074/jbc.M113.466920; Leamy AK, 2014, J LIPID RES, V55, P1478, DOI 10.1194/jlr.M050237; Leamy AK, 2013, PROG LIPID RES, V52, P165, DOI 10.1016/j.plipres.2012.10.004; Lee J, 2012, NAT PROD REP, V29, P404, DOI 10.1039/c2np00065b; Lee KT, 2009, MOL CELLS, V28, P529, DOI 10.1007/s10059-009-0147-3; Li J, 2012, J HEPATOL, V56, P900, DOI 10.1016/j.jhep.2011.10.018; Li ZZ, 2009, J BIOL CHEM, V284, P5637, DOI 10.1074/jbc.M807616200; Li ZZ, 2008, HEPATOLOGY, V47, P1495, DOI 10.1002/hep.22183; Luedde T, 2014, GASTROENTEROLOGY, V147, P765, DOI 10.1053/j.gastro.2014.07.018; Mantzaris MD, 2011, FEBS J, V278, P519, DOI 10.1111/j.1742-4658.2010.07972.x; Marco E, 2004, J MED CHEM, V47, P4439, DOI 10.1021/jm0306428; Mateyak MK, 2010, J BIOL CHEM, V285, P21209, DOI 10.1074/jbc.R110.113795; Mei S, 2011, J PHARMACOL EXP THER, V339, P487, DOI 10.1124/jpet.111.184341; Minella O, 1996, CELL MOL BIOL, V42, P805; Ndozangue-Touriguine O, 2008, BIOCHEM PHARMACOL, V76, P11, DOI 10.1016/j.bcp.2008.03.016; NIGAM SK, 1989, J BIOL CHEM, V264, P16927; Nivala AM, 2013, METABOLISM, V62, P753, DOI 10.1016/j.metabol.2012.12.001; Nolan CJ, 2009, J GASTROEN HEPATOL, V24, P703, DOI 10.1111/j.1440-1746.2009.05823.x; Ozcan U, 2006, SCIENCE, V313, P1137, DOI 10.1126/science.1128294; Ozcan U, 2004, SCIENCE, V306, P457, DOI 10.1126/science.1103160; Pagliassotti MJ, 2012, ANNU REV NUTR, V32, P17, DOI 10.1146/annurev-nutr-071811-150644; Paredes AH, 2012, CLIN LIVER DIS, V16, P397, DOI 10.1016/j.cld.2012.03.005; Perez WB, 2014, J BIOL CHEM, V289, P20928, DOI 10.1074/jbc.M114.570077; Pfaffenbach KT, 2010, AM J PHYSIOL-ENDOC M, V298, pE1027, DOI 10.1152/ajpendo.00642.2009; Potts MB, 2015, NAT CHEM BIOL, V11, P401, DOI 10.1038/nchembio.1797; Reynet C, 2001, P NATL ACAD SCI USA, V98, P3422, DOI 10.1073/pnas.051630398; Soriguer F, 2009, OBESITY, V17, P10, DOI 10.1038/oby.2008.475; Srivastava S, 2008, BIOTECHNOL BIOENG, V99, P399, DOI 10.1002/bit.21568; Unger RH, 2010, BBA-MOL CELL BIOL L, V1801, P209, DOI 10.1016/j.bbalip.2009.10.006; Wang D, 2006, ENDOCRINOLOGY, V147, P943, DOI 10.1210/en.2005-0570; Wei Y, 2006, AM J PHYSL ENDOCRINO; Wei Y, 2007, MOL CELL BIOCHEM, V303, P105, DOI 10.1007/s11010-007-9461-2; Wei YR, 2009, MOL CELL BIOCHEM, V331, P31, DOI 10.1007/s11010-009-0142-1; Wu XD, 2008, HEPATOLOGY, V47, P1905, DOI 10.1002/hep.22239; Yang JS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013858; Zhang HN, 2011, J PROTEOME RES, V10, P4757, DOI 10.1021/pr200553c; Zhang YZ, 2010, J LIPID RES, V51, P53, DOI 10.1194/jlr.M900146-JLR200	62	11	12	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2015	10	6							e0131269	10.1371/journal.pone.0131269	http://dx.doi.org/10.1371/journal.pone.0131269			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4DD	26102086	Green Published, Green Submitted, gold			2022-12-26	WOS:000356901900075
J	Xia, CY; Meng, XK; Wang, Z				Xia, Cheng-Yi; Meng, Xiao-Kun; Wang, Zhen			Heterogeneous Coupling between Interdependent Lattices Promotes the Cooperation in the Prisoner's Dilemma Game	PLOS ONE			English	Article							EVOLUTIONARY GAMES; NETWORKS; EMERGENCE; DIVERSITY; REWARD; COEVOLUTION; RECIPROCITY	In the research realm of game theory, interdependent networks have extended the content of spatial reciprocity, which needs the suitable coupling between networks. However, thus far, the vast majority of existing works just assume that the coupling strength between networks is symmetric. This hypothesis, to some extent, seems inconsistent with the ubiquitous observation of heterogeneity. Here, we study how the heterogeneous coupling strength, which characterizes the interdependency of utility between corresponding players of both networks, affects the evolution of cooperation in the prisoner's dilemma game with two types of coupling schemes (symmetric and asymmetric ones). Compared with the traditional case, we show that heterogeneous coupling greatly promotes the collective cooperation. The symmetric scheme seems much better than the asymmetric case. Moreover, the role of varying amplitude of coupling strength is also studied on these two interdependent ways. Current findings are helpful for us to understand the evolution of cooperation within many real-world systems, in particular for the interconnected and interrelated systems.	[Xia, Cheng-Yi; Meng, Xiao-Kun] Tianjin Univ Technol, Tianjin Key Lab Intelligence Comp & Novel Softwar, Tianjin 300384, Peoples R China; [Xia, Cheng-Yi; Meng, Xiao-Kun] Tianjin Univ Technol, Minist Educ, Key Lab Comp Vis & Syst, Tianjin 300384, Peoples R China; [Wang, Zhen] Kyushu Univ, Interdisciplinary Grad Sch Engn Sci, Fukuoka 8168580, Japan	Tianjin University of Technology; Tianjin University of Technology; Kyushu University	Xia, CY (corresponding author), Tianjin Univ Technol, Tianjin Key Lab Intelligence Comp & Novel Softwar, Tianjin 300384, Peoples R China.	xialooking@163.com; zhengwang0@gmail.com	Xia, Chengyi/A-2752-2012	Xia, Chengyi/0000-0003-2686-5072	National Natural Science Foundation of China [61374169]; Tianjin Training Plan of University Innovation Team [TD12-5016]; Scientific Research Foundation for the Returned Overseas Chinese Scholars (Ministry of Education)	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Tianjin Training Plan of University Innovation Team; Scientific Research Foundation for the Returned Overseas Chinese Scholars (Ministry of Education)(Scientific Research Foundation for the Returned Overseas Chinese Scholars)	This project is partially supported by the National Natural Science Foundation of China under grant no. 61374169, and Tianjin Training Plan of University Innovation Team under no. TD12-5016. CYX also acknowledges the financial support from the Scientific Research Foundation for the Returned Overseas Chinese Scholars (Ministry of Education). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramson G, 2001, PHYS REV E, V63, DOI 10.1103/PhysRevE.63.030901; Albert R, 2002, REV MOD PHYS, V74, P47, DOI 10.1103/RevModPhys.74.47; [Anonymous], 1877, DIFFERENT FORMS FLOW; Ansari A, 2011, J MARKETING RES, V48, P713, DOI 10.1509/jmkr.48.4.713; Axelrod R., 2006, EVOLUTION COOPERATIO; Baxter GJ, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.248701; Boccaletti S, 2006, PHYS REP, V424, P175, DOI 10.1016/j.physrep.2005.10.009; Boccaletti S, 2014, PHYS REP, V544, P1, DOI 10.1016/j.physrep.2014.07.001; Buldyrev SV, 2010, NATURE, V464, P1025, DOI 10.1038/nature08932; Castellano C, 2009, REV MOD PHYS, V81, P591, DOI 10.1103/RevModPhys.81.591; De Domenico M, 2013, 130605219 ARXIV; Droz M, 2009, EUR PHYS J B, V71, P579, DOI 10.1140/epjb/e2009-00160-1; Ebel H, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.056118; Fehr E, 2002, NATURE, V415, P137, DOI 10.1038/415137a; Fu F, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.046707; Gao JX, 2012, NAT PHYS, V8, P40, DOI 10.1038/nphys2180; Gintis H., 2000, GAME THEORY EVOLVING; Gneezy A, 2012, P ROY SOC B-BIOL SCI, V279, P219, DOI 10.1098/rspb.2011.0805; Gomez-Gardenes J, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.108103; Gomez-Gardenes J, 2012, PHYS REV E, V86, DOI 10.1103/PhysRevE.86.056113; Granell C, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.128701; Hauert C, 2004, NATURE, V428, P643, DOI 10.1038/nature02360; Helbing D, 2009, P NATL ACAD SCI USA, V106, P3680, DOI 10.1073/pnas.0811503106; Huang XQ, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.065101; Ji SJ, 2013, MATCH-COMMUN MATH CO, V70, P697; Jiang LL, 2013, SCI REP-UK, V3, DOI 10.1038/srep02483; Jimenez R, 2008, J THEOR BIOL, V250, P475, DOI 10.1016/j.jtbi.2007.10.010; Jin Q, 2014, SCI REP-UK, V4, DOI 10.1038/srep04095; Kivela M, 2014, J COMPLEX NETW, V2, P203, DOI 10.1093/comnet/cnu016; Li XL, 2014, MATCH-COMMUN MATH CO, V72, P183; Li XL, 2013, MATCH-COMMUN MATH CO, V70, P85; Masuda N, 2014, 14034763 ARXIV; Maynard Smith J., 1982, pi; Meng XK, 2015, PHYS LETT A, V379, P767, DOI 10.1016/j.physleta.2014.12.051; NOWAK MA, 1992, NATURE, V359, P826, DOI 10.1038/359826a0; Nowak MA, 2006, EVOLUTIONARY DYNAMIC; Nowak MA, 2006, SCIENCE, V314, P1560, DOI 10.1126/science.1133755; Perc M, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.011904; Perc M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015117; Perc M, 2010, BIOSYSTEMS, V99, P109, DOI 10.1016/j.biosystems.2009.10.003; Roca CP, 2011, P NATL ACAD SCI USA, V108, P11370, DOI 10.1073/pnas.1101044108; Roca CP, 2009, PHYS LIFE REV, V6, P208, DOI 10.1016/j.plrev.2009.08.001; Romance M, 2014, 14117557 ARXIV; Santos FC, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.098104; Santos FC, 2008, NATURE, V454, P213, DOI 10.1038/nature06940; Sanz J, 2014, PHYS REV X, V4, DOI 10.1103/PhysRevX.4.041005; Sigmund K, 2001, P NATL ACAD SCI USA, V98, P10757, DOI 10.1073/pnas.161155698; Son SW, 2012, EPL-EUROPHYS LETT, V97, DOI 10.1209/0295-5075/97/16006; Stark HU, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.018701; Sysi-Aho M, 2005, EUR PHYS J B, V44, P129, DOI 10.1140/epjb/e2005-00108-5; Szabo G, 1998, PHYS REV E, V58, P69, DOI 10.1103/PhysRevE.58.69; Szabo G, 2007, PHYS REP, V446, P97, DOI 10.1016/j.physrep.2007.04.004; Szabo G, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.016106; Szolnoki A, 2010, EPL-EUROPHYS LETT, V92, DOI 10.1209/0295-5075/92/38003; Szolnoki A, 2013, NEW J PHYS, V15, DOI 10.1088/1367-2630/15/5/053010; Szolnoki A, 2008, NEW J PHYS, V10, DOI 10.1088/1367-2630/10/4/043036; Tang L, 2012, DATA MIN KNOWL DISC, V25, P1, DOI 10.1007/s10618-011-0231-0; Tanimoto J, 2009, PHYSICA A, V388, P953, DOI 10.1016/j.physa.2008.11.023; Tomassini M, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.73.016132; Vainstein MH, 2007, J THEOR BIOL, V244, P722, DOI 10.1016/j.jtbi.2006.09.012; Wang L, 2014, CHAOS SOLITON FRACT, V66, P9, DOI 10.1016/j.chaos.2014.04.011; Wang L, 2013, SCI REP-UK, V3, DOI 10.1038/srep01468; Wang Z, 2014, NEW J PHYS, V16, DOI 10.1088/1367-2630/16/3/033041; Wang Z, 2013, SCI REP-UK, V3, DOI 10.1038/srep02470; Wang Z, 2013, SCI REP-UK, V3, DOI 10.1038/srep01183; Wang Z, 2012, EPL-EUROPHYS LETT, V97, DOI 10.1209/0295-5075/97/48001; Xia CY, 2015, EPL-EUROPHYS LETT, V109, DOI 10.1209/0295-5075/109/58002; Xia CY, 2012, ADV COMPLEX SYST, V15, DOI 10.1142/S0219525912500567; Xia CY, 2014, APPL MATH COMPUT, V246, P389, DOI 10.1016/j.amc.2014.08.006; Zhu CJ, 2014, PHYSICA A, V406, P145, DOI 10.1016/j.physa.2014.03.035; Zimmermann MG, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.065102	71	99	99	2	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2015	10	6							e0129542	10.1371/journal.pone.0129542	http://dx.doi.org/10.1371/journal.pone.0129542			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4DD	26102082	Green Published, gold, Green Submitted			2022-12-26	WOS:000356901900015
J	Baiget, E; Fernandez-Fernandez, J; Iglesias, X; Rodriguez, FA				Baiget, Ernest; Fernandez-Fernandez, Jaime; Iglesias, Xavier; Rodriguez, Ferran A.			Tennis Play Intensity Distribution and Relation with Aerobic Fitness in Competitive Players	PLOS ONE			English	Article							ON-COURT ENDURANCE; PHYSIOLOGICAL DEMANDS; PERCEIVED EXERTION; MATCH ACTIVITY; BLOOD LACTATE; ELITE TENNIS; HEART-RATE; PERFORMANCE; RESPONSES; TOURNAMENT	The aims of this study were (i) to describe the relative intensity of simulated tennis play based on the cumulative time spent in three metabolic intensity zones, and (ii) to determine the relationships between this play intensity distribution and the aerobic fitness of a group of competitive players. 20 male players of advanced to elite level (ITN) performed an incremental on-court specific endurance tennis test to exhaustion to determine maximal oxygen uptake (VO2max) and the first and second ventilatory thresholds (VT1, VT2). Ventilatory and gas exchange parameters were monitored using a telemetric portable gas analyser (K4 b(2), Cosmed, Rome, Italy). Two weeks later the participants played a simulated tennis set against an opponent of similar level. Intensity zones (1: low, 2: moderate, and 3: high) were delimited by the individual VO2 values corresponding to VT1 and VT2, and expressed as percentage of maximum VO2 and heart rate. When expressed relative to VO2max, percentage of playing time in zone 1 (77 +/- 25%) was significantly higher (p < 0.001) than in zone 2 (20 +/- 21%) and zone 3 (3 +/- 5%). Moderate to high positive correlations were found between VT1, VT2 and VO2max, and the percentage of playing time spent in zone 1 (r = 0.68-0.75), as well as low to high inverse correlations between the metabolic variables and the percentage of time spent in zone 2 and 3 (r = -0.49-0.75). Players with better aerobic fitness play at relatively lower intensities. We conclude that players spent more than 75% of the time in their low-intensity zone, with less than 25% of the time spent at moderate to high intensities. Aerobic fitness appears to determine the metabolic intensity that players can sustain throughout the game.	[Baiget, Ernest] Univ Vic, Sport Performance Anal Res Grp, Barcelona, Spain; [Fernandez-Fernandez, Jaime] Miguel Hernandez Univ, Sports Res Ctr, Elche, Spain; [Iglesias, Xavier; Rodriguez, Ferran A.] Univ Barcelona, Inst Nacl Educ Fis Catalunya, INEFC Barcelona Sports Sci Res Grp, Barcelona, Spain	Universitat de Vic - Universitat Central de Catalunya (UVic-UCC); Universidad Miguel Hernandez de Elche; University of Barcelona	Baiget, E (corresponding author), Univ Vic, Sport Performance Anal Res Grp, Barcelona, Spain.	ernest.baiget@uvic.cat	Iglesias, X/M-7292-2013; Baiget, Ernest/S-5414-2016; Fernandez-Fernandez, Jaime/AAO-9270-2020; Rodriguez, Ferran A./H-4892-2011	Iglesias, X/0000-0001-6813-6527; Baiget, Ernest/0000-0002-2059-2846; Fernandez-Fernandez, Jaime/0000-0002-5284-303X; Rodriguez, Ferran A./0000-0002-2280-8962	Institut Nacional d'Educacio Fisica de Barcelona (Projectes d'investigacio i recerca preferencial); Institut Nacional d'Educacio Fisica de Catalunya	Institut Nacional d'Educacio Fisica de Barcelona (Projectes d'investigacio i recerca preferencial); Institut Nacional d'Educacio Fisica de Catalunya	This work was supported by research grants from Institut Nacional d'Educacio Fisica de Barcelona (Projectes d'investigacio i recerca preferencial) http://www.inefc.cat/inefc/AppPHP/index.php?id_pagina=1. EB was supported by Institut Nacional d'Educacio Fisica de Catalunya. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akubat I, 2012, J SPORT SCI, V30, P1473, DOI 10.1080/02640414.2012.712711; Algroy EA, 2011, INT J SPORT PHYSIOL, V6, P70, DOI 10.1123/ijspp.6.1.70; Amann M, 2006, SCAND J MED SCI SPOR, V16, P27, DOI 10.1111/j.1600-0838.2004.00424.x; Baiget E, 2015, J STRENGTH COND RES, V29, P765, DOI 10.1519/JSC.0000000000000664; Baiget E, 2014, J STRENGTH COND RES, V28, P256, DOI 10.1519/JSC.0b013e3182955dad; Banzer W, 2008, BRIT J SPORT MED, V42, P152, DOI 10.1136/bjsm.2007.036798; Castagna C, 2013, J STRENGTH COND RES, V27, P2959, DOI 10.1519/JSC.0b013e31828d61a8; Cohen J.E., 1988, STAT POWER ANAL BEHA; Esteve-Lanao J, 2005, MED SCI SPORT EXER, V37, P496, DOI 10.1249/01.MSS.0000155393.78744.86; Fernandez J, 2006, BRIT J SPORT MED, V40, P387, DOI 10.1136/bjsm.2005.023168; Fernandez-Fernandez J, 2014, BRIT J SPORT MED, V48, DOI 10.1136/bjsports-2013-093152; Fernandez-Fernandez J, 2012, J STRENGTH COND RES, V26, P53, DOI 10.1519/JSC.0b013e318220b4ff; Fernandez-Fernandez J, 2009, STRENGTH COND J, V31, P15, DOI 10.1519/SSC.0b013e3181ada1cb; Fernandez-Fernandez J, 2007, BRIT J SPORT MED, V41, DOI 10.1136/bjsm.2007.036210; Fernandez-Fernandez J, 2008, J SPORT SCI, V26, P1589, DOI 10.1080/02640410802287089; Ferrauti A, 2003, J SCI MED SPORT, V6, P28, DOI 10.1016/S1440-2440(03)80006-3; Ferrauti A, 2011, J SPORT SCI, V29, P485, DOI 10.1080/02640414.2010.539247; Girard O, 2006, BRIT J SPORT MED, V40, P791, DOI 10.1136/bjsm.2006.027680; Gomes RV, 2013, BIOL SPORT, V30, P173, DOI 10.5604/20831862.1059169; Gomes RV, 2011, EUR J SPORT SCI, V11, P105, DOI 10.1080/17461391.2010.487118; Harriss DJ, 2011, INT J SPORTS MED, V32, P819, DOI 10.1055/s-0031-1287829; Kovacs MS, 2007, SPORTS MED, V37, P189, DOI 10.2165/00007256-200737030-00001; Mann T, 2013, SPORTS MED, V43, P613, DOI 10.1007/s40279-013-0045-x; Martin C, 2011, J STRENGTH COND RES, V25, P163, DOI 10.1519/JSC.0b013e3181fb459b; Mendez-Villanueva A, 2007, BRIT J SPORT MED, V41, P296, DOI 10.1136/bjsm.2006.030536; Mendez-Villanueva A, 2010, J STRENGTH COND RES, V24, P165, DOI 10.1519/JSC.0b013e3181a5bc6d; Mendez-Villanueva A, 2007, BRIT J SPORT MED, V41, DOI 10.1136/bjsm.2007.037259; Meyer T, 1999, MED SCI SPORT EXER, V31, P1342, DOI 10.1097/00005768-199909000-00017; Murias JM, 2007, J STRENGTH COND RES, V21, P112, DOI 10.1519/00124278-200702000-00021; Novas AMP, 2003, J SCI MED SPORT, V6, P40, DOI 10.1016/S1440-2440(03)80007-5; Ojala T, 2013, J SPORT SCI MED, V12, P240; Orie J, 2014, INT J SPORT PHYSIOL, V9, P93, DOI 10.1123/IJSPP.2013-0427; Perry AC, 2004, J STRENGTH COND RES, V18, P136; Scharhag-Rosenberger F, 2010, J SCI MED SPORT, V13, P74, DOI 10.1016/j.jsams.2008.12.626; SKINNER JS, 1980, RES Q EXERCISE SPORT, V51, P234, DOI 10.1080/02701367.1980.10609285; Smekal G, 2001, MED SCI SPORT EXER, V33, P999, DOI 10.1097/00005768-200106000-00020; Smekal G, 2000, INT J SPORTS MED, V21, P242, DOI 10.1055/s-2000-310; Stoggl T, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00033; USTA, 2014, OFF RUL TENN; Vergauwen L, 1998, MED SCI SPORT EXER, V30, P1281, DOI 10.1097/00005768-199808000-00016; Wasserman K., 2005, PRINCIPLES EXERCISE, V4th edn	41	17	17	3	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2015	10	6							e0131304	10.1371/journal.pone.0131304	http://dx.doi.org/10.1371/journal.pone.0131304			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL3FM	26098638	Green Published, Green Submitted, gold			2022-12-26	WOS:000356835800168
J	Brecher, M; Chen, H; Liu, BB; Banavali, NK; Jones, SA; Zhang, J; Li, Z; Kramer, LD; Li, HM				Brecher, Matthew; Chen, Hui; Liu, Binbin; Banavali, Nilesh K.; Jones, Susan A.; Zhang, Jing; Li, Zhong; Kramer, Laura D.; Li, Hongmin			Novel Broad Spectrum Inhibitors Targeting the Flavivirus Methyltransferase	PLOS ONE			English	Article							NILE-VIRUS METHYLTRANSFERASE; DENGUE VIRUS; RNA CAP; NS5; METHYLATIONS; DISCOVERY; PROTEIN; ASSAY	The flavivirus methyltransferase (MTase) is an essential enzyme that sequentially methylates the N7 and 2'-O positions of the viral RNA cap, using S-adenosyl-L-methionine (SAM) as a methyl donor. We report here that small molecule compounds, which putatively bind to the SAM-binding site of flavivirus MTase and inhibit its function, were identified by using virtual screening. In vitro methylation experiments demonstrated significant MTase inhibition by 13 of these compounds, with the most potent compound displaying sub-micromolar inhibitory activity. The most active compounds showed broad spectrum activity against the MTase proteins of multiple flaviviruses. Two of these compounds also exhibited low cytotoxicity and effectively inhibited viral replication in cell-based assays, providing further structural insight into flavivirus MTase inhibition.	[Brecher, Matthew; Chen, Hui; Liu, Binbin; Banavali, Nilesh K.; Jones, Susan A.; Zhang, Jing; Li, Zhong; Kramer, Laura D.; Li, Hongmin] New York State Dept Hlth, Wadsworth Ctr, Albany, NY 12208 USA; [Banavali, Nilesh K.; Kramer, Laura D.; Li, Hongmin] SUNY Albany, Sch Publ Hlth, Dept Biomed Sci, Albany, NY 12201 USA	State University of New York (SUNY) System; Wadsworth Center; State University of New York (SUNY) System; State University of New York (SUNY) Albany	Li, HM (corresponding author), New York State Dept Hlth, Wadsworth Ctr, 120 New Scotland Ave, Albany, NY 12208 USA.	Hongmin.li@health.ny.gov	Li, Hongmin/ABI-2439-2020	Li, Hongmin/0000-0002-8684-5308; Banavali, Nilesh/0000-0003-2206-7049; Brecher, Matthew/0000-0003-1151-2290; Li, Zhong/0000-0002-1039-7000	National Institute of Health (NIH) [AI094335]; NIAID [1T32AI055429]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI055429, R01AI094335] Funding Source: NIH RePORTER	National Institute of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported by grants (AI094335 to L.D.K. and H.L.) from the National Institute of Health (NIH)). M.B. was supported by funding from a NIAID training grant (1T32AI055429).	Benarroch D, 2004, J BIOL CHEM, V279, P35638, DOI 10.1074/jbc.M400460200; Bhattacharya D, 2008, VIROLOGY, V380, P276, DOI 10.1016/j.virol.2008.07.013; Bollati M, 2010, ANTIVIR RES, V87, P125, DOI 10.1016/j.antiviral.2009.11.009; Brecher Matthew, 2013, Virologica Sinica, V28, P326, DOI 10.1007/s12250-013-3390-x; Burke DS, 2001, FLAVIVIRUSES, VFourth; Byrd CM, 2013, ANTIMICROB AGENTS CH, V57, P15, DOI 10.1128/AAC.01429-12; CHAMBERS TJ, 1990, ANNU REV MICROBIOL, V44, P649, DOI 10.1146/annurev.mi.44.100190.003245; Chen H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076900; Chen H, 2013, ANTIVIR RES, V97, P232, DOI 10.1016/j.antiviral.2012.12.012; CLEAVES GR, 1979, VIROLOGY, V96, P159, DOI 10.1016/0042-6822(79)90181-8; Dong HP, 2008, ANTIVIR RES, V80, P1, DOI 10.1016/j.antiviral.2008.05.003; Dong HP, 2008, J VIROL, V82, P4295, DOI 10.1128/JVI.02202-07; Dong HP, 2008, VIROLOGY, V377, P1, DOI 10.1016/j.virol.2008.04.026; Dong HP, 2007, J VIROL, V81, P4412, DOI 10.1128/JVI.02455-06; Dong HP, 2014, J GEN VIROL, V95, P763, DOI 10.1099/vir.0.062208-0; Dong HP, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002642; Dong HP, 2010, J BIOL CHEM, V285, P32586, DOI 10.1074/jbc.M110.129197; Egloff MP, 2002, EMBO J, V21, P2757, DOI 10.1093/emboj/21.11.2757; Feng BY, 2006, NAT PROTOC, V1, P550, DOI 10.1038/nprot.2006.77; Feng BY, 2005, NAT CHEM BIOL, V1, P146, DOI 10.1038/nchembio718; Heinz FX, 2012, VACCINE, V30, P4301, DOI 10.1016/j.vaccine.2011.09.114; Khromykh AA, 1998, J VIROL, V72, P7270, DOI 10.1128/JVI.72.9.7270-7279.1998; Kramer L, 2007, LANCET NEUR IN PRESS; Kroschewski H, 2008, J BIOL CHEM, V283, P19410, DOI 10.1074/jbc.M800613200; Li SH, 2013, J VIROL, V87, P5812, DOI 10.1128/JVI.02806-12; Lim SP, 2013, ANTIVIR RES, V100, P500, DOI 10.1016/j.antiviral.2013.09.013; Lim SP, 2011, J BIOL CHEM, V286, P6233, DOI 10.1074/jbc.M110.179184; Lim SP, 2008, ANTIVIR RES, V80, P360, DOI 10.1016/j.antiviral.2008.08.005; Lindenbach B., 2001, FLAVIVIRIDAE VIRUS T; Liu Lihui, 2010, Front Biol (Beijing), V5, P286; Luzhkov VB, 2007, BIOORGAN MED CHEM, V15, P7795, DOI 10.1016/j.bmc.2007.08.049; Milani M, 2009, ANTIVIR RES, V83, P28, DOI 10.1016/j.antiviral.2009.03.001; Noble CG, 2010, ANTIVIR RES, V85, P450, DOI 10.1016/j.antiviral.2009.12.011; O'Boyle NM, 2011, J CHEMINFORMATICS, V3, DOI 10.1186/1758-2946-3-33; Podvinec M, 2010, J MED CHEM, V53, P1483, DOI 10.1021/jm900776m; Puig-Basagoiti F, 2009, ANTIVIR RES, V83, P71, DOI 10.1016/j.antiviral.2009.03.005; Ray D, 2006, J VIROL, V80, P8362, DOI 10.1128/JVI.00814-06; Sampath A, 2009, ANTIVIR RES, V81, P6, DOI 10.1016/j.antiviral.2008.08.004; Schweitzer BK, 2009, LABMEDICINE, V40, P493, DOI 10.1309/LM5YWS85NJPCWESW; Selisko B, 2010, J GEN VIROL, V91, P112, DOI 10.1099/vir.0.015511-0; TERUELLOPEZ E, 1991, INVEST CLIN, V32, P201; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Turtle L, 2012, QJM-INT J MED, V105, P219, DOI 10.1093/qjmed/hcs013; van Cleef KWR, 2013, ANTIVIR RES, V99, P165, DOI 10.1016/j.antiviral.2013.05.011; Xie XP, 2011, J VIROL, V85, P11183, DOI 10.1128/JVI.05468-11; Zhou YS, 2007, J VIROL, V81, P3891, DOI 10.1128/JVI.02704-06	46	44	45	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2015	10	6							e0130062	10.1371/journal.pone.0130062	http://dx.doi.org/10.1371/journal.pone.0130062			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL3FM	26098995	Green Published, Green Submitted, gold			2022-12-26	WOS:000356835800052
J	Kemmerer, M; Finkernagel, F; Cavalcante, MF; Abdalla, DSP; Muller, R; Brune, B; Namgaladze, D				Kemmerer, Marina; Finkernagel, Florian; Cavalcante, Marcela Frota; Parra Abdalla, Dulcineia Saes; Mueller, Rolf; Bruene, Bernhard; Namgaladze, Dmitry			AMP-Activated Protein Kinase Interacts with the Peroxisome Proliferator-Activated Receptor Delta to Induce Genes Affecting Fatty Acid Oxidation in Human Macrophages	PLOS ONE			English	Article							LOW-DENSITY-LIPOPROTEIN; ENDOPLASMIC-RETICULUM STRESS; PPAR-DELTA; INSULIN-RESISTANCE; METABOLIC SYNDROME; SKELETAL-MUSCLE; TRANSCRIPTIONAL REPRESSION; INFLAMMATION; ATHEROSCLEROSIS; MICE	AMP-activated protein kinase (AMPK) maintains energy homeostasis by suppressing cellular ATP-consuming processes and activating catabolic, ATP-producing pathways such as fatty acid oxidation (FAO). The transcription factor peroxisome proliferator-activated receptor delta (PPAR delta) also affects fatty acid metabolism, stimulating the expression of genes involved in FAO. To question the interplay of AMPK and PPAR delta in human macrophages we transduced primary human macrophages with lentiviral particles encoding for the constitutively active AMPK alpha 1 catalytic subunit, followed by microarray expression analysis after treatment with the PPAR delta agonist GW501516. Microarray analysis showed that coactivation of AMPK and PPAR delta increased expression of FAO genes, which were validated by quantitative PCR. Induction of these FAO-associated genes was also observed upon infecting macrophages with an adenovirus coding for AMPK gamma 1 regulatory subunit carrying an activating R70Q mutation. The pharmacological AMPK activator A-769662 increased expression of several FAO genes in a PPAR delta- and AMPK-dependent manner. Although GW501516 significantly increased FAO and reduced the triglyceride amount in very low density lipoproteins (VLDL)-loaded foam cells, AMPK activation failed to potentiate this effect, suggesting that increased expression of fatty acid catabolic genes alone may be not sufficient to prevent macrophage lipid overload.	[Kemmerer, Marina; Bruene, Bernhard; Namgaladze, Dmitry] Goethe Univ Frankfurt, Inst Biochem 1, Fac Med, D-60590 Frankfurt, Germany; [Finkernagel, Florian; Mueller, Rolf] Univ Marburg, Inst Mol Biol & Tumor Res IMT, Marburg, Germany; [Cavalcante, Marcela Frota; Parra Abdalla, Dulcineia Saes] Univ Sao Paulo, Dept Clin & Toxicol Anal, Fac Pharmaceut Sci, Sao Paulo, Brazil	Goethe University Frankfurt; Philipps University Marburg; Universidade de Sao Paulo	Namgaladze, D (corresponding author), Goethe Univ Frankfurt, Inst Biochem 1, Fac Med, Theodor Stern Kai 7, D-60590 Frankfurt, Germany.	namgaladze@biochem.uni-frankfurt.de	Müller, Rolf/L-4997-2016	Müller, Rolf/0000-0003-3339-4248	Deutsche Forschungsgemeinschaft [NA429/2-1, SFB 1039-A05, SFB 1039-B04]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft (www.dfg.de): Grant NA429/2-1 (DN, BB); Grant SFB 1039-A05 (DN); and Grant SFB 1039-B04 (BB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhikary T, 2013, ONCOGENE, V32, P5241, DOI 10.1038/onc.2012.549; Grundy Scott M, 2005, Crit Pathw Cardiol, V4, P198; Barish GD, 2008, P NATL ACAD SCI USA, V105, P4271, DOI 10.1073/pnas.0711875105; Bojic LA, 2014, ARTERIOSCL THROM VAS, V34, P52, DOI 10.1161/ATVBAHA.113.301830; Bojic LA, 2012, ARTERIOSCL THROM VAS, V32, P2919, DOI 10.1161/ATVBAHA.112.255208; Brasaemle DL, 1997, J LIPID RES, V38, P2249; Cerami EG, 2011, NUCLEIC ACIDS RES, V39, pD685, DOI 10.1093/nar/gkq1039; Chawla A, 2003, P NATL ACAD SCI USA, V100, P1268, DOI 10.1073/pnas.0337331100; Chawla A, 2010, CIRC RES, V106, P1559, DOI 10.1161/CIRCRESAHA.110.216523; Cheang WS, 2014, ARTERIOSCL THROM VAS, V34, P830, DOI 10.1161/ATVBAHA.113.301938; Coll Teresa, 2009, Curr Mol Pharmacol, V2, P46; Cool B, 2006, CELL METAB, V3, P403, DOI 10.1016/j.cmet.2006.05.005; Dunning MJ, 2007, BIOINFORMATICS, V23, P2183, DOI 10.1093/bioinformatics/btm311; Eckel RH, 2005, LANCET, V365, P1415, DOI 10.1016/S0140-6736(05)66378-7; Flicek P, 2013, NUCLEIC ACIDS RES, V41, pD48, DOI 10.1093/nar/gks1236; Folmes KD, 2007, AM J PHYSIOL-HEART C, V293, pH3456, DOI 10.1152/ajpheart.00936.2007; Galic S, 2011, J CLIN INVEST, V121, P4903, DOI 10.1172/JCI58577; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Goransson O, 2007, J BIOL CHEM, V282, P32549, DOI 10.1074/jbc.M706536200; Graham TL, 2005, ATHEROSCLEROSIS, V181, P29, DOI 10.1016/j.atherosclerosis.2004.12.028; Hamilton SR, 2001, FEBS LETT, V500, P163, DOI 10.1016/S0014-5793(01)02602-3; Hawley SA, 2012, SCIENCE, V336, P918, DOI 10.1126/science.1215327; Huang SCC, 2014, NAT IMMUNOL, V15, P846, DOI 10.1038/ni.2956; Kang K, 2008, CELL METAB, V7, P485, DOI 10.1016/j.cmet.2008.04.002; Lee CH, 2003, SCIENCE, V302, P453, DOI 10.1126/science.1087344; Lee CH, 2006, P NATL ACAD SCI USA, V103, P2434, DOI 10.1073/pnas.0510815103; Li B, 2000, NAT MED, V6, P1115, DOI 10.1038/80450; Makoveichuk E, 2012, BIOCHEM BIOPH RES CO, V425, P138, DOI 10.1016/j.bbrc.2012.07.048; Mihaylova MM, 2011, CELL, V145, P607, DOI 10.1016/j.cell.2011.03.043; Moore KJ, 2011, CELL, V145, P341, DOI 10.1016/j.cell.2011.04.005; Mounier R, 2013, CELL METAB, V18, P251, DOI 10.1016/j.cmet.2013.06.017; Muoio DM, 1999, BIOCHEM J, V338, P783, DOI 10.1042/0264-6021:3380783; Nakamura MT, 2014, PROG LIPID RES, V53, P124, DOI 10.1016/j.plipres.2013.12.001; Namgaladze D, 2014, BBA-MOL CELL BIOL L, V1841, P1329, DOI 10.1016/j.bbalip.2014.06.007; Namgaladze D, 2014, DIABETOLOGIA, V57, P1067, DOI 10.1007/s00125-014-3173-4; Namgaladze D, 2010, ARTERIOSCL THROM VAS, V30, P313, DOI 10.1161/ATVBAHA.109.199232; Narkar VA, 2008, CELL, V134, P405, DOI 10.1016/j.cell.2008.06.051; Nathan DM, 2009, DIABETES CARE, V32, P193, DOI 10.2337/dc08-9025; O'Neill LAJ, 2013, NATURE, V493, P346, DOI 10.1038/nature11862; Odegaard JI, 2013, IMMUNITY, V38, P644, DOI 10.1016/j.immuni.2013.04.001; Odegaard JI, 2011, ANNU REV PATHOL-MECH, V6, P275, DOI 10.1146/annurev-pathol-011110-130138; Peters JM, 2012, NAT REV CANCER, V12, P181, DOI 10.1038/nrc3214; Pickup JC, 2004, DIABETES CARE, V27, P813, DOI 10.2337/diacare.27.3.813; Ruderman N, 1998, DIABETES, V47, P699, DOI 10.2337/diabetes.47.5.699; Salvado L, 2014, DIABETOLOGIA, V57, P2126, DOI 10.1007/s00125-014-3331-8; Shi YH, 2002, P NATL ACAD SCI USA, V99, P2613, DOI 10.1073/pnas.052707099; Smyth GK, 2005, BIOINFORMATICS, V21, P2067, DOI 10.1093/bioinformatics/bti270; Stein SC, 2000, BIOCHEM J, V345, P437, DOI 10.1042/0264-6021:3450437; Stern MP, 2004, DIABETES CARE, V27, P2676, DOI 10.2337/diacare.27.11.2676; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tanaka T, 2003, P NATL ACAD SCI USA, V100, P15924, DOI 10.1073/pnas.0306981100; Vats D, 2006, CELL METAB, V4, P13, DOI 10.1016/j.cmet.2006.05.011; Wang YX, 2003, CELL, V113, P159, DOI 10.1016/S0092-8674(03)00269-1; Zhang S, 2014, NUTR METAB, V11, DOI 10.1186/1743-7075-11-10; Zordoky BNM, 2014, CIRC RES, V115, P518, DOI 10.1161/CIRCRESAHA.115.304538	55	14	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2015	10	6							e0130893	10.1371/journal.pone.0130893	http://dx.doi.org/10.1371/journal.pone.0130893			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL3FM	26098914	Green Published, gold, Green Submitted			2022-12-26	WOS:000356835800118
J	Shen, FH; Liu, HB; Yuan, JX; Han, B; Cui, K; Ding, Y; Fan, XY; Cao, H; Yao, SQ; Suo, X; Sun, ZQ; Yun, X; Hua, ZB; Chen, J				Shen, Fuhai; Liu, Hongbo; Yuan, Juxiang; Han, Bing; Cui, Kai; Ding, Yu; Fan, Xueyun; Cao, Hong; Yao, Sanqiao; Suo, Xia; Sun, Zhiqian; Yun, Xiang; Hua, Zhengbing; Chen, Jie			Cost-Effectiveness of Coal Workers' Pneumoconiosis Prevention Based on Its Predicted Incidence within the Datong Coal Mine Group in China	PLOS ONE			English	Article							OCCUPATIONAL-HEALTH; ECONOMIC BURDEN; PREVALENCE; RISK; INTERVENTIONS; SILICOSIS; EXPOSURE; DISEASE; SAFETY; COHORT	We aimed to estimate the economic losses currently caused by coal workers' pneumoconiosis (CWP) and, on the basis of these measurements, confirm the economic benefit of preventive measures. Our cohort study included 1,847 patients with CWP and 43,742 coal workers without CWP who were registered in the employment records of the Datong Coal Mine Group. We calculated the cumulative incidence rate of pneumoconiosis using the life-table method. We used the dose-response relationship between cumulative incidence density and cumulative dust exposure to predict the future trend in the incidence of CWP. We calculate the economic loss caused by CWP and economic effectiveness of CWP prevention by a step-wise model. The cumulative incidence rates of CWP in the tunneling, mining, combining, and helping cohorts were 58.7%, 28.1%, 21.7%, and 4.0%, respectively. The cumulative incidence rates increased gradually with increasing cumulative dust exposure (CDE). We predicted 4,300 new CWP cases, assuming the dust concentrations remained at the levels of 2011. If advanced dustproof equipment was adopted, 537 fewer people would be diagnosed with CWP. In all, losses of 1.207 billion Renminbi (RMB, official currency of China) would be prevented and 4,698.8 healthy life years would be gained. Investments in advanced dustproof equipment would be total 843 million RMB, according to our study; the ratio of investment to restored economic losses was 1:1.43. Controlling workplace dust concentrations is critical to reduce the onset of pneumoconiosis and to achieve economic benefits.	[Shen, Fuhai; Liu, Hongbo; Han, Bing; Cui, Kai; Chen, Jie] China Med Univ, Sch Publ Hlth, Shenyang 110013, Liaoning, Peoples R China; [Shen, Fuhai; Yuan, Juxiang; Fan, Xueyun; Yao, Sanqiao; Sun, Zhiqian; Yun, Xiang; Hua, Zhengbing] Hebei United Univ, Sch Publ Hlth, Tangshan 063000, Hebei, Peoples R China; [Ding, Yu; Cao, Hong; Suo, Xia] Datong Coal Mine Grp, Occupat Dis Prevent & Treatment Hosp, Datong 037003, Shanxi, Peoples R China	China Medical University; North China University of Science & Technology	Chen, J (corresponding author), China Med Univ, Sch Publ Hlth, Shenyang 110013, Liaoning, Peoples R China.	chenjie@mail.cmu.edu.cn			National Natural Science Foundation of China [71073176]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Natural Science Foundation of China (No. 71073176). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adio AO, 2012, CLIN OPHTHALMOL, V6, P2023, DOI 10.2147/OPTH.S37145; ATTFIELD MD, 1995, AM J IND MED, V27, P137, DOI 10.1002/ajim.4700270113; BARNUM H, 1987, SOC SCI MED, V24, P833, DOI 10.1016/0277-9536(87)90184-5; Bertram Melanie Y, 2013, Int J Stroke, V8 Suppl A100, P76, DOI 10.1111/j.1747-4949.2012.00955.x; Bhagia Lakho J, 2008, Indian J Occup Environ Med, V12, P128, DOI 10.4103/0019-5278.44694; Centers for Disease Control and Prevention (CDC) Department of Health and Human Services (HHS), 2012, FED REGISTER, V77, P56717; Chen WG, 2012, J NANOMATER, V2012, DOI 10.1155/2012/612420; Datong Coal Mine Group, INTR DOT COAL MIN GR; Department of human resources and social security of Shanxi Province, 2006, INF STAND COMP ADJ I; General Administration of Quality Supervision Inspection and Quarantine of the People's Republic of China, 161802006 GBT GEN AD; International labour organization (ILO), GUID US ILO INT CLAS; Ji XM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047949; Lahiri S, 2005, AM J IND MED, V48, P503, DOI 10.1002/ajim.20222; Laney A. Scott, 2012, Morbidity and Mortality Weekly Report, V61, P431; Lee WJ, 2013, TUBERC RESPIR DIS, V74, P56, DOI 10.4046/trd.2013.74.2.56; Leigh JP, 2004, MILBANK Q, V82, P689, DOI 10.1111/j.0887-378X.2004.00328.x; Leigh JP, 2003, SCAND J WORK ENV HEA, V29, P304, DOI 10.5271/sjweh.735; Liang YX, 2003, OCCUP ENVIRON MED, V60, P383, DOI 10.1136/oem.60.6.383; Liu HB, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-366; Liu HB, 2009, IND HEALTH, V47, P369, DOI 10.2486/indhealth.47.369; LOU JZ, 1989, AM J PUBLIC HEALTH, V79, P1613, DOI 10.2105/AJPH.79.12.1613; Mo J, 2013, INT J HYG ENVIR HEAL, V26, P00044; Murray CJL, 1996, GLOBAL BURDEN DIS IN, V1; Naidoo RN, 2005, AM J IND MED, V48, P217, DOI 10.1002/ajim.20207; National Bureau of Statistics of China, CHIN STAT YB 2012; National Health and Family Planning Commission of the People's Republic of China, 2013 NAT REP OCC DIS; National Health and Family Planning Commission of the People's Republic of China, 19222007 GBZT NAT HL; National Health and Family Planning Commission of the People's Republic of China, OCC HLTH STAND PEOPL; National Health and Family Planning Commission of the People's Republic of China, GBZ212007 NAT HLTH F; National Health and Family Planning Commission of the People's Republic of China, 2007, 19212007 GBZT NAT HL; Oxenburgh M, 2005, J SAFETY RES, V36, P209, DOI 10.1016/j.jsr.2005.06.002; Oyunbileg S, 2011, AM J IND MED, V54, P285, DOI 10.1002/ajim.20930; Petsonk EL, 2013, AM J RESP CRIT CARE, V187, P1178, DOI 10.1164/rccm.201301-0042CI; Pingle S, 2012, IND HEALTH, V50, P167, DOI 10.2486/indhealth.MS1366; Ren XW, 2012, J OCCUP ENVIRON HYG, V9, pD77, DOI 10.1080/15459624.2012.667288; Rohr P, 2013, ENVIRON MOL MUTAGEN, V54, P65, DOI 10.1002/em.21744; Rydlewska-Liszkowska Izabela, 2002, Int J Occup Med Environ Health, V15, P193; Scarisbrick DA, 2005, OCCUP MED-OXFORD, V55, P72, DOI 10.1093/occmed/kqi005; Soutar CA, 2004, OCCUP ENVIRON MED, V61, P477, DOI 10.1136/oem.2002.006726; Sun Y, 2011, INT J ENV RES PUB HE, V8, P2923, DOI 10.3390/ijerph8072923; The Central People's Government of the people's Republic of China, 1987, REG PEOPL REP CHIN P; Wooding J, 1999, POINT PRODUCTION	42	15	15	4	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2015	10	6							e0130958	10.1371/journal.pone.0130958	http://dx.doi.org/10.1371/journal.pone.0130958			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CL3FM	26098706	Green Submitted, Green Published, gold			2022-12-26	WOS:000356835800125
J	Yang, JN; Nan, CL; Ripps, H; Shen, W				Yang, Jinnan; Nan, ChangLong; Ripps, Harris; Shen, Wen			Destructive Changes in the Neuronal Structure of the FVB/N Mouse Retina	PLOS ONE			English	Article							HORIZONTAL CELLS; GANGLION-CELLS; MUTANT MOUSE; PHOTORECEPTOR DEGENERATION; CGMP-PHOSPHODIESTERASE; NEURITE OUTGROWTH; RD MOUSE; PIGMENTOSA; PROTEIN; MICE	We applied a series of selective antibodies for labeling the various cell types in the mammalian retina. These were used to identify the progressive loss of neurons in the FVB/N mouse, a model of early onset retinal degeneration produced by a mutation in the pde6b gene. The immunocytochemical studies, together with electroretinogram (ERG) recordings, enabled us to examine the time course of the degenerative changes that extended from the photoreceptors to the ganglion cells at the proximal end of the retina. Our study indicates that photoreceptors in FVB/N undergo a rapid degeneration within three postnatal weeks, and that there is a concomitant loss of retinal neurons in the inner nuclear layer. Although the loss of rods was detected at an earlier age during which time M-and S-opsin molecules were translocated to the cone nuclei; by 6 months all cones had also degenerated. Neuronal remodeling was also seen in the second-order neurons with horizontal cells sprouting processes proximally and dendritic retraction in rod-driven bipolar cells. Interestingly, the morphology of cone-driven bipolar cells were affected less by the disease process. The cellular structure of inner retinal neurons, i.e., ChAT amacrine cells, ganglion cells, and melanopsin-positive ganglion cells did not exhibit any gross changes of cell densities and appeared to be relatively unaffected by the massive photoreceptor degeneration in the distal retina. However, Muller cell processes began to express GFAP at their endfeet at p14, and it climbed progressively to the cell's distal ends by 6 months. Our study indicates that FVB/N mouse provides a useful model with which to assess possible intervention strategies to arrest photoreceptor death in related diseases.	[Yang, Jinnan; Nan, ChangLong; Shen, Wen] Florida Atlantic Univ, Charles E Schmidt Coll Med, Dept Biomed Sci, Boca Raton, FL 33431 USA; [Ripps, Harris] Marine Biol Lab, Woods Hole, MA 02543 USA	State University System of Florida; Florida Atlantic University; Marine Biological Laboratory - Woods Hole	Shen, W (corresponding author), Florida Atlantic Univ, Charles E Schmidt Coll Med, Dept Biomed Sci, Boca Raton, FL 33431 USA.	wshen@fau.edu			National Science Foundation (NSF) [IOS-1021646]; National Eye Institute (NEI) [EY 14161]; NATIONAL EYE INSTITUTE [R01EY014161] Funding Source: NIH RePORTER	National Science Foundation (NSF)(National Science Foundation (NSF)); National Eye Institute (NEI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This study was supported by grants from the National Science Foundation (NSF, IOS-1021646, WS) and the National Eye Institute (NEI, EY 14161, WS).	Berson DM, 2002, SCIENCE, V295, P1070, DOI 10.1126/science.1067262; BOWES C, 1990, NATURE, V347, P677, DOI 10.1038/347677a0; Chang B, 2002, VISION RES, V42, P517, DOI 10.1016/S0042-6989(01)00146-8; CHU Y, 1993, EXP EYE RES, V57, P141, DOI 10.1006/exer.1993.1109; Clagett-Dame M, 2006, J NEUROBIOL, V66, P739, DOI 10.1002/neu.20241; Damiani D, 2012, J COMP NEUROL, V520, P1406, DOI 10.1002/cne.22802; EKSTROM P, 1988, INVEST OPHTH VIS SCI, V29, P1363; Fariss RN, 2000, AM J OPHTHALMOL, V129, P215, DOI 10.1016/S0002-9394(99)00401-8; Fei Y., 2000, MOL VIS, V8, P306; Gargini C, 2007, J COMP NEUROL, V500, P222, DOI 10.1002/cne.21144; Gimenez E, 2001, LAB ANIM-UK, V35, P153, DOI 10.1258/0023677011911525; GRAFSTEI.B, 1972, BRAIN RES, V44, P37, DOI 10.1016/0006-8993(72)90364-2; HAGEMAN GS, 1986, J COMP NEUROL, V249, P499, DOI 10.1002/cne.902490406; Hattar S, 2002, SCIENCE, V295, P1065, DOI 10.1126/science.1069609; Jones BW, 2012, JPN J OPHTHALMOL, V56, P289, DOI 10.1007/s10384-012-0147-2; Jones BW, 2005, EXP EYE RES, V81, P123, DOI 10.1016/j.exer.2005.03.006; Jones BW, 2003, J COMP NEUROL, V464, P1, DOI 10.1002/cne.10703; Koulen P, 1998, J NEUROSCI, V18, P10136; Lewis GP, 1998, INVEST OPHTH VIS SCI, V39, P424; Lin B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068084; Lin B, 2009, EXP EYE RES, V88, P589, DOI 10.1016/j.exer.2008.11.022; Lin Y, 2011, ARVO M, V52, P1846; Lin YH, 2012, FASEB J, V26, P81, DOI 10.1096/fj.11-192914; Marc RE, 1998, INVEST OPHTH VIS SCI, V39, P1694; Marc RE, 2003, PROG RETIN EYE RES, V22, P607, DOI 10.1016/S1350-9462(03)00039-9; Mataruga A, 2007, J COMP NEUROL, V502, P1123, DOI 10.1002/cne.21367; Middeldorp J, 2011, PROG NEUROBIOL, V93, P421, DOI 10.1016/j.pneurobio.2011.01.005; Nir I, 1989, Prog Clin Biol Res, V314, P251; Park SJ, 2001, CELL TISSUE RES, V306, P341, DOI 10.1007/s004410100453; Pawlyk BS, 2005, INVEST OPHTH VIS SCI, V46, P3039, DOI 10.1167/iovs.05-0371; PEICHL L, 1994, VISUAL NEUROSCI, V11, P501, DOI 10.1017/S095252380000242X; Phelan JK, 2000, EXP EYE RES, V71, P119, DOI 10.1006/exer.2000.0861; PORTERACAILLIAU C, 1994, P NATL ACAD SCI USA, V91, P974, DOI 10.1073/pnas.91.3.974; Sagdullaev BT, 2004, DOC OPHTHALMOL, V108, P181, DOI 10.1007/s10633-004-5734-1; Strettoi E, 2000, P NATL ACAD SCI USA, V97, P11020, DOI 10.1073/pnas.190291097; TAKETO M, 1991, P NATL ACAD SCI USA, V88, P2065, DOI 10.1073/pnas.88.6.2065; Wassle H, 1998, CELL TISSUE RES, V292, P211, DOI 10.1007/s004410051052; Zaidi FH, 2007, CURR BIOL, V17, P2122, DOI 10.1016/j.cub.2007.11.034	38	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2015	10	6							e0129719	10.1371/journal.pone.0129719	http://dx.doi.org/10.1371/journal.pone.0129719			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL3FE	26091175	Green Published, Green Submitted, gold			2022-12-26	WOS:000356835000053
J	Dou, WF; Xu, YM; Pagadala, V; Pedersen, LC; Liu, J				Dou, Wenfang; Xu, Yongmei; Pagadala, Vijayakanth; Pedersen, Lars C.; Liu, Jian			Role of Deacetylase Activity of N-Deacetylase/N-Sulfotransferase 1 in Forming N-Sulfated Domain in Heparan Sulfate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR-WEIGHT HEPARINS; SUBSTRATE-SPECIFICITY; CHEMOENZYMATIC SYNTHESIS; BIOSYNTHESIS; NDST-1; CELLS; MOUSE; MICE; 2-O-SULFOTRANSFERASE; GLYCOSAMINOGLYCANS	Heparan sulfate (HS) is a highly sulfated polysaccharide that plays important physiological roles. The biosynthesis of HS involves a series of enzymes, including glycosyltransferases (or HS polymerase), epimerase, and sulfotransferases. N-Deacetylase/N-Sulfotransferase isoform 1 (NDST-1) is a critical enzyme in this pathway. NDST-1, a bifunctional enzyme, displays N-deacetylase and N-sulfotransferase activities to convert an N-acetylated glucosamine residue to an N-sulfo glucosamine residue. Here, we report the cooperative effects between N-deacetylase and N-sulfotransferase activities. Using baculovirus expression in insect cells, we obtained three recombinant proteins: full-length NDST-1 and the individual N-deacetylase and N-sulfotransferase domains. Structurally defined oligosaccharide substrates were synthesized to test the substrate specificities of the enzymes. We discovered that N-deacetylation is the limiting step and that interplay between the N-sulfotransferase and N-deacetylase accelerates the reaction. Furthermore, combining the individually expressed N-deacetylase and N-sulfotransferase domains produced different sulfation patterns when compared with that made by the NDST-1 enzyme. Our data demonstrate the essential role of domain cooperation within NDST-1 in producing HS with specific domain structures.	[Dou, Wenfang; Xu, Yongmei; Pagadala, Vijayakanth; Liu, Jian] Univ N Carolina, Eshelman Sch Pharm, Div Chem Biol & Med Chem, Chapel Hill, NC 27599 USA; [Dou, Wenfang] Jiangnan Univ, Sch Pharmaceut Sci, Lab Pharmaceut Engn, Wuxi 214122, Peoples R China; [Pedersen, Lars C.] NIEHS, Genome Integr & Struct Biol Lab, NIH, Res Triangle Pk, NC 27709 USA	University of North Carolina; University of North Carolina Chapel Hill; Jiangnan University; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Liu, J (corresponding author), Univ N Carolina, Rm 1044,Genet Med Bldg,120 Mason Farm Rd, Chapel Hill, NC 27599 USA.	jian_liu@unc.edu	Regan, Clinton/E-6250-2012; Pagadala, Vijayakanth/ABI-8446-2020; Pedersen, Lars/C-6173-2019	Pedersen, Lars/0000-0002-4488-4077; Pagadala, Vijayakanth/0000-0001-7349-4230	National Institutes of Health [GM102137, HL094463]; Division of Intramural Research of the NIEHS, National Institutes of Health Research [ZIA ES102645]; China Scholarship Council; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES102645] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Division of Intramural Research of the NIEHS, National Institutes of Health Research; China Scholarship Council(China Scholarship Council); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported in part by National Institutes of Health Grants GM102137 and HL094463 and by the Division of Intramural Research of the NIEHS, National Institutes of Health Research Project number ZIA ES102645 (to L. C. P.). The authors declare that they have no conflicts of interest with the contents of this article.; Partially supported by a fellowship from the China Scholarship Council.	Aikawa J, 1999, J BIOL CHEM, V274, P2690, DOI 10.1074/jbc.274.5.2690; Aikawa J, 2001, J BIOL CHEM, V276, P5876, DOI 10.1074/jbc.M009606200; Bengtsson J, 2003, BIOCHEMISTRY-US, V42, P2110, DOI 10.1021/bi026928g; Bishop JR, 2007, NATURE, V446, P1030, DOI 10.1038/nature05817; Blair DE, 2005, P NATL ACAD SCI USA, V102, P15429, DOI 10.1073/pnas.0504339102; Carlsson P, 2008, J BIOL CHEM, V283, P20008, DOI 10.1074/jbc.M801652200; Chen J, 2007, CHEM BIOL, V14, P986, DOI 10.1016/j.chembiol.2007.07.015; Crawford BE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010691; Duncan MB, 2006, BIOCHEM BIOPH RES CO, V339, P1232, DOI 10.1016/j.bbrc.2005.11.142; Esko JD, 2002, ANNU REV BIOCHEM, V71, P435, DOI 10.1146/annurev.biochem.71.110601.135458; Fan GP, 2000, FEBS LETT, V467, P7, DOI 10.1016/S0014-5793(00)01111-X; Forsberg E, 1999, NATURE, V400, P773, DOI 10.1038/23488; Fuster MM, 2007, J CELL BIOL, V177, P539, DOI 10.1083/jcb.200610086; Gama CI, 2006, NAT CHEM BIOL, V2, P467, DOI 10.1038/nchembio810; Jemth P, 2003, J BIOL CHEM, V278, P24371, DOI 10.1074/jbc.M212155200; Kakuta Y, 1999, J BIOL CHEM, V274, P10673, DOI 10.1074/jbc.274.16.10673; Kreuger J, 2006, J CELL BIOL, V174, P323, DOI 10.1083/jcb.200604035; Kusche-Gullberg M, 1998, J BIOL CHEM, V273, P11902, DOI 10.1074/jbc.273.19.11902; Li JP, 2001, J BIOL CHEM, V276, P20069, DOI 10.1074/jbc.M011783200; Liu CH, 2014, J BIOL CHEM, V289, P13407, DOI 10.1074/jbc.M113.530535; Liu JA, 1999, J BIOL CHEM, V274, P38155, DOI 10.1074/jbc.274.53.38155; Liu J, 2014, NAT PROD REP, V31, P1676, DOI 10.1039/c4np00076e; Liu RP, 2011, BIOCHEMISTRY-US, V50, P4382, DOI 10.1021/bi200072t; Liu RP, 2010, J BIOL CHEM, V285, P34240, DOI 10.1074/jbc.M110.159152; MacArthur JM, 2007, J CLIN INVEST, V117, P153, DOI 10.1172/JCI29154; Miller TA, 2003, J MED CHEM, V46, P5097, DOI 10.1021/jm0303094; Mottet D, 2008, CLIN EXP METASTAS, V25, P183, DOI 10.1007/s10585-007-9131-5; Murphy KJ, 2004, J BIOL CHEM, V279, P27239, DOI 10.1074/jbc.M401774200; Pallerla SR, 2008, J BIOL CHEM, V283, P16885, DOI 10.1074/jbc.M709774200; Peterson S, 2012, J BIOL CHEM, V287, P34836, DOI 10.1074/jbc.M112.390161; Reuter MS, 2014, AM J MED GENET A, V164, P2753, DOI 10.1002/ajmg.a.36723; RIESENFELD J, 1982, J BIOL CHEM, V257, P7050; RIESENFELD J, 1980, J BIOL CHEM, V255, P922; Rong JH, 2001, BIOCHEMISTRY-US, V40, P5548, DOI 10.1021/bi002926p; Saribas AS, 2004, GLYCOBIOLOGY, V14, P1217, DOI 10.1093/glycob/cwh129; Sasaki N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008262; SHAKLEE PN, 1984, BIOCHEM J, V217, P187, DOI 10.1042/bj2170187; Sheng JZ, 2012, J BIOL CHEM, V287, P20996, DOI 10.1074/jbc.M112.359885; Sheng JZ, 2011, J BIOL CHEM, V286, P19768, DOI 10.1074/jbc.M111.224311; Shively J. E., 1976, BIOCHEMISTRY-US, V15, P3932; Smeds E, 2003, BIOCHEM J, V372, P371, DOI 10.1042/BJ20021665; Taylor EJ, 2006, J BIOL CHEM, V281, P10968, DOI 10.1074/jbc.M513066200; Wang LC, 2005, NAT IMMUNOL, V6, P902, DOI 10.1038/ni1233; Xu D, 2008, NAT CHEM BIOL, V4, P200, DOI 10.1038/nchembio.66; Xu YM, 2014, NAT CHEM BIOL, V10, P248, DOI [10.1038/NCHEMBIO.1459, 10.1038/nchembio.1459]; Xu YM, 2011, SCIENCE, V334, P498, DOI 10.1126/science.1207478	46	18	19	1	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 14	2015	290	33					20427	20437		10.1074/jbc.M115.664409	http://dx.doi.org/10.1074/jbc.M115.664409			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CP1AT	26109066	hybrid, Green Published, Green Submitted			2022-12-26	WOS:000359608900040
J	Lizarraga-Mollinedo, E; Fernandez-Millan, E; Garcia-San Frutos, M; de Toro-Martin, J; Fernandez-Agullo, T; Ros, M; Alvarez, C; Escriva, F				Lizarraga-Mollinedo, Esther; Fernandez-Millan, Elisa; Garcia-San Frutos, Miriam; de Toro-Martin, Juan; Fernandez-Agullo, Teresa; Ros, Manuel; Alvarez, Carmen; Escriva, Fernando			Early and Long-term Undernutrition in Female Rats Exacerbates the Metabolic Risk Associated with Nutritional Rehabilitation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POSTNATAL LEPTIN SURGE; HIGH-FAT; GLUCOSE-UPTAKE; ADULT-RATS; OBESITY; INSULIN; RESTRICTION; NEURONS; MALNUTRITION; RESISTANCE	Human studies have suggested that early undernutrition increases the risk of obesity, thereby explaining the increase in overweight among individuals from developing countries who have been undernourished as children. However, this conclusion is controversial, given that other studies do not concur. This study sought to determine whether rehabilitation after undernutrition increases the risk of obesity and metabolic disorders. Weemployed a published experimental food-restriction model. Wistar female rats subjected to severe food restriction since fetal stage and controls were transferred to a moderately high-fat diet (cafeteria) provided at 70 days of life to 6.5 months. Another group of undernourished rats were rehabilitated with chow. The energy intake of undernourished animals transferred to cafeteria formula exceeded that of the controls under this regime and was probably driven by hypothalamic disorders in insulin and leptin signal transduction. The cafeteria diet resulted in greater relative increases in both fat and lean body mass in the undernourished rats when compared with controls, enabling the former group to completely catch up in length and body mass index. White adipose tissues of undernourished rats transferred to the high-lipid regime developed a browning which, probably, contributed to avoid the obesigenic effect observed in controls. Nevertheless, the restricted group rehabilitated with cafeteria formula had greater accretion of visceral than subcutaneous fat, showed increased signs of macrophage infiltration and inflammation in visceral pad, dyslipidemia, and ectopic fat accumulation. The data indicate that early long-term undernutrition is associated with increased susceptibility to the harmful effects of nutritional rehabilitation, without causing obesity.	[Lizarraga-Mollinedo, Esther; de Toro-Martin, Juan; Alvarez, Carmen; Escriva, Fernando] Univ Complutense, Fac Farm, Dept Bioquim & Biol Mol 2, E-28040 Madrid, Spain; [Lizarraga-Mollinedo, Esther; Fernandez-Millan, Elisa; Alvarez, Carmen; Escriva, Fernando] Ctr Invest Red Diabet & Enfermedades Metab Asocia, ISCIII, Madrid 28029, Spain; [Garcia-San Frutos, Miriam; Fernandez-Agullo, Teresa; Ros, Manuel] Univ Rey Juan Carlos, Fac Ciencias Salud, Dept Bioquim Fisiol & Genet Mol, Madrid 28922, Spain	Complutense University of Madrid; Instituto de Salud Carlos III; Universidad Rey Juan Carlos	Escriva, F (corresponding author), Univ Complutense, Fac Farm, Dept Bioquim & Biol Mol 2, Ciudad Univ S-N, E-28040 Madrid, Spain.	fescriva@farm.ucm.es	Lizárraga-Mollinedo, Esther/B-3867-2015; FERNÁNDEZ MILLÁN, ELISA/B-2674-2015; Frutos, Miriam García-San/C-1592-2015; Alvarez, Carmen/B-2582-2015	Lizárraga-Mollinedo, Esther/0000-0002-1059-8654; FERNÁNDEZ MILLÁN, ELISA/0000-0002-2807-3776; Frutos, Miriam García-San/0000-0001-7097-3498; Alvarez, Carmen/0000-0003-1874-1045; , Teresa/0000-0002-7812-747X	Ministerio de Economia y Competitividad (MINECO) [BFU 2011-25420]; Comunidad de Madrid, CIBER de Diabetes y Enfermedades Metabolicas (CIBERDEM, ISCIII) [MOIR S2010/BMD-2423]; UCM-Comunidad de Madrid [CCG97-UCM/SAL-30041]	Ministerio de Economia y Competitividad (MINECO); Comunidad de Madrid, CIBER de Diabetes y Enfermedades Metabolicas (CIBERDEM, ISCIII); UCM-Comunidad de Madrid(Comunidad de Madrid)	This work was supported Grant BFU 2011-25420 from the Ministerio de Economia y Competitividad (MINECO), Grant MOIR S2010/BMD-2423 from Comunidad de Madrid, CIBER de Diabetes y Enfermedades Metabolicas (CIBERDEM, ISCIII), and Grant CCG97-UCM/SAL-30041 from UCM-Comunidad de Madrid. The authors declare that they have no conflicts of interest with the contents of this article.	Ahima RS, 1998, J CLIN INVEST, V101, P1020, DOI 10.1172/JCI1176; Barja G, 2002, AGEING RES REV, V1, P397, DOI 10.1016/S1568-1637(02)00008-9; Bellinger L, 2004, BRIT J NUTR, V92, P513, DOI 10.1079/BJN20041224; Bergeron G, 2012, ADV NUTR, V3, P242, DOI 10.3945/an.111.001263; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bonet ML, 2013, BBA-MOL CELL BIOL L, V1831, P969, DOI 10.1016/j.bbalip.2012.12.002; Bouret SG, 2004, SCIENCE, V304, P108, DOI 10.1126/science.1095004; Buettner R, 2007, OBESITY, V15, P798, DOI 10.1038/oby.2007.608; Cawthorn WP, 2008, FEBS LETT, V582, P117, DOI 10.1016/j.febslet.2007.11.051; Couturier A, 2013, NUTR METAB, V10, DOI 10.1186/1743-7075-10-48; de Rooij SR, 2014, CURR DIABETES REP, V14, DOI 10.1007/s11892-014-0536-7; De Toro-Martin J, 2014, ENDOCRINOLOGY, V155, P3769, DOI 10.1210/en.2013-2043; Delahaye F, 2008, ENDOCRINOLOGY, V149, P470, DOI 10.1210/en.2007-1263; Drewnowski A, 2004, AM J CLIN NUTR, V79, P6; Escriva F, 1997, ENDOCRINOLOGY, V138, P49, DOI 10.1210/en.138.1.49; ESCRIVA F, 1992, AM J PHYSIOL, V263, pE1, DOI 10.1152/ajpendo.1992.263.1.E1; Fernandez E, 2006, AM J PHYSIOL-ENDOC M, V291, pE913, DOI 10.1152/ajpendo.00638.2005; Fernandez-Galaz C, 2002, DIABETOLOGIA, V45, P997, DOI 10.1007/s00125-002-0851-4; FORBES GB, 1987, NUTR REV, V45, P225; Garcia AP, 2010, DIABETES OBES METAB, V12, P403, DOI 10.1111/j.1463-1326.2009.01174.x; Gavete ML, 2002, ENDOCRINOLOGY, V143, P4295, DOI 10.1210/en.2002-220258; Kirk SL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005870; Koletzko B, 2014, ANN NUTR METAB, V65, P101, DOI 10.1159/000365873; Kozak LP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030392; Lai M, 2014, NUTR DIABETES, V4, DOI 10.1038/nutd.2014.30; Leonardsson G, 2004, P NATL ACAD SCI USA, V101, P8437, DOI 10.1073/pnas.0401013101; Li YM, 2009, J HEPATOL, V50, P1029, DOI 10.1016/j.jhep.2008.11.021; Liu XM, 2013, J CLIN BIOCHEM NUTR, V52, P43, DOI 10.3164/jcbn.12-28; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lizarraga-Mollinedo E, 2012, AM J PHYSIOL-ENDOC M, V302, pE1070, DOI 10.1152/ajpendo.00495.2011; Misra A, 2008, J CLIN ENDOCR METAB, V93, pS9, DOI 10.1210/jc.2008-1595; Nomura K, 2010, J AM GERIATR SOC, V58, P1658, DOI 10.1111/j.1532-5415.2010.03018.x; Plagemann A, 2012, BEST PRACT RES CL EN, V26, P641, DOI 10.1016/j.beem.2012.03.008; Ravelli ACJ, 1999, AM J CLIN NUTR, V70, P811; Rocha VZ, 2009, NAT REV CARDIOL, V6, P399, DOI 10.1038/nrcardio.2009.55; Sanchez-Lozada LG, 2010, EUR J NUTR, V49, P1, DOI 10.1007/s00394-009-0042-x; Sardinha FLC, 2006, NUTRITION, V22, P1152, DOI 10.1016/j.nut.2006.07.002; Schulz TJ, 2013, NATURE, V495, P379, DOI 10.1038/nature11943; Shabalina IG, 2013, CELL REP, V5, P1196, DOI 10.1016/j.celrep.2013.10.044; Storlien LH, 1997, ANN NY ACAD SCI, V827, P287, DOI 10.1111/j.1749-6632.1997.tb51842.x; Sumiyoshi M, 2006, J NUTR, V136, P582, DOI 10.1093/jn/136.3.582; Tchkonia T, 2010, AGING CELL, V9, P667, DOI 10.1111/j.1474-9726.2010.00608.x; Thomas EL, 2003, INT J OBESITY, V27, P211, DOI 10.1038/sj.ijo.802229; Vickers MH, 2010, NUTR DIET SUPPL, V2, P137, DOI 10.2147/NDS.S8555; Vickers MH, 2000, AM J PHYSIOL-ENDOC M, V279, pE83; Wattez JS, 2013, HORM METAB RES, V45, P980, DOI 10.1055/s-0033-1357182; Wurtz P, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001765; Yu ZB, 2011, OBES REV, V12, P525, DOI 10.1111/j.1467-789X.2011.00867.x; Yura S, 2005, CELL METAB, V1, P371, DOI 10.1016/j.cmet.2005.05.005; Zhang XL, 2007, ARCH INTERN MED, V167, P886, DOI 10.1001/archinte.167.9.886	50	8	9	0	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 31	2015	290	31					19353	19366		10.1074/jbc.M114.549204	http://dx.doi.org/10.1074/jbc.M114.549204			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CN9PK	26105051	Green Published, hybrid			2022-12-26	WOS:000358781100046
J	Beerens, JM; Noonburg, EG; Gawlik, DE				Beerens, James M.; Noonburg, Erik G.; Gawlik, Dale E.			Linking Dynamic Habitat Selection with Wading Bird Foraging Distributions across Resource Gradients	PLOS ONE			English	Article							SPECIES DISTRIBUTION MODELS; WOOD STORK; CONSPECIFIC ATTRACTION; FUNCTIONAL-RESPONSES; WHITE IBIS; AVAILABILITY; RESTORATION; INDICATORS; PREDATION; PATTERNS	Species distribution models (SDM) link species occurrence with a suite of environmental predictors and provide an estimate of habitat quality when the variable set captures the biological requirements of the species. SDMs are inherently more complex when they include components of a species' ecology such as conspecific attraction and behavioral flexibility to exploit resources that vary across time and space. Wading birds are highly mobile, demonstrate flexible habitat selection, and respond quickly to changes in habitat quality; thus serving as important indicator species for wetland systems. We developed a spatio-temporal, multi-SDM framework using Great Egret (Ardea alba), White Ibis (Eudocimus albus), and Wood Stork (Mycteria Americana) distributions over a decadal gradient of environmental conditions to predict species-specific abundance across space and locations used on the landscape over time. In models of temporal dynamics, species demonstrated conditional preferences for resources based on resource levels linked to differing temporal scales. Wading bird abundance was highest when prey production from optimal periods of inundation was concentrated in shallow depths. Similar responses were observed in models predicting locations used over time, accounting for spatial autocorrelation. Species clustered in response to differing habitat conditions, indicating that social attraction can co-vary with foraging strategy, water-level changes, and habitat quality. This modeling framework can be applied to evaluate the multi-annual resource pulses occurring in real-time, climate change scenarios, or restorative hydrological regimes by tracking changing seasonal and annual distribution and abundance of high quality foraging patches.	[Beerens, James M.; Noonburg, Erik G.; Gawlik, Dale E.] Florida Atlantic Univ, Dept Biol Sci, Boca Raton, FL 33431 USA; [Beerens, James M.] US Geol Survey, Southeast Ecol Sci Ctr, Ft Lauderdale, FL USA	State University System of Florida; Florida Atlantic University; United States Department of the Interior; United States Geological Survey	Beerens, JM (corresponding author), Florida Atlantic Univ, Dept Biol Sci, Boca Raton, FL 33431 USA.	jbeerens@usgs.gov			Army Corps of Engineers [W912HZ-10-2-0024]; U.S. Geological Survey; Florida Atlantic University; Everglades Foundation	Army Corps of Engineers(United States Department of DefenseUnited States Army); U.S. Geological Survey(United States Geological Survey); Florida Atlantic University; Everglades Foundation	Financial or inkind support was provided by the U.S. This work received support from the Army Corps of Engineers (grant/contract number: W912HZ-10-2-0024) and U.S. Geological Survey. The authors appreciate the support of Florida Atlantic University and The Everglades Foundation for additional financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arthur SM, 1996, ECOLOGY, V77, P215, DOI 10.2307/2265671; Austin M, 2007, ECOL MODEL, V200, P1, DOI 10.1016/j.ecolmodel.2006.07.005; Bancroft G. Thomas, 1994, P615; Beerens JM, 2011, AUK, V128, P651, DOI 10.1525/auk.2011.10165; Beerens JM., 2014, THESIS FLORIDA ATLAN; Beerens JM, 2010, USING WOOD STORK DIS, V3A, pB1; Beyer HL, 2010, PHILOS T R SOC B, V365, P2245, DOI 10.1098/rstb.2010.0083; Borkhataria RR, 2013, PREDICTING WOO UNPUB; Botson B., 2012, THESIS FLORIDA ATLAN; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Campomizzi AJ, 2008, J WILDLIFE MANAGE, V72, P331, DOI 10.2193/2007-204; Chick JH, 2004, WETLANDS, V24, P652, DOI 10.1672/0277-5212(2004)024[0652:SSAAPO]2.0.CO;2; Cook MI, 2007, S FLORIDA WADING BIR, V13, P1; Dormann CF, 2007, GLOBAL ECOL BIOGEOGR, V16, P129, DOI 10.1111/j.1466-8238.2006.00279.x; Dorn NJ, 2011, IBIS, V153, P323, DOI 10.1111/j.1474-919X.2011.01101.x; Elith J, 2009, ANNU REV ECOL EVOL S, V40, P677, DOI 10.1146/annurev.ecolsys.110308.120159; FLEMING DM, 1994, ENVIRON MANAGE, V18, P743, DOI 10.1007/BF02394637; Folmer EO, 2012, OIKOS, V121, P551, DOI 10.1111/j.1600-0706.2011.19739.x; Frederick PC, 2001, WETLANDS, V21, P484, DOI 10.1672/0277-5212(2001)021[0484:PBOLLW]2.0.CO;2; Frederick PC, 1997, COLON WATERBIRD, V20, P316, DOI 10.2307/1521699; Frederick P, 2009, ECOL INDIC, V9, pS83, DOI 10.1016/j.ecolind.2008.10.012; Frederick Peter C., 1994, P659; Frid A, 2002, CONSERV ECOL, V6; Garshelis DL, 2000, METH C CONS, P111; Gawlik DE, 2007, AUK, V124, P1075, DOI 10.1642/0004-8038(2007)124[1075:ATOCAH]2.0.CO;2; Gawlik DE, 2002, ECOL MONOGR, V72, P329, DOI 10.1890/0012-9615(2002)072[0329:TEOPAO]2.0.CO;2; Gillies CS, 2006, J ANIM ECOL, V75, P887, DOI 10.1111/j.1365-2656.2006.01106.x; Godvik IMR, 2009, ECOLOGY, V90, P699, DOI 10.1890/08-0576.1; Gunderson Lance H., 1994, P323; Hebblewhite M, 2008, J APPL ECOL, V45, P834, DOI 10.1111/j.1365-2664.2008.01466.x; Herring HK, 2011, WATERBIRDS, V34, P133, DOI 10.1675/063.034.0201; Institute SAS, 2010, SAS 9 2 HELP DOC MIX; Institute SAS, 2010, SAS 9 2 HELP DOC GLI; KAHL MP, 1964, ECOL MONOGR, V34, P97, DOI 10.2307/1948449; Kellogg CM, 2012, OECOLOGIA, V168, P1111, DOI 10.1007/s00442-011-2162-2; Kuhn I, 2007, DIVERS DISTRIB, V13, P66, DOI 10.1111/j.1472-4642.2006.00293.x; KUSHLAN JA, 1976, AUK, V93, P464; Lantz SM, 2011, WATERBIRDS, V34, P439, DOI 10.1675/063.034.0406; Liu ZW, 2009, ECOHYDROLOGY, V2, P182, DOI 10.1002/eco.56; Loftus William F., 1994, P461; Mazzotti FJ, 2009, ECOL INDIC, V9, pS137, DOI 10.1016/j.ecolind.2008.06.008; McCarter K, 2010, P 10 INT C PREC AGR; McLoughlin PD, 2010, J ANIM ECOL, V79, P4, DOI 10.1111/j.1365-2656.2009.01613.x; Mysterud A, 1998, ECOLOGY, V79, P1435, DOI 10.1890/0012-9658(1998)079[1435:FRIHUA]2.0.CO;2; Ogden JC, 2005, WETLANDS, V25, P810, DOI 10.1672/0277-5212(2005)025[0810:ERASCE]2.0.CO;2; OGDEN JC, 1976, CONDOR, V78, P324, DOI 10.2307/1367691; Ogden John C., 1994, P533; RECOVER, 2014, CERP MON ASS PLAN PU; Rittenhouse CD, 2010, J WILDLIFE MANAGE, V74, P411, DOI 10.2193/2008-272; Russell GJ, 2002, ANIM CONSERV, V5, P185, DOI 10.1017/S136794300200224X; Telis PA, 2006, EVERGLADES DEPTH EST, P2006; TOBLER WR, 1970, ECON GEOGR, V46, P234, DOI 10.2307/143141; Trexler JC., 2010, GREATER EVE IN PRESS; Trexler Joel C., 2002, P153	54	28	28	0	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2015	10	6							e0128182	10.1371/journal.pone.0128182	http://dx.doi.org/10.1371/journal.pone.0128182			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4OM	26107386	Green Published, gold, Green Submitted			2022-12-26	WOS:000356932500015
J	Fleischman, DS; Hamilton, LD; Fessler, DMT; Meston, CM				Fleischman, Diana S.; Hamilton, Lisa Dawn; Fessler, Daniel M. T.; Meston, Cindy M.			Disgust versus Lust: Exploring the Interactions of Disgust and Fear with Sexual Arousal in Women	PLOS ONE			English	Article							INDIVIDUAL-DIFFERENCES; VOLUNTEER BIAS; SENSITIVITY; STIMULI; DISEASE; PERSPECTIVE; VAGINISMUS; RESPONSES; PATHOGEN; HISTORY	Sexual arousal is a motivational state that moves humans toward situations that inherently pose a risk of disease transmission. Disgust is an emotion that adaptively moves humans away from such situations. Incongruent is the fact that sexual activity is elementary to human fitness yet involves strong disgust elicitors. Using an experimental paradigm, we investigated how these two states interact. Women (final N=76) were assigned to one of four conditions: rate disgust stimuli then watch a pornographic clip; watch a pornographic clip then rate disgust stimuli; rate fear stimuli then watch a pornographic clip; or watch a pornographic clip then rate fear stimuli. Women's genital sexual arousal was measured with vaginal photoplethysmography and their disgust and fear reactions were measured via self-report. We did not find that baseline disgust propensity predicted sexual arousal in women who were exposed to neutral stimuli before erotic content. In the Erotic-before-Disgust condition we did not find that sexual arousal straightforwardly predicted decreased image disgust ratings. However, we did find some evidence that sexual arousal increased self-reported disgust in women with high trait disgust and sexual arousal decreased self-reported disgust in women with low trait disgust. Women who were exposed to disgusting images before erotic content showed significantly less sexual arousal than women in the control condition or women exposed to fear-inducing images before erotic content. In the Disgust-before-Erotic condition the degree of self-reported disgust was negatively correlated with genital sexual arousal. Hence, in the conflict between the ultimate goals of reproduction and disease avoidance, cues of the presence of pathogens significantly reduce the motivation to engage in mating behaviors that, by their nature, entail a risk of pathogen transmission.	[Fleischman, Diana S.] Univ Portsmouth, Dept Psychol, Portsmouth, Hants, England; [Hamilton, Lisa Dawn] Mt Allison Univ, Dept Psychol, Sackville, NB E0A 3C0, Canada; [Fessler, Daniel M. T.] Univ Calif Los Angeles, Dept Anthropol, Los Angeles, CA 90024 USA; [Fessler, Daniel M. T.] Univ Calif Los Angeles, Ctr Behav Evolut & Culture, Los Angeles, CA 90024 USA; [Meston, Cindy M.] Univ Texas Austin, Dept Psychol, Austin, TX 78712 USA	University of Portsmouth; Mount Allison University; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of Texas System; University of Texas Austin	Fleischman, DS (corresponding author), Univ Portsmouth, Dept Psychol, Portsmouth, Hants, England.	dianafleischman@gmail.com		Meston, Cindy/0000-0002-8771-3956; Fleischman, Diana Santos/0000-0002-2505-1037	American Association of University Women dissertation fellowship	American Association of University Women dissertation fellowship	Reimbursement for participants was funded by the American Association of University Women dissertation fellowship. There was no other external funding for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ariely D, 2006, J BEHAV DECIS MAKING, V19, P87, DOI 10.1002/bdm.501; Borg C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044111; Borg C, 2010, J SEX MED, V7, P2149, DOI 10.1111/j.1743-6109.2010.01800.x; Both S, 2004, J SEX RES, V41, P242, DOI 10.1080/00224490409552232; Brauer M, 2007, EUR J PAIN, V11, P788, DOI 10.1016/j.ejpain.2006.12.006; Brauer M, 2012, ARCH SEX BEHAV, V41, P891, DOI 10.1007/s10508-011-9820-7; CANTOR JR, 1975, J PERS SOC PSYCHOL, V32, P69, DOI 10.1037/h0076784; Carnes P. J., 1998, SEXUAL ADDICTION COM, V5, P293, DOI DOI 10.1080/10720169808402338; Carrigan M, 2011, SEXUALITIES, V14, P462, DOI 10.1177/1363460711406462; Chivers ML, 2010, ARCH SEX BEHAV, V39, P5, DOI 10.1007/s10508-009-9556-9; Clark JA, MESSY EVOLUTIO UNPUB; Cosmides L., 2000, HDB EMOTIONS, V2, P91, DOI DOI 10.31887/DCNS.2000.2.2/ASSCHACHTER; Curtis V, 2004, P ROY SOC B-BIOL SCI, V271, pS131, DOI 10.1098/rsbl.2003.0144; de Jong PJ, 2009, ARCH SEX BEHAV, V38, P244, DOI 10.1007/s10508-007-9240-x; Doyle C, 2007, PERSPECT BIOL MED, V50, P181, DOI 10.1353/pbm.2007.0015; Fessler DMT, 2005, EVOL HUM BEHAV, V26, P344, DOI 10.1016/j.evolhumbehav.2004.12.001; Fessler DMT, 2003, EVOL HUM BEHAV, V24, P406, DOI 10.1016/S1090-5138(03)00054-0; Fessler DMT, 2001, RIV BIOL-BIOL FORUM, V94, P403; Fessler DMT., 1990, FIELD NOTES; Fleischman DS, 2011, HORM BEHAV, V59, P271, DOI 10.1016/j.yhbeh.2010.11.014; Fleischman DS, 2014, EVOL PSYCHOL-SER, P277, DOI 10.1007/978-1-4939-0314-6_15; Grauvogl A, 2014, ARCH SEX BEHAV, P1, DOI [10.1007/s10508-013-0227-5, DOI 10.1007/S10508-013-0227-5]; HAIDT J, 1994, PERS INDIV DIFFER, V16, P701, DOI 10.1016/0191-8869(94)90212-7; Hamilton LD, 2008, J SEX MED, V5, P845, DOI 10.1111/j.1743-6109.2007.00751.x; Hamilton LD, 2013, J SEX MED, V10, P2443, DOI 10.1111/jsm.12249; Hamilton LD, 2011, HORM BEHAV, V59, P765, DOI 10.1016/j.yhbeh.2010.12.011; HOON PW, 1977, J ABNORM PSYCHOL, V86, P65, DOI 10.1037/0021-843X.86.1.65; Janssen E, 2000, J SEX RES, V37, P8, DOI 10.1080/00224490009552016; Janssen E, 2007, HANDBOOK OF PSYCHOPHYSIOLOGY, 3RD EDITION, P245, DOI 10.1017/CBO9780511546396.011; Koukounas E, 1997, SEXUAL EMOTIONAL VAR; Laland KN, 2011, SENSE NONSENSE EVOLU; Lang PJ, 1998, INT AFFECTIVE PICTUR; Lee EM, 2014, ARCH SEX BEHAV, V43, P1115, DOI 10.1007/s10508-014-0271-9; Madkan VK, 2006, ARCH DERMATOL, V142, P365, DOI 10.1001/archderm.142.3.365; MALAMUTH NM, 1980, J ABNORM PSYCHOL, V89, P763, DOI 10.1037/0021-843X.89.6.763; Marshall DS, 1971, SEXUAL BEHAV MANGAIA, P163; Meston CA, 2006, J CONSULT CLIN PSYCH, V74, P229, DOI 10.1037/0022-006X.74.2.229; MESTON CM, 1995, BEHAV RES THER, V33, P651, DOI 10.1016/0005-7967(95)00006-J; Murray DR, 2013, PERS INDIV DIFFER, V54, P103, DOI 10.1016/j.paid.2012.08.021; Nesse R M, 1990, Hum Nat, V1, P261, DOI 10.1007/BF02733986; Oaten M, 2009, PSYCHOL BULL, V135, P303, DOI 10.1037/a0014823; PALACE EM, 1990, J ABNORM PSYCHOL, V99, P403, DOI 10.1037/0021-843X.99.4.403; Rellini AH, 2012, ARCH SEX BEHAV, V41, P329, DOI 10.1007/s10508-011-9772-y; Rieger G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040256; Rohrmann S, 2008, INT J PSYCHOPHYSIOLO; Rosen R, 2000, J SEX MARITAL THER, V26, P191, DOI 10.1080/009262300278597; ROZIN P, 1987, PSYCHOL REV, V94, P23, DOI 10.1037/0033-295X.94.1.23; Schaller M, 2007, SYD SYM SOC PSYCHOL, P293; Sherman NC, 1998, PSYCHOL REP, V82, P1192, DOI 10.2466/PR0.82.3.1192-1194; SINTCHAK G, 1975, PSYCHOPHYSIOLOGY, V12, P113, DOI 10.1111/j.1469-8986.1975.tb03074.x; Stevenson RJ, 2011, ARCH SEX BEHAV, V40, P79, DOI 10.1007/s10508-009-9529-z; STRASSBERG DS, 1995, ARCH SEX BEHAV, V24, P369, DOI 10.1007/BF01541853; ter Kuile MM, 2007, BEHAV RES THER, V45, P2078, DOI 10.1016/j.brat.2007.03.006; Tybur JM, COMMUNICATION; Tybur JM, 2013, PSYCHOL REV, V120, P65, DOI 10.1037/a0030778; Tybur JM, 2011, PERS INDIV DIFFER, V51, P343, DOI 10.1016/j.paid.2011.04.003; Tybur JM, 2011, PSYCHOL SCI, V22, P478, DOI 10.1177/0956797611400096; Tybur JM, 2009, J PERS SOC PSYCHOL, V97, P103, DOI 10.1037/a0015474; van Overveld M, 2013, J SEX MED, V10, P396, DOI 10.1111/j.1743-6109.2012.02979.x; van Overveld M, 2010, PERS INDIV DIFFER, V49, P706, DOI 10.1016/j.paid.2010.06.008; van Overveld WJM, 2006, PERS INDIV DIFFER, V41, P1241, DOI 10.1016/j.paid.2006.04.021; Vonderheide SG, 1988, J PSYCHOL HUMAN SEXU, V1, P97, DOI DOI 10.1300/J056V01N01_08; VRANA SR, 1993, PSYCHOPHYSIOLOGY, V30, P279, DOI 10.1111/j.1469-8986.1993.tb03354.x; WOLCHIK SA, 1983, ARCH SEX BEHAV, V12, P399, DOI 10.1007/BF01542883	64	37	37	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2015	10	6							e0118151	10.1371/journal.pone.0118151	http://dx.doi.org/10.1371/journal.pone.0118151			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CL4OM	26106894	gold, Green Published, Green Submitted			2022-12-26	WOS:000356932500002
J	Startin, CM; Fiorentini, C; de Haan, M; Skuse, DH				Startin, Carla M.; Fiorentini, Chiara; de Haan, Michelle; Skuse, David H.			Variation in the X-Linked EFHC2 Gene Is Associated with Social Cognitive Abilities in Males	PLOS ONE			English	Article							FEAR RECOGNITION; TURNER-SYNDROME; MONOAMINE-OXIDASE; SEX-DIFFERENCES; AMYGDALA; EMOTION; CHILDREN; MIND; IDENTIFICATION; VARIABILITY	Females outperform males on many social cognitive tasks. X-linked genes may contribute to this sex difference. Males possess one X chromosome, while females possess two X chromosomes. Functional variations in X-linked genes are therefore likely to impact more on males than females. Previous studies of X-monosomic women with Turner syndrome suggest a genetic association with facial fear recognition abilities at Xp11.3, specifically at a single nucleotide polymorphism (SNP rs7055196) within the EFHC2 gene. Based on a strong hypothesis, we investigated an association between variation at SNP rs7055196 and facial fear recognition and theory of mind abilities in males. As predicted, males possessing the G allele had significantly poorer facial fear detection accuracy and theory of mind abilities than males possessing the A allele (with SNP variant accounting for up to 4.6% of variance). Variation in the X-linked EFHC2 gene at SNP rs7055196 is therefore associated with social cognitive abilities in males.	[Startin, Carla M.; Fiorentini, Chiara; de Haan, Michelle; Skuse, David H.] UCL, Inst Child Hlth, London, England; [Fiorentini, Chiara] Univ Western Australia, ARC Ctr Excellence Cognit & Disorders, Sch Psychol, Perth, WA 6009, Australia	University of London; University College London; University of Western Australia	Startin, CM (corresponding author), UCL, Div Psychiat, London, England.	carla.startin.09@ucl.ac.uk	Startin, Carla/H-9660-2019	Startin, Carla/0000-0001-9261-9924	Great Ormond Street Hospital Children's Charity; Medical Research Council	Great Ormond Street Hospital Children's Charity; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was performed as a part of a studentship provided to CMS, funded by the Great Ormond Street Hospital Children's Charity and the Medical Research Council. MdH was supported by Great Ormond Street Hospital Children's Charity. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADOLPHS R, 1994, NATURE, V372, P669, DOI 10.1038/372669a0; Baron-Cohen S, 2001, J AUTISM DEV DISORD, V31, P5, DOI 10.1023/A:1005653411471; Baron-Cohen S, 2001, J CHILD PSYCHOL PSYC, V42, P241, DOI 10.1017/S0021963001006643; BaronCohen S, 1997, J CHILD PSYCHOL PSYC, V38, P813, DOI 10.1111/j.1469-7610.1997.tb01599.x; Blakemore SJ, 2012, NEUROIMAGE, V61, P397, DOI 10.1016/j.neuroimage.2011.11.080; Blaya C, 2009, NEUROSCI LETT, V452, P84, DOI 10.1016/j.neulet.2009.01.036; Bortolato M, 2013, INT J NEUROPSYCHOPH, V16, P869, DOI 10.1017/S1461145712000715; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Brothers L., 1990, CONCEPTS NEUROSCIENC, V1, P27, DOI DOI 10.1093/SCHBUL/SBQ012; Carrel L, 2005, NATURE, V434, P400, DOI 10.1038/nature03479; Castagne R, 2011, GENOMICS, V98, P320, DOI 10.1016/j.ygeno.2011.06.009; Corden B, 2006, J COGNITIVE NEUROSCI, V18, P889, DOI 10.1162/jocn.2006.18.6.889; Dorris L, 2004, J CHILD PSYCHOL PSYC, V45, P412, DOI 10.1111/j.1469-7610.2004.00232.x; Dumontheil I, 2014, SOC NEUROSCI-UK, V9, P437, DOI 10.1080/17470919.2014.925503; Ekman P., 1976, PICTURES FACIAL AFFE; Fiorentini C, 2013, GENDER EMOTION INTER, P15; Fiorentini C, 2012, PERCEPTION, V41, P532, DOI 10.1068/p7052; Fiorentini C, 2011, J VISION, V11, DOI 10.1167/11.3.17; Fiorentini C, 2009, VIS COGN, V17, P373, DOI 10.1080/13506280701821019; Frazer KA, 2009, NAT REV GENET, V10, P241, DOI 10.1038/nrg2554; Fried I, 1997, NEURON, V18, P753, DOI 10.1016/S0896-6273(00)80315-3; Fusar-Poli P, 2009, J PSYCHIATR NEUROSCI, V34, P418; Good CD, 2003, BRAIN, V126, P2431, DOI 10.1093/brain/awg242; Gu WL, 2005, EPILEPSY RES, V66, P91, DOI 10.1016/j.eplepsyres.2005.07.003; Gur RC, 2012, NEUROPSYCHOLOGY, V26, P251, DOI 10.1037/a0026712; Hall JK, 2010, COGNITION EMOTION, V24, P629, DOI 10.1080/02699930902906882; Helsmoortel C, CLIN GENET IN PRESS; Hong DS, 2014, SOC COGN AFFECT NEUR, V9, P255, DOI 10.1093/scan/nss133; Knickmeyer RC, 2012, CURR OPIN NEUROL, V25, P144, DOI 10.1097/WCO.0b013e3283515e9e; Lawrence K, 2007, COGNITION, V102, P84, DOI 10.1016/j.cognition.2005.12.003; Lawrence K, 2003, NEUROPSYCHOLOGIA, V41, P894, DOI 10.1016/S0028-3932(03)00002-2; Lawrence K, 2003, NEUROPSYCHOLOGY, V17, P39, DOI 10.1037/0894-4105.17.1.39; McCall C, 2012, NAT NEUROSCI, V15, P681, DOI 10.1038/nn.3084; Nguyen DK, 2006, NAT GENET, V38, P47, DOI 10.1038/ng1705; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Robinson EB, 2013, P NATL ACAD SCI USA, V110, P5258, DOI 10.1073/pnas.1211070110; Rodriguez-Revenga L, 2007, AM J MED GENET A, V143A, P916, DOI 10.1002/ajmg.a.31521; Ropers HH, 2005, NAT REV GENET, V6, P46, DOI 10.1038/nrg1501; Skuse DH, 2009, J AM ACAD CHILD PSY, V48, P128, DOI 10.1097/CHI.0b013e31819176b8; Skuse DH, 2005, BRAIN, V128, P2084, DOI 10.1093/brain/awh562; Skuse DH, 2005, HUM MOL GENET, V14, pR27, DOI 10.1093/hmg/ddi112; Slane MM, 2014, DEV COGN NEUROS-NETH, V9, P160, DOI 10.1016/j.dcn.2014.04.001; Viviani P, 2007, VIS COGN, V15, P420, DOI 10.1080/13506280600761134; Wakabayashi A, 2012, J INDIVID DIFFER, V33, P24, DOI 10.1027/1614-0001/a000058; Wallis JD, 2012, NAT NEUROSCI, V15, P13, DOI 10.1038/nn.2956; Weisenbach SL, 2014, SOC COGN AFFECT NEUR, V9, P316, DOI 10.1093/scan/nss137; Weiss LA, 2007, HUM MOL GENET, V16, P107, DOI 10.1093/hmg/ddl445; Williams LM, 2009, J CLIN EXP NEUROPSYC, V31, P257, DOI 10.1080/13803390802255635; Zink CF, 2012, HORM BEHAV, V61, P400, DOI 10.1016/j.yhbeh.2012.01.016	49	9	9	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2015	10	6							e0131604	10.1371/journal.pone.0131604	http://dx.doi.org/10.1371/journal.pone.0131604			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4OM	26107779	Green Published, gold, Green Submitted			2022-12-26	WOS:000356932500169
J	Widjaja, I; Rigter, A; Jacobino, S; van Kuppeveld, FJM; Leenhouts, K; Palomo, C; Melero, JA; Leusen, JHW; Haijema, BJ; Rottier, PJM; de Haan, CAM				Widjaja, Ivy; Rigter, Alan; Jacobino, Shamir; van Kuppeveld, Frank J. M.; Leenhouts, Kees; Palomo, Concepcion; Melero, Jose A.; Leusen, Jeanette H. W.; Haijema, Bert Jan; Rottier, Peter J. M.; de Haan, Cornelis A. M.			Recombinant Soluble Respiratory Syncytial Virus F Protein That Lacks Heptad Repeat B, Contains a GCN4 Trimerization Motif and Is Not Cleaved Displays Prefusion-Like Characteristics	PLOS ONE			English	Article							2 DISTINCT SITES; FUSION PROTEIN; STRUCTURAL BASIS; GLYCOPROTEIN; ANTIBODY; ACTIVATION; MUTANTS; VACCINE; DESIGN; ENTRY	The respiratory syncytial virus (RSV) fusion protein F is considered an attractive vaccine candidate especially in its prefusion conformation. We studied whether recombinant soluble RSV F proteins could be stabilized in a prefusion-like conformation by mutation of heptad repeat B (HRB). The results show that soluble, trimeric, non-cleaved RSV F protein, produced by expression of the furin cleavage site-mutated F ectodomain extended with a GCN4 trimerization sequence, is efficiently recognized by pre-as well as postfusion-specific antibodies. In contrast, a similar F protein completely lacking HRB displayed high reactivity with prefusion-specific antibodies recognizing antigenic site O, but did not expose postfusion- specific antigenic site I, in agreement with this protein maintaining a prefusion-like conformation. These features were dependent on the presence of the GCN4 trimerization domain. Absence of cleavage also contributed to binding of prefusion-specific antibodies. Similar antibody reactivity profiles were observed when the prefusion form of F was stabilized by the introduction of cysteine pairs in HRB. To study whether the inability to form the 6HB was responsible for the prefusion-like antibody reactivity profile, alanine mutations were introduced in HRB. Although introduction of alanine residues in HRB inhibited the formation of the 6HB, the exposure of postfusion-specific antigenic site I was not prevented. In conclusion, proteins that are not able to form the 6HB, due to mutation of HRB, may still display postfusion-specific antigenic site I. Replacement of HRB by the GCN4 trimerization domain in a non-cleaved soluble F protein resulted, however, in a protein with prefusion-like characteristics, suggesting that this HRB-lacking protein may represent a potential prefusion F protein subunit vaccine candidate.	[Widjaja, Ivy; Rigter, Alan; van Kuppeveld, Frank J. M.; Rottier, Peter J. M.; de Haan, Cornelis A. M.] Univ Utrecht, Fac Vet Med, Dept Infect Dis & Immunol, Div Virol, NL-3894 CL Utrecht, Netherlands; [Widjaja, Ivy; Rigter, Alan; Leenhouts, Kees; Haijema, Bert Jan] Mucosis BV, Meditech Ctr, NL-9713 GX Groningen, Netherlands; [Jacobino, Shamir; Leusen, Jeanette H. W.] Univ Med Ctr Utrecht, Dept Immunol, NL-3508 AB Utrecht, Netherlands; [Palomo, Concepcion; Melero, Jose A.] Inst Salud Carlos III, Ctr Nacl Microbiol, Madrid 28220, Spain; [Palomo, Concepcion; Melero, Jose A.] Inst Salud Carlos III, CIBERES, Madrid 28220, Spain	Utrecht University; Utrecht University; Utrecht University Medical Center; Instituto de Salud Carlos III; Centro Nacional de Microbiologa (CNM); CIBER - Centro de Investigacion Biomedica en Red; CIBERES; Instituto de Salud Carlos III	de Haan, CAM (corresponding author), Univ Utrecht, Fac Vet Med, Dept Infect Dis & Immunol, Div Virol, NL-3894 CL Utrecht, Netherlands.	c.a.m.dehaan@uu.nl	, Jeanette/AAG-3736-2019; Palomo, Concepcion/AAF-4788-2019	Palomo, Concepcion/0000-0003-4138-1930; Leusen, Jeanette/0000-0003-4982-6914; van Kuppeveld, Frank/0000-0001-5800-749X; de Haan, Cornelis/0000-0002-4459-9874; Melero, Jose A./0000-0001-8148-6521	Mucosis B. V.	Mucosis B. V.	This study was funded in part by Mucosis B. V. No additional external funding was received for this study. We agree that the funder provided support in the form of salaries for authors [IW, AR, KL, BJH], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the "author contributions" section.	ANDERSON LJ, 1988, J VIROL, V62, P4232, DOI 10.1128/JVI.62.11.4232-4238.1988; Beaumont T., 2012, Patent No. [US/2012/0070446 A1, 20120070446]; Chang A, 2012, VIRUSES-BASEL, V4, P613, DOI 10.3390/v4040613; Collins PL, 2011, VIRUS RES, V162, P80, DOI 10.1016/j.virusres.2011.09.020; Connolly SA, 2006, P NATL ACAD SCI USA, V103, P17903, DOI 10.1073/pnas.0608678103; Del Vecchio A, 2013, J MATERN-FETAL NEO M, V26, P55, DOI 10.3109/14767058.2013.831282; Eckert DM, 2001, P NATL ACAD SCI USA, V98, P11187, DOI 10.1073/pnas.201392898; Gonzalez-Reyes L, 2001, P NATL ACAD SCI USA, V98, P9859, DOI 10.1073/pnas.151098198; Hallak LK, 2000, J VIROL, V74, P10508, DOI 10.1128/JVI.74.22.10508-10513.2000; Johnson S, 1997, J INFECT DIS, V176, P1215, DOI 10.1086/514115; Krzyzaniak MA, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003309; Kwakkenbos MJ, 2010, NAT MED, V16, P123, DOI 10.1038/nm.2071; Lamb RA, 2007, CURR OPIN STRUC BIOL, V17, P427, DOI 10.1016/j.sbi.2007.08.016; Liljeroos L, 2013, P NATL ACAD SCI USA, V110, P11133, DOI 10.1073/pnas.1309070110; Magro M, 2012, P NATL ACAD SCI USA, V109, P3089, DOI 10.1073/pnas.1115941109; McLellan JS, 2013, SCIENCE, V342, P592, DOI 10.1126/science.1243283; McLellan JS, 2013, SCIENCE, V340, P1113, DOI 10.1126/science.1234914; McLellan JS, 2011, J VIROL, V85, P7788, DOI 10.1128/JVI.00555-11; Palomo C, 2014, VIROLOGY, V460, P119, DOI 10.1016/j.virol.2014.05.001; Paterson RG, 2000, VIROLOGY, V270, P17, DOI 10.1006/viro.2000.0267; Plattet P, 2013, MBIO, V4, DOI 10.1128/mBio.00413-13; Poor TA, 2015, J VIROL, V89, P3438, DOI 10.1128/JVI.03221-14; Rigter A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071072; Ruiz-Arguello MB, 2004, J GEN VIROL, V85, P3677, DOI 10.1099/vir.0.80318-0; Ruiz-Arguello MB, 2002, VIROLOGY, V298, P317, DOI 10.1006/viro.2002.1497; Russell CJ, 2003, J CELL BIOL, V163, P363, DOI 10.1083/jcb.200305130; Russell CJ, 2001, EMBO J, V20, P4024, DOI 10.1093/emboj/20.15.4024; Sakurai H, 1999, J VIROL, V73, P2956, DOI 10.1128/JVI.73.4.2956-2962.1999; Schlender J, 2003, J VIROL, V77, P4609, DOI 10.1128/JVI.77.8.4609-4616.2003; Spits H, 2008, International patent, Patent No. [WO/2008/147196, 2008147196]; Swanson KA, 2011, P NATL ACAD SCI USA, V108, P9619, DOI 10.1073/pnas.1106536108; Tan L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051439; Techaarpornkul S, 2001, J VIROL, V75, P6825, DOI 10.1128/JVI.75.15.6825-6834.2001; Tsui P, 1996, J IMMUNOL, V157, P772; van Roosmalen ML, 2006, METHODS, V38, P144, DOI 10.1016/j.ymeth.2005.09.015; Yin HS, 2005, P NATL ACAD SCI USA, V102, P9288, DOI 10.1073/pnas.0503989102; Zimmer G, 2001, J BIOL CHEM, V276, P31642, DOI 10.1074/jbc.M102633200	37	9	16	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2015	10	6							e0130829	10.1371/journal.pone.0130829	http://dx.doi.org/10.1371/journal.pone.0130829			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4OM	26107504	Green Published, Green Submitted, gold			2022-12-26	WOS:000356932500126
J	Scialom, S; Malamut, G; Meresse, B; Guegan, N; Brousse, N; Verkarre, V; Derrieux, C; Macintyre, E; Seksik, P; Savoye, G; Cadiot, G; Vuitton, L; Marthey, L; Carbonnel, F; Cerf-Bensussan, N; Cellier, C				Scialom, Sophie; Malamut, Georgia; Meresse, Bertrand; Guegan, Nicolas; Brousse, Nicole; Verkarre, Virginie; Derrieux, Coralie; Macintyre, Elizabeth; Seksik, Philippe; Savoye, Guillaume; Cadiot, Guillaume; Vuitton, Lucine; Marthey, Lysiane; Carbonnel, Franck; Cerf-Bensussan, Nadine; Cellier, Christophe			Gastrointestinal Disorder Associated with Olmesartan Mimics Autoimmune Enteropathy	PLOS ONE			English	Article							LYMPHOMA; SPRUE	Background and Objectives Anti-hypertensive treatment with the angiotensin II receptor antagonist olmesartan is a rare cause of severe Sprue-like enteropathy. To substantiate the hypothesis that olmesartan interferes with gut immune homeostasis, clinical, histopathological and immune features were compared in olmesartan-induced-enteropathy (OIE) and in autoimmune enteropathy (AIE). Methods Medical files of seven patients with OIE and 4 patients with AIE enrolled during the same period were retrospectively reviewed. Intestinal biopsies were collected for central histopathological review, T cell Receptor clonality and flow cytometric analysis of isolated intestinal lymphocytes. Results Among seven olmesartan-treated patients who developed villous atrophy refractory to a gluten free diet, three had extra-intestinal autoimmune diseases, two had antibodies reacting with the 75 kilodalton antigen characteristic of AIE and one had serum anti-goblet cell antibodies. Small intestinal lesions and signs of intestinal lymphocyte activation were thus reminiscent of the four cases of AIE diagnosed during the same period. Before olmesartan discontinuation, remission was induced in all patients (7/7) by immunosuppressive drugs. After interruption of both olmesartan and immunosuppressive drugs in six patients, remission was maintained in 4 but anti-TNF-alpha therapy was needed in two. Conclusion This case-series shows that olmesartan can induce intestinal damage mimicking AIE. OIE usually resolved after olmesartan interruption but immunosuppressive drugs may be necessary to achieve remission. Our data sustain the hypothesis that olmesartan interferes with intestinal immuno regulation in predisposed individuals.	[Scialom, Sophie; Malamut, Georgia; Meresse, Bertrand; Guegan, Nicolas; Brousse, Nicole; Verkarre, Virginie; Derrieux, Coralie; Macintyre, Elizabeth; Cerf-Bensussan, Nadine; Cellier, Christophe] Univ Paris 05, Sorbonne Paris Ctr, Paris, France; [Scialom, Sophie; Malamut, Georgia; Cellier, Christophe] Hop Europeen Georges Pompidou, AP HP, Dept Gastroenterol, Paris, France; [Malamut, Georgia; Meresse, Bertrand; Guegan, Nicolas; Cerf-Bensussan, Nadine; Cellier, Christophe] INSERM, Lab Intestinal Immunol, UMR 1163, Paris, France; [Malamut, Georgia; Meresse, Bertrand; Guegan, Nicolas; Cerf-Bensussan, Nadine; Cellier, Christophe] Inst Imagine, Paris, France; [Brousse, Nicole; Verkarre, Virginie] Hop Necker Enfants Malad, AP HP, Dept Pathol, Paris, France; [Derrieux, Coralie; Macintyre, Elizabeth] Hop Necker Enfants Malad, AP HP, Biol Hematol, Paris, France; [Seksik, Philippe] Hop St Antoine, AP HP, Dept Gastroenterol, F-75571 Paris, France; [Savoye, Guillaume] CHU Rouen, Gastroenterol, Rouen, France; [Cadiot, Guillaume] CHU Reims, Dept Gastroenterol, Reims, France; [Vuitton, Lucine] CHRU, Dept Gastroenterol, Besancon, France; [Marthey, Lysiane; Carbonnel, Franck] Hop Bicetre, AP HP, Dept Gastroenterol, Paris, France	UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite; CHU de Rouen; CHU de Reims; Universite de Reims Champagne-Ardenne; Universite de Franche-Comte; CHU Besancon; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay	Malamut, G (corresponding author), Univ Paris 05, Sorbonne Paris Ctr, Paris, France.	georgia.malamut@egp.aphp.fr	Meresse, Bertrand/N-6325-2017; Cerf-Bensussan, nadine/H-9505-2017; GUEGAN, Nicolas/H-9484-2017; SEKSIK, Philippe/ABE-2962-2020	Meresse, Bertrand/0000-0002-8978-8636; Cerf-Bensussan, nadine/0000-0003-0665-1245; GUEGAN, Nicolas/0000-0003-2434-4564; SEKSIK, Philippe/0000-0003-3596-9893; christophe, Cellier/0000-0003-0784-2318; Savoye, Guillaume/0000-0002-9200-2067; Macintyre-Davi, Elizabeth Anne/0000-0003-0520-0493; Malamut, Georgia/0000-0003-4030-3025				Brunner HR, 2003, J HYPERTENS, V21, pS43, DOI 10.1097/00004872-200305002-00008; Burnier M, 2000, LANCET, V355, P637, DOI 10.1016/S0140-6736(99)10365-9; Cellier C, 1998, GASTROENTEROLOGY, V114, P471, DOI 10.1016/S0016-5085(98)70530-X; DeGaetani M, 2013, AM J GASTROENTEROL, V108, P647, DOI 10.1038/ajg.2013.45; Dreifuss SE, 2013, CASE REP GASTROINTES, V2013, DOI 10.1155/2013/618071; Greywoode R, 2014, MAYO CLIN PROC, V89, P1239, DOI 10.1016/j.mayocp.2014.05.012; Hmida NB, 2012, AM J GASTROENTEROL, V107, P604, DOI 10.1038/ajg.2011.397; Ianiro G, 2014, ALIMENT PHARM THER, V40, P16, DOI 10.1111/apt.12780; Jabado N, 1996, PEDIATRICS, V98, P420; KAGAMI S, 1994, J CLIN INVEST, V93, P2431, DOI 10.1172/JCI117251; Kirch W, 2001, EUR J CLIN INVEST, V31, P698, DOI 10.1046/j.1365-2362.2001.00871.x; Malamut G, 2014, CLIN GASTROENTEROL H, V12, P599, DOI 10.1016/j.cgh.2013.11.028; Malamut G, 2012, GASTROENTEROLOGY, V142, P726, DOI 10.1053/j.gastro.2011.12.040; Malamut G, 2009, GASTROENTEROLOGY, V136, P81, DOI 10.1053/j.gastro.2008.09.069; Marthey L, 2014, ALIMENT PHARM THER, V40, P1103, DOI 10.1111/apt.12937; Rubio-Tapia A, 2012, MAYO CLIN PROC, V87, P732, DOI 10.1016/j.mayocp.2012.06.003; Verkarre V, 2003, GUT, V52, P205, DOI 10.1136/gut.52.2.205	17	39	41	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2015	10	6							e0125024	10.1371/journal.pone.0125024	http://dx.doi.org/10.1371/journal.pone.0125024			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4DD	26101883	Green Published, Green Submitted, gold			2022-12-26	WOS:000356901900002
J	Borg, RM; Bordonne, R; Vassallo, N; Cauchi, RJ				Borg, Rebecca M.; Bordonne, Remy; Vassallo, Neville; Cauchi, Ruben J.			Genetic Interactions between the Members of the SMN-Gemins Complex in Drosophila	PLOS ONE			English	Article							SPINAL MUSCULAR-ATROPHY; SURVIVAL-MOTOR-NEURON; DEAD-BOX PROTEIN; SPLICING DEFECTS; U SNRNPS; EXPRESSION; REVEALS; BIOGENESIS; PHENOTYPE; COMPONENT	The SMN-Gemins complex is composed of Gemins 2-8, Unrip and the survival motor neuron (SMN) protein. Limiting levels of SMN result in the neuromuscular disorder, spinal muscular atrophy (SMA), which is presently untreatable. The most-documented function of the SMN-Gemins complex concerns the assembly of spliceosomal small nuclear ribonucleoproteins (snRNPs). Despite multiple genetic studies, the Gemin proteins have not been identified as prominent modifiers of SMN-associated mutant phenotypes. In the present report, we make use of the Drosophila model organism to investigate whether viability and motor phenotypes associated with a hypomorphic Gemin3 mutant are enhanced by changes in the levels of SMN, Gemin2 and Gemin5 brought about by various genetic manipulations. We show a modifier effect by all three members of the minimalistic fly SMN-Gemins complex within the muscle compartment of the motor unit. Interestingly, muscle-specific overexpression of Gemin2 was by itself sufficient to depress normal motor function and its enhanced upregulation in all tissues leads to a decline in fly viability. The toxicity associated with increased Gemin2 levels is conserved in the yeast S. pombe in which we find that the cytoplasmic retention of Sm proteins, likely reflecting a block in the snRNP assembly pathway, is a contributing factor. We propose that a disruption in the normal stoichiometry of the SMN-Gemins complex depresses its function with consequences that are detrimental to the motor system.	[Borg, Rebecca M.; Vassallo, Neville; Cauchi, Ruben J.] Univ Malta, Fac Med & Surg, Dept Physiol & Biochem, Msida, Malta; [Borg, Rebecca M.; Bordonne, Remy] Univ Montpellier 1&2, CNRS UMR5535, Inst Genet Mol Montpellier, Montpellier, France	University of Malta; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier	Cauchi, RJ (corresponding author), Univ Malta, Fac Med & Surg, Dept Physiol & Biochem, Msida, Malta.	ruben.cauchi@um.edu.mt		Cauchi, Ruben/0000-0001-6150-1608; Vassallo, Neville/0000-0002-8985-5587	University of Malta Research Fund [PHBRP09]; University of Malta Faculty of Medicine and Surgery Dean's Initiative; Malta Council for Science & Technology through the National Research & Innovation Programme [RI-2012-066]; Strategic Educational Pathways Scholarship (Malta); European Union - European Social Fund under Operational Programme II - Cohesion Policy, "Empowering People for More Jobs and a Better Quality of Life"; Embassy of France to Malta; French National Centre for Scientific Research; University of Malta; Malta Council for Science Technology	University of Malta Research Fund; University of Malta Faculty of Medicine and Surgery Dean's Initiative; Malta Council for Science & Technology through the National Research & Innovation Programme; Strategic Educational Pathways Scholarship (Malta); European Union - European Social Fund under Operational Programme II - Cohesion Policy, "Empowering People for More Jobs and a Better Quality of Life"; Embassy of France to Malta; French National Centre for Scientific Research; University of Malta; Malta Council for Science Technology	This work was supported by the University of Malta Research Fund (PHBRP09) and the University of Malta Faculty of Medicine and Surgery Dean's Initiative. RJC and NV are both supported by the Malta Council for Science & Technology through the National Research & Innovation Programme 2012 (R&I-2012-066). RMB is supported by a Strategic Educational Pathways Scholarship (Malta), part-financed by the European Union - European Social Fund under Operational Programme II - Cohesion Policy 2007-2013, "Empowering People for More Jobs and a Better Quality of Life", and an internship grant awarded by the Embassy of France to Malta, the French National Centre for Scientific Research, Malta Council for Science & Technology and the University of Malta.	Barbarossa A, 2014, MOL CELL BIOL, V34, P595, DOI 10.1128/MCB.01407-13; Battle DJ, 2006, MOL CELL, V23, P273, DOI 10.1016/j.molcel.2006.05.036; BERTRAM MJ, 1992, MECH DEVELOP, V38, P33, DOI 10.1016/0925-4773(92)90036-J; Bordonne R, 2000, MOL CELL BIOL, V20, P7943, DOI 10.1128/MCB.20.21.7943-7954.2000; Borg R, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00325; Borg R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083878; Boulisfane N, 2011, HUM MOL GENET, V20, P641, DOI 10.1093/hmg/ddq508; Burghes AHM, 2009, NAT REV NEUROSCI, V10, P597, DOI 10.1038/nrn2670; Campbell L, 2000, HUM MOL GENET, V9, P1093, DOI 10.1093/hmg/9.7.1093; Campion Y, 2010, EMBO J, V29, P1817, DOI 10.1038/emboj.2010.70; Carissimi C, 2006, J BIOL CHEM, V281, P8126, DOI 10.1074/jbc.M512243200; Cauchi RJ, 2011, CELL BIOL INT, V35, P1233, DOI 10.1042/CBI20110147; Cauchi RJ, 2010, BIOESSAYS, V32, P1077, DOI 10.1002/bies.201000088; Cauchi RJ, 2010, EXP CELL RES, V316, P2354, DOI 10.1016/j.yexcr.2010.05.001; Cauchi RJ, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000265; Chan YB, 2003, HUM MOL GENET, V12, P1367, DOI 10.1093/hmg/ddg157; Chang HCH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003209; Charroux B, 1999, J CELL BIOL, V147, P1181, DOI 10.1083/jcb.147.6.1181; Dimitriadi M, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001172; Feng WQ, 2005, HUM MOL GENET, V14, P1605, DOI 10.1093/hmg/ddi168; FISCHER U, 1993, EMBO J, V12, P573, DOI 10.1002/j.1460-2075.1993.tb05689.x; Gates J, 2004, DEVELOPMENT, V131, P25, DOI 10.1242/dev.00920; Grice SJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002030; Grimm C, 2013, MOL CELL, V49, P692, DOI 10.1016/j.molcel.2012.12.009; Guruharsha KG, 2011, CELL, V147, P690, DOI 10.1016/j.cell.2011.08.047; Hamilton G, 2013, TRENDS MOL MED, V19, P40, DOI 10.1016/j.molmed.2012.11.002; Hao LT, 2007, BMC CELL BIOL, V8, DOI 10.1186/1471-2121-8-28; Hayles J, 2013, OPEN BIOL, V3, DOI 10.1098/rsob.130053; Helmken C, 2003, HUM GENET, V114, P11, DOI 10.1007/s00439-003-1025-2; Hua YM, 2015, GENE DEV, V29, P288, DOI 10.1101/gad.256644.114; Imlach WL, 2012, CELL, V151, P427, DOI 10.1016/j.cell.2012.09.011; Jablonka S, 2002, P NATL ACAD SCI USA, V99, P10126, DOI 10.1073/pnas.152318699; Kim MS, 2014, NATURE, V509, P575, DOI 10.1038/nature13302; Kroiss M, 2008, P NATL ACAD SCI USA, V105, P10045, DOI 10.1073/pnas.0802287105; Lau CK, 2009, NAT STRUCT MOL BIOL, V16, P486, DOI 10.1038/nsmb.1584; Lee AJH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046353; Li DK, 2014, SEMIN CELL DEV BIOL, V32, P22, DOI 10.1016/j.semcdb.2014.04.026; Liu JL, 2007, P NATL ACAD SCI USA, V104, P11655, DOI 10.1073/pnas.0704977104; Liu Q, 1996, EMBO J, V15, P3555, DOI 10.1002/j.1460-2075.1996.tb00725.x; Lotti F, 2012, CELL, V151, P440, DOI 10.1016/j.cell.2012.09.012; Matera AG, 2014, NAT REV MOL CELL BIO, V15, P108, DOI 10.1038/nrm3742; MAUNDRELL K, 1993, GENE, V123, P127, DOI 10.1016/0378-1119(93)90551-D; Monani UR, 2014, FUTUR NEUROL, V9, P49, DOI 10.2217/FNL.13.58; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Ogawa C, 2007, J BIOL CHEM, V282, P11122, DOI 10.1074/jbc.M609297200; Oprea GE, 2008, SCIENCE, V320, P524, DOI 10.1126/science.1155085; Otter S, 2007, J BIOL CHEM, V282, P5825, DOI 10.1074/jbc.M608528200; Pellizzoni L, 1998, CELL, V95, P615, DOI 10.1016/S0092-8674(00)81632-3; Prior TW, 2004, AM J MED GENET A, V130A, P307, DOI 10.1002/ajmg.a.30251; Sen A, 2013, P NATL ACAD SCI USA, V110, pE2371, DOI 10.1073/pnas.1301738110; Shpargel KB, 2009, MOL BIOL CELL, V20, P90, DOI 10.1091/mbc.E08-01-0024; Shpargel KB, 2005, P NATL ACAD SCI USA, V102, P17372, DOI 10.1073/pnas.0508947102; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; Winkler C, 2005, GENE DEV, V19, P2320, DOI 10.1101/gad.342005; Wirth B, 2006, HUM GENET, V119, P422, DOI 10.1007/s00439-006-0156-7; Wood V, 2002, NATURE, V415, P871, DOI 10.1038/nature724; Workman E, 2012, BRAIN RES, V1462, P93, DOI 10.1016/j.brainres.2012.02.051; Workman E, 2009, HUM MOL GENET, V18, P2215, DOI 10.1093/hmg/ddp157; Yan XM, 2003, MOL CELL BIOL, V23, P414, DOI 10.1128/MCB.23.1.414-423.2003; Yong J, 2010, MOL CELL, V38, P551, DOI 10.1016/j.molcel.2010.03.014; Zhang RD, 2011, CELL, V146, P384, DOI 10.1016/j.cell.2011.06.043; Zhang Z, 2008, CELL, V133, P585, DOI 10.1016/j.cell.2008.03.031; Zhang ZX, 2013, P NATL ACAD SCI USA, V110, P19348, DOI 10.1073/pnas.1319280110	63	18	18	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2015	10	6							e0130974	10.1371/journal.pone.0130974	http://dx.doi.org/10.1371/journal.pone.0130974			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL3FM	26098872	Green Published, gold			2022-12-26	WOS:000356835800127
J	Genaro-Mattos, TC; Mauricio, AQ; Rettori, D; Alonso, A; Hermes-Lima, M				Genaro-Mattos, Thiago C.; Mauricio, Angelo Q.; Rettori, Daniel; Alonso, Antonio; Hermes-Lima, Marcelo			Antioxidant Activity of Caffeic Acid against Iron-Induced Free Radical Generation-A Chemical Approach	PLOS ONE			English	Article							ISONICOTINOYL HYDRAZONE PIH; DIHYDROCAFFEIC ACID; LIPID-PEROXIDATION; CHLOROGENIC ACIDS; PHENETHYL ESTER; DERIVATIVES; QUERCETIN; OXIDATION; KINETICS; PLASMA	Caffeic acid (CA) is a phenolic compound widely found in coffee beans with known beneficial effects in vivo. Many studies showed that CA has anti-inflammatory, anti-mutagenic, antibacterial and anti-carcinogenic properties, which could be linked to its antioxidant activity. Taking in consideration the reported in vitro antioxidant mechanism of other polyphenols, our working hypothesis was that the CA antioxidant activity could be related to its metal-chelating property. With that in mind, we sought to investigate the chemical antioxidant mechanism of CA against in vitro iron-induced oxidative damage under different assay conditions. CA was able to prevent hydroxyl radical formation promoted by the classical Fenton reaction, as determined by 2-deoxyribose (2-DR) oxidative degradation and DMPO hydroxylation. In addition to its ability to prevent hydroxyl radical formation, CA had a great inhibition of membrane lipid peroxidation. In the lipid peroxidation assays CA acted as both metal-chelator and as hydrogen donor, preventing the deleterious action promoted by lipid-derived peroxyl and alkoxyl radicals. Our results indicate that the observed antioxidant effects were mostly due to the formation of iron-CA complexes, which are able to prevent 2-DR oxidation and DMPO hydroxylation. Noteworthy, the formation of iron-CA complexes and prevention of oxidative damage was directly related to the pH of the medium, showing better antioxidant activity at higher pH values. Moreover, in the presence of lipid membranes the antioxidant potency of CA was much higher, indicating its enhanced effectiveness in a hydrophobic environment. Overall, our results show that CA acts as an antioxidant through an iron chelating mechanism, preventing the formation of free hydroxyl radicals and, therefore, inhibiting Fenton-induced oxidative damage. The chemical properties of CA described here - in association with its reported signaling effects-could be an explanation to its beneficial effects observed in vivo.	[Genaro-Mattos, Thiago C.; Mauricio, Angelo Q.; Hermes-Lima, Marcelo] Univ Brasilia, Dept Biol Celular, Lab Radicais Livres, Brasilia, DF, Brazil; [Genaro-Mattos, Thiago C.] Embrapa Recursos Genet & Biotecnol, Lab Espectrometria Massa, Brasilia, DF, Brazil; [Genaro-Mattos, Thiago C.] Univ Brasilia, Inst Quim, Brasilia, DF, Brazil; [Rettori, Daniel] Univ Fed Sao Paulo UNIFESP, Dept Ciencias Exatas & Terra, Lab Quim & Bioquim Especies Altamente Reat, Sao Paulo, SP, Brazil; [Alonso, Antonio] Univ Fed Goias, Inst Fis, Goiania, Go, Brazil	Universidade de Brasilia; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Universidade de Brasilia; Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal de Goias	Hermes-Lima, M (corresponding author), Univ Brasilia, Dept Biol Celular, Lab Radicais Livres, Brasilia, DF, Brazil.	m_hermes_lima@yahoo.com.br	Hermes-Lima, Marcelo/AAP-1167-2020; Alonso, Antonio/I-8969-2012	Alonso, Antonio/0000-0003-4768-6372; Genaro-Mattos, Thiago/0000-0001-9377-2285; Hermes-Lima, Marcelo/0000-0003-1732-0927				Ader P, 1996, EXP PHYSIOL, V81, P943, DOI 10.1113/expphysiol.1996.sp003995; Andrade RG, 2006, BIOCHIMIE, V88, P1287, DOI 10.1016/j.biochi.2006.02.006; Ani V, 2006, EUR FOOD RES TECHNOL, V224, P109, DOI 10.1007/s00217-006-0295-z; BATES GW, 1971, J BIOL CHEM, V246, P3679; CASTILHO RF, 1994, ARCH BIOCHEM BIOPHYS, V308, P158, DOI 10.1006/abbi.1994.1022; CHEN YF, 1995, PLANTA MED, V61, P2, DOI 10.1055/s-2006-957987; Cheng YT, 2014, J NUTR BIOCHEM, V25, P1045, DOI 10.1016/j.jnutbio.2014.05.007; Chung TW, 2004, FASEB J, V18, P1670, DOI 10.1096/fj.04-2126com; Farah A, 2008, J NUTR, V138, P2309, DOI 10.3945/jn.108.095554; Garcia P, 1996, J AGR FOOD CHEM, V44, P2101, DOI 10.1021/jf9503265; Genaro-Mattos TC, 2009, BBA-GEN SUBJECTS, V1790, P1636, DOI 10.1016/j.bbagen.2009.09.003; Ginani JS, ESTUDO DA ACAO ANTIO; GOLDSTEIN DS, 1984, J CHROMATOGR, V311, P148, DOI 10.1016/S0378-4347(00)84701-5; Graefe EU, 2001, J CLIN PHARMACOL, V41, P492, DOI 10.1177/00912700122010366; GUTTERIDGE JMC, 1988, BIOCHEM J, V253, P932, DOI 10.1042/bj2530932; Hermes-Lima M, 2001, MOL CELL BIOCHEM, V228, P73, DOI 10.1023/A:1013348005312; Hermes-Lima M, 2000, BBA-GEN SUBJECTS, V1523, P154, DOI 10.1016/S0304-4165(00)00115-X; Hollman PCH, 1997, FEBS LETT, V418, P152, DOI 10.1016/S0014-5793(97)01367-7; Hynes MJ, 2004, J INORG BIOCHEM, V98, P1457, DOI 10.1016/j.jinorgbio.2004.05.009; Jung JE, 2007, CARCINOGENESIS, V28, P1780, DOI 10.1093/carcin/bgm130; Kang NJ, 2009, CARCINOGENESIS, V30, P321, DOI 10.1093/carcin/bgn282; Khvan AM, 2001, CHEM NAT COMPD, V37, P72, DOI 10.1023/A:1017662812611; Kim H, 2013, FREE RADICAL BIO MED, V65, P552, DOI 10.1016/j.freeradbiomed.2013.07.015; Kunsagi-Mate S, 2008, FOOD RES INT, V41, P693, DOI 10.1016/j.foodres.2008.05.001; Lee JS, 2005, CANCER LETT, V224, P171, DOI 10.1016/j.canlet.2004.09.042; LEE MJ, 1995, CANCER EPIDEM BIOMAR, V4, P393; Lopes GKB, 1999, BBA-GEN SUBJECTS, V1472, P142, DOI 10.1016/S0304-4165(99)00117-8; Manach C, 1998, FEBS LETT, V426, P331, DOI 10.1016/S0014-5793(98)00367-6; Maurya DK, 2010, FOOD CHEM TOXICOL, V48, P3369, DOI 10.1016/j.fct.2010.09.006; Moon JH, 1998, J AGR FOOD CHEM, V46, P5062, DOI 10.1021/jf9805799; NARDINI M, 1995, FREE RADICAL BIO MED, V19, P541, DOI 10.1016/0891-5849(95)00052-Y; Olthof MR, 2001, J NUTR, V131, P66, DOI 10.1093/jn/131.1.66; Pardo-Andreu GL, 2006, PHARMACOL RES, V53, P253, DOI 10.1016/j.phrs.2005.06.006; Scapagnini G, 2002, MOL PHARMACOL, V61, P554, DOI 10.1124/mol.61.3.554; Scapagnini G, 2011, MOL NEUROBIOL, V44, P192, DOI 10.1007/s12035-011-8181-5; Shi John, 2003, Journal of Medicinal Food, V6, P291, DOI 10.1089/109662003772519831; Silva FAM, 2000, J AGR FOOD CHEM, V48, P2122, DOI 10.1021/jf9913110; Sorensen ADM, 2008, J AGR FOOD CHEM, V56, P1740, DOI 10.1021/jf072946z; Yamada J, 1996, BIOSCI BIOTECH BIOCH, V60, P328, DOI 10.1271/bbb.60.328; Yamanaka N, 1997, FEBS LETT, V405, P186, DOI 10.1016/S0014-5793(97)00185-3; Yin HY, 2011, CHEM REV, V111, P5944, DOI 10.1021/cr200084z	42	77	80	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2015	10	6							e0129963	10.1371/journal.pone.0129963	http://dx.doi.org/10.1371/journal.pone.0129963			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL3FM	26098639	Green Published, Green Submitted, gold			2022-12-26	WOS:000356835800047
J	Grapentin, C; Barnert, S; Schubert, R				Grapentin, Christoph; Barnert, Sabine; Schubert, Rolf			Monitoring the Stability of Perfluorocarbon Nanoemulsions by Cryo-TEM Image Analysis and Dynamic Light Scattering	PLOS ONE			English	Article							F-19 MRI; FLUOROCARBON EMULSIONS; MOLECULAR-DIFFUSION; OXYGEN; INFLAMMATION; CELLS; CHEMISTRY	Perfluorocarbon nanoemulsions (PFC-NE) are disperse systems consisting of nanoscale liquid perfluorocarbon droplets stabilized by an emulsifier, usually phospholipids. Perfluorocarbons are chemically inert and non-toxic substances that are exhaled after in vivo administration. The manufacture of PFC-NE can be done in large scales by means of high pressure homogenization or microfluidization. Originally investigated as oxygen carriers for cases of severe blood loss, their application nowadays is more focused on using them as marker agents in F-19 Magnetic Resonance Imaging (F-19 MRI). F-19 is scarce in organisms and thus PFC-NE are a promising tool for highly specific and non-invasive imaging of inflammation via F-19 MRI. Neutrophils, monocytes and macrophages phagocytize PFC-NE and subsequently migrate to inflamed tissues. This technique has proven feasibility in numerous disease models in mice, rabbits and mini pigs. The translation to clinical trials in human needs the development of a stable nanoemulsion whose droplet size is well characterized over a long storage time. Usually dynamic light scattering (DLS) is applied as the standard method for determining particle sizes in the nanometer range. Our study uses a second method, analysis of transmission electron microscopy images of cryo-fixed samples (Cryo-TEM), to evaluate stability of PFC-NE in comparison to DLS. Four nanoemulsions of different composition are observed for one year. The results indicate that DLS alone cannot reveal the changes in particle size, but can even mislead to a positive estimation of stability. The combination with Cryo-TEM images gives more insight in the particulate evolution, both techniques supporting one another. The study is one further step in the development of analytical tools for the evaluation of a clinically applicable perfluorooctylbromide nanoemulsion.	[Grapentin, Christoph; Barnert, Sabine; Schubert, Rolf] Univ Freiburg, Dept Pharmaceut Technol & Biopharm, Freiburg, Germany	University of Freiburg	Schubert, R (corresponding author), Univ Freiburg, Dept Pharmaceut Technol & Biopharm, Freiburg, Germany.	rolf.schubert@pharmazie.uni-freiburg.de			German Research Foundation (DFG) [SCHU800/8-1, SCHU800/8-2]	German Research Foundation (DFG)(German Research Foundation (DFG))	This work was supported by the German Research Foundation (DFG) by grants SCHU800/8-1 and SCHU800/8-2 (http://www.dfg.de/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahrens ET, 2013, NAT REV IMMUNOL, V13, P755, DOI 10.1038/nri3531; Ahrens ET, 2013, NMR BIOMED, V26, P860, DOI 10.1002/nbm.2948; ARLAUSKAS RA, 1994, ARTIF CELL BLOOD SUB, V22, P1317, DOI 10.3109/10731199409138832; Bernsen MR, 2010, EUR RADIOL, V20, P255, DOI 10.1007/s00330-009-1540-1; Bonner F, 2015, EUR HEART J IN PRESS; Castro CI, 2010, ARTIF ORGANS, V34, P622, DOI 10.1111/j.1525-1594.2009.00944.x; CLARK LC, 1966, SCIENCE, V152, P1755, DOI 10.1126/science.152.3730.1755; Cohn SM, J TRAUMA, V54, P193; CORNELUS C, 1993, COLLOID SURFACE A, V70, P233, DOI 10.1016/0927-7757(93)80297-R; Diou O, 2012, BIOMATERIALS, V33, P5593, DOI 10.1016/j.biomaterials.2012.04.037; Ebner B, 2010, CIRC-CARDIOVASC IMAG, V3, P202, DOI 10.1161/CIRCIMAGING.109.902312; Flogel U, 2011, AM J TRANSPLANT, V11, P235, DOI 10.1111/j.1600-6143.2010.03372.x; Flogel U, 2008, CIRCULATION, V118, P140, DOI 10.1161/CIRCULATIONAHA.107.737890; GOLLAN F, 1968, EXP MED SURG, V26, P249; Grapentin C., 2014, NANOMED, P268, DOI DOI 10.1182/ASHEDUCATI0N-2014.1.268; Hertlein T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018246; HIGUCHI WI, 1962, J PHARM SCI, V51, P459, DOI 10.1002/jps.2600510514; Holzer M, 2009, J CHROMATOGR A, V1216, P5838, DOI 10.1016/j.chroma.2009.06.023; Jacoby C, 2014, NMR BIOMED, V27, P261, DOI 10.1002/nbm.3059; Janjic JM, 2009, WIRES NANOMED NANOBI, V1, P492, DOI 10.1002/wnan.35; KABALNOV AS, 1987, COLLOID SURFACE, V24, P19, DOI 10.1016/0166-6622(87)80258-5; Krafft MP, 2007, J POLYM SCI POL CHEM, V45, P1185, DOI 10.1002/pola.21937; KRAFFT MP, 1991, J PHYS CHEM-US, V95, P5673, DOI 10.1021/j100167a054; Mayenfels F, 2012, THESIS A LUDWIG U FR; O'Hagan D, 2008, CHEM SOC REV, V37, P308, DOI 10.1039/b711844a; Riess JG, 2005, ARTIF CELL BLOOD SUB, V33, P47, DOI 10.1081/BIO-200046659; Riess JG, 2001, CHEM REV, V101, P2797, DOI 10.1021/cr970143c; RIESS JG, 1992, BIOMAT ARTIF CELL IM, V20, P839, DOI 10.3109/10731199209119726; Ruiz-Cabello J, 2011, NMR BIOMED, V24, P114, DOI 10.1002/nbm.1570; Sandford G, 2003, TETRAHEDRON, V59, P437, DOI 10.1016/S0040-4020(02)01568-5; Soehnlein O, 2010, NAT REV IMMUNOL, V10, P427, DOI 10.1038/nri2779; Srinivas M, 2012, BIOMATERIALS, V33, P8830, DOI 10.1016/j.biomaterials.2012.08.048; Srinivas M, 2010, BIOMATERIALS, V31, P7070, DOI 10.1016/j.biomaterials.2010.05.069; Temme S, 2012, WIRES NANOMED NANOBI, V4, P329, DOI 10.1002/wnan.1163; Vasudeva K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090589; Vorob'ev SI, 2009, PHARM CHEM J, V43, P209, DOI 10.1007/s11094-009-0268-1; Waiczies H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021981; WEERS JG, 1994, COLLOID SURFACE A, V84, P81, DOI 10.1016/0927-7757(93)02662-X; Weibel S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056317; Weise G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028143; WESTESEN K, 1993, COLLOID SURFACE A, V78, P125, DOI 10.1016/0927-7757(93)80318-9	41	43	43	1	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2015	10	6							e0130674	10.1371/journal.pone.0130674	http://dx.doi.org/10.1371/journal.pone.0130674			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL3FM	26098661	Green Published, gold, Green Submitted			2022-12-26	WOS:000356835800092
J	Kelloniemi, A; Szabo, Z; Serpi, R; Napankangas, J; Ohukainen, P; Tenhunen, O; Kaikkonen, L; Koivisto, E; Bagyura, Z; Kerkela, R; Leosdottir, M; Hedner, T; Melander, O; Ruskoaho, H; Rysa, J				Kelloniemi, Annina; Szabo, Zoltan; Serpi, Raisa; Napankangas, Juha; Ohukainen, Pauli; Tenhunen, Olli; Kaikkonen, Leena; Koivisto, Elina; Bagyura, Zsolt; Kerkela, Risto; Leosdottir, Margret; Hedner, Thomas; Melander, Olle; Ruskoaho, Heikki; Rysa, Jaana			The Early-Onset Myocardial Infarction Associated PHACTR1 Gene Regulates Skeletal and Cardiac Alpha-Actin Gene Expression	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; GENOME-WIDE ASSOCIATION; NATRIURETIC-PEPTIDE; SUSCEPTIBILITY LOCI; DYNAMICS; HEART; P38; SCAPININ; BINDING; GATA-4	The phosphatase and actin regulator 1 (PHACTR1) locus is a very commonly identified hit in genome-wide association studies investigating coronary artery disease and myocardial infarction (MI). However, the function of PHACTR1 in the heart is still unknown. We characterized the mechanisms regulating Phactr1 expression in the heart, used adenoviral gene delivery to investigate the effects of Phactr1 on cardiac function, and analyzed the relationship between MI associated PHACTR1 allele and cardiac function in human subjects. Phactr1 mRNA and protein levels were markedly reduced (60%, P<0.01 and 90%, P<0.001, respectively) at 1 day after MI in rats. When the direct myocardial effects of Phactr1 were studied, the skeletal a-actin to cardiac a-actin isoform ratio was significantly higher (1.5-fold, P<0.05) at 3 days but 40% lower (P<0.05) at 2 weeks after adenovirus-mediated Phactr1 gene delivery into the anterior wall of the left ventricle. Similarly, the skeletal a-actin to cardiac a-actin ratio was lower at 2 weeks in infarcted hearts overexpressing Phactr1. In cultured neonatal cardiac myocytes, adenovirus-mediated Phactr1 overexpression for 48 hours markedly increased the skeletal a-actin to cardiac a-actin ratio, this being associated with an enhanced DNA binding activity of serum response factor. Phactr1 overexpression exerted no major effects on the expression of other cardiac genes or LV structure and function in normal and infarcted hearts during 2 weeks' follow-up period. In human subjects, MI associated PHACTR1 allele was not associated significantly with cardiac function (n = 1550). Phactr1 seems to regulate the skeletal to cardiac a-actin isoform ratio.	[Kelloniemi, Annina; Szabo, Zoltan; Serpi, Raisa; Ohukainen, Pauli; Tenhunen, Olli; Kaikkonen, Leena; Koivisto, Elina; Kerkela, Risto; Ruskoaho, Heikki; Rysa, Jaana] Univ Oulu, Dept Pharmacol & Toxicol, Inst Biomed, Oulu, Finland; [Napankangas, Juha] Univ Oulu, Oulu Univ Hosp, Dept Pathol, Oulu, Finland; [Bagyura, Zsolt] Semmelweis Univ, Ctr Heart, H-1085 Budapest, Hungary; [Kerkela, Risto] Univ Oulu, Oulu Univ Hosp, Med Res Ctr Oulu, Oulu, Finland; [Leosdottir, Margret; Melander, Olle] Lund Univ, Dept Clin Sci, Malmo, Sweden; [Hedner, Thomas] Univ Gothenburg, Sahlgrenska Acad, Inst Med, Gothenburg, Sweden	University of Oulu; University of Oulu; Semmelweis University; University of Oulu; Lund University; University of Gothenburg	Ruskoaho, H (corresponding author), Univ Helsinki, Div Pharmacol & Pharmacotherapy, Helsinki, Finland.	heikki.ruskoaho@helsinki.fi; jaana.rysa@uef.fi	Ohukainen, Pauli/P-7811-2019	Ohukainen, Pauli/0000-0002-0919-7204; Szabo, Zoltan/0000-0003-0778-1113; Napankangas, Juha/0000-0003-3088-5180; Melander, Olle/0000-0002-2581-484X; Rysa, Jaana/0000-0003-2205-6323; Serpi, Raisa/0000-0002-8207-4673; Leosdottir, Margret/0000-0003-1677-1566	Academy of Finland (Center of Excellence) [276747, 266661]; Sigrid Juselius Foundation; Finnish Foundation for Cardiovascular Research; Aarne Koskelo Foundation; Finnish Cultural Foundation; European Research Council [StG-282255]; Swedish Medical Research Council; Swedish Heart and Lung Foundation;  [LUA/ALF-ALFGBG151121]	Academy of Finland (Center of Excellence)(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Finnish Foundation for Cardiovascular Research; Aarne Koskelo Foundation; Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science); European Research Council(European Research Council (ERC)European Commission); Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); Swedish Heart and Lung Foundation(Swedish Heart-Lung Foundation); 	This work was supported by the Academy of Finland (Center of Excellence, HR; grant 276747, JR; grant 266661, HR), Sigrid Juselius Foundation (HR), Finnish Foundation for Cardiovascular Research (HR, JR, AK), the Aarne Koskelo Foundation (AK), Finnish Cultural Foundation (JR), LUA/ALF-ALFGBG151121 (TH), European Research Council StG-282255 (OM), the Swedish Medical Research Council (OM) and the Swedish Heart and Lung Foundation (OM).	Agrawal R, 2010, PHARMACOL RES, V61, P269, DOI 10.1016/j.phrs.2009.11.012; Allain B, 2012, CELL SIGNAL, V24, P214, DOI 10.1016/j.cellsig.2011.09.003; Allen PB, 2004, P NATL ACAD SCI USA, V101, P7187, DOI 10.1073/pnas.0401673101; Barry SP, 2008, INT J BIOCHEM CELL B, V40, P2023, DOI 10.1016/j.biocel.2008.02.020; Berglund G, 2000, J INTERN MED, V247, P19, DOI 10.1046/j.1365-2796.2000.00568.x; Carlier MF, 1999, J BIOL CHEM, V274, P33827, DOI 10.1074/jbc.274.48.33827; DAVEY HW, 1995, DNA CELL BIOL, V14, P609, DOI 10.1089/dna.1995.14.609; Farghaian H, 2011, J BIOL CHEM, V286, P19724, DOI 10.1074/jbc.M110.205781; Fava C, 2013, HYPERTENSION, V61, P319, DOI 10.1161/HYPERTENSIONAHA.112.202655; Fils-Aime N, 2013, J BIOL CHEM, V288, P11807, DOI 10.1074/jbc.M112.430934; Force T, 2002, J CARD FAIL, V8, pS351, DOI 10.1054/jcaf.2002.129272; Frey N, 2004, CIRCULATION, V109, P1580, DOI 10.1161/01.CIR.0000120390.68287.BB; Go AS, 2014, CIRCULATION, V129, pE28, DOI 10.1161/01.cir.0000441139.02102.80; GUSTAFSON TA, 1989, MOL CELL BIOL, V9, P3269, DOI 10.1128/MCB.9.8.3269; Hager J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038663; Heusch G, 2014, LANCET, V383, P1933, DOI 10.1016/S0140-6736(14)60107-0; HEWETT TE, 1994, CIRC RES, V74, P740, DOI 10.1161/01.RES.74.4.740; Huet G, 2013, J CELL SCI, V126, P497, DOI 10.1242/jcs.113241; IZUMO S, 1988, P NATL ACAD SCI USA, V85, P339, DOI 10.1073/pnas.85.2.339; Jarray R, 2011, BIOCHIMIE, V93, P1668, DOI 10.1016/j.biochi.2011.07.010; Jessup M, 2003, NEW ENGL J MED, V348, P2007, DOI 10.1056/NEJMra021498; Kathiresan S, 2009, NAT GENET, V41, P334, DOI 10.1038/ng.327; Koivisto E, 2011, CAN J PHYSIOL PHARM, V89, P539, DOI [10.1139/Y11-049, 10.1139/y11-049]; Koivisto E, 2011, MOL CELL ENDOCRINOL, V338, P18, DOI 10.1016/j.mce.2011.02.015; KOMURO I, 1991, J BIOL CHEM, V266, P1265; Kumar A, 1997, P NATL ACAD SCI USA, V94, P4406, DOI 10.1073/pnas.94.9.4406; Leosdottir M, 2010, AM HEART J, V159, P414, DOI 10.1016/j.ahj.2009.12.028; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Lu XF, 2012, NAT GENET, V44, P890, DOI 10.1038/ng.2337; Luosujarvi H, 2010, BLOOD PRESSURE, V19, P54, DOI 10.3109/08037050903464519; Matsuoka R, 2015, INT J MOL MED, V35, P1451, DOI 10.3892/ijmm.2015.2115; McGuigan FEA, 2002, PSYCHIATR GENET, V12, P133, DOI 10.1097/00041444-200209000-00003; Mikhailov AT, 2012, BIOCHEM RES INT, V2012, DOI 10.1155/2012/973723; Mizuno K, 2013, CELL SIGNAL, V25, P457, DOI 10.1016/j.cellsig.2012.11.001; Molkentin JD, 1996, J MOL CELL CARDIOL, V28, P1211, DOI 10.1006/jmcc.1996.0112; Morin S, 2001, MOL CELL BIOL, V21, P1036, DOI 10.1128/MCB.21.4.1036-1044.2001; NADALGINARD B, 1989, J CLIN INVEST, V84, P1693, DOI 10.1172/JCI114351; O'Donnell CJ, 2011, CIRCULATION, V124, P2855, DOI 10.1161/CIRCULATIONAHA.110.974899; Olson EN, 2010, NAT REV MOL CELL BIO, V11, P353, DOI 10.1038/nrm2890; Omura T, 2000, BASIC RES CARDIOL, V95, P316, DOI 10.1007/s003950070051; Pikkarainen S, 2003, J BIOL CHEM, V278, P23807, DOI 10.1074/jbc.M302719200; Ronkainen VP, 2007, FASEB J, V21, P1821, DOI 10.1096/fj.06-7294com; Rose BA, 2010, PHYSIOL REV, V90, P1507, DOI 10.1152/physrev.00054.2009; RUSKOAHO H, 1992, PHARMACOL REV, V44, P479; Rysa J, 2010, CIRC-HEART FAIL, V3, P440, DOI 10.1161/CIRCHEARTFAILURE.109.889642; SADOSHIMA J, 1992, J BIOL CHEM, V267, P10551; Sagara J, 2003, J BIOL CHEM, V278, P45611, DOI 10.1074/jbc.M305227200; Sagara J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004247; Schunkert H, 2011, NAT GENET, V43, P333, DOI [10.1038/ng.784, 10.1161/CIRCGENETICS.111.960443]; SCHWARTZ K, 1986, CIRC RES, V59, P551, DOI 10.1161/01.RES.59.5.551; Swynghedauw B, 1999, PHYSIOL REV, V79, P215, DOI 10.1152/physrev.1999.79.1.215; Tenhunen O, 2004, J BIOL CHEM, V279, P24852, DOI 10.1074/jbc.M314317200; Tenhunen O, 2006, FASEB J, V20, P1907, DOI 10.1096/fj.05-5618fje; Tenhunen O, 2006, CIRC RES, V99, P485, DOI 10.1161/01.RES.0000238387.85144.92; Wiezlak M, 2012, J CELL SCI, V125, P5860, DOI 10.1242/jcs.112078; Zhang Y, 2012, GENE DEV, V26, P69, DOI 10.1101/gad.179283.111	56	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2015	10	6							e0130502	10.1371/journal.pone.0130502	http://dx.doi.org/10.1371/journal.pone.0130502			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL3FM	26098115	Green Published, Green Submitted, gold			2022-12-26	WOS:000356835800076
J	Leng, JH; Li, WQ; Zhang, S; Liu, HK; Wang, LS; Liu, GS; Li, N; Redman, LM; Baccarelli, AA; Hou, LF; Hu, G				Leng, Junhong; Li, Weiqin; Zhang, Shuang; Liu, Huikun; Wang, Leishen; Liu, Gongshu; Li, Nan; Redman, Leanne M.; Baccarelli, Andrea A.; Hou, Lifang; Hu, Gang			GDM Women's Pre-Pregnancy Overweight/Obesity and Gestational Weight Gain on Offspring Overweight Status	PLOS ONE			English	Article							BODY-MASS INDEX; DIABETES-MELLITUS; INCREASING PREVALENCE; CHINESE WOMEN; MATERNAL OBESITY; BLOOD-PRESSURE; BIRTH-WEIGHT; FETAL-GROWTH; RISK; ASSOCIATIONS	Objectives To examine the association of maternal pre-pregnancy body mass index (BMI) and gestational weight gain (GWG) with anthropometry in the offspring of mothers with gestational diabetes mellitus (GDM). Methods We performed a retrospective cohort study in 1263 GDM mother-child pairs. General linear models and Logistic regression models were used to assess the single and joint associations of maternal pre-pregnancy BMI (normal weight, overweight, and obesity) and GWG (inadequate, adequate and excessive GWG) with anthropometry and overweight status in the offspring from birth to 1-5 years old. Results Maternal pre-pregnancy BMI and GWG were positively associated with birth weight for gestational age Z score and birth weight for length for gestational age Z score at birth, and weight for age Z score, length/height for age Z score, and weight for length/height Z score at of 1-5 years old offspring. Maternal pre-pregnancy overweight, obesity, and excessive GWG were associated with increased risks of large for gestational age [ORs 95% CIs = 1.87 (1.37-2.55), 2.98 (1.89-4.69), and 2.93 (2.07-4.13), respectively] and macrosomia [ORs 95% CIs = 2.06 (1.50-2.84), 2.89 (1.78-4.70), and 2.84 (1.98-4.06), respectively] at birth and childhood overweight at 1-5 years old [ORs 95% CIs = 1.26 (0.92-1.73), 1.96 (1.24-3.09), and 1.59 (1.15-2.21), respectively]. Conclusions Offspring born to GDM mothers with pre-pregnancy overweight/obesity or excessive GWG were associated with increased risks of large for gestational age and macrosomia at birth, and childhood overweight at 1-5 years old, compared with those born to GDM mothers with pre-pregnancy normal weight and adequate GWG.	[Leng, Junhong; Li, Weiqin; Zhang, Shuang; Liu, Huikun; Wang, Leishen; Liu, Gongshu; Li, Nan] Tianjin Womens & Childrens Hlth Ctr, Project Off, Tianjin, Peoples R China; [Li, Weiqin; Redman, Leanne M.; Hu, Gang] Pennington Biomed Res Ctr, Chron Dis Epidemiol Lab, Baton Rouge, LA 70808 USA; [Baccarelli, Andrea A.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Baccarelli, Andrea A.] Harvard Univ, Sch Publ Hlth, Dept Environm Hlth, Boston, MA 02115 USA; [Hou, Lifang] Northwestern Univ, Dept Prevent Med, Feinberg Sch Med, Chicago, IL 60611 USA	Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Northwestern University; Feinberg School of Medicine	Hu, G (corresponding author), Pennington Biomed Res Ctr, Chron Dis Epidemiol Lab, 6400 Perkins Rd, Baton Rouge, LA 70808 USA.	gang.hu@pbrc.edu	Hu, Gang/V-7947-2019; Hu, Gang/N-1971-2017; Redman, Leanne M/N-1986-2017	Hu, Gang/0000-0002-6172-8017; Hu, Gang/0000-0002-6172-8017; Baccarelli, Andrea/0000-0002-3436-0640	Tianjin Women's and Children's Health Center; Tianjin Public Health Bureau; European Foundation for the Study of Diabetes (EFSD)/Chinese Diabetes Society (CDS)/Lilly Programme for Collaborative Research; National Institute Of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health [R01DK100790]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK100790] Funding Source: NIH RePORTER	Tianjin Women's and Children's Health Center; Tianjin Public Health Bureau; European Foundation for the Study of Diabetes (EFSD)/Chinese Diabetes Society (CDS)/Lilly Programme for Collaborative Research; National Institute Of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by Tianjin Women's and Children's Health Center, Tianjin Public Health Bureau, European Foundation for the Study of Diabetes (EFSD)/Chinese Diabetes Society (CDS)/Lilly Programme for Collaborative Research between China and Europe, and the National Institute Of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health under Award Number R01DK100790. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], PREGNANCY NUTRITION; Baird J, 2005, BMJ-BRIT MED J, V331, P929, DOI 10.1136/bmj.38586.411273.E0; Belfort MB, 2007, J PEDIATR-US, V151, P670, DOI 10.1016/j.jpeds.2007.05.010; Berggren EK, 2015, AM J PERINAT, V32, P251, DOI 10.1055/s-0034-1383848; Bowers K, 2013, DIABETOLOGIA, V56, P1263, DOI 10.1007/s00125-013-2881-5; Bowers K, 2011, PEDIATRICS, V127, pE1272, DOI 10.1542/peds.2010-2213; Cedergren MI, 2007, OBSTET GYNECOL, V110, P759, DOI 10.1097/01.AOG.0000279450.85198.b2; Cedergren MI, 2004, OBSTET GYNECOL, V103, P219, DOI 10.1097/01.AOG.0000107291.46159.00; Chagnon YC, 2003, OBES RES, V11, P313, DOI 10.1038/oby.2003.47; Chen Chunming, 2004, Biomed Environ Sci, V17 Suppl, P1; Chen Y, 2013, LANCET, V381, P1916, DOI 10.1016/S0140-6736(13)60903-4; Chu SY, 2009, PREV MED, V49, P265, DOI 10.1016/j.ypmed.2009.07.001; Dabelea D, 2005, DIABETES CARE, V28, P579, DOI 10.2337/diacare.28.3.579; Dabelea D, 2007, DIABETES CARE, V30, pS169, DOI 10.2337/dc07-s211; Ferrara A, 2004, OBSTET GYNECOL, V103, P526, DOI 10.1097/01.AOG.0000113623.18286.20; Frederick IO, 2008, MATERN CHILD HLTH J, V12, P557, DOI 10.1007/s10995-007-0276-2; Guelinckx I, 2008, OBES REV, V9, P140, DOI 10.1111/j.1467-789X.2007.00464.x; Haidar Yarah M, 2011, Clin Colon Rectal Surg, V24, P205, DOI 10.1055/s-0031-1295684; Harper LM, 2015, AM J PERINAT, V32, P239, DOI 10.1055/s-0034-1383846; Hillier TA, 2007, DIABETES CARE, V30, P2287, DOI 10.2337/dc06-2361; Hu G, 2012, DIABETES RES CLIN PR, V98, P508, DOI 10.1016/j.diabres.2012.09.015; Hunt KJ, 2007, OBSTET GYN CLIN N AM, V34, P173, DOI 10.1016/j.ogc.2007.03.002; Kim SY, 2007, OBESITY, V15, P986, DOI 10.1038/oby.2007.621; Kim SY, 2014, OBSTET GYNECOL, V123, P737, DOI 10.1097/AOG.0000000000000177; Leunissen RWJ, 2009, JAMA-J AM MED ASSOC, V301, P2234, DOI 10.1001/jama.2009.761; Li CY, 2007, OBESITY, V15, P760, DOI 10.1038/oby.2007.585; Li N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077809; Li WQ, 2014, DIABETES CARE, V37, P2533, DOI 10.2337/dc14-0573; Li Yan-ping, 2006, Zhonghua Yufang Yixue Zazhi, V40, P273; Liu HK, 2014, OBESITY, V22, P1560, DOI 10.1002/oby.20722; Ma G, 2008, OBES REV, V9, P113, DOI 10.1111/j.1467-789X.2007.00451.x; Most O, 2012, J MATERN-FETAL NEO M, V25, P2458, DOI 10.3109/14767058.2011.650250; Ng M, 2014, LANCET, V384, P766, DOI 10.1016/S0140-6736(14)60460-8; Nohr EA, 2008, AM J CLIN NUTR, V87, P1750, DOI 10.1093/ajcn/87.6.1750; Oken E, 2003, OBES RES, V11, P496, DOI 10.1038/oby.2003.69; Pajak A., 1988, RELATION, V41, P115; Pettitt DJ, 2010, DIABETES CARE, V33, P1219, DOI 10.2337/dc09-2384; Rasmussen KM, 2009, WEIGHT GAIN DURING P; Sebire NJ, 2001, INT J OBESITY, V25, P1175, DOI 10.1038/sj.ijo.0801670; Stunkard AJ, 1999, INT J OBESITY, V23, P159, DOI 10.1038/sj.ijo.0800785; Wang L, 2014, DIABETIC MED, V31, P1368, DOI 10.1111/dme.12532; Wang YJ, 2012, J WOMENS HEALTH, V21, P319, DOI 10.1089/jwh.2011.2838; WHO Consultation, 1999, DEFINITION DIAGNOSIS; World Health Organization, 2006, THE WHO CHILD GROWTH; Wu YF, 2006, BMJ-BRIT MED J, V333, P362, DOI 10.1136/bmj.333.7564.362; Yang Yan-dong, 2012, Zhonghua Fu Chan Ke Za Zhi, V47, P646; Young TK, 2002, AM J OBSTET GYNECOL, V187, P312, DOI 10.1067/mob.2002.126200; Zhang F, 2011, DIABETIC MED, V28, P652, DOI 10.1111/j.1464-5491.2010.03205.x; Zhang X, 2009, PREV MED, V49, P172, DOI 10.1016/j.ypmed.2009.07.013	49	40	41	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2015	10	6							e0129536	10.1371/journal.pone.0129536	http://dx.doi.org/10.1371/journal.pone.0129536			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL3FM	26098307	gold, Green Published, Green Submitted			2022-12-26	WOS:000356835800033
J	McLeod, M; Barber, N; Franklin, BD				McLeod, Monsey; Barber, Nicholas; Franklin, Bryony Dean			Facilitators and Barriers to Safe Medication Administration to Hospital Inpatients: A Mixed Methods Study of Nurses' Medication Administration Processes and Systems (the MAPS Study)	PLOS ONE			English	Article							HEALTH-CARE SETTINGS; ERRORS; INTERRUPTIONS; WORKAROUNDS; IMPACT	Context Research has documented the problem of medication administration errors and their causes. However, little is known about how nurses administer medications safely or how existing systems facilitate or hinder medication administration; this represents a missed opportunity for implementation of practical, effective, and low-cost strategies to increase safety. Aim To identify system factors that facilitate and/or hinder successful medication administration focused on three inter-related areas: nurse practices and workarounds, workflow, and interruptions and distractions. Methods We used a mixed-methods ethnographic approach involving observational fieldwork, field notes, participant narratives, photographs, and spaghetti diagrams to identify system factors that facilitate and/or hinder successful medication administration in three inpatient wards, each from a different English NHS trust. We supplemented this with quantitative data on interruptions and distractions among other established medication safety measures. Findings Overall, 43 nurses on 56 drug rounds were observed. We identified a median of 5.5 interruptions and 9.6 distractions per hour. We identified three interlinked themes that facilitated successful medication administration in some situations but which also acted as barriers in others: (1) system configurations and features, (2) behaviour types among nurses, and (3) patient interactions. Some system configurations and features acted as a physical constraint for parts of the drug round, however some system effects were partly dependent on nurses' inherent behaviour; we grouped these behaviours into 'task focused', and 'patient-interaction focused'. The former contributed to a more streamlined workflow with fewer interruptions while the latter seemed to empower patients to act as a defence barrier against medication errors by being: (1) an active resource of information, (2) a passive information resource, and/or (3) a 'double-checker'. Conclusions We have identified practical examples of system effects on work optimisation and nurse behaviours that potentially increase medication safety, and conceptualized ways in which patient involvement can increase medication safety in hospitals.	[McLeod, Monsey; Franklin, Bryony Dean] Imperial Coll Healthcare NHS Trust, Dept Pharm, Ctr Medicat Safety & Serv Qual, London, England; [McLeod, Monsey; Franklin, Bryony Dean] UCL Sch Pharm, Res Dept Practice & Policy, London, England; [Barber, Nicholas] Hlth Fdn, London, England	Imperial College London; University of London; University College London	Franklin, BD (corresponding author), Imperial Coll Healthcare NHS Trust, Dept Pharm, Ctr Medicat Safety & Serv Qual, London, England.	bryony.deanfranklin@imperial.nhs.uk	McLeod, Monsey/AAR-7989-2021	McLeod, Monsey/0000-0001-5571-2417	National Institute for Health Research (NIHR) Imperial Patient Safety Translational Research Centre	National Institute for Health Research (NIHR) Imperial Patient Safety Translational Research Centre	This paper represents independent research supported by the National Institute for Health Research (NIHR) Imperial Patient Safety Translational Research Centre. The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed Z, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080378; ALLAN EL, 1990, AM J HOSP PHARM, V47, P555, DOI 10.1093/ajhp/47.3.555; [Anonymous], 2011, GOV ARR RES ETH COMM; Australian Council for Safety and Quality in Health Care, 2002, SAF QUAL COUNC 2 NAT; Barker KN, 1962, AM J HOSP PHARM, V19, P361; Berwick D, 2013, IMPROVING SAFETY PAT; Bevington J, 2004, HLTH SERV J, VII4, P28; Biron AD, 2009, WORLDV EVID-BASED NU, V6, P70, DOI 10.1111/j.1741-6787.2009.00151.x; Britten N, 2009, BRIT J CLIN PHARMACO, V67, P646, DOI 10.1111/j.1365-2125.2009.03421.x; Chaudhury H, 2009, ENVIRON BEHAV, V41, P755, DOI 10.1177/0013916508330392; Coiera E, 2012, BMJ QUAL SAF, V21, P357, DOI 10.1136/bmjqs-2012-000783; Dean B, 2001, AM J HEALTH-SYST PH, V58, P54, DOI 10.1093/ajhp/58.1.54; DEAN BS, 1995, AM J HEALTH-SYST PH, V52, P2543, DOI 10.1093/ajhp/52.22.2543; Debono DS, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-175; Department of Health, 2000, ORG MEM; Dixon-Woods M, 2014, BMJ QUAL SAF, V23, P106, DOI 10.1136/bmjqs-2013-001947; Donabedian A, 2003, INTRO QUALITY ASSURA; Flynn EA, 1999, AM J HEALTH-SYST PH, V56, P1319, DOI 10.1093/ajhp/56.13.1319; Francis R., 2013, REPORT MIDSTAFFORD 1, V1; Francis R, 2013, REPORT MID STAFFOR 1; Francis R., 2013, REPORT MID STAFFORDS; Francis R., 2013, REPORT MIDSTAFFORDSH, V3; Franklin BD, 2007, QUAL SAF HEALTH CARE, V16, P279, DOI 10.1136/qshc.2006.019497; Goddard M, 1999, HEALTH POLICY, V48, P119, DOI 10.1016/S0168-8510(99)00035-4; Greenhalgh T, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-45; Halbesleben JRB, 2008, HEALTH CARE MANAGE R, V33, P2, DOI 10.1097/01.HMR.0000304495.95522.ca; Hundt A., 2007, J PATIENT SAF, V3, P34, DOI DOI 10.1097/PTS.0B013E3180319DE7; Keers RN, 2013, DRUG SAFETY, V36, P1045, DOI 10.1007/s40264-013-0090-2; Keers RN, 2013, ANN PHARMACOTHER, V47, P237, DOI 10.1345/aph.1R147; Kohn L.T., 2000, ERR IS HUMAN BUILDIN, VVolume 600; Koppel R, 2008, J AM MED INFORM ASSN, V15, P408, DOI 10.1197/jamia.M2616; Lofland John, 2006, ANAL SOCIAL SETTINGS, V4; McLeod M, 2013, THESIS U COLL LONDON; McLeod M, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-93; McLeod MC, 2013, BMJ QUAL SAF, V22, P278, DOI 10.1136/bmjqs-2012-001330; Pape Theresa M, 2003, Medsurg Nurs, V12, P77; Pedersen CA, 2011, AM J HEALTH-SYST PH, V68, P669, DOI [10.2146/ajhp100711, 10.2146/ajhp090596]; Perrow C., 1984, NORMAL ACCIDENTS LIV; Popescu A, 2011, WORLDV EVID-BASED NU, V8, P15, DOI 10.1111/j.1741-6787.2010.00212.x; Reason J., 1991, HUMAN ERROR, DOI 10.1017/cbo9781139062367; Relihan E, 2010, QUAL SAF HEALTH CARE, V19, DOI 10.1136/qshc.2009.036871; Ritchie J., 2003, GUIDE SOCIAL SCI STU, P77; Taxis K, 1999, PHARM WORLD SCI, V21, P25, DOI 10.1023/A:1008616622472; Westbrook JI, 2014, BMJ QUAL SAF, V23, P877, DOI 10.1136/bmjqs-2014-003372; Westbrook JI, 2010, ARCH INTERN MED, V170, P683, DOI 10.1001/archinternmed.2010.65; Young Judith, 2010, J Patient Saf, V6, P115, DOI 10.1097/PTS.0b013e3181de35f7	46	30	30	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2015	10	6							e0128958	10.1371/journal.pone.0128958	http://dx.doi.org/10.1371/journal.pone.0128958			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CL3FM	26098106	Green Submitted, Green Published, gold			2022-12-26	WOS:000356835800021
J	Ravoori, MK; Nishimura, M; Singh, SP; Lu, CH; Han, L; Hobbs, BP; Pradeep, S; Choi, HJ; Bankson, JA; Sood, AK; Kundra, V				Ravoori, Murali K.; Nishimura, Masato; Singh, Sheela P.; Lu, Chunhua; Han, Lin; Hobbs, Brian P.; Pradeep, Sunila; Choi, Hyun J.; Bankson, James A.; Sood, Anil K.; Kundra, Vikas			Tumor T-1 Relaxation Time for Assessing Response to Bevacizumab Anti-Angiogenic Therapy in a Mouse Ovarian Cancer Model	PLOS ONE			English	Article							METASTATIC COLORECTAL-CANCER; PHASE-II CONSORTIA; XENOGRAFTS IN-VIVO; CELL LUNG-CANCER; MAGNETIC-RESONANCE; BREAST-CANCER; INTERSTITIAL HYPERTENSION; PRIMARY PERITONEAL; RECURRENT OVARIAN; 1ST-LINE THERAPY	Purpose To assess whether T-1 relaxation time of tumors may be used to assess response to bevacizumab anti-angiogenic therapy. Procedures: 12 female nude mice bearing subcutaneous SKOV3ip1-LC ovarian tumors were administered bevacizumab (6.25ug/g, n=6) or PBS (control, n=6) therapy twice a week for two weeks. T-1 maps of tumors were generated before, two days, and 2 weeks after initiating therapy. Tumor weight was assessed by MR and at necropsy. Histology for microvessel density, proliferation, and apoptosis was performed. Results Bevacizumab treatment resulted in tumor growth inhibition (p<0.04, n=6), confirming therapeutic efficacy. Tumor T-1 relaxation times increased in bevacizumab treated mice 2 days and 2 weeks after initiating therapy (p<.05, n=6). Microvessel density decreased 59% and cell proliferation (Ki67+) decreased 50% in the bevacizumab treatment group (p<.001, n=6), but not apoptosis. Conclusions Findings suggest that increased tumor T-1 relaxation time is associated with response to bevacizumab therapy in ovarian cancer model and might serve as an early indicator of response.	[Ravoori, Murali K.; Singh, Sheela P.; Han, Lin; Kundra, Vikas] Univ Texas MD Anderson Canc Ctr, Dept Canc Syst Imaging, Houston, TX 77030 USA; [Nishimura, Masato] Univ Tokushima, Grad Sch, Dept Obstet & Gynecol, Tokushima 770, Japan; [Lu, Chunhua; Pradeep, Sunila; Choi, Hyun J.; Sood, Anil K.] Univ Texas MD Anderson Canc Ctr, Dept Gynecol Oncol, Houston, TX 77030 USA; [Hobbs, Brian P.] Univ Texas MD Anderson Canc Ctr, Dept Biostat, Houston, TX 77030 USA; [Bankson, James A.] Univ Texas MD Anderson Canc Ctr, Dept Imaging Phys, Houston, TX 77030 USA; [Sood, Anil K.] Univ Texas MD Anderson Canc Ctr, Dept Canc Biol, Houston, TX 77030 USA; [Sood, Anil K.] Univ Texas MD Anderson Canc Ctr, Ctr RNA Interference & Noncoding RNA, Houston, TX 77030 USA; [Kundra, Vikas] Univ Texas MD Anderson Canc Ctr, Dept Radiol, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; Tokushima University; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Kundra, V (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Canc Syst Imaging, Houston, TX 77030 USA.	vkundra@mdanderson.org	Choi, Hyun Jin/Y-7144-2018; Sood, Anoop Kumar/A-7344-2013; Bankson, James A./J-9798-2014	Choi, Hyun Jin/0000-0003-4058-9094; Sood, Anoop Kumar/0000-0001-5702-4108; Bankson, James A./0000-0002-8574-154X	NIH [CA109298, CA159042, P50CA083639, U54CA151668, CA016672]; NATIONAL CANCER INSTITUTE [R01CA159042, R01CA109298, P30CA016672, P50CA083639, U54CA151668] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants from the NIH (CA109298, CA159042, P50CA083639, U54CA151668, CA016672). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BOUCHER Y, 1992, CANCER RES, V52, P5110; Burger RA, 2007, J CLIN ONCOL, V25, P5165, DOI 10.1200/JCO.2007.11.5345; Cannistra SA, 2007, J CLIN ONCOL, V25, P5180, DOI 10.1200/JCO.2007.12.0782; Chenevert TL, 1997, CLIN CANCER RES, V3, P1457; Chun YS, 2009, JAMA-J AM MED ASSOC, V302, P2338, DOI 10.1001/jama.2009.1755; Cole CL, 2014, J BIOL CHEM, V289, P10488, DOI 10.1074/jbc.M113.534263; DAMADIAN R, 1971, SCIENCE, V171, P1151, DOI 10.1126/science.171.3976.1151; de Graaf RA, 2006, MAGN RESON MED, V56, P386, DOI 10.1002/mrm.20946; Deoni SCL, 2008, NEUROIMAGE, V40, P662, DOI 10.1016/j.neuroimage.2007.11.052; Duvvuri U, 2001, CANCER RES, V61, P7747; Ehses P, 2013, MAGN RESON MED, V69, P71, DOI 10.1002/mrm.24225; Escudier B, 2007, LANCET, V370, P2103, DOI 10.1016/S0140-6736(07)61904-7; Fatouros PP, 1999, J NEUROSURG, V90, P109, DOI 10.3171/jns.1999.90.1.0109; Ferrara N, 2005, ONCOLOGY-BASEL, V69, P11, DOI 10.1159/000088479; Ferreira VM, 2012, J CARDIOVASC MAGN R, V14, DOI 10.1186/1532-429X-14-42; Garcia AA, 2008, J CLIN ONCOL, V26, P76, DOI 10.1200/JCO.2007.12.1939; Giantonio BJ, 2007, J CLIN ONCOL, V25, P1539, DOI 10.1200/JCO.2006.09.6305; Helmlinger G, 1997, NAT MED, V3, P177, DOI 10.1038/nm0297-177; Hurwitz H, 2004, NEW ENGL J MED, V350, P2335, DOI 10.1056/NEJMoa032691; Jain RK, 2007, CANCER RES, V67, P2729, DOI 10.1158/0008-5472.CAN-06-4102; Jain Rakesh K, 2005, Oncology (Williston Park), V19, P7; JAKOBSEN I, 1995, BRIT J CANCER, V71, P456, DOI 10.1038/bjc.1995.93; JAKOBSEN I, 1995, MAGN RESON IMAGING, V13, P693, DOI 10.1016/0730-725X(95)00019-D; Jamin Y, 2013, RADIOLOGY, V266, P130, DOI 10.1148/radiol.12120128; Kabbinavar F, 2003, J CLIN ONCOL, V21, P60, DOI 10.1200/JCO.2003.10.066; Katsube T, 2011, INVEST RADIOL, V46, P277, DOI 10.1097/RLI.0b013e318200f67d; Kim TJ, 2009, CANCER BIOL THER, V8, P2263; Koller M, 2011, COMPUT STAT DATA AN, V55, P2504, DOI 10.1016/j.csda.2011.02.014; Lawrenson K, 2015, INT J CANCER, V136, P1390, DOI 10.1002/ijc.29092; LEMOYEC L, 1988, RADIOTHER ONCOL, V13, P1, DOI 10.1016/0167-8140(88)90291-5; Lutz AM, 2014, CLIN CANCER RES, V20, P1313, DOI 10.1158/1078-0432.CCR-13-1642; McSheehy PMJ, 2010, CLIN CANCER RES, V16, P212, DOI 10.1158/1078-0432.CCR-09-0686; Miles DW, 2010, J CLIN ONCOL, V28, P3239, DOI 10.1200/JCO.2008.21.6457; Miller K, 2007, NEW ENGL J MED, V357, P2666, DOI 10.1056/NEJMoa072113; Murukesh N, 2010, BRIT J CANCER, V102, P8, DOI 10.1038/sj.bjc.6605483; Nimeiri HS, 2008, GYNECOL ONCOL, V110, P49, DOI 10.1016/j.ygyno.2008.02.009; O'Connor JPB, 2009, CLIN CANCER RES, V15, P6674, DOI 10.1158/1078-0432.CCR-09-0731; Rapisarda A, 2009, MOL CANCER THER, V8, P1867, DOI 10.1158/1535-7163.MCT-09-0274; Reck M, 2009, J CLIN ONCOL, V27, P1227, DOI 10.1200/JCO.2007.14.5466; ROFSTAD EK, 1994, INT J RADIAT BIOL, V65, P387, DOI 10.1080/09553009414550451; Saltz LB, 2008, J CLIN ONCOL, V26, P2013, DOI 10.1200/JCO.2007.14.9930; Sandler A, 2006, NEW ENGL J MED, V355, P2542, DOI 10.1056/NEJMoa061884; Siegel AB, 2008, J CLIN ONCOL, V26, P2992, DOI 10.1200/JCO.2007.15.9947; Utsumi F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081576; Varallyay CG, 2009, J CEREBR BLOOD F MET, V29, P853, DOI 10.1038/jcbfm.2008.162; Wedam SB, 2006, J CLIN ONCOL, V24, P769, DOI 10.1200/JCO.2005.03.4645; Weidensteiner C, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-88; Willett CG, 2004, NAT MED, V10, P145, DOI 10.1038/nm988; Willett CG, 2009, J CLIN ONCOL, V27, P3020, DOI 10.1200/JCO.2008.21.1771; Yang D, 2005, RADIOLOGY, V235, P950, DOI 10.1148/radiol.2353040108	50	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2015	10	6							e0131095	10.1371/journal.pone.0131095	http://dx.doi.org/10.1371/journal.pone.0131095			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL3FM	26098849	gold, Green Published, Green Submitted			2022-12-26	WOS:000356835800149
J	Sandel, V; Kiko, R; Brandt, P; Dengler, M; Stemmann, L; Vandromme, P; Sommer, U; Hauss, H				Sandel, Vera; Kiko, Rainer; Brandt, Peter; Dengler, Marcus; Stemmann, Lars; Vandromme, Pieter; Sommer, Ulrich; Hauss, Helena			Nitrogen Fuelling of the Pelagic Food Web of the Tropical Atlantic	PLOS ONE			English	Article							MICROSTRUCTURE-TURBULENCE; PHYTOPLANKTON CARBON; SUBTROPICAL ATLANTIC; TRICHODESMIUM SPP.; FIXED-NITROGEN; PARTICLE-SIZE; FIXATION; PACIFIC; PROFILER; SCALE	We estimated the relative contribution of atmosphere (ic Nitrogen (N) input (wet and dry deposition and N fixation) to the epipelagic food web by measuring N isotopes of different functional groups of epipelagic zooplankton along 23 degrees W(17 degrees N-4 degrees S) and 18 degrees N (20-24 degrees W) in the Eastern Tropical Atlantic. Results were related to water column observations of nutrient distribution and vertical diffusive flux as well as colony abundance of Trichodesmium obtained with an Underwater Vision Profiler (UVP5). The thickness and depth of the nitracline and phosphocline proved to be significant predictors of zooplankton stable N isotope values. Atmospheric N input was highest (61% of total N) in the strongly stratified and oligotrophic region between 3 and 7 degrees N, which featured very high depth-integrated Trichodesmium abundance (up to 9.4x10(4) colonies m(-2)), strong thermohaline stratification and low zooplankton delta N-15 (similar to 2 parts per thousand). Relative atmospheric N input was lowest south of the equatorial upwelling between 3 and 5 degrees S (27%). Values in the Guinea Dome region and north of Cape Verde ranged between 45 and 50%, respectively. The microstructure-derived estimate of the vertical diffusive N flux in the equatorial region was about one order of magnitude higher than in any other area (approximately 8 mmol m(-2) d (1)). At the same time, this region received considerable atmospheric N input (35% of total). In general, zooplankton delta N-15 and Trichodesmium abundance were closely correlated, indicating that N fixation is the major source of atmospheric N input. Although Trichodesmium is not the only N fixing organism, its abundance can be used with high confidence to estimate the relative atmospheric N input in the tropical Atlantic (r(2) = 0.95). Estimates of absolute N fixation rates are two-to tenfold higher than incubation-derived rates reported for the same regions. Our approach integrates over large spatial and temporal scales and also quantifies fixed N released as dissolved inorganic and organic N. In a global analysis, it may thus help to close the gap in oceanic N budgets.	[Sandel, Vera; Kiko, Rainer; Brandt, Peter; Dengler, Marcus; Vandromme, Pieter; Sommer, Ulrich; Hauss, Helena] GEOMAR Helmholtz Ctr Ocean Res Kiel, Kiel, Germany; [Stemmann, Lars] Univ Paris 06, Sorbonne Univ, Observ Oceanol, UMR7093,LOV, Villefranche Sur Mer, France	Helmholtz Association; GEOMAR Helmholtz Center for Ocean Research Kiel; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; Sorbonne Universite	Hauss, H (corresponding author), GEOMAR Helmholtz Ctr Ocean Res Kiel, Dusternbrooker Weg 20, Kiel, Germany.	hhauss@geomar.de	stemmann, lars/E-6899-2011; Dengler, Marcus/A-7327-2014; Hauss, Helena M/S-1718-2018; Brandt, Peter/C-8254-2013; stemmann, lars/Q-8458-2019	Dengler, Marcus/0000-0001-5993-9088; Hauss, Helena M/0000-0002-0754-3388; Brandt, Peter/0000-0002-9235-955X; stemmann, lars/0000-0001-8935-4531; Kiko, Rainer/0000-0002-7851-9107	German Research Foundation (DFG) [SFB754]; Federal Ministry of Education and Research (BMBF) [03F0651B, 03F0462A, 03F0611A, 03F0662A]; National Center for Scientific Research (CNRS); University Pierre and Marie Curie (UPMC)	German Research Foundation (DFG)(German Research Foundation (DFG)); Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); National Center for Scientific Research (CNRS)(Centre National de la Recherche Scientifique (CNRS)); University Pierre and Marie Curie (UPMC)	This work is a contribution of the German Research Foundation (DFG) supported project SFB754 (www.sfb754.de) and involved the Federal Ministry of Education and Research (BMBF) joint projects RACE (03F0651B) and SOPRAN 03F0462A, 03F0611A, 03F0662A). LS was supported by the Chair VISION from the National Center for Scientific Research (CNRS) and University Pierre and Marie Curie (UPMC).	Agusti S, 2001, DEEP-SEA RES PT II, V48, P2295, DOI 10.1016/S0967-0645(00)00179-X; Arashkevich Y. G., 1969, OCEANOLOGY, V9, P5; Baker AR, 2007, DEEP-SEA RES PT I, V54, P1704, DOI 10.1016/j.dsr.2007.07.001; Banyte D, 2012, J GEOPHYS RES-OCEANS, V117, DOI 10.1029/2011JC007762; BERKES F, 1975, Crustaceana (Leiden), V29, P266; Brandt P, 2015, BIOGEOSCIENCES, V12, P489, DOI 10.5194/bg-12-489-2015; Capone DG, 2005, GLOBAL BIOGEOCHEM CY, V19, DOI 10.1029/2004GB002331; Carpenter EJ, 1997, DEEP-SEA RES PT I, V44, P27, DOI 10.1016/S0967-0637(96)00091-X; Christian JR, 2003, DEEP-SEA RES PT II, V50, P2947, DOI 10.1016/j.dsr2.2003.07.005; Codispoti LA, 2007, BIOGEOSCIENCES, V4, P233, DOI 10.5194/bg-4-233-2007; Coles VJ, 2013, J GEOPHYS RES-OCEANS, V118, P6894, DOI 10.1002/2013JC008981; Dabundo R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110335; Eberl R, 2007, MAR ECOL PROG SER, V333, P205, DOI 10.3354/meps333205; Fernandez A, 2013, ICES J MAR SCI, V70, P223, DOI 10.1093/icesjms/fss142; Fernandez-Castro B, 2014, DEEP-SEA RES PT I, V94, P15, DOI 10.1016/j.dsr.2014.08.006; Fischer T, 2013, BIOGEOSCIENCES, V10, P5079, DOI 10.5194/bg-10-5079-2013; FOFONOFF NP, 1985, J GEOPHYS RES-OCEANS, V90, P3332, DOI 10.1029/JC090iC02p03332; Foster RA, 2009, ENVIRON MICROBIOL, V11, P741, DOI 10.1111/j.1462-2920.2008.01796.x; Francis CA, 2007, ISME J, V1, P19, DOI 10.1038/ismej.2007.8; Fry B., 2006, STABLE ISOTOPE ECOLO; Gorsky G, 2010, J PLANKTON RES, V32, P285, DOI 10.1093/plankt/fbp124; Grasshoff K, 1999, METHODS SEAWATER ANA; Grosskopf T, 2012, NATURE, V488, P361, DOI 10.1038/nature11338; Gruber N, 1997, GLOBAL BIOGEOCHEM CY, V11, P235, DOI 10.1029/97GB00077; Hauss H, 2013, DEEP-SEA RES PT I, V75, P135, DOI 10.1016/j.dsr.2013.01.010; Holl CM, 2007, LIMNOL OCEANOGR, V52, P2249, DOI 10.4319/lo.2007.52.5.2249; Hummels R, 2014, CLIM DYNAM, V43, P3179, DOI 10.1007/s00382-014-2339-6; Hummels R, 2013, PROG OCEANOGR, V111, P52, DOI 10.1016/j.pocean.2012.11.001; Jennings S, 2003, MAR BIOL, V142, P1131, DOI 10.1007/s00227-003-1020-0; Karstensen J, 2015, BIOGEOSCIENCES, V12, P2597, DOI 10.5194/bg-12-2597-2015; Landrum JP, 2011, DEEP-SEA RES PT I, V58, P615, DOI 10.1016/j.dsr.2011.01.012; Langlois RJ, 2005, APPL ENVIRON MICROB, V71, P7910, DOI 10.1128/AEM.71.12.7910-7919.2005; LAWS EA, 1995, GEOCHIM COSMOCHIM AC, V59, P1131, DOI 10.1016/0016-7037(95)00030-4; Macoun P, 2004, J ATMOS OCEAN TECH, V21, P284, DOI 10.1175/1520-0426(2004)021<0284:MTSROT>2.0.CO;2; McMahon KW, 2013, LIMNOL OCEANOGR, V58, P697, DOI 10.4319/lo.2013.58.2.0697; Mingkwan P, 2011, THESIS U SOUTHAMPTON; Montoya JP, 2002, LIMNOL OCEANOGR, V47, P1617, DOI 10.4319/lo.2002.47.6.1617; Moum JN, 2009, J MARINE SYST, V77, P409, DOI 10.1016/j.jmarsys.2008.10.013; Mourino-Carballido B, 2011, LIMNOL OCEANOGR, V56, P999, DOI 10.4319/lo.2011.56.3.0999; Mulholland MR, 2006, LIMNOL OCEANOGR, V51, P1762, DOI 10.4319/lo.2006.51.4.1762; OSBORN TR, 1980, J PHYS OCEANOGR, V10, P83, DOI 10.1175/1520-0485(1980)010<0083:EOTLRO>2.0.CO;2; Painter SC, 2013, J GEOPHYS RES-OCEANS, V118, P5732, DOI 10.1002/jgrc.20416; Picheral M, 2010, LIMNOL OCEANOGR-METH, V8, P462, DOI 10.4319/lom.2010.8.462; Prandke H, 1998, AQUAT SCI, V60, P191, DOI 10.1007/s000270050036; RAU GH, 1982, DEEP-SEA RES, V29, P1035, DOI 10.1016/0198-0149(82)90026-7; Rau GH, 2003, DEEP-SEA RES PT II, V50, P2431, DOI 10.1016/S0967-0645(03)00128-0; Ryabenko E, 2012, BIOGEOSCIENCES, V9, P203, DOI 10.5194/bg-9-203-2012; Schafstall J, 2010, J GEOPHYS RES-OCEANS, V115, DOI 10.1029/2009JC005940; Schlosser C, 2014, P NATL ACAD SCI USA, V111, P1438, DOI 10.1073/pnas.1318670111; Sohm JA, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL048315; Spokes LJ, 2000, TELLUS B, V52, P37, DOI 10.1034/j.1600-0889.2000.00062.x; Stemmann L, 2012, ANNU REV MAR SCI, V4, P263, DOI 10.1146/annurev-marine-120710-100853; Subramaniam A, 2013, GEOPHYS RES LETT, V40, P1766, DOI 10.1002/grl.50250; Takai N, 2000, J MAR BIOL ASSOC UK, V80, P675, DOI 10.1017/S0025315400002502; Villareal TA, 2003, MICROB ECOL, V45, P1, DOI 10.1007/s00248-002-1012-5; VOITURIEZ B, 1979, DEEP-SEA RES, V26, P77, DOI 10.1016/0198-0149(79)90087-6; Wang XJ, 2013, J MARINE SYST, V109, P138, DOI 10.1016/j.jmarsys.2012.03.004; Wolk F, 2002, J ATMOS OCEAN TECH, V19, P780, DOI 10.1175/1520-0426(2002)019<0780:ANFFPF>2.0.CO;2	58	17	17	1	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2015	10	6							e0131258	10.1371/journal.pone.0131258	http://dx.doi.org/10.1371/journal.pone.0131258			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL3FM	26098917	Green Submitted, Green Accepted, Green Published, gold			2022-12-26	WOS:000356835800162
J	Visweswaran, S; Ferreira, A; Ribeiro, GA; Oliveira, AC; Cooper, GF				Visweswaran, Shyam; Ferreira, Antonio; Ribeiro, Guilherme A.; Oliveira, Alexandre C.; Cooper, Gregory F.			Personalized Modeling for Prediction with Decision-Path Models	PLOS ONE			English	Article							TREES; CLASSIFICATION; PNEUMONIA; RISK	Deriving predictive models in medicine typically relies on a population approach where a single model is developed from a dataset of individuals. In this paper we describe and evaluate a personalized approach in which we construct a new type of decision tree model called decision-path model that takes advantage of the particular features of a given person of interest. We introduce three personalized methods that derive personalized decision-path models. We compared the performance of these methods to that of Classification And Regression Tree (CART) that is a population decision tree to predict seven different outcomes in five medical datasets. Two of the three personalized methods performed statistically significantly better on area under the ROC curve (AUC) and Brier skill score compared to CART. The personalized approach of learning decision path models is a new approach for predictive modeling that can perform better than a population approach.	[Visweswaran, Shyam; Ferreira, Antonio; Cooper, Gregory F.] Univ Pittsburgh, Dept Biomed Informat, Pittsburgh, PA 15213 USA; [Visweswaran, Shyam; Cooper, Gregory F.] Univ Pittsburgh, Intelligent Syst Program, Pittsburgh, PA USA; [Ribeiro, Guilherme A.; Oliveira, Alexandre C.] Fed Univ Maranhao UFMA, Dept Informat, Sao Luis, MA, Brazil	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Universidade Federal do Maranhao	Visweswaran, S (corresponding author), Univ Pittsburgh, Dept Biomed Informat, Pittsburgh, PA 15213 USA.	shv3@pitt.edu	Oliveira, Alexandre/N-7781-2014; de Oliveira, Alexandre Cesar Muniz/P-2498-2019	Oliveira, Alexandre/0000-0002-1499-5307; Visweswaran, Shyam/0000-0002-2079-8684	NIH [HHSN276201000030C, T15-LM/DE07059]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG008540] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [R01LM012095, T15LM007059] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This work was supported by the NIH, Grant HHSN276201000030C to Shyam Visweswaran and NIH Grant T15-LM/DE07059 funded Antonio Ferreira's training. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afonso AM, 2012, FAM PRACT, V29, P671, DOI 10.1093/fampra/cms020; Auble TE, 2005, ACAD EMERG MED, V12, P514, DOI 10.1197/j.aem.2004.11.026; COVER TM, 1967, IEEE T INFORM THEORY, V13, P21, DOI 10.1109/TIT.1967.1053964; Duda R.O., 2000, PATTERN CLASSIFICATI; Fayyad UM, 1993, INT JOINT C ARTIF IN, V13, P1022; Ferreira A, 2013, AMIA ANN S P, P413; Fine MJ, 1999, ARCH INTERN MED, V159, P970, DOI 10.1001/archinte.159.9.970; Friedman J. H., 1996, AAAI IAAI, V1, P717; Hauskrecht M, 2013, J BIOMED INFORM, V46, P47, DOI 10.1016/j.jbi.2012.08.004; HECKERMAN D, 1995, MACH LEARN, V20, P197, DOI 10.1007/BF00994016; Hong WD, 2011, DIGEST DIS SCI, V56, P3664, DOI 10.1007/s10620-011-1849-x; Kellum JA, 2007, ARCH INTERN MED, V167, P1655, DOI 10.1001/archinte.167.15.1655; Murthy SK, 1998, DATA MIN KNOWL DISC, V2, P345, DOI 10.1023/A:1009744630224; Podgorelec Vili, 2002, J Med Syst, V26, P445, DOI 10.1023/A:1016409317640; Reiman EM, 2007, NEURON, V54, P713, DOI 10.1016/j.neuron.2007.05.022; Tsai CL, 2010, AM J EMERG MED, V28, P803, DOI 10.1016/j.ajem.2009.04.009; Visweswaran S, 2004, ADV NEURAL INF PROCE, P1449; Visweswaran S, 2010, J MACH LEARN RES, V11, P3333; Visweswaran S, 2010, J BIOMED INFORM, V43, P669, DOI 10.1016/j.jbi.2010.04.009; Visweswaran Shyam, 2005, AMIA Annu Symp Proc, P759; Wilks D.S., 2011, STAT METHODS ATMOSPH	21	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2015	10	6							e0131022	10.1371/journal.pone.0131022	http://dx.doi.org/10.1371/journal.pone.0131022			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL3FM	26098570	Green Published, gold, Green Submitted, Green Accepted			2022-12-26	WOS:000356835800134
J	Li, Y; Li, GQ; Wang, ZH				Li, Yang; Li, Guoqing; Wang, Zhenhao			Rule Extraction Based on Extreme Learning Machine and an Improved Ant-Miner Algorithm for Transient Stability Assessment	PLOS ONE			English	Article							DYNAMIC SECURITY ASSESSMENT; POWER-SYSTEMS; CLASSIFICATION	In order to overcome the problems of poor understandability of the pattern recognition-based transient stability assessment (PRTSA) methods, a new rule extraction method based on extreme learning machine (ELM) and an improved Ant-miner (IAM) algorithm is presented in this paper. First, the basic principles of ELM and Ant-miner algorithm are respectively introduced. Then, based on the selected optimal feature subset, an example sample set is generated by the trained ELM-based PRTSA model. And finally, a set of classification rules are obtained by IAM algorithm to replace the original ELM network. The novelty of this proposal is that transient stability rules are extracted from an example sample set generated by the trained ELM-based transient stability assessment model by using IAM algorithm. The effectiveness of the proposed method is shown by the application results on the New England 39-bus power system and a practical power system-the southern power system of Hebei province.	[Li, Yang; Li, Guoqing; Wang, Zhenhao] Northeast Dianli Univ, Sch Elect Engn, Jilin, Peoples R China	Northeast Electric Power University	Li, Y (corresponding author), Northeast Dianli Univ, Sch Elect Engn, Jilin, Peoples R China.	liyang@nedu.edu.cn	Li, Yang/B-7314-2018	Li, Yang/0000-0002-6515-4567				Amjady N, 2010, IET GENER TRANSM DIS, V4, P509, DOI 10.1049/iet-gtd.2009.0255; Anderson P. M., 2003, POWER SYSTEM CONTROL; Andersson G, 2005, IEEE T POWER SYST, V20, P1922, DOI 10.1109/TPWRS.2005.857942; Frieman JH, 2008, ANN APPL STAT, V2, P916, DOI 10.1214/07-AOAS148; Gomez FR, 2011, IEEE T POWER SYST, V26, P1474, DOI 10.1109/TPWRS.2010.2082575; Gu XP, 2015, INT J ELEC POWER, V64, P664, DOI 10.1016/j.ijepes.2014.07.070; Huang GB, 2006, NEUROCOMPUTING, V70, P489, DOI 10.1016/j.neucom.2005.12.126; Huang GB, 2012, IEEE T SYST MAN CY B, V42, P513, DOI 10.1109/TSMCB.2011.2168604; Kamwa I, 2009, IEEE T POWER SYST, V24, P258, DOI 10.1109/TPWRS.2008.2009430; Kundur P, 2004, IEEE T POWER SYST, V19, P1387, DOI 10.1109/TPWRS.2004.825981; Lin YJ, 2010, INT J ELEC POWER, V32, P873, DOI 10.1016/j.ijepes.2010.01.026; LIU B, 2004, IEEE COMPUTATIONAL I, V3, P31; Martens D, 2007, IEEE T EVOLUT COMPUT, V11, P651, DOI 10.1109/TEVC.2006.890229; Mohammadi M, 2010, ENERG CONVERS MANAGE, V51, P640, DOI 10.1016/j.enconman.2009.10.021; Moulin LS, 2004, IEEE T POWER SYST, V19, P818, DOI 10.1109/TPWRS.2004.826018; Pai M.A., 1989, ENERGY FUNCTION ANAL; Parpinelli RS, 2002, IEEE T EVOLUT COMPUT, V6, P321, DOI 10.1109/TEVC.2002.802452; Phadke AG, 2008, POWER ELECTRON POWER, P3, DOI 10.1007/978-0-387-76537-2_1; Rodriguez JJ, 2006, IEEE T PATTERN ANAL, V28, P1619, DOI 10.1109/TPAMI.2006.211; Sun K, 2007, IEEE T POWER SYST, V22, P1935, DOI 10.1109/TPWRS.2007.908476; Taylor CW, 2005, P IEEE, V93, P892, DOI 10.1109/JPROC.2005.846338; Terzija V, 2011, P IEEE, V99, P80, DOI 10.1109/JPROC.2010.2060450; Wehenkel L, 1997, IEEE EXPERT, V12, P60, DOI 10.1109/64.621229; Wolpert D. H., 1997, IEEE Transactions on Evolutionary Computation, V1, P67, DOI 10.1109/4235.585893; Xu Y, 2012, IEEE T POWER SYST, V27, P1253, DOI 10.1109/TPWRS.2012.2183899; XUE Y, 1992, IEEE T POWER SYST, V7, P1012, DOI 10.1109/59.207314; Zhang R, 2007, IEEE ACM T COMPUT BI, V4, P185; Zhou ZH, 2003, AI COMMUN, V16, P3	28	110	117	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2015	10	6							e0130814	10.1371/journal.pone.0130814	http://dx.doi.org/10.1371/journal.pone.0130814			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX8JO	26091524	Green Published, Green Submitted, gold			2022-12-26	WOS:000365949500001
J	Yang, J; Zhou, S; Gu, JJ; Wang, YJ; Guo, MF; Liu, YZ				Yang, Jing; Zhou, Sheng; Gu, Jianjun; Wang, Yujuan; Guo, Minfei; Liu, Yizhi			Differences in Unfolded Protein Response Pathway Activation in the Lenses of Three Types of Cataracts	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; ER STRESS; TRANSCRIPTION FACTOR; OXIDATIVE STRESS; MESSENGER-RNA; ATF6; IRE1; EXPRESSION; CHAPERONE; DISEASE	Purpose To investigate the activation of three unfolded protein response (UPR) pathways in the lenses of age-related, high myopia-related and congenital cataracts. Methods and Materials Lens specimens were collected from patients during small incision cataract surgery. Lenses from young cadaver eyes were collected as normal controls. Real-time PCR and Western blotting were performed to detect the expression of GRP78, p-eIF2 alpha, spliced XBP1, ATF6, ATF4 and p-IRE1 alpha in the lenses of normal human subjects and patients with age-related, myopia-related or congenital cataracts. Results In the lenses of the age-related and high myopia-related cataract groups, the protein levels of ATF6, p-eIF2 alpha and p-IRE1 alpha and the gene expression levels of spliced XBP1, GRP78, ATF6 and ATF4 were greatly increased. Additionally, in the congenital cataract group, the protein levels of p-eIF2 alpha and p-IRE1 alpha and the gene expression levels of spliced XBP1, GRP78 and ATF4 were greatly increased. However, the protein and gene expression levels of ATF6 were not up-regulated in the congenital cataract group compared with the normal control group. Conclusions The UPR is activated via different pathways in the lenses of age-related, high myopia-related and congenital cataracts. UPR activation via distinct pathways might play important roles in cataractogenesis mechanisms in different types of cataracts.	[Yang, Jing; Gu, Jianjun; Wang, Yujuan; Liu, Yizhi] Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, Guangzhou, Guangdong, Peoples R China; [Zhou, Sheng] First Peoples Hosp, Dept Ophthalmol, Foshan, Guangdong, Peoples R China; [Guo, Minfei] Huichang Cty Peoples Hosp, Dept Ophthalmol, Ganzhou, Jiangxi, Peoples R China	Sun Yat Sen University	Liu, YZ (corresponding author), Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, Guangzhou, Guangdong, Peoples R China.	yizhi_liu@aliyun.com	liu, yi/GXE-9662-2022; wang, yujuan/C-8428-2016		Chinese State Key Laboratory of Ophthalmology grant [303060202400402001]	Chinese State Key Laboratory of Ophthalmology grant	This study was supported by the Chinese State Key Laboratory of Ophthalmology grant (No. 303060202400402001).	Adachi Y, 2008, CELL STRUCT FUNCT, V33, P75, DOI 10.1247/csf.07044; Ali MMU, 2011, EMBO J, V30, P894, DOI 10.1038/emboj.2011.18; Benjamin IJ, 2006, CIRC RES, V98, P1120, DOI 10.1161/01.RES.0000223522.47948.16; Cao SS, 2014, ANTIOXID REDOX SIGN, V21, P396, DOI 10.1089/ars.2014.5851; Churchill A, 2011, PHILOS T R SOC B, V366, P1234, DOI 10.1098/rstb.2010.0227; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Halliday M, 2014, NEUROPHARMACOLOGY, V76, P169, DOI 10.1016/j.neuropharm.2013.08.034; Harding HP, 1999, NATURE, V397, P271, DOI 10.1038/16729; Harding HP, 2003, MOL CELL, V11, P619, DOI 10.1016/S1097-2765(03)00105-9; Hotamisligil GS, 2010, CELL, V140, P900, DOI 10.1016/j.cell.2010.02.034; Ikesugi K, 2006, EXP EYE RES, V83, P508, DOI 10.1016/j.exer.2006.01.033; Kaufman RJ, 1999, GENE DEV, V13, P1211, DOI 10.1101/gad.13.10.1211; Lee AH, 2003, MOL CELL BIOL, V23, P7448, DOI 10.1128/MCB.23.21.7448-7459.2003; Lee AS, 2005, METHODS, V35, P373, DOI 10.1016/j.ymeth.2004.10.010; Lee AS, 2001, TRENDS BIOCHEM SCI, V26, P504, DOI 10.1016/S0968-0004(01)01908-9; Luo K, 2015, GASTROENT RES PRACT, V2015, DOI 10.1155/2015/328791; Malhi H, 2011, J HEPATOL, V54, P795, DOI 10.1016/j.jhep.2010.11.005; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Rutkowski DT, 2004, TRENDS CELL BIOL, V14, P20, DOI 10.1016/j.tcb.2003.11.001; Schroder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134; Schroder M, 2006, MOL BIOTECHNOL, V34, P279, DOI 10.1385/MB:34:2:279; Sherman MY, 2001, NEURON, V29, P15, DOI 10.1016/S0896-6273(01)00177-5; Shinohara T, 2006, MED HYPOTHESES, V66, P365, DOI 10.1016/j.mehy.2005.08.044; Shinohara T, 2007, MED HYPOTHESES, V69, P669, DOI 10.1016/j.mehy.2006.11.051; Tirasophon W, 1998, GENE DEV, V12, P1812, DOI 10.1101/gad.12.12.1812; Vong QP, 2003, J ENDOCRINOL, V178, P513, DOI 10.1677/joe.0.1780513; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Wang XZ, 1998, EMBO J, V17, P5708, DOI 10.1093/emboj/17.19.5708; Ye J, 2000, MOL CELL, V6, P1355, DOI 10.1016/S1097-2765(00)00133-7; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Yoshida H, 2003, DEV CELL, V4, P265, DOI 10.1016/S1534-5807(03)00022-4; Zhang K, 2006, HANDB EXP PHARM, V172, P69; Zhang L, 2010, CURR MOL MED, V10, P864, DOI 10.2174/156652410793937741; Zoric Lepsa, 2010, Med Pregl, V63, P522, DOI 10.2298/MPNS1008522Z	34	16	16	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2015	10	6							e0130705	10.1371/journal.pone.0130705	http://dx.doi.org/10.1371/journal.pone.0130705			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL3FE	26091066	Green Published, Green Submitted, gold			2022-12-26	WOS:000356835000143
J	Liao, XH; Wang, N; Zhao, DW; Zheng, DL; Zheng, L; Xing, WJ; Ma, WJ; Bao, LY; Dong, J; Zhang, TC				Liao, Xing-Hua; Wang, Nan; Zhao, Dong-Wei; Zheng, De-Liang; Zheng, Li; Xing, Wen-Jing; Ma, Wen-Jian; Bao, Le-Yuan; Dong, Jian; Zhang, Tong-Cun			STAT3 Protein Regulates Vascular Smooth Muscle Cell Phenotypic Switch by Interaction with Myocardin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOTHELIAL GROWTH-FACTOR; SERUM RESPONSE FACTOR; GENE-EXPRESSION; DEPENDENT TRANSCRIPTION; NEOINTIMA FORMATION; SIGNALING PATHWAYS; INDUCED APOPTOSIS; TUBE FORMATION; VEGF-A; DIFFERENTIATION	The JAK-STAT3 signaling pathway is one of the critical pathways regulating cell proliferation, differentiation, and apoptosis. Myocardin is regarded as a key mediator for the change of smooth muscle phenotypes. However, the relationship between STAT3 and myocardin in the vascular smooth muscle cell (VSMC) phenotypic switch has not been investigated. The goal of this study was to investigate the molecular mechanism by which STAT3 affects the myocardin-regulated VSMC phenotypic switch. Data presented in this study demonstrated that STAT3 was rapidly up-regulated after stimulation with VEGF. Inhibition of the STAT3 activation process impaired VSMC proliferation and enhanced the expression of VSMC contractile genes by increasing serum-response factor binding to the CArG-containing regions of VSMC-specific contractile genes. In contrast, the interaction between serum-response factor and its co-activator myocardin was reduced by overexpression of STAT3. In addition, treated VEGF inhibited the transcription activity of myocardin, and overexpression of STAT3 inhibited myocardin-induced up-regulation of VSMC contractile phenotype-specific genes. Although myocardin and STAT3 are negatively correlated, interestingly, both of them can enhance the expression of VEGF, suggesting a feedback loop to regulate the VSMC phenotypic switch. Taken together, these results indicate that the JAK-STAT3 signaling pathway plays a key role in controlling the phenotypic switch of VSMCs through the interactions between STAT3 and myocardin by various coordinated gene regulation pathways and feedback loops.	[Liao, Xing-Hua; Bao, Le-Yuan; Dong, Jian; Zhang, Tong-Cun] Wuhan Univ Sci & Technol, Inst Biol & Med, Wuhan 43000, Peoples R China; [Liao, Xing-Hua; Wang, Nan; Zhao, Dong-Wei; Zheng, De-Liang; Zheng, Li; Xing, Wen-Jing; Ma, Wen-Jian; Zhang, Tong-Cun] Tianjin Univ Sci & Technol, Coll Biotechnol, Key Lab Ind Fermentat Microbiol, Minist Educ, Tianjin 300457, Peoples R China	Wuhan University of Science & Technology; Tianjin University Science & Technology	Zhang, TC (corresponding author), Wuhan Univ Sci & Technol, Inst Biol & Med, Wuhan 43000, Peoples R China.	zhangtongcun@wust.edu.cn	Zhang, Tong/HGC-1090-2022; Wang, Nan/GRY-3150-2022		National Natural Science Foundation of China [30970615, 31071126, 31000343, 31171303, 31171297, 31200955]; Program for Changjiang Scholars and Innovative Research Team in University of Ministry of Education of China [IRT1166]; Research Fund for the Doctoral Program of Higher Education of China [20111208110001]; Chinese Ministry of Education [212010]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for Changjiang Scholars and Innovative Research Team in University of Ministry of Education of China; Research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Chinese Ministry of Education(Ministry of Education, China)	This work was supported by National Natural Science Foundation of China Grants 30970615, 31071126, 31000343, 31171303, 31171297, and 31200955, Program for Changjiang Scholars and Innovative Research Team in University of Ministry of Education of China Grant IRT1166, Research Fund for the Doctoral Program of Higher Education of China Grant 20111208110001, and Key Project of Chinese Ministry of Education Grant 212010. The authors declare that they have no conflicts of interest with the contents of this article.	ALON T, 1995, NAT MED, V1, P1024, DOI 10.1038/nm1095-1024; Badorff C, 2005, CIRC RES, V97, P645, DOI 10.1161/01.RES.0000184684.88750.FE; Bartoli M, 2003, FASEB J, V17, P1562, DOI 10.1096/fj.02-1084fje; Belgore F, 2004, J CLIN PATHOL, V57, P266, DOI 10.1136/jcp.2003.012419; Carmeliet P, 2000, NATURE, V407, P249, DOI 10.1038/35025220; Chai JY, 2004, FASEB J, V18, P1264, DOI 10.1096/fj.03-1232fje; Chen JY, 2002, J MOL CELL CARDIOL, V34, P1345, DOI 10.1006/jmcc.2002.2086; Chen KH, 2004, NAT CELL BIOL, V6, P872, DOI 10.1038/ncb1161; Chen SH, 2008, CANCER BIOL THER, V7, P1994, DOI 10.4161/cbt.7.12.6967; Chiu CZ, 2010, CLIN SCI, V119, P273, DOI 10.1042/CS20100084; Daniel JM, 2012, BASIC RES CARDIOL, V107, DOI 10.1007/s00395-012-0261-9; Demyanets S, 2011, BASIC RES CARDIOL, V106, P217, DOI 10.1007/s00395-010-0141-0; Devarajan E, 2009, CURR MOL MED, V9, P626, DOI 10.2174/156652409788488720; Du KL, 2003, MOL CELL BIOL, V23, P2425, DOI 10.1128/MCB.23.7.2425-2437.2003; Ferrara N, 2009, EUR CYTOKINE NETW, V20, P158, DOI 10.1684/ecn.2009.0170; Ferrara N, 2009, ARTERIOSCL THROM VAS, V29, P789, DOI 10.1161/ATVBAHA.108.179663; Fournier NM, 2012, NEUROPHARMACOLOGY, V63, P642, DOI 10.1016/j.neuropharm.2012.04.033; Franco CA, 2008, DEV CELL, V15, P448, DOI 10.1016/j.devcel.2008.07.019; Fukada T, 1998, EMBO J, V17, P6670, DOI 10.1093/emboj/17.22.6670; Grote K, 2005, VASC PHARMACOL, V43, P357, DOI 10.1016/j.vph.2005.08.021; Haridas V, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005578; Jin J, 2013, MOL CELL BIOCHEM, V381, P267, DOI 10.1007/s11010-013-1710-y; Kimura Y, 2010, CANCER RES, V70, P501, DOI 10.1158/0008-5472.CAN-09-1469; Lamalice L, 2006, J BIOL CHEM, V281, P34009, DOI 10.1074/jbc.M603928200; Liao XH, 2014, CELL SIGNAL, V26, P2370, DOI 10.1016/j.cellsig.2014.07.023; Liao XH, 2014, CELL SIGNAL, V26, P1335, DOI 10.1016/j.cellsig.2014.03.001; Liao XH, 2011, IUBMB LIFE, V63, P54, DOI 10.1002/iub.415; Long XC, 2008, ARTERIOSCL THROM VAS, V28, P1505, DOI 10.1161/ATVBAHA.108.166066; Mack CP, 2000, CIRC RES, V86, P221, DOI 10.1161/01.RES.86.2.221; Majesky MW, 2007, ARTERIOSCL THROM VAS, V27, P1248, DOI 10.1161/ATVBAHA.107.141069; Miano JM, 2003, J MOL CELL CARDIOL, V35, P577, DOI 10.1016/S0022-2828(03)00110-X; Neeli I, 2004, J BIOL CHEM, V279, P46122, DOI 10.1074/jbc.M406922200; Niwa Y, 2005, ONCOGENE, V24, P6406, DOI 10.1038/sj.onc.1208788; Owens GK, 2004, PHYSIOL REV, V84, P767, DOI 10.1152/physrev.00041.2003; Richard DE, 1999, J BIOL CHEM, V274, P32631, DOI 10.1074/jbc.274.46.32631; Shi X, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.282; Sun Q, 2006, GENOME RES, V16, P197, DOI 10.1101/gr.4108706; Tallquist MD, 1999, ONCOGENE, V18, P7917, DOI 10.1038/sj.onc.1203216; Tang RH, 2008, P NATL ACAD SCI USA, V105, P3362, DOI 10.1073/pnas.0705842105; Taurin S, 2009, J BIOL CHEM, V284, P33789, DOI 10.1074/jbc.M109.048983; Wang D, 2007, CIRC RES, V100, P807, DOI 10.1161/01.RES.0000261350.61711.9e; Wang DZ, 2001, CELL, V105, P851, DOI 10.1016/S0092-8674(01)00404-4; Wang HB, 2012, AM J PATHOL, V180, P1243, DOI 10.1016/j.ajpath.2011.11.031; Wang MJ, 2007, J MOL CELL CARDIOL, V42, P1009, DOI 10.1016/j.yjmcc.2007.04.010; Wang ZG, 2003, P NATL ACAD SCI USA, V100, P7129, DOI 10.1073/pnas.1232341100; Wang ZG, 2004, NATURE, V428, P185, DOI 10.1038/nature02382; Watanabe Y, 1997, EXP CELL RES, V233, P340, DOI 10.1006/excr.1997.3583; Weinl C, 2013, J CLIN INVEST, V123, P2193, DOI 10.1172/JCI64201; Xie CQ, 2012, J BIOL CHEM, V287, P14598, DOI 10.1074/jbc.M111.329268; Xie CQ, 2011, ARTERIOSCL THROM VAS, V31, P1485, DOI 10.1161/ATVBAHA.110.221101; Xie P, 2009, MOL CELL BIOL, V29, P2398, DOI 10.1128/MCB.01737-08; Xu Q, 2005, ONCOGENE, V24, P5552, DOI 10.1038/sj.onc.1208719; Yahata Y, 2003, J BIOL CHEM, V278, P40026, DOI 10.1074/jbc.M301866200; Yoshida T, 2004, ARTERIOSCL THROM VAS, V24, P1596, DOI 10.1161/01.ATV.0000137190.63214.c5; Yoshida T, 2003, CIRC RES, V92, P856, DOI 10.1161/01.RES.0000068405.49081.09; Zhang MX, 2010, J CANCER RES CLIN, V136, P981, DOI 10.1007/s00432-009-0743-9	56	52	53	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 7	2015	290	32					19641	19652		10.1074/jbc.M114.630111	http://dx.doi.org/10.1074/jbc.M114.630111			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CO7TL	26100622	hybrid, Green Published			2022-12-26	WOS:000359364600025
J	Choi, H; Krantz, A; Smith, J; Trick, W				Choi, Humberto; Krantz, Anne; Smith, Jennifer; Trick, William			Medical Diagnoses Associated with Substance Dependence among Inpatients at a Large Urban Hospital	PLOS ONE			English	Article							RISK-FACTORS; ASTHMA EXACERBATIONS; HISTAMINE-RELEASE; UNITED-STATES; USE DISORDERS; MORPHINE; INFECTION; INCREASE; CHILDREN; ALCOHOL	Background There are limited data on reasons for hospital admission among patients dependent on substances other than alcohol. We compared primary discharge diagnoses for heroin-or cocaine-dependent patients to non-dependent patients. Material and Methods We evaluated a cohort of patients admitted to a general medicine service at a public teaching hospital during July 2005-June 2008. Through bedside interviews, we identified patients who had substance-use disorders. We categorized patients by substance used, route of administration, and dependent or non-dependent use. We grouped diagnostic codes (i.e., ICD-9) using Healthcare Utilization Project categories. We excluded HIV-infected patients. Results Of 11,397 patients, 341 (3.0%) were dependent on inhalational heroin, 260 (2.3%) on non-injection cocaine, and 106 (0.9%) on injection heroin. Compared to non-dependent patients, inhalational heroin-dependent patients were over three-fold more likely to have been admitted for respiratory diseases (28% vs. 8%, p<0.01); this association was strongest for asthma exacerbation (OR=7.0; 95% CI, 4.7 to 70.4, p<0.01). Of the 225 admissions for an asthma exacerbation, 44 (19.6%) had co-occurrent heroin-dependence. The most frequent diagnostic category among cocaine-dependent patients was circulatory, which was similar to non-dependent patients (22% vs. 21%, p=0.92). Discussion There is a strong association between heroin dependence and hospital admission for an asthma exacerbation. Provision of specialized substance-use treatment for inhalational heroin users will be necessary to reduce the frequency of exacerbations and repeat hospital admissions.	[Choi, Humberto] Cleveland Clin, Resp Inst, Cleveland, OH 44195 USA; [Krantz, Anne] Rush Univ, Div Pulm & Crit Care Med, Stroger Hosp Cook Cty, Med Ctr, Chicago, IL 60612 USA; [Smith, Jennifer] Rush Univ, Dept Med, Stroger Hosp Cook Cty, Med Ctr, Chicago, IL 60612 USA; [Trick, William] Rush Univ, Dept Med, Stroger Hosp Cook Cty, Collaborat Res Unit,Med Ctr, Chicago, IL 60612 USA	Cleveland Clinic Foundation; John H Stroger Junior Hospital Cook County; Rush University; John H Stroger Junior Hospital Cook County; Rush University; John H Stroger Junior Hospital Cook County; Rush University	Choi, H (corresponding author), Cleveland Clin, Resp Inst, Cleveland, OH 44195 USA.	choih@ccf.org		Trick, William/0000-0002-3243-5098	U.S. Department of Health and Human Services, Substance Abuse and Mental Health Services Administration - Center for Substance Abuse Treatment [TI15968]	U.S. Department of Health and Human Services, Substance Abuse and Mental Health Services Administration - Center for Substance Abuse Treatment	This work was supported by the U.S. Department of Health and Human Services, Substance Abuse and Mental Health Services Administration - Center for Substance Abuse Treatment [Grant TI15968]. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], CLIN CLASS SOFTW; BARKE KE, 1993, LIFE SCI, V53, P1391, DOI 10.1016/0024-3205(93)90581-M; Baxter JD, 2008, J ADDICT MED, V2, P79, DOI 10.1097/ADM.0b013e318160e448; CALL RS, 1992, J PEDIATR-US, V121, P862, DOI 10.1016/S0022-3476(05)80329-4; CRANE LR, 1986, REV INFECT DIS, V8, P364; Cygan J, 2000, CHEST, V117, P272, DOI 10.1378/chest.117.1.272; DOENICKE A, 1995, CLIN PHARMACOL THER, V58, P81, DOI 10.1016/0009-9236(95)90075-6; Harwood HJ, 1999, ADDICTION, V94, P631; Katz A, 2008, J HOSP MED, V3, P369, DOI 10.1002/jhm.358; Krantz AJ, 2003, CHEST, V123, P510, DOI 10.1378/chest.123.2.510; Levenson T, 1996, CHEST, V110, P604, DOI 10.1378/chest.110.3.604; Levine M, 2005, CHEST, V128, P1951, DOI 10.1378/chest.128.4.1951; Mokdad AH, 2004, JAMA-J AM MED ASSOC, V291, P1238, DOI 10.1001/jama.291.10.1238; Murray CS, 2006, THORAX, V61, P376, DOI 10.1136/thx.2005.042523; Naureckas ET, 2007, CHEST, V132, p858S, DOI 10.1378/chest.07-1913; Peters RH, 2000, J SUBST ABUSE TREAT, V18, P349, DOI 10.1016/S0740-5472(99)00081-1; Steiner Claudia, 2002, Eff Clin Pract, V5, P143; Ulinski S, 1996, ALLERGY, V51, P914; Weitzman JB, 1998, ARCH PATHOL LAB MED, V122, P691; Wisniewski MF, 2003, J AM MED INFORM ASSN, V10, P454, DOI 10.1197/jamia.M1299; WITHINGTON DE, 1993, ANAESTHESIA, V48, P26	21	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2015	10	6							e0131324	10.1371/journal.pone.0131324	http://dx.doi.org/10.1371/journal.pone.0131324			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CL4OM	26107402	Green Published, Green Submitted, gold			2022-12-26	WOS:000356932500156
J	Deikumah, JP; McAlpine, CA; Maron, M				Deikumah, Justus P.; McAlpine, Clive A.; Maron, Martine			Matrix Intensification Affects Body and Physiological Condition of Tropical Forest-Dependent Passerines	PLOS ONE			English	Article							SPECIES RESPONSES; FOOD AVAILABILITY; CONDITION INDEXES; HABITAT QUALITY; SURFACE SOIL; STRESS; SIZE; FRAGMENTATION; AREA; CONSERVATION	Matrix land-use intensification is a relatively recent and novel landscape change that can have important influences on the biota within adjacent habitat patches. While there are immediate local changes that it brings about, the influences on individual animals occupying adjacent habitats may be less evident initially. High-intensity land use could induce chronic stress in individuals in nearby remnants, leading ultimately to population declines. We investigated how physiological indicators and body condition measures of tropical forest-dependent birds differ between forest adjacent to surface mining sites and that near farmlands at two distances from remnant edge in southwest Ghana. We used mixed effects models of several condition indices including residual body mass and heterophil to lymphocyte (H/L) ratios (an indicator of elevated chronic stress) to explore the effect of matrix intensity on forest-dependent passerines classed as either sedentary area-sensitive habitat specialists or nomadic generalists. Individual birds occupying tropical forest remnants near surface mining sites were in poorer condition, as indicated by lower residual body mass and elevated chronic stress, compared to those in remnants near agricultural lands. The condition of the sedentary forest habitat specialists white-tailed alethe, Alethe diademata and western olive sunbird, Cyanomitra obscura was most negatively affected by high-intensity surface mining land-use adjacent to remnants, whereas generalist species were not affected. Land use intensification may set in train a new trajectory of faunal relaxation beyond that expected based on habitat loss alone. Patterns of individual condition may be useful in identifying habitats where species population declines may occur before faunal relaxation has concluded.	[Deikumah, Justus P.; McAlpine, Clive A.; Maron, Martine] Univ Queensland, Sch Geog Planning & Environm Management, Landscape Ecol & Conservat Grp, Brisbane, Qld 4072, Australia	University of Queensland	Deikumah, JP (corresponding author), Univ Cape Coast, Sch Biol Sci, Dept Entomol & Wildlife, Central Reg, Ghana.	j.deikumah@ucc.edu.gh	Maron, Martine/D-9699-2011; Deikumah, Justus P/AGK-9872-2022	Maron, Martine/0000-0002-5563-5789; Deikumah, Justus P/0000-0001-8800-3780; McAlpine, Clive/0000-0003-0457-8144	University of Queensland International Research Tuition Award (UQIRTA); UQ Research Scholarship (UQRS)	University of Queensland International Research Tuition Award (UQIRTA); UQ Research Scholarship (UQRS)	This research was supported by a University of Queensland International Research Tuition Award (UQIRTA) and a UQ Research Scholarship (UQRS).	Adimado AA, 2002, B ENVIRON CONTAM TOX, V68, P339, DOI [10.1007/s00128-001-0259-8, 10.1007/s001280259]; Adjorlolo-Gasokpoh A, 2012, B ENVIRON CONTAM TOX, V89, P1106, DOI 10.1007/s00128-012-0849-7; Agyeman, 2011, IMPACT LOGGING DAMAG; Amankwah RK, 2003, RESOUR POLICY, V29, P131, DOI 10.1016/j.resourpol.2004.07.002; Ambrose-Oji B, 2003, INT FOREST REV, V5, P106, DOI 10.1505/IFOR.5.2.106.17420; [Anonymous], CHECKLIST BIRDS AFRO; Areendran G, 2013, TROP ECOL, V54, P239; Aryee BNA, 2003, J CLEAN PROD, V11, P131, DOI 10.1016/S0959-6526(02)00043-4; Asante KA, 2007, CHEMOSPHERE, V66, P1513, DOI 10.1016/j.chemosphere.2006.08.022; Barton K., 2012, MUMIN MULTIMODEL INF; BATES D, 2012, LME4 LINEAR MIXEDEFF; Bennun Leon, 1998, Journal of East African Natural History, V85, P23, DOI 10.2982/0012-8317(1996)85[23:TFBOKA]2.0.CO;2; BIERREGAARD RO, 1992, BIOSCIENCE, V42, P859, DOI 10.2307/1312085; BirdLife International, 2013, IUCN RED LIST BIRDS; BLAKE JG, 1983, WILSON BULL, V95, P416; Bonier F, 2009, TRENDS ECOL EVOL, V24, P634, DOI 10.1016/j.tree.2009.04.013; Booth G, 1994, INT470 USDA FOR SERV; Brooks TM, 1999, J ANIM ECOL, V68, P1061, DOI 10.1046/j.1365-2656.1999.00353.x; Brosset A., 1986, OISEAUX REGIONS FORE, V1; Brotons L, 2003, AM NAT, V162, P343, DOI 10.1086/376887; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; CAMPBELL PM, 1992, BIOL REPROD, V47, P1140, DOI 10.1095/biolreprod47.6.1140; Campbell TW, 1995, AVIAN HEMATOLOGY CYT; CHEN JQ, 1993, AGR FOREST METEOROL, V63, P219, DOI 10.1016/0168-1923(93)90061-L; Cyr NE, 2007, GEN COMP ENDOCR, V151, P82, DOI 10.1016/j.ygcen.2006.12.003; Dadebo MA, 1999, J FOREST RES, V4, P1, DOI [10.1007/BF02760317, DOI 10.1007/BF02760317)]; Davis AK, 2008, FUNCT ECOL, V22, P760, DOI 10.1111/j.1365-2435.2008.01467.x; Deikumah JP, 2014, BIOL CONSERV, V169, P334, DOI 10.1016/j.biocon.2013.11.030; Deikumah JP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074852; DIAMOND JM, 1972, P NATL ACAD SCI USA, V69, P3199, DOI 10.1073/pnas.69.11.3199; DOWSETT-LEMAIRE F, 1990, Bulletin du Jardin Botanique National de Belgique, V60, P9, DOI 10.2307/3668330; Ellis RD, 2012, LANDSCAPE ECOL, V27, P1, DOI 10.1007/s10980-011-9671-6; ESRI, 2011, ARCGIS DESKT REL 10; Ewers RM, 2006, BIOL REV, V81, P117, DOI 10.1017/S1464793105006949; Fry CH., 2000, BIRDS AFRICA, VVI; Golow AA, 2002, B ENVIRON CONTAM TOX, V69, P228, DOI 10.1007/s00128-002-0051-4; GOWATY PA, 1993, AM NAT, V141, P263, DOI 10.1086/285472; Green AJ, 2001, ECOLOGY, V82, P1473, DOI 10.2307/2680003; Hawthorne WD, 1995, FOREST PROTECTION GH; Helms CW, 1960, BIRD BANDING, V31, P1, DOI DOI 10.2307/4510793; Herring G, 2007, THESCIENTIFICWORLDJO, V7, P1596, DOI 10.1100/tsw.2007.242; Hilson G., 2002, NAT RESOUR FORUM, V26, P3, DOI DOI 10.1111/1477-8947.00002; Hilson G, 2007, AFR AFFAIRS, V106, P413, DOI 10.1093/afraf/adm038; Hilson G, 2009, RESOUR POLICY, V34, P1, DOI 10.1016/j.resourpol.2008.12.001; Hinam HL, 2008, BIOL CONSERV, V141, P524, DOI 10.1016/j.biocon.2007.11.011; Holbech LH, 2005, BIRD CONSERV INT, V15, P27, DOI 10.1017/S0959270905000031; Homan RN, 2003, ANIM CONSERV, V6, P11, DOI 10.1017/S13679430030032; Homyack JA, 2010, WILDLIFE RES, V37, P332, DOI 10.1071/WR08093; Horak P, 1998, FUNCT ECOL, V12, P750, DOI 10.1046/j.1365-2435.1998.00244.x; Horak P, 2002, CAN J ZOOL, V80, P636, DOI 10.1139/Z02-038; Howell S. N, 1997, IDENTIFICATION GUIDE; Janin A, 2012, CONSERV BIOL, V26, P923, DOI 10.1111/j.1523-1739.2012.01910.x; Janin A, 2011, BIOL CONSERV, V144, P1008, DOI 10.1016/j.biocon.2010.12.009; Johnson MD, 2006, CONSERV BIOL, V20, P1433, DOI 10.1111/j.1523-1739.2006.00490.x; Johnstone CP, 2012, J COMP PHYSIOL B, V182, P861, DOI 10.1007/s00360-012-0656-9; Kaminski P, 2014, J ORNITHOL, V155, P307, DOI 10.1007/s10336-013-1016-6; Keith S., 1992, BIRDS AFRICA, V4; Kennedy CM, 2010, ECOL MONOGR, V80, P651, DOI 10.1890/09-0904.1; Kitaysky AS, 2007, MAR ECOL PROG SER, V352, P245, DOI 10.3354/meps07074; Kitaysky AS, 2006, P ROY SOC B-BIOL SCI, V273, P445, DOI 10.1098/rspb.2005.3351; Kitaysky AS, 1999, FUNCT ECOL, V13, P577, DOI 10.1046/j.1365-2435.1999.00352.x; Kupfer JA, 2006, GLOBAL ECOL BIOGEOGR, V15, P8, DOI 10.1111/j.1466-822x.2006.00204.x; Latta SC, 2002, ECOLOGY, V83, P2502, DOI 10.1890/0012-9658(2002)083[2502:DAPROC]2.0.CO;2; Lebigre C, 2012, J ORNITHOL, V153, P95, DOI 10.1007/s10336-011-0701-6; Major RE, 1999, J APPL ECOL, V36, P901, DOI 10.1046/j.1365-2664.1999.00457.x; Maron M, 2012, BIODIVERS CONSERV, V21, P2509, DOI 10.1007/s10531-012-0314-2; Mazerolle DF, 2002, OECOLOGIA, V130, P356, DOI 10.1007/s00442-001-0818-z; McEwen BS, 2000, BRAIN RES, V886, P172, DOI 10.1016/S0006-8993(00)02950-4; Milenkaya O, 2013, VALIDATING BODY COND; Moreno J, 2002, ECOSCIENCE, V9, P434, DOI 10.1080/11956860.2002.11682731; Norte AC, 2009, J ORNITHOL, V150, P651, DOI 10.1007/s10336-009-0387-1; Ockinger E, 2010, ECOL LETT, V13, P969, DOI 10.1111/j.1461-0248.2010.01487.x; Ockinger E, 2009, BASIC APPL ECOL, V10, P573, DOI [10.1016/j.baac.2008.12.002, 10.1016/j.baae.2008.12.002]; Oppong SOB, 2010, B ENVIRON CONTAM TOX, V85, P324, DOI 10.1007/s00128-010-0059-0; Paull D., 2006, GEOCARTO INT, V21, P33, DOI [10.1080/10106040608542372, DOI 10.1080/10106040608542372]; Peig J, 2010, FUNCT ECOL, V24, P1323, DOI 10.1111/j.1365-2435.2010.01751.x; Peig J, 2009, OIKOS, V118, P1883, DOI 10.1111/j.1600-0706.2009.17643.x; Polo-Cavia N, 2010, ANIM CONSERV, V13, P256, DOI 10.1111/j.1469-1795.2009.00329.x; R Development CoreTeam, 2012, R LANG ENV STAT COMP; Redfern C. P. F, 2001, RINGERS MANUAL; RISING JD, 1989, AUK, V106, P666; Rodewald AD, 2003, WILDLIFE SOC B, V31, P586; Romero LM, 2004, TRENDS ECOL EVOL, V19, P249, DOI 10.1016/j.tree.2004.03.008; Romero LM, 2001, P NATL ACAD SCI USA, V98, P7366, DOI 10.1073/pnas.131091498; RUNNING SW, 1984, AGR FOREST METEOROL, V32, P267, DOI 10.1016/0168-1923(84)90054-6; Sapolsky RM, 2000, ENDOCR REV, V21, P55, DOI 10.1210/er.21.1.55; SAPOLSKY RM, 1985, SCIENCE, V229, P1397, DOI 10.1126/science.4035356; Schamber JL, 2009, J AVIAN BIOL, V40, P49, DOI 10.1111/j.1600-048X.2008.04462.x; Schueler V, 2011, AMBIO, V40, P528, DOI 10.1007/s13280-011-0141-9; Schulte-Hostedde AI, 2005, ECOLOGY, V86, P155, DOI 10.1890/04-0232; Sieving KE, 1997, ROPICAL FOREST REMNA, P616; Stevenson RD, 2006, INTEGR COMP BIOL, V46, P1169, DOI 10.1093/icb/icl052; Suorsa P, 2004, P ROY SOC B-BIOL SCI, V271, P435, DOI 10.1098/rspb.2003.2620; TILMAN D, 1994, NATURE, V371, P65, DOI 10.1038/371065a0; Verso ML, 1962, EVOLUTION BLOOD COUN, P159; Vleck CM, 2002, INTEGR COMP BIOL, V42, P76, DOI 10.1093/icb/42.1.76; Wasser SK, 1997, CONSERV BIOL, V11, P1019, DOI 10.1046/j.1523-1739.1997.96240.x; WHITTAKER RH, 1975, ECOLOGY, V56, P771, DOI 10.2307/1936291; Wikelski M, 2006, TRENDS ECOL EVOL, V21, P38, DOI 10.1016/j.tree.2005.10.018; WINGFIELD JC, 1982, CONDOR, V84, P399, DOI 10.2307/1367443; Wingfield John C., 1997, P95; Zanette L, 2000, ECOLOGY, V81, P1654, DOI 10.1890/0012-9658(2000)081[1654:FSISFE]2.0.CO;2; Zar J. H., 1996, BIOSTATISTICAL ANAL; Zuur AF, 2010, METHODS ECOL EVOL, V1, P3, DOI 10.1111/j.2041-210X.2009.00001.x	104	10	10	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2015	10	6							e0128521	10.1371/journal.pone.0128521	http://dx.doi.org/10.1371/journal.pone.0128521			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4OM	26107179	gold, Green Published, Green Submitted			2022-12-26	WOS:000356932500023
J	Seifan, A; Assuras, S; Huey, ED; Mez, J; Tsapanou, A; Caccappolo, E				Seifan, Alon; Assuras, Stephanie; Huey, Edward D.; Mez, Jesse; Tsapanou, Angeliki; Caccappolo, Elise			Childhood Learning Disabilities and Atypical Dementia: A Retrospective Chart Review	PLOS ONE			English	Article							PRIMARY PROGRESSIVE APHASIA; FRONTOTEMPORAL LOBAR DEGENERATION; ALZHEIMERS-DISEASE; HIPPOCAMPAL VOLUME; GENE; CONNECTIVITY; ASSOCIATION; PREVALENCE; PLASTICITY; GUIDELINES	Objective To further our understanding of the association between self-reported childhood learning disabilities (LDs) and atypical dementia phenotypes (Atypical Dementia), including logopenic primary progressive aphasia (L-PPA), Posterior Cortical Atrophy (PCA), and Dysexecutive-type Alzheimer's Disease (AD). Methods This retrospective case series analysis of 678 comprehensive neuropsychological assessments compared rates of self-reported LD between dementia patients diagnosed with Typical AD and those diagnosed with Atypical Dementia. 105 cases with neuroimaging or CSF data available and at least one neurology follow-up were identified as having been diagnosed by the neuropsychologist with any form of neurodegenerative dementia. These cases were subject to a consensus diagnostic process among three dementia experts using validated clinical criteria for AD and PPA. LD was considered Probable if two or more statements consistent with prior LD were documented within the Social & Developmental History of the initial neuropsychological evaluation. Results 85 subjects (Typical AD n=68, Atypical AD n=17) were included in the final analysis. In logistic regression models adjusted for age, gender, handedness, education and symptom duration, patients with Probable LD, compared to patients without Probable LD, were significantly more likely to be diagnosed with Atypical Dementia vs. Typical AD (OR 13.1, 95% CI 1.3-128.4). All three of the L-PPA cases reporting a childhood LD endorsed childhood difficulty with language. By contrast, both PCA cases reporting Probable childhood LD endorsed difficulty with attention and/or math. Conclusions In people who develop dementia, childhood LD may predispose to atypical phenotypes. Future studies are required to confirm whether atypical neurodevelopment predisposes to regional-specific neuropathology in AD and other dementias.	[Seifan, Alon] Weill Cornell Med Coll, Dept Neurol, New York, NY 10065 USA; [Huey, Edward D.] Columbia Univ, Dept Neurol, New York, NY USA; [Huey, Edward D.] Columbia Univ, Gertrude H Sergievsky Ctr, New York, NY 10027 USA; [Huey, Edward D.; Tsapanou, Angeliki] Columbia Univ, Cognit Neurosci Div, Taub Inst Res Alzheimers Dis & Aging Brain, New York, NY USA; [Mez, Jesse] Boston Univ, Sch Med, Dept Neurol, Boston, MA 02118 USA; [Assuras, Stephanie; Caccappolo, Elise] Columbia Univ, Dept Neuropsychol, New York, NY USA	Cornell University; Columbia University; Columbia University; Columbia University; Boston University; Columbia University	Seifan, A (corresponding author), Weill Cornell Med Coll, Dept Neurol, New York, NY 10065 USA.	als9122@med.cornell.edu	Tsapanou, Angeliki/Y-6064-2018	Tsapanou, Angeliki/0000-0003-0471-5786; Seifan, Alon/0000-0001-6470-3600	NIH [5T32NS007153]; Taub Institute for Research on Alzheimer's Disease and the Aging Brain; Henry P. Panasci Fund; Charles and Ann Lee Brown Fellowship Fund; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS007153] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG013846, K23AG046377] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Taub Institute for Research on Alzheimer's Disease and the Aging Brain; Henry P. Panasci Fund; Charles and Ann Lee Brown Fellowship Fund; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Support for this study included NIH grant #5T32NS007153 as well as the Taub Institute for Research on Alzheimer's Disease and the Aging Brain, the Henry P. Panasci Fund, and the Charles and Ann Lee Brown Fellowship Fund. These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boyle CA, 2011, PEDIATRICS, V127, P1034, DOI 10.1542/peds.2010-2989; Braak H, 2013, J ALZHEIMERS DIS, V33, pS155, DOI 10.3233/JAD-2012-129029; Bralten J, 2011, AM J PSYCHIAT, V168, P1083, DOI 10.1176/appi.ajp.2011.10101509; Bufill E, 2006, AM J HUM BIOL, V18, P556, DOI 10.1002/ajhb.20516; Dean DC, 2014, JAMA NEUROL, V71, P11, DOI 10.1001/jamaneurol.2013.4544; Dickerson BC, 2011, J NEUROL NEUROSUR PS, V82, P45, DOI 10.1136/jnnp.2009.199505; Felsky D, 2014, MOL PSYCHIATR, V19, P1125, DOI 10.1038/mp.2013.142; Finn ES, 2014, BIOL PSYCHIAT, V76, P397, DOI 10.1016/j.biopsych.2013.08.031; Funfschilling U, 2012, NATURE, V485, P517, DOI 10.1038/nature11007; Gorno-Tempini ML, 2011, NEUROLOGY, V76, P1006, DOI 10.1212/WNL.0b013e31821103e6; Greenspan S, 2014, CURR OPIN PSYCHIATR, V27, P110, DOI 10.1097/YCO.0000000000000037; Ikeda M, 2014, AMYLOID, V21, P238, DOI 10.3109/13506129.2014.949231; Iulita MF, 2014, TRENDS PHARMACOL SCI, V35, P338, DOI 10.1016/j.tips.2014.04.010; Janocko NJ, 2012, ACTA NEUROPATHOL, V124, P681, DOI 10.1007/s00401-012-1044-y; Karageorgiou E, 2014, SEMIN NEUROL, V34, P189, DOI 10.1055/s-0034-1381735; Kim T, 2013, SCIENCE, V341, P1399, DOI 10.1126/science.1242077; Kuceyeski A, 2012, NEUROIMAGE, V61, P1311, DOI 10.1016/j.neuroimage.2012.03.039; Lam B, 2013, ALZHEIMERS RES THER, V5, DOI 10.1186/alzrt155; Lind J, 2006, NEUROSCI LETT, V396, P23, DOI 10.1016/j.neulet.2005.11.070; McKhann GM, 2011, ALZHEIMERS DEMENT, V7, P263, DOI 10.1016/j.jalz.2011.03.005; Mesulam MM, 2014, NEUROLOGY, V82, P1108, DOI 10.1212/WNL.0000000000000272; Mesulam MM, 2014, BRAIN, V137, P1176, DOI 10.1093/brain/awu024; Mez J, 2013, ALZ DIS ASSOC DIS, V27, P218, DOI 10.1097/WAD.0b013e31826a94bd; Miller ZA, 2013, BRAIN, V136, P3461, DOI 10.1093/brain/awt242; Njiokiktjien C, 2001, Fiziol Cheloveka, V27, P17; Padovani A, 2010, J ALZHEIMERS DIS, V22, P923, DOI 10.3233/JAD-2010-101206; Patrick KE, 2013, PEDIATRICS, V132, pE1257, DOI 10.1542/peds.2013-1530; Premi E, 2012, J ALZHEIMERS DIS, V28, P941, DOI 10.3233/JAD-2011-111541; Ranasinghe KG, 2014, NEUROIMAGE-CLIN, V5, P385, DOI 10.1016/j.nicl.2014.07.006; Rascovsky K, 2011, BRAIN, V134, P2456, DOI 10.1093/brain/awr179; Rogalski E, 2008, ARCH NEUROL-CHICAGO, V65, P244, DOI 10.1001/archneurol.2007.34; Rogalski EJ, 2014, JAMA NEUROL, V71, P1576, DOI 10.1001/jamaneurol.2014.2805; Sajjadi SA, 2014, NEUROLOGY, V82, P1127, DOI 10.1212/WNL.0000000000000271; Santangelo R, 2015, J ALZHEIMERS DIS, V43, P1429, DOI 10.3233/JAD-141122; Shaw P, 2007, LANCET NEUROL, V6, P494, DOI 10.1016/S1474-4422(07)70106-0; Singh TD, 2015, J NEUROL, V262, P1483, DOI 10.1007/s00415-015-7732-5; Tagawa K, 2015, HUM MOL GENET, V24, P540, DOI 10.1093/hmg/ddu475; Valla J, 2010, J ALZHEIMERS DIS, V22, P307, DOI 10.3233/JAD-2010-100129; Vandermosten M, 2013, NEUROPSYCHOLOGIA, V51, P2087, DOI 10.1016/j.neuropsychologia.2013.07.008; Wicklund MR, 2014, NEUROLOGY, V82, P1119, DOI 10.1212/WNL.0000000000000261; Woodward MC, 2015, J ALZHEIMERS DIS, V44, P233, DOI 10.3233/JAD-141110; Zhang W, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4330	42	14	14	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2015	10	6							e0129919	10.1371/journal.pone.0129919	http://dx.doi.org/10.1371/journal.pone.0129919			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4OM	26106899	Green Published, Green Submitted, gold			2022-12-26	WOS:000356932500072
J	Thatje, S; Marsh, L; Roterman, CN; Mavrogordato, MN; Linse, K				Thatje, Sven; Marsh, Leigh; Roterman, Christopher Nicolai; Mavrogordato, Mark N.; Linse, Katrin			Adaptations to Hydrothermal Vent Life in Kiwa tyleri, a New Species of Yeti Crab from the East Scotia Ridge, Antarctica	PLOS ONE			English	Article							MITOCHONDRIAL GENE REARRANGEMENTS; DECAPODA; WATER; CRUSTACEA; SEA; ANOMURA; GALATHEIDAE; PACIFIC; FAMILY	Hydrothermal vents in the Southern Ocean are the physiologically most isolated chemosynthetic environments known. Here, we describe Kiwa tyleri sp. nov., the first species of yeti crab known from the Southern Ocean. Kiwa tyleri belongs to the family Kiwaidae and is the visually dominant macrofauna of two known vent sites situated on the northern and southern segments of the East Scotia Ridge (ESR). The species is known to depend on primary productivity by chemosynthetic bacteria and resides at the warm-eurythermal vent environment for most of its life; its short-range distribution away from vents (few metres) is physiologically constrained by the stable, cold waters of the surrounding Southern Ocean. Kiwa tylerihas been shown to present differential life history adaptations in response to this contrasting thermal environment. Morphological adaptations specific to life in warm-eurythermal waters, as found on - or in close proximity of - vent chimneys, are discussed in comparison with adaptations seen in the other two known members of the family (K. hirsuta, K. puravida), which show a preference for low temperature chemosynthetic environments.	[Thatje, Sven; Marsh, Leigh] Univ Southampton, Ocean & Earth Sci, Southampton SO14 3ZH, Hants, England; [Roterman, Christopher Nicolai] Natl Oceanog Ctr, Southampton SO14 3ZH, Hants, England; [Mavrogordato, Mark N.] Univ Southampton, VIS CT Imaging Ctr, Engn Sci, Southampton SO17 1BJ, Hants, England; [Linse, Katrin] British Antarctic Survey, Cambridge CB3 0ET, England	University of Southampton; NERC National Oceanography Centre; University of Southampton; UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC British Antarctic Survey	Thatje, S (corresponding author), Univ Southampton, Ocean & Earth Sci, European Way, Southampton SO14 3ZH, Hants, England.	svth@noc.soton.ac.uk	Marsh, Leigh/J-6068-2013; Roterman, Christopher Nicolai/AAX-4395-2021; Marsh, Leigh/AAT-5597-2020	Marsh, Leigh/0000-0002-4613-1538; Roterman, Christopher Nicolai/0000-0002-6636-6078; Marsh, Leigh/0000-0002-4613-1538; Linse, Katrin/0000-0003-3477-3047	NERC (UK) [NE/D01249X/1]; Total Foundation [Abyss2100]; Natural Environment Research Council [NE/D01249X/1, NE/D010470/2, bas0100036] Funding Source: researchfish; NERC [NE/D010470/2, NE/D01249X/1, bas0100036] Funding Source: UKRI	NERC (UK)(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Total Foundation(Total SA); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was supported by a NERC (UK) Consortium Grant (NE/D01249X/1; ChEsSo), as well as a grant from the Total Foundation (Abyss2100) to Sven Thatje.	Ahyong Shane T., 2009, Crustacean Issues, V18, P399; Ahyong ST, 2004, RAFFLES B ZOOL, V52, P673; Aronson RB, 2015, J BIOGEOGR, V42, P1, DOI 10.1111/jbi.12414; Boisselier-Dubayle MC, 2010, CR BIOL, V333, P755, DOI 10.1016/j.crvi.2010.08.007; Brown A, 2014, BIOL REV, V89, P406, DOI 10.1111/brv.12061; Buckeridge JS, 2013, ZOOTAXA, V 3745, P551, DOI 10.11646/zootaxa.3745.5.4; Cabezas P, 2011, ZOOL J LINN SOC-LOND, V162, P245, DOI 10.1111/j.1096-3642.2010.00681.x; Copley JT, 2011, JC066 CRUIS; da Silva JM, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0028233, 10.1371/journal.pone.0019449]; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Frederich M, 2001, POLAR BIOL, V24, P719, DOI 10.1007/s003000100270; Garabato ACN, 2002, DEEP-SEA RES PT I, V49, P681, DOI 10.1016/S0967-0637(01)00071-1; Garabato ACN, 2002, DEEP-SEA RES PT II, V49, P4715, DOI 10.1016/S0967-0645(02)00156-X; Goffredi SK, 2014, MOL ECOL, V23, P1457, DOI 10.1111/mec.12439; Griffiths HJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066981; Halanych KM, 1998, CAH BIOL MAR, V39, P355; Hickerson MJ, 2000, MOL BIOL EVOL, V17, P639, DOI 10.1093/oxfordjournals.molbev.a026342; Kim Won, 1992, Korean Journal of Systematic Zoology Special Issue, V3, P139; Machordom A, 2004, MOL PHYLOGENET EVOL, V33, P259, DOI 10.1016/j.ympev.2004.06.001; Macpherson E, 2005, ZOOSYSTEMA, V27, P709; Mantelatto FL, 2009, ZOOTAXA, P20, DOI 10.11646/zootaxa.2133.1.2; Marsh L, 2015, J ANIM ECOL, V84, P898, DOI 10.1111/1365-2656.12337; Marsh L, 2013, DEEP-SEA RES PT II, V92, P124, DOI 10.1016/j.dsr2.2013.02.007; Marsh L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048348; Morrison CL, 2002, P ROY SOC B-BIOL SCI, V269, P345, DOI 10.1098/rspb.2001.1886; Perez-Losada M, 2004, SYST BIOL, V53, P767, DOI 10.1080/10635150490522331; Perez-Losada M, 2002, J CRUSTACEAN BIOL, V22, P670, DOI 10.1651/0278-0372(2002)022[0670:PPOTFA]2.0.CO;2; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Raso JEG, 2008, POLAR BIOL, V31, P1281, DOI 10.1007/s00300-008-0476-2; Reid WDK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065553; Robles R., 2009, DECAPOD CRUSTACEAN P, V18, P301; Rogers AD, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001234; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Roterman CN, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.0718; Schnabel KE, 2011, MOL PHYLOGENET EVOL, V58, P157, DOI 10.1016/j.ympev.2010.11.011; Shevenell AE, 2004, SCIENCE, V305, P1766, DOI 10.1126/science.1100061; Smith F, 2013, DEEP-SEA RES PT II, V92, P234, DOI 10.1016/j.dsr2.2012.12.003; Thatje S, 2004, POLAR BIOL, V27, P195, DOI 10.1007/s00300-003-0583-z; Thatje S., 2015, SEXUALITY EARLY DEV, V1, P109, DOI [DOI 10.3354/SEDAO00011, 10.3354/sedao00011]; Thurber AR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026243; Toon A, 2009, DECAPOD CRUSTACEAN P, P348; WHITWORTH T, 1994, DEEP-SEA RES PT I, V41, P629, DOI 10.1016/0967-0637(94)90046-9; Xu JW, 2009, MOL ECOL, V18, P904, DOI 10.1111/j.1365-294X.2008.04070.x; Yang JS, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-257; Zwirglmaier K, 2015, MICROBIOLOGYOPEN, V4, P136, DOI 10.1002/mbo3.227	45	31	33	3	75	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2015	10	6							e0127621	10.1371/journal.pone.0127621	http://dx.doi.org/10.1371/journal.pone.0127621			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4OM	26107940	Green Accepted, Green Published, gold, Green Submitted			2022-12-26	WOS:000356932500011
J	Yu, Y; Gong, L; Wang, ZH				Yu Yang; Gong Long; Wang Zhenhu			Analysis of Interlimb Asymmetry in Patients Undergoing Simultaneous Bilateral Total Knee Arthroplasty	PLOS ONE			English	Article							COMPONENT ASYMMETRY; ONE-STAGE; TOTAL HIP; REPLACEMENT; EXTENSOR; OUTCOMES; SAFETY	Simultaneous bilateral TKA (SBTKA) has been a favored surgical solution due to reduced costs and patient suffering. The purpose of the present study was to investigate the risk factors of asymmetric recovery in patients who underwent SBTKA and whether that affected quality of life. A total of 187 patients undergoing SBTKA were included. During this study, patients underwent physical examination (knee swelling, active range of motion (ROM) of knee and quadriceps strength) and completed three surveys (VAS pain rating, Short Form-36 and requisite information lists in this study). Our results reveal interlimb asymmetries existed at least two years postoperatively. Between-limb differences in active ROM, quadriceps strength, and VAS pain scores were significantly detected in our study. Risk factors included being female, being older, and having high BMI and high levels of anxiety and depression; different diagnosis and different component size could be risk factors. Finally, interlimb differences in VAS pain scores and active ROM were negatively associated with SF-36 scores. However, interlimb differences in swelling and quadriceps strength were unrelated to SF-36 scores. Risk factors of asymmetric recovery should be evaluated and appreciated due to their significant impact on patients' quality of life. Before performing SBTKA, clinicians should consider possible risk factors and inform patients of asymmetric recovery between limbs, which could help decrease the unnecessary consultations and postoperative patient dissatisfaction.	[Yu Yang; Gong Long; Wang Zhenhu] 252 Hosp Chinese PLA, Dept Orthoped, Baoding City, Hebei, Peoples R China		Wang, ZH (corresponding author), 252 Hosp Chinese PLA, Dept Orthoped, Baoding City, Hebei, Peoples R China.	wzh_0312@sina.com						Ali A, 2014, ACTA ORTHOP, V85, P229, DOI 10.3109/17453674.2014.916487; BERMAN AT, 1987, J BONE JOINT SURG AM, V69A, P1340; Brown T E, 2001, Am J Knee Surg, V14, P81; Capeci CM, 2006, J ARTHROPLASTY, V21, P749, DOI 10.1016/j.arth.2005.09.010; Cohen RG, 1997, J ARTHROPLASTY, V12, P497, DOI 10.1016/S0883-5403(97)90171-6; Duivenvoorden T, 2013, OSTEOARTHR CARTILAGE, V21, P1834, DOI 10.1016/j.joca.2013.08.022; Forsythe ME, 2008, PAIN RES MANAG, V13, P335, DOI 10.1155/2008/730951; Gong L, 2014, J ORTHOP SCI, V19, P820, DOI 10.1007/s00776-014-0599-y; Huotari K, 2007, J HOSP INFECT, V65, P219, DOI 10.1016/j.jhin.2006.10.018; Ivory J P, 1993, J R Coll Surg Edinb, V38, P105; JANKIEWICZ JJ, 1994, CLIN ORTHOP RELAT R, P94; Kim YH, 2009, J BONE JOINT SURG BR, V91B, P64, DOI 10.1302/0301-620X.91B1.21320; Lane GJ, 1997, CLIN ORTHOP RELAT R, P106, DOI 10.1097/00003086-199712000-00015; MCLAUGHLIN TP, 1985, CLIN ORTHOP RELAT R, P220; Noble J, 2009, KNEE, V16, P420, DOI 10.1016/j.knee.2009.04.009; Noiseux NO, 2014, J ARTHROPLASTY, V29, P1383, DOI 10.1016/j.arth.2014.01.034; Parvizi J, 2001, J BONE JOINT SURG AM, V83A, P1157, DOI 10.2106/00004623-200108000-00004; Reddy VG, 2011, INDIAN J ORTHOP, V45, P251, DOI 10.4103/0019-5413.80044; Ritter M, 1997, CLIN ORTHOP RELAT R, P99; Rossi MD, 2006, AM J PHYS MED REHAB, V85, P737, DOI 10.1097/01.phm.0000233178.22621.a5; Rossi MD, 2002, ARCH PHYS MED REHAB, V83, P523, DOI 10.1053/apmr.2002.30935; Stubbs G, 2005, ANZ J SURG, V75, P739, DOI 10.1111/j.1445-2197.2005.03516.x; Trojani C, 2012, ORTHOP TRAUMATOL-SUR, V98, P857, DOI 10.1016/j.otsr.2012.08.003; Worland R L, 1996, Am J Orthop (Belle Mead NJ), V25, P292	24	0	0	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2015	10	6							e0129783	10.1371/journal.pone.0129783	http://dx.doi.org/10.1371/journal.pone.0129783			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4OM	26107692	Green Submitted, Green Published, gold			2022-12-26	WOS:000356932500068
J	Prokopenko, D; Hecker, J; Silverman, E; Nothen, MM; Schmid, M; Lange, C; Fier, HL				Prokopenko, Dmitry; Hecker, Julian; Silverman, Edwin; Noethen, Markus M.; Schmid, Matthias; Lange, Christoph; Fier, Heide Loehlein			Using Network Methodology to Infer Population Substructure	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; MISSING HERITABILITY; SUSCEPTIBILITY LOCI; STRATIFICATION; MODEL; IMPACT	One of the main caveats of association studies is the possible affection by bias due to population stratification. Existing methods rely on model-based approaches like structure and ADMIXTURE or on principal component analysis like EIGENSTRAT. Here we provide a novel visualization technique and describe the problem of population substructure from a graph-theoretical point of view. We group the sequenced individuals into triads, which depict the relational structure, on the basis of a predefined pairwise similarity measure. We then merge the triads into a network and apply community detection algorithms in order to identify homogeneous subgroups or communities, which can further be incorporated as covariates into logistic regression. We apply our method to populations from different continents in the 1000 Genomes Project and evaluate the type 1 error based on the empirical p-values. The application to 1000 Genomes data suggests that the network approach provides a very fine resolution of the underlying ancestral population structure. Besides we show in simulations, that in the presence of discrete population structures, our developed approach maintains the type 1 error more precisely than existing approaches.	[Prokopenko, Dmitry; Hecker, Julian; Lange, Christoph; Fier, Heide Loehlein] Univ Bonn, Inst Genom Math, Bonn, Germany; [Lange, Christoph] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; [Silverman, Edwin; Lange, Christoph] Brigham & Womens Hosp, Channing Lab, Boston, MA 02115 USA; [Lange, Christoph] German Ctr Neurodegenerat Dis DZNE, Bonn, Germany; [Prokopenko, Dmitry; Hecker, Julian; Noethen, Markus M.; Fier, Heide Loehlein] Univ Bonn, Inst Human Genet, Bonn, Germany; [Schmid, Matthias] Univ Bonn, Inst Med Biometr Informat & Epidemiol, Bonn, Germany	University of Bonn; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); University of Bonn; University of Bonn	Prokopenko, D (corresponding author), Univ Bonn, Inst Genom Math, Bonn, Germany.	dmitry.prokopenko@uni-bonn.de		Schmid, Matthias/0000-0002-0788-0317; Nothen, Markus/0000-0002-8770-2464; Prokopenko, Dmitry/0000-0002-1844-5652	National Institute of Mental Health [R01MH081862, R01MH087590]; National Heart, Lung, and Blood Institute [U01HL089856, U01HL089897]; National Research Foundation of Korea Grant - Korean Government [NRF-2014S1A2A2028559]; Cure Alzheimer's fund; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL089856, U01HL089897] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH081862, R01MH087590] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Research Foundation of Korea Grant - Korean Government; Cure Alzheimer's fund; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The project described was supported by Cure Alzheimer's fund, Award Number (R01MH081862, R01MH087590) from the National Institute of Mental Health and Award Number (U01HL089856, U01HL089897) from the National Heart, Lung, and Blood Institute. The research of C. Lange was supported by the National Research Foundation of Korea Grant, funded by the Korean Government (NRF-2014S1A2A2028559).	Alexander DH, 2009, GENOME RES, V19, P1655, DOI 10.1101/gr.094052.109; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Blondel VD, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/10/P10008; Campbell CD, 2005, NAT GENET, V37, P868, DOI 10.1038/ng1607; Csardi G., 2005, INTERJ COMPLEX SYST, P1695; de Bakker PIW, 2005, NAT GENET, V37, P1217, DOI 10.1038/ng1669; Deloukas P, 2013, NAT GENET, V45, P25, DOI 10.1038/ng.2480; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Eichler EE, 2010, NAT REV GENET, V11, P446, DOI 10.1038/nrg2809; Freedman ML, 2004, NAT GENET, V36, P388, DOI 10.1038/ng1333; Goldstein DB, 2009, NEW ENGL J MED, V360, P1696, DOI 10.1056/NEJMp0806284; Hanneman RA, INTRO SOCIAL NETWORK; Helgason A, 2005, NAT GENET, V37, P90, DOI 10.1038/ng1492; Kang HM, 2010, NAT GENET, V42, P348, DOI 10.1038/ng.548; Kimmel G, 2007, AM J HUM GENET, V81, P895, DOI 10.1086/521372; Laird NM, 2006, NAT REV GENET, V7, P385, DOI 10.1038/nrg1839; Lee SH, 2011, AM J HUM GENET, V88, P294, DOI 10.1016/j.ajhg.2011.02.002; Li QZ, 2008, GENET EPIDEMIOL, V32, P215, DOI 10.1002/gepi.20296; Liu L, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-132; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Marchini J, 2004, NAT GENET, V36, P512, DOI 10.1038/ng1337; McCarthy MI, 2008, NAT REV GENET, V9, P356, DOI 10.1038/nrg2344; Michailidou K, 2013, NAT GENET, V45, P353, DOI 10.1038/ng.2563; Newman MEJ, 2004, PHYS REV E, V70, DOI [10.1103/PhysRevE.70.056131, 10.1103/PhysRevE.69.026113]; Park JH, 2011, P NATL ACAD SCI USA, V108, P18026, DOI 10.1073/pnas.1114759108; Park JH, 2010, NAT GENET, V42, P570, DOI 10.1038/ng.610; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Pharoah PDP, 2013, NAT GENET, V45, P362, DOI 10.1038/ng.2564; Price AL, 2008, AM J HUM GENET, V83, P132, DOI 10.1016/j.ajhg.2008.06.005; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Price AL, 2010, NAT REV GENET, V11, P459, DOI 10.1038/nrg2813; Pritchard JK, 2000, GENETICS, V155, P945; Rosenberg NA, 2006, GENETICS, V173, P1665, DOI 10.1534/genetics.105.055335; Schneider S, 2000, ARLEQUIN V2 0 SOFTWA; Schunkert H, 2011, NAT GENET, V43, P333, DOI [10.1038/ng.784, 10.1161/CIRCGENETICS.111.960443]; So HC, 2011, GENET EPIDEMIOL, V35, P447, DOI 10.1002/gepi.20593; Sul JH, 2013, NAT REV GENET, V14, P300, DOI 10.1038/nrg2813-c1; Visscher PM, 2012, AM J HUM GENET, V90, P7, DOI 10.1016/j.ajhg.2011.11.029; Zhang ZW, 2010, NAT GENET, V42, P355, DOI 10.1038/ng.546; Zhu XF, 2002, GENET EPIDEMIOL, V23, P181, DOI 10.1002/gepi.210	40	1	1	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2015	10	6							e0130708	10.1371/journal.pone.0130708	http://dx.doi.org/10.1371/journal.pone.0130708			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL3FM	26098940	gold, Green Published, Green Submitted			2022-12-26	WOS:000356835800097
J	Chou, MH; Hsieh, YC; Huang, CW; Chen, PH; Chan, SP; Tsao, YP; Lee, HH; Wu, JT; Chen, SL				Chou, Meng-Hsuan; Hsieh, Yi-Chen; Huang, Chu-Wei; Chen, Po-Han; Chan, Shih-Peng; Tsao, Yeou-Ping; Lee, Hsiu-Hsiang; Wu, June-Tai; Chen, Show-Li			BCAS2 Regulates Delta-Notch Signaling Activity through Delta Pre-mRNA Splicing in Drosophila Wing Development	PLOS ONE			English	Article							PRP19P-ASSOCIATED COMPLEX; SPLICEOSOME ACTIVATION; FUNCTIONAL-ANALYSIS; MASS-SPECTROMETRY; RECENT INSIGHTS; EXPRESSION; PROTEIN; PATHWAY; PRP19P; GENE	Previously, we showed that BCAS2 is essential for Drosophila viability and functions in pre-mRNA splicing. In this study, we provide strong evidence that BCAS2 regulates the activity of Delta-Notch signaling via Delta pre-mRNA splicing. Depletion of dBCAS2 reduces Delta mRNA expression and leads to accumulation of Delta pre-mRNA, resulting in diminished transcriptions of Delta-Notch signaling target genes, such as cut and E(spl)m8. Furthermore, ectopic expression of human BCAS2 (hBCAS2) and Drosophila BCAS2 (dBCAS2) in a dBCAS2-deprived fly can rescue dBCAS2 depletion-induced wing damage to the normal phenotypes. These rescued phenotypes are correlated with the restoration of Delta pre-mRNA splicing, which affects Delta-Notch signaling activity. Additionally, overexpression of Delta can rescue the wing deformation by deprivation of dBCAS2; and the depletion of dBCAS2 can restore the aberrant eye associated with Delta-overexpressing retinas; providing supporting evidence for the regulation of Delta-Notch signaling by dBCAS2. Taken together, dBCAS2 participates in Delta pre-mRNA splicing that affects the regulation of Delta-Notch signaling in Drosophila wing development.	[Chou, Meng-Hsuan; Hsieh, Yi-Chen; Huang, Chu-Wei; Chen, Po-Han; Chan, Shih-Peng; Chen, Show-Li] Natl Taiwan Univ, Coll Med, Grad Inst Microbiol, Taipei 100, Taiwan; [Tsao, Yeou-Ping] Mackay Mem Hosp, Dept Ophthalmol, Taipei 104, Taiwan; [Lee, Hsiu-Hsiang; Wu, June-Tai] Natl Taiwan Univ, Coll Med, Inst Mol Med, Taipei 100, Taiwan; [Wu, June-Tai] Natl Taiwan Univ Hosp, Dept Med Res, Taipei 100, Taiwan	National Taiwan University; Mackay Memorial Hospital; National Taiwan University; National Taiwan University; National Taiwan University Hospital	Wu, JT (corresponding author), Natl Taiwan Univ, Coll Med, Inst Mol Med, Taipei 100, Taiwan.	junetai@ntuh.gov.tw; showlic@ntu.edu.tw	CHEN, PO-HAN/ABB-6690-2021	CHEN, PO-HAN/0000-0002-9471-4471; LEE, HSIU-HSIANG/0000-0001-7707-8461; Chan, Shih-Peng/0000-0001-6322-2821; WU, JUNE-TAI/0000-0002-4023-7315; Hsieh, Yi-Chen/0000-0002-8137-990X	National Science Council [NSC102-2320-B-002-033-MY3, NSC99-3112-B-002-037, NSC99-2628-B-002-023-MY3]; National Taiwan University [98R0066-13, 99R311001, 98F008-201]	National Science Council(Ministry of Science and Technology, Taiwan); National Taiwan University(National Taiwan University)	This work was supported by the National Science Council (NSC102-2320-B-002-033-MY3, NSC99-3112-B-002-037, NSC99-2628-B-002-023-MY3), National Taiwan University (98R0066-13; 99R311001, 98F008-201). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajuh P, 2000, EMBO J, V19, P6569, DOI 10.1093/emboj/19.23.6569; ANDERSON L. E., 1954, BRYOLOGIST, V57, P242; Andersson ER, 2011, DEVELOPMENT, V138, P3593, DOI 10.1242/dev.063610; Blair SS, 2007, ANNU REV CELL DEV BI, V23, P293, DOI 10.1146/annurev.cellbio.23.090506.123606; BLOCHLINGER K, 1993, DEVELOPMENT, V117, P441; Bolos V, 2007, ENDOCR REV, V28, P339, DOI 10.1210/er.2006-0046; Boudrez A, 2000, J BIOL CHEM, V275, P25411, DOI 10.1074/jbc.M001676200; Bray SJ, 2006, NAT REV MOL CELL BIO, V7, P678, DOI 10.1038/nrm2009; Brou C, 2009, EXP CELL RES, V315, P1549, DOI 10.1016/j.yexcr.2008.09.010; BROWER DL, 1986, EMBO J, V5, P2649, DOI 10.1002/j.1460-2075.1986.tb04547.x; Chan SP, 2005, J BIOL CHEM, V280, P31190, DOI 10.1074/jbc.M505060200; Chan SP, 2003, SCIENCE, V302, P279, DOI 10.1126/science.1086602; Chen HR, 1999, P NATL ACAD SCI USA, V96, P5406, DOI 10.1073/pnas.96.10.5406; Chen HR, 1998, MOL CELL BIOL, V18, P2196, DOI 10.1128/MCB.18.4.2196; Chen PH, 2013, RNA, V19, P208, DOI 10.1261/rna.034835.112; Chitnis A, 2006, DEV DYNAM, V235, P886, DOI 10.1002/dvdy.20683; CROOK NE, 1993, J VIROL, V67, P2168, DOI 10.1128/JVI.67.4.2168-2174.1993; deCelis JF, 1996, DEVELOPMENT, V122, P359; deCelis JF, 1997, DEVELOPMENT, V124, P3241; del Alamo D, 2011, CURR BIOL, V21, pR40, DOI 10.1016/j.cub.2010.10.034; Fortschegger K, 2007, MOL CELL BIOL, V27, P3123, DOI 10.1128/MCB.01188-06; Grote M, 2010, MOL CELL BIOL, V30, P2105, DOI 10.1128/MCB.01505-09; Guruharsha KG, 2012, NAT REV GENET, V13, P654, DOI 10.1038/nrg3272; Gustafson K, 1996, GENOME, V39, P174, DOI 10.1139/g96-023; HAENLIN M, 1990, DEVELOPMENT, V110, P905; HAY BA, 1994, DEVELOPMENT, V120, P2121; Huppert SS, 1997, DEVELOPMENT, V124, P3283; Kankel MW, 2007, GENETICS, V177, P2493, DOI 10.1534/genetics.107.080994; Kleinridders A, 2009, MOL CELL BIOL, V29, P3173, DOI 10.1128/MCB.01807-08; Kuo PC, 2014, BRIT J CANC; Kuo PC, 2009, CANCER RES, V69, P8877, DOI 10.1158/0008-5472.CAN-09-2023; Le Borgne R, 2006, CURR OPIN CELL BIOL, V18, P213, DOI 10.1016/j.ceb.2006.02.011; LECOURTOIS M, 1995, GENE DEV, V9, P2598, DOI 10.1101/gad.9.21.2598; Leong KG, 2006, BLOOD, V107, P2223, DOI 10.1182/blood-2005-08-3329; Micchelli CA, 1997, DEVELOPMENT, V124, P1485; Milan M, 1998, GENE DEV, V12, P2912, DOI 10.1101/gad.12.18.2912; Miller AC, 2009, CURR BIOL, V19, P1378, DOI 10.1016/j.cub.2009.06.042; Nagaraj R, 2007, DEVELOPMENT, V134, P825, DOI 10.1242/dev.02788; Nagaraj R, 2009, EMBO J, V28, P337, DOI 10.1038/emboj.2008.286; Neubauer G, 1998, NAT GENET, V20, P46, DOI 10.1038/1700; Nichols JT, 2007, TRAFFIC, V8, P959, DOI 10.1111/j.1600-0854.2007.00592.x; Ohi MD, 2005, MOL CELL BIOL, V25, P451, DOI 10.1128/MCB.25.1.451-460.2005; Ohi MD, 2002, MOL CELL BIOL, V22, P2011, DOI 10.1128/MCB.22.7.2011-2024.2002; Ohi MD, 2002, RNA, V8, P798, DOI 10.1017/S1355838202025050; Perrimon N, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a005975; Qi C, 2005, BIOCHEM BIOPH RES CO, V328, P393, DOI 10.1016/j.bbrc.2004.12.187; Roignant JY, 2009, INT J DEV BIOL, V53, P795, DOI 10.1387/ijdb.072483jr; Saj A, 2010, DEV CELL, V18, P862, DOI 10.1016/j.devcel.2010.03.013; Sengupta S, 2014, BBA-GEN SUBJECTS, V1840, P1861, DOI 10.1016/j.bbagen.2014.01.005; Shalaby NA, 2009, GENETICS, V182, P1061, DOI 10.1534/genetics.108.099986; Tomlinson A, 2001, MOL CELL, V7, P487, DOI 10.1016/S1097-2765(01)00196-4; Tsuda L, 2002, CELL, V110, P625, DOI 10.1016/S0092-8674(02)00875-9; Xia K, 2014, MOL PSYCHIATR, V19, P1212, DOI 10.1038/mp.2013.146	53	10	10	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2015	10	6							e0130706	10.1371/journal.pone.0130706	http://dx.doi.org/10.1371/journal.pone.0130706			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL3FE	26091239	gold, Green Submitted, Green Published			2022-12-26	WOS:000356835000144
J	Dvoriantchikova, G; Perea-Martinez, I; Pappas, S; Barry, AF; Danek, D; Dvoriantchikova, X; Pelaez, D; Ivanov, D				Dvoriantchikova, Galina; Perea-Martinez, Isabel; Pappas, Steve; Barry, Ariel Faye; Danek, Dagmara; Dvoriantchikova, Xenia; Pelaez, Daniel; Ivanov, Dmitry			Molecular Characterization of Notch1 Positive Progenitor Cells in the Developing Retina	PLOS ONE			English	Article							DEVELOPING NERVOUS-SYSTEM; DELTA-LIKE; NEURONAL DIFFERENTIATION; ULTRADIAN OSCILLATIONS; ISCHEMIA-REPERFUSION; NEURAL PROGENITORS; GENE-EXPRESSION; FATE DECISIONS; BHLH GENES; HES GENES	The oscillatory expression of Notch signaling in neural progenitors suggests that both repressors and activators of neural fate specification are expressed in the same progenitors. Since Notch1 regulates photoreceptor differentiation and contributes (together with Notch3) to ganglion cell fate specification, we hypothesized that genes encoding photoreceptor and ganglion cell fate activators would be highly expressed in Notch1 receptor-bearing (Notch1(+)) progenitors, directing these cells to differentiate into photoreceptors or into ganglion cells when Notch1 activity is diminished. To identify these genes, we used microarray analysis to study expression profiles of whole retinas and isolated from them Notch1(+) cells at embryonic day 14 (E14) and postnatal day 0 (P0). To isolate Notch1(+) cells, we utilized immunomagnetic cell separation. We also used Notch3 knockout (Notch3KO) animals to evaluate the contribution of Notch3 signaling in ganglion cell differentiation. Hierarchical clustering of 6,301 differentially expressed genes showed that Notch1+ cells grouped near the same developmental stage retina cluster. At E14, we found higher expression of repressors (Notch1, Hes5) and activators (Dll3, Atoh7, Otx2) of neuronal differentiation in Notch1(+) cells compared to whole retinal cell populations. At P0, Notch1, Hes5, and Dll1 expression was significantly higher in Notch1(+) cells than in whole retinas. Otx2 expression was more than thirty times higher than Atoh7 expression in Notch1(+) cells at P0. We also observed that retinas of wild type animals had only 14% (P < 0.05) more ganglion cells compared to Notch3KO mice. Since this number is relatively small and Notch1 has been shown to contribute to ganglion cell fate specification, we suggested that Notch1 signaling may play a more significant role in RGC development than the Notch3 signaling cascade. Finally, our findings suggest that Notch1(+) progenitors-since they heavily express both pro-ganglion cell (Atoh7) and pro-photoreceptor cell (Otx2) activators-can differentiate into either ganglion cells or photoreceptors.	[Dvoriantchikova, Galina; Perea-Martinez, Isabel; Pappas, Steve; Barry, Ariel Faye; Danek, Dagmara; Dvoriantchikova, Xenia; Pelaez, Daniel; Ivanov, Dmitry] Univ Miami, Miller Sch Med, Bascom Palmer Eye Inst, Dept Ophthalmol, Miami, FL 33136 USA; [Pelaez, Daniel] Univ Miami, Dept Biomed Engn, Coral Gables, FL 33124 USA; [Ivanov, Dmitry] Univ Miami, Miller Sch Med, Dept Microbiol & Immunol, Miami, FL 33136 USA	Bascom Palmer Eye Institute; University of Miami; University of Miami; University of Miami	Ivanov, D (corresponding author), Univ Miami, Miller Sch Med, Bascom Palmer Eye Inst, Dept Ophthalmol, Miami, FL 33136 USA.	divanov@med.miami.edu		Pelaez, Daniel/0000-0002-4483-5160; Ivanov, Dmitry/0000-0002-5573-4402	National Eye Institute/National Institutes of Health (NIH)Grant [R01 EY022348]; Dr. Nasser Al-Rashid Orbital Vision Research Center Grant; GemCon Family Foundation Research Grant;  [P30EY014801]; NATIONAL EYE INSTITUTE [R01EY022348, P30EY014801] Funding Source: NIH RePORTER	National Eye Institute/National Institutes of Health (NIH)Grant; Dr. Nasser Al-Rashid Orbital Vision Research Center Grant; GemCon Family Foundation Research Grant; ; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	Supported in part by National Eye Institute/National Institutes of Health (NIH)Grant R01 EY022348 (DI), Center Core Grant P30EY014801 to the University of Miami Department of Ophthalmology, Dr. Nasser Al-Rashid Orbital Vision Research Center Grant (DP), GemCon Family Foundation Research Grant (DP).	Akpek EK, 2013, AM J MANAG CARE, V19, pS67; Bae SK, 2000, DEVELOPMENT, V127, P2933; BETTENHAUSEN B, 1995, DEVELOPMENT, V121, P2407; Cepko C, 2014, NAT REV NEUROSCI, V15, P615, DOI 10.1038/nrn3767; Chapman G, 2011, HUM MOL GENET, V20, P905, DOI 10.1093/hmg/ddq529; Chiodini F, 2013, CELL REP, V3, P796, DOI 10.1016/j.celrep.2013.01.035; Dvoriantchikova G, 2014, EUR J NEUROSCI, V40, P2502, DOI 10.1111/ejn.12603; Dvoriantchikova G, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-81; Eiraku M, 2011, NATURE, V472, P51, DOI 10.1038/nature09941; GUILLEMOT F, 1993, MECH DEVELOP, V42, P171, DOI 10.1016/0925-4773(93)90006-J; Hammerle B, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001169; Hatakeyama J, 2004, DEVELOPMENT, V131, P5539, DOI 10.1242/dev.01436; Hatakeyama J, 2006, CEREB CORTEX, V16, pI132, DOI 10.1093/cercor/bhj166; Imayoshi T, 2014, TRENDS NEUROSCI, V37, P531, DOI 10.1016/j.tins.2014.07.006; Imayoshi I, 2013, SCIENCE, V342, P1203, DOI 10.1126/science.1242366; Isomura A, 2014, DEVELOPMENT, V141, P3627, DOI 10.1242/dev.104497; Ivanov D, 2008, J NEUROSCI METH, V174, P10, DOI 10.1016/j.jneumeth.2008.06.016; Jadhav AR, 2006, DEVELOPMENT, V133, P913, DOI 10.1242/dev.02245; Jadhav AP, 2006, P NATL ACAD SCI USA, V103, P18998, DOI 10.1073/pnas.0608155103; James AC, 2014, BBA-MOL CELL RES, V1843, P1272, DOI 10.1016/j.bbamcr.2014.03.015; Kageyama R, 2008, NAT NEUROSCI, V11, P1247, DOI 10.1038/nn.2208; Kageyama R, 2010, CURR TOP DEV BIOL, V92, P311, DOI 10.1016/S0070-2153(10)92010-3; Koch U, 2013, DEVELOPMENT, V140, P689, DOI 10.1242/dev.080614; Ladi E, 2005, J CELL BIOL, V170, P983, DOI 10.1083/jcb.200503113; Lindsell CE, 1996, MOL CELL NEUROSCI, V8, P14, DOI 10.1006/mcne.1996.0040; Mizeracka K, 2013, DEVELOPMENT, V140, P3188, DOI 10.1242/dev.090696; Muranishi Y, 2011, J NEUROSCI, V31, P16792, DOI 10.1523/JNEUROSCI.3109-11.2011; Nakano T, 2012, CELL STEM CELL, V10, P771, DOI 10.1016/j.stem.2012.05.009; Nelson BR, 2008, DEV DYNAM, V237, P1565, DOI 10.1002/dvdy.21550; Nelson BR, 2009, DEV DYNAM, V238, P2163, DOI 10.1002/dvdy.21848; Nieto M, 2001, NEURON, V29, P401, DOI 10.1016/S0896-6273(01)00214-8; Ohsawa R, 2008, BRAIN RES, V1192, P90, DOI 10.1016/j.brainres.2007.04.014; Retinal Diseases and VISION 2020, 2003, GOMMUNITY EYE HLTH I, V16, P19; Riesenberg AN, 2009, J NEUROSCI, V29, P12865, DOI 10.1523/JNEUROSCI.3382-09.2009; Rosenberg EA, 2008, AM FAM PHYSICIAN, V77, P1431; Rusanescu G, 2014, J CELL MOL MED, V18, P2103, DOI 10.1111/jcmm.12362; Sasai Y, 2012, SCI AM, V307, P44, DOI 10.1038/scientificamerican1112-44; Shimojo H, 2008, NEURON, V58, P52, DOI 10.1016/j.neuron.2008.02.014; VANGELDER RN, 1990, P NATL ACAD SCI USA, V87, P1663, DOI 10.1073/pnas.87.5.1663; Wang RQ, 2011, BIOINFORMATICS, V27, P3158, DOI 10.1093/bioinformatics/btr551; Wang S, 2014, DEV CELL, V30, P513, DOI 10.1016/j.devcel.2014.07.018; Xiang MQ, 2013, CELL MOL LIFE SCI, V70, P2519, DOI 10.1007/s00018-012-1183-2; Zhong XF, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5047; Zhu MY, 2013, GENE EXPR PATTERNS, V13, P78, DOI 10.1016/j.gep.2012.12.001	44	13	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2015	10	6							e0131054	10.1371/journal.pone.0131054	http://dx.doi.org/10.1371/journal.pone.0131054			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL3FE	26091508	Green Published, gold, Green Submitted			2022-12-26	WOS:000356835000165
J	Nagaya, M; Ueno, S; Kominami, T; Nakanishi, A; Koyasu, T; Kondo, M; Furukawa, T; Terasaki, H				Nagaya, Masatoshi; Ueno, Shinji; Kominami, Taro; Nakanishi, Ayami; Koyasu, Toshiyuki; Kondo, Mineo; Furukawa, Takahisa; Terasaki, Hiroko			Pikachurin Protein Required for Increase of Cone Electroretinogram B-Wave during Light Adaptation	PLOS ONE			English	Article							BIPOLAR CELLS; MAMMALIAN RETINA; HORIZONTAL CELLS; ROD; SYSTEM; MOUSE; AMPLITUDE; ACID; DARK; PHOTORECEPTOR	In normal eyes, the amplitude of the b-wave of the photopic ERGs increases during light adaptation, but the mechanism causing this increase has not been fully determined. The purpose of this study was to evaluate the contribution of receptoral and post-receptoral components of the retina to this phenomenon. To accomplish this, we examined the ERGs during light adaptation in Pikachurin null-mutant (Pika -/-) mice, which have a misalignment of the bipolar cell dendritic tips to the photoreceptor ribbon synapses. After dark-adaptation, photopic ERGs were recorded from Pika -/- and wild type (WT) mice during the first 9 minutes of light adaptation. In some of the mice, post-receptoral components were blocked pharmacologically. The photopic b-waves of WT mice increased by 50% during the 9 min of light adaptation as previously reported. On the other hand, the b-waves of the Pika -/- mice decreased by 20% during the same time period. After blocking post-receptoral components, the b-waves were abolished from the WT mice, and the ERGs resembled those of the Pika -/- mice. The extracted post-receptoral component increased during light adaptation in the WT mice, but decreased for the first 3 minutes to a plateau in Pika -/- mice. We conclude that the normal synaptic connection between photoreceptor and retinal ON bipolar cells, which is controlled by pikachurin, is required for the ERGs to increase during light-adaptation. The contributions of post-receptoral components are essential for the photopic b-wave increase during the light adaptation.	[Nagaya, Masatoshi; Ueno, Shinji; Kominami, Taro; Nakanishi, Ayami; Terasaki, Hiroko] Nagoya Univ, Grad Sch Med, Dept Ophthalmol, Nagoya, Aichi 4648601, Japan; [Koyasu, Toshiyuki; Kondo, Mineo] Mie Univ, Grad Sch Med, Dept Ophthalmol, Tsu, Mie 514, Japan; [Furukawa, Takahisa] Osaka Univ, Inst Prot Res, Lab Mol & Dev Biol, Suita, Osaka 565, Japan; [Furukawa, Takahisa] JST, CREST, Suita, Osaka, Japan	Nagoya University; Mie University; Osaka University; Japan Science & Technology Agency (JST)	Ueno, S (corresponding author), Nagoya Univ, Grad Sch Med, Dept Ophthalmol, Nagoya, Aichi 4648601, Japan.	ueno@med.nagoya-u.ac.jp	Ueno, Shinji/M-5063-2014; Terasaki, Hiroko/M-5054-2014		Takayanagi retinal research grant; Ministry of Education, Culture, Sports, Science and Technology [25462709[SU]]	Takayanagi retinal research grant; Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This research was supported by Takayanagi retinal research grant 2013 and by Grant-in-Aid for Scientific Research C (No. 25462709[SU]) from the Ministry of Education, Culture, Sports, Science and Technology (http://www.jsps.go.jp/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARDEN GB, 1986, VISION RES, V26, P711, DOI 10.1016/0042-6989(86)90085-4; ARMINGTON JC, 1958, J COMP PHYSIOL PSYCH, V51, P1, DOI 10.1037/h0044572; BRETON ME, 1994, INVEST OPHTH VIS SCI, V35, P295; Bui BV, 2006, VISUAL NEUROSCI, V23, P155, DOI 10.1017/S0952523806232024; BURIAN HM, 1954, AMA ARCH OPHTHALMOL, V51, P509; Carolina V, 2005, VISION RES, V45, P2659, DOI 10.1016/j.visres.2005.03.020; Deans MR, 2002, NEURON, V36, P703, DOI 10.1016/S0896-6273(02)01046-2; GOURAS P, 1989, INVEST OPHTH VIS SCI, V30, P625; Herrmann R, 2011, NEURON, V72, P101, DOI 10.1016/j.neuron.2011.07.030; HOOD DC, 1990, VISUAL NEUROSCI, V5, P379, DOI 10.1017/S0952523800000468; HOOD DC, 1972, VISION RES, V12, P875, DOI 10.1016/0042-6989(72)90012-0; HOOD DC, 1972, VISION RES, V12, P889, DOI 10.1016/0042-6989(72)90013-2; Hood DC, 1996, J OPT SOC AM A, V13, P623, DOI 10.1364/JOSAA.13.000623; HORIGUCHI M, 1988, Nippon Ganka Gakkai Zasshi, V92, P395; Jackson CR, 2012, J NEUROSCI, V32, P9359, DOI 10.1523/JNEUROSCI.0711-12.2012; Kondo M, 1999, INVEST OPHTH VIS SCI, V40, P2633; Li X, 2008, J NEUROSCI, V28, P9769, DOI 10.1523/JNEUROSCI.2137-08.2008; Marmor MF, 2009, DOC OPHTHALMOL, V118, P69, DOI 10.1007/s10633-008-9155-4; MILLER S, 1991, INVEST OPHTH VIS SCI, V32, P2536; MIYAKE Y, 1987, INVEST OPHTH VIS SCI, V28, P1816; Omori Y, 2012, J NEUROSCI, V32, P6126, DOI 10.1523/JNEUROSCI.0322-12.2012; PEACHEY NS, 1989, APPL OPTICS, V28, P1145, DOI 10.1364/AO.28.001145; PEACHEY NS, 1993, NEUROSCI LETT, V162, P9, DOI 10.1016/0304-3940(93)90547-X; REMTULLA S, 1985, VISION RES, V25, P21, DOI 10.1016/0042-6989(85)90076-8; ROBSON JG, 1995, VISUAL NEUROSCI, V12, P837, DOI 10.1017/S0952523800009408; Sato S, 2008, NAT NEUROSCI, V11, P923, DOI 10.1038/nn.2160; SCHWARTZ EA, 1987, SCIENCE, V238, P350, DOI 10.1126/science.2443977; SLAUGHTER MM, 1983, SCIENCE, V219, P1230, DOI 10.1126/science.6131536; SLAUGHTER MM, 1981, SCIENCE, V211, P182, DOI 10.1126/science.6255566; Thoreson WB, 2012, PROG RETIN EYE RES, V31, P407, DOI 10.1016/j.preteyeres.2012.04.003; Trumpler J, 2008, J NEUROSCI, V28, P6818, DOI 10.1523/JNEUROSCI.1564-08.2008; Tsukamoto Y, 2007, J NEUROSCI, V27, P6261, DOI 10.1523/JNEUROSCI.5646-06.2007; Ueno S, 2005, EXP EYE RES, V81, P751, DOI 10.1016/j.exer.2005.04.013; Ueno S, 2004, INVEST OPHTH VIS SCI, V45, P1033, DOI 10.1167/iovs.03-0657; Ueno S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081507; Volgyi B, 2004, J NEUROSCI, V24, P11182, DOI 10.1523/JNEUROSCI.3096-04.2004; Xin DY, 1999, J COMP NEUROL, V405, P75, DOI 10.1002/(SICI)1096-9861(19990301)405:1<75::AID-CNE6>3.0.CO;2-D; Zhang AJ, 2011, J COMP NEUROL, V519, P2125, DOI 10.1002/cne.22604	38	7	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2015	10	6							e0128921	10.1371/journal.pone.0128921	http://dx.doi.org/10.1371/journal.pone.0128921			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL3FE	26091521	Green Published, gold, Green Submitted			2022-12-26	WOS:000356835000034
J	Reddy, DL; Venter, WDF; Pather, S				Reddy, Denasha Lavanya; Venter, Willem Daniel Francois; Pather, Sugeshnee			Patterns of Lymph Node Pathology; Fine Needle Aspiration Biopsy as an Evaluation Tool for Lymphadenopathy: A Retrospective Descriptive Study Conducted at the Largest Hospital in Africa	PLOS ONE			English	Article							TUBERCULOUS LYMPHADENITIS; DIAGNOSIS; ADULTS	Background Lymphadenopathy is a common clinical presentation of disease in South Africa (SA), particularly in the era of Human Immunodeficiency Virus (HIV) and tuberculosis (TB) co-infection. Methods Data from 560 lymph node biopsy reports of specimens from patients older than 12 years at Chris Hani Baragwanath Academic Hospital (CHBAH) between 1 January 2010 and 31 December 2012 was extracted from the National Health Laboratory Service (NHLS), division of Anatomical Pathology. Cytology reports of lymph node fine needle aspirates (FNAs) performed prior to lymph node biopsy in 203 patients were also extracted from the NHLS. Consent was not obtained from participants for their records to be used as patient information was anonymized and de-identified prior to analysis. Results The majority of patients were female (55%) and of the African/black racial group (90%). The median age of patients was 40 years (range12-94). The most common indication for biopsy was an uncertain diagnosis (more than two differential diagnoses entertained), followed by a suspicion for lymphoma, carcinoma and TB. Overall, malignancy constituted the largest biopsy pathology group (39%), with 36% of this group being carcinoma and 27% non-Hodgkin lymphoma. 22% of the total sampled nodes displayed necrotizing granulomatous inflammation (including histopathology and cytology demonstrating definite, and suspicious for mycobacterial infection), 8% comprised HIV reactive nodes; in the remainder no specific pathology was identified (nonspecific reactive lymphoid hyperplasia). Kaposi sarcoma (KS) accounted for 2.5% of lymph node pathology in this sample. Concomitant lymph node pathology was diagnosed in four cases of nodal KS (29% of the subset). The co-existing pathologies were TB and Castleman disease. HIV positive patients constituted 49% of this study sample and the majority (64%) of this subset had CD4 counts less than 350 cells/ul. 27% were HIV negative and in the remaining nodes, the HIV status of patients was unknown. The most common lymph node pathologies in HIV positive patients were Mycobacterial infection (31%), HIV reactive nodes (15%), non-Hodgkin lymphoma (15%) and nonspecific reactive lymphoid hyperplasia (15%). Only 8.7% were of Hodgkin lymphoma. In contrast, the most common lymph node pathologies in HIV negative patients were nonspecific reactive lymphoid hyperplasia (45%), carcinoma (25%) and Mycobacterial infection (11%). In this group, non-Hodgkin lymphoma and Hodgkin lymphoma constituted 9% and 8%, respectively. There were more cases of high-grade non-Hodgkin lymphoma in the HIV positive group compared to the HIV negative group. FNA and lymph node biopsy had statistically significant good agreement with regard to Hodgkin lymphoma (K 0.774, SE 0.07, 95% CI 0.606-0.882, p=0.001), non-Hodgkin lymphoma (K 0.640, SE 0.07, 95% CI 0.472-0.807, p=0.001), carcinoma (K 0.723, SE 0.069, 95% CI 0.528-0.918, p=0.001), and mycobacterial infection (K 0.726, SE 0.07, 95% CI 0.618-0.833, p=0.001). Conclusions The most common lymph node pathologies in CHBAH are malignancies, nonspecific reactive lymphoid hyperplasia, necrotizing granulomatous inflammation and HIV reactive nodes. The distribution of disease differs in HIV positive patients. Overall, adequate FNA samples of lymph nodes have been found to have good correlation with lymph node biopsy findings in our setting.	[Reddy, Denasha Lavanya] Univ Witwatersrand, Chris Hani Baragwanath Acad Hosp, Dept Internal Med, Johannesburg, South Africa; [Venter, Willem Daniel Francois] Univ Witwatersrand, Dept Med, Fac Hlth Sci, Wits Reprod Hlth & HIV Inst RHI, ZA-2001 Johannesburg, South Africa; [Pather, Sugeshnee] Univ Witwatersrand, Chris Hani Baragwanath Acad Hosp, Fac Hlth Sci, Sch Pathol,Div Anat Pathol,Natl Hlth Lab Serv, Johannesburg, South Africa	University of Witwatersrand; University of Witwatersrand; National Health Laboratory Service; University of Witwatersrand	Reddy, DL (corresponding author), Univ Witwatersrand, Chris Hani Baragwanath Acad Hosp, Dept Internal Med, Johannesburg, South Africa.	denasha.lavanya@gmail.com		Reddy, Denasha L./0000-0002-1199-021X; Venter, Willem/0000-0002-4157-732X	PEPFAR (President's Emergency Plan for AIDS Relief); SATBAT/FIC (South Africa Tuberculosis AIDS Training/Fogarty International Center) grant [3U2RTW007370-05S1]; PEPFAR or SATBAT/FIC	PEPFAR (President's Emergency Plan for AIDS Relief); SATBAT/FIC (South Africa Tuberculosis AIDS Training/Fogarty International Center) grant; PEPFAR or SATBAT/FIC	Professor Venter is supported by PEPFAR (President's Emergency Plan for AIDS Relief). Dr. Pather was supported by SATBAT/FIC (South Africa Tuberculosis AIDS Training/Fogarty International Center) grant 3U2RTW007370-05S1. There was no specific funding from PEPFAR or SATBAT/FIC for this study.	Bem C, 1996, BRIT J SURG, V83, P75, DOI 10.1002/bjs.1800830124; Churchyard GJ, 2014, SAMJ S AFR MED J, V104, P244, DOI [10.7196/samj.7689, 10.7196/SAMJ.7689]; Department of Health, 2009, NAT TUB MAN GUID; Dupin N, 1999, P NATL ACAD SCI USA, V96, P4546, DOI 10.1073/pnas.96.8.4546; Edginton ME, 2005, INT J TUBERC LUNG D, V9, P398; Fontanilla JM, 2011, CLIN INFECT DIS, V53, P555, DOI 10.1093/cid/cir454; Handa U, 2012, J INFECT DEV COUNTR, V6, P6, DOI 10.3855/jidc.2090; Kaplan LD, 2012, BEST PRACT RES CL HA, V25, P101, DOI 10.1016/j.beha.2012.01.001; Karstaedt AS, 2014, SAMJ S AFR MED J, V104, P22, DOI [10.7196/samj.6374, 10.7196/SAMJ.6374]; Ligthelm LJ, 2011, J CLIN MICROBIOL, V49, P3967, DOI 10.1128/JCM.01310-11; Mahe Etienne, 2011, Patholog Res Int, V2011, P618760, DOI 10.4061/2011/618760; Martinson Neil A, 2011, Proc Am Thorac Soc, V8, P288, DOI 10.1513/pats.201010-064WR; Muthuphei M N, 1998, Cent Afr J Med, V44, P311; Olu-eddo AN, 2011, PAN AFR MED J, V10; Puvaneswaran B, 2013, SAMJ S AFR MED J, V103, P32, DOI [10.7196/SAMJ.6093, 10.7196/samj.6093]; Razack R, 2014, SAMJ S AFR MED J, V104, P27, DOI [10.7196/SAMJ.7492, 10.7196/samj.7492]; Schutz C, 2013, S AFR MED J, V102, P506; SIBANDA EN, 1993, Q J MED, V86, P811; Streicher EM, 2012, INFECT GENET EVOL, V12, P686, DOI 10.1016/j.meegid.2011.07.019; Wiggill TM, 2011, JAIDS-J ACQ IMM DEF, V56, P460, DOI 10.1097/QAI.0b013e31820bb06a; Wong EB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047542	21	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2015	10	6							e0130148	10.1371/journal.pone.0130148	http://dx.doi.org/10.1371/journal.pone.0130148			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL3FE	26091519	Green Submitted, Green Published, gold			2022-12-26	WOS:000356835000090
J	Yeh, FC; Kao, CF; Kuo, PH				Yeh, Fan-Chi; Kao, Chung-Feng; Kuo, Po-Hsiu			Explore the Features of Brain-Derived Neurotrophic Factor in Mood Disorders	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; BIPOLAR DISORDER; MATURE BDNF; VAL66MET POLYMORPHISM; MAJOR DEPRESSION; METAANALYSIS; GENETICS; GENES; COMPLEX; RISK	Objectives Brain-derived neurotrophic factor (BDNF) plays important roles in neuronal survival and differentiation; however, the effects of BDNF on mood disorders remain unclear. We investigated BDNF from the perspective of various aspects of systems biology, including its molecular evolution, genomic studies, protein functions, and pathway analysis. Methods We conducted analyses examining sequences, multiple alignments, phylogenetic trees and positive selection across 12 species and several human populations. We summarized the results of previous genomic and functional studies of pro-BDNF and mature-BDNF (m-BDNF) found in a literature review. We identified proteins that interact with BDNF and performed pathway-based analysis using large genome-wide association (GWA) datasets obtained for mood disorders. Results BDNF is encoded by a highly conserved gene. The chordate BDNF genes exhibit an average of 75% identity with the human gene, while vertebrate orthologues are 85.9%-100% identical to human BDNF. No signs of recent positive selection were found. Associations between BDNF and mood disorders were not significant in most of the genomic studies (e.g., linkage, association, gene expression, GWA), while relationships between serum/plasma BDNF level and mood disorders were consistently reported. Pro-BDNF is important in the response to stress; the literature review suggests the necessity of studying both pro-and m-BDNF with regard to mood disorders. In addition to conventional pathway analysis, we further considered proteins that interact with BDNF (I-Genes) and identified several biological pathways involved with BDNF or I-Genes to be significantly associated with mood disorders. Conclusions Systematically examining the features and biological pathways of BDNF may provide opportunities to deepen our understanding of the mechanisms underlying mood disorders.	[Yeh, Fan-Chi; Kao, Chung-Feng; Kuo, Po-Hsiu] Natl Taiwan Univ, Dept Publ Hlth, Coll Publ Hlth, Taipei 10764, Taiwan; [Yeh, Fan-Chi; Kao, Chung-Feng; Kuo, Po-Hsiu] Natl Taiwan Univ, Coll Publ Hlth, Inst Epidemiol & Prevent Med, Taipei 10764, Taiwan; [Kuo, Po-Hsiu] Natl Taiwan Univ, Res Ctr Genes Environm & Human Hlth, Taipei 10764, Taiwan	National Taiwan University; National Taiwan University; National Taiwan University	Kuo, PH (corresponding author), Natl Taiwan Univ, Dept Publ Hlth, Coll Publ Hlth, Taipei 10764, Taiwan.	phkuo@ntu.edu.tw		Kuo, Po-Hsiu/0000-0003-0365-3587	Ministry of Science and Technology [NSC 99-2314-B-002-140-MY3, NSC 102-2314-B-002-117-MY3]; National Health Research Institute [NHRI-EX102-9918NC]	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); National Health Research Institute(National Health Research Institutes - Taiwan)	This research was supported by Ministry of Science and Technology (NSC 99-2314-B-002-140-MY3 and NSC 102-2314-B-002-117-MY3; http://www.most.gov.tw/) and National Health Research Institute (NHRI-EX102-9918NC; http://www.nhri.org.tw/NHRI_WEB/nhriw001Action.do), grants to Dr. P-H Kuo (PI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barker PA, 2009, NAT NEUROSCI, V12, P105, DOI 10.1038/nn0209-105; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Binder DK, 2004, GROWTH FACTORS, V22, P123, DOI 10.1080/08977190410001723308; Bocchio-Chiavetto L, 2010, WORLD J BIOL PSYCHIA, V11, P763, DOI 10.3109/15622971003611319; Brunoni AR, 2008, INT J NEUROPSYCHOPH, V11, P1169, DOI 10.1017/S1461145708009309; Camargo LM, 2007, MOL PSYCHIATR, V12, P74, DOI 10.1038/sj.mp.4001880; Carvalho AL, 2008, BRIT J PHARMACOL, V153, pS310, DOI 10.1038/sj.bjp.0707509; Craddock N, 2005, J MED GENET, V42, P193, DOI 10.1136/jmg.2005.030718; Craddock N, 2009, TRENDS GENET, V25, P99, DOI 10.1016/j.tig.2008.12.002; Duman RS, 2006, BIOL PSYCHIAT, V59, P1116, DOI 10.1016/j.biopsych.2006.02.013; Dunham JS, 2009, J PSYCHIATR RES, V43, P1175, DOI 10.1016/j.jpsychires.2009.03.008; Efron B, 2007, ANN APPL STAT, V1, P107, DOI 10.1214/07-AOAS101; Fernandes BS, 2011, J PSYCHIATR RES, V45, P995, DOI 10.1016/j.jpsychires.2011.03.002; Gatt JM, 2009, MOL PSYCHIATR, V14, P681, DOI 10.1038/mp.2008.143; Hasbi A, 2009, P NATL ACAD SCI USA, V106, P21377, DOI 10.1073/pnas.0903676106; Hashimoto K, 2010, PSYCHIAT CLIN NEUROS, V64, P341, DOI 10.1111/j.1440-1819.2010.02113.x; Hayden EP, 2006, GENES BRAIN BEHAV, V5, P85, DOI 10.1111/j.1601-183X.2005.00138.x; Jia PL, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-S3-S12; Juhasz G, 2011, BIOL PSYCHIAT, V69, P762, DOI 10.1016/j.biopsych.2010.11.019; Kanazawa T, 2007, PSYCHIAT GENET, V17, P165, DOI 10.1097/YPG.0b013e32801da2e2; Kao CF, 2014, AM J MED GENET B, V165, P596, DOI 10.1002/ajmg.b.32263; Kao CF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018696; Keller MC, 2006, BEHAV BRAIN SCI, V29, P385, DOI 10.1017/S0140525X06009095; Koshimizu H, 2010, NEUROSCI LETT, V473, P229, DOI 10.1016/j.neulet.2010.02.055; Kunugi H, 2010, PSYCHIAT CLIN NEUROS, V64, P447, DOI 10.1111/j.1440-1819.2010.02135.x; Lanave C, 2007, GENE, V394, P1, DOI 10.1016/j.gene.2007.01.021; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lee SY, 2012, PROG NEURO-PSYCHOPH, V39, P382, DOI 10.1016/j.pnpbp.2012.07.015; Levinson DF, 2006, BIOL PSYCHIAT, V60, P84, DOI 10.1016/j.biopsych.2005.08.024; Li MLJ, 2014, NUCLEIC ACIDS RES, V42, pD910, DOI 10.1093/nar/gkt1052; Lin PY, 2009, NEUROSCI LETT, V466, P139, DOI 10.1016/j.neulet.2009.09.044; Liu Y, 2011, MOL PSYCHIATR, V16, P2, DOI 10.1038/mp.2009.107; Lohoff FW, 2010, CURR PSYCHIAT REP, V12, P539, DOI 10.1007/s11920-010-0150-6; Lu B, 2003, NEURON, V39, P735, DOI 10.1016/S0896-6273(03)00538-5; Mandel AL, 2009, ARCH ORAL BIOL, V54, P689, DOI 10.1016/j.archoralbio.2009.04.005; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Martinowich K, 2007, NAT NEUROSCI, V10, P1089, DOI 10.1038/nn1971; McMahon FJ, 2010, NAT GENET, V42, P128, DOI 10.1038/ng.523; Menashe I, 2010, CANCER RES, V70, P4453, DOI 10.1158/0008-5472.CAN-09-4502; Mirina A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049093; Munkholm K, 2012, BIPOLAR DISORD, V14, P684, DOI 10.1111/bdi.12005; Neeley EW, 2011, NEUROSCIENCE, V187, P24, DOI 10.1016/j.neuroscience.2011.03.065; Numakawa T, 2010, HISTOL HISTOPATHOL, V25, P237, DOI 10.14670/HH-25.237; Patel SD, 2010, AM J MED GENET B, V153B, P850, DOI 10.1002/ajmg.b.31087; Petryshen TL, 2010, MOL PSYCHIATR, V15, P810, DOI 10.1038/mp.2009.24; Proux E, 2009, NUCLEIC ACIDS RES, V37, pD404, DOI 10.1093/nar/gkn768; Roshanaei-Moghaddam B, 2009, PSYCHIAT SERV, V60, P147, DOI 10.1176/appi.ps.60.2.147; Saccone C, 2005, HDB COMP GENOMICS; Sanacora G, 2012, NEUROPHARMACOLOGY, V62, P63, DOI 10.1016/j.neuropharm.2011.07.036; Savas S, 2009, INT J CANCER, V125, P1257, DOI 10.1002/ijc.24535; Scott LJ, 2009, P NATL ACAD SCI USA, V106, P7501, DOI 10.1073/pnas.0813386106; Segawa M, 2013, INT J NEUROPSYCHOPH, V16, P339, DOI 10.1017/S1461145712000053; Seifuddin F, 2012, AM J MED GENET B, V159B, P508, DOI 10.1002/ajmg.b.32057; Sen S, 2008, BIOL PSYCHIAT, V64, P527, DOI 10.1016/j.biopsych.2008.05.005; Serretti A, 2008, MOL PSYCHIATR, V13, P742, DOI 10.1038/mp.2008.29; Shabalina SA, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-4-105; Smith EN, 2009, MOL PSYCHIATR, V14, P755, DOI 10.1038/mp.2009.43; Sullivan PF, 2009, MOL PSYCHIATR, V14, P359, DOI 10.1038/mp.2008.125; Sullivan PF, 2013, MOL PSYCHIATR, V18, P497, DOI 10.1038/mp.2012.21; Sun JC, 2011, SCHIZOPHR RES, V125, P201, DOI 10.1016/j.schres.2010.12.002; Suyama M, 2006, NUCLEIC ACIDS RES, V34, pW609, DOI 10.1093/nar/gkl315; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Teng HK, 2005, J NEUROSCI, V25, P5455, DOI 10.1523/JNEUROSCI.5123-04.2005; Tettamanti G, 2010, GENE, V450, P85, DOI 10.1016/j.gene.2009.07.023; Tognoli C, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-4; Tsai SJ, 2007, MED HYPOTHESES, V68, P180, DOI 10.1016/j.mehy.2006.06.005; Verhagen M, 2010, MOL PSYCHIATR, V15, P260, DOI 10.1038/mp.2008.109; Voight BF, 2006, PLOS BIOL, V4, P446, DOI 10.1371/journal.pbio.0040072; Wang K, 2007, AM J HUM GENET, V81, P1278, DOI 10.1086/522374; Wray NR, 2012, MOL PSYCHIATR, V17, P36, DOI 10.1038/mp.2010.109; Yeh CM, 2012, J PHYSIOL-LONDON, V590, P991, DOI 10.1113/jphysiol.2011.222042; Yoshida T., 2012, OPEN CLIN CHEM J, V5, P7, DOI [10.2174/1874241601205010007, DOI 10.2174/1874241601205010007]	72	11	11	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2015	10	6							e0128605	10.1371/journal.pone.0128605	http://dx.doi.org/10.1371/journal.pone.0128605			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL3FE	26091093	Green Published, gold, Green Submitted			2022-12-26	WOS:000356835000025
J	Antonopoulos, C; Russo, HM; El Sanadi, C; Martin, BN; Li, XX; Kaiser, WJ; Mocarski, ES; Dubyak, GR				Antonopoulos, Christina; Russo, Hana M.; El Sanadi, Caroline; Martin, Bradley N.; Li, Xiaoxia; Kaiser, William J.; Mocarski, Edward S.; Dubyak, George R.			Caspase-8 as an Effector and Regulator of NLRP3 Inflammasome Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; CELL-DEATH; P2X7 RECEPTOR; ATP RELEASE; INTERLEUKIN-1-BETA MATURATION; CASPASE-8-DEPENDENT APOPTOSIS; IL-1-BETA PRODUCTION; CONVERTING-ENZYME; MOLECULAR-CLONING; MATURE IL-1-BETA	We recently described the induction of noncanonical IL-1 beta processing via caspase-8 recruited to ripoptosome signaling platforms in myeloid leukocytes. Here, we demonstrate that activated NLRP3.ASC inflammasomes recruit caspase-8 to drive IL-1 beta processing in murine bone marrow-derived dendritic cells (BMDC) independent of caspase-1 and -11. Sustained stimulation (> 2 h) of LPS-primed caspase-1-deficient (Casp1/11(-/-)) BMDC with the canonical NLRP3 inflammasome agonist nigericin results in release of bioactive IL-1 beta in conjunction with robust caspase-8 activation. This IL-1 beta processing and caspase-8 activation do not proceed in Nlrp3(-/-) or Asc(-/-) BMDC and are suppressed by pharmacological inhibition of caspase-8, indicating that caspase-8 can act as a direct IL-1 beta-converting enzyme during NLRP3 inflammasome activation. In contrast to the rapid caspase-1-mediated death of wild type (WT) BMDC via NLRP3-dependent pyroptosis, nigericinstimulated Casp1/11(-/-) BMDC exhibit markedly delayed cell death via NLRP3-dependent apoptosis. Biochemical analyses of WTand Casp1/11(-/-) BMDCindicated that caspase-8 is proteolytically processed within detergent-insoluble ASC-enriched protein complexes prior to extracellular export during nigericin treatment. Although nigericin-stimulated caspase-1 activation and activity are only modestly attenuated in caspase-8-deficient (Casp8(-/-) Rip3(-/-)) BMDC, these cells do not exhibit the rapid loss of viability ofWTcells. These results support a contribution of caspase-8 to both IL-1 beta production and regulated death signaling via NLRP3 inflammasomes. In the absence of caspase-1, NLRP3 inflammasomes directly utilize caspase-8 as both a proapoptotic initiator and major IL-1 beta-converting protease. In the presence of caspase-1, caspase-8 acts as a positive modulator of the NLRP3-dependent caspase-1 signaling cascades that drive both IL-1 beta production and pyroptotic death.	[El Sanadi, Caroline; Dubyak, George R.] Case Western Reserve Univ, Sch Med, Dept Physiol & Biophys, Cleveland, OH 44106 USA; [Antonopoulos, Christina; Russo, Hana M.; Martin, Bradley N.; Dubyak, George R.] Case Western Reserve Univ, Sch Med, Dept Pathol, Cleveland, OH 44106 USA; [Martin, Bradley N.; Li, Xiaoxia] Cleveland Clin Fdn, Dept Immunol, Lerner Res Inst, Cleveland, OH 44195 USA; [Kaiser, William J.; Mocarski, Edward S.] Emory Univ, Sch Med, Dept Microbiol & Immunol, Emory Vaccine Ctr, Atlanta, GA 30322 USA	Case Western Reserve University; Case Western Reserve University; Cleveland Clinic Foundation; Emory University	Dubyak, GR (corresponding author), Case Western Reserve Univ, Sch Med, Dept Physiol & Biophys, 10900 Euclid Ave, Cleveland, OH 44106 USA.	george.dubyak@case.edu	Regan, Clinton/E-6250-2012; Martin, Bradley/AAM-5041-2020; Mocarski, Edward/ABC-2893-2020	Martin, Bradley/0000-0002-8902-8805; Dubyak, George/0000-0001-9720-4226	National Institutes of Health [R01-GM36387, R01-AI118853, OD012198, T32-AI089474, T32-GM007250]; National Multiple Sclerosis Society [RG 5130A2/1]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [TL1TR000441] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL029582] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI089474, R01AI118853] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM036387, T32GM007250] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP5OD012198] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Multiple Sclerosis Society(National Multiple Sclerosis Society); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported, in whole or in part, by National Institutes of Health Grants R01-GM36387 (to G. R. D.), R01-AI118853 (to E. S. M.), and OD012198 (to W. J. K.). This work was also supported by National Multiple Sclerosis Society Grant RG 5130A2/1 (to X. L.). The authors declare that they have no conflicts of interest with the contents of this article.; Supported in part by National Institutes of Health Training Grants T32-AI089474 and T32-GM007250.	Ainscough JS, 2014, J BIOL CHEM, V289, P35582, DOI 10.1074/jbc.M114.595686; Allam R, 2014, EMBO REP, V15, P982, DOI 10.15252/embr.201438463; Antonopoulos C, 2013, J IMMUNOL, V191, P4789, DOI 10.4049/jimmunol.1300645; Baroja-Mazo A, 2014, NAT IMMUNOL, V15, P738, DOI 10.1038/ni.2919; Bergsbaken T, 2009, NAT REV MICROBIOL, V7, P99, DOI 10.1038/nrmicro2070; Bossaller L, 2012, J IMMUNOL, V189, P5508, DOI 10.4049/jimmunol.1202121; Boyd-Tressler A, 2014, J BIOL CHEM, V289, P27246, DOI 10.1074/jbc.M114.590240; Cai X, 2014, CELL, V156, P1207, DOI 10.1016/j.cell.2014.01.063; CERRETTI DP, 1992, SCIENCE, V256, P97, DOI 10.1126/science.1373520; Cuda CM, 2014, J IMMUNOL, V192, P5548, DOI 10.4049/jimmunol.1400122; Dinarello CA, 2011, BLOOD, V117, P3720, DOI 10.1182/blood-2010-07-273417; Doitsh G, 2014, NATURE, V505, P509, DOI 10.1038/nature12940; Duong BH, 2015, IMMUNITY, V42, P55, DOI 10.1016/j.immuni.2014.12.031; Estacion M, 2003, AM J PHYSIOL-CELL PH, V284, pC1006, DOI 10.1152/ajpcell.00258.2002; Fernandes-Alnemri T, 2007, CELL DEATH DIFFER, V14, P1590, DOI 10.1038/sj.cdd.4402194; Fink SL, 2008, P NATL ACAD SCI USA, V105, P4312, DOI 10.1073/pnas.0707370105; Fink SL, 2006, CELL MICROBIOL, V8, P1812, DOI 10.1111/j.1462-5822.2006.00751.x; Franklin BS, 2014, NAT IMMUNOL, V15, P727, DOI 10.1038/ni.2913; Gabay C, 2010, NAT REV RHEUMATOL, V6, P232, DOI 10.1038/nrrheum.2010.4; Ganesan S, 2014, J IMMUNOL, V193, P2519, DOI 10.4049/jimmunol.1400276; Gringhuis SI, 2012, NAT IMMUNOL, V13, P246, DOI 10.1038/ni.2222; Guarda G, 2011, J IMMUNOL, V186, P2529, DOI 10.4049/jimmunol.1002720; Gurung P, 2015, AM J PATHOL, V185, P17, DOI 10.1016/j.ajpath.2014.08.025; Gurung P, 2014, J IMMUNOL, V192, P1835, DOI 10.4049/jimmunol.1302839; Hasegawa M, 2007, ONCOGENE, V26, P1748, DOI 10.1038/sj.onc.1209965; Hildebrand JM, 2014, P NATL ACAD SCI USA, V111, P15072, DOI 10.1073/pnas.1408987111; Hu WH, 2000, J BIOL CHEM, V275, P10838, DOI 10.1074/jbc.275.15.10838; Kahlenberg JM, 2004, AM J PHYSIOL-CELL PH, V286, pC1100, DOI 10.1152/ajpcell.00494.2003; Kaiser WJ, 2011, NATURE, V471, P368, DOI 10.1038/nature09857; Karki R, 2015, CELL HOST MICROBE, V17, P357, DOI 10.1016/j.chom.2015.01.006; Karmakar M, 2012, J IMMUNOL, V189, P4231, DOI 10.4049/jimmunol.1201447; Katsnelson MA, 2015, J IMMUNOL, V194, P3937, DOI 10.4049/jimmunol.1402658; Kayagaki N, 2011, NATURE, V479, P117, DOI 10.1038/nature10558; Latz E, 2013, NAT REV IMMUNOL, V13, P397, DOI 10.1038/nri3452; Lawlor KE, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7282; LI P, 1995, CELL, V80, P401, DOI 10.1016/0092-8674(95)90490-5; Lin XY, 2000, J BIOL CHEM, V275, P39920, DOI 10.1074/jbc.M007255200; Lu A, 2014, CELL, V156, P1193, DOI 10.1016/j.cell.2014.02.008; Maelfait J, 2008, J EXP MED, V205, P1967, DOI 10.1084/jem.20071632; Man SM, 2014, P NATL ACAD SCI USA, V111, P7403, DOI 10.1073/pnas.1402911111; Man SM, 2013, J IMMUNOL, V191, P5239, DOI 10.4049/jimmunol.1301581; Masumoto J, 1999, J BIOL CHEM, V274, P33835, DOI 10.1074/jbc.274.48.33835; Masumoto J, 2003, BIOCHEM BIOPH RES CO, V303, P69, DOI 10.1016/S0006-291X(03)00309-7; Miao EA, 2011, IMMUNOL REV, V243, P206, DOI 10.1111/j.1600-065X.2011.01044.x; Mocarski ES, 2014, J IMMUNOL, V192, P2019, DOI 10.4049/jimmunol.1302426; Mocarski ES, 2012, NAT REV IMMUNOL, V12, P79, DOI 10.1038/nri3131; Monie TP, 2015, IMMUNOL REV, V265, P181, DOI 10.1111/imr.12284; Moriwaki K, 2015, J IMMUNOL, V194, P1938, DOI 10.4049/jimmunol.1402167; Motani K, 2010, CANCER SCI, V101, P1822, DOI 10.1111/j.1349-7006.2010.01610.x; NETT MA, 1992, J IMMUNOL, V149, P3254; Oberst A, 2011, NATURE, V471, P363, DOI 10.1038/nature09852; PERREGAUX D, 1992, J IMMUNOL, V149, P1294; PERREGAUX D, 1994, J BIOL CHEM, V269, P15195; Philip NH, 2014, P NATL ACAD SCI USA, V111, P7385, DOI 10.1073/pnas.1403252111; Pierini R, 2012, CELL DEATH DIFFER, V19, P1709, DOI 10.1038/cdd.2012.51; Qu Y, 2011, J IMMUNOL, V186, P6553, DOI 10.4049/jimmunol.1100478; Qu Y, 2009, J IMMUNOL, V182, P5052, DOI 10.4049/jimmunol.0802968; Rathinam VAK, 2012, NAT IMMUNOL, V13, P333, DOI 10.1038/ni.2237; Sagulenko V, 2013, CELL DEATH DIFFER, V20, P1149, DOI 10.1038/cdd.2013.37; Sandilos JK, 2012, J BIOL CHEM, V287, P11303, DOI 10.1074/jbc.M111.323378; Schilling WP, 2006, AM J PHYSIOL-CELL PH, V291, pC657, DOI 10.1152/ajpcell.00063.2006; Shenderov K, 2014, J IMMUNOL, V192, P2029, DOI 10.4049/jimmunol.1302549; Stehlik C, 2009, ARTHRITIS RHEUM-US, V60, P3524, DOI 10.1002/art.24961; Stoll S, 2002, SCIENCE, V296, P1873, DOI 10.1126/science.1071065; Su H, 2005, SCIENCE, V307, P1465, DOI 10.1126/science.1104765; Tait SWG, 2014, J CELL SCI, V127, P2135, DOI 10.1242/jcs.093575; Uchiyama R, 2013, J IMMUNOL, V190, P4245, DOI 10.4049/jimmunol.1203059; Verhoef PA, 2005, J IMMUNOL, V175, P7623, DOI 10.4049/jimmunol.175.11.7623; Verhoef PA, 2003, J IMMUNOL, V170, P5728, DOI 10.4049/jimmunol.170.11.5728; Verhoef PA, 2004, MOL PHARMACOL, V66, P909, DOI 10.1124/mol.66.4.909; Vince JE, 2012, IMMUNITY, V36, P215, DOI 10.1016/j.immuni.2012.01.012; Wang XQ, 2014, NAT IMMUNOL, V15, P1126, DOI 10.1038/ni.3015; Wang ZG, 2012, CELL, V148, P228, DOI 10.1016/j.cell.2011.11.030; Weng D, 2014, P NATL ACAD SCI USA, V111, P7391, DOI 10.1073/pnas.1403477111; Wu YH, 2014, CELL DEATH DIFFER, V21, P451, DOI 10.1038/cdd.2013.165; Xiao H, 2013, CIRCULATION, V128, P632, DOI 10.1161/CIRCULATIONAHA.113.002714; Yabal M, 2014, CELL REP, V7, P1796, DOI 10.1016/j.celrep.2014.05.008; Zhang Y, 2014, J IMMUNOL, V192, P5296, DOI 10.4049/jimmunol.1400653	78	128	130	1	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 14	2015	290	33					20167	20184		10.1074/jbc.M115.652321	http://dx.doi.org/10.1074/jbc.M115.652321			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CP1AT	26100631	hybrid, Green Published			2022-12-26	WOS:000359608900019
J	Wen, GM; Zhang, C; Chen, QS; Luong, LA; Mustafa, A; Ye, S; Xiao, QZ				Wen, Guanmei; Zhang, Cheng; Chen, Qishan; Luong, Le Anh; Mustafa, Arif; Ye, Shu; Xiao, Qingzhong			A Novel Role of Matrix Metalloproteinase-8 in Macrophage Differentiation and Polarization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR-BETA; SMOOTH-MUSCLE-CELLS; IN-VIVO; ACTIVATION; MICE; FIBROMODULIN; SUBSETS; ATHEROSCLEROSIS; HETEROGENEITY; INFLAMMATION	Matrix metalloproteinase-8 (MMP8) has been shown to influence various cellular functions. As monocytes and macrophages (M phi) express MMP8, we investigated if MMP8 played a role in macrophage differentiation and polarization. MMP8 expression was significantly increased during monocyte differentiation into M phi. Monocyte-derived M phi from MMP8-deficient mice expressed higher levels of M1-M phi markers but lower levels of M2-M phi markers than monocyte-derived M phi from wild-type mice. Although M phi from either MMP8-deficient or wild-type mice were inducible by interferon-gamma into M1-M phi, only wildtype M phi but not MMP8-deficient M phi could be induced into M2-M phi by interleukin-4. However, MMP8-deficient M phi exposed to conditioned culture media of wild-type M phi developed a M2-M phi phenotype. Compared with conditioned culture media of wild-type M phi, conditioned culture media of MMP8-deficient M phi contained a lower concentration of active transforming growth factor-beta (TGF-beta), an M2-M phi inducer. Moreover, evidence also showed that the degradation of the TGF-beta sequester, fibromodulin, was modulated by MMP8. The data indicate a previously unknown role of MMP8 in M2-M phi polarization by cleaving fibromodulin and therefore increasing the bioavailability of the M2-M phi inducer TGF-beta.	[Wen, Guanmei; Zhang, Cheng; Chen, Qishan; Luong, Le Anh; Ye, Shu; Xiao, Qingzhong] Queen Mary Univ London, Ctr Clin Pharmacol, London EC1M 6BQ, England; [Mustafa, Arif] Queen Mary Univ London, Biol Serv Unit, William Harvey Res Inst, Barts & London Sch Med & Dent, London EC1M 6BQ, England; [Wen, Guanmei] Guangzhou Med Univ, Dept Pathophysiol, Guangzhou 510182, Guangdong, Peoples R China; [Zhang, Cheng] Chongqing Med Univ, Affiliated Hosp 1, Dept Thorac Surg & Cardio Thorac Surg, Chongqing 400016, Peoples R China	University of London; Queen Mary University London; University of London; Queen Mary University London; Guangzhou Medical University; Chongqing Medical University	Xiao, QZ (corresponding author), Queen Mary Univ London, Ctr Clin Pharmacol, London EC1M 6BQ, England.	sy127@le.ac.uk; q.xiao@qmul.ac.uk	Ye, Shu/R-6384-2017; wen, guanmei/E-4969-2013	Ye, Shu/0000-0002-4126-4278; 	National Institute of Health Research; British Heart Foundation [PG/13/45/30326, FS/09/044/28007, PG/11/40/28891, PG/15/11/31279] Funding Source: researchfish	National Institute of Health Research(National Institute for Health Research (NIHR)); British Heart Foundation(British Heart Foundation)	This work forms part of the research themes contributing to the translational research portfolio of Barts and the London Cardiovascular Biomedical Research Unit, which is supported and funded by the National Institute of Health Research.	Annes JP, 2003, J CELL SCI, V116, P217, DOI 10.1242/jcs.00229; Baitsch D, 2011, ARTERIOSCL THROM VAS, V31, P1160, DOI 10.1161/ATVBAHA.111.222745; Balbin M, 2003, NAT GENET, V35, P252, DOI 10.1038/ng1249; Biswas SK, 2010, NAT IMMUNOL, V11, P889, DOI 10.1038/ni.1937; Butcher MJ, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00044; Cox JH, 2008, J BIOL CHEM, V283, P19389, DOI 10.1074/jbc.M800266200; Embree MC, 2010, AM J PATHOL, V176, P812, DOI 10.2353/ajpath.2010.090450; Fang CC, 2013, CARDIOVASC RES, V99, P146, DOI 10.1093/cvr/cvt060; Gharib SA, 2014, J LEUKOCYTE BIOL, V95, P9, DOI 10.1189/jlb.1112587; Gong DP, 2012, BMC IMMUNOL, V13, DOI 10.1186/1471-2172-13-31; Gueders MM, 2005, J IMMUNOL, V175, P2589, DOI 10.4049/jimmunol.175.4.2589; Hayes EM, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00537; Heathfield TF, 2004, J BIOL CHEM, V279, P6286, DOI 10.1074/jbc.M307765200; HILDEBRAND A, 1994, BIOCHEM J, V302, P527, DOI 10.1042/bj3020527; Horiguchi M, 2012, J BIOCHEM, V152, P321, DOI 10.1093/jb/mvs089; Johnson JL, 2009, CURR OPIN LIPIDOL, V20, P370, DOI 10.1097/MOL.0b013e3283309848; Krakowiak MS, 2015, ONCOGENE, V34, P1865, DOI 10.1038/onc.2014.135; Laxton RC, 2009, CIRC RES, V105, P921, DOI 10.1161/CIRCRESAHA.109.200279; Luo ZL, 2013, STEM CELLS, V31, P1749, DOI 10.1002/stem.1448; Ma YG, 2013, CIRC RES, V112, P675, DOI 10.1161/CIRCRESAHA.111.300502; Mantovani A, 2009, ARTERIOSCL THROM VAS, V29, P1419, DOI 10.1161/ATVBAHA.108.180497; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Owen CA, 2004, J IMMUNOL, V172, P7791, DOI 10.4049/jimmunol.172.12.7791; Quintero PA, 2010, J IMMUNOL, V184, P1575, DOI 10.4049/jimmunol.0900290; Ray Avijit, 2010, J Vis Exp, DOI 10.3791/1488; Rifkin DB, 2005, J BIOL CHEM, V280, P7409, DOI 10.1074/jbc.R400029200; Roch T, 2014, CLIN HEMORHEOL MICRO, V58, P147, DOI 10.3233/CH-141885; Shimada K, 2009, CIRC J, V73, P994, DOI 10.1253/circj.CJ-09-0277; Sica A, 2012, J CLIN INVEST, V122, P787, DOI 10.1172/JCI59643; Soo C, 2000, AM J PATHOL, V157, P423, DOI 10.1016/S0002-9440(10)64555-5; Soria-Valles C, 2014, ONCOGENE, V33, P3054, DOI 10.1038/onc.2013.267; Van den Steen PE, 2003, EUR J BIOCHEM, V270, P3739, DOI 10.1046/j.1432-1033.2003.03760.x; Van Lint P, 2005, J IMMUNOL, V175, P7642, DOI 10.4049/jimmunol.175.11.7642; Van Lint P, 2006, CYTOKINE GROWTH F R, V17, P217, DOI 10.1016/j.cytogfr.2006.04.001; Williams HJ, 2012, J INNATE IMMUN, V4, P498, DOI 10.1159/000336618; Wolfs IMJ, 2011, THROMB HAEMOSTASIS, V106, P763, DOI 10.1160/TH11-05-0320; Xiao QZ, 2007, AM J PHYSIOL-CELL PH, V292, pC342, DOI 10.1152/ajpcell.00341.2006; Xiao QZ, 2014, ARTERIOSCL THROM VAS, V34, P90, DOI 10.1161/ATVBAHA.113.301418; Xiao QZ, 2013, CIRC RES, V112, P35, DOI 10.1161/CIRCRESAHA.112.274019; Xiao QZ, 2009, AM J PHYSIOL-CELL PH, V296, pC711, DOI 10.1152/ajpcell.00442.2008; Zheng Z, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0096011, 10.1371/journal.pone.0090817]	41	31	32	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 31	2015	290	31					19158	19172		10.1074/jbc.M114.634022	http://dx.doi.org/10.1074/jbc.M114.634022			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CN9PK	26092731	Green Published, hybrid, Green Submitted			2022-12-26	WOS:000358781100031
J	Chandra, M; Oro, I; Ferreira-Dias, S; Malfeito-Ferreira, M				Chandra, Mahesh; Oro, Ines; Ferreira-Dias, Suzana; Malfeito-Ferreira, Manuel			Effect of Ethanol, Sulfur Dioxide and Glucose on the Growth of Wine Spoilage Yeasts Using Response Surface Methodology	PLOS ONE			English	Article							VOLATILE PHENOL PRODUCTION; DEKKERA-BRUXELLENSIS; ESCHERICHIA-COLI; SURVIVAL; CULTURABILITY; FERMENTATION; TEMPERATURE; ESTUARINE; VIABILITY; STATE	Response surface methodology (RSM) was used to study the effect of three factors, sulfur dioxide, ethanol and glucose, on the growth of wine spoilage yeast species, Zygosaccharomyces bailii, Schizosaccharomyces pombe, Saccharomycodes ludwigii and Saccharomyces cerevisiae. Seventeen central composite rotatable design (CCRD) trials were designed for each test yeast using realistic concentrations of the factors (variables) in premium red wine. Polynomial regression equations were fitted to experimental data points, and the growth inhibitory conditions of these three variables were determined. The overall results showed Sa. ludwigii as the most resistant species growing under high ethanol/free sulfur dioxide concentrations, i.e., 15% (v/v)/20 mg L-1, 14% (v/v)/32 mg L-1 and 12.5% (v/v)/40 mg L-1, whereas other yeasts did not survive under the same levels of ethanol/free sulfur dioxide concentrations. The inhibitory effect of ethanol was primarily observed during longer incubation periods, compared with sulfur dioxide, which showed an immediate effect. In some CCRD trials, Sa. ludwigii and S. cerevisiae showed growth recovery after a short death period under the exposure of 20-32 mg L-1 sulfur dioxide in the presence of 11% (v/v) or more ethanol. However, Sc. pombe and Z. bailii did not show such growth recovery under similar conditions. Up to 10 g L-1 of glucose did not prevent cell death under the sulfur dioxide or ethanol stress. This observation demonstrates that the sugar levels commonly used in wine to sweeten the mouthfeel do not increase wine susceptibility to spoilage yeasts, contrary to the anecdotal evidence.	[Chandra, Mahesh; Oro, Ines; Malfeito-Ferreira, Manuel] Univ Lisbon, Inst Super Agron, Lab Microbiol Linking Landscape Environm Agr & F, P-1349017 Lisbon, Portugal; [Ferreira-Dias, Suzana] Univ Lisbon, Inst Super Agron, Ctr Engn Biossistemas CEER, P-1349017 Lisbon, Portugal	Universidade de Lisboa; Universidade de Lisboa	Chandra, M (corresponding author), Univ Lisbon, Inst Super Agron, Lab Microbiol Linking Landscape Environm Agr & F, P-1349017 Lisbon, Portugal.	mchandra@isa.ulisboa.pt	Malfeito-Ferreira, Manuel/B-3215-2019; Malfeito-Ferreira, Manuel/J-4915-2019; Ferreira-Dias, Suzana/F-2388-2010; Chandra, Mahesh/T-2473-2018	Malfeito-Ferreira, Manuel/0000-0002-7985-963X; Malfeito-Ferreira, Manuel/0000-0002-7985-963X; Ferreira-Dias, Suzana/0000-0003-3655-8201; Chandra, Mahesh/0000-0003-2725-2948	Fundacao para a Ciencia e a Tecnologia, Portugal [PTDC/AGR-ALI/113565/2009, SFRH/BPD/70888/2010]	Fundacao para a Ciencia e a Tecnologia, Portugal(Portuguese Foundation for Science and Technology)	The work was supported by the following: to author MMF, grant PTDC/AGR-ALI/113565/2009, from Fundacao para a Ciencia e a Tecnologia, Portugal, www.fct.pt; and to author MC, grant SFRH/BPD/70888/2010, from Fundacao para a Ciencia e a Tecnologia, Portugal, www.fct.pt. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnolucci M, 2010, INT J FOOD MICROBIOL, V143, P76, DOI 10.1016/j.ijfoodmicro.2010.07.022; Barata A, 2008, INT J FOOD MICROBIOL, V121, P201, DOI 10.1016/j.ijfoodmicro.2007.11.020; Butzke C, 2010, WOODHEAD PUBL FOOD S, P15; Chandra M, 2014, FOOD MICROBIOL, V42, P40, DOI 10.1016/j.fm.2014.03.002; Chatonnet P., 1993, Journal International des Sciences de la Vigne et du Vin, V27, P277; Costa A, 2008, FOOD MICROBIOL, V25, P422, DOI 10.1016/j.fm.2007.10.003; Coulter A, 2004, DEKKERA BRETTANOMYCE; D'Amato D, 2006, INT J FOOD SCI TECH, V41, P1152, DOI 10.1111/j.1365-2621.2005.01128.x; Deaak T, 2007, HDB FOOD SPOILAGE YE, P369; Divol B, 2005, FOOD MICROBIOL, V22, P169, DOI 10.1016/j.fm.2004.07.003; Divol B, 2005, J APPL MICROBIOL, V99, P85, DOI 10.1111/j.1365-2672.2005.02578.x; du Toit WJ, 2005, J APPL MICROBIOL, V98, P862, DOI 10.1111/j.1365-2672.2004.02549.x; Duckitt E., 2012, INVESTIGATING IMPACT; Fugelsang K. C., 1997, WINE MICROBIOLOGY; Kunkee R. E., 1993, The yeasts. Volume 5: yeast technology., P69; Lonvaud, 2006, HDB ENOLOGY, V1, P193; Lopez FNA, 2006, INT J FOOD MICROBIOL, V106, P45, DOI [10.1016/j.ijfoodinicro.2005.06.010, 10.1016/j.ijfoodmicro.2005.06.010]; Loureiro V, 2003, INT J FOOD MICROBIOL, V86, P23, DOI 10.1016/S0168-1605(03)00246-0; Loureiro V, 2006, WOODHEAD PUBL FOOD S, P354, DOI 10.1533/9781845691417.3.354; Malfeito-Ferreira M, 2011, ANN MICROBIOL, V61, P95, DOI 10.1007/s13213-010-0098-0; McMeekin TA, 1993, PREDICTIVE MICROBIOL; Mills DA, 2002, APPL ENVIRON MICROB, V68, P4884, DOI 10.1128/AEM.68.10.4884-4893.2002; OIV, 2006, REC INT METH AN VINS; OLIVER JD, 1995, APPL ENVIRON MICROB, V61, P2624, DOI 10.1128/AEM.61.7.2624-2630.1995; ROLLINS DM, 1986, APPL ENVIRON MICROB, V52, P531, DOI 10.1128/AEM.52.3.531-538.1986; ROTH WG, 1988, APPL ENVIRON MICROB, V54, P3142, DOI 10.1128/AEM.54.12.3142-3146.1988; Serpaggi V, 2012, FOOD MICROBIOL, V30, P438, DOI 10.1016/j.fm.2011.12.020; Sturm ME, 2014, INT J FOOD MICROBIOL, V170, P83, DOI 10.1016/j.ijfoodmicro.2013.10.019; Thomas D. S., 1993, The yeasts. Volume 5: yeast technology., P517; Umiker NL, 2013, J FOOD PROCESS PRES, V37, P799, DOI 10.1111/j.1745-4549.2012.00702.x; Weisberg S., 1985, APPL LINEAR REGRESSI; XU HS, 1982, MICROBIAL ECOL, V8, P313, DOI 10.1007/BF02010671; Yamamoto H, 2000, J Infect Chemother, V6, P112, DOI 10.1007/PL00012149; Zoecklein BW, 1999, J IND MICROBIOL BIOT, V22, P100, DOI 10.1038/sj.jim.2900613	34	17	17	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2015	10	6							e0128702	10.1371/journal.pone.0128702	http://dx.doi.org/10.1371/journal.pone.0128702			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4OM	26107389	Green Published, gold			2022-12-26	WOS:000356932500025
J	de Weerd, N; van Langevelde, F; van Oeveren, H; Nolet, BA; Kolzsch, A; Prins, HHT; de Boer, WF				de Weerd, Nelleke; van Langevelde, Frank; van Oeveren, Herman; Nolet, Bart A.; Kolzsch, Andrea; Prins, Herbert H. T.; de Boer, W. Fred			Deriving Animal Behaviour from High-Frequency GPS: Tracking Cows in Open and Forested Habitat	PLOS ONE			English	Article							COLLAR PERFORMANCE; LARGE HERBIVORES; MOVEMENT; TECHNOLOGY; SELECTION; POSITION; ECOLOGY; MODELS; SYSTEM; STATES	The increasing spatiotemporal accuracy of Global Navigation Satellite Systems (GNSS) tracking systems opens the possibility to infer animal behaviour from tracking data. We studied the relationship between high-frequency GNSS data and behaviour, aimed at developing an easily interpretable classification method to infer behaviour from location data. Behavioural observations were carried out during tracking of cows (Bos Taurus) fitted with high-frequency GPS (Global Positioning System) receivers. Data were obtained in an open field and forested area, and movement metrics were calculated for 1 min, 12 s and 2 s intervals. We observed four behaviour types (Foraging, Lying, Standing and Walking). We subsequently used Classification and Regression Trees to classify the simultaneously obtained GPS data as these behaviour types, based on distances and turning angles between fixes. GPS data with a 1 min interval from the open field was classified correctly for more than 70% of the samples. Data from the 12 s and 2 s interval could not be classified successfully, emphasizing that the interval should be long enough for the behaviour to be defined by its characteristic movement metrics. Data obtained in the forested area were classified with a lower accuracy (57%) than the data from the open field, due to a larger positional error of GPS locations and differences in behavioural performance influenced by the habitat type. This demonstrates the importance of understanding the relationship between behaviour and movement metrics, derived from GNSS fixes at different frequencies and in different habitats, in order to successfully infer behaviour. When spatially accurate location data can be obtained, behaviour can be inferred from high-frequency GNSS fixes by calculating simple movement metrics and using easily interpretable decision trees. This allows for the combined study of animal behaviour and habitat use based on location data, and might make it possible to detect deviations in behaviour at the individual level.	[de Weerd, Nelleke; van Langevelde, Frank; van Oeveren, Herman; Prins, Herbert H. T.; de Boer, W. Fred] Wageningen Univ, Resource Ecol Grp, NL-6700 AP Wageningen, Netherlands; [Nolet, Bart A.; Kolzsch, Andrea] Netherlands Inst Ecol NIOO KNAW, Dept Anim Ecol, Wageningen, Netherlands; [Nolet, Bart A.; Kolzsch, Andrea] Netherlands Inst Ecol NIOO KNAW, Project Grp Movement Ecol, Wageningen, Netherlands	Wageningen University & Research; Royal Netherlands Academy of Arts & Sciences; Netherlands Institute of Ecology (NIOO-KNAW); Royal Netherlands Academy of Arts & Sciences; Netherlands Institute of Ecology (NIOO-KNAW)	de Boer, WF (corresponding author), Wageningen Univ, Resource Ecol Grp, NL-6700 AP Wageningen, Netherlands.	fred.deboer@wur.nl	Nolet, Bart A/C-1416-2008; KNAW, NIOO-KNAW/A-4320-2012	Nolet, Bart A/0000-0002-7437-4879; Van Langevelde, Frank/0000-0001-8870-0797; Prins, Herbert/0000-0003-1131-5107; KNAW, NIOO-KNAW/0000-0002-3835-159X	Galileo FP7 R D program [277679-2]	Galileo FP7 R D program	The project was carried out within the framework of the E-track project, which was supported by a grant from the Galileo FP7 R& D program supervised by the GSA (nr. 277679-2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams AL, 2014, BIOL INVASIONS, V16, P1791, DOI 10.1007/s10530-013-0627-4; Adams AL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068496; Asher GW, 2014, APPL ANIM BEHAV SCI, V154, P93, DOI 10.1016/j.applanim.2014.02.010; Basso D, 2008, COMPSTAT 2008: PROCEEDINGS IN COMPUTATIONAL STATISTICS, P411, DOI 10.1007/978-3-7908-2084-3_34; Bidder OR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088609; Bouten W, 2013, J ORNITHOL, V154, P571, DOI 10.1007/s10336-012-0908-1; Bramer M, 2005, INT J SYST SCI, V36, P909, DOI 10.1080/00207720500382027; Calenge C, 2006, ECOL MODEL, V197, P516, DOI 10.1016/j.ecolmodel.2006.03.017; Cumming GS, 2012, J BIOGEOGR, V39, P1401, DOI 10.1111/j.1365-2699.2012.02711.x; DeCesare NJ, 2005, WILDLIFE SOC B, V33, P935, DOI 10.2193/0091-7648(2005)33[935:EOFCOG]2.0.CO;2; du Toit JT, 2005, OECOLOGIA, V143, P317, DOI 10.1007/s00442-004-1789-7; FENG C., 1994, MACHINE LEARNING NEU, P50; Frair JL, 2010, PHILOS T R SOC B, V365, P2187, DOI 10.1098/rstb.2010.0084; Freeman R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009236; Fryxell JM, 2008, P NATL ACAD SCI USA, V105, P19114, DOI 10.1073/pnas.0801737105; Guo Y, 2009, ECOL MODEL, V220, P2068, DOI 10.1016/j.ecolmodel.2009.04.047; Hebblewhite M, 2010, PHILOS T R SOC B, V365, P2303, DOI 10.1098/rstb.2010.0087; Hulbert I. A. R., 2001, TRACKING ANIMALS GPS, P69; Hurford A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005632; Jiang Z, 2008, ECOL RES, V23, P581, DOI 10.1007/s11284-007-0412-x; Langley R.B, 1997, GPS WORLD, V8, P51; Lewis RJ, 2000, INTRO CLASSIFICATION; Martin J, 2013, J ANIM ECOL, V82, P290, DOI 10.1111/j.1365-2656.2012.02038.x; Mitlohner FM, 2001, J ANIM SCI, V79, P1189; Nams VO, 2014, ECOL LETT, V17, P1228, DOI 10.1111/ele.12328; Nathan R, 2012, J EXP BIOL, V215, P986, DOI 10.1242/jeb.058602; Owen-Smith N, 2010, PHILOS T R SOC B, V365, P2267, DOI 10.1098/rstb.2010.0095; Owen-Smith N, 2012, WILDLIFE RES, V39, P452, DOI 10.1071/WR12062; Patterson TA, 2008, TRENDS ECOL EVOL, V23, P87, DOI 10.1016/j.tree.2007.10.009; Ponchon A, 2013, METHODS ECOL EVOL, V4, P143, DOI 10.1111/j.2041-210x.2012.00259.x; Recio MR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028225; Rokach L, 2008, DATAMINING DECISION; Sand H, 2005, WILDLIFE SOC B, V33, P914, DOI 10.2193/0091-7648(2005)33[914:UGTAGC]2.0.CO;2; Shamoun-Baranes J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037997; Spink A., 2013, P 6 EUR C PREC LIV F, P229; Stache Anja, 2012, Silva Gabreta, V18, P35; Thiebault A, 2013, BEHAV ECOL SOCIOBIOL, V67, P1013, DOI 10.1007/s00265-013-1546-1; Trotter MG, 2010, ANIM PROD SCI, V50, P616, DOI 10.1071/AN09203; Turchin Peter, 1998; Turner LW, 2000, CAN J ANIM SCI, V80, P405, DOI 10.4141/A99-093; Ungar ED, 2005, RANGELAND ECOL MANAG, V58, P256, DOI 10.2111/1551-5028(2005)58[256:IOAAFG]2.0.CO;2; van Beest FM, 2013, J MAMMAL, V94, P691, DOI 10.1644/12-MAMM-A-080.1; Van Moorter B, 2010, J WILDLIFE MANAGE, V74, P588, DOI 10.2193/2009-155; Wheeler RE, 2010, PERMUTATION TESTS FO; Williams DM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048439; Witte TH, 2005, J BIOMECH, V38, P1717, DOI 10.1016/j.jbiomech.2004.07.028; Yamazaki Koji, 2008, Mammal Study, V33, P131, DOI 10.3106/1348-6160-33.4.131; Zolman J., 1993, BIOSTATISTICS EXPT D	48	34	34	1	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2015	10	6							e0129030	10.1371/journal.pone.0129030	http://dx.doi.org/10.1371/journal.pone.0129030			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4OM	26107643	Green Published, Green Submitted, gold			2022-12-26	WOS:000356932500038
J	Lee, EH; Lee, K; Kwak, GH; Park, YS; Lee, KJ; Hwang, KY; Kim, HY				Lee, Eun Hye; Lee, Kitaik; Kwak, Geun-Hee; Park, Yeon Seung; Lee, Kong-Joo; Hwang, Kwang Yeon; Kim, Hwa-Young			Evidence for the Dimerization-Mediated Catalysis of Methionine Sulfoxide Reductase A from Clostridium oremlandii	PLOS ONE			English	Article							STRUCTURAL-ANALYSIS; MECHANISM; PROTEIN	Clostridium oremlandii MsrA (CoMsrA) is a natively selenocysteine-containing methionine-S- sulfoxide reductase and classified into a 1-Cys type MsrA. CoMsrA exists as a monomer in solution. Herein, we report evidence that CoMsrA can undergo homodimerization during catalysis. The monomeric CoMsrA dimerizes in the presence of its substrate methionine sulfoxide via an intermolecular disulfide bond between catalytic Cys16 residues. The dimeric CoMsrA is resolved by the reductant glutaredoxin, suggesting the relevance of dimerization in catalysis. The dimerization reaction occurs in a concentration-and time-dependent manner. In addition, the occurrence of homodimer formation in the native selenoprotein CoMsrA is confirmed. We also determine the crystal structure of the dimeric CoMsrA, having the dimer interface around the two catalytic Cys16 residues. A central cone-shaped hole is present in the surface model of dimeric structure, and the two Cys16 residues constitute the base of the hole. Collectively, our biochemical and structural analyses suggest a novel dimerization-mediated mechanism for CoMsrA catalysis that is additionally involved in CoMsrA regeneration by glutaredoxin.	[Lee, Eun Hye; Lee, Kitaik; Hwang, Kwang Yeon] Korea Univ, Div Biotechnol, Coll Life Sci & Biotechnol, Seoul 136701, South Korea; [Kwak, Geun-Hee; Kim, Hwa-Young] Yeungnam Univ, Coll Med, Dept Biochem & Mol Biol, Daegu 705717, South Korea; [Park, Yeon Seung; Lee, Kong-Joo] Ewha Womans Univ, Grad Sch Pharmaceut Sci, Coll Pharm, Seoul 120750, South Korea	Korea University; Yeungnam University; Ewha Womans University	Hwang, KY (corresponding author), Korea Univ, Div Biotechnol, Coll Life Sci & Biotechnol, Seoul 136701, South Korea.	chahong@korea.ac.kr; hykim@ynu.ac.kr		Lee, Kong-Joo/0000-0001-7972-6020; Lee, Kitaik/0000-0002-7761-5586	Yeungnam University	Yeungnam University	This work was supported by the 2014 Yeungnam University Research Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Boschi-Muller S, 2000, J BIOL CHEM, V275, P35908, DOI 10.1074/jbc.M006137200; Boschi-Muller S, 2008, ARCH BIOCHEM BIOPHYS, V474, P266, DOI 10.1016/j.abb.2008.02.007; Choi S, 2010, J PROTEOME RES, V9, P626, DOI 10.1021/pr900771r; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Jeong JH, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.000513; Kim HY, 2007, BIOCHEM J, V407, P321, DOI 10.1042/BJ20070929; Kim HY, 2012, ACTA BIOCH BIOPH SIN, V44, P623, DOI 10.1093/abbs/gms038; Kim HY, 2009, PROTEINS, V74, P1008, DOI 10.1002/prot.22212; Kim MJ, 2015, BIOCHEM BIOPH RES CO, V457, P567, DOI 10.1016/j.bbrc.2015.01.025; Kim MJ, 2011, MOL MICROBIOL, V79, P1194, DOI 10.1111/j.1365-2958.2010.07500.x; Kim YK, 2009, MOL MICROBIOL, V72, P699, DOI 10.1111/j.1365-2958.2009.06680.x; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lee EH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117836; Lee EH, 2014, ARCH BIOCHEM BIOPHYS, V545, P1, DOI 10.1016/j.abb.2013.12.024; Lim JC, 2012, J BIOL CHEM, V287, P25589, DOI 10.1074/jbc.M112.368936; Lowther WT, 2000, BIOCHEMISTRY-US, V39, P13307, DOI 10.1021/bi0020269; Lowther WT, 2000, P NATL ACAD SCI USA, V97, P6463, DOI 10.1073/pnas.97.12.6463; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Ranaivoson FM, 2008, J MOL BIOL, V377, P268, DOI 10.1016/j.jmb.2008.01.021; Roberts BR, 2005, PROTEIN SCI, V14, P2414, DOI 10.1110/ps.051459705; Seo J, 2008, J PROTEOME RES, V7, P587, DOI 10.1021/pr700657y; Tarrago L, 2009, MOL PLANT, V2, P202, DOI 10.1093/mp/ssn067; Taylor AB, 2003, J BACTERIOL, V185, P4119, DOI 10.1128/JB.185.14.4119-4126.2003; Tete-Favier F, 2000, STRUCTURE, V8, P1167, DOI 10.1016/S0969-2126(00)00526-8; Weik M, 2000, P NATL ACAD SCI USA, V97, P623, DOI 10.1073/pnas.97.2.623	26	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2015	10	6							e0131523	10.1371/journal.pone.0131523	http://dx.doi.org/10.1371/journal.pone.0131523			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4OM	26107511	Green Submitted, Green Published, gold			2022-12-26	WOS:000356932500166
J	Murovets, VO; Bachmanov, AA; Zolotarev, VA				Murovets, Vladimir O.; Bachmanov, Alexander A.; Zolotarev, Vasiliy A.			Impaired Glucose Metabolism in Mice Lacking the Tas1r3 Taste Receptor Gene	PLOS ONE			English	Article							BETA-CELL FUNCTION; UMAMI TASTE; INSULIN-SECRETION; EXCITED NEURONS; MAMMALIAN SWEET; MOUSE; GUT; T1R3; HOMEOSTASIS; EXPRESSION	The G-protein-coupled sweet taste receptor dimer T1R2/T1R3 is expressed in taste bud cells in the oral cavity. In recent years, its involvement in membrane glucose sensing was discovered in endocrine cells regulating glucose homeostasis. We investigated importance of extraorally expressed T1R3 taste receptor protein in age-dependent control of blood glucose homeostasis in vivo, using nonfastedmice with a targeted mutation of the Tas1r3 gene that encodes the T1R3 protein. Glucose and insulin tolerance tests, as well as behavioral tests measuring taste responses to sucrose solutions, were performed with C57BL/6ByJ (Tas1r3 +/+) inbred mice bearing the wild-type allele and C57BL/6J-Tas1r3(tm1Rfm) mice lacking the entire Tas1r3 coding region and devoid of the T1R3 protein (Tas1r3-/-). Compared with Tas1r3+/+ mice, Tas1r3-/- mice lacked attraction to sucrose in brief-access licking tests, had diminished taste preferences for sucrose solutions in the two-bottle tests, and had reduced insulin sensitivity and tolerance to glucose administered intraperitoneally or intragastrically, which suggests that these effects are due to absence of T1R3. Impairment of glucose clearance in Tas1r3-/- mice was exacerbated with age after intraperitoneal but not intragastric administration of glucose, pointing to a compensatory role of extraoral T1R3-dependent mechanisms in offsetting age-dependent decline in regulation of glucose homeostasis. Incretin effects were similar in Tas1r3+/+ and Tas1r3-/-mice, which suggests that control of blood glucose clearance is associated with effects of extraoral T1R3 in tissues other than the gastrointestinal tract. Collectively, the obtained data demonstrate that the T1R3 receptor protein plays an important role in control of glucose homeostasis not only by regulating sugar intake but also via its extraoral function, probably in the pancreas and brain.	[Murovets, Vladimir O.; Zolotarev, Vasiliy A.] IP Pavlov Physiol Inst, Dept Physiol Digest, St Petersburg 199034, Russia; [Bachmanov, Alexander A.] Monell Chem Senses Ctr, Philadelphia, PA 19104 USA	Russian Academy of Sciences; St. Petersburg Scientific Centre of the Russian Academy of Sciences; Pavlov Institute of Physiology Russian Academy of Sciences; Monell Chemical Senses Center	Zolotarev, VA (corresponding author), IP Pavlov Physiol Inst, Dept Physiol Digest, St Petersburg 199034, Russia.	vasiliy_zolotarev@hotmail.com	Murovets, Vladimir/AAA-7637-2021; Zolotarev, Vasiliy/AAA-7665-2021	Murovets, Vladimir/0000-0001-5741-1562; Zolotarev, Vasiliy/0000-0001-8784-2435; Bachmanov, Alexander/0000-0002-2861-3322	National Institutes of Health (NIH) [R03DC013526, R01DC00882]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R03DC013526, R01DC000882] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by the National Institutes of Health (NIH) (http://www.nih.gov/) grant# R03DC013526 to AAB and VAZ and National Institutes of Health (NIH) (http://www.nih.gov/) grant# R01DC00882 to AAB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrikopoulos S, 2008, AM J PHYSIOL-ENDOC M, V295, pE1323, DOI 10.1152/ajpendo.90617.2008; Ayala JE, 2006, DIABETES, V55, P390, DOI 10.2337/diabetes.55.02.06.db05-0686; Ayala JE, 2010, DIS MODEL MECH, V3, P525, DOI 10.1242/dmm.006239; Bachmanov AA, 2002, BEHAV GENET, V32, P435, DOI 10.1023/A:1020884312053; Bachmanov AA, 2001, CHEM SENSES, V26, P925, DOI 10.1093/chemse/26.7.925; Bezencon C, 2007, CHEM SENSES, V32, P41, DOI 10.1093/chemse/bjl034; BORG WP, 1995, DIABETES, V44, P180, DOI 10.2337/diabetes.44.2.180; Burdakov D, 2005, PHILOS T R SOC B, V360, P2227, DOI 10.1098/rstb.2005.1763; Buse MG, 2006, AM J PHYSIOL-ENDOC M, V290, pE1, DOI 10.1152/ajpendo.00329.2005; Chang AM, 2006, J CLIN ENDOCR METAB, V91, P3303, DOI 10.1210/jc.2006-0913; Chen QY, 2009, AM J CLIN NUTR, V90, p770S, DOI 10.3945/ajcn.2009.27462N; Damak S, 2003, SCIENCE, V301, P850, DOI 10.1126/science.1087155; Drucker DJ, 2013, DIABETES, V62, P3316, DOI 10.2337/db13-0822; Elahi D, 2000, EUR J CLIN NUTR, V54, pS112, DOI 10.1038/sj.ejcn.1601032; ELRICK H, 1964, J CLIN ENDOCR METAB, V24, P1076, DOI 10.1210/jcem-24-10-1076; Eny KM, 2010, AM J CLIN NUTR, V92, P1501, DOI 10.3945/ajcn.2010.29836; Fioramonti X, 2004, DIABETES, V53, P2767, DOI 10.2337/diabetes.53.11.2767; Fujita Y, 2009, AM J PHYSIOL-ENDOC M, V296, pE473, DOI 10.1152/ajpendo.90636.2008; Fushan AA, 2009, CURR BIOL, V19, P1288, DOI 10.1016/j.cub.2009.06.015; GEMBAL M, 1992, J CLIN INVEST, V89, P1288, DOI 10.1172/JCI115714; Geraedts MCP, 2012, AM J PHYSIOL-ENDOC M, V303, pE464, DOI 10.1152/ajpendo.00163.2012; Glendinning JI, 2002, CHEM SENSES, V27, P461, DOI 10.1093/chemse/27.5.461; Gribble FM, 2003, DIABETES, V52, P1147, DOI 10.2337/diabetes.52.5.1147; Heijboer AC, 2005, J LIPID RES, V46, P582, DOI 10.1194/jlr.M400440-JLR200; Hofer D, 1996, P NATL ACAD SCI USA, V93, P6631, DOI 10.1073/pnas.93.13.6631; Jang HJ, 2007, P NATL ACAD SCI USA, V104, P15069, DOI 10.1073/pnas.0706890104; Kim UK, 2006, CHEM SENSES, V31, P599, DOI 10.1093/chemse/bjj065; Kojima I, 2011, DIABETES METAB J, V35, P451, DOI 10.4093/dmj.2011.35.5.451; Kokrashvili Z, 2009, AM J CLIN NUTR, V90, p822S, DOI 10.3945/ajcn.2009.27462T; Kyriazis GA, 2012, P NATL ACAD SCI USA, V109, pE524, DOI 10.1073/pnas.1115183109; Lam TKT, 2005, SCIENCE, V309, P943, DOI 10.1126/science.1112085; Maedler K, 2006, DIABETES, V55, P2455, DOI 10.2337/db05-1586; Margolskee RF, 2007, P NATL ACAD SCI USA, V104, P15075, DOI 10.1073/pnas.0706678104; McGuinness OP, 2009, AM J PHYSIOL-ENDOC M, V297, pE849, DOI 10.1152/ajpendo.90996.2008; MCINTYRE N, 1964, LANCET, V2, P20, DOI 10.1016/s0140-6736(64)90011-x; Mountjoy PD, 2007, EXP PHYSIOL, V92, P311, DOI 10.1113/expphysiol.2006.036004; Murovets VO, 2014, J EVOL BIOCHEM PHYS+, V50, P334, DOI 10.1134/S0022093014040061; Nakagawa Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005106; Nelson G, 2001, CELL, V106, P381, DOI 10.1016/S0092-8674(01)00451-2; Nonogaki K, 2000, DIABETOLOGIA, V43, P533, DOI 10.1007/s001250051341; Ohkuri T, 2009, AM J PHYSIOL-REG I, V296, pR960, DOI 10.1152/ajpregu.91018.2008; OLEFSKY JM, 1975, ENDOCRINOLOGY, V96, P1486, DOI 10.1210/endo-96-6-1486; Oya M, 2011, GENES CELLS, V16, P608, DOI 10.1111/j.1365-2443.2011.01509.x; Preitner F, 2004, J CLIN INVEST, V113, P635, DOI 10.1172/JCI200420518; Raliou M, 2009, NEUROSCI LETT, V451, P217, DOI 10.1016/j.neulet.2008.12.060; Reimann F, 2002, DIABETES, V51, P2757, DOI 10.2337/diabetes.51.9.2757; Reimann F, 2008, CELL METAB, V8, P532, DOI 10.1016/j.cmet.2008.11.002; Ren XY, 2009, FRONT INTEGR NEUROSC, V3, DOI 10.3389/neuro.07.012.2009; Ritter S, 2001, J COMP NEUROL, V432, P197, DOI 10.1002/cne.1097; Rozengurt N, 2006, AM J PHYSIOL-GASTR L, V291, pG792, DOI 10.1152/ajpgi.00074.2006; Sclafani A, 2010, AM J PHYSIOL-REG I, V299, pR1643, DOI 10.1152/ajpregu.00495.2010; Shigemura N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006717; Shih S, 2009, TAIWAN GERIATRICS GE, V4, P27; SILVER IA, 1994, J NEUROSCI, V14, P5068; Simon BR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086454; SOLL AH, 1974, J BIOL CHEM, V249, P4127; Song Z, 2005, DIABETES, V54, P15, DOI 10.2337/diabetes.54.1.15; Steinert RE, 2011, CLIN NUTR, V30, P524, DOI 10.1016/j.clnu.2011.01.007; Straub SG, 2002, DIABETES-METAB RES, V18, P451, DOI 10.1002/dmrr.329; Sutherland K, 2007, AM J PHYSIOL-GASTR L, V292, pG1420, DOI 10.1152/ajpgi.00504.2006; Szoke E, 2008, DIABETES CARE, V31, P539, DOI 10.2337/dc07-1443; Taniguchi K, 2004, J VET MED SCI, V66, P1311, DOI 10.1292/jvms.66.1311; Wang R, 2004, DIABETES, V53, P1959, DOI 10.2337/diabetes.53.8.1959; Wu SV, 2002, P NATL ACAD SCI USA, V99, P2392, DOI 10.1073/pnas.042617699; Yee KK, 2011, P NATL ACAD SCI USA, V108, P5431, DOI 10.1073/pnas.1100495108; Yi CX, 2009, DIABETES, V58, P1998, DOI 10.2337/db09-0385; Zhao GQ, 2003, CELL, V115, P255, DOI 10.1016/S0092-8674(03)00844-4	67	24	26	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2015	10	6							e0130997	10.1371/journal.pone.0130997	http://dx.doi.org/10.1371/journal.pone.0130997			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4OM	26107521	Green Submitted, Green Published, gold			2022-12-26	WOS:000356932500136
J	van Herwijnen, MJC; van der Zee, R; van Eden, W; Broere, F				van Herwijnen, Martijn J. C.; van der Zee, Ruurd; van Eden, Willem; Broere, Femke			In Vivo Induction of Functionally Suppressive Induced Regulatory T Cells from CD4(+) CD25(-) T Cells Using an Hsp70 Peptide	PLOS ONE			English	Article							HEAT-SHOCK PROTEINS; AUTOIMMUNE ARTHRITIS; RHEUMATOID-ARTHRITIS; MONOCLONAL-ANTIBODY; ADJUVANT ARTHRITIS; EPITHELIAL-CELLS; TREG CELLS; ANTIGEN; ACTIVATION; RAPAMYCIN	Therapeutic peptides that target antigen-specific regulatory T cells (Tregs) can suppress experimental autoimmune diseases. The heat shock protein (Hsp) 70, with its expression elevated in inflamed tissue, is a suitable candidate antigen because administration of both bacterial and mouse Hsp70 peptides has been shown to induce strong immune responses and to reduce inflammation via the activation or induction of Hsp specific Tregs. Although two subsets of Tregs exist, little is known about which subset of Tregs are activated by Hsp70 epitopes. Therefore, we set out to determine whether natural nTregs (derived from the thymus), or induced iTregs (formed in the periphery from CD4(+)CD25(-) naive T cells) were targeted after Hsp70-peptide immunization. We immunized mice with the previously identified Hsp70 T cell epitope B29 and investigated the formation of functional iTregs by using an in vitro suppression assay and adoptive transfer therapy in mice with experimental arthritis. To study the in vivo induction of Tregs after peptide immunization, we depleted CD25(+) cells prior to immunization, allowing the in vivo formation of Tregs from CD4(+) CD25(-) precursors. This approach allowed us to study in vivo B29-induced Tregs and to compare these cells with Tregs from non-depleted immunized mice. Our results show that using this approach, immunization induced CD4(+)CD25(+) T cells in the periphery, and that these cells were suppressive in vitro. Additionally, adoptive transfer of B29-specific iTregs suppressed disease in a mouse model of arthritis. This study shows that immunization of mice with Hsp70 epitope B29 induces functionally suppressive iTregs from CD4(+) CD25(-) T cells.	[van Herwijnen, Martijn J. C.; van der Zee, Ruurd; van Eden, Willem; Broere, Femke] Univ Utrecht, Dept Infect Dis & Immunol, Utrecht, Netherlands	Utrecht University	Broere, F (corresponding author), Univ Utrecht, Dept Infect Dis & Immunol, Utrecht, Netherlands.	f.broere@uu.nl	van der Zee, Ruurd/O-5256-2015; van Herwijnen, Martijn/AAG-8231-2020	van der Zee, Ruurd/0000-0002-4331-2755; van Herwijnen, Martijn/0000-0002-3158-1026; van Eden, Willem/0000-0003-1272-704X	Innovation Oriented Programme in Genomics Project [IGE3018, IGE07004]; European Union [TOLERAGE: HEALTH-F4-2008-202156]; Dutch Arthritis Association; ReumaFonds [13-3-303] Funding Source: researchfish	Innovation Oriented Programme in Genomics Project; European Union(European Commission); Dutch Arthritis Association; ReumaFonds	This work was supported by Innovation Oriented Programme in Genomics Project Grants IGE3018 and IGE07004, European Union Grant Seventh Framework Programme TOLERAGE: HEALTH-F4-2008-202156, and the Dutch Arthritis Association.	Akimova T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024226; Battaglia M, 2006, J IMMUNOL, V177, P8338, DOI 10.4049/jimmunol.177.12.8338; Bilate AM, 2012, ANNU REV IMMUNOL, V30, P733, DOI 10.1146/annurev-immunol-020711-075043; Bluestone JA, 2004, P NATL ACAD SCI USA, V101, P14622, DOI 10.1073/pnas.0405234101; BOOG CJP, 1992, J EXP MED, V175, P1805, DOI 10.1084/jem.175.6.1805; Davidson TS, 2007, J IMMUNOL, V178, P4022, DOI 10.4049/jimmunol.178.7.4022; de Lafaille MAC, 2009, IMMUNITY, V30, P626, DOI 10.1016/j.immuni.2009.05.002; Dengjel J, 2005, P NATL ACAD SCI USA, V102, P7922, DOI 10.1073/pnas.0501190102; Halder T, 1997, CANCER RES, V57, P3238; Hanyecz A, 2004, ARTHRITIS RHEUM-US, V50, P1665, DOI 10.1002/art.20180; Haribhai D, 2011, IMMUNITY, V35, P109, DOI 10.1016/j.immuni.2011.03.029; Herold KC, 2002, NEW ENGL J MED, V346, P1692, DOI 10.1056/NEJMoa012864; Hsieh CS, 2006, NAT IMMUNOL, V7, P401, DOI 10.1038/ni1318; Keijzer C, 2012, EXPERT OPIN THER TAR, V16, P849, DOI 10.1517/14728222.2012.706605; Kong N, 2012, ARTHRITIS RHEUM-US, V64, P2548, DOI 10.1002/art.34513; Lal G, 2009, BLOOD, V114, P3727, DOI 10.1182/blood-2009-05-219584; Long SA, 2009, EUR J IMMUNOL, V39, P612, DOI 10.1002/eji.200838819; McGuirk P, 2002, J EXP MED, V195, P221, DOI 10.1084/jem.20011288; Miller SD, 2007, NAT REV IMMUNOL, V7, P665, DOI 10.1038/nri2153; Miyara M, 2011, AUTOIMMUN REV, V10, P744, DOI 10.1016/j.autrev.2011.05.004; Muntasell A, 2004, J IMMUNOL, V173, P1085, DOI 10.4049/jimmunol.173.2.1085; Tenorio EP, 2011, FEMS IMMUNOL MED MIC, V62, P362, DOI 10.1111/j.1574-695X.2011.00805.x; Prakken BJ, 2004, P NATL ACAD SCI USA, V101, P4228, DOI 10.1073/pnas.0400061101; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Raz I, 2001, LANCET, V358, P1749, DOI 10.1016/S0140-6736(01)06801-5; SAKAGUCHI S, 1995, J IMMUNOL, V155, P1151; Sanjeevi CB, 2002, ANN NY ACAD SCI, V958, P317; Satpute SR, 2008, SEMIN ARTHRITIS RHEU, V38, P195, DOI 10.1016/j.semarthrit.2007.10.002; Schett G, 1998, J CLIN INVEST, V102, P302, DOI 10.1172/JCI2465; Schett G, 2001, ARTHRITIS RES, V3, P80, DOI 10.1186/ar144; Setiady YY, 2010, EUR J IMMUNOL, V40, P780, DOI 10.1002/eji.200939613; Shin HJ, 2011, BLOOD, V118, P2342, DOI 10.1182/blood-2010-10-313684; SHINNICK TM, 1991, CURR TOP MICROBIOL, V167, P145; Strauss L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005994; Tanaka S, 1999, J IMMUNOL, V163, P5560; Tao Y, 2006, AM J PHYSIOL-CELL PH, V290, pC1018, DOI 10.1152/ajpcell.00131.2005; Toker A, 2013, J IMMUNOL, V190, P3180, DOI 10.4049/jimmunol.1203473; Toker A, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001783; van Eden W, 2005, NAT REV IMMUNOL, V5, P318, DOI 10.1038/nri1593; van Herwijnen MJC, 2012, P NATL ACAD SCI USA, V109, P14134, DOI 10.1073/pnas.1206803109; VANEDEN W, 1988, NATURE, V331, P171, DOI 10.1038/331171a0; Wieten L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004186; Wright GP, 2009, P NATL ACAD SCI USA, V106, P19078, DOI 10.1073/pnas.0907396106	43	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2015	10	6							e0128373	10.1371/journal.pone.0128373	http://dx.doi.org/10.1371/journal.pone.0128373			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4OM	26107957	Green Submitted, Green Published, gold			2022-12-26	WOS:000356932500021
J	Martins, CD; Roque, FD; Santos, BA; Ferreira, VL; Strussmann, C; Tomas, WM				Martins, Clarissa de Araujo; Roque, Fabio de Oliveira; Santos, Braulio A.; Ferreira, Vanda Lucia; Struessmann, Christine; Tomas, Walfrido Moraes			What Shapes the Phylogenetic Structure of Anuran Communities in a Seasonal Environment? The Influence of Determinism at Regional Scale to Stochasticity or Antagonistic Forces at Local Scale	PLOS ONE			English	Article							REPRODUCTIVE MODES; GLOBAL PATTERNS; HABITAT USE; SIMILARITY; TREE; RELATEDNESS; DIVERSITY; AMPHIBIA; STATE; AREA	Ecological communities are structured by both deterministic and stochastic processes. We investigated phylogenetic patterns at regional and local scales to understand the influences of seasonal processes in shaping the structure of anuran communities in the southern Pantanal wetland, Brazil. We assessed the phylogenetic structure at different scales, using the Net Relatedness Index (NRI), the Nearest Taxon Index (NTI), and phylobetadiversity indexes, as well as a permutation test, to evaluate the effect of seasonality. The anuran community was represented by a non-random set of species with a high degree of phylogenetic relatedness at the regional scale. However, at the local scale the phylogenetic structure of the community was weakly related with the seasonality of the system, indicating that oriented stochastic processes (e.g. colonization, extinction and ecological drift) and/or antagonist forces drive the structure of such communities in the southern Pantanal.	[Martins, Clarissa de Araujo] Univ Fed Mato Grosso do Sul, Ctr Ciencias Biol & Saude, Programa Posgrad Ecol & Conservacao, Campo Grande, MS, Brazil; [Roque, Fabio de Oliveira; Ferreira, Vanda Lucia] Univ Fed Mato Grosso do Sul, Ctr Ciencias Biol & Saude, Campo Grande, MS, Brazil; [Santos, Braulio A.] Univ Fed Paraiba, Dept Sistemat & Ecol, BR-58059900 Joao Pessoa, Paraiba, Brazil; [Struessmann, Christine] Univ Fed Mato Grosso, Fac Agron Med Vet & Zootecnia, Dept Ciencias Basicas & Prod Anim, Cuiaba, Mato Grosso, Brazil; [Tomas, Walfrido Moraes] Empresa Brasileira Pesquisa Agr, Embrapa Pantanal, Lab Vida Selvagem, Corumba, MS, Brazil	Universidade Federal de Mato Grosso do Sul; Universidade Federal de Mato Grosso do Sul; Universidade Federal da Paraiba; Universidade Federal de Mato Grosso; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA)	Martins, CD (corresponding author), Univ Fed Mato Grosso do Sul, Ctr Ciencias Biol & Saude, Programa Posgrad Ecol & Conservacao, Campo Grande, MS, Brazil.	martins.ca2@gmail.com	Roque, Fabio/B-5514-2013; Ferreira, Vanda Lúcia L/K-1725-2016; Strüssmann, Christine/D-5971-2013; Santos, Bráulio A./M-2582-2013	Strüssmann, Christine/0000-0001-9880-9489; Santos, Bráulio A./0000-0001-6046-4024; Ferreira, Vanda/0000-0001-5032-6752	CNPq [480414/2009-2, 307360/2009-1]; Project Probio [02.02.12]; Project Prodetab [02.02.5.24]; Projects Embrapa [SEG 02.06.06.010.00.00, SEG 02.07.05.003.00.00, SEG 02.10.06.007.00.00]	CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Project Probio; Project Prodetab; Projects Embrapa(Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA))	Financial support for this work was provided in part by the CNPq (480414/2009-2, 307360/2009-1), the Project Probio 02.02.12, the Project Prodetab 02.02.5.24, and the Projects Embrapa SEG 02.06.06.010.00.00, SEG 02.07.05.003.00.00 and SEG 02.10.06.007.00.00.	Buckley LB, 2007, P ROY SOC B-BIOL SCI, V274, P1167, DOI 10.1098/rspb.2006.0436; Cadotte MW, 2009, DIVERS DISTRIB, V15, P481, DOI 10.1111/j.1472-4642.2009.00560.x; Cavender-Bares J, 2009, ECOL LETT, V12, P693, DOI 10.1111/j.1461-0248.2009.01314.x; Chase JM, 2011, ECOSPHERE, V2, DOI 10.1890/ES10-00117.1; Chase JM, 2011, PHILOS T R SOC B, V366, P2351, DOI 10.1098/rstb.2011.0063; Cianciaruso Marcus Vinicius, 2009, Biota Neotrop., V9, P93; Corn PS, 1994, MEASURING MONITORING, P109; da Silva F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109642; Desdevises Y, 2003, EVOLUTION, V57, P2647; dos Santos TG, 2012, TROPICAL FORESTS, P119; Duarte LDS, 2014, GLOBAL ECOL BIOGEOGR, V23, P213, DOI 10.1111/geb.12089; Faivovich J, 2005, B AM MUS NAT HIST, P6, DOI 10.1206/0003-0090(2005)294[0001:SROTFF]2.0.CO;2; Fine PVA, 2011, ECOGRAPHY, V34, P552, DOI 10.1111/j.1600-0587.2010.06548.x; Fritz SA, 2012, J BIOGEOGR, V39, P1373, DOI 10.1111/j.1365-2699.2012.02757.x; Garnier E, 2012, AGRON SUSTAIN DEV, V32, P365, DOI 10.1007/s13593-011-0036-y; Godoy O, 2014, ECOL LETT, V17, P836, DOI 10.1111/ele.12289; Gomez JM, 2010, NATURE, V465, P918, DOI 10.1038/nature09113; GORDO M., 2003, EMBRAPA PANTANAL SER, V58, P1; Hamilton S. K., 2002, The ecohydrology of South American rivers and wetlands, P133; Hamilton SK, 1996, ARCH HYDROBIOL, V137, P1; Helmus MR, 2010, ECOL LETT, V13, P162, DOI 10.1111/j.1461-0248.2009.01411.x; Horner-Devine MC, 2006, ECOLOGY, V87, pS100, DOI 10.1890/0012-9658(2006)87[100:PCAOIB]2.0.CO;2; Hubbell Stephen P., 2001, V32, pi; HUTCHINSON GE, 1959, AM NAT, V93, P145, DOI 10.1086/282070; Junk WJ, 2006, AQUAT SCI, V68, P278, DOI 10.1007/s00027-006-0851-4; Junk Wolfgang J., 1997, Ecological Studies, V126, P455; Kembel SW, 2006, ECOLOGY, V87, pS86, DOI 10.1890/0012-9658(2006)87[86:TPSOAN]2.0.CO;2; Kopp K, 2010, IHERINGIA SER ZOOL, V100, P192, DOI 10.1590/S0073-47212010000300002; Kunstler G, 2012, ECOL LETT, V15, P831, DOI 10.1111/j.1461-0248.2012.01803.x; Lajmanovich RC, 2000, INTERCIENCIA, V25, P71; Leibold MA, 1998, EVOL ECOL, V12, P95, DOI 10.1023/A:1006511124428; Letcher SG, 2012, PERSPECT PLANT ECOL, V14, P79, DOI 10.1016/j.ppees.2011.09.005; Letcher SG, 2010, P ROY SOC B-BIOL SCI, V277, P97, DOI 10.1098/rspb.2009.0865; Letten AD, 2013, ECOGRAPHY, V36, P1341, DOI 10.1111/j.1600-0587.2013.00346.x; LEVIN SA, 1992, ECOLOGY, V73, P1943, DOI 10.2307/1941447; Lovette IJ, 2006, ECOLOGY, V87, pS14, DOI 10.1890/0012-9658(2006)87[14:SEOPNC]2.0.CO;2; MacArthur RH, 1973, CHALLENGING BIOL PRO, P253; Maffei F, 2011, BIOTA NEOTROP, V11, P221, DOI 10.1590/S1676-06032011000200023; Mayfield MM, 2010, ECOL LETT, V13, P1085, DOI 10.1111/j.1461-0248.2010.01509.x; MORIN PJ, 1983, ECOL MONOGR, V53, P119, DOI 10.2307/1942491; NASCIMENTO L. B, 2005, ARQ MUS NAC, V63, P297; Norden N, 2012, ECOLOGY, V93, pS70, DOI 10.1890/10-2179.1; Parmentier I, 2014, J ECOL, V102, P1008, DOI 10.1111/1365-2745.12254; Pausas JG, 2010, BIOSCIENCE, V60, P614, DOI 10.1525/bio.2010.60.8.7; Prado CPA, 2005, AMPHIBIA-REPTILIA, V26, P211, DOI 10.1163/1568538054253375; Pramuk JB, 2006, ZOOL J LINN SOC-LOND, V146, P407, DOI 10.1111/j.1096-3642.2006.00212.x; Pyron RA, 2011, MOL PHYLOGENET EVOL, V61, P543, DOI 10.1016/j.ympev.2011.06.012; Ricklefs RE, 2008, AM NAT, V172, P741, DOI 10.1086/593002; Rodela L. G, 2007, REV BRASILEIRA CARTO, V59, P101; Santos BA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113109; Sargent RD, 2008, TRENDS ECOL EVOL, V23, P123, DOI 10.1016/j.tree.2007.11.003; Souza FL, IHERINGIA Z IN PRESS, DOI [10.1016/j.pcd.2015.03.009, DOI 10.1016/J.PCD.2015.03.009]; STRUSSMANN C., 2011, PANTANAL ECOLOGY BIO, P495; Thomaz SM, 2007, HYDROBIOLOGIA, V579, P1, DOI 10.1007/s10750-006-0285-y; Vamosi SM, 2009, MOL ECOL, V18, P572, DOI 10.1111/j.1365-294X.2008.04001.x; Vasconcelos TD, 2010, J TROP ECOL, V26, P423, DOI 10.1017/S0266467410000167; Vellend M, 2014, OIKOS, V123, P1420, DOI 10.1111/oik.01493; Violle C, 2011, ECOL LETT, V14, P782, DOI 10.1111/j.1461-0248.2011.01644.x; Wang JJ, 2013, ISME J, V7, P1310, DOI 10.1038/ismej.2013.30; Webb CO, 2005, MOL ECOL NOTES, V5, P181, DOI 10.1111/j.1471-8286.2004.00829.x; Webb CO, 2002, ANNU REV ECOL SYST, V33, P475, DOI 10.1146/annurev.ecolsys.33.010802.150448; Webb CO, 2000, AM NAT, V156, P145, DOI 10.1086/303378; WEBB CO, 2008, PHYLOCOM SOFTWARE AN; Weiher E, 2011, PHILOS T R SOC B, V366, P2403, DOI 10.1098/rstb.2011.0056; Wells DK., 2007, ECOLOGY BEHAV AMPHIB; Willis CG, 2010, ECOGRAPHY, V33, P565, DOI 10.1111/j.1600-0587.2009.05975.x; Zhou JZ, 2013, MBIO, V4, DOI 10.1128/mBio.00584-12	67	9	9	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2015	10	6							e0130075	10.1371/journal.pone.0130075	http://dx.doi.org/10.1371/journal.pone.0130075			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4DD	26102202	gold, Green Published			2022-12-26	WOS:000356901900028
J	Nazareno, AG; Carlsen, M; Lohmann, LG				Nazareno, Alison Goncalves; Carlsen, Monica; Lohmann, Lucia Garcez			Complete Chloroplast Genome of Tanaecium tetragonolobum: The First Bignoniaceae Plastome	PLOS ONE			English	Article							NUCLEOTIDE SUBSTITUTION; GENE ORGANIZATION; EVOLUTIONARY RATE; SEQUENCE; MICROSATELLITES; RATES; BIGNONIEAE; PHYLOGENY; CLASSIFICATION; EXPANSION	Bignoniaceae is a Pantropical plant family that is especially abundant in the Neotropics. Members of the Bignoniaceae are diverse in many ecosystems and represent key components of the Tropical flora. Despite the ecological importance of the Bignoniaceae and all the efforts to reconstruct the phylogeny of this group, whole chloroplast genome information has not yet been reported for any members of the family. Here, we report the complete chloroplast genome sequence of Tanaecium tetragonolobum (Jacq.) L.G. Lohmann, which was reconstructed using de novo and referenced-based assembly of single-end reads generated by shotgun sequencing of total genomic DNA in an Illumina platform. The gene order and organization of the chloroplast genome of T. tetragonolobum exhibits the general structure of flowering plants, and is similar to other Lamiales chloroplast genomes. The chloroplast genome of T. tetragonolobum is a circular molecule of 153,776 base pairs (bp) with a quadripartite structure containing two single copy regions, a large single copy region (LSC, 84,612 bp) and a small single copy region (SSC, 17,586 bp) separated by inverted repeat regions (IRs, 25,789 bp). In addition, the chloroplast genome of T. tetragonolobum has 38.3% GC content and includes 121 genes, of which 86 are protein-coding, 31 are transfer RNA, and four are ribosomal RNA. The chloroplast genome of T. tetragonolobum presents a total of 47 tandem repeats and 347 simple sequence repeats (SSRs) with mononucleotides being the most common and di-, tri-, tetra-, and hexanucleotides occurring with less frequency. The results obtained here were compared to other chloroplast genomes of Lamiales available to date, providing new insight into the evolution of chloroplast genomes within Lamiales. Overall, the evolutionary rates of genes in Lamiales are lineage-, locus-, and region-specific, indicating that the evolutionary pattern of nucleotide substitution in chloroplast genomes of flowering plants is complex. The discovery of tandem repeats within T. tetragonolobum and the presence of divergent regions between chloroplast genomes of Lamiales provides the basis for the development of markers at various taxonomic levels. The newly developed markers have the potential to greatly improve the resolution of molecular phylogenies.	[Nazareno, Alison Goncalves; Lohmann, Lucia Garcez] Univ Sao Paulo, Inst Biociencias, Dept Bot, Sao Paulo, SP, Brazil; [Carlsen, Monica] Univ Missouri, Dept Biol, St Louis, MO 63121 USA	Universidade de Sao Paulo; University of Missouri System; University of Missouri Saint Louis	Nazareno, AG (corresponding author), Univ Sao Paulo, Inst Biociencias, Dept Bot, Sao Paulo, SP, Brazil.	alison_nazareno@yahoo.com.br; llohmann@usp.br	Lohmann, Lucia G./AAF-7259-2021; Fapesp, Biota/F-8655-2017	Lohmann, Lucia G./0000-0003-4960-0587; Fapesp, Biota/0000-0002-9887-8449; Nazareno, Alison/0000-0001-9681-5877	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2013/12633-8]; collaborative BIOTA/Dimensions of Biodiversity grant; NSF; FAPESP grant [2011/50859-2, 2012/50260-6]; Pq-1C grant [307781/2013-5]; NASA	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); collaborative BIOTA/Dimensions of Biodiversity grant; NSF(National Science Foundation (NSF)); FAPESP grant(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Pq-1C grant; NASA(National Aeronautics & Space Administration (NASA))	This project was funded by the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) through a post-doctoral fellowship to AGN (2013/12633-8), a collaborative BIOTA/Dimensions of Biodiversity grant co-funded by NSF, NASA & FAPESP (2012/50260-6), and a regular FAPESP grant (2011/50859-2) to LGL. Additional funds were provided through a Pq-1C grant to LGL (307781/2013-5).	Alcantara S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090177; Alcantara S, 2011, BIOL J LINN SOC, V102, P378, DOI 10.1111/j.1095-8312.2010.01567.x; Alvarez-Ponce D, 2012, GENOME BIOL EVOL, V4, P1263, DOI 10.1093/gbe/evs101; Cathebras C, 2014, APPL PLANT SCI, V2, DOI 10.3732/apps.1400027; Cavalier-Smith T, 2002, CURR BIOL, V12, pR62, DOI 10.1016/S0960-9822(01)00675-3; Chase MW, 2009, BOT J LINN SOC, V161, P122, DOI 10.1111/j.1095-8339.2009.01002.x; Chung SM, 2003, THEOR APPL GENET, V107, P757, DOI 10.1007/s00122-003-1311-3; Conant GC, 2008, BIOINFORMATICS, V24, P861, DOI 10.1093/bioinformatics/btm598; Cosner ME, 1997, CURR GENET, V31, P419, DOI 10.1007/s002940050225; Delannoy E, 2011, MOL BIOL EVOL, V28, P2077, DOI 10.1093/molbev/msr028; Dong WP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077965; Doyle JJ, 1987, PHYTOCHEM B, V19, P11, DOI 10.1016/j.bse.2009.07.003; Ebert D, 2009, MOL ECOL RESOUR, V9, P777, DOI 10.1111/j.1755-0998.2008.02320.x; Edh K, 2007, MOL ECOL, V16, P4972, DOI 10.1111/j.1365-294X.2007.03585.x; Fajardo D, 2013, TREE GENET GENOMES, V9, P489, DOI 10.1007/s11295-012-0573-9; Frazer KA, 2004, NUCLEIC ACIDS RES, V32, pW273, DOI 10.1093/nar/gkh458; GAUT BS, 1993, MOL PHYLOGENET EVOL, V2, P89, DOI 10.1006/mpev.1993.1009; GENTRY AH, 1973, BRITTONIA, V25, P226, DOI 10.2307/2805585; Goulding SE, 1996, MOL GEN GENET, V252, P195, DOI 10.1007/BF02173220; Hansen AK, 2007, AM J BOT, V94, P42, DOI 10.3732/ajb.94.1.42; Huang YY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074736; Jakobsson M, 2007, THEOR APPL GENET, V114, P223, DOI 10.1007/s00122-006-0425-9; Jansen RK, 2005, METHOD ENZYMOL, V395, P348, DOI 10.1016/S0076-6879(05)95020-9; Jansen RK, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-32; Jones SS, 2014, PLANT SYST EVOL, V300, P1421, DOI 10.1007/s00606-013-0971-y; Kalia RK, 2011, EUPHYTICA, V177, P309, DOI 10.1007/s10681-010-0286-9; Katoh Kazutaka, 2013, Mol Biol Evol, V30, P772, DOI 10.1093/molbev/mst010; Kim Mincheol, 2013, Genomics & Informatics, V11, P102, DOI 10.5808/GI.2013.11.3.102; Knief C, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00216; Kurtz S, 1999, BIOINFORMATICS, V15, P426, DOI 10.1093/bioinformatics/15.5.426; Liu Yang, 2013, Biomed Res Int, V2013, P839683, DOI 10.1155/2013/839683; Lohmann LG, 2006, AM J BOT, V93, P304, DOI 10.3732/ajb.93.2.304; Lohmann LG, 2006, IPLANTS PROTOTYPE CH; Lohmann LG, 2014, ANN MO BOT GARD, V99, P348, DOI 10.3417/2003187; Lohmann LG, 2013, BOT J LINN SOC, V171, P154, DOI 10.1111/j.1095-8339.2012.01311.x; Luo J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099016; Marcais G, 2011, BIOINFORMATICS, V27, P764, DOI 10.1093/bioinformatics/btr011; Mariotti R, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-211; Martins WS, 2009, BIOINFORMATION, V3, P282, DOI 10.6026/97320630003282; McInerney JO, 2006, TRENDS ECOL EVOL, V21, P230, DOI 10.1016/j.tree.2006.03.008; McNeal JR, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-57; Monaco MK, 2014, NUCLEIC ACIDS RES, V42, pD1193, DOI 10.1093/nar/gkt1110; Muse SV, 2000, PLANT MOL BIOL, V42, P25, DOI 10.1023/A:1006319803002; Muse SV, 1997, GENETICS, V146, P393; Nazareno AG, 2011, AM J BOT, V98, pE198, DOI 10.3732/ajb.1100064; Nie XJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036869; Nogueira A, 2012, J EVOLUTION BIOL, V25, P2325, DOI 10.1111/j.1420-9101.2012.02615.x; Nogueira A, 2013, ANN BOT-LONDON, V112, P1331, DOI 10.1093/aob/mct201; OHYAMA K, 1986, NATURE, V322, P572, DOI 10.1038/322572a0; Olmstead RG, 2009, AM J BOT, V96, P1731, DOI 10.3732/ajb.0900004; Parks MB, 2011, THESIS OREGON STATE; Primmer CR, 1996, MOL ECOL, V5, P365, DOI 10.1046/j.1365-294X.1996.00092.x; Provan J, 2001, TRENDS ECOL EVOL, V16, P142, DOI 10.1016/S0169-5347(00)02097-8; Ratan A, 2009, THESIS PENN STATE U; Ravi V, 2008, PLANT SYST EVOL, V271, P101, DOI 10.1007/s00606-007-0608-0; Rico C, 1996, P ROY SOC B-BIOL SCI, V263, P549, DOI 10.1098/rspb.1996.0083; Rozen S, 2000, Methods Mol Biol, V132, P365; Saski C, 2005, PLANT MOL BIOL, V59, P309, DOI 10.1007/s11103-005-8882-0; Schattner P, 2005, NUCLEIC ACIDS RES, V33, pW686, DOI 10.1093/nar/gki366; Selkoe KA, 2006, ECOL LETT, V9, P615, DOI 10.1111/j.1461-0248.2006.00889.x; Shaw J, 2007, AM J BOT, V94, P275, DOI 10.3732/ajb.94.3.275; SHINOZAKI K, 1986, EMBO J, V5, P2043, DOI 10.1002/j.1460-2075.1986.tb04464.x; Song Sze-Looi, 2014, BMC Res Notes, V7, P77, DOI 10.1186/1756-0500-7-77; Sousa-Baena MS, 2013, ANN MISSOURI BOT GAR, V99, P323; SUGIURA M, 1992, PLANT MOL BIOL, V19, P149, DOI 10.1007/BF00015612; Sun YX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060429; Walker JF, 2014, AM J BOT, V101, P722, DOI 10.3732/ajb.1400049; Wang Z, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000329; Weising K, 1999, GENOME, V42, P9, DOI 10.1139/gen-42-1-9; Wright TF, 2004, GENET RES, V84, P27, DOI 10.1017/S0016672304006986; Wu FH, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-68; Wyman SK, 2004, BIOINFORMATICS, V20, P3252, DOI 10.1093/bioinformatics/bth352; Yi DK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035872; Yu H, 2013, NEW PHYTOL, V197, P276, DOI 10.1111/j.1469-8137.2012.04383.x; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zhang HY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080508; Zhang TW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030531; Zhang YJ, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0021342, 10.1371/journal.pone.0020596]; Zhang Zhang, 2006, Genomics Proteomics & Bioinformatics, V4, P259, DOI 10.1016/S1672-0229(07)60007-2	79	60	62	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2015	10	6							e0129930	10.1371/journal.pone.0129930	http://dx.doi.org/10.1371/journal.pone.0129930			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4DD	26103589	Green Published, Green Submitted, gold			2022-12-26	WOS:000356901900024
J	Wu, LP; Chen, JT; Ding, CS; Wei, ST; Zhu, YH; Yang, WY; Zhang, XY; Wei, XJ; Han, DZ				Wu, Liping; Chen, Jingtao; Ding, Chunsheng; Wei, Shutang; Zhu, Yanhong; Yang, Wenyi; Zhang, Xiaoyang; Wei, Xuejv; Han, Dazheng			MicroRNA-137 Contributes to Dampened Tumorigenesis in Human Gastric Cancer by Targeting AKT2	PLOS ONE			English	Article							CARCINOMA; PROLIFERATION; APOPTOSIS	MiRNAs play important roles in tumorigenesis. This study focused on exploring the effects and regulation mechanism of miRNA-137 on the biological behaviors of gastric cancer. Total RNA was extracted from tissues of 100 patients with gastric cancer and from four gastric cancer cell lines. Expression of miR-137 was detected by real-time PCR from 100 patients. The effects of miR-137 overexpression on gastric cancer cells' proliferation, apoptosis, migration and invasion ability were investigated in vitro and in vivo. The target gene of miR-137 was predicted by Targetscan on line software, screened by dual luciferase reporter gene assay and demonstrated by western blot. As a result, the expression of miR-137 was significant reduced in gastric cancer cell line HGC-27, HGC-803, SGC-7901 and MKN-45 as well as in gastric cancer tissues compared with GES-1 cell or matched adjacent non-neoplastic tissues (p<0.001). The re-introduction of miR-137 into gastric cancer cells was able to inhibit cell proliferation, migration and invasion. The in vivo experiments demonstrated that the miR-137 overexpression can reduce the gastric cancer cell proliferation and metastasis. Bioinformatic and western blot analysis indicated that the miR-137 acted as tumor suppressor roles on gastric cancer cells through targeting AKT2 and further affecting the Bad and GSK-3 beta. In conclusion, the miR-137 which is frequently down-regulated in gastric cancer is potentially involved in gastric cancer tumorigenesis and metastasis by regulating AKT2 related signal pathways.	[Wu, Liping; Chen, Jingtao; Ding, Chunsheng; Wei, Shutang; Zhu, Yanhong; Yang, Wenyi; Zhang, Xiaoyang; Wei, Xuejv; Han, Dazheng] Henan Univ, Affiliated Hosp 1, Dept Gastroenterol, Kaifeng, Henan, Peoples R China	Henan University	Han, DZ (corresponding author), Henan Univ, Affiliated Hosp 1, Dept Gastroenterol, Kaifeng, Henan, Peoples R China.	handazheng99@hotmail.com			Medical science and technology research projects of Henan province, China [2011030004]	Medical science and technology research projects of Henan province, China	This work was supported by Medical science and technology research projects of Henan province, China (2011030004).	Balaguer F, 2010, CANCER RES, V70, P6609, DOI 10.1158/0008-5472.CAN-10-0622; Bandres E, 2009, CLIN CANCER RES, V15, P2281, DOI 10.1158/1078-0432.CCR-08-1818; Chen QJ, 2011, DIGEST DIS SCI, V56, P2009, DOI 10.1007/s10620-010-1536-3; Guo SL, 2011, INT J BIOL SCI, V7, P567, DOI 10.7150/ijbs.7.567; Herranz H, 2010, GENE DEV, V24, P1339, DOI 10.1101/gad.1937010; Katada T, 2009, INT J ONCOL, V34, P537, DOI 10.3892/ijo_00000179; Kim YK, 2009, NUCLEIC ACIDS RES, V37, P1672, DOI 10.1093/nar/gkp002; Kogo R, 2011, CLIN CANCER RES, V17, P4277, DOI 10.1158/1078-0432.CCR-10-2866; Krol J, 2010, NAT REV GENET, V11, P597, DOI 10.1038/nrg2843; Langevin SM, 2010, CARCINOGENESIS, V31, P864, DOI 10.1093/carcin/bgq051; Li YY, 2006, CANCER RES, V66, P6741, DOI 10.1158/0008-5472.CAN-05-4272; Liu LL, 2014, ONCOTARGET, V5, P5113, DOI 10.18632/oncotarget.2089; Liu R, 2011, EUR J CANCER, V47, P784, DOI 10.1016/j.ejca.2010.10.025; Mathers CD, 2002, BMC CANCER, V2, DOI 10.1186/1471-2407-2-36; Petrocca F, 2008, CANCER CELL, V13, P272, DOI 10.1016/j.ccr.2008.02.013; Tamim S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085591; Wang R, 2011, ONCOGENE, V30, P2644, DOI 10.1038/onc.2010.642; Xiao BX, 2009, CLIN CHIM ACTA, V400, P97, DOI 10.1016/j.cca.2008.10.021; Zhang TF, 2011, CLIN SCI, V121, P437, DOI 10.1042/CS20110207; Zhang X, 2011, ANN ONCOL, V22, P2257, DOI 10.1093/annonc/mdq758	20	28	29	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2015	10	6							e0130124	10.1371/journal.pone.0130124	http://dx.doi.org/10.1371/journal.pone.0130124			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4DD	26102366	Green Published, Green Submitted, gold			2022-12-26	WOS:000356901900030
J	Banik, S; Mansour, AA; Suresh, RV; Wykoff-Clary, S; Malik, M; McCormick, AA; Bakshi, CS				Banik, Sukalyani; Mansour, Ahd Ahmed; Suresh, Ragavan Varadharajan; Wykoff-Clary, Sherri; Malik, Meenakshi; McCormick, Alison A.; Bakshi, Chandra Shekhar			Development of a Multivalent Subunit Vaccine against Tularemia Using Tobacco Mosaic Virus (TMV) Based Delivery System	PLOS ONE			English	Article							OUTER-MEMBRANE PROTEIN; FRANCISELLA-TULARENSIS; IMMUNOREACTIVE ANTIGENS; PROTECTIVE IMMUNITY; STRAIN; LIPOPOLYSACCHARIDE; IDENTIFICATION; MUTANT; MICE; CHALLENGE	Francisella tularensis is a facultative intracellular pathogen, and is the causative agent of a fatal human disease known as tularemia. F. tularensis is classified as a Category A Biothreat agent by the CDC based on its use in bioweapon programs by several countries in the past and its potential to be used as an agent of bioterrorism. No licensed vaccine is currently available for prevention of tularemia. In this study, we used a novel approach for development of a multivalent subunit vaccine against tularemia by using an efficient tobacco mosaic virus (TMV) based delivery platform. The multivalent subunit vaccine was formulated to contain a combination of F. tularensis protective antigens: OmpA-like protein (OmpA), chaperone protein DnaK and lipoprotein Tul4 from the highly virulent F. tularensis SchuS4 strain. Two different vaccine formulations and immunization schedules were used. The immunized mice were challenged with lethal (10xLD(100)) doses of F. tularensis LVS on day 28 of the primary immunization and observed daily for morbidity and mortality. Results from this study demonstrate that TMV can be used as a carrier for effective delivery of multiple F. tularensis antigens. TMV-conjugate vaccine formulations are safe and multiple doses can be administered without causing any adverse reactions in immunized mice. Immunization with TMV-conjugated F. tularensis proteins induced a strong humoral immune response and protected mice against respiratory challenges with very high doses of F. tularensis LVS. This study provides a proof-of-concept that TMV can serve as a suitable platform for simultaneous delivery of multiple protective antigens of F. tularensis. Refinement of vaccine formulations coupled with TMV-targeting strategies developed in this study will provide a platform for development of an effective tularemia subunit vaccine as well as a vaccination approach that may broadly be applicable to many other bacterial pathogens.	[Banik, Sukalyani; Mansour, Ahd Ahmed; Suresh, Ragavan Varadharajan; Bakshi, Chandra Shekhar] New York Med Coll, Dept Microbiol & Immunol, Valhalla, NY 10595 USA; [Wykoff-Clary, Sherri; McCormick, Alison A.] Touro Univ Calif, Coll Pharm, Vallejo, CA USA; [Malik, Meenakshi] Albany Coll Pharm & Hlth Sci, Albany, NY USA	New York Medical College; Touro University California; Albany College of Pharmacy & Health Sciences	Bakshi, CS (corresponding author), New York Med Coll, Dept Microbiol & Immunol, Valhalla, NY 10595 USA.	Shekhar_Bakshi@nymc.edu	Malik, Meenakshi/F-1501-2015	Malik, Meenakshi/0000-0003-0051-4485	Touro University Seed Grant; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R15AI107698] Funding Source: NIH RePORTER	Touro University Seed Grant; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by Touro University Seed Grant to AAM and CSB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altman Gaylene Bouska, 2002, AAOHN J, V50, P373; Apicella MA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011060; Ashtekar AR, 2008, J LEUKOCYTE BIOL, V84, P1434, DOI 10.1189/jlb.0308215; Ashtekar AR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050460; Atlas RM, 2002, ANNU REV MICROBIOL, V56, P167, DOI 10.1146/annurev.micro.56.012302.160616; Barker JH, 2006, INFECT IMMUN, V74, P3277, DOI 10.1128/IAI.02011-05; Baron SD, 2007, INFECT IMMUN, V75, P2152, DOI 10.1128/IAI.01606-06; Barry EM, 2009, HUM VACCINES, V5, P832, DOI 10.4161/hv.10297; Bossi P, 2003, PRESSE MED, V32, P1126; Cole LE, 2009, P NATL ACAD SCI USA, V106, P4343, DOI 10.1073/pnas.0813411106; Dennis DT, 2001, JAMA-J AM MED ASSOC, V285, P2763, DOI 10.1001/jama.285.21.2763; Dotson RJ, 2013, J BIOL CHEM, V288, P23844, DOI 10.1074/jbc.M113.490086; Eyles JE, 2008, MICROB PATHOGENESIS, V44, P164, DOI 10.1016/j.micpath.2007.08.009; Eyles JE, 2007, PROTEOMICS, V7, P2172, DOI 10.1002/pmic.200600985; FORSMAN M, 1994, INT J SYST BACTERIOL, V44, P38, DOI 10.1099/00207713-44-1-38; Foshay L, 1942, AM J PUBLIC HEALTH N, V32, P1131, DOI 10.2105/AJPH.32.10.1131; FULOP M, 1995, VACCINE, V13, P1220, DOI 10.1016/0264-410X(95)00062-6; Gregory SH, 2010, VACCINE, V28, P2908, DOI 10.1016/j.vaccine.2010.01.067; Griffin AJ, 2015, CLIN VACCINE IMMUNOL, V22, P119, DOI 10.1128/CVI.00648-14; Havlasova J, 2005, PROTEOMICS, V5, P2090, DOI 10.1002/pmic.200401123; Havlasova J, 2002, PROTEOMICS, V2, P857, DOI 10.1002/1615-9861(200207)2:7<857::AID-PROT857>3.0.CO;2-L; Hickey AJ, 2011, VACCINE, V29, P6941, DOI 10.1016/j.vaccine.2011.07.075; HOLLIS DG, 1989, J CLIN MICROBIOL, V27, P1601, DOI 10.1128/JCM.27.7.1601-1608.1989; HOLM SE, 1980, INT ARCH ALLER A IMM, V61, P136, DOI 10.1159/000232426; Huntley JF, 2008, INFECT IMMUN, V76, P3664, DOI 10.1128/IAI.00374-08; Huntley JF, 2007, J BACTERIOL, V189, P561, DOI 10.1128/JB.01505-06; Janovska S, 2007, IMMUNOL LETT, V108, P151, DOI 10.1016/j.imlet.2006.12.004; Jia QM, 2013, INFECT IMMUN, V81, P1550, DOI 10.1128/IAI.01013-12; Kaur R, 2012, CLIN VACCINE IMMUNOL, V19, P359, DOI 10.1128/CVI.05384-11; Khlebnikov VS, 1996, FEMS IMMUNOL MED MIC, V13, P227, DOI 10.1111/j.1574-695X.1996.tb00241.x; Lavine CL, 2007, EUR J IMMUNOL, V37, P3007, DOI 10.1002/eji.200737620; Liu RL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060621; Mahawar M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061539; Mahawar M, 2012, J BIOL CHEM, V287, P25216, DOI 10.1074/jbc.M112.367672; Mallajosyula JK, 2014, HUM VACC IMMUNOTHER, V10, P586, DOI 10.4161/hv.27567; Mara-Koosham G, 2011, INFECT IMMUN, V79, P1770, DOI 10.1128/IAI.00605-10; McCormick AA, 2006, VACCINE, V24, P6414, DOI 10.1016/j.vaccine.2006.06.003; McCormick AA, 2006, BIOCONJUGATE CHEM, V17, P1330, DOI 10.1021/bc060124m; Mohapatra SK, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-10; Noah CE, 2010, INFECT IMMUN, V78, P1797, DOI 10.1128/IAI.01135-09; Oyston PCF, 2008, J MED MICROBIOL, V57, P921, DOI 10.1099/jmm.0.2008/000653-0; Pechous R, 2006, INFECT IMMUN, V74, P4452, DOI 10.1128/IAI.00666-06; Rawool DB, 2008, J IMMUNOL, V180, P5548, DOI 10.4049/jimmunol.180.8.5548; Rockx-Brouwer D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037752; RUCHMAN I, 1949, J IMMUNOL, V61, P229; Sammons-Jackson WL, 2008, DNA CELL BIOL, V27, P387, DOI 10.1089/dna.2007.0687; Sebastian S, 2007, INFECT IMMUN, V75, P2591, DOI 10.1128/IAI.01789-06; Smith ML, 2007, VIROLOGY, V358, P321, DOI 10.1016/j.virol.2006.08.040; Smith ML, 2006, VIROLOGY, V348, P475, DOI 10.1016/j.virol.2005.12.039; Steiner DJ, 2014, INFECT DRUG RESIST, V7, P239, DOI 10.2147/IDR.S53700; Suresh RV, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124326; Svensson K, 2005, J BACTERIOL, V187, P3903, DOI 10.1128/JB.187.11.3903-3908.2005; Twine S, 2005, INFECT IMMUN, V73, P8345, DOI 10.1128/IAI.73.12.8345-8352.2005	53	38	39	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2015	10	6							e0130858	10.1371/journal.pone.0130858	http://dx.doi.org/10.1371/journal.pone.0130858			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL3FM	26098553	Green Published, Green Submitted, gold			2022-12-26	WOS:000356835800112
J	Bonds, JA; Kuttner-Hirshler, Y; Bartolotti, N; Tobin, MK; Pizzi, M; Marr, R; Lazarov, O				Bonds, Jacqueline A.; Kuttner-Hirshler, Yafit; Bartolotti, Nancy; Tobin, Matthew K.; Pizzi, Michael; Marr, Robert; Lazarov, Orly			Presenilin-1 Dependent Neurogenesis Regulates Hippocampal Learning and Memory	PLOS ONE			English	Article							GAMMA-SECRETASE ACTIVITY; NEURAL STEM-CELLS; ADULT NEUROGENESIS; ALZHEIMERS-DISEASE; BETA-CATENIN; NATIONAL INSTITUTE; ASSOCIATION; CLEAVAGE; ENDOPROTEOLYSIS; DIFFERENTIATION	Presenilin-1 (PS1), the catalytic core of the aspartyl protease gamma-secretase, regulates adult neurogenesis. However, it is not clear whether the role of neurogenesis in hippocampal learning and memory is PS1-dependent, or whether PS1 loss of function in adult hippocampal neurogenesis can cause learning and memory deficits. Here we show that downregulation of PS1 in hippocampal neural progenitor cells causes progressive deficits in pattern separation and novelty exploration. New granule neurons expressing reduced PS1 levels exhibit decreased dendritic branching and dendritic spines. Further, they exhibit reduced survival. Lastly, we show that PS1 effect on neurogenesis is mediated via beta-catenin phosphorylation and notch signaling. Together, these observations suggest that impairments in adult neurogenesis induce learning and memory deficits and may play a role in the cognitive deficits observed in Alzheimer's disease.	[Bonds, Jacqueline A.; Tobin, Matthew K.; Lazarov, Orly] Univ Illinois, Grad Program Neurosci, Chicago, IL 60612 USA; [Bonds, Jacqueline A.; Kuttner-Hirshler, Yafit; Bartolotti, Nancy; Tobin, Matthew K.; Lazarov, Orly] Univ Illinois, Coll Med, Dept Anat & Cell Biol, Chicago, IL 60612 USA; [Tobin, Matthew K.] Univ Illinois, Med Scientist Training Program, Chicago, IL 60612 USA; [Pizzi, Michael] Midwestern Univ, Downers Grove, IL 60515 USA; [Marr, Robert] Rosalind Franklin Univ Med & Sci, Dept Neurosci, N Chicago, IL 60064 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Midwestern University; Rosalind Franklin University Medical & Science	Lazarov, O (corresponding author), Univ Illinois, Grad Program Neurosci, Chicago, IL 60612 USA.	olazarov@uic.edu		Lazarov, Orly/0000-0002-5887-948X	US National Institutes of Health [RO1 AG033570, 1 RC1 AG036208-01]; Brain Research Foundation [G-2010-10, 5 T32 HL 007692-24]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007692] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG033570, RC1AG036208] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Brain Research Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was funded by the US National Institutes of Health grants RO1 AG033570, 1 RC1 AG036208-01, the Brain Research Foundation G-2010-10 (OL), and 5 T32 HL 007692-24 (JAB).	Ables JL, 2010, J NEUROSCI, V30, P10484, DOI 10.1523/JNEUROSCI.4721-09.2010; Aimone JB, 2014, PHYSIOL REV, V94, P991, DOI 10.1152/physrev.00004.2014; Aimone JB, 2011, NEURON, V70, P589, DOI 10.1016/j.neuron.2011.05.010; Aimone JB, 2010, TRENDS COGN SCI, V14, P325, DOI 10.1016/j.tics.2010.04.003; Albert MS, 2011, ALZHEIMERS DEMENT, V7, P270, DOI 10.1016/j.jalz.2011.03.008; Antunes M, 2012, COGN PROCESS, V13, P93, DOI 10.1007/s10339-011-0430-z; Balderas I, 2008, LEARN MEMORY, V15, P618, DOI 10.1101/lm.1028008; Bonaguidi MA, 2008, J NEUROSCI, V28, P9194, DOI 10.1523/JNEUROSCI.3314-07.2008; Borghese L, 2010, STEM CELLS, V28, P955, DOI 10.1002/stem.408; Chavez-Gutierrez L, 2012, EMBO J, V31, P2261, DOI 10.1038/emboj.2012.79; Chen Q, 2008, J NEUROSCI RES, V86, P1615, DOI 10.1002/jnr.21601; Ciani L, 2005, NAT REV NEUROSCI, V6, P351, DOI 10.1038/nrn1665; Dayer AG, 2003, J COMP NEUROL, V460, P563, DOI 10.1002/cne.10675; De Strooper B, 1999, NATURE, V398, P518, DOI 10.1038/19083; De Strooper B, 1998, NATURE, V391, P387, DOI 10.1038/34910; De Strooper B, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006304; EINSTEIN G, 1994, J NEUROSCI, V14, P5077; Fortress AM, 2013, J NEUROSCI, V33, P12619, DOI 10.1523/JNEUROSCI.0659-13.2013; Franklin KBJ, 2008, THE MOUSE BRAIN IN S; Gadadhar A, 2011, J NEUROSCI, V31, P2615, DOI 10.1523/JNEUROSCI.4767-10.2011; Heilig EA, 2013, J NEUROSCI, V33, P11606, DOI 10.1523/JNEUROSCI.0954-13.2013; Heilig EA, 2010, J BIOL CHEM, V285, P22350, DOI 10.1074/jbc.M110.116962; Herreman A, 2000, NAT CELL BIOL, V2, P461, DOI 10.1038/35017105; Hyman BT, 2012, ALZHEIMERS DEMENT, V8, P1, DOI 10.1016/j.jalz.2011.10.007; Jagasia R, 2009, J NEUROSCI, V29, P7966, DOI 10.1523/JNEUROSCI.1054-09.2009; Kang DE, 1999, J NEUROSCI, V19, P4229; Kulic L, 2000, P NATL ACAD SCI USA, V97, P5913, DOI 10.1073/pnas.100049897; Lavado A, 2014, DEV BIOL, V388, P11, DOI 10.1016/j.ydbio.2014.02.004; Li YM, 2000, P NATL ACAD SCI USA, V97, P6138, DOI 10.1073/pnas.110126897; Lie DC, 2005, NATURE, V437, P1370, DOI 10.1038/nature04108; Marambaud P, 2002, EMBO J, V21, P1948, DOI 10.1093/emboj/21.8.1948; Marambaud P, 2003, CELL, V114, P635, DOI 10.1016/j.cell.2003.08.008; Palacino JJ, 2001, J BIOL CHEM, V276, P38563, DOI 10.1074/jbc.M105376200; Sahay A, 2011, NATURE, V472, P466, DOI 10.1038/nature09817; Saura CA, 2004, NEURON, V42, P23, DOI 10.1016/S0896-6273(04)00182-5; Serban G, 2005, J BIOL CHEM, V280, P36007, DOI 10.1074/jbc.M507503200; Shin J, 2007, DEVELOPMENT, V134, P1911, DOI 10.1242/dev.001602; Spalding KL, 2013, CELL, V153, P1219, DOI 10.1016/j.cell.2013.05.002; Sun F, 2013, AGING CELL, V12, P978, DOI 10.1111/acel.12134; Wang BX, 2010, SCIENCE, V330, P1065, DOI 10.1126/science.1196284; Watanabe H, 2009, J BIOL CHEM, V284, P13705, DOI 10.1074/jbc.M809168200; Wolfe MS, 1999, NATURE, V398, P513, DOI 10.1038/19077; Xia D, 2015, NEURON, V85, P967, DOI 10.1016/j.neuron.2015.02.010; Zhang ZH, 2000, NAT CELL BIOL, V2, P463, DOI 10.1038/35017108	44	25	26	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2015	10	6							e0131266	10.1371/journal.pone.0131266	http://dx.doi.org/10.1371/journal.pone.0131266			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL3FM	26098332	Green Submitted, Green Published, gold			2022-12-26	WOS:000356835800165
J	Hiramuki, Y; Sato, T; Furuta, Y; Surani, MA; Sehara-Fujisawa, A				Hiramuki, Yosuke; Sato, Takahiko; Furuta, Yasuhide; Surani, M. Azim; Sehara-Fujisawa, Atsuko			Mest but Not MiR-335 Affects Skeletal Muscle Growth and Regeneration	PLOS ONE			English	Article							IMPRINTED GENE NETWORK; MATERNAL-BEHAVIOR; EMBRYONIC GROWTH; DYSTROPHIN; MICRORNAS; LOCUS; MOUSE; QUIESCENCE; DISRUPTION; DELETION	When skeletal muscle fibers are injured, they regenerate and grow until their sizes are adjusted to surrounding muscle fibers and other relevant organs. In this study, we examined whether Mest, one of paternally expressed imprinted genes that regulates body size during development, and miR-335 located in the second intron of the Mest gene play roles in muscle regeneration. We generated miR-335-deficient mice, and found that miR-335 is a paternally expressed imprinted microRNA. Although both Mest and miR-335 are highly expressed during muscle development and regeneration, only Mest(+/-) (maternal/paternal) mice show retardation of body growth. In addition to reduced body weight in Mest(+/-); DMD-null mice, decreased muscle growth was observed in Mest(+/-) mice during cardiotoxin-induced regeneration, suggesting roles of Mest in muscle regeneration. Moreover, expressions of H19 and Igf2r, maternally expressed imprinted genes were affected in tibialis anterior muscle of Mest(+/-); DMD-null mice compared to DMD-null mice. Thus, Mest likely mediates muscle regeneration through regulation of imprinted gene networks in skeletal muscle.	[Hiramuki, Yosuke; Sato, Takahiko; Sehara-Fujisawa, Atsuko] Kyoto Univ, Inst Frontier Med Sci, Dept Growth Regulat, Kyoto, Japan; [Furuta, Yasuhide] RIKEN Ctr Life Sci Technol, Anim Resource Dev Unit, Kobe, Hyogo, Japan; [Furuta, Yasuhide] RIKEN Ctr Life Sci Technol, Genet Engn Team, Kobe, Hyogo, Japan; [Surani, M. Azim] Univ Cambridge, Wellcome Trust Canc Res UK Gurdon Inst, Cambridge, England; [Surani, M. Azim] Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge, England; [Surani, M. Azim] Univ Cambridge, Wellcome Trust Med Res Council Stem Cell Inst, Cambridge, England	Kyoto University; RIKEN; RIKEN; University of Cambridge; University of Cambridge; University of Cambridge	Sato, T (corresponding author), Kyoto Univ, Inst Frontier Med Sci, Dept Growth Regulat, Kyoto, Japan.	takahiko@frontier.kyoto-u.ac.jp; asehara@frontier.kyoto-u.ac.jp		Sato, Takahiko/0000-0003-3836-7978	Ministry of Education, Culture, Sports, Science and Technology [22122007]; Nervous and Mental Disorders from the Ministry of Health, Labour and Welfare [23124504]; Takeda Science Foundation; Uehara Memorial Foundation; Center for Frontier Medicine of the Kyoto University Global COE Program; Grants-in-Aid for Scientific Research [15K21745, 26870285, 26650077, 22122007] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Nervous and Mental Disorders from the Ministry of Health, Labour and Welfare; Takeda Science Foundation(Takeda Science Foundation (TSF)); Uehara Memorial Foundation(Uehara Memorial Foundation); Center for Frontier Medicine of the Kyoto University Global COE Program; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grants-in-aid from the Ministry of Education, Culture, Sports, Science and Technology (ASF: grant numbers 22122007), a grant from Nervous and Mental Disorders from the Ministry of Health, Labour and Welfare (ASF), molecular mechanisms underlying reconstruction of 3D structures during regeneration (TS: grant number 23124504), a grant from Takeda Science Foundation (TS), a grant from Uehara Memorial Foundation (TS). A Grant from Platform for Dynamic Approaches to Living System from the Ministry of Education, Culture, Sports, Science and Technology, Japan (YH and ASF). YH and TS were supported by a research assistantship and postdoctoral fellowship from the Center for Frontier Medicine of the Kyoto University Global COE Program, respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen DC, 2013, DEVELOPMENT, V140, P3743, DOI 10.1242/dev.095810; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Charalambous M, 2003, P NATL ACAD SCI USA, V100, P8292, DOI 10.1073/pnas.1532175100; DECHIARA TM, 1990, NATURE, V345, P78, DOI 10.1038/345078a0; Emery AEH, 2002, LANCET, V359, P687, DOI 10.1016/S0140-6736(02)07815-7; Gabory A, 2010, BIOESSAYS, V32, P473, DOI 10.1002/bies.200900170; Gabory A, 2009, DEVELOPMENT, V136, P3413, DOI 10.1242/dev.036061; Girardot M, 2012, EPIGENETICS-US, V7, P1341, DOI 10.4161/epi.22884; Gong M, 2014, MOL CANCER RES, V12, P101, DOI 10.1158/1541-7786.MCR-13-0136; Greco S, 2009, FASEB J, V23, P3335, DOI 10.1096/fj.08-128579; Heyn H, 2011, INT J CANCER, V129, P2797, DOI 10.1002/ijc.25962; HOFFMAN EP, 1987, CELL, V51, P919, DOI 10.1016/0092-8674(87)90579-4; Kallen AN, 2013, MOL CELL, V52, P101, DOI 10.1016/j.molcel.2013.08.027; Kudoh H, 2005, BIOCHEM BIOPH RES CO, V328, P507, DOI 10.1016/j.bbrc.2004.12.191; Lagha M, 2009, DEV CELL, V17, P892, DOI 10.1016/j.devcel.2009.10.021; Lefebvre L, 1998, NAT GENET, V20, P163, DOI 10.1038/2464; LEIGHTON PA, 1995, NATURE, V375, P34, DOI 10.1038/375034a0; Li LL, 1999, SCIENCE, V284, P330, DOI 10.1126/science.284.5412.330; Lui JC, 2008, AM J PHYSIOL-REG I, V295, pR189, DOI 10.1152/ajpregu.00182.2008; Muntoni F, 2003, LANCET NEUROL, V2, P731, DOI 10.1016/S1474-4422(03)00585-4; Riclet R, 2009, MOL BIOL CELL, V20, P296, DOI 10.1091/mbc.E08-05-0510; Sakai K, 1997, BIOCHEM BIOPH RES CO, V237, P318, DOI 10.1006/bbrc.1997.7111; Sato T, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5597; Scarola M, 2010, CANCER RES, V70, P6925, DOI 10.1158/0008-5472.CAN-10-0141; Schiaffino S, 2013, FEBS J, V280, P4294, DOI 10.1111/febs.12253; Shenoy A, 2014, NAT REV MOL CELL BIO, V15, P565, DOI 10.1038/nrm3854; Tavazoie SF, 2008, NATURE, V451, P147, DOI 10.1038/nature06487; Tome M, 2011, CELL DEATH DIFFER, V18, P985, DOI 10.1038/cdd.2010.167; Varrault A, 2006, DEV CELL, V11, P711, DOI 10.1016/j.devcel.2006.09.003; Venkatraman A, 2013, NATURE, V500, P345, DOI 10.1038/nature12303; WANG ZQ, 1994, NATURE, V372, P464, DOI 10.1038/372464a0; YAGI T, 1993, ANAL BIOCHEM, V214, P70, DOI 10.1006/abio.1993.1458; Yan Z, 2003, J BIOL CHEM, V278, P8826, DOI 10.1074/jbc.M209879200	33	17	17	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2015	10	6							e0130436	10.1371/journal.pone.0130436	http://dx.doi.org/10.1371/journal.pone.0130436			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL3FM	26098312	Green Submitted, gold, Green Published			2022-12-26	WOS:000356835800066
J	Kilbaugh, TJ; Lvova, M; Karlsson, M; Zhang, Z; Leipzig, J; Wallace, DC; Margulies, SS				Kilbaugh, Todd J.; Lvova, Maria; Karlsson, Michael; Zhang, Zhe; Leipzig, Jeremy; Wallace, Douglas C.; Margulies, Susan S.			Peripheral Blood Mitochondrial DNA as a Biomarker of Cerebral Mitochondrial Dysfunction following Traumatic Brain Injury in a Porcine Model	PLOS ONE			English	Article							RESPONSES	Background Traumatic brain injury (TBI) has been shown to activate the peripheral innate immune system and systemic inflammatory response, possibly through the central release of damage associated molecular patterns (DAMPs). Our main purpose was to gain an initial understanding of the peripheral mitochondrial response following TBI, and how this response could be utilized to determine cerebral mitochondrial bioenergetics. We hypothesized that TBI would increase peripheral whole blood relative mtDNA copy number, and that these alterations would be associated with cerebral mitochondrial bioenergetics triggered by TBI. Methodology Blood samples were obtained before, 6 h after, and 25 h after focal (controlled cortical impact injury: CCI) and diffuse (rapid non-impact rotational injury: RNR) TBI. PCR primers, unique to mtDNA, were identified by aligning segments of nuclear DNA (nDNA) to mtDNA, normalizing values to nuclear 16S rRNA, for a relative mtDNA copy number. Three unique mtDNA regions were selected, and PCR primers were designed within those regions, limited to 25-30 base pairs to further ensure sequence specificity, and measured utilizing qRT-PCR. Results Mean relative mtDNA copy numbers increased significantly at 6 and 25 hrs after following both focal and diffuse traumatic brain injury. Specifically, the mean relative mtDNA copy number from three mitochondrial-specific regions pre-injury was 0.84 +/- 0.05. At 6 and 25 h after diffuse non-impact TBI, mean mtDNA copy number was significantly higher: 2.07 +/- 0.19 (P < 0.0001) and 2.37 +/- 0.42 (P < 0.001), respectively. Following focal impact TBI, relative mtDNA copy number was also significantly higher, 1.35 +/- 0.12 (P < 0.0001) at 25 hours. Alterations in mitochondrial respiration in the hippocampus and cortex post-TBI correlated with changes in the relative mtDNA copy number measured in peripheral blood. Conclusions Alterations in peripheral blood relative mtDNA copy numbers may be a novel biosignature of cerebral mitochondrial bioenergetics with exciting translational potential for non-invasive diagnostic and interventional studies.	[Kilbaugh, Todd J.] Univ Penn, Childrens Hosp Philadelphia, Perelman Sch Med, Dept Anesthesiol & Crit Care Med, Philadelphia, PA 19104 USA; [Lvova, Maria; Zhang, Zhe; Leipzig, Jeremy; Wallace, Douglas C.] Univ Penn, Childrens Hosp Philadelphia, Perelman Sch Med, Ctr Mitochondrial & Epigen Med,Dept Pathol & Lab, Philadelphia, PA 19104 USA; [Karlsson, Michael] Lund Univ, Mitochondrial Med, Dept Clin Sci, Lund, Sweden; [Margulies, Susan S.] Univ Penn, Dept Bioengn, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Lund University; University of Pennsylvania	Kilbaugh, TJ (corresponding author), Univ Penn, Childrens Hosp Philadelphia, Perelman Sch Med, Dept Anesthesiol & Crit Care Med, Philadelphia, PA 19104 USA.	kilbaugh@chop.edu	Karlsson, Michael/AAL-8743-2020	Karlsson, Michael/0000-0002-7247-2133; Leipzig, Jeremy/0000-0001-7224-9620; Kilbaugh, Todd/0000-0002-4959-3092	NIH/NINDS grant [U01NS069545]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS021328, U01NS069545] Funding Source: NIH RePORTER	NIH/NINDS grant; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by NIH/NINDS grant: U01NS069545.	Adelson PD, 2012, J NEUROTRAUM, V29, P639, DOI 10.1089/neu.2011.1952; Block ML, 2007, NAT REV NEUROSCI, V8, P57, DOI 10.1038/nrn2038; Chan JK, 2012, J CLIN INVEST, V122, P2711, DOI 10.1172/JCI62423; Dantzer R, 2008, NAT REV NEUROSCI, V9, P46, DOI 10.1038/nrn2297; Das M, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-236; Di Filippo M, 2010, J ALZHEIMERS DIS, V20, pS369, DOI 10.3233/JAD-2010-100543; Duhaime AC, 2006, DEV NEUROSCI-BASEL, V28, P380, DOI 10.1159/000094164; Durham SR, 2007, J NEUROTRAUM, V24, P5, DOI 10.1089/neu.2006.0054; Eucker SA, 2011, EXP NEUROL, V227, P79, DOI 10.1016/j.expneurol.2010.09.015; Forde CT, 2014, BRIT J NEUROSURG, V28, P8, DOI 10.3109/02688697.2013.815317; Gean AD, 2010, NEUROIMAG CLIN N AM, V20, P527, DOI 10.1016/j.nic.2010.08.001; Gilmer LK, 2010, J NEUROTRAUM, V27, P939, DOI 10.1089/neu.2009.1181; Gnaiger E, 2009, INT J BIOCH CELL BIO; Grate LL, 2003, J NEUROSCI METH, V123, P201, DOI 10.1016/S0165-0270(02)00361-8; Hunter JV, 2012, J NEUROTRAUM, V29, P654, DOI 10.1089/neu.2011.1906; Jaber SM, 2015, DEV NEUROPSYCHOL, V40, P34, DOI 10.1080/87565641.2014.969733; Karlsson M, 2012, INT J BIOCHEM CELL B, DOI [10.1016/j.biocel.2012.08.008, DOI 10.1016/J.BI0CEL.2012.08.008]; Kirkinezos IG, 2001, SEMIN CELL DEV BIOL, V12, P449, DOI 10.1006/scdb.2001.0282; Lartigue L, 2013, INT J BIOCHEM CELL B, V45, P2052, DOI 10.1016/j.biocel.2013.06.014; Lifshitz J, 2004, MITOCHONDRION, V4, P705, DOI 10.1016/j.mito.2004.07.021; Lu J, 2009, FRONT BIOSCI-LANDMRK, V14, P3795, DOI [10.2735/3489, 10.2741/3489]; Malik AN, 2013, MITOCHONDRION, V13, P481, DOI 10.1016/j.mito.2012.10.011; Marcoux J, 2008, CRIT CARE MED, V36, P2871, DOI 10.1097/CCM.0b013e318186a4a0; Margulies SS, 2015, BRAIN PATHOL, V25, P289, DOI 10.1111/bpa.12247; Miller AC, 2012, COMMON DATA ELEMENTS; Missios S, 2009, J NEUROTRAUM, V26, P1943, DOI [10.1089/neu.2009.0956, 10.1089/neu.2009-0956]; Morganti-Kossmann MC, 2007, INJURY, V38, P1392, DOI 10.1016/j.injury.2007.10.005; Robertson CL, 2006, DEV NEUROSCI-BASEL, V28, P432, DOI 10.1159/000094169; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Utagawa A, 2008, EXP NEUROL, V211, P283, DOI 10.1016/j.expneurol.2008.02.001; Walko TD, 2014, SHOCK, V41, P499, DOI 10.1097/SHK.0000000000000160; Weeks D, 2014, J NEUROTRAUM, V31, P206, DOI 10.1089/neu.2013.3113; West AP, 2011, NAT REV IMMUNOL, V11, P389, DOI 10.1038/nri2975; Zhang Q, 2010, SHOCK, V34, P55, DOI 10.1097/SHK.0b013e3181cd8c08; Zhang Q, 2010, NATURE, V464, P104, DOI 10.1038/nature08780; Zhang QG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034504	36	29	30	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2015	10	6							e0130927	10.1371/journal.pone.0130927	http://dx.doi.org/10.1371/journal.pone.0130927			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL3FM	26098565	Green Published, gold, Green Submitted			2022-12-26	WOS:000356835800123
J	Russell, S; Sullivan, CA; Reichelt-Brushett, AJ				Russell, Shaina; Sullivan, Caroline A.; Reichelt-Brushett, Amanda J.			Aboriginal Consumption of Estuarine Food Resources and Potential Implications for Health through Trace Metal Exposure; A Study in Gumbaynggirr Country, Australia	PLOS ONE			English	Article							MULLET MUGIL-CEPHALUS; HEAVY-METALS; RIVER; KNOWLEDGE; FISHERIES; POLLUTION; MERCURY; PEOPLES; TISSUES; RIGHTS	Fishing and resource use continues to be an essential aspect of life for many Aboriginal communities throughout Australia. It is important for dietary sustenance, and also retains deep social, cultural and economic significance, playing a fundamental role in maintaining group cohesion, transferring cultural knowledge and affirming Indigenous identities. We surveyed approximately 20% of the Gumbaynggirr Aboriginal community of Nambucca Heads, New South Wales, Australia. This paper explores Gumbaynggirr Connection to Country and engagement in cultural practice. It quantifies fishing efforts and consumption of seafood within the community. We found 95% of the sample group fish, with the highest rate of fishing being 2-3 times a week (27%). Furthermore, 98% of participants eat seafood weekly or more frequently, up to more than once a day (24%). Survey results revealed that Myxus elongatus (Sand mullet) and naturally recruited Saccostrea glomerata (Sydney rock oysters) continue to be important wild resources to the Gumbaynggirr community. Trace metals were measured in M. elongatus and S. glomerata samples collected by community participants in this study. Maximum levels prescribed in the Australia New Zealand Food Standards Code were not exceeded in the edible tissue for either species, however both species exceeded the generally expected levels for zinc and copper and S. glomerata samples exceeded the generally expected level for selenium. Furthermore the average dietary exposure to trace metals from consuming seafood was calculated for the surveyed population. Trace metal intake was then compared to the provisional tolerable weekly intake prescribed by the Joint Expert Committee on Food Additives. This process revealed that copper and selenium intake were both within the provisional tolerable weekly intake, while there is no guideline for zinc. Furthermore, participants relying heavily on wild resources from the Nambucca River estuary may exceed the provisional tolerable weekly intake for cadmium. This suggests the need for further investigation of this issue to minimize any possible health risk.	[Reichelt-Brushett, Amanda J.] So Cross Univ, Sch Environm Sci & Engn, Lismore, NSW 2480, Australia; So Cross Univ, Marine Ecol Res Ctr, Lismore, NSW 2480, Australia	Southern Cross University; Southern Cross University	Reichelt-Brushett, AJ (corresponding author), So Cross Univ, Sch Environm Sci & Engn, Lismore, NSW 2480, Australia.	amanda.reichelt-brushett@scu.edu.au	Reichelt-Brushett, Amanda J/Q-8348-2017; Sullivan, Caroline/T-8668-2017	Reichelt-Brushett, Amanda J/0000-0002-5212-7586; Sullivan, Caroline/0000-0001-8486-0523; Chiaradia, Andre/0000-0002-6178-4211	Marine Ecology Research Centre (support for independent post graduate student project); School of Environment, Science and Engineering (support for independent postgraduate student project)	Marine Ecology Research Centre (support for independent post graduate student project); School of Environment, Science and Engineering (support for independent postgraduate student project)	Funding was received from the Marine Ecology Research Centre (support for independent post graduate student project) and the School of Environment, Science and Engineering (support for independent postgraduate student project). Both are not for profit organisations and the funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asafu-Adjaye J., 1996, International Journal of Social Economics, V23, P125, DOI 10.1108/03068299610121750; *AUSTR BUR STAT, 2008, NAT AB TORR STRAIT I; Australia New Zealand Food Authority, 1998, REG CONT OTH RESTR S; Australian Bureau of Statistics, 2011, NAMB HEADS IND POP; Australian Government Department of Health and Ageing National Health and Medical Research Council, 2005, FOOD HLTH DIET GUID; Australian Government Department of Sustainability Environment Water Population and Communities, 2012, DUG; Australian Institute of Aboriginal and Torres Strait Islander Studies, 2011, GUID ETH RES AUSTR I; Berkes F., 1998, LINKING SOCIAL ECOLO, P1; Bess R, 2007, MAR POLICY, V31, P719, DOI 10.1016/j.marpol.2006.12.009; Boischio AAP, 2000, ENVIRON RES, V84, P108, DOI 10.1006/enrs.2000.4035; Buchanan G, 2009, ALWAYS PART US SOCIO; Butler JRA, 2012, ECOL SOC, V17, DOI 10.5751/ES-05165-170434; Calta M, 2006, WATER ENVIRON RES, V78, P548, DOI 10.2175/106143006X99849; Capistrano RCG, 2012, OCEAN COAST MANAGE, V69, P200, DOI 10.1016/j.ocecoaman.2012.08.011; Carsten J, 1999, AKADEMIKA, V54, P175; Carvalho ML, 2005, ANAL BIOANAL CHEM, V382, P426, DOI 10.1007/s00216-004-3005-3; Chan HM, 2000, ENVIRON POLLUT, V110, P1, DOI 10.1016/S0269-7491(00)00061-0; Chute JE, 1998, EARTH WATER AIR FIRE; Coffey Geotechnics Pty Ltd, 2009, PHAS 1 ENV SIT ASS W; Commonwealth of Australia, 2011, AUSTR NZ FOOD STAND; Egan H, 2010, THESIS SO CROSS U; El-Hayek YH, 2007, J DEV DISABILITIES, V13; English A, 2002, SEA ROCK GIVES US FE; Fang JY, 2013, CLIN CHIM ACTA, V423, P23, DOI 10.1016/j.cca.2013.04.012; Flood J, 2000, ARCHAEOLOGY DREAMTIM; Franklyn EM, 2003, ABORIGINAL FISHING S; GADGIL M, 1993, AMBIO, V22, P151; Green D, 2010, CLIMATIC CHANGE, V100, P337, DOI 10.1007/s10584-010-9803-z; Halpern BS, 2012, NATURE, V488, P615, DOI 10.1038/nature11397; Haswell-Elkins M, 2007, J EXPO SCI ENV EPID, V17, P372, DOI 10.1038/sj.jes.7500520; Henry GW, 2003, NATL RECREATIONAL IN; HU H, 2002, LIFE SUPPORT ENV HUM; Humphries Paul, 2007, Ecological Management & Restoration, V8, P106, DOI 10.1111/j.1442-8903.2007.00347.x; Inglis J. T., 1993, TRADITIONAL ECOLOGIC; Jackson S, 2012, HUM ECOL, V40, P893, DOI 10.1007/s10745-012-9518-z; Jarup L, 2003, BRIT MED B, V68, P71; Kalay M, 1999, B ENVIRON CONTAM TOX, V63, P673, DOI 10.1007/s001289901033; Kijas J., 1999, J AUSTR STUDIES, V61, P143; Laird BD, 2013, ENVIRON INT, V59, P33, DOI 10.1016/j.envint.2013.05.010; LARSEN EH, 1993, J ANAL ATOM SPECTROM, V8, P1075, DOI 10.1039/ja9930801075; Licata P, 2003, CHEMOSPHERE, V52, P231, DOI 10.1016/S0045-6535(03)00271-6; Lloyd D, 1996, SALTWATER PEOPLE; Luffman B, NAMBUCCA RIVER ESTUA; Marshall C, 2010, SEA MEETS LAND MAPPI; Maykut P., 1994, BEGINNING QUALITATIV; McNiven IJ, 2003, WORLD ARCHAEOL, V35, P329, DOI 10.1080/0043824042000185757; MICHAELIS H, 1993, HYDROBIOLOGIA, V258, P175, DOI 10.1007/BF00006195; Moncrieff CF, 2003, TRADITION ECOLOGICAL; Morais SF, 2012, ENV ISSUES PRACTICE; Morrens B, 2012, INT J HYG ENVIR HEAL, V215, P474, DOI 10.1016/j.ijheh.2011.10.008; Muralidharan S, 2012, PROTEOMICS, V12, P906, DOI 10.1002/pmic.201100417; Narchi NE, 2014, OCEAN COAST MANAGE, V89, P117, DOI 10.1016/j.ocecoaman.2013.09.014; Neuman LW., 2007, SOCIAL RES METHODS, V6th; New South Wales Department of Primary Industries, 2002, IND FISH STRAT IMPL; New South Wales Health Department, 2001, MET CONT NSW FISH SP; ODUM WE, 1968, LIMNOL OCEANOGR, V13, P92, DOI 10.4319/lo.1968.13.1.0092; Petrenya N, 2011, INT J CIRCUMPOL HEAL, V70, P46, DOI 10.3402/ijch.v70i1.17798; Priya SL, 2011, TOXICOL IND HEALTH, V27, P117, DOI 10.1177/0748233710381892; Prober SM, 2011, ECOL SOC, V16; Roach AC, 2007, ARCH ENV CONTAMINATI, V54, P292; Roberts A, 2010, ABORIGINAL WOMENS FI; ROE A, 2003, B SCI TECHNOL SOC, V23, P368, DOI DOI 10.1177/0270467603259787; Rose D. B., 1996, AUSTR ABORIGINAL VIE; Rouja PM, 2003, LIPIDS, V38, P399, DOI 10.1007/s11745-003-1075-z; Schnierer S., 2011, ABORIGINAL FISHERIES; Sharp N., 2002, SALTWATER PEOPLE WAV; Smyth D, 2010, RIGHTS USE COUNTRY F; Smyth D., 1993, VOICE ALL PLACES ABO; Somerville M., 2010, SINGING COAST; Spooner DR, 2003, ARCH ENVIRON CON TOX, V45, P92, DOI 10.1007/s00244-002-0111-0; Stankovic S, 2013, ENVIRON CHEM LETT, P1; Sveiby KE, 2009, SUSTAIN DEV, V17, P341, DOI 10.1002/sd.389; United States Environmental Protection Agency, 1991, CASRN7782492 US EPA; WHO, 1989, 33 M JOINT FAO WHO E; Wightman, 2001, ECOLOGICAL MANAGEMEN, V2, P99, DOI [10.1046/j.1442-8903.2001.00073.x, DOI 10.1046/J.1442-8903.2001.00073.X, 10.1046/J.1442-8903.2001.00073.X]; Woodward E, 2012, UTILISING INDIGENOUS; World Health Organisation, 1982, TECHN REP SER, V683; World Health Organization, 2010, 8 WHO HARM	78	9	9	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2015	10	6							e0130689	10.1371/journal.pone.0130689	http://dx.doi.org/10.1371/journal.pone.0130689			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CL3FM	26098897	Green Published, Green Submitted, gold			2022-12-26	WOS:000356835800096
J	Shomali, M; Opie, D; Avasthi, T; Trilling, A				Shomali, Majdi; Opie, David; Avasthi, Trisha; Trilling, Ariel			Nitrogen Dioxide Sterilization in Low-Resource Environments: A Feasibility Study	PLOS ONE			English	Article							AFRICA	Access to sterilization is a critical need for global healthcare, as it is one of the prerequisites for safe surgical care. Lack of sterilization capability has driven up healthcare infection rates as well as limited access to healthcare, especially in low-resource environments. Sterilization technology has for the most part been static and none of the established sterilization methods has been so far successfully adapted for use in low-resource environments on a large scale. It is evident that healthcare facilities in low-resource settings require reliable, deployable, durable, affordable, easily operable sterilization equipment that can operate independently of scarce resources. Recently commercialized nitrogen dioxide (NO2) sterilization technology was analyzed and adapted into a form factor suitable for use in low-resource environments. Lab testing was conducted in microbiological testing facilities simulating low-resource environments and in accordance with the requirements of the international sterilization standard ANSI/AAMI/ISO 14937 to assess effectiveness of the device and process. The feasibility of a portable sterilizer based on nitrogen dioxide has been demonstrated, showing that sterilization of medical instruments can occur in a form factor suitable for use in low-resource environments. If developed and deployed, NO2 sterilization technology will have the twin benefits of reducing healthcare acquired infections and limiting a major constraint for access to surgical care on a global scale. Additional benefits are achieved in reducing costs and biohazard waste generated by current health care initiatives that rely primarily on disposable kits, increasing the effectiveness and outreach of these initiatives.	[Shomali, Majdi; Avasthi, Trisha; Trilling, Ariel] Eniware LLC, Washington, DC 20037 USA; [Opie, David] Noxilizer Inc, Baltimore, MD USA		Trilling, A (corresponding author), Eniware LLC, Washington, DC 20037 USA.	ariel.trilling@eniwaresterile.com			Eniware, LLC; Eniware LLC; Noxilizer Inc.	Eniware, LLC; Eniware LLC; Noxilizer Inc.	Eniware, LLC provided funding for the study. As employees of Eniware LLC, Majdi Shomali, Trisha Avasthi and Ariel Trilling participated in the study design, analysis of data, preparation of the manuscript, and decision to publish. As an employee of Noxilizer Inc., David Opie participated in study design, analysis of data, and preparation of the manuscript. Eniware LLC and Noxilizer Inc. provided support in the form of salaries for these authors.	Adair-Rohani H, 2013, GLOB HEALTH-SCI PRAC, V1, P249, DOI 10.9745/GHSP-D-13-00037; Alkire BC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034595; [Anonymous], 2003, SURG CAR DISTR HOSP; Bermudez E, 1999, ENVIRON RES, V81, P72, DOI 10.1006/enrs.1999.3955; Edgil D, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001128; *FDA, 1993, GUID PREM NOT 510 K; GORSDORF S, 1990, CARCINOGENESIS, V11, P37, DOI 10.1093/carcin/11.1.37; Grimes CE, 2014, WORLD J SURG, V38, P252, DOI 10.1007/s00268-013-2243-y; ISO, 2009, 149372009 ISO; ISO, 2009, 1099312009 ISO; Meara JG, 2015, LANCET, V386, P569, DOI 10.1016/S0140-6736(15)60160-X; Nejad SB, 2011, B WORLD HEALTH ORGAN, V89, P757, DOI 10.2471/BLT.11.088179; Noxilizer, 2012, WHIT PAP MECH OV NIT; Opie D, 2014, PAR DRUG ASS ANN M P; Opie D, 2013, PDA AS PROC STER C C	15	17	17	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2015	10	6							e0130043	10.1371/journal.pone.0130043	http://dx.doi.org/10.1371/journal.pone.0130043			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL3FM	26098905	Green Published, gold, Green Submitted			2022-12-26	WOS:000356835800051
J	Stewart-Jones, GBE; Thomas, PV; Chen, M; Druz, A; Joyce, MG; Kong, WP; Sastry, M; Soto, C; Yang, YP; Zhang, BS; Chen, L; Chuang, GY; Georgiev, IS; McLellan, JS; Srivatsan, S; Zhou, TQ; Baxa, U; Mascola, JR; Graham, BS; Kwong, PD				Stewart-Jones, Guillaume B. E.; Thomas, Paul V.; Chen, Man; Druz, Aliaksandr; Joyce, M. Gordon; Kong, Wing-Pui; Sastry, Mallika; Soto, Cinque; Yang, Yongping; Zhang, Baoshan; Chen, Lei; Chuang, Gwo-Yu; Georgiev, Ivelin S.; McLellan, Jason S.; Srivatsan, Sanjay; Zhou, Tongqing; Baxa, Ulrich; Mascola, John R.; Graham, Barney S.; Kwong, Peter D.			A Cysteine Zipper Stabilizes a Pre-Fusion F Glycoprotein Vaccine for Respiratory Syncytial Virus	PLOS ONE			English	Article							COILED-COIL; NEUTRALIZING ANTIBODIES; PROTEIN; TRIMERS; DOMAIN; DESIGN	Recombinant subunit vaccines should contain minimal non-pathogen motifs to reduce potential off-target reactivity. We recently developed a vaccine antigen against respiratory syncytial virus (RSV), which comprised the fusion (F) glycoprotein stabilized in its pre-fusion trimeric conformation by "DS-Cav1" mutations and by an appended C-terminal trimerization motif or "foldon" from T4-bacteriophage fibritin. Here we investigate the creation of a cysteine zipper to allow for the removal of the phage foldon, while maintaining the immunogenicity of the parent DS-Cav1+foldon antigen. Constructs without foldon yielded RSV F monomers, and enzymatic removal of the phage foldon from pre-fusion F trimers resulted in their dissociation into monomers. Because the native C terminus of the pre-fusion RSV F ectodomain encompasses a viral trimeric coiled-coil, we explored whether introduction of cysteine residues capable of forming inter-protomer disulfides might allow for stable trimers. Structural modeling indicated the introduced cysteines to form disulfide "rings", with each ring comprising a different set of inward facing residues of the coiled-coil. Three sets of rings could be placed within the native RSV F coiled-coil, and additional rings could be added by duplicating portions of the coiled-coil. High levels of neutralizing activity in mice, equivalent to that of the parent DS-Cav1+foldon antigen, were elicited by a 4-ring stabilized RSV F trimer with no foldon. Structure-based alteration of a viral coiled-coil to create a cysteine zipper thus allows a phage trimerization motif to be removed from a candidate vaccine antigen.	[Stewart-Jones, Guillaume B. E.; Thomas, Paul V.; Chen, Man; Druz, Aliaksandr; Joyce, M. Gordon; Kong, Wing-Pui; Sastry, Mallika; Soto, Cinque; Yang, Yongping; Zhang, Baoshan; Chen, Lei; Chuang, Gwo-Yu; Georgiev, Ivelin S.; McLellan, Jason S.; Srivatsan, Sanjay; Zhou, Tongqing; Mascola, John R.; Graham, Barney S.; Kwong, Peter D.] NIAID, Vaccine Res Ctr, NIH, Bethesda, MD 20892 USA; [McLellan, Jason S.] Geisel Sch Med Dartmouth, Dept Biochem, Hanover, NH USA; [Baxa, Ulrich] Leidos Biomed Res Inc, Electron Microscopy Lab, Canc Res Technol Program, Frederick Natl Lab Canc Res, Frederick, MD USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Dartmouth College; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Kwong, PD (corresponding author), NIAID, Vaccine Res Ctr, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	pdkwong@nih.gov	Mascola, John/AAI-7193-2021; Zhou, Tongqing/A-6880-2010; Graham, Barney S./AAC-5898-2019	Zhou, Tongqing/0000-0002-3935-4637; Graham, Barney S./0000-0001-8112-0853; McLellan, Jason/0000-0003-3991-542X; Baxa, Ulrich/0000-0002-7263-5078	Intramural Research Program of the Vaccine Research Center, National Institute of Allergy and Infectious Diseases [ZIA AI005024-13]; Frederick National Laboratory for Cancer Research, National Institutes of Health [HHSN261200800001E]; Leidos Biomedical Research, Inc.; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZICAI005113, ZICAI005114, ZICAI005112, ZIAAI005024] Funding Source: NIH RePORTER	Intramural Research Program of the Vaccine Research Center, National Institute of Allergy and Infectious Diseases; Frederick National Laboratory for Cancer Research, National Institutes of Health; Leidos Biomedical Research, Inc.; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Support for this work was provided by the Intramural Research Program of the Vaccine Research Center, National Institute of Allergy and Infectious Diseases, ZIA AI005024-13. This project has been funded in part with Federal funds from the Frederick National Laboratory for Cancer Research, National Institutes of Health, under contract HHSN261200800001E. Leidos Biomedical Research, Inc., provided support in the form of a salary for author UB. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson L, 2013, ART NEWS, V112, P26; Beaumont T, 2012, RSV SPECIFIC BINDING; Chakrabarti BK, 2013, J VIROL, V87, P13239, DOI 10.1128/JVI.01247-13; Chang J, 2011, BMB REP, V44, P232, DOI 10.5483/BMBRep.2011.44.4.232; Citartan M, 2013, ANALYST, V138, P3576, DOI 10.1039/c3an36828a; Corti D, 2013, NATURE, V501, P439, DOI 10.1038/nature12442; Dames SA, 1998, NAT STRUCT BIOL, V5, P687, DOI 10.1038/1382; Du LY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016555; Du SX, 2009, VIROLOGY, V395, P33, DOI 10.1016/j.virol.2009.07.042; Earp LJ, 2005, CURR TOP MICROBIOL, V285, P25; Eckert DM, 1998, J MOL BIOL, V284, P859, DOI 10.1006/jmbi.1998.2214; Eggink D, 2014, J VIROL, V88, P699, DOI 10.1128/JVI.02608-13; Forsell MNE, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000171; Frank S, 2001, J MOL BIOL, V308, P1081, DOI 10.1006/jmbi.2001.4644; GRAHAM BS, 1988, J MED VIROL, V26, P153, DOI 10.1002/jmv.1890260207; Grigoryan G, 2008, CURR OPIN STRUC BIOL, V18, P477, DOI 10.1016/j.sbi.2008.04.008; Grigoryan G, 2011, J MOL BIOL, V405, P1079, DOI 10.1016/j.jmb.2010.08.058; Guthe S, 2004, J MOL BIOL, V337, P905, DOI 10.1016/j.jmb.2004.02.020; Hall Caroline Breese, 2012, Infectious Disorders - Drug Targets, V12, P92; Heymann JB, 2007, J STRUCT BIOL, V157, P3, DOI 10.1016/j.jsb.2006.06.006; Homaira Nusrat, 2014, Int J Pediatr, V2014, P571609, DOI 10.1155/2014/571609; Hotard AL, 2012, VIROLOGY, V434, P129, DOI 10.1016/j.virol.2012.09.022; Hurwitz JL, 2011, EXPERT REV VACCINES, V10, P1415, DOI [10.1586/erv.11.120, 10.1586/ERV.11.120]; Kovacs JM, 2014, P NATL ACAD SCI USA, V111, P18542, DOI 10.1073/pnas.1422269112; Liljeroos L, 2013, P NATL ACAD SCI USA, V110, P11133, DOI 10.1073/pnas.1309070110; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Magro M, 2012, P NATL ACAD SCI USA, V109, P3089, DOI 10.1073/pnas.1115941109; Mason JM, 2007, METH MOL B, V352, P35; McDonald Terence P, 2007, Methods Mol Biol, V379, P97; McLellan JS, 2013, SCIENCE, V342, P592, DOI 10.1126/science.1243283; McLellan JS, 2013, SCIENCE, V340, P1113, DOI 10.1126/science.1234914; McLellan JS, 2011, J VIROL, V85, P7788, DOI 10.1128/JVI.00555-11; Nair H, 2010, LANCET, V375, P1545, DOI 10.1016/S0140-6736(10)60206-1; Nkolola JP, 2010, J VIROL, V84, P3270, DOI 10.1128/JVI.02252-09; Null D, 1998, PEDIATRICS, V102, P531, DOI 10.1542/peds.102.3.531; Oshaben KM, 2012, BIOCHEMISTRY-US, V51, P9581, DOI 10.1021/bi301132k; Sliepen K, 2015, J BIOL CHEM, V290, P7436, DOI 10.1074/jbc.M114.620534; Spits H, 2010, RSV SPECIFIC BINDING; Sundling C, 2010, J EXP MED, V207, P2003, DOI 10.1084/jem.20100025; Swanson KA, 2014, J VIROL, V88, P11802, DOI 10.1128/JVI.01225-14; Swanson KA, 2011, P NATL ACAD SCI USA, V108, P9619, DOI 10.1073/pnas.1106536108; Tao YZ, 1997, STRUCTURE, V5, P789, DOI 10.1016/S0969-2126(97)00233-5; Van Vliet K, 2009, MICROBIOL MOL BIOL R, V73, P730, DOI 10.1128/MMBR.00026-09; Zokarkar A, 2012, J VIROL, V86, P12397, DOI 10.1128/JVI.02006-12	45	29	35	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2015	10	6							e0128779	10.1371/journal.pone.0128779	http://dx.doi.org/10.1371/journal.pone.0128779			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL3FM	26098893	gold, Green Published, Green Submitted			2022-12-26	WOS:000356835800019
J	Cole, JH; Filippetti, ML; Allin, MPG; Walshe, M; Nam, KW; Gutman, BA; Murray, RM; Rifkin, L; Thompson, PM; Nosarti, C				Cole, James H.; Filippetti, Maria Laura; Allin, Matthew P. G.; Walshe, Muriel; Nam, Kie Woo; Gutman, Boris A.; Murray, Robin M.; Rifkin, Larry; Thompson, Paul M.; Nosarti, Chiara			Subregional Hippocampal Morphology and Psychiatric Outcome in Adolescents Who Were Born Very Preterm and at Term	PLOS ONE			English	Article							LOW-BIRTH-WEIGHT; AL DELUSIONS INVENTORY; HIGH-RISK INDIVIDUALS; BRAIN VOLUME CHANGES; CHRONIC-SCHIZOPHRENIA; WORKING-MEMORY; NEURODEVELOPMENTAL IMPAIRMENT; ULTRASOUND APPEARANCE; EPISODIC MEMORY; CHILDREN	Background The hippocampus has been reported to be structurally and functionally altered as a sequel of very preterm birth (<33 weeks gestation), possibly due its vulnerability to hypoxic-ischemic damage in the neonatal period. We examined hippocampal volumes and subregional morphology in very preterm born individuals in mid-and late adolescence and their association with psychiatric outcome. Methods Structural brain magnetic resonance images were acquired at two time points (baseline and follow-up) from 65 ex-preterm adolescents (mean age = 15.5 and 19.6 years) and 36 term-born controls (mean age=15.0 and 19.0 years). Hippocampal volumes and subregional morphometric differences were measured from manual tracings and with three-dimensional shape analysis. Psychiatric outcome was assessed with the Rutter Parents' Scale at baseline, the General Health Questionnaire at follow-up and the Peters Delusional Inventory at both time points. Results In contrast to previous studies we did not find significant difference in the cross-sectional or longitudinal hippocampal volumes between individuals born preterm and controls, despite preterm individual having significantly smaller whole brain volumes. Shape analysis at baseline revealed subregional deformations in 28% of total bilateral hippocampal surface, reflecting atrophy, in ex-preterm individuals compared to controls, and in 22% at follow-up. In ex-preterm individuals, longitudinal changes in hippocampal shape accounted for 11% of the total surface, while in controls they reached 20%. In the whole sample (both groups) larger right hippocampal volume and bilateral anterior surface deformations at baseline were associated with delusional ideation scores at follow-up. Conclusions This study suggests a dynamic association between cross-sectional hippocampal volumes, longitudinal changes and surface deformations and psychosis proneness.	[Cole, James H.] Univ London Imperial Coll Sci Technol & Med, Dept Med, Computat Cognit & Clin Neuroimaging Lab, London, England; [Filippetti, Maria Laura; Allin, Matthew P. G.; Walshe, Muriel; Nam, Kie Woo; Murray, Robin M.; Rifkin, Larry; Nosarti, Chiara] Kings Coll London, Kings Hlth Partners, Inst Psychiat, Dept Psychosis Studies, London, England; [Gutman, Boris A.; Thompson, Paul M.] Univ So Calif, Imaging Genet Ctr, Marina Del Rey, CA USA	Imperial College London; University of London; King's College London; University of Southern California	Nosarti, C (corresponding author), Kings Coll London, Kings Hlth Partners, Inst Psychiat, Dept Psychosis Studies, De Crespigny Pk, London, England.	chiara.nosarti@kcl.ac.uk	Filippetti, Maria Laura/ABG-7461-2021; Cole, James H/I-5197-2019; Walshe, Muriel/E-5214-2010; Thompson, Paul M/C-4194-2018; Nosarti, Chiara/G-5638-2010; murray, robin/F-8658-2012	Filippetti, Maria Laura/0000-0002-1824-9774; Cole, James H/0000-0003-1908-5588; Walshe, Muriel/0000-0001-6829-1105; Thompson, Paul M/0000-0002-4720-8867; Nosarti, Chiara/0000-0001-6305-9710; Rifkin, Larry/0000-0003-2590-9010; murray, robin/0000-0003-0829-0519	Sir Jules Thorne Charitable Trust; Wellcome Trust, UK [065699/Z/01/Z]; MRC [MR/K004867/1] Funding Source: UKRI	Sir Jules Thorne Charitable Trust; Wellcome Trust, UK(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The study was funded by the Sir Jules Thorne Charitable Trust (no grant number; (www.julesthorntrust.org.uk)) and the Wellcome Trust, UK (Grant No. 065699/Z/01/Z; (www.wellcome.ac.uk)). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abernethy LJ, 2002, ARCH DIS CHILD, V87, P279, DOI 10.1136/adc.87.4.279; Adriano F, 2012, NEUROSCIENTIST, V18, P180, DOI 10.1177/1073858410395147; Allin M, 2001, BRAIN, V124, P60, DOI 10.1093/brain/124.1.60; Allin M, 2007, ARCH PEDIAT ADOL MED, V161, P1183, DOI 10.1001/archpedi.161.12.1183; Anderson P, 2003, JAMA-J AM MED ASSOC, V289, P3264, DOI 10.1001/jama.289.24.3264; ANDREASEN NC, 1993, AM J PSYCHIAT, V150, P130; Arnold SE, 1996, J COMP NEUROL, V367, P274, DOI 10.1002/(SICI)1096-9861(19960401)367:2<274::AID-CNE9>3.0.CO;2-2; Baddeley A, 2011, J COGNITIVE NEUROSCI, V23, P3855, DOI 10.1162/jocn_a_00066; Barbas H, 1995, HIPPOCAMPUS, V5, P511, DOI 10.1002/hipo.450050604; Beauchamp MH, 2008, BRAIN, V131, P2986, DOI 10.1093/brain/awn227; BENES FM, 1994, ARCH GEN PSYCHIAT, V51, P477; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bigler ED, 1997, AM J NEURORADIOL, V18, P11; Blumberg HP, 2003, ARCH GEN PSYCHIAT, V60, P1201, DOI 10.1001/archpsyc.60.12.1201; Botting N, 1998, DEV MED CHILD NEUROL, V40, P652; Botting N, 1997, J CHILD PSYCHOL PSYC, V38, P931, DOI 10.1111/j.1469-7610.1997.tb01612.x; Broome MR, 2007, BRIT J PSYCHIAT, V191, pS38, DOI 10.1192/bjp.191.51.s38; Broome MR, 2012, EUR PSYCHIAT, V27, P258, DOI 10.1016/j.eurpsy.2010.07.008; BRUGGER P, 1994, MED HYPOTHESES, V43, P397, DOI 10.1016/0306-9877(94)90015-9; Buehlmann E, 2010, J PSYCHIATR RES, V44, P447, DOI 10.1016/j.jpsychires.2009.10.008; Cole J, 2010, J AFFECT DISORDERS, V126, P272, DOI 10.1016/j.jad.2010.03.004; CONNELL HM, 1982, AUST NZ J PSYCHIAT, V16, P43, DOI 10.3109/00048678209161190; COSTELLO AMD, 1988, DEV MED CHILD NEUROL, V30, P711; Csernansky JG, 1998, P NATL ACAD SCI USA, V95, P11406, DOI 10.1073/pnas.95.19.11406; Dagnall N, 2008, PERCEPT MOTOR SKILL, V106, P67; Desgranges B, 1998, NEUROIMAGE, V8, P198, DOI 10.1006/nimg.1998.0359; Duvernoy H. M., 1988, HUMAN HIPPOCAMPUS AT; Eisenberger NI, 2007, EMOTION, V7, P745, DOI 10.1037/1528-3542.7.4.745; Erickson KI, 2011, P NATL ACAD SCI USA, V108, P3017, DOI 10.1073/pnas.1015950108; Geddes JR, 1999, SCHIZOPHRENIA BULL, V25, P413, DOI 10.1093/oxfordjournals.schbul.a033389; Gimenez M, 2004, NEUROIMAGE, V23, P869, DOI 10.1016/j.neuroimage.2004.07.029; Gogtay N, 2006, HIPPOCAMPUS, V16, P664, DOI 10.1002/hipo.20193; Gogtay N, 2010, BRAIN COGNITION, V72, P6, DOI 10.1016/j.bandc.2009.08.009; Goldberg D.P., 1988, USERS GUIDE GEN HLTH; Goldberg DP, 1997, PSYCHOL MED, V27, P191, DOI 10.1017/S0033291796004242; Groen W, 2010, J AM ACAD CHILD PSY, V49, P552, DOI 10.1016/j.jaac.2009.12.023; Grunwald T, 2006, CLIN EEG NEUROSCI, V37, P309, DOI 10.1177/155005940603700408; Hack M, 2000, JAMA-J AM MED ASSOC, V284, P1973, DOI 10.1001/jama.284.15.1973; Henke K, 1999, P NATL ACAD SCI USA, V96, P5884, DOI 10.1073/pnas.96.10.5884; Ho BC, 2010, NEUROIMAGE, V49, P3385, DOI 10.1016/j.neuroimage.2009.11.033; Indredavik MS, 2010, J DEV BEHAV PEDIATR, V31, P286, DOI 10.1097/DBP.0b013e3181d7b1d3; Isaacs EB, 2000, PEDIATR RES, V47, P713, DOI 10.1203/00006450-200006000-00006; Johnson S, 2010, J AM ACAD CHILD PSY, V49, P453, DOI 10.1016/j.jaac.2010.02.002; Jung HY, 2008, COMPR PSYCHIAT, V49, P202, DOI 10.1016/j.comppsych.2007.08.011; Limperopoulos C, 2008, PEDIATRICS, V121, P758, DOI 10.1542/peds.2007-2158; Linney YM, 1998, BRIT J CLIN PSYCHOL, V37, P285, DOI 10.1111/j.2044-8260.1998.tb01386.x; Lodygensky GA, 2008, PEDIATR RES, V63, P438, DOI 10.1203/PDR.0b013e318165c005; Lubsen J, 2011, SEMIN PERINATOL, V35, P34, DOI 10.1053/j.semperi.2010.10.006; Maguire EA, 2000, P NATL ACAD SCI USA, V97, P4398, DOI 10.1073/pnas.070039597; Mattai A, 2011, AM J PSYCHIAT, V168, P427, DOI 10.1176/appi.ajp.2010.10050681; McEwen BS, 2001, ANN NY ACAD SCI, V933, P265, DOI 10.1111/j.1749-6632.2001.tb05830.x; Ment LR, 2009, PEDIATRICS, V123, P503, DOI 10.1542/peds.2008-0025; Miller GA, 2001, J ABNORM PSYCHOL, V110, P40, DOI 10.1037//0021-843X.110.1.40; NAKAMURA Y, 1986, ACTA PATHOL JAPON, V36, P551; Narr KL, 2004, NEUROIMAGE, V21, P1563, DOI 10.1016/j.neuroimage.2003.11.011; Nosarti C, 2005, BIOL PSYCHIAT, V57, P661, DOI 10.1016/j.biopsych.2004.12.003; Nosarti C, 2002, BRAIN, V125, P1616, DOI 10.1093/brain/awf157; Nosarti C, 2008, BRAIN, V131, P205, DOI 10.1093/brain/awm282; Nosarti C, 2012, ARCH GEN PSYCHIAT, V69, P610, DOI 10.1001/archgenpsychiatry.2011.1374; Parker J, 2008, BRAIN, V131, P1344, DOI 10.1093/brain/awn062; Pavlova MA, 2013, BRAIN, V136, P998, DOI 10.1093/brain/aws334; Peters E, 2004, SCHIZOPHRENIA BULL, V30, P1005, DOI 10.1093/oxfordjournals.schbul.a007116; Peterson BS, 2003, PEDIATRICS, V111, P939, DOI 10.1542/peds.111.5.939; Phillips ML, 2003, BIOL PSYCHIAT, V54, P515, DOI 10.1016/S0006-3223(03)00171-9; Plessen KJ, 2006, ARCH GEN PSYCHIAT, V63, P795, DOI 10.1001/archpsyc.63.7.795; Preti A, 2007, COMPR PSYCHIAT, V48, P62, DOI 10.1016/j.comppsych.2006.05.003; Raikkonen K, 2008, ARCH GEN PSYCHIAT, V65, P290, DOI 10.1001/archgenpsychiatry.2007.40; Reig S, 2009, SCHIZOPHRENIA BULL, V35, P233, DOI 10.1093/schbul/sbm160; Rex DE, 2003, NEUROIMAGE, V19, P1033, DOI 10.1016/S1053-8119(03)00185-X; Rogers CE, 2012, J AM ACAD CHILD PSY, V51, P181, DOI 10.1016/j.jaac.2011.11.009; Rosoklija G, 2000, ARCH GEN PSYCHIAT, V57, P349, DOI 10.1001/archpsyc.57.4.349; ROTH SC, 1993, DEV MED CHILD NEUROL, V35, P755; Rugg MD, 2002, PHILOS T R SOC B, V357, P1097, DOI 10.1098/rstb.2002.1102; Rushe TM, 2004, ARCH DIS CHILD-FETAL, V89, P112, DOI 10.1136/adc.2001.005314; RUTTER M, 1965, J CHILD PSYCHOL PSYC, V6, P71, DOI 10.1111/j.1469-7610.1965.tb02229.x; Rutter M., 1970, ED HLTH BEHAV; Shaw P, 2006, NATURE, V440, P676, DOI 10.1038/nature04513; Shaw P, 2010, HUM BRAIN MAPP, V31, P917, DOI 10.1002/hbm.21028; Shi YG, 2009, LECT NOTES COMPUT SC, V5636, P467; St Jacques PL, 2011, J PSYCHIATR RES, V45, P630, DOI 10.1016/j.jpsychires.2010.10.011; Stein JL, 2012, NAT GENET, V44, P552, DOI 10.1038/ng.2250; STEWART AL, 1989, DEV MED CHILD NEUROL, V31, P756; Strange BA, 1999, MOL PSYCHIATR, V4, P508, DOI 10.1038/sj.mp.4000593; Taylor HG, 2000, CHILD DEV, V71, P1495, DOI 10.1111/1467-8624.00242; Thompson DK, 2008, ANN NEUROL, V63, P642, DOI 10.1002/ana.21367; Thompson DK, 2014, HUM BRAIN MAPP, V35, P4129, DOI 10.1002/hbm.22464; Thompson DK, 2009, HIPPOCAMPUS, V19, P118, DOI 10.1002/hipo.20492; Thompson PM, 2004, NEUROIMAGE, V22, P1754, DOI 10.1016/j.neuroimage.2004.03.040; Tupler LA, 2006, BIOL PSYCHIAT, V59, P523, DOI 10.1016/j.biopsych.2005.08.007; Van Petten C, 2004, NEUROPSYCHOLOGIA, V42, P1394, DOI 10.1016/j.neuropsychologia.2004.04.006; VanEssen DC, 1997, NATURE, V385, P313, DOI 10.1038/385313a0; VANGROEN T, 1990, J COMP NEUROL, V302, P515, DOI 10.1002/cne.903020308; Velakoulis D, 2006, ARCH GEN PSYCHIAT, V63, P139, DOI 10.1001/archpsyc.63.2.139; Velakoulis D, 1999, ARCH GEN PSYCHIAT, V56, P133, DOI 10.1001/archpsyc.56.2.133; WEINBERGER DR, 1992, AM J PSYCHIAT, V149, P890; Woods RP, 2003, NEUROIMAGE, V19, P1829, DOI 10.1016/S1053-8119(03)00243-X	96	12	13	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2015	10	6							e0130094	10.1371/journal.pone.0130094	http://dx.doi.org/10.1371/journal.pone.0130094			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL3FE	26091104	gold, Green Accepted, Green Published			2022-12-26	WOS:000356835000088
J	Redondo, N; Madan, V; Alvarez, E; Carrasco, L				Redondo, Natalia; Madan, Vanesa; Alvarez, Enrique; Carrasco, Luis			Impact of Vesicular Stomatitis Virus M Proteins on Different Cellular Functions	PLOS ONE			English	Article							MATRIX PROTEIN; GENE-EXPRESSION; TRANSLATION INITIATION; MESSENGER-RNAS; PSAP MOTIF; MEMBRANE PERMEABILIZATION; HOST RNA; INHIBITION; INFECTION; CELLS	Three different matrix (M) proteins termed M1, M2 and M3 have been described in cells infected with vesicular stomatitis virus (VSV). Individual expression of VSV M proteins induces an evident cytopathic effect including cell rounding and detachment, in addition to a partial inhibition of cellular protein synthesis, likely mediated by an indirect mechanism. Analogous to viroporins, M1 promotes the budding of new virus particles; however, this process does not produce an increase in plasma membrane permeability. In contrast to M1, M2 and M3 neither interact with the cellular membrane nor promote the budding of double membrane vesicles at the cell surface. Nonetheless, all three species of M protein interfere with the transport of cellular mRNAs from the nucleus to the cytoplasm and also modulate the redistribution of the splicing factor. The present findings indicate that all three VSV M proteins share some activities that interfere with host cell functions.	[Redondo, Natalia; Alvarez, Enrique; Carrasco, Luis] UAM, CSIC, Ctr Biol Mol Severo Ochoa, Madrid, Spain; [Madan, Vanesa] Heidelberg Univ, Dept Infect Dis, Mol Virol, Heidelberg, Germany	Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); Ruprecht Karls University Heidelberg	Redondo, N (corresponding author), UAM, CSIC, Ctr Biol Mol Severo Ochoa, Nicolas Cabrera 1,Campus Cantoblanco, Madrid, Spain.	nataliasevillano@yahoo.es	Carrasco, Luis/H-3001-2017	Carrasco, Luis/0000-0003-3833-8835; REDONDO, NATALIA/0000-0001-9356-8102; Alvarez Vazquez, Enrique/0000-0002-4889-175X	DGICYT (Direccion General de Investigacion Cientifica y Tecnica. Ministerio de Economia y Competitividad, Spain) grant [BFU2012-31861]; Fundacion Ramon Areces	DGICYT (Direccion General de Investigacion Cientifica y Tecnica. Ministerio de Economia y Competitividad, Spain) grant; Fundacion Ramon Areces	This study was supported by a DGICYT (Direccion General de Investigacion Cientifica y Tecnica. Ministerio de Economia y Competitividad, Spain) grant (BFU2012-31861). The Institutional Grant awarded to the Centro de Biologia Molecular "Severo Ochoa" (CSIC-UAM) by the Fundacion Ramon Areces is acknowledged.	Agirre A, 2002, J BIOL CHEM, V277, P40434, DOI 10.1074/jbc.M205393200; Ahmed M, 1998, J VIROL, V72, P8413, DOI 10.1128/JVI.72.10.8413-8419.1998; Ahmed M, 2003, J VIROL, V77, P4646, DOI 10.1128/JVI.77.8.4646-4657.2003; ALDABE R, 1995, BIOCHEM BIOPH RES CO, V206, P64, DOI 10.1006/bbrc.1995.1010; Aldabe R, 1996, J BIOL CHEM, V271, P23134, DOI 10.1074/jbc.271.38.23134; Aldabe R, 1995, FEBS LETT, V377, P1, DOI 10.1016/0014-5793(95)01269-9; Alvarez E, 2003, J VIROL, V77, P12392, DOI 10.1128/JVI.77.23.12392-12400.2003; Alvarez E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073723; Alvarez E, 2011, BIOCHEM BIOPH RES CO, V414, P142, DOI 10.1016/j.bbrc.2011.09.040; Sanz MA, 2010, J MOL BIOL, V402, P101, DOI 10.1016/j.jmb.2010.07.014; BARCO A, 1995, EMBO J, V14, P3349, DOI 10.1002/j.1460-2075.1995.tb07341.x; Barr JN, 2002, BBA-GENE STRUCT EXPR, V1577, P337, DOI 10.1016/S0167-4781(02)00462-1; Belsham GJ, 2009, VIRUS RES, V139, P183, DOI 10.1016/j.virusres.2008.07.001; BLACK BL, 1994, J VIROL, V68, P555, DOI 10.1128/JVI.68.1.555-560.1994; BLACK BL, 1993, J VIROL, V67, P4814, DOI 10.1128/JVI.67.8.4814-4821.1993; Buchholz UJ, 1999, J VIROL, V73, P251, DOI 10.1128/JVI.73.1.251-259.1999; Castello A, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/369648; CHENIK M, 1995, J VIROL, V69, P707, DOI 10.1128/JVI.69.2.707-712.1995; Connor JH, 2005, J BIOL CHEM, V280, P13512, DOI 10.1074/jbc.M501156200; Connor JH, 2002, J VIROL, V76, P10177, DOI 10.1128/JVI.76.20.10177-10187.2002; Craven RC, 1999, J VIROL, V73, P3359, DOI 10.1128/JVI.73.4.3359-3365.1999; de Mathos CA, 2001, FIELDS VIROLOGY, P1245; Faria PA, 2005, MOL CELL, V17, P93, DOI 10.1016/j.molcel.2004.11.023; Firth AE, 2012, J GEN VIROL, V93, P1385, DOI 10.1099/vir.0.042499-0; Gaudier M, 2002, EMBO J, V21, P2886, DOI 10.1093/emboj/cdf284; GAUDIN Y, 1995, VIROLOGY, V206, P28, DOI 10.1016/S0042-6822(95)80016-6; Ge P, 2010, SCIENCE, V327, P689, DOI 10.1126/science.1181766; Gonzalez ME, 2003, FEBS LETT, V552, P28, DOI 10.1016/S0014-5793(03)00780-4; Graham SC, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000251; Harty RN, 1999, J VIROL, V73, P2921, DOI 10.1128/JVI.73.4.2921-2929.1999; Harty RN, 2001, J VIROL, V75, P10623, DOI 10.1128/JVI.75.22.10623-10629.2001; Her LS, 1997, SCIENCE, V276, P1845, DOI 10.1126/science.276.5320.1845; Irie T, 2005, J VIROL, V79, P12617, DOI 10.1128/JVI.79.20.12617-12622.2005; Irie T, 2004, J VIROL, V78, P7823, DOI 10.1128/JVI.78.14.7823-7827.2004; Irie T, 2012, VIRUSES-BASEL, V4, P1605, DOI 10.3390/v4091605; Jayakar HR, 2000, J VIROL, V74, P9818, DOI 10.1128/JVI.74.21.9818-9827.2000; Jayakar HR, 2002, J VIROL, V76, P8011, DOI 10.1128/JVI.76.16.8011-8018.2002; Kneller ELP, 2009, J VIROL, V83, P770, DOI 10.1128/JVI.01279-08; LEFRANCOIS L, 1982, VIROLOGY, V121, P157, DOI 10.1016/0042-6822(82)90125-8; Nieva JL, 2012, NAT REV MICROBIOL, V10, P563, DOI 10.1038/nrmicro2820; Lyles DS, 2007, FIELDS VIROLOGY, V2, P1364; Madan V, 2008, CELL MICROBIOL, V10, P437, DOI 10.1111/j.1462-5822.2007.01057.x; MCCREEDY BJ, 1990, J VIROL, V64, P902, DOI 10.1128/JVI.64.2.902-906.1990; Obiang L, 2012, J GEN VIROL, V93, P857, DOI 10.1099/vir.0.039800-0; Petersen JM, 2000, MOL CELL BIOL, V20, P8590, DOI 10.1128/MCB.20.22.8590-8601.2000; Quan BL, 2014, P NATL ACAD SCI USA, V111, P9127, DOI 10.1073/pnas.1409076111; Rajani KR, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002929; Rodrigues JP, 2001, P NATL ACAD SCI USA, V98, P1030, DOI 10.1073/pnas.98.3.1030; Sakaguchi T, 1999, VIROLOGY, V263, P230, DOI 10.1006/viro.1999.9960; Sanz MA, 2003, J BIOL CHEM, V278, P2051, DOI 10.1074/jbc.M206611200; Sanz MA, 2001, J VIROL, V75, P7778, DOI 10.1128/JVI.75.16.7778-7784.2001; SIMON KO, 1990, VIROLOGY, V177, P289, DOI 10.1016/0042-6822(90)90482-7; Solon J, 2005, J GEN VIROL, V86, P3357, DOI 10.1099/vir.0.81129-0; Ventoso I, 2001, P NATL ACAD SCI USA, V98, P12966, DOI 10.1073/pnas.231343498; von Kobbe C, 2000, MOL CELL, V6, P1243, DOI 10.1016/S1097-2765(00)00120-9; Welnowska E, 2009, J MOL BIOL, V394, P506, DOI 10.1016/j.jmb.2009.09.036; Whitlow ZW, 2008, J VIROL, V82, P2286, DOI 10.1128/JVI.01761-07; YE ZP, 1994, J VIROL, V68, P7386, DOI 10.1128/JVI.68.11.7386-7396.1994	58	11	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2015	10	6							e0131137	10.1371/journal.pone.0131137	http://dx.doi.org/10.1371/journal.pone.0131137			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL3FE	26091335	Green Published, gold			2022-12-26	WOS:000356835000171
J	Shim, JE; Hwang, S; Lee, I				Shim, Jung Eun; Hwang, Sohyun; Lee, Insuk			Pathway-Dependent Effectiveness of Network Algorithms for Gene Prioritization	PLOS ONE			English	Article							DISEASE GENES	A network-based approach has proven useful for the identification of novel genes associated with complex phenotypes, including human diseases. Because network-based gene prioritization algorithms are based on propagating information of known phenotype-associated genes through networks, the pathway structure of each phenotype might significantly affect the effectiveness of algorithms. We systematically compared two popular network algorithms with distinct mechanisms - direct neighborhood which propagates information to only direct network neighbors, and network diffusion which diffuses information throughout the entire network - in prioritization of genes for worm and human phenotypes. Previous studies reported that network diffusion generally outperforms direct neighborhood for human diseases. Although prioritization power is generally measured for all ranked genes, only the top candidates are significant for subsequent functional analysis. We found that high prioritizing power of a network algorithm for all genes cannot guarantee successful prioritization of top ranked candidates for a given phenotype. Indeed, the majority of the phenotypes that were more efficiently prioritized by network diffusion showed higher prioritizing power for top candidates by direct neighborhood. We also found that connectivity among pathway genes for each phenotype largely determines which network algorithm is more effective, suggesting that the network algorithm used for each phenotype should be chosen with consideration of pathway gene connectivity.	[Shim, Jung Eun; Hwang, Sohyun; Lee, Insuk] Yonsei Univ, Dept Biotechnol, Coll Life Sci & Biotechnol, Seoul 120749, South Korea	Yonsei University	Lee, I (corresponding author), Yonsei Univ, Dept Biotechnol, Coll Life Sci & Biotechnol, Seoul 120749, South Korea.	insuklee@yonsei.ac.kr		shim, Jung eun/0000-0001-6341-9923	National Research Foundation of Korea [2012M3A9B4028641, 2012M3A9C7050151]	National Research Foundation of Korea(National Research Foundation of Korea)	This work was supported by the National Research Foundation of Korea (2012M3A9B4028641, 2012M3A9C7050151). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berrar D, 2012, BRIEF BIOINFORM, V13, P83, DOI 10.1093/bib/bbr008; Clark RD, 2008, J COMPUT AID MOL DES, V22, P141, DOI 10.1007/s10822-008-9181-z; Franceschini A, 2013, NUCLEIC ACIDS RES, V41, pD808, DOI 10.1093/nar/gks1094; Ideker T, 2008, GENOME RES, V18, P644, DOI 10.1101/gr.071852.107; Lee I, 2013, ANIM CELLS SYST, V17, P75, DOI 10.1080/19768354.2013.789076; Lee I, 2011, GENOME RES, V21, P1109, DOI 10.1101/gr.118992.110; Lee I, 2010, GENOME RES, V20, P1143, DOI 10.1101/gr.102749.109; Lehner Ben, 2008, Briefings in Functional Genomics & Proteomics, V7, P217, DOI 10.1093/bfgp/eln020; Linghu B, 2009, GENOME BIOL, V10; Linghu B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-9-r91; Mostafavi S, 2008, GENOME BIOL, V9; Rhodes DR, 2005, NAT BIOTECHNOL, V23, P951, DOI 10.1038/nbt1103; Schriml LM, 2012, NUCLEIC ACIDS RES, V40, pD940, DOI 10.1093/nar/gkr972; Sheridan RP, 2001, J CHEM INF COMP SCI, V41, P1395, DOI 10.1021/ci0100144; Swamidass SJ, 2010, BIOINFORMATICS, V26, P1348, DOI 10.1093/bioinformatics/btq140; Truchon JF, 2007, J CHEM INF MODEL, V47, P488, DOI 10.1021/ci600426e; Wang PI, 2010, J PROTEOMICS, V73, P2277, DOI 10.1016/j.jprot.2010.07.005; Wu GM, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-5-r53; Yook K, 2012, NUCLEIC ACIDS RES, V40, pD735, DOI 10.1093/nar/gkr954; Zhao W, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-225	20	15	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2015	10	6							e0130589	10.1371/journal.pone.0130589	http://dx.doi.org/10.1371/journal.pone.0130589			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL3FE	26091506	Green Published, gold, Green Submitted			2022-12-26	WOS:000356835000132
J	Castillo-Lluva, S; Hontecillas-Prieto, L; Blanco-Gomez, A; Saez-Freire, MD; Garcia-Cenador, B; Garcia-Criado, J; Perez-Andres, M; Orfao, A; Canamero, M; Mao, JH; Gridley, T; Castellanos-Martin, A; Perez-Losada, J				Castillo-Lluva, S.; Hontecillas-Prieto, L.; Blanco-Gomez, A.; del Mar Saez-Freire, M.; Garcia-Cenador, B.; Garcia-Criado, J.; Perez-Andres, M.; Orfao, A.; Canamero, M.; Mao, J. H.; Gridley, T.; Castellanos-Martin, A.; Perez-Losada, J.			A new role of SNAI2 in postlactational involution of the mammary gland links it to luminal breast cancer development	ONCOGENE			English	Article							TUMOR-INITIATING CELLS; PROGENITOR CELLS; MESENCHYMAL TRANSITION; KINASE-ACTIVITY; PROTO-ONCOGENE; SELF-RENEWAL; SLUG GENE; STEM; EXPRESSION; CYCLIN	Breast cancer is a major cause of mortality in women. The transcription factor SNAI2 has been implicated in the pathogenesis of several types of cancer, including breast cancer of basal origin. Here we show that SNAI2 is also important in the development of breast cancer of luminal origin in MMTV-ErbB2 mice. SNAI2 deficiency leads to longer latency and fewer luminal tumors, both of these being characteristics of pretumoral origin. These effects were associated with reduced proliferation and a decreased ability to generate mammospheres in normal mammary glands. However, the capacity to metastasize was not modified. Under conditions of increased ERBB2 oncogenic activity after pregnancy plus SNAI2 deficiency, both pretumoral defects-latency and tumor load-were compensated. However, the incidence of lung metastases was dramatically reduced. Furthermore, SNAI2 was required for proper postlactational involution of the breast. At 3 days post lactational involution, the mammary glands of Snai2-deficient mice exhibited lower levels of pSTAT3 and higher levels of pAKT1, resulting in decreased apoptosis. Abundant noninvoluted ducts were still present at 30 days post lactation, with a greater number of residual ERBB2+ cells. These results suggest that this defect in involution leads to an increase in the number of susceptible target cells for transformation, to the recovery of the capacity to generate mammospheres and to an increase in the number of tumors. Our work demonstrates the participation of SNAI2 in the pathogenesis of luminal breast cancer, and reveals an unexpected connection between the processes of postlactational involution and breast tumorigenesis in Snai2-null mutant mice.	[Castillo-Lluva, S.; Hontecillas-Prieto, L.; Blanco-Gomez, A.; del Mar Saez-Freire, M.; Perez-Andres, M.; Orfao, A.; Castellanos-Martin, A.; Perez-Losada, J.] Univ Salamanca, CSIC, Inst Biol Mol & Celular Canc IBMCC, Salamanca 37007, Spain; [Castillo-Lluva, S.; Hontecillas-Prieto, L.; Blanco-Gomez, A.; del Mar Saez-Freire, M.; Garcia-Cenador, B.; Garcia-Criado, J.; Perez-Andres, M.; Orfao, A.; Castellanos-Martin, A.; Perez-Losada, J.] Hosp Univ Salamanca, Inst Invest Biomed Salamanca IBSAL, Salamanca, Spain; [Garcia-Cenador, B.; Garcia-Criado, J.] Univ Salamanca, Dept Cirugia, Salamanca 37007, Spain; [Perez-Andres, M.; Orfao, A.] Univ Salamanca, IBSAL, Unidad Citometria Flujo, Salamanca, Spain; [Canamero, M.] Ctr Nacl Invest Oncol CNIO, Madrid, Spain; [Mao, J. H.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Life Sci Div, Berkeley, CA 94720 USA; [Gridley, T.] Maine Med Ctr, Res Inst, Ctr Mol Med, Scarborough, ME USA	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-USAL - Instituto de Biologia Molecular y Celular del Cancer de Salamanca (IBMCC); University of Salamanca; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-USAL - Instituto de Biologia Molecular y Celular del Cancer de Salamanca (IBMCC); University of Salamanca; University of Salamanca; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Maine Medical Center	Castellanos-Martin, A (corresponding author), Univ Salamanca, CSIC, Inst Biol Mol & Celular Canc, Ctr Invest Canc, Campus Miguel de Unamuno Sn, Salamanca 37007, Spain.	andres.castellanos@irbbarcelona.org; jperezlosada@usal.es	Perez-Andres, Martin/B-3692-2019; Orfao, Alberto/B-5801-2017; Blanco-Gomez, Adrian/GPK-8337-2022; Pérez-Losada, Jesús/A-5883-2019; Cenador, María Begoña García/CAI-2603-2022; Castellanos, Andres/F-3302-2016; Cenador, Begoña García/Q-9417-2018; Mao, Jian-Hua/EIZ-8595-2022; /AAI-3238-2021; CASTILLO-LLUVA, SONIA/AAA-1776-2020	Perez-Andres, Martin/0000-0003-4599-0776; Pérez-Losada, Jesús/0000-0003-2400-624X; Cenador, María Begoña García/0000-0002-8950-8542; Castellanos, Andres/0000-0003-2864-7271; Cenador, Begoña García/0000-0002-8950-8542; Mao, Jian-Hua/0000-0001-9320-6021; Castillo-LLuva, Sonia/0000-0001-5357-7178; Blanco Gomez, Adrian/0000-0002-1956-088X	FEDER; MICINN [PLE2009-119, SAF2014-56989-R]; Instituto de Salud Carlos III [PI07/0057, PI10/00328, PIE14/00066]; Junta de Castilla y Leon [SAN673/SA26/08, SAN126/SA66/09, SA078A09, CSI034U13]; Fundacion Eugenio Rodriguez Pascual; 'Fundacion Inbiomed' (Instituto Oncologico Obra Social de la Caja Guipozcoa-San Sebastian, Kutxa); Fundacion Sandra Ibarra de Solidaridad frente al Cancer; FIS [PI07/0057]; JAEdoc Fellowship (CSIC)/FSE; Junta de Castilla y Leon; National Institutes of Health; National Cancer Institute [R01 CA116481]; Low-Dose Scientific Focus Area, Office of Biological and Environmental Research, US Department of Energy [DE-AC02-05CH11231]; NATIONAL CANCER INSTITUTE [R01CA116481] Funding Source: NIH RePORTER	FEDER(European Commission); MICINN(Ministry of Science and Innovation, Spain (MICINN)Spanish GovernmentEuropean Commission); Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Junta de Castilla y Leon(Junta de Castilla y Leon); Fundacion Eugenio Rodriguez Pascual; 'Fundacion Inbiomed' (Instituto Oncologico Obra Social de la Caja Guipozcoa-San Sebastian, Kutxa); Fundacion Sandra Ibarra de Solidaridad frente al Cancer; FIS(Instituto de Salud Carlos III); JAEdoc Fellowship (CSIC)/FSE; Junta de Castilla y Leon(Junta de Castilla y Leon); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Low-Dose Scientific Focus Area, Office of Biological and Environmental Research, US Department of Energy(United States Department of Energy (DOE)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	JP-L was partially supported by FEDER and MICINN (PLE2009-119, SAF2014-56989-R), Instituto de Salud Carlos III (PI07/0057, PI10/00328, PIE14/00066), Junta de Castilla y Leon (SAN673/SA26/08, SAN126/SA66/09, SA078A09, CSI034U13), the 'Fundacion Eugenio Rodriguez Pascual', the 'Fundacion Inbiomed' (Instituto Oncologico Obra Social de la Caja Guipozcoa-San Sebastian, Kutxa) and the 'Fundacion Sandra Ibarra de Solidaridad frente al Cancer'. AC-M was supported by FIS (PI07/0057) and MICINN (PLE2009-119). SC-L was funded by a JAEdoc Fellowship (CSIC)/FSE. MMS-F and AB-G are funded by fellowships from the Junta de Castilla y Leon. J-HM was supported by the National Institutes of Health, a National Cancer Institute Grant (R01 CA116481) and the Low-Dose Scientific Focus Area, Office of Biological and Environmental Research, US Department of Energy (DE-AC02-05CH11231). We thank Dr Montoliu for HC11 cells, Dr Garcia Macias and the Comparative Pathology Core Facility of the 'Centro de Investigacion del Cancer (CIC) de la Universidad de Salamanca' for Pathology support, Maria Luz Hernandez Mulas and Isabel Ramos for technical assistance, Dr Sanchez-Garcia and Dr Martin-Zanca for useful comments along this project, Dr Balmain and Dr Lazo for comments about the manuscript and Nicholas Skinner for his useful help in English editing.	Barrallo-Gimeno A, 2005, DEVELOPMENT, V132, P3151, DOI 10.1242/dev.01907; Berclaz G, 2001, INT J ONCOL, V19, P1155; Bowe DB, 2002, ONCOGENE, V21, P291, DOI 10.1038/sj/onc/1205025; Cao YX, 2007, P NATL ACAD SCI USA, V104, P15852, DOI 10.1073/pnas.0706728104; Cardiff RD, 1999, J MAMMARY GLAND BIOL, V4, P105, DOI 10.1023/A:1018712905244; Carpenter RL, 2014, ONCOGENE, V34, P546; Castellanos-Martin A, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0599-z; Chapman RS, 1999, GENE DEV, V13, P2604, DOI 10.1101/gad.13.19.2604; Cheung KJ, 2013, CELL, V155, P1639, DOI 10.1016/j.cell.2013.11.029; Cicalese A, 2009, CELL, V138, P1083, DOI 10.1016/j.cell.2009.06.048; Cobaleda C, 2007, ANNU REV GENET, V41, P41, DOI 10.1146/annurev.genet.41.110306.130146; Come C, 2006, CLIN CANCER RES, V12, P5395, DOI 10.1158/1078-0432.CCR-06-0478; Davie SA, 2007, TRANSGENIC RES, V16, P193, DOI 10.1007/s11248-006-9056-9; Deugnier MA, 2006, DEV BIOL, V293, P414, DOI 10.1016/j.ydbio.2006.02.007; Diaz N, 2006, CLIN CANCER RES, V12, P20, DOI 10.1158/1078-0432.CCR-04-1749; Dillon RL, 2010, CANCER RES, V70, P4260, DOI 10.1158/0008-5472.CAN-10-0266; Dontu G, 2003, GENE DEV, V17, P1253, DOI 10.1101/gad.1061803; GUNZBURG WH, 1992, BIOCHEM J, V283, P625; Guo WJ, 2012, CELL, V148, P1015, DOI 10.1016/j.cell.2012.02.008; GUY CT, 1992, P NATL ACAD SCI USA, V89, P10578, DOI 10.1073/pnas.89.22.10578; Hajra KM, 2002, CANCER RES, V62, P1613; Herschkowitz JI, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-r76; Hinohara K, 2012, P NATL ACAD SCI USA, V109, P6584, DOI 10.1073/pnas.1113271109; Hudson LG, 2007, MOL CARCINOGEN, V46, P257, DOI 10.1002/mc.20257; Hutchinson JN, 2004, CANCER RES, V64, P3171, DOI 10.1158/0008-5472.CAN-03-3465; Inukai T, 1999, MOL CELL, V4, P343, DOI 10.1016/S1097-2765(00)80336-6; Jeselsohn R, 2010, CANCER CELL, V17, P65, DOI 10.1016/j.ccr.2009.11.024; Jiang RL, 1998, DEV BIOL, V198, P277, DOI 10.1016/S0012-1606(98)80005-5; KNIGHT CH, 1982, J REPROD FERTIL, V65, P521, DOI 10.1530/jrf.0.0650521; Korkaya H, 2008, ONCOGENE, V27, P6120, DOI 10.1038/onc.2008.207; Kuperwasser C, 2004, P NATL ACAD SCI USA, V101, P4966, DOI 10.1073/pnas.0401064101; Landis MD, 2006, ONCOGENE, V25, P3325, DOI 10.1038/sj.onc.1209365; Little JL, 2014, ONCOGENE, V33, P411, DOI 10.1038/onc.2012.607; Liu JC, 2007, CANCER RES, V67, P8671, DOI 10.1158/0008-5472.CAN-07-1486; Lo PK, 2012, ONCOGENE, V31, P2614, DOI [10.1038/onc.2011.439, 10.1038/onc.2012.147]; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Manzanares M, 2001, TRENDS GENET, V17, P178, DOI 10.1016/S0168-9525(01)02232-6; Markel P, 1997, NAT GENET, V17, P280, DOI 10.1038/ng1197-280; Mittal MK, 2011, J BIOL CHEM, V286, P469, DOI 10.1074/jbc.M110.164384; Mukherjee S, 2000, ONCOGENE, V19, P5982, DOI 10.1038/sj.onc.1203964; Muraoka RS, 2002, MOL CELL BIOL, V22, P2204, DOI 10.1128/MCB.22.7.2204-2219.2002; Nassour M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053498; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Nieto MA, 2002, NAT REV MOL CELL BIO, V3, P155, DOI 10.1038/nrm757; Perez-Losada J, 2003, NAT REV CANCER, V3, P434, DOI 10.1038/nrc1095; Perez-Mancera PA, 2005, ONCOGENE, V24, P3073, DOI 10.1038/sj.onc.1208505; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Phillips S, 2014, STEM CELL REP, V2, P633, DOI 10.1016/j.stemcr.2014.03.008; Prater MD, 2014, NAT CELL BIOL, V16, P942, DOI 10.1038/ncb3025; Proia TA, 2011, CELL STEM CELL, V8, P149, DOI 10.1016/j.stem.2010.12.007; Rowse GJ, 1998, CANCER RES, V58, P2675; Sanchez-Garcia I, 2009, NEW ENGL J MED, V360, P297, DOI 10.1056/NEJMcibr0808031; Schwertfeger KL, 2001, MOL ENDOCRINOL, V15, P867, DOI 10.1210/me.15.6.867; Shackleton M, 2006, NATURE, V439, P84, DOI 10.1038/nature04372; Shaw FL, 2012, J MAMMARY GLAND BIOL, V17, P111, DOI 10.1007/s10911-012-9255-3; Shehata M, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3334; SLAMON DJ, 1989, SCIENCE, V244, P707, DOI 10.1126/science.2470152; Stingl J, 2006, NATURE, V439, P993, DOI 10.1038/nature04496; Storci G, 2008, J PATHOL, V214, P25, DOI 10.1002/path.2254; Ullrich RL, 1996, RADIAT RES, V146, P353, DOI 10.2307/3579468; VANDUUREN BL, 1975, CANCER RES, V35, P502; Ventura A, 2004, P NATL ACAD SCI USA, V101, P10380, DOI 10.1073/pnas.0403954101; Villarejo A, 2015, CARCINOGENESIS, V36, P585, DOI 10.1093/carcin/bgv021; Wang GH, 2014, MOL CANCER THER, V13, P1837, DOI 10.1158/1535-7163.MCT-14-0049; Watson CJ, 2011, INT J DEV BIOL, V55, P757, DOI 10.1387/ijdb.113414cw; Wu WS, 2005, CELL, V123, P641, DOI 10.1016/j.cell.2005.09.029; Zhang WZ, 2013, CANCER CELL, V23, P647, DOI 10.1016/j.ccr.2013.03.012	67	8	8	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 3	2015	34	36					4777	4790		10.1038/onc.2015.224	http://dx.doi.org/10.1038/onc.2015.224			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CQ9JU	26096931	Green Submitted, Green Accepted			2022-12-26	WOS:000360931500011
J	Gupta, K; Martin, R; Sharp, R; Sarachan, KL; Ninan, NS; Van Duyne, GD				Gupta, Kushol; Martin, Renee; Sharp, Robert; Sarachan, Kathryn L.; Ninan, Nisha S.; Van Duyne, Gregory D.			Oligomeric Properties of Survival Motor Neuron.Gemin2 Complexes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SPINAL MUSCULAR-ATROPHY; X-RAY-SCATTERING; NEURON SMN PROTEIN; SELF-ASSOCIATION; SINGLE NUCLEOTIDE; GENE-PRODUCT; POMBE; MACROMOLECULES; IDENTIFICATION; INTERMEDIATE	The survival motor neuron(SMN) protein forms the oligomeric core of a multiprotein complex required for the assembly of spliceosomal small nuclear ribonucleoproteins. Deletions and mutations in the SMN1 gene are associated with spinal muscular atrophy (SMA), a devastating neurodegenerative disease that is the leading heritable cause of infant mortality. Oligomerization of SMN is required for its function, and some SMA patient mutations disrupt the ability of SMN to self-associate. Here, we investigate the oligomeric nature of the SMN.Gemin2 complexes from humans and fission yeast (hSMN.Gemin2 and ySMN.Gemin2). We find that hSMN.Gemin2 forms oligomers spanning the dimer to octamer range. The YG box oligomerization domain of SMN is both necessary and sufficient to form these oligomers. ySMN.Gemin2 exists as a dimer-tetramer equilibrium with K-d = 1.0 +/- 0.9 mu M. A 1.9 angstrom crystal structure of the ySMN YG box confirms a high level of structural conservation with the human ortholog in this important region of SMN. Disulfide cross-linking experiments indicate that SMN tetramers are formed by self-association of stable, non-dissociating dimers. Thus, SMN tetramers do not form symmetric helical bundles such as those found in glycine zipper transmembrane oligomers. The dimer-tetramer nature of SMN complexes and the dimer of dimers organization of the SMN tetramer provide an important foundation for ongoing studies to understand the mechanism of SMN-assisted small nuclear ribonucleoprotein assembly and the underlying causes of SMA.	[Gupta, Kushol; Martin, Renee; Sharp, Robert; Sarachan, Kathryn L.; Ninan, Nisha S.; Van Duyne, Gregory D.] Univ Penn, Dept Biochem & Biophys, Perelman Sch Med, Philadelphia, PA 19104 USA; [Martin, Renee; Sarachan, Kathryn L.; Ninan, Nisha S.] Univ Penn, Perelman Sch Med, Grad Grp Biochem & Mol Biophys, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine	Van Duyne, GD (corresponding author), Univ Penn, Dept Biochem & Biophys, Perelman Sch Med, 242 Anat Chem Bldg, Philadelphia, PA 19104 USA.	vanduyne@mail.med.upenn.edu	Gupta, Kushol/GOE-5620-2022; Regan, Clinton/E-6250-2012	Gupta, Kushol/0000-0002-7006-2667; Sarachan, Kathryn/0000-0003-2511-1404	National Science Foundation [DMR 0225180]; National Institutes of Health [RR-01646]; Office of Biological and Environmental Research of the United States Department of Energy; Office of Basic Energy Sciences of the United States Department of Energy; National Center for Research Resources of the National Institutes of Health; Molecular Assemblies Genes and Genomics Integrated Efficiently (MAGGIE) [DE-AC02-05CH11231]; United States Department of Energy; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001646] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008275] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Office of Biological and Environmental Research of the United States Department of Energy(United States Department of Energy (DOE)); Office of Basic Energy Sciences of the United States Department of Energy(United States Department of Energy (DOE)); National Center for Research Resources of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Molecular Assemblies Genes and Genomics Integrated Efficiently (MAGGIE); United States Department of Energy(United States Department of Energy (DOE)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to Richard Gillilan (Cornell University High Energy Synchrotron Source (CHESS)), Gregory Hura, Jane Tanamachi, Kevin Dyer, and Michal Hammel (Advanced Light Source (ALS)), and Lin Yang and Marc Allaire (National Synchrotron Light Source (NSLS)) for technical expertise and support and G. V. laboratory members for helpful discussions. CHESS is supported by National Science Foundation Grant DMR 0225180, and the Mac-CHESS facility is supported by National Institutes of Health Grant RR-01646. Financial support for the NSLS comes principally from the Offices of Biological and Environmental Research and of Basic Energy Sciences of the United States Department of Energy and from the National Center for Research Resources of the National Institutes of Health. X-ray scattering and diffraction technologies and their applications to the determination of macromolecular shapes and conformations at the SIBYLS beamline at ALS, Lawrence Berkeley National Laboratory, are supported in part by the Department of Energy programs Integrated Diffraction Analysis Technologies (IDAT) and Molecular Assemblies Genes and Genomics Integrated Efficiently (MAGGIE) under Contract DE-AC02-05CH11231 with the United States Department of Energy.	Allaire M, 2011, J SYNCHROTRON RADIAT, V18, P41, DOI 10.1107/S0909049510036022; Anderton RS, 2013, MOL NEUROBIOL, V47, P821, DOI 10.1007/s12035-013-8399-5; Battle DJ, 2007, J BIOL CHEM, V282, P27953, DOI 10.1074/jbc.M702317200; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; Burghes AHM, 2009, NAT REV NEUROSCI, V10, P597, DOI 10.1038/nrn2670; Campion Y, 2010, EMBO J, V29, P1817, DOI 10.1038/emboj.2010.70; Carissimi C, 2006, J BIOL CHEM, V281, P8126, DOI 10.1074/jbc.M512243200; Carvalho T, 1999, J CELL BIOL, V147, P715, DOI 10.1083/jcb.147.4.715; Chari A, 2008, CELL, V135, P497, DOI 10.1016/j.cell.2008.09.020; Chari A, 2009, CURR OPIN CELL BIOL, V21, P387, DOI 10.1016/j.ceb.2009.02.004; Charroux B, 1999, J CELL BIOL, V147, P1181, DOI 10.1083/jcb.147.6.1181; Crawford TO, 1996, NEUROBIOL DIS, V3, P97, DOI 10.1006/nbdi.1996.0010; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fallini C, 2012, BRAIN RES, V1462, P81, DOI 10.1016/j.brainres.2012.01.044; GENNARELLI M, 1995, BIOCHEM BIOPH RES CO, V213, P342, DOI 10.1006/bbrc.1995.2135; Green MR, 2012, MOL CLONING LAB MANU, V1; Grimm C, 2013, MOL CELL, V49, P692, DOI 10.1016/j.molcel.2012.12.009; Gupta K, 2014, J BIOL CHEM, V289, P20477, DOI 10.1074/jbc.M114.551119; Gupta K, 2010, J BIOL CHEM, V285, P20303, DOI 10.1074/jbc.M110.114413; Hamilton G, 2013, TRENDS MOL MED, V19, P40, DOI 10.1016/j.molmed.2012.11.002; Hannus S, 2000, HUM MOL GENET, V9, P663, DOI 10.1093/hmg/9.5.663; Hebert MD, 2000, MOL BIOL CELL, V11, P4159, DOI 10.1091/mbc.11.12.4159; Hura GL, 2009, NAT METHODS, V6, P606, DOI 10.1038/nmeth.1353; KEGELES G, 1967, P NATL ACAD SCI USA, V58, P45, DOI 10.1073/pnas.58.1.45; Kim S, 2005, P NATL ACAD SCI USA, V102, P14278, DOI 10.1073/pnas.0501234102; Kozlowski LP, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-111; Laue TM, 1992, BIOCH POLYM SCI, P90; LEFEBVRE S, 1995, CELL, V80, P155, DOI 10.1016/0092-8674(95)90460-3; Li DK, 2014, SEMIN CELL DEV BIOL, V32, P22, DOI 10.1016/j.semcdb.2014.04.026; Liu Q, 1996, EMBO J, V15, P3555, DOI 10.1002/j.1460-2075.1996.tb00725.x; Lorson CL, 1999, P NATL ACAD SCI USA, V96, P6307, DOI 10.1073/pnas.96.11.6307; Lorson CL, 1998, NAT GENET, V19, P63, DOI 10.1038/ng0598-63; MacRaild CA, 2003, BIOPHYS J, V84, P2562, DOI 10.1016/S0006-3495(03)75061-9; Marguerat S, 2012, CELL, V151, P671, DOI 10.1016/j.cell.2012.09.019; Martin R, 2012, STRUCTURE, V20, P1929, DOI 10.1016/j.str.2012.08.024; Monani UR, 1999, HUM MOL GENET, V8, P1177, DOI 10.1093/hmg/8.7.1177; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Narayanan U, 2004, MOL CELL, V16, P223, DOI 10.1016/j.molcel.2004.09.024; Nielsen SS, 2012, J APPL CRYSTALLOGR, V45, P213, DOI 10.1107/S0021889812000957; Nurputra DK, 2013, ANN HUM GENET, V77, P435, DOI 10.1111/ahg.12031; Ogawa C, 2007, J BIOL CHEM, V282, P11122, DOI 10.1074/jbc.M609297200; Otter S, 2007, J BIOL CHEM, V282, P5825, DOI 10.1074/jbc.M608528200; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Owen N, 2000, HUM MOL GENET, V9, P675, DOI 10.1093/hmg/9.5.675; Owen N, 2000, HUM MOL GENET, V9, P1142; Pante N, 2002, MOL BIOL CELL, V13, P425, DOI 10.1091/mbc.01-06-0308; Paushkin S, 2000, J BIOL CHEM, V275, P23841, DOI 10.1074/jbc.M001441200; Paushkin S, 2002, CURR OPIN CELL BIOL, V14, P305, DOI 10.1016/S0955-0674(02)00332-0; Pellizzoni L, 1999, P NATL ACAD SCI USA, V96, P11167, DOI 10.1073/pnas.96.20.11167; Praveen K, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004489; Sanchez G, 2013, HUM MOL GENET, V22, P668, DOI 10.1093/hmg/dds474; Sarachan KL, 2012, BIOCHEM J, V445, P361, DOI 10.1042/BJ20120241; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Scott DJ, 2005, ANALYTICAL ULTRACENTRIFUGATION: TECHNIQUES AND METHODS, P1, DOI 10.1039/9781847552617-00001; Selenko P, 2001, NAT STRUCT BIOL, V8, P27; SEMENYUK AV, 1991, J APPL CRYSTALLOGR, V24, P537, DOI 10.1107/S002188989100081X; Tiziano FD, 2013, AM J MED GENET A, V161, P2836, DOI 10.1002/ajmg.a.36251; Vistica J, 2004, ANAL BIOCHEM, V326, P234, DOI 10.1016/j.ab.2003.12.014; Young PJ, 2000, HUM MOL GENET, V9, P2869, DOI 10.1093/hmg/9.19.2869; Young PJ, 2000, EXP CELL RES, V256, P365, DOI 10.1006/excr.2000.4858; Zhang RD, 2011, CELL, V146, P384, DOI 10.1016/j.cell.2011.06.043	61	17	17	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 14	2015	290	33					20185	20199		10.1074/jbc.M115.667279	http://dx.doi.org/10.1074/jbc.M115.667279			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CP1AT	26092730	Green Published, hybrid			2022-12-26	WOS:000359608900020
J	Mongan, M; Meng, QH; Wang, JJ; Kao, WWY; Puga, A; Xia, Y				Mongan, Maureen; Meng, Qinghang; Wang, Jingjing; Kao, Winston W. -Y.; Puga, Alvaro; Xia, Ying			Gene-Environment Interactions Target Mitogen- activated Protein 3 Kinase 1 (MAP3K1) Signaling in Eyelid Morphogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ARYL-HYDROCARBON RECEPTOR; DIOXIN-LIKE COMPOUNDS; C-JUN; DEVELOPMENTAL TOXICITY; PALATE DEVELOPMENT; CELL-MIGRATION; RETINOIC ACID; BIRTH-DEFECTS; C57BL/6N MICE; EGF RECEPTOR	Gene-environment interactions determine the biological outcomes through mechanisms that are poorly understood. Mouse embryonic eyelid closure is a well defined model to study the genetic control of developmental programs. Using this model, we investigated how exposure to dioxin-like environmental pollutants modifies the genetic risk of developmental abnormalities. Our studies reveal that mitogen-activated protein 3 kinase 1 (MAP3K1) signaling is a focal point of gene-environment crosstalk. Dioxin exposure, acting through the aryl hydrocarbon receptor (AHR), blocked eyelid closure in genetic mutants in which MAP3K1 signaling was attenuated but did not disturb this developmental program in either wild type or mutant mice with attenuated epidermal growth factor receptor or WNT signaling. Exposure also markedly inhibited c-Jun phosphorylation in Map3k1(+/-) embryonic eyelid epithelium, suggesting that dioxin-induced AHR pathways can synergize with gene mutations to inhibit MAP3K1 signaling. Our studies uncover a novel mechanism through which the dioxin-AHR axis interacts with the MAP3K1 signaling pathways during fetal development and provide strong empirical evidence that specific gene alterations can increase the risk of developmental abnormalities driven by environmental pollutant exposure.	[Mongan, Maureen; Meng, Qinghang; Wang, Jingjing; Puga, Alvaro; Xia, Ying] Univ Cincinnati, Coll Med, Dept Environm Hlth, Cincinnati, OH 45267 USA; [Kao, Winston W. -Y.; Xia, Ying] Univ Cincinnati, Coll Med, Dept Ophthalmol, Cincinnati, OH 45267 USA	University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati	Xia, Y (corresponding author), Univ Cincinnati, Coll Med, Dept Environm Hlth, Cincinnati, OH 45267 USA.	ying.xia@uc.edu	Wang, Jingjing/GLS-7536-2022; Regan, Clinton/E-6250-2012	Wang, Jingjing/0000-0003-2347-7824; Xia, Ying/0000-0001-9532-9527	National Institutes of Health [RO1 EY15227, R21 ES023507, RO1 ES006273, RO1 ES024744, P30 ES006096]; NATIONAL EYE INSTITUTE [R01EY015227] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R21ES023507, R01ES024744, P30ES006096, R01ES006273] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1 EY15227, R21 ES023507, RO1 ES006273, RO1 ES024744, and P30 ES006096. The authors declare that they have no conflicts of interest with the contents of this article.	Abbott BD, 2003, TOXICOL SCI, V76, P427, DOI 10.1093/toxsci/kfg238; Ashery-Padan R, 2000, GENE DEV, V14, P2701, DOI 10.1101/gad.184000; Banerji S, 2012, NATURE, V486, P405, DOI 10.1038/nature11154; Bard-Chapeau EA, 2005, NAT MED, V11, P567, DOI 10.1038/nm1227; BIRNBAUM LS, 1989, TOXICOL APPL PHARM, V98, P487, DOI 10.1016/0041-008X(89)90177-4; Birnbaum LS, 1995, TOXICOL LETT, V82-3, P743, DOI 10.1016/0378-4274(95)03592-3; Brent RL, 2004, PEDIATRICS, V113, P957; Carney SA, 2006, BIRTH DEFECTS RES A, V76, P7, DOI 10.1002/bdra.20216; Carvajal-Gonzalez JM, 2009, MOL BIOL CELL, V20, P1715, DOI 10.1091/mbc.E08-05-0451; Chevallier A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053520; Choudhary M, 2015, J PATHOL, V235, P101, DOI 10.1002/path.4433; COUTURE LA, 1990, TERATOLOGY, V42, P619, DOI 10.1002/tera.1420420606; Curran CP, 2011, TOXICOL SCI, V119, P189, DOI 10.1093/toxsci/kfq314; Das Dhanjit Kumar, 2013, Indian J Hum Genet, V19, P437, DOI 10.4103/0971-6866.124372; DEVITO MJ, 1995, ENVIRON HEALTH PERSP, V103, P820, DOI 10.2307/3432395; Dragin N, 2006, J BIOL CHEM, V281, P18591, DOI 10.1074/jbc.M601159200; FINDLATER GS, 1993, J ANAT, V183, P121; Fujii-Kuriyama Y, 2005, BIOCHEM BIOPH RES CO, V338, P311, DOI 10.1016/j.bbrc.2005.08.162; Gage PJ, 2008, DEV BIOL, V317, P310, DOI 10.1016/j.ydbio.2008.02.030; Gallagher ED, 2004, J BIOL CHEM, V279, P1872, DOI 10.1074/jbc.M309525200; Geh E, 2011, P NATL ACAD SCI USA, V108, P17349, DOI 10.1073/pnas.1102297108; Gonzalez FJ, 1998, DRUG METAB DISPOS, V26, P1194; Gritli-Linde A, 2007, DEV BIOL, V301, P309, DOI 10.1016/j.ydbio.2006.07.042; Hakk H, 2009, TOXICOL APPL PHARM, V241, P119, DOI 10.1016/j.taap.2009.08.009; Heller E, 2014, DEV CELL, V28, P617, DOI 10.1016/j.devcel.2014.02.011; Hope WC, 2015, J AAPOS, V19, P277, DOI 10.1016/j.jaapos.2015.01.018; Huang J, 2009, DEVELOPMENT, V136, P1741, DOI 10.1242/dev.034082; Jacobs H, 2011, ENVIRON HEALTH PERSP, V119, P1590, DOI 10.1289/ehp.1003075; Jaillard S, 2011, AM J MED GENET A, V155A, P725, DOI 10.1002/ajmg.a.33758; Kim SY, 2014, INVEST OPHTH VIS SCI, V55, P6031, DOI 10.1167/iovs.14-15091; Li XF, 2005, NAT GENET, V37, P945, DOI 10.1038/ng1614; LIU CY, 1993, CURR EYE RES, V12, P963, DOI 10.3109/02713689309029222; Loke J, 2014, HUM MOL GENET, V23, P1073, DOI 10.1093/hmg/ddt502; Maklad A, 2009, J INVEST DERMATOL, V129, P690, DOI 10.1038/jid.2008.281; Mandal PK, 2005, J COMP PHYSIOL B, V175, P221, DOI 10.1007/s00360-005-0483-3; Meng QH, 2014, INVEST OPHTH VIS SCI, V55, P7652, DOI 10.1167/iovs.14-15155; Meng QH, 2014, DEV BIOL, V395, P29, DOI 10.1016/j.ydbio.2014.09.001; Nebert DW, 2000, BIOCHEM PHARMACOL, V59, P65, DOI 10.1016/S0006-2952(99)00310-X; Ngo AD, 2006, INT J EPIDEMIOL, V35, P1220, DOI 10.1093/ije/dyl038; Ojesina AI, 2014, NATURE, V506, P371, DOI 10.1038/nature12881; Pearlman A, 2010, AM J HUM GENET, V87, P898, DOI 10.1016/j.ajhg.2010.11.003; PRESLAN M W, 1985, Journal of Pediatric Ophthalmology and Strabismus, V22, P166; Schaeper U, 2007, P NATL ACAD SCI USA, V104, P15376, DOI 10.1073/pnas.0702555104; SEVEL D, 1988, EYE, V2, P123, DOI 10.1038/eye.1988.25; Takatori A, 2008, DEVELOPMENT, V135, P23, DOI 10.1242/dev.007120; Tan ZQ, 2002, BIOCHEM PHARMACOL, V64, P771, DOI 10.1016/S0006-2952(02)01138-3; THREADGILL DW, 1995, SCIENCE, V269, P230, DOI 10.1126/science.7618084; Van den Berg M, 2006, TOXICOL SCI, V93, P223, DOI 10.1093/toxsci/kfl055; Warr N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019572; WEBER H, 1985, ARCH TOXICOL, V57, P159, DOI 10.1007/BF00290880; White SS, 2009, J ENVIRON SCI HEAL C, V27, P197, DOI 10.1080/10590500903310047; WHITLOCK JP, 1993, CHEM RES TOXICOL, V6, P754, DOI 10.1021/tx00036a003; Xia Y, 2004, TRENDS CELL BIOL, V14, P94, DOI 10.1016/j.tcb.2003.12.005; Xia Y, 2000, P NATL ACAD SCI USA, V97, P5243, DOI 10.1073/pnas.97.10.5243; YAMASHITA F, 1985, ENVIRON HEALTH PERSP, V59, P41, DOI 10.2307/3429872; Yujiri T, 2000, P NATL ACAD SCI USA, V97, P7272, DOI 10.1073/pnas.130176697; Zhang L, 2003, EMBO J, V22, P4443, DOI 10.1093/emboj/cdg440; Zieske JD, 2004, INT J DEV BIOL, V48, P903, DOI 10.1387/ijdb.041860jz	58	7	8	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 7	2015	290	32					19770	19779		10.1074/jbc.M115.665729	http://dx.doi.org/10.1074/jbc.M115.665729			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CO7TL	26109068	hybrid, Green Published			2022-12-26	WOS:000359364600034
J	He, T; Gershenson, A; Eyles, SJ; Lee, YJ; Liu, WSR; Wang, JY; Gao, JM; Roberts, MF				He, Tao; Gershenson, Anne; Eyles, Stephen J.; Lee, Yan-Jiun; Liu, Wenshe R.; Wang, Jiangyun; Gao, Jianmin; Roberts, Mary F.			Fluorinated Aromatic Amino Acids Distinguish Cation-pi Interactions from Membrane Insertion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FLUORESCENCE CORRELATION SPECTROSCOPY; PHOSPHOLIPASE-C; BINDING-SITES	Cation-pi interactions, where protein aromatic residues supply pi systems while a positive-charged portion of phospholipid head groups are the cations, have been suggested as important binding modes for peripheral membrane proteins. However, aromatic amino acids can also insert into membranes and hydrophobically interact with lipid tails. Heretofore there has been no facile way to differentiate these two types of interactions. We show that specific incorporation of fluorinated amino acids into proteins can experimentally distinguish cation-pi interactions from membrane insertion of the aromatic side chains. Fluorinated aromatic amino acids destabilize the cation-pi interactions by altering electrostatics of the aromatic ring, whereas their increased hydrophobicity enhances membrane insertion. Incorporation of pentafluorophenylalanine or difluorotyrosine into a Staphylococcus aureus phosphatidylinositol-specific phospholipase C variant engineered to contain a specific PC-binding site demonstrates the effectiveness of this methodology. Applying this methodology to the plethora of tyrosine residues in Bacillus thuringiensis phosphatidylinositol-specific phospholipase C definitively identifies those involved in cation-pi interactions with phosphatidylcholine. This powerful method can easily be used to determine the roles of aromatic residues in other peripheral membrane proteins and in integral membrane proteins.	[He, Tao; Gao, Jianmin; Roberts, Mary F.] Boston Coll, Dept Chem, Chestnut Hill, MA 02467 USA; [Gershenson, Anne; Eyles, Stephen J.] Univ Massachusetts, Dept Biochem & Mol Biol, Amherst, MA 01003 USA; [Lee, Yan-Jiun; Liu, Wenshe R.] Texas A&M Univ, Dept Chem, College Stn, TX 77843 USA; [Wang, Jiangyun] Chinese Acad Sci, Inst Biophys, Beijing 100101, Peoples R China	Boston College; University of Massachusetts System; University of Massachusetts Amherst; Texas A&M University System; Texas A&M University College Station; Chinese Academy of Sciences; Institute of Biophysics, CAS	Roberts, MF (corresponding author), Boston Coll, Merkert Chem Ctr, Dept Chem, 2609 Beacon St, Chestnut Hill, MA 02467 USA.	mary.roberts@bc.edu	Regan, Clinton/E-6250-2012; Liu, wenshe/O-4425-2014	Liu, wenshe/0000-0002-7078-6534; Eyles, Stephen/0000-0003-0451-2903; Gao, Jianmin/0000-0001-9341-1287; Gershenson, Anne/0000-0003-3124-9610; wang, jiang yun/0000-0002-5974-1562	National Institutes of Health [60418]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060418] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant 60418 (to M. F. R.).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Cheng JJ, 2013, J BIOL CHEM, V288, P14863, DOI 10.1074/jbc.M113.466532; Cheng JJ, 2013, BIOPHYS J, V104, P185, DOI 10.1016/j.bpj.2012.11.015; Cheng JJ, 2012, J BIOL CHEM, V287, P40317, DOI 10.1074/jbc.M112.395277; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Feng JW, 2002, J BIOL CHEM, V277, P19867, DOI 10.1074/jbc.M200938200; Goldstein R, 2012, BIOCHEMISTRY-US, V51, P2579, DOI 10.1021/bi300057q; Grauffel C, 2013, J AM CHEM SOC, V135, P5740, DOI 10.1021/ja312656v; HEINZ DW, 1995, EMBO J, V14, P3855, DOI 10.1002/j.1460-2075.1995.tb00057.x; Karathanassis D, 2002, EMBO J, V21, P5057, DOI 10.1093/emboj/cdf519; Krick R, 2012, P NATL ACAD SCI USA, V109, pE2042, DOI 10.1073/pnas.1205128109; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Kutateladze TG, 2010, NAT CHEM BIOL, V6, P507, DOI [10.1038/NCHEMBIO.390, 10.1038/nchembio.390]; Lemmon MA, 2008, NAT REV MOL CELL BIO, V9, P99, DOI 10.1038/nrm2328; Li FH, 2013, ANGEW CHEM INT EDIT, V52, P3958, DOI 10.1002/anie.201300463; Ma JC, 1997, CHEM REV, V97, P1303, DOI 10.1021/cr9603744; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McIlwain BC, 2015, J BIOL CHEM, V290, P9780, DOI 10.1074/jbc.M114.630590; Middleton ER, 2010, BIOPHYS J, V99, P2279, DOI 10.1016/j.bpj.2010.07.056; Pace CJ, 2013, ACCOUNTS CHEM RES, V46, P907, DOI 10.1021/ar300086n; Pflugrath JW, 1999, ACTA CRYSTALLOGR D, V55, P1718, DOI 10.1107/S090744499900935X; Pu MM, 2010, J BIOL CHEM, V285, P26916, DOI 10.1074/jbc.M110.123083; Pu MM, 2009, BIOCHEMISTRY-US, V48, P6835, DOI 10.1021/bi900633p; Ravichandran KR, 2013, BIOCHEMISTRY-US, V52, P8907, DOI 10.1021/bi401494f; Rusu L, 2004, BIOPHYS J, V87, P1044, DOI 10.1529/biophysj.104.039958; Seyedsayamdost MR, 2007, NAT PROTOC, V2, P1225, DOI 10.1038/nprot.2007.159; Thompson NL, 1991, TOPICS FLUORESCENCE, P337; Yang BQ, 2015, J AM CHEM SOC, V137, P14, DOI 10.1021/ja508631n; Young TS, 2010, J MOL BIOL, V395, P361, DOI 10.1016/j.jmb.2009.10.030	30	19	19	0	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 31	2015	290	31					19334	19342		10.1074/jbc.M115.668343	http://dx.doi.org/10.1074/jbc.M115.668343			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CN9PK	26092728	Green Published, hybrid			2022-12-26	WOS:000358781100044
J	Cimmaruta, R; Lucente, D; Nascetti, G				Cimmaruta, Roberta; Lucente, Daniela; Nascetti, Giuseppe			Persistence, Isolation and Diversification of a Naturally Fragmented Species in Local Refugia: The Case of Hydromantes strinatii	PLOS ONE			English	Article							CAVE SALAMANDERS; POPULATION-GROWTH; GENETIC DIVERSITY; GLACIAL REFUGIA; DNA-SEQUENCES; MITOCHONDRIAL; PHYLOGEOGRAPHY; PLETHODONTIDAE; SOFTWARE; DISPERSAL	The study of the European plethodontid salamander Hydromantes strinatii using allozyme and mitochondrial markers showed a strong geographical genetic structure. This was likely the outcome of different evolutionary mechanisms leaving their signature despite the effects of the genetic drift due to the low population size typical of this species. Two highly divergent clades were identified in the eastern and central-western part of the range, with further geographic sub-structure. Nuclear and mitochondrial markers substantially recovered the same population groups but were conflicting in reconstructing their relationships. This apparent incongruence highlighted the action of different mechanisms such as secondary contacts and incomplete lineage sorting in originating the observed genetic variation. The troglophilic habit of this species provided the opportunity to show the importance of caves as local refugia in maintaining the genetic diversity through the persistence of local populations. Accordingly, high nucleotide and haplotype diversity, strong geographic genetic structuring and lack of expansion were evidenced. This signature was found in the populations from the Ligurian and Maritime Alps, in agreement with the complex orography and paleoclimatic history of this Mediterranean hotspot.	[Cimmaruta, Roberta; Lucente, Daniela; Nascetti, Giuseppe] Univ Tuscia, Dipartimento Sci Ecol & Biol, Viterbo, Italy	Tuscia University	Cimmaruta, R (corresponding author), Univ Tuscia, Dipartimento Sci Ecol & Biol, Viterbo, Italy.	cimmaruta@unitus.it	Cimmaruta, Roberta/AAC-9151-2020; Nascetti, Giuseppe/AAA-6396-2020	Nascetti, Giuseppe/0000-0002-1159-8103; Cimmaruta, Roberta/0000-0002-1421-5155				Allegrucci G, 2005, MOL PHYLOGENET EVOL, V37, P153, DOI 10.1016/j.ympev.2005.04.022; Amos W, 1998, PHILOS T ROY SOC B, V353, P177, DOI 10.1098/rstb.1998.0200; [Anonymous], 2014, TRACER V1 6; Arnold ML, 2004, MOL ECOL, V13, P997, DOI 10.1111/j.1365-294X.2004.02145.x; Ashcroft MB, 2012, GLOBAL CHANGE BIOL, V18, P1866, DOI 10.1111/j.1365-2486.2012.02661.x; Ayres DL, 2012, SYST BIOL, V61, P170, DOI [10.1093/sysbio/syr100, 10.1093/sysbio/sys029]; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; BARBUJANI G, 1994, AM J PHYS ANTHROPOL, V95, P137, DOI 10.1002/ajpa.1330950203; Beheregaray LB, 2008, MOL ECOL, V17, P3754, DOI 10.1111/j.1365-294X.2008.03857.x; Belkhir K, 2001, FRANCE BIOSCIENCES, V205, P19; Bryson RW, 2014, BMC EVOL BIOL, V14, DOI 10.1186/1471-2148-14-9; Carranza S, 2008, J BIOGEOGR, V35, P724, DOI 10.1111/j.1365-2699.2007.01817.x; Casazza G., 2010, BOLL MUS IST BIOL UN, V72, P130; Casazza G, 2008, DIVERS DISTRIB, V14, P47, DOI 10.1111/j.1472-4642.2007.00412.x; Casazza G, 2013, BOT J LINN SOC, V173, P637, DOI 10.1111/boj.12110; Cheng L, 2013, MOL BIOL EVOL, V30, P1224, DOI 10.1093/molbev/mst028; Chiari Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032332; Cimmaruta R, 1999, ETHOL ECOL EVOL, V11, P383, DOI 10.1080/08927014.1999.9522821; Cimmaruta R, 2013, AMPHIBIA-REPTILIA, V34, P413, DOI 10.1163/15685381-00002906; Corander J, 2008, COMPUTATION STAT, V23, P111, DOI 10.1007/s00180-007-0072-x; Corander J, 2007, MATH BIOSCI, V205, P19, DOI 10.1016/j.mbs.2006.09.015; Corander J, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-539; Culver DC, 2000, CONSERV BIOL, V14, P386, DOI 10.1046/j.1523-1739.2000.99026.x; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Derkarabetian S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010388; Diadema K, 2005, TAXON, V54, P887, DOI 10.2307/25065475; Doyle JJ, 1987, PHYTOCHEM B, V19, P11, DOI 10.1016/j.bse.2009.07.003; Dupanloup I, 2002, MOL ECOL, V11, P2571, DOI 10.1046/j.1365-294X.2002.01650.x; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; FOULDS LR, 1979, J MOL EVOL, V13, P127, DOI 10.1007/BF01732868; Fu YX, 1997, GENETICS, V147, P915; Funk DJ, 2003, ANNU REV ECOL EVOL S, V34, P397, DOI 10.1146/annurev.ecolsys.34.011802.132421; Garnier S, 2004, MOL ECOL, V13, P1883, DOI 10.1111/j.1365-294X.2004.02212.x; Garrick RC, 2011, J INSECT CONSERV, V15, P469, DOI 10.1007/s10841-010-9349-4; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; Grassi F, 2009, J PLANT RES, V122, P377, DOI 10.1007/s10265-009-0230-z; Habel JC, 2005, J BIOGEOGR, V32, P1489, DOI 10.1111/j.1365-2699.2005.01273.x; HARPENDING HC, 1993, CURR ANTHROPOL, V34, P483, DOI 10.1086/204195; HARPENDING HC, 1994, HUM BIOL, V66, P591; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Hewitt GM, 2004, PHILOS T R SOC B, V359, P183, DOI 10.1098/rstb.2003.1388; HSU KJ, 1973, NATURE, V242, P240, DOI 10.1038/242240a0; Ibrahim KM, 1996, HEREDITY, V77, P282, DOI 10.1038/hdy.1996.142; Ivy-Ochs S, 2006, GEOL SOC AM SPEC PAP, V415, P43, DOI 10.1130/2006.2415(04); Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Jockusch EL, 2002, BIOL J LINN SOC, V76, P361, DOI 10.1046/j.1095-8312.2002.d01-6.x; Keppel G, 2012, GLOBAL ECOL BIOGEOGR, V21, P393, DOI 10.1111/j.1466-8238.2011.00686.x; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Krijgsman W, 1999, NATURE, V400, P652, DOI 10.1038/23231; Kropf M, 2002, MOL ECOL, V11, P447, DOI 10.1046/j.1365-294X.2002.01446.x; Lanza B, 1995, MONOGRAFIE MUSEO REG; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Liebgold EB, 2011, MOL ECOL, V20, P249, DOI 10.1111/j.1365-294X.2010.04946.x; Lunghi E, 2014, SALAMANDRA, V50, P105; Martinez-Solano I, 2012, MOL PHYLOGENET EVOL, V63, P131, DOI 10.1016/j.ympev.2011.12.026; Meirmans PG, 2004, MOL ECOL NOTES, V4, P792, DOI 10.1111/j.1471-8286.2004.00770.x; Minuto L, 2006, PLANT BIOSYST, V140, P146, DOI 10.1080/11263500600756348; Mosblech NAS, 2011, J BIOGEOGR, V38, P419, DOI 10.1111/j.1365-2699.2010.02436.x; Nascetti G, 1996, J HERPETOL, V30, P161, DOI 10.2307/1565507; Niemiller ML, 2008, MOL ECOL, V17, P2258, DOI 10.1111/j.1365-294X.2008.03750.x; Petit RJ, 2003, SCIENCE, V300, P1563, DOI 10.1126/science.1083264; Pritchard JK, 2000, GENETICS, V155, P945; Qi Y, 2014, MOL ECOL, V23, P5575, DOI 10.1111/mec.12960; Ramos-Onsins SE, 2002, MOL BIOL EVOL, V19, P2092, DOI 10.1093/oxfordjournals.molbev.a004034; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Rousselet J, 2010, J BIOGEOGR, V37, P1478, DOI 10.1111/j.1365-2699.2010.02289.x; Salvidio S, 2013, NORTH-WEST J ZOOL, V9, P429; Salvidio Sebastiano, 1994, Amphibia-Reptilia, V15, P35, DOI 10.1163/156853894X00533; Schonswetter P, 2005, MOL ECOL, V14, P3547, DOI 10.1111/j.1365-294X.2005.02683.x; Silvestro D., 2011, ORG DIVERS EVOL, V12, P335, DOI [10.1007/sI3127-011-0056-0, DOI 10.1007/S13127-011-0056-0]; SLATKIN M, 1991, GENETICS, V129, P555; Snowman CV, 2010, J ARACHNOL, V38, P49, DOI 10.1636/A09-057.1; Stefani F, 2012, MOL PHYLOGENET EVOL, V65, P718, DOI 10.1016/j.ympev.2012.07.022; Taberlet P, 1998, MOL ECOL, V7, P453, DOI 10.1046/j.1365-294x.1998.00289.x; TAJIMA F, 1989, GENETICS, V123, P585; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tapper SL, 2014, DIVERS DISTRIB, V20, P987, DOI 10.1111/ddi.12185; Tapper SL, 2014, J BIOGEOGR, V41, P2032, DOI 10.1111/jbi.12343; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Toews DPL, 2012, MOL ECOL, V21, P3907, DOI 10.1111/j.1365-294X.2012.05664.x; van der Meijden A, 2009, MOL PHYLOGENET EVOL, V51, P399, DOI 10.1016/j.ympev.2008.12.011; Vieites DR, 2007, P NATL ACAD SCI USA, V104, P19903, DOI 10.1073/pnas.0705056104; Weber LC, 2014, J BIOGEOGR, V41, P222, DOI 10.1111/jbi.12219; Weisrock DW, 2005, MOL ECOL, V14, P1457, DOI 10.1111/j.1365-294X.2005.02524.x; Xia XH, 2013, MOL BIOL EVOL, V30, P1720, DOI 10.1093/molbev/mst064; Xia XH, 2011, MOL PHYLOGENET EVOL, V59, P342, DOI 10.1016/j.ympev.2011.01.017; Zecca G, 2011, ORG DIVERS EVOL, V11, P357, DOI 10.1007/s13127-011-0063-1	92	7	8	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2015	10	6							e0131298	10.1371/journal.pone.0131298	http://dx.doi.org/10.1371/journal.pone.0131298			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4OM	26107249	Green Published, Green Submitted, gold			2022-12-26	WOS:000356932500154
J	Spricigo, JFW; Diogenes, MN; Leme, LO; Guimaraes, AL; Muterlle, CV; Silva, BDM; Sola-Oriol, D; Pivato, I; Silva, LP; Dode, MAN				Spricigo, Jose F. W.; Diogenes, Mateus N.; Leme, Ligiane O.; Guimaraes, Ana L.; Muterlle, Carolle V.; Marques Silva, Bianca Damiani; Sola-Oriol, David; Pivato, Ivo; Silva, Luciano Paulino; Dode, Margot A. N.			Effects of Different Maturation Systems on Bovine Oocyte Quality, Plasma Membrane Phospholipid Composition and Resistance to Vitrification and Warming	PLOS ONE			English	Article							IN-VITRO PRODUCTION; METHYL-BETA-CYCLODEXTRIN; EMBRYO DEVELOPMENT; MASS-SPECTROMETRY; MATURED OOCYTES; GENE-EXPRESSION; BOS-INDICUS; PORCINE EMBRYOS; CUMULUS CELLS; MALDI-MS	The objective of this study was to evaluate the effects of different maturation systems on oocyte resistance after vitrification and on the phospholipid profile of the oocyte plasma membrane (PM). Four different maturation systems were tested: 1) in vitro maturation using immature oocytes aspirated from slaughterhouse ovaries (CONT; n = 136); 2) in vitro maturation using immature oocytes obtained by ovum pick-up (OPU) from unstimulated heifers (IMA; n = 433); 3) in vitro maturation using immature oocytes obtained by OPU from stimulated heifers (FSH; n = 444); and 4) in vivo maturation using oocytes obtained from heifers stimulated 24 hours prior by an injection of GnRH (MII; n = 658). A sample of matured oocytes from each fresh group was analyzed by matrix associated laser desorption-ionization (MALDI-TOF) to determine their PM composition. Then, half of the matured oocytes from each group were vitrified/warmed (CONT VIT, IMA VIT, FSH VIT and MII VIT), while the other half were used as fresh controls. Afterwards, the eight groups underwent IVF and IVC, and blastocyst development was assessed at D2, D7 and D8. A chi-square test was used to compare embryo development between the groups. Corresponding phospholipid ion intensity was expressed in arbitrary units, and following principal components analyses (PCA) the data were distributed on a 3D graph. Oocytes obtained from superstimulated animals showed a greater rate of developmental (P<0.05) at D7 (MII = 62.4 +/- 17.5% and FSH = 58.8 +/- 16.1%) compared to those obtained from unstimulated animals (CONT = 37.9 +/- 8.5% and IMA = 50.6 +/- 14.4%). However, the maturation system did not affect the resistance of oocytes to vitrification because the blastocyst rate at D7 was similar (P>0.05) for all groups (CONT VIT = 2.8 +/- 3.5%, IMA VIT = 2.9 +/- 4.0%, FSH VIT = 4.3 +/- 7.2% and MII VIT = 3.6 +/- 7.2%). MALDI-TOF revealed that oocytes from all maturation groups had similar phospholipid contents, except for 760.6 ([PC (34:1) + H](+)), which was more highly expressed in MII compared to FSH (P<0.05). The results suggest that although maturation systems improve embryonic development, they do not change the PM composition nor the resistance of bovine oocytes to vitrification.	[Spricigo, Jose F. W.; Diogenes, Mateus N.; Leme, Ligiane O.; Guimaraes, Ana L.; Muterlle, Carolle V.; Pivato, Ivo; Dode, Margot A. N.] Univ Brasilia, Sch Agr & Vet Med, Brasilia, DF, Brazil; [Marques Silva, Bianca Damiani; Silva, Luciano Paulino; Dode, Margot A. N.] Embrapa Genet Resources & Biotechnol, Lab Anim Reprod, Brasilia, DF, Brazil; [Sola-Oriol, David] Univ Autonoma Barcelona, Dept Ciencia Anim & Aliments, Serv Nutr & Benestar Anim SNiBA, Bellaterra 08193, Spain	Universidade de Brasilia; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Autonomous University of Barcelona	Dode, MAN (corresponding author), Univ Brasilia, Sch Agr & Vet Med, Brasilia, DF, Brazil.	margot.dode@embrapa.br	Silva, Luciano Paulino/G-4915-2012; Guimarães, Ana Luiza/ABG-2608-2020; Dode, Margot/O-2486-2014; Sprícigo, José Felipe Warmling/L-9564-2015; Solà-Oriol, David/AAA-5730-2022; Leme, Ligiane/P-3814-2019; dode, margot alves nunes/S-6524-2019; Sola-Oriol, David/B-5493-2008	Silva, Luciano Paulino/0000-0001-9075-7725; Guimarães, Ana Luiza/0000-0002-6533-2490; Dode, Margot/0000-0002-1096-0457; Sprícigo, José Felipe Warmling/0000-0002-5507-3923; Solà-Oriol, David/0000-0001-8365-340X; Leme, Ligiane/0000-0003-4818-1202; dode, margot alves nunes/0000-0002-1096-0457; Sola-Oriol, David/0000-0001-8365-340X; Pivato, Ivo/0000-0001-7295-352X; Vieira Muterlle Spricigo, Carolle/0000-0002-8904-8312; Silva, Bianca/0000-0003-2206-2600	Embrapa Macroprograma 1, CAPES [01.13.06.001.04.00]	Embrapa Macroprograma 1, CAPES(Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA))	This work was funded by Embrapa Macroprograma 1 (#01.13.06.001.04.00), CAPES (who financially supported the first author).	Anchamparuthy VM, 2009, J ASSIST REPROD GEN, V26, P613, DOI 10.1007/s10815-009-9362-2; Apparicio M, 2012, REPROD DOMEST ANIM, V47, P113, DOI 10.1111/rda.12003; Batista EOS, 2014, REPROD DOMEST ANIM, V49, P448, DOI 10.1111/rda.12304; Blondin P, 2002, BIOL REPROD, V66, P38, DOI 10.1095/biolreprod66.1.38; Chamayou S, 2011, CRYOBIOLOGY, V62, P130, DOI 10.1016/j.cryobiol.2011.01.014; Chang CC, 2013, FERTIL STERIL, V99, P1891, DOI 10.1016/j.fertnstert.2013.02.008; Chang CC, 2008, REPROD BIOMED ONLINE, V17, P684, DOI 10.1016/S1472-6483(10)60316-1; Chankitisakul V, 2013, THERIOGENOLOGY, V79, P590, DOI 10.1016/j.theriogenology.2012.11.011; Coyral-Castel S, 2012, THERIOGENOLOGY, V77, P1822, DOI 10.1016/j.theriogenology.2011.12.028; Dieleman SJ, 2002, THERIOGENOLOGY, V57, P5, DOI 10.1016/S0093-691X(01)00655-0; Edidin M, 2003, NAT REV MOL CELL BIO, V4, P414, DOI 10.1038/nrm1102; Ferreira CR, 2010, J LIPID RES, V51, P1218, DOI 10.1194/jlr.D001768; Ferreira CR, 2009, RAPID COMMUN MASS SP, V23, P1313, DOI 10.1002/rcm.3995; Guerreiro BM, 2014, DOMEST ANIM ENDOCRIN, V49, P96, DOI 10.1016/j.domaniend.2014.07.002; Hagemann LJ, 1999, THERIOGENOLOGY, V51, P449, DOI 10.1016/S0093-691X(98)00239-8; Holm P, 1999, THERIOGENOLOGY, V52, P683, DOI 10.1016/S0093-691X(99)00162-4; Horvath G, 2006, THERIOGENOLOGY, V66, P1026, DOI 10.1016/j.theriogenology.2006.03.004; Humblot P, 2005, THERIOGENOLOGY, V63, P1149, DOI 10.1016/j.theriogenology.2004.06.002; Kuwayama M, 2005, REPROD BIOMED ONLINE, V11, P300, DOI 10.1016/S1472-6483(10)60837-1; Lapa M, 2011, REPROD DOMEST ANIM, V46, P904, DOI 10.1111/j.1439-0531.2011.01762.x; Machado GM, 2009, THERIOGENOLOGY, V71, P1289, DOI 10.1016/j.theriogenology.2009.01.002; Mamo S, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-151; Matsui M, 2009, VET J, V181, P232, DOI 10.1016/j.tvjl.2008.02.027; McEvoy TG, 2000, J REPROD FERTIL, V118, P163, DOI 10.1530/reprod/118.1.163; Men HS, 2006, THERIOGENOLOGY, V66, P2008, DOI 10.1016/j.theriogenology.2006.05.018; Men HS, 2005, THERIOGENOLOGY, V64, P1340, DOI 10.1016/j.theriogenology.2005.02.013; Moawad AR, 2013, BIOL REPROD, V88, DOI 10.1095/biolreprod.112.107433; Morato R, 2008, THERIOGENOLOGY, V70, P1536, DOI 10.1016/j.theriogenology.2008.07.002; Morato R, 2008, CRYOBIOLOGY, V57, P137, DOI 10.1016/j.cryobiol.2008.07.003; Niedermeyer THJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044913; PARRISH JJ, 1995, THERIOGENOLOGY, V44, P859, DOI 10.1016/0093-691X(95)00271-9; Prates EG, 2013, IN VITRO CELL DEV-AN, V49, P335, DOI 10.1007/s11626-013-9624-2; Rizos D, 2002, MOL REPROD DEV, V61, P234, DOI 10.1002/mrd.1153; Shirazi A, 2014, ZYGOTE, V22, P165, DOI 10.1017/S096719941200038X; Silva-Santos KC, 2014, REPROD DOMEST ANIM, V49, P711, DOI 10.1111/rda.12352; Spricigo JFW, 2012, CRYOBIOLOGY, V65, P319, DOI 10.1016/j.cryobiol.2012.09.001; Spricigo JFW, 2014, CRYOBIOLOGY, V69, P256, DOI 10.1016/j.cryobiol.2014.07.015; Sudano MJ, 2012, BIOL REPROD, V87, DOI 10.1095/biolreprod.112.102897; Sudano MJ, 2011, THERIOGENOLOGY, V75, P1211, DOI 10.1016/j.theriogenology.2010.11.033; Taylor TH, 2008, REPROD BIOMED ONLINE, V17, P515, DOI 10.1016/S1472-6483(10)60238-6; Tesfaye D, 2009, REPROD FERT DEVELOP, V21, P451, DOI 10.1071/RD08190; van de Leemput EE, 1999, THERIOGENOLOGY, V52, P335, DOI 10.1016/S0093-691X(99)00133-8; Vieira AD, 2002, CRYOBIOLOGY, V45, P91, DOI 10.1016/S0011-2240(02)00109-8; Yazaki T, 2013, ANIM SCI J, V84, P395, DOI 10.1111/asj.12016; Zeron Y, 2002, MOL REPROD DEV, V61, P271, DOI 10.1002/mrd.1156; Zhou XL, 2010, CRYOBIOLOGY, V61, P66, DOI 10.1016/j.cryobiol.2010.05.002	46	23	23	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2015	10	6							e0130164	10.1371/journal.pone.0130164	http://dx.doi.org/10.1371/journal.pone.0130164			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4OM	26107169	Green Published, Green Submitted, gold			2022-12-26	WOS:000356932500083
J	Wallace, APC; Milner-Gulland, EJ; Jones, JPG; Bunnefeld, N; Young, R; Nicholson, E				Wallace, Andrea P. C.; Milner-Gulland, E. J.; Jones, Julia P. G.; Bunnefeld, Nils; Young, Richard; Nicholson, Emily			Quantifying the Short-Term Costs of Conservation Interventions for Fishers at Lake Alaotra, Madagascar	PLOS ONE			English	Article							GEAR-BASED MANAGEMENT; MARINE RESERVES; ARTISANAL FISHERY; RESTRICTIONS; UNCERTAINTY; UNDERSTAND; DYNAMICS; CLOSURES; BEHAVIOR; AREAS	Artisanal fisheries are a key source of food and income for millions of people, but if poorly managed, fishing can have declining returns as well as impacts on biodiversity. Management interventions such as spatial and temporal closures can improve fishery sustainability and reduce environmental degradation, but may carry substantial short-term costs for fishers. The Lake Alaotra wetland in Madagascar supports a commercially important artisanal fishery and provides habitat for a Critically Endangered primate and other endemic wildlife of conservation importance. Using detailed data from more than 1,600 fisher catches, we used linear mixed effects models to explore and quantify relationships between catch weight, effort, and spatial and temporal restrictions to identify drivers of fisher behaviour and quantify the potential effect of fishing restrictions on catch. We found that restricted area interventions and fishery closures would generate direct short-term costs through reduced catch and income, and these costs vary between groups of fishers using different gear. Our results show that conservation interventions can have uneven impacts on local people with different fishing strategies. This information can be used to formulate management strategies that minimise the adverse impacts of interventions, increase local support and compliance, and therefore maximise conservation effectiveness.	[Wallace, Andrea P. C.; Milner-Gulland, E. J.; Bunnefeld, Nils; Nicholson, Emily] Univ London Imperial Coll Sci Technol & Med, Dept Life Sci, Ascot SL5 7PY, Berks, England; [Wallace, Andrea P. C.] Univ London Imperial Coll Sci Technol & Med, Ctr Environm Policy, Ascot SL5 7PY, Berks, England; [Jones, Julia P. G.] Bangor Univ, Sch Environm, Nat Resources & Geog, Bangor LL57 2UW, Gwynedd, Wales; [Bunnefeld, Nils] Univ Stirling, Biol & Environm Sci, Sch Nat Sci, Stirling FK9 4LA, Scotland; [Young, Richard] Durrell Wildlife Conservat Trust, Jersey JE3 5BP, Channel Islands, England; [Young, Richard] Univ Bath, Dept Biol & Biochem, Bath BA2 7AY, Avon, England; [Nicholson, Emily] Deakin Univ, Sch Life & Environm Sci, Ctr Integrat Ecol, Burwood, Vic 3125, Australia	Imperial College London; Imperial College London; Bangor University; University of Stirling; University of Bath; Deakin University	Wallace, APC (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Life Sci, Silwood Pk Campus, Ascot SL5 7PY, Berks, England.	a.wallace08@imperial.ac.uk	Jones, Julia P G/A-3031-2011; Nicholson, Emily/H-9001-2013; Jones, Julia P G/ABD-5629-2021	Jones, Julia P G/0000-0002-5199-3335; Nicholson, Emily/0000-0003-2199-3446; Jones, Julia P G/0000-0002-5199-3335; Bunnefeld, Nils/0000-0002-1349-4463; Young, Richard/0000-0002-6515-6343	UK Economic and Social Research Council (ESRC); Durrell Wildlife Conservation Trust (DWCT); Royal Society; Marie Curie Fellowship	UK Economic and Social Research Council (ESRC)(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Durrell Wildlife Conservation Trust (DWCT); Royal Society(Royal Society of London); Marie Curie Fellowship(European Commission)	AW was supported by the UK Economic and Social Research Council (ESRC) and Durrell Wildlife Conservation Trust (DWCT). EJMG acknowledges a Royal Society Wolfson Research Merit award, and EN a Marie Curie Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abernethy KE, 2007, CAN J FISH AQUAT SCI, V64, P1595, DOI 10.1139/F07-125; Adams VM, 2011, BIOL CONSERV, V144, P350, DOI 10.1016/j.biocon.2010.09.012; Allnutt TF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028969; Andrianandrasana H. T., 2009, MEMOIRE DIPLOME ETUD; Andrianandrasana HT, 2005, BIODIVERS CONSERV, V14, P2757, DOI 10.1007/s10531-005-8413-y; Ban NC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006258; Bene C, 2001, HUM ECOL, V29, P157, DOI 10.1023/A:1011059830170; Berkes F, 2004, CONSERV BIOL, V18, P621, DOI 10.1111/j.1523-1739.2004.00077.x; Berkes F., 2003, ENVIRONMENTS, V31, P16; Bernard H.R., 2002, RES METHODS ANTHR QU, V3rd; Blyth RE, 2002, ENVIRON CONSERV, V29, P493, DOI 10.1017/S0376892902000358; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; Bunnefeld N, 2011, TRENDS ECOL EVOL, V26, P441, DOI 10.1016/j.tree.2011.05.003; Burnham KP, 2002, MODEL SELECTION MULT, V2nd, DOI [DOI 10.1007/B97636, 10.1007/978-1-4757-2917-7, DOI 10.1007/978-1-4757-2917-7]; Carwardine J, 2010, CONSERV BIOL, V24, P1529, DOI 10.1111/j.1523-1739.2010.01535.x; Charles A, 2009, ICES J MAR SCI, V66, P6, DOI 10.1093/icesjms/fsn182; Cinner JE, 2009, CONSERV BIOL, V23, P124, DOI 10.1111/j.1523-1739.2008.01041.x; Cinner J, 2014, CONSERV LETT, V7, P224, DOI 10.1111/conl.12057; Cinner JE, 2011, GLOBAL ENVIRON CHANG, V21, P7, DOI 10.1016/j.gloenvcha.2010.09.001; Clark C.W., 2005, MATH BIOECONOMICS OP; Copsey J. A., 2009, Madagascar Conservation and Development, V4, P25; Davies TE, 2009, FISHERIES MANAG ECOL, V16, P279, DOI 10.1111/j.1365-2400.2009.00665.x; Daw TM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031460; de Peche Dina, 2006, JOINT CONVENTION REG; Dimech M, 2009, BIOL CONSERV, V142, P2691, DOI 10.1016/j.biocon.2009.06.019; FAO, 2022, BLUE TRANSFORMATION, DOI [DOI 10.4060/CC0461EN, 10.4060/cc0461en]; Faraway J.J., 2006, C&H TEXT STAT SCI, P59; Felthoven RG, 2004, AM J AGR ECON, V86, P619, DOI 10.1111/j.0002-9092.2004.00605.x; Ferry L, 2009, Z GEOMORPHOL, V53, P299, DOI 10.1127/0372-8854/2009/0053-0299; Freckleton RP, 2011, BEHAV ECOL SOCIOBIOL, V65, P91, DOI 10.1007/s00265-010-1045-6; Fulton EA, 2011, FISH FISH, V12, P2, DOI 10.1111/j.1467-2979.2010.00371.x; Game ET, 2009, ECOL LETT, V12, P1336, DOI 10.1111/j.1461-0248.2009.01384.x; Gavin MC, 2010, CONSERV BIOL, V24, P89, DOI 10.1111/j.1523-1739.2009.01387.x; Grantham Hedley S., 2008, Endangered Species Research, V5, P291, DOI 10.3354/esr00159; Greenstreet SPR, 2009, ICES J MAR SCI, V66, P90, DOI 10.1093/icesjms/fsn214; Hiddink JG, 2006, ICES J MAR SCI, V63, P822, DOI 10.1016/j.icesjms.2006.02.006; Hilborn R, 2004, OCEAN COAST MANAGE, V47, P197, DOI 10.1016/j.ocecoaman.2004.04.001; Holland DS, 2009, MAR RESOUR ECON, V24, P289, DOI 10.1086/mre.24.3.42629656; Keane A, 2008, ANIM CONSERV, V11, P75, DOI 10.1111/j.1469-1795.2008.00170.x; Kolding J., 2011, Forum for Development Studies, V38, P267, DOI 10.1080/08039410.2011.577798; Kolding J, 2012, FISH RES, V115, P99, DOI 10.1016/j.fishres.2011.11.008; Lorenzen K, 1996, AQUACULTURE, V142, P191, DOI 10.1016/0044-8486(95)01229-X; Maccord PFL, 2007, HYDROBIOLOGIA, V583, P365, DOI 10.1007/s10750-006-0486-4; Margules CR, 2000, NATURE, V405, P243, DOI 10.1038/35012251; Mascia MB, 2010, CONSERV BIOL, V24, P1424, DOI 10.1111/j.1523-1739.2010.01523.x; McClanahan TR, 2008, ECOL APPL, V18, P1516, DOI 10.1890/07-0876.1; McClanahan TR, 2014, ECOL SOC, V19, DOI 10.5751/ES-06080-190105; McClanahan TR, 2009, MAR ECOL PROG SER, V396, P99, DOI 10.3354/meps08279; McClanahan TR, 2010, CONSERV BIOL, V24, P1519, DOI 10.1111/j.1523-1739.2010.01530.x; McClanahan TR, 2004, FISHERIES MANAG ECOL, V11, P51, DOI 10.1111/j.1365-2400.2004.00358.x; Milner-Gulland, 2007, CONSERVATION SUSTAIN; MOREAU J, 1982, ACTA OECOL-OEC APPL, V3, P3; Naidoo R, 2006, TRENDS ECOL EVOL, V21, P681, DOI 10.1016/j.tree.2006.10.003; PCD, 2004, PLAN COMM DEV UNPUB; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Razanadrakoto D.R., 2005, DELIMITATION ZONES F; Roberts CM, 2001, SCIENCE, V294, P1920, DOI 10.1126/science.294.5548.1920; Russ GR, 2005, MAR ECOL PROG SER, V292, P1, DOI 10.3354/meps292001; Salas S, 2004, FISH FISH, V5, P153, DOI 10.1111/j.1467-2979.2004.00146.x; Sarkar S, 2011, BIOL CONSERV, V144, P979, DOI 10.1016/j.biocon.2010.03.008; Shertzer KW, 2007, ICES J MAR SCI, V64, P149, DOI 10.1093/icesjms/fsl005; Sommerville M, 2010, ECOL ECON, V69, P1262, DOI 10.1016/j.ecolecon.2009.11.005; Tidd AN, 2011, ICES J MAR SCI, V68, P961, DOI 10.1093/icesjms/fsr015; Wallace A. P. C., 2012, THESIS IMPERIAL COLL; Welcomme RL, 2010, PHILOS T R SOC B, V365, P2881, DOI 10.1098/rstb.2010.0168; Zuur Alain F., 2009, P1	66	8	8	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2015	10	6							e0129440	10.1371/journal.pone.0129440	http://dx.doi.org/10.1371/journal.pone.0129440			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CL4OM	26107284	Green Published, gold			2022-12-26	WOS:000356932500054
J	Xiao, X; Zhou, XY; Ming, HX; Zhang, JY; Huang, GW; Zhang, Z; Li, P				Xiao, Xue; Zhou, Xiaoying; Ming, Huixin; Zhang, Jinyan; Huang, Guangwu; Zhang, Zhe; Li, Ping			Chick Chorioallantoic Membrane Assay: A 3D Animal Model for Study of Human Nasopharyngeal Carcinoma	PLOS ONE			English	Article							EPSTEIN-BARR-VIRUS; LYMPH-NODE METASTASIS; ESTABLISHMENT; ASSOCIATION; METHYLATION; EXPRESSION; CELLS; GENE; DNA	Nasopharyngeal carcinoma (NPC) is a highly invasive and metastatic head and neck cancer. However, mechanistic study of the invasion and metastasis of NPC has been hampered by the lack of proper in vivo models. We established an in vivo chick embryo chorioallantoic membrane (CAM) model to study NPC tumor biology. We found 100% micro-tumor formation 3 days after inoculation with NPC cell lines (4/4) or primary tumor biopsy tissue (35/35). The transplanted NPC micro-tumors grew on CAMs with extracellular matrix interaction and induced angiogenesis. In addition, the CAM model could be used to study the growth of transplanted NPC tumors and also several important steps of metastasis, including tumor invasion by detecting the extent of basement membrane penetration, tumor angiogenesis by analyzing the area of neo-vessels, and tumor metastasis by quantifying tumor cells in distant organs. We established and described a feasible, easy-to-manipulate and reliable CAM model for in vivo study of NPC tumor biology. This model closely simulates the clinical features of NPC growth, progression and metastasis and could help elucidate the biological mechanisms of the growth pattern and invasion of NPC cells and in quantitative assessment of angiogenesis and cell intravasation.	[Xiao, Xue; Zhou, Xiaoying; Ming, Huixin; Zhang, Jinyan; Huang, Guangwu; Zhang, Zhe] Guangxi Med Univ, Affiliated Hosp 1, Dept Otolaryngol Head & Neck Surg, Nanning, Peoples R China; [Li, Ping] Guangxi Med Univ, Affiliated Hosp 1, Dept Pathol, Nanning, Peoples R China	Guangxi Medical University; Guangxi Medical University	Zhang, Z (corresponding author), Guangxi Med Univ, Affiliated Hosp 1, Dept Otolaryngol Head & Neck Surg, Nanning, Peoples R China.	zhangzhe@gxmu.edu.cn; liping@gxmu.edu.cn	Zhou, Xiaoying/Y-4217-2019	Zhou, Xiaoying/0000-0003-3298-5089; Zhang, Jinyan/0000-0002-9874-2744	Program for New Century Excellent Talents in University [NCET-12-0654]; National Basic Research Program of China [2011CB504300, 2012CB526600]; National Natural Scientific Foundation of China [81272983]; Guangxi Natural Science Foundation [2010GXNSFA013144, 2013GXNSFGA 019002]; Health Department of Guangxi Province [200919]	Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); National Basic Research Program of China(National Basic Research Program of China); National Natural Scientific Foundation of China(National Natural Science Foundation of China (NSFC)); Guangxi Natural Science Foundation(National Natural Science Foundation of Guangxi Province); Health Department of Guangxi Province	This study was supported by grants from the Program for New Century Excellent Talents in University (no. NCET-12-0654), National Basic Research Program of China (no. 2011CB504300 and 2012CB526600), National Natural Scientific Foundation of China (no. 81272983), Guangxi Natural Science Foundation (no. 2010GXNSFA013144 and 2013GXNSFGA 019002) and Key Project of Health Department of Guangxi Province (200919). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adham M, 2013, CLIN CANCER RES, V19, P2175, DOI 10.1158/1078-0432.CCR-12-2897; Avissar Patricia, 2009, V511, P361, DOI 10.1007/978-1-59745-447-6_16; BROOKS L, 1992, J VIROL, V66, P2689, DOI 10.1128/JVI.66.5.2689-2697.1992; Busch C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053970; BUSSON P, 1988, INT J CANCER, V42, P599, DOI 10.1002/ijc.2910420422; Chan ATC, 2002, ANN ONCOL, V13, P1007, DOI 10.1093/annonc/mdf179; Chan SYY, 2008, INT J CANCER, V122, P2169, DOI 10.1002/ijc.23374; Chang ET, 2006, CANCER EPIDEM BIOMAR, V15, P1765, DOI 10.1158/1055-9965.EPI-06-0353; Chen PY, 2004, ACTA PHARMACOL SIN, V25, P943; Cheung CCM, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-184; Cheung ST, 1999, INT J CANCER, V83, P121, DOI 10.1002/(SICI)1097-0215(19990924)83:1<121::AID-IJC21>3.0.CO;2-F; Fischer Andrew H, 2008, CSH Protoc, V2008, DOI 10.1101/pdb.prot4986; Garcia-Closas M, 2001, CANCER EPIDEM BIOMAR, V10, P687; GILLIGAN KJ, 1991, J VIROL, V65, P6252, DOI 10.1128/JVI.65.11.6252-6259.1991; GIOVANELLA BC, 1974, JNCI-J NATL CANCER I, V52, P921, DOI 10.1093/jnci/52.3.921; Gressette M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091325; Gullo C, 2008, ANN ACAD MED SINGAP, V37, P769; HUANG DP, 1989, INT J CANCER, V43, P936, DOI 10.1002/ijc.2910430535; Kunzi-Rapp K, 2001, J UROLOGY, V166, P1502, DOI 10.1016/S0022-5347(05)65820-X; Lester RD, 2007, J CELL BIOL, V178, P425, DOI 10.1083/jcb.200701092; Lin Jin-Ching, 2000, Kaohsiung Journal of Medical Sciences, V16, P1; Liu M, 2013, TRANSL ONCOL, V6, P273, DOI 10.1593/tlo.13175; Liu TF, 2007, CLIN CANCER RES, V13, P3960, DOI 10.1158/1078-0432.CCR-07-0089; Lokman NA, 2012, INT J MOL SCI, V13, P9959, DOI 10.3390/ijms13089959; Mira E, 2002, CLIN EXP METASTAS, V19, P313, DOI 10.1023/A:1015563031769; Ribatti D, 1996, INT J DEV BIOL, V40, P1189; Song Li-bing, 2002, Ai Zheng, V21, P158; Sun D, 2007, ORAL ONCOL, V43, P82, DOI 10.1016/j.oraloncology.2006.01.007; Wakisaka N, 1999, LARYNGOSCOPE, V109, P810, DOI 10.1097/00005537-199905000-00024; Wan XB, 2009, CANCER BIOL THER, V8, P1500, DOI 10.4161/cbt.8.15.8958; Wei WI, 2005, LANCET, V365, P2041, DOI 10.1016/S0140-6736(05)66698-6; Whelan JA, 2003, J IMMUNOL METHODS, V278, P261, DOI 10.1016/S0022-1759(03)00223-0; YAO K, 1990, INT J CANCER, V45, P83, DOI 10.1002/ijc.2910450116; Zhang Z, 2007, INT J CANCER, V120, P32, DOI 10.1002/ijc.22185; Zhang Z, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045908	35	39	39	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2015	10	6							e0130935	10.1371/journal.pone.0130935	http://dx.doi.org/10.1371/journal.pone.0130935			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4OM	26107941	gold, Green Published, Green Submitted			2022-12-26	WOS:000356932500131
J	Wang, C; Jiang, LP; Wang, SQ; Shi, HG; Wang, JW; Wang, R; Li, YM; Dou, YH; Liu, Y; Hou, GQ; Ke, Y; Liu, HM				Wang, Cong; Jiang, Liping; Wang, Saiqi; Shi, Hongge; Wang, Junwei; Wang, Ran; Li, Yongmei; Dou, Yinhui; Liu, Ying; Hou, Guiqin; Ke, Yu; Liu, Hongmin			The Antitumor Activity of the Novel Compound Jesridonin on Human Esophageal Carcinoma Cells	PLOS ONE			English	Article							BREAST-CANCER; BCL-2 FAMILY; KAPPA-B; ORIDONIN; APOPTOSIS; P53; CYCLE; DITERPENOIDS; ACTIVATION; MECHANISMS	Jesridonin, a small molecule obtained through the structural modification of Oridonin, has extensive antitumor activity. In this study, we evaluated both its in vitro activity in the cancer cell line EC109 and its in vivo effect on tumor xenografts in nude mice. Apoptosis induced by Jesridonin was determined using an MTT assay, Annexin-V FITC assay and Hoechest 33258 staining. Apoptosis via mitochondrial and death receptor pathways were confirmed by detecting the regulation of MDM2, p53, and Bcl-2 family members and by activation of caspase-3/-8/-9. In addition, vena caudalis injection of Jesridonin showed significant inhibition of tumor growth in the xenograft model, and Jesridonin-induced cell apoptosis in tumor tissues was determined using TUNEL. Biochemical serum analysis of alkaline phosphatase (ALP), alanine transaminase (ALT), aspartate transaminase (AST), gamma-glutamyl transferase (GGT), total protein (TP) and albumin (ALB) indicated no obvious effects on liver function. Histopathological examination of the liver, kidney, lung, heart and spleen revealed no signs of JD-induced toxicity. Taken together, these results demonstrated that Jesridonin exhibits antitumor activity in human esophageal carcinomas EC109 cells both in vitro and in vivo and demonstrated no adverse effects on major organs in nude mice. These studies provide support for new drug development.	[Wang, Cong; Jiang, Liping; Wang, Saiqi; Shi, Hongge; Wang, Junwei; Wang, Ran; Li, Yongmei; Dou, Yinhui; Liu, Ying; Hou, Guiqin; Ke, Yu; Liu, Hongmin] Zhengzhou Univ, Sch Pharmaceut Sci, Zhengzhou 450001, Henan, Peoples R China; [Wang, Cong; Jiang, Liping; Wang, Saiqi; Shi, Hongge; Wang, Junwei; Wang, Ran; Li, Yongmei; Dou, Yinhui; Liu, Ying; Hou, Guiqin; Ke, Yu; Liu, Hongmin] Zhengzhou Univ, New Drug Res & Dev Ctr, Zhengzhou 450001, Henan, Peoples R China	Zhengzhou University; Zhengzhou University	Ke, Y (corresponding author), Zhengzhou Univ, Sch Pharmaceut Sci, 100 Kexue Ave, Zhengzhou 450001, Henan, Peoples R China.	ky@zzu.edu.cn; liuhm@zzu.edu.cn	wang, sai/HGB-8344-2022; li, yong/HDN-3885-2022		National Natural Science Foundation of China [81430085, 21372206, 81172937]; Science and Technology Research Key Project in Henan province Department of Education [14B350011]; Colleges and Universities in Henan province Youth Backbone Teachers Scheme	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Research Key Project in Henan province Department of Education; Colleges and Universities in Henan province Youth Backbone Teachers Scheme	This work was supported by National Natural Science Foundation of China (Project No. 81430085, No. 21372206 and No. 81172937 for Hongmin Liu), Science and Technology Research Key Project in Henan province Department of Education (Project No. 14B350011 for Cong Wang), Colleges and Universities in Henan province Youth Backbone Teachers Scheme 2010 (for Cong Wang).	Brunelle JK, 2009, J CELL SCI, V122, P437, DOI 10.1242/jcs.031682; Creagh EM, 2003, IMMUNOL REV, V193, P10, DOI 10.1034/j.1600-065X.2003.00048.x; Elias J, 2014, BBA-PROTEINS PROTEOM, V1844, P232, DOI 10.1016/j.bbapap.2013.09.019; Elizabeth A., 2001, J BIOL CHEM, V276, P7320; Fan Q, 2010, J MED RES CHINESE, V39, P14; Giansanti V, 2011, BIOCHEM PHARMACOL, V82, P1304, DOI 10.1016/j.bcp.2011.05.023; Hsieh TC, 2005, BIOCHEM BIOPH RES CO, V337, P224, DOI 10.1016/j.bbrc.2005.09.040; Huang LJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108286; Khan N, 2008, BIOCHEM PHARMACOL, V76, P1333, DOI 10.1016/j.bcp.2008.07.015; Komarova EA, 2000, BIOCHEMISTRY-MOSCOW+, V65, P41; Leung CH, 2005, MOL PHARMACOL, V68, P286, DOI 10.1124/mol.105.012765; Li CY, 2011, INT J BIOCHEM CELL B, V43, P701, DOI 10.1016/j.biocel.2011.01.020; Li XB, 2015, FOOD AGR IMMUNOL, V26, P109, DOI 10.1080/09540105.2013.873390; Liu C.J., 1998, CHIN PHARM J, V33, P577; Liu J, 2004, STRAIT PHARM J, V16, P1; Liu Z, 2012, CELL PROLIFERAT, V45, P499, DOI 10.1111/j.1365-2184.2012.00849.x; Lou HY, 2011, COLLOID SURFACE B, V87, P319, DOI 10.1016/j.colsurfb.2011.05.037; Marzo I, 2008, BIOCHEM PHARMACOL, V76, P939, DOI 10.1016/j.bcp.2008.06.009; Mayerl C, 2006, J IMMUNOL METHODS, V316, P163, DOI 10.1016/j.jim.2006.08.013; Mohan S, 2010, J ETHNOPHARMACOL, V131, P592, DOI 10.1016/j.jep.2010.07.043; Nakano K, 2001, MOL CELL, V7, P683, DOI 10.1016/S1097-2765(01)00214-3; Ren KK, 2006, J ETHNOPHARMACOL, V103, P176, DOI 10.1016/j.jep.2005.07.020; Sax JK, 2003, CELL DEATH DIFFER, V10, P413, DOI 10.1038/sj.cdd.4401227; Sun HD, 2006, NAT PROD REP, V23, P673, DOI 10.1039/b604174d; Tian W, 2013, CHIN J INTEGR MED, V19, P315, DOI 10.1007/s11655-013-1437-3; Turner N, 2013, CANCER TREAT REV, V39, P541, DOI 10.1016/j.ctrv.2012.12.001; Vousden KH, 2002, NAT REV CANCER, V2, P594, DOI 10.1038/nrc864; Wang RL, 1994, STUDY TUMOR PREVENTI, V11, P86; Wang RL, 1984, CANC CHINESE, V1, P50; Woo GH, 2006, NEUROTOXICOL TERATOL, V28, P125, DOI 10.1016/j.ntt.2005.08.002; Xu ZK, 2007, MODERN TRADITIONAL C, V9, P43; Zang LH, 2012, ARCH BIOCHEM BIOPHYS, V518, P31, DOI 10.1016/j.abb.2011.11.019; Zhang YH, 2011, ACTA PHARMACOL SIN, V32, P1266, DOI 10.1038/aps.2011.92; Zhou GB, 2007, CELL RES, V17, P274, DOI 10.1038/cr.2007.21; [左海军 Zuo Haijun], 2005, [沈阳药科大学学报, Journal of Shenyang Pharmaceutical University], V22, P258	35	27	27	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2015	10	6							e0130284	10.1371/journal.pone.0130284	http://dx.doi.org/10.1371/journal.pone.0130284			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4DD	26103161	Green Published, gold, Green Submitted			2022-12-26	WOS:000356901900034
J	Bitar, A; Mastouri, R; Kreutz, RP				Bitar, Abbas; Mastouri, Ronald; Kreutz, Rolf P.			Caffeine Consumption and Heart Rate and Blood Pressure Response to Regadenoson	PLOS ONE			English	Article							CORONARY VASODILATION; RECEPTOR AGONISTS; HEALTHY-SUBJECTS; PHARMACOKINETICS; ELIMINATION; CLEARANCE; RELEASE; STRESS; FLOW	Background Current guidelines recommend that caffeinated products should be avoided for at least 12 hours prior to regadenoson administration. We intended to examine the effect of caffeine consumption and of timing of last dose on hemodynamic effects after regadenoson administration for cardiac stress testing. Methods 332 subjects undergoing regadenoson stress testing were enrolled. Baseline characteristics, habits of coffee/caffeine exposure, baseline vital signs and change in heart rate, blood pressure, percent of maximal predicted heart rate, and percent change in heart rate were prospectively collected. Results Non-coffee drinkers (group 1) (73 subjects) and subjects who last drank coffee >24 hours (group 3) (139 subjects) prior to regadenoson did not demonstrate any difference in systolic blood pressure, heart rate change, maximal predicted heart rate and percent change in heart rate. Systolic blood pressure change (15.2 +/- 17.1 vs. 7.2 +/- 10.2 mmHg, p = 0.001), heart rate change (32.2 +/- 14 vs. 27.3 +/- 9.6 bpm, p = 0.038) and maximal predicted heart rate (65.5 +/- 15.6 vs. 60.7 +/- 8.6%, p = 0.038) were significantly higher in non-coffee drinkers (group 1) compared to those who drank coffee 12-24 hours prior (group 2) (108 subjects). Subjects who drank coffee >24 hours prior (group 3) exhibited higher systolic blood pressure change (13 +/- 15.8 vs. 7 +/- 10.2, p = 0.007), and heart rate change (32.1 +/- 15.3 vs. 27.3 +/- 9.6, p = 0.017) as compared to those who drank coffee 12-24 hours prior to testing (group 2). Conclusions Caffeine exposure 12-24 hours prior to regadenoson administration attenuates the vasoactive effects of regadenoson, as evidenced by a blunted rise in heart rate and systolic blood pressure. These results suggest that caffeine exposure within 24 hours may reduce the effects of regadenoson administered for vasodilatory cardiac stress testing.	[Bitar, Abbas; Mastouri, Ronald; Kreutz, Rolf P.] Indiana Univ, Sch Med, Krannert Inst Cardiol, Indianapolis, IN 46204 USA	Indiana University System; Indiana University-Purdue University Indianapolis	Kreutz, RP (corresponding author), Indiana Univ, Sch Med, Krannert Inst Cardiol, Indianapolis, IN 46204 USA.	rkreutz@iu.edu	Bitar, Abbas/K-9653-2019; Kreutz, Rolf/ABF-7160-2021		National Institutes of Health, National Center for Advancing Translational Sciences, Clinical and Translational Sciences Award [U54-RR025761]; NCRR [C06-RR020128-01]; Indiana University Health Values Grant; Indiana University Health - Indiana University School of Medicine Strategic Research Initiative; Methodist Research Institute Showalter Grant for Cardiovascular Research; Indiana Clinical and Translational Sciences Institute; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR002529, UL1TR001108] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR020128, UL1RR025761] Funding Source: NIH RePORTER	National Institutes of Health, National Center for Advancing Translational Sciences, Clinical and Translational Sciences Award; NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Indiana University Health Values Grant; Indiana University Health - Indiana University School of Medicine Strategic Research Initiative; Methodist Research Institute Showalter Grant for Cardiovascular Research; Indiana Clinical and Translational Sciences Institute; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This publication was made possible in part, with support from the Indiana Clinical and Translational Sciences Institute funded, in part by Grant Number (U54-RR025761. Anantha Shekhar, PI) from the National Institutes of Health, National Center for Advancing Translational Sciences, Clinical and Translational Sciences Award, and the Indiana CTSI Specimen Storage Facility which was funded in part by a NCRR construction grant (C06-RR020128-01. R.S. Fife, PI, K. Cornetta, Co-I). The project was supported by the Indiana University Health Values Grant, the Indiana University Health - Indiana University School of Medicine Strategic Research Initiative, and the Methodist Research Institute Showalter Grant for Cardiovascular Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti C, 1997, J CARDIOVASC PHARM, V30, P320, DOI 10.1097/00005344-199709000-00008; BALOGH A, 1992, INT J CLIN PHARM TH, V30, P383; Belardinelli L, 1998, J PHARMACOL EXP THER, V284, P1066; BLANCHARD J, 1983, EUR J CLIN PHARMACOL, V24, P93, DOI 10.1007/BF00613933; Buhr C, 2008, VASC HEALTH RISK MAN, V4, P337; Cerqueira Manuel D, 2006, Curr Cardiol Rep, V8, P119, DOI 10.1007/s11886-006-0022-1; Conlay LA, 1997, NATURE, V389, P136, DOI 10.1038/38160; Dhalla AK, 2006, J PHARMACOL EXP THER, V316, P695, DOI 10.1124/jpet.105.095323; Gaemperli O, 2008, J AM COLL CARDIOL, V51, P328, DOI 10.1016/j.jacc.2007.10.014; Gaemperli O, 2011, J NUCL CARDIOL, V18, P830, DOI 10.1007/s12350-011-9410-z; GREEN RM, 1986, J CLIN INVEST, V77, P222, DOI 10.1172/JCI112280; Hove-Madsen L, 2006, CARDIOVASC RES, V72, P292, DOI 10.1016/j.cardiores.2006.07.020; Hsiao E, 2013, J NUCL MED; Jodynis-Liebert J, 2004, J CLIN PHARMACOL, V44, P338, DOI 10.1177/0091270004263468; Lakatta EG, 2002, J CARDIAC SURG, V17, P451; LELO A, 1986, BRIT J CLIN PHARMACO, V22, P177, DOI 10.1111/j.1365-2125.1986.tb05246.x; Lieu HD, 2007, J NUCL CARDIOL, V14, P514, DOI 10.1016/j.nuclcard.2007.02.016; MAY DC, 1982, CLIN PHARMACOL THER, V31, P656, DOI 10.1038/clpt.1982.91; McLean C, 2002, J APPL PHYSIOL, V93, P1471, DOI 10.1152/japplphysiol.00762.2000; Miyamoto MI, 2007, J NUCL CARDIOL, V14, P250, DOI 10.1016/j.nuclcard.2007.01.006; PARSONS WD, 1978, CLIN PHARMACOL THER, V24, P40; PATWARDHAN RV, 1980, J LAB CLIN MED, V95, P603; Ralevic V, 1998, PHARMACOL REV, V50, P413; Shryock JC, 1998, CIRCULATION, V98, P711, DOI 10.1161/01.CIR.98.7.711; STATLAND BE, 1980, AM J CLIN PATHOL, V73, P390; Tejani FH1 TR, 2014, INT J CARDIOVASC IMA; Thompson CA, 2008, AM J HEALTH-SYST PH, V65, P890, DOI 10.2146/news080038; Tikh EI, 2006, AM J PHYSIOL-HEART C, V290, pH348, DOI 10.1152/ajpheart.00740.2005; WIETHOLTZ H, 1995, J HEPATOL, V22, P78, DOI 10.1016/0168-8278(95)80263-0; Zhao G, 2007, J CARDIOVASC PHARM, V49, P369, DOI 10.1097/FJC.0b013e318046f364	30	4	6	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2015	10	6							e0130487	10.1371/journal.pone.0130487	http://dx.doi.org/10.1371/journal.pone.0130487			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL3FM	26098883	gold, Green Published			2022-12-26	WOS:000356835800073
J	Jatau, B; Avong, Y; Ogundahunsi, O; Shah, S; Smith, KT; van den Bergh, R; Zachariah, R; van Griensven, J; Ekong, E; Dakum, P				Jatau, Bolajoko; Avong, Yohanna; Ogundahunsi, Olumide; Shah, Safieh; Smith, Katherine Tayler; van den Bergh, Rafael; Zachariah, Rony; van Griensven, Johan; Ekong, Ernest; Dakum, Patrick			Procurement and Supply Management System for MDR-TB in Nigeria: Are the Early Warning Targets for Drug Stock Outs and Over Stock of Drugs Being Achieved?	PLOS ONE			English	Article								Background The World Health Organisation (WHO) introduced the twelve early warning indicators for monitoring and evaluating drug Procurement and Supply management (PSM) systems, intended to prevent drug stock-outs and overstocking. Nigeria- one of the high Multi Drug Resistant Tuberculosis (MDR-TB) burden countries, scaled-up treatment in 2012 with the concurrent implementation of a PSM system. Method We evaluated how well this system functioned using the WHO indicators, including all seven MDR-TB treatment centres in the country that were functional throughout 2013. Results The quantity of MDR-TB drugs ordered for 2013 matched the annual forecast and all central orders placed during the year were delivered in full and on time. Drug consumption was 81%-106% of the quantity allocated for routine consumption. Timely submission of complete inventory reports ranged from 86-100%, late submissions being 5-15 days late. Forty to 71% of treatment centres placed a drug order when stock was below the minimum level of three months. The proportion of drug orders received at the treatment centres in full and on time ranged from 29-80%, late orders being 1-19 days late. Conclusion The PSM was found to be performing well in terms of forecasting and procurement of MDR-TB drugs, but there were shortcomings in drug distribution, reporting at treatment centre level and in drug order placements. Despite these gaps, there were no stock outs. These findings indicate that where it matters most, namely ensuring that no drug stock outs affect patient management, the PSM system is effective. Addressing the observed shortcomings will help to strengthen the existing PSM system in anticipation of a growing MDR-TB case burden in the country.	[Jatau, Bolajoko; Avong, Yohanna; Ekong, Ernest; Dakum, Patrick] Inst Human Virol Nigeria, Abuja, Nigeria; [Ogundahunsi, Olumide] Special Program Res & Training Trop Dis, Geneva, Switzerland; [Shah, Safieh; Smith, Katherine Tayler; van den Bergh, Rafael; Zachariah, Rony] MSF Luxembourg, Operat Res Unit, Operat Ctr Brussels, Med Sans Frontieres, Luxembourg, Luxembourg; [van Griensven, Johan] Inst Trop Med, B-2000 Antwerp, Belgium	Doctors Without Borders; Institute of Tropical Medicine (ITM)	Jatau, B (corresponding author), Inst Human Virol Nigeria, Abuja, Nigeria.	bolajatau@gmail.com	Shah, Safieh/Z-2078-2018; Avong, Yohanna/AAS-4891-2020; Shah, Safieh/AAK-3257-2020	Shah, Safieh/0000-0001-5358-9240; Avong, Yohanna/0000-0001-6798-8576; Shah, Safieh/0000-0001-5358-9240; Van den Bergh, Rafael/0000-0001-6277-8713; zachariah, rony/0000-0002-2915-9328	WHO; MSF; The Union; Department for International Development (DFID)	WHO(World Health Organization); MSF; The Union; Department for International Development (DFID)	The programme was funded by MSF, The Union, the Department for International Development (DFID) and WHO. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, HARM MON EV IND PROC; [Anonymous], TUBERCULOSIS MULTIDR; Central Intelligence Agency, 2012, NIG PEOPL 2012; Geeta A., 2013, WALL STREET J, V6; Management Sciences for Health, 1997, MAN DRUG SUPPL; Nigeria Federal Ministry of Health, 2011, GUID CONTR CLIN MAN; Pasquet A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013414; Seaworth BJ, 2013, MMWR-MORBID MORTAL W, V62, P23; WHO, 2010, TREATMENT OF TUBERCULOSIS: GUIDELINES, FOURTH EDITION, P1; WHO, 2014, GLOB TUB REP 2014; Windisch R, 2011, GLOBALIZATION HEALTH, V7, DOI 10.1186/1744-8603-7-25; World Health Organization, 2008, GUID PROGR MAN DRUG, DOI [10.1186/1471-2334-8-166, DOI 10.1186/1471-2334-8-166]	12	5	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2015	10	6							e0128500	10.1371/journal.pone.0128500	http://dx.doi.org/10.1371/journal.pone.0128500			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL3FM	26098673	gold, Green Published			2022-12-26	WOS:000356835800015
J	Kurtz, BE				Kurtz, Bruce E.			The Effect of Natural Multidecadal Ocean Temperature Oscillations on Contiguous US Regional Temperatures	PLOS ONE			English	Article							NORTH-AMERICAN; CLIMATE; VARIABILITY; CIRCULATION	Atmospheric temperature time series for the nine climate regions of the contiguous U.S. are accurately reproduced by the superposition of oscillatory modes, representing the Atlantic multidecadal oscillation (AMO) and the Pacific decadal oscillation (PDO), on a monotonic mode representing, at least in part, the effect of radiant forcing due to increasing atmospheric CO2. The relative importance of the different modes varies among the nine climate regions, grouping them into three mega-regions: Southeastern comprising the South, Southeast and Ohio Valley; Central comprising the Southwest, Upper Midwest, and Northeast; and Northwestern comprising the West, Northwest, and Northern Rockies & Plains. The defining characteristics of the mega-regions are: Southeastern - dominated by the AMO, no PDO influence; Central - influenced by the AMO, no PDO influence, Northwestern - influenced by both the AMO and PDO. Temperature vs. time curves calculated by combining the separate monotonic and oscillatory modes agree well with the measured temperature time series, indicating that the 1938-1974 small decrease in contiguous U.S. temperature was caused by the superposition of the downward-trending oscillatory mode on the upward-trending monotonic mode while the 1980-2000 large increase in temperature was caused by the superposition of the upward-trending oscillatory mode on the upward-trending monotonic mode. The oscillatory mode, mostly representing the AMO, was responsible for about 72% of the entire contiguous U.S. temperature increase over that time span with the contribution varying from 86 to 42% for individual climate regions.				kurtz36ti@gmail.com		Kurtz, Bruce/0000-0001-5108-3510				Chen XY, 2014, SCIENCE, V345, P897, DOI 10.1126/science.1254937; Delworth TL, 2000, CLIM DYNAM, V16, P661, DOI 10.1007/s003820000075; Edwards M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057212; Enfield DB, 2001, GEOPHYS RES LETT, V28, P2077, DOI 10.1029/2000GL012745; Gentle J. E., 2004, HDB COMPUTATIONAL ST; Gray ST, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL019932; HALL MM, 1982, DEEP-SEA RES, V29, P339, DOI 10.1016/0198-0149(82)90099-1; Hu Q, 2011, J CLIMATE, V24, P5555, DOI 10.1175/2011JCLI4060.1; Kaplan A, 1998, J GEOPHYS RES-OCEANS, V103, P18567, DOI 10.1029/97JC01734; Kerr R. A., 2005, SIENCE, V5731, P41, DOI DOI 10.1126/SCIENCE.309.5731.41; Knight JR, 2009, J CLIMATE, V22, P1610, DOI 10.1175/2008JCLI2628.1; Knight JR, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL024233; Knudsen MF, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1186; Kumar S, 2013, J CLIMATE, V26, P3511, DOI 10.1175/JCLI-D-12-00535.1; Kurtz BE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100306; Macias D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107222; Macias D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081591; Mantua NJ, 2002, J OCEANOGR, V58, P35, DOI 10.1023/A:1015820616384; McCarthy GD, 2015, PROG OCEANOGR, V130, P91, DOI 10.1016/j.pocean.2014.10.006; Polyakov IV, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL023740; Polyakov IV, 2005, J CLIMATE, V18, P4562, DOI 10.1175/JCLI3548.1; SCHLESINGER ME, 1994, NATURE, V367, P723, DOI 10.1038/367723a0; STOMMEL H, 1961, TELLUS, V13, P224, DOI 10.1111/j.2153-3490.1961.tb00079.x; Stommel H, 1959, CONTRIBUTION, P140; Sutton RT, 2005, SCIENCE, V309, P115, DOI 10.1126/science.1109496; Tung KK, 2013, P NATL ACAD SCI USA, V110, P2058, DOI 10.1073/pnas.1212471110; Wang XC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022740; Wei W, 2012, J CLIMATE, V25, P6989, DOI 10.1175/JCLI-D-11-00667.1; Wu ZW, 2011, CLIM DYNAM, V37, P1661, DOI 10.1007/s00382-010-0938-4; Wyatt MG, 2012, CLIM DYNAM, V38, P929, DOI 10.1007/s00382-011-1071-8; Yao SL, 2016, THEOR APPL CLIMATOL, V123, P349, DOI 10.1007/s00704-014-1358-x; Zhang R, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2006GL028683	32	4	4	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2015	10	6							e0131349	10.1371/journal.pone.0131349	http://dx.doi.org/10.1371/journal.pone.0131349			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL3FM	26098932	gold, Green Published, Green Submitted			2022-12-26	WOS:000356835800172
J	Liu, DY; Suchard, SJ; Nadler, SG; Ford, ML				Liu, Danya; Suchard, Suzanne J.; Nadler, Steve G.; Ford, Mandy L.			Inhibition of Donor-Reactive CD8+T Cell Responses by Selective CD28 Blockade Is Independent of Reduced ICOS Expression	PLOS ONE			English	Article							CD8(+) T-CELLS; 2B4 CD244; COSTIMULATION BLOCKADE; INDUCIBLE COSTIMULATOR; CO-STIMULATION; CUTTING EDGE; RECEPTOR; PATHWAY; EXHAUSTION; AUTOIMMUNE	Programmed T cell differentiation is critically influenced by the complement of costimulatory and coinhibitory signals transmitted during initial antigen encounter. We previously showed that selective CD28 blockade with novel domain antibodies that leave CTLA-4-mediated coinhibitory signaling intact resulted in more profound attenuation of donor-reactive T cell responses and improved graft survival in a murine transplant model. Selective CD28 blockade was also associated with decreased ICOS expression on donor-reactive CD8(+) T cell responses as compared to CTLA-4 Ig, but the functional importance of this reduced ICOS expression was not known. In this study, we created retrogenic donor-reactive CD8(+) T cells that overexpress ICOS in order to determine whether reduced ICOS expression mechanistically underlies the increased efficacy of selective CD28 blockade in controlling graft-specific T cell responses as compared to conventional costimulation blockade with CTLA-4 Ig. Results indicated that the ability of selective CD28 blockade to blunt donor-reactive CD8(+) T cell expansion following transplantation was independent of its ability to inhibit ICOS expression. Furthermore, we have previously published that 2B4 coinhibitory signals are functionally important for controlling graft-specific CD8(+) T cell responses in mice treated with CD28 blockade. Here we used a co-adoptive transfer approach to determine that 2B4 coinhibitory signals on antigen-specific CD8(+) T cells function in a cell-intrinsic manner to limit ICOS expression in the setting of selective CD28 blockade.	[Liu, Danya; Ford, Mandy L.] Emory Univ, Emory Transplant Ctr, Atlanta, GA 30322 USA; [Liu, Danya; Ford, Mandy L.] Emory Univ, Dept Surg, Atlanta, GA 30322 USA; [Suchard, Suzanne J.; Nadler, Steve G.] Bristol Myers Squibb Co, Princeton, NJ USA	Emory University; Emory University; Bristol-Myers Squibb	Ford, ML (corresponding author), Emory Univ, Emory Transplant Ctr, Atlanta, GA 30322 USA.	mandy.ford@emory.edu			National Institute of Allergy and Infectious Disease grants [AI104699, AI073707]; Bristol-Myers Squibb; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI104699, R01AI073707] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Disease grants; Bristol-Myers Squibb(Bristol-Myers Squibb); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was funded by the National Institute of Allergy and Infectious Disease grants AI104699 and AI073707 to MLF. Bristol-Myers Squibb provided support in the form of salaries for authors SJS and SGN, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Ansaria MJI, 2008, CLIN IMMUNOL, V126, P140, DOI 10.1016/j.clim.2007.07.019; AZUMA M, 1993, J IMMUNOL, V150, P1147; Barnden MJ, 1998, IMMUNOL CELL BIOL, V76, P34, DOI 10.1046/j.1440-1711.1998.00709.x; Batliwalla F, 1996, HUM IMMUNOL, V48, P68, DOI 10.1016/0198-8859(96)00077-8; Bengsch B, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000947; Bertram EM, 2002, EUR J IMMUNOL, V32, P3376, DOI 10.1002/1521-4141(200212)32:12<3376::AID-IMMU3376>3.0.CO;2-Y; Blackburn SD, 2009, NAT IMMUNOL, V10, P29, DOI 10.1038/ni.1679; Boles KS, 2001, IMMUNOL REV, V181, P234, DOI 10.1034/j.1600-065X.2001.1810120.x; Chen LP, 2013, NAT REV IMMUNOL, V13, P227, DOI 10.1038/nri3405; Coyle AJ, 2000, IMMUNITY, V13, P95, DOI 10.1016/S1074-7613(00)00011-X; Crotty S, 2011, ANNU REV IMMUNOL, V29, P621, DOI 10.1146/annurev-immunol-031210-101400; Dong C, 2001, NATURE, V409, P97, DOI 10.1038/35051100; Ehst BD, 2003, AM J TRANSPLANT, V3, P1355, DOI 10.1046/j.1600-6135.2003.00246.x; Fan XZ, 2014, J EXP MED, V211, P715, DOI 10.1084/jem.20130590; Ford ML, 2014, NAT REV NEPHROL, V10, P14, DOI 10.1038/nrneph.2013.183; Ford ML, 2009, IMMUNOL REV, V229, P294, DOI 10.1111/j.1600-065X.2009.00776.x; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; Hutloff A, 1999, NATURE, V397, P263, DOI 10.1038/16717; Laouar A, 2007, J IMMUNOL, V178, P652, DOI 10.4049/jimmunol.178.2.652; Lee KM, 2004, J EXP MED, V199, P1245, DOI 10.1084/jem.20031989; Liu DY, 2014, J EXP MED, V211, P297, DOI 10.1084/jem.20130902; Lo DJ, 2015, AM J TRANSPLANT, V15, P984, DOI 10.1111/ajt.13100; Lo DJ, 2011, AM J TRANSPLANT, V11, P22, DOI 10.1111/j.1600-6143.2010.03317.x; McAdam AJ, 2001, NATURE, V409, P102, DOI 10.1038/35051107; Nanji SA, 2006, DIABETES, V55, P27, DOI 10.2337/diabetes.55.01.06.db04-1154; Ozkaynak E, 2001, NAT IMMUNOL, V2, P591, DOI 10.1038/89731; Raziorrouh B, 2010, HEPATOLOGY, V52, P1934, DOI 10.1002/hep.23936; Rey J, 2006, EUR J IMMUNOL, V36, P2359, DOI 10.1002/eji.200635935; Riley JL, 2001, J IMMUNOL, V166, P4943, DOI 10.4049/jimmunol.166.8.4943; Rudd CE, 2003, NAT REV IMMUNOL, V3, P544, DOI 10.1038/nri1131; Salomon B, 2001, ANNU REV IMMUNOL, V19, P225, DOI 10.1146/annurev.immunol.19.1.225; Schenk AD, 2009, AM J TRANSPLANT, V9, P64, DOI 10.1111/j.1600-6143.2008.02460.x; SHAHINIAN A, 1993, SCIENCE, V261, P609, DOI 10.1126/science.7688139; Sporici RA, 2001, CLIN IMMUNOL, V100, P263, DOI 10.1006/clim.2001.5093; Sporici RA, 2001, CLIN IMMUNOL, V100, P277, DOI 10.1006/clim.2001.5074; Tafuri A, 2001, NATURE, V409, P105, DOI 10.1038/35051113; Taylor PA, 2005, BLOOD, V105, P3372, DOI 10.1182/blood-2004-10-3869; Trambley J, 1999, J CLIN INVEST, V104, P1715, DOI 10.1172/JCI8082; Vaidya SV, 2005, J IMMUNOL, V174, P800, DOI 10.4049/jimmunol.174.2.800; Vidric M, 2005, J IMMUNOL, V175, P7288, DOI 10.4049/jimmunol.175.11.7288; Waggoner SN, 2010, J CLIN INVEST, V120, P1925, DOI 10.1172/JCI41264; Wang NH, 2010, J IMMUNOL, V185, P5683, DOI 10.4049/jimmunol.1001974; Wang SD, 2000, BLOOD, V96, P2808; Weng NP, 2009, TRENDS IMMUNOL, V30, P306, DOI 10.1016/j.it.2009.03.013; West EE, 2011, IMMUNITY, V35, P285, DOI 10.1016/j.immuni.2011.05.017; Wherry EJ, 2007, IMMUNITY, V27, P670, DOI 10.1016/j.immuni.2007.09.006; Wherry EJ, 2007, IMMUNITY; Xu HP, 2013, NATURE, V496, P523, DOI 10.1038/nature12058; Yoshinaga SK, 1999, NATURE, V402, P827, DOI 10.1038/45582	49	4	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2015	10	6							e0130490	10.1371/journal.pone.0130490	http://dx.doi.org/10.1371/journal.pone.0130490			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL3FM	26098894	Green Published, gold, Green Submitted			2022-12-26	WOS:000356835800074
J	Liu, N; Liu, ZL; Gong, GS; Zhang, M; Wang, X; Zhou, Y; Qi, XB; Chen, HB; Yang, JZ; Luo, PG; Yang, CP				Liu, Na; Liu, Z. Lewis; Gong, Guoshu; Zhang, Min; Wang, Xu; Zhou, You; Qi, Xiaobo; Chen, Huabao; Yang, Jizhi; Luo, Peigao; Yang, Chunping			Virulence Structure of Blumeria graminis f. sp tritici and Its Genetic Diversity by ISSR and SRAP Profiling Analyses	PLOS ONE			English	Article							WHEAT POWDERY MILDEW; AMPLIFIED POLYMORPHISM SRAP; POPULATIONS; RAPD; MARKERS; ACCESSIONS; RESISTANCE; SOFTWARE; TOMATO; POTATO	Blumeria graminis f. sp. tritici, which causes wheat powdery mildew, is an obligate biotrophic pathogen that can easily genetically adapt to its host plant. Understanding the virulence structure of and genetic variations in this pathogen is essential for disease control and for breeding resistance to wheat powdery mildew. This study investigated 17 pathogenic populations in Sichuan, China and classified 109 isolates into two distinct groups based on pathogenicity analysis: high virulence (HV, 92 isolates) and low virulence (LV, 17 isolates). Populations from Yibin (Southern region), Xichang (Western region), and Meishan (Middle region) showed lower virulence frequencies than populations from other regions. Many of the previously known resistance genes did not confer resistance in this study. The resistance gene Pm21 displayed an immune response to pathogenic challenge with all populations in Sichuan, and Pm13, Pm5b, Pm2+6, and PmXBD maintained resistance. AMOVA revealed significantly higher levels of variation within populations and lower levels of variation among populations within regions. High levels of gene flow were detected among populations in the four regions. Closely related populations within each region were distinguished by cluster analyses using ISSR and SRAP alleles. Both ISSR and SRAP allele profiling analyses revealed high levels of genetic diversity among pathogenic populations in Sichuan. Although ISSR and SRAP profiling analysis showed similar resolutions, the SRAP alleles appeared to be more informative. We did not detect any significant association between these alleles and the virulence or pathogenicity of the pathogen. Our results suggest that ISSR and SRAP alleles are more efficient for the characterization of small or closely related populations versus distantly related populations.	[Liu, Na; Gong, Guoshu; Zhang, Min; Zhou, You; Qi, Xiaobo; Chen, Huabao; Yang, Jizhi; Luo, Peigao; Yang, Chunping] Sichuan Agr Univ, Coll Agron, Chengdu, Sichuan, Peoples R China; [Liu, Z. Lewis] ARS, Natl Ctr Agr Utilizat Res, USDA, Peoria, IL USA; [Wang, Xu] Sichuan Agr Univ, Coll Resources, Chengdu, Sichuan, Peoples R China	Sichuan Agricultural University; United States Department of Agriculture (USDA); Sichuan Agricultural University	Gong, GS (corresponding author), Sichuan Agr Univ, Coll Agron, Chengdu, Sichuan, Peoples R China.	guoshugong@126.com			Public Welfare Specific Foundation of Agronomy, China [201303016]; ARS [ARS-0427438] Funding Source: Federal RePORTER	Public Welfare Specific Foundation of Agronomy, China; ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	This work was supported by the Public Welfare Specific Foundation of Agronomy (No. 201303016), China.	APPEL DJ, 1995, EXP MYCOL, V19, P120, DOI 10.1006/emyc.1995.1014; Astolfi P, 2012, PLANT PATHOL, V61, P289, DOI 10.1111/j.1365-3059.2011.02515.x; Brown JKM, 2002, SCIENCE, V297, P537, DOI 10.1126/science.1072678; Chen LF, 2001, AGR PHYTOPATHOLOGY; Comlekcioglu N, 2010, GENET MOL RES, V9, P2263, DOI 10.4238/vol9-4gmr876; Culley TM, 2007, ANN BOT-LONDON, V100, P91, DOI 10.1093/aob/mcm077; Dinolfo MI, 2010, EUR J PLANT PATHOL, V127, P483, DOI 10.1007/s10658-010-9613-1; Esposito MA, 2007, SCI HORTIC-AMSTERDAM, V113, P329, DOI 10.1016/j.scienta.2007.04.006; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; FELSENSTEIN FG, 1991, INTEGRATED CONTROL OF CEREAL MILDEWS : VIRULENCE PATTERNS AND THEIR CHANGE, P1; FLOR HH, 1971, ANNU REV PHYTOPATHOL, V9, P275, DOI 10.1146/annurev.py.09.090171.001423; Fu XP, 2008, SCI HORTIC-AMSTERDAM, V117, P263, DOI 10.1016/j.scienta.2008.04.001; Gao LX, 2008, SCI HORTIC-AMSTERDAM, V117, P369, DOI 10.1016/j.scienta.2008.05.016; Guan XJ, 2008, WORLD J MICROB BIOT, V24, P1617, DOI 10.1007/s11274-007-9647-5; Hadian J, 2014, PLANT SYST EVOL, V300, P1525, DOI 10.1007/s00606-013-0979-3; Huo YunFeng, 2010, Acta Phytophylacica Sinica, V37, P481; Imani Y, 2002, PLANT DIS, V86, P383, DOI 10.1094/PDIS.2002.86.4.383; Jia SF, 2008, ACTA PHYTOPATHYL SIN, V34, P493; Jian SG, 2002, J GENET MOL BIOL, V13, P272; Jiang Y, 2011, GENET MOL RES, V10, P2934, DOI 10.4238/2011.November.29.4; [江玉姬 Jiang Yuji], 2013, [菌物学报, Mygosystema], V32, P25; Knapova G, 2002, PLANT PATHOL, V51, P641, DOI 10.1046/j.1365-3059.2002.00750.x; LAST FT, 1953, ANN APPL BIOL, V40, P312, DOI 10.1111/j.1744-7348.1953.tb01085.x; Li G, 2003, THEOR APPL GENET, V107, P168, DOI 10.1007/s00122-003-1236-x; Li G, 2001, THEOR APPL GENET, V103, P455, DOI 10.1007/s001220100570; Li GP, 2007, EUPHYTICA, V155, P305, DOI 10.1007/s10681-006-9332-z; Li YaHong, 2012, Acta Phytophylacica Sinica, V39, P31; Liu LW, 2008, SCI HORTIC-AMSTERDAM, V116, P240, DOI 10.1016/j.scienta.2007.12.011; Liu N, 2012, CROP PROT, V34, P112, DOI 10.1016/j.cropro.2011.12.011; LYNCH M, 1988, MOL BIOL EVOL, V5, P584; Ma DL, 2010, AFR J BIOTECHNOL, V9, P6244; MANTEL N, 1967, CANCER RES, V27, P209; MOSEMAN JG, 1984, EUPHYTICA, V33, P41, DOI 10.1007/BF00022748; Nan P, 2003, ANN BOT-LONDON, V91, P329, DOI 10.1093/aob/mcg018; Niewoehner AS, 1998, PLANT DIS, V82, P64, DOI 10.1094/PDIS.1998.82.1.64; Parks R, 2008, PLANT DIS, V92, P1074, DOI 10.1094/PDIS-92-7-1074; Parks R, 2009, PHYTOPATHOLOGY, V99, P840, DOI 10.1094/PHYTO-99-7-0840; Pasquali M, 2010, J PHYTOPATHOL, V158, P708, DOI 10.1111/j.1439-0434.2010.01687.x; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Powell W, 1996, MOL BREEDING, V2, P225, DOI 10.1007/BF00564200; Prevost A, 1999, THEOR APPL GENET, V98, P107, DOI 10.1007/s001220051046; Que YX, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/390107; Reddy MP, 2002, EUPHYTICA, V128, P9, DOI 10.1023/A:1020691618797; Rohlf FJ, 2000, NTSYS PC NUMERICAL T; Shao YC, 2011, MYCOSCIENCE, V52, P224, DOI 10.1007/s10267-010-0087-y; Sheng BQ, 1996, CHINA INTEGR PEST MA, P380; Shi YaQian, 2009, Journal of Triticeae Crops, V29, P706; Si Q.M., 1992, ACTA PHYTOPATHOL SIN, V22, P349, DOI [10.13926/j.cnki.apps.1992.04.021, DOI 10.13926/J.CNKI.APPS.1992.04.021]; Sneller CH, 1997, CROP SCI, V37, P1595, DOI 10.2135/cropsci1997.0011183X003700050032x; Song ZQ, 2010, GENETICA, V138, P241, DOI 10.1007/s10709-009-9416-5; Talebi M, 2012, PLANT OMICS, V5, P136; Wang Z, 2012, GENET RESOUR CROP EV, V59, P865, DOI 10.1007/s10722-011-9727-0; Wolfe MS, 1987, INTEGRATED CONTROL C; Wu YG, 2010, BIOCHEM SYST ECOL, V38, P63, DOI 10.1016/j.bse.2009.12.006; [肖仲久 XIAO Zhong-jiu], 2009, [湖北农业科学, Hubei Agricultural Sciences], V48, P769; [杨立军 Yang Lijun], 2009, [植物保护, Plant Protection], V35, P76; Yeh F.C., 1999, POPGENE 32 VERSION 1; Yi YJ, 2008, PLANT BREEDING, V127, P116, DOI 10.1111/j.1439-0523.2007.01443.x; Yi YanJie, 2013, Australian Journal of Crop Science, V7, P454; [余垚颖 Yu Yaoying], 2013, [植物病理学报, Acta Phytopathologica Sinica], V43, P383; Zeng B, 2008, CAN J PLANT SCI, V88, P53, DOI 10.4141/CJPS07017; Zeybek A., 2004, Pakistan Journal of Biological Sciences, V7, P1967, DOI 10.3923/pjbs.2004.1967.1971; Zhang XL, 2008, PLANT PROT, V3, P007; Zhang YJ, 2011, J MED PLANTS RES, V5, P6890, DOI 10.5897/JMPR11.1455; Zhao ZiHui, 2013, Acta Agronomica Sinica, V39, P1377, DOI 10.3724/SP.J.1006.2013.01377; [朱海荣 Zhu Hairong], 2010, [植物保护, Plant Protection], V36, P125	67	19	23	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2015	10	6							e0130881	10.1371/journal.pone.0130881	http://dx.doi.org/10.1371/journal.pone.0130881			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL3FM	26098844	gold, Green Published, Green Submitted			2022-12-26	WOS:000356835800116
J	Muller, M; Seufferlein, T; Perkhofer, L; Wagner, M; Kleger, A				Mueller, Martin; Seufferlein, Thomas; Perkhofer, Lukas; Wagner, Martin; Kleger, Alexander			Self-Expandable Metal Stents for Persisting Esophageal Variceal Bleeding after Band Ligation or Injection-Therapy: A Retrospective Study	PLOS ONE			English	Article							BALLOON TAMPONADE; MANAGEMENT; SOMATOSTATIN; HEMORRHAGE; ENDOSCOPY; CIRRHOSIS	Background and Study Aims Despite a pronounced reduction of lethality rates due to upper gastrointestinal bleeding, esophageal variceal bleeding remains a challenge for the endoscopist and still accounts for a mortality rate of up to 40% within the first 6 weeks. A relevant proportion of patients with esophageal variceal bleeding remains refractory to standard therapy, thus making a call for additional tools to achieve hemostasis. Self-expandable metal stents (SEMS) incorporate such a tool. Methods We evaluated a total number of 582 patients admitted to our endoscopy unit with the diagnosis "gastrointestinal bleeding" according to our documentation software between 2011 and 2014. 82 patients suffered from esophageal variceal bleeding, out of which 11 cases were refractory to standard therapy leading to SEMS application. Patients with esophageal malignancy, fistula, or stricture and a non-esophageal variceal bleeding source were excluded from the analysis. A retrospective analysis reporting a series of clinically relevant parameters in combination with bleeding control rates and adverse events was performed. Results The initial bleeding control rate after SEMS application was 100%. Despite this success, we observed a 27% mortality rate within the first 42 days. All of these patients died due to non-directly hemorrhage-associated reasons. The majority of patients exhibited an extensive demand of medical care with prolonged hospital stay. Common complications were hepatic decompensation, pulmonary infection and decline of renal function. Interestingly, we found in 7 out of 11 patients (63.6%) stent dislocation at time of control endoscopy 24 h after hemostasis or at time of stent removal. The presence of hiatal hernia did not affect obviously stent dislocation rates. Refractory patients had significantly longer hospitalization times compared to non-refractory patients. Conclusions Self-expandable metal stents for esophageal variceal bleeding seem to be safe and efficient after failed standard therapy. Stent migration appeared to be a common incident that did not lead to reactivation of bleeding in any of our patients. SEMS should be considered a reasonable treatment option for refractory esophageal variceal bleeding after treatment failure of ligature and sclerotherapy and non-availability of or contraindication for other measures (e.g. TIPS).	[Mueller, Martin; Seufferlein, Thomas; Perkhofer, Lukas; Wagner, Martin; Kleger, Alexander] Univ Ulm, Dept Internal Med 1, D-89069 Ulm, Germany	Ulm University	Wagner, M (corresponding author), Univ Ulm, Dept Internal Med 1, D-89069 Ulm, Germany.	martin.wagner@uni-ulm.de; alexander.kleger@uni-ulm.de	Seufferlein, Thomas TW/P-7147-2018	Kleger, Alexander/0000-0003-0592-5232	Baden-Wurttemberg Stiftung	Baden-Wurttemberg Stiftung	A.K. is indebted to the Baden-Wurttemberg Stiftung for the financial support of this research project by the Eliteprogramme for Postdocs. A.K. is also an Else-Kroner-Fresenius Memorial Fellow.	Abraldes JG, 2008, J HEPATOL, V48, P229, DOI 10.1016/j.jhep.2007.10.008; Augustin S, 2011, AM J GASTROENTEROL, V106, P1787, DOI 10.1038/ajg.2011.173; AVGERINOS A, 1991, J HEPATOL, V13, P78, DOI 10.1016/0168-8278(91)90867-B; Bosch J, 2008, J HEPATOL, V48, pS68, DOI 10.1016/j.jhep.2008.01.021; Dechene A, 2012, DIGESTION, V85, P185, DOI 10.1159/000335081; Fierz Fabienne C, 2013, Case Rep Gastroenterol, V7, P97, DOI 10.1159/000350192; Holster IL, 2013, ENDOSCOPY, V45, P485, DOI 10.1055/s-0032-1326227; Hsu YC, 2011, INT J HEPATOL, V2011, DOI 10.4061/2011/893973; Hsu YC, 2009, J GASTROEN HEPATOL, V24, P1294, DOI 10.1111/j.1440-1746.2009.05903.x; Hubmann R, 2006, ENDOSCOPY, V38, P896, DOI 10.1055/s-2006-944662; JARAMILLO JL, 1991, J HEPATOL, V12, P100, DOI 10.1016/0168-8278(91)90917-Z; Khamaysi I, 2013, BEST PRACT RES CL GA, V27, P633, DOI 10.1016/j.bpg.2013.09.002; Lu Y, 2014, BRIT J SURG, V101, pE34, DOI 10.1002/bjs.9351; Matull WR, 2008, GASTROINTEST ENDOSC, V68, P767, DOI 10.1016/j.gie.2008.03.1078; Maufa F, 2012, INT J HEPATOL, V2012, DOI 10.1155/2012/418369; O'Brien J, 2013, NAT REV GASTRO HEPAT, V10, P402, DOI 10.1038/nrgastro.2013.51; PANES J, 1988, DIGEST DIS SCI, V33, P454, DOI 10.1007/BF01536031; Riphaus A, 2008, Z GASTROENTEROL, V46, P1298, DOI 10.1055/s-2008-1027850; Rossle M, 2013, J HEPATOL, V59, P1081, DOI 10.1016/j.jhep.2013.06.014; SARIN SK, 1984, ANN ROY COLL SURG, V66, P30; Villanueva C, 2006, J HEPATOL, V45, P560, DOI 10.1016/j.jhep.2006.05.016; Wright G, 2010, GASTROINTEST ENDOSC, V71, P71, DOI 10.1016/j.gie.2009.07.028; Zakaria MS, 2013, SAUDI J GASTROENTERO, V19, P177, DOI 10.4103/1319-3767.114516; Zehetner J, 2008, SURG ENDOSC, V22, P2149, DOI 10.1007/s00464-008-0009-7	24	10	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2015	10	6							e0126525	10.1371/journal.pone.0126525	http://dx.doi.org/10.1371/journal.pone.0126525			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL3FM	26098635	Green Submitted, Green Published, gold			2022-12-26	WOS:000356835800003
J	Park, SY; Kang, WJ; Cho, A; Chae, JR; Cho, YL; Kim, JY; Lee, JW; Chung, KY				Park, Seong Yong; Kang, Won Jun; Cho, Arthur; Chae, Ju Ri; Cho, Ye Lim; Kim, Jung Young; Lee, Ji Woong; Chung, Kyung Young			64Cu-ATSM Hypoxia Positron Emission Tomography for Detection of Conduit Ischemia in an Experimental Rat Esophagectomy Model	PLOS ONE			English	Article							IMAGING AGENT; CARCINOMA; PET; CU-64-ATSM; RESECTION; TISSUE; STROKE	Background We designed a hypoxia-imaging modality to detect ischemia of the gastric conduit after esophagectomy. Materials and Methods A rat esophagectomy model was created using 12-16-week-old, 300-350 g male Sprague-Dawley rats. In the operation group (n=6), partial gastric devascularization was performed by ligating the left gastric artery and the short gastric arteries and an esophagogastric anastomosis was performed. In the control group (n=6), the esophageal-gastric junction was incised and suturing was performed without gastric devascularization. Positron emission tomography (PET) images were taken using a microPET rodent model scanner, 24 h after the initial operation, after injection of 200 mu Ci 64Cu-diacetyl-bis (N4-methylsemicarbazone) (64Cu-ATSM) and pimonidazole 120 mg/kg. After microPET imaging, autoradiography and immunohistochemistry were performed. Results The PET image revealed 64Cu-ATSM uptake at the fundus in the operation group 3 h after 64Cu-ATSM injection. The maximum percentage of the injected dose per gram of tissue was higher in the operation group (0.047 +/- 0.015 vs. 0.026 +/- 0.006, p=0.021). The fundus/liver ratio was also higher in the operation group (0.541 +/- 0.126 vs. 0.278 +/- 0.049, p=0.002). Upon autoradiography, 64Cu-ATSM uptake was observed in the fundus in the operation group, and was well-correlated to that observed on the PET image. Upon immunohistochemistry, expression of hypoxia-inducible factor 1a and pimonidazole were significantly increased at the fundus and lesser curvature compared to the greater curvature in the operation group. Conclusion Hypoxia PET imaging with 64Cu-ATSM can detect ischemia in a rat esophagectomy model. Further clinical studies are needed to verify whether hypoxia imaging may be useful in humans.	[Park, Seong Yong; Chung, Kyung Young] Yonsei Univ, Coll Med, Dept Thorac & Cardiovasc Surg, Seoul, South Korea; [Park, Seong Yong] Ajou Univ, Sch Med, Dept Thorac & Cardiovasc Surg, Suwon 441749, South Korea; [Kang, Won Jun; Cho, Arthur; Chae, Ju Ri; Cho, Ye Lim] Yonsei Univ, Coll Med, Dept Nucl Med, Seoul, South Korea; [Kim, Jung Young; Lee, Ji Woong] Korea Inst Radiol & Med Sci, Mol Imaging Res Ctr, Seoul, South Korea	Yonsei University; Yonsei University Health System; Ajou University; Yonsei University; Yonsei University Health System; Korea Institute of Radiological & Medical Sciences	Kang, WJ (corresponding author), Yonsei Univ, Coll Med, Dept Nucl Med, Seoul, South Korea.	mdkwj@yuhs.ac		Park, Seong Yong/0000-0002-5180-3853; Cho, Arthur/0000-0001-8670-2473; Kang, Won Jun/0000-0002-2107-8160	National Research Foundation of Korea grant - Korean Government [2012027176]; National R&D Program for Cancer Control, Ministry of Health and Welfare [1320210]	National Research Foundation of Korea grant - Korean Government; National R&D Program for Cancer Control, Ministry of Health and Welfare(Ministry of Health & Welfare (MOHW), Republic of Korea)	This study was supported by the National Research Foundation of Korea grant funded by the Korean Government (no. 2012027176) and the National R&D Program for Cancer Control, Ministry of Health and Welfare (1320210).	Carlin S, 2012, J NUCL MED, V53, P1171, DOI 10.2967/jnumed.111.099770; Cui YJ, 1999, J INVEST SURG, V12, P295, DOI 10.1080/089419399272412; Fujibayashi Y, 1999, NUCL MED BIOL, V26, P117, DOI 10.1016/S0969-8051(98)00049-3; Fujibayashi Y, 1997, J NUCL MED, V38, P1155; Imam SK, 2010, CANCER BIOTHER RADIO, V25, P365, DOI 10.1089/cbr.2009.0740; Isozaki M, 2011, EUR J NUCL MED MOL I, V38, P1075, DOI 10.1007/s00259-011-1734-z; Koury J, 2004, SHOCK, V22, P270, DOI 10.1097/01.shk.0000135256.67441.3f; Lewis JS, 2008, J NUCL MED, V49, P1177, DOI 10.2967/jnumed.108.051326; LIEBERMANNMEFFERT DMI, 1992, ANN THORAC SURG, V54, P1110, DOI 10.1016/0003-4975(92)90077-H; Matsumoto KI, 2007, INT J ONCOL, V30, P873; MOOREHEAD RJ, 1990, HEPATO-GASTROENTEROL, V37, P364; MULLER JM, 1990, BRIT J SURG, V77, P845, DOI 10.1002/bjs.1800770804; Oezcelik A, 2010, SURG ENDOSC, V24, P1948, DOI 10.1007/s00464-010-0884-6; Read SJ, 1998, NEUROLOGY, V51, P1617, DOI 10.1212/WNL.51.6.1617; Takahashi N, 2001, ANN NUCL MED, V15, P293, DOI 10.1007/BF02987849; Takasawa M, 2008, STROKE, V39, P1629, DOI 10.1161/STROKEAHA.107.485938; THOMAS DM, 1979, BRIT J SURG, V66, P230, DOI 10.1002/bjs.1800660404; Urschel JD, 1997, J SURG ONCOL, V66, P254, DOI 10.1002/(SICI)1096-9098(199712)66:4<254::AID-JSO6>3.0.CO;2-A; URSCHEL JD, 1995, AM J SURG, V169, P634, DOI 10.1016/S0002-9610(99)80238-4; Valverde A, 1996, SURGERY, V120, P476, DOI 10.1016/S0039-6060(96)80066-3; Yuan H, 2006, J NUCL MED, V47, P989	21	6	6	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2015	10	6							e0131083	10.1371/journal.pone.0131083	http://dx.doi.org/10.1371/journal.pone.0131083			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL3FM	26098420	Green Published, Green Submitted, gold			2022-12-26	WOS:000356835800144
J	Rakotonjanahary, J; De Carli, E; Delion, M; Kalifa, C; Grill, J; Doz, F; Leblond, P; Bertozzi, AI; Rialland, X				Rakotonjanahary, Josue; De Carli, Emilie; Delion, Matthieu; Kalifa, Chantal; Grill, Jacques; Doz, Francois; Leblond, Pierre; Bertozzi, Anne-Isabelle; Rialland, Xavier		Brain Tumor Comm SFCE	Mortality in Children with Optic Pathway Glioma Treated with Up-Front BB-SFOP Chemotherapy	PLOS ONE			English	Article							LOW-GRADE GLIOMA; HIT-LGG 1996; PEDIATRIC-ONCOLOGY; PILOCYTIC ASTROCYTOMAS; TREATMENT STRATEGY; TUMORS; NEUROFIBROMATOSIS; SURVIVAL; NERVE; MULTICENTER	Background In terms of overall survival (OS), limited data are available for the very long-term outcomes of children treated for optic pathway glioma (OPG) with up-front chemotherapy. Therefore, we undertook this study with the aim of clarifying long-term OS and causes of death in these patients. Methods We initiated and analyzed a historical cohort study of 180 children with OPG treated in France with BB-SFOP chemotherapy between 1990 and 2004. The survival distributions were estimated using Kaplan-Meier method. The effect of potential risk factors on the risk of death was described using Cox regression analysis. Results The OS was 95% [95% CI: 90.6-97.3] 5 years after diagnosis and significantly decreased over time without ever stabilizing: 91.6% at 10 years [95% CI: 86.5-94.8], 80.7% at 15 years [95% CI: 72.7-86.8] and 75.5% [95% CI: 65.6-83] at 18 years. Tumor progression was the most common cause of death (65%). Age and intracranial hypertension at diagnosis were significantly associated with a worse prognosis. Risk of death was increased by 3.1[95% CI: 1.5-6.2] (p=0.002) for patients less than 1 year old at diagnosis and by 5.2[95% CI: 1.5-17.6] (p=0.007) for patients with initial intracranial hypertension. Boys without diencephalic syndrome had a better prognosis (HR: 0.3 [95% CI: 0.1-0.8], p=0.007). Conclusions This study shows that i) in children with OPG, OS is not as favorable as previously described and ii) patients can be classified into 2 groups depending on risk factors (age, intracranial hypertension, sex and diencephalic syndrome) with an OS rate of 50.4% at 18 years [95% CI: 31.4-66.6] in children with the worst prognosis. These findings could justify, depending on the initial risk, a different therapeutic approach to this tumor with more aggressive treatment (especially chemotherapy) in patients with high risk factors.	[Rakotonjanahary, Josue; De Carli, Emilie; Rialland, Xavier] Univ Hosp, Dept Pediat Oncol, Angers, France; [Rakotonjanahary, Josue] Univ Paris Diderot, Sorbonne Paris Cite, INSERM Robert Debre Hosp CIE5, AP HP, Paris, France; [Delion, Matthieu] Univ Hosp, Dept Neurosurg, Angers, France; [Kalifa, Chantal; Grill, Jacques] Inst Gustave Roussy, Dept Pediat & Adolescent Oncol, Villejuif, France; [Doz, Francois] Inst Curie, Dept Pediat Oncol, Paris, France; [Doz, Francois] Univ Paris 05, Sorbonne Paris Cite, Paris, France; [Leblond, Pierre] Ctr Oscar Lambret, Dept Pediat Oncol, F-59020 Lille, France; [Bertozzi, Anne-Isabelle] Univ Hosp, Dept Pediat Oncol, Toulouse, France	Universite d'Angers; Centre Hospitalier Universitaire d'Angers; Assistance Publique Hopitaux Paris (APHP); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Universite d'Angers; Centre Hospitalier Universitaire d'Angers; UNICANCER; Gustave Roussy; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; Universite Paris Cite; UNICANCER; Centre Oscar Lambret; CHU de Toulouse	Rakotonjanahary, J (corresponding author), Univ Hosp, Dept Pediat Oncol, Angers, France.	JoRakotonjanahary@chu-angers.fr	Grill, Jacques/R-8093-2019; Muracciole, Xavier/P-5640-2016; Carrie, Christian/K-5488-2014	LEBLOND, Pierre/0000-0002-7088-2614; Carrie, Christian/0000-0002-0766-2547; Doz, Francois/0000-0001-9286-4831; faure conter, cecile/0000-0002-4717-4943; ANDRE, Nicolas/0000-0002-6786-4968	Ligue Nationale Contre le Cancer; Pfizer Foundation, France	Ligue Nationale Contre le Cancer(Ligue nationale contre le cancer); Pfizer Foundation, France	This work was supported by Ligue Nationale Contre le Cancer and by the Pfizer Foundation, France. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albers AC, 2009, EXPERT REV NEUROTHER, V9, P535, DOI [10.1586/ern.09.4, 10.1586/ERN.09.4]; Binning Mandy J, 2007, Neurosurg Focus, V23, pE2; BRAUNER R, 1990, EUR J PEDIATR, V149, P825, DOI 10.1007/BF02072067; Cappelli C, 1998, ARCH DIS CHILD, V79, P334, DOI 10.1136/adc.79.4.334; Chen YH, 2014, ONCOGENE, V33, P2019, DOI 10.1038/onc.2013.148; Colin C, 2013, NEUROPATH APPL NEURO, V39, P693, DOI 10.1111/nan.12013; DUTTON JJ, 1994, SURV OPHTHALMOL, V38, P427, DOI 10.1016/0039-6257(94)90173-2; Fisher MJ, 2014, ANN NEUROL, V75, P799, DOI 10.1002/ana.24157; Fouladi M, 2003, CANCER-AM CANCER SOC, V97, P1084, DOI 10.1002/cncr.11119; Gnekow AK, 2004, KLIN PADIATR, V216, P331, DOI 10.1055/s-2004-832355; Gnekow AK, 2012, NEURO-ONCOLOGY, V14, P1265, DOI 10.1093/neuonc/nos202; Grill J, 1999, ANN NEUROL, V45, P393, DOI 10.1002/1531-8249(199903)45:3<393::AID-ANA17>3.0.CO;2-B; Grill J, 2000, EUR J PEDIATR, V159, P692, DOI 10.1007/s004310000531; Hawkins C, 2011, CLIN CANCER RES, V17, P4790, DOI 10.1158/1078-0432.CCR-11-0034; Heideman RL., 1993, PRINCIPLES PRACTICE, P633; Henson JW, 2008, AM J NEURORADIOL, V29, P419, DOI 10.3174/ajnr.A0963; Jahraus CD, 2006, PEDIATR BLOOD CANCER, V46, P586, DOI 10.1002/pbc.20655; JENKIN D, 1993, INT J RADIAT ONCOL, V25, P215, DOI 10.1016/0360-3016(93)90342-S; Kaul A, 2012, GENE DEV, V26, P2561, DOI 10.1101/gad.200907.112; Kilday JP, 2014, J NEURO-ONCOL, V116, P195, DOI 10.1007/s11060-013-1284-2; Laithier V, 2003, J CLIN ONCOL, V21, P4572, DOI 10.1200/JCO.2003.03.043; Mahoney DH, 2000, NEURO-ONCOLOGY, V2, P213, DOI 10.1093/neuonc/2.4.213; Mirow C, 2014, PEDIATR BLOOD CANCER, V61, P457, DOI 10.1002/pbc.24729; Mishra MV, 2012, J NEURO-ONCOL, V107, P591, DOI 10.1007/s11060-011-0783-2; Nicolin G, 2009, PEDIATR BLOOD CANCER, V53, P1231, DOI 10.1002/pbc.22198; Opocher E, 2006, EUR J CANCER, V42, P1807, DOI 10.1016/j.ejca.2006.02.022; PACKER RJ, 1988, ANN NEUROL, V23, P79, DOI 10.1002/ana.410230113; Packer RJ, 1997, J NEUROSURG, V86, P747, DOI 10.3171/jns.1997.86.5.0747; Pfister S, 2008, J CLIN INVEST, V118, P1739, DOI 10.1172/JCI33656; PIERCE SM, 1990, CANCER, V65, P45, DOI 10.1002/1097-0142(19900101)65:1<45::AID-CNCR2820650111>3.0.CO;2-Z; Poussaint TY, 1997, AM J NEURORADIOL, V18, P1499; Prados MD, 1997, J NEURO-ONCOL, V32, P235, DOI 10.1023/A:1005736104205; Reis GF, 2013, MODERN PATHOL, V26, P1279, DOI 10.1038/modpathol.2013.79; Rodriguez FJ, 2012, J NEUROPATH EXP NEUR, V71, P789, DOI 10.1097/NEN.0b013e3182656ef8; Sadighi Z, 2013, J CHILD NEUROL, V28, P625, DOI 10.1177/0883073813476141; Sharif S, 2006, J CLIN ONCOL, V24, P2570, DOI 10.1200/JCO.2005.03.8349; Shuper A, 2000, PEDIATR HEMAT ONCOL, V17, P463, DOI 10.1080/08880010050120818; Stokland T, 2010, NEURO-ONCOLOGY, V12, P1257, DOI 10.1093/neuonc/noq092; Therasse P, 2000, J NATL CANCER I, V92, P205, DOI 10.1093/jnci/92.3.205; Vos MJ, 2003, NEUROLOGY, V60, P826, DOI 10.1212/01.WNL.0000049467.54667.92; WRIGHT JE, 1989, BRIT J OPHTHALMOL, V73, P967, DOI 10.1136/bjo.73.12.967	41	22	27	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2015	10	6							e0127676	10.1371/journal.pone.0127676	http://dx.doi.org/10.1371/journal.pone.0127676			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL3FM	26098902	Green Submitted, gold, Green Published			2022-12-26	WOS:000356835800008
J	Wang, HJ; Long, L; Cai, H; Wu, Y; Xu, J; Shu, C; Wang, P; Li, B; Wei, QY; Shang, XJ; Wang, XY; Zhang, MM; Xiong, CL; Yin, P				Wang, Hongjing; Long, Lu; Cai, Hui; Wu, Yue; Xu, Jing; Shu, Chang; Wang, Peng; Li, Bo; Wei, Qinyu; Shang, Xuejun; Wang, Xueyi; Zhang, Meimei; Xiong, Chengliang; Yin, Ping			Contraception and Unintended Pregnancy among Unmarried Female University Students: A Cross-sectional Study from China	PLOS ONE			English	Article							SEXUALLY-TRANSMITTED INFECTIONS; EMERGENCY CONTRACEPTION; COLLEGE-STUDENTS; WOMEN SEEKING; ABORTION; KNOWLEDGE; ATTITUDES; EXPERIENCE; BEHAVIORS; WUHAN	This study aims to understand the level of contraceptive knowledge and attitudes towards contraception, and then to explore the association between the contraceptive behavior and unintended pregnancy in unmarried female university students in China. A cross-sectional study was conducted of university students in 49 universities across 7 cities in China from September 2007 to January 2008. We distributed 74,800 questionnaires, of which 69,842 were returned. In this paper, the data from 35,383 unmarried female university students were analyzed. The prevalence of sexual intercourse in unmarried female university students was 10.2%. The prevalence of unintended pregnancy in those sexually active female university students, was 31.8%. Among students with pregnancy, 53.5% experienced two or more pregnancies. 28.3% of the students with sexual intercourse reported that they always adopted contraceptive methods, and of those 82.9% chose to use male condoms. The majority (83.9%) of students with unintended pregnancy chose to terminate the latest pregnancy by surgical abortion or medical abortion. The contraceptive knowledge level of students who experienced unintended pregnancy was lower than those who did not. In China, about one third of unmarried female students with sexual intercourse experience unintended pregnancy. A variety of contraceptive methods are adopted, but the frequency of contraceptive use is low. Most of unmarried female students who experienced unintended pregnancy would choose to terminate the pregnancy with surgical or medical abortion. University students, especially the ones who have experienced unintended pregnancy, lack contraceptive and reproductive health knowledge.	[Wang, Hongjing; Cai, Hui] Gansu Prov Hosp, Dept Med Affairs, Lanzhou, Gansu, Peoples R China; [Wang, Hongjing; Long, Lu; Shu, Chang; Wang, Peng; Li, Bo; Wei, Qinyu; Yin, Ping] Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, Dept Epidemiol & Biostat, Wuhan 430074, Hubei, Peoples R China; [Wu, Yue] Gansu Prov Hosp, Lanzhou, Gansu, Peoples R China; [Xu, Jing] Henan Univ Tradit Chinese Med, Humanities Sch, Publ Management Teaching & Res Sect, Zhengzhou, Henan, Peoples R China; [Shang, Xuejun] Nanjing Univ, Sch Med, Jinling Hosp, Inst Lab Med, Nanjing 210008, Jiangsu, Peoples R China; [Wang, Xueyi] Sexual Hlth Educ Res Ctr, Inst Populat & Family Planning Chongqing City, Chongqing, Peoples R China; [Zhang, Meimei] Capital Normal Univ, Sexual Hlth Educ Res Ctr, Beijing, Peoples R China; [Xiong, Chengliang] Huazhong Univ Sci & Technol, Tongji Med Coll, Inst Family Planning, Wuhan 430074, Hubei, Peoples R China	Huazhong University of Science & Technology; Henan University of Traditional Chinese Medicine; Nanjing University; Capital Normal University; Huazhong University of Science & Technology	Yin, P (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, Dept Epidemiol & Biostat, Wuhan 430074, Hubei, Peoples R China.	pingyin2000@126.com		cai, hui/0000-0003-2440-4256	Chinese "11th Five-Year Plan" Supporting Science and Technology Project [2006BAI15B00]	Chinese "11th Five-Year Plan" Supporting Science and Technology Project(National Key Technology R&D Program)	This work was supported by The Chinese "11th Five-Year Plan" Supporting Science and Technology Project [No. 2006BAI15B00].	Agardh A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023670; Amin SF, 2009, EUR J SCI RES, V26, P108; BARRETT FM, 1980, ARCH SEX BEHAV, V9, P367, DOI 10.1007/BF02115939; Chen Bin, 2005, Zhonghua Nan Ke Xue, V11, P744; Cheng Y, 2004, INT J GYNECOL OBSTET, V87, P199, DOI 10.1016/j.ijgo.2004.06.010; Cheng YM, 1997, CONTRACEPTION, V55, P15; Cheng YM, 2002, J ADOLESCENT HEALTH, V31, P482, DOI 10.1016/S1054-139X(02)00449-4; China MOE, 2012, NUMB STUD SCH HIGH E, V12, P15; Huang J, 2005, AIDS PATIENT CARE ST, V19, P769, DOI 10.1089/apc.2005.19.769; Jones RK, 2002, PERSPECT SEX REPRO H, V34, P294, DOI 10.2307/3097748; Kelly J, 2001, SEX ROLES, V45, P785, DOI 10.1023/A:1015640419862; Kongnyuy EJ, 2007, BMC EMERG MED, V7, DOI 10.1186/1471-227X-7-7; Kuroki LM, 2008, AM J OBSTET GYNECOL, V199, DOI 10.1016/j.ajog.2008.03.049; Lakha F, 2006, LANCET, V368, P1782, DOI 10.1016/S0140-6736(06)69737-7; Ma QQ, 2008, CONTRACEPTION, V77, P108, DOI 10.1016/j.contraception.2007.10.008; Qian X, 2004, BMC HEALTH SERV RES, V4, DOI 10.1186/1472-6963-4-1; Ryan I J, 1988, Fam Pract Res J, V7, P153; Santelli JS, 1997, FAM PLANN PERSPECT, V29, P261, DOI 10.2307/2953414; Schwarz J, 2008, THESIS U WASHINGTON; Shah IH, 2004, REPROD CONTRACEPTION, V15, P1; Templeton A, 2011, NEW ENGL J MED, V365, P2198, DOI 10.1056/NEJMcp1103639; The Ministry of Health in P. R. China, 2010, ALM CHIN HLTH 2009; Turchik JA, 2009, ARCH SEX BEHAV, V38, P936, DOI 10.1007/s10508-008-9388-z; Yan H, 2010, WOMEN HEALTH, V50, P767, DOI 10.1080/03630242.2010.530926; Zhang DG, 2013, J INFECT DEV COUNTR, V7, P966, DOI 10.3855/jidc.3872; Zhang DX, 2010, ASIA-PAC J PUBLIC HE, V22, P118, DOI 10.1177/1010539509350614; Zhang K, 1999, AIDS CARE, V11, P581, DOI 10.1080/09540129947730; Zhang LY, 2002, SEX TRANSM DIS, V29, P212, DOI 10.1097/00007435-200204000-00005; Zhou M, 2005, REPROD CONTRACEPTION, V25; Zou YL, 2013, EUR J CONTRACEP REPR, V18, P127, DOI 10.3109/13625187.2013.772974	30	30	32	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2015	10	6							e0130212	10.1371/journal.pone.0130212	http://dx.doi.org/10.1371/journal.pone.0130212			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CL3FE	26091505	Green Published, gold, Green Submitted			2022-12-26	WOS:000356835000097
J	Liu, WJ; Shen, TT; Chen, RH; Wu, HL; Wang, YJ; Deng, JK; Chen, QH; Pan, QJ; Fu, CMH; Tao, JL; Liang, D; Liu, HF				Liu, Wei Jing; Shen, Ting Ting; Chen, Rui Hong; Wu, Hong-Luan; Wang, Yan Jin; Deng, Jian Kun; Chen, Qiu Hua; Pan, Qingjun; Fu, Chang-mei Huang; Tao, Jing-li; Liang, Dong; Liu, Hua-feng			Autophagy-Lysosome Pathway in Renal Tubular Epithelial Cells Is Disrupted by Advanced Glycation End Products in Diabetic Nephropathy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-DEGRADATION; KIDNEY INJURY; HIGH GLUCOSE; DEATH; NEURODEGENERATION; APOPTOSIS; MEMBRANE; DISEASE; ALBUMIN; RAGE	It has been suggested that autophagy protects renal tubular epithelial cells (TECs) from injury in diabetic nephropathy (DN). However, the manner in which the autophagy-lysosome pathway is changed in this state remains unclear. In this study of DN, we investigated the autophagic activity and lysosomal alterations in vivo and in vitro. We found that autophagic vacuoles and SQSTM1-positive proteins accumulated in TECs from patients with DN and in human renal tubular epithelial cell line (HK-2 cells) treated with advanced glycation end products (AGEs), the important factors that involved in the pathogenesis of DN. In HK-2 cells, exposure to AGEs caused a significant increase in autophagosomes but a marked decrease in autolysosomes, and the lysosomal turnover of LC3-II was not observed, although LC3-II puncta were co-localized with the irregular lysosomal-associated membrane protein1 granules after AGEs treatment. Furthermore, lysosomal membrane permeabilization was triggered by AGEs, which likely resulted in a decrease in the enzymatic activities of cathepsin B and cathepsin L, the defective acidification of lysosomes, and suppression of the lysosomal degradation of DQ-ovalbumin. Oxidative stress evoked by AGEs-receptor for AGE interaction likely played an important role in the lysosomal dysfunction. Additionally, ubiquitinated proteins were co-localized with SQSTM1-positive puncta and accumulated in HK-2 cells after exposure to AGEs, indicating blocked degradation of SQSTM1-positive and ubiquitinated aggregates. Taken together, the results show that lysosomal membrane permeabilization and lysosomal dysfunction are triggered by AGEs, which induce autophagic inactivation in TECs from patients with DN. Disruption of the autophagy-lysosome pathway should be focused when studying the mechanisms underlying DN.	[Liu, Wei Jing; Shen, Ting Ting; Chen, Rui Hong; Wu, Hong-Luan; Wang, Yan Jin; Deng, Jian Kun; Chen, Qiu Hua; Pan, Qingjun; Fu, Chang-mei Huang; Tao, Jing-li; Liang, Dong; Liu, Hua-feng] Guangdong Med Coll, Inst Nephrol, Zhanjiang 524001, Guangdong, Peoples R China	Guangdong Medical University	Liu, HF (corresponding author), Guangdong Med Coll, Inst Nephrol, 57 Renmin Rd, Zhanjiang 524001, Guangdong, Peoples R China.	hf-liu@263.net			National Natural Science Foundation of China [81270798]; Guangdong Natural Science Foundation [2014A030313540, S2012040006276]; Zhanjiang Science and Technology Planning Project [2013B01056]; Scientific Research Foundation for the Returned Overseas Doctors in Guangdong Medical College [B2012080, BK201201]; Affiliated Hospital of Guangdong Medical College [B2012080, BK201201]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Natural Science Foundation(National Natural Science Foundation of Guangdong Province); Zhanjiang Science and Technology Planning Project; Scientific Research Foundation for the Returned Overseas Doctors in Guangdong Medical College(Scientific Research Foundation for the Returned Overseas Chinese Scholars); Affiliated Hospital of Guangdong Medical College	This work was supported by National Natural Science Foundation of China Grant 81270798, Guangdong Natural Science Foundation Grants 2014A030313540 and S2012040006276, Zhanjiang Science and Technology Planning Project 2013B01056, and Grants B2012080 and BK201201 from the Project Sponsored by the Scientific Research Foundation for the Returned Overseas Doctors in Guangdong Medical College and the Affiliated Hospital of Guangdong Medical College. The authors declare that they have no conflicts of interest with the contents of this article.	Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002; Boya P, 2008, ONCOGENE, V27, P6434, DOI 10.1038/onc.2008.310; Daroux M, 2010, DIABETES METAB, V36, P1, DOI 10.1016/j.diabet.2009.06.005; Fang L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060546; Furukawa M, 2013, SCI WORLD J, DOI 10.1155/2013/928197; Howell GM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069520; Johansson AC, 2010, APOPTOSIS, V15, P527, DOI 10.1007/s10495-009-0452-5; Kimura S, 2007, AUTOPHAGY, V3, P452, DOI 10.4161/auto.4451; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Komatsu M, 2005, J CELL BIOL, V169, P425, DOI 10.1083/jcb.200412022; Kume S, 2013, ARCH PHARM RES, V36, P230, DOI 10.1007/s12272-013-0019-4; Lee AS, 2011, CANCER RES, V71, P4506, DOI 10.1158/0008-5472.CAN-10-3787; Lim CH, 2007, CELL PHYSIOL BIOCHEM, V20, P473, DOI 10.1159/000107531; Liu WJ, 2014, AUTOPHAGY, V10, P243, DOI 10.4161/auto.27004; Liu WJ, 2012, J PHARMACOL EXP THER, V340, P248, DOI 10.1124/jpet.111.186866; Ma TA, 2013, EXP CELL RES, V319, P779, DOI 10.1016/j.yexcr.2013.01.018; Malicdan MCV, 2007, AUTOPHAGY, V3, P396, DOI 10.4161/auto.4270; Mizushima N, 2007, GENE DEV, V21, P2861, DOI 10.1101/gad.1599207; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Osicka TM, 2001, DIABETOLOGIA, V44, P230, DOI 10.1007/s001250051604; Osicka TM, 2000, DIABETES, V49, P1579, DOI 10.2337/diabetes.49.9.1579; Pallet N, 2008, AUTOPHAGY, V4, P783, DOI 10.4161/auto.6477; Pan TH, 2008, BRAIN, V131, P1969, DOI 10.1093/brain/awm318; Pangare Meenal, 2012, Journal of Smooth Muscle Research, V48, P1; Phillips AO, 2002, HISTOL HISTOPATHOL, V17, P247, DOI 10.14670/HH-17.247; Repnik U, 2012, BBA-PROTEINS PROTEOM, V1824, P22, DOI 10.1016/j.bbapap.2011.08.016; Rubinsztein DC, 2006, NATURE, V443, P780, DOI 10.1038/nature05291; Rubinsztein DC, 2009, AUTOPHAGY, V5, P585, DOI 10.4161/auto.5.5.8823; Sakurai S, 2003, J AM SOC NEPHROL, V14, pS259, DOI 10.1097/01.ASN.0000077414.59717.74; Sevillano N, 2009, J BIOCHEM, V145, P21, DOI 10.1093/jb/mvn137; SHECHTER P, 1994, J AM SOC NEPHROL, V4, P1582; Shi L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066781; Takahashi A, 2012, AM J PATHOL, V180, P517, DOI 10.1016/j.ajpath.2011.11.001; Tanaka Y, 2012, EXP DIABETES RES, DOI 10.1155/2012/628978; Tojo A, 2001, HISTOCHEM CELL BIOL, V116, P269, DOI 10.1007/s004180100317; Yu CY, 2013, ANAT REC, V296, P31, DOI 10.1002/ar.22612; Zeng YJ, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0030312, 10.1371/journal.pone.0043478]; Zhan M, 2015, J AM SOC NEPHROL, V26, P1304, DOI 10.1681/ASN.2014050457; Zhao X, 2015, INT J MOL MED, V35, P684, DOI 10.3892/ijmm.2014.2052	39	82	91	1	35	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 14	2015	290	33					20499	20510		10.1074/jbc.M115.666354	http://dx.doi.org/10.1074/jbc.M115.666354			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CP1AT	26100632	Green Published, hybrid			2022-12-26	WOS:000359608900047
J	Yu, HN; Park, WK; Nam, KH; Song, DY; Kim, HS; Baik, TK; Woo, RS				Yu, Ha-Nul; Park, Woo-Kyu; Nam, Ki-Hoan; Song, Dae-Yong; Kim, Hye-Sun; Baik, Tai-Kyoung; Woo, Ran-Sook			Neuregulin 1 Controls Glutamate Uptake by Up-regulating Excitatory Amino Acid Carrier 1 (EAAC1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LONG-TERM POTENTIATION; PREFRONTAL CORTEX; POSITIVE INTERNEURONS; NEURAL DEVELOPMENT; TRANSPORTER EAAC1; PYRAMIDAL CELLS; CEREBRAL-CORTEX; NMDA RECEPTORS; ERBB4 RECEPTOR; GABA SYNTHESIS	Neuregulin 1 (NRG1) is a trophic factor that is thought to have important roles in the regulating brain circuitry. Recent studies suggest that NRG1 regulates synaptic transmission, although the precise mechanisms remain unknown. Here we report that NRG1 influences glutamate uptake by increasing the protein level of excitatory amino acid carrier (EAAC1). Our data indicate that NRG1 induced the up-regulation of EAAC1 in primary cortical neurons with an increase in glutamate uptake. These in vitro results were corroborated in the prefrontal cortex (PFC) of mice given NRG1. The stimulatory effect of NRG1 was blocked by inhibition of the NRG1 receptor ErbB4. The suppressed expression of ErbB4 by siRNA led to a decrease in the expression of EAAC1. In addition, the ablation of ErbB4 in parvalbumin (PV)-positive neurons in PV-ErbB4(-/-) mice suppressed EAAC1 expression. Taken together, our results show that NRG1 signaling through ErbB4 modulates EAAC1. These findings link proposed effectors in schizophrenia: NRG1/ErbB4 signaling perturbation, EAAC1 deficit, and neurotransmission dysfunction.	[Yu, Ha-Nul; Song, Dae-Yong; Baik, Tai-Kyoung; Woo, Ran-Sook] Eulji Univ, Dept Anat & Neurosci, Coll Med, Taejon 301746, South Korea; [Park, Woo-Kyu] Korea Res Inst Chem Technol, Pharmacol Res Ctr, Taejon 305343, South Korea; [Nam, Ki-Hoan] Korea Res Inst Biosci & Biotechnol, Biomed Mouse Resource Ctr, Cheongju 363883, South Korea; [Kim, Hye-Sun] Seoul Natl Univ, Dept Pharmacol, Coll Med, Seoul 110799, South Korea	Eulji University; Korea Research Institute of Chemical Technology (KRICT); Korea Research Institute of Bioscience & Biotechnology (KRIBB); Seoul National University (SNU)	Baik, TK (corresponding author), Eulji Univ, Dept Anat & Neurosci, Coll Med, 143-5 Yongdu Dong, Taejon 301746, South Korea.	tkbaik@eulji.ac.kr; rswoo@eulji.ac.kr			National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology [NRF-2013R1A1A4A01012426]	National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of KoreaNational Research Foundation of Korea)	This work was supported by the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology, Grant Number NRF-2013R1A1A4A01012426. The authors declare that they have no conflicts of interest with the contents of this article.	Abbott C, 2006, CURR OPIN PSYCHIATR, V19, P135, DOI 10.1097/01.yco.0000214337.29378.cd; Bauer D, 2008, SCHIZOPHR RES, V104, P108, DOI 10.1016/j.schres.2008.06.012; Bianchi MG, 2008, NEUROSCIENCE, V151, P1042, DOI 10.1016/j.neuroscience.2007.11.055; Bianchi MG, 2014, CELL MOL LIFE SCI, V71, P2001, DOI 10.1007/s00018-013-1484-0; Bin Kwon O, 2008, P NATL ACAD SCI USA, V105, P15587, DOI 10.1073/pnas.0805722105; Bressan RA, 2000, EUR J NUCL MED, V27, P1723, DOI 10.1007/s002590000372; Conti F, 1998, CEREB CORTEX, V8, P108, DOI 10.1093/cercor/8.2.108; DELRIO JA, 1994, DEV BRAIN RES, V81, P247, DOI 10.1016/0165-3806(94)90311-5; Fisahn A, 2009, CEREB CORTEX, V19, P612, DOI 10.1093/cercor/bhn107; Gu ZL, 2005, J NEUROSCI, V25, P4974, DOI 10.1523/JNEUROSCI.1086-05.2005; Hahn CG, 2006, NAT MED, V12, P824, DOI 10.1038/nm1418; Hashimoto T, 2003, J NEUROSCI, V23, P6315; He Y, 2000, J COMP NEUROL, V418, P255; Hof PR, 1999, J CHEM NEUROANAT, V16, P77, DOI 10.1016/S0891-0618(98)00065-9; Holmseth S, 2012, J NEUROSCI, V32, P6000, DOI 10.1523/JNEUROSCI.5347-11.2012; Huang YZ, 2000, NEURON, V26, P443, DOI 10.1016/S0896-6273(00)81176-9; Javitt DC, 2004, MOL PSYCHIATR, V9, P984, DOI 10.1038/sj.mp.4001551; Kiryu-Seo S, 2006, EMBO J, V25, P3411, DOI 10.1038/sj.emboj.7601225; Kwon OB, 2005, J NEUROSCI, V25, P9378, DOI 10.1523/JNEUROSCI.2100-05.2005; Law AJ, 2006, P NATL ACAD SCI USA, V103, P6747, DOI 10.1073/pnas.0602002103; Levenson J, 2002, NAT NEUROSCI, V5, P155, DOI 10.1038/nn791; Lewis DA, 2005, NAT REV NEUROSCI, V6, P312, DOI 10.1038/nrn1648; Lortet S, 2008, NEUROCHEM INT, V52, P1373, DOI 10.1016/j.neuint.2008.02.007; Mathews GC, 2003, J NEUROSCI, V23, P2040; McCullumsmith RE, 2002, NEUROPSYCHOPHARMACOL, V26, P368, DOI 10.1016/S0893-133X(01)00370-0; Mei L, 2008, NAT REV NEUROSCI, V9, P437, DOI 10.1038/nrn2392; Nudrnamud-Thanoi S, 2007, J NEURAL TRANSM-SUPP, P281; Ohnuma T, 1999, NEUROSCIENCE, V93, P441, DOI 10.1016/S0306-4522(99)00189-X; Peghini P, 1997, EMBO J, V16, P3822, DOI 10.1093/emboj/16.13.3822; Pietraszek M, 2003, POL J PHARMACOL, V55, P133; Pilowsky LS, 2006, MOL PSYCHIATR, V11, P118, DOI 10.1038/sj.mp.4001751; Pitcher GM, 2008, NEUROREPORT, V19, P139, DOI 10.1097/WNR.0b013e3282f3da10; Pitcher GM, 2011, NAT MED, V17, P470, DOI 10.1038/nm.2315; ROTHSTEIN JD, 1994, NEURON, V13, P713, DOI 10.1016/0896-6273(94)90038-8; Rothstein JD, 1996, NEURON, V16, P675, DOI 10.1016/S0896-6273(00)80086-0; Ryu J, 2012, J PHARMACOL SCI, V119, P73, DOI 10.1254/jphs.12057FP; Sepkuty JP, 2002, J NEUROSCI, V22, P6372; Shimamoto K, 2004, MOL PHARMACOL, V65, P1008, DOI 10.1124/mol.65.4.1008; Song CH, 2008, J GEN VIROL, V89, P1533, DOI 10.1099/vir.0.83578-0; Stefansson H, 2002, AM J HUM GENET, V71, P877, DOI 10.1086/342734; Vullhorst D, 2009, J NEUROSCI, V29, P12255, DOI 10.1523/JNEUROSCI.2454-09.2009; Wen L, 2010, P NATL ACAD SCI USA, V107, P1211, DOI 10.1073/pnas.0910302107; Woo RS, 2012, NEUROSCIENCE, V202, P413, DOI 10.1016/j.neuroscience.2011.11.026; Woo RS, 2007, NEURON, V54, P599, DOI 10.1016/j.neuron.2007.04.009; Yang JZ, 2003, MOL PSYCHIATR, V8, P706, DOI 10.1038/sj.mp.4001377; Yau HJ, 2003, CEREB CORTEX, V13, P252, DOI 10.1093/cercor/13.3.252; Yin DM, 2013, J NEUROSCI, V33, P19295, DOI 10.1523/JNEUROSCI.2090-13.2013	47	20	20	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 14	2015	290	33					20233	20244		10.1074/jbc.M114.591867	http://dx.doi.org/10.1074/jbc.M114.591867			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CP1AT	26092725	Green Published, hybrid			2022-12-26	WOS:000359608900024
J	Bociek, K; Ferluga, S; Mardirossian, M; Benincasa, M; Tossi, A; Gennaro, R; Scocchi, M				Bociek, Karol; Ferluga, Sara; Mardirossian, Mario; Benincasa, Monica; Tossi, Alessandro; Gennaro, Renato; Scocchi, Marco			Lipopolysaccharide Phosphorylation by the WaaY Kinase Affects the Susceptibility of Escherichia coli to the Human Antimicrobial Peptide LL-37	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACTERIAL-RESISTANCE; HUMAN CATHELICIDIN; MOLECULAR-BASIS; PRIMATE CATHELICIDIN; GENE; SALMONELLA; POLYMYXIN; DIVERSITY; ROLES; CORE	The human cathelicidin LL-37 is a multifunctional host defense peptide with immunomodulatory and antimicrobial roles. It kills bacteria primarily by altering membrane barrier properties, although the exact sequence of events leading to cell lysis has not yet been completely elucidated. Random insertion mutagenesis allowed isolation of Escherichia coli mutants with altered susceptibility to LL-37, pointing to factors potentially relevant to its activity. Among these, inactivation of the waaY gene, encoding a kinase responsible for heptose II phosphorylation in the LPS inner core, leads to a phenotype with decreased susceptibility to LL-37, stemming from a reduced amount of peptide binding to the surface of the cells, and a diminished capacity to lyse membranes. This points to a specific role of the LPS inner core in guiding LL-37 to the surface of Gram-negative bacteria. Although electrostatic interactions are clearly relevant, the susceptibility of the waaY mutant to other cationic helical cathelicidins was unaffected, indicating that particular structural features or LL-37 play a role in this interaction.	[Bociek, Karol; Ferluga, Sara; Mardirossian, Mario; Benincasa, Monica; Tossi, Alessandro; Gennaro, Renato; Scocchi, Marco] Univ Trieste, Dept Life Sci, I-34127 Trieste, Italy	University of Trieste	Scocchi, M (corresponding author), Univ Trieste, Dept Life Sci, Via Giorgieri 5, I-34127 Trieste, Italy.	mscocchi@units.it	Benincasa, Monica/R-6457-2016; Tossi, Alessandro/ABC-9061-2020; Gennaro, Renato/AAJ-2511-2021	Benincasa, Monica/0000-0001-6087-4461; Gennaro, Renato/0000-0003-1331-3885; Ferluga, Sara/0000-0002-6151-5492	Italian Ministry for University and Research (PRIN); Regione Friuli Venezia Giulia [LR 26/2005]	Italian Ministry for University and Research (PRIN)(Ministry of Education, Universities and Research (MIUR)); Regione Friuli Venezia Giulia(Regione Friuli Venezia Giulia)	This work was supported by grants from the Italian Ministry for University and Research (PRIN) and from the Regione Friuli Venezia Giulia (grant under the LR 26/2005, art. 23 for the R<SUP>3</SUP>A<SUP>2</SUP> network). The authors declare that they have no conflicts of interest with the contents of this article.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Benincasa M, 2004, PEPTIDES, V25, P2055, DOI 10.1016/j.peptides.2004.08.004; BIRNBOIM HC, 1983, METHOD ENZYMOL, V100, P243; CLEMENTZ T, 1992, J BACTERIOL, V174, P7750, DOI 10.1128/JB.174.23.7750-7756.1992; Cullen TW, 2015, SCIENCE, V347, P170, DOI 10.1126/science.1260580; Diamond G, 2009, CURR PHARM DESIGN, V15, P2377, DOI 10.2174/138161209788682325; DOWER WJ, 1988, NUCLEIC ACIDS RES, V16, P6127, DOI 10.1093/nar/16.13.6127; Epand RM, 1999, BBA-BIOMEMBRANES, V1462, P11, DOI 10.1016/S0005-2736(99)00198-4; Frirdich E, 2003, J BACTERIOL, V185, P1659, DOI 10.1128/JB.185.5.1659-1671.2003; Frohm M, 1997, J BIOL CHEM, V272, P15258, DOI 10.1074/jbc.272.24.15258; Grenier F, 2014, GENOME ANNOUNCEMENTS, V2, DOI 10.1128/genomeA.01038-14; Gudmundsson GH, 1996, EUR J BIOCHEM, V238, P325, DOI 10.1111/j.1432-1033.1996.0325z.x; Gunn JS, 1998, MOL MICROBIOL, V27, P1171, DOI 10.1046/j.1365-2958.1998.00757.x; Guo L, 1998, CELL, V95, P189, DOI 10.1016/S0092-8674(00)81750-X; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Heinrichs DE, 1998, MOL MICROBIOL, V30, P221, DOI 10.1046/j.1365-2958.1998.01063.x; Ishiwa A, 2000, MOL GEN GENET, V263, P159, DOI 10.1007/s004380050043; Johansson J, 1998, J BIOL CHEM, V273, P3718, DOI 10.1074/jbc.273.6.3718; Karp PD, 2005, NUCLEIC ACIDS RES, V33, P6083, DOI 10.1093/nar/gki892; KLENA JD, 1992, J BACTERIOL, V174, P7297, DOI 10.1128/jb.174.22.7297-7307.1992; Kraus D, 2006, CURR TOP MICROBIOL, V306, P231; Lai YP, 2009, TRENDS IMMUNOL, V30, P131, DOI 10.1016/j.it.2008.12.003; LARRICK JW, 1995, INFECT IMMUN, V63, P1291, DOI 10.1128/IAI.63.4.1291-1297.1995; Lee JH, 2009, J BACTERIOL, V191, P4441, DOI 10.1128/JB.01474-08; Lofton H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068875; Mattiuzzo M, 2007, MOL MICROBIOL, V66, P151, DOI 10.1111/j.1365-2958.2007.05903.x; Morgera F, 2009, BIOCHEM J, V417, P727, DOI 10.1042/BJ20081726; Moser S, 2014, CHEMBIOCHEM, V15, P2684, DOI 10.1002/cbic.201402354; Nagaoka I, 2002, CLIN DIAGN LAB IMMUN, V9, P972, DOI 10.1128/CDLI.9.5.972-982.2002; Nijnik A, 2009, CURR OPIN HEMATOL, V16, P41, DOI 10.1097/MOH.0b013e32831ac517; NIKAIDO H, 1985, MICROBIOL REV, V49, P1; Nishino K, 2006, MOL MICROBIOL, V61, P645, DOI 10.1111/j.1365-2958.2006.05273.x; Oren Z, 1999, BIOCHEM J, V341, P501, DOI 10.1042/0264-6021:3410501; Pazgier M, 2007, CURR PHARM DESIGN, V13, P3096, DOI 10.2174/138161207782110381; Podda E, 2006, BBA-GEN SUBJECTS, V1760, P1732, DOI 10.1016/j.bbagen.2006.09.006; Raetz CRH, 2007, ANNU REV BIOCHEM, V76, P295, DOI 10.1146/annurev.biochem.76.010307.145803; Reeves PR, 1996, TRENDS MICROBIOL, V4, P495, DOI 10.1016/S0966-842X(97)82912-5; Rosenfeld Y, 2006, BBA-BIOMEMBRANES, V1758, P1513, DOI 10.1016/j.bbamem.2006.05.017; SCHNAITMAN CA, 1993, MICROBIOL REV, V57, P655, DOI 10.1128/MMBR.57.3.655-682.1993; Selsted ME, 2005, NAT IMMUNOL, V6, P551, DOI 10.1038/ni1206; Sorensen OE, 2001, BLOOD, V97, P3951, DOI 10.1182/blood.V97.12.3951; Tomasinsig L, 2005, CURR PROTEIN PEPT SC, V6, P23, DOI 10.2174/1389203053027520; Tran AX, 2005, J BIOL CHEM, V280, P28186, DOI 10.1074/jbc.M505020200; Trent MS, 2006, J ENDOTOXIN RES, V12, P205, DOI 10.1179/096805106X118825; Trent MS, 2001, J BIOL CHEM, V276, P43122, DOI 10.1074/jbc.M106961200; Turner J, 1998, ANTIMICROB AGENTS CH, V42, P2206, DOI 10.1128/AAC.42.9.2206; VAARA M, 1992, MICROBIOL REV, V56, P395, DOI 10.1128/MMBR.56.3.395-411.1992; Wildman KAH, 2003, BIOCHEMISTRY-US, V42, P6545, DOI 10.1021/bi0273563; Xhindoli D, 2014, BIOCHEM J, V457, P263, DOI 10.1042/BJ20131048; Yethon JA, 1998, J BIOL CHEM, V273, P26310, DOI 10.1074/jbc.273.41.26310; Yethon JA, 2000, INFECT IMMUN, V68, P4485, DOI 10.1128/IAI.68.8.4485-4491.2000; Yount NY, 2006, BIOPOLYMERS, V84, P435, DOI 10.1002/bip.20543; ZANETTI M, 1995, FEBS LETT, V374, P1, DOI 10.1016/0014-5793(95)01050-O; Zanetti M, 2004, J LEUKOCYTE BIOL, V75, P39, DOI 10.1189/jlb.0403147; Zelezetsky I, 2006, J BIOL CHEM, V281, P19861, DOI 10.1074/jbc.M511108200	56	16	16	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 7	2015	290	32					19933	19941		10.1074/jbc.M114.634758	http://dx.doi.org/10.1074/jbc.M114.634758			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CO7TL	26100635	Green Published, hybrid			2022-12-26	WOS:000359364600048
J	Grauer, A; Konig, A; Bunnefeld, N				Grauer, Andreas; Koenig, Andreas; Bunnefeld, Nils			Citizen Science Based Monitoring of Greylag goose (Anser anser) in Bavaria (Germany): Combining Count Data and Bag Data to Estimate Long-Term Trends between 1988/89 and 2010/11	PLOS ONE			English	Article							ECOLOGICAL RESEARCH; TOOL; GEESE; DISTURBANCE; EFFICIENCY; HABITATS; SUCCESS; DESIGN; STATE; COST	Introduction, Material and Methods Numbers of large grazing bird (geese, swans, cranes) have increased all over Europe, but monitoring these species, e.g. for management purposes, can be time consuming and costly. In Bavaria, sedentary Greylag geese (Anser anser) are monitored during the winter by two different citizen-based monitoring schemes: the International Waterbird Census [IWC] and hunting bag statistics. We compared the results of both schemes for the seasons 1988/89 to 2010/11 by analysing annual indices calculated using the software TRends and Indices for Monitoring Data-TRIM. Results and Discussion We identified similar, highly significant rates of increase in both data sets for the entire region of Bavaria (IWC 14% [13-15%], bag 13% [12-14%]). Furthermore, in all of the seven Bavarian regions, trends in annual indices of both data sets correlated significantly. The quality of both datasets as indicators of abundances in Greylag geese populations in Bavaria was not undermined by either weaknesses typically associated with citizen based monitoring or problems generally assumed for IWC and bag data. We also show that bag data are, under the German system of collecting bag statistics, a reliable indicator of species' distribution, especially for detecting newly colonized areas. Therefore, wildlife managers may want to consider bag data from citizen science led monitoring programmes as evidence supporting the decision making processes. We also discuss requirements for any bag monitoring schemes being established to monitor trends in species' distribution and abundance.	[Grauer, Andreas; Koenig, Andreas] Tech Univ Munich, Wildlife Biol & Management Working Grp, Inst Anim Ecol, Freising Weihenstephan, Germany; [Bunnefeld, Nils] Univ Stirling, Biol & Environm Sci, Stirling FK9 4LA, Scotland	Technical University of Munich; University of Stirling	Grauer, A (corresponding author), Tech Univ Munich, Wildlife Biol & Management Working Grp, Inst Anim Ecol, Freising Weihenstephan, Germany.	andreas.grauer@web.de		Bunnefeld, Nils/0000-0002-1349-4463				AEWA, 1995, AGR CONS AFR EUR MIG; Austin GE, 2007, BIRD STUDY, V54, P343, DOI 10.1080/00063650709461494; Battersby JE, 2004, MAMMAL REV, V34, P3, DOI 10.1046/j.0305-1838.2003.00023.x; Bauer S, 2008, ECOLOGY, V89, P1953, DOI 10.1890/07-1101.1; BayJG, 2007, BAYER JAGDG; BayUIG, 2006, BAYER UMW; Bezzel E., 2005, BRUTVOGEL IN BAYERN; Block WA, 2001, RESTOR ECOL, V9, P293, DOI 10.1046/j.1526-100x.2001.009003293.x; BMEL, 2013, BUND FASS BEK; Bonney R, 2009, BIOSCIENCE, V59, P977, DOI 10.1525/bio.2009.59.11.9; Bregnballe T, 2006, WATERBIRDS WORLD, P960; Brunner H, 2014, LUDWIGSTRASSE; Bunnefeld N, 2009, J ANIM ECOL, V78, P485, DOI 10.1111/j.1365-2656.2008.01500.x; Cooch Evan G., 2014, Wildfowl, P220; Cooper CB, 2007, ECOL SOC, V12; Delany S, 2006, WATERBIRD POPULATION; Dickinson JL, 2012, FRONT ECOL ENVIRON, V10, P291, DOI 10.1890/110236; Dickinson JL, 2010, ANNU REV ECOL EVOL S, V41, P149, DOI 10.1146/annurev-ecolsys-102209-144636; Elmberg J, 2006, WILDLIFE BIOL, V12, P121, DOI 10.2981/0909-6396(2006)12[121:TSBFNA]2.0.CO;2; Fox AD, 1997, J APPL ECOL, V34, P1, DOI 10.2307/2404842; Gaidet-Drapier N, 2006, BIODIVERS CONSERV, V15, P735, DOI 10.1007/s10531-004-1063-7; Gibbs JP, 1998, BIOSCIENCE, V48, P935, DOI 10.2307/1313297; Glutz von Blotzheim UN, 1990, HDB VOGEL MITTELEURO; Grauer A., 2009, Wildlife Biology in Practice, V5, P115; Griffin C, 2005, P 27 C IUGB HANN INT; Gu W, 2014, BIOL CONSERV, V116, P195; Heldbjerg H, 2008, BIRD STUDY, V55, P267, DOI 10.1080/00063650809461532; Homma S, 2003, OKOLOGIE AUSGEWAHLTE; Hussell David J.T., 2008, P151; Kalchreuter H., 1996, Gibier Faune Sauvage, V13, P991; Keuling O, 2011, EUR J WILDLIFE RES, V57, P95, DOI 10.1007/s10344-010-0403-z; Kinahan Anouska A., 2012, Endangered Species Research, V18, P105, DOI 10.3354/esr00438; Konig A., 2013, OKOLOGIE MANAGEMENT; Lindenmayer DB, 2012, AUSTRAL ECOL, V37, P285, DOI 10.1111/j.1442-9993.2011.02314.x; MADSEN J, 1995, IBIS, V137, pS67, DOI 10.1111/j.1474-919X.1995.tb08459.x; Madsen J., 1996, STATUS JAGTTIDER DAN; Madsen J, 1999, GOOSE POPULATINS W P; Madsen J, 2015, REPORT WATERBIRD HAR; Meynen E, 1961, HDB NATURRAUMLICHEN; Mooij Johan H., 2005, Beitraege zur Jagd- und Wildforschung, V30, P49; Pannekoek J, 2001, TRIM 3 MANUAL TRENDS; Pollock KH, 2002, ENVIRONMETRICS, V13, P105, DOI 10.1002/env.514; Rehfisch MM, 2002, BIRD STUDY, V49, P50, DOI 10.1080/00063650209461244; Rist J, 2010, CONSERV BIOL, V24, P489, DOI 10.1111/j.1523-1739.2010.01470.x; Singh NJ, 2011, J APPL ECOL, V48, P35, DOI 10.1111/j.1365-2664.2010.01905.x; Stafford JD, 2010, WILDLIFE BIOL, V16, P113, DOI 10.2981/09-071; Sudbeck P., 2005, METHODENSTANDARDS ER; Sudfeldt Christoph, 1996, Vogelwelt, V117, P311; Sudfeldt Christoph, 2000, Vogelwelt, V121, P307; Thomas L, 1996, ECOLOGY, V77, P49, DOI 10.2307/2265653; Tombre IM, 2005, AGR ECOSYST ENVIRON, V111, P311, DOI 10.1016/j.agee.2005.06.007; Tombre IM, 2005, AGR ECOSYST ENVIRON, V109, P284, DOI 10.1016/j.agee.2005.02.023; Tulloch AIT, 2013, BIOL CONSERV, V165, P128, DOI 10.1016/j.biocon.2013.05.025; Voslamber B, 2010, LEVENDE NATUUR, V111; Wetlands International SOVON, 2011, AN TRENDS SEL WAT PO; Yoccoz NG, 2001, TRENDS ECOL EVOL, V16, P446, DOI 10.1016/S0169-5347(01)02205-4	56	8	9	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2015	10	6							e0130159	10.1371/journal.pone.0130159	http://dx.doi.org/10.1371/journal.pone.0130159			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4OM	26107952	gold, Green Published, Green Submitted			2022-12-26	WOS:000356932500081
J	Luz, AL; Rooney, JP; Kubik, LL; Gonzalez, CP; Song, DH; Meyer, JN				Luz, Anthony L.; Rooney, John P.; Kubik, Laura L.; Gonzalez, Claudia P.; Song, Dong Hoon; Meyer, Joel N.			Mitochondrial Morphology and Fundamental Parameters of the Mitochondrial Respiratory Chain Are Altered in Caenorhabditis elegans Strains Deficient in Mitochondrial Dynamics and Homeostasis Processes	PLOS ONE			English	Article							COMPLEX I ACTIVITY; C-ELEGANS; LIFE-SPAN; OXIDATIVE-PHOSPHORYLATION; COUPLING DEFECT; BOVINE HEART; MUTATIONS; PINK1; METABOLISM; FUSION	Mitochondrial dysfunction has been linked to myriad human diseases and toxicant exposures, highlighting the need for assays capable of rapidly assessing mitochondrial health in vivo. Here, using the Seahorse XF(e)24 Analyzer and the pharmacological inhibitors dicyclo-hexylcarbodiimide and oligomycin (ATP-synthase inhibitors), carbonyl cyanide 4-(trifluoro-methoxy) phenylhydrazone (mitochondrial uncoupler) and sodium azide (cytochrome c oxidase inhibitor), we measured the fundamental parameters of mitochondrial respiratory chain function: basal oxygen consumption, ATP-linked respiration, maximal respiratory capacity, spare respiratory capacity and proton leak in the model organism Caenhorhabditis elegans. Since mutations in mitochondrial homeostasis genes cause mitochondrial dysfunction and have been linked to human disease, we measured mitochondrial respiratory function in mitochondrial fission (drp-1)-, fusion (fzo-1)-, mitophagy (pdr-1, pink-1)-, and electron transport chain complex III (isp-1)-deficient C. elegans. All showed altered function, but the nature of the alterations varied between the tested strains. We report increased basal oxygen consumption in drp-1; reduced maximal respiration in drp-1, fzo-1, and isp-1; reduced spare respiratory capacity in drp-1 and fzo-1; reduced proton leak in fzo-1 and isp-1; and increased proton leak in pink-1 nematodes. As mitochondrial morphology can play a role in mitochondrial energetics, we also quantified the mitochondrial aspect ratio for each mutant strain using a novel method, and for the first time report increased aspect ratios in pdr-1-and pink-1-deficient nematodes.	[Luz, Anthony L.; Rooney, John P.; Kubik, Laura L.; Gonzalez, Claudia P.; Meyer, Joel N.] Duke Univ, Nicholas Sch Environm, Durham, NC 27708 USA; [Song, Dong Hoon] Samsung SDI, Simulat Grp, Suwon, Gyeonggi Do, South Korea	Duke University; Samsung	Meyer, JN (corresponding author), Duke Univ, Nicholas Sch Environm, Durham, NC 27708 USA.	joel.meyer@duke.edu	; Meyer, Joel/G-9836-2017	Gonzalez-Hunt, Claudia/0000-0002-2736-0001; Maurer, Laura/0000-0001-7738-7117; Meyer, Joel/0000-0003-1219-0983; Rooney, John/0000-0002-4820-0867	National Institute of Environmental Health Sciences [R01-ES017540-01A2]; Superfund Basic Research Program [P42 ES010356-10A2]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P42ES010356, R01ES017540] Funding Source: NIH RePORTER	National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Superfund Basic Research Program; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by the National Institute of Environmental Health Sciences (R01-ES017540-01A2 to JNM) and the Superfund Basic Research Program (P42 ES010356-10A2 to JNM). Some strains were obtained from the Caenorhabditis Genetics Center. The authors confirm that Samsung SDI provided support in the form of salary for author Dong Hoon Song, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author are articulated in the 'author contributions' section.	Andreux PA, 2014, SCI REP-UK, V4, DOI 10.1038/srep05285; Arena G, 2013, CELL DEATH DIFFER, V20, P920, DOI 10.1038/cdd.2013.19; Bach D, 2003, J BIOL CHEM, V278, P17190, DOI 10.1074/jbc.M212754200; Bess AS, 2013, WORM; Boyd WA, 2010, TOXICOL APPL PHARM, V245, P153, DOI 10.1016/j.taap.2010.02.014; Boyd WA, 2010, NEUROTOXICOL TERATOL, V32, P68, DOI 10.1016/j.ntt.2008.12.004; Boyd WA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007024; Braeckman BP, 2002, MECH AGEING DEV, V123, P105, DOI 10.1016/S0047-6374(01)00331-1; Brand MD, 2004, FREE RADICAL BIO MED, V37, P755, DOI 10.1016/j.freeradbiomed.2004.05.034; Bratic I, 2009, NUCLEIC ACIDS RES; Breckenridge DG, 2008, MOL CELL, V31, P586, DOI 10.1016/j.molcel.2008.07.015; C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; Chan DC, 2012, ANNU REV GENET, V46, P265, DOI 10.1146/annurev-genet-110410-132529; Chen HC, 2007, CELL, V130, P548, DOI 10.1016/j.cell.2007.06.026; Chen HC, 2010, CELL, V141, P280, DOI 10.1016/j.cell.2010.02.026; Chen Y, 2011, CIRC RES, V109, P1327, DOI 10.1161/CIRCRESAHA.111.258723; Dagda RK, 2014, J NEUROCHEM, V128, P864, DOI 10.1111/jnc.12494; Delettre C, 2000, NAT GENET, V26, P207, DOI 10.1038/79936; Dingley S, 2010, MITOCHONDRION, V10, P125, DOI 10.1016/j.mito.2009.11.003; Falk MJ, 2008, MOL GENET METAB, V93, P388, DOI 10.1016/j.ymgme.2007.11.007; Fei MJ, 2000, ACTA CRYSTALLOGR D, V56, P529, DOI 10.1107/S0907444900002213; Felix MA, 2010, CURR BIOL, V20, pR965, DOI 10.1016/j.cub.2010.09.050; Feng JL, 2001, DEV CELL, V1, P633, DOI 10.1016/S1534-5807(01)00071-5; Fernie AR, 2004, CURR OPIN PLANT BIOL, V7, P254, DOI 10.1016/j.pbi.2004.03.007; Fraser AG, 2000, NATURE, V408, P325, DOI 10.1038/35042517; GAUSE EM, 1981, J BIOL CHEM, V256, P557; Gautier CA, 2008, P NATL ACAD SCI USA, V105, P11364, DOI 10.1073/pnas.0802076105; Guan MX, 2011, MITOCHONDRION, V11, P237, DOI 10.1016/j.mito.2010.10.006; Guillet V, 2010, NEUROGENETICS, V11, P127, DOI 10.1007/s10048-009-0207-z; HEWITT EJ, 1963, METABOLIC INHIBITORS, V2, P311; HEYTLER PG, 1962, BIOCHEM BIOPH RES CO, V7, P272, DOI 10.1016/0006-291X(62)90189-4; Hong S, 2008, MICROBIOL MOL BIOL R, V72, P590, DOI 10.1128/MMBR.00016-08; Ichishita R, 2008, J BIOCHEM, V143, P449, DOI 10.1093/jb/mvm245; Jastroch M, 2010, ESSAYS BIOCHEM, V47, P53, DOI [10.1042/BSE0470053, 10.1042/bse0470053]; Johannsen DL, 2009, CURR OPIN PHARMACOL, V9, P780, DOI 10.1016/j.coph.2009.09.002; Johnson D, 2010, MOL BIOL CELL, V21, P2191, DOI 10.1091/mbc.E09-10-0874; Kageyama Y, 2012, J CELL BIOL, V197, P535, DOI 10.1083/jcb.201110034; Kaletta T, 2006, NAT REV DRUG DISCOV, V5, P387, DOI 10.1038/nrd2031; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Kayser EB, 2004, J BIOL CHEM, V279, P54479, DOI 10.1074/jbc.M403066200; Kayser EB, 2003, ALCOHOL CLIN EXP RES, V27, P584, DOI [10.1111/j.1530-0277.2003.tb04394.x, 10.1097/01.ALC.0000060524.62805.D2]; Kayser EB, 2001, J BIOL CHEM, V276, P20551, DOI 10.1074/jbc.M011066200; Kim I, 2007, ARCH BIOCHEM BIOPHYS, V462, P245, DOI 10.1016/j.abb.2007.03.034; Krijgsveld J, 2003, NAT BIOTECHNOL, V21, P927, DOI 10.1038/nbt848; Lagido Cristina, 2008, BMC Physiology, V8, P7, DOI 10.1186/1472-6793-8-7; Lee SJ, 2010, CURR BIOL, V20, P2131, DOI 10.1016/j.cub.2010.10.057; Lemire BD, 2009, MECH AGEING DEV, V130, P461, DOI 10.1016/j.mad.2009.05.001; Leung MCK, 2013, BMC PHARMACOL TOXICO, V14, DOI 10.1186/2050-6511-14-9; Lewis JA, 1995, METHOD CELL BIOL, V48, P3; LINNETT PE, 1978, BIOCHEM J, V170, P503, DOI 10.1042/bj1700503; Liu ZC, 2006, ANNU REV GENET, V40, P159, DOI 10.1146/annurev.genet.40.110405.090613; Loiseau D, 2007, ANN NEUROL, V61, P315, DOI 10.1002/ana.21086; McBride HM, 2006, CURR BIOL, V16, pR551, DOI 10.1016/j.cub.2006.06.054; Meyer JN, 2013, TOXICOL SCI, V134, P1, DOI 10.1093/toxsci/kft102; MIYOSHI H, 1987, BIOCHIM BIOPHYS ACTA, V891, P194, DOI 10.1016/0005-2728(87)90011-9; Morais VA, 2014, SCIENCE, V344, P203, DOI 10.1126/science.1249161; Morais VA, 2009, EMBO MOL MED, V1, P99, DOI 10.1002/emmm.200900006; Neustadt J, 2008, MOL NUTR FOOD RES, V52, P780, DOI 10.1002/mnfr.200700075; Nicholls DG, 2005, CELL CALCIUM, V38, P311, DOI 10.1016/j.ceca.2005.06.011; Nuytemans K, 2010, HUM MUTAT, V31, P763, DOI 10.1002/humu.21277; Ono T, 2001, NAT GENET, V28, P272, DOI 10.1038/90116; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; PAGE A, 2007, THE CUTICLE; Palikaras K, 2015, NATURE; Partridge FA, 2008, DEV BIOL, V317, P549, DOI 10.1016/j.ydbio.2008.02.060; Pfeiffer M, 2011, J BIOL CHEM, V286, P37712, DOI 10.1074/jbc.M111.271452; Pich S, 2005, HUM MOL GENET, V14, P1405, DOI 10.1093/hmg/ddi149; Schaefer AM, 2004, BBA-BIOENERGETICS, V1659, P115, DOI 10.1016/j.bbabio.2004.09.005; SCHAPIRA AHV, 1990, J NEUROCHEM, V54, P823, DOI 10.1111/j.1471-4159.1990.tb02325.x; Silva MFB, 2008, J INHERIT METAB DIS, V31, P205, DOI 10.1007/s10545-008-0841-x; Skulachev VP, 2001, TRENDS BIOCHEM SCI, V26, P23, DOI 10.1016/S0968-0004(00)01735-7; Song W, 2008, METHODS, V46, P295, DOI 10.1016/j.ymeth.2008.10.003; Stiernagle T, 1999, PRACT APPROACH SER, V213, P51; Susin SA, 1999, NATURE, V397, P441, DOI 10.1038/17135; Swerdlow RH, 1996, ANN NEUROL, V40, P663, DOI 10.1002/ana.410400417; Taddei ML, 2012, J SIGNAL TRANSDUCTIO, V2012; Tan FJ, 2008, J CELL SCI, V121, P3373, DOI 10.1242/jcs.032904; Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606; TERADA H, 1990, ENVIRON HEALTH PERSP, V87, P213, DOI 10.2307/3431027; Thompson O, 2013, GENOME RES, V23, P1749, DOI 10.1101/gr.157651.113; Tsang WY, 2003, BBA-MOL BASIS DIS, V1638, P91, DOI 10.1016/S0925-4439(03)00079-6; Tsang WY, 2002, BIOCHEM BIOPH RES CO, V291, P8, DOI 10.1006/bbrc.2002.6394; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Waterham HR, 2007, NEW ENGL J MED, V356, P1736, DOI 10.1056/NEJMoa064436; Weber, 1991, METHODS MEASURING AC; Yang W, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000556; Yang W, 2010, AGING CELL, V9, P433, DOI 10.1111/j.1474-9726.2010.00571.x; Yasuda K, 2011, BIOCHEM BIOPH RES CO, V404, P751, DOI 10.1016/j.bbrc.2010.12.017; Yee C, 2014, CELL, V157, P897, DOI 10.1016/j.cell.2014.02.055; Yoshikawa S, 1998, SCIENCE, V280, P1723, DOI 10.1126/science.280.5370.1723; Zhao F, 2013, TOXICOL APPL PHARM, V271, P72, DOI 10.1016/j.taap.2013.04.020; Zuchner S, 2004, NAT GENET, V36, P449, DOI 10.1038/ng1341	92	52	54	3	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2015	10	6							e0130940	10.1371/journal.pone.0130940	http://dx.doi.org/10.1371/journal.pone.0130940			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4OM	26106885	gold, Green Published, Green Submitted			2022-12-26	WOS:000356932500132
J	Moreau, P; Faury, N; Burgeot, T; Renault, T				Moreau, Pierrick; Faury, Nicole; Burgeot, Thierry; Renault, Tristan			Pesticides and Ostreid Herpesvirus 1 Infection in the Pacific Oyster, Crassostrea gigas	PLOS ONE			English	Article							PROPIDIUM MONOAZIDE; POLYCHLORINATED-BIPHENYLS; QUANTITATIVE PCR; EXPOSURE; SUSCEPTIBILITY; MIXTURE; CELLS; SPAT; GLYCOPROTEINS; APOPTOSIS	Since 2008, mass mortality outbreaks have been reported in all French regions producing Pacific oysters, and in several Member States of the European Union. These mass mortality events of Pacific oysters are related to OsHV-1 infection. They occur during spring and summer periods leaving suspect the quality of the marine environment and the role of seasonal use of pesticides associated with the arrival of freshwater in oyster rearing areas. Pesticides have been also detected in French coastal waters, especially in areas of oyster production. Using PMA real-time PCR we showed that a mixture of 14 pesticides has no effect on the integrity of virus capsids from viral suspension in the conditions tested. A contact of oysters with this pesticide mixture was related to higher mortality rates among experimentally infected animals in comparison with control ones (no previous pesticide exposure before experimental infection). We therefore suggest that pesticides at realistic concentration can exert adverse effects on Pacific oysters and causes an increased susceptibility to the viral infection in experimental conditions.	[Moreau, Pierrick; Faury, Nicole; Renault, Tristan] IFREMER, Unite Sante Genet & Microbiol Mollusques, Lab Genet & Pathol Mollusques Marins, F-17390 Ronce Les Bains, La Tremblade, France; [Burgeot, Thierry] IFREMER, Res Unit Biogeochem & Ecotoxicol, F-44311 Nantes, France; [Moreau, Pierrick] Inst Pasteur, Unite Hepacivirus & Immunite Innee, Paris, France	Ifremer; Ifremer; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Renault, T (corresponding author), IFREMER, Unite Sante Genet & Microbiol Mollusques, Lab Genet & Pathol Mollusques Marins, F-17390 Ronce Les Bains, La Tremblade, France.	tristan.renault@ifremer.fr		Moreau, Pierrick/0000-0003-3380-6214	EU project Bivalife [266157]; Poitou Charentes Region	EU project Bivalife; Poitou Charentes Region(Region Nouvelle-Aquitaine)	This work was partially funded through the EU project Bivalife (no 266157) and the Poitou Charentes Region. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anguiano G, 2007, ENVIRON TOXICOL CHEM, V26, P2192, DOI 10.1897/06-377R3.1; [Anonymous], 2011, BILAN 2010 DU RESEAU; Bae S, 2012, APPL ENVIRON MICROB, V78, P922, DOI 10.1128/AEM.05157-11; Baker NJ, 2013, SCI TOTAL ENVIRON, V449, P150, DOI 10.1016/j.scitotenv.2013.01.056; Banerjee B. D., 1996, Indian Journal of Experimental Biology, V34, P723; Benachour N, 2009, CHEM RES TOXICOL, V22, P97, DOI 10.1021/tx800218n; Bernal-Hernandez YY, 2010, ECOTOXICOLOGY, V19, P819, DOI 10.1007/s10646-009-0459-2; Burgeot T, 2008, QUAE, P107; Bushek D, 2007, MAR ENVIRON RES, V64, P535, DOI 10.1016/j.marenvres.2007.03.004; Calviello G, 2006, TOXICOL APPL PHARM, V211, P87, DOI 10.1016/j.taap.2005.06.001; Checkley MA, 2011, J MOL BIOL, V410, P582, DOI 10.1016/j.jmb.2011.04.042; Chou HY, 1998, FISH PATHOLOGY JAPAN; Christensen MM, 1996, TOXICOLOGY, V114, P57, DOI 10.1016/S0300-483X(96)03409-9; Collin H, 2010, J EXP BIOL, V213, P4010, DOI 10.1242/jeb.048033; Fittipaldi M, 2010, J VIROL METHODS, V168, P228, DOI 10.1016/j.jviromet.2010.06.011; Forson DD, 2006, ECOL APPL, V16, P2325, DOI 10.1890/1051-0761(2006)016[2325:AIRSIT]2.0.CO;2; FOURNIER M, 1988, J TOXICOL ENV HEALTH, V25, P103, DOI 10.1080/15287398809531192; Gagnaire B, 2003, CURR PHARM DESIGN, V9, P193, DOI 10.2174/1381612033392305; Gagnaire B, 2007, AQUAT TOXICOL, V84, P92, DOI 10.1016/j.aquatox.2007.06.002; Garcia C., 2011, VET RES, V42, P1, DOI DOI 10.1186/1297-9716-42-73; Gendron AD, 2003, OECOLOGIA, V135, P469, DOI 10.1007/s00442-003-1210-y; Greco L, 2011, ENVIRON TOXICOL CHEM, V30, P132, DOI 10.1002/etc.359; Jepson PD, 2005, ENVIRON TOXICOL CHEM, V24, P238, DOI 10.1897/03-663.1; Kerby JL, 2009, ECOHEALTH, V6, P91, DOI 10.1007/s10393-009-0234-0; Kim SH, 2012, KOREAN J ORTHOD, V42, P55, DOI 10.4041/kjod.2012.42.2.55; Kim Y, 2008, MAR ENVIRON RES, V65, P101, DOI 10.1016/j.marenvres.2007.09.003; Lin WT, 2011, CURR MICROBIOL, V62, P374, DOI 10.1007/s00284-010-9716-0; Liu SQ, 2008, J MOL MODEL, V14, P857, DOI 10.1007/s00894-008-0327-7; Luna-Acosta A, 2012, CHEMOSPHERE, V87, P1335, DOI 10.1016/j.chemosphere.2012.02.022; Masuda M, 2012, BIOSCI BIOTECH BIOCH, V76, P73, DOI 10.1271/bbb.110506; Moreau P, 2014, ENVIRON SCI POLLUT R, V21, P4940, DOI 10.1007/s11356-013-1931-3; Nicolas JL, 1992, B EUROPEAN ASS FISH; Parshionikar S, 2010, APPL ENVIRON MICROB, V76, P4318, DOI 10.1128/AEM.02800-09; Ramu K, 2007, ENVIRON POLLUT, V148, P562, DOI 10.1016/j.envpol.2006.11.034; Rehman H, 2011, SCAND J IMMUNOL, V73, P459, DOI 10.1111/j.1365-3083.2011.02521.x; Renault T, 2011, PESTICIDES IN THE MODERN WORLD - RISKS AND BENEFITS, P227; RENAULT T, 1995, VET RES, V26, P539; Renault T, 2012, J VIROL, V86, P5942, DOI 10.1128/JVI.06534-11; Reske A, 2007, REV MED VIROL, V17, P205, DOI 10.1002/rmv.531; Rohr JR, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1502; Rostagno B, 1999, QUALITE DESEAUX LITT; Savage C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042708; Schikorski D, 2011, VET RES, V42, DOI 10.1186/1297-9716-42-27; Segarra A, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-580; Segarra A, 2010, VIRUS RES, V153, P92, DOI 10.1016/j.virusres.2010.07.011; Shaw PL, 2010, VIRUS GENES, V40, P307, DOI 10.1007/s11262-010-0455-x; Stanojlovic O, 2013, ENVIRON TOXICOL PHAR, V35, P161, DOI 10.1016/j.etap.2012.12.006; Tanguy A, 2005, FEBS J, V272, P390, DOI 10.1111/j.1742-4658.2004.04479.x; Taskin B, 2011, APPL ENVIRON MICROB, V77, P4329, DOI 10.1128/AEM.02895-10; Van Loveren H, 2000, TOXICOL LETT, V112, P319, DOI 10.1016/S0378-4274(99)00198-8; Webb SC, 2007, AQUACULTURE, V272, P126, DOI 10.1016/j.aquaculture.2007.07.224; Yin LN, 2011, NEUROTOXICOL TERATOL, V33, P415, DOI 10.1016/j.ntt.2011.02.012; Zhang GF, 2012, NATURE, V490, P49, DOI 10.1038/nature11413	53	11	11	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2015	10	6							e0130628	10.1371/journal.pone.0130628	http://dx.doi.org/10.1371/journal.pone.0130628			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4OM	26107171	Green Published, gold			2022-12-26	WOS:000356932500113
J	Pardo, JD; Szostakiwskyj, M; Anderson, JS				Pardo, Jason D.; Szostakiwskyj, Matt; Anderson, Jason S.			Cranial Morphology of the Brachystelechid 'Microsaur' Quasicaecilia texana Carroll Provides New Insights into the Diversity and Evolution of Braincase Morphology in Recumbirostran 'Microsaurs'	PLOS ONE			English	Article							AMPHIBAMID TEMNOSPONDYLI; LEPOSPONDYLI; ORIGIN; DISSOROPHOIDEA; REAPPRAISAL; GYMNOPHIONA; AMPHIBIANS; PHYLOGENY; TETRAPODA; SHAPE	Recumbirostran 'microsaurs,' a group of early tetrapods from the Late Carboniferous and Early Permian, are the earliest known example of adaptation to head-first burrowing in the tetrapod fossil record. However, understanding of the diversity of fossorial adaptation within the Recumbirostra has been hindered by poor anatomical knowledge of the more divergent forms within the group. Here we report the results of mu CT study of Quasicaecilia texana, a poorly-known recumbirostran with a unique, broad, shovel-like snout. The organization of the skull roof and braincase of Quasicaecilia is found to be more in line with that of other recumbirostrans than previously described, despite differences in overall shape. The braincase is found to be broadly comparable to Carrolla craddocki, with a large presphenoid that encompasses much of the interorbital septum and the columella ethmoidalis, and a single compound ossification encompassing the sphenoid, otic, and occipital regions. The recumbirostran braincase conserves general structure and topology of braincase regions and cranial nerve foramina, but it is highly variable in the number of ossifications and their extent, likely associated with the reliance on braincase ossifications to resist compression during sediment compaction and mechanical manipulation by epaxial and hypaxial musculature. Expansion of the deep ventral neck musculature in Quasicaecilia, autapomorphic among recumbirostrans, may reflect unique biomechanical function, and underscores the importance of future attention to the role of the cervical musculature in contextualizing the origin and evolution of fossoriality in recumbirostrans.	[Pardo, Jason D.; Anderson, Jason S.] Univ Calgary, Dept Comparat Biol & Expt Med, Fac Vet Med, Calgary, AB, Canada; [Szostakiwskyj, Matt] Univ Calgary, Dept Biol Sci, Calgary, AB T2N 1N4, Canada	University of Calgary; University of Calgary	Pardo, JD (corresponding author), Univ Calgary, Dept Comparat Biol & Expt Med, Fac Vet Med, Calgary, AB, Canada.	jdpardo@ucalgary.ca			Natural Sciences and Engineering Research Council of Canada (NSERC) [327756-2011]; Directorate For Geosciences [1258878] Funding Source: National Science Foundation	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This study was supported by the Natural Sciences and Engineering Research Council of Canada (NSERC) Discovery Grant 327756-2011 held by Jason S. Anderson. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson JS, 2008, NATURE, V453, P515, DOI 10.1038/nature06865; Anderson Jason S., 2007, P182; Anderson JS, 2013, J VERTEBR PALEONTOL, V33, P553, DOI 10.1080/02724634.2013.726676; Anderson JS, 2009, J VERTEBR PALEONTOL, V29, P379, DOI 10.1671/039.029.0222; Anderson JS, 2001, SYST BIOL, V50, P170; Barros FC, 2011, J EVOLUTION BIOL, V24, P2423, DOI 10.1111/j.1420-9101.2011.02372.x; Berman DS, 2000, J PALEONTOL, V74, P938, DOI 10.1666/0022-3360(2000)074<0938:OAEEOT>2.0.CO;2; BOLT J R, 1975, Paleobiology, V1, P320; Bourget H, 2011, J VERTEBR PALEONTOL, V31, P32, DOI 10.1080/02724634.2011.539652; Burkhammer S, 1975, P 1 IC WHIT MEM S AG, P69; CARROLL R L, 1971, Journal of Paleontology, V45, P450; Carroll R. L., 1968, American Museum Novitates, VNo. 2337, P1; Carroll R.L., 1978, Memoirs of the American Philosophical Society, V126, P1; CARROLL RL, 1990, PALAEONTOLOGY, V33, P893; CARROLL RL, 1975, ZOOL J LINN SOC-LOND, V57, P229, DOI 10.1111/j.1096-3642.1975.tb00817.x; Carroll RL, 2007, ZOOL J LINN SOC-LOND, V150, P1, DOI 10.1111/j.1096-3642.2007.00246.x; CARROLL ROBERT L., 1964, BULL MUS COMP ZOOL HARVARD UNIV, V131, P161; de Barros JD, 2008, INT J MORPHOL, V26, P411, DOI 10.4067/S0717-95022008000200027; de Beer S.G.R., 1937, DEV VERTEBRATE SKULL; GANS CARL, 1960, BULL AMER MUS NAT HIST, V119, P129; Glienke S, 2013, NEUES JAHRB GEOL P-A, V269, P73, DOI 10.1127/0077-7749/2013/0336; Heaton M.J., 1979, OKLAHOMA GEOL SURV B, V127, P1; Hohl LSL, 2014, J ZOOL, V294, P234, DOI 10.1111/jzo.12173; Huttenlocker AK, 2007, J VERTEBR PALEONTOL, V27, P316, DOI 10.1671/0272-4634(2007)27[316:PSGESN]2.0.CO;2; Huttenlocker AK, 2013, J VERTEBR PALEONTOL, V33, P540, DOI 10.1080/02724634.2013.728998; Jones MEH, 2009, PALAEONTOL ELECTRON, V12; Lebedkina NS, 2004, EVOLUTION AMPHIBIAN; Maddin HC, 2013, CR PALEVOL, V12, P447, DOI 10.1016/j.crpv.2013.06.007; Maddin Hillary C., 2012, Fieldiana-Life and Earth Sciences, V5, P59; Maddin HC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050743; Maddin HC, 2011, J MORPHOL, V272, P850, DOI 10.1002/jmor.10953; Maddin HC, 2011, J MORPHOL, V272, P722, DOI 10.1002/jmor.10946; Marjanovic D, 2013, GEODIVERSITAS, V35, P207, DOI 10.5252/g2013n1a8; Marjanovic D, 2008, CONTRIB ZOOL, V77, P149, DOI 10.1163/18759866-07703002; Navas CA, 2004, J EXP BIOL, V207, P2433, DOI 10.1242/jeb.01041; Olori JC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032450; Romer A. S., 1940, GEOLOGICAL SOC AM SP, V28, P1, DOI DOI 10.1130/SPE28-P1; Sherratt E, 2014, EVOL BIOL, V41, P528, DOI 10.1007/s11692-014-9287-2; Shiino K., 1914, ANAT HEFTE, V50, P254; Szostakiwskyj M, PLOS ONE IN PRESS; Vallin G, 2004, J VERTEBR PALEONTOL, V24, P56, DOI 10.1671/5.1; WAKE MH, 1985, J HERPETOL, V19, P68, DOI 10.2307/1564421; WAKE MH, 1982, J MORPHOL, V173, P203, DOI 10.1002/jmor.1051730208; WELLSTEAD CF, 1991, B AM MUS NAT HIST, P1	44	18	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2015	10	6							e0130359	10.1371/journal.pone.0130359	http://dx.doi.org/10.1371/journal.pone.0130359			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4OM	26107260	Green Submitted, Green Published, gold			2022-12-26	WOS:000356932500094
J	Tauer, JT; Hofbauer, LC; Jung, R; Gerdes, S; Glauche, I; Erben, RG; Suttorp, M				Tauer, Josephine T.; Hofbauer, Lorenz C.; Jung, Roland; Gerdes, Sebastian; Glauche, Ingmar; Erben, Reinhold G.; Suttorp, Meinolf			Impact of Long-Term Exposure to the Tyrosine Kinase Inhibitor Imatinib on the Skeleton of Growing Rats	PLOS ONE			English	Article							CHRONIC MYELOID-LEUKEMIA; BONE-FORMATION; SECONDARY HYPERPARATHYROIDISM; MESYLATE; CHILDREN; GROWTH; CML; OSTEOCLASTOGENESIS; RECEPTOR; THERAPY	The tyrosine kinase (TK) inhibitor imatinib provides a highly effective therapy for chronic myeloid leukemia (CML) via inhibition of the oncogenic TK BCR-ABL1. However, off-target TKs like platelet-derived growth factor receptors (PDGF-R) and colony-stimulating factor-1 receptor (c-fms), involved in bone remodeling, are also inhibited. Thus, pediatric patients with CML on imatinib exhibit altered bone metabolism, leading to linear growth failure. As TKI treatment might be necessary for a lifetime, long-term effects exerted on bone in children are of major concern. Therefore, we studied the skeletal long-term effects of continuous and intermittent imatinib exposure in a juvenile rat model. Four-weeks-old male Wistar rats were chronically exposed to imatinib via drinking water over a period of 10 weeks. Animals were exposed to a standard and high imatinib dosage continuously and to the high imatinib dose intermittently. Bone mass and strength were assessed using pQCT, micro-computed tomography (mu CT), and biomechanical testing at the prepubertal, pubertal, and postpubertal age. Bone length and vertebral height as well as biochemical markers of bone turnover were analyzed. Femoral and tibial bone length were dose-dependently reduced by up to 24% (p<0.0001), femoral and tibial trabecular bone mass density (BMD) were reduced by up to 25% (p<0.01), and femoral breaking strength was lowered by up to 20% (p<0.05). Intermittent exposure mitigated these skeletal effects. Long-term exposure resulted in reduced vertebral height by 15% and lower trabecular BMD by 5%. Skeletal changes were associated with suppressed serum osteocalcin (p<0.01) and non-significantly elevated serum CTX-I and PINP levels. In conclusion, imatinib mainly impaired longitudinal growth of long bones rather than the vertebrae of growing rats. Interestingly, intermittent imatinib exposure has less skeletal side effects, which may be beneficial in pediatric patients taking imatinib.	[Tauer, Josephine T.; Suttorp, Meinolf] Tech Univ Dresden, Univ Hosp Carl Gustav Carus, Dept Pediat, Dresden, Germany; [Hofbauer, Lorenz C.] Tech Univ Dresden, Univ Hosp Carl Gustav Carus, Dept Internal Med 3, Dresden, Germany; [Jung, Roland] Tech Univ Dresden, Med Fac Carl Gustav Carus, Expt Ctr, Dresden, Germany; [Gerdes, Sebastian; Glauche, Ingmar] Tech Univ Dresden, Med Fac Carl Gustav Carus, Inst Med Informat & Biometry, Dresden, Germany; [Erben, Reinhold G.] Univ Vet Med, Dept Biomed Sci, Vienna, Austria	Technische Universitat Dresden; Carl Gustav Carus University Hospital; Technische Universitat Dresden; Carl Gustav Carus University Hospital; Technische Universitat Dresden; Carl Gustav Carus University Hospital; Technische Universitat Dresden; Carl Gustav Carus University Hospital; University of Veterinary Medicine Vienna	Tauer, JT (corresponding author), Tech Univ Dresden, Univ Hosp Carl Gustav Carus, Dept Pediat, Dresden, Germany.	JosephineTabea.Tauer@uniklinikum-dresden.de	Tauer, Josephine T./M-1384-2019; Erben, Reinhold/AAG-8007-2020; Hofbauer, Lorenz C/G-2490-2010	Tauer, Josephine T./0000-0002-6079-4653; Erben, Reinhold/0000-0003-0801-6958; Hofbauer, Lorenz C/0000-0002-8691-8423	Deutsche Forschungsgemeinschaft [SU 122/3-1, HO 1875/10-1]; Austrian Science Fund (FWF) [I 734-B13]; Sonnenstrahl e.V.; Peter-Escher Foundation; Austrian Science Fund (FWF) [I 734] Funding Source: researchfish	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Sonnenstrahl e.V.; Peter-Escher Foundation; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by grants from Deutsche Forschungsgemeinschaft (to MS and LCH) SU 122/3-1, HO 1875/10-1, the Austrian Science Fund (FWF) I 734-B13 (to RGE), Sonnenstrahl e.V. (to MS), and Peter-Escher Foundation (to MS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ando W, 2006, J BONE MINER METAB, V24, P274, DOI 10.1007/s00774-006-0684-1; Bachmanov AA, 2002, BEHAV GENET, V32, P435, DOI 10.1023/A:1020884312053; Bansal D, 2012, PEDIATR BLOOD CANCER, V59, P481, DOI 10.1002/pbc.23389; Bende G, 2010, J CHROMATOGR SCI, V48, P334, DOI 10.1093/chromsci/48.5.334; Berman E, 2006, NEW ENGL J MED, V354, P2006, DOI 10.1056/NEJMoa051140; Bouxsein ML, 2010, J BONE MINER RES, V25, P1468, DOI 10.1002/jbmr.141; Champagne MA, 2004, BLOOD, V104, P2655, DOI 10.1182/blood-2003-09-3032; Damsch S, 2011, TOXICOL PATHOL, V39, P348, DOI 10.1177/0192623310388431; Davis MI, 2011, NAT BIOTECHNOL, V29, P1046, DOI 10.1038/nbt.1990; Dewar AL, 2005, CELL CYCLE, V4, P851, DOI 10.4161/cc.4.7.1788; Dewar AL, 2003, LEUKEMIA, V17, P1713, DOI 10.1038/sj.leu.2403071; Dewar AL, 2006, BLOOD, V107, P4334, DOI 10.1182/blood-2005-09-3568; Dib IE, 2006, EUR J PHARMACOL, V551, P27, DOI 10.1016/j.ejphar.2006.09.007; Druker BJ, 2001, NEW ENGL J MED, V344, P1031, DOI 10.1056/NEJM200104053441401; Erben RG, 2009, J NUTR, V139, P703, DOI 10.3945/jn.108.099077; Fitter S, 2008, BLOOD, V111, P2538, DOI 10.1182/blood-2007-07-104281; Giona Fiorina, 2013, Haematologica, V98, pe25, DOI 10.3324/haematol.2012.067447; Grey A, 2006, NEW ENGL J MED, V355, P2494, DOI 10.1056/NEJMc062388; Hijiya N, 2015, PEDIATR CLIN N AM, V62, P107, DOI 10.1016/j.pcl.2014.09.008; Hobernicht SL, 2011, PEDIATR BLOOD CANCER, V56, P671, DOI 10.1002/pbc.22945; Jaeger BAS, 2012, MED SCI MONITOR, V18, pCR721, DOI 10.12659/MSM.883599; Jonsson S, 2008, HAEMATOL-HEMATOL J, V93, P1101, DOI 10.3324/haematol.12373; Jonsson S, 2012, AM J HEMATOL, V87, P550, DOI 10.1002/ajh.23155; Millot F, 2014, EUR J CANCER, V50, P3206, DOI 10.1016/j.ejca.2014.10.007; Nurmio M, 2011, TOXICOL APPL PHARM, V254, P267, DOI 10.1016/j.taap.2011.04.019; O'Sullivan S, 2007, J BONE MINER RES, V22, P1679, DOI 10.1359/JBMR.070719; O'Sullivan S, 2011, CALCIFIED TISSUE INT, V88, P16, DOI 10.1007/s00223-010-9429-1; O'Sullivan S, 2009, J CLIN ENDOCR METAB, V94, P1131, DOI 10.1210/jc.2008-2324; Osorio S, 2007, AM J HEMATOL, V82, P394, DOI 10.1002/ajh.20778; Peng B, 2004, J CLIN ONCOL, V22, P935, DOI 10.1200/JCO.2004.03.050; Peng B, 2004, J CLIN PHARMACOL, V44, P158, DOI 10.1177/0091270003262101; Picard S, 2007, BLOOD, V109, P3496, DOI 10.1182/blood-2006-07-036012; Rastogi MV, 2012, PEDIATR BLOOD CANCER, V59, P840, DOI 10.1002/pbc.24121; Russo D, 2013, BLOOD, V121, P5138, DOI 10.1182/blood-2013-01-480194; Schleyer E, 2004, J CHROMATOGR B, V799, P23, DOI 10.1016/j.jchromb.2003.10.025; Shima H, 2011, J PEDIATR-US, V159, P676, DOI 10.1016/j.jpeds.2011.03.046; Suttorp M, 2014, BLOOD, V124; Suttorp M, 2012, CURR HEMATOL MALIG R, V7, P116, DOI 10.1007/s11899-012-0113-6; Suttorp M, 2010, HEMATOL-AM SOC HEMAT, P368, DOI 10.1182/asheducation-2010.1.368; Tanaka C, 1999, AAPS J, V1; Tauer JT, 2013, BLOOD, V122, DOI 10.1182/blood.V122.21.1472.1472; Taylor JR, 2006, ONCOGENE, V25, P147, DOI 10.1038/sj.onc.1209007; TURNER CH, 1993, BONE, V14, P595, DOI 10.1016/8756-3282(93)90081-K; Ulmer A, 2013, KLIN PADIATR, V225, P120, DOI 10.1055/s-0033-1343483; Vandyke K, 2009, LEUKEMIA, V23, P2155, DOI 10.1038/leu.2009.150; Vandyke K, 2013, IMATINIB CHEM STRUCT; Vandyke K, 2013, J CLIN ENDOCR METAB, V98, P67, DOI 10.1210/jc.2012-2426; Vandyke K, 2010, BLOOD, V115, P766, DOI 10.1182/blood-2009-08-237404	48	27	31	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2015	10	6							e0131192	10.1371/journal.pone.0131192	http://dx.doi.org/10.1371/journal.pone.0131192			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4OM	26107505	Green Published, gold, Green Submitted			2022-12-26	WOS:000356932500146
J	Wang, CH; Gu, ZH; Cui, H; Zhu, HH; Fu, SL; Yao, Q				Wang, Caihuan; Gu, Zhenhong; Cui, Hang; Zhu, Honghui; Fu, Shenlei; Yao, Qing			Differences in Arbuscular Mycorrhizal Fungal Community Composition in Soils of Three Land Use Types in Subtropical Hilly Area of Southern China	PLOS ONE			English	Article							DIVERSITY; EROSION; UNDERSTORY; CARBON; COLONIZATION; RESTORATION; WATERMELON; MANAGEMENT; BACTERIAL; ECOSYSTEM	Land use type is key factor in restoring the degraded soils due to its impact on soil chemical properties and microbial community. In this study, the influences of land use type on arbuscular mycorrhizal fungal (AMF) community and soil chemical properties were assessed in a long-run experimental station in subtropical hilly area of southern China. Soil samples were collected from forest land, orchard and vegetable field. Soil chemical properties were analyzed, and PCR-DGGE was performed to explore the AMF community structure. Cloning and sequencing of DGGE bands were conducted to monitor AMF community composition. Results indicate that the contents of total P, available P and available K were the highest while the contents of soil organic matter, total N, total K and available N were the lowest in vegetable field soils, with forest land soils vice versa. According to DGGE profiling, AMF community in forest soils was more closely related to that in orchard soils than that in vegetable field soils. Sequencing indicated that 45 out of 53 excised bands were AMF and 64.4% of AMF belonged to Glomeraceae, including some "generalists" present in all soils and some "specialists" present only in soils of particular land use. Category principle component analysis demonstrated that total N, soil organic matter and available P were the most important factors affecting AMF community, and some AMF phylotypes were closely associated with particular soil chemical properties. Our data suggest that AMF communities are different with different land use types.	[Wang, Caihuan; Gu, Zhenhong; Cui, Hang; Yao, Qing] South China Agr Univ, Coll Hort, Guangzhou 510642, Guangdong, Peoples R China; [Gu, Zhenhong; Zhu, Honghui; Yao, Qing] Guangdong Inst Microbiol, Guangzhou 510070, Guangdong, Peoples R China; [Fu, Shenlei] Chinese Acad Sci, South China Bot Garden, Key Lab Vegetat Restorat & Management Degraded Ec, Guangzhou 510160, Guangdong, Peoples R China	South China Agricultural University; Guangdong Academy of Sciences; Institute of Microbiology, Guangdong Academy of Sciences; Chinese Academy of Sciences; South China Botanical Garden, CAS	Yao, Q (corresponding author), South China Agr Univ, Coll Hort, Guangzhou 510642, Guangdong, Peoples R China.	yaoqscau@scau.edu.cn	Zhu, Honghui/N-2251-2015; YAO, Qing/B-3206-2009	YAO, Qing/0000-0003-3449-6166; ZHU, Honghui/0000-0001-6854-8417	Natural Science Foundation of China-Guangdong [U1131001]	Natural Science Foundation of China-Guangdong	This work was financially supported by the Natural Science Foundation of China-Guangdong Joint Project (grant number U1131001, URL http://www.nsfc.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bedini S, 2007, AGR ECOSYST ENVIRON, V120, P463, DOI 10.1016/j.agee.2006.09.010; Berthrong ST, 2013, MICROB ECOL, V66, P158, DOI 10.1007/s00248-013-0225-0; Ciampalini R, 2012, AGR ECOSYST ENVIRON, V146, P197, DOI 10.1016/j.agee.2011.11.006; de Neergaard A, 2008, AGR ECOSYST ENVIRON, V125, P182, DOI 10.1016/j.agee.2007.12.013; DOUDS DD, 1990, NEW PHYTOL, V116, P621, DOI 10.1111/j.1469-8137.1990.tb00547.x; Duan WJ, 2008, J INTEGR PLANT BIOL, V50, P147, DOI 10.1111/j.1744-7909.2007.00603.x; Gai JP, 2006, MYCORRHIZA, V16, P229, DOI 10.1007/s00572-005-0023-8; Gonzalez-Cortes JC, 2012, FUNGAL ECOL, V5, P16, DOI 10.1016/j.funeco.2011.09.002; Helgason T, 1998, NATURE, V394, P431, DOI 10.1038/28764; Houghton RA, 2002, SCI CHINA SER C, V45, P10; Iqbal J, 2008, SOIL BIOL BIOCHEM, V40, P2324, DOI 10.1016/j.soilbio.2008.05.010; Jefwa JM, 2012, AGR ECOSYST ENVIRON, V157, P32, DOI 10.1016/j.agee.2012.04.009; Ji BM, 2012, OECOLOGIA, V168, P187, DOI 10.1007/s00442-011-2067-0; Jiao H, 2011, MYCORRHIZA, V21, P681, DOI 10.1007/s00572-011-0377-z; Kovacs GM, 2007, MYCORRHIZA, V17, P597, DOI 10.1007/s00572-007-0137-2; Lee J, 2008, FEMS MICROBIOL ECOL, V65, P339, DOI 10.1111/j.1574-6941.2008.00531.x; Li XF, 2011, PROCEDIA ENVIRON SCI, V10, P14, DOI 10.1016/j.proenv.2011.09.004; Liang ZB, 2008, SOIL BIOL BIOCHEM, V40, P956, DOI 10.1016/j.soilbio.2007.11.016; Lin S, 2012, AGR ECOSYST ENVIRON, V146, P168, DOI 10.1016/j.agee.2011.10.024; Liu H, 2008, AGR ECOSYST ENVIRON, V124, P125, DOI 10.1016/j.agee.2007.09.002; Lou YS, 2003, WATER AIR SOIL POLL, V149, P281, DOI 10.1023/A:1025727504841; Lumini E, 2010, ENVIRON MICROBIOL, V12, P2165, DOI 10.1111/j.1462-2920.2009.02099.x; Mander C, 2012, SOIL BIOL BIOCHEM, V44, P93, DOI 10.1016/j.soilbio.2011.09.009; Muthukumar T, 2013, SYMBIOSIS, V59, P15, DOI 10.1007/s13199-012-0185-z; Oehl F, 2003, APPL ENVIRON MICROB, V69, P2816, DOI 10.1128/AEM.69.5.2816-2824.2003; Oehl F, 2010, SOIL BIOL BIOCHEM, V42, P724, DOI 10.1016/j.soilbio.2010.01.006; Opik M, 2009, NEW PHYTOL, V184, P424, DOI 10.1111/j.1469-8137.2009.02920.x; Ogura-Tsujita Y, 2013, J PLANT RES, V126, P41, DOI 10.1007/s10265-012-0511-9; Omirou M, 2013, APPL SOIL ECOL, V63, P112, DOI 10.1016/j.apsoil.2012.09.013; Piao HC, 2012, PEDOBIOLOGIA, V55, P167, DOI 10.1016/j.pedobi.2012.03.003; Qiao YJ, 2012, PLANT SOIL ENVIRON, V58, P174, DOI 10.17221/351/2011-PSE; Requena N, 2001, APPL ENVIRON MICROB, V67, P495, DOI 10.1128/AEM.67.2.495-498.2001; Rillig MC, 2003, PLANT SOIL, V253, P293, DOI 10.1023/A:1024807820579; Schechter SP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055507; Semenov AV, 2012, SOIL BIOL BIOCHEM, V49, P88, DOI 10.1016/j.soilbio.2012.02.016; Smith S.E., 2008, MYCORRHIZAL SYMBIOSI, V3rd ed; Smith SE, 2011, ANNU REV PLANT BIOL, V62, P227, DOI 10.1146/annurev-arplant-042110-103846; Smith SE, 2010, PLANT SOIL, V326, P3, DOI 10.1007/s11104-009-9981-5; Sturmer SL, 2011, MYCORRHIZA, V21, P255, DOI 10.1007/s00572-010-0330-6; Tchabi A, 2008, MYCORRHIZA, V18, P181, DOI 10.1007/s00572-008-0171-8; Valverde A, 2011, CHEMOSPHERE, V85, P129, DOI 10.1016/j.chemosphere.2011.06.025; Veresoglou SD, 2012, SOIL BIOL BIOCHEM, V46, P53, DOI 10.1016/j.soilbio.2011.11.018; Wang XL, 2011, FOREST ECOL MANAG, V261, P1053, DOI 10.1016/j.foreco.2010.12.027; White TJ, 1990, AMPLIFICATION DIRECT, V18, P315; Whiteside MD, 2012, SOIL BIOL BIOCHEM, V55, P7, DOI 10.1016/j.soilbio.2012.06.001; Xiong YM, 2008, PLANT SOIL, V304, P179, DOI 10.1007/s11104-007-9536-6; Xu YQ, 2011, J GEOGR SCI, V21, P1138, DOI 10.1007/s11442-011-0906-x; Yamato M, 2002, MYCORRHIZA, V12, P291, DOI 10.1007/s00572-002-0187-4; Zarei M, 2010, ENVIRON POLLUT, V158, P2757, DOI 10.1016/j.envpol.2010.04.017; Zhang B, 2004, CATENA, V57, P77, DOI 10.1016/j.catena.2003.07.001; Zhang Y, 2004, MYCORRHIZA, V14, P25, DOI 10.1007/s00572-003-0272-3; Zhang Y, 2011, PLANT SOIL, V339, P447, DOI 10.1007/s11104-010-0600-2; Zhao J, 2012, SOIL BIOL BIOCHEM, V49, P78, DOI 10.1016/j.soilbio.2012.02.020; Zhao J, 2011, SOIL BIOL BIOCHEM, V43, P954, DOI 10.1016/j.soilbio.2011.01.010; Zokaib S, 2011, INT J SEDIMENT RES, V26, P343, DOI 10.1016/S1001-6279(11)60098-X	56	24	24	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2015	10	6							e0130983	10.1371/journal.pone.0130983	http://dx.doi.org/10.1371/journal.pone.0130983			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4OM	26107285	Green Published, gold, Green Submitted			2022-12-26	WOS:000356932500134
J	Wei, SX; Lu, ZH; Zou, YF; Lin, X; Lin, CW; Liu, BM; Zheng, L; Zhao, JM				Wei, Shixiu; Lu, Zhenhui; Zou, Yunfeng; Lin, Xiao; Lin, Cuiwu; Liu, Buming; Zheng, Li; Zhao, Jinmin			A Novel Synthesized Sulfonamido-Based Gallate-JEZ-C as Potential Therapeutic Agents for Osteoarthritis	PLOS ONE			English	Article							FACTOR-KAPPA-B; GALLIC ACID; CARTILAGE PROTEOGLYCAN; GENE-EXPRESSION; II COLLAGEN; SOX9 GENE; CHONDROCYTES; PHENOTYPE; CELL; CHONDROGENESIS	Gallic acid (GA) and its derivatives are anti-inflammatory agents reported to have an effect on osteoarthritis (OA). However, GA has much weaker anti-oxidant effects and inferior bioactivity compared with its derivatives. We modified GA with the introduction of sulfonamide to synthesize a novel compound named JEZ-C and analyzed its anti-arthritis and chondro-protective effects. Comparison of JEZ-C with its sources i.e. GA and Sulfamethoxazole (SMZ) was also performed. Results showed that JEZ-C could effectively inhibit the IL-1-mediated induction of MMP-1 and MMP-13 and could induce the expression of TIMP-1, which demonstrated its ability to reduce the progression of OA. JEZ-C can also exert chondro-protective effects by promoting cell proliferation and maintaining the phenotype of articular chondrocytes, as evidenced by improved cell growth, enhanced synthesis of cartilage specific markers such as aggrecan, collagen II and Sox9. Meanwhile, expression of the collagen I gene was effectively downregulated, revealing the inhibition of chondrocytes dedifferentiation by JEZ-C. Hypertrophy that may lead to chondrocyte ossification was also undetectable in JEZ-C groups. The recommended dose of JEZ-C ranges from 6.25x10(-7) mu g/ml to 6.25x10(-5) mu g/ml, among which the most profound response was observed with 6.25x10(-6) mu g/ml. In contrast, its source products of GA and SMZ have a weak effect not only in the inhibition of OA but also in the bioactivity of chondrocytes, which indicated the significance of this modification. This study revealed JEZ-C as a promising novel agent in the treatment of chondral and osteochondral lesions.	[Wei, Shixiu; Lu, Zhenhui; Zheng, Li; Zhao, Jinmin] Guangxi Med Univ, Med & Sci Res Ctr, Nanning 530021, Peoples R China; [Lu, Zhenhui; Zheng, Li; Zhao, Jinmin] Guangxi Med Univ, Guangxi Key Lab Regenerat Med, Nanning 530021, Peoples R China; [Lu, Zhenhui; Zheng, Li; Zhao, Jinmin] Guangxi Med Univ, Guangxi Coll & Univ Key Lab Regenerat Med, Nanning 530021, Peoples R China; [Zou, Yunfeng] Guangxi Med Univ, Sch Publ Hlth, Dept Toxicol, Nanning 530021, Peoples R China; [Lin, Xiao; Lin, Cuiwu] Guangxi Med Univ, Sch Chem & Chem Engn, Nanning 530021, Peoples R China; [Liu, Buming] Guangxi Inst Tradit Med & Pharmaceut Sci, Guangxi Key Lab Tradit Chinese Med Qual Stand, Nanning 530022, Peoples R China	Guangxi Medical University; Guangxi Medical University; Guangxi Medical University; Guangxi Medical University; Guangxi Medical University	Zheng, L (corresponding author), Guangxi Med Univ, Med & Sci Res Ctr, Nanning 530021, Peoples R China.	zhengli224@163.com		Zhao, Jinmin/0000-0002-1047-8820; Zheng, Li/0000-0002-9666-0024	National Science & Technology Pillar Program of China [2012BAI42G00]; Guangxi Scientific Research and Technological Development Foundation [14125008-2-14]; Guangxi Science Fund for Distinguished Young Scholars [2014GXNSFGA118006]; Research Center for Regenerative Medicine of Guangxi Medical University; Collaborative Innovation Center of Guangxi Biological Medicine	National Science & Technology Pillar Program of China; Guangxi Scientific Research and Technological Development Foundation; Guangxi Science Fund for Distinguished Young Scholars(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); Research Center for Regenerative Medicine of Guangxi Medical University; Collaborative Innovation Center of Guangxi Biological Medicine	This work has been financially supported by National Science & Technology Pillar Program of China (Grant No. 2012BAI42G00) and Guangxi Scientific Research and Technological Development Foundation (Grant No. Guikehe 14125008-2-14), Guangxi Science Fund for Distinguished Young Scholars (Grant No. 2014GXNSFGA118006). This work has been supported by Research Center for Regenerative Medicine of Guangxi Medical University and Collaborative Innovation Center of Guangxi Biological Medicine. The National Science & Technology Pillar Program of China supported the study design, the Guangxi Scientific Research and Technological Development Foundation supported the data collection and analysis, and the Guangxi Science Fund for Distinguished Young Scholars supported the decision to publish.	Adcocks C, 2002, J NUTR, V132, P341, DOI 10.1093/jn/132.3.341; Akiyama Haruhiko, 2011, Clin Calcium, V21, P845, DOI CliCa1106845851; Andriamanalijaona R, 2005, J RHEUMATOL, V32, P1958; Baran W, 2011, J HAZARD MATER, V196, P1, DOI 10.1016/j.jhazmat.2011.08.082; BENYA PD, 1982, CELL, V30, P215, DOI 10.1016/0092-8674(82)90027-7; BUSCHMANN MD, 1995, J BIOMECH ENG-T ASME, V117, P179, DOI 10.1115/1.2796000; DASCHNER F, 1976, CHEMOTHERAPY, V22, P12, DOI 10.1159/000221905; Davies SR, 2007, GENOME RES, V17, P1438, DOI 10.1101/gr.6224007; Goldring MB, 2001, EXPERT OPIN BIOL TH, V1, P817, DOI 10.1517/14712598.1.5.817; Hardy MM, 2002, ARTHRITIS RHEUM, V46, P1789, DOI 10.1002/art.10356; Hsiang CY, 2013, FOOD CHEM, V136, P426, DOI 10.1016/j.foodchem.2012.08.009; Ishiguro N, 1999, ARTHRITIS RHEUM, V42, P129, DOI 10.1002/1529-0131(199901)42:1<129::AID-ANR16>3.0.CO;2-4; Karlsen TA, 2011, TISSUE ENG PART C-ME, V17, P219, DOI [10.1089/ten.tec.2010.0200, 10.1089/ten.TEC.2010.0200]; KROES BH, 1992, PLANTA MED, V58, P499, DOI 10.1055/s-2006-961535; Kuppan G, 2010, CYTOKINE, V49, P229, DOI 10.1016/j.cyto.2009.11.003; Kwan KM, 1997, J CELL BIOL, V136, P459, DOI 10.1083/jcb.136.2.459; Lin X, 2014, BIOORG MED CHEM LETT, V24, P2497, DOI 10.1016/j.bmcl.2014.04.015; Liu L, 2014, IN VITRO CELL DEV-AN, V50, P982, DOI 10.1007/s11626-014-9795-5; Liu Q, 2014, CHEM-BIOL INTERACT, V221, P127, DOI 10.1016/j.cbi.2014.08.002; Lotz M, 2001, CLIN ORTHOP RELAT R, pS108; Lu ZB, 2006, NEUROCHEM INT, V48, P263, DOI 10.1016/j.neuint.2005.10.010; Lu ZH, 2014, BIOORG CHEM, V57, P99, DOI 10.1016/j.bioorg.2014.09.005; Marshall OJ, 2000, MOL GENET METAB, V71, P455, DOI 10.1006/mgme.2000.3081; Mengshol JA, 2000, ARTHRITIS RHEUM, V43, P801, DOI 10.1002/1529-0131(200004)43:4<801::AID-ANR10>3.0.CO;2-4; Moldovan F, 2000, OSTEOARTHR CARTILAGE, V8, P186, DOI 10.1053/joca.1999.0289; Ng LJ, 1997, DEV BIOL, V183, P108, DOI 10.1006/dbio.1996.8487; Nuti E, 2013, EUR J MED CHEM, V62, P379, DOI 10.1016/j.ejmech.2012.12.058; Ou TT, 2013, CURR MED CHEM, V20, P3944; Paul R, 2003, SPINE, V28, P755, DOI 10.1097/00007632-200304150-00006; Qin J, 2013, EVID-BASED COMPL ALT, V2013, P761; Robinson D, 2001, CELL TRANSPLANT, V10, P203; Schnabel M, 2002, OSTEOARTHR CARTILAGE, V10, P62, DOI 10.1053/joca.2001.0482; Tew SR, 2011, TISSUE ENG PT A, V17, P1801, DOI 10.1089/ten.tea.2010.0579; Tew SR, 2005, OSTEOARTHR CARTILAGE, V13, P80, DOI 10.1016/j.joca.2004.10.011; Tsuchiya H, 2003, BIOCHEM BIOPH RES CO, V301, P338, DOI 10.1016/S0006-291X(02)03026-7; Xu GJ, 2014, BRAZ J MED BIOL RES, V47, P637, DOI 10.1590/1414-431X20143935; Yoon CH, 2013, JOINT BONE SPINE, V80, P274, DOI 10.1016/j.jbspin.2012.08.010	37	6	6	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2015	10	6							e0125930	10.1371/journal.pone.0125930	http://dx.doi.org/10.1371/journal.pone.0125930			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4OM	26107568	Green Published, gold, Green Submitted			2022-12-26	WOS:000356932500007
J	Chor, D; Ribeiro, ALP; Carvalho, MS; Duncan, BB; Lotufo, PA; Nobre, AA; de Aquino, EMLL; Schmidt, MI; Griep, RH; Molina, MDCB; Barreto, SM; Passos, VMDA; Judith, I; Bensenor, M; Matos, SMA; Mill, JG				Chor, Dora; Ribeiro, Antonio Luiz Pinho; Carvalho, Marilia Sa; Duncan, Bruce Bartholow; Lotufo, Paulo Andrade; Nobre, Aline Araujo; de Aquino, Estela Mota Lima Leao; Schmidt, Maria Ines; Griep, Rosane Harter; Molina, Maria Del Carmen Bisi; Barreto, Sandhi Maria; Passos, Valeria Maria de Azeredo; Judith, Isabela; Bensenor, Martins; Matos, Sheila Maria Alvim; Mill, Jose Geraldo			Prevalence, Awareness, Treatment and Influence of Socioeconomic Variables on Control of High Blood Pressure: Results of the ELSA-Brasil Study	PLOS ONE			English	Article							HYPERTENSION AWARENESS; CARDIOVASCULAR HEALTH; COUNTRIES; CHALLENGES; INCOME; RACE; CARE; DISCRIMINATION; DISPARITIES; POPULATION	High blood pressure (HBP) is the leading risk factor for years of life lost in Brazil. Factors associated with HBP awareness, treatment and control need to be understood better. Our aim is to estimate prevalence, awareness, and types of anti-hypertensive treatment and to investigate the association of HBP control with social position. Data of 15,103 (54% female) civil servants in six Brazilian state capitals collected at the Brazilian Longitudinal Study of Adult Health (ELSA-Brasil) baseline (2008-2010) were used to estimate prevalence and cross-sectional association of HBP control with education, per capita family income and self-reported race, using multiple logistic regression. Blood pressure was measured by the oscillometric method. 35.8% were classified as presenting HBP; 76.8% of these used anti-hypertensive medication. Women were more aware than men (84.8% v. 75.8%) and more often using medication (83.1% v. 70.7%). Adjusted HBP prevalence was, in ascending order, Whites (30.3%), Browns (38.2%) and Blacks (49.3%). The therapeutic schemes most used were angiotensin-converting enzyme inhibitors, in isolation (12.4%) or combined with diuretics (13.3%). Among those in drug treatment, controlled blood pressure was more likely in the (postgraduate) higher education group than among participants with less than secondary school education (PR = 1.21; 95% CI: 1.14-1.28), and among Asian (PR = 1.21; 95% CI: 1.12-1.32) and 'Whites (PR = 1.19; 95% CI: 1.12-1.26) compared to Blacks. Socioeconomic and racial inequality-as measured by different indicators-are strongly associated with HBP control, beyond the expected influence of health services access.	[Chor, Dora] Fundacao Oswaldo Cruz, Natl Sch Publ Hlth, Dept Epidemiol, Rio De Janeiro, RJ, Brazil; [Ribeiro, Antonio Luiz Pinho] Univ Fed Minas Gerais, Dept Internal Med, Belo Horizonte, MG, Brazil; [Carvalho, Marilia Sa; Nobre, Aline Araujo] Fundacao Oswaldo Cruz, Comp Sci Program, Rio De Janeiro, RJ, Brazil; [Duncan, Bruce Bartholow; Schmidt, Maria Ines] Univ Fed Rio Grande do Sul, Sch Med, Postgrad Studies Program Epidemiol, Porto Alegre, RS, Brazil; [Lotufo, Paulo Andrade; Bensenor, Martins] Univ Sao Paulo, Sch Med, Sao Paulo, SP, Brazil; [de Aquino, Estela Mota Lima Leao; Matos, Sheila Maria Alvim] Univ Fed Bahia, Inst Collect Hlth, Salvador, BA, Brazil; [Griep, Rosane Harter] Fundacao Oswaldo Cruz, Lab Hlth & Environm Educ, Rio De Janeiro, RJ, Brazil; [Molina, Maria Del Carmen Bisi] Univ Fed Espirito Santo, Postgrad Program Collect Hlth, Vitoria, ES, Spain; [Barreto, Sandhi Maria; Passos, Valeria Maria de Azeredo] Univ Fed Minas Gerais, Fac Med, Belo Horizonte, MG, Brazil; [Mill, Jose Geraldo] Univ Fed Espirito Santo, Dept Physiol Sci, Vitoria, ES, Spain	Fundacao Oswaldo Cruz; Universidade Federal de Minas Gerais; Fundacao Oswaldo Cruz; Universidade Federal do Rio Grande do Sul; Universidade de Sao Paulo; Universidade Federal da Bahia; Fundacao Oswaldo Cruz; Universidade Federal de Minas Gerais	Chor, D (corresponding author), Fundacao Oswaldo Cruz, Natl Sch Publ Hlth, Dept Epidemiol, Rio De Janeiro, RJ, Brazil.	dorachor@fiocruz.br	Lotufo, Paulo/A-9843-2008; Passos, Valeria/AAJ-2761-2021; Passos, Valéria/B-5345-2014; Aquino, Estela M. L./G-2599-2012; Schmidt, Maria Inês/AGP-6441-2022; CARVALHO, MARILIA/AAD-8283-2020; Schmidt, Maria/V-3196-2019; Duncan, Bruce B/L-4140-2016; Ribeiro, Ana Cristina/HHN-7466-2022; Griep, Rosane H/E-3763-2013; Schmidt, Maria Inês/AGT-5691-2022; Ribeiro, Antonio L/C-2707-2009; Griep, Rosane Härter/ABB-4509-2020; Barreto, Sandhi M/D-2855-2014	Lotufo, Paulo/0000-0002-4856-8450; Passos, Valéria/0000-0003-2829-5798; Aquino, Estela M. L./0000-0002-8204-1249; Schmidt, Maria Inês/0000-0002-3837-0731; CARVALHO, MARILIA/0000-0002-9566-0284; Duncan, Bruce B/0000-0002-7491-2630; Ribeiro, Ana Cristina/0000-0002-0493-8376; Griep, Rosane H/0000-0002-6250-2036; Ribeiro, Antonio L/0000-0002-2740-0042; Barreto, Sandhi M/0000-0001-7383-7811	Brazilian Ministry of Health (Science and Technology Department); Brazilian Ministry of Science and Technology (Financiadora de Estudos e Projetos) [01 06 0071.00 RJ, 01 06 0212.00 BA, 01 06 0300.00 ES, 01 06 0278.00 MG, 01 06 0115.00 SP, 01 060010.00 RS]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (National Council for Scientific and Technological Development) [300694/2010-5]; CNPq [309692/2013-0]; FAPERJ [E-23557/2014]; Brazilian Ministry of Science and Technology (CNPq National Research Council) [01 06 0071.00 RJ, 01 06 0212.00 BA, 01 06 0300.00 ES, 01 06 0278.00 MG, 01 06 0115.00 SP, 01 060010.00 RS]	Brazilian Ministry of Health (Science and Technology Department); Brazilian Ministry of Science and Technology (Financiadora de Estudos e Projetos); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (National Council for Scientific and Technological Development)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPERJ(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Brazilian Ministry of Science and Technology (CNPq National Research Council)	The ELSA-Brasil study was supported by the Brazilian Ministry of Health (Science and Technology Department) and the Brazilian Ministry of Science and Technology (Financiadora de Estudos e Projetos and CNPq National Research Council) (grants 01 06 0071.00 RJ, 01 06 0212.00 BA, 01 06 0300.00 ES, 01 06 0278.00 MG, 01 06 0115.00 SP, 01 060010.00 RS). DC received a fellowship from the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (National Council for Scientific and Technological Development) under Award Number 300694/2010-5. MSC received a fellowship from the CNPq under Award Number 309692/2013-0 and FAPERJ E-23557/2014. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler N, 2012, P NATL ACAD SCI USA, V109, P17154, DOI 10.1073/pnas.1121399109; Aquino EML, 2012, AM J EPIDEMIOL, V175, P315, DOI 10.1093/aje/kwr294; Bastos L, 2015, CAD SAUDEPUBLICA; Basu S, 2013, HYPERTENSION, V62, P18, DOI 10.1161/HYPERTENSIONAHA.113.01374; Bensenor IM, 2013, REV SAUDE PUBL, V47, P37, DOI 10.1590/S0034-8910.2013047003780; Brazil Health Ministry, 2012, VIGILANCIA DE FATORE; Brazil Health Ministry, 2013, INFORMATION IN HEALT; Carrington MJ, 2013, J HYPERTENS, V31, P1265, DOI 10.1097/HJH.0b013e3283606bc7; Carroll-Scott A, 2013, SOC SCI MED, V95, P106, DOI 10.1016/j.socscimed.2013.04.003; Chobanian AV., 2003, HYPERTENSION, V42, P1206, DOI [10.1161/01.HYP.0000107251, DOI 10.1161/01.HYP.9.2_PT_2.II36, DOI 10.1161/01.HYP.0000107251.49515.C2]; Chor Dóra, 2005, Cad. Saúde Pública, V21, P1586, DOI 10.1590/S0102-311X2005000500033; Chor D, 2013, REV SAUDE PUBL, V47, P27, DOI 10.1590/S0034-8910.2013047003835; de Gaudemaris R, 2002, HYPERTENSION, V39, P1119, DOI 10.1161/01.HYP.0000018912.05345.55; Dolezsar CM, 2014, HEALTH PSYCHOL, V33, P20, DOI 10.1037/a0033718; Elder K, 2012, AM J PUBLIC HEALTH, V102, P2242, DOI 10.2105/AJPH.2012.300777; Ernst ME, 2006, HYPERTENSION, V47, P352, DOI 10.1161/01.HYP.0000203309.07140.d3; Faerstein Eduardo, 2014, Rev. bras. epidemiol., V17, P81, DOI 10.1590/1809-4503201400060007; Falaschetti E, 2009, HYPERTENSION, V53, P480, DOI 10.1161/HYPERTENSIONAHA.108.125617; Fasce E, 2007, J HYPERTENS, V25, P1807, DOI 10.1097/HJH.0b013e328244e481; Feng XL, 2014, B WORLD HEALTH ORGAN, V92, P29, DOI 10.2471/BLT.13.124495; Firmo Josélia Oliveira Araújo, 2004, Cad. Saúde Pública, V20, P512, DOI 10.1590/S0102-311X2004000200019; FLANDERS WD, 1987, J CHRON DIS, V40, P697, DOI 10.1016/0021-9681(87)90106-8; Guo F, 2010, ACCIDENT ANAL PREV, V42, P84, DOI 10.1016/j.aap.2009.07.005; Gus Iseu, 2004, Arq. Bras. Cardiol., V83, P424, DOI 10.1590/S0066-782X2004001700009; Ibrahim MM, 2012, LANCET, V380, P611, DOI 10.1016/S0140-6736(12)60861-7; Ikeda N, 2014, B WORLD HEALTH ORGAN, V92, P10, DOI 10.2471/BLT.13.121954; Instituto Brasileiro de Geografia e Estatistica, 2010, PESQUISA NACIONAL PO; Kuzawa CW, 2009, AM J HUM BIOL, V21, P2, DOI 10.1002/ajhb.20822; Lawes CMM, 2008, LANCET, V371, P1513, DOI 10.1016/S0140-6736(08)60655-8; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Lloyd-Sherlock P, 2014, INT J EPIDEMIOL, V43, P116, DOI 10.1093/ije/dyt215; Lotufo PA, 2013, REV SAUDE PUBL, V47, P1201, DOI 10.1590/S0034-8910.2013047004890; Maimaris W, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001490; Mancia G, 2013, J HYPERTENS, V31, P1094, DOI 10.1097/HJH.0b013e32836184cf; McAlister FA, 2011, CAN MED ASSOC J, V183, P1007, DOI 10.1503/cmaj.101767; Mill JG, 2013, REV SAUDE PUBL, V47, P54, DOI 10.1590/S0034-8910.2013047003851; Moreira Gisela C, 2009, J Hypertens, V27, P1900, DOI 10.1097/HJH.0b013e32832dd10f; Mosca L, 2006, CIRCULATION, V113, P525, DOI 10.1161/CIRCULATIONAHA.105.588103; MOY E, 1995, ARCH INTERN MED, V155, P1497, DOI 10.1001/archinte.155.14.1497; Mozumdar A, 2010, WOMENS HEALTH, V6, P37, DOI [10.2217/whe.09.78, 10.2217/WHE.09.78]; Muntner P, 2004, HYPERTENSION, V43, P578, DOI 10.1161/01.HYP.0000116302.08484.14; Nissinen A, 2004, DIABETOLOGIA, V47, P1245, DOI 10.1007/s00125-004-1433-4; Nogueira D, 2010, REV PANAM SALUD PUBL, V27, P103, DOI 10.1590/S1020-49892010000200003; Nwankwo Tatiana, 2013, NCHS Data Brief, P1; O'Brien, 1996, Blood Press Monit, V1, P55; Ong KL, 2007, HYPERTENSION, V49, P69, DOI 10.1161/01.HYP.0000252676.46043.18; Ordunez P, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-169; Paim J, 2011, LANCET, V377, P1778, DOI 10.1016/S0140-6736(11)60054-8; Pereira MR, 2007, CAD SAUDE PUBLICA, V23, P2363, DOI 10.1590/S0102-311X2007001000011; Phillips SP, 2011, PUBLIC HEALTH REP, V126, P16, DOI 10.1177/00333549111260S304; Picon RV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048255; Rose G, 1992, THE STRATEGY OF PREV; Schmidt MI, 2015, INT J EPIDEMIOL, V44, P68, DOI 10.1093/ije/dyu027; Schmidt MI, 2013, REV SAUDE PUBL, V47, P105, DOI 10.1590/S0034-8910.2013047003889; Schmidt MI, 2011, LANCET, V377, P1949, DOI 10.1016/S0140-6736(11)60135-9; Sichieri Rosely, 2001, Ethnicity and Disease, V11, P412; Sims M, 2012, AM J PUBLIC HEALTH, V102, pS258, DOI 10.2105/AJPH.2011.300523; Smith PM, 2013, CAN J PUBLIC HEALTH, V104, pE82, DOI 10.1007/BF03405661; Team R. c, 2013, R A LANGUAGE AND ENV; Travassos Cláudia, 2002, Rev Panam Salud Publica, V11, P365, DOI 10.1590/S1020-49892002000500011; Umscheid CA, 2010, AM J HYPERTENS, V23, P54, DOI 10.1038/ajh.2009.201; Vitale C, 2007, CLIMACTERIC, V10, P16, DOI 10.1080/13697130701602712; WILCOSKY TC, 1985, J CHRON DIS, V38, P849, DOI 10.1016/0021-9681(85)90109-2; Williams DR, 2010, ANN NY ACAD SCI, V1186, P69, DOI 10.1111/j.1749-6632.2009.05339.x; World Health Organization, 2012, WORLD HEALTH STATIST; Wyatt SB, 2008, HYPERTENSION, V51, P650, DOI 10.1161/HYPERTENSIONAHA.107.100081; Yunis Carla, 1998, Ethnicity and Disease, V8, P406	67	99	110	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2015	10	6							e0127382	10.1371/journal.pone.0127382	http://dx.doi.org/10.1371/journal.pone.0127382			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CL4DD	26102079	Green Published, Green Submitted, gold			2022-12-26	WOS:000356901900003
J	Zhang, L; Fan, DZ; Liu, L; Yang, T; Ding, N; Hu, YT; Cai, GQ; Wang, L; Xin, LH; Xia, Q; Li, XN; Xu, SQ; Xu, JH; Yang, X; Zou, YF; Pan, FM				Zhang, Li; Fan, Dazhi; Liu, Li; Yang, Ting; Ding, Ning; Hu, Yanting; Cai, Guoqi; Wang, Li; Xin, Lihong; Xia, Qing; Li, Xiaona; Xu, Shengqian; Xu, Jianhua; Yang, Xiao; Zou, Yanfeng; Pan, Faming			Association Study of IL-12B Polymorphisms Susceptibility with Ankylosing Spondylitis in Mainland Han Population	PLOS ONE			English	Article							DISEASE SUSCEPTIBILITY; RISK; INFLAMMATION; SEVERITY; HLA-B27; LOCI; IMMUNOPATHOGENESIS; IDENTIFICATION; METAANALYSIS; RELIABILITY	Objective This study aims to determine whether the genetic polymorphisms of IL-12B gene is a susceptibility factor to Ankylosing spondylitis (AS) in mainland Han Chinese population. Method Eight single-nucleotide polymorphisms (SNPs) (rs10045431, rs11167764, rs3212227, rs6556412, rs6556416, rs6871626, rs6887695 and rs7709212) in the IL-12B gene were genotyped by iMLDR Assay technology in 400 patients [96% (384/400) HLA-B27(+)] and 395 geographically and ethnically matched healthy controls in mainland Han Chinese population. The correlation between IL-12B genetic polymorphisms and AS activity index (BASDAI, BASFI) were tested. Results The significant difference was found in genotype distribution between AS and healthy controls (chi(2) = 6.942, P-value = 0.031) of the SNP rs6871626. Furthermore, significant evidence was also detected under the recessive model for minor allele A. The AA genotype carrier had 1.830 fold risk compared with C allele carrier (with CC and AC genotypes) [OR (95% CI) = 1.830 (1.131-2.961), P-value = 0.014]. Nevertheless, the difference was no longer significant after Bonferroni correction. Subset analysis on cases with HLA-B27(+) did find the same results. Three genotypic groups (AA, CC and CA) in rs6871626 site was highly associated with the BASDAI and BASFI (P-value = 0.012 and P-value = 0.023, respectively), after adjustment for effect of age, sex, and disease duration, the P-value was 0.031 and 0.041, respectively. The AA genotype of rs6871626 was also significantly correlated with an increased BASDAI and BASFI compared to the AC and CC genotypes in AS patients. Conclusion Our findings suggest that rs6871626 may be associated AS susceptibility and with disease activity (BASDAI, BASFI) in mainland Han Chinese population.	[Zhang, Li] Anhui Med Coll, Ctr Med Genet, Hefei 230061, Peoples R China; [Fan, Dazhi; Liu, Li; Yang, Ting; Ding, Ning; Hu, Yanting; Cai, Guoqi; Wang, Li; Xin, Lihong; Xia, Qing; Li, Xiaona; Yang, Xiao; Zou, Yanfeng; Pan, Faming] Anhui Med Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Hefei 230032, Anhui, Peoples R China; [Xu, Shengqian; Xu, Jianhua] Anhui Med Univ, Affiliated Hosp 1, Dept Rheumatism & Immun, Hefei 230032, Anhui, Peoples R China	Anhui Medical College; Anhui Medical University; Anhui Medical University	Pan, FM (corresponding author), Anhui Med Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, 81 Meishan Rd, Hefei 230032, Anhui, Peoples R China.	famingpan@ahmu.edu.cn	Fan, Dazhi/C-2695-2018; Cai, Guoqi/HGE-7097-2022	Fan, Dazhi/0000-0003-2773-9166; Cai, Guoqi/0000-0002-6481-704X	National Natural Science Foundation of China [30771849, 30972530, 81273169]; Natural Science Fund of Education Department of Anhui province [KJ2014A127]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Fund of Education Department of Anhui province	This work was supported by grants from the National Natural Science Foundation of China (30771849, 30972530, and 81273169, http://isisn.nsfc.gov.cn/; Faming Pan received the funding) and supported by the Natural Science Fund of Education Department of Anhui province (KJ2014A127, http://218.22.27.67/Ahzrjj/index.action; Li Zhang received the funding). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson CA, 2011, NAT GENET, V43, P246, DOI 10.1038/ng.764; Becher B, 2002, J CLIN INVEST, V110, P493, DOI 10.1172/JCI200215751; Brown MA, 2000, ANN RHEUM DIS, V59, P883, DOI 10.1136/ard.59.11.883; Chen HL, 2012, MOL BIOL REP, V39, P10235, DOI 10.1007/s11033-012-1899-y; Collison LW, 2008, IMMUNOL REV, V226, P248, DOI 10.1111/j.1600-065X.2008.00704.x; Cortes A, 2013, NAT GENET, V45, P730, DOI 10.1038/ng.2667; Danoy P, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001195; Davidson SI, 2011, ANN RHEUM DIS, V70, P289, DOI 10.1136/ard.2010.133322; Di Cesare A, 2009, J INVEST DERMATOL, V129, P1339, DOI 10.1038/jid.2009.59; Duan ZH, 2012, SCAND J RHEUMATOL, V41, P219, DOI 10.3109/03009742.2011.625972; Evans DM, 2011, NAT GENET, V43, P761, DOI 10.1038/ng.873; Fan D, 2014, SCAND J RHEUMATOL, P1, DOI [10.3109/03009742.2013.805242, DOI 10.3109/03009742.2013.805242]; Fan D, 2014, MOD RHEUMATOL; Fuss IJ, 2006, INFLAMM BOWEL DIS, V12, P9, DOI 10.1097/01.MIB.0000194183.92671.b6; Haywood KL, 2004, RHEUMATOLOGY, V43, P750, DOI 10.1093/rheumatology/keh169; Kastelein RA, 2007, ANNU REV IMMUNOL, V25, P221, DOI 10.1146/annurev.immunol.22.012703.104758; Lai NS, 2013, CLIN EXP IMMUNOL, V173, P47, DOI 10.1111/cei.12089; Lin ZM, 2012, NAT GENET, V44, P73, DOI 10.1038/ng.1005; Liu H, 2012, AM J HUM GENET, V91, P935, DOI 10.1016/j.ajhg.2012.09.010; Nilsen TW, 2007, TRENDS GENET, V23, P243, DOI 10.1016/j.tig.2007.02.011; Paunovic V, 2008, RHEUMATOLOGY, V47, P771, DOI 10.1093/rheumatology/kem352; Reveille JD, 2010, NAT GENET, V42, P123, DOI 10.1038/ng.513; Sawcer S, 2011, NATURE, V476, P214, DOI 10.1038/nature10251; Trinchieri G, 2003, IMMUNITY, V19, P641, DOI 10.1016/S1074-7613(03)00296-6; VANDERLINDEN S, 1984, ARTHRITIS RHEUM, V27, P361; Vegvari A, 2009, JOINT BONE SPINE, V76, P623, DOI 10.1016/j.jbspin.2009.02.006; Wang CM, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3855; WARRINGTON JA, 1994, GENOMICS, V24, P395, DOI 10.1006/geno.1994.1636; Wei JCC, 2007, CLIN RHEUMATOL, V26, P1685, DOI 10.1007/s10067-007-0573-6; Wei JCC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052801; Wei JCC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020426; Wei J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047979; Wen YF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104525; Wong RH, 2012, J RHEUMATOL, V39, P135, DOI 10.3899/jrheum.110613; Yang T, 2014, MOD RHEUMATOL, V24, P150, DOI 10.3109/14397595.2013.852856; Zeng Z, 2012, CLIN RHEUMATOL, V31, P1449, DOI 10.1007/s10067-012-2028-y; Zhou L, 2013, INT J LAB MED, V34, P1372	37	15	17	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2015	10	6							e0130982	10.1371/journal.pone.0130982	http://dx.doi.org/10.1371/journal.pone.0130982			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4DD	26103568	gold, Green Published, Green Submitted			2022-12-26	WOS:000356901900071
J	Damjanovic, D; Khera, A; Afkhami, S; Lai, R; Zganiacz, A; Jeyanathan, M; Xing, Z				Damjanovic, Daniela; Khera, Amandeep; Afkhami, Sam; Lai, Rocky; Zganiacz, Anna; Jeyanathan, Mangalakumari; Xing, Zhou			Age at Mycobacterium bovis BCG Priming Has Limited Impact on Anti-Tuberculosis Immunity Boosted by Respiratory Mucosal AdHu5Ag85A Immunization in a Murine Model	PLOS ONE			English	Article							T-CELL RESPONSES; CALMETTE-GUERIN VACCINATION; IFN-GAMMA PRODUCTION; INNATE IMMUNITY; PROTECTION; TUBERCULOSIS; VACCINES; MECHANISMS; CYTOKINE; MEMORY	Tuberculosis (TB) remains a global pandemic despite the use of Bacillus Calmette-Guerin (BCG) vaccine, partly because BCG fails to effectively control adult pulmonary TB. The introduction of novel boost vaccines such as the human Adenovirus 5-vectored AdHu5Ag85A could improve and prolong the protective immunity of BCG immunization. Age at which BCG immunization is implemented varies greatly worldwide, and research is ongoing to discover the optimal stage during childhood to administer the vaccine, as well as when to boost the immune response with potential novel vaccines. Using a murine model of subcutaneous BCG immunization followed by intranasal AdHu5Ag85A boosting, we investigated the impact of age at BCG immunization on protective efficacy of BCG prime and AdHu5Ag85A boost immunization-mediated protection. Our results showed that age at parenteral BCG priming has limited impact on the efficacy of BCG prime-AdHu5Ag85A respiratory mucosal boost immunization-enhanced protection. However, when BCG immunization was delayed until the maturity of the immune system, longer sustained memory T cells were generated and resulted in enhanced boosting effect on T cells of AdHu5Ag85A respiratory mucosal immunization. Our findings hold implications for the design of new TB immunization protocols for humans.	[Jeyanathan, Mangalakumari] McMaster Univ, McMaster Immunol Res Ctr, Hamilton, ON, Canada; McMaster Univ, Dept Pathol & Mol Med, Hamilton, ON, Canada	McMaster University; McMaster University	Jeyanathan, M (corresponding author), McMaster Univ, McMaster Immunol Res Ctr, Hamilton, ON, Canada.	jeyanat@gmail.com; xingz@mcmaster.ca		Lai, Rocky/0000-0002-3394-3086	Canadian Institutes of Health Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	The study was supported by funds from the Canadian Institutes of Health Research.	Aagaard C, 2009, IMMUNOL CELL BIOL, V87, P279, DOI 10.1038/icb.2009.14; Adkins B, 2004, NAT REV IMMUNOL, V4, P553, DOI 10.1038/nri1394; Alexander-Miller MA, 2014, J IMMUNOL, V193, P5363, DOI 10.4049/jimmunol.1401410; [Anonymous], 2014, GUID INJ BCG VACCINE; Bennekov T, 2006, EUR J IMMUNOL, V36, P3346, DOI 10.1002/eji.200636128; Brennan MJ, 2012, TUBERCULOSIS, V92, pS6, DOI 10.1016/S1472-9792(12)70005-7; Burl S, 2010, J IMMUNOL, V185, P2620, DOI 10.4049/jimmunol.1000552; Demirjian A, 2009, EUR J IMMUNOL, V39, P36, DOI 10.1002/eji.200838620; Driessche KV, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/781320; Friedman A, 2008, EXP GERONTOL, V43, P275, DOI 10.1016/j.exger.2007.12.004; Harari A, 2005, J IMMUNOL, V174, P1037, DOI 10.4049/jimmunol.174.2.1037; Horvath CN, 2012, MUCOSAL IMMUNOL, V5, P420, DOI 10.1038/mi.2012.19; Hussey GD, 2002, IMMUNOLOGY, V105, P314, DOI 10.1046/j.1365-2567.2002.01366.x; Jeyanathan M, 2013, MUCOSAL IMMUNOL, V6, P612, DOI 10.1038/mi.2012.103; Jeyanathan M, 2010, TRENDS IMMUNOL, V31, P247, DOI 10.1016/j.it.2010.05.002; Kagina BMN, 2010, AM J RESP CRIT CARE, V182, P1073, DOI 10.1164/rccm.201003-0334OC; Kagina BMN, 2009, VACCINE, V27, P5488, DOI 10.1016/j.vaccine.2009.06.103; Kaveh DA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021566; Levy O, 2007, NAT REV IMMUNOL, V7, P379, DOI 10.1038/nri2075; LIEBERMAN JM, 1995, J PEDIATR-US, V126, P198, DOI 10.1016/S0022-3476(95)70545-7; Lutwama F, 2014, J INFECT DIS, V209, P887, DOI 10.1093/infdis/jit570; Majlessi L, 2006, INFECT IMMUN, V74, P2128, DOI 10.1128/IAI.74.4.2128-2137.2006; Marchant A, 1999, J IMMUNOL, V163, P2249; Mittrucker HW, 2007, P NATL ACAD SCI USA, V104, P12434, DOI 10.1073/pnas.0703510104; Moyo S, 2010, INT J TUBERC LUNG D, V14, P149; Nelson LJ, 2004, INT J TUBERC LUNG D, V8, P636; de Val BP, 2012, CLIN VACCINE IMMUNOL, V19, P1339, DOI 10.1128/CVI.00275-12; PrabhuDas M, 2011, NAT IMMUNOL, V12, P189, DOI 10.1038/ni0311-189; Rahman MJ, 2009, VACCINE, V27, P4038, DOI 10.1016/j.vaccine.2009.04.027; Ritz N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037535; Roux X, 2011, EUR J IMMUNOL, V41, P2852, DOI 10.1002/eji.201041224; Sallusto F, 2004, ANNU REV IMMUNOL, V22, P745, DOI 10.1146/annurev.immunol.22.012703.104702; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Santosuosso M, 2005, J IMMUNOL, V174, P7986, DOI 10.4049/jimmunol.174.12.7986; Santosuosso M, 2006, INFECT IMMUN, V74, P4634, DOI 10.1128/IAI.00517-06; Satti I, 2014, LANCET INFECT DIS, V14, P939, DOI 10.1016/S1473-3099(14)70845-X; Sharma SK, 2013, PEDIAT ALLER IMM PUL, V26, P4, DOI 10.1089/ped.2012.0181; Shey MS, 2014, J IMMUNOL, V192, P4833, DOI 10.4049/jimmunol.1400062; Siegrist C A, 2000, Int Rev Immunol, V19, P195, DOI 10.3109/08830180009088505; Siegrist CA, 2001, VACCINE, V19, P3331, DOI 10.1016/S0264-410X(01)00028-7; Smaill F, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006843; Soares AP, 2008, J IMMUNOL, V180, P3569, DOI 10.4049/jimmunol.180.5.3569; Vekemans J, 2001, EUR J IMMUNOL, V31, P1531, DOI 10.1002/1521-4141(200105)31:5<1531::AID-IMMU1531>3.0.CO;2-1; Vekemans J, 2002, CLIN EXP IMMUNOL, V127, P495, DOI 10.1046/j.1365-2249.2002.01788.x; Vordermeier HM, 2006, INFECT IMMUN, V74, P1416, DOI 10.1128/IAI.74.2.1416-1418.2006; Wang J, 2004, J IMMUNOL, V173, P6357, DOI 10.4049/jimmunol.173.10.6357; WHO, 2013, GLOB TUB REP 2013, V18; World Health Organization, 2004, Weekly Epidemiological Record, V79, P27; Xing Z, 2007, EXPERT REV VACCINES, V6, P539, DOI 10.1586/14760584.6.4.539; Xing Z, 2014, CHEST, V146, P804, DOI 10.1378/chest.14-0439; Xing Z, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005856; Zaghouani H, 2009, TRENDS IMMUNOL, V30, P585, DOI 10.1016/j.it.2009.09.002; Zwerling A, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001012	53	3	3	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2015	10	6							e0131175	10.1371/journal.pone.0131175	http://dx.doi.org/10.1371/journal.pone.0131175			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL3FM	26098423	Green Published, gold, Green Submitted			2022-12-26	WOS:000356835800155
J	Duivenvoorde, LPM; van Schothorst, EM; Swarts, HM; Kuda, O; Steenbergh, E; Termeulen, S; Kopecky, J; Keijer, J				Duivenvoorde, Loes P. M.; van Schothorst, Evert M.; Swarts, Hans M.; Kuda, Ondrej; Steenbergh, Esther; Termeulen, Sander; Kopecky, Jan; Keijer, Jaap			A Difference in Fatty Acid Composition of Isocaloric High-Fat Diets Alters Metabolic Flexibility in Male C57BL/6JOlaHsd Mice	PLOS ONE			English	Article							OBESE-DIABETIC MICE; INSULIN-RESISTANCE; ADIPOSE-TISSUE; ENERGY-EXPENDITURE; MITOCHONDRIAL-FUNCTION; INDIRECT CALORIMETRY; CHRONIC DISEASES; BODY-WEIGHT; FISH-OIL; N-3	Poly-unsaturated fatty acids (PUFAs) are considered to be healthier than saturated fatty acids (SFAs), but others postulate that especially the ratio of omega-6 to omega-3 PUFAs (n6/n3 ratio) determines health. Health can be determined with biomarkers, but functional health status is likely better reflected by challenge tests that assess metabolic flexibility. The aim of this study was to determine the effect of high-fat diets with different fatty acid compositions, but similar n6/n3 ratio, on metabolic flexibility. Therefore, adult male mice received isocaloric high-fat diets with either predominantly PUFAs (HFpu diet) or predominantly SFAs (HFs diet) but similar n6/n3 ratio for six months, during and after which several biomarkers for health were measured. Metabolic flexibility was assessed by the response to an oral glucose tolerance test, a fasting and re-feeding test and an oxygen restriction test (OxR; normobaric hypoxia). The latter two are non-invasive, indirect calorimetry-based tests that measure the adaptive capacity of the body as a whole. We found that the HFs diet, compared to the HFpu diet, increased mean adipocyte size, liver damage, and ectopic lipid storage in liver and muscle; although, we did not find differences in body weight, total adiposity, adipose tissue health, serum adipokines, whole body energy balance, or circadian rhythm between HFs and HFpu mice. HFs mice were, furthermore, less flexible in their response to both fasting-re-feeding and OxR, while glucose tolerance was indistinguishable. To conclude, the HFs versus the HFpu diet increased ectopic fat storage, liver damage, and mean adipocyte size and reduced metabolic flexibility in male mice. This study underscores the physiological relevance of indirect calorimetry-based challenge tests.	[Duivenvoorde, Loes P. M.; van Schothorst, Evert M.; Swarts, Hans M.; Steenbergh, Esther; Termeulen, Sander; Keijer, Jaap] Wageningen Univ, Human & Anim Physiol, NL-6700 AP Wageningen, Netherlands; [Kuda, Ondrej; Kopecky, Jan] Acad Sci Czech Republic, Inst Physiol, Dept Adipose Tissue Biol, Vvi, Prague, Czech Republic	Wageningen University & Research; Czech Academy of Sciences; Institute of Physiology of the Czech Academy of Sciences	Keijer, J (corresponding author), Wageningen Univ, Human & Anim Physiol, NL-6700 AP Wageningen, Netherlands.	jaap.keijer@wur.nl	Kopecky, Jan/B-8244-2012; Kuda, Ondrej/B-7990-2012; Biguzzi, Felipe A/E-4724-2015; Keijer, Jaap/J-8089-2013	Kopecky, Jan/0000-0001-8072-2035; Kuda, Ondrej/0000-0001-7034-4536; van Schothorst, Evert/0000-0002-3036-5903; Keijer, Jaap/0000-0002-9720-7491	European Union [244995]	European Union(European Commission)	This work was supported by the European Union's Seventh Framework Program FP7 2007-2013 under grant agreement no. 244995 (BIOCLAIMS Project). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARCELLI UO, 1988, LIPIDS, V23, P309, DOI 10.1007/BF02537339; Berthiaume N, 2002, METABOLISM, V51, P595, DOI 10.1053/meta.2002.31989; BLACK AE, 1986, HUM NUTR-CLIN NUTR, V40C, P381; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bray GA, 1998, AM J CLIN NUTR, V68, P1157, DOI 10.1093/ajcn/68.6.1157; Buettner R, 2006, J MOL ENDOCRINOL, V36, P485, DOI 10.1677/jme.1.01909; Cinti S, 2005, J LIPID RES, V46, P2347, DOI 10.1194/jlr.M500294-JLR200; Cintra DEC, 2006, NUTRITION, V22, P197, DOI 10.1016/j.nut.2005.09.003; COLLIER G, 1983, AM J CLIN NUTR, V37, P941, DOI 10.1093/ajcn/37.6.941; Constantinides Christakis, 2011, ILAR J, V52, pe21; DeLany JP, 2000, AM J CLIN NUTR, V72, P905; Desaulniers D, 2011, INT J TOXICOL, V30, P334, DOI 10.1177/1091581810397774; Djousse L, 2001, AM J CLIN NUTR, V74, P612; Donnelly KL, 2005, J CLIN INVEST, V115, P1343, DOI 10.1172/JCI200523621; Du CY, 2003, BIOL PHARM BULL, V26, P766, DOI 10.1248/bpb.26.766; Duivenvoorde LPM, 2015, PFLUG ARCH EUR J PHY, V467, P1179, DOI 10.1007/s00424-014-1553-8; Duivenvoorde LPM, 2015, J GERONTOL A-BIOL, V70, P282, DOI 10.1093/gerona/glu027; Eissing L, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2537; Ejsing CS, 2006, ANAL CHEM, V78, P6202, DOI 10.1021/ac060545x; El Akoum S, 2011, DIABETOL METAB SYNDR, V3, DOI 10.1186/1758-5996-3-34; El-Badry AM, 2007, J HEPATOL, V47, P718, DOI 10.1016/j.jhep.2007.08.005; Ellenbroek D, 2015, J SPINAL CORD MED, V38, P468, DOI 10.1179/2045772314Y.0000000199; Enos RT, 2013, J LIPID RES, V54, P152, DOI 10.1194/jlr.M030700; Fiorini RN, 2004, CLIN TRANSPLANT, V18, P700, DOI 10.1111/j.1399-0012.2004.00282.x; Flachs P, 2014, PHYSIOL RES, V63, pS93, DOI 10.33549/physiolres.932715; Flachs P, 2011, DIABETOLOGIA, V54, P2626, DOI 10.1007/s00125-011-2233-2; Gaiva MH, 2003, NUTRITION, V19, P144, DOI 10.1016/S0899-9007(02)00909-7; Galgani JE, 2008, AM J PHYSIOL-ENDOC M, V295, pE1009, DOI 10.1152/ajpendo.90558.2008; GERICH JE, 1990, DIABETES, V39, P211, DOI 10.2337/diabetes.39.2.211; Guilherme A, 2008, NAT REV MOL CELL BIO, V9, P367, DOI 10.1038/nrm2391; Heilbronn L, 2004, INT J OBESITY, V28, pS12, DOI 10.1038/sj.ijo.0802853; Hoek-van den Hil EF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0051588; Hoek-van den Hil EF, 2012, ANAL BIOANAL CHEM, V402, P1389, DOI 10.1007/s00216-011-5563-5; Hoevenaars FPM, 2014, GENES NUTR, V9, DOI 10.1007/s12263-014-0391-9; Hoevenaars FPM, 2014, MOL NUTR FOOD RES, V58, P799, DOI 10.1002/mnfr.201300285; Hoevenaars FPM, 2013, EXP PHYSIOL, V98, P1053, DOI 10.1113/expphysiol.2012.069518; Hoevenaars FPM, 2012, GENES NUTR, V7, P399, DOI 10.1007/s12263-011-0262-6; Horakova O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043764; Huber J, 2007, INT J OBESITY, V31, P1004, DOI 10.1038/sj.ijo.0803511; James MJ, 2000, AM J CLIN NUTR, V71, p343S, DOI 10.1093/ajcn/71.1.343s; JONES PJH, 1985, AM J CLIN NUTR, V42, P769, DOI 10.1093/ajcn/42.5.769; Kennedy A, 2009, J NUTR, V139, P1, DOI 10.3945/jn.108.098269; Koves TR, 2008, CELL METAB, V7, P45, DOI 10.1016/j.cmet.2007.10.013; Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013; Lee JY, 2010, NUTR REV, V68, P38, DOI 10.1111/j.1753-4887.2009.00259.x; Lee JS, 2006, J APPL PHYSIOL, V100, P1467, DOI 10.1152/japplphysiol.01438.2005; LIVESEY G, 1988, AM J CLIN NUTR, V47, P608, DOI 10.1093/ajcn/47.4.608; Monetti M, 2007, CELL METAB, V6, P69, DOI 10.1016/j.cmet.2007.05.005; Montell E, 2001, AM J PHYSIOL-ENDOC M, V280, pE229, DOI 10.1152/ajpendo.2001.280.2.E229; Nagao K, 2010, PHARMACOL RES, V61, P208, DOI 10.1016/j.phrs.2009.11.007; Naggert J, 2015, MPD NAGGERT1; National Research Council, 1995, NUTR REQ LAB AN, V4 th ed.; Nuernberg K, 2011, NUTR METAB, V8, DOI 10.1186/1743-7075-8-56; Peronnet F., 1991, CANAD J SPORT SCI, V9, P16; Radulescu A, 2009, J AM COLL NUTR, V28, P286, DOI 10.1080/07315724.2009.10719783; Riediger ND, 2008, EUR J NUTR, V47, P153, DOI 10.1007/s00394-008-0709-8; SALANS LB, 1968, J CLIN INVEST, V47, P153, DOI 10.1172/JCI105705; SCHNEIDER BS, 1981, AM J PHYSIOL, V240, pE358, DOI 10.1152/ajpendo.1981.240.4.E358; Sherman H, 2012, FASEB J, V26, P3493, DOI 10.1096/fj.12-208868; Shulman GI, 2000, J CLIN INVEST, V106, P171, DOI 10.1172/JCI10583; Simopoulos AP, 2008, EXP BIOL MED, V233, P674, DOI 10.3181/0711-MR-311; St-Onge MP, 2003, OBES RES, V11, P395, DOI 10.1038/oby.2003.53; Storlien L, 2004, P NUTR SOC, V63, P363, DOI 10.1079/PNS2004349; Tiret L, 2000, EUR J CLIN INVEST, V30, P578; Todoric J, 2006, DIABETOLOGIA, V49, P2109, DOI 10.1007/s00125-006-0300-x; Tsukumo DML, 2007, DIABETES, V56, P1986, DOI 10.2337/db06-1595; U.S. Department of Agriculture ARS, 2013, SDA NATIONAL NUTRIEN; Unger RH, 2001, FASEB J, V15, P312, DOI 10.1096/fj.00-0590; van Ommen B, 2009, MOL NUTR FOOD RES, V53, P795, DOI 10.1002/mnfr.200800390; Voigt A, 2013, MOL NUTR FOOD RES, V57, P1423, DOI 10.1002/mnfr.201200671; Wang S, 2009, ATHEROSCLEROSIS, V204, P147, DOI 10.1016/j.atherosclerosis.2008.08.024; Wein S, 2009, DIABETES-METAB RES, V25, P185, DOI 10.1002/dmrr.925; Weyer C, 2000, DIABETOLOGIA, V43, P1498, DOI 10.1007/s001250051560; Wijendran V, 2004, ANNU REV NUTR, V24, P597, DOI 10.1146/annurev.nutr.24.012003.132106; Yamashita T, 2005, THROMB RES, V116, P393, DOI 10.1016/j.thromres.2005.01.011; Yin HY, 2009, FREE RADICAL BIO MED, V47, P622, DOI 10.1016/j.freeradbiomed.2009.05.033	76	22	23	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2015	10	6							e0128515	10.1371/journal.pone.0128515	http://dx.doi.org/10.1371/journal.pone.0128515			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL3FM	26098756	Green Published, Green Submitted, gold			2022-12-26	WOS:000356835800016
J	Koni, P; Chishinga, N; Nyirenda, L; Kasonde, P; Nsakanya, R; Welsh, M				Koni, Phillip; Chishinga, Nathaniel; Nyirenda, Lameck; Kasonde, Prisca; Nsakanya, Richard; Welsh, Michael			Health Facility Graduation from Donor-Supported Intensive Technical Assistance and Associated Factors in Zambia	PLOS ONE			English	Article							PROGRAMS; SERVICES	Introduction The FHI360-led Zambia Prevention Care and Treatment partnership II (ZPCT II) with funding from United States Agency for International Development, supports the Zambian Ministry of Health in scaling up HIV/AIDS services. To improve the quality of HIV/AIDS services, ZPCT II provides technical assistance until desired standards are met and districts are weaned-off intensive technical support, a process referred to as district graduation. This study describes the graduation process and determines performance domains associated with district graduation. Methods Data were collected from 275 health facilities in 39 districts in 5 provinces of Zambia between 2008 and 2012. Performance in technical capacity, commodity management, data management and human resources domains were assessed in the following services areas: HIV counselling and testing and prevention of mother to child transmission, antiretroviral therapy/clinical care, pharmacy and laboratory. The overall mean percentage score was calculated by obtaining the mean of mean percentage scores for the four domains. Logistic regression models were used to obtain odds ratios (OR) and 95% confidence intervals (CI) for the domain mean percentage scores in graduated versus non-graduated districts; according to rural-urban, and province strata. Results 24 districts out of 39 graduated from intensive donor supported technical assistance while 15 districts did not graduate. The overall mean percentage score for all four domains was statistically significantly higher in graduated than non-graduated districts (93.2% versus 91.2%, OR = 1.34, 95% CI: 1.20-1.49); including rural settings (92.4% versus 89.4%, OR = 1.43,95% CI: 1.24-1.65). The mean percentage score in human resource domain was statistically significantly higher in graduated than non-graduated districts (93.6% versus 71.6%, OR = 5.81, 95% CI: 4.29-7.86) and in both rural and urban settings. Conclusions QA/QI tools can be used to assess performance at health facilities and determine readiness for district graduation. Human resources management domain was found to be an important factor associated with district graduation.	[Koni, Phillip; Chishinga, Nathaniel; Nyirenda, Lameck; Kasonde, Prisca; Welsh, Michael] FHI 360, Lusaka, Zambia; [Nsakanya, Richard] Cardno, Lusaka, Zambia		Koni, P (corresponding author), FHI 360, POB 320303, Lusaka, Zambia.	pkoni@fhi360.org			Cardno	Cardno	Co-author Dr. Richard Nsakanya worked for Cardno during the course of the study. Cardno provided support in the form of salary for author RN, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author are articulated in the 'author contributions' section.	Health ZMo, 2011, NAT HLTH STRAT PLAN; LaPelle NR, 2006, AM J PUBLIC HEALTH, V96, P1363, DOI 10.2105/AJPH.2005.067124; Mutale W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058650; Nalwadda G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027908; Torpey K, 2010, J INT AIDS SOC, V13, DOI 10.1186/1758-2652-13-19; USAID, 1988, SUST DEV PROGR COMP; Vermund SH, 2012, AIDS, V26, P1303, DOI 10.1097/QAD.0b013e3283552185; World Bank, 2007, WORLD BANK COUNTRY, P1, DOI 10.1596/978-0-8213-7102-2; World Health Organisation, 2007, WHO STRENGTH HLTH SE; World Health Organization, 2009, SYSTEMS THINKING HLT; World Health Organization, 2008, UN ACC SCAL PRIOR HI; Zambia Prevention Care and Treatment Partnership, 2008, QUAL ASS QUAL IMPR P	12	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2015	10	6							e0131084	10.1371/journal.pone.0131084	http://dx.doi.org/10.1371/journal.pone.0131084			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL3FM	26098555	Green Published, gold, Green Submitted			2022-12-26	WOS:000356835800145
J	Nandi, SK; Panda, AK; Chakraborty, A; Ray, SS; Biswas, A				Nandi, Sandip Kumar; Panda, Alok Kumar; Chakraborty, Ayon; Ray, Sougata Sinha; Biswas, Ashis			Role of Subunit Exchange and Electrostatic Interactions on the Chaperone Activity of Mycobacterium leprae HSP18	PLOS ONE			English	Article							HEAT-SHOCK PROTEINS; ALPHA-A-CRYSTALLIN; METHANOCOCCUS-JANNASCHII; MOLECULAR CHAPERONES; ACQUIRED THERMOTOLERANCE; CONSERVED DOMAIN; B-CRYSTALLIN; TEMPERATURE; SUBSTRATE; STABILITY	Mycobacterium leprae HSP18, a major immunodominant antigen of M. leprae pathogen, is a small heat shock protein. Previously, we reported that HSP18 is a molecular chaperone that prevents aggregation of different chemically and thermally stressed client proteins and assists refolding of denatured enzyme at normal temperature. We also demonstrated that it can efficiently prevent the thermal killing of E. coli at higher temperature. However, molecular mechanism behind the chaperone function of HSP18 is still unclear. Therefore, we studied the structure and chaperone function of HSP18 at normal temperature (25 degrees C) as well as at higher temperatures (31-43 degrees C). Our study revealed that the chaperone function of HSP18 is enhanced significantly with increasing temperature. Far- and near-UV CD experiments suggested that its secondary and tertiary structure remain intact in this temperature range (25-43 degrees C). Besides, temperature has no effect on the static oligomeric size of this protein. Subunit exchange study demonstrated that subunits of HSP18 exchange at 25 degrees C with a rate constant of 0.018 min(-1). Both rate of subunit exchange and chaperone activity of HSP18 is found to increase with rise in temperature. However, the surface hydrophobicity of HSP18 decreases markedly upon heating and has no correlation with its chaperone function in this temperature range. Furthermore, we observed that HSP18 exhibits diminished chaperone function in the presence of NaCl at 25 degrees C. At elevated temperatures, weakening of interactions between HSP18 and stressed client proteins in the presence of NaCl results in greater reduction of its chaperone function. The oligomeric size, rate of subunit exchange and structural stability of HSP18 were also found to decrease when electrostatic interactions were weakened. These results clearly indicated that subunit exchange and electrostatic interactions play a major role in the chaperone function of HSP18.	[Nandi, Sandip Kumar; Panda, Alok Kumar; Chakraborty, Ayon; Biswas, Ashis] Indian Inst Technol Bhubaneswar, Sch Basic Sci, Bhubaneswar, Orissa, India; [Ray, Sougata Sinha] Wipro GE Healthcare, Kolkata, India	Indian Institute of Technology System (IIT System); Indian Institute of Technology Bhubaneswar; General Electric	Biswas, A (corresponding author), Indian Inst Technol Bhubaneswar, Sch Basic Sci, Bhubaneswar, Orissa, India.	abiswas@iitbbs.ac.in	NANDI, SANDIP/AAG-3040-2019; PANDA, ALOK/G-6818-2015	NANDI, SANDIP/0000-0003-0304-4255; PANDA, ALOK/0000-0002-4452-993X; Chakraborty, Ayon/0000-0002-1155-7862	Council of Scientific and Industrial Research, India [37(1535)/12/EMR-II]; Indian Institute of Technology Bhubaneswar; ICMR, India [45/25/2012-Bio/BMS]	Council of Scientific and Industrial Research, India(Council of Scientific & Industrial Research (CSIR) - India); Indian Institute of Technology Bhubaneswar; ICMR, India(Indian Council of Medical Research (ICMR))	This work was supported by the Council of Scientific and Industrial Research, India grant 37(1535)/12/EMR-II. S.K.N. and A.C. acknowledge the receipt of an Institute Fellowship from Indian Institute of Technology Bhubaneswar. A.K.P. acknowledges ICMR, India (no. 45/25/2012-Bio/BMS) for providing a fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banerjee V, 2013, COLLOID SURFACE B, V111, P71, DOI 10.1016/j.colsurfb.2013.04.052; Banerjee V, 2012, COLLOID SURFACE B, V92, P142, DOI 10.1016/j.colsurfb.2011.11.036; Berengian AR, 1997, BIOCHEMISTRY-US, V36, P9951, DOI 10.1021/bi9712347; Berengian AR, 1999, J BIOL CHEM, V274, P6305, DOI 10.1074/jbc.274.10.6305; Biswas A, 2004, J BIOL CHEM, V279, P42648, DOI 10.1074/jbc.M404444200; Biswas A, 2007, BIOPOLYMERS, V85, P189, DOI 10.1002/bip.20630; Biswas A, 2007, BIOCHEMISTRY-US, V46, P1117, DOI 10.1021/bi061323w; BOOTH RJ, 1993, INFECT IMMUN, V61, P1509, DOI 10.1128/IAI.61.4.1509-1515.1993; Boston RS, 1996, PLANT MOL BIOL, V32, P191, DOI 10.1007/BF00039383; Bova MP, 2000, J BIOL CHEM, V275, P1035, DOI 10.1074/jbc.275.2.1035; Bova MP, 2002, J BIOL CHEM, V277, P38468, DOI 10.1074/jbc.M205594200; Bova MP, 1997, J BIOL CHEM, V272, P29511, DOI 10.1074/jbc.272.47.29511; Bruylants G, 2005, CURR MED CHEM, V12, P2011, DOI 10.2174/0929867054546564; Chebotareva NA, 2009, DOKL BIOCHEM BIOPHYS, V428, P245, DOI 10.1134/S1607672909050068; Chowdary TK, 2004, BIOCHEM J, V381, P379, DOI 10.1042/BJ20031958; Cole ST, 2001, NATURE, V409, P1007, DOI 10.1038/35059006; Cosma CL, 2003, ANNU REV MICROBIOL, V57, P641, DOI 10.1146/annurev.micro.57.030502.091033; Cunningham AF, 1998, J BACTERIOL, V180, P801, DOI 10.1128/JB.180.4.801-808.1998; DAS KP, 1995, FEBS LETT, V369, P321, DOI 10.1016/0014-5793(95)00775-5; del Valle LJ, 2002, BBA-PROTEINS PROTEOM, V1601, P100, DOI 10.1016/S1570-9639(02)00429-6; DELLAGOSTIN OA, 1995, MICROBIOL-UK, V141, P1785, DOI 10.1099/13500872-141-8-1785; Fu XM, 2004, BIOCHEM BIOPH RES CO, V316, P291, DOI 10.1016/j.bbrc.2004.02.053; GETHING MJ, 1992, NATURE, V355, P33, DOI 10.1038/355033a0; Hartl FU, 1996, NATURE, V381, P571, DOI 10.1038/381571a0; Haslbeck M, 1999, EMBO J, V18, P6744, DOI 10.1093/emboj/18.23.6744; Kauzmann W., 1969, ADV PROTEIN CHEM, V14, P1; Khalili-Hezarjaribi H, 2012, PROTEIN PEPTIDE LETT, V19, P450, DOI 10.2174/092986612799789396; Kim DR, 2003, BIOCHEM BIOPH RES CO, V307, P991, DOI 10.1016/S0006-291X(03)01302-0; Kim KK, 1998, J STRUCT BIOL, V121, P76, DOI 10.1006/jsbi.1998.3969; Kotak S, 2007, CURR OPIN PLANT BIOL, V10, P310, DOI 10.1016/j.pbi.2007.04.011; Koteiche HA, 1998, BIOCHEMISTRY-US, V37, P12681, DOI 10.1021/bi9814078; Kregel KC, 2002, J APPL PHYSIOL, V92, P2177, DOI 10.1152/japplphysiol.01267.2001; Kundu M, 2007, BIOPOLYMERS, V86, P177, DOI 10.1002/bip.20716; Lee GJ, 1997, EMBO J, V16, P659, DOI 10.1093/emboj/16.3.659; Lelj-Garolla B, 2006, J BIOL CHEM, V281, P8169, DOI 10.1074/jbc.M512553200; Lini N, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-208; Maheshwari JJ, 2013, J MED MICROBIOL, V62, P959, DOI 10.1099/jmm.0.057851-0; Mao Q, 2001, BIOCHEMISTRY-MOSCOW+, V66, P904, DOI 10.1023/A:1011960904542; MARKY LA, 1987, BIOPOLYMERS, V26, P1601, DOI 10.1002/bip.360260911; MATTHEW JB, 1985, ANNU REV BIOPHYS BIO, V14, P387; MEHRA V, 1992, J EXP MED, V175, P275, DOI 10.1084/jem.175.1.275; Nagaraj RH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030257; Nahomi RB, 2013, BIOCHEMISTRY-US, V52, P8126, DOI 10.1021/bi400638s; Nakamura H, 1996, Q REV BIOPHYS, V29, P1, DOI 10.1017/S0033583500005746; Nandi SK, 2013, FEBS J, V280, P5994, DOI 10.1111/febs.12519; Nandi SK, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003661; PESSOLANI MCV, 1994, J EXP MED, V180, P319, DOI 10.1084/jem.180.1.319; Petsko GA, 2001, METHOD ENZYMOL, V334, P469; PLESOFSKYVIG N, 1992, J MOL EVOL, V35, P537, DOI 10.1007/BF00160214; Reddy GB, 2000, J BIOL CHEM, V275, P4565, DOI 10.1074/jbc.275.7.4565; RITOSSA F, 1962, EXPERIENTIA, V18, P571, DOI 10.1007/BF02172188; SCHLESINGER MJ, 1990, J BIOL CHEM, V265, P12111; Sharma KK, 2009, BBA-GEN SUBJECTS, V1790, P1095, DOI 10.1016/j.bbagen.2009.05.008; Singh I, 2012, CELL IMMUNOL, V278, P63, DOI 10.1016/j.cellimm.2012.06.011; Smykal P, 2000, PLANT J, V23, P703, DOI 10.1046/j.1365-313x.2000.00837.x; Stromer T, 2004, J BIOL CHEM, V279, P11222, DOI 10.1074/jbc.M310149200; Szilagyi A, 2000, STRUCTURE, V8, P493, DOI 10.1016/S0969-2126(00)00133-7; Tiroli-Cepeda AO, 2010, PLANT PHYSIOL BIOCH, V48, P108, DOI 10.1016/j.plaphy.2010.01.001; Trent JD, 1996, FEMS MICROBIOL REV, V18, P249; van Montfort RLM, 2001, NAT STRUCT BIOL, V8, P1025, DOI 10.1038/nsb722; VEGALOPEZ F, 1988, J CLIN MICROBIOL, V26, P2474, DOI 10.1128/JCM.26.12.2474-2479.1988; WATERS ER, 1995, GENETICS, V141, P785	62	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2015	10	6							e0129734	10.1371/journal.pone.0129734	http://dx.doi.org/10.1371/journal.pone.0129734			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL3FM	26098662	gold, Green Published, Green Submitted			2022-12-26	WOS:000356835800037
J	Parolin, C; Marangoni, A; Laghi, L; Foschi, C; Palomino, RAN; Calonghi, N; Cevenini, R; Vitali, B				Parolin, Carola; Marangoni, Antonella; Laghi, Luca; Foschi, Claudio; Palomino, Rogers Alberto Nahui; Calonghi, Natalia; Cevenini, Roberto; Vitali, Beatrice			Isolation of Vaginal Lactobacilli and Characterization of Anti-Candida Activity	PLOS ONE			English	Article							HISTONE DEACETYLASE INHIBITORS; CANDIDA-ALBICANS; WOMEN; IDENTIFICATION; MICROBIOTA; INERS; MICROFLORA; RECURRENCE; PROBIOTICS; VAGINOSIS	Healthy vaginal microbiota is dominated by Lactobacillus spp., which form a critical line of defence against pathogens, including Candida spp. The present study aims to identify vaginal lactobacilli exerting in vitro activity against Candida spp. and to characterize their antifungal mechanisms of action. Lactobacillus strains were isolated from vaginal swabs of healthy premenopausal women. The isolates were taxonomically identified to species level (L. crispatus B1-BC8, L. gasseri BC9-BC14 and L. vaginalis BC15-BC17) by sequencing the 16S rRNA genes. All strains produced hydrogen peroxide and lactate. Fungistatic and fungicidal activities against C. albicans, C. glabrata, C. krusei, C. tropicalis, C. parapsilosis and C. lusitaniae were evaluated by broth micro-dilution method. The broadest spectrum of activity was observed for L. crispatus BC1, BC4, BC5 and L. vaginalis BC15, demonstrating fungicidal activity against all isolates of C. albicans and C. lusitaniae. Metabolic profiles of lactobacilli supernatants were studied by H-1-NMR analysis. Metabolome was found to be correlated with both taxonomy and activity score. Exclusion, competition and displacement experiments were carried out to investigate the interference exerted by lactobacilli toward the yeast adhesion to HeLa cells. Most Lactobacillus strains significantly reduced C. albicans adhesion through all mechanisms. In particular, L. crispatus BC2, L. gasseri BC10 and L. gasseri BC11 appeared to be the most active strains in reducing pathogen adhesion, as their effects were mediated by both cells and supernatants. Inhibition of histone deacetylases was hypothesised to support the antifungal activity of vaginal lactobacilli. Our results are prerequisites for the development of new therapeutic agents based on probiotics for prophylaxis and adjuvant therapy of Candida infection.	[Parolin, Carola; Palomino, Rogers Alberto Nahui; Calonghi, Natalia; Vitali, Beatrice] Univ Bologna, Dept Pharm & Biotechnol, Bologna, Italy; [Marangoni, Antonella; Foschi, Claudio; Cevenini, Roberto] Univ Bologna, Microbiol, DIMES, Bologna, Italy; [Laghi, Luca] Univ Bologna, Dept Agrofood Sci & Technol, Ctr Food, Bologna, Italy	University of Bologna; University of Bologna; University of Bologna	Vitali, B (corresponding author), Univ Bologna, Dept Pharm & Biotechnol, Bologna, Italy.	b.vitali@unibo.it	Foschi, Claudio/A-7299-2016; Laghi, Luca/R-5278-2016; parolin, carola/C-1144-2013	Foschi, Claudio/0000-0001-7253-8799; Laghi, Luca/0000-0003-1593-7376; parolin, carola/0000-0003-1536-9276; Marangoni, Antonella/0000-0002-7397-6560; NAHUI PALOMINO, Rogers Alberto/0000-0003-4923-2120	Ministry of Instruction, University and Research, Italy	Ministry of Instruction, University and Research, Italy	RC and BV received founding from the Ministry of Instruction, University and Research, Italy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramov V, 2014, PROBIOTICS ANTIMICRO, V6, P165, DOI 10.1007/s12602-014-9164-4; Antonio MAD, 1999, J INFECT DIS, V180, P1950, DOI 10.1086/315109; Aroutcheva A, 2001, AM J OBSTET GYNECOL, V185, P375, DOI 10.1067/mob.2001.115867; Babula O, 2005, CLIN INFECT DIS, V40, P1258, DOI 10.1086/429246; Bisanz JE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104511; Borges S, 2014, ARCH GYNECOL OBSTET, V289, P479, DOI 10.1007/s00404-013-3064-9; Burton JP, 2003, APPL ENVIRON MICROB, V69, P97, DOI 10.1128/AEM.69.1.97-101.2003; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Coste A, 2007, EUKARYOT CELL, V6, P1889, DOI 10.1128/EC.00151-07; Cotch MF, 1998, AM J OBSTET GYNECOL, V178, P374, DOI 10.1016/S0002-9378(98)80028-8; De Seta F, 2014, EUR J OBSTET GYN R B, V182, P136, DOI 10.1016/j.ejogrb.2014.09.018; Donders GGG, 2010, GYNECOL OBSTET INVES, V70, P264, DOI 10.1159/000314016; Donnarumma G, 2014, BMC MICROBIOL, V14, DOI 10.1186/1471-2180-14-137; Falagas ME, 2006, J ANTIMICROB CHEMOTH, V58, P266, DOI 10.1093/jac/dkl246; Falsen E, 1999, INT J SYST BACTERIOL, V49, P217, DOI 10.1099/00207713-49-1-217; Food and Agriculture Organization of the United nations/World Health Organization (FAO/WHO), 2006, 85 FAOWHO; Giraudeau P, 2015, METABOLOMICS, V11, P1041, DOI 10.1007/s11306-015-0794-7; Hnisz D, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000889; Hyman RW, 2005, P NATL ACAD SCI USA, V102, P7952, DOI 10.1073/pnas.0503236102; Kaewsrichan J, 2006, FEMS IMMUNOL MED MIC, V48, P75, DOI 10.1111/j.1574-695X.2006.00124.x; Knapp AR, 2007, METHODS, V41, P312, DOI 10.1016/j.ymeth.2006.08.017; Kohler Gerwald A, 2012, Infect Dis Obstet Gynecol, V2012, P636474, DOI 10.1155/2012/636474; Laghi L, 2014, ANTIMICROB AGENTS CH, V58, P3411, DOI 10.1128/AAC.02469-14; Lane D.J., 1991, NUCL ACID TECH BACT, P115, DOI DOI 10.1007/S00227-012-2133-0; Latham T, 2012, NUCLEIC ACIDS RES, V40, P4794, DOI 10.1093/nar/gks066; Liu W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103442; Nguyen LN, 2011, J ANTIMICROB CHEMOTH, V66, P2573, DOI 10.1093/jac/dkr358; Macklaim JM, 2013, MICROBIOME, V1, DOI 10.1186/2049-2618-1-12; Mastromarino P, 2002, J APPL MICROBIOL, V93, P884, DOI 10.1046/j.1365-2672.2002.01759.x; Osset J, 2001, J INFECT DIS, V183, P485, DOI 10.1086/318070; Pendharkar S, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-43; Rathod SD, 2014, BMC WOMENS HEALTH, V14, DOI 10.1186/1472-6874-14-43; Ravel J, 2011, P NATL ACAD SCI USA, V108, P4680, DOI 10.1073/pnas.1002611107; Reid G, 2001, FEMS IMMUNOL MED MIC, V32, P37, DOI 10.1111/j.1574-695X.2001.tb00531.x; Reid G, 2011, NAT REV MICROBIOL, V9, P27, DOI 10.1038/nrmicro2473; Rizzo A, 2013, IMMUNOL LETT, V156, P102, DOI 10.1016/j.imlet.2013.08.013; Simonetti G, 2007, FEMS YEAST RES, V7, P1371, DOI 10.1111/j.1567-1364.2007.00276.x; Smith WL, 2002, ANTIMICROB AGENTS CH, V46, P3532, DOI 10.1128/AAC.46.11.3532-3539.2002; Sobel JD, 2007, LANCET, V369, P1961, DOI 10.1016/S0140-6736(07)60917-9; Sobel JD, 1997, NEW ENGL J MED, V337, P1896, DOI 10.1056/NEJM199712253372607; van de Wijgert JHHM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105998; Verdenelli MC, 2014, J APPL MICROBIOL, V116, P1297, DOI 10.1111/jam.12459; Verstraelen H, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-116; Vitali B, 2007, APPL ENVIRON MICROB, V73, P5731, DOI 10.1128/AEM.01251-07; Walter J, 2001, APPL ENVIRON MICROB, V67, P2578, DOI 10.1128/AEM.67.6.2578-2585.2001; Workowski Kimberly A, 2010, MMWR Recomm Rep, V59, P1; Wurtele H, 2010, NAT MED, V16, P774, DOI 10.1038/nm.2175	47	128	137	2	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2015	10	6							e0131220	10.1371/journal.pone.0131220	http://dx.doi.org/10.1371/journal.pone.0131220			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL3FM	26098675	Green Published, gold			2022-12-26	WOS:000356835800158
J	Pena-Oliver, Y; Giuliano, C; Economidou, D; Goodlett, CR; Robbins, TW; Dalley, JW; Everitt, BJ				Pena-Oliver, Yolanda; Giuliano, Chiara; Economidou, Daina; Goodlett, Charles R.; Robbins, Trevor W.; Dalley, Jeffrey W.; Everitt, Barry J.			Alcohol-Preferring Rats Show Goal Oriented Behaviour to Food Incentives but Are Neither Sign-Trackers Nor Impulsive	PLOS ONE			English	Article							HIGH-RISK; P RAT; CONSUMPTION; DRINKING; ETHANOL; PREDICTS; SEEKING; CHOICE; LINES; TASK	Drug addiction is often associated with impulsivity and altered behavioural responses to both primary and conditioned rewards. Here we investigated whether selectively bred alcohol-preferring (P) and alcohol-nonpreferring (NP) rats show differential levels of impulsivity and conditioned behavioural responses to food incentives. P and NP rats were assessed for impulsivity in the 5-choice serial reaction time task (5-CSRTT), a widely used translational task in humans and other animals, as well as Pavlovian conditioned approach to measure sign-and goal-tracking behaviour. Drug-naive P and NP rats showed similar levels of impulsivity on the 5-CSRTT, assessed by the number of premature, anticipatory responses, even when the waiting interval to respond was increased. However, unlike NP rats, P rats were faster to enter the food magazine and spent more time in this area. In addition, P rats showed higher levels of goal-tracking responses than NP rats, as measured by the number of magazine nose-pokes during the presentation of a food conditioned stimulus. By contrast, NP showed higher levels of sign-tracking behaviour than P rats. Following a 4-week exposure to intermittent alcohol we confirmed that P rats had a marked preference for, and consumed more alcohol than, NP rats, but were not more impulsive when re-tested in the 5-CSRTT. These findings indicate that high alcohol preferring and drinking P rats are neither intrinsically impulsive nor do they exhibit impulsivity after exposure to alcohol. However, P rats do show increased goal-directed behaviour to food incentives and this may be associated with their strong preference for alcohol.	[Pena-Oliver, Yolanda; Giuliano, Chiara; Economidou, Daina; Robbins, Trevor W.; Dalley, Jeffrey W.; Everitt, Barry J.] Univ Cambridge, Dept Psychol, Cambridge, England; [Pena-Oliver, Yolanda; Giuliano, Chiara; Economidou, Daina; Robbins, Trevor W.; Dalley, Jeffrey W.; Everitt, Barry J.] Univ Cambridge, Behav & Clin Neurosci Inst, Cambridge, England; [Goodlett, Charles R.] Indiana Univ Purdue Univ, Dept Psychol, Indianapolis, IN 46205 USA; [Dalley, Jeffrey W.] Univ Cambridge, Addenbrookes Hosp, Dept Psychiat, Cambridge CB2 2QQ, England	University of Cambridge; University of Cambridge; Indiana University System; Indiana University-Purdue University Indianapolis; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	Pena-Oliver, Y (corresponding author), Univ Cambridge, Dept Psychol, Downing St, Cambridge, England.	yp249@cam.ac.uk	Giuliano, Chiara/K-8919-2019; Robbins, Trevor W/A-7551-2008	Dalley, Jeffrey/0000-0002-2282-3660; Robbins, Trevor/0000-0003-0642-5977	Wellcome Trust; Medical Research Council Programme (MRC) [G1002231, 093875/Z/10/Z]; MRC [G1000183, G1002231] Funding Source: UKRI; Medical Research Council [G0001354B, G1000183B, G1000183, G1002231, G0001354] Funding Source: researchfish; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [P60AA007611, R24AA015512, U24AA015512] Funding Source: NIH RePORTER	Wellcome Trust(Wellcome TrustEuropean Commission); Medical Research Council Programme (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	The present study was funded by the Wellcome Trust and the Medical Research Council Programme (MRC Ref: G1002231 awarded to BJE, JWD, TWR, Wellcome Trust Ref: 093875/Z/10/Z). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beckwith SW, 2014, ALCOHOL CLIN EXP RES, V38, P2607, DOI 10.1111/acer.12523; Belin D, 2008, SCIENCE, V320, P1352, DOI 10.1126/science.1158136; Bell RL, 2006, ADDICT BIOL, V11, P270, DOI 10.1111/j.1369-1600.2005.00029.x; Broos N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036781; Crabbe JC, 2010, BEHAV GENET, V40, P737, DOI 10.1007/s10519-010-9371-z; Dalley JW, 2007, SCIENCE, V315, P1267, DOI 10.1126/science.1137073; Diergaarde L, 2008, BIOL PSYCHIAT, V63, P301, DOI 10.1016/j.biopsych.2007.07.011; Diergaarde L, 2012, ADDICT BIOL, V17, P576, DOI 10.1111/j.1369-1600.2011.00376.x; Eagle DM, 2010, NEUROSCI BIOBEHAV R, V34, P50, DOI 10.1016/j.neubiorev.2009.07.003; Ernst M, 2006, PEDIATRICS, V117, P2030, DOI 10.1542/peds.2005-0704; Evenden JL, 1999, PSYCHOPHARMACOLOGY, V146, P348, DOI 10.1007/PL00005481; Fitzpatrick CJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075042; Flagel SB, 2014, NEUROPHARMACOLOGY, V76, P425, DOI 10.1016/j.neuropharm.2013.04.033; Flagel SB, 2010, NEUROPSYCHOPHARMACOL, V35, P388, DOI 10.1038/npp.2009.142; Flagel SB, 2009, NEUROPHARMACOLOGY, V56, P139, DOI 10.1016/j.neuropharm.2008.06.027; Irimia C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109948; Irimia C, 2015, ADDICT BIOL, V20, P263, DOI 10.1111/adb.12119; LI TK, 1993, BEHAV GENET, V23, P163, DOI 10.1007/BF01067421; Loos M, 2013, FRONT BEHAV NEUROSCI, V7, DOI 10.3389/fnbeh.2013.00151; Lovic V, 2011, BEHAV BRAIN RES, V223, P255, DOI 10.1016/j.bbr.2011.04.006; McMillen BA, 1998, PHYSIOL BEHAV, V63, P371, DOI 10.1016/S0031-9384(97)00442-3; McNamara R, 2010, PSYCHOPHARMACOLOGY, V212, P453, DOI 10.1007/s00213-010-1974-9; Mejia-Toiber J, 2014, BEHAV BRAIN RES, V266, P19, DOI 10.1016/j.bbr.2014.02.019; Mole TB, 2015, PSYCHOL MED, V45, P771, DOI 10.1017/S0033291714001834; Murray JE, 2014, BIOL PSYCHIAT, V76, P15, DOI 10.1016/j.biopsych.2013.09.011; Oberlin BG, 2009, ALCOHOL CLIN EXP RES, V33, P1294, DOI 10.1111/j.1530-0277.2009.00955.x; Petry NM, 2002, J STUD ALCOHOL, V63, P83; Petry NM, 2001, PSYCHOPHARMACOLOGY, V154, P243, DOI 10.1007/s002130000638; Richards JB, 2013, GENES BRAIN BEHAV, V12, P490, DOI 10.1111/gbb.12050; Robinson ESJ, 2009, BEHAV BRAIN RES, V196, P310, DOI 10.1016/j.bbr.2008.09.021; Sanchez-Roige S, 2014, NEUROPSYCHOPHARMACOL, V39, P2919, DOI 10.1038/npp.2014.151; Saunders BT, 2010, BIOL PSYCHIAT, V67, P730, DOI 10.1016/j.biopsych.2009.11.015; SCHULSINGER F, 1986, ARCH GEN PSYCHIAT, V43, P755; SINCLAIR JD, 1992, ALCOHOL, V9, P155, DOI 10.1016/0741-8329(92)90027-8; Steinmetz JE, 2000, PROG NEURO-PSYCHOPH, V24, P1025, DOI 10.1016/S0278-5846(00)00122-6; STEWART RB, 1994, ALCOHOL CLIN EXP RES, V18, P375, DOI 10.1111/j.1530-0277.1994.tb00028.x; Stoffel EC, 2008, DRUG ALCOHOL DEPEN, V92, P69, DOI 10.1016/j.drugalcdep.2007.06.012; Tomie A, 1998, PSYCHOPHARMACOLOGY, V139, P376, DOI 10.1007/s002130050728; Tomie Arthur, 2013, Curr Drug Abuse Rev, V6, P201; Verdejo-Garcia A, 2008, NEUROSCI BIOBEHAV R, V32, P777, DOI 10.1016/j.neubiorev.2007.11.003; Walker SE, 2011, PSYCHOPHARMACOLOGY, V217, P433, DOI 10.1007/s00213-011-2298-0; Whelan R, 2014, NATURE, V512, P185, DOI 10.1038/nature13402; Wilhelm CJ, 2008, GENES BRAIN BEHAV, V7, P705, DOI 10.1111/j.1601-183X.2008.00406.x; Wilhelm CJ, 2007, ALCOHOL CLIN EXP RES, V31, P1839, DOI 10.1111/j.1530-0277.2007.00508.x; Wilhelm CJ, 2012, ALCOHOL ALCOHOLISM, V47, P518, DOI 10.1093/alcalc/ags059	45	20	20	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2015	10	6							e0131016	10.1371/journal.pone.0131016	http://dx.doi.org/10.1371/journal.pone.0131016			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL3FM	26098361	Green Published, gold, Green Submitted			2022-12-26	WOS:000356835800132
J	Stevens, KP; Holland, GJ; Clarke, RH; Cooke, R; Bennett, AF				Stevens, Kate P.; Holland, Greg J.; Clarke, Rohan H.; Cooke, Raylene; Bennett, Andrew F.			What Determines Habitat Quality for a Declining Woodland Bird in a Fragmented Environment: The Grey-Crowned Babbler Pomatostomus temporalis in South-Eastern Australia?	PLOS ONE			English	Article							REPRODUCTIVE SUCCESS; LANDSCAPE; HELPERS; DISTRIBUTIONS; SELECTION; VICTORIA; ECOLOGY; SIZE	Understanding what constitutes high quality habitat is crucial for the conservation of species, especially those threatened with extinction. Habitat quality frequently is inferred by comparing the attributes of sites where a species is present with those where it is absent. However, species presence may not always indicate high quality habitat. Demographic parameters are likely to provide a more biologically relevant measure of quality, including a species' ability to successfully reproduce. We examined factors believed to influence territory quality for the grey-crowned babbler (Pomatostomus temporalis), a cooperatively breeding woodland bird that has experienced major range contraction and population decline in south-eastern Australia. Across three broad regions, we identified active territories and determined the presence of fledglings and the size of family groups, as surrogates of territory quality. These measures were modelled in relation to habitat attributes within territories, the extent of surrounding wooded vegetation, isolation from neighbouring groups, and the size of the neighbourhood population. Fledgling presence was strongly positively associated with group size, indicating that helpers enhance breeding success. Surprisingly, no other territory or landscape-scale variables predicted territory quality, as inferred from either breeding success or group size. Relationships between group size and environmental variables may be obscured by longer-term dynamics in group size. Variation in biotic interactions, notably competition from the noisy miner (Manorina melanocephala), also may contribute. Conservation actions that enhance the number and size of family groups will contribute towards reversing declines of this species. Despite associated challenges, demographic studies have potential to identify mechanistic processes that underpin population performance; critical knowledge for effective conservation management.	[Stevens, Kate P.; Holland, Greg J.; Cooke, Raylene; Bennett, Andrew F.] Deakin Univ, Sch Life & Environm Sci, Melbourne, Vic, Australia; [Clarke, Rohan H.] Monash Univ, Sch Biol Sci, Melbourne, Vic 3004, Australia; [Bennett, Andrew F.] La Trobe Univ, Dept Ecol Environm & Evolut, Melbourne, Vic, Australia	Deakin University; Monash University; La Trobe University	Cooke, R (corresponding author), Deakin Univ, Sch Life & Environm Sci, Melbourne, Vic, Australia.	raylene.cooke@deakin.edu.au			Stuart Leslie Bird Research Award (BirdLife Australia); Professor Allen Keast Research Award (BirdLife Australia); Holsworth Wildlife Research Endowment; Deakin University	Stuart Leslie Bird Research Award (BirdLife Australia); Professor Allen Keast Research Award (BirdLife Australia); Holsworth Wildlife Research Endowment; Deakin University	Funding was provided by a Stuart Leslie Bird Research Award (BirdLife Australia); a Professor Allen Keast Research Award (BirdLife Australia); the Holsworth Wildlife Research Endowment; and Deakin University, for which the authors are most grateful.	Adam P., 1996, Victorian Naturalist (Blackburn), V113, P4; [Anonymous], 2010, TEMPERATE WOODLAND C; Balshine S, 2001, BEHAV ECOL SOCIOBIOL, V50, P134, DOI 10.1007/s002650100343; Barton K., 2012, MUMIN MULTIMODEL INF; Bates B., 2013, [lme4: linear mixed-effects models using S4 classes, R package version 0.999375-39]; Blackmore CJ, 2007, J ZOOL, V273, P326, DOI 10.1111/j.1469-7998.2007.00332.x; Blackmore CJ, 2011, J ANIM ECOL, V80, P69, DOI 10.1111/j.1365-2656.2010.01761.x; BROWN JL, 1983, BEHAV ECOL SOCIOBIOL, V13, P115, DOI 10.1007/BF00293801; BROWN JL, 1982, SCIENCE, V215, P421, DOI 10.1126/science.215.4531.421; Bureau of Meteorology, 2012, CLIM STAT AUSTR LOC; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Carroll C, 2001, ECOL APPL, V11, P961, DOI 10.1890/1051-0761(2001)011[0961:CAFSFC]2.0.CO;2; Clarke KR., 2001, CHANGE MARINE COMMUN, V2; Clutton-Brock T, 2002, SCIENCE, V296, P69, DOI 10.1126/science.296.5565.69; Clutton-Brock TH, 1998, P ROY SOC B-BIOL SCI, V265, P185, DOI 10.1098/rspb.1998.0281; Clutton-Brock TH, 2001, SCIENCE, V293, P2446, DOI 10.1126/science.1061274; Counsilman J.J, 1977, Babbler, V1, P23; Davidson I., 2009, CONSERVATION PLAN GR; Department of Environment and Heritage, 2013, GREY CROWN BABBL E S; DOW DD, 1984, EMU, V84, P193, DOI 10.1071/MU9840193; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Emison W., 1987, ATLAS VICTORIAN BIRD; Environment Conservation Council, 2001, BOX IR FOR WOODL INV; Ford HA, 2001, BIOL CONSERV, V97, P71, DOI 10.1016/S0006-3207(00)00101-4; Fox J., 2019, R COMPANION APPL REG, V.; Garnett S. T., 2011, ACTION PLAN AUSTR BI; Gibbons Philip, 2002, Ecological Management & Restoration, V3, P205, DOI 10.1046/j.1442-8903.2002.00114.x; Gorley C.K., 2006, GETTING STARTED PRIM; Guisan A, 2000, ECOL MODEL, V135, P147, DOI 10.1016/S0304-3800(00)00354-9; Hatchwell BJ, 1999, AM NAT, V154, P205, DOI 10.1086/303227; Holland GJ, 2007, WILDLIFE RES, V34, P387, DOI 10.1071/WR07061; Holland GJ, 2010, ECOGRAPHY, V33, P841, DOI 10.1111/j.1600-0587.2010.06127.x; Kuussaari M, 2009, TRENDS ECOL EVOL, V24, P564, DOI 10.1016/j.tree.2009.04.011; Lindenmayer D, 2006, HABITAT FRAGMENTATIO; Loyn RH, 2001, BIOL CONSERV, V97, P361, DOI 10.1016/S0006-3207(00)00135-X; Lunt I, 2000, TEMPERATE EUCALYPT WOODLANDS IN AUSTRALIA, P17; Manning AD, 2004, BIOL CONSERV, V120, P363, DOI 10.1016/j.biocon.2004.03.008; Maron Martine, 2005, Ecological Management & Restoration, V6, P206, DOI 10.1111/j.1442-8903.2005.00238.x; Maron M, 2013, DIVERS DISTRIB, V19, P1468, DOI 10.1111/ddi.12128; Mazerolle MJ, 2012, AICCMODAVG MODEL SEL; MUMME RL, 1992, BEHAV ECOL SOCIOBIOL, V31, P319; Nakagawa S, 2013, METHODS ECOL EVOL, V4, P133, DOI 10.1111/j.2041-210x.2012.00261.x; PULLIAM HR, 1988, AM NAT, V132, P652, DOI 10.1086/284880; R Core Team, 2013, R LANG ENV STAT COMP, DOI [10.3758/s13428-013-0330-5, DOI 10.3758/S13428-013-0330-5]; Radford J. Q, 2008, INFLUENCE LANDSCAPE; Robertson O, 2014, AUSTRAL ECOL, V39, P255, DOI 10.1111/aec.12074; Robinson D, 1993, HABITAT REQUIREMENTS; Robinson Doug, 2006, Ecological Management & Restoration, V7, P93, DOI 10.1111/j.1442-8903.2006.00263.x; Schlaepfer MA, 2002, TRENDS ECOL EVOL, V17, P474, DOI 10.1016/S0169-5347(02)02580-6; Taylor S. C., 2008, VICTORIAN NAT, V125, P19; Thomas Ray, 2009, Ecological Management & Restoration, V10, P84, DOI 10.1111/j.1442-8903.2009.00470.x; Tzaros C., 1995, POPULATION MONITORIN; Tzaros C., 2001, FIELD SURVEYS POPULA; Uezu A, 2011, BIODIVERS CONSERV, V20, P3627, DOI 10.1007/s10531-011-0154-5; Whittingham MJ, 2005, J APPL ECOL, V42, P270, DOI 10.1111/j.1365-2664.2005.01007.x; Wintle BA, 2005, AUSTRAL ECOL, V30, P719, DOI 10.1111/j.1442-9993.2005.01514.x; Zuur Alain F., 2009, P1	57	6	8	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2015	10	6							e0130738	10.1371/journal.pone.0130738	http://dx.doi.org/10.1371/journal.pone.0130738			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL3FM	26098355	gold, Green Published, Green Submitted			2022-12-26	WOS:000356835800099
J	Ten Have, GAM; van der Pijl, PC; Kies, AK; Deutz, NEP				Ten Have, Gabriella A. M.; van der Pijl, Pieter C.; Kies, Arie K.; Deutz, Nicolaas E. P.			Enhanced Lacto-Tri-Peptide Bio-Availability by Co-Ingestion of Macronutrients	PLOS ONE			English	Article							SPONTANEOUSLY HYPERTENSIVE-RATS; ANGIOTENSIN-CONVERTING ENZYME; RANDOMIZED CONTROLLED-TRIAL; VAL-PRO-PRO; BLOOD-PRESSURE; PROTEIN-METABOLISM; AMINO-ACID; ANTIHYPERTENSIVE PEPTIDES; BIOACTIVE PEPTIDES; HEALTHY HUMANS	Some food-derived peptides possess bioactive properties, and may affect health positively. For example, the C-terminal lacto-tri-peptides Ile-Pro-Pro (IPP), Leu-Pro-Pro (LPP) and Val-Pro-Pro (VPP) (together named here XPP) are described to lower blood pressure. The bioactivity depends on their availability at the site of action. Quantitative trans-organ availability/kinetic measurements will provide more insight in C-terminal tri-peptides behavior in the body. We hypothesize that the composition of the meal will modify their systemic availability. We studied trans-organ XPP fluxes in catheterized pigs (25 kg; n=10) to determine systemic and portal availability, as well as renal and hepatic uptake of a water-based single dose of synthetic XPP and a XPP containing protein matrix (casein hydrolyte, CasH). In a second experiment (n=10), we compared the CasH-containing protein matrix with a CasH-containing meal matrix and the modifying effects of macronutrients in a meal on the availability (high carbohydrates, low quality protein, high fat, and fiber). Portal availability of synthetic XPP was 0.08 +/- 0.01% of intake and increased when a protein matrix was present (respectively 3.1, 1.8 and 83 times for IPP, LPP and VPP). Difference between individual XPP was probably due to release from longer peptides. CasH prolonged portal bioavailability with 18 min (absorption half-life, synthetic XPP: 15 +/- 2 min, CasH: 33 +/- 3 min, p<0.0001) and increased systemic elimination with 20 min (synthetic XPP: 12 +/- 2 min; CasH: 32 +/- 3 min, p<0.0001). Subsequent renal and hepatic uptake is about 75% of the portal release. A meal containing CasH, increased portal 1.8 and systemic bioavailability 1.2 times. Low protein quality and fiber increased XPP systemic bioavailability further (respectively 1.5 and 1.4 times). We conclude that the amount and quality of the protein, and the presence of fiber in a meal, are the main factors that increase the systemic bioavailability of food-derived XPP.	[Ten Have, Gabriella A. M.; Deutz, Nicolaas E. P.] Texas A&M Univ, Dept Hlth & Kinesiol, Ctr Translat Res Aging & Longev, College Stn, TX 77843 USA; [Ten Have, Gabriella A. M.; Deutz, Nicolaas E. P.] Maastricht Univ, Dept Surg, Nutr & Toxicol Inst Maastricht, NL-6200 MD Maastricht, Netherlands; [van der Pijl, Pieter C.] Unilever Res Labs, Vlaardingen, Netherlands; [Kies, Arie K.] DSM Biotechnol Ctr, Delft, Netherlands	Texas A&M University System; Texas A&M University College Station; Maastricht University; Unilever; DSM NV	Deutz, NEP (corresponding author), Texas A&M Univ, Dept Hlth & Kinesiol, Ctr Translat Res Aging & Longev, College Stn, TX 77843 USA.	nep.deutz@ctral.org	Deutz, Nicolaas E/J-5200-2012	Deutz, Nicolaas/0000-0001-5845-6447	SenterNovem; agency of the Dutch Ministry of Economic Affairs [TSGE301]; DSM Food Specialties; Unilever Research Development; DSM Biotechnology Center	SenterNovem; agency of the Dutch Ministry of Economic Affairs; DSM Food Specialties; Unilever Research Development(Unilever); DSM Biotechnology Center	This study was funded in part by SenterNovem, an agency of the Dutch Ministry of Economic Affairs (Grant number TSGE301), and DSM Food Specialties. Co-author Pieter C. van der Pijl is employed by Unilever Research & Development. Unilever Research & Development provided support in the form of salary for author PCP, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section. Co-author Arie K. Kies is employed by DSM Biotechnology Center. DSM Biotechnology Center, provided support in the form of salary for author AKK, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Adegoke OAJ, 2003, AM J PHYSIOL-GASTR L, V284, pG1017, DOI 10.1152/ajpgi.00402.2002; Alpers DH, 2002, CURR OPIN CLIN NUTR, V5, P679, DOI 10.1097/00075197-200211000-00011; Boelsma E, 2010, NUTR J, V9, DOI 10.1186/1475-2891-9-52; Boutrou R, 2013, AM J CLIN NUTR, V97, P1314, DOI 10.3945/ajcn.112.055202; Bruins MJ, 2004, NEUROGASTROENT MOTIL, V16, P819, DOI 10.1111/j.1365-2982.2004.00579.x; Bruins MJ, 2003, CLIN SCI, V104, P127, DOI 10.1042/CS20020275; Bruins MJ, 2000, J NUTR, V130, P3003, DOI 10.1093/jn/130.12.3003; de Leeuw PW, 2009, BLOOD PRESSURE, V18, P44, DOI 10.1080/08037050902761209; DEUTZ NEP, 1995, CLIN NUTR, V14, P354, DOI 10.1016/S0261-5614(95)80053-0; DEUTZ NEP, 1992, CLIN SCI, V83, P607, DOI 10.1042/cs0830607; Deutz NEP, 1998, J NUTR, V128, P2435, DOI 10.1093/jn/128.12.2435; Deutz NEP, 1996, CLIN NUTR, V15, P119, DOI 10.1016/S0261-5614(96)80036-7; Edens L, 2005, J AGR FOOD CHEM, V53, P7950, DOI 10.1021/jf050652c; Engberink MF, 2008, HYPERTENSION, V51, P399, DOI 10.1161/HYPERTENSIONAHA.107.098988; Foltz M, 2010, J NUTR, V140, P117, DOI 10.3945/jn.109.116228; Foltz M, 2009, J FOOD SCI, V74, pH243, DOI 10.1111/j.1750-3841.2009.01301.x; GENOME K, 2013, BOS TAURUS COW 28109; Hammarqvist F, 1997, CRIT CARE MED, V25, P78, DOI 10.1097/00003246-199701000-00016; Hernandez F, 2011, ANIMAL, V5, P1290, DOI 10.1017/S1751731111000115; Hirota T, 2007, HYPERTENS RES, V30, P489, DOI 10.1291/hypres.30.489; Jakala P, 2009, J PHYSIOL PHARMACOL, V60, P11; Koopman R, 2009, AM J CLIN NUTR, V90, P106, DOI 10.3945/ajcn.2009.27474; Liu ZQ, 2002, AM J PHYSIOL-ENDOC M, V283, pE1105, DOI 10.1152/ajpendo.00337.2002; Luiking YC, 2005, J NUTR, V135, P1080, DOI 10.1093/jn/135.5.1080; Masuda O, 1996, J NUTR, V126, P3063, DOI 10.1093/jn/126.12.3063; Moller NP, 2008, EUR J NUTR, V47, P171, DOI 10.1007/s00394-008-0710-2; Mourad FH, 2011, PROG NEUROBIOL, V95, P149, DOI 10.1016/j.pneurobio.2011.07.010; Nakamura T, 2009, J MED FOOD, V12, P1221, DOI 10.1089/jmf.2009.0159; Picariello G, 2010, J CHROMATOGR B, V878, P295, DOI 10.1016/j.jchromb.2009.11.033; Poeze M, 2011, AM J CLIN NUTR, V93, P1237, DOI 10.3945/ajcn.110.007237; Ross AB, 2013, J NUTR, V143, P766, DOI 10.3945/jn.112.172197; Rubio-Aliaga I, 2008, XENOBIOTICA, V38, P1022, DOI [10.1080/00498250701875254, 10.1080/00498250701875254 ]; Satake M, 2002, BIOSCI BIOTECH BIOCH, V66, P378, DOI 10.1271/bbb.66.378; Ten Have GA, 2011, CLIN NUTR; Ten Have GAM, 2007, INT J SPORT NUTR EXE, V17, pS23; Tenhave GAM, 1996, LAB ANIM-UK, V30, P347, DOI 10.1258/002367796780739862; Terashima M, 2011, J AGR FOOD CHEM, V59, P11234, DOI 10.1021/jf202902r; van der Pijl PC, 2008, PEPTIDES, V29, P2196, DOI 10.1016/j.peptides.2008.08.011; van der Zander K, 2008, J HUM HYPERTENS, V22, P804, DOI 10.1038/jhh.2008.59; van der Zander K, 2008, AM J CLIN NUTR, V88, P1697, DOI 10.3945/ajcn.2008.26003; van Mierlo LAJ, 2009, AM J CLIN NUTR, V89, P617, DOI 10.3945/ajcn.2008.26918; van Platerink CJ, 2008, ANAL BIOANAL CHEM, V391, P299, DOI 10.1007/s00216-008-1990-3; Vermeirssen V, 2004, BRIT J NUTR, V92, P357, DOI 10.1079/BJN20041189; WILLIAMS EJ, 1949, AUST J SCI RES SER A, V2, P149, DOI 10.1071/CH9490149; Wuerzner G, 2009, J HYPERTENS, V27, P1404, DOI 10.1097/HJH.0b013e32832b4759; Yamamoto N, 1997, BIOPOLYMERS, V43, P129, DOI [10.1002/(SICI)1097-0282(1997)43:2<129::AID-BIP5>3.0.CO;2-X, 10.1002/(SICI)1097-0282(1997)43:2&lt;129::AID-BIP5&gt;3.0.CO;2-X]; Ytrebo LM, 2006, SCAND J GASTROENTERO, V41, P1350, DOI 10.1080/00365520600714527	47	23	23	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2015	10	6							e0130638	10.1371/journal.pone.0130638	http://dx.doi.org/10.1371/journal.pone.0130638			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL3FM	26098114	Green Published, Green Submitted, gold			2022-12-26	WOS:000356835800087
J	Uhlmann, SS; Broadhurst, MK; Millar, RB				Uhlmann, Sven Sebastian; Broadhurst, Matt Kenyon; Millar, Russell Brian			Effects of Modified Handling on the Physiological Stress of Trawled-and-Discarded Yellowfin Bream (Acanthopagrus australis)	PLOS ONE			English	Article							PAGRUS-AURATUS; AIR EXPOSURE; SPARUS-AURATA; ATLANTIC COD; MORTALITY; CAPTURE; FISH; SEA; RELEASE; CAUGHT	Modified handling is often claimed to reduce (sub-)lethal impacts among organisms caught-and-released in fisheries. Improving welfare of discarded fish warrants investigation, when their survival is of both economic and ecological importance. In this study, juvenile yellowfin bream (Acanthopagrus australis) were trawled in an Australian penaeid fishery and then discarded after on-board sorting in either dry or water-filled (modified) trays and with delays in starting sorting of either 2 or 15 mins. Blood plasma cortisol, glucose and potassium were sampled immediately from some yellowfin bream, while others were placed into cages (with controls) and sampled after five days. Irrespective of their on-board handling, all trawled fish incurred a relatively high acute stress response (i.e. an increase in Mean +/- SE cortisol from a baseline of <4 to 122.0 +/- 14.9 ng/mL) that was mostly attributed to the trawling process, and exacerbated by variation in key parameters (low salinity, changes in water temperature and the presence of jellyfish Catostylus mosaicus in catches). When C. mosaicus was present, the potassium concentrations of fish sampled immediately after sorting were significantly elevated, possibly due to nematocyst contact and subsequent inhibition of ion pumps or cytolysis. Stress also increased during handling in response to warmer air temperatures and longer exposure. While most fish had substantially recovered by 120 hours after discarding, deploying selective trawls (to reduce jellyfish) for short periods and then quickly sorting catches in water would benefit discard welfare.	[Uhlmann, Sven Sebastian] Univ New England, Sch Environm Sci & Nat Resources Management, Natl Marine Sci Ctr, Coffs Harbour, NSW, Australia; [Broadhurst, Matt Kenyon] Dept Primary Ind, Fisheries Conservat Technol Unit, Coffs Harbour, NSW, Australia; [Broadhurst, Matt Kenyon] Univ Queensland, Marine & Estuarine Ecol Unit, Sch Biol Sci, Brisbane, Qld, Australia; [Millar, Russell Brian] Univ Auckland, Dept Stat, Auckland 1, New Zealand	Southern Cross University; University of New England; University of Queensland; University of Auckland	Uhlmann, SS (corresponding author), Inst Agr & Fisheries Res ILVO, Fisheries & Aquat Prod Div, Anim Sci Unit, Oostende, Belgium.	sven.uhlmann@gmx.net	Broadhurst, Matt/I-6783-2015	Broadhurst, Matt/0000-0003-0184-7249; Uhlmann, Sven Sebastian/0000-0003-2830-5845	NSW DPI; Australian Fisheries Research and Development Corporation [2005/056]	NSW DPI; Australian Fisheries Research and Development Corporation	This work was approved by the NSW Department of Primary Industries (DPI) Animal Care and Ethics Committee (ACEC REF 05/10), and funded by the NSW DPI and the Australian Fisheries Research and Development Corporation (Grant no. 2005/056). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTIMIRAS J, 1994, COMP BIOCHEM PHYS A, V108, P81, DOI 10.1016/0300-9629(94)90058-2; Arends RJ, 1999, J ENDOCRINOL, V163, P149, DOI 10.1677/joe.0.1630149; Baker MR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069615; Barton B.A., 1991, Annual Review of Fish Diseases, V1, P3, DOI 10.1016/0959-8030(91)90019-G; Barton BA, 2000, N AM J AQUACULT, V62, P12, DOI 10.1577/1548-8454(2000)062<0012:SFDITC>2.0.CO;2; Basti D, 2010, DIS AQUAT ORGAN, V90, P153, DOI 10.3354/dao02205; BERGHAHN R, 1992, J APPL ICHTHYOL, V8, P293, DOI 10.1111/j.1439-0426.1992.tb00696.x; Bergmann M, 2001, J EXP MAR BIOL ECOL, V259, P215, DOI 10.1016/S0022-0981(01)00231-3; Broadhurst MK, 2008, J EXP MAR BIOL ECOL, V364, P54, DOI 10.1016/j.jembe.2008.07.001; Broadhurst MK, 2008, DIS AQUAT ORGAN, V80, P51, DOI 10.3354/dao01904; Broadhurst MK, 2007, DIS AQUAT ORGAN, V74, P27, DOI 10.3354/dao074027; Broadhurst MK, 2006, FISH FISH, V7, P180, DOI 10.1111/j.1467-2979.2006.00213.x; Broadhurst MK, 1999, B MAR SCI, V64, P255; Broadhurst MK, 2005, J EXP MAR BIOL ECOL, V321, P171, DOI 10.1016/j.jembe.2005.02.001; Butcher PA, 2007, DIS AQUAT ORGAN, V74, P17, DOI 10.3354/dao074017; CAMPBELL PM, 1992, BIOL REPROD, V47, P1140, DOI 10.1095/biolreprod47.6.1140; Chopin FS, 1996, FISH RES, V28, P277, DOI 10.1016/0165-7836(96)00512-7; Cleary JJ, 2002, AQUAC RES, V33, P829, DOI 10.1046/j.1365-2109.2002.00718.x; Cleary JJ, 2000, J WORLD AQUACULT SOC, V31, P558, DOI 10.1111/j.1749-7345.2000.tb00905.x; Cooke SJ, 2013, FISHERIES MANAG ECOL, V20, P268, DOI 10.1111/j.1365-2400.2012.00867.x; Darnell MZ, 2010, T AM FISH SOC, V139, P1677, DOI 10.1577/T10-034.1; Davis MW, 2005, T AM FISH SOC, V134, P991, DOI 10.1577/T04-209.1; Davis MW, 2001, J FISH BIOL, V58, P1, DOI 10.1111/j.1095-8649.2001.tb00495.x; Diggles BK, 2011, REV FISH BIOL FISHER, V21, P739, DOI 10.1007/s11160-011-9206-x; Donaldson MR, 2013, CAN J FISH AQUAT SCI, V70, P90, DOI 10.1139/cjfas-2012-0218; Farrell AP, 2001, CAN J FISH AQUAT SCI, V58, P1932, DOI 10.1139/cjfas-58-10-1932; Gale MK, 2013, FISH FISH, V14, P1, DOI 10.1111/j.1467-2979.2011.00441.x; Gale MK, 2011, FISH RES, V112, P85, DOI 10.1016/j.fishres.2011.08.014; Herbert NA, 2005, MAR BIOL, V147, P1403, DOI 10.1007/s00227-005-0003-8; Li RF, 2014, J PROTEOMICS, V106, P17, DOI 10.1016/j.jprot.2014.04.011; Mattei C, 2014, TOXICON, V91, P84, DOI 10.1016/j.toxicon.2014.09.016; MAZEAUD MM, 1977, T AM FISH SOC, V106, P201, DOI 10.1577/1548-8659(1977)106&lt;201:PASEOS&gt;2.0.CO;2; McDonald G., 1997, FISH STRESS HLTH AQU, V62, P119; Millar RB, 2004, FISH RES, V70, P397, DOI 10.1016/j.fishres.2004.08.016; Mommsen TP, 1999, REV FISH BIOL FISHER, V9, P211, DOI 10.1023/A:1008924418720; Morgan MJ, 1999, J FISH BIOL, V54, P477, DOI 10.1111/j.1095-8649.1999.tb00629.x; Pankhurst NW, 2011, GEN COMP ENDOCR, V170, P265, DOI 10.1016/j.ygcen.2010.07.017; PANKHURST NW, 1992, AUST J MAR FRESH RES, V43, P345, DOI 10.1071/MF9920345; Parker SJ, 2003, N AM J FISH MANAGE, V23, P530, DOI 10.1577/1548-8675(2003)023<0530:DMOTCL>2.0.CO;2; Peach MB, 2005, INVERTEBR BIOL, V124, P98, DOI 10.1111/j.1744-7410.2005.00012.x; Portz DE, 2006, REV FISH BIOL FISHER, V16, P125, DOI 10.1007/s11160-006-9012-z; Raicevich S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105060; Reynolds DP, 2009, J APPL ICHTHYOL, V25, P100, DOI 10.1111/j.1439-0426.2009.01182.x; Schreck CB, 2010, GEN COMP ENDOCR, V165, P549, DOI 10.1016/j.ygcen.2009.07.004; Stentiford GD, 2000, J FISH DIS, V23, P251, DOI 10.1046/j.1365-2761.2000.00241.x; Sumpter J.P., 1997, P95; Suuronen Petri, 2010, P265, DOI 10.1002/9780813810966.ch11; Uhlmann SS, 2007, DIS AQUAT ORGAN, V76, P173, DOI 10.3354/dao076173; Wardle CS., 1993, BEHAV TELEOST FISHES, P463, DOI DOI 10.1007/978-1-4684-8261-4_18; Wilson SM, 2014, BIOL CONSERV, V171, P61, DOI 10.1016/j.biocon.2014.01.020	50	5	6	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2015	10	6							e0131109	10.1371/journal.pone.0131109	http://dx.doi.org/10.1371/journal.pone.0131109			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL3FM	26098900	gold, Green Submitted, Green Published			2022-12-26	WOS:000356835800151
J	Wu, CY; Hu, HY; Chow, LH; Chou, YJ; Huang, N; Wang, PN; Li, CP				Wu, Chen-Yi; Hu, Hsiao-Yun; Chow, Lok-Hi; Chou, Yiing-Jenq; Huang, Nicole; Wang, Pei-Ning; Li, Chung-Pin			The Effects of Anti-Dementia and Nootropic Treatments on the Mortality of Patients with Dementia: A Population-Based Cohort Study in Taiwan	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; CHOLINESTERASE-INHIBITORS; LIFE EXPECTANCY; DONEPEZIL; SURVIVAL; MEMANTINE; RISK; PREVALENCE; ANTIPSYCHOTICS; RIVASTIGMINE	Background Few studies have examined the contribution of treatment on the mortality of dementia based on a population-based study. Objective To investigate the effects of anti-dementia and nootropic treatments on the mortality of dementia using a population-based cohort study. Methods 12,193 incident dementia patients were found from 2000 to 2010. Their data were compared with 12,193 age-and sex-matched non-dementia controls that were randomly selected from the same database. Dementia was classified into vascular (VaD) and degenerative dementia. Mortality incidence and hazard ratios (HRs) were calculated. Results The median survival time was 3.39 years (95% confidence interval [CI]: 2.88-3.79) for VaD without medication, 6.62 years (95% CI: 6.24-7.21) for VaD with nootropics, 3.01 years (95% CI: 2.85-3.21) for degenerative dementia without medication, 8.11 years (95% CI: 6.30-8.55) for degenerative dementia with anti-dementia medication, 6.00 years (95% CI: 5.73-6.17) for degenerative dementia with nootropics, and 9.03 years (95% CI: 8.02-9.87) for degenerative dementia with both anti-dementia and nootropic medications. Compared to the non-dementia group, the HRs among individuals with degenerative dementia were 2.69 (95% CI: 2.55-2.83) without medication, 1.46 (95% CI: 1.39-1.54) with nootropics, 1.05 (95% CI: 0.82-1.34) with anti-dementia medication, and 0.92 (95% CI: 0.80-1.05) with both nootropic and anti-dementia medications. VaD with nootropics had a lower mortality (HR: 1.25, 95% CI: 1.15-1.37) than VaD without medication (HR: 2.46, 95% CI: 2.22-2.72). Conclusion Pharmacological treatments have beneficial effects for patients with dementia in prolonging their survival.	[Wu, Chen-Yi] Taipei Vet Gen Hosp, Dept Dermatol, Taipei, Taiwan; [Wu, Chen-Yi; Hu, Hsiao-Yun; Chou, Yiing-Jenq] Natl Yang Ming Univ, Inst Publ Hlth, Taipei 112, Taiwan; [Wu, Chen-Yi; Hu, Hsiao-Yun; Chou, Yiing-Jenq] Natl Yang Ming Univ, Dept Publ Hlth, Taipei 112, Taiwan; [Hu, Hsiao-Yun] Taipei City Hosp, Dept Educ & Res, Taipei, Taiwan; [Chow, Lok-Hi] Taipei Vet Gen Hosp, Dept Anesthesiol, Taipei, Taiwan; [Chow, Lok-Hi] Natl Yang Ming Univ, Sch Med, Dept Anesthesiol, Taipei 112, Taiwan; [Chow, Lok-Hi] Natl Def Med Ctr, Dept Anesthesiol, Taipei, Taiwan; [Huang, Nicole] Natl Yang Ming Univ, Inst Hosp & Hlth Care Adm, Taipei 112, Taiwan; [Wang, Pei-Ning] Taipei Vet Gen Hosp, Dept Neurol, Taipei, Taiwan; [Wang, Pei-Ning] Natl Yang Ming Univ, Aging & Hlth Res Ctr, Taipei 112, Taiwan; [Wang, Pei-Ning] Natl Yang Ming Univ, Brain Res Ctr, Taipei 112, Taiwan; [Li, Chung-Pin] Taipei Vet Gen Hosp, Div Gastroenterol, Dept Med, Taipei, Taiwan; [Li, Chung-Pin] Natl Yang Ming Univ, Sch Med, Taipei 112, Taiwan	Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Taipei City Hospital; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; National Defense Medical Center; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University	Wang, PN (corresponding author), Taipei Vet Gen Hosp, Dept Neurol, Taipei, Taiwan.	pnwang@vghtpe.gov.tw; cpli@vghtpe.gov.tw		Huang, Nicole/0000-0002-6629-1176	National Science Council, Taiwan [NSC 98-2314-B-075-029]; Taipei Veterans General Hospital, Taipei, Taiwan [VGH V103C-201]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); Taipei Veterans General Hospital, Taipei, Taiwan(Taipei Veterans General Hospital)	This work was supported by grant number NSC 98-2314-B-075-029 from the National Science Council, Taiwan, and grant number VGH V103C-201 from Taipei Veterans General Hospital, Taipei, Taiwan.	Atri A, 2008, ALZ DIS ASSOC DIS, V22, P209, DOI 10.1097/WAD.0b013e31816653bc; Atri A, 2012, NEURODEGENER DIS, V10, P170, DOI 10.1159/000335156; Attems J, 2014, BMC MED, V12, DOI 10.1186/s12916-014-0206-2; BELLONISONZOGNI A, 1989, ARCH GERONTOL GERIAT, V9, P193, DOI 10.1016/0167-4943(89)90039-3; BIRKS J, 2009, COCHRANE DB SYST REV, V1, DOI DOI 10.1002/14651858.CD003120.PUB3; Bond M, 2012, HEALTH TECHNOL ASSES, V16, P1, DOI 10.3310/hta16210; Chou YJ, 2006, BIRTH-ISS PERINAT C, V33, P195, DOI 10.1111/j.1523-536X.2006.00104.x; Di Santo SG, 2013, J ALZHEIMERS DIS, V35, P349, DOI 10.3233/JAD-122140; Fang Y, 2014, EXP THER MED, V7, P429, DOI 10.3892/etm.2013.1425; Ferri CP, 2005, LANCET, V366, P2112, DOI 10.1016/S0140-6736(05)67889-0; Froestl W, 2012, J ALZHEIMERS DIS, V32, P793, DOI 10.3233/JAD-2012-121186; Ganguli M, 2005, ARCH NEUROL-CHICAGO, V62, P779, DOI 10.1001/archneur.62.5.779; Garcia-Ptacek S, 2014, J ALZHEIMERS DIS, V41, P467, DOI 10.3233/JAD-131856; Gasper Mason C, 2005, Am J Geriatr Pharmacother, V3, P1, DOI 10.1016/j.amjopharm.2005.02.001; Geldmacher DS, 2003, J AM GERIATR SOC, V51, P937, DOI 10.1046/j.1365-2389.2003.51306.x; Gill SS, 2007, ANN INTERN MED, V146, P775, DOI 10.7326/0003-4819-146-11-200706050-00006; Helmer C, 2001, AM J EPIDEMIOL, V154, P642, DOI 10.1093/aje/154.7.642; HOGAN DB, 1994, CAN J NEUROL SCI, V21, P331, DOI 10.1017/S0317167100040919; Jin P, 2004, NEUROLOGY, V63, P739, DOI 10.1212/01.WNL.0000134604.48018.97; Jolley DJ, 2000, INT J CLIN PRACT, V54, P117; Kane Michael N, 2002, Am J Alzheimers Dis Other Demen, V17, P101, DOI 10.1177/153331750201700206; Koopmans RTCM, 2003, J AM GERIATR SOC, V51, P184, DOI 10.1046/j.1532-5415.2003.51056.x; Langballe EM, 2014, AM J GERIAT PSYCHIAT, V22, P321, DOI 10.1016/j.jagp.2013.06.007; Lanni C, 2008, PHARMACOL RES, V57, P196, DOI 10.1016/j.phrs.2008.02.004; Lee M, 2009, J AM MED DIR ASSOC, V10, P466, DOI 10.1016/j.jamda.2009.03.014; Lin RT, 1998, J NEUROL SCI, V160, P67, DOI 10.1016/S0022-510X(98)00225-1; LIU HC, 1995, J AM GERIATR SOC, V43, P144, DOI 10.1111/j.1532-5415.1995.tb06379.x; Lopez OL, 2009, J NEUROL NEUROSUR PS, V80, P600, DOI 10.1136/jnnp.2008.158964; Lopez OL, 2002, J NEUROL NEUROSUR PS, V72, P310, DOI 10.1136/jnnp.72.3.310; Matsui Y, 2009, J NEUROL NEUROSUR PS, V80, P366, DOI 10.1136/jnnp.2008.155481; Mazza M, 2006, EUR J NEUROL, V13, P981, DOI 10.1111/j.1468-1331.2006.01409.x; Meguro K, 2014, BMC NEUROL, V14, DOI 10.1186/1471-2377-14-83; Molino I, 2013, SCI WORLD J, DOI 10.1155/2013/925702; Nilsson K, 2011, DEMENT GERIATR COGN, V32, P342, DOI 10.1159/000335728; Nordstrom P, 2013, EUR HEART J, V34, P2585, DOI 10.1093/eurheartj/eht182; ROMANO PS, 1993, J CLIN EPIDEMIOL, V46, P1075, DOI 10.1016/0895-4356(93)90103-8; Rossom RC, 2010, J AM GERIATR SOC, V58, P1027, DOI 10.1111/j.1532-5415.2010.02873.x; Rountree SD, 2013, ALZHEIMERS DEMENT, V9, P338, DOI 10.1016/j.jalz.2012.01.002; Rountree SD, 2012, ALZHEIMERS RES THER, V4, DOI 10.1186/alzrt119; Schneider LS, 2014, J INTERN MED, V275, P251, DOI 10.1111/joim.12191; Sun Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100303; Vidal JS, 2008, ALZ DIS ASSOC DIS, V22, P125, DOI 10.1097/WAD.0b013e31815a9e10; Waegemans T, 2002, DEMENT GERIATR COGN, V13, P217, DOI 10.1159/000057700; Waring SC, 2005, ALZ DIS ASSOC DIS, V19, P178; Wattmo C, 2014, DEMENT GERIATR COGN, V38, P286, DOI 10.1159/000362926; Wattmo C, 2014, BMC NEUROL, V14, DOI 10.1186/s12883-014-0173-4; Wolfson C, 2001, NEW ENGL J MED, V344, P1111, DOI 10.1056/NEJM200104123441501; Xie J, 2008, BMJ-BRIT MED J, V336, P258, DOI 10.1136/bmj.39433.616678.25	48	11	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2015	10	6							e0130993	10.1371/journal.pone.0130993	http://dx.doi.org/10.1371/journal.pone.0130993			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CL3FM	26098910	gold, Green Published, Green Submitted			2022-12-26	WOS:000356835800129
J	Sun, D; Yi, SV				Sun, Dan; Yi, Soojin V.			Impacts of Chromatin States and Long-Range Genomic Segments on Aging and DNA Methylation	PLOS ONE			English	Article							EPIGENETIC CHANGES; AGE; DISCOVERY; LANDSCAPE; METHYLOME; TISSUES; GENES; BLOOD; CELLS; DRIFT	Understanding the fundamental dynamics of epigenome variation during normal aging is critical for elucidating key epigenetic alterations that affect development, cell differentiation and diseases. Advances in the field of aging and DNA methylation strongly support the aging epigenetic drift model. Although this model aligns with previous studies, the role of other epigenetic marks, such as histone modification, as well as the impact of sampling specific CpGs, must be evaluated. Ultimately, it is crucial to investigate how all CpGs in the human genome change their methylation with aging in their specific genomic and epigenomic contexts. Here, we analyze whole genome bisulfite sequencing DNA methylation maps of brain frontal cortex from individuals of diverse ages. Comparisons with blood data reveal tissue-specific patterns of epigenetic drift. By integrating chromatin state information, divergent degrees and directions of aging-associated methylation in different genomic regions are revealed. Whole genome bisulfite sequencing data also open a new door to investigate whether adjacent CpG sites exhibit coordinated DNA methylation changes with aging. We identified significant 'aging-segments', which are clusters of nearby CpGs that respond to aging by similar DNA methylation changes. These segments not only capture previously identified aging-CpGs but also include specific functional categories of genes with implications on epigenetic regulation of aging. For example, genes associated with development are highly enriched in positive aging segments, which are gradually hyper-methylated with aging. On the other hand, regions that are gradually hypo-methylated with aging ('negative aging segments') in the brain harbor genes involved in metabolism and protein ubiquitination. Given the importance of protein ubiquitination in proteome homeostasis of aging brains and neurodegenerative disorders, our finding suggests the significance of epigenetic regulation of this posttranslational modification pathway in the aging brain. Utilizing aging segments rather than individual CpGs will provide more comprehensive genomic and epigenomic contexts to understand the intricate associations between genomic neighborhoods and developmental and aging processes. These results complement the aging epigenetic drift model and provide new insights.	[Sun, Dan; Yi, Soojin V.] Georgia Inst Technol, Sch Biol, Atlanta, GA 30332 USA	University System of Georgia; Georgia Institute of Technology	Yi, SV (corresponding author), Georgia Inst Technol, Sch Biol, Atlanta, GA 30332 USA.	soojinyi@gatech.edu		Sun, Dan/0000-0003-2147-9308	Georgia Tech-Atlanta Zoo collaborative research program at School of Biology of Georgia Institute of Technology; National Science Foundation [BCS-1317195]; National Institute of Health [R21MH102677]; Brainpool program of the Ministry of Science, Information/Communication Technology & Future Planning (MSIP) of Korea; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH102677] Funding Source: NIH RePORTER; Direct For Social, Behav & Economic Scie [1317195] Funding Source: National Science Foundation	Georgia Tech-Atlanta Zoo collaborative research program at School of Biology of Georgia Institute of Technology; National Science Foundation(National Science Foundation (NSF)); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Brainpool program of the Ministry of Science, Information/Communication Technology & Future Planning (MSIP) of Korea; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Direct For Social, Behav & Economic Scie(National Science Foundation (NSF)NSF - Directorate for Social, Behavioral & Economic Sciences (SBE))	This work was supported by the Bioinformatics Masters Program, the Georgia Tech-Atlanta Zoo collaborative research program at School of Biology of Georgia Institute of Technology, and grants from the National Science Foundation (BCS-1317195), National Institute of Health (R21MH102677), and the Brainpool program of the Ministry of Science, Information/Communication Technology & Future Planning (MSIP) of Korea to SVY. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahuja N, 1998, CANCER RES, V58, P5489; [Anonymous], 2014, BRAINSPAN ATL DEV HU; Aran D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-3-r21; Bell JT, 2012, PLOS GENET, V8, P189, DOI 10.1371/journal.pgen.1002629; Bernstein BE, 2010, NAT BIOTECHNOL, V28, P1045, DOI 10.1038/nbt1010-1045; Bocklandt S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014821; Boks MP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006767; Bollati V, 2009, MECH AGEING DEV, V130, P234, DOI 10.1016/j.mad.2008.12.003; Cedar H, 2009, NAT REV GENET, V10, P295, DOI 10.1038/nrg2540; Christensen BC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000602; Cokus SJ, 2008, NATURE, V452, P215, DOI 10.1038/nature06745; Day K, 2013, GENOME BIOL, V14; Day K, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-9-r102; Dennissen FJA, 2011, FEBS LETT, V585, P2568, DOI 10.1016/j.febslet.2011.06.037; Eckhardt F, 2006, NAT GENET, V38, P1378, DOI 10.1038/ng1909; Ernst J, 2012, NAT METHODS, V9, P215, DOI 10.1038/nmeth.1906; Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906; Ernst J, 2010, NAT BIOTECHNOL, V28, P817, DOI 10.1038/nbt.1662; Florath I, 2014, HUM MOL GENET, V23, P1186, DOI 10.1093/hmg/ddt531; Fuks F, 2005, CURR OPIN GENET DEV, V15, P490, DOI 10.1016/j.gde.2005.08.002; Green P, 2003, NAT GENET, V33, P514, DOI 10.1038/ng1103; Gronniger E, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000971; Gronbaek K, 2007, APMIS, V115, P1039, DOI 10.1111/j.1600-0463.2007.apm_636.xml.x; Hahne F, 2013, GVIZ PLOTTING DATA A; Hannum G, 2013, MOL CELL, V49, P359, DOI 10.1016/j.molcel.2012.10.016; Hernandez DG, 2011, HUM MOL GENET, V20, P1164, DOI 10.1093/hmg/ddq561; Heyn H, 2012, P NATL ACAD SCI USA, V109, P10522, DOI 10.1073/pnas.1120658109; HOALVANHELDEN EG, 1989, MUTAT RES, V219, P263, DOI 10.1016/0921-8734(89)90027-1; Horvath S, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-10-r115; Horvath S, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-10-r97; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Huh I, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-608; Huh I, 2013, EPIGENET CHROMATIN, V6, DOI 10.1186/1756-8935-6-9; Issa JP, 2014, J CLIN INVEST, V124, P24, DOI 10.1172/JCI69735; Issa JPJ, 1996, P NATL ACAD SCI USA, V93, P11757, DOI 10.1073/pnas.93.21.11757; Jaffe AE, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-2-r31; Jenkins TG, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004458; Jjingo D, 2012, ONCOTARGET, V3, P462, DOI 10.18632/oncotarget.497; Johansson A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067378; Kevei E, 2014, NAT STRUCT MOL BIOL, V21, P290, DOI 10.1038/nsmb.2806; Ko YA, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-10-r108; Koch CM, 2011, AGING-US, V3, P1018, DOI 10.18632/aging.100395; Komander D, 2009, BIOCHEM SOC T, V37, P937, DOI 10.1042/BST0370937; Kozlenkov A, 2014, NUCLEIC ACIDS RES, V42, P109, DOI 10.1093/nar/gkt838; Kwabi-Addo B, 2007, CLIN CANCER RES, V13, P3796, DOI 10.1158/1078-0432.CCR-07-0085; Lister R, 2013, SCIENCE, V341, P629, DOI 10.1126/science.1237905; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Maegawa S, 2010, WIDESPREAD TISSUE SP; Maunakea AK, 2010, NATURE, V466, P253, DOI 10.1038/nature09165; Miller JA, 2014, NATURE, V508, P199, DOI 10.1038/nature13185; Numata S, 2012, AM J HUM GENET, V90, P260, DOI 10.1016/j.ajhg.2011.12.020; Ong ML, 2014, AGING CELL, V13, P142, DOI 10.1111/acel.12159; R Core Team, 2014, R LANG ENV STAT COMP, DOI [10.1016/j.jneumeth.2014.06.019, DOI 10.1016/J.JNEUMETH.2014.06.019]; Raddatz G, 2013, EPIGENET CHROMATIN, V6, DOI 10.1186/1756-8935-6-36; Rakyan VK, 2010, GENOME RES, V20, P434, DOI 10.1101/gr.103101.109; Richardson B, 2003, AGEING RES REV, V2, P245, DOI 10.1016/S1568-1637(03)00010-2; Richardson BC, 2002, J NUTR, V132, p2401S, DOI 10.1093/jn/132.8.2401S; Riederer IM, 2009, BRAIN RES BULL, V80, P233, DOI 10.1016/j.brainresbull.2009.04.018; Ronnerblad M, 2014, BLOOD, V123, pE79, DOI 10.1182/blood-2013-02-482893; Ruzzo W L, 1999, Proc Int Conf Intell Syst Mol Biol, P234; Stadler MB, 2011, NATURE, V480, P490, DOI 10.1038/nature10716; Stieren ES, 2011, J BIOL CHEM, V286, P35689, DOI 10.1074/jbc.M111.243147; Tanay A, 2013, CURR OPIN GENET DEV, V23, P197, DOI 10.1016/j.gde.2012.12.009; Teschendorff AE, 2013, HUM MOL GENET, V22, pR7, DOI 10.1093/hmg/ddt375; Teschendorff AE, 2010, GENOME RES, V20, P440, DOI 10.1101/gr.103606.109; Tomasetti C, 2015, SCIENCE, V347, P78, DOI 10.1126/science.1260825; Wang JR, 2012, NUCLEIC ACIDS RES, V40, P511, DOI 10.1093/nar/gkr750; Weidner CI, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-2-r24; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; WILSON VL, 1983, SCIENCE, V220, P1054; Xu K, 2013, MOL PHYLOGENET EVOL, V69, P276, DOI 10.1016/j.ympev.2013.06.003; Zeng J, 2014, EPIGENETICS, V9, P0; Zeng J, 2012, AM J HUM GENET, V91, P455, DOI 10.1016/j.ajhg.2012.07.024; Ziller MJ, 2013, NATURE, V500, P477, DOI 10.1038/nature12433; Zykovich A, 2014, AGING CELL, V13, P360, DOI 10.1111/acel.12180	76	17	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2015	10	6							e0128517	10.1371/journal.pone.0128517	http://dx.doi.org/10.1371/journal.pone.0128517			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL3FE	26091484	Green Submitted, Green Published, gold			2022-12-26	WOS:000356835000020
J	Kodali, S; Vinogradov, E; Lin, F; Khoury, N; Hao, L; Pavliak, V; Jones, CH; Laverde, D; Huebner, J; Jansen, KU; Anderson, AS; Donald, RGK				Kodali, Srinivas; Vinogradov, Evgeny; Lin, Fiona; Khoury, Nancy; Hao, Li; Pavliak, Vilo; Jones, C. Hal; Laverde, Diana; Huebner, Johannes; Jansen, Kathrin U.; Anderson, Annaliesa S.; Donald, Robert G. K.			A Vaccine Approach for the Prevention of Infections by Multidrug-resistant Enterococcus faecium	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VANCOMYCIN-RESISTANT; CAPSULAR POLYSACCHARIDE; LEGIONAMINIC ACID; PNEUMOCOCCAL CONJUGATE; STAPHYLOCOCCUS-AUREUS; NOSOCOMIAL PATHOGEN; LIPOTEICHOIC ACID; GENOME ANALYSIS; GENE-CLUSTER; CELL-WALL	The incidence of multidrug-resistant Enterococcus faecium hospital infections has been steadily increasing. With the goal of discovering new vaccine antigens, we systematically fractionated and purified four distinct surface carbohydrates from E. faecium endocarditis isolate Tx16, shown previously to be resistant to phagocytosis in the presence of human serum. The two most abundant polysaccharides consist of novel branched heteroglycan repeating units that include signature sugars altruronic acid and legionaminic acid, respectively. A minor high molecular weight polysaccharide component was recognized as the fructose homopolymer levan, and a glucosylated lipoteichoic acid (LTA) was identified in a micellar fraction. The polysaccharides were conjugated to the CRM197 carrier protein, and the resulting glycoconjugates were used to immunize rabbits. Rabbit immune sera were evaluated for their ability to kill Tx16 in opsonophagocytic assays and in a mouse passive protection infection model. Although antibodies raised against levan failed to mediate opsonophagocytic killing, the other glycoconjugates induced effective opsonic antibodies, with the altruronic acid-containing polysaccharide antisera showing the greatest opsonophagocytic assay activity. Antibodies directed against either novel heteroglycan or the LTA reduced bacterial load in mouse liver or kidney tissue. To assess antigen prevalence, we screened a diverse collection of blood isolates (n = 101) with antibodies to the polysaccharides. LTA was detected on the surface of 80% of the strains, and antigens recognized by antibodies to the two major heteroglycans were co-expressed on 63% of these clinical isolates. Collectively, these results represent the first steps toward identifying components of a glycoconjugate vaccine to prevent E. faecium infection.	[Kodali, Srinivas; Lin, Fiona; Khoury, Nancy; Hao, Li; Pavliak, Vilo; Jones, C. Hal; Jansen, Kathrin U.; Anderson, Annaliesa S.; Donald, Robert G. K.] Pfizer Vaccine Res & Early Dev, Pearl River, NY 10654 USA; [Vinogradov, Evgeny] CNR, Ottawa, ON K1A 0R6, Canada; [Laverde, Diana; Huebner, Johannes] Univ Hosp, Div Infect Dis, Dept Med, D-79106 Freiburg, Germany; [Huebner, Johannes] Univ Munich, Dr von Hauner Childrens Hosp, Dept Pediat, D-80338 Munich, Germany	Pfizer; National Research Council Canada; University of Freiburg; University of Munich	Donald, RGK (corresponding author), Pfizer Vaccine Res, 401 N Middletown Rd, Pearl River, NY 10965 USA.	robert.donald@pfizer.com	Donald, Robert George Konrad/GNP-4958-2022	Huebner, Johannes/0000-0003-1232-4646	Wellcome Trust	Wellcome Trust(Wellcome TrustEuropean Commission)	Baseclear (Leiden, Netherlands) generated MLST data for the E. faecium blood isolates. We acknowledge the use of the E. faecium MLST database, which is located at Imperial College London and funded by The Wellcome Trust. We thank Michael Gilmore, Barbara Murray, and Rob Willems for strains and Philip Lee (Pfizer) and Lorna Nunez (Pfizer) for help with genome sequencing. We thank Ellen Murphy for help with bioinformatic analysis of putative biosynthetic genes. Dominique Wobser contributed expert technical support for the mouse model. We also thank Dee Illenburger, Jennifer Obregon, and Kathryn Mason for generating rabbit antibodies.	Allen GP, 2009, INT J ANTIMICROB AG, V34, P21, DOI 10.1016/j.ijantimicag.2008.12.011; Anderson AS, 2012, HUM VACC IMMUNOTHER, V8, P1585, DOI 10.4161/hv.21872; ARDUINO RC, 1994, INFECT IMMUN, V62, P5587, DOI 10.1128/IAI.62.12.5587-5594.1994; Arias CA, 2007, CLIN INFECT DIS, V45, P1343, DOI 10.1086/522656; Arias CA, 2012, NAT REV MICROBIOL, V10, P266, DOI 10.1038/nrmicro2761; Arias CA, 2011, NEW ENGL J MED, V365, P892, DOI 10.1056/NEJMoa1011138; Bychowska A, 2011, CARBOHYD RES, V346, P2816, DOI 10.1016/j.carres.2011.09.026; Carlin AF, 2007, J BACTERIOL, V189, P1231, DOI 10.1128/JB.01155-06; Cescutti P, 2003, CARBOHYD RES, V338, P2687, DOI 10.1016/S0008-6215(03)00384-7; CIUCANU I, 1984, CARBOHYD RES, V131, P209, DOI 10.1016/0008-6215(84)85242-8; CLARKE AJ, 1993, ANAL BIOCHEM, V212, P344, DOI 10.1006/abio.1993.1339; CLEWELL DB, 1982, J BACTERIOL, V152, P1220; Clutterbuck EA, 2012, J INFECT DIS, V205, P1408, DOI 10.1093/infdis/jis212; de Roux A, 2008, CLIN INFECT DIS, V46, P1015, DOI 10.1086/529142; DISCHE Z, 1948, J BIOL CHEM, V175, P595; Edmond MB, 1996, CLIN INFECT DIS, V23, P1234, DOI 10.1093/clinids/23.6.1234; Guerrero MLF, 2007, MEDICINE, V86, P363, DOI 10.1097/MD.0b013e31815d5386; Hancock LE, 2002, P NATL ACAD SCI USA, V99, P1574, DOI 10.1073/pnas.032448299; Harding SE, 2012, CARBOHYD POLYM, V90, P237, DOI 10.1016/j.carbpol.2012.05.030; HERMANSSON K, 1990, CARBOHYD RES, V208, P145, DOI 10.1016/0008-6215(90)80094-J; Hidron AI, 2008, INFECT CONT HOSP EP, V29, P996, DOI 10.1086/591861; Hsu CT, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-62; Huebner J, 1999, INFECT IMMUN, V67, P1213, DOI 10.1128/IAI.67.3.1213-1219.1999; Huebner J, 2000, INFECT IMMUN, V68, P4631, DOI 10.1128/IAI.68.8.4631-4636.2000; Joels CS, 2003, AM SURGEON, V69, P514; Jolley KA, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-595; KNIREL YA, 1994, EUR J BIOCHEM, V221, P239, DOI 10.1111/j.1432-1033.1994.tb18734.x; Knirel YA, 2003, ADV CARBOHYD CHEM BI, V58, P371, DOI 10.1016/S0065-2318(03)58007-6; Koczan JM, 2009, PHYTOPATHOLOGY, V99, P1237, DOI 10.1094/PHYTO-99-11-1237; Lam MMC, 2012, J BACTERIOL, V194, P2334, DOI 10.1128/JB.00259-12; Leendertse M, 2009, INFECT IMMUN, V77, P485, DOI 10.1128/IAI.00863-08; Lees A, 1996, VACCINE, V14, P190, DOI 10.1016/0264-410X(95)00195-7; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MacLean LL, 2011, CARBOHYD RES, V346, P2589, DOI 10.1016/j.carres.2011.09.003; Matulova M, 2011, CARBOHYD RES, V346, P501, DOI 10.1016/j.carres.2010.12.012; Morath S, 2001, J EXP MED, V193, P393, DOI 10.1084/jem.193.3.393; Palmer KL, 2012, MBIO, V3, DOI 10.1128/mBio.00318-11; Palmer KL, 2010, J BACTERIOL, V192, P2469, DOI 10.1128/JB.00153-10; Palusinska-Szysz Marta, 2009, Recent Pat Antiinfect Drug Discov, V4, P96; Paoletti Lawrence C, 2002, Semin Neonatol, V7, P315, DOI 10.1053/siny.2002.0114; Qin X, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-135; Rakita RM, 2000, FEMS IMMUNOL MED MIC, V28, P291, DOI 10.1111/j.1574-695X.2000.tb01489.x; SAWARDEKAR JS, 1967, ANAL CHEM, V37, P1602; Schoenhofen IC, 2009, GLYCOBIOLOGY, V19, P715, DOI 10.1093/glycob/cwp039; Schulte B, 2008, EPIDEMIOL INFECT, V136, P1131, DOI 10.1017/S0950268807009508; Schwartz S, 2000, GENOME RES, V10, P577, DOI 10.1101/gr.10.4.577; Sievert DM, 2013, INFECT CONT HOSP EP, V34, P1, DOI 10.1086/668770; Swierzko AS, 1996, FEBS LETT, V398, P297; Teng F, 2009, INFECT IMMUN, V77, P3759, DOI 10.1128/IAI.00149-09; Theilacker C, 2009, INFECTION, V37, P540, DOI 10.1007/s15010-009-9023-5; Theilacker C, 2006, INFECT IMMUN, V74, P5703, DOI 10.1128/IAI.00570-06; Theilacker C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017839; Thurlow LR, 2009, J BACTERIOL, V191, P6203, DOI 10.1128/JB.00592-09; Toniolo C, 2015, J BIOL CHEM, V290, P9521, DOI 10.1074/jbc.M114.631499; Toth A, 2000, BIOORG MED CHEM LETT, V10, P19, DOI 10.1016/S0960-894X(99)00585-5; Tran TT, 2013, ANTIMICROB AGENTS CH, V57, P261, DOI 10.1128/AAC.01454-12; TREVELYAN WE, 1952, NATURE, V170, P626, DOI 10.1038/170626a0; van Schaik W, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-239; Vergis EN, 2001, ANN INTERN MED, V135, P484, DOI 10.7326/0003-4819-135-7-200110020-00007; Vimr E, 2002, TRENDS MICROBIOL, V10, P254, DOI 10.1016/S0966-842X(02)02361-2; Weidenmaier C, 2008, NAT REV MICROBIOL, V6, P276, DOI 10.1038/nrmicro1861; Willems RJL, 2012, MBIO, V3, DOI 10.1128/mBio.00151-12; Willems RJL, 2009, FUTURE MICROBIOL, V4, P1125, DOI [10.2217/fmb.09.82, 10.2217/FMB.09.82]; Zunk M, 2014, RSC ADV, V4, P3413, DOI 10.1039/c3ra44924f	64	21	24	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 7	2015	290	32					19512	19526		10.1074/jbc.M115.655852	http://dx.doi.org/10.1074/jbc.M115.655852			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CO7TL	26109072	Green Published, hybrid			2022-12-26	WOS:000359364600012
J	Sani, MA; Henriques, ST; Weber, D; Separovic, F				Sani, Marc-Antoine; Henriques, Sonia Troeira; Weber, Daniel; Separovic, Frances			Bacteria May Cope Differently from Similar Membrane Damage Caused by the Australian Tree Frog Antimicrobial Peptide Maculatin 1.1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHOLIPID-BILAYER MEMBRANES; LIPID-COMPOSITION; STAPHYLOCOCCUS-AUREUS; LITORIA-GENIMACULATA; CELLS; MECHANISM; INSERTION	Maculatin 1.1 (Mac1) is an antimicrobial peptide from the skin of Australian tree frogs and is known to possess selectivity toward Gram-positive bacteria. Although Mac1 has membrane disrupting activity, it is not known how Mac1 selectively targets Gram-positive over Gram-negative bacteria. The interaction of Mac1 with Escherichia coli, Staphylococcus aureus, and human red blood cells (hRBC) and with their mimetic model membranes is here reported. The peptide showed a 16-fold greater growth inhibition activity against S. aureus (4 mu M) than against E. coli (64 mu M) and an intermediate cytotoxicity against hRBC (30 mu M). Surprisingly, Sytox Green uptake monitored by flow cytometry showed that Mac1 compromised both bacterial membranes with similar efficiency at similar to 20-fold lower concentration than the reported minimum inhibition concentration against S. aureus. Mac1 also reduced the negative potential of S. aureus and E. coli membrane with similar efficacy. Furthermore, liposomes mimicking the cell membrane of S. aureus (POPG/TOCL) and E. coli (POPE/POPG) were lysed at similar concentrations, whereas hRBC-like vesicles (POPC/SM/Chol) remained mostly intact in the presence of Mac1. Remarkably, when POPG/TOCL and POPE/POPG liposomes were co-incubated, Mac1 did not induce leakage from POPE/POPG liposomes, suggesting a preference toward POPG/TOCL membranes that was supported by surface plasma resonance assays. Interestingly, circular dichroism spectroscopy showed a similar helical conformation in the presence of the anionic liposomes but not the hRBC mimics. Overall, the study showed that Mac1 disrupts bacterial membranes in a similar fashion before cell death events and would preferentially target S. aureus over E. coli or hRBC membranes.	[Sani, Marc-Antoine; Weber, Daniel; Separovic, Frances] Univ Melbourne, Sch Chem, Inst Bio21, Parkville, Vic 3010, Australia; [Henriques, Sonia Troeira] Univ Queensland, Inst Mol Biosci, St Lucia, Qld 4072, Australia	University of Melbourne; University of Queensland	Sani, MA (corresponding author), Univ Melbourne, Sch Chem, Parkville, Vic 3010, Australia.	msani@unimelb.edu.au	Weber, Daniel/AAA-2329-2019; Henriques, Sonia Troeira/J-3500-2016; Separovic, Frances/D-9698-2011	Weber, Daniel/0000-0001-8400-767X; Henriques, Sonia Troeira/0000-0001-9564-9651; Separovic, Frances/0000-0002-6484-2763; Sani, Marc-antoine/0000-0003-3284-2176	Australian Research Council [DP140102127, DE120103152]	Australian Research Council(Australian Research Council)	This work was supported in part by Australian Research Council Grant DP140102127 (to F. S.). The authors declare that they have no conflicts of interest with the contents of this article.; Recipient of Discovery Early Career Researcher Award DE120103152 from the Australian Research Council.	Bahar AA, 2013, PHARMACEUTICALS-BASE, V6, P1543, DOI 10.3390/ph6121543; BEINING PR, 1975, J BACTERIOL, V121, P137, DOI 10.1128/JB.121.1.137-143.1975; Brogden KA, 2005, NAT REV MICROBIOL, V3, P238, DOI 10.1038/nrmicro1098; Chia BCS, 2000, EUR J BIOCHEM, V267, P1894, DOI 10.1046/j.1432-1327.2000.01089.x; Chia CSB, 2011, BIOPOLYMERS, V96, P147, DOI 10.1002/bip.21438; Epand RF, 2007, BBA-BIOMEMBRANES, V1768, P2500, DOI 10.1016/j.bbamem.2007.05.023; Filippov A, 2004, BIOPHYS J, V86, P891, DOI 10.1016/S0006-3495(04)74164-8; Gehman JD, 2008, BIOCHEMISTRY-US, V47, P8557, DOI 10.1021/bi800320v; Henriques ST, 2008, BIOPHYS J, V95, P1877, DOI 10.1529/biophysj.108.131458; Henriques ST, 2011, J BIOL CHEM, V286, P24231, DOI 10.1074/jbc.M111.253393; Hoskin DW, 2008, BBA-BIOMEMBRANES, V1778, P357, DOI 10.1016/j.bbamem.2007.11.008; HURST A, 1977, CAN J MICROBIOL, V23, P935, DOI 10.1139/m77-139; Jamasbi E, 2014, AMINO ACIDS, V46, P2759, DOI 10.1007/s00726-014-1833-9; Morein S, 1996, J BIOL CHEM, V271, P6801, DOI 10.1074/jbc.271.12.6801; Prenner EJ, 2001, BBA-BIOMEMBRANES, V1510, P83, DOI 10.1016/S0005-2736(00)00337-0; Ramamoorthy A, 2010, BBA-BIOMEMBRANES, V1798, P223, DOI 10.1016/j.bbamem.2009.08.012; Roth BL, 1997, APPL ENVIRON MICROB, V63, P2421, DOI 10.1128/AEM.63.6.2421-2431.1997; Rozek T, 1998, J PEPT SCI, V4, P111, DOI 10.1002/(SICI)1099-1387(199804)4:2<111::AID-PSC134>3.0.CO;2-8; SALVIOLI G, 1978, GUT, V19, P844, DOI 10.1136/gut.19.9.844; Sando L, 2011, CHEMBIOCHEM, V12, P2456, DOI 10.1002/cbic.201100450; Sani MA, 2013, ANTIMICROB AGENTS CH, V57, P3593, DOI 10.1128/AAC.00195-13; Sani MA, 2014, EUR BIOPHYS J BIOPHY, V43, P445, DOI 10.1007/s00249-014-0970-0; Sani MA, 2012, BBA-BIOMEMBRANES, V1818, P205, DOI 10.1016/j.bbamem.2011.07.015; Sani MA, 2009, BBA-BIOMEMBRANES, V1788, P623, DOI 10.1016/j.bbamem.2008.12.014; Shai Y, 1999, BBA-BIOMEMBRANES, V1462, P55, DOI 10.1016/S0005-2736(99)00200-X; Shai Y, 2002, BIOPOLYMERS, V66, P236, DOI 10.1002/bip.10260; Shepherd NE, 2005, J AM CHEM SOC, V127, P2974, DOI 10.1021/ja0456003; Sudheendra US, 2015, EUR J MED CHEM, V91, P91, DOI 10.1016/j.ejmech.2014.08.021; Thennarasu S, 2010, BIOPHYS J, V98, P248, DOI 10.1016/j.bpj.2009.09.060; Torcato IM, 2013, BBA-BIOMEMBRANES, V1828, P944, DOI 10.1016/j.bbamem.2012.12.002; Tossi A, 2000, BIOPOLYMERS, V55, P4; Wiegand I, 2008, NAT PROTOC, V3, P163, DOI 10.1038/nprot.2007.521; Yeaman MR, 2003, PHARMACOL REV, V55, P27, DOI 10.1124/pr.55.1.2; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a	34	38	38	1	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 7	2015	290	32					19853	19862		10.1074/jbc.M115.643262	http://dx.doi.org/10.1074/jbc.M115.643262			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CO7TL	26100634	Green Published, hybrid			2022-12-26	WOS:000359364600041
J	Kim, B; Figueroa-Romero, C; Pacut, C; Backus, C; Feldman, EL				Kim, Bhumsoo; Figueroa-Romero, Claudia; Pacut, Crystal; Backus, Carey; Feldman, Eva L.			Insulin Resistance Prevents AMPK-induced Tau Dephosphorylation through Akt-mediated Increase in AMPK(Ser-485) Phosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; HIGH-FAT DIET; ALZHEIMERS-DISEASE; COGNITIVE PERFORMANCE; DIABETES-MELLITUS; INCREASED RISK; FOOD-INTAKE; NEURONS; HYPERGLYCEMIA; BRAIN	Metabolic syndrome (MetS) is a cluster of cardiovascular risk factors including obesity, diabetes, and dyslipidemia, and insulin resistance (IR) is the central feature of MetS. Recent studies suggest that MetS is a risk factor for Alzheimer disease (AD). AMP-activated kinase (AMPK) is an evolutionarily conserved fuel-sensing enzyme and a key player in regulating energy metabolism. In this report, we examined the role of IR on the regulation of AMPK phosphorylation and AMPK-mediated Tau phosphorylation. We found that AMPK(Ser-485), but not AMPK(Thr-172), phosphorylation is increased in the cortex of db/db and high fat diet-fed obese mice, two mouse models of IR. In vitro, treatment of human cortical stem cell line (HK-5320) and primary mouse embryonic cortical neurons with the AMPK activator, 5-aminoimidazole-4-carboxamide 1-beta-D-ribofuranoside (AICAR), induced AMPK phosphorylation at both Thr-172 and Ser-485. AMPK activation also triggered Tau dephosphorylation. When IR was mimicked in vitro by chronically treating the cells with insulin, AICAR specifically induced AMPK(Ser-485), but not AMPK(Thr-172), hyperphosphorylation whereas AICAR-induced Tau dephosphorylation was inhibited. IR also resulted in the overactivation of Akt by AICAR treatment; however, preventing Akt overactivation during IR prevented AMPKSer-485 hyperphosphorylation and restored AMPK-mediated Tau dephosphorylation. Transfection of AMPK(S485A) mutant caused similar results. Therefore, our results suggest the following mechanism for the adverse effect of IR on AD pathology: IR -> 3 chronic overactivation of Akt3 -> AMPK(Ser-485) hyperphosphorylation -> inhibition of AMPK-mediated Tau dephosphorylation. Together, our results show for the first time a possible contribution of IR-induced AMPK(Ser-485) phosphorylation to the increased risk of AD in obesity and diabetes.	[Kim, Bhumsoo; Figueroa-Romero, Claudia; Pacut, Crystal; Backus, Carey; Feldman, Eva L.] Univ Michigan, Dept Neurol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Kim, B (corresponding author), Univ Michigan, Dept Neurol, 109 Zina Pitcher Pl,5371 AAT BSRB, Ann Arbor, MI 48109 USA.	bhumsoo@umich.edu	Regan, Clinton/E-6250-2012	Figueroa-Romero, Claudia/0000-0001-7546-4190; Feldman, Eva/0000-0002-9162-2694	National Institutes of Health [1DP3DK094292, 1R24082841]; Program for Neurology Research and Discovery; NATIONAL CANCER INSTITUTE [P30CA046592] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020572, DP3DK094292] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Program for Neurology Research and Discovery; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants 1DP3DK094292 and 1R24082841 (to E. L. F.). This work was also supported by the Program for Neurology Research and Discovery. The authors declare that they have no conflicts of interest with the contents of this article.	Ahren J, 2010, ISLETS, V2, P353, DOI 10.4161.islets.2.6.13619; Arnold SE, 2014, NEUROBIOL DIS, V67, P79, DOI 10.1016/j.nbd.2014.03.011; Biessels GJ, 2005, BIOCHEM SOC T, V33, P1041, DOI 10.1042/BST0331041; Brands AMA, 2005, DIABETES CARE, V28, P726, DOI 10.2337/diacare.28.3.726; Cai ZY, 2012, NEUROMOL MED, V14, P1, DOI 10.1007/s12017-012-8173-2; Carling D, 2008, INT J OBESITY, V32, pS55, DOI 10.1038/ijo.2008.124; Carling D, 2011, NAT CHEM BIOL, V7, P512, DOI [10.1038/nchembio.610, 10.1038/NCHEMBIO.610]; Carlsson CM, 2010, J ALZHEIMERS DIS, V20, P711, DOI 10.3233/JAD-2010-100012; Copps KD, 2012, DIABETOLOGIA, V55, P2565, DOI 10.1007/s00125-012-2644-8; Cox DJ, 2005, DIABETES CARE, V28, P71, DOI 10.2337/diacare.28.1.71; Dagon Y, 2012, CELL METAB, V16, P104, DOI 10.1016/j.cmet.2012.05.010; de la Monte SM, 2009, BMB REP, V42, P475, DOI 10.5483/BMBRep.2009.42.8.475; Du LL, 2015, J ALZHEIMERS DIS, V43, P775, DOI 10.3233/JAD-140564; Duvnjak L, 2009, J PHYSIOL PHARMACOL, V60, P19; Frisardi V, 2010, J ALZHEIMERS DIS, V21, P57, DOI 10.3233/JAD-2010-100015; Galindo MF, 2010, J NEUROCHEM, V114, P933, DOI 10.1111/j.1471-4159.2010.06814.x; Greco SJ, 2011, BIOCHEM BIOPH RES CO, V414, P170, DOI 10.1016/j.bbrc.2011.09.050; Greco SJ, 2009, BIOCHEM BIOPH RES CO, V380, P98, DOI 10.1016/j.bbrc.2009.01.041; HA J, 1994, J BIOL CHEM, V269, P22162; Holscher C, 2011, BIOCHEM SOC T, V39, P891, DOI 10.1042/BST0390891; Horman S, 2006, J BIOL CHEM, V281, P5335, DOI 10.1074/jbc.M506850200; Hurley RL, 2006, J BIOL CHEM, V281, P36662, DOI 10.1074/jbc.M606676200; Janson J, 2004, DIABETES, V53, P474, DOI 10.2337/diabetes.53.2.474; Jessen N, 2003, J APPL PHYSIOL, V94, P1373, DOI 10.1152/japplphysiol.00250.2002; Johnson GVW, 2004, J CELL SCI, V117, P5721, DOI 10.1242/jcs.01558; Kim B, 2013, J ALZHEIMERS DIS, V34, P727, DOI 10.3233/JAD-121669; Kim B, 2012, TRENDS ENDOCRIN MET, V23, P133, DOI 10.1016/j.tem.2011.12.004; Kim B, 2011, ENDOCRINOLOGY, V152, P3638, DOI 10.1210/en.2011-0029; Kim B, 2011, ANTIOXID REDOX SIGN, V14, P1829, DOI 10.1089/ars.2010.3816; Kim B, 2009, ENDOCRINOLOGY, V150, P5294, DOI 10.1210/en.2009-0695; Kimura T, 2010, J BIOL CHEM, V285, P4387, DOI 10.1074/jbc.M109.043869; Kovacic S, 2003, J BIOL CHEM, V278, P39422, DOI 10.1074/jbc.M305371200; Leinninger GM, 2006, NEUROBIOL DIS, V23, P11, DOI 10.1016/j.nbd.2006.01.017; Lester-Coll N, 2006, J ALZHEIMERS DIS, V9, P13; Luchsinger JA, 2002, ARCH NEUROL-CHICAGO, V59, P1258, DOI 10.1001/archneur.59.8.1258; Martin L, 2011, NEUROCHEM INT, V58, P458, DOI 10.1016/j.neuint.2010.12.023; Mihaylova MM, 2011, NAT CELL BIOL, V13, P1016, DOI 10.1038/ncb2329; Ning JY, 2011, ENDOCRINOLOGY, V152, P3143, DOI 10.1210/en.2011-0155; Obrosova IG, 2007, DIABETES, V56, P2598, DOI 10.2337/db06-1176; Ott A, 1999, NEUROLOGY, V53, P1937, DOI 10.1212/WNL.53.9.1937; Peila R, 2002, DIABETES, V51, P1256, DOI 10.2337/diabetes.51.4.1256; Querfurth HW, 2010, NEW ENGL J MED, V362, P329, DOI 10.1056/NEJMra0909142; Salminen A, 2011, J NEUROCHEM, V118, P460, DOI 10.1111/j.1471-4159.2011.07331.x; SZENDREI GI, 1993, J NEUROSCI RES, V34, P243, DOI 10.1002/jnr.490340212; Thornton C, 2011, BIOCHEM J, V434, P503, DOI 10.1042/BJ20101485; Vincent AM, 2005, FASEB J, V19, P638, DOI 10.1096/fj.04-2513fje; Vingtdeux V, 2011, ACTA NEUROPATHOL, V121, P337, DOI 10.1007/s00401-010-0759-x; Vingtdeux V, 2010, J BIOL CHEM, V285, P9100, DOI 10.1074/jbc.M109.060061; Wang XL, 2009, J NEUROSCI, V29, P9090, DOI 10.1523/JNEUROSCI.1357-09.2009; Watcho P, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/268547; Won JS, 2010, BIOCHEM BIOPH RES CO, V399, P487, DOI 10.1016/j.bbrc.2010.07.081; Xue BZ, 2006, J PHYSIOL-LONDON, V574, P73, DOI 10.1113/jphysiol.2006.113217	52	38	39	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 31	2015	290	31					19146	19157		10.1074/jbc.M115.636852	http://dx.doi.org/10.1074/jbc.M115.636852			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CN9PK	26100639	hybrid, Green Published			2022-12-26	WOS:000358781100030
J	Albo, MJ; Peretti, AV				Albo, Maria J.; Peretti, Alfredo V.			Worthless and Nutritive Nuptial Gifts: Mating Duration, Sperm Stored and Potential Female Decisions in Spiders	PLOS ONE			English	Article							MALE COPULATORY COURTSHIP; SEXUAL SELECTION; FERTILIZATION SUCCESS; TRIBOLIUM-CASTANEUM; MALE SACRIFICE; MATE CHOICE; INSECTS; EVOLUTION; MALES; SILK	In nuptial gift-giving species females sometimes select their potential mates based on the presence and size of the gift. But in some species, such as the Neotropical polyandrous spider Paratrechalea ornate male gifts vary in quality, from nutritive to worthless, and this male strategy can be in conflict with female nutritional benefits. In this species, males without gifts experience a reduction in mating success and duration, while males that offer worthless or genuine nutritive gifts mate with similar frequencies and durations. The female apparently controls the duration of copulation. Thus, there is scope for females to favour males offering gifts and further if these are nutritious, via post-copulatory processes. We first tested whether females differentially store sperm from males that offer the highest nutritional benefits by experimentally presenting females with males that offer either nutritive or worthless gifts (uninterrupted matings). Second, we carried out another set of experiments to examine whether females can select sperm based only on gift presence. This time we interrupted matings after the first pedipalp insertion, thus matching number of insertions and mating duration for males that: offered and did not offer gift. Our results showed that the amount of sperm stored is positive related to mating duration in all groups, except in matings with worthless gifts. Gift presence itself did not affect the sperm stored by females, while they store similar number of sperm in matings with males offering either nutritive or worthless gifts. We discuss whether females prefer males with gifts regardless, if content, because it represents an attractive and/or reliable signal. Or alternatively, they prefer nutritive nuptial gifts, as they are an important source of food supply and/or signal of male donor ability.	[Albo, Maria J.] IIBCE, Lab Etol Ecol & Evoluc, Montevideo, Uruguay; [Peretti, Alfredo V.] Univ Nacl Cordoba, CONICET, Inst Diversidad & Ecol Anim, RA-5000 Cordoba, Argentina	Instituto de Investigaciones Biologicas Clemente Estable Uruguay; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Cordoba	Albo, MJ (corresponding author), IIBCE, Lab Etol Ecol & Evoluc, Montevideo, Uruguay.	mjalbograna@gmail.com	Albo, Maria/AAH-6703-2021	Albo, Maria/0000-0003-4332-7612	ANII; Consejo Nacional de Investigaciones Cientificas y Tecnicas of Argentina (CONICET); FONCYT; Secretaria de Ciencia y Tecnica of the Universidad Nacional de Cordoba, Argentina	ANII; Consejo Nacional de Investigaciones Cientificas y Tecnicas of Argentina (CONICET)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); FONCYT(FONCyT); Secretaria de Ciencia y Tecnica of the Universidad Nacional de Cordoba, Argentina(Secretaria de Ciencia y Tecnologia (SECYT))	M.J. Albo was supported by ANII, Uruguay-Ph.D. fellowship 2011-2013. A.V. Peretti was supported by Consejo Nacional de Investigaciones Cientificas y Tecnicas of Argentina (CONICET), FONCYT, and Secretaria de Ciencia y Tecnica of the Universidad Nacional de Cordoba, Argentina. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aisenberg A, 2009, BEHAV ECOL, V20, P1236, DOI 10.1093/beheco/arp117; Albo MJ, 2009, J ZOOL, V277, P284, DOI 10.1111/j.1469-7998.2008.00539.x; Albo MJ, 2014, ANIM BEHAV, V92, P25, DOI 10.1016/j.anbehav.2014.03.018; Albo MJ, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1735; Albo MJ, 2012, ANIM BEHAV, V84, P907, DOI 10.1016/j.anbehav.2012.07.014; Albo MJ, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-329; Albo MJ, 2010, ANIM BEHAV, V79, P1031, DOI 10.1016/j.anbehav.2010.01.018; Andersen T, 2008, ETHOLOGY, V114, P775, DOI 10.1111/j.1439-0310.2008.01529.x; Andersson M, 2006, TRENDS ECOL EVOL, V21, P296, DOI 10.1016/j.tree.2006.03.015; Andrade MCB, 1996, SCIENCE, V271, P70, DOI 10.1126/science.271.5245.70; Andres JA, 2000, ANIM BEHAV, V59, P695, DOI 10.1006/anbe.1999.1372; Arnqvist G, 2000, ANIM BEHAV, V60, P145, DOI 10.1006/anbe.2000.1446; Arnqvist G, 2014, EVOLUTION OF INSECT MATING SYSTEMS, P204; Arnqvist Goran, 2005, pUnpaginated; BARKER DM, 1994, ANIM BEHAV, V48, P147, DOI 10.1006/anbe.1994.1221; Bilde T, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-295; Bretman A, 2009, MOL ECOL, V18, P3340, DOI 10.1111/j.1365-294X.2009.04301.x; Briceno RD, 2009, J INSECT PHYSIOL, V55, P989, DOI 10.1016/j.jinsphys.2009.07.001; Briceno RD, 2009, J EVOLUTION BIOL, V22, P1516, DOI 10.1111/j.1420-9101.2009.01761.x; Bukowski TC, 1997, ANIM BEHAV, V53, P381, DOI 10.1006/anbe.1996.0329; Burger M, 2010, ZOOLOGY, V113, P19, DOI 10.1016/j.zool.2009.04.002; Cordoba-Aguilar A, 2006, PHYSIOL ENTOMOL, V31, P146, DOI 10.1111/j.1365-3032.2005.00498.x; Costa-Schmidt LE, 2008, NATURWISSENSCHAFTEN, V95, P731, DOI 10.1007/s00114-008-0379-7; Eberhard W. G., 1996, FEMALE CONTROL SEXUA; EBERHARD WG, 1994, EVOLUTION, V48, P711, DOI [10.2307/2410481, 10.1111/j.1558-5646.1994.tb01356.x]; EBERHARD WG, 1991, BIOL REV, V66, P1, DOI 10.1111/j.1469-185X.1991.tb01133.x; Edvardsson M, 2000, P ROY SOC B-BIOL SCI, V267, P559, DOI 10.1098/rspb.2000.1037; Engqvist L, 2003, J EVOLUTION BIOL, V16, P1196, DOI 10.1046/j.1420-9101.2003.00613.x; Fedina TY, 2007, J INSECT PHYSIOL, V53, P93, DOI 10.1016/j.jinsphys.2006.10.011; Fisher RA, 1930, GENETICAL THEORY NAT; Foelix R. F, 2011, BIOL SPIDERS; Gwynne Darryl T., 1997, P110, DOI 10.1017/CBO9780511721946.007; Herberstein ME, 2011, BEHAV ECOL, V22, P692, DOI 10.1093/beheco/arr053; Herberstein ME, 2011, J ETHOL, V29, P9, DOI 10.1007/s10164-010-0213-5; Klann AE, 2009, THESIS U GREIFSWALD; Klein AL, 2014, ETHOL ECOL EVOL, V26, P29, DOI 10.1080/03949370.2013.850452; Kokko H, 2001, ECOL LETT, V4, P322, DOI 10.1046/j.1461-0248.2001.00224.x; Lang A, 1996, BEHAVIOUR, V133, P697, DOI 10.1163/156853996X00431; LeBas NR, 2005, CURR BIOL, V15, P64, DOI 10.1016/j.cub.2004.12.043; Lewis S, 2012, ADV STUD BEHAV, V44, P53, DOI 10.1016/B978-0-12-394288-3.00002-2; PARKER GA, 1970, BIOL REV, V45, P525, DOI 10.1111/j.1469-185X.1970.tb01176.x; Peretti AV, 2010, J EVOLUTION BIOL, V23, P271, DOI 10.1111/j.1420-9101.2009.01900.x; Pilastro A, 2007, ANIM BEHAV, V74, P321, DOI 10.1016/j.anbehav.2006.09.016; Pizzari T, 2000, NATURE, V405, P787, DOI 10.1038/35015558; Preston-Mafham KG, 1999, J ZOOL, V247, P239, DOI 10.1111/j.1469-7998.1999.tb00987.x; SAKALUK SK, 1984, SCIENCE, V223, P609, DOI 10.1126/science.223.4636.609; Sauer KP, 1997, ENTOMOL GEN, V21, P189; Schneider JM, 2009, P ROY SOC B-BIOL SCI, V276, P3105, DOI 10.1098/rspb.2009.0694; Simmons LW, 1991, BEHAV ECOLOGY, V12, P691, DOI [10.1093/beheco/2.4.276, DOI 10.1093/BEHECO/2.4.276]; Simmons LW, 2001, MONOGRAPHS BEHAV ECO; Snook RR, 2004, NATURE, V428, P939, DOI 10.1038/nature02455; Snow LSE, 2004, BEHAV ECOL, V15, P785, DOI 10.1093/beheco/arh080; Tallamy DW, 2003, P ROY SOC B-BIOL SCI, V270, P77, DOI 10.1098/rspb.2002.2198; Trillo MC, 2014, NATURWISSENSCHAFTEN, V101, P123, DOI 10.1007/s00114-013-1139-x; Tyler F, 2013, ENTOMOL EXP APPL, V146, P199, DOI 10.1111/j.1570-7458.2012.01292.x; Useta G, 2007, EUR J ENTOMOL, V104, P777, DOI 10.14411/eje.2007.099; Vahed K, 1998, BIOL REV, V73, P43, DOI 10.1017/S0006323197005112; Vahed K, 2007, ETHOLOGY, V113, P105, DOI 10.1111/j.1439-0310.2006.01312.x; Vocking O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072660; ZAHAVI A, 1975, J THEOR BIOL, V53, P205, DOI 10.1016/0022-5193(75)90111-3	60	15	17	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2015	10	6							e0129453	10.1371/journal.pone.0129453	http://dx.doi.org/10.1371/journal.pone.0129453			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4OM	26107397	Green Published, Green Submitted, gold			2022-12-26	WOS:000356932500055
J	Fancourt, BA; Bateman, BL; VanDerWal, J; Nicol, SC; Hawkins, CE; Jones, ME; Johnson, CN				Fancourt, Bronwyn A.; Bateman, Brooke L.; VanDerWal, Jeremy; Nicol, Stewart C.; Hawkins, Clare E.; Jones, Menna E.; Johnson, Christopher N.			Testing the Role of Climate Change in Species Decline: Is the Eastern Quoll a Victim of a Change in the Weather?	PLOS ONE			English	Article							DISTRIBUTION MODELS; DASYURUS-VIVERRINUS; RELATIVE ABUNDANCE; GEOGRAPHICAL RANGE; POPULATION DECLINE; EXTINCTION; DISTRIBUTIONS; PREDICTION; IMPACTS; DISEASE	To conserve a declining species we first need to diagnose the causes of decline. This is one of the most challenging tasks faced by conservation practitioners. In this study, we used temporally explicit species distribution models (SDMs) to test whether shifting weather can explain the recent decline of a marsupial carnivore, the eastern quoll (Dasyurus viverrinus). We developed an SDM using weather variables matched to occurrence records of the eastern quoll over the last 60 years, and used the model to reconstruct variation through time in the distribution of climatically suitable range for the species. The weather model produced a meaningful prediction of the known distribution of the species. Abundance of quolls, indexed by transect counts, was positively related to the modelled area of suitable habitat between 1990 and 2004. In particular, a sharp decline in abundance from 2001 to 2003 coincided with a sustained period of unsuitable weather over much of the species' distribution. Since 2004, abundance has not recovered despite a return to suitable weather conditions, and abundance and area of suitable habitat have been uncorrelated. We suggest that fluctuations in weather account for the species' recent decline, but other unrelated factors have suppressed recovery.	[Fancourt, Bronwyn A.; Nicol, Stewart C.; Hawkins, Clare E.; Jones, Menna E.; Johnson, Christopher N.] Univ Tasmania, Sch Biol Sci, Hobart, Tas, Australia; [Bateman, Brooke L.] Univ Wisconsin, SILVIS Lab, Dept Forest & Wildlife Ecol, Madison, WI USA; [VanDerWal, Jeremy] James Cook Univ, Ctr Trop Biodivers & Climate Change, Townsville, Qld 4811, Australia; [VanDerWal, Jeremy] James Cook Univ, eRes Ctr, Townsville, Qld 4811, Australia	University of Tasmania; University of Wisconsin System; University of Wisconsin Madison; James Cook University; James Cook University	Fancourt, BA (corresponding author), Univ Tasmania, Sch Biol Sci, Hobart, Tas, Australia.	Bronwyn.Fancourt@utas.edu.au	Fancourt, Bronwyn/R-4278-2019; Johnson, Christopher/J-7894-2014	Fancourt, Bronwyn/0000-0003-2969-1530; Johnson, Christopher/0000-0002-9719-3771; Jones, Menna/0000-0001-7558-9022; Hawkins, Clare/0000-0002-1909-2545; Bateman, Brooke/0000-0001-5474-4599	National Climate Change Adaptation Research Facility (Terrestrial Biodiversity Network)	National Climate Change Adaptation Research Facility (Terrestrial Biodiversity Network)	Funding was provided by the National Climate Change Adaptation Research Facility (Terrestrial Biodiversity Network) through a PhD student collaborative travel grant awarded to BAF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Austin M, 2007, ECOL MODEL, V200, P1, DOI 10.1016/j.ecolmodel.2006.07.005; Bateman BL, 2012, ECOGRAPHY, V35, P306, DOI 10.1111/j.1600-0587.2011.06871.x; BLACKHALL S, 1980, AUST WILDLIFE RES, V7, P191, DOI 10.1071/WR9800191; BROWN JH, 1971, ECOLOGY, V52, P305, DOI 10.2307/1934589; BROWN JH, 1984, AM NAT, V124, P255, DOI 10.1086/284267; Burbidge A.A., 2014, P15; CAUGHLEY G, 1994, J ANIM ECOL, V63, P215, DOI 10.2307/5542; Caughley G., 1996, CONSERVATION BIOL TH; Chown SL, 2007, ADV INSECT PHYSIOL, V33, P50; Crooks KR, 1999, NATURE, V400, P563, DOI 10.1038/23028; Department of Primary Industries Parks Water and Environment, 2014, NAT VAL ATL; Driessen MM, 1992, REV ANAL SPOTLIGHT; Dudik Miroslav, 2005, ADV NEURAL INF PROCE, V18, P323; Eckley I.A., 2011, BAYESIAN TIME SERIES; EHRLICH PR, 1980, OECOLOGIA, V46, P101, DOI 10.1007/BF00346973; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Elith J, 2010, METHODS ECOL EVOL, V1, P330, DOI 10.1111/j.2041-210X.2010.00036.x; Elith J, 2009, ECOGRAPHY, V32, P66, DOI 10.1111/j.1600-0587.2008.05505.x; Fancourt BA, 2015, THESIS U TASMANIA; Fancourt BA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119303; Fancourt BA, 2013, AUST MAMMAL, V35, P195, DOI 10.1071/AM13004; FERSON S, 1995, BIOL CONSERV, V73, P101, DOI 10.1016/0006-3207(95)00047-8; Foden W, 2007, DIVERS DISTRIB, V13, P645, DOI 10.1111/j.1472-4642.2007.00391.x; Forest Practices Authority, 2012, STATE FORESTS TASMAN; Gaston KJ, 2000, J APPL ECOL, V37, P39, DOI 10.1046/j.1365-2664.2000.00485.x; Gaston KJ, 2003, STRUCTURE DYNAMICS G; Godsell J., 1982, P199; Godsell J., 1983, THESIS; Guisan A, 2000, ECOL MODEL, V135, P147, DOI 10.1016/S0304-3800(00)00354-9; Hawkins CE, 2006, BIOL CONSERV, V131, P307, DOI 10.1016/j.biocon.2006.04.010; Hocking GJ, 1992, TASMANIAN SPOLIGHTIN; HUTCHINSON GE, 1957, COLD SPRING HARB SYM, V22, P415, DOI 10.1101/SQB.1957.022.01.039; Jiguet F, 2010, GLOBAL CHANGE BIOL, V16, P497, DOI 10.1111/j.1365-2486.2009.01963.x; Jimenez-Valverde A, 2008, DIVERS DISTRIB, V14, P885, DOI 10.1111/j.1472-4642.2008.00496.x; Jones DA, 2009, AUST METEOROL OCEAN, V58, P233, DOI 10.22499/2.5804.003; Jones ME, 1998, J ANIM ECOL, V67, P410, DOI 10.1046/j.1365-2656.1998.00203.x; Jones ME, 1996, PRELIMINARY ASSESSME; Killick R, 2014, J STAT SOFTW, V58, P1; KING DR, 1989, AUST WILDLIFE RES, V16, P131; Lima M, 1998, ACTA THERIOL, V43, P225, DOI 10.4098/AT.arch.98-19; Liu CR, 2005, ECOGRAPHY, V28, P385, DOI 10.1111/j.0906-7590.2005.03957.x; Martin TG, 2012, CONSERV LETT, V5, P274, DOI 10.1111/j.1755-263X.2012.00239.x; McKnight M, 2008, IUCN RED LIST THREAT; O'Grady JJ, 2004, BIOL CONSERV, V118, P513, DOI 10.1016/j.biocon.2003.10.002; PAGE ES, 1954, BIOMETRIKA, V41, P100, DOI 10.1093/biomet/41.1-2.100; Parmesan C, 2000, B AM METEOROL SOC, V81, P443, DOI 10.1175/1520-0477(2000)081<0443:IOEWAC>2.3.CO;2; Peacock D, 2014, AUST J ZOOL, V62, P294, DOI 10.1071/ZO14029; Pearson RG, 2003, GLOBAL ECOL BIOGEOGR, V12, P361, DOI 10.1046/j.1466-822X.2003.00042.x; Peterson AT, 2001, ECOL MODEL, V144, P21, DOI 10.1016/S0304-3800(01)00345-3; Phillips S., 2011, BRIEF TUTORIAL MAXEN; Phillips S.J, 2004, P 21 INT C MACH LEAR, P83, DOI [10.1145/1015330.1015412, DOI 10.1145/1015330.1015412]; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2009, ECOL APPL, V19, P181, DOI 10.1890/07-2153.1; PIGOTT CD, 1981, NEW PHYTOL, V87, P817, DOI 10.1111/j.1469-8137.1981.tb01716.x; Pounds JA, 2006, NATURE, V439, P161, DOI 10.1038/nature04246; PREDAVEC M, 1994, WILDLIFE RES, V21, P569, DOI 10.1071/WR9940569; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; Reddy S, 2003, J BIOGEOGR, V30, P1719, DOI 10.1046/j.1365-2699.2003.00946.x; Reside AE, 2011, ECOL MODEL, V222, P3444, DOI 10.1016/j.ecolmodel.2011.06.015; Reside AE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013569; Rogers TL, 2013, MAR BIOL, V160, P853, DOI 10.1007/s00227-012-2139-7; Roubicek AJ, 2010, ECOL MODEL, V221, P2280, DOI 10.1016/j.ecolmodel.2010.06.021; ROUNSEVELL DE, 1991, WILDLIFE RES, V18, P699, DOI 10.1071/WR9910699; Russell DJF, 2015, DIVERS DISTRIB, V21, P211, DOI 10.1111/ddi.12272; Sarre SD, 2013, J APPL ECOL, V50, P459, DOI 10.1111/1365-2664.12011; Saunders G, 2006, FOXES TASMANAI REPOR; SHAFFER ML, 1981, BIOSCIENCE, V31, P131, DOI 10.2307/1308256; SOULE ME, 1985, BIOSCIENCE, V35, P727, DOI 10.2307/1310054; Southwell C, 1985, INVESTIGATIONS METHO; STCLAIR RC, 1990, COPEIA, P1083; Taylor Robert J., 1993, Papers and Proceedings of the Royal Society of Tasmania, V127, P33; Thomas CD, 1996, AM NAT, V148, P957, DOI 10.1086/285966; VanDerWal J, 2009, AM NAT, V174, P282, DOI 10.1086/600087; VanDerWal J, 2009, ECOL MODEL, V220, P589, DOI 10.1016/j.ecolmodel.2008.11.010; Venier LA, 1998, OIKOS, V82, P483, DOI 10.2307/3546369; White CJ, 2010, CLIMATE FUTURE TASMA; Wiley E. O., 2003, OCEANOGRAPHY, V16, P120, DOI [http://dx.doi.org/10.5670/oceanog.2003.42, DOI 10.5670/OCEANOG.2003.42, 10.5670/oceanog.2003.42]; Wilson KA, 2005, BIOL CONSERV, V122, P99, DOI 10.1016/j.biocon.2004.07.004; Winder M, 2004, ECOLOGY, V85, P2100, DOI 10.1890/04-0151; WOODWARD FI, 1990, PHILOS T ROY SOC B, V326, P585, DOI 10.1098/rstb.1990.0033; Zimmermann NE, 2009, P NATL ACAD SCI USA, V106, P19723, DOI 10.1073/pnas.0901643106	81	18	19	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2015	10	6							e0129420	10.1371/journal.pone.0129420	http://dx.doi.org/10.1371/journal.pone.0129420			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4OM	26106887	Green Submitted, Green Published, Green Accepted, gold			2022-12-26	WOS:000356932500052
J	Lin, YC; Lin, YC; Hsu, CY; Kao, CC; Chang, FC; Chen, TW; Chen, HH; Hsu, CC; Wu, MS				Lin, Yen-Chung; Lin, Yi-Chun; Hsu, Chiao-Ying; Kao, Chih-Chin; Chang, Fan-Chi; Chen, Tzen-Wen; Chen, Hsi-Hsien; Hsu, Chi-Cheng; Wu, Mai-Szu		Taiwan Soc Nephrology	Effect Modifying Role of Serum Calcium on Mortality-Predictability of PTH and Alkaline Phosphatase in Hemodialysis Patients: An Investigation Using Data from the Taiwan Renal Registry Data System from 2005 to 2012	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; PARATHYROID-HORMONE; CARDIOVASCULAR-DISEASE; PERITONEAL-DIALYSIS; BONE-DISEASE; ASSOCIATION; PHOSPHORUS; CALCIFICATION; SURVIVAL; COHORT	Predicting mortality in dialysis patients based on low intact parathyroid hormone levels is difficult, because aluminum intoxication, malnutrition, older age, race, diabetes, or peritoneal dialysis may influence these levels. We investigated the clinical implications of low parathyroid hormone levels in relation to the mortality of dialysis patients using sensitive, stratified, and adjusted models and a nationwide dialysis database. We analyzed data from 2005 to 2012 that were held on the Taiwan Renal Registry Data System, and 94,983 hemodialysis patients with valid data regarding their intact parathyroid levels were included in this study. The patient cohort was subdivided based on the intact parathyroid hormone and alkaline phosphatase levels. The mean hemodialysis duration within this cohort was 3.5 years. The mean (standard deviation) age was 62 (14) years. After adjusting for age, sex, diabetes, the hemodialysis duration, serum albumin levels, hematocrit levels, calcium levels, phosphate levels, and the hemodialysis treatment adequacy score, the single-pool Kt/V, the crude and adjusted all-cause mortality rates increased when alkaline phosphatase levels were higher or intact parathyroid hormone levels were lower. In general, at any given level of serum calcium or phosphate, patients with low intact parathyroid hormone levels had higher mortality rates than those with normal or high iPTH levels. At a given alkaline phosphatase level, the hazard ratio for all-cause mortality was 1.33 (p < 0.01, 95% confidence interval 1.27-1.39) in the group with intact parathyroid hormone levels < 150 pg/mL and serum calcium levels > 9.5 mg/dL, but in the group with intact parathyroid hormone levels > 300 pg/mL and serum calcium levels > 9.5 mg/dL, the hazard ratio was 0.92 (95% confidence interval 0.85-1.01). Hence, maintaining albumin-corrected high serum calcium levels at > 9.5 mg/dL may correlate with poor prognoses for patients with low intact parathyroid hormone levels.	[Lin, Yen-Chung; Hsu, Chiao-Ying; Kao, Chih-Chin; Chang, Fan-Chi; Chen, Tzen-Wen; Chen, Hsi-Hsien; Wu, Mai-Szu] Taipei Med Univ Hosp, Div Nephrol, Dept Internal Med, Taipei, Taiwan; [Lin, Yen-Chung; Wu, Mai-Szu] Taipei Med Univ, Sch Med, Dept Internal Med, Coll Med, Taipei, Taiwan; [Lin, Yen-Chung] Taipei Med Univ, Grad Inst Clin Med, Coll Med, Taipei, Taiwan; [Lin, Yi-Chun] Taipei Vet Gen Hosp, Div Endocrinol & Metab, Dept Med, Taipei, Taiwan; [Lin, Yi-Chun] Natl Yang Ming Univ, Fac Med, Taipei 112, Taiwan; [Hsu, Chi-Cheng] Natl Hlth Res Inst, Ctr Hlth Policy Res & Dev, Miaoli, Taiwan	Taipei Medical University; Taipei Medical University Hospital; Taipei Medical University; Taipei Medical University; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; National Health Research Institutes - Taiwan	Wu, MS (corresponding author), Taipei Med Univ Hosp, Div Nephrol, Dept Internal Med, Taipei, Taiwan.	maiszuwu@gmail.com	Chang, Fan-Chi/GOK-2657-2022	lin, yenchung/0000-0002-8981-8671; HUNG, KUAN-YU/0000-0003-3472-5512; WU, KWAN-DUN/0000-0002-3339-1509				[Anonymous], 2008, ACTA NEPHROLOGICA, V22, P215; Barreto FC, 2008, KIDNEY INT, V73, P771, DOI 10.1038/sj.ki.5002769; Cantor T, 2006, CLIN CHEM, V52, P1771, DOI 10.1373/clinchem.2006.071589; Dukkipati R, 2010, J RENAL NUTR, V20, P243, DOI 10.1053/j.jrn.2009.10.006; Filipowicz R, 2013, CLIN J AM SOC NEPHRO, V8, P26, DOI 10.2215/CJN.12031111; Fournier A, 1997, Adv Nephrol Necker Hosp, V27, P131; Fukagawa M, 2000, CURR OPIN NEPHROL HY, V9, P363, DOI 10.1097/00041552-200007000-00007; Huang CC, 2008, PERITON DIALYSIS INT, V28, pS15; Hwang SJ, 2008, NEPHROL DIAL TRANSPL, V23, P3192, DOI 10.1093/ndt/gfn222; Hwang SJ, 2010, NEPHROL DIAL TRANSPL, V25, P2616, DOI 10.1093/ndt/gfq308; Inaba M, 2004, CLIN CHEM, V50, P385, DOI 10.1373/clinchem.2003.026831; Jean G, 2011, NEPHRON CLIN PRACT, V118, pC211, DOI 10.1159/000321642; Jeloka Tarun, 2012, J Assoc Physicians India, V60, P102; Lau WL, 2014, HEMODIAL INT, V18, P720, DOI 10.1111/hdi.12190; Levine BS, 2014, NEFROLOGIA, V34, P658, DOI 10.3265/Nefrologia.pre2014.Jun.12379; Li JN, 2013, NEPHROL DIAL TRANSPL, V28, P1516, DOI 10.1093/ndt/gfs598; Lin Y-C., 2014, ACTANEPHROLOGICA, V28, P65, DOI 10.6221/AN.2014011; Locatelli F, 2002, NEPHROL DIAL TRANSPL, V17, P723, DOI 10.1093/ndt/17.5.723; Maruyama Y, 2014, NEPHROL DIAL TRANSPL; Mason MA, 2010, PHARMACOTHERAPY, V30, P741, DOI 10.1592/phco.30.7.741; Natoli JL, 2013, BMC NEPHROL, V14, DOI 10.1186/1471-2369-14-88; Palmer SC, 2011, JAMA-J AM MED ASSOC, V305, P1119, DOI 10.1001/jama.2011.308; Raggi P, 2002, J AM COLL CARDIOL, V39, P695, DOI 10.1016/S0735-1097(01)01781-8; Regidor DL, 2008, J AM SOC NEPHROL, V19, P2193, DOI 10.1681/ASN.2008010014; Rhee CM, 2014, PERITON DIALYSIS INT, V34, P732, DOI 10.3747/pdi.2013.00110; Rivara MB, 2015, J AM SOC NEPHROL; Shantouf R, 2009, CLIN J AM SOC NEPHRO, V4, P1106, DOI 10.2215/CJN.06091108; Stevens LA, 2004, J AM SOC NEPHROL, V15, P770, DOI 10.1097/01.ASN.0000113243.24155.2F; Stolic R, 2010, MED HYPOTHESES, V75, P497, DOI 10.1016/j.mehy.2010.07.004; Streja E, 2014, BONE, V61, P201, DOI 10.1016/j.bone.2014.01.016; Tangri N, 2011, AM J KIDNEY DIS, V57, P415, DOI 10.1053/j.ajkd.2010.08.037; Tentori F, 2008, AM J KIDNEY DIS, V52, P519, DOI 10.1053/j.ajkd.2008.03.020; Wang AY, 2014, PERIT DIAL INT; Yang WC, 2008, NEPHROL DIAL TRANSPL, V23, P3977, DOI 10.1093/ndt/gfn406; Zhang CL, 2013, BMC NEPHROL, V14, DOI 10.1186/1471-2369-14-226	35	7	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2015	10	6							e0129737	10.1371/journal.pone.0129737	http://dx.doi.org/10.1371/journal.pone.0129737			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4OM	26107510	gold, Green Published, Green Submitted			2022-12-26	WOS:000356932500066
J	Cokl, A; Laumann, RA; Kosi, AZ; Blassioli-Moraes, MC; Virant-Doberlet, M; Borges, M				Cokl, Andrej; Laumann, Raul Alberto; Kosi, Alenka Zunic; Blassioli-Moraes, Maria Carolina; Virant-Doberlet, Meta; Borges, Miguel			Interference of Overlapping Insect Vibratory Communication Signals: An Eushistus heros Model	PLOS ONE			English	Article							BORNE VIBRATIONAL SIGNALS; VIRIDULA L HETEROPTERA; GREEN STINK BUG; NEZARA-VIRIDULA; HOST PLANTS; SUBSTRATE; BEHAVIOR; HEMIPTERA; SONGS	Plants limit the range of insect substrate-borne vibratory communication by their architecture and mechanical properties that change transmitted signal time, amplitude and frequency characteristics. Stinkbugs gain higher signal-to-noise ratio and increase communication distance by emitting narrowband low frequency vibratory signals that are tuned with transmission properties of plants. The objective of the present study was to investigate hitherto overlooked consequences of duetting with mutually overlapped narrowband vibratory signals. The overlapped vibrations of the model stinkbug species Eushistus heros, produced naturally or induced artificially on different plants, have been analysed. They represent female and male strategies to preserve information within a complex masked signal. The brown stinkbugs E. heros communicate with species and gender specific vibratory signals that constitute characteristic duets in the calling, courtship and rivalry phases of mating behaviour. The calling female pulse overlaps the male vibratory response when the latency of the latter is shorter than the duration of the female triggering signal or when the male response does not inhibit the following female pulse. Overlapping of signals induces interference that changes their amplitude pattern to a sequence of regularly repeated pulses in which their duration and the difference between frequencies of overlapped vibrations are related inversely. Interference does not occur in overlapped narrow band female calling pulses and broadband male courtship pulse trains. In a duet with overlapped signals females and males change time parameters and increase the frequency difference between signals by changing the frequency level and frequency modulation pattern of their calls.	[Cokl, Andrej; Kosi, Alenka Zunic; Virant-Doberlet, Meta] Natl Inst Biol, Dept Entomol, Ljubljana, Slovenia; [Laumann, Raul Alberto; Blassioli-Moraes, Maria Carolina; Borges, Miguel] EMBRAPA Genet Resources & Biotechnol, Semiochem Lab, Brasilia, DF, Brazil	National Institute of Biology - Slovenia; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA)	Cokl, A (corresponding author), Natl Inst Biol, Dept Entomol, Ljubljana, Slovenia.	Andrej.cokl@nib.si	Borges, Miguel/K-9918-2019; laumann, raul/AAC-4416-2019; Blassioli-Moraes, Maria carolina/C-6072-2013; Virant-Doberlet, Meta/G-9251-2019; Borges, Miguel/C-6937-2013	Borges, Miguel/0000-0003-3364-9677; laumann, raul/0000-0003-3531-2613; Blassioli-Moraes, Maria carolina/0000-0001-7569-9985; Virant-Doberlet, Meta/0000-0001-7510-2392; Zunic Kosi, Alenka/0000-0003-4774-6902	Slovenian Research Agency [P1-0255, BI-BR/12-12/002]; CNPq-MHNEST [40245/2011-0]	Slovenian Research Agency(Slovenian Research Agency - Slovenia); CNPq-MHNEST	Slovenian Research Agency, program number: P1-0255, project number: BI-BR/12-12/002 and CNPq-MHNEST 40245/2011-0. Authors who received funding from the above mentioned funder: AC. The founders had no role in study design, data collection and analyses, decision to publish, or preparation of the manuscript.	[Anonymous], STUDYING VIBRATIONAL; Bagwell GJ, 2008, ANN ENTOMOL SOC AM, V101, P235, DOI 10.1603/0013-8746(2008)101[235:CACOSV]2.0.CO;2; BRENNAN BM, 1977, ENVIRON ENTOMOL, V6, P169, DOI 10.1093/ee/6.1.169; Broughton W. B., 1963, ACOUSTIC BEHAVIOUR A, P3; Cocroft RB, 2005, BIOSCIENCE, V55, P323, DOI 10.1641/0006-3568(2005)055[0323:TBEOIV]2.0.CO;2; Cokl A, 2005, J EXP BIOL, V208, P1481, DOI 10.1242/jeb.01557; Cokl A, 2003, ANNU REV ENTOMOL, V48, P29, DOI 10.1146/annurev.ento.48.091801.112605; COKL A, 1983, J COMP PHYSIOL, V150, P261; Cokl A, 2000, PHYSIOL ENTOMOL, V25, P196, DOI 10.1046/j.1365-3032.2000.00187.x; Cokl A., 2014, STUDYING VIBRATIONAL, P171; Cokl AJ, 2006, PHYSIOL ENTOMOL, V31, P371, DOI 10.1111/j.1365-3032.2006.00530.x; Cokl A, 2008, J INSECT PHYSIOL, V54, P1113, DOI 10.1016/j.jinsphys.2008.06.004; Cokl A, 2007, BEHAV PROCESS, V75, P40, DOI 10.1016/j.beproc.2007.01.003; Cremer L., 2005, STRUCTURE BORNE SOUN, V3rd edn.; de Groot M, 2011, BEHAV ECOL, V22, P1209, DOI 10.1093/beheco/arr115; de Groot M, 2011, CENT EUR J BIOL, V6, P756, DOI 10.2478/s11535-011-0056-2; Eriksson A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019692; GOGALA M, 1974, Bioloski Vestnik, V22, P209; Gogala M, 2006, CONT T ENT, P275; Hrabar Nika, 2004, Acta Zoologica Sinica, V50, P566; irant-Doberlet M., 2014, STUDYING VIBRATIONAL, P93; Kavcic A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056503; Legendre F, 2012, ANIM BEHAV, V83, P361, DOI 10.1016/j.anbehav.2011.11.003; Mazzoni V, 2009, ENTOMOL EXP APPL, V133, P174, DOI 10.1111/j.1570-7458.2009.00911.x; McBrien HL, 2003, CAN ENTOMOL, V135, P555; MICHEL K, 1983, REV CAN BIOL EXPTL, V42, P139; Michelsen A, 2014, STUDYING VIBRATIONAL, P199, DOI DOI 10.1007/978-3-662-43607-3_11; Miklas N, 2001, J INSECT BEHAV, V14, P313, DOI 10.1023/A:1011115111592; Moraes MCB, 2005, PHYSIOL ENTOMOL, V30, P175, DOI 10.1111/j.1365-3032.2005.00446.x; Polajnar J, 2008, CENT EUR J BIOL, V3, P189, DOI 10.2478/s11535-008-0008-7; Polajnar J, 2012, J R SOC INTERFACE, V9, P1898, DOI 10.1098/rsif.2011.0770; Rodriguez RL, 2012, BEHAV ECOL, V23, P1218, DOI 10.1093/beheco/ars105; Rodriguez RL, 2004, EVOLUTION, V58, P571, DOI 10.1111/j.0014-3820.2004.tb01679.x; Virant-Doberlet M, 2006, CONT T ENT, P81; Zorovic M, 2008, J COMP NEUROL, V508, P365, DOI 10.1002/cne.21656; Zorovic M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026843; Zunic A, 2011, J INSECT BEHAV, V24, P468, DOI 10.1007/s10905-011-9272-x	37	14	14	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2015	10	6							e0130775	10.1371/journal.pone.0130775	http://dx.doi.org/10.1371/journal.pone.0130775			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL3FM	26098637	Green Published, Green Submitted, gold			2022-12-26	WOS:000356835800102
J	Delerue, F; Gonzalez, M; Michalet, R; Pellerin, S; Augusto, L				Delerue, Florian; Gonzalez, Maya; Michalet, Richard; Pellerin, Sylvain; Augusto, Laurent			Weak Evidence of Regeneration Habitat but Strong Evidence of Regeneration Niche for a Leguminous Shrub	PLOS ONE			English	Article							SPECIES COEXISTENCE; PINUS-PINASTER; PLANT-COMMUNITIES; N-2 FIXATION; PHOSPHORUS; SURVIVAL; TEMPERATE; SEEDLINGS; FOREST; HETEROGENEITY	The identification of an ecological niche specific to the regeneration phase has mobilised significant attention. However, the importance of the regeneration niche concept remains unclear. Our main objective was to study the existence of such a regeneration niche for a leguminous shrub, Ulex europaeus. This study was carried out in southwest France in the context of water and nutrient stresses (mainly phosphorus limitation) due to the presence of nutrient-poor sandy soils. We analysed the regeneration of the species from the germination of seeds and emergence of new seedlings until the seedlings reached young shrub size. Our design included a P fertilisation treatment. We also investigated microsite characteristics (micro-topography and vegetation development) as they can interact with meteorological conditions and determine water availability for seeds and seedlings. We found that P availability controlled seedling growth and the time necessary to reach young shrub size. Water availability appeared to impact the species germination and seedlings survival. We also found that P and water availability depended on the interactions between microsite characteristics and climatic variations. Finally we found evidence that P and water availability are important ecological factors shaping the regeneration niche of the species, but we found weak evidence that any microsite would be appropriate for the regeneration of the species in the long term. Future studies regarding regeneration niches need to distinguish more clearly the ecological factors important for regeneration (the regeneration niche per se) and the physical world where the seedlings appear and develop (the regeneration habitat).	[Delerue, Florian; Gonzalez, Maya; Pellerin, Sylvain; Augusto, Laurent] INRA, UMR ISPA 1391, F-33140 Villenave Dornon, France; [Delerue, Florian; Gonzalez, Maya] Bordeaux Sci Agro, UMR ISPA 1391, F-33883 Gradignan, France; [Delerue, Florian] Bordeaux INP, G&E, EA 4592, F-33600 Pessac, France; [Delerue, Florian] Univ Bordeaux Montaigne, G&E, EA 4592, F-33600 Pessac, France; [Michalet, Richard] Univ Bordeaux, UMR EPOC 5805, F-33405 Talence, France	INRAE; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; Universite de Bordeaux	Delerue, F (corresponding author), INRA, UMR ISPA 1391, F-33140 Villenave Dornon, France.	florian.delerue@bordeaux-inp.fr		Delerue, Florian/0000-0002-9809-5321; AUGUSTO, Laurent/0000-0002-7049-6000; Gonzalez, Maya/0000-0002-5589-3227	ABIOGEN project (FEDER) [32973]	ABIOGEN project (FEDER)	We thank David Achat, Mark Bakker, Anne Budynek, Nathalie Gallegos, SylvieMillin and Sylvie Niollet for their field support. We are grateful to Pierre Trichet and the INRA Experimental Unit for the preparation of the experimental stand. We thank Alexandre Bosc, Christophe Chipeaux, Helene Lagraulet and Jean Marc Gion for their help regarding soil water content data. The experimental stand management was done by the GIS 'pin maritime du futur', and granted by the Conseil Regional d'Aquitaine and the French Ministry of Agriculture, Food and Forest. Soil water content data were measured in the context of the ABIOGEN project (FEDER no 32973).	Augusto L, 2005, CAN J FOREST RES, V35, P1183, DOI 10.1139/X05-054; Augusto L, 2010, EUR J SOIL SCI, V61, P807, DOI 10.1111/j.1365-2389.2010.01286.x; Augusto L, 2013, GLOBAL BIOGEOCHEM CY, V27, P804, DOI 10.1002/gbc.20069; Baraloto C, 2004, OECOLOGIA, V141, P701, DOI 10.1007/s00442-004-1691-3; Beckage B, 2003, ECOLOGY, V84, P1849, DOI 10.1890/0012-9658(2003)084[1849:SSAGOT]2.0.CO;2; Beckage B, 2005, J ECOL, V93, P1177, DOI 10.1111/j.1365-2745.2005.01053.x; Brooker RW, 2008, J ECOL, V96, P18, DOI 10.1111/j.1365-2745.2007.01295.x; Callaway RM, 1997, ECOLOGY, V78, P1958, DOI 10.1890/0012-9658(1997)078[1958:CAFASA]2.0.CO;2; Cavard X, 2007, ANN FOREST SCI, V64, P875, DOI 10.1051/forest:2007066; Ceccon E, 2003, FOREST ECOL MANAG, V182, P387, DOI 10.1016/S0378-1127(03)00085-9; Christie DA, 2003, J ECOL, V91, P776, DOI 10.1046/j.1365-2745.2003.00813.x; Colwell RK, 2009, P NATL ACAD SCI USA, V106, P19651, DOI 10.1073/pnas.0901650106; de la Cruz M, 2008, ECOGRAPHY, V31, P720, DOI 10.1111/j.0906-7590.2008.05299.x; De Luis M, 2008, ECOLOGY, V89, P3061, DOI 10.1890/07-1828.1; De Luis M, 2005, J ENVIRON MANAGE, V76, P159, DOI 10.1016/j.jenvman.2005.01.014; De Luis M, 2008, ECOGRAPHY, V31, P620, DOI 10.1111/j.0906-7590.2008.05433.x; Delerue F, 2013, ANN FOREST SCI, V70, P219, DOI 10.1007/s13595-012-0260-x; Gonzalez M, 2013, FOREST ECOL MANAG, V289, P38, DOI 10.1016/j.foreco.2012.10.026; Gonzalez M, 2010, SEED SCI RES, V20, P31, DOI 10.1017/S0960258509990237; GRANIER A, 1990, AGR FOREST METEOROL, V51, P309, DOI 10.1016/0168-1923(90)90115-M; GRUBB PJ, 1977, BIOL REV, V52, P107, DOI 10.1111/j.1469-185X.1977.tb01347.x; HARTGERINK AP, 1984, ECOLOGY, V65, P198, DOI 10.2307/1939471; Hartmann H, 2013, NEW PHYTOL, V200, P340, DOI 10.1111/nph.12331; Hill RL, 1996, PROCEEDINGS OF THE FORTY NINTH NEW ZEALAND PLANT PROTECTION CONFERENCE, P114, DOI 10.30843/nzpp.1996.49.11440; Holmgren M, 1997, ECOLOGY, V78, P1966; HUTCHINSON GE, 1957, COLD SPRING HARB SYM, V22, P415, DOI 10.1101/SQB.1957.022.01.039; Ivens G.W., 1982, P NZ WEED PEST CONTR, P152; Jin MG, 1999, AGR WATER MANAGE, V42, P173, DOI 10.1016/S0378-3774(99)00039-6; Jonard M, 2010, ECOL MODEL, V221, P927, DOI 10.1016/j.ecolmodel.2009.12.017; Laurans M, 2012, J ECOL, V100, P1440, DOI 10.1111/j.1365-2745.2012.02007.x; Le Bagousse-Pinguet Y, 2013, J VEG SCI, V24, P375, DOI 10.1111/j.1654-1103.2012.01462.x; Marks PL, 1998, J TORREY BOT SOC, V125, P287, DOI 10.2307/2997242; McInerny GJ, 2012, J BIOGEOGR, V39, P2096, DOI 10.1111/jbi.12033; Michalet R, 2003, PLANT ECOL, V165, P145, DOI 10.1023/A:1022297624381; Michalet R, 2006, ECOL LETT, V9, P767, DOI 10.1111/j.1461-0248.2006.00935.x; Nakashizuka T, 2001, TRENDS ECOL EVOL, V16, P205, DOI 10.1016/S0169-5347(01)02117-6; Neatrour MA, 2007, J ECOL, V95, P1274, DOI 10.1111/j.1365-2745.2007.01304.x; Oberson A, 2007, PLANT SOIL, V290, P69, DOI 10.1007/s11104-006-9122-3; Powers MD, 2008, FOREST ECOL MANAG, V256, P2127, DOI 10.1016/j.foreco.2008.08.003; Raventos J, 2012, ACTA OECOL, V38, P17, DOI 10.1016/j.actao.2011.08.004; Rees M, 2001, J APPL ECOL, V38, P364, DOI 10.1046/j.1365-2664.2001.00598.x; Ren X, 2010, J AGRON CROP SCI, V196, P109, DOI 10.1111/j.1439-037X.2009.00401.x; Rizopoulos D, 2010, J STAT SOFTW, V35, P1; Santana VM, 2012, ACTA OECOL, V39, P51, DOI 10.1016/j.actao.2011.12.001; SHIBATA M, 1995, ECOLOGY, V76, P1099, DOI 10.2307/1940918; SIPE TW, 1995, ECOLOGY, V76, P1587, DOI 10.2307/1938160; STRENG DR, 1989, ECOL MONOGR, V59, P177, DOI 10.2307/2937285; Trichet P, 2009, FOREST SCI, V55, P390; Uliassi DD, 2000, ECOSCIENCE, V7, P73, DOI 10.1080/11956860.2000.11682574; Valladares F, 2003, ANN BOT-LONDON, V91, P577, DOI 10.1093/aob/mcg059; Verdu M, 2005, ECOLOGY, V86, P1385, DOI 10.1890/04-1647; Vitousek PM, 2002, BIOGEOCHEMISTRY, V57, P1, DOI 10.1023/A:1015798428743; WHITTAKER RH, 1973, AM NAT, V107, P321, DOI 10.1086/282837; WIENS JA, 1989, FUNCT ECOL, V3, P385, DOI 10.2307/2389612; Wright SJ, 2002, OECOLOGIA, V130, P1, DOI 10.1007/s004420100809; Zhang BC, 2016, J BASIC MICROB, V56, P670, DOI 10.1002/jobm.201500751	56	8	8	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2015	10	6							e0130886	10.1371/journal.pone.0130886	http://dx.doi.org/10.1371/journal.pone.0130886			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL3FM	26098877	Green Published, gold, Green Submitted			2022-12-26	WOS:000356835800117
J	Freire, MAM; Faber, J; Lemos, NAM; Santos, JR; Cavalcanti, PF; Lima, RH; Morya, E				Freire, Marco Aurelio M.; Faber, Jean; Lemos, Nelson Alessandretti M.; Santos, Jose Ronaldo; Cavalcanti, Pedro Franca; Lima, Ramon Hypolito; Morya, Edgard			Distribution and Morphology of Calcium-Binding Proteins Immunoreactive Neurons following Chronic Tungsten Multielectrode Implants	PLOS ONE			English	Article							BRAIN-INJURY; CHEMICAL CHARACTERISTICS; CEREBRAL-CORTEX; INTERNEURONS; CALRETININ; VULNERABILITY; DEGENERATION; CONNECTIONS; RECORDINGS; RESISTANCE	The development of therapeutic approaches to improve the life quality of people suffering from different types of body paralysis is a current major medical challenge. Brain-machine interface (BMI) can potentially help reestablishing lost sensory and motor functions, allowing patients to use their own brain activity to restore sensorimotor control of paralyzed body parts. Chronic implants of multielectrodes, employed to record neural activity directly from the brain parenchyma, constitute the fundamental component of a BMI. However, before this technique may be effectively available to human clinical trials, it is essential to characterize its long-term impact on the nervous tissue in animal models. In the present study we evaluated how chronic implanted tungsten microelectrode arrays impact the distribution and morphology of interneurons reactive to calcium-binding proteins calbindin (CB), calretinin (CR) and parvalbumin (PV) across the rat's motor cortex. Our results revealed that chronic microelectrode arrays were well tolerated by the nervous tissue, with recordings remaining viable for up to 6 months after implantation. Furthermore, neither the morphology nor the distribution of inhibitory neurons were broadly impacted. Moreover, restricted microglial activation was observed on the implanted sites. On the whole, our results confirm and expand the notion that tungsten multielectrodes can be deemed as a feasible candidate to future human BMI studies.	[Freire, Marco Aurelio M.; Lemos, Nelson Alessandretti M.; Cavalcanti, Pedro Franca; Morya, Edgard] Santos Dumont Inst, ELS IIN, Macaiba, RN, Brazil; [Faber, Jean] Fed Univ Sao Paulo UNIFESP, Dept Sci & Technol, Lab Neuroengn, Sao Jose Dos Campos, SP, Brazil; [Santos, Jose Ronaldo] Fed Univ Sergipe UFS, Dept Biosci, Lab Neurosci, Itabaiana, SE, Brazil; [Lima, Ramon Hypolito] Fed Univ Rio Grande Norte UFRN, Dept Physiol, Memory Studies Lab, Natal, RN, Brazil; [Morya, Edgard] Sirio Libanes Hosp, Assoc Alberto Santos Dumont Apoio Pesquisa, Sao Paulo, SP, Brazil	Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal do Rio Grande do Norte; Hospital Sirio Libanes	Morya, E (corresponding author), Santos Dumont Inst, ELS IIN, Macaiba, RN, Brazil.	edgard@isd.org.br	Santos, José R/N-2505-2013; Lima, Ramon H/I-1032-2012; MORYA, EDGARD/R-1251-2019; Freire, Marco/A-1450-2010; Alessandretti de Mello Lemos, Nelson/N-1413-2014	Lima, Ramon H/0000-0002-5471-9147; MORYA, EDGARD/0000-0003-0954-5317; Freire, Marco/0000-0002-6483-0498; Santos, Jose Ronaldo/0000-0001-9108-7532; Faber, Jean/0000-0002-2129-8251; Alessandretti de Mello Lemos, Nelson/0000-0001-9382-9982	Associacao Alberto Santos Dumont para Apoio a Pesquisa, Financiadora de Estudos e Projetos [01.06.1092.00]; Fundacao de Apoio a Pesquisa do Rio Grande do Norte, Instituto Nacional de Interface Cerebro-Maquina [704134/2009]; Instituto de Ensino e Pesquisa Alberto Santos Dumont; CAPES/PNPD postdoctoral fellowship	Associacao Alberto Santos Dumont para Apoio a Pesquisa, Financiadora de Estudos e Projetos; Fundacao de Apoio a Pesquisa do Rio Grande do Norte, Instituto Nacional de Interface Cerebro-Maquina; Instituto de Ensino e Pesquisa Alberto Santos Dumont; CAPES/PNPD postdoctoral fellowship	This study was supported by Associacao Alberto Santos Dumont para Apoio a Pesquisa, Financiadora de Estudos e Projetos (01.06.1092.00), Fundacao de Apoio a Pesquisa do Rio Grande do Norte, Instituto Nacional de Interface Cerebro-Maquina (704134/2009) and Instituto de Ensino e Pesquisa Alberto Santos Dumont. RHL is recipient of a CAPES/PNPD postdoctoral fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allan SM, 2001, NAT REV NEUROSCI, V2, P734, DOI 10.1038/35094583; Buritica E, 2009, J NEUROTRAUM, V26, P2145, DOI 10.1089/neu.2009.0894; Buzsaki G, 2004, TRENDS NEUROSCI, V27, P186, DOI 10.1016/j.tins.2004.02.007; Casanova MF, 2013, FRONT SYST NEUROSCI, V7, DOI 10.3389/fnsys.2013.00077; Cauli B, 1997, J NEUROSCI, V17, P3894; de Araujo IE, 2006, NEURON, V51, P483, DOI 10.1016/j.neuron.2006.07.009; DEFELIPE J, 1992, PROG NEUROBIOL, V39, P563, DOI 10.1016/0301-0082(92)90015-7; DeFelipe J, 2002, PROG BRAIN RES, V136, P215; DeFelipe J, 1997, J CHEM NEUROANAT, V14, P1, DOI 10.1016/S0891-0618(97)10013-8; DeFelipe J, 2013, NAT REV NEUROSCI, V14, P202, DOI 10.1038/nrn3444; DeKosky ST, 2010, NEW ENGL J MED, V363, P1293, DOI 10.1056/NEJMp1007051; Druga R, 2009, FOLIA BIOL-PRAGUE, V55, P201; Eyles DW, 2002, SCHIZOPHR RES, V57, P27, DOI 10.1016/S0920-9964(01)00299-7; Finkelstein E., 2006, INCIDENCE EC BURDEN, DOI [10.1093/acprof:oso/9780195179484.001.0001, DOI 10.1093/ACPROF:OSO/9780195179484.001.0001]; Frahm C, 2004, NEUROSCIENCE, V127, P341, DOI 10.1016/j.neuroscience.2004.05.027; Freire MAM, 2012, W INDIAN MED J, V61, P751; Freire MAM, 2015, IEEE 16 INT C EHEALT, V16, P18; Freire MAM, 2007, NEUROTOXICOLOGY, V28, P175, DOI 10.1016/j.neuro.2006.06.007; Freire MAM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027554; Freund TF, 1996, HIPPOCAMPUS, V6, P347, DOI 10.1002/(SICI)1098-1063(1996)6:4<347::AID-HIPO1>3.0.CO;2-I; GERMAN DC, 1992, ANN NY ACAD SCI, V648, P42, DOI 10.1111/j.1749-6632.1992.tb24523.x; Gonchar Yuri, 2007, Front Neuroanat, V1, P3, DOI 10.3389/neuro.05.003.2007; Gonzalez-Burgos G, 2007, AM J PSYCHIAT, V164, P12, DOI 10.1176/appi.ajp.164.1.12; Griffith RW, 2006, NEUROSCI LETT, V406, P81, DOI 10.1016/j.neulet.2006.07.018; Guimaraes JS, 2010, BRAIN RES, V1329, P182, DOI 10.1016/j.brainres.2010.03.007; Guimares JS, 2009, REV NEUROLOGIA, V48, P304, DOI 10.33588/rn.4806.2008512; Heizmann Claus W., 1993, Acta Neurobiologiae Experimentalis (Warsaw), V53, P15; IACOPINO AM, 1990, P NATL ACAD SCI USA, V87, P4078, DOI 10.1073/pnas.87.11.4078; Jackson AB, 2004, ARCH PHYS MED REHAB, V85, P1740, DOI 10.1016/j.apmr.2004.04.035; Kepecs A, 2014, NATURE, V505, P318, DOI 10.1038/nature12983; Kohler P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119340; Kralik JD, 2001, METHODS, V25, P121, DOI 10.1006/meth.2001.1231; Kuruba R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024493; Lebedev MA, 2006, TRENDS NEUROSCI, V29, P536, DOI 10.1016/j.tins.2006.07.004; LERANTH C, 1991, EXP BRAIN RES, V85, P129; Lind G, 2013, SCI REP-UK, V3, DOI 10.1038/srep02942; LUKAS W, 1994, NEUROSCIENCE, V61, P307, DOI 10.1016/0306-4522(94)90233-X; Markram H, 2004, NAT REV NEUROSCI, V5, P793, DOI 10.1038/nrn1519; MATTSON MP, 1991, NEURON, V6, P41, DOI 10.1016/0896-6273(91)90120-O; McMahon A, 1998, MOL BRAIN RES, V54, P56, DOI 10.1016/S0169-328X(97)00305-7; Mendez P, 2011, NEURAL PLAST, V2011, DOI 10.1155/2011/976856; MOCKEL V, 1994, BRAIN RES, V648, P109, DOI 10.1016/0006-8993(94)91911-9; Morganti-Kossmann Maria Cristina, 2002, Curr Opin Crit Care, V8, P101; Nicolelis MAL, 2003, P NATL ACAD SCI USA, V100, P11041, DOI 10.1073/pnas.1934665100; NICOLELIS MAL, 1995, SCIENCE, V268, P1353, DOI 10.1126/science.7761855; NICOLELIS MAL, 1993, P NATL ACAD SCI USA, V90, P2212, DOI 10.1073/pnas.90.6.2212; Nicolelis MAL, 2009, NAT REV NEUROSCI, V10, P530, DOI 10.1038/nrn2653; Park HJ, 2013, SCIENCE, V342, P579, DOI 10.1126/science.1238411; Paxinos G., 2007, RAT BRAIN STEREOTAXI, V6th ed.; Pekny M, 2005, GLIA, V50, P427, DOI 10.1002/glia.20207; Prasad Abhishek, 2014, Front Neuroeng, V7, P2, DOI 10.3389/fneng.2014.00002; Prasad A, 2012, J NEURAL ENG, V9, DOI 10.1088/1741-2560/9/5/056015; Rao L, 2012, ACTA BIOMATER, V8, P2233, DOI 10.1016/j.actbio.2012.03.001; Rieke F, 1998, SPIKES EXPLORING NEU; Rosenfeld JV, 2012, LANCET, V380, P1088, DOI 10.1016/S0140-6736(12)60864-2; Rothschild Ryan Mark, 2010, Front Neuroeng, V3, P112, DOI 10.3389/fneng.2010.00112; Rozell CJ, 2005, NEUROCOMPUTING, V65, P429, DOI 10.1016/j.neucom.2004.10.042; Sahler CS, 2012, REHABIL RES PRACT, V2012, DOI 10.1155/2012/659652; Sakai T, 2008, NEUROPATHOLOGY, V28, P143, DOI 10.1111/j.1440-1789.2007.00867.x; Santana MB, 2014, NEURON, V84, P716, DOI 10.1016/j.neuron.2014.08.061; Santos JR, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00206; Schousboe A, 2005, NEUROTOX RES, V8, P221, DOI 10.1007/BF03033975; Shetty AK, 2009, J CELL MOL MED, V13, P2408, DOI 10.1111/j.1582-4934.2009.00675.x; Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8; Stice P, 2009, J NEURAL ENG, V6, DOI 10.1088/1741-2560/6/4/046004; Stichel CC, 1998, CELL TISSUE RES, V294, P1, DOI 10.1007/s004410051151; Streit WJ, 2000, TOXICOL PATHOL, V28, P28, DOI 10.1177/019262330002800104; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Tsytsarev V, 2006, J NEURAL ENG, V3, P293, DOI 10.1088/1741-2560/3/4/006; Vasconcelos N, 2011, P NATL ACAD SCI USA, V108, P15408, DOI 10.1073/pnas.1102780108	70	8	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2015	10	6							e0130354	10.1371/journal.pone.0130354	http://dx.doi.org/10.1371/journal.pone.0130354			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL3FM	26098896	Green Published, gold, Green Submitted			2022-12-26	WOS:000356835800063
J	Mousel, MR; Reynolds, JO; White, SN				Mousel, Michelle R.; Reynolds, James O.; White, Stephen N.			Genome-Wide Association Identifies SLC2A9 and NLN Gene Regions as Associated with Entropion in Domestic Sheep	PLOS ONE			English	Article							CONGENITAL ENTROPION; INVOLUTIONAL ECTROPION; CELLS; HISTOPATHOLOGY; POPULATION; MECHANISM; EXPRESSION; DISORDERS; APOPTOSIS; LITTER	Entropion is an inward rolling of the eyelid allowing contact between the eyelashes and cornea that may lead to blindness if not corrected. Although many mammalian species, including humans and dogs, are afflicted by congenital entropion, no specific genes or gene regions related to development of entropion have been reported in any mammalian species to date. Entropion in domestic sheep is known to have a genetic component therefore, we used domestic sheep as a model system to identify genomic regions containing genes associated with entropion. A genome-wide association was conducted with congenital entropion in 998 Columbia, Polypay, and Rambouillet sheep genotyped with 50,000 SNP markers. Prevalence of entropion was 6.01%, with all breeds represented. Logistic regression was performed in PLINK with additive allelic, recessive, dominant, and genotypic inheritance models. Two genome-wide significant (empirical P<0.05) SNP were identified, specifically markers in SLC2A9 (empirical P = 0.007; genotypic model) and near NLN (empirical P = 0.026; dominance model). Six additional genome-wide suggestive SNP (nominal P<1x10(-5)) were identified including markers in or near PIK3CB (P = 2.22x10(-6); additive model), KCNB1 (P = 2.93x10(-6); dominance model), ZC3H12C (P = 3.25x10(-6); genotypic model), JPH1 (P = 4.68x20(-6); genotypic model), and MYO3B (P = 5.74x10(-6); recessive model). This is the first report of specific gene regions associated with congenital entropion in any mammalian species, to our knowledge. Further, none of these genes have previously been associated with any eyelid traits. These results represent the first genome-wide analysis of gene regions associated with entropion and provide target regions for the development of sheep genetic markers for marker-assisted selection.	[Mousel, Michelle R.] ARS, Range Sheep Prod Efficiency Res Unit, USDA, Dubois, ID USA; [Reynolds, James O.; White, Stephen N.] ARS, USDA, Anim Dis Res Unit, Pullman, WA 99164 USA; [White, Stephen N.] Washington State Univ, Dept Vet Microbiol & Pathol, Pullman, WA 99164 USA	United States Department of Agriculture (USDA); United States Department of Agriculture (USDA); Washington State University	Mousel, MR (corresponding author), ARS, USDA, Anim Dis Res Unit, Pullman, WA 99164 USA.	Michelle.Mousel@ars.usda.gov	Mousel, Michelle/I-6398-2013	Mousel, Michelle/0000-0003-1367-7005; White, Stephen N./0000-0001-9255-6054	USDA-ARS CWA [5348-32000-031-00D]	USDA-ARS CWA(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	This research was funded by USDA-ARS CWA No. 5348-32000-031-00D (http://www.ars.usda.gov/main/main.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allbaugh RA, 2009, VET OPHTHALMOL, V12, P115, DOI 10.1111/j.1463-5224.2008.00686.x; ALRAJHI AA, 1993, OPHTHALMOLOGY, V100, P1293; Augustin R, 2004, J BIOL CHEM, V279, P16229, DOI 10.1074/jbc.M312226200; Balogun BG, 2013, ANN AFR MED, V12, P193, DOI 10.4103/1596-3519.122682; Bashour M, 2000, OPHTHAL PLAST RECONS, V16, P131, DOI 10.1097/00002341-200003000-00008; Becker D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008689; BISTNER S, 1981, VET MED SM ANIM CLIN, V76, P1246; Blajecka K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044945; Cavalcanti DMLP, 2014, J BIOL CHEM, V289, P15426, DOI 10.1074/jbc.M113.539148; Claine F, 2013, SMALL RUMINANT RES, V111, P1, DOI 10.1016/j.smallrumres.2012.11.037; Collins LM, 2011, VET J, V189, P147, DOI 10.1016/j.tvjl.2011.06.012; da Silva L, 2011, BBA-MOL CELL RES, V1813, P1863, DOI 10.1016/j.bbamcr.2011.06.018; Doblado M, 2009, AM J PHYSIOL-ENDOC M, V297, pE831, DOI 10.1152/ajpendo.00296.2009; Donnelly KS, 2014, VET OPHTHALMOL, V17, P443, DOI 10.1111/vop.12170; FINDLATER GS, 1993, J ANAT, V183, P121; Foth BJ, 2006, P NATL ACAD SCI USA, V103, P3681, DOI 10.1073/pnas.0506307103; Fox CS, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002695; FOX JG, 1979, LAB ANIM SCI, V29, P509; FOX SA, 1956, ARCH OPHTHALMOL-CHIC, V56, P839; Freund M, 2014, EUR NEUROPSYCHOPHARM, V24, P302, DOI 10.1016/j.euroneuro.2013.06.004; Golini L, 2011, J BIOL CHEM, V286, P43717, DOI 10.1074/jbc.M111.292755; Gonzalez MV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074700; Greber D, 2013, ACTA VET SCAND, V55, DOI 10.1186/1751-0147-55-27; GREEN LE, 1995, PREV VET MED, V24, P15, DOI 10.1016/0167-5877(95)00468-C; Guzey M, 2000, OPHTHALMOLOGICA, V214, P277, DOI 10.1159/000027504; Heaton MP, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002467; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Hourde C, 2013, AM J PATHOL, V182, P1509, DOI 10.1016/j.ajpath.2013.01.020; Jiang Y, 2014, SCIENCE, V344, P1168, DOI 10.1126/science.1252806; Khuly P, 2012, EMBRACE PET INSURANC; Kijas JW, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001258; Kocaoglu FA, 2009, CAN J OPHTHALMOL, V44, P677, DOI 10.3129/i09-152; Liu L, 2013, BIOCHEM J, V451, P55, DOI 10.1042/BJ20130019; Maman DY, 2011, ANN PLAS SURG, V66, P351, DOI 10.1097/SAP.0b013e3181e56e69; Matsuo H, 2008, AM J HUM GENET, V83, P744, DOI 10.1016/j.ajhg.2008.11.001; McMANUS T. J., 1960, Australian Veterinary Journal, V36, P91, DOI 10.1111/j.1751-0813.1960.tb08577.x; MENGES RW, 1946, J AM VET MED ASSOC, V109, P464; Michels KS, 2014, J OPHTHALMOL, V2014, DOI 10.1155/2014/231487; Mohamed YH, 2003, EXP EYE RES, V76, P115, DOI 10.1016/S0014-4835(02)00269-5; Moura LIF, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/941764; Norman MU, 2003, AM J PHYSIOL-HEART C, V284, pH1978, DOI 10.1152/ajpheart.01116.2002; Ohuchi H, 2012, OCUL SURF, V10, P212, DOI 10.1016/j.jtos.2012.07.005; PEIFFER RL, 1977, VET MED SM ANIM CLIN, V72, P1219; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Pyla R, 2013, AM J PHYSIOL-CELL PH, V304, pC574, DOI 10.1152/ajpcell.00275.2012; R Core Team, 2021, R LANGUAGE ENV STAT; Rice DS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047168; Sakul H, 1996, SMALL RUMINANT RES, V20, P187, DOI 10.1016/0921-4488(95)00797-0; Sakul H, 1996, SMALL RUMINANT RES; Shepherd PR, 1998, BIOCHEM J, V333, P471, DOI 10.1042/bj3330471; Silva MVB, 2012, ANIM GENET, V43, P63, DOI 10.1111/j.1365-2052.2011.02202.x; SMYTH R S, 1947, Vet Rec, V59, P148; Takanaga H, 2008, BBA-BIOMEMBRANES, V1778, P1091, DOI 10.1016/j.bbamem.2007.11.015; Thier L, 1965, Berl Munch Tierarztl Wochenschr, V78, P328; Vassy JL, 2012, BEST PRACT RES CL EN, V26, P189, DOI 10.1016/j.beem.2011.09.002; Vitart V, 2008, NAT GENET, V40, P437, DOI 10.1038/ng.106; Walsh KB, 2001, J MOL CELL CARDIOL, V33, P1233, DOI 10.1006/jmcc.2001.1386; WARWICK BL, 1962, J HERED, V53, P10, DOI 10.1093/oxfordjournals.jhered.a107107; WHITE DG, 1983, VET REC, V113, P542; White SN, 2014, ANIM GENET, V45, P297, DOI 10.1111/age.12107; White SN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047829; Wu XH, 2011, J BIOL CHEM, V286, P13512, DOI 10.1074/jbc.M110.187351; Yao HL, 2009, J NEUROCHEM, V108, P909, DOI 10.1111/j.1471-4159.2008.05834.x; Zagora E, 1966, OPHTHALMOLOGY, V50, P6; Zhao X, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021739	65	9	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2015	10	6							e0128909	10.1371/journal.pone.0128909	http://dx.doi.org/10.1371/journal.pone.0128909			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL3FM	26098909	gold, Green Published, Green Submitted			2022-12-26	WOS:000356835800020
J	Servais, S; Menten-Dedoyart, C; Beguin, Y; Seidel, L; Gothot, A; Daulne, C; Willems, E; Delens, L; Humblet-Baron, S; Hannon, M; Baron, F				Servais, Sophie; Menten-Dedoyart, Catherine; Beguin, Yves; Seidel, Laurence; Gothot, Andre; Daulne, Coline; Willems, Evelyne; Delens, Loic; Humblet-Baron, Stephanie; Hannon, Muriel; Baron, Frederic			Impact of Pre-Transplant Anti-T Cell Globulin (ATG) on Immune Recovery after Myeloablative Allogeneic Peripheral Blood Stem Cell Transplantation	PLOS ONE			English	Article							VERSUS-HOST-DISEASE; INTENSITY CONDITIONING REGIMEN; ANTITHYMOCYTE GLOBULIN; UNRELATED DONORS; THYMIC FUNCTION; RECONSTITUTION; PROPHYLAXIS; INFECTION; DEPLETION; LEUKEMIA	Background Pre-transplant infusion of rabbit anti-T cell globulin (ATG) is increasingly used as prevention of graft-versus-host disease (GVHD) after allogeneic peripheral blood stem cell transplantation (PBSCT). However, the precise impact of pre-transplant ATG on immune recovery after PBSCT is still poorly documented. Methods In the current study, we compared immune recovery after myeloablative PBSCT in 65 patients who either received (n = 37) or did not (n = 28) pre-transplant ATG-Fresenius (ATG-F). Detailed phenotypes of circulating T, B, natural killer (NK) and invariant NKT (iNKT) cells were analyzed by multicolor flow cytometry at serial time-points from day 40 to day 365 after transplantation. Thymic function was also assessed by sjTREC quantification. Serious infectious events were collected up to 2 years post-transplantation. Results Pre-transplant ATG-F had a prolonged (for at least up to 1-year) and selective negative impact on the T-cell pool, while it did not impair the recovery of B, NK nor iNKT cells. Among T cells, ATG-F selectively compromised the recovery of naive CD4(+), central memory CD4+ and naive CD8(+) cells, while it spared effector memory T and regulatory T cells. Levels of sjTRECs were similar in both cohorts at 1-year after PBSCT, suggesting that ATG-F unlikely impaired thymopoiesis at long-term after PBSCT. Finally, the incidence and rate of serious infections were similar in both groups, while ATG-F patients had a lower incidence of grade II-IV acute graft-versus-host disease. Conclusions Pre-transplant ATG-F induces long-lasting modulation of the circulating T-cell pool after myeloablative PBSCT, that may participate in preventing graft-versus-host disease without deeply compromising anti-pathogen defenses.	[Servais, Sophie; Menten-Dedoyart, Catherine; Beguin, Yves; Daulne, Coline; Delens, Loic; Humblet-Baron, Stephanie; Hannon, Muriel; Baron, Frederic] Univ Liege, Hematol Res Unit, GIGA I3, Liege, Belgium; [Servais, Sophie; Beguin, Yves; Willems, Evelyne; Baron, Frederic] CHU Liege, Dept Clin Hematol, Bone Marrow Transplantat Unit, Liege, Belgium; [Seidel, Laurence] CHU Liege, Dept Biostat, SIME, Liege, Belgium; [Gothot, Andre] CHU Liege, Dept Lab Med, Liege, Belgium	University of Liege; University of Liege; University of Liege; University of Liege	Servais, S (corresponding author), Univ Liege, Hematol Res Unit, GIGA I3, Liege, Belgium.	s.servais@chu.ulg.ac.be; c.menten@chu.ulg.ac.be		Humblet-Baron, Stephanie/0000-0003-4684-069X	Leon Fredericq fund; Anti-Cancer Center at the University of Liege	Leon Fredericq fund; Anti-Cancer Center at the University of Liege	FB is a senior research associate of the National Fund for Scientific Research (FNRS) Belgium. This study was supported by funds from the Leon Fredericq fund and Anti-Cancer Center at the University of Liege. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	al-Jurf M, 2005, J CLIN ONCOL, V23, P5074, DOI 10.1200/JCO.2005.09.020; Anderson BE, 2003, J CLIN INVEST, V112, P101, DOI 10.1172/JCI200317601; Armand P, 2014, BLOOD, V123, P3664, DOI 10.1182/blood-2014-01-552984; Bacigalupo A, 2001, BLOOD, V98, P2942, DOI 10.1182/blood.V98.10.2942; Bacigalupo A, 2009, BIOL BLOOD MARROW TR, V15, P1628, DOI 10.1016/j.bbmt.2009.07.004; Baron F, 2014, BONE MARROW TRANSPL, V49, P389, DOI 10.1038/bmt.2013.204; Bleakley M, 2014, BIOL BLOOD MARROW TR, V20, P705, DOI 10.1016/j.bbmt.2014.01.032; Bonifazi F, 2014, ASH ABSTRACT BLOOD, V124, P27; Bosch M, 2012, CYTOTHERAPY, V14, P1258, DOI 10.3109/14653249.2012.715243; Bosch M, 2012, CURR OPIN HEMATOL, V19, P324, DOI 10.1097/MOH.0b013e328353bc7d; Castermans E, 2008, HAEMATOLOGICA, V93, P240, DOI 10.3324/haematol.11708; Castermans E, 2011, HAEMATOL-HEMATOL J, V96, P298, DOI 10.3324/haematol.2010.029702; Chawla S, 2014, BIOL BLOOD MARROW TR, V20, P1156, DOI 10.1016/j.bbmt.2014.04.007; Chen BJ, 2004, BLOOD, V103, P1534, DOI 10.1182/blood-2003-08-2987; Clave E, 2009, BLOOD, V113, P6477, DOI 10.1182/blood-2008-09-176594; Copelan E, 2007, BIOL BLOOD MARROW TR, V13, P1469, DOI 10.1016/j.bbmt.2007.08.047; Devillier R, 2014, BIOL BLOOD MARROW TR, V20, P370, DOI 10.1016/j.bbmt.2013.11.030; Filipovich AH, 2005, BIOL BLOOD MARROW TR, V11, P945, DOI 10.1016/j.bbmt.2005.09.004; Finke J, 2009, LANCET ONCOL, V10, P855, DOI 10.1016/S1470-2045(09)70225-6; Hamadani M, 2009, BIOL BLOOD MARROW TR, V15, P1422, DOI 10.1016/j.bbmt.2009.07.006; Hannon M, 2015, CLIN CANC R IN PRESS; Hannon M, 2014, TRANSFUSION, V54, P353, DOI 10.1111/trf.12279; Humblet-Baron S, 2015, IMMUNOL CELL BIOL, V93, P321, DOI 10.1038/icb.2014.120; Jameson SC, 2002, NAT REV IMMUNOL, V2, P547, DOI 10.1038/nri853; Krenger W, 2011, BLOOD, V117, P6768, DOI 10.1182/blood-2011-02-334623; Ljungman P, 2002, CLIN INFECT DIS, V34, P1094, DOI 10.1086/339329; Matsuoka K, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005265; Mensen A, 2014, J CANCER RES CLIN, V140, P1971, DOI 10.1007/s00432-014-1742-z; Mohty M, 2007, LEUKEMIA, V21, P1387, DOI 10.1038/sj.leu.2404683; Na IK, 2013, HAEMATOL-HEMATOL J, V98, P23, DOI 10.3324/haematol.2012.067611; Nakai K, 2003, TRANSPLANTATION, V75, P2135, DOI 10.1097/01.TP.0000066453.32263.F7; Pearl JP, 2005, AM J TRANSPLANT, V5, P465, DOI 10.1111/j.1600-6143.2005.00759.x; Poulin JF, 2003, BLOOD, V102, P4600, DOI 10.1182/blood-2003-05-1428; PRZEPIORKA D, 1995, BONE MARROW TRANSPL, V15, P825; Remberger M, 2005, HAEMATOLOGICA, V90, P931; Roll P, 2015, EUR J HAEMATOL, V95, P514, DOI 10.1111/ejh.12524; Sairafi D, 2012, CLIN IMMUNOL, V142, P343, DOI 10.1016/j.clim.2011.12.001; Servais S, 2014, BIOL BLOOD MARROW TR, V20, P507, DOI 10.1016/j.bbmt.2014.01.001; Socie G, 2011, BLOOD, V117, P6375, DOI 10.1182/blood-2011-01-329821; Soiffer RJ, 2011, BLOOD, V117, P6963, DOI 10.1182/blood-2011-01-332007; Storek J, 2015, BIOL BLOOD MARROW TR, V21, P959, DOI 10.1016/j.bbmt.2014.11.676; Toubert A, 2012, TISSUE ANTIGENS, V79, P83, DOI 10.1111/j.1399-0039.2011.01820.x; Wang Y, 2014, BONE MARROW TRANSPL, V49, P426, DOI 10.1038/bmt.2013.191; Wingard J R, 1999, Transpl Infect Dis, V1, P3, DOI 10.1034/j.1399-3062.1999.10102.x; Yakoub-Agha I, 2006, LEUKEMIA, V20, P1557, DOI 10.1038/sj.leu.2404308; Zheng H, 2008, BLOOD, V111, P2476, DOI 10.1182/blood-2007-08-109678	46	33	36	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2015	10	6							e0130026	10.1371/journal.pone.0130026	http://dx.doi.org/10.1371/journal.pone.0130026			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL3FM	26098781	Green Published, Green Submitted, gold			2022-12-26	WOS:000356835800049
J	Wang, XB; Zhou, BY; Sun, XF; Yue, Y; Ma, W; Zhao, M				Wang, Xinbing; Zhou, Baoyuan; Sun, Xuefang; Yue, Yang; Ma, Wei; Zhao, Ming			Soil Tillage Management Affects Maize Grain Yield by Regulating Spatial Distribution Coordination of Roots, Soil Moisture and Nitrogen Status	PLOS ONE			English	Article							WATER-USE EFFICIENCY; PEA PISUM-SATIVUM; CONSERVATION TILLAGE; MECHANICAL IMPEDANCE; NO-TILLAGE; SYSTEM ARCHITECTURE; PHYSICAL-PROPERTIES; LOAM SOIL; GROWTH; COMPACTION	The spatial distribution of the root system through the soil profile has an impact on moisture and nutrient uptake by plants, affecting growth and productivity. The spatial distribution of the roots, soil moisture, and fertility are affected by tillage practices. The combination of high soil density and the presence of a soil plow pan typically impede the growth of maize (Zea mays L.). We investigated the spatial distribution coordination of the root system, soil moisture, and N status in response to different soil tillage treatments (NT: no-tillage, RT: rotary-tillage, SS: subsoiling) and the subsequent impact on maize yield, and identify yield-increasing mechanisms and optimal soil tillage management practices. Field experiments were conducted on the Huang-Huai-Hai plain in China during 2011 and 2012. The SS and RT treatments significantly reduced soil bulk density in the top 0-20 cm layer of the soil profile, while SS significantly decreased soil bulk density in the 20-30 cm layer. Soil moisture in the 20-50 cm profile layer was significantly higher for the SS treatment compared to the RT and NT treatment. In the 0-20 cm topsoil layer, the NT treatment had higher soil moisture than the SS and RT treatments. Root length density of the SS treatment was significantly greater than density of the RT and NT treatments, as soil depth increased. Soil moisture was reduced in the soil profile where root concentration was high. SS had greater soil moisture depletion and a more concentration root system than RT and NT in deep soil. Our results suggest that the SS treatment improved the spatial distribution of root density, soil moisture and N states, thereby promoting the absorption of soil moisture and reducing N leaching via the root system in the 20-50 cm layer of the profile. Within the context of the SS treatment, a root architecture densely distributed deep into the soil profile, played a pivotal role in plants' ability to access nutrients and water. An optimal combination of deeper deployment of roots and resource (water and N) availability was realized where the soil was prone to leaching. The correlation between the depletion of resources and distribution of patchy roots endorsed the SS tillage practice. It resulted in significantly greater post-silking biomass and grain yield compared to the RT and NT treatments, for summer maize on the Huang-Huai-Hai plain.	[Wang, Xinbing; Zhou, Baoyuan; Sun, Xuefang; Ma, Wei; Zhao, Ming] Chinese Acad Agr Sci, Inst Crop Sci, Beijing 100193, Peoples R China; [Yue, Yang] China Agr Univ, Coll Agron & Biotechnol, Beijing 100094, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Crop Sciences, CAAS; China Agricultural University	Ma, W (corresponding author), Chinese Acad Agr Sci, Inst Crop Sci, Beijing 100193, Peoples R China.	weiwei_8200@126.com; zhaomingcau@163.net	Wang, Xin/AAN-8435-2021; Wang, Xin/GYU-1129-2022; Zhou, Baoyuan/HDM-1095-2022	Wang, Xin/0000-0002-4457-7376; Zhou, Baoyuan/0000-0003-0979-4460	Special Fund for Agro-scientific Research in the Public Interest [201203096]; planning subject of 'the twelfth five-year-plan' in national science and technology for the rural development in China [2013BAD07B00]; Field crops mechanized production key technology research and demonstration [2013BAD08B00]; Innovation Program of CAAS (Chinese Academy of Agricultural Sciences)	Special Fund for Agro-scientific Research in the Public Interest; planning subject of 'the twelfth five-year-plan' in national science and technology for the rural development in China; Field crops mechanized production key technology research and demonstration; Innovation Program of CAAS (Chinese Academy of Agricultural Sciences)	This work was supported by Special Fund for Agro-scientific Research in the Public Interest (NO. 201203096); The planning subject of 'the twelfth five-year-plan' in national science and technology for the rural development in China (NO.2013BAD07B00); Field crops mechanized production key technology research and demonstration (2013BAD08B00); and the Innovation Program of CAAS (Chinese Academy of Agricultural Sciences). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amato M, 2002, CROP SCI, V42, P773, DOI 10.2135/cropsci2002.0773; [Anonymous], 1994, SOIL COMPACTION CROP; Becel C, 2012, PLANT SOIL, V353, P169, DOI 10.1007/s11104-011-1020-7; Bengough AG, 2011, J EXP BOT, V62, P59, DOI 10.1093/jxb/erq350; Bengough AG, 1997, PLANT SOIL, V189, P155, DOI 10.1023/A:1004240706284; BENGOUGH AG, 1990, J SOIL SCI, V41, P341, DOI 10.1111/j.1365-2389.1990.tb00070.x; Bernier J, 2009, FIELD CROP RES, V110, P139, DOI 10.1016/j.fcr.2008.07.010; Bohm W, 1979, ECOL STUD, V33, P188; Chassot A, 2001, PLANT SOIL, V231, P123, DOI 10.1023/A:1010335229111; Christopher SF, 2007, CRIT REV PLANT SCI, V26, P45, DOI 10.1080/07352680601174830; Croser C, 2000, PHYSIOL PLANTARUM, V109, P150, DOI 10.1034/j.1399-3054.2000.100207.x; Doussan C, 2006, PLANT SOIL, V283, P99, DOI 10.1007/s11104-004-7904-z; Dunbabin V, 2003, PLANT CELL ENVIRON, V26, P835, DOI 10.1046/j.1365-3040.2003.01015.x; Dunbabin VM, 2013, PLANT SOIL, V372, P93, DOI 10.1007/s11104-013-1769-y; Endale D. M., 2002, Making conservation tillage conventional: building a future on 25 years of research. Proceedings of 25th Annual Southern Conservation Tillage Conference for Sustainable Agriculture, Auburn, AL, USA, 24-26 June, 2002, P256; Fabrizzi KP, 2005, SOIL TILL RES, V81, P57, DOI 10.1016/j.still.2004.05.001; Fageria NK, 2004, J PLANT NUTR, V27, P1517, DOI 10.1081/PLN-200025995; Grant RF, 1997, SOIL SCI SOC AM J, V61, P1159, DOI 10.2136/sssaj1997.03615995006100040023x; GREB BW, 1966, SOIL SCI SOC AM PRO, V30, P786, DOI 10.2136/sssaj1966.03615995003000060035x; Hamza MA, 2005, SOIL TILL RES, V82, P121, DOI 10.1016/j.still.2004.08.009; Hassan M M, 1999, PAKISTAN J SOIL SCI, V16, P29; Hatfield JL, 2001, AGRON J, V93, P271, DOI 10.2134/agronj2001.932271x; He J, 2009, SOIL USE MANAGE, V25, P201, DOI 10.1111/j.1475-2743.2009.00210.x; He J, 2007, SOIL TILL RES, V94, P493, DOI 10.1016/j.still.2006.10.005; Heuscher SA, 2005, SOIL SCI SOC AM J, V69, P51; Hou XQ, 2012, FIELD CROP RES, V129, P7, DOI 10.1016/j.fcr.2011.12.021; Huggett RJ, 1998, CATENA, V32, P155, DOI 10.1016/S0341-8162(98)00053-8; Jonard F, 2013, GEODERMA, V207, P310, DOI 10.1016/j.geoderma.2013.05.024; Karunatilake U, 2000, SOIL TILL RES, V55, P31, DOI 10.1016/S0167-1987(00)00096-9; Lampurlanes J, 2001, FIELD CROP RES, V69, P27, DOI 10.1016/S0378-4290(00)00130-1; Lecompte F, 2003, AGRONOMIE, V23, P209, DOI 10.1051/agro:2002084; Li C. H., 1994, Acta Agriculturae Boreali-Sinica, V9, P49; Li CJ, 2008, MINERAL NUTR HIGHER, P9; Linkohr BI, 2002, PLANT J, V29, P751, DOI 10.1046/j.1365-313X.2002.01251.x; Lipiec J, 2012, SOIL TILL RES, V121, P74, DOI 10.1016/j.still.2012.01.013; [刘爽 LIU Shuang], 2010, [干旱地区农业研究, Agricultural Research in the Arid Areas], V28, P65; Lopez-Fando C, 2012, SOIL TILL RES, V118, P32, DOI 10.1016/j.still.2011.10.010; Lynch JP, 2007, AUST J BOT, V55, P493, DOI 10.1071/BT06118; Lynch JP, 2011, PLANT PHYSIOL, V156, P1041, DOI 10.1104/pp.111.175414; Ma Fengyun, 2006, Yingyong Shengtai Xuebao, V17, P789; Mi GH, 2010, SCI CHINA LIFE SCI, V53, P1369, DOI 10.1007/s11427-010-4097-y; Mosaddeghi MR, 2009, SOIL TILL RES, V104, P173, DOI 10.1016/j.still.2008.10.011; MULLINS CE, 1987, SOIL USE MANAGE, V3, P79, DOI 10.1111/j.1475-2743.1987.tb00715.x; Munoz-Romero V, 2012, FIELD CROP RES, V128, P76, DOI 10.1016/j.fcr.2011.12.015; Munoz-Romero V, 2011, FIELD CROP RES, V120, P338, DOI 10.1016/j.fcr.2010.11.008; Nosalewicz A, 2014, PLANT SOIL, V375, P229, DOI 10.1007/s11104-013-1961-0; Pages L, 2011, PLANT CELL ENVIRON, V34, P1749, DOI 10.1111/j.1365-3040.2011.02371.x; Qin RJ, 2006, SOIL TILL RES, V85, P50, DOI 10.1016/j.still.2004.12.003; Ruiz-Sanchez MC, 2005, PLANT SOIL, V272, P211, DOI 10.1007/s11104-004-4781-4; SHIERLAW J, 1984, PLANT SOIL, V77, P15, DOI 10.1007/BF02182808; Smith S, 2012, PHILOS T R SOC B, V367, P1441, DOI 10.1098/rstb.2011.0234; Steele KA, 2007, FIELD CROP RES, V101, P180, DOI 10.1016/j.fcr.2006.11.002; Su ZY, 2007, AGR WATER MANAGE, V87, P307, DOI 10.1016/j.agwat.2006.08.005; Thierfelder C, 2009, SOIL TILL RES, V105, P217, DOI 10.1016/j.still.2009.07.007; Urban DL, 2000, LANDSCAPE ECOL, V15, P603, DOI 10.1023/A:1008183331604; Verhulst N, 2010, ADV SOIL SCI-SER, P137; Vocanson A, 2006, PLANT SOIL, V281, P121, DOI 10.1007/s11104-005-3938-0; Walk TC, 2006, PLANT SOIL, V279, P347, DOI 10.1007/s11104-005-0389-6; Walk TC, 2004, ANN BOT-LONDON, V94, P119, DOI 10.1093/aob/mch116; Wang JingFeng, 2011, Scientia Agricultura Sinica, V44, P699, DOI 10.1360/032010-943; Wang K.J., 2001, ACTA PHYS SIN-CH ED, V25, P472; Watson Gary W., 2006, Urban Forestry & Urban Greening, V4, P69, DOI 10.1016/j.ufug.2005.08.001; Wei Li, 2009, Guizhou Agricultural Sciences, P25; WHALLEY WR, 1995, SOIL TILL RES, V35, P53, DOI 10.1016/0167-1987(95)00473-6; Whalley WR, 2000, ROOT METHODS: A HANDBOOK, P75; Whitmore AP, 2011, PLANT SOIL, V339, P363, DOI 10.1007/s11104-010-0588-7; WIESLER F, 1994, PLANT SOIL, V163, P267, DOI 10.1007/BF00007976; Xu D, 2001, SOIL TILL RES, V60, P11, DOI 10.1016/S0167-1987(01)00167-2; Zhang WuPing, 2006, Scientia Agricultura Sinica, V39, P2261; [郑盛华 ZHENG ShengHua], 2006, [生态学报, Acta Ecologica Sinica], V26, P1138	70	36	51	2	85	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2015	10	6							e0129231	10.1371/journal.pone.0129231	http://dx.doi.org/10.1371/journal.pone.0129231			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL3FM	26098548	Green Published, gold, Green Submitted			2022-12-26	WOS:000356835800024
J	Westergren, HU; Gronros, J; Heinonen, SE; Miliotis, T; Jennbacken, K; Sabirsh, A; Ericsson, A; Jonsson-Rylander, AC; Svedlund, S; Gan, LM				Westergren, Helena U.; Gronros, Julia; Heinonen, Suvi E.; Miliotis, Tasso; Jennbacken, Karin; Sabirsh, Alan; Ericsson, Anette; Jonsson-Rylander, Ann-Cathrine; Svedlund, Sara; Gan, Li-Ming			Impaired Coronary and Renal Vascular Function in Spontaneously Type 2 Diabetic Leptin-Deficient Mice	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; ENDOTHELIAL DYSFUNCTION; RESISTIVE INDEX; KIDNEY-DISEASE; FLOW-VELOCITY; OBESE; ATHEROSCLEROSIS; INHIBITION; RESERVE; ECHOCARDIOGRAPHY	Background Type 2 diabetes is associated with macro-and microvascular complications in man. Microvascular dysfunction affects both cardiac and renal function and is now recognized as a main driver of cardiovascular mortality and morbidity. However, progression of microvascular dysfunction in experimental models is often obscured by macrovascular pathology and consequently demanding to study. The obese type 2 diabetic leptin-deficient (ob/ob) mouse lacks macrovascular complications, i.e. occlusive atherosclerotic disease, and may therefore be a potential model for microvascular dysfunction. The present study aimed to test the hypothesis that these mice with an insulin resistant phenotype might display microvascular dysfunction in both coronary and renal vascular beds. Methods and Results In this study we used non-invasive Doppler ultrasound imaging to characterize microvascular dysfunction during the progression of diabetes in ob/ob mice. Impaired coronary flow velocity reserve was observed in the ob/ob mice at 16 and 21 weeks of age compared to lean controls. In addition, renal resistivity index as well as pulsatility index was higher in the ob/ob mice at 21 weeks compared to lean controls. Moreover, plasma L-arginine was lower in ob/ob mice, while asymmetric dimethylarginine was unaltered. Furthermore, a decrease in renal vascular density was observed in the ob/ob mice. Conclusion In parallel to previously described metabolic disturbances, the leptin-deficient ob/ob mice also display cardiac and renal microvascular dysfunction. This model may therefore be suitable for translational, mechanistic and interventional studies to improve the understanding of microvascular complications in type 2 diabetes.	[Westergren, Helena U.; Gan, Li-Ming] Univ Gothenburg, Sahlgrenska Acad, Inst Med, Dept Mol & Clin Med, Gothenburg, Sweden; [Gronros, Julia; Heinonen, Suvi E.; Miliotis, Tasso; Jennbacken, Karin; Sabirsh, Alan; Ericsson, Anette; Jonsson-Rylander, Ann-Cathrine; Gan, Li-Ming] AstraZeneca R&D, CVMD iMED, Molndal, Sweden; [Svedlund, Sara; Gan, Li-Ming] Sahlgrens Univ Hosp, Dept Clin Physiol, Gothenburg, Sweden	University of Gothenburg; AstraZeneca; Sahlgrenska University Hospital	Gan, LM (corresponding author), Univ Gothenburg, Sahlgrenska Acad, Inst Med, Dept Mol & Clin Med, Gothenburg, Sweden.	li-ming.gan@gu.se		Sabirsh, Alan/0000-0001-5310-0281	Sahlgrenska University Hospital, Gothenburg Sweden; AstraZeneca	Sahlgrenska University Hospital, Gothenburg Sweden; AstraZeneca(AstraZeneca)	Agreement concerning research and education of doctors, Sahlgrenska University Hospital, Gothenburg Sweden together with AstraZeneca are the funders of all work. Co-authors Julia Gronros, Suvi E Heinonen, Tasso Miliotis, Karin Jennbacken, Alan Sabirsh, Anette Ericsson, Ann-Cathrine Jonsson-Rylander and Li-ming Gan are employed by AstraZeneca R&D Molndal. First author and co-author Sara Svedlund is supported by Agreement concerning research and education of doctors. The funder AstraZeneca provided support in the form of salaries for authors JG, SEH, TM, KJ, AS, AE, ACJR and LMG but did not have any additional role in the study design, data collection and analysis, or preparation of the manuscript. The decision to publish was made by an internal AstraZeneca review of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Bailes, 2002, AORN J, V76, P265, DOI [10.1016/S0001-2092(06)61065-X, DOI 10.1016/S0001-2092(06)61065-X]; Bailes Barbara K, 2002, AORN J, V76, P266; BAILES BK, 2002, AORN J, V76, P283; Boudina S, 2005, CIRCULATION, V112, P2686, DOI 10.1161/CIRCULATIONAHA.105.554360; Bruno RM, 2011, DIABETOLOGIA, V54, P2430, DOI 10.1007/s00125-011-2148-y; Bude RO, 1999, RADIOLOGY, V211, P411, DOI 10.1148/radiology.211.2.r99ma48411; Buus NH, 2001, CIRCULATION, V104, P2305, DOI 10.1161/hc4401.098293; Chade AR, 2006, KIDNEY INT, V69, P266, DOI 10.1038/sj.ki.5000031; Christoffersen C, 2003, ENDOCRINOLOGY, V144, P3483, DOI 10.1210/en.2003-0242; Cicoira M, 2013, INT J CARDIOL, V167, P3050, DOI 10.1016/j.ijcard.2012.11.088; Cortigiani L, 2007, J AM COLL CARDIOL, V50, P1354, DOI 10.1016/j.jacc.2007.06.027; Cosson E, 2006, DIABETES CARE, V29, P107, DOI 10.2337/diacare.29.1.107; Durante W, 2007, CLIN EXP PHARMACOL P, V34, P906, DOI 10.1111/j.1440-1681.2007.04638.x; Ennezat PV, 2011, NEPHROL DIAL TRANSPL, V26, P3908, DOI 10.1093/ndt/gfr116; FRIEDMAN JM, 1991, GENOMICS, V11, P1054, DOI 10.1016/0888-7543(91)90032-A; Gao X, 2008, AM J PHYSIOL-HEART C, V295, pH491, DOI 10.1152/ajpheart.00464.2008; Ge F, 2012, J OBES, V2012, DOI 10.1155/2012/205648; Georgi MK, 2011, MICROCIRCULATION, V18, P238, DOI 10.1111/j.1549-8719.2011.00084.x; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Gronros J, 2011, AM J PHYSIOL-HEART C, V300, pH1174, DOI 10.1152/ajpheart.00560.2010; Hartley CJ, 2007, ULTRASOUND MED BIOL, V33, P512, DOI 10.1016/j.ultrasmedbio.2006.11.002; Hudkins KL, 2010, J AM SOC NEPHROL, V21, P1533, DOI 10.1681/ASN.2009121290; Katz PS, 2011, BASIC RES CARDIOL, V106, P1123, DOI 10.1007/s00395-011-0201-0; Ma F, 2013, NEPHROLOGY, V18, P750, DOI 10.1111/nep.12159; Mazumder PK, 2004, DIABETES, V53, P2366, DOI 10.2337/diabetes.53.9.2366; Montalescot G, 2013, EUR HEART J, V34, P2949, DOI 10.1093/eurheartj/eht296; Monu SR, 2013, HYPERTENSION, V62, P310, DOI 10.1161/HYPERTENSIONAHA.111.00495; Nakanishi K, 2013, AM J CARDIOL; Nemes A, 2007, CAN J CARDIOL, V23, P445, DOI 10.1016/S0828-282X(07)70782-1; Nevelsteen I, 2013, J VASC RES, V50, P486, DOI 10.1159/000355221; NISHINA PM, 1994, METABOLISM, V43, P554, DOI 10.1016/0026-0495(94)90195-3; NITENBERG A, 1993, DIABETES, V42, P1017, DOI 10.2337/diabetes.42.7.1017; Ohta Y, 2005, J HYPERTENS, V23, P1905, DOI 10.1097/01.hjh.0000181323.44162.01; Saraiva RM, 2007, NITRIC OXIDE-BIOL CH, V16, P331, DOI 10.1016/j.niox.2006.12.001; Sarnak MJ, 2003, CIRCULATION, V108, P2154, DOI 10.1161/01.CIR.0000095676.90936.80; Schwedhelm E, 2005, CLIN CHEM, V51, P1268, DOI 10.1373/clinchem.2004.046037; Taguchi K, 2011, AM J PHYSIOL-HEART C, V301, pH571, DOI 10.1152/ajpheart.01189.2010; Tona F, 2014, NUTR METAB CARDIOVAS, V24, P447, DOI 10.1016/j.numecd.2013.09.021; Wallace TM, 2004, DIABETES CARE, V27, P1487, DOI 10.2337/diacare.27.6.1487; Wang BX, 2014, CURR DIABETES REV, V10, P131, DOI 10.2174/1573399810666140508121012; Wikstrom J, 2005, J AM COLL CARDIOL, V46, P720, DOI 10.1016/j.jacc.2005.04.053; Wikstrom J, 2008, ULTRASOUND MED BIOL, V34, P1053, DOI 10.1016/j.ultrasmedbio.2007.12.004; Winters B, 2000, J APPL PHYSIOL, V89, P2382, DOI 10.1152/jappl.2000.89.6.2382; Wu JA, 2010, J ULTRAS MED, V29, P1771, DOI 10.7863/jum.2010.29.12.1771; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0	45	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2015	10	6							e0130648	10.1371/journal.pone.0130648	http://dx.doi.org/10.1371/journal.pone.0130648			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL3FM	26098416	Green Submitted, gold, Green Published			2022-12-26	WOS:000356835800089
J	Xie, M; Roy, R				Xie, Meng; Roy, Richard			AMP-Activated Kinase Regulates Lipid Droplet Localization and Stability of Adipose Triglyceride Lipase in C-elegans Dauer Larvae	PLOS ONE			English	Article							HORMONE-SENSITIVE LIPASE; PERILIPIN-A; PROTEIN; LIPOLYSIS; PHOSPHORYLATION; METABOLISM; MECHANISMS; AUTOPHAGY; TISSUE	Animals have developed diverse mechanisms to adapt to their changing environment. Like many organisms the free-living nematode C. elegans can alternate between a reproductive mode or a diapause-like "dauer" stage during larval development to circumvent harsh environmental conditions. The master metabolic regulator AMP-activated protein kinase (AMPK) is critical for survival during the dauer stage, where it phosphorylates adipose triglyceride lipase (ATGL-1) at multiple sites to block lipid hydrolysis and ultimately protect the cellular triglyceride-based energy depot from rapid depletion. However, how the AMPK-mediated phosphorylation affects the function of ATGL-1 has not been characterised at the molecular level. Here we show that AMPK phosphorylation leads to the generation of 14-3-3 binding sites on ATGL-1, which are recognized by the C. elegans 14-3-3 protein orthologue PAR-5. Physical interaction of ATGL-1 with PAR-5 results in sequestration of ATGL-1 away from the lipid droplets and eventual proteasome-mediated degradation. In addition, we also show that the major AMPK phosphorylation site on ATGL-1, Ser 303, is required for both modification of its lipid droplet localization and its degradation. Our data provide mechanistic insight as to how AMPK functions to enhance survival through its ability to protect the accumulated triglyceride deposits from rapid hydrolysis to preserve the energy stores during periods of extended environmental duress.	[Xie, Meng; Roy, Richard] McGill Univ, Dept Biol, Montreal, PQ, Canada	McGill University	Roy, R (corresponding author), McGill Univ, Dept Biol, 1205 Ave Docteur Penfield, Montreal, PQ, Canada.	richard.roy@mcgill.ca			Canadian Institutes of Health Research [MOP84486]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by funding from the Canadian Institutes of Health Research, MOP84486.	Ahmadian M, 2011, CELL METAB, V13, P739, DOI 10.1016/j.cmet.2011.05.002; Apfeld J, 2004, GENE DEV, V18, P3004, DOI 10.1101/gad.1255404; Baskin KK, 2011, TRENDS CARDIOVAS MED, V21, P124, DOI 10.1016/j.tcm.2012.03.010; BRENNER S, 1974, GENETICS, V77, P71; Burdine RD, 1996, WORM BREEDERS GAZETT, V14, DOI [10.1007/s00436-012-3257-3, DOI 10.1007/S00436-012-3257-3]; CASSADA RC, 1975, DEV BIOL, V46, P326, DOI 10.1016/0012-1606(75)90109-8; Chitraju C, 2012, J LIPID RES, V53, P2141, DOI 10.1194/jlr.M028902; Collins S, 2001, RECENT PROG HORM RES, V56, P309, DOI 10.1210/rp.56.1.309; Donsmark M, 2004, BIOCHEM BIOPH RES CO, V316, P867, DOI 10.1016/j.bbrc.2004.02.140; Goodman CA, 2011, CELL SIGNAL, V23, P1896, DOI 10.1016/j.cellsig.2011.07.013; Gwinn DM, 2008, MOL CELL, V30, P214, DOI 10.1016/j.molcel.2008.03.003; Haemmerle G, 2006, SCIENCE, V312, P734, DOI 10.1126/science.1123965; Hardie DG, 2002, BIOCHEM SOC T, V30, P1064, DOI 10.1042/BST0301064; Holliday R, BIOESSAYS, V10, P125; Jonkel CJ, 1977, WILDLIFE MONOGR, V27, P1; Kamath RS, 2001, GENOME BIOL, V2, DOI 10.1186/gb-2000-2-1-research0002; KIRKWOOD TBL, 1977, NATURE, V270, P301, DOI 10.1038/270301a0; Kohler A, 2001, MOL CELL, V7, P1143, DOI 10.1016/S1097-2765(01)00274-X; Kovsan J, 2010, AM J PHYSIOL-ENDOC M, V298, pE1, DOI 10.1152/ajpendo.00562.2009; Lee I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044720; Lee JH, 2014, MOL CELL BIOL, V34, P4165, DOI 10.1128/MCB.00722-14; Mak HY, 2006, NAT GENET, V38, P363, DOI 10.1038/ng1739; Martin S, 2006, NAT REV MOL CELL BIO, V7, P373, DOI 10.1038/nrm1912; Mihaylova MM, 2011, NAT CELL BIOL, V13, P1016, DOI 10.1038/ncb2329; Miyoshi H, 2007, J BIOL CHEM, V282, P996, DOI 10.1074/jbc.M605770200; Morton DG, 2002, DEV BIOL, V241, P47, DOI 10.1006/dbio.2001.0489; Narbonne P, 2006, DEVELOPMENT, V133, P611, DOI 10.1242/dev.02232; Narbonne P, 2009, NATURE, V457, P210, DOI 10.1038/nature07536; Narbonne P, 2009, M S-MED SCI, V25, P565, DOI 10.1051/medsci/2009256-7565; Obsilova V, 2014, PHYSIOL RES, V63, pS155, DOI 10.33549/physiolres.932659; Riddle D.L., 1997, GENETIC ENV REGULATI; Selesniemi K, 2008, AGING CELL, V7, P622, DOI 10.1111/j.1474-9726.2008.00409.x; Sztalryd C, 2003, J CELL BIOL, V161, P1093, DOI 10.1083/jcb.200210169; Thrower JS, 2000, EMBO J, V19, P94, DOI 10.1093/emboj/19.1.94; Yang XF, 2010, PART FIBRE TOXICOL, V7, DOI 10.1186/1743-8977-7-1; Zhang P, 2012, MOL CELL PROTEOMICS, V11, P317, DOI 10.1074/mcp.M111.016345; Zhang SBO, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-96; Zimmermann R, 2004, SCIENCE, V306, P1383, DOI 10.1126/science.1100747; Zimmermann R, 2009, BBA-MOL CELL BIOL L, V1791, P494, DOI 10.1016/j.bbalip.2008.10.005	39	18	21	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2015	10	6							e0130480	10.1371/journal.pone.0130480	http://dx.doi.org/10.1371/journal.pone.0130480			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL3FM	26098762	Green Published, gold, Green Submitted			2022-12-26	WOS:000356835800071
J	Jungreuthmayer, C; Ruckerbauer, DE; Gerstl, MP; Hanscho, M; Zanghellini, J				Jungreuthmayer, Christian; Ruckerbauer, David E.; Gerstl, Matthias P.; Hanscho, Michael; Zanghellini, Juergen			Avoiding the Enumeration of Infeasible Elementary Flux Modes by Including Transcriptional Regulatory Rules in the Enumeration Process Saves Computational Costs	PLOS ONE			English	Article							PATHWAY ANALYSIS; ACETYL-COENZYME; GENETIC-CONTROL; NETWORKS; RESPONSES; PATTERN; ACETATE; LYASE; TOOL	Despite the significant progress made in recent years, the computation of the complete set of elementary flux modes of large or even genome-scale metabolic networks is still impossible. We introduce a novel approach to speed up the calculation of elementary flux modes by including transcriptional regulatory information into the analysis of metabolic networks. Taking into account gene regulation dramatically reduces the solution space and allows the presented algorithm to constantly eliminate biologically infeasible modes at an early stage of the computation procedure. Thereby, computational costs, such as runtime, memory usage, and disk space, are extremely reduced. Moreover, we show that the application of transcriptional rules identifies non-trivial system-wide effects on metabolism. Using the presented algorithm pushes the size of metabolic networks that can be studied by elementary flux modes to new and much higher limits without the loss of predictive quality. This makes unbiased, system-wide predictions in large scale metabolic networks possible without resorting to any optimization principle.	[Jungreuthmayer, Christian; Ruckerbauer, David E.; Gerstl, Matthias P.; Hanscho, Michael; Zanghellini, Juergen] Austrian Ctr Ind Biotechnol, Vienna, Austria; [Jungreuthmayer, Christian; Ruckerbauer, David E.; Gerstl, Matthias P.; Hanscho, Michael; Zanghellini, Juergen] Univ Nat Resources & Life Sci, Dept Biotechnol, Vienna, Austria	Austrian Centre of Industrial Biotechnology; University of Natural Resources & Life Sciences, Vienna	Jungreuthmayer, C (corresponding author), Austrian Ctr Ind Biotechnol, Vienna, Austria.	christian.jungreuthmayer@acib.at; juergen.zanghellini@acib.at	Zanghellini, Jürgen/A-4635-2017	Zanghellini, Jürgen/0000-0002-1964-2455; Ruckerbauer, David/0000-0003-3374-8456	Federal Ministry of Science, Research and Economy (BMWFW); Federal Ministry of Traffic, Innovation and Technology (BMVIT); Styrian Business Promotion Agency SFG; Standortagentur Tirol; ZIT-Technology Agency of the City of Vienna through the COMET-Funding Program	Federal Ministry of Science, Research and Economy (BMWFW); Federal Ministry of Traffic, Innovation and Technology (BMVIT); Styrian Business Promotion Agency SFG; Standortagentur Tirol; ZIT-Technology Agency of the City of Vienna through the COMET-Funding Program	This work has been supported by the Federal Ministry of Science, Research and Economy (BMWFW, http://www.bmwfw.at/), the Federal Ministry of Traffic, Innovation and Technology (BMVIT, http://www.bmvit.gv.at/), the Styrian Business Promotion Agency SFG, the Standortagentur Tirol and ZIT-Technology Agency of the City of Vienna through the COMET-Funding Program managed by the Austrian Research Promotion Agency FFG (https://www.ffg.at/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert R, 2003, J THEOR BIOL, V223, P1, DOI 10.1016/S0022-5193(03)00035-3; Chandrasekaran S, 2010, P NATL ACAD SCI; Christensen TS, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-7; CLAASSEN PAM, 1986, J GEN MICROBIOL, V132, P3179; Covert MW, 2004, NATURE, V429, P92, DOI 10.1038/nature02456; ETH Zurich Computational Systems Biology Group, 2012, EFMT EL FLUX MOD TOO; Fukuda K., 1996, Combinatorics and Computer Science. 8th Franco-Japanese and 4th Franco-Chinese Conference. Selected Papers, P91; Gagneur J, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-175; Hadicke O, 2011, METAB ENG, V13, P204, DOI 10.1016/j.ymben.2010.12.004; Han L, 1997, J BACTERIOL, V179, P5157, DOI 10.1128/jb.179.16.5157-5164.1997; Herrgard MJ, 2006, GENOME RES, V16, P627, DOI 10.1101/gr.4083206; Hunt KA, 2014, BIOINFORMATICS, V30, P1569, DOI 10.1093/bioinformatics/btu021; Jensen PA, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-147; Jevremovic D, 2011, PARALLEL COMPUT, V37, P261, DOI 10.1016/j.parco.2011.04.002; Jol SJ, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002415; Jungreuthmayer C, 2013, IEEE ACM T COMPUT BI, V10, P1329, DOI 10.1109/TCBB.2013.116; Jungreuthmayer C, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-318; Jungreuthmayer C, 2013, BIOSYSTEMS, V113, P37, DOI 10.1016/j.biosystems.2013.04.002; Jungreuthmayer C, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-103; Kaleta C., 2009, LECT NOTES INFORM P, VP-157, P179; Kaleta C, 2009, GENOME RES, V19, P1872, DOI 10.1101/gr.090639.108; KAUFFMAN S, 1969, NATURE, V224, P177, DOI 10.1038/224177a0; Klamt S, 2002, MOL BIOL REP, V29, P233, DOI 10.1023/A:1020390132244; Klamt S, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-2; Larhlimi A, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-57; Machado D, 2012, BIOINFORMATICS, V28, pI515, DOI 10.1093/bioinformatics/bts401; Meister M, 2005, J BACTERIOL, V187, P1415, DOI 10.1128/JB.187.4.1415-1425.2005; Mendoza L, 1999, BIOINFORMATICS, V15, P593, DOI 10.1093/bioinformatics/15.7.593; Open Source Initiative, 2012, BSD LIC; Orth J, 2010, ECOSAL PLUS; Pahlman AK, 2001, J BIOL CHEM, V276, P3555, DOI 10.1074/jbc.M007164200; Palmieri L, 2000, BBA-BIOENERGETICS, V1459, P363, DOI 10.1016/S0005-2728(00)00173-0; Pey J, 2014, SYSTEMS BIO IN PRESS, P1; Saadatpour A, 2013, METHODS, V62, P3, DOI 10.1016/j.ymeth.2012.10.012; Schlitt Thomas, 2013, Methods Mol Biol, V1021, P13, DOI 10.1007/978-1-62703-450-0_2; Schuster S, 2000, NAT BIOTECHNOL, V18, P326, DOI 10.1038/73786; Schuster S, 1999, TRENDS BIOTECHNOL, V17, P53, DOI 10.1016/S0167-7799(98)01290-6; Schwartz JM, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-186; Shlomi T, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100141; Tabe-Bordbar S, 2013, BIOTECHNOL LETT, V35, P2039, DOI 10.1007/s10529-013-1328-x; Terzer M., 2009, THESIS ETH ZURICH; Terzer M, 2008, BIOINFORMATICS, V24, P2229, DOI 10.1093/bioinformatics/btn401; Thomas R., 1990, BIOL FEEDBACK; Trinh Cong T, 2012, Subcell Biochem, V64, P21, DOI 10.1007/978-94-007-5055-5_2; University of California San Diego Systems Biology Research Group, 2012, COR E COL MOD; van den Berg MA, 1998, YEAST, V14, P1089, DOI 10.1002/(SICI)1097-0061(19980915)14:12<1089::AID-YEA312>3.3.CO;2-B; VANDENBERG MA, 1995, EUR J BIOCHEM, V231, P704; von Kamp A, 2006, BIOINFORMATICS, V22, P1930, DOI 10.1093/bioinformatics/btl267; von Kamp A, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003378; Wang RS, 2012, PHYS BIOL, V9, DOI 10.1088/1478-3975/9/5/055001; Zanghellini J, 2013, BIOTECHNOL J, V8, P1009, DOI 10.1002/biot.201200269; Zolotykh NY, 2012, COMP MATH MATH PHYS+, V52, P146, DOI 10.1134/S0965542512010162	52	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2015	10	6							e0129840	10.1371/journal.pone.0129840	http://dx.doi.org/10.1371/journal.pone.0129840			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL3FE	26091045	Green Published, Green Submitted, gold			2022-12-26	WOS:000356835000066
J	Cailliau, K; Lescuyer, A; Burnol, AF; Cuesta-Marban, A; Widmann, C; Browaeys-Poly, E				Cailliau, Katia; Lescuyer, Arlette; Burnol, Anne-Francoise; Cuesta-Marban, Alvaro; Widmann, Christian; Browaeys-Poly, Edith			RasGAP Shields Akt from Deactivating Phosphatases in Fibroblast Growth Factor Signaling but Loses This Ability Once Cleaved by Caspase-3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SRC TYROSINE KINASE; PROTEIN-KINASE; HUMAN BREAST; MESSENGER-RNAS; XENOPUS OOCYTE; SH3 DOMAIN; PHOSPHATIDYLINOSITOL 3-KINASE; FRAGMENT N2; CELL-CYCLE; AURORA-A	Fibroblast growth factor receptors (FGFRs) are involved in proliferative and differentiation physiological responses. Deregulation of FGFR-mediated signaling involving the Ras/PI3K/Akt and the Ras/Raf/ERK MAPK pathways is causally involved in the development of several cancers. The caspase-3/p120 RasGAP module is a stress sensor switch. Under mild stress conditions, RasGAP is cleaved by caspase-3 at position 455. The resulting N-terminal fragment, called fragment N, stimulates anti-death signaling. When caspase-3 activity further increases, fragment N is cleaved at position 157. This generates a fragment, called N2, that no longer protects cells. Here, we investigated in Xenopus oocytes the impact of RasGAP and its fragments on FGF1-mediated signaling during G(2)/M cell cycle transition. RasGAP used its N-terminal Src homology 2 domain to bind FGFR once stimulated by FGF1, and this was necessary for the recruitment of Akt to the FGFR complex. Fragment N, which did not associate with the FGFR complex, favored FGF1-induced ERK stimulation, leading to accelerated G(2)/M transition. In contrast, fragment N2 bound the FGFR, and this inhibited mTORC2-dependent Akt Ser-473 phosphorylation and ERK2 phosphorylation but not phosphorylation of Akt on Thr-308. This also blocked cell cycle progression. Inhibition of Akt Ser-473 phosphorylation and entry into G(2)/M was relieved by PHLPP phosphatase inhibition. Hence, full-length RasGAP favors Akt activity by shielding it from deactivating phosphatases. This shielding was abrogated by fragment N2. These results highlight the role played by RasGAP in FGFR signaling and how graded stress intensities, by generating different RasGAP fragments, can positively or negatively impact this signaling.	[Cailliau, Katia; Lescuyer, Arlette; Browaeys-Poly, Edith] Univ Lille 1, Sci & Technol, Team Signal Div Regulat, CNRS,UMR 8576,SN3, F-59655 Villeneuve Dascq, France; [Burnol, Anne-Francoise] INSERM, Inst Cochin, U1016, Paris, France; [Burnol, Anne-Francoise] CNRS, Inst Cochin, UMR8104, F-75014 Paris, France; [Burnol, Anne-Francoise] Univ Paris 05, Sorbonne Paris Cite, F-75014 Paris, France; [Cuesta-Marban, Alvaro; Widmann, Christian] Univ Lausanne, Dept Physiol, CH-1005 Lausanne, Switzerland	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Lille - ISITE; Universite de Lille; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; University of Lausanne	Cailliau, K (corresponding author), Univ Lille 1, Equipe Regulat Signaux Div, CNRS, UMR 8576,SN3,Sci & Technol, F-59655 Villeneuve Dascq, France.	katia.maggio@univ-lille1.fr	Burnol, Anne-Francoise/P-2181-2017; Widmann, Christian/N-9851-2013	cailliau, katia/0000-0003-1772-1034; Cailliau, Katia/0000-0001-7993-8437; Widmann, Christian/0000-0002-6881-0363; Cuesta Marban, Alvaro/0000-0002-7144-0500	Ligue Nationale Contre le Cancer, Comite du Nord; Swiss National Science Foundation [31003A_141242/1]	Ligue Nationale Contre le Cancer, Comite du Nord(Ligue nationale contre le cancer); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by the "Ligue Nationale Contre le Cancer, Comite du Nord" and by Swiss National Science Foundation Grant 31003A_141242/1 (to C. W.). The authors declare that they have no conflicts of interest with the contents of this article.	Alessi DR, 1996, EMBO J, V15, P6541, DOI 10.1002/j.1460-2075.1996.tb01045.x; ANANDAPPA SY, 1994, BRIT J CANCER, V69, P772, DOI 10.1038/bjc.1994.146; Annibaldi A, 2014, APOPTOSIS, V19, P719, DOI 10.1007/s10495-013-0958-8; Annibaldi A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029024; Annibaldi A, 2009, EXP CELL RES, V315, P2081, DOI 10.1016/j.yexcr.2009.03.015; Barras D, 2014, ONCOGENE, V33, P5163, DOI 10.1038/onc.2013.465; Barras D, 2014, INT J CANCER, V135, P242, DOI 10.1002/ijc.28674; Brognard J, 2008, TRENDS ENDOCRIN MET, V19, P223, DOI 10.1016/j.tem.2008.04.001; Browaeys-Poly E, 2000, EUR J BIOCHEM, V267, P6256, DOI 10.1046/j.1432-1327.2000.01710.x; Browaeys-Poly E, 2005, BBA-MOL CELL RES, V1743, P1, DOI 10.1016/j.bbamcr.2004.07.003; Browaeys-Poly E, 2001, CELL SIGNAL, V13, P363, DOI 10.1016/S0898-6568(01)00149-8; Browaeys-Poly E, 2009, ANTICANCER RES, V29, P4965; Bulat N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022609; Cailliau K, 2001, FEBS LETT, V496, P161, DOI 10.1016/S0014-5793(01)02410-3; Cailliau Katia, 2009, V518, P43, DOI 10.1007/978-1-59745-202-1_4; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; Crowell JA, 2007, MOL CANCER THER, V6, P2139, DOI 10.1158/1535-7163.MCT-07-0120; Cybulski N, 2009, TRENDS BIOCHEM SCI, V34, P620, DOI 10.1016/j.tibs.2009.09.004; Dieci MV, 2013, CANCER DISCOV, V3, P264, DOI 10.1158/2159-8290.CD-12-0362; Dillon C, 2004, J MAMMARY GLAND BIOL, V9, P207, DOI 10.1023/B:JOMG.0000037163.56461.1e; DUCHESNE M, 1993, SCIENCE, V259, P525, DOI 10.1126/science.7678707; Eswarakumar VP, 2005, CYTOKINE GROWTH F R, V16, P139, DOI 10.1016/j.cytogfr.2005.01.001; Fernig DG, 2000, BIOCHEM BIOPH RES CO, V267, P770, DOI 10.1006/bbrc.1999.2028; Ferrell JE, 1999, BIOESSAYS, V21, P833, DOI 10.1002/(SICI)1521-1878(199910)21:10<833::AID-BIES5>3.0.CO;2-P; Furdui CM, 2006, MOL CELL, V21, P711, DOI 10.1016/j.molcel.2006.01.022; Gigoux V, 2002, J BIOL CHEM, V277, P23742, DOI 10.1074/jbc.C200121200; GURDON JB, 1971, NATURE, V233, P177, DOI 10.1038/233177a0; Hemmings BA, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a011189; Hu KQ, 1997, EMBO J, V16, P473, DOI 10.1093/emboj/16.3.473; Itoh N, 2011, J BIOCHEM, V149, P121, DOI 10.1093/jb/mvq121; JACQUEMIER J, 1994, INT J CANCER, V59, P373, DOI 10.1002/ijc.2910590314; Khalil H, 2014, TRENDS CELL BIOL, V24, P83, DOI 10.1016/j.tcb.2013.08.002; Khalil H, 2012, MOL CELL BIOL, V32, P4523, DOI 10.1128/MCB.00774-12; Kumar A, 2013, SCI WORLD J, DOI 10.1155/2013/756134; Kuo YC, 2008, J BIOL CHEM, V283, P1882, DOI 10.1074/jbc.M709585200; Lemmon MA, 2007, BIOCHEM SOC SYMP, V74, P81, DOI 10.1042/BSS2007c08; Liu PD, 2014, NATURE, V508, P541, DOI 10.1038/nature13079; LUQMANI YA, 1992, BRIT J CANCER, V66, P273, DOI 10.1038/bjc.1992.256; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Martin HL, 2014, BREAST CANCER-TARGET, V6, P1, DOI 10.2147/BCTT.S37638; Mendoza MC, 2007, MOL CELL, V25, P798, DOI 10.1016/j.molcel.2007.03.007; Michod D, 2004, ONCOGENE, V23, P8971, DOI 10.1038/sj.onc.1207999; Michod D, 2007, MOL CANCER RES, V5, P497, DOI 10.1158/1541-7786.MCR-06-0257; Michod D, 2009, JNCI-J NATL CANCER I, V101, P828, DOI 10.1093/jnci/djp100; Moore SF, 2011, J BIOL CHEM, V286, P24553, DOI 10.1074/jbc.M110.202341; Nebreda AR, 2000, CURR OPIN CELL BIOL, V12, P666, DOI 10.1016/S0955-0674(00)00150-2; Ornitz DM, 2001, GENOME BIOL, V2; Pamonsinlapatham P, 2009, BIOCHIMIE, V91, P320, DOI 10.1016/j.biochi.2008.10.010; Pascreau G, 2008, DEV BIOL, V317, P523, DOI 10.1016/j.ydbio.2008.02.053; PENAULTLLORCA F, 1995, INT J CANCER, V61, P170, DOI 10.1002/ijc.2910610205; Pittet O, 2007, J PHOTOCH PHOTOBIO B, V88, P29, DOI 10.1016/j.jphotobiol.2007.04.009; Pomerance M, 1996, MOL CELL BIOL, V16, P3179; Renaud F, 1996, BIOCHEM BIOPH RES CO, V219, P679, DOI 10.1006/bbrc.1996.0294; Rong SB, 2001, J MED CHEM, V44, P898, DOI 10.1021/jm000493i; Ryan PJ, 1998, BIOCHEM BIOPH RES CO, V244, P763, DOI 10.1006/bbrc.1998.8326; Sarkissian M, 2004, GENE DEV, V18, P48, DOI 10.1101/gad.1136004; StebbinsBoaz B, 1996, EMBO J, V15, P2582, DOI 10.1002/j.1460-2075.1996.tb00616.x; Steelman LS, 2011, AGING-US, V3, P192, DOI 10.18632/aging.100296; Vincent EE, 2011, BRIT J CANCER, V104, P1755, DOI 10.1038/bjc.2011.132; Wesche J, 2011, BIOCHEM J, V437, P199, DOI 10.1042/BJ20101603; Woodcock SA, 2004, BIOCHEM J, V380, P767, DOI 10.1042/BJ20031848; Yang JY, 2005, MOL BIOL CELL, V16, P3511, DOI 10.1091/mbc.E05-01-0080; Yang JY, 2004, BIOCHEM PHARMACOL, V68, P1027, DOI 10.1016/j.bcp.2004.03.043; Yang JY, 2004, MOL CELL BIOL, V24, P10425, DOI 10.1128/MCB.24.23.10425-10436.2004; Yang JY, 2002, J BIOL CHEM, V277, P14641, DOI 10.1074/jbc.M111540200; Yang JY, 2001, MOL CELL BIOL, V21, P5346, DOI 10.1128/MCB.21.16.5346-5358.2001; YANG YS, 1994, EMBO J, V13, P1270, DOI 10.1002/j.1460-2075.1994.tb06379.x; Yoshimura N, 1998, CLIN IMMUNOL IMMUNOP, V89, P28, DOI 10.1006/clin.1998.4551; Yue YZ, 2004, J BIOL CHEM, V279, P12883, DOI 10.1074/jbc.M312308200	69	4	4	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 7	2015	290	32					19653	19665		10.1074/jbc.M115.644633	http://dx.doi.org/10.1074/jbc.M115.644633			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CO7TL	26109071	hybrid, Green Published			2022-12-26	WOS:000359364600026
J	Carrillo, JA; He, YH; Luo, J; Menendez, KR; Tablante, NL; Zhao, K; Paulson, JN; Li, BC; Song, JZ				Carrillo, Jose A.; He, Yanghua; Luo, Juan; Menendez, Kimberly R.; Tablante, Nathaniel L.; Zhao, Keji; Paulson, Joseph N.; Li, Bichun; Song, Jiuzhou			Methylome Analysis in Chickens Immunized with Infectious Laryngotracheitis Vaccine	PLOS ONE			English	Article							DNA METHYLATION; BIOCONDUCTOR PACKAGE; GENE-EXPRESSION; VIRUS-VACCINE; HUMAN GENOME; IN-VITRO; CHIP-SEQ; CANCER; INITIATION; PROMOTERS	In this study we investigated the methylome of chickens immunized with Infectious laryngotracheitis (ILT) vaccine derived from chicken embryos. Methyl-CpG binding domain protein-enriched genome sequencing (MBD-Seq) method was employed in the detection of the 1,155 differentially methylated regions (DMRs) across the entire genome. After validation, we ascertained the genomic DMRs distribution and annotated them regarding genes, transcription start sites (TSS) and CpG islands. We found that global DNA methylation decreased in vaccinated birds, presenting 704 hypomethylated and 451 hypermethylated DMRs, respectively. Additionally, we performed an enrichment analysis detecting gene networks, in which cancer and RNA post-transcriptional modification appeared in the first place, followed by humoral immune response, immunological disease and inflammatory disease. The top four identified canonical pathways were EIF2 signaling, regulation of EIF4 and p70S6K signaling, axonal guidance signaling and mTOR signaling, providing new insight regarding the mechanisms of ILT etiology. Lastly, the association between DNA methylation and differentially expressed genes was examined, and detected negative correlation in seventeen of the eighteen genes.	[Carrillo, Jose A.; He, Yanghua; Luo, Juan; Song, Jiuzhou] Univ Maryland, Dept Anim & Avian Sci, College Pk, MD 20742 USA; [Menendez, Kimberly R.; Tablante, Nathaniel L.] Univ Maryland, Virginia Maryland Reg Coll Vet Med, College Pk, MD 20742 USA; [Zhao, Keji] NHLBI, NIH, Lab Mol Immunol, Bethesda, MD 20892 USA; [Paulson, Joseph N.] Univ Maryland, Ctr Bioinformat & Computat Biol, College Pk, MD 20742 USA; [Li, Bichun] Yangzhou Univ, Coll Anim Sci & Technol, Yangzhou City, Jiangsu, Peoples R China	University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); University System of Maryland; University of Maryland College Park; Yangzhou University	Song, JZ (corresponding author), Univ Maryland, Dept Anim & Avian Sci, College Pk, MD 20742 USA.	songj88@umd.edu	Song, Jiuzhou/AAD-6440-2020		United States Department of Agriculture (USDA)-Natural Resources Institute/National Institute of Food and Agriculture from the USDA National Institute of Food and Agriculture [2010-65205-20588]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL005801] Funding Source: NIH RePORTER	United States Department of Agriculture (USDA)-Natural Resources Institute/National Institute of Food and Agriculture from the USDA National Institute of Food and Agriculture; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This project was supported by United States Department of Agriculture (USDA)-Natural Resources Institute/National Institute of Food and Agriculture 2010-65205-20588 from the USDA National Institute of Food and Agriculture. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberg KA, 2012, EPIGENOMICS-UK, V4, P605, DOI [10.2217/EPI.12.59, 10.2217/epi.12.59]; AbouElela S, 1997, NUCLEIC ACIDS RES, V25, P1788, DOI 10.1093/nar/25.9.1788; Badve S, 2002, J HISTOCHEM CYTOCHEM, V50, P473, DOI 10.1177/002215540205000404; Bagust TJ, 2000, REV SCI TECH OIE, V19, P483, DOI 10.20506/rst.19.2.1229; Chandra YG, 2012, VIRUS GENES, V44, P470, DOI 10.1007/s11262-012-0728-7; Chen K, 2007, NAT REV GENET, V8, P93, DOI 10.1038/nrg1990; Chen ZX, 2011, J BIOL CHEM, V286, P18347, DOI 10.1074/jbc.R110.205286; Chitra P, 2011, CLIN CHIM ACTA, V412, P1151, DOI 10.1016/j.cca.2011.01.037; Chung W, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002079; Cooper JC, 2007, BIOL REPROD, V77, P274, DOI 10.1095/biolreprod.106.057125; Coppo MJC, 2013, DEV COMP IMMUNOL, V41, P454, DOI 10.1016/j.dci.2013.03.022; Coppo MJC, 2012, AVIAN PATHOL, V41, P99, DOI 10.1080/03079457.2011.643222; Das PM, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-28; Das PM, 2004, DNA METHYLATION CANC, DOI [10.1200/JCO.2004.07.151, DOI 10.1200/JCO.2004.07.151]; Dufour-Zavala L, 2008, AVIAN DIS, V52, P1, DOI 10.1637/8018-051007-Review; EHRLICH M, 1982, NUCLEIC ACIDS RES, V10, P2709, DOI 10.1093/nar/10.8.2709; Fuchs W, 2005, J VIROL, V79, P705, DOI 10.1128/JVI.79.2.705-716.2005; Gagniuc P, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-278; GARDINERGARDEN M, 1987, J MOL BIOL, V196, P261, DOI 10.1016/0022-2836(87)90689-9; GUNDERSON SI, 1990, GENE DEV, V4, P2048, DOI 10.1101/gad.4.12a.2048; Harris RA, 2010, NAT BIOTECHNOL, V28, P1097, DOI 10.1038/nbt.1682; HOLST C, 1993, HUM MOL GENET, V2, P367, DOI 10.1093/hmg/2.4.367; Irizarry RA, 2009, NAT GENET, V41, P178, DOI 10.1038/ng.298; Jiang L, 2008, CANCER RES, V68, P9900, DOI 10.1158/0008-5472.CAN-08-1319; Johnson DI, 2010, AVIAN DIS, V54, P1251, DOI 10.1637/9401-052310-Reg.1; Kimball SR, 1999, INT J BIOCHEM CELL B, V31, P25, DOI 10.1016/S1357-2725(98)00128-9; Kulis M, 2010, ADV GENET, V70, P27, DOI [10.1016/S0065-2660(10)70002-X, 10.1016/B978-0-12-380866-0.60002-2]; Laird PW, 2010, NAT REV GENET, V11, P191, DOI 10.1038/nrg2732; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lee JY, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-445; Lee J, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-143; Lee SW, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-197; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Luo J, 2014, POULTRY SCI, V93, P848, DOI 10.3382/ps.2013-03624; Maksimov D A, 2013, Tsitologiia, V55, P190; Martinez-Llordella M, 2013, J EXP MED, V210, P1603, DOI 10.1084/jem.20122387; McEwen KR, 2010, EPIGENET CHROMATIN, V3, DOI 10.1186/1756-8935-3-2; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; Pavlova SP, 2010, J GEN VIROL, V91, P847, DOI 10.1099/vir.0.016634-0; Portz C, 2008, VET MICROBIOL, V131, P57, DOI 10.1016/j.vetmic.2008.02.029; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rodriguez-Avila A, 2009, REPLICATION TRANSMIS; Ross-Innes CS, 2012, NATURE, V481, P389, DOI 10.1038/nature10730; Saxonov S, 2006, P NATL ACAD SCI USA, V103, P1412, DOI 10.1073/pnas.0510310103; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; Takai D, 2002, P NATL ACAD SCI USA, V99, P3740, DOI 10.1073/pnas.052410099; Thanapprapasr D, 2013, ASIAN PAC J CANCER P, V14, P3419, DOI 10.7314/APJCP.2013.14.6.3419; Tian F, 2013, EPIGENETICS-US, V8, P431, DOI 10.4161/epi.24361; Vara JAF, 2004, CANCER TREAT REV, V30, P193, DOI 10.1016/j.ctrv.2003.07.007; Varriale A, 2010, GENOMICS, V95, P25, DOI 10.1016/j.ygeno.2009.09.006; Wei W, 2011, TRENDS GENET, V27, P267, DOI 10.1016/j.tig.2011.04.002; Yang HJ, 2013, NATURE, V497, P217, DOI 10.1038/nature12122; Yao YL, 1998, NUCL ACIDS RES, V26, P3776; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhu LJ, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-237	57	9	10	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2015	10	6							e0100476	10.1371/journal.pone.0100476	http://dx.doi.org/10.1371/journal.pone.0100476			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4OM	26107953	Green Published, gold, Green Submitted			2022-12-26	WOS:000356932500001
J	Forno, I; Ferrero, S; Russo, MV; Gazzano, G; Giangiobbe, S; Montanari, E; Del Nero, A; Rocco, B; Albo, G; Languino, LR; Altieri, DC; Vaira, V; Bosari, S				Forno, Irene; Ferrero, Stefano; Russo, Maria Veronica; Gazzano, Giacomo; Giangiobbe, Sara; Montanari, Emanuele; Del Nero, Alberto; Rocco, Bernardo; Albo, Giancarlo; Languino, Lucia R.; Altieri, Dario C.; Vaira, Valentina; Bosari, Silvano			Deregulation of MiR-34b/Sox2 Predicts Prostate Cancer Progression	PLOS ONE			English	Article							MICRORNA EXPRESSION PROFILES; TUMOR-SUPPRESSIVE FUNCTIONS; STEM-CELL MARKERS; METASTASIS; MECHANISMS; ANDROGEN; SURVIVAL; TARGETS; CLUSTER; GROWTH	Most men diagnosed with prostate cancer will have an indolent and curable disease, whereas approximately 15% of these patients will rapidly progress to a castrate-resistant and metastatic stage with high morbidity and mortality. Therefore, the identification of molecular signature(s) that detect men at risk of progressing disease remains a pressing and still unmet need for these patients. Here, we used an integrated discovery platform combining prostate cancer cell lines, a Transgenic Adenocarcinoma of the Mouse Prostate (TRAMP) model and clinically-annotated human tissue samples to identify loss of expression of microRNA-34b as consistently associated with prostate cancer relapse. Mechanistically, this was associated with epigenetics silencing of the MIR34B/C locus and increased DNA copy number loss, selectively in androgen-dependent prostate cancer. In turn, loss of miR-34b resulted in downstream deregulation and overexpression of the "stemness" marker, Sox2. These findings identify loss of miR-34b as a robust biomarker for prostate cancer progression in androgen-sensitive tumors, and anticipate a potential role of progenitor/stem cell signaling in this stage of disease.	[Forno, Irene; Ferrero, Stefano; Russo, Maria Veronica; Gazzano, Giacomo; Giangiobbe, Sara; Vaira, Valentina; Bosari, Silvano] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Div Pathol, Milan, Italy; [Forno, Irene; Russo, Maria Veronica; Giangiobbe, Sara; Bosari, Silvano] Univ Milan, Dept Pathophysiol & Organ Transplant, Milan, Italy; [Ferrero, Stefano] Univ Milan, Dept Biomed Surg & Dent Sci, Milan, Italy; [Montanari, Emanuele] Univ Milan, Dept Hlth Sci, Milan, Italy; [Montanari, Emanuele; Del Nero, Alberto] San Paolo Hosp, Div Urol 1, Milan, Italy; [Rocco, Bernardo; Albo, Giancarlo] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Div Urol, Milan, Italy; [Languino, Lucia R.; Altieri, Dario C.] Wistar Inst Anat & Biol, Prostate Canc Discover & Dev Program, Philadelphia, PA 19104 USA; [Languino, Lucia R.] Thomas Jefferson Univ, Kimmel Canc Ctr, Dept Canc Biol, Philadelphia, PA 19107 USA; [Altieri, Dario C.] Wistar Inst Anat & Biol, Tumor Microenvironm & Metastasis Program, Philadelphia, PA 19104 USA; [Vaira, Valentina] Ist Nazl Genet Mol Romeo & Enrica Invernizzi, Milan, Italy	IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan; University of Milan; University of Milan; San Paolo-Polo Universitaria Hospital; IRCCS Ca Granda Ospedale Maggiore Policlinico; The Wistar Institute; Jefferson University; The Wistar Institute	Vaira, V (corresponding author), Fdn IRCCS Ca Granda Osped Maggiore Policlin, Div Pathol, Milan, Italy.	vaira@ingm.org; silvano.bosari@unimi.it	Bosari, Silvano/K-7744-2016; Rocco, Bernardo/R-4041-2016; Vaira, Valentina/K-6499-2016; Gazzano, Giacomo/AAC-1971-2022; MONTANARI, EMANUELE/I-8034-2015	Bosari, Silvano/0000-0002-9744-6951; Rocco, Bernardo/0000-0002-9135-0035; Vaira, Valentina/0000-0003-4416-6216; Gazzano, Giacomo/0000-0002-7416-4644; Languino, Lucia/0000-0001-9011-7031; MONTANARI, EMANUELE/0000-0002-3586-666X; ALBO, Giancarlo/0000-0003-1979-3437	Fondazione Cariplo [2010-0846]; National Institutes of Health [CA140043, CA190027]; NATIONAL CANCER INSTITUTE [R01CA190027, R01CA078810, P01CA140043, P30CA010815] Funding Source: NIH RePORTER	Fondazione Cariplo(Fondazione Cariplo); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Fondazione Cariplo with award n. 2010-0846 (to SB) (http://www.fondazionecariplo.it/it/index.html) and the National Institutes of Health grants CA140043 (to LRL and DCA) and CA190027 (to DCA) (http://grants.nih.gov/grants/oer.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Augello C, 2012, LIVER INT, V32, P772, DOI 10.1111/j.1478-3231.2012.02795.x; Barberis M, 2008, AM J CLIN PATHOL, V129, P563, DOI 10.1309/1AKQDQ057PQT9AKX; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Boll K, 2013, ONCOGENE, V32, P277, DOI 10.1038/onc.2012.55; Briganti A, 2014, CANCER TREAT REV, V40, P3, DOI 10.1016/j.ctrv.2013.07.001; Celia-Terrassa T, 2012, J CLIN INVEST, V122, P1849, DOI 10.1172/JCI59218; Cereda V, 2014, EXPERT OPIN INV DRUG, V23, P469, DOI 10.1517/13543784.2014.885950; Chae YC, 2012, CANCER CELL, V22, P331, DOI 10.1016/j.ccr.2012.07.015; Choi YJ, 2011, NAT CELL BIOL, V13, P1353, DOI 10.1038/ncb2366; Corney DC, 2007, CANCER RES, V67, P8433, DOI 10.1158/0008-5472.CAN-07-1585; Deng S, 2008, CELL CYCLE, V7, P2643, DOI 10.4161/cc.7.17.6597; Di Leva G, 2010, TRENDS MOL MED, V16, P257, DOI 10.1016/j.molmed.2010.04.001; Domingo-Domenech J, 2012, CANCER CELL, V22, P373, DOI 10.1016/j.ccr.2012.07.016; Fujimura T, 2014, CLIN CANCER RES, V20, P4625, DOI 10.1158/1078-0432.CCR-13-1105; Gandellini P, 2009, CANCER RES, V69, P2287, DOI 10.1158/0008-5472.CAN-08-2894; Guzel E, 2014, PROSTATE, V74, P1498, DOI 10.1002/pros.22867; Hagman Z, 2013, BRIT J CANCER, V108, P1668, DOI 10.1038/bjc.2013.131; Hulf T, 2013, ONCOGENE, V32, P2891, DOI 10.1038/onc.2012.300; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; Jia XP, 2011, J MOL CELL BIOL, V3, P230, DOI 10.1093/jmcb/mjr002; Kang BH, 2011, BRIT J CANCER, V104, P629, DOI 10.1038/bjc.2011.9; Kerr CL, 2014, CURR OPIN ONCOL, V26, P328, DOI 10.1097/CCO.0000000000000080; Kim WT, 2013, PROSTATE INT, V1, P3, DOI 10.12954/PI.12011; Kregel S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053701; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Ling H, 2013, NAT REV DRUG DISCOV, V12, P847, DOI 10.1038/nrd4140; Liu C, 2012, CANCER RES, V72, P3393, DOI 10.1158/0008-5472.CAN-11-3864; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Majid S, 2013, CLIN CANCER RES, V19, P73, DOI 10.1158/1078-0432.CCR-12-2952; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Murakami Y, 2006, ONCOGENE, V25, P2537, DOI 10.1038/sj.onc.1209283; Rokavec M, 2014, J MOL CELL BIOL, V6, P214, DOI 10.1093/jmcb/mju003; Rubin MA, 2015, UROL ONCOL-SEMIN ORI, V33, P73, DOI 10.1016/j.urolonc.2014.10.011; Saini S, 2011, CLIN CANCER RES, V17, P5287, DOI 10.1158/1078-0432.CCR-10-2619; Savi F, 2014, CLIN SCI, V127, P233, DOI 10.1042/CS20130580; Schaefer A, 2010, INT J CANCER, V126, P1166, DOI 10.1002/ijc.24827; Selth LA, 2012, INT J CANCER, V131, P652, DOI 10.1002/ijc.26405; Siegel RL, 2015, CA-CANCER J CLIN, V65, P5, DOI 10.3322/caac.21254; Stoyanova T, 2013, P NATL ACAD SCI USA, V110, P20111, DOI 10.1073/pnas.1320565110; Vaira V, 2012, ONCOGENE, V31, P27, DOI 10.1038/onc.2011.209; Vaira V, 2015, LIVER INT, V35, P1077, DOI 10.1111/liv.12636; Vaira V, 2013, CANCER RES, V73, P2695, DOI 10.1158/0008-5472.CAN-12-4232; Vaira V, 2012, J MOL ENDOCRINOL, V49, P115, DOI 10.1530/JME-11-0189; Wach S, 2012, INT J CANCER, V130, P611, DOI 10.1002/ijc.26064; Wang ZA, 2011, ONCOGENE, V30, P1261, DOI 10.1038/onc.2010.530; Wu XY, 2013, ENDOCR-RELAT CANCER, V20, pR155, DOI 10.1530/ERC-12-0285; Xi YG, 2007, RNA, V13, P1668, DOI 10.1261/rna.642907; Yanaihara N, 2006, CANCER CELL, V9, P189, DOI 10.1016/j.ccr.2006.01.025; Yu X, 2014, PROSTATE CANCER P D, V17, P301, DOI 10.1038/pcan.2014.29	49	20	21	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2015	10	6							e0130060	10.1371/journal.pone.0130060	http://dx.doi.org/10.1371/journal.pone.0130060			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4OM	26107383	gold, Green Published, Green Submitted			2022-12-26	WOS:000356932500075
J	Hirata, Y; Morino, K; Akakura, K; Higano, CS; Bruchovsky, N; Gambol, T; Hall, S; Tanaka, G; Aihara, K				Hirata, Yoshito; Morino, Kai; Akakura, Koichiro; Higano, Celestia S.; Bruchovsky, Nicholas; Gambol, Teresa; Hall, Susan; Tanaka, Gouhei; Aihara, Kazuyuki			Intermittent Androgen Suppression: Estimating Parameters for Individual Patients Based on Initial PSA Data in Response to Androgen Deprivation Therapy	PLOS ONE			English	Article							PROSTATE TUMOR-GROWTH; PROSPECTIVE PHASE-II; MATHEMATICAL-MODEL; HORMONE-THERAPY; CANCER; PROGRESSION; RECURRENCE; PREDICTS; MEN	When a physician decides on a treatment and its schedule for a specific patient, information gained from prior patients and experience in the past is taken into account. A more objective way to make such treatment decisions based on actual data would be useful to the clinician. Although there are many mathematical models proposed for various diseases, so far there is no mathematical method that accomplishes optimization of the treatment schedule using the information gained from past patients or "rapid learning" technology. In an attempt to use this approach, we integrate the information gained from patients previously treated with intermittent androgen suppression (IAS) with that from a current patient by first fitting the time courses of clinical data observed from the previously treated patients, then constructing the prior information of the parameter values of the mathematical model, and finally, maximizing the posterior probability for the parameters of the current patient using the prior information. Although we used data from prostate cancer patients, the proposed method is general, and thus can be applied to other diseases once an appropriate mathematical model is established for that disease.	[Hirata, Yoshito; Tanaka, Gouhei; Aihara, Kazuyuki] Univ Tokyo, Inst Ind Sci, Meguro Ku, Tokyo 1538505, Japan; [Hirata, Yoshito; Morino, Kai; Tanaka, Gouhei; Aihara, Kazuyuki] Univ Tokyo, Grad Sch Informat Sci & Technol, Tokyo, Japan; [Akakura, Koichiro] Japan Community Hlth Care Org Tokyo, Dept Urol, JCHO Tokyo Shinjuku Med Ctr, Tokyo, Japan; [Higano, Celestia S.; Gambol, Teresa; Hall, Susan] Univ Washington, Dept Med, Seattle, WA USA; [Higano, Celestia S.; Gambol, Teresa; Hall, Susan] Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA; [Bruchovsky, Nicholas] Vancouver Prostate Ctr, Vancouver, BC, Canada; [Tanaka, Gouhei; Aihara, Kazuyuki] Univ Tokyo, Grad Sch Engn, Tokyo, Japan	University of Tokyo; University of Tokyo; University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center; University of Tokyo	Hirata, Y (corresponding author), Univ Tokyo, Inst Ind Sci, Meguro Ku, 7-22-1 Roppongi, Tokyo 1538505, Japan.	yoshito@sat.t.u-tokyo.ac.jp	Tanaka, Gouhei/Y-3230-2019; Hirata, Yoshito/L-9297-2018	Tanaka, Gouhei/0000-0002-6223-4406; Hirata, Yoshito/0000-0002-9245-2543	Aihara Innovative Mathematical Modelling Project; Japan Society for the Promotion of Science (JSPS) through the "Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program)"; Council for Science and Technology Policy (CSTP); Platform for Dynamic Approaches to Living System from the Ministry of Education, Culture, Sports, Science and Technology, Japan	Aihara Innovative Mathematical Modelling Project(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan Society for the Promotion of Science (JSPS) through the "Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program)"(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Council for Science and Technology Policy (CSTP)(Council for Science and Technology Policy (CSTP)); Platform for Dynamic Approaches to Living System from the Ministry of Education, Culture, Sports, Science and Technology, Japan	This work was supported by the Aihara Innovative Mathematical Modelling Project, the Japan Society for the Promotion of Science (JSPS) through the "Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program)," initiated by the Council for Science and Technology Policy (CSTP), and Platform for Dynamic Approaches to Living System from the Ministry of Education, Culture, Sports, Science and Technology, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAKURA K, 1993, CANCER, V71, P2782, DOI 10.1002/1097-0142(19930501)71:9<2782::AID-CNCR2820710916>3.0.CO;2-Z; Anderson ARA, 2005, MATH MED BIOL, V22, P163, DOI 10.1093/imammb/dqi005; Bishop C. M, 2006, PATTERN RECOGNITION; Bruchovsky N, 2007, CANCER-AM CANCER SOC, V109, P858, DOI 10.1002/cncr.22464; Bruchovsky N, 2006, CANCER-AM CANCER SOC, V107, P389, DOI 10.1002/cncr.21989; Chitnis N, 2006, SIAM J APPL MATH, V67, P24, DOI 10.1137/050638941; Crook JM, 2012, NEW ENGL J MED, V367, P895, DOI 10.1056/NEJMoa1201546; Everett R. A., 2014, Biophysical Reviews and Letters, V9, P173, DOI 10.1142/S1793048014300023; Goldstein ST, 2005, INT J EPIDEMIOL, V34, P1329, DOI 10.1093/ije/dyi206; Granich RM, 2009, LANCET, V373, P48, DOI 10.1016/S0140-6736(08)61697-9; Guo Q, 2008, INT J BIFURCAT CHAOS, V18, P3789, DOI 10.1142/S0218127408022743; Hatano T, 2015, J THEOR BIOL, V366, P33, DOI 10.1016/j.jtbi.2014.10.034; Higano C, 2004, UROLOGY, V64, P1182, DOI 10.1016/j.urology.2004.07.019; Hirata Y, 2014, METHODS, V67, P278, DOI 10.1016/j.ymeth.2014.03.018; Hirata Y, 2012, J MOL CELL BIOL, V4, P127, DOI 10.1093/jmcb/mjs020; Hirata Y, 2012, ASIAN J ANDROL, V14, P270, DOI 10.1038/aja.2011.155; Hirata Y, 2010, CHAOS, V20, DOI 10.1063/1.3526968; Hirata Y, 2010, J THEOR BIOL, V264, P517, DOI 10.1016/j.jtbi.2010.02.027; Hussain M, 2013, NEW ENGL J MED, V368, P1314, DOI 10.1056/NEJMoa1212299; Ideta AM, 2008, J NONLINEAR SCI, V18, P593, DOI 10.1007/s00332-008-9031-0; Jackson TL, 2004, NEOPLASIA, V6, P697, DOI 10.1593/neo.04259; Jackson TL, 2004, DISCRETE CONT DYN-B, V4, P187; Jain HV, 2011, P NATL ACAD SCI USA, V108, P19701, DOI 10.1073/pnas.1115750108; Jain RK, 2007, CANCER RES, V67, P2729, DOI 10.1158/0008-5472.CAN-06-4102; Komarova SV, 2003, BONE, V33, P206, DOI 10.1016/S8756-3282(03)00157-1; Kronik N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015482; MARDIA KV, 1970, BIOMETRIKA, V57, P519, DOI 10.1093/biomet/57.3.519; Morino K, 2015, SCI REP-UK, V5, DOI 10.1038/srep08953; Morken JD, 2014, CANCER RES, V74, P3673, DOI 10.1158/0008-5472.CAN-13-3162; Portz T, 2012, AIP ADV, V2, DOI 10.1063/1.3697848; Price K, 2006, NAT COMP SER, DOI 10.1007/3-540-31306-0; RVACHEV LA, 1985, MATH BIOSCI, V75, P3, DOI 10.1016/0025-5564(85)90064-1; Shimada T, 2008, MATH BIOSCI, V214, P134, DOI 10.1016/j.mbs.2008.03.001; Suzuki T, 2010, PHILOS T R SOC A, V368, P5045, DOI 10.1098/rsta.2010.0220; Tanaka G, 2010, PHILOS T R SOC A, V368, P5029, DOI 10.1098/rsta.2010.0221; Tao YS, 2010, J NONLINEAR SCI, V20, P219, DOI 10.1007/s00332-009-9056-z; Tao YS, 2009, MATH MOD METH APPL S, V19, P2177, DOI 10.1142/S021820250900408X; Yu EY, 2010, J CLIN ONCOL, V28, P2668, DOI 10.1200/JCO.2009.25.1330	38	8	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2015	10	6							e0130372	10.1371/journal.pone.0130372	http://dx.doi.org/10.1371/journal.pone.0130372			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4OM	26107379	Green Submitted, Green Published, gold			2022-12-26	WOS:000356932500095
J	Ivarsson, M; Broman, C; Gustafsson, H; Holm, NG				Ivarsson, Magnus; Broman, Curt; Gustafsson, Hakan; Holm, Nils G.			Biogenic Mn-Oxides in Subseafloor Basalts	PLOS ONE			English	Article							DIVERSITY; FUNGI; LIFE; OCEAN; PACIFIC; FLUID; ROCKS; CRUST	The deep biosphere of the subseafloor basalts is recognized as a major scientific frontier in disciplines like biology, geology, and oceanography. Recently, the presence of fungi in these environments has involved a change of view regarding diversity and ecology. Here, we describe fossilized fungal communities in vugs in subseafloor basalts from a depth of 936.65 metres below seafloor at the Detroit Seamount, Pacific Ocean. These fungal communities are closely associated with botryoidal Mn oxides composed of todorokite. Analyses of the Mn oxides by Electron Paramagnetic Resonance spectroscopy (EPR) indicate a biogenic signature. We suggest, based on mineralogical, morphological and EPR data, a biological origin of the botryoidal Mn oxides. Our results show that fungi are involved in Mn cycling at great depths in the seafloor and we introduce EPR as a means to easily identify biogenic Mn oxides in these environments.	[Ivarsson, Magnus] Swedish Museum Nat Hist, Dept Palaeobiol, S-10405 Stockholm, Sweden; [Ivarsson, Magnus] Swedish Museum Nat Hist, Nord Ctr Earth Evolut NordCEE, S-10405 Stockholm, Sweden; [Broman, Curt; Holm, Nils G.] Stockholm Univ, Dept Geol Sci, S-10691 Stockholm, Sweden; [Gustafsson, Hakan] Linkoping Univ, Dept Med & Hlth Sci, Dept Biomed Engn MTO, Cty Council Ostergotland,Radiat Phys, Linkoping, Sweden	Swedish Museum of Natural History; Swedish Museum of Natural History; Stockholm University; City Council Ostergotland; Linkoping University	Ivarsson, M (corresponding author), Swedish Museum Nat Hist, Dept Palaeobiol, S-10405 Stockholm, Sweden.	Magnus.ivarsson@nrm.se			Swedish Research Council [2012-4364]; Danish National Research Foundation [DNRF53]	Swedish Research Council(Swedish Research CouncilEuropean Commission); Danish National Research Foundation(Danmarks Grundforskningsfond)	This work was supported by Swedish Research Council Contract No. 2012-4364, MI received funding; Danish National Research Foundation (DNRF53), Nordic Center for Earth Evolution (NordCEE) received funding.	Bach W, 2003, GEOCHIM COSMOCHIM AC, V67, P3871, DOI 10.1016/S0016-7037(03)00304-1; Bargar JR, 2009, GEOCHIM COSMOCHIM AC, V73, P889, DOI 10.1016/j.gca.2008.10.036; Bekins BA, 2007, GEOLOGY, V35, P679, DOI 10.1130/G23797A.1; Bengtson S, 2014, GEOBIOLOGY, V12, P489, DOI 10.1111/gbi.12100; Burns RG, 1979, MARINE MINERALS, V6, P1; Connell L, 2009, GEOMICROBIOL J, V26, P597, DOI 10.1080/01490450903316174; Downs R. T., 2006, 19 GEN M INT MIN ASS, pO03; Ehrlich H., 2002, GEOMICROBIOLOGY; Fisher AT, 2010, OCEANOGRAPHY, V23, P74, DOI 10.5670/oceanog.2010.63; Gadd GM, 2007, MYCOL RES, V111, P3, DOI 10.1016/j.mycres.2006.12.001; Gorbushina AA, 2002, ASTROBIOLOGY, V2, P203, DOI 10.1089/15311070260192273; Israel EJ, 1997, J GEOPHYS RES-PLANET, V102, P28705, DOI 10.1029/97JE02399; Ivarsson M, 2012, BIOGEOSCIENCES, V9, P3625, DOI 10.5194/bg-9-3625-2012; Ivarsson M, 2013, GEO-MAR LETT, V33, P233, DOI 10.1007/s00367-013-0321-7; Ivarsson M, 2012, GEOLOGY, V40, P163, DOI 10.1130/G32590.1; Kim SS, 2011, ASTROBIOLOGY, V11, P775, DOI 10.1089/ast.2011.0619; Kurtzman C.P., 1998, YEASTS TAXONOMIC STU; Lever MA, 2013, SCIENCE, V339, P1305, DOI 10.1126/science.1229240; Lopez-Garcia P, 2007, ENVIRON MICROBIOL, V9, P546, DOI 10.1111/j.1462-2920.2006.01158.x; Lysnes K, 2004, FEMS MICROBIOL ECOL, V50, P213, DOI 10.1016/j.femsec.2004.06.014; Mason OU, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015399; McCarthy MD, 2011, NAT GEOSCI, V4, P32, DOI 10.1038/NGEO1015; Mccollom TM, 2007, ASTROBIOLOGY, V7, P933, DOI 10.1089/ast.2006.0119; Miyata N, 2007, J BIOSCI BIOENG, V104, P1, DOI 10.1263/jbb.104.1; Orcutt BN, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3539; Orcutt BN, 2011, MICROBIOL MOL BIOL R, V75, P361, DOI 10.1128/MMBR.00039-10; Orcutt BN, 2011, ISME J, V5, P692, DOI 10.1038/ismej.2010.157; Orsi W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056335; Orsi WD, 2013, NATURE, V499, P205, DOI 10.1038/nature12230; Peckmann J, 2008, GEOBIOLOGY, V6, P125, DOI 10.1111/j.1472-4669.2007.00131.x; Santelli CM, 2008, NATURE, V453, P653, DOI 10.1038/nature06899; Schrenk MO, 2010, ANNU REV MAR SCI, V2, P279, DOI 10.1146/annurev-marine-120308-081000; Schumann G, 2004, GEOMICROBIOL J, V21, P241, DOI 10.1080/01490450490438748; STALEY JT, 1982, SCIENCE, V215, P1093, DOI 10.1126/science.215.4536.1093; Staudigel H, 2008, EARTH-SCI REV, V89, P156, DOI 10.1016/j.earscirev.2008.04.005; Stoll S, 2006, J MAGN RESON, V178, P42, DOI 10.1016/j.jmr.2005.08.013; Tarduno J. A., 2002, P OCEAN DRILLING PRO, V197, P1, DOI DOI 10.2973/ODP.PROC.IR.197.105.2002; TAYLORGEORGE S, 1983, MICROBIAL ECOL, V9, P227, DOI 10.1007/BF02097739; Tebo BM, 2005, TRENDS MICROBIOL, V13, P421, DOI 10.1016/j.tim.2005.07.009; Tebo BM, 2004, ANNU REV EARTH PL SC, V32, P287, DOI 10.1146/annurev.earth.32.101802.120213; Tebo BM, 1997, REV MIN, P35225; Templeton AS, 2005, GEOMICROBIOL J, V22, P127, DOI 10.1080/01490450590945951; Thorseth IH, 2001, EARTH PLANET SC LETT, V194, P31, DOI 10.1016/S0012-821X(01)00537-4; Webster J., 2007, INTRO FUNGI, V3rd; Weil JA, 2007, ELECT PARAMAGNETIC R, V2nd	45	23	23	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2015	10	6							e0128863	10.1371/journal.pone.0128863	http://dx.doi.org/10.1371/journal.pone.0128863			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4OM	26107948	Green Published, Green Submitted, gold			2022-12-26	WOS:000356932500031
J	Reta, C; Altamirano, L; Gonzalez, JA; Diaz-Hernandez, R; Peregrina, H; Olmos, I; Alonso, JE; Lobato, R				Reta, Carolina; Altamirano, Leopoldo; Gonzalez, Jesus A.; Diaz-Hernandez, Raquel; Peregrina, Hayde; Olmos, Ivan; Alonso, Jose E.; Lobato, Ruben			Segmentation and Classification of Bone Marrow Cells Images Using Contextual Information for Medical Diagnosis of Acute Leukemias	PLOS ONE			English	Article							BLOOD	Morphological identification of acute leukemia is a powerful tool used by hematologists to determine the family of such a disease. In some cases, experienced physicians are even able to determine the leukemia subtype of the sample. However, the identification process may have error rates up to 40% (when classifying acute leukemia subtypes) depending on the physician's experience and the sample quality. This problem raises the need to create automatic tools that provide hematologists with a second opinion during the classification process. Our research presents a contextual analysis methodology for the detection of acute leukemia subtypes from bone marrow cells images. We propose a cells separation algorithm to break up overlapped regions. In this phase, we achieved an average accuracy of 95% in the evaluation of the segmentation process. In a second phase, we extract descriptive features to the nucleus and cytoplasm obtained in the segmentation phase in order to classify leukemia families and subtypes. We finally created a decision algorithm that provides an automatic diagnosis for a patient. In our experiments, we achieved an overall accuracy of 92% in the supervised classification of acute leukemia families, 84% for the lymphoblastic subtypes, and 92% for the myeloblastic subtypes. Finally, we achieved accuracies of 95% in the diagnosis of leukemia families and 90% in the diagnosis of leukemia subtypes.	[Reta, Carolina; Altamirano, Leopoldo; Gonzalez, Jesus A.; Diaz-Hernandez, Raquel; Peregrina, Hayde] Natl Inst Astrophys Opt & Elect, Dept Comp Sci, Puebla, Mexico; [Olmos, Ivan] Autonomous Univ Puebla, Fac Comp Sci, Puebla, Mexico; [Alonso, Jose E.; Lobato, Ruben] Mexican Social Secur Inst, Dept Hematol, Puebla, Mexico	Instituto Nacional de Astrofisica, Optica y Electronica; Benemerita Universidad Autonoma de Puebla; Instituto Mexicano del Seguro Social	Reta, C (corresponding author), Natl Inst Astrophys Opt & Elect, Dept Comp Sci, Puebla, Mexico.	creta@inaoep.mx	Altamirano, Leopoldo/V-5533-2019; Reta, Carolina/M-3167-2018	Reta, Carolina/0000-0002-0843-129X; Altamirano, Leopoldo/0000-0003-0965-6420	National Council of Science and Technology (CONACyT) of Mexico [13125]	National Council of Science and Technology (CONACyT) of Mexico(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	National Council of Science and Technology (CONACyT) of Mexico, Grant Number 13125: CR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENNETT JM, 1976, BRIT J HAEMATOL, V33, P451, DOI 10.1111/j.1365-2141.1976.tb03563.x; BROWMAN GP, 1986, BLOOD, V68, P900; Colantonio S, 2007, LECT NOTES ARTIF INT, V4826, P115; Dorini LB, 2007, SIBGRAPI, P294, DOI 10.1109/SIBGRAPI.2007.33; FRANCOS JM, 1993, IEEE T SIGNAL PROCES, V41, P2665, DOI 10.1109/78.229897; Galindo M., 2008, THESIS INAOE MEXICO; Hall M., 2009, SIGKDD EXPLORATIONS, V11, P10, DOI [10.1145/1656274.1656278, DOI 10.1145/1656274.1656278]; Hengen H, 2002, P SOC PHOTO-OPT INS, V4684, P624, DOI 10.1117/12.467205; Huey Nee Lim, 2012, 2012 International Conference on Biomedical Engineering (ICoBE), P357, DOI 10.1109/ICoBE.2012.6179038; INEGI-National Institute of Statistics Geography and Informatics, 2006, STAT RESP WORLD DAY; Kato Z.., 1994, THESIS INRIA FRANCE; Kim K, 2001, ADV ARTIFICIAL INTEL, P225; Li SZ, 2000, STOCHASTIC PROCESSES, P473; Liu F, 1999, INT CONF ACOUST SPEE, P3501, DOI 10.1109/ICASSP.1999.757597; Mohapatra S, 2014, NEURAL COMPUT APPL, V24, P1887, DOI 10.1007/s00521-013-1438-3; Morales B, 2005, BONE MARROW SMEARS D; Morales B., 2006, THESIS INAOE MEXICO; Pan C, 2012, EXPERT SYST APPL, V39, P7479, DOI 10.1016/j.eswa.2012.01.114; Pan C, 2009, LECT NOTES COMPUT SC, V5754, P336; Paschos G, 2001, IEEE T IMAGE PROCESS, V10, P932, DOI 10.1109/83.923289; Rao A. R., 1993, Proceedings Visualization '93. (Cat. No.93CH3354-8), P220, DOI 10.1109/VISUAL.1993.398872; Theera-Umpon N, 2005, LECT NOTES ARTIF INT, V3614, P787; Wang WX, 2007, ICNC 2007: THIRD INTERNATIONAL CONFERENCE ON NATURAL COMPUTATION, VOL 4, PROCEEDINGS, P833; Won CS, 2004, LECT NOTES COMPUT SC, V3117, P281	24	31	31	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2015	10	6							e0130805	10.1371/journal.pone.0130805	http://dx.doi.org/10.1371/journal.pone.0130805			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4OM	26107374	gold, Green Published, Green Submitted			2022-12-26	WOS:000356932500125
J	Ekstrand, M; Trajkovska, MG; Perman-Sundelin, J; Fogelstrand, P; Adiels, M; Johansson, M; Mattsson-Hulten, L; Boren, J; Levin, M				Ekstrand, Matias; Trajkovska, Maria Gustafsson; Perman-Sundelin, Jeanna; Fogelstrand, Per; Adiels, Martin; Johansson, Martin; Mattsson-Hulten, Lillemor; Boren, Jan; Levin, Max			Imaging of Intracellular and Extracellular ROS Levels in Atherosclerotic Mouse Aortas Ex Vivo: Effects of Lipid Lowering by Diet or Atorvastatin	PLOS ONE			English	Article							OXIDATIVE STRESS; SUPEROXIDE; PLAQUES; HYPERCHOLESTEROLEMIA; DYSFUNCTION; ATHERECTOMY; EXPRESSION; ANGINA; CELLS; ATP	Objective The first objective was to investigate if intracellular and extracellular levels of reactive oxygen species (ROS) within the mouse aorta increase before or after diet-induced lesion formation. The second objective was to investigate if intracellular and extracellular ROS correlates to cell composition in atherosclerotic lesions. The third objective was to investigate if intracellular and extracellular ROS levels within established atherosclerotic lesions can be reduced by lipid lowering by diet or atorvastatin. Approach and Results To address our objectives, we established a new imaging technique to visualize and quantify intracellular and extracellular ROS levels within intact mouse aortas ex vivo. Using this technique, we found that intracellular, but not extracellular, ROS levels increased prior to lesion formation in mouse aortas. Both intracellular and extracellular ROS levels were increased in advanced lesions. Intracellular ROS correlated with lesion content of macrophages. Extracellular ROS correlated with lesion content of smooth muscle cells. The high levels of ROS in advanced lesions were reduced by 5 days high dose atorvastatin treatment but not by lipid lowering by diet. Atorvastatin treatment did not affect lesion inflammation (aortic arch mRNA levels of CXCL 1, ICAM-1, MCP-1, TNF-alpha, VCAM, IL-6, and IL-1 beta) or cellular composition (smooth muscle cell, macrophage, and T-cell content). Conclusions Aortic levels of intracellular ROS increase prior to lesion formation and may be important in initiation of atherosclerosis. Our results suggest that within lesions, macrophages produce mainly intracellular ROS whereas smooth muscle cells produce extracellular ROS. Short term atorvastatin treatment, but not lipid lowering by diet, decreases ROS levels within established advanced lesions; this may help explain the lesion stabilizing and anti-inflammatory effects of long term statin treatment.	[Ekstrand, Matias; Trajkovska, Maria Gustafsson; Perman-Sundelin, Jeanna; Fogelstrand, Per; Adiels, Martin; Mattsson-Hulten, Lillemor; Boren, Jan; Levin, Max] Univ Gothenburg, Dept Mol & Clin Med Wallenberg Lab, SE-41345 Gothenburg, Sweden; [Ekstrand, Matias; Trajkovska, Maria Gustafsson; Perman-Sundelin, Jeanna; Fogelstrand, Per; Adiels, Martin; Mattsson-Hulten, Lillemor; Boren, Jan; Levin, Max] Sahlgrens Univ Hosp, SE-41345 Gothenburg, Sweden; [Levin, Max] Sahlgrens Univ Hosp, Dept Oncol, SE-41345 Gothenburg, Sweden; [Johansson, Martin] Lund Univ, Dept Pathol, Malmo Univ Hosp, SE-20502 Malmo, Sweden	University of Gothenburg; Sahlgrenska University Hospital; Sahlgrenska University Hospital; Lund University; Skane University Hospital	Levin, M (corresponding author), Univ Gothenburg, Dept Mol & Clin Med Wallenberg Lab, SE-41345 Gothenburg, Sweden.	max.levin@wlab.gu.se		Ekstrand, Matias/0000-0002-0403-9266	Swedish research council; Swedish heart and lung foundation; Swedish foundation for Strategic Research; Sahlgrenska University Hospital; Ake Wibergs fond; Jubileumsklinikens fond; Emelle fond; Novo Nordisk Fonden [NNF14OC0010799] Funding Source: researchfish	Swedish research council(Swedish Research CouncilEuropean Commission); Swedish heart and lung foundation(Swedish Heart-Lung Foundation); Swedish foundation for Strategic Research(Swedish Foundation for Strategic Research); Sahlgrenska University Hospital; Ake Wibergs fond; Jubileumsklinikens fond; Emelle fond; Novo Nordisk Fonden(Novo Nordisk Foundation)	This work was supported by grants from The Swedish research council, The Swedish heart and lung foundation, The Swedish foundation for Strategic Research, ALF grants from Sahlgrenska University Hospital, Ake Wibergs fond, Jubileumsklinikens fond, and Emelle fond. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azumi H, 2002, ARTERIOSCL THROM VAS, V22, P1838, DOI 10.1161/01.ATV.0000037101.40667.62; Ballinger SW, 2002, CIRCULATION, V106, P544, DOI 10.1161/01.CIR.0000023921.93743.89; Benati D, 2010, J LEUKOCYTE BIOL, V87, P433, DOI 10.1189/jlb.0409273; Bernal-Mizrachi C, 2005, NATURE, V435, P502, DOI 10.1038/nature03527; BJORNHEDEN T, 1987, ARTERIOSCLEROSIS, V7, P238, DOI 10.1161/01.ATV.7.3.238; Brasen JH, 2007, J AM COLL CARDIOL, V50, P2249, DOI 10.1016/j.jacc.2007.08.038; Bylund J, 2014, METHODS MOL BIOL, V1124, P321, DOI 10.1007/978-1-62703-845-4_21; Cai Hua, 2007, V139, P293; Crisby M, 2001, CIRCULATION, V103, P926, DOI 10.1161/01.cir.103.7.926; De Keulenaer GW, 1998, CIRC RES, V82, P1094, DOI 10.1161/01.RES.82.10.1094; Gutierrez J, 2006, CIRC RES, V99, P924, DOI 10.1161/01.RES.0000248212.86638.e9; Guzik TJ, 2005, METH MOLEC MED, V108, P73; Hulten LM, 2009, CURR OPIN LIPIDOL, V20, P409, DOI 10.1097/MOL.0b013e3283307be8; Lassegue B, 2012, CIRC RES, V110, P1364, DOI 10.1161/CIRCRESAHA.111.243972; Lee R, 2012, CURR MED CHEM, V19, P2504, DOI 10.2174/092986712800493057; Leppanen O, 2006, ATHEROSCLEROSIS, V188, P323, DOI 10.1016/j.atherosclerosis.2005.11.017; Levin M, 2003, ARTERIOSCL THROM VAS, V23, P1801, DOI 10.1161/01.ATV.0000092872.54026.8D; Madamanchi NR, 2007, CIRC RES, V100, P460, DOI 10.1161/01.RES.0000258450.44413.96; NAKASHIMA Y, 1994, ARTERIOSCLER THROMB, V14, P133, DOI 10.1161/01.ATV.14.1.133; OHARA Y, 1993, J CLIN INVEST, V91, P2546, DOI 10.1172/JCI116491; OHARA Y, 1995, CIRCULATION, V92, P898, DOI 10.1161/01.CIR.92.4.898; Reagan-Shaw S, 2008, FASEB J, V22, P659, DOI 10.1096/fj.07-9574LSF; Sentman ML, 2001, ARTERIOSCL THROM VAS, V21, P1477, DOI 10.1161/hq0901.094248; Sepac A, 2010, ANESTHESIOLOGY, V113, P906, DOI 10.1097/ALN.0b013e3181eff6b7; Solem J, 2006, J INTERN MED, V259, P267, DOI 10.1111/j.1365-2796.2006.01608.x; van der Hoorn JWA, 2007, J HYPERTENS, V25, P2454, DOI 10.1097/HJH.0b013e3282ef79f7; Vecchione C, 2002, CIRC RES, P91; Verreth W, 2007, BRIT J PHARMACOL, V151, P347, DOI 10.1038/sj.bjp.0707231; Wassmann S, 2001, HYPERTENSION, V37, P1450, DOI 10.1161/01.HYP.37.6.1450; Wassmann S, 2001, MOL PHARMACOL, V59, P646, DOI 10.1124/mol.59.3.646; Williams KJ, 2008, NAT CLIN PRACT CARD, V5, P91, DOI 10.1038/ncpcardio1086; WITZTUM JL, 1991, J CLIN INVEST, V88, P1785, DOI 10.1172/JCI115499	32	28	29	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2015	10	6							e0130898	10.1371/journal.pone.0130898	http://dx.doi.org/10.1371/journal.pone.0130898			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL3FM	26098110	Green Published, Green Submitted, gold			2022-12-26	WOS:000356835800120
J	Hirasawa, M; Hagihara, K; Okudaira, N; Izumi, T				Hirasawa, Makoto; Hagihara, Katsunobu; Okudaira, Noriko; Izumi, Takashi			The Possible Mechanism of Idiosyncratic Lapatinib-Induced Liver Injury in Patients Carrying Human Leukocyte Antigen-DRB1*07:01	PLOS ONE			English	Article							HLA; MOLECULES; PEPTIDE; DETERMINANTS	Idiosyncratic lapatinib-induced liver injury has been reported to be associated with human leukocyte antigen (HLA)-DRB1*07:01. In order to investigate its mechanism, interaction of lapatinib with HLA-DRB1*07:01 and its ligand peptide derived from tetanus toxoid, has been evaluated in vitro. Here we show that lapatinib enhances binding of the ligand peptide to HLA-DRB1*07:01. Furthermore in silico molecular dynamics analysis revealed that lapatinib could change the beta chain helix in the HLA-DRB1*07:01 specifically to form a tightly closed binding groove structure and modify a large part of the binding groove. These results indicate that lapatinib affects the ligand binding to HLA-DRB1*07:01 and idiosyncratic lapatinib-induced liver injury might be triggered by this mechanism. This is the first report showing that the clinically available drug can enhance the binding of ligand peptide to HLA class II molecules in vitro and in silico.	[Hirasawa, Makoto; Hagihara, Katsunobu; Okudaira, Noriko; Izumi, Takashi] Daiichi Sankyo Co Ltd, Drug Metab & Pharmacokinet Res Labs, Tokyo, Japan	Daiichi Sankyo Company Limited	Hirasawa, M (corresponding author), Daiichi Sankyo Co Ltd, Drug Metab & Pharmacokinet Res Labs, Tokyo, Japan.	hirasawa.makoto.n4@daiichisankyo.co.jp		Hagihara, Katsunobu/0000-0003-0094-2543; Hirasawa, Makoto/0000-0002-1678-8539	Daiichi Sankyo Co., Ltd.	Daiichi Sankyo Co., Ltd.(Daiichi Sankyo Company Limited)	Daiichi Sankyo Co., Ltd. provided support in the form of salaries for all authors. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Geyer CE, 2006, NEW ENGL J MED, V355, P2733, DOI 10.1056/NEJMoa064320; Gupta S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001814; Hopner S, 2006, J BIOL CHEM, V281, P38535, DOI 10.1074/jbc.M606437200; Huey R, 2007, J COMPUT CHEM, V28, P1145, DOI 10.1002/jcc.20634; Illing PT, 2012, NATURE, V486, P554, DOI 10.1038/nature11147; Johnston S, 2009, J CLIN ONCOL, V27, P5538, DOI 10.1200/JCO.2009.23.3734; Kindmark A, 2008, PHARMACOGENOMICS J, V8, P186, DOI 10.1038/sj.tpj.6500458; Michels AW, 2011, J IMMUNOL, V187, P5921, DOI 10.4049/jimmunol.1100746; Moy B, 2009, J CLIN ONCOL, V27; Norcross MA, 2012, AIDS, V26, pF21, DOI 10.1097/QAD.0b013e328355fe8f; Padovan E, 1997, EUR J IMMUNOL, V27, P1303, DOI 10.1002/eji.1830270602; Pichler Werner J, 2006, Allergol Int, V55, P17, DOI 10.2332/allergolint.55.17; Schaid D. J., 2014, J CLIN ONCOL, V31, P1, DOI DOI 10.1200/JC0.2013.52.9867; Spraggs CF, 2012, CLIN PHARMACOL THER, V91, P647, DOI 10.1038/clpt.2011.277; Spraggs CF, 2011, J CLIN ONCOL, V29, P667, DOI 10.1200/JCO.2010.31.3197; Steere AC, 2006, J EXP MED, V203, P961, DOI 10.1084/jem.20052471; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Uetrecht J, 2013, PHARMACOL REV, V65, P779, DOI 10.1124/pr.113.007450; ul-Haq Z, 2011, J COMPUT AID MOL DES, V25, P81, DOI 10.1007/s10822-010-9404-y	19	10	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2015	10	6							e0130928	10.1371/journal.pone.0130928	http://dx.doi.org/10.1371/journal.pone.0130928			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL3FM	26098642	Green Published, Green Submitted, gold			2022-12-26	WOS:000356835800124
J	Ladner, J; Besson, MH; Rodrigues, M; Saba, J; Audureau, E				Ladner, Joel; Besson, Marie-Helene; Rodrigues, Mariana; Saba, Joseph; Audureau, Etienne			Performance of HIV Prevention of Mother-To-Child Transmission Programs in Sub-Saharan Africa: Longitudinal Assessment of 64 Nevirapine-Based Programs Implemented in 25 Countries, 2000-2011	PLOS ONE			English	Article							RESOURCE-LIMITED SETTINGS; SINGLE-DOSE NEVIRAPINE; COTE-DIVOIRE; ANTIRETROVIRAL THERAPY; RANDOMIZED-TRIAL; ORAL ZIDOVUDINE; SERVICES; PMTCT; CARE; INTERVENTIONS	Background To evaluate the performance and to identify predictive factors of performance in prevention of mother-to-child HIV transmission programs (PMTCT) in sub-Saharan African countries. Methods From 2000 to 2011, PMTCT programs included in the Viramune Donation Programme (VDP) were prospectively followed. Each institution included in the VDP provided data on program implementation, type of management institution, number of PMTCT sites, key programs outputs (HIV counseling and testing, NVP regimens received by mothers and new-borns). Nevirapine Coverage Ratio (NCR), defined as the number of women who should have received nevirapine (observed HIV prevalence x number of women in antenatal care), was used to measure performance. Included programs were followed every six months through progress reports. Results A total of 64 programs in 25 sub-Saharan African countries were included. The mean program follow-up was 48.0 months (SD = 24.5); 20,084,490 women attended in antenatal clinics were included. The overall mean NCR was 0.52 (SD = 0.25), with an increase from 0.37 to 0.57 between the first and last progress reports (p < .0001); NCR increased by 3.26% per year-program. Between the first and the last report, the number of women counseled and tested increased from 64.3% to 86.0%(p < .0001), the number of women post-counseled from 87.5% to 91.3% (p = 0.08). After mixed linear regression analysis, type of responsible institution, number of women attended in ANC, and program initiation in 2005-2006 were significant predictive factors associated with the NCR. The effect of the time period increased from earlier to later periods. Conclusion A longitudinal assessment of large PMTCT programs shows that scaling-up of programs was increased in sub-Saharan African countries. The PMTCT coverage increased throughout the study period, especially after 2006. Performance may be better for programs with a small or medium number of women attended in ANC. Identification of factors that predict PMTCT program performance may help in the development and expansion of additional large PMTCT services in sub-Saharan Africa.	[Ladner, Joel] Rouen Univ Hosp, Epidemiol & Publ Hlth Dept, Rouen, France; [Besson, Marie-Helene; Rodrigues, Mariana; Saba, Joseph] Axios Int, Paris, France; [Audureau, Etienne] Paris Est Univ, Hop Henri Mondor Hosp, AP HP, Biostat & Epidemiol Unit,Publ Hlth, Creteil, France	CHU de Rouen; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP	Ladner, J (corresponding author), Rouen Univ Hosp, Epidemiol & Publ Hlth Dept, Rouen, France.	joel.ladner@univ-rouen.fr	Audureau, Etienne/R-4359-2018; Ladner, Joel/AAU-3564-2020; Audureau, Etienne/AHE-2826-2022	Audureau, Etienne/0000-0002-6166-149X; Audureau, Etienne/0000-0002-6166-149X				Abrams EJ, 2007, AM J OBSTET GYNECOL, V197, pS101, DOI 10.1016/j.ajog.2007.03.068; Alzire J, 2013, CURR HIV RES, V11, P144; Audureau E, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-286; Buchanan AM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088679; Car LT, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008741.pub2; CONNOR EM, 1994, NEW ENGL J MED, V331, P1173, DOI 10.1056/NEJM199411033311801; Dabis F, 1999, LANCET, V353, P786, DOI 10.1016/S0140-6736(98)11046-2; Darak S, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-320; Ekouevi DK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029823; Gourlay A, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.1.18588; Govender T, 2014, J INFECTION, V68, pS57, DOI 10.1016/j.jinf.2013.09.015; Guay LA, 1999, LANCET, V354, P795, DOI 10.1016/S0140-6736(99)80008-7; Haile-Selassie HT, 2011, HIV MED, V12, P422, DOI 10.1111/j.1468-1293.2010.00902.x; Horwood C, 2010, TROP MED INT HEALTH, V15, P992, DOI 10.1111/j.1365-3156.2010.02576.x; Kuonza LR, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-218; Lussiana C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036381; Msellati P, 2009, SOC SCI MED, V69, P807, DOI 10.1016/j.socscimed.2009.05.034; Nash D, 2011, AIDS, V25, P1523, DOI 10.1097/QAD.0b013e32834811b2; Paintsil E, 2009, CURR OPIN PEDIATR, V21, P94, DOI 10.1097/MOP.0b013e32831ec353; Scanlon ML, 2013, HIV AIDS-RES PALLIAT, V5, P1, DOI 10.2147/HIV.S28912; Spensley A, 2009, AM J PUBLIC HEALTH, V99, P631, DOI 10.2105/AJPH.2007.114421; Sripipatana T, 2007, AM J OBSTET GYNECOL, V197, pS107, DOI 10.1016/j.ajog.2007.03.069; Stringer EM, 2010, JAMA-J AM MED ASSOC, V304, P293, DOI 10.1001/jama.2010.990; Suthar AB, 2013, B WORLD HEALTH ORGAN, V91, P46, DOI 10.2471/BLT.12.107003; Toure S, 2008, AIDS, V22, P873, DOI 10.1097/QAD.0b013e3282f768f8; Townsend CL, 2008, AIDS, V22, P973, DOI 10.1097/QAD.0b013e3282f9b67a; Tsague L, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-753; UNAIDS, GETT TO ZER; UNAIDS, 2013, WORLD AIDS DAY REP R; UNAIDS, 2011, POL DECL HIV AIDS IN; Wettstein C, 2012, AIDS, V26, P2361, DOI 10.1097/QAD.0b013e328359ab0c; Wiktor SZ, 1999, LANCET, V353, P781, DOI 10.1016/S0140-6736(98)10412-9; World Health Organization, GLOB HIV AIDS RESP E; Youngleson MS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013891; Zolfo M, 2010, AIDS RES THER, V7, DOI 10.1186/1742-6405-7-35	35	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2015	10	6							e0130103	10.1371/journal.pone.0130103	http://dx.doi.org/10.1371/journal.pone.0130103			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL3FM	26098311	Green Published, Green Submitted, gold			2022-12-26	WOS:000356835800055
J	Zhang, XK; Aoyama, T; Takaishi, R; Higuchi, S; Yamada, S; Kuroki, H; Takakuwa, T				Zhang, Xiangkai; Aoyama, Tomoki; Takaishi, Ryota; Higuchi, Shinya; Yamada, Shigehito; Kuroki, Hiroshi; Takakuwa, Tetsuya			Spatial Change of Cruciate Ligaments in Rat Embryo Knee Joint by Three-Dimensional Reconstruction	PLOS ONE			English	Article							ANTERIOR; ANATOMY	This study aimed to analyze the spatial developmental changes of rat cruciate ligaments by three-dimensional (3D) reconstruction using episcopic fluorescence image capture (EFIC). Cruciate ligaments of Wister rat embryos between embryonic day (E) 16 and E20 were analyzed. Samples were sectioned and visualized using EFIC. 3D reconstructions were generated using Amira software. The length of the cruciate ligaments, distances between attachment points to femur and tibia, angles of the cruciate ligaments and the cross angle of the cruciate ligaments were measured. The shape of cruciate ligaments was clearly visible at E17. The lengths of the anterior cruciate ligament (ACL) and posterior cruciate ligament (PCL) increased gradually from E17 to E19 and drastically at E20. Distances between attachment points to the femur and tibia gradually increased. The ACL angle and PCL angle gradually decreased. The cross angle of the cruciate ligaments changed in three planes. The primordium of the 3D structure of rat cruciate ligaments was constructed from the early stage, with the completion of the development of the structures occurring just before birth.	[Zhang, Xiangkai; Aoyama, Tomoki; Takaishi, Ryota; Higuchi, Shinya; Yamada, Shigehito; Kuroki, Hiroshi; Takakuwa, Tetsuya] Kyoto Univ, Grad Sch Med, Human Hlth Sci, Kyoto, Japan; [Yamada, Shigehito] Kyoto Univ, Grad Sch Med, Congenital Anomaly Res Ctr, Kyoto, Japan	Kyoto University; Kyoto University	Aoyama, T (corresponding author), Kyoto Univ, Grad Sch Med, Human Hlth Sci, Kyoto, Japan.	blue@hs.med.kyoto-u.ac.jp	Yamada, Shigehito/G-2061-2010	Yamada, Shigehito/0000-0002-8194-6927	Japan Society for the Promotion of Science [26282154, 25246164]; Grants-in-Aid for Scientific Research [15H01121] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (#26282154 & #25246164), url: https://www.jsps.go.jp/english/.	Amis AA, 2006, KNEE SURG SPORT TR A, V14, P257, DOI 10.1007/s00167-005-0686-x; Boeree NR, 1992, KNEE SURG CURRENT CR; Cunningham DJ, 1918, CUNNIGHAMS TXB ANATO; Duthon VB, 2006, KNEE SURG SPORT TR A, V14, P204, DOI 10.1007/s00167-005-0679-9; FU FH, 1993, J BONE JOINT SURG AM, V75A, P1716, DOI 10.2106/00004623-199311000-00018; GARDNER E, 1968, J ANAT, V102, P289; GENTILI A, 1994, RADIOLOGY, V193, P835, DOI 10.1148/radiology.193.3.7972834; Kim HK, 2008, RADIOLOGY, V247, P826, DOI 10.1148/radiol.2473071097; Matsumoto H, 2001, J Orthop Sci, V6, P28, DOI 10.1007/s007760170021; MeridaVelasco JA, 1997, ANAT REC, V248, P259, DOI 10.1002/(SICI)1097-0185(199706)248:2<259::AID-AR13>3.0.CO;2-O; MITROVIC D, 1978, AM J ANAT, V151, P475, DOI 10.1002/aja.1001510403; ORAHILLY R, 1975, ANAT EMBRYOL, V148, P1, DOI 10.1007/BF00315559; Ratajczak W, 2000, Folia Morphol (Warsz), V59, P285; Takaishi R, 2014, OSTEOARTHR CARTILAGE, V22, P1401, DOI 10.1016/j.joca.2014.06.016; Tsuchiya M, 2014, CONGENITAL ANOMALIES; Weninger WJ, 2008, CURR GENOMICS, V9, P282, DOI 10.2174/138920208784533601; Yamada S, 2010, DEV DYNAM, V239, P1585, DOI 10.1002/dvdy.22316; Zampeli F, 2014, AM J SPORT MED, V42, P665, DOI 10.1177/0363546513512780	18	1	1	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2015	10	6							e0131092	10.1371/journal.pone.0131092	http://dx.doi.org/10.1371/journal.pone.0131092			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL3FM	26098761	Green Published, Green Submitted, gold			2022-12-26	WOS:000356835800148
J	Shipkowski, KA; Taylor, AJ; Thompson, EA; Glista-Baker, EE; Sayers, BC; Messenger, ZJ; Bauer, RN; Jaspers, I; Bonner, JC				Shipkowski, Kelly A.; Taylor, Alexia J.; Thompson, Elizabeth A.; Glista-Baker, Ellen E.; Sayers, Brian C.; Messenger, Zachary J.; Bauer, Rebecca N.; Jaspers, Ilona; Bonner, James C.			An Allergic Lung Microenvironment Suppresses Carbon Nanotube-Induced Inflammasome Activation via STAT6-Dependent Inhibition of Caspase-1	PLOS ONE			English	Article							NLRP3 INFLAMMASOME; MACROPHAGE DIFFERENTIATION; ASTHMA EXACERBATIONS; NALP3 INFLAMMASOME; EPITHELIAL-CELLS; AIRWAY DISEASE; NANOPARTICLES; RESPONSES; PATHOGENESIS; FIBROBLASTS	Background Multi-walled carbon nanotubes (MWCNTs) represent a human health risk as mice exposed by inhalation display pulmonary fibrosis. Production of IL-1 beta via inflammasome activation is a mechanism of MWCNT-induced acute inflammation and has been implicated in chronic fibrogenesis. Mice sensitized to allergens have elevated T-helper 2 (Th2) cytokines, IL-4 and IL-13, and are susceptible to MWCNT-induced airway fibrosis. We postulated that Th2 cytokines would modulate MWCNT-induced inflammasome activation and IL-1 beta release in vitro and in vivo during allergic inflammation. Methods THP-1 macrophages were primed with LPS, exposed to MWCNTs and/or IL-4 or IL-13 for 24 hours, and analyzed for indicators of inflammasome activation. C57BL6 mice were sensitized to house dust mite (HDM) allergen and MWCNTs were delivered to the lungs by oropharyngeal aspiration. Mice were euthanized 1 or 21 days post-MWCNT exposure and evaluated for lung inflammasome components and allergic inflammatory responses. Results Priming of THP-1 macrophages with LPS increased pro-IL-1 beta and subsequent exposure to MWCNTs induced IL-1 beta secretion. IL-4 or IL-13 decreased MWCNT-induced IL-1 beta secretion by THP-1 cells and reduced pro-caspase-1 but not pro-IL-1 beta. Treatment of THP-1 cells with STAT6 inhibitors, either Leflunomide or JAK I inhibitor, blocked suppression of caspase activity by IL-4 and IL-13. In vivo, MWCNTs alone caused neutrophilic infiltration into the lungs of mice 1 day post-exposure and increased IL-1 beta in bronchoalveolar lavage fluid (BALF) and pro-caspase-1 immuno-staining in macrophages and airway epithelium. HDM sensitization alone caused eosinophilic inflammation with increased IL-13. MWCNT exposure after HDM sensitization increased total cell numbers in BALF, but decreased numbers of neutrophils and IL-1 beta in BALF as well as reduced pro-caspase-1 in lung tissue. Despite reduced IL-1 beta mice exposed to MWCNTs after HDM developed more severe airway fibrosis by 21 days and had increased pro-fibrogenic cytokine mRNAs. Conclusions These data indicate that Th2 cytokines suppress MWCNT-induced inflammasome activation via STAT6-dependent down-regulation of pro-caspase-1 and suggest that suppression of inflammasome activation and IL-1 beta by an allergic lung microenvironment is a mechanism through which MWCNTs exacerbate allergen-induced airway fibrosis.	[Shipkowski, Kelly A.; Taylor, Alexia J.; Thompson, Elizabeth A.; Glista-Baker, Ellen E.; Sayers, Brian C.; Messenger, Zachary J.; Bonner, James C.] N Carolina State Univ, Environm & Mol Toxicol Program, Dept Biol Sci, Raleigh, NC 27695 USA; [Bauer, Rebecca N.; Jaspers, Ilona] Univ N Carolina, Sch Med, Ctr Environm Med Asthma & Lung Biol, Chapel Hill, NC USA	University of North Carolina; North Carolina State University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Bonner, JC (corresponding author), N Carolina State Univ, Environm & Mol Toxicol Program, Dept Biol Sci, Raleigh, NC 27695 USA.	james_bonner@ncsu.edu	Jaspers, Ilona/AAZ-5035-2020		NIEHS Grants [R01-ES020897, RC2-ES018772]; NIEHS training grant [T32 ES007046, T32 ES007126]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES007046, R01ES020897, RC2ES018772, T32ES007126] Funding Source: NIH RePORTER	NIEHS Grants; NIEHS training grant; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was funded by NIEHS Grants R01-ES020897 and RC2-ES018772. EEG and BCS were supported by NIEHS training grant T32 ES007046. RNB was supported by NIEHS training grant T32 ES007126. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antao-Menezes A, 2008, J IMMUNOL, V180, P4200, DOI 10.4049/jimmunol.180.6.4200; Barnes PJ, 2008, J CLIN INVEST, V118, P3546, DOI 10.1172/JCI36130; Bauer RN, 2012, J ALLERGY CLIN IMMUN, V130, P958, DOI 10.1016/j.jaci.2012.07.013; Bauer RN, 2014, THESIS U N CAROLINA; Birrell MA, 2011, PHARMACOL THERAPEUT, V130, P364, DOI 10.1016/j.pharmthera.2011.03.007; Bonner JC, 2010, FIBROGENESIS TISSUE, V3, DOI 10.1186/1755-1536-3-15; Bonner James C, 2010, Proc Am Thorac Soc, V7, P138, DOI 10.1513/pats.200907-061RM; Brickey WJ, 2011, J ALLERGY CLIN IMMUN, V128, P900, DOI 10.1016/j.jaci.2011.08.012; Cihakova D, 2008, AM J PATHOL, V172, P1195, DOI 10.2353/ajpath.2008.070207; Cruz CM, 2007, J BIOL CHEM, V282, P2871, DOI 10.1074/jbc.M608083200; Davis BK, 2011, ANNU REV IMMUNOL, V29, P707, DOI 10.1146/annurev-immunol-031210-101405; Dostert C, 2008, SCIENCE, V320, P674, DOI 10.1126/science.1156995; Eisenbarth SC, 2008, NATURE, V453, P1122, DOI 10.1038/nature06939; Finkelman FD, 2010, J IMMUNOL, V184, P1663, DOI 10.4049/jimmunol.0902185; Gaffin JM, 2009, CURR OPIN ALLERGY CL, V9, P128, DOI 10.1097/ACI.0b013e32832678b0; Glista-Baker EE, 2014, PART FIBRE TOXICOL, V11, DOI 10.1186/1743-8977-11-7; Gwinn MR, 2006, ENVIRON HEALTH PERSP, V114, P1818, DOI 10.1289/ehp.8871; Hussain S, 2011, EUR RESPIR J, V37, P299, DOI 10.1183/09031936.00168509; Hussain S, 2014, PART FIBRE TOXICOL, V11, DOI 10.1186/1743-8977-11-28; Ingram JL, 2006, J IMMUNOL, V177, P4141, DOI 10.4049/jimmunol.177.6.4141; Inoue K, 2009, TOXICOL APPL PHARM, V237, P306, DOI 10.1016/j.taap.2009.04.003; Jessop F, 2015, NANOTOXICOLOGY, V9, P365, DOI 10.3109/17435390.2014.933904; Kummer JA, 2007, J HISTOCHEM CYTOCHEM, V55, P443, DOI 10.1369/jhc.6A7101.2006; Lamkanfi M, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000510; Ledford JG, 2009, J IMMUNOL, V182, P7818, DOI 10.4049/jimmunol.0900452; Martinez FO, 2006, J IMMUNOL, V177, P7303, DOI 10.4049/jimmunol.177.10.7303; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; Meunier E, 2012, NANOMED-NANOTECHNOL, V8, P987, DOI 10.1016/j.nano.2011.11.004; Muller J, 2005, TOXICOL APPL PHARM, V207, P221, DOI 10.1016/j.taap.2005.01.008; Nel A, 2006, SCIENCE, V311, P622, DOI 10.1126/science.1114397; Niebuhr M, 2014, ALLERGY, V69, P1058, DOI 10.1111/all.12428; NIOSH, 2007, DHHS NIOSH PUBL, V2005-149; Palomaki J, 2011, ACS NANO, V5, P6861, DOI 10.1021/nn200595c; Park EJ, 2009, TOXICOLOGY, V259, P113, DOI 10.1016/j.tox.2009.02.009; Porter DW, 2010, TOXICOLOGY, V269, P136, DOI 10.1016/j.tox.2009.10.017; Ryman-Rasmussen JP, 2009, AM J RESP CELL MOL, V40, P349, DOI 10.1165/rcmb.2008-0276OC; Sayers BC, 2013, AM J RESP CELL MOL, V49, P525, DOI 10.1165/rcmb.2013-0019OC; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Scotton CJ, 2005, J IMMUNOL, V174, P834, DOI 10.4049/jimmunol.174.2.834; Siemasko K, 1998, J IMMUNOL, V160, P1581; Singh AM, 2006, THORAX, V61, P809, DOI 10.1136/thx.2005.045179; Taylor AJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106870; Thompson EA, 2013, J ENV IMMUNOL TOXICO, V1, P150; TSUCHIYA S, 1982, CANCER RES, V42, P1530; Wang X, 2011, ACS NANO, V5, P9772, DOI 10.1021/nn2033055; Wark PAB, 2006, THORAX, V61, P909, DOI 10.1136/thx.2005.045187; Willart MAM, 2012, J EXP MED, V209, P1505, DOI 10.1084/jem.20112691; Xia T, 2013, ENVIRON HEALTH PERSP, V121, P683, DOI 10.1289/ehp.1306561; Yazdi AS, 2010, P NATL ACAD SCI USA, V107, P19449, DOI 10.1073/pnas.1008155107	49	23	27	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2015	10	6							e0128888	10.1371/journal.pone.0128888	http://dx.doi.org/10.1371/journal.pone.0128888			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL3FE	26091108	Green Submitted, Green Published, gold			2022-12-26	WOS:000356835000032
J	ElAzzouny, MA; Evans, CR; Burant, CF; Kennedy, RT				ElAzzouny, Mahmoud A.; Evans, Charles R.; Burant, Charles F.; Kennedy, Robert T.			Metabolomics Analysis Reveals that AICAR Affects Glycerolipid, Ceramide and Nucleotide Synthesis Pathways in INS-1 Cells	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; STIMULATED INSULIN-SECRETION; PANCREATIC BETA-CELLS; SENSITIVE K+ CHANNEL; CHAIN ACYL-COA; 5-AMINOIMIDAZOLE-4-CARBOXAMIDE RIBONUCLEOSIDE; INTRAVENOUS AICAR; FATTY-ACIDS; GLUCOSE; AMPK	AMPK regulates many metabolic pathways including fatty acid and glucose metabolism, both of which are closely associated with insulin secretion in pancreatic beta-cells. Insulin secretion is regulated by metabolic coupling factors such as ATP/ADP ratio and other metabolites generated by the metabolism of nutrients such as glucose, fatty acid and amino acids. However, the connection between AMPK activation and insulin secretion in beta-cells has not yet been fully elucidated at a metabolic level. To study the effect of AMPK activation on glucose stimulated insulin secretion, we applied the pharmacological activator 5-aminoimidazole-4-carboxamide ribonucleotide (AICAR) to an INS-1 (832/13) beta-cell line. We measured the change in 66 metabolites in the presence or absence of AICAR using different stable isotopic labeled nutrients to probe selected pathways. AMPK activation by AICAR increased basal insulin secretion and reduced the glucose stimulation index. Although ATP/ADP ratios were not strongly affected by AICAR, several other metabolites and pathways important for insulin secretion were affected by AICAR treatment including long-chain CoAs, malonyl-CoA, 3-hydroxy-3 methylglutaryl CoA, diacylglycerol, and farnesyl pyrophosphate. Tracer studies using C-13-glucose revealed lower glucose flux in the purine and pyrimidine pathway and in the glycerolipid synthesis pathway. Untargeted metabolomics revealed reduction in ceramides caused by AICAR that may explain the beneficial role of AMPK in protecting beta-cells from lipotoxicity. Taken together, the results provide an overall picture of the metabolic changes associated with AICAR treatment and how it modulates insulin secretion and beta-cell survival.	[ElAzzouny, Mahmoud A.; Kennedy, Robert T.] Univ Michigan, Dept Chem, Ann Arbor, MI 48109 USA; [ElAzzouny, Mahmoud A.; Evans, Charles R.; Burant, Charles F.] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA; [Kennedy, Robert T.] Univ Michigan, Dept Pharmacol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Kennedy, RT (corresponding author), Univ Michigan, Dept Chem, Ann Arbor, MI 48109 USA.	rtkenn@umich.edu	Burant, Charles/GPC-5690-2022; Kennedy, Robert/G-9095-2016	Burant, Charles/0000-0001-9189-5003; Kennedy, Robert/0000-0003-2447-7471; Evans, Charles/0000-0001-6698-5330	National Institutes of Health [DK046960, DK079084, K25DK092558]; Michigan Nutrition Obesity Research Center [P30 DK089503]; Michigan Diabetes Research and Training Center [P60 DK20572]; Michigan Regional Comprehensive Metabolomics Resource Core [U24 DK097153]; Robert C. and Veronica Atkins Foundation; A. Alfred Taubman Institute; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK046960, U24DK097153, R01DK046960, P60DK020572, K25DK092558, P30DK020572, P30DK089503, R01DK079084] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Michigan Nutrition Obesity Research Center; Michigan Diabetes Research and Training Center; Michigan Regional Comprehensive Metabolomics Resource Core; Robert C. and Veronica Atkins Foundation; A. Alfred Taubman Institute; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK046960 (to RTK), DK079084 (to CFB and RTK), and K25DK092558 (to CRE). This work was also supported by Michigan Nutrition Obesity Research Center Grant P30 DK089503, by Michigan Diabetes Research and Training Center Grant P60 DK20572, by Michigan Regional Comprehensive Metabolomics Resource Core Grant U24 DK097153, by the Robert C. and Veronica Atkins Foundation (to CFB), and by the A. Alfred Taubman Institute (to CFB).	Bardeleben C, 2013, MOL CANC THER; Boon H, 2008, DIABETOLOGIA, V51, P1893, DOI 10.1007/s00125-008-1108-7; Boslem E, 2012, ISLETS, V4, P177, DOI 10.4161/isl.20102; Bosselaar M, 2011, J CLIN PHARMACOL, V51, P1449, DOI 10.1177/0091270010382912; Boutilier JM, 2012, J CHROMATOGR B, V908, P59, DOI 10.1016/j.jchromb.2012.09.035; Burant CF, 2012, LANCET, V379, P1403, DOI 10.1016/S0140-6736(11)61879-5; Champe PC, 2008, LIPPINCOTTS ILLUSTRA, P293; Chen SH, 1997, BIOCHEMISTRY-US, V36, P10718, DOI 10.1021/bi9711893; CORTON JM, 1995, EUR J BIOCHEM, V229, P558, DOI 10.1111/j.1432-1033.1995.0558k.x; El-Assaad W, 2003, ENDOCRINOLOGY, V144, P4154, DOI 10.1210/en.2003-0410; El-Azzouny M, 2014, J BIOL CHEM, V289, P13575, DOI 10.1074/jbc.M113.531970; Erickson KA, 2012, DIABETOL METAB SYNDR, V4, DOI 10.1186/1758-5996-4-45; Eto K, 2002, DIABETES, V51, pS414, DOI 10.2337/diabetes.51.2007.S414; Fahien LA, 2002, DIABETES, V51, P2669, DOI 10.2337/diabetes.51.9.2669; Fu A, 2013, MOL CELL ENDOCRINOL, V366, P127, DOI 10.1016/j.mce.2012.06.020; Gleason CE, 2007, J BIOL CHEM, V282, P10341, DOI 10.1074/jbc.M610631200; GRUBER HE, 1991, ADV EXP MED BIOL, V309, P363; Guo HD, 2010, INT J DIGIT EARTH, V3, P1, DOI 10.1080/17538941003650702; Habegger KM, 2012, ENDOCRINOLOGY, V153, P2130, DOI 10.1210/en.2011-2099; Hardie DG, 2012, CHEM BIOL, V19, P1222, DOI 10.1016/j.chembiol.2012.08.019; Hardie DG, 2011, BIOCHEM SOC T, V39, P1, DOI 10.1042/BST0390001; Hohmeier HE, 2000, DIABETES, V49, P424, DOI 10.2337/diabetes.49.3.424; Houweling M, 2002, BIOCHEM J, V362, P97, DOI 10.1042/0264-6021:3620097; Jacobs RL, 2007, J BIOL CHEM, V282, P4516, DOI 10.1074/jbc.M605702200; Jitrapakdee S, 2010, DIABETOLOGIA, V53, P1019, DOI 10.1007/s00125-010-1685-0; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Kowluru A, 2010, DIABETES, V59, P967, DOI 10.2337/db09-1334; Lanner JT, 2012, NAT MED, V18, P244, DOI 10.1038/nm.2598; Larsson O, 1996, J BIOL CHEM, V271, P10623, DOI 10.1074/jbc.271.18.10623; Li D, 2010, J BIOL CHEM, V285, P33499, DOI 10.1074/jbc.M110.159772; Lorenz MA, 2013, J BIOL CHEM, V288, P10923, DOI 10.1074/jbc.M112.414961; Muoio DM, 1999, BIOCHEM J, V338, P783, DOI 10.1042/0264-6021:3380783; Paglia G, 2012, ANAL BIOANAL CHEM, V402, P1183, DOI 10.1007/s00216-011-5556-4; PRENTKI M, 1992, J BIOL CHEM, V267, P5802; Prentki M, 2013, CELL METAB, V18, P162, DOI 10.1016/j.cmet.2013.05.018; SABINA RL, 1985, J BIOL CHEM, V260, P6107; Salt IP, 1998, BIOCHEM J, V335, P533, DOI 10.1042/bj3350533; Santidrian AF, 2010, BLOOD, V116, P3023, DOI 10.1182/blood-2010-05-283960; Sato Y, 2010, ANAL CHEM, V82, P9858, DOI 10.1021/ac102211r; Scott SA, 2009, NAT CHEM BIOL, V5, P108, DOI 10.1038/nchembio.140; SMITH RJ, 1990, J PHARMACOL EXP THER, V253, P688; Straub SG, 2002, DIABETES-METAB RES, V18, P451, DOI 10.1002/dmrr.329; Suzuki T, 2013, MOL CELL, V50, P407, DOI 10.1016/j.molcel.2013.03.022; Tautenhahn R, 2012, ANAL CHEM, V84, P5035, DOI 10.1021/ac300698c; Wang CZ, 2005, BIOCHEM BIOPH RES CO, V330, P1073, DOI 10.1016/j.bbrc.2005.03.093; Xavier GD, 2003, BIOCHEM J, V371, P761; Yue J, 2013, BIOCHEM BIOPH RES CO, V440, P756, DOI 10.1016/j.bbrc.2013.10.002	48	16	16	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2015	10	6							e129029	10.1371/journal.pone.0129029	http://dx.doi.org/10.1371/journal.pone.0129029			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4OM	26107620	Green Published, gold, Green Submitted			2022-12-26	WOS:000356932500037
J	Georgescu, W; Osseiran, A; Rojec, M; Liu, YY; Bombrun, M; Tang, J; Costes, SV				Georgescu, Walter; Osseiran, Alma; Rojec, Maria; Liu, Yueyong; Bombrun, Maxime; Tang, Jonathan; Costes, Sylvain V.			Characterizing the DNA Damage Response by Cell Tracking Algorithms and Cell Features Classification Using High-Content Time-Lapse Analysis	PLOS ONE			English	Article							DOUBLE-STRAND BREAKS; POSITIONAL STABILITY; RADIATION; REPAIR; MOBILITY; DYNAMICS; FOCI	Traditionally, the kinetics of DNA repair have been estimated using immunocytochemistry by labeling proteins involved in the DNA damage response (DDR) with fluorescent markers in a fixed cell assay. However, detailed knowledge of DDR dynamics across multiple cell generations cannot be obtained using a limited number of fixed cell time-points. Here we report on the dynamics of 53BP1 radiation induced foci (RIF) across multiple cell generations using live cell imaging of non-malignant human mammary epithelial cells (MCF10A) expressing histone H2B-GFP and the DNA repair protein 53BP1-mCherry. Using automatic extraction of RIF imaging features and linear programming techniques, we were able to characterize detailed RIF kinetics for 24 hours before and 24 hours after exposure to low and high doses of ionizing radiation. High-content-analysis at the single cell level over hundreds of cells allows us to quantify precisely the dose dependence of 53BP1 protein production, RIF nuclear localization and RIF movement after exposure to X-ray. Using elastic registration techniques based on the nuclear pattern of individual cells, we could describe the motion of individual RIF precisely within the nucleus. We show that DNA repair occurs in a limited number of large domains, within which multiple small RIFs form, merge and/or resolve with random motion following normal diffusion law. Large foci formation is shown to be mainly happening through the merging of smaller RIF rather than through growth of an individual focus. We estimate repair domain sizes of 7.5 to 11 mu m(2) with a maximum number of similar to 15 domains per MCF10A cell. This work also highlights DDR which are specific to doses larger than 1 Gy such as rapid 53BP1 protein increase in the nucleus and foci diffusion rates that are significantly faster than for spontaneous foci movement. We hypothesize that RIF merging reflects a "stressed" DNA repair process that has been taken outside physiological conditions when too many DSB occur at once. High doses of ionizing radiation lead to RIF merging into repair domains which in turn increases DSB proximity and misrepair. Such finding may therefore be critical to explain the supralinear dose dependence for chromosomal rearrangement and cell death measured after exposure to ionizing radiation.	[Georgescu, Walter; Osseiran, Alma; Rojec, Maria; Tang, Jonathan; Costes, Sylvain V.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Div Life Sci, Berkeley, CA 94720 USA; [Liu, Yueyong] Harvard Univ, Sch Med, Dept Pathol, Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA; [Bombrun, Maxime] CNRS, LIMOS, UMR 6158, F-63173 Aubiere, France	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Centre National de la Recherche Scientifique (CNRS); Universite Clermont Auvergne (UCA)	Costes, SV (corresponding author), Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Div Life Sci, Berkeley, CA 94720 USA.	svcostes@lbl.gov	Costes, Sylvain V/D-2522-2013	Costes, Sylvain V/0000-0002-8542-2389; Bombrun, Maxime/0000-0001-5028-1945	Low Dose Scientific Focus Area, United States Department of Energy [DE-AC02-05CH11231]	Low Dose Scientific Focus Area, United States Department of Energy(United States Department of Energy (DOE))	This work was supported by the Low Dose Scientific Focus Area, United States Department of Energy [DE-AC02-05CH11231]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2007, SMC5 SMC6 COMPLEX SU; Asaithamby A, 2009, NUCLEIC ACIDS RES, V37, P3912, DOI 10.1093/nar/gkp237; Aten JA, 2004, SCIENCE, V303, P92, DOI 10.1126/science.1088845; Brenner DJ, 2003, P NATL ACAD SCI USA, V100, P13761, DOI 10.1073/pnas.2235592100; Calabrese EJ, 2009, ARCH TOXICOL, V83, P227, DOI 10.1007/s00204-009-0411-5; Chiolo I, 2013, MUTAT RES-FUND MOL M, V750, P56, DOI 10.1016/j.mrfmmm.2013.08.001; Chiolo I, 2011, CELL, V144, P732, DOI 10.1016/j.cell.2011.02.012; Costes SV, 2006, RADIAT RES, V165, P505, DOI 10.1667/RR3538.1; Costes SV, 2007, PLOS COMPUT BIOL, V3, P1477, DOI 10.1371/journal.pcbi.0030155; Deckbar D, 2007, J CELL BIOL, V176, P749, DOI 10.1083/jcb.200612047; Dion V, 2012, NAT CELL BIOL, V14, P502, DOI 10.1038/ncb2465; Douglas D.H., 1973, CARTOGRAPHICA INT J, V10, P112, DOI [10.3138/FM57-6770-U75U-7727, DOI 10.3138/FM57-6770-U75U-7727]; Georgescu W, 2012, BIOINFORMATICS, V28, P138, DOI 10.1093/bioinformatics/btr633; Groesser T, 2011, INT J RADIAT BIOL, V87, P696, DOI 10.3109/09553002.2010.549535; Helleday T, 2007, DNA REPAIR, V6, P923, DOI 10.1016/j.dnarep.2007.02.006; Jakob B, 2009, RADIAT RES, V171, P405, DOI 10.1667/RR1520.1; Jakob B, 2009, P NATL ACAD SCI USA, V106, P3172, DOI 10.1073/pnas.0810987106; Jakob B, 2011, NUCLEIC ACIDS RES, V39, P6489, DOI 10.1093/nar/gkr230; Krawczyk PM, 2012, J CELL SCI, V125, P2127, DOI 10.1242/jcs.089847; Lin YF, 2009, RADIAT RES, V171, P708, DOI 10.1667/RR1554.1; Lisby M, 2003, NAT CELL BIOL, V5, P572, DOI 10.1038/ncb997; Mine-Hattab J, 2012, NAT CELL BIOL, V14, P510, DOI 10.1038/ncb2472; Neumaier T, 2012, P NATL ACAD SCI USA, V109, P443, DOI 10.1073/pnas.1117849108; Preston DL, 2007, RADIAT RES, V168, P1, DOI 10.1667/RR0763.1; Ruusuvuori P, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-248; Savage JRK, 1996, MUTAT RES-REV GENET, V366, P81, DOI 10.1016/S0165-1110(96)90030-5; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Soutoglou E, 2007, NAT CELL BIOL, V9, P675, DOI 10.1038/ncb1591; Tang J, 2014, STEM CELLS, V32, P649, DOI 10.1002/stem.1533; Vadhavkar N, 2014, RADIAT RES, V182, P273, DOI 10.1667/RR13792.1; Wang TJ, 2010, LANCET, V376, P180, DOI 10.1016/S0140-6736(10)60588-0; Wang WX, 1998, PATTERN RECOGN, V31, P1503, DOI 10.1016/S0031-3203(97)00145-3; Zhang PJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep08919	33	22	22	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2015	10	6							e0129438	10.1371/journal.pone.0129438	http://dx.doi.org/10.1371/journal.pone.0129438			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4OM	26107175	Green Published, gold, Green Submitted			2022-12-26	WOS:000356932500053
J	Hoelen, H; Zaldumbide, A; van Leeuwen, WF; Torfs, ECW; Engelse, MA; Hassan, C; Lebbink, RJ; de Koning, EJ; Resssing, ME; de Ru, AH; van Veelen, PA; Hoeben, RC; Roep, BO; Wiertz, EJHJ				Hoelen, Hanneke; Zaldumbide, Arnaud; van Leeuwen, Wouter F.; Torfs, Ellen C. W.; Engelse, Marten A.; Hassan, Chopie; Lebbink, Robert Jan; de Koning, Eelco J.; Resssing, Maaike E.; de Ru, Arnoud H.; van Veelen, Peter A.; Hoeben, Rob C.; Roep, Bart O.; Wiertz, Emmanuel J. H. J.			Proteasomal Degradation of Proinsulin Requires Derlin-2, HRD1 and p97	PLOS ONE			English	Article							UNFOLDED PROTEIN RESPONSE; ER-ASSOCIATED DEGRADATION; CLASS-I MOLECULES; CD8 T-CELLS; ENDOPLASMIC-RETICULUM; UBIQUITIN-LIGASE; BETA-CELLS; MULTIPROTEIN COMPLEXES; ANTIGEN PRESENTATION; RETRO-TRANSLOCATION	Patients with type 1 diabetes (T1D) suffer from beta-cell destruction by CD8(+) T-cells that have preproinsulin as an important target autoantigen. It is of great importance to understand the molecular mechanism underlying the processing of preproinsulin into these CD8(+) T-cell epitopes. We therefore studied a pathway that may contribute to the production of these antigenic peptides: degradation of proinsulin via ER associated protein degradation (ERAD). Analysis of the MHC class I peptide ligandome confirmed the presentation of the most relevant MHC class I-restricted diabetogenic epitopes in our cells: the signal peptide-derived sequence A15-A25 and the insulin B-chain epitopes H29-A38 and H34-V42. We demonstrate that specific silencing of Derlin-2, p97 and HRD1 by shRNAs increases steady state levels of proinsulin. This indicates that these ERAD constituents are critically involved in proinsulin degradation and may therefore also play a role in subsequent antigen generation. These ERAD proteins therefore represent interesting targets for novel therapies aiming at the reduction and possibly also prevention of beta-cell directed auto-immune reactions in T1D.	[Hoelen, Hanneke; van Leeuwen, Wouter F.; Torfs, Ellen C. W.; Lebbink, Robert Jan; Resssing, Maaike E.; Wiertz, Emmanuel J. H. J.] Univ Med Ctr Utrecht, Dept Med Microbiol, Utrecht, Netherlands; [Zaldumbide, Arnaud; Resssing, Maaike E.; Hoeben, Rob C.] Leiden Univ, Dept Mol Cell Biol, Med Ctr, Leiden, Netherlands; [Engelse, Marten A.; de Koning, Eelco J.] Leiden Univ, Dept Nephrol, Med Ctr, Leiden, Netherlands; [Hassan, Chopie; de Ru, Arnoud H.; van Veelen, Peter A.; Roep, Bart O.] Leiden Univ, Dept Immunohematol & Blood Transfus, Med Ctr, Leiden, Netherlands	Utrecht University; Utrecht University Medical Center; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Wiertz, EJHJ (corresponding author), Univ Med Ctr Utrecht, Dept Med Microbiol, Utrecht, Netherlands.	e.wiertz@umcutrecht.nl	Roep, Bart/AAD-7609-2021; hassan, cesare/H-2844-2012; Hoeben, Rob C./A-5771-2008; Lebbink, Robert Jan/GNH-5209-2022; de Koning, Eelco JP/H-6030-2011	hassan, cesare/0000-0001-7167-1459; Hoeben, Rob C./0000-0001-9443-8377; de Koning, Eelco JP/0000-0002-1232-7022; Lebbink, Robert Jan/0000-0002-1981-0420; van Leeuwen, Wouter/0000-0002-3874-5441; van Veelen, Peter/0000-0002-7898-9408	Dutch Diabetes Foundation [DFN 2008.04.001]; Dr. Valliant Foundation	Dutch Diabetes Foundation; Dr. Valliant Foundation	This work was part of the "Diabetes Foundation Expert Center Beta Cell Protection" funded by the Dutch Diabetes Foundation (DFN 2008.04.001), to HH and EW (http://www.diabetesfonds.nl/). This work was also financially supported by the Dr. Valliant Foundation, to HH and EW (http://www.lvc-online.nl/dr-c-j-vaillantfonds). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen JR, 2004, BIOCHEM BIOPH RES CO, V324, P166, DOI 10.1016/j.bbrc.2004.09.035; BENNETT DL, 1992, J BIOL CHEM, V267, P15229; Britten CM, 2002, J IMMUNOL METHODS, V259, P95, DOI 10.1016/S0022-1759(01)00499-9; Brodsky JL, 1997, TRENDS CELL BIOL, V7, P151, DOI 10.1016/S0962-8924(97)01020-9; Burr ML, 2013, P NATL ACAD SCI USA, V110, P14290, DOI 10.1073/pnas.1303380110; Carlotti F, 2004, MOL THER, V9, P209, DOI 10.1016/j.ymthe.2003.11.021; Carvalho P, 2010, CELL, V143, P579, DOI 10.1016/j.cell.2010.10.028; Coppieters KT, 2012, J EXP MED, V209, P51, DOI 10.1084/jem.20111187; DANIEL D, 1995, EUR J IMMUNOL, V25, P1056, DOI 10.1002/eji.1830250430; Daniel D, 1996, P NATL ACAD SCI USA, V93, P956, DOI 10.1073/pnas.93.2.956; Dougan SK, 2011, MOL CELL BIOL, V31, P1145, DOI 10.1128/MCB.00967-10; Eura Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034298; Fang SY, 2001, P NATL ACAD SCI USA, V98, P14422, DOI 10.1073/pnas.251401598; Fiebiger E, 2004, MOL BIOL CELL, V15, P1635, DOI 10.1091/mbc.E03-07-0506; Fonseca SG, 2009, CURR OPIN PHARMACOL, V9, P763, DOI 10.1016/j.coph.2009.07.003; Fukuda S, 2001, BIOCHEM BIOPH RES CO, V280, P407, DOI 10.1006/bbrc.2000.4111; Greenblatt EJ, 2012, NAT STRUCT MOL BIOL, V19, P979, DOI 10.1038/nsmb.2398; Hartley T, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-59; Hassink G, 2005, BIOCHEM J, V388, P647, DOI 10.1042/BJ20041241; Horst D, 2009, J IMMUNOL, V182, P2313, DOI 10.4049/jimmunol.0803218; Hsu HT, 2014, J IMMUNOL, V192, P4957, DOI 10.4049/jimmunol.1300631; Huang CH, 2013, J BIOL CHEM, V288, P25330, DOI 10.1074/jbc.M113.455212; Jansens Annemieke, 2003, Methods Mol Biol, V232, P133; Kikkert M, 2004, J BIOL CHEM, V279, P3525, DOI 10.1074/jbc.M307453200; Kloetzel PM, 2004, NAT IMMUNOL, V5, P661, DOI 10.1038/ni1090; Kopito RR, 2000, TRENDS CELL BIOL, V10, P524, DOI 10.1016/S0962-8924(00)01852-3; Lilley BN, 2005, P NATL ACAD SCI USA, V102, P14296, DOI 10.1073/pnas.0505014102; Lilley BN, 2004, NATURE, V429, P834, DOI 10.1038/nature02592; Liu M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013333; Lopez-Avalos MD, 2006, DIABETES, V55, P1223, DOI 10.2337/db05-0450; Meunier L, 2002, MOL BIOL CELL, V13, P4456, DOI 10.1091/mbc.E02-05-0311; Moriyama H, 2002, P NATL ACAD SCI USA, V99, P5539, DOI 10.1073/pnas.082120099; Oda Y, 2006, J CELL BIOL, V172, P383, DOI 10.1083/jcb.200507057; Pinkse GGM, 2005, P NATL ACAD SCI USA, V102, P18425, DOI 10.1073/pnas.0508621102; Roep BO, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006103; Scheuner D, 2008, ENDOCR REV, V29, P317, DOI 10.1210/er.2007-0039; Schubert U, 2000, NATURE, V404, P770, DOI 10.1038/35008096; Schulze A, 2005, J MOL BIOL, V354, P1021, DOI 10.1016/j.jmb.2005.10.020; Skowera A, 2008, J CLIN INVEST, V118, P3390, DOI 10.1172/JCI35449; Stagg HR, 2009, J CELL BIOL, V186, P685, DOI 10.1083/jcb.200906110; Stein A, 2014, CELL, V158, P1375, DOI 10.1016/j.cell.2014.07.050; Tiwari A, 2013, J CELL SCI, V126, P1962, DOI 10.1242/jcs.117374; Toma A, 2005, P NATL ACAD SCI USA, V102, P10581, DOI 10.1073/pnas.0504230102; van de Weijer ML, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4832; van den Boomen DJH, 2014, P NATL ACAD SCI USA, V111, P11425, DOI 10.1073/pnas.1409099111; van Lummel M, 2012, J BIOL CHEM, V287, P9514, DOI 10.1074/jbc.M111.313940; Wong FS, 1999, NAT MED, V5, P1026, DOI 10.1038/12465; Ye YH, 2001, NATURE, V414, P652, DOI 10.1038/414652a; Ye YH, 2004, NATURE, V429, P841, DOI 10.1038/nature02656; Zhang L, 2008, CURR OPIN IMMUNOL, V20, P111, DOI 10.1016/j.coi.2007.11.005	50	16	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2015	10	6							e0128206	10.1371/journal.pone.0128206	http://dx.doi.org/10.1371/journal.pone.0128206			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4OM	26107514	gold, Green Published, Green Submitted			2022-12-26	WOS:000356932500016
J	Thompson, EC; White-Schwoch, T; Tierney, A; Kraus, N				Thompson, Elaine C.; White-Schwoch, Travis; Tierney, Adam; Kraus, Nina			Beat Synchronization across the Lifespan: Intersection of Development and Musical Experience	PLOS ONE			English	Article							SENSORIMOTOR SYNCHRONIZATION; AUDITORY SEQUENCES; PERCEPTION; CHILDREN; SPEECH; RHYTHM; ABILITY; CORTEX; PERIOD; ADULTS	Rhythmic entrainment, or beat synchronization, provides an opportunity to understand how multiple systems operate together to integrate sensory-motor information. Also, synchronization is an essential component of musical performance that may be enhanced through musical training. Investigations of rhythmic entrainment have revealed a developmental trajectory across the lifespan, showing synchronization improves with age and musical experience. Here, we explore the development and maintenance of synchronization in childhood through older adulthood in a large cohort of participants (N = 145), and also ask how it may be altered by musical experience. We employed a uniform assessment of beat synchronization for all participants and compared performance developmentally and between individuals with and without musical experience. We show that the ability to consistently tap along to a beat improves with age into adulthood, yet in older adulthood tapping performance becomes more variable. Also, from childhood into young adulthood, individuals are able to tap increasingly close to the beat (i.e., asynchronies decline with age), however, this trend reverses from younger into older adulthood. There is a positive association between proportion of life spent playing music and tapping performance, which suggests a link between musical experience and auditory-motor integration. These results are broadly consistent with previous investigations into the development of beat synchronization across the lifespan, and thus complement existing studies and present new insights offered by a different, large cross-sectional sample.	[Thompson, Elaine C.; White-Schwoch, Travis; Tierney, Adam; Kraus, Nina] Northwestern Univ, Auditory Neurosci Lab, Evanston, IL 60208 USA; [Thompson, Elaine C.; White-Schwoch, Travis; Tierney, Adam; Kraus, Nina] Northwestern Univ, Dept Commun Sci & Disorders, Evanston, IL USA; [Kraus, Nina] Northwestern Univ, Inst Neurosci, Evanston, IL 60208 USA; [Kraus, Nina] Northwestern Univ, Dept Neurobiol & Physiol, Evanston, IL 60208 USA; [Kraus, Nina] Northwestern Univ, Dept Otolaryngol, Chicago, IL 60611 USA	Northwestern University; Northwestern University; Northwestern University; Northwestern University; Northwestern University	Kraus, N (corresponding author), Northwestern Univ, Auditory Neurosci Lab, Evanston, IL 60208 USA.	nkraus@northwestern.edu		Tierney, Adam/0000-0002-7624-6918; Thompson, Elaine/0000-0003-1293-6247	National Institute of Health [DC10016]; National Association of Music Merchant; Knowles Hearing Center; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC010016] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Association of Music Merchant; Knowles Hearing Center; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by the National Institute of Health DC10016 to NK, The National Association of Music Merchant to NK (http://www.namm.org) and The Knowles Hearing Center to NK (http://comm.soc.northwestern.edu/knowles-hearing-center/).	Anderson S, 2012, J NEUROSCI, V32, P14156, DOI 10.1523/JNEUROSCI.2176-12.2012; Aschersleben G, 2002, BRAIN COGNITION, V48, P66, DOI 10.1006/brcg.2001.1304; Bailey J, 2012, ANN NY ACAD SCI, V1252, P163, DOI 10.1111/j.1749-6632.2011.06434.x; Besson M, 2007, RESTOR NEUROL NEUROS, V25, P399; Bhide A, 2013, MIND BRAIN EDUC, V7, P113, DOI 10.1111/mbe.12016; Brown L., 1997, TEST NONVERBAL INTEL; Casey BJ, 2005, CURR OPIN NEUROBIOL, V15, P239, DOI 10.1016/j.conb.2005.03.012; Caspary DM, 2005, J NEUROSCI, V25, P10952, DOI 10.1523/JNEUROSCI.2451-05.2005; Chen JL, 2006, NEUROIMAGE, V32, P1771, DOI 10.1016/j.neuroimage.2006.04.207; Chen YQ, 2002, HUM MOVEMENT SCI, V21, P515, DOI 10.1016/S0167-9457(02)00138-0; Clayton M., 2005, EUR MEET ETHNOMUSICO, V11, P3, DOI DOI 10.1093/ACPROF:OSO/9780195339680.001.0001; Corrigall KA, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00222; Corriveau KH, 2009, CORTEX, V45, P119, DOI 10.1016/j.cortex.2007.09.008; Drake C, 2000, COGNITION, V77, P251, DOI 10.1016/S0010-0277(00)00106-2; Drewing K, 2006, INT J BEHAV DEV, V30, P280, DOI 10.1177/0165025406066764; Gogtay N, 2004, P NATL ACAD SCI USA, V101, P8174, DOI 10.1073/pnas.0402680101; Hannon EE, 2005, COGNITIVE PSYCHOL, V50, P354, DOI 10.1016/j.cogpsych.2004.09.003; HUTTENLOCHER PR, 1979, BRAIN RES, V163, P195; Iversen JR, 2009, ANN NY ACAD SCI, V1169, P58, DOI 10.1111/j.1749-6632.2009.04579.x; Kirschner S, 2010, EVOL HUM BEHAV, V31, P354, DOI 10.1016/j.evolhumbehav.2010.04.004; Kraus N, 2010, NAT REV NEUROSCI, V11, P599, DOI 10.1038/nrn2882; Krause V, 2010, ACTA PSYCHOL, V133, P28, DOI 10.1016/j.actpsy.2009.08.003; Kuo BC, 2011, NEUROPSYCHOLOGIA, V49, P1589, DOI 10.1016/j.neuropsychologia.2010.12.043; Large EW, 2009, ANN NY ACAD SCI, V1169, P46, DOI 10.1111/j.1749-6632.2009.04550.x; Madison G, 2009, INTELLIGENCE, V37, P68, DOI 10.1016/j.intell.2008.07.006; McAuley JD, 2006, J EXP PSYCHOL GEN, V135, P348, DOI 10.1037/0096-3445.135.3.348; Moreno S, 2009, CEREB CORTEX, V19, P712, DOI 10.1093/cercor/bhn120; Orsmond G.I., 1999, PSYCHOL MUSIC, V27, P18, DOI [10.1177/0305735699271003, DOI 10.1177/0305735699271003]; Parbery-Clark A, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.12.015; Patel A. D., 2008, MUSIC LANGUAGE BRAIN; Peretz I, 2006, COGNITION, V100, P1, DOI 10.1016/j.cognition.2005.11.004; Pichora-Fuller MK, 2007, HEARING RES, V223, P114, DOI 10.1016/j.heares.2006.10.009; Provasi JL, 2003, INT J BEHAV DEV, V27, P220, DOI 10.1080/01650250244000290; Repp BH, 2005, PSYCHON B REV, V12, P969, DOI 10.3758/BF03206433; Repp BH, 2004, HUM MOVEMENT SCI, V23, P389, DOI 10.1016/j.humov.2004.08.014; Repp BH, 2004, Q J EXP PSYCHOL-A, V57, P499, DOI 10.1080/02724980343000369; Repp BH, 2010, HUM MOVEMENT SCI, V29, P200, DOI 10.1016/j.humov.2009.08.002; Schellenberg EG, 2012, EMOTION, V12, P887, DOI 10.1037/a0027971; Seidler RD, 2010, NEUROSCI BIOBEHAV R, V34, P721, DOI 10.1016/j.neubiorev.2009.10.005; Slater J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077250; Snyder J, 2001, MUSIC PERCEPT, V18, P455, DOI 10.1525/mp.2001.18.4.455; Strait DL, 2014, HEARING RES, V308, P109, DOI 10.1016/j.heares.2013.08.004; Thomson JM, 2008, J PHYSIOL-PARIS, V102, P120, DOI 10.1016/j.jphysparis.2008.03.007; Thomson JM, 2006, J RES READ, V29, P334, DOI 10.1111/j.1467-9817.2006.00312.x; Tierney A, 2013, J NEUROSCI, V33, P14981, DOI 10.1523/JNEUROSCI.0612-13.2013; Tierney AT, 2013, BRAIN LANG, V124, P225, DOI 10.1016/j.bandl.2012.12.014; TREHUB SE, 1989, CAN J PSYCHOL, V43, P217, DOI 10.1037/h0084223; Wechsler D., 2011, WASI 2 WECHSLER ABBR; White-Schwoch T, 2013, J NEUROSCI, V33, P17667, DOI 10.1523/JNEUROSCI.2560-13.2013; Wolff P.H., 2002, READ WRIT, V15, P179, DOI [10.1023/A:1013880723925, DOI 10.1023/A:1013880723925, 10.1023/a:1013880723925]; Zendel BR, 2012, PSYCHOL AGING, V27, P410, DOI 10.1037/a0024816; Zentner M, 2010, P NATL ACAD SCI USA, V107, P5768, DOI 10.1073/pnas.1000121107	52	28	28	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2015	10	6							e0128839	10.1371/journal.pone.0128839	http://dx.doi.org/10.1371/journal.pone.0128839			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CL4OM	26107927	Green Published, Green Accepted, Green Submitted, gold			2022-12-26	WOS:000356932500030
J	Klinke, OK; Mizani, T; Baldwin, G; Bancel, B; Devouassoux-Shisheboran, M; Scoazec, JY; Bringuier, PP; Feederle, R; Jauch, A; Hinderhofer, K; Taniere, P; Delecluse, HJ				Klinke, Olaf Karl; Mizani, Tuba; Baldwin, Gouri; Bancel, Brigitte; Devouassoux-Shisheboran, Mojgan; Scoazec, Jean-Yves; Bringuier, Pierre-Paul; Feederle, Regina; Jauch, Anna; Hinderhofer, Katrin; Taniere, Philippe; Delecluse, Henri-Jacques			KIT Mutation and Loss of 14q May Be Sufficient for the Development of Clinically Symptomatic Very Low-Risk GIST	PLOS ONE			English	Article							GASTROINTESTINAL STROMAL TUMORS; OF-FUNCTION MUTATIONS; SUPPRESSOR GENE LOCI; BREAST-CANCER RISK; SUCCINATE-DEHYDROGENASE; FREQUENT LOSS; VARIANT; FAMILY; DOMAIN; BRCA2	The aim of this study was to determine the minimal set of genetic alterations required for the development of a very low risk clinically symptomatic gastro-intestinal stromal tumour within the stomach wall. We studied the genome of a very low-risk gastric gastro-intestinal stromal tumour by whole-genome sequencing, comparative genomic hybridisation and methylation profiling. The studied tumour harboured two typical genomic lesions: loss of the long arm of chromosome 14 and an activating mutation in exon 11 of KIT. Besides these genetic lesions, only two point mutations that may affect tumour progression were identified: A frame-shift deletion in RNF146 and a missense mutation in a zinc finger of ZNF407. Whilst the frame-shift deletion in RNF146 seemed to be restricted to this particular tumour, a similar yet germline mutation in ZNF407 was found in a panel of 52 gastro-intestinal stromal tumours from different anatomical sites and different categories. Germline polymorphisms in the mitotic checkpoint proteins Aurora kinase A and BUB1 kinase B may have furthered tumour growth. The epigenetic profile of the tumour matches that of other KIT-mutant tumours. We have identified mutations in three genes and loss of the long arm of chromosome 14 as the so far minimal set of genetic abnormalities sufficient for the development of a very low risk clinically symptomatic gastric stromal tumour.	[Klinke, Olaf Karl; Mizani, Tuba; Feederle, Regina; Delecluse, Henri-Jacques] German Canc Res Ctr DKFZ Unit F100, Heidelberg, Germany; [Klinke, Olaf Karl; Mizani, Tuba; Feederle, Regina; Delecluse, Henri-Jacques] Inserm Unit U1074, Heidelberg, Germany; [Baldwin, Gouri; Taniere, Philippe] Trust Queen Elizabeth Hosp Birmingham, NHS Fdn, Histopathol Cellular Pathol Univ Hosp Birmingh, Edgbaston Birmingham B15 2WB, England; [Bancel, Brigitte; Devouassoux-Shisheboran, Mojgan] Hop Croix Rousse, Serv Anat & Cytol Pathol, F-69317 Lyon 04, France; [Scoazec, Jean-Yves; Bringuier, Pierre-Paul] Hop Edouard Herriot, Serv Anat Pathol, F-69437 Lyon 03, France; [Jauch, Anna; Hinderhofer, Katrin] Heidelberg Univ, Inst Human Genet, Heidelberg, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); CHU Lyon; CHU Lyon; Ruprecht Karls University Heidelberg	Delecluse, HJ (corresponding author), German Canc Res Ctr DKFZ Unit F100, Heidelberg, Germany.	H.Delecluse@dkfz-heidelberg.de		Feederle, Regina/0000-0002-3981-367X; Delecluse, Henri-Jacques/0000-0002-1744-6274	Birmingham Science City - Experimental Medicine Network of Excellence project	Birmingham Science City - Experimental Medicine Network of Excellence project	The authors gratefully acknowledge the contribution to this study made by the University of Birmingham's Human Biomaterials Resource Centre, which has been supported through Birmingham Science City - Experimental Medicine Network of Excellence project. HJD is the director of Inserm unit U1074, http://www.grand-est.inserm.fr/rubriques/l-inserm-grand-est/organisation/structures-de-recherche/heidelberg/annexes/unite-inserm-1074.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Andrabi SA, 2011, NAT MED, V17, P692, DOI 10.1038/nm.2387; AU HC, 1995, GENE, V159, P249, DOI 10.1016/0378-1119(95)00162-Y; Bandera CA, 1997, CANCER RES, V57, P513; Beghini A, 2001, CANCER, V92, P657, DOI 10.1002/1097-0142(20010801)92:3<657::AID-CNCR1367>3.0.CO;2-D; Bibikova M, 2009, EPIGENOMICS-UK, V1, P177, DOI [10.2217/epi.09.14, 10.2217/EPI.09.14]; Blay JY, 2012, ANN ONCOL, V23, P49, DOI 10.1093/annonc/mds252; Borrego S, 2003, AM J HUM GENET, V72, P88, DOI 10.1086/345466; Cahill DP, 1998, NATURE, V392, P300, DOI 10.1038/32688; Corless CL, 2011, NAT REV CANCER, V11, P865, DOI 10.1038/nrc3143; Curtin JA, 2006, J CLIN ONCOL, V24, P4340, DOI 10.1200/JCO.2006.06.2984; Du P, 2008, BIOINFORMATICS, V24, P1547, DOI 10.1093/bioinformatics/btn224; El-Rifai W, 2000, GENE CHROMOSOME CANC, V27, P387, DOI 10.1002/(SICI)1098-2264(200004)27:4<387::AID-GCC8>3.0.CO;2-C; Ewart-Toland A, 2005, CARCINOGENESIS, V26, P1368, DOI 10.1093/carcin/bgi085; Falchook Gerald S., 2013, ONCOTARGET, V4; Filippova GN, 2002, CANCER RES, V62, P48; Filippova GN, 1996, MOL CELL BIOL, V16, P2802; Gao Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085377; Gill AJ, 2010, AM J SURG PATHOL, V34, P636, DOI 10.1097/PAS.0b013e3181d6150d; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Healey CS, 2000, NAT GENET, V26, P362, DOI 10.1038/81691; Hirota S, 1998, SCIENCE, V279, P577, DOI 10.1126/science.279.5350.577; Hodis E, 2012, CELL, V150, P251, DOI 10.1016/j.cell.2012.06.024; Irusta PM, 1998, EMBO J, V17, P6912, DOI 10.1093/emboj/17.23.6912; Janeway KA, 2011, P NATL ACAD SCI USA, V108, P314, DOI 10.1073/pnas.1009199108; Joensuu H, 2013, LANCET, V382, P973, DOI 10.1016/S0140-6736(13)60106-3; Jones DTW, 2013, NAT GENET, V45, P927, DOI 10.1038/ng.2682; Killian JK, 2013, CANCER DISCOV, V3, P648, DOI 10.1158/2159-8290.CD-13-0092; Kroeger N, 2013, CANCER-AM CANCER SOC, V119, P1547, DOI 10.1002/cncr.27947; Landrum MJ, 2014, NUCLEIC ACIDS RES, V42, pD980, DOI 10.1093/nar/gkt1113; Lesueur F, 2006, CANCER RES, V66, P1177, DOI 10.1158/0008-5472.CAN-05-2995; Liu XM, 2011, HUM MUTAT, V32, P894, DOI 10.1002/humu.21517; Maher ER, 2002, HUM MOL GENET, V11, P2347, DOI 10.1093/hmg/11.20.2347; Menon AG, 1997, ONCOGENE, V14, P611, DOI 10.1038/sj.onc.1200853; Miettinen M, 2006, ARCH PATHOL LAB MED, V130, P1466; Miettinen M, 2011, AM J SURG PATHOL, V35, P1712, DOI 10.1097/PAS.0b013e3182260752; Miranda C, 2012, CLIN CANCER RES, V18, P1769, DOI 10.1158/1078-0432.CCR-11-2230; Monzon FA, 2011, MODERN PATHOL, V24, P1470, DOI 10.1038/modpathol.2011.107; Nakai N, 2008, J PATHOL, V214, P302, DOI 10.1002/path.2296; Nannini M, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-685; Okamoto Y, 2012, GUT, V61, P392, DOI 10.1136/gut.2011.241034; Palli D, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-170; Pantaleo MA, 2011, J NATL CANCER I, V103, P983, DOI 10.1093/jnci/djr130; Rubio-Casadevall J, 2015, WORLD J SURG ONCOL, V13, DOI 10.1186/s12957-015-0474-0; Sambrook J., 2001, MOL CLONING LAB MANU; Schoppmann SF, 2013, CLIN CANCER RES, V19, P5329, DOI 10.1158/1078-0432.CCR-12-3863; Shen HB, 2005, ONCOL REP, V13, P355; Spurdle AB, 2002, CANCER EPIDEM BIOMAR, V11, P413; Stubbs L, 2011, SUBCELL BIOCHEM, V52, P75, DOI 10.1007/978-90-481-9069-0_4; TAKAYAMA H, 1992, ONCOGENE, V7, P1185; Tarn C, 2005, CLIN CANCER RES, V11, P3668, DOI 10.1158/1078-0432.CCR-04-2515; Terheyden P, 2010, J INVEST DERMATOL, V130, P314, DOI 10.1038/jid.2009.197; Theobald M, 1999, GENE CHROMOSOME CANC, V26, P40, DOI 10.1002/(SICI)1098-2264(199909)26:1<40::AID-GCC6>3.0.CO;2-W; Ylipaa A, 2011, CANCER-AM CANCER SOC, V117, P380, DOI 10.1002/cncr.25594; YOUNG J, 1993, ONCOGENE, V8, P671	55	5	5	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2015	10	6							e0130149	10.1371/journal.pone.0130149	http://dx.doi.org/10.1371/journal.pone.0130149			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4DD	26102504	Green Published, Green Submitted, gold			2022-12-26	WOS:000356901900031
J	Wyatt, AR; Kumita, JR; Farrawell, NE; Dobson, CM; Wilson, MR				Wyatt, Amy R.; Kumita, Janet R.; Farrawell, Natalie E.; Dobson, Christopher M.; Wilson, Mark R.			Alpha-2-Macroglobulin Is Acutely Sensitive to Freezing and Lyophilization: Implications for Structural and Functional Studies	PLOS ONE			English	Article							RECEPTOR-RELATED PROTEIN; BETA-AMYLOID PEPTIDE; HUMAN ALPHA(2)-MACROGLOBULIN; GROWTH-FACTOR; BINDING-PROTEIN; TRANSFORMED ALPHA(2)-MACROGLOBULIN; RECOGNIZED ALPHA(2)-MACROGLOBULIN; ACTIVATED ALPHA-2-MACROGLOBULIN; ELECTROPHORETICALLY SLOW; TERTIARY STRUCTURE	Alpha-2-macroglobulin is an abundant secreted protein that is of particular interest because of its diverse ligand binding profile and multifunctional nature, which includes roles as a protease inhibitor and as a molecular chaperone. The activities of alpha-2-macroglobulin are typically dependent on whether its conformation is native or transformed (i.e. adopts a more compact conformation after interactions with proteases or small nucleophiles), and are also influenced by dissociation of the native alpha-2-macroglobulin tetramer into stable dimers. Alpha-2-macroglobulin is predominately present as the native tetramer in vivo; once purified from human blood plasma, however, alpha-2-macroglobulin can undergo a number of conformational changes during storage, including transformation, aggregation or dissociation. We demonstrate that, particularly in the presence of sodium chloride or amine containing compounds, freezing and/or lyophilization of alpha-2-macroglobulin induces conformational changes with functional consequences. These conformational changes in alpha-2-macroglobulin are not always detected by standard native polyacrylamide gel electrophoresis, but can be measured using bisANS fluorescence assays. Increased surface hydrophobicity of alpha-2-macroglobulin, as assessed by bisANS fluorescence measurements, is accompanied by (i) reduced trypsin binding activity, (ii) increased chaperone activity, and (iii) increased binding to the surfaces of SH-SY5Y neurons, in part, via lipoprotein receptors. We show that sucrose (but not glycine) effectively protects native alpha-2-macroglobulin from denaturation during freezing and/or lyophilization, thereby providing a reproducible method for the handling and long-term storage of this protein.	[Wyatt, Amy R.; Farrawell, Natalie E.; Wilson, Mark R.] Univ Wollongong, Illawarra Hlth & Med Res Inst, Wollongong, NSW 2522, Australia; [Wyatt, Amy R.; Farrawell, Natalie E.; Wilson, Mark R.] Univ Wollongong, Sch Biol Sci, Wollongong, NSW 2522, Australia; [Kumita, Janet R.; Dobson, Christopher M.] Univ Cambridge, Dept Chem, Cambridge CB2 1EW, England	University of Wollongong; University of Wollongong; University of Cambridge	Wyatt, AR (corresponding author), Univ Wollongong, Illawarra Hlth & Med Res Inst, Wollongong, NSW 2522, Australia.	awyatt@uow.edu.au	Kumita, Janet/AAO-5254-2021; Wilson, Mark R/B-3254-2018	Wilson, Mark R/0000-0002-9551-7445; Wyatt, Amy/0000-0002-3650-2438; Farrawell, Natalie/0000-0001-8060-4629	National Health and Medical Research Council [GNT1012521]; Wellcome Trust Programme Grant [094425/Z/10/Z]; Samsung GRO Grant	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Wellcome Trust Programme Grant(Wellcome Trust); Samsung GRO Grant(Samsung)	This work was supported by a Early Career Fellowship from the National Health and Medical Research Council GNT1012521 (A.R.W.); Wellcome Trust Programme Grant (J.R.K., C.M.D.) 094425/Z/10/Z; and Samsung GRO Grant (M.R.W.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABBINK JJ, 1991, THROMB HAEMOSTASIS, V65, P32; Adler V, 2007, NEUROCHEM J+, V1, P43, DOI 10.1134/S1819712407010060; Allison SD, 1999, ARCH BIOCHEM BIOPHYS, V365, P289, DOI 10.1006/abbi.1999.1175; Arakawa T, 2007, AMINO ACIDS, V33, P587, DOI 10.1007/s00726-007-0506-3; BANKS RE, 1990, J IMMUNOL METHODS, V126, P13, DOI 10.1016/0022-1759(90)90006-H; BARRETT AJ, 1981, METHOD ENZYMOL, V80, P737; BARRETT AJ, 1979, BIOCHEM J, V181, P401, DOI 10.1042/bj1810401; BARRETT AJ, 1973, BIOCHEM J, V133, P709, DOI 10.1042/bj1330709; Birkenmeier G, 1998, EUR J ENDOCRINOL, V139, P224, DOI 10.1530/eje.0.1390224; BIRKENMEIER G, 1989, EUR J BIOCHEM, V183, P239, DOI 10.1111/j.1432-1033.1989.tb14919.x; Boisset N, 1996, J BIOL CHEM, V271, P25762, DOI 10.1074/jbc.271.42.25762; BONNER JC, 1992, J BIOL CHEM, V267, P12837; BORTH W, 1992, FASEB J, V6, P3345, DOI 10.1096/fasebj.6.15.1281457; Carpenter J. F., 2002, CURR PROTOC PROTEIN, DOI [10.1002/0471140864.ps0406s27, DOI 10.1002/0471140864]; CARPENTER JF, 1988, CRYOBIOLOGY, V25, P244, DOI 10.1016/0011-2240(88)90032-6; CROOKSTON KP, 1993, BIOCHEM J, V293, P443, DOI 10.1042/bj2930443; CROOKSTON KP, 1994, J BIOL CHEM, V269, P1533; DENNIS PA, 1989, J BIOL CHEM, V264, P7210; DONNELLY PK, 1990, CLIN CHIM ACTA, V195, P85, DOI 10.1016/0009-8981(90)90197-Z; Du YS, 1997, J NEUROCHEM, V69, P299; ERLANGER BF, 1961, ARCH BIOCHEM BIOPHYS, V95, P271, DOI 10.1016/0003-9861(61)90145-X; Fabrizi C, 2001, J NEUROCHEM, V78, P406, DOI 10.1046/j.1471-4159.2001.00419.x; FELDMAN SR, 1983, BIOCHEM BIOPH RES CO, V114, P757, DOI 10.1016/0006-291X(83)90845-8; FLORY ED, 1982, ANN RHEUM DIS, V41, P520, DOI 10.1136/ard.41.5.520; French K, 2008, BIOCHEMISTRY-US, V47, P1176, DOI 10.1021/bi701976f; Gabellieri E, 2006, BIOPHYS J, V90, P3239, DOI 10.1529/biophysj.105.074948; Gabellieri E, 2003, BIOPHYS J, V85, P3214, DOI 10.1016/S0006-3495(03)74739-0; Gunnarsson M, 2003, ACTA NEUROL SCAND, V108, P16, DOI 10.1034/j.1600-0404.2003.00079.x; Hartl FU, 2011, NATURE, V475, P324, DOI 10.1038/nature10317; Hawe A, 2008, PHARM RES-DORDR, V25, P1487, DOI 10.1007/s11095-007-9516-9; HERZ J, 1991, J BIOL CHEM, V266, P21232; HOLLANDER W, 1979, ATHEROSCLEROSIS, V34, P391, DOI 10.1016/0021-9150(79)90064-9; Hughes SR, 1998, P NATL ACAD SCI USA, V95, P3275, DOI 10.1073/pnas.95.6.3275; Ignjatovic V, 2007, BRIT J HAEMATOL, V138, P366, DOI 10.1111/j.1365-2141.2007.06663.x; IMBER MJ, 1981, J BIOL CHEM, V256, P8134; Jackson SE, 2013, TOP CURR CHEM, V328, P69, DOI 10.1007/128_2012_324; KURECKI T, 1979, ANAL BIOCHEM, V99, P415, DOI 10.1016/S0003-2697(79)80026-3; Lale SV, 2011, INT J PHARM INVESTIG, V1, P214, DOI 10.4103/2230-973X.93007; LAMARRE J, 1991, LAB INVEST, V65, P3; LARSSON LJ, 1987, BIOCHEM J, V243, P47, DOI 10.1042/bj2430047; Lauer D, 2001, EXP NEUROL, V167, P385, DOI 10.1006/exnr.2000.7569; LEE JC, 1981, J BIOL CHEM, V256, P7193; Manning MC, 2010, PHARM RES-DORDR, V27, P544, DOI 10.1007/s11095-009-0045-6; Marrero A, 2012, ANGEW CHEM INT EDIT, V51, P3340, DOI 10.1002/anie.201108015; Mettenburg JM, 2002, J BIOL CHEM, V277, P13338, DOI 10.1074/jbc.M106792200; Misra UK, 2015, J BIOL CHEM, V290, P9571, DOI 10.1074/jbc.M114.617837; MOESTRUP SK, 1991, J BIOL CHEM, V266, P14011; Narita M, 1997, J NEUROCHEM, V69, P1904; Ozawa D, 2011, J BIOL CHEM, V286, P9668, DOI 10.1074/jbc.M110.167965; PANYUTICH A, 1991, AM J RESP CELL MOL, V5, P101, DOI 10.1165/ajrcmb/5.2.101; PETERSEN CM, 1989, J IMMUNOL, V142, P629; Pikal-Cleland KA, 2002, J PHARM SCI, V91, P1969, DOI 10.1002/jps.10184; REDDY VY, 1994, J BIOL CHEM, V269, P4683; REDDY VY, 1989, J BIOL CHEM, V264, P13801; Roman SG, 2011, BIOCHEMISTRY-US, V50, P10607, DOI 10.1021/bi201030y; SALVESEN GS, 1981, BIOCHEM J, V195, P453, DOI 10.1042/bj1950453; SALVESEN GS, 1980, BIOCHEM J, V187, P695, DOI 10.1042/bj1870695; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; SOTTRUPJENSEN L, 1990, J BIOL CHEM, V265, P17727; STRICKLAND DK, 1990, J BIOL CHEM, V265, P17401; Sunderic M, 2015, EXP MOL PATHOL, V98, P173, DOI 10.1016/j.yexmp.2015.03.003; Thal DR, 1997, BRAIN RES, V777, P223, DOI 10.1016/S0006-8993(97)01021-4; VANLEUVEN F, 1982, BIOCHEM J, V201, P119, DOI 10.1042/bj2010119; VANLEUVEN F, 1981, J BIOL CHEM, V256, P9016; Wu SM, 1997, J BIOL CHEM, V272, P20627, DOI 10.1074/jbc.272.33.20627; Wu SM, 1998, J IMMUNOL, V161, P4356; Wyatt AR, 2014, P NATL ACAD SCI USA, V111, pE2081, DOI 10.1073/pnas.1403379111; Wyatt AR, 2013, FEBS LETT, V587, P398, DOI 10.1016/j.febslet.2013.01.020; Yerbury JJ, 2009, J BIOL CHEM, V284, P4246, DOI 10.1074/jbc.M807242200	69	11	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2015	10	6							e0130036	10.1371/journal.pone.0130036	http://dx.doi.org/10.1371/journal.pone.0130036			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4DD	26103636	Green Published, Green Submitted, gold			2022-12-26	WOS:000356901900025
J	Zhang, JC; Zhang, YQ; Fan, DQ; Qin, SG; Jia, X; Wu, B; Chen, D; Gao, H; Zhu, LF				Zhang, Jiachen; Zhang, Yuqing; Fan, Dongqing; Qin, Shugao; Jia, Xin; Wu, Bin; Chen, Dong; Gao, Hao; Zhu, Linfeng			Effects of Sand Dune Stabilization on the Spatial Pattern of Artemisia ordosica Population in Mu Us Desert, Northwest China	PLOS ONE			English	Article							TENGGER DESERT; WOODY VEGETATION; HETEROGENEITY; COMMUNITY; FOREST	Vegetation patterns are strongly influenced by sand mobility in desert ecosystems. However, little is known about the spatial patterns of Artemisia ordosica, a dominant shrub in the Mu Us desert of Northwest China, in relation to sand fixation. The aim of this study was to investigate and contrast the effects of sand dune stabilization on the population and spatial distribution of this desert shrub. Spatial autocorrelation, semi-variance analysis, and point-pattern analysis were used jointly in this study to investigate the spatial patterns of A. ordosica populations on dunes in Yanchi County of Ningxia, China. The results showed that the spatial autocorrelation and spatial heterogeneity declined gradually, and the distance between the clustered individuals shortened following sand dune fixation. Seedlings were more aggregated than adults in all stage of dune stabilization, and both were more aggregated on shifting sand dunes separately. Spatial associations of the seedlings with the adults were mostly positive at distances of 0-5 m in shifting sand dunes, and the spatial association changed from positive to neutral in semi-fixed sand dunes. The seedlings were spaced in an almost random pattern around the adults, and their distances from the adults did not seem to affect their locations in semi-fixed sand dunes. Furthermore, spatial associations of the seedlings with the adults were negative in the fixed sand dune. These findings demonstrate that sand stabilization is an important factor affecting the spatial patterns of A. ordosica populations in the Mu Us desert. These findings suggest that, strong association between individuals may be the mechanism to explain the spatial pattern formation at preliminary stage of dune fixation. Sand dune stabilization can change the spatial pattern of shrub population by weakening the spatial association between native shrub individuals, which may affect the development direction of desert shrubs.	[Zhang, Jiachen; Zhang, Yuqing; Fan, Dongqing; Qin, Shugao; Jia, Xin; Wu, Bin; Chen, Dong; Gao, Hao; Zhu, Linfeng] Beijing Forestry Univ, Sch Soil & Water Conservat, Yanchi Res Stn, Beijing, Peoples R China; [Zhang, Jiachen; Zhang, Yuqing; Fan, Dongqing; Qin, Shugao; Jia, Xin; Wu, Bin; Chen, Dong; Gao, Hao; Zhu, Linfeng] Beijing Forestry Univ, Minist Educ, Key Lab Soil & Water Conservat & Desertificat Com, Beijing, Peoples R China	Beijing Forestry University; Beijing Forestry University	Qin, SG (corresponding author), Beijing Forestry Univ, Sch Soil & Water Conservat, Yanchi Res Stn, Beijing, Peoples R China.	qinshugao@gmail.com			National Basic Research Program of P. R. China (973 Program) [2013CB429901]; National Technology & Science Support Program of P. R. China [2012BAD16B02]; Fundamental Research Funds for the Central Universities of P. R. China [BJFU-TD2011-04]	National Basic Research Program of P. R. China (973 Program)(National Basic Research Program of China); National Technology & Science Support Program of P. R. China; Fundamental Research Funds for the Central Universities of P. R. China	This work was financial supported by the National Basic Research Program of P. R. China (973 Program, 2013CB429901), the National Technology & Science Support Program of P. R. China (2012BAD16B02) and the Fundamental Research Funds for the Central Universities of P. R. China (BJFU-TD2011-04).	Asner GP, 2003, GLOBAL CHANGE BIOL, V9, P316, DOI 10.1046/j.1365-2486.2003.00594.x; Borcard D, 2004, ECOLOGY, V85, P1826, DOI 10.1890/03-3111; Borcard D, 2011, USE R, P1, DOI 10.1007/978-1-4419-7976-6; CALE WG, 1989, BIOSCIENCE, V39, P600, DOI 10.2307/1311089; Camarero JJ, 2000, FOREST ECOL MANAG, V134, P1, DOI 10.1016/S0378-1127(99)00241-8; Condit R, 2000, SCIENCE, V288, P1414, DOI 10.1126/science.288.5470.1414; Dale M.R.T., 1999, SPATIAL PATTERN ANAL; De Smith M.J., 2007, GEOSPATIAL ANAL COMP; Fortin MJ, 2005, SPATIAL ANALYSIS: A GUIDE FOR ECOLOGISTS; Getzin S, 2008, J ECOL, V96, P807, DOI 10.1111/j.1365-2745.2008.01377.x; Haase P, 1996, J VEG SCI, V7, P527, DOI 10.2307/3236301; [韩路 HAN Lu], 2007, [生态学报, Acta Ecologica Sinica], V27, P1315; Hao ZQ, 2007, FOREST ECOL MANAG, V252, P1, DOI 10.1016/j.foreco.2007.06.026; Huang ZY, 2000, ACTA BOT SIN, V42, P71; JANZEN DH, 1970, AM NAT, V104, P501, DOI 10.1086/282687; Jiang H., 2010, PLANT ECOLOGY; KENKEL NC, 1988, ECOLOGY, V69, P1017, DOI 10.2307/1941257; KOBAYASHI T, 1995, ECOL RES, V10, P339, DOI 10.1007/BF02347860; Law R, 2009, J ECOL, V97, P616, DOI 10.1111/j.1365-2745.2009.01510.x; Li SL, 2010, ECOL RES, V25, P655, DOI 10.1007/s11284-010-0699-x; Li XR, 2003, PLANT SOIL, V251, P237, DOI 10.1023/A:1023023702248; Li XR, 2002, BIOL FERT SOILS, V35, P147, DOI 10.1007/s00374-002-0453-9; Li XR, 2004, RESTOR ECOL, V12, P376, DOI 10.1111/j.1061-2971.2004.00313.x; Li XR, 2005, SCI CHINA SER D, V48, P2020, DOI 10.1360/04yd0139; McGarigal K., 1994, FRAGSTATS SPATIAL PA, V2, P128; McIntire EJB, 2009, ECOLOGY, V90, P46, DOI 10.1890/07-2096.1; NEWBERY DM, 1986, VEGETATIO, V65, P77, DOI 10.1007/BF00044877; Perry JN, 2002, ECOGRAPHY, V25, P578, DOI 10.1034/j.1600-0587.2002.250507.x; PHILLIPS DL, 1981, J ECOL, V69, P97, DOI 10.2307/2259818; Pueyo Y, 2013, ECOSYSTEMS, V16, P452, DOI 10.1007/s10021-012-9620-5; ROBERTSON GP, 2000, GS GEOSTATISTICS ENV; ROSSI RE, 1992, ECOL MONOGR, V62, P277, DOI 10.2307/2937096; Schenk HJ, 1999, PLANT ECOL, V141, P41, DOI 10.1023/A:1009895603783; SILVERTOWN J, 1994, ECOLOGY, V75, P409, DOI 10.2307/1939544; SKARPE C, 1991, J VEG SCI, V2, P565, DOI 10.2307/3236039; Tao Y, 2013, EXCLI J, V12, P658; Wang Hai-Tao, 2007, Zhiwu Shengtai Xuebao, V31, P1145; WANG Y, 2013, PLOS ONE, V2013; Wang Z., 1999, GEOSTATISTICS ITS AP; Wiegand T, 2004, OIKOS, V104, P209, DOI 10.1111/j.0030-1299.2004.12497.x; Wiegand T., 2004, INTRO POINT PATTERN; Wu B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058331; [闫海冰 Yan Haibing], 2010, [生态学报, Acta Ecologica Sinica], V30, P2311; Yang Hong-Xiao, 2006, Zhiwu Shengtai Xuebao, V30, P563; [杨洪晓 YANG HongXiao], 2008, [生态学报, Acta Ecologica Sinica], V28, P1901; 李进, 1991, 中国沙漠, V11, P55	46	7	10	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2015	10	6							e0129728	10.1371/journal.pone.0129728	http://dx.doi.org/10.1371/journal.pone.0129728			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4DD	26102584	Green Submitted, Green Published, gold			2022-12-26	WOS:000356901900020
J	Chan, PH; Li, WH; Hai, JJ; Tse, HF; Siu, CW				Chan, Pak Hei; Li, Wen Hua; Hai, Jo Jo; Tse, Hung Fat; Siu, Chung Wah			Impact of Antithrombotic Therapy in Atrial Fibrillation on the Presentation of Coronary Artery Disease	PLOS ONE			English	Article							ASSOCIATION TASK-FORCE; MYOCARDIAL-INFARCTION; AMERICAN-COLLEGE; INTRACRANIAL HEMORRHAGE; ISCHEMIC-STROKE; RISK; MANAGEMENT; GUIDELINE; ANGIOGRAPHY; DIAGNOSIS	Background Little is known about whether atrial fibrillation is a presentation of coronary disease. There is a paucity of knowledge about their causal relationship and also the impact of different antithrombotic strategies on the subsequent presentation of symptomatic coronary disease. Methods and Results We studied 7,526 Chinese patients diagnosed with non-valvular atrial fibrillation and no documented history of coronary artery disease. The primary endpoint was the new occurrence of coronary artery disease-either stable coronary artery disease or acute coronary syndrome. After a mean follow-up of 3.2 +/- 3.5 years (24,071 patient-years), a primary endpoint occurred in 987 patients (13.1%). The overall annual incidence of coronary artery disease was 4.10%/year. No significant differences in age, sex, and mean CHA(2)DS(2)-VASc score were observed between patients with and without the primary endpoint. When stratified according to the antithrombotic strategies applied for stroke prevention, the annual incidence of coronary artery disease was 5.49%/year, 4.45%/year and 2.16%/year respectively in those prescribed no antithrombotic therapy, aspirin, and warfarin. Similar trends were observed in patients with acute coronary syndromes. Diabetes mellitus, smoking history and renal failure requiring dialysis were predictors for primary endpoint in all antithrombotic therapies. Conclusion In patients with non-valvular atrial fibrillation, there is a modest association with coronary artery disease. Patients prescribed warfarin had the lowest risk of new onset coronary artery disease.	[Chan, Pak Hei; Li, Wen Hua; Hai, Jo Jo; Tse, Hung Fat; Siu, Chung Wah] Univ Hong Kong, Li Ka Shing Fac Med, Dept Med, Div Cardiol, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong	Siu, CW (corresponding author), Univ Hong Kong, Li Ka Shing Fac Med, Dept Med, Div Cardiol, Hong Kong, Hong Kong, Peoples R China.	cwdsiu@hku.hk	Tse, Hung-Fat/C-4426-2009; Siu, Chung Wah/C-6947-2011	Tse, Hung-Fat/0000-0002-9578-7808; Tse, Hung Fat/0000-0003-4665-7887				Amsterdam EA, 2014, CIRCULATION, V130, pE344, DOI [10.1161/CIR.0000000000000134, 10.1161/CIR.0000000000000151]; Anand SS, 1999, JAMA-J AM MED ASSOC, V282, P2058, DOI 10.1001/jama.282.21.2058; Aznaouridis KA, 2007, J AM COLL CARDIOL, V50, P1909, DOI 10.1016/j.jacc.2007.08.005; Casaclang-Verzosa G, 2008, J AM COLL CARDIOL, V51, P1, DOI 10.1016/j.jacc.2007.09.026; Chan KH, 2014, WORLD NEUROSURG, V82, pE219, DOI 10.1016/j.wneu.2013.02.070; Fihn SD, 2014, J AM COLL CARDIOL, V64, P1929, DOI 10.1016/j.jacc.2014.07.017; HADDAD AH, 1978, J ELECTROCARDIOL, V11, P67, DOI 10.1016/S0022-0736(78)80031-4; Ho CW, 2015, STROKE, V46, P23, DOI 10.1161/STROKEAHA.114.006476; Ho MH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101245; Hohnloser SH, 2009, NEW ENGL J MED, V360, P668, DOI 10.1056/NEJMoa0803778; Huang D, 2014, PACE, V37, P1442, DOI 10.1111/pace.12445; January CT, 2014, J AM COLL CARDIOL, V64, pE1, DOI [10.1161/CIR.0000000000000041, 10.1016/j.jacc.2014.03.022, 10.1161/CIR.0000000000000142, 10.1016/j.jacc.2014.03.021]; Kannell WB, 1999, ARCH INTERN MED, V159, P1197, DOI 10.1001/archinte.159.11.1197; Kralev S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024964; Lam CCS, 2012, THROMB HAEMOSTASIS, V107, P6, DOI 10.1160/TH11-11-0807; Lau CP, 2012, J CARDIOVASC ELECTR, V23, ps36, DOI 10.1111/jce.12022; Lip GYH, 2010, CHEST, V137, P263, DOI 10.1378/chest.09-1584; LIP GYH, 1995, BRIT MED J, V311, P1361, DOI 10.1136/bmj.311.7016.1361; Lokshyn S, 2000, INT J CARDIOL, V72, P133, DOI 10.1016/S0167-5273(99)00180-1; Mancini GBJ, 2014, CAN J CARDIOL, V30, P837, DOI 10.1016/j.cjca.2014.05.013; Meade TW, 1998, LANCET, V351, P233; Miyasaka Y, 2007, AM J MED, V120, P357, DOI 10.1016/j.amjmed.2006.06.042; Nucifora G, 2009, CIRC-CARDIOVASC IMAG, V2, P100, DOI 10.1161/CIRCIMAGING.108.795328; O'Gara PT, 2013, CIRCULATION, V127, pE362, DOI 10.1161/CIR.0b013e3182742cf6; Pong V, 2012, CEREBELLUM, V11, P939, DOI 10.1007/s12311-012-0371-9; Schnabel RB, 2009, LANCET, V373, P739, DOI 10.1016/S0140-6736(09)60443-8; Siu CW, 2007, CHEST, V132, P44, DOI 10.1378/chest.06-2733; Siu CW, 2007, J CLIN ENDOCR METAB, V92, P1736, DOI 10.1210/jc.2006-1877; Siu CW, 2007, HEART, V93, P483, DOI 10.1136/hrt.2006.100628; Siu CW, 2014, HEART RHYTHM, V11, P1401, DOI 10.1016/j.hrthm.2014.04.021; Siu CW, 2014, CIRC-ARRHYTHMIA ELEC, V7, P300, DOI 10.1161/CIRCEP.113.000858; Siu CW, 2009, HEART RHYTHM, V6, P169, DOI 10.1016/j.hrthm.2008.10.023; Siu CW, 2009, AM J CARDIOL, V103, P540, DOI 10.1016/j.amjcard.2008.10.019; Teo KC, 2014, NEUROL RES, V36, P143, DOI 10.1179/1743132813Y.0000000275; Tsigkas G, 2014, CAN J CARDIOL, V30, P920, DOI 10.1016/j.cjca.2014.03.023; van Es RF, 2002, LANCET, V360, P109, DOI 10.1016/S0140-6736(02)09409-6; Yue WS, 2011, CLIN ENDOCRINOL, V74, P636, DOI 10.1111/j.1365-2265.2011.03981.x	37	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2015	10	6							e0131479	10.1371/journal.pone.0131479	http://dx.doi.org/10.1371/journal.pone.0131479			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL3FM	26098876	Green Submitted, gold, Green Published			2022-12-26	WOS:000356835800181
J	Chang, MM; Imperiali, B; Eichler, J; Guan, ZQ				Chang, Michelle M.; Imperiali, Barbara; Eichler, Jerry; Guan, Ziqiang			N-Linked Glycans Are Assembled on Highly Reduced Dolichol Phosphate Carriers in the Hyperthermophilic Archaea Pyrococcus furiosus	PLOS ONE			English	Article							S-LAYER GLYCOPROTEIN; PROTEIN GLYCOSYLATION; BIOSYNTHESIS; OLIGOSACCHARYLTRANSFERASE; OLIGOSACCHARIDES; POLYISOPRENOIDS; PATHWAY; IDENTIFICATION; POLYPRENOLS; DOMAIN	In all three domains of life, N-glycosylation begins with the assembly of glycans on phosphorylated polyisoprenoid carriers. Like eukaryotes, archaea also utilize phosphorylated dolichol for this role, yet whereas the assembled oligosaccharide is transferred to target proteins from dolichol pyrophosphate in eukaryotes, archaeal N-linked glycans characterized to date are derived from a dolichol monophosphate carrier, apart from a single example. In this study, glycan-charged dolichol phosphate from the hyperthermophile Pyrococcus furiosus was identified and structurally characterized. Normal and reverse phase liquid chromatography-electrospray ionization mass spectrometry revealed the existence of dolichol phosphate charged with the heptasaccharide recently described in in vitro studies of N-glycosylation on this species. As with other described archaeal dolichol phosphates, the alpha- and omega-terminal isoprene subunits of the P. furiosus lipid are saturated, in contrast to eukaryal phosphodolichols that present only a saturated alpha-position isoprene subunit. Interestingly, an additional 1-4 of the 12-14 isoprene subunits comprising P. furiosus dolichol phosphate are saturated, making this lipid not only the longest archaeal dolichol phosphate described to date but also the most highly saturated.	[Chang, Michelle M.; Imperiali, Barbara] MIT, Dept Biol, Cambridge, MA 02139 USA; [Chang, Michelle M.; Imperiali, Barbara] MIT, Dept Chem, Cambridge, MA 02139 USA; [Eichler, Jerry] Ben Gurion Univ Negev, Dept Life Sci, IL-84105 Beer Sheva, Israel; [Guan, Ziqiang] Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Ben Gurion University; Duke University	Guan, ZQ (corresponding author), Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA.	ziqiang.guan@duke.edu	EICHLER, JERRY/F-2351-2012; Guan, Ziqiang/AAE-5110-2019	EICHLER, JERRY/0000-0001-9409-8026; Imperiali, Barbara/0000-0002-5749-7869	National Institutes of Health (NIH) [GM-039334]; Israel Science Foundation [8/11]; NIH through the LIPID MAPS Large Scale Collaborative Grant [GM-069338]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM069338, R29GM039334, R01GM039334] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Israel Science Foundation(Israel Science Foundation); NIH through the LIPID MAPS Large Scale Collaborative Grant; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institutes of Health (NIH) through grant GM-039334 to B.I. and by the Israel Science Foundation through grant 8/11 to J.E. The mass spectrometry facility in the Department of Biochemistry of the Duke University Medical Center and Z.G. were supported by the NIH through the LIPID MAPS Large Scale Collaborative Grant number GM-069338 to Z.G.	Abu-Qarn M, 2006, MOL MICROBIOL, V61, P511, DOI 10.1111/j.1365-2958.2006.05252.x; Bajda A, 2009, PHYSIOL PLANTARUM, V135, P351, DOI 10.1111/j.1399-3054.2009.01204.x; Breitling J, 2013, COLD SPRING HARBOR P, V5; Brochier-Armanet C, 2011, CURR OPIN MICROBIOL, V14, P274, DOI 10.1016/j.mib.2011.04.015; BROCK TD, 1972, ARCH MIKROBIOL, V84, P54, DOI 10.1007/BF00408082; Burda P, 1999, BBA-GEN SUBJECTS, V1426, P239, DOI 10.1016/S0304-4165(98)00127-5; Calo D, 2011, MICROB BIOTECHNOL, V4, P461, DOI 10.1111/j.1751-7915.2011.00250.x; Chaban B, 2006, MOL MICROBIOL, V61, P259, DOI 10.1111/j.1365-2958.2006.05226.x; Cohen-Rosenzweig C, 2014, APPL ENVIRON MICROB, V80, P486, DOI 10.1128/AEM.03191-13; DEROSA M, 1986, MICROBIOL REV, V50, P70, DOI 10.1128/MMBR.50.1.70-80.1986; Eichler J, 2013, NAT REV MICROBIOL, V11, P151, DOI 10.1038/nrmicro2957; FIALA G, 1986, ARCH MICROBIOL, V145, P56, DOI 10.1007/BF00413027; Fujinami D, 2014, CARBOHYD RES, V387, P30, DOI 10.1016/j.carres.2014.01.021; Guan ZQ, 2011, BBA-MOL CELL BIOL L, V1811, P607, DOI 10.1016/j.bbalip.2011.06.022; Guan ZQ, 2011, BBA-MOL CELL BIOL L, V1811, P800, DOI 10.1016/j.bbalip.2011.04.009; Guan ZQ, 2010, MOL MICROBIOL, V78, P1294, DOI 10.1111/j.1365-2958.2010.07405.x; Hartley MD, 2012, ARCH BIOCHEM BIOPHYS, V517, P83, DOI 10.1016/j.abb.2011.10.018; Igura M, 2008, EMBO J, V27, P234, DOI 10.1038/sj.emboj.7601940; Jarrell KF, 2014, MICROBIOL MOL BIOL R, V78, P304, DOI 10.1128/MMBR.00052-13; Jones MB, 2009, BBA-GEN SUBJECTS, V1790, P485, DOI 10.1016/j.bbagen.2009.03.030; Kaminski L, 2013, MBIO, V4, DOI 10.1128/mBio.00716-13; Kohda D, 2007, GLYCOBIOLOGY, V17, P1175, DOI 10.1093/glycob/cwm087; Kuntz C, 1997, GLYCOBIOLOGY, V7, P897, DOI 10.1093/glycob/7.7.897; Larkin A, 2013, NAT CHEM BIOL, V9, P367, DOI 10.1038/nchembio.1249; LECHNER J, 1989, ANNU REV BIOCHEM, V58, P173, DOI 10.1146/annurev.bi.58.070189.001133; LECHNER J, 1985, J BIOL CHEM, V260, P8984; Lizak C, 2011, NATURE, V474, P350, DOI 10.1038/nature10151; Magidovich H, 2009, FEMS MICROBIOL LETT, V300, P122, DOI 10.1111/j.1574-6968.2009.01775.x; Matsumoto S, 2013, P NATL ACAD SCI USA, V110, P17868, DOI 10.1073/pnas.1309777110; Matsumoto S, 2013, BMC STRUCT BIOL, V13, DOI 10.1186/1472-6807-13-11; Matsumoto S, 2012, BIOCHEMISTRY-US, V51, P4157, DOI 10.1021/bi300076u; MCGARVEY DJ, 1995, PLANT CELL, V7, P1015, DOI 10.1105/tpc.7.7.1015; Nothaft H, 2010, NAT REV MICROBIOL, V8, P765, DOI 10.1038/nrmicro2383; Nyirenda J, 2013, STRUCTURE, V21, P32, DOI 10.1016/j.str.2012.10.011; Reid CW, 2010, METHODS MOL BIOL, V600, P187, DOI 10.1007/978-1-60761-454-8_13; Swiezewska E, 2005, PROG LIPID RES, V44, P235, DOI 10.1016/j.plipres.2005.05.002; Wood AC, 1999, MICROBIOL-UK, V145, P379, DOI 10.1099/13500872-145-2-379	37	21	21	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2015	10	6							e0130482	10.1371/journal.pone.0130482	http://dx.doi.org/10.1371/journal.pone.0130482			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL3FM	26098850	Green Published, gold, Green Submitted			2022-12-26	WOS:000356835800072
J	Choudhury, JH; Ghosh, SK				Choudhury, Javed Hussain; Ghosh, Sankar Kumar			Promoter Hypermethylation Profiling Identifies Subtypes of Head and Neck Cancer with Distinct Viral, Environmental, Genetic and Survival Characteristics	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; CPG ISLAND METHYLATION; TUMOR-RELATED GENES; DNA METHYLATION; MICROSATELLITE INSTABILITY; BRAF MUTATION; POLYMORPHISMS; PHENOTYPE; RISK; BIOMARKER	Background Epigenetic and genetic alteration plays a major role to the development of head and neck squamous cell carcinoma (HNSCC). Consumption of tobacco (smoking/chewing) and human papilloma virus (HPV) are also associated with an increase the risk of HNSCC. Promoter hypermethylation of the tumor suppression genes is related with transcriptional inactivation and loss of gene expression. We investigated epigenetic alteration (promoter methylation of tumor-related genes/loci) in tumor tissues in the context of genetic alteration, viral infection, and tobacco exposure and survival status. Methodology The study included 116 tissue samples (71 tumor and 45 normal tissues) from the Northeast Indian population. Methylation specific polymerase chain reaction (MSP) was used to determine the methylation status of 10 tumor-related genes/loci (p16, DAPK, RASSF1, BRAC1, GSTP1, ECAD, MLH1, MINT1, MINT2 and MINT31). Polymorphisms of CYP1A1, GST (M1 & T1), XRCC1 and XRCC2 genes were studied by using polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) and multiplex-PCR respectively. Principal Findings Unsupervised hierarchical clustering analysis based on methylation pattern had identified two tumor clusters, which significantly differ by CpG island methylator phenotype (CIMP), tobacco, GSTM1, CYP1A1, HPV and survival status. Analyzing methylation of genes/loci individually, we have found significant higher methylation of DAPK, RASSF1, p16 and MIN-T31genes (P = 0.031, 0.013, 0.031 and 0.015 respectively) in HPV (+) cases compared to HPV (-). Furthermore, a CIMP-high and Cluster-1 characteristic was also associated with poor survival. Conclusions Promoter methylation profiles reflecting a correlation with tobacco, HPV, survival status and genetic alteration and may act as a marker to determine subtypes and patient outcome in HNSCC.	[Choudhury, Javed Hussain; Ghosh, Sankar Kumar] Assam Univ, Dept Biotechnol, Mol Med Lab, Silchar 788011, Assam, India	Assam University	Ghosh, SK (corresponding author), Assam Univ, Dept Biotechnol, Mol Med Lab, Silchar 788011, Assam, India.	drsankarghosh@gmail.com	Choudhury, Javed H/ABF-7723-2021					[Anonymous], 2014, Cancer Discov, V4, pOF11, DOI 10.1158/2159-8290.CD-RW2014-200; Anuradha V, 2013, INDIAN J MED PAEDIAT, V34, P11, DOI 10.4103/0971-5851.113404; Arantes LMRB, 2014, ORAL ONCOL, V50, P587, DOI 10.1016/j.oraloncology.2014.02.015; Basu R, 2008, ASIAN PAC J CANCER P, V9, P381; Baylin SB, 2001, HUM MOL GENET, V10, P687, DOI 10.1093/hmg/10.7.687; Bernstein JM, 2013, EUR ARCH OTO-RHINO-L, V270, P2585, DOI 10.1007/s00405-012-2323-x; Chen JX, 2011, ASIAN PAC J CANCER P, V12, P2163; Choudhury JH, 2015, TUMOR BIOL, V36, P5773, DOI 10.1007/s13277-015-3246-0; Choudhury JH, 2014, MED ONCOL, V31, DOI 10.1007/s12032-014-0067-8; Choudhury JH, 2014, J ORAL PATHOL MED, DOI [10.1111/jop.12249, DOI 10.1111/J0P.12249]; Dong YY, 2014, BIOMED REP, V2, P326, DOI 10.3892/br.2014.237; Fakhry C, 2008, JNCI-J NATL CANCER I, V100, P261, DOI 10.1093/jnci/djn011; Fotopoulos G, 2015, ORAL ONCOL, V51, P119, DOI 10.1016/j.oraloncology.2014.10.018; Hansen KD, 2011, NAT GENET, V43, P768, DOI 10.1038/ng.865; Hasegawa M, 2002, ONCOGENE, V21, P4231, DOI 10.1038/sj.onc.1205528; Hernandez JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050533; Ho T, 2007, HEAD NECK-J SCI SPEC, V29, P682, DOI 10.1002/hed.20570; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jithesh PV, 2013, BRIT J CANCER, V108, P370, DOI 10.1038/bjc.2012.568; Kanai Y, 2007, CARCINOGENESIS, V28, P2434, DOI 10.1093/carcin/bgm206; Kang KJ, 2015, GUT LIVER, V9, P202, DOI 10.5009/gnl13352; Lacko M, 2009, ANTICANCER RES, V29, P753; Laskar RS, 2015, MOL CARCINOGEN, V54, P1786, DOI 10.1002/mc.22250; Lechner M, 2013, GENOME MED, V5, DOI 10.1186/gm419; Li X, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/236361; Ling Y, 2011, J CLIN PATHOL, V64, P246, DOI 10.1136/jcp.2010.082875; Lleras RA, 2013, CLIN CANCER RES, V19, P5444, DOI 10.1158/1078-0432.CCR-12-3280; Lochhead P, 2013, JNCI-J NATL CANCER I, V105, P1151, DOI 10.1093/jnci/djt173; Lothaire P, 2006, HEAD NECK-J SCI SPEC, V28, P256, DOI 10.1002/hed.20326; Mani S, 2012, EPIGENETICS-US, V7, P270, DOI 10.4161/epi.7.3.19306; Mondal R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057771; Nazemalhosseini Mojarad Ehsan, 2013, Gastroenterol Hepatol Bed Bench, V6, P120; Ogi K, 2002, CLIN CANCER RES, V8, P3164; Ogino S, 2009, GUT, V58, P90, DOI 10.1136/gut.2008.155473; Park SJ, 2003, AM J PATHOL, V162, P815, DOI 10.1016/S0002-9440(10)63878-3; Perez-Ordonez B, 2006, J CLIN PATHOL, V59, P445, DOI 10.1136/jcp.2003.007641; Pierini S, 2014, HEAD NECK-J SCI SPEC, V36, P1103, DOI 10.1002/hed.23413; Ramshankar V, 2013, INDIA J SURG ONCOL, V4, P59, DOI 10.1007/s13193-012-0196-5; Righini CA, 2007, CLIN CANCER RES, V13, P1179, DOI 10.1158/1078-0432.CCR-06-2027; Rodriguez-Paredes M, 2011, NAT MED, V17, P330, DOI 10.1038/nm.2305; Roessler J, 2015, EPIGENOMICS-UK, V7, P187, DOI [10.2217/EPI.14.74, 10.2217/epi.14.74]; Roh JL, 2013, CLIN CANCER RES, V19, P2528, DOI 10.1158/1078-0432.CCR-12-3047; Shaw RJ, 2007, ORAL ONCOL, V43, P878, DOI 10.1016/j.oraloncology.2006.10.006; Steinmann K, 2009, ONCOL REP, V22, P1519, DOI 10.3892/or_00000596; Su PF, 2010, ORAL ONCOL, V46, P734, DOI 10.1016/j.oraloncology.2010.07.002; Supic G, 2011, ORAL ONCOL, V47, P702, DOI 10.1016/j.oraloncology.2011.05.014; Tahara T, 2011, HELICOBACTER, V16, P99, DOI 10.1111/j.1523-5378.2011.00821.x; Talukdar FR, 2015, MOL CARCINOGEN, V54, P1387, DOI 10.1002/mc.22214; Teodoridis JM, 2004, DRUG RESIST UPDATE, V7, P267, DOI 10.1016/j.drup.2004.06.005; Toyota M, 1999, P NATL ACAD SCI USA, V96, P8681, DOI 10.1073/pnas.96.15.8681; Viswanathan M, 2003, INT J CANCER, V105, P41, DOI 10.1002/ijc.11028; Wise-Draper TM, 2008, FRONT BIOSCI-LANDMRK, V13, P1003, DOI 10.2741/2739; Worsham MJ, 2013, OTOLARYNG HEAD NECK, V149, P409, DOI 10.1177/0194599813490895	53	44	44	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2015	10	6							e0129808	10.1371/journal.pone.0129808	http://dx.doi.org/10.1371/journal.pone.0129808			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL3FM	26098903	Green Published, gold, Green Submitted			2022-12-26	WOS:000356835800041
J	Conti, V; Gandaglia, A; Galli, F; Tirone, M; Bellini, E; Campana, L; Kilstrup-Nielsen, C; Rovere-Querini, P; Brunelli, S; Landsberger, N				Conti, Valentina; Gandaglia, Anna; Galli, Francesco; Tirone, Mario; Bellini, Elisa; Campana, Lara; Kilstrup-Nielsen, Charlotte; Rovere-Querini, Patrizia; Brunelli, Silvia; Landsberger, Nicoletta			MeCP2 Affects Skeletal Muscle Growth and Morphology through Non Cell-Autonomous Mechanisms	PLOS ONE			English	Article							RETT-SYNDROME; MOUSE MODEL; IMMUNE NEUTRALIZATION; EXPRESSION; IGF1; MICROGLIA; SYMPTOMS; INJURY	Rett syndrome (RTT) is an autism spectrum disorder mainly caused by mutations in the X-linked MECP2 gene and affecting roughly 1 out of 10.000 born girls. Symptoms range in severity and include stereotypical movement, lack of spoken language, seizures, ataxia and severe intellectual disability. Notably, muscle tone is generally abnormal in RTT girls and women and the Mecp2-null mouse model constitutively reflects this disease feature. We hypothesized that MeCP2 in muscle might physiologically contribute to its development and/or homeostasis, and conversely its defects in RTT might alter the tissue integrity or function. We show here that a disorganized architecture, with hypotrophic fibres and tissue fibrosis, characterizes skeletal muscles retrieved from Mecp2-null mice. Alterations of the IGF-1/Akt/mTOR pathway accompany the muscle phenotype. A conditional mouse model selectively depleted of Mecp2 in skeletal muscles is characterized by healthy muscles that are morphologically and molecularly indistinguishable from those of wild-type mice raising the possibility that hypotonia in RTT is mainly, if not exclusively, mediated by non-cell autonomous effects. Our results suggest that defects in paracrine/endocrine signaling and, in particular, in the GH/IGF axis appear as the major cause of the observed muscular defects. Remarkably, this is the first study describing the selective deletion of Mecp2 outside the brain. Similar future studies will permit to unambiguously define the direct impact of MeCP2 on tissue dysfunctions.	[Conti, Valentina] Ist Sci San Raffaele, Div Regenerat Med Stem Cells & Gene Therapy, I-20132 Milan, Italy; [Gandaglia, Anna; Galli, Francesco; Bellini, Elisa; Landsberger, Nicoletta] Ist Sci San Raffaele, Div Neurosci, San Raffaele Rett Res Unit, I-20132 Milan, Italy; [Gandaglia, Anna] Univ Insubria, PhD Sch Neurobiol, Busto Arsizio, Italy; [Tirone, Mario; Brunelli, Silvia] Univ Milano Bicocca, Dept Hlth Sci, Monza, Italy; [Tirone, Mario; Campana, Lara; Rovere-Querini, Patrizia] Ist Sci San Raffaele, Div Immunol Transplantat & Infect Dis, I-20132 Milan, Italy; [Campana, Lara; Rovere-Querini, Patrizia] Univ Vita Salute San Raffaele, Sch Med, Milan, Italy; [Kilstrup-Nielsen, Charlotte] Univ Insubria, Dept Theoret & Appl Sci, Div Biomed Res, Lab Genet & Epigenet Control Gene Express, Busto Arsizio, Italy; [Landsberger, Nicoletta] Univ Milan, Dept Med Biotechnol & Translat Med, Segrate, Italy	Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; University of Insubria; University of Milano-Bicocca; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; University of Insubria; University of Milan	Brunelli, S (corresponding author), Univ Milano Bicocca, Dept Hlth Sci, Monza, Italy.	silvia.brunelli@unimib.it; Nicoletta.landsberger@unimi.it	Brunelli, Silvia/J-3248-2014; Brunelli, Silvia/P-3853-2019; Campana, Lara/AAI-9372-2020; Conti, Valentina/AAN-2591-2020; Rovere-Querini, Patrizia/J-2340-2012	Brunelli, Silvia/0000-0003-1753-5346; Brunelli, Silvia/0000-0003-1753-5346; Campana, Lara/0000-0003-1805-4755; Conti, Valentina/0000-0001-7287-2658; Landsberger, Nicoletta/0000-0003-0820-3155; Kilstrup-Nielsen, Charlotte/0000-0003-4977-4077	Ministero dell'Istruzione, Universita e Ricerca (PRIN); proRETT ricerca	Ministero dell'Istruzione, Universita e Ricerca (PRIN); proRETT ricerca	Funding for this work was provided by Ministero dell'Istruzione, Universita e Ricerca (PRIN2010-2011) to SB. Additional funding was provided by proRETT ricerca to NL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abuhatzira L, 2014, EPIGENETICS OFFICIAL, V2, P214; Alvarez-Saavedra M, 2010, HUM MOL GENET, V19, P2177, DOI 10.1093/hmg/ddq096; Ballas N, 2009, NAT NEUROSCI, V12, P311, DOI 10.1038/nn.2275; Castro J, 2014, P NATL ACAD SCI USA, V111, P9941, DOI 10.1073/pnas.1311685111; Chahrour M, 2007, NEURON, V56, P422, DOI 10.1016/j.neuron.2007.10.001; Charge SBP, 2004, PHYSIOL REV, V84, P209, DOI 10.1152/physrev.00019.2003; Chen JCJ, 2005, GENESIS, V41, P116, DOI 10.1002/gene.20104; Chen RZ, 2001, NAT GENET, V27, P327, DOI 10.1038/85906; Chevrel G, 2006, MUSCLE NERVE, V33, P462, DOI 10.1002/mus.20444; Chikani V, 2014, J MOL ENDOCRINOL, V52, pR107, DOI 10.1530/JME-13-0208; Clow C, 2010, MOL BIOL CELL, V21, P2182, DOI 10.1091/mbc.E10-02-0154; Corvin AP, 2012, NEUROSCI LETT, V520, P51, DOI 10.1016/j.neulet.2012.05.029; Cronk JC, 2015, IMMUNITY, V42, P679, DOI 10.1016/j.immuni.2015.03.013; Derecki NC, 2012, NATURE, V484, P105, DOI 10.1038/nature10907; Didier N, 2012, EMBO MOL MED, V4, P910, DOI 10.1002/emmm.201101075; EYRE JA, 1990, J NEUROL NEUROSUR PS, V53, P874, DOI 10.1136/jnnp.53.10.874; Fyffe SL, 2008, NEURON, V59, P947, DOI 10.1016/j.neuron.2008.07.030; Gow DJ, 2010, J LEUKOCYTE BIOL, V88, P475, DOI 10.1189/jlb.0310158; Guy J, 2001, NAT GENET, V27, P322, DOI 10.1038/85899; Iizuka K, 2014, J PHARMACOL SCI, V125, P125, DOI 10.1254/jphs.14R02CP; Katz D M, 2014, Handb Exp Pharmacol, V220, P481, DOI 10.1007/978-3-642-45106-5_18; Kerr B, 2008, HUM MOL GENET, V17, P1707, DOI 10.1093/hmg/ddn061; Khwaja OS, 2014, P NATL ACAD SCI USA, V111, P4596, DOI 10.1073/pnas.1311141111; LEFAUCHEUR JP, 1995, J NEUROIMMUNOL, V57, P85, DOI 10.1016/0165-5728(94)00166-L; Lefaucheur JP, 1996, J NEUROIMMUNOL, V70, P37, DOI 10.1016/S0165-5728(96)00099-9; Li W, 2014, NEUROPHARMACOLOGY, V76, P737, DOI 10.1016/j.neuropharm.2013.03.024; Li Y, 2013, CELL STEM CELL, V13, P446, DOI 10.1016/j.stem.2013.09.001; Martinowich K, 2003, SCIENCE, V302, P890, DOI 10.1126/science.1090842; Mellios N, 2014, P NATL ACAD SCI USA, V111, P9947, DOI 10.1073/pnas.1309426111; Neul JL, 2010, ANN NEUROL, V68, P944, DOI 10.1002/ana.22124; Percy AK, 2005, J CHILD NEUROL, V20, P718, DOI 10.1177/08830738050200090301; Pitts EV, 2006, INT ANESTHESIOL CLIN, V44, P21, DOI 10.1097/00004311-200604420-00004; Ricceri L, 2008, BEHAV PHARMACOL, V19, P501, DOI 10.1097/FBP.0b013e32830c3645; Ricciardi S, 2011, HUM MOL GENET, V20, P1182, DOI 10.1093/hmg/ddq563; Schiaffino S, 2013, FEBS J, V280, P4294, DOI 10.1111/febs.12253; Schiaffino S, 2011, SKELET MUSCLE, V1, DOI 10.1186/2044-5040-1-4; Skene PJ, 2010, MOL CELL, V37, P457, DOI 10.1016/j.molcel.2010.01.030; Touvier T, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2014.595; Tropea D, 2009, P NATL ACAD SCI USA, V106, P2029, DOI 10.1073/pnas.0812394106; Zordan P, 2013, EUR J PHARMACOL, V715, P296, DOI 10.1016/j.ejphar.2013.05.007	40	20	20	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2015	10	6							e0130183	10.1371/journal.pone.0130183	http://dx.doi.org/10.1371/journal.pone.0130183			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL3FM	26098633	Green Published, gold, Green Submitted			2022-12-26	WOS:000356835800058
J	Lazzarini, PA; O'Rourke, SR; Russell, AW; Derhy, PH; Kamp, MC				Lazzarini, Peter A.; O'Rourke, Sharon R.; Russell, Anthony W.; Derhy, Patrick H.; Kamp, Maarten C.			Reduced Incidence of Foot-Related Hospitalisation and Amputation amongst Persons with Diabetes in Queensland, Australia	PLOS ONE			English	Article							LOWER-LIMB AMPUTATIONS; PEOPLE; CARE; MANAGEMENT; SCOTLAND; QUALITY	Objective To determine trends in the incidence of foot-related hospitalisation and amputation amongst persons with diabetes in Queensland (Australia) between 2005 and 2010 that coincided with changes in state-wide ambulatory diabetic foot-related complication management. Methods All data from cases admitted for the principal reason of diabetes foot-related hospitalisation or amputation in Queensland from 2005-2010 were obtained from the Queensland Hospital Admitted Patient Data Collection dataset. Incidence rates for foot-related hospitalisation (admissions, bed days used) and amputation (total, minor, major) cases amongst persons with diabetes were calculated per 1,000 person-years with diabetes (diabetes population) and per 100,000 person-years (general population). Age-sex standardised incidence and age-sex adjusted Poisson regression models were also calculated for the general population. Results There were 4,443 amputations, 24,917 hospital admissions and 260,085 bed days used for diabetes foot-related complications in Queensland. Incidence per 1,000 person-years with diabetes decreased from 2005 to 2010: 43.0% for hospital admissions (36.6 to 20.9), 40.1% bed days (391 to 234), 40.0% total amputations (6.47 to 3.88), 45.0% major amputations ( 2.18 to 1.20), 37.5% minor amputations (4.29 to 2.68) (p < 0.01 respectively). Age-sex standardised incidence per 100,000 person-years in the general population also decreased from 2005 to 2010: 23.3% hospital admissions (105.1 to 80.6), 19.5% bed days (1,122 to 903), 19.3% total amputations (18.57 to 14.99), 26.4% major amputations (6.26 to 4.61), 15.7% minor amputations (12.32 to 10.38) (p < 0.01 respectively). The age-sex adjusted incidence rates per calendar year decreased in the general population (rate ratio (95% CI)); hospital admissions 0.949 (0.942-0.956), bed days 0.964 (0.962-0.966), total amputations 0.962 (0.946-0.979), major amputations 0.945 (0.917-0.974), minor amputations 0.970 (0.950-0.991) (p < 0.05 respectively). Conclusions There were significant reductions in the incidence of foot-related hospitalisation and amputation amongst persons with diabetes in the population of Queensland over a recent six-year period.	[Lazzarini, Peter A.; Kamp, Maarten C.] Queensland Univ Technol, Sch Clin Sci, Brisbane, Qld 4001, Australia; [Lazzarini, Peter A.] Queensland Hlth, Metro North Hosp & Hlth Serv, Allied Hlth Res Collaborat, Brisbane, Qld, Australia; [O'Rourke, Sharon R.] Queensland Hlth, Cairns Diabet Ctr, Cairns, Qld, Australia; [Russell, Anthony W.] Princess Alexandra Hosp, Dept Endocrinol & Diabet, Brisbane, Qld 4102, Australia; [Russell, Anthony W.] Univ Queensland, Sch Med, Brisbane, Qld, Australia; [Derhy, Patrick H.] Queensland Hlth, Clin Access & Redesign Unit, Brisbane, Qld, Australia; [Kamp, Maarten C.] Diabet Australia Queensland, Brisbane, Qld, Australia	Queensland University of Technology (QUT); Queensland Health; Queensland Health; University of Queensland; Queensland Health	Lazzarini, PA (corresponding author), Queensland Univ Technol, Sch Clin Sci, Brisbane, Qld 4001, Australia.	Peter_Lazzarini@health.qld.gov.au	Russell, Anthony/AGE-0557-2022; Russell, Anthony/A-8807-2011	Russell, Anthony/0000-0001-7886-8844; Russell, Anthony/0000-0003-4902-6693; Lazzarini, Peter/0000-0002-8235-7964	Queensland Statewide Diabetes Clinical Network; Queensland Statewide Diabetes Foot Working Group; Queensland Statewide Podiatry Network	Queensland Statewide Diabetes Clinical Network; Queensland Statewide Diabetes Foot Working Group; Queensland Statewide Podiatry Network	The authors acknowledge the support provided to this work by the Queensland Statewide Diabetes Clinical Network, Queensland Statewide Diabetes Foot Working Group and Queensland Statewide Podiatry Network.	AIHW, 2008, FOOT COMPL, P44; Anichini R, 2007, DIABETES RES CLIN PR, V75, P153, DOI 10.1016/j.diabres.2006.05.014; [Anonymous], TYP 2 DIAB PREV MAN; [Anonymous], 2015, NAT DIAB SERV SCHEM; Armstrong David G, 2007, Int Wound J, V4, P286; Australian Bureau of Statistics (ABS), 2013, AUTR DEM STAT; Australian Bureau of Statistics (ABS), 2014, ALL STAT; Bakker K, 2012, DIABETES-METAB RES, V28, P225, DOI 10.1002/dmrr.2253; Bergin SM, 2012, MED J AUSTRALIA, V197, P197, DOI 10.5694/mja10.10837; Boulton AJM, 2005, LANCET, V366, P1719, DOI 10.1016/S0140-6736(05)67698-2; Bureau of Health Information, 2010, HEALTHC FOC NSW COMP; Canavan RJ, 2008, DIABETES CARE, V31, P459, DOI 10.2337/dc07-1159; Department of Health Western Australia, 2010, HIGH RISK FOOT MOD C; Dillon MP, 2014, PROSTHET ORTHOT INT, V38, P122, DOI 10.1177/0309364613490441; Goodridge D, 2005, J WOUND OSTOMY CONT, V32, P368, DOI 10.1097/00152192-200511000-00007; Health Statistics Branch, 2011, IMP CHANG DIAB COD Q; Health Statistics Branch, 2013, QUEENSL HOSP ADM PAT; Holstein P, 2000, DIABETOLOGIA, V43, P844, DOI 10.1007/s001250051459; International Working Group on the Diabetic Foot, 2005, DIAB FOOTC TIM ACT; Ismail K, 2007, DIABETES CARE, V30, P1473, DOI 10.2337/dc06-2313; Jeffcoate WJ, 2012, DIABETES CARE, V35, P2419, DOI 10.2337/dc12-1143; Jeffcoate WJ, 2004, DIABETOLOGIA, V47, P2051, DOI 10.1007/s00125-004-1584-3; Kanade RV, 2006, DIABETOLOGIA, V49, P1747, DOI 10.1007/s00125-006-0309-1; Kennon B, 2012, DIABETES CARE, V35, P2588, DOI 10.2337/dc12-0511; Kevat D, 2014, LANCET, V383, P1268, DOI 10.1016/S0140-6736(14)60487-6; Kirkwood BR, 2003, ESSENTIAL MED STAT; Krishnan S, 2008, DIABETES CARE, V31, P99, DOI 10.2337/dc07-1178; Lazzarini PA, 2011, J FOOT ANKLE RES, V4, pO25; Lazzarini PA, 2012, J FOOT ANKLE RES, V5, DOI 10.1186/1757-1146-5-24; Lazzarini PA, 2012, J FOOT ANKLE RES, V5, DOI 10.1186/1757-1146-5-12; Lazzarini PA, 2012, AUST HEALTH REV, V36, P8, DOI 10.1071/AH10978; O'Rourke SR, 2012, AUST HEALTH REV, V36, P105, DOI 10.1071/AH10969; Organisation for Economic Co-operation and Development (OECD), 2013, HLTH CAR QUAL IND PR; Payne CB, 2000, MED J AUSTRALIA, V173, P352, DOI 10.5694/j.1326-5377.2000.tb125685.x; Peters EJG, 2001, DIABETES CARE, V24, P1799, DOI 10.2337/diacare.24.10.1799; Pinhas-Hamiel O, 2005, J PEDIATR-US, V146, P693, DOI 10.1016/j.jpeds.2004.12.042; Queensland Health, 2014, ADM PAT EP CAR PAT D; Ray JA, 2005, CURR MED RES OPIN, V21, P1617, DOI 10.1185/030079905X65349; Squires David A, 2011, Issue Brief (Commonw Fund), V16, P1; The Department of Health, 2013, INF REL NAT DIAB SER; The University of Sydney, 2005, GUID DEC CLIN BIOL W; Trautner C, 2007, DIABETES CARE, V30, P2633, DOI 10.2337/dc07-0876; Tseng CL, 2011, DIABETES CARE, V34, P1157, DOI 10.2337/dc10-1775; Unwin N, 2000, BRIT J SURG, V87, P328, DOI 10.1046/j.1365-2168.2000.01344.x; Wraight PR, 2005, DIABETIC MED, V22, P127, DOI 10.1111/j.1464-5491.2004.01363.x; Wrobel James S, 2006, J Foot Ankle Surg, V45, P375, DOI 10.1053/j.jfas.2006.09.015	46	49	49	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2015	10	6							e0130609	10.1371/journal.pone.0130609	http://dx.doi.org/10.1371/journal.pone.0130609			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL3FM	26098890	gold, Green Published, Green Submitted			2022-12-26	WOS:000356835800084
J	Reddy, NRR; Mehta, RH; Soni, PH; Makasana, J; Gajbhiye, NA; Ponnuchamy, M; Kumar, J				Reddy, Nagaraja Reddy Rama; Mehta, Rucha Harishbhai; Soni, Palak Harendrabhai; Makasana, Jayanti; Gajbhiye, Narendra Athamaram; Ponnuchamy, Manivel; Kumar, Jitendra			Next Generation Sequencing and Transcriptome Analysis Predicts Biosynthetic Pathway of Sennosides from Senna (Cassia angustifolia Vahl.), a Non-Model Plant with Potent Laxative Properties	PLOS ONE			English	Article							PENTATRICOPEPTIDE REPEAT PROTEINS; ZINC-FINGER PROTEINS; ALKALOID BIOSYNTHESIS; RNA-SEQ; MICROSATELLITE MARKERS; FUNCTIONAL GENOMICS; CATHARANTHUS-ROSEUS; CELL-CULTURES; SSR MARKERS; GENES	Senna (Cassia angustifolia Vahl.) is a world's natural laxative medicinal plant. Laxative properties are due to sennosides (anthraquinone glycosides) natural products. However, little genetic information is available for this species, especially concerning the biosynthetic pathways of sennosides. We present here the transcriptome sequencing of young and mature leaf tissue of Cassia angustifolia using Illumina MiSeq platform that resulted in a total of 6.34 Gb of raw nucleotide sequence. The sequence assembly resulted in 42230 and 37174 transcripts with an average length of 1119 bp and 1467 bp for young and mature leaf, respectively. The transcripts were annotated using NCBI BLAST with 'green plant database (txid 33090)', Swiss Prot, Kyoto Encylcopedia of Genes & Genomes (KEGG), Cluster of Orthologous Gene (COG) and Gene Ontology (GO). Out of the total transcripts, 40138 (95.0%) and 36349 (97.7%) from young and mature leaf, respectively, were annotated by BLASTX against green plant database of NCBI. We used InterProscan to see protein similarity at domain level, a total of 34031 (young leaf) and 32077 (mature leaf) transcripts were annotated against the Pfam domains. All transcripts from young and mature leaf were assigned to 191 KEGG pathways. There were 166 and 159 CDS, respectively, from young and mature leaf involved in metabolism of terpenoids and polyketides. Many CDS encoding enzymes leading to biosynthesis of sennosides were identified. A total of 10,763 CDS differentially expressing in both young and mature leaf libraries of which 2,343 (21.7%) CDS were up-regulated in young compared to mature leaf. Several differentially expressed genes found functionally associated with sennoside biosynthesis. CDS encoding for many CYPs and TF families were identified having probable roles in metabolism of primary as well as secondary metabolites. We developed SSR markers for molecular breeding of senna. We have identified a set of putative genes involved in various secondary metabolite pathways, especially those related to the synthesis of sennosides which will serve as an important platform for public information about gene expression, genomics, and functional genomics in senna.	[Reddy, Nagaraja Reddy Rama; Mehta, Rucha Harishbhai; Soni, Palak Harendrabhai; Makasana, Jayanti; Gajbhiye, Narendra Athamaram; Ponnuchamy, Manivel; Kumar, Jitendra] ICAR Res Complex, DMAPR, Anand, Gujarat, India	Indian Council of Agricultural Research (ICAR); ICAR - Directorate of Medicinal & Aromatic Plants Research	Reddy, NRR (corresponding author), ICAR Res Complex, DMAPR, Anand, Gujarat, India.	Nagaraja.R@icar.gov.in	Kumar, Jitendra/L-7722-2019; R, Smitha G/P-5150-2016	R, Smitha G/0000-0002-4052-9756				ALDAKAN AA, 1995, PHARMACOL TOXICOL, V77, P288, DOI 10.1111/j.1600-0773.1995.tb01029.x; Alexandrov NN, 2006, PLANT MOL BIOL, V60, P69, DOI 10.1007/s11103-005-2564-9; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Annadurai RS, 2012, BMC GENOMICS, V13, P1, DOI 10.1186/1471-2164-13-663; [Anonymous], 1997, ALAKLOIDS; ATZORN R, 1981, PLANTA MED, V41, P1, DOI 10.1055/s-2007-971666; Bahl J. R., 1987, Nucleus, India, V30, P99; Barkan A, 2014, ANNU REV PLANT BIOL, V65, P415, DOI 10.1146/annurev-arplant-050213-040159; Barrero RA, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-600; BOHNERT HJ, 1995, PLANT CELL, V7, P1099, DOI 10.1105/tpc.7.7.1099; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Bown D, 1995, ENCYCLOPEDIA OF HERB; Carels N, 2000, GENETICS, V154, P1819; Chateigner-Boutin AL, 2013, PLANT J, V74, P935, DOI 10.1111/tpj.12180; Contin A, 1999, PLANT PHYSIOL BIOCH, V37, P139, DOI 10.1016/S0981-9428(99)80075-8; Cooper B, 2003, P NATL ACAD SCI USA, V100, P4945, DOI 10.1073/pnas.0737574100; Cummings CJ, 2000, HUM MOL GENET, V9, P909, DOI 10.1093/hmg/9.6.909; Davis MS, 2000, J BIOL CHEM, V275, P28593, DOI 10.1074/jbc.M004756200; De J, 1999, GENE, V228, P133, DOI 10.1016/S0378-1119(98)00617-9; Delaney KJ, 2006, PLANT PHYSIOL, V140, P1507, DOI 10.1104/pp.105.070672; DICKE M, 1990, J CHEM ECOL, V16, P3091, DOI 10.1007/BF00979614; DON RH, 1991, NUCLEIC ACIDS RES, V19, P4008, DOI 10.1093/nar/19.14.4008; Endt DV, 2002, PHYTOCHEMISTRY, V61, P107, DOI 10.1016/S0031-9422(02)00185-1; Furumoto T, 2011, PHYTOCHEMISTRY, V72, P871, DOI 10.1016/j.phytochem.2011.03.012; Gagne SJ, 2012, P NATL ACAD SCI USA, V109, P12811, DOI 10.1073/pnas.1200330109; Gago G, 2011, FEMS MICROBIOL REV, V35, P475, DOI 10.1111/j.1574-6976.2010.00259.x; Gahlan P, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-126; Ganjewala D, 2009, CURR ISSUES MOL BIOL, V11, pI35; Gao S, 2006, J BIOCHEM MOL BIOL, V39, P502; GARCIAVILLAR R, 1980, J PHARM PHARMACOL, V32, P323, DOI 10.1111/j.2042-7158.1980.tb12929.x; Garzon-Martinez GA, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-151; Gongora-Castillo E, 2013, NAT PROD REP, V30, P490, DOI 10.1039/c3np20099j; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Guevara-Garcia A, 2005, PLANT CELL, V17, P628, DOI 10.1105/tpc.104.028860; Guo HZ, 1998, PHYTOCHEMISTRY, V49, P1623, DOI 10.1016/S0031-9422(98)00325-2; Gupta P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062714; Gupta PK, 1996, CURR SCI INDIA, V70, P45; Gupta PK, 2000, EUPHYTICA, V113, P163, DOI 10.1023/A:1003910819967; GUPTA R, 1977, S INDIAN HORTICULTUR, V25, P26; Gupta R., 1995, ADVANCES IN HORTICUL, P325; Gupta S, 2009, GENOME, V52, P761, DOI [10.1139/g09-051, 10.1139/G09-051]; Han YS, 2002, PHYTOCHEMISTRY, V59, P45, DOI 10.1016/S0031-9422(01)00296-5; Han YS, 2001, PLANT CELL TISS ORG, V67, P201, DOI 10.1023/A:1012758922713; He M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042081; INOUE K, 1984, PHYTOCHEMISTRY, V23, P307, DOI 10.1016/S0031-9422(00)80323-4; Inouye H, 1988, CHEM QUINONOID COMPO, V2, P1293; Irmler S, 2000, PLANT J, V24, P797, DOI 10.1046/j.1365-313x.2000.00922.x; Irwine HS, 1982, MEMOIRS OF THE NEW Y, V35; Jiang AL, 2014, PLANT MOL BIOL REP, V32, P1241, DOI 10.1007/s11105-014-0719-z; Jin H, 2006, MOL BIOL+, V40, P914, DOI 10.1134/S0026893306060100; Kalra S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083336; Kantety RV, 2002, PLANT MOL BIOL, V48, P501, DOI 10.1023/A:1014875206165; Khan IA, 2010, LEUNGS ENCYCLOPEDIA; Kim TW, 2005, PLANT CELL, V17, P2397, DOI 10.1105/tpc.105.033738; Kobe B, 2001, CURR OPIN STRUC BIOL, V11, P725, DOI 10.1016/S0959-440X(01)00266-4; Krishnan NM, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-464; Lange BM, 1999, P NATL ACAD SCI USA, V96, P13714, DOI 10.1073/pnas.96.24.13714; Leistner E., 1981, The biochemistry of plants. A comprehensive treatise. Volume 7. Secondary plant products., P403; LEISTNER E, 1975, PLANTA MED, P214, DOI 10.1055/s-0028-1105797; LENGPESCHLOW E, 1986, J PHARM PHARMACOL, V38, P369, DOI 10.1111/j.2042-7158.1986.tb04589.x; LENGPESCHLOW E, 1993, PHARMACOLOGY, V47, P14, DOI 10.1159/000139838; Li CF, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-245; Li JJ, 2001, PLANT CELL, V13, P2269, DOI 10.1105/tpc.13.10.2269; Li Y, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-268; Li Ying, 2010, Yaoxue Xuebao, V45, P524; Lin XH, 2011, PHYSIOL PLANTARUM, V143, P207, DOI 10.1111/j.1399-3054.2011.01500.x; Lin XY, 1999, NATURE, V402, P761, DOI 10.1038/45471; Liu ZB, 2014, BIOSCI BIOTECH BIOCH, V78, P791, DOI 10.1080/09168451.2014.905182; Luo HM, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-209; Maiti S, 2000, TECHNICAL BULLETIN; Memelink J, 2001, ADV BIOCHEM ENG BIOT, V72, P103; Metzgar D, 2000, GENOME RES, V10, P72; Min XJ, 2005, NUCLEIC ACIDS RES, V33, pW677, DOI 10.1093/nar/gki394; Naika M, 2013, PLANT CELL PHYSIOL, V54, pE8, DOI 10.1093/pcp/pcs185; Nair P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060375; OHRI D, 1986, PLANT SYST EVOL, V153, P223, DOI 10.1007/BF00983689; Ohyanagi H, 2006, NUCLEIC ACIDS RES, V34, pD741, DOI 10.1093/nar/gkj094; Ozsolak F, 2011, NAT REV GENET, V12, P87, DOI 10.1038/nrg2934; Page JE, 2004, PLANT PHYSIOL, V134, P1401, DOI 10.1104/pp.103.038133; Portis E, 2007, PLANT SCI, V172, P640, DOI 10.1016/j.plantsci.2006.11.016; Ramilowski JA, 2013, PLANT CELL PHYSIOL, V54, P697, DOI 10.1093/pcp/pct057; Ratnayaka HH, 2002, HORTSCIENCE, V37, P768, DOI 10.21273/HORTSCI.37.5.768; Reddy RN, 2011, INDIAN J AGR SCI, V81, P1063; Reddy RN, 2012, MOL BREEDING, V29, P543, DOI 10.1007/s11032-011-9571-0; Rohdich F, 2000, P NATL ACAD SCI USA, V97, P8251, DOI 10.1073/pnas.140209197; Sato S, 2000, DNA RES, V7, P131, DOI 10.1093/dnares/7.2.131; Schapire AL, 2006, PLANT SIGNAL BEHAV, V1, P229, DOI 10.4161/psb.1.5.3491; Schatz MC, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-4-243; Schuler MA, 2003, ANNU REV PLANT BIOL, V54, P629, DOI 10.1146/annurev.arplant.54.031902.134840; Schwender J, 1999, FEBS LETT, V455, P140, DOI 10.1016/S0014-5793(99)00849-2; Seki M, 2002, ARABIDOPSIS THALIANA; Senthil K, 2010, MOL BIOL REP, V37, P893, DOI 10.1007/s11033-009-9696-y; Smith JSC, 2000, CROP SCI, V40, P226, DOI 10.2135/cropsci2000.401226x; Soetaert SSA, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-220; Squirrell J, 2003, MOL ECOL, V12, P1339, DOI 10.1046/j.1365-294X.2003.01825.x; Srivastava VK, 1981, HERBA HUNG, V20, P1; STOLL A, 1950, FORT CHEM ORG NAT, V7, P248; Stuppner H, 1996, CHROMATOGRAPHIA, V42, P697, DOI 10.1007/BF02267704; Subramanian S, 2003, BIOINFORMATICS, V19, P549, DOI 10.1093/bioinformatics/btg029; Suganuma T, 2008, GENE DEV, V22, P1265, DOI 10.1101/gad.1676208; Sun YZ, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-533; Takatsuji H, 1998, CELL MOL LIFE SCI, V54, P582, DOI 10.1007/s000180050186; Temnykh S, 2000, THEOR APPL GENET, V100, P697, DOI 10.1007/s001220051342; Thompson MJ, 1996, GENE, V174, P225, DOI 10.1016/0378-1119(96)00084-4; Toth G, 2000, GENOME RES, V10, P967, DOI 10.1101/gr.10.7.967; Upadhyay S, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-746; Van den Berg AJJ., 1989, METHODS PLANT BIOCH, P451; Verpoorte R, 1999, PR PHYT SOC, V43, P11; Wang LK, 2010, BIOINFORMATICS, V26, P136, DOI 10.1093/bioinformatics/btp612; Wang Y, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-836; Wang Z, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092029; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wichtl M, 1997, EIN HANDBUCH FUR DIE; Yamazaki M, 2013, PLANT CELL PHYSIOL, V54, P686, DOI 10.1093/pcp/pct040; Yang L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080464; Yu J, 2005, PLOS BIOL, V3, P266, DOI 10.1371/journal.pbio.0030038; Zeng J, 2013, PLOS ONE, DOI [10.1371/annotation/6848d2aa-d15f-4632-9074-727b25958da3, DOI 10.1371/ANNOTATI0N/6848D2AA-D15F-4632-9074-727B25958DA3]; Zhang YF, 2009, PLANT CELL REP, V28, P337, DOI 10.1007/s00299-008-0644-4	118	70	72	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2015	10	6							e0129422	10.1371/journal.pone.0129422	http://dx.doi.org/10.1371/journal.pone.0129422			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL3FM	26098898	Green Published, Green Submitted, gold			2022-12-26	WOS:000356835800029
J	Wang, LS; Lin, P; Ma, AX; Zheng, HZ; Wang, KX; Li, WJ; Wang, C; Zhao, RX; Liang, K; Liu, FQ; Hou, XG; Song, J; Lu, YR; Zhu, P; Sun, Y; Chen, L				Wang, Lingshu; Lin, Peng; Ma, Aixia; Zheng, Huizhen; Wang, Kexin; Li, Wenjuan; Wang, Chuan; Zhao, Ruxing; Liang, Kai; Liu, Fuqiang; Hou, Xinguo; Song, Jun; Lu, Yiran; Zhu, Ping; Sun, Yu; Chen, Li			C-Peptide Is Independently Associated with an Increased Risk of Coronary Artery Disease in T2DM Subjects: A Cross-Sectional Study	PLOS ONE			English	Article							INSULIN-RESISTANCE; HEART-DISEASE; CARDIOVASCULAR MORTALITY; DIABETES-MELLITUS; VASCULAR-DISEASE; OBESITY; ATHEROSCLEROSIS; HYPERGLYCEMIA; INVOLVEMENT; CHEMOTAXIS	Objective C-peptide has been reported to be a marker of subclinical atherosclerosis in type 2 diabetes mellitus (T2DM) patients, whereas its role in coronary artery disease (CAD) has not been clarified, especially in diabetics with differing body mass indices (BMIs). Design and Methods This cross-sectional study included 501 patients with T2DM. First, all subjects were divided into the following two groups: CAD and non-CAD. Then, binary logistic regression was used to determine the risk factors for CAD for all patients. To clarify the role of obesity, we redivided all subjects into two additional groups (obese and non-obese) based on BMI. Finally, binary logistic regression was used to determine the risk factors for CAD for each weight group. Results The patients with CAD showed a higher BMI and fasting C-peptide level in addition to an increased prevalence of traditional risk factors for CAD, such as hypertension, insulin resistance, higher cholesterol, cysteine-C (Cys-C) and lower estimated glomerular filtration rate (eGFR). Logistic regression analysis showed that fasting C-peptide (OR=1.513, p=0.005), insulin treatment (OR=1.832, p=0.027) hypertension (OR=1.987, p=0.016) and hyperlipidemia (OR=4.159, p<0.001) significantly increased the risk of clinical CAD in the T2DM patients independent of age, gender, diabetes duration, smoking and alcohol statuses, fasting insulin and glucose, hypoglycemic episodes, UA and eGFR. Additionally, in both of the obese (OR=1.488, p=0.049) and non-obese (OR=1.686, p=0.037) DM groups, C-peptide was associated with an increased risk of CAD after multiple adjustments. Conclusions C-peptide is associated with an increased CAD risk in T2DM patients, no matter whether they are obese or not.	[Wang, Lingshu; Lin, Peng; Ma, Aixia; Zheng, Huizhen; Li, Wenjuan; Wang, Chuan; Zhao, Ruxing; Liang, Kai; Liu, Fuqiang; Hou, Xinguo; Song, Jun; Lu, Yiran; Sun, Yu; Chen, Li] Shandong Univ, Qilu Hosp, Dept Endocrinol, Jinan 250012, Shandong, Peoples R China; [Wang, Kexin] Shandong Univ, Qilu Hosp, Dept Gen Surg, Jinan 250012, Shandong, Peoples R China; [Zhu, Ping] Univ Florida, Coll Med, Dept Ophthalmol, Gainesville, FL 32610 USA; [Chen, Li] Shandong Univ, Inst Endocrinol & Metab, Jinan 250012, Shandong, Peoples R China	Shandong University; Shandong University; State University System of Florida; University of Florida; Shandong University	Sun, Y (corresponding author), Shandong Univ, Qilu Hosp, Dept Endocrinol, Jinan 250012, Shandong, Peoples R China.	sunyujn@aliyun.com; chenli3@medmail.com.cn	Lu, YiRan/GQO-9465-2022	hou, xinguo/0000-0003-2045-1290	National Natural Science Foundation of China [81370943, 81100617, 81200608, 81471020, 81400770]; Shandong Natural Science Foundation [ZR2013HQ054]; Jinan Young Science and Technology Stars Project [20120139]; Innovation Funding of Shandong University [2012TS141]; Chinese Society of Endocrinology	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shandong Natural Science Foundation(Natural Science Foundation of Shandong Province); Jinan Young Science and Technology Stars Project; Innovation Funding of Shandong University; Chinese Society of Endocrinology	This study is supported by the National Natural Science Foundation of China (Grant No: 81370943, 81100617, 81200608, 81471020 and 81400770), Shandong Natural Science Foundation (Grant No:ZR2013HQ054), Jinan Young Science and Technology Stars Project (Grant No:20120139), Innovation Funding of Shandong University (Grant No:2012TS141), and the Chinese Society of Endocrinology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; Albu JB, 2010, OBESITY, V18, P1046, DOI 10.1038/oby.2009.339; An XQ, 2012, CARDIOVASC DIABETOL, V11, DOI 10.1186/1475-2840-11-71; BAVENHOLM P, 1995, CIRCULATION, V92, P1422, DOI 10.1161/01.CIR.92.6.1422; Bhatt MP, 2013, DIABETES, V62, P243, DOI 10.2337/db12-0293; Bi YF, 2014, J DIABETES, V6, P147, DOI 10.1111/1753-0407.12108; Dalmas E, 2013, DIABETES CARE, V36, P3793, DOI 10.2337/dc13-0256; Finfer S, 2012, NEW ENGL J MED, V367, P1108, DOI 10.1056/NEJMoa1204942; Hajjar DP, 2013, AM J PATHOL, V182, P1474, DOI 10.1016/j.ajpath.2013.01.010; Hoefle G, 2005, INT J OBESITY, V29, P785, DOI 10.1038/sj.ijo.0802985; Holman RR, 2014, LANCET, V383, P2008, DOI 10.1016/S0140-6736(14)60794-7; Karrowni W, 2013, ARTERIOSCL THROM VAS, V33, P2245, DOI 10.1161/ATVBAHA.113.301585; Kim ST, 2011, DIABETES METAB J, V35, P41, DOI 10.4093/dmj.2011.35.1.41; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Li N, 2014, DIABETES CARE, V37, P3204, DOI 10.2337/dc14-1091; Lu Y, 2014, LANCET, V383, P970, DOI 10.1016/S0140-6736(13)61836-X; Marx N, 2004, ARTERIOSCL THROM VAS, V24, P540, DOI 10.1161/01.ATV.0000116027.81513.68; Marx N, 2013, DIABETES CARE, V36, P708, DOI 10.2337/dc12-1211; Matsushita K, 2010, LANCET, V375, P2073, DOI 10.1016/S0140-6736(10)60674-5; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Meigs JB, 2000, JAMA-J AM MED ASSOC, V283, P221, DOI 10.1001/jama.283.2.221; Murthy VL, 2012, CIRCULATION, V126, P1858, DOI 10.1161/CIRCULATIONAHA.112.120402; Niccoli G, 2013, EUR HEART J, V34, P729, DOI 10.1093/eurheartj/ehs393; Orchard TJ, 2003, DIABETES CARE, V26, P1374, DOI 10.2337/diacare.26.5.1374; Paneni F, 2013, EUR HEART J, V34, P2436, DOI 10.1093/eurheartj/eht149; Patel N, 2012, J AM HEART ASSOC, V1, DOI 10.1161/JAHA.112.003152; Sarwar N, 2010, LANCET, V375, P2215, DOI 10.1016/S0140-6736(10)60484-9; Vasic D, 2012, INT J INFLAMM, V2012, DOI 10.1155/2012/932725; Walcher D, 2004, DIABETES, V53, P1664, DOI 10.2337/diabetes.53.7.1664; Walcher D, 2006, CIRC RES, V99, P1181, DOI 10.1161/01.RES.0000251231.16993.88; Wang C, 2014, INT UROL NEPHROL, V46, P1793, DOI 10.1007/s11255-014-0797-8; Yakubovich N, 2011, CIRCULATION, V123, P342, DOI 10.1161/CIRCULATIONAHA.110.948489; Yang WY, 2010, NEW ENGL J MED, V362, P1090, DOI 10.1056/NEJMoa0908292	33	7	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2015	10	6							e0127112	10.1371/journal.pone.0127112	http://dx.doi.org/10.1371/journal.pone.0127112			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL3FM	26098780	gold, Green Submitted, Green Published			2022-12-26	WOS:000356835800005
J	Chornokur, G; Lin, HY; Tyrer, JP; Lawrenson, K; Dennis, J; Amankwah, EK; Qu, XT; Tsai, YY; Jim, HSL; Chen, ZH; Chen, AY; Permuth-Wey, J; Aben, KKH; Anton-Culver, H; Antonenkova, N; Bruinsma, F; Bandera, EV; Bean, YT; Beckmann, MW; Bisogna, M; Bjorge, L; Bogdanova, N; Brinton, LA; Brooks-Wilson, A; Bunker, CH; Butzow, R; Campbell, IG; Carty, K; Chang-Claude, J; Cook, LS; Cramer, DW; Cunningham, JM; Cybulski, C; Dansonka-Mieszkowska, A; du Bois, A; Despierre, E; Dicks, E; Doherty, JA; Dork, T; Durst, M; Easton, DF; Eccles, DM; Edwards, RP; Ekici, AB; Fasching, PA; Fridley, BL; Gao, YT; Gentry-Maharaj, A; Giles, GG; Glasspool, R; Goodman, MT; Gronwald, J; Harrington, P; Harter, P; Hein, A; Heitz, F; Hildebrandt, MAT; Hillemanns, P; Hogdall, CK; Hogdall, E; Hosono, S; Jakubowska, A; Jensen, A; Ji, BT; Karlan, BY; Kelemen, LE; Kellar, M; Kiemeney, LA; Krakstad, C; Kjaer, SK; Kupryjanczyk, J; Lambrechts, D; Lambrechts, S; Le, ND; Lee, AW; Lele, S; Leminen, A; Lester, J; Levine, DA; Liang, D; Lim, BK; Lissowska, J; Lu, K; Lubinski, J; Lundvall, L; Massuger, LFAG; Matsuo, K; McGuire, V; McLaughlin, JR; McNeish, I; Menon, U; Milne, RL; Modugno, F; Moysich, KB; Ness, RB; Nevanlinna, H; Eilber, U; Odunsi, K; Olson, SH; Orlow, I; Orsulic, S; Weber, RP; Paul, J; Pearce, CL; Pejovic, T; Pelttari, LM; Pike, MC; Poole, EM; Risch, HA; Rosen, B; Rossing, MA; Rothstein, JH; Rudolph, A; Runnebaum, IB; Rzepecka, IK; Salvesen, HB; Schernhammer, E; Schwaab, I; Shu, XO; Shvetsov, YB; Siddiqui, N; Sieh, W; Song, H; Southey, MC; Spiewankiewicz, B; Sucheston, L; Teo, SH; Terry, KL; Thompson, PJ; Thomsen, L; Tangen, IL; Tworoger, SS; van Altena, AM; Vierkant, RA; Vergote, I; Walsh, CS; Wang-Gohrke, S; Wentzensen, N; Whittemore, AS; Wicklund, KG; Wilkens, LR; Wu, AH; Wu, XF; Woo, YL; Yang, HN; Zheng, W; Ziogas, A; Hasmad, HN; Berchuck, A; Iversen, ES; Schildkraut, JM; Ramus, SJ; Goode, EL; Monteiro, ANA; Gayther, SA; Narod, SA; Pharoah, PP; Sellers, TA; Phelan, CM				Chornokur, Ganna; Lin, Hui-Yi; Tyrer, Jonathan P.; Lawrenson, Kate; Dennis, Joe; Amankwah, Ernest K.; Qu, Xiaotao; Tsai, Ya-Yu; Jim, Heather S. L.; Chen, Zhihua; Chen, Ann Y.; Permuth-Wey, Jennifer; Aben, Katja K. H.; Anton-Culver, Hoda; Antonenkova, Natalia; Bruinsma, Fiona; Bandera, Elisa V.; Bean, Yukie T.; Beckmann, Matthias W.; Bisogna, Maria; Bjorge, Line; Bogdanova, Natalia; Brinton, Louise A.; Brooks-Wilson, Angela; Bunker, Clareann H.; Butzow, Ralf; Campbell, Ian G.; Carty, Karen; Chang-Claude, Jenny; Cook, Linda S.; Cramer, Daniel W.; Cunningham, Julie M.; Cybulski, Cezary; Dansonka-Mieszkowska, Agnieszka; du Bois, Andreas; Despierre, Evelyn; Dicks, Ed; Doherty, Jennifer A.; Dork, Thilo; Durst, Matthias; Easton, Douglas F.; Eccles, Diana M.; Edwards, Robert P.; Ekici, Arif B.; Fasching, Peter A.; Fridley, Brooke L.; Gao, Yu-Tang; Gentry-Maharaj, Aleksandra; Giles, Graham G.; Glasspool, Rosalind; Goodman, Marc T.; Gronwald, Jacek; Harrington, Patricia; Harter, Philipp; Hein, Alexander; Heitz, Florian; Hildebrandt, Michelle A. T.; Hillemanns, Peter; Hogdall, Claus K.; Hogdall, Estrid; Hosono, Satoyo; Jakubowska, Anna; Jensen, Allan; Ji, Bu-Tian; Karlan, Beth Y.; Kelemen, Linda E.; Kellar, Mellissa; Kiemeney, Lambertus A.; Krakstad, Camilla; Kjaer, Susanne K.; Kupryjanczyk, Jolanta; Lambrechts, Diether; Lambrechts, Sandrina; Le, Nhu D.; Lee, Alice W.; Lele, Shashi; Leminen, Arto; Lester, Jenny; Levine, Douglas A.; Liang, Dong; Lim, Boon Kiong; Lissowska, Jolanta; Lu, Karen; Lubinski, Jan; Lundvall, Lene; Massuger, Leon F. A. G.; Matsuo, Keitaro; McGuire, Valerie; McLaughlin, John R.; McNeish, Iain; Menon, Usha; Milne, Roger L.; Modugno, Francesmary; Moysich, Kirsten B.; Ness, Roberta B.; Nevanlinna, Heli; Eilber, Ursula; Odunsi, Kunle; Olson, Sara H.; Orlow, Irene; Orsulic, Sandra; Weber, Rachel Palmieri; Paul, James; Pearce, Celeste L.; Pejovic, Tanja; Pelttari, Liisa M.; Pike, Malcolm C.; Poole, Elizabeth M.; Risch, Harvey A.; Rosen, Barry; Rossing, Mary Anne; Rothstein, Joseph H.; Rudolph, Anja; Runnebaum, Ingo B.; Rzepecka, Iwona K.; Salvesen, Helga B.; Schernhammer, Eva; Schwaab, Ira; Shu, Xiao-Ou; Shvetsov, Yurii B.; Siddiqui, Nadeem; Sieh, Weiva; Song, Honglin; Southey, Melissa C.; Spiewankiewicz, Beata; Sucheston, Lara; Teo, Soo-Hwang; Terry, Kathryn L.; Thompson, Pamela J.; Thomsen, Lotte; Tangen, Ingvild L.; Tworoger, Shelley S.; van Altena, Anne M.; Vierkant, Robert A.; Vergote, Ignace; Walsh, Christine S.; Wang-Gohrke, Shan; Wentzensen, Nicolas; Whittemore, Alice S.; Wicklund, Kristine G.; Wilkens, Lynne R.; Wu, Anna H.; Wu, Xifeng; Woo, Yin-Ling; Yang, Hannah; Zheng, Wei; Ziogas, Argyrios; Hasmad, Hanis N.; Berchuck, Andrew; Iversen, Edwin S.; Schildkraut, Joellen M.; Ramus, Susan J.; Goode, Ellen L.; Monteiro, Alvaro N. A.; Gayther, Simon A.; Narod, Steven A.; Pharoah, Pauld. P.; Sellers, Thomas A.; Phelan, Catherine M.		Georgia Chenevix-Trench AOCS Ma	Common Genetic Variation In Cellular Transport Genes and Epithelial Ovarian Cancer (EOC) Risk	PLOS ONE			English	Article							UDP-GLUCURONOSYLTRANSFERASES; IRON TRANSPORT; FAMILY SLC25; COLON-CANCER; ASSOCIATION; EXPRESSION; POLYMORPHISM; HEPHAESTIN; CARCINOMA; PROTEINS	Background Defective cellular transport processes can lead to aberrant accumulation of trace elements, iron, small molecules and hormones in the cell, which in turn may promote the formation of reactive oxygen species, promoting DNA damage and aberrant expression of key regulatory cancer genes. As DNA damage and uncontrolled proliferation are hallmarks of cancer, including epithelial ovarian cancer (EOC), we hypothesized that inherited variation in the cellular transport genes contributes to EOC risk. Methods In total, DNA samples were obtained from 14,525 case subjects with invasive EOC and from 23,447 controls from 43 sites in the Ovarian Cancer Association Consortium (OCAC). Two hundred seventy nine SNPs, representing 131 genes, were genotyped using an Illumina Infinium iSelect BeadChip as part of the Collaborative Oncological Gene-environment Study (COGS). SNP analyses were conducted using unconditional logistic regression under a log-additive model, and the FDR q<0.2 was applied to adjust for multiple comparisons. Results The most significant evidence of an association for all invasive cancers combined and for the serous subtype was observed for SNP rs17216603 in the iron transporter gene HEPH (invasive: OR = 0.85, P = 0.00026; serous: OR = 0.81, P = 0.00020); this SNP was also associated with the borderline/low malignant potential (LMP) tumors (P = 0.021). Other genes significantly associated with EOC histological subtypes (p<0.05) included the UGT1A (endometrioid), SLC25A45 (mucinous), SLC39A11 (low malignant potential), and SERPINA7 (clear cell carcinoma). In addition, 1785 SNPs in six genes (HEPH, MGST1, SERPINA, SLC25A45, SLC39A11 and UGT1A) were imputed from the 1000 Genomes Project and examined for association with INV EOC in white-European subjects. The most significant imputed SNP was rs117729793 in SLC39A11 (per allele, OR = 2.55, 95% CI = 1.5-4.35, p = 5.66x10(-4)). Conclusion These results, generated on a large cohort of women, revealed associations between inherited cellular transport gene variants and risk of EOC histologic subtypes.	[Chornokur, Ganna; Amankwah, Ernest K.; Tsai, Ya-Yu; Permuth-Wey, Jennifer; Monteiro, Alvaro N. A.; Sellers, Thomas A.; Phelan, Catherine M.] H Lee Moffitt Canc Ctr & Res Inst, Div Populat Sci, Dept Canc Epidemiol, Tampa, FL 33612 USA; [Lin, Hui-Yi; Qu, Xiaotao; Chen, Zhihua; Chen, Ann Y.] H Lee Moffitt Canc Ctr & Res Inst, Dept Biostat & Bioinformat, Tampa, FL USA; [Tyrer, Jonathan P.; Dicks, Ed; Song, Honglin; Pharoah, Pauld. P.] Univ Cambridge, Strangeways Res Lab, Dept Oncol, Cambridge, England; [Lawrenson, Kate; Dennis, Joe; Easton, Douglas F.; Lee, Alice W.; Pearce, Celeste L.; Pike, Malcolm C.; Wu, Anna H.; Ramus, Susan J.; Gayther, Simon A.] Univ So Calif, Dept Prevent Med, Keck Sch Med, Norris Comprehens Canc Ctr, Los Angeles, CA 90089 USA; [Amankwah, Ernest K.] All Childrens Hosp Johns Hopkins Med, Clin & Translat Res Org, St Petersburg, FL USA; [Jim, Heather S. L.] H Lee Moffitt Canc Ctr & Res Inst, Dept Hlth Outcomes & Behav, Tampa, FL USA; [Aben, Katja K. H.; Kiemeney, Lambertus A.] Radboud Univ Nijmegen Med Ctr, Radboud Inst Hlth Sci, Nijmegen, Netherlands; [Aben, Katja K. H.] Comprehens Canc Ctr Netherlands, Nijmegen, Netherlands; [Anton-Culver, Hoda; Ziogas, Argyrios] Univ Calif Irvine, Genet Epidemiol Res Inst, Ctr Canc Genet Res & Prevent, Irvine, CA USA; [Antonenkova, Natalia] NN Alexandrov Natl Canc Ctr Belarus, Minsk, BELARUS; [Bruinsma, Fiona; Giles, Graham G.; Milne, Roger L.] Canc Council Victoria, Canc Epidemiol Ctr, Melbourne, Australia; [Bandera, Elisa V.; Bean, Yukie T.] Rutgers Canc Inst New Jersey, Canc Prevent & Control Program, New Brunswick, NJ USA; [Kellar, Mellissa; Pejovic, Tanja] Oregon Hlth & Sci Univ, Dept Obstet & Gynecol, Portland, OR 97201 USA; [Bean, Yukie T.; Kellar, Mellissa; Pejovic, Tanja] Oregon Hlth & Sci Univ, Knight Canc Inst, Portland, OR 97201 USA; [Beckmann, Matthias W.; Fasching, Peter A.; Hein, Alexander] Univ Erlangen Nurnberg, Univ Hosp Erlangen, Dept Gynecol & Obstet, Erlangen Nuremberg Comprehens Canc Ctr,Erlangen E, D-91054 Erlangen, Germany; [Bisogna, Maria; Levine, Douglas A.] Mem Sloan Kettering Canc Ctr, Gynecol Serv, Dept Surg, New York, NY 10021 USA; [Bjorge, Line; Krakstad, Camilla; Salvesen, Helga B.; Tangen, Ingvild L.] Haukeland Hosp, Dept Gynecol & Obstet, N-5021 Bergen, Norway; [Bjorge, Line; Krakstad, Camilla; Salvesen, Helga B.; Tangen, Ingvild L.] Univ Bergen, Dept Clin Med, Ctr Canc Biomarkers, Bergen, Norway; [Bogdanova, Natalia] Hannover Med Sch, Radiat Oncol Res Unit, Hannover, Germany; [Brinton, Louise A.; Ji, Bu-Tian; Wentzensen, Nicolas; Yang, Hannah] NCI, Div Canc Epidemiol & Genet, Bethesda, MD 20892 USA; [Brooks-Wilson, Angela] BC Canc Agcy, Canadas Michael Smith Genome Sci Ctr, Vancouver, BC, Canada; [Brooks-Wilson, Angela] Simon Fraser Univ, Dept Biomed Physiol & Kinesiol, Burnaby, BC V5A 1S6, Canada; [Bunker, Clareann H.; Modugno, Francesmary] Univ Pittsburgh, Dept Epidemiol, Grad Sch Publ Hlth, Pittsburgh, PA 15261 USA; [Butzow, Ralf; Leminen, Arto; Nevanlinna, Heli; Pelttari, Liisa M.] Univ Helsinki, Dept Obstet & Gynecol, Helsinki, Finland; [Butzow, Ralf; Leminen, Arto; Nevanlinna, Heli; Pelttari, Liisa M.] Univ Helsinki, Cent Hosp, Helsinki, Finland; [Butzow, Ralf] Univ Helsinki, Cent Hosp, Dept Pathol, Helsinki, Finland; [Campbell, Ian G.] Peter MacCallum Canc Ctr, Canc Genet Lab, Div Res, St Andrews, Australia; [Campbell, Ian G.; Southey, Melissa C.] Univ Melbourne, Dept Pathol, Parkville, Vic 3052, Australia; [Campbell, Ian G.] Univ Melbourne, Sir Peter MacCallum Dept Oncol, Parkville, Vic 3052, Australia; [Carty, Karen; Siddiqui, Nadeem] Glasgow Royal Infirm, Dept Gynaecol Oncol, Glasgow G4 0SF, Lanark, Scotland; [Carty, Karen; Glasspool, Rosalind; Paul, James] Beatson West Scotland Canc Ctr, Glasgow, Lanark, Scotland; [Chang-Claude, Jenny; Eilber, Ursula; Rudolph, Anja; Wang-Gohrke, Shan] German Canc Res Ctr, Div Canc Epidemiol, Heidelberg, Germany; [Cook, Linda S.] Univ New Mexico, Div Epidemiol & Biostat, Dept Internal Med, Albuquerque, NM 87131 USA; [Cramer, Daniel W.; Terry, Kathryn L.; Tworoger, Shelley S.] Brigham & Womens Hosp, Obstet & Gynecol Ctr, Boston, MA 02115 USA; [Cramer, Daniel W.; Terry, Kathryn L.; Tworoger, Shelley S.] Harvard Univ, Sch Med, Boston, MA USA; [Cunningham, Julie M.] Mayo Clin, Dept Lab Med & Pathol, Rochester, MN USA; [Cybulski, Cezary; Gronwald, Jacek; Jakubowska, Anna; Lubinski, Jan] Pomeranian Med Univ, Int Hereditary Canc Ctr, Dept Genet & Pathol, Szczecin, Poland; [Dansonka-Mieszkowska, Agnieszka; Kupryjanczyk, Jolanta; Rzepecka, Iwona K.] Maria Sklodowska Curie Mem Canc Ctr, Dept Pathol, Warsaw, Poland; [Dansonka-Mieszkowska, Agnieszka; Kupryjanczyk, Jolanta; Rzepecka, Iwona K.] Inst Oncol, Warsaw, Poland; [du Bois, Andreas; Harter, Philipp; Heitz, Florian] Knappschaft GmbH, Dept Gynaecol & Gynaecol Oncol, Kliniken Essen Mitte Evang Huyssens Stiftung, Essen, Germany; [du Bois, Andreas; Harter, Philipp; Heitz, Florian] Dr Horst Schmidt Kliniken Wiesbaden, Dept Gynaecol & Gynaecol Oncol, Wiesbaden, Germany; [Despierre, Evelyn; Lambrechts, Sandrina; Vergote, Ignace] Univ Hosp Leuven, Div Gynecol Oncol, Dept Obstet & Gynaecol, Leuven, Belgium; [Despierre, Evelyn; Lambrechts, Sandrina; Vergote, Ignace] Univ Hosp Leuven, Leuven Canc Inst, Leuven, Belgium; [Harrington, Patricia] Univ Cambridge, Dept Oncol, Strangeways Res Lab, Ctr Canc Epidemiol, Cambridge, England; [Doherty, Jennifer A.] Geisel Sch Med, Dept Epidemiol, Hanover, NH USA; [Doherty, Jennifer A.; Rossing, Mary Anne; Wicklund, Kristine G.] Univ Washington, Program Epidemiol, Div Publ Hlth Sci, Fred Hutchinson Canc Res Ctr, Seattle, WA 98195 USA; [Dork, Thilo; Hillemanns, Peter] Hannover Med Sch, Gynaecol Res Unit, Hannover, Germany; [Durst, Matthias; Runnebaum, Ingo B.] Univ Jena, Jena Univ Hosp, Dept Gynecol, Jena, Germany; [Easton, Douglas F.] Univ Cambridge, Dept Oncol, Ctr Canc Genet Epidemiol, Cambridge, England; [Eccles, Diana M.] Univ Southampton, Fac Med, Southampton SO9 5NH, Hants, England; [Edwards, Robert P.] Magee Womens Res Inst, Ovarian Canc Ctr Excellence, Womens Canc Res Program, Pittsburgh, PA USA; [Edwards, Robert P.] Univ Pittsburgh, Inst Canc, Pittsburgh, PA USA; [Ekici, Arif B.] Univ Erlangen Nurnberg, Inst Human Genet, Comprehens Canc Ctr Erlangen Nuremberg, D-91054 Erlangen, Germany; [Fasching, Peter A.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Div Hematol & Oncol, Los Angeles, CA 90095 USA; [Fridley, Brooke L.] Univ Kansas, Med Ctr, Biostat & Informat Shared Resource, Kansas City, KS 66103 USA; [Gao, Yu-Tang] Shanghai Canc Inst, Dept Epidemiol, Shanghai, Peoples R China; [Gentry-Maharaj, Aleksandra; Menon, Usha] UCL, Inst Womens Hlth, Womens Canc, London, England; [Giles, Graham G.] Univ Melbourne, Ctr Epidemiol & Biostat, Sch Populat & Global Hlth, Melbourne, Australia; [Goodman, Marc T.; Thompson, Pamela J.] Cedars Sinai Med Ctr, Canc Prevent & Control Samuel Oschin Comprehens C, Los Angeles, CA 90048 USA; [Goodman, Marc T.; Thompson, Pamela J.] Cedars Sinai Med Ctr, Community & Populat Hlth Res Inst, Dept Biomed Sci, Los Angeles, CA 90048 USA; [Hildebrandt, Michelle A. T.; Wu, Xifeng] Univ Texas MD Anderson Canc Ctr, Dept Epidemiol, Houston, TX 77030 USA; [Hogdall, Estrid] Univ Copenhagen, Mol Unit, Dept Pathol, Herlev Hosp, Copenhagen, Denmark; [Hogdall, Estrid; Jensen, Allan; Kjaer, Susanne K.] Danish Canc Soc Res Ctr, Dept Virus Lifestyle & Genes, Copenhagen, Denmark; [Hosono, Satoyo; Matsuo, Keitaro] Kyushu Univ, Dept Prevent Med, Fac Med Sci, Nagoya, Aichi, Japan; [Karlan, Beth Y.; Lester, Jenny; Orsulic, Sandra; Walsh, Christine S.] Cedars Sinai Med Ctr, Womens Canc Program, Samuel Oschin Comprehens Canc Inst, Los Angeles, CA 90048 USA; [Kelemen, Linda E.] Med Univ S Carolina, Dept Publ Hlth Sci, Charleston, SC 29425 USA; [Kjaer, Susanne K.] Univ Copenhagen, Dept Gynaecol, Rigshosp, Copenhagen, Denmark; [Hogdall, Claus K.; Lundvall, Lene] Univ Copenhagen, Dept Gynaecol, Juliane Marie Ctr, Righosp, Copenhagen, Denmark; [Lambrechts, Diether] VIB, Vesalius Res Ctr, Leuven, Belgium; [Lambrechts, Diether] Univ Leuven, Dept Oncol, Lab Translat Genet, Louvain, Belgium; [Le, Nhu D.] BC Canc Agcy, Canc Control Res, Vancouver, BC, Canada; [Lele, Shashi; Moysich, Kirsten B.; Sucheston, Lara] Roswell Pk Canc Inst, Dept Canc Prevent & Control, Buffalo, NY 14263 USA; [Liang, Dong] Texas So Univ, Coll Pharm & Hlth Sci, Houston, TX 77004 USA; [Lim, Boon Kiong; Woo, Yin-Ling] Univ Malaya, Dept Obstet & Gynaecol, Med Ctr, Kuala Lumpur, Malaysia; [Lissowska, Jolanta] M Sklodowska Curie Mem Canc Ctr, Dept Canc Epidemiol & Prevent, Warsaw, Poland; [Lissowska, Jolanta] Inst Oncol, Warsaw, Poland; [Lu, Karen] Univ Texas MD Anderson Canc Ctr, Dept Gynecol Oncol, Houston, TX 77030 USA; [Massuger, Leon F. A. G.; van Altena, Anne M.] Radboud Univ Nijmegen, Med Ctr, Dept Gynaecol, Nijmegen, Netherlands; [McGuire, Valerie] Stanford Univ, Dept Hlth Res & Policy Epidemiol, Sch Med, Stanford, CA 94305 USA; [McLaughlin, John R.] Publ Hlth Ontario, Toronto, ON, Canada; [McNeish, Iain] Univ Glasgow, Inst Canc Sci, Wolfson Wohl Canc Res Ctr, Beatson Inst Canc Res, Glasgow, Lanark, Scotland; [Modugno, Francesmary] Magee Womens Res Inst, Womens Canc Res Program, Pittsburgh, PA USA; [Modugno, Francesmary] Univ Pittsburgh, Inst Canc, Pittsburgh, PA USA; [Modugno, Francesmary] Univ Pittsburgh, Dept Obstet Gynecol & Reprod Sci, Sch Med, Pittsburgh, PA USA; [Thomsen, Lotte] Univ Copenhagen, Dept Pathol, Rigshosp, Copenhagen, Denmark; [Ness, Roberta B.] Univ Texas Houston, Sch Publ Hlth, Houston, TX USA; [Odunsi, Kunle] Roswell Pk Canc Inst, Dept Gynecol Oncol, Buffalo, NY 14263 USA; [Olson, Sara H.; Orlow, Irene; Pike, Malcolm C.] Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, New York, NY 10021 USA; [Weber, Rachel Palmieri] Duke Univ, Med Ctr, Dept Community & Family Med, Durham, NC 27710 USA; [Pearce, Celeste L.] Univ Michigan, Dept Epidemiol, Sch Publ Hlth, Ann Arbor, MI 48109 USA; [Poole, Elizabeth M.; Schernhammer, Eva] Brigham & Womens Hosp, Channing Div Network Med, Boston, MA 02115 USA; [Poole, Elizabeth M.; Schernhammer, Eva; Tworoger, Shelley S.] Harvard Univ, Sch Med, Boston, MA USA; [Risch, Harvey A.] Yale Sch Publ Hlth, Dept Chron Dis Epidemiol, New Haven, CT USA; [Rosen, Barry] Univ Toronto, Fac Med, Dept Gynecol Oncol, Princess Margaret Hosp, Toronto, ON, Canada; [Rosen, Barry] Univ Toronto, Fac Med, Dept Obstet & Gynecol, Toronto, ON, Canada; [Rothstein, Joseph H.; Sieh, Weiva; Whittemore, Alice S.] Stanford Univ, Dept Hlth Res & Policy Epidemiol, Sch Med, Stanford, CA 94305 USA; [Schwaab, Ira] Inst Human Genet & Anthropol, Wiesbaden, Germany; [Shu, Xiao-Ou] Vanderbilt Univ, Epidemiol Ctr & Vanderbilt, Ingram Canc Ctr, Sch Med, Nashville, TN 37235 USA; [Shvetsov, Yurii B.; Wilkens, Lynne R.] Univ Hawaii, Canc Epidemiol Program, Ctr Canc, Honolulu, HI 96822 USA; [Spiewankiewicz, Beata] Maria Sklodowska Curie Mem Canc Ctr, Dept Gynecol Oncol, Warsaw, Poland; [Spiewankiewicz, Beata] Inst Oncol, Warsaw, Poland; [Teo, Soo-Hwang; Hasmad, Hanis N.] Canc Res Initiat Fdn, Sime Darby Med Ctr, Subang Jaya, Malaysia; [Teo, Soo-Hwang] Univ Malaya, Med Ctr, Canc Res Inst, Kuala Lumpur, Malaysia; [Vierkant, Robert A.] Mayo Clin, Div Biomed Stat & Informat, Dept Hlth Sci Res, Rochester, MN USA; [Zheng, Wei] Vanderbilt Univ, Vanderbilt Epidemiol Ctr, Sch Med, Nashville, TN 37235 USA; [Berchuck, Andrew] Duke Univ, Med Ctr, Dept Obstet & Gynecol, Durham, NC 27710 USA; QIMR, Berghofer Med Res Inst, Brisbane, Qld, Australia; [Georgia Chenevix-Trench AOCS Ma] Peter MacCallum Canc Ctr, East Melbourne, Australia; [Iversen, Edwin S.] Duke Univ, Dept Stat, Durham, NC USA; [Schildkraut, Joellen M.] Duke Canc Inst, Canc Prevent Detect & Control Res Program, Durham, NC USA; [Goode, Ellen L.] Mayo Clin, Dept Hlth Sci Res, Div Epidemiol, Rochester, MN USA; [Narod, Steven A.] Univ Toronto, Womens Coll Res Inst, Toronto, ON, Canada; [Pharoah, Pauld. P.] Univ Cambridge, Dept Publ Hlth & Primary Care, Cambridge, England	H Lee Moffitt Cancer Center & Research Institute; H Lee Moffitt Cancer Center & Research Institute; University of Cambridge; University of Southern California; Johns Hopkins University; Johns Hopkins Medicine; H Lee Moffitt Cancer Center & Research Institute; Radboud University Nijmegen; University of California System; University of California Irvine; Cancer Council Victoria; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers Cancer Institute of New Jersey; Oregon Health & Science University; Oregon Health & Science University; University of Erlangen Nuremberg; Memorial Sloan Kettering Cancer Center; University of Bergen; Haukeland University Hospital; University of Bergen; Hannover Medical School; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); British Columbia Cancer Agency; Simon Fraser University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; Helsinki University Central Hospital; Peter Maccallum Cancer Center; University of Melbourne; Peter Maccallum Cancer Center; University of Melbourne; University of Glasgow; Beatson Oncology Centre; Helmholtz Association; German Cancer Research Center (DKFZ); University of New Mexico; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Mayo Clinic; Pomeranian Medical University; Maria Sklodowska-Curie National Research Institute of Oncology; Maria Sklodowska-Curie National Research Institute of Oncology; Kliniken Essen-Mitte; KU Leuven; University Hospital Leuven; KU Leuven; University Hospital Leuven; University of Cambridge; Dartmouth College; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; Hannover Medical School; Friedrich Schiller University of Jena; University of Cambridge; University of Southampton; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Magee-Womens Research Institute; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Erlangen Nuremberg; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Kansas; University of Kansas Medical Center; Shanghai Jiao Tong University; University of London; University College London; University of Melbourne; Cedars Sinai Medical Center; Cedars Sinai Medical Center; University of Texas System; UTMD Anderson Cancer Center; University of Copenhagen; Herlev & Gentofte Hospital; Danish Cancer Society; Kyushu University; Cedars Sinai Medical Center; Medical University of South Carolina; Rigshospitalet; University of Copenhagen; University of Copenhagen; Flanders Institute for Biotechnology (VIB); KU Leuven; British Columbia Cancer Agency; Roswell Park Cancer Institute; Texas Southern University; Universiti Malaya; Maria Sklodowska-Curie National Research Institute of Oncology; Maria Sklodowska-Curie National Research Institute of Oncology; University of Texas System; UTMD Anderson Cancer Center; Radboud University Nijmegen; Stanford University; Beatson Institute; University of Glasgow; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Magee-Womens Research Institute; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Rigshospitalet; University of Copenhagen; University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health; Roswell Park Cancer Institute; Memorial Sloan Kettering Cancer Center; Duke University; University of Michigan System; University of Michigan; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Yale University; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto; Stanford University; Vanderbilt University; Cancer Research Center of Hawaii; University of Hawaii System; Maria Sklodowska-Curie National Research Institute of Oncology; Maria Sklodowska-Curie National Research Institute of Oncology; Universiti Malaya; Mayo Clinic; Vanderbilt University; Duke University; QIMR Berghofer Medical Research Institute; Peter Maccallum Cancer Center; Duke University; Duke University; Mayo Clinic; University of Toronto; University Toronto Affiliates; Womens College Hospital; University of Cambridge	Phelan, CM (corresponding author), H Lee Moffitt Canc Ctr & Res Inst, Div Populat Sci, Dept Canc Epidemiol, Tampa, FL 33612 USA.	catherine.phelan@moffitt.org	Rzepecka, Iwona K/AFO-1670-2022; Hein, Alexander/F-6999-2010; Zheng, Wei/O-3351-2013; Dörk, Thilo/J-8620-2012; Fasching, Peter A/ABH-9912-2020; Pharoah, Paul/V-6658-2019; Wentzensen, Nicolas/AAG-8522-2019; Kiemeney, Lambertus A./D-3357-2009; Bandera, Elisa V/M-4169-2014; gao, yi/HCI-8298-2022; Lambrechts, Diether/AAJ-3167-2020; Krakstad, Camilla/AAB-5138-2020; Bjorge, Line/C-1307-2017; Woo, Yin Ling/GPX-0086-2022; Bjorge, Line/AAD-6179-2021; Bogdanova, Natalia V./Y-2205-2019; campbell, Ian G/F-6006-2011; Ramus, Susan/AAG-8352-2019; Monteiro, Alvaro N. A./A-7566-2009; Gronwald, Jacek/A-4576-2017; salvesen, Helga B/C-1187-2017; Schernhammer, Eva S/L-7898-2018; Eccles, Diana/K-6327-2019; Haviv, Izhak/E-3782-2015; Narod, Steven A/AAA-6112-2022; Shvetsov, Yurii/ABA-3196-2020; Teo, Soo-hwang/H-2353-2014; Bowtell, David/H-1007-2016; van Altena, Anne M/B-9824-2016; Massuger, Leon F.A.G./H-8072-2014; Woo, Yin Ling/B-5198-2010; Gao, Yu/HGE-1937-2022; Brooks-Wilson, Angela/E-9399-2012; Menon, Usha/C-4716-2008; jones, Rob j/N-9379-2017; Modugno, Francesmary/AIB-6722-2022; zhang, weihua/GXV-1334-2022; Vierkant, Robert/AAP-4927-2020; Jim, Heather/T-2957-2019; Jakubowska, Anna/O-8050-2014; Aben, Katja KH/G-9686-2016; Gao, Y./GWZ-3665-2022; Ekici, Arif B/C-3971-2013; Lissowska, Jolanta/AAH-3252-2020; Matsuo, Keitaro/H-6758-2019	Hein, Alexander/0000-0003-2601-3398; Zheng, Wei/0000-0003-1226-070X; Dörk, Thilo/0000-0002-9458-0282; Fasching, Peter A/0000-0003-4885-8471; Pharoah, Paul/0000-0001-8494-732X; Kiemeney, Lambertus A./0000-0002-2368-1326; Bandera, Elisa V/0000-0002-8789-2755; Lambrechts, Diether/0000-0002-3429-302X; Krakstad, Camilla/0000-0002-0174-8139; Bjorge, Line/0000-0002-0240-2770; Woo, Yin Ling/0000-0003-1742-1066; Bjorge, Line/0000-0002-0240-2770; Ramus, Susan/0000-0003-0005-7798; Monteiro, Alvaro N. A./0000-0002-8448-4801; Gronwald, Jacek/0000-0002-3643-2871; salvesen, Helga B/0000-0002-4438-8831; Schernhammer, Eva S/0000-0002-4337-9415; Eccles, Diana/0000-0002-9935-3169; Haviv, Izhak/0000-0002-0837-5005; Bowtell, David/0000-0001-9089-7525; Woo, Yin Ling/0000-0003-1742-1066; Brooks-Wilson, Angela/0000-0003-1009-6408; Menon, Usha/0000-0003-3708-1732; Vierkant, Robert/0000-0001-6242-5221; Jakubowska, Anna/0000-0002-5650-0501; Aben, Katja KH/0000-0002-0214-2147; Ekici, Arif B/0000-0001-6099-7066; Lissowska, Jolanta/0000-0003-2695-5799; Matsuo, Keitaro/0000-0003-1761-6314; Dansonka-Mieszkowska, Agnieszka/0000-0002-2482-6523; Weber, Rachel/0000-0001-7119-7734; Campbell, Ian/0000-0002-7773-4155; Olson, Sara/0000-0003-0182-2754; Paul, James/0000-0001-7367-5816; Hogdall, Estrid/0000-0003-4689-5658; McNeish, Iain/0000-0002-9387-7586; Orlow, Irene/0000-0001-6234-6961; Lawrenson, Kate/0000-0002-6469-2515; Kupryjanczyk, Jolanta/0000-0001-5820-0214; Giles, Graham/0000-0003-4946-9099; Levine, Douglas/0000-0003-1038-8232; Heitz, Florian/0000-0002-2412-0352; Goodman, Marc/0000-0002-4839-3021; Lubinski, Jan/0000-0003-2931-3003; Southey, Melissa/0000-0002-6313-9005; Pelttari, Liisa/0000-0001-8091-9751; Lin, Hui-Yi/0000-0002-3307-5549; Jensen, Allan/0000-0001-8124-4880; Lee, Alice/0000-0001-8756-7066; Glasspool, Rosalind/0000-0002-5000-1680; Chenevix-Trench, Georgia/0000-0002-1878-2587; Kjaer, Susanne/0000-0002-8347-1398; Hogdall, Claus/0000-0002-5959-8874; Rzepecka, Iwona Krystyna/0000-0001-7305-6687	NIH [R01 CA-1491429]; European Commission [223175 HEALTH F2 2009-223175]; Genetic Associations and Mechanisms in Oncology (GAME-ON); NCI Cancer Post-GWAS Initiative [U19-CA148112]; Ovarian Cancer Research Fund [PPD/RPCI.07]; National Health and Medical Research Council; Canadian Institute of Health Research New Investigator Award [MSH-87734]; NIEHS T32 training grant [T32ES013678]; California Cancer Research Program [00-01389V- 20170, N01-CN25403, 2II0200]; Canadian Institutes of Health Research [MOP-86727]; Cancer Australia; Cancer Council Victoria; Cancer Council Queensland; Cancer Council New South Wales; Cancer Council South Australia; Cancer Council Tasmania; Cancer Foundation of Western Australia; Cancer Institute of New Jersey; Cancer Research UK [C490/A6187, C490/A10119, C490/A10124]; Danish Cancer Society [94-222-52]; ELAN Program of the University of Erlangen-Nuremberg; Eve Appeal; Helsinki University Central Hospital Research Fund; Helse Vest; Norwegian Cancer Society; Norwegian Research Council; Ovarian Cancer Research Fund; Nationaal Kankerplan of Belgium; Ministry of Health Labour and Welfare of Japan; L & S Milken Foundation; Polish Ministry of Science and Higher Education [4 PO5C 028 14, 2 PO5A 068 27]; Roswell Park Cancer Institute Alliance Foundation; US National Cancer Institute [K07-CA095666, K07-CA143047, K22-CA138563, N01-CN55424, N01-PC67001, N01-PC067010, N01-PC035137, P01-CA017054, P01-CA087696, P30-CA072720, P50-CA105009, P50-CA136393, R01-CA014089, R01-CA016056, R01-CA017054, R01-CA049449, R01-CA050385, R01-CA054419, R01-CA058598]; US Public Health Service [PSA-042205]; National Health and Medical Research Council of Australia [199600, 400281]; German Federal Ministry of Education and Research of Germany Programme of Clinical Biomedical Research [01GB 9401]; State of Baden-Wurttemberg through Medical Faculty of the University of Ulm [P.685]; Minnesota Ovarian Cancer Alliance; Mayo Foundation; Fred C. and Katherine B. Andersen Foundation; Lon V. Smith Foundation [LVS-39420]; Oak Foundation; OHSU Foundation; Rudolf-Bartling Foundation; UK National Institute for Health Research Biomedical Research Centres at the University of Cambridge, Imperial College London, University College Hospital "Womens Health Theme"; Royal Marsden Hospital; Mermaid I project; WorkSafeBC 14;  [R01-CA080978];  [R01-CA083918];  [R01-CA087538];  [R01-CA092044];  [R01-095023];  [R01-CA122443];  [R01-CA112523];  [R01-CA114343];  [R01-CA126841];  [R01-CA136924];  [R03-CA113148];  [R03-CA115195];  [U01-CA069417];  [U01-CA071966];  [R01-CA076016];  [R01-CA061132];  [R01-CA067262];  [R01-CA071766];  [R01-CA074850];  [R01-CA080742];  [R01-CA058860];  [R01-CA061107]; Cancer Research UK [16561, 15960] Funding Source: researchfish; The Francis Crick Institute [10124] Funding Source: researchfish; DIVISION OF CANCER CONTROL &POPULATION SCIENCE [N01PC067010, N01PC067001] Funding Source: NIH RePORTER; DIVISION OF CANCER PREVENTION AND CONTROL [N01CN055424] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [ZIACP010126, R01CA080742, R03CA115195, P30CA008748, K07CA095666, R01CA087696, R01CA122443, R01CA076016, K07CA143047, R01CA054419, R01CA080978, P30CA016056, UM1CA182910, R01CA074850, R03CA113148, U01CA069417, P50CA105009, P30CA016672, R01CA126841, P50CA136393, U01CA067262, P30CA072720, K22CA138563, P01CA017054, R01CA114343, R01CA058860, R01CA061132, R01CA061107, R21CA179659, U01CA071966, R01CA087538, P30CA076292, R01CA058598, U19CA148112, R01CA083918, R01CA067262, P30CA014089, R01CA112523, P30CA071789, R01CA050385, R01CA049449, R01CA136924, U01CA058860, U01CA049449] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000005] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES013678] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European Commission(European CommissionEuropean Commission Joint Research Centre); Genetic Associations and Mechanisms in Oncology (GAME-ON); NCI Cancer Post-GWAS Initiative; Ovarian Cancer Research Fund; National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Canadian Institute of Health Research New Investigator Award(Canadian Institutes of Health Research (CIHR)); NIEHS T32 training grant; California Cancer Research Program; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Cancer Australia; Cancer Council Victoria(Canadian Institutes of Health Research (CIHR)Cancer Council Victoria); Cancer Council Queensland(Cancer Council Queensland); Cancer Council New South Wales(Cancer Council New South Wales); Cancer Council South Australia(Cancer Council South Australia); Cancer Council Tasmania(Cancer Council Tasmania); Cancer Foundation of Western Australia(Cancer Council Western Australia); Cancer Institute of New Jersey; Cancer Research UK(Cancer Research UK); Danish Cancer Society(Danish Cancer Society); ELAN Program of the University of Erlangen-Nuremberg; Eve Appeal; Helsinki University Central Hospital Research Fund; Helse Vest; Norwegian Cancer Society(Norwegian Cancer Society); Norwegian Research Council(Research Council of NorwayEuropean Commission); Ovarian Cancer Research Fund; Nationaal Kankerplan of Belgium; Ministry of Health Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); L & S Milken Foundation; Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland); Roswell Park Cancer Institute Alliance Foundation; US National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); US Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); German Federal Ministry of Education and Research of Germany Programme of Clinical Biomedical Research; State of Baden-Wurttemberg through Medical Faculty of the University of Ulm; Minnesota Ovarian Cancer Alliance; Mayo Foundation; Fred C. and Katherine B. Andersen Foundation; Lon V. Smith Foundation; Oak Foundation; OHSU Foundation; Rudolf-Bartling Foundation; UK National Institute for Health Research Biomedical Research Centres at the University of Cambridge, Imperial College London, University College Hospital "Womens Health Theme"; Royal Marsden Hospital(Royal Society of New ZealandMarsden Fund (NZ)); Mermaid I project; WorkSafeBC 14; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; Cancer Research UK(Cancer Research UK); The Francis Crick Institute; DIVISION OF CANCER CONTROL &POPULATION SCIENCE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)NIH National Cancer Institute- Division of Cancer Control & Population Sciences); DIVISION OF CANCER PREVENTION AND CONTROL(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	The scientific development and funding for this project were funded by the following: NIH R01 CA-1491429 (Phelan PI); the US National Cancer Institute (R01-CA076016); the COGS project is funded through a European Commission's Seventh Framework Programme grant (agreement number 223175 HEALTH F2 2009-223175); the Genetic Associations and Mechanisms in Oncology (GAME-ON): a NCI Cancer Post-GWAS Initiative (U19-CA148112); the Ovarian Cancer Association Consortium is supported by a grant from the Ovarian Cancer Research Fund thanks to donations by the family and friends of Kathryn Sladek Smith (PPD/RPCI.07). Investigator-specific funding: GCT is supported by the National Health and Medical Research Council; BK holds an ACS Early Detection Professorship (SIOP-06-258-01-COUN); LEK is supported by a Canadian Institute of Health Research New Investigator Award (MSH-87734). AWL is supported by NIEHS T32 training grant (T32ES013678). Funding of included studies: Funding of the constituent studies was provided by the California Cancer Research Program (00-01389V- 20170, N01-CN25403, 2II0200); the Canadian Institutes of Health Research (MOP-86727); Cancer Australia; Cancer Council Victoria; Cancer Council Queensland; Cancer Council New South Wales; Cancer Council South Australia; Cancer Council Tasmania; Cancer Foundation of Western Australia; the Cancer Institute of New Jersey; Cancer Research UK (C490/A6187, C490/A10119, C490/A10124); the Danish Cancer Society (94-222-52); the ELAN Program of the University of Erlangen-Nuremberg; the Eve Appeal; the Helsinki University Central Hospital Research Fund; Helse Vest; the Norwegian Cancer Society; the Norwegian Research Council; the Ovarian Cancer Research Fund; Nationaal Kankerplan of Belgium; Grant-in-Aid for the Third Term Comprehensive 10-Year Strategy For Cancer Control from the Ministry of Health Labour and Welfare of Japan; the L & S Milken Foundation; the Polish Ministry of Science and Higher Education (4 PO5C 028 14, 2 PO5A 068 27); the Roswell Park Cancer Institute Alliance Foundation; the US National Cancer Institute (K07-CA095666, K07-CA143047, K22-CA138563, N01-CN55424, N01-PC67001, N01-PC067010, N01-PC035137, P01-CA017054, P01-CA087696, P30-CA072720, P50-CA105009, P50-CA136393, R01-CA014089, R01-CA016056, R01-CA017054, R01-CA049449, R01-CA050385, R01-CA054419, R01-CA058598, R01-CA058860, R01-CA061107, R01-CA061132, R01-CA067262, R01-CA071766, R01-CA074850, R01-CA080742, R01-CA080978, R01-CA083918, R01-CA087538, R01-CA092044, R01-095023, R01-CA122443, R01-CA112523, R01-CA114343, R01-CA126841, R01-CA136924, R03-CA113148, R03-CA115195, U01-CA069417, U01-CA071966 and Intramural research funds); the US Army Medical Research and Material Command (DAMD17-01-1-0729, DAMD17-02-1-0666, DAMD17-02-1-0669, W81XWH-07-0449, W81XWH-10-1-02802); the US Public Health Service (PSA-042205); The National Health and Medical Research Council of Australia (199600 and 400281); the German Federal Ministry of Education and Research of Germany Programme of Clinical Biomedical Research (01GB 9401); the State of Baden-Wurttemberg through Medical Faculty of the University of Ulm (P.685); the Minnesota Ovarian Cancer Alliance; the Mayo Foundation; the Fred C. and Katherine B. Andersen Foundation; the Lon V.; Smith Foundation (LVS-39420); the Oak Foundation; the OHSU Foundation; the Mermaid I project; the Rudolf-Bartling Foundation; the UK National Institute for Health Research Biomedical Research Centres at the University of Cambridge, Imperial College London, University College Hospital "Womens Health Theme" and the Royal Marsden Hospital; WorkSafeBC 14.	Abu E, 2013, BRIEF BIOINFORM, DOI [10.1093/bib/bbt004, DOI 10.1093/BIB/BBT004]; Anderson AS, 2013, EXP CELL RES, V319, P1431, DOI 10.1016/j.yexcr.2013.02.017; Araki J, 2005, EUR J CANCER, V41, P2360, DOI 10.1016/j.ejca.2005.04.043; Brookes MJ, 2006, GUT, V55, P1449, DOI 10.1136/gut.2006.094060; Buys SS, 2011, JAMA-J AM MED ASSOC, V305, P2295, DOI 10.1001/jama.2011.766; Chaib H, 2001, NEOPLASIA, V3, P43, DOI 10.1038/sj.neo.7900126; Chen JX, 2009, CANCER BIOL THER, V8, P1699, DOI 10.4161/cbt.8.18.9146; Chornokur G, 2013, GYNECOL ONCOL, V129, P258, DOI 10.1016/j.ygyno.2012.12.016; Cristofanilli M, 2005, CANCER-AM CANCER SOC, V103, P1122, DOI 10.1002/cncr.20881; Cross AJ, 2011, CANCER PREV RES, V4, P1465, DOI 10.1158/1940-6207.CAPR-11-0103; Domingues R, 2009, ENDOCRINE, V36, P83, DOI 10.1007/s12020-009-9202-2; Duguay Y, 2004, CANCER RES, V64, P1202, DOI 10.1158/0008-5472.CAN-03-3295; Eide DJ, 2004, PFLUG ARCH EUR J PHY, V447, P796, DOI 10.1007/s00424-003-1074-3; Filetti S, 1999, EUR J ENDOCRINOL, V141, P443, DOI 10.1530/eje.0.1410443; Fleming RE, 2003, BLOOD, V102, P1567, DOI 10.1182/blood-2003-06-2023; Foy SP, 2011, BIOMATERIALS, V32, P9155, DOI 10.1016/j.biomaterials.2011.09.047; Frumovitz M, 2010, GYNECOL ONCOL, V117, P491, DOI 10.1016/j.ygyno.2010.02.010; Galaris D, 2008, CRIT REV CL LAB SCI, V45, P1, DOI [10.1080/10408360701713104, 10.1080/10408360701713104 ]; Giuliani L, 2005, ONCOL REP, V13, P185; Guilbert A, 2009, AM J PHYSIOL-CELL PH, V297, pC493, DOI 10.1152/ajpcell.00624.2008; Haitina T, 2006, GENOMICS, V88, P779, DOI 10.1016/j.ygeno.2006.06.016; Hetland TE, 2012, GYNECOL ONCOL, V126, P460, DOI 10.1016/j.ygyno.2012.05.029; Howie B, 2012, NAT GENET, V44, P955, DOI 10.1038/ng.2354; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; Huang X, 2003, MUTAT RES-FUND MOL M, V533, P153, DOI 10.1016/j.mrfmmm.2003.08.023; Iacobazzi V, 2004, HUM MUTAT, V24, P312, DOI 10.1002/humu.20085; Ishihara T, 2011, J BIOL CHEM, V286, P44086, DOI 10.1074/jbc.M111.251694; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kobayashi H, 1999, THYROID, V9, P159, DOI 10.1089/thy.1999.9.159; Kurian AW, 2005, GYNECOL ONCOL, V96, P520, DOI 10.1016/j.ygyno.2004.10.037; Kurzawski M, 2005, EUR J CLIN PHARMACOL, V61, P389, DOI 10.1007/s00228-005-0926-5; Lacka K, 2007, THYROID, V17, P1143, DOI 10.1089/thy.2007.0023; Law RHP, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-5-216; Lenaz G, 2010, BBA-BIOENERGETICS, V1797, P633, DOI 10.1016/j.bbabio.2010.01.025; Levesque E, 2007, HEPATOLOGY, V45, P128, DOI 10.1002/hep.21464; Li LT, 2003, BIOCHEM J, V375, P793, DOI 10.1042/BJ20030866; Lin SF, 2009, J NUTR BIOCHEM, V20, P1000, DOI 10.1016/j.jnutbio.2008.09.004; Linnerth NM, 2005, INT J CANCER, V114, P977, DOI 10.1002/ijc.20814; Macheda ML, 2005, J CELL PHYSIOL, V202, P654, DOI 10.1002/jcp.20166; Merlot AM, 2013, ANTIOXID REDOX SIGN, V18, P973, DOI 10.1089/ars.2012.4540; Morgenstern R, 2011, DRUG METAB REV, V43, P300, DOI 10.3109/03602532.2011.558511; Nemeth E, 2008, CURR OPIN HEMATOL, V15, P169, DOI 10.1097/MOH.0b013e3282f73335; Ockenga J, 2003, GASTROENTEROLOGY, V124, P1802, DOI 10.1016/S0016-5085(03)00294-4; Ota I, 2010, ANTICANCER RES, V30, P5189; Palmieri F, 2004, PFLUG ARCH EUR J PHY, V447, P689, DOI 10.1007/s00424-003-1099-7; Palmieri F, 2013, MOL ASPECTS MED, V34, P465, DOI 10.1016/j.mam.2012.05.005; Pertega-Gomes N, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-312; Petitti D., 1994, META ANALYSIS DECISI; Pharoah PDP, 2013, NAT GENET, V45, P362, DOI 10.1038/ng.2564; Pinheiro C, 2011, HISTOL HISTOPATHOL, V26, P1279, DOI 10.14670/HH-26.1279; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Ries LAG, 2007, PATIENT TUMOR CHARAC, V07-6215; Risch HA, 1996, AM J EPIDEMIOL, V144, P363, DOI 10.1093/oxfordjournals.aje.a008937; Sankararaman S, 2008, AM J HUM GENET, V82, P290, DOI 10.1016/j.ajhg.2007.09.022; Sebastiani G, 2010, CELLULAR MOL BIOL; Shimada M, 2009, GYNECOL ONCOL, V113, P331, DOI 10.1016/j.ygyno.2009.02.010; Storey JD, 2002, J ROY STAT SOC B, V64, P479, DOI 10.1111/1467-9868.00346; Taylor KM, 2007, MOL MED, V13, P396, DOI 10.2119/2007-00040.Taylor; Tukey RH, 2000, ANNU REV PHARMACOL, V40, P581, DOI 10.1146/annurev.pharmtox.40.1.581; Vulpe CD, 1999, NAT GENET, V21, P195, DOI 10.1038/5979; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Xu Zongli, 2009, NUCL ACIDS RES; Yeh KY, 2011, GASTROENTEROLOGY, V141, P292, DOI 10.1053/j.gastro.2011.03.059; Zhang H, 2007, INT J COLORECTAL DIS, V22, P1185, DOI 10.1007/s00384-007-0308-9	65	15	18	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2015	10	6							e0128106	10.1371/journal.pone.0128106	http://dx.doi.org/10.1371/journal.pone.0128106			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL3FE	26091520	Green Submitted, Green Accepted, gold, Green Published			2022-12-26	WOS:000356835000013
J	Gillot, G; Jany, JL; Coton, M; Le Floch, G; Debaets, S; Ropars, J; Lopez-Villavicencio, M; Dupont, J; Branca, A; Giraud, T; Coton, E				Gillot, Guillaume; Jany, Jean-Luc; Coton, Monika; Le Floch, Gaetan; Debaets, Stella; Ropars, Jeanne; Lopez-Villavicencio, Manuela; Dupont, Joelle; Branca, Antoine; Giraud, Tatiana; Coton, Emmanuel			Insights into Penicillium roqueforti Morphological and Genetic Diversity	PLOS ONE			English	Article							PHYLOGENETIC SPECIES RECOGNITION; SACCHAROMYCES-CEREVISIAE; CHAPERONIN SUBUNITS; SOFTWARE; PROGRAM; INFERENCE; SEQUENCE; SPECIATION; TAXONOMY; GENOTYPE	Fungi exhibit substantial morphological and genetic diversity, often associated with cryptic species differing in ecological niches. Penicillium roqueforti is used as a starter culture for blue-veined cheeses, being responsible for their flavor and color, but is also a common spoilage organism in various foods. Different types of blue-veined cheeses are manufactured and consumed worldwide, displaying specific organoleptic properties. These features may be due to the different manufacturing methods and/or to the specific P. roqueforti strains used. Substantial morphological diversity exists within P. roqueforti and, although not taxonomically valid, several technological names have been used for strains on different cheeses (e.g., P. gorgonzolae, P. stilton). A worldwide P. roqueforti collection from 120 individual blue-veined cheeses and 21 other substrates was analyzed here to determine (i) whether P. roqueforti is a complex of cryptic species, by applying the Genealogical Concordance Phylogenetic Species Recognition criterion (GC-PSR), (ii) whether the population structure assessed using microsatellite markers correspond to blue cheese types, and (iii) whether the genetic clusters display different morphologies. GC-PSR multi-locus sequence analyses showed no evidence of cryptic species. The population structure analysis using microsatellites revealed the existence of highly differentiated populations, corresponding to blue cheese types and with contrasted morphologies. This suggests that the population structure has been shaped by different cheese-making processes or that different populations were recruited for different cheese types. Cheese-making fungi thus constitute good models for studying fungal diversification under recent selection.	[Gillot, Guillaume; Jany, Jean-Luc; Coton, Monika; Le Floch, Gaetan; Debaets, Stella; Coton, Emmanuel] Univ Brest, ESIAB, Lab Univ Biodivers & Ecol Microbienne, Technopole Brest Iroise,EA 3882, Plouzane, France; [Ropars, Jeanne; Lopez-Villavicencio, Manuela; Dupont, Joelle] CNRS, MNHN, Origine Struct Evolut Biodivers, UMR 7205, Paris 05, France; [Ropars, Jeanne; Branca, Antoine; Giraud, Tatiana] Univ Paris Sud, Ecol Systemat & Evolut, Orsay, France; [Ropars, Jeanne; Branca, Antoine; Giraud, Tatiana] CNRS, Orsay, France	Universite de Bretagne Occidentale; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Museum National d'Histoire Naturelle (MNHN); AgroParisTech; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS)	Coton, E (corresponding author), Univ Brest, ESIAB, Lab Univ Biodivers & Ecol Microbienne, Technopole Brest Iroise,EA 3882, Plouzane, France.	emmanuel.coton@univ-brest.fr	LE FLOCH, Gaétan/I-2486-2014; Branca, Antoine/H-6088-2012; Ropars, Jeanne/O-4113-2018	LE FLOCH, Gaétan/0000-0001-7413-8852; Ropars, Jeanne/0000-0002-3740-9673; Jany, Jean-Luc/0000-0001-9132-2555; COTON, Emmanuel/0000-0003-0912-8804; Coton, Monika/0000-0002-0148-6802; Giraud, Tatiana/0000-0002-2685-6478	Ministere de l'Education Nationale, de l'Enseignement Superieur et de la Recherche (France); French Dairy Interbranch Organization (CNIEL, France); ERC starting grant [GenomeFun 309403]; ANR Fromagen grant; ATM Microorganisms-MNHN grant	Ministere de l'Education Nationale, de l'Enseignement Superieur et de la Recherche (France); French Dairy Interbranch Organization (CNIEL, France); ERC starting grant(European Research Council (ERC)); ANR Fromagen grant(French National Research Agency (ANR)); ATM Microorganisms-MNHN grant	GG is funded by the Ministere de l'Education Nationale, de l'Enseignement Superieur et de la Recherche (France) & the French Dairy Interbranch Organization (CNIEL, France). The authors acknowledge an ERC starting grant, GenomeFun 309403, awarded to TG, an ANR Fromagen grant to AB and an ATM Microorganisms-MNHN 2013 grant to MLV. The funders had no role in study design, data collection and analysis, or preparation of the manuscript.	Abbas A, 2011, ENCY DAIRY SCI, P772; Bass David, 2011, Fungal Biology Reviews, V25, P159, DOI 10.1016/j.fbr.2011.10.003; Beresford TP, 2001, INT DAIRY J, V11, P259, DOI 10.1016/S0958-6946(01)00056-5; Cantor M.D., 2004, CHEESE CHEM PHYS MIC, V2, P175, DOI DOI 10.1016/S1874-558X(04)80044-7; Cheeseman K, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms3876; Chen H, 2010, GENOME RES, V20, P393, DOI 10.1101/gr.100545.109; Chung Y, 2012, THESIS U WISCONSIN M; CNIEL, 2014, EC LAIT CHIFFR; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Degnan JH, 2009, TRENDS ECOL EVOL, V24, P332, DOI 10.1016/j.tree.2009.01.009; Dettman JR, 2007, NATURE, V447, P585, DOI 10.1038/nature05856; Dumay R, 1982, LE ROQUEFORT; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; EXCOFFIER L, 1992, GENETICS, V131, P479; Farris JS, 1995, CLADISTICS, V10, P315, DOI [DOI 10.1111/J.1096-0031.1994.TB00181.X, DOI 10.1111/J.1096-0031.1996.TB00196.X]; Fay JC, 2005, PLOS GENET, V1, P66, DOI 10.1371/journal.pgen.0010005; Fox P.F., 2004, CHEESE CHEM PHYS MIC, V1, DOI DOI 10.1016/S1874-558X(04)80060-5; GARGAS A, 1992, MYCOLOGIA, V84, P589, DOI 10.2307/3760327; Gelperin D, 2001, RNA, V7, P1268, DOI 10.1017/S1355838201013073; Gibbons JG, 2012, CURR BIOL, V22, P1403, DOI 10.1016/j.cub.2012.05.033; Giraud T, 2008, FUNGAL GENET BIOL, V45, P791, DOI 10.1016/j.fgb.2008.02.001; Gladieux P, 2014, MOL ECOL, V23, P753, DOI 10.1111/mec.12631; GLASS NL, 1995, APPL ENVIRON MICROB, V61, P1323, DOI 10.1128/AEM.61.4.1323-1330.1995; Grunig CR, 2007, FUNGAL GENET BIOL, V44, P773, DOI 10.1016/j.fgb.2006.12.008; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; HAWKSWORTH DL, 1991, MYCOL RES, V95, P641, DOI 10.1016/S0953-7562(09)80810-1; Hermet A, 2012, FUNGAL BIOL-UK, V116, P692, DOI 10.1016/j.funbio.2012.04.002; Hong SB, 2005, MYCOLOGIA, V97, P1316, DOI 10.3852/mycologia.97.6.1316; Houbraken J, 2012, ANTON LEEUW INT J G, V101, P403, DOI 10.1007/s10482-011-9647-1; Houbraken J, 2011, STUD MYCOL, P1, DOI 10.3114/sim.2011.70.01; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Huson DH, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-460; Huson DH, 2012, SYST BIOL, V61, P1061, DOI 10.1093/sysbio/sys062; Institute SAS, 2007, JMP VERS 7; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; KAPLAN NL, 1989, GENETICS, V123, P887; Katoh Kazutaka, 2013, Mol Biol Evol, V30, P772, DOI 10.1093/molbev/mst010; Kauff F, 2002, MOL PHYLOGENET EVOL, V25, P138, DOI 10.1016/S1055-7903(02)00214-2; Kearsey SE, 1998, BBA-GENE STRUCT EXPR, V1398, P113, DOI 10.1016/S0167-4781(98)00033-5; KIM S, 1994, TRENDS BIOCHEM SCI, V19, P543, DOI 10.1016/0968-0004(94)90058-2; Knowles LL, 2009, SYST BIOL, V58, P463, DOI 10.1093/sysbio/syp061; Kofler R, 2007, BIOINFORMATICS, V23, P1683, DOI 10.1093/bioinformatics/btm157; Koressaar T, 2007, BIOINFORMATICS, V23, P1289, DOI 10.1093/bioinformatics/btm091; Le Gac M, 2007, EVOLUTION, V61, P15, DOI 10.1111/j.1558-5646.2007.00002.x; Leger-Silvestre I, 2004, EMBO J, V23, P2336, DOI 10.1038/sj.emboj.7600252; Legras JL, 2007, MOL ECOL, V16, P2091, DOI 10.1111/j.1365-294X.2007.03266.x; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Liti G, 2009, NATURE, V458, P337, DOI 10.1038/nature07743; Liu YJJ, 1999, MOL BIOL EVOL, V16, P1799, DOI 10.1093/oxfordjournals.molbev.a026092; Maddison WP, 2009, MESQUITE MODULAR SYS; Meglecz E, 2010, BIOINFORMATICS, V26, P403, DOI 10.1093/bioinformatics/btp670; Meirmans PG, 2004, MOL ECOL NOTES, V4, P792, DOI 10.1111/j.1471-8286.2004.00770.x; Miller AN, 2004, MYCOLOGIA, V96, P1106, DOI 10.2307/3762093; Munsell Color Company, 2009, MUNS SOIL COL CHARTS; Novo M, 2009, P NATL ACAD SCI USA, V106, P16333, DOI 10.1073/pnas.0904673106; Nylander JAA, 2008, BIOINFORMATICS, V24, P581, DOI 10.1093/bioinformatics/btm388; Pavlic D, 2009, MOL PHYLOGENET EVOL, V51, P259, DOI 10.1016/j.ympev.2008.12.017; Peterson SW, 2011, IMA FUNGUS, V2, P121, DOI 10.5598/imafungus.2011.02.02.02; Peterson SW, 2004, MYCOL RES, V108, P434, DOI 10.1017/S0953756204009761; PITT JI, 1988, LAB GUIDE COMMON PEN; Pitt JI, 2009, FUNGI AND FOOD SPOILAGE, THIRD EDITION, P3, DOI 10.1007/978-0-387-92207-2_2; Pritchard JK, 2000, GENETICS, V155, P945; R Core Team, 2021, R LANGUAGE ENV STAT; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; REHNER SA, 1994, MYCOL RES, V98, P625, DOI 10.1016/S0953-7562(09)80409-7; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Ropars J, 2014, EVOL APPL, V7, P433, DOI 10.1111/eva.12140; Ropars J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049665; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Sabeti PC, 2006, SCIENCE, V312, P1614, DOI 10.1126/science.1124309; Salque M, 2013, NATURE, V493, P522, DOI 10.1038/nature11698; Samson RA, 2004, STUD MYCOL, P175; Samson RA, 2010, FOOD INDOOR FUNGI; SANDINE WE, 1970, J AGR FOOD CHEM, V18, P557, DOI 10.1021/jf60170a023; Schmitt I, 2009, PERSOONIA, V23, P35, DOI 10.3767/003158509X470602; Sicard D, 2011, CR BIOL, V334, P229, DOI 10.1016/j.crvi.2010.12.016; Smith JM, 2007, GENET RES, V89, P391, DOI [10.1017/S0016672308009579, 10.1017/S0016672300014634]; Stoldt V, 1996, YEAST, V12, P523, DOI 10.1002/(SICI)1097-0061(199605)12:6<523::AID-YEA962>3.3.CO;2-3; Sweet MJ, 2012, ADV APPL MICROBIOL, V81, P169, DOI 10.1016/B978-0-12-394382-8.00005-8; Swofford DL., 2003, PAUP PHYLOGENETIC AN; Taylor JW, 2000, FUNGAL GENET BIOL, V31, P21, DOI 10.1006/fgbi.2000.1228; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; Vialle A, 2013, MOL PHYLOGENET EVOL, V66, P628, DOI 10.1016/j.ympev.2012.10.021; VILGALYS R, 1990, J BACTERIOL, V172, P4238, DOI 10.1128/jb.172.8.4238-4246.1990; Visagie CM, 2014, STUD MYCOL, P343, DOI 10.1016/j.simyco.2014.09.001; White TJ, 1990, AMPLIFICATION DIRECT, V18, P315	88	38	39	2	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2015	10	6							e0129849	10.1371/journal.pone.0129849	http://dx.doi.org/10.1371/journal.pone.0129849			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL3FE	26091176	Green Published, gold, Green Submitted			2022-12-26	WOS:000356835000067
J	He, SL; Zou, Y; Zhang, LF; Ma, WQ; Zhang, XY; Yue, BS				He, Shi-Lin; Zou, Yuan; Zhang, Li-Fang; Ma, Wen-Qi; Zhang, Xiu-Yue; Yue, Bi-Song			The Complete Mitochondrial Genome of the Beet Webworm, Spoladea recurvalis (Lepidoptera: Crambidae) and Its Phylogenetic Implications	PLOS ONE			English	Article							COMPLETE NUCLEOTIDE-SEQUENCE; GENE ORGANIZATION; ADVANCED MOTHS; DNA SEQUENCE; BUTTERFLIES; EVOLUTION; PATTERNS; MODEL; TRANSCRIPTION; HYMENOPTERA	The complete mitochondrial genome (mitogenome) of the beet webworm, Spoladea recurvalis has been sequenced. The circular genome is 15,273 bp in size, encoding 13 protein-coding genes (PCGs), two rRNA genes, and 22 tRNA genes and containing a control region with gene order and orientation identical to that of other ditrysian lepidopteran mitogenomes. The nucleotide composition of the mitogenome shows a high A+T content of 80.9%, and the AT skewness is slightly negative (-0.023). All PCGs start with the typical ATN codons, except for COX1, which may start with the CGA codon. Nine of 13 PCGs have the common stop codon TAA; however, COX1, COX2 and ND5 utilize the T nucleotide and ND4 utilizes TA nucleotides as incomplete termination codons. All tRNAs genes are folded into the typical cloverleaf structure of mitochondrial tRNAs, except for the tRNA(Ser(AGY)) gene, in which the DHU arm fails to form a stable stem-loop structure. A total of 157 bp intergenic spacers are scattered in 17 regions. The overlapping sequences are 42 bp in total and found in eight different locations. The 329 bp AT-rich region is comprised of non-repetitive sequences, including the motif ATAG, which is followed by a 14 bp poly-T stretch, a (AT(11)microsatellite-like repeat, which is adjacent to the motif ATTTA, and a 9 bp poly-A, which is immediately upstream from the tRNA(Met) gene. Phylogenetic analysis, based on 13 PCGs and 13 PCGs+2 rRNAs using Bayesian inference and Maximum likelihood methods, show that the classification position of Pyraloidea is inconsistent with the traditional classification. Hesperioidea is placed within the Papilionoidea rather than as a sister group to it. The Pyraloidea is placed within the Macrolepidoptera with other superfamilies instead of the Papilionoidea.	[He, Shi-Lin; Zou, Yuan; Zhang, Li-Fang; Ma, Wen-Qi; Zhang, Xiu-Yue; Yue, Bi-Song] Sichuan Univ, Coll Life Sci, Minist Educ, Key Lab Bioresources & Ecoenvironm, Chengdu 610064, Peoples R China; [Zhang, Xiu-Yue; Yue, Bi-Song] Sichuan Univ, Coll Life Sci, Sichuan Key Lab Conservat Biol Endangered Wildlif, Chengdu 610064, Peoples R China	Sichuan University; Sichuan University	Yue, BS (corresponding author), Sichuan Univ, Coll Life Sci, Minist Educ, Key Lab Bioresources & Ecoenvironm, Chengdu 610064, Peoples R China.	bsyue@scu.edu.cn		Yue, Bisong/0000-0001-6731-538X	National Natural Science Foundation of China [31272039]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by the National Natural Science Foundation of China (grant No. 31272039).	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; Avise JC, 2000, MOL ECOL, V9, P1783, DOI 10.1046/j.1365-294x.2000.01068.x; Ballard JWO, 2000, J MOL EVOL, V51, P48, DOI 10.1007/s002390010066; Beard C.B., 1993, Insect Molecular Biology, V2, P103, DOI 10.1111/j.1365-2583.1993.tb00131.x; Boore JL, 1999, NUCLEIC ACIDS RES, V27, P1767, DOI 10.1093/nar/27.8.1767; Boore JL, 1998, NATURE, V392, P667, DOI 10.1038/33577; Bybee SM, 2004, MOL PHYLOGENET EVOL, V30, P789, DOI 10.1016/S1055-7903(03)00253-7; Cameron SL, 2006, MOL PHYLOGENET EVOL, V38, P274, DOI 10.1016/j.ympev.2005.09.020; Cameron SL, 2008, GENE, V408, P112, DOI 10.1016/j.gene.2007.10.023; Cameron SL, 2007, SYST ENTOMOL, V32, P40, DOI 10.1111/j.1365-3113.2006.00355.x; Cao SS, 2014, GENE, V533, P356, DOI 10.1016/j.gene.2013.07.072; Cao YQ, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-276; Chai HN, 2012, INT J BIOL SCI, V8, P561, DOI 10.7150/ijbs.3540; CLARY DO, 1985, J MOL EVOL, V22, P252, DOI 10.1007/BF02099755; Coates BS, 2005, INT J BIOL SCI, V1, P13; Crease TJ, 1999, GENE, V233, P89, DOI 10.1016/S0378-1119(99)00151-1; DEBRUIJN MHL, 1983, NATURE, V304, P234, DOI 10.1038/304234a0; Feng X, 2010, MOL BIOL REP, V37, P3877, DOI 10.1007/s11033-010-0044-z; Flook PK, 1995, J MOL EVOL, V41, P928, DOI 10.1007/BF00173173; Guindon S, 2005, NUCLEIC ACIDS RES, V33, pW557, DOI 10.1093/nar/gki352; Haines WP, 2012, MOL PHYLOGENET EVOL, V65, P305, DOI 10.1016/j.ympev.2012.06.021; Hao JS, 2012, COMP FUNCT GENOM, DOI 10.1155/2012/328049; Hebert PDN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068535; Heikkila M, 2012, P ROY SOC B-BIOL SCI, V279, P1093, DOI 10.1098/rspb.2011.1430; HILLIS DM, 1993, SYST BIOL, V42, P182, DOI 10.2307/2992540; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Hurst GDD, 2005, P ROY SOC B-BIOL SCI, V272, P1525, DOI 10.1098/rspb.2005.3056; Jiang ST, 2009, INT J BIOL SCI, V5, P351; Kim I, 2006, INSECT MOL BIOL, V15, P217, DOI 10.1111/j.1365-2583.2006.00630.x; Kim I, 2005, GENE, V353, P155, DOI 10.1016/j.gene.2005.04.019; Kim MI, 2009, MOL CELLS, V28, P347, DOI 10.1007/s10059-009-0129-5; Kim MJ, 2011, MOL PHYLOGENET EVOL, V61, P436, DOI 10.1016/j.ympev.2011.07.013; Kristensen Niels P., 1999, Handbuch der Zoologie (Berlin), V4, P7; Kristensen NP, 2007, ZOOTAXA, P699, DOI 10.11646/zootaxa.1668.1.30; Krzywinski J, 2006, MOL PHYLOGENET EVOL, V39, P417, DOI 10.1016/j.ympev.2006.01.006; Lavrov DV, 2000, P NATL ACAD SCI USA, V97, P13738, DOI 10.1073/pnas.250402997; Li WW, 2011, DNA CELL BIOL, V30, P3, DOI 10.1089/dna.2010.1058; Liao F, 2010, INT J BIOL SCI, V6, P172; Liu YQ, 2008, ACTA BIOCH BIOPH SIN, V40, P693, DOI [10.1111/j.1745-7270.2008.00449.x, 10.1093/abbs/40.8.693]; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Lu HD, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0069950, 10.1371/journal.pone.0072410]; Lutz-Bonengel S, 2004, INT J LEGAL MED, V118, P274, DOI 10.1007/s00414-004-0457-0; Margam VM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016444; MINET J, 1991, ENTOMOL SCAND, V22, P69; MITCHELL SE, 1993, GENOME, V36, P1058, DOI 10.1139/g93-141; Mutanen M, 2010, P ROY SOC B-BIOL SCI, V277, P2839, DOI 10.1098/rspb.2010.0392; Nardi F, 2003, INSECT MOL BIOL, V12, P605, DOI 10.1046/j.1365-2583.2003.00445.x; Nuss M, 2006, GLOBAL INFORMATION S; Ogoh K, 2004, GENE, V327, P131, DOI 10.1016/j.gene.2003.11.011; OJALA D, 1981, NATURE, V290, P470, DOI 10.1038/290470a0; Park J.S., 2013, MITOCHONDR DNA, V6, P1; PERNA NT, 1995, J MOL EVOL, V41, P353, DOI 10.1007/BF01215182; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Rambaut A., 2009, FIGTREE; Regier JC, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-280; Saito S, 2005, GENETICS, V171, P1695, DOI 10.1534/genetics.105.046243; Sambrook J., 2001, MOL CLONING LAB MANU; Scheffler IE, 1999, MITOCHONDRIA; SHADEL GS, 1993, J BIOL CHEM, V268, P16083; Simon C, 2006, ANNU REV ECOL EVOL S, V37, P545, DOI 10.1146/annurev.ecolsys.37.091305.110018; Skerratt LF, 2002, PARASITOL RES, V88, P376, DOI 10.1007/s00436-001-0556-5; Spanos L, 2000, INSECT MOL BIOL, V9, P139, DOI 10.1046/j.1365-2583.2000.00165.x; Taanman JW, 1999, BBA-BIOENERGETICS, V1410, P103, DOI 10.1016/S0005-2728(98)00161-3; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Traut W, 2013, CHROMOSOME RES, V21, P491, DOI 10.1007/s10577-013-9376-6; Wahlberg N, 2005, P ROY SOC B-BIOL SCI, V272, P1577, DOI 10.1098/rspb.2005.3124; Wei SJ, 2013, DNA CELL BIOL, V32, P173, DOI 10.1089/dna.2012.1942; Wei SJ, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-371; Wei SJ, 2009, GENOME, V52, P308, DOI [10.1139/G09-008, 10.1139/g09-008]; Wilson K, 2000, MOL BIOL EVOL, V17, P863, DOI 10.1093/oxfordjournals.molbev.a026366; WOLSTENHOLME DR, 1992, INT REV CYTOL, V141, P173, DOI 10.1016/S0074-7696(08)62066-5; Wu QL, 2013, MITOCHONDR DNA, V24, P105, DOI 10.3109/19401736.2012.726621; Wu YP, 2012, DNA CELL BIOL, V31, P1508, DOI 10.1089/dna.2012.1642; Yamauchi MM, 2002, GENE, V295, P89, DOI 10.1016/S0378-1119(02)00824-7; Yang XS, 2013, GENE, V515, P349, DOI 10.1016/j.gene.2012.11.031; Ye F, 2016, MITOCHONDRIAL DNA A, V27, P28, DOI 10.3109/19401736.2013.869678; Yukuhiro K, 2002, MOL BIOL EVOL, V19, P1385, DOI 10.1093/oxfordjournals.molbev.a004200; Zakharov EV, 2004, SYST BIOL, V53, P193, DOI 10.1080/10635150490423403; Zhang DX, 1997, BIOCHEM SYST ECOL, V25, P99, DOI 10.1016/S0305-1978(96)00042-7; Zhang ZQ, 2011, ZOOTAXA, P7, DOI 10.11646/zootaxa.3148.1.3; Zou Y, 2014, MITOCHONDR DNA, P1	83	16	19	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2015	10	6							e0129355	10.1371/journal.pone.0129355	http://dx.doi.org/10.1371/journal.pone.0129355			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL3FE	26091291	gold, Green Submitted, Green Published			2022-12-26	WOS:000356835000040
J	Wang, JY; Chen, SY; Sun, CN; Chien, T; Chern, Y				Wang, J-Y; Chen, S-Y; Sun, C-N; Chien, T.; Chern, Y.			A central role of TRAX in the ATM-mediated DNA repair	ONCOGENE			English	Article							DOUBLE-STRAND BREAKS; FACTOR-X TRAX; A(2A) ADENOSINE RECEPTOR; SUPPRESSES TUMOR-GROWTH; KINESIN FAMILY-MEMBER; INDUCED CELL-DEATH; MRN COMPLEX; MRE11-RAD50-NBS1 COMPLEX; SACCHAROMYCES-CEREVISIAE; DAMAGE RESPONSE	DNA repair is critical for the maintenance of genome stability. Upon genotoxic stress, dysregulated DNA repair may induce apoptosis. Translin-associated factor X (TRAX), which was initially identified as a binding partner of Translin, has been implicated in genome stability. However, the exact role of TRAX in DNA repair remains largely unknown. Here, we showed that TRAX participates in the ATM/H2AX-mediated DNA repair machinery by interacting with ATM and stabilizing the MRN complex at double-strand breaks. The exogenous expression of wild-type (WT) TRAX, but not a TRAX variant lacking the nuclear localization signal (NLS), rescued the vulnerability of TRAX-null mouse embryo fibroblasts (MEFs). This finding confirms the importance of the nuclear localization of TRAX in the repair of DNA damage. Compared with WT MEFs, TRAX-null MEFs exhibited impaired DNA repair (for example, reduced phosphorylation of ATM and H2AX) after treatment with ultra violet-C or.-ray irradiation and a higher incidence of p53-mediated apoptosis. Our findings demonstrate that TRAX is required for MRN complex-ATM-H2AX signaling, which optimizes DNA repair by interacting with the activated ATM and protects cells from genotoxic stress-induced apoptosis.	[Wang, J-Y] Kaohsiung Med Univ, Sch Med, Dept Neurol, Coll Med, Kaohsiung, Taiwan; [Wang, J-Y; Chen, S-Y; Sun, C-N; Chern, Y.] Acad Sinica, Inst Biomed Sci, Neurosci Div, N333 IBMS, Taipei 115, Taiwan; [Chien, T.; Chern, Y.] Natl Def Med Ctr, Inst Life Sci, Taipei, Taiwan	Kaohsiung Medical University; Academia Sinica - Taiwan; National Defense Medical Center	Chern, Y (corresponding author), Acad Sinica, Inst Biomed Sci, Neurosci Div, N333 IBMS, Taipei 115, Taiwan.	bmychern@ibms.sinica.edu.tw	chern, yijuang/S-7013-2018	chern, yijuang/0000-0002-5842-5429	Ministrant of Technology and Science of Taiwan [NSC96-2321-B-001-015, NSC97-2321-B-001-012, 100-2320-B-001-0110MY3]; Institute of Biomedical Sciences of Academia Sinica; Kaohsiung Medical University [KMU-Q102011]	Ministrant of Technology and Science of Taiwan; Institute of Biomedical Sciences of Academia Sinica(Academia Sinica - Taiwan); Kaohsiung Medical University	We thank Hsing-Lin Lai and Shuyung Chang for technical support. This work was supported by grants from the Ministrant of Technology and Science of Taiwan (NSC96-2321-B-001-015, NSC97-2321-B-001-012 and 100-2320-B-001-0110MY3 to YC), the Institute of Biomedical Sciences of Academia Sinica (to YC) and the Kaohsiung Medical University (KMU-Q102011 to J-YW).	Aisiku OR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015001; AJIMURA M, 1993, GENETICS, V133, P51; Amano T, 2009, J NEURO-ONCOL, V92, P357, DOI 10.1007/s11060-009-9844-1; Aoki K, 1997, FEBS LETT, V401, P109, DOI 10.1016/S0014-5793(96)01444-5; AOKI K, 1995, NAT GENET, V10, P167, DOI 10.1038/ng0695-167; Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; Bray JD, 2004, MOL REPROD DEV, V69, P387, DOI 10.1002/mrd.20171; Bray JD, 2002, GENOMICS, V79, P799, DOI 10.1006/geno.2002.6779; Chalk JG, 1997, ONCOGENE, V15, P1199, DOI 10.1038/sj.onc.1201285; Chen SH, 2007, MOL BIOL CELL, V18, P2525, DOI 10.1091/mbc.E07-02-0188; Chen WSV, 2003, METHOD ENZYMOL, V365, P367; Chennathukuzhi VM, 2001, J BIOL CHEM, V276, P13256, DOI 10.1074/jbc.M009707200; Colton SL, 2006, J BIOL CHEM, V281, P27117, DOI 10.1074/jbc.M602826200; D'Amours D, 2002, NAT REV MOL CELL BIO, V3, P317, DOI 10.1038/nrm805; Delmas S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000552; Devon RS, 2000, MAMM GENOME, V11, P395, DOI 10.1007/s003350010074; Dupre A, 2008, NAT CHEM BIOL, V4, P119, DOI 10.1038/nchembio.63; Erdemir T, 2002, MOL MICROBIOL, V46, P947, DOI 10.1046/j.1365-2958.2002.03224.x; Erdemir T, 2002, J CELL SCI, V115, P207; GAME JC, 1974, MUTAT RES, V24, P281, DOI 10.1016/0027-5107(74)90176-6; Hakem R, 2008, EMBO J, V27, P589, DOI 10.1038/emboj.2008.15; Herzog KH, 1998, SCIENCE, V280, P1089, DOI 10.1126/science.280.5366.1089; Hong SH, 2012, ONCOL REP, V27, P1251, DOI 10.3892/or.2012.1641; IWABUCHI K, 1994, P NATL ACAD SCI USA, V91, P6098, DOI 10.1073/pnas.91.13.6098; Kaina B, 2003, BIOCHEM PHARMACOL, V66, P1547, DOI 10.1016/S0006-2952(03)00510-0; Kerzendorfer C, 2009, DNA REPAIR, V8, P1139, DOI 10.1016/j.dnarep.2009.04.018; Kim GD, 1999, J BIOL CHEM, V274, P31127, DOI 10.1074/jbc.274.44.31127; Lamarche BJ, 2010, FEBS LETT, V584, P3682, DOI 10.1016/j.febslet.2010.07.029; Lavin MF, 2007, CELL CYCLE, V6, P931, DOI 10.4161/cc.6.8.4180; Lee JH, 2005, SCIENCE, V308, P551, DOI 10.1126/science.1108297; Lee JH, 2010, EMBO J, V29, P574, DOI 10.1038/emboj.2009.372; Li Z, 2008, BBA-GENE REGUL MECH, V1779, P479, DOI 10.1016/j.bbagrm.2008.03.008; LIMOLI CL, 1993, RADIAT RES, V134, P160, DOI 10.2307/3578455; Limoli CL, 2002, P NATL ACAD SCI USA, V99, P233, DOI 10.1073/pnas.231611798; Liu Y, 2009, SCIENCE, V325, P750, DOI 10.1126/science.1176325; Malmlof M, 2007, J BIOL CHEM, V282, P2288, DOI 10.1074/jbc.M604953200; Mayo LD, 2001, P NATL ACAD SCI USA, V98, P11598, DOI 10.1073/pnas.181181198; Meng G, 2000, J HUM GENET, V45, P305, DOI 10.1007/s100380070022; Mochan TA, 2004, DNA REPAIR, V3, P945, DOI 10.1016/j.dnarep.2004.03.017; Mochan TA, 2003, CANCER RES, V63, P8586; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; Pabla N, 2008, J BIOL CHEM, V283, P6572, DOI 10.1074/jbc.M707568200; Robison JG, 2007, CELL CYCLE, V6, P2408, DOI 10.4161/cc.6.19.4773; Roos WP, 2006, TRENDS MOL MED, V12, P440, DOI 10.1016/j.molmed.2006.07.007; Rotman G, 1999, ONCOGENE, V18, P6135, DOI 10.1038/sj.onc.1203124; Schroer U, 2007, EUR J NEUROSCI, V26, P2169, DOI 10.1111/j.1460-9568.2007.05849.x; Schultz LB, 2000, J CELL BIOL, V151, P1381, DOI 10.1083/jcb.151.7.1381; Shiloh Y, 2001, CURR OPIN GENET DEV, V11, P71, DOI 10.1016/S0959-437X(00)00159-3; Sun CN, 2006, MOL PHARMACOL, V70, P454, DOI 10.1124/mol.105.021261; Sun CN, 2010, DEV NEUROBIOL, V70, P604, DOI 10.1002/dneu.20802; SYMONDS H, 1994, CELL, V78, P703, DOI 10.1016/0092-8674(94)90534-7; Tibbetts RS, 1999, GENE DEV, V13, P152, DOI 10.1101/gad.13.2.152; Unger T, 1999, ONCOGENE, V18, P3205, DOI 10.1038/sj.onc.1202656; van den Bosch M, 2003, EMBO REP, V4, P844, DOI 10.1038/sj.embor.embor925; Warmerdam DO, 2010, MUTAT RES-REV MUTAT, V704, P2, DOI 10.1016/j.mrrev.2009.12.001; Wu YC, 2011, J NEUROCHEM, V116, P1112, DOI 10.1111/j.1471-4159.2010.07166.x; Xu M, 2004, INT J HYPERTHER, V20, P157, DOI 10.1080/02656730310001625986; Yajima H, 2009, J MOL BIOL, V385, P800, DOI 10.1016/j.jmb.2008.11.036; Yang L, 2004, WORLD J GASTROENTERO, V10, P155; Yavuzer U, 1998, GENE DEV, V12, P2188, DOI 10.1101/gad.12.14.2188; Ye XC, 2011, NAT STRUCT MOL BIOL, V18, P650, DOI 10.1038/nsmb.2032; Yuan JS, 2010, FEBS LETT, V584, P3717, DOI 10.1016/j.febslet.2010.05.021; Zgheib O, 2005, RADIOTHER ONCOL, V76, P119, DOI 10.1016/j.radonc.2005.06.026; Zhao X, 2008, J VIROL, V82, P5316, DOI 10.1128/JVI.02677-07; Zheng L, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh110; Zufferey R, 1998, J VIROL, V72, P9873, DOI 10.1128/JVI.72.12.9873-9880.1998	66	15	15	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 31	2016	35	13					1657	1670		10.1038/onc.2015.228	http://dx.doi.org/10.1038/onc.2015.228			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DH8RP	26096928				2022-12-26	WOS:000373064200005
J	Sabirzhanova, I; Pacheco, ML; Rapino, D; Grover, R; Handa, JT; Guggino, WB; Cebotaru, L				Sabirzhanova, Inna; Pacheco, Miqueias Lopes; Rapino, Daniele; Grover, Rahul; Handa, James T.; Guggino, William B.; Cebotaru, Liudmila			Rescuing Trafficking Mutants of the ATP-binding Cassette Protein, ABCA4, with Small Molecule Correctors as a Treatment for Stargardt Eye Disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; HEAT-SHOCK PROTEINS; CYSTIC-FIBROSIS; MACULAR DEGENERATION; DELTA-F508 CFTR; RIM PROTEIN; WILD-TYPE; DEGRADATION; GENE; CHAPERONES	Stargardt disease is the most common form of early onset macular degeneration. Mutations in ABCA4, a member of the ATP-binding cassette (ABC) family, are associated with Stargardt disease. Here, we have examined two disease-causing mutations in the NBD1 region of ABCA4, R1108C, and R1129C, which occur within regions of high similarity with CFTR, another ABC transporter gene, which is associated with cystic fibrosis. We show that R1108C and R1129C are both temperature-sensitive processing mutants that engage the cellular quality control mechanism and show a strong interaction with the chaperone Hsp 27. Both mutant proteins also interact with HDCAC6 and are degraded in the aggresome. We also demonstrate that novel corrector compounds that are being tested as treatment for cystic fibrosis, such as VX-809, can rescue the processing of the ABCA4 mutants, particularly their expression at the cell surface, and can reduce their binding to HDAC6. Thus, our data suggest that VX-809 can potentially be developed as a new therapy for Stargardt disease, for which there is currently no treatment.	[Sabirzhanova, Inna; Pacheco, Miqueias Lopes; Rapino, Daniele; Grover, Rahul; Guggino, William B.; Cebotaru, Liudmila] Johns Hopkins Univ, Dept Med, Div Gastroenterol, Baltimore, MD 21205 USA; [Sabirzhanova, Inna; Pacheco, Miqueias Lopes; Rapino, Daniele; Grover, Rahul; Cebotaru, Liudmila] Johns Hopkins Univ, Physiol Ctr Retinal Biol, Baltimore, MD 21231 USA; [Handa, James T.; Cebotaru, Liudmila] Johns Hopkins Univ, Dept Ophthalmol, Baltimore, MD 21231 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Cebotaru, L (corresponding author), Johns Hopkins Univ, Dept Med, Div Gastroenterol, Baltimore, MD 21205 USA.	lcebotaru@jhmi.edu	Lopes-Pacheco, Miquéias/AAM-7432-2020; Lopes-Pacheco, Miquéias/I-1290-2017	Lopes-Pacheco, Miquéias/0000-0002-7444-9359; Lopes-Pacheco, Miquéias/0000-0002-7444-9359; Grover, Rahul/0000-0002-3143-0228	National Council for Scientific and Technological Development (CNPq) Brazil;  [DK072084]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK072084] Funding Source: NIH RePORTER	National Council for Scientific and Technological Development (CNPq) Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); ; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was funded by the National Council for Scientific and Technological Development (CNPq) Brazil (Lopes Pacheco) and DK072084 (to W. B. G.). The authors declare that they have no conflicts of interest with the contents of this article.	Ahner A, 2007, MOL BIOL CELL, V18, P806, DOI 10.1091/mbc.E06-05-0458; Ahner A, 2013, MOL BIOL CELL, V24, P74, DOI 10.1091/mbc.E12-09-0678; Albrecht C, 2007, PFLUG ARCH EUR J PHY, V453, P581, DOI 10.1007/s00424-006-0047-8; Aleksandrov AA, 2007, PFLUG ARCH EUR J PHY, V453, P693, DOI 10.1007/s00424-006-0140-z; Allikmets R, 2000, AM J HUM GENET, V67, P487, DOI 10.1086/303018; Amaral MD, 2004, J MOL NEUROSCI, V23, P41, DOI 10.1385/JMN:23:1-2:041; Boinot C, 2014, J PHARMACOL EXP THER, V350, P624, DOI 10.1124/jpet.114.214890; Boyault C, 2006, EMBO J, V25, P3357, DOI 10.1038/sj.emboj.7601210; Cebotaru L, 2008, J BIOL CHEM, V283, P21926, DOI 10.1074/jbc.M709156200; Cheng J, 2004, J BIOL CHEM, V279, P1892, DOI 10.1074/jbc.M308640200; Clancy JP, 2012, THORAX, V67, P12, DOI 10.1136/thoraxjnl-2011-200393; Fujinami K, 2013, INVEST OPHTH VIS SCI, V54, P8181, DOI 10.1167/iovs.13-12104; Gusev NB, 2005, BIOCHEMISTRY-MOSCOW+, V70, P629, DOI 10.1007/s10541-005-0162-8; Hartl FU, 2002, SCIENCE, V295, P1852, DOI 10.1126/science.1068408; Holland IB, 2011, ESSAYS BIOCHEM, V50, P1, DOI [10.1042/BSE0500001, 10.1042/bse0500001]; Holleran JP, 2013, J CELL SCI, V126, P2692, DOI 10.1242/jcs.120196; Illing M, 1997, J BIOL CHEM, V272, P10303, DOI 10.1074/jbc.272.15.10303; Johnston JA, 1998, J CELL BIOL, V143, P1883, DOI 10.1083/jcb.143.7.1883; Kawaguchi Y, 2003, CELL, V115, P727, DOI 10.1016/S0092-8674(03)00939-5; Kim YE, 2013, ANNU REV BIOCHEM, V82, P323, DOI 10.1146/annurev-biochem-060208-092442; Koenekoop Robert K, 2003, Ophthalmic Genet, V24, P75, DOI 10.1076/opge.24.2.75.13996; Mendoza JL, 2012, CELL, V148, P164, DOI 10.1016/j.cell.2011.11.023; Molday RS, 2009, BBA-MOL CELL BIOL L, V1791, P573, DOI 10.1016/j.bbalip.2009.02.004; Molday RS, 2006, ADV EXP MED BIOL, V572, P465; OBRIG TG, 1971, J BIOL CHEM, V246, P174; Okiyoneda T, 2012, J CELL BIOL, V199, P199, DOI 10.1083/jcb.201208083; Pedemonte N, 2005, J CLIN INVEST, V115, P2564, DOI 10.1172/JCI24898; Quazi F, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1927; Ren HY, 2013, MOL BIOL CELL, V24, P3016, DOI 10.1091/mbc.E13-05-0240; RIORDAN JR, 1989, SCIENCE, V245, P1066; Sosnay PR, 2013, NAT GENET, V45, P1160, DOI 10.1038/ng.2745; Stargardt K., 1909, GRAEFES ARCH CLIN EX, V71, P534, DOI DOI 10.1007/BF01961301; Stone EM, 1998, NAT GENET, V20, P328, DOI 10.1038/3798; Sudnitsyna MV, 2012, CURR PROTEIN PEPT SC, V13, P76; Sun H, 2000, NAT GENET, V26, P242, DOI 10.1038/79994; Van Goor F, 2006, AM J PHYSIOL-LUNG C, V290, pL1117, DOI 10.1152/ajplung.00169.2005; Wei XF, 1996, J CELL PHYSIOL, V168, P373, DOI 10.1002/(SICI)1097-4652(199608)168:2<373::AID-JCP16>3.0.CO;2-4; Weng J, 1999, CELL, V98, P13, DOI 10.1016/S0092-8674(00)80602-9; Yan J, 2014, DNA CELL BIOL, V33, P567, DOI 10.1089/dna.2013.2300; Younger JM, 2006, CELL, V126, P571, DOI 10.1016/j.cell.2006.06.041	40	37	38	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 7	2015	290	32					19743	19755		10.1074/jbc.M115.647685	http://dx.doi.org/10.1074/jbc.M115.647685			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CO7TL	26092729	Green Published, hybrid			2022-12-26	WOS:000359364600032
J	Seto, DN; Kandarian, SC; Jackman, RW				Seto, Danielle N.; Kandarian, Susan C.; Jackman, Robert W.			A Key Role for Leukemia Inhibitory Factor in C26 Cancer Cachexia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SKELETAL-MUSCLE; COLON-26 ADENOCARCINOMA; STAT3; INTERLEUKIN-6; CELLS; DIFFERENTIATION; PATHWAY; MICE; TRANSCRIPTION; ACTIVATION	Cachexia is an exacerbating event in many types of cancer that is strongly associated with a poor prognosis. We have identified cytokine, signaling, and transcription factors that are required for cachexia in the mouse C26 colon carcinoma model of cancer. C2C12 myotubes treated with conditioned medium from C26 cancer cells induced atrophy and activated a STAT-dependent reporter gene but not reporter genes dependent on SMAD, FOXO, C/EBP, NF-kappa B, or AP-1. Of the gp130 family members IL-11, IL-6, oncostatinM(OSM), and leukemia inhibitory factor (LIF), only OSM and LIF were sufficient to activate the STAT reporter in myotubes. LIF was elevated in C26 conditioned medium (CM), but IL-6, OSM, TNF alpha, and myostatin were not. A LIF-blocking antibody abolished C26 CM-induced STAT reporter activation, STAT3 phosphorylation, and myotube atrophy but blocking antibodies to IL-6 or OSM did not. JAK2 inhibitors also blocked C26 CM-induced STAT reporter activation, STAT3 phosphorylation, and atrophy in myotubes. LIF at levels found in the C26 CM was sufficient for STAT reporter activation and atrophy in myotubes. In vivo, an increase in serum LIF preceded the increase in IL-6 in mice with C26 tumors. Overexpression of a dominant negative Stat3C beta-EGFP gene in myotubes and in mouse muscle blocked the atrophy caused by C26 CM or C26 tumors, respectively. Taken together, these data support an important role of LIF-JAK2-STAT3 in C26 cachexia and point to a therapeutic approach for at least some types of cancer cachexia.	[Seto, Danielle N.; Kandarian, Susan C.; Jackman, Robert W.] Boston Univ, Dept Hlth Sci, Boston, MA 02215 USA	Boston University	Jackman, RW (corresponding author), Boston Univ, Dept Hlth Sci, 635 Commonwealth Ave, Boston, MA 02215 USA.	rjackman@bu.edu	Regan, Clinton/E-6250-2012		National Institutes of Health [R01 AR060217]; CTSA Grant [UL1-TR000157]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000157] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR060217] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CTSA Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 AR060217 (to S. C. K. and R. W. J.). The microarray analysis was supported by CTSA Grant UL1-TR000157 (to the CTSI at the Boston University Microarray Resource Core Facility). The authors declare that they have no conflicts of interest with the contents of this article.	Acharyya S, 2005, CANCER CELL, V8, P421, DOI 10.1016/j.ccr.2005.10.004; Argiles JM, 2005, INT J BIOCHEM CELL B, V37, P1609, DOI 10.1016/j.biocel.2005.03.007; Aulino P, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-363; Baltgalvis KA, 2008, AM J PHYSIOL-REG I, V294, pR393, DOI 10.1152/ajpregu.00716.2007; BERG M, 1994, CYTOKINE, V6, P425, DOI 10.1016/1043-4666(94)90067-1; Bonetto A, 2012, AM J PHYSIOL-ENDOC M, V303, pE410, DOI 10.1152/ajpendo.00039.2012; Bonetto A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022538; Bromberg JF, 1999, CELL, V98, P295, DOI 10.1016/S0092-8674(00)81959-5; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Caldenhoven E, 1996, J BIOL CHEM, V271, P13221, DOI 10.1074/jbc.271.22.13221; Chung CD, 1997, SCIENCE, V278, P1803, DOI 10.1126/science.278.5344.1803; Cornwell EW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087776; Dauer DJ, 2005, ONCOGENE, V24, P3397, DOI 10.1038/sj.onc.1208469; Di Marco S, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1899; Duluc D, 2007, BLOOD, V110, P4319, DOI 10.1182/blood-2007-02-072587; Fearon KCH, 2012, CELL METAB, V16, P153, DOI 10.1016/j.cmet.2012.06.011; Fujiki F, 1997, CANCER RES, V57, P94; GASCAN H, 1990, J IMMUNOL, V144, P2592; Hunter RB, 2002, FASEB J, V16, P529, DOI 10.1096/fj.01-0866com; Janssen SPM, 2005, CIRCULATION, V111, P996, DOI 10.1161/01.CIR.0000156469.96135.0D; Judge SM, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-997; Lazarus DD, 1999, AM J PHYSIOL-ENDOC M, V277, pE332, DOI 10.1152/ajpendo.1999.277.2.E332; Li J, 2010, NEOPLASIA, V12, P28, DOI 10.1593/neo.91192; Lokireddy S, 2012, BIOCHEM J, V446, P23, DOI 10.1042/BJ20112024; McFarlane C, 2006, J CELL PHYSIOL, V209, P501, DOI 10.1002/jcp.20757; MORI M, 1991, CANCER RES, V51, P6656; Park JI, 2003, MOL CELL BIOL, V23, P543, DOI 10.1128/MCB.23.2.543-554.2003; Penna F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013604; Silva KAS, 2015, J BIOL CHEM, V290, P11177, DOI 10.1074/jbc.M115.641514; Schindler C, 2007, J BIOL CHEM, V282, P20059, DOI 10.1074/jbc.R700016200; SODA K, 1994, JPN J CANCER RES, V85, P1124, DOI 10.1111/j.1349-7006.1994.tb02917.x; STRASSMANN G, 1992, J CLIN INVEST, V89, P1681, DOI 10.1172/JCI115767; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; TANAKA Y, 1990, CANCER RES, V50, P2290; Tisdale MJ, 2009, PHYSIOL REV, V89, P381, DOI 10.1152/physrev.00016.2008; TOMIDA M, 1984, FEBS LETT, V178, P291, DOI 10.1016/0014-5793(84)80619-5; YASUMOTO K, 1995, CANCER RES, V55, P921; Zhang GH, 2011, EMBO J, V30, P4323, DOI 10.1038/emboj.2011.292; Zhou XL, 2010, CELL, V142, P531, DOI 10.1016/j.cell.2010.07.011; Zimmers TA, 2002, SCIENCE, V296, P1486, DOI 10.1126/science.1069525	40	71	73	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 7	2015	290	32					19976	19986		10.1074/jbc.M115.638411	http://dx.doi.org/10.1074/jbc.M115.638411			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CO7TL	26092726	Green Published, hybrid			2022-12-26	WOS:000359364600052
J	Campos, Z; Mourao, G; Coutinho, M; Magnusson, WE; Soriano, BMA				Campos, Zilca; Mourao, Guilherme; Coutinho, Marcos; Magnusson, William E.; Soriano, Balbina M. A.			Spatial and Temporal Variation in Reproduction of a Generalist Crocodilian, Caiman crocodilus yacare, in a Seasonally Flooded Wetland	PLOS ONE			English	Article							PANTANAL WETLAND; EXTINCTION; RISK; COMMUNITY; PATTERNS; HABITAT; DAUDIN; SIZE	We monitored the number of caiman (Caiman crocodilus yacare) nests in two ranches in the Brazilian Pantanal that cover an area of about 50.000 ha for 28 years (1987-2014). The number of nests was related to combinations of rainfall, water level, and number of days with temperature below 20 degrees C, depending on the area. Most of the variation in number of nests could not be predicted by the environmental variables, but could be represented mathematically by a sine wave. We were not able to identify any external driver and suspect that the regular fluctuations may have resulted from an intrinsic population process. Presently, ranches are used as management units under the legislation for ranching Pantanal caimans. However, although some breeding females were recaptured in the area after periods of up to 21 years, most were not recaptured near nests or in general surveys of the area, suggesting that females are not strongly philopatric and that ranches do not represent isolated demographic units.	[Campos, Zilca; Mourao, Guilherme; Soriano, Balbina M. A.] Embrapa Pantanal, Corumba, MS, Brazil; [Coutinho, Marcos] Inst Chico Mendes Conservacao Biodiversidade, Lagoa Santa, MG, Brazil; [Magnusson, William E.] Inst Nacl Pesquisas Amaonia, Coordenacao Biodiversidade, Manaus, Amazonas, Brazil	Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA)	Campos, Z (corresponding author), Embrapa Pantanal, Corumba, MS, Brazil.	zilca.campos@embrapa.br	Mourão, Guilherme M/C-3319-2013	Mourão, Guilherme M/0000-0002-8300-4191	Embrapa; WWF_USA; Conservation International-USA; Fundacao O Boticario; Fundect	Embrapa(Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA)); WWF_USA; Conservation International-USA; Fundacao O Boticario; Fundect(Fundacao de Apoio ao Desenvolvimento do Ensino Ciencia e Tecnologia do Estado de Mato Grosso do Sul (FUNDECT MS))	The study was funded by Embrapa, WWF_USA, Conservation International-USA, Fundacao O Boticario and Fundect.	[Anonymous], 2006, IMPACTOS AMBIENTAIS; Billick I, 2010, THE ECOLOGY OF PLACE; Brazaitis P, 1998, AMPHIBIA-REPTILIA, V19, P193, DOI 10.1163/156853898X00476; Cadavid EAG, 1984, CLIMA PANTANAL MATOG; Calheiros D, 2009, INFLUENCIAS USINAS H; Campos Z, 2005, HERPETOL J, V15, P97; CAMPOS Z, 1995, J TROP ECOL, V11, P351, DOI 10.1017/S0266467400008828; CAMPOS Z, 1993, J HERPETOL, V27, P127, DOI 10.2307/1564927; Campos Z, 1995, VIDA SILVESTE NEOTRO, V3, P46; Campos Z, 2006, HERPETOL J, V16, P123; Campos Z, 2011, HERPETOL J, V21, P91; Caughley G., 1987, P159; Coutinho Marcos E., 2013, Biodiversidade Brasileira, V3, P13; Da Silva CJ, 2014, CLIMATIC CHANGE, V127, P83, DOI 10.1007/s10584-014-1150-z; Eversole CB, 2013, HERPETOL CONSERV BIO, V8, P756; Farias Izeni Pires, 2013, Biodiversidade Brasileira, V3, P21; Farias Izeni Pires, 2013, Biodiversidade Brasileira, V3, P4; Gigg G, 2015, BIOL EVOLUTION CROCO; Hamilton SK, 1996, ARCH HYDROBIOL, V137, P1; Hrbek T, 2008, J EXP ZOOL PART A, V309A, P588, DOI 10.1002/jez.430; IORIS A., 2014, ALTERN ROUTES, V25, P119; Joanen T, 1970, P SE ASS GAME FISH C, V22, P166; Junk WJ, 2006, AQUAT SCI, V68, P278, DOI 10.1007/s00027-006-0851-4; KUSHLAN JA, 1990, J HERPETOL, V24, P176, DOI 10.2307/1564225; Landeiro VL, 2011, NAT CONSERVACAO, V9, P7, DOI 10.4322/natcon.2011.002; MAGNUSSON WE, 1991, J HERPETOL, V25, P41, DOI 10.2307/1564793; Magnusson WE, 2015, EYE CROCODILE; Magnusson WE, 2013, NAT CONSERVACAO, V11, P1, DOI 10.4322/natcon.2013.007; Mourao G, 1996, BIOL CONSERV, V75, P261, DOI 10.1016/0006-3207(95)00076-3; Mourao G, 2000, BIOL CONSERV, V92, P175, DOI 10.1016/S0006-3207(99)00051-8; Mourao G, 2013, PELD CNPQ DEZ ANOS P, P90; Mourao GM, 1988, ACTA LIMNOL BRAS, V2, P181; Nussey DH, 2005, BIOL LETT-UK, V1, P457, DOI 10.1098/rsbl.2005.0352; Pera A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088538; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Radder RS, 2008, FUNCT ECOL, V22, P332, DOI 10.1111/j.1365-2435.2007.01380.x; REZNICK D, 1993, ECOLOGY, V74, P2011, DOI 10.2307/1940844; Shine R, 2008, PHILOS T R SOC B, V363, P363, DOI 10.1098/rstb.2007.2144; Simoncini MS, 2013, HERPETOL CONSERV BIO, V8, P409; Soriano BMA, 1997, B AGROMETEOROLOGICO, V3; Soriano BMA., 2000, B AGROMETEROLOGICAO, V4; Soriano BMA., 2000, B AGROMETEREOLOGICO, V5; Tomas W, 2009, DOCUMENTOS EMBRAPA P; Vasconcelos W, 2007, CROCODILE SPECIALIST, V26, P6; Velasco A, 2009, P 19 WORK M IUCN SSC, P72; WILKINSON L, 1990, SYSTAT SYSTEM STAT S; Zar J.H., 1999, ZAR KUHR 5 2019, V4th; Zeilhofer P, 2009, ECOL ENG, V35, P105, DOI 10.1016/j.ecoleng.2008.09.011	48	8	9	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2015	10	6							e0129368	10.1371/journal.pone.0129368	http://dx.doi.org/10.1371/journal.pone.0129368			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4OM	26107847	gold, Green Published, Green Submitted			2022-12-26	WOS:000356932500050
J	Matsushita, H; Sano, A; Wu, H; Wang, ZD; Jiao, JA; Kasinathan, P; Sullivan, EJ; Kuroiwa, Y				Matsushita, Hiroaki; Sano, Akiko; Wu, Hua; Wang, Zhongde; Jiao, Jin-an; Kasinathan, Poothappillai; Sullivan, Eddie J.; Kuroiwa, Yoshimi			Species-Specific Chromosome Engineering Greatly Improves Fully Human Polyclonal Antibody Production Profile in Cattle	PLOS ONE			English	Article							B-CELL RECEPTOR; HUMAN-IMMUNOGLOBULIN; MICE; TRANSCRIPTION; IMMUNIZATION; EXPRESSION; RESPONSES; CHILDREN; GENES; HEAVY	Large-scale production of fully human IgG (hIgG) or human polyclonal antibodies (hpAbs) by transgenic animals could be useful for human therapy. However, production level of hpAbs in transgenic animals is generally very low, probably due to the fact that evolutionarily unique interspecies-incompatible genomic sequences between human and nonhuman host species may impede high production of fully hIgG in the non-human environment. To address this issue, we performed species-specific human artificial chromosome (HAC) engineering and tested these engineered HAC in cattle. Our previous study has demonstrated that site-specific genomic chimerization of pre-B cell receptor/B cell receptor (pre-BCR/BCR) components on HAC vectors significantly improves human IgG expression in cattle where the endogenous bovine immunoglobulin genes were knocked out. In this report, hIgG1 class switch regulatory elements were subjected to site-specific genomic chimerization on HAC vectors to further enhance hIgG expression and improve hIgG subclass distribution in cattle. These species-specific modifications in a chromosome scale resulted in much higher production levels of fully hIgG of up to 15 g/L in sera or plasma, the highest ever reported for a transgenic animal system. Transchromosomic (Tc) cattle containing engineered HAC vectors generated hpAbs with high titers against human-origin antigens following immunization. This study clearly demonstrates that species-specific sequence differences in pre-BCR/BCR components and IgG1 class switch regulatory elements between human and bovine are indeed functionally distinct across the two species, and therefore, are responsible for low production of fully hIgG in our early versions of Tc cattle. The high production levels of fully hIgG with hIgG1 subclass dominancy in a large farm animal species achieved here is an important milestone towards broad therapeutic applications of hpAbs.	[Matsushita, Hiroaki; Wu, Hua; Jiao, Jin-an; Sullivan, Eddie J.] SAB Biotherapeut Inc, Sioux Falls, SD 57104 USA; [Sano, Akiko; Kuroiwa, Yoshimi] Kyowa Hakko Kirin Co Ltd, Chiyoda Ku, Tokyo, Japan; [Wang, Zhongde] Utah State Univ, Dept Anim Dairy & Vet Sci, Logan, UT 84322 USA; [Kasinathan, Poothappillai] Trans Ova Genet, Sioux Ctr, IA USA; [Matsushita, Hiroaki; Sano, Akiko; Wu, Hua; Wang, Zhongde; Jiao, Jin-an; Kasinathan, Poothappillai; Sullivan, Eddie J.; Kuroiwa, Yoshimi] Hematech Inc, Sioux Falls, SD USA	Kyowa Kirin Ltd; Utah System of Higher Education; Utah State University	Sullivan, EJ (corresponding author), SAB Biotherapeut Inc, Sioux Falls, SD 57104 USA.	esullivan@sabbiotherapeutics.com		Sullivan, Eddie/0000-0001-7468-2006; Wang, Zhongde/0000-0003-2441-4729	Hematech, Inc.	Hematech, Inc.	This work was financed by internal funding of Hematech, Inc., which no longer exists and no longer has financial interest in the work. There was no external funding sources for this study. Financial interest in this work is currently owned by SAB Biotherapeutics, Inc, who did have a role in the decision to publish as well as the preparation of the manuscript. While it is considered beneficial to the interests of SAB Biotherapeutics, Inc to publish this work, this consideration played no role in the study design, data collection and analysis and preparation of the manuscript. This is evidenced by the inclusion of now independent authors with no affiliation to SAB Biotherapeutics, Inc.	Baral TN, 2011, J IMMUNOL METHODS, V371, P70, DOI 10.1016/j.jim.2011.06.017; Casola S, 2004, NAT IMMUNOL, V5, P317, DOI 10.1038/ni1036; Chaudhuri J, 2004, NAT REV IMMUNOL, V4, P541, DOI 10.1038/nri1395; Devoy A, 2012, NAT REV GENET, V13, P14, DOI 10.1038/nrg3116; Dostalek M, 2013, CLIN PHARMACOKINET, V52, P83, DOI 10.1007/s40262-012-0027-4; Echelard Y, 2009, NAT BIOTECHNOL, V27, P146, DOI 10.1038/nbt0209-146; Flajnik MF, 2002, NAT REV IMMUNOL, V2, P688, DOI 10.1038/nri889; Herberich E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009788; Hothorn T, 2008, BIOMETRICAL J, V50, P346, DOI 10.1002/bimj.200810425; Jolles S, 2005, CLIN EXP IMMUNOL, V142, P1, DOI 10.1111/j.1365-2249.2005.02834.X; Kaisho T, 1997, SCIENCE, V276, P412, DOI 10.1126/science.276.5311.412; Kawano Y, 2006, J IMMUNOL, V177, P2242, DOI 10.4049/jimmunol.177.4.2242; Keenan RA, 2008, SCIENCE, V321, P696, DOI 10.1126/science.1157533; Kuroiwa Y, 2004, NAT GENET, V36, P775, DOI 10.1038/ng1373; Kuroiwa Y, 2002, NAT BIOTECHNOL, V20, P889, DOI 10.1038/nbt727; Kuroiwa Y, 2009, NAT BIOTECHNOL, V27, P173, DOI 10.1038/nbt.1521; Lemieux W, 2005, MOL IMMUNOL, V42, P839, DOI 10.1016/j.molimm.2004.07.046; Lonberg N, 2005, NAT BIOTECHNOL, V23, P1117, DOI 10.1038/nbt1135; Martin F, 2002, NAT REV IMMUNOL, V2, P323, DOI 10.1038/nri799; Matsushita H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090383; Mendez MJ, 1997, NAT GENET, V15, P146, DOI 10.1038/ng0297-146; Newcombe C, 2007, J CHROMATOGR B, V848, P2, DOI 10.1016/j.jchromb.2006.07.004; Sano A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078119; SHACKELFORD PG, 1985, J CLIN IMMUNOL, V5, P390, DOI 10.1007/BF00915336; SIBER GR, 1980, NEW ENGL J MED, V303, P178, DOI 10.1056/NEJM198007243030402; STOOP JW, 1969, CLIN EXP IMMUNOL, V4, P101; Tomizuka K, 2000, P NATL ACAD SCI USA, V97, P722, DOI 10.1073/pnas.97.2.722; Wilson MD, 2008, SCIENCE, V322, P434, DOI 10.1126/science.1160930; Yoshimi K, 2000, NAT BIOTECHNOL, V18, P1086, DOI 10.1038/80287; ZEILEIS A., 2006, J STAT SOFTW, V16, P1, DOI DOI 10.18637/JSS.V016.I09	30	25	27	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2015	10	6							e0130699	10.1371/journal.pone.0130699	http://dx.doi.org/10.1371/journal.pone.0130699			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4OM	26107496	gold, Green Published, Green Submitted			2022-12-26	WOS:000356932500116
J	Laitz, AVN; Acencio, ML; Budzinski, IGF; Labate, MTV; Lemke, N; Ribolla, PEM; Maia, IG				Nunes Laitz, Alessandra Vasconcellos; Acencio, Marcio Luis; Budzinski, Ilara G. F.; Labate, Monica T. V.; Lemke, Ney; Martins Ribolla, Paulo Eduardo; Maia, Ivan G.			Transcriptome Response Signatures Associated with the Overexpression of a Mitochondrial Uncoupling Protein (AtUCP1) in Tobacco	PLOS ONE			English	Article							ALTERNATIVE OXIDASE; GENE-EXPRESSION; ARABIDOPSIS-THALIANA; RESPIRATORY-CHAIN; OXIDATIVE STRESS; REDOX POISE; PLANTS; PHOTORESPIRATION; PHOTOSYNTHESIS; METABOLISM	Mitochondrial inner membrane uncoupling proteins (UCP) dissipate the proton electrochemical gradient established by the respiratory chain, thus affecting the yield of ATP synthesis. UCP overexpression in plants has been correlated with oxidative stress tolerance, improved photosynthetic efficiency and increased mitochondrial biogenesis. This study reports the main transcriptomic responses associated with the overexpression of an UCP (AtUCP1) in tobacco seedlings. Compared to wild-type (WT), AtUCP1 transgenic seedlings showed unaltered ATP levels and higher accumulation of serine. By using RNA-sequencing, a total of 816 differentially expressed genes between the investigated overexpressor lines and the untransformedWT control were identified. Among them, 239 were up-regulated and 577 were down-regulated. As a general response to AtUCP1 overexpression, noticeable changes in the expression of genes involved in energy metabolism and redox homeostasis were detected. A substantial set of differentially expressed genes code for products targeted to the chloroplast and mainly involved in photosynthesis. The overall results demonstrate that the alterations in mitochondrial function provoked by AtUCP1 overexpression require important transcriptomic adjustments to maintain cell homeostasis. Moreover, the occurrence of an important cross-talk between chloroplast and mitochondria, which culminates in the transcriptional regulation of several genes involved in different pathways, was evidenced.	[Nunes Laitz, Alessandra Vasconcellos; Maia, Ivan G.] UNESP, Inst Biociencias, Dept Genet, Botucatu, SP, Brazil; [Acencio, Marcio Luis; Lemke, Ney] UNESP, Inst Biociencias, Dept Fis & Biofis, Botucatu, SP, Brazil; [Budzinski, Ilara G. F.; Labate, Monica T. V.] Univ Sao Paulo, Dept Genet, Escola Super Agr Luiz de Queiroz, Piracicaba, SP, Brazil; [Martins Ribolla, Paulo Eduardo] UNESP, Inst Biociencias, Dept Parasitol, Botucatu, SP, Brazil	Universidade Estadual Paulista; Universidade Estadual Paulista; Universidade de Sao Paulo; Universidade Estadual Paulista	Maia, IG (corresponding author), UNESP, Inst Biociencias, Dept Genet, Botucatu, SP, Brazil.	igmaia@ibb.unesp.br	Maia, Ivan G/H-7832-2012; Budzinski, Ilara G.F/J-3278-2012; Acencio, Marcio L/D-9264-2012; Acencio, Marcio Luis/ABH-1930-2020; Lemke, Ney/A-8213-2008; Ribolla, Paulo EM/B-9122-2012; Ribolla, Paulo/AAH-3354-2020; de Godoy Maia, Ivan/AAW-8584-2021; Lemke, Ney/L-6761-2019	Maia, Ivan G/0000-0002-3875-8664; Budzinski, Ilara G.F/0000-0002-0389-7023; Acencio, Marcio L/0000-0002-8278-240X; Acencio, Marcio Luis/0000-0002-8278-240X; Lemke, Ney/0000-0001-7463-4303; Ribolla, Paulo EM/0000-0001-8735-6090; Lemke, Ney/0000-0001-7463-4303	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [13/12947-2]; CAPES; CNPq	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was funded by grant 13/12947-2 from Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP). A. V. Nunes Laitz and M. L. Acencio are recipients of a PhD and a PNPD fellowship from CAPES, respectively. I. G. Maia and P. E. M. Ribolla are recipients of research fellowships from CNPq. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amirsadeghi S, 2007, PHYSIOL PLANTARUM, V129, P253, DOI 10.1111/j.1399-3054.2006.00775.x; Araujo WL, 2011, PLANT CELL, V23, P600, DOI 10.1105/tpc.110.081224; Barreto P, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-144; Begcy K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023776; Blake JA, 2013, NUCLEIC ACIDS RES, V41, pD530, DOI 10.1093/nar/gks1050; Boldt R, 2005, PLANT CELL, V17, P2413, DOI 10.1105/tpc.105.033993; Brandalise M, 2003, J BIOENERG BIOMEMBR, V35, P203, DOI 10.1023/A:1024603530043; Camara Y, 2009, CELL PHYSIOL BIOCHEM, V24, P243, DOI 10.1159/000233249; Chen SC, 2014, J PLANT BIOL, V57, P9, DOI 10.1007/s12374-013-0350-9; Chen SC, 2013, PLANT PHYSIOL BIOCH, V73, P245, DOI 10.1016/j.plaphy.2013.10.002; Chen SC, 2013, ACTA PHYSIOL PLANT, V35, P2547, DOI 10.1007/s11738-013-1290-1; Clifton R, 2006, BBA-BIOENERGETICS, V1757, P730, DOI 10.1016/j.bbabio.2006.03.009; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Cuadros-Inostroza A, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-428; Douette P, 2006, FREE RADICAL BIO MED, V40, P303, DOI 10.1016/j.freeradbiomed.2005.08.024; Vercesi AE, 2006, ANNU REV PLANT BIOL, V57, P383, DOI 10.1146/annurev.arplant.57.032905.105335; Gandin A, 2014, J EXP BOT, V65, P3133, DOI 10.1093/jxb/eru158; Gullberg J, 2004, ANAL BIOCHEM, V331, P283, DOI 10.1016/j.ab.2004.04.037; Jacoby RP, 2012, J INTEGR PLANT BIOL, V54, P887, DOI 10.1111/j.1744-7909.2012.01177.x; Kal AJ, 1999, MOL BIOL CELL, V10, P1859, DOI 10.1091/mbc.10.6.1859; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Keunen E, 2013, ENVIRON EXP BOT, V91, P63, DOI 10.1016/j.envexpbot.2013.02.008; Kopka J, 2005, BIOINFORMATICS, V21, P1635, DOI 10.1093/bioinformatics/bti236; Kowaltowski AJ, 1998, FEBS LETT, V425, P213, DOI 10.1016/S0014-5793(98)00231-2; Lee BH, 2002, PLANT CELL, V14, P1235, DOI 10.1105/tpc.010433; Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551; Mailloux RJ, 2012, TRENDS ENDOCRIN MET, V23, P451, DOI 10.1016/j.tem.2012.04.004; Mailloux RJ, 2011, J BIOL CHEM, V286, P21865, DOI 10.1074/jbc.M111.240242; Matsuo M, 2006, PLANT J, V47, P873, DOI 10.1111/j.1365-313X.2006.02839.x; Matsuo M, 2011, PLANT CELL PHYSIOL, V52, P333, DOI 10.1093/pcp/pcq192; Meyer EH, 2009, PLANT PHYSIOL, V151, P603, DOI 10.1104/pp.109.141770; Monaco MK, 2014, NUCLEIC ACIDS RES, V42, pD1193, DOI 10.1093/nar/gkt1110; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nott A, 2006, ANNU REV PLANT BIOL, V57, P739, DOI 10.1146/annurev.arplant.57.032905.105310; Queval G, 2012, PHILOS T R SOC B, V367, P3475, DOI 10.1098/rstb.2012.0068; Rhoads DM, 2007, MITOCHONDRION, V7, P177, DOI 10.1016/j.mito.2007.01.002; Rintamaki E, 2009, PLANT SIGNAL BEHAV, V4, P545, DOI 10.1104/pp.108.133777; Schauer N, 2005, FEBS LETT, V579, P1332, DOI 10.1016/j.febslet.2005.01.029; Schwarzlander M, 2012, J EXP BOT, V63, P1735, DOI 10.1093/jxb/err374; Smith AMO, 2004, J BIOL CHEM, V279, P51944, DOI 10.1074/jbc.M408920200; Sun F, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-752; Sweetlove LJ, 2006, P NATL ACAD SCI USA, V103, P19587, DOI 10.1073/pnas.0607751103; Timm S, 2013, PLANT PHYSIOL, V162, P379, DOI 10.1104/pp.113.215970; Tomaz T, 2010, PLANT PHYSIOL, V154, P1143, DOI 10.1104/pp.110.161612; Umbach AL, 2005, PLANT PHYSIOL, V139, P1806, DOI 10.1104/pp.105.070763; Van Aken O, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00281; Van Aken O, 2009, PHYSIOL PLANTARUM, V137, P354, DOI 10.1111/j.1399-3054.2009.01240.x; Vanlerberghe GC, 2013, INT J MOL SCI, V14, P6805, DOI 10.3390/ijms14046805; Wingler A, 2000, PHILOS T R SOC B, V355, P1517, DOI 10.1098/rstb.2000.0712; Xia JG, 2012, NUCLEIC ACIDS RES, V40, pW127, DOI 10.1093/nar/gks374	50	9	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2015	10	6							e0130744	10.1371/journal.pone.0130744	http://dx.doi.org/10.1371/journal.pone.0130744			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4OM	26106890	Green Submitted, Green Published, gold			2022-12-26	WOS:000356932500122
J	Ozaki, T; Nakazawa, M; Yamashita, T; Ishiguro, SI				Ozaki, Taku; Nakazawa, Mitsuru; Yamashita, Tetsuro; Ishiguro, Sei-Ichi			Delivery of Topically Applied Calpain Inhibitory Peptide to the Posterior Segment of the Rat Eye	PLOS ONE			English	Article							OPTIC-NERVE; RABBIT EYE; PHARMACOKINETICS; MITOCHONDRIA; ACTIVATION; ANTIBODY; RETINA	We developed an inhibitory peptide that specifically acts against mitochondrial mu-calpain (Tat-mu CL, 23 amino acid, 2857.37 Da) and protects photoreceptors in retinal dystrophic rats. In the present study, we topically administered Tat-mu CL to the eyes of Sprague-Dawley rats for 7 days to determine both the delivery route of the peptide to the posterior segment of the eye and the kinetics after topical application in adult rats. Distribution of the peptide was determined by immunohistochemical analysis, and enzyme-linked immune-absorbent assay was used to quantify the accumulation in the retina. Peptides were prominently detected in both the anterior and posterior segments of the eye at 1 h after the final eye drop application. Immunohistochemically positive reactions were observed in the retina, optic nerve, choroid, sclera and the retrobulbar tissues, even in the posterior portion of the eye. Immunoactivities gradually diminished at 3 and 6 h after the final eye drop. Quantitative estimations of the amount of peptide in the retina were 15.3, 5.8 and 1.0 pg/mu g protein at 1, 3 and 6 h after the final instillation, respectively. Current results suggest that while the topically applied Tat-mu CL peptide reaches the posterior segment of the retina and the optic nerve, the sufficient concentration (>IC50) is maintained for at least 6 h in the rat retina. Our findings suggest that delivery of topically applied peptide to the posterior segment and optic nerve occurs through the conjunctiva, periocular connective tissue, sclera and optic nerve sheath.	[Ozaki, Taku; Nakazawa, Mitsuru] Hirosaki Univ, Grad Sch Med, Dept Ophthalmol, Hirosaki, Aomori, Japan; [Yamashita, Tetsuro] Iwate Univ, Fac Agr, Dept Biol Chem, Morioka, Iwate 020, Japan; [Ishiguro, Sei-Ichi] Hirosaki Univ, Fac Agr & Life Sci, Dept Biochem & Mol Biol, Hirosaki, Aomori, Japan	Hirosaki University; Iwate University; Hirosaki University	Nakazawa, M (corresponding author), Hirosaki Univ, Grad Sch Med, Dept Ophthalmol, Hirosaki, Aomori, Japan.	mitsuru@hirosaki-u.ac.jp	Nakazawa, Mitsuru/ABI-7897-2020	Nakazawa, Mitsuru/0000-0001-6095-5712; Ozaki, Taku/0000-0001-8183-5453	Japan Society for the Promotion of Science (Tokyo, Japan) [24592616, 25861611]	Japan Society for the Promotion of Science (Tokyo, Japan)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This study was supported in part by a Grant-in-Aid for Scientific Research C-24592616 (M. N.) and a Grant-in-Aid for Young Investigators B-25861611 (T.O.) from the Japan Society for the Promotion of Science (Tokyo, Japan).	El Sanharawi M, 2010, PROG RETIN EYE RES, V29, P443, DOI 10.1016/j.preteyeres.2010.04.001; Endo S, 1999, BBA-MOL CELL RES, V1450, P385, DOI 10.1016/S0167-4889(99)00062-2; Furrer E, 2009, INVEST OPHTH VIS SCI, V50, P771, DOI 10.1167/iovs.08-2370; Inserte J, 2012, CARDIOVASC RES, V96, P23, DOI 10.1093/cvr/cvs232; Koevary SB, 2001, INVEST OPHTH VIS SCI, V43, P797; Lambiase A, 2005, INVEST OPHTH VIS SCI, V46, P3800, DOI 10.1167/iovs.05-0301; Mizukoshi S, 2010, EXP EYE RES, V91, P353, DOI 10.1016/j.exer.2010.06.004; Ozaki T, 2009, BIOCHIM BIOPHYS ACTA, V1783, P1955; Ozaki T, 2013, PLOS ONE, V2013, P1; Ozaki T, 2007, J BIOCHEM, V142, P365, DOI 10.1093/jb/mvm143; Ozaki T, 2013, CELL STRUCT FUNCT, V38, P205, DOI 10.1247/csf.13008; Ozaki T, 2012, BBA-MOL BASIS DIS, V1822, P1783, DOI 10.1016/j.bbadis.2012.07.018; Ozaki T, 2011, ARCH BIOCHEM BIOPHYS, V507, P254, DOI 10.1016/j.abb.2010.12.003; Suzuki K, 2004, DIABETES, V53, pS12, DOI 10.2337/diabetes.53.2007.S12; TAVARES A, 1991, BIOMED BIOCHIM ACTA, V50, P523; Williams KA, 2005, EYE, V19, P910, DOI 10.1038/sj.eye.6701669; YOSHIDA A, 1993, INVEST OPHTH VIS SCI, V34, P3154	17	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2015	10	6							e0130986	10.1371/journal.pone.0130986	http://dx.doi.org/10.1371/journal.pone.0130986			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4OM	26107400	Green Submitted, gold, Green Published			2022-12-26	WOS:000356932500135
J	Yuan, Y; Yao, YF; Hu, SN; Gao, J; Zhang, LL				Yuan, Yuan; Yao, Yu Feng; Hu, Sai Nan; Gao, Jin; Zhang, Li-Li			MiR-133a Is Functionally Involved in Doxorubicin-Resistance in Breast Cancer Cells MCF-7 via Its Regulation of the Expression of Uncoupling Protein 2	PLOS ONE			English	Article							UCP2; CHEMORESISTANCE; MICRORNA-133A; GENE	The development of novel targeted therapies holds promise for conquering chemotherapy resistance, which is one of the major hurdles in current breast cancer treatment. Previous studies indicate that mitochondria uncoupling protein 2 (UCP-2) is involved in the development of chemotherapy resistance in colon cancer and lung cancer cells. In the present study we found that lower level of miR133a is accompanied by increased expression of UCP-2 in Doxorubicin-resistant breast cancer cell cline MCF-7/Dox as compared with its parental cell line MCF-7. We postulated that miR133a might play a functional role in the development of Doxorubicin-resistant in breast cancer cells. In this study we showed that: 1) exogenous expression of miR133a in MCF-7/Dox cells can sensitize their reaction to the treatment of Doxorubicin, which is coincided with reduced expression of UCP-2; 2) knockdown of UCP-2 in MCF-7/Dox cells can also sensitize their reaction to the treatment of Doxorubicin; 3) intratumoral delivering of miR133a can restore Doxorubicin treatment response in Doxorubicin-resistant xenografts in vivo, which is concomitant with the decreased expression of UCP-2. These findings provided direct evidences that the miR133a/UCP-2 axis might play an essential role in the development of Doxorubicin-resistance in breast cancer cells, suggesting that the miR133a/UCP-2 signaling cohort could be served as a novel therapeutic target for the treatment of chemotherapy resistant in breast cancer.	[Yuan, Yuan; Hu, Sai Nan; Gao, Jin; Zhang, Li-Li] Jiangsu Canc Hosp & Res Inst, Dept Chemotherapy, Nanjing, Jiangsu, Peoples R China; [Yao, Yu Feng] Jiangsu Canc Hosp & Res Inst, Dept Surg, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing Medical University	Yuan, Y (corresponding author), Jiangsu Canc Hosp & Res Inst, Dept Chemotherapy, Nanjing, Jiangsu, Peoples R China.	yuany130122@163.com		gao, jin/0000-0002-5845-2750	Jiangsu Province Science Foundation of China [BK2012873]	Jiangsu Province Science Foundation of China	The study was supported by a grant from the Jiangsu Province Science Foundation of China (BK2012873) (http://www.jskjjh.gov.cn/13kjskj2/).	Baffy G, 2011, BRIT J CANCER, V105, P469, DOI 10.1038/bjc.2011.245; Baffy G, 2010, MITOCHONDRION, V10, P243, DOI 10.1016/j.mito.2009.12.143; Bandyopadhyay S, 2013, BIOCHEM BIOPH RES CO, V439, P407, DOI 10.1016/j.bbrc.2013.08.056; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Boss O, 1998, EUR J ENDOCRINOL, V139, P1, DOI 10.1530/eje.0.1390001; Brand MD, 2005, CELL METAB, V2, P85, DOI 10.1016/j.cmet.2005.06.002; Chang Z, 2014, TUMOR BIOL, V35, P10503, DOI 10.1007/s13277-014-2323-0; Chen X, 2009, J BIOL CHEM, V284, P5362, DOI 10.1074/jbc.M807523200; Gil EMC, 2014, CANCER TREAT REV, V40, P862, DOI 10.1016/j.ctrv.2014.03.004; Crown J, 2002, LANCET ONCOL, V3, P719, DOI 10.1016/S1470-2045(02)00927-0; Dalla Pozza E, 2012, BBA-MOL CELL RES, V1823, P1856, DOI 10.1016/j.bbamcr.2012.06.007; Derdak Z, 2008, CANCER RES, V68, P2813, DOI 10.1158/0008-5472.CAN-08-0053; Dong YJ, 2013, MOL CANCER RES, V11, P1051, DOI 10.1158/1541-7786.MCR-13-0061; Febriansah Rifki, 2014, Asian Pacific Journal of Tropical Biomedicine, V4, P228, DOI 10.1016/S2221-1691(14)60236-7; Fleury C, 1997, NAT GENET, V15, P269, DOI 10.1038/ng0397-269; Glackin CA, 2014, MATURITAS, V79, P48, DOI 10.1016/j.maturitas.2014.06.015; Horimoto M, 2004, CLIN CANCER RES, V10, P6203, DOI 10.1158/1078-0432.CCR-04-0419; Li WT, 2014, TUMOR BIOL, V35, P8883, DOI 10.1007/s13277-014-2101-z; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Luo J, 2014, ONCOL LETT, V7, P1043, DOI 10.3892/ol.2014.1841; Moriya Y, 2012, J HUM GENET, V57, P38, DOI 10.1038/jhg.2011.126; Nicholls DG, 1999, J BIOENERG BIOMEMBR, V31, P399, DOI 10.1023/A:1005436121005; Noguchi K, 2014, PHARMACOGN PERS MED, V7, P53, DOI 10.2147/PGPM.S38295; Nubel T, 2008, BBA-BIOENERGETICS, V1777, P48, DOI 10.1016/j.bbabio.2007.11.002; Pfefferle A, 2013, BBA-MOL CELL RES, V1833, P80, DOI 10.1016/j.bbamcr.2012.10.006; Rial E, 2011, CHEM BIOL, V18, P264, DOI 10.1016/j.chembiol.2010.12.012; Saleh MC, 2006, J ENDOCRINOL, V190, P659, DOI 10.1677/joe.1.06715; TOMAYKO MM, 1989, CANCER CHEMOTH PHARM, V24, P148, DOI 10.1007/BF00300234; Turrens JF, 2003, J PHYSIOL-LONDON, V552, P335, DOI 10.1113/jphysiol.2003.049478; Videira M, 2014, BBA-REV CANCER, V1846, P312, DOI 10.1016/j.bbcan.2014.07.011; Wu ZS, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-51	31	35	36	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2015	10	6							e0129843	10.1371/journal.pone.0129843	http://dx.doi.org/10.1371/journal.pone.0129843			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4OM	26107945	Green Published, gold, Green Submitted			2022-12-26	WOS:000356932500070
J	Di Staso, M; Gravina, GL; Zugaro, L; Bonfili, P; Gregori, L; Franzese, P; Marampon, F; Vittorini, F; Moro, R; Tombolini, V; Di Cesare, E; Masciocchi, C				Di Staso, Mario; Gravina, Giovanni Luca; Zugaro, Luigi; Bonfili, Pierluigi; Gregori, Lorenzo; Franzese, Pietro; Marampon, Francesco; Vittorini, Francesca; Moro, Roberto; Tombolini, Vincenzo; Di Cesare, Ernesto; Masciocchi, Carlo			Treatment of Solitary Painful Osseous Metastases with Radiotherapy, Cryoablation or Combined Therapy: Propensity Matching Analysis in 175 Patients	PLOS ONE			English	Article							CELL LUNG-CANCER; PERCUTANEOUS RADIOFREQUENCY ABLATION; IMAGE-GUIDED CRYOABLATION; FUTURE CLINICAL-TRIALS; BONE METASTASES; RADIATION-THERAPY; INTERNATIONAL CONSENSUS; THERMAL ABLATION; END-POINTS; DISEASE	Purpose aim of this study was to identify outcomes in pain relief and quality of life in patients with a solitary painful osseous metastasis treated by radiotherapy, cryoablation or the combination using a propensity score matching study design. Materials and Methods 175 patients with painful bone metastases were included in the study. Twenty-five of them underwent a radiation course (20 Gy in five daily fractions) 15 days after the cryoablation. These subjects were retrospectively matched by propensity analysis with a group of subjects treated by radiotherapy (125 subjects) and with a group treated by Cryoablation (25 subjects). The pain relief in terms of complete response, rate of subjects requiring analgesics after treatments and the changes in self-rated quality of life were measured. Informed consent was obtained from the subject and the study was approved by the local Ethical Committee. Results An higher proportion of subjects treated by cryoablation (32%) or cryoablation followed by RT (72%;) experienced a complete response compared with patients treated by radiotherapy alone (11.2%). After Bonferroni correction strategy, the addition of radiotherapy to cryoablation significantly improved the rate of complete response compared with cryoablation alone (p = 0.011) and this paralleled with an improved self-rated quality of life. Seventeen subjects (13.6%) of patients in the radiotherapy group, 9 (36%) in the cryoablation group, and 19 (76)% in the cryoablation-radiotherapy group did not require narcotic medications. Conclusions The addition of radiotherapy to cryoablation favorably impacts on perceived pain, with a favorable toxicity profile. However, our data should be interpreted with caution and could serve as a framework around which to design future trials.	[Di Staso, Mario; Gravina, Giovanni Luca; Bonfili, Pierluigi; Franzese, Pietro; Marampon, Francesco; Di Cesare, Ernesto] Univ Aquila, Sch Med, S Salvatore Hosp, Dept Biotechnol & Appl Clin Sci,Div Radiat Oncol, I-67100 Laquila, Italy; [Zugaro, Luigi; Gregori, Lorenzo; Masciocchi, Carlo] Univ Aquila, Sch Med, S Salvatore Hosp, Dept Biotechnol & Appl Clin Sci,Div Radiol, I-67100 Laquila, Italy; [Tombolini, Vincenzo] Univ Roma La Sapienza, Dept Radiol Oncol & Anatomopathol Sci, I-00185 Rome, Italy; [Vittorini, Francesca; Moro, Roberto] San Salvatore Hosp, Serv Med Phys, Laquila, Italy	University of L'Aquila; University of L'Aquila; Sapienza University Rome	Gravina, GL (corresponding author), Univ Aquila, Sch Med, S Salvatore Hosp, Dept Biotechnol & Appl Clin Sci,Div Radiat Oncol, I-67100 Laquila, Italy.	giovanniluca.gravina@libero.it	Di Staso, Mario/AAD-9008-2019; di Cesare, Ernesto/AAC-7428-2022; di cesare, ernesto/D-8381-2016	Marampon, Francesco/0000-0002-0588-3039; Gravina, Giovanni Luca/0000-0002-6797-8324; di cesare, ernesto/0000-0002-0995-3081; Tombolini, Vincenzo/0000-0001-5359-9991				Andrade RS, 2010, INT J RADIAT ONCOL, V78, P855, DOI 10.1016/j.ijrobp.2009.09.002; Callstrom MR, 2006, RADIOLOGY, V241, P572, DOI 10.1148/radiol.2412051247; Callstrom MR, 2013, CANCER-AM CANCER SOC, V119, P1033, DOI 10.1002/cncr.27793; Callstrom MR, 2002, RADIOLOGY, V224, P87, DOI 10.1148/radiol.2241011613; Chan MD, 2011, BRACHYTHERAPY, V10, P253, DOI 10.1016/j.brachy.2010.07.002; Chow E, 2002, RADIOTHER ONCOL, V64, P275, DOI 10.1016/S0167-8140(02)00170-6; Chow E, 2012, INT J RADIAT ONCOL, V82, P1730, DOI 10.1016/j.ijrobp.2011.02.008; COHEN SR, 1995, PALLIATIVE MED, V9, P207, DOI 10.1177/026921639500900306; Coleman RE, 2001, CANCER TREAT REV, V27, P165, DOI 10.1053/ctrv.2000.0210; Coleman RE, 2006, CLIN CANCER RES, V12, p6243S, DOI 10.1158/1078-0432.CCR-06-0931; Di Staso M, 2011, EUR RADIOL, V21, P2004, DOI 10.1007/s00330-011-2133-3; Di Staso M, 2011, CLIN ONCOL-UK, V23, P65, DOI 10.1016/j.clon.2010.11.002; DIPETRILLO TA, 2003, SEMIN INTERVENT RAD, V20, P341; Dupuy DE, 2013, J VASC INTERV RADIOL, V24, P1139, DOI 10.1016/j.jvir.2013.04.021; Dupuy DE, 2010, CANCER-AM CANCER SOC, V116, P989, DOI 10.1002/cncr.24837; Dupuy DE, 2006, CHEST, V129, P738, DOI 10.1378/chest.129.3.738; Goetz MP, 2004, J CLIN ONCOL, V22, P300, DOI 10.1200/JCO.2004.03.097; Grieco CA, 2007, AM J CLIN ONCOL-CANC, V30, P361, DOI 10.1097/COC.0b013e318033e76a; Grieco CA, 2006, J VASC INTERV RADIOL, V17, P1117, DOI 10.1097/01.RVI.0000228373.58498.6E; Harvey HA, 2007, CLIN BREAST CANCER, V7, pS7, DOI 10.3816/CBC.2007.s.001; Horkan C, 2005, RADIOLOGY, V235, P81, DOI 10.1148/radiol.2351040269; Howell DD, 2013, CANCER-AM CANCER SOC, V119, P888, DOI 10.1002/cncr.27616; Lutz S, 2009, CLIN ONCOL-UK, V21, P659, DOI 10.1016/j.clon.2009.07.013; Lutz S, 2011, INT J RADIAT ONCOL, V79, P965, DOI 10.1016/j.ijrobp.2010.11.026; Roodman GD, 2004, NEW ENGL J MED, V350, P1655, DOI 10.1056/NEJMra030831; Rosenthal D, 2012, RADIOLOGY, V262, P765, DOI 10.1148/radiol.11101384; Silverman SG, 2000, RADIOLOGY, V217, P657, DOI 10.1148/radiology.217.3.r00dc40657; Smith HS, 2011, PAIN PHYSICIAN, V14, pE373; Suva LJ, 2011, NAT REV ENDOCRINOL, V7, P208, DOI 10.1038/nrendo.2010.227; Suva LJ, 2009, ENDOCR-RELAT CANCER, V16, P703, DOI 10.1677/ERC-09-0012; Tharmalingam Sukirtha, 2008, J Pain Res, V1, P49; Timmerman RD, 2009, CA-CANCER J CLIN, V59, P145, DOI 10.3322/caac.20013; WIDMANN G, 2009, CANC IMAGING, V9, P63, DOI DOI 10.1102/1470-7330.2009.0011; Yu HHM, 2012, CANCER CONTROL, V19, P84	34	33	33	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2015	10	6							e0129021	10.1371/journal.pone.0129021	http://dx.doi.org/10.1371/journal.pone.0129021			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4DD	26103516	Green Submitted, Green Published, gold			2022-12-26	WOS:000356901900011
J	Vohra, RS; Lott, D; Mathur, S; Senesac, C; Deol, J; Germain, S; Bendixen, R; Forbes, SC; Sweeney, HL; Walter, GA; Vandenborne, K				Vohra, Ravneet S.; Lott, Donovan; Mathur, Sunita; Senesac, Claudia; Deol, Jasjit; Germain, Sean; Bendixen, Roxanna; Forbes, Sean C.; Sweeney, H. Lee; Walter, Glenn A.; Vandenborne, Krista			Magnetic Resonance Assessment of Hypertrophic and Pseudo-Hypertrophic Changes in Lower Leg Muscles of Boys with Duchenne Muscular Dystrophy and Their Relationship to Functional Measurements	PLOS ONE			English	Article							QUALITY-OF-LIFE; CROSS-SECTIONAL AREA; NEUROMUSCULAR DISEASES; QUANTITATIVE ULTRASOUND; NONCONTRACTILE TISSUE; CLINICAL-ASSESSMENTS; MDX MOUSE; FOLLOW-UP; CONTRACTILE; CALF	Introduction The primary objectives of this study were to evaluate contractile and non-contractile content of lower leg muscles of boys with Duchenne muscular dystrophy (DMD) and determine the relationships between non-contractile content and functional abilities. Methods Lower leg muscles of thirty-two boys with DMD and sixteen age matched unaffected controls were imaged. Non-contractile content, contractile cross sectional area and non-contractile cross sectional area of lower leg muscles (tibialis anterior, extensor digitorum longus, peroneal, medial gastrocnemius and soleus) were assessed by magnetic resonance imaging (MRI). Muscle strength, timed functional tests and the Brooke lower extremity score were also assessed. Results Non-contractile content of lower leg muscles (peroneal, medial gastrocnemius, and soleus) was significantly greater than control group (p< 0.05). Non-contractile content of lower leg muscles correlated with Brooke score (r(s) = 0.64-0.84) and 30 feet walk (r(s) = 0.66-0.80). Dorsiflexor (DF) and plantarflexor (PF) specific torque was significantly different between the groups. Discussion Overall, non-contractile content of the lower leg muscles was greater in DMD than controls. Furthermore, there was an age dependent increase in contractile content in the medial gastrocnemius of boys with DMD. The findings of this study suggest that T1 weighted MR images can be used to monitor disease progression and provide a quantitative estimate of contractile and non-contractile content of tissue in children with DMD.	[Vohra, Ravneet S.; Lott, Donovan; Mathur, Sunita; Senesac, Claudia; Deol, Jasjit; Germain, Sean; Forbes, Sean C.; Vandenborne, Krista] Univ Florida, Dept Phys Therapy, Gainesville, FL 32611 USA; [Bendixen, Roxanna] Univ Florida, Dept Occupat Therapy, Gainesville, FL USA; [Sweeney, H. Lee] Univ Penn, Dept Physiol, Sch Med, Philadelphia, PA 19104 USA; [Walter, Glenn A.] Univ Florida, Dept Physiol & Funct Genom, Gainesville, FL USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; University of Pennsylvania; State University System of Florida; University of Florida	Vandenborne, K (corresponding author), Univ Florida, Dept Phys Therapy, Gainesville, FL 32611 USA.	kvandenb@phhp.ufl.edu	Vohra, Ravneet/AAD-5864-2019	Mathur, Sunita/0000-0001-5564-9796; Vohra, Ravneet/0000-0001-6258-2710	Muscular dystrophy Association [MDA4170]; Senator Paul D. Wellstone Muscular Dystrophy Cooperative Research center [U54AR052646]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR056973, U54AR052646] Funding Source: NIH RePORTER	Muscular dystrophy Association(Muscular Dystrophy Association); Senator Paul D. Wellstone Muscular Dystrophy Cooperative Research center; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	The study was supported by Muscular dystrophy Association (grant no. MDA4170) and Senator Paul D. Wellstone Muscular Dystrophy Cooperative Research center (grant no. U54AR052646).	Akima H, 2012, NEUROMUSCULAR DISORD, V22, P16, DOI 10.1016/j.nmd.2011.06.750; ARAI Y, 1995, BRAIN DEV-JPN, V17, P95, DOI 10.1016/0387-7604(95)00006-W; Arpan I, 2013, NMR BIOMED, V26, P320, DOI 10.1002/nbm.2851; Baiardini I, 2011, J CHILD NEUROL, V26, P707, DOI 10.1177/0883073810389043; Beenakker EAC, 2002, NEUROMUSCULAR DISORD, V12, P639, DOI 10.1016/S0960-8966(02)00019-6; Bendixen RM, 2012, HEALTH QUAL LIFE OUT, V10, DOI 10.1186/1477-7525-10-43; Bray P, 2010, J CHILD NEUROL, V25, P1188, DOI 10.1177/0883073809357624; BROOKE MH, 1981, MUSCLE NERVE, V4, P186, DOI 10.1002/mus.880040304; BULFIELD G, 1984, P NATL ACAD SCI-BIOL, V81, P1189, DOI 10.1073/pnas.81.4.1189; CARPENTER JL, 1989, AM J PATHOL, V135, P909; COOPER BJ, 1988, NATURE, V334, P154, DOI 10.1038/334154a0; CROS D, 1989, J NEUROL, V236, P43, DOI 10.1007/BF00314217; D'Angelo MG, 2009, GAIT POSTURE, V29, P36, DOI 10.1016/j.gaitpost.2008.06.002; Deconinck N, 2007, PEDIATR NEUROL, V36, P1, DOI 10.1016/j.pediatrneurol.2006.09.016; Desguerre I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004347; Doglio L, 2011, EUR J PHYS REHAB MED, V47, P587; Emery A E, 1991, Neuromuscul Disord, V1, P19, DOI 10.1016/0960-8966(91)90039-U; Forbes SC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106435; Gaeta M, 2012, SKELETAL RADIOL, V41, P955, DOI 10.1007/s00256-011-1301-5; GASCHEN FP, 1992, J NEUROL SCI, V110, P149, DOI 10.1016/0022-510X(92)90022-D; Gaudreault N, 2010, GAIT POSTURE, V32, P342, DOI 10.1016/j.gaitpost.2010.06.003; Gillis JM, 1999, J MUSCLE RES CELL M, V20, P605, DOI 10.1023/A:1005545325254; Gray C, 2011, CLIN NUTR, V30, P106, DOI 10.1016/j.clnu.2010.07.012; Hasson CJ, 2011, J BIOMECH, V44, P2299, DOI 10.1016/j.jbiomech.2011.05.031; HOFFMAN EP, 1987, CELL, V51, P919, DOI 10.1016/0092-8674(87)90579-4; Hoffman EP, 2013, DISCOV MED, V16, P233; Humbertclaude V, 2012, EUR J PAEDIATR NEURO, V16, P149, DOI 10.1016/j.ejpn.2011.07.001; Jansen M, 2012, NEUROMUSCULAR DISORD, V22, P306, DOI 10.1016/j.nmd.2011.10.020; Jayaraman A, 2008, J SPINAL CORD MED, V31, P185, DOI 10.1080/10790268.2008.11760710; JONES DA, 1983, J NEUROL SCI, V60, P307, DOI 10.1016/0022-510X(83)90071-0; Kent-Braun JA, 2000, J APPL PHYSIOL, V88, P662, DOI 10.1152/jappl.2000.88.2.662; Kim HK, 2010, RADIOLOGY, V255, P899, DOI 10.1148/radiol.10091547; Kinali M, 2011, NEUROLOGY, V76, P346, DOI 10.1212/WNL.0b013e318208811f; KORNEGAY JN, 1988, MUSCLE NERVE, V11, P1056, DOI 10.1002/mus.880111008; Krivickas LS, 2000, MUSCLE NERVE, V23, P529, DOI 10.1002/(SICI)1097-4598(200004)23:4<529::AID-MUS11>3.0.CO;2-Y; LAMMINEN AE, 1990, BRIT J RADIOL, V63, P946, DOI 10.1259/0007-1285-63-756-946; Lynch GS, 2001, J PHYSIOL-LONDON, V535, P591, DOI 10.1111/j.1469-7793.2001.00591.x; Manini TM, 2007, AM J CLIN NUTR, V85, P377, DOI 10.1093/ajcn/85.2.377; Marden FA, 2005, SKELETAL RADIOL, V34, P140, DOI 10.1007/s00256-004-0825-3; Mathur S, 2010, ARCH PHYS MED REHAB, V91, P1051, DOI 10.1016/j.apmr.2010.03.024; MCDONALD CM, 1995, AM J PHYS MED REHAB, V74, pS70, DOI 10.1097/00002060-199509001-00003; MCDOUALL RM, 1990, J NEUROL SCI, V99, P199, DOI 10.1016/0022-510X(90)90156-H; Mendell JR, 2012, ANN NEUROL, V71, P304, DOI 10.1002/ana.23528; Mercuri E, 2007, J MAGN RESON IMAGING, V25, P433, DOI 10.1002/jmri.20804; PRADHAN S, 1995, CLIN NEUROL NEUROSUR, V97, P134, DOI 10.1016/0303-8467(95)00013-A; Reimers CD, 1996, J NEUROL SCI, V143, P46, DOI 10.1016/S0022-510X(96)00037-8; Richards P, 2000, DEV MED CHILD NEUROL, V42, P786, DOI 10.1017/S0012162200241455; Rutkove SB, 2014, PEDIATR NEUROL, V51, P88, DOI 10.1016/j.pediatrneurol.2014.02.015; Sampaolesi M, 2006, NATURE, V444, P574, DOI 10.1038/nature05282; Shah PK, 2006, ARCH PHYS MED REHAB, V87, P772, DOI 10.1016/j.apmr.2006.02.028; Sled JG, 1998, IEEE T MED IMAGING, V17, P87, DOI 10.1109/42.668698; STEDMAN HH, 1991, NATURE, V352, P536, DOI 10.1038/352536a0; Torriani M, 2012, SKELETAL RADIOL, V41, P437, DOI 10.1007/s00256-011-1240-1; van der Graaf M, 2010, NMR BIOMED, V23, P133, DOI 10.1002/nbm.1433; van Deutekom JC, 2007, NEW ENGL J MED, V357, P2677, DOI 10.1056/NEJMoa073108; Wattjes MP, 2010, EUR RADIOL, V20, P2447, DOI 10.1007/s00330-010-1799-2; Wren TAL, 2008, AM J ROENTGENOL, V190, pW8, DOI 10.2214/AJR.07.2732	57	36	36	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2015	10	6							e0128915	10.1371/journal.pone.0128915	http://dx.doi.org/10.1371/journal.pone.0128915			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4DD	26103164	Green Submitted, Green Published, gold			2022-12-26	WOS:000356901900010
J	Wang, J; Hilchey, SP; Hyrien, O; Huertas, N; Perry, S; Ramanunninair, M; Bucher, D; Zand, MS				Wang, Jiong; Hilchey, Shannon P.; Hyrien, Ollivier; Huertas, Nelson; Perry, Sheldon; Ramanunninair, Manojkumar; Bucher, Doris; Zand, Martin S.			Multi-Dimensional Measurement of Antibody-Mediated Heterosubtypic Immunity to Influenza	PLOS ONE			English	Article							LINKED-IMMUNOSORBENT-ASSAY; A VIRUS HEMAGGLUTININ; ANTIGENIC CARTOGRAPHY; GENETIC EVOLUTION; H3N2 VIRUSES; VACCINE; INFECTION; INDUCTION; RESPONSES; STRAIN	The human immune response to influenza vaccination depends in part on preexisting cross-reactive (heterosubtypic) immunity from previous infection by, and/or vaccination with, influenza strains that share antigenic determinants with the vaccine strains. However, current methods for assessing heterosubtypic antibody responses against influenza, including the hemagglutination-inhibition (HAI) assay and ELISA, are time and labor intensive, and require moderate amounts of serum and reagents. To address these issues we have developed a fluorescent multiplex assay, mPlex-Flu, that rapidly and simultaneously measures strain specific IgG, IgA, and IgM antibodies against influenza hemagglutinin (HA) from multiple viral strains. We cloned, expressed and purified HA proteins from 12 influenza strains, and coupled them to multiplex beads. Assay validation showed that minimal sample volumes (<5 mu l of serum) were needed, and the assay had a linear response over a four Log(10) range. The assay detected nanogram levels of anti-influenza specific antibodies, had high accuracy and reproducibility, with an average percentage coefficient of variation (%CV) of 9.06 for intra-assay and 12.94 for inter-assay variability. Pre- and post-intramuscular trivalent influenza vaccination levels of virus specific Ig were consistent with HAI titer and ELISA measurements. A significant advantage of the mPLEX-Flu assay over the HAI assay is the ability to perform antigenic cartography, determining the antigenic distances between influenza HA's, without mathematical correction for HAI data issues. For validation we performed antigenic cartography on 14 different post-influenza infection ferret sera assayed against 12 different influenza HA's. Results were in good agreement with a phylogenetic tree generated from hierarchical clustering of the genomic HA sequences. This is the first report of the use of a multiplex method for antigenic cartography using ferret sera. Overall, the mPlex-Flu assay provides a powerful tool to rapidly assess the influenza antibody repertoire in large populations and to study heterosubtypic immunity induced by influenza vaccination.	[Wang, Jiong; Hilchey, Shannon P.; Huertas, Nelson; Perry, Sheldon; Zand, Martin S.] Univ Rochester, Med Ctr, Dept Med, Div Nephrol, Rochester, NY 14642 USA; [Wang, Jiong; Hilchey, Shannon P.; Huertas, Nelson; Perry, Sheldon; Zand, Martin S.] Univ Rochester, Med Ctr, Rochester Ctr Biodefense Immune Modeling, Rochester, NY 14642 USA; [Hyrien, Ollivier] Univ Rochester, Med Ctr, Dept Biostat & Computat Biol, Rochester, NY 14642 USA; [Zand, Martin S.] Univ Rochester, Med Ctr, Rochester Ctr Hlth Informat, Rochester, NY 14642 USA; [Ramanunninair, Manojkumar; Bucher, Doris] New York Med Coll, Dept Microbiol & Immunol, Valhalla, NY 10595 USA	University of Rochester; University of Rochester; University of Rochester; University of Rochester; New York Medical College	Zand, MS (corresponding author), Univ Rochester, Med Ctr, Dept Med, Div Nephrol, Rochester, NY 14642 USA.	Martin_zand@urmc.rochester.edu		Zand, Martin/0000-0002-7095-8682; Wang, Jiong/0000-0002-4938-5074	National Institutes of Health, National Institute of Allergy, Immunology and Infectious Diseases [HHSN272201000055C, AI098112, AI069351]; University of Rochester CTSA from National Center for Advancing Translational Sciences of the National Institutes of Health [UL1 TR000042]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000042] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI098112, R01AI069351] Funding Source: NIH RePORTER	National Institutes of Health, National Institute of Allergy, Immunology and Infectious Diseases; University of Rochester CTSA from National Center for Advancing Translational Sciences of the National Institutes of Health; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported by the National Institutes of Health, National Institute of Allergy, Immunology and Infectious Diseases grants and contracts numbers: HHSN272201000055C, AI098112, and AI069351. The project described in this publication was also supported by the University of Rochester CTSA award number UL1 TR000042 from the National Center for Advancing Translational Sciences of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2013, WEST PAC SURVEILL RE, V4, DOI [10.5365/wpsar.2013.4.1.009, 10.5365/WPSAR.2013.4.1.009]; Barnett JL, 2012, BIOINFORMATICS, V28, P1292, DOI 10.1093/bioinformatics/bts105; Barr IG, 2010, VACCINE, V28, P1156, DOI 10.1016/j.vaccine.2009.11.043; Bedford T, 2014, ELIFE, V3, DOI 10.7554/eLife.01914; Bodewes R, 2010, J GEN VIROL, V91, P1743, DOI 10.1099/vir.0.020784-0; Bodewes R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005538; Brady MT, 2013, PEDIATRICS, V132, pE1089, DOI 10.1542/peds.2013-2377; BURLINGTON DB, 1983, INFECT IMMUN, V41, P540, DOI 10.1128/IAI.41.2.540-545.1983; BURLINGTON DB, 1985, J CLIN MICROBIOL, V21, P847, DOI 10.1128/JCM.21.5.847-849.1985; Cai ZP, 2011, INFLUENZA OTHER RESP, V5, P204; Cai ZP, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000949; Chowdhury MYE, 2014, VIROL J, V11, DOI 10.1186/1743-422X-11-21; Daly JM, 2013, VACCINE, V31, P6043, DOI 10.1016/j.vaccine.2013.06.070; de Jong JC, 2007, J VIROL, V81, P4315, DOI 10.1128/JVI.02458-06; de Jong JC, 2000, J MED VIROL, V61, P94, DOI 10.1002/(SICI)1096-9071(200005)61:1&lt;94::AID-JMV15&gt;3.0.CO;2-C; Desbien AL, 2013, BIOTECHNIQUES, V54, P345, DOI 10.2144/000114041; Ekiert DC, 2011, SCIENCE, V333, P843, DOI 10.1126/science.1204839; Ekiert DC, 2009, SCIENCE, V324, P246, DOI 10.1126/science.1171491; Ellebedy AH, 2014, P NATL ACAD SCI USA, V111, P13133, DOI 10.1073/pnas.1414070111; Epstein SL, 1997, J IMMUNOL, V158, P1222; Fonville JM, 2014, SCIENCE, V346, P996, DOI 10.1126/science.1256427; Fouchier RAM, 2010, AVIAN DIS, V54, P220, DOI 10.1637/8740-032509-ResNote.1; Gall A, 2009, J CLIN MICROBIOL, V47, P327, DOI 10.1128/JCM.01330-08; Greenbaum JA, 2009, P NATL ACAD SCI USA, V106, P20365, DOI 10.1073/pnas.0911580106; Henn AD, 2013, SCI REP-UK, V3, DOI 10.1038/srep02327; Lal G, 2005, J IMMUNOL METHODS, V296, P135, DOI 10.1016/j.jim.2004.11.006; Lewis NS, 2014, J VIROL, V88, P4752, DOI 10.1128/JVI.03805-13; Margine I, 2013, J VIROL, V87, P10435, DOI 10.1128/JVI.01715-13; Margine I, 2013, J VIROL, V87, P4728, DOI 10.1128/JVI.03509-12; McVernon J, 2011, INFLUENZA OTHER RESP, V5, P7, DOI 10.1111/j.1750-2659.2010.00172.x; Medeiros R, 2001, VIROLOGY, V289, P74, DOI 10.1006/viro.2001.1121; Muramatsu M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085582; MURPHY BR, 1981, J CLIN MICROBIOL, V13, P554, DOI 10.1128/JCM.13.3.554-560.1981; Nayak JL, 2015, J INFECT DIS, V211, P1408, DOI 10.1093/infdis/jiu616; Nguyen HH, 2001, J INFECT DIS, V183, P368, DOI 10.1086/318084; Ohmit SE, 2011, J INFECT DIS, V204, P1879, DOI 10.1093/infdis/jir661; Price JV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064555; QUATAERT SA, 1995, CLIN DIAGN LAB IMMUN, V2, P590, DOI 10.1128/CDLI.2.5.590-597.1995; Remarque EJ, 1998, J MED VIROL, V55, P82, DOI 10.1002/(SICI)1096-9071(199805)55:1&lt;82::AID-JMV13&gt;3.0.CO;2-1; Sangster MY, 2013, CLIN VACCINE IMMUNOL, V20, P867, DOI 10.1128/CVI.00735-12; Santiago FW, 2012, VACCINE, V30, P4606, DOI 10.1016/j.vaccine.2012.05.005; Smith DJ, 2004, SCIENCE, V305, P371, DOI 10.1126/science.1097211; Squires RB, 2012, INFLUENZA OTHER RESP, V6, P404, DOI 10.1111/j.1750-2659.2011.00331.x; Stanekova Z, 2013, ANTIVIR RES, V97, P24, DOI 10.1016/j.antiviral.2012.09.008; Sun HL, 2013, MBIO, V4, DOI 10.1128/mBio.00230-13; Tharakaraman K, 2014, CELL HOST MICROBE, V15, P644, DOI 10.1016/j.chom.2014.04.009; VANDEWATER C, 1993, J IMMUNOL METHODS, V166, P157, DOI 10.1016/0022-1759(93)90356-C; Wang K, 2006, VACCINE, V24, P2176, DOI 10.1016/j.vaccine.2005.11.005; Watson DS, 2009, J IMMUNOL METHODS, V340, P123, DOI 10.1016/j.jim.2008.10.007; Wiersma EJ, 1998, J IMMUNOL, V160, P5979; Wyrzucki A, 2014, J VIROL, V88, P7083, DOI 10.1128/JVI.00178-14	51	22	22	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2015	10	6							e0129858	10.1371/journal.pone.0129858	http://dx.doi.org/10.1371/journal.pone.0129858			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4DD	26103163	gold, Green Published, Green Submitted			2022-12-26	WOS:000356901900022
J	Whalley, HC; Dimitrova, R; Sprooten, E; Dauvermann, MR; Romaniuk, L; Duff, B; Watson, AR; Moorhead, B; Bastin, M; Semple, SI; Giles, S; Hall, J; Thomson, P; Roberts, N; Hughes, ZA; Brandon, NJ; Dunlop, J; Whitcher, B; Blackwood, DHR; McIntosh, AM; Lawrie, SM				Whalley, Heather C.; Dimitrova, Rali; Sprooten, Emma; Dauvermann, Maria R.; Romaniuk, Liana; Duff, Barbara; Watson, Andrew R.; Moorhead, Bill; Bastin, Mark; Semple, Scott I.; Giles, Stephen; Hall, Jeremy; Thomson, Pippa; Roberts, Neil; Hughes, Zoe A.; Brandon, Nick J.; Dunlop, John; Whitcher, Brandon; Blackwood, Douglas H. R.; McIntosh, Andrew M.; Lawrie, Stephen M.			Effects of a Balanced Translocation between Chromosomes 1 and 11 Disrupting the DISC1 Locus on White Matter Integrity	PLOS ONE			English	Article							HIGH GENETIC RISK; CORPUS-CALLOSUM; BIPOLAR DISORDER; PREFRONTAL CORTEX; POSITIVE SYMPTOMS; RATING-SCALE; GRAY-MATTER; SCHIZOPHRENIA; ASSOCIATION; PSYCHOSIS	Objective Individuals carrying rare, but biologically informative genetic variants provide a unique opportunity to model major mental illness and inform understanding of disease mechanisms. The rarity of such variations means that their study involves small group numbers, however they are amongst the strongest known genetic risk factors for major mental illness and are likely to have large neural effects. DISC1 (Disrupted in Schizophrenia 1) is a gene containing one such risk variant, identified in a single Scottish family through its disruption by a balanced translocation of chromosomes 1 and 11;t(1;11) (q42.1;q14.3). Method Within the original pedigree, we examined the effects of the t(1;11) translocation on white matter integrity, measured by fractional anisotropy (FA). This included family members with (n = 7) and without (n = 13) the translocation, along with a clinical control sample of patients with psychosis (n = 34), and a group of healthy controls (n = 33). Results We report decreased white matter integrity in five clusters in the genu of the corpus callosum, the right inferior fronto-occipital fasciculus, acoustic radiation and fornix. Analysis of the mixed psychosis group also demonstrated decreased white matter integrity in the above regions. FA values within the corpus callosum correlated significantly with positive psychotic symptom severity. Conclusions We demonstrate that the t(1;11) translocation is associated with reduced white matter integrity in frontal commissural and association fibre tracts. These findings overlap with those shown in affected patients with psychosis and in DISC1 animal models and highlight the value of rare but biologically informative mutations in modeling psychosis.	[Whalley, Heather C.; Dimitrova, Rali; Dauvermann, Maria R.; Romaniuk, Liana; Duff, Barbara; Watson, Andrew R.; Moorhead, Bill; Giles, Stephen; Hall, Jeremy; Blackwood, Douglas H. R.; McIntosh, Andrew M.; Lawrie, Stephen M.] Univ Edinburgh, Div Psychiat, Edinburgh, Midlothian, Scotland; [Dimitrova, Rali] Kings Coll London, St Thomas Hosp, Ctr Developing Brain, London, England; [Sprooten, Emma] Yale Univ, Dept Psychiat, New Haven, CT 06520 USA; [Dauvermann, Maria R.] McGovern Inst Brain Res, Cambridge, MA USA; [Bastin, Mark] Univ Edinburgh, Western Gen Hosp, Ctr Clin Brain Sci, Edinburgh, Midlothian, Scotland; [Semple, Scott I.; Roberts, Neil] Univ Edinburgh, Clin Res Imaging Ctr, Edinburgh, Midlothian, Scotland; [Semple, Scott I.] Univ Edinburgh, British Heart Fdn Ctr Cardiovasc Sci, Edinburgh, Midlothian, Scotland; [Hall, Jeremy] Cardiff Univ, Neurosci & Mental Hlth Res Inst, Cardiff CF10 3AX, S Glam, Wales; [Thomson, Pippa] Univ Edinburgh, MRC Inst Genet & Mol Med, Dept Med Genet, Edinburgh, Midlothian, Scotland; [Roberts, Neil] Univ Edinburgh, Ctr Inflammat Res, Edinburgh, Midlothian, Scotland; [Hughes, Zoe A.; Brandon, Nick J.; Dunlop, John] Pfizer Inc, Neurosci Res Unit, Cambridge, MA USA; [Whitcher, Brandon] Pfizer Inc, Clin & Translat Imaging, Cambridge, MA USA	University of Edinburgh; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; Yale University; University of Edinburgh; University of Edinburgh; University of Edinburgh; Cardiff University; University of Edinburgh; University of Edinburgh; Pfizer; Pfizer	Whalley, HC (corresponding author), Univ Edinburgh, Div Psychiat, Edinburgh, Midlothian, Scotland.	heather.whalley@ed.ac.uk	Whalley, Heather C/N-1886-2019; Dauvermann, Maria/ABA-8847-2021; Dimitrova, Ralica/AAX-7887-2020; Sprooten, Emma/N-3836-2017; Hughes, Zoe/P-5119-2019; McIntosh, Andrew M/B-9379-2008; blackwood, douglas/AIB-8874-2022; Lawrie, Stephen MacGregor/AAD-1607-2021	Whalley, Heather C/0000-0002-4505-8869; Dauvermann, Maria/0000-0002-2873-8512; Dimitrova, Ralica/0000-0002-6903-7990; Sprooten, Emma/0000-0002-1691-9105; Hughes, Zoe/0000-0001-7174-0944; McIntosh, Andrew M/0000-0002-0198-4588; Lawrie, Stephen MacGregor/0000-0002-2444-5675; Hall, Jeremy/0000-0002-0403-3278; Brandon, Nicholas/0000-0002-3917-0096; Whitcher, Brandon/0000-0002-6452-2399	Translational Medicine Research Collaboration; Scottish Enterprise; Pfizer; Dr Mortimer and Theresa Sackler Foundation; National Health Service (NHS) Research Scotland, through the Scottish Mental Health Research Network; Royal College of Physicians of Edinburgh; Pfizer Inc.; MRC [MR/J004367/1, G0600429] Funding Source: UKRI; Medical Research Council [MR/L010305/1, G0600429, MR/K026992/1, MR/J004367/1] Funding Source: researchfish	Translational Medicine Research Collaboration; Scottish Enterprise; Pfizer(Pfizer); Dr Mortimer and Theresa Sackler Foundation; National Health Service (NHS) Research Scotland, through the Scottish Mental Health Research Network; Royal College of Physicians of Edinburgh; Pfizer Inc.(Pfizer); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by an award from the Translational Medicine Research Collaboration-consortium made up of the Universities of Aberdeen, Dundee, Edinburgh and Glasgow, the four associated NHS Health Boards (Grampian, Tayside, Lothian and Greater Glasgow & Clyde), Scottish Enterprise and Pfizer. Imaging aspects also received financial support from the Dr Mortimer and Theresa Sackler Foundation. The investigators also acknowledge the financial support of National Health Service (NHS) Research Scotland, through the Scottish Mental Health Research Network (http://www.smhrn.org.uk) who provided assistance with subject recruitment and cognitive assessments. HCW is supported by a College Fellowship from the University of Edinburgh and a JMAS SIM fellowship from the Royal College of Physicians of Edinburgh. Pfizer Inc., provided support in the form of salaries for authors ZAH, NJB, JD and BW but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the author contributions section.	ANDREASEN NC, 1989, BRITISH JOURNAL OF PSYCHIATRY, VOL 155, SUPP NO. 7, P49; Arnone D, 2008, ACTA PSYCHIAT SCAND, V118, P357, DOI 10.1111/j.1600-0447.2008.01229.x; Arnone D, 2008, SCHIZOPHR RES, V101, P124, DOI 10.1016/j.schres.2008.01.005; BARBAS H, 1984, EXP BRAIN RES, V55, P187; Behrens TEJ, 2003, MAGN RESON MED, V50, P1077, DOI 10.1002/mrm.10609; Blackwood DHR, 2001, AM J HUM GENET, V69, P428, DOI 10.1086/321969; Brandon NJ, 2011, NAT REV NEUROSCI, V12, P707, DOI 10.1038/nrn3120; Burdick KE, 2005, NEUROREPORT, V16, P1399, DOI 10.1097/01.wnr.0000175248.25535.f6; Burns J, 2003, BRIT J PSYCHIAT, V182, P439, DOI 10.1192/bjp.182.5.439; Callicott JH, 2005, P NATL ACAD SCI USA, V102, P8627, DOI 10.1073/pnas.0500515102; Camchong J, 2009, FRONT HUM NEUROSCI, V3, DOI 10.3389/neuro.09.035.2009; Cannon TD, 2005, ARCH GEN PSYCHIAT, V62, P1205, DOI 10.1001/archpsyc.62.11.1205; Chubb JE, 2008, MOL PSYCHIATR, V13, P36, DOI 10.1038/sj.mp.4002106; DAVID AS, 1994, BEHAV BRAIN RES, V64, P203, DOI 10.1016/0166-4328(94)90132-5; DeRosse P, 2007, BIOL PSYCHIAT, V61, P1208, DOI 10.1016/j.biopsych.2006.07.023; Di X, 2009, PROG NEURO-PSYCHOPH, V33, P1390, DOI 10.1016/j.pnpbp.2009.08.020; Duff BJ, 2013, SCHIZOPHR RES, V147, P1, DOI 10.1016/j.schres.2013.03.015; Eastwood SL, 2010, HUM MOL GENET, V19, P2487, DOI 10.1093/hmg/ddq130; Edgar N, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.34; El-Hassar L, 2014, BIOL PSYCHIAT, V76, P476, DOI 10.1016/j.biopsych.2013.12.019; Ellison-Wright I, 2009, SCHIZOPHR RES, V108, P3, DOI 10.1016/j.schres.2008.11.021; Fields RD, 2008, TRENDS NEUROSCI, V31, P361, DOI 10.1016/j.tins.2008.04.001; First MB, 2002, STRUCTURED CLIN INTE; Gasparotti R, 2009, SCHIZOPHR RES, V108, P41, DOI 10.1016/j.schres.2008.11.015; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; Hamshere ML, 2005, ARCH GEN PSYCHIAT, V62, P1081, DOI 10.1001/archpsyc.62.10.1081; Hashimoto R, 2006, HUM MOL GENET, V15, P3024, DOI 10.1093/hmg/ddl244; Hattori T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088506; Hulshoff-Pol HE, 2006, J NEUROSCI, V26, P10235, DOI 10.1523/JNEUROSCI.1312-06.2006; JACOBS PA, 1970, ANN HUM GENET, V33, P325, DOI 10.1111/j.1469-1809.1970.tb01658.x; Johnstone M, 2011, SCHIZOPHRENIA BULL, V37, P14, DOI 10.1093/schbul/sbq135; Jones DK, 2013, NEUROIMAGE, V73, P239, DOI 10.1016/j.neuroimage.2012.06.081; KAY SR, 1987, SCHIZOPHRENIA BULL, V13, P261, DOI 10.1093/schbul/13.2.261; Koressaar T, 2007, BIOINFORMATICS, V23, P1289, DOI 10.1093/bioinformatics/btm091; Lawrie SM, 2002, BIOL PSYCHIAT, V51, P1008, DOI 10.1016/S0006-3223(02)01316-1; Lichtenstein P, 2009, LANCET, V373, P234, DOI 10.1016/S0140-6736(09)60072-6; Maniega SM, 2008, SCHIZOPHR RES, V106, P132, DOI 10.1016/j.schres.2008.09.016; Mao YW, 2009, CELL, V136, P1017, DOI 10.1016/j.cell.2008.12.044; Millar JK, 2005, MOL CELL NEUROSCI, V30, P477, DOI 10.1016/j.mcn.2005.08.021; Ming GL, 2009, CELL, V136, P990, DOI 10.1016/j.cell.2009.03.005; Murray CJL, 1997, LANCET, V349, P1436, DOI 10.1016/S0140-6736(96)07495-8; Narr KL, 2000, CEREB CORTEX, V10, P40, DOI 10.1093/cercor/10.1.40; Osbun N, 2011, AM J MED GENET A, V155A, P1865, DOI 10.1002/ajmg.a.34081; Paul LK, 2007, NAT REV NEUROSCI, V8, P287, DOI 10.1038/nrn2107; Peper JS, 2007, HUM BRAIN MAPP, V28, P464, DOI 10.1002/hbm.20398; Phillips ML, 2003, BIOL PSYCHIAT, V54, P515, DOI 10.1016/S0006-3223(03)00171-9; Porteous DJ, 2006, BIOL PSYCHIAT, V60, P123, DOI 10.1016/j.biopsych.2006.04.008; Prata DP, 2008, MOL PSYCHIATR, V13, P915, DOI 10.1038/mp.2008.76; Price G, 2007, NEUROIMAGE, V35, P458, DOI 10.1016/j.neuroimage.2006.12.019; Puthuran MJ, 2005, AM J MED GENET A, V138A, P68, DOI 10.1002/ajmg.a.30888; Randall AD, 2014, EUR J NEUROSCI, V39, P1068, DOI 10.1111/ejn.12500; Ripke S, 2014, NATURE, V511, P421, DOI 10.1038/nature13595; Shen SB, 2008, J NEUROSCI, V28, P10893, DOI 10.1523/JNEUROSCI.3299-08.2008; Shimizu S, 2014, GLIA, V62, P709, DOI 10.1002/glia.22636; Skudlarski P, 2013, AM J PSYCHIAT, V170, P886, DOI 10.1176/appi.ajp.2013.12111448; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Smith SM, 2009, NEUROIMAGE, V44, P83, DOI 10.1016/j.neuroimage.2008.03.061; Smoller JW, 2013, LANCET, V381, P1371, DOI 10.1016/S0140-6736(12)62129-1; Sprooten E, 2011, MOL PSYCHIATR, V16, P688, DOI 10.1038/mp.2011.15; Sprooten E, 2011, BIOL PSYCHIAT, V70, P350, DOI 10.1016/j.biopsych.2011.01.021; STCLAIR D, 1990, LANCET, V336, P13, DOI 10.1016/0140-6736(90)91520-K; Stephan KE, 2009, SCHIZOPHRENIA BULL, V35, P509, DOI 10.1093/schbul/sbn176; Szeszko PR, 2008, BIOL PSYCHOL, V79, P103, DOI 10.1016/j.biopsycho.2007.10.011; Takahashi N, 2011, PROG NEUROBIOL, V93, P13, DOI 10.1016/j.pneurobio.2010.09.004; Takahashi T, 2009, PSYCHIAT RES-NEUROIM, V172, P128, DOI 10.1016/j.pscychresns.2009.01.005; Thomson Pippa A, 2013, Front Biol (Beijing), V8, P1; Tomppo L, 2009, ARCH GEN PSYCHIAT, V66, P134, DOI 10.1001/archgenpsychiatry.2008.524; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; Venkatasubramanian G, 2010, PSYCHIAT RES-NEUROIM, V182, P141, DOI 10.1016/j.pscychresns.2010.01.004; Wang Q, 2011, MOL CELL NEUROSCI, V48, P359, DOI 10.1016/j.mcn.2011.06.004; Whalley HC, 2005, BRAIN, V128, P2097, DOI 10.1093/brain/awh556; Whalley HC, 2012, AM J MED GENET B, V159B, P343, DOI 10.1002/ajmg.b.32035; YOUNG RC, 1978, BRIT J PSYCHIAT, V133, P429, DOI 10.1192/bjp.133.5.429; Zhan L, 2009, LECT NOTES COMPUT SC, V5761, P845, DOI 10.1007/978-3-642-04268-3_104	74	18	18	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2015	10	6							e0130900	10.1371/journal.pone.0130900	http://dx.doi.org/10.1371/journal.pone.0130900			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4DD	26102360	Green Submitted, Green Accepted, Green Published, gold			2022-12-26	WOS:000356901900066
J	Hong, EH; Song, JH; Shim, A; Lee, BR; Kwon, BE; Song, HH; Kim, YJ; Chang, SY; Jeong, HG; Kim, JG; Seo, SU; Kim, H; Kwon, Y; Ko, HJ				Hong, Eun-Hye; Song, Jae-Hyoung; Shim, Aeri; Lee, Bo-Ra; Kwon, Bo-Eun; Song, Hyuk-Hwan; Kim, Yeon-Jeong; Chang, Sun-Young; Jeong, Hyeon Gun; Kim, Jong Geal; Seo, Sang-Uk; Kim, HyunPyo; Kwon, YongSoo; Ko, Hyun-Jeong			Coadministration of Hedera helix L. Extract Enabled Mice to Overcome Insufficient Protection against Influenza A/PR/8 Virus Infection under Suboptimal Treatment with Oseltamivir	PLOS ONE			English	Article							NEURAMINIDASE INHIBITORS; GENE-EXPRESSION; IVY PLANT; TNF-ALPHA; TRITERPENOID SAPONINS; ANTIVIRAL ACTIVITY; RESISTANT; RESPONSES; IMMUNOPATHOLOGY; CYTOKINE	Several anti-influenza drugs that reduce disease manifestation exist, and although these drugs provide clinical benefits in infected patients, their efficacy is limited by the emergence of drug-resistant influenza viruses. In the current study, we assessed the therapeutic strategy of enhancing the antiviral efficacy of an existing neuraminidase inhibitor, oseltamivir, by coadministering with the leaf extract from Hedera helix L, commonly known as ivy. Ivy extract has anti-inflammatory, antibacterial, antifungal, and antihelminthic properties. In the present study, we investigated its potential antiviral properties against influenza A/PR/8 (PR8) virus in a mouse model with suboptimal oseltamivir that mimics a poor clinical response to antiviral drug treatment. Suboptimal oseltamivir resulted in insufficient protection against PR8 infection. Oral administration of ivy extract with suboptimal oseltamivir increased the antiviral activity of oseltamivir. Ivy extract and its compounds, particularly hedrasaponin F, significantly reduced the cytopathic effect in PR8-infected A549 cells in the presence of oseltamivir. Compared with oseltamivir treatment alone, coadministration of the fraction of ivy extract that contained the highest proportion of hedrasaponin F with oseltamivir decreased pulmonary inflammation in PR8-infected mice. Inflammatory cytokines and chemokines, including tumor necrosis factor-alpha and chemokine (C-C motif) ligand 2, were reduced by treatment with oseltamivir and the fraction of ivy extract. Analysis of inflammatory cell infiltration in the bronchial alveolar of PR8-infected mice revealed that CD11b(+-)Ly6G(+) and CD11b(+)Ly6C(int) cells were recruited after virus infection; coadministration of the ivy extract fraction with oseltamivir reduced infiltration of these inflammatory cells. In a model of suboptimal oseltamivir treatment, coadministration of ivy extract fraction that includes hedrasaponin F increased protection against PR8 infection that could be explained by its antiviral and anti-inflammatory activities.	[Hong, Eun-Hye; Song, Jae-Hyoung; Shim, Aeri; Lee, Bo-Ra; Kwon, Bo-Eun; Kim, HyunPyo; Kwon, YongSoo; Ko, Hyun-Jeong] Kangwon Natl Univ, Coll Pharm, Lab Microbiol & Immunol, Chunchon, South Korea; [Song, Hyuk-Hwan] Korea Res Inst Biosci & Biotechnol, Nat Med Res Ctr, Chungcheongbuk Do, South Korea; [Kim, Yeon-Jeong] Inje Univ, Coll Pharm, Gimhae, South Korea; [Chang, Sun-Young] Ajou Univ, Coll Pharm, Suwon 441749, South Korea; [Jeong, Hyeon Gun; Kim, Jong Geal] Ahngook Pharm, R&D Ctr, Seoul, South Korea; [Seo, Sang-Uk] Int Vaccine Inst, Mucosal Immunol Sect, Seoul, South Korea	Kangwon National University; Korea Research Institute of Bioscience & Biotechnology (KRIBB); Inje University; Ajou University; International Vaccine Institute	Kwon, Y (corresponding author), Kangwon Natl Univ, Coll Pharm, Lab Microbiol & Immunol, Chunchon, South Korea.	yskwon@kangwon.ac.kr; hjko@kangwon.ac.kr		Ko, Hyun-Jeong/0000-0002-3844-928X	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT and future Planning [NRF-428 2014R1A2A2A01002576]; Ahngook pharm.	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT and future Planning; Ahngook pharm.	This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT and future Planning (NRF-428 2014R1A2A2A01002576). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. HGJ and JGK are employed by Ahngook pharm. Ahngook pharm. provided support in the form of salaries for authors HGJ and JGK and provided hederasaponin F, after isolating and identifying the structure of hederasaponin F, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Abdel-Ghafar AN, 2008, NEW ENGL J MED, V358, P261, DOI 10.1056/NEJMra0707279; An SC, 2011, MED HYPOTHESES, V77, P1054, DOI 10.1016/j.mehy.2011.09.001; Burch J, 2009, LANCET INFECT DIS, V9, P537, DOI 10.1016/S1473-3099(09)70199-9; Cady SD, 2010, NATURE, V463, P689, DOI 10.1038/nature08722; Canini L, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003568; CIOACA C, 1978, PHARMAZIE, V33, P609; Damjanovic D, 2011, AM J PATHOL, V179, P2963, DOI 10.1016/j.ajpath.2011.09.003; De Clercq E, 2006, NAT REV DRUG DISCOV, V5, P1015, DOI 10.1038/nrd2175; de Jong MD, 2005, NEW ENGL J MED, V353, P2667, DOI 10.1056/NEJMoa054512; DeBerge MP, 2014, J IMMUNOL, V192, P5839, DOI 10.4049/jimmunol.1302729; Fazio S, 2009, PHYTOMEDICINE, V16, P17, DOI 10.1016/j.phymed.2006.05.003; Fischer MA, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002374; Fritz RS, 1999, J INFECT DIS, V180, P586, DOI 10.1086/314938; Gepdiremen A, 2005, PHYTOMEDICINE, V12, P440, DOI 10.1016/j.phymed.2004.04.005; GRISHKOVETS VI, 1995, BIOORG KHIM+, V21, P468; Han LT, 2013, EVID-BASED COMPL ALT, V517931, P2013, DOI DOI 10.1155/2013/517931; Hehlgans T, 2005, IMMUNOLOGY, V115, P1, DOI 10.1111/j.1365-2567.2005.02143.x; Hocaoglu AB, 2012, IRAN J ALLERGY ASTHM, V11, P316, DOI 011.04/ijaai.316323; Hufford MM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046581; Hurt AC, 2014, CURR OPIN VIROL, V8, P22, DOI 10.1016/j.coviro.2014.04.009; Hurt AC, 2009, J VIROL, V83, P10366, DOI 10.1128/JVI.01200-09; Jeisy-Scott V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025242; JULIEN J, 1985, PLANTA MED, V51, P205, DOI 10.1055/s-2007-969457; Julkunen I, 2000, VACCINE, V19, pS32, DOI 10.1016/S0264-410X(00)00275-9; Julkunen I, 2001, CYTOKINE GROWTH F R, V12, P171, DOI 10.1016/S1359-6101(00)00026-5; Kok WL, 2012, J LEUKOCYTE BIOL, V91, P357, DOI 10.1189/jlb.0411184; MAJESTERSAVORNIN B, 1991, PLANTA MED, V57, P260, DOI 10.1055/s-2006-960086; Matikainen S, 2006, J VIROL, V80, P3515, DOI 10.1128/JVI.80.7.3515-3522.2006; Monto AS, 2006, ANTIMICROB AGENTS CH, V50, P2395, DOI 10.1128/AAC.01339-05; Moulin-Traffort J, 1998, MYCOSES, V41, P411, DOI 10.1111/j.1439-0507.1998.tb00362.x; Mshvildadze V, 2004, CHEM PHARM BULL, V52, P1411, DOI 10.1248/cpb.52.1411; Ozdemir C, 2003, HAUTARZT, V54, P966, DOI 10.1007/s00105-003-0584-4; Pizzorno A, 2011, J INFECT DIS, V203, P25, DOI 10.1093/infdis/jiq010; Samson M, 2013, ANTIVIR RES, V98, P174, DOI 10.1016/j.antiviral.2013.03.014; Seo SU, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001304; Shale Matt, 2010, Therap Adv Gastroenterol, V3, P173, DOI 10.1177/1756283X10366368; Shim DH, 2007, VACCINE, V25, P4828, DOI 10.1016/j.vaccine.2007.03.050; Simoes CMO, 1999, PHYTOTHER RES, V13, P323, DOI 10.1002/(SICI)1099-1573(199906)13:4&lt;323::AID-PTR448&gt;3.0.CO;2-C; Song J, 2014, BIOMOL THER, V22, P41, DOI 10.4062/biomolther.2013.108; Suleyman H, 2003, PHYTOMEDICINE, V10, P370, DOI 10.1078/0944-7113-00260; Trute A, 1997, PLANTA MED, V63, P125, DOI 10.1055/s-2006-957627; Veckman V, 2006, VIROLOGY, V345, P96, DOI 10.1016/j.virol.2005.09.043; Youn HJ, 2007, VACCINE, V25, P5189, DOI 10.1016/j.vaccine.2007.04.081; Yu XL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028680	44	9	10	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2015	10	6							e0131089	10.1371/journal.pone.0131089	http://dx.doi.org/10.1371/journal.pone.0131089			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL3FM	26098681	Green Published, gold, Green Submitted			2022-12-26	WOS:000356835800147
J	Noyan, H; El-Mounayri, O; Isserlin, R; Arab, S; Momen, A; Cheng, HS; Wu, J; Afroze, T; Li, RK; Fish, JE; Bader, GD; Husain, M				Noyan, Hossein; El-Mounayri, Omar; Isserlin, Ruth; Arab, Sara; Momen, Abdul; Cheng, Henry S.; Wu, Jun; Afroze, Talat; Li, Ren-Ke; Fish, Jason E.; Bader, Gary D.; Husain, Mansoor			Cardioprotective Signature of Short-Term Caloric Restriction	PLOS ONE			English	Article							CARDIOMYOCYTE CIRCADIAN CLOCK; ACTIVATED PROTEIN-KINASE; DIETARY RESTRICTION; LIFE-SPAN; MEDIATES CARDIOPROTECTION; MITOCHONDRIAL BIOGENESIS; MYOCARDIAL-ISCHEMIA; OXIDATIVE STRESS; RHESUS-MONKEYS; DISEASE	Objective To understand the molecular pathways underlying the cardiac preconditioning effect of short-term caloric restriction (CR). Background Lifelong CR has been suggested to reduce the incidence of cardiovascular disease through a variety of mechanisms. However, prolonged adherence to a CR life-style is difficult. Here we reveal the pathways that are modulated by short-term CR, which are associated with protection of the mouse heart from ischemia. Methods Male 10-12 wk old C57bl/6 mice were randomly assigned to an ad libitum(AL) diet with free access to regular chow, or CR, receiving 30% less food for 7 days (d), prior to myocardial infarction (MI) via permanent coronary ligation. At d8, the left ventricles (LV) of AL and CR mice were collected for Western blot, mRNA and microRNA (miR) analyses to identify cardio-protective gene expression signatures. In separate groups, infarct size, cardiac hemodynamics and protein abundance of caspase 3 was measured at d2 post-MI. Results This short-term model of CR was associated with cardio-protection, as evidenced by decreased infarct size (18.5 +/- 2.4% vs. 26.6 +/- 1.7%, N=10/group; P=0.01). mRNA and miR profiles pre-MI (N=5/group) identified genes modulated by short-term CR to be associated with circadian clock, oxidative stress, immune function, apoptosis, metabolism, angiogenesis, cytoskeleton and extracellular matrix (ECM). Western blots pre-MI revealed CR-associated increases in phosphorylated Akt and GSK3 beta, reduced levels of phosphorylated AMPK and mitochondrial related proteins PGC-1 alpha, cytochrome C and cyclooxygenase (COX) IV, with no differences in the levels of phosphorylated eNOS or MAPK (ERK1/2; p38). CR regimen was also associated with reduced protein abundance of cleaved caspase 3 in the infarcted heart and improved cardiac function.	[Noyan, Hossein; El-Mounayri, Omar; Arab, Sara; Momen, Abdul; Afroze, Talat; Husain, Mansoor] Toronto Gen Res Inst, Div Expt Therapeut, Toronto, ON, Canada; [Isserlin, Ruth; Bader, Gary D.] Univ Toronto, Dept Mol Genet, Toronto, ON, Canada; [Cheng, Henry S.; Wu, Jun; Li, Ren-Ke; Fish, Jason E.] Toronto Gen Res Inst, Div Adv Diagnost, Toronto, ON, Canada; [Fish, Jason E.; Husain, Mansoor] Univ Toronto, Dept Lab Med Pathobiol, Toronto, ON, Canada; [Li, Ren-Ke; Fish, Jason E.; Husain, Mansoor] Univ Toronto, Heart & Stroke Richard Lewar Ctr Excellence Cardi, Toronto, ON, Canada; [Bader, Gary D.] Univ Toronto, Donnelly Ctr, Toronto, ON, Canada; [Li, Ren-Ke; Fish, Jason E.; Husain, Mansoor] Univ Hlth Network, Peter Munk Cardiac Ctr, Toronto, ON, Canada; [Husain, Mansoor] Univ Toronto, Dept Med, Toronto, ON, Canada; [Husain, Mansoor] Univ Hlth Network, Ted Rogers Ctr Heart Res, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of Toronto; University of Toronto; University of Toronto; University of Toronto; Peter Munk Cardiac Centre; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto	Husain, M (corresponding author), Toronto Gen Res Inst, Div Expt Therapeut, Toronto, ON, Canada.	mansoor.husain@uhn.ca	Bader, Gary/C-1176-2009	Bader, Gary/0000-0003-0185-8861; Cheng, Henry/0000-0002-4254-962X; Fish, Jason/0000-0003-0640-7277; Husain, Mansoor/0000-0002-3740-6739; Li, Ren-Ke/0000-0002-2584-060X	Heart and Stroke Foundation of Ontario (HSFO) [T6757]; Career Investigator Award of the HSFO [CI6824]; NATIONAL CANCER INSTITUTE [R01CA121941] Funding Source: NIH RePORTER	Heart and Stroke Foundation of Ontario (HSFO)(Heart & Stroke Foundation of Ontario); Career Investigator Award of the HSFO; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was funded by an operating grant to MH from the Heart and Stroke Foundation of Ontario (HSFO; T6757). MH is recipient of a Career Investigator Award of the HSFO (CI6824).	Arad M, 2007, CIRC RES, V100, P474, DOI 10.1161/01.RES.0000258446.23525.37; Aurora AB, 2012, J CLIN INVEST, V122, P1222, DOI 10.1172/JCI59327; Barth S, 2010, J PATHOL, V221, P117, DOI 10.1002/path.2694; Bishop NA, 2007, NAT REV GENET, V8, P835, DOI 10.1038/nrg2188; Bonney S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071493; Bordone L, 2005, NAT REV MOL CELL BIO, V6, P298, DOI 10.1038/nrm1616; Bornfeldt KE, 2011, CELL METAB, V14, P575, DOI 10.1016/j.cmet.2011.07.015; Broderick TL, 2002, MOL CELL BIOCHEM, V233, P119, DOI 10.1023/A:1015506327849; Calvillo L, 2011, J CARDIOVASC PHARM, V58, P500, DOI 10.1097/FJC.0b013e31822b7204; Cao SX, 2001, P NATL ACAD SCI USA, V98, P10630, DOI 10.1073/pnas.191313598; Cava E, 2013, AGING-US, V5, P507, DOI 10.18632/aging.100581; Chandrasekar B, 2001, AM J PHYSIOL-HEART C, V280, pH2094, DOI 10.1152/ajpheart.2001.280.5.H2094; Chung KW, 2013, EXP GERONTOL, V48, P1049, DOI 10.1016/j.exger.2012.11.007; Colman RJ, 2009, SCIENCE, V325, P201, DOI 10.1126/science.1173635; Cushing L, 2011, AM J RESP CELL MOL, V45, P287, DOI 10.1165/rcmb.2010-0323OC; Dhahbi JM, 2004, P NATL ACAD SCI USA, V101, P5524, DOI 10.1073/pnas.0305300101; Dolinsky VW, 2011, BBA-MOL BASIS DIS, V1812, P1477, DOI 10.1016/j.bbadis.2011.06.010; Durgan DJ, 2010, CIRC RES, V106, P647, DOI 10.1161/CIRCRESAHA.109.209957; Durgan DJ, 2010, CIRC RES, V106, P546, DOI 10.1161/CIRCRESAHA.109.209346; Eckle T, 2012, NAT MED, V18, P774, DOI 10.1038/nm.2728; Edwards AG, 2010, MECH AGEING DEV, V131, P739, DOI 10.1016/j.mad.2010.09.007; Fan D, 2014, CIRC RES, V114, P889, DOI 10.1161/CIRCRESAHA.114.302335; Fontana L, 2004, P NATL ACAD SCI USA, V101, P6659, DOI 10.1073/pnas.0308291101; Fontana L, 2010, SCIENCE, V328, P321, DOI 10.1126/science.1172539; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Han XF, 2012, J NUTR BIOCHEM, V23, P1592, DOI 10.1016/j.jnutbio.2011.11.002; Ji F, 2013, BONE, V56, P220, DOI 10.1016/j.bone.2013.05.020; Juhaszova M, 2009, CIRC RES, V104, P1240, DOI 10.1161/CIRCRESAHA.109.197996; Kennedy BK, 2007, CELL MOL LIFE SCI, V64, P1323, DOI 10.1007/s00018-007-6470-y; KENYON C, 1993, NATURE, V366, P461, DOI 10.1038/366461a0; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Kunuthur SP, 2012, J CELL MOL MED, V16, P1739, DOI 10.1111/j.1582-4934.2011.01491.x; Lamia KA, 2008, P NATL ACAD SCI USA, V105, P15172, DOI 10.1073/pnas.0806717105; Lee J, 2010, AGING-US, V2, P527, DOI 10.18632/aging.100184; Lemmer B, 2006, PHARMACOL THERAPEUT, V111, P629, DOI 10.1016/j.pharmthera.2005.11.008; Libby P, 2000, CIRCULATION, V102, P1874, DOI 10.1161/01.CIR.102.16.1874; Lin JD, 2004, CELL, V119, P121, DOI 10.1016/j.cell.2004.09.013; Liu N, 2010, DEV CELL, V18, P510, DOI 10.1016/j.devcel.2010.03.010; Longo VD, 2014, CELL METAB, V19, P181, DOI 10.1016/j.cmet.2013.12.008; Lopez-Lluch G, 2006, P NATL ACAD SCI USA, V103, P1768, DOI 10.1073/pnas.0510452103; Maillet M, 2013, NAT REV MOL CELL BIO, V14, P38, DOI 10.1038/nrm3495; Mair W, 2003, SCIENCE, V301, P1731, DOI 10.1126/science.1086016; Mair W, 2008, ANNU REV BIOCHEM, V77, P727, DOI 10.1146/annurev.biochem.77.061206.171059; Marzetti E, 2009, CLIN GERIATR MED, V25, P715, DOI 10.1016/j.cger.2009.07.002; Mattison JA, 2012, NATURE, V489, P318, DOI 10.1038/nature11432; MCCAY CM, 1989, NUTRITION, V5, P155; Mercken EM, 2013, AGING CELL, V12, P645, DOI 10.1111/acel.12088; Merico D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013984; Mishra PK, 2013, BBA-MOL BASIS DIS, V1832, P2271, DOI 10.1016/j.bbadis.2013.09.004; Noyan-Ashraf MH, 2005, NUTR NEUROSCI, V8, P101, DOI 10.1080/10284150500069470; Noyan-Ashraf MH, 2006, FASEB J, V20, P371, DOI 10.1096/fj.05-4889fje; Noyan-Ashraf MH, 2013, CIRCULATION, V127, P74, DOI 10.1161/CIRCULATIONAHA.112.091215; Noyan-Ashraf MH, 2009, DIABETES, V58, P975, DOI 10.2337/db08-1193; Oshima Y, 2005, CARDIOVASC RES, V65, P428, DOI 10.1016/j.cardiores.2004.10.021; Ouyang YB, 2012, MITOCHONDRION, V12, P213, DOI 10.1016/j.mito.2011.09.001; Paschos GK, 2010, CIRC RES, V106, P833, DOI 10.1161/CIRCRESAHA.109.211706; Pearson KJ, 2008, P NATL ACAD SCI USA, V105, P2325, DOI 10.1073/pnas.0712162105; Piper MDW, 2008, CELL METAB, V8, P99, DOI 10.1016/j.cmet.2008.06.012; Pospisilik JA, 2007, CELL, V131, P476, DOI 10.1016/j.cell.2007.08.047; Robertson LT, 2013, EXP GERONTOL, V48, P1043, DOI 10.1016/j.exger.2013.01.009; Rose BA, 2010, PHYSIOL REV, V90, P1507, DOI 10.1152/physrev.00054.2009; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shinmura K, 2005, J MOL CELL CARDIOL, V39, P285, DOI 10.1016/j.yjmcc.2005.03.010; Shinmura K, 2011, CIRC RES, V109, P396, DOI 10.1161/CIRCRESAHA.111.243097; Shinmura K, 2008, AM J PHYSIOL-HEART C, V295, pH2348, DOI 10.1152/ajpheart.00602.2008; Silver AC, 2012, IMMUNITY, V36, P251, DOI 10.1016/j.immuni.2011.12.017; Small EM, 2011, NATURE, V469, P336, DOI 10.1038/nature09783; Small EM, 2010, CIRCULATION, V121, P1022, DOI 10.1161/CIRCULATIONAHA.109.889048; Sohal RS, 1996, SCIENCE, V273, P59, DOI 10.1126/science.273.5271.59; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sussman MA, 2011, PHYSIOL REV, V91, P1023, DOI 10.1152/physrev.00024.2010; Swindell WR, 2008, MECH AGEING DEV, V129, P138, DOI 10.1016/j.mad.2007.11.003; Swindell WR, 2011, AGEING RES REV, V10, P132, DOI 10.1016/j.arr.2010.09.007; Swindell WR, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-585; Swindell WR, 2008, MECH AGEING DEV, V129, P580, DOI 10.1016/j.mad.2008.06.001; Trepanowski JF, 2011, NUTR J, V10, DOI 10.1186/1475-2891-10-107; Ungvari Z, 2008, CIRC RES, V102, P519, DOI 10.1161/CIRCRESAHA.107.168369; van Heemst D, 2005, AGING CELL, V4, P79, DOI 10.1111/j.1474-9728.2005.00148.x; Varady KA, 2007, AM J CLIN NUTR, V86, P7, DOI 10.1093/ajcn/86.1.7; Vigneron F, 2011, CARDIOVASC RES, V90, P49, DOI 10.1093/cvr/cvr002; Vora M, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003737; Wang Q, 2011, ONCOGENE, V30, P3875, DOI 10.1038/onc.2011.103; WEINDRUCH R, 1982, SCIENCE, V215, P1415, DOI 10.1126/science.7063854; Wu LY, 2004, P NATL ACAD SCI USA, V101, P7094, DOI 10.1073/pnas.0402004101; Wu QL, 2012, SHOCK, V38, P165, DOI 10.1097/SHK.0b013e31825b5633; Zhang LH, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-290; Zong HH, 2002, P NATL ACAD SCI USA, V99, P15983, DOI 10.1073/pnas.252625599	87	43	43	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2015	10	6							e0130658	10.1371/journal.pone.0130658	http://dx.doi.org/10.1371/journal.pone.0130658			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL3FM	26098549	Green Published, gold, Green Submitted			2022-12-26	WOS:000356835800090
J	Onishi, S; Adnan, E; Ishizaki, J; Miyazaki, T; Tanaka, Y; Matsumoto, T; Suemori, K; Shudou, M; Okura, T; Takeda, H; Sawasaki, T; Yasukawa, M; Hasegawa, H				Onishi, Sachiko; Adnan, Endy; Ishizaki, Jun; Miyazaki, Tatsuhiko; Tanaka, Yuki; Matsumoto, Takuya; Suemori, Koichiro; Shudou, Masachika; Okura, Takafumi; Takeda, Hiroyuki; Sawasaki, Tatsuya; Yasukawa, Masaki; Hasegawa, Hitoshi			Novel Autoantigens Associated with Lupus Nephritis	PLOS ONE			English	Article							GLOMERULAR-BASEMENT-MEMBRANE; ANTI-DNA ANTIBODIES; ALPHA-ACTININ; ANTINUCLEOSOME ANTIBODIES; ANIONIC SITES; IN-VIVO; AUTOANTIBODIES; PATHOGENESIS; DSDNA; GLOMERULONEPHRITIS	Systemic lupus erythematosus (SLE) is characterized by production of a variety of autoantibodies. Although anti-double-stranded DNA (anti-dsDNA) antibodies contribute to the pathogenesis of lupus nephritis (LN), they are not sufficient for diagnosis and evaluation of disease activity. To obtain other autoantibodies associated with LN, we screened autoantigens reacting with the sera of LN patients by using an N-terminal biotinylated protein library created from a wheat cell-free protein production system. We screened 17 proteins that showed higher positive signals in the active phase than in the inactive phase of SLE, and higher positive signals in the serum of SLE patient with nephritis than in that of patient without nephritis. Of these, two LN-associated autoantigens, ribosomal RNA-processing protein 8 (RRP8) and spermatid nuclear transition protein 1 (TNP1) were identified by immunoprecipitation and immunofluorescence of renal tissues. Circulating anti-RRP8 and anti-TNP1 autoantibodies were recognized and deposited as an immune complex (IC) in glomeruli. IC was deposited preferentially in glomeruli rather than in other organs in C57BL/6 mice injected with RRP8 or TNP1. ELISA analysis of sera from patients with various rheumatic diseases demonstrated reactivity for RRP8 and TNP1 in 20% and 14.7% of SLE patients, respectively, whereas there was little or no reactivity in patients with other rheumatic diseases. Among SLE patients, 63.6% and 45.5% of those with LN were positive for anti-RRP8 and anti-TNP1 antibodies, compared with 12.5% and 9.4% of SLE patients without nephritis, respectively. Both proteins are cationic, and their respective antibodies did not cross-react with dsDNA. These proteins released from apoptotic cells form ICs with each autoantibody, and their ICs may become trapped at anionic sites in the glomerular basement membrane, leading to deposition in glomeruli. These autoantibodies may be useful for prediction of LN in subsets of SLE patients who are negative for anti-dsDNA antibodies.	[Onishi, Sachiko; Adnan, Endy; Ishizaki, Jun; Matsumoto, Takuya; Suemori, Koichiro; Yasukawa, Masaki; Hasegawa, Hitoshi] Ehime Univ, Dept Hematol Clin Immunol & Infect Dis, Grad Sch Med, Matsuyama, Ehime 790, Japan; [Miyazaki, Tatsuhiko] Gifu Univ Hosp, Dept Pathol, Gifu, Japan; [Tanaka, Yuki; Shudou, Masachika] Ehime Univ, Integrated Ctr Sci, Matsuyama, Ehime 790, Japan; [Okura, Takafumi] Ehime Univ, Dept Cardiol Pulmonol Hypertens & Nephrol, Grad Sch Med, Matsuyama, Ehime 790, Japan; [Takeda, Hiroyuki; Sawasaki, Tatsuya] Ehime Univ, Proteosci Ctr, Matsuyama, Ehime 790, Japan	Ehime University; Gifu University; Ehime University; Ehime University; Ehime University	Hasegawa, H (corresponding author), Ehime Univ, Dept Hematol Clin Immunol & Infect Dis, Grad Sch Med, Matsuyama, Ehime 790, Japan.	hitoshih@m.ehime-u.ac.jp	ADNAN, ENDY/Q-3099-2018	ADNAN, ENDY/0000-0002-1005-629X; Sawasaki, Tatsuya/0000-0002-7952-0556	Ehime University [2009-05]	Ehime University	This work was supported by grant-in-aid for research promotion, Ehime University to HH (number 2009-05). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALARCONSEGOVIA D, 1989, J RHEUMATOL, V16, P328; Alba P, 2003, ANN RHEUM DIS, V62, P556, DOI 10.1136/ard.62.6.556; Alexander JJ, 2010, J IMMUNOL, V185, P3759, DOI 10.4049/jimmunol.1000683; Amoura Z, 2000, ARTHRITIS RHEUM-US, V43, P76, DOI 10.1002/1529-0131(200001)43:1<76::AID-ANR10>3.0.CO;2-I; ANDREWS BS, 1978, J EXP MED, V148, P1198, DOI 10.1084/jem.148.5.1198; [Anonymous], 1980, ARTHRITIS RHEUM, V23, P581, DOI 10.1002/art.1780230510; Bigler C, 2008, AM J KIDNEY DIS, V51, P624, DOI 10.1053/j.ajkd.2007.10.041; BOHAN A, 1977, MEDICINE, V56, P255, DOI 10.1097/00005792-197707000-00001; Bowcock AM, 2005, ANNU REV GENOM HUM G, V6, P93, DOI 10.1146/annurev.genom.6.080604.162324; Bruns A, 2000, ARTHRITIS RHEUM-US, V43, P2307, DOI 10.1002/1529-0131(200010)43:10<2307::AID-ANR19>3.0.CO;2-J; Bruschi M, 2014, J AM SOC NEPHROL, V25, P2483, DOI 10.1681/ASN.2013090987; CAULFIELD JP, 1976, P NATL ACAD SCI USA, V73, P1646, DOI 10.1073/pnas.73.5.1646; Chindalore V, 1998, CLIN IMMUNOL IMMUNOP, V87, P292, DOI 10.1006/clin.1998.4541; Cornelis F, 1998, P NATL ACAD SCI USA, V95, P10746, DOI 10.1073/pnas.95.18.10746; Deocharan B, 2002, J IMMUNOL, V168, P3072, DOI 10.4049/jimmunol.168.6.3072; Deshmukh US, 2006, AUTOIMMUN REV, V5, P414, DOI 10.1016/j.autrev.2005.10.010; Du H, 2005, J CLIN IMMUNOL, V25, P281, DOI 10.1007/s10875-005-4082-6; Duan LH, 2011, LAB INVEST, V91, P43, DOI 10.1038/labinvest.2010.141; Exley Andrew R., 1996, Current Opinion in Rheumatology, V8, P12, DOI 10.1097/00002281-199601000-00002; Gladman DD, 2000, J RHEUMATOL, V29, P288, DOI DOI 10.3899/JRHEUM.110550; Grootscholten C, 2003, ARTHRITIS RHEUM, V48, P1355, DOI 10.1002/art.10974; Grootscholten C, 2007, ANN RHEUM DIS, V66, P693, DOI 10.1136/ard.2006.065425; Hochberg MC, 1997, ARTHRITIS RHEUM, V40, P1725, DOI 10.1002/art.1780400928; Ishikawa K, 1997, DNA Res, V4, P307, DOI 10.1093/dnares/4.5.307; Jawaheer D, 2001, AM J HUM GENET, V68, P927, DOI 10.1086/319518; Kalaaji M, 2007, KIDNEY INT, V71, P664, DOI 10.1038/sj.ki.5002133; Kalaaji M, 2006, AM J PATHOL, V168, P1779, DOI 10.2353/ajpath.2006.051329; KANWAR YS, 1979, J CELL BIOL, V81, P137, DOI 10.1083/jcb.81.1.137; Korbet SM, 2007, J AM SOC NEPHROL, V18, P244, DOI 10.1681/ASN.2006090992; Lech M, 2013, J AM SOC NEPHROL, V24, P1357, DOI 10.1681/ASN.2013010026; LUERSSEN H, 1990, GENOMICS, V8, P324, DOI 10.1016/0888-7543(90)90289-7; Mannik M, 2003, J RHEUMATOL, V30, P1495; Manson JJ, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2831; Masutani K, 2001, ARTHRITIS RHEUM, V44, P2097, DOI 10.1002/1529-0131(200109)44:9<2097::AID-ART360>3.0.CO;2-6; Matsumoto T, 2013, J IMMUNOL, V191, P2247, DOI 10.4049/jimmunol.1203053; Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; Matsuoka K, 2010, J PROTEOME RES, V9, P4264, DOI 10.1021/pr9010553; Meistrich ML, 2003, CHROMOSOMA, V111, P483, DOI 10.1007/s00412-002-0227-z; Meyer OC, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2725; Mizutani Y, 2013, J IMMUNOL METHODS, V387, P57, DOI 10.1016/j.jim.2012.09.011; Mok CC, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/638413; Moura CG, 2009, J CLIN LAB ANAL, V23, P19, DOI 10.1002/jcla.20280; Murayama A, 2008, CELL, V133, P627, DOI 10.1016/j.cell.2008.03.030; Nemoto K, 2011, J TOXICOL SCI, V36, P357, DOI 10.2131/jts.36.357; Neogi T, 2010, ARTHRITIS RHEUM-US, V62, P2582, DOI 10.1002/art.27580; Pisetsky DS, 2004, RHEUM DIS CLIN N AM, V30, P575, DOI 10.1016/j.rdc.2004.04.009; Rekvig OP, 2014, SEMIN IMMUNOPATHOL, V36, P301, DOI 10.1007/s00281-014-0428-6; Renaudineau Y, 2006, ARTHRITIS RHEUM-US, V54, P2523, DOI 10.1002/art.22015; Sawasaki T, 2002, P NATL ACAD SCI USA, V99, P14652, DOI 10.1073/pnas.232580399; Schwartz N, 2014, CURR OPIN RHEUMATOL, V26, P502, DOI 10.1097/BOR.0000000000000089; Sherer Y, 2004, SEMIN ARTHRITIS RHEU, V34, P501, DOI 10.1016/j.semarthrit.2004.07.002; SIEGERT CEH, 1993, ANN RHEUM DIS, V52, P851, DOI 10.1136/ard.52.12.851; Sinico RA, 2005, ANN NY ACAD SCI, V1050, P193, DOI 10.1196/annals.1313.020; SUN KH, 1995, IMMUNOLOGY, V85, P262; Trendelenburg M, 2005, SPRINGER SEMIN IMMUN, V27, P276, DOI 10.1007/s00281-005-0007-y; Trendelenburg M, 2006, NEPHROL DIAL TRANSPL, V21, P3115, DOI 10.1093/ndt/gfl436; Tsai YC, 2012, MOL CELL PROTEOMICS, V11, P60, DOI 10.1074/mcp.A111.015156; Tsirogianni A, 2009, ANN NY ACAD SCI, V1173, P243, DOI 10.1111/j.1749-6632.2009.04750.x; Vitali C, 2002, ANN RHEUM DIS, V61, P554, DOI 10.1136/ard.61.6.554; Waldman M, 2005, LUPUS, V14, P19, DOI 10.1191/0961203305lu2054oa; WECHSLER B, 1992, BRIT J RHEUMATOL, V31, P299; Xie C, 2003, ARTHRITIS RHEUM, V48, P2343, DOI 10.1002/art.11092; Yang LX, 2013, MOL CELL BIOL, V33, P3835, DOI 10.1128/MCB.00476-13; Yoshio T, 2012, MOD RHEUMATOL, V22, P488, DOI 10.1007/s10165-011-0549-x; Yung S, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/139365; Yung S, 2010, J AM SOC NEPHROL, V21, P1912, DOI 10.1681/ASN.2009080805; Zhao ZG, 2005, ARTHRITIS RHEUM-US, V52, P522, DOI 10.1002/art.20862	67	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2015	10	6							e0126564	10.1371/journal.pone.0126564	http://dx.doi.org/10.1371/journal.pone.0126564			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL3FM	26098692	gold, Green Published, Green Submitted			2022-12-26	WOS:000356835800004
J	Lu, YM; Qu, WB; Shan, GY; Zhang, CG				Lu, Yiming; Qu, Wubin; Shan, Guangyu; Zhang, Chenggang			DELTA: A Distal Enhancer Locating Tool Based on AdaBoost Algorithm and Shape Features of Chromatin Modifications	PLOS ONE			English	Article							TRANSCRIPTION FACTOR-BINDING; HISTONE MODIFICATIONS; PREDICTION; SIGNATURES; DISCOVERY; ELEMENTS; IDENTIFICATION; METHYLATIONS; DROSOPHILA; DYNAMICS	Accurate identification of DNA regulatory elements becomes an urgent need in the post-genomic era. Recent genome-wide chromatin states mapping efforts revealed that DNA elements are associated with characteristic chromatin modification signatures, based on which several approaches have been developed to predict transcriptional enhancers. However, their practical application is limited by incomplete extraction of chromatin features and model inconsistency for predicting enhancers across different cell types. To address these issues, we define a set of non-redundant shape features of histone modifications, which shows high consistency across cell types and can greatly reduce the dimensionality of feature vectors. Integrating shape features with a machine-learning algorithm AdaBoost, we developed an enhancer predicting method, DELTA (Distal Enhancer Locating Tool based on AdaBoost). We show that DELTA significantly outperforms current enhancer prediction methods in prediction accuracy on different datasets and can predict enhancers in one cell type using models trained in other cell types without loss of accuracy. Overall, our study presents a novel framework for accurately identifying enhancers from epigenetic data across multiple cell types.	[Lu, Yiming; Qu, Wubin; Shan, Guangyu; Zhang, Chenggang] Beijing Inst Radiat Med, State Key Lab Prote, Beijing 100850, Peoples R China	Academy of Military Medical Sciences - China	Zhang, CG (corresponding author), Beijing Inst Radiat Med, State Key Lab Prote, Beijing 100850, Peoples R China.	zhangcg@bmi.ac.cn	Qu, Wubin/B-1529-2009; Zhang, Chenggang/B-1480-2009	Zhang, Chenggang/0000-0002-4521-3304; Shan, Guangyu/0000-0002-2922-8477	National Basic Research Project (973 program) [2012CB518200]; Natural Science Foundation of China [31401141, 30900830]; State Key Laboratory of Proteomics of China [SKLP-Y201303, SKLP-O201104, SKLP-K201004]; Special Key Programs for Science and Technology of China [2012ZX09102301-016]	National Basic Research Project (973 program)(National Basic Research Program of China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Key Laboratory of Proteomics of China; Special Key Programs for Science and Technology of China	This work was supported by the National Basic Research Project (973 program) (2012CB518200) (http://www.973.gov.cn/), the General Program (31401141, 30900830) of the Natural Science Foundation of China (www.nsfc.gov.cn), the State Key Laboratory of Proteomics of China (SKLP-Y201303, SKLP-O201104 and SKLP-K201004) (www.bprc.ac.cn), and the Special Key Programs for Science and Technology of China (2012ZX09102301-016).	Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bauer E, 1999, MACH LEARN, V36, P105, DOI 10.1023/A:1007515423169; Bejerano G, 2004, SCIENCE, V304, P1321, DOI 10.1126/science.1098119; Bernstein BE, 2010, NAT BIOTECHNOL, V28, P1045, DOI 10.1038/nbt1010-1045; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Boyle AP, 2008, CELL, V132, P311, DOI 10.1016/j.cell.2007.12.014; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Breiman L., 2017, CLASSIFICATION REGRE; Cheng C, 2012, NUCLEIC ACIDS RES, V40, P553, DOI 10.1093/nar/gkr752; Culp M, 2006, J STAT SOFTW, V17, P1; Dale RK, 2011, BIOINFORMATICS, V27, P3423, DOI 10.1093/bioinformatics/btr539; Dodge Y, 2003, OXFORD DICT STAT TER; Ernst J, 2012, NAT METHODS, V9, P215, DOI 10.1038/nmeth.1906; Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906; Feingold EA, 2004, SCIENCE, V306, P636, DOI 10.1126/science.1105136; Fernandez M, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks149; Firpi HA, 2010, BIOINFORMATICS, V26, P1579, DOI 10.1093/bioinformatics/btq248; Freund Y, 1997, J COMPUT SYST SCI, V55, P119, DOI 10.1006/jcss.1997.1504; Hastie T., 2009, ELEMENTS STAT LEARNI, Vsecond, pXXII, DOI DOI 10.1007/978-0-387-84858-7; Hatzis P, 2002, MOL CELL, V10, P1467, DOI 10.1016/S1097-2765(02)00786-4; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; Hoffman MM, 2012, NAT METHODS, V9, P473, DOI [10.1038/NMETH.1937, 10.1038/nmeth.1937]; Hon G, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000201; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kim TH, 2007, CELL, V128, P1231, DOI 10.1016/j.cell.2006.12.048; Lu Y, 2014, IET SYSTEMS BIOL; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Negre N, 2011, NATURE, V471, P527, DOI 10.1038/nature09990; Ohler U, 2006, NUCLEIC ACIDS RES, V34, P5943, DOI 10.1093/nar/gkl608; Ong CT, 2011, NAT REV GENET, V12, P283, DOI 10.1038/nrg2957; Oppenheim AV, 1999, DISCRETE TIME SIGNAL, Vxxvi; Park PJ, 2009, NAT REV GENET, V10, P669, DOI 10.1038/nrg2641; Pennacchio LA, 2007, GENOME RES, V17, P201, DOI 10.1101/gr.5972507; Rajagopal N, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002968; ROUSSEEUW PJ, 1987, J COMPUT APPL MATH, V20, P53, DOI 10.1016/0377-0427(87)90125-7; Schmidl C, 2014, BLOOD, V123, pE68, DOI 10.1182/blood-2013-02-486944; Shen Y, 2012, NATURE, V488, P116, DOI 10.1038/nature11243; Visel A, 2007, SEMIN CELL DEV BIOL, V18, P140, DOI 10.1016/j.semcdb.2006.12.014; Visel A, 2009, NATURE, V457, P854, DOI 10.1038/nature07730; Wang JR, 2012, NUCLEIC ACIDS RES, V40, P10642, DOI 10.1093/nar/gks848; Wang J, 2012, GENOME RES, V22, P1798, DOI 10.1101/gr.139105.112; Wang QB, 2005, MOL CELL, V19, P631, DOI 10.1016/j.molcel.2005.07.018; Wang ZB, 2008, NAT GENET, V40, P897, DOI 10.1038/ng.154; Wang ZB, 2009, CELL, V138, P1019, DOI 10.1016/j.cell.2009.06.049; Won KJ, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-1-r7; Won KJ, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-547; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	49	33	33	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2015	10	6							e0130622	10.1371/journal.pone.0130622	http://dx.doi.org/10.1371/journal.pone.0130622			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL3FE	26091399	Green Published, Green Submitted, gold			2022-12-26	WOS:000356835000138
J	Anquetin, J; Puntener, C; Billon-Bruyat, JP				Anquetin, Jeremy; Puentener, Christian; Billon-Bruyat, Jean-Paul			Portlandemys gracilis n. sp., a New Coastal Marine Turtle from the Late Jurassic of Porrentruy (Switzerland) and a Reconsideration of Plesiochelyid Cranial Anatomy	PLOS ONE			English	Article							ISLE-OF-WIGHT; PHYLOGENETIC-RELATIONSHIPS; EVOLUTION; REASSESSMENT; TESTUDINES; ECOLOGY; REDESCRIPTION; EUCRYPTODIRA; ANTIQUITY; EUROPE	Background Several groups of stem cryptodires became adapted to coastal marine environments as early as the Late Jurassic, 40 million years before the Pan-Chelonioidea. The Plesiochelyidae are a major component of this first radiation of crown-group turtles into marine habitats. They are abundant in many European localities, but their systematics is still greatly confused. Only three species are represented by cranial material: Plesiochelys etalloni, Plesiochelys planiceps, and Portlandemys mcdowelli. Methodology/Principal Findings In the present study, we describe a cranium and a mandible from the Kimmeridgian of Porrentruy (Switzerland), which we refer to a new species, Portlandemys gracilis n. sp. This new taxon differs from Portlandemys mcdowelli in several aspects of the cranium and mandible, notably in being generally more gracile, but the two species share a narrow skull, a more acute angle between the labial ridges on the mandible, and a unique configuration of the anterodorsal part of the basicranium. The cranial anatomy of plesiochelyid turtles is discussed in details based primarily on these new specimens and new cranial material of Plesiochelys etalloni from Solothurn, Switzerland. Conclusions/Significance Several characters (e.g., the contribution of the parietal to the foramen nervi trigemini, the configuration of the dorsum sellae and sella turcica, the presence of an infolding ridge on the posterior surface of the quadrate) appear as potential candidates to help elucidate plesiochelyid relationships. Some of these characters are included in a previously published phylogenetic dataset and help to stabilize the relationships of plesiochelyid turtles and closely related taxa. For the first time, our results suggest that plesiochelyids, 'Thalassemys' moseri, and Solnhofia parsonsi (representing the Eurysternidae) form a clade at the base of Eucryptodira.	[Anquetin, Jeremy; Puentener, Christian; Billon-Bruyat, Jean-Paul] Republ & Canton Jura, Sect darcheol & paleontol, Off culture, CH-2900 Porrentruy, Switzerland		Anquetin, J (corresponding author), Republ & Canton Jura, Sect darcheol & paleontol, Off culture, CH-2900 Porrentruy, Switzerland.	j.anquetin@gmail.com		Anquetin, Jeremy/0000-0001-5539-8691	Swiss Federal Roads Office (FEDRO); Republic and Canton of Jura (RCJU); SYNTHESYS Project - European Community Research Infrastructure Action under the FP7 "Capacities" Program [GB-TAF-3481]	Swiss Federal Roads Office (FEDRO); Republic and Canton of Jura (RCJU); SYNTHESYS Project - European Community Research Infrastructure Action under the FP7 "Capacities" Program	The "Section d'archeologie et paleontologie" was funded by the Swiss Federal Roads Office (FEDRO, 95%) and the Republic and Canton of Jura (RCJU, 5%). This research also received support from the SYNTHESYS Project, http://www.synthesys.info/, which is financed by the European Community Research Infrastructure Action under the FP7 "Capacities" Program (GB-TAF-3481). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBRECHT PW, 1976, J MORPHOL, V149, P159, DOI 10.1002/jmor.1051490203; [Anonymous], 1979, B AM MUS NAT HIST, V164, P67; Anquetin J, 2014, J VERTEBR PALEONTOL, V2014, P80, DOI [10.6084/m9.figshare.1221728, DOI 10.6084/M9.FIGSHARE.1221728]; Anquetin J, 2014, J VERTEBR PALEONTOL, V34, P1317, DOI 10.1080/02724634.2014.880449; Anquetin J, 2014, PEERJ, V2, DOI 10.7717/peerj.369; Anquetint J, 2014, PEERJ, V2, DOI 10.7717/peerj.258; Anquetin J, 2012, J SYST PALAEONTOL, V10, P3, DOI 10.1080/14772019.2011.558928; Barley AJ, 2010, MOL PHYLOGENET EVOL, V55, P1189, DOI 10.1016/j.ympev.2009.11.005; Batsch AJGC., 1788, VERSUCH ANLEITUNG KE; Baur G., 1887, JAHRESBERICHTE MITTE, V20, P17; Baur G., 1888, ZOOL ANZ, V11, P417; Baur G., 1891, P ACAD NAT SCI PHILA, V43, P411; BAUR G, 1893, AM NAT, V27, P672; Bever GS, 2009, B AM MUS NAT HIST, P3; Billon-Bruyat J-P., 2005, 3 SWISS GEOSC M ZUR, P238; Billon-Bruyat JP, 2005, PALAEOGEOGR PALAEOCL, V216, P359, DOI 10.1016/j.palaeo.2004.11.011; Bonaparte C. L, 1836, CHELONIORUM TABULA A; Bram-Embrach H., 1965, Schweizerische Palaeontologische Abhandlungen, V83, P1; BRINKMAN DB, 1993, CAN J EARTH SCI, V30, P2128, DOI 10.1139/e93-184; Brinkman Donald B., 1999, Paludicola, V2, P134; CODDINGTON J, 1994, CLADISTICS, V10, P415; Comment G, 2011, B ANGEW GEOLOGIE, V16, P3, DOI [DOI 10.5169/SEALS-327738, 10.5169/seals-327738]; Cope E.D., 1882, P AM PHILOS SOC, V10, P139; Cope E. D, 1872, GEOLOGY PALEONTOLOGY, P318; Cope ED, 1873, P ACAD NAT SCI PHILA, V1873, P10; Cope ED., 1868, P ACAD NATURAL SCI, V1868, P242; Crawford NG, 2015, MOL PHYLOGENET EVOL, V83, P250, DOI 10.1016/j.ympev.2014.10.021; CUVIER G, 1824, RECHERCHES OSSEMEN 2, V5; Danilov IG, 2005, HDB REPTILIEN AMPHIB, V3/IIIB, P329; Danilov IG, 2008, J VERTEBR PALEONTOL, V28, P306, DOI 10.1671/0272-4634(2008)28[306:AROSPK]2.0.CO;2; Danilov IG, 2006, J VERTEBR PALEONTOL, V26, P573, DOI 10.1671/0272-4634(2006)26[573:AROPTF]2.0.CO;2; deBroin FD, 1996, CR ACAD SCI II A, V323, P729; Dollo L., 1886, Bull Mus Belg, Viv, P75; Fujita MK, 2004, MOL PHYLOGENET EVOL, V31, P1031, DOI 10.1016/j.ympev.2003.09.016; Gaffney E.S., 1972, American Museum Novitates, VNo. 2486, P1; Gaffney E.S., 1972, Bulletin Am Mus nat Hist, V147, P241; GAFFNEY E S, 1975, Bulletin of the American Museum of Natural History, V155, P387; Gaffney E.S., 1976, Bulletin Am Mus nat Hist, V157, P487; Gaffney E.S., 1975, American Museum Novitates, VNo. 2574, P1; Gaffney E.S., 1988, Systematics Association Special Volume Series, P157; Gaffney E.S., 1975, American Museum Novitates, VNo. 2576, P1; GAFFNEY ES, 1990, B AM MUS NAT HIST, P5; GAFFNEY ES, 1991, CLADISTICS, V7, P313, DOI 10.1111/j.1096-0031.1991.tb00041.x; Gaffney ES, 2002, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2002)379<0001:GANSNT>2.0.CO;2; Gaffney Eugene S., 1996, Bulletin of the American Museum of Natural History, V229, P1; Gaffney ES, 2006, B AM MUS NAT HIST, P1; Gaffney ES, 2009, AM MUS NOVIT, P1, DOI 10.1206/672.1; Gaffney ES, 2007, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2007)3599[1:CANETF]2.0.CO;2; Goloboff PA, 2008, CLADISTICS, V24, P774, DOI 10.1111/j.1096-0031.2008.00217.x; Hirayama R, 1998, NATURE, V392, P705, DOI 10.1038/33669; Hirayama Ren, 2000, Russian Journal of Herpetology, V7, P181; Hummel K., 1929, GEOLOGISCHE PALAEONT, V16, P359; Jamniczky HA, 2008, BIOL J LINN SOC, V93, P239, DOI 10.1111/j.1095-8312.2007.00923.x; Jones MEH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047852; Joyce Walter G., 2007, Bulletin of the Peabody Museum of Natural History, V48, P3, DOI 10.3374/0079-032X(2007)48[3:PROMT]2.0.CO;2; Joyce WG, 2014, J PALEONTOL, V88, P1257, DOI 10.1666/14-002; Joyce WG, 2011, SPEC PAP PALAEONTOL, P75, DOI 10.1111/j.1475-4983.2011.01075.x; Joyce WG, 2004, J PALEONTOL, V78, P989, DOI 10.1666/0022-3360(2004)078<0989:DAPFTC>2.0.CO;2; Klein I. T., 1760, KLASSIFICATION KURZE; Krenz JG, 2005, MOL PHYLOGENET EVOL, V37, P178, DOI 10.1016/j.ympev.2005.04.027; Lapparent de Broin F., 1996, REV PALEOBIOL, V15, P533; Lyson TR, 2009, J PALEONTOL, V83, P833, DOI 10.1666/09-035.1; Mallison H., 2014, J PALEONTOL TECHN, V12, P1; Marty D, 2003, ACTES SOC JURASSIENN, V2003, P27, DOI DOI 10.4330/WJC.V6.I8.713; Marty D, 2009, 5 INT S LITH LIM PLA, P94; Mateus O, 2009, ACTA PALAEONTOL POL, V54, P581, DOI 10.4202/app.2008.0063; Meyer CA, 1989, HEFT MITTEILUNGEN NA, V34, P187; Meyer Christian A., 2011, Annalen des Naturhistorischen Museums in Wien A Mineralogie Petrologie Geologie Palaeontologie Archaeozoologie Anthropologie Praehistorie, V113A, P555; Meyer Christian A., 1994, Geobios Memoire Special (Villeurbanne), V16, P227; Meyer Hvon., 1864, PALAEONTOGRAPHICA, V11, P289; Meylan PA, 2000, J VERTEBR PALEONTOL, V20, P522, DOI 10.1671/0272-4634(2000)020[0522:SHAHDT]2.0.CO;2; Miyashita Tetsuto, 2013, P71; Muller MK, 2011, SWISS J GEOSCI, V104, pS133, DOI 10.1007/s00015-011-0061-5; Nesov L.A., 1990, Ezhegodnik Vsesoyuznogo Paleontologicheskogo Obshchestva, V33, P185; OLeary M. A., 2012, MORPHOBANK 3 0 WEB A; Owen R., 1842, REPORTS BRIT ASS ADV, V11, P60; Parham JF, 2010, J PALEONTOL, V84, P231, DOI 10.1666/09-077R.1; Parham JF, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-11; Parsons T. S., 1961, Bulletin of the Museum of Comparative Zoology, V125, P43; Carabajal AP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069264; Philippe M, 2010, PALAEONTOLOGY, V53, P201, DOI 10.1111/j.1475-4983.2009.00926.x; Pictet F.-J., 1857, MATERIAUX PALEONTOLO, p1e10; Puntener C, 2014, J VERTEBR PALEONTOL, V34, P353, DOI 10.1080/02724634.2013.804412; Rabi M, 2014, J VERTEBR PALEONTOL, V34, P327, DOI 10.1080/02724634.2013.807274; Rabi M, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-203; RIEPPEL O, 1980, Palaeontographica Abteilung A Palaeozoologie-Stratigraphie, V171, P105; Romer A, 1956, OSTEOLOGY REPTILES; ROUGIER GW, 1995, SCIENCE, V268, P855, DOI 10.1126/science.268.5212.855; Rutimeyer L., 1873, NEUE DENKSCHRIFT ALL, V25, P1; Scheyer TM, 2014, BIOL J LINN SOC, V112, P701, DOI 10.1111/bij.12265; Schumacher G. H., 1973, P101; Schumacher GH, 1953, WISS Z ERNST MORITZ, V3, P457; Shaffer HB, 1997, SYST BIOL, V46, P235, DOI 10.1093/sysbio/46.2.235; Sterli J, 2007, PALAEONTOGR ABT A, V281, P1; Sterli J, 2013, CLADISTICS, V29, P233, DOI 10.1111/j.1096-0031.2012.00425.x; Sterli J, 2010, CAN J EARTH SCI, V47, P1337, DOI 10.1139/E10-061; Sterli J, 2010, CONTRIB ZOOL, V79, P93, DOI 10.1163/18759866-07903002; Sukhanov Vladimir B., 2006, P119; Tong Haiyan, 2013, P187; Werneburg I, 2011, PALAEONTOL ELECTRON, V14; ZANGERL R., 1953, FIELDIANA GEOLOGY ME, P137, DOI DOI 10.5962/BHL.TITLE.7198; Zittel KA., HDB PALAEONTOLOGIE, V3	102	26	29	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2015	10	6							e0129193	10.1371/journal.pone.0129193	http://dx.doi.org/10.1371/journal.pone.0129193			49	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4OM	26106888	Green Published, Green Submitted, gold			2022-12-26	WOS:000356932500042
J	Coulson-Thomas, YM; Coulson-Thomas, VJ; Norton, AL; Gesteira, TF; Cavalheiro, RP; Meneghetti, MCZ; Martins, JR; Dixon, RA; Nader, HB				Coulson-Thomas, Yvette M.; Coulson-Thomas, Vivien J.; Norton, Andrew L.; Gesteira, Tarsis F.; Cavalheiro, Renan P.; Meneghetti, Maria Cecilia Z.; Martins, Joao R.; Dixon, Ronald A.; Nader, Helena B.			The Identification of Proteoglycans and Glycosaminoglycans in Archaeological Human Bones and Teeth	PLOS ONE			English	Article							LEUCINE-RICH PROTEOGLYCANS; FLAVOBACTERIUM-HEPARINUM; MATRIX PROTEINS; EXTRACELLULAR-MATRIX; COLLAGEN FIBRILLOGENESIS; NONCOLLAGENOUS PROTEINS; SULFATE PROTEOGLYCAN; HYALURONIC-ACID; TOOTH CEMENTUM; DECORIN	Bone tissue is mineralized dense connective tissue consisting mainly of a mineral component (hydroxyapatite) and an organic matrix comprised of collagens, non-collagenous proteins and proteoglycans (PGs). Extracellular matrix proteins and PGs bind tightly to hydroxyapatite which would protect these molecules from the destructive effects of temperature and chemical agents after death. DNA and proteins have been successfully extracted from archaeological skeletons from which valuable information has been obtained; however, to date neither PGs nor glycosaminoglycan (GAG) chains have been studied in archaeological skeletons. PGs and GAGs play a major role in bone morphogenesis, homeostasis and degenerative bone disease. The ability to isolate and characterize PG and GAG content from archaeological skeletons would unveil valuable paleontological information. We therefore optimized methods for the extraction of both PGs and GAGs from archaeological human skeletons. PGs and GAGs were successfully extracted from both archaeological human bones and teeth, and characterized by their electrophoretic mobility in agarose gel, degradation by specific enzymes and HPLC. The GAG populations isolated were chondroitin sulfate (CS) and hyaluronic acid (HA). In addition, a CSPG was detected. The localization of CS, HA, three small leucine rich PGs (biglycan, decorin and fibromodulin) and glypican was analyzed in archaeological human bone slices. Staining patterns were different for juvenile and adult bones, whilst adolescent bones had a similar staining pattern to adult bones. The finding that significant quantities of PGs and GAGs persist in archaeological bones and teeth opens novel venues for the field of Paleontology.	[Coulson-Thomas, Yvette M.; Coulson-Thomas, Vivien J.; Gesteira, Tarsis F.; Cavalheiro, Renan P.; Meneghetti, Maria Cecilia Z.; Martins, Joao R.; Nader, Helena B.] Univ Fed Sao Paulo, Dept Biochem, Sao Paulo, Brazil; [Coulson-Thomas, Yvette M.; Dixon, Ronald A.] Lincoln Univ, Sch Life Sci, Lincoln, Lincs, England; [Coulson-Thomas, Vivien J.; Gesteira, Tarsis F.] Univ Cincinnati, Coll Med, Dept Ophthalmol, Edith J Crawley Vis Res Ctr, Cincinnati, OH USA; [Norton, Andrew L.] Univ Durham, Durham, England	Universidade Federal de Sao Paulo (UNIFESP); University of Lincoln; University System of Ohio; University of Cincinnati; Durham University	Coulson-Thomas, YM (corresponding author), Univ Fed Sao Paulo, Dept Biochem, Sao Paulo, Brazil.	ycoulsonthomas@gmail.com	Martins, João Roberto/AAC-6063-2021; Nader, Helena Bonciani/D-9253-2012; Meneghetti, Maria Cecília Zorel/X-3425-2019; Martins, João Roberto M/J-6042-2015; Norton, Andrew/D-4749-2012	Martins, João Roberto/0000-0002-0204-3552; Meneghetti, Maria Cecília Zorel/0000-0003-1386-3211; Martins, João Roberto M/0000-0002-0204-3552; Norton, Andrew/0000-0003-4899-1686; NADER, HELENA/0000-0002-7569-2166	CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior); CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico); FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo)	CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This research was made possible by support from CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior), CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico) and FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AXELSSON S, 1992, ACTA ODONTOL SCAND, V50, P113, DOI 10.3109/00016359209012753; BOHMER LH, 1990, J BIOL CHEM, V265, P13609; Boskey AL, 1997, CALCIFIED TISSUE INT, V61, P298, DOI 10.1007/s002239900339; CATINI C, 1990, Archivio Italiano di Anatomia e di Embriologia, V95, P237; Cheng H, 1996, CONNECT TISSUE RES, V34, P87, DOI 10.3109/03008209609021494; Cheng H, 1999, CONNECT TISSUE RES, V40, P37, DOI 10.3109/03008209909005276; CLARK RD, 1965, BIOCHIM BIOPHYS ACTA, V101, P267, DOI 10.1016/0926-6534(65)90004-7; DIETRICH CP, 1976, ANAL BIOCHEM, V70, P645, DOI 10.1016/0003-2697(76)90496-6; Embery G, 2001, CRIT REV ORAL BIOL M, V12, P331, DOI 10.1177/10454411010120040401; FRANC S, 1995, EUR J BIOCHEM, V234, P125, DOI 10.1111/j.1432-1033.1995.125_c.x; Geng YQ, 2006, MATRIX BIOL, V25, P484, DOI 10.1016/j.matbio.2006.08.259; Gori F, 2001, J CELL BIOCHEM, V82, P46, DOI 10.1002/jcb.1115; GREENWALD RA, 1975, BIOCHEM J, V145, P601, DOI 10.1042/bj1450601; Hameetman L, 2007, J PATHOL, V211, P399, DOI 10.1002/path.2127; HILDEBRAND A, 1994, BIOCHEM J, V302, P527, DOI 10.1042/bj3020527; Igwe JC, 2011, CONNECT TISSUE RES, V52, P401, DOI 10.3109/03008207.2010.546536; INGRAM RT, 1993, J BONE MINER RES, V8, P1019; Iozzo RV, 1997, CRIT REV BIOCHEM MOL, V32, P141, DOI 10.3109/10409239709108551; JONES IL, 1974, ARCH ORAL BIOL, V19, P371, DOI 10.1016/0003-9969(74)90178-2; JUNQUEIRA LCU, 1983, ARCH HISTOL JAPON, V46, P589, DOI 10.1679/aohc.46.589; Kawano M, 2011, BIOCHEM BIOPH RES CO, V405, P575, DOI 10.1016/j.bbrc.2011.01.071; Keene DR, 2000, J BIOL CHEM, V275, P21801, DOI 10.1074/jbc.C000278200; KITAMIKADO M, 1975, APPL MICROBIOL, V29, P414, DOI 10.1128/AEM.29.3.414-421.1975; KJELLEN L, 1991, ANNU REV BIOCHEM, V60, P443, DOI 10.1146/annurev.bi.60.070191.002303; Kolacna L, 2007, PHYSIOL RES, V56, pS51, DOI 10.33549/physiolres.931302; KORN ED, 1956, J BIOL CHEM, V223, P859; LARJAVA H, 1982, ARCH ORAL BIOL, V27, P147, DOI 10.1016/0003-9969(82)90135-2; LINSENMAYER TF, 1990, ANN NY ACAD SCI, V580, P143, DOI 10.1111/j.1749-6632.1990.tb17926.x; Martins JRM, 2003, ANAL BIOCHEM, V319, P65, DOI 10.1016/S0003-2697(03)00251-3; MICHELACCI YM, 1973, BIOCHIMIE, V55, P893, DOI 10.1016/S0300-9084(73)80166-X; MICHELACCI YM, 1975, BIOCHEM J, V151, P121, DOI 10.1042/bj1510121; Nader HB, 1999, BRAZ J MED BIOL RES, V32, P529, DOI 10.1590/S0100-879X1999000500005; Neame PJ, 2000, CELL MOL LIFE SCI, V57, P859, DOI 10.1007/s000180050048; Nikitovic D, 2012, J BIOL CHEM, V287, P33926, DOI 10.1074/jbc.R112.379602; Orgel JPRO, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007028; Passerotti CC, 2006, EUR UROL, V49, P71, DOI 10.1016/j.eururo.2005.09.015; Raouf A, 2002, MATRIX BIOL, V21, P361, DOI 10.1016/S0945-053X(02)00027-6; Redini F, 2012, METHODS MOL BIOL, V836, P1, DOI 10.1007/978-1-61779-498-8; Rees SG, 2001, BBA-GEN SUBJECTS, V1568, P118, DOI 10.1016/S0304-4165(01)00209-4; Rees SG, 2002, BIOMATERIALS, V23, P481, DOI 10.1016/S0142-9612(01)00130-2; Rucci N, 2009, J CELL BIOL, V187, P669, DOI 10.1083/jcb.200906014; Salbach J, 2012, J MOL MED, V90, P625, DOI 10.1007/s00109-011-0843-2; Schmidt-Schultz TH, 2005, BIOL CHEM, V386, P767, DOI 10.1515/BC.2005.090; Schmidt-Schultz TH, 2004, AM J PHYS ANTHROPOL, V123, P30, DOI 10.1002/ajpa.10308; Schultz M, 2007, INT J CANCER, V121, P2591, DOI 10.1002/ijc.23073; Scott JE, 1996, BIOCHEMISTRY-US, V35, P8795, DOI 10.1021/bi960773t; SILVA ME, 1976, BIOCHIM BIOPHYS ACTA, V437, P129, DOI 10.1016/0304-4165(76)90354-8; SILVA ME, 1974, BIOCHEM BIOPH RES CO, V56, P965, DOI 10.1016/S0006-291X(74)80283-4; Spessotto P, 2002, J CELL BIOL, V158, P1133, DOI 10.1083/jcb.200202120; SPEZIALE P, 1980, BIOCHEM J, V187, P655, DOI 10.1042/bj1870655; Sroga GE, 2012, CURR OSTEOPOROS REP, V10, P141, DOI 10.1007/s11914-012-0103-6; Townley RA, 2011, J BIOL CHEM, V286, P16824, DOI 10.1074/jbc.M111.227926; VEJLENS L, 1971, CALC TISS RES, V7, P175, DOI 10.1007/BF02062605; Waddington R. J., 2003, European Cells & Materials, V6, P12; WADDINGTON RJ, 1989, ARCH ORAL BIOL, V34, P587, DOI 10.1016/0003-9969(89)90100-3; Wang XB, 2005, COMP BIOCHEM PHYS B, V140, P665, DOI 10.1016/j.cbpc.2005.01.010; Weber IT, 1996, J BIOL CHEM, V271, P31767, DOI 10.1074/jbc.271.50.31767; Wendel M, 1998, J CELL BIOL, V141, P839, DOI 10.1083/jcb.141.3.839; YAMAGATA T, 1968, J BIOL CHEM, V243, P1523; Young MF, 2003, OSTEOPOROSIS INT, V14, pS35, DOI 10.1007/s00198-002-1342-7; Zhou HY, 2007, ANN NY ACAD SCI, V1116, P323, DOI 10.1196/annals.1402.023	61	24	25	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2015	10	6							e0131105	10.1371/journal.pone.0131105	http://dx.doi.org/10.1371/journal.pone.0131105			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4OM	26107959	Green Published, Green Accepted, gold, Green Submitted			2022-12-26	WOS:000356932500141
J	McCurry, MR; Mahony, M; Clausen, PD; Quayle, MR; Walmsley, CW; Jessop, TS; Wroe, S; Richards, H; McHenry, CR				McCurry, Matthew R.; Mahony, Michael; Clausen, Phillip D.; Quayle, Michelle R.; Walmsley, Christopher W.; Jessop, Tim S.; Wroe, Stephen; Richards, Heather; McHenry, Colin R.			The Relationship between Cranial Structure, Biomechanical Performance and Ecological Diversity in Varanoid Lizards	PLOS ONE			English	Article							FINITE-ELEMENT-ANALYSIS; GEOMETRIC MORPHOMETRICS; MECHANICAL PERFORMANCE; PREDATORY BEHAVIOR; FEEDING-BEHAVIOR; KOMODO-DRAGON; BITE FORCE; EVOLUTION; BONE; SKULL	Skull structure is intimately associated with feeding ability in vertebrates, both in terms of specific performance measures and general ecological characteristics. This study quantitatively assessed variation in the shape of the cranium and mandible in varanoid lizards, and its relationship to structural performance (von Mises strain) and interspecific differences in feeding ecology. Geometric morphometric and linear morphometric analyses were used to evaluate morphological differences, and finite element analysis was used to quantify variation in structural performance (strain during simulated biting, shaking and pulling). This data was then integrated with ecological classes compiled from relevant scientific literature on each species in order to establish structure-function relationships. Finite element modelling results showed that variation in cranial morphology resulted in large differences in the magnitudes and locations of strain in biting, shaking and pulling load cases. Gracile species such as Varanus salvadorii displayed high strain levels during shaking, especially in the areas between the orbits. All models exhibit less strain during pull back loading compared to shake loading, even though a larger force was applied (pull =30N, shake =20N). Relationships were identified between the morphology, performance, and ecology. Species that did not feed on hard prey clustered in the gracile region of cranial morphospace and exhibited significantly higher levels of strain during biting (P = 0.0106). Species that fed on large prey clustered in the elongate area of mandible morphospace. This relationship differs from those that have been identified in other taxonomic groups such as crocodiles and mammals. This difference may be due to a combination of the open 'space-frame' structure of the varanoid lizard skull, and the 'pull back' behaviour that some species use for processing large prey.	[McCurry, Matthew R.; Quayle, Michelle R.; Walmsley, Christopher W.; McHenry, Colin R.] Monash Univ, Dept Anat & Dev Biol, Melbourne, Vic 3004, Australia; [McCurry, Matthew R.; Mahony, Michael] Univ Newcastle, Sch Environm & Life Sci, Newcastle, NSW 2300, Australia; [McCurry, Matthew R.] Museum Victoria, Geosci, Melbourne, Vic, Australia; [Clausen, Phillip D.; Wroe, Stephen; Richards, Heather; McHenry, Colin R.] Univ Newcastle, Sch Engn, Newcastle, NSW 2300, Australia; [Jessop, Tim S.] Univ Melbourne, Dept Zool, Melbourne, Vic, Australia; [Wroe, Stephen] Univ New England, Funct Evolut & Anat Res Lab, Sch Environm & Rural Sci, Div Zool, Armidale, NSW, Australia	Monash University; University of Newcastle; Museum Victoria; University of Newcastle; University of Melbourne; University of New England	McCurry, MR (corresponding author), Monash Univ, Dept Anat & Dev Biol, Melbourne, Vic 3004, Australia.	m.r.mccurry1@gmail.com	Jessop, Tim/Q-2473-2019; Clausen, Philip/G-7337-2013	McCurry, Matthew/0000-0002-2452-1404; Jessop, Tim S./0000-0002-7712-4373; Clausen, Philip/0000-0003-1186-6419; Wroe, Stephen/0000-0002-6365-5915	UNSW; Division Of Earth Sciences [1258878] Funding Source: National Science Foundation	UNSW; Division Of Earth Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This study was funded by a summer research scholarship from UNSW awarded to MRM. The funding body had no role in study design, data collection, analysis, decision to publish or preparation of the manuscript.	Ast JC, 2001, CLADISTICS, V17, P211, DOI 10.1111/j.1096-0031.2001.tb00118.x; Beck D., 2004, VARANOID LIZARDS WOR, P521; Bennett D, 2004, VARANOID LIZARDS WOR, P95; Bennett D, 2002, B CHICAGO HERPETOL S, V35, P177; Bourke J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002200; Bright JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031769; Bull JJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011097; Chalk J, 2011, AM J PHYS ANTHROPOL, V145, P1, DOI 10.1002/ajpa.21416; Christian KA, 2004, VARANOID LIZARDS WOR, P423; Ciofi C., 2004, VARANOID LIZARDS WOR, P197; Clemente CJ, 2009, J ZOOL, V278, P270, DOI 10.1111/j.1469-7998.2009.00559.x; Clemente CJ, 2011, J EXP BIOL, V214, P3013, DOI 10.1242/jeb.059345; Curtis N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029804; Curtis N, 2011, ANAT REC, V294, P1178, DOI 10.1002/ar.21415; D'Amore DC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026226; D'Amore DC, 2009, PALEOBIOLOGY, V35, P525, DOI 10.1666/0094-8373-35.4.525; Dryden G, 2004, VARANOID LIZARDS OF THE WORLD, P297; Dumont ER, 2011, J ANAT, V218, P151, DOI 10.1111/j.1469-7580.2010.01247.x; Dumont ER, 2005, ANAT REC PART A, V283A, P319, DOI 10.1002/ar.a.20165; Eidenmuller B., 2004, VARANOID LIZARDS WOR, P472; Erickson GM, 2002, ANAT RECORD, V268, P115, DOI 10.1002/ar.10145; Figueirido B, 2010, LETHAIA, V43, P209, DOI 10.1111/j.1502-3931.2009.00184.x; Fitch AJ, 2006, AUST J ZOOL, V54, P253, DOI 10.1071/ZO05038; Fry BG, 2009, P NATL ACAD SCI USA, V106, P8969, DOI 10.1073/pnas.0810883106; Gaulke M., 2004, VARANOID LIZARDS WOR, P244; Greene H. W, 2004, VARANOID LIZARDS WOR, P225; Henderson DM, 2002, J VERTEBR PALEONTOL, V22, P766, DOI 10.1671/0272-4634(2002)022[0766:TEHITS]2.0.CO;2; Herrel A, 2007, INTEGR COMP BIOL, V47, P107, DOI 10.1093/icb/icm014; Holliday CM, 2009, ANAT REC, V292, P1246, DOI 10.1002/ar.20982; Horn H-G, 2004, VARANOID LIZARDS WOR, P231; Imansyah MJ, 2008, J ZOOL, V274, P107, DOI 10.1111/j.1469-7998.2007.00368.x; Jasinoski SC, 2010, J MORPHOL, V271, P705, DOI 10.1002/jmor.10828; Jones MEH, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-208; King Dennis, 2008, Biawak, V2, P11; Klingenberg CP, 2010, SYST BIOL, V59, P245, DOI 10.1093/sysbio/syp106; Lautenschlager S, 2013, P NATL ACAD SCI USA, V110, P20657, DOI 10.1073/pnas.1310711110; LOOP M S, 1974, Herpetologica, V30, P123; LOSOS JB, 1988, BIOL J LINN SOC, V35, P379, DOI 10.1111/j.1095-8312.1988.tb00477.x; McHenry C, 2009, DEVOURER GODS PALAEC; McHenry CR, 2007, P NATL ACAD SCI USA, V104, P16010, DOI 10.1073/pnas.0706086104; Mchenry CR, 2006, ANAT REC PART A, V288A, P827, DOI 10.1002/ar.a.20360; Moazen M, 2009, P ROY SOC B-BIOL SCI, V276, P39, DOI 10.1098/rspb.2008.0863; Moreno K, 2008, J ANAT, V212, P736, DOI 10.1111/j.1469-7580.2008.00899.x; O'Higgins P, 2006, MORPHOLOGIKA 2 V 24; O'Higgins P, 2011, J ANAT, V218, P3, DOI 10.1111/j.1469-7580.2010.01301.x; Oldfield CC, 2012, J ZOOL, V286, P163, DOI 10.1111/j.1469-7998.2011.00862.x; Openshaw GH, 2014, J EVOLUTION BIOL, V27, P363, DOI 10.1111/jeb.12299; Parr WCH, 2012, J THEOR BIOL, V301, P1, DOI 10.1016/j.jtbi.2012.01.030; PIANKA ER, 1994, AUST J ECOL, V19, P395, DOI 10.1111/j.1442-9993.1994.tb00505.x; PIANKA ER, 1995, AM NAT, V146, P398, DOI 10.1086/285806; Pianka ER, 2004, VARANOID LIZARDS WOR; Pianka ER., 2004, VARANOID LIZARDS WOR, P535; Pierce SE, 2008, J MORPHOL, V269, P840, DOI 10.1002/jmor.10627; Piras P, 2013, SYST BIOL, V62, P878, DOI 10.1093/sysbio/syt053; R Core Team, 2021, R LANGUAGE ENV STAT; Rayfield EJ, 2005, ANAT REC PART A, V283A, P349, DOI 10.1002/ar.a.20168; Rayfield EJ, 2004, P ROY SOC B-BIOL SCI, V271, P1451, DOI 10.1098/rspb.2004.2755; Rayfield EJ, 2001, NATURE, V409, P1033, DOI 10.1038/35059070; Rayfield EJ, 2007, ANNU REV EARTH PL SC, V35, P541, DOI 10.1146/annurev.earth.35.031306.140104; Reed DA, 2011, J ANAT, V218, P59, DOI 10.1111/j.1469-7580.2010.01319.x; Reeder TW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118199; Richards Jr R, 2010, PRINCIPLES SOLID MEC; RIEPPEL O, 1979, HERPETOLOGICA, V35, P158; Ross CF, 2011, J ANAT, V218, P112, DOI 10.1111/j.1469-7580.2010.01322.x; Shannon R, 2009, INT VARANID INTREST, V3, P85; SHINE R, 1986, HERPETOLOGICA, V42, P346; Slater GJ, 2009, J EVOLUTION BIOL, V22, P2278, DOI 10.1111/j.1420-9101.2009.01845.x; Snively E, 2008, PALAEONTOL ELECTRON, V11; Soons J, 2010, PHILOS T R SOC B, V365, P1093, DOI 10.1098/rstb.2009.0280; Stayton CT, 2005, J MORPHOL, V263, P47, DOI 10.1002/jmor.10288; Thompson G., 2004, VARANOID LIZARDS WOR, P380; Thompson GG, 1997, J MORPHOL, V233, P127, DOI 10.1002/(SICI)1097-4687(199708)233:2<127::AID-JMOR4>3.0.CO;2-3; Tseng ZJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065305; Tseng ZJ, 2011, BIOL J LINN SOC, V102, P540, DOI 10.1111/j.1095-8312.2010.01602.x; Vidal N, 2012, BIOL LETTERS, V8, P853, DOI 10.1098/rsbl.2012.0460; Wainwright Peter C., 1994, P42; Walmsley CW, 2013, PEERJ, V1, DOI 10.7717/peerj.204; Walmsley CW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053873; Wang QA, 2010, ANAT REC, V293, P1477, DOI 10.1002/ar.21203; Wang Q, 2010, ANAT REC, V293, P607, DOI 10.1002/ar.21123; Wiley D., 2006, LANDM ED 3 0; Wroe S, 2008, J ZOOL, V274, P332, DOI 10.1111/j.1469-7998.2007.00389.x; Wroe S, 2005, P ROY SOC B-BIOL SCI, V272, P619, DOI 10.1098/rspb.2004.2986; Wroe S, 2007, P ROY SOC B-BIOL SCI, V274, P2819, DOI 10.1098/rspb.2007.0906; Wroe S, 2010, P ROY SOC B-BIOL SCI, V277, P3579, DOI 10.1098/rspb.2010.0509	85	29	30	0	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2015	10	6							e0130625	10.1371/journal.pone.0130625	http://dx.doi.org/10.1371/journal.pone.0130625			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4OM	26106889	Green Submitted, Green Published, gold			2022-12-26	WOS:000356932500112
J	Miyashita, A; Takahashi, S; Ishii, K; Sekimizu, K; Kaito, C				Miyashita, Atsushi; Takahashi, Shinji; Ishii, Kenichi; Sekimizu, Kazuhisa; Kaito, Chikara			Primed Immune Responses Triggered by Ingested Bacteria Lead to Systemic Infection Tolerance in Silkworms	PLOS ONE			English	Article							DROSOPHILA HOST-DEFENSE; PEPTIDOGLYCAN-RECOGNITION; MODEL; GUT; COMMENSAL; LARVAE; SPECIFICITY; ACTIVATION; PATHWAYS; CYTOKINE	In the present study, we examined whether microorganisms collaterally ingested by insects with their food activate the innate immune system to confer systemic resistance against subsequent bacterial invasion. Silkworms orally administered heat-killed Pseudomonas aeruginosa cells showed resistance against intra-hemolymph infection by P. aeruginosa. Oral administration of peptidoglycans, cell wall components of P. aeruginosa, conferred protective effects against P. aeruginosa infection, whereas oral administration of lipopolysaccharides, bacterial surface components, did not. In silkworms orally administered heat-killed P. aeruginosa cells, P. aeruginosa growth was inhibited in the hemolymph, and mRNA amounts of the antimicrobial peptides cecropin A and moricin were increased in the hemocytes and fat body. Furthermore, the amount of paralytic peptide, an insect cytokine that activates innate immune reactions, was increased in the hemolymph of silkworms orally administered heat-killed P. aeruginosa cells. These findings suggest that insects sense bacteria present in their food by peptidoglycan recognition, which activates systemic immune reactions to defend the insects against a second round of infection.	[Miyashita, Atsushi; Takahashi, Shinji; Ishii, Kenichi; Sekimizu, Kazuhisa; Kaito, Chikara] Univ Tokyo, Grad Sch Pharmaceut Sci, Microbiol Lab, Bunkyo Ku, Tokyo 1130033, Japan	University of Tokyo	Kaito, C (corresponding author), Univ Tokyo, Grad Sch Pharmaceut Sci, Microbiol Lab, Bunkyo Ku, 3-1,7 Chome, Tokyo 1130033, Japan.	kaito@mol.f.u-tokyo.ac.jp	Ishii, Kenichi/H-5469-2019; Kaito, Chikara/W-1815-2019; Kaito, Chikara/G-1248-2017	Kaito, Chikara/0000-0002-2895-3386; Kaito, Chikara/0000-0002-2895-3386; Miyashita, Atsushi/0000-0002-9076-0569	Japan Society for the Promotion of Science Research Fellowships for Young Scientists [25-8664]; Genome Pharmaceutical Institute;  [23249009];  [24590519];  [25117507];  [26670025]	Japan Society for the Promotion of Science Research Fellowships for Young Scientists(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Genome Pharmaceutical Institute; ; ; ; 	This study was supported by Grants-in-Aid for Scientific Research 23249009, 24590519, 25117507, 26670025 and Japan Society for the Promotion of Science Research Fellowships for Young Scientists Grant 25-8664 (to A.M.). This study was supported in part by the Genome Pharmaceutical Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal K, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000120; BARTONWILLIS PA, 1984, PHYSIOL PLANT PATHOL, V25, P387, DOI 10.1016/0048-4059(84)90045-6; Basset A, 2000, P NATL ACAD SCI USA, V97, P3376, DOI 10.1073/pnas.070357597; Braxton SM, 2003, J INVERTEBR PATHOL, V83, P185, DOI 10.1016/S0022-2011(03)00089-2; De Gregorio E, 2002, DEV CELL, V3, P581, DOI 10.1016/S1534-5807(02)00267-8; GRIMONT PAD, 1978, ANNU REV MICROBIOL, V32, P221, DOI 10.1146/annurev.mi.32.100178.001253; Ha EM, 2009, NAT IMMUNOL, V10, P949, DOI 10.1038/ni.1765; Ha EM, 2009, DEV CELL, V16, P386, DOI 10.1016/j.devcel.2008.12.015; Hamamoto H, 2004, ANTIMICROB AGENTS CH, V48, P774, DOI 10.1128/AAC.48.3.774-779.2004; Hamamoto H, 2009, COMP BIOCHEM PHYS C, V149, P334, DOI 10.1016/j.cbpc.2008.08.008; Hooper LV, 2001, SCIENCE, V292, P1115, DOI 10.1126/science.1058709; Ishii K, 2008, J BIOL CHEM, V283, P2185, DOI 10.1074/jbc.M705480200; Ishii K, 2010, J BIOL CHEM, V285, P33338, DOI 10.1074/jbc.M110.112987; Ishii K, 2010, J BIOL CHEM, V285, P28635, DOI 10.1074/jbc.M110.138446; Kaito C, 2005, MOL MICROBIOL, V56, P934, DOI 10.1111/j.1365-2958.2005.04596.x; Kaito C, 2002, MICROB PATHOGENESIS, V32, P183, DOI 10.1006/mpat.2002.0494; Kaito C, 2007, DRUG DISCOV THER, V1, P89; Kaneko T, 2004, IMMUNITY, V20, P637, DOI 10.1016/S1074-7613(04)00104-9; Kurata S, 2014, DEV COMP IMMUNOL, V42, P36, DOI 10.1016/j.dci.2013.06.006; Lemaitre B, 2004, NAT REV IMMUNOL, V4, P521, DOI 10.1038/nri1390; Lemaitre B, 1996, CELL, V86, P973, DOI 10.1016/S0092-8674(00)80172-5; LEMAITRE B, 1995, P NATL ACAD SCI USA, V92, P9465, DOI 10.1073/pnas.92.21.9465; Lemaitre B, 2007, ANNU REV IMMUNOL, V25, P697, DOI 10.1146/annurev.immunol.25.022106.141615; Leulier F, 2003, NAT IMMUNOL, V4, P478, DOI 10.1038/ni922; MacDonald TT, 2005, SCIENCE, V307, P1920, DOI 10.1126/science.1106442; Macpherson AJ, 2004, NAT REV IMMUNOL, V4, P478, DOI 10.1038/nri1373; Miyashita A, 2014, J BIOL CHEM, V289, P14412, DOI 10.1074/jbc.M113.525139; Miyazaki S, 2012, FEMS MICROBIOL LETT, V326, P116, DOI 10.1111/j.1574-6968.2011.02439.x; Pham LN, 2007, PLOS PATHOG, V3, DOI 10.1371/journal.ppat.0030026; Rodrigues J, 2010, SCIENCE, V329, P1353, DOI 10.1126/science.1190689; Roth O, 2009, DEV COMP IMMUNOL, V33, P1151, DOI 10.1016/j.dci.2009.04.005; Sadd BM, 2006, CURR BIOL, V16, P1206, DOI 10.1016/j.cub.2006.04.047; Sansonetti PJ, 2004, NAT REV IMMUNOL, V4, P953, DOI 10.1038/nri1499; Sun JC, 2014, EMBO J, V33, P1295, DOI 10.1002/embj.201387651; Takehana A, 2002, P NATL ACAD SCI USA, V99, P13705, DOI 10.1073/pnas.212301199; Tzou P, 2000, IMMUNITY, V13, P737, DOI 10.1016/S1074-7613(00)00072-8; Vodovar N, 2005, P NATL ACAD SCI USA, V102, P11414, DOI 10.1073/pnas.0502240102; Wu S, 2010, DEV COMP IMMUNOL, V34, P93, DOI 10.1016/j.dci.2009.08.010; Zaidman-Remy A, 2006, IMMUNITY, V24, P463, DOI 10.1016/j.immuni.2006.02.012	39	26	27	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2015	10	6							e0130486	10.1371/journal.pone.0130486	http://dx.doi.org/10.1371/journal.pone.0130486			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4OM	26107254	Green Published, Green Submitted, gold			2022-12-26	WOS:000356932500104
J	Langlois, R; Grokopf, T; Mills, M; Takeda, S; LaRoche, J				Langlois, Rebecca; Grokopf, Tobias; Mills, Matthew; Takeda, Shigenobu; LaRoche, Julie			Widespread Distribution and Expression of Gamma A (UMB), an Uncultured, Diazotrophic, gamma-Proteobacterial nifH Phylotype	PLOS ONE			English	Article							SOUTH CHINA SEA; NITROGEN-FIXATION; N-2 FIXATION; DIVERSITY; ATLANTIC; OCEAN; GENES; WATERS; MICROORGANISMS; SEASONALITY	Marine dinitrogen (N-2) fixation studies have focused nearly exclusively on cyanobacterial diazotrophs; however gamma-proteobacteria are an abundant component of the marine community and have been largely overlooked until recently. Here we present a phylogenetic analysis of all nifH gamma-proteobacterial sequences available in public databases and qPCR data of a gamma-proteobacterial phylotype, Gamma A (UMB), obtained during several research cruises. Our analysis revealed a complex diversity of diazotrophic gamma-proteobacteria. One phylotype in particular, Gamma A, was described in several traditional and quantitative PCR studies. Though several gamma-proteobacterial nifH sequences have been described as laboratory contaminants, Gamma A is part of a large cluster of sequences isolated from marine environments and distantly related to the clade of contaminants. Using a TaqMan probe and primer set, Gamma A nifH DNA abundance and expression were analyzed in nearly 1000 samples collected during 15 cruises to the Atlantic and Pacific Oceans. The data showed that Gamma A is an active, cosmopolitan diazotroph found throughout oxygenated, oligotrophic waters reaching maximum abundances of 8 x 10(4) nifH DNA copies l(-1) and 5 x 10(5) nifH transcript copies l(-1). Gamma A nifH transcript abundances were on average 3 fold higher than nifH DNA abundances. The widespread distribution and activity of Gamma A indicate that it has potential to be a globally important N-2 fixing organism.	[Langlois, Rebecca; LaRoche, Julie] Dalhousie Univ, Dept Oceanog, Halifax, NS, Canada; [Grokopf, Tobias] Univ Warwick, Coventry CV4 7AL, W Midlands, England; [Mills, Matthew] Stanford Univ, Environm Earth Syst Sci, Stanford, CA 94305 USA; [Takeda, Shigenobu] Nagasaki Univ, Fac Fisheries, Nagasaki 852, Japan	Dalhousie University; University of Warwick; Stanford University; Nagasaki University	Langlois, R (corresponding author), Dalhousie Univ, Dept Oceanog, Halifax, NS, Canada.	rebecca.langlois@dal.ca		Langlois, Rebecca/0000-0002-8382-4448; LaRoche, Julie/0000-0003-4809-6411	New Zealand Ministry of Fisheries BRAG Project [ZBD200811]; Deutsche Forschungsgemeinschaft [RO2138/5-1]; Bundesministerium fur Bildung und Forschung (SOPRAN); National Sciences and Engineering Research Council; Canada Excellence Research Chair in Ocean Sciences Technologies	New Zealand Ministry of Fisheries BRAG Project; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Bundesministerium fur Bildung und Forschung (SOPRAN)(Federal Ministry of Education & Research (BMBF)); National Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Excellence Research Chair in Ocean Sciences Technologies	Tasman Sea sample collection was supported by the New Zealand Ministry of Fisheries BRAG Project ZBD200811 & FRST Oceans Outcome-based Investment. This work was supported by the Deutsche Forschungsgemeinschaft (RO2138/5-1), Bundesministerium fur Bildung und Forschung (SOPRAN), and National Sciences and Engineering Research Council grants to JL and a Canada Excellence Research Chair in Ocean Sciences Technologies grant to Douglas Wallace.	Berman-Frank I, 2001, SCIENCE, V294, P1534, DOI 10.1126/science.1064082; Bird C, 2005, APPL ENVIRON MICROB, V71, P2079, DOI 10.1128/AEM.71.4.2079-2085.2005; Bombar D, 2011, MAR ECOL PROG SER, V424, P39, DOI 10.3354/meps08976; Bonnet S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081265; Church MJ, 2008, LIMNOL OCEANOGR, V53, P63, DOI 10.4319/lo.2008.53.1.0063; Church MJ, 2005, AQUAT MICROB ECOL, V38, P3, DOI 10.3354/ame038003; Duarte CM, 2013, ANNU REV MAR SCI, V5, P551, DOI 10.1146/annurev-marine-121211-172337; Dupont CL, 2012, ISME J, V6, P1186, DOI 10.1038/ismej.2011.189; Farnelid H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019223; Fernandez C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020539; Foster RA, 2007, LIMNOL OCEANOGR, V52, P517, DOI 10.4319/lo.2007.52.2.0517; Foster RA, 2009, LIMNOL OCEANOGR, V54, P219, DOI 10.4319/lo.2009.54.1.0219; Giovannoni SJ, 2012, SCIENCE, V335, P671, DOI 10.1126/science.1198078; Grimes DJ, 2009, MICROB ECOL, V58, P447, DOI 10.1007/s00248-009-9578-9; GUERINOT ML, 1982, INT J SYST BACTERIOL, V32, P350, DOI 10.1099/00207713-32-3-350; Halm H, 2012, ISME J, V6, P1238, DOI 10.1038/ismej.2011.182; Hamersley MR, 2011, AQUAT MICROB ECOL, V63, P193, DOI 10.3354/ame01494; Hansell DA, 2009, OCEANOGRAPHY, V22, P202, DOI 10.5670/oceanog.2009.109; Hewson I, 2007, AQUAT MICROB ECOL, V46, P15, DOI 10.3354/ame046015; Huang Y, 2010, BIOINFORMATICS, V26, P680, DOI 10.1093/bioinformatics/btq003; Jayakumar A, 2012, FEMS MICROBIOL ECOL, V82, P597, DOI 10.1111/j.1574-6941.2012.01430.x; Kolber ZS, 2001, SCIENCE, V292, P2492, DOI 10.1126/science.1059707; Langlois RJ, 2008, APPL ENVIRON MICROB, V74, P1922, DOI 10.1128/AEM.01720-07; Langlois RJ, 2005, APPL ENVIRON MICROB, V71, P7910, DOI 10.1128/AEM.71.12.7910-7919.2005; Loscher C. R., 2014, ISME J, V8, P2180, DOI DOI 10.1038/ismej.2014.71; Luo YW, 2012, EARTH SYST SCI DATA, V4, P47, DOI 10.5194/essd-4-47-2012; Man-Aharonovich D, 2007, ENVIRON MICROBIOL, V9, P2354, DOI 10.1111/j.1462-2920.2007.01353.x; Moisander PH, 2008, ISME J, V2, P954, DOI 10.1038/ismej.2008.51; Moisander PH, 2014, ISME J, V8, P1962, DOI 10.1038/ismej.2014.49; Moore CM, 2009, NAT GEOSCI, V2, P867, DOI 10.1038/ngeo667; PAERL HW, 1985, LIMNOL OCEANOGR, V30, P1246, DOI 10.4319/lo.1985.30.6.1246; PAERL HW, 1987, APPL ENVIRON MICROB, V53, P1078, DOI 10.1128/AEM.53.5.1078-1087.1987; PAYNE WJ, 1961, ANTON VAN LEE J M S, V27, P121, DOI 10.1007/BF02538432; Poretsky RS, 2009, ENVIRON MICROBIOL, V11, P1358, DOI 10.1111/j.1462-2920.2008.01863.x; Postgate J., 1998, NITROGEN FIXATION; Riemann L, 2010, AQUAT MICROB ECOL, V61, P225, DOI 10.3354/ame01431; Rijkenberg MJA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028989; Rusch DB, 2007, PLOS BIOL, V5, P398, DOI 10.1371/journal.pbio.0050077; Shiozaki T, 2014, GLOBAL BIOGEOCHEM CY, V28, P1096, DOI 10.1002/2014GB004886; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Thompson AW, 2012, SCIENCE, V337, P1546, DOI 10.1126/science.1222700; Turk-Kubo KA, 2014, ENVIRON MICROBIOL, V16, P3095, DOI 10.1111/1462-2920.12346; Venter JC, 2004, SCIENCE, V304, P66, DOI 10.1126/science.1093857; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Yang JC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006085; Yurkov VV, 1998, MICROBIOL MOL BIOL R, V62, P695, DOI 10.1128/MMBR.62.3.695-724.1998; ZAVARZIN GA, 1991, CAN J MICROBIOL, V37, P1, DOI 10.1139/m91-001; Zehr JP, 1998, APPL ENVIRON MICROB, V64, P3444; Zehr JP, 2003, BIOTECHNIQUES, V35, P996, DOI 10.2144/03355st08; Zhang Y, 2011, FEMS MICROBIOL ECOL, V78, P417, DOI 10.1111/j.1574-6941.2011.01174.x	50	40	40	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2015	10	6							e0128912	10.1371/journal.pone.0128912	http://dx.doi.org/10.1371/journal.pone.0128912			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4DD	26103055	gold, Green Submitted, Green Published			2022-12-26	WOS:000356901900009
J	Thieme, R; Kurz, S; Kolb, M; Debebe, T; Holtze, S; Morhart, M; Huse, K; Szafranski, K; Platzer, M; Hildebrandt, TB; Birkenmeier, G				Thieme, Rene; Kurz, Susanne; Kolb, Marlen; Debebe, Tewodros; Holtze, Susanne; Morhart, Michaela; Huse, Klaus; Szafranski, Karol; Platzer, Matthias; Hildebrandt, Thomas B.; Birkenmeier, Gerd			Analysis of Alpha-2 Macroglobulin from the Long-Lived and Cancer-Resistant Naked Mole-Rat and Human Plasma	PLOS ONE			English	Article							RECEPTOR-RELATED PROTEIN; LIPOPROTEIN RECEPTOR; HETEROCEPHALUS-GLABER; BINDING-PROTEIN; LIVING RODENT; AMYLOID-BETA; GROWTH; ALPHA(2)-MACROGLOBULIN; LONGEVITY; INSIGHTS	Background The naked mole-rat (NMR) is a long-lived and cancer resistant species. Identification of potential anti-cancer and age related mechanisms is of great interest and makes this species eminent to investigate anti-cancer strategies and understand aging mechanisms. Since it is known that the NMR expresses higher liver mRNA-levels of alpha 2-macroglobulin than mice, nothing is known about its structure, functionality or expression level in the NMR compared to the human A2M. Results Here we show a comprehensive analysis of NMR-and human plasma-A2M, showing a different prediction in glycosylation of NMR-A2M, which results in a higher molecular weight compared to human A2M. Additionally, we found a higher concentration of A2M (8.3 +/- 0.44 mg/mL vs. and 4.4 +/- 0.20 mg/mL) and a lower total plasma protein content (38.7 +/- 1.79 mg/mL vs. 61.7 +/- 3.20 mg/mL) in NMR compared to human. NMR-A2M can be transformed by methylamine and trypsin resulting in a conformational change similar to human A2M. NMR-A2M is detectable by a polyclonal antibody against human A2M. Determination of tryptic and anti-tryptic activity of NMR and human plasma revealed a higher anti-tryptic activity of the NMR plasma. On the other hand, less proteolytic activity was found in NMR plasma compared to human plasma. Conclusion We found transformed NMR-A2M binding to its specific receptor LRP1. We could demonstrate lower protein expression of LRP1 in the NMR liver tissue compared to human but higher expression of A2M. This was accompanied by a higher EpCAM protein expression as central adhesion molecule in cancer progression. NMR-plasma was capable to increase the adhesion in human fibroblast in vitro most probably by increasing CD29 protein expression. This is the first report, demonstrating similarities as well as distinct differences between A2M in NMR and human plasma. This might be directly linked to the intriguing phenotype of the NMR and suggests that A2M might probably play an important role in anti-cancer and the anti-aging mechanisms in the NMR.	[Thieme, Rene; Kurz, Susanne; Kolb, Marlen; Debebe, Tewodros; Birkenmeier, Gerd] Univ Leipzig, Inst Biochem, D-04109 Leipzig, Germany; [Holtze, Susanne; Morhart, Michaela; Hildebrandt, Thomas B.] Leibniz Inst Zoo & Wildlife Res, Dept Reprod Management, Berlin, Germany; [Huse, Klaus; Szafranski, Karol; Platzer, Matthias] Leibniz Inst Age Res, Fritz Lipmann Inst, Jena, Germany	Leipzig University; Leibniz Institut fur Zoo und Wildtierforschung; Leibniz Institut fur Alternsforschung - Fritz-Lipmann-Institut (FLI)	Birkenmeier, G (corresponding author), Univ Leipzig, Inst Biochem, D-04109 Leipzig, Germany.	gerd.birkenmeier@medizin.uni-leipzig.de		Aklilu, Tewodros Debebe/0000-0002-8421-1651; Kolb, Marlen/0000-0002-8397-8295; Huse, Klaus/0000-0003-3854-1884	Europaischer Sozialfond - ESF [100098250]; Leibniz Association	Europaischer Sozialfond - ESF; Leibniz Association	This work was supported by grants from the Europaischer Sozialfond - ESF www.esf.de (100098250) to GB. This work was supported by grants from the Leibniz Association (SAW 2012) www.leibniz-gemeinschaft.de/ to MP.	Azpurua J, 2013, P NATL ACAD SCI USA, V110, P17350, DOI 10.1073/pnas.1313473110; Bao B, 2010, AM J CLIN NUTR, V91, P1634, DOI 10.3945/ajcn.2009.28836; Birkenmeier G, 2003, EXP NEUROL, V184, P153, DOI 10.1016/S0014-4886(03)00110-9; Birkenmeier G, 1998, EUR J ENDOCRINOL, V139, P224, DOI 10.1530/eje.0.1390224; Birkenmeier G, 1997, FEBS LETT, V416, P193, DOI 10.1016/S0014-5793(97)01201-5; Birkenmeier G, 1998, ARCH DERMATOL RES, V290, P561, DOI 10.1007/s004030050352; Birkenmeier G, 2006, J PHARMACOL EXP THER, V318, P762, DOI 10.1124/jpet.106.104265; BORTH W, 1992, FASEB J, V6, P3345, DOI 10.1096/fasebj.6.15.1281457; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Buffenstein R, 2005, J GERONTOL A-BIOL, V60, P1369, DOI 10.1093/gerona/60.11.1369; Buffenstein R, 2008, J COMP PHYSIOL B, V178, P439, DOI 10.1007/s00360-007-0237-5; Cascella R, 2013, BBA-MOL BASIS DIS, V1832, P1217, DOI 10.1016/j.bbadis.2013.04.012; COLEMAN JE, 1992, ANNU REV BIOCHEM, V61, P897, DOI 10.1146/annurev.bi.61.070192.004341; Dalli J, 2014, EMBO MOL MED, V6, P27, DOI 10.1002/emmm.201303503; Daly TJM, 1997, J ANAT, V190, P321, DOI 10.1046/j.1469-7580.1997.19030321.x; de Magalhaes JP, 2009, AGING CELL, V8, P65, DOI 10.1111/j.1474-9726.2008.00442.x; De Paula RCS, 2014, BBA CLIN, V2, P1, DOI 10.1016/j.bbacli.2014.07.002; De Souza EM, 2008, EXP PARASITOL, V118, P331, DOI 10.1016/j.exppara.2007.09.004; Faulkes CG, 1997, P ROY SOC B-BIOL SCI, V264, P1619, DOI 10.1098/rspb.1997.0226; Fraker PJ, 2004, ANNU REV NUTR, V24, P277, DOI 10.1146/annurev.nutr.24.012003.132454; Gaultier A, 2010, J PROTEOME RES, V9, P6689, DOI 10.1021/pr1008288; GONIAS SL, 1994, ANN NY ACAD SCI, V737, P273, DOI 10.1111/j.1749-6632.1994.tb44318.x; GONIAS SL, 1983, J BIOL CHEM, V258, P4682; Gopal U, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017649; Gorbunova V, 2014, NAT REV GENET, V15, P531, DOI 10.1038/nrg3728; Gordts PLSM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038330; Harper JM, 2006, AGING CELL, V5, P441, DOI 10.1111/j.1474-9726.2006.00236.x; HERZ J, 1988, EMBO J, V7, P4119, DOI 10.1002/j.1460-2075.1988.tb03306.x; Isaac L, 1999, INFLAMM RES, V48, P446, DOI 10.1007/s000110050485; Kanekiyo T, 2013, J NEUROSCI, V33, P19276, DOI 10.1523/JNEUROSCI.3487-13.2013; Keller L, 2006, EXP GERONTOL, V41, P553, DOI 10.1016/j.exger.2006.04.002; Kim EB, 2011, NATURE, V479, P223, DOI 10.1038/nature10533; Kratzsch J, 1996, ACTA PAEDIATR, V85, P108, DOI 10.1111/j.1651-2227.1996.tb14315.x; Kuang W, 1998, PROTEIN SCI, V7, P2602; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lauer D, 2001, EXP NEUROL, V167, P385, DOI 10.1006/exnr.2000.7569; Lee C, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/502093; Liang ST, 2010, AGING CELL, V9, P626, DOI 10.1111/j.1474-9726.2010.00588.x; Lindner I, 2010, CANCER RES, V70, P277, DOI 10.1158/0008-5472.CAN-09-1462; Mekkawy AH, 2014, MED RES REV, V34, P918, DOI 10.1002/med.21308; Mocchegiani E, 2006, EXP GERONTOL, V41, P1094, DOI 10.1016/j.exger.2006.08.010; Pawaria S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050365; Perez VI, 2009, P NATL ACAD SCI USA, V106, P3059, DOI 10.1073/pnas.0809620106; Perrot G, 2012, MOL CELL BIOL, V32, P3293, DOI 10.1128/MCB.00228-12; PHILIP A, 1991, J BIOL CHEM, V266, P22290; Sekiguchi R, 2012, DEV COMP IMMUNOL, V36, P483, DOI 10.1016/j.dci.2011.05.003; Seluanov A, 2009, P NATL ACAD SCI USA, V106, P19352, DOI 10.1073/pnas.0905252106; Soler-Lopez M, 2011, GENOME RES, V21, P364, DOI 10.1101/gr.114280.110; SOTTRUPJENSEN L, 1986, FEBS LETT, V205, P20, DOI 10.1016/0014-5793(86)80857-2; SOTTRUPJENSEN L, 1989, J BIOL CHEM, V264, P11539; Strickland DK, 2014, ARTERIOSCL THROM VAS, V34, P487, DOI 10.1161/ATVBAHA.113.301924; Tian X, 2013, NATURE, V499, P346, DOI 10.1038/nature12234; van der Gun BTF, 2010, CARCINOGENESIS, V31, P1913, DOI 10.1093/carcin/bgq187; VANLEUVEN F, 1981, J BIOL CHEM, V256, P9023; Villeda SA, 2014, NAT MED, V20, P659, DOI 10.1038/nm.3569; Westwood M, 2001, J BIOL CHEM, V276, P41668, DOI 10.1074/jbc.M102793200; Yamashita T, 2007, CANCER RES, V67, P10831, DOI 10.1158/0008-5472.CAN-07-0908; Yu CF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026729	58	22	23	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2015	10	6							e0130470	10.1371/journal.pone.0130470	http://dx.doi.org/10.1371/journal.pone.0130470			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4DD	26103567	Green Submitted, Green Published, gold			2022-12-26	WOS:000356901900047
J	Wilson, B; Bialocerkowski, A				Wilson, Brendan; Bialocerkowski, Andrea			The Effects of Kinesiotape Applied to the Lateral Aspect of the Ankle: Relevance to Ankle Sprains - A Systematic Review	PLOS ONE			English	Review							TAPE; PROPRIOCEPTION; INSTABILITY; PREVENTION; INJURIES; PLAYERS	Objective To identify, evaluate and synthesise evidence on the effect of kinesiotape applied to the lateral aspect of the ankle, through a systematic review of quantitative studies. Data Sources A search for quantitative studies was undertaken using key terms of "kinesiotape" and "ankle" in seven electronic databases, using the maximum date ranges. Databases included: the Cochrane Library, Cumulative Index to Nursing and Allied Health Literature, Medline, Physiotherapy Evidence Database, Scopus, SPORTDiscus and Web of Science. Study Selection Database hits were evaluated against explicit inclusion criteria. From 107 database hits, 8 quantitative studies were included. Data Extraction Two independent reviewers appraised the methodological rigour of the studies using the McMaster Critical Review Form for Quantitative Studies. Data were extracted on participant characteristics, kinesiotape parameters, comparison interventions, outcome measures and findings. Data Syntheses Most studies (n=7) had good to very good methodological rigour. Meta-analysis was not possible due to heterogeneity in participants, interventions and outcome measures. No adverse events were reported. Kinesiotape may produce different effects in healthy and injured ankles. In healthy ankles, kinesiotape may increase postural control, whereas in injured ankles it may improve proprioception, plantarflexor endurance and the performance of activities. These trends were identified from a small body of evidence including 276 participants. Conclusions It is recommended that kinesiotape may be used in clinical practice to prevent lateral ankle injuries (through its effects on postural control) and manage lateral ankle injuries due to its positive effects on proprioception, muscle endurance and activity performance. It appears that kinesiotape may not provide sufficient mechanical support to improve postural control in unstable ankles. Adverse events associated with kinseiotape are unlikely.	[Wilson, Brendan; Bialocerkowski, Andrea] Griffith Univ, Sch Allied Hlth Sci, Menzies Hlth Inst Queensland, Nathan, Qld 4111, Australia	Griffith University	Bialocerkowski, A (corresponding author), Griffith Univ, Sch Allied Hlth Sci, Menzies Hlth Inst Queensland, Gold Coast Campus, Nathan, Qld 4111, Australia.	a.bialocerkowski@griffith.edu.au						ADAMS JA, 1971, J MOTOR BEHAV, V3, P111; Basset KT, 2010, NZ J PHYSIOTHERAPY, V38, P56; Bialocerkowski AE, 2005, DEV MED CHILD NEUROL, V47, P563, DOI 10.1017/S0012162205001118; Bialocerkowski A, 2013, DEV MED CHILD NEUROL, V55, P1075, DOI 10.1111/dmcn.12194; Bicici S, 2012, INT J SPORTS PHYS TH, V7, P154; Briem K, 2011, J ORTHOP SPORT PHYS, V41, P328, DOI 10.2519/jospt.2011.3501; Daly AE, 2009, EUR J PAIN, V13, P339, DOI 10.1016/j.ejpain.2008.05.003; de Vet HC, 2006, HEALTH QUAL LIFE OUT, V4, DOI 10.1186/1477-7525-4-54; Delahunt E, 2010, MED SCI SPORT EXER, V42, P2106, DOI 10.1249/MSS.0b013e3181de7a8a; Doherty C, 2014, SPORTS MED, V44, P123, DOI 10.1007/s40279-013-0102-5; Du Toit V, 2013, CLINICAL GUIDELINES; Engebretsen AH, 2008, AM J SPORT MED, V36, P1052, DOI 10.1177/0363546508314432; Fayson SD, 2013, RES SPORTS MED, V21, P204, DOI 10.1080/15438627.2013.792083; Fong DTP, 2009, BMC SPORTS SCI MED R, V1, DOI 10.1186/1758-2555-1-14; Fong DTP, 2007, SPORTS MED, V37, P73, DOI 10.2165/00007256-200737010-00006; Gotzsche PC, 2007, JAMA-J AM MED ASSOC, V298, P430, DOI 10.1001/jama.298.4.430; Halseth T, 2004, J SPORT SCI MED, V3, P1; Hartling L, 2005, ANN INTERN MED, V142, P1100, DOI 10.7326/0003-4819-142-12_Part_2-200506211-00010; Herbert R., 2013, CONFIDENCE INTERVAL; Hertel J, 2002, J ATHL TRAINING, V37, P364; Hertel J, 2000, SPORTS MED, V29, P361, DOI 10.2165/00007256-200029050-00005; Hertel J, 2008, CLIN SPORT MED, V27, P353, DOI 10.1016/j.csm.2008.03.006; Higgins J.P., 2011, COCHRANE HDB SYSTEMA, V4, DOI [10.1002/9780470712184, DOI 10.1002/9780470712184]; HILL AB, 1965, P ROY SOC MED, V58, P295, DOI 10.1177/003591576505800503; Hopewell S, 2008, LANCET, V371, P281, DOI 10.1016/S0140-6736(07)61835-2; Hubbard TJ, 2009, ARCH PHYS MED REHAB, V90, P1142, DOI 10.1016/j.apmr.2009.01.020; Kadam Prashant, 2010, Int J Ayurveda Res, V1, P55, DOI 10.4103/0974-7788.59946; Kalron A, 2013, EUR J PHYS REHAB MED, V49, P699; Kase K., 2003, CLIN THERAPEUTIC APP, V2; Kinesion UK, BRIEF HIST KIN TEXT; Law M, 1998, EVIDENCE BASED REHAB; Law M, 1998, GUIDELINES FOR CRITI; Lephart SM, 1998, SPORTS MED, V25, P149, DOI 10.2165/00007256-199825030-00002; Martin RS, 2013, INFORM CULT, V48, P1, DOI 10.7560/IC48101; Mays N, 2005, J HLTH SERV RESPOLIC, V13, P339; Merlin T, 2009, BMC MED RES METHODOL, V9, DOI 10.1186/1471-2288-9-34; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Morris D, 2013, PHYSIOTHER THEOR PR, V29, P259, DOI 10.3109/09593985.2012.731675; Mostafavifar M, 2012, PHYSICIAN SPORTSMED, V40, P33, DOI 10.3810/psm.2012.11.1986; Munn J, 2010, J SCI MED SPORT, V13, P2, DOI 10.1016/j.jsams.2009.03.004; Nakajima MA, 2013, INT J SPORTS PHYS TH, V8, P393; Norris S, 2008, METHODS GUIDE FOR EF, P180; PETERS JW, 1991, FOOT ANKLE, V12, P182, DOI 10.1177/107110079101200310; Ross MD, 2002, KNEE SURG SPORT TR A, V10, P10, DOI 10.1007/s001670100238; Semple S, 2012, J PHYS THER SCI, V24, P1239, DOI 10.1589/jpts.24.1239; Shields CA, 2013, FOOT ANKLE INT, V34, P1427, DOI 10.1177/1071100713491076; Simon J, 2014, CLIN J SPORT MED, V24, P289, DOI 10.1097/JSM.0000000000000030; SMITH RW, 1986, AM J SPORT MED, V14, P465, DOI 10.1177/036354658601400606; Valderrabano V, 2006, AM J SPORT MED, V34, P612, DOI 10.1177/0363546505281813; van Rijn RM, 2008, AM J MED, V121, P324, DOI 10.1016/j.amjmed.2007.11.018; Viera AJ, 2005, FAM MED, V37, P360; Wells C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100402; Whitley E, 2002, CRIT CARE, V6, P335; Wikstrom EA, 2013, SPORTS MED, V43, P385, DOI 10.1007/s40279-013-0043-z; Wilkerson GB, 2002, J ATHL TRAINING, V37, P436; Williams S, 2012, SPORTS MED, V42, P153, DOI 10.2165/11594960-000000000-00000; Willke RJ, 2012, BMC MED RES METHODOL, V12, DOI 10.1186/1471-2288-12-185; World Health Organization (WHO), 2001, INTERNATIONAL CLASSI	58	19	19	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2015	10	6							e0124214	10.1371/journal.pone.0124214	http://dx.doi.org/10.1371/journal.pone.0124214			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4DD	26103637	Green Published, Green Submitted, gold			2022-12-26	WOS:000356901900001
J	Carson, C; Raman, P; Tullai, J; Xu, L; Henault, M; Thomas, E; Yeola, S; Lao, JM; McPate, M; Verkuyl, JM; Marsh, G; Sarber, J; Amaral, A; Bailey, S; Lubicka, D; Pham, H; Miranda, N; Ding, J; Tang, HM; Ju, HS; Tranter, P; Ji, N; Krastel, P; Jain, RK; Schumacher, AM; Loureiro, JJ; George, E; Berellini, G; Ross, NT; Bushell, SM; Erdemli, G; Solomon, JM				Carson, Cheryl; Raman, Pichai; Tullai, Jennifer; Xu, Lei; Henault, Martin; Thomas, Emily; Yeola, Sarita; Lao, Jianmin; McPate, Mark; Verkuyl, J. Martin; Marsh, George; Sarber, Jason; Amaral, Adam; Bailey, Scott; Lubicka, Danuta; Pham, Helen; Miranda, Nicolette; Ding, Jian; Tang, Hai-Ming; Ju, Haisong; Tranter, Pamela; Ji, Nan; Krastel, Philipp; Jain, Rishi K.; Schumacher, Andrew M.; Loureiro, Joseph J.; George, Elizabeth; Berellini, Giuliano; Ross, Nathan T.; Bushell, Simon M.; Erdemli, Guel; Solomon, Jonathan M.			Englerin A Agonizes the TRPC4/C5 Cation Channels to Inhibit Tumor Cell Line Proliferation	PLOS ONE			English	Article							THETA PKC-THETA; TARGET IDENTIFICATION; DRUG DISCOVERY; TRPC5 CHANNELS; EXPRESSION; CANCER; OPTIMIZATION; ACTIVATION; MECHANISMS; BIOLOGY	Englerin A is a structurally unique natural product reported to selectively inhibit growth of renal cell carcinoma cell lines. A large scale phenotypic cell profiling experiment (CLiP) of englerin A on over 500 well characterized cancer cell lines showed that englerin A inhibits growth of a subset of tumor cell lines from many lineages, not just renal cell carcinomas. Expression of the TRPC4 cation channel was the cell line feature that best correlated with sensitivity to englerin A, suggesting the hypothesis that TRPC4 is the efficacy target for englerin A. Genetic experiments demonstrate that TRPC4 expression is both necessary and sufficient for englerin A induced growth inhibition. Englerin A induces calcium influx and membrane depolarization in cells expressing high levels of TRPC4 or its close ortholog TRPC5. Electrophysiology experiments confirmed that englerin A is a TRPC4 agonist. Both the englerin A induced current and the englerin A induced growth inhibition can be blocked by the TRPC4/C5 inhibitor ML204. These experiments confirm that activation of TRPC4/C5 channels inhibits tumor cell line proliferation and confirms the TRPC4 target hypothesis generated by the cell line profiling. In selectivity assays englerin A weakly inhibits TRPA1, TRPV3/V4, and TRPM8 which suggests that englerin A may bind a common feature of TRP ion channels. In vivo experiments show that englerin A is lethal in rodents near doses needed to activate the TRPC4 channel. This toxicity suggests that englerin A itself is probably unsuitable for further drug development. However, since englerin A can be synthesized in the laboratory, it may be a useful chemical starting point to identify novel modulators of other TRP family channels.	[Carson, Cheryl; Raman, Pichai; Tullai, Jennifer; Xu, Lei; Henault, Martin; Thomas, Emily; Yeola, Sarita; Marsh, George; Sarber, Jason; Amaral, Adam; Bailey, Scott; Lubicka, Danuta; Pham, Helen; Miranda, Nicolette; Ding, Jian; Ji, Nan; Jain, Rishi K.; Loureiro, Joseph J.; George, Elizabeth; Berellini, Giuliano; Ross, Nathan T.; Bushell, Simon M.; Erdemli, Guel; Solomon, Jonathan M.] Novartis Inst Biomed Res, Cambridge, MA 02139 USA; [Tang, Hai-Ming; Ju, Haisong] Novartis Inst Biomed Res, E Hanover, NJ USA; [McPate, Mark; Verkuyl, J. Martin; Tranter, Pamela] Novartis Inst Biomed Res, Horsham, W Sussex, England; [Krastel, Philipp] Novartis Inst Biomed Res, Basel, Switzerland; [Lao, Jianmin; Schumacher, Andrew M.] Novartis Res Fdn, Genom Inst, San Diego, CA USA	Novartis; Novartis; Novartis; Novartis; Novartis	Solomon, JM (corresponding author), Novartis Inst Biomed Res, Cambridge, MA 02139 USA.	jonathan.solomon@novartis.com		Verkuyl, J. Martin/0000-0003-4115-6506	Novartis Institutes for Biomedical Research; NATIONAL CANCER INSTITUTE [P01CA080124] Funding Source: NIH RePORTER	Novartis Institutes for Biomedical Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was fully funded by the Novartis Institutes for Biomedical Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akbulut Y, 2015, ANGEW CHEM INT EDIT, V54, P3787, DOI 10.1002/anie.201411511; Azad MA, 2012, BIOORGAN MED CHEM, V20, P1929, DOI 10.1016/j.bmc.2011.10.088; Bahar FG, 2012, J PHARM SCI-US, V101, P3979, DOI 10.1002/jps.23258; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Blair NT, 2009, J GEN PHYSIOL, V133, P525, DOI 10.1085/jgp.200810153; Cao EH, 2013, NATURE, V504, P113, DOI 10.1038/nature12823; Cao XY, 2010, ASSAY DRUG DEV TECHN, V8, P766, DOI 10.1089/adt.2010.0333; Capiod T, 2011, BIOCHIMIE, V93, P2075, DOI 10.1016/j.biochi.2011.07.015; Cavalie A., 2007, V179, P93; Clapham DE, 2001, NAT REV NEUROSCI, V2, P387, DOI 10.1038/35077544; Cragg GM, 2013, BBA-GEN SUBJECTS, V1830, P3670, DOI 10.1016/j.bbagen.2013.02.008; Fowler MA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000573; Freichel Marc, 2004, Novartis Found Symp, V258, P189; Futamura Y, 2013, MOL BIOSYST, V9, P897, DOI 10.1039/c2mb25468a; Hinman A, 2006, P NATL ACAD SCI USA, V103, P19564, DOI 10.1073/pnas.0609598103; Jimenez JM, 2013, J MED CHEM, V56, P1799, DOI 10.1021/jm301465a; Li MH, 2011, ADV EXP MED BIOL, V704, P1, DOI 10.1007/978-94-007-0265-3_1; Li ZW, 2011, J AM CHEM SOC, V133, P6553, DOI 10.1021/ja201921j; Liao MF, 2013, NATURE, V504, P107, DOI 10.1038/nature12822; Mathes C, 2009, COMB CHEM HIGH T SCR, V12, P78, DOI 10.2174/138620709787047948; Mermel CH, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-4-r41; Newman DJ, 2012, J NAT PRODUCTS, V75, P311, DOI DOI 10.1021/NP200906S; Nilius B, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-3-218; Plant TD, 2003, CELL CALCIUM, V33, P441, DOI 10.1016/S0143-4160(03)00055-1; Pouwer RH, 2012, CHEM-ASIAN J, V7, P22, DOI 10.1002/asia.201100780; Ratnayake R, 2009, ORG LETT, V11, P57, DOI 10.1021/ol802339w; Riccio A, 2009, CELL, V137, P761, DOI 10.1016/j.cell.2009.03.039; Roderick HL, 2008, NAT REV CANCER, V8, P361, DOI 10.1038/nrc2374; Rooney L, 2014, J MED CHEM, V57, P5129, DOI 10.1021/jm401986p; Sourbier C, 2013, CANCER CELL, V23, P228, DOI 10.1016/j.ccr.2012.12.007; Sulzmaier FJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048032; Taboureau O, 2012, CHEM BIOL, V19, P29, DOI 10.1016/j.chembiol.2011.12.007; Tiruppathi C, 2002, CIRC RES, V91, P70, DOI 10.1161/01.RES.0000023391.40106.A8; Tukey RH, 2000, ANNU REV PHARMACOL, V40, P581, DOI 10.1146/annurev.pharmtox.40.1.581; Turner PV, 2011, J AM ASSOC LAB ANIM, V50, P600; Vazquez G, 2004, BBA-MOL CELL RES, V1742, P21, DOI 10.1016/j.bbamcr.2004.08.015; Williams RT, 2013, J EXP CLIN CANC RES, V32, DOI 10.1186/1756-9966-32-57; Willot M, 2009, ANGEW CHEM INT EDIT, V48, P9105, DOI 10.1002/anie.200905032; Yip H, 2004, HISTOCHEM CELL BIOL, V122, P553, DOI 10.1007/s00418-004-0720-y; Zhang EY, 2013, ADV PHARMACOL, V66, P267, DOI 10.1016/B978-0-12-404717-4.00006-8; Ziegler S, 2013, ANGEW CHEM INT EDIT, V52, P2744, DOI 10.1002/anie.201208749	41	65	68	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2015	10	6							e0127498	10.1371/journal.pone.0127498	http://dx.doi.org/10.1371/journal.pone.0127498			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL3FM	26098886	gold, Green Published, Green Submitted			2022-12-26	WOS:000356835800007
J	Liao, LN; Li, CI; Liu, CS; Huang, CC; Lin, WY; Chiang, JH; Lin, CC; Li, TC				Liao, Li-Na; Li, Chia-Ing; Liu, Chiu-Shong; Huang, Chiu-Ching; Lin, Wen-Yuan; Chiang, Jen-Huai; Lin, Cheng-Chieh; Li, Tsai-Chung			Extreme Levels of HbA1c Increase Incident ESRD Risk in Chinese Patients with Type 2 Diabetes: Competing Risk Analysis in National Cohort of Taiwan Diabetes Study	PLOS ONE			English	Article							INTENSIVE GLUCOSE CONTROL; STAGE RENAL-DISEASE; GLYCATED HEMOGLOBIN; GLYCEMIC CONTROL; OUTCOMES; COMPLICATIONS; HYPERGLYCEMIA; POPULATION; MELLITUS	Background Whether HbA1c is a predictor of end-stage renal disease (ESRD) in type 2 diabetes patients remains unclear. This study evaluated relationship between HbA1c and ESRD in Chinese patients with type 2 diabetes. Methods Patients aged >= 30 years who were free of ESRD (n = 51 681) were included from National Diabetes Care Management Program from 2002-2003. Extended Cox proportional hazard model with competing risk of death served to evaluate association between HbA1c level and ESRD. Results A total of 2613 (5.06%) people developed ESRD during a follow-up period of 8.1 years. Overall incidence rate of ESRD was 6.26 per 1000 person-years. Patients with high levels of HbA1c had a high incidence rate of ESRD, from 4.29 for HbA1c of 6.0%-6.9% to 10.33 for HbA1c >= 10.0% per 1000 person-years. Patients with HbA1c < 6.0% particularly had a slightly higher ESRD incidence (4.34 per 1000 person-years) than those with HbA1c of 6.0%-6.9%. A J-shaped relationship between HbA1c level and ESRD risk was observed. After adjustment, patients with HbA1c < 6.0% and >= 10.0% exhibited an increased risk of ESRD (HR: 1.99, 95% CI: 1.62-2.44; HR: 4.42, 95% CI: 3.80-5.14, respectively) compared with those with HbA1c of 6.0%-6.9%. Conclusions Diabetes care has focused on preventing hyperglycemia, but not hypoglycemia. Our study revealed that HbA1c level >= 7.0% was linked with increased ESRD risk in type 2 diabetes patients, and that HbA1c < 6.0% also had the potential to increase ESRD risk. Our study provides epidemiological evidence that appropriate glycemic control is essential for diabetes care to meet HbA1c targets and improve outcomes without increasing the risk to this population. Clinicians need to pay attention to HbA1c results on diabetic nephropathy.	[Liao, Li-Na] China Med Univ, Coll Publ Hlth, Dept Publ Hlth, Taichung, Taiwan; [Li, Chia-Ing; Liu, Chiu-Shong; Lin, Cheng-Chieh] China Med Univ Hosp, Dept Med Res, Taichung, Taiwan; [Li, Chia-Ing; Liu, Chiu-Shong; Huang, Chiu-Ching; Lin, Wen-Yuan; Lin, Cheng-Chieh] China Med Univ, Sch Med, Coll Med, Taichung, Taiwan; [Liu, Chiu-Shong; Lin, Wen-Yuan; Lin, Cheng-Chieh] China Med Univ Hosp, Dept Family Med, Taichung, Taiwan; [Huang, Chiu-Ching] China Med Univ Hosp, Kidney Inst, Dept Internal Med, Taichung, Taiwan; [Huang, Chiu-Ching] China Med Univ Hosp, Div Nephrol, Dept Internal Med, Taichung, Taiwan; [Chiang, Jen-Huai] China Med Univ Hosp, Management Off Hlth Data, Taichung, Taiwan; [Chiang, Jen-Huai] China Med Univ, Res Ctr Chinese Med & Acupuncture, Taichung, Taiwan; [Li, Tsai-Chung] China Med Univ, Grad Inst Biostat, Coll Publ Hlth, Taichung, Taiwan; [Li, Tsai-Chung] Asia Univ, Coll Hlth Sci, Dept Healthcare Adm, Taichung, Taiwan	China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Taiwan; Asia University Taiwan	Lin, CC (corresponding author), China Med Univ Hosp, Dept Med Res, Taichung, Taiwan.	cclin@mail.cmuh.org.tw; tcli@mail.cmu.edu.tw	Lin, Cheng-Chieh/P-2564-2015; Li, Tsai-Chung/P-2052-2015	Lin, Cheng-Chieh/0000-0002-9625-6216; Li, Tsai-Chung/0000-0002-3346-7462	Bureau of National Health Insurance [DOH94-NH-1007]; Ministry of Science and Technology of Taiwan (National Science Council) [NSC101-2314-B-039-017-MY3, NSC102-2314-B-039-005-MY2]; China Medical University [CMU103-S-10]; Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence [MOHW103-TDU-B-212-113002]; Ministry of Health and Welfare [DOH101-HP-1102, DOH102-HP-1102, MOHW103-HPA-H-114-133105]	Bureau of National Health Insurance; Ministry of Science and Technology of Taiwan (National Science Council); China Medical University(China Medical University); Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence; Ministry of Health and Welfare(Ministry of Health, Labour and Welfare, Japan)	This study was funded primarily by the Bureau of National Health Insurance (DOH94-NH-1007), the Ministry of Science and Technology of Taiwan (National Science Council) (NSC101-2314-B-039-017-MY3 & NSC102-2314-B-039-005-MY2), China Medical University (CMU103-S-10) and the Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence (MOHW103-TDU-B-212-113002), and the Ministry of Health and Welfare (DOH101-HP-1102, DOH102-HP-1102, MOHW103-HPA-H-114-133105). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2013, LANCET, V382, P1680, DOI 10.1016/S0140-6736(13)62390-9; [Anonymous], 2012, DIABETES CARE, V35, pS11, DOI [10.2337/dc12-s011, 10.2337/dc12-s004, 10.2337/dc35-S011]; [Anonymous], 2007, REP NAT HLTH INS 200; [Anonymous], INTRO NAT HLTH INS R; [Anonymous], 2011, REP NAT HLTH INS 201; Ceriello A, 2012, DIABETES, V61, P2993, DOI 10.2337/db12-0224; Coca SG, 2012, ARCH INTERN MED, V172, P761, DOI 10.1001/archinternmed.2011.2230; Cohen RM, 2008, CURR OPIN CLIN NUTR, V11, P512, DOI 10.1097/MCO.0b013e32830467bd; Collins AJ, 2011, AM J KIDNEY DIS, V57, pA8, DOI 10.1053/j.ajkd.2010.10.007; Dronavalli S, 2008, NAT CLIN PRACT ENDOC, V4, P444, DOI 10.1038/ncpendmet0894; Duckworth W, 2009, NEW ENGL J MED, V360, P129, DOI 10.1056/NEJMoa0808431; Friedman EA, 1999, NEPHROL DIAL TRANSPL, V14, P1, DOI 10.1093/ndt/14.suppl_3.1; Gerstein HC, 2008, NEW ENGL J MED, V358, P2545, DOI 10.1056/NEJMoa0802743; HARRIS RD, 1991, KIDNEY INT, V40, P107, DOI 10.1038/ki.1991.187; HEILIG CW, 1995, J CLIN INVEST, V96, P1802, DOI 10.1172/JCI118226; Inaba M, 2007, J AM SOC NEPHROL, V18, P896, DOI 10.1681/ASN.2006070772; Ismail-Beigi F, 2010, LANCET, V376, P419, DOI 10.1016/S0140-6736(10)60576-4; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Lin CL, 2006, J AM SOC NEPHROL, V17, P2812, DOI 10.1681/ASN.2005121355; LUNN M, 1995, BIOMETRICS, V51, P524, DOI 10.2307/2532940; Mishra R, 2005, KIDNEY INT, V67, P82, DOI 10.1111/j.1523-1755.2005.00058.x; Oh SW, 2011, NEPHROL DIAL TRANSPL, V26, P2238, DOI 10.1093/ndt/gfq707; Patel A, 2008, NEW ENGL J MED, V358, P2560, DOI 10.1056/NEJMoa0802987; Perkovic V, 2013, KIDNEY INT, V83, P517, DOI 10.1038/ki.2012.401; Porte D, 1996, SCIENCE, V272, P699, DOI 10.1126/science.272.5262.699; Riveline JP, 2009, NEPHROL DIAL TRANSPL, V24, P2866, DOI 10.1093/ndt/gfp181; Shurraw S, 2011, ARCH INTERN MED, V171, P1920, DOI 10.1001/archinternmed.2011.537; Tu ST, 2010, ARCH INTERN MED, V170, P155, DOI 10.1001/archinternmed.2009.471; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; Yang WC, 2008, NEPHROL DIAL TRANSPL, V23, P3977, DOI 10.1093/ndt/gfn406	30	14	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2015	10	6							e0130828	10.1371/journal.pone.0130828	http://dx.doi.org/10.1371/journal.pone.0130828			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL3FM	26098901	Green Submitted, Green Published, gold			2022-12-26	WOS:000356835800107
J	Nakatsuma, A; Kaneda, M; Kodama, H; Morikawa, M; Watabe, S; Nakaishi, K; Yamashita, M; Yoshimura, T; Miura, T; Ninomiya, M; Ito, E				Nakatsuma, Akira; Kaneda, Mugiho; Kodama, Hiromi; Morikawa, Mika; Watabe, Satoshi; Nakaishi, Kazunari; Yamashita, Masakane; Yoshimura, Teruki; Miura, Toshiaki; Ninomiya, Masaki; Ito, Etsuro			Detection of HIV-1 p24 at Attomole Level by Ultrasensitive ELISA with Thio-NAD Cycling	PLOS ONE			English	Article							TRANSFER ENZYME-IMMUNOASSAY; 3-ALPHA-HYDROXYSTEROID DEHYDROGENASE; 4TH-GENERATION IMMUNOASSAY; ANTIGEN; SENSITIVITY; INFECTION; SERUM; ASSAY; ACID; PCR	To reduce the window period between HIV-1 infection and the ability to diagnose it, a fourth-generation immunoassay including the detection of HIV-1 p24 antigen has been developed. However, because the commercially available systems for this assay use special, high-cost instruments to measure, for example, chemiluminescence, it is performed only by diagnostics companies and hub hospitals. To overcome this limitation, we applied an ultrasensitive ELISA coupled with a thio-NAD cycling, which is based on a usual enzyme immunoassay without special instruments, to detect HIV-1 p24. The p24 detection limit by our ultrasensitive ELISA was 0.0065 IU/assay (i.e., ca. 10(-18) moles/assay). Because HIV-1 p24 antigen is thought to be present in the virion in much greater numbers than viral RNA copies, the value of 10(-18) moles of the p24/assay corresponds to ca. 10(3) copies of the HIV-1 RNA/assay. That is, our ultrasensitive ELISA is chasing the detection limit (10(2) copies/assay) obtained by PCR-based nucleic acid testing (NAT) with a margin of only one different order. Further, the detection limit by our ultrasensitive ELISA is less than that mandated for a CE-marked HIV antigen/antibody assay. An additional recovery test using blood supported the reliability of our ultrasensitive ELISA.	[Nakatsuma, Akira; Kaneda, Mugiho; Kodama, Hiromi; Morikawa, Mika; Ninomiya, Masaki; Ito, Etsuro] Tokushima Bunri Univ, Kagawa Sch Pharmaceut Sci, Sanuki, Japan; [Morikawa, Mika; Nakaishi, Kazunari] TAUNS Labs Inc, Izunokuni, Japan; [Watabe, Satoshi] BL Co Ltd, Numazu, Japan; [Yamashita, Masakane] Hokkaido Univ, Fac Sci, Sapporo, Hokkaido 060, Japan; [Yoshimura, Teruki] Hlth Sci Univ Hokkaido, Fac Pharmaceut Sci, Ishikari, Hokkaido 06102, Japan; [Miura, Toshiaki] Hokkaido Univ, Grad Sch Pharmaceut Sci, Sapporo, Hokkaido, Japan	Tokushima Bunri University; Hokkaido University; Health Sciences University of Hokkaido; Hokkaido University	Ito, E (corresponding author), Tokushima Bunri Univ, Kagawa Sch Pharmaceut Sci, Sanuki, Japan.	eito@kph.bunri-u.ac.jp	Yamashita, Masakane/A-4556-2012	Yamashita, Masakane/0000-0002-3696-451X	grant for the Development of Systems and Technology for Advanced Measurement and Analysis from JST; grant for the Regional Innovation Strategy Support Program from MEXT; grant for the New Regional Consortium Research and Development Project from METI; Hokkaido Bureau of Economy, Trade, and Industry	grant for the Development of Systems and Technology for Advanced Measurement and Analysis from JST; grant for the Regional Innovation Strategy Support Program from MEXT; grant for the New Regional Consortium Research and Development Project from METI; Hokkaido Bureau of Economy, Trade, and Industry	This study was supported by a grant for the Development of Systems and Technology for Advanced Measurement and Analysis from JST, a grant for the Regional Innovation Strategy Support Program 2009 from MEXT, a grant for the New Regional Consortium Research and Development Project from METI and the Hokkaido Bureau of Economy, Trade, and Industry to E.I. and the others.	[Anonymous], 2009, OFF J EUR COMMUN L, VL39, P3; Barletta JM, 2004, AM J CLIN PATHOL, V122, P20, DOI 10.1309/529T2WDNEB6X8VUN; Biancotto A, 2009, J VIROL METHODS, V157, P98, DOI 10.1016/j.jviromet.2008.11.013; de la Rica R, 2012, NAT NANOTECHNOL, V7, P821, DOI [10.1038/nnano.2012.186, 10.1038/NNANO.2012.186]; George CRR, 2014, J CLIN MICROBIOL, V52, P4105, DOI 10.1128/JCM.01573-14; Hashida S, 1998, J CLIN LAB ANAL, V12, P115, DOI 10.1002/(SICI)1098-2825(1998)12:2&lt;115::AID-JCLA7&gt;3.0.CO;2-9; Ishikawa E, 1998, J CLIN LAB ANAL, V12, P154, DOI 10.1002/(SICI)1098-2825(1998)12:3<154::AID-JCLA5>3.3.CO;2-Y; Iwai A, 2013, ANAL SCI, V29, P455, DOI 10.2116/analsci.29.455; Liu JK, 2014, BIOSENS BIOELECTRON, V61, P177, DOI 10.1016/j.bios.2014.04.057; Ly TD, 2012, J CLIN VIROL, V55, P121, DOI 10.1016/j.jcv.2012.06.012; Matsuoka T, 2012, J LIPID RES, V53, P1987, DOI 10.1194/jlr.D028621; Miedouge M, 2011, J CLIN VIROL, V50, P57, DOI 10.1016/j.jcv.2010.09.003; Pandori MW, 2009, J CLIN MICROBIOL, V47, P2639, DOI 10.1128/JCM.00119-09; Patel P, 2010, ARCH INTERN MED, V170, P66, DOI 10.1001/archinternmed.2009.445; Sano Takako, 2013, Kansenshogaku Zasshi, V87, P415; Schupbach J, 2001, J MED VIROL, V65, P225, DOI 10.1002/jmv.2024; SKALHEGG BA, 1975, EUR J BIOCHEM, V50, P603, DOI 10.1111/j.1432-1033.1975.tb09901.x; Teeparuksapun K, 2010, ANAL CHEM, V82, P8406, DOI 10.1021/ac102144a; Ueda S, 2004, ANAL BIOCHEM, V332, P84, DOI 10.1016/j.ab.2004.04.035; Wagatsuma A, 2005, J EXP BIOL, V208, P2389, DOI 10.1242/jeb.01625; Watabe Satoshi, 2014, Biophysics (Nagoya-shi), V10, P49, DOI 10.2142/biophysics.10.49; YOKOYAMA S, 2002, JPN J TRANSFUSION ME, V48, P279; Zhang GH, 2005, BIOCHEM BIOPH RES CO, V326, P87, DOI 10.1016/j.bbrc.2004.11.005	23	22	22	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2015	10	6							e0131319	10.1371/journal.pone.0131319	http://dx.doi.org/10.1371/journal.pone.0131319			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL3FM	26098695	gold, Green Published, Green Submitted			2022-12-26	WOS:000356835800169
J	Rolon-Reyes, K; Kucheryavykh, YV; Cubano, LA; Inyushin, M; Skatchkov, SN; Eaton, MJ; Harrison, JK; Kucheryavykh, LY				Rolon-Reyes, Kimberleve; Kucheryavykh, Yuriy V.; Cubano, Luis A.; Inyushin, Mikhail; Skatchkov, Serguei N.; Eaton, Misty J.; Harrison, Jeffrey K.; Kucheryavykh, Lilia Y.			Microglia Activate Migration of Glioma Cells through a Pyk2 Intracellular Pathway	PLOS ONE			English	Article							TYROSINE KINASE PYK2; CATHEPSIN-B; MOLECULAR-MECHANISMS; TUMOR-GROWTH; GLIOBLASTOMA; EXPRESSION; INVASION; BRAIN; PROLIFERATION; INFILTRATION	Glioblastoma is one of the most aggressive and fatal brain cancers due to the highly invasive nature of glioma cells. Microglia infiltrate most glioma tumors and, therefore, make up an important component of the glioma microenvironment. In the tumor environment, microglia release factors that lead to the degradation of the extracellular matrix and stimulate signaling pathways to promote glioma cell invasion. In the present study, we demonstrated that microglia can promote glioma migration through a mechanism independent of extracellular matrix degradation. Using western blot analysis, we found upregulation of proline rich tyrosine kinase 2 (Pyk2) protein phosphorylated at Tyr579/580 in glioma cells treated with microglia conditioned medium. This upregulation occurred in rodent C6 and GL261 as well as in human glioma cell lines with varying levels of invasiveness (U-87MG, A172, and HS683). siRNA knock-down of Pyk2 protein and pharmacological blockade by the Pyk2/focal-adhesion kinase (FAK) inhibitor PF-562,271 reversed the stimulatory effect of microglia on glioma migration in all cell lines. A lower concentration of PF-562,271 that selectively inhibits FAK, but not Pyk2, did not have any effect on glioma cell migration. Moreover, with the use of the CD11b-HSVTK microglia ablation mouse model we demonstrated that elimination of microglia in the implanted tumors (GL261 glioma cells were used for brain implantation) by the local in-tumor administration of Ganciclovir, significantly reduced the phosphorylation of Pyk2 at Tyr579/580 in implanted tumor cells. Taken together, these data indicate that microglial cells activate glioma cell migration/dispersal through the pro-migratory Pyk2 signaling pathway in glioma cells.	[Rolon-Reyes, Kimberleve; Kucheryavykh, Yuriy V.; Skatchkov, Serguei N.; Eaton, Misty J.; Kucheryavykh, Lilia Y.] Univ Cent Caribe, Sch Med, Dept Biochem, Bayamon, PR 00960 USA; [Cubano, Luis A.] Univ Cent Caribe, Sch Med, Dept Anat & Cell Biol, Bayamon, PR USA; [Inyushin, Mikhail; Skatchkov, Serguei N.] Univ Cent Caribe, Sch Med, Dept Physiol, Bayamon, PR USA; [Harrison, Jeffrey K.] Univ Florida, Coll Med, Dept Pharmacol & Therapeut, Gainesville, FL 32610 USA	State University System of Florida; University of Florida	Kucheryavykh, LY (corresponding author), Univ Cent Caribe, Sch Med, Dept Biochem, Bayamon, PR 00960 USA.	lilia.kucheryavykh@uccaribe.edu	Inyushin, Mikhail/B-2459-2016	Inyushin, Mikhail/0000-0003-3253-7307	National Institute of Health [5SC2GM102040, 5SC2GM095410, 5R01NS065201, R25GM110513, 8G12MD007583]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [SC2GM095410, SC2GM102040, R25GM110513] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS065201] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [G12MD007583] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	LYK 5SC2GM102040, National Institute of Health, http://projectreporter.nih.gov/reporter_searchresults.cfm; YVK 5SC2GM095410, National Institute of Health, http://projectreporter.nih.gov/reporter_searchresults.cfm; SNS 5R01NS065201, National Institute of Health, http://projectreporter.nih.gov/reporter_searchresults.cfm; LAC R25GM110513, National Institute of Health, http://projectreporter.nih.gov/reporter_searchresults.cfm; MJE 8G12MD007583, National Institute of Health, http://projectreporter.nih.gov/project_info_description.cfm? aid=8495125&icde=23354349&ddparam=&ddvalue=&ddsub=&cr=1&csb=default&cs=ASC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold T, 2013, VASC CELL, V5, DOI 10.1186/2045-824X-5-4; Azevedo H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110934; Badie B, 2001, MICROSC RES TECHNIQ, V54, P106, DOI 10.1002/jemt.1125; Baugher PJ, 2005, BREAST CANCER RES, V7, pR965, DOI 10.1186/bcr1329; Bettinger I, 2002, ACTA NEUROPATHOL, V103, P351, DOI 10.1007/s00401-001-0472-x; Charles NA, 2011, GLIA, V59, P1169, DOI 10.1002/glia.21136; Combs CK, 1999, J NEUROSCI, V19, P928; Coniglio SJ, 2012, MOL MED, V18, P519, DOI 10.2119/molmed.2011.00217; Denny WA, 2003, J BIOMED BIOTECHNOL, P48; Dunty JM, 2002, J BIOL CHEM, V277, P45644, DOI 10.1074/jbc.M201779200; Eaton MJ, 2002, NEUROREPORT, V13, P57, DOI 10.1097/00001756-200201210-00016; Emlet DR, 1997, J BIOL CHEM, V272, P4079, DOI 10.1074/jbc.272.7.4079; Fan YC, 2014, MED ONCOL, V31, DOI 10.1007/s12032-014-0227-x; Flannery T, 2003, AM J PATHOL, V163, P175, DOI 10.1016/S0002-9440(10)63641-3; FOGH J, 1977, JNCI-J NATL CANCER I, V59, P221, DOI 10.1093/jnci/59.1.221; Gabrusiewicz K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023902; GERSHWIN ME, 1977, J NATL CANCER I, V58, P1455, DOI 10.1093/jnci/58.5.1455; GIARD DJ, 1973, J NATL CANCER I, V51, P1417, DOI 10.1093/jnci/51.5.1417; Gilbert MR, 2011, SEMIN ONCOL, V38, pS21, DOI 10.1053/j.seminoncol.2011.09.008; Graeber MB, 2010, ACTA NEUROPATHOL, V119, P89, DOI 10.1007/s00401-009-0622-0; Graeber MB, 2002, GLIA, V40, P252, DOI 10.1002/glia.10147; Guillamo JS, 2009, CLIN CANCER RES, V15, P3697, DOI 10.1158/1078-0432.CCR-08-2042; Gutenberg A, 2004, ACTA NEUROPATHOL, V108, P224, DOI 10.1007/s00401-004-0886-3; Hanisch UK, 2007, NAT NEUROSCI, V10, P1387, DOI 10.1038/nn1997; Heppner FL, 2005, NAT MED, V11, P146, DOI 10.1038/nm1177; Hingtgen S, 2013, J NEURO-ONCOL, V111, P153, DOI 10.1007/s11060-012-1008-z; Hodges RR, 2007, EXP EYE RES, V85, P836, DOI 10.1016/j.exer.2007.08.019; Hu J, 2014, ONCOGENE, DOI [10.1038/onc.2014336, DOI 10.1038/ONC.2014336]; Hussain SF, 2006, NEURO-ONCOLOGY, V8, P261, DOI 10.1215/15228517-2006-008; Jacobs VL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037955; JANABI N, 1995, NEUROSCI LETT, V195, P105, DOI 10.1016/0304-3940(94)11792-H; Jiang YX, 2011, MOL VIS, V17, P291; Krall JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015945; Kucheryavykh LY, 2012, BIOTECHNIQUES, V0, P1, DOI [10.2144/000113926, DOI 10.2144/000113926]; Kucheryavykh YV, 2007, GLIA, V55, P274, DOI 10.1002/glia.20455; La Porta C, 2010, CELL ADHES MIGR, V4, P204, DOI 10.4161/cam.4.2.10949; LAWS ER, 1993, INT J DEV NEUROSCI, V11, P691, DOI 10.1016/0736-5748(93)90056-J; Li W, 2012, NEURO-ONCOLOGY, V14, P958, DOI 10.1093/neuonc/nos116; LIBERMANN TA, 1985, NATURE, V313, P144, DOI 10.1038/313144a0; Lindemann C, 2011, ACTA NEUROPATHOL, V122, P241, DOI 10.1007/s00401-011-0832-0; Lipinski CA, 2005, NEOPLASIA, V7, P435, DOI 10.1593/neo.04712; Lipinski CA, 2008, J NEURO-ONCOL, V90, P181, DOI 10.1007/s11060-008-9656-8; Liu C, 2008, J NEUROIMMUNOL, V198, P98, DOI 10.1016/j.jneuroim.2008.04.016; Loftus JC, 2009, MOL CANCER THER, V8, P1505, DOI 10.1158/1535-7163.MCT-08-1055; Lysechko TL, 2010, J BIOL CHEM, V285, P31174, DOI 10.1074/jbc.M110.118265; Mai JX, 2002, BIOL CHEM, V383, P1407, DOI 10.1515/BC.2002.159; Markovic DS, 2009, P NATL ACAD SCI USA, V106, P12530, DOI 10.1073/pnas.0804273106; Markovic DS, 2005, J NEUROPATH EXP NEUR, V64, P754, DOI 10.1097/01.jnen.0000178445.33972.a9; Paulino VM, 2010, MOL CANCER RES, V8, P1558, DOI 10.1158/1541-7786.MCR-10-0334; Phillips-Mason PJ, 2011, J CELL BIOCHEM, V112, P39, DOI 10.1002/jcb.22710; Platten M, 2003, ANN NEUROL, V54, P388, DOI 10.1002/ana.10679; Platten M, 2001, MICROSC RES TECHNIQ, V52, P401, DOI 10.1002/1097-0029(20010215)52:4<401::AID-JEMT1025>3.0.CO;2-C; Rao JS, 2003, NAT REV CANCER, V3, P489, DOI 10.1038/nrc1121; REMPEL SA, 1994, CANCER RES, V54, P6027; Riggs D, 2011, CELL SIGNAL, V23, P288, DOI 10.1016/j.cellsig.2010.09.015; Roberts WG, 2008, CANCER RES, V68, P1935, DOI 10.1158/0008-5472.CAN-07-5155; Roggendorf W, 1996, ACTA NEUROPATHOL, V92, P288, DOI 10.1007/s004010050520; Rolls A, 2004, EUR J NEUROSCI, V20, P1973, DOI 10.1111/j.1460-9568.2004.03676.x; Roth P, 2014, NEURO-ONCOLOGY, V16, pviii14, DOI 10.1093/neuonc/nou222; Sliwa M, 2007, BRAIN, V130, P476, DOI 10.1093/brain/awl263; SLOANE BF, 1990, BIOL CHEM H-S, V371, P193; STREIT WJ, 1987, J NEUROCYTOL, V16, P249, DOI 10.1007/BF01795308; Strik HM, 2004, ANTICANCER RES, V24, P37; Thota B, 2014, J NEUROSURG, V121, P374, DOI 10.3171/2014.4.JNS131198; Tian D, 2002, J NEUROSCI, V20, P6478; Watters JJ, 2005, J NEUROSCI RES, V81, P447, DOI 10.1002/jnr.20485; Yamaoka T, 2011, AM J PHYSIOL-GASTR L, V301, pG368, DOI 10.1152/ajpgi.00327.2010; Yang MH, 2011, J NEURO-ONCOL, V105, P27, DOI 10.1007/s11060-011-0557-x; Zahonero C, 2014, CELL MOL LIFE SCI, V71, P3465, DOI 10.1007/s00018-014-1608-1; Zhai HY, 2011, GLIA, V59, P472, DOI 10.1002/glia.21117; Zhang X, 2015, MOL CARCINOGEN, V54, P1252, DOI 10.1002/mc.22197	71	31	33	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2015	10	6							e0131059	10.1371/journal.pone.0131059	http://dx.doi.org/10.1371/journal.pone.0131059			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL3FM	26098895	Green Published, gold, Green Submitted			2022-12-26	WOS:000356835800139
J	Su, W; Xiao, WH; Wang, Y; Liu, D; Zhou, X; Yuan, YJ				Su, Wan; Xiao, Wen-Hai; Wang, Ying; Liu, Duo; Zhou, Xiao; Yuan, Ying-Jin			Alleviating Redox Imbalance Enhances 7-Dehydrocholesterol Production in Engineered Saccharomyces cerevisiae	PLOS ONE			English	Article							ESCHERICHIA-COLI; MENIPPE-MERCENARIA; Y-ORGANS; YEAST; METABOLISM; OVEREXPRESSION; REDISTRIBUTION; BIOSYNTHESIS; AVAILABILITY; FERMENTATION	Maintaining redox balance is critical for the production of heterologous secondary metabolites, whereas on various occasions the native cofactor balance does not match the needs in engineered microorganisms. In this study, 7-dehydrocholesterol (7-DHC, a crucial precursor of vitamin D-3) biosynthesis pathway was constructed in Saccharomyces cerevisiae BY4742 with endogenous ergosterol synthesis pathway blocked by knocking out the erg5 gene (encoding C-22 desaturase). The deletion of erg5 led to redox imbalance with higher ratio of cytosolic free NADH/NAD(+) and more glycerol and ethanol accumulation. To alleviate the redox imbalance, a water-forming NADH oxidase (NOX) and an alternative oxidase (AOX1) were employed in our system based on cofactor regeneration strategy. Consequently, the production of 7-dehydrocholesterol was increased by 74.4% in shake flask culture. In the meanwhile, the ratio of free NADH/NAD(+) and the concentration of glycerol and ethanol were reduced by 78.0%, 50.7% and 7.9% respectively. In a 5-L bioreactor, the optimal production of 7-DHC reached 44.49(+/- 9.63) mg/L. This study provides a reference to increase the production of some desired compounds that are restricted by redox imbalance.	[Su, Wan; Xiao, Wen-Hai; Wang, Ying; Liu, Duo; Zhou, Xiao; Yuan, Ying-Jin] Tianjin Univ, Key Lab Syst Bioengn, Minist Educ, Tianjin 300072, Peoples R China; [Su, Wan; Xiao, Wen-Hai; Wang, Ying; Liu, Duo; Zhou, Xiao; Yuan, Ying-Jin] Tianjin Univ, SynBio Res Platform, Collaborat Innovat Ctr Chem Sci & Engn Tianjin, Sch Chem Engn & Technol, Tianjin 300072, Peoples R China	Tianjin University; Tianjin University	Yuan, YJ (corresponding author), Tianjin Univ, Key Lab Syst Bioengn, Minist Educ, Tianjin 300072, Peoples R China.	yjyuan@tju.edu.cn		Wang, Ying/0000-0003-2311-015X	National Natural Science Foundation of China [21390203, 21206114]; Ministry of Science and Technology of China ("863" Program) [2012AA02A701]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China ("863" Program)(Ministry of Science and Technology, ChinaNational High Technology Research and Development Program of China)	This work was supported by the National Natural Science Foundation of China (Major Program: 21390203 and 21206114) and the Ministry of Science and Technology of China ("863" Program: 2012AA02A701).	Arabidopsis AA, 2002, PLANT PHYSIOL, V130, P740; Auzat I, 1999, MOL MICROBIOL, V34, P1018, DOI 10.1046/j.1365-2958.1999.01663.x; Berrios-Rivera SJ, 2002, METAB ENG, V4, P217, DOI 10.1006/mben.2002.0227; Berrios-Rivera SJ, 2002, METAB ENG, V4, P230, DOI 10.1006/mben.2002.0228; Bikle DD, 2014, CHEM BIOL, V21, P319, DOI 10.1016/j.chembiol.2013.12.016; Canelas AB, 2008, METABOLOMICS, V4, P226, DOI 10.1007/s11306-008-0116-4; Canelas AB, 2008, BIOTECHNOL BIOENG, V100, P734, DOI 10.1002/bit.21813; Chen XL, 2014, TRENDS BIOTECHNOL, V32, P337, DOI 10.1016/j.tibtech.2014.04.003; Chen Y, 2013, METAB ENG, V15, P48, DOI 10.1016/j.ymben.2012.11.002; Chenault H K, 1988, Biotechnol Genet Eng Rev, V6, P221; CONFALONE PN, 1981, J ORG CHEM, V46, P1030, DOI 10.1021/jo00318a041; de Jong BW, 2014, MICROB CELL FACT, V13, DOI 10.1186/1475-2859-13-39; DEDEKEN RH, 1966, J GEN MICROBIOL, V44, P149, DOI 10.1099/00221287-44-2-149; Ding JM, 2009, APPL MICROBIOL BIOT, V85, P253, DOI 10.1007/s00253-009-2223-1; Grabinska K, 2002, FEMS YEAST RES, V2, P259, DOI 10.1016/S1567-1356(02)00110-1; Guo TT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036296; Jain VK, 2012, APPL MICROBIOL BIOT, V93, P131, DOI 10.1007/s00253-011-3431-z; Johnson CH, 2003, YEAST, V20, P381, DOI 10.1002/yea.968; Kato H, 2012, J BIOSCI BIOENG, V113, P665, DOI 10.1016/j.jbiosc.2011.12.013; King ZA, 2014, METAB ENG, V24, P117, DOI 10.1016/j.ymben.2014.05.009; Kristan K, 2012, J STEROID BIOCHEM, V129, P79, DOI 10.1016/j.jsbmb.2011.08.012; LEWIS D, 1995, STEROIDS, V60, P475, DOI 10.1016/0039-128X(95)00054-T; Lian JZ, 2014, METAB ENG, V24, P139, DOI 10.1016/j.ymben.2014.05.010; Lin QH, 2015, ACS SYNTH BIOL, V4, P213, DOI 10.1021/sb500241e; Nielsen J, 1998, CURR OPIN MICROBIOL, V1, P330, DOI 10.1016/S1369-5274(98)80037-4; Nielsen J, 2014, MBIO, V5, DOI 10.1128/mBio.02153-14; Opgenorth PH, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5113; Pahlman IL, 2001, YEAST, V18, P611, DOI 10.1002/yea.709; Polakowski T, 1998, APPL MICROBIOL BIOT, V49, P66, DOI 10.1007/s002530051138; RUDOLPH PH, 1992, GEN COMP ENDOCR, V88, P235, DOI 10.1016/0016-6480(92)90255-I; RUDOLPH PH, 1992, GEN COMP ENDOCR, V88, P224, DOI 10.1016/0016-6480(92)90254-H; Salusjarvi L, 2013, J IND MICROBIOL BIOT, V40, P1383, DOI 10.1007/s10295-013-1344-9; San KY, 2002, METAB ENG, V4, P182, DOI 10.1006/mben.2001.0220; Shiba Y, 2007, METAB ENG, V9, P160, DOI 10.1016/j.ymben.2006.10.005; Strijbis K, 2010, EUKARYOT CELL, V9, P1809, DOI 10.1128/EC.00172-10; Sun J, 2012, BIOTECHNOL BIOENG, V109, P2082, DOI 10.1002/bit.24481; Tang XL, 2013, METAB ENG, V16, P95, DOI 10.1016/j.ymben.2013.01.003; Vemuri GN, 2007, P NATL ACAD SCI USA, V104, P2402, DOI 10.1073/pnas.0607469104; Wang X, 2014, BIOTECHNOL BIOENG, V111, P152, DOI 10.1002/bit.24992; Wang YP, 2013, CURR OPIN BIOTECH, V24, P994, DOI 10.1016/j.copbio.2013.03.022; Wriessnegger T, 2013, PROG LIPID RES, V52, P277, DOI 10.1016/j.plipres.2013.03.001; Yang H, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7129; Zhou YJJ, 2013, MICROB CELL FACT, V12, DOI 10.1186/1475-2859-12-103	43	27	32	6	74	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2015	10	6							e0130840	10.1371/journal.pone.0130840	http://dx.doi.org/10.1371/journal.pone.0130840			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL3FM	26098102	Green Published, gold, Green Submitted			2022-12-26	WOS:000356835800109
J	Taguchi, R; Minami, A; Matsuda, Y; Takahashi, T; Otsubo, T; Ikeda, K; Suzuki, T				Taguchi, Risa; Minami, Akira; Matsuda, Yukino; Takahashi, Tadanobu; Otsubo, Tadamune; Ikeda, Kiyoshi; Suzuki, Takashi			Preferential Accumulation of C-14-N-Glycolylneuraminic Acid over C-14-N-Acetylneuraminic Acid in the Rat Brain after Tail Vein Injection	PLOS ONE			English	Article							N-GLYCOLYLNEURAMINIC ACID; NONHUMAN SIALIC-ACID; CELL-ADHESION MOLECULE; ACETYLNEURAMINIC ACID; POLYSIALIC ACID; PSA-NCAM; EXPRESSION; MOUSE; GANGLIOSIDES; METABOLISM	The two main molecular species of sialic acid existing in nature are N-acetylneuraminic acid (Neu5Ac) and N-glycolylneuraminic acid (Neu5Gc). Neu5Ac is abundant in mammalian brains and plays crucial roles in many neural functions. In contrast, Neu5Gc is present only at a trace level in vertebrate brains. The brain-specific suppression of Neu5Gc synthesis, which is a common feature in mammals, suggests that Neu5Gc has toxicity against brain functions. However, in vivo kinetics of Neu5Gc in the whole body, especially in the brain, has not been studied in sufficient detail. To determine the in vivo kinetics of Neu5Gc, C-14-Neu5Gc was enzymatically synthesized and injected into rat tail veins. Although most of C-14-Neu5Gc was excreted in urine, a small amount of C-14-Neu5Gc was detected in the brain. Brain autoradiography indicated that C-14-Neu5Gc was accumulated predominantly in the hippocampus. C-14-Neu5Gc transferred into the brain was incorporated into gangliosides including GM1, GD1a, GD1b, GT1b and GQ1b. Reduction of C-14-Neu5Gc after intracereb-roventricular infusion was slower than that of C-14-Neu5Ac in the brain and hippocampus. The results suggest that Neu5Gc is transferred from blood into the brain across the blood brain barrier and accumulates in the brain more preferentially than does Neu5Ac.	[Taguchi, Risa; Minami, Akira; Matsuda, Yukino; Takahashi, Tadanobu; Suzuki, Takashi] Univ Shizuoka, Sch Pharmaceut Sci, Dept Biochem, Shizuoka 4228526, Japan; [Otsubo, Tadamune; Ikeda, Kiyoshi] Hiroshima Int Univ, Sch Pharmaceut Sci, Dept Organ Chem, Hiroshima, Japan	University of Shizuoka	Suzuki, T (corresponding author), Univ Shizuoka, Sch Pharmaceut Sci, Dept Biochem, Shizuoka 4228526, Japan.	suzukit@u-shizuoka-ken.ac.jp		Otsubo, Tadamune/0000-0003-1949-9780	Amano Foundation of Industrial Technology; Japan Science Society;  [24790080]; Grants-in-Aid for Scientific Research [15K08037, 24790080] Funding Source: KAKEN	Amano Foundation of Industrial Technology; Japan Science Society; ; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a Grant-in-Aid for Young Scientists (B) (KAKENHI; no. 24790080) (A.M.), a Scientific Research Grant from the Amano Foundation of Industrial Technology (A.M.) and a Sasakawa Scientific Research Grant from the Japan Science Society (R.T.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ando S., 1990, SHIN SEIKAGAKU JIKKE, P37; Bardor M, 2005, J BIOL CHEM, V280, P4228, DOI 10.1074/jbc.M412040200; Becker CG, 1996, J NEUROSCI RES, V45, P143, DOI 10.1002/(SICI)1097-4547(19960715)45:2<143::AID-JNR6>3.0.CO;2-A; Bonfanti L, 2006, PROG NEUROBIOL, V80, P129, DOI 10.1016/j.pneurobio.2006.08.003; Chen Y, 2014, BRIT J NUTR, V111, P332, DOI 10.1017/S0007114513002468; CORFIELD AP, 1981, BIOCHEM J, V197, P293, DOI 10.1042/bj1970293; Davies LRL, 2012, J BIOL CHEM, V287, P28917, DOI 10.1074/jbc.M112.365056; Di Cristo G, 2007, NAT NEUROSCI, V10, P1569, DOI 10.1038/nn2008; Diaz SL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004241; Eckhardt M, 2000, J NEUROSCI, V20, P5234, DOI 10.1523/JNEUROSCI.20-14-05234.2000; Furuse H, 1998, EXP BRAIN RES, V123, P307, DOI 10.1007/s002210050573; Inoue S, 2010, GLYCOBIOLOGY, V20, P752, DOI 10.1093/glycob/cwq030; Jung WR, 2008, NEUROSCI LETT, V439, P220, DOI 10.1016/j.neulet.2008.05.020; KAWANO T, 1995, J BIOL CHEM, V270, P16458, DOI 10.1074/jbc.270.27.16458; Marquina G, 1996, CANCER RES, V56, P5165; Minami A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0081941; Minami A, 2013, FEBS OPEN BIO, V3, P231, DOI 10.1016/j.fob.2013.05.002; Minami A, 2012, TRENDS GLYCOSCI GLYC, V24, P112, DOI 10.4052/tigg.24.112; Minami A, 2011, NEUROIMAGE, V58, P34, DOI 10.1016/j.neuroimage.2011.06.017; Miyagi T, 2012, GLYCOBIOLOGY, V22, P880, DOI 10.1093/glycob/cws057; Muller D, 1996, NEURON, V17, P413, DOI 10.1016/S0896-6273(00)80174-9; Murase Y, 2010, CANCER LETT, V287, P165, DOI 10.1016/j.canlet.2009.06.008; NAKAMURA K, 1988, J BIOCHEM-TOKYO, V103, P201, DOI 10.1093/oxfordjournals.jbchem.a122232; NOHLE U, 1981, H-S Z PHYSIOL CHEM, V362, P1495, DOI 10.1515/bchm2.1981.362.2.1495; NOHLE U, 1982, EUR J BIOCHEM, V126, P543, DOI 10.1111/j.1432-1033.1982.tb06815.x; Paxinos G., 2007, RAT BRAIN STEREOTAXI, V6th ed.; Samraj AN, 2015, P NATL ACAD SCI USA, V112, P542, DOI 10.1073/pnas.1417508112; Samraj AN, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00033; Schauer R, 1996, BIOL CHEM H-S, V377, P293, DOI 10.1515/bchm3.1996.377.5.293; Schauer R, 2009, CURR OPIN STRUC BIOL, V19, P507, DOI 10.1016/j.sbi.2009.06.003; Schnaar RL, 2014, PHYSIOL REV, V94, P461, DOI 10.1152/physrev.00033.2013; Senkov O, 2012, INT J BIOCHEM CELL B, V44, P591, DOI 10.1016/j.biocel.2012.01.008; Shiozaki K, 2009, J BIOL CHEM, V284, P21157, DOI 10.1074/jbc.M109.012708; Song KH, 2010, BIOCHEM J, V427, P179, DOI 10.1042/BJ20090835; Takeda A, 2001, CANCER RES, V61, P5065; Tangvoranuntakul P, 2003, P NATL ACAD SCI USA, V100, P12045, DOI 10.1073/pnas.2131556100; Varki A, 2009, GLYCOCONJUGATE J, V26, P231, DOI 10.1007/s10719-008-9183-z; WAKI H, 1994, ANAL BIOCHEM, V222, P156, DOI 10.1006/abio.1994.1467; Wang B, 2009, ANNU REV NUTR, V29, P177, DOI 10.1146/annurev.nutr.28.061807.155515	39	2	2	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2015	10	6							e0131061	10.1371/journal.pone.0131061	http://dx.doi.org/10.1371/journal.pone.0131061			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL3FM	26098915	Green Submitted, Green Published, gold			2022-12-26	WOS:000356835800140
J	Yuan, X; Yang, SY				Yuan, Xue; Yang, Shuying			Deletion of IFT80 Impairs Epiphyseal and Articular Cartilage Formation Due to Disruption of Chondrocyte Differentiation	PLOS ONE			English	Article							INTRAFLAGELLAR TRANSPORT PROTEIN; ASPHYXIATING THORACIC DYSTROPHY; POSTNATAL-GROWTH PLATE; BETA-CATENIN; INDIAN HEDGEHOG; PRIMARY CILIA; MURINE CHONDROCYTES; BONE-DEVELOPMENT; MAMMALIAN CILIA; MOUSE MODELS	Intraflagellar transport proteins (IFT) play important roles in cilia formation and organ development. Partial loss of IFT80 function leads Jeune asphyxiating thoracic dystrophy (JATD) or short-rib polydactyly (SRP) syndrome type III, displaying narrow thoracic cavity and multiple cartilage anomalies. However, it is unknown how IFT80 regulates cartilage formation. To define the role and mechanism of IFT80 in chondrocyte function and cartilage formation, we generated a Col2 alpha 1; IFT80(f/f) mouse model by crossing IFT80(f/f) mice with inducible Col2 alpha 1-CreER mice, and deleted IFT80 in chondrocyte lineage by injection of tamoxifen into the mice in embryonic or postnatal stage. Loss of IFT80 in the embryonic stage resulted in short limbs at birth. Histological studies showed that IFT80-deficient mice have shortened cartilage with marked changes in cellular morphology and organization in the resting, proliferative, pre-hypertrophic, and hypertrophic zones. Moreover, deletion of IFT80 in the postnatal stage led to mouse stunted growth with shortened growth plate but thickened articular cartilage. Defects of ciliogenesis were found in the cartilage of IFT80-deficient mice and primary IFT80-deficient chondrocytes. Further study showed that chondrogenic differentiation was significantly inhibited in IFT80-deficient mice due to reduced hedgehog (Hh) signaling and increased Wnt signaling activities. These findings demonstrate that loss of IFT80 blocks chondrocyte differentiation by disruption of ciliogenesis and alteration of Hh and Wnt signaling transduction, which in turn alters epiphyseal and articular cartilage formation.	[Yuan, Xue; Yang, Shuying] SUNY Buffalo, Sch Dent Med, Dept Oral Biol, Buffalo, NY 14260 USA; [Yang, Shuying] SUNY Buffalo, New York State Ctr Excellence Bioinformat & Life, Dev Genom Grp, Buffalo, NY 14260 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Yang, SY (corresponding author), SUNY Buffalo, Sch Dent Med, Dept Oral Biol, Buffalo, NY 14260 USA.	sy47@buffalo.edu	Yuan, Xue/L-8066-2017	Yuan, Xue/0000-0002-8063-9431	National Institute of Arthritis and Musculoskeletal and Skin Diseases; National Institute of Dental and Craniofacial Research [DE023105, AR061052, AR066101]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR066101, R03AR061052] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE023105] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG048388] Funding Source: NIH RePORTER	National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); National Institute of Dental and Craniofacial Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the National Institute of Arthritis and Musculoskeletal and Skin Diseases, and National Institute of Dental and Craniofacial Research under Award Numbers DE023105, AR061052, and AR066101 (to S.Y) (http://www.nidcr.nih.gov/grantsandfunding/; http://www.niams.nih.gov/funding/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama H, 2004, GENE DEV, V18, P1072, DOI 10.1101/gad.1171104; Badano JL, 2006, ANNU REV GENOM HUM G, V7, P125, DOI 10.1146/annurev.genom.7.080505.115610; Beales PL, 2007, NAT GENET, V39, P727, DOI 10.1038/ng2038; Cavalcanti DP, 2011, J MED GENET, V48, P88, DOI 10.1136/jmg.2009.069468; Chang CF, 2012, OSTEOARTHR CARTILAGE, V20, P152, DOI 10.1016/j.joca.2011.11.009; Chang CF, 2013, J ORTHOP RES, V31, P350, DOI 10.1002/jor.22237; Chen M, 2008, J CELL SCI, V121, P1455, DOI 10.1242/jcs.020362; Chen W, 2014, P NATL ACAD SCI USA, V111, P8482, DOI 10.1073/pnas.1310617111; Cortellino S, 2009, DEV BIOL, V325, P225, DOI 10.1016/j.ydbio.2008.10.020; Doube M, 2010, BONE, V47, P1076, DOI 10.1016/j.bone.2010.08.023; Drummond IA, 2012, CURR OPIN CELL BIOL, V24, P24, DOI 10.1016/j.ceb.2011.12.007; Eggenschwiler JT, 2007, ANNU REV CELL DEV BI, V23, P345, DOI 10.1146/annurev.cellbio.23.090506.123249; Elefteriou F, 2011, BONE, V49, P1242, DOI 10.1016/j.bone.2011.08.021; Farnum CE, 2011, ANAT REC, V294, P533, DOI 10.1002/ar.21330; Friedland-Little JM, 2011, HUM MOL GENET, V20, P3725, DOI 10.1093/hmg/ddr241; Fukai A, 2010, ARTHRITIS RHEUM-US, V62, P826, DOI 10.1002/art.27296; Goetz SC, 2010, NAT REV GENET, V11, P331, DOI 10.1038/nrg2774; Gosset M, 2008, NAT PROTOC, V3, P1253, DOI 10.1038/nprot.2008.95; Guo XZ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006067; Hsu SHC, 2012, J BIOL CHEM, V287, P36222, DOI 10.1074/jbc.M112.382275; Huber C., 2012, AM J MED GENETICS C; Hudak LM, 2010, INVEST OPHTH VIS SCI, V51, P3792, DOI 10.1167/iovs.09-4312; Kolpakova-Hart E, 2008, MATRIX BIOL, V27, P505, DOI 10.1016/j.matbio.2008.05.002; Kurita S, 2010, ONCOGENE, V29, P4848, DOI 10.1038/onc.2010.235; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Long FX, 2001, DEVELOPMENT, V128, P5099; Maeda Y, 2007, P NATL ACAD SCI USA, V104, P6382, DOI 10.1073/pnas.0608449104; McGlashan SR, 2007, MATRIX BIOL, V26, P234, DOI 10.1016/j.matbio.2006.12.003; Murcia NS, 2000, DEVELOPMENT, V127, P2347; Nakamura E, 2006, DEV DYNAM, V235, P2603, DOI 10.1002/dvdy.20892; Oshima Y, 2008, J BIOL CHEM, V283, P26499, DOI 10.1074/jbc.M800933200; Ovchinnikov DA, 2000, GENESIS, V26, P145, DOI 10.1002/(SICI)1526-968X(200002)26:2<145::AID-GENE14>3.0.CO;2-C; Ovchinnikov Dmitry, 2009, Cold Spring Harb Protoc, V2009, DOI 10.1101/pdb.prot5170; Patra D, 2011, J BIOL CHEM, V286, P29227, DOI 10.1074/jbc.M110.208686; Pedersen LB, 2008, CURR TOP DEV BIOL, V85, P23, DOI 10.1016/S0070-2153(08)00802-8; Qiu N, 2012, J CELL SCI, V125, P1945, DOI 10.1242/jcs.095893; Razzaque MS, 2005, J PATHOL, V207, P453, DOI 10.1002/path.1870; Regard JB, 2010, TOP BONE BIOL, V6, P65, DOI 10.1007/978-1-84882-822-3_4; Rigueur D, 2014, WHOLE MOUNT SKELETAL, P113; Rix S, 2011, HUM MOL GENET, V20, P1306, DOI 10.1093/hmg/ddr013; Ryu JH, 2002, DEVELOPMENT, V129, P5541, DOI 10.1242/dev.00110; Sassi N, 2014, J RECEPT SIG TRANSD, V34, P73, DOI 10.3109/10799893.2013.863919; Satir P, 2008, HISTOCHEM CELL BIOL, V129, P687, DOI 10.1007/s00418-008-0416-9; Satir P, 2007, ANNU REV PHYSIOL, V69, P377, DOI 10.1146/annurev.physiol.69.040705.141236; Satir P, 2010, J CELL SCI, V123, P499, DOI 10.1242/jcs.050377; SCHERFT JP, 1967, J ULTRA MOL STRUCT R, V19, P546, DOI 10.1016/S0022-5320(67)80080-7; Song B, 2007, DEV BIOL, V305, P202, DOI 10.1016/j.ydbio.2007.02.003; St-Jacques B, 1999, GENE DEV, V13, P2072, DOI 10.1101/gad.13.16.2072; Wang CD, 2013, EXP CELL RES, V319, P623, DOI 10.1016/j.yexcr.2012.12.028; WILSMAN NJ, 1978, J ULTRA MOL STRUCT R, V64, P270, DOI 10.1016/S0022-5320(78)90036-9; Wilusz RE, 2014, MATRIX BIOL, V39, P25, DOI 10.1016/j.matbio.2014.08.009; Wu MR, 2014, BONE, V65, P49, DOI 10.1016/j.bone.2014.04.031; Yang SY, 2012, BONE, V51, P407, DOI 10.1016/j.bone.2012.06.021; Yuan X, 2015, ANN NY ACAD SCI, V1335, P78, DOI 10.1111/nyas.12463; Yuan X, 2015, FRONT BIOSCI-LANDMRK, V20, P515, DOI 10.2741/4323; Yuasa T, 2009, AM J PATHOL, V175, P1993, DOI 10.2353/ajpath.2009.081173; Zhang QH, 2003, DEV DYNAM, V227, P78, DOI 10.1002/dvdy.10289; Zhen GH, 2014, TRENDS PHARMACOL SCI, V35, P227, DOI 10.1016/j.tips.2014.03.005	58	25	27	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2015	10	6							e0130618	10.1371/journal.pone.0130618	http://dx.doi.org/10.1371/journal.pone.0130618			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL3FM	26098911	Green Submitted, gold, Green Published			2022-12-26	WOS:000356835800085
J	Vyas, M; Fisher, TW; He, RF; Nelson, W; Yin, GH; Cicero, JM; Willer, M; Kim, R; Kramer, R; May, GA; Crow, JA; Soderlund, CA; Gang, DR; Brown, JK				Vyas, Meenal; Fisher, Tonja W.; He, Ruifeng; Nelson, William; Yin, Guohua; Cicero, Joseph M.; Willer, Mark; Kim, Ryan; Kramer, Robin; May, Greg A.; Crow, John A.; Soderlund, Carol A.; Gang, David R.; Brown, Judith K.			Asian Citrus Psyllid Expression Profiles Suggest Candidatus Liberibacter Asiaticus-Mediated Alteration of Adult Nutrition and Metabolism, and of Nymphal Development and Immunity	PLOS ONE			English	Article							DIAPHORINA-CITRI; GENE-EXPRESSION; GENOME SEQUENCE; INSERTIONAL MUTAGENESIS; DROSOPHILA-MELANOGASTER; TRANSPOSABLE ELEMENTS; INSECT VECTOR; PEA APHID; DISEASE; TRANSMISSION	The Asian citrus psyllid (ACP) Diaphorina citri Kuwayama (Hemiptera: Psyllidae) is the insect vector of the fastidious bacterium Candidatus Liberibacter asiaticus (CLas), the causal agent of citrus greening disease, or Huanglongbing (HLB). The widespread invasiveness of the psyllid vector and HLB in citrus trees worldwide has underscored the need for non-traditional approaches to manage the disease. One tenable solution is through the deployment of RNA interference technology to silence protein-protein interactions essential for ACP-mediated CLas invasion and transmission. To identify psyllid interactor-bacterial effector combinations associated with psyllid-CLas interactions, cDNA libraries were constructed from CLas-infected and CLas-free ACP adults and nymphs, and analyzed for differential expression. Library assemblies comprised 24,039,255 reads and yielded 45,976 consensus contigs. They were annotated (UniProt), classified using Gene Ontology, and subjected to in silico expression analyses using the Transcriptome Computational Workbench (TCW) (http://www.sohomoptera.org/ACPPoP/). Functional-biological pathway interpretations were carried out using the Kyoto Encyclopedia of Genes and Genomes databases. Differentially expressed contigs in adults and/or nymphs represented genes and/or metabolic/pathogenesis pathways involved in adhesion, biofilm formation, development-related, immunity, nutrition, stress, and virulence. Notably, contigs involved in gene silencing and transposon-related responses were documented in a psyllid for the first time. This is the first comparative transcriptomic analysis of ACP adults and nymphs infected and uninfected with CLas. The results provide key initial insights into host-parasite interactions involving CLas effectors that contribute to invasion-virulence, and to host nutritional exploitation and immune-related responses that appear to be essential for successful ACP-mediated circulative, propagative CLas transmission.	[Vyas, Meenal; Fisher, Tonja W.; Yin, Guohua; Cicero, Joseph M.; Brown, Judith K.] Univ Arizona, Sch Plant Sci, Tucson, AZ 85721 USA; [He, Ruifeng; Gang, David R.] Washington State Univ, Inst Biol Chem, Pullman, WA 99164 USA; [Nelson, William; Willer, Mark; Soderlund, Carol A.] Univ Arizona, BIO5, Tucson, AZ USA; [Kim, Ryan; Kramer, Robin; May, Greg A.; Crow, John A.] Natl Ctr Genome Resources, Santa Fe, NM USA	University of Arizona; Washington State University; University of Arizona; National Center for Genome Resources (NCGR)	Brown, JK (corresponding author), Univ Arizona, Sch Plant Sci, Tucson, AZ 85721 USA.	jkbrown@email.arizona.edu		Vyas, Meenal/0000-0002-8513-2381	United States Department of Agriculture National Institute of Food and Agriculture Coordinated Agricultural Project [2012-51181-20086]; Citrus Research and Development Foundation (CRDF); Florida Citrus Advanced Technology Program [21, 510]	United States Department of Agriculture National Institute of Food and Agriculture Coordinated Agricultural Project; Citrus Research and Development Foundation (CRDF); Florida Citrus Advanced Technology Program	The authors gratefully acknowledge the United States Department of Agriculture National Institute of Food and Agriculture Coordinated Agricultural Project (Award No. 2012-51181-20086), the Citrus Research and Development Foundation (CRDF) and Florida Citrus Advanced Technology Program, Contracts 21 and 510, respectively for providing generous financial and professional support for this research. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ammar ED, 2011, J PHYTOPATHOL, V159, P726, DOI 10.1111/j.1439-0434.2011.01836.x; Ammar E, 2011, ANN ENTOMOL SOC AM, V104, P526, DOI 10.1603/AN10134; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bian GW, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000833; Biere A, 2013, FUNCT ECOL, V27, P567, DOI 10.1111/1365-2435.12100; Birol I, 2009, BIOINFORMATICS, V25, P2872, DOI 10.1093/bioinformatics/btp367; Bonazzi M, 2006, FEBS LETT, V580, P2962, DOI 10.1016/j.febslet.2006.04.010; Bonin CP, 2004, GENETICS, V167, P1801, DOI 10.1534/genetics.104.027557; Bove JM, 2006, J PLANT PATHOL, V88, P7; Brubaker-Purkey BJ, 2013, J INSECT SCI, V13, DOI 10.1673/031.013.6801; Burke GR, 2011, INSECT MOL BIOL, V20, P357, DOI 10.1111/j.1365-2583.2011.01070.x; Burmester T, 1999, EUR J ENTOMOL, V96, P213; Cambronne ED, 2006, TRAFFIC, V7, P929, DOI 10.1111/j.1600-0854.2006.00446.x; Chan QWT, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-387; Charles JP, 2010, INSECT BIOCHEM MOLEC, V40, P205, DOI 10.1016/j.ibmb.2009.12.005; Chevreux B, 2004, GENOME RES, V14, P1147, DOI 10.1101/gr.1917404; Cicero J, 2014, J CITRUS PATHOLOGY, V1; Colinet D, 2007, PLOS PATHOG, V3, P2029, DOI 10.1371/journal.ppat.0030203; Critchley DR, 2004, BIOCHEM SOC T, V32, P831, DOI 10.1042/BST0320831; Dallas PB, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-59; Dean P, 2011, FEMS MICROBIOL REV, V35, P1100, DOI 10.1111/j.1574-6976.2011.00271.x; Donald Claire L, 2012, Insects, V3, P511, DOI 10.3390/insects3020511; Dong CH, 2011, FISH SHELLFISH IMMUN, V30, P1223, DOI 10.1016/j.fsi.2011.04.014; Duan YP, 2009, MOL PLANT MICROBE IN, V22, P1011, DOI 10.1094/MPMI-22-8-1011; El-Shesheny I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065392; Fillingham I, 2005, STRUCTURE, V13, P65, DOI 10.1016/j.str.2004.11.006; Fisher T, 2014, J CITRUS PATHOLOGY, V1; Fisher TW, 2014, PATHOGENS, V3, P875, DOI 10.3390/pathogens3040875; Gerardo NM, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r21; Gonzalez J, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000905; Gottwald TR, 2012, CROP PROT, V36, P73, DOI 10.1016/j.cropro.2012.01.004; Gottwald T. R., 2007, PLANT HLTH PROGR, P6, DOI [10.1094/PHP2007-090601-RV, DOI 10.1094/PHP2007-090601-RV]; Govind S, 2008, INSECT SCI, V15, P29, DOI 10.1111/j.1744-7917.2008.00185.x; Grafton-Cardwell EE, 2013, ANNU REV ENTOMOL, V58, P413, DOI 10.1146/annurev-ento-120811-153542; Gray YHM, 2000, TRENDS GENET, V16, P461, DOI 10.1016/S0168-9525(00)02104-1; Halbert SE, 2002, ESTABLISHMET 2 NEW V, P1016; Hall DG, 2013, ENTOMOL EXP APPL, V146, P207, DOI 10.1111/eea.12025; Hartung JS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023289; He HJ, 2012, MOL BIOL REP, V39, P1691, DOI 10.1007/s11033-011-0909-9; He RF, 2012, AM J BOT, V99, P232, DOI 10.3732/ajb.1100429; Hilf ME, 2013, PHYTOPATHOLOGY, V103, P545, DOI 10.1094/PHYTO-09-12-0226-R; Hogenhout SA, 2008, ANNU REV PHYTOPATHOL, V46, P327, DOI 10.1146/annurev.phyto.022508.092135; Holt RA, 2002, SCIENCE, V298, P129, DOI 10.1126/science.1076181; Horn C, 2003, GENETICS, V163, P647; Huang C, 2004, J CELL SCI, V117, P4619, DOI 10.1242/jcs.01481; Hunter W.B., 2009, Open Entomology Journal, V3, P18, DOI 10.2174/1874407900903010018; Hurd H, 2003, ANNU REV ENTOMOL, V48, P141, DOI 10.1146/annurev.ento.48.091801.112722; Hussain M, 2011, P NATL ACAD SCI USA, V108, P9250, DOI 10.1073/pnas.1105469108; Ingham PW, 2001, GENE DEV, V15, P3059, DOI 10.1101/gad.938601; Inoue H, 2009, ANN APPL BIOL, V155, P29, DOI 10.1111/j.1744-7348.2009.00317.x; Itokawa K, 2010, INSECT BIOCHEM MOLEC, V40, P631, DOI 10.1016/j.ibmb.2010.06.001; JAGOUEIX S, 1994, INT J SYST BACTERIOL, V44, P379, DOI 10.1099/00207713-44-3-379; Jiang H, 2007, APPL ENVIRON MICROB, V73, P4959, DOI 10.1128/AEM.02993-06; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kim GS, 2010, J INSECT PHYSIOL, V56, P559, DOI 10.1016/j.jinsphys.2009.11.022; Klinakis AG, 2000, EMBO REP, V1, P416, DOI 10.1093/embo-reports/kvd089; Laughton AM, 2011, J INSECT PHYSIOL, V57, P830, DOI 10.1016/j.jinsphys.2011.03.015; Lemaitre B, 2007, ANNU REV IMMUNOL, V25, P697, DOI 10.1146/annurev.immunol.25.022106.141615; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Li WL, 2012, PROTEINS, V80, P2614, DOI 10.1002/prot.24147; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Mann RS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029197; Martini X, 2013, FLA ENTOMOL, V96, P658, DOI 10.1653/024.096.0240; Meng Y, 2008, ARCH INSECT BIOCHEM, V67, P9, DOI 10.1002/arch.20214; Mukherjee K, 2012, FRONT ZOOL, V9, DOI 10.1186/1742-9994-9-25; Nachappa P, 2012, PHYTOPATHOLOGY, V102, P41, DOI 10.1094/PHYTO-03-11-0084; Nene V, 2007, SCIENCE, V316, P1718, DOI 10.1126/science.1138878; Nwugo CC, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-59; Orban TI, 2005, RNA, V11, P459, DOI 10.1261/rna.7231505; Pasyukova EG, 2004, J HERED, V95, P284, DOI 10.1093/jhered/esh050; Pelz-Stelinski KS, 2010, J ECON ENTOMOL, V103, P1531, DOI 10.1603/EC10123; Reese Justin, 2014, J Genomics, V2, P54; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Roignant JY, 2003, RNA, V9, P299, DOI 10.1261/rna.2154103; Rosenfield CL, 2001, INSECT BIOCHEM MOLEC, V31, P949, DOI 10.1016/S0965-1748(01)00043-1; ROSSIGNOL PA, 1986, AM J TROP MED HYG, V35, P277, DOI 10.4269/ajtmh.1986.35.277; Saha S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050067; Seehuus SC, 2006, P NATL ACAD SCI USA, V103, P962, DOI 10.1073/pnas.0502681103; Shames SR, 2012, TRENDS MICROBIOL, V20, P214, DOI 10.1016/j.tim.2012.02.007; Siomi MC, 2011, NAT REV MOL CELL BIO, V12, P246, DOI 10.1038/nrm3089; Soderlund C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069401; Spradling AC, 1999, GENETICS, V153, P135; Thao ML, 2001, CURR MICROBIOL, V42, P419, DOI 10.1007/s002840010240; Thornburg BG, 2006, GENE, V365, P104, DOI 10.1016/j.gene.2005.09.036; Ungewickell EJ, 2007, CURR OPIN CELL BIOL, V19, P417, DOI 10.1016/j.ceb.2007.05.003; van Rij RP, 2006, GENE DEV, V20, P2985, DOI 10.1101/gad.1482006; Veiga E, 2007, CELL HOST MICROBE, V2, P340, DOI 10.1016/j.chom.2007.10.001; Voinnet O, 2005, FEBS LETT, V579, P5858, DOI 10.1016/j.febslet.2005.09.039; Wang N, 2013, PHYTOPATHOLOGY, V103, P652, DOI 10.1094/PHYTO-12-12-0331-RVW; Wang SB, 2013, TRENDS BIOTECHNOL, V31, P185, DOI 10.1016/j.tibtech.2013.01.001; Wang YY, 2012, CELL HOST MICROBE, V12, P129, DOI 10.1016/j.chom.2012.07.006; Warr E, 2006, INSECT MOL BIOL, V15, P497, DOI 10.1111/j.1365-2583.2006.00663.x; Werr M, 2009, INSECT BIOCHEM MOLEC, V39, P634, DOI 10.1016/j.ibmb.2009.07.001; Wicker T, 2007, NAT REV GENET, V8, P973, DOI 10.1038/nrg2165; Williams MJ, 2006, J CELL SCI, V119, P2015, DOI 10.1242/jcs.02920; Winston WM, 2002, SCIENCE, V295, P2456, DOI 10.1126/science.1068836; Wolfstetter G, 2012, CELL MOL LIFE SCI, V69, P267, DOI 10.1007/s00018-011-0652-3; Wu ZH, 2010, MOL CELL, V40, P75, DOI 10.1016/j.molcel.2010.09.010; Wuriyanghan H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027736; Xu WN, 2008, J INSECT SCI, V8, DOI 10.1673/031.008.3001; Young MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r14; Zou HS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046447	104	55	59	3	73	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2015	10	6							e0130328	10.1371/journal.pone.0130328	http://dx.doi.org/10.1371/journal.pone.0130328			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL3FE	26091106	Green Submitted, Green Published, gold			2022-12-26	WOS:000356835000102
J	Boudjadi, S; Carrier, JC; Groulx, JF; Beaulieu, JF				Boudjadi, S.; Carrier, J. C.; Groulx, J-F; Beaulieu, J-F			Integrin alpha 1 beta 1 expression is controlled by c-MYC in colorectal cancer cells	ONCOGENE			English	Article							TRANSCRIPTIONAL REGULATION; EPITHELIAL-CELLS; GENE-EXPRESSION; DNA-BINDING; MAX; APOPTOSIS; PROLIFERATION; CARCINOMA; INVASION; SUBUNIT	The alpha 1 beta 1 collagen receptor is only present in a few epithelial cell types. In the intestine, it is specifically expressed in proliferating crypt cells. This integrin has been reported to be involved in various cancers where it mediates the downstream activation of the Ras/ERK proliferative pathway. We have recently shown that integrin alpha 1 beta 1 is present in two-thirds of colon adenocarcinomas, but the mechanism by which ITGA1 expression is regulated is not known. DNA methylation, involved in ITGA1 repression during megakaryocyte differentiation, is not the mechanism of ITGA1 regulation in colorectal cancer cells. Our in silico analysis of the ITGA1 promoter revealed two response elements for MYC, an oncogenic factor known to regulate cancer cell proliferation, invasion and migration. In situ, the expressions of both MYC and ITGA1 are localized in the lower crypt of the normal colon and correlate in 72% of the 65 analyzed colorectal cancers. MYC pharmacological inhibition or downregulation of expression with short hairpin RNA in HT29, T84 and SW480 cells resulted in reduced ITGA1 expression at both the transcript and protein levels. Chromatin immunoprecipitation assays revealed that MYC was bound to the chromatin region of the ITGA1 proximal promoter, whereas MYC overexpression enhanced ITGA1 promoter activity that was reduced with MAD co-transfection or by the disruption of the response elements. We concluded that MYC is a key regulating factor for the control of ITGA1 expression.	[Boudjadi, S.; Carrier, J. C.; Groulx, J-F; Beaulieu, J-F] Univ Sherbrooke, Lab Intestinal Physiopathol, Dept Anat & Cell Biol, Sherbrooke, PQ J1K 2R1, Canada; [Boudjadi, S.; Carrier, J. C.] Univ Sherbrooke, Dept Med, Fac Med & Hlth Sci, Sherbrooke, PQ J1K 2R1, Canada	University of Sherbrooke; University of Sherbrooke	Beaulieu, JF (corresponding author), Fac Med & Sci Sante, Dept Anat & Biol Cellulaire, Aile 4,Local 9425,3001,12e Ave Nord, Sherbrooke, PQ J1H 5N4, Canada.	Jean-Francois.Beaulieu@USherbrooke.ca			Canadian Institute of Health Research Grants [MOP-97836, MOP-123415]; Canadian Research Chair in Intestinal Physiopathology; Fonds de la Recherche en Sante du Quebec; Fonds de la Recherche du Quebec-Sante (FRQS)	Canadian Institute of Health Research Grants(Canadian Institutes of Health Research (CIHR)); Canadian Research Chair in Intestinal Physiopathology; Fonds de la Recherche en Sante du Quebec(Fonds de la Recherche en Sante du Quebec); Fonds de la Recherche du Quebec-Sante (FRQS)	We thank Elizabeth Herring for technical support and reviewing the manuscript, Eric Tremblay for virus production, Dr Marie-Pierre Garand of the Biostatistics Facility of the Centre de Recherche du CHUS for assistance in statistical analyses and Dr Andrea Quaroni (Cornell University, Ithaca) for the gift of Caco-2/15 cells. This work was supported by the Canadian Institute of Health Research Grants MOP-97836 and MOP-123415 (to J-FB). J-FB is the recipient of the Canadian Research Chair in Intestinal Physiopathology. JCC is a scholar of the Fonds de la Recherche du Quebec-Sante (FRQS). J-FB and JCC are members of the Fonds de la Recherche en Sante du Quebec-funded Centre de Recherche of the Centre Hospitalier Universitaire de Sherbrooke.	Abair TD, 2008, BLOOD, V112, P3242, DOI 10.1182/blood-2007-12-126433; AYER DE, 1993, CELL, V72, P211, DOI 10.1016/0092-8674(93)90661-9; Barczyk M, 2010, CELL TISSUE RES, V339, P269, DOI 10.1007/s00441-009-0834-6; Basora N, 1998, INT J CANCER, V75, P738, DOI 10.1002/(SICI)1097-0215(19980302)75:5<738::AID-IJC12>3.0.CO;2-2; Beaulieu Jean-Francois, 2010, World J Gastrointest Pathophysiol, V1, P3, DOI 10.4291/wjgp.v1.i1.3; BEAULIEU JF, 1992, J CELL SCI, V102, P427; Beausejour M, 2012, APOPTOSIS, V17, P566, DOI 10.1007/s10495-012-0713-6; Belaguli NS, 2010, NEOPLASIA, V12, P856, DOI 10.1593/neo.10224; Benoit YD, 2010, BIOCHEM BIOPH RES CO, V399, P434, DOI 10.1016/j.bbrc.2010.07.107; Bettess MD, 2005, MOL CELL BIOL, V25, P7868, DOI 10.1128/MCB.25.17.7868-7878.2005; BLACKWELL TK, 1990, SCIENCE, V250, P1149, DOI 10.1126/science.2251503; BLACKWOOD EM, 1991, SCIENCE, V251, P1211, DOI 10.1126/science.2006410; Boudjadi S, 2013, BIOMARK RES, V1, DOI 10.1186/2050-7771-1-16; Boudjadi S, 2013, AM J PATHOL, V183, P266, DOI 10.1016/j.ajpath.2013.03.021; Bustin SA, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-74; Cheli Y, 2007, BBA-GENE STRUCT EXPR, V1769, P546, DOI 10.1016/j.bbaexp.2007.06.004; Chen YH, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-246; Dang CV, 2006, SEMIN CANCER BIOL, V16, P253, DOI 10.1016/j.semcancer.2006.07.014; Dang CV, 2012, CELL, V149, P22, DOI 10.1016/j.cell.2012.03.003; Dydensborg AB, 2006, AM J PHYSIOL-GASTR L, V290, pG1067, DOI 10.1152/ajpgi.00234.2005; Dydensborg AB, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-223; ERISMAN MD, 1985, MOL CELL BIOL, V5, P1969, DOI 10.1128/MCB.5.8.1969; Fernandez PC, 2003, GENE DEV, V17, P1115, DOI 10.1101/gad.1067003; Fujimoto H, 2001, GENES CELLS, V6, P337, DOI 10.1046/j.1365-2443.2001.00428.x; Giancotti FG, 1997, CURR OPIN CELL BIOL, V9, P691, DOI 10.1016/S0955-0674(97)80123-8; Giancotti FG, 2000, NAT CELL BIOL, V2, pE13, DOI 10.1038/71397; Grandori C, 2000, ANNU REV CELL DEV BI, V16, P653, DOI 10.1146/annurev.cellbio.16.1.653; Groulx JF, 2014, CARCINOGENESIS, V35, P1217, DOI 10.1093/carcin/bgu006; Guenther MG, 2007, CELL, V130, P77, DOI 10.1016/j.cell.2007.05.042; Huang MJ, 2006, EXP HEMATOL, V34, P1480, DOI 10.1016/j.exphem.2006.06.019; Hurlin PJ, 1997, GENE DEV, V11, P44, DOI 10.1101/gad.11.1.44; Kerkhoff E, 1998, ONCOGENE, V16, P211, DOI 10.1038/sj.onc.1201520; Kim TH, 2005, NATURE, V436, P876, DOI 10.1038/nature03877; Li ZR, 2003, P NATL ACAD SCI USA, V100, P8164, DOI 10.1073/pnas.1332764100; Lin CP, 2007, ANTI-CANCER DRUG, V18, P161, DOI 10.1097/CAD.0b013e3280109424; Lochter A, 1999, MOL BIOL CELL, V10, P271, DOI 10.1091/mbc.10.2.271; Macias-Perez I, 2008, CANCER RES, V68, P6127, DOI 10.1158/0008-5472.CAN-08-1395; Mo H, 2006, P NATL ACAD SCI USA, V103, P6344, DOI 10.1073/pnas.0601418103; Ni HH, 2005, ONCOGENE, V24, P6820, DOI 10.1038/sj.onc.1208848; Nishida W, 2002, J BIOL CHEM, V277, P7308, DOI 10.1074/jbc.M111824200; Obata H, 1997, J BIOL CHEM, V272, P26643, DOI 10.1074/jbc.272.42.26643; Oster SK, 2002, ADV CANCER RES, V84, P81, DOI 10.1016/S0065-230X(02)84004-0; Park S, 2004, BBA-GEN SUBJECTS, V1670, P217, DOI 10.1016/j.bbagen.2003.12.007; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Sabo A, 2014, NATURE, V511, P488, DOI 10.1038/nature13537; SIKORA K, 1987, CANCER-AM CANCER SOC, V59, P1289, DOI 10.1002/1097-0142(19870401)59:7<1289::AID-CNCR2820590710>3.0.CO;2-O; Suzuki H, 2010, CARCINOGENESIS, V31, P342, DOI 10.1093/carcin/bgp179; Tanaka N, 2008, INT J ONCOL, V33, P815, DOI 10.3892/ijo_00000069; Vachon Pierre H, 2011, J Signal Transduct, V2011, P738137, DOI 10.1155/2011/738137; van Golen CM, 2003, ONCOGENE, V22, P2664, DOI 10.1038/sj.onc.1206362; Van Slambrouck S, 2007, INT J ONCOL, V31, P1501; Wary KK, 1998, CELL, V94, P625, DOI 10.1016/S0092-8674(00)81604-9; Yang CQ, 2003, CANCER RES, V63, P8312; Yang HP, 2009, HEPATOLOGY, V49, P860, DOI 10.1002/hep.22720; Yin XY, 2003, ONCOGENE, V22, P6151, DOI 10.1038/sj.onc.1206641	55	37	37	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 31	2016	35	13					1671	1678		10.1038/onc.2015.231	http://dx.doi.org/10.1038/onc.2015.231			8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DH8RP	26096932	hybrid, Green Published			2022-12-26	WOS:000373064200006
J	Diderrich, R; Kock, M; Maestre-Reyna, M; Keller, P; Steuber, H; Rupp, S; Essen, LO; Mosch, HU				Diderrich, Rike; Kock, Michael; Maestre-Reyna, Manuel; Keller, Petra; Steuber, Holger; Rupp, Steffen; Essen, Lars-Oliver; Moesch, Hans-Ulrich			Structural Hot Spots Determine Functional Diversity of the Candida glabrata Epithelial Adhesin Family	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-WALL; PA14 DOMAIN; YEAST; SPECIFICITY; EXPRESSION; CONSURF; TOOLS; EPIDEMIOLOGY; ALBICANS; EPA1P	For host colonization, the human fungal pathogen Candida glabrata is known to utilize a large family of highly related surface-exposed cell wall proteins, the lectin-like epithelial adhesins (Epas). To reveal the structure-function relationships within the entire Epa family, we have performed a large scale functional analysis of the adhesion (A) domains of 17 Epa paralogs in combination with three-dimensional structural studies of selected members with cognate ligands. Our study shows that most EpaA domains exert lectin-like functions and together recognize a wide variety of glycans with terminal galactosides for conferring epithelial cell adhesion. We further identify several conserved and variable structural features within the diverse Epa ligand binding pockets, which affect affinity and specificity. These features rationalize why mere phylogenetic relationships within the Epa family are weak indicators for functional classification and explain how Epa-like adhesins have evolved in C. glabrata and related fungal species.	[Diderrich, Rike; Moesch, Hans-Ulrich] Univ Marburg, Dept Genet, D-35043 Marburg, Germany; [Kock, Michael; Maestre-Reyna, Manuel; Steuber, Holger; Essen, Lars-Oliver] Univ Marburg, Dept Biochem, D-35043 Marburg, Germany; [Keller, Petra; Rupp, Steffen] Fraunhofer Inst Grenzflachen & Bioverfahrenstech, D-70569 Stuttgart, Germany; [Rupp, Steffen] Univ Stuttgart, Inst Grenzflachenverfahrenstech & Plasmatech, D-70569 Stuttgart, Germany	Philipps University Marburg; Philipps University Marburg; Fraunhofer Gesellschaft; University of Stuttgart	Essen, LO (corresponding author), Univ Marburg, Dept Biochem, D-35043 Marburg, Germany.	essen@chemie.uni-marburg.de; moesch@staff.uni-marburg.de	Essen, Lars-Oliver/L-3862-2016	Essen, Lars-Oliver/0000-0003-4272-4026	Deutsche Forschungsgemeinschaft [ES 152/7, MO 825/3, SFB 987, GRK 1216]; International Max-Planck Research School for Environmental, Cellular and Molecular Microbiology; Marburg Center for Synthetic Microbiology	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); International Max-Planck Research School for Environmental, Cellular and Molecular Microbiology; Marburg Center for Synthetic Microbiology	This work was supported by Deutsche Forschungsgemeinschaft Grants ES 152/7, MO 825/3, SFB 987, and GRK 1216, the International Max-Planck Research School for Environmental, Cellular and Molecular Microbiology, and the Marburg Center for Synthetic Microbiology. The authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; [Anonymous], 1991, Methods Enzymol, V194, P1; Bolotin-Fukuhara M, 2014, YEAST, V31, P279, DOI 10.1002/yea.3019; Brown GD, 2012, SCIENCE, V336, P647, DOI 10.1126/science.1222236; Castano I, 2006, MOLECULAR PRINCIPLES OF FUNGAL PATHOGENESIS, P163; Celniker G, 2013, ISR J CHEM, V53, P199, DOI 10.1002/ijch.201200096; Cormack BP, 1999, SCIENCE, V285, P578, DOI 10.1126/science.285.5427.578; de Groot PWJ, 2008, EUKARYOT CELL, V7, P1951, DOI 10.1128/EC.00284-08; de Groot PWJ, 2008, MOL MICROBIOL, V68, P535, DOI 10.1111/j.1365-2958.2008.06182.x; de Groot PWJ, 2013, EUKARYOT CELL, V12, P470, DOI 10.1128/EC.00364-12; de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078; DeLano W. L., 2002, PYMOL MOL GRAPHICS S, DOI DOI 10.1007/S10822-016-9944-X; Desai C, 2011, FEMS YEAST RES, V11, P595, DOI 10.1111/j.1567-1364.2011.00743.x; Dieterich C, 2002, MICROBIOL-SGM, V148, P497, DOI 10.1099/00221287-148-2-497; Domergue R, 2005, SCIENCE, V308, P866, DOI 10.1126/science.1108640; Dranginis AM, 2007, MICROBIOL MOL BIOL R, V71, P282, DOI 10.1128/MMBR.00037-06; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Frieman MB, 2002, MOL MICROBIOL, V46, P479, DOI 10.1046/j.1365-2958.2002.03166.x; Gallegos-Garcia V, 2012, GENETICS, V190, P1285, DOI 10.1534/genetics.111.138099; Geissner A, 2014, CURR OPIN CHEM BIOL, V18, P38, DOI 10.1016/j.cbpa.2013.11.013; GIETZ RD, 1988, GENE, V74, P527, DOI 10.1016/0378-1119(88)90185-0; Glaser F, 2003, BIOINFORMATICS, V19, P163, DOI 10.1093/bioinformatics/19.1.163; Halliwell SC, 2012, EUKARYOT CELL, V11, P141, DOI 10.1128/EC.05232-11; Heinig M, 2004, NUCLEIC ACIDS RES, V32, pW500, DOI 10.1093/nar/gkh429; Ielasi FS, 2012, ACTA CRYSTALLOGR D, V68, P210, DOI 10.1107/S0907444911054898; Inglis DO, 2012, NUCLEIC ACIDS RES, V40, pD667, DOI 10.1093/nar/gkr945; Kaur R, 2005, CURR OPIN MICROBIOL, V8, P378, DOI 10.1016/j.mib.2005.06.012; Landau M, 2005, NUCLEIC ACIDS RES, V33, pW299, DOI 10.1093/nar/gki370; Liu YP, 2011, EUKARYOT CELL, V10, P168, DOI 10.1128/EC.00279-10; Maestre-Reyna M, 2012, P NATL ACAD SCI USA, V109, P16864, DOI 10.1073/pnas.1207653109; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; O'Sullivan O, 2004, J MOL BIOL, V340, P385, DOI 10.1016/j.jmb.2004.04.058; Perlroth J, 2007, MED MYCOL, V45, P321, DOI 10.1080/13693780701218689; Pfaller MA, 2007, CLIN MICROBIOL REV, V20, P133, DOI 10.1128/CMR.00029-06; Phan QT, 2007, PLOS BIOL, V5, P543, DOI 10.1371/journal.pbio.0050064; Rigden DJ, 2004, TRENDS BIOCHEM SCI, V29, P335, DOI 10.1016/j.tibs.2004.05.002; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Salgado PS, 2011, P NATL ACAD SCI USA, V108, P15775, DOI 10.1073/pnas.1103496108; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sim L, 2013, FEBS J, V280, P1073, DOI 10.1111/febs.12102; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Veelders M, 2010, P NATL ACAD SCI USA, V107, P22511, DOI 10.1073/pnas.1013210108; Verstrepen KJ, 2004, NAT REV MICROBIOL, V2, P533, DOI 10.1038/nrmicro927; Webb Benjamin, 2016, Curr Protoc Protein Sci, V86, DOI [10.1002/cpbi.3, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50, 10.1002/cpps.20]; Wittmann V, 2013, CHEM SOC REV, V42, P4492, DOI 10.1039/c3cs60089k; Zepelin MBV, 2007, J ANTIMICROB CHEMOTH, V60, P424, DOI 10.1093/jac/dkm145; Zupancic ML, 2008, MOL MICROBIOL, V68, P547, DOI 10.1111/j.1365-2958.2008.06184.x	50	33	33	0	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 7	2015	290	32					19597	19613		10.1074/jbc.M115.655654	http://dx.doi.org/10.1074/jbc.M115.655654			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CO7TL	26105055	Green Published, hybrid			2022-12-26	WOS:000359364600022
J	He, YN; Rangarajan, S; Kerzic, M; Luo, M; Chen, YH; Wang, Q; Yin, YY; Workman, CJ; Vignali, KM; Vignali, DAA; Mariuzza, RA; Orban, J				He, Yanan; Rangarajan, Sneha; Kerzic, Melissa; Luo, Ming; Chen, Yihong; Wang, Qian; Yin, Yiyuan; Workman, Creg J.; Vignali, Kate M.; Vignali, Dario A. A.; Mariuzza, Roy A.; Orban, John			Identification of the Docking Site for CD3 on the T Cell Receptor beta Chain by Solution NMR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; CD3-EPSILON-GAMMA HETERODIMER; SECONDARY STRUCTURE; NEGATIVE SELECTION; ANTIGEN RECEPTOR; RETROGENIC MICE; COMPLEX; PROTEIN; TCR; RECOGNITION	The T cell receptor (TCR)-CD3 complex is composed of a genetically diverse alpha beta TCR heterodimer associated noncovalently with the invariant CD3 dimers CD3 epsilon gamma, CD3 epsilon delta, and CD3 zeta zeta. The TCR mediates peptide-MHC recognition, whereas the CD3 molecules transduce activation signals to the T cell. Although much is known about downstream T cell signaling pathways, the mechanism whereby TCR engagement by peptide-MHC initiates signaling is poorly understood. A key to solving this problem is defining the spatial organization of the TCR-CD3 complex and the interactions between its subunits. We have applied solution NMR methods to identify the docking site for CD3 on the beta chain of a human autoimmune TCR. We demonstrate a low affinity but highly specific interaction between the extracellular domains of CD3 and the TCR constant beta (C beta) domain that requires both CD3 epsilon gamma and CD3 epsilon delta subunits. The mainly hydrophilic docking site, comprising 9-11 solvent-accessible C beta residues, is relatively small (similar to 400 angstrom(2)), consistent with the weak interaction between TCR and CD3 extracellular domains, and devoid of glycosylation sites. The docking site is centered on the alpha A and alpha B helices of C beta, which are located at the base of the TCR. This positions CD3 epsilon gamma and CD3 epsilon delta between the TCR and the T cell membrane, permitting us to distinguish among several possible models of TCR-CD3 association. We further correlate structural results from NMR with mutational data on TCR-CD3 interactions from cell-based assays.	[Mariuzza, Roy A.] Univ Maryland, Inst Biosci & Biotechnol Res, Rockville, MD 20850 USA; [He, Yanan; Rangarajan, Sneha; Kerzic, Melissa; Luo, Ming; Chen, Yihong; Wang, Qian; Yin, Yiyuan; Mariuzza, Roy A.; Orban, John] Univ Maryland, Inst Biosci & Biotechnol Res, WM Keck Lab Struct Biol, Rockville, MD 20850 USA; [He, Yanan; Orban, John] Univ Maryland, Dept Chem & Biochem, College Pk, MD 20742 USA; [Rangarajan, Sneha; Mariuzza, Roy A.] Univ Maryland, Dept Cell Biol & Mol Genet, College Pk, MD 20742 USA; [Luo, Ming] Univ Sci & Technol China, Hefei Natl Lab Phys Sci Microscale, Hefei 230027, Anhui, Peoples R China; [Luo, Ming] Univ Sci & Technol China, Sch Life Sci, Hefei 230027, Anhui, Peoples R China; [Workman, Creg J.; Vignali, Kate M.; Vignali, Dario A. A.] Univ Pittsburgh, Sch Med, Dept Immunol, Pittsburgh, PA 15261 USA	University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Mariuzza, RA (corresponding author), Univ Maryland, Inst Biosci & Biotechnol Res, 9600 Gudelsky Dr, Rockville, MD 20850 USA.	rmariuzz@umd.edu	Yin, Yiyuan/A-1384-2016; Yin, Yiyuan/AAP-3069-2020; Regan, Clinton/E-6250-2012	Yin, Yiyuan/0000-0003-1077-810X; Yin, Yiyuan/0000-0003-1077-810X; 	National Institutes of Health [AI101911, AI036900, AI52199]; W. M. Keck Foundation; China Scholarship Council; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI052199, R01AI036900, R56AI052199, R21AI101911, R37AI036900, R01AI052199] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); W. M. Keck Foundation(W.M. Keck Foundation); China Scholarship Council(China Scholarship Council); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants AI101911 (to J. O. and R. A. M.), AI036900 (to R. A. M.), and AI52199 (to D. A. A. V.). The NMR facility is jointly supported by the University of Maryland, the National Institute of Standards and Technology, and a grant from the W. M. Keck Foundation. The authors declare that they have no conflicts of interest with the contents of this article.r Supported by the joint supervision Ph.D. Project of the China Scholarship Council.	Arnett KL, 2004, P NATL ACAD SCI USA, V101, P16268, DOI 10.1073/pnas.0407359101; Backstrom BT, 1996, IMMUNITY, V5, P437, DOI 10.1016/S1074-7613(00)80500-2; Birnbaum ME, 2014, P NATL ACAD SCI USA, V111, P17576, DOI 10.1073/pnas.1420936111; Birnbaum ME, 2012, IMMUNOL REV, V250, P82, DOI 10.1111/imr.12006; Boulter JM, 2003, PROTEIN ENG, V16, P707, DOI 10.1093/protein/gzg087; Brazin KN, 2014, J BIOL CHEM, V289, P18880, DOI 10.1074/jbc.M114.574996; Call ME, 2002, CELL, V111, P967, DOI 10.1016/S0092-8674(02)01194-7; Call ME, 2004, EMBO J, V23, P2348, DOI 10.1038/sj.emboj.7600245; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Fernandes RA, 2012, J BIOL CHEM, V287, P13324, DOI 10.1074/jbc.M111.332783; Goddard T.D., 2004, SPARKY 3; He YN, 2007, PROTEIN SCI, V16, P1490, DOI 10.1110/ps.072799507; Holst J, 2006, NAT METHODS, V3, P191, DOI 10.1038/nmeth858; Holst J, 2008, NAT IMMUNOL, V9, P658, DOI 10.1038/ni.1611; Holst J, 2006, NAT PROTOC, V1, P406, DOI 10.1038/nprot.2006.61; Hyberts SG, 2012, J BIOMOL NMR, V52, P315, DOI 10.1007/s10858-012-9611-z; Kjer-Nielsen L, 2004, P NATL ACAD SCI USA, V101, P7675, DOI 10.1073/pnas.0402295101; Kuhns MS, 2007, IMMUNITY, V26, P357, DOI 10.1016/j.immuni.2007.01.015; Kuhns MS, 2012, IMMUNOL REV, V250, P120, DOI 10.1111/imr.12000; Kuhns MS, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00159; Kuhns MS, 2010, P NATL ACAD SCI USA, V107, P5094, DOI 10.1073/pnas.1000925107; Kuhns MS, 2006, IMMUNITY, V24, P133, DOI 10.1016/j.immuni.2006.01.006; Li YL, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00206; Lo Conte L, 1999, J MOL BIOL, V285, P2177; Martinez-Martin N, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000402; Motlagh HN, 2014, NATURE, V508, P331, DOI 10.1038/nature13001; Nooren IMA, 2003, J MOL BIOL, V325, P991, DOI 10.1016/S0022-2836(02)01281-0; Pervushin K, 1997, P NATL ACAD SCI USA, V94, P12366, DOI 10.1073/pnas.94.23.12366; Quandt JA, 2004, J EXP MED, V200, P223, DOI 10.1084/jem.20030994; Rossjohn J, 2015, ANNU REV IMMUNOL, V33, P169, DOI 10.1146/annurev-immunol-032414-112334; Rudolph MG, 2006, ANNU REV IMMUNOL, V24, P419, DOI 10.1146/annurev.immunol.23.021704.115658; Samelson LE, 2002, ANNU REV IMMUNOL, V20, P371, DOI 10.1146/annurev.immunol.20.092601.111357; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Smock RG, 2009, SCIENCE, V324, P198, DOI 10.1126/science.1169377; Sun ZYJ, 2004, P NATL ACAD SCI USA, V101, P16867, DOI 10.1073/pnas.0407576101; Sun ZYJ, 2001, CELL, V105, P913, DOI 10.1016/S0092-8674(01)00395-6; Szymczak AL, 2004, NAT BIOTECHNOL, V22, P589, DOI 10.1038/nbt957; Touma M, 2006, J IMMUNOL, V176, P6812, DOI 10.4049/jimmunol.176.11.6812; Tugarinov V, 2002, J AM CHEM SOC, V124, P10025, DOI 10.1021/ja0205636; Tzeng SR, 2012, NATURE, V488, P236, DOI 10.1038/nature11271; Tzeng SR, 2011, CURR OPIN STRUC BIOL, V21, P62, DOI 10.1016/j.sbi.2010.10.007; Wang YB, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000253; WISHART DS, 1994, J BIOMOL NMR, V4, P171; Wucherpfennig KW, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a005140; Xu CQ, 2006, J BIOL CHEM, V281, P36977, DOI 10.1074/jbc.M607164200; Yin YY, 2012, IMMUNOL REV, V250, P32, DOI 10.1111/imr.12002; Yin YY, 2012, P NATL ACAD SCI USA, V109, P5405, DOI 10.1073/pnas.1118801109; Yin YY, 2011, EMBO J, V30, P1137, DOI 10.1038/emboj.2011.21	48	29	29	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 7	2015	290	32					19796	19805		10.1074/jbc.M115.663799	http://dx.doi.org/10.1074/jbc.M115.663799			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CO7TL	26109064	Green Published, hybrid			2022-12-26	WOS:000359364600036
J	Peshenko, IV; Olshevskaya, EV; Dizhoor, AM				Peshenko, Igor V.; Olshevskaya, Elena V.; Dizhoor, Alexander M.			Dimerization Domain of Retinal Membrane Guanylyl Cyclase 1 (RetGC1) Is an Essential Part of Guanylyl Cyclase-activating Protein (GCAP) Binding Interface	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LEBER CONGENITAL AMAUROSIS; CONE-ROD DYSTROPHY; KNOCK-OUT MICE; PHOTORECEPTOR CELLS; CALCIUM SENSITIVITY; CATALYTIC-ACTIVITY; IDENTIFICATION; DEGENERATION; MUTATIONS; MECHANISM	The photoreceptor-specific proteins guanylyl cyclase-activating proteins (GCAPs) bind and regulate retinal membrane guanylyl cyclase 1 (RetGC1) but not natriuretic peptide receptor A (NPRA). Study of RetGC1 regulation in vitro and its association with fluorescently tagged GCAP in transfected cells showed that R822P substitution in the cyclase dimerization domain causing congenital early onset blindness disrupted RetGC1 ability to bind GCAP but did not eliminate its affinity for another photo-receptor-specific protein, retinal degeneration 3 (RD3). Likewise, the presence of the NPRA dimerization domain in RetGC1/NPRA chimera specifically disabled binding of GCAPs but not of RD3. In subsequent mapping using hybrid dimerization domains in RetGC1/NPRA chimera, multiple RetGC1-specific residues contributed to GCAP binding by the cyclase, but the region around Met(823) was the most crucial. Either positively or negatively charged residues in that position completely blocked GCAP1 and GCAP2 but not RD3 binding similarly to the disease-causing mutation in the neighboring Arg(822). The specificity of GCAP binding imparted by RetGC1 dimerization domain was not directly related to promoting dimerization of the cyclase. The probability of coiled coil dimer formation computed for RetGC1/NPRA chimeras, even those incapable of binding GCAP, remained high, and functional complementation tests showed that the RetGC1 active site, which requires dimerization of the cyclase, was formed even when Met(823) or Arg(822) was mutated. These results directly demonstrate that the interface for GCAP binding on RetGC1 requires not only the kinase homology region but also directly involves the dimerization domain and especially its portion containing Arg(822) and Met(823).	[Peshenko, Igor V.; Olshevskaya, Elena V.; Dizhoor, Alexander M.] Salus Univ, Dept Res, Elkins Pk, PA 19027 USA		Dizhoor, AM (corresponding author), Salus Univ, Res S416, 8360 Old York Rd, Elkins Pk, PA 19027 USA.	adizhoor@salus.edu		Dizhoor, Alexander/0000-0001-6770-9186	National Institutes of Health from the NEI [EY11522]; Common-wealth Universal Research Enhancement formula grant from the Pennsylvania Department of Health; NATIONAL EYE INSTITUTE [R01EY011522] Funding Source: NIH RePORTER	National Institutes of Health from the NEI; Common-wealth Universal Research Enhancement formula grant from the Pennsylvania Department of Health; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by National Institutes of Health Grant EY11522 from the NEI. This work was also supported by a Common-wealth Universal Research Enhancement formula grant from the Pennsylvania Department of Health. The authors declare that they have no conflicts of interest with the contents of this article.	Azadi S, 2010, P NATL ACAD SCI USA, V107, P21158, DOI 10.1073/pnas.1010460107; Burns ME, 2002, NEURON, V36, P81, DOI 10.1016/S0896-6273(02)00911-X; Delorenzi M, 2002, BIOINFORMATICS, V18, P617, DOI 10.1093/bioinformatics/18.4.617; Dizhoor AM, 2010, MOL CELL BIOCHEM, V334, P117, DOI 10.1007/s11010-009-0328-6; DIZHOOR AM, 1995, J BIOL CHEM, V270, P25200, DOI 10.1074/jbc.270.42.25200; DIZHOOR AM, 1994, NEURON, V12, P1345, DOI 10.1016/0896-6273(94)90449-9; Duda T, 2005, BIOCHEMISTRY-US, V44, P7336, DOI 10.1021/bi050068x; Duda T, 2015, J BIOL CHEM, V290, P11052, DOI 10.1074/jbc.M115.650408; Duda T, 2012, BIOCHEMISTRY-US, V51, P4650, DOI 10.1021/bi300572w; Friedman JS, 2006, AM J HUM GENET, V79, P1059, DOI 10.1086/510021; Garbers DL, 1999, METHODS, V19, P477, DOI 10.1006/meth.1999.0890; GRAYKELLER MP, 1994, NEURON, V13, P849, DOI 10.1016/0896-6273(94)90251-8; Horton MR, 1991, DIRECTED MUTAGENESIS, P217; Imanishi Y, 2004, J MOL EVOL, V59, P204, DOI 10.1007/s00239-004-2614-y; Jacobson SG, 2013, HUM MOL GENET, V22, P168, DOI 10.1093/hmg/dds421; Kelsell RE, 1998, HUM MOL GENET, V7, P1179, DOI 10.1093/hmg/7.7.1179; KOCH KW, 1988, NATURE, V334, P64, DOI 10.1038/334064a0; KOCH KW, 1991, J BIOL CHEM, V266, P8634; Krylov DM, 2001, J BIOL CHEM, V276, P30648, DOI 10.1074/jbc.M104121200; Lange C, 1999, FEBS LETT, V460, P27, DOI 10.1016/S0014-5793(99)01312-5; Laura RP, 1996, J BIOL CHEM, V271, P11646, DOI 10.1074/jbc.271.20.11646; Laura RP, 1998, BIOCHEMISTRY-US, V37, P11264, DOI 10.1021/bi9809674; Lim S, 2009, BIOCHEMISTRY-US, V48, P850, DOI 10.1021/bi801897p; Liu Y, 1997, P NATL ACAD SCI USA, V94, P13414, DOI 10.1073/pnas.94.25.13414; LOWE DG, 1995, P NATL ACAD SCI USA, V92, P5535, DOI 10.1073/pnas.92.12.5535; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; Makino CL, 2008, J BIOL CHEM, V283, P29135, DOI 10.1074/jbc.M804445200; Makino CL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047637; Olshevskaya EV, 2012, J NEUROSCI, V32, P7208, DOI 10.1523/JNEUROSCI.0976-12.2012; Olshevskaya EV, 1999, J BIOL CHEM, V274, P25583, DOI 10.1074/jbc.274.36.25583; Olshevskaya EV, 1997, J BIOL CHEM, V272, P14327, DOI 10.1074/jbc.272.22.14327; PALCZEWSKI K, 1994, NEURON, V13, P395, DOI 10.1016/0896-6273(94)90355-7; Perrault I, 1996, NAT GENET, V14, P461, DOI 10.1038/ng1296-461; Peshenko IV, 2008, J BIOL CHEM, V283, P21747, DOI 10.1074/jbc.M801899200; Peshenko IV, 2007, J BIOL CHEM, V282, P21645, DOI 10.1074/jbc.M702368200; Peshenko IV, 2015, J BIOL CHEM, V290, P6913, DOI 10.1074/jbc.M114.629642; Peshenko IV, 2014, J BIOL CHEM, V289, P10140, DOI 10.1074/jbc.M113.540716; Peshenko IV, 2012, J BIOL CHEM, V287, P13972, DOI 10.1074/jbc.M112.341883; Peshenko IV, 2012, FRONT MOL NEUROSCI, V5, DOI 10.3389/fnmol.2012.00019; Peshenko IV, 2011, BIOCHEMISTRY-US, V50, P9511, DOI 10.1021/bi201342b; Peshenko IV, 2011, BIOCHEMISTRY-US, V50, P5590, DOI 10.1021/bi200491b; Peshenko IV, 2010, BIOCHEMISTRY-US, V49, P709, DOI 10.1021/bi901495y; Peshenko IV, 2004, BIOCHEMISTRY-US, V43, P13796, DOI 10.1021/bi048943m; Peshenko IV, 2004, J BIOL CHEM, V279, P16903, DOI 10.1074/jbc.C400065200; Ramamurthy V, 2001, J BIOL CHEM, V276, P26218, DOI 10.1074/jbc.M010495200; Sakurai K, 2011, J NEUROSCI, V31, P7991, DOI 10.1523/JNEUROSCI.6650-10.2011; Scholten A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023117; Sharma RK, 2014, FRONT MOL NEUROSCI, V7, DOI 10.3389/fnmol.2014.00056; Sokal I, 1999, BIOCHEMISTRY-US, V38, P1387, DOI 10.1021/bi982512k; Stone EM, 2007, AM J OPHTHALMOL, V144, P791, DOI 10.1016/j.ajo.2007.08.022; Tucker CL, 1999, P NATL ACAD SCI USA, V96, P9039, DOI 10.1073/pnas.96.16.9039; Tucker CL, 1998, P NATL ACAD SCI USA, V95, P5993, DOI 10.1073/pnas.95.11.5993; Woodruff ML, 2002, J PHYSIOL-LONDON, V542, P843, DOI 10.1113/jphysiol.2001.013987; Yang RB, 1997, J BIOL CHEM, V272, P13738, DOI 10.1074/jbc.272.21.13738; YANG RB, 1995, P NATL ACAD SCI USA, V92, P602, DOI 10.1073/pnas.92.2.602; Yu H, 1999, J BIOL CHEM, V274, P15547, DOI 10.1074/jbc.274.22.15547; Zagel P, 2013, BIOCHEMISTRY-US, V52, P5065, DOI 10.1021/bi400288p; Zinchuk Vadim, 2008, Curr Protoc Cell Biol, VChapter 4, DOI 10.1002/0471143030.cb0419s39; Zulliger R, 2015, J BIOL CHEM, V290, P3488, DOI 10.1074/jbc.M114.616656	59	23	23	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 7	2015	290	32					19584	19596		10.1074/jbc.M115.661371	http://dx.doi.org/10.1074/jbc.M115.661371			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CO7TL	26100624	Green Published, hybrid			2022-12-26	WOS:000359364600021
J	Tomasello, DL; Gancarz-Kausch, AM; Dietz, DM; Bhattacharjee, A				Tomasello, Danielle L.; Gancarz-Kausch, Amy M.; Dietz, David M.; Bhattacharjee, Arin			Transcriptional Regulation of the Sodium-activated Potassium Channel SLICK (KCNT2) Promoter by Nuclear Factor-kappa B	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							K-NA CHANNELS; C-REL; PHOSPHORYLATION; LOCALIZATION; EXPRESSION; MECHANISM; SURVIVAL; NEURONS; DIMERS	Although recent studies have shown the sodium-activated potassium channel SLACK (KCNT1) can contribute to neuronal excitability, there remains little information on the physiological role of the closely related SLICK (KCNT2) channel. Activation of SLICK channels may be important during pathological states such as ischemia, in which an increase in intracellular sodium and chloride can perturb membrane potential and ion homeostasis. Wehave identified two NF kappa B-binding sites within the promoter region of the human SLICK (KCNT2) and orthologous rat Slick (Kcnt2) genes, suggesting that conditions in which NF kappa B transcriptional activity is elevated promote expression of this channel. NF kappa B binding to the rat Slick promoter was confirmed in vivo by ChIP analyses, and NF kappa B was found differentially bound to the two sites. We verified NF kappa B transcriptional regulation of SLICK/Slick by mutational analyses and studying gene expression by luciferase assay in P19 cells, where NF kappa B is constitutively active. For the rat gene, activation of the Slick promoter was found to be additive in single NF kappa B mutations and synergistic in double mutations. Unexpectedly, for the human gene, NF kappa B exhibited cooperativity in activating the SLICK promoter. The human SLICK promoter constructs were then tested under hypoxic conditions in PC-12 cells, where NF kappa B is not active. Only under hypoxic conditions could luciferase activity be detected; the double NF kappa B mutant construct failed to exhibit activity. Transcriptional regulation of Slick by NF kappa B was verified in primary neurons. The Slick transcript decreased 24 h after NF kappa B inhibition. Our data show SLICK expression is predominantly under the control of NF kappa B. Because neuronal NF kappa B activation occurs during stressful stimuli such as hypoxia and injury, our findings suggest that SLICK is a neuroprotective gene.	[Tomasello, Danielle L.; Dietz, David M.; Bhattacharjee, Arin] SUNY Buffalo, Program Neurosci, Buffalo, NY 14214 USA; [Gancarz-Kausch, Amy M.; Dietz, David M.; Bhattacharjee, Arin] SUNY Buffalo, Dept Pharmacol & Toxicol, Buffalo, NY 14214 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Bhattacharjee, A (corresponding author), SUNY Buffalo, 102 Farber Hall,3435 Main St, Buffalo, NY 14214 USA.	ab68@buffalo.edu	Dietz, David/J-9458-2015; Regan, Clinton/E-6250-2012; Dietz, David/AAW-4574-2021	Dietz, David/0000-0002-6927-9236; Dietz, David/0000-0002-6927-9236; Gancarz-Kausch, Amy/0000-0002-3231-9732	National Institutes of Health [NS078184]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS078184] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant NS078184 (to A. B.). The authors declare that they have no conflicts of interest with the contents of this article.	Allen D, 2011, J CEREBR BLOOD F MET, V31, P2302, DOI 10.1038/jcbfm.2011.90; Allen D, 2011, NAT NEUROSCI, V14, P744, DOI 10.1038/nn.2832; Bhakar AL, 2002, J NEUROSCI, V22, P8466; Bhattacharjee A, 2003, J NEUROSCI, V23, P11681; Blondeau N, 2001, J NEUROSCI, V21, P4668, DOI 10.1523/JNEUROSCI.21-13-04668.2001; Brattacharjee A, 2005, J COMP NEUROL, V484, P80, DOI 10.1002/cne.20462; Burke MA, 2003, J NEUROBIOL, V55, P191, DOI 10.1002/neu.10174; CHALAZONITIS A, 1987, P NATL ACAD SCI USA, V84, P289, DOI 10.1073/pnas.84.1.289; Chiechio S, 2006, MOL PAIN, V2, DOI 10.1186/1744-8069-2-20; Das M, 2008, IUBMB LIFE, V60, P199, DOI 10.1002/iub.31; Deng P, 2011, J CEREBR BLOOD F MET, V31, P1823, DOI 10.1038/jcbfm.2011.88; Fridmacher V, 2003, J NEUROSCI, V23, P9403; Garg P, 2014, PHYSIOL REP, V2, DOI 10.14814/phy2.12118; Giorgetti L, 2010, MOL CELL, V37, P418, DOI 10.1016/j.molcel.2010.01.016; Hayden MS, 2012, GENE DEV, V26, P203, DOI 10.1101/gad.183434.111; Kaltschmidt B., 2009, COLD SPRING HARB PER, V2, P1, DOI DOI 10.1101/CSHPERSPECT.A001271; KOONG AC, 1994, CANCER RES, V54, P1425; Kye MJ, 2007, MOL CELL BIOCHEM, V300, P9, DOI 10.1007/s11010-006-9320-6; Lang F, 2007, METHOD ENZYMOL, V428, P209, DOI 10.1016/S0076-6879(07)28011-5; Maggirwar SB, 1998, J NEUROSCI, V18, P10356; Maze I, 2010, SCIENCE, V327, P213, DOI 10.1126/science.1179438; Moorthy AK, 2007, J MOL BIOL, V373, P723, DOI 10.1016/j.jmb.2007.08.039; Nuwer MO, 2010, J NEUROSCI, V30, P14165, DOI 10.1523/JNEUROSCI.3150-10.2010; Panet H, 2001, J NEUROCHEM, V77, P391, DOI 10.1046/j.1471-4159.2001.00213.x; Paramar PN, 2006, BIOCHEM J, V394, P173, DOI 10.1042/BJ20051296; Pizzi M, 2002, J BIOL CHEM, V277, P20717, DOI 10.1074/jbc.M201014200; Sarnico I, 2009, J NEUROCHEM, V108, P475, DOI 10.1111/j.1471-4159.2008.05783.x; Shah NH, 2014, J NEUROSCI, V34, P4326, DOI 10.1523/JNEUROSCI.5184-13.2014; Tamsett TJ, 2009, J NEUROSCI, V29, P5127, DOI 10.1523/JNEUROSCI.0859-09.2009; Tejada MA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110833; Wong D, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-7-r70	31	9	9	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 24	2015	290	30					18575	18583		10.1074/jbc.M115.643536	http://dx.doi.org/10.1074/jbc.M115.643536			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CN5ZE	26100633	Green Published, hybrid			2022-12-26	WOS:000358512100028
J	Hao, S; Liu, Y; Yu, KD; Chen, S; Yang, WT; Shao, ZM				Hao, Shuang; Liu, Yin; Yu, Ke-Da; Chen, Sheng; Yang, Wen-Tao; Shao, Zhi-Min			Overweight as a Prognostic Factor for Triple-Negative Breast Cancers in Chinese Women	PLOS ONE			English	Article							BODY-MASS INDEX; ESTROGEN-RECEPTOR; POOLED ANALYSIS; DISEASE-FREE; SURVIVAL; OBESITY; IMPACT; SUBTYPES; WEIGHT	Purpose Obesity is associated with poorer outcomes in patients with hormone receptor-positive breast cancers, but this association is not well established for women with triple-negative breast cancers (TNBC). Here, we investigated the prognostic effects of body mass index (BMI) on clinical outcomes in patients with TNBC. Methods We identified 1106 patients with TNBC who met the inclusion criteria and were treated between January 2002 and June 2012. Clinical and biological features were collected to evaluate the relation between BMI and breast cancer-specific survival (BCSS) and overall survival (OS) after controlling for other clinically significant variables. Results Of 1106 patients, 656 (59.3%) were normal weight (BMI <= 24) and 450 patients (40.7%) were overweight(BMI>24). Median follow-up time was 44.8 months. Breast cancer specific death was observed in 140 patients. After adjusting for clinicopathologic risk factors, overweight was associated with OS (hazard ratio [HR]: 1.46, 95% confidence interval [CI]: 1.04-2.06, P = 0.028) but not BCSS (HR: 1.34, 95% CI: 0.90-2.01, P = 0.15) in all the patients with TNBC. When stratified with menopausal status, overweight was associated with BCSS and OS (HR: 2.27, 95% CI: 1.11-4.63, P = 0.024 and HR: 2.16, 95% CI: 1.21-3.87, P = 0.010, respectively) in premenopausal women. BMI was not associated with BCSS or OS in postmenopausal women. Conclusions Overweight is an independent prognostic factor of OS in all women with TNBC, and menopause status may be a mitigating factor. Among premenopausal women, overweight women are at a greater risk of poor prognosis than normal weight women. If validated, these findings should be considered in developing preventive programs.	[Hao, Shuang; Liu, Yin; Yu, Ke-Da; Chen, Sheng; Shao, Zhi-Min] Fudan Univ, Shanghai Canc Ctr, Dept Breast Surg, Shanghai 200433, Peoples R China; [Hao, Shuang; Liu, Yin; Yu, Ke-Da; Chen, Sheng; Yang, Wen-Tao; Shao, Zhi-Min] Fudan Univ, Dept Oncol, Shanghai Med Coll, Shanghai 200433, Peoples R China; [Yang, Wen-Tao] Fudan Univ, Shanghai Canc Ctr, Dept Pathol, Shanghai 200433, Peoples R China; [Shao, Zhi-Min] Fudan Univ, Inst Biomed Sci, Shanghai 200433, Peoples R China; [Shao, Zhi-Min] Fudan Univ, Shanghai Canc Ctr, Key Lab Breast Canc Shanghai, Dept Breast Surg, Shanghai 200433, Peoples R China	Fudan University; Fudan University; Fudan University; Fudan University; Fudan University	Shao, ZM (corresponding author), Fudan Univ, Shanghai Canc Ctr, Dept Breast Surg, Shanghai 200433, Peoples R China.	yukd@shca.org.cn; zhimingshao@yahoo.com			Shanghai Committee of Science and Technology Fund [12DZ2260100]	Shanghai Committee of Science and Technology Fund(Shanghai Science & Technology Committee)	This study was supported by grants from the Shanghai Committee of Science and Technology Fund (12DZ2260100).	Ademuyiwa FO, 2011, CANCER-AM CANCER SOC, V117, P4132, DOI 10.1002/cncr.26019; Ades F, 2014, J CLIN ONCOL, V32, P2794, DOI 10.1200/JCO.2013.54.1870; Berclaz G, 2004, ANN ONCOL, V15, P875, DOI 10.1093/annonc/mdh222; Caan BJ, 2008, CANCER CAUSE CONTROL, V19, P1319, DOI 10.1007/s10552-008-9203-0; Carey LA, 2006, JAMA-J AM MED ASSOC, V295, P2492, DOI 10.1001/jama.295.21.2492; Chen XL, 2010, BREAST CANCER RES TR, V122, P823, DOI 10.1007/s10549-009-0708-3; Datema FR, 2012, HEAD NECK-J SCI SPEC, V34, P50, DOI 10.1002/hed.21698; Dawood S, 2008, CLIN CANCER RES, V14, P1718, DOI 10.1158/1078-0432.CCR-07-1479; Dawood S, 2012, CLIN BREAST CANCER, V12, P364, DOI 10.1016/j.clbc.2012.07.013; de Azambuja E, 2010, BREAST CANCER RES TR, V119, P145, DOI 10.1007/s10549-009-0512-0; Ewertz M, 2011, J CLIN ONCOL, V29, P25, DOI 10.1200/JCO.2010.29.7614; Fontanella C, 2015, BREAST CANCER RES TR, V150, P127, DOI 10.1007/s10549-015-3287-5; Gouvea AP, 2006, APPL IMMUNOHISTO M M, V14, P103, DOI 10.1097/01.pai.0000155794.64525.11; Hammond MEH, 2010, ARCH PATHOL LAB MED, V134, P907, DOI [10.1043/1543-2165-134.6.907, 10.1200/JCO.2009.25.6529, 10.1200/JOP.777003]; Howe LR, 2013, CLIN CANCER RES, V19, P6074, DOI 10.1158/1078-0432.CCR-12-2603; Jacobs TW, 1999, J CLIN ONCOL, V17, P1983, DOI 10.1200/JCO.1999.17.7.1983; Kroenke CH, 2005, J CLIN ONCOL, V23, P1370, DOI 10.1200/JCO.2005.01.079; Ladoire S, 2014, EUR J CANCER, V50, P506, DOI 10.1016/j.ejca.2013.11.013; Majed B, 2008, BREAST CANCER RES TR, V111, P329, DOI 10.1007/s10549-007-9785-3; Mowad R, 2013, J SURG RES, V184, P253, DOI 10.1016/j.jss.2013.05.037; Nelson ER, 2013, SCIENCE, V342, P1094, DOI 10.1126/science.1241908; Pajares B, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3572; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Pierobon M, 2013, BREAST CANCER RES TR, V137, P307, DOI 10.1007/s10549-012-2339-3; Rody A, 2004, ONCOL REP, V12, P695; SHIMADA A, 1985, P NATL ACAD SCI USA, V82, P4803, DOI 10.1073/pnas.82.14.4803; Tait S, 2014, BREAST CANCER RES TR, V146, P189, DOI 10.1007/s10549-014-3002-y; Turkoz FP, 2013, J BUON, V18, P335; Zheng Q, 2013, ENDOCR-RELAT CANCER, V20, P797, DOI 10.1530/ERC-13-0329; Zhou BF, 2002, BIOMED ENVIRON SCI, V15, P83	30	34	35	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2015	10	6							e0129741	10.1371/journal.pone.0129741	http://dx.doi.org/10.1371/journal.pone.0129741			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4OM	26107623	gold, Green Published, Green Submitted			2022-12-26	WOS:000356932500067
J	Mullhaupt, B; Bruggmann, P; Bihl, F; Blach, S; Lavanchy, D; Razavi, H; Semela, D; Negro, F				Muellhaupt, Beat; Bruggmann, Philip; Bihl, Florian; Blach, Sarah; Lavanchy, Daniel; Razavi, Homie; Semela, David; Negro, Francesco			Modeling the Health and Economic Burden of Hepatitis C Virus in Switzerland	PLOS ONE			English	Article							DISEASE BURDEN; UNITED-STATES; INFECTION; MORTALITY; HCV; EPIDEMIOLOGY; CARE; PREVALENCE; OUTCOMES; COHORT	Background Chronic hepatitis C virus infection is a major cause of liver disease in Switzerland and carries a significant cost burden. Currently, only conservative strategies are in place to mitigate the burden of hepatitis C in Switzerland. This study expands on previously described modeling efforts to explore the impact of: no treatment, and treatment to reduce HCC and mortality. Furthermore, the costs associated with untreated HCV were modeled. Methods Hepatitis C disease progression and mortality were modeled. Baseline historical assumptions were collected from the literature and expert interviews and strategies were developed to show the impact of different levels of intervention (improved drug cure rates, treatment and diagnosis) until 2030. Results Under the historical standard of care, the number of advanced stage cases was projected to increase until 2030, at which point the annual economic burden of untreated viremic infections was projected to reach (sic)96.8 (95% Uncertainty Interval: (sic)36-(sic)232) million. Scenarios to reduce HCV liver-related mortality by 90% by 2030 required treatment of 4,190 >= F2 or 3,200 >= F3 patients annually by 2018 using antivirals with a 95% efficacy rate. Delaying the implementation of these scenarios by 2 or 5 years reduced the impact on mortality to 75% and 57%, respectively. Conclusions With today's treatment efficacy and uptake rates, hepatitis C disease burden is expected to increase through 2030. A substantial reduction in disease burden can be achieved by means of both higher efficacy drugs and increased treatment uptake. However, these efforts cannot be undertaken without a simultaneous effort to diagnose more infections.	[Muellhaupt, Beat] Univ Zurich Hosp, Swiss HPB Hepato Pancreato Biliary Ctr, CH-8091 Zurich, Switzerland; [Muellhaupt, Beat] Univ Zurich Hosp, Dept Gastroenterol & Hepatol, CH-8091 Zurich, Switzerland; [Bruggmann, Philip] Arud Ctr Addict Med, Zurich, Switzerland; [Bihl, Florian] Osped Cantonale, Dept Gastroenterol, Bellinzona, Switzerland; [Blach, Sarah; Razavi, Homie] CDA, Louisville, CO USA; [Semela, David] Cantonal Hosp St Gallen, Div Gastroenterol & Hepatol, St Gallen, Switzerland; [Negro, Francesco] Univ Hosp, Div Gastroenterol & Hepatol, Geneva, Switzerland; [Negro, Francesco] Univ Hosp, Div Clin Pathol, Geneva, Switzerland	University of Zurich; University Zurich Hospital; University of Zurich; University Zurich Hospital; Kantonsspital St. Gallen; University of Geneva; University of Geneva	Mullhaupt, B (corresponding author), Univ Zurich Hosp, Swiss HPB Hepato Pancreato Biliary Ctr, CH-8091 Zurich, Switzerland.	beat.muellhaupt@usz.ch	Blach, Sarah/J-5833-2019; Semela, David/D-1988-2010; Negro, Francesco/E-2183-2012; Mullhaupt, Beat/O-3744-2016	Blach, Sarah/0000-0002-9252-7576; Razavi, Homie/0000-0002-2658-6930; Mullhaupt, Beat/0000-0002-9020-8192	Gilead Sciences	Gilead Sciences(Gilead Sciences)	This project was supported by Gilead Sciences. Gilead Sciences had no input on the content, the study design, data selection, decision to publish, or preparation of the manuscript.	Aleman S, 2013, CLIN INFECT DIS, V57, P230, DOI 10.1093/cid/cit234; [Anonymous], 2011, WORLD POP PROSP 2010; Armstrong GL, 2000, HEPATOLOGY, V31, P777, DOI 10.1002/hep.510310332; Armstrong GL, 2006, ANN INTERN MED, V144, P705, DOI 10.7326/0003-4819-144-10-200605160-00004; Aronsohn A, 2014, HEPATOLOGY, V59, P13, DOI 10.1002/hep.26590; Arora S, 2011, NEW ENGL J MED, V364, P2199, DOI 10.1056/NEJMoa1009370; Ashley D L, 2008, World Health Organ Tech Rep Ser, P1; Bruggmann P, 2014, J VIRAL HEPATITIS, V21, P5, DOI 10.1111/jvh.12247; Cornberg M, 2011, LIVER INT, V31, P30, DOI 10.1111/j.1478-3231.2011.02539.x; Degenhardt L, 2006, SEX TRANSM INFECT, V82, pIII56, DOI 10.1136/sti.2005.019273; Dubois-Arber F, 2008, EURO SURVEILL, V13; Edlin BR, 2011, NATURE, V474, pS18, DOI 10.1038/474S18a; Evon DM, 2007, DIGEST DIS SCI, V52, P3251, DOI 10.1007/s10620-006-9669-0; Fretz R, 2013, SWISS MED WKLY, V143, DOI 10.4414/smw.2013.13793; Hanafiah KM, 2013, HEPATOLOGY, V57, P1333, DOI 10.1002/hep.26141; Hickman M, 2009, J PUBLIC HEALTH-UK, V31, P374, DOI 10.1093/pubmed/fdp067; IMS Health, 2013, IMS HLTH MIDAS DAT; Lavanchy D, 2011, CLIN MICROBIOL INFEC, V17, P107, DOI 10.1111/j.1469-0691.2010.03432.x; Ly KN, 2012, ANN INTERN MED, V156, P271, DOI 10.7326/0003-4819-156-4-201202210-00004; Mathers BM, 2013, B WORLD HEALTH ORGAN, V91, P102, DOI 10.2471/BLT.12.108282; Mdege ND, 2013, HEALTH POLICY PLANN, V28, P223, DOI 10.1093/heapol/czs058; Morrill JA, 2005, J GEN INTERN MED, V20, P754, DOI 10.1111/j.1525-1497.2005.0161.x; Nordt C, 2010, DRUG ALCOHOL REV, V29, P540, DOI 10.1111/j.1465-3362.2009.00167.x; Poynard T, 2002, GASTROENTEROLOGY, V122, P1303, DOI 10.1053/gast.2002.33023; Prasad L, 2007, INT J EPIDEMIOL, V36, P731, DOI 10.1093/ije/dym096; Razavi H, 2014, J VIRAL HEPATITIS, V21, P34, DOI 10.1111/jvh.12248; Razavi H, 2013, HEPATOLOGY, V57, P2164, DOI 10.1002/hep.26218; Sagmeister M, 2002, EUR J GASTROEN HEPAT, V14, P25, DOI 10.1097/00042737-200201000-00006; Smith Bryce D., 2012, Morbidity and Mortality Weekly Report, V61, P1; Swiss Federal Office of Public Health, 2013, NUMB HEP C CAS REP S; Swiss Federal Office of Public Health, 2013, NUMB AC CAS HEP C SW; Swiss Federal Statistics Office, 2011, PERM FOR RES POP NAT; Swiss Federal Statistics Office, 2013, FAT I DIV GEND NAT M; The Swiss Hepatitis C Cohort Study, 2014, STUD POP SOM SAL FEA; University of California B Max Planck Institute for Demographic Research, 2013, HUM MORT DAT; Wong JB, 2000, AM J PUBLIC HEALTH, V90, P1562, DOI 10.2105/AJPH.90.10.1562; World Health Organization-Department of Immunization VaB, 2006, WHOIVB0601 DEP IMM V	37	23	24	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2015	10	6							e0125214	10.1371/journal.pone.0125214	http://dx.doi.org/10.1371/journal.pone.0125214			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CL4OM	26107467	Green Published, Green Accepted, Green Submitted, gold			2022-12-26	WOS:000356932500006
J	Smith, RL; Grohn, YT				Smith, Rebecca Lee; Groehn, Yrjoe Tapio			Use of Approximate Bayesian Computation to Assess and Fit Models of Mycobacterium leprae to Predict Outcomes of the Brazilian Control Program	PLOS ONE			English	Article							LEPROSY; SELECTION; SYSTEMS; TRANSMISSION; STATISTICS	Hansen's disease (leprosy) elimination has proven difficult in several countries, including Brazil, and there is a need for a mathematical model that can predict control program efficacy. This study applied the Approximate Bayesian Computation algorithm to fit 6 different proposed models to each of the 5 regions of Brazil, then fitted hierarchical models based on the best-fit regional models to the entire country. The best model proposed for most regions was a simple model. Posterior checks found that the model results were more similar to the observed incidence after fitting than before, and that parameters varied slightly by region. Current control programs were predicted to require additional measures to eliminate Hansen's Disease as a public health problem in Brazil.	[Smith, Rebecca Lee] Univ Illinois, Coll Vet Med, Dept Pathobiol, Urbana, IL 61801 USA; [Groehn, Yrjoe Tapio] Cornell Univ, Coll Vet Med, Dept Populat Med & Diagnost Sci, Ithaca, NY 14853 USA	University of Illinois System; University of Illinois Urbana-Champaign; Cornell University	Smith, RL (corresponding author), Univ Illinois, Coll Vet Med, Dept Pathobiol, Urbana, IL 61801 USA.	rlsdvm@illinois.edu			Office of Research Infrastructure Programs (ORIP) of the National Institutes of Health [8K01OD010968-03]; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [K01OD010968] Funding Source: NIH RePORTER	Office of Research Infrastructure Programs (ORIP) of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This project was supported by the Office of Research Infrastructure Programs (ORIP) of the National Institutes of Health through Grant Number 8K01OD010968-03. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnes CP, 2012, STAT COMPUT, V22, P1181, DOI 10.1007/s11222-012-9335-7; Beaumont MA, 2002, GENETICS, V162, P2025; Bennett BH, 2008, PUBLIC HEALTH REP, V123, P198, DOI 10.1177/003335490812300212; Blok DJ, 2015, ADV PARASIT, V87, P33, DOI 10.1016/bs.apar.2014.12.002; Brooks-Pollock E, 2014, NATURE, V511, P228, DOI 10.1038/nature13529; Chiyaka E.T., 2013, SCI RES, V4, P387, DOI [10.4236/am.2013.42059, DOI 10.4236/AM.2013.42059]; Conlan AJK, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002730; Dhlamini M, 2012, UNDERSTANDING DYNAMI, V37, P01; Penna MLF, 2009, LEPROSY REV, V80, P332; Gillis TP., 2010, LEPROSY REV, V78, P338; Goulart L, 2009, ARCH DERMATOL RES, V301, P123, DOI 10.1007/s00403-008-0917-3; LECHAT MF, 1974, B WORLD HEALTH ORGAN, V51, P361; Liepe J, 2014, NAT PROTOC, V9, P439, DOI 10.1038/nprot.2014.025; Lu Z, 2013, BMC VET RES, V9, DOI 10.1186/1746-6148-9-245; McKinley T, 2009, INT J BIOSTAT, V5, DOI 10.2202/1557-4679.1171; Meima A, 2002, INT J EPIDEMIOL, V31, P991, DOI 10.1093/ije/31.5.991; Meima A, 1999, INT J LEPROSY, V67, P215; Misra R, 1993, LEPROSY REFERENCE GU; Mushayabasa S, 2012, MATH SCI, V6, DOI 10.1186/2251-7456-6-12; Nery JS, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003357; Queiroz JW, 2010, AM J TROP MED HYG, V82, P306, DOI 10.4269/ajtmh.2010.08-0675; Robert CP, 2011, P NATL ACAD SCI USA, V108, P15112, DOI 10.1073/pnas.1102900108; Saunderson PR, 2008, PUBLIC HEALTH REP, V123, P213, DOI 10.1177/003335490812300214; Toni T, 2010, BIOINFORMATICS, V26, P104, DOI 10.1093/bioinformatics/btp619; Toni T, 2009, J R SOC INTERFACE, V6, P187, DOI 10.1098/rsif.2008.0172; WHO, 2000, EL LEPR PUBL HLTH PR; World Health Organization, 2010, Weekly Epidemiological Record, V85, P46	27	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2015	10	6							e0129535	10.1371/journal.pone.0129535	http://dx.doi.org/10.1371/journal.pone.0129535			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4OM	26107951	Green Published, Green Submitted, gold			2022-12-26	WOS:000356932500061
J	Tahtinen, S; Kaikkonen, S; Merisalo-Soikkeli, M; Gronberg-Vaha-Koskela, S; Kanerva, A; Parviainen, S; Vaha-Koskela, M; Hemminki, A				Tahtinen, Siri; Kaikkonen, Saija; Merisalo-Soikkeli, Maiju; Gronberg-Vaha-Koskela, Susanna; Kanerva, Anna; Parviainen, Suvi; Vaha-Koskela, Markus; Hemminki, Akseli			Favorable Alteration of Tumor Microenvironment by Immunomodulatory Cytokines for Efficient T-Cell Therapy in Solid Tumors	PLOS ONE			English	Article							COLONY-STIMULATING FACTOR; DENDRITIC CELLS; IN-VIVO; MELANOMA; CANCER; IMMUNOTHERAPY; ANTIGEN; IL-2; PROGRESSION; RESPONSES	Unfavorable ratios between the number and activation status of effector and suppressor immune cells infiltrating the tumor contribute to resistance of solid tumors to T-cell based therapies. Here, we studied the capacity of FDA and EMA approved recombinant cytokines to manipulate this balance in favor of efficient anti-tumor responses in B16. OVA melanoma bearing C57BL/6 mice. Intratumoral administration of IFN-alpha 2, IFN-gamma, TNF-alpha, and IL-2 significantly enhanced the anti-tumor effect of ovalbumin-specific CD8+ T-cell (OT-I) therapy, whereas GM-CSF increased tumor growth in association with an increase in immunosuppressive cell populations. None of the cytokines augmented tumor trafficking of OT-I cells significantly, but injections of IFN-alpha 2, IFN-gamma and IL-2 increased intratumoral cytokine secretion and recruitment of endogenous immune cells capable of stimulating T-cells, such as natural killer and maturated CD11c+ antigen-presenting cells. Moreover, IFN-alpha 2 and IL-2 increased the levels of activated tumor-infiltrating CD8+ T-cells concomitant with reduction in the CD8+ T-cell expression of anergy markers CTLA-4 and PD-1. In conclusion, intratumoral administration of IFN-alpha 2, IFN-gamma and IL-2 can lead to immune sensitization of the established tumor, whereas GM-CSF may contribute to tumor-associated immunosuppression. The results described here provide rationale for including local administration of immunostimulatory cytokines into T-cell therapy regimens. One appealing embodiment of this would be vectored delivery which could be advantageous over direct injection of recombinant molecules with regard to efficacy, cost, persistence and convenience.	[Tahtinen, Siri; Kaikkonen, Saija; Merisalo-Soikkeli, Maiju; Gronberg-Vaha-Koskela, Susanna; Kanerva, Anna; Parviainen, Suvi; Vaha-Koskela, Markus; Hemminki, Akseli] Univ Helsinki, Haartman Inst, Canc Gene Therapy Grp, Dept Pathol, Helsinki, Finland; [Tahtinen, Siri; Kaikkonen, Saija; Merisalo-Soikkeli, Maiju; Gronberg-Vaha-Koskela, Susanna; Kanerva, Anna; Parviainen, Suvi; Vaha-Koskela, Markus; Hemminki, Akseli] Univ Helsinki, Haartman Inst, Canc Gene Therapy Grp, Transplantat Lab, Helsinki, Finland; [Kanerva, Anna] Univ Helsinki, Cent Hosp, Dept Obstet & Gynecol, FIN-00290 Helsinki, Finland; [Parviainen, Suvi; Hemminki, Akseli] TILT Biotherapeut Ltd, Helsinki, Finland; [Hemminki, Akseli] Univ Helsinki, Cent Hosp, Dept Oncol, Helsinki, Finland	University of Helsinki; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; Helsinki University Central Hospital	Hemminki, A (corresponding author), Univ Helsinki, Haartman Inst, Canc Gene Therapy Grp, Dept Pathol, Helsinki, Finland.	akseli.hemminki@helsinki.fi		Vaha-Koskela, Markus/0000-0001-7764-7820	TILT Biotherapeutics Ltd; Biocentrum Helsinki; Biocenter Finland; European Research Council; Finnish Cultural Foundation; Jane and Aatos Erkko Foundation; American Society of Clinical Oncology Foundation; Helsinki University Central Hospital Research Funds (EVO); Sigrid Juselius Foundation; Academy of Finland; Emil Aaltonen Foundation; Finnish Konkordia Fund; K. Albin Stiftelse; University of Helsinki Funds; Finnish Cancer Organizations	TILT Biotherapeutics Ltd; Biocentrum Helsinki; Biocenter Finland; European Research Council(European Research Council (ERC)European Commission); Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science); Jane and Aatos Erkko Foundation; American Society of Clinical Oncology Foundation; Helsinki University Central Hospital Research Funds (EVO); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Academy of Finland(Academy of Finland); Emil Aaltonen Foundation; Finnish Konkordia Fund(Finnish IT center for science); K. Albin Stiftelse; University of Helsinki Funds; Finnish Cancer Organizations	The study has been supported by TILT Biotherapeutics Ltd, Biocentrum Helsinki, Biocenter Finland, European Research Council, Finnish Cultural Foundation, Jane and Aatos Erkko Foundation, American Society of Clinical Oncology Foundation, Helsinki University Central Hospital Research Funds (EVO), Sigrid Juselius Foundation, Academy of Finland, Emil Aaltonen Foundation, Finnish Konkordia Fund, K. Albin Stiftelse, The University of Helsinki Funds and Finnish Cancer Organizations. The funder provided support in the form of salaries for authors AH and SP, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Ahmadzadeh M, 2006, BLOOD, V107, P2409, DOI 10.1182/blood-2005-06-2399; Biron CA, 2001, IMMUNITY, V14, P661, DOI 10.1016/S1074-7613(01)00154-6; Bronte V, 1999, J IMMUNOL, V162, P5728; Burkholder B, 2014, BBA-REV CANCER, V1845, P182, DOI 10.1016/j.bbcan.2014.01.004; Cerullo V, 2012, ADV CANCER RES, V115, P265, DOI 10.1016/B978-0-12-398342-8.00008-2; Cerullo V, 2010, CANCER RES, V70, P4297, DOI 10.1158/0008-5472.CAN-09-3567; Demaria S, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00128; Dietlin TA, 2007, J LEUKOCYTE BIOL, V81, P1205, DOI 10.1189/jlb.1006640; Dillman RO, 2012, CANCER BIOTHER RADIO, V27, P337, DOI 10.1089/cbr.2012.1220; Domschke C, 2009, CANCER RES, V69, P8420, DOI 10.1158/0008-5472.CAN-09-1627; Dranoff G, 2003, ONCOGENE, V22, P3188, DOI 10.1038/sj.onc.1206459; Dudley ME, 2008, J CLIN ONCOL, V26, P5233, DOI 10.1200/JCO.2008.16.5449; Dudley ME, 2005, J CLIN ONCOL, V23, P2346, DOI 10.1200/JCO.2005.00.240; FIDLER IJ, 1976, CANCER RES, V36, P3160; Gajewski TF, 2013, NAT IMMUNOL, V14, P1014, DOI 10.1038/ni.2703; Galluzzi L, 2012, NAT REV DRUG DISCOV, V11, P215, DOI 10.1038/nrd3626; Garrido F, 1997, IMMUNOL TODAY, V18, P89, DOI 10.1016/S0167-5699(96)10075-X; Geynisman DM, 2013, J IMMUNOTHER CANCER, V1, DOI 10.1186/2051-1426-1-8; Gilham DE, 2012, TRENDS MOL MED, V18, P377, DOI 10.1016/j.molmed.2012.04.009; Henry CJ, 2008, J IMMUNOL, V181, P8576, DOI 10.4049/jimmunol.181.12.8576; Hu JCC, 2006, CLIN CANCER RES, V12, P6737, DOI 10.1158/1078-0432.CCR-06-0759; Jackaman C, 2003, J IMMUNOL, V171, P5051, DOI 10.4049/jimmunol.171.10.5051; Kalos M, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002842; Kaluza KM, 2012, INT J CANCER, V131, P844, DOI 10.1002/ijc.26447; KARRE K, 1986, NATURE, V319, P675, DOI 10.1038/319675a0; Klebanoff CA, 2005, P NATL ACAD SCI USA, V102, P9571, DOI 10.1073/pnas.0503726102; Kohn DB, 2011, MOL THER, V19, P432, DOI 10.1038/mt.2011.1; Kunert A, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00363; Lee Sylvia, 2011, Cancers (Basel), V3, P3856, DOI 10.3390/cancers3043856; Lenschow DJ, 1996, ANNU REV IMMUNOL, V14, P233, DOI 10.1146/annurev.immunol.14.1.233; Levin AM, 2012, NATURE, V484, P529, DOI 10.1038/nature10975; Linardakis E, 2002, CANCER RES, V62, P5495; LOTZE MT, 1981, CANCER RES, V41, P4420; Mapara MY, 2004, J CLIN ONCOL, V22, P1136, DOI 10.1200/JCO.2004.10.041; Maude SL, 2014, NEW ENGL J MED, V371, P1507, DOI 10.1056/NEJMoa1407222; Metcalf D, 2010, NAT REV CANCER, V10, P425, DOI 10.1038/nrc2843; Mocikat R, 2003, IMMUNITY, V19, P561, DOI 10.1016/S1074-7613(03)00264-4; Moon EK, 2014, CLIN CANCER RES, V20, P4262, DOI 10.1158/1078-0432.CCR-13-2627; Obermueller E, 2004, CANCER RES, V64, P7801, DOI 10.1158/0008-5472.CAN-03-3301; Ott PA, 2013, CLIN CANCER RES, V19, P5300, DOI 10.1158/1078-0432.CCR-13-0143; Peter I, 2002, CANCER GENE THER, V9, P597, DOI 10.1038/sj.cgt.7700475; Petersen CC, 2006, J IMMUNOTHER, V29, P241, DOI 10.1097/01.cji.0000203078.97493.c3; Pozzi LAM, 2005, J IMMUNOL, V175, P2071, DOI 10.4049/jimmunol.175.4.2071; Quail DF, 2013, NAT MED, V19, P1423, DOI 10.1038/nm.3394; Reissfelder C, 2015, J CLIN INVEST, V125, P739, DOI 10.1172/JCI74894; Rosenberg SA, 2014, J IMMUNOL, V192, P5451, DOI 10.4049/jimmunol.1490019; Rosenberg SA, 2011, CLIN CANCER RES, V17, P4550, DOI 10.1158/1078-0432.CCR-11-0116; Sica A, 2012, J CLIN INVEST, V122, P787, DOI 10.1172/JCI59643; Spear P, 2013, ONCOIMMUNOLOGY, V2, DOI 10.4161/onci.23564; Spitler LE, 2000, J CLIN ONCOL, V18, P1614, DOI 10.1200/JCO.2000.18.8.1614; Tartour E, 1998, J NATL CANCER I, V90, P287, DOI 10.1093/jnci/90.4.287; Vacchelli E, 2013, ONCOIMMUNOLOGY, V2, DOI 10.4161/onci.24850; Vacchelli E, 2012, ONCOIMMUNOLOGY, V1, DOI 10.4161/onci.20459; van Horssen R, 2006, ONCOLOGIST, V11, P397, DOI 10.1634/theoncologist.11-4-397; Vignard V, 2005, J IMMUNOL, V175, P4797, DOI 10.4049/jimmunol.175.7.4797; Wang L, 2013, J IMMUNOL, V190, P794, DOI 10.4049/jimmunol.1202088; Zhang QW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050946	57	33	36	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2015	10	6							e0131242	10.1371/journal.pone.0131242	http://dx.doi.org/10.1371/journal.pone.0131242			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4OM	26107883	gold, Green Published, Green Submitted			2022-12-26	WOS:000356932500150
J	Xing, LL; Yu, H; Qi, JJ; Jiang, P; Sun, BQ; Cui, JS; Ou, CC; Chang, WS; Hu, QH				Xing, Linlin; Yu, Hui; Qi, Jingjing; Jiang, Pan; Sun, Bingqing; Cui, Junsheng; Ou, Changcan; Chang, Weishan; Hu, Qinghai			ErmF and ereD Are Responsible for Erythromycin Resistance in Riemerella anatipestifer	PLOS ONE			English	Article							BACTEROIDES CONJUGATIVE TRANSPOSON; STAPHYLOCOCCUS-AUREUS; NUCLEOTIDE-SEQUENCE; MACROLIDE; GENE; ANTIBIOTICS; LINCOSAMIDE; FRAGILIS; ELEMENTS; MSR(A)	To investigate the genetic basis of erythromycin resistance in Riemerella anatipestifer, the MIC to erythromycin of 79 R. anatipestifer isolates from China and one typed strain, ATCC11845, were evaluated. The results showed that 43 of 80 (53.8%) of the tested R. anatipestifer strains showed resistance to erythromycin, and 30 of 43 erythromycin-resistant R. anatipestifer strains carried ermF or ermFU with an MIC in the range of 32-2048 mu g/ml, while the other 13 strains carrying the ereD gene exhibited an MIC of 4-16 mu g/ml. Of 30 ermF + R. anatipestifer strains, 27 (90.0%) carried the ermFU gene which may have been derived from the CTnDOT-like element, while three other strains carried ermF from transposon Tn4351. Moreover, sequence analysis revealed that ermF, ermFU, and ereD were located within the multiresistance region of the R. anatipestifer genome.	[Xing, Linlin; Yu, Hui; Qi, Jingjing; Jiang, Pan; Sun, Bingqing; Cui, Junsheng; Ou, Changcan; Hu, Qinghai] Chinese Acad Agr Sci, Shanghai Vet Res Inst, Shanghai 200241, Peoples R China; [Xing, Linlin; Chang, Weishan] Shandong Agr Univ, Coll Anim Sci & Vet Med, Tai An 271018, Shandong, Peoples R China	Chinese Academy of Agricultural Sciences; Shanghai Veterinary Research Institute, CAAS; Shandong Agricultural University	Chang, WS (corresponding author), Shandong Agr Univ, Coll Anim Sci & Vet Med, 61 Daizong Rd, Tai An 271018, Shandong, Peoples R China.	wschang@sdau.edu.cn; huqinghai@caas.cn			National Natural Science Foundation of China [31072156, 31272590, 31472224]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (31072156, 31272590 and 31472224). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aktas Z, 2007, J MICROBIOL, V45, P286; [Anonymous], 2013, DIS POULTRY; Chen YP, 2012, VET MICROBIOL, V154, P325, DOI 10.1016/j.vetmic.2011.07.012; Chen YP, 2010, AVIAN PATHOL, V39, P333, DOI 10.1080/03079457.2010.507761; Chung WSO, 1999, J ANTIMICROB CHEMOTH, V43, P5, DOI 10.1093/jac/43.1.5; Clinical and Laboratory Standards Institute, 2012, M100S22 CLSI; DUBNAU D, 1984, CRC CR REV BIOCH MOL, V16, P103, DOI 10.3109/10409238409102300; Gupta A, 2003, APPL ENVIRON MICROB, V69, P6455, DOI 10.1128/AEM.69.11.6455-6463.2003; HALULA M, 1990, REV INFECT DIS, V12, pS235; Hu QH, 2013, J MICROBIOL METH, V95, P262, DOI 10.1016/j.mimet.2013.09.011; Hu QH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039805; Hu QH, 2011, VET MICROBIOL, V150, P278, DOI 10.1016/j.vetmic.2011.01.022; Hu QingHai, 1997, Chinese Journal of Veterinary Science and Technology, V27, P22; Leclercq R, 2002, CLIN INFECT DIS, V34, P482, DOI 10.1086/324626; Matsuoka M, 2003, FEMS MICROBIOL LETT, V220, P287, DOI 10.1016/S0378-1097(03)00134-4; Morar M, 2012, BIOCHEMISTRY-US, V51, P1740, DOI 10.1021/bi201790u; Piatkowska E, 2012, CELL MOL BIOL LETT, V17, P633, DOI 10.2478/s11658-012-0034-3; RASMUSSEN JL, 1986, J BACTERIOL, V168, P523, DOI 10.1128/jb.168.2.523-533.1986; Reynolds E, 2003, INT J ANTIMICROB AG, V22, P228, DOI 10.1016/S0924-8579(03)00218-8; SALYERS AA, 1992, EUR J CLIN MICROBIOL, V11, P1032, DOI 10.1007/BF01967795; SEGERS P, 1993, INT J SYST BACTERIOL, V43, P768, DOI 10.1099/00207713-43-4-768; SMITH CJ, 1987, J BACTERIOL, V169, P4589, DOI 10.1128/jb.169.10.4589-4596.1987; Subramaniam S, 1997, INT J SYST BACTERIOL, V47, P562, DOI 10.1099/00207713-47-2-562; Whittle G, 2001, APPL ENVIRON MICROB, V67, P3488, DOI 10.1128/AEM.67.8.3488-3495.2001	24	27	32	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2015	10	6							e0131078	10.1371/journal.pone.0131078	http://dx.doi.org/10.1371/journal.pone.0131078			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4OM	26107936	gold, Green Published, Green Submitted			2022-12-26	WOS:000356932500140
J	Zhang, QH; Li, AM; He, SL; Yao, XD; Zhu, J; Zhang, ZW; Sheng, ZY; Yao, YM				Zhang, Qing-Hong; Li, An-Min; He, Sai-Lin; Yao, Xu-Dong; Zhu, Jing; Zhang, Zhi-Wen; Sheng, Zhi-Yong; Yao, Yong-Ming			Serum Total Cholinesterase Activity on Admission Is Associated with Disease Severity and Outcome in Patients with Traumatic Brain Injury	PLOS ONE			English	Article							DISABILITY RATING-SCALE; SEVERE HEAD-INJURY; CLASSIFICATION-SYSTEM; CHOLINERGIC SYSTEM; STROKE PATIENTS; ORGAN FAILURE; MORTALITY; ACETYLCHOLINE; INFLAMMATION; RECOVERY	Background Traumatic brain injury (TBI) is one of the leading causes of neurological disability. In this retrospective study, serum total cholinesterase (ChE) activities were analyzed in 188 patients for diagnostic as well as predictive values for mortality. Methods and Findings Within 72 hours after injury, serum ChE activities including both acetylcholinesterase and butyrylcholinesterase were measured. Disease severity was evaluated with Acute Physiology and Chronic Health Evaluation (APACHE) II score, Glasgow Coma Score, length of coma, post-traumatic amnesia and injury feature. Neurocognitive and functional scores were assessed using clinical records. Of 188 patients, 146 (77.7%) survived and 42 (22.3%) died within 90 days. Lower ChE activities were noted in the non-survivors vs. survivors (5.94 +/- 2.19 vs. 7.04 +/- 2.16 kU/L, p= 0.023), in septic vs. non-infected patients (5.93 +/- 1.89 vs. 7.31 +/- 2.45 kU/L, p=0.0005) and in patients with extremely severe injury vs. mild injury (6.3 +/- 1.98 vs. 7.57 +/- 2.48 kU/L, p=0.049). The trajectories of serum ChE levels were also different between non-survivors and survivors, septic and non-infected patients, mild and severely injured patients, respectively. Admission ChE activities were closely correlated with blood cell counts, neurocognitive and functional scores both on admission and at discharge. Receiver operating characteristic analysis showed that the area under the curve for ChE was inferior to that for either APACHE II or white blood cell (WBC) count. However, at the optimal cutoff value of 5 kU/L, the sensitivity of ChE for correct prediction of 90-day mortality was 65.5% and the specificity was 86.4%. Kaplan-Meier analysis showed that lower ChE activity (<5 kU/L) was more closely correlated with poor survival than higher ChE activity (>5 kU/L) (p=0.04). After adjusting for other variables, ChE was identified as a borderline independent predictor for mortality as analyzed by Binary logistic regression (P=0.078).	[Zhang, Qing-Hong; Sheng, Zhi-Yong; Yao, Yong-Ming] Chinese Peoples Liberat Army Gen Hosp, Key Res Lab Tissue Repair & Regenerat PLA, Hosp 1, Beijing 100048, Peoples R China; [Zhang, Qing-Hong; Sheng, Zhi-Yong; Yao, Yong-Ming] Chinese Peoples Liberat Army Gen Hosp, Beijing Key Res Lab Skin Injury Repair & Regenera, Hosp 1, Beijing 100048, Peoples R China; [Li, An-Min] Hainan Branch Chinese PLA Gen Hosp, Dept Neurosurg, Sanya 572013, Hainan, Peoples R China; [He, Sai-Lin; Zhang, Zhi-Wen] Chinese Peoples Liberat Army Gen Hosp, Dept Neurosurg, Hosp 1, Beijing 100048, Peoples R China; [Yao, Xu-Dong] Wenzhou Med Univ, Dept Emergency, Hosp 1, Wenzhou 325000, Peoples R China; [Zhu, Jing] Chinese Peoples Liberat Army Gen Hosp, Dept Lab Med, Hosp 1, Beijing 100048, Peoples R China	Chinese People's Liberation Army General Hospital; Chinese People's Liberation Army General Hospital; Chinese People's Liberation Army General Hospital; Wenzhou Medical University; Chinese People's Liberation Army General Hospital	Zhang, QH (corresponding author), Chinese Peoples Liberat Army Gen Hosp, Key Res Lab Tissue Repair & Regenerat PLA, Hosp 1, Beijing 100048, Peoples R China.	z_qinghong@aliyun.com; c_ff@sina.com			National Natural Science Foundation [81272089, 81130035, 81372054, 81121004]; National Basic Research Program of China [2012CB518102]; Twelve-Five Plan for Military Scientific Foundation [BWS12J050]	National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); Twelve-Five Plan for Military Scientific Foundation	This study was supported by National Natural Science Foundation (81272089, 81130035, 81372054, 81121004) for QHZ and YMY in the collection and analysis of data, the National Basic Research Program of China (2012CB518102) for YMY in the writing of the manuscript and decision to submit the manuscript, and Twelve-Five Plan for Military Scientific Foundation (BWS12J050) for QHZ in the design and in the collection of data.	Adabag AS, 2008, AM J CARDIOL, V101, P1437, DOI 10.1016/j.amjcard.2008.01.021; Adamczak S, 2012, J NEUROSURG, V117, P1119, DOI 10.3171/2012.9.JNS12815; Andrews PJD, 2002, J NEUROSURG, V97, P326, DOI 10.3171/jns.2002.97.2.0326; Ballard C, 2011, LANCET, V377, P1019, DOI 10.1016/S0140-6736(10)61349-9; Ben Assayag E, 2010, MOL MED, V16, P278, DOI 10.2119/molmed.2010.00015; BONE RC, 1992, CHEST, V101, P1644, DOI 10.1378/chest.101.6.1644; Borovikova LV, 2000, NATURE, V405, P458, DOI 10.1038/35013070; Catania A, 2009, BRAIN BEHAV IMMUN, V23, P877, DOI 10.1016/j.bbi.2009.04.006; Chamorro A, 2007, STROKE, V38, P1097, DOI 10.1161/01.STR.0000258346.68966.9d; Chrousos GP, 2009, NAT REV ENDOCRINOL, V5, P374, DOI 10.1038/nrendo.2009.106; Cole CR, 1999, NEW ENGL J MED, V341, P1351, DOI 10.1056/NEJM199910283411804; Cunningham C, 2013, BRAIN BEHAV IMMUN, V28, P1, DOI 10.1016/j.bbi.2012.07.012; Da Silva AS, 2011, EXP PARASITOL, V127, P475, DOI 10.1016/j.exppara.2010.10.017; da Silva CB, 2012, J MED MICROBIOL, V61, P278, DOI 10.1099/jmm.0.035501-0; De Filippis S, 2008, J HEADACHE PAIN, V9, P349, DOI 10.1007/s10194-008-0072-4; Field RH, 2012, J NEUROSCI, V32, P6288, DOI 10.1523/JNEUROSCI.4673-11.2012; Gilboa-Geffen A, 2012, FRONT MOL NEUROSCI, V5, DOI 10.3389/fnmol.2012.00030; Hammond FM, 2001, J HEAD TRAUMA REHAB, V16, P318, DOI 10.1097/00001199-200108000-00003; Hanks RA, 2008, ARCH PHYS MED REHAB, V89, P950, DOI 10.1016/j.apmr.2008.01.011; Hopkins RO, 2006, CHEST, V130, P869, DOI 10.1378/chest.130.3.869; Hu T, 2009, J NEUROIMMUNOL, V211, P84, DOI 10.1016/j.jneuroim.2009.04.002; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; JENNETT B, 1975, LANCET, V1, P480; Kang J, 2014, J STROKE, V16, P36, DOI 10.5853/jos.2014.16.1.36; Kaufer D, 1998, NATURE, V393, P373, DOI 10.1038/30741; Kawashima K, 2000, PHARMACOL THERAPEUT, V86, P29, DOI 10.1016/S0163-7258(99)00071-6; KAWASHIMA K, 1980, J PHARMACOL METHOD, V3, P115, DOI 10.1016/0160-5402(80)90022-4; Kennedy RE, 2003, PSYCHOSOMATICS, V44, P283, DOI 10.1176/appi.psy.44.4.283; Kiguchi T, 2013, CRIT CARE MED, V41, P1443, DOI 10.1097/CCM.0b013e31827ca960; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Kouloulas EJ, 2013, INT J REHABIL RES, V36, P260, DOI 10.1097/MRR.0b013e32835fd99a; Kox M, 2008, NEUROLOGY, V70, P480, DOI 10.1212/01.wnl.0000279479.69502.3e; Kraus JF, 1996, NEUROL CLIN, V14, P435, DOI 10.1016/S0733-8619(05)70266-8; LEGALL JR, 1993, JAMA-J AM MED ASSOC, V270, P2957, DOI 10.1001/jama.270.24.2957; Levy MM, 2003, CRIT CARE MED, V31, P1250, DOI 10.1097/01.CCM.0000050454.01978.3B; Li DJ, 2011, HYPERTENSION, V57, P298, DOI 10.1161/HYPERTENSIONAHA.110.160077; LOEWENSTEINLICHTENSTEIN Y, 1995, NAT MED, V1, P1082, DOI 10.1038/nm1095-1082; Meisel C, 2005, NAT REV NEUROSCI, V6, P775, DOI 10.1038/nrn1765; Ofek K, 2007, J MOL MED, V85, P1239, DOI 10.1007/s00109-007-0226-x; Ostberg A, 2011, NEUROLOGY, V76, P1046, DOI 10.1212/WNL.0b013e318211c1c4; Padgett DA, 2003, TRENDS IMMUNOL, V24, P444, DOI 10.1016/S1471-4906(03)00173-X; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; PIEK J, 1992, J NEUROSURG, V77, P901, DOI 10.3171/jns.1992.77.6.0901; RAO CJ, 1978, INDIAN J MED RES, V68, P668; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Rosas-Ballina M, 2011, SCIENCE, V334, P98, DOI 10.1126/science.1209985; Schirmer-Mikalsen K, 2007, ACTA ANAESTH SCAND, V51, P1194, DOI 10.1111/j.1399-6576.2007.01372.x; Seong JW, 2014, ANN REHABIL MED-ARM, V38, P13, DOI 10.5535/arm.2014.38.1.13; Shaked I, 2009, IMMUNITY, V31, P965, DOI 10.1016/j.immuni.2009.09.019; Shukla D, 2011, CLIN NEUROL NEUROSUR, V113, P435, DOI 10.1016/j.clineuro.2011.02.013; Sklan EH, 2004, P NATL ACAD SCI USA, V101, P5512, DOI 10.1073/pnas.0307659101; Soreq H, 2001, NAT REV NEUROSCI, V2, P294, DOI 10.1038/35067589; Su CF, 2005, CLIN NEUROPHYSIOL, V116, P1273, DOI 10.1016/j.clinph.2005.01.010; Torrance GW, 1996, MED CARE, V34, P702, DOI 10.1097/00005650-199607000-00004; Valiyaveettil M, 2013, CHEM-BIOL INTERACT, V203, P371, DOI 10.1016/j.cbi.2012.10.022; Valvezan AJ, 2012, FRONT MOL NEUROSCI, V5, DOI 10.3389/fnmol.2012.00001; VANSWIETEN JC, 1988, STROKE, V19, P604, DOI 10.1161/01.STR.19.5.604; Veysey BM, 1998, LAW HUMAN BEHAV, V22, P205, DOI 10.1023/A:1025794104048; Wang H, 2003, NATURE, V421, P384, DOI 10.1038/nature01339; Wolkmer P, 2010, EXP PARASITOL, V125, P251, DOI 10.1016/j.exppara.2010.01.024; Woodcock T, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00018; Zygun DA, 2005, CRIT CARE MED, V33, P654, DOI 10.1097/01.ccm.0000155911.01844.54	62	16	19	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2015	10	6							e0129082	10.1371/journal.pone.0129082	http://dx.doi.org/10.1371/journal.pone.0129082			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CL4OM	26107885	Green Submitted, gold, Green Published			2022-12-26	WOS:000356932500040
J	Eze, IC; Schaffner, E; Foraster, M; Imboden, M; von Eckardstein, A; Gerbase, MW; Rothe, T; Rochat, T; Kunzli, N; Schindler, C; Probst-Hensch, N				Eze, Ikenna C.; Schaffner, Emmanuel; Foraster, Maria; Imboden, Medea; von Eckardstein, Arnold; Gerbase, Margaret W.; Rothe, Thomas; Rochat, Thierry; Kuenzli, Nino; Schindler, Christian; Probst-Hensch, Nicole			Long-Term Exposure to Ambient Air Pollution and Metabolic Syndrome in Adults	PLOS ONE			English	Article							PARTICULATE MATTER; DIESEL-EXHAUST; CARDIOVASCULAR EVENTS; INSULIN-RESISTANCE; DIABETES-MELLITUS; BLOOD-PRESSURE; SWISS COHORT; DIAGNOSIS; RISK; ASSOCIATIONS	Air pollutants (AP) play a role in subclinical inflammation, and are associated with cardiovascular morbidity and mortality. Metabolic syndrome (MetS) is inflammatory and precedes cardiovascular morbidity and type 2 diabetes. Thus, a positive association between AP and MetS may be hypothesized. We explored this association, (taking into account, pathway-specific MetS definitions), and its potential modifiers in Swiss adults. We studied 3769 participants of the Swiss Cohort Study on Air Pollution and Lung and Heart Diseases in Adults, reporting at least four-hour fasting time before venepuncture. AP exposures were 10-year mean residential PM10 (particulate matter <10 mu m in diameter) and NO2 (nitrogen dioxide). Outcomes included MetS defined by World Health Organization (MetS-W), International Diabetes Federation (MetS-I) and Adult Treatment Panel-III (MetS-A) using four-and eight-hour fasting time limits. We also explored associations with individual components of MetS. We applied mixed logistic regression models to explore these associations. The prevalence of MetS-W, MetS-I and MetS-A were 10%, 22% and 18% respectively. Odds of MetS-W, MetS-I and MetS-A increased by 72% (51-102%), 31% (11-54%) and 18% (4-34%) per 10 mu g/m(3) increase in 10-year mean PM10. We observed weaker associations with NO2. Associations were stronger among physically-active, ever-smokers and non-diabetic participants especially with PM10 (p<0.05). Associations remained robust across various sensitivity analyses including ten imputations of missing observations and exclusion of diabetes cases. The observed associations between AP exposure and MetS were sensitive to MetS definitions. Regarding the MetS components, we observed strongest associations with impaired fasting glycemia, and positive but weaker associations with hypertension and waist-circumference-based obesity. Cardio-metabolic effects of AP may be majorly driven by impairment of glucose homeostasis, and to a less-strong extent, visceral adiposity. Well-designed prospective studies are needed to confirm these findings.	[Eze, Ikenna C.; Schaffner, Emmanuel; Foraster, Maria; Imboden, Medea; Kuenzli, Nino; Schindler, Christian; Probst-Hensch, Nicole] Swiss Trop & Publ Hlth Inst, Basel, Switzerland; [Eze, Ikenna C.; Schaffner, Emmanuel; Foraster, Maria; Kuenzli, Nino; Schindler, Christian; Probst-Hensch, Nicole] Univ Basel, Basel, Switzerland; [von Eckardstein, Arnold] Univ Zurich Hosp, Inst Clin Chem, CH-8091 Zurich, Switzerland; [Gerbase, Margaret W.; Rochat, Thierry] Univ Hosp Geneva, Div Pneumol, Geneva, Switzerland; [Rothe, Thomas] Zurcher Hohenklin, Davos, Switzerland	University of Basel; Swiss Tropical & Public Health Institute; University of Basel; University of Zurich; University Zurich Hospital; University of Geneva	Probst-Hensch, N (corresponding author), Swiss Trop & Publ Hlth Inst, Basel, Switzerland.	Nicole.Probst@unibas.ch	Kuenzli, Nino/F-7195-2014; Eze, Ikenna C./AAF-6415-2021	Kuenzli, Nino/0000-0001-8360-080X; Eze, Ikenna C./0000-0001-9748-2162; Foraster, Maria/0000-0003-4450-4123	Swiss National Science Foundation [33CSCO-134276/1, 33CSCO-108796, 3247BO-104283, 3247BO-104288, 3247BO-104284, 3247-065896, 3100-059302, 3200-052720, 3200-042532, 4026-028099, PMPDP3_129021/1, PMPDP3_141671/1]; Federal Office for Environment; Federal Office of Public health; Federal office of Roads and Transport; cantonal government of Aargau; cantonal government of Basel-Stadt; cantonal government of Basel-Land; cantonal government of Geneva; cantonal government of Luzem; cantonal government of Ticino; cantonal government of Zurich; Swiss Lung League; Lung Leagues of Basel-Stadt/Basel-Landschaft, Geneva, Ticino and Zurich	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Federal Office for Environment; Federal Office of Public health; Federal office of Roads and Transport; cantonal government of Aargau; cantonal government of Basel-Stadt; cantonal government of Basel-Land; cantonal government of Geneva; cantonal government of Luzem; cantonal government of Ticino; cantonal government of Zurich; Swiss Lung League; Lung Leagues of Basel-Stadt/Basel-Landschaft, Geneva, Ticino and Zurich	This study was supported by the Swiss National Science Foundation [grants no. 33CSCO-134276/1, 33CSCO-108796, 3247BO-104283, 3247BO-104288, 3247BO-104284, 3247-065896, 3100-059302, 3200-052720, 3200-042532, 4026-028099, PMPDP3_129021/1, PMPDP3_141671/1]; the Federal Office for Environment; the Federal Office of Public health; the Federal office of Roads and Transport; the cantonal governments of Aargau, Basel-Stadt, Basel-Land, Geneva, Luzem, Ticino and Zurich; the Swiss Lung League and the Lung Leagues of Basel-Stadt/Basel-Landschaft, Geneva, Ticino and Zurich. The funders had no role in study design, data collection and analysis, decision to publish, or prepare the manuscript.	Ackermann-Liebrich U, 2005, SOZ PRAVENTIV MED, V50, P245, DOI 10.1007/s00038-005-4075-5; Alberti KGMM, 2005, LANCET, V366, P1059, DOI 10.1016/S0140-6736(05)67402-8; Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; Andersen ZJ, 2012, DIABETES CARE, V35, P92, DOI 10.2337/dc11-1155; Babisch W, 2014, ENVIRON HEALTH PERSP, V122, P492, DOI 10.1289/ehp.1306981; Badyda AJ, 2013, ADV EXP MED BIOL, V788, P229, DOI 10.1007/978-94-007-6627-3_33; Bansal S, 2007, JAMA-J AM MED ASSOC, V298, P309, DOI 10.1001/jama.298.3.309; Brauner EV, 2008, PART FIBRE TOXICOL, V5, DOI 10.1186/1743-8977-5-13; Brocato J, 2014, J TOXICOL ENV HEAL A, V77, P751, DOI 10.1080/15287394.2014.892446; Brook RD, 2013, DIABETES CARE, V36, P3313, DOI 10.2337/dc12-2189; Brook RD, 2013, SCI TOTAL ENVIRON, V448, P66, DOI 10.1016/j.scitotenv.2012.07.034; Brook RD, 2010, CIRCULATION, V121, P2331, DOI 10.1161/CIR.0b013e3181dbece1; Chen JC, 2008, ENVIRON HEALTH PERSP, V116, P612, DOI 10.1289/ehp.10565; Chuang KJ, 2010, J OCCUP ENVIRON MED, V52, P258, DOI 10.1097/JOM.0b013e3181ceff7a; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Devlin RB, 2014, TOXICOL SCI, V140, P61, DOI 10.1093/toxsci/kfu063; Eeftens M, 2012, ATMOS ENVIRON, V62, P303, DOI 10.1016/j.atmosenv.2012.08.038; Eze IC, 2015, ENVIRON HEALTH PERSP, V123, P381, DOI 10.1289/ehp.1307823; Eze IC, 2014, ENVIRON INT, V70, P95, DOI 10.1016/j.envint.2014.05.014; Fuks KB, 2014, ENVIRON HEALTH PERSP, V122, P896, DOI 10.1289/ehp.1307725; Grundy SM, 2005, CIRCULATION, V112, P2735, DOI 10.1161/CIRCULATIONAHA.105.169404; Krishnan RM, 2013, PART FIBRE TOXICOL, V10, DOI 10.1186/1743-8977-10-7; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Liu CQ, 2013, TOXICOL PATHOL, V41, P361, DOI 10.1177/0192623312464531; Liu LJS, 2007, ENVIRON HEALTH PERSP, V115, P1638, DOI 10.1289/ehp.10177; Liu LJS, 2012, ATMOS ENVIRON, V46, P460, DOI 10.1016/j.atmosenv.2011.09.021; MIETTINEN O, 1985, STAT MED, V4, P213, DOI 10.1002/sim.4780040211; Miller KA, 2007, NEW ENGL J MED, V356, P447, DOI 10.1056/NEJMoa054409; Miller MR, 2013, PART FIBRE TOXICOL, V10, DOI 10.1186/1743-8977-10-61; Mills NL, 2007, NEW ENGL J MED, V357, P1075, DOI 10.1056/NEJMoa066314; Panczak R, 2012, J EPIDEMIOL COMMUN H, V66, P1129, DOI 10.1136/jech-2011-200699; Park SK, 2010, ENVIRON HEALTH PERSP, V118, P1406, DOI 10.1289/ehp.0901778; Peters A, 2004, NEW ENGL J MED, V351, P1721, DOI 10.1056/NEJMoa040203; Rahill AA, 1996, AVIAT SPACE ENVIR MD, V67, P640; Rajagopalan S, 2012, DIABETES, V61, P3037, DOI 10.2337/db12-0190; Roberts JD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090143; Sun QH, 2009, CIRCULATION, V119, P538, DOI 10.1161/CIRCULATIONAHA.108.799015; Swiss Agency for the Environment Forests and Landscape, 2003, ENV DOC, V169, P47; Thiering E, 2013, DIABETOLOGIA, V56, P1696, DOI 10.1007/s00125-013-2925-x; Tong HY, 2012, ENVIRON HEALTH PERSP, V120, P952, DOI 10.1289/ehp.1104472; Troisi RJ, 2000, JAMA-J AM MED ASSOC, V284, P3157, DOI 10.1001/jama.284.24.3157; Villeneuve PJ, 2011, OCCUP ENVIRON MED, V68, P920, DOI 10.1136/oem.2010.062521; Willi C, 2007, JAMA-J AM MED ASSOC, V298, P2654, DOI 10.1001/jama.298.22.2654; Xie B, 2010, NICOTINE TOB RES, V12, P198, DOI 10.1093/ntr/ntp194; Xu XH, 2010, ARTERIOSCL THROM VAS, V30, P2518, DOI 10.1161/ATVBAHA.110.215350	45	75	77	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2015	10	6							e0130337	10.1371/journal.pone.0130337	http://dx.doi.org/10.1371/journal.pone.0130337			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4DD	26103580	Green Submitted, Green Published, gold, Green Accepted			2022-12-26	WOS:000356901900036
J	Hayden, KM; Lutz, MW; Kuchibhatla, M; Germain, C; Plassman, BL				Hayden, Kathleen M.; Lutz, Michael W.; Kuchibhatla, Maragatha; Germain, Cassandra; Plassman, Brenda L.			Effect of APOE and CD33 on Cognitive Decline	PLOS ONE			English	Article							APOLIPOPROTEIN-E EPSILON-4; GENOME-WIDE ASSOCIATION; ALZHEIMER-DISEASE; IDENTIFIES VARIANTS; COMMON VARIANTS; RISK; DEMENTIA; IMPAIRMENT; GENOTYPE; HEALTH	Objective An Alzheimer's disease (AD) diagnosis is preceded by a long period of cognitive decline. We previously demonstrated increased risk of decline among individuals possessing one or more APOE epsilon 4 alleles together with a family history of AD. The objective of this study is to investigate the possibility that such an increased risk might be due to AD risk genes with small effects in combination with APOE. Methods Participants in the Health and Retirement Study (HRS) over the age of 65, who contributed DNA, and had two or more evaluations with an abbreviated version of the modified Telephone Interview for Cognitive Status (TICS-m) were eligible for the study (n = 7451). A genetic risk score (g-score) was derived using AD risk genes' meta-analyses data, assigning risk according to the number of risk alleles and summed over all the risk genes. Trajectories of cognitive function were modeled in four groups of Caucasian participants with and without one or more APOE epsilon 4 alleles and either a high or low g-score: APOE epsilon 4-/low g-score; APOE epsilon 4-/high g-score; APOE epsilon 4+/low g-score; and APOE epsilon 4+/high g-score. Post hoc analyses evaluated interactions between individual genes and APOE. Results Individuals in the APOE epsilon 4+/high g-score group exhibited the greatest cognitive decline over time (p<.0001). This risk appeared to be greater than the sum of the effects of either high g-score or APOE epsilon 4 alone. When gene interactions were individually tested with APOE, a statistically significant interaction with CD33 was discovered (p = 0.04) although the interaction was no longer significant when adjusted for multiple comparisons. Conclusions Individuals with multiple AD risk genes in addition to having one or more APOE epsilon 4 alleles are at greater risk of cognitive decline than individuals with either APOE epsilon 4 or a high genetic risk score. Among those with one or more APOE epsilon 4 alleles, having one or more copies of the CD33 C (risk) allele may further increase the risk of cognitive decline.	[Hayden, Kathleen M.; Germain, Cassandra; Plassman, Brenda L.] Duke Univ, Med Ctr, Dept Psychiat & Behav Sci, Durham, NC USA; [Hayden, Kathleen M.; Lutz, Michael W.; Plassman, Brenda L.] Duke Univ, Med Ctr, Joseph & Kathleen Bryan Alzheimers Dis Res Ctr, Durham, NC USA; [Lutz, Michael W.; Plassman, Brenda L.] Duke Univ, Med Ctr, Dept Neurol, Durham, NC USA; [Kuchibhatla, Maragatha] Duke Univ, Med Ctr, Dept Biostat, Durham, NC USA	Duke University; Duke University; Duke University; Duke University	Hayden, KM (corresponding author), Wake Forest Sch Med, Div Publ Hlth Sci, Dept Social Sci & Hlth Policy, Winston Salem, NC 27157 USA.	khayden@wakehealth.edu	Plassman, Brenda L/K-2620-2015; Hayden, Kathleen/AAW-4411-2020; Germain, Cassandra/C-7185-2016	Lutz, Michael/0000-0001-8809-5574; Germain, Cassandra/0000-0003-4712-0969	National Institute on Aging [R01AG042633]; NATIONAL INSTITUTE ON AGING [R01AG042633] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported funded by the National Institute on Aging, grant # R01AG042633 (http://www.nia.nih.gov/) to KMH, MWL, MK, CG, and BLP. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bertram L, 2007, NAT GENET, V39, P17, DOI 10.1038/ng1934; Bi R, 2014, NEUROBIOL AGING, V35, DOI [10.1016/j.neurobiolaging.2013.08.013, 10.1016/j.neurobiolaging.2013.12.021]; Bradshaw EM, 2013, NAT NEUROSCI, V16, P848, DOI 10.1038/nn.3435; Carrasquillo MM, 2015, NEUROBIOL AGING, V36, P60, DOI 10.1016/j.neurobiolaging.2014.07.042; DUNN OJ, 1961, J AM STAT ASSOC, V56, P52, DOI 10.2307/2282330; Farrer LA, 1997, JAMA-J AM MED ASSOC, V278, P1349, DOI 10.1001/jama.1997.03550160069041; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Griciuc A, 2013, NEURON, V78, P631, DOI 10.1016/j.neuron.2013.04.014; Harold D, 2009, NAT GENET, V41, P1088, DOI 10.1038/ng.440; Hayden KM, 2009, ARCH NEUROL-CHICAGO, V66, P1378, DOI 10.1001/archneurol.2009.237; Hollingworth P, 2011, NAT GENET, V43, P429, DOI 10.1038/ng.803; Hu N, 2014, NEUROSCI LETT, V563, P51, DOI 10.1016/j.neulet.2014.01.004; Jack CR, 2010, LANCET NEUROL, V9, P119, DOI 10.1016/S1474-4422(09)70299-6; Jiang T, 2014, MOL NEUROBIOL, V49, P529, DOI 10.1007/s12035-013-8536-1; JORM AF, 1989, PSYCHOL MED, V19, P1015, DOI 10.1017/S0033291700005742; Juster FT, 1995, J HUM RESOUR, V30, pS7, DOI 10.2307/146277; Karch CM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050976; LAIRD NM, 1982, BIOMETRICS, V38, P963, DOI 10.2307/2529876; Lambert JC, 2009, NAT GENET, V41, P1094, DOI 10.1038/ng.439; Lopez Oscar L, 2010, Neuroepidemiology, V34, P63, DOI 10.1159/000264678; Manly JJ, 2011, ARCH NEUROL-CHICAGO, V68, P607, DOI 10.1001/archneurol.2011.88; Marden JR, 2014, BRAIN BEHAV, V4, P687, DOI 10.1002/brb3.248; McArdle JJ, 2007, PSYCHOL AGING, V22, P525, DOI 10.1037/0882-7974.22.3.525; Naj AC, 2011, NAT GENET, V43, P436, DOI 10.1038/ng.801; Ofstedal M, 2005, DOCUMENTATION COGNIT, DOI DOI 10.1371/journal.pone.0144722; Qiu CX, 2003, NEUROLOGY, V61, P655, DOI 10.1212/WNL.61.5.655; Reitz C, 2013, JAMA-J AM MED ASSOC, V309, P1483, DOI 10.1001/jama.2013.2973; Rodriguez-Rodriguez E, 2013, J NEURAL TRANSM, V120, P807, DOI 10.1007/s00702-012-0920-x; The Mixed Procedure, 1992, SAS STAT SOFTW CHANG; Verhaaren BFJ, 2013, BIOL PSYCHIAT, V73, P429, DOI 10.1016/j.biopsych.2012.04.009	30	12	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2015	10	6							e0130419	10.1371/journal.pone.0130419	http://dx.doi.org/10.1371/journal.pone.0130419			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4DD	26102276	Green Submitted, gold, Green Published			2022-12-26	WOS:000356901900041
J	Illias, HA; Chai, XR; Abu Bakar, AH; Mokhlis, H				Illias, Hazlee Azil; Chai, Xin Rui; Abu Bakar, Ab Halim; Mokhlis, Hazlie			Transformer Incipient Fault Prediction Using Combined Artificial Neural Network and Various Particle Swarm Optimisation Techniques	PLOS ONE			English	Article							DIAGNOSIS	It is important to predict the incipient fault in transformer oil accurately so that the maintenance of transformer oil can be performed correctly, reducing the cost of maintenance and minimise the error. Dissolved gas analysis (DGA) has been widely used to predict the incipient fault in power transformers. However, sometimes the existing DGA methods yield inaccurate prediction of the incipient fault in transformer oil because each method is only suitable for certain conditions. Many previous works have reported on the use of intelligence methods to predict the transformer faults. However, it is believed that the accuracy of the previously proposed methods can still be improved. Since artificial neural network (ANN) and particle swarm optimisation (PSO) techniques have never been used in the previously reported work, this work proposes a combination of ANN and various PSO techniques to predict the transformer incipient fault. The advantages of PSO are simplicity and easy implementation. The effectiveness of various PSO techniques in combination with ANN is validated by comparison with the results from the actual fault diagnosis, an existing diagnosis method and ANN alone. Comparison of the results from the proposed methods with the previously reported work was also performed to show the improvement of the proposed methods. It was found that the proposed ANN-Evolutionary PSO method yields the highest percentage of correct identification for transformer fault type than the existing diagnosis method and previously reported works.	[Illias, Hazlee Azil; Chai, Xin Rui; Mokhlis, Hazlie] Univ Malaya, Fac Engn, Dept Elect Engn, Kuala Lumpur 50603, Malaysia; [Abu Bakar, Ab Halim] Univ Malaya, Wisma R&D UM, UMPEDAC, Kuala Lumpur 59990, Malaysia	Universiti Malaya; Universiti Malaya	Illias, HA (corresponding author), Univ Malaya, Fac Engn, Dept Elect Engn, Kuala Lumpur 50603, Malaysia.	h.illias@um.edu.my	Illias, Hazlee/K-2630-2015; Abu Bakar, Ab Halim/B-8085-2010; MOKHLIS, HAZLIE/B-8616-2010	Abu Bakar, Ab Halim/0000-0001-8390-0204; MOKHLIS, HAZLIE/0000-0002-1166-1934; Illias, Hazlee Azil/0000-0002-5061-1809	High Impact Research (HIR), Malaysian Ministry of Higher Education, HAI [H-16001-D00048]; Fundamental Research Grant Scheme (FRGS), Malaysian Ministry of Higher Education, HAI [FP026-2012A]	High Impact Research (HIR), Malaysian Ministry of Higher Education, HAI; Fundamental Research Grant Scheme (FRGS), Malaysian Ministry of Higher Education, HAI	This work was supported by a High Impact Research (HIR) grant: H-16001-D00048, Malaysian Ministry of Higher Education, HAI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Fundamental Research Grant Scheme (FRGS) grant: FP026-2012A, Malaysian Ministry of Higher Education, HAI, "The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript."	Abdullah M. H. L., 2012, 47 INT U POW ENG C U, P1; Ahmed MR, 2013, MED C CONTR AUTOMAT, P584, DOI 10.1109/MED.2013.6608781; Andras P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048710; [Anonymous], C571042008 IEEE; Bhattacharya S.K., 1993, N AM POW S; Changxin Liu, 2010, Proceedings of the 2010 Fourth International Conference on Genetic and Evolutionary Computing (ICGEC 2010), P8, DOI 10.1109/ICGEC.2010.10; Ding X, 1994, N AM POW S; Garg H, 2013, ISA T, V52, P701, DOI 10.1016/j.isatra.2013.06.010; Gracia J, 2005, IEEE T POWER DELIVER, V20, P2389, DOI 10.1109/TPWRD.2005.855482; Guardado JL, 2001, IEEE T POWER DELIVER, V16, P643, DOI 10.1109/61.956751; Hamadneh N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066080; Hammestrom P, 1993, IEEE SPECTRUM; Hsu CC, 2009, ISA T, V48, P264, DOI 10.1016/j.isatra.2009.01.008; Huang YC, 2003, IEE P-SCI MEAS TECH, V150, P25, DOI 10.1049/ip-smt:20020454; Liu C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097822; Malabanan R., 2014, TENCON 2014 2014 IEE, P1; Mehta AK, 2013, 2013 INTERNATIONAL CONFERENCE ON POWER, ENERGY AND CONTROL (ICPEC), P181, DOI 10.1109/ICPEC.2013.6527647; Miranda V, 2002, IEEE/PES TRANSMISSION AND DISTRIBUTION CONFERENCE AND EXHIBITION 2002: ASIA PACIFIC, VOLS 1-3, CONFERENCE PROCEEDINGS, P745, DOI 10.1109/TDC.2002.1177567; Poultangari I, 2012, ISA T, V51, P641, DOI 10.1016/j.isatra.2012.06.001; Seifeddine S., 2012, 2012 First International Conference on Renewable Energies and Vehicular Technology (REVET), P230, DOI 10.1109/REVET.2012.6195276; Setiawan NA, 2012, PROCEEDINGS OF 2012 IEEE INTERNATIONAL CONFERENCE ON CONDITION MONITORING AND DIAGNOSIS (IEEE CMD 2012), P950, DOI 10.1109/CMD.2012.6416311; Shintemirov A, 2009, IEEE T SYST MAN CY C, V39, P69, DOI 10.1109/TSMCC.2008.2007253; Siva Sarma D. V. S. S., 2004, TENCON 2004. 2004 IEEE Region 10 Conference (IEEE Cat. No. 04CH37582), P444; Wang XX, 2008, 2008 INTERNATIONAL SYMPOSIUM ON INTELLIGENT INFORMATION TECHNOLOGY APPLICATION, VOL I, PROCEEDINGS, P545, DOI 10.1109/IITA.2008.381; Wang ZY, 2000, 2000 IEEE POWER ENGINEERING SOCIETY WINTER MEETING - VOLS 1-4, CONFERENCE PROCEEDINGS, P1261, DOI 10.1109/PESW.2000.850127; Weidong Ji, 2011, Proceedings of the 2011 International Conference on Computer Science and Network Technology (ICCSNT), P585, DOI 10.1109/ICCSNT.2011.6182027; Wu PF, 2011, ISA T, V50, P71, DOI 10.1016/j.isatra.2010.08.005; Yang HT, 1998, IEEE T POWER SYST, V13, P946, DOI 10.1109/59.708845; Zakaria F, 2014, 2014 IEEE 8TH INTERNATIONAL POWER ENGINEERING AND OPTIMIZATION CONFERENCE (PEOCO), P635, DOI 10.1109/PEOCO.2014.6814505; Zhang JL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021787; Zhang Y, 1996, IEEE T POWER DELIVER, V11, P1836, DOI 10.1109/61.544265	31	41	42	2	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2015	10	6							e0129363	10.1371/journal.pone.0129363	http://dx.doi.org/10.1371/journal.pone.0129363			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4DD	26103634	Green Accepted, Green Submitted, Green Published, gold			2022-12-26	WOS:000356901900013
J	Brito, AM; Kendall, C; Kerr, L; Mota, RMS; Drew, M; Guimaraes, C; Dourado, I; Pinho, AA; Benzaken, AS; Brignol, S; Reingold, AL				Brito, Ana Maria; Kendall, Carl; Kerr, Ligia; Salani Mota, Rosa Maria; Drew, Mark; Guimaraes, Crosland; Dourado, Ines; Pinho, Adriana A.; Benzaken, Adele Schwartz; Brignol, Sandra; Reingold, Arthur L.			Factors Associated with Low Levels of HIV Testing among Men Who Have Sex with Men (MSM) in Brazil	PLOS ONE			English	Article							BEHAVIORAL SURVEILLANCE SYSTEM; INTERNET SURVEY; UNITED-STATES; PREVENTION; RISK; INFECTION; PREVALENCE; CHALLENGES; EPIDEMIC; TRENDS	The aim of this study was to assess risk factors associated with low levels of HIV testing among MSM recruited through respondent driven sampling (RDS) in Brazil. Of 3,617 participants, 48.4% had never tested previously for HIV. A logistic model indicated that younger age, lower socioeconomic class, education, poor HIV/AIDS knowledge, no history of cruising, and having been tested during the study were characteristics independently associated with low levels of previous HIV testing. The HIV testing rate among MSM in Brazil is still low in spite of the availability of a large number services providing universal and free access to HIV/AIDS diagnosis and treatment. To respond to low utilization, the authors propose a higher priority for testing for key populations such as MSM, expanded education, expanding testing sites and a welcoming and nonjudgmental environment in health services.	[Brito, Ana Maria] Fiocruz MS, Ctr Pesquisas Aggeu Magalhaes, Recife, PE, Brazil; [Kendall, Carl] Tulane Univ, Sch Publ Hlth & Trop Med, Ctr Global Hlth Equ, New Orleans, LA 70118 USA; [Kerr, Ligia; Salani Mota, Rosa Maria] Univ Fed Ceara, Dept Community Hlth, Fortaleza, CE, Brazil; [Guimaraes, Crosland] Univ Fed Minas Gerais, Sch Med, Belo Horizonte, MG, Brazil; [Dourado, Ines; Brignol, Sandra] Univ Fed Bahia, Inst Collect Hlth, Salvador, BA, Brazil; [Pinho, Adriana A.] Inst Comunicacao & Informacao Cient & Tecnol Saud, Rio De Janeiro, RJ, Brazil; [Benzaken, Adele Schwartz] Fundacao Alfredo da Mata, Manaus, AM, Brazil; [Reingold, Arthur L.] Univ Calif Berkeley, Sch Publ Hlth, Berkeley, CA 94720 USA	Fundacao Oswaldo Cruz; Tulane University; Universidade Federal do Ceara; Universidade Federal de Minas Gerais; Universidade Federal da Bahia; University of California System; University of California Berkeley	Kendall, C (corresponding author), Tulane Univ, Sch Publ Hlth & Trop Med, Ctr Global Hlth Equ, New Orleans, LA 70118 USA.	carl.kendall@gmail.com	Dourado, Ines/Q-6535-2016; Kendall, Carl/F-9002-2012; BRIGNOL, SANDRA/AAL-2368-2020; KERR, LIGIA REGINA FRANCO SANSIGOLO/F-9250-2012	Dourado, Ines/0000-0003-1675-2146; Kendall, Carl/0000-0002-0794-4333; KERR, LIGIA REGINA FRANCO SANSIGOLO/0000-0003-4941-408X; Schwartz Benzaken, Adele/0000-0002-5789-0695	National STD/AIDS and Hepatitis Department of the Ministry of Health, Brazil [CSV 234/07]; United Nations Programme on HIV/AIDS (UNAIDS)	National STD/AIDS and Hepatitis Department of the Ministry of Health, Brazil; United Nations Programme on HIV/AIDS (UNAIDS)	The research was funded by the National STD/AIDS and Hepatitis Department of the Ministry of Health, Brazil (Grant number: CSV 234/07). The Joint United Nations Programme on HIV/AIDS (UNAIDS) provided additional funding for Manaus to extend data collection.	Abell N, 2007, AIDS CARE, V19, P242, DOI 10.1080/09540120600774297; ABEP - Associacao Brasileira de Empresas de Pesquisa, 2008, CRITERIO DE CLASSIFI; Adam PCG, 2009, JAIDS-J ACQ IMM DEF, V52, pS143, DOI 10.1097/QAI.0b013e3181baf111; [Anonymous], 2007, ANTHROPOLOGY AND EPI; Baral S, 2007, PLOS MED, V4, P1901, DOI 10.1371/journal.pmed.0040339; Baral S, 2012, AIDS RES HUM RETROV, V28, P874, DOI [10.1089/aid.2011.0264, 10.1089/AID.2011.0264]; Barbosa A, 2011, CAD SAUDE PUBLICA, V27, pS36, DOI 10.1590/S0102-311X2011001300005; Barbosa A, 2009, CAD SAUDE PUBLICA, V25, P727, DOI 10.1590/S0102-311X2009000400003; Berg RC, 2013, SOC SCI MED, V78, P61, DOI 10.1016/j.socscimed.2012.11.033; Blas MM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027334; Brahmam GNV, 2008, AIDS, V22, pS45, DOI 10.1097/01.aids.0000343763.54831.15; Branson BM, 2010, JAIDS-J ACQ IMM DEF, V55, pS102, DOI 10.1097/QAI.0b013e3181fbca44; Brasil. Ministerio da Saude. Departamento de DST AeHV, 2010, BOLETIM EPIDEMIOLOGI; Brasil. Ministerio da Saude. Secretaria de Vigilancia em Saude. Departamento Nacional de DST/AIDS e Hepatites virais, 2012, AIDS NO BRASIL EPIDE; Chow EPF, 2012, HIV MED, V13, P255, DOI 10.1111/j.1468-1293.2011.00974.x; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Copeland B, 2012, AIDS PATIENT CARE ST, V26, P202, DOI 10.1089/apc.2011.0303; de Arazoza H, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-130; Do TD, 2005, AIDS EDUC PREV, V17, P540, DOI 10.1521/aeap.2005.17.6.540; Ferreira MdPS, 2001, CIENC SAUDE COLETIVA, V6, P481; Flowers P, 2013, HIV MED, V14, P92, DOI 10.1111/j.1468-1293.2012.01041.x; França Junior Ivan, 2008, Rev. Saúde Pública, V42, P84, DOI 10.1590/S0034-89102008000800011; Golden MR, 2008, JAIDS-J ACQ IMM DEF, V49, P212, DOI 10.1097/QAI.0b013e31818455e8; Grangeiro A, 2009, REV SAUDE PUBL, V43, DOI 10.1590/S0034-89102009000300006; Grulich AE, 2008, SEX HEALTH, V5, P113, DOI 10.1071/SH07075; Hall HI, 2012, AIDS BEHAV, V16, P36, DOI 10.1007/s10461-011-9944-8; Heckathorn DD, 1997, SOC PROBL, V44, P174, DOI 10.1525/sp.1997.44.2.03x0221m; Heckathorn DD, 2007, SOCIOL METHODOL, V37, P151, DOI 10.1111/j.1467-9531.2007.00188.x; Holt M, 2012, AIDS BEHAV, V16, P13, DOI 10.1007/s10461-010-9872-z; Jaffe HW, 2007, JAMA-J AM MED ASSOC, V298, P2412, DOI 10.1001/jama.298.20.2412; Johnston LG, 2008, AIDS BEHAV, V12, pS131, DOI 10.1007/s10461-008-9413-1; Karim SSA, 2007, INFECT DIS CLIN N AM, V21, P1, DOI 10.1016/j.idc.2007.01.010; Kerr LRFS, 2013, AIDS, V27, P427, DOI 10.1097/QAD.0b013e32835ad504; Knox J, 2011, INT J STD AIDS, V22, P709, DOI 10.1258/ijsa.2011.010350; Lane T, 2011, AIDS BEHAV, V15, P626, DOI 10.1007/s10461-009-9598-y; Lansky A, 2007, PUBLIC HEALTH REP, V122, P48, DOI 10.1177/00333549071220S108; Lau JTF, 2011, PUBLIC HEALTH, V125, P260, DOI 10.1016/j.puhe.2011.01.007; Lauby JL, 2008, ARCH SEX BEHAV, V37, P708, DOI 10.1007/s10508-008-9365-6; Lo YC, 2012, SEX TRANSM DIS, V39, P306, DOI 10.1097/OLQ.0b013e31824018d4; Lyons A, 2012, AIDS BEHAV, V16, P1934, DOI 10.1007/s10461-012-0148-7; Marcus U, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-978; Marks G, 2005, JAIDS-J ACQ IMM DEF, V39, P446, DOI 10.1097/01.qai.0000151079.33935.79; Mello MA, 2008, REPORT NO; Neilands TB, 2008, ARCH SEX BEHAV, V37, P838, DOI 10.1007/s10508-007-9305-x; Oster AM, 2011, MMWR-MORBID MORTAL W, V60, P6; Pinto Rogerio M, 2012, Am J Public Health, V102, pe69, DOI 10.2105/AJPH.2012.300972; Sanchez Travis, 2006, Morbidity and Mortality Weekly Report, V55, P1; Sherr L, 2007, AIDS, V21, P851, DOI 10.1097/QAD.0b013e32805e8711; Sifakis F, 2010, AIDS BEHAV, V14, P904, DOI 10.1007/s10461-007-9317-5; Sullivan PS, 2012, LANCET, V380, P388, DOI 10.1016/S0140-6736(12)60955-6; Szwarcwald C, 2009, J ACQUIRED IMMUNE S3, V57, pS129, DOI DOI 10.1097/QAI; van Griensven F, 2010, AIDS, V24, pS30, DOI 10.1097/01.aids.0000390087.22565.b4; Vu BN, 2008, SEX HEALTH, V5, P83, DOI 10.1071/SH07064; Wagner GJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045566; Wimonsate W, 2011, AIDS BEHAV, V15, P693, DOI 10.1007/s10461-010-9755-3; Zou HC, 2012, AIDS BEHAV, V16, P1717, DOI 10.1007/s10461-012-0225-y	56	35	37	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2015	10	6							e0130445	10.1371/journal.pone.0130445	http://dx.doi.org/10.1371/journal.pone.0130445			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CL3FM	26098559	Green Published, gold, Green Submitted			2022-12-26	WOS:000356835800068
J	Land, AD; Hogan, P; Fritz, S; Levin, PA				Land, Adrian D.; Hogan, Patrick; Fritz, Stephanie; Levin, Petra Anne			Phenotypic Variation Is Almost Entirely Independent of the Host-Pathogen Relationship in Clinical Isolates of S. aureus	PLOS ONE			English	Article							RESISTANT STAPHYLOCOCCUS-AUREUS; SMALL COLONY VARIANTS; METHICILLIN-RESISTANT; VANCOMYCIN-INTERMEDIATE; ACETATE CATABOLISM; BIOFILM FORMATION; IN-VITRO; VIRULENCE; GENOME; STAPHYLOXANTHIN	Background A key feature of Staphylococcus aureus biology is its ability to switch from an apparently benign colonizer of similar to 30% of the population to a cutaneous pathogen, to a deadly invasive pathogen. Little is known about the mechanisms driving this transition or the propensity of different S. aureus strains to engender different types of host-pathogen interactions. At the same time, significant weight has been given to the role of specific in vitro phenotypes in S. aureus virulence. Biofilm formation, hemolysis and pigment formation have all been associated with virulence in mice. Design To determine if there is a correlation between in vitro phenotype and the three types of host-pathogen relationships commonly exhibited by S. aureus in the context of its natural human host, we assayed 300 clinical isolates for phenotypes implicated in virulence including hemolysis, sensitivity to autolysis, and biofilm formation. For comparative purposes, we also assayed phenotype in 9 domesticated S. aureus strains routinely used for analysis of virulence determinants in laboratory settings. Results Strikingly, the clinical strains exhibited significant phenotypic uniformity in each of the assays evaluated in this study. One exception was a small, but significant, correlation between an increased propensity for biofilm formation and isolation from skin and soft tissue infections (SSTIs). In contrast, we observed a high degree of phenotypic variation between common laboratory strains that exhibit virulence in mouse models. These data suggest the existence of significant evolutionary pressure on the S. aureus genome and highlight a role for host factors as a strong determinant of the host-pathogen relationship. In addition, the high degree of variation between laboratory strains emphasizes the need for caution when applying data obtained in one lab strain to the analysis of another.	[Land, Adrian D.; Levin, Petra Anne] Washington Univ, Dept Biol, St Louis, MO 63130 USA; [Hogan, Patrick; Fritz, Stephanie] Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL)	Levin, PA (corresponding author), Washington Univ, Dept Biol, Campus Box 1137, St Louis, MO 63130 USA.	plevin@biology.wustl.edu		Hogan, Patrick/0000-0003-3196-9618; Levin, Petra/0000-0003-2071-0547	Children's Discovery Institute of Washington University; St. Louis Children's Hospital; National Institutes of Health (NIH) grants [K23-AI091690, UL1-TR000448]; National Institutes of Health [GM64671]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000448] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K23AI091690] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM064671] Funding Source: NIH RePORTER	Children's Discovery Institute of Washington University; St. Louis Children's Hospital; National Institutes of Health (NIH) grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding for this project was provided by the Children's Discovery Institute of Washington University and St. Louis Children's Hospital and the National Institutes of Health (NIH) grants K23-AI091690 and UL1-TR000448. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. Work in the Levin laboratory is supported in part by a grant from the National Institutes of Health, GM64671 (to P.A.L.) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdallah M, 2014, ARCH MICROBIOL, V196, P453, DOI 10.1007/s00203-014-0983-1; Antignac A, 2007, J BACTERIOL, V189, P7573, DOI 10.1128/JB.01048-07; Baba T, 2002, LANCET, V359, P1819, DOI 10.1016/S0140-6736(02)08713-5; Baba T, 2008, J BACTERIOL, V190, P300, DOI 10.1128/JB.01000-07; Baek KT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077122; Blevins JS, 2002, INFECT IMMUN, V70, P470, DOI 10.1128/IAI.70.2.470-480.2002; Boles BR, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000052; Burnside K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011071; Cassat JE, 2005, J BACTERIOL, V187, P576, DOI 10.1128/JB.187.2.576-592.2005; Clauditz A, 2006, INFECT IMMUN, V74, P4950, DOI 10.1128/IAI.00204-06; Conrad TM, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.42; Cui L, 2003, J CLIN MICROBIOL, V41, P5, DOI 10.1128/JCM.41.1.5-14.2003; Deleo FR, 2009, J CLIN INVEST, V119, P2464, DOI 10.1172/JCI38226; Diep BA, 2006, LANCET, V367, P731, DOI 10.1016/S0140-6736(06)68231-7; Eydallin G, 2014, ENVIRON MICROBIOL, V16, P813, DOI 10.1111/1462-2920.12208; Faure D, 2004, J BACTERIOL, V186, P6437, DOI 10.1128/JB.186.19.6437-6442.2004; Feng Y, 2008, FEMS MICROBIOL REV, V32, P23, DOI 10.1111/j.1574-6976.2007.00086.x; Freeman-Cook L, 2006, STAPHYLOCOCCUS AUREU, P12; Fritz SA, 2011, INFECT CONT HOSP EP, V32, P872, DOI 10.1086/661285; Gillaspy A. F., 2006, GRAM POSITIVE PATHOG, P381, DOI DOI 10.1128/; Hart E, 2008, INFECT IMMUN, V76, P5247, DOI 10.1128/IAI.00770-08; Herbert S, 2010, INFECT IMMUN, V78, P2877, DOI 10.1128/IAI.00088-10; Highlander SK, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-99; Hill NS, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003663; Hiramatsu K, 2001, TRENDS MICROBIOL, V9, P486, DOI 10.1016/S0966-842X(01)02175-8; Howden BP, 2010, CLIN MICROBIOL REV, V23, P99, DOI 10.1128/CMR.00042-09; Ibarra JA, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-126; Ingavale SS, 2003, MOL MICROBIOL, V48, P1451, DOI 10.1046/j.1365-2958.2003.03503.x; Klevens RM, 2007, JAMA-J AM MED ASSOC, V298, P1763, DOI 10.1001/jama.298.15.1763; Kluytmans J, 1997, CLIN MICROBIOL REV, V10, P505, DOI 10.1128/CMR.10.3.505; Kuroda M, 2001, LANCET, V357, P1225, DOI 10.1016/S0140-6736(00)04403-2; Lannergard J, 2008, ANTIMICROB AGENTS CH, V52, P4017, DOI 10.1128/AAC.00668-08; Ledala N, 2014, J BACTERIOL, V196, P2178, DOI 10.1128/JB.01475-14; Lee JH, 2012, CURR MICROBIOL, V65, P726, DOI 10.1007/s00284-012-0229-x; Leejae S, 2013, J MED MICROBIOL, V62, P421, DOI 10.1099/jmm.0.047316-0; Lei MG, 2011, J BACTERIOL, V193, P5231, DOI 10.1128/JB.05454-11; Malachowa N, 2011, VIRULENCE, V2, P567, DOI 10.4161/viru.2.6.17732; Malachowa N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018617; Massilamany C, 2011, MOL CELL BIOCHEM, V355, P75, DOI 10.1007/s11010-011-0840-3; Nelson JL, 2007, ANTIMICROB AGENTS CH, V51, P616, DOI 10.1128/AAC.01057-06; O'Neill AJ, 2010, LETT APPL MICROBIOL, V51, P358, DOI 10.1111/j.1472-765X.2010.02885.x; O'Toole GA, 1999, METHOD ENZYMOL, V310, P91; O'Toole GA, 1998, MOL MICROBIOL, V30, P295, DOI 10.1046/j.1365-2958.1998.01062.x; Oldfield E, 2010, ACCOUNTS CHEM RES, V43, P1216, DOI 10.1021/ar100026v; Otto M, 2008, CURR TOP MICROBIOL, V322, P207; Otto M, 2014, CURR OPIN MICROBIOL, V17, P32, DOI 10.1016/j.mib.2013.11.004; Otto M, 2013, INT J MED MICROBIOL, V303, P324, DOI 10.1016/j.ijmm.2013.02.007; Otto M, 2013, ANNU REV MED, V64, P175, DOI 10.1146/annurev-med-042711-140023; Otto M, 2010, ANNU REV MICROBIOL, V64, P143, DOI 10.1146/annurev.micro.112408.134309; Otto M, 2010, MED RES REV, V30, P1, DOI 10.1002/med.20160; Passerini D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015306; Periasamy S, 2012, P NATL ACAD SCI USA, V109, P1281, DOI 10.1073/pnas.1115006109; Proctor RA, 2006, NAT REV MICROBIOL, V4, P295, DOI 10.1038/nrmicro1384; Rodriguez M, 2014, J PEDIATR-US, V164, P105, DOI 10.1016/j.jpeds.2013.08.072; Ruimy R, 2010, J INFECT DIS, V202, P924, DOI 10.1086/655901; Ryu S, 2014, INT J MOL SCI, V15, P8753, DOI 10.3390/ijms15058753; Sadykov MR, 2010, J BACTERIOL, V192, P1459, DOI 10.1128/JB.01377-09; Schaaff F, 2003, INT J MED MICROBIOL, V293, P427, DOI 10.1078/1438-4221-00282; Somerville GA, 2003, INFECT IMMUN, V71, P4724, DOI 10.1128/IAI.71.8.4724-4732.2003; Somerville GA, 2002, J BACTERIOL, V184, P1430, DOI 10.1128/JB.184.5.1430-1437.2002; Somerville GA, 2002, INFECT IMMUN, V70, P6373, DOI 10.1128/IAI.70.11.6373-6382.2002; Somerville GA, 2009, MICROBIOL MOL BIOL R, V73, P233, DOI 10.1128/MMBR.00005-09; Song YC, 2009, J MED CHEM, V52, P3869, DOI 10.1021/jm9001764; Sutton A, 2000, J BACTERIOL, V182, P4375, DOI 10.1128/JB.182.16.4375-4379.2000; Tenover FC, 2009, J ANTIMICROB CHEMOTH, V64, P441, DOI 10.1093/jac/dkp241; Tsang LH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003361; Uhlemann AC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022407; vonEiff C, 1997, J BACTERIOL, V179, P4706, DOI 10.1128/jb.179.15.4706-4712.1997; Yang J, 2011, TRENDS MICROBIOL, V19, P128, DOI 10.1016/j.tim.2010.12.001; Young BC, 2012, P NATL ACAD SCI USA, V109, P4550, DOI 10.1073/pnas.1113219109; Zhu YF, 2009, INFECT IMMUN, V77, P4256, DOI 10.1128/IAI.00195-09	71	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2015	10	6							e0129670	10.1371/journal.pone.0129670	http://dx.doi.org/10.1371/journal.pone.0129670			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL3FM	26098551	Green Published, Green Submitted, gold			2022-12-26	WOS:000356835800035
J	Moon, Y; Choi, SM; Chang, S; Park, B; Lee, S; Lee, MO; Choi, HS; Park, H				Moon, Yunwon; Choi, Su Mi; Chang, Soojeong; Park, Bongju; Lee, Seongyeol; Lee, Mi-Ock; Choi, Hueng-Sik; Park, Hyunsung			Chenodeoxycholic Acid Reduces Hypoxia Inducible Factor-1 alpha Protein and Its Target Genes	PLOS ONE			English	Article							ORPHAN NUCLEAR RECEPTOR; FACTOR-DEPENDENT PRODUCTION; SMALL HETERODIMER PARTNER; PROLYL HYDROXYLASES PHD1; HIF-PROLYL; PROFIBROTIC MEDIATORS; FACTOR 1-ALPHA; DOMAIN; TRANSLATION; BINDING	This study evaluated HIF-1 alpha inhibitors under different hypoxic conditions, physiological hypoxia (5% O-2) and severe hypoxia (0.1% O-2). We found that chenodeoxy cholic acid (CDCA) reduced the amount of HIF-1 alpha protein only under physiological hypoxia but not under severe hypoxia without decreasing its mRNA level. By using a proteasome inhibitor MG132 and a translation inhibitor cyclohexamide, we showed that CDCA reduced HIF-1 alpha protein by decreasing its translation but not by enhancing its degradation. The following findings indicated that farnesoid X receptor (FXR), a CDCA receptor and its target gene, Small heterodimer partner (SHP) are not involved in this effect of CDCA. Distinctly from CDCA, MG132 prevented SHP and an exogenous FXR agonist, GW4064 from reducing HIF-1 alpha protein. Furthermore a FXR antagonist, guggulsterone failed to prevent CDCA from decreasing HIF-1 alpha protein. Furthermore, guggulsterone by itself reduced HIF-1 alpha protein even in the presence of MG132. These findings suggested that CDCA and guggulsterone reduced the translation of HIF-1 alpha in a mechanism which FXR and SHP are not involved. This study reveals novel therapeutic functions of traditional nontoxic drugs, CDCA and guggulsterone, as inhibitors of HIF-1 alpha protein.	[Moon, Yunwon; Choi, Su Mi; Chang, Soojeong; Park, Bongju; Lee, Seongyeol; Park, Hyunsung] Univ Seoul, Dept Life Sci, Seoul, South Korea; [Lee, Mi-Ock] Seoul Natl Univ, Coll Pharm, Seoul, South Korea; [Choi, Hueng-Sik] Chonnam Natl Univ, Natl Creat Res Initiat Ctr Nucl Receptor Signals, Sch Biol Sci & Technol, Gwangju, South Korea; [Choi, Hueng-Sik] Chonnam Natl Univ, Hormone Res Ctr, Sch Biol Sci & Technol, Gwangju, South Korea	University of Seoul; Seoul National University (SNU); Chonnam National University; Chonnam National University	Park, H (corresponding author), Univ Seoul, Dept Life Sci, Seoul, South Korea.	hspark@uos.ac.kr		Chang, Soojeong/0000-0002-1961-6687	National Research Foundation of Korea (NRF) grants [NRF-2012M3A9B6055343, NRF-2013M3A9D3046248]	National Research Foundation of Korea (NRF) grants	This work was supported by the National Research Foundation of Korea (NRF) grants, NRF-2012M3A9B6055343 and NRF-2013M3A9D3046248.	Appelhoff RJ, 2004, J BIOL CHEM, V279, P38458, DOI 10.1074/jbc.M406026200; Arteel GE, 1997, HEPATOLOGY, V25, P920, DOI 10.1002/hep.510250422; Berra E, 2003, EMBO J, V22, P4082, DOI 10.1093/emboj/cdg392; Bruick RK, 2001, SCIENCE, V294, P1337, DOI 10.1126/science.1066373; Chanda D, 2010, NUCLEIC ACIDS RES, V38, P4607, DOI 10.1093/nar/gkq227; Chun YS, 2001, BIOCHEM PHARMACOL, V61, P947, DOI 10.1016/S0006-2952(01)00564-0; Copple BL, 2010, HEPATOL RES, V40, P530, DOI 10.1111/j.1872-034X.2010.00635.x; Copple BL, 2009, LIVER INT, V29, P1010, DOI 10.1111/j.1478-3231.2009.02015.x; Del Bufalo D, 2006, CANCER RES, V66, P5549, DOI 10.1158/0008-5472.CAN-05-2825; del Castillo-Olivares A, 2004, J BIOL CHEM, V279, P16813, DOI 10.1074/jbc.M400646200; Freeman RS, 2003, MOL CELLS, V16, P1; Galban S, 2008, MOL CELL BIOL, V28, P93, DOI 10.1128/MCB.00973-07; Goodwin B, 2000, MOL CELL, V6, P517, DOI 10.1016/S1097-2765(00)00051-4; Hewitson KS, 2002, J BIOL CHEM, V277, P26351, DOI 10.1074/jbc.C200273200; Hirsila M, 2003, J BIOL CHEM, V278, P30772, DOI 10.1074/jbc.M304982200; Hsu CC, 2013, BBA-GEN SUBJECTS, V1830, P4743, DOI 10.1016/j.bbagen.2013.06.004; Huang JH, 2002, J BIOL CHEM, V277, P39792, DOI 10.1074/jbc.M206955200; Huang LE, 1998, P NATL ACAD SCI USA, V95, P7987, DOI 10.1073/pnas.95.14.7987; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Jungermann K, 2000, HEPATOLOGY, V31, P255, DOI 10.1002/hep.510310201; Kallio PJ, 1999, J BIOL CHEM, V274, P6519, DOI 10.1074/jbc.274.10.6519; Kim JY, 2004, MOL ENDOCRINOL, V18, P2880, DOI 10.1210/me.2004-0211; Koh MY, 2008, TRENDS BIOCHEM SCI, V33, P526, DOI 10.1016/j.tibs.2008.08.002; Koumenis C, 2002, MOL CELL BIOL, V22, P7405, DOI 10.1128/MCB.22.21.7405-7416.2002; Lando D, 2002, GENE DEV, V16, P1466, DOI 10.1101/gad.991402; Lee HY, 2013, CARCINOGENESIS, V34, P2706, DOI 10.1093/carcin/bgt256; Lee YK, 2000, MOL CELL BIOL, V20, P187, DOI 10.1128/MCB.20.1.187-195.2000; Masson N, 2004, FEBS LETT, V570, P166, DOI 10.1016/j.febslet.2004.06.040; Masson N, 2003, J CELL SCI, V116, P3041, DOI 10.1242/jcs.00655; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; Metzen E, 2005, BIOCHEM J, V387, P711, DOI 10.1042/BJ20041736; Min JH, 2002, SCIENCE, V296, P1886, DOI 10.1126/science.1073440; Mirrakhimov Aibek E, 2012, Front Neurol, V3, P149, DOI 10.3389/fneur.2012.00149; Moon JO, 2009, AM J PHYSIOL-GASTR L, V296, pG582, DOI 10.1152/ajpgi.90368.2008; Nath B, 2012, HEPATOLOGY, V55, P622, DOI 10.1002/hep.25497; Nath B, 2011, HEPATOLOGY, V53, P1526, DOI 10.1002/hep.24256; Nishizawa H, 2002, J BIOL CHEM, V277, P1586, DOI 10.1074/jbc.M104301200; Ohh M, 2000, NAT CELL BIOL, V2, P423, DOI 10.1038/35017054; Sapra P, 2011, ANGIOGENESIS, V14, P245, DOI 10.1007/s10456-011-9209-1; Schepens B, 2005, NUCLEIC ACIDS RES, V33, P6884, DOI 10.1093/nar/gki1000; Schneider M, 2010, GASTROENTEROLOGY, V138, P1143, DOI 10.1053/j.gastro.2009.09.057; Semenza GL, 2013, J CLIN INVEST, V123, P3664, DOI 10.1172/JCI67230; Seol W, 1996, SCIENCE, V272, P1336, DOI 10.1126/science.272.5266.1336; Taylor MS, 2001, GENE, V275, P125, DOI 10.1016/S0378-1119(01)00633-3; Tennant DA, 2010, NAT REV CANCER, V10, P267, DOI 10.1038/nrc2817; Tuckerman JR, 2004, FEBS LETT, V576, P145, DOI 10.1016/j.febslet.2004.09.005; Vadasz Z, 2005, J HEPATOL, V43, P499, DOI 10.1016/j.jhep.2005.02.052; van den Beucken T, 2006, CANCER BIOL THER, V5, P749, DOI 10.4161/cbt.5.7.2972; van Malenstein H, 2010, CLIN CANCER RES, V16, P4278, DOI 10.1158/1078-0432.CCR-09-3274; Wilson GK, 2014, J HEPATOL, V61, P1397, DOI 10.1016/j.jhep.2014.08.025; Wouters BG, 2008, NAT REV CANCER, V8, P851, DOI 10.1038/nrc2501; Xia Y, 2012, EUR J MED CHEM, V49, P24, DOI 10.1016/j.ejmech.2012.01.033; Young RM, 2008, J BIOL CHEM, V283, P16309, DOI 10.1074/jbc.M710079200	54	7	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2015	10	6							e0130911	10.1371/journal.pone.0130911	http://dx.doi.org/10.1371/journal.pone.0130911			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL3FM	26098428	Green Published, gold, Green Submitted			2022-12-26	WOS:000356835800122
J	Wang, Y; Zhang, J; Qian, YS; Tang, XF; Ling, HW; Chen, KM; Gao, PJ; Zhu, DL				Wang, Yan; Zhang, Jin; Qian, Yuesheng; Tang, Xiaofeng; Ling, Huawei; Chen, Kemin; Gao, Pingjin; Zhu, Dingliang			Association of Lp-PLA(2) Mass and Aysmptomatic Intracranial and Extracranial Arterial Stenosis in Hypertension Patients	PLOS ONE			English	Article							LIPOPROTEIN-ASSOCIATED PHOSPHOLIPASE-A2; INTIMA-MEDIA THICKNESS; CORONARY-HEART-DISEASE; RISK-FACTORS; ATHEROSCLEROTIC DISEASE; OCCLUSIVE DISEASE; CHINESE PATIENTS; ISCHEMIC-STROKE; CT ANGIOGRAPHY; SHEAR-STRESS	Background and Purpose Intracranial arterial stenosis (ICAS) is a common cause of ischemic stroke in Asians, whereas whites tend to have more extracranial lesions. Lipoprotein-associated phospholipase A(2) (Lp-PLA(2)) has been associated with ischemic stroke by a large amount of work. However, there are few studies focusing on the relationship of Lp-PLA(2) and asymptomatic ICAS or extracranial arterial stenosis (ECAS). We here by sought to explore the relationship of Lp-PLA(2) and ICAS, ECAS and concurrent stenosis in stroke-free hypertensive patients in Chinese population. Methods All the subjects were evaluated for the presence and severity of ICAS and ECAS through computerized tomographic angiography (CTA) covered the whole brain down to the level of aortic arch. Lp-PLA(2) mass was measured by enzyme linked immunoassay. The association of Lp-PLA(2) and vascular stenosis was analyzed through multivariate logistic regression. Results Among 414 participants, 163 (39.4%) had no ICAS or ECAS, 63 (15.2%) had ECAS only, 111 (26.8%) had ICAS only and 77 (18.6%) had concurrent extraintracranial stenosis. Lp-PLA(2) mass was significantly associated with isolated ICAS (OR: 2.3; 95% CI: 1.14-4.64), and concurrent stenosis (OR: 3.93; 95% CI: 1.62-9.51), but was not related to isolated ECAS (OR: 1.54; 95% CI: 0.68-3.48). Lp-PLA(2) mass was also associated with moderate to severe ICAS no matter how was the ECAS. Moreover, patients with higher Lp-PLA(2) mass showed more sever ICAS and had more intracranial arterial lesions. Conclusion This study revealed the association of Lp-PLA(2) mass with ICAS in stroke-free hypertensive patients in Chinese population. The further long-term cohort study was warranted to elucidate the concrete effect of Lp-PLA(2) on the asymptomatic ICAS.	[Wang, Yan; Zhang, Jin; Qian, Yuesheng; Tang, Xiaofeng; Gao, Pingjin; Zhu, Dingliang] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp,Shanghai Key Lab Hypertens,Res Ctr Hy, State Key Lab Med Genom,Shanghai Inst Hypertens, Shanghai 200030, Peoples R China; [Ling, Huawei; Chen, Kemin] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Dept Radiol, Shanghai 200030, Peoples R China	Chinese Academy of Sciences; Shanghai Jiao Tong University; Shanghai Jiao Tong University	Zhu, DL (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp,Shanghai Key Lab Hypertens,Res Ctr Hy, State Key Lab Med Genom,Shanghai Inst Hypertens, Shanghai 200030, Peoples R China.	zhudingliang@sibs.ac.cn			National Key Program for Basic Research [2009CB521905]; National Natural Science Foundation of China [81000037, 81370205]; National High Technology Research and Development Program [2006AA02Z179]; Shanghai Hospital Development Center Foundation [SHDC12012304]	National Key Program for Basic Research(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High Technology Research and Development Program(National High Technology Research and Development Program of China); Shanghai Hospital Development Center Foundation	This project was supported by grants from the National Key Program for Basic Research (2009CB521905), National Natural Science Foundation of China (81000037 and 81370205), National High Technology Research and Development Program (2006AA02Z179), and Shanghai Hospital Development Center Foundation (SHDC12012304). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson GB, 2000, STROKE, V31, P2168, DOI 10.1161/01.STR.31.9.2168; Bae HJ, 2007, CEREBROVASC DIS, V24, P355, DOI 10.1159/000106982; Blake GJ, 2001, J AM COLL CARDIOL, V38, P1302, DOI 10.1016/S0735-1097(01)01554-6; CAPLAN LR, 1986, STROKE, V17, P648, DOI 10.1161/01.STR.17.4.648; Chen CT, 2014, HYPERTENSION, V63, P61, DOI 10.1161/HYPERTENSIONAHA.113.01838; Cucchiara BL, 2009, STROKE, V40, P2332, DOI 10.1161/STROKEAHA.109.553545; He J, 2005, NEW ENGL J MED, V353, P1124, DOI 10.1056/NEJMsa050467; Honda HM, 2001, ATHEROSCLEROSIS, V158, P385, DOI 10.1016/S0021-9150(01)00462-2; Hsia DC, 1998, STROKE, V29, P346, DOI 10.1161/01.STR.29.2.346; Huang YN, 1997, NEUROLOGY, V48, P524, DOI 10.1212/WNL.48.2.524; Jellinger Paul S, 2012, Endocr Pract, V18 Suppl 1, P1; Jenny NS, 2010, ATHEROSCLEROSIS, V209, P528, DOI 10.1016/j.atherosclerosis.2009.09.021; Kardys I, 2006, ARTERIOSCL THROM VAS, V26, P631, DOI 10.1161/01.ATV.0000201289.83256.cf; Leng XY, 2013, STROKE, V44, P68, DOI 10.1161/STROKEAHA.112.675652; Leng XY, 2014, STROKE, V45, P645, DOI 10.1161/STROKEAHA.113.002491; Liu HM, 1996, STROKE, V27, P650, DOI 10.1161/01.STR.27.4.650; Lopez-Cancio E, 2012, STROKE, V43, P2712, DOI 10.1161/STROKEAHA.112.661702; Luo X, 2011, CLIN RADIOL, V66, P393, DOI 10.1016/j.crad.2010.12.002; Massot A, 2011, ATHEROSCLEROSIS, V218, P181, DOI 10.1016/j.atherosclerosis.2011.04.031; Mohler ER, 2008, ARTERIOSCL THROM VAS, V28, P850, DOI 10.1161/ATVBAHA.107.154534; Nambi V, 2009, STROKE, V40, P376, DOI 10.1161/STROKEAHA.107.513259; Nguyen-Huynh MN, 2008, STROKE, V39, P1184, DOI 10.1161/STROKEAHA.107.502906; Oei HHS, 2005, CIRCULATION, V111, P570, DOI 10.1161/01.CIR.0000154553.12214.CD; Packard CJ, 2000, NEW ENGL J MED, V343, P1148, DOI 10.1056/NEJM200010193431603; Rallidis LS, 2012, J AM COLL CARDIOL, V60, P2053, DOI 10.1016/j.jacc.2012.06.057; Resnick N, 1997, ADV EXP MED BIOL, V430, P155; Ryu SK, 2012, CIRCULATION, V125, P757, DOI 10.1161/CIRCULATIONAHA.111.063487; Thompson A, 2010, LANCET, V375, P1536, DOI 10.1016/S0140-6736(10)60319-4; Uehara T, 2005, EUR J NEUROL, V12, P218, DOI 10.1111/j.1468-1331.2004.00959.x; White H, 2005, CIRCULATION, V111, P1327, DOI 10.1161/01.CIR.0000157736.19739.D0; Wong KS, 2000, STROKE, V31, P2641, DOI 10.1161/01.STR.31.11.2641; Zalewski A, 2005, ARTERIOSCL THROM VAS, V25, P923, DOI 10.1161/01.ATV.0000160551.21962.a7; Zhang J, 2011, AM J HYPERTENS, V24, P304, DOI 10.1038/ajh.2010.246	33	10	14	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2015	10	6							e0130473	10.1371/journal.pone.0130473	http://dx.doi.org/10.1371/journal.pone.0130473			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL3FM	26098634	Green Submitted, Green Published, gold			2022-12-26	WOS:000356835800069
J	Liu, J; You, P; Chen, G; Fu, X; Zeng, X; Wang, C; Huang, Y; An, L; Wan, X; Navone, N; Wu, CL; McKeehan, WL; Zhang, Z; Zhong, W; Wang, F				Liu, J.; You, P.; Chen, G.; Fu, X.; Zeng, X.; Wang, C.; Huang, Y.; An, L.; Wan, X.; Navone, N.; Wu, C-L; McKeehan, W. L.; Zhang, Z.; Zhong, W.; Wang, F.			Hyperactivated FRS2 alpha-mediated signaling in prostate cancer cells promotes tumor angiogenesis and predicts poor clinical outcome of patients	ONCOGENE			English	Article							ENDOTHELIAL GROWTH-FACTOR; EXPRESSION; FGFR1; PROGRESSION; ACTIVATION; INDUCTION; MOUSE; GENE; ADENOCARCINOMA; AMPLIFICATION	Metastasis of tumors requires angiogenesis, which is comprised of multiple biological processes that are regulated by angiogenic factors. The fibroblast growth factor (FGF) is a potent angiogenic factor and aberrant FGF signaling is a common property of tumors. Yet, how the aberration in cancer cells contributes to angiogenesis in the tumor is not well understood. Most studies of its angiogenic signaling mechanisms have been in endothelial cells. FGF receptor substrate 2 alpha (FRS2 alpha) is an FGF receptor-associated protein required for activation of downstream signaling molecules that include those in the mitogen-activated protein and AKT kinase pathways. Herein, we demonstrated that overactivation and hyperactivity of FRS2 alpha, as well as overexpression of cJUN and HIF1 alpha, were positively correlated with vessel density and progression of human prostate cancer (PCa) toward malignancy. We also demonstrate that FGF upregulated the production of vascular endothelial growth factor A mainly by increasing expression of cJUN and HIF1 alpha. This then promoted recruitment of endothelial cells and vessel formation for the tumor. Tumor angiogenesis in mouse PCa tissues was compromised by tissue-specific ablation of Frs2 alpha in prostate epithelial cells. Depletion of Frs2 alpha expression in human PCa cells and in a preclinical xenograft model, MDA PCa 118b, also significantly suppressed tumor angiogenesis accompanied with decreased tumor growth in the bone. The results underscore the angiogenic role of FRS2 alpha-mediated signaling in tumor epithelial cells in angiogenesis. They provide a rationale for treating PCa with inhibitors of FGF signaling. They also demonstrate the potential of overexpressed FRS2 alpha as a biomarker for PCa diagnosis, prognosis and response to therapies.	[Liu, J.; You, P.; Chen, G.; Fu, X.; Zeng, X.; Wang, C.; Huang, Y.; An, L.; McKeehan, W. L.; Wang, F.] Texas A&M Hlth Sci Ctr, Inst Biosci & Technol, Ctr Canc & Stem Cell Biol, Houston, TX USA; [Liu, J.; You, P.; Chen, G.; Fu, X.; Zeng, X.; Wang, C.; Huang, Y.; An, L.; McKeehan, W. L.; Wang, F.] Texas A&M Hlth Sci Ctr, Coll Med, Houston, TX USA; [You, P.; Zhang, Z.] Xiamen Univ, Affiliated Zhongshan Hosp, Xiamen, Peoples R China; [Chen, G.; Fu, X.; Zhong, W.] Guangzhou Med Univ, Guangzhou Peoples Hosp 1, Guangdong Key Lab Clin Mol Med & Diagnost, Dept Urol, Guangzhou, Guangdong, Peoples R China; [Zeng, X.] Jinan Univ, Inst Tissue Transplantat & Immunol, Guangzhou, Guangdong, Peoples R China; [Wang, C.] Wenzhou Med Univ, Coll Pharm, Wenzhou, Peoples R China; [Wan, X.; Navone, N.] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA; [Wu, C-L] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Wu, C-L] Massachusetts Gen Hosp, Dept Urol, Boston, MA 02114 USA; [Wu, C-L] Harvard Univ, Sch Med, Boston, MA USA	Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; Xiamen University; Guangzhou Medical University; Jinan University; Wenzhou Medical University; University of Texas System; UTMD Anderson Cancer Center; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Zhang, Z; Zhong, W; Wang, F (corresponding author), Texas A&M Univ, Inst Biosci & Technol, 2121 W Holcombe Blvd, Houston, TX 77030 USA.	zzy11603@163.com; wdezhong@21cn.com; fwang@ibt.tamhsc.edu		Liu, Junchen/0000-0003-2765-9780	National Institutes of Health [CA96824, DE023106, CA140388]; Cancer Prevention and Research Institution of Texas [CPRIT110555]; National Natural Science Foundation of China [81170699, 81272813, 81101712, 81270761, 510180, 81072016]; NATIONAL CANCER INSTITUTE [R01CA096824, P50CA140388, P50CA083639, R56CA096824] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R56DE023106] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Prevention and Research Institution of Texas; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	We thank Dr Stefan Siwko and Samantha Del Castillo for critical reading of the manuscript. This work was supported in part by the National Institutes of Health CA96824 and DE023106 to FW, CA140388 to NN, WLM and FW, and The Cancer Prevention and Research Institution of Texas CPRIT110555 to FW and WLM, and the National Natural Science Foundation of China 81170699, 81272813 to CW, 81101712, 81270761 to XL, 510180 to WZ and 81072016 to ZYZ.	Acevedo VD, 2007, CANCER CELL, V12, P559, DOI 10.1016/j.ccr.2007.11.004; Bergers G, 2003, NAT REV CANCER, V3, P401, DOI 10.1038/nrc1093; Cross MJ, 2001, TRENDS PHARMACOL SCI, V22, P201, DOI 10.1016/S0165-6147(00)01676-X; Devilard E, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-272; Francescone RA, 2011, JOVE-J VIS EXP, DOI 10.3791/3040; Giri D, 1999, J CELL PHYSIOL, V180, P53, DOI 10.1002/(SICI)1097-4652(199907)180:1<53::AID-JCP6>3.0.CO;2-P; Giri D, 1999, CLIN CANCER RES, V5, P1063; Gotoh N, 2004, P NATL ACAD SCI USA, V101, P17144, DOI 10.1073/pnas.0407577101; GREENBERG NM, 1995, P NATL ACAD SCI USA, V92, P3439, DOI 10.1073/pnas.92.8.3439; Hadari YR, 2001, P NATL ACAD SCI USA, V98, P8578, DOI 10.1073/pnas.161259898; Harris AL, 1996, BREAST CANCER RES TR, V38, P97, DOI 10.1007/BF01803788; Huang XQ, 2006, CANCER RES, V66, P1481, DOI 10.1158/0008-5472.CAN-05-2412; Huang YQ, 2014, MED ONCOL, V31, DOI 10.1007/s12032-013-0820-4; Jin CL, 2003, CANCER RES, V63, P8784; Jin CL, 2003, PROSTATE, V57, P160, DOI 10.1002/pros.10283; Li ZG, 2008, J CLIN INVEST, V118, P2697, DOI 10.1172/JCI33093; Lin YS, 2007, GENESIS, V45, P554, DOI 10.1002/dvg.20327; McDougall SR, 2006, J THEOR BIOL, V241, P564, DOI 10.1016/j.jtbi.2005.12.022; McKeehan W. L., 2009, HDB CELL SIGNALING; Memarzadeh S, 2007, CANCER CELL, V12, P572, DOI 10.1016/j.ccr.2007.11.002; Ozen M, 2001, J NATL CANCER I, V93, P1783, DOI 10.1093/jnci/93.23.1783; Pages G, 2005, CARDIOVASC RES, V65, P564, DOI 10.1016/j.cardiores.2004.09.032; Polnaszek N, 2003, CANCER RES, V63, P5754; Song ZG, 2000, CANCER RES, V60, P6730; Taylor BS, 2010, CANCER CELL, V18, P11, DOI 10.1016/j.ccr.2010.05.026; Teishima J, 2014, ANTICANCER RES, V34, P695; TISCHER E, 1991, J BIOL CHEM, V266, P11947; Tsujii M, 1998, CELL, V93, P705, DOI 10.1016/S0092-8674(00)81433-6; Valencia T, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-484; Valta MP, 2008, INT J CANCER, V123, P22, DOI 10.1002/ijc.23422; Wan XH, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009332; Wang F, 2004, PROSTATE, V58, P1, DOI 10.1002/pros.10311; Wang JH, 2004, CLIN CANCER RES, V10, P6169, DOI 10.1158/1078-0432.CCR-04-0408; Wang XK, 2011, GENE CHROMOSOME CANC, V50, P849, DOI 10.1002/gcc.20906; WEIDNER N, 1993, AM J PATHOL, V143, P401; Winter SF, 2007, ONCOGENE, V26, P4897, DOI 10.1038/sj.onc.1210288; Yang F, 2013, CANCER RES, V73, P3716, DOI 10.1158/0008-5472.CAN-12-3274; Yu EM, 2010, DISCOV MED, V10, P521; Zhang KQ, 2013, CANCER RES, V73, P1298, DOI 10.1158/0008-5472.CAN-12-2086; Zhang YY, 2008, DEVELOPMENT, V135, P775, DOI 10.1242/dev.009910; Zhong WD, 2012, INT J CANCER, V130, P300, DOI 10.1002/ijc.25982	41	21	21	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 7	2016	35	14					1750	1759		10.1038/onc.2015.239	http://dx.doi.org/10.1038/onc.2015.239			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DI6LM	26096936	Green Accepted			2022-12-26	WOS:000373610400002
J	Matsumoto, S; Nakao, H; Kawabe, K; Nonaka, M; Toyoda, H; Takishima, Y; Kawabata, K; Yamaguchi, T; Furue, MK; Taki, T; Okumura, T; Yamazaki, Y; Nakaya, S; Kawasaki, N; Kawasaki, T				Matsumoto, Shogo; Nakao, Hiromi; Kawabe, Keiko; Nonaka, Motohiro; Toyoda, Hidenao; Takishima, Yuto; Kawabata, Kenji; Yamaguchi, Tomoko; Furue, Miho K.; Taki, Takao; Okumura, Takeshi; Yamazaki, Yuzo; Nakaya, Shuuichi; Kawasaki, Nobuko; Kawasaki, Toshisuke			A Cytotoxic Antibody Recognizing Lacto-N-fucopentaose I (LNFP I) on Human Induced Pluripotent Stem (hiPS) Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN TERATOCARCINOMA CELLS; EMBRYONAL CARCINOMA-CELLS; 3 MONOCLONAL-ANTIBODIES; LECTIN MICROARRAY; DIFFERENTIATION; GLYCOSPHINGOLIPIDS; APOPTOSIS; ANTIGENS; SERIES; BIOMARKERS	We have generated a mouse monoclonal antibody (R-17F, IgG1 subtype) specific to human induced pluripotent stem (hiPS)/embryonic stem (ES) cells by using a hiPS cell line as an antigen. Triple-color confocal immunostaining images of hiPS cells with R-17F indicated that the R-17F epitope was expressed exclusively and intensively on the cell membranes of hiPS cells and co-localized partially with those of SSEA-4 and SSEA-3. Lines of evidence suggested that the predominant part of the R-17F epitope was a glycolipid. Upon TLC blot of total lipid extracts from hiPS cells with R-17F, one major R-17F-positive band was observed at a slow migration position close to that of anti-blood group H1(O) antigen. MALDI-TOF-MS and MSn analyses of the purified antigen indicated that the presumptive structure of the R-17F antigen was Fuc-Hex-HexNAc-Hex-Hex-Cer. Glycan microarray analysis involving 13 different synthetic oligosaccharides indicated that R-17F bound selectively to LNFP I (Fuc alpha 1-2Gal beta 1-3GlcNAc beta 1-3Gal beta 1-4Glc). Acritical role of the terminal Fuc alpha 1-2 residue was confirmed by the selective disappearance of R-17F binding to the purified antigen upon alpha 1-2 fucosidase digestion. Most interestingly, R-17F, when added to hiPS/ES cell suspensions, exhibited potent dose-dependent cytotoxicity. The cytotoxic effect was augmented markedly upon the addition of the secondary antibody (goat anti-mouse IgG1 antibody). R-17F may be beneficial for safer regenerative medicine by eliminating residual undifferentiated hiPS cells in hiPS-derived regenerative tissues, which are considered to be a strong risk factor for carcinogenesis.	[Matsumoto, Shogo; Nakao, Hiromi; Kawabe, Keiko; Nonaka, Motohiro; Kawasaki, Nobuko; Kawasaki, Toshisuke] Ritsumeikan Univ, Res Ctr Glycobiotechnol, Kusatsu, Shiga 5258577, Japan; [Kawabe, Keiko; Furue, Miho K.] Natl Inst Biomed Innovat Hlth & Nutr, Lab Stem Cell Cultures, Osaka 5670085, Japan; [Kawabata, Kenji; Yamaguchi, Tomoko] Natl Inst Biomed Innovat Hlth & Nutr, Lab Stem Cell Regulat, Osaka 5670085, Japan; [Toyoda, Hidenao; Takishima, Yuto] Ritsumeikan Univ, Coll Pharmaceut Sci, Lab Bioanalyt Chem, Kusatsu, Shiga 5258577, Japan; [Taki, Takao] Niigata Univ Pharm & Appl Life Sci, Niigata 9560841, Japan; [Taki, Takao] AGT&T Co Ltd, Tokushima 7711151, Japan; [Okumura, Takeshi; Yamazaki, Yuzo; Nakaya, Shuuichi] Shimadzu Co Ltd, Analyt & Measuring Instruments Div, Kyoto 6048511, Japan	Ritsumeikan University; Ritsumeikan University; Niigata University; Shimadzu Corporation	Kawasaki, T (corresponding author), Ritsumeikan Univ, Res Ctr Glycobiotechnol, Noji Higashi 1-1-1, Kusatsu, Shiga 5258577, Japan.	tkawasak@fc.ritsumei.ac.jp		Furue, Miho/0000-0001-5032-9953	Japan Society for the Promotion of Science [24570171, 24110517]; Adaptable and Seamless Technology Transfer Program through target-driven R&D from the Japan Science and Technology Agency [AS242Z01520P, AS251Z01560P]; Ministry of Health, Labor, and Welfare; Ritsumeikan University	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Adaptable and Seamless Technology Transfer Program through target-driven R&D from the Japan Science and Technology Agency; Ministry of Health, Labor, and Welfare(Ministry of Health, Labour and Welfare, Japan); Ritsumeikan University	This work was supported by Grants-in-Aid for Scientific Research C 24570171 (to T. K.) and for Scientific Research on Innovative Areas 24110517 (to T. K.) from the Japan Society for the Promotion of Science. This work was also supported by the Adaptable and Seamless Technology Transfer Program through target-driven R&D AS242Z01520P (to T. K.) and AS251Z01560P (to H. T.) from the Japan Science and Technology Agency; Grants-in-Aid for Research on Regenerative Medicine for Clinical Application (to M. K. F. and T. K.) from the Ministry of Health, Labor, and Welfare; and Grants-in-Aid for the R-GIRO (Ritsumeikan Global Innovation Research Organization) Program (to H. T.) from Ritsumeikan University. The authors declare that they have no conflicts of interest with the contents of this article.	Andrews PW, 2011, NAT BIOTECHNOL, V29, P803, DOI 10.1038/nbt.1974; ANDREWS PW, 1984, HYBRIDOMA, V3, P347, DOI 10.1089/hyb.1984.3.347; Barone A, 2013, J BIOL CHEM, V288, P10035, DOI 10.1074/jbc.M112.436162; Choo AB, 2008, STEM CELLS, V26, P1454, DOI 10.1634/stemcells.2007-0576; COOPER S, 1992, BIOCHEM J, V286, P959, DOI 10.1042/bj2860959; D'Amour KA, 2005, NAT BIOTECHNOL, V23, P1534, DOI 10.1038/nbt1163; Fujitani N, 2013, P NATL ACAD SCI USA, V110, P2105, DOI 10.1073/pnas.1214233110; Fukui S, 2002, NAT BIOTECHNOL, V20, P1011, DOI 10.1038/nbt735; Furue MK, 2008, P NATL ACAD SCI USA, V105, P13409, DOI 10.1073/pnas.0806136105; HOCKENBERY D, 1995, AM J PATHOL, V146, P16; Inamura M, 2011, MOL THER, V19, P400, DOI 10.1038/mt.2010.241; INOKUCHI JI, 1987, J LIPID RES, V28, P565; Itskovitz-Eldor J, 2011, CELL STEM CELL, V9, P291, DOI 10.1016/j.stem.2011.09.005; KANNAGI R, 1983, J BIOL CHEM, V258, P8934; KANNAGI R, 1983, EMBO J, V2, P2355, DOI 10.1002/j.1460-2075.1983.tb01746.x; Kawabe K, 2013, GLYCOBIOLOGY, V23, P322, DOI 10.1093/glycob/cws159; Kurosawa H, 2007, J BIOSCI BIOENG, V103, P389, DOI 10.1263/jbb.103.389; Lanctot PM, 2007, CURR OPIN CHEM BIOL, V11, P373, DOI 10.1016/j.cbpa.2007.05.032; Liang YJ, 2010, P NATL ACAD SCI USA, V107, P22564, DOI 10.1073/pnas.1007290108; MAJNO G, 1995, AM J PATHOL, V146, P3; Makino H, 2009, EXP CELL RES, V315, P2727, DOI 10.1016/j.yexcr.2009.06.016; MEHMET H, 1986, EUR J BIOCHEM, V157, P385, DOI 10.1111/j.1432-1033.1986.tb09680.x; Na J, 2010, STEM CELL RES, V5, P157, DOI 10.1016/j.scr.2010.06.002; Nakamura K, 2006, ANAL CHEM, V78, P5736, DOI 10.1021/ac0605501; Okuda S., 2014, GLYCOSCI BIOL MED, DOI [10.1007/978-4-431-54836-2_27-1, DOI 10.1007/978-4-431-54836-2_27-1]; PERA MF, 1988, DIFFERENTIATION, V39, P139, DOI 10.1111/j.1432-0436.1988.tb00089.x; SHEVINSKY LH, 1982, CELL, V30, P697, DOI 10.1016/0092-8674(82)90274-4; Stoll MS, 2000, EUR J BIOCHEM, V267, P1795, DOI 10.1046/j.1432-1327.2000.01178.x; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Taki T, 1997, ANAL BIOCHEM, V251, P135, DOI 10.1006/abio.1997.2247; Taki T, 2009, METHODS MOL BIOL, V536, P545, DOI 10.1007/978-1-59745-542-8_55; Tan HL, 2009, STEM CELLS, V27, P1792, DOI 10.1002/stem.109; Tang C, 2011, NAT BIOTECHNOL, V29, P829, DOI 10.1038/nbt.1947; Tateno H, 2011, J BIOL CHEM, V286, P20345, DOI 10.1074/jbc.M111.231274; Toyoda M, 2011, GENES CELLS, V16, P1, DOI 10.1111/j.1365-2443.2010.01459.x; Watanabe K, 2007, NAT BIOTECHNOL, V25, P681, DOI 10.1038/nbt1310; Wright AJ, 2009, STEM CELL RES, V3, P3, DOI 10.1016/j.scr.2009.04.001; WYLLIE AH, 1980, NATURE, V284, P555, DOI 10.1038/284555a0; Yu Y, 2012, J BIOL CHEM, V287, P44784, DOI 10.1074/jbc.M112.425819	39	20	20	2	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 14	2015	290	33					20071	20085		10.1074/jbc.M115.657692	http://dx.doi.org/10.1074/jbc.M115.657692			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CP1AT	26100630	Green Published, hybrid			2022-12-26	WOS:000359608900006
J	Xu, X; Xu, X; Liu, P; Zhu, ZY; Chen, J; Fu, HA; Chen, LL; Hu, LH; Shen, X				Xu, Xing; Xu, Xin; Liu, Peng; Zhu, Zhi-yuan; Chen, Jing; Fu, Hai-an; Chen, Li-li; Hu, Li-hong; Shen, Xu			Structural Basis for Small Molecule NDB (N-Benzyl-N-(3-(tert-butyl)-4-hydroxyphenyl)-2,6-dichloro-4-(dimethylamino) Benzamide) as a Selective Antagonist of Farnesoid X Receptor alpha (FXR alpha) in Stabilizing the Homodimerization of the Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ORPHAN NUCLEAR RECEPTOR; BILE-ACID RECEPTOR; NATURAL PRODUCT; IDENTIFICATION; LIGAND; AGONIST; OBESITY; CHOLESTEROL; HOMEOSTASIS; METABOLISM	Farnesoid X receptor alpha (FXR alpha) as a bile acid sensor plays potent roles in multiple metabolic processes, and its antagonist has recently revealed special interests in the treatment of metabolic disorders, although the underlying mechanisms still remain unclear. Here, we identified that the small molecule N-benzyl-N-(3-(tert-butyl)-4-hydroxyphenyl)-2,6-dichloro-4-(dimethylamino) benzamide (NDB) functioned as a selective antagonist of human FXR alpha (hFXR alpha), and the crystal structure of hFXR alpha ligand binding domain (hFXR alpha-LBD) in complex with NDB was analyzed. It was unexpectedly discovered that NDB induced rearrangements of helix 11 (H11) and helix 12 (H12, AF-2) by forming a homodimer of hFXR alpha-LBD, totally different from the active conformation in monomer state, and the binding details were further supported by the mutation analysis. Moreover, functional studies demonstrated that NDB effectively antagonized the GW4064-stimulated FXR/RXR interaction and FXR alpha target gene expression in primary mouse hepatocytes, including the small heterodimer partner (SHP) and bile-salt export pump (BSEP); meanwhile, administration of NDBto db/db mice efficiently decreased the gene expressions of phosphoenolpyruvate carboxykinase (PEPCK), glucose 6-phosphatase (G6-pase), small heterodimer partner, and BSEP. It is expected that our first analyzed crystal structure of hFXR alpha-LBD.NDB will help expound the antagonistic mechanism of the receptor, and NDB may find its potential as a lead compound in anti-diabetes research.	[Xu, Xing; Xu, Xin; Liu, Peng; Zhu, Zhi-yuan; Chen, Jing; Chen, Li-li; Hu, Li-hong; Shen, Xu] Chinese Acad Sci, Shanghai Inst Mat Med, CAS Key Lab Receptor Res, Shanghai 201203, Peoples R China; [Xu, Xing] Shanghai Jiao Tong Univ, Shanghai Key Lab Bone & Joint Dis, Shanghai Inst Traumatol & Orthopaed, Shanghai Ruijin Hosp,Sch Med, Shanghai 200025, Peoples R China; [Fu, Hai-an] Emory Univ, Dept Pharmacol, Sch Med, Atlanta, GA 30322 USA	Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; Shanghai Jiao Tong University; Emory University	Chen, LL (corresponding author), Chinese Acad Sci, Shanghai Inst Mat Med, CAS Key Lab Receptor Res, 555 Zuchongzhi Rd, Shanghai 201203, Peoples R China.	lilichen@simm.ac.cn; lhhu@simm.ac.cn; xshen@mail.shcnc.ac.cn			National Natural Science Foundation of China [91413102, 81373462, 81173105]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China Grants 91413102, 81373462, and 81173105.	Claudel T, 2002, J CLIN INVEST, V109, P961; Downes M, 2003, MOL CELL, V11, P1079, DOI 10.1016/S1097-2765(03)00104-7; Duran-Sandoval D, 2005, J BIOL CHEM, V280, P29971, DOI 10.1074/jbc.M501931200; Evans MJ, 2009, AM J PHYSIOL-GASTR L, V296, pG543, DOI 10.1152/ajpgi.90585.2008; Fiorucci S, 2005, J PHARMACOL EXP THER, V313, P604, DOI 10.1124/jpet.104.079665; Flatt B, 2009, J MED CHEM, V52, P904, DOI 10.1021/jm8014124; FORMAN BM, 1995, CELL, V81, P687, DOI 10.1016/0092-8674(95)90530-8; Huang H, 2012, J MED CHEM, V55, P7037, DOI 10.1021/jm3002718; Jin LH, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2924; Kim JY, 2010, J MOL BIOL, V396, P747, DOI 10.1016/j.jmb.2009.12.008; Koszewski NJ, 2001, BIOCHEM BIOPH RES CO, V283, P188, DOI 10.1006/bbrc.2001.4734; Lee FY, 2006, TRENDS BIOCHEM SCI, V31, P572, DOI 10.1016/j.tibs.2006.08.002; Lien F, 2014, J CLIN INVEST, V124, P1037, DOI 10.1172/JCI68815; Maloney PR, 2000, J MED CHEM, V43, P2971, DOI 10.1021/jm0002127; Mi LZ, 2003, MOL CELL, V11, P1093, DOI 10.1016/S1097-2765(03)00112-6; Parks DJ, 1999, SCIENCE, V284, P1365, DOI 10.1126/science.284.5418.1365; Prawitt J, 2009, DRUG DISCOV TODAY DI, V6, pe55; Prawitt J, 2011, DIABETES, V60, P1861, DOI 10.2337/db11-0030; Puckett MC, 2013, MOL CELL BIOL, V33, P2252, DOI 10.1128/MCB.00047-13; Schoch GA, 2010, J MOL BIOL, V395, P568, DOI 10.1016/j.jmb.2009.11.011; SEOL WG, 1995, MOL ENDOCRINOL, V9, P72, DOI 10.1210/me.9.1.72; Sepe V, 2011, J MED CHEM, V54, P1314, DOI 10.1021/jm101336m; Soisson SM, 2008, P NATL ACAD SCI USA, V105, P5337, DOI 10.1073/pnas.0710981105; Song YY, 2012, J HEPATOL, V56, P248, DOI 10.1016/j.jhep.2011.07.014; Tan MHE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074359; Urizar NL, 2002, SCIENCE, V296, P1703, DOI 10.1126/science.1072891; Watanabe M, 2011, J BIOL CHEM, V286, P26913, DOI 10.1074/jbc.M111.248203; Wu J, 2002, MOL ENDOCRINOL, V16, P1590, DOI 10.1210/me.16.7.1590; Xu X, 2013, STEROIDS, V78, P813, DOI 10.1016/j.steroids.2013.04.018; Zhang HT, 2011, J BIOL CHEM, V286, P24593, DOI 10.1074/jbc.M111.245498; Zhang YQ, 2008, FEBS LETT, V582, P10, DOI 10.1016/j.febslet.2007.11.015; Zhang YQ, 2012, MOL ENDOCRINOL, V26, P272, DOI 10.1210/me.2011-1157	32	39	40	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 7	2015	290	32					19888	19899		10.1074/jbc.M114.630475	http://dx.doi.org/10.1074/jbc.M114.630475			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CO7TL	26100621	Green Published, hybrid			2022-12-26	WOS:000359364600044
J	Blancafort, A; Giro-Perafita, A; Oliveras, G; Palomeras, S; Turrado, C; Campuzano, O; Carrion-Salip, D; Massaguer, A; Brugada, R; Palafox, M; Gomez-Miragaya, J; Gonzalez-Suarez, E; Puig, T				Blancafort, Adriana; Giro-Perafita, Ariadna; Oliveras, Gloria; Palomeras, Sonia; Turrado, Carlos; Campuzano, Oscar; Carrion-Salip, Dolors; Massaguer, Anna; Brugada, Ramon; Palafox, Marta; Gomez-Miragaya, Jorge; Gonzalez-Suarez, Eva; Puig, Teresa			Dual Fatty Acid Synthase and HER2 Signaling Blockade Shows Marked Antitumor Activity against Breast Cancer Models Resistant to Anti-HER2 Drugs	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; TRASTUZUMAB RESISTANCE; HER2-TARGETED THERAPY; FOOD-INTAKE; GREEN TEA; LAPATINIB; INHIBITOR; SURVIVAL; CELLS; XENOGRAFTS	Blocking the enzyme Fatty Acid Synthase (FASN) leads to apoptosis of HER2-positive breast carcinoma cells. The hypothesis is that blocking FASN, in combination with anti-HER2 signaling agents, would be an effective antitumor strategy in preclinical HER2+ breast cancer models of trastuzumab and lapatinib resistance. We developed and molecularly characterized in vitro HER2+ models of resistance to trastuzumab (SKTR), lapatinib (SKLR) and both (SKLTR). The cellular interactions of combining anti-FASN polyphenolic compounds (EGCG and the synthetic G28UCM) with anti-HER2 signaling drugs (trastuzumab plus pertuzumab and temsirolimus) were analyzed. Tumor growth inhibition after treatment with EGCG, pertuzumab, temsirolimus or the combination was evaluated in two in vivo orthoxenopatients: one derived from a HER2+ patient and another from a patient who relapsed on trastuzumab and lapatinib-based therapy. SKTR, SKLR and SKLTR showed hyperactivation of EGFR and p-ERK1/2 and PI3KCA mutations. Dual-resistant cells (SKLTR) also showed hyperactivation of HER4 and recovered levels of p-AKT compared with mono-resistant cells. mTOR, p-mTOR and FASN expression remained stable in SKTR, SKLR and SKLTR. In vitro, anti-FASN compounds plus pertuzumab showed synergistic interactions in lapatinib- and dual-resistant cells and improved the results of pertuzumab plus trastuzumab co-treatment. FASN inhibitors combined with temsirolimus displayed the strongest synergistic interactions in resistant cells. In vivo, both orthoxenopatients showed strong response to the antitumor activity of the combination of EGCG with pertuzumab or temsirolimus, without signs of toxicity. We showed that the simultaneous blockade of FASN and HER2 pathways is effective in cells and in breast cancer models refractory to anti-HER2 therapies.	[Blancafort, Adriana; Giro-Perafita, Ariadna; Oliveras, Gloria; Palomeras, Sonia; Puig, Teresa] Univ Girona, Fac Med, Dept Med Sci, New Therapeut Targets Lab,TargetsLab, Girona, Spain; [Oliveras, Gloria] Hosp Dr Josep Trueta, Catalan Inst Oncol, Girona, Spain; [Turrado, Carlos] Univ Complutense, Fac Ciencias Quim, Quim Organ 1, E-28040 Madrid, Spain; [Campuzano, Oscar; Brugada, Ramon] Univ Girona IDIBGi, Cardiovasc Genet Ctr, Girona, Spain; [Carrion-Salip, Dolors; Massaguer, Anna] Univ Girona, Biochem & Mol Biol Unit, Dept Biol, Girona, Spain; [Palafox, Marta; Gomez-Miragaya, Jorge; Gonzalez-Suarez, Eva] Hosp Llobregat Barcelona, Bellvitge Inst Biomed Res IDIBELL, Canc Epigenet & Biol Program PEBC, Barcelona, Spain	Universitat de Girona; Catalan Institute of Oncology; Universitat de Girona; Girona University Hospital Dr. Josep Trueta; Complutense University of Madrid; Universitat de Girona; Girona University Hospital Dr. Josep Trueta; Institut d'Investigacio Biomedica de Girona (IDIBGI); Universitat de Girona; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL)	Puig, T (corresponding author), Univ Girona, Fac Med, Dept Med Sci, New Therapeut Targets Lab,TargetsLab, Girona, Spain.	teresa.puig@udg.edu	Gonzalez-Suarez, Eva/L-6298-2014; Giró, Ariadna/AAB-7158-2020; campuzano, oscar/J-1968-2014; Pairet, Sònia Palomeras/AAB-1724-2020; Massaguer, Anna/L-5993-2014	Gonzalez-Suarez, Eva/0000-0003-0858-8171; Giró, Ariadna/0000-0002-1055-7123; campuzano, oscar/0000-0001-5298-5276; Gomez-Miragaya, Jorge/0000-0003-1801-4681; Massaguer, Anna/0000-0003-1312-593X	Spanish Instituto de Salud Carlos III (ISCIII) [FIS PI11/00692]; Spanish Ministerio de Ciencia e Innovacion [MICCIN CIT-090000-2009-10, SAF-2011-22893]; La Marato de TV3 Foundation; La Caixa Foundation; Pfizer S.L.; University of Girona	Spanish Instituto de Salud Carlos III (ISCIII)(Instituto de Salud Carlos III); Spanish Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); La Marato de TV3 Foundation; La Caixa Foundation(La Caixa Foundation); Pfizer S.L.; University of Girona	This work was supported by the Spanish Instituto de Salud Carlos III (ISCIII) (FIS PI11/00692, TP) and the Spanish Ministerio de Ciencia e Innovacion (MICCIN CIT-090000-2009-10, TP and SAF-2011-22893, EG-S), La Marato de TV3 Foundation (TP, EG-S), La Caixa Foundation (RB) and Pfizer S.L. (TP). The University of Girona awarded AB and AG-P with a predoctoral grant and La Marato de TV3 Foundation awarded SP with a predoctoral grant.	Aja S, 2008, AM J PHYSIOL-REG I, V294, pR352, DOI 10.1152/ajpregu.00862.2006; Andre F, 2014, LANCET ONCOL, V15, P580, DOI 10.1016/S1470-2045(14)70138-X; Arpino G, 2007, JNCI-J NATL CANCER I, V99, P694, DOI 10.1093/jnci/djk151; Baselga J, 2009, NAT REV CANCER, V9, P463, DOI 10.1038/nrc2656; Berns K, 2007, CANCER CELL, V12, P395, DOI 10.1016/j.ccr.2007.08.030; Carpten JD, 2007, NATURE, V448, P439, DOI 10.1038/nature05933; Carrion-Salip D, 2012, INT J ONCOL, V41, P1128, DOI 10.3892/ijo.2012.1509; Chen Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097697; Citri A, 2006, NAT REV MOL CELL BIO, V7, P505, DOI 10.1038/nrm1962; Del Bufalo D, 2006, CANCER RES, V66, P5549, DOI 10.1158/0008-5472.CAN-05-2825; Dua R, 2010, BREAST CANCER RES TR, V122, P685, DOI 10.1007/s10549-009-0592-x; Eichhorn PJA, 2008, CANCER RES, V68, P9221, DOI 10.1158/0008-5472.CAN-08-1740; Esteva FJ, 2010, NAT REV CLIN ONCOL, V7, P98, DOI 10.1038/nrclinonc.2009.216; Fan D, 2009, DRUG RESISTANCE IN CANCER CELLS, P21, DOI 10.1007/978-0-387-89445-4_2; Ferguson KM, 2003, MOL CELL, V11, P507, DOI 10.1016/S1097-2765(03)00047-9; Gaur S, 2011, CANCER LETT, V311, P20, DOI 10.1016/j.canlet.2011.06.005; Geyer CE, 2006, NEW ENGL J MED, V355, P2733, DOI 10.1056/NEJMoa064320; Grunt TW, 2009, BIOCHEM BIOPH RES CO, V385, P454, DOI 10.1016/j.bbrc.2009.05.085; Jatoi A, 2003, CANCER-AM CANCER SOC, V97, P1442, DOI 10.1002/cncr.11200; Junttila TT, 2009, CANCER CELL, V15, P429, DOI 10.1016/j.ccr.2009.03.020; Kaneko M, 2014, J CANCER RES CLIN, V140, P769, DOI 10.1007/s00432-014-1628-0; Liang Y, 2002, CURR CANCER DRUG TAR, V2, P257, DOI 10.2174/1568009023333872; Loftus TM, 2000, SCIENCE, V288, P2379, DOI 10.1126/science.288.5475.2379; Maier T, 2006, SCIENCE, V311, P1258, DOI 10.1126/science.1123248; Migita T, 2009, JNCI-J NATL CANCER I, V101, P519, DOI 10.1093/jnci/djp030; Mittendorf EA, 2009, CLIN CANCER RES, V15, P7381, DOI 10.1158/1078-0432.CCR-09-1735; Nagata Y, 2004, CANCER CELL, V6, P117, DOI 10.1016/j.ccr.2004.06.022; Nahta R, 2004, CANCER RES, V64, P2343, DOI 10.1158/0008-5472.CAN-03-3856; Nahta R, 2004, CANCER CHEMOTH PHARM, V53, P186, DOI 10.1007/s00280-003-0728-3; Nahta R, 2006, NAT CLIN PRACT ONCOL, V3, P269, DOI 10.1038/ncponc0509; O'Brien NA, 2014, CLIN CANCER RES, V20, P3507, DOI 10.1158/1078-0432.CCR-13-2769; Olayioye MA, 2000, EMBO J, V19, P3159, DOI 10.1093/emboj/19.13.3159; Oliveras G, 2010, ANN NY ACAD SCI, V1210, P86, DOI 10.1111/j.1749-6632.2010.05777.x; Populo H, 2012, INT J MOL SCI, V13, P1886, DOI 10.3390/ijms13021886; Puglisi F, 2012, DRUGS, V72, P1175, DOI 10.2165/11634000-000000000-00000; Puig T, 2008, ANTICANCER RES, V28, P3671; Puig T, 2008, BREAST CANCER RES TR, V109, P471, DOI 10.1007/s10549-007-9678-5; Puig T, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr3077; Puig T, 2009, CLIN CANCER RES, V15, P7608, DOI 10.1158/1078-0432.CCR-09-0856; Rhee J, 2011, BREAST CANCER RES TR, V125, P107, DOI 10.1007/s10549-010-1200-9; Ritter CA, 2007, CLIN CANCER RES, V13, P4909, DOI 10.1158/1078-0432.CCR-07-0701; Sabbisetti V, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005877; Sassen A, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2339; Scaltriti M, 2007, J NATL CANCER I, V99, P628, DOI 10.1093/jnci/djk134; Siddiqui RA, 2007, NUTR CLIN PRACT, V22, P74, DOI 10.1177/011542650702200174; SLAMON DJ, 1989, SCIENCE, V244, P707, DOI 10.1126/science.2470152; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; Tee AR, 2003, J BIOL CHEM, V278, P37288, DOI 10.1074/jbc.M303257200; Trempe G L, 1976, Recent Results Cancer Res, P33; Turrado C, 2012, J MED CHEM, V55, P5013, DOI 10.1021/jm2016045; Wang YC, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr3067; Williamson G, 2005, AM J CLIN NUTR, V81, p243S, DOI [10.1093/ajcn/81.1.243S, 10.1093/ajcn/81.1.230S]; Zhang HT, 2007, J CLIN INVEST, V117, P2051, DOI 10.1172/JCI32278; Zoppoli G, 2010, CURR CANCER DRUG TAR, V10, P168, DOI 10.2174/156800910791054211	54	41	43	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2015	10	6							e0131241	10.1371/journal.pone.0131241	http://dx.doi.org/10.1371/journal.pone.0131241			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4OM	26107737	Green Submitted, gold, Green Published			2022-12-26	WOS:000356932500149
J	Krynak, KL; Burke, DJ; Benard, MF				Krynak, Katherine L.; Burke, David J.; Benard, Michael F.			Larval Environment Alters Amphibian Immune Defenses Differentially across Life Stages and Populations	PLOS ONE			English	Article							ANTIMICROBIAL PEPTIDE DEFENSES; CUTANEOUS BACTERIA; CARBARYL EXPOSURE; CHYTRIDIOMYCOSIS; SALAMANDER; GROWTH; ECTOMYCORRHIZAS; ACIDIFICATION; PESTICIDES; PLANTATION	Recent global declines, extirpations and extinctions of wildlife caused by newly emergent diseases highlight the need to improve our knowledge of common environmental factors that affect the strength of immune defense traits. To achieve this goal, we examined the influence of acidification and shading of the larval environment on amphibian skin-associated innate immune defense traits, pre and post-metamorphosis, across two populations of American Bullfrogs (Rana catesbeiana), a species known for its wide-ranging environmental tolerance and introduced global distribution. We assessed treatment effects on 1) skin-associated microbial communities and 2) post-metamorphic antimicrobial peptide (AMP) production and 3) AMP bioactivity against the fungal pathogen Batrachochytrium dendrobatidis (Bd). While habitat acidification did not affect survival, time to metamorphosis or juvenile mass, we found that a change in average pH from 7 to 6 caused a significant shift in the larval skin microbial community, an effect which disappeared after metamorphosis. Additionally, we found shifts in skin-associated microbial communities across life stages suggesting they are affected by the physiological or ecological changes associated with amphibian metamorphosis. Moreover, we found that post-metamorphic AMP production and bioactivity were significantly affected by the interactions between pH and shade treatments and interactive effects differed across populations. In contrast, there were no significant interactions between treatments on post-metamorphic microbial community structure suggesting that variation in AMPs did not affect microbial community structure within our study. Our findings indicate that commonly encountered variation in the larval environment (i.e. pond pH and degree of shading) can have both immediate and long-term effects on the amphibian innate immune defense traits. Our work suggests that the susceptibility of amphibians to emerging diseases could be related to variability in the larval environment and calls for research into the relative influence of potentially less benign anthropogenic environmental changes on innate immune defense traits.	[Krynak, Katherine L.; Benard, Michael F.] Case Western Reserve Univ, Dept Biol, Cleveland, OH 44106 USA; [Burke, David J.] Holden Arboretum, Res Dept, Kirtland, OH USA	Case Western Reserve University	Krynak, KL (corresponding author), Case Western Reserve Univ, Dept Biol, Cleveland, OH 44106 USA.	klk73@case.edu		Benard, Michael/0000-0002-8585-3816	National Science Foundation Graduate Research Fellowship [DGE-0951783]; Holden Arboretum Trust	National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF)); Holden Arboretum Trust	This material is based upon work supported by the National Science Foundation Graduate Research Fellowship, under Grant No. DGE-0951783, to KLK, fieldwork was supported by Case Western Reserve University to MFB, and laboratory work was supported by The Holden Arboretum Trust to DJB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2013, R LANG ENV STAT COMP; Bashey F, 2006, EVOLUTION, V60, P348, DOI 10.1554/05-087.1; Becker MH, 2009, APPL ENVIRON MICROB, V75, P6635, DOI 10.1128/AEM.01294-09; Belden LK, 2007, FRONT ECOL ENVIRON, V5, P533; Benard MF, 2004, ANNU REV ECOL EVOL S, V35, P651, DOI 10.1146/annurev.ecolsys.35.021004.112426; Benitez-Mandujano M, 1997, GROWTH METAMORPHOSIS, P481; Boes MW, 2013, COPEIA, P717, DOI 10.1643/CE-12-091; Boone MD, 2005, J HERPETOL, V39, P416, DOI 10.1670/187-04A.1; Bradley CA, 2007, TRENDS ECOL EVOL, V22, P95, DOI 10.1016/j.tree.2006.11.001; Bressan W, 2001, PESQUI AGROPECU BRAS, V36, P315, DOI 10.1590/S0100-204X2001000200015; Brucker RM, 2008, J CHEM ECOL, V34, P39, DOI 10.1007/s10886-007-9352-8; Burke DJ, 2008, FEMS MICROBIOL ECOL, V65, P299, DOI 10.1111/j.1574-6941.2008.00491.x; Burke DJ, 2006, CAN J BOT, V84, P924, DOI 10.1139/B06-046; Burke DJ, 2006, FEMS MICROBIOL ECOL, V57, P409, DOI 10.1111/j.1574-6941.2006.00125.x; Burke DJ, 2005, SOIL BIOL BIOCHEM, V37, P1683, DOI 10.1016/j.soilbio.2005.01.028; Chapman BB, 2010, BEHAV ECOL, V21, P501, DOI 10.1093/beheco/arq003; COLLINS JP, 1979, ECOLOGY, V60, P738, DOI 10.2307/1936611; Conlon JM, 2010, ANTIMICROBIAL PEPTID; Crawley M.J., 2007, R BOOK; Davidson C, 2007, ENVIRON SCI TECHNOL, V41, P1771, DOI 10.1021/es0611947; Dittmar J, 2014, J ANIM ECOL, V83, P744, DOI 10.1111/1365-2656.12175; Engering A, 2013, EMERG MICROBES INFEC, V2, DOI 10.1038/emi.2013.5; Ficetola GF, 2007, DIVERS DISTRIB, V13, P476, DOI 10.1111/j.1472-4642.2007.00377.x; Fockedey N, 2005, J EXP MAR BIOL ECOL, V326, P27, DOI 10.1016/j.jembe.2005.05.005; Frost DR, 2006, B AM MUS NAT HIST, P8, DOI 10.1206/0003-0090(2006)297[0001:TATOL]2.0.CO;2; Gibble RE, 2011, ECOTOX ENVIRON SAFE, V74, P593, DOI 10.1016/j.ecoenv.2010.11.009; Gibble RE, 2008, ECOTOX ENVIRON SAFE, V71, P506, DOI 10.1016/j.ecoenv.2007.10.016; GOATER CP, 1994, ECOLOGY, V75, P2264, DOI 10.2307/1940882; Gosner K. L., 1960, Herpetologica, V16, P183; Gray MJ, 2009, DIS AQUAT ORGAN, V87, P243, DOI 10.3354/dao02138; Grice EA, 2011, NAT REV MICROBIOL, V9, P244, DOI 10.1038/nrmicro2537; Groner ML, 2014, J EXP BIOL, V217, P351, DOI 10.1242/jeb.091611; Groner ML, 2013, ECOL APPL, V23, P1443, DOI 10.1890/12-1572.1; Gruwez R, 2014, ANN BOT-LONDON, V113, P489, DOI 10.1093/aob/mct272; Hagman M, 2009, FUNCT ECOL, V23, P126, DOI 10.1111/j.1365-2435.2008.01470.x; Harris RN, 2006, ECOHEALTH, V3, P53, DOI 10.1007/s10393-005-0009-1; Harris RN, 2009, ISME J, V3, P818, DOI 10.1038/ismej.2009.27; Kiesecker J, 1996, ECOL APPL, V6, P1325, DOI 10.2307/2269610; Kueneman JG, 2014, MOL ECOL, V23, P1238, DOI 10.1111/mec.12510; Kung D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087101; Lacoul P, 2011, ENVIRON REV, V19, P429, DOI [10.1139/A11-016, 10.1139/a11-016]; Lauer A, 2007, COPEIA, P630, DOI 10.1643/0045-8511(2007)2007[630:CCBFTE]2.0.CO;2; Longcore JE, 1999, MYCOLOGIA, V91, P219, DOI 10.2307/3761366; Loudon AH, 2014, ISME J, V8, P830, DOI 10.1038/ismej.2013.200; Lucio WD, 2013, SEMIN-CIENC AGRAR, V34, P1587, DOI 10.5433/1679-0359.2013v34n4p1587; McCune B., 2002, ANAL ECOLOGICAL COMM, DOI 10.1016/S0022-0981(03)00091-1; McKenzie VJ, 2012, ISME J, V6, P588, DOI 10.1038/ismej.2011.129; Murphy AD, 2014, J EVOLUTION BIOL, V27, P1613, DOI 10.1111/jeb.12414; MUYZER G, 1993, APPL ENVIRON MICROB, V59, P695, DOI 10.1128/AEM.59.3.695-700.1993; Norris K, 2000, BEHAV ECOL, V11, P19, DOI 10.1093/beheco/11.1.19; PIERCE BA, 1985, BIOSCIENCE, V35, P239, DOI 10.2307/1310132; Pounds JA, 2006, NATURE, V439, P161, DOI 10.1038/nature04246; Provenzano SE, 2009, J HERPETOL, V43, P49, DOI 10.1670/08-052R1.1; Raffel TR, 2008, PARASITOLOGY, V135, P203, DOI 10.1017/S0031182007003708; Relyea R.A., 2009, OECOLOGIA, V159, P363, DOI DOI 10.1007/s00442-008-1213-9; Relyea RA, 2006, ECOTOXICOLOGY, V15, P503, DOI 10.1007/s10646-006-0086-0; Rollins-Smith LA, 2005, INTEGR COMP BIOL, V45, P137, DOI 10.1093/icb/45.1.137; Rollins-Smith LA, 2005, DEV COMP IMMUNOL, V29, P589, DOI 10.1016/j.dci.2004.11.004; Rollins-Smith LA, 2002, DEV COMP IMMUNOL, V26, P471, DOI 10.1016/S0145-305X(01)00088-X; Rollins-Smith LA, 2011, INTEGR COMP BIOL, V51, P552, DOI 10.1093/icb/icr095; Rollins-Smith LA, 2009, BBA-BIOMEMBRANES, V1788, P1593, DOI 10.1016/j.bbamem.2009.03.008; ROWE CL, 1992, ARCH ENVIRON CON TOX, V23, P339, DOI 10.1007/BF00216243; Schadich E, 2010, J EXP ZOOL PART A, V313A, P532, DOI 10.1002/jez.582; Schlosser IJ, 2000, ECOLOGY, V81, P1046, DOI 10.2307/177177; Scott DM, 2006, BIOL CONSERV, V127, P72, DOI 10.1016/j.biocon.2005.07.014; Sheafor B, 2008, J WILDLIFE DIS, V44, P226, DOI 10.7589/0090-3558-44.2.226; Skelly DK, 2001, ISRAEL J ZOOL, V47, P313, DOI 10.1092/BVT1-LUYF-2XG6-B007; Stillwell RC, 2005, ECOLOGY, V86, P924, DOI 10.1890/04-0547; Tejedo M, 2010, CLIM RES, V43, P31, DOI 10.3354/cr00878; Tukey JW, 1977, EXPLORATORY DATA ANA; van Dorst J, 2014, FEMS MICROBIOL ECOL, V89, P316, DOI 10.1111/1574-6941.12308; Webber NR, 2010, ENVIRON TOXICOL CHEM, V29, P2323, DOI 10.1002/etc.269; Williams AP, 2013, NAT CLIM CHANGE, V3, P292, DOI [10.1038/nclimate1693, 10.1038/NCLIMATE1693]; Woodhams DC, 2007, ANIM CONSERV, V10, P409, DOI 10.1111/j.1469-1795.2007.00130.x; Woodhams DC, 2007, BIOL CONSERV, V138, P390, DOI 10.1016/j.biocon.2007.05.004; Wright A, 1949, HDB FROGS TOADS US C	77	21	23	1	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2015	10	6							e0130383	10.1371/journal.pone.0130383	http://dx.doi.org/10.1371/journal.pone.0130383			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4OM	26107644	Green Published, Green Submitted, gold			2022-12-26	WOS:000356932500098
J	Torres-Sanchez, J; Lopez-Granados, F; Serrano, N; Arquero, O; Pena, JM				Torres-Sanchez, Jorge; Lopez-Granados, Francisca; Serrano, Nicolas; Arquero, Octavio; Pena, Jose M.			High-Throughput 3-D Monitoring of Agricultural-Tree Plantations with Unmanned Aerial Vehicle (UAV) Technology	PLOS ONE			English	Article							PRECISION AGRICULTURE; IMAGERY; IDENTIFICATION; VISION	The geometric features of agricultural trees such as canopy area, tree height and crown volume provide useful information about plantation status and crop production. However, these variables are mostly estimated after a time-consuming and hard field work and applying equations that treat the trees as geometric solids, which produce inconsistent results. As an alternative, this work presents an innovative procedure for computing the 3-dimensional geometric features of individual trees and tree-rows by applying two consecutive phases: 1) generation of Digital Surface Models with Unmanned Aerial Vehicle (UAV) technology and 2) use of object-based image analysis techniques. Our UAV-based procedure produced successful results both in single-tree and in tree-row plantations, reporting up to 97% accuracy on area quantification and minimal deviations compared to in-field estimations of tree heights and crown volumes. The maps generated could be used to understand the linkages between tree grown and field-related factors or to optimize crop management operations in the context of precision agriculture with relevant agro-environmental implications.	[Torres-Sanchez, Jorge; Lopez-Granados, Francisca; Pena, Jose M.] Inst Sustainable Agr IAS CSIC, Dept Crop Protect, Cordoba, Spain; [Serrano, Nicolas; Arquero, Octavio] Inst Agr Res & Training IFAPA Alameda del Obispo, Cordoba, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Agricultura Sostenible (IAS)	Pena, JM (corresponding author), Inst Sustainable Agr IAS CSIC, Dept Crop Protect, Cordoba, Spain.	jmpena@ias.csic.es	Torres-Sánchez, Jorge/H-4714-2019; Arquero, Octavio/ABF-5923-2021; Peña, Jose M/K-4201-2014; Lopez-Granados, Francisca/J-5617-2014	Torres-Sánchez, Jorge/0000-0003-1420-0145; Peña, Jose M/0000-0003-4592-3792; Lopez-Granados, Francisca/0000-0001-9165-7558	Spanish CSIC; MINECO, EU-FEDER; Marie Curie Actions, Spanish Ministry of Economy and Competitiveness - FPI [FP7-PEOPLE-2011-CIG-293991]; Ramon y Cajal grant	Spanish CSIC; MINECO, EU-FEDER; Marie Curie Actions, Spanish Ministry of Economy and Competitiveness - FPI; Ramon y Cajal grant(Spanish Government)	This research was partly financed by the RECUPERA-2020 Project (agreement between Spanish CSIC and MINECO, EU-FEDER funds) and the Marie Curie Actions (ref.: Project FP7-PEOPLE-2011-CIG-293991, EU-7th Frame Program), Spanish Ministry of Economy and Competitiveness partially funded JTS (FPI grant) and JMP (Ramon y Cajal grant) research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson C, 2014, MIT TECHNOLOGY  0423; Baatz M., 2000, P ANGEW GEOGRAPHISCH, P12, DOI [DOI 10.3390/RS5010183, 10.1207/s15326888chc1304_3]; Bendig J, 2014, REMOTE SENS-BASEL, V6, P10395, DOI 10.3390/rs61110395; Blaschke T, 2014, ISPRS J PHOTOGRAMM, V87, P180, DOI 10.1016/j.isprsjprs.2013.09.014; Dandois JP, 2013, REMOTE SENS ENVIRON, V136, P259, DOI 10.1016/j.rse.2013.04.005; Diaz-Varela RA, 2014, J ENVIRON MANAGE, V134, P117, DOI 10.1016/j.jenvman.2014.01.006; Diaz-Varela RA, 2015, REMOTE SENS-BASEL, V7, P4213, DOI 10.3390/rs70404213; Fernandez-Sarria A, 2013, COMPUT ELECTRON AGR, V90, P176, DOI 10.1016/j.compag.2012.09.017; Hengl T, 2006, COMPUT GEOSCI-UK, V32, P1283, DOI 10.1016/j.cageo.2005.11.008; Kattenborn T, 2014, INT ARCH PHOTOGRAMME, P139; Laliberte AS, 2011, GISCI REMOTE SENS, V48, P4, DOI 10.2747/1548-1603.48.1.4; Luo C, 2014, SCIENCE, V344, P1351, DOI 10.1126/science.344.6190.1351-b; Pena JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077151; Marris E, 2013, NATURE, V498, P156, DOI 10.1038/498156a; Moorthy I, 2011, AGR FOREST METEOROL, V151, P204, DOI 10.1016/j.agrformet.2010.10.005; Nex F, 2014, APPL GEOMAT, V6, P1, DOI 10.1007/s12518-013-0120-x; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; Pastor M, 2005, CULTIVO OLIVO CON RI; Qin RJ, 2014, REMOTE SENS-BASEL, V6, P7911, DOI 10.3390/rs6097911; Rosell JR, 2012, COMPUT ELECTRON AGR, V81, P124, DOI 10.1016/j.compag.2011.09.007; Rouse JW, 1973, THIRD ERTS SYMPOSIUM, VI, P309; Rovira-Mas F, 2008, COMPUT ELECTRON AGR, V60, P133, DOI 10.1016/j.compag.2007.07.007; Torres-Sanchez J, 2015, COMPUT ELECTRON AGR, V114, P43, DOI 10.1016/j.compag.2015.03.019; Torres-Sanchez J, 2014, COMPUT ELECTRON AGR, V103, P104, DOI 10.1016/j.compag.2014.02.009; Torres-Sanchez J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058210; West P. W., 2009, TREE FOREST MEASUREM, DOI [DOI 10.1007/978-3-540-95966-3, 10.1007/978-3-540-95966-3]; WOEBBECKE DM, 1995, T ASAE, V38, P259, DOI 10.13031/2013.27838; Zarco-Tejada PJ, 2014, EUR J AGRON, V55, P89, DOI 10.1016/j.eja.2014.01.004; Zhang CH, 2012, PRECIS AGRIC, V13, P693, DOI 10.1007/s11119-012-9274-5	29	152	158	1	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2015	10	6							e0130479	10.1371/journal.pone.0130479	http://dx.doi.org/10.1371/journal.pone.0130479			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4OM	26107174	Green Submitted, gold, Green Published			2022-12-26	WOS:000356932500103
J	Valverde, A; Penarando, J; Canas, A; Lopez-Sanchez, LM; Conde, F; Hernandez, V; Peralbo, E; Lopez-Pedrera, C; de la Haba-Rodriguez, J; Aranda, E; Rodriguez-Ariza, A				Valverde, Araceli; Penarando, Jon; Canas, Amanda; Lopez-Sanchez, Laura M.; Conde, Francisco; Hernandez, Vanessa; Peralbo, Esther; Lopez-Pedrera, Chary; de la Haba-Rodriguez, Juan; Aranda, Enrique; Rodriguez-Ariza, Antonio			Simultaneous Inhibition of EGFR/VEGFR and Cyclooxygenase-2 Targets Stemness-Related Pathways in Colorectal Cancer Cells	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; TYROSINE KINASE INHIBITOR; TRANSCRIPTION FACTOR; EXPRESSION; AEE788; VEGF; TRANSACTIVATION; PLURIPOTENCY; APOPTOSIS; MOTILITY	Despite the demonstrated benefits of anti-EGFR/VEGF targeted therapies in metastatic colorectal cancer (mCRC), many patients initially respond, but then show evidence of disease progression. New therapeutic strategies are needed to make the action of available drugs more efficient. Our study aimed to explore whether simultaneous targeting of EGFR/VEGF and cyclooxygenase-2 (COX-2) may aid the treatment and management of mCRC patients. The dual tyrosine kinase inhibitor AEE788 and celecoxib were used to inhibit EGFR/VEGFR and COX-2, respectively, in colorectal cancer cells. COX-2 inhibition with celecoxib augmented the antitumoral and antiangiogenic efficacy of AEE788, as indicated by the inhibition of cell proliferation, induction of apoptosis and G1 cell cycle arrest, down-regulation of VEGF production by cancer cells and reduction of cell migration. These effects were related with a blockade in the EGFR/VEGFR signaling axis. Notably, the combined AEE788/celecoxib treatment prevented beta-catenin nuclear accumulation in tumor cells. This effect was associated with a significant downregulation of FOXM1 protein levels and an impairment in the interaction of this transcription factor with beta-catenin, which is required for its nuclear localization. Furthermore, the combined treatment also reduced the expression of the stem cell markers Oct 3/4, Nanog, Sox-2 and Snail in cancer cells, and contributed to the diminution of the CSC subpopulation, as indicated by colonosphere formation assays. In conclusion, the combined treatment of AEE788 and celecoxib not only demonstrated enhanced anti-tumoral efficacy in colorectal cancer cells, but also reduced colon CSCs subpopulation by targeting stemness-related pathways. Therefore, the simultaneous targeting of EGFR/VEGF and COX-2 may aid in blocking mCRC progression and improve the efficacy of existing therapies in colorectal cancer.	[Valverde, Araceli; Penarando, Jon; Canas, Amanda; Lopez-Sanchez, Laura M.; Conde, Francisco; Hernandez, Vanessa; de la Haba-Rodriguez, Juan; Aranda, Enrique; Rodriguez-Ariza, Antonio] Univ Cordoba, Maimonides Inst Biomed Res IMIBIC, Reina Sofia Hosp, Dept Oncol, Cordoba, Spain; [Valverde, Araceli; Penarando, Jon; Canas, Amanda; Lopez-Sanchez, Laura M.; Conde, Francisco; Hernandez, Vanessa; de la Haba-Rodriguez, Juan; Aranda, Enrique; Rodriguez-Ariza, Antonio] Inst Salud Carlos III, Spanish Canc Network RTICC, Madrid, Spain; [Peralbo, Esther; Lopez-Pedrera, Chary] Univ Cordoba, Maimonides Inst Biomed Res IMIBIC, Reina Sofia Hosp, Res Unit, Cordoba, Spain	Universidad de Cordoba; Instituto de Salud Carlos III; Universidad de Cordoba	Rodriguez-Ariza, A (corresponding author), Univ Cordoba, Maimonides Inst Biomed Res IMIBIC, Reina Sofia Hosp, Dept Oncol, Cordoba, Spain.	antonio.rodriguez.exts@juntadeandalucia.es	Conde, Francisco/R-6924-2016; Rodriguez-Ariza, Antonio/U-4854-2017; Aranda, Enrique/AAA-4147-2019; López-Sánchez, Laura María/E-3260-2018; Conde, Francisco M./AAC-7672-2019; Peñarando, Jon/AAB-2890-2021; Lopez-Pedrera, Chary/M-4603-2015	Conde, Francisco/0000-0003-3143-6520; Rodriguez-Ariza, Antonio/0000-0001-5304-5745; López-Sánchez, Laura María/0000-0002-0763-1804; Conde, Francisco M./0000-0003-3143-6520; Lopez-Pedrera, Chary/0000-0003-2067-4603; Haba Rodriguez, Juan Rafael de la/0000-0001-5111-1702	Spanish Cancer Network (RTICC), Instituto de Salud Carlos III [RD12/0036/0038]	Spanish Cancer Network (RTICC), Instituto de Salud Carlos III(Instituto de Salud Carlos III)	EA was supported by Spanish Cancer Network (RTICC), Instituto de Salud Carlos III (RD12/0036/0038) (www.isciii.es). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anastas JN, 2013, NAT REV CANCER, V13, P11, DOI 10.1038/nrc3419; Banu N, 2007, CELL PROLIFERAT, V40, P768, DOI 10.1111/j.1365-2184.2007.00459.x; Barbarroja N, 2010, EXP HEMATOL, V38, P641, DOI 10.1016/j.exphem.2010.03.017; Bardelli A, 2010, J CLIN ONCOL, V28, P1254, DOI 10.1200/JCO.2009.24.6116; Baselga J, 2012, CLIN CANCER RES, V18, P6364, DOI 10.1158/1078-0432.CCR-12-1499; Botchkina G, 2013, CANCER LETT, V338, P127, DOI 10.1016/j.canlet.2012.04.006; Castellone MD, 2005, SCIENCE, V310, P1504, DOI 10.1126/science.1116221; Dannenberg AJ, 2005, J CLIN ONCOL, V23, P254, DOI 10.1200/JCO.2005.09.112; Donnini S, 2007, FASEB J, V21, P2418, DOI 10.1096/fj.06-7581com; Faunes F, 2013, DEVELOPMENT, V140, P1171, DOI 10.1242/dev.085654; Ferlay J, 2013, EUR J CANCER, V49, P1374, DOI 10.1016/j.ejca.2012.12.027; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Fodde R, 2007, CURR OPIN CELL BIOL, V19, P150, DOI 10.1016/j.ceb.2007.02.007; Goel HL, 2013, NAT REV CANCER, V13, P871, DOI 10.1038/nrc3627; Grau R, 2006, BIOCHEM J, V395, P81, DOI 10.1042/BJ20050964; Han C, 2006, J CELL PHYSIOL, V207, P261, DOI 10.1002/jcp.20560; Henderson BR, 2002, EMBO REP, V3, P834, DOI 10.1093/embo-reports/kvf181; Holland JD, 2013, CURR OPIN CELL BIOL, V25, P254, DOI 10.1016/j.ceb.2013.01.004; Hubbard J, 2010, CURR OPIN ONCOL, V22, P374, DOI 10.1097/CCO.0b013e328339524e; Larkins TL, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-181; Li XQ, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-114; Luraghi P, 2014, CANCER RES, V74, P1857, DOI 10.1158/0008-5472.CAN-13-2340-T; Ma RYM, 2010, METHODS MOL BIOL, V647, P113, DOI 10.1007/978-1-60761-738-9_6; Marques I, 2013, WORLD J GASTROENTERO, V19, P7955, DOI 10.3748/wjg.v19.i44.7955; Merlos-Suarez A, 2011, CELL STEM CELL, V8, P511, DOI 10.1016/j.stem.2011.02.020; Moreira L, 2011, CURR DRUG TARGETS, V12, P1888, DOI 10.2174/138945011798184218; Mulder K, 2011, EXPERT OPIN BIOL TH, V11, P405, DOI 10.1517/14712598.2011.557657; Neumann J, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-518; Oommen S, 2011, J BIOL CHEM, V286, P1083, DOI 10.1074/jbc.M110.175158; Park YW, 2005, CLIN CANCER RES, V11, P1963, DOI 10.1158/1078-0432.CCR-04-1665; Perrot-Applanat M, 2012, CELL ADHES MIGR, V6, P547, DOI 10.4161/cam.23332; Siena S, 2009, JNCI-J NATL CANCER I, V101, P1308, DOI 10.1093/jnci/djp280; Toomey DP, 2009, SURG-J R COLL SURG E, V7, P174, DOI 10.1016/S1479-666X(09)80042-5; Traxler P, 2004, CANCER RES, V64, P4931, DOI 10.1158/0008-5472.CAN-03-3681; Venkatesan P, 2012, LIFE SCI, V91, P789, DOI 10.1016/j.lfs.2012.08.024; Vermeulen L, 2012, LANCET ONCOL, V13, pE83, DOI 10.1016/S1470-2045(11)70257-1; Vermeulen L, 2010, NAT CELL BIOL, V12, P468, DOI 10.1038/ncb2048; Visvader JE, 2012, CELL STEM CELL, V10, P717, DOI 10.1016/j.stem.2012.05.007; Wang IC, 2014, ONCOGENE, V33, P5391, DOI 10.1038/onc.2013.475; Wang Y, 2013, STEM CELLS, V31, P1921, DOI 10.1002/stem.1438; Xu LH, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008455; Zhang N, 2011, CANCER CELL, V20, P427, DOI 10.1016/j.ccr.2011.08.016; Zhao D, 2014, ONCOGENE	43	29	33	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2015	10	6							e0131363	10.1371/journal.pone.0131363	http://dx.doi.org/10.1371/journal.pone.0131363			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4OM	26107817	Green Submitted, Green Published, gold			2022-12-26	WOS:000356932500160
J	Wu, A; Budge, PJ; Williams, J; Griffin, MR; Edwards, KM; Johnson, M; Zhu, YW; Hartinger, S; Verastegui, H; Gil, AI; Lanata, CF; Grijalva, CG				Wu, Andrew; Budge, Philip J.; Williams, John; Griffin, Marie R.; Edwards, Kathryn M.; Johnson, Monika; Zhu, Yuwei; Hartinger, Stella; Verastegui, Hector; Gil, Ana I.; Lanata, Claudio F.; Grijalva, Carlos G.			Incidence and Risk Factors for Respiratory Syncytial Virus and Human Metapneumovirus Infections among Children in the Remote Highlands of Peru	PLOS ONE			English	Article							COMMUNITY-ACQUIRED PNEUMONIA; EPIDEMIOLOGY; ETIOLOGY; DISEASE; INFANTS; BURDEN	Introduction The disease burden and risk factors for respiratory syncytial virus (RSV) and human metapneumovirus (MPV) infections among children living in remote, rural areas remain unclear. Materials and Methods We conducted a prospective, household-based cohort study of children aged <3 years living in remote rural highland communities in San Marcos, Cajamarca, Peru. Acute respiratory illnesses (ARI), including lower respiratory tract infection (LRTI), were monitored through weekly household visits from March 2009 through September 2011. Nasal swabs collected during ARI/LRTI were tested for RSV, MPV, and other respiratory viruses using real-time RT-PCR. Incidence rates and rate ratios were calculated using mixed effects Poisson regression. Results Among 892 enrolled children, incidence rates of RSV and MPV ARI were 30 and 17 episodes per 100 child-years, respectively. The proportions of RSV and MPV ARI that presented as LRTI were 12.5% and 8.9%, respectively. Clinic visits for ARI and hospitalizations were significantly more frequent (all p values <0.05) among children with RSV (clinic 41% and hospital 5.3%) and MPV ARI (38% and 3.5%) when compared with other viral infections (23% and 0.7%) and infections without virus detected (24% and 0.6%). In multivariable analysis, risk factors for RSV detection included younger age (RR 1.02, 95% CI: 1.00-1.03), the presence of a smoker in the house (RR 1.63, 95% CI: 1.12-2.38), residing at higher altitudes (RR 1.93, 95% CI: 1.25-3.00 for 2nd compared to 1st quartile residents; RR 1.98, 95% CI: 1.26-3.13 for 3rd compared to 1st quartile residents). Having an unemployed household head was significantly associated with MPV risk (RR 2.11, 95% CI: 1.12-4.01). Conclusion In rural high altitude communities in Peru, childhood ARI due to RSV or MPV were common and associated with higher morbidity than ARI due to other viruses or with no viral detections. The risk factors identified in this study may be considered for interventional studies to control infections by these viruses among young children from developing countries.	[Wu, Andrew] Vanderbilt Univ, Sch Med, Nashville, TN 37212 USA; [Budge, Philip J.] Washington Univ, Sch Med, Div Infect Dis, St Louis, MO 63110 USA; [Williams, John; Edwards, Kathryn M.; Johnson, Monika] Vanderbilt Univ, Dept Pediat, Nashville, TN 37235 USA; [Williams, John] Vanderbilt Univ, Dept Pathol Microbiol & Immunol, Nashville, TN 37235 USA; [Griffin, Marie R.; Grijalva, Carlos G.] Vanderbilt Univ, Dept Hlth Policy, Nashville, TN 37235 USA; [Edwards, Kathryn M.] Vanderbilt Univ, Div Infect Dis, Dept Pediat, Vanderbilt Vaccine Res Program, Nashville, TN 37235 USA; [Zhu, Yuwei] Vanderbilt Univ, Dept Biostat, Nashville, TN 37235 USA; [Hartinger, Stella] Swiss Trop & Publ Hlth Inst, Basel, Switzerland; [Hartinger, Stella; Verastegui, Hector; Gil, Ana I.; Lanata, Claudio F.] Inst Invest Nutr, Lima, Peru	Vanderbilt University; Washington University (WUSTL); Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; University of Basel; Swiss Tropical & Public Health Institute	Grijalva, CG (corresponding author), Vanderbilt Univ, Dept Hlth Policy, 221 Kirkland Hall, Nashville, TN 37235 USA.	Carlos.grijalva@vanderbilt.edu	Budge, Philip/ABE-6458-2020; Williams, John/ABE-3227-2020; Williams, John/F-6962-2010; Lanata, Claudio F./N-7997-2018	Williams, John/0000-0001-8377-5175; Williams, John/0000-0001-8377-5175; Lanata, Claudio F./0000-0002-6994-7425	Vanderbilt University CTSA grant from National Institutes of Health [UL1 RR024975]; Pfizer [IIR WS1898786(0887X1-4492)]; Thrasher Research Fund [02832-9]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024975] Funding Source: NIH RePORTER	Vanderbilt University CTSA grant from National Institutes of Health; Pfizer(Pfizer); Thrasher Research Fund; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by the Vanderbilt University CTSA grant UL1 RR024975 from National Institutes of Health, an investigator initiated research grant from Pfizer (IIR WS1898786(0887X1-4492), http://www.pfizer.com) and grant 02832-9 from the Thrasher Research Fund (www.thrasherresearch.org/default.aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Sonboli N, 2006, EMERG INFECT DIS, V12, P1437, DOI 10.3201/eid1209.060207; [Anonymous], 2010, INF INC RESP SYNC VI; [Anonymous], 1997, INT MAN CHILDH ILLN; Barry PW, 1997, EUR RESPIR J, V10, P35, DOI 10.1183/09031936.97.10010035; Budge PJ, 2014, PEDIAT INFECT DIS J; Bulkow LR, 2002, PEDIATRICS, P1098; Carpenter JR, 2011, J STAT SOFTWARE, V45; CLAESSON BA, 1989, PEDIATR INFECT DIS J, V8, P856, DOI 10.1097/00006454-198912000-00006; Colosia AD, BMC INFECT DIS, P1471; Compare G, 2010, GLOBAL BURDEN DIS GB; da Silva ER, 2013, BMC INFECT DIS, P1471; Duff AL, 1993, PEDIATRICS; Edwards KM, NEW ENGLAND J MED, P1533; Foulongne V, 2007, PEDIATR INFECT DIS J; Gove S, 1997, B WORLD HEALTH ORGAN; Grijalva CG, 2013, INT J EPIDEMIOL, P1464; Hall CB, 2009, NEW ENGL J MED, V360, P588, DOI 10.1056/NEJMoa0804877; Hartinger SM, 2011, CONTEMP CLIN TRIALS, P1559; Homaira N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032056; Hortal M, 1990, REV INFECT DIS; Jansen RR, 2011, J CLIN MICROBIOL, V49, P2631, DOI 10.1128/JCM.02094-10; Juven T, 2000, PEDIATR INFECT DIS J, V19, P293, DOI 10.1097/00006454-200004000-00006; Lambrechts T, 1999, B WORLD HEALTH ORGAN; Law BJ, 2002, RESP MED, V96, pS1, DOI 10.1053/rmed.2002.1294; Liu L, 2012, LANCET, V379, P2151, DOI 10.1016/S0140-6736(12)60560-1; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; McConnochie KM, 1986, AM J DIS CHILDREN; Michelow IC, 2004, PEDIATRICS, V113, P701, DOI 10.1542/peds.113.4.701; Mulholland K, 2003, PEDIAT PULMONOLOGY, P8755; Munywoki PK, 2014, J INFECT DIS, V209, P1685, DOI 10.1093/infdis/jit828; Nair H, 2010, LANCET; NIERMEYER S, 1993, J PEDIATR-US, V123, P767, DOI 10.1016/S0022-3476(05)80857-1; Nokes DJ, 2004, J INFECT DIS, V190, P1828, DOI 10.1086/425040; Nokes DJ, 2008, CLIN INFECT DIS; Okiro EA, 2008, TROP MED INT HEALTH, V13, P914, DOI 10.1111/j.1365-3156.2008.02092.x; Papenburg J, 2012, J INFECT DIS, V206, P178, DOI 10.1093/infdis/jis333; Peltola V, 2008, CLIN INFECT DIS, V46, P58, DOI 10.1086/524020; Rudan I, 2005, LANCET, V365, P2031, DOI 10.1016/S0140-6736(05)66697-4; Rudan I, 2008, B WORLD HEALTH ORGAN, P1564; Simoes EAF, 2003, J PEDIATR-US, V143, pS118, DOI 10.1067/S0022-3476(03)00511-0; Simoes EAF, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P483; Singeton RJ, 2010, J MED VIROL, V82, P1282, DOI 10.1002/jmv.21790; Smith KR, 2011, LANCET, V378, P1717, DOI 10.1016/S0140-6736(11)60921-5; Sommer C, 2011, OPEN MICROBIOLOGY J, P1874; van der Zalm MM, 2009, J PEDIATR-US, V154, P396, DOI 10.1016/j.jpeds.2008.08.036; von Linstow ML, 2008, EUROPEAN J PEDIAT; Weber MW, 1999, INT J EPIDEMIOL, V28, P157, DOI 10.1093/ije/28.1.157; Williams JV, 2004, NEW ENGL J MED, V350, P443, DOI 10.1056/NEJMoa025472; Wubbel L, 1999, PEDIATR INFECT DIS J, V18, P98, DOI 10.1097/00006454-199902000-00004	49	17	18	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2015	10	6							e0130233	10.1371/journal.pone.0130233	http://dx.doi.org/10.1371/journal.pone.0130233			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4OM	26107630	Green Submitted, Green Accepted, gold, Green Published			2022-12-26	WOS:000356932500087
J	Chen, JZ; Miao, XY; Xu, M; He, JL; Xie, Y; Wu, XW; Chen, G; Yu, LY; Zhang, WH				Chen, Jiazhen; Miao, Xinyu; Xu, Meng; He, Junlin; Xie, Yi; Wu, Xingwen; Chen, Gang; Yu, Liying; Zhang, Wenhong			Intra-Genomic Heterogeneity in 16S rRNA Genes in Strictly Anaerobic Clinical Isolates from Periodontal Abscesses	PLOS ONE			English	Article							HUMAN ORAL-CAVITY; RPOB SEQUENCE-ANALYSIS; SP NOV.; VEILLONELLA-PARVULA; MOLECULAR-IDENTIFICATION; GENUS BACTEROIDES; MALDI-TOF; COMB. NOV; PREVOTELLA; PCR	Background Members of the genera Prevotella, Veillonella and Fusobacterium are the predominant culturable obligate anaerobic bacteria isolated from periodontal abscesses. When determining the cumulative number of clinical anaerobic isolates from periodontal abscesses, ambiguous or overlapping signals were frequently encountered in 16S rRNA gene sequencing chromatograms, resulting in ambiguous identifications. With the exception of the genus Veillonella, the high intra-chromosomal heterogeneity of rrs genes has not been reported. Methods The 16S rRNA genes of 138 clinical, strictly anaerobic isolates and one reference strain were directly sequenced, and the chromatograms were carefully examined. Gene cloning was performed for 22 typical isolates with doublet sequencing signals for the 16S rRNA genes, and four copies of the rrs-ITS genes of 9 Prevotella intermedia isolates were separately amplified by PCR, sequenced and compared. Five conserved housekeeping genes, hsp60, recA, dnaJ, gyrB1 and rpoB from 89 clinical isolates of Prevotella were also amplified by PCR and sequenced for identification and phylogenetic analysis along with 18 Prevotella reference strains. Results Heterogeneity of 16S rRNA genes was apparent in clinical, strictly anaerobic oral bacteria, particularly in the genera Prevotella and Veillonella. One hundred out of 138 anaerobic strains (72%) had intragenomic nucleotide polymorphisms (SNPs) in multiple locations, and 13 strains (9.4%) had intragenomic insertions or deletions in the 16S rRNA gene. In the genera Prevotella and Veillonella, 75% (67/89) and 100% (19/19) of the strains had SNPs in the 16S rRNA gene, respectively. Gene cloning and separate amplifications of four copies of the rrs-ITS genes confirmed that 2 to 4 heterogeneous 16S rRNA copies existed. Conclusion Sequence alignment of five housekeeping genes revealed that intra-species nucleotide similarities were very high in the genera Prevotella, ranging from 94.3-100%. However, the inter-species similarities were relatively low, ranging from 68.7-97.9%. The housekeeping genes rpoB and gyrB1 were demonstrated to be alternative classification markers to the species level based on intra-and inter-species comparisons, whereas based on phylogenetic tree rpoB proved to be reliable phylogenetic marker for the genus Prevotella.	[Chen, Jiazhen; Miao, Xinyu; Chen, Gang; Zhang, Wenhong] Fudan Univ, Huashan Hosp, Dept Infect Dis, Shanghai 200040, Peoples R China; [Xu, Meng; He, Junlin; Xie, Yi; Wu, Xingwen; Yu, Liying] Fudan Univ, Huashan Hosp, Dept Stomatol, Shanghai 200040, Peoples R China	Fudan University; Fudan University	Yu, LY (corresponding author), Fudan Univ, Huashan Hosp, Dept Stomatol, Shanghai 200040, Peoples R China.	wuyu1984@hotmail.com; zhangwenhong@fudan.edu.cn		Wu, Xingwen/0000-0002-6943-7185	National Natural Science Foundation of China 443 [81101226, 81471987]; Foundation of Fudan University	National Natural Science Foundation of China 443; Foundation of Fudan University	The work was supported all by the National Natural Science Foundation of China 443 (81101226 and 81471987) and the Foundation of Fudan University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alauzet C, 2007, INT J SYST EVOL MICR, V57, P2216, DOI 10.1099/ijs.0.65173-0; Alauzet C, 2010, ANTIMICROB AGENTS CH, V54, P60, DOI 10.1128/AAC.01003-09; Alexandre A, 2008, INT J SYST EVOL MICR, V58, P2839, DOI 10.1099/ijs.0.2008/001636-0; Bhatti MA, 2000, CLIN INFECT DIS, V31, P839, DOI 10.1086/314046; Boo TW, 2005, J INFECTION, V50, P81, DOI 10.1016/j.jinf.2003.11.008; Carrasco G, 2013, J CLIN MICROBIOL, V51, P3602, DOI 10.1128/JCM.00515-13; Ciantar M, 2005, J CLIN MICROBIOL, V43, P1894, DOI 10.1128/JCM.43.4.1894-1901.2005; Downes J, 2013, INT J SYST EVOL MICR, V63, P1214, DOI 10.1099/ijs.0.041376-0; Downes J, 2011, INT J SYST EVOL MICR, V61, P854, DOI 10.1099/ijs.0.023861-0; Drancourt M, 2000, J CLIN MICROBIOL, V38, P3623, DOI 10.1128/JCM.38.10.3623-3630.2000; Garner O, 2014, CLIN MICROBIOL INFEC, V20, P335, DOI 10.1111/1469-0691.12317; Graf J, 1999, J CLIN MICROBIOL, V37, P3194, DOI 10.1128/JCM.37.10.3194-3197.1999; Grif K, 2012, J CLIN MICROBIOL, V50, P2250, DOI 10.1128/JCM.00362-12; Haag H, 2013, DIAGN MICR INFEC DIS, V76, P413, DOI 10.1016/j.diagmicrobio.2013.04.027; Hedberg ME, 2013, INT J SYST EVOL MICR, V63, P4218, DOI 10.1099/ijs.0.052647-0; Jaramillo A, 2005, J CLIN PERIODONTOL, V32, P1213, DOI 10.1111/j.1600-051X.2005.00839.x; Jensen S, 2009, FEMS MICROBIOL LETT, V294, P207, DOI 10.1111/j.1574-6968.2009.01567.x; Kitahara M, 2012, INT J SYST EVOL MICR, V62, P1145, DOI 10.1099/ijs.0.032706-0; Ko KS, 2007, CLIN MICROBIOL INFEC, V13, P48, DOI 10.1111/j.1469-0691.2006.01553.x; La Scola B, 2011, ANAEROBE, V17, P106, DOI 10.1016/j.anaerobe.2011.05.010; Lazarevic V, 2009, J MICROBIOL METH, V79, P266, DOI 10.1016/j.mimet.2009.09.012; Lopez-Lopez A, 2007, J MOL EVOL, V65, P687, DOI 10.1007/s00239-007-9047-3; Marchandin H, 2003, MICROBIOL-SGM, V149, P1493, DOI 10.1099/mic.0.26132-0; Marriott D, 2007, J CLIN MICROBIOL, V45, P672, DOI 10.1128/JCM.01633-06; Mashima I, 2013, INT J SYST EVOL MICR, V63, P1443, DOI 10.1099/ijs.0.042515-0; Michon AL, 2010, MICROBIOL-SGM, V156, P2080, DOI 10.1099/mic.0.038224-0; Nagy E, 2012, J MED MICROBIOL, V61, P1393, DOI 10.1099/jmm.0.043927-0; Pei AY, 2010, APPL ENVIRON MICROB, V76, P3886, DOI 10.1128/AEM.02953-09; Robertson D, 2009, J MED MICROBIOL, V58, P155, DOI 10.1099/jmm.0.003517-0; Rodriguez-Cavallini E, 2011, CLIN MICROBIOL INFEC, V17, P1043, DOI 10.1111/j.1469-0691.2010.03419.x; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sakamoto M, 2002, INT J SYST EVOL MICR, V52, P841, DOI [10.1099/ijs.0.01945-0, 10.1099/00207713-52-3-841]; Sakamoto M, 2011, MICROBIOL-SGM, V157, P3388, DOI 10.1099/mic.0.052332-0; Sakamoto M, 2010, J MED MICROBIOL, V59, P1293, DOI 10.1099/jmm.0.020420-0; Sakamoto M, 2010, INT J SYST EVOL MICR, V60, P500, DOI 10.1099/ijs.0.012831-0; Satokari RM, 2001, APPL ENVIRON MICROB, V67, P504, DOI 10.1128/AEM.67.2.504-513.2001; SHAH HN, 1990, INT J SYST BACTERIOL, V40, P205, DOI 10.1099/00207713-40-2-205; Sun DL, 2013, APPL ENVIRON MICROB, V79, P5962, DOI 10.1128/AEM.01282-13; Takada K, 2010, INT J SYST EVOL MICR, V60, P1637, DOI 10.1099/ijs.0.017020-0; Takeda K, 2010, J MED MICROBIOL, V59, P165, DOI 10.1099/jmm.0.011346-0; Ueda K, 1999, J BACTERIOL, V181, P78, DOI 10.1128/JB.181.1.78-82.1999; Wade WG, 2011, J CLIN PERIODONTOL, V38, P7, DOI 10.1111/j.1600-051X.2010.01679.x; Wellinghausen N, 2009, J CLIN MICROBIOL, V47, P2759, DOI 10.1128/JCM.00567-09; Weng FY, 2009, J APPL MICROBIOL, V107, P452, DOI 10.1111/j.1365-2672.2009.04235.x; Woo PCY, 2003, J CLIN MICROBIOL, V41, P1996, DOI 10.1128/JCM.41.5.1996-2001.2003; Wybo I, 2012, J CLIN MICROBIOL, V50, P1415, DOI 10.1128/JCM.06326-11; Xie Y, 2014, J PERIODONTOL, V85, P327, DOI 10.1902/jop.2013.130081; Yang JJ, 2013, ANN LAB MED, V33, P379, DOI 10.3343/alm.2013.33.5.379	48	5	5	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2015	10	6							e0130265	10.1371/journal.pone.0130265	http://dx.doi.org/10.1371/journal.pone.0130265			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4DD	26103050	Green Submitted, gold, Green Published			2022-12-26	WOS:000356901900033
J	Cocco, S; Secondo, A; Del Viscovo, A; Procaccini, C; Formisano, L; Franco, C; Esposito, A; Scorziello, A; Matarese, G; Di Renzo, G; Canzoniero, LMT				Cocco, Stefania; Secondo, Agnese; Del Viscovo, Adelaide; Procaccini, Claudio; Formisano, Luigi; Franco, Cristina; Esposito, Alba; Scorziello, Antonella; Matarese, Giuseppe; Di Renzo, Gianfranco; Canzoniero, Lorella Maria Teresa			Polychlorinated Biphenyls Induce Mitochondrial Dysfunction in SH-SY5Y Neuroblastoma Cells	PLOS ONE			English	Article							INDUCED NEURONAL DEATH; NITRIC-OXIDE; AROCLOR 1254; TRANSCRIPTION FACTOR; RESPIRATORY-CHAIN; PYRUVATE PROTECTS; ZINC TOXICITY; PEROXYNITRITE; CALCIUM; PATHWAY	Chronic exposure to polychlorinated biphenyls (PCBs), ubiquitous environmental contaminants, can adversely affect the development and function of the nervous system. Here we evaluated the effect of PCB exposure on mitochondrial function using the PCB mixture Aroclor-1254 (A 1254) in SH-SY5Y neuroblastoma cells. A 6-hour exposure to A1254 (5 mu g/ml) reduced cellular ATP production by 45%+/- 7, and mitochondrial membrane potential, detected by TMRE, by 49%+/- 7. Consistently, A1254 significantly decreased oxidative phosphorylation and aerobic glycolysis measured by extracellular flux analyzer. Furthermore, the activity of mitochondrial protein complexes I, II, and IV, but not V (ATPase), measured by BN-PAGE technique, was significantly reduced after 6-hour exposure to A1254. The addition of pyruvic acid during exposure to A1254 significantly prevent A1254-induced cell injury, restoring resting mitochondrial membrane potential, ATP levels, oxidative phosphorylation and aerobic glycolysis. Furthermore, pyruvic acid significantly preserved the activity of mitochondrial complexes I, II and IV and increased basal activity of complex V. Collectively, the present results indicate that the neurotoxicity of A1254 depends on the impairment of oxidative phosphorylation, aerobic glycolysis, and mitochondrial complexes I, II, and IV activity and it was counteracted by pyruvic acid.	[Cocco, Stefania; Secondo, Agnese; Franco, Cristina; Esposito, Alba; Scorziello, Antonella; Di Renzo, Gianfranco] Univ Naples Federico II, Sch Med, Dept Neurosci & Reprod & Odontostomatol Sci, Div Pharmacol, I-80131 Naples, Italy; [Del Viscovo, Adelaide; Formisano, Luigi; Canzoniero, Lorella Maria Teresa] Univ Sannio, DST, I-82100 Benevento, Italy; [Procaccini, Claudio] Univ Naples Federico II, Dipartimento Med Mol & Biotecnol Med, IEOS CNR, Lab Immunol, Naples, Italy; [Matarese, Giuseppe] Univ Salerno, Dipartimento Med & Chirurg, I-84100 Salerno, Italy; [Matarese, Giuseppe] IRCCS MultiMed, Milan, Italy	University of Naples Federico II; University of Sannio; Consiglio Nazionale delle Ricerche (CNR); Istituto per Endocrinologia e Oncologia "Gaetano Salvatore" (IEOS-CNR); University of Naples Federico II; University of Salerno; IRCCS Multimedica	Canzoniero, LMT (corresponding author), Univ Sannio, DST, Via PortArsa 11, I-82100 Benevento, Italy.	canzoniero@unisannio.it	Scorziello, Antonella/K-6131-2018; Cocco, Stefania/AAA-6454-2019; Di Renzo, Gian C./P-3819-2017; Procaccini, Claudio/AAB-3696-2019; Matarese, Giuseppe/AAO-4077-2021; Secondo, Agnese/AAA-3407-2022; Franco, Cristina/AHE-8992-2022	Di Renzo, Gian C./0000-0003-4467-240X; Matarese, Giuseppe/0000-0001-9429-0616; cocco, stefania/0000-0003-3169-1580; PROCACCINI, CLAUDIO/0000-0002-2184-0442; Secondo, Agnese/0000-0001-5054-4098; Formisano, Luigi/0000-0001-7294-8595; Franco, Cristina/0000-0001-8186-9274; CANZONIERO, Lorella Maria Teresa/0000-0003-2255-5341	Ministero della Salute, Ricerca Sanitaria, Ricerca finalizzata [GR2010-2318138]; Ministero della Salute, Ricerca Oncologica; Ministero della Salute, Progetto Strategico; Ministero della Salute, Progetto Ordinario; Progetto Giovani Ricercatori from Ministero della Salute [GR-2010-2318138]; Fondazione Italiana Sclerosi Multipla (FISM) [2012/R/11]; European Union IDEAS Programme European Research Council (ERC)-Starting Grant "menTORingTregs" [310496]; CNR-Medicina Personalizzata; FIRB MERIT Grant [RBNE08HWLZ_15]; COFIN; Ministero della Salute, Ricerca finalizzata	Ministero della Salute, Ricerca Sanitaria, Ricerca finalizzata(Ministry of Health, Italy); Ministero della Salute, Ricerca Oncologica(Ministry of Health, Italy); Ministero della Salute, Progetto Strategico(Ministry of Health, Italy); Ministero della Salute, Progetto Ordinario(Ministry of Health, Italy); Progetto Giovani Ricercatori from Ministero della Salute; Fondazione Italiana Sclerosi Multipla (FISM)(Fondazione Italiana Sclerosi Multipla (FISM)); European Union IDEAS Programme European Research Council (ERC)-Starting Grant "menTORingTregs"; CNR-Medicina Personalizzata; FIRB MERIT Grant; COFIN; Ministero della Salute, Ricerca finalizzata(Ministry of Health, Italy)	This work was supported by grants from [COFIN 2008], Ministero della Salute, Ricerca Sanitaria [GR2010-2318138], Ricerca finalizzata [2006]; Ministero della Salute, Ricerca Oncologica [2006]; Ministero della Salute, Progetto Strategico, [2007]; Ministero della Salute, Progetto Ordinario, [2007]; Progetto Giovani Ricercatori GR-2010-2318138 from Ministero della Salute; G.M. is supported by Fondazione Italiana Sclerosi Multipla (FISM) 2012/R/11, European Union IDEAS Programme European Research Council (ERC)-Starting Grant "menTORingTregs" 310496, the CNR-Medicina Personalizzata and from FIRB MERIT Grant n. RBNE08HWLZ_15.	Almeida A, 2001, J NEUROCHEM, V77, P676, DOI 10.1046/j.1471-4159.2001.00276.x; Alvarez G, 2003, J NEUROSCI RES, V73, P260, DOI 10.1002/jnr.10648; BOLANOS JP, 1994, J NEUROCHEM, V63, P910; BOLANOS JP, 1995, J NEUROCHEM, V64, P1965; Bolanos JP, 2008, BBA-BIOENERGETICS, V1777, P789, DOI 10.1016/j.bbabio.2008.04.011; Canzoniero LMT, 2006, J NEUROSCI RES, V84, P692, DOI 10.1002/jnr.20971; Chen CJ, 2003, J NEUROCHEM, V85, P443, DOI 10.1046/j.1471-4159.2003.01691.x; Corona C, 2003, CELL DEATH DIS, V28, pe91; Del Viscovo A, 2012, AM J PHYSIOL-ENDOC M, V302, pE1419, DOI 10.1152/ajpendo.00389.2011; Desagher S, 1997, J NEUROSCI, V17, P9060; Formisano L, 2015, J NEUROSCI RES, V93, P167, DOI 10.1002/jnr.23464; Formisano L, 2011, J PHARMACOL EXP THER, V338, P997, DOI 10.1124/jpet.111.181289; Goldstein S, 2008, METHOD ENZYMOL, V436, P49, DOI 10.1016/S0076-6879(08)36004-2; Guida N, 2014, TOXICOL APPL PHARM, V280, P190, DOI 10.1016/j.taap.2014.07.014; Inglefield JR, 2000, J PHARMACOL EXP THER, V295, P105; Jagtap JC, 2003, J CHEM NEUROANAT, V26, P109, DOI 10.1016/S0891-0618(03)00037-1; Kawahara M, 2002, CELL MOL NEUROBIOL, V22, P87, DOI 10.1023/A:1015345813075; Kodavanti PRS, 2011, TOXICOL APPL PHARM, V256, P290, DOI 10.1016/j.taap.2011.07.005; Kodavanti PRS, 1998, TOXICOL APPL PHARM, V153, P186, DOI 10.1006/taap.1998.8533; Livigni A, 2006, MOL BIOL CELL, V17, P263, DOI 10.1091/mbc.e05-09-0827; Maeda M, 2003, J PHARMACEUT BIOMED, V30, P1725, DOI 10.1016/S0731-7085(02)00514-9; Mallet RT, 2005, EXP BIOL MED, V230, P435; Mazzio E, 2003, NEUROSCI LETT, V337, P77, DOI 10.1016/S0304-3940(02)01327-7; Moncada S, 2006, J NEUROCHEM, V97, P1676, DOI 10.1111/j.1471-4159.2006.03988.x; Mundy WR, 1999, TOXICOLOGY, V136, P27, DOI 10.1016/S0300-483X(99)00052-9; Nicholls DG, 2003, CELL CALCIUM, V34, P407, DOI 10.1016/S0143-4160(03)00144-1; Radi R, 2002, BIOL CHEM, V383, P401, DOI 10.1515/BC.2002.044; Sadeghi-Aliabadi H, 2007, CHEM-BIOL INTERACT, V167, P184, DOI 10.1016/j.cbi.2007.02.011; Sheline CT, 2010, EUR J NEUROSCI, V32, P894, DOI 10.1111/j.1460-9568.2010.07372.x; TILSON HA, 1990, NEUROTOXICOL TERATOL, V12, P239, DOI 10.1016/0892-0362(90)90095-T; Wong PW, 1997, J BIOL CHEM, V272, P15145, DOI 10.1074/jbc.272.24.15145; Yoo MH, 2004, INVEST OPHTH VIS SCI, V45, P1523, DOI 10.1167/iovs.03-1315	32	20	22	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2015	10	6							e0129481	10.1371/journal.pone.0129481	http://dx.doi.org/10.1371/journal.pone.0129481			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4DD	26101884	gold, Green Submitted, Green Published			2022-12-26	WOS:000356901900014
J	Shan, L; Qiu, T; Ling, Y; Guo, L; Zheng, B; Wang, BN; Li, WB; Li, L; Ying, JM				Shan, Ling; Qiu, Tian; Ling, Yun; Guo, Lei; Zheng, Bo; Wang, Bingning; Li, Wenbin; Li, Lin; Ying, Jianming			Prevalence and Clinicopathological Characteristics of HER2 and BRAF Mutation in Chinese Patients with Lung Adenocarcinoma	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; KINASE DOMAIN; CANCER; FEATURES; EGFR	Aims To determine the prevalence and clinicopathological characteristics of BRAF V600E mutation and HER2 exon 20 insertions in Chinese lung adenocarcinoma (ADC) patients. Methods Given the fact that the driver mutations are mutually exclusive in lung ADCs, 204 EGFR/KRAS wild-type cases were enrolled in this study. Direct Sanger sequencing was performed to examine BRAF V600E and HER2 exon 20 mutations. The association of BRAF and HER2 mutations with clinicopathological characteristics was statistically analyzed. Results Among the 204 lung ADCs tested, 11 cases (5.4%) carried HER2 exon 20 insertions and 4 cases (2.0%) had BRAF V600E mutation. HER2 mutation status was identified to be associated with a non-smoking history (p<0.05). HER2 mutation occurs in 9.4% of never smokers (10/106), 8.7% of female (8/92) and 2.7% of male (3/112) in this selected cohort. All four BRAF mutated patients were women and three of them were never-smokers. No HER2 mutant patients harbor BRAF mutation. Conclusions HER2 and BRAF mutations identify a distinct subset of lung ADCs. Given the high prevalence of lung cancer and the availability of targeted therapy, Chinese lung ADC patients without EGFR and KRAS mutations are recommended for HER2 and BRAF mutations detection, especially for those never smokers.	[Shan, Ling; Qiu, Tian; Ling, Yun; Guo, Lei; Zheng, Bo; Wang, Bingning; Li, Wenbin; Li, Lin; Ying, Jianming] Chinese Acad Med Sci, Peking Union Med Coll, Canc Hosp, Dept Pathol, Beijing 100730, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS; Peking Union Medical College	Ying, JM (corresponding author), Chinese Acad Med Sci, Peking Union Med Coll, Canc Hosp, Dept Pathol, Beijing 100730, Peoples R China.	jmying@cicams.ac.cn	Guo, Lei/AEU-0178-2022		Youth Backbone Program of Cancer Hospital, CAMS, Beijing, China; National Natural Science Foundation of China [81402464]; National Key Scientific and Technological Project [2011ZX09307-001-01]	Youth Backbone Program of Cancer Hospital, CAMS, Beijing, China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Scientific and Technological Project	This work was supported by the Youth Backbone Program (to JY) of Cancer Hospital, CAMS, Beijing, China (http://www.cicams.ac.cn/), National Natural Science Foundation of China (to LS), Grant No. 81402464 (http://www.nsfc.gov.cn/), and the National Key Scientific and Technological Project (to JY), Grant No. 2011ZX09307-001-01 (http://www.most.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agus DB, 2002, CANCER CELL, V2, P127, DOI 10.1016/S1535-6108(02)00097-1; An SJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040109; Arcila ME, 2012, CLIN CANCER RES, V18, P4910, DOI 10.1158/1078-0432.CCR-12-0912; Brustugun OT, 2014, LUNG CANCER, V84, P36, DOI 10.1016/j.lungcan.2014.01.023; Cardarella S, 2013, CLIN CANCER RES, V19, P4532, DOI 10.1158/1078-0432.CCR-13-0657; Chen D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101354; De Greve J, 2012, LUNG CANCER, V76, P123, DOI 10.1016/j.lungcan.2012.01.008; Feng SD, 2014, J THORAC DIS, V6, P503, DOI 10.3978/j.issn.2072-1439.2014.03.20; Hu HC, 2014, ONCOTARGETS THER, V7, P1423, DOI 10.2147/OTT.S58900; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kris MG, 2014, JAMA-J AM MED ASSOC, V311, P1998, DOI 10.1001/jama.2014.3741; Landi L, 2013, EXPERT REV ANTICANC, V13, P1219, DOI 10.1586/14737140.2013.846830; Li CG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107276; Li CG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028204; Litvak AM, 2014, J THORAC ONCOL, V9, P1669, DOI 10.1097/JTO.0000000000000344; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Marchetti A, 2011, J CLIN ONCOL, V29, P3574, DOI 10.1200/JCO.2011.35.9638; Mazieres J, 2013, J CLIN ONCOL, V31, P1997, DOI 10.1200/JCO.2012.45.6095; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Perera SA, 2009, P NATL ACAD SCI USA, V106, P474, DOI 10.1073/pnas.0808930106; Peters S, 2013, J CLIN ONCOL, V31, pE341, DOI 10.1200/JCO.2012.47.6143; Planchard D, 2013, J CLIN ONCOL, V31; Robinson SD, 2014, LUNG CANCER, V85, P326, DOI 10.1016/j.lungcan.2014.05.009; Sasaki H, 2012, EXP THER MED, V3, P771, DOI 10.3892/etm.2012.500; Serizawa M, 2014, CANCER-AM CANCER SOC, V120, P1471, DOI 10.1002/cncr.28604; Shigematsu H, 2005, CANCER RES, V65, P1642, DOI 10.1158/0008-5472.CAN-04-4235; Shimamura T, 2006, CANCER RES, V66, P6487, DOI 10.1158/0008-5472.CAN-06-0971; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Sun YH, 2010, J CLIN ONCOL, V28, P4616, DOI 10.1200/JCO.2010.29.6038; Tomizawa K, 2011, LUNG CANCER, V74, P139, DOI 10.1016/j.lungcan.2011.01.014; Villaruz LC, 2014, CANCER; Wang SZE, 2006, CANCER CELL, V10, P25, DOI 10.1016/j.ccr.2006.05.023; Zhou Wei, 2011, Chin J Cancer, V30, P287	33	17	18	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2015	10	6							e0130447	10.1371/journal.pone.0130447	http://dx.doi.org/10.1371/journal.pone.0130447			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4DD	26102513	Green Published, gold, Green Submitted			2022-12-26	WOS:000356901900043
J	Forkert, ND; Verleger, T; Cheng, B; Thomalla, G; Hilgetag, CC; Fiehler, J				Forkert, Nils Daniel; Verleger, Tobias; Cheng, Bastian; Thomalla, Goetz; Hilgetag, Claus C.; Fiehler, Jens			Multiclass Support Vector Machine-Based Lesion Mapping Predicts Functional Outcome in Ischemic Stroke Patients	PLOS ONE			English	Article							INTRAVENOUS THROMBOLYSIS; INFARCT LOCATION; PERFUSION; VOLUME; AGREEMENT; MODELS; MRI	Purpose The aim of this study was to investigate if ischemic stroke final infarction volume and location can be used to predict the associated functional outcome using a multi-class support vector machine (SVM). Material and Methods Sixty-eight follow-up MR FLAIR datasets of ischemic stroke patients with known modified Rankin Scale (mRS) functional outcome after 30 days were used. The infarct regions were segmented and used to calculate the percentage of lesioned voxels in the predefined MNI, Harvard-Oxford cortical and subcortical atlas regions as well as using four problem-specific VOIs, which were identified from the database using voxel-based lesion symptom mapping. An overall of 12 SVM classification models for predicting the corresponding mRS score were generated using the lesion overlap values from the different brain region definitions, stroke laterality information, and the optional parameters infarct volume, admission NIHSS, and patient age. Results Leave-one-out cross validations revealed that including information about the stroke location in terms of lesion overlap measurements led to improved mRS prediction results compared to classification models not utilizing the stroke location information. Furthermore, integration of the optional features led to improved mRS prediction results in all cases tested. The problem-specific brain regions and additional integration of the optional features led to the best mRS predictions with a precise multi-value mRS prediction accuracy of 56%, sliding window multi-value mRS prediction accuracy (mRS +/- 1) of 82%, and binary mRS (0-2 vs. 3-5) prediction accuracy of 85%. Conclusion Therefore, a graded SVM-based functional stroke outcome prediction using the problem-specific brain regions for lesion overlap quantification leads to promising results but needs to be further validated using an independent database to rule out a potential methodical bias and overfitting effects. The prediction of the graded mRS functional outcome could be a valuable tool if combined with voxel-wise tissue outcome predictions based on multiparametric datasets acquired at the acute phase.	[Forkert, Nils Daniel] Univ Calgary, Dept Radiol, Calgary, AB T2N 4N1, Canada; [Forkert, Nils Daniel] Univ Calgary, Hotchkiss Brain Inst, Calgary, AB T2N 4N1, Canada; [Verleger, Tobias; Fiehler, Jens] Univ Med Ctr Hamburg Eppendorf, Dept Diagnost & Intervent Neuroradiol, D-20246 Hamburg, Germany; [Cheng, Bastian; Thomalla, Goetz] Univ Med Ctr Hamburg Eppendorf, Dept Neurol, D-20246 Hamburg, Germany; [Hilgetag, Claus C.] Univ Med Ctr Hamburg Eppendorf, Dept Computat Neurosci, D-20246 Hamburg, Germany; [Hilgetag, Claus C.] Boston Univ, Dept Hlth Sci, Boston, MA 02215 USA	University of Calgary; University of Calgary; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; Boston University	Forkert, ND (corresponding author), Univ Calgary, Dept Radiol, 3330 Hosp Dr NW, Calgary, AB T2N 4N1, Canada.	nils.forkert@ucalgary.ca	Forkert, Nils Daniel/K-6273-2012; Hilgetag, Claus C/L-7282-2013	Forkert, Nils Daniel/0000-0003-2556-3224; Hilgetag, Claus C/0000-0003-2129-8910	Germany Federal Ministry of Education and Research (BMBF) by the ERA-NET NEURON project "BEYONDVIS" [BMBF 01EW1002]; German Research Foundation (DFG) [SFB 936]	Germany Federal Ministry of Education and Research (BMBF) by the ERA-NET NEURON project "BEYONDVIS"; German Research Foundation (DFG)(German Research Foundation (DFG))	This work was supported by the Germany Federal Ministry of Education and Research (BMBF) by the ERA-NET NEURON project "BEYONDVIS", BMBF 01EW1002, and the by the German Research Foundation (DFG) SFB 936 "Multi-site Communication in the Brain" (Projects A1, C2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bagher-Ebadian H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022626; Baird AE, 1997, ANN NEUROL, V41, P581, DOI 10.1002/ana.410410506; Bates E, 2003, NAT NEUROSCI, V6, P448, DOI 10.1038/nn1050; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Chen YW, 2006, STUD FUZZ SOFT COMP, V207, P315; Cheng B, 2014, STROKE, V45, P1695, DOI 10.1161/STROKEAHA.114.005152; Counsell C, 2001, CEREBROVASC DIS, V12, P159, DOI 10.1159/000047699; Crammer K, 2002, J MACH LEARN RES, V2, P265, DOI 10.1162/15324430260185628; Fan RE, 2008, J MACH LEARN RES, V9, P1871; Forkert ND, 2014, METHOD INFORM MED, V53, P469, DOI 10.3414/ME14-01-0007; Forkert ND, 2013, AM J NEURORADIOL, V34, P1697, DOI 10.3174/ajnr.A3460; Gottrup C, 2005, ARTIF INTELL MED, V33, P223, DOI 10.1016/j.artmed.2004.06.003; Kent DM, 2006, STROKE, V37, P2957, DOI 10.1161/01.STR.0000249054.96644.c6; Kidwell CS, 2013, STROKE, V44, P73, DOI 10.1161/STROKEAHA.112.670034; Kruetzelmann A, 2011, STROKE, V42, P1251, DOI 10.1161/STROKEAHA.110.600148; Kwakkel G, 1996, AGE AGEING, V25, P479, DOI 10.1093/ageing/25.6.479; MAHONEY F I, 1965, Md State Med J, V14, P61; Mattera D, 1999, ADVANCES IN KERNEL METHODS, P211; Mazziotta J, 2001, PHILOS T R SOC B, V356, P1293, DOI 10.1098/rstb.2001.0915; Medina J, 2010, NEUROPSYCHOLOGIA, V48, P341, DOI 10.1016/j.neuropsychologia.2009.09.016; Meijer R, 2003, CLIN REHABIL, V17, P119, DOI 10.1191/0269215503cr585oa; Menezes NM, 2007, STROKE, V38, P194, DOI 10.1161/01.STR.0000251792.76080.45; Neumann-Haefelin T, 1999, STROKE, V30, P1591, DOI 10.1161/01.STR.30.8.1591; Ng YS, 2007, STROKE, V38, P2309, DOI 10.1161/STROKEAHA.106.475483; RANKIN J, 1957, Scott Med J, V2, P254; Reid JM, 2010, AGE AGEING, V39, P360, DOI 10.1093/ageing/afq027; Rorden C, 2007, J COGNITIVE NEUROSCI, V19, P1081, DOI 10.1162/jocn.2007.19.7.1081; Schiemanck SK, 2006, NEUROREHAB NEURAL RE, V20, P492, DOI 10.1177/1545968306289298; Siemonsen S, 2014, J CEREBR BLOOD F MET, V34, P813, DOI 10.1038/jcbfm.2014.13; Thijs VN, 2000, STROKE, V31, P2597, DOI 10.1161/01.STR.31.11.2597; VANSWIETEN JC, 1988, STROKE, V19, P604, DOI 10.1161/01.STR.19.5.604; Weimar C, 2002, J NEUROL, V249, P888, DOI 10.1007/s00415-002-0755-8; Wells W M 3rd, 1996, Med Image Anal, V1, P35; Wu O, 2001, STROKE, V32, P933, DOI 10.1161/01.STR.32.4.933	34	25	26	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2015	10	6							e0129569	10.1371/journal.pone.0129569	http://dx.doi.org/10.1371/journal.pone.0129569			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL3FM	26098418	Green Published, Green Submitted, gold			2022-12-26	WOS:000356835800034
J	Liang, LQ; Chang, YM; He, XL; Tang, R				Liang, LiQun; Chang, YuMei; He, XuLing; Tang, Ran			Transcriptome Analysis to Identify Cold-Responsive Genes in Amur Carp (Cyprinus carpio haematopterus)	PLOS ONE			English	Article							TEMPERATURE-ACCLIMATION; GENOME ANNOTATION; RNA-SEQ; FISH; EXPRESSION; ADAPTATION; MECHANISMS; ZEBRAFISH; TILAPIA; SHOCK	The adaptation of fish to low temperatures is the result of long-term evolution. Amur carp (Cyprinus carpio haematopterus) survives low temperatures (0-4 degrees C) for six months per year. Therefore, we chose this fish as a model organism to study the mechanisms of cold-adaptive responses using high-throughput sequencing technology. This system provided an excellent model for exploring the relationship between evolutionary genomic changes and environmental adaptations. The Amur carp transcriptome was sequenced using the Illumina platform and was assembled into 163,121 cDNA contigs, with an average read length of 594 bp and an N50 length of 913 bp. A total of 162,339 coding sequences (CDSs) were identified and of 32,730 unique CDSs were annotated. Gene Ontology (GO), EuKaryotic Orthologous Groups (KOG) and Kyoto Encyclopedia of Genes and Genomes (KEGG) analyses were performed to classify all CDSs into different functional categories. A large number of cold-responsive genes were detected in different tissues at different temperatures. A total of 9,427 microsatellites were identified and classified, with 1952 identifying in cold-responsive genes. Based on GO enrichment analysis of the cold-induced genes, "protein localization" and "protein transport" were the most highly represented biological processes. "Circadian rhythm," "protein processing in endoplasmic reticulum," "endocytosis," "insulin signaling pathway," and "lysosome" were the most highly enriched pathways for the genes induced by cold stress. Our data greatly contribute to the common carp (C. carpio) transcriptome resource, and the identification of cold-responsive genes in different tissues at different temperatures will aid in deciphering the genetic basis of ecological and environmental adaptations in this species. Based on our results, the Amur carp has evolved special strategies to survive low temperatures, and these strategies include the system-wide or tissue-specific induction of gene expression during their six-month overwintering period.	[Liang, LiQun; Chang, YuMei; Tang, Ran] Chinese Acad Fishery Sci, Heilongjiang River Fisheries Res Inst,Natl & Loca, Key Lab Fish Stress Resistance Breeding & Germpla, Minist Agr,Key Lab Freshwater Aquat Biotechnol &, Harbin, Heilongjiang, Peoples R China; [He, XuLing] Chinese Natl Human Genome Ctr Shanghai, Shanghai, Peoples R China	Chinese Academy of Fishery Sciences; Heilongjiang River Fisheries Research Institute, CAFS; Ministry of Agriculture & Rural Affairs	Liang, LQ (corresponding author), Chinese Acad Fishery Sci, Heilongjiang River Fisheries Res Inst,Natl & Loca, Key Lab Fish Stress Resistance Breeding & Germpla, Minist Agr,Key Lab Freshwater Aquat Biotechnol &, Harbin, Heilongjiang, Peoples R China.	llq1019@aliyun.com			National Basic Research Program of China (973 Program) [2010CB126305]; Central-Level Nonprofit Scientific Research Institute's Special Funds [HSY201205]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); Central-Level Nonprofit Scientific Research Institute's Special Funds	This manuscript is supported by: 1. The National Basic Research Program of China (973 Program, 2010CB126305) (received by LQL); 2. The Central-Level Nonprofit Scientific Research Institute's Special Funds (HSY201205) (received by YMC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BLY JE, 1991, VET IMMUNOL IMMUNOP, V28, P365, DOI 10.1016/0165-2427(91)90127-X; Bowden TJ, 2008, FISH SHELLFISH IMMUN, V25, P373, DOI 10.1016/j.fsi.2008.03.017; Chen ZZ, 2008, P NATL ACAD SCI USA, V105, P12944, DOI 10.1073/pnas.0802432105; Chen ZZ, 2010, J GENET GENOMICS, V37, P205, DOI 10.1016/S1673-8527(09)60039-4; Chen ZZ, 2005, PROG BIOCHEM BIOPHYS, V32, P187; Chou MY, 2008, J EXP BIOL, V211, P3077, DOI 10.1242/jeb.019950; Cnaani A, 2003, AQUACULTURE, V223, P117, DOI 10.1016/S0044-8486(03)00163-7; Cossins A, 2006, J EXP BIOL, V209, P2328, DOI 10.1242/jeb.02256; Cossins AR, 2005, NAT REV GENET, V6, P324, DOI 10.1038/nrg1590; DEVRIES AL, 1971, SCIENCE, V172, P1152, DOI 10.1126/science.172.3988.1152; Donaldson MR, 2008, J FISH BIOL, V73, P1491, DOI 10.1111/j.1095-8649.2008.02061.x; GOLDSPINK G, 1995, J THERM BIOL, V20, P167, DOI 10.1016/0306-4565(94)00045-K; Gracey AY, 2004, P NATL ACAD SCI USA, V101, P16970, DOI 10.1073/pnas.0403627101; Green BS, 2004, J EXP MAR BIOL ECOL, V299, P115, DOI 10.1016/j.jembe.2003.09.001; Hirayama Y, 1998, J EXP BIOL, V201, P2815; Huang JF, 2015, AQUAC RES, V46, P2776, DOI 10.1111/are.12432; Hwang HK, 2012, B EUR ASSOC FISH PAT, V32, P34; Itoi S, 2003, AM J PHYSIOL-REG I, V284, pR153, DOI 10.1152/ajpregu.00182.2002; Ju Z, 2002, MOL GENET GENOMICS, V268, P87, DOI 10.1007/s00438-002-0727-9; Kanehisa M, 2010, NUCLEIC ACIDS RES, V38, pD355, DOI 10.1093/nar/gkp896; Kofler R, 2007, BIOINFORMATICS, V23, P1683, DOI 10.1093/bioinformatics/btm157; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Long Y, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-612; Long Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037209; Lopez-Olmeda JF, 2011, J THERM BIOL, V36, P91, DOI 10.1016/j.jtherbio.2010.12.005; Mao XZ, 2005, BIOINFORMATICS, V21, P3787, DOI 10.1093/bioinformatics/bti430; Moriya Y, 2007, NUCLEIC ACIDS RES, V35, pW182, DOI 10.1093/nar/gkm321; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Shen JB, 2000, STUDIES COMMON CARP; Sidell BD, 2006, J EXP BIOL, V209, P1791, DOI 10.1242/jeb.02091; Sun XW, 2000, AQUACULTURE, V1-4, P165; Tanck MWT, 2000, J FISH BIOL, V57, P881, DOI 10.1111/j.1095-8649.2000.tb02199.x; Tiku PE, 1996, SCIENCE, V271, P815, DOI 10.1126/science.271.5250.815; Vergauwen L, 2010, COMP BIOCHEM PHYS A, V157, P149, DOI 10.1016/j.cbpa.2010.06.160; Wang LK, 2010, BIOINFORMATICS, V26, P136, DOI 10.1093/bioinformatics/btp612; WODTKE E, 1981, BIOCHIM BIOPHYS ACTA, V640, P710, DOI 10.1016/0005-2736(81)90101-2; Wu CL, 2011, TRANSGENIC RES, V20, P1217, DOI 10.1007/s11248-011-9488-8; Zerai DB, 2010, J WORLD AQUACULT SOC, V41, P800, DOI 10.1111/j.1749-7345.2010.00422.x	39	31	35	5	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2015	10	6							e0130526	10.1371/journal.pone.0130526	http://dx.doi.org/10.1371/journal.pone.0130526			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL3FM	26098567	Green Published, gold, Green Submitted			2022-12-26	WOS:000356835800079
J	Massilamany, C; Gangaplara, A; Basavalingappa, RH; Rajasekaran, RA; Vu, H; Riethoven, JJ; Steffen, D; Pattnaik, AK; Reddy, J				Massilamany, Chandirasegaran; Gangaplara, Arunakumar; Basavalingappa, Rakesh H.; Rajasekaran, Rajkumar A.; Vu, Hiep; Riethoven, Jean-Jack; Steffen, David; Pattnaik, Asit K.; Reddy, Jay			Mutations in the 5 ' NTR and the Non-Structural Protein 3A of the Coxsackievirus B3 Selectively Attenuate Myocarditogenicity	PLOS ONE			English	Article							INFECTIOUS CDNA COPY; HEAVY CHAIN-ALPHA; AUTOIMMUNE MYOCARDITIS; NONTRANSLATED REGION; NUCLEOTIDE-SEQUENCE; PUFF REGION; VIRUS B3; GENOME; CARDIOVIRULENT; PHENOTYPE	The 5' non-translated region (NTR) is an important molecular determinant that controls replication and virulence of coxsackievirus B (CVB) 3. Previous studies have reported many nucleotide (nt) sequence differences in the Nancy strain of the virus, including changes in the 5' NTR with varying degrees of disease severity. In our studies of CVB3-induced myocarditis, we sought to generate an infectious clone of the virus for routine in vivo experimentation. By determining the viral nt sequence, we identified three new nt substitutions in the clone that differed from the parental virus strain: C97U in the 5' NTR; a silent mutation, A4327G, in non-structural protein 2C; and C5088U (resulting in P1449L amino acid change) in non-structural protein 3A of the virus leading us to evaluate the role of these changes in the virulence properties of the virus. We noted that the disease-inducing ability of the infectious clone-derived virus in three mouse strains was restricted to pancreatitis alone, and the incidence and severity of myocarditis were significantly reduced. We then reversed the mutations by creating three new clones, representing 1) U97C; 2) G4327A and U5088C; and 3) their combination together in the third clone. The viral titers obtained from all the clones were comparable, but the virions derived from the third clone induced myocarditis comparable to that induced by wild type virus; however, the pancreatitis-inducing ability remained unaltered, suggesting that the mutations described above selectively influence myocarditogenicity. Because the accumulation of mutations during passages is a continuous process in RNA viruses, it is possible that CVB3 viruses containing such altered nts may evolve naturally, thus favoring their survival in the environment.	[Massilamany, Chandirasegaran; Gangaplara, Arunakumar; Basavalingappa, Rakesh H.; Rajasekaran, Rajkumar A.; Vu, Hiep; Steffen, David; Pattnaik, Asit K.; Reddy, Jay] Univ Nebraska, Sch Vet Med & Biomed Sci, Lincoln, NE 68583 USA; [Riethoven, Jean-Jack] Univ Nebraska, Ctr Biotechnol, Lincoln, NE USA; [Pattnaik, Asit K.] Univ Nebraska, Nebraska Ctr Virol, Lincoln, NE USA	University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln	Reddy, J (corresponding author), Univ Nebraska, Sch Vet Med & Biomed Sci, Lincoln, NE 68583 USA.	nreddy2@unl.edu	Driemeier, David/H-3461-2012; Pattnaik, Asit K./X-1531-2019; Reddy, Jay/K-7200-2014; Vu, Hiep/AAA-1655-2019; Steffen, David/ABI-5565-2020; Gangaplara, Arunakumar/K-5922-2019; Massilamany, Chandirasegaran/D-9305-2016	Driemeier, David/0000-0003-3766-0654; Pattnaik, Asit K./0000-0002-9581-6787; Reddy, Jay/0000-0003-4082-9254; Vu, Hiep/0000-0001-8084-4358; Steffen, David/0000-0002-5166-2296; Gangaplara, Arunakumar/0000-0001-6307-9391; Massilamany, Chandirasegaran/0000-0002-0205-282X; Riethoven, Jean-Jack/0000-0002-2709-7880	Nebraska Research Initiative Grant; Myocarditis Foundation, NJ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL114669] Funding Source: NIH RePORTER	Nebraska Research Initiative Grant; Myocarditis Foundation, NJ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the Nebraska Research Initiative Grant. CM is a recipient of a postdoctoral research fellowship grant awarded by the Myocarditis Foundation, NJ.	Afanasyeva M, 2001, AM J PATHOL, V159, P193, DOI 10.1016/S0002-9440(10)61685-9; Akaike H., 1985, PREDICTION ENTROPY; Bailey JM, 2007, J VIROL, V81, P650, DOI 10.1128/JVI.01327-06; BANERJEE AK, 1980, MICROBIOL REV, V44, P175, DOI 10.1128/MMBR.44.2.175-205.1980; Bradrick SS, 2001, J VIROL, V75, P6472, DOI 10.1128/JVI.75.14.6472-6481.2001; Cameron-Wilson CL, 1998, CLIN DIAGN VIROL, V9, P99, DOI 10.1016/S0928-0197(98)00008-7; Chapman NM, 1997, J MED VIROL, V52, P258; Chapman NM, 2000, J VIROL, V74, P4047, DOI 10.1128/JVI.74.9.4047-4056.2000; CHAPMAN NM, 1994, ARCH VIROL, V135, P115, DOI 10.1007/BF01309769; Cox D. R., 1984, ANAL SURVIVAL DATA; Dunn JJ, 2003, J INFECT DIS, V187, P1552, DOI 10.1086/374877; Esfandiarei M, 2008, ANNU REV PATHOL-MECH, V3, P127, DOI 10.1146/annurev.pathmechdis.3.121806.151534; Fairweather D, 2007, METHODS, V41, P118, DOI 10.1016/j.ymeth.2006.07.009; Gangaplara A, 2012, CLIN IMMUNOL, V144, P237, DOI 10.1016/j.clim.2012.07.003; HERSKOWITZ A, 1987, J AM COLL CARDIOL, V9, P1311, DOI 10.1016/S0735-1097(87)80471-0; Hollander M., 2014, NONPARAMETRIC STAT M, V3rd ed.; Huber S, 2008, CURR TOP MICROBIOL, V323, P199; HYYPIA T, 1993, VIRUS RES, V27, P71, DOI 10.1016/0168-1702(93)90113-2; JACOBSON MF, 1968, P NATL ACAD SCI USA, V61, P77, DOI 10.1073/pnas.61.1.77; JANG SK, 1988, J VIROL, V62, P2636, DOI 10.1128/JVI.62.8.2636-2643.1988; Jenkins GM, 2002, J MOL EVOL, V54, P156, DOI 10.1007/s00239-001-0064-3; Kim KS, 2008, J VIROL, V82, P2033, DOI 10.1128/JVI.01774-07; KLUMP WM, 1990, J VIROL, V64, P1573, DOI 10.1128/JVI.64.4.1573-1583.1990; Knipe DM, 2007, FIELDS VIROLOGY; Knowlton KU, 1996, J VIROL, V70, P7811, DOI 10.1128/JVI.70.11.7811-7818.1996; KRUSKAL WH, 1952, J AM STAT ASSOC, V47, P583, DOI 10.1080/01621459.1952.10483441; Lane D.M., 2012, ENCY RES DESIGN, P1566, DOI [10.4135/9781412961288, DOI 10.4135/9781412961288]; Lee C, 1997, J MED VIROL, V52, P341, DOI 10.1002/(SICI)1096-9071(199707)52:3<341::AID-JMV18>3.0.CO;2-L; Levi LI, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001163; Li HS, 2008, AUTOIMMUN REV, V7, P168, DOI 10.1016/j.autrev.2007.11.010; LILLIEFORS HW, 1967, J AM STAT ASSOC, V62, P399, DOI 10.2307/2283970; LINDBERG AM, 1987, VIROLOGY, V156, P50, DOI 10.1016/0042-6822(87)90435-1; LINDBERG AM, 1992, VIRUS RES, V24, P187, DOI 10.1016/0168-1702(92)90006-U; Massilamany C, 2011, CELL IMMUNOL, V271, P438, DOI 10.1016/j.cellimm.2011.08.013; Pan JY, 2011, J VIROL, V85, P7436, DOI 10.1128/JVI.00503-11; PAQUE RE, 1981, INFECT IMMUN, V31, P470, DOI 10.1128/IAI.31.1.470-479.1981; PELLETIER J, 1988, NATURE, V334, P320, DOI 10.1038/334320a0; REED L. J., 1938, AMER JOUR HYG, V27, P493; ROSE NR, 1986, ANN NY ACAD SCI, V475, P146, DOI 10.1111/j.1749-6632.1986.tb20864.x; Schmidtke M, 2000, VIROLOGY, V275, P77, DOI 10.1006/viro.2000.0485; Stadnick E, 2004, J VIROL, V78, P13987, DOI 10.1128/JVI.78.24.13987-14002.2004; TRACY S, 1985, VIRUS RES, V3, P263, DOI 10.1016/0168-1702(85)90050-4; TRACY S, 1985, ARCH VIROL, V85, P157, DOI 10.1007/BF01317016; TRACY S, 1992, ARCH VIROL, V122, P399, DOI 10.1007/BF01317202; Truong HM, 2004, VIROLOGY, V325, P308, DOI 10.1016/j.virol.2004.04.046; Willian S, 2000, ARCH VIROL, V145, P2061, DOI 10.1007/s007050070040; WIMMER E, 1993, ANNU REV GENET, V27, P353, DOI 10.1146/annurev.ge.27.120193.002033	47	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2015	10	6							e0131052	10.1371/journal.pone.0131052	http://dx.doi.org/10.1371/journal.pone.0131052			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL3FM	26098885	Green Published, gold			2022-12-26	WOS:000356835800138
J	Jannuzzi, GP; Tavares, AHFP; Kaihami, GH; de Almeida, JRF; de Almeida, SR; Ferreira, KS				Jannuzzi, Grasielle Pereira; Tavares, Aldo Henrique F. P.; Kaihami, Gilberto Hideo; Fogaca de Almeida, Jose Roberto; de Almeida, Sandro Rogerio; Ferreira, Karen Spadari			scFv from Antibody That Mimics gp43 Modulates the Cellular and Humoral Immune Responses during Experimental Paracoccidioidomycosis	PLOS ONE			English	Article							DENDRITIC CELLS; DNA VACCINE; BRASILIENSIS; ANTIGEN; ANTIIDIOTYPE; IMMUNIZATION; EXPRESSION; MICE; HELP	Paracoccidioidomycosis (PCM), caused by Paracoccidioides species is a prevalent systemic and progressive mycosis that occurs in Latin America. It is caused by Paracoccidioides species. Immunization with dendritic cells transfected with a plasmid encoding the scFv (pMAC/PS-scFv) that mimics the main antigen of P. brasiliensis (gp43) confers protection in experimental PCM. DCs link innate and adaptive immunity by recognizing invading pathogens and selecting the type of effector T cell to mediate the immune response. Here, we showed that DC-pMAC/PS-scFv induces the activation of CD4(+) and CD8(+) T cells. Moreover, our results demonstrated that BALB/c mice infected with P. brasiliensis and treated with DC-pMAC/PS-scFv showed the induction of specific IgG production against gp43 and IFN-gamma, IL-12 and IL-4 cytokines. Analysis of regional lymph nodes revealed increases in the expression of clec7a, myd88, tlr2, gata3 and tbx21, which are involved in the immune response. Taken together, our results indicate that the scFv modulates the humoral and cellular immune responses and presents epitopes to CD4(+) and CD8(+) T cells.	[Jannuzzi, Grasielle Pereira; Fogaca de Almeida, Jose Roberto; de Almeida, Sandro Rogerio] Univ Sao Paulo, Fac Ciencias Farmaceut, Dept Anal Clin, Sao Paulo, Brazil; [Tavares, Aldo Henrique F. P.] Univ Brasilia, Inst Biol, Brasilia, DF, Brazil; [Kaihami, Gilberto Hideo] Univ Sao Paulo, Inst Quim, Dept Quim, Sao Paulo, Brazil; [Ferreira, Karen Spadari] Univ Fed Sao Paulo, Inst Ciencias Ambientais Quim & Farmaceut, Dept Ciencias Biol, Diadema, Brazil	Universidade de Sao Paulo; Universidade de Brasilia; Universidade de Sao Paulo; Universidade Federal de Sao Paulo (UNIFESP)	Ferreira, KS (corresponding author), Univ Fed Sao Paulo, Inst Ciencias Ambientais Quim & Farmaceut, Dept Ciencias Biol, Diadema, Brazil.	karenspadari@gmail.com	almeida, sandro r/F-5816-2012; Almeida, José Roberto Fogaça/F-2821-2014; Jannuzzi, Grasielle/I-7909-2015; TAVARES, ALDO HENRIQUE/AGI-3412-2022; TAVARES, ALDO HENRIQUE/L-5662-2015; Ferreira/Spadari, Karen SF/D-4437-2013; Kaihami, Gilberto/E-9542-2014; Ferreira, Karen/AAA-4363-2022	almeida, sandro r/0000-0002-0562-1610; TAVARES, ALDO HENRIQUE/0000-0003-0579-3380; Kaihami, Gilberto/0000-0002-8161-0403; Spadari, Karen/0000-0003-2832-5942	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [Proces: 2011/50346-5, Proces: 2013/08548-5]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was supported by grants from Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP Process: 2011/50346-5 and 2013/08548-5 to KSF); GPJ was supported by the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES).	Ahmad ZA, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/980250; Beninati C, 2004, J IMMUNOL, V172, P2461, DOI 10.4049/jimmunol.172.4.2461; Beninati C, 2000, NAT BIOTECHNOL, V18, P1060, DOI 10.1038/80250; Bennett SRM, 1998, NATURE, V393, P478, DOI 10.1038/30996; Bocca AL, 2013, FUTURE MICROBIOL, V8, P1177, DOI 10.2217/fmb.13.68; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brown GD, 2011, ANNU REV IMMUNOL, V29, P1, DOI 10.1146/annurev-immunol-030409-101229; Buss NAPS, 2012, CURR OPIN PHARMACOL, V12, P615, DOI 10.1016/j.coph.2012.08.001; CANO LE, 1995, INFECT IMMUN, V63, P1777, DOI 10.1128/IAI.63.5.1777-1783.1995; Chiarella AP, 2007, MICROBES INFECT, V9, P1078, DOI 10.1016/j.micinf.2007.04.016; Coffman RL, 2010, IMMUNITY, V33, P492, DOI 10.1016/j.immuni.2010.10.002; Ferreira KS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015935; Ferreira KS, 2007, J INFECT DIS, V196, P1108, DOI 10.1086/521369; Herzenberg LA, 2006, NAT IMMUNOL, V7, P681, DOI 10.1038/ni0706-681; INABA K, 1992, J EXP MED, V176, P1693, DOI 10.1084/jem.176.6.1693; Jeong KJ, 2011, BIOTECHNOL J, V6, P16, DOI 10.1002/biot.201000381; Magliani W, 1997, NAT BIOTECHNOL, V15, P155, DOI 10.1038/nbt0297-155; Martins EMDN, 2007, VACCINE, V25, P7893, DOI 10.1016/j.vaccine.2007.09.011; NISONOFF A, 1981, CLIN IMMUNOL IMMUNOP, V21, P397, DOI 10.1016/0090-1229(81)90228-2; Fortes MRP, 2011, AN BRAS DERMATOL, V86, P516, DOI 10.1590/S0365-05962011000300014; Parker SA, 2013, PROTEIN EXPRES PURIF, V89, P136, DOI 10.1016/j.pep.2013.02.016; PUCCIA R, 1986, INFECT IMMUN, V53, P199, DOI 10.1128/IAI.53.1.199-206.1986; PUCCIA R, 1991, J CLIN MICROBIOL, V29, P1610, DOI 10.1128/JCM.29.8.1610-1615.1991; Ribeiro AM, 2013, J BIOMED NANOTECHNOL, V9, P221, DOI 10.1166/jbn.2013.1491; Ribeiro AM, 2009, VACCINE, V27, P606, DOI 10.1016/j.vaccine.2008.10.022; Rittner GMG, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001519; Sanchez-Sanchez N, 2006, J IMMUNOL, V176, P5153, DOI 10.4049/jimmunol.176.9.5153; Schoenberger SP, 1998, NATURE, V393, P480, DOI 10.1038/31002; Souza AR, 1998, CLIN EXP IMMUNOL, V114, P40; Souza EB, 2004, CLIN EXP IMMUNOL, V137, P123, DOI 10.1111/j.1365-2249.2004.02507.x; Travassos LR, 2012, HUM VACC IMMUNOTHER, V8, P1450, DOI 10.4161/hv.21283; Villadangos JA, 2007, NAT REV IMMUNOL, V7, P543, DOI 10.1038/nri2103; Weck MM, 2008, BLOOD, V111, P4264, DOI 10.1182/blood-2006-10-051375; Zar J. H., 1984, BIOSTAT ANAL, P718	34	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2015	10	6							e0129401	10.1371/journal.pone.0129401	http://dx.doi.org/10.1371/journal.pone.0129401			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL3FE	26091522	Green Submitted, Green Published, gold			2022-12-26	WOS:000356835000041
J	Zindy, F; Lee, Y; Kawauchi, D; Ayrault, O; Ben Merzoug, L; Li, Y; McKinnon, PJ; Roussel, MF				Zindy, Frederique; Lee, Youngsoo; Kawauchi, Daisuke; Ayrault, Olivier; Ben Merzoug, Leila; Li, Yang; McKinnon, Peter J.; Roussel, Martine F.			Dicer Is Required for Normal Cerebellar Development and to Restrain Medulloblastoma Formation	PLOS ONE			English	Article							MIR-17-SIMILAR-TO-92 CLUSTER FAMILY; MICRORNA BIOGENESIS; CONDITIONAL LOSS; EXPRESSION; ABSENCE; DIFFERENTIATION; PROLIFERATION; TUMORIGENESIS; DEGENERATION; MIDBRAIN	Dicer, a ribonuclease III enzyme, is required for the maturation of microRNAs. To assess its role in cerebellar and medulloblastoma development, we genetically deleted Dicer in Nestin-positive neural progenitors and in mice lacking one copy for the Sonic Hedgehog receptor, Patched 1. We found that conditional loss of Dicer in mouse neural progenitors induced massive Trp53-independent apoptosis in all proliferative zones of the brain and decreased proliferation of cerebellar granule progenitors at embryonic day 15.5 leading to abnormal cerebellar development and perinatal lethality. Loss of one copy of Dicer significantly accelerated the formation of mouse medulloblastoma of the Sonic Hedgehog subgroup in Patched1-heterozygous mice. We conclude that Dicer is required for proper cerebellar development, and to restrain medulloblastoma formation.	[Zindy, Frederique; Kawauchi, Daisuke; Ayrault, Olivier; Ben Merzoug, Leila; Roussel, Martine F.] St Jude Childrens Res Hosp, Dept Tumor Cell Biol, Memphis, TN 38105 USA; [Lee, Youngsoo; Li, Yang; McKinnon, Peter J.] St Jude Childrens Res Hosp, Dept Genet, Memphis, TN 38105 USA	St Jude Children's Research Hospital; St Jude Children's Research Hospital	Roussel, MF (corresponding author), St Jude Childrens Res Hosp, Dept Tumor Cell Biol, 332 N Lauderdale St, Memphis, TN 38105 USA.	martine.roussel@stjude.org	Roussel, Martine F/F-1469-2016; Kawauchi, Daisuke/ABE-9133-2021	Roussel, Martine F/0000-0002-1740-8139; Lee, Youngsoo/0000-0003-4773-6464	National Cancer Institute [CA-096832, CA-21765]; NIH [NS-37956]; Gephardt Endowed Fellowship; American Lebanese-Syrian Associated Charities (ALSAC) of St. Jude Children's Research Hospital; Anderson Endowed Fellowship SJCRH; NATIONAL CANCER INSTITUTE [P01CA096832, P30CA021765] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS037956, R56NS037956] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Gephardt Endowed Fellowship; American Lebanese-Syrian Associated Charities (ALSAC) of St. Jude Children's Research Hospital(American Lebanese Syrian Associated Charities (ALSAC)); Anderson Endowed Fellowship SJCRH; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the National Cancer Institute CA-096832 (MFR) CA-21765 (MFR, PJM), NIH NS-37956 (PJM), Gephardt Endowed Fellowship (OA), the American Lebanese-Syrian Associated Charities (ALSAC) of St. Jude Children's Research Hospital, and The Anderson Endowed Fellowship (DK) SJCRH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arrate MP, 2010, CANCER RES, V70, P6083, DOI 10.1158/0008-5472.CAN-09-4736; Bernstein E, 2003, NAT GENET, V35, P215, DOI 10.1038/ng1253; Bremer J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012450; Carmell MA, 2004, NAT STRUCT MOL BIOL, V11, P214, DOI 10.1038/nsmb729; CLARKE AR, 1993, NATURE, V362, P849, DOI 10.1038/362849a0; Cuellar TL, 2008, P NATL ACAD SCI USA, V105, P5614, DOI 10.1073/pnas.0801689105; Damiani D, 2008, J NEUROSCI, V28, P4878, DOI 10.1523/JNEUROSCI.0828-08.2008; Davis TH, 2008, J NEUROSCI, V28, P4322, DOI 10.1523/JNEUROSCI.4815-07.2008; Foulkes WD, 2014, NAT REV CANCER, V14, P662, DOI 10.1038/nrc3802; Friedman LM, 2009, P NATL ACAD SCI USA, V106, P7915, DOI 10.1073/pnas.0812446106; Gantier MP, 2011, NUCLEIC ACIDS RES, V39, P5692, DOI 10.1093/nar/gkr148; Georgi SA, 2010, J NEUROSCI, V30, P4048, DOI 10.1523/JNEUROSCI.4982-09.2010; Graus-Porta D, 2001, NEURON, V31, P367, DOI 10.1016/S0896-6273(01)00374-9; Hatten ME, 2011, TRENDS NEUROSCI, V34, P134, DOI 10.1016/j.tins.2011.01.002; Huang TW, 2010, J MOL CELL BIOL, V2, P152, DOI 10.1093/jmcb/mjq008; JACKS T, 1994, CURR BIOL, V4, P1, DOI 10.1016/S0960-9822(00)00002-6; Kaneko H, 2011, NATURE, V471, P325, DOI 10.1038/nature09830; Kawase-Koga Y, 2009, DEV DYNAM, V238, P2800, DOI 10.1002/dvdy.22109; Kim VN, 2005, NAT REV MOL CELL BIO, V6, P376, DOI 10.1038/nrm1644; Kumar MS, 2009, GENE DEV, V23, P2700, DOI 10.1101/gad.1848209; Lambertz I, 2010, CELL DEATH DIFFER, V17, P633, DOI 10.1038/cdd.2009.202; Li QS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026000; Machold R, 2005, NEURON, V48, P17, DOI 10.1016/j.neuron.2005.08.028; McKinnon PJ, 2013, NAT NEUROSCI, V16, P1523, DOI 10.1038/nn.3537; McLoughlin HS, 2012, NEUROSCIENCE, V223, P285, DOI 10.1016/j.neuroscience.2012.08.009; Murchison EP, 2005, P NATL ACAD SCI USA, V102, P12135, DOI 10.1073/pnas.0505479102; Murphy BL, 2013, CANCER RES, V73, P7068, DOI 10.1158/0008-5472.CAN-13-0927; Northcott PA, 2009, CANCER RES, V69, P3249, DOI 10.1158/0008-5472.CAN-08-4710; Nowakowski TJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023013; Pang XY, 2014, MOL CELL NEUROSCI, V58, P22, DOI 10.1016/j.mcn.2013.10.009; Ravi A, 2012, CANCER CELL, V21, P848, DOI 10.1016/j.ccr.2012.04.037; Roberts KG, 2014, NEW ENGL J MED, V371, P1005, DOI 10.1056/NEJMoa1403088; Schaefer A, 2007, J EXP MED, V204, P1553, DOI 10.1084/jem.20070823; Shalaby T, 2014, INT J MOL SCI, V15, P21554, DOI 10.3390/ijms151121554; Slade I, 2011, J MED GENET, V48, P273, DOI 10.1136/jmg.2010.083790; Soukup GA, 2009, DEV BIOL, V328, P328, DOI 10.1016/j.ydbio.2009.01.037; Tao JF, 2011, J NEUROSCI, V31, P8306, DOI 10.1523/JNEUROSCI.0567-11.2011; Tonelli DD, 2008, DEVELOPMENT, V135, P3911, DOI 10.1242/dev.025080; Tronche F, 1999, NAT GENET, V23, P99, DOI 10.1038/12703; Uziel T, 2005, GENE DEV, V19, P2656, DOI 10.1101/gad.1368605; Uziel T, 2009, P NATL ACAD SCI USA, V106, P2812, DOI 10.1073/pnas.0809579106; Zindy F, 1997, ONCOGENE, V15, P203, DOI 10.1038/sj.onc.1201178; Zindy F, 2014, BIOL OPEN, V3, P597, DOI 10.1242/bio.20146734	43	7	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2015	10	6							e0129642	10.1371/journal.pone.0129642	http://dx.doi.org/10.1371/journal.pone.0129642			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL3FE	26091048	Green Published, gold, Green Submitted			2022-12-26	WOS:000356835000052
J	Latina, A; Viticchie, G; Lena, AM; Piro, MC; Annicchiarico-Petruzzelli, M; Melino, G; Candi, E				Latina, A.; Viticchie, G.; Lena, A. M.; Piro, M. C.; Annicchiarico-Petruzzelli, M.; Melino, G.; Candi, E.			Delta Np63 targets cytoglobin to inhibit oxidative stress-induced apoptosis in keratinocytes and lung cancer	ONCOGENE			English	Article							DOWN-REGULATION; TUMOR-SUPPRESSOR; CELL-SURVIVAL; P53 HOMOLOG; P63; GENE; PROTEIN; EXPRESSION; OVEREXPRESSION; PROLIFERATION	During physiological aerobic metabolism, the epidermis undergoes significant oxidative stress as a result of the production of reactive oxygen species (ROS). To maintain a balanced oxidative state, cells have developed protective antioxidant systems, and preliminary studies suggest that the transcriptional factor p63 is involved in cellular oxidative defence. Supporting this hypothesis, the Delta Np63a isoform of p63 is expressed at high levels in the proliferative basal layer of the epidermis. Here we identify the CYGB gene as a novel transcriptional target of Delta Np63 that is involved in maintaining epidermal oxidative defence. The CYGB gene encodes cytoglobin, a member of the globin protein family, which facilitates the diffusion of oxygen through tissues and acts as a scavenger for nitric oxide or other ROS. By performing promoter activity assays and chromatin immunoprecipitation, reverse transcriptase quantitative PCR and western blotting analyses, we confirm the direct regulation of CYGB by Delta Np63a. We also demonstrate that CYGB has a protective role in proliferating keratinocytes grown under normal conditions, as well as in cells treated with exogenous hydrogen peroxide. These results indicate that Delta Np63, through its target CYGB has an important role in the cellular antioxidant system and protects keratinocytes from oxidative stress-induced apoptosis. The Delta Np63-CYGB axis is also present in lung and breast cancer cell lines, indicating that CYGB-mediated ROS-scavenging activity may also have a role in epithelial tumours. In human lung cancer data sets, the p63-CYGB interaction significantly predicts reduction of patient survival.	[Latina, A.; Viticchie, G.; Lena, A. M.; Piro, M. C.; Melino, G.; Candi, E.] Univ Roma Tor Vergata, Dept Expt Med & Surg, Via Montpellier 1, I-00133 Rome, Italy; [Annicchiarico-Petruzzelli, M.; Candi, E.] IDI IRCCS, Biochem Lab, Rome, Italy; [Melino, G.] Med Res Council Toxicol Unit, Leicester, Leics, England	University of Rome Tor Vergata; IRCCS Istituto Dermopatico dell'Immacolata (IDI); UK Research & Innovation (UKRI); Medical Research Council UK (MRC)	Melino, G; Candi, E (corresponding author), Univ Roma Tor Vergata, Dept Expt Med & Surg, Via Montpellier 1, I-00133 Rome, Italy.	gerry.melino@uniroma2.it; candi@uniroma2.it	Annicchiarico-Petruzzelli, Margherita/AAG-7746-2020; Lena, Anna Maria/AAI-5042-2020; PIRO, MARIA CRISTINA/GVT-4380-2022	Annicchiarico-Petruzzelli, Margherita/0000-0002-4717-4740; PIRO, MARIA CRISTINA/0000-0003-3004-367X	AIRC grant [IG13387]; Min. Salute (Ric oncol) [26/07]; IDI-IRCCS [RF08 c.15, RF07 c.57]; MRC [MC_U132670600] Funding Source: UKRI; Medical Research Council [MC_U132670600] Funding Source: researchfish	AIRC grant(Fondazione AIRC per la ricerca sul cancro); Min. Salute (Ric oncol); IDI-IRCCS; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was mainly supported by the AIRC grant (IG13387) to EC and Min. Salute (Ric oncol 26/07) and IDI-IRCCS (RF08 c.15, RF07 c.57) to GM.	Adams PD, 2009, MOL CELL, V36, P2, DOI 10.1016/j.molcel.2009.09.021; Agrelo R, 2013, ONCOGENE, V32, P5492, DOI 10.1038/onc.2013.158; Allen RG, 2000, FREE RADICAL BIO MED, V28, P463, DOI 10.1016/S0891-5849(99)00242-7; Amelio I, 2014, ONCOGENE, V33, P5039, DOI 10.1038/onc.2013.456; Balaban RS, 2005, CELL, V120, P483, DOI 10.1016/j.cell.2005.02.001; Bause AS, 2013, J BIOL CHEM, V288, P36484, DOI 10.1074/jbc.M113.472324; Bensaad K, 2006, CELL, V126, P107, DOI 10.1016/j.cell.2006.05.036; Berkers CR, 2013, CELL METAB, V18, P617, DOI 10.1016/j.cmet.2013.06.019; Bickers DR, 2006, J INVEST DERMATOL, V126, P2565, DOI 10.1038/sj.jid.5700340; Borrelli S, 2010, CELL DEATH DIFFER, V17, P1896, DOI 10.1038/cdd.2010.59; Browne G, 2011, J CELL SCI, V124, P2200, DOI 10.1242/jcs.079327; Budanov AV, 2011, ANTIOXID REDOX SIGN, V15, P1679, DOI 10.1089/ars.2010.3530; Burmester T, 2002, MOL BIOL EVOL, V19, P416, DOI 10.1093/oxfordjournals.molbev.a004096; Burnley P, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.460; Candi E, 2008, CELL MOL LIFE SCI, V65, P3126, DOI 10.1007/s00018-008-8119-x; Candi E, 2006, CELL DEATH DIFFER, V13, P1037, DOI 10.1038/sj.cdd.4401926; Candi E, 2007, P NATL ACAD SCI USA, V104, P11999, DOI 10.1073/pnas.0703458104; Candi E, 2007, CELL CYCLE, V6, P274, DOI 10.4161/cc.6.3.3797; Candi E, 2006, J CELL SCI, V119, P4617, DOI 10.1242/jcs.03265; Carroll DK, 2006, NAT CELL BIOL, V8, P551, DOI 10.1038/ncb1420; Celardo I, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.175; Cervo PRD, 2012, P NATL ACAD SCI USA, V109, P1133, DOI 10.1073/pnas.1112257109; Crum CP, 2010, ANNU REV PATHOL-MECH, V5, P349, DOI 10.1146/annurev-pathol-121808-102117; DeYoung MP, 2006, CANCER RES, V66, P9362, DOI 10.1158/0008-5472.CAN-06-1619; Dhar A, 2002, MOL CELL BIOCHEM, V234, P185, DOI 10.1023/A:1015948505117; Dhar SK, 2006, J BIOL CHEM, V281, P21698, DOI 10.1074/jbc.M601083200; di Fagagna FD, 2008, NAT REV CANCER, V8, P512, DOI 10.1038/nrc2440; Drane P, 2001, ONCOGENE, V20, P430, DOI 10.1038/sj.onc.1204101; Ellisen LW, 2002, MOL CELL, V10, P995, DOI 10.1016/S1097-2765(02)00706-2; Emara M, 2010, CANCER CELL INT, V10, DOI 10.1186/1475-2867-10-33; Fordel E, 2004, BIOCHEM BIOPH RES CO, V319, P342, DOI 10.1016/j.bbrc.2004.05.010; Fordel E, 2006, NEUROSCI LETT, V410, P146, DOI 10.1016/j.neulet.2006.09.027; Gao B, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.298; Genin O, 2008, NEOPLASIA, V10, P940, DOI 10.1593/neo.08456; Gorr TA, 2011, ACTA PHYSIOL, V202, P563, DOI 10.1111/j.1748-1716.2010.02205.x; Guo XM, 2006, BBA-GENE STRUCT EXPR, V1759, P208, DOI 10.1016/j.bbaexp.2006.04.002; Ihrie RA, 2005, CELL, V120, P843, DOI 10.1016/j.cell.2005.01.008; Italiano D, 2012, CELL CYCLE, V11, P4589, DOI 10.4161/cc.22853; John R, 2014, DNA REPAIR, V24, P107, DOI 10.1016/j.dnarep.2014.09.003; Katsuyama M, 2012, J CLIN BIOCHEM NUTR, V50, P9, DOI 10.3164/jcbn.11-06SR; Kenyon CJ, 2010, NATURE, V464, P504, DOI 10.1038/nature08980; Keyes WM, 2005, GENE DEV, V19, P1986, DOI 10.1101/gad.342305; Kouwenhoven EN, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001065; Laurikkala J, 2006, DEVELOPMENT, V133, P1553, DOI 10.1242/dev.02325; Leikam C, 2014, ONCOGENE, V33, P771, DOI 10.1038/onc.2012.641; Lena AM, 2010, BIOCHEM BIOPH RES CO, V401, P568, DOI 10.1016/j.bbrc.2010.09.102; Li C, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.468; Liefer KM, 2000, CANCER RES, V60, P4016; Liu G, 2002, ONCOGENE, V21, P7195, DOI 10.1038/sj.onc.1205862; Massion PP, 2003, CANCER RES, V63, P7113; McRonald FE, 2006, HUM MOL GENET, V15, P1271, DOI 10.1093/hmg/ddl042; Mills AA, 1999, NATURE, V398, P708, DOI 10.1038/19531; Nakanome A, 2013, ONCOGENE, V32, P3231, DOI 10.1038/onc.2012.336; Nguyen BC, 2006, GENE DEV, V20, P1028, DOI 10.1101/gad.1406006; Ogawa E, 2008, ONCOGENE, V27, P848, DOI 10.1038/sj.onc.1210682; Oleksiewicz U, 2013, HUM MOL GENET, V22, P3207, DOI 10.1093/hmg/ddt174; Paris M, 2012, CELL DEATH DIFFER, V19, P186, DOI 10.1038/cdd.2011.181; Park Eun-sung, 2003, J Vet Sci, V4, P129; Patel A, 2015, ONCOGENE, V34, P2586, DOI 10.1038/onc.2014.195; Pinton P, 2007, SCIENCE, V315, P659, DOI 10.1126/science.1135380; Polyak K, 1997, NATURE, V389, P300, DOI 10.1038/38525; Presneau N, 2005, MOL CARCINOGEN, V43, P141, DOI 10.1002/mc.20096; Ramsey MR, 2013, J CLIN INVEST, V123, P3525, DOI 10.1172/JCI68899; Ramsey MR, 2011, CANCER RES, V71, P4373, DOI 10.1158/0008-5472.CAN-11-0046; Rinne T, 2008, HUM MOL GENET, V17, P1968, DOI 10.1093/hmg/ddn094; Rivera A, 2005, J BIOL CHEM, V280, P29346, DOI 10.1074/jbc.M504852200; Romano RA, 2012, DEVELOPMENT, V139, P772, DOI 10.1242/dev.071191; Rufini A, 2006, BIOCHEM BIOPH RES CO, V340, P737, DOI 10.1016/j.bbrc.2005.12.065; Rufini A, 2012, GENE DEV, V26, P2009, DOI 10.1101/gad.197640.112; Sablina AA, 2005, NAT MED, V11, P1306, DOI 10.1038/nm1320; Schmidt M, 2004, J BIOL CHEM, V279, P8063, DOI 10.1074/jbc.M310540200; Senoo M, 2007, CELL, V129, P523, DOI 10.1016/j.cell.2007.02.045; Shalom-Feuerstein R, 2011, CELL DEATH DIFFER, V18, P887, DOI 10.1038/cdd.2010.159; Shaw RJ, 2009, BRIT J CANCER, V101, P139, DOI 10.1038/sj.bjc.6605121; Sommer M, 2006, CELL CYCLE, V5, P2005, DOI 10.4161/cc.5.17.3194; Stagner JI, 2005, TRANSPL P, V37, P3452, DOI 10.1016/j.transproceed.2005.10.001; Stambolsky P, 2006, CELL DEATH DIFFER, V13, P2140, DOI 10.1038/sj.cdd.4401965; Truong AB, 2006, GENE DEV, V20, P3185, DOI 10.1101/gad.1463206; Vanbokhoven H, 2011, J INVEST DERMATOL, V131, P1196, DOI 10.1038/jid.2011.84; Wajcman H, 2009, CR BIOL, V332, P273, DOI 10.1016/j.crvi.2008.07.026; Wansleben S, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.365; Wiel C, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.382; Wolyniec K, 2013, ONCOGENE, V32, P3510, DOI 10.1038/onc.2012.365; Xinarianos G, 2006, HUM MOL GENET, V15, P2038, DOI 10.1093/hmg/ddl128; Yan WS, 2006, J BIOL CHEM, V281, P7856, DOI 10.1074/jbc.M512655200; Yang A, 1999, NATURE, V398, P714, DOI 10.1038/19539; Yang AN, 1998, MOL CELL, V2, P305, DOI 10.1016/S1097-2765(00)80275-0; Yu XL, 2013, NEURAL REGEN RES, V8, P2198, DOI 10.3969/j.issn.1673-5374.2013.23.010	88	45	48	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 24	2016	35	12					1493	1503		10.1038/onc.2015.222	http://dx.doi.org/10.1038/onc.2015.222			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DH8RJ	26096935				2022-12-26	WOS:000373063600003
J	Wang, SB; Awad, KS; Elinoff, JM; Dougherty, EJ; Ferreyra, GA; Wang, JY; Cai, RM; Sun, JF; Ptasinska, A; Danner, RL				Wang, Shuibang; Awad, Keytam S.; Elinoff, Jason M.; Dougherty, Edward J.; Ferreyra, Gabriela A.; Wang, Jennifer Y.; Cai, Rongman; Sun, Junfeng; Ptasinska, Anetta; Danner, Robert L.			G Protein-coupled Receptor 40 (GPR40) and Peroxisome Proliferator-activated Receptor gamma (PPAR gamma) AN INTEGRATED TWO-RECEPTOR SIGNALING PATHWAY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FREE FATTY-ACIDS; P38 MAPK; COACTIVATOR PGC-1-ALPHA; GLUCOSE-METABOLISM; INSULIN-SECRETION; DIABETES-MELLITUS; ENDOTHELIAL-CELLS; DEPENDENT MANNER; RETINOIC ACID; KINASE	Peroxisome proliferator-activated receptor gamma (PPAR gamma) ligands have been widely used to treat type 2 diabetes mellitus. However, knowledge of PPAR gamma signaling remains incomplete. In addition to PPAR gamma, these drugs also activate G protein-coupled receptor 40 (GPR40), a G alpha(q)-coupled free fatty acid receptor linked to MAPK networks and glucose homeostasis. Notably, p38 MAPK activation has been implicated in PPAR gamma signaling. Here, rosiglitazone (RGZ) activation of GPR40 and p38 MAPK was found to boost PPAR gamma-induced gene transcription in human endothelium. Inhibition or knockdown of p38 MAPK or expression of a dominant negative (DN) p38 MAPK mutant blunted RGZ-induced PPAR gamma DNA binding and reporter activity in EA.hy926 human endothelial cells. GPR40 inhibition or knockdown, or expression of a DN-G(alpha)q mutant likewise blocked activation of both p38 MAPK and PPAR gamma reporters. Importantly, RGZ induction of PPAR gamma target genes in primary human pulmonary artery endothelial cells (PAECs) was suppressed by knockdown of either p38 MAPK or GPR40. GPR40/PPAR gamma signal transduction was dependent on p38 MAPK activation and induction of PPAR gamma co-activator-1 (PGC1 alpha). Silencing of p38 MAPK or GPR40 abolished the ability of RGZ to induce phosphorylation and expression of PGC1 alpha in PAECs. Knockdown of PGC1 alpha, its essential activator SIRT1, or its binding partner/co-activator EP300 inhibited RGZ induction of PPAR gamma-regulated genes in PAECs. RGZ/GPR40/p38 MAPK signaling also led to EP300 phosphorylation, an event that enhances PPAR gamma target gene transcription. Thus, GPR40 and PPAR gamma can function as an integrated two-receptor signal transduction pathway, a finding with implications for rational drug development.	[Wang, Shuibang; Awad, Keytam S.; Elinoff, Jason M.; Dougherty, Edward J.; Ferreyra, Gabriela A.; Wang, Jennifer Y.; Cai, Rongman; Sun, Junfeng; Ptasinska, Anetta; Danner, Robert L.] NIH, Dept Crit Care Med, Ctr Clin, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Clinical Center (CC)	Danner, RL (corresponding author), NIH, Dept Crit Care Med, 10 Ctr Dr,Rm 2C145, Bethesda, MD 20892 USA.	rdanner@nih.gov	Regan, Clinton/E-6250-2012		National Institutes of Health; CLINICAL CENTER [ZIACL000188] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CLINICAL CENTER	This work was supported, in whole or in part, by National Institutes of Health intramural funds. The authors declare that they have no conflicts of interest with the contents of this article.	Adams M, 1997, J BIOL CHEM, V272, P5128, DOI 10.1074/jbc.272.8.5128; Akimoto T, 2005, J BIOL CHEM, V280, P19587, DOI 10.1074/jbc.M408862200; Alquier T, 2009, DIABETES, V58, P2607, DOI 10.2337/db09-0362; Bordicchia M, 2012, J CLIN INVEST, V122, P1022, DOI 10.1172/JCI59701; Bratton MR, 2009, CARCINOGENESIS, V30, P106, DOI 10.1093/carcin/bgn213; Buse JB, 2007, CIRCULATION, V115, P114, DOI 10.1161/CIRCULATIONAHA.106.179294; Camp HS, 2000, DIABETES, V49, P539, DOI 10.2337/diabetes.49.4.539; Camp HS, 1997, J BIOL CHEM, V272, P10811; Cao WH, 2004, MOL CELL BIOL, V24, P3057, DOI 10.1128/MCB.24.7.3057-3067.2004; Chu KM, 2007, J PHARM PHARM SCI, V10, P411, DOI 10.18433/J3159D; DeWire SM, 2011, CIRC RES, V109, P205, DOI 10.1161/CIRCRESAHA.110.231308; Duan SZ, 2005, CIRC RES, V97, P372, DOI 10.1161/01.RES.0000179226.34112.6d; Fan M, 2004, GENE DEV, V18, P278, DOI 10.1101/gad.1152204; Fernandez-Pisonero I, 2012, J IMMUNOL, V189, P5402, DOI 10.4049/jimmunol.1201309; FORMAN BM, 1995, CELL, V83, P803, DOI 10.1016/0092-8674(95)90193-0; Gardner OS, 2005, J BIOL CHEM, V280, P10109, DOI 10.1074/jbc.M410445200; Ge K, 2008, MOL CELL BIOL, V28, P1081, DOI 10.1128/MCB.00967-07; Gelman L, 1999, J BIOL CHEM, V274, P7681, DOI 10.1074/jbc.274.12.7681; Gerhart-Hines Z, 2007, EMBO J, V26, P1913, DOI 10.1038/sj.emboj.7601633; Goldberg RB, 2005, DIABETES CARE, V28, P1547, DOI 10.2337/diacare.28.7.1547; Gras D, 2009, AM J PHYSIOL-LUNG C, V296, pL970, DOI 10.1152/ajplung.90219.2008; Handschin C, 2006, ENDOCR REV, V27, P728, DOI 10.1210/er.2006-0037; Hansmann G, 2008, J CLIN INVEST, V118, P1846, DOI 10.1172/JCI32503; Hata K, 2003, MOL BIOL CELL, V14, P545, DOI 10.1091/mbc.E02-06-0356; Hong EH, 2010, J BIOL CHEM, V285, P1283, DOI 10.1074/jbc.M109.058628; Hu ED, 1996, SCIENCE, V274, P2100, DOI 10.1126/science.274.5295.2100; Itoh Y, 2003, NATURE, V422, P173, DOI 10.1038/nature01478; Kahn BB, 2010, NEW ENGL J MED, V363, P2667, DOI 10.1056/NEJMcibr1012075; Ketsawatsomkron P, 2010, J BIOL CHEM, V285, P9311, DOI 10.1074/jbc.R109.025031; Kim HS, 2008, BIOCHEM BIOPH RES CO, V367, P623, DOI 10.1016/j.bbrc.2007.12.192; KLIEWER SA, 1992, NATURE, V358, P771, DOI 10.1038/358771a0; Kotarsky K, 2003, BIOCHEM BIOPH RES CO, V301, P406, DOI 10.1016/S0006-291X(02)03064-4; LEHMANN JM, 1995, J BIOL CHEM, V270, P12953, DOI 10.1074/jbc.270.22.12953; Lennon AM, 2002, J BIOL CHEM, V277, P29681, DOI 10.1074/jbc.M201517200; Lerin C, 2006, CELL METAB, V3, P429, DOI 10.1016/j.cmet.2006.04.013; Maciag AE, 2013, REDOX BIOL, V1, P115, DOI 10.1016/j.redox.2012.12.002; Maekawa T, 2010, MOL CELL BIOL, V30, P613, DOI 10.1128/MCB.00685-09; McGuire DK, 2008, CIRCULATION, V117, P440, DOI 10.1161/CIRCULATIONAHA.107.704080; Mieczkowska A, 2012, J BIOL CHEM, V287, P23517, DOI 10.1074/jbc.M111.324814; Nasrin N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008414; Nemoto S, 2005, J BIOL CHEM, V280, P16456, DOI 10.1074/jbc.M501485200; Pascual G, 2005, NATURE, V437, P759, DOI 10.1038/nature03988; Ptasinska A, 2007, FASEB J, V21, P950, DOI 10.1096/fj.06-6822com; Puigserver P, 1999, SCIENCE, V286, P1368, DOI 10.1126/science.286.5443.1368; Puigserver P, 2001, MOL CELL, V8, P971, DOI 10.1016/S1097-2765(01)00390-2; Rajagopal S, 2010, NAT REV DRUG DISCOV, V9, P373, DOI 10.1038/nrd3024; Rangwala SM, 2003, DEV CELL, V5, P657, DOI 10.1016/S1534-5807(03)00274-0; Reddy RC, 2008, BLOOD, V112, P4250, DOI 10.1182/blood-2007-12-128967; Rodgers JT, 2007, P NATL ACAD SCI USA, V104, P12861, DOI 10.1073/pnas.0702509104; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; Smith NJ, 2009, J BIOL CHEM, V284, P17527, DOI 10.1074/jbc.M109.012849; SOHDA T, 1982, CHEM PHARM BULL, V30, P3563; Spiegelman BM, 1998, DIABETES, V47, P507, DOI 10.2337/diabetes.47.4.507; Stoddart LA, 2007, MOL PHARMACOL, V71, P994, DOI 10.1124/mol.106.031534; Sugawara Y, 2007, CELL SIGNAL, V19, P1301, DOI 10.1016/j.cellsig.2007.01.012; Tanaka H, 2013, J PHARMACOL EXP THER, V346, P443, DOI 10.1124/jpet.113.206466; Teruel T, 2003, J BIOL CHEM, V278, P263, DOI 10.1074/jbc.M207200200; Wallberg AE, 2003, MOL CELL, V12, P1137, DOI 10.1016/S1097-2765(03)00391-5; Wang L, 2009, EUR J PHARMACOL, V609, P40, DOI 10.1016/j.ejphar.2009.03.033; Wang NP, 2002, J BIOL CHEM, V277, P34176, DOI 10.1074/jbc.M203436200; Wang QE, 2013, NUCLEIC ACIDS RES, V41, P1722, DOI 10.1093/nar/gks1312; Yang C, 2001, DIABETES, V50, P2598, DOI 10.2337/diabetes.50.11.2598; Yeo SJ, 2003, J BIOL CHEM, V278, P22563, DOI 10.1074/jbc.M302076200; Yki-Jarvinen H, 2004, NEW ENGL J MED, V351, P1106, DOI 10.1056/NEJMra041001; Yu B, 2000, J BIOL CHEM, V275, P71, DOI 10.1074/jbc.275.1.71; Zhou CY, 2010, BIOORG MED CHEM LETT, V20, P1298, DOI 10.1016/j.bmcl.2009.10.052	66	32	33	1	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 7	2015	290	32					19544	19557		10.1074/jbc.M115.638924	http://dx.doi.org/10.1074/jbc.M115.638924			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CO7TL	26105050	Green Published, hybrid			2022-12-26	WOS:000359364600018
J	Han, JH; Kim, S; Jang, H; Kim, SW; Lee, MG; Koh, H; Lee, JH				Han, Joo Hyung; Kim, Seung; Jang, Hoon; Kim, So Won; Lee, Min Goo; Koh, Hong; Lee, Ji Hyun			Identification of a Novel p.Q1772X ANK1 Mutation in a Korean Family with Hereditary Spherocytosis	PLOS ONE			English	Article							INCREASED OSMOTIC FRAGILITY; GILBERTS-SYNDROME; GENE; GLUCURONOSYLTRANSFERASE; HYPERBILIRUBINEMIA; PREVALENCE; DOMINANT	Hereditary spherocytosis (HS), a common form of inherited hemolytic anemia, is a heterogeneous group of disorders with regard to clinical severity, protein defects, and mode of inheritance. Causal mutations in at least five genes have been reported so far. Because multiple genes have been associated with HS, clinical genetic testing that relies on direct sequencing will be a challenge. In this study, we used whole exome sequencing to identify a novel nonsense mutation in ANK1 (p.Q1772X, NM_020476) that resulted in a truncated protein in a Korean patient with HS. Sanger sequencing confirmed the two affected individuals in the patient's family were heterozygous for the mutation. This is the first report of a Korean family that carries an ANK1 mutation responsible for HS. Our results demonstrate that next generation sequencing is a powerful approach for rapidly determining the genetic etiology of HS.	[Han, Joo Hyung] Yonsei Univ, Coll Med, Seoul, South Korea; [Kim, Seung; Koh, Hong] Yonsei Univ, Severance Childrens Hosp, Dept Pediat, Coll Med, Seoul, South Korea; [Jang, Hoon] Yonsei Univ, Dept Chem, Seoul 120749, South Korea; [Kim, So Won] Inje Univ, Coll Med, Dept Pharmacol, Busan, South Korea; [Kim, So Won] Inje Univ, Coll Med, PharmacoGen Res Ctr, Busan, South Korea; [Kim, So Won] Inje Univ, Busan Paik Hosp, Dept Clin Pharmacol, Busan, South Korea; [Lee, Min Goo] Yonsei Univ, Brain Korea PLUS Project Med Sci 21, Pharmacogen Res Ctr Membrane Transporters, Dept Pharmacol,Severance Biomed Sci Inst,Coll Med, Seoul, South Korea; [Lee, Ji Hyun] Yonsei Univ, Dept Oral Biol, Coll Dent, Seoul, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Inje University; Inje University; Inje University; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Koh, H (corresponding author), Yonsei Univ, Severance Childrens Hosp, Dept Pediat, Coll Med, Seoul, South Korea.	KHONG@yuhs.ac; jihyni@yuhs.ac	Lee, Min Goo/D-5635-2012; Lee, Min Goo/AAS-4636-2020	Lee, Min Goo/0000-0001-7436-012X; Lee, Min Goo/0000-0001-7436-012X; Han, Joo Hyung/0000-0003-4276-3439; Kim, Seung/0000-0003-4373-9828; Koh, Hong/0000-0002-3660-7483	Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea [HI14C0070]; Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning [NRF-2012R1A1A3007521]	Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea; Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning	This research was supported by a Korea Health Technology R&D Project grant through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea (Grant No.: HI14C0070) and by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT & Future Planning (Grant No.: NRF-2012R1A1A3007521).	Akaba K, 1998, BIOCHEM MOL BIOL INT, V46, P21; AONO S, 1995, LANCET, V345, P958, DOI 10.1016/S0140-6736(95)90702-5; Bolton-Maggs PHB, 2012, BRIT J HAEMATOL, V156, P37, DOI 10.1111/j.1365-2141.2011.08921.x; BOSMA PJ, 1995, NEW ENGL J MED, V333, P1171, DOI 10.1056/NEJM199511023331802; del Giudice EM, 1999, BLOOD, V94, P2259, DOI 10.1182/blood.V94.7.2259.419k42_2259_2262; Delaunay J, 2002, ACTA HAEMATOL-BASEL, V108, P210, DOI 10.1159/000065657; Eber SW, 1996, NAT GENET, V13, P214, DOI 10.1038/ng0696-214; EBER SW, 1992, ANN HEMATOL, V64, P88, DOI 10.1007/BF01715351; Flintoft L, 2013, NAT REV GENET, V14, P824, DOI 10.1038/nrg3620; Gallagher PG, 2005, BLOOD CELL MOL DIS, V35, P345, DOI 10.1016/j.bcmd.2005.08.008; Gilissen C, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-9-228; GODAL HC, 1981, SCAND J HAEMATOL, V27, P30; Hsieh TY, 2007, PHARMACOGENET GENOM, V17, P229, DOI 10.1097/FPC.0b013e328012d0da; Hughes MR, 2011, EXP HEMATOL, V39, P305, DOI 10.1016/j.exphem.2010.12.009; JAROLIM P, 1995, J CLIN INVEST, V95, P941, DOI 10.1172/JCI117802; Koboldt DC, 2013, CELL, V155, P27, DOI 10.1016/j.cell.2013.09.006; LUX SE, 1990, NATURE, V344, P36, DOI 10.1038/344036a0; Perrotta S, 2008, LANCET, V372, P1411, DOI 10.1016/S0140-6736(08)61588-3; PLATT OS, 1993, J BIOL CHEM, V268, P24421; Sharma S, 1997, ANN HEMATOL, V74, P287, DOI 10.1007/s002770050302; Skierka JM, 2013, J PEDIATR-US, V162, P1146, DOI 10.1016/j.jpeds.2012.11.042; Stenson PD, 2003, HUM MUTAT, V21, P577, DOI 10.1002/humu.10212; Sugita K, 2007, PEDIATR INT, V49, P540, DOI 10.1111/j.1442-200X.2007.02410.x; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Yang YP, 2013, NEW ENGL J MED, V369, P1502, DOI 10.1056/NEJMoa1306555; Yocum AO, 2012, BLOOD, V120, P3586, DOI 10.1182/blood-2012-08-450262	26	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2015	10	6							e0131251	10.1371/journal.pone.0131251	http://dx.doi.org/10.1371/journal.pone.0131251			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4OM	26107955	Green Published, gold, Green Submitted			2022-12-26	WOS:000356932500151
J	Holwell, GI; Kazakova, O; Evans, F; O'Hanlon, JC; Barry, KL				Holwell, Gregory I.; Kazakova, Olga; Evans, Felicity; O'Hanlon, James C.; Barry, Katherine L.			The Functional Significance of Chiral Genitalia: Patterns of Asymmetry, Functional Morphology and Mating Success in the Praying Mantis Ciulfina baldersoni	PLOS ONE			English	Article							REPRODUCTIVE ANATOMY; EVOLUTION; MANTODEA; SYMMETRY; REVERSAL; DIPTERA	Genital asymmetry is relatively common and widespread throughout the animal kingdom. The functional significance of genital asymmetry is however, poorly understood for most species. Male praying mantids of the genus Ciulfina are remarkable in possessing complex and directionally asymmetric genital phallomeres in some species, and chirally dimorphic/antisymmetric genitalia in others. Here we explore the chiral dimorphism in male genitalia of Ciulfina baldersoni which appear to exhibit genital antisymmetry. We test whether genital orientation influences mating success, copulation duration and the attachment duration of spermatophores. Additionally we investigate genital interactions between male and females using x-ray micro-computed tomography (micro-CT) and scanning electron microscopy (SEM). Lastly we assess whether genital asymmetry is associated with non-genital morphological asymmetry of a range of traits. Our results highlight the complex functional morphology of genitalia in this praying mantis species and yet demonstrate no functional difference between dextral and sinistral morphs other than the direction of attachment with both morphs enjoying equal levels of mating success. Chiral morphs also did not strongly associate with any other forms of asymmetry. We therefore conclude that genital chirality in Ciulfina baldersoni is a likely case of antisymmetry with no functional significance to genital orientation, and is likely to be selectively neutral.	[Holwell, Gregory I.] Univ Auckland, Sch Biol Sci, Auckland 1142, New Zealand; [Holwell, Gregory I.; Kazakova, Olga; Evans, Felicity; O'Hanlon, James C.; Barry, Katherine L.] Macquarie Univ, Dept Biol Sci, Sydney, NSW 2109, Australia	University of Auckland; Macquarie University	Holwell, GI (corresponding author), Univ Auckland, Sch Biol Sci, Auckland 1142, New Zealand.	g.holwell@auckland.ac.nz		Holwell, Gregory/0000-0002-6059-6032; O'Hanlon, James/0000-0002-7382-5543				Ahrens D, 2008, J ZOOL SYST EVOL RES, V46, P110, DOI 10.1111/j.1439-0469.2007.00449.x; Anisyutkin L.N., 2005, Russian Entomological Journal, V13, P119; Arnqvist G, 1998, NATURE, V393, P784, DOI 10.1038/31689; Arnqvist Goran, 2005, pUnpaginated; BALDERSON J, 1978, J AUST ENTOMOL SOC, V17, P235; BOHN H, 1987, ENTOMOL SCAND, V18, P293; Eberhard W.G., 1985, SEXUAL SELECTION ANI; Eberhard WG, 2001, EVOLUTION, V55, P93, DOI 10.1111/j.0014-3820.2001.tb01275.x; Eberhard WG, 2011, TRENDS ECOL EVOL, V26, P17, DOI 10.1016/j.tree.2010.10.009; Hill PJB, 2004, ACTA OECOL, V26, P1, DOI 10.1016/j.actao.2004.02.002; Holwell GI, 2008, J ZOOL, V276, P108, DOI 10.1111/j.1469-7998.2008.00475.x; Holwell GI, 2007, J ZOOL, V271, P255, DOI 10.1111/j.1469-7998.2006.00263.x; Holwell GI, 2007, ZOOTAXA, P23, DOI 10.11646/zootaxa.1583.1.3; Holwell GI, 2014, ZOOTAXA, V3797, P29, DOI 10.11646/zootaxa.3797.1.6; Holwell GI, 2010, J MORPHOL, V271, P1176, DOI 10.1002/jmor.10861; Holwell GI, 2010, BEHAV ECOL SOCIOBIOL, V64, P617, DOI 10.1007/s00265-009-0879-2; Hosken DJ, 1999, CAN J ZOOL, V77, P1975, DOI 10.1139/cjz-77-12-1975; Huber BA, 2007, BIOL REV, V82, P647, DOI 10.1111/j.1469-185X.2007.00029.x; KLASS KD, 1997, EXTERNAL MALE GENITA; McPeek MA, 2008, AM NAT, V171, pE158, DOI 10.1086/587076; O'Hanlon J, 2009, AUST J ZOOL, V57, P85, DOI 10.1071/ZO09056; O'Hanlon JC, 2011, INSECT CONSERV DIVER, V4, P107, DOI 10.1111/j.1752-4598.2010.00111.x; Palmer, 1994, DEV INSTABILITY ITS, P335, DOI DOI 10.1007/978-94-011-0830-0_; Palmer AR, 2004, SCIENCE, V306, P828, DOI 10.1126/science.1103707; Palmer AR, 1996, P NATL ACAD SCI USA, V93, P14279, DOI 10.1073/pnas.93.25.14279; Schilthuizen M, 2007, J EVOLUTION BIOL, V20, P1941, DOI 10.1111/j.1420-9101.2007.01370.x; Schilthuizen M, 2005, NATURWISSENSCHAFTEN, V92, P504, DOI 10.1007/s00114-05-0045-2; Schilthuizen Menno, 2007, Tijdschrift voor Entomologie, V150, P347; Schilthuizen M, 2013, ANIM BIOL, V63, P1, DOI 10.1163/15707563-00002398; Simmons LW, 2014, AUSTRAL ENTOMOL, V53, P1, DOI 10.1111/aen.12053; Werner M, 2008, BIOL J LINN SOC, V93, P257, DOI 10.1111/j.1095-8312.2007.00924.x; Winnick CG, 2009, ARTHROPOD STRUCT DEV, V38, P60, DOI 10.1016/j.asd.2008.07.002; Wojcieszek JM, 2012, J ZOOL, V287, P91, DOI 10.1111/j.1469-7998.2011.00892.x	33	8	9	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2015	10	6							e0128755	10.1371/journal.pone.0128755	http://dx.doi.org/10.1371/journal.pone.0128755			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4OM	26107629	Green Published, gold, Green Submitted			2022-12-26	WOS:000356932500027
J	Kato, H; Ishida, J; Matsusaka, T; Ishimaru, T; Tanimoto, K; Sugiyama, F; Yagami, K; Nangaku, M; Fukamizu, A				Kato, Hideki; Ishida, Junji; Matsusaka, Taiji; Ishimaru, Tomohiro; Tanimoto, Keiji; Sugiyama, Fumihiro; Yagami, Ken-ichi; Nangaku, Masaomi; Fukamizu, Akiyoshi			Erythropoiesis and Blood Pressure Are Regulated via AT1 Receptor by Distinctive Pathways	PLOS ONE			English	Article							RENIN-ANGIOTENSIN-SYSTEM; CONVERTING ENZYME-INHIBITORS; CHRONIC-HEMODIALYSIS PATIENTS; CHRONIC KIDNEY-DISEASE; DEFICIENT MICE; II RECEPTOR; ACE-INHIBITORS; POSTTRANSPLANT ERYTHROCYTOSIS; ERYTHROID PRECURSORS; RENAL-FAILURE	The renin-angiotensin system (RAS) plays a central role in blood pressure regulation. Although clinical and experimental studies have suggested that inhibition of RAS is associated with progression of anemia, little evidence is available to support this claim. Here we report that knockout mice that lack angiotensin II, including angiotensinogen and renin knockout mice, exhibit anemia. The anemia of angiotensinogen knockout mice was rescued by angiotensin II infusion, and rescue was completely blocked by simultaneous administration of AT1 receptor blocker. To genetically determine the responsible receptor subtype, we examined AT1a, AT1b, and AT2 knockout mice, but did not observe anemia in any of them. To investigate whether pharmacological AT1 receptor inhibition recapitulates the anemic phenotype, we administered AT1 receptor antagonist in hypotensive AT1a receptor knockout mice to inhibit the remaining AT1b receptor. In these animals, hematocrit levels barely decreased, but blood pressure further decreased to the level observed in angiotensinogen knockout mice. We then generated AT1a and AT1b double-knockout mice to completely ablate the AT1 receptors; the mice finally exhibited the anemic phenotype. These results provide clear evidence that although erythropoiesis and blood pressure are negatively controlled through the AT1 receptor inhibition in vivo, the pathways involved are complex and distinct, because erythropoiesis is more resistant to AT1 receptor inhibition than blood pressure control.	[Kato, Hideki; Ishida, Junji; Tanimoto, Keiji; Fukamizu, Akiyoshi] Univ Tsukuba, TARA, Life Sci Ctr, Tsukuba, Ibaraki 3058577, Japan; [Ishimaru, Tomohiro; Tanimoto, Keiji; Fukamizu, Akiyoshi] Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki 3058577, Japan; [Sugiyama, Fumihiro; Yagami, Ken-ichi] Univ Tsukuba, Lab Anim Resource Ctr, Tsukuba, Ibaraki 3058577, Japan; [Kato, Hideki; Nangaku, Masaomi] Univ Tokyo, Grad Sch Med, Div Nephrol & Endocrinol, Bunkyo Ku, Tokyo 1138655, Japan; [Matsusaka, Taiji] Tokai Univ, Sch Med, Inst Med Sci, Isehara, Kanagawa 2591193, Japan	University of Tsukuba; University of Tsukuba; University of Tsukuba; University of Tokyo; Tokai University	Fukamizu, A (corresponding author), Univ Tsukuba, TARA, Life Sci Ctr, Tsukuba, Ibaraki 3058577, Japan.	akif@tara.tsukuba.ac.jp	Tanimoto, Keiji/B-2600-2014	Tanimoto, Keiji/0000-0003-1971-6546	Ministry of Education, Culture, Sports, Science, and Technology of Japan; University of Tsukuba Special Research Program, Japan; Heart Foundation	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); University of Tsukuba Special Research Program, Japan; Heart Foundation	This work was supported by grants as follows: 21st Century COE Program, Grant-in-Aid for Scientific Research (S) and (C), and Grant-in-Aid for Young Scientists (B) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan; the University of Tsukuba Special Research Program, Japan; and the Heart Foundation Research Grant.	Ajmal Adnan, 2013, BMC Res Notes, V6, P443, DOI 10.1186/1756-0500-6-443; Albitar S, 1998, NEPHROL DIAL TRANSPL, V13, P1206, DOI 10.1093/ndt/13.5.1206; Barshishat-Kupper M, 2011, EXP HEMATOL, V39, P293, DOI 10.1016/j.exphem.2010.12.002; Billet S, 2007, J CLIN INVEST, V117, P1914, DOI 10.1172/JCI28764; BONNET D, 1993, BLOOD, V82, P3307; BURSON JM, 1994, AM J PHYSIOL, V267, pE260, DOI 10.1152/ajpendo.1994.267.2.E260; Chen XM, 1997, AM J PHYSIOL-RENAL, V272, pF299, DOI 10.1152/ajprenal.1997.272.3.F299; Chew CG, 1999, NEPHROL DIAL TRANSPL, V14, P2047, DOI 10.1093/ndt/14.8.2047; Cole J, 2000, J CLIN INVEST, V106, P1391, DOI 10.1172/JCI10557; CONLON PJ, 1994, NEPHROL DIAL TRANSPL, V9, P1358; Conlon PJ, 1996, NEPHROL DIAL TRANSPL, V11, P2524, DOI 10.1093/oxfordjournals.ndt.a027238; Crowley SD, 2004, ACTA PHYSIOL SCAND, V181, P561, DOI 10.1111/j.1365-201X.2004.01331.x; Cruz DN, 1996, AM J KIDNEY DIS, V28, P535, DOI 10.1016/S0272-6386(96)90464-3; Fandrey J, 2004, AM J PHYSIOL-REG I, V286, pR977, DOI 10.1152/ajpregu.00577.2003; Franco RS, 2009, AM J HEMATOL, V84, P109, DOI 10.1002/ajh.21298; FUKAMIZU A, 1993, J BIOL CHEM, V268, P11617; Glezerman I, 2003, AM J NEPHROL, V23, P195, DOI 10.1159/000071188; Glicklich D, 2001, J AM SOC NEPHROL, V12, P1958, DOI 10.1681/ASN.V1291958; Hayashi K, 2001, KIDNEY INT, V60, P1910, DOI 10.1046/j.1523-1755.2001.00028.x; HIRAKATA H, 1986, CLIN NEPHROL, V26, P27; HIRAKATA H, 1984, AM J NEPHROL, V4, P355, DOI 10.1159/000166851; ICHIKI T, 1995, NATURE, V377, P748, DOI 10.1038/377748a0; Iodice C, 2003, KIDNEY INT, V63, P2214, DOI 10.1046/j.1523-1755.2003.00015.x; Ishani A, 2005, J AM COLL CARDIOL, V45, P391, DOI 10.1016/j.jacc.2004.10.038; ISRAELI A, 1985, ACTA HAEMATOL-BASEL, V73, P106, DOI 10.1159/000206292; IWAI N, 1992, BIOCHEM BIOPH RES CO, V188, P298, DOI 10.1016/0006-291X(92)92384-A; Jezek T, 2003, Bratisl Lek Listy, V104, P19; Kato H, 2005, FASEB J, V19, P2023, DOI 10.1096/fj.05-3820fje; Keane WF, 2003, AM J KIDNEY DIS, V41, pS22, DOI 10.1053/ajkd.2003.50078; Kim YC, 2014, MOL PHARMACOL, V85, P898, DOI 10.1124/mol.113.091157; Kuriyama S, 2002, HYPERTENS RES, V25, P849; LENFANT M, 1989, P NATL ACAD SCI USA, V86, P779, DOI 10.1073/pnas.86.3.779; Macdougall IC, 1999, NEPHROL DIAL TRANSPL, V14, P1836, DOI 10.1093/ndt/14.8.1836; Malyszko J, 2012, TRANSPL INT, V25, P1013, DOI 10.1111/j.1432-2277.2012.01513.x; Marathias KP, 2004, CURR TOP MED CHEM, V4, P483, DOI 10.2174/1568026043451311; Mrug M, 2004, SEMIN NEPHROL, V24, P120, DOI 10.1016/j.semnephrol.2003.11.006; Naeshiro I, 1998, EUR J PHARMACOL, V354, P179, DOI 10.1016/S0014-2999(98)00451-8; Nakamoto Hidetomo, 2004, Adv Perit Dial, V20, P111; Oliverio MI, 1997, AM J PHYSIOL-RENAL, V272, pF515, DOI 10.1152/ajprenal.1997.272.4.F515; ONOYAMA K, 1989, J CARDIOVASC PHARM, V13, pS27, DOI 10.1097/00005344-198900133-00007; Pajek J, 2005, THER APHER DIAL, V9, P228, DOI 10.1111/j.1774-9987.2005.00260.x; Piccoli A, 2005, J NEPHROL, V18, P585; Plata R, 2002, LANCET, V359, P663, DOI 10.1016/S0140-6736(02)07812-1; Ripamonti V, 2006, CHEST, V130, P79, DOI 10.1378/chest.130.1.79; Robles NR, 2004, RENAL FAILURE, V26, P399, DOI 10.1081/JDI-120039824; Rossert J, 2007, NEPHROL DIAL TRANSPL, V22, P794, DOI 10.1093/ndt/gfl716; SANCHEZ JA, 1995, NEPHROL DIAL TRANSPL, V10, P1476; Saudan P, 2006, J NEPHROL, V19, P91; SUGAYA T, 1995, J BIOL CHEM, V270, P18719, DOI 10.1074/jbc.270.32.18719; Suzuki N, 2011, MOL CELL BIOL, V31, P3896, DOI 10.1128/MCB.05463-11; TAKASE K, 1995, ARZNEIMITTEL-FORSCH, V45-1, P15; TANIMOTO K, 1994, J BIOL CHEM, V269, P31334; Tsuchida S, 1998, J CLIN INVEST, V101, P755, DOI 10.1172/JCI1899; VERHAAREN HA, 1986, EUR J PEDIATR, V144, P554, DOI 10.1007/BF00496034; Vlahakos DV, 2010, AM J KIDNEY DIS, V56, P558, DOI 10.1053/j.ajkd.2009.12.042; Vlahakos DV, 2003, KIDNEY INT, V63, P1187, DOI 10.1046/j.1523-1755.2003.00850.x; VLAHAKOS DV, 1991, AM J KIDNEY DIS, V17, P199, DOI 10.1016/S0272-6386(12)81129-2; Wuhl E, 2004, KIDNEY INT, V66, P768, DOI 10.1111/j.1523-1755.2004.00802.x; Yanai K, 2000, J BIOL CHEM, V275, P5, DOI 10.1074/jbc.275.1.5	59	13	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2015	10	6							e0129484	10.1371/journal.pone.0129484	http://dx.doi.org/10.1371/journal.pone.0129484			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4OM	26107632	Green Published, gold, Green Submitted			2022-12-26	WOS:000356932500057
J	Shirai, Y; Fujita, Y; Hashimoto, R; Ohi, K; Yamamori, H; Yasuda, Y; Ishima, T; Suganuma, H; Ushida, Y; Takeda, M; Hashimoto, K				Shirai, Yumi; Fujita, Yuko; Hashimoto, Ryota; Ohi, Kazutaka; Yamamori, Hidenaga; Yasuda, Yuka; Ishima, Tamaki; Suganuma, Hiroyuki; Ushida, Yusuke; Takeda, Masatoshi; Hashimoto, Kenji			Dietary Intake of Sulforaphane-Rich Broccoli Sprout Extracts during Juvenile and Adolescence Can Prevent Phencyclidine-Induced Cognitive Deficits at Adulthood	PLOS ONE			English	Article							ASYMMETRIC SPINE SYNAPSES; PREFRONTAL CORTEX; OXIDATIVE STRESS; PARVALBUMIN INTERNEURONS; MISSING HERITABILITY; SCHIZOPHRENIA; PSYCHOSIS; MICE; DISORDERS; IMPACT	Oxidative stress and inflammation play a role in cognitive impairment, which is a core symptom of schizophrenia. Furthermore, a hallmark of the pathophysiology of this disease is the dysfunction of cortical inhibitory gamma-aminobutyric acid (GABA) neurons expressing parvalbumin (PV), which is also involved in cognitive impairment. Sulforaphane (SFN), an isothiocyanate derived from broccoli, is a potent activator of the transcription factor Nrf2, which plays a central role in the inducible expressions of many cytoprotective genes in response to oxidative stress. Keap1 is a cytoplasmic protein that is essential for the regulation of Nrf2 activity. Here, we found that pretreatment with SFN attenuated cognitive deficits, the increase in 8-oxo-dG-positive cells, and the decrease in PV-positive cells in the medial prefrontal cortex and hippocampus after repeated administration of phencyclidine (PCP). Furthermore, PCP-induced cognitive deficits were improved by the subsequent subchronic administration of SFN. Interestingly, the dietary intake of glucoraphanin (a glucosinolate precursor of SFN) during the juvenile and adolescence prevented the onset of PCP-induced cognitive deficits as well as the increase in 8-oxo-dG-positive cells and the decrease in PV-positive cells in the brain at adulthood. Moreover, the NRF2 gene and the KEAP1 gene had an epistatic effect on cognitive impairment (e.g., working memory and processing speed) in patients with schizophrenia. These findings suggest that SFN may have prophylactic and therapeutic effects on cognitive impairment in schizophrenia. Therefore, the dietary intake of SFN-rich broccoli sprouts during the juvenile and adolescence may prevent the onset of psychosis at adulthood.	[Shirai, Yumi; Fujita, Yuko; Ishima, Tamaki; Hashimoto, Kenji] Chiba Univ, Ctr Forens Mental Hlth, Div Clin Neurosci, Chiba, Japan; [Hashimoto, Ryota] Osaka Univ, United Grad Sch Child Dev, Mol Res Ctr Childrens Mental Dev, Osaka, Japan; [Hashimoto, Ryota; Ohi, Kazutaka; Yamamori, Hidenaga; Yasuda, Yuka; Takeda, Masatoshi] Osaka Univ, Grad Sch Med, Dept Psychiat, Osaka, Japan; [Suganuma, Hiroyuki; Ushida, Yusuke] Kagome Co Ltd, Div Res & Dev, Nasushiobara City, Tochigi, Japan	Chiba University; Osaka University; Osaka University; Kagome Co., Ltd.	Hashimoto, K (corresponding author), Chiba Univ, Ctr Forens Mental Hlth, Div Clin Neurosci, Chiba, Japan.	hashimoto@faculty.chiba-u.jp	Hashimoto, Ryota/P-8572-2014; Hashimoto, Ryota/AAE-3200-2019; Ohi, Kazutaka/J-7851-2019; Hashimoto, Kenji/I-5800-2015	Hashimoto, Ryota/0000-0002-5941-4238; Hashimoto, Ryota/0000-0002-5941-4238; Ohi, Kazutaka/0000-0001-9577-9640; Ushida, Yusuke/0000-0003-4117-929X; Suganuma, Hiroyuki/0000-0001-6596-9881; Hashimoto, Kenji/0000-0002-8892-0439	Ministry of Education, Culture, Sports, Science and Technology, Japan [24116006]; Ministry of Education, Science, Sports and Culture of Japan; Kagome Co. Ltd.	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Education, Science, Sports and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Kagome Co. Ltd.	This work was supported by a Grant-in-Aid for Scientific Research on Innovative Areas of the Ministry of Education, Culture, Sports, Science and Technology, Japan (to K. H., #24116006), and a Grant-in-Aid for Scientific Research on Innovative Areas (Comprehensive Brain Science Network) from the Ministry of Education, Science, Sports and Culture of Japan (to R. H. and K. H.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Kagome Co. Ltd. provided support in the form of salaries for authors HS and YS, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aas M, 2014, FRONT PSYCHIATRY, V4, DOI 10.3389/fpsyt.2013.00182; Benedict AL, 2012, J NEUROTRAUM, V29, P2576, DOI 10.1089/neu.2012.2474; Bennett RN, 2004, J AGR FOOD CHEM, V52, P5856, DOI 10.1021/jf040091+; Cabungcal JH, 2013, P NATL ACAD SCI USA, V110, P9130, DOI 10.1073/pnas.1300454110; Cabungcal JH, 2013, BIOL PSYCHIAT, V73, P574, DOI 10.1016/j.biopsych.2012.09.020; Carrion RE, 2011, AM J PSYCHIAT, V168, P806, DOI 10.1176/appi.ajp.2011.10081209; Chen HX, 2012, PSYCHOPHARMACOLOGY, V222, P37, DOI 10.1007/s00213-011-2619-3; COSGROVE J, 1991, J CLIN PSYCHOL, V47, P159, DOI 10.1002/1097-4679(199101)47:1<159::AID-JCLP2270470125>3.0.CO;2-O; Dinkova-Kostova AT, 2012, TRENDS MOL MED, V18, P337, DOI 10.1016/j.molmed.2012.04.003; Do KQ, 2010, J NUTRIGENET NUTRIGE, V3, P267, DOI 10.1159/000324366; Elsworth JD, 2011, INT J NEUROPSYCHOPH, V14, P1411, DOI 10.1017/S1461145711000939; Elsworth JD, 2011, NEUROPSYCHOPHARMACOL, V36, P2054, DOI 10.1038/npp.2011.96; Fahey JW, 2012, CANCER PREV RES, V5, P179, DOI 10.1158/1940-6207.CAPR-11-0572; Fahey JW, 1997, P NATL ACAD SCI USA, V94, P10367, DOI 10.1073/pnas.94.19.10367; Frommann I, 2011, SCHIZOPHRENIA BULL, V37, P861, DOI 10.1093/schbul/sbp155; Fujino H, 2014, PSYCHIAT CLIN NEUROS, V68, P534, DOI 10.1111/pcn.12165; Fusar-Poli P, 2012, ARCH GEN PSYCHIAT, V69, P562, DOI 10.1001/archgenpsychiatry.2011.1592; Girgis RR, 2014, BIOL PSYCHIAT, V75, P292, DOI 10.1016/j.biopsych.2013.12.002; Glantz LA, 2000, ARCH GEN PSYCHIAT, V57, P65, DOI 10.1001/archpsyc.57.1.65; Glausier JR, 2013, NEUROSCIENCE, V251, P90, DOI 10.1016/j.neuroscience.2012.04.044; Green Michael F, 2014, Schizophr Res Cogn, V1, pe1; Hajszan T, 2006, BIOL PSYCHIAT, V60, P639, DOI 10.1016/j.biopsych.2006.03.015; Hashimoto K, 2005, EUR J PHARMACOL, V519, P114, DOI 10.1016/j.ejphar.2005.07.002; Hashimoto K, 2008, BIOL PSYCHIAT, V63, P92, DOI 10.1016/j.biopsych.2007.04.034; Hashimoto K, 2007, NEUROPSYCHOPHARMACOL, V32, P514, DOI 10.1038/sj.npp.1301047; Hashimoto K, 2014, EXPERT OPIN THER TAR, V18, P1049, DOI 10.1517/14728222.2014.934225; Hashimoto R, 2007, MOL PSYCHIATR, V12, P1026, DOI 10.1038/sj.mp.4001982; Hashimoto R, 2006, HUM MOL GENET, V15, P3024, DOI 10.1093/hmg/ddl244; Hashimoto R, 2013, AM J PSYCHIAT, V170, P683, DOI 10.1176/appi.ajp.2013.12091228; Hashimoto R, 2010, AM J MED GENET B, V153B, P1459, DOI 10.1002/ajmg.b.31123; Jentsch JD, 1999, NEUROPSYCHOPHARMACOL, V20, P201, DOI 10.1016/S0893-133X(98)00060-8; Juge N, 2007, CELL MOL LIFE SCI, V64, P1105, DOI 10.1007/s00018-007-6484-5; Keefe Richard S E, 2012, Handb Exp Pharmacol, P11, DOI 10.1007/978-3-642-25758-2_2; Kensler TW, 2013, TOP CURR CHEM, V329, P163, DOI 10.1007/128_2012_339; Kolluri N, 2005, AM J PSYCHIAT, V162, P1200, DOI 10.1176/appi.ajp.162.6.1200; Kwak MK, 2010, TOXICOL APPL PHARM, V244, P66, DOI 10.1016/j.taap.2009.08.028; Lewis DA, 2012, TRENDS NEUROSCI, V35, P57, DOI 10.1016/j.tins.2011.10.004; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Marzec JM, 2007, FASEB J, V21, P2237, DOI 10.1096/fj.06-7759com; Matsuzawa D, 2011, ANTIOXID REDOX SIGN, V15, P2057, DOI 10.1089/ars.2010.3453; Milatovic D., 2010, CURR PROTOCOLS TOXIC, V12, P1, DOI [DOI 10.1002/0471140856.TX1216S43, DOI 10.1002/0471140856.tx1216s43]; Millan MJ, 2012, NAT REV DRUG DISCOV, V11, P141, DOI 10.1038/nrd3628; O'Connor RM, 2014, BIOL PSYCHIAT, V75, P4, DOI 10.1016/j.biopsych.2013.10.022; Ohi K, 2009, SCHIZOPHR RES, V109, P80, DOI 10.1016/j.schres.2009.01.019; Paus T, 2008, NAT REV NEUROSCI, V9, P947, DOI 10.1038/nrn2513; Potvin S, 2008, BIOL PSYCHIAT, V63, P801, DOI 10.1016/j.biopsych.2007.09.024; Rosoklija G, 2000, ARCH GEN PSYCHIAT, V57, P349, DOI 10.1001/archpsyc.57.4.349; Sawa A, 2014, NEURON, V83, P991, DOI 10.1016/j.neuron.2014.08.028; Shiina A, 2015, CLIN PSYCHOPHARM NEU, V13, P62, DOI 10.9758/cpn.2015.13.1.62; Shirai Yumi, 2012, Clin Psychopharmacol Neurosci, V10, P94, DOI 10.9758/cpn.2012.10.2.94; Singh K, 2014, P NATL ACAD SCI USA, V111, P15550, DOI 10.1073/pnas.1416940111; Solis M, 2014, NATURE, V508, pS12, DOI 10.1038/508S12a; Steullet P, 2016, SCHIZOPHR RES, V176, P41, DOI 10.1016/j.schres.2014.06.021; Suzuki T, 2013, TRENDS PHARMACOL SCI, V34, P340, DOI 10.1016/j.tips.2013.04.005; Tan HY, 2007, P NATL ACAD SCI USA, V104, P12536, DOI 10.1073/pnas.0610125104; Tortorella SM, 2015, ANTIOXID REDOX SIGN, V22, P1382, DOI 10.1089/ars.2014.6097; Wechsler D., 1997, MANUAL WECHSLER ADUL, V3rd ed.; West LG, 2004, J AGR FOOD CHEM, V52, P916, DOI 10.1021/jf0307189; Yang C, 2015, INT J NEUROPSYCHOPH, V18, DOI 10.1093/ijnp/pyu121; Yao JK, 2011, ANTIOXID REDOX SIGN, V15, P2011, DOI 10.1089/ars.2010.3603; Zhang J, 2015, BIOMED SIGNAL PROCES, V18, P1, DOI 10.1016/j.bspc.2014.11.010; ZHANG YS, 1992, P NATL ACAD SCI USA, V89, P2399, DOI 10.1073/pnas.89.6.2399; Zuk O, 2014, P NATL ACAD SCI USA, V111, pE455, DOI 10.1073/pnas.1322563111	63	50	53	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2015	10	6							e0127244	10.1371/journal.pone.0127244	http://dx.doi.org/10.1371/journal.pone.0127244			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CL4OM	26107664	gold, Green Published, Green Submitted			2022-12-26	WOS:000356932500009
J	Yang, M; Mamy, J; Gao, PC; Xiao, SY				Yang, Mei; Mamy, Jules; Gao, Pengcheng; Xiao, Shuiyuan			From Abstinence to Relapse: A Preliminary Qualitative Study of Drug Users in a Compulsory Drug Rehabilitation Center in Changsha, China	PLOS ONE			English	Article							ADDICTION TREATMENT; FOLLOW-UP; PREVENTION; DEPENDENCE; BARRIERS	Background Relapse among abstinent drug users is normal. Several factors are related to relapse, but it remains unclear what individuals' actual life circumstances are during periods of abstinence, and how these circumstances facilitate or prevent relapse. Objective To illuminate drug users' experiences during abstinence periods and explore the real-life catalysts and inhibitors contributing to drug use relapse. Method Qualitative in-depth interviews were conducted with 20 drug users recruited from a compulsory isolated drug rehabilitation center in Changsha. The interviews were guided by open-ended questions on individuals' experiences in drug use initiation, getting addicted, treatment history, social environment, abstinence, and relapse. Participants were also encouraged to share their own stories. Interviews were digitally recorded and fully transcribed. The data of 18 participants who reported abstinence experiences before admission were included in the analyses. The data were analyzed using a thematic analysis with inductive hand coding to derive themes. Results Most drug users were able to successfully abstain from drugs. During abstinence, their lives were congested with challenges, such as adverse socioeconomic conditions, poor family/social support, interpersonal conflicts, and stigma and discrimination, all of which kept them excluded from mainstream society. Furthermore, the police's system of ID card registration, which identifies individuals as drug users, worsened already grave situations. Relapse triggers reported by the participants focused mainly on negative feelings, interpersonal conflicts, and stressful events. Craving was experienced but not perceived as a relapse trigger by most participants. Conclusions This study of in-depth interview with drug users found evidence of situations and environments they live during abstinence appear rather disadvantaged, making it extremely difficult for them to remain abstinent. Comprehensive programs on relapse prevention that acknowledge these disadvantages are implicated.	[Yang, Mei; Mamy, Jules; Xiao, Shuiyuan] Cent S Univ, Sch Publ Hlth, Dept Social Med & Hlth Management, Changsha, Hunan, Peoples R China; [Yang, Mei] Shenzhen Kangning Hosp, Shenzhen Mental Hlth Ctr, Shenzhen, Peoples R China; [Gao, Pengcheng] Hunan Judicial Police Vocat Coll, Changsha, Hunan, Peoples R China	Central South University	Xiao, SY (corresponding author), Cent S Univ, Sch Publ Hlth, Dept Social Med & Hlth Management, Changsha, Hunan, Peoples R China.	xiaosy@csu.edu.cn			CMB-Collaborating Program in Mental Health Policy [CMB11-058]; China Postdoctoral Science Foundation [2013M540645]; Central South University Postdoctoral Science Foundation [12671]	CMB-Collaborating Program in Mental Health Policy; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Central South University Postdoctoral Science Foundation	This work was supported by CMB-Collaborating Program in Mental Health Policy (CMB11-058), the China Postdoctoral Science Foundation (2013M540645) and the Central South University Postdoctoral Science Foundation (12671). The funding source had no role in the study design, collection, analysis or interpretation of the data, writing the manuscript, or the decision to submit the paper for publication.	Alverson H, 2001, Ment Health Serv Res, V3, P3, DOI 10.1023/A:1010104317348; [Anonymous], 2013, CHINA DAILY; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, 10.1191/1478088706qp063oa]; Henkel Dieter, 2011, Curr Drug Abuse Rev, V4, P4; James RK, 2013, CRISIS INTERVENTION, P399; Li JH, 2010, HARM REDUCT J, V7, DOI 10.1186/1477-7517-7-4; Li SP, 2013, INT J TUBERC LUNG D, V17, P1358, DOI 10.5588/ijtld.12.0784; Liamputtong P., 2005, QUALITATIVE RES METH; Lin CQ, 2011, SUBST USE MISUSE, V46, P1190, DOI 10.3109/10826084.2011.561905; Liu ZM, 2004, CHINESE J DRUG DEPEN, V13, P233; Lu L, 2008, CELL MOL NEUROBIOL, V28, P479, DOI 10.1007/s10571-007-9225-2; Luo T, 2014, DRUG ALCOHOL DEPEN, V134, P285, DOI 10.1016/j.drugalcdep.2013.10.015; Maehira Y, 2013, HARM REDUCT J, V10, DOI 10.1186/1477-7517-10-14; McLellan AT, 2000, JAMA-J AM MED ASSOC, V284, P1689, DOI 10.1001/jama.284.13.1689; McLellan AT, 2005, ADDICTION, V100, P447, DOI 10.1111/j.1360-0443.2005.01012.x; Meng Jinmei, 2013, Int J Drug Policy, V24, pe25, DOI 10.1016/j.drugpo.2013.03.010; Min Z, 2011, AM J DRUG ALCOHOL AB, V37, P141, DOI 10.3109/00952990.2010.538943; National Narcotic Control Commission, 2014, ANN REP DRUG CONTR C; Quimby E, 1995, CONT DRUG PROBLE SUM, P265; Salyers MP, 2004, PSYCHIAT SERV, V55, P302, DOI 10.1176/appi.ps.55.3.302; Sau M, 2013, AFR HEALTH SCI, V13, P791, DOI 10.4314/ahs.v13i3.39; Sells DJ, 2003, PSYCHIAT SERV, V54, P1253, DOI 10.1176/appi.ps.54.9.1253; Stewart J, 2008, PHILOS T R SOC B, V363, P3147, DOI 10.1098/rstb.2008.0084; Witkiewitz K, 2004, AM PSYCHOL, V59, P224, DOI 10.1037/0003-066X.59.4.224; Witkiewitz K, 2013, ADDICT BEHAV, V38, P1563, DOI 10.1016/j.addbeh.2012.04.001; Wray JM, 2013, NICOTINE TOB RES, V15, P1167, DOI 10.1093/ntr/nts268; Xue YX, 2012, SCIENCE, V336, P241, DOI 10.1126/science.1215070; Yang M, 2014, ADDICT BEHAV, V39, P573, DOI 10.1016/j.addbeh.2013.11.003; Yu M, 2014, THERE 2 58 MILLION D; Zedong Mao, 2010, ON CONTRADICTION	30	36	41	2	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2015	10	6							e0130711	10.1371/journal.pone.0130711	http://dx.doi.org/10.1371/journal.pone.0130711			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CL4OM	26107639	Green Published, Green Submitted, gold			2022-12-26	WOS:000356932500118
J	Hayat, T; Muhammad, T; Shehzad, SA; Alsaedi, A				Hayat, Tasawar; Muhammad, Taseer; Shehzad, Sabir Ali; Alsaedi, Ahmed			Temperature and Concentration Stratification Effects in Mixed Convection Flow of an Oldroyd-B Fluid with Thermal Radiation and Chemical Reaction	PLOS ONE			English	Article							BOUNDARY-LAYER-FLOW; VERTICAL PLATE; HELICAL FLOWS; SHEAR-STRESS; NANOFLUID; SUBJECT	This research addresses the mixed convection flow of an Oldroyd-B fluid in a doubly stratified surface. Both temperature and concentration stratification effects are considered. Thermal radiation and chemical reaction effects are accounted. The governing nonlinear boundary layer equations are converted to coupled nonlinear ordinary differential equations using appropriate transformations. Resulting nonlinear systems are solved for the convergent series solutions. Graphs are plotted to examine the impacts of physical parameters on the non-dimensional temperature and concentration distributions. The local Nusselt number and the local Sherwood number are computed and analyzed numerically.	[Hayat, Tasawar; Muhammad, Taseer] Quaid I Azam Univ, Dept Math, Islamabad 45320, Pakistan; [Hayat, Tasawar; Muhammad, Taseer] Quaid I Azam Univ, Dept Math, Islamabad 44000, Pakistan; [Hayat, Tasawar; Alsaedi, Ahmed] King Abdulaziz Univ, Res Grp, NAAM, Jeddah 21589, Saudi Arabia; [Shehzad, Sabir Ali] Comsats Inst Informat Technol, Dept Math, Sahiwal 57000, Pakistan	Quaid I Azam University; Quaid I Azam University; King Abdulaziz University; COMSATS University Islamabad (CUI)	Muhammad, T (corresponding author), Quaid I Azam Univ, Dept Math, Islamabad 45320, Pakistan.	taseer_muhammad@yahoo.com	Hayat, Tasawar/Y-2524-2019; Hayat, Tasawar/A-3853-2013; Alsaedi, Ahmed/A-2094-2013; Muhammad, Taseer/F-9103-2018; Shehzad, Sabir Ali/J-3885-2014	Alsaedi, Ahmed/0000-0003-3452-8922; Muhammad, Taseer/0000-0002-0838-2731; 	Deanship of Scientific Research (DSR) [26-130-35-HiCi]	Deanship of Scientific Research (DSR)	This project was funded by the Deanship of Scientific Research (DSR) under grant no. 26-130-35-HiCi. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbasbandy S, 2013, QUAEST MATH, V36, P93, DOI 10.2989/16073606.2013.780336; Alves MA, 2003, J NON-NEWTON FLUID, V110, P45, DOI 10.1016/S0377-0257(02)00191-X; [Anonymous], 2013, J EGYPTIAN MATH SOC, DOI DOI 10.1016/j.joems.2013.02.006; Bachok N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060766; Chang CL, 2008, MECH RES COMMUN, V35, P421, DOI 10.1016/j.mechrescom.2008.03.007; Cheng CY, 2009, INT COMMUN HEAT MASS, V36, P351, DOI 10.1016/j.icheatmasstransfer.2009.01.003; Fetecau C, 2010, COMPUT MATH APPL, V60, P74, DOI 10.1016/j.camwa.2010.04.031; Gizzi LA, 2011, PHYS REV SPEC TOP-AC, V14, DOI 10.1103/PhysRevSTAB.14.011301; Gupta P, 2014, SCI WORLD J, DOI 10.1155/2014/824586; Hayat T, 2013, EUR PHYS J PLUS, V128, DOI 10.1140/epjp/i2013-13157-2; Hayat T, 2012, APPL MATH MECH-ENGL, V33, P1301, DOI 10.1007/s10483-012-1623-6; Hayat T, 2011, ARAB J SCI ENG, V36, P1113, DOI 10.1007/s13369-011-0066-4; Hayat T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083153; Hayat T, 2012, INT J CHEM REACT ENG, V10, DOI 10.1515/1542-6580.2655; Ibrahim W, 2013, COMPUT FLUIDS, V86, P433, DOI 10.1016/j.compfluid.2013.07.029; Jamil M, 2011, COMMUN NONLINEAR SCI, V16, P1378, DOI 10.1016/j.cnsns.2010.07.004; Jamil M, 2012, THEOR APPL MECH LETT, V2, DOI 10.1063/2.1201201; LARSON RG, 1992, RHEOL ACTA, V31, P213, DOI 10.1007/BF00366504; Li CR, 2012, COMMUN NONLINEAR SCI, V17, P5026, DOI 10.1016/j.cnsns.2012.04.012; Liao S.J., 2012, HOMOTOPY ANAL METHOD; Megahed M A, 2013, CHINESE PHYS B, V9; Noreen S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078770; Qi HT, 2009, APPL MATH MODEL, V33, P4184, DOI 10.1016/j.apm.2009.03.002; RAJAGOPAL KR, 1995, ACTA MECH, V113, P233, DOI 10.1007/BF01212645; Rajagopal KR, 2000, J NON-NEWTON FLUID, V88, P207, DOI 10.1016/S0377-0257(99)00023-3; Rashidi MM, 2012, J APPL MATH, DOI 10.1155/2012/780415; Rashidi MM, 2012, INT J NUMER METHOD H, V22, P971, DOI 10.1108/09615531211271817; Sajid M, 2010, CAN J PHYS, V88, P635, DOI 10.1139/P10-049; Shaaban AM, 2000, AM J ROENTGENOL, V174, P1657, DOI 10.2214/ajr.174.6.1741657; Shaqfeh ESG, 1996, ANNU REV FLUID MECH, V28, P129, DOI 10.1146/annurev.fl.28.010196.001021; Shehzad SA, 2013, BRAZ J CHEM ENG, V30, P897, DOI 10.1590/S0104-66322013000400021; Shehzad SA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078240; Shehzad SA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068139; Srinivasacharya D, 2015, APPL NANOSCI, V5, P29, DOI 10.1007/s13204-013-0289-7; Srinivasacharya D, 2012, MATEMATIKA, V28, P133; Srinivasacharya D, 2014, INT J ENG MATH, V2014; Su J, 2013, PHYS REV E, V88, DOI 10.1103/PhysRevE.88.053304; Tan WC, 2005, PHYS FLUIDS, V17, DOI 10.1063/1.1850409; Tong DK, 2009, J NON-NEWTON FLUID, V156, P75, DOI 10.1016/j.jnnfm.2008.07.004; Tripathi D, 2014, COMPUT METHOD BIOMEC, V17, P433, DOI 10.1080/10255842.2012.688109; Turkyilmazoglu M, 2012, COMMUN NONLINEAR SCI, V17, P4097, DOI 10.1016/j.cnsns.2012.01.030; Turkyilmazoglu M, 2011, INT J THERM SCI, V50, P2264, DOI 10.1016/j.ijthermalsci.2011.05.014; Wang YC, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.028106; Zheng LC, 2012, NONLINEAR ANAL-REAL, V13, P513, DOI 10.1016/j.nonrwa.2011.02.016	45	27	27	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2015	10	6							e0127646	10.1371/journal.pone.0127646	http://dx.doi.org/10.1371/journal.pone.0127646			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4DD	26102200	gold, Green Published, Green Submitted			2022-12-26	WOS:000356901900004
J	Aravindhan, K; Bao, WK; Harpel, MR; Willette, RN; Lepore, JJ; Jucker, BM				Aravindhan, Karpagam; Bao, Weike; Harpel, Mark R.; Willette, Robert N.; Lepore, John J.; Jucker, Beat M.			Cardioprotection Resulting from Glucagon-Like Peptide-1 Administration Involves Shifting Metabolic Substrate Utilization to Increase Energy Efficiency in the Rat Heart	PLOS ONE			English	Article							MYOCARDIAL ISCHEMIA/REPERFUSION INJURY; INTRAMUSCULAR GLUCOSE-METABOLISM; VENTRICULAR SYSTOLIC FUNCTION; FAILURE-PRONE RAT; IN-VIVO; DILATED CARDIOMYOPATHY; INDIVIDUAL TISSUES; PROLONGS SURVIVAL; GLYCEMIC CONTROL; CONSCIOUS DOGS	Previous studies have shown that glucagon-like peptide-1 (GLP-1) provides cardiovascular benefits independent of its role on peripheral glycemic control. However, the precise mechanism(s) by which GLP-1 treatment renders cardioprotection during myocardial ischemia remain unresolved. Here we examined the role for GLP-1 treatment on glucose and fatty acid metabolism in normal and ischemic rat hearts following a 30 min ischemia and 24 h reperfusion injury, and in isolated cardiomyocytes (CM). Relative carbohydrate and fat oxidation levels were measured in both normal and ischemic hearts using a 1-C-13 glucose clamp coupled with NMR-based isotopomer analysis, as well as in adult rat CMs by monitoring pH and O-2 consumption in the presence of glucose or palmitate. In normal heart, GLP-1 increased glucose uptake (up arrow 64%, p<0.05) without affecting glycogen levels. In ischemic hearts, GLP-1 induced metabolic substrate switching by increasing the ratio of carbohydrate versus fat oxidation (up arrow 14%, p<0.01) in the LV area not at risk, without affecting cAMP levels. Interestingly, no substrate switching occurred in the LV area at risk, despite an increase in cAMP (up arrow 106%, p<0.05) and lactate (up arrow 121%, p<0.01) levels. Furthermore, in isolated CMs GLP-1 treatment increased glucose utilization (up arrow 14%, p<0.05) and decreased fatty acid oxidation (down arrow 15%, p<0.05) consistent with in vivo finding. Our results show that this benefit may derive from distinct and complementary roles of GLP-1 treatment on metabolism in myocardial sub-regions in response to this injury. In particular, a switch to anaerobic glycolysis in the ischemic area provides a compensatory substrate switch to overcome the energetic deficit in this region in the face of reduced tissue oxygenation, whereas a switch to more energetically favorable carbohydrate oxidation in more highly oxygenated remote regions supports maintaining cardiac contractility in a complementary manner.	[Aravindhan, Karpagam; Bao, Weike; Harpel, Mark R.; Willette, Robert N.; Lepore, John J.; Jucker, Beat M.] GlaxoSmithKline, Heart Failure Discovery Performance Unit, Metab Pathways & Cardiovasc Therapeut Area, King Of Prussia, PA USA	GlaxoSmithKline	Jucker, BM (corresponding author), GlaxoSmithKline, Preclin & Translat Imaging, Lab Anim Sci Platform Technol & Sci, Collegeville, PA 19426 USA.	Beat.M.Jucker@gsk.com			GlaxoSmithKline	GlaxoSmithKline(GlaxoSmithKline)	GlaxoSmithKline provided support in the form of salaries for authors KA, WB, MRH, RNW, JJL and BMJ but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Abozguia K, 2006, NAT CLIN PRACT CARD, V3, P490, DOI 10.1038/ncpcardio0583; Balteau M, 2014, AM J PHYSIOL-HEART C, V307, pH1120, DOI 10.1152/ajpheart.00210.2014; Ban K, 2008, CIRCULATION, V117, P2340, DOI 10.1161/CIRCULATIONAHA.107.739938; Bao WK, 2013, CARDIOVASC DIABETOL, V12, DOI 10.1186/1475-2840-12-148; Bao WK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023570; Bao WK, 2004, CARDIOVASC RES, V61, P548, DOI 10.1016/j.cardiores.2003.12.004; Bhashyam S, 2010, CIRC-HEART FAIL, V3, P512, DOI 10.1161/CIRCHEARTFAILURE.109.900282; BLOCH G, 1994, AM J PHYSIOL, V266, pE85, DOI 10.1152/ajpendo.1994.266.1.E85; Bose AK, 2005, CARDIOVASC DRUG THER, V19, P9, DOI 10.1007/s10557-005-6892-4; Bose AK, 2005, DIABETES, V54, P146, DOI 10.2337/diabetes.54.1.146; Bose AK, 2007, CARDIOVASC DRUG THER, V21, P253, DOI 10.1007/s10557-007-6030-6; Chang GL, 2013, INT J MOL MED, V32, P1011, DOI 10.3892/ijmm.2013.1475; Depre C, 1999, CIRCULATION, V99, P578, DOI 10.1161/01.CIR.99.4.578; Dranka BP, 2010, FREE RADICAL BIO MED, V48, P905, DOI 10.1016/j.freeradbiomed.2010.01.015; Ferrick DA, 2008, DRUG DISCOV TODAY, V13, P268, DOI 10.1016/j.drudis.2007.12.008; Grieve DJ, 2009, BRIT J PHARMACOL, V157, P1340, DOI 10.1111/j.1476-5381.2009.00376.x; Hausenloy DJ, 2008, CIRC-HEART FAIL, V1, P147, DOI 10.1161/CIRCHEARTFAILURE.108.810887; Hue L, 2009, AM J PHYSIOL-ENDOC M, V297, pE578, DOI 10.1152/ajpendo.00093.2009; Huisamen B, 2008, CARDIOVASC J AFR, V19, P77; Jia G, 2012, CHIN J PATHOPHYSIOL, V28, P858; Jucker BM, 1997, J BIOL CHEM, V272, P10464, DOI 10.1074/jbc.272.16.10464; Jucker BM, 1997, AM J PHYSIOL-ENDOC M, V273, pE139, DOI 10.1152/ajpendo.1997.273.1.E139; KRAEGEN EW, 1985, AM J PHYSIOL, V248, pE353; Liu Q, 2010, CARDIOVASC DIABETOL, V9, DOI [10.1186/1475-2840-9-76, 10.1186/1475-2840-9-32]; Neubauer S, 2007, NEW ENGL J MED, V356, P1140, DOI 10.1056/NEJMra063052; Nguyen TD, 2013, INT J CARDIOL, V168, P4085, DOI 10.1016/j.ijcard.2013.07.018; Nguyen TD, 2009, CIRC-HEART FAIL, V2, pE1, DOI 10.1161/CIRCHEARTFAILURE.108.832162; Nikolaidis LA, 2005, J PHARMACOL EXP THER, V312, P303, DOI 10.1124/jpet.104.073890; Nikolaidis LA, 2004, CIRCULATION, V110, P955, DOI 10.1161/01.CIR.0000139339.85840.DD; Nikolaidis LA, 2004, CIRCULATION, V109, P962, DOI 10.1161/01.CIR.0000120505.91348.58; Noyan-Ashraf MH, 2009, DIABETES, V58, P975, DOI 10.2337/db08-1193; Park TS, 2007, CURR OPIN LIPIDOL, V18, P277, DOI 10.1097/MOL.0b013e32814a57db; Parkes DG, 2001, METABOLISM, V50, P583, DOI 10.1053/meta.2001.22519; Perrone CE, 2008, J LIPID RES, V49, P12, DOI 10.1194/jlr.M700194-JLR200; Poornima I, 2008, CIRC-HEART FAIL, V1, P153, DOI 10.1161/CIRCHEARTFAILURE.108.766402; Ravassa S, 2012, CARDIOVASC RES, V94, P316, DOI 10.1093/cvr/cvs123; Snabaitis AK, 2005, CELL SIGNAL, V17, P655, DOI 10.1016/j.cellsig.2004.10.008; Sokos GG, 2007, AM J CARDIOL, V100, P824, DOI 10.1016/j.amjcard.2007.05.022; Sokos GG, 2006, J CARD FAIL, V12, P694, DOI 10.1016/j.cardfail.2006.08.211; Tomas E, 2010, TRENDS ENDOCRIN MET, V21, P59, DOI 10.1016/j.tem.2009.11.007; Wetter TJ, 1999, AM J PHYSIOL-ENDOC M, V276, pE728; Willette RN, 2008, J PHARMACOL EXP THER, V326, P443, DOI 10.1124/jpet.107.134551; Yue TL, 2008, J PHARMACOL EXP THER, V325, P466, DOI 10.1124/jpet.107.135327; Zhao TC, 2006, J PHARMACOL EXP THER, V317, P1106, DOI 10.1124/jpet.106.100982	44	29	32	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2015	10	6							e0130894	10.1371/journal.pone.0130894	http://dx.doi.org/10.1371/journal.pone.0130894			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL3FM	26098939	Green Published, Green Submitted, gold			2022-12-26	WOS:000356835800119
J	Bach, DR; Seifritz, E; Dolan, RJ				Bach, Dominik R.; Seifritz, Erich; Dolan, Raymond J.			Temporally Unpredictable Sounds Exert a Context-Dependent Influence on Evaluation of Unrelated Images	PLOS ONE			English	Article							MODEL-BASED ANALYSIS; STOCHASTIC RESONANCE; ANXIETY; EVENTS; RATS	Temporally unpredictable stimuli influence murine and human behaviour, as previously demonstrated for sequences of simple sounds with regular or irregular onset. It is unknown whether this influence is mediated by an evaluation of the unpredictable sound sequences themselves, or by an interaction with task context. Here, we find that humans evaluate unrelated neutral pictures as more negative when these are presented together with a temporally unpredictable sound sequence, compared to a predictable sequence. The same is observed for evaluation of neutral, angry and fearful face photographs. Control experiments suggest this effect is specific to interspersed presentation of negative and neutral visual stimuli. Unpredictable sounds presented on their own were evaluated as more activating, but not more aversive, and were preferred over predictable sounds. When presented alone, these sound sequences also did not elicit tonic autonomic arousal or negative mood change. We discuss how these findings might account for previous data on the effects of unpredictable sounds, in humans and rodents.	[Bach, Dominik R.; Dolan, Raymond J.] UCL, Wellcome Trust Ctr Neuroimaging, London, England; [Bach, Dominik R.; Seifritz, Erich] Univ Bern, Univ Hosp Psychiat, Bern, Switzerland; [Bach, Dominik R.] Berlin Inst Technol, Dept Psychol & Ergon, Berlin, Germany; [Bach, Dominik R.; Seifritz, Erich] Univ Zurich, Dept Psychiat Psychotherapy & Psychosomat, Zurich, Switzerland	University of London; University College London; University of Bern; University Hospital of Bern; Technical University of Berlin; University of Zurich	Bach, DR (corresponding author), UCL, Wellcome Trust Ctr Neuroimaging, London, England.	dominik.bach@uzh.ch	Bach, Dominik R/B-4302-2019	Bach, Dominik R/0000-0003-3717-2036	Wellcome Trust [091593/Z/10/Z]; Swiss National Science Foundation; University of Zurich	Wellcome Trust(Wellcome Trust); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); University of Zurich	This research was funded by the Wellcome Trust [Programme Grant to RJD] and the Swiss National Science Foundation [Project Grant to ES and Advanced Postdoc Mobility Fellowship to DRB], and the University of Zurich. The Wellcome Trust Centre for Neuroimaging is supported by core funding from the Wellcome Trust [091593/Z/10/Z].	Anselme P, 2010, BEHAV BRAIN RES, V208, P291, DOI 10.1016/j.bbr.2009.12.020; Bach DR, 2007, COGNITION EMOTION, V21, P1091, DOI 10.1080/02699930600934269; Bach DR, 2006, EUR J GASTROEN HEPAT, V18, P629, DOI 10.1097/00042737-200606000-00009; Bach DR, 2015, PSYCHOPHYSIOLOGY, V52, P1106, DOI 10.1111/psyp.12434; Bach DR, 2014, BIOL PSYCHOL, V103, P63, DOI 10.1016/j.biopsycho.2014.08.006; Bach DR, 2013, BIOL PSYCHOL, V94, P490, DOI 10.1016/j.biopsycho.2013.09.010; Bach DR, 2013, PSYCHOPHYSIOLOGY, V50, P15, DOI 10.1111/j.1469-8986.2012.01483.x; Bach DR, 2012, NAT REV NEUROSCI, V13, P572, DOI 10.1038/nrn3289; Bach DR, 2011, PSYCHOPHYSIOLOGY, V48, P252, DOI 10.1111/j.1469-8986.2010.01052.x; Bach DR, 2010, INT J PSYCHOPHYSIOL, V75, P349, DOI 10.1016/j.ijpsycho.2010.01.005; Bach DR, 2009, J NEUROSCI METH, V184, P224, DOI 10.1016/j.jneumeth.2009.08.005; Berridge KC, 1996, NEUROSCI BIOBEHAV R, V20, P1, DOI 10.1016/0149-7634(95)00033-B; Boucsein W, 2012, PSYCHOPHYSIOLOGY, V49, P1017, DOI 10.1111/j.1469-8986.2012.01384.x; Cacioppo JT, 2007, HANDBOOK OF PSYCHOPHYSIOLOGY, 3RD EDITION, P1, DOI 10.2277/ 0521844711; DALY HB, 1989, BEHAV NEUROSCI, V103, P1356, DOI 10.1037/0735-7044.103.6.1356; DALY HB, 1989, J EXP PSYCHOL ANIM B, V15, P3, DOI 10.1037/0097-7403.15.1.3; Erdmann G, 1996, Z EXP PSYCHOL, V43, P224; Friston KJ, 2010, NAT REV NEUROSCI, V11, P127, DOI 10.1038/nrn2787; Herry C, 2007, J NEUROSCI, V27, P5958, DOI 10.1523/JNEUROSCI.5218-06.2007; HILL AB, 1985, BRIT J PSYCHOL, V76, P235, DOI 10.1111/j.2044-8295.1985.tb01947.x; HYGGE S, 1985, PSYCHOPHYSIOLOGY, V22, P365, DOI 10.1111/j.1469-8986.1985.tb01616.x; Janke W, 2002, CHAIR BIOL CLI UNPUB; Janke W, 1978, EIGENSCHAFTSWOERTERL; Kitajo K, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.218103; Lang P. J., 2005, A6 U FLOR, DOI DOI 10.1027/0269-8803/A000147; Laux L., 1981, STATE TRAIT ANGSTINV; Lugo E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002860; Lundqvist D, 1998, KAROLINSKA DIRECTED, DOI [10.1016/j.brainres.2015.01.027, DOI 10.1016/J.BRAINRES.2015.01.027]; MACLEOD C, 1988, Q J EXP PSYCHOL-A, V40, P653, DOI 10.1080/14640748808402292; MINEKA S, 1978, J ABNORM PSYCHOL, V87, P256, DOI 10.1037/0021-843X.87.2.256; MOGG K, 1994, Q J EXP PSYCHOL-A, V47, P841, DOI 10.1080/14640749408401099; Parmentier FBR, 2008, COGNITION, V106, P408, DOI 10.1016/j.cognition.2007.03.008; PERKINS RE, 1985, BRIT J PSYCHOL, V76, P221, DOI 10.1111/j.2044-8295.1985.tb01946.x; Sasaki H, 2008, BEHAV BRAIN RES, V193, P152, DOI 10.1016/j.bbr.2008.05.003; Sasaki H, 2008, NEUROSCI LETT, V436, P255, DOI 10.1016/j.neulet.2008.03.036; SELIGMAN ME, 1970, J COMP PHYSIOL PSYCH, V73, P202, DOI 10.1037/h0030219; Simonotto E, 1997, PHYS REV LETT, V78, P1186, DOI 10.1103/PhysRevLett.78.1186	37	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2015	10	6							e0131065	10.1371/journal.pone.0131065	http://dx.doi.org/10.1371/journal.pone.0131065			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CL3FM	26098105	Green Published, Green Accepted, gold			2022-12-26	WOS:000356835800142
J	Delgado-Gonzalez, JC; Mansilla-Legorburo, F; Florensa-Vila, J; Insausti, AM; Vinuela, A; Tunon-Alvarez, T; Cruz, M; Mohedano-Moriano, A; Insausti, R; Artacho-Perula, E				Carlos Delgado-Gonzalez, Jose; Mansilla-Legorburo, Francisco; Florensa-Vila, Jose; Maria Insausti, Ana; Vinuela, Antonio; Tunon-Alvarez, Teresa; Cruz, Marcos; Mohedano-Moriano, Alicia; Insausti, Ricardo; Artacho-Perula, Emilio			Quantitative Measurements in the Human Hippocampus and Related Areas: Correspondence between Ex-Vivo MRI and Histological Preparations	PLOS ONE			English	Article							MEDIAL TEMPORAL-LOBE; ENTORHINAL CORTEX; CORTICAL THICKNESS; ALZHEIMERS-DISEASE; AMYGDALA VOLUME; NEURON NUMBER; MEMORY; SCHIZOPHRENIA; CONNECTIVITY; REGIONS	The decrease of volume estimates in different structures of the medial temporal lobe related to memory correlate with the decline of cognitive functions in neurodegenerative diseases. This study presents data on the association between MRI quantitative parameters of medial temporal lobe structures and their quantitative estimate in microscopic examination. Twelve control cases had ex-vivo MRI, and thereafter, the temporal lobe of both hemispheres was sectioned from the pole as far as the level of the splenium of the corpus callosum. Nissl stain was used to establish anatomical boundaries between structures in the medial temporal lobe. The study included morphometrical and stereological estimates of the amygdaloid complex, hippocampus, and temporal horn of the lateral ventricle, as well as different regions of grey and white matter in the temporal lobe. Data showed a close association between morphometric MRI images values and those based on the histological determination of boundaries. Only values in perimeter and circularity of the piamater were different. This correspondence is also revealed by the stereological study, although irregular compartments resulted in a lesser agreement. Neither age (< 65 yr and > 65yr) nor hemisphere had any effect. Our results indicate that ex-vivo MRI is highly associated with quantitative information gathered by histological examination, and these data could be used as structural MRI biomarker in neurodegenerative diseases.	[Carlos Delgado-Gonzalez, Jose; Mohedano-Moriano, Alicia; Insausti, Ricardo; Artacho-Perula, Emilio] Univ Castilla La Mancha, Sch Med, Human Neuroanat Lab, E-13071 Ciudad Real, Spain; [Carlos Delgado-Gonzalez, Jose; Mohedano-Moriano, Alicia; Insausti, Ricardo; Artacho-Perula, Emilio] Univ Castilla La Mancha, Sch Med, CRIB, E-13071 Ciudad Real, Spain; [Mansilla-Legorburo, Francisco] CHUA, Magnet Resonance Unit, Serv Radiol, Albacete, Spain; [Florensa-Vila, Jose] HNP, Radiodiagnost Serv, Toledo, Spain; [Maria Insausti, Ana] Univ Publ Navarra, Phys Therapy Sch, Dept Hlth, Tudela, Spain; [Vinuela, Antonio] Sch Adv Educ Res & Accreditat, Castellon De La Plana, Spain; [Tunon-Alvarez, Teresa] Hosp Complex Navarre, Pathol Serv, Pamplona, Spain; [Cruz, Marcos] Univ Cantabria, Dept Math Stat & Computat, E-39005 Santander, Spain	Universidad de Castilla-La Mancha; Universidad de Castilla-La Mancha; Universidad Publica de Navarra; Servicio Navarro de Salud - Osasunbidea; Universidad de Cantabria	Artacho-Perula, E (corresponding author), Univ Castilla La Mancha, Sch Med, Human Neuroanat Lab, E-13071 Ciudad Real, Spain.	emilio.artacho@uclm.es	Viñuela, antonio/S-1128-2019; Cruz, Marcos/N-3429-2014; Viñuela, antonio/AAD-7599-2020; Artacho-Pérula, Emilio/T-6787-2019; Mohedano-Moriano, Alicia/L-1121-2016; Insausti-Serrano, Ana M./I-1203-2015; Florensa-Vila, José/AAA-5194-2019	Viñuela, antonio/0000-0003-4306-1607; Cruz, Marcos/0000-0002-4767-530X; Viñuela, antonio/0000-0003-4306-1607; Mohedano-Moriano, Alicia/0000-0003-4904-6774; Insausti-Serrano, Ana M./0000-0002-4707-8046; 	Spanish Ministry of Science and Innovation I+D+i Project [BFU-2009-14705]; Education, Culture and Sports of Castilla-La Mancha Autonomic Government Project [PPII-2014-013-A]; Health Research Foundation of Castilla-La Mancha (FISCAM) Project [PI-2007-59]	Spanish Ministry of Science and Innovation I+D+i Project(Ministry of Science and Innovation, Spain (MICINN)); Education, Culture and Sports of Castilla-La Mancha Autonomic Government Project; Health Research Foundation of Castilla-La Mancha (FISCAM) Project	This study was funded by the Spanish Ministry of Science and Innovation I+D+i Project BFU-2009-14705 (EAP and RI), the Education, Culture and Sports of Castilla-La Mancha Autonomic Government Project PPII-2014-013-A (EAP and RI), and from the Health Research Foundation of Castilla-La Mancha (FISCAM) Project PI-2007-59. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Artacho-Perula E, 2007, ANAL QUANT CYTOL, V29, P1; Augustinack JC, 2013, NEUROIMAGE, V64, P32, DOI 10.1016/j.neuroimage.2012.08.071; Aylward EH, 1999, AM J PSYCHIAT, V156, P564; Bigler ED, 1997, AM J NEURORADIOL, V18, P11; Binney RJ, 2012, J COGNITIVE NEUROSCI, V24, P1998, DOI 10.1162/jocn_a_00263; Burggren AC, 2008, NEUROIMAGE, V41, P1177, DOI 10.1016/j.neuroimage.2008.03.039; Chareyron LJ, 2011, J COMP NEUROL, V519, P3218, DOI 10.1002/cne.22677; Clerx L, 2013, NEUROBIOL AGING, V34, P2003, DOI 10.1016/j.neurobiolaging.2013.02.002; Cloutman LL, 2012, NEUROIMAGE, V59, P3514, DOI 10.1016/j.neuroimage.2011.11.016; Cruz-Orive LM, 2014, J MICROSC-OXFORD, V253, P119, DOI 10.1111/jmi.12103; Cruz-Orive LM, 1993, B INT STAT I, V55, P451; Davachi L, 2006, CURR OPIN NEUROBIOL, V16, P693, DOI 10.1016/j.conb.2006.10.012; Dickerson BC, 2009, NEUROBIOL AGING, V30, P432, DOI 10.1016/j.neurobiolaging.2007.07.022; Dolan MC, 2002, PSYCHIAT RES-NEUROIM, V116, P133, DOI 10.1016/S0925-4927(02)00085-9; Franko E, 2014, HUM BRAIN MAPP, V35, P248, DOI 10.1002/hbm.22170; FREE SL, 1995, AM J NEURORADIOL, V16, P637; Furlong C, 2013, MAGN RESON IMAGING, V31, P456, DOI 10.1016/j.mri.2012.09.001; Gabrieli JDE, 1997, SCIENCE, V276, P264, DOI 10.1126/science.276.5310.264; GomezIsla T, 1996, J NEUROSCI, V16, P4491; Pereira PMG, 2006, REV NEUROLOGIA, V42, P713, DOI 10.33588/rn.4212.2005352; GUNDERSEN HJG, 1987, J MICROSC-OXFORD, V147, P229, DOI 10.1111/j.1365-2818.1987.tb02837.x; Hallahan BP, 2011, NEUROIMAGE, V54, P16, DOI 10.1016/j.neuroimage.2010.08.015; Insausti R, 1998, AM J NEURORADIOL, V19, P659; Insausti R, 2011, LECT NOTES COMPUT SC, V6687, P112, DOI 10.1007/978-3-642-21326-7_13; INSAUSTI R, 1995, J COMP NEUROL, V355, P171, DOI 10.1002/cne.903550203; Insausti R, 1998, MICROSC RES TECHNIQ, V43, P8, DOI 10.1002/(SICI)1097-0029(19981001)43:1<8::AID-JEMT2>3.0.CO;2-4; Insausti R., 2012, HUMAN NERVOUS SYSTEM, P896, DOI DOI 10.1016/B978-0-12-374236-0.10024-0; Insausti R, 2009, LECT NOTES COMPUT SC, V5602, P134, DOI 10.1007/978-3-642-02267-8_15; Jabes A, 2011, J COMP NEUROL, V519, P1051, DOI 10.1002/cne.22549; Karnik-Henry MS, 2012, SCHIZOPHR RES, V138, P128, DOI 10.1016/j.schres.2012.03.015; Keeley RJ, 2015, NEUROSCIENCE, V289, P194, DOI 10.1016/j.neuroscience.2014.12.077; Lehmann M, 2010, NEUROIMAGE, V49, P2264, DOI 10.1016/j.neuroimage.2009.10.056; Lemaitre H, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2010.07.013; Machado-de-Sousa JP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088523; Maller JJ, 2007, PSYCHIAT RES-NEUROIM, V156, P185, DOI 10.1016/j.pscychresns.2007.06.005; Manns JR, 2006, HIPPOCAMPUS, V16, P795, DOI 10.1002/hipo.20205; Morey RA, 2012, ARCH GEN PSYCHIAT, V69, P1169, DOI 10.1001/archgenpsychiatry.2012.50; Noble KG, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00307; Pakkenberg B, 1997, J COMP NEUROL, V384, P312, DOI 10.1002/(SICI)1096-9861(19970728)384:2<312::AID-CNE10>3.0.CO;2-K; Pitkanen A, 2002, HIPPOCAMPUS, V12, P186, DOI 10.1002/hipo.1099; Price JL, 2001, ARCH NEUROL-CHICAGO, V58, P1395, DOI 10.1001/archneur.58.9.1395; Pruessner JC, 2000, CEREB CORTEX, V10, P433, DOI 10.1093/cercor/10.4.433; Pujol J, 2002, NEUROIMAGE, V17, P670, DOI 10.1106/nimg.2002.1203; Schmahl CG, 2003, PSYCHIAT RES-NEUROIM, V122, P193, DOI 10.1016/S0925-4927(03)00023-4; Schumann CM, 2004, J NEUROSCI, V24, P6392, DOI 10.1523/JNEUROSCI.1297-04.2004; Squire LR, 2004, ANNU REV NEUROSCI, V27, P279, DOI 10.1146/annurev.neuro.27.070203.144130; Starcevic A, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/968495; Stark AK, 2007, NEUROSCIENCE, V150, P121, DOI 10.1016/j.neuroscience.2007.06.062; Takahashi T, 2006, SCHIZOPHR RES, V87, P116, DOI 10.1016/j.schres.2006.04.023; Teipel SJ, 2006, J NEUROL, V253, P794, DOI 10.1007/s00415-006-0120-4; Westlye ET, 2012, NEUROIMAGE, V63, P507, DOI 10.1016/j.neuroimage.2012.06.072; Winter H, 2004, AM J PSYCHIAT, V161, P2194, DOI 10.1176/appi.ajp.161.12.2194; Wisse LEM, 2012, NEUROIMAGE, V61, P1043, DOI 10.1016/j.neuroimage.2012.03.023; Yin XT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086423	54	8	8	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2015	10	6							e0130314	10.1371/journal.pone.0130314	http://dx.doi.org/10.1371/journal.pone.0130314			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL3FM	26098887	Green Published, Green Submitted, gold			2022-12-26	WOS:000356835800062
J	Gunther, G; Berrios, E; Pizarro, N; Valdes, K; Montero, G; Arriagada, F; Morales, J				Guenther, German; Berrios, Eduardo; Pizarro, Nancy; Valdes, Karina; Montero, Guillermo; Arriagada, Francisco; Morales, Javier			Flavonoids in Microheterogeneous Media, Relationship between Their Relative Location and Their Reactivity towards Singlet Oxygen	PLOS ONE			English	Article							HUMAN-ERYTHROCYTE-GHOSTS; PARTITION-COEFFICIENTS; PHOTOSENSITIZED OXYGENATION; PHENOTHIAZINE-DERIVATIVES; DISSOCIATION-CONSTANTS; ANTIOXIDANT ACTIVITIES; MEMBRANE-FLUIDITY; QUERCETIN; DIFFUSION; MODEL	In this work, the relationship between the molecular structure of three flavonoids (kaempferol, quercetin and morin), their relative location in microheterogeneous media (liposomes and erythrocyte membranes) and their reactivity against singlet oxygen was studied. The changes observed in membrane fluidity induced by the presence of these flavonoids and the influence of their lipophilicity/hydrophilicity on the antioxidant activity in lipid membranes were evaluated by means of fluorescent probes such as Laurdan and diphenylhexatriene (DPH). The small differences observed for the value of generalized polarization of Laurdan (GP) curves in function of the concentration of flavonoids, indicate that these three compounds promote similar alterations in liposomes and erythrocyte membranes. In addition, these compounds do not produce changes in fluorescence anisotropy of DPH, discarding their location in deeper regions of the lipid bilayer. The determined chemical reactivity sequence is similar in all the studied media (kaempferol < quercetin < morin). Morin is approximately 10 times more reactive than quercetin and 20 to 30 times greater than kaempferol, depending on the medium.	[Guenther, German; Berrios, Eduardo] Univ Chile, Fac Ciencias Quim & Farmaceut, Dept Quim Organ & Fis Quim, Santiago, Chile; [Pizarro, Nancy] Univ Andres Bello, Fac Ciencias Exactas, Dept Ciencias Quim, Santiago, Chile; [Valdes, Karina; Montero, Guillermo; Arriagada, Francisco; Morales, Javier] Univ Chile, Fac Ciencias Quim & Farmaceut, Dept Ciencias & Tecnol Farmaceut, Santiago, Chile	Universidad de Chile; Universidad Andres Bello; Universidad de Chile	Morales, J (corresponding author), Univ Chile, Fac Ciencias Quim & Farmaceut, Dept Ciencias & Tecnol Farmaceut, Santiago, Chile.	javiermv@ciq.uchile.cl	Gunther, German/I-1028-2013; Pizarro, Nancy/E-1131-2015; Valdés, Karina/H-4882-2014	Gunther, German/0000-0002-4733-8426; Pizarro, Nancy/0000-0002-4688-0889; Valdés, Karina/0000-0001-9987-9358; Morales Valenzuela, Javier Eduardo/0000-0002-9880-2567	FONDECYT [11121172]	FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT)	The financial support from FONDECYT (grant 11121172).	AARTS PAMM, 1983, BLOOD, V62, P214; Arora A, 2000, ARCH BIOCHEM BIOPHYS, V373, P102, DOI 10.1006/abbi.1999.1525; Arora A, 1998, ARCH BIOCHEM BIOPHYS, V356, P133, DOI 10.1006/abbi.1998.0783; AUDOUIN L, 1994, J MATER SCI, V29, P569, DOI 10.1007/BF00445968; Ayouni L, 2005, CHROMATOGRAPHIA, V62, P251, DOI 10.1365/s10337-005-0608-6; BACKMAN L, 1986, J CELL SCI, V80, P281; Barenholz Y, 2001, CURR OPIN COLLOID IN, V6, P66, DOI 10.1016/S1359-0294(00)00090-X; BECKE AD, 1993, J CHEM PHYS, V98, P5648, DOI 10.1063/1.464913; Bhattacharyya S, 2014, J PHYS CHEM C, V118, P9733, DOI 10.1021/jp4127094; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Briviba K, 1997, BIOL CHEM, V378, P1259; Cao GH, 1997, FREE RADICAL BIO MED, V22, P749, DOI 10.1016/S0891-5849(96)00351-6; CHATTERJEE SN, 1988, FREE RADICAL BIO MED, V4, P51, DOI 10.1016/0891-5849(88)90011-1; Chaudhuri S, 2007, INT J BIOL MACROMOL, V41, P42, DOI 10.1016/j.ijbiomac.2006.12.003; CHRISTOP.AJ, 1967, MICROCHEM J, V12, P593, DOI 10.1016/0026-265X(67)90097-5; CLARK JH, 1980, CHEM REV, V80, P429, DOI 10.1021/cr60327a004; DeRosa MC, 2002, COORDIN CHEM REV, V233, P351, DOI 10.1016/S0010-8545(02)00034-6; DODGE JT, 1963, ARCH BIOCHEM BIOPHYS, V100, P119, DOI 10.1016/0003-9861(63)90042-0; Erlejman AG, 2004, FREE RADICAL RES, V38, P1311, DOI 10.1080/10715760400016105; Feller SE, 1997, LANGMUIR, V13, P6555, DOI 10.1021/la970746j; GARCIA NA, 1994, J PHOTOCH PHOTOBIO B, V22, P185, DOI 10.1016/1011-1344(93)06932-S; Genis R, 1989, BIOMEMBRANES MOLECUL; Giugliano D, 2000, NUTR METAB CARDIOVAS, V10, P38; Goncalves ES, 2008, LANGMUIR, V24, P9056, DOI 10.1021/la801353n; Gulyaeva N, 2003, EUR J MED CHEM, V38, P391, DOI 10.1016/S0223-5234(03)00044-8; HALLIWELL B, 1994, LANCET, V344, P721, DOI 10.1016/S0140-6736(94)92211-X; Herrero-Martinez JM, 2005, ELECTROPHORESIS, V26, P1886, DOI 10.1002/elps.200410258; Hertog MGL, 1996, EUR J CLIN NUTR, V50, P63; Hollman PCH, 1999, FREE RADICAL RES, V31, pS75, DOI 10.1080/10715769900301351; Hou LF, 2004, ORG BIOMOL CHEM, V2, P1419, DOI 10.1039/b401550a; Huang DJ, 2005, J AGR FOOD CHEM, V53, P1841, DOI 10.1021/jf030723c; Hulten LM, 1999, FREE RADICAL BIO MED, V27, P1203; IOKU K, 1995, BBA-BIOMEMBRANES, V1234, P99, DOI 10.1016/0005-2736(94)00262-N; Jensen RL, 2012, J AM CHEM SOC, V134, P9820, DOI 10.1021/ja303710m; JOVANOVIC SV, 1994, J AM CHEM SOC, V116, P4846, DOI 10.1021/ja00090a032; KAWATO S, 1977, BIOCHEMISTRY-US, V16, P2319, DOI 10.1021/bi00630a002; Kitamura K, 1998, TALANTA, V46, P1433, DOI 10.1016/S0039-9140(98)00014-9; KITAMURA K, 1991, ANAL CHIM ACTA, V242, P131, DOI 10.1016/0003-2670(91)87057-E; Klinger M, 2009, ACS APPL MATER INTER, V1, P661, DOI 10.1021/am800197j; Kochevar IE, 2000, METHOD ENZYMOL, V319, P20; LEE CT, 1988, PHYS REV B, V37, P785, DOI 10.1103/PhysRevB.37.785; LENAZ G, 1987, BIOSCIENCE REP, V7, P823, DOI 10.1007/BF01119473; LENTZ BR, 1989, CHEM PHYS LIPIDS, V50, P171, DOI 10.1016/0009-3084(89)90049-2; LEO A, 1971, CHEM REV, V71, P525, DOI 10.1021/cr60274a001; LIEBER MR, 1982, J BIOL CHEM, V257, P1651; LISSI EA, 1993, CHEM REV, V93, P699, DOI 10.1021/cr00018a004; Lopez-Revuelta A, 2006, CHEM-BIOL INTERACT, V161, P79, DOI 10.1016/j.cbi.2006.03.004; MATSUURA T, 1970, TETRAHEDRON, V26, P435, DOI 10.1016/S0040-4020(01)97840-8; McNeil PL, 2003, ANNU REV CELL DEV BI, V19, P697, DOI 10.1146/annurev.cellbio.19.111301.140101; MICHAELI A, 1994, PHOTOCHEM PHOTOBIOL, V59, P284, DOI 10.1111/j.1751-1097.1994.tb05035.x; Montana MP, 2010, PHOTOCHEM PHOTOBIOL, V86, P827, DOI 10.1111/j.1751-1097.2010.00754.x; Montenegro MA, 2007, J PHOTOCH PHOTOBIO A, V186, P47, DOI 10.1016/j.jphotochem.2006.07.013; Morales J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040548; Musialik M, 2009, J ORG CHEM, V74, P2699, DOI 10.1021/jo802716v; Nagai S, 2005, J PHYS CHEM B, V109, P4234, DOI 10.1021/jp0451389; Nagle JF, 2000, BBA-REV BIOMEMBRANES, V1469, P159, DOI 10.1016/S0304-4157(00)00016-2; OGILBY PR, 1992, MACROMOLECULES, V25, P3399, DOI 10.1021/ma00039a014; OZATO K, 1978, J IMMUNOL, V121, P1376; Parasassi T, 1995, J Fluoresc, V5, P59, DOI 10.1007/BF00718783; PARASASSI T, 1990, BIOPHYS J, V57, P1179, DOI 10.1016/S0006-3495(90)82637-0; Park H, 2014, BIOMATERIALS, V35, P7963, DOI 10.1016/j.biomaterials.2014.05.063; Peterson J, 1998, NUTR RES, V18, P1995, DOI 10.1016/S0271-5317(98)00169-9; Pola A, 2004, EUR J PHARM SCI, V21, P421, DOI 10.1016/j.ejps.2003.10.007; Potapovich AI, 2003, BIOCHEMISTRY-MOSCOW+, V68, P514, DOI 10.1023/A:1023947424341; Poulsen L, 2003, J PHYS CHEM B, V107, P13885, DOI 10.1021/jp0362739; Poulsen L, 2003, MACROMOLECULES, V36, P7189, DOI 10.1021/ma034744j; Rice-Evans C, 2001, CURR MED CHEM, V8, P797, DOI 10.2174/0929867013373011; RiceEvans CA, 1996, FREE RADICAL BIO MED, V20, P933, DOI 10.1016/0891-5849(95)02227-9; RiceEvans CA, 1996, BIOCHEM SOC T, V24, P790, DOI 10.1042/bst0240790; Rothwell JA, 2005, J AGR FOOD CHEM, V53, P4355, DOI 10.1021/jf0483669; Sachidanandam K, 2005, CARDIOVASC DRUG REV, V23, P115; SAIJA A, 1995, FREE RADICAL BIO MED, V19, P481, DOI 10.1016/0891-5849(94)00240-K; SALAH N, 1995, ARCH BIOCHEM BIOPHYS, V322, P339, DOI 10.1006/abbi.1995.1473; Scheidt HA, 2004, BBA-BIOMEMBRANES, V1663, P97, DOI 10.1016/j.bbamem.2004.02.004; Schreier S, 2000, BBA-BIOMEMBRANES, V1508, P210, DOI 10.1016/S0304-4157(00)00012-5; Seydel J. K., 2002, METHODS PRINC MED CH, V15, P35; Sies H, 2010, ARCH BIOCHEM BIOPHYS, V501, P2, DOI 10.1016/j.abb.2010.04.006; Solovieva A, 2005, MICRON, V36, P508, DOI 10.1016/j.micron.2005.05.004; Stief TW, 2003, MED HYPOTHESES, V60, P567, DOI 10.1016/S0306-9877(03)00026-4; STUDER SL, 1989, J AM CHEM SOC, V111, P7643, DOI 10.1021/ja00201a071; TERAO J, 1994, ARCH BIOCHEM BIOPHYS, V308, P278, DOI 10.1006/abbi.1994.1039; Tokumasu F, 2012, EXP PARASITOL, V131, P245, DOI 10.1016/j.exppara.2012.03.005; TOURNAIRE C, 1993, J PHOTOCH PHOTOBIO B, V19, P205, DOI 10.1016/1011-1344(93)87086-3; Valiev M, 2010, COMPUT PHYS COMMUN, V181, P1477, DOI 10.1016/j.cpc.2010.04.018; vanAcker SABE, 1996, FREE RADICAL BIO MED, V20, P331, DOI 10.1016/0891-5849(95)02047-0; WASSERMAN HH, 1982, J AM CHEM SOC, V104, P4695, DOI 10.1021/ja00381a040; WELTI R, 1984, BIOCHEMISTRY-US, V23, P6086, DOI 10.1021/bi00320a028	87	14	14	4	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2015	10	6							e0129749	10.1371/journal.pone.0129749	http://dx.doi.org/10.1371/journal.pone.0129749			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL3FM	26098745	gold, Green Published, Green Submitted			2022-12-26	WOS:000356835800038
J	Liu, ZX; Zhang, MY; Wu, J; Zhou, P; Liu, Y; Wu, YC; Yang, YJ; Lu, X				Liu, Zhengxia; Zhang, Mengyao; Wu, Jin; Zhou, Ping; Liu, Ying; Wu, Yucheng; Yang, Yujiao; Lu, Xiang			Serum CD121a (Interleukin 1 Receptor, Type I): A Potential Novel Inflammatory Marker for Coronary Heart Disease	PLOS ONE			English	Article							MYOCARDIAL-INFARCTION; PULMONARY INFLAMMATION; ARTERY-DISEASE; ATHEROSCLEROSIS; FAMILY; IL-1; IL-1-BETA; MICE; ACTIVATION; MECHANISMS	Inflammation is now believed to be responsible for coronary heart disease (CHD). This belief has stimulated the evaluation of various inflammatory markers for predicting CHD. This study was designed to investigate the association between four inflammatory cytokines (CD121a, interleukin [IL]-1 beta, IL-8, and IL-11) and CHD. Here, we evaluated 443 patients with CHD and 160 CHD-free controls who underwent coronary angiography. Cytokines were evaluated using flow cytometry, and statistical analyses were performed to investigate the association between cytokine levels and the risk of CHD. Patients with CHD had significantly higher levels of CD121a. The odds ratios for CHD according to increasing CD121a quartiles were 1.00, 1.47 [95% confidence interval (CI): 0.79-2.72], 2.67 (95% CI: 1.47-4.84), and 4.71 (95% CI: 2.65-8.37) in an age- and sex-adjusted model, compared to 1.00, 1.48 (95% CI: 0.70-3.14), 2.25 (95% CI: 1.10-4.62), and 4.39 (95% CI: 2.19-8.79) in a model that was adjusted for multiple covariates. A comparison of the stable angina, unstable angina, and acute myocardial infarction (AMI) subgroups revealed that patients with AMI had the highest CD121a levels, although IL-1 beta levels were similar across all groups. IL-8 levels were also increased in AMI patients, and IL-11 levels were higher in CHD patients than in non-CHD patients. Correlation analysis revealed a positive association between CD121a, IL-8, and the Gensini score. Together, the significant increase in CD121a levels among CHD patients suggests that it may be a novel inflammatory marker for predicting CHD.	[Liu, Zhengxia; Zhang, Mengyao; Wu, Jin; Zhou, Ping; Liu, Ying; Wu, Yucheng; Yang, Yujiao; Lu, Xiang] Nanjing Med Univ, Affiliated Hosp 2, Dept Geriatr, Nanjing 210029, Jiangsu, Peoples R China	Nanjing Medical University	Lu, X (corresponding author), Nanjing Med Univ, Affiliated Hosp 2, Dept Geriatr, Nanjing 210029, Jiangsu, Peoples R China.	luxiang66@njmu.edu.cn			National Science Foundation of China [81300999, 81270428, 81470501]	National Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work is supported by grants from the National Science Foundation of China (No. 81300999 for ZL, 81270428 and 81470501 for XL). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander MR, 2012, J CLIN INVEST, V122, P70, DOI 10.1172/JCI43713; Apostolakis S, 2009, CARDIOVASC RES, V84, P353, DOI 10.1093/cvr/cvp241; Beaulieu LM, 2014, ARTERIOSCL THROM VAS, V34, P552, DOI 10.1161/ATVBAHA.113.302700; Bhaskar V, 2011, ATHEROSCLEROSIS, V216, P313, DOI 10.1016/j.atherosclerosis.2011.02.026; Boraschi D, 2013, SEMIN IMMUNOL, V25, P394, DOI 10.1016/j.smim.2013.10.023; Chamberlain J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005073; Dams-Kozlowska H, 2012, BMC BIOTECHNOL, V12, DOI 10.1186/1472-6750-12-8; Davaro F, 2014, J BIOL CHEM, V289, P16214, DOI 10.1074/jbc.M114.571505; Dinarello CA, 2011, EUR J IMMUNOL, V41, P1203, DOI 10.1002/eji.201141550; Dinarello CA, 2009, ANNU REV IMMUNOL, V27, P519, DOI 10.1146/annurev.immunol.021908.132612; Doz E, 2008, J IMMUNOL, V180, P1169, DOI 10.4049/jimmunol.180.2.1169; Duewell P, 2010, NATURE, V464, P1357, DOI 10.1038/nature08938; Garlanda C, 2013, IMMUNITY, V39, P1003, DOI 10.1016/j.immuni.2013.11.010; Gasse P, 2007, J CLIN INVEST, V117, P3786, DOI 10.1172/JCI32285; Geneau R, 2010, LANCET, V376, P1689, DOI 10.1016/S0140-6736(10)61414-6; Herder C, 2006, ARTERIOSCL THROM VAS, V26, P2147, DOI 10.1161/01.ATV.0000235691.84430.86; Inoue T, 2008, INT J CARDIOL, V124, P319, DOI 10.1016/j.ijcard.2007.02.012; McCarty S, 2014, CARDIOL REV, V22, P176, DOI 10.1097/CRD.0000000000000022; Obana M, 2012, AM J PHYSIOL-HEART C, V303, pH569, DOI 10.1152/ajpheart.00060.2012; Obana M, 2010, CIRCULATION, V121, P684, DOI 10.1161/CIRCULATIONAHA.109.893677; Olofsson PS, 2009, CIRC J, V73, P1531, DOI 10.1253/circj.CJ-08-1150; Pang T, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-102; Rader DJ, 2012, J CLIN INVEST, V122, P27, DOI 10.1172/JCI61163; Rajamaki K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011765; Ridker PM, 2011, AM HEART J, V162, P597, DOI 10.1016/j.ahj.2011.06.012; Riesenberg K, 1997, EUR J CLIN INVEST, V27, P398, DOI 10.1046/j.1365-2362.1997.1270667.x; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Rothenbacher D, 2006, ARTERIOSCL THROM VAS, V26, P194, DOI 10.1161/01.ATV.0000191633.52585.14; Rothenbacher D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045907; Saxena A, 2013, J IMMUNOL, V191, P4838, DOI 10.4049/jimmunol.1300725; Sims JE, 2010, NAT REV IMMUNOL, V10, P89, DOI 10.1038/nri2691; Velasquez IM, 2014, INT J CARDIOL, V172, P173, DOI 10.1016/j.ijcard.2013.12.170; Waehre T, 2004, CIRCULATION, V109, P1966, DOI 10.1161/01.CIR.0000125700.33637.B1; Xing DQ, 2012, CIRCULATION, V125, P1533, DOI 10.1161/CIRCULATIONAHA.111.078436	34	86	86	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2015	10	6							e0131086	10.1371/journal.pone.0131086	http://dx.doi.org/10.1371/journal.pone.0131086			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL3FM	26098632	Green Published, gold, Green Submitted			2022-12-26	WOS:000356835800146
J	Pagano, S; Fait, E; Monti, A; Brignani, D; Mazza, V				Pagano, Silvia; Fait, Elisa; Monti, Alessia; Brignani, Debora; Mazza, Veronica			Electrophysiological Correlates of Subitizing in Healthy Aging	PLOS ONE			English	Article							VISUAL WORKING-MEMORY; SPATIAL ATTENTION; NEURAL MEASURES; AGE-DIFFERENCES; INDIVIDUAL-DIFFERENCES; AMPLITUDE MODULATIONS; ALPHA-OSCILLATIONS; NORMATIVE VALUES; PHASE-STABILITY; OLDER-ADULTS	To understand the nature of age-related changes in enumeration abilities we measured two ERP responses -N2pc and CDA, associated respectively to attentive individuation and VWM- and posterior alpha band (8-15 Hz) event-related desynchronization (ERD), traditionally linked to enhanced target processing. Two groups of old and young participants enumerated a variable number (1-6) of targets presented among distractors. Older participants were less accurate in enumerating targets. ERP results in old participants showed a suppression of N2pc amplitudes for all numerosities, and a decrease in CDA only for the largest set (4-6 targets). In contrast with the pattern for young adults, time/frequency results on older adults revealed neither a modulation of alpha oscillations as a function of target numerosity, nor an effect of ERD lateralization. These patterns indicate that both attention and working memory contribute to the age-related decline in enumeration, and point to an overall decrease in the activity of the visual areas responsible for the processing of the hemifield where the relevant objects are presented.	[Pagano, Silvia; Fait, Elisa; Monti, Alessia; Mazza, Veronica] Univ Trento, Ctr Mind Brain Sci CIMeC, Trento, Italy; [Brignani, Debora; Mazza, Veronica] IRCCS Ist Ctr San Giovanni di Dio Fatebenefratell, Brescia, Italy; [Mazza, Veronica] Univ Trento, Dept Psychol & Cognit Sci, Trento, Italy	University of Trento; University of Trento	Pagano, S (corresponding author), Univ Trento, Ctr Mind Brain Sci CIMeC, Trento, Italy.	silvia.pagano@unitn.it	Brignani, Debora/K-4495-2016	Brignani, Debora/0000-0003-0848-5164; Mazza, Veronica/0000-0002-8898-4651	Italian Ministry of Health [114/GR-2010-2314972]	Italian Ministry of Health(Ministry of Health, Italy)	This work has been supported by a Grant from the Italian Ministry of Health awarded to VM (Premio Giovani Ricercatori, grant number: 114/GR-2010-2314972). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basso A, 1987, Funct Neurol, V2, P189; Caffarra P, 2002, NEUROL SCI, V22, P443, DOI 10.1007/s100720200003; Caffarra P., 2002, NUOVA RIV NEUROL, V12, P111; Carlesimo G. A., 1995, Archivio di Psicologia Neurologia e Psichiatria, V56, P471; Cashdollar N, 2013, PSYCHOL AGING, V28, P77, DOI 10.1037/a0029899; Drew T, 2008, J NEUROSCI, V28, P4183, DOI 10.1523/JNEUROSCI.0556-08.2008; Drew T, 2012, J COGNITIVE NEUROSCI, V24, P440, DOI 10.1162/jocn_a_00107; Eimer M, 1996, ELECTROEN CLIN NEURO, V99, P225, DOI 10.1016/0013-4694(96)95711-9; Ester EF, 2012, J NEUROSCI, V32, P7169, DOI 10.1523/JNEUROSCI.1218-12.2012; Fukuda K, 2010, CURR OPIN NEUROBIOL, V20, P177, DOI 10.1016/j.conb.2010.03.005; Gazzaley A, 2008, P NATL ACAD SCI USA, V105, P13122, DOI 10.1073/pnas.0806074105; Giovagnoli AR, 1996, ITAL J NEUROL SCI, V17, P305, DOI 10.1007/BF01997792; Grimault S, 2009, HUM BRAIN MAPP, V30, P3378, DOI 10.1002/hbm.20759; Hong XF, 2015, NEUROIMAGE, V106, P353, DOI 10.1016/j.neuroimage.2014.11.019; Ikkai A, 2010, J NEUROPHYSIOL, V103, P1963, DOI 10.1152/jn.00978.2009; Jensen O, 2002, CEREB CORTEX, V12, P877, DOI 10.1093/cercor/12.8.877; Jost K, 2011, CEREB CORTEX, V21, P1147, DOI 10.1093/cercor/bhq185; Karrasch M, 2004, NEUROSCI LETT, V366, P18, DOI 10.1016/j.neulet.2004.05.010; KAUFMAN EL, 1949, AM J PSYCHOL, V62, P498, DOI 10.2307/1418556; Kelly SP, 2009, EUR J NEUROSCI, V30, P2224, DOI 10.1111/j.1460-9568.2009.06980.x; Klimesch W, 2007, BRAIN RES REV, V53, P63, DOI 10.1016/j.brainresrev.2006.06.003; Li L, 2013, NEUROBIOL AGING, V34, P477, DOI 10.1016/j.neurobiolaging.2012.02.025; Lorenzo-Lopez L, 2008, NEUROBIOL AGING, V29, P1101, DOI 10.1016/j.neurobiolaging.2007.02.007; LUCK SJ, 1994, PSYCHOPHYSIOLOGY, V31, P291, DOI 10.1111/j.1469-8986.1994.tb02218.x; Magni E, 1996, EUR J NEUROL, V3, P198, DOI 10.1111/j.1468-1331.1996.tb00423.x; MAKEIG S, 1993, ELECTROEN CLIN NEURO, V86, P283, DOI 10.1016/0013-4694(93)90110-H; MANDLER G, 1982, J EXP PSYCHOL GEN, V111, P1, DOI 10.1037/0096-3445.111.1.1; Maylor EA, 2011, DEV PSYCHOL, V47, P1440, DOI 10.1037/a0024464; Mazza V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017453; Mazza V, 2009, CORTEX, V45, P879, DOI 10.1016/j.cortex.2008.10.009; McCollough AW, 2007, CORTEX, V43, P77, DOI 10.1016/S0010-9452(08)70447-7; Monaco M, 2013, NEUROL SCI, V34, P749, DOI 10.1007/s10072-012-1130-x; Novelli G., 1986, ARCH PSICOL NEUROL P; Pagano S, 2014, BRAIN RES, V1543, P244, DOI 10.1016/j.brainres.2013.11.025; Pagano S, 2012, NEUROPSYCHOLOGIA, V50, P754, DOI 10.1016/j.neuropsychologia.2012.01.009; Pfurtscheller G, 1996, INT J PSYCHOPHYSIOL, V24, P39, DOI 10.1016/S0167-8760(96)00066-9; Pfurtscheller G, 1999, CLIN NEUROPHYSIOL, V110, P1842, DOI 10.1016/S1388-2457(99)00141-8; Robitaille N, 2009, PSYCHOPHYSIOLOGY, V46, P1090, DOI 10.1111/j.1469-8986.2009.00837.x; Sander MC, 2011, CEREB CORTEX, V21, P2809, DOI 10.1093/cercor/bhr076; Sander MC, 2012, NEUROIMAGE, V59, P646, DOI 10.1016/j.neuroimage.2011.06.092; Sauseng P, 2005, EUR J NEUROSCI, V22, P2917, DOI 10.1111/j.1460-9568.2005.04482.x; Sauseng P, 2009, CURR BIOL, V19, P1846, DOI 10.1016/j.cub.2009.08.062; SPINNLER H, 1987, ITAL J NEUROL SCI S8, V6, P1; Spitzer B, 2014, J NEUROSCI, V34, P4293, DOI 10.1523/JNEUROSCI.4580-13.2014; Stormer VS, 2013, NEUROIMAGE, V73, P167, DOI 10.1016/j.neuroimage.2013.02.004; Tollner T, 2012, CEREB CORTEX, V22, P1554, DOI 10.1093/cercor/bhr231; Vaden RJ, 2012, NEUROIMAGE, V63, P1127, DOI 10.1016/j.neuroimage.2012.07.050; Vogel EK, 2004, NATURE, V428, P748, DOI 10.1038/nature02447; Wascher E, 1996, ELECTROEN CLIN NEURO, V99, P149, DOI 10.1016/0013-4694(96)95602-3; Watson DG, 2007, J EXP PSYCHOL HUMAN, V33, P1389, DOI 10.1037/0096-1523.33.6.1389; Watson DG, 2007, J EXP PSYCHOL HUMAN, V33, P549, DOI 10.1037/0096-1523.33.3.549; Watson DG, 2005, Q J EXP PSYCHOL-A, V58, P1119, DOI 10.1080/02724980443000511; Watson DG, 2002, PSYCHOL AGING, V17, P496, DOI 10.1037//0882-7974.17.3.496; Werkle-Bergner M, 2012, NEUROIMAGE, V60, P71, DOI 10.1016/j.neuroimage.2011.11.071; Wiegand I, 2014, NEUROBIOL AGING, V35, P2161, DOI 10.1016/j.neurobiolaging.2014.02.023; Wiegand I, 2013, NEUROBIOL AGING, V34, P973, DOI 10.1016/j.neurobiolaging.2012.08.002; YESAVAGE JA, 1983, J PSYCHIATR RES, V17, P37, DOI 10.1016/0022-3956(82)90033-4; Zumer JM, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001965	58	15	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2015	10	6							e0131063	10.1371/journal.pone.0131063	http://dx.doi.org/10.1371/journal.pone.0131063			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL3FM	26098959	Green Published, gold, Green Submitted			2022-12-26	WOS:000356835800141
J	Peinado, A; Abrams, CK				Peinado, Alejandro; Abrams, Charles K.			Patterns of Spontaneous Local Network Activity in Developing Cerebral Cortex: Relationship to Adult Cognitive Function	PLOS ONE			English	Article							SENSORIMOTOR GATING DEFICITS; ELECTRICAL-ACTIVITY; ENTORHINAL CORTEX; NEURONAL DIFFERENTIATION; BRATTLEBORO RATS; GENE-EXPRESSION; LAYER-II; WAVES; PERFORMANCE; CLOZAPINE	Detecting neurodevelopmental disorders of cognition at the earliest possible stages could assist in understanding them mechanistically and ultimately in treating them. Finding early physiological predictors that could be visualized with functional neuroimaging would represent an important advance in this regard. We hypothesized that one potential source of physiological predictors is the spontaneous local network activity prominent during specific periods in development. To test this we used calcium imaging in brain slices and analyzed variations in the frequency and intensity of this early activity in one area, the entorhinal cortex (EC), in order to correlate early activity with level of cognitive function later in life. We focused on EC because of its known role in different types of cognitive processes and because it is an area where spontaneous activity is prominent during early postnatal development in rodent models of cortical development. Using rat strains (Long-Evans, Wistar, Sprague-Dawley and Brattleboro) known to differ in cognitive performance in adulthood we asked whether neonatal animals exhibit corresponding strain-related differences in EC spontaneous activity. Our results show significant differences in this activity between strains: compared to a high cognitive-performing strain, we consistently found an increase in frequency and decrease in intensity in neonates from three lower performing strains. Activity was most different in one strain considered a model of schizophrenia-like psychopathology. While we cannot necessarily infer a causal relationship between early activity and adult cognition our findings suggest that the pattern of spontaneous activity in development could be an early predictor of a developmental trajectory advancing toward sub-optimal cognitive performance in adulthood. Our results further suggest that the strength of dopaminergic signaling, by setting the balance between excitation and inhibition, is a potential underlying mechanism that could explain the observed differences in early spontaneous activity patterns.	[Peinado, Alejandro] Suny Downstate Med Ctr, Dept Neurol, Brooklyn, NY 11203 USA; Suny Downstate Med Ctr, Dept Physiol & Pharmacol, Brooklyn, NY 11203 USA	State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center	Peinado, A (corresponding author), Suny Downstate Med Ctr, Dept Neurol, Brooklyn, NY 11203 USA.	alejandro.peinado@downstate.edu			SUNY-Downstate Medical Center	SUNY-Downstate Medical Center	This work was funded by a pilot project grant to AP and CKA from SUNY-Downstate Medical Center. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarde SM, 2006, HORM BEHAV, V49, P501, DOI 10.1016/j.yhbeh.2005.11.002; Akil M, 2000, BIOL PSYCHIAT, V47, P361, DOI 10.1016/S0006-3223(99)00282-6; Anderson AL, 2013, NEUROSCI BIOBEHAV R, V37, P2220, DOI 10.1016/j.neubiorev.2013.03.013; ANDREWS JS, 1995, PHYSIOL BEHAV, V57, P785, DOI 10.1016/0031-9384(94)00336-X; Ben-Ari Y, 2001, TRENDS NEUROSCI, V24, P353, DOI 10.1016/S0166-2236(00)01813-0; Benes FM, 1996, SYNAPSE, V22, P338; Bolea S, 2006, J NEUROPHYSIOL, V95, P552, DOI 10.1152/jn.00321.2005; Calderon DP, 2005, J NEUROSCI, V25, P1737, DOI 10.1523/JNEUROSCI.2765-04.2005; Caruana DA, 2006, J NEUROPHYSIOL, V96, P3006, DOI 10.1152/jn.00572.2006; Cilia J, 2010, J PSYCHOPHARMACOL, V24, P407, DOI 10.1177/0269881108098787; Clancy B, 2001, NEUROSCIENCE, V105, P7, DOI 10.1016/S0306-4522(01)00171-3; COLOMBO G, 1992, PHYSIOL BEHAV, V52, P827, DOI 10.1016/0031-9384(92)90422-X; Cools R, 2011, BIOL PSYCHIAT, V69, pE113, DOI 10.1016/j.biopsych.2011.03.028; Du C, 2014, P NATL ACAD SCI US; Feifel D, 2004, NEUROPSYCHOPHARMACOL, V29, P731, DOI 10.1038/sj.npp.1300378; Feifel D, 2001, BIOL PSYCHIAT, V50, P425, DOI 10.1016/S0006-3223(01)01100-3; Feifel D, 2009, NEUROPSYCHOPHARMACOL, V34, P2011, DOI 10.1038/npp.2009.15; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Glovaci I, 2014, NEUROSCIENCE, V258, P74, DOI 10.1016/j.neuroscience.2013.10.076; Goto K, 2002, BEHAV BRAIN RES, V134, P201, DOI 10.1016/S0166-4328(02)00039-6; Gu XN, 1997, DEV NEUROSCI-BASEL, V19, P33, DOI 10.1159/000111183; Hanson MG, 2006, J NEUROSCI, V26, P12769, DOI 10.1523/JNEUROSCI.4170-06.2006; Harker KT, 2002, BEHAV BRAIN RES, V134, P467; Hensch TK, 2005, NAT REV NEUROSCI, V6, P877, DOI 10.1038/nrn1787; Insel TR, 2010, NATURE, V468, P187, DOI 10.1038/nature09552; JONES RSG, 1989, NEUROSCI LETT, V104, P93, DOI 10.1016/0304-3940(89)90335-2; Kasyanov AM, 2004, P NATL ACAD SCI USA, V101, P3967, DOI 10.1073/pnas.0305974101; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; Khazipov R, 2001, J NEUROSCI, V21, P9770, DOI 10.1523/JNEUROSCI.21-24-09770.2001; Khazipov R, 2006, TRENDS NEUROSCI, V29, P414, DOI 10.1016/j.tins.2006.05.007; Knierim JJ, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0369; Lewis DA, 2005, NAT REV NEUROSCI, V6, P312, DOI 10.1038/nrn1648; Lewis DA, 2003, ANN NY ACAD SCI, V1003, P102, DOI 10.1196/annals.1300.007; Lewis DA, 2002, ANNU REV NEUROSCI, V25, P409, DOI 10.1146/annurev.neuro.25.112701.142754; MacGregor DG, 2001, NEUROSCI LETT, V303, P141, DOI 10.1016/S0304-3940(01)01690-1; Namiki S, 2013, J NEUROSCI, V33, P987, DOI 10.1523/JNEUROSCI.2522-12.2013; O'Donovan MJ, 1999, CURR OPIN NEUROBIOL, V9, P94, DOI 10.1016/S0959-4388(99)80012-9; Paxinos G., 1991, ATLAS DEV RAT BRAIN; Peinado A, 2000, J NEUROSCI, V20; ROMIJN HJ, 1991, EARLY HUM DEV, V26, P61, DOI 10.1016/0378-3782(91)90044-4; Sanchez-Vives MV, 2000, NAT NEUROSCI, V3, P1027, DOI 10.1038/79848; Seki M, 2012, EUR J NEUROSCI, V35, P673, DOI 10.1111/j.1460-9568.2012.07995.x; Sheroziya MG, 2009, J NEUROSCI, V29, P12131, DOI 10.1523/JNEUROSCI.1333-09.2009; Shilling PD, 2008, BIOL PSYCHIAT, V63, P748, DOI 10.1016/j.biopsych.2007.10.015; Spitzer NC, 2004, TRENDS NEUROSCI, V27, P415, DOI 10.1016/j.tins.2004.05.003; Spitzer NC, 2006, NATURE, V444, P707, DOI 10.1038/nature05300; Spitzer NC, 2012, NAT REV NEUROSCI, V13, P94, DOI 10.1038/nrn3154; Stewart CV, 2006, J NEUROSCI, V26, P8148, DOI 10.1523/JNEUROSCI.0723-06.2006; Swerdlow NR, 2012, PSYCHOPHARMACOLOGY, V224, P349, DOI 10.1007/s00213-012-2758-1; Swerdlow NR, 2001, BRAIN RES, V898, P195, DOI 10.1016/S0006-8993(01)02143-6; Turner KM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093411; Vijayraghavan S, 2007, NAT NEUROSCI, V10, P376, DOI 10.1038/nn1846; WIESEL TN, 1982, NATURE, V299, P583, DOI 10.1038/299583a0; Youngren KD, 1999, NEUROPSYCHOPHARMACOL, V20, P403, DOI 10.1016/S0893-133X(98)00082-7; Zhang LI, 2001, NAT NEUROSCI, V4, P1207, DOI 10.1038/nn753; Zilles K., 1985, CORTEX RAT STEREOTAX	56	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2015	10	6							e0131259	10.1371/journal.pone.0131259	http://dx.doi.org/10.1371/journal.pone.0131259			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL3FM	26098958	Green Published, gold, Green Submitted			2022-12-26	WOS:000356835800163
J	Singh, VP; Aggarwal, R; Singh, S; Banik, A; Ahmad, T; Patnaik, BR; Nappanveettil, G; Singh, KP; Aggarwal, ML; Ghosh, B; Agrawal, A				Singh, Vijay Pal; Aggarwal, Rangoli; Singh, Suchita; Banik, Arpita; Ahmad, Tanveer; Patnaik, Bijay Ranjan; Nappanveettil, Giridharan; Singh, Kunal Pratap; Aggarwal, Madan Lal; Ghosh, Balaram; Agrawal, Anurag			Metabolic Syndrome Is Associated with Increased Oxo-Nitrative Stress and Asthma-Like Changes in Lungs	PLOS ONE			English	Article							EXHALED NITRIC-OXIDE; BODY-MASS INDEX; AIRWAY INFLAMMATION; INSULIN-RESISTANCE; OBESE SUBJECTS; SYMPTOMS; DEFINITION; PREVALENCE; PREDICTOR; IMPACT	Epidemiological studies have shown an increased obesity-related risk of asthma. In support, obese mice develop airway hyperresponsiveness (AHR). However, it remains unclear whether the increased risk is a consequence of obesity, adipogenic diet, or the metabolic syndrome (MetS). Altered L-arginine and nitric oxide (NO) metabolism is a common feature between asthma and metabolic syndrome that appears independent of body mass. Increased asthma risk resulting from such metabolic changes would have important consequences in global health. Since high-sugar diets can induce MetS, without necessarily causing obesity, studies of their effect on arginine/NO metabolism and airway function could clarify this aspect. We investigated whether normal-weight mice with MetS, due to high-fructose diet, had dysfunctional arginine/NO metabolism and features of asthma. Mice were fed chow-diet, high-fat-diet, or high-fructose-diet for 18 weeks. Only the high-fat-diet group developed obesity or adiposity. Hyperinsulinemia, hyperglycaemia, and hyperlipidaemia were common to both high-fat-diet and high-fructose-diet groups and the high-fructose-diet group additionally developed hypertension. At 18 weeks, airway hyperresponsiveness (AHR) could be seen in obese high-fat-diet mice as well as non-obese high-fructose-diet mice, when compared to standard chow-diet mice. No inflammatory cell infiltrate or goblet cell metaplasia was seen in either high-fat-diet or high-fructose-diet mice. Exhaled NO was reduced in both these groups. This reduction in exhaled NO correlated with reduced arginine bioavailability in lungs. In summary, mice with normal weight but metabolic obesity show reduced arginine bioavailability, reduced NO production, and asthma-like features. Reduced NO related bronchodilation and increased oxo-nitrosative stress may contribute to the pathogenesis.	[Singh, Vijay Pal; Aggarwal, Rangoli; Singh, Suchita; Banik, Arpita; Ahmad, Tanveer; Patnaik, Bijay Ranjan; Singh, Kunal Pratap; Ghosh, Balaram; Agrawal, Anurag] CSIR Inst Genom & Integrat Biol, Ctr Excellence Translat Res Asthma & Lung Dis, Delhi, India; [Nappanveettil, Giridharan] Natl Inst Nutr, Natl Ctr Lab Anim Sci, Hyderabad 500007, Andhra Pradesh, India; [Aggarwal, Madan Lal] Shriram Inst Ind Res, Delhi, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Genomics & Integrative Biology (IGIB); Indian Council of Medical Research (ICMR); ICMR - National Animal Resource Facility for Biomedical Research (NARFBR); ICMR - National Institute of Nutrition (NIN)	Singh, VP (corresponding author), CSIR Inst Genom & Integrat Biol, Ctr Excellence Translat Res Asthma & Lung Dis, Delhi, India.	vp.singh@igib.res.in	Pratap, Kunal/E-9042-2017; Agrawal, Anurag/GZL-5821-2022	Pratap, Kunal/0000-0002-3888-2577; Agrawal, Anurag/0000-0002-0340-5252; Ahmad, Tanveer/0000-0002-8384-5273; Singh, Vijay Pal/0000-0003-0547-3336	Lady Tata Memorial Trust; CSIR (Council of Scientific and Industrial Research) MLP (Mega Laboratory Project) [5502]; CSIR (Council of Scientific and Industrial Research) BSC (Biological Science Cluster) project [0403]; DST (Department of Science and Technology); ICMR (Indian Council of Medical Research)	Lady Tata Memorial Trust; CSIR (Council of Scientific and Industrial Research) MLP (Mega Laboratory Project); CSIR (Council of Scientific and Industrial Research) BSC (Biological Science Cluster) project; DST (Department of Science and Technology)(Department of Science & Technology (India)); ICMR (Indian Council of Medical Research)(Indian Council of Medical Research (ICMR))	Funding was provided by the Lady Tata Memorial Trust, CSIR (Council of Scientific and Industrial Research) MLP (Mega Laboratory Project) 5502 & BSC (Biological Science Cluster) 0403 projects, the DST (Department of Science and Technology) Swarnjayanti awards for the financial support and ICMR (Indian Council of Medical Research) for scholarship of Suchita Singh. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adeyeye Olufunke O, 2012, Int Arch Med, V5, P20, DOI 10.1186/1755-7682-5-20; Agrawal A, 2011, AM J RESP CELL MOL, V44, P270, DOI 10.1165/rcmb.2010-0141TR; Ahmad T, 2010, AM J RESP CELL MOL, V42, P3, DOI 10.1165/rcmb.2009-0137RC; Ahmad T, 2009, J APPL PHYSIOL, V107, P295, DOI 10.1152/japplphysiol.00235.2009; Akagiri S, 2008, J CLIN BIOCHEM NUTR, V42, P150, DOI 10.3164/jcbn.2008022; ALVING K, 1993, EUR RESPIR J, V6, P1368; Assad N, 2013, AM J RESP CRIT CARE, V188, P319, DOI 10.1164/rccm.201303-0457OC; Beigh SH, 2012, BIOINFORMATION, V8, P613, DOI 10.6026/97320630008613; Berg CM, 2011, CHEST, V139, P1109, DOI 10.1378/chest.10-1299; Beuther DA, 2009, CLIN CHEST MED, V30, P479, DOI 10.1016/j.ccm.2009.05.002; Boulet LP, 2013, CLIN EXP ALLERGY, V43, P8, DOI 10.1111/j.1365-2222.2012.04040.x; Brumpton BM, 2013, EUR RESPIR J, V42, P1495, DOI 10.1183/09031936.00046013; Cottrell L, 2011, AM J RESP CRIT CARE, V183, P441, DOI 10.1164/rccm.201004-0603OC; Eckel RH, 2010, LANCET, V375, P181, DOI 10.1016/S0140-6736(09)61794-3; Ervin R. B., 2009, NATL HLTH STAT REPOR, P1; Farzan Sherry, 2013, J Allergy (Cairo), V2013, P602908, DOI 10.1155/2013/602908; Fernando H, 2012, AM THOR SOC INT C AB, pA2197; Galisteo M, 2008, J NUTR BIOCHEM, V19, P71, DOI 10.1016/j.jnutbio.2007.02.009; Grundy SM, 2004, CIRCULATION, V109, P433, DOI 10.1161/01.CIR.0000111245.75752.C6; Haldar P, 2008, AM J RESP CRIT CARE, V178, P218, DOI 10.1164/rccm.200711-1754OC; Holguin Fernando, 2013, J Allergy (Cairo), V2013, P714595, DOI 10.1155/2013/714595; Holguin F, 2013, AM J RESP CRIT CARE, V187, P153, DOI 10.1164/rccm.201207-1270OC; Huang PL, 2009, DIS MODEL MECH, V2, P231, DOI 10.1242/dmm.001180; Johnston RA, 2008, J APPL PHYSIOL, V104, P1727, DOI 10.1152/japplphysiol.00075.2008; Komakula S, 2007, RESP RES, V8, DOI 10.1186/1465-9921-8-32; Korhonen Riku, 2005, Current Drug Targets - Inflammation and Allergy, V4, P471, DOI 10.2174/1568010054526359; Lee EJ, 2009, J ASTHMA, V46, P339, DOI 10.1080/02770900802660931; Leishangthem G.D., 2010, MICROSCOPY SCI TECHN, V3, P347; Leishangthem Geeta Devi, 2013, ISRN Allergy, V2013, P261297, DOI 10.1155/2013/261297; Leone N, 2012, OBESITY, V20, P628, DOI 10.1038/oby.2011.308; Lugogo NL, 2010, J APPL PHYSIOL, V108, P729, DOI 10.1152/japplphysiol.00845.2009; Mabalirajan U, 2010, INT IMMUNOPHARMACOL, V10, P1514, DOI 10.1016/j.intimp.2010.08.025; Mabalirajan U, 2010, J ALLERGY CLIN IMMUN, V125, P626, DOI 10.1016/j.jaci.2009.10.065; Mosen DM, 2008, J ALLERGY CLIN IMMUN, V122, P507, DOI 10.1016/j.jaci.2008.06.024; Novosad Shannon, 2013, J Allergy (Cairo), V2013, P538642, DOI 10.1155/2013/538642; Sarkar S, 2006, INDIAN J MED RES, V123, P679; Scott R, 2011, CARDIOVASC DIABETOL, V10, DOI 10.1186/1475-2840-10-102; Singh Suchita, 2013, J Allergy (Cairo), V2013, P627384, DOI 10.1155/2013/627384; Stream AR, 2012, CURR OPIN ALLERGY CL, V12, P76, DOI 10.1097/ACI.0b013e32834eca41; Sutherland TJT, 2008, AM J RESP CRIT CARE, V178, P469, DOI 10.1164/rccm.200802-301OC; Thuesen BH, 2009, CLIN EXP ALLERGY, V39, P700, DOI 10.1111/j.1365-2222.2008.03197.x; Todd DC, 2007, CLIN EXP ALLERGY, V37, P1049, DOI 10.1111/j.1365-2222.2007.02748.x; van Huisstede A, 2013, J OBES, V2013, DOI 10.1155/2013/131349; Varghese F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096801; Wells SM, 2007, AM J RESP CELL MOL, V36, P520, DOI 10.1165/rcmb.2006-0302SM; Wells SM, 2009, AM J RESP CELL MOL, V40, P179, DOI 10.1165/rcmb.2008-0148OC	46	48	50	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2015	10	6							e0129850	10.1371/journal.pone.0129850	http://dx.doi.org/10.1371/journal.pone.0129850			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL3FM	26098111	Green Published, Green Submitted, gold			2022-12-26	WOS:000356835800043
J	Werling, M; Fandriks, L; Olbers, T; Bueter, M; Sjostrom, L; Lonroth, H; Wallenius, V; Stenlof, K; le Roux, CW				Werling, Malin; Fandriks, Lars; Olbers, Torsten; Bueter, Marco; Sjostrom, Lars; Lonroth, Hans; Wallenius, Ville; Stenlof, Kaj; le Roux, Carel W.			Roux-en-Y Gastric Bypass Surgery Increases Respiratory Quotient and Energy Expenditure during Food Intake	PLOS ONE			English	Article							VERTICAL BANDED GASTROPLASTY; BARIATRIC SURGERY; BODY-COMPOSITION; PHYSICAL-ACTIVITY; WEIGHT; OBESE; GLUCOSE; LIMB; GUT; DETERMINANT	Objective The mechanisms determining long-term weight maintenance after Roux-en-Y gastric bypass (RYGB) remain unclear. Cross sectional studies have suggested that enhanced energy expenditure (EE) may play a significant role and the aim of this study was to reveal the impact of RYGB on each major component constituting total EE. Design Six obese female subjects, without other co-morbidities, were assessed before and at 10 days, 3 and 20 months after RYGB. Indirect calorimetry in a metabolic chamber was used to assess 24h EE at each study visit. Other measurements included body composition by DEXA, gut hormone profiles and physical activity (PA) using high sensitivity accelerometers. Results Median Body Mass Index decreased from 41.1 (range 39.1-44.8) at baseline to 28 kg/m(2) (range 22.3-30.3) after 20 months (p<0.05). Lean tissue decreased from 55.9 (range 47.5-59.3) to 49.5 (range 41.1-54.9) kg and adipose tissue from 61 (range 56-64.6) to 27 (range 12-34.3) kg (both p<0.05). PA over 24h did not change after surgery whereas 24h EE and basal metabolic rate (BMR) decreased. EE after a standard meal increased after surgery when adjusted for total tissue (p<0.05). After an initial drop, RQ (respiratory quotient) had increased at 20 months, both as measured during 24h and after food intake (p<0.05). Conclusion RYGB surgery up-regulates RQ and EE after food intake resulting in an increased contribution to total EE over 24h when corrected for total tissue.	[Werling, Malin; Fandriks, Lars; Olbers, Torsten; Lonroth, Hans; Wallenius, Ville; le Roux, Carel W.] Univ Gothenburg, Sahlgrenska Univ Hosp Sahlgrenska, Dept Gastrosurg Res & Educ, Sahlgrenska Acad,Dept Surg, Gothenburg, Sweden; [Bueter, Marco] Univ Zurich Hosp, Dept Surg, Div Visceral & Transplantat Surg, CH-8091 Zurich, Switzerland; [Sjostrom, Lars] Sahlgrens Univ Hosp, Swedish Obese Subjects Secretariat, Inst Med, Gothenburg, Sweden; [Stenlof, Kaj] Sahlgrens Univ Hosp, Gothia Forum, Gothenburg, Sweden; [le Roux, Carel W.] Univ Coll Dublin, Conway Inst, Diabet Complicat Res Ctr, Dublin 2, Ireland; [le Roux, Carel W.] Univ London Imperial Coll Sci Technol & Med, Invest Sci, London, England	Sahlgrenska University Hospital; University of Gothenburg; University of Zurich; University Zurich Hospital; Sahlgrenska University Hospital; Sahlgrenska University Hospital; University College Dublin; Imperial College London	Werling, M (corresponding author), Univ Gothenburg, Sahlgrenska Univ Hosp Sahlgrenska, Dept Gastrosurg Res & Educ, Sahlgrenska Acad,Dept Surg, Gothenburg, Sweden.	malin.werling@gmail.com	Wallenius, Ville Raymond/C-5486-2014	Wallenius, Ville Raymond/0000-0001-8668-3196; Olbers, Torsten/0000-0002-7218-3390; Le Roux, Carel/0000-0001-5521-5445	Swedish Research Council [K2010-55X-21432-01-2]; University of Gothenburg; Sahlgrenska University Hospital (ALF); Gothenburg Medical Association; Ethicon Endosurgery; Science Foundation Ireland [12/YI/B2480]	Swedish Research Council(Swedish Research CouncilEuropean Commission); University of Gothenburg; Sahlgrenska University Hospital (ALF); Gothenburg Medical Association; Ethicon Endosurgery; Science Foundation Ireland(Science Foundation IrelandEuropean Commission)	This study received financial support for staff salaries and running costs by the Swedish Research Council (LF; grant no K2010-55X-21432-01-2), the University of Gothenburg (LF, MW) and Sahlgrenska University Hospital (ALF: LF, HL), the Gothenburg Medical Association (MW) and Ethicon Endosurgery (HL). CleR was supported by Science Foundation Ireland for material and salary; 12/YI/B2480. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainsworth BE, 2011, MED SCI SPORT EXER, V43, P1575, DOI 10.1249/MSS.0b013e31821ece12; Bjorklund P, 2010, OBES SURG, V20, P1408, DOI 10.1007/s11695-010-0192-1; Blouet C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051898; Bond DS, 2010, OBESITY, V18, P2395, DOI 10.1038/oby.2010.88; Bond DS, 2009, OBESITY, V17, P78, DOI 10.1038/oby.2008.501; Borg CM, 2006, BRIT J SURG, V93, P210, DOI 10.1002/bjs.5227; Brolin RE, 2002, JAMA-J AM MED ASSOC, V288, P2793, DOI 10.1001/jama.288.22.2793; Bueter M, 2010, GASTROENTEROLOGY, V138, P1845, DOI 10.1053/j.gastro.2009.11.012; Carrasco F, 2007, OBES SURG, V17, P608, DOI 10.1007/s11695-007-9117-z; Carswell KA, 2014, OBES SURG, V24, P796, DOI 10.1007/s11695-013-1166-x; Cesar MD, 2008, OBES SURG, V18, P1376, DOI 10.1007/s11695-008-9460-8; Das SK, 2003, AM J CLIN NUTR, V78, P22, DOI 10.1093/ajcn/78.1.22; Faria SL, 2012, OBES SURG, V22, P1450, DOI 10.1007/s11695-012-0672-6; Flancbaum L, 1997, SURGERY, V122, P943, DOI 10.1016/S0039-6060(97)90336-6; Freire RH, 2012, NUTRITION, V28, P53, DOI 10.1016/j.nut.2011.01.011; Henning B, 1996, MED BIOL ENG COMPUT, V34, P207, DOI 10.1007/BF02520075; Henry CJK, 2005, PUBLIC HEALTH NUTR, V8, P1133, DOI 10.1079/PHN2005801; Iesari S, 2013, J CLIN ENDOCR METAB, V98, pE321, DOI 10.1210/jc.2012-2876; Kuipers F, 2014, NAT REV ENDOCRINOL, V10, P488, DOI 10.1038/nrendo.2014.60; Laferrere B, 2010, J CLIN ENDOCR METAB, V95, P4072, DOI 10.1210/jc.2009-2767; le Roux CW, 2010, ANN SURG, V252, P50, DOI 10.1097/SLA.0b013e3181d3d21f; le Roux CW, 2005, J CLIN ENDOCR METAB, V90, P591, DOI 10.1210/jc.2004-2211; Levine JA, 2005, PUBLIC HEALTH NUTR, V8, P1123, DOI 10.1079/PHN2005800; Levine JA, 2004, AM J PHYSIOL-ENDOC M, V286, pE675, DOI 10.1152/ajpendo.00562.2003; Levine JA, 2002, BEST PRACT RES CL EN, V16, P679, DOI 10.1053/beem.2002.0227; MacLean LD, 2001, J GASTROINTEST SURG, V5, P525, DOI 10.1016/S1091-255X(01)80091-3; Olbers T, 2005, BRIT J SURG, V92, P557, DOI 10.1002/bjs.4974; Olbers T, 2006, ANN SURG, V244, P715, DOI 10.1097/01.sla.0000218085.25902.f8; RAVUSSIN E, 1986, J CLIN INVEST, V78, P1568, DOI 10.1172/JCI112749; Redman LM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004377; Saeidi N, 2012, INT J OBESITY, V36, P1396, DOI 10.1038/ijo.2012.167; Saeidi N, 2013, SCIENCE, V341, P406, DOI 10.1126/science.1235103; Schmidt JB, 2014, AM J PHYSIOL-ENDOC M, V306, pE1248, DOI 10.1152/ajpendo.00569.2013; Shephard RJ, 2012, EUR J APPL PHYSIOL, V112, P2785, DOI 10.1007/s00421-011-2268-6; Sjostrom L, 2007, NEW ENGL J MED, V357, P741, DOI 10.1056/NEJMoa066254; Sloth B, 2007, AM J PHYSIOL-ENDOC M, V292, pE1062, DOI 10.1152/ajpendo.00450.2006; Spak E, 2010, HISTOPATHOLOGY, V57, P680, DOI 10.1111/j.1365-2559.2010.03677.x; Stylopoulos N, 2009, OBESITY, V17, P1839, DOI 10.1038/oby.2009.207; van den Beukel JC, 2014, FRONT HORM RES, V42, P107, DOI 10.1159/000358320; Vosselman MJ, 2013, AM J CLIN NUTR, V98, P57, DOI 10.3945/ajcn.113.059022; Werling M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060280; Westerterp Klaas R, 2004, Nutr Metab (Lond), V1, P5; Wilms B, 2013, J CLIN ENDOCR METAB, V98, P3776, DOI 10.1210/jc.2013-1087	43	25	25	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2015	10	6							e0129784	10.1371/journal.pone.0129784	http://dx.doi.org/10.1371/journal.pone.0129784			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL3FM	26098889	gold, Green Published, Green Submitted			2022-12-26	WOS:000356835800040
J	Chen, C; Sun, XL; Duanmu, HZ; Yu, Y; Liu, AL; Xiao, JL; Zhu, YM				Chen, Chen; Sun, Xiaoli; Duanmu, Huizi; Yu, Yang; Liu, Ailin; Xiao, Jialei; Zhu, Yanming			Ectopic Expression of a Glycine soja myo-Inositol Oxygenase Gene (GsMIOX1a) in Arabidopsis Enhances Tolerance to Alkaline Stress	PLOS ONE			English	Article							REAL-TIME PCR; MYOINOSITOL OXYGENASE; ASCORBIC-ACID; WATER-STRESS; VITAMIN-C; HIGHER-PLANTS; FREE PROLINE; CELL-WALLS; BIOSYNTHESIS; SALT	Myo-inositol participates in various aspects of plant physiology, and myo-inositol oxygenase is the key enzyme of the myo-inositol oxygenation pathway. Previous studies indicated that myo-inositol oxygenase may play a role in plant responses to abiotic stresses. In this study, we focused on the functional characterization of GsMIOX1a, a remarkable alkaline stress-responsive gene of Glycine soja 07256, based on RNA-seq data. Using quantitative real-time PCR, we demonstrated that GsMIOX1a is rapidly induced by alkaline stress and expressed predominantly in flowers. We also elucidated the positive function of GsMIOX1a in the alkaline response in the wild type, atmiox1 mutant as well as GsMIOX1a-overexpressing Arabidopsis. We determined that atmiox1 mutant decreased Arabidopsis tolerance to alkaline stress, whereas GsMIOX1a overexpression increased tolerance. Moreover, the expression levels of some alkaline stress-responsive and inducible marker genes, including H+-Ppase, NADP-ME, KIN1 and RD29B, were also up-regulated in GsMIOX1a overexpression lines compared with the wild type and atmiox1 mutant. Together, these results suggest that the GsMIOX1a gene positively regulates plant tolerance to alkaline stress. This is the first report to demonstrate that ectopic expression of myo-inositol oxygenase improves alkaline tolerance in plants.	[Chen, Chen; Duanmu, Huizi; Yu, Yang; Liu, Ailin; Xiao, Jialei; Zhu, Yanming] Northeast Agr Univ, Key Lab Agr Biol Funct Genes, Harbin 150030, Peoples R China; [Sun, Xiaoli] Heilongjiang Bayi Agr Univ, Agron Coll, Daqing 163319, Peoples R China	Northeast Agricultural University - China; Heilongjiang Bayi Agricultural University	Zhu, YM (corresponding author), Northeast Agr Univ, Key Lab Agr Biol Funct Genes, Harbin 150030, Peoples R China.	ymzhu2001@neau.edu.cn	Sun, Xiaoli/AAH-2265-2020	Sun, Xiaoli/0000-0003-1134-3976	Heilongjiang Provincial Higher School Science and Technology Innovation Team Building Program [2011TD005]; National Natural Science Foundation of China [31171578]; National Major Project for Cultivation of Transgenic Crops [2011ZX08004-002]	Heilongjiang Provincial Higher School Science and Technology Innovation Team Building Program; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Major Project for Cultivation of Transgenic Crops	This work was supported by Heilongjiang Provincial Higher School Science and Technology Innovation Team Building Program (grant no. 2011TD005 to YMZ), National Natural Science Foundation of China (grant no. 31171578 to YMZ), National Major Project for Cultivation of Transgenic Crops (grant no. 2011ZX08004-002 to YMZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agius F, 2003, NAT BIOTECHNOL, V21, P177, DOI 10.1038/nbt777; Alford SR, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00069; ARAKAWA N, 1981, AGR BIOL CHEM TOKYO, V45, P1289, DOI 10.1080/00021369.1981.10864697; Arner RJ, 2001, BIOCHEM J, V360, P313, DOI 10.1042/bj3600313; BATES LS, 1973, PLANT SOIL, V39, P205, DOI 10.1007/BF00018060; Bhatnagar-Mathur P, 2008, PLANT CELL REP, V27, P411, DOI 10.1007/s00299-007-0474-9; Bohnert HJ, 1996, TRENDS BIOTECHNOL, V14, P89, DOI 10.1016/0167-7799(96)80929-2; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; DAVIES DD, 1986, PHYSIOL PLANTARUM, V67, P702, DOI 10.1111/j.1399-3054.1986.tb05081.x; Dionisio-Sese ML, 1998, PLANT SCI, V135, P1, DOI 10.1016/S0168-9452(98)00025-9; Duan JZ, 2012, PLANT SCI, V196, P143, DOI 10.1016/j.plantsci.2012.08.003; Endres S, 2011, PLANTA, V234, P157, DOI 10.1007/s00425-011-1394-z; Endres S, 2009, PLANT PHYSIOL, V149, P1042, DOI 10.1104/pp.108.130948; Ge Ying, 2009, Pratacultural Science, V26, P47; GIBEAUT DM, 1994, FASEB J, V8, P904, DOI 10.1096/fasebj.8.12.8088456; Gillaspy GE, 2011, NEW PHYTOL, V192, P823, DOI 10.1111/j.1469-8137.2011.03939.x; Gong B, 2014, FREE RADICAL BIO MED, V71, P36, DOI 10.1016/j.freeradbiomed.2014.02.018; Kanter U, 2005, PLANTA, V221, P243, DOI 10.1007/s00425-004-1441-0; Kanter U, 2003, YEAST, V20, P1317, DOI 10.1002/yea.1050; Kawanabe S., 1991, Nippon Sochi Gakkaishi = Journal of Japanese Society of Grassland Science, V37, P91; Kozera B, 2013, J APPL GENET, V54, P391, DOI 10.1007/s13353-013-0173-x; Krasensky J, 2012, J EXP BOT, V63, P1593, DOI 10.1093/jxb/err460; KROH M, 1968, SCIENCE, V160, P1353, DOI 10.1126/science.160.3834.1352; Liu J, 2010, PHOTOSYNTHETICA, V48, P127, DOI 10.1007/s11099-010-0017-4; Loewus FA, 2000, PLANT SCI, V150, P1, DOI 10.1016/S0168-9452(99)00150-8; LOEWUS FA, 1962, P NATL ACAD SCI USA, V48, P421, DOI 10.1073/pnas.48.3.421; Lorence A, 2004, PLANT PHYSIOL, V134, P1200, DOI 10.1104/pp.103.033936; MARRE E, 1985, J BIOENERG BIOMEMBR, V17, P1, DOI 10.1007/BF00744985; Mittler R, 2002, TRENDS PLANT SCI, V7, P405, DOI 10.1016/S1360-1385(02)02312-9; Munns R, 2002, PLANT CELL ENVIRON, V25, P239, DOI 10.1046/j.0016-8025.2001.00808.x; Nour-Eldin HH, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl635; Pang CY, 2010, MOL CELL PROTEOMICS, V9, P2019, DOI 10.1074/mcp.M110.000349; Radzio JA, 2003, PLANT MOL BIOL, V53, P837, DOI 10.1023/B:PLAN.0000023671.99451.1d; Reboul R, 2011, J BIOL CHEM, V286, P39982, DOI 10.1074/jbc.M111.255695; Reiter WD, 2001, PLANT MOL BIOL, V47, P95, DOI 10.1023/A:1010671129803; Running JA, 2003, J EXP BOT, V54, P1841, DOI 10.1093/jxb/erg207; Seifert GJ, 2004, CURR OPIN PLANT BIOL, V7, P277, DOI 10.1016/j.pbi.2004.03.004; Seitz B, 2000, PLANT J, V21, P537, DOI 10.1046/j.1365-313x.2000.00696.x; Shi DC, 2005, PLANT SOIL, V271, P15, DOI 10.1007/s11104-004-1307-z; Smirnoff N, 2001, ANNU REV PLANT PHYS, V52, P437, DOI 10.1146/annurev.arplant.52.1.437; Smirnoff N, 2011, ADV BOT RES, V59, P107, DOI 10.1016/B978-0-12-385853-5.00003-9; Stein H, 2011, PLANT SCI, V181, P140, DOI 10.1016/j.plantsci.2011.04.013; Sze H, 1999, PLANT CELL, V11, P677, DOI 10.1105/tpc.11.4.677; TARDIEU F, 1992, PLANT PHYSIOL, V98, P540, DOI 10.1104/pp.98.2.540; TORIMITSU K, 1984, PLANT CELL PHYSIOL, V25, P1403, DOI 10.1093/oxfordjournals.pcp.a076851; WANG H, 1995, PLANT MOL BIOL, V28, P605, DOI 10.1007/BF00021187; Wang HE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048307; Wheeler GL, 1998, NATURE, V393, P365, DOI 10.1038/30728; Willems E, 2008, ANAL BIOCHEM, V379, P127, DOI 10.1016/j.ab.2008.04.036; Xiong L, 2002, PLANT CELL ENVIRON, V25, P131, DOI 10.1046/j.1365-3040.2002.00782.x; YAMAGUCHISHINOZAKI K, 1993, PLANT PHYSIOL, V101, P1119, DOI 10.1104/pp.101.3.1119; Yang CW, 2008, PHOTOSYNTHETICA, V46, P107, DOI [10.1007/s11099-008-0018-8, 10.1007/s11099-008-0047-3]; Yang CW, 2007, PLANT SOIL, V294, P263, DOI 10.1007/s11104-007-9251-3; Zhang W, 2008, PLANT PHYSIOL, V146, P431, DOI 10.1104/pp.107.109934	54	7	11	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2015	10	6							e0129998	10.1371/journal.pone.0129998	http://dx.doi.org/10.1371/journal.pone.0129998			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL3FE	26091094	Green Submitted, Green Published, gold			2022-12-26	WOS:000356835000081
J	Hein, SM; Haricharan, S; Johnston, AN; Toneff, MJ; Reddy, JP; Dong, J; Bu, W; Li, Y				Hein, S. M.; Haricharan, S.; Johnston, A. N.; Toneff, M. J.; Reddy, J. P.; Dong, J.; Bu, W.; Li, Y.			Luminal epithelial cells within the mammary gland can produce basal cells upon oncogenic stress	ONCOGENE			English	Article							HUMAN-BREAST-CANCER; MIDDLE T-ANTIGEN; STEM-CELLS; MOUSE MODEL; IDENTIFICATION; PROGENITORS; EXPRESSION; LINEAGE; TRANSFORMATION; TUMORIGENESIS	In the normal mammary gland, the basal epithelium is known to be bipotent and can generate either basal or luminal cells, whereas the luminal epithelium has not been demonstrated to contribute to the basal compartment in an intact and normally developed mammary gland. It is not clear whether cellular heterogeneity within a breast tumor results from transformation of bipotent basal cells or from transformation and subsequent basal conversion of the more differentiated luminal cells. Here we used a retroviral vector to express an oncogene specifically in a small number of the mammary luminal epithelial cells and tested their potential to produce basal cells during tumorigenesis. This in-vivo lineage-tracing work demonstrates that luminal cells are capable of producing basal cells on activation of either polyoma middle T antigen or ErbB2 signaling. These findings reveal the plasticity of the luminal compartment during tumorigenesis and provide an explanation for cellular heterogeneity within a cancer.	[Hein, S. M.; Toneff, M. J.; Reddy, J. P.; Dong, J.; Bu, W.; Li, Y.] Baylor Coll Med, Dept Mol & Cellular Biol, One Baylor Plaza MS600, Houston, TX 77030 USA; [Hein, S. M.; Haricharan, S.; Johnston, A. N.; Dong, J.; Bu, W.; Li, Y.] Baylor Coll Med, Lester & Sue Smith Breast Ctr, Houston, TX 77030 USA; [Reddy, J. P.] Univ Texas MD Anderson Canc Ctr, Dept Radiat Oncol, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; University of Texas System; UTMD Anderson Cancer Center	Li, Y (corresponding author), Baylor Coll Med, Dept Mol & Cellular Biol, One Baylor Plaza MS600, Houston, TX 77030 USA.	liyi@bcm.edu	; Li, Yi/A-7635-2009	Reddy, Jay Paul/0000-0001-9378-4585; Li, Yi/0000-0002-9976-518X	NIH [CA124820, U54CA149196, T32AG000183, T32GM088129, P30 AI036211, P30 CA125123, S10 RR024574]; DOD [BC085050, BC112704, BC073703]; Nancy Owens Memorial Foundation; CPRIT Training Program [RP101499]; Cytometry and Cell Sorting Core at Baylor College of Medicine; Dan L. Duncan Cancer Center [P30CA125123]; Lester & Sue Smith Breast Center [P50CA058183, P50-CA186784]; NATIONAL CANCER INSTITUTE [U54CA149196] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM088129] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DOD(United States Department of Defense); Nancy Owens Memorial Foundation; CPRIT Training Program; Cytometry and Cell Sorting Core at Baylor College of Medicine; Dan L. Duncan Cancer Center; Lester & Sue Smith Breast Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Dr Jeffrey Rosen for critical reading of this manuscript. This work was supported in part by funds from NIH CA124820 (to YL) and U54CA149196 (to YL; PI: Stephan Wong); from DOD CDMRP BC085050 (to YL), BC112704 (to YL) and BC073703 (YL); and from the Nancy Owens Memorial Foundation (to YL); as well as by the resources from the Dan L. Duncan Cancer Center (P30CA125123) and the Lester & Sue Smith Breast Center (P50CA058183 & P50-CA186784). SMH was supported by the CPRIT Training Program (RP101499) and by NIH training award T32AG000183. ANJ was supported by NIH training award T32GM088129. This project was supported by the Cytometry and Cell Sorting Core at Baylor College of Medicine with funding from the NIH (P30 AI036211, P30 CA125123 and S10 RR024574) and the expert assistance of Joel M. Sederstrom.	Chang THT, 2014, BREAST CANCER RES, V16, DOI 10.1186/bcr3593; Desai TJ, 2014, NATURE, V507, P190, DOI 10.1038/nature12930; Driessens G, 2012, NATURE, V488, P527, DOI 10.1038/nature11344; Du ZJ, 2006, P NATL ACAD SCI USA, V103, P17396, DOI 10.1073/pnas.0608607103; Fluck MM, 2009, MICROBIOL MOL BIOL R, V73, P542, DOI 10.1128/MMBR.00009-09; Gastaldi S, 2013, ONCOGENE, V32, P1428, DOI 10.1038/onc.2012.154; Greaves M, 2012, NATURE, V481, P306, DOI 10.1038/nature10762; Guo WJ, 2012, CELL, V148, P1015, DOI 10.1016/j.cell.2012.02.008; GUY CT, 1992, MOL CELL BIOL, V12, P954, DOI 10.1128/MCB.12.3.954; Haricharan S, 2014, ONCOGENE, V33, P5729, DOI 10.1038/onc.2013.521; Haricharan S, 2013, ELIFE, V2, DOI 10.7554/eLife.00996; Herschkowitz JI, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-r76; Holland EC, 2000, NAT GENET, V25, P55, DOI 10.1038/75596; Holland EC, 2000, AM J PATHOL, V157, P1031, DOI 10.1016/S0002-9440(10)64615-9; Ichaso N, 2001, ONCOGENE, V20, P7908, DOI 10.1038/sj.onc.1204859; Ince TA, 2007, CANCER CELL, V12, P160, DOI 10.1016/j.ccr.2007.06.013; Keller PJ, 2012, P NATL ACAD SCI USA, V109, P2772, DOI 10.1073/pnas.1017626108; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Li Y, 2003, P NATL ACAD SCI USA, V100, P15853, DOI 10.1073/pnas.2136825100; Lim E, 2009, NAT MED, V15, P907, DOI 10.1038/nm.2000; Ling H, 2013, ONCOGENE, V32, P3410, DOI 10.1038/onc.2012.341; Malzahn K, 1998, VIRCHOWS ARCH, V433, P119, DOI 10.1007/s004280050226; Molyneux G, 2010, CELL STEM CELL, V7, P403, DOI 10.1016/j.stem.2010.07.010; Navin N, 2011, NATURE, V472, P90, DOI 10.1038/nature09807; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Pfefferle AD, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-11-r125; Proia TA, 2011, CELL STEM CELL, V8, P149, DOI 10.1016/j.stem.2010.12.007; Rakha EA, 2008, J CLIN ONCOL, V26, P2568, DOI 10.1200/JCO.2007.13.1748; Reddy JP, 2010, P NATL ACAD SCI USA, V107, P3728, DOI 10.1073/pnas.0910665107; Reddy JP, 2009, J MAMMARY GLAND BIOL, V14, P405, DOI 10.1007/s10911-009-9157-1; Reis JS, 2006, HISTOPATHOLOGY, V49, P10, DOI 10.1111/j.1365-2559.2006.02467.x; Revillion F, 1998, EUR J CANCER, V34, P791, DOI 10.1016/S0959-8049(97)10157-5; Rios AC, 2014, NATURE, V506, P322, DOI 10.1038/nature12948; ROBINSON GW, 1995, DEVELOPMENT, V121, P2079; Rosner A, 2002, AM J PATHOL, V161, P1087, DOI 10.1016/S0002-9440(10)64269-1; Schepers AG, 2012, SCIENCE, V337, P730, DOI 10.1126/science.1224676; Shackleton M, 2006, NATURE, V439, P84, DOI 10.1038/nature04372; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; Stingl J, 2006, NATURE, V439, P993, DOI 10.1038/nature04496; Toneff MJ, 2010, NEOPLASIA, V12, P718, DOI 10.1593/neo.10516; van Amerongen R, 2012, CELL STEM CELL, V11, P387, DOI 10.1016/j.stem.2012.05.023; Van Keymeulen A, 2011, NATURE, V479, P189, DOI 10.1038/nature10573; Youssef KK, 2010, NAT CELL BIOL, V12, P299, DOI 10.1038/ncb2031; Zhang M, 2008, CANCER RES, V68, P4674, DOI 10.1158/0008-5472.CAN-07-6353	44	25	25	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 17	2016	35	11					1461	1467		10.1038/onc.2015.206	http://dx.doi.org/10.1038/onc.2015.206			7	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DG6LQ	26096929	Green Accepted			2022-12-26	WOS:000372196400012
J	Wang, L; Di, LJ				Wang, Li; Di, Li-jun			Wnt/beta-Catenin Mediates AICAR Effect to Increase GATA3 Expression and Inhibit Adipogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; NUCLEAR BETA-CATENIN; ADIPOCYTE DIFFERENTIATION; TRANSCRIPTION FACTORS; CO-REPRESSOR; COREPRESSOR CTBP2; BINDING-PROTEIN; RETINOIC ACID; TARGET GENES; AMPK	A better understanding of the mechanism and manipulation of the tightly regulated cellular differentiation process of adipogenesis may contribute to a reduction in obesity and diabetes. Multiple transcription factors and signaling pathways are involved in the regulation of adipogenesis. Here, we report that the AMP-activated protein kinase activator, 5-aminoimidazole-4-carboxamide ribonucleoside (AICAR) can activate AMPK in preadipocytes and thus increase the expression of GATA3, an anti-adipogenic factor. However, AICAR-increased GATA3 is mediated by the stimulation of Wnt/beta-catenin signaling in preadipocytes. Mechanistically, AICAR-activated AMPK inhibits GSK3 beta through a phosphorylation process that stabilizes beta-catenin. This stabilized beta-catenin then translocates into nucleus where it interacts with T-cell factors (TCF), leading to the increased beta-catenin/TCF transcriptional activity that induces GATA3 expression. In addition, AICAR also relieves the repressing effect of the C-terminal-binding protein (CtBP) co-repressor by diverting CtBP away from the beta-catenin center dot TCF complex at the GATA3 promoter. The anti-adipogenic effect of GATA3 and AICAR is consistently attenuated by the disruption of Wnt/beta-catenin signaling. Furthermore, GATA3 suppresses key adipogenic regulators by binding to the promoters of these regulators, such as the peroxisome proliferator-activated receptor-gamma (PPAR gamma) gene, and the disruption of Wnt/beta-catenin signaling reduces the GATA3 binding at the PPAR gamma promoter. In differentiated adipocytes, GATA3 expression inhibition is facilitated by the down-regulation of beta-catenin levels, the reduction in beta-catenin binding, and the increase in CtBP binding at the GATA3 promoter. Our findings shed light on the molecular mechanism of adipogenesis by suggesting that different regulation pathways and adipogenic regulators collectively modulate adipocyte differentiation through cross-talk.	[Wang, Li] Univ Macau, Fac Hlth Sci, Metab Core, Macau Sar, Peoples R China; [Di, Li-jun] Univ Macau, Fac Hlth Sci, Macau Sar, Peoples R China	University of Macau; University of Macau	Di, LJ (corresponding author), Univ Macau, Fac Hlth Sci, Macau Sar, Peoples R China.	lijundi@umac.mo	Di, Li-jun/B-3352-2011		Science and Technology Development Fund (FDCT) of Macao SAR [FDCT 025/2014/A1, FDCT 088/2014/A2]; University of Macau [MYRG2015-00037-FHS, MYRG2015-00167-FHS]	Science and Technology Development Fund (FDCT) of Macao SAR; University of Macau	This work was supported by Grants FDCT 025/2014/A1 and FDCT 088/2014/A2 from the Science and Technology Development Fund (FDCT) of Macao SAR (to L. J. D.) and by Multi-year Research Grants MYRG2015-00037-FHS and MYRG2015-00167-FHS from the University of Macau (to L. J. D.). The authors declare that they have no conflicts of interest with the contents of this article.	Bajpe PK, 2013, MOL CELL BIOL, V33, P3343, DOI 10.1128/MCB.01213-12; Barolo S, 2002, GENE DEV, V16, P1167, DOI 10.1101/gad.976502; Behrens J, 1998, SCIENCE, V280, P596, DOI 10.1126/science.280.5363.596; Bennett CN, 2002, J BIOL CHEM, V277, P30998, DOI 10.1074/jbc.M204527200; Bergeron R, 2001, AM J PHYSIOL-ENDOC M, V281, pE1340, DOI 10.1152/ajpendo.2001.281.6.E1340; Bhambhani C, 2011, EMBO J, V30, P2031, DOI 10.1038/emboj.2011.100; Brannon M, 1999, DEVELOPMENT, V126, P3159; Cadigan KM, 1997, GENE DEV, V11, P3286, DOI 10.1101/gad.11.24.3286; Cavallo RA, 1998, NATURE, V395, P604, DOI 10.1038/26982; Christodoulides C, 2009, TRENDS ENDOCRIN MET, V20, P16, DOI 10.1016/j.tem.2008.09.002; Daniels DL, 2001, TRENDS BIOCHEM SCI, V26, P672, DOI 10.1016/S0968-0004(01)01952-1; Daniels DL, 2005, NAT STRUCT MOL BIOL, V12, P364, DOI 10.1038/nsmb912; Di LJ, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2438; Di LJ, 2010, NAT STRUCT MOL BIOL, V17, P1406, DOI 10.1038/nsmb.1941; Ding YN, 2002, TRENDS BIOCHEM SCI, V27, P327, DOI 10.1016/S0968-0004(02)02137-0; Giri S, 2006, NUTR METAB, V3, DOI 10.1186/1743-7075-3-31; Habinowski SA, 2001, BIOCHEM BIOPH RES CO, V286, P852, DOI 10.1006/bbrc.2001.5484; Hamada F, 2004, DEV CELL, V7, P677, DOI 10.1016/j.devcel.2004.08.022; Hardie DG, 2011, GENE DEV, V25, P1895, DOI 10.1101/gad.17420111; Kim JH, 2005, NAT STRUCT MOL BIOL, V12, P423, DOI 10.1038/nsmb924; Lee H, 2011, INT J MOL MED, V28, P65, DOI 10.3892/ijmm.2011.674; Longo KA, 2004, J BIOL CHEM, V279, P35503, DOI 10.1074/jbc.M402937200; Marchildon F, 2010, J BIOL CHEM, V285, P13274, DOI 10.1074/jbc.M109.054536; Moldes M, 2003, BIOCHEM J, V376, P607, DOI 10.1042/BJ20030426; Narkar VA, 2008, CELL, V134, P405, DOI 10.1016/j.cell.2008.06.051; Paliwal Seema, 2012, Genes Cancer, V3, P481, DOI 10.1177/1947601912463695; Primus A, 2004, BIOESSAYS, V26, P474, DOI 10.1002/bies.20031; Roose J, 1999, BBA-REV CANCER, V1424, pM23, DOI 10.1016/S0304-419X(99)00026-8; Roose J, 1998, NATURE, V395, P608, DOI 10.1038/26989; Rosen ED, 2006, NAT REV MOL CELL BIO, V7, P885, DOI 10.1038/nrm2066; Ross SE, 2000, SCIENCE, V289, P950, DOI 10.1126/science.289.5481.950; Sharma M, 2002, J BIOL CHEM, V277, P30935, DOI 10.1074/jbc.M201919200; Shi YJ, 2003, NATURE, V422, P735, DOI 10.1038/nature01550; Sierra J, 2006, GENE DEV, V20, P586, DOI 10.1101/gad.1385806; Stossi F, 2009, MOL CELL BIOL, V29, P1749, DOI 10.1128/MCB.01476-08; Subramanian T, 2003, FEBS LETT, V540, P255, DOI 10.1016/S0014-5793(03)00275-8; Tong Q, 2005, MOL CELL BIOL, V25, P706, DOI 10.1128/MCB.25.2.706-715.2005; Tong Q, 2000, SCIENCE, V290, P134, DOI 10.1126/science.290.5489.134; Valenta T, 2003, NUCLEIC ACIDS RES, V31, P2369, DOI 10.1093/nar/gkg346; Vingtdeux V, 2011, MOL MED, V17, P1022, DOI 10.2119/molmed.2011.00163; Viollet B, 2003, J CLIN INVEST, V111, P91, DOI 10.1172/JCI200316567; Wang L, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2014.587; Wang L, 2014, INT J BIOCHEM CELL B, V54, P1, DOI 10.1016/j.biocel.2014.06.008; Wang L, 2013, INT J BIOCHEM CELL B, V45, P1155, DOI 10.1016/j.biocel.2013.03.007; Wang L, 2012, J BIOL CHEM, V287, P30157, DOI 10.1074/jbc.M112.376640; Wu DQ, 2010, TRENDS BIOCHEM SCI, V35, P161, DOI 10.1016/j.tibs.2009.10.002; Yang WB, 2001, J BIOL CHEM, V276, P38341, DOI 10.1074/jbc.C100316200; Zhao JX, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.199372; Zhao JX, 2010, BIOCHEM BIOPH RES CO, V395, P146, DOI 10.1016/j.bbrc.2010.03.161; Zhao LJ, 2007, ONCOGENE, V26, P7544, DOI 10.1038/sj.onc.1210569; Zhao LJ, 2006, J BIOL CHEM, V281, P36613, DOI 10.1074/jbc.M603550200; Zhao LJ, 2006, J BIOL CHEM, V281, P4183, DOI 10.1074/jbc.M509051200	52	30	33	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 7	2015	290	32					19458	19468		10.1074/jbc.M115.641332	http://dx.doi.org/10.1074/jbc.M115.641332			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CO7TL	26109067	Green Published, hybrid			2022-12-26	WOS:000359364600006
J	Wang, XC; Karamariti, E; Simpson, R; Wang, W; Xu, QB				Wang, Xiaocong; Karamariti, Eirini; Simpson, Russell; Wang, Wen; Xu, Qingbo			Dickkopf Homolog 3 Induces Stem Cell Differentiation into Smooth Muscle Lineage via ATF6 Signalling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM STRESS; SERUM RESPONSE FACTOR; BETA-CATENIN; GENE-EXPRESSION; DOWN-REGULATION; MELANOMA-CELLS; ER STRESS; IN-VITRO; MYOCARDIN; PATHWAY	Smooth muscle cells (SMCs) are a key component of healthy and tissue engineered vessels and play a crucial role in vascular development and the pathogenic events of vascular remodeling i.e. restenosis. However, the cell source from which they can be isolated is limited. Embryonic stem (ES) cells that have the remarkable capability to differentiate into vascular SMCs in response to specific stimuli provide a useful model for studying SMC differentiation. Previous studies suggested that dickkopf homolog 3 (DKK3) has a role in human partially induced pluripotent stem cell to SMC differentiation. Here, we demonstrate that the expression of DKK3 is essential for the expression of SMC markers and myocardin at both the mRNA and protein levels during mouse ES cell differentiation into SMCs (ESC-SMC differentiation). Overexpression of DKK3 leads to further up-regulation of the aforementioned markers. Further investigation indicates that DKK3 added as a cytokine activates activating transcription factor 6 (ATF6), leading to the increased binding of ATF6 on the myocardin promoter and increased its expression. In addition, inhibition of extracellular signal-regulated kinases 1/2 (ERK1/2) promotes the expression of ATF6 and leads to further increase of myocardin transcription. Our findings offer a novel mechanism by which DKK3 regulates ESC-SMC differentiation by activating ATF6 and promoting myocardin expression.	[Wang, Xiaocong; Karamariti, Eirini; Simpson, Russell; Xu, Qingbo] Kings Coll London BHF Ctr, Div Cardiovasc, London SE5 9NU, England; [Wang, Xiaocong; Wang, Wen] Queen Mary Univ London, Inst Bioengn, London E1 4NS, England	University of London; King's College London; University of London; Queen Mary University London	Xu, QB (corresponding author), Kings Coll London BHF Ctr, Div Cardiovasc, London SE5 9NU, England.			Wang, Xiaocong/0000-0001-7080-7502	British Heart Foundation [RG/14/6/31144]; Oak Foundation; Queen Mary University of London	British Heart Foundation(British Heart Foundation); Oak Foundation; Queen Mary University of London	This work was supported by grants from the British Heart Foundation (RG/14/6/31144), Oak Foundation, and Queen Mary University of London. The authors declare that they have no conflicts of interest with the contents of this article.	Chen JY, 2002, J MOL CELL CARDIOL, V34, P1345, DOI 10.1006/jmcc.2002.2086; Chiu CZ, 2010, CLIN SCI, V119, P273, DOI 10.1042/CS20100084; Croft A, 2014, J INVEST DERMATOL, V134, P488, DOI 10.1038/jid.2013.325; Du KL, 2003, MOL CELL BIOL, V23, P2425, DOI 10.1128/MCB.23.7.2425-2437.2003; Gerecht-Nir S, 2003, LAB INVEST, V83, P1811, DOI 10.1097/01.LAB.0000106502.41391.F0; Gittenberger-de Groot AC, 1999, ARTERIOSCL THROM VAS, V19, P1589; Gu YM, 2011, WORLD J GASTROENTERO, V17, P3810, DOI 10.3748/wjg.v17.i33.3810; Han XF, 2014, HISTOCHEM CELL BIOL, V142, P497, DOI 10.1007/s00418-014-1233-y; Hoang BH, 2004, CANCER RES, V64, P2734, DOI 10.1158/0008-5472.CAN-03-1952; Huang JH, 2008, J CLIN INVEST, V118, P515, DOI [10.1172/JC133304, 10.1172/JCI33304]; Karamariti E, 2013, CIRC RES, V112, P1433, DOI 10.1161/CIRCRESAHA.111.300415; Kavurma MM, 2003, J CELL BIOCHEM, V89, P289, DOI 10.1002/jcb.10497; Kim JW, 2014, J DENT RES, V93, P483, DOI 10.1177/0022034514525199; Krupnik VE, 1999, GENE, V238, P301, DOI 10.1016/S0378-1119(99)00365-0; Lee EJ, 2009, INT J CANCER, V124, P287, DOI 10.1002/ijc.23913; Lowe CE, 2012, INT J OBESITY, V36, P1248, DOI 10.1038/ijo.2011.233; Margariti A, 2010, CIRC RES, V106, P1202, DOI 10.1161/CIRCRESAHA.109.213165; Margariti A, 2009, J CELL SCI, V122, P460, DOI 10.1242/jcs.034850; Nakamura REI, 2010, GROWTH FACTORS, V28, P232, DOI 10.3109/08977191003738832; Nozaki I, 2001, INT J ONCOL, V19, P117; OWENS GK, 1995, PHYSIOL REV, V75, P487; Pepe AE, 2010, CIRC RES, V106, P870, DOI 10.1161/CIRCRESAHA.109.211417; Romero D, 2013, J CELL SCI, V126, P1858, DOI 10.1242/jcs.119388; ROSS R, 1993, NATURE, V362, P801, DOI 10.1038/362801a0; Rudijanto Achmad, 2007, Acta Med Indones, V39, P86; Siegel R, 2004, MAGN RESON CHEM, V42, P1022, DOI 10.1002/mrc.1485; Tang ZY, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1867; Tay KH, 2014, CELL SIGNAL, V26, P287, DOI 10.1016/j.cellsig.2013.11.008; Tsuji T, 2000, BIOCHEM BIOPH RES CO, V268, P20, DOI 10.1006/bbrc.1999.2067; Veeck J, 2012, BBA-REV CANCER, V1825, P18, DOI 10.1016/j.bbcan.2011.09.003; Wang DZ, 2001, CELL, V105, P851, DOI 10.1016/S0092-8674(01)00404-4; Wang ZG, 2003, P NATL ACAD SCI USA, V100, P7129, DOI 10.1073/pnas.1232341100; Watanabe M, 2009, INT J ONCOL, V34, P657, DOI 10.3892/ijo_00000191; Xiao QZ, 2007, AM J PHYSIOL-CELL PH, V292, pC342, DOI 10.1152/ajpcell.00341.2006; Xiao QZ, 2012, ARTERIOSCL THROM VAS, V32, P730, DOI 10.1161/ATVBAHA.111.243188; Xiao QZ, 2009, AM J PHYSIOL-CELL PH, V296, pC711, DOI 10.1152/ajpcell.00442.2008; Xie CQ, 2007, ARTERIOSCL THROM VAS, V27, pE311, DOI 10.1161/ATVBAHA.107.154260; Xu CY, 2005, J CLIN INVEST, V115, P2656, DOI 10.1172/JCI26373; Ye J, 2000, MOL CELL, V6, P1355, DOI 10.1016/S1097-2765(00)00133-7; Zhang L, 2010, J BIOL CHEM, V285, P38463, DOI 10.1074/jbc.M110.153999; Zhou AX, 2013, SEMIN IMMUNOPATHOL, V35, P321, DOI 10.1007/s00281-013-0372-x	41	29	31	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 7	2015	290	32					19844	19852		10.1074/jbc.M115.641415	http://dx.doi.org/10.1074/jbc.M115.641415			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CO7TL	26105053	Green Published, hybrid			2022-12-26	WOS:000359364600040
J	Amat, F; St-Pierre, P; Bourrat, E; Nemni, A; Couderc, R; Boutmy-Deslandes, E; Sahraoui, F; Panse, I; Bagot, M; Fouere, S; Just, J				Amat, Flore; St-Pierre, Philippe; Bourrat, Emmanuelle; Nemni, Ariane; Couderc, Remy; Boutmy-Deslandes, Emmanuelle; Sahraoui, Fatiha; Panse, Isabelle; Bagot, Martine; Fouere, Sebastien; Just, Jocelyne			Early-Onset Atopic Dermatitis in Children: Which Are the Phenotypes at Risk of Asthma? Results from the ORCA Cohort	PLOS ONE			English	Article							YOUNG-CHILDREN; NATURAL-HISTORY; SENSITIZATION; CHILDHOOD; ALLERGIES; SEVERITY; ECZEMA; ASSOCIATION; SCORAD; WHEEZE	Background Atopic dermatitis (AD) is known to predate asthma and other atopic disorders described under the term "atopic march". However, this classic sequence is not always present and only a few studies have addressed children at risk of developing asthma. The objective of this study is to define early-onset AD phenotypes leading to asthma. Methods We performed a cluster analysis with 9 variables of 214 infants with early-onset AD prospectively enrolled in the ORCA cohort and followed each year on the occurrence of asthma until the age of 6. Results We identified 3 clusters - cluster 1 (n = 94) with low to no sensitization to food (27.7%) or aeroallergens (10.6%) and moderate AD severity (SCORAD 25.29 +/-14.6) called "AD with low sensitization"; -cluster 2 (n = 84) characterized by a higher AD severity (SCORAD 32.66+/-16.6) and frequent sensitization to food (98.9%) or aeroallergens (26.2%), most likely multiple (96.4% for food allergens), called "AD with multiple sensitizations" -cluster 3 (n = 36) with parental history, moderate AD severity (SCORAD 24.46+/-15.7), moderate rate of sensitization to food allergens (38.9%) (exclusively single) with no sensitization to aeroallergens, called "AD with familial history of asthma". Percentages of children suffering from asthma at the age of 6 were higher in clusters 2 and 3 (36.1% and 33.3% respectively versus 14.9% in cluster 1, p<0.01). Conclusion Two phenotypes in infants with early-onset AD convey a higher risk of developing asthma during childhood: multiple sensitization and familial history of asthma.	[Amat, Flore; Nemni, Ariane; Just, Jocelyne] Hop Enfants Armand Trousseau, AP HP, Ctr Asthme & Allergies, Dept Allergol, Paris, France; [Amat, Flore; St-Pierre, Philippe; Just, Jocelyne] INSERM, Inst Pierre Louis Epidemiol & Sante Publ, Equipe EPAR, UMR S1136, Paris, France; [Amat, Flore; St-Pierre, Philippe; Just, Jocelyne] Sorbonne Univ, Univ Paris 06, Paris, France; [St-Pierre, Philippe] Sorbonne Univ, Univ Paris 06, Lab Theoret & Appl Stat, Lab Stat Theor & Appl, Paris, France; [Bourrat, Emmanuelle; Panse, Isabelle; Bagot, Martine; Fouere, Sebastien] Hop St Louis, AP HP, Dept Dermatol, Paris, France; [Couderc, Remy] Hop Enfants Armand Trousseau, AP HP, Lab Biochem & Mol Biol, Lab Biochim & Biol Mol, Paris, France; [Boutmy-Deslandes, Emmanuelle] Hop St Louis, AP HP, Dept Biostat & Med Informat, Serv Biostat & Informat Med, Paris, France; [Boutmy-Deslandes, Emmanuelle] Univ Paris 07, INSERM, U717, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Armand-Trousseau - APHP; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Armand-Trousseau - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Amat, F (corresponding author), Hop Enfants Armand Trousseau, AP HP, Ctr Asthme & Allergies, Dept Allergol, Paris, France.	flore.amat@trs.aphp.fr	Fouéré, Sébastien/GOH-0348-2022; Amat, Flore/GPF-4655-2022					ASHER MI, 1995, EUR RESPIR J, V8, P483, DOI 10.1183/09031936.95.08030483; Belgrave DCM, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001748; Bieber T, 2012, ALLERGY, V67, P969, DOI 10.1111/j.1398-9995.2012.02845.x; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Breiman L., 2017, CLASSIFICATION REGRE; Brown S, 2006, BMJ-BRIT MED J, V332, P584, DOI 10.1136/bmj.332.7541.584; Carlsten C, 2013, ANN ALLERG ASTHMA IM, V110, P24, DOI 10.1016/j.anai.2012.10.005; Deckers IAG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039803; Ekback M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099609; Flohr C, 2014, J INVEST DERMATOL, V134, P345, DOI 10.1038/jid.2013.298; Gelmetti C, 2004, ALLERGY, V59, P61, DOI 10.1111/j.1398-9995.2004.00651.x; Gustafsson D, 2000, ALLERGY, V55, P240, DOI 10.1034/j.1398-9995.2000.00391.x; Harada M, 2011, AM J RESP CELL MOL, V44, P787, DOI 10.1165/rcmb.2009-0418OC; Herr M, 2012, J ALLERGY CLIN IMMUN, V130, P389, DOI 10.1016/j.jaci.2012.05.054; Illi S, 2004, J ALLERGY CLIN IMMUN, V113, P925, DOI 10.1016/j.jaci.2004.01.778; Just J, 2008, CLIN EXP ALLERGY, V38, P767, DOI 10.1111/j.1365-2222.2008.02966.x; Just J, 2014, PEDIAT ALLE IN PRESS; Just J, 2012, J ALLERGY CLIN IMMUN, V130, P103, DOI 10.1016/j.jaci.2012.02.041; Kaufman L., 1990, FINDING GROUPS DATA; Lai CKW, 2009, THORAX, V64, P476, DOI 10.1136/thx.2008.106609; Lowe AJ, 2008, J ALLERGY CLIN IMMUN, V121, P1190, DOI 10.1016/j.jaci.2008.01.034; Nissen SP, 2013, PEDIAT ALLERG IMM-UK, V24, P549, DOI 10.1111/pai.12108; Oranje AP, 2007, BRIT J DERMATOL, V157, P645, DOI 10.1111/j.1365-2133.2007.08112.x; Pinart M, 2014, LANCET RESP MED, V2, P131, DOI 10.1016/S2213-2600(13)70277-7; Roby Keith D, 2013, Drug Discov Today Dis Mech, V10, pe79; Silverberg JI, 2013, PEDIAT ALLERG IMM-UK, V24, P476, DOI 10.1111/pai.12095; Simpson A, 2005, J ALLERGY CLIN IMMUN, V116, P744, DOI 10.1016/j.jaci.2005.06.032; Skripak JM, 2007, J ALLERGY CLIN IMMUN, V120, P1172, DOI 10.1016/j.jaci.2007.08.023; Suarez-Farinas M, 2013, J ALLERGY CLIN IMMUN, V132, P361, DOI 10.1016/j.jaci.2013.04.046; van der Hulst AE, 2007, J ALLERGY CLIN IMMUN, V120, P565, DOI 10.1016/j.jaci.2007.05.042; Williams HC, 1996, BRIT J DERMATOL, V135, P12; Wisniewski JA, 2013, CLIN EXP ALLERGY, V43, P1160, DOI 10.1111/cea.12169; Ziegler SF, 2010, CURR OPIN IMMUNOL, V22, P795, DOI 10.1016/j.coi.2010.10.020	33	35	35	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2015	10	6							e0131369	10.1371/journal.pone.0131369	http://dx.doi.org/10.1371/journal.pone.0131369			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4OM	26107938	Green Submitted, gold, Green Published			2022-12-26	WOS:000356932500161
J	Das, M; Bhowmick, TS; Ahern, SJ; Young, R; Gonzalez, CF				Das, Mayukh; Bhowmick, Tushar Suvra; Ahern, Stephen J.; Young, Ry; Gonzalez, Carlos F.			Control of Pierce's Disease by Phage	PLOS ONE			English	Article							XYLELLA-FASTIDIOSA; STRAINS; NEONICOTINOIDS	Pierce's Disease (PD) of grapevines, caused by Xylella fastidiosa subsp. fastidiosa (Xf), is a limiting factor in the cultivation of grapevines in the US. There are presently no effective control methods to prevent or treat PD. The therapeutic and prophylactic efficacy of a phage cocktail composed of four virulent (lytic) phages was evaluated for control of PD. Xf levels in grapevines were significantly reduced in therapeutically or prophylactically treated grapevines. PD symptoms ceased to progress one week post-therapeutic treatment and symptoms were not observed in prophylactically treated grapevines. Cocktail phage levels increased in grapevines in the presence of the host. No in planta phage-resistant Xfisolates were obtained. Moreover, Xf mutants selected for phage resistance in vitro did not cause PD symptoms. Our results indicate that phages have great potential for biocontrol of PD and other economically important diseases caused by Xylella.	[Das, Mayukh; Bhowmick, Tushar Suvra; Ahern, Stephen J.; Gonzalez, Carlos F.] Texas A&M Univ, Dept Plant Pathol & Microbiol, College Stn, TX 77843 USA; [Das, Mayukh; Bhowmick, Tushar Suvra; Ahern, Stephen J.; Young, Ry; Gonzalez, Carlos F.] Texas A&M Univ, Ctr Phage Technol, College Stn, TX 77843 USA; [Young, Ry] Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX 77843 USA	Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station	Gonzalez, CF (corresponding author), Texas A&M Univ, Dept Plant Pathol & Microbiol, College Stn, TX 77843 USA.	cf-gonzalez@tamu.edu	Ahern, Stephen/J-2237-2014; rolshausen, philippe/F-7999-2011	Ahern, Stephen/0000-0002-6008-4635; Young, Ry/0000-0001-8001-2914	Otsuka Pharmaceutical Co., Ltd.	Otsuka Pharmaceutical Co., Ltd.(Otsuka Pharmaceutical)	This project was funded by a grant to the Center for Phage Technology and Texas A&M AgriLife Research from Otsuka Pharmaceutical Co., Ltd. The funders had no role in experimental design, data collection and analysis, and manuscript preparation.	Aguero CB, 2005, MOL PLANT PATHOL, V6, P43, DOI 10.1111/j.1364-3703.2004.00262.x; Ahern SJ, 2014, J BACTERIOL, V196, P459, DOI 10.1128/JB.01080-13; Almeida RPP, 2003, APPL ENVIRON MICROB, V69, P7447, DOI 10.1128/AEM.69.12.7447-7452.2003; [Anonymous], 2014, IPM NEWS         MAR; Buckingham SD, 1997, J EXP BIOL, V200, P2685; Byrne FJ, P 2010 PIERC DIS RES, P33; Chen M, 2014, J AGR FOOD CHEM, V62, P6082, DOI 10.1021/jf501397m; European Commission, 2013, OFFICIAL J EUROPEAN; European Food Safety Authority, 2013, EFSA ISS URG ADV PLA; Gilchrist D, 2010, P 2010 PIERC DIS RES, P180; Gill JJ, 2010, CURR PHARM BIOTECHNO, V11, P2, DOI 10.2174/138920110790725311; Hendrix RW, 2002, THEOR POPUL BIOL, V61, P471, DOI 10.1006/tpbi.2002.1590; Hernandez-Martinez R, 2006, PLANT DIS, V90, P1382, DOI 10.1094/PD-90-1382; Hopkins DL, 2005, PLANT DIS, V89, P1348, DOI 10.1094/PD-89-1348; Janse JD, 2010, J PLANT PATHOL, V92, pS35; Kimura-Kuroda J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032432; Kirkpatrick B, 2010, P 2010 PIERC DIS RES, P191; Kropinski Andrew M, 2006, Can J Infect Dis Med Microbiol, V17, P297; Levin BR, 2004, NAT REV MICROBIOL, V2, P166, DOI 10.1038/nrmicro822; Li YX, 2007, MICROBIOL-SGM, V153, P719, DOI 10.1099/mic.0.2006/002311-0; Lin H, 2005, APPL ENVIRON MICROB, V71, P4888, DOI 10.1128/AEM.71.8.4888-4892.2005; Lindow SE, 2010, P 2010 PIERC DIS RES, P118; Loc-Carrillo Catherine, 2011, Bacteriophage, V1, P111; Lu CS, 2014, B INSECTOL, V67, P125; Matsuda K, 2001, TRENDS PHARMACOL SCI, V22, P573, DOI 10.1016/S0165-6147(00)01820-4; Meng YZ, 2005, J BACTERIOL, V187, P5560, DOI 10.1128/JB.187.16.5560-5567.2005; Newman KL, 2003, APPL ENVIRON MICROB, V69, P7319, DOI 10.1128/AEM.69.12.7319-7327.2003; Nocker A, 2006, J MICROBIOL METH, V67, P310, DOI 10.1016/j.mimet.2006.04.015; SMITH HW, 1983, J GEN MICROBIOL, V129, P2659; Starner K, 2012, B ENVIRON CONTAM TOX, V88, P316, DOI 10.1007/s00128-011-0515-5; Summer EJ, 2010, J BACTERIOL, V192, P179, DOI 10.1128/JB.01174-09; Suttle CA, 2005, NATURE, V437, P356, DOI 10.1038/nature04160; U.S. Environmental Protection Agency, 2013, REG PROD CONT IM DIN; Van Dijk TC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062374	34	45	47	0	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2015	10	6							e0128902	10.1371/journal.pone.0128902	http://dx.doi.org/10.1371/journal.pone.0128902			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4OM	26107261	gold, Green Submitted, Green Published			2022-12-26	WOS:000356932500034
J	Galford, GL; Soares-Filho, BS; Sonter, LJ; Laporte, N				Galford, Gillian L.; Soares-Filho, Britaldo S.; Sonter, Laura J.; Laporte, Nadine			Will Passive Protection Save Congo Forests?	PLOS ONE			English	Article							LAND-USE CHANGE; GLOBAL LAND; CELLULAR-AUTOMATA; CLIMATE-CHANGE; CARBON; DEFORESTATION; CONSERVATION; EMISSIONS	Central Africa's tropical forests are among the world's largest carbon reserves. Historically, they have experienced low rates of deforestation. Pressures to clear land are increasing due to development of infrastructure and livelihoods, foreign investment in agriculture, and shifting land use management, particularly in the Democratic Republic of Congo (DRC). The DRC contains the greatest area of intact African forests. These store approximately 22 billion tons of carbon in aboveground live biomass, yet only 10% are protected. Can the status quo of passive protection-forest management that is low or nonexistent-ensure the preservation of this forest and its carbon? We have developed the SimCongo model to simulate changes in land cover and land use based on theorized policy scenarios from 2010 to 2050. Three scenarios were examined: the first (Historical Trends) assumes passive forest protection; the next (Conservation) posits active protection of forests and activation of the national REDD+ action plan, and the last (Agricultural Development) assumes increased agricultural activities in forested land with concomitant increased deforestation. SimCongo is a cellular automata model based on Bayesian statistical methods tailored for the DRC, built with the Dinamica-EGO platform. The model is parameterized and validated with deforestation observations from the past and runs the scenarios from 2010 through 2050 with a yearly time step. We estimate the Historical Trends trajectory will result in average emissions of 139 million t CO2 year(-1) by the 2040s, a 15% increase over current emissions. The Conservation scenario would result in 58% less clearing than Historical Trends and would conserve carbon-dense forest and woodland savanna areas. The Agricultural Development scenario leads to emissions of 212 million t CO2 year(-1) by the 2040s. These scenarios are heuristic examples of policy's influence on forest conservation and carbon storage. Our results suggest that 1) passive protection of the DRC's forest and woodland savanna is insufficient to reduce deforestation; and 2): enactment of a REDD+ plan or similar conservation measure is needed to actively protect Congo forests, their unique ecology, and their important role in the global carbon cycle.	[Galford, Gillian L.; Sonter, Laura J.] Univ Vermont, Gund Inst Ecol Econ, Burlington, VT 05405 USA; [Soares-Filho, Britaldo S.] Univ Fed Minas Gerais, Ctr Sensoriamento Remoto, BR-31270901 Belo Horizonte, MG, Brazil; [Laporte, Nadine] Woods Hole Res Ctr, Falmouth, MA 02540 USA	University of Vermont; Universidade Federal de Minas Gerais; Woods Hole Research Center	Galford, GL (corresponding author), Univ Vermont, Gund Inst Ecol Econ, 617 Main St, Burlington, VT 05405 USA.	Gillian.Galford@UVM.edu	Galford, Gillian/K-6240-2012; Galford, Gillian/AAH-3190-2021; Sonter, Laura/I-6756-2013	Galford, Gillian/0000-0003-2192-7385; Sonter, Laura/0000-0002-6590-3986	Gordon and Betty Moore Foundation; Google.org; David & Lucile Packard Foundation; NASA Applied Sciences Program [NNX12AL27G]; Congo Basin Forest Fund; Gund Institute for Ecological Economics; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico; Climate and Land Use Alliance	Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); Google.org(Google Incorporated); David & Lucile Packard Foundation(The David & Lucile Packard Foundation); NASA Applied Sciences Program(National Aeronautics & Space Administration (NASA)); Congo Basin Forest Fund; Gund Institute for Ecological Economics; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Climate and Land Use Alliance	This work was supported by the Gordon and Betty Moore Foundation, Google.org, the David & Lucile Packard Foundation, the NASA Applied Sciences Program (Grant NNX12AL27G), the Congo Basin Forest Fund, and the Gund Institute for Ecological Economics. Britaldo Soares-Filho receives support from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico and the Climate and Land Use Alliance. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida CM, 2008, INT J GEOGR INF SCI, V22, P943, DOI 10.1080/13658810701731168; [Anonymous], 2010, GLOBAL FOREST RESOUR; Baccini A, 2012, NAT CLIM CHANGE, V2, P182, DOI [10.1038/NCLIMATE1354, 10.1038/nclimate1354]; CARPE UMD, 1997, DEM REP CONG RAILR; CARPE UMD, 1997, DEM REP CONG RIV; CdlNe Tourisme, 2012, SYNTH ET CAUS DEF DE, P40; Ciais P, 2011, PHILOS T R SOC A, V369, P2038, DOI 10.1098/rsta.2010.0328; Cotula, 2011, LAND DEALS AFRICA WH; Davidson EA, 2008, GLOBAL CHANGE BIOL, V14, P998, DOI 10.1111/j.1365-2486.2008.01542.x; Department of Economic and Social Affairs, 2010, WORLD POP PROSP 2008; Dickinson R.E., 2007, CLIMATE CHANGE 2007; DRC, 2012, NAT REDD FRAM STRAT; DRC, 2010, READ PLAN REDD 2010; FAO/IIASA/ISRIC/ISS-CAS/JRC, 2012, HARM WORLD SOIL DAT; FAO-Africover, 2003, DR CONG MULT LANDC D; Farr TG, 2007, REV GEOPHYS, V45, DOI 10.1029/2005RG000183; Friedl MA, 2002, REMOTE SENS ENVIRON, V83, P287, DOI 10.1016/S0034-4257(02)00078-0; Friis C., 2010, 1 GLP IPO; Fritz S, 2009, REMOTE SENS-BASEL, V1, P345, DOI 10.3390/rs1030345; Hansen MC, 2003, EARTH INTERACT, V7; HarvestChoice, 2011, AGROECOLOGIAL ZON AE; Houghton RA, 2012, BIOGEOSCIENCES, V9, P5125, DOI 10.5194/bg-9-5125-2012; Houghton RA, 2000, NATURE, V403, P301, DOI 10.1038/35002062; Institute WR, 2010, INT FOR ATL DEM REP; Jantz P, 2014, NAT CLIM CHANGE, V4, P138, DOI 10.1038/NCLIMATE2105; Laporte NT, 2007, SCIENCE, V316, P1451, DOI 10.1126/science.1141057; MATHER AS, 1992, AREA, V24, P367; Melillo JM, 2009, INDIRECT EMISSIONS B; Naidoo R, 2008, P NATL ACAD SCI USA, V105, P9495, DOI 10.1073/pnas.0707823105; Olson DM, 2001, BIOSCIENCE, V51, P933, DOI 10.1641/0006-3568(2001)051[0933:TEOTWA]2.0.CO;2; Potapov PV, 2012, REMOTE SENS ENVIRON, V122, P106, DOI 10.1016/j.rse.2011.08.027; Rudel TK, 2005, GLOBAL ENVIRON CHANG, V15, P23, DOI 10.1016/j.gloenvcha.2004.11.001; Rulli MC, 2013, P NATL ACAD SCI USA, V110, P892, DOI 10.1073/pnas.1213163110; Sanchez PA, 2003, GEODERMA, V114, P157, DOI 10.1016/S0016-7061(03)00040-5; Silva WP, 2011, LAB FIT CURVE FITTIN; Soares B, 2004, GLOBAL CHANGE BIOL, V10, P745, DOI 10.1111/j.1529-8817.2003.00769.x; Soares BS, 2002, ECOL MODEL, V154, P217, DOI 10.1016/S0304-3800(02)00059-5; Soares BS, 2006, NATURE, V440, P520, DOI 10.1038/nature04389; Soares B, 2013, ENVIRON MODELL SOFTW, V43, P80, DOI 10.1016/j.envsoft.2013.01.010; Soares B, 2010, P NATL ACAD SCI USA, V107, P10821, DOI 10.1073/pnas.0913048107; Sonter LJ, 2014, GLOBAL ENVIRON CHANG, V26, P63, DOI 10.1016/j.gloenvcha.2014.03.014; Strassburg B, 2009, GLOBAL ENVIRON CHANG, V19, P265, DOI 10.1016/j.gloenvcha.2008.11.004; Tatem A, 2011, NATURE, V474, P36, DOI 10.1038/474036d; United Nations, 2019, WORLD FERT TRENDS OU; von Grebmer K, 2011, 2011 GLOBAL HUNGER I, P8	45	18	18	5	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2015	10	6							e0128473	10.1371/journal.pone.0128473	http://dx.doi.org/10.1371/journal.pone.0128473			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CL4OM	26106897	Green Published, gold			2022-12-26	WOS:000356932500022
J	Giordano, C; Lemaire, C; Li, T; Kimoff, RJ; Petrof, BJ				Giordano, Christian; Lemaire, Christian; Li, Tong; Kimoff, R. John; Petrof, Basil J.			Autophagy-Associated Atrophy and Metabolic Remodeling of the Mouse Diaphragm after Short-Term Intermittent Hypoxia	PLOS ONE			English	Article							PYRUVATE-DEHYDROGENASE KINASE; RESPIRATORY MUSCLE FATIGUE; OBSTRUCTIVE SLEEP-APNEA; SKELETAL-MUSCLE; LIPID-ACCUMULATION; OXIDATIVE STRESS; SDH ACTIVITY; FIBER-TYPE; RAT MODEL; ENDURANCE	Background Short-term intermittent hypoxia (IH) is common in patients with acute respiratory disorders. Although prolonged exposure to hypoxia induces atrophy and increased fatigability of skeletal muscle, the response to short-term IH is less well known. We hypothesized that the diaphragm and limb muscles would adapt differently to short-term IH given that hypoxia stimulates ventilation and triggers a superimposed exercise stimulus in the diaphragm. Methods We determined the structural, metabolic, and contractile properties of the mouse diaphragm after 4 days of IH (8 hours per day, 30 episodes per hour to a FiO2 nadir=6%), and compared responses in the diaphragm to a commonly studied reference limb muscle, the tibialis anterior. Outcome measures included muscle fiber size, assays of muscle proteolysis (calpain, ubiquitin-proteasome, and autophagy pathways), markers of oxidative stress and mitochondrial function, quantification of intramyocellular lipid and lipid metabolism genes, type I myosin heavy chain (MyHC) expression, and in vitro contractile properties. Results After 4 days of IH, the diaphragm alone demonstrated significant atrophy (30% decrease of myofiber size) together with increased LC3B-II protein (2.4-fold) and mRNA markers of the autophagy pathway (LC3B, Gabarapl1, Bnip3), whereas active calpain and E3 ubiquitin ligases (MuRF1, atrogin-1) were unaffected in both muscles. Succinate dehydrogenase activity was significantly reduced by IH in both muscles. However, only the diaphragm exhibited increased intramyocellular lipid droplets (2.5-fold) after IH, along with upregulation of genes linked to activated lipid metabolism. In addition, although the diaphragm showed evidence for acute fatigue immediately following IH, it underwent an adaptive fiber type switch toward slow type I MyHC-expressing fibers, associated with greater intrinsic endurance of the muscle during repetitive stimulation in vitro. Conclusions Short-term IH induces preferential atrophy in the mouse diaphragm together with increased autophagy and a rapid compensatory metabolic adaptation associated with enhanced fatigue resistance.	[Giordano, Christian; Lemaire, Christian; Li, Tong; Kimoff, R. John; Petrof, Basil J.] McGill Univ, Meakins Christie Labs, Montreal, PQ, Canada; [Giordano, Christian; Lemaire, Christian; Li, Tong; Kimoff, R. John; Petrof, Basil J.] McGill Univ, Div Resp, Montreal, PQ, Canada; [Giordano, Christian; Lemaire, Christian; Li, Tong; Kimoff, R. John; Petrof, Basil J.] McGill Univ, Ctr Hlth, Res Inst, Program Translat Res Resp Dis, Montreal, PQ, Canada	McGill University; McGill University; McGill University	Petrof, BJ (corresponding author), McGill Univ, Meakins Christie Labs, Montreal, PQ, Canada.	basil.petrof@mcgill.ca			Canadian Institutes of Health Research; Fonds de Recherche du Quebec - Sante; Research Institute of the McGill University Health Centre	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Fonds de Recherche du Quebec - Sante(Fonds de la Recherche en Sante du Quebec); Research Institute of the McGill University Health Centre	This study was funded by the Canadian Institutes of Health Research, the Fonds de Recherche du Quebec - Sante, and the Research Institute of the McGill University Health Centre. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguer C, 2013, FASEB J, V27, P4213, DOI 10.1096/fj.13-234302; Almendros I, 2014, AM J PHYSIOL-LUNG C, V307, pL129, DOI 10.1152/ajplung.00089.2014; Bellot G, 2009, MOL CELL BIOL, V29, P2570, DOI 10.1128/MCB.00166-09; Bostrom P, 2006, ARTERIOSCL THROM VAS, V26, P1871, DOI 10.1161/01.ATV.0000229665.78997.0b; Brose SA, 2014, J NEUROCHEM, V129, P400, DOI 10.1111/jnc.12617; Chabowski A, 2006, FEBS LETT, V580, P3617, DOI 10.1016/j.febslet.2006.05.045; Chien MY, 2010, EUR RESPIR J, V35, P373, DOI 10.1183/09031936.00190208; Clanton TL, 2001, J APPL PHYSIOL, V90, P2508, DOI 10.1152/jappl.2001.90.6.2508; Consitt LA, 2009, IUBMB LIFE, V61, P47, DOI 10.1002/iub.142; Covington JD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091675; de Theije CC, 2015, J APPL PHYSIOL, V118, P200, DOI 10.1152/japplphysiol.00624.2014; Desplanches D, 2014, EUR J APPL PHYSIOL, V114, P405, DOI 10.1007/s00421-013-2783-8; Dobrzyn P, 2010, J APPL PHYSIOL, V109, P1653, DOI 10.1152/japplphysiol.00598.2010; Foletta VC, 2011, PFLUG ARCH EUR J PHY, V461, P325, DOI 10.1007/s00424-010-0919-9; Fukuda R, 2007, CELL, V129, P111, DOI 10.1016/j.cell.2007.01.047; Galbes O, 2008, ACTA PHYSIOL, V193, P163, DOI 10.1111/j.1748-1716.2007.01794.x; Gamboa JL, 2012, PFLUG ARCH EUR J PHY, V463, P327, DOI 10.1007/s00424-011-1057-8; Goodpaster BH, 2001, J CLIN ENDOCR METAB, V86, P5755, DOI 10.1210/jc.86.12.5755; GORDON GB, 1977, AM J PATHOL, V88, P663; He J, 2001, DIABETES, V50, P817, DOI 10.2337/diabetes.50.4.817; Horscroft JA, 2014, EXTREME PHYSIOL MED, V3, DOI 10.1186/2046-7648-3-19; Kammoun M, 2014, EUR J HISTOCHEM, V58, P163, DOI 10.4081/ejh.2014.2254; Lira VA, 2013, FASEB J, V27, P4184, DOI 10.1096/fj.13-228486; Maeda H, 2013, BBA-MOL BASIS DIS, V1832, P1159, DOI 10.1016/j.bbadis.2013.02.014; McMorrow C, 2011, EUR RESPIR J, V37, P1474, DOI 10.1183/09031936.00079810; Mehlem A, 2013, NAT PROTOC, V8, P1149, DOI 10.1038/nprot.2013.055; Mirrakhimov Aibek E, 2012, Front Neurol, V3, P149, DOI 10.3389/fneur.2012.00149; Miyata T, 2011, AM J PHYSIOL-CELL PH, V300, pC226, DOI 10.1152/ajpcell.00430.2010; Montserrat JM, 1997, EUR RESPIR J, V10, P133, DOI 10.1183/09031936.97.10010133; Pialoux V, 2009, AM J RESP CRIT CARE, V180, P1002, DOI 10.1164/rccm.200905-0671OC; Picard M, 2012, AM J RESP CRIT CARE, V186, P1140, DOI 10.1164/rccm.201206-0982OC; Poulain L, 2014, EUR RESPIR J, V43, P513, DOI 10.1183/09031936.00019913; Quinlan CL, 2012, J BIOL CHEM, V287, P27255, DOI 10.1074/jbc.M112.374629; Reggiani C, 1997, J PHYSIOL-LONDON, V502, P449, DOI 10.1111/j.1469-7793.1997.449bk.x; Rowe GC, 2013, CELL REP, V3, P1449, DOI 10.1016/j.celrep.2013.04.023; Sandri M, 2010, AM J PHYSIOL-CELL PH, V298, pC1291, DOI 10.1152/ajpcell.00531.2009; Sano S, 2014, BIOCHEM BIOPH RES CO, V445, P327, DOI 10.1016/j.bbrc.2014.01.183; Savransky V, 2008, CIRC RES, V103, P1173, DOI 10.1161/CIRCRESAHA.108.178533; Savransky V, 2007, AM J RESP CRIT CARE, V175, P1290, DOI 10.1164/rccm.200612-1771OC; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schulze A, 2011, MOL CELL, V44, P846, DOI 10.1016/j.molcel.2011.12.004; Shepherd SO, 2013, J PHYSIOL-LONDON, V591, P657, DOI 10.1113/jphysiol.2012.240952; Shepherd SO, 2012, EXP PHYSIOL, V97, P970, DOI 10.1113/expphysiol.2012.064592; Shortt CM, 2014, EXP PHYSIOL, V99, P688, DOI 10.1113/expphysiol.2013.076828; Shortt CM, 2013, J HISTOCHEM CYTOCHEM, V61, P487, DOI 10.1369/0022155413490947; SIECK GC, 1989, J APPL PHYSIOL, V66, P2196, DOI 10.1152/jappl.1989.66.5.2196; Slot IGM, 2014, CELL SIGNAL, V26, P1837, DOI 10.1016/j.cellsig.2014.04.016; Smith IJ, 2008, AM J PHYSIOL-ENDOC M, V295, pE762, DOI 10.1152/ajpendo.90226.2008; Sztalryd C, 2014, BIOCHIMIE, V96, P96, DOI 10.1016/j.biochi.2013.08.026; Tagaito Y, 2001, J APPL PHYSIOL, V91, P2758, DOI 10.1152/jappl.2001.91.6.2758; Verges S, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-109; Vogt M, 2010, PROG CARDIOVASC DIS, V52, P525, DOI 10.1016/j.pcad.2010.02.013; WATCHKO JF, 1993, J APPL PHYSIOL, V75, P1341, DOI 10.1152/jappl.1993.75.3.1341; Wolf A, 2011, J EXP MED, V208, P313, DOI 10.1084/jem.20101470; Wu CA, 2013, BBA-MOL CELL RES, V1833, P1147, DOI 10.1016/j.bbamcr.2013.01.025; Wu SN, 2011, FEBS J, V278, P941, DOI 10.1111/j.1742-4658.2011.08010.x; Zhang S, 2014, NUTR METAB, V11, DOI 10.1186/1743-7075-11-10	57	14	18	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2015	10	6							e0131068	10.1371/journal.pone.0131068	http://dx.doi.org/10.1371/journal.pone.0131068			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4OM	26107816	Green Submitted, Green Published, gold			2022-12-26	WOS:000356932500139
J	Morimoto, A; Mogami, T; Watanabe, M; Iijima, K; Akiyama, Y; Katayama, K; Futami, T; Yamamoto, N; Sawada, T; Koizumi, F; Koh, Y				Morimoto, Atsushi; Mogami, Toshifumi; Watanabe, Masaru; Iijima, Kazuki; Akiyama, Yasuyuki; Katayama, Koji; Futami, Toru; Yamamoto, Nobuyuki; Sawada, Takeshi; Koizumi, Fumiaki; Koh, Yasuhiro			High-Density Dielectrophoretic Microwell Array for Detection, Capture, and Single-Cell Analysis of Rare Tumor Cells in Peripheral Blood	PLOS ONE			English	Article							METASTATIC BREAST-CANCER; LUNG-CANCER; SYSTEM; CHEMOTHERAPY; BIOMARKERS; BIOPSIES; CHIP	Development of a reliable platform and workflow to detect and capture a small number of mutation-bearing circulating tumor cells (CTCs) from a blood sample is necessary for the development of noninvasive cancer diagnosis. In this preclinical study, we aimed to develop a capture system for molecular characterization of single CTCs based on high-density dielectrophoretic microwell array technology. Spike-in experiments using lung cancer cell lines were conducted. The microwell array was used to capture spiked cancer cells, and captured single cells were subjected to whole genome amplification followed by sequencing. A high detection rate (70.2%-90.0%) and excellent linear performance (R-2 = 0.8189-0.9999) were noted between the observed and expected numbers of tumor cells. The detection rate was markedly higher than that obtained using the CellSearch system in a blinded manner, suggesting the superior sensitivity of our system in detecting EpCAM - tumor cells. Isolation of single captured tumor cells, followed by detection of EGFR mutations, was achieved using Sanger sequencing. Using a microwell array, we established an efficient and convenient platform for the capture and characterization of single CTCs. The results of a proof-of-principle preclinical study indicated that this platform has potential for the molecular characterization of captured CTCs from patients.	[Morimoto, Atsushi; Mogami, Toshifumi; Iijima, Kazuki; Akiyama, Yasuyuki; Katayama, Koji; Futami, Toru] Tosoh Corp, Life Sci Res Lab, Yokohama, Kanagawa, Japan; [Watanabe, Masaru; Yamamoto, Nobuyuki; Koh, Yasuhiro] Wakayama Med Univ, Dept Internal Med 3, Wakayama, Japan; [Sawada, Takeshi; Koizumi, Fumiaki] Natl Canc Ctr, Shien Lab, Tokyo, Japan	Tosoh Corporation; Wakayama Medical University; National Cancer Center - Japan	Koh, Y (corresponding author), Wakayama Med Univ, Dept Internal Med 3, Wakayama, Japan.	ykoh@wakayama-med.ac.jp			Advanced Research and Development Project on Diagnosis and Treatment for Early Stage of Cancer, Development of Automatic Testing System for Genetic Diagnosis using Peripheral Blood, of the New Energy and Industrial Technology Development Organization; Tosoh Corp.	Advanced Research and Development Project on Diagnosis and Treatment for Early Stage of Cancer, Development of Automatic Testing System for Genetic Diagnosis using Peripheral Blood, of the New Energy and Industrial Technology Development Organization; Tosoh Corp.	This research was supported by the Advanced Research and Development Project on Diagnosis and Treatment for Early Stage of Cancer, Development of Automatic Testing System for Genetic Diagnosis using Peripheral Blood, of the New Energy and Industrial Technology Development Organization (NEDO), Japan. Tosoh Corp. provided support in the form of salaries for authors [AM, TM, KI, YA, KK and TF], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alix-Panabieres C, 2013, CLIN CHEM, V59, P110, DOI 10.1373/clinchem.2012.194258; Cann GM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049144; Chang CL, 2015, LAB CHIP, V15, P1677, DOI 10.1039/c5lc00100e; Coumans FAW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061770; Cristofanilli M, 2004, NEW ENGL J MED, V351, P781, DOI 10.1056/NEJMoa040766; Fabbri F, 2013, CANCER LETT, V335, P225, DOI 10.1016/j.canlet.2013.02.015; Farace F, 2011, BRIT J CANCER, V105, P847, DOI 10.1038/bjc.2011.294; Gasch C, 2013, CLIN CHEM, V59, P252, DOI 10.1373/clinchem.2012.188557; Gascoyne PRC, 2004, P IEEE, V92, P22, DOI 10.1109/JPROC.2003.820535; Gorges TM, 2013, CANCER IMMUNOL IMMUN, V62, P931, DOI 10.1007/s00262-012-1387-1; Gupta V, 2012, BIOMICROFLUIDICS, V6, DOI 10.1063/1.4731647; Heitzer E, 2013, GENOME MED, V5, DOI 10.1186/gm477; Heitzer E, 2013, CANCER RES, V73, P2965, DOI 10.1158/0008-5472.CAN-12-4140; Hosokawa M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067466; Hou JM, 2012, J CLIN ONCOL, V30, P525, DOI 10.1200/JCO.2010.33.3716; Krebs MG, 2011, J CLIN ONCOL, V29, P1556, DOI 10.1200/JCO.2010.28.7045; La Thangue NB, 2011, NAT REV CLIN ONCOL, V8, P587, DOI 10.1038/nrclinonc.2011.121; Lianidou ES, 2012, CLIN CHEM, V58, P805, DOI 10.1373/clinchem.2011.180646; Lin HK, 2010, CLIN CANCER RES, V16, P5011, DOI 10.1158/1078-0432.CCR-10-1105; Maemondo M, 2010, NEW ENGL J MED, V362, P2380, DOI 10.1056/NEJMoa0909530; Magbanua MJM, 2013, CANCER RES, V73, P30, DOI 10.1158/0008-5472.CAN-11-3017; Matsusaka S, 2010, CANCER SCI, V101, P1067, DOI 10.1111/j.1349-7006.2010.01492.x; Menachery A, 2005, IEE P-NANOBIOTECHNOL, V152, P145, DOI 10.1049/ip-nbt:20050010; Naito T, 2012, J THORAC ONCOL, V7, P512, DOI 10.1097/JTO.0b013e31823f125d; Overman MJ, 2013, J CLIN ONCOL, V31, P17, DOI 10.1200/JCO.2012.43.1718; Ozkumur E, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005616; Pantel K, 2008, NAT REV CANCER, V8, P329, DOI 10.1038/nrc2375; Peeters DJE, 2013, BRIT J CANCER, V108, P1358, DOI 10.1038/bjc.2013.92; Pethig R, 2010, BIOMICROFLUIDICS, V4, DOI 10.1063/1.3456626; Pohl HA, 1978, DIELECTROPHOTRESIS B; Powell AA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033788; Shim S, 2013, BIOMICROFLUIDICS, V7, DOI 10.1063/1.4774304; Stott SL, 2010, P NATL ACAD SCI USA, V107, P18392, DOI 10.1073/pnas.1012539107; Swennenhuis JF, 2013, GENOME MED, V5, DOI 10.1186/gm510; Watanabe M, 2014, CYTOM PART A, V85, P206, DOI 10.1002/cyto.a.22422; Wendel M, 2012, PHYS BIOL, V9, DOI [10.1088/1478-3967/9/1/016005, 10.1088/1478-3975/9/1/016005]; Yamamura S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032370; Yoshimoto N, 2013, SCI REP-UK, V3, DOI 10.1038/srep01191; Yu M, 2011, J CELL BIOL, V192, P373, DOI 10.1083/jcb.201010021	39	37	38	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2015	10	6							e0130418	10.1371/journal.pone.0130418	http://dx.doi.org/10.1371/journal.pone.0130418			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4OM	26107884	Green Published, Green Submitted, gold			2022-12-26	WOS:000356932500100
J	Ohno, Y; Otaki, JM				Ohno, Yoshikazu; Otaki, Joji M.			Live Cell Imaging of Butterfly Pupal and Larval Wings In Vivo	PLOS ONE			English	Article							COLOR-PATTERN MODIFICATIONS; PRECIS-COENIA LEPIDOPTERA; EPIDERMAL FEET; EYESPOT PATTERNS; DISTAL-LESS; EVOLUTION; MORPHOGENESIS; NYMPHALIDAE; ARRANGEMENT; TUNGSTATE	Butterfly wing color patterns are determined during the late larval and early pupal stages. Characterization of wing epithelial cells at these stages is thus critical to understand how wing structures, including color patterns, are determined. Previously, we successfully recorded real-time in vivo images of developing butterfly wings over time at the tissue level. In this study, we employed similar in vivo fluorescent imaging techniques to visualize developing wing epithelial cells in the late larval and early pupal stages 1 hour post-pupation. Both larval and pupal epithelial cells were rich in mitochondria and intracellular networks of endoplasmic reticulum, suggesting high metabolic activities, likely in preparation for cellular division, polyploidization, and differentiation. Larval epithelial cells in the wing imaginal disk were relatively large horizontally and tightly packed, whereas pupal epithelial cells were smaller and relatively loosely packed. Furthermore, larval cells were flat, whereas pupal cells were vertically elongated as deep as 130 mu m. In pupal cells, many endosome-like or autophagosome-like structures were present in the cellular periphery down to approximately 10 mu m in depth, and extensive epidermal feet or filopodia-like processes were observed a few micrometers deep from the cellular surface. Cells were clustered or bundled from approximately 50 mu m in depth to deeper levels. From 60 mu m to 80 mu m in depth, horizontal connections between these clusters were observed. The prospective eyespot and marginal focus areas were resistant to fluorescent dyes, likely because of their non-flat cone-like structures with a relatively thick cuticle. These in vivo images provide important information with which to understand processes of epithelial cell differentiation and color pattern determination in butterfly wings.	[Ohno, Yoshikazu; Otaki, Joji M.] Univ Ryukyus, Dept Chem Biol & Marine Sci, BCPH Unit Mol Physiol, Fac Sci, Nishihara, Okinawa 9030213, Japan	University of the Ryukyus	Otaki, JM (corresponding author), Univ Ryukyus, Dept Chem Biol & Marine Sci, BCPH Unit Mol Physiol, Fac Sci, Nishihara, Okinawa 9030213, Japan.	otaki@sci.u-ryukyu.ac.jp	Ohno, Yoshikazu/AAU-9366-2021	Ohno, Yoshikazu/0000-0002-6179-0363	Research Foundation for Opto-Science and Technology, Hamamatsu, Japan; Promotion of the Supporting System for Education and Research from the University of the Ryukyus; International Research Hub Project for Climate Change and Coral Reef/Island Dynamics of University of the Ryukyus	Research Foundation for Opto-Science and Technology, Hamamatsu, Japan; Promotion of the Supporting System for Education and Research from the University of the Ryukyus; International Research Hub Project for Climate Change and Coral Reef/Island Dynamics of University of the Ryukyus	This work was supported by the Research Foundation for Opto-Science and Technology, Hamamatsu, Japan (JMO) (http://www.refost-hq.jp/kenkyu.html) and the Promotion of the Supporting System for Education and Research from the University of the Ryukyus (JMO) (http://www.uryukyu.ac.jp/en/index.html). This project is partially supported by the International Research Hub Project for Climate Change and Coral Reef/Island Dynamics of University of the Ryukyus. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ando T, 2013, DEVELOPMENT, V140, P454, DOI 10.1242/dev.085241; Beldade P, 2002, NATURE, V415, P315, DOI 10.1038/415315a; Brakefield PM, 1996, NATURE, V384, P236, DOI 10.1038/384236a0; BRAKEFIELD PM, 1995, DEV BIOL, V168, P98, DOI 10.1006/dbio.1995.1064; CARROLL SB, 1994, SCIENCE, V265, P109, DOI 10.1126/science.7912449; Cho EH, 2013, ARTHROPOD STRUCT DEV, V42, P37, DOI 10.1016/j.asd.2012.09.003; DELHANTY P, 1989, TISSUE CELL, V21, P891, DOI 10.1016/0040-8166(89)90040-2; Dhungel B, 2014, ENTOMOL SCI, V17, P207, DOI 10.1111/ens.12046; Dhungel B, 2013, J THERM BIOL, V38, P427, DOI 10.1016/j.jtherbio.2013.06.002; Dhungel B, 2013, BMC BIOTECHNOL, V13, DOI 10.1186/1472-6750-13-27; Dhungel B, 2009, ZOOL SCI, V26, P758, DOI 10.2108/zsj.26.758; FRENCH V, 1992, DEVELOPMENT, V116, P103; Ghiradella H, 1998, MICROSCOPIC ANATOMY OF INVERTEBRATES, VOL 11 A-C, P257; GREENSTEIN ME, 1972, J MORPHOL, V136, P23, DOI 10.1002/jmor.1051360103; HENKE K, 1952, Z NATURFORSCH B, V7, P65; Henke K., 1946, Biologisches Zentralblatt Leipzig, V65, P120; Hiyama Atsuki, 2012, Frontiers in Genetics, V3, P15, DOI 10.3389/fgene.2012.00015; Hiyama A, 2010, ENTOMOL SCI, V13, P293, DOI 10.1111/j.1479-8298.2010.00387.x; Iwata M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089500; Kodandaramaiah U, 2013, ECOL EVOL, V3, P4518, DOI 10.1002/ece3.831; Kornberg TB, 2014, DEVELOPMENT, V141, P729, DOI 10.1242/dev.086223; Kristensen Niels P., 2003, Handbuch der Zoologie (Berlin), V4, P9; Kuhn A, 1954, VORLESUNGEN UNBER EN; KUNTZE HELMUT, 1935, ZOOL JAHRB ABT ALLG ZOOL U PHYSIOL, V30, P544, DOI 10.1007/BF00403137; Kusaba K, 2009, J INSECT PHYSIOL, V55, P174, DOI 10.1016/j.jinsphys.2008.11.006; LOCKE M, 1981, NATURE, V293, P733, DOI 10.1038/293733a0; LOCKE M, 1985, TISSUE CELL, V17, P901, DOI 10.1016/0040-8166(85)90045-X; LOCKE M, 1981, TISSUE CELL, V13, P787, DOI 10.1016/S0040-8166(81)80014-6; Mahdi SHA, 2010, J INSECT PHYSIOL, V56, P1022, DOI 10.1016/j.jinsphys.2010.02.013; Monteiro A, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-52; Monteiro A, 2013, J EXP ZOOL PART B, V320B, P321, DOI 10.1002/jez.b.22503; NARDI JB, 1986, DEV BIOL, V116, P278, DOI 10.1016/0012-1606(86)90131-4; NARDI JB, 1976, J EMBRYOL EXP MORPH, V36, P489; Nie J, 2015, BMC DEV BIOL, V15, DOI 10.1186/s12861-015-0056-y; Nijhout H.F., 1991, DEV EVOLUTION BUTTER; NIJHOUT HF, 1985, J EMBRYOL EXP MORPH, V86, P191; NIJHOUT HF, 1980, DEV BIOL, V80, P267, DOI 10.1016/0012-1606(80)90403-0; NIJHOUT HF, 1980, DEV BIOL, V80, P275, DOI 10.1016/0012-1606(80)90404-2; Nijhout HF, 2001, J EXP ZOOL, V291, P213, DOI 10.1002/jez.1099; Ohno Y, 2015, BMC DEV BIOL, V15, DOI 10.1186/s12861-015-0067-8; Otaki JM, 2005, ZOOL SCI, V22, P21, DOI 10.2108/zsj.22.21; Otaki JM, 2005, ZOOL SCI, V22, P635, DOI 10.2108/zsj.22.635; Otaki JM, 2004, DEV GROWTH DIFFER, V46, P1; Otaki JM, 2007, J INSECT PHYSIOL, V53, P526, DOI 10.1016/j.jinsphys.2007.02.005; Otaki JM, 2012, ZOOL SCI, V29, P568, DOI 10.2108/zsj.29.568; Otaki JM, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-17; Otaki JM, 2011, SCI REP-UK, V1, DOI 10.1038/srep00111; Reed RD, 2004, CURR BIOL, V14, P1159, DOI 10.1016/j.cub.2004.06.046; Saenko SV, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-111; Shirai LT, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-21; Taira W, 2015, ZOOL SCI, V32, P38, DOI 10.2108/zs140058; Taira W, 2014, J HERED, V105, P710, DOI 10.1093/jhered/esu013; Tokita Christopher K, 2013, Int J Evol Biol, V2013, P926702, DOI 10.1155/2013/926702; YOSHIDA A, 1983, P JPN ACAD B-PHYS, V59, P236, DOI 10.2183/pjab.59.236; YOSHIDA A, 1989, DEV GROWTH DIFFER, V31, P601	55	22	22	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2015	10	6							e0128332	10.1371/journal.pone.0128332	http://dx.doi.org/10.1371/journal.pone.0128332			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4OM	26107809	Green Published, Green Submitted, gold			2022-12-26	WOS:000356932500019
J	Veillon, L; Go, SJ; Matsuyama, W; Suzuki, A; Nagasaki, M; Yatomi, Y; Inokuchi, J				Veillon, Lucas; Go, Shinji; Matsuyama, Wakana; Suzuki, Akemi; Nagasaki, Mika; Yatomi, Yutaka; Inokuchi, Jin-ichi			Identification of Ganglioside GM3 Molecular Species in Human Serum Associated with Risk Factors of Metabolic Syndrome	PLOS ONE			English	Article							INSULIN-RESISTANCE; MEMBRANE MICRODOMAINS; HEPATIC STEATOSIS; ADIPOSE-TISSUE; OBESE MICE; SENSITIVITY; SUSCEPTIBILITY; OXIDATION; PROTEINS; LIVER	Serum GM3 molecular species were quantified in 125 Japanese residents using tandem mass spectrometry multiple reaction monitoring. Individuals were categorized by the presence or absence of metabolic disease risk factors including visceral fat accumulation, hyperglycemia and dyslipidemia. A total of 23 GM3 molecular species were measured, of these, eight were found to be significantly elevated in individuals with visceral fat accumulation and metabolic disease, defined as the presence of hyperglycemia and dyslipidemia. All of the GM3 molecular species were composed of the sphingoid base sphingosine (d18:1 (Delta 4)) and, interestingly, six of the eight elevated GM3 molecular species contained a hydroxylated ceramide moiety. The hydroxylated GM3 species were, in order of decreasing abundance, d18:1-h24:0 approximate to d18:1-h24:1 > d18:1-h22:0 >> d18:1-h20:0 > d18:1-h21:0 > d18:1-h18:1. Univariate and multiple linear regression analyses were conducted using a number of clinical health variables associated with obesity, type 2 diabetes, metabolic disease, atherosclerosis and hypertension. GM3(d18:1-h24: 1) was identified as the best candidate for metabolic screening, proving to be significantly correlated with intima-media thickness, used for the detection of atherosclerotic disease in humans, and a number of metabolic disease risk factors including autotaxin, LDL-c and homeostatic model assessment insulin resistance (HOMA-IR).	[Veillon, Lucas; Go, Shinji; Matsuyama, Wakana; Inokuchi, Jin-ichi] Tohoku Pharmaceut Univ, Inst Mol Biomembrane & Glycobiol, Div Glycopathol, Sendai, Miyagi, Japan; [Suzuki, Akemi] Tokai Univ, Inst Glycosci, Hiratsuka, Kanagawa 25912, Japan; [Nagasaki, Mika] Univ Tokyo, Grad Sch Med, Dept Cardiovasc Med, Tokyo, Japan; [Yatomi, Yutaka] Univ Tokyo, Grad Sch Med, Dept Clin Lab Med, Tokyo, Japan	Tohoku Medical & Pharmaceutical University; Tokai University; University of Tokyo; University of Tokyo	Inokuchi, J (corresponding author), Tohoku Pharmaceut Univ, Inst Mol Biomembrane & Glycobiol, Div Glycopathol, Sendai, Miyagi, Japan.	jin@tohoku-pharm.ac.jp	Inokuchi, Jin-ichi/AAW-9964-2020	Inokuchi, Jin-ichi/0000-0002-0703-5746; Yatomi, Yutaka/0000-0003-1719-4297	MEXT, Japan [23370064]; Mizutani Research Foundation for Glycoscience; Naito Foundation; Uehara Memorial Foundation; MEXT-Supported Program for the Strategic Research Foundation at Private Universities	MEXT, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Mizutani Research Foundation for Glycoscience; Naito Foundation(Naito Memorial Foundation); Uehara Memorial Foundation(Uehara Memorial Foundation); MEXT-Supported Program for the Strategic Research Foundation at Private Universities(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by research grants for a Grant-in-Aid for Scientific Research (B) (J.-i.I.) (No. 23370064) from MEXT, Japan, http://www.jsps.go.jp/english/e-grants/, The Mizutani Research Foundation for Glycoscience (J.-i.I.), http://www.mizutanifdn.or.jp, The Naito Foundation (J.-i.I.), https://www.naito-f.or.jp/en/, The Uehara Memorial Foundation (J.-i.I.), http://www.ueharazaidan.or.jp, and MEXT-Supported Program for the Strategic Research Foundation at Private Universities (J.-i.I., L.V.A.S., W.M., S.G.) http://www.jsps.go.jp/english/e-grants/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aerts JM, 2007, DIABETES, V56, P1341, DOI 10.2337/db06-1619; AUSTIN MA, 1988, JAMA-J AM MED ASSOC, V260, P1917; Bijl N, 2009, HEPATOLOGY, V50, P1431, DOI 10.1002/hep.23175; Chavez JA, 2012, CELL METAB, V15, P585, DOI 10.1016/j.cmet.2012.04.002; Chen L, 2012, NAT REV ENDOCRINOL, V8, P228, DOI 10.1038/nrendo.2011.183; Couet J, 1997, J BIOL CHEM, V272, P6525, DOI 10.1074/jbc.272.10.6525; DEGRAAF J, 1991, ARTERIOSCLER THROMB, V11, P298, DOI 10.1161/01.ATV.11.2.298; Hakomori S, 2002, P NATL ACAD SCI USA, V99, P225, DOI 10.1073/pnas.012540899; Hama H, 2010, BBA-MOL CELL BIOL L, V1801, P405, DOI 10.1016/j.bbalip.2009.12.004; Ibarguren M, 2013, BBA-BIOMEMBRANES, V1828, P2553, DOI 10.1016/j.bbamem.2013.06.014; Inokuchi J, 2013, METHOD DETECTION DIS; Inokuchi J, 2014, GLYCOCONJUGATE J, V31, P193, DOI 10.1007/s10719-013-9516-4; Inokuchi J, 2011, P JPN ACAD B-PHYS, V87, P179, DOI 10.2183/pjab.87.179; Inokuchi J, 2010, FEBS LETT, V584, P1864, DOI 10.1016/j.febslet.2009.10.012; Kabayama K, 2005, GLYCOBIOLOGY, V15, P21, DOI 10.1093/glycob/cwh135; Kabayama K, 2007, P NATL ACAD SCI USA, V104, P13678, DOI 10.1073/pnas.0703650104; KAYA K, 1984, J BIOL CHEM, V259, P3548; Maitra A, 2005, ROBBINS COTRAN PATHO, P1156; Nagafuku M, 2015, GLYCOBIOLOGY, V25, P303, DOI 10.1093/glycob/cwu112; Nemoto M, 2014, J OBES, V2014, DOI 10.1155/2014/495084; Nishimura S, 2014, DIABETES, V63, P4154, DOI 10.2337/db13-1694; RIBONI L, 1992, EUR J BIOCHEM, V203, P107, DOI 10.1111/j.1432-1033.1992.tb19834.x; Samad F, 2006, DIABETES, V55, P2579, DOI 10.2337/db06-0330; Sato T, 2008, OBES RES CLIN PRACT, V2, P231, DOI 10.1016/j.orcp.2008.06.001; SENN HJ, 1992, ATHEROSCLEROSIS, V94, P109, DOI 10.1016/0021-9150(92)90235-9; SENN HJ, 1992, EUR J BIOCHEM, V205, P809, DOI 10.1111/j.1432-1033.1992.tb16845.x; SENN HJ, 1989, EUR J BIOCHEM, V181, P657, DOI 10.1111/j.1432-1033.1989.tb14773.x; Tagami S, 2002, J BIOL CHEM, V277, P3085, DOI 10.1074/jbc.M103705200; TRIBBLE DL, 1995, J LIPID RES, V36, P662; Uemura S, 2014, J LIPID RES, V55, P1343, DOI 10.1194/jlr.M048637; van Eijk M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004723; Yamashita T, 2003, P NATL ACAD SCI USA, V100, P3445, DOI 10.1073/pnas.0635898100; Zhao HM, 2007, DIABETES, V56, P1210, DOI 10.2337/db06-0719; Zhao HM, 2009, HEPATOLOGY, V50, P85, DOI 10.1002/hep.22970	34	34	36	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2015	10	6							e0129645	10.1371/journal.pone.0129645	http://dx.doi.org/10.1371/journal.pone.0129645			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4DD	26102277	gold, Green Published, Green Submitted			2022-12-26	WOS:000356901900017
J	Lim, J; Bhoo-Pathy, N; Sothilingam, S; Malek, R; Sundram, M; Tan, GH; Bahadzor, B; Ong, TA; Ng, KL; Razack, AHA				Lim, Jasmine; Bhoo-Pathy, Nirmala; Sothilingam, Selvalingam; Malek, Rohan; Sundram, Murali; Tan, Guan Hee; Bahadzor, Badrulhisham; Ong, Teng Aik; Ng, Keng Lim; Razack, Azad Hassan Abdul			Cardiovascular Risk Factors and Ethnicity Are Independent Factors Associated with Lower Urinary Tract Symptoms	PLOS ONE			English	Article							INTERNATIONAL DIABETES FEDERATION; BENIGN PROSTATIC HYPERPLASIA; METABOLIC SYNDROME; ERECTILE DYSFUNCTION; AGING MEN; PREVALENCE; POPULATION; PATHOPHYSIOLOGY; EPIDEMIOLOGY; DEFINITION	Objectives To determine the lower urinary tract symptoms (LUTS) profile and factors affecting its degree of severity including cardiovascular risk profile, age, ethnicity, education level and prostate volume in a multiethnic Asian setting. Materials and Methods We conducted a cross-sectional study of 1021 men aged 40-79 years with no clinical evidence of prostate cancer, prostate surgery or 5 alpha-reductase inhibitor treatment of known prostate conditions. The severity of LUTS was assessed using the International Prostate Symptom Score (IPSS). Potential factors associated with LUTS including age, ethnicity, education, history of hypertension, diabetes and hypercholesterolemia, height, weight, and prostate volume were evaluated using univariable and multivariable analyses. Results There were 506 (50%) men found to have moderate-to-severe LUTS attaining an IPSS above 7. Overall, nocturia (45.5%) was the most frequently reported symptom. Multivariable analysis showed that age, ethnicity, prostate volume and history of hypertension and hypercholesterolemia were independent factors associated with severity of LUTS (p < 0.05). Considering individual lower urinary tract symptoms, we found a strong association of storage symptom with history of hypertension and hypercholesterolemia. Malay men were significantly bothered by post micturition symptom compared to their Chinese and Indian counterparts. Stratified analyses of LUTS demonstrated a mutually exclusive cardiovascular risk factors profile defined by ethnicity. Conclusion Severity of LUTS varies between different ethnicities across all age groups. In addition to age and prostate volume, ethnicity and cardiovascular risk factors including hypertension and hypercholesterolemia may also need to be taken into account in managing men with LUTS.	[Lim, Jasmine; Sothilingam, Selvalingam; Ong, Teng Aik; Ng, Keng Lim; Razack, Azad Hassan Abdul] Univ Malaya, Fac Med, Dept Surg, Kuala Lumpur, Malaysia; [Bhoo-Pathy, Nirmala] Univ Malaya, Fac Med, Dept Social & Prevent Med, Julius Ctr, Kuala Lumpur, Malaysia; [Bhoo-Pathy, Nirmala] Univ Med Ctr Utrecht, Primary Care, NL-3508 GA Utrecht, Netherlands; [Malek, Rohan] Selayang Hosp, Dept Urol, Selangor, Malaysia; [Sundram, Murali] Kuala Lumpur Hosp, Dept Urol, Kuala Lumpur, Malaysia; [Tan, Guan Hee; Bahadzor, Badrulhisham] Univ Kebangsaan Malaysia, Med Ctr, Dept Surg, Kuala Lumpur, Malaysia; [Ng, Keng Lim] Univ Queensland, Sch Med, Ctr Kidney Dis Res, Translat Res Inst, Brisbane, Qld, Australia	Universiti Malaya; Universiti Malaya; Utrecht University; Utrecht University Medical Center; Universiti Kebangsaan Malaysia; University of Queensland	Razack, AHA (corresponding author), Univ Malaya, Fac Med, Dept Surg, Kuala Lumpur, Malaysia.	azad@ummc.edu.my	Ong, Teng Aik/B-2284-2010; Ong, Teng Aik/B-5321-2010; Pathy, Nirmala Bhoo/C-1228-2010; JASMINE, LIM/F-7404-2015; Razack, Azad HA/B-8152-2009	Ong, Teng Aik/0000-0002-0207-8966; Pathy, Nirmala Bhoo/0000-0003-0568-8863; JASMINE, LIM/0000-0002-7501-1834; Razack, Azad HA/0000-0002-4237-6511	University Malaya [HIR/MOHE/MED/35]	University Malaya(Universiti Malaya)	This work was funded by the University Malaya High Impact Research Grant (HIR/MOHE/MED/35 to AHAR). The funder had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Abrams P, 2002, NEUROUROL URODYNAM, V21, P167, DOI 10.1002/nau.10052; Alberti KGMM, 2006, DIABETIC MED, V23, P469, DOI 10.1111/j.1464-5491.2006.01858.x; BARRY MJ, 1992, J UROLOGY, V148, P1549, DOI 10.1016/S0022-5347(17)36966-5; Barry MJ, 1992, J UROLOGY, V148, P1564, DOI DOI 10.1016/S0022-5347(17)36966-5; Beltran-Sanchez H, 2013, J AM COLL CARDIOL, V62, P697, DOI 10.1016/j.jacc.2013.05.064; Chapple CR, 2006, EUR UROL, V49, P651, DOI 10.1016/j.eururo.2006.02.018; Chong C, 2012, PROSTATE CANCER P D, V15, P273, DOI 10.1038/pcan.2011.69; Creager MA, 2003, CIRCULATION, V108, P1527, DOI 10.1161/01.CIR.0000091257.27563.32; Deepa M, 2007, DIABETES-METAB RES, V23, P127, DOI 10.1002/dmrr.658; Fitzgerald MP, 2007, EUR UROL, V52, P407, DOI 10.1016/j.eururo.2007.03.014; Gu DF, 2005, LANCET, V365, P1398, DOI 10.1016/S0140-6736(05)66375-1; Jacobsen SJ, 1996, J UROLOGY, V155, P595, DOI 10.1016/S0022-5347(01)66461-9; Kaplan SA, 2011, J UROLOGY, V185, P1369, DOI 10.1016/j.juro.2010.11.060; Khoo EM, 2008, J SEX MED, V5, P2925, DOI 10.1111/j.1743-6109.2008.00988.x; Ko GTC, 2006, DIABETES RES CLIN PR, V73, P58, DOI 10.1016/j.diabres.2005.11.009; Kok ET, 2009, J UROLOGY, V181, P710, DOI 10.1016/j.juro.2008.10.025; Kupelian V, 2006, ARCH INTERN MED, V166, P2381, DOI 10.1001/archinte.166.21.2381; Kupelian V, 2009, J UROLOGY, V182, P616, DOI 10.1016/j.juro.2009.04.025; Lee J, 2008, CLIN ENDOCRINOL, V69, P225, DOI 10.1111/j.1365-2265.2008.03174.x; Lim J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104917; Mariappan P, 2006, BJU INT, V98, P1264, DOI 10.1111/j.1464-410X.2006.06525.x; Martin S, 2014, J UROLOGY, V191, P130, DOI 10.1016/j.juro.2013.06.018; McVary K, 2006, BJU INT, V97, P23, DOI 10.1111/j.1464-410X.2006.06102.x; Mohamud WNW, 2011, DIABETES RES CLIN PR, V91, P239, DOI 10.1016/j.diabres.2010.11.025; Parsons JK, 2011, EUR UROL, V60, P1173, DOI 10.1016/j.eururo.2011.07.040; Rahman NU, 2007, BJU INT, V100, P658, DOI 10.1111/j.1464-410X.2007.07069.x; Rees RW, 2003, J UROLOGY, V170, P2517, DOI 10.1097/01.ju.0000085024.47406.6c; Roehrborn CG, 1999, UROLOGY, V54, P662, DOI 10.1016/S0090-4295(99)00232-0; Temml C, 2009, UROLOGY, V73, P544, DOI 10.1016/j.urology.2008.10.027; Zamuner M, 2014, ADV UROL, V2014, DOI 10.1155/2014/203854	30	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2015	10	6							e0130820	10.1371/journal.pone.0130820	http://dx.doi.org/10.1371/journal.pone.0130820			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL3FM	26098884	Green Published, Green Submitted, gold			2022-12-26	WOS:000356835800106
J	Liu, YP; Liang, HP; Gao, ZK				Liu, Ying-Pei; Liang, Hai-Ping; Gao, Zhong-Ke			The Application of Auto-Disturbance Rejection Control Optimized by Least Squares Support Vector Machines Method and Time-Frequency Representation in Voltage Source Converter-High Voltage Direct Current System	PLOS ONE			English	Article							RENEWABLE ENERGY-SOURCES; MULTITERMINAL VSC-HVDC; LITHIUM-ION BATTERY; COMPLEX NETWORK; ELECTRIC VEHICLES; MODEL	In order to improve the performance of voltage source converter-high voltage direct current (VSC-HVDC) system, we propose an improved auto-disturbance rejection control (ADRC) method based on least squares support vector machines (LSSVM) in the rectifier side. Firstly, we deduce the high frequency transient mathematical model of VSC-HVDC system. Then we investigate the ADRC and LSSVM principles. We ignore the tracking differentiator in the ADRC controller aiming to improve the system dynamic response speed. On this basis, we derive the mathematical model of ADRC controller optimized by LSSVM for direct current voltage loop. Finally we carry out simulations to verify the feasibility and effectiveness of our proposed control method. In addition, we employ the time-frequency representation methods, i.e., Wigner-Ville distribution (WVD) and adaptive optimal kernel (AOK) time-frequency representation, to demonstrate our proposed method performs better than the traditional method from the perspective of energy distribution in time and frequency plane.	[Liu, Ying-Pei; Liang, Hai-Ping] North China Elect Power Univ, Sch Elect & Elect Engn, Baoding 071003, Hebei Province, Peoples R China; [Gao, Zhong-Ke] Tianjin Univ, Sch Elect Engn & Automat, Tianjin 300072, Peoples R China	North China Electric Power University; Tianjin University	Liu, YP (corresponding author), North China Elect Power Univ, Sch Elect & Elect Engn, Baoding 071003, Hebei Province, Peoples R China.	liuyingpei_123@126.com; zhongkegao@tju.edu.cn			Fundamental Research Funds for the Central Universities [2014MS89, 13MS72]; Natural Science Foundation of Hebei Province [E2015502012]	Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Natural Science Foundation of Hebei Province(Natural Science Foundation of Hebei Province)	This paper is supported by the Fundamental Research Funds for the Central Universities (YPL, No. 2014MS89) and (HPL, No. 13MS72) as well as the Natural Science Foundation of Hebei Province (E2015502012). These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Khalik AS, 2013, IEEE T POWER SYST, V28, P3401, DOI 10.1109/TPWRS.2013.2238685; Beerten J, 2014, IEEE T POWER SYST, V29, P34, DOI 10.1109/TPWRS.2013.2279268; Bernal-Perez S, 2013, IEEE T IND ELECTRON, V60, P2401, DOI 10.1109/TIE.2012.2222855; Bilgen S, 2004, ENERG SOURCE, V26, P1119, DOI 10.1080/00908310490441421; Chen J, 2015, CHINA COMMUN, V12, P9, DOI 10.1109/CC.2015.7084359; Chen Qian, 2005, Electric Power Automation Equipment, V25, P1; Chen X, 2011, IEEE T IND APPL, V47, P965, DOI 10.1109/TIA.2010.2102326; Cohen L., 1999, IEEE SIGNAL PROCESSI, V16, P22; Ding H, 2010, IEEE T POWER DELIVER, V25, P2976, DOI 10.1109/TPWRD.2010.2043373; Du M, 2012, CHEM ENG SCI, V82, P144, DOI 10.1016/j.ces.2012.07.028; Foley AM, 2012, RENEW ENERG, V37, P1, DOI 10.1016/j.renene.2011.05.033; Gao ZK, 2015, EPL-EUROPHYS LETT, V109, DOI 10.1209/0295-5075/109/30005; Gao ZK, 2015, SCI REP-UK, V5, DOI 10.1038/srep08222; Gao ZK, 2015, EXP THERM FLUID SCI, V60, P157, DOI 10.1016/j.expthermflusci.2014.09.008; Gao ZK, 2012, NONLINEAR ANAL-REAL, V13, P947, DOI 10.1016/j.nonrwa.2011.08.029; George JK, 1995, FUZZY SETS FUZZY LOG; Han JQ, 2014, CONTROL DECIS, V29, P506; Haykin S., 1994, NEURAL NETWORKS, DOI 10.5555/521706; He LN, 2014, IEEE T POWER DELIVER, V29, P493, DOI 10.1109/TPWRD.2013.2271761; Hu XS, 2011, J CENT SOUTH UNIV T, V18, P1525, DOI 10.1007/s11771-011-0869-1; Hu XS, 2014, IEEE T INTELL TRANSP, V15, P1193, DOI 10.1109/TITS.2013.2294675; Hu Xiaosong, 2011, 2011 American Control Conference - ACC 2011, P936; Hu XS, 2009, INT C INTEL HUM MACH, P392, DOI 10.1109/IHMSC.2009.106; JONES DL, 1995, IEEE T SIGNAL PROCES, V43, P2361, DOI 10.1109/78.469854; Kaygusuz K, 2002, ENERG SOURCE, V24, P787, DOI 10.1080/00908310290086707; Kim JS, 2013, KSCE J CIV ENG, V17, P1284, DOI 10.1007/s12205-013-0418-6; Li HS, 2005, THESIS S CHINA U TEC; Li SQ, 2014, IEEE T IND ELECTRON, V61, P6892, DOI 10.1109/TIE.2014.2317141; [李响 Li Xiang], 2013, [电工技术学报, Transactions of China Electrotechnical Society], V28, P42; Liu Guohai, 2012, Proceedings of the CSEE, V32, P138; Liu Y, 2013, IEEE T POWER SYST, V28, P1568, DOI 10.1109/TPWRS.2012.2222057; [刘英培 Liu Yingpei], 2014, [中国电机工程学报, Proceedings of the Chinese Society of Electrical Engineering], V34, P4654; Liu Yingpei, 2011, Electric Power Automation Equipment, V31, P78; Liu YP, 2014, J SENSORS; Mahlia TMI, 2014, RENEW SUST ENERG REV, V33, P532, DOI 10.1016/j.rser.2014.01.068; Moharana A, 2010, IEEE T POWER DELIVER, V25, P1952, DOI 10.1109/TPWRD.2010.2042469; PENG CK, 1994, PHYS REV E, V49, P1685, DOI 10.1103/PhysRevE.49.1685; Pizzocaro M, 2013, IEEE T ULTRASON FERR, V60, P273, DOI 10.1109/TUFFC.2013.2563; Rafael T, 2013, IEEE T SIGNAL PROCES, V61, P1555; Saber AY, 2011, IEEE T IND ELECTRON, V58, P1229, DOI 10.1109/TIE.2010.2047828; Segundo-Ramirez J, 2009, IEEE T POWER DELIVER, V24, P1815, DOI 10.1109/TPWRD.2009.2028799; [施小成 Shi Xiaocheng], 2012, [华中科技大学学报. 自然科学版, Journal of Huazhong University of Science and Technology. Nature Science], V40, P59; Torrence C, 1998, B AM METEOROL SOC, V79, P61, DOI 10.1175/1520-0477(1998)079<0061:APGTWA>2.0.CO;2; Van Hertem D, 2010, RENEW SUST ENERG REV, V14, P3156, DOI 10.1016/j.rser.2010.07.068; Ville J., 1948, CABLES TRANSM, V2A, P61; Wang Changshun, 2013, Applied Mechanics and Materials, V427-429, P897, DOI 10.4028/www.scientific.net/AMM.427-429.897; [王贺 Wang He], 2012, [电力系统保护与控制, Power System Protection and Control], V40, P107; Wang HQ, 2010, SOFT COMPUT, V14, P171, DOI 10.1007/s00500-009-0435-z; Wang WY, 2014, IEEE T POWER DELIVER, V29, P1978, DOI 10.1109/TPWRD.2014.2322498; Wang WY, 2014, IEEE T POWER SYST, V29, P1721, DOI 10.1109/TPWRS.2013.2294198; Wang X, 2013, IEEE ICC, P4197, DOI 10.1109/ICC.2013.6655221; Wang XY, 2011, J COMPUT INF SYST, V7, P3317; Wang ZY, 2009, INT J ENERGY SECT MA, V3, P50, DOI 10.1108/17506220910947845; Wei XY, P CSEE, V202, P50; Wenxin Shi, 2010, Reviews in Environmental Science and Bio/Technology, V9, P35, DOI 10.1007/s11157-010-9187-6; Widjaja J, 2013, OPT LASER ENG, V51, P311, DOI 10.1016/j.optlaseng.2012.09.009; Wigner E, 1932, PHYS REV, V40, P0749, DOI 10.1103/PhysRev.40.749; Yuan XL, 2011, RENEW ENERG, V36, P1111, DOI 10.1016/j.renene.2010.09.012; Yuan Xufeng, 2010, Electric Power Automation Equipment, V30, P1; Zhang LD, 2011, IEEE T POWER SYST, V26, P783, DOI 10.1109/TPWRS.2010.2070085; Zhang Shuning, 2010, Chinese Journal of Scientific Instrument, V31, P2081; Zhao CZ, 2012, J SYST SCI COMPLEX, V25, P625, DOI 10.1007/s11424-012-1022-4; Zheng Q, 2009, IEEE T CONTR SYST T, V17, P1432, DOI 10.1109/TCST.2008.2008638	63	2	2	2	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2015	10	6							e0130135	10.1371/journal.pone.0130135	http://dx.doi.org/10.1371/journal.pone.0130135			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL3FM	26098556	gold, Green Published, Green Submitted			2022-12-26	WOS:000356835800057
J	Marcondes, MC; Fernandes, ACS; Itabaiana, I; de Souza, ROMA; Sola-Penna, M; Zancan, P				Marcondes, Mariah C.; Fernandes, Anne C. S.; Itabaiana, Ivaldo, Jr.; de Souza, Rodrigo O. M. A.; Sola-Penna, Mauro; Zancan, Patricia			Nanomicellar Formulation of Clotrimazole Improves Its Antitumor Action toward Human Breast Cancer Cells	PLOS ONE			English	Article							MUSCLE-TYPE 6-PHOSPHOFRUCTO-1-KINASE; GLUCOSE-METABOLISM; GLYCOLYTIC-ENZYMES; AEROBIC GLYCOLYSIS; LUNG-CARCINOMA; SWEET TOOTH; VIABILITY; THERAPY; BIOAVAILABILITY; CYTOSKELETON	Background Although demonstrated as a selective anticancer drug, the clinical use of clotrimazole (CTZ) is limited due to its low solubility in hydrophilic fluids. Thus, we prepared a water-soluble nanomicellar formulation of CTZ (nCTZ) and tested on the human breast cancer cell line MCF-7 biology. Methodology/Principal Findings CTZ was nanoencapsulated in tween 80 micelles, which generated nanomicelles of, approximately, 17 nm of diameter. MCF-7 cells were treated with nCTZ and unencapsulated DMSO-solubilized drug (sCTZ) was used for comparison. After treatment, the cells were evaluated in terms of metabolism, proliferation, survival and structure. We found that nCTZ was more efficient than sCTZ at inhibiting glycolytic and other cytosolic and mitochondrial enzymes. Moreover, this increased activity was also observed for lactate production, intracellular ATP content, ROS production and antioxidant potential. As a consequence, (n)CTZ-treated MCF-7 cells displayed alterations to the plasma membrane, mitochondria and the nucleus. Finally, nCTZ induced both apoptosis and necrosis in MCF-7 cells. Conclusions/Significance MCF-7 cells are more sensible to nCTZ than to sCTZ. This was especially evident on regard to antioxidant potential, which is an important cell defense against drugs that affect cell metabolism. Moreover, this water-soluble formulation of CTZ strengths its potential use as an anticancer medicine.	[Marcondes, Mariah C.; Zancan, Patricia] Univ Fed Rio de Janeiro, Fac Farm, Dept Biotecnol Farmaceut BioTecFar, Lab Oncobiol Mol LabOMol, Rio De Janeiro, RJ, Brazil; [Fernandes, Anne C. S.] Univ Fed Rio de Janeiro, Inst Microbiol Paulo de Goes, Rio De Janeiro, RJ, Brazil; [Itabaiana, Ivaldo, Jr.; de Souza, Rodrigo O. M. A.] Univ Fed Rio de Janeiro, Inst Quim, Lab Biocatalise & Sintense Organ, Rio De Janeiro, RJ, Brazil; [Sola-Penna, Mauro] Univ Fed Rio de Janeiro, Fac Farm, Dept Biotecnol Farmaceut BioTecFar, Lab Enzimol & Controle Metab LabECom, Rio De Janeiro, RJ, Brazil	Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro	Zancan, P (corresponding author), Univ Fed Rio de Janeiro, Fac Farm, Dept Biotecnol Farmaceut BioTecFar, Lab Oncobiol Mol LabOMol, Rio De Janeiro, RJ, Brazil.	pzancan@ufrj.br	Sola-Penna, Mauro/E-8221-2011; Zancan, Patricia/Q-6281-2016; Junior, Ivaldo/A-6308-2014	Sola-Penna, Mauro/0000-0001-9796-6829; Zancan, Patricia/0000-0002-0503-028X; Junior, Ivaldo/0000-0003-0725-0881	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Fundacao do Cancer/Programa de Oncobiologia-UFRJ; Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ) [E-26/110.164/2014, E - 26 /103.283/2011]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [471470/2012-0]	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao do Cancer/Programa de Oncobiologia-UFRJ; Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	Funding was provided by Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES; Nano 2008); Fundacao do Cancer/Programa de Oncobiologia-UFRJ - Edital 2013; Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ): E-26/110.164/2014; and E - 26 /103.283/2011 and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) - 471470/2012-0.	Aktipis CA, 2013, NAT REV CANCER, V13, P883, DOI 10.1038/nrc3606; Ashrafian H, 2006, LANCET, V367, P618, DOI 10.1016/S0140-6736(06)68228-7; Balakrishnan P, 2012, ARCH PHARM RES, V35, P1169, DOI 10.1007/s12272-012-0707-5; Bayley JP, 2012, CURR OPIN ONCOL, V24, P62, DOI 10.1097/CCO.0b013e32834deb9e; BENZAQUEN LR, 1995, NAT MED, V1, P534, DOI 10.1038/nm0695-534; Blanchoin L, 2014, PHYSIOL REV, V94, P235, DOI 10.1152/physrev.00018.2013; Cairns RA, 2011, NAT REV CANCER, V11, P85, DOI 10.1038/nrc2981; Chen Z, 2009, BBA-BIOENERGETICS, V1787, P553, DOI 10.1016/j.bbabio.2009.03.003; Coelho RG, 2011, MOL GENET METAB, V103, P394, DOI 10.1016/j.ymgme.2011.04.003; DeBerardinis RJ, 2007, P NATL ACAD SCI USA, V104, P19345, DOI 10.1073/pnas.0709747104; Dobson PD, 2008, NAT REV DRUG DISCOV, V7, P205, DOI 10.1038/nrd2438; Fanun M, 2011, J COLLOID INTERF SCI, V361, P115, DOI 10.1016/j.jcis.2011.05.042; Fanun M, 2010, J COLLOID INTERF SCI, V343, P496, DOI 10.1016/j.jcis.2009.12.008; Fauvel B, 2014, MABS-AUSTIN, V6, P838, DOI 10.4161/mabs.29089; Feng ST, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100732; Fonseca NA, 2014, CANCER TREAT REV, V40, P626, DOI 10.1016/j.ctrv.2014.02.002; Furtado CM, 2015, INT J BIOCHEM CELL B, V62, P132, DOI 10.1016/j.biocel.2015.03.004; Furtado CM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030462; Geschwind JFH, 2002, CANCER RES, V62, P3909; GlassMarmor L, 1997, EUR J PHARMACOL, V328, P241, DOI 10.1016/S0014-2999(97)83051-8; Gomez LS, 2013, BIOCHIMIE, V95, P1336, DOI 10.1016/j.biochi.2013.02.013; Grosse R, 2013, NAT REV MOL CELL BIO, V14, P693, DOI 10.1038/nrm3681; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hirschhaeuser F, 2011, CANCER RES, V71, P6921, DOI 10.1158/0008-5472.CAN-11-1457; Home P, 2013, DIABETES CARE, V36, pS240, DOI 10.2337/dcS13-2002; Hsu PP, 2008, CELL, V134, P703, DOI 10.1016/j.cell.2008.08.021; Kell DB, 2011, DRUG DISCOV TODAY, V16, P704, DOI 10.1016/j.drudis.2011.05.010; Kim JW, 2006, CANCER RES, V66, P8927, DOI 10.1158/0008-5472.CAN-06-1501; Ko YH, 2004, BIOCHEM BIOPH RES CO, V324, P269, DOI 10.1016/j.bbrc.2004.09.047; Krtkova V, 2014, ANAL BIOANAL CHEM, V406, P3909, DOI 10.1007/s00216-014-7823-7; Kumari A, 2010, COLLOID SURFACE B, V75, P1, DOI 10.1016/j.colsurfb.2009.09.001; Lauro S, 2014, ANTICANCER RES, V34, P1537; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Lunt SY, 2011, ANNU REV CELL DEV BI, V27, P441, DOI 10.1146/annurev-cellbio-092910-154237; Marcondes MC, 2011, IUBMB LIFE, V63, P435, DOI 10.1002/iub.464; Marcondes MC, 2010, ARCH BIOCHEM BIOPHYS, V497, P62, DOI 10.1016/j.abb.2010.03.013; Meira DD, 2005, MOL GENET METAB, V84, P354, DOI 10.1016/j.ymgme.2004.11.012; Muthu MS, 2009, NANOMEDICINE-UK, V4, P657, DOI 10.2217/nnm.09.44; Parks SK, 2013, NAT REV CANCER, V13, P611, DOI 10.1038/nrc3579; Pelicano H, 2006, ONCOGENE, V25, P4633, DOI 10.1038/sj.onc.1209597; Penso J, 1998, EUR J PHARMACOL, V342, P113, DOI 10.1016/S0014-2999(97)01507-0; Penso J, 2002, EUR J PHARMACOL, V451, P227, DOI 10.1016/S0014-2999(02)02103-9; Penso J, 2002, MOL GENET METAB, V76, P181, DOI 10.1016/S1096-7192(02)00046-X; Pistollato F, 2010, BIOCHEM PHARMACOL, V80, P1517, DOI 10.1016/j.bcp.2010.08.003; Prabagar B, 2007, ARCH PHARM RES, V30, P249, DOI 10.1007/BF02977701; Roma LP, 2009, FREE RADICAL BIO MED, V47, P1386, DOI 10.1016/j.freeradbiomed.2009.08.010; Rowe Raymond C., 2009, HDB PHARM EXCIPIENTS, Vxxvii; Sola-Penna M, 2010, IUBMB LIFE, V62, P791, DOI 10.1002/iub.393; Spitz GA, 2009, BIOCHEM PHARMACOL, V77, P46, DOI 10.1016/j.bcp.2008.09.020; Vacchelli E, 2013, ONCOIMMUNOLOGY, V2, DOI 10.4161/onci.25238; van der Bliek AM, 2013, COLD SPRING HARB PER, V5; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Wong CC, 2012, J MOL MED BERL; Yeung S, 2008, CELLULAR MOL LIFE SC, V65, P3981, DOI [10.1007/ 400018 008-8224-x, DOI 10.1007/400018]; Yong CS, 2007, PHARMAZIE, V62, P756, DOI 10.1691/ph.2007.10.7018; Zancan P, 2007, BIOCHEM PHARMACOL, V73, P1520, DOI 10.1016/j.bcp.2007.01.018; Zancan P, 2010, MOL GENET METAB, V100, P372, DOI 10.1016/j.ymgme.2010.04.006; Zhang WJ, 2002, DRUG METAB DISPOS, V30, P314, DOI 10.1124/dmd.30.3.314; Zheng J, 2012, ONCOL LETT, V4, P1151, DOI 10.3892/ol.2012.928; Zhuang HQ, 2014, DRUG DES DEV THER, V8, P667, DOI 10.2147/DDDT.S61977; Zu XL, 2004, BIOCHEM BIOPH RES CO, V313, P459, DOI 10.1016/j.bbrc.2003.11.136	62	11	11	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2015	10	6							e0130555	10.1371/journal.pone.0130555	http://dx.doi.org/10.1371/journal.pone.0130555			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL3FM	26098874	Green Published, gold, Green Submitted			2022-12-26	WOS:000356835800083
J	St John-Saaltink, E; Utzerath, C; Kok, P; Lau, HC; de Lange, FP				St John-Saaltink, Elexa; Utzerath, Christian; Kok, Peter; Lau, Hakwan C.; de Lange, Floris P.			Expectation Suppression in Early Visual Cortex Depends on Task Set	PLOS ONE			English	Article							WORKING-MEMORY; SELECTIVE ATTENTION; REPETITION SUPPRESSION; PREDICTION ERROR; HUMAN BRAIN; ADAPTATION; REPRESENTATIONS; LOAD; TRANSITIONS; PERCEPTION	Stimulus expectation can modulate neural responses in early sensory cortical regions, with expected stimuli often leading to a reduced neural response. However, it is unclear whether this expectation suppression is an automatic phenomenon or is instead dependent on the type of task a subject is engaged in. To investigate this, human subjects were presented with visual grating stimuli in the periphery that were either predictable or non-predictable while they performed three tasks that differently engaged cognitive resources. In two of the tasks, the predictable stimulus was task-irrelevant and spatial attention was engaged at fixation, with a high load on either perceptual or working memory resources. In the third task, the predictable stimulus was task-relevant, and therefore spatially attended. We observed that expectation suppression is dependent on the cognitive resources engaged by a subjects' current task. When the grating was task-irrelevant, expectation suppression for predictable items was visible in retinotopically specific areas of early visual cortex (V1-V3) during the perceptual task, but it was abolished when working memory was loaded. When the grating was task-relevant and spatially attended, there was no significant effect of expectation in early visual cortex. These results suggest that expectation suppression is not an automatic phenomenon, but dependent on attentional state and type of available cognitive resources.	[St John-Saaltink, Elexa; Utzerath, Christian; Kok, Peter; Lau, Hakwan C.; de Lange, Floris P.] Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, NL-6525 ED Nijmegen, Netherlands; [Lau, Hakwan C.] Univ Calif Los Angeles, Dept Psychol, Los Angeles, CA 90024 USA	Radboud University Nijmegen; University of California System; University of California Los Angeles	St John-Saaltink, E (corresponding author), Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, NL-6525 ED Nijmegen, Netherlands.	e.st.john-saaltink@donders.ru.nl	de Lange, Floris/D-2860-2009; Kok, Peter/M-1184-2013	de Lange, Floris/0000-0002-6730-1452; Kok, Peter/0000-0001-5153-4959	Netherlands Organization for Scientific Research [NWO 404-10-037]	Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO))	This work was supported by the Netherlands Organization for Scientific Research (NWO 404-10-037; http://www.nwo.nl/), awarded to FPDL and HCL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albers AM, 2013, CURR BIOL, V23, P1427, DOI 10.1016/j.cub.2013.05.065; Albright TD, 2012, NEURON, V74, P227, DOI 10.1016/j.neuron.2012.04.001; Alink A, 2010, J NEUROSCI, V30, P2960, DOI 10.1523/JNEUROSCI.3730-10.2010; Arnal LH, 2011, NAT NEUROSCI, V14, P797, DOI 10.1038/nn.2810; Bar M, 2004, NAT REV NEUROSCI, V5, P617, DOI 10.1038/nrn1476; Bendixen A, 2012, INT J PSYCHOPHYSIOL, V83, P120, DOI 10.1016/j.ijpsycho.2011.08.003; Bosch SE, 2014, J NEUROSCI, V34, P7493, DOI 10.1523/JNEUROSCI.0805-14.2014; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Chaumon M, 2008, J VISION, V8, DOI 10.1167/8.3.10; Cousineau D, 2005, TUTOR QUANT METHODS, V1, P42, DOI 10.20982/tqmp.01.1.p042; Curtis CE, 2003, TRENDS COGN SCI, V7, P415, DOI 10.1016/S1364-6613(03)00197-9; den Ouden HEM, 2010, J NEUROSCI, V30, P3210, DOI 10.1523/JNEUROSCI.4458-09.2010; den Ouden HEM, 2009, CEREB CORTEX, V19, P1175, DOI 10.1093/cercor/bhn161; Doherty JR, 2005, J NEUROSCI, V25, P8259, DOI 10.1523/JNEUROSCI.1821-05.2005; Friston KJ, 2009, TRENDS COGN SCI, V13, P293, DOI 10.1016/j.tics.2009.04.005; Friston KJ, 1996, NEUROIMAGE, V4, P223, DOI 10.1006/nimg.1996.0074; Friston KJ, 2005, PHILOS T R SOC B, V360, P815, DOI 10.1098/rstb.2005.1622; FUSTER JM, 1973, J NEUROPHYSIOL, V36, P61, DOI 10.1152/jn.1973.36.1.61; Gazzaley A, 2012, TRENDS COGN SCI, V16, P129, DOI 10.1016/j.tics.2011.11.014; Gulbinaite R, 2014, NEUROIMAGE, V99, P197, DOI 10.1016/j.neuroimage.2014.05.060; Harrison SA, 2009, NATURE, V458, P632, DOI 10.1038/nature07832; Kok P, 2014, J COGNITIVE NEUROSCI; Kok P, 2013, J NEUROSCI, V33, P16275, DOI 10.1523/JNEUROSCI.0742-13.2013; Kok P, 2012, CEREB CORTEX, V22, P2197, DOI 10.1093/cercor/bhr310; Kok P, 2012, NEURON, V75, P265, DOI 10.1016/j.neuron.2012.04.034; Krekelberg B, 2006, TRENDS NEUROSCI, V29, P250, DOI 10.1016/j.tins.2006.02.008; Larsson J, 2012, CEREB CORTEX, V22, P567, DOI 10.1093/cercor/bhr119; Lavie N, 2005, TRENDS COGN SCI, V9, P75, DOI 10.1016/j.tics.2004.12.004; Lavie N, 2004, J EXP PSYCHOL GEN, V133, P339, DOI 10.1037/0096-3445.133.3.339; Lee TS, 2003, J OPT SOC AM A, V20, P1434, DOI 10.1364/JOSAA.20.001434; Marini F, 2014, NEUR M PLANN WASH DC; Maunsell JHR, 2006, TRENDS NEUROSCI, V29, P317, DOI 10.1016/j.tins.2006.04.001; Meyer T, 2011, P NATL ACAD SCI USA, V108, P19401, DOI 10.1073/pnas.1112895108; Morey RD, 2008, TUTOR QUANT METHODS, V4, P61, DOI 10.20982/tqmp.04.2.p061; Murray MM, 2002, J NEUROSCI, V22, P5055, DOI 10.1523/JNEUROSCI.22-12-05055.2002; POSNER MI, 1990, ANNU REV NEUROSCI, V13, P25, DOI 10.1146/annurev.ne.13.030190.000325; Rahnev D, 2011, J NEUROSCI, V31, P10741, DOI 10.1523/JNEUROSCI.1478-11.2011; Rao RPN, 1999, NAT NEUROSCI, V2, P79, DOI 10.1038/4580; Riggall AC, 2012, J NEUROSCI, V32, P12990, DOI 10.1523/JNEUROSCI.1892-12.2012; Serences JT, 2009, PSYCHOL SCI, V20, P207, DOI 10.1111/j.1467-9280.2009.02276.x; SERENO MI, 1995, SCIENCE, V268, P889, DOI 10.1126/science.7754376; Solomon SG, 2014, CURR BIOL, V24, pR1012, DOI 10.1016/j.cub.2014.09.001; Summerfield C, 2006, SCIENCE, V314, P1311, DOI 10.1126/science.1132028; Summerfield C, 2014, NAT REV NEUROSCI, V15, P745, DOI 10.1038/nrn3838; Summerfield C, 2009, TRENDS COGN SCI, V13, P403, DOI 10.1016/j.tics.2009.06.003; Todorovic A, 2012, J NEUROSCI, V32, P13389, DOI 10.1523/JNEUROSCI.2227-12.2012; Todorovic A, 2011, J NEUROSCI, V31, P9118, DOI 10.1523/JNEUROSCI.1425-11.2011; Turk-Browne NB, 2009, J COGNITIVE NEUROSCI, V21, P1934, DOI 10.1162/jocn.2009.21131; WATSON AB, 1983, PERCEPT PSYCHOPHYS, V33, P113, DOI 10.3758/BF03202828; Yi DJ, 2004, NAT NEUROSCI, V7, P992, DOI 10.1038/nn1294	50	22	22	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2015	10	6							e0131172	10.1371/journal.pone.0131172	http://dx.doi.org/10.1371/journal.pone.0131172			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL3FM	26098331	Green Published, gold, Green Submitted			2022-12-26	WOS:000356835800154
J	Tamaki, H; Reguera, M; Abdel-Tawab, YM; Takebayashi, Y; Kasahara, H; Blumwald, E				Tamaki, Hiroaki; Reguera, Maria; Abdel-Tawab, Yasser M.; Takebayashi, Yumiko; Kasahara, Hiroyuki; Blumwald, Eduardo			Targeting Hormone-Related Pathways to Improve Grain Yield in Rice: A Chemical Approach	PLOS ONE			English	Article							ABSCISIC-ACID BIOSYNTHESIS; BOX PROTEIN TIR1; GREEN-REVOLUTION; ETHYLENE BIOSYNTHESIS; DROUGHT TOLERANCE; METHYL JASMONATE; AUXIN RECEPTOR; WATER-STRESS; BRASSINOSTEROID-BIOSYNTHESIS; GIBBERELLIN BIOSYNTHESIS	Sink/source relationships, regulating the mobilization of stored carbohydrates from the vegetative tissues to the grains, are of key importance for grain filling and grain yield. We used different inhibitors of plant hormone action to assess their effects on grain yield and on the expression of hormone-associated genes. Among the tested chemicals, 2-indol-3-yl-4-oxo-4-phenylbutanoic acid (PEO-IAA; antagonist of auxin receptor), nordihydroguaiaretic acid (NDGA; abscisic acid (ABA) biosynthesis inhibitor), and 2-aminoisobutyric acid (AIB; ethylene biosynthesis inhibitor) improved grain yield in a concentration dependent manner. These effects were also dependent on the plant developmental stage. NDGA and AIB treatments induced an increase in photosynthesis in flag leaves concomitant to the increments of starch content in flag leaves and grains. NDGA inhibited the expression of ABA-responsive gene, but did not significantly decrease ABA content. Instead, NDGA significantly decreased jasmonic acid and jasmonic acid-isoleucine. Our results support the notion that the specific inhibition of jasmonic acid and ethylene biosynthesis resulted in grain yield increase in rice.	[Tamaki, Hiroaki; Reguera, Maria; Abdel-Tawab, Yasser M.; Blumwald, Eduardo] Univ Calif Davis, Dept Plant Sci, Davis, CA 95616 USA; [Tamaki, Hiroaki] Sumitomo Chem Co Ltd, Hlth & Crop Sci Res Lab, Takarazuka, Hyogo 6658555, Japan; [Takebayashi, Yumiko; Kasahara, Hiroyuki] RIKEN Ctr Sustainable Resource Sci, Yokohama, Kanagawa 2300045, Japan	University of California System; University of California Davis; Sumitomo Chem Co Ltd; RIKEN	Blumwald, E (corresponding author), Univ Calif Davis, Dept Plant Sci, Davis, CA 95616 USA.	eblumwald@ucdavis.edu	Reguera, Maria/K-9608-2015; Kasahara, Hiroyuki/F-6445-2012; Takebayashi, Yumiko/C-8190-2017; Blumwald, Eduardo/Y-2751-2019	Reguera, Maria/0000-0001-5939-8576; Kasahara, Hiroyuki/0000-0002-4858-0978; Takebayashi, Yumiko/0000-0003-4207-297X; 	Will W. Lester Endowment of University of California; Sumitomo Chemical Co. Ltd.	Will W. Lester Endowment of University of California; Sumitomo Chemical Co. Ltd.(Sumitomo Chem Co Ltd)	This study was supported by a grant from the Will W. Lester Endowment of University of California. Sumitomo Chemical Co. Ltd. provided support in the form of salaries for an author (H.T.), but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Abou-Khalifa AAB., 2008, AFR J PLANT SCI, V2, P147, DOI [10.5897/AJPS.9000084, DOI 10.5897/AJPS.9000084]; Adachi S, 2013, J EXP BOT, V64, P1061, DOI 10.1093/jxb/ers382; Ashikari M, 2002, BREEDING SCI, V52, P143, DOI 10.1270/jsbbs.52.143; Beltrano J, 1998, J PLANT GROWTH REGUL, V17, P53, DOI 10.1007/PL00007012; Biswal AK, 2013, MOL BREEDING, V31, P749, DOI 10.1007/s11032-013-9847-7; Chen X, 2012, CURR BIOL, V22, P1326, DOI 10.1016/j.cub.2012.05.020; Chung Y, 2013, CRIT REV PLANT SCI, V32, P396, DOI 10.1080/07352689.2013.797856; CRACKER L E, 1969, Plant Physiology (Rockville), V44, P1144, DOI 10.1104/pp.44.8.1144; CREELMAN RA, 1992, PLANT PHYSIOL, V99, P1258, DOI 10.1104/pp.99.3.1258; Depuydt S, 2011, CURR BIOL, V21, pR365, DOI 10.1016/j.cub.2011.03.013; Dharmasiri N, 2005, NATURE, V435, P441, DOI 10.1038/nature03543; Divi UK, 2009, NEW BIOTECHNOL, V26, P131, DOI 10.1016/j.nbt.2009.07.006; Du H, 2012, J EXP BOT, V63, P6467, DOI 10.1093/jxb/ers300; Fan CH, 2006, THEOR APPL GENET, V112, P1164, DOI 10.1007/s00122-006-0218-1; FARQUHAR GD, 1980, PLANTA, V149, P78, DOI 10.1007/BF00386231; Fernandez MGS, 2009, TRENDS PLANT SCI, V14, P454, DOI 10.1016/j.tplants.2009.06.005; Garg R, 2012, PLANT SIGNAL BEHAV, V7, P951, DOI 10.4161/psb.20910; GLADUN IV, 1993, RUSS J PLANT PHYSL+, V40, P629; GRAEBE JE, 1987, ANNU REV PLANT PHYS, V38, P419, DOI 10.1146/annurev.pp.38.060187.002223; Graf A, 2010, P NATL ACAD SCI USA, V107, P9458, DOI 10.1073/pnas.0914299107; Gray WM, 2004, PLOS BIOL, V2, P1270, DOI 10.1371/journal.pbio.0020311; Guimaraes Elcio P., 2009, V3, P99; Guo HQ, 2013, CURR OPIN PLANT BIOL, V16, P545, DOI 10.1016/j.pbi.2013.08.002; Han SY, 2004, PLANT PHYSIOL, V135, P1574, DOI 10.1104/pp.104.039511; Hartwig T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036625; Hayashi K, 2012, ACS CHEM BIOL, V7, P590, DOI 10.1021/cb200404c; Hays DB, 2007, PLANT SCI, V172, P1113, DOI 10.1016/j.plantsci.2007.03.004; Hirasawa T, 2010, PLANT PROD SCI, V13, P53, DOI 10.1626/pps.13.53; Holden MJ, 2003, J PLANT PHYSIOL, V160, P261, DOI 10.1078/0176-1617-00929; Huberman M, 2014, PLANT GROWTH REGUL, V73, P249, DOI 10.1007/s10725-013-9885-5; Ishimaru K, 2013, NAT GENET, V45, P707, DOI 10.1038/ng.2612; Jaillais Y, 2010, NAT STRUCT MOL BIOL, V17, P642, DOI 10.1038/nsmb0610-642; Jain M, 2006, GENOMICS, V88, P360, DOI 10.1016/j.ygeno.2006.04.008; Jikumaru Y, 2004, BIOSCI BIOTECH BIOCH, V68, P1461, DOI 10.1271/bbb.68.1461; Kepinski S, 2005, NATURE, V435, P446, DOI 10.1038/nature03542; Kim EH, 2009, PLANT PHYSIOL, V149, P1751, DOI 10.1104/pp.108.134684; Kucera B, 2005, SEED SCI RES, V15, P281, DOI 10.1079/SSR2005218; Kyozuka J, 2007, CURR OPIN PLANT BIOL, V10, P442, DOI 10.1016/j.pbi.2007.08.010; LENTON JR, 1994, PLANT GROWTH REGUL, V15, P281, DOI 10.1007/BF00029901; Liang J, 1997, PHOTOSYNTH RES, V51, P149, DOI 10.1023/A:1005797410190; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu G, 2009, PLANTA, V229, P605, DOI 10.1007/s00425-008-0857-3; Lu Y, 2005, PLANT PHYSIOL, V138, P2280, DOI 10.1104/pp.105.061903; Lyons R, 2013, PLANT CELL REP, V32, P815, DOI 10.1007/s00299-013-1400-y; Matschi S, 2015, PLANT CELL, V27, P591, DOI 10.1105/tpc.15.00024; Mi GH, 2002, J PLANT NUTR, V25, P213, DOI 10.1081/PLN-100108831; Morinaka Y, 2006, PLANT PHYSIOL, V141, P924, DOI 10.1104/pp.106.077081; NAKANO H, 1995, PLANT CELL PHYSIOL, V36, P653; Nishimura T, 2009, PLANT CELL PHYSIOL, V50, P1874, DOI 10.1093/pcp/pcp129; PALLAS JE, 1982, PLANT PHYSIOL, V70, P598, DOI 10.1104/pp.70.2.598; Peleg Z, 2011, CURR OPIN PLANT BIOL, V14, P290, DOI 10.1016/j.pbi.2011.02.001; Peleg Z, 2011, PLANT BIOTECHNOL J, V9, P747, DOI 10.1111/j.1467-7652.2010.00584.x; Peng JR, 1999, NATURE, V400, P256, DOI 10.1038/22307; PEREZ CM, 1971, PLANT PHYSIOL, V47, P404, DOI 10.1104/pp.47.3.404; Perez-Flores L, 2003, J EXP BOT, V54, P2071, DOI 10.1093/jxb/erg233; Qi JF, 2011, PLANT PHYSIOL, V157, P1987, DOI 10.1104/pp.111.183749; RADEMACHER W, 1987, PESTIC SCI, V21, P241, DOI 10.1002/ps.2780210402; Rademacher W, 2000, ANNU REV PLANT PHYS, V51, P501, DOI 10.1146/annurev.arplant.51.1.501; Reguera M, 2013, PLANT PHYSIOL, V163, P1609, DOI 10.1104/pp.113.227702; Ren HB, 2007, J EXP BOT, V58, P211, DOI [10.1093/jxb/erl1117, 10.1093/jxb/erl117]; Riemann M, 2013, PLANT J, V74, P226, DOI 10.1111/tpj.12115; Rijnders JGHM, 1997, PLANTA, V203, P20, DOI 10.1007/s004250050160; Robert S, 2010, CELL, V143, P111, DOI 10.1016/j.cell.2010.09.027; Rupp HM, 1999, PLANT J, V18, P557, DOI 10.1046/j.1365-313X.1999.00472.x; Rzewuski G, 2008, PLANT SCI, V175, P32, DOI 10.1016/j.plantsci.2008.01.012; SAIRAM RK, 1994, PLANT GROWTH REGUL, V14, P173, DOI 10.1007/BF00025220; Sakamoto T, 2006, NAT BIOTECHNOL, V24, P105, DOI 10.1038/nbt1173; Sakata T, 2010, P NATL ACAD SCI USA, V107, P8569, DOI 10.1073/pnas.1000869107; Sasaki A, 2002, NATURE, V416, P701, DOI 10.1038/416701a; SATOH S, 1983, PHYSIOL PLANTARUM, V57, P521, DOI 10.1111/j.1399-3054.1983.tb02779.x; Silverman FP, 2004, PLANT GROWTH REGUL, V43, P153, DOI 10.1023/B:GROW.0000040113.05826.d2; Soeno K, 2010, PLANT CELL PHYSIOL, V51, P524, DOI 10.1093/pcp/pcq032; Spielmeyer W, 2002, P NATL ACAD SCI USA, V99, P9043, DOI 10.1073/pnas.132266399; STREET JE, 1986, AGRON J, V78, P288, DOI 10.2134/agronj1986.00021962007800020015x; Su YH, 2011, MOL PLANT, V4, P616, DOI 10.1093/mp/ssr007; Tanaka A, 2009, PLANT PHYSIOL, V151, P669, DOI 10.1104/pp.109.140806; THORNE JH, 1974, PLANT PHYSIOL, V54, P201, DOI 10.1104/pp.54.2.201; Toyomasu T, 1997, PHYSIOL PLANTARUM, V99, P111, DOI 10.1034/j.1399-3054.1997.990116.x; Vanneste S, 2009, CELL, V136, P1005, DOI 10.1016/j.cell.2009.03.001; Wakuta S, 2011, BIOCHEM BIOPH RES CO, V409, P634, DOI 10.1016/j.bbrc.2011.05.055; Wang E, 2008, NAT GENET, V40, P1370, DOI 10.1038/ng.220; Wang R, 2008, PLANT MOL BIOL, V66, P401, DOI 10.1007/s11103-007-9278-0; Wang SY, 1999, J PLANT GROWTH REGUL, V18, P127, DOI 10.1007/PL00007060; Weiss D, 2007, PLANT PHYSIOL, V144, P1240, DOI 10.1104/pp.107.100370; Werbrouck SPO, 2003, PHYSIOL PLANTARUM, V119, P69, DOI 10.1034/j.1399-3054.2003.00155.x; Wu CY, 2008, PLANT CELL, V20, P2130, DOI 10.1105/tpc.107.055087; Wuriyanghan H, 2009, PLANT CELL, V21, P1473, DOI 10.1105/tpc.108.065391; Xiang Y, 2008, PLANT PHYSIOL, V148, P1938, DOI 10.1104/pp.108.128199; Yamamoto Y, 2007, PLANT PHYSIOL, V143, P1362, DOI 10.1104/pp.106.091561; Yang JC, 2004, PLANT CELL ENVIRON, V27, P1055, DOI 10.1111/j.1365-3040.2004.01210.x; YANG SF, 1984, ANNU REV PLANT PHYS, V35, P155, DOI 10.1146/annurev.pp.35.060184.001103; Yau CP, 2004, J EXP BOT, V55, P547, DOI 10.1093/jxb/erh055; Ye NH, 2011, PLANT CELL PHYSIOL, V52, P689, DOI 10.1093/pcp/pcr028; Yoshimitsu Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023851; Zhang M, 2009, J PLANT PHYSIOL, V166, P1241, DOI 10.1016/j.jplph.2009.01.013; Zhang M, 2009, J EXP BOT, V60, P1579, DOI 10.1093/jxb/erp026; ZHANG XS, 1993, PLANT CELL, V5, P403, DOI 10.1105/tpc.5.4.403	97	19	20	5	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2015	10	6							e0131213	10.1371/journal.pone.0131213	http://dx.doi.org/10.1371/journal.pone.0131213			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL3FM	26098557	gold, Green Published, Green Submitted			2022-12-26	WOS:000356835800156
J	Leyria, J; Fruttero, LL; Nazar, M; Canavoso, LE				Leyria, Jimena; Fruttero, Leonardo L.; Nazar, Magali; Canavoso, Lilian E.			The Role of DmCatD, a Cathepsin D-Like Peptidase, and Acid Phosphatase in the Process of Follicular Atresia in Dipetalogaster maxima (Hemiptera: Reduviidae), a Vector of Chagas' Disease	PLOS ONE			English	Article							TRIATOMA-INFESTANS HEMIPTERA; YOLK PROTEIN-DEGRADATION; RHODNIUS-PROLIXUS STAHL; PERIPLANETA-AMERICANA; TYROSINE-PHOSPHATASE; ASPARTIC PROTEASE; INORGANIC POLYPHOSPHATE; PROGRAMMED DEGRADATION; CELL-DEATH; EMBRYOGENESIS	In this work, we have investigated the involvement of DmCatD, a cathepsin D-like peptidase, and acid phosphatase in the process of follicular atresia of Dipetalogaster maxima, a hematophagous insect vector of Chagas' disease. For the studies, fat bodies, ovaries and hemolymph were sampled from anautogenous females at representative days of the reproductive cycle: pre-vitellogenesis, vitellogenesis as well as early and late atresia. Real time PCR (qPCR) and western blot assays showed that DmCatD was expressed in fat bodies and ovaries at all reproductive stages, being the expression of its active form significantly higher at the atretic stages. In hemolymph samples, only the immunoreactive band compatible with pro-DmCatD was observed by western blot. Acid phosphatase activity in ovarian tissues significantly increased during follicular atresia in comparison to pre-vitellogenesis and vitellogenesis. A further enzyme characterization with inhibitors showed that the high levels of acid phosphatase activity in atretic ovaries corresponded mainly to a tyrosine phosphatase. Immunofluorescence assays demonstrated that DmCatD and tyrosine phosphatase were associated with yolk bodies in vitellogenic follicles, while in atretic stages they displayed a different cellular distribution. DmCatD and tyrosine phosphatase partially co-localized with vitellin. Moreover, their interaction was supported by FRET analysis. In vitro assays using homogenates of atretic ovaries as the enzyme source and enzyme inhibitors demonstrated that DmCatD, together with a tyrosine phosphatase, were necessary to promote the degradation of vitellin. Taken together, the results strongly suggested that both acid hydrolases play a central role in early vitellin proteolysis during the process of follicular atresia.	[Leyria, Jimena; Fruttero, Leonardo L.; Nazar, Magali; Canavoso, Lilian E.] Univ Nacl Cordoba, Fac Ciencias Quim, CONICET, CIBICI,Dept Bioquim Clin, RA-5000 Cordoba, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Cordoba	Canavoso, LE (corresponding author), Univ Nacl Cordoba, Fac Ciencias Quim, CONICET, CIBICI,Dept Bioquim Clin, RA-5000 Cordoba, Argentina.	lcanavo@fcq.unc.edu.ar	Leyria, Jimena/B-9248-2018	Leyria, Jimena/0000-0002-9145-5523	Secretaria de Ciencia y Tecnologia-Universidad Nacional de Cordoba [SECyT-UNC 05/C456]; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET) [PIP 2011-2013/D4063]; Agencia Nacional de Promocion Cientifica y Tecnologica [PICT 2013-0626]; Ministerio de Industria, Comercio, Mineria y Desarrollo Cientifico Tecnologico de Cordoba [PID 2010-000113]	Secretaria de Ciencia y Tecnologia-Universidad Nacional de Cordoba(Secretaria de Ciencia y Tecnologia (SECYT)); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Agencia Nacional de Promocion Cientifica y Tecnologica(ANPCyT); Ministerio de Industria, Comercio, Mineria y Desarrollo Cientifico Tecnologico de Cordoba	This research was supported by grants to LEC from Secretaria de Ciencia y Tecnologia-Universidad Nacional de Cordoba (SECyT-UNC 05/C456, http://www.secyt.unc.edu.ar), Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET, PIP 2011-2013/D4063, http://www.conicet.gov.ar), Agencia Nacional de Promocion Cientifica y Tecnologica (PICT 2013-0626, http://www.agencia.mincyt.gob.ar), and Ministerio de Industria, Comercio, Mineria y Desarrollo Cientifico Tecnologico de Cordoba (PID 2010-000113, http://www.cba.gov.ar). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abreu LA, 2004, INSECT BIOCHEM MOLEC, V34, P443, DOI 10.1016/j.ibmb.2004.01.006; Aguirre SA, 2008, J INSECT PHYSIOL, V54, P393, DOI 10.1016/j.jinsphys.2007.10.012; Aguirre SA, 2013, J INSECT PHYSIOL, V59, P532, DOI 10.1016/j.jinsphys.2013.03.001; Aguirre SA, 2011, INSECT BIOCHEM MOLEC, V41, P832, DOI 10.1016/j.ibmb.2011.06.005; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Anand A, 2012, APPL BIOCHEM BIOTECH, V167, P2174, DOI 10.1007/s12010-012-9694-8; BELL WJ, 1975, BIOL REV, V50, P373, DOI 10.1111/j.1469-185X.1975.tb01058.x; BELL WJ, 1971, J INSECT PHYSIOL, V17, P1099, DOI 10.1016/0022-1910(71)90013-8; Benes P, 2008, CRIT REV ONCOL HEMAT, V68, P12, DOI 10.1016/j.critrevonc.2008.02.008; Bookout Angie L, 2006, Curr Protoc Mol Biol, VChapter 15, DOI 10.1002/0471142727.mb1508s73; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CANAVOSO LE, 1995, COMP BIOCHEM PHYS A, V112, P143, DOI 10.1016/0300-9629(95)00077-K; Cho WL, 1999, J BIOL CHEM, V274, P13311, DOI 10.1074/jbc.274.19.13311; CHO WL, 1992, J BIOL CHEM, V267, P21823; CHO WL, 1991, P NATL ACAD SCI USA, V88, P10821, DOI 10.1073/pnas.88.23.10821; de la Merced Stoka A., 1987, P109; Defferrari MS, 2011, INSECT BIOCHEM MOLEC, V41, P388, DOI 10.1016/j.ibmb.2011.02.008; FAGOTTO F, 1995, J CELL SCI, V108, P3645; Fialho E, 2005, ARCH BIOCHEM BIOPHYS, V436, P246, DOI 10.1016/j.abb.2005.01.005; Fialho E, 2002, INSECT BIOCHEM MOLEC, V32, P871, DOI 10.1016/S0965-1748(01)00175-8; Gacko M, 2007, FOLIA HISTOCHEM CYTO, V45, P291; Giorgi F, 2005, REPRO BIOL, V12, P355; Giorgi F, 2005, REPRO BIOL, V12, P33; Gomes FM, 2010, J CELL PHYSIOL, V222, P606, DOI 10.1002/jcp.21975; Goncu E, 2008, AUTOPHAGY, V4, P1069, DOI 10.4161/auto.6953; Guzmin-Bracho C, 2001, TRENDS PARASITOL, V17, P372, DOI 10.1016/S1471-4922(01)01952-3; Hermanson G. T., 1996, BIOCONJUGATE TECHNIQ, P456; HUEBNER E, 1972, J MORPHOL, V138, P1, DOI 10.1002/jmor.1051380102; IZUMI S, 1994, J INSECT PHYSIOL, V40, P735, DOI 10.1016/0022-1910(94)90001-9; Kenworthy AK, 2001, METHODS, V24, P289, DOI 10.1006/meth.2001.1189; Kotaki T, 2003, J INSECT PHYSIOL, V49, P105, DOI 10.1016/S0022-1910(02)00254-8; Leyria J, 2014, ARCH INSECT BIOCHEM, V87, P148, DOI 10.1002/arch.21186; Malagoli D, 2010, AUTOPHAGY, V6, P575, DOI 10.4161/auto.6.5.11962; Medeiros MN, 2011, J INSECT PHYSIOL, V57, P945, DOI 10.1016/j.jinsphys.2011.04.010; Moore PJ, 2011, ECOL EVOL, V1, P37, DOI 10.1002/ece3.4; NARISE S, 1984, INSECT BIOCHEM, V14, P473, DOI 10.1016/0020-1790(84)90104-5; NORIEGA FG, 1992, J MED ENTOMOL, V29, P273, DOI 10.1093/jmedent/29.2.273; Nunez J.A., 1987, P31; NUSSENZVEIG RH, 1992, ARCH INSECT BIOCHEM, V21, P253, DOI 10.1002/arch.940210402; Oliveira DMP, 2006, ARCH INSECT BIOCHEM, V63, P24, DOI 10.1002/arch.20139; Oliveira DMP, 2008, J INSECT PHYSIOL, V54, P883, DOI 10.1016/j.jinsphys.2008.04.005; Oliveira DMP, 2013, J INSECT PHYSIOL, V59, P1242, DOI 10.1016/j.jinsphys.2013.09.008; Maria SSP, 2010, J SELVA ANDIN RES SO, V1, P57; Peuhu E, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-521; PURCELL JP, 1988, ARCH INSECT BIOCHEM, V9, P237, DOI 10.1002/arch.940090307; RAIKHEL AS, 1992, ANNU REV ENTOMOL, V37, P217, DOI 10.1146/annurev.en.37.010192.001245; RIBOLLA PEM, 1993, INSECT BIOCHEM MOLEC, V23, P217, DOI 10.1016/0965-1748(93)90002-A; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; Silveira AB, 2006, INSECT BIOCHEM MOLEC, V36, P200, DOI 10.1016/j.ibmb.2006.01.015; Snigirevskaya ES, 1997, CELL TISSUE RES, V290, P129, DOI 10.1007/s004410050915; Swevers L., 2005, P87; Tonks NK, 2006, NAT REV MOL CELL BIO, V7, P833, DOI 10.1038/nrm2039; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Tufail M, 2008, J INSECT PHYSIOL, V54, P1447, DOI 10.1016/j.jinsphys.2008.08.007; Uchida K, 2001, DEV BIOL, V237, P68, DOI 10.1006/dbio.2001.0357; WHO, 2014, CHAG DIS AM TRYP; Wimmer M, 1998, EXP PARASITOL, V88, P139, DOI 10.1006/expr.1998.4235; Wittlin S, 1999, EUR J BIOCHEM, V265, P384, DOI 10.1046/j.1432-1327.1999.00747.x; Yamaguchi S, 2005, J BIOCHEM, V138, P721, DOI 10.1093/jb/mvi176; Yamahama Y, 2003, J INSECT PHYSIOL, V49, P131, DOI 10.1016/S0022-1910(02)00257-3; Yamahama Y, 2005, REPRO BIOL, V12, P315; YAMAMOTO Y, 1993, COMP BIOCHEM PHYS B, V106, P35, DOI 10.1016/0305-0491(93)90004-O; Yamamoto Y, 2000, J INSECT PHYSIOL, V46, P783, DOI 10.1016/S0022-1910(99)00167-5	63	18	19	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2015	10	6							e0130144	10.1371/journal.pone.0130144	http://dx.doi.org/10.1371/journal.pone.0130144			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL3FE	26091289	Green Published, Green Submitted, gold			2022-12-26	WOS:000356835000089
J	Suenaga, T; Matsumoto, M; Arisawa, F; Kohyama, M; Hirayasu, K; Mori, Y; Arase, H				Suenaga, Tadahiro; Matsumoto, Maki; Arisawa, Fuminori; Kohyama, Masako; Hirayasu, Kouyuki; Mori, Yasuko; Arase, Hisashi			Sialic Acids on Varicella-Zoster Virus Glycoprotein B Are Required for Cell-Cell Fusion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MYELIN-ASSOCIATED GLYCOPROTEIN; HERPES-SIMPLEX; CRYSTALLOGRAPHIC ANALYSIS; MEMBRANE-FUSION; RECEPTOR; GB; COMPLEX; SIALOADHESIN; SIGLEC-7; GLYCAN	Varicella-zoster virus (VZV) is a member of the human Herpesvirus family that causes varicella (chicken pox) and zoster (shingles). VZV latently infects sensory ganglia and is also responsible for encephalomyelitis. Myelin-associated glycoprotein (MAG), a member of the sialic acid (SA)-binding immunoglobulin-like lectin family, is mainly expressed in neural tissues. VZV glycoprotein B (gB) associates with MAG and mediates membrane fusion during VZV entry into host cells. The SA requirements of MAG when associating with its ligands vary depending on the specific ligand, but it is unclear whether the SAs on gB are involved in the association with MAG. In this study, we found that SAs on gB are essential for the association with MAG as well as for membrane fusion during VZV infection. MAG with a point mutation in the SA-binding site did not bind to gB and did not mediate cell-cell fusion or VZV entry. Cell-cell fusion and VZV entry mediated by the gB-MAG interaction were blocked by sialidase treatment. N-glycosylation or O-glycosylation inhibitors also inhibited the fusion and entry mediated by gB-MAG interaction. Furthermore, gB with mutations in N-glycosylation sites, i.e. asparagine residues 557 and 686, did not associate with MAG, and the cell-cell fusion efficiency was low. Fusion between the viral envelope and cellular membrane is essential for host cell entry by herpesviruses. Therefore, these results suggest that SAs on gB play important roles in MAG-mediated VZV infection.	[Suenaga, Tadahiro; Matsumoto, Maki; Arisawa, Fuminori; Kohyama, Masako; Hirayasu, Kouyuki; Arase, Hisashi] Osaka Univ, Dept Immunochem, Microbial Dis Res Inst, Suita, Osaka 5650871, Japan; [Suenaga, Tadahiro; Matsumoto, Maki; Kohyama, Masako; Hirayasu, Kouyuki; Arase, Hisashi] Osaka Univ, WPI Immunol Frontier Res Ctr, Lab Immunochem, Suita, Osaka 5650871, Japan; [Mori, Yasuko] Kobe Univ, Grad Sch Med, Div Clin Virol, Ctr Infect Dis, Kobe, Hyogo 6500017, Japan	Osaka University; Osaka University; Kobe University	Mori, Y (corresponding author), Osaka Univ, Dept Immunochem, Microbial Dis Res Inst, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	tsue@biken.osaka-u.ac.jp; arase@biken.osaka-u.ac.jp	Arase, Hisashi/C-8442-2009	Arase, Hisashi/0000-0002-1153-3166	JSPS KAKENHI Japan [15H02545, 24115005, 25460565]; Takeda Science Foundation; Terumo Life Science Foundation; Uehara Memorial Foundation; Tokyo Biochemical Research Foundation; Naito Foundation	JSPS KAKENHI Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Terumo Life Science Foundation(Terumo Life Science Foundation); Uehara Memorial Foundation(Uehara Memorial Foundation); Tokyo Biochemical Research Foundation; Naito Foundation(Naito Memorial Foundation)	This research was supported by JSPS KAKENHI grants 15H02545, 24115005, and 25460565 Japan (to T. S. and H. A.) and partly by grants from the Takeda Science Foundation (to T. S.) and from the Terumo Life Science Foundation, the Uehara Memorial Foundation, the Tokyo Biochemical Research Foundation, and the Naito Foundation (to H. A.). The authors declare that they have no conflicts of interest with the contents of this article.	Alphey MS, 2003, J BIOL CHEM, V278, P3372, DOI 10.1074/jbc.M210602200; An HJ, 2009, CURR OPIN CHEM BIOL, V13, P421, DOI 10.1016/j.cbpa.2009.07.022; [Anonymous], 2009, ESSENTIALS GLYCOBIOL; Arvin AM, 2001, CURR OPIN MICROBIOL, V4, P442, DOI 10.1016/S1369-5274(00)00233-2; Attrill H, 2006, J BIOL CHEM, V281, P32774, DOI 10.1074/jbc.M601714200; Attrill H, 2006, BIOCHEM J, V397, P271, DOI 10.1042/BJ20060103; Atwal JK, 2008, SCIENCE, V322, P967, DOI 10.1126/science.1161151; Berarducci B, 2009, J VIROL, V83, P228, DOI 10.1128/JVI.00913-08; Bukrinsky JT, 2004, BBA-PROTEINS PROTEOM, V1702, P173, DOI 10.1016/j.bbapap.2004.08.015; Cohen J.I., 2006, FIELDS VIROL, V2, P2773; Connolly SA, 2011, NAT REV MICROBIOL, V9, P369, DOI 10.1038/nrmicro2548; Crocker PR, 2007, NAT REV IMMUNOL, V7, P255, DOI 10.1038/nri2056; Dimasi N, 2003, ACTA CRYSTALLOGR D, V59, P1856, DOI 10.1107/S0907444903018146; Domeniconi M, 2002, NEURON, V35, P283, DOI 10.1016/S0896-6273(02)00770-5; Gerken TA, 2012, METHODS MOL BIOL, V842, P81, DOI 10.1007/978-1-61779-513-8_5; Goh ELK, 2008, MOL BRAIN, V1, DOI 10.1186/1756-6606-1-10; Haan KM, 2001, VIROLOGY, V290, P106, DOI 10.1006/viro.2001.1141; KELM S, 1994, CURR BIOL, V4, P965, DOI 10.1016/S0960-9822(00)00220-7; Kitamura T, 2003, EXP HEMATOL, V31, P1007, DOI 10.1016/j.exphem.2003.07.005; Kuroki K, 2014, P NATL ACAD SCI USA, V111, P8877, DOI 10.1073/pnas.1324105111; Laughlin ST, 2007, NAT PROTOC, V2, P2930, DOI 10.1038/nprot.2007.422; LITWIN V, 1992, J VIROL, V66, P3643, DOI 10.1128/JVI.66.6.3643-3651.1992; Liu BP, 2002, SCIENCE, V297, P1190, DOI 10.1126/science.1073031; Marsh M, 2006, CELL, V124, P729, DOI 10.1016/j.cell.2006.02.007; MATSUI S, 1994, VIROLOGY, V198, P50, DOI 10.1006/viro.1994.1007; MONTALVO EA, 1985, J VIROL, V53, P761, DOI 10.1128/JVI.53.3.761-770.1985; MONTALVO EA, 1987, J VIROL, V61, P2877, DOI 10.1128/JVI.61.9.2877-2884.1987; Nosaka T, 1999, EMBO J, V18, P4754, DOI 10.1093/emboj/18.17.4754; Okuma K, 1999, VIROLOGY, V254, P235, DOI 10.1006/viro.1998.9530; Oliver SL, 2009, J VIROL, V83, P7495, DOI 10.1128/JVI.00400-09; Paulson JC, 2012, ANN NY ACAD SCI, V1253, P37, DOI 10.1111/j.1749-6632.2011.06362.x; Pertel PE, 2002, J VIROL, V76, P4390, DOI 10.1128/JVI.76.9.4390-4400.2002; Prescher JA, 2006, CELL, V126, P851, DOI 10.1016/j.cell.2006.08.017; Quarles RH, 2009, NEUROCHEM RES, V34, P79, DOI 10.1007/s11064-008-9668-y; Sareneva T, 1996, EUR J BIOCHEM, V242, P191, DOI 10.1111/j.1432-1033.1996.0191r.x; Schnaar RL, 2010, FEBS LETT, V584, P1741, DOI 10.1016/j.febslet.2009.10.011; Sedy JR, 2008, NAT REV IMMUNOL, V8, P861, DOI 10.1038/nri2434; Shiraki K, 1997, ARCH VIROL, V142, P2295, DOI 10.1007/s007050050243; Shiratori I, 2005, J IMMUNOL, V175, P4441, DOI 10.4049/jimmunol.175.7.4441; Smith AE, 2004, SCIENCE, V304, P237, DOI 10.1126/science.1094823; Steiner I, 2007, LANCET NEUROL, V6, P1015, DOI 10.1016/S1474-4422(07)70267-3; Steven AC, 2006, SCIENCE, V313, P177, DOI 10.1126/science.1129761; Strenge K, 1999, FEBS LETT, V444, P59, DOI 10.1016/S0014-5793(99)00029-0; Strenge K, 1998, EUR J BIOCHEM, V258, P677, DOI 10.1046/j.1432-1327.1998.2580677.x; Strenge K, 2001, FEBS LETT, V499, P262, DOI 10.1016/S0014-5793(01)02566-2; Suenaga T, 2010, P NATL ACAD SCI USA, V107, P866, DOI 10.1073/pnas.0913351107; SUTTON CW, 1994, ANAL BIOCHEM, V218, P34, DOI 10.1006/abio.1994.1138; Tanaka Y, 2013, J VIROL, V87, P10900, DOI 10.1128/JVI.01427-13; Ten Hagen KG, 2003, GLYCOBIOLOGY, V13, p1R, DOI 10.1093/glycob/cwg007; Teuton JR, 2007, J VIROL, V81, P3731, DOI 10.1128/JVI.02250-06; Turner A, 1998, J VIROL, V72, P873, DOI 10.1128/JVI.72.1.873-875.1998; Vanarsdall AL, 2008, J VIROL, V82, P11837, DOI 10.1128/JVI.01623-08; Varki A, 2006, GLYCOBIOLOGY, V16, p1R, DOI 10.1093/glycob/cwj008; Venkatesh K, 2005, J NEUROSCI, V25, P808, DOI 10.1523/JNEUROSCI.4464-04.2005; Vigerust DJ, 2007, TRENDS MICROBIOL, V15, P211, DOI 10.1016/j.tim.2007.03.003; Vinson M, 2001, J BIOL CHEM, V276, P20280, DOI 10.1074/jbc.M100345200; Vyas AA, 2002, P NATL ACAD SCI USA, V99, P8412, DOI 10.1073/pnas.072211699; Wang J, 2009, J VIROL, V83, P13042, DOI 10.1128/JVI.00792-09; Worter V, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005218; Zaccai NR, 2007, J MOL BIOL, V365, P1469, DOI 10.1016/j.jmb.2006.10.084; Zaccai NR, 2003, STRUCTURE, V11, P557, DOI 10.1016/S0969-2126(03)00073-X; Zerboni L, 2000, VIROLOGY, V270, P278, DOI 10.1006/viro.2000.0304; Zerboni L, 2014, NAT REV MICROBIOL, V12, P197, DOI 10.1038/nrmicro3215; Zhuravleva MA, 2008, J MOL BIOL, V375, P437, DOI 10.1016/j.jmb.2007.10.009	64	19	22	2	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 7	2015	290	32					19833	19843		10.1074/jbc.M114.635508	http://dx.doi.org/10.1074/jbc.M114.635508			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CO7TL	26105052	Green Published, hybrid			2022-12-26	WOS:000359364600039
J	Chen, S; Ilany, A; White, BJ; Sanderson, MW; Lanzas, C				Chen, Shi; Ilany, Amiyaal; White, Brad J.; Sanderson, Michael W.; Lanzas, Cristina			Spatial-Temporal Dynamics of High-Resolution Animal Networks: What Can We Learn from Domestic Animals?	PLOS ONE			English	Article							SOCIAL NETWORKS; MODELS; SPACE; TIME	Animal social network is the key to understand many ecological and epidemiological processes. We used real-time location system(RTLS) to accurately track cattle position, analyze their proximity networks, and tested the hypothesis of temporal stationarity and spatial homogeneity in these networks during different daily time periods and in different areas of the pen. The network structure was analyzed using global network characteristics (network density), subgroup clustering (modularity), triadic property (transitivity), and dyadic interactions (correlation coefficient from a quadratic assignment procedure) at hourly level. We demonstrated substantial spatial-temporal heterogeneity in these networks and potential link between indirect animal-environment contact and direct animal-animal contact. But such heterogeneity diminished if data were collected at lower spatial (aggregated at entire pen level) or temporal (aggregated at daily level) resolution. The network structure (described by the characteristics such as density, modularity, transitivity, etc.) also changed substantially at different time and locations. There were certain time (feeding) and location (hay) that the proximity network structures were more consistent based on the dyadic interaction analysis. These results reveal new insights for animal network structure and spatial-temporal dynamics, provide more accurate descriptions of animal social networks, and allow more accurate modeling of multiple (both direct and indirect) disease transmission pathways.	[Chen, Shi; Lanzas, Cristina] N Carolina State Univ, Dept Populat Hlth & Pathobiol, Raleigh, NC 27607 USA; [Ilany, Amiyaal] Univ Penn, Dept Biol, Philadelphia, PA 19104 USA; [White, Brad J.; Sanderson, Michael W.] Kansas State Univ, Coll Vet Med, Manhattan, KS 66506 USA	University of North Carolina; North Carolina State University; University of Pennsylvania; Kansas State University	Chen, S (corresponding author), N Carolina State Univ, Dept Populat Hlth & Pathobiol, Raleigh, NC 27607 USA.	schen31@ncsu.edu		Ilany, Amiyaal/0000-0001-8089-569X; Lanzas, Cristina/0000-0002-4039-0336	U.S. National Science Foundation; U.S. Department of Homeland Security; U.S. Department of Agriculture through NSF [EF-0832858]; University of Tennessee, Knoxville; Div Of Biological Infrastructure [1300426] Funding Source: National Science Foundation	U.S. National Science Foundation(National Science Foundation (NSF)); U.S. Department of Homeland Security(United States Department of Homeland Security (DHS)); U.S. Department of Agriculture through NSF(National Science Foundation (NSF)); University of Tennessee, Knoxville; Div Of Biological Infrastructure(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was conducted with partial funding provided at NIMBioS, an institute sponsored by the U.S. National Science Foundation, the U.S. Department of Homeland Security, and the U.S. Department of Agriculture through NSF Award # EF-0832858, with additional support from the University of Tennessee, Knoxville. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansmann IC, 2012, ANIM BEHAV, V84, P575, DOI 10.1016/j.anbehav.2012.06.009; Bansal S, 2007, J R SOC INTERFACE, V4, P879, DOI 10.1098/rsif.2007.1100; Blonder B, 2012, METHODS ECOL EVOL, V3, P958, DOI 10.1111/j.2041-210X.2012.00236.x; Blonder B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020298; Blumstein DT, 2009, P ROY SOC B-BIOL SCI, V276, P3007, DOI 10.1098/rspb.2009.0703; Cantor M, 2012, ANIM BEHAV, V84, P641, DOI 10.1016/j.anbehav.2012.06.019; Chen S, 2014, SCI REP-UK, V4, DOI 10.1038/srep04472; Chen S, 2013, SCI REP-UK, V3, DOI 10.1038/srep03112; Cortez MH, 2013, AM NAT, V181, pE43, DOI 10.1086/668826; Croft DP, 2008, EXPLORING ANIMAL SOCIAL NETWORKS, P1; Croft DP, 2004, P ROY SOC B-BIOL SCI, V271, pS516, DOI 10.1098/rsbl.2004.0206; de Silva Shermin, 2011, BMC Ecology, V11, P17, DOI 10.1186/1472-6785-11-17; Faust K, 2002, SOCIOL METHODOL, V32, P267, DOI 10.1111/1467-9531.00118; Faust K, 2007, SOCIOL METHODOL, V37, P209, DOI 10.1111/j.1467-9531.2007.00179.x; Fefferman NH, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.031919; FIENBERG SE, 1981, J AM STAT ASSOC, V76, P54; Flack JC, 2006, NATURE, V439, P426, DOI 10.1038/nature04326; Fortunato S, 2010, PHYS REP, V486, P75, DOI 10.1016/j.physrep.2009.11.002; Gygax L, 2010, ETHOLOGY, V116, P10, DOI 10.1111/j.1439-0310.2009.01708.x; Henzi SP, 2009, BEHAV ECOL SOCIOBIOL, V63, P1015, DOI 10.1007/s00265-009-0720-y; Holekamp KE, 2012, MOL ECOL, V21, P613, DOI 10.1111/j.1365-294X.2011.05240.x; Holme P, 2013, TEMPORAL NETWORKS; Holme P, 2012, PHYS REP, V519, P97, DOI 10.1016/j.physrep.2012.03.001; Hunter DR, 2008, J AM STAT ASSOC, V103, P248, DOI 10.1198/016214507000000446; Ilany A, 2013, ANIM BEHAV, V85, P1397, DOI 10.1016/j.anbehav.2013.03.032; KRACKHARDT D, 1988, SOC NETWORKS, V10, P359, DOI 10.1016/0378-8733(88)90004-4; Krause J, 2013, TRENDS ECOL EVOL, V28, P541, DOI 10.1016/j.tree.2013.06.002; Kurvers RHJM, 2014, TRENDS ECOL EVOL, V29, P326, DOI 10.1016/j.tree.2014.04.002; McDonald DB, 2007, P NATL ACAD SCI USA, V104, P10910, DOI 10.1073/pnas.0701159104; McDonald DB, 2009, BEHAV ECOL SOCIOBIOL, V63, P1029, DOI 10.1007/s00265-009-0722-9; Newman MEJ, 2006, P NATL ACAD SCI USA, V103, P8577, DOI 10.1073/pnas.0601602103; Newman MEJ, 2004, PHYS REV E, V70, DOI [10.1103/PhysRevE.70.056131, 10.1103/PhysRevE.69.026113]; Opsahl T, 2009, SOC NETWORKS, V31, P155, DOI 10.1016/j.socnet.2009.02.002; Peletier MA, 2003, J THEOR BIOL, V225, P477, DOI 10.1016/S0022-5193(03)00289-3; Peterson EE, 2013, ECOL LETT, V16, P707, DOI 10.1111/ele.12084; Philips C, 2002, CATTLE BEHAV WELFARE; Pinter-Wollman N, 2014, BEHAV ECOL, V25, P242, DOI 10.1093/beheco/art047; Pinter-Wollman N, 2011, J R SOC INTERFACE, V8, P1562, DOI 10.1098/rsif.2011.0059; Robins G, 2007, SOC NETWORKS, V29, P173, DOI 10.1016/j.socnet.2006.08.002; Wilson ADM, 2014, BEHAV ECOL SOCIOBIOL, V68, P915, DOI 10.1007/s00265-014-1704-0	40	15	15	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2015	10	6							e0129253	10.1371/journal.pone.0129253	http://dx.doi.org/10.1371/journal.pone.0129253			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CL4OM	26107251	Green Published, gold, Green Submitted			2022-12-26	WOS:000356932500044
J	Eyal, G; Wiedenmann, J; Grinblat, M; D'Angelo, C; Kramarsky-Winter, E; Treibitz, T; Ben-Zvi, O; Shaked, Y; Smith, TB; Harii, S; Denis, V; Noyes, T; Tamir, R; Loya, Y				Eyal, Gal; Wiedenmann, Joerg; Grinblat, Mila; D'Angelo, Cecilia; Kramarsky-Winter, Esti; Treibitz, Tali; Ben-Zvi, Or; Shaked, Yonathan; Smith, Tyler B.; Harii, Saki; Denis, Vianney; Noyes, Tim; Tamir, Raz; Loya, Yossi			Spectral Diversity and Regulation of Coral Fluorescence in a Mesophotic Reef Habitat in the Red Sea	PLOS ONE			English	Article							STYLOPHORA-PISTILLATA; BUILDING CORALS; MONTASTRAEA-CAVERNOSA; CENSUS TECHNIQUES; PROTEINS; LIGHT; GREEN; MECHANISMS; PIGMENTS; EOSFP	The phenomenon of coral fluorescence in mesophotic reefs, although well described for shallow waters, remains largely unstudied. We found that representatives of many scleractinian species are brightly fluorescent at depths of 50-60 m at the Interuniversity Institute for Marine Sciences (IUI) reef in Eilat, Israel. Some of these fluorescent species have distribution maxima at mesophotic depths (40-100 m). Several individuals from these depths displayed yellow or orange-red fluorescence, the latter being essentially absent in corals from the shallowest parts of this reef. We demonstrate experimentally that in some cases the production of fluorescent pigments is independent of the exposure to light; while in others, the fluorescence signature is altered or lost when the animals are kept in darkness. Furthermore, we show that green-to-red photoconversion of fluorescent pigments mediated by short-wavelength light can occur also at depths where ultraviolet wavelengths are absent from the underwater light field. Intraspecific colour polymorphisms regarding the colour of the tissue fluorescence, common among shallow water corals, were also observed for mesophotic species. Our results suggest that fluorescent pigments in mesophotic reefs fulfil a distinct biological function and offer promising application potential for coral-reef monitoring and biomedical imaging.	[Eyal, Gal; Grinblat, Mila; Ben-Zvi, Or; Loya, Yossi] Tel Aviv Univ, Dept Zool, IL-69978 Tel Aviv, Israel; [Eyal, Gal; Shaked, Yonathan; Tamir, Raz] Interuniv Inst Marine Sci Eilat, Elat, Israel; [Wiedenmann, Joerg; D'Angelo, Cecilia] Univ Southampton, Coral Reef Lab, NOCS, Southampton, Hants, England; [Wiedenmann, Joerg] Univ Southampton, Inst Life Sci IFLS, Southampton, Hants, England; [Kramarsky-Winter, Esti] Ben Gurion Univ Negev, Dept Biotechnol Engn, IL-84105 Beer Sheva, Israel; [Treibitz, Tali] Univ Haifa, Charney Sch Marine Sci, IL-31999 Haifa, Israel; [Smith, Tyler B.] Univ Virgin Isl, Ctr Marine & Environm Studies, St Thomas, VI USA; [Harii, Saki] Univ Ryukyus, Motobu, Okinawa, Japan; [Denis, Vianney] Acad Sinica, Biodivers Res Ctr, Taipei 115, Taiwan; [Noyes, Tim] Bermuda Inst Ocean Sci, St Georges, Bermuda; [Tamir, Raz] Bar Ilan Univ, Fac Life Sci, Ramat Gan, Israel	Tel Aviv University; NERC National Oceanography Centre; University of Southampton; University of Southampton; Ben Gurion University; University of Haifa; University of the Virgin Islands; University of the Ryukyus; Academia Sinica - Taiwan; Bermuda Institute of Ocean Sciences; Bar Ilan University	Wiedenmann, J (corresponding author), Univ Southampton, Coral Reef Lab, NOCS, Southampton, Hants, England.	joerg.wiedenmann@soton.ac.uk	Harii, Saki/AHC-2263-2022; Eyal, Gal/P-7884-2019; Loya, Joseph/AAJ-9014-2020; Denis, Vianney/E-6868-2013; Loya, Yossi/J-3039-2012	Harii, Saki/0000-0003-0440-7169; Eyal, Gal/0000-0002-3028-8653; Denis, Vianney/0000-0002-0914-5586; Loya, Yossi/0000-0001-6870-9444; Treibitz, Tali/0000-0002-3078-282X; Ben-Zvi, Or/0000-0003-3708-567X	Israel Taxonomy Initiative (ITI); Sciences-based Management (SBM) doctoral Fellowships; Israel Science Foundation (ISF) [341/12]; USAID/MERC [M32-037]; Israel Ministry of Environmental Protection (MoEP); Israel Nature and Parks Authority (INPA); Natural Environment Research Council [NE/I01683X/1, NE/I012648/1]; Deutsche Forschungsgemeinschaft (DFG) [Wi1990/2-1]; ASSEMBLE; European Research Council under the European Union [311179]; Tropical Marine Centre (TMC) London; NERC [NE/H012303/1, NE/K00641X/1, NE/I01683X/1] Funding Source: UKRI; Natural Environment Research Council [NE/K00641X/1, NE/H012303/1] Funding Source: researchfish	Israel Taxonomy Initiative (ITI); Sciences-based Management (SBM) doctoral Fellowships; Israel Science Foundation (ISF)(Israel Science Foundation); USAID/MERC(United States Agency for International Development (USAID)); Israel Ministry of Environmental Protection (MoEP); Israel Nature and Parks Authority (INPA); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); ASSEMBLE; European Research Council under the European Union(European Research Council (ERC)); Tropical Marine Centre (TMC) London; NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	GE was supported by the Israel Taxonomy Initiative (ITI) and Sciences-based Management (SBM) doctoral Fellowships (http://taxonomy.tau.ac.il/en/). YL acknowledges funding by the Israel Science Foundation (ISF) (http://www.isf.org.il) grant No. 341/12, USAID/MERC grant No. M32-037, The Israel Ministry of Environmental Protection (MoEP) (http://www.sviva.gov.il/english/pages/homepage.aspx) and the Israel Nature and Parks Authority (INPA) (http://www.parks.org.il/parks/Pages/WhoWeAre.aspx). JW/CDA acknowledge funding from Natural Environment Research Council (http://www.nerc.ac.uk/) (NE/I01683X/1, NE/I01683X/1 & NE/I012648/1), Deutsche Forschungsgemeinschaft (DFG) (http://www.dfg.de/en/) (Wi1990/2-1), ASSEMBLE and the European Research Council (http://erc.europa.eu/) under the European Union's Seventh Framework Programme (ERC Grant Agreement no. 311179) and support from Tropical Marine Centre (TMC) London (http://www.tropicalmarinecentre.co.uk/en/index.aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alieva NO, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002680; Baird AH, 2006, CORAL REEFS, V25, P73, DOI 10.1007/s00338-005-0072-7; Ben-Zvi O, 2014, HYDROBIOLOGIA, P1; Betzig E, 2006, SCIENCE, V313, P1642, DOI 10.1126/science.1127344; Chudakov DM, 2010, PHYSIOL REV, V90, P1103, DOI 10.1152/physrev.00038.2009; D'Angelo C, 2012, CORAL REEFS, V31, P1045, DOI 10.1007/s00338-012-0926-8; D'Angelo C, 2008, MAR ECOL PROG SER, V364, P97, DOI 10.3354/meps07588; D'angelo C, 2012, J MAR BIOL ASSOC UK, V92, P769, DOI 10.1017/S0025315411001883; Day RN, 2009, CHEM SOC REV, V38, P2887, DOI 10.1039/b901966a; DUSTAN P, 1982, MAR BIOL, V68, P253, DOI 10.1007/BF00409592; EDMUNDS PJ, 1986, MAR BIOL, V92, P339, DOI 10.1007/BF00392674; Einbinder S, 2009, MAR ECOL PROG SER, V381, P167, DOI 10.3354/meps07908; Falkowski P.G., 1990, P89; FALKOWSKI PG, 1981, NATURE, V289, P172, DOI 10.1038/289172a0; Field SF, 2006, J MOL EVOL, V62, P332, DOI 10.1007/s00239-005-0129-9; FRICKE H W, 1983, Marine Ecology, V4, P163, DOI 10.1111/j.1439-0485.1983.tb00294.x; Gittins JR, 2015, MOL ECOL, V24, P453, DOI 10.1111/mec.13041; Gruber DF, 2008, BIOL BULL-US, V215, P143, DOI 10.2307/25470695; Hedley JD, 2002, ADV MAR BIOL, V43, P277, DOI 10.1016/S0065-2881(02)43006-4; Hoeksema BW, 1989, ZOOLOGISCHE VERHANDE, V254, P1; Hume BCC, 2015, SCI REP-UK, V5, DOI 10.1038/srep08562; Kahng SE, 2014, CURR OPIN ENV SUST, V7, P72, DOI 10.1016/j.cosust.2013.11.019; Kawaguti S., 1969, Micronesica, V5, P313; Kawaguti S, 1944, PALAO TROP BIOL STN, V2; Kelmanson IV, 2003, MOL BIOL EVOL, V20, P1125, DOI 10.1093/molbev/msg130; Kuguru B, 2008, MAR ECOL PROG SER, V369, P115, DOI 10.3354/meps07651; Kuguru B, 2007, MAR BIOL, V151, P1287, DOI 10.1007/s00227-006-0589-5; Lesser MP, 2010, ECOLOGY, V91, P990, DOI 10.1890/09-0313.1; Leutenegger A, 2007, FEBS J, V274, P2496, DOI 10.1111/j.1742-4658.2007.05785.x; LOYA Y, 1972, MAR BIOL, V13, P100, DOI 10.1007/BF00366561; Mass T, 2010, J EXP BIOL, V213, P4084, DOI 10.1242/jeb.039891; Mass T, 2007, MAR ECOL PROG SER, V334, P93, DOI 10.3354/meps334093; Matz MV, 2006, PHOTOCHEM PHOTOBIOL, V82, P345, DOI 10.1562/2005-08-18-RA-653; Mazel CH, 2005, LIMNOL OCEANOGR-METH, V3, P499, DOI 10.4319/lom.2005.3.499; Mazel CH, 1997, OPT ENG, V36, P2612, DOI 10.1117/1.601486; Meadows MG, 2014, P ROY SOC LOND B BIO, P281, DOI DOI 10.1098/RSPB.2014.1211; Muscatine L., 1990, ECOSYSTEMS WORLD 25, P5; Nienhaus GU, 2009, CHEMPHYSCHEM, V10, P1369, DOI 10.1002/cphc.200800839; Nienhaus K, 2005, P NATL ACAD SCI USA, V102, P9156, DOI 10.1073/pnas.0501874102; Oswald F, 2007, FEBS J, V274, P1102, DOI 10.1111/j.1742-4658.2007.05661.x; Piniak GA, 2005, CORAL REEFS, V24, P496, DOI 10.1007/s00338-005-0495-1; Pozzi EA, 2012, J PHYS CHEM B, V116, P10311, DOI 10.1021/jp306093h; Pyle RL, 2000, MAR TECHNOL SOC J, V34, P82, DOI 10.4031/MTSJ.34.4.11; Roth MS, 2015, MAR ECOL PROG SER, V521, P63, DOI 10.3354/meps11108; Roth MS, 2013, SCI REP-UK, V3, DOI 10.1038/srep01421; Salih A, 2000, NATURE, V408, P850, DOI 10.1038/35048564; Salih A, 2006, ROLE HOST BASED COLO, P746; Scheer G, 1983, ZOOLOGICA, V131, P1; SCHLICHTER D, 1994, OECOLOGIA, V99, P124, DOI 10.1007/BF00317092; SCHLICHTER D, 1991, HYDROBIOLOGIA, V216, P389, DOI 10.1007/BF00026491; SCHLICHTER D, 1986, MAR BIOL, V91, P403, DOI 10.1007/BF00428634; Schnitzler CE, 2008, MAR BIOTECHNOL, V10, P328, DOI 10.1007/s10126-007-9072-7; Smith EG, 2013, CORAL REEFS, V32, P463, DOI 10.1007/s00338-012-0994-9; Smith EG, 2012, HDB MARINE NATURAL P, P1231; Smith-Keune C, 2007, MARINE BIOTECHNOLOGY, P1; Treibitz T, 2015, SCI REP-UK, V5, DOI 10.1038/srep07694; Verkhusha VV, 2003, BBA-GEN SUBJECTS, V1622, P192, DOI 10.1016/S0304-4165(03)00140-5; VERON J E N, 1990, Galaxea, V9, P95; Veron J.E.N., 2000, CORALS WORLD, V1-3; Vogt A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003766; Wacker SA, 2007, DEV DYNAM, V236, P473, DOI 10.1002/dvdy.20955; Wallace C.C., 1999, STAGHORN CORALS WORL, DOI 10.1071/9780643101388; Wiedenmann J, 2004, P NATL ACAD SCI USA, V101, P15905, DOI 10.1073/pnas.0403668101; Wiedenmann J, 2012, FLUORESCENT PROTEINS, P3; Wiedenmann J, 1999, VERHANDLUNGEN GESELL, V29, P497; Wiedenmann J, 2006, EXPERT REV PROTEOMIC, V3, P361, DOI 10.1586/14789450.3.3.361; Wiedenmann J, 2009, IUBMB LIFE, V61, P1029, DOI 10.1002/iub.256; Zawada DG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084570; Zawada DG, 2003, LIMNOL OCEANOGR, V48, P412, DOI 10.4319/lo.2003.48.1_part_2.0412	69	48	48	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2015	10	6							e0128697	10.1371/journal.pone.0128697	http://dx.doi.org/10.1371/journal.pone.0128697			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4OM	26107282	gold, Green Accepted, Green Published, Green Submitted			2022-12-26	WOS:000356932500024
J	Kasztelan-Szczerbinska, B; Surdacka, A; Celinski, K; Rolinski, J; Zwolak, A; Miacz, S; Szczerbinski, M				Kasztelan-Szczerbinska, Beata; Surdacka, Agata; Celinski, Krzysztof; Rolinski, Jacek; Zwolak, Agnieszka; Miacz, Slawomir; Szczerbinski, Mariusz			Prognostic Significance of the Systemic Inflammatory and Immune Balance in Alcoholic Liver Disease with a Focus on Gender-Related Differences	PLOS ONE			English	Article							REGULATORY T-CELLS; INNATE IMMUNITY; NECROSIS-FACTOR; TH17; MORTALITY; SEVERITY; DRINKING; DIFFERENTIATION; SUSCEPTIBILITY; INTERLEUKIN-6	Objectives Mechanisms of immune regulation in alcoholic liver disease (ALD) are still unclear. The aim of our study was to determine an impact of Th17 / regulatory T (Treg) cells balance and its corresponding cytokine profile on the ALD outcome. Possible gender-related differences in the alcohol-induced inflammatory response were also assessed. Materials and Methods 147 patients with ALD were prospectively recruited, assigned to subgroups based on their gender, severity of liver dysfunction and presence of ALD complications at admission, and followed for 90 days. Peripheral blood frequencies of Th17 and Treg cells together with IL-1beta, IL-6, IL-17A, IL-23, and TGF-beta1 levels were investigated. Flow cytometry was used to identify T cell phenotype and immunoenzymatic ELISAs for the corresponding cytokine concentrations assessment. Multivariable logistic regression was applied in order to select independent predictors of advanced liver dysfunction and the disease complications. Results IL-17A, IL-1beta, IL-6 levels were significantly increased, while TGF-beta1 decreased in ALD patients. The imbalance with significantly higher Th17 and lower Treg frequencies was observed in non-survivors. IL-6 and TGF-beta1 levels differed in relation to patient gender in ALD group. Concentrations of IL-6 were associated with the severity of liver dysfunction, development of ALD complications, and turned out to be the only independent immune predictor of 90-day survival in the study cohort. Conclusions We conclude that IL-6 revealed the highest diagnostic and prognostic potential among studied biomarkers and was related to the fatal ALD course. Gender-related differences in immune regulation might influence the susceptibility to alcohol-associated liver injury.	[Kasztelan-Szczerbinska, Beata; Celinski, Krzysztof; Szczerbinski, Mariusz] Med Univ Lublin, Dept Gastroenterol, Endoscopy Unit, Lublin, Poland; [Surdacka, Agata; Rolinski, Jacek] Med Univ Lublin, Dept Clin Immunol, Lublin, Poland; [Zwolak, Agnieszka] Med Univ Lublin, Lublin, Poland; [Miacz, Slawomir] Prov Specialist Hosp, Dept Gastroenterol, Lublin, Poland	Medical University of Lublin; Medical University of Lublin; Medical University of Lublin	Kasztelan-Szczerbinska, B (corresponding author), Med Univ Lublin, Dept Gastroenterol, Endoscopy Unit, Lublin, Poland.	beata.szczerbinska@op.pl	Kasztelan-Szczerbinska, Beata/H-2854-2019	Kasztelan-Szczerbinska, Beata/0000-0002-7198-4428; Surdacka, Agata/0000-0002-0307-7535; Rolinski, Jacek Mariusz/0000-0001-5596-2651; Rolinski, Jacek/0000-0003-4841-6120	Medical University of Lublin, Poland [PW445/2010-2011]	Medical University of Lublin, Poland	This study was supported by the research grants from the Medical University of Lublin, Poland (PW445/2010-2011); BKS.	Ali AK, 2012, EUR J GASTROEN HEPAT, V24, P798, DOI 10.1097/MEG.0b013e328353a367; Alunno A, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/823085; ASHLEY MJ, 1977, ARCH INTERN MED, V137, P883, DOI 10.1001/archinte.137.7.883; Babor TF., 2001, AUDIT ALCOHOL USE DI; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Chang Q, 2012, J GASTROEN HEPATOL, V27, P273, DOI 10.1111/j.1440-1746.2011.06782.x; Corthay A, 2009, SCAND J IMMUNOL, V70, P326, DOI 10.1111/j.1365-3083.2009.02308.x; Curtis BJ, 2014, ALCOHOL CLIN EXP RES, V38, P1347, DOI 10.1111/acer.12369; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Dettling A, 2007, ALCOHOL, V41, P415, DOI 10.1016/j.alcohol.2007.05.003; Durazzo M, 2014, WORLD J GASTROENTERO, V20, P2127, DOI 10.3748/wjg.v20.i9.2127; Eagon PK, 2010, WORLD J GASTROENTERO, V16, P1377, DOI 10.3748/wjg.v16.i11.1377; El-Assal O, 2004, CELL MOL IMMUNOL, V1, P205; Farcomeni A, 2012, STAT METHODS MED RES, V21, P111, DOI 10.1177/0962280210385865; Ferenci P, 2002, HEPATOLOGY, V35, P716, DOI 10.1053/jhep.2002.31250; Gao B, 2012, J GASTROEN HEPATOL, V27, P89, DOI 10.1111/j.1440-1746.2011.07003.x; Gleeson D, 2009, ALCOHOL ALCOHOLISM, V44, P392, DOI 10.1093/alcalc/agp008; Huang H, 2013, INT J MOL SCI, V14, P21463, DOI 10.3390/ijms141121463; Kamath PS, 2007, HEPATOLOGY, V45, P797, DOI 10.1002/hep.21563; Kasztelan-Szczerbinska B, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/148526; Kerr WC, 2012, DRUG ALCOHOL REV, V31, P200, DOI 10.1111/j.1465-3362.2011.00374.x; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Kovacs EJ, 2002, ALCOHOL RES HEALTH, V26, P257; Leise MD, 2011, GASTROENTEROLOGY, V140, P1952, DOI 10.1053/j.gastro.2011.02.017; Lemmers A, 2009, HEPATOLOGY, V49, P646, DOI 10.1002/hep.22680; Li J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039307; Li QX, 2013, ONCOL REP, V30, P1215, DOI 10.3892/or.2013.2570; Li TK, 2001, ALCOHOL CLIN EXP RES, V25, P136, DOI 10.1111/j.1530-0277.2001.tb02138.x; Lim YS, 2010, J HEPATOL, V52, P523, DOI 10.1016/j.jhep.2010.01.009; Liu LL, 2011, CLIN IMMUNOL, V139, P314, DOI 10.1016/j.clim.2011.02.018; LOFT S, 1987, SCAND J GASTROENTERO, V22, P1251, DOI 10.3109/00365528708996472; Ma X, 2007, HEPATOLOGY, V46, P1519, DOI 10.1002/hep.21823; McClain CJ, 1998, ALCOHOL CLIN EXP RES, V22, p248S, DOI 10.1111/j.1530-0277.1998.tb04011.x; Miller AM, 2011, ALCOHOL CLIN EXP RES, V35, P787, DOI 10.1111/j.1530-0277.2010.01399.x; Muller C, 2006, WIEN MED WOCHENSCHR, V156, P523, DOI [10.1007/s10354-006-0348-8, 10.1007/s10354-006-0314-5]; Naveau S, 2004, HEPATOLOGY, V39, P1390, DOI 10.1002/hep.20206; Nolen-Hoeksema S, 2004, CLIN PSYCHOL REV, V24, P981, DOI 10.1016/j.cpr.2004.08.003; Paula H, 2010, AM J GASTROENTEROL, V105, P1782, DOI 10.1038/ajg.2010.46; Piccioni M, 2014, ADV EXP MED BIOL, V841, P67, DOI 10.1007/978-94-017-9487-9_4; Prud'homme GJ, 2000, J AUTOIMMUN, V14, P23, DOI 10.1006/jaut.1999.0339; PUGH RNH, 1973, BRIT J SURG, V60, P646, DOI 10.1002/bjs.1800600817; Qin GS, 2008, STAT METHODS MED RES, V17, P207, DOI 10.1177/0962280207087173; Rehm J, 2010, DRUG ALCOHOL REV, V29, P437, DOI 10.1111/j.1465-3362.2009.00153.x; Rollnik JD, 1997, ACTA NEUROL SCAND, V96, P101; Schisterman EF, 2005, EPIDEMIOLOGY, V16, P73, DOI 10.1097/01.ede.0000147512.81966.ba; SHERON N, 1991, CLIN EXP IMMUNOL, V84, P449; Song XY, 2014, ADV EXP MED BIOL, V841, P99, DOI 10.1007/978-94-017-9487-9_5; STOCKWELL T, 1989, BRIT MED J, V298, P571, DOI 10.1136/bmj.298.6673.571-a; Stoy S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055101; Sun XF, 2014, WORLD J GASTROENTERO, V20, P2062, DOI 10.3748/wjg.v20.i8.2062; Szabo G, 2011, ALCOHOL CLIN EXP RES, V35, P782, DOI 10.1111/j.1530-0277.2010.01398.x; Szabo G, 2012, DIGEST DIS, V30, P55, DOI 10.1159/000341126; Szabo G, 2009, ALCOHOL CLIN EXP RES, V33, P220, DOI 10.1111/j.1530-0277.2008.00842.x; Tilg H, 2003, J HEPATOL, V38, P419, DOI 10.1016/S0168-8278(02)00442-7; Viitala K, 2000, ALCOHOL CLIN EXP RES, V24, P1103; Wang LY, 2011, INT J MOL MED, V27, P385, DOI 10.3892/ijmm.2011.594; Wang WH, 2012, RHEUMATOL INT, V32, P887, DOI 10.1007/s00296-010-1710-0; Ward RJ, 2014, ALCOHOL ALCOHOLISM, V49, P193, DOI 10.1093/alcalc/agu002; World Health Organisation, 2011, GLOB STAT REP ALC HL; Xing Q, 2012, RHEUMATOL INT, V32, P949, DOI 10.1007/s00296-010-1771-0; Yang CY, 2014, HEPATOLOGY, V59, P1944, DOI 10.1002/hep.26979; Zakhari S, 2007, HEPATOLOGY, V46, P2032, DOI 10.1002/hep.22010; Zhang XY, 2010, HEPATOLOGY, V52, P2137, DOI 10.1002/hep.23909; Zhao L, 2013, MED ONCOL, V30, DOI 10.1007/s12032-013-0461-7	64	14	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2015	10	6							e0128347	10.1371/journal.pone.0128347	http://dx.doi.org/10.1371/journal.pone.0128347			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4OM	26107937	gold, Green Published, Green Submitted			2022-12-26	WOS:000356932500020
J	Kim, SA; Lee, YM; Lee, HW; Jacobs, DR; Lee, DH				Kim, Se-A; Lee, Yu-Mi; Lee, Ho-Won; Jacobs, David R., Jr.; Lee, Duk-Hee			Greater Cognitive Decline with Aging among Elders with High Serum Concentrations of Organochlorine Pesticides	PLOS ONE			English	Article							RISK; HEALTH; AGE	Although cognitive decline is very common in elders, age-related cognitive decline substantially differs among elders and the determinants of the differences in age-related cognitive decline are unclear. We investigated our hypothesis that the association between age and cognition was stronger in those with higher serum concentrations of organochlorine (OC) pesticides, common persistent and strongly lipophilic neurotoxic chemicals. Participants were 644 elders aged 60-85, participating in the National Health and Nutrition Examination Survey 1999-2002. Six OC pesticides (p, p'-dichlorodiphenyltrichloroethane (DDT), p, p'-dichlorodipenyldichloroethylene (DDE), beta-hexachlorocyclohexane, trans-nonachlor, oxychlordane, and heptachlor epoxide) were evaluated. "Lower cognitive function" was defined as having a low Digit-Symbol Substitution Test (DSST) score (<25th percentile of DSST score, cutpoint 28 symbols substituted). Higher levels of beta-hexachlorocyclohexane, transnonachlor, oxychlordane, and heptachlor epoxide modified the associations between age and lower cognitive function (P-interaction<0.01, 0.03, <0.01, and 0.02, respectively). Elders in the 3rd tertile of these chemicals demonstrated a greater risk of lower cognitive function with aging, compared to those in the combined 1st and 2nd tertiles. Among those with highest OC pesticides (3rd tertile), the odds ratio for the risk of lower cognitive function was about 6 to 11 for the highest quintile of age (80-85 years) vs. the first quintile of age (60-63 years), while the association between age and lower cognitive function became flatter in those with lower OC pesticides (combined 1st and 2nd tertiles). Both DDT and DDE showed no interaction, with lower DSST scores for higher age irrespective of serum concentrations of DDT or DDE. Even though DSST score measures only one aspect of cognition, several OC pesticides modified aging-related prevalence of low cognitive score, a finding which should be evaluated in prospective studies.	[Kim, Se-A; Lee, Duk-Hee] Kyungpook Natl Univ, Dept Biomed Sci, Daegu, South Korea; [Kim, Se-A; Lee, Duk-Hee] Kyungpook Natl Univ, Dept Biomed Sci, Plus KNU Biomed Convergence Program BK21, Daegu, South Korea; [Lee, Yu-Mi; Lee, Duk-Hee] Kyungpook Natl Univ, Dept Prevent Med, Sch Med, Daegu, South Korea; [Lee, Ho-Won] Kyungpook Natl Univ, Dept Neurol, Sch Med, Daegu, South Korea; [Lee, Ho-Won] Kyungpook Natl Univ, Brain Sci & Engn Inst, Daegu, South Korea; [Jacobs, David R., Jr.] Univ Minnesota, Sch Publ Hlth, Div Epidemiol, Minneapolis, MN 55455 USA	Kyungpook National University; Kyungpook National University; Kyungpook National University; Kyungpook National University; Kyungpook National University; University of Minnesota System; University of Minnesota Twin Cities	Lee, DH (corresponding author), Kyungpook Natl Univ, Dept Biomed Sci, Daegu, South Korea.	lee_dh@knu.ac.kr		Jacobs, David/0000-0002-7232-0543	Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea [HI13C0715]; National Research Foundation of Korea (NRF) grant - Korea government (MEST) [2013R1A2A2A01068254]	Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea; National Research Foundation of Korea (NRF) grant - Korea government (MEST)	This work was financially supported by a grant of the Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea (HI13C0715) and by a National Research Foundation of Korea (NRF) grant funded by the Korea government (MEST) (No. 2013R1A2A2A01068254). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anstey K, 2000, GERONTOLOGY, V46, P163, DOI 10.1159/000022153; Colosio C, 2003, NEUROTOXICOLOGY, V24, P577, DOI 10.1016/S0161-813X(03)00055-X; Deary IJ, 2009, BRIT MED BULL, V92, P135, DOI 10.1093/bmb/ldp033; Fabrigoule C, 1998, BRAIN, V121, P135, DOI 10.1093/brain/121.1.135; Fisher BE, 1999, ENVIRON HEALTH PERSP, V107, pA18, DOI 10.2307/3434279; Graubard BL, 1999, JNCI-J NATL CANCER I, V91, P1005, DOI 10.1093/jnci/91.12.1005; Harada CN, 2013, CLIN GERIATR MED, V29, P737, DOI 10.1016/j.cger.2013.07.002; Kaplan RJ, 2001, AM J CLIN NUTR, V74, P687; Kim KS, 2014, INT ENV; KORN EL, 1991, AM J PUBLIC HEALTH, V81, P1166, DOI 10.2105/AJPH.81.9.1166; Lee DH, 2014, ENDOCR REV, V35, P557, DOI 10.1210/er.2013-1084; Lipnicki DM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065841; Park HL, 2003, INT J GERIATR PSYCH, V18, P1121, DOI 10.1002/gps.1023; Parkin AJ, 1999, NEUROPSYCHOLOGY, V13, P539, DOI 10.1037/0894-4105.13.4.539; Richardson JR, 2014, JAMA NEUROL, V71, P284, DOI 10.1001/jamaneurol.2013.6030; Rosano C, 2008, J AM GERIATR SOC, V56, P1618, DOI 10.1111/j.1532-5415.2008.01856.x; Singh NK, 2013, HUM EXP TOXICOL, V32, P24, DOI 10.1177/0960327112456315; Stuck AE, 1999, SOC SCI MED, V48, P445, DOI 10.1016/S0277-9536(98)00370-0	18	18	18	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2015	10	6							e0130623	10.1371/journal.pone.0130623	http://dx.doi.org/10.1371/journal.pone.0130623			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CL4OM	26107947	Green Submitted, Green Published, gold			2022-12-26	WOS:000356932500111
J	Marce-Nogue, J; Fortuny, J; De Esteban-Trivigno, S; Sanchez, M; Gil, L; Galobart, A				Marce-Nogue, Jordi; Fortuny, Josep; De Esteban-Trivigno, Soledad; Sanchez, Montserrat; Gil, Lluis; Galobart, Angel			3D Computational Mechanics Elucidate the Evolutionary Implications of Orbit Position and Size Diversity of Early Amphibians	PLOS ONE			English	Article							GEOMETRIC MORPHOMETRICS; TEMNOSPONDYL; STEREOSPONDYL; SENSITIVITY; PERFORMANCE; INTEGRATION; MADAGASCAR; PATTERNS; REVISION; BITE	For the first time in vertebrate palaeontology, the potential of joining Finite Element Analysis (FEA) and Parametrical Analysis (PA) is used to shed new light on two different cranial parameters from the orbits to evaluate their biomechanical role and evolutionary patterns. The early tetrapod group of Stereospondyls, one of the largest groups of Temnospondyls is used as a case study because its orbits position and size vary hugely within the members of this group. An adult skull of Edingerella madagascariensis was analysed using two different cases of boundary and loading conditions in order to quantify stress and deformation response under a bilateral bite and during skull raising. Firstly, the variation of the original geometry of its orbits was introduced in the models producing new FEA results, allowing the exploration of the ecomorphology, feeding strategy and evolutionary patterns of these top predators. Secondly, the quantitative results were analysed in order to check if the orbit size and position were correlated with different stress patterns. These results revealed that in most of the cases the stress distribution is not affected by changes in the size and position of the orbit. This finding supports the high mechanical plasticity of this group during the Triassic period. The absence of mechanical constraints regarding the orbit probably promoted the ecomorphological diversity acknowledged for this group, as well as its ecological niche differentiation in the terrestrial Triassic ecosystems in clades as lydekkerinids, trematosaurs, capitosaurs or metoposaurs.	[Marce-Nogue, Jordi; Fortuny, Josep; Sanchez, Montserrat; Gil, Lluis] Univ Politecn Catalunya BarcelonaTech, Terrassa, Spain; [Marce-Nogue, Jordi; Fortuny, Josep; De Esteban-Trivigno, Soledad; Galobart, Angel] Inst Catala Paleontol Miquel Crusafont, Cerdanyola Del Valles, Spain; [De Esteban-Trivigno, Soledad] Transmitting Sci, Piera, Spain	Universitat Politecnica de Catalunya; Institut Catala de Paleontologia Miquel Crusafont (ICP)	Marce-Nogue, J (corresponding author), Univ Politecn Catalunya BarcelonaTech, Terrassa, Spain.	jordi.marce@upc.edu	Fortuny, Josep/L-2523-2014; Marcé-Nogué, Jordi/B-3933-2012; Galobart, Àngel À/H-5024-2011; De Esteban-Trivigno, Soledad/K-8081-2017; Gil, Lluís/K-9157-2013	Fortuny, Josep/0000-0003-4282-1619; Marcé-Nogué, Jordi/0000-0001-9852-7027; Galobart, Àngel À/0000-0003-1508-4561; De Esteban-Trivigno, Soledad/0000-0002-2049-0890; Gil, Lluís/0000-0002-2007-4846	SYNTHESYS Project [FR-TAF-3353]; European Community Research Infrastructure Action under the FP7 "Capacities" Program	SYNTHESYS Project; European Community Research Infrastructure Action under the FP7 "Capacities" Program	This research received support from the SYNTHESYS Project FR-TAF-3353 to J.F. (http://www.synthesys.info/) which is financed by European Community Research Infrastructure Action under the FP7 "Capacities" Program. The funds were only for trips in visiting collections. For the rest of the research, the authors received no specific funding for this work.	Alexander R., 1992, EXPLORING BIOMECHANI; Benton MJ, 2013, PALAEOGEOGR PALAEOCL, V372, P18, DOI 10.1016/j.palaeo.2012.09.005; BUSBEY AB, 1995, FUNCTIONAL MORPHOLOGY IN VERTEBRATE PALEONTOLOGY, P173; Bystrow AP, 1940, T PALEONTOLOGICHESKO, V10, P1; Carroll R, 1980, ZOOL J LINN SOC; Cox PG, 2011, J ANAT, V219, P696, DOI 10.1111/j.1469-7580.2011.01436.x; Croxton FE, 1968, APPL GEN STAT, P650; CURREY JD, 1987, J BIOMECH, V20, P1035, DOI 10.1016/0021-9290(87)90021-2; Damiani RJ, 2001, ZOOL J LINN SOC-LOND, V133, P379, DOI 10.1006/zjls.2001.0304; Doblare M, 2004, ENG FRACT MECH, V71, P1809, DOI 10.1016/j.engfracmech.2003.08.003; Dutuit J. M., 1976, INTRO ETUDE PALEONTO; Erickson GM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031781; Fortuny J, 2011, J EVOLUTION BIOL, V24, P2040, DOI 10.1111/j.1420-9101.2011.02338.x; Fortuny J, 2012, ANAT REC, V295, P1134, DOI 10.1002/ar.22486; Fortuny J, 2011, ACTA PALAEONTOL POL, V56, P553, DOI 10.4202/app.2010.0025; Gil L, 2015, PALAEONTOL ELECTRON, V18; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Kupczik K, 2007, J ANAT, V210, P41, DOI 10.1111/j.1469-7580.2006.00662.x; Maganuco Simone, 2009, Memorie della Societa Italiana di Scienze Naturali e del Museo Civico di Storia Naturale di Milano, V36, P1; Maisch MW, 2004, NATURWISSENSCHAFTEN, V91, P589, DOI 10.1007/s00114-004-0569-x; Marce-Nogue J, 2015, SPANISH J P IN PRESS; Marce-Nogue J., 2011, P 13 INT C CIV STRUC; McHenry CR, 2007, P NATL ACAD SCI USA, V104, P16010, DOI 10.1073/pnas.0706086104; Piras P, 2014, INTEGR ZOOL, V9, P498, DOI 10.1111/1749-4877.12062; Piras P, 2013, SYST BIOL, V62, P878, DOI 10.1093/sysbio/syt053; Quinn GP, 2003, EXPT DESIGN DATA ANA; Rayfield EJ, 2007, ANNU REV EARTH PL SC, V35, P541, DOI 10.1146/annurev.earth.35.031306.140104; Ruta M, 2008, PALAEONTOLOGY, V51, P1261, DOI 10.1111/j.1475-4983.2008.00808.x; Schoch R.R., 2000, ENCY PALEOHERPETOL B, P1, DOI DOI 10.1127/0077-7749/2007/0246-0001; Schoch RR, 2008, ZOOL J LINN SOC-LOND, V152, P79, DOI 10.1111/j.1096-3642.2007.00363.x; Schoch Rainer R., 2002, Stuttgarter Beitraege zur Naturkunde Serie B (Geologie und Palaeontologie), V321, P1; Schoch RR, 2014, PALAEONTOLOGY, V57, P517, DOI 10.1111/pala.12100; Schoch Rainer R., 1999, Stuttgarter Beitraege zur Naturkunde Serie B (Geologie und Palaeontologie), P1; Schoch RR, 2014, TOP PALEOBIOL, P1, DOI 10.1002/9781118759127; Schoch RR, 2002, PALAEONTOLOGY, V45, P627, DOI 10.1111/1475-4983.00252; SEILACHE.A, 1970, LETHAIA, V3, P393, DOI 10.1111/j.1502-3931.1970.tb00830.x; Stayton CT, 2006, PALAEONTOLOGY, V49, P307, DOI 10.1111/j.1475-4983.2006.00523.x; Steyer JS, 2003, J VERTEBR PALEONTOL, V23, P544, DOI 10.1671/1740; Steyer JS, 2002, PALAEONTOLOGY, V45, P771, DOI 10.1111/1475-4983.00260; Sulej T, 2005, PALAEONTOLOGY, V48, P157, DOI 10.1111/j.1475-4983.2004.00430.x; Sulej Tomasz, 2007, PALAEONTOLOGIA POLONICA, P29; Tseng ZJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019171; Walmsley CW, 2013, PEERJ, V1, DOI 10.7717/peerj.204; Walmsley CW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053873; Warren Anne, 2000, Amphibian Biology, V4, P1121; Witzmann F, 2005, T ROY SOC EDIN-EARTH, V96, P131, DOI 10.1017/S0263593300001279; Witzmann F, 2013, J MORPHOL, V274, P525, DOI 10.1002/jmor.20113; Zienkiewicz O.C., 1971, FINITE ELEMENT METHO, P98	48	11	11	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2015	10	6							e0131320	10.1371/journal.pone.0131320	http://dx.doi.org/10.1371/journal.pone.0131320			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4OM	26107295	Green Published, Green Submitted, gold			2022-12-26	WOS:000356932500155
J	Pribbenow, S; East, ML; Ganswindt, A; Tordiffe, ASW; Hofer, H; Dehnhard, M				Pribbenow, Susanne; East, Marion L.; Ganswindt, Andre; Tordiffe, Adrian S. W.; Hofer, Heribert; Dehnhard, Martin			Measuring Faecal Epi-Androsterone as an Indicator of Gonadal Activity in Spotted Hyenas (Crocuta crocuta)	PLOS ONE			English	Article							EURASIAN LYNX-LYNX; SOCIAL-STATUS; GLUCOCORTICOID METABOLITES; ENZYME-IMMUNOASSAY; NONINVASIVE ASSESSMENT; ENDOCRINE FUNCTION; STEROID ANALYSIS; ANDROGEN LEVELS; TESTOSTERONE; HORMONES	Enzyme immunoassays (EIA) that measure faecal testosterone metabolites (fTM) are useful tools to monitor gonadal activity. The aim of this study was to validate an "in-house" epiandrosterone EIA to monitor fTM in spotted hyenas. FTM were characterised in a male and a female hyena that each received an injection of H-3-testosterone. High-performance liquid chromatography (HPLC) analyses revealed a cluster of highly polar enzyme-hydrolysable hormone metabolite conjugates. We performed hydrolysis using beta-glucuronidase to deconjugate metabolites and improve sensitivity of the assay. Because beta-glucuronidase from Helix pomatia has been reported to bias testosterone measurements in some species, we compared the enzymatic activity of the commonly used beta-glucuronidase extracted from H. pomatia with the same enzyme from Escherichia coli. Our results showed that beta-glucuronidases from both sources produced similar results from spotted hyena faeces. We therefore hydrolysed samples with H. pomatia enzymes. HPLC analyses also demonstrated that following hydrolysis the epiandrosterone EIA measured significant amounts of immunoreactive metabolites corresponding to radiolabelled metabolites in both sexes. Additionally, HPLC and GC-MS analyses confirmed the presence of epiandrosterone in faeces of spotted hyenas. The biological relevance of the epiandrosterone EIA was validated by demonstrating (1) a significant increase in fTM levels in response to a testosterone injection within 16 h, (2) no biological responsiveness to an adrenocorticotropic hormone (ACTH) injection and (3) significant differences in fTM levels between juvenile males and adult immigrant males in a free-ranging wild population. Our results clearly demonstrate that the epiandrosterone EIA is a reliable non-invasive method to monitor gonadal activity in spotted hyenas.	[Pribbenow, Susanne; East, Marion L.; Hofer, Heribert; Dehnhard, Martin] Forschungsverbund Berlin eV, Leibniz Inst Zoo & Wildlife Res, Dept Reprod Biol & Evolutionary Ecol, Berlin, Germany; [Ganswindt, Andre; Tordiffe, Adrian S. W.] Univ Pretoria, Dept Anat & Physiol, Endocrine Res Lab, Fac Vet Sci, ZA-0110 Onderstepoort, South Africa; [Ganswindt, Andre; Tordiffe, Adrian S. W.] Natl Zool Gardens South Africa, Pretoria, South Africa; [Tordiffe, Adrian S. W.] Univ Pretoria, Fac Vet Sci, Dept Compan Anim Clin Studies, ZA-0110 Onderstepoort, South Africa	Leibniz Institut fur Zoo und Wildtierforschung; Technical University of Berlin; University of Pretoria; National Research Foundation - South Africa; National Zoological Gardens of South Africa; University of Pretoria	Pribbenow, S (corresponding author), Forschungsverbund Berlin eV, Leibniz Inst Zoo & Wildlife Res, Dept Reprod Biol & Evolutionary Ecol, Berlin, Germany.	pribbenow@izw-berlin.de	Ganswindt, Andre/G-9856-2014; Tordiffe, Adrian/T-4517-2017; Hofer, Heribert/AAF-7854-2021	Ganswindt, Andre/0000-0002-1474-7602; Tordiffe, Adrian/0000-0001-5416-3153; Hofer, Heribert/0000-0002-2813-7442	National Research Council of South Africa; Leibniz Institute for Zoo & Wildlife Research (IZW); International Bureau of the German Federal Ministry for Education and Research (BMBF) [SUA 10/020]	National Research Council of South Africa; Leibniz Institute for Zoo & Wildlife Research (IZW); International Bureau of the German Federal Ministry for Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF))	The study was funded by a joint "Collaboration in the field of sustainable management of wildlife populations" grant (SUA 10/020) of the International Bureau of the German Federal Ministry for Education and Research (BMBF) and the National Research Council of South Africa, and the Leibniz Institute for Zoo & Wildlife Research (IZW).	[Anonymous], 2014, R LANG ENV STAT COMP; Bales KL, 2006, HORM BEHAV, V49, P88, DOI 10.1016/j.yhbeh.2005.05.006; Benhaiem S, 2012, P ROY SOC B-BIOL SCI, V279, P3727, DOI 10.1098/rspb.2012.0925; Benhaiem S, 2012, GEN COMP ENDOCR, V178, P265, DOI 10.1016/j.ygcen.2012.05.006; Brown JL, 1996, J REPROD FERTIL, V106, P337, DOI 10.1530/jrf.0.1060337; Browne P, 2006, REPRODUCTION, V132, P649, DOI 10.1530/rep.1.01120; Conover WJ., 1999, PRACTICAL NONPARAMET, V3rd; Creel S, 1997, BEHAV ECOL, V8, P298, DOI 10.1093/beheco/8.3.298; Dehnhard M, 2008, REPROD DOMEST ANIM, V43, P74, DOI 10.1111/j.1439-0531.2008.01145.x; Dloniak SM, 2004, GEN COMP ENDOCR, V135, P51, DOI 10.1016/j.ygcen.2003.08.011; EAST M, 1989, J ZOOL, V219, P690, DOI 10.1111/j.1469-7998.1989.tb02614.x; East M. L., 2013, MAMMALS AFRICA CARNI, P273; East ML, 2009, BEHAV ECOL, V20, P478, DOI 10.1093/beheco/arp020; EAST ML, 1993, BEHAV ECOL SOCIOBIOL, V33, P355; East ML, 2003, P ROY SOC B-BIOL SCI, V270, P1247, DOI 10.1098/rspb.2003.2363; East ML, 2001, BEHAV ECOL, V12, P558, DOI 10.1093/beheco/12.5.558; ENNE G, 1981, Reproduccion, V5, P217; FRANK LG, 1985, J ZOOL, V206, P525, DOI 10.1111/j.1469-7998.1985.tb03556.x; FRANK LG, 1990, J ZOOL, V221, P308, DOI 10.1111/j.1469-7998.1990.tb04001.x; FRANK LG, 1986, ANIM BEHAV, V34, P1500, DOI 10.1016/S0003-3472(86)80220-2; Ganswindt A, 2003, GEN COMP ENDOCR, V134, P156, DOI 10.1016/S0016-6480(03)00251-X; Ganswindt A, 2002, ZOO BIOL, V21, P27, DOI 10.1002/zoo.10034; GASTWIRTH JL, 1985, J AM STAT ASSOC, V80, P380, DOI 10.2307/2287901; Ghosal R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084787; Gibbons J. D., 2010, NONPARAMETRIC STAT I, DOI DOI 10.5005/JP/BOOKS/10313_14; Girard-Buttoz C, 2009, PHYSIOL BEHAV, V98, P168, DOI 10.1016/j.physbeh.2009.05.005; Golla W, 1999, ANIM BEHAV, V58, P715, DOI 10.1006/anbe.1999.1189; Goymann W, 1999, GEN COMP ENDOCR, V114, P340, DOI 10.1006/gcen.1999.7268; Goymann W, 2005, ANN NY ACAD SCI, V1046, P35, DOI 10.1196/annals.1343.005; Goymann W, 2003, PHYSIOL BIOCHEM ZOOL, V76, P586, DOI 10.1086/375659; Gudermuth DF, 1998, THERIOGENOLOGY, V50, P237, DOI 10.1016/S0093-691X(98)00131-9; Hauser B, 2008, GEN COMP ENDOCR, V158, P77, DOI 10.1016/j.ygcen.2008.05.006; Honer OP, 2007, NATURE, V448, P798, DOI 10.1038/nature06040; Hofer H, 2003, EVOL ECOL, V17, P315, DOI 10.1023/A:1027352517231; Hofer H, 2008, BEHAV ECOL SOCIOBIOL, V62, P341, DOI 10.1007/s00265-007-0421-3; Holekamp KE, 1998, HORM BEHAV, V33, P205, DOI 10.1006/hbeh.1998.1450; Holekamp KE, 1996, J REPROD FERTIL, V108, P229; Hollander M, 2014, NONPARAMETRIC STAT M; HOUGHTON E, 1992, ORG MASS SPECTROM, V27, P1061, DOI 10.1002/oms.1210271016; Jewgenow K, 2006, GEN COMP ENDOCR, V149, P151, DOI 10.1016/j.ygcen.2006.05.015; Kruuk H., 1972, SPOTTED HYENA STUDY; Ludwig C, 2013, GEN COMP ENDOCR, V180, P15, DOI 10.1016/j.ygcen.2012.10.005; MARCHUT M, 1977, ENDOCRINOL EXP, V11, P195; Mareck U, 2008, J MASS SPECTROM, V43, P877, DOI 10.1002/jms.1457; MATTHEWS L. HARRISON, 1939, PHIL TRANS ROY SOC LONDON SER B BIOL SCI, V230, P1; MESSERI G, 1984, J STEROID BIOCHEM, V20, P793, DOI 10.1016/0022-4731(84)90088-8; Mohle U, 2002, GEN COMP ENDOCR, V129, P135, DOI 10.1016/S0016-6480(02)00525-7; Mostl E, 2002, DOMEST ANIM ENDOCRIN, V23, P67, DOI 10.1016/S0739-7240(02)00146-7; Muller MN, 2004, ANIM BEHAV, V67, P113, DOI 10.1016/j.anbehav.2003.03.013; OLSON PN, 1984, AM J VET RES, V45, P145; Ostner J, 2002, BEHAV ECOL SOCIOBIOL, V52, P485, DOI 10.1007/s00265-002-0532-9; Palme R, 2005, ANN NY ACAD SCI, V1040, P162, DOI 10.1196/annals.1327.021; Palme R, 2005, ANN NY ACAD SCI, V1046, P75, DOI 10.1196/annals.1343.007; Palme R, 2013, WIEN TIERARZTL MONAT, V100, P238; Pribbenow S, 2014, GEN COMP ENDOCR, V206, P166, DOI 10.1016/j.ygcen.2014.07.015; Roelants H, 2002, BIOL REPROD, V66, P305, DOI 10.1095/biolreprod66.2.305; Roff Derek A., 1992; SAPOLSKY RM, 1982, HORM BEHAV, V16, P279, DOI 10.1016/0018-506X(82)90027-7; Schwarzenberger F., 2007, International Zoo Yearbook, V41, P52, DOI 10.1111/j.1748-1090.2007.00017.x; Schwarzenberger F, 2004, THERIOGENOLOGY, V62, P1677, DOI 10.1016/j.theriogenology.2004.03.007; Sotchell JM, 2001, HORM BEHAV, V39, P177, DOI 10.1006/hbeh.2000.1628; Stearns S.C., 1992, pi; Surbeck M, 2012, ANIM BEHAV, V83, P659, DOI 10.1016/j.anbehav.2011.12.010; Szykman M, 2007, BEHAVIOUR, V144, P815, DOI 10.1163/156853907781476418; Velloso AL, 1998, GEN COMP ENDOCR, V112, P96, DOI 10.1006/gcen.1998.7147; VENTURELLI E, 1995, J CHROMATOGR B, V671, P363, DOI 10.1016/0378-4347(95)00062-N; WILSON JD, 1995, RECENT PROG HORM RES, V50, P349; WINGFIELD JC, 1990, AM NAT, V136, P829, DOI 10.1086/285134; Young KM, 2004, GEN COMP ENDOCR, V137, P148, DOI 10.1016/j.ygcen.2004.02.016	69	7	7	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2015	10	6							e0128706	10.1371/journal.pone.0128706	http://dx.doi.org/10.1371/journal.pone.0128706			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4OM	26107516	Green Published, Green Submitted, gold			2022-12-26	WOS:000356932500026
J	Volpov, BL; Hoskins, AJ; Battaile, BC; Viviant, M; Wheatley, KE; Marshall, G; Abernathy, K; Arnould, JPY				Volpov, Beth L.; Hoskins, Andrew J.; Battaile, Brian C.; Viviant, Morgane; Wheatley, Kathryn E.; Marshall, Greg; Abernathy, Kyler; Arnould, John P. Y.			Identification of Prey Captures in Australian Fur Seals (Arctocephalus pusillus doriferus) Using Head-Mounted Accelerometers: Field Validation with Animal-Borne Video Cameras	PLOS ONE			English	Article							SOUTHERN ELEPHANT SEAL; STOMACH TEMPERATURE; FORAGING SUCCESS; FEEDING-BEHAVIOR; MIROUNGA-LEONINA; DIVING BEHAVIOR; PHOCA-VITULINA; MONK SEALS; PINNIPEDS; CLASSIFICATION	This study investigated prey captures in free-ranging adult female Australian fur seals (Arctocephalus pusillus doriferus) using head-mounted 3-axis accelerometers and animal-borne video cameras. Acceleration data was used to identify individual attempted prey captures (APC), and video data were used to independently verify APC and prey types. Results demonstrated that head-mounted accelerometers could detect individual APC but were unable to distinguish among prey types (fish, cephalopod, stingray) or between successful captures and unsuccessful capture attempts. Mean detection rate (true positive rate) on individual animals in the testing subset ranged from 67-100%, and mean detection on the testing subset averaged across 4 animals ranged from 82-97%. Mean False positive (FP) rate ranged from 15-67% individually in the testing subset, and 26-59% averaged across 4 animals. Surge and sway had significantly greater detection rates, but also conversely greater FP rates compared to heave. Video data also indicated that some head movements recorded by the accelerometers were unrelated to APC and that a peak in acceleration variance did not always equate to an individual prey item. The results of the present study indicate that head-mounted accelerometers provide a complementary tool for investigating foraging behaviour in pinnipeds, but that detection and FP correction factors need to be applied for reliable field application.	[Volpov, Beth L.; Hoskins, Andrew J.; Wheatley, Kathryn E.; Arnould, John P. Y.] Deakin Univ, Sch Life & Environm Sci, Burwood, Vic, Australia; [Battaile, Brian C.] Univ British Columbia, Marine Mammal Res Unit, Fisheries Ctr, Vancouver, BC V5Z 1M9, Canada; [Viviant, Morgane] CNRS, Ctr Etud Biol Chize, Villiers En Bois, France; [Marshall, Greg; Abernathy, Kyler] Natl Geog, Remote Imaging Dept, Washington, DC USA	Deakin University; University of British Columbia; Centre National de la Recherche Scientifique (CNRS); National Geographic Society	Volpov, BL (corresponding author), Deakin Univ, Sch Life & Environm Sci, Burwood, Vic, Australia.	byou@deakin.edu.au	Hoskins, Andrew/T-2694-2019	Hoskins, Andrew/0000-0001-8907-6682	Office of Naval Research (USA); Australian Research Council; M.A. the Ingram Trust; Holsworth Wildlife Research Endowment; Deakin University Postgraduate Research Scholarship	Office of Naval Research (USA)(Office of Naval Research); Australian Research Council(Australian Research Council); M.A. the Ingram Trust; Holsworth Wildlife Research Endowment; Deakin University Postgraduate Research Scholarship	Financial support for this project was provided by the Office of Naval Research (USA), the Australian Research Council, M.A. the Ingram Trust and the Holsworth Wildlife Research Endowment. Graduate support to B. Volpov was provided by Deakin University Postgraduate Research Scholarship.	Andrews RD, 1998, MAR ECOL PROG SER, V175, P289, DOI 10.3354/meps175289; Arlot S, 2010, STAT SURV, V4, P40, DOI 10.1214/09-SS054; Arnould JPY, 2007, AQUAT CONSERV, V17, pS53, DOI 10.1002/aqc.908; Arnould JPY, 1996, J ZOOL, V239, P769, DOI 10.1111/j.1469-7998.1996.tb05477.x; Arnould JPY, 2001, CAN J ZOOL, V79, P35, DOI 10.1139/cjz-79-1-35; Austin D, 2006, ECOLOGY, V87, P3095, DOI 10.1890/0012-9658(2006)87[3095:LMDAHT]2.0.CO;2; Bekkby T, 1998, MAR MAMMAL SCI, V14, P627, DOI 10.1111/j.1748-7692.1998.tb00750.x; BENGTSON JL, 1992, POLAR BIOL, V12, P635; Bowen WD, 2002, MAR ECOL PROG SER, V244, P235, DOI 10.3354/meps244235; Bowen WD., 2010, MARINE MAMMAL ECOLOG; Boyd IL, 1999, BEHAV ECOL, V10, P198, DOI 10.1093/beheco/10.2.198; Carroll G, 2014, J EXPT BIOL; Davis RW, 1999, SCIENCE, V283, P993, DOI 10.1126/science.283.5404.993; Dorville N, 2013, DETERMINING DIET AUS; GALES R, 1993, AUST J MAR FRESH RES, V44, P657; Gallon S, 2012, DEEP SEA RES 2; Green JA, 2007, MAR ECOL PROG SER, V346, P299, DOI 10.3354/meps07024; Heaslip SG, 2008, DEEP-SEA RES PT I, V55, P1179, DOI 10.1016/j.dsr.2008.05.006; Hedd A, 1996, POLAR BIOL, V16, P261, DOI 10.1007/s003000050053; Hennicke JC, 2005, MAR ECOL PROG SER, V296, P173, DOI 10.3354/meps296173; HINDELL MA, 1991, AUST J ZOOL, V39, P595, DOI 10.1071/ZO9910595; Horsburgh JM, 2008, MAR MAMMAL SCI, V24, P207, DOI 10.1111/j.1748-7692.2007.00156.x; Hoskins AJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079484; Iwata T, 2012, MAR MAMMAL SCI, V28, P345, DOI 10.1111/j.1748-7692.2011.00482.x; Kuhn CE, 2006, J EXP BIOL, V209, P4524, DOI 10.1242/jeb.02530; LEBOEUF BJ, 1988, CAN J ZOOL, V66, P446, DOI 10.1139/z88-064; Lesage V, 1999, CAN J ZOOL, V77, P74, DOI 10.1139/cjz-77-1-74; Littnan CL, 2004, MAR MAMMAL SCI, V20, P345, DOI 10.1111/j.1748-7692.2004.tb01164.x; LUNN NJ, 1994, J ANIM ECOL, V63, P827, DOI 10.2307/5260; Naito Y, 2010, POLAR SCI, V4, P309, DOI 10.1016/j.polar.2010.05.009; Parrish FA, 2005, MAR MAMMAL SCI, V21, P93, DOI 10.1111/j.1748-7692.2005.tb01210.x; Pinheiro J, 2001, MIXED EFFECTS MODELS; Pistorius PA, 2004, J ZOOL, V263, P107, DOI 10.1017/S0952836904004984; R Core Development Team, 2015, R LANG ENV STAT COMP; Schreer JF, 2001, ECOL MONOGR, V71, P137, DOI 10.1890/0012-9615(2001)071[0137:CDPOPA]2.0.CO;2; Shepard EL, 2008, ENDANGER SPECIES RES, V10; Skinner John P., 2010, Endangered Species Research, V10, P61, DOI 10.3354/esr00236; Stehman SV, 1997, REMOTE SENS ENVIRON, V62, P77, DOI 10.1016/S0034-4257(97)00083-7; Suzuki I, 2009, POLAR BIOL, V32, P667, DOI 10.1007/s00300-009-0596-3; Viviant M, 2010, POLAR BIOL, V33, P713, DOI 10.1007/s00300-009-0750-y; Watanabe YY, 2013, P NATL ACAD SCI USA, V110, P2199, DOI 10.1073/pnas.1216244110; Weimerskirch H, 2005, ECOLOGY, V86, P2611, DOI 10.1890/04-1866; Ydesen KS, 2014, J EXPT BIOL; Zar JH., 2010, BIOSTAT ANAL, V5th	44	34	34	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2015	10	6							e0128789	10.1371/journal.pone.0128789	http://dx.doi.org/10.1371/journal.pone.0128789			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4OM	26107647	gold, Green Published, Green Submitted			2022-12-26	WOS:000356932500028
J	Appelgren, A; Bengtsson, SL				Appelgren, Alva; Bengtsson, Sara L.			Feedback on Trait or Action Impacts on Caudate and Paracingulum Activity	PLOS ONE			English	Article							SELF-ESTEEM; COGNITIVE NEUROSCIENCE; SOCIAL ANXIETY; PERFORMANCE; UNCERTAINTY; MOTIVATION; DOPAMINE; CORTEX; REWARD; INTELLIGENCE	There is a general conception that positive associations to one's trait, e.g. 'I'm clever', are beneficial for cognitive performance. Scientific evidence shows that this is a simplification. In this functional magnetic resonance imaging (fMRI) study we used written trial-based trait feedback 'you are clever', or task feedback 'your choice was correct', on each correct response of a rule-switching task, to investigate how the character of positive self-associations influences performance outcome. Twenty participants took part in this crossover design study. We found that trait feedback was less beneficial for motivation and performance improvement, and resulting in enhanced neural activation on more difficult bivalent rule trials. This indicates that the task was treated as more complex in this condition. For example, 'you are clever' feedback led to enhanced activation in anterior caudate nucleus, an area known to process uncertainty. We further observed that activation in anterior paracingulate cortex was sensitive to whether self-reflection was imposed by external feedback or generated from internal processes, where the latter activation correlated positively with performance when following after task feedback. Our results illustrate how feedback can evoke self-reflections that either help or hinder motivation and performance, most likely by impacting on processes of uncertainty. The results support social psychological models stipulating that trait focus take resources away from task focus.	[Appelgren, Alva; Bengtsson, Sara L.] Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden	Karolinska Institutet	Bengtsson, SL (corresponding author), Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden.	sara.bengtsson@ki.se		Bengtsson, Sara/0000-0003-0887-7344; Bengtsson, Sara/0000-0003-4567-102X	Swedish Research Council (VR); VINNMER - Swedish Governmental Agency for Innovation Systems; Cornell's Foundation [25213063]; Marta Lundqvist's foundation;  [522-2009-2745];  [2009-04078];  [25213033]	Swedish Research Council (VR)(Swedish Research Council); VINNMER - Swedish Governmental Agency for Innovation Systems; Cornell's Foundation; Marta Lundqvist's foundation; ; ; 	(SB) 522-2009-2745; Swedish Research Council (VR); www.vr.se (SB) 2009-04078; VINNMER - Swedish Governmental Agency for Innovation Systems. www.vinnova.se (SB) 25213033; Cornell's Foundation no webpage, (SB) 25213063; Marta Lundqvist's foundation no webpage,	Amodio DM, 2006, NAT REV NEUROSCI, V7, P268, DOI 10.1038/nrn1884; Appelgren A, 2013, EXP PSYCHOL, P1; Aron AR, 2004, J NEUROPHYSIOL, V92, P1144, DOI 10.1152/jn.01209.2003; Baumeister RF, 2003, PSYCHOL SCI, P1, DOI 10.1111/1529-1006.01431; Bengtsson SL, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00490; Bengtsson SL, 2011, SOC COGN AFFECT NEUR, V6, P417, DOI 10.1093/scan/nsq048; Bengtsson SL, 2009, CEREB CORTEX, V19, P797, DOI 10.1093/cercor/bhn127; Burns D., 1989, FEELING GOOD HDB USI; Caouette JD, 2014, DEV COGN NEUROS-NETH, V8, P65, DOI 10.1016/j.dcn.2013.10.003; Crocker J, 2006, J PERS, V74, P1749, DOI 10.1111/j.1467-6494.2006.00427.x; Crone EA, 2006, CEREB CORTEX, V16, P475, DOI 10.1093/cercor/bhi127; Dahlin M, 2007, MED TEACH, V29, P43, DOI 10.1080/01421590601175309; Duvernoy H.M., 1999, HUMAN BRAIN SURFACE; Dweck C. S., 2004, MOTIVATION EMOTION C, V2, P41; DWECK CS, 1986, AM PSYCHOL, V41, P1040, DOI 10.1037/0003-066X.41.10.1040; EYSENCK MW, 1992, COGNITION EMOTION, V6, P409, DOI 10.1080/02699939208409696; Fiorillo CD, 2003, SCIENCE, V299, P1898, DOI 10.1126/science.1077349; Friston K, 2007, STATISTICAL PARAMETRIC MAPPING: THE ANALYSIS OF FUNCTIONAL BRAIN IMAGES, P1; Grant H, 2003, J PERS SOC PSYCHOL, V85, P541, DOI 10.1037/0022-3514.85.3.541; Guyer AE, 2006, J NEUROSCI, V26, P6399, DOI 10.1523/JNEUROSCI.0666-06.2006; Heitmann CY, 2014, HUM BRAIN MAPP, V35, P6023, DOI 10.1002/hbm.22602; Kamins ML, 1999, DEV PSYCHOL, V35, P835, DOI 10.1037/0012-1649.35.3.835; KANFER R, 1989, J APPL PSYCHOL, V74, P657, DOI 10.1037/0021-9010.74.4.657; Kelley WM, 2002, J COGNITIVE NEUROSCI, V14, P785, DOI 10.1162/08989290260138672; Macrae CN, 2004, CEREB CORTEX, V14, P647, DOI 10.1093/cercor/bhh025; Mangels JA, 2006, SOC COGN AFFECT NEUR, V1, P75, DOI 10.1093/scan/nsl013; MARKUS H, 1987, ANNU REV PSYCHOL, V38, P299, DOI 10.1146/annurev.ps.38.020187.001503; MCFARLIN DB, 1985, PERS SOC PSYCHOL B, V11, P153, DOI 10.1177/0146167285112004; MCLENNAN H, 1967, J PHYSIOL-LONDON, V189, P393, DOI 10.1113/jphysiol.1967.sp008175; Mueller CM, 1998, J PERS SOC PSYCHOL, V75, P33, DOI 10.1037/0022-3514.75.1.33; Muhammad R, 2006, J COGNITIVE NEUROSCI, V18, P974, DOI 10.1162/jocn.2006.18.6.974; Nakamura K, 2006, J NEUROSCI, V26, P5360, DOI 10.1523/JNEUROSCI.4853-05.2006; O'Doherty JP, 2002, NEURON, V33, P815, DOI 10.1016/S0896-6273(02)00603-7; Ochsner KN, 2005, NEUROIMAGE, V28, P797, DOI 10.1016/j.neuroimage.2005.06.069; Passingham RE, 2010, TRENDS COGN SCI, V14, P16, DOI 10.1016/j.tics.2009.11.001; Rosenberg M., 1979, CONCEIVING SELF, P319; Rushworth MFS, 2008, NAT NEUROSCI, V11, P389, DOI 10.1038/nn2066; Schmader T, 2003, J PERS SOC PSYCHOL, V85, P440, DOI 10.1037/0022-3514.85.3.440; Toni I, 2002, CEREB CORTEX, V12, P1040, DOI 10.1093/cercor/12.10.1040; Wackerly D., 1996, MATH STAT APPL	40	0	0	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2015	10	6							e0129714	10.1371/journal.pone.0129714	http://dx.doi.org/10.1371/journal.pone.0129714			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4DD	26102501	Green Published, gold, Green Submitted, Green Accepted			2022-12-26	WOS:000356901900019
J	Ye, XB; Liu, H; Gong, YS; Liu, SF				Ye, Xiaobing; Liu, Hong; Gong, Yong-Sheng; Liu, Shu Fang			LPS Down-Regulates Specificity Protein 1 Activity by Activating NF-kappa B Pathway in Endotoxemic Mice	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; ACUTE LUNG INJURY; ALVEOLAR-CAPILLARY BARRIER; GENE-EXPRESSION; SEPTIC SHOCK; TRANSCRIPTION FACTORS; BACTERIAL CLEARANCE; ENDOTHELIAL-CELLS; BINDING-SITES; CANCER CELLS	Background Specificity protein (Sp) 1 mediates the transcription of a large number of constitutive genes encoding physiological mediators. NF-kappa B mediates the expression of hundreds of inducible genes encoding pathological mediators. Crosstalk between Sp1 and NF-kappa B pathways could be pathophysiologically significant, but has not been studied. This study examined the crosstalk between the two pathways and defined the role of NF-kappa B signaling in LPS-induced down-regulation of Sp1 activity. Methods and Main Findings Challenge of wild type mice with samonelia enteritidis LPS (10 mg/kg, i.p.) down-regulated Sp1 binding activity in lungs in a time-dependent manner, which was concomitantly associated with an increased NF-kappa B activity. LPS down-regulates Sp1 activity by inducing an LPS inducible Sp1-degrading enzyme (LISPDE) activity, which selectively degrades Sp1 protein, resulting in Sp1 down-regulation. Blockade of NF-kappa B activation in mice deficient in NF kappa B p50 gene (NF-kappa B-KO) suppressed LISPDE activity, prevented Sp1 protein degradation, and reversed the down-regulation of Sp1 DNA binding activity and eNOS expression (an indicator of Sp1 transactivation activity). Inhibition of LISPDE activity using a selective LISPDE inhibitor mimicked the effects of NF-kappa B blockade. Pretreatment of LPS-challenged WT mice with a selective LISPDE inhibitor increased nuclear Sp1 protein content, restored Sp1 DNA binding activity and reversed eNOS protein down-regulation in lungs. Enhancing tissue level of Sp1 activity by inhibiting NF-kappa B-mediated Sp1 down-regulation increased tissue level of IL-10 and decreased tissue level of TNF-alpha in the lungs. Conclusions NF-kappa B signaling mediates LPS-induced down-regulation of Sp1 activity. Activation of NF-kappa B pathway suppresses Sp1 activity and Sp1-mediated anti-inflammatory signals. Conversely, Sp1 signaling counter-regulates NF-kappa B-mediated inflammatory response. Crosstalk between NF-kappa B and Sp1 pathways regulates the balance between pro- and anti-inflammatory cytokines.	[Ye, Xiaobing; Liu, Shu Fang] Feinstein Inst Med Res, Ctr Heart & Lung Res, Manhasset, NY 11030 USA; [Ye, Xiaobing; Liu, Shu Fang] Feinstein Inst Med Res, Ctr Pulm & Crit Care Med, Manhasset, NY USA; [Liu, Hong; Gong, Yong-Sheng; Liu, Shu Fang] Wenzhou Med Univ, Inst Hypoxia Med, Wenzhou, Peoples R China	Northwell Health; Northwell Health; Wenzhou Medical University	Liu, SF (corresponding author), Feinstein Inst Med Res, Ctr Heart & Lung Res, Manhasset, NY 11030 USA.	sliu@nshs.edu			National Institute of Health grant [R21AI076987]; American Heart Association grant [12GRNT1214002]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI076987] Funding Source: NIH RePORTER	National Institute of Health grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association grant(American Heart Association); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institute of Health grant R21AI076987 (SL), and American Heart Association grant 12GRNT1214002 (SL).	Abdelrahim M, 2004, CANCER RES, V64, P6740, DOI 10.1158/0008-5472.CAN-04-0713; Abumiya T, 2002, ARTERIOSCL THROM VAS, V22, P907, DOI 10.1161/01.ATV.0000018300.43492.83; Ammanamanchi S, 1998, J BIOL CHEM, V273, P16527, DOI 10.1074/jbc.273.26.16527; Baker DL, 1996, J BIOL CHEM, V271, P5921, DOI 10.1074/jbc.271.10.5921; Beauchef G, 2012, J BIOL CHEM, V287, P3462, DOI 10.1074/jbc.M111.286443; Benjamin JT, 2010, J IMMUNOL, V185, P4896, DOI 10.4049/jimmunol.1001857; Bhattacharya J, 2013, ANNU REV PHYSIOL, V75, P593, DOI 10.1146/annurev-physiol-030212-183756; Bouwman P, 2002, MOL CELL ENDOCRINOL, V195, P27, DOI 10.1016/S0303-7207(02)00221-6; Cai DS, 2005, NAT MED, V11, P183, DOI 10.1038/nm1166; Cao SJ, 2006, J BIOL CHEM, V281, P26041, DOI 10.1074/jbc.M602222200; Chambers I, 1997, BIOCHEM J, V328, P879, DOI 10.1042/bj3280879; DECATERINA R, 1995, J CLIN INVEST, V96, P60, DOI 10.1172/JCI118074; Ehlting C, 2005, BIOCHEM J, V387, P737, DOI 10.1042/BJ20041101; Elsharkawy AM, 2010, J HEPATOL, V53, P519, DOI 10.1016/j.jhep.2010.03.025; EMORINE LJ, 1987, P NATL ACAD SCI USA, V84, P6995, DOI 10.1073/pnas.84.20.6995; Fakhrzadeh L, 2004, AM J PHYSIOL-LUNG C, V287, pL279, DOI 10.1152/ajplung.00348.2003; FLORQUIN S, 1994, J EXP MED, V180, P1153, DOI 10.1084/jem.180.3.1153; GEARING KL, 1994, BIOCHEM BIOPH RES CO, V199, P255, DOI 10.1006/bbrc.1994.1222; Grundstrom S, 2004, J BIOL CHEM, V279, P8460, DOI 10.1074/jbc.M312398200; Grunig G, 1997, J EXP MED, V185, P1089, DOI 10.1084/jem.185.6.1089; Grutkoski PS, 2003, J LEUKOCYTE BIOL, V74, P916, DOI 10.1189/jlb.0303108; Herold S, 2013, AM J PHYSIOL-LUNG C, V305, pL665, DOI 10.1152/ajplung.00232.2013; Holmes KW, 2003, AM J RESP CELL MOL, V29, P499, DOI 10.1165/rcmb.2003-0030OC; HOWARD M, 1993, J EXP MED, V177, P1205, DOI 10.1084/jem.177.4.1205; Huang F, 1998, Cell Res, V8, P143; Kaltschmidt B., 2009, COLD SPRING HARB PER, V2, P1, DOI DOI 10.1101/CSHPERSPECT.A001271; KUBES P, 1991, P NATL ACAD SCI USA, V88, P4651, DOI 10.1073/pnas.88.11.4651; Lefer AM, 1999, AM J PHYSIOL-GASTR L, V276, pG572, DOI 10.1152/ajpgi.1999.276.3.G572; Leung-Pineda V, 2002, J BIOL CHEM, V277, P16585, DOI 10.1074/jbc.M110972200; Liu SF, 2006, AM J PHYSIOL-LUNG C, V290, pL622, DOI 10.1152/ajplung.00477.2005; Liu SF, 1997, J IMMUNOL, V159, P3976; Luster TA, 2000, MOL REPROD DEV, V57, P4, DOI 10.1002/1098-2795(200009)57:1<4::AID-MRD3>3.0.CO;2-I; Magee C, 2005, J BIOL CHEM, V280, P25331, DOI 10.1074/jbc.M412549200; MINTH CD, 1990, J BIOL CHEM, V265, P12933; Parakati R, 2002, J BIOL CHEM, V277, P9278, DOI 10.1074/jbc.M108411200; PENG HB, 1995, J BIOL CHEM, V270, P14214, DOI 10.1074/jbc.270.23.14214; PHILIPPE M, 1994, EUR J BIOCHEM, V226, P377, DOI 10.1111/j.1432-1033.1994.tb20062.x; Poynter ME, 2003, J IMMUNOL, V170, P6257, DOI 10.4049/jimmunol.170.12.6257; Rajasingh J, 2006, FASEB J, V20, P2112, DOI 10.1096/fj.06-6084fje; Ritchie S, 2000, J BIOL CHEM, V275, P847, DOI 10.1074/jbc.275.2.847; Rolland V, 1996, J BIOL CHEM, V271, P21297, DOI 10.1074/jbc.271.35.21297; Sarma JV, 2011, COMPR PHYSIOL, V1, P1365, DOI 10.1002/cphy.c100068; Sawa T, 1997, J IMMUNOL, V159, P2858; Schottelius AJG, 1999, J BIOL CHEM, V274, P31868, DOI 10.1074/jbc.274.45.31868; Sewnath ME, 2001, J IMMUNOL, V166, P6323, DOI 10.4049/jimmunol.166.10.6323; Tone M, 2000, J IMMUNOL, V165, P286, DOI 10.4049/jimmunol.165.1.286; Van der Heiden K, 2010, CLIN SCI, V118, P593, DOI 10.1042/CS20090557; Vanden Berghe W, 2003, ADV EXP MED BIOL, V544, P181; Verrecchia F, 2001, J INVEST DERMATOL, V116, P755, DOI 10.1046/j.1523-1747.2001.01326.x; WANG P, 1995, J BIOL CHEM, V270, P9558, DOI 10.1074/jbc.270.16.9558; Wang W, 2004, AM J PHYSIOL-RENAL, V287, pF1044, DOI 10.1152/ajprenal.00136.2004; WARING PM, 1995, P NATL ACAD SCI USA, V92, P1337, DOI 10.1073/pnas.92.5.1337; Wierstra I, 2008, BIOCHEM BIOPH RES CO, V372, P1, DOI 10.1016/j.bbrc.2008.03.074; WINK DA, 1993, P NATL ACAD SCI USA, V90, P9813, DOI 10.1073/pnas.90.21.9813; Yamashita T, 2000, CIRCULATION, V101, P931, DOI 10.1161/01.CIR.101.8.931; Ye XB, 2002, J BIOL CHEM, V277, P31863, DOI 10.1074/jbc.M205544200; Ye XB, 2008, J EXP MED, V205, P1303, DOI 10.1084/jem.20071393; Ye XB, 2007, BBA-MOL CELL RES, V1773, P243, DOI 10.1016/j.bbamcr.2006.09.013; ZEIHER AM, 1995, CIRC RES, V76, P980, DOI 10.1161/01.RES.76.6.980; ZHANG R, 1995, J BIOL CHEM, V270, P15320, DOI 10.1074/jbc.270.25.15320; Zingarelli B, 2003, CRIT CARE MED, V31, pS105, DOI 10.1097/00003246-200301001-00015	61	12	13	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2015	10	6							e0130317	10.1371/journal.pone.0130317	http://dx.doi.org/10.1371/journal.pone.0130317			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4DD	26103469	Green Published, Green Submitted, gold			2022-12-26	WOS:000356901900035
J	Zhang, J; Liang, Z; Han, CJ				Zhang, J.; Liang, Z.; Han, C. J.			Numerical Modeling of Mechanical Behavior for Buried Steel Pipelines Crossing Subsidence Strata	PLOS ONE			English	Article								This paper addresses the mechanical behavior of buried steel pipeline crossing subsidence strata. The investigation is based on numerical simulation of the nonlinear response of the pipeline-soil system through finite element method, considering large strain and displacement, inelastic material behavior of buried pipeline and the surrounding soil, as well as contact and friction on the pipeline-soil interface. Effects of key parameters on the mechanical behavior of buried pipeline were investigated, such as strata subsidence, diameter-thickness ratio, buried depth, internal pressure, friction coefficient and soil properties. The results show that the maximum strain appears on the outer transition subsidence section of the pipeline, and its cross section is concave shaped. With the increasing of strata subsidence and diameter-thickness ratio, the out of roundness, longitudinal strain and equivalent plastic strain increase gradually. With the buried depth increasing, the deflection, out of roundness and strain of the pipeline decrease. Internal pressure and friction coefficient have little effect on the deflection of buried pipeline. Out of roundness is reduced and the strain is increased gradually with the increasing of internal pressure. The physical properties of soil have a great influence on the mechanical properties of buried pipeline. The results from the present study can be used for the development of optimization design and preventive maintenance for buried steel pipelines.	[Zhang, J.; Liang, Z.; Han, C. J.] Southwest Petr Univ, Sch Mech Engn, Chengdu, Peoples R China	Southwest Petroleum University	Zhang, J (corresponding author), Southwest Petr Univ, Sch Mech Engn, Chengdu, Peoples R China.	longmenshao@163.com	Zhang, Jie/S-7218-2016	Zhang, Jie/0000-0002-0437-9834				American Society of Mechanical Engineers, 2007, B318 ANSIASME; ARIMAN T, 1981, EARTHQUAKE ENG STRUC, V9, P133, DOI 10.1002/eqe.4290090204; [戴文亭 DAI Wenting], 2008, [吉林大学学报. 地球科学版, Journal of Jilin University. Earth Science Edition], V38, P831; Fitness-for-Service, 2002, API REC PRACT; Huiying G, 1997, EARTHQ ENG ENG VIB, V17, P68; KENNEDY RP, 1977, TRANSPORT ENG-J ASCE, V103, P617; Liang Z, 1999, MECH PROBLEMS PETROL, V1th; Lillig D.B., 2009, P INT SOC OFFSH POL; Liu A. W., 2002, RESPONSE ANAL BURIED; Liu CG, 2009, J EARTH ENG VIB, V29, P197; Ma LR, 2009, ELECT POWER SURV DES, V16, P05; [马廷霞 Ma Tingxia], 2012, [西南石油大学学报．自然科学版, Journal of Southwest Petroleum University], V34, P165; Mohitpour M, 2007, PIPELINE DESIGN CONS, Vthird, DOI [10.1115/1.802574, DOI 10.1115/1.802574]; Newmark NM, 1975, P US NAT C EARTHQ EN, P416; Shang E. J., 2009, J XIAN PET U, V24, P46; Vazouras P, 2012, SOIL DYN EARTHQ ENG, V41, P164, DOI 10.1016/j.soildyn.2012.05.012; Vougiokas EA, 1979, J TECHNICAL COUNCILS, V105, P432; Wang LRL, 1985, MECH ENG, V106, P115; [王树丰 Wang Shufeng], 2010, [水文地质工程地质, Hydrogeology & Engineering Geology], V37, P22; Wang XL, 2011, ROCK SOIL MECH, V32, P3373; Yuan F, 2012, APPL OCEAN RES, V35, P105, DOI 10.1016/j.apor.2011.12.002	21	10	11	2	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2015	10	6							e0130459	10.1371/journal.pone.0130459	http://dx.doi.org/10.1371/journal.pone.0130459			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4DD	26103460	gold, Green Submitted, Green Published			2022-12-26	WOS:000356901900046
J	Ayanu, Y; Conrad, C; Jentsch, A; Koellner, T				Ayanu, Yohannes; Conrad, Christopher; Jentsch, Anke; Koellner, Thomas			Unveiling Undercover Cropland Inside Forests Using Landscape Variables: A Supplement to Remote Sensing Image Classification	PLOS ONE			English	Article							MOUNTAINS-NATIONAL-PARK; SUB-SAHARAN AFRICA; BALE-MOUNTAINS; AGROFORESTRY SYSTEMS; ECOSYSTEM SERVICES; TOPOGRAPHIC ASPECT; WHEAT-VARIETIES; CLIMATE-CHANGE; LAND-USE; BIODIVERSITY	The worldwide demand for food has been increasing due to the rapidly growing global population, and agricultural lands have increased in extent to produce more food crops. The pattern of cropland varies among different regions depending on the traditional knowledge of farmers and availability of uncultivated land. Satellite images can be used to map cropland in open areas but have limitations for detecting undergrowth inside forests. Classification results are often biased and need to be supplemented with field observations. Undercover cropland inside forests in the Bale Mountains of Ethiopia was assessed using field observed percentage cover of land use/land cover classes, and topographic and location parameters. The most influential factors were identified using Boosted Regression Trees and used to map undercover cropland area. Elevation, slope, easterly aspect, distance to settlements, and distance to national park were found to be the most influential factors determining undercover cropland area. When there is very high demand for growing food crops, constrained under restricted rights for clearing forest, cultivation could take place within forests as an undercover. Further research on the impact of undercover cropland on ecosystem services and challenges in sustainable management is thus essential.	[Ayanu, Yohannes; Koellner, Thomas] Univ Bayreuth, Fac Biol Chem & Earth Sci, Professorship Ecol Serv, D-95440 Bayreuth, Germany; [Conrad, Christopher] Univ Wurzburg, Dept Geog, Remote Sensing Unit, D-97074 Wurzburg, Germany; [Jentsch, Anke] Univ Bayreuth, Fac Biol Chem & Earth Sci, Professorship Disturbance Ecol, D-95440 Bayreuth, Germany	University of Bayreuth; University of Wurzburg; University of Bayreuth	Ayanu, Y (corresponding author), Univ Bayreuth, Fac Biol Chem & Earth Sci, Professorship Ecol Serv, Univ Str 30, D-95440 Bayreuth, Germany.	yohanneszer@yahoo.com	Koellner, Thomas/B-8286-2008	Koellner, Thomas/0000-0001-5022-027X; Conrad, Christopher/0000-0002-0807-7059	University of Bayreuth Germany	University of Bayreuth Germany	The University of Bayreuth Germany provided financial support for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aerts R, 2011, FOREST ECOL MANAG, V261, P1034, DOI 10.1016/j.foreco.2010.12.025; Anthofer J, 1998, AGROFOREST SYST, V40, P1, DOI 10.1023/A:1006058024152; Ayanu YZ, 2011, IJBSM, P1; Baptist R, 2001, ETHIOPIAN J NATURAL, V3, P109; Blanco-Canqui H, 2008, PRINCIPLES SOIL CONS, P425; Breiman L., 2001, MACH LEARN, V45, P5; Briner S, 2013, ECOL SOC, V18, DOI 10.5751/ES-05576-180335; Cao FL, 2010, AGROFOREST SYST, V79, P369, DOI 10.1007/s10457-009-9268-0; Chan JCW, 2008, REMOTE SENS ENVIRON, V112, P2999, DOI 10.1016/j.rse.2008.02.011; Clarke N., 2012, SUSTAINABLE FOREST M, P167; Conrad C, 2014, COMPUT ELECTRON AGR, V103, P63, DOI 10.1016/j.compag.2014.02.003; Cord A, 2010, J ARID ENVIRON, V74, P1083, DOI 10.1016/j.jaridenv.2010.03.012; Crabtree B, 1998, J ENVIRON MANAGE, V52, P1, DOI 10.1006/jema.1997.0159; Crase B, 2012, ECOGRAPHY, V35, P879, DOI 10.1111/j.1600-0587.2011.07138.x; De'ath G, 2007, ECOLOGY, V88, P243, DOI 10.1890/0012-9658(2007)88[243:BTFEMA]2.0.CO;2; Denniston D, 1995, HIGH PRIORITIES CONS, P80; Dereje GTD, 2013, EGU GEN ASS C ABSTR, V15, P3498; Elith J, 2008, J ANIM ECOL, V77, P802, DOI 10.1111/j.1365-2656.2008.01390.x; Estoque RC, 2013, LANDSCAPE URBAN PLAN, V116, P60, DOI 10.1016/j.landurbplan.2013.04.008; Exelis Visual Information Solutions, 2013, ENV 5 0 SOFTW; Garcia-Ruiz JM, 2010, CATENA, V81, P1, DOI 10.1016/j.catena.2010.01.001; George SJ, 2012, AGR ECOSYST ENVIRON, V163, P28, DOI 10.1016/j.agee.2012.06.022; Gibbs HK, 2010, P NATL ACAD SCI USA, V107, P16732, DOI 10.1073/pnas.0910275107; Gill RIS, 2009, AGROFOREST SYST, V76, P579, DOI 10.1007/s10457-009-9223-0; Gimmi U, 2008, ECOSYSTEMS, V11, P113, DOI 10.1007/s10021-007-9111-2; Gislason PO, 2006, PATTERN RECOGN LETT, V27, P294, DOI 10.1016/j.patrec.2005.08.011; Gower DJ, 2013, ORYX, V47, P59, DOI 10.1017/S0030605311001426; Gret-Regamey A, 2012, MT RES DEV, V32, pS23, DOI 10.1659/MRD-JOURNAL-D-10-00115.S1; Hanson MA, 2012, SCIENCE, V335, P851, DOI [10.1126/science.1244693, 10.1126/science.1215904]; Hole DG, 2011, ADAPTIVE MANAGEMENT; Jamnadass RH, 2011, INT FOREST REV, V13, P338, DOI 10.1505/146554811798293836; Johansson M., 2013, FIRE GRAZING SUBALPI; Kasperson JX., 2013, GLOBAL ENV RISK; KHYBRI ML, 1992, AGROFOREST SYST, V17, P193, DOI 10.1007/BF00054147; Kidane Y, 2012, ENVIRON MONIT ASSESS, V184, P7473, DOI 10.1007/s10661-011-2514-8; Kohli A, 2003, AGROFOREST SYST, V58, P109, DOI 10.1023/A:1026090918747; Korner C, 2004, AMBIO, P11; Lambin EF, 2013, GLOBAL ENVIRON CHANG, V23, P892, DOI 10.1016/j.gloenvcha.2013.05.005; Lavers T, 2012, J PEASANT STUD, V39, P105, DOI 10.1080/03066150.2011.652091; Le Saout S, 2013, SCIENCE, V342, P803, DOI 10.1126/science.1239268; Leathwick JR, 2006, ECOL MODEL, V199, P188, DOI 10.1016/j.ecolmodel.2006.05.022; Li FD, 2008, AGROFOREST SYST, V74, P163, DOI 10.1007/s10457-008-9122-9; Littell JS, 2012, CLIMATIC CHANGE, V110, P269, DOI 10.1007/s10584-011-0066-0; Mahboubi P, 1997, AGROFOREST SYST, V37, P59, DOI 10.1023/A:1005873008532; Mamo Y, 2011, TROP ECOL, V52, P265; Mehari Alebachew, 2012, International Research Journal of Agricultural Science and Soil Science, V2, P194; Negash M, 2012, AGROFOREST SYST, V85, P9, DOI 10.1007/s10457-011-9408-1; Nelson E, 2009, FRONT ECOL ENVIRON, V7, P4, DOI 10.1890/080023; Peres CA, 2012, BIOL CONSERV, V151, P65, DOI 10.1016/j.biocon.2011.11.011; Phalan B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0051759; Plath M, 2011, AGROFOREST SYST, V81, P79, DOI 10.1007/s10457-010-9308-9; Pollock MM, 2012, ECOSPHERE, V3, DOI 10.1890/ES12-00175.1; R Core Team, 2018, R LANG ENV STAT COMP; Richter R, 1998, APPL OPTICS, V37, P4004, DOI 10.1364/AO.37.004004; Richter R, 2002, INT J REMOTE SENS, V23, P2631, DOI 10.1080/01431160110115834; Rodriguez-Galiano VF, 2012, ISPRS J PHOTOGRAMM, V67, P93, DOI 10.1016/j.isprsjprs.2011.11.002; Rulli MC, 2013, P NATL ACAD SCI USA, V110, P892, DOI 10.1073/pnas.1213163110; Sankhayan PL, 2001, ECOL ECON, V38, P423, DOI 10.1016/S0921-8009(01)00189-6; Seppelt R, 2011, J APPL ECOL, V48, P630, DOI 10.1111/j.1365-2664.2010.01952.x; SHARMA KK, 1992, AGROFOREST SYST, V17, P43, DOI 10.1007/BF00122926; SINGH A, 1993, AGROFOREST SYST, V22, P83, DOI 10.1007/BF00707473; Singh B, 2007, AGROFOREST SYST, V71, P25, DOI 10.1007/s10457-007-9065-6; Singh HP, 1998, AGROFOREST SYST, V40, P207, DOI 10.1023/A:1005949818756; Smith J, 2012, RENEW AGR FOOD SYST, V27, P323, DOI 10.1017/S1742170511000597; Smits N, 2012, AGROFOREST SYST, V85, P153, DOI 10.1007/s10457-011-9473-5; Stage AR, 2007, FOREST SCI, V53, P486; Stephens PA, 2001, BIOL CONSERV, V100, P307, DOI 10.1016/S0006-3207(01)00035-0; Nguyen TT, 2013, LAND USE POLICY, V33, P130, DOI 10.1016/j.landusepol.2012.12.015; Tyc G, 2005, ACTA ASTRONAUT, V56, P213, DOI 10.1016/j.actaastro.2004.09.029; Viviroli D, 2011, HYDROL EARTH SYST SC, V15, P471, DOI 10.5194/hess-15-471-2011; Wondie M., 2012, INT J REMOTE SENS AP, V2, P36; Yimer F, 2006, GEODERMA, V135, P335, DOI 10.1016/j.geoderma.2006.01.005; Yimer F, 2006, FOREST ECOL MANAG, V232, P90, DOI 10.1016/j.foreco.2006.05.055; Yuejiao L, 2013, SCI WORLD J, V2013, P1; Zhang W, 2013, AGROFOREST SYST, V87, P929, DOI 10.1007/s10457-013-9609-x; Zhu Z, 2012, REMOTE SENS ENVIRON, V117, P72, DOI 10.1016/j.rse.2011.07.020	76	3	3	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2015	10	6							e0130079	10.1371/journal.pone.0130079	http://dx.doi.org/10.1371/journal.pone.0130079			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL3FM	26098107	gold, Green Accepted, Green Submitted, Green Published			2022-12-26	WOS:000356835800054
J	Bahls, M; Friedrich, N; Atzler, D; Felix, SB; Nauck, MA; Boger, RH; Volzke, H; Schwedhelm, E; Dorr, M				Bahls, Martin; Friedrich, Nele; Atzler, Dorothee; Felix, Stephan B.; Nauck, Matthias A.; Boeger, Rainer H.; Voelzke, Henry; Schwedhelm, Edzard; Doerr, Marcus			L-Arginine and SDMA Serum Concentrations Are Associated with Subclinical Atherosclerosis in the Study of Health in Pomerania (SHIP)	PLOS ONE			English	Article							INTIMA-MEDIA THICKNESS; NITRIC-OXIDE SYNTHASE; ASYMPTOMATIC CAROTID ATHEROSCLEROSIS; ASYMMETRIC DIMETHYLARGININE ADMA; CARDIOVASCULAR-DISEASE; VASCULAR-DISEASE; THYROID-FUNCTION; CORONARY-ARTERY; RISK MARKER; MORTALITY	Objective Even though L-arginine (ARG) derivatives can predict cardiovascular mortality, their role as atherosclerotic biomarkers is unclear. We tested the hypothesis if asymmetric dimethylarginine (ADMA), symmetric dimethylarginine (SDMA) and the sum of both (DMA) are positively, while ARG and ARG/ADMA ratio are inversely associated with carotid intima-media thickness (cIMT) and atherosclerotic plaque in the carotid artery. Approach and Results Cross-sectional data of 1999 subjects (age: 45-81 years; 48.2% female) from the population-based Study of Health in Pomerania (SHIP-0) was used. Analysis of variance and logistic regression models were calculated and all adjusted models were corrected for sex, age, smoking status, waist-to-hip ratio and estimated glomerular filtration rate. Increased cIMT (>75th age-sex specific percentile) was found in 517 subjects (25.7%), while atherosclerotic plaque was detected in 1413 subjects (70.4%). SDMA tertiles were significantly positively associated with larger cIMT among subjects with high SDMA levels [>66th: 0.82 (95%-CI 0.80; 0.85) mm]. High SDMA levels were related to a higher odds ratio (OR) of increased cIMT [OR 1.39 (95%-CI 1.08; 1.79)]. Furthermore, ARG was positively associated with atherosclerotic plaques [OR 1.41 (95%-CI 1.07; 1.85)]. No relation was found for ADMA and atherosclerosis. Conclusions In conclusion, the hypothesis of a positive association between SDMA with an increased cIMT was confirmed. Unexpectedly, ARG was positively related to atherosclerotic plaque. In view of these inconsistent findings, the impact of ARG derivatives as atherosclerotic biomarkers deserves further research.	[Bahls, Martin; Felix, Stephan B.; Doerr, Marcus] Univ Med Greifswald, Dept Internal Med B, Greifswald, Germany; [Bahls, Martin; Friedrich, Nele; Atzler, Dorothee; Felix, Stephan B.; Nauck, Matthias A.; Boeger, Rainer H.; Voelzke, Henry; Schwedhelm, Edzard; Doerr, Marcus] DZHK German Ctr Cardiovasc Res, Greifswald, Germany; [Friedrich, Nele; Nauck, Matthias A.] Ernst Moritz Arndt Univ Greifswald, Inst Clin Chem & Lab Med, Greifswald, Germany; [Atzler, Dorothee] Univ Oxford, Div Cardiovasc Med, Radcliffe Dept Med, Oxford, England; [Atzler, Dorothee; Boeger, Rainer H.; Schwedhelm, Edzard] Univ Med Ctr Hamburg Eppendorf, Inst Clin Pharmacol & Toxicol, Hamburg, Germany; [Voelzke, Henry] Ernst Moritz Arndt Univ Greifswald, Inst Community Med, Greifswald, Germany	Greifswald Medical School; German Centre for Cardiovascular Research; Ernst Moritz Arndt Universitat Greifswald; University of Oxford; University of Hamburg; University Medical Center Hamburg-Eppendorf; Ernst Moritz Arndt Universitat Greifswald	Bahls, M (corresponding author), Univ Med Greifswald, Dept Internal Med B, Greifswald, Germany.	martin.bahls@uni-greifswald.de	Dörr, Marcus/F-1919-2010; Bahls, Martin/Q-6639-2018	Dörr, Marcus/0000-0001-7471-475X; Bahls, Martin/0000-0002-2016-5852; Atzler, Dorothee/0000-0002-6551-1544	German Federal Ministry of Education and Research (BMBF) [01ZZ96030, 01ZZ0701]; Ministry for Education, Research, and Cultural Affairs; Ministry for Social Affairs of the Federal State of Mecklenburg-West Pomerania; DZHK (Deutsches Zentrum fur Herz-Kreislauf-Forschung e.V.); BMBF (Bundesministerium fur Bildung und Forschung); European Union	German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Ministry for Education, Research, and Cultural Affairs; Ministry for Social Affairs of the Federal State of Mecklenburg-West Pomerania; DZHK (Deutsches Zentrum fur Herz-Kreislauf-Forschung e.V.); BMBF (Bundesministerium fur Bildung und Forschung)(Federal Ministry of Education & Research (BMBF)); European Union(European Commission)	SHIP is part of the Community Medicine Net (http://www.medizin.uni-greifswald.de/icm) of the University of Greifswald, which is funded by grants from the German Federal Ministry of Education and Research (BMBF, grant 01ZZ96030, 01ZZ0701); the Ministry for Education, Research, and Cultural Affairs; and the Ministry for Social Affairs of the Federal State of Mecklenburg-West Pomerania as well by the DZHK (Deutsches Zentrum fur Herz-Kreislauf-Forschung e.V.) and by the BMBF (Bundesministerium fur Bildung und Forschung). Dr. Atzler acknowledges the support of the European Union under a Marie Curie Intra-European Fellowship for Career Development. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderssohn M, 2012, J CARD FAIL, V18, P904, DOI 10.1016/j.cardfail.2012.10.011; Atzler D, 2014, CLIN CHEM LAB MED; Augustine MS, 2013, CURR PROTOC TOXICOL, V58, DOI [10.1002/0471140856.tx0440s58, DOI 10.1002/0471140856.TX0440S58]; Ayer JG, 2009, ARTERIOSCL THROM VAS, V29, P943, DOI 10.1161/ATVBAHA.109.184184; Bai YY, 2013, AGEING RES REV, V12, P699, DOI 10.1016/j.arr.2012.02.003; Bedi US, 2010, J CARDIOVASC PHARM T, V15, P268, DOI 10.1177/1074248410369110; Boger RH, 2011, J INTERN MED, V269, P349, DOI 10.1111/j.1365-2796.2010.02322.x; Boger RH, 2009, CIRCULATION, V119, P1592, DOI 10.1161/CIRCULATIONAHA.108.838268; Boger RH, 2003, ATHEROSCLEROSIS SUPP, V4, P23, DOI 10.1016/S1567-5688(03)00030-8; Chirinos JA, 2008, HYPERTENSION, V52, P1051, DOI 10.1161/HYPERTENSIONAHA.108.120352; CREAGER MA, 1992, J CLIN INVEST, V90, P1248, DOI 10.1172/JCI115987; Ding KY, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-55; Dorr M, 2008, EUR J ENDOCRINOL, V159, P145, DOI 10.1530/EJE-08-0140; Dorr M, 2009, EUR J EPIDEMIOL, V24, P389, DOI 10.1007/s10654-009-9354-7; DUBOISRANDE JL, 1992, AM J CARDIOL, V70, P1269, DOI 10.1016/0002-9149(92)90760-V; Forstermann U, 2006, CIRCULATION, V113, P1708, DOI 10.1161/CIRCULATIONAHA.105.602532; Furuki K, 2007, ATHEROSCLEROSIS, V191, P206, DOI 10.1016/j.atherosclerosis.2006.03.022; Gore MO, 2013, ARTERIOSCL THROM VAS, V33, P2682, DOI 10.1161/ATVBAHA.113.301219; Inaba Y, 2012, ATHEROSCLEROSIS, V220, P128, DOI 10.1016/j.atherosclerosis.2011.06.044; Jazwinska-Kozuba A, 2013, INT J MOL SCI, V14, P21819, DOI 10.3390/ijms141121819; Jin RC, 2010, J BLOOD MED, V1, P147; John U, 2001, SOZ PRAVENTIV MED, V46, P186, DOI 10.1007/BF01324255; Ludemann J, 2000, GESUNDHEITSWESEN, V62, P234, DOI 10.1055/s-2000-10857; Luedemann J, 2002, STROKE, V33, P2929, DOI 10.1161/01.STR.0000038422.57919.7F; Maas R, 2009, STROKE, V40, P2715, DOI 10.1161/STROKEAHA.109.552539; Notsu Y, 2015, ATHEROSCLEROSIS, V239, P61, DOI 10.1016/j.atherosclerosis.2014.12.030; O'Leary DH, 1999, NEW ENGL J MED, V340, P14, DOI 10.1056/NEJM199901073400103; PALMER RMJ, 1988, NATURE, V333, P664, DOI 10.1038/333664a0; Rajapakse NW, 2009, CLIN EXP PHARMACOL P, V36, P249, DOI 10.1111/j.1440-1681.2008.05123.x; Riccioni G, 2014, INT J MOL SCI, V15, P6391, DOI 10.3390/ijms15046391; Schwedhelm E, 2007, J CHROMATOGR B, V851, P211, DOI 10.1016/j.jchromb.2006.11.052; Schwedhelm E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096875; Sen Nihat, 2009, Atherosclerosis, V204, pe82, DOI 10.1016/j.atherosclerosis.2008.09.029; Siegerink B, 2013, CLIN RES CARDIOL, V102, P193, DOI 10.1007/s00392-012-0515-4; Stevens LA, 2006, NEW ENGL J MED, V354, P2473, DOI 10.1056/NEJMra054415; Sydow K, 2010, CLIN CHEM, V56, P111, DOI 10.1373/clinchem.2009.136200; Taner A, 2013, ATHEROSCLEROSIS, V228, P432, DOI 10.1016/j.atherosclerosis.2013.02.024; Tropeano AI, 2011, FUND CLIN PHARMACOL, V25, P395, DOI 10.1111/j.1472-8206.2010.00832.x; Volzke H, 2011, INT J EPIDEMIOL, V40, P294, DOI 10.1093/ije/dyp394; Volzke H, 2004, J CLIN ENDOCR METAB, V89, P2145, DOI 10.1210/jc.2003-031028; Wang Hongju, 2011, J Cardiovasc Dis Res, V2, P177, DOI 10.4103/0975-3583.85265; Zoccali C, 2002, J AM SOC NEPHROL, V13, P490, DOI 10.1681/ASN.V132490	42	12	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2015	10	6							e0131293	10.1371/journal.pone.0131293	http://dx.doi.org/10.1371/journal.pone.0131293			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL3FM	26098562	gold, Green Submitted, Green Published			2022-12-26	WOS:000356835800167
J	Kimani-Murage, EW; Muthuri, SK; Oti, SO; Mutua, MK; van de Vijver, S; Kyobutungi, C				Kimani-Murage, Elizabeth W.; Muthuri, Stella K.; Oti, Samuel O.; Mutua, Martin K.; van de Vijver, Steven; Kyobutungi, Catherine			Evidence of a Double Burden of Malnutrition in Urban Poor Settings in Nairobi, Kenya	PLOS ONE			English	Article							CHILDHOOD OVERWEIGHT; NUTRITION TRANSITION; DUAL BURDEN; CHILDREN; OBESITY; UNDERNUTRITION; PREVALENCE; HOUSEHOLD; POVERTY; SLUMS	Background Many low- and middle-income countries are undergoing a nutrition transition associated with rapid social and economic transitions. We explore the coexistence of over and undernutrition at the neighborhood and household level, in an urban poor setting in Nairobi, Kenya. Methods Data were collected in 2010 on a cohort of children aged under five years born between 2006 and 2010. Anthropometric measurements of the children and their mothers were taken. Additionally, dietary intake, physical activity, and anthropometric measurements were collected from a stratified random sample of adults aged 18 years and older through a separate cross-sectional study conducted between 2008 and 2009 in the same setting. Proportions of stunting, underweight, wasting and overweight/obesity were dettermined in children, while proportions of underweight and overweight/obesity were determined in adults. Results Of the 3335 children included in the analyses with a total of 6750 visits, 46% (51% boys, 40% girls) were stunted, 11% (13% boys, 9% girls) were underweight, 2.5% (3% boys, 2% girls) were wasted, while 9% of boys and girls were overweight/obese respectively. Among their mothers, 7.5% were underweight while 32% were overweight/obese. A large proportion (43% and 37%%) of overweight and obese mothers respectively had stunted children. Among the 5190 adults included in the analyses, 9% (6% female, 11% male) were underweight, and 22% (35% female, 13% male) were overweight/obese. Conclusion The findings confirm an existing double burden of malnutrition in this setting, characterized by a high prevalence of undernutrition particularly stunting early in life, with high levels of overweight/obesity in adulthood, particularly among women. In the context of a rapid increase in urban population, particularly in urban poor settings, this calls for urgent action. Multisectoral action may work best given the complex nature of prevailing circumstances in urban poor settings. Further research is needed to understand the pathways to this coexistence, and to test feasibility and effectiveness of context-specific interventions to curb associated health risks.	[Kimani-Murage, Elizabeth W.; Muthuri, Stella K.; Oti, Samuel O.; Mutua, Martin K.; van de Vijver, Steven; Kyobutungi, Catherine] African Populat & Hlth Res Ctr, Nairobi, Kenya; [Oti, Samuel O.; van de Vijver, Steven] Univ Amsterdam, Acad Med Ctr, Dept Global Hlth, Amsterdam Inst Global Hlth & Dev, NL-1105 AZ Amsterdam, Netherlands	African Population & Health Research Centre; University of Amsterdam; Academic Medical Center Amsterdam	Kimani-Murage, EW (corresponding author), African Populat & Hlth Res Ctr, Nairobi, Kenya.	ekimani@aphrc.org	Kimani-Murage, Elizabeth/HGB-3312-2022; Mutua, Martin Kavao/O-4533-2019	Mutua, Martin Kavao/0000-0003-1643-9934; Kyobutungi, Catherine/0000-0002-5344-5631	Wellcome Trust UK [WT092775MA, 078530/Z/05/Z]; Wellcome Trust Fellow [097146/Z/11/Z]; William and Flora Hewlett Foundation [2009-40510]; Swedish International Cooperation Agency (SIDA) [2011-001578]	Wellcome Trust UK(Wellcome Trust); Wellcome Trust Fellow(Wellcome Trust); William and Flora Hewlett Foundation; Swedish International Cooperation Agency (SIDA)	The two studies that provided data for this study were supported by grants from the Wellcome Trust UK (Grant Number WT092775MA and 078530/Z/05/Z). Dr. Elizabeth Kimani-Murage is a Wellcome Trust Fellow (Grant #097146/Z/11/Z). This work was also made possible through the generous core funding for APHRC by The William and Flora Hewlett Foundation (Grant Number 2009-40510), and the Swedish International Cooperation Agency (SIDA) (Grant Number 2011-001578).	Abuya BA, 2012, BMC PEDIATR, V12, DOI 10.1186/1471-2431-12-80; African Population and Health Research Center (APHRC), 2014, POPULATION AND HEALT; Ayah R, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-371; Beaglehole R, 2014, LANCET, V384, P105, DOI 10.1016/S0140-6736(14)61091-6; Beguy D, 2013, J BIOSOC SCI, V45, P721, DOI 10.1017/S0021932013000199; Bhutta Z.A., 2008, LANCET, V371, P417, DOI [10.1016/S0140-6736(07)61693-6, DOI 10.1016/S0140-6736(07)61693-6]; Bhutta ZA, 2013, LANCET, V382, P452, DOI 10.1016/S0140-6736(13)60996-4; Black RE, 2003, LANCET, V361, P2226, DOI 10.1016/S0140-6736(03)13779-8; DALLOSSO HM, 1984, INT J OBESITY, V8, P365; Davison K K, 2001, Obes Rev, V2, P159, DOI 10.1046/j.1467-789x.2001.00036.x; Dieffenbach S, 2012, J NUTR, V142, P771, DOI 10.3945/jn.111.153387; Emina J, 2011, J URBAN HEALTH, V88, P200, DOI 10.1007/s11524-011-9594-1; Engle PL, 2000, P NUTR SOC, V59, P25, DOI 10.1017/S0029665100000045; Ettarh R, 2013, PREV CHRONIC DIS, V10, DOI 10.5888/pcd10.130198; Food and Agriculture Organisation (FAO) of the United Nations, 2006, FAO FOOD AND NUTRITI; Fotso JC, 2012, HEALTH PLACE, V18, P375, DOI 10.1016/j.healthplace.2011.12.003; Ganchimeg T, 2014, BJOG-INT J OBSTET GY, V121, P40, DOI 10.1111/1471-0528.12630; Gardner DS, 2009, ADV EXP MED BIOL, V646, P83, DOI 10.1007/978-1-4020-9173-5_9; Gewa CA, 2012, PUBLIC HEALTH NUTR, V15, P1029, DOI 10.1017/S136898001100245X; Gewa CA, 2010, PUBLIC HEALTH NUTR, V13, P496, DOI 10.1017/S136898000999187X; International Food Policy Research Institute, 2014, GLOBAL NUTRITION REP; Jehn M, 2009, ECON HUM BIOL, V7, P28, DOI 10.1016/j.ehb.2009.01.007; Kabubo-Mariara J, 2009, J AFR ECON, V18, P363, DOI 10.1093/jae/ejn024; Kamau JW, 2011, KENYA AFR J PHYS HEA, V17; Kelishadi R, 2007, EPIDEMIOL REV, V29, P62, DOI 10.1093/epirev/mxm003; Kenya National Bureau of Statistics (KNBS) ICF Macro, 2009, KENYA DEMOGRAPHIC AN; Kenya National Bureau of Statistics Ministry of Health National AIDS Control Council Kenya Medical Research Institute National Council for Population and Development, 2015, KENYA DEMOGRAPHIC AN; Kimani-Murage E, 2011, BMC PUBLIC HEALTH, V91, P1098; Kimani-Murage EW, 2014, J URBAN HEALTH, V91, P1098, DOI 10.1007/s11524-014-9894-3; Kimani-Murage EW, 2014, HEALTH PLACE, V29, P95, DOI 10.1016/j.healthplace.2014.06.003; Kimani-Murage EW, 2013, GLOBAL HEALTH ACTION, V6, P193, DOI 10.3402/gha.v6i0.19249; Kimani-Murage EW, 2015, MATERN CHILD NUTR, V11, P314, DOI 10.1111/mcn.12161; Linnemayr S, 2008, ECON HUM BIOL, V6, P252, DOI 10.1016/j.ehb.2008.04.003; Madise NJ, 2012, HEALTH PLACE, V18, P1144, DOI 10.1016/j.healthplace.2012.04.003; Martorell R, 2001, J NUTR, V131, p874S, DOI 10.1093/jn/131.3.874S; Masibo PK, 2012, PUBLIC HEALTH NUTR, V15, P1715, DOI 10.1017/S1368980012002856; Mberu BU, 2014, AFR DEV REV, V26, P172, DOI 10.1111/1467-8268.12073; Mitsuhashi T, 2012, J OCCUP HEALTH, V54, P25, DOI 10.1539/joh.11-0100-OA; Monteiro CA, 2004, AM J PUBLIC HEALTH, V94, P433, DOI 10.2105/AJPH.94.3.433; Muthuri SK, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-436; Muthuri SK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092846; Mutua MK, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-6; Norris SA, 2014, ANN NUTR METAB, V64, P8, DOI 10.1159/000365122; Olack B, 2011, J HEALTH POPUL NUTR, V29, P357, DOI 10.3329/jhpn.v29i4.8451; Oti SO, 2013, TROP MED INT HEALTH, V18, P1520, DOI 10.1111/tmi.12200; Popkin BM, 2012, NUTR REV, V70, P3, DOI 10.1111/j.1753-4887.2011.00456.x; Reilly JJ, 2011, INT J OBESITY, V35, P891, DOI 10.1038/ijo.2010.222; Requejo JH, 2015, LANCET, V385, P466, DOI 10.1016/S0140-6736(14)60925-9; Roemling C, 2013, ECON HUM BIOL, V11, P563, DOI 10.1016/j.ehb.2013.07.001; Tzioumis E, 2014, FOOD NUTR BULL, V35, P230, DOI 10.1177/156482651403500210; UNHABITAT, 2008, STATE OF THE WORLDS; UNICEF, 2011, NUTRITION STRATEGIES; United Nations, 2012, WORLD URBANIZATION P; United Nations Standing Committee on Nutrition (SCN), 2010, SIXTH REPORT ON THE; Van de Poel E, 2007, SOC SCI MED, V65, P1986, DOI 10.1016/j.socscimed.2007.06.032; van de Vijver SJM, 2013, J HYPERTENS, V31, P1018, DOI 10.1097/HJH.0b013e32835e3a56; Varadharajan KS, 2013, ASIA PAC J CLIN NUTR, V22, P326, DOI 10.6133/apjcn.2013.22.3.19; Victora CG, 2008, LANCET, V371, P340, DOI 10.1016/S0140-6736(07)61692-4; WHO, 2011, WORLD REPORT ON DISABILITY, P1; WHO, 2003, GLOBAL STRATEGY FOR; WHO, 2010, GLOB REC PHYS ACT HL, V1st, P15; World Bank, 2012, AFRICAN DEVELOPMENT; World Health Organisation, 2006, SOFTWARE FOR ASSESSI; World Health Organization, 2010, CHILDHOOD OVERWEIGHT; World Health Organization, 2000, WHO TECHN REP SER, V894, DOI DOI 10.1007/978-0-387-71799-9_454; World Health Organization, 2009, GLOBAL HEALTH RISKS; World Health Organization, 2003, DIET NUTRITION AND T; Ziraba AK, 2009, BMC HEALTH SERV RES, V9, DOI [10.1186/1471-2458-9-465, 10.1186/1472-6963-9-46]; Ziraba Abdhalah Kasiira, 2009, Reprod Health, V6, P6, DOI 10.1186/1742-4755-6-6	69	105	106	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2015	10	6							e0129943	10.1371/journal.pone.0129943	http://dx.doi.org/10.1371/journal.pone.0129943			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CL3FM	26098561	Green Published, gold			2022-12-26	WOS:000356835800046
J	Nuhrenberg, TG; Hammann, N; Schnick, T; Preissl, S; Witten, A; Stoll, M; Gilsbach, R; Neumann, FJ; Hein, L				Nuehrenberg, Thomas G.; Hammann, Nils; Schnick, Tilman; Preissl, Sebastian; Witten, Anika; Stoll, Monika; Gilsbach, Ralf; Neumann, Franz-Josef; Hein, Lutz			Cardiac Myocyte De Novo DNA Methyltransferases 3a/3b Are Dispensable for Cardiac Function and Remodeling after Chronic Pressure Overload in Mice	PLOS ONE			English	Article							MAMMALIAN DEVELOPMENT; METHYLATION; DNMT3B; CARDIOMYOCYTES; INACTIVATION; DYNAMICS; DISEASE; HEARTS; CANCER	Background Recent studies reported altered DNA methylation in failing human hearts. This may suggest a role for de novo DNA methylation in the development of heart failure. Here, we tested whether cardiomyocyte-specific loss of de novo DNA methyltransferases Dnmt3a and Dnmt3b altered cardiac function and remodeling after chronic left ventricular pressure overload. Methods Mice with specific ablation of Dnmt3a and Dnmt3b expression in cardiomyocytes were generated by crossing floxed Dnmt3a(fl) and Dnmt3b(fl) alleles with mice expressing Cre recombinase under control of the atrial myosin light chain gene promoter. The efficacy of combined Dnmt3a/3b ablation (DKO) was characterized on cardiomyocyte-specific genomic DNA and mRNA levels. Cardiac phenotyping was carried out without (sham) or with left ventricular pressure overload induced by transverse aortic constriction (TAC). Under similar conditions, cardiac genome-wide transcriptional profiling was performed and DNA methylation levels of promoters of differentially regulated genes were assessed by pyrosequencing. Results DKO cardiomyocytes showed virtual absence of targeted Dnmt3a and Dnmt3b mRNA transcripts. Cardiac phenotyping revealed no significant differences between DKO and control mice under sham and TAC conditions. Transcriptome analyses identified upregulation of 44 and downregulation of 9 genes in DKO as compared with control sham mice. TAC mice showed similar changes with substantial overlap of regulated genes compared to sham. Promoters of upregulated genes were largely unmethylated in DKO compared to control mice. Conclusion The absence of cardiac pathology in the presence of the predicted molecular phenotype suggests that de novo DNA methylation in cardiomyocytes is dispensable for adaptive mechanisms after chronic cardiac pressure overload.	[Nuehrenberg, Thomas G.; Hammann, Nils; Schnick, Tilman; Preissl, Sebastian; Gilsbach, Ralf; Hein, Lutz] Univ Freiburg, Inst Expt & Clin Pharmacol & Toxicol, D-79106 Freiburg, Germany; [Nuehrenberg, Thomas G.; Neumann, Franz-Josef] Univ Herzzentrum Freiburg, Klin Kardiol & Angiol 2, Bad Krozingen, Germany; [Schnick, Tilman] Univ Herzzentrum Freiburg, Klin Angeborene Herzfehler & Padiat Kardiol, D-79106 Freiburg, Germany; [Preissl, Sebastian] Univ Freiburg, Hermann Staudinger Grad Sch, D-79104 Freiburg, Germany; [Witten, Anika; Stoll, Monika] Univ Munster, Core Unit Genom Hochdurchsatzgenet & Genom, Med Fak Munster, D-48149 Munster, Germany; [Hein, Lutz] Univ Freiburg, BIOSS Ctr Biol Signalling Studies, D-79104 Freiburg, Germany	University of Freiburg; Universitats Herzzentrum Freiburg; Universitats Herzzentrum Freiburg; University of Freiburg; University of Munster; University of Freiburg	Hein, L (corresponding author), Univ Freiburg, Inst Expt & Clin Pharmacol & Toxicol, Hugstetter Str 55, D-79106 Freiburg, Germany.	lutz.hein@pharmakol.uni-freiburg.de	Hein, Lutz/GRJ-8644-2022; Witten, Anika/C-5297-2019	Gilsbach, Ralf/0000-0002-0895-1535	Deutsche Forschungsgemeinschaft, Bonn, Germany [SFB992]	Deutsche Forschungsgemeinschaft, Bonn, Germany(German Research Foundation (DFG))	This study was supported by the Deutsche Forschungsgemeinschaft, Bonn, Germany (SFB992, project B03). (www.dfg.de) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bergmann O, 2011, EXP CELL RES, V317, P188, DOI 10.1016/j.yexcr.2010.08.017; Brookes E, 2014, ANNU REV GENET, V48, P237, DOI 10.1146/annurev-genet-120213-092518; Burton A, 2014, NAT REV MOL CELL BIO, V15, P722, DOI 10.1038/nrm3885; Dawson MA, 2012, CELL, V150, P12, DOI 10.1016/j.cell.2012.06.013; Deaton AM, 2011, GENE DEV, V25, P1010, DOI 10.1101/gad.2037511; Dodge JE, 2005, J BIOL CHEM, V280, P17986, DOI 10.1074/jbc.M413246200; Falkenberg KJ, 2014, NAT REV DRUG DISCOV, V13, P673, DOI 10.1038/nrd4360; Filippakopoulos P, 2014, NAT REV DRUG DISCOV, V13, P339, DOI 10.1038/nrd4286; Gilsbach R, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6288; Haas J, 2013, EMBO MOL MED, V5, P413, DOI 10.1002/emmm.201201553; Kaneda M, 2004, NATURE, V429, P900, DOI 10.1038/nature02633; Kawahara Y, 2005, J PHARMACOL SCI, V99, P95, DOI 10.1254/jphs.FP0050343; Kohli RM, 2013, NATURE, V502, P472, DOI 10.1038/nature12750; Lister R, 2013, SCIENCE, V341, P629, DOI 10.1126/science.1237905; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lother A, 2011, HYPERTENSION, V57, P746, DOI 10.1161/HYPERTENSIONAHA.110.163287; Movassagh M, 2011, CIRCULATION, V124, P2411, DOI 10.1161/CIRCULATIONAHA.111.040071; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Royo JL, 2007, NAT PROTOC, V2, P1734, DOI 10.1038/nprot.2007.244; Senyo SE, 2013, NATURE, V493, P433, DOI 10.1038/nature11682; Smith ZD, 2013, NAT REV GENET, V14, P204, DOI 10.1038/nrg3354; Soonpaa MH, 1997, AM J PHYSIOL-HEART C, V272, pH220, DOI 10.1152/ajpheart.1997.272.1.H220; Suzuki MM, 2008, NAT REV GENET, V9, P465, DOI 10.1038/nrg2341; Tost J, 2007, NAT PROTOC, V2, P2265, DOI 10.1038/nprot.2007.314; Vujic A, 2015, J MOL CELL CARDIOL, V82, P174, DOI 10.1016/j.yjmcc.2015.03.007; Wang Qing-Dong, 2004, Journal of Pharmacological and Toxicological Methods, V50, P163, DOI 10.1016/j.vascn.2004.05.005; Wettschureck N, 2001, NAT MED, V7, P1236, DOI 10.1038/nm1101-1236	27	25	26	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2015	10	6							e0131019	10.1371/journal.pone.0131019	http://dx.doi.org/10.1371/journal.pone.0131019			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL3FM	26098432	Green Published, Green Submitted, gold			2022-12-26	WOS:000356835800133
J	Zhang, KF; Bosch-Serra, AD; Boixadera, J; Thompson, AJ				Zhang, Kefeng; Bosch-Serra, Angela D.; Boixadera, Jaume; Thompson, Andrew J.			Investigation of Water Dynamics and the Effect of Evapotranspiration on Grain Yield of Rainfed Wheat and Barley under a Mediterranean Environment: A Modelling Approach	PLOS ONE			English	Article							SOIL HYDRAULIC PARAMETERS; WINTER-WHEAT; SIMULATION-MODELS; USE EFFICIENCY; CLIMATE-CHANGE; IRRIGATION; CONDUCTIVITY; CULTIVARS; EQUATION; SYSTEMS	Agro-hydrological models have increasingly become useful and powerful tools in optimizing water and fertilizer application, and in studying the environmental consequences. Accurate prediction of water dynamics in such models is essential for models to produce reasonable results. In this study, detailed simulations were performed for water dynamics of rainfed winter wheat and barley grown under a Mediterranean climate over a 10-year period. The model employed (Yang et al., 2009. J. Hydrol., 370, 177-190) uses easily available agronomic data, and takes into consideration of all key soil and plant processes in controlling water dynamics in the soil-crop system, including the dynamics of root growth. The water requirement for crop growth was calculated according to the FAO56, and the soil hydraulic properties were estimated using peto-transfer functions (PTFs) based on soil physical properties and soil organic matter content. Results show that the simulated values of soil water content at the depths of 15, 45 and 75 cm agreed with the measurements well with the root of the mean squared errors of 0.027 cm(3) cm(-3) and the model agreement index of 0.875. The simulated seasonal evapotranspiration (ET) ranged from 208 to 388 mm, and grain yield was found to correlate with the simulated seasonal ET in a linear manner within the studied ET range. The simulated rates of grain yield increase were 17.3 and 23.7 kg ha-l for every mm of water evapotranspired for wheat and barley, respectively. The good agreement of soil water content between measurement and simulation and the simulated relationships between grain yield and seasonal ET supported by the data in the literature indicates that the model performed well in modelling water dynamics for the studied soil-crop system, and therefore has the potential to be applied reliably and widely in precision agriculture. Finally, a two-staged approach using inverse modelling techniques to further improve model performance was discussed.	[Zhang, Kefeng] Zhejiang Univ, Ningbo Inst Technol, Ningbo, Zhejiang, Peoples R China; [Bosch-Serra, Angela D.; Boixadera, Jaume] Univ Lleida, Dept Environm & Soil Sci, Lleida, Spain; [Boixadera, Jaume] Generalitat Catalunya, Dept Agr Livestock Fisheries Food & Nat Environm, Lleida, Spain; [Thompson, Andrew J.] Cranfield Univ, Cranfield Soil & AgriFood Inst, Sch Appl Sci, Cranfield MK43 0AL, Beds, England	Zhejiang University; Universitat de Lleida; Cranfield University	Zhang, KF (corresponding author), Zhejiang Univ, Ningbo Inst Technol, Ningbo, Zhejiang, Peoples R China.	kfzhang@hotmail.com	zhang, ke/AAH-8217-2019; Thompson, Andrew J./AAF-3017-2020	Thompson, Andrew J./0000-0002-7419-3402	National Institute for Agricultural and Food Scientific Research and Technology of Spain-INIA [RTA2004-114, RTA2010-126]; FEDER (European Fund for Regional Development); FEADER (European Agricultural Fund for Rural Development); Departament d'Universitats, Recerca i Societat de la Informacio. Generalitat de Catalunya (PIV-DGR); National Natural Science Foundation of China [51379187]	National Institute for Agricultural and Food Scientific Research and Technology of Spain-INIA; FEDER (European Fund for Regional Development)(European Commission); FEADER (European Agricultural Fund for Rural Development); Departament d'Universitats, Recerca i Societat de la Informacio. Generalitat de Catalunya (PIV-DGR); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was funded by National Institute for Agricultural and Food Scientific Research and Technology of Spain-INIA (projects RTA2004-114 and RTA2010-126), FEDER (European Fund for Regional Development), FEADER (European Agricultural Fund for Rural Development), the Departament d'Universitats, Recerca i Societat de la Informacio. Generalitat de Catalunya (2010-PIV-DGR), and National Natural Science Foundation of China (Grant No. 51379187). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbaspour KC, 2001, ADV WATER RESOUR, V24, P827, DOI 10.1016/S0309-1708(01)00018-5; Ahuja L. R., 1990, Agronomy, P143; Allen R. G., 1998, FAO Irrigation and Drainage Paper; Austin RB, 1998, EUR J AGRON, V8, P239, DOI 10.1016/S1161-0301(97)00063-4; Bastiaanssen WGM, 2007, AGR WATER MANAGE, V92, P111, DOI 10.1016/j.agwat.2007.05.013; Boone A, 1996, GLOBAL PLANET CHANGE, V13, P161, DOI 10.1016/0921-8181(95)00044-5; Boscaggin A, 2010, ELECTRON J QUAL THEO, P1; Cannavo P, 2008, ADV AGRON, V97, P131, DOI 10.1016/S0065-2113(07)00004-1; CanteroMartinez C, 1995, EUR J AGRON, V4, P317, DOI 10.1016/S1161-0301(14)80032-4; Clay J, 2004, WORLD AGR ENV KCOMMO; Cortis C, 2013, PROCEDIA ENVIRON SCI, V19, P67, DOI 10.1016/j.proenv.2013.06.008; Dong BD, 2011, AGR WATER MANAGE, V99, P103, DOI 10.1016/j.agwat.2011.07.013; ECKERSTEN H, 1991, FERT RES, V27, P313, DOI 10.1007/BF01051137; Feddes R. A., 1978, SIMULATION FIELD WAT; Ferrero R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098220; GERWITZ A, 1974, J APPL ECOL, V11, P773, DOI 10.2307/2402227; Godwin D, 1990, SIMULATION REPORTS C; Gomez S, 2009, AGR WATER MANAGE, V96, P504, DOI 10.1016/j.agwat.2008.09.025; Greenwood DJ, 2010, J AGR SCI-CAMBRIDGE, V148, P1, DOI 10.1017/S0021859609990487; Greenwood DJ, 2001, J PLANT NUTR, V24, P1799, DOI 10.1081/PLN-100107313; Groot JJR, 1987, SIMULATION REPORTS C, V13; HOPMANS JH, 1999, CHARACTERIZATION MEA, P634; Jamieson P., 1988, Proceedings Annual Conference - Agronomy Society of New Zealand, V18, P7; Jhorar RK, 2002, J HYDROL, V258, P198, DOI 10.1016/S0022-1694(01)00564-9; JOHNSSON H, 1987, AGR ECOSYST ENVIRON, V18, P333, DOI 10.1016/0167-8809(87)90099-5; Kalra N, 2007, AGR WATER MANAGE, V93, P54, DOI 10.1016/j.agwat.2007.06.004; Kang SZ, 2002, AGR WATER MANAGE, V55, P203, DOI 10.1016/S0378-3774(01)00180-9; Kersebatum KC, 2007, MODELLING WATER AND NUTRIENT DYNAMICS IN SOIL-CROP SYSTEMS, P147, DOI 10.1007/978-1-4020-4479-3_11; Kersebaum KC, 2007, MODELLING WATER AND NUTRIENT DYNAMICS IN SOIL-CROP SYSTEMS, P1, DOI 10.1007/978-1-4020-4479-3_1; Lai CT, 2000, ADV WATER RESOUR, V23, P427, DOI 10.1016/S0309-1708(99)00023-8; Lee DH, 1999, J GEOPHYS RES-ATMOS, V104, P27519, DOI 10.1029/1999JD900951; Li KY, 2001, J HYDROL, V252, P189, DOI 10.1016/S0022-1694(01)00456-5; Lu S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113518; Mirschel W, 2007, MODELLING WATER AND NUTRIENT DYNAMICS IN SOIL-CROP SYSTEMS, P59, DOI 10.1007/978-1-4020-4479-3_6; Norman JM, 2013, PROCEDIA ENVIRON SCI, V19, P15, DOI 10.1016/j.proenv.2013.06.003; Pedersen A, 2010, PLANT SOIL, V326, P493, DOI 10.1007/s11104-009-0028-8; Porter J. R., 1993, European Journal of Agronomy, V2, P69, DOI 10.1016/S1161-0301(14)80136-6; PORTER JR, 1984, J AGR SCI-CAMBRIDGE, V102, P383, DOI 10.1017/S0021859600042714; Qin W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078828; Rahn CR, 2010, EUR J HORTIC SCI, V75, P20; Rao S. S., 1984, OPTIMIZATION THEORY; Renaud FG, 2008, SCI TOTAL ENVIRON, V394, P112, DOI 10.1016/j.scitotenv.2007.11.038; Ritchie JT, 1985, DESCRIPTION PERFORMA, P159; Saxton KE, 2006, SOIL SCI SOC AM J, V70, P1569, DOI 10.2136/sssaj2005.0117; Schelle H, 2013, PROCEDIA ENVIRON SCI, V19, P564, DOI 10.1016/j.proenv.2013.06.064; Schelle H, 2012, VADOSE ZONE J, V11, DOI 10.2136/vzj2011.0169; Schmitz GH, 2005, EUR J SOIL SCI, V56, P19, DOI 10.1111/j.1351-0754.2004.00631.x; Semenov MA, 1996, CLIMATE RES, V7, P271, DOI 10.3354/cr007271; SHARRATT BS, 1994, AGR WATER MANAGE, V25, P109, DOI 10.1016/0378-3774(94)90039-6; Soil Survey Staff, 2010, SOIL TAX BAS SYST SO; Sonnleitner MA, 2003, EUR J SOIL SCI, V54, P127, DOI 10.1046/j.1365-2389.2002.00491.x; Stalham MA, 2007, J AGR SCI-CAMBRIDGE, V145, P295, DOI 10.1017/S0021859607006867; Stanley C.D., 1990, IRRIGATION AGR CROPS, P922; Steduto P, 2007, IRRIGATION SCI, V25, P189, DOI 10.1007/s00271-007-0064-1; VANGENUCHTEN MT, 1980, SOIL SCI SOC AM J, V44, P892, DOI 10.2136/sssaj1980.03615995004400050002x; Wild A., 1988, RUSSELLS SOIL CONDIT, V11th; Willmott C.J., 1981, PHYS GEOGR, V2, P184, DOI [10.1080/02723646.1981.10642213, DOI 10.1080/02723646.1981.10642213]; Wolf J, 1996, CLIMATE RES, V7, P253, DOI 10.3354/cr007253; Wosten JHM, 1999, GEODERMA, V90, P169, DOI 10.1016/S0016-7061(98)00132-3; Wright JL, 1990, IRRIGATION AGR CROPS, P860; Yadav BK, 2009, J HYDROL ENG, V14, P913, DOI 10.1061/(ASCE)HE.1943-5584.0000066; Yang DJ, 2009, J HYDROL, V370, P177, DOI 10.1016/j.jhydrol.2009.03.005; Zhang HP, 1999, AGR WATER MANAGE, V38, P195, DOI 10.1016/S0378-3774(98)00069-9; Zhang KF, 2007, PLANT SOIL, V298, P81, DOI 10.1007/s11104-007-9342-1; Zhang KF, 2011, AGR WATER MANAGE, V98, P1081, DOI 10.1016/j.agwat.2011.02.001; Zhang KF, 2010, AGR WATER MANAGE, V97, P399, DOI 10.1016/j.agwat.2009.10.011; Zhang XY, 2011, AGR WATER MANAGE, V98, P1097, DOI 10.1016/j.agwat.2011.02.003; Zwart SJ, 2004, AGR WATER MANAGE, V69, P115, DOI 10.1016/j.agwat.2004.04.007	68	4	4	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2015	10	6							e0131360	10.1371/journal.pone.0131360	http://dx.doi.org/10.1371/journal.pone.0131360			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL3FM	26098946	Green Submitted, Green Published, gold			2022-12-26	WOS:000356835800173
J	Huang, BX; Ning, S; Zhuang, LL; Jiang, CY; Cui, YG; Fan, GP; Qin, LJ; Liu, JY				Huang, Boxian; Ning, Song; Zhuang, Lili; Jiang, Chunyan; Cui, Yugui; Fan, Guoping; Qin, Lianju; Liu, Jiayin			Ethanol Inactivated Mouse Embryonic Fibroblasts Maintain the Self-Renew and Proliferation of Human Embryonic Stem Cells	PLOS ONE			English	Article							SYNTHETIC-POLYMER COATINGS; HEPARAN-SULFATE; CULTURE; GROWTH; DIFFERENTIATION; DERIVATION; IMMOBILIZATION; PLURIPOTENCY; INDUCTION; PROTEINS	Conventionally, mouse embryonic fibroblasts (MEFs) inactivated by mitomycin C or irradiation were applied to support the self-renew and proliferation of human embryonic stem cells (hESCs). To avoid the disadvangtages of mitomycin C and irradiation, here MEFs were treated by ethanol (ET). Our data showed that 10% ET-inactivated MEFs (eiMEFs) could well maintain the self-renew and proliferation of hESCs. hESCs grown on eiMEFs expressed stem cell markers of NANOG, octamer-binding protein 4 (OCT4), stage-specific embryonic antigen-4 (SSEA4) and tumour related antigen-1-81 (TRA-1-81), meanwhile maintained normal karyotype after long time culture. Also, hESCs cocultured with eiMEFs were able to form embryoid body (EB) in vitro and develop teratoma in vivo. Moreover, eiMEFs could keep their nutrient functions after long time cryopreservation. Our results indicate that the application of eiMEF in hESCs culture is safe, economical and convenient, thus is a better choice.	[Huang, Boxian; Liu, Jiayin] China Pharmaceut Univ, Sch Life Sci & Technol, Nanjing 210038, Jiangsu, Peoples R China; [Huang, Boxian; Ning, Song; Jiang, Chunyan; Cui, Yugui; Qin, Lianju; Liu, Jiayin] Nanjing Med Univ, Affiliated Hosp 1, Ctr Clin Reprod Med, State Key Lab Reprod Med, Nanjing 210029, Jiangsu, Peoples R China; [Zhuang, Lili] Nanjing Med Univ, Affiliated Hosp 1, Dept Pediat, Nanjing 210029, Jiangsu, Peoples R China; [Fan, Guoping] Univ Calif Los Angeles, David Geffen Sch Med, Dept Human Genet, Los Angeles, CA 90095 USA	China Pharmaceutical University; Nanjing Medical University; Nanjing Medical University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Qin, LJ (corresponding author), Nanjing Med Univ, Affiliated Hosp 1, Ctr Clin Reprod Med, State Key Lab Reprod Med, Nanjing 210029, Jiangsu, Peoples R China.	ljqin@njmu.edu.cn; jyliu_nj@126.com			State Major Research Program of China [2012CB944902]; National Natural Science Foundation of China [81370764]; Jiangsu projects [BL2012009, FXK201221]; PAPD project; China Scholarship Council [201307060009]	State Major Research Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jiangsu projects; PAPD project; China Scholarship Council(China Scholarship Council)	This work was supported by the grants from the State Major Research Program of China (2012CB944902), National Natural Science Foundation of China (81370764) Jiangsu projects (BL2012009, FXK201221 and the PAPD project) and China Scholarship Council (201307060009).	Alberti K, 2008, NAT METHODS, V5, P645, DOI 10.1038/nmeth.1222; Baker M, 2011, NAT METHODS, V8, P293, DOI 10.1038/nmeth0411-293; BISSELL DM, 1987, J CLIN INVEST, V79, P801, DOI 10.1172/JCI112887; Brons IGM, 2007, NATURE, V448, P191, DOI 10.1038/nature05950; Chen GK, 2011, NAT METHODS, V8, P424, DOI [10.1038/nmeth.1593, 10.1038/NMETH.1593]; Cheng LZ, 2003, STEM CELLS, V21, P131, DOI 10.1634/stemcells.21-2-131; Cho MS, 2008, P NATL ACAD SCI USA, V105, P3392, DOI 10.1073/pnas.0712359105; Crews FT, 2004, ALCOHOL, V33, P63, DOI 10.1016/j.alcohol.2004.04.005; DeBerardinis RJ, 2008, CURR OPIN GENET DEV, V18, P54, DOI 10.1016/j.gde.2008.02.003; Draper JS, 2004, NAT BIOTECHNOL, V22, P53, DOI 10.1038/nbt922; FRIDAY KE, 1991, METABOLISM, V40, P562, DOI 10.1016/0026-0495(91)90044-W; Gobaa S, 2011, NAT METHODS, V8, P949, DOI [10.1038/NMETH.1732, 10.1038/nmeth.1732]; Hao J, 2006, DEV BIOL, V290, P81, DOI 10.1016/j.ydbio.2005.11.011; Ito Y, 2007, J BIOSCI BIOENG, V103, P113, DOI 10.1263/jbb.103.113; Joddar B, 2014, BIOMATER SCI-UK, V2, P1595, DOI 10.1039/c4bm00126e; KLEINMAN HK, 1982, BIOCHEMISTRY-US, V21, P6188, DOI 10.1021/bi00267a025; Klimanskaya I, 2005, LANCET, V365, P1636, DOI 10.1016/S0140-6736(05)66473-2; Konno T, 2006, J BIOSCI BIOENG, V102, P304, DOI 10.1263/jbb.102.304; Kraushaar DC, 2013, BIOL CHEM, V394, P741, DOI 10.1515/hsz-2012-0353; Krishnamoorthy M, 2013, BIRTH DEFECTS RES B, V98, P283, DOI 10.1002/bdrb.21063; Kruta M, 2013, STEM CELLS, V31, P693, DOI 10.1002/stem.1312; Li L, 2010, NAT METHODS, V7, P989, DOI DOI 10.1038/NMETH.1532; Loh XJ, 2009, MACROMOL BIOSCI, V9, P1069, DOI 10.1002/mabi.200900081; Lu J, 2006, P NATL ACAD SCI USA, V103, P5688, DOI 10.1073/pnas.0601383103; Ludwig TE, 2006, NAT BIOTECHNOL, V24, P185, DOI 10.1038/nbt1177; Makino H, 2004, J BIOSCI BIOENG, V98, P374, DOI 10.1263/jbb.98.374; Matsuo I, 2013, CURR OPIN GENET DEV, V23, P399, DOI 10.1016/j.gde.2013.02.004; Mei Y, 2010, NAT MATER, V9, P768, DOI [10.1038/NMAT2812, 10.1038/nmat2812]; Melkoumian Z, 2010, NAT BIOTECHNOL, V28, P606, DOI 10.1038/nbt.1629; Nagaoka M, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000015; Nandivada H, 2011, NAT PROTOC, V6, P1037, DOI 10.1038/nprot.2011.342; Nash R, 2012, EXP NEUROL, V234, P127, DOI 10.1016/j.expneurol.2011.12.022; Niccols A, 2007, BRAIN COGNITION, V65, P135, DOI 10.1016/j.bandc.2007.02.009; Palmer JA, 2012, ALCOHOL CLIN EXP RES, V36, P1314, DOI 10.1111/j.1530-0277.2011.01732.x; Sato N, 2004, NAT MED, V10, P55, DOI 10.1038/nm979; Shamblott MJ, 1998, P NATL ACAD SCI USA, V95, P13726, DOI 10.1073/pnas.95.23.13726; Shi Y, 2008, CELL STEM CELL, V3, P568, DOI 10.1016/j.stem.2008.10.004; Stelling MP, 2013, GLYCOBIOLOGY, V23, P337, DOI 10.1093/glycob/cws133; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takemoto N, 2013, J AM CHEM SOC, V135, P11032, DOI 10.1021/ja4018682; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Trounson A, 2006, ENDOCR REV, V27, P208, DOI 10.1210/er.2005-0016; VandeVoort CA, 2011, ALCOHOL CLIN EXP RES, V35, P1534, DOI 10.1111/j.1530-0277.2011.01490.x; Venu P, 2010, IN VITRO CELL DEV-AN, V46, P200, DOI 10.1007/s11626-010-9277-3; Villa-Diaz LG, 2010, NAT BIOTECHNOL, V28, P581, DOI 10.1038/nbt.1631; Wang ZT, 2012, RADIOCARBON, V54, P195, DOI 10.2458/azu_js_rc.v54i2.15869; WILLIAMS RL, 1988, NATURE, V336, P684, DOI 10.1038/336684a0; Xi JF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014457; Xie CQ, 2004, BIOCHEM BIOPH RES CO, V315, P581, DOI 10.1016/j.bbrc.2004.01.089; Xu CH, 2001, NAT BIOTECHNOL, V19, P971, DOI 10.1038/nbt1001-971; Yoon TM, 2010, STEM CELL REV REP, V6, P425, DOI 10.1007/s12015-010-9158-x; Yue XS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032707	52	2	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2015	10	6							e0130332	10.1371/journal.pone.0130332	http://dx.doi.org/10.1371/journal.pone.0130332			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL3FE	26091287	Green Submitted, gold, Green Published			2022-12-26	WOS:000356835000103
J	Paoloni, M; Mazcko, C; Selting, K; Lana, S; Barber, L; Phillips, J; Skorupski, K; Vail, D; Wilson, H; Biller, B; Avery, A; Kiupel, M; LeBlanc, A; Bernhardt, A; Brunkhorst, B; Tighe, R; Khanna, C				Paoloni, Melissa; Mazcko, Christina; Selting, Kimberly; Lana, Susan; Barber, Lisa; Phillips, Jeffrey; Skorupski, Katherine; Vail, David; Wilson, Heather; Biller, Barbara; Avery, Anne; Kiupel, Matti; LeBlanc, Amy; Bernhardt, Anna; Brunkhorst, Beatrice; Tighe, Robert; Khanna, Chand			Defining the Pharmacodynamic Profile and Therapeutic Index of NHS-IL12 Immunocytokine in Dogs with Malignant Melanoma	PLOS ONE			English	Article							METASTATIC MELANOMA; MURAMYL TRIPEPTIDE; CLINICAL-TRIALS; TNF-ALPHA; CANCER; INTERLEUKIN-2; VACCINE; IMMUNOTHERAPY; OSTEOSARCOMA; CISPLATIN	Background Interleukin (IL)-12 is a pro-inflammatory cytokine that mediates T-helper type 1 responses and cytotoxic T-cell activation, contributing to its utility as anti-cancer agent. Systemic administration of IL-12 often results in unacceptable toxicity; therefore, strategies to direct delivery of IL-12 to tumors are under investigation. The objective of this study was to assist the preclinical development of NHS-IL12, an immunocytokine consisting of an antibody, which targets necrotic tumor regions, linked to IL-12. Specifically this study sought to evaluate the safety, serum pharmacokinetics, anti-tumor activity, and immune modulation of NHS-IL12 in dogs with naturally occurring cancers. Methodology/Principal Findings A rapid dose-escalation study of NHS-IL12 administered subcutaneously to dogs with melanoma was conducted through the Comparative Oncology Trials Consortium (COTC). Eleven dogs were enrolled in four dose-escalation cohorts; thereafter, an additional seven dogs were treated at the defined tolerable dose of 0.8 mg/m(2). The expanded cohort at this fixed dose (ten dogs in total) was accrued for further pharmacokinetics and pharmacodynamics assessment. NHS-IL12 levels, serum cytokine concentrations, and peripheral blood mononuclear cell characterization (post-treatment) and draining lymph node immune profiling, and tumor biopsies (pre- and post-treatment) were collected. Adverse events included thrombocytopenia, liver enzymopathies, fever, and vasculitis. Correlation between interferon (IFN)-gamma induction, adverse events, and NHS-IL12 exposure (maximum concentration and area under the concentration-time curve) were dose-dependent. Serum IL-10 levels and intratumoral CD8(+) populations increased after treatment. Partial responses, according to Response Evaluation Criteria in Solid Tumors (RECIST) criteria, were observed in two dogs treated with NHS-IL12 0.8 mg/m(2) and 1.6 mg/m(2). Conclusions/Significance NHS-IL12 was administered safely to dogs with melanoma and both immunologic and clinical activity was observed. This study successfully defined a narrow therapeutic window for systemic delivery of NHS-IL12 via the subcutaneous route. Results will inform the design and implementation of first-in-human clinical trials of NHS-IL12 in cancer patients.	[Paoloni, Melissa; Mazcko, Christina; LeBlanc, Amy; Khanna, Chand] NCI, Comparat Oncol Program, Ctr Canc Res, Bethesda, MD 20892 USA; [Selting, Kimberly] Univ Missouri, Coll Vet Med, Columbia, MO USA; [Lana, Susan; Biller, Barbara; Avery, Anne] Colorado State Univ, Coll Vet Med & Biol Sci, Ft Collins, CO 80523 USA; [Barber, Lisa] Tufts Univ, Sch Vet Med, North Grafton, MA 01536 USA; [Phillips, Jeffrey] Univ Tennessee, Coll Vet Med, Knoxville, TN USA; [Skorupski, Katherine] Univ Calif Davis, Sch Vet Med, Davis, CA 95616 USA; [Vail, David] Univ Wisconsin, Sch Vet Med, Madison, WI 53706 USA; [Wilson, Heather] Texas A&M Univ, Coll Vet Med, College Stn, TX 77843 USA; [Kiupel, Matti] Michigan State Univ, Coll Vet Med, E Lansing, MI 48824 USA; [Bernhardt, Anna; Brunkhorst, Beatrice; Tighe, Robert] EMD Serono Res & Dev Inst, Billerica, MA USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Missouri System; University of Missouri Columbia; Colorado State University; Tufts University; University of Tennessee System; University of Tennessee Knoxville; UT Institute of Agriculture; University of California System; University of California Davis; University of Wisconsin System; University of Wisconsin Madison; Texas A&M University System; Texas A&M University College Station; Michigan State University	Khanna, C (corresponding author), NCI, Comparat Oncol Program, Ctr Canc Res, Bethesda, MD 20892 USA.	khannac@mail.nih.gov	Skorupski, Katherine/AAP-7753-2021; Kiupel, Matti/G-2827-2011	Skorupski, Katherine/0000-0003-0324-445X; Kiupel, Matti/0000-0003-4429-9529	Intramural Research Program of the National Institutes of Health (NIH); Merck KGaA, Darmstadt, Germany; National Cancer Institute, Center for Cancer Research; NATIONAL CANCER INSTITUTE [ZIGBC011619] Funding Source: NIH RePORTER	Intramural Research Program of the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Merck KGaA, Darmstadt, Germany(Merck & Company); National Cancer Institute, Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported in part by the Intramural Research Program of the National Institutes of Health (NIH), National Cancer Institute, Center for Cancer Research, and by Merck KGaA, Darmstadt, Germany. NHS-IL12 was provided by EMD Serono, Billerica, MA. Editorial assistance was provided by Marianne Jenal-Eyholzer, PhD CMPP, TRM Oncology, The Hague, The Netherlands, funded by Merck KGaA, Darmstadt, Germany. AB, BB, and RT are employees of EMD Serono, Billerica, MA, USA (a subsidiary of Merck KGaA, Darmstadt, Germany). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atkins MB, 1999, J CLIN ONCOL, V17, P2105, DOI 10.1200/JCO.1999.17.7.2105; Bergman PJ, 2006, VACCINE, V24, P4582, DOI 10.1016/j.vaccine.2005.08.027; Browne SK, 2010, CURR OPIN ALLERGY CL, V10, P534, DOI 10.1097/ACI.0b013e3283402b41; Cebon Jonathan, 2003, Cancer Immun, V3, P7; COHEN J, 1995, SCIENCE, V270, P908; Colombo MP, 2002, CYTOKINE GROWTH F R, V13, P155, DOI 10.1016/S1359-6101(01)00032-6; Del Vecchio M, 2007, CLIN CANCER RES, V13, P4677, DOI 10.1158/1078-0432.CCR-07-0776; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Finocchiaro LME, 2008, GENE THER, V15, P267, DOI 10.1038/sj.gt.3303072; Gillies SD, 1998, J IMMUNOL, V160, P6195; Gordon I, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000161; Haicheur N, 2000, CLIN EXP IMMUNOL, V119, P28, DOI 10.1046/j.1365-2249.2000.01112.x; Hogge GS, 1999, CANCER GENE THER, V6, P26, DOI 10.1038/sj.cgt.7700015; Jia L, 2008, FOOD CHEM TOXICOL, V46, P203, DOI 10.1016/j.fct.2007.07.017; Khanna C, 1997, CANCER-AM CANCER SOC, V79, P1409, DOI 10.1002/(SICI)1097-0142(19970401)79:7<1409::AID-CNCR19>3.0.CO;2-3; Kirkwood JM, 1998, LANCET, V351, P1901, DOI 10.1016/S0140-6736(05)78608-6; KIRKWOOD JM, 1994, IMMUNOL SER, V61, P239; Kurzman ID, 1995, CLIN CANCER RES, V1, P1595; Nardin A, 2006, CURR CANCER DRUG TAR, V6, P123, DOI 10.2174/156800906776056473; Oleksowicz Leslie, 1994, Am J Ther, V1, P107, DOI 10.1097/00045391-199408000-00002; Paoloni M, 2008, NAT REV CANCER, V8, P147, DOI 10.1038/nrc2273; Paoloni MC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011013; Paoloni MC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004972; Portielje JEA, 2003, CLIN CANCER RES, V9, P76; Rosen MA, 2010, CANCER BIOL THER, V9, P20, DOI 10.4161/cbt.9.1.10716; Rosenberg SA, 1999, J CLIN ONCOL, V17, P968, DOI 10.1200/JCO.1999.17.3.968; ROSENBERG SA, 1988, NEW ENGL J MED, V319, P1676, DOI 10.1056/NEJM198812223192527; Trikha M, 2003, CLIN CANCER RES, V9, P4653; Trinchieri G, 2003, NAT REV IMMUNOL, V3, P133, DOI 10.1038/nri1001; Trinchieri G, 2003, IMMUNITY, V19, P641, DOI 10.1016/S1074-7613(03)00296-6; Vail David M, 2004, Vet Comp Oncol, V2, P194, DOI 10.1111/j.1476-5810.2004.0053a.x; van Horssen R, 2006, ONCOLOGIST, V11, P397, DOI 10.1634/theoncologist.11-4-397; Wolchok JD, 2007, MOL THER, V15, P2044, DOI 10.1038/sj.mt.6300290; Xie KP, 2001, CYTOKINE GROWTH F R, V12, P375, DOI 10.1016/S1359-6101(01)00016-8	34	34	35	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2015	10	6							e0129954	10.1371/journal.pone.0129954	http://dx.doi.org/10.1371/journal.pone.0129954			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL3FE	26091536	gold, Green Published, Green Submitted			2022-12-26	WOS:000356835000076
J	Howley, BV; Hussey, GS; Link, LA; Howe, PH				Howley, B. V.; Hussey, G. S.; Link, L. A.; Howe, P. H.			Translational regulation of inhibin beta A by TGF beta via the RNA-binding protein hnRNP E1 enhances the invasiveness of epithelial-to-mesenchymal transitioned cells	ONCOGENE			English	Article							ACTIVIN-A; STEM-CELLS; BREAST; CANCER; EXPRESSION; ACTIVATION; PATHWAY; STATES; INHBA	The epithelial-to-mesenchymal transition (EMT) is a cellular process that functions during embryonic development and tissue regeneration, thought to be aberrantly activated in epithelial-derived cancer and has an important role in the process of metastasis. The transforming growth factor (TGF)-beta signaling pathway is a key inducer of EMT and we have elucidated a posttranscriptional mechanism by which TGF beta modulates expression of select transcripts via the RNA-binding protein hnRNP E1 during EMT. One such transcript inhibin beta A is a member of the TGF beta superfamily. Here, we show by polysome profiling that inhibin beta A is translationally regulated by TGF beta via hnRNP E1. TGF beta treatment or knockdown of hnRNP E1 relieves silencing of the inhibin beta A transcript, resulting in increased protein expression and secreted levels of the inhibin beta A homodimer, activin A. Our data indicate that the translational upregulation of inhibin beta A enhances the migration and invasion of cells that have undergone an EMT and promotes cancer progression in vivo.	[Howley, B. V.; Hussey, G. S.; Link, L. A.; Howe, P. H.] Med Univ S Carolina, Dept Biochem & Mol Biol, 173 Ashley Ave,MSC 509,Room 501, Charleston, SC 29425 USA; [Howley, B. V.; Hussey, G. S.; Link, L. A.; Howe, P. H.] Med Univ S Carolina, Hollings Canc Ctr, Charleston, SC 29425 USA; [Link, L. A.] Kent State Univ, Dept Biomed Sci, Kent, OH 44242 USA	Medical University of South Carolina; Medical University of South Carolina; University System of Ohio; Kent State University; Kent State University Kent; Kent State University Salem	Howe, PH (corresponding author), Med Univ S Carolina, Dept Biochem & Mol Biol, 173 Ashley Ave,MSC 509,Room 501, Charleston, SC 29425 USA.	howep@musc.edu			National Cancer Institute [CA055536, CA154663]; Abney Foundation; American Heart Association Pre-doctoral Fellowship [10PRE3870024]; National Institute of General Medicine [P30GM103331, P30GM103342, P30CA138313]; Biorepository & Tissue Analysis Shared Resource, Hollings Cancer Center, MUSC; Gene Targeting and Knockout Shared Resource at MUSC; NATIONAL CANCER INSTITUTE [R01CA154663, R01CA055536] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Abney Foundation; American Heart Association Pre-doctoral Fellowship(American Heart Association); National Institute of General Medicine(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Biorepository & Tissue Analysis Shared Resource, Hollings Cancer Center, MUSC; Gene Targeting and Knockout Shared Resource at MUSC; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by Grants CA055536 and CA154663 from the National Cancer Institute. BVH was supported by funding from the Abney Foundation. GSH was supported by an American Heart Association Pre-doctoral Fellowship 10PRE3870024. This study used the services of the MUSC Center for Oral Health Research (COHR), which is partially supported by the National Institute of General Medicine grant P30GM103331, the MUSC Flow Cytometry Facility which is supported by P30GM103342, the Cell & Molecular Imaging Shared Resource of MUSC supported by P30CA138313, the Biorepository & Tissue Analysis Shared Resource, Hollings Cancer Center, MUSC and the Gene Targeting and Knockout Shared Resource at MUSC. We would like to thank Maya El Sabban for assisting us with xenograft experiments.	Antenos M, 2007, MOL ENDOCRINOL, V21, P1670, DOI 10.1210/me.2007-0050; Arai KY, 2011, ENDOCRINOLOGY, V152, P3779, DOI 10.1210/en.2011-0255; Burdette JE, 2005, CANCER RES, V65, P7968, DOI 10.1158/0008-5472.CAN-04-3553; Chaudhury A, 2010, NAT CELL BIOL, V12, P286, DOI 10.1038/ncb2029; Gunasinghe NPAD, 2012, CANCER METAST REV, V31, P469, DOI 10.1007/s10555-012-9377-5; Hussey GS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052624; Hussey GS, 2011, MOL CELL, V41, P419, DOI 10.1016/j.molcel.2011.02.003; Kang HY, 2009, J BONE MINER RES, V24, P1180, DOI [10.1359/JBMR.090219, 10.1359/jbmr.090219]; Kim ES, 2005, CYTOKINE, V29, P84, DOI 10.1016/j.cyto.2004.10.001; Kim H, 2010, BMC MED GENOMICS, V3, DOI 10.1186/1755-8794-3-51; Le Bras GF, 2014, LAB INVEST, V94, P1134, DOI 10.1038/labinvest.2014.97; Lee KL, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002130; Leto G, 2006, CLIN EXP METASTAS, V23, P117, DOI 10.1007/s10585-006-9010-5; LI RH, 1995, ENDOCRINOLOGY, V136, P849, DOI 10.1210/en.136.3.849; Lonardo E, 2011, CELL STEM CELL, V9, P433, DOI 10.1016/j.stem.2011.10.001; Massague J, 2000, CELL, V103, P295, DOI 10.1016/S0092-8674(00)00121-5; MATZUK MM, 1995, NATURE, V374, P354, DOI 10.1038/374354a0; OGAWA Y, 1992, J BIOL CHEM, V267, P14233; Pearson S, 2008, DEVELOPMENT, V135, P1525, DOI 10.1242/dev.011767; Piek E, 1999, J CELL SCI, V112, P4557; Polyak K, 2009, NAT REV CANCER, V9, P265, DOI 10.1038/nrc2620; Radisky DC, 2005, J CELL SCI, V118, P4325, DOI 10.1242/jcs.02552; Reis FM, 2002, J CLIN ENDOCR METAB, V87, P2277, DOI 10.1210/jc.87.5.2277; Scheel C, 2011, CELL, V145, P926, DOI 10.1016/j.cell.2011.04.029; Schmierer B, 2007, NAT REV MOL CELL BIO, V8, P970, DOI 10.1038/nrm2297; Seder CW, 2009, NEOPLASIA, V11, P388, DOI 10.1593/neo.81582; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Valcourt U, 2005, MOL BIOL CELL, V16, P1987, DOI 10.1091/mbc.e04-08-0658; Walia V, 2010, STEM CELLS DEV, V19, P1175, DOI 10.1089/scd.2009.0430; Wamsley JJ, 2015, CANCER RES, V75, P426, DOI 10.1158/0008-5472.CAN-13-2702; Wang Q, 2012, MED ONCOL, V29, P77, DOI 10.1007/s12032-010-9766-y; Wildi S, 2001, GUT, V49, P409, DOI 10.1136/gut.49.3.409	32	25	26	1	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 31	2016	35	13					1725	1735		10.1038/onc.2015.238	http://dx.doi.org/10.1038/onc.2015.238			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DH8RP	26096938	Green Accepted			2022-12-26	WOS:000373064200011
J	Delville, M; Sabbah, L; Girard, D; Elie, C; Manceau, S; Piketty, M; Martinez, F; Mejean, A; Legendre, C; Sberro-Soussan, R				Delville, Marianne; Sabbah, Laurent; Girard, Delphine; Elie, Caroline; Manceau, Sandra; Piketty, Marie; Martinez, Frank; Mejean, Arnaud; Legendre, Christophe; Sberro-Soussan, Rebecca			Prevalence and Predictors of Early Cardiovascular Events after Kidney Transplantation: Evaluation of Pre-Transplant Cardiovascular Work-Up	PLOS ONE			English	Article							LEFT-VENTRICULAR HYPERTROPHY; CORONARY-ARTERY-DISEASE; STAGE RENAL-DISEASE; 2010 ACCF/AHA GUIDELINE; ASSOCIATION TASK-FORCE; MYOCARDIAL-INFARCTION; HEART-ASSOCIATION; PROGNOSTIC VALUE; STRESS ECHOCARDIOGRAPHY; ASYMPTOMATIC ADULTS	Introduction Cardiovascular disease is the leading cause of mortality after renal transplantation. The purpose of this study was to analyze cardiovascular risk factors at transplantation, occurrence of cardiovascular events in the first year after transplantation and evaluate pre-transplant work-up. Material and Method In total, 244 renal transplant recipients older than 50 years were included. The results of pre-transplant work-up, including clinical evaluation, electrocardiogram, echocardiography, myocardial perfusion testing and coronary angiography were analyzed. Results Patients hadmultiple risk factors at inclusion on renal transplantation waiting list as high blood pressure (94.7%), dyslipidemia (81.1%), smoking (45.3%), diabetes (23.6%), past history of cardiovascular disease (21.3%) and obesity (12.7%). Following transplantation, 15.5% (n = 38) of patients experienced a cardiovascular event, including 2.8% (n = 7) acute coronary syndrome, 5.8% (n = 14) isolated increase in troponin level and 5.3% (n = 13) new onset atrial fibrillation. The pre-transplant parameters associated with a cardiovascular event were a past medical history of cardiovascular disease (HR = 2.06 [1.06-4.03], p = 0.03), echocardiographic left ventricular hypertrophy (HR = 2.04 [1.04-3.98], p = 0.037) and abnormal myocardial perfusion testing (HR = 2.25 [1.09-5.96], p = 0.03). Pre-transplantation evaluation allowed the diagnosis of unknown coronary artery lesions in 8.9% of patients.	[Delville, Marianne; Martinez, Frank; Legendre, Christophe; Sberro-Soussan, Rebecca] Univ Paris 05, Hop Necker, AP HP, Sorbonne Paris Cite,Dept Nephrol & Transplantat, Paris, France; [Sabbah, Laurent] Hop Necker Enfants Malad, APHP, Dept Cardiol, Paris, France; [Girard, Delphine; Elie, Caroline] Hop Necker Enfants Malad, APHP, Dept Biostat, Paris, France; [Delville, Marianne; Sabbah, Laurent; Girard, Delphine; Elie, Caroline; Manceau, Sandra; Piketty, Marie; Martinez, Frank; Mejean, Arnaud; Legendre, Christophe; Sberro-Soussan, Rebecca] Univ Paris 05, Sorbonne Paris Cite, RTRS Centaure Labex Transplantex, Paris, France; [Manceau, Sandra] Hop Necker Enfants Malad, APHP, Dept Clin Res, Paris, France; [Piketty, Marie] Hop Necker Enfants Malad, APHP, Dept Funct Explorat, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite	Delville, M (corresponding author), Univ Paris 05, Hop Necker, AP HP, Sorbonne Paris Cite,Dept Nephrol & Transplantat, Paris, France.	marianne.delville@gmail.com	Delville, Marianne/H-2985-2017	Delville, Marianne/0000-0002-9585-2307	Renal Transplant Unit at Necker Hospital belongs to the Fondation Centaure; Labex Transplantex	Renal Transplant Unit at Necker Hospital belongs to the Fondation Centaure; Labex Transplantex	The Renal Transplant Unit at Necker Hospital belongs to the Fondation Centaure and the Labex Transplantex, which support French transplantation research networks.	Aalten J, 2008, TRANSPL INT, V21, P985, DOI 10.1111/j.1432-2277.2008.00717.x; Abbud M, 2007, TRANSPLANTATION, V83, pS1, DOI 10.1097/01.tp.0000260765.41275.e2; [Anonymous], 2005, AM J KIDNEY DIS OFFI, V45, pS1; Arend SM, 1997, NEPHROL DIAL TRANSPL, V12, P1672, DOI 10.1093/ndt/12.8.1672; Berger AK, 2003, J AM COLL CARDIOL, V42, P201, DOI 10.1016/S0735-1097(03)00572-2; BOUDREAU RJ, 1990, RADIOLOGY, V175, P103, DOI 10.1148/radiology.175.1.2315467; Dahan M, 1998, KIDNEY INT, V54, P255, DOI 10.1046/j.1523-1755.1998.00988.x; Foley RN, 2003, SEMIN DIALYSIS, V16, P111, DOI 10.1046/j.1525-139X.2003.160271.x; Greenland P, 2010, CIRCULATION, V122, pE584, DOI 10.1161/CIR.0b013e3182051b4c; Greenland P, 2010, J AM COLL CARDIOL, V56, pE50, DOI 10.1016/j.jacc.2010.09.001; Greenwood JP, 2012, LANCET, V379, P453, DOI 10.1016/S0140-6736(11)61335-4; Hoftman N, 2013, TRANSPLANTATION; Jardine AG, 2011, LANCET, V378, P1419, DOI 10.1016/S0140-6736(11)61334-2; Jardine MJ, 2010, J AM COLL CARDIOL, V56, P956, DOI 10.1016/j.jacc.2010.02.068; Kahn MR, 2011, AM J TRANSPLANT, V11, P2665, DOI 10.1111/j.1600-6143.2011.03734.x; Kasiske BL, 2010, KIDNEY INT, V77, P299, DOI 10.1038/ki.2009.377; Kasiske BL, 2001, TRANSPLANTATION, V72, pS5; Lee TH, 1999, NEW ENGL J MED, V341, P1838, DOI 10.1056/NEJM199912093412410; Lentine KL, 2005, J AM SOC NEPHROL, V16, P496, DOI 10.1681/ASN.2004070580; Lentine KL, 2012, CIRCULATION, V126, P617, DOI 10.1161/CIR.0b013e31823eb07a; Lentine KL, 2010, AM J KIDNEY DIS, V55, P152, DOI 10.1053/j.ajkd.2009.06.032; LEVY D, 1990, CIRCULATION, V81, P815, DOI 10.1161/01.CIR.81.3.815; Lewis MS, 2002, AM J CARDIOL, V89, P847, DOI 10.1016/S0002-9149(02)02197-5; London GM, 1997, KIDNEY INT, V51, P1678, DOI 10.1038/ki.1997.233; Mahajan N, 2010, HEART, V96, P956, DOI 10.1136/hrt.2009.182295; Marcen R, 2006, NEPHROL DIAL TRAN S3, V21, piii3, DOI DOI 10.1093/NDT/GFL298; Ojo AO, 2000, KIDNEY INT, V57, P307, DOI 10.1046/j.1523-1755.2000.00816.x; Parikh NI, 2008, AM J CARDIOL, V102, P47, DOI 10.1016/j.amjcard.2008.02.095; Patel AD, 2003, AM J CARDIOL, V92, P146, DOI 10.1016/S0002-9149(03)00529-0; Paterson S, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.256101; Pilmore H, 2010, TRANSPLANTATION, V89, P851, DOI 10.1097/TP.0b013e3181caeead; Poldermans D, 1999, NEW ENGL J MED, V341, P1789, DOI 10.1056/NEJM199912093412402; Rigatto C, 2003, J AM SOC NEPHROL, V14, P462, DOI 10.1097/01.ASN.0000043141.67989.39; Sadowski EA, 2007, RADIOLOGY, V243, P148, DOI 10.1148/radiol.2431062144; Sharma R, 2005, NEPHROL DIAL TRANSPL, V20, P2207, DOI 10.1093/ndt/gfi005; Sharma R, 2007, HEART, V93, P464, DOI 10.1136/hrt.2006.096826; Venkataraman R, 2008, AM J CARDIOL, V102, P1451, DOI 10.1016/j.amjcard.2008.07.029; Wolfe RA, 1999, NEW ENGL J MED, V341, P1725, DOI 10.1056/NEJM199912023412303	38	27	28	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2015	10	6							e0131237	10.1371/journal.pone.0131237	http://dx.doi.org/10.1371/journal.pone.0131237			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4OM	26107641	Green Submitted, Green Published, gold			2022-12-26	WOS:000356932500148
J	Duan, ZY; Chen, SR; Sun, CJ; Shi, FY; Wu, GQ; Liu, AQ; Xu, GY; Yang, N				Duan, Zhongyi; Chen, Sirui; Sun, Congjiao; Shi, Fengying; Wu, Guiqin; Liu, Aiqiao; Xu, Guiyun; Yang, Ning			Polymorphisms in Ion Transport Genes Are Associated with Eggshell Mechanical Property	PLOS ONE			English	Article							SHELL GLAND UTERUS; AVIAN EGGSHELL; EGG-SHELL; HAPLOTYPE RECONSTRUCTION; ENDOPLASMIC-RETICULUM; CALCIUM HOMEOSTASIS; POTASSIUM CHANNELS; PROTEOMIC ANALYSIS; UTERINE FLUID; LAYING HENS	Eggshell mechanical property traits such as eggshell breaking strength (ESS), eggshell thickness (EST) and eggshell weight (ESW) are most common and important indexes to evaluate eggshell quality in poultry industry. Uterine ion transporters involve in eggshell formation and might be associated with eggshell mechanical property traits. In this study, 99 SNPs in 15 ion transport genes were selected to genotype 976 pedigreed hens of Rhode Island Red. ESS, EST and ESW were measured for each bird at 55 weeks of age. The association study showed that 14 SNPs in 8 genes were significantly related (p < 0.05) with at least one trait, and their contributions to phenotypic variance ranged from 0.23% to 4.14%. Both ATP2A3 and SLC4A5 had a significant effect on all the three traits. Strong linkage disequilibrium (LD) was detected among SNPs in four genes: ATP2A3, ITPR1, SLC8A3, SCNN1a. The significant effects of those diplotypes on eggshell mechanical property traits were found, and their contributions to phenotypic variance ranged from 0.50% to 0.70%. It was concluded that the identified SNPs and diplotypes in this study were potential markers influencing the eggshell mechanical properties, which could contribute to the genetic improvement of eggshell quality.	[Duan, Zhongyi; Chen, Sirui; Sun, Congjiao; Xu, Guiyun; Yang, Ning] China Agr Univ, Natl Engn Lab Anim Breeding, Coll Anim Sci & Technol, Beijing 100094, Peoples R China; [Duan, Zhongyi; Chen, Sirui; Sun, Congjiao; Xu, Guiyun; Yang, Ning] China Agr Univ, MOA Key Lab Anim Genet & Breeding, Coll Anim Sci & Technol, Beijing 100094, Peoples R China; [Shi, Fengying; Wu, Guiqin; Liu, Aiqiao] Beijing Huadu Yukou Poultry Ind Co Ltd, Beijing, Peoples R China	China Agricultural University; China Agricultural University	Yang, N (corresponding author), China Agr Univ, Natl Engn Lab Anim Breeding, Coll Anim Sci & Technol, Beijing 100094, Peoples R China.	nyang@cau.edu.cn		Yang, Ning/0000-0001-5772-3320	National Natural Science Foundation of China [31472084]; National High Technology Development Plan of China [2013AA102501]; Programs for Changjiang Scholars and Innovative Research in University [IRT1191]; National Scientific Supporting Projects of China [2011BAD28B03]; Beijing Huadu Yukou Poultry Industry Co., Ltd.	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High Technology Development Plan of China(National High Technology Research and Development Program of China); Programs for Changjiang Scholars and Innovative Research in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); National Scientific Supporting Projects of China; Beijing Huadu Yukou Poultry Industry Co., Ltd.	The current research was supported in parts by National Natural Science Foundation of China (31472084), National High Technology Development Plan of China (2013AA102501), Programs for Changjiang Scholars and Innovative Research in University (IRT1191), and National Scientific Supporting Projects of China (2011BAD28B03). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. In this study, Beijing Huadu Yukou Poultry Industry Co., Ltd. provided support in the form of salaries for authors FS, GW and AL, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the "author contributions" section.	Ardlie KG, 2002, NAT REV GENET, V3, P299, DOI 10.1038/nrg777; Arias J.L., 2007, HDB BIOMINERALIZATIO, V1, P309; Bar A., 2009, COMP BIOCHEM PHYS A, V152, P447, DOI [DOI 10.1016/j.cbpa.2008.11.020, 10.1016/j.cbpa.2008.11.020]; Bar A, 2008, COMP BIOCHEM PHYS A, V151, P477, DOI [10.1016/j.cbpa.2008.07.006, 10.1016/j.cbpa.2008.11.020]; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Brionne A, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-220; CAIN CJ, 1964, BIOPHYS J, V4, P23, DOI 10.1016/S0006-3495(64)86767-9; CANESSA CM, 1994, NATURE, V367, P463, DOI 10.1038/367463a0; de Ketelaere B, 2002, BRIT POULTRY SCI, V43, P238, DOI 10.1080/00071660120121454; EASTIN WC, 1978, BIOL REPROD, V19, P493, DOI 10.1095/biolreprod19.3.493; EASTIN WC, 1978, BIOL REPROD, V19, P505, DOI 10.1095/biolreprod19.3.505; Fan YF, 2013, BMC GENET, V14, DOI 10.1186/1471-2156-14-90; Gorlach A, 2006, ANTIOXID REDOX SIGN, V8, P1391, DOI 10.1089/ars.2006.8.1391; Griffin JB, 2006, J NUTR BIOCHEM, V17, P272, DOI 10.1016/j.jnutbio.2005.05.005; HAMILTON RMG, 1979, WORLD POULTRY SCI J, V35, P177, DOI 10.1079/WPS19790014; Hebert SC, 2005, PHYSIOL REV, V85, P319, DOI 10.1152/physrev.00051.2003; Heitzmann D, 2008, PHYSIOL REV, V88, P1119, DOI 10.1152/physrev.00020.2007; Hincke MT, 2013, PROTEOMICS, V13, P3369, DOI 10.1002/pmic.201300471; Hocking PM, 2003, BRIT POULTRY SCI, V44, P365, DOI [10.1080/0007166031000085535, NO_DOI]; HODGES RD, 1967, NATURE, V216, P609, DOI 10.1038/216609a0; Hurwitz S, 1996, CRIT REV BIOCHEM MOL, V31, P41, DOI 10.3109/10409239609110575; Jonchere Vincent, 2012, BMC Physiology, V12, P10, DOI 10.1186/1472-6793-12-10; Jonchere V, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-57; Liu WB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028600; LORCHER K, 1970, ANN BIOL ANIM BIOCH, V10, P133, DOI 10.1051/rnd:19700612; Mann K, 2006, PROTEOMICS, V6, P3801, DOI 10.1002/pmic.200600120; Marie P, 2015, J PROTEOMICS, V113, P178, DOI 10.1016/j.jprot.2014.09.024; Maxwell T, 2012, FRONT BIOSCI, DOI [10.2741/3985, DOI 10.2741/3985]; MONTGOMERY JC, 1991, GENOMICS, V11, P835, DOI 10.1016/0888-7543(91)90006-Z; Nys Y, 2004, CR PALEVOL, V3, P549, DOI 10.1016/j.crpv.2004.08.002; Nys Y, 2011, WOODHEAD PUBL FOOD S, P83; Nys Y, 1999, POULT AVIAN BIOL REV, V10, P143; NYS Y, 1991, POULTRY SCI, V70, P1236, DOI 10.3382/ps.0701236; Patterson RL, 2005, P NATL ACAD SCI USA, V102, P1357, DOI 10.1073/pnas.0409657102; Periasamy M, 2007, MUSCLE NERVE, V35, P430, DOI 10.1002/mus.20745; Rodriguez-Navarro A, 2002, BRIT POULTRY SCI, V43, P395, DOI 10.1080/00071660120103675; Rodriguez-Navarro AB, 2007, EUR J MINERAL, V19, P391, DOI 10.1127/0935-1221/2007/0019-1724; Sasayama Y, 1999, ZOOL SCI, V16, P857, DOI 10.2108/zsj.16.857; SHARP RM, 1984, BIOPHYS J, V46, P175, DOI 10.1016/S0006-3495(84)84010-2; Stephens M, 2003, AM J HUM GENET, V73, P1162, DOI 10.1086/379378; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Sun CJ, 2013, PROTEOMICS, V13, P3523, DOI 10.1002/pmic.201300286; Vermassen E, 2004, BIOL CELL, V96, P3, DOI 10.1016/j.biolcel.2003.11.004; WUYTACK F, 1994, J BIOL CHEM, V269, P1410	44	8	10	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2015	10	6							e0130160	10.1371/journal.pone.0130160	http://dx.doi.org/10.1371/journal.pone.0130160			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4OM	26106883	Green Published, Green Submitted, gold			2022-12-26	WOS:000356932500082
J	Hestand, MS; Kalbfleisch, TS; Coleman, SJ; Zeng, Z; Liu, JZ; Orlando, L; MacLeod, JN				Hestand, Matthew S.; Kalbfleisch, Theodore S.; Coleman, Stephen J.; Zeng, Zheng; Liu, Jinze; Orlando, Ludovic; MacLeod, James N.			Annotation of the Protein Coding Regions of the Equine Genome	PLOS ONE			English	Article							ALIGNMENT; BROWSER; TRANSCRIPTOME; FRAMEWORK; SEQUENCE; VARIANT	Current gene annotation of the horse genome is largely derived from in silico predictions and cross-species alignments. Only a small number of genes are annotated based on equine EST and mRNA sequences. To expand the number of equine genes annotated from equine experimental evidence, we sequenced mRNA from a pool of forty-three different tissues. From these, we derived the structures of 68,594 transcripts. In addition, we identified 301,829 positions with SNPs or small indels within these transcripts relative to EquCab2. Interestingly, 780 variants extend the open reading frame of the transcript and appear to be small errors in the equine reference genome, since they are also identified as homozygous variants by genomic DNA resequencing of the reference horse. Taken together, we provide a resource of equine mRNA structures and protein coding variants that will enhance equine and cross-species transcriptional and genomic comparisons.	[Hestand, Matthew S.; Coleman, Stephen J.; MacLeod, James N.] Univ Kentucky, Dept Vet Sci, Maxwell H Gluck Equine Res Ctr, Lexington, KY 40506 USA; [Kalbfleisch, Theodore S.] Univ Louisville, Sch Med, Biochem & Mol Biol Dept, Louisville, KY 40292 USA; [Zeng, Zheng; Liu, Jinze] Univ Kentucky, Dept Comp Sci, Lexington, KY 40506 USA; [Orlando, Ludovic] Univ Copenhagen, Ctr GeoGenet, Nat Hist Museum Denmark, Copenhagen, Denmark	University of Kentucky; University of Louisville; University of Kentucky; University of Copenhagen	MacLeod, JN (corresponding author), Univ Kentucky, Dept Vet Sci, Maxwell H Gluck Equine Res Ctr, Lexington, KY 40506 USA.	jnmacleod@uky.edu	Orlando, Ludovic/A-8932-2013; Kalbfleisch, Theodore/AAN-5407-2021	Orlando, Ludovic/0000-0003-3936-1850; Kalbfleisch, Theodore/0000-0002-2370-8189; Coleman, Stephen/0000-0001-7686-4866	National Science Foundation [Crosscut-EF-0850237, 1054631]; Kentucky Infrastructure for Biomedical Research Excellence award (KY-INBRE) from the National Institutes of Health [5P20RR016481-09]; Lourie Foundation; Gluck Equine Research Center, University of Kentucky; KY IDeA Networks of Biomedical Research Excellence (Cooper PI) NIH/NIGMS [5P20GM103436-13]; Div Of Information & Intelligent Systems [1054631] Funding Source: National Science Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016481] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG006272] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); Kentucky Infrastructure for Biomedical Research Excellence award (KY-INBRE) from the National Institutes of Health; Lourie Foundation; Gluck Equine Research Center, University of Kentucky; KY IDeA Networks of Biomedical Research Excellence (Cooper PI) NIH/NIGMS; Div Of Information & Intelligent Systems(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was supported by the National Science Foundation (Crosscut-EF-0850237 to JL and JNM and 1054631 to JL) and a Kentucky Infrastructure for Biomedical Research Excellence award (KY-INBRE, 5P20RR016481-09) from the National Institutes of Health. Additional financial support was received from the Lourie Foundation and through endowments at the Gluck Equine Research Center, University of Kentucky. TSK's effort was supported in part by the KY IDeA Networks of Biomedical Research Excellence (Cooper PI) NIH/NIGMS 5P20GM103436-13, and this work was conducted in part using the resources of the University of Louisville's research computing group and the Cardinal Research Cluster. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; Coleman SJ, 2010, ANIM GENET, V41, P121, DOI 10.1111/j.1365-2052.2010.02118.x; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Doan R, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-78; Flicek P, 2013, NUCLEIC ACIDS RES, V41, pD48, DOI 10.1093/nar/gks1236; Fujita PA, 2011, NUCLEIC ACIDS RES, V39, pD876, DOI 10.1093/nar/gkq963; Hestand MS, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq602; Karolchik D, 2004, NUCLEIC ACIDS RES, V32, pD493, DOI 10.1093/nar/gkh103; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Ladoukakis E, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-11-r118; Lambert JD, 2010, INTEGR COMP BIOL, V50, P768, DOI 10.1093/icb/icq121; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; MacLeod JN, 1996, J BIOL CHEM, V271, P18954, DOI 10.1074/jbc.271.31.18954; Magny EG, 2013, SCIENCE, V341, P1116, DOI 10.1126/science.1238802; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Metzger J, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-562; Orlando L, 2013, NATURE, V499, P74, DOI 10.1038/nature12323; Rebolledo-Mendez J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126852; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Rustici G, 2013, NUCLEIC ACIDS RES, V41, pD987, DOI 10.1093/nar/gks1174; Schwarzbauer JE, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005041; Tang FC, 2009, NAT METHODS, V6, P377, DOI [10.1038/NMETH.1315, 10.1038/nmeth.1315]; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Wade CM, 2009, SCIENCE, V326, P865, DOI 10.1126/science.1178158; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq622	28	18	18	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2015	10	6							e0124375	10.1371/journal.pone.0124375	http://dx.doi.org/10.1371/journal.pone.0124375			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4OM	26107351	Green Published, Green Submitted, gold			2022-12-26	WOS:000356932500005
J	Kang, RH; Xun, HM; Zhang, Y; Wang, W; Wang, X; Jiang, BF; Ma, W				Kang, Ruihua; Xun, Huanmiao; Zhang, Ying; Wang, Wei; Wang, Xin; Jiang, Baofa; Ma, Wei			Impacts of Different Grades of Tropical Cyclones on Infectious Diarrhea in Guangdong, 2005-2011	PLOS ONE			English	Article							HURRICANE-KATRINA; OUTBREAK; PRECIPITATION; DISASTERS; EVACUEES; HOUSTON; AILA	Objective Guangdong province is one of the most vulnerable provinces to tropical cyclones in China. Most prior studies concentrated on the relationship between tropical cyclones and injuries and mortality. This study aimed to explore the impacts of different grades of tropical cyclones on infectious diarrhea incidence in Guangdong province, from 2005 to 2011. Methods Mann-Whitney U test was firstly used to examine if infectious diarrhea were sensitive to tropical cyclone. Then unidirectional 1:1 case-crossover design was performed to quantitatively evaluate the relationship between daily number of infectious diarrhea and tropical cyclone from 2005 to 2011 in Guangdong, China. Principal component analysis (PCA) was applied to eliminate multicollinearity. Multivariate logistic regression model was used to estimate the hazard ratios (HRs) and the 95% confidence intervals (CI). Results There were no significant relationships between tropical cyclone and bacillary dysentery, amebic dysentery, typhoid, and paratyphoid cases. Infectious diarrhea other than cholera, dysentery, typhoid and paratyphoid significantly increased after tropical cyclones. The strongest effect were shown on lag 1 day (HRs = 1.95, 95% CI = 1.22, 3.12) and no lagged effect was detected for tropical depression, tropical storm, severe tropical storm and typhoon, with the largest HRs (95% CI) of 2.16 (95% CI = 1.69, 2.76), 2.43 (95% CI = 1.65, 3.58) and 2.21 (95% CI = 1.65, 2.69), respectively. Among children below 5 years old, the impacts of all grades of tropical cyclones were strongest at lag 0 day. And HRs were 2.67 (95% CI = 1.10, 6.48), 2.49 (95% CI = 1.80, 3.44), 4.89 (95% CI = 2.37, 7.37) and 3.18 (95% CI = 2.10, 4.81), respectively. Conclusion All grades of tropical cyclones could increase risk of other infectious diarrhea. Severe tropical storm has the strongest influence on other infectious diarrhea. The impacts of tropical cyclones on children under 5 years old were higher than total population.	[Kang, Ruihua; Xun, Huanmiao; Wang, Wei; Wang, Xin; Jiang, Baofa; Ma, Wei] Shandong Univ, Dept Epidemiol, Sch Publ Hlth, Jinan 250100, Shandong, Peoples R China; [Xun, Huanmiao; Jiang, Baofa; Ma, Wei] Shandong Univ, Climate Change & Hlth Ctr, Jinan 250100, Shandong, Peoples R China; [Zhang, Ying] Univ Sydney, Sch Publ Hlth, Sydney, NSW 2006, Australia	Shandong University; Shandong University; University of Sydney	Ma, W (corresponding author), Shandong Univ, Dept Epidemiol, Sch Publ Hlth, Jinan 250100, Shandong, Peoples R China.	weima@sdu.edu.cn	Ma, Wei/L-2374-2019; Zhang, Ying/ABE-2275-2021; Ma, Wei/C-4748-2019	Ma, Wei/0000-0002-8092-3280; Zhang, Ying/0000-0001-6214-2440; Ma, Wei/0000-0002-8092-3280	National Basic Research Program of China (973 Program) [2012CB955500-955502]	National Basic Research Program of China (973 Program)(National Basic Research Program of China)	Grant NO. 2012CB955500-955502; URLs: http://www.most.gov.cn/eng/programmes1/200610/t20061009_36223.htm; Funding institution: National Basic Research Program of China (973 Program). Received the funding: WM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2007, 2712007 WS NAT HLTH; Bhunia R, 2011, T ROY SOC TROP MED H, V105, P214, DOI 10.1016/j.trstmh.2010.12.008; Bryce J, 2005, LANCET, V365, P1147, DOI 10.1016/S0140-6736(05)71877-8; Bush KF, 2014, ENVIRON HEALTH PERSP, V122, P249, DOI 10.1289/ehp.1306807; Centers for Disease Control and Prevention (CDC), 2005, MMWR Morb Mortal Wkly Rep, V54, P928; Deng ZY, 2015, INT J ENV RES PUB HE, V12, P1054, DOI 10.3390/ijerph120201054; Faul M, 2011, J EMERG NURS, V37, P460, DOI 10.1016/j.jen.2010.12.019; General Administration of Quality Supervision Inspection and Quarantine of the People's Republic of China; Standardization Administration of the People's Republic of China, 2006, 192012006 GBT GEN AD; [贺海晏 He Haiyan], 2003, [气象科学, Scientia Meteorologlca Sinica], V23, P401; Kim S, 2013, INT J ENVIRON HEAL R, V23, P365, DOI 10.1080/09603123.2012.733940; Kouadio IK, 2012, EXPERT REV ANTI-INFE, V10, P95, DOI [10.1586/ERI.11.155, 10.1586/eri.11.155]; Lane K, 2013, J ENVIRON PUBLIC HEA, V2013, DOI 10.1155/2013/913064; Liu Hai-xia, 2013, Zhonghua Yu Fang Yi Xue Za Zhi, V47, P328; MACLURE M, 1991, AM J EPIDEMIOL, V133, P144, DOI 10.1093/oxfordjournals.aje.a115853; McKinney N, 2011, INT J BIOMETEOROL, V55, P533, DOI 10.1007/s00484-010-0370-9; Myint Nyan Win, 2011, Confl Health, V5, P9, DOI 10.1186/1752-1505-5-9; Nagendra SMS, 2003, TRANSPORT RES D-TR E, V8, P285, DOI 10.1016/S1361-9209(03)00006-3; National Health and Family Planning Commission of the People's Republic of China, 2008, 2802008 WS NAT HLTH; National Health and Family Planning Commission of the People's Republic of China, 2008, 2872008 WS NAT HLTH; Niederkrotenthaler T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083038; Norovirus outbreak among evacuees from hurricane Katrina-Houston Texas, 2005, MMWR-MORBID MORTAL W, V54, P1016; Panda S, 2011, INDIAN J MED RES, V133, P395; Park Kwan Jun, 2013, Osong Public Health Res Perspect, V4, P140, DOI 10.1016/j.phrp.2013.04.009; Sun Li-mei, 2013, Zhonghua Liu Xing Bing Xue Za Zhi, V34, P989; Wang X, 2014, SCI WORLD J, DOI 10.1155/2014/204675; WHO,, 2017, DIARRH DIS; Yee EL, 2007, CLIN INFECT DIS, V44, P1032, DOI 10.1086/512195; Zhang QA, 2009, B AM METEOROL SOC, V90, P489, DOI 10.1175/2008BAMS2631.1	28	10	10	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2015	10	6							e0131423	10.1371/journal.pone.0131423	http://dx.doi.org/10.1371/journal.pone.0131423			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4OM	26106882	gold, Green Published, Green Submitted			2022-12-26	WOS:000356932500162
J	Li, GR; Li, JJ; Tan, B; Wang, J; Kong, XF; Guan, GP; Li, FN; Yin, YL				Li, Guangran; Li, Jianjun; Tan, Bie; Wang, Jing; Kong, Xiangfeng; Guan, Guiping; Li, Fengna; Yin, Yulong			Characterization and Regulation of the Amino Acid Transporter SNAT2 in the Small Intestine of Piglets	PLOS ONE			English	Article							DIETARY SUPPLEMENTATION; MOLECULAR-CLONING; GLUTAMATE TRANSPORTERS; ONTOGENIC EXPRESSION; TISSUE DISTRIBUTION; GENE-EXPRESSION; MESSENGER-RNA; SYSTEM-N; INCREASES; STRESS	The sodium-dependent neutral amino acid transporter 2 (SNAT2), which has dual transport/receptor functions, is well documented in eukaryotes and some mammalian systems, but has not yet been verified in piglets. The objective of this study was to investigate the characteristics and regulation of SNAT2 in the small intestine of piglets. The 1,521-bp porcine full cDNA sequence of SNAT2 (KC769999) from the small intestine of piglets was cloned. The open reading frame of cDNA encodes 506 deduced amino acid residues with a calculated molecular mass of 56.08 kDa and an isoelectric point (pI) of 7.16. Sequence alignment and phylogenetic analysis revealed that SNAT2 is highly evolutionarily conserved in mammals. SNAT2 mRNA can be detected in the duodenum, jejunum and ileum by real-time quantitative PCR. During the suckling period from days 1 to 21, the duodenum had the highest abundance of SNAT2 mRNA among the three segments of the small intestine. There was a significant decrease in the expression of SNAT2 mRNA in the duodenal and jejunal mucosa and in the expression of SNAT2 protein in the jejunal and ileal mucosa on day 1 after weaning (P < 0.05). Studies with enterocytes in vitro showed that amino acid starvation and supplementation with glutamate, arginine or leucine enhanced, while supplementation with glutamine reduced, SNAT2 mRNA expression (P < 0.05). These results regarding the characteristics and regulation of SNAT2 should help to provide some information to further clarify its roles in the absorption of amino acids and signal transduction in the porcine small intestine.	[Li, Guangran; Li, Jianjun; Tan, Bie; Wang, Jing; Kong, Xiangfeng; Guan, Guiping; Li, Fengna; Yin, Yulong] Chinese Acad Sci, Observat & Expt Stn Anim Nutr & Feed Sci South Ce, Hunan Prov Engn Res Ctr Hlth Livestock & Poultry, Key Lab Agroecol Proc Subtrop Reg,Inst Subtrop Ag, Changsha 410125, Hunan, Peoples R China; [Yin, Yulong] Hunan Normal Univ, Coll Life Sci, Changsha 41008, Hunan, Peoples R China; [Li, Guangran; Wang, Jing] Univ Chinese Acad Sci, Beijing 10008, Peoples R China; [Tan, Bie] Hunan Collaborat Innovat Ctr Utilizat Bot Funct I, Changsha 410000, Hunan, Peoples R China; [Guan, Guiping] Hunan Agr Univ, Coll Biosci & Biotechnol, Changsha 410128, Hunan, Peoples R China	Chinese Academy of Sciences; Hunan Normal University; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Hunan Agricultural University	Tan, B (corresponding author), Chinese Acad Sci, Observat & Expt Stn Anim Nutr & Feed Sci South Ce, Hunan Prov Engn Res Ctr Hlth Livestock & Poultry, Key Lab Agroecol Proc Subtrop Reg,Inst Subtrop Ag, Changsha 410125, Hunan, Peoples R China.	bietan@isa.ac.cn; yinyulong@isa.ac.cn			National Natural Science Foundation of China [31372326, 31330075]; 973 National Projects Subject [2013CB127302, 2013CB127306]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 973 National Projects Subject(National Basic Research Program of China)	This work was supported by the National Natural Science Foundation of China (31372326 and 31330075) and the 973 National Projects Subject (2013CB127302 and 2013CB127306).	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Angelina R, 2011, INT J DEV NEUROSCI, V29, P743, DOI 10.1016/j.ijdevneu.2011.05.010; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Baird FE, 2006, BIOCHEM J, V397, P369, DOI 10.1042/BJ20060026; Broer S, 2008, PHYSIOL REV, V88, P249, DOI 10.1152/physrev.00018.2006; Buddington RK, 2001, AM J PHYSIOL-REG I, V280, pR241, DOI 10.1152/ajpregu.2001.280.1.R241; Campbell JM, 2013, J ANIM SCI BIOTECHNO, V4, DOI 10.1186/2049-1891-4-19; Chen G, 2014, AMINO ACIDS, V46, P245, DOI 10.1007/s00726-013-1615-9; Deng D, 2009, J NUTR BIOCHEM, V20, P544, DOI 10.1016/j.jnutbio.2008.05.014; Du QX, 2013, FORENSIC SCI MED PAT, V9, P528, DOI 10.1007/s12024-013-9482-y; Duan JL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112357; Dunker AK, 2001, NAT BIOTECHNOL, V19, P805, DOI 10.1038/nbt0901-805; Evans K, 2007, J AM SOC NEPHROL, V18, P1426, DOI 10.1681/ASN.2006091014; Fan MZ, 2004, AM J PHYSIOL-GASTR L, V287, pG385, DOI 10.1152/ajpgi.00232.2003; Feng D, 2009, ANIMAL, V3, P402, DOI 10.1017/S1751731108003649; Franchi-Gazzola R, 2006, ACTA PHYSIOL, V187, P273, DOI 10.1111/j.1748-1716.2006.01552.x; Fu DZ, 2013, MOL BIOL REP, V40, P3341, DOI 10.1007/s11033-012-2409-y; Geng MM, 2011, AMINO ACIDS, V40, P1513, DOI 10.1007/s00726-010-0761-6; Grewal S, 2009, J BIOL CHEM, V284, P11224, DOI 10.1074/jbc.M806470200; He QH, 2011, J PROTEOME RES, V10, P5214, DOI 10.1021/pr200688u; HEATON JH, 1977, J BIOL CHEM, V252, P2900; Howell JA, 2001, J ANIM SCI, V79, P1329; Hundal HS, 2009, AM J PHYSIOL-ENDOC M, V296, pE603, DOI 10.1152/ajpendo.91002.2008; Hyde R, 2003, BIOCHEM J, V373, P1, DOI 10.1042/BJ20030405; Kong XF, 2014, BIOL REPROD, V91, DOI 10.1095/biolreprod.113.113977; Li FN, 2011, ANIMAL, V5, P1903, DOI 10.1017/S1751731111001194; Li FN, 2015, BRIT J NUTR, V113, P739, DOI 10.1017/S0007114514004346; Nelson DM, 2003, AM J PHYSIOL-CELL PH, V284, pC310, DOI 10.1152/ajpcell.00253.2002; Reimer RJ, 2000, P NATL ACAD SCI USA, V97, P7715, DOI 10.1073/pnas.140152797; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tan B, 2015, FRONT BIOSCI-LANDMRK, V20, P989, DOI 10.2741/4352; Wang J, 2015, J ANIM SCI, V93, P1679, DOI 10.2527/jas.2014-8230; Wang JJ, 2008, J NUTR, V138, P1025, DOI 10.1093/jn/138.6.1025; Wang WC, 2009, COMP BIOCHEM PHYS B, V154, P157, DOI 10.1016/j.cbpb.2009.05.014; Wang W, 2009, AMINO ACIDS, V37, P593, DOI 10.1007/s00726-008-0178-7; Wu GY, 1998, J NUTR, V128, P1249, DOI 10.1093/jn/128.8.1249; Wu L, 2015, TOXINS, V7, P1341, DOI 10.3390/toxins7041341; Xiao DF, 2013, INT IMMUNOPHARMACOL, V17, P670, DOI 10.1016/j.intimp.2013.07.023; Xiong X, 2015, J ANIM SCI, V93, P1089, DOI 10.2527/jas.2014-7851; Xiong X, 2015, LIVEST SCI, V171, P20, DOI 10.1016/j.livsci.2014.10.012; Yang C, 2011, THESIS U GUELPH; Yang HS, 2013, J ANIM SCI, V91, P2740, DOI 10.2527/jas.2012-5795; Yin J, 2014, J ANIM SCI, V92, P612, DOI 10.2527/jas.2013-6986; Yin J, 2014, AMINO ACIDS, V46, P883, DOI 10.1007/s00726-013-1643-5; Yin YL, 2010, AMINO ACIDS, V39, P1581, DOI 10.1007/s00726-010-0577-4; Zhang J, 2013, AMINO ACIDS, V45, P1169, DOI 10.1007/s00726-013-1573-2	47	16	17	3	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2015	10	6							e0128207	10.1371/journal.pone.0128207	http://dx.doi.org/10.1371/journal.pone.0128207			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4OM	26107628	Green Published, Green Submitted, gold			2022-12-26	WOS:000356932500017
J	Morrison, EN; Emery, RJN; Saville, BJ				Morrison, Erin N.; Emery, R. J. Neil; Saville, Barry J.			Phytohormone Involvement in the Ustilago maydis-Zea mays Pathosystem: Relationships between Abscisic Acid and Cytokinin Levels and Strain Virulence in Infected Cob Tissue	PLOS ONE			English	Article							PLANT-PATHOGEN INTERACTIONS; CORN SMUT FUNGUS; SALICYLIC-ACID; CIS-ZEATIN; GENE-EXPRESSION; MASS-SPECTROMETRY; MAIZE LEAVES; TRANSFER-RNA; IN-VITRO; METABOLISM	Ustilago maydis is the causative agent of common smut of corn. Early studies noted its ability to synthesize phytohormones and, more recently these growth promoting substances were confirmed as cytokinins (CKs). Cytokinins comprise a group of phytohormones commonly associated with actively dividing tissues. Lab analyses identified variation in virulence between U. maydis dikaryon and solopathogen infections of corn cob tissue. Samples from infected cob tissue were taken at sequential time points post infection and biochemical profiling was performed using high performance liquid chromatography-electrospray ionization tandem mass spectrometry (HPLC-ESI MS/MS). This hormone profiling revealed that there were altered levels of ABA and major CKs, with a marked reduction in CK glucosides, increases in methylthiol CKs and a particularly dramatic increase in cisZ CK forms, in U. maydis infected tissue. These changes were more pronounced in the more virulent dikaryon relative to the solopathogenic strain suggesting a role for cytokinins in moderating virulence during biotrophic infection. These findings highlight the fact that U. maydis does not simply mimic a fertilized seed but instead reprograms the host tissue. Results underscore the suitability of the Ustilago maydis-Zea mays model as a basis for investigating the control of phytohormone dynamics during biotrophic infection of plants.	[Morrison, Erin N.] Trent Univ, Environm & Life Sci Grad Program, Peterborough, ON K9J 7B8, Canada; [Emery, R. J. Neil] Trent Univ, Dept Biol, Peterborough, ON K9J 7B8, Canada; [Saville, Barry J.] Trent Univ, Forens Sci Program, Peterborough, ON K9J 7B8, Canada	Trent University; Trent University; Trent University	Morrison, EN (corresponding author), Trent Univ, Environm & Life Sci Grad Program, Peterborough, ON K9J 7B8, Canada.	erinmorrison@trentu.ca		Morrison, Erin/0000-0001-7407-7113; Emery, Neil/0000-0003-1304-6430	Natural Sciences and Engineering Research Council (NSERC) of Canada	Natural Sciences and Engineering Research Council (NSERC) of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	The authors acknowledge the Natural Sciences and Engineering Research Council (NSERC) of Canada for research funding (BJS, RJNE) and the Ontario Graduate Scholarship programme for student support (ENM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashby AM, 2000, PHYSIOL MOL PLANT P, V57, P147, DOI 10.1006/pmpp.2000.0294; Audenaert K, 2002, PLANT PHYSIOL, V128, P491, DOI 10.1104/pp.010605; Babu MR, 2005, CURR GENET, V47, P316, DOI 10.1007/s00294-005-0574-4; Banuett F, 1996, DEVELOPMENT, V122, P2965; BANUETT F, 1989, P NATL ACAD SCI USA, V86, P5878, DOI 10.1073/pnas.86.15.5878; Behr M, 2012, MOL PLANT MICROBE IN, V25, P1073, DOI 10.1094/MPMI-01-12-0012-R; Bolker M, 2008, FUNGAL GENET BIOL, V45, pS88, DOI 10.1016/j.fgb.2008.05.007; BOLKER M, 1995, CAN J BOT, V73, pS320; Brefort T, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003866; Bruce SA, 2011, J PLANT GROWTH REGUL, V30, P51, DOI 10.1007/s00344-010-9166-8; Brugiere N, 2003, PLANT PHYSIOL, V132, P1228, DOI 10.1104/pp.102.017707; Cao FY, 2011, J PLANT RES, V124, P489, DOI 10.1007/s10265-011-0409-y; Cheng ZJ, 2014, PLANT CELL, V26, P1053, DOI 10.1105/tpc.113.121566; Choi J, 2011, TRENDS PLANT SCI, V16, P388, DOI 10.1016/j.tplants.2011.03.003; Cooper SJ, 1998, PHYSIOL MOL PLANT P, V53, P61, DOI 10.1006/pmpp.1998.0171; Rodriguez-Gacio MD, 2009, PLANT SIGNAL BEHAV, V4, P1035, DOI 10.4161/psb.4.11.9902; Djamei A, 2011, NATURE, V478, P395, DOI 10.1038/nature10454; Dobrev PI, 2002, J CHROMATOGR A, V950, P21, DOI 10.1016/S0021-9673(02)00024-9; Doehlemann G, 2008, PLANT J, V56, P181, DOI 10.1111/j.1365-313X.2008.03590.x; Doehlemann G, 2008, J PLANT PHYSIOL, V165, P29, DOI 10.1016/j.jplph.2007.05.016; Esberg B, 1999, J BACTERIOL, V181, P7256, DOI 10.1128/JB.181.23.7256-7265.1999; Farrow SC, 2012, PLANT METHODS, V8, DOI 10.1186/1746-4811-8-42; Frebort I, 2011, J EXP BOT, V62, P2431, DOI 10.1093/jxb/err004; Gajdosova S, 2011, J EXP BOT, V62, P2827, DOI 10.1093/jxb/erq457; Gao L, 2013, PLANT J, V75, P903, DOI 10.1111/tpj.12270; Giron D, 2014, J CHEM ECOL, V40, P826, DOI 10.1007/s10886-014-0466-5; Hartung W, 2010, FUNCT PLANT BIOL, V37, P806, DOI 10.1071/FP10058; Hinsch J, 2015, ENVIRON MICROBIOL, V17, P2935, DOI 10.1111/1462-2920.12838; Horst RJ, 2008, J PLANT PHYSIOL, V165, P19, DOI 10.1016/j.jplph.2007.05.008; Horst RJ, 2010, PLANT PHYSIOL, V152, P293, DOI 10.1104/pp.109.147702; Jacobsen JV, 2002, PHYSIOL PLANTARUM, V115, P428, DOI 10.1034/j.1399-3054.2002.1150313.x; Jameson PE, 2000, PLANT GROWTH REGUL, V32, P369, DOI 10.1023/A:1010733617543; Jiang CJ, 2013, MOL PLANT MICROBE IN, V26, P287, DOI 10.1094/MPMI-06-12-0152-R; Jiang CJ, 2010, MOL PLANT MICROBE IN, V23, P791, DOI 10.1094/MPMI-23-6-0791; Jones RJ, 2000, CSSA SPEC PUBL, P25; Kamper J, 2006, NATURE, V444, P97, DOI 10.1038/nature05248; Kudo T, 2010, J INTEGR PLANT BIOL, V52, P53, DOI 10.1111/j.1744-7909.2010.00898.x; Martin RC, 2001, P NATL ACAD SCI USA, V98, P5922, DOI 10.1073/pnas.101128798; Mauch-Mani B, 2005, CURR OPIN PLANT BIOL, V8, P409, DOI 10.1016/j.pbi.2005.05.015; MILLS LJ, 1978, PHYSIOL PLANT PATHOL, V13, P73, DOI 10.1016/0048-4059(78)90076-0; Mohr PG, 2007, FUNCT INTEGR GENOMIC, V7, P181, DOI 10.1007/s10142-006-0041-4; Mok DWS, 2001, ANNU REV PLANT PHYS, V52, P89, DOI 10.1146/annurev.arplant.52.1.89; Morrison EN, 2015, MYCOLOGIA, V107, P245, DOI 10.3852/14-157; Morrison EN, 2012, CAN J PLANT PATHOL, V34, P417, DOI 10.1080/07060661.2012.697077; MYERS PN, 1990, PLANT PHYSIOL, V94, P1330, DOI 10.1104/pp.94.3.1330; Novakova M, 2005, J EXP BOT, V56, P2877, DOI 10.1093/jxb/eri282; Pataky J.K., 2006, PLANT HLTH INSTRUCTO, DOI [https://doi.org/10.1094/PHI-I-2006-0927-01, DOI 10.1094/PHI-I-2006-0927-01]; Pataky JK, 2003, MYCOLOGIA, V95, P1261, DOI 10.2307/3761926; PERSSON BC, 1994, BIOCHIMIE, V76, P1152, DOI 10.1016/0300-9084(94)90044-2; Pertry I, 2009, P NATL ACAD SCI USA, V106, P929, DOI 10.1073/pnas.0811683106; Quesnelle PE, 2007, CAN J BOT, V85, P91, DOI 10.1139/B06-149; Rabe F, 2013, MOL MICROBIOL, V89, P179, DOI 10.1111/mmi.12269; Rijavec T, 2012, ADV SELECTED PLANT P; Rijavec T, 2011, ANN BOT-LONDON, V107, P1235, DOI 10.1093/aob/mcq247; Ross ARS, 2004, ANAL BIOCHEM, V329, P324, DOI 10.1016/j.ab.2004.02.026; Sakakibara H, 2006, ANNU REV PLANT BIOL, V57, P431, DOI 10.1146/annurev.arplant.57.032905.105231; Schafer M, 2015, J INTEGR PLANT BIOL, V57, P198, DOI 10.1111/jipb.12227; Schmidt K, 2008, MOL PLANT PATHOL, V9, P661, DOI 10.1111/J.1364-3703.2008.00491.X; Skibbe DS, 2010, SCIENCE, V328, P89, DOI 10.1126/science.1185775; Snetselaar KM, 2001, CAN J BOT, V79, P1390, DOI 10.1139/cjb-79-12-1390; Spichal L, 2012, FUNCT PLANT BIOL, V39, P267, DOI 10.1071/FP11276; Stirk WA, 2010, PLANT GROWTH REGUL, V62, P101, DOI 10.1007/s10725-010-9481-x; Ton J, 2009, TRENDS PLANT SCI, V14, P310, DOI 10.1016/j.tplants.2009.03.006; Tsavkelova EA, 2006, APPL BIOCHEM MICRO+, V42, P117, DOI 10.1134/S0003683806020013; Veach YK, 2003, PLANT PHYSIOL, V131, P1374, DOI 10.1104/pp.017210; Walbot V, 2010, SEX PLANT REPROD, V23, P1, DOI 10.1007/s00497-009-0109-0; Walters DR, 2006, TRENDS PLANT SCI, V11, P581, DOI 10.1016/j.tplants.2006.10.003; Xu J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067413; Yarian C, 2002, J BIOL CHEM, V277, P16391, DOI 10.1074/jbc.M200253200; Yonekura-Sakakibara K, 2004, PLANT PHYSIOL, V134, P1654, DOI 10.1104/pp.103.037176	70	41	43	2	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2015	10	6							e0130945	10.1371/journal.pone.0130945	http://dx.doi.org/10.1371/journal.pone.0130945			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4OM	26107181	Green Published, gold, Green Submitted			2022-12-26	WOS:000356932500133
J	Rebolledo-Mendez, J; Hestand, MS; Coleman, SJ; Zeng, Z; Orlando, L; MacLeod, JN; Kalbfleisch, T				Rebolledo-Mendez, Jovan; Hestand, Matthew S.; Coleman, Stephen J.; Zeng, Zheng; Orlando, Ludovic; MacLeod, James N.; Kalbfleisch, Ted			Comparison of the Equine Reference Sequence with Its Sanger Source Data and New Illumina Reads	PLOS ONE			English	Article							BURROWS-WHEELER TRANSFORM; GENOME SEQUENCE; ALIGNMENT; GENETICS; HORSE	The reference assembly for the domestic horse, EquCab2, published in 2009, was built using approximately 30 million Sanger reads from a Thoroughbred mare named Twilight. Contiguity in the assembly was facilitated using nearly 315 thousand BAC end sequences from Twilight's half brother Bravo. Since then, it has served as the foundation for many genome-wide analyses that include not only the modern horse, but ancient horses and other equid species as well. As data mapped to this reference has accumulated, consistent variation between mapped datasets and the reference, in terms of regions with no read coverage, single nucleotide variants, and small insertions/deletions have become apparent. In many cases, it is not clear whether these differences are the result of true sequence variation between the research subjects' and Twilight's genome or due to errors in the reference. EquCab2 is regarded as "The Twilight Assembly." The objective of this study was to identify inconsistencies between the EquCab2 assembly and the source Twilight Sanger data used to build it. To that end, the original Sanger and BAC end reads have been mapped back to this equine reference and assessed with the addition of approximately 40X coverage of new Illumina Paired-End sequence data. The resulting mapped datasets identify those regions with low Sanger read coverage, as well as variation in genomic content that is not consistent with either the original Twilight Sanger data or the new genomic sequence data generated from Twilight on the Illumina platform. As the haploid EquCab2 reference assembly was created using Sanger reads derived largely from a single individual, the vast majority of variation detected in a mapped dataset comprised of those same Sanger reads should be heterozygous. In contrast, homozygous variations would represent either errors in the reference or contributions from Bravo's BAC end sequences. Our analysis identifies 720,843 homozygous discrepancies between new, high throughput genomic sequence data generated for Twilight and the EquCab2 reference assembly. Most of these represent errors in the assembly, while approximately 10,000 are demonstrated to be contributions from another horse. Other results are presented that include the binary alignment map file of the mapped Sanger reads, a list of variants identified as discrepancies between the source data and resulting reference, and a BED annotation file that lists the regions of the genome whose consensus was likely derived from low coverage alignments.	[Rebolledo-Mendez, Jovan; Kalbfleisch, Ted] Univ Louisville, Sch Med, Dept Biochem & Mol Biol, Louisville, KY 40292 USA; [Hestand, Matthew S.; Coleman, Stephen J.; MacLeod, James N.] Univ Kentucky, Dept Vet Sci, Maxwell H Gluck Equine Res Ctr, Lexington, KY USA; [Zeng, Zheng] Univ Kentucky, Dept Comp Sci, Lexington, KY 40506 USA; [Orlando, Ludovic] Univ Copenhagen, Nat Hist Museum Denmark, Ctr GeoGenet, Copenhagen, Denmark; [Kalbfleisch, Ted] Intrepid Bioinformat, Louisville, KY USA	University of Louisville; University of Kentucky; University of Kentucky; University of Copenhagen	Kalbfleisch, T (corresponding author), Univ Louisville, Sch Med, Dept Biochem & Mol Biol, Louisville, KY 40292 USA.	ted.kalbfleisch@louisville.edu	Kalbfleisch, Theodore/AAN-5407-2021; Orlando, Ludovic/A-8932-2013	Orlando, Ludovic/0000-0003-3936-1850; Kalbfleisch, Theodore/0000-0002-2370-8189; Coleman, Stephen/0000-0001-7686-4866	National Institute of General Medical Sciences [5P20GM103436-13]; Lourie Foundation; University of Kentucky Gluck Equine Research Foundation; National Science Foundation [EF0850237]; Marie-Curie Career Integration grant [FP7-CIG-293845]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103436] Funding Source: NIH RePORTER	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Lourie Foundation; University of Kentucky Gluck Equine Research Foundation; National Science Foundation(National Science Foundation (NSF)); Marie-Curie Career Integration grant; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institute of General Medical Sciences 5P20GM103436-13; JNM: Lourie Foundation, the University of Kentucky Gluck Equine Research Foundation, and the National Science Foundation (Liu PI) EF0850237; LO: the Danish National Research Foundation and a Marie-Curie Career Integration grant (FP7-CIG-293845). TSK does have a significant financial interest in Intrepid Bioinformatics, but Intrepid did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of the authors are articulated in the 'author contributions' section.	Coleman SJ, 2010, ANIM GENET, V41, P121, DOI 10.1111/j.1365-2052.2010.02118.x; Coleman SJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070125; Finno CJ, 2014, EQUINE VET J, V46, P538, DOI 10.1111/evj.12294; Hestand MS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124375; Hyman Richard W, 2010, BMC Res Notes, V3, P257, DOI 10.1186/1756-0500-3-257; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Orlando L, 2013, NATURE, V499, P74, DOI 10.1038/nature12323; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Wade CM, 2009, SCIENCE, V326, P865, DOI 10.1126/science.1178158	13	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2015	10	6							e0126852	10.1371/journal.pone.0126852	http://dx.doi.org/10.1371/journal.pone.0126852			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4OM	26107638	Green Published, gold, Green Submitted			2022-12-26	WOS:000356932500008
J	Sota, T; Belton, P; Tseng, M; Yong, HS; Mogi, M				Sota, Teiji; Belton, Peter; Tseng, Michelle; Yong, Hoi Sen; Mogi, Motoyoshi			Phylogeography of the Coastal Mosquito Aedes togoi across Climatic Zones: Testing an Anthropogenic Dispersal Hypothesis	PLOS ONE			English	Article							THEOBALD DIPTERA; RAPID EVOLUTION; LARVAL DIAPAUSE; UNITED-STATES; CULICIDAE; MITOCHONDRIAL; TEMPERATURE; PHOTOPERIOD; ALBOPICTUS; AUTOGENY	The coastal mosquito Aedes togoi occurs more or less continuously from subarctic to subtropic zones along the coasts of the Japanese islands and the East Asian mainland. It occurs also in tropical Southeast Asia and the North American Pacific coast, and the populations there are thought to have been introduced from Japan by ship. To test this hypothesis, the genetic divergence among geographic populations of A. togoi was studied using one mitochondrial and three nuclear gene sequences. We detected 71 mitochondrial haplotypes forming four lineages, with high nucleotide diversity around temperate Japan and declining towards peripheral ranges. The major lineage (L1) comprised 57 haplotypes from temperate and subarctic zones in Japan and Southeast Asia including southern China and Taiwan. Two other lineages were found from subtropical islands (L3) and a subarctic area (L4) of Japan. The Canadian population showed one unique haplotype (L2) diverged from the other lineages. In the combined nuclear gene tree, individuals with mitochondrial L4 haplotypes diverged from those with the other mitochondrial haplotypes L1-L3; although individuals with L1-L3 haplotypes showed shallow divergences in the nuclear gene sequences, individuals from Southeast Asia and Canada each formed a monophyletic group. Overall, the genetic composition of the Southeast Asian populations was closely related to that of temperate Japanese populations, suggesting recent gene flow between these regions. The Canadian population might have originated from anthropogenic introduction from somewhere in Asia, but the possibility that it could have spread across the Beringian land bridge cannot be ruled out.	[Sota, Teiji] Kyoto Univ, Grad Sch Sci, Dept Zool, Kyoto 6068502, Japan; [Belton, Peter] Simon Fraser Univ, Dept Biol Sci, Burnaby, BC V5A 1S6, Canada; [Tseng, Michelle] Univ British Columbia, Dept Zool, Vancouver, BC V6T 1Z4, Canada; [Yong, Hoi Sen] Univ Malaya, Inst Biol Sci, Kuala Lumpur 50603, Malaysia; [Mogi, Motoyoshi] Saga Univ, Fac Med, Div Parasitol, Dept Pathol & Biodef, Saga 8498501, Japan	Kyoto University; Simon Fraser University; University of British Columbia; Universiti Malaya; Saga University	Sota, T (corresponding author), Kyoto Univ, Grad Sch Sci, Dept Zool, Kyoto 6068502, Japan.	sota@terra.zool.kyoto-u.ac.jp	Yong, Hoi Sen/C-1548-2010	Yong, Hoi Sen/0000-0002-9832-8826	Japan Society for the Promotion of Science (JSPS) [17405007, 23405009, 15H02637]; Ministry of Higher Education High Impact Research (MoHE-HIR) [H-50001-00-A000025]	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Higher Education High Impact Research (MoHE-HIR)	This study was partly supported by Japan Society for the Promotion of Science (JSPS) KAKENHI Grant Numbers 17405007, 23405009 and 15H02637 to TS. HY was supported by the Ministry of Higher Education High Impact Research (MoHE-HIR) grant H-50001-00-A000025.	BELTON P, 1980, MOSQ NEWS, V40, P624; BELTON P, 1990, J AM MOSQUITO CONTR, V6, P328; Cheun HI, 2011, KOREAN J PARASITOL, V49, P59, DOI 10.3347/kjp.2011.49.1.59; Cho Shin Hyeong, 2012, Osong Public Health Res Perspect, V3, P145, DOI 10.1016/j.phrp.2012.07.008; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; GALKA BE, 1987, CAN J ZOOL, V65, P2262, DOI 10.1139/z87-341; GALKA BE, 1987, CAN J ZOOL, V65, P2266, DOI 10.1139/z87-342; Gilchrist GW, 2001, GENETICA, V112, P273, DOI 10.1023/A:1013358931816; GOULD DJ, 1968, AM J TROP MED HYG, V17, P609, DOI 10.4269/ajtmh.1968.17.609; HAWLEY WA, 1987, SCIENCE, V236, P1114, DOI 10.1126/science.3576225; Ho SYW, 2005, MOL BIOL EVOL, V22, P1561, DOI 10.1093/molbev/msi145; Huey RB, 2000, SCIENCE, V287, P308, DOI 10.1126/science.287.5451.308; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Juliano SA, 2005, ECOL LETT, V8, P558, DOI 10.1111/j.1461-0248.2005.00755.x; KAMBHAMPATI S, 1991, HEREDITY, V67, P85, DOI 10.1038/hdy.1991.67; Kampen H, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-59; Kaufman MG, 2014, ANNU REV ENTOMOL, V59, P31, DOI 10.1146/annurev-ento-011613-162012; KUNO E, 1992, RES POPUL ECOL, V34, P275, DOI 10.1007/BF02514797; Kurihara Takeshi, 2003, Medical Entomology and Zoology, V54, P135; Lounibos LP, 2003, ANN ENTOMOL SOC AM, V96, P512, DOI 10.1603/0013-8746(2003)096[0512:AEOPDI]2.0.CO;2; Matthews JV, 1979, MEM ENTOMOL SOC CAN, V108, P65; Mogi M., 1995, Mosquito Systematics, V27, P155; MOGI M, 1981, J MED ENTOMOL, V18, P477, DOI 10.1093/jmedent/18.6.477; Mogi M, 2012, J AM MOSQUITO CONTR, V28, P28, DOI 10.2987/8756-971X-28.4s.28; MORI A, 1985, Tropical Medicine, V27, P283; Mousson L, 2005, GENET RES, V86, P1, DOI 10.1017/S0016672305007627; Papadopoulou A, 2010, MOL BIOL EVOL, V27, P1659, DOI 10.1093/molbev/msq051; Quy DV, 1966, LES EXPED SCI, V1, P89; RAMALINGAM S, 1969, Medical Journal of Malaya, V23, P288; Rambaut A., 2014, TRACER V1 6; Reidenbach KR, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-298; Reinert JF, 2004, ZOOL J LINN SOC-LOND, V142, P289, DOI 10.1111/j.1096-3642.2004.00144.x; RIBEIRO JMC, 1986, AM NAT, V128, P513, DOI 10.1086/284584; ROSEN L, 1986, ANNU REV MICROBIOL, V40, P395, DOI 10.1146/annurev.mi.40.100186.002143; SIMON C, 1994, ANN ENTOMOL SOC AM, V87, P651, DOI 10.1093/aesa/87.6.651; SOTA T, 1994, RES POPUL ECOL, V36, P105, DOI 10.1007/BF02515091; SOTA T, 1994, CAN J ZOOL, V72, P1462, DOI 10.1139/z94-193; SOTA T, 1995, J MED ENTOMOL, V32, P181, DOI 10.1093/jmedent/32.2.181; Sota T, 2006, J MED ENTOMOL, V43, P795, DOI 10.1603/0022-2585(2006)43[795:OOPPMI]2.0.CO;2; Sota Teiji, 1995, Japanese Journal of Sanitary Zoology, V46, P173; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; TABACHNICK WJ, 1979, GENET RES, V34, P215, DOI 10.1017/S0016672300019467; Takahashi S., 1973, Japanese J Sanit Zool, V24, P143; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; TANAKA K, 1979, Contributions of the American Entomological Institute, V16, P1; Toma Takako, 2005, Medical Entomology and Zoology, V56, P237; Tripet F, 2011, AM J TROP MED HYG, V85, P265, DOI 10.4269/ajtmh.2011.10-0677; Urbanski J, 2012, AM NAT, V179, P490, DOI 10.1086/664709; Watanabe Katsutoshi, 2006, Japanese Journal of Ichthyology, V53, P1; Wood DM, 1979, DIPTERA CULICIDAE 6	53	7	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2015	10	6							e0131230	10.1371/journal.pone.0131230	http://dx.doi.org/10.1371/journal.pone.0131230			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4OM	26107619	Green Published, gold, Green Submitted			2022-12-26	WOS:000356932500147
J	Morales, IO; Landa, E; Angeles, CC; Toledo, JC; Rivera, AL; Temis, JM; Frank, A				Morales, Irving O.; Landa, Emmanuel; Calderon Angeles, Carlos; Toledo, Juan C.; Leonor Rivera, Ana; Mendoza Temis, Joel; Frank, Alejandro			Behavior of Early Warnings near the Critical Temperature in the Two-Dimensional Ising Model	PLOS ONE			English	Article							SELF-ORGANIZED PATCHINESS; SLOWING-DOWN; CATASTROPHIC SHIFTS; EPILEPTIC SEIZURES; REGIME SHIFTS; ECOSYSTEMS; COMPLEXITY; DYNAMICS; VARIABILITY; TRANSITIONS	Among the properties that are common to complex systems, the presence of critical thresholds in the dynamics of the system is one of the most important. Recently, there has been interest in the universalities that occur in the behavior of systems near critical points. These universal properties make it possible to estimate how far a system is from a critical threshold. Several early-warning signals have been reported in time series representing systems near catastrophic shifts. The proper understanding of these early-warnings may allow the prediction and perhaps control of these dramatic shifts in a wide variety of systems. In this paper we analyze this universal behavior for a system that is a paradigm of phase transitions, the Ising model. We study the behavior of the early-warning signals and the way the temporal correlations of the system increase when the system is near the critical point.	[Morales, Irving O.; Toledo, Juan C.; Leonor Rivera, Ana; Mendoza Temis, Joel; Frank, Alejandro] Univ Nacl Autonoma Mexico, Inst Ciencias Nucl, Mexico City 04510, DF, Mexico; [Morales, Irving O.; Toledo, Juan C.; Mendoza Temis, Joel; Frank, Alejandro] Univ Nacl Autonoma Mexico, Ctr Ciencias Complejidad, Mexico City 04510, DF, Mexico; [Landa, Emmanuel] Univ Sao Paulo, Inst Biociencias, BR-05508 Sao Paulo, Brazil; [Calderon Angeles, Carlos] Univ Nacl Autonoma Mexico, Fac Ciencias, Mexico City 04510, DF, Mexico; [Leonor Rivera, Ana] Univ Nacl Autonoma Mexico, Ctr Fis Aplicada & Tecnol Avanzada, Mexico City 04510, DF, Mexico; [Morales, Irving O.; Landa, Emmanuel; Calderon Angeles, Carlos; Toledo, Juan C.; Leonor Rivera, Ana; Mendoza Temis, Joel; Frank, Alejandro] Lab Nacl Ciencias Complejidad, Mexico City, DF, Mexico	Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico; Universidade de Sao Paulo; Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico	Morales, IO (corresponding author), Univ Nacl Autonoma Mexico, Inst Ciencias Nucl, Mexico City 04510, DF, Mexico.	irvingm@nucleares.unam.mx	Rivera, Ana Leonor/B-5062-2010; Rivera, Ana Leonor/L-4433-2019; Nucleares, Instituto/AAK-6270-2020	Rivera, Ana Leonor/0000-0002-0296-7966; Rivera, Ana Leonor/0000-0002-0296-7966; 	Universidad Nacional Autonoma de Mexico-Direccion General de Asuntos del Personal Academico-Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica [IA100914]	Universidad Nacional Autonoma de Mexico-Direccion General de Asuntos del Personal Academico-Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica	This work was supported by Universidad Nacional Autonoma de Mexico-Direccion General de Asuntos del Personal Academico-Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica IA100914 project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	APPEL ML, 1989, J AM COLL CARDIOL, V14, P1139, DOI 10.1016/0735-1097(89)90408-7; BAK P, 1988, PHYS REV A, V38, P364, DOI 10.1103/PhysRevA.38.364; Carpenter SR, 1999, ECOL APPL, V9, P751, DOI 10.1890/1051-0761(1999)009[0751:MOEFLS]2.0.CO;2; Carpenter SR, 2006, ECOL LETT, V9, P308, DOI 10.1111/j.1461-0248.2005.00877.x; Castellano C, 2009, REV MOD PHYS, V81, P591, DOI 10.1103/RevModPhys.81.591; Champeney D.C., 1989, HDB FOURIER THEOREMS; CRUTCHFIELD JP, 1989, PHYS REV LETT, V63, P105, DOI 10.1103/PhysRevLett.63.105; Dai L, 2012, SCIENCE, V336, P1175, DOI 10.1126/science.1219805; Dakos V, 2008, P NATL ACAD SCI USA, V105, P14308, DOI 10.1073/pnas.0802430105; Dakos V, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0041010, 10.1371/journal.pone.0045586]; Dakos V, 2011, AM NAT, V177, pE153, DOI 10.1086/659945; Das TK, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/237898; Deyoung B, 2008, TRENDS ECOL EVOL, V23, P402, DOI 10.1016/j.tree.2008.03.008; Faranda D, 2014, J PHYS A-MATH THEOR, V47, DOI 10.1088/1751-8113/47/25/252001; Gershenson C, 2012, COMPLEXITY, V18, P29, DOI 10.1002/cplx.21424; GLAUBER RJ, 1963, J MATH PHYS, V4, P294, DOI 10.1063/1.1703954; Guttal V, 2008, ECOL LETT, V11, P450, DOI 10.1111/j.1461-0248.2008.01160.x; Henry ER, 2013, P NATL ACAD SCI USA, V110, P17880, DOI 10.1073/pnas.1317105110; Ising E, 1925, Z PHYS, V31, P253, DOI 10.1007/BF02980577; Iyengar N, 1996, AM J PHYSIOL-REG I, V271, pR1078, DOI 10.1152/ajpregu.1996.271.4.R1078; Jeldtoft JH, 1998, SELF ORG CRITICALITY; Kauffman S.A., 1993, ORIGINS ORDER; Kefi S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092097; Kefi S, 2013, OIKOS, V122, P641, DOI 10.1111/j.1600-0706.2012.20838.x; Kitzbichler MG, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000314; Kleinen T, 2003, OCEAN DYNAM, V53, P53, DOI DOI 10.1007/S10236-002-0023-6; KOBAYASHI M, 1982, IEEE T BIO-MED ENG, V29, P456, DOI 10.1109/TBME.1982.324972; Landa E, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.016224; LIPSITZ LA, 1990, CIRCULATION, V81, P1803, DOI 10.1161/01.CIR.81.6.1803; Litt B, 2001, NEURON, V30, P51, DOI 10.1016/S0896-6273(01)00262-8; LIU Y, 1993, BIOPHYS J, V64, P26, DOI 10.1016/S0006-3495(93)81337-7; Majewski J, 2001, AM J HUM GENET, V69, P853, DOI 10.1086/323419; Marinazzo D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093616; May RM, 2008, NATURE, V451, P893, DOI 10.1038/451893a; McSharry PE, 2003, NAT MED, V9, P241, DOI 10.1038/nm0303-241; METROPOLIS N, 1953, J CHEM PHYS, V21, P1087, DOI 10.1063/1.1699114; PENG CK, 1994, PHYS REV E, V49, P1685, DOI 10.1103/PhysRevE.49.1685; Prokopenko M, 2009, COMPLEXITY, V15, P11, DOI 10.1002/cplx.20249; Razak FA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099462; Rice JJ, 2003, BIOPHYS J, V84, P897, DOI 10.1016/S0006-3495(03)74907-8; Rietkerk M, 2004, SCIENCE, V305, P1926, DOI 10.1126/science.1101867; Scheffer M, 2009, NATURE, V461, P53, DOI 10.1038/nature08227; Sole R. V., 1995, Complexity, V1, P13; Torquato S, 2011, PHYS BIOL, V8, DOI 10.1088/1478-3975/8/1/015017; Venegas JG, 2005, NATURE, V434, P777, DOI 10.1038/nature03490; WANG J, 1993, PHYS REV B, V47, P869, DOI 10.1103/PhysRevB.47.869	46	13	13	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2015	10	6							e0130751	10.1371/journal.pone.0130751	http://dx.doi.org/10.1371/journal.pone.0130751			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4DD	26103513	Green Submitted, gold, Green Published			2022-12-26	WOS:000356901900059
J	Pathak, JL; Bakker, AD; Verschueren, P; Lems, WF; Luyten, FP; Klein-Nulend, J; Bravenboer, N				Pathak, Janak L.; Bakker, Astrid D.; Verschueren, Patrick; Lems, Willem F.; Luyten, Frank P.; Klein-Nulend, Jenneke; Bravenboer, Nathalie			CXCL8 and CCL20 Enhance Osteoclastogenesis via Modulation of Cytokine Production by Human Primary Osteoblasts	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; GENERALIZED BONE LOSS; RHEUMATOID-ARTHRITIS; MECHANICAL-STRESS; NITRIC-OXIDE; INTERLEUKIN-8 IL-8; CELLS; DIFFERENTIATION; EXPRESSION; INHIBITION	Generalized osteoporosis is common in patients with inflammatory diseases, possibly because of circulating inflammatory factors that affect osteoblast and osteoclast formation and activity. Serum levels of the inflammatory factors CXCL8 and CCL20 are elevated in rheumatoid arthritis, but whether these factors affect bone metabolism is unknown. We hypothesized that CXCL8 and CCL20 decrease osteoblast proliferation and differentiation, and enhance osteoblast-mediated osteoclast formation and activity. Human primary osteoblasts were cultured with or without CXCL8 (2-200 pg/ml) or CCL20 (5-500 pg/ml) for 14 days. Osteoblast proliferation and gene expression of matrix proteins and cytokines were analyzed. Osteoclast precursors were cultured with CXCL8 (200 pg/ml) and CCL20 (500 pg/ml), or with conditioned medium (CM) from CXCL8 and CCL20-treated osteoblasts with or without IL-6 inhibitor. After 3 weeks osteoclast formation and activity were determined. CXCL8 (200 pg/ml) and CCL20 (500 pg/ml) enhanced mRNA expression of KI67 (2.5-2.7-fold), ALP (1.6-1.7-fold), and IL-6 protein production (1.3-1.6-fold) by osteoblasts. CXCL8-CM enhanced the number of osteoclasts with 3-5 nuclei (1.7-fold), and with > 5 nuclei (3-fold). CCL20-CM enhanced the number of osteoclasts with 3-5 nuclei (1.3-fold), and with > 5 nuclei (2.8-fold). IL-6 inhibition reduced the stimulatory effect of CXCL8-CM and CCL20-CM on formation of osteoclasts. In conclusion, CXCL8 and CCL20 did not decrease osteoblast proliferation or gene expression of matrix proteins. CXCL8 and CCL20 did not directly affect osteoclastogenesis. However, CXCL8 and CCL20 enhanced osteoblast-mediated osteoclastogenesis, partly via IL-6 production, suggesting that CXCL8 and CCL20 may contribute to osteoporosis in rheumatoid arthritis by affecting bone cell communication.	[Pathak, Janak L.; Bakker, Astrid D.; Klein-Nulend, Jenneke] Univ Amsterdam, Acad Ctr Dent Amsterdam ACTA, Dept Oral Cell Biol, Amsterdam, Netherlands; [Pathak, Janak L.; Bakker, Astrid D.; Klein-Nulend, Jenneke] Vrije Univ Amsterdam, MOVE Res Inst Amsterdam, Amsterdam, Netherlands; [Pathak, Janak L.; Verschueren, Patrick; Luyten, Frank P.] Katholieke Univ Leuven, Skeletal Biol & Engn Res Ctr, Leuven, Belgium; [Lems, Willem F.] Vrije Univ Amsterdam, Med Ctr, MOVE Res Inst Amsterdam, Dept Rheumatol, Amsterdam, Netherlands; [Bravenboer, Nathalie] Vrije Univ Amsterdam, Med Ctr, MOVE Res Inst Amsterdam, Dept Clin Chem, Amsterdam, Netherlands	Academic Center for Dentistry Amsterdam; University of Amsterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; KU Leuven; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam	Klein-Nulend, J (corresponding author), Univ Amsterdam, Acad Ctr Dent Amsterdam ACTA, Dept Oral Cell Biol, Amsterdam, Netherlands.	j.kleinnulend@acta.nl	Bakker, Astrid Diana/AAD-1286-2019; Verschueren, Patrick/L-6397-2019; Luyten, Frank/GPS-7793-2022; Pathak, Janak Lal/AAI-5637-2020	Verschueren, Patrick/0000-0002-0340-3580; Pathak, Janak Lal/0000-0003-2576-443X	European Commission through MOVE-AGE, and Erasmus Mundus Joint Doctorate programme [2011-0015]	European Commission through MOVE-AGE, and Erasmus Mundus Joint Doctorate programme	This research was funded by the European Commission through MOVE-AGE, and Erasmus Mundus Joint Doctorate programme (2011-0015).	Aerts NE, 2010, RHEUMATOLOGY, V49, P2264, DOI 10.1093/rheumatology/keq224; Bakker AD, 2006, OSTEOPOROSIS INT, V17, P827, DOI 10.1007/s00198-006-0072-7; Bakker AD, 2009, ARTHRITIS RHEUM-US, V60, P3336, DOI 10.1002/art.24920; Bakker AD, 2005, OSTEOPOROSIS INT, V16, P983, DOI 10.1007/s00198-004-1785-0; BERTOLINI DR, 1986, NATURE, V319, P516, DOI 10.1038/319516a0; Bloemen V, 2009, BIOCHEM BIOPH RES CO, V385, P640, DOI 10.1016/j.bbrc.2009.05.145; Brennan FM, 2008, J CLIN INVEST, V118, P3537, DOI 10.1172/JCI36389; CHAUDHARY LR, 1992, ENDOCRINOLOGY, V130, P2528, DOI 10.1210/en.130.5.2528; David M, 2014, J BIOL CHEM, V289, P6551, DOI 10.1074/jbc.M113.533232; De Benedetti F, 2006, ARTHRITIS RHEUM, V54, P3551, DOI 10.1002/art.22175; de Vries TJ, 2009, MOL CANCER RES, V7, P476, DOI 10.1158/1541-7786.MCR-08-0219; ENDO H, 1991, LYMPHOKINE CYTOK RES, V10, P245; Feldmann M, 1996, ANNU REV IMMUNOL, V14, P397, DOI 10.1146/annurev.immunol.14.1.397; Gilbert L, 2000, ENDOCRINOLOGY, V141, P3956, DOI 10.1210/en.141.11.3956; GOUGH AKS, 1994, LANCET, V344, P23, DOI 10.1016/S0140-6736(94)91049-9; HARADA A, 1994, J LEUKOCYTE BIOL, V56, P559, DOI 10.1002/jlb.56.5.559; Haugeberg G, 2008, NAT CLIN PRACT RHEUM, V4, P402, DOI 10.1038/ncprheum0843; Hela S, 2005, JOINT BONE SPINE, V72, P403, DOI 10.1016/j.jbspin.2004.09.006; Hofbauer LC, 1999, BONE, V25, P255, DOI 10.1016/S8756-3282(99)00162-3; Kawashiri SY, 2009, J RHEUMATOL, V36, P2397, DOI 10.3899/jrheum.090132; Kim CH, 2002, IMMUNOPHARM IMMUNOT, V24, P395, DOI 10.1081/IPH-120014725; Klein-Nulend J, 1998, BIOCHEM BIOPH RES CO, V250, P108, DOI 10.1006/bbrc.1998.9270; Klein-Nulend J, 2002, OSTEOPOROSIS INT, V13, P137, DOI 10.1007/s001980200005; Kochi Y, 2010, NAT GENET, V42, P515, DOI 10.1038/ng.583; Kornak U, 2001, CELL, V104, P205, DOI 10.1016/S0092-8674(01)00206-9; Kraan MC, 2001, ARTHRITIS RES, V3, P65, DOI 10.1186/ar141; Kuan WP, 2010, J RHEUMATOL, V37, P257, DOI 10.3899/jrheum.090769; Le Goff B, 2010, JOINT BONE SPINE, V77, P201, DOI 10.1016/j.jbspin.2010.03.002; Lee AYS, 2014, IMMUNOL CELL BIOL, V92, P354, DOI 10.1038/icb.2013.97; Lisignoli G, 2003, J CELL PHYSIOL, V194, P71, DOI 10.1002/jcp.10188; Lisignoli G, 2007, J CELL PHYSIOL, V210, P798, DOI 10.1002/jcp.20905; Lisignoli G, 2009, J CELL PHYSIOL, V221, P154, DOI 10.1002/jcp.21839; Mackay CR, 2001, NAT IMMUNOL, V2, P95, DOI 10.1038/84298; Mielants H, 2009, CLIN EXP RHEUMATOL, V27, pS56; Min SH, 2010, BIOCHEM BIOPH RES CO, V391, P1080, DOI 10.1016/j.bbrc.2009.12.025; Naka T, 2002, ARTHRITIS RES THER, V4, pS233, DOI 10.1186/ar565; Okamoto F, 2008, AM J PHYSIOL-CELL PH, V294, pC693, DOI 10.1152/ajpcell.00251.2007; Oostlander AE, 2012, J CELL BIOCHEM, V113, P2424, DOI 10.1002/jcb.24119; Pathak JL, 2014, OSTEOPOROSIS INT, V25, P2453, DOI 10.1007/s00198-014-2779-1; Rossi D, 2000, ANNU REV IMMUNOL, V18, P217, DOI 10.1146/annurev.immunol.18.1.217; Schett G, 2012, NAT REV RHEUMATOL, V8, P656, DOI 10.1038/nrrheum.2012.153; Schlenk J, 2005, J RHEUMATOL, V32, P2291; Shigeyama Y, 2000, ARTHRITIS RHEUM, V43, P2523, DOI 10.1002/1529-0131(200011)43:11<2523::AID-ANR20>3.0.CO;2-Z; Sterck JGH, 1998, AM J PHYSIOL-ENDOC M, V274, pE1113, DOI 10.1152/ajpendo.1998.274.6.E1113; Suda T, 1999, ENDOCR REV, V20, P345, DOI 10.1210/er.20.3.345; Vis M, 2013, OSTEOPOROSIS INT, V24, P2541, DOI 10.1007/s00198-013-2334-5; Wilson SR, 2009, J BIOL CHEM, V284, P2584, DOI 10.1074/jbc.M805280200; Yano S, 2005, ENDOCRINOLOGY, V146, P2324, DOI 10.1210/en.2005-0065	48	33	36	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2015	10	6							e0131041	10.1371/journal.pone.0131041	http://dx.doi.org/10.1371/journal.pone.0131041			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4DD	26103626	Green Published, gold, Green Submitted			2022-12-26	WOS:000356901900072
J	Standaert-Vitse, A; Aliouat-Denis, CM; Martinez, A; Khalife, S; Pottier, M; Gantois, N; Dei-Cas, E; Aliouat, E				Standaert-Vitse, Annie; Aliouat-Denis, Cecile-Marie; Martinez, Anna; Khalife, Sara; Pottier, Muriel; Gantois, Nausicaa; Dei-Cas, Eduardo; Aliouat, El Moukhtar			SYTO-13, a Viability Marker as a New Tool to Monitor In Vitro Pharmacodynamic Parameters of Anti-Pneumocystis Drugs	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; PNEUMOCYSTIS-CARINII; GROWTH; DEATH; ASSAY; DNA; INVOLVEMENT; DERIVATIVES; INFECTIONS; PNEUMONIA	While Pneumocystis pneumonia (PcP) still impacts the AIDS patients, it has a growing importance in immunosuppressed HIV-negative patients. To determine the anti-Pneumocystis therapeutic efficacy of new compounds, animal and in vitro models have been developed. Indeed, well-designed mouse or rat experimental models of pneumocystosis can be used to describe the in vivo anti-Pneumocystis activity of new drugs. In vitro models, which enable the screening of a large panel of new molecules, have been developed using axenic cultures or co-culture with feeder cells; but no universally accepted standard method is currently available to evaluate anti-Pneumocystis molecules in vitro. Thus, we chose to explore the use of the SYTO-13 dye, as a new indicator of Pneumocystis viability. In the present work, we established the experimental conditions to define the in vitro pharmacodynamic parameters (EC50, Emax) of marketed compounds (trimethoprim/sulfamethoxazole, pentamidine, atovaquone) in order to specifically measure the intrinsic activity of these anti-P. carinii molecules using the SYTO-13 dye for the first time. Co-labelling the fungal organisms with anti-P. carinii specific antibodies enabled the measurement of viability of Pneumocystis organisms while excluding host debris from the analysis. Moreover, contrary to microscopic observation, large numbers of fungal cells can be analyzed by flow cytometry, thus increasing statistical significance and avoiding misreading during fastidious quantitation of stained organisms. In conclusion, the SYTO-13 dye allowed us to show a reproducible dose/effect relationship for the tested anti-Pneumocystis drugs.	[Standaert-Vitse, Annie; Aliouat-Denis, Cecile-Marie; Martinez, Anna; Khalife, Sara; Pottier, Muriel; Gantois, Nausicaa; Dei-Cas, Eduardo; Aliouat, El Moukhtar] Univ Lille, Pasteur Inst Lille, CNRS UMR 8204, INSERM U1019,CIIL,BDEEP, Lille, France; [Martinez, Anna] Natl Inst Adv Ind Sci & Technol, Biomed Res Inst, RNA Proc Res Grp, Ibaraki, Japan; [Khalife, Sara] Univ Libanaise, Ctr AZM Rech Biotechnol & Ses Applicat, Lab Microbiol Sante & Environm, Tripoli, Lebanon; [Dei-Cas, Eduardo] CHRU Lille, Biol & Pathol Ctr, Parasitol Mycol, F-59037 Lille, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; National Institute of Advanced Industrial Science & Technology (AIST); Lebanese University; Universite de Lille - ISITE; CHU Lille	Aliouat, E (corresponding author), Univ Lille, Pasteur Inst Lille, CNRS UMR 8204, INSERM U1019,CIIL,BDEEP, Lille, France.	elmoukhtar.aliouat-3@univ-lille2.fr	Martinez, Anna/AAI-6447-2021; Standaert, Annie/AAD-8209-2020; Aliouat, El Moukhtar/D-2859-2018; Standaert, Annie/R-5826-2018; Aliouat-Denis, Cecile-Marie/P-1934-2016	Standaert, Annie/0000-0002-7752-3964; Aliouat, El Moukhtar/0000-0003-2905-7126; Standaert, Annie/0000-0002-7752-3964; Martinez, Anna/0000-0001-7245-9687; Khalife, Sara/0000-0001-7326-0477; Aliouat-Denis, Cecile-Marie/0000-0001-8388-4662	ANR-ERA-NET 'Pneumocystis' PathoGenoMics [ANR-06-319 PATHO-009-01]; Lille-Nord-de-France University; Pasteur Institute of Lille; microscopy platform of the Lille-Nord-de-France BioImaging Center (BiCeL) [IFR142]	ANR-ERA-NET 'Pneumocystis' PathoGenoMics(French National Research Agency (ANR)); Lille-Nord-de-France University; Pasteur Institute of Lille; microscopy platform of the Lille-Nord-de-France BioImaging Center (BiCeL)	This work was partly supported by ANR-ERA-NET 'Pneumocystis' PathoGenoMics (ANR-06-319 PATHO-009-01). The authors also thank Lille-Nord-de-France University, the Pasteur Institute of Lille, and the microscopy platform of the Lille-Nord-de-France BioImaging Center (BiCeL, IFR142) for their support. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aliouat E, 1999, J EUKARYOT MICROBIOL, V46, p116S; Ambrose HE, 2004, MICROBIOL-SGM, V150, P293, DOI 10.1099/mic.0.26539-0; ARMSTRONG MYK, 1991, J PROTOZOOL, V38, pS88; Aviles P, 2000, ANTIMICROB AGENTS CH, V44, P1284, DOI 10.1128/AAC.44.5.1284-1290.2000; Bonnet F, 2005, SCAND J INFECT DIS, V37, P482, DOI 10.1080/00365540510035328; Calderon EJ, 1996, LANCET, V347, P977, DOI 10.1016/S0140-6736(96)91468-3; Calderon EJ, 2007, CLIN INFECT DIS, V45, pE17, DOI 10.1086/518989; Chabe M, 2004, MICROBIOL-SGM, V150, P1167, DOI 10.1099/mic.0.26895-0; CHEN F, 1994, J EUKARYOT MICROBIOL, V41, pS79; CHEN F, 1994, J CLIN MICROBIOL, V32, P2791, DOI 10.1128/JCM.32.11.2791-2800.1994; Cirioni O, 1997, J ANTIMICROB CHEMOTH, V39, P45, DOI 10.1093/jac/39.1.45; Comas-Riu J, 2002, J APPL MICROBIOL, V92, P475, DOI 10.1046/j.1365-2672.2002.01549.x; COMLEY JCW, 1991, ANTIMICROB AGENTS CH, V35, P1965, DOI 10.1128/AAC.35.10.1965; Crothers K, 2005, AIDS, V19, P801, DOI 10.1097/01.aids.0000168974.67090.70; CUSHION MT, 1989, J PROTOZOOL, V36, P45; CUSHION MT, 1990, J CLIN MICROBIOL, V28, P1385, DOI 10.1128/JCM.28.6.1385-1394.1990; Dei-Cas E, 1998, FEMS IMMUNOL MED MIC, V22, P163, DOI [10.1111/j.1574-695X.1998.tb01201.x, 10.1111/j.1574-695X.1998.tb01203.x]; Dei-Cas E, 2000, MED MYCOL, V38, P23, DOI 10.1080/mmy.38.s1.23.32; DeiCas E, 1996, PARASITOL TODAY, V12, P245, DOI 10.1016/0169-4758(96)80812-X; Guindulain T, 2002, LETT APPL MICROBIOL, V34, P182, DOI 10.1046/j.1472-765x.2002.01069.x; Herreros E, 1997, J EUKARYOT MICROBIOL, V44, p43S, DOI 10.1111/j.1550-7408.1997.tb05766.x; Huang L, 2004, EMERG INFECT DIS, V10, P1721, DOI 10.3201/eid1010.030994; HUGHES WT, 1994, J INFECT DIS, V170, P906, DOI 10.1093/infdis/170.4.906; Jain MK, 2003, CLIN INFECT DIS, V36, P1030, DOI 10.1086/368186; Jimenez E, 2002, ANTIMICROB AGENTS CH, V46, P2648, DOI 10.1128/AAC.46.8.2648-2650.2002; KANESHIRO ES, 1991, J PROTOZOOL, V38, pS85; KOVACS JA, 1989, J INFECT DIS, V160, P312, DOI 10.1093/infdis/160.2.312; LAPINSKY SE, 1991, J CLIN MICROBIOL, V29, P911, DOI 10.1128/JCM.29.5.911-915.1991; Latouche S, 2001, J EUKARYOT MICROBIOL, p176S; Lebaron P, 1998, APPL ENVIRON MICROB, V64, P1725; Maher N, 2000, J CLIN MICROBIOL, V38, P1947, DOI 10.1128/JCM.38.5.1947-1952.2000; Martinez A, 2009, J EUKARYOT MICROBIOL, V56, P446, DOI 10.1111/j.1550-7408.2009.00423.x; Merali S, 1999, P NATL ACAD SCI USA, V96, P2402, DOI 10.1073/pnas.96.5.2402; Morris A, 2004, EMERG INFECT DIS, V10, P1713, DOI 10.3201/eid1010.030985; Mouton JW, 1997, ANTIMICROB AGENTS CH, V41, P733, DOI 10.1128/AAC.41.4.733; Peterson JC, 2005, CURR OPIN MICROBIOL, V8, P393, DOI 10.1016/j.mib.2005.06.010; Poot M, 1997, CYTOMETRY, V27, P358, DOI 10.1002/(SICI)1097-0320(19970401)27:4<358::AID-CYTO7>3.0.CO;2-8; Probst M, 2000, EUR J CLIN MICROBIOL, V19, P644, DOI 10.1007/s100960000329; Shenkin M, 2007, CYTOM PART B-CLIN CY, V72B, P427, DOI 10.1002/cyto.b.20179; Sing A, 1999, J CLIN MICROBIOL, V37, P3409, DOI 10.1128/JCM.37.10.3409-3410.1999; Stanicki D, 2013, PHARMACEUTICALS, V6, P837, DOI 10.3390/ph6070837; Tarnok A, 2008, CYTOM PART A, V73A, P477, DOI 10.1002/cyto.a.20588; van Zandvoort MAMJ, 2002, CYTOMETRY, V47, P226, DOI 10.1002/cyto.10076; Vargas SL, 2007, PEDIATR INFECT DIS J, V26, P81, DOI 10.1097/01.inf.0000247071.40739.fd; Vargas SL, 2003, EMERG INFECT DIS, V9, P605, DOI 10.3201/eid0905.020660; Wise RA, 2007, AM J MED, V120, pS14, DOI 10.1016/j.amjmed.2007.04.008; Yale SH, 1996, MAYO CLIN PROC, V71, P5, DOI 10.4065/71.1.5	47	2	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2015	10	6							e0130358	10.1371/journal.pone.0130358	http://dx.doi.org/10.1371/journal.pone.0130358			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4DD	26103633	Green Published, gold, Green Submitted			2022-12-26	WOS:000356901900037
J	Bellaloui, N; Turley, RB; Stetina, SR				Bellaloui, Nacer; Turley, Rickie B.; Stetina, Salliana R.			Water Stress and Foliar Boron Application Altered Cell Wall Boron and Seed Nutrition in Near-Isogenic Cotton Lines Expressing Fuzzy and Fuzzless Seed Phenotypes	PLOS ONE			English	Article							CHANNEL-MEDIATED TRANSPORT; FATTY-ACID-COMPOSITION; RHAMNOGALACTURONAN-II; IRRIGATION REGIMES; PLANT AQUAPORINS; BORIC-ACID; QUALITY; REQUIREMENT; SQUASH; IDENTIFICATION	Our previous research, conducted under well-watered conditions without fertilizer application, showed that fuzziness cottonseed trait resulted in cottonseed nutrition differences between fuzzy (F) and fuzzless (N) cottonseed. Under water stress conditions, B mobility is further limited, inhibiting B movement within the plant, affecting seed nutrition (quality). Therefore, we hypothesized that both foliar B and water stress can affect B mobility, altering cottonseed protein, oil, and mineral nutrition. The objective of the current research was to evaluate the effects of the fuzziness seed trait on boron (B) and seed nutrition under water stress and foliar B application using near-isogenic cotton lines (NILs) grown in a repeated greenhouse experiment. Plants were grown under-well watered conditions (The soil water potential was kept between -15 to -20 kPa, considered field capacity) and water stress conditions (soil water potential between -100 and -150 kPa, stressed conditions). Foliar B was applied at a rate of 1.8 kg B ha(-1) as H3BO3. Under well-watered conditions without B the concentrations of seed oil in N lines were higher than in F lines, and seed K and N levels were lower in N lines than in Flines. Concentrations of K, N, and B in leaves were higher in Nlines than in Flines, opposing the trend in seeds. Water-stress resulted in higher seed protein concentrations, and the contribution of cell wall (structural) B to the total B exceeded 90%, supporting the structural role of B in plants. Foliar B application under well-watered conditions resulted in higher seed protein, oil, C, N, and B in only some lines. This research showed that cottonseed nutrition differences can occur due to seed fuzziness trait, and water stress and foliar B application can alter cottonseed nutrition.	[Bellaloui, Nacer; Turley, Rickie B.; Stetina, Salliana R.] ARS, Crop Genet Res Unit, USDA, Stoneville, MS 38776 USA	United States Department of Agriculture (USDA)	Bellaloui, N (corresponding author), ARS, Crop Genet Res Unit, USDA, Stoneville, MS 38776 USA.	nacer.bellaloui@ars.usda.gov		Turley, Rickie/0000-0002-1792-9559	USDA, Agricultural Research Service [6066-21220-012-00D, 6066-21000-051-00D]	USDA, Agricultural Research Service(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	Funding for this research was provided by USDA, Agricultural Research Service projects 6066-21220-012-00D and 6066-21000-051-00D (http://www.ars.usda.gov/pandp/people/projects.htm?personid=37050).	Ahmed N, 2013, COMMUN SOIL SCI PLAN, V44, P1293, DOI 10.1080/00103624.2012.756508; ANDERSON OE, 1971, AGRON J, V63, P566, DOI 10.2134/agronj1971.00021962006300040016x; [Anonymous], 1990, AOAC OFFICIAL METHOD, V15th ed., DOI [10.1016/b0-12-765490-9/00006-9, DOI 10.1016/B0-12-765490-9/00006-9]; [Anonymous], 2013, USDA ERS COTT WOOL O; Bechere E, 2009, EUPHYTICA, V167, P333, DOI 10.1007/s10681-009-9890-y; Bellaloui N., 2009, Crop Management, pCM; Bellaloui N, 2008, J AGR FOOD CHEM, V56, P2765, DOI 10.1021/jf703615m; Bellaloui N, 2008, IRRIGATION SCI, V26, P261, DOI 10.1007/s00271-007-0091-y; Bellaloui N, 2014, CROP SCI, V54, P1782, DOI 10.2135/cropsci2013.07.0463; Bellaloui N, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00516; Bellaloui N, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00270; Boydak E, 2002, J AGR FOOD CHEM, V50, P4718, DOI 10.1021/jf0255331; Brown PH, 1997, PLANT SOIL, V193, P85, DOI 10.1023/A:1004211925160; Brown PH, 2002, PLANT BIOLOGY, V4, P205, DOI 10.1055/s-2002-25740; Chen X, 2002, NATURE, V415, P545, DOI 10.1038/415545a; Cherry J P, 1978, Adv Exp Med Biol, V105, P343; CHERRY JP, 1982, COTTON AGRON MONOGR, V24, P511; Dannel F, 2002, PLANT BIOLOGY, V4, P193, DOI 10.1055/s-2002-25730; Dannel F, 2002, AUST J PLANT PHYSL, V27, P397; Dordas C, 2000, PLANT PHYSIOL, V124, P1349, DOI 10.1104/pp.124.3.1349; Dordas C, 2001, PLANT SOIL, V235, P95, DOI 10.1023/A:1011837903688; Dordas C, 2006, NUTR CYCL AGROECOSYS, V76, P19, DOI 10.1007/s10705-006-9037-7; Dowd MK, 2010, J COTTON SCI, V14, P64; ELMORE CD, 1979, AGRON J, V71, P713, DOI 10.2134/agronj1979.00021962007100050005x; GIPSON JR, 1969, AGRON J, V61, P365, DOI 10.2134/agronj1969.00021962006100030008x; He ZQ, 2013, AGRON J, V105, P341, DOI 10.2134/agronj2012.0351; Helrich K., 1990, OFFICIAL METHODS ANA, V15th ed.; HU HI, 1994, PLANT PHYSIOL, V105, P681, DOI 10.1104/pp.105.2.681; Hu HN, 1997, PLANT SOIL, V193, P49, DOI 10.1023/A:1004255707413; Hu HN, 1996, J EXP BOT, V47, P227, DOI 10.1093/jxb/47.2.227; Kobayashi M, 1996, PLANT PHYSIOL, V110, P1017, DOI 10.1104/pp.110.3.1017; KOHEL RJ, 1983, CROP SCI, V23, P1119, DOI 10.2135/cropsci1983.0011183X002300060023x; LEFFLER HR, 1977, CROP SCI, V17, P953, DOI 10.2135/cropsci1977.0011183X001700060034x; LOHSE G, 1982, COMMUN SOIL SCI PLAN, V13, P127, DOI 10.1080/00103628209367251; Lukonge E, 2007, J SCI FOOD AGR, V87, P340, DOI 10.1002/jsfa.2731; Marschner P, 2012, MARSCHNER'S MINERAL NUTRITION OF HIGHER PLANTS, 3RD EDITION, P1; Nabi G, 2006, J PLANT NUTR, V29, P717, DOI 10.1080/01904160600564543; Nadia MAN, 2006, J APPL SCI RES, V2, P1330; Nyomora AMS, 1999, HORTSCIENCE, V34, P242, DOI 10.21273/HORTSCI.34.2.242; O'Neill MA, 2004, ANNU REV PLANT BIOL, V55, P109, DOI 10.1146/annurev.arplant.55.031903.141750; O'Neill MA, 2001, SCIENCE, V294, P846, DOI 10.1126/science.1062319; Padmalatha KV, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-624; Perica S, 2001, HORTSCIENCE, V36, P714, DOI 10.21273/HORTSCI.36.4.714; Pettigrew WT, 2011, CROP SCI, V51, P2155, DOI 10.2135/cropsci2011.02.0085; Plank CO, 1979, PLANT ANAL HDB GEORG; Rashid A, 2002, BORON IN PLANT AND ANIMAL NUTRITION, P357; RASHID A, 2008, MICR DEF GLOB CROP, P149; Reuter D.J., 1997, PLANT ANAL INTERPRET, P83; SAS, 2002, STAT AN SYST VERS 9; SIMS J T, 1991, P427; Stetina SR, 2014, J CROP IMPROV, V28, P680, DOI 10.1080/15427528.2014.931901; Steudle E, 2000, J EXP BOT, V51, P1531, DOI 10.1093/jexbot/51.350.1531; Takano J, 2002, NATURE, V420, P337, DOI 10.1038/nature01139; Takano J, 2005, P NATL ACAD SCI USA, V102, P12276, DOI 10.1073/pnas.0502060102; Turley RB, 2002, J HERED, V93, P359, DOI 10.1093/jhered/93.5.359; Turley RB, 2007, EUPHYTICA, V156, P57, DOI 10.1007/s10681-006-9351-9; Tyerman SD, 2002, PLANT CELL ENVIRON, V25, P173, DOI 10.1046/j.0016-8025.2001.00791.x; Tyerman SD, 1999, J EXP BOT, V50, P1055, DOI 10.1093/jexbot/50.suppl_1.1055; Wilcox JR, 2001, CROP SCI, V41, P11, DOI 10.2135/cropsci2001.41111x; Wu JX, 2009, EUPHYTICA, V167, P371, DOI 10.1007/s10681-009-9896-5; Yu JZ, 2012, EUPHYTICA, V187, P203, DOI 10.1007/s10681-012-0643-y; YUNUSOVA SG, 1991, KHIM PRIR SOEDIN+, P173	62	10	10	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2015	10	6							e0130759	10.1371/journal.pone.0130759	http://dx.doi.org/10.1371/journal.pone.0130759			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL3FM	26098564	gold, Green Published, Green Submitted			2022-12-26	WOS:000356835800101
J	Santarem, GCDS; de Cleva, R; Santo, MA; Bernhard, B; Gadducci, AV; Greve, JMD; Silva, PRS				Correia de Faria Santarem, G.; de Cleva, R.; Santo, Marco Aurelio; Bernhard, Biaseto; Gadducci, Alexandre Vieira; D'Andrea Greve, Julia Maria; Santos Silva, Paulo Roberto			Correlation between Body Composition and Walking Capacity in Severe Obesity	PLOS ONE			English	Article							6-MINUTE WALK; MASS INDEX; WEIGHT-LOSS; DISABILITY; PERFORMANCE; PREDICTORS; IMPACT; MEN; FAT; SEX	Background Obesity is associated with mobility reduction due to mechanical factors and excessive body fat. The six-minute walk test (6MWT) has been used to assess functional capacity in severe obesity. Objective To determine the association of BMI, total and segmental body composition with distance walked (6MWD) during the six-minute walk test (6MWT) according to gender and obesity grade. Setting University of Sao Paulo Medical School, Brazil; Public Practice. Methods Functional capacity was assessed by 6MWD and body composition (%) by bioelectrical impedance analysis in 90 patients. Results The mean 6MWD was 514.9 +/- 50.3 m for both genders. The male group (M: 545.2 +/- 46.9 m) showed a 6MWD higher (p = 0.002) than the female group (F: 505.6 +/- 47.9 m). The morbid obese group (MO: 524.7 +/- 44.0 m) also showed a 6MWD higher (p = 0.014) than the super obese group (SO: 494.2 +/- 57.0 m). There was a positive relationship between 6MWD and fat free mass (FFM), FFM of upper limps (FFM_UL), trunk (FFM_TR) and lower limbs (FFM_LL). Female group presented a positive relationship between 6MWD and FFM, FFM_UL and FFM_LL and male group presented a positive relationship between 6MWD and FFM_TR. In morbid obese group there was a positive relationship between 6MWD with FFM, FFM_UL, FFM_TR and FFM_LL. The super obese group presented a positive relationship between 6MWD with FFM, FFM_TR and FFM_LL. Conclusions Total and segmental FFM is associated with a better walking capacity than BMI.	[Correia de Faria Santarem, G.; de Cleva, R.; Santo, Marco Aurelio; Bernhard, Biaseto; Gadducci, Alexandre Vieira] Univ Sao Paulo, Sch Med, Dept Gastroenterol, Sao Paulo, SP, Brazil; [D'Andrea Greve, Julia Maria; Santos Silva, Paulo Roberto] Univ Sao Paulo, Sch Med, Dept Orthoped & Traumatol, Sao Paulo, SP, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo	Santarem, GCDS (corresponding author), Univ Sao Paulo, Sch Med, Dept Gastroenterol, Sao Paulo, SP, Brazil.	gabrielafaria@hotmail.com	Santo, Marco Aurelio/AGI-6884-2022; Gadducci, Alexandre V/D-9860-2019; Santos-Silva, Paulo Roberto/AAY-4269-2020; de cleva, roberto/AAG-6927-2019; GREVE, JULIA/A-7849-2013; de cleva, roberto/L-8456-2013	Santos-Silva, Paulo Roberto/0000-0003-1223-5862; de cleva, roberto/0000-0001-8673-9014; GREVE, JULIA/0000-0003-1778-0448; de cleva, roberto/0000-0001-8673-9014				Anandacoomarasamy A, 2008, INT J OBESITY, V32, P211, DOI 10.1038/sj.ijo.0803715; Beriault K, 2009, INT J SPORTS MED, V30, P725, DOI 10.1055/s-0029-1231043; BORG GAV, 1982, MED SCI SPORT EXER, V14, P377, DOI 10.1249/00005768-198205000-00012; Brazilian Society of Thoracic, 1996, J PNEUMOL, V22, P1; Broadwin J, 2001, J AM GERIATR SOC, V49, P1641, DOI 10.1111/j.1532-5415.2001.49273.x; Brusasco V, 2005, EUR RESPIR J, V26, P1, DOI 10.1183/09031936.05.00034205; Casanova C, 2011, EUR RESPIR J, V37, P150, DOI 10.1183/09031936.00194909; Donini LM, 2011, DISABIL REHABIL, V33, P2509, DOI 10.3109/09638288.2011.575529; Donini LM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075491; Enright PL, 2003, CHEST, V123, P387, DOI 10.1378/chest.123.2.387; Enright PL, 1998, AM J RESP CRIT CARE, V158, P1384, DOI 10.1164/ajrccm.158.5.9710086; de Souza SAF, 2010, OBES SURG, V20, P871, DOI 10.1007/s11695-010-0109-z; de Souza SAF, 2009, SURG OBES RELAT DIS, V5, P540, DOI 10.1016/j.soard.2009.05.003; Finkelstein EA, 2012, AM J PREV MED, V42, P563, DOI 10.1016/j.amepre.2011.10.026; Gallagher D, 1996, AM J EPIDEMIOL, V143, P228, DOI 10.1093/oxfordjournals.aje.a008733; Gontijo PL, 2011, REV ASSOC MED BRAS, V57, P387, DOI 10.1590/S0104-42302011000400010; GoodmanGruen D, 1996, AM J EPIDEMIOL, V143, P898, DOI 10.1093/oxfordjournals.aje.a008833; Hemmingsson E, 2007, INT J OBESITY, V31, P663, DOI 10.1038/sj.ijo.0803458; Hulens M, 2003, SCAND J MED SCI SPOR, V13, P98, DOI 10.1034/j.1600-0838.2003.10273.x; Lai PPK, 2008, CLIN BIOMECH, V23, pS2, DOI 10.1016/j.clinbiomech.2008.02.004; Larsson U, 2002, INT J OBESITY, V26, P417, DOI 10.1038/sj.ijo.0801919; Larsson UE, 2004, INT J OBESITY, V28, P269, DOI 10.1038/sj.ijo.0802534; Larsson UE, 2008, PHYSIOTHER RES INT, V13, P84, DOI 10.1002/pri.398; Lord SR, 2002, ARCH PHYS MED REHAB, V83, P907, DOI 10.1053/apmr.2002.33227; PODSIADLO D, 1991, J AM GERIATR SOC, V39, P142, DOI 10.1111/j.1532-5415.1991.tb01616.x; Ponta ML, 2014, OBES SURG; Romero-Corral A, 2008, INT J OBESITY, V32, P959, DOI 10.1038/ijo.2008.11; Rubim Valéria Siqueira Martins, 2006, Arq. Bras. Cardiol., V86, P120, DOI 10.1590/S0066-782X2006000200007; Shah NR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033308; Sternfeld B, 2002, AM J EPIDEMIOL, V156, P110, DOI 10.1093/aje/kwf023	30	12	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2015	10	6							e0130268	10.1371/journal.pone.0130268	http://dx.doi.org/10.1371/journal.pone.0130268			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL3FM	26098769	Green Published, gold, Green Submitted			2022-12-26	WOS:000356835800060
J	Hennicke, JC; James, DJ; Weimerskirch, H				Hennicke, Janos C.; James, David J.; Weimerskirch, Henri			Sex-Specific Habitat Utilization and Differential Breeding Investments in Christmas Island Frigatebirds throughout the Breeding Cycle	PLOS ONE			English	Article							FORAGING BEHAVIOR; PARENTAL CARE; DIMORPHISM; SEGREGATION; ALBATROSSES	In seabirds, equal bi-parental care is the rule, as it is considered crucial for raising chicks successfully because seabirds forage in an environment with unpredictable and highly variable food supply. Frigatebirds forage in poor tropical waters, yet males reduce and even stop parental care soon after chick brooding, leaving the female to provision the chick alone for an extended fledging period. Using bird-borne tracking devices, male and female Christmas Island Frigatebirds (Fregata andrewsi) were investigated during the brooding, late chick rearing and post-fledging period to examine whether sexes exhibit foraging strategies that may be linked to differential breeding investments. During brooding, males and females showed similar foraging behaviour under average marine productivity of oceanic waters close to the colony, but males shifted to more distant and more productive habitats when conditions deteriorated to continue with reduced chick provisioning. During the late chick rearing period, females progressively increased their foraging range to the more distant but productive marine areas that only males had visited during brooding. Birds spent the non-breeding period roosting in highly productive waters of the Sunda Shelf. The sex-specific utilisation of three different foraging habitats with different primary productivity (oceanic, coastal, and shelf areas) allowed for temporal and spatial segregation in the exploitation of favourable habitats which seems to enable each sex to optimise its foraging profitability. In addition, post-fledging foraging movements of females suggest a biennial breeding cycle, while limited information on males suggests the possibility of an annual breeding cycle.	[Hennicke, Janos C.; Weimerskirch, Henri] CNRS, CEBC, Marine Top Predator Grp, Villiers En Bois, France; [Hennicke, Janos C.] Univ Hamburg, Dept Ecol & Conservat, Hamburg, Germany	Centre National de la Recherche Scientifique (CNRS); University of Hamburg	Hennicke, JC (corresponding author), CNRS, CEBC, Marine Top Predator Grp, Villiers En Bois, France.	janos.hennicke@uni-hamburg.de	Weimerskirch, Henri/K-7306-2019; Weimerskirch, Henri/F-5562-2013	Weimerskirch, Henri/0000-0002-0457-586X; 	Universitat Hamburg; MiniWunderland Hamburg; CI Island Trust; CI Territory Week Committee; CI Tourist Association; Australian Department of Finance and Administration; Department of the Environment & Water Resources; European Union [PIEF-GA-2009-236295]	Universitat Hamburg; MiniWunderland Hamburg; CI Island Trust; CI Territory Week Committee; CI Tourist Association; Australian Department of Finance and Administration; Department of the Environment & Water Resources; European Union(European Commission)	This work was supported by grants from the Universitat Hamburg, MiniWunderland Hamburg, CI Island Trust, CI Territory Week Committee, CI Tourist Association, and anonymous charitable donations. Parts of the study were also conducted within the framework of the Christmas Island Biodiversity Monitoring Programme (2003-2007), which was funded by the Australian Department of Finance and Administration and Department of the Environment & Water Resources. Globetrotter Hamburg, Grube KG Hutzel, Rische & Herfurth Hamburg and The North Face Inc. USA provided in-kind support. Satellite transmitters used in 2005 and 2007 were provided by the North Star Science and Technology LLC Annual Grant Program by Northstar Science & Technology LLC, USA, in association with the American Ornithologists Union in 2005 (4 devices) and in 2006 (2 devices). During the main analyses and parts of the fieldwork, JCH was funded by a Marie Curie Research Fellowship from the European Union (PIEF-GA-2009-236295). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainley D. G., 1983, STUD AVIAN BIOL, V8, P2; ANDERSSON M, 1981, BIOL J LINN SOC, V15, P105, DOI 10.1111/j.1095-8312.1981.tb00752.x; [Anonymous], 2010, R LANG ENV STAT COMP; [Anonymous], 1994, SEXUAL SELECTION; De Monte S, 2012, J R SOC INTERFACE, V9, P3351, DOI 10.1098/rsif.2012.0509; DIAMOND AW, 1972, IBIS, V114, P395, DOI 10.1111/j.1474-919X.1972.tb00839.x; DIAMOND AW, 1973, CONDOR, V75, P200, DOI 10.2307/1365868; Diamond AW, 2002, BIRDS N AM, V601; DUJARDIN J-L, 1990, Alauda, V58, P107; Froese R., 2014, FISHBASE; Furness R. W., 1987, SKUAS; GIBSON-HILL C. A., 1947, BULL RAFFLES MUS, V18, P87; Gonzalez-Solis J, 2000, OIKOS, V90, P390, DOI 10.1034/j.1600-0706.2000.900220.x; Gray H. S., 1995, CHRISTMAS ISLAND NAT; Lack D., 1968, ECOLOGICAL ADAPTATIO; Lagarde F, 2004, REV ECOL-TERRE VIE, V59, P465; Lewis S, 2005, IBIS, V147, P408, DOI 10.1111/j.1474-919x.2005.00428.x; Lewis S, 2002, P ROY SOC B-BIOL SCI, V269, P1687, DOI 10.1098/rspb.2002.2083; Longhurst AR, 1987, ECOLOGY TROPICAL OCE; Marchant S., 1990, HDB AUSTR NZ ANTARCT, V1; MCCONNELL BJ, 1992, ANTARCT SCI, V4, P393, DOI 10.1017/S0954102092000580; Metz V. G., 2002, BIRDS N AM, V681; NELSON J B, 1975, Living Bird, V14, P113; Nelson JB, 2005, PELICANS CORMORANTS; OLSEN KM, 1995, TERNS EUROPE N AM; Orians G.H., 1979, P155; Osorno JL, 1999, J AVIAN BIOL, V30, P335, DOI 10.2307/3677005; Osorno JL, 2004, ANIM BEHAV, V68, P337, DOI 10.1016/j.anbehav.2003.06.027; Phillipps Q., 2009, PHILLIPPS FIELD GUID; Phillips RA, 2004, P ROY SOC B-BIOL SCI, V271, P1283, DOI 10.1098/rspb.2004.2718; Phillips RA, 2003, AUK, V120, P1082, DOI 10.1642/0004-8038(2003)120[1082:EOSTOA]2.0.CO;2; Robinson A.H., 1978, ELEMENTS CARTOGRAPHY, V4th ed.; Seaman DE, 1996, ECOLOGY, V77, P2075, DOI 10.2307/2265701; Stearns S., 1992, EVOLUTION LIFE HIST; Tomascik T, 1997, ECOLOGY INDONESIAN S; WARHAM J, 1990, PETRELS THEIR ECOLOG; Weimerskirch H, 2000, POLAR BIOL, V23, P733, DOI 10.1007/s003000000144; Weimerskirch H, 2006, CONDOR, V108, P220, DOI 10.1650/0010-5422(2006)108[0220:PMOFTW]2.0.CO;2; Weimerskirch H, 2004, MAR ECOL PROG SER, V275, P297, DOI 10.3354/meps275297; Weimerskirch H, 1999, P 22 INT ORN C DURB, P1178; Weimerskirch H, 2010, PROG OCEANOGR, V86, P204, DOI 10.1016/j.pocean.2010.04.003; Weimerskirch H, 2009, OECOLOGIA, V161, P637, DOI 10.1007/s00442-009-1397-7; Wells D. R, 1999, BIRDS THAI MALAY PEN, V1; Wood AG, 2000, J AVIAN BIOL, V31, P278, DOI 10.1034/j.1600-048X.2000.310302.x; [No title captured]; [No title captured]; [No title captured]	47	11	12	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2015	10	6							e0129437	10.1371/journal.pone.0129437	http://dx.doi.org/10.1371/journal.pone.0129437			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL3FM	26098941	gold, Green Published, Green Submitted			2022-12-26	WOS:000356835800030
J	de Rezende, LFM; Azeredo, CM; Silva, KS; Claro, RM; Franca, I; Peres, MFT; Luiz, OD; Levy, RB; Eluf-Neto, J				Machado de Rezende, Leandro Fornias; Azeredo, Catarina Machado; Silva, Kelly Samara; Claro, Rafael Moreira; Franca-Junior, Ivan; Tourinho Peres, Maria Fernanda; Luiz, Olinda do Carmo; Levy, Renata Bertazzi; Eluf-Neto, Jose			The Role of School Environment in Physical Activity among Brazilian Adolescents	PLOS ONE			English	Article							CHILDREN; ASSOCIATIONS; PREVALENCE; STUDENTS; BEHAVIOR; RECESS	Objective To analyze the association of physical activity facilities and extracurricular sports activities in schools with physical activity among adolescents. Methodology/Principal Findings We used data collected for the National Survey of School Health in 2012. The national representative sample comprised 109,104 Brazilian students from 2,842 schools. We calculated the prevalence of participation in physical education classes, leisure-time physical activity, and total physical activity level. We also evaluated the following physical activity facilities: sports courts, running/athletics tracks, schoolyard with teacher-directed physical activities, swimming pools, locker rooms; and the offer of extracurricular sports activities. Schools with at least one physical activity facility had increased odds of participation in physical education (OR 1.59; 95% CI 1.20 to 2.10). However, in order to increase leisure-time physical activity (OR 1.14; 95% CI 1.03 to 1.26) and total physical activity level (OR 1.15; 95% CI 1.06 to 1.24) at least four and two facilities, respectively, were necessary. Extracurricular sports activities in schools were positively associated with leisure-time physical activity and physical activity level. The number of sports courts and swimming pool in a school were associated with participation in physical education classes. Availability of sports courts, running/athletics tracks, and swimming pool in schools were associated with leisure-time physical activity. Total physical activity was associated with schools with sports courts, schoolyard with teacher-directed physical activities, and swimming pool. Conclusions School-level characteristics have important potential to increase the possibility of engagement in physical activity in and out of school, and therefore have a fundamental role in promoting these practices.	[Machado de Rezende, Leandro Fornias; Azeredo, Catarina Machado; Tourinho Peres, Maria Fernanda; Luiz, Olinda do Carmo; Levy, Renata Bertazzi; Eluf-Neto, Jose] Univ Sao Paulo, Fac Med, Dept Med Prevent, Sao Paulo, Brazil; [Azeredo, Catarina Machado] Univ Fed Uberlandia, Fac Med, Uberlandia, MG, Brazil; [Silva, Kelly Samara] Univ Fed Santa Catarina, Ctr Desportos, BR-88040900 Florianopolis, SC, Brazil; [Claro, Rafael Moreira] Univ Fed Minas Gerais, Dept Nutr, Belo Horizonte, MG, Brazil; [Franca-Junior, Ivan] Univ Sao Paulo, Fac Saude Publ, Dept Saude Maternoinfantil, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade Federal de Uberlandia; Universidade Federal de Santa Catarina (UFSC); Universidade Federal de Minas Gerais; Universidade de Sao Paulo	de Rezende, LFM (corresponding author), Univ Sao Paulo, Fac Med, Dept Med Prevent, Sao Paulo, Brazil.	lerezende@usp.br	Rezende, Leandro F. M./C-1724-2012; Silva, Kelly S/A-9997-2012; Peres, Maria Fernanda/AAV-4349-2020; Levy, Renata Bertazzi/F-8931-2012; Eluf-Neto, Jose/B-2522-2009; Azeredo, Catarina Machado/AAG-7216-2019; Franca-Junior, Ivan/C-4110-2012; Claro, Rafael/F-8996-2012; Luiz, Olinda do Carmo/C-6075-2012; Azeredo, Catarina Machado/B-2308-2015; da Silva, Kelly Samara/AAX-8307-2020; Peres, Maria Fernanda T/F-9561-2012	Rezende, Leandro F. M./0000-0002-7469-1399; Silva, Kelly S/0000-0002-7356-1680; Peres, Maria Fernanda/0000-0002-7049-905X; Levy, Renata Bertazzi/0000-0001-5388-7002; Eluf-Neto, Jose/0000-0001-7504-2115; Azeredo, Catarina Machado/0000-0002-6189-4429; Franca-Junior, Ivan/0000-0002-7004-7301; Luiz, Olinda do Carmo/0000-0002-2596-3626; Azeredo, Catarina Machado/0000-0002-6189-4429; da Silva, Kelly Samara/0000-0002-7356-1680; Peres, Maria Fernanda T/0000-0002-7049-905X; Claro, Rafael/0000-0001-9690-575X	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [444794/2014-0]	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This study was funded by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq - process number 444794/2014-0). CMA received a doctoral scholarship from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq).	Aarts MJ, 2013, INT J BEHAV MED, V20, P538, DOI 10.1007/s12529-012-9271-0; Azeredo CM, 2015, PUBLIC HEALTH NUTR, V18, P1215, DOI 10.1017/S1368980014001463; Bastos JP, 2008, J PHYS ACT HEALTH, V5, P777, DOI 10.1123/jpah.5.6.777; Bauman AE, 2012, LANCET, V380, P258, DOI 10.1016/S0140-6736(12)60735-1; Brasil. Ministerio da Educacao, 2014, PROGR SAUD ESC 2014; Brasil. Ministerio da Educacao e da Cultura, 1997, PAR CURR NAC ED FIS; Brasil. Ministerio da Educacao e da Cultura, 1988, PAR CURR NAC ED FIS; Brener ND, 2013, MMWR RECOMM REP, V62, P1; Button B, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-1191; Hallal ALC, 2009, REV SAUDE PUBL, V43, P779, DOI 10.1590/S0034-89102009005000056; da Silva R C, 2000, Cad Saude Publica, V16, P1091, DOI 10.1590/S0102-311X2000000400027; Fernandes M, 2010, PREV MED, V50, pS30, DOI 10.1016/j.ypmed.2009.09.022; Haerens Leen, 2009, J Environ Public Health, V2009, P320372, DOI 10.1155/2009/320372; Hallal PC, 2012, LANCET, V380, P247, DOI 10.1016/S0140-6736(12)60646-1; Haug E, 2010, HEALTH EDUC RES, V25, P248, DOI 10.1093/her/cyn050; Hobin EP, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-74; Hohepa M, 2006, J ADOLESCENT HEALTH, V39, P328, DOI 10.1016/j.jadohealth.2005.12.024; Instituto Brasileiro de Geografia e Estatistica, 2013, PESQ NAC SAUD ESC; Janssen I, 2010, INT J BEHAV NUTR PHY, V7, DOI 10.1186/1479-5868-7-40; Kohl Harold W 3rd, 2012, Lancet, V380, P294, DOI 10.1016/S0140-6736(12)60898-8; de Rezende LFM, 2014, BMC PUBLIC HEALTH, V14, DOI [10.1186/1471-2458-14-485, 10.1186/1471-2458-14-333]; McGrath LJ, 2015, SPORTS MED, V45, P841, DOI 10.1007/s40279-015-0301-3; Merlo J, 2006, J EPIDEMIOL COMMUN H, V60, P290, DOI 10.1136/jech.2004.029454; O'Malley PM, 2009, J ADOLESCENT HEALTH, V45, pS71, DOI 10.1016/j.jadohealth.2009.04.008; Patnode CD, 2010, INT J BEHAV NUTR PHY, V7, DOI 10.1186/1479-5868-7-79; Pawlowski CS, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-639; de Castro IRR, 2008, CAD SAUDE PUBLICA, V24, P2279, DOI 10.1590/S0102-311X2008001000009; Robertson-Wilson JE, 2008, J ADOLESCENT HEALTH, V42, P486, DOI 10.1016/j.jadohealth.2007.10.006; Sallis JF, 2001, AM J PUBLIC HEALTH, V91, P618, DOI 10.2105/AJPH.91.4.618; Strong WB, 2005, J PEDIATR-US, V146, P732, DOI 10.1016/j.jpeds.2005.01.055; Tavares LF, 2014, CAD SAUDE PUBLICA, V30, P1861, DOI 10.1590/0102-311X00151913; Trost SG, 2010, MED SCI SPORT EXER, V42, P520, DOI 10.1249/MSS.0b013e3181cea3ef; Weiler R, 2014, BRIT J SPORT MED, V48, P1010, DOI 10.1136/bjsports-2013-093018; White IR, 2011, STAT MED, V30, P377, DOI 10.1002/sim.4067; WHO, 2010, SCREENING DONATED BLOOD FOR TRANSFUSION: TRANSMISSIBLE INFECTIONS, P1; WHO, 2014, GLOB SCH BAS STUD HL	36	15	17	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2015	10	6							e0131342	10.1371/journal.pone.0131342	http://dx.doi.org/10.1371/journal.pone.0131342			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CL3FM	26098906	Green Published, gold			2022-12-26	WOS:000356835800171
J	Tan, DD; Yang, HP; Yuan, Y; Bonnemann, C; Chang, XZ; Wang, S; Wu, YC; Wu, XR; Xiong, H				Tan, Dandan; Yang, Haipo; Yuan, Yun; Bonnemann, Carsten; Chang, Xingzhi; Wang, Shuang; Wu, Yuchen; Wu, Xiru; Xiong, Hui			Phenotype-Genotype Analysis of Chinese Patients with Early-Onset LMNA-Related Muscular Dystrophy	PLOS ONE			English	Article							LAMIN A/C MUTATIONS; GENE-MUTATIONS; DROPPED HEAD; TISSUE; INVOLVEMENT; DEFECTS; DEATH	This study aimed to analyze the correlation between the phenotype and genotype of Chinese patients with early-onset lamin A (LMNA)-related muscular dystrophy (MD). The clinical and myopathological data of 21 Chinese pediatric patients with early-onset LMNA-related MD were collected and analyzed. LMNA gene mutation analysis was performed by direct sequencing of genomic DNA. Sublocalization of wild-type and mutant proteins were observed by immunofluorescence using cultured fibroblasts and human embryonic kidney 293 (HEK 293) cell. Seven patients were diagnosed with Emery-Dreifuss muscular dystrophy (EDMD) and 14 were diagnosed with LMNA-associated congenital muscular dystrophy (L-CMD). Four biopsy specimens from the L-CMD cases exhibited inflammatory changes. Abnormal nuclear morphology was observed with both transmission electron microscopy and lamin A/C staining. We identified 10 novel and nine known LMNA gene mutations in the 21 patients. Some mutations (c.91G>A, c.94_96delAAG, c.116A>G, c.745C>T, c.746G>A, and c.1580G>C) were well correlated with EDMD or L-CMD. LMNA-related MD has a common symptom triad of muscle weakness, joint contractures, and cardiac involvement, but the severity of symptoms and disease progression differ greatly. Inflammatory change in biopsied muscle is a characteristic of early-stage L-CMD. Phenotype-genotype analysis determines that some mutations are well correlated with LMNA-related MD.	[Tan, Dandan; Yang, Haipo; Chang, Xingzhi; Wang, Shuang; Wu, Xiru; Xiong, Hui] Peking Univ, Hosp 1, Dept Pediat, Beijing 100871, Peoples R China; [Tan, Dandan; Wu, Yuchen] Nanchang Univ, Affiliated Hosp 1, Dept Neurol, Nanchang, Peoples R China; [Yuan, Yun] Peking Univ, Hosp 1, Dept Neurol, Beijing 100871, Peoples R China; [Bonnemann, Carsten] NINDS, Neuromuscular & Neurogenet Disorders Childhood Se, NIH, Bethesda, MD 20892 USA	Peking University; Nanchang University; Peking University; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	Xiong, H (corresponding author), Peking Univ, Hosp 1, Dept Pediat, Beijing 100871, Peoples R China.	xh_bjbj@163.com			National Natural Science Foundation of China [81271400]; National Basic Research Program of China [2012CB944602]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS003129] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by grants from the National Natural Science Foundation of China (81271400), and the National Basic Research Program of China (2012CB944602).	Bertrand AT, 2012, HUM MOL GENET, V21, P1037, DOI 10.1093/hmg/ddr534; Bonne G, 2000, ANN NEUROL, V48, P170, DOI 10.1002/1531-8249(200008)48:2<170::AID-ANA6>3.0.CO;2-J; Boriani G, 2003, STROKE, V34, P901, DOI 10.1161/01.STR.0000064322.47667.49; Chemla JC, 2010, MUSCLE NERVE, V42, P839, DOI 10.1002/mus.21820; Chen LS, 2003, LANCET, V362, P440, DOI 10.1016/S0140-6736(03)14069-X; Das A, 2013, NUCLEUS-AUSTIN, V4, P410, DOI 10.4161/nucl.26873; Dittmer T, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-5-222; Finsterer J, 2012, J ELECTROCARDIOL, V45, P376, DOI 10.1016/j.jelectrocard.2012.02.003; Hattori A, 2012, NEUROMUSCULAR DISORD, V22, P149, DOI 10.1016/j.nmd.2011.08.009; Komaki H, 2011, NEUROMUSCULAR DISORD, V21, P563, DOI 10.1016/j.nmd.2011.04.010; Lammerding J, 2004, J CLIN INVEST, V113, P370, DOI 10.1172/JCI200419670; Lattanzi G, 2012, EUR J HISTOCHEM, V56, P284, DOI 10.4081/ejh.2012.e45; Makri S, 2009, NEUROMUSCULAR DISORD, V19, P26, DOI 10.1016/j.nmd.2008.09.016; Maraldi NM, 2011, J CELL BIOCHEM, V112, P979, DOI 10.1002/jcb.22992; Menezes MP, 2012, NEUROLOGY, V78, P1258, DOI 10.1212/WNL.0b013e318250d839; Meune C, 2012, NEUROMUSCULAR DISORD, V22, P252, DOI 10.1016/j.nmd.2011.09.005; Motsch I, 2005, EUR J CELL BIOL, V84, P765, DOI 10.1016/j.ejcb.2005.04.004; Puckelwartz Megan, 2011, Handb Clin Neurol, V101, P155, DOI 10.1016/B978-0-08-045031-5.00012-8; Puckelwartz MJ, 2011, NUCLEUS-PHILA, V2, P162, DOI [10.4161/nucl.2.3.16003, 10.1083/jcb.201101046]; Quijano-Roy S, 2008, ANN NEUROL, V64, P177, DOI 10.1002/ana.21417; van Berlo JH, 2005, J MOL MED, V83, P79, DOI 10.1007/s00109-004-0589-1; Worman HJ, 2012, J PATHOL, V226, P316, DOI 10.1002/path.2999; Zuela N, 2012, EMBO REP, V13, P1070, DOI 10.1038/embor.2012.167; Zwerger M, 2013, HUM MOL GENET, V22, P2335, DOI 10.1093/hmg/ddt079	24	23	28	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2015	10	6							e0129699	10.1371/journal.pone.0129699	http://dx.doi.org/10.1371/journal.pone.0129699			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL3FM	26098624	Green Published, gold, Green Submitted			2022-12-26	WOS:000356835800036
J	Busacca, S; Law, EWP; Powley, IR; Proia, DA; Sequeira, M; Le Quesne, J; Klabatsa, A; Edwards, JM; Matchett, KB; Luo, JL; Pringle, JH; El-Tanani, M; MacFarlane, M; Fennell, DA				Busacca, S.; Law, E. W. P.; Powley, I. R.; Proia, D. A.; Sequeira, M.; Le Quesne, J.; Klabatsa, A.; Edwards, J. M.; Matchett, K. B.; Luo, J. L.; Pringle, J. H.; El-Tanani, M.; MacFarlane, M.; Fennell, D. A.			Resistance to HSP90 inhibition involving loss of MCL1 addiction	ONCOGENE			English	Article							CANCER-CELLS; STRUCTURAL BASIS; APOPTOSIS; SENSITIVITY; EML4-ALK; BCL-2; IDENTIFICATION; EXPRESSION; DEATH; GENE	Inhibition of the chaperone heat-shock protein 90 (HSP90) induces apoptosis, and it is a promising anti-cancer strategy. The mechanisms underpinning apoptosis activation following HSP90 inhibition and how they are modified during acquired drug resistance are unknown. We show for the first time that, to induce apoptosis, HSP90 inhibition requires the cooperation of multi BH3-only proteins (BID, BIK, PUMA) and the reciprocal suppression of the pro-survival BCL-2 family member MCL1, which occurs via inhibition of STAT5A. A subset of tumour cell lines exhibit dependence on MCL1 expression for survival and this dependence is also associated with tumour response to HSP90 inhibition. In the acquired resistance setting, MCL1 suppression in response to HSP90 inhibitors is maintained; however, a switch in MCL1 dependence occurs. This can be exploited by the BH3 peptidomimetic ABT737, through non-BCL-2-dependent synthetic lethality.	[Busacca, S.; Law, E. W. P.; Le Quesne, J.; Luo, J. L.; Pringle, J. H.; Fennell, D. A.] Univ Leicester, Dept Canc Studies, Canc Res UK Leicester Ctr, Hodgkin Bldg,Lancaster Rd, Leicester LE1 9HN, Leics, England; [Powley, I. R.; Le Quesne, J.; Edwards, J. M.; MacFarlane, M.] MRC Toxicol Unit, Leicester, Leics, England; [Proia, D. A.; Sequeira, M.] Synta Pharmaceut Corp, Lexington, MA USA; [Klabatsa, A.] Kings Coll London, Div Canc Studies, London WC2R 2LS, England; [Matchett, K. B.] Queens Univ Belfast, Ctr Canc Res & Cell Biol, Belfast, Antrim, North Ireland; [El-Tanani, M.] Univ Bradford, Sch Life Sci, Inst Canc Therapeut, Bradford BD7 1DP, W Yorkshire, England	Cancer Research UK; University of Leicester; University of London; King's College London; Queens University Belfast; University of Bradford	Fennell, DA (corresponding author), Univ Leicester, Dept Canc Studies, Canc Res UK Leicester Ctr, Hodgkin Bldg,Lancaster Rd, Leicester LE1 9HN, Leics, England.	df132@leicester.ac.uk	Klampatsa, Astero/AAK-4419-2020	Klampatsa, Astero/0000-0003-0572-502X; Le Quesne, John/0000-0003-3552-7446; Luo, Jinli/0000-0002-9241-5283; Matchett, Kyle/0000-0001-6148-6022; El-Tanani, Mohamed/0000-0002-4735-5445; Law, Edward/0000-0001-5089-6341	University of Leicester; Medical Research Council (MRC); British Lung Foundation (BLF); MRC [MC_PC_14117, MC_PC_15045, MC_U132685863, MC_UP_1203/1] Funding Source: UKRI; Medical Research Council [MC_U132685863, MC_PC_15045, MC_UP_1203/1, MC_PC_14117] Funding Source: researchfish	University of Leicester; Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Lung Foundation (BLF); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank Dr Meike Vogler (University of Leicester) for critically revising the manuscript. DAF and SB are supported by the University of Leicester. MMF and IRP are funded by Medical Research Council (MRC) and British Lung Foundation (BLF).	Acquaviva J, 2014, MOL CANCER RES, V12, P1042, DOI 10.1158/1541-7786.MCR-14-0004; Akgul C, 2009, CELL MOL LIFE SCI, V66, P1326, DOI 10.1007/s00018-008-8637-6; Akgul C, 2000, CELL MOL LIFE SCI, V57, P684, DOI 10.1007/PL00000728; Altieri DC, 2012, BBA-MOL CELL RES, V1823, P767, DOI 10.1016/j.bbamcr.2011.08.007; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Busacca S, 2012, J PATHOL, V227, P200, DOI 10.1002/path.3979; Costa DB, 2007, PLOS MED, V4, P1669, DOI 10.1371/journal.pmed.0040315; Cragg MS, 2007, PLOS MED, V4, P1681, DOI 10.1371/journal.pmed.0040316; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; Fritsch RM, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M702673200; Fu Y, 2007, CANCER RES, V67, P3734, DOI 10.1158/0008-5472.CAN-06-4594; Garnett MJ, 2012, NATURE, V483, P570, DOI 10.1038/nature11005; Geserick P, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.379; Gong YX, 2007, PLOS MED, V4, P1655, DOI 10.1371/journal.pmed.0040294; Green DR, 2004, SCIENCE, V305, P626, DOI 10.1126/science.1099320; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Heuckmann JM, 2012, CLIN CANCER RES, V18, P4682, DOI 10.1158/1078-0432.CCR-11-3260; Kim H, 2006, NAT CELL BIOL, V8, P1348, DOI 10.1038/ncb1499; KORSMEYER SJ, 1993, SEMIN CANCER BIOL, V4, P327; Kotha A, 2006, MOL CANCER THER, V5, P621, DOI 10.1158/1535-7163.MCT-05-0268; Landmann H, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.378; McCollum AK, 2006, CANCER RES, V66, P10967, DOI 10.1158/0008-5472.CAN-06-1629; McDonnell JM, 1999, CELL, V96, P625, DOI 10.1016/S0092-8674(00)80573-5; Messeguer X, 2002, BIOINFORMATICS, V18, P333, DOI 10.1093/bioinformatics/18.2.333; Mills JR, 2008, P NATL ACAD SCI USA, V105, P10853, DOI 10.1073/pnas.0804821105; Moulick K, 2011, NAT CHEM BIOL, V7, P818, DOI 10.1038/nchembio.670; Nakano K, 2001, MOL CELL, V7, P683, DOI 10.1016/S1097-2765(01)00214-3; Nam S, 2007, MOL CANCER THER, V6, P1400, DOI 10.1158/1535-7163.MCT-06-0446; Oltersdorf T, 2005, NATURE, V435, P677, DOI 10.1038/nature03579; Paraiso KHT, 2012, CLIN CANCER RES, V18, P2502, DOI 10.1158/1078-0432.CCR-11-2612; Paul I, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.186; Paul I, 2011, J PATHOL, V224, P564, DOI 10.1002/path.2925; Pillai RN, 2014, CURR OPIN ONCOL, V26, P159, DOI 10.1097/CCO.0000000000000047; Powers MV, 2013, ONCOTARGET, V4, P1963, DOI 10.18632/oncotarget.1419; Prodromou C, 2009, ACS CHEM BIOL, V4, P289, DOI 10.1021/cb9000316; Ricci MS, 2007, CANCER CELL, V12, P66, DOI 10.1016/j.ccr.2007.05.006; Richards MW, 2014, P NATL ACAD SCI USA, V111, P5195, DOI 10.1073/pnas.1322892111; Rutherford SL, 1998, NATURE, V396, P336, DOI 10.1038/24550; Samant RS, 2014, P NATL ACAD SCI USA, V111, P6834, DOI 10.1073/pnas.1322412111; Sathe P, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5539; Shah OJ, 2010, P NATL ACAD SCI USA, V107, P12634, DOI 10.1073/pnas.0913615107; Soda M, 2007, NATURE, V448, P561, DOI 10.1038/nature05945; Sun XM, 2002, J BIOL CHEM, V277, P11345, DOI 10.1074/jbc.M109893200; Travers J, 2012, DRUG DISCOV TODAY, V17, P242, DOI 10.1016/j.drudis.2011.12.021; Trepel J, 2010, NAT REV CANCER, V10, P537, DOI 10.1038/nrc2887; Twiddy D, 2010, BREAST CANCER RES, P58; Upton JP, 2008, MOL CELL BIOL, V28, P3943, DOI 10.1128/MCB.00013-08; Walensky LD, 2006, MOL CELL, V24, P199, DOI 10.1016/j.molcel.2006.08.020; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Workman P, 2013, NAT REV DRUG DISCOV, V12, P889, DOI 10.1038/nrd4184; Workman P, 2013, CURR OPIN PHARMACOL, V13, P486, DOI 10.1016/j.coph.2013.06.004	51	19	20	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 24	2016	35	12					1483	1492		10.1038/onc.2015.213	http://dx.doi.org/10.1038/onc.2015.213			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DH8RJ	26096930	Green Published, hybrid			2022-12-26	WOS:000373063600002
J	Goodman, CR; Sato, T; Peck, AR; Girondo, MA; Yang, N; Liu, C; Yanac, AF; Kovatich, AJ; Hooke, JA; Shriver, CD; Mitchell, EP; Hyslop, T; Rui, H				Goodman, C. R.; Sato, T.; Peck, A. R.; Girondo, M. A.; Yang, N.; Liu, C.; Yanac, A. F.; Kovatich, A. J.; Hooke, J. A.; Shriver, C. D.; Mitchell, E. P.; Hyslop, T.; Rui, H.			Steroid induction of therapy-resistant cytokeratin-5-positive cells in estrogen receptor-positive breast cancer through a BCL6-dependent mechanism	ONCOGENE			English	Article							MEDROXYPROGESTERONE ACETATE; SIGNAL TRANSDUCER; BCL6 EXPRESSION; PROLACTIN; STAT5; DIFFERENTIATION; INHIBITION; PROGESTERONE; ACTIVATOR; SURVIVAL	Therapy resistance remains a major problem in estrogen receptor-alpha (ER alpha)-positive breast cancer. A subgroup of ER alpha-positive breast cancer is characterized by mosaic presence of a minor population of ER alpha-negative cancer cells expressing the basal cytokeratin-5 (CK5). These CK5-positive cells are therapy resistant and have increased tumor-initiating potential. Although a series of reports document induction of the CK5-positive cells by progestins, it is unknown if other 3-ketosteroids share this ability. We now report that glucocorticoids and mineralocorticoids effectively expand the CK5-positive cell population. CK5-positive cells induced by 3-ketosteroids lacked ER alpha and progesterone receptors, expressed stem cell marker, CD44, and displayed increased clonogenicity in soft agar and broad drug-resistance in vitro and in vivo. Upregulation of CK5-positive cells by 3-ketosteroids required induction of the transcriptional repressor BCL6 based on suppression of BCL6 by two independent BCL6 small hairpin RNAs or by prolactin. Prolactin also suppressed 3-ketosteroid induction of CK5+ cells in T47D xenografts in vivo. Survival analysis with recursive partitioning in node-negative ER alpha-positive breast cancer using quantitative CK5 and BCL6 mRNA or protein expression data identified patients at high or low risk for tumor recurrence in two independent patient cohorts. The data provide a mechanism by which common pathophysiological or pharmacologic elevations in glucocorticoids or other 3-ketosteroids may adversely affect patients with mixed ER alpha+/CK5+ breast cancer. The observations further suggest a cooperative diagnostic utility of CK5 and BCL6 expression levels and justify exploring efficacy of inhibitors of BCL6 and 3-ketosteroid receptors for a subset of ER alpha-positive breast cancers.	[Goodman, C. R.; Sato, T.; Peck, A. R.; Girondo, M. A.; Yang, N.; Liu, C.; Yanac, A. F.; Rui, H.] Thomas Jefferson Univ, Dept Canc Biol, 233 S 10th St,BLSB 330, Philadelphia, PA 19107 USA; [Kovatich, A. J.; Hooke, J. A.; Shriver, C. D.] Walter Reed Natl Mil Med Ctr, John P Murtha Canc Ctr, Bethesda, MD USA; [Mitchell, E. P.; Rui, H.] Thomas Jefferson Univ, Dept Med Oncol, Philadelphia, PA 19107 USA; [Hyslop, T.] Duke Univ, Duke Canc Inst, Dept Biostat & Bioinformat, Durham, NC USA; [Rui, H.] Thomas Jefferson Univ, Dept Pathol, Kimmel Canc Ctr, Philadelphia, PA 19107 USA	Jefferson University; Walter Reed National Military Medical Center; Jefferson University; Duke University; Jefferson University	Rui, H (corresponding author), Thomas Jefferson Univ, Dept Canc Biol, 233 S 10th St,BLSB 330, Philadelphia, PA 19107 USA.	hallgeir.rui@jefferson.edu		Kovatich, Albert/0000-0002-5169-4087; Rui, Hallgeir/0000-0002-8778-261X; Goodman, Chelain/0000-0001-9083-3652	Susan G Komen [KG091116]; Ladies of Port Richmond; NCI [CA185918, CA188575, 1P30CA56036]; Commonwealth University Research Enhancement Program grant with the Pennsylvania Department of Health; NATIONAL CANCER INSTITUTE [R01CA188575, P30CA056036, R21CA185918] Funding Source: NIH RePORTER	Susan G Komen(Susan G. Komen Breast Cancer Foundation); Ladies of Port Richmond; NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Commonwealth University Research Enhancement Program grant with the Pennsylvania Department of Health; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work is supported by grants from Susan G Komen (KG091116), Ladies of Port Richmond and NCI (CA185918, CA188575; Support Grant 1P30CA56036), and in part, under a Commonwealth University Research Enhancement Program grant with the Pennsylvania Department of Health. The Department specifically disclaims responsibility for any analyses, interpretations or conclusions. We thank Colleen Lord for expert editorial assistance.	Anderson WF, 2002, BREAST CANCER RES TR, V76, P27, DOI 10.1023/A:1020299707510; Axlund SD, 2013, HORM CANCER-US, V4, P36, DOI 10.1007/s12672-012-0127-5; Bentel JM, 1999, MOL CELL ENDOCRINOL, V154, P11, DOI 10.1016/S0303-7207(99)00109-4; Byrne MJ, 1997, J CLIN ONCOL, V15, P3141, DOI 10.1200/JCO.1997.15.9.3141; Cheang MCU, 2008, CLIN CANCER RES, V14, P1368, DOI 10.1158/1078-0432.CCR-07-1658; Chida Y, 2008, NAT CLIN PRACT ONCOL, V5, P466, DOI 10.1038/ncponc1134; Cittelly DM, 2013, ONCOGENE, V32, P2555, DOI 10.1038/onc.2012.275; Conde I, 2008, HISTOL HISTOPATHOL, V23, P77, DOI 10.14670/HH-23.77; Costanzo ES, 2011, IMMUNOL ALLERGY CLIN, V31, P109, DOI 10.1016/j.iac.2010.09.001; Duy C, 2011, NATURE, V473, P384, DOI 10.1038/nature09883; El-Rehim DMA, 2004, J PATHOL, V203, P661, DOI 10.1002/path.1559; Gonzalez-Angulo AM, 2007, ADV EXP MED BIOL, V608, P1; Haughian JM, 2012, P NATL ACAD SCI USA, V109, P2742, DOI 10.1073/pnas.1106509108; Horwitzt KB, 2008, P NATL ACAD SCI USA, V105, P5774, DOI 10.1073/pnas.0706216105; Hothorn T, 2006, J COMPUT GRAPH STAT, V15, P651, DOI 10.1198/106186006X133933; Joensuu K, 2013, BREAST CANCER-BASIC, V7, P23, DOI 10.4137/BCBCR.S10701; Johnson KJ, 2010, AM J PATHOL, V177, P2971, DOI 10.2353/ajpath.2010.090399; Kabos P, 2011, BREAST CANCER RES TR, V128, P45, DOI 10.1007/s10549-010-1078-6; Knox AJ, 2014, BREAST CANCER RES, V16, DOI 10.1186/s13058-014-0418-6; Li XT, 2003, MOL CELL BIOL, V23, P3763, DOI 10.1128/MCB.23.11.3763-3773.2003; Logarajah S, 2003, ONCOGENE, V22, P5572, DOI 10.1038/sj.onc.1206689; Loi S, 2007, J CLIN ONCOL, V25, P1239, DOI 10.1200/JCO.2006.07.1522; Neilson LM, 2007, MOL ENDOCRINOL, V21, P2218, DOI 10.1210/me.2007-0173; Nelson CC, 1999, MOL ENDOCRINOL, V13, P2090, DOI 10.1210/me.13.12.2090; Nevalainen MT, 2004, J CLIN ONCOL, V22, P2053, DOI 10.1200/JCO.2004.11.046; Nouhi Z, 2006, CANCER RES, V66, P1824, DOI 10.1158/0008-5472.CAN-05-2292; Osborne CK, 2011, ANNU REV MED, V62, P233, DOI 10.1146/annurev-med-070909-182917; Ouatas T, 2003, CLIN CANCER RES, V9, P3763; Palesh O, 2007, J PSYCHOSOM RES, V63, P233, DOI 10.1016/j.jpsychores.2007.05.012; Pang D, 2006, CANCER BIOL THER, V5, P933, DOI 10.4161/cbt.5.8.2875; Paredes J, 2007, VIRCHOWS ARCH, V450, P73, DOI 10.1007/s00428-006-0334-y; Peck AR, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3328; Peck AR, 2011, J CLIN ONCOL, V29, P2448, DOI 10.1200/JCO.2010.30.3552; Plotnikov A, 2009, CANCER RES, V69, P3165, DOI 10.1158/0008-5472.CAN-08-4033; Rakha EA, 2007, HISTOPATHOLOGY, V50, P434, DOI 10.1111/j.1365-2559.2007.02638.x; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Sartorius CA, 2005, CANCER RES, V65, P9779, DOI 10.1158/0008-5472.CAN-05-0505; Sasano H, 1997, ANTICANCER RES, V17, P2001; Sato T, 2014, ONCOGENE, V33, P2215, DOI 10.1038/onc.2013.172; Sato T, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-59; Shaffer AL, 2000, IMMUNITY, V13, P199, DOI 10.1016/S1074-7613(00)00020-0; Sultan AS, 2008, CANCER SCI, V99, P272, DOI 10.1111/j.1349-7006.2007.00685.x; Sultan AS, 2005, ONCOGENE, V24, P746, DOI 10.1038/sj.onc.1208203; Tran TH, 2010, CANCER RES, V70, P1711, DOI 10.1158/0008-5472.CAN-09-2314; Voduc KD, 2010, J CLIN ONCOL, V28, P1684, DOI 10.1200/JCO.2009.24.9284; Volden PA, 2013, BRAIN BEHAV IMMUN, V30, pS26, DOI 10.1016/j.bbi.2012.10.022; Wagner SD, 2011, BRIT J HAEMATOL, V152, P3, DOI 10.1111/j.1365-2141.2010.08420.x; Walker SR, 2007, ONCOGENE, V26, P224, DOI 10.1038/sj.onc.1209775; Wan YH, 2002, MOL ENDOCRINOL, V16, P1204, DOI 10.1210/me.16.6.1204; Wu Q, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-418; Wu W, 2004, CANCER RES, V64, P1757, DOI 10.1158/0008-5472.CAN-03-2546; Yamashita H, 2006, ENDOCR-RELAT CANCER, V13, P885, DOI 10.1677/erc.1.01095; Yang N, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3467; Yin P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029021; Yoo BH, 2012, J BIOMOL SCREEN, V17, P1211, DOI 10.1177/1087057112452138; Zhang C, 2007, CANCER BIOL THER, V6, P278, DOI 10.4161/cbt.6.2.3652	56	23	23	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 17	2016	35	11					1373	1385		10.1038/onc.2015.193	http://dx.doi.org/10.1038/onc.2015.193			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DG6LQ	26096934	hybrid, Green Published			2022-12-26	WOS:000372196400004
J	Vandal, M; White, PJ; Chevrier, G; Tremblay, C; St-Amour, I; Planel, E; Marette, A; Calon, F				Vandal, Milene; White, Phillip J.; Chevrier, Genevieve; Tremblay, Cyntia; St-Amour, Isabelle; Planel, Emmanuel; Marette, Andre; Calon, Frederic			Age-dependent impairment of glucose tolerance in the 3xTg-AD mouse model of Alzheimer's disease	FASEB JOURNAL			English	Article						amyloid; insulin; pancreas	ISLET AMYLOID POLYPEPTIDE; APOLIPOPROTEIN-E GENOTYPE; A-BETA; DIABETES-MELLITUS; INSULIN-RESISTANCE; TRANSGENIC MICE; METABOLIC SYNDROME; COGNITIVE DECLINE; AMYLIN RECEPTOR; INCREASED RISK	Alzheimer's disease (AD) has been associated with type II diabetes (T2D) and obesity in several epidemiologic studies. To determine whether AD neuropathology can cause peripheral metabolic impairments, we investigated metabolic parameters in the triple-transgenic (3xTg)-AD mouse model of AD, compared with those in nontransgenic (non-Tg) controls, at 6, 8, and 14 mo of age. We found a more pronounced cortical A beta accumulation (2- and 3.5-fold increase in A beta 42 in the soluble and insoluble protein fractions, respectively) in female 3xTg-AD mice than in the males. Furthermore, female 3xTg-AD mice displayed a significant deterioration in glucose tolerance (AUC, +118% vs. non-Tg mice at 14 mo). Fasting plasma insulin levels rose 2.5-fold from 6 to 14mo of age in female 3xTg-AD mice. Glucose intolerance and cortical amyloid pathology worsened with age, and both were more pronounced in the females. Pancreatic amyloidopathy was revealed and could underlie the observed deficit in glycemic response in 3xTg-AD mice. The present results suggest that AD-like neuropathology extends to the pancreas in the 3xTg-AD mouse, leading to glucose intolerance and contributing to a pathologic self-amplifying loop between AD and T2D.	[Vandal, Milene; St-Amour, Isabelle; Calon, Frederic] Univ Laval, Fac Pharm, Quebec City, PQ, Canada; [Vandal, Milene; White, Phillip J.; Marette, Andre; Calon, Frederic] Univ Laval, Inst Nutraceut & Aliments Fonct, Quebec City, PQ, Canada; [White, Phillip J.; Chevrier, Genevieve; Marette, Andre] Univ Laval, Fac Med, Dept Med, Axe Cardiol, Quebec City, PQ, Canada; [Vandal, Milene; Tremblay, Cyntia; St-Amour, Isabelle; Planel, Emmanuel; Calon, Frederic] CHUL, Ctr Rech, Axe Neurosci, Quebec City, PQ, Canada; [White, Phillip J.] Duke Mol Physiol Inst, Sarah W Stedman Nutr & Metab Ctr, Durham, NC USA; [White, Phillip J.; Chevrier, Genevieve; Marette, Andre] Inst Univ Pneumol & Cardiol, Quebec City, PQ, Canada	Laval University; Laval University; Laval University; Laval University	Calon, F (corresponding author), CHU Q, Ctr Rech, Pavillon CHUL,2705,Blvd Laurier, Quebec City, PQ G1V 4G2, Canada.		White, Phillip J/H-3048-2019; Calon, Frederic/AAF-4390-2020	White, Phillip J/0000-0002-0957-425X; St-Amour, Isabelle/0000-0003-2042-804X; Marette, Andre/0000-0003-3950-5973; Planel, Emmanuel/0000-0001-5128-0565; Calon, Frederic/0000-0002-4203-0887	Canadian Institutes of Health Research (CIHR) [MOP 102532, IAO 74443]; Alzheimer Society Canada; Canada Foundation for Innovation (CFI); Fonds de la Recherche en Sante du Quebec (FRQ-S); CIHR scholarship	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Alzheimer Society Canada; Canada Foundation for Innovation (CFI)(Canada Foundation for Innovation); Fonds de la Recherche en Sante du Quebec (FRQ-S); CIHR scholarship(Canadian Institutes of Health Research (CIHR))	This study was made possible by funding from the Canadian Institutes of Health Research (CIHR) (MOP 102532 and IAO 74443), the Alzheimer Society Canada, and the Canada Foundation for Innovation (CFI). F.C. is supported by a salary award from the Fonds de la Recherche en Sante du Quebec (FRQ-S). M.V. was supported by a CIHR scholarship. M.V. designed the experiments; performed the animal experiments, insulin ELISA, immunofluorescence, and data analyses; and wrote the first versions of the paper. P.J.W. contributed to experimental design. G.C. performed the ELISA for the C-peptide. C.T. and I.S.A. performed the ELISA for A beta. C.T. performed the Western blot analysis for cortical tau. A.M. contributed to experiment design and data interpretation. F.C. conceived the experimental design, obtained funding, and wrote the paper.	Aguzzi A, 2009, NEURON, V64, P783, DOI 10.1016/j.neuron.2009.12.016; Akomolafe A, 2006, ARCH NEUROL-CHICAGO, V63, P1551, DOI 10.1001/archneur.63.11.1551; Bomba M, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.139; Bories C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046111; BRANDT MR, 1977, CLIN ENDOCRINOL, V6, P167, DOI 10.1111/j.1365-2265.1977.tb02008.x; Callahan MJ, 2001, AM J PATHOL, V158, P1173, DOI 10.1016/S0002-9440(10)64064-3; Clinton LK, 2007, NEUROBIOL DIS, V28, P76, DOI 10.1016/j.nbd.2007.06.013; COOPER GJS, 1987, P NATL ACAD SCI USA, V84, P8628, DOI 10.1073/pnas.84.23.8628; Craft S, 1999, NEUROENDOCRINOLOGY, V70, P146, DOI 10.1159/000054469; Craft S, 1998, NEUROLOGY, V50, P164, DOI 10.1212/WNL.50.1.164; Eisele YS, 2010, SCIENCE, V330, P980, DOI 10.1126/science.1194516; El Khoury NB, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00022; Espana J, 2010, BIOL PSYCHIAT, V67, P513, DOI 10.1016/j.biopsych.2009.06.015; FABER OK, 1978, J CLIN INVEST, V62, P197, DOI 10.1172/JCI109106; FERRANNINI E, 1983, AM J PHYSIOL, V244, pE517; Forti P, 2010, J AM GERIATR SOC, V58, P487, DOI 10.1111/j.1532-5415.2010.02731.x; Frolich L, 1998, J NEURAL TRANSM, V105, P423, DOI 10.1007/s007020050068; Gotz J, 2009, CELL MOL LIFE SCI, V66, P1321, DOI 10.1007/s00018-009-9070-1; Habicht G, 2007, P NATL ACAD SCI USA, V104, P19232, DOI 10.1073/pnas.0703793104; Halban PA, 2014, J CLIN ENDOCR METAB, V99, P1983, DOI 10.1210/jc.2014-1425; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Harper JD, 1997, CHEM BIOL, V4, P119, DOI 10.1016/S1074-5521(97)90255-6; Hirata-Fukae C, 2008, BRAIN RES, V1216, P92, DOI 10.1016/j.brainres.2008.03.079; Ho L, 2004, FASEB J, V18, P902, DOI 10.1096/fj.03-0978fje; Hyman BT, 2012, ALZHEIMERS DEMENT, V8, P1, DOI 10.1016/j.jalz.2011.10.007; Janson J, 1996, P NATL ACAD SCI USA, V93, P7283, DOI 10.1073/pnas.93.14.7283; Janson J, 2004, DIABETES, V53, P474, DOI 10.2337/diabetes.53.2.474; Jhamandas JH, 2011, AM J PATHOL, V178, P140, DOI 10.1016/j.ajpath.2010.11.022; Jimenez-Palomares M, 2012, AM J PHYSIOL-ENDOC M, V302, pE1373, DOI 10.1152/ajpendo.00500.2011; JOHNSTON DG, 1977, LANCET, V1, P10; Julien C, 2010, NEUROBIOL AGING, V31, P1516, DOI 10.1016/j.neurobiolaging.2008.08.022; Kalaria RN, 2009, NAT REV NEUROL, V5, P305, DOI 10.1038/nrneurol.2009.72; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Kimura R, 2012, J NEUROSCI, V32, P17401, DOI 10.1523/JNEUROSCI.3028-12.2012; Lebbadi M, 2011, J ALZHEIMERS DIS, V27, P853, DOI 10.3233/JAD-2011-111010; Leibson CL, 1997, AM J EPIDEMIOL, V145, P301; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; Lewis J, 2001, SCIENCE, V293, P1487, DOI 10.1126/science.1058189; Lim YA, 2010, PROTEOMICS, V10, P1621, DOI 10.1002/pmic.200900651; LORENZO A, 1994, NATURE, V368, P756, DOI 10.1038/368756a0; Luchsinger JA, 2012, ALZ DIS ASSOC DIS, V26, P101, DOI 10.1097/WAD.0b013e318222f0d4; Masciopinto F, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.189; Mastrangelo MA, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-81; Miklossy J, 2010, NEUROBIOL AGING, V31, P1503, DOI 10.1016/j.neurobiolaging.2008.08.019; Mody N, 2011, DIABETOLOGIA, V54, P2143, DOI 10.1007/s00125-011-2160-2; Montane J, 2012, DIABETES OBES METAB, V14, P68, DOI 10.1111/j.1463-1326.2012.01657.x; Naslund J, 2000, JAMA-J AM MED ASSOC, V283, P1571, DOI 10.1001/jama.283.12.1571; Nelson PT, 2012, J NEUROPATH EXP NEUR, V71, P362, DOI 10.1097/NEN.0b013e31825018f7; Nugent DA, 2008, TOXICOL PATHOL, V36, P529, DOI 10.1177/0192623308318209; Oddo S, 2003, NEURON, V39, P409, DOI 10.1016/S0896-6273(03)00434-3; Ott A, 1999, NEUROLOGY, V53, P1937, DOI 10.1212/WNL.53.9.1937; Papon MA, 2013, DIABETES, V62, P609, DOI 10.2337/db12-0187; Pedersen WA, 2004, NEUROBIOL DIS, V17, P500, DOI 10.1016/j.nbd.2004.08.003; Pietropaolo S, 2008, BEHAV NEUROSCI, V122, P733, DOI 10.1037/a0012520; Planel E, 2007, J NEUROSCI, V27, P13635, DOI 10.1523/JNEUROSCI.3949-07.2007; Profenno LA, 2010, BIOL PSYCHIAT, V67, P505, DOI 10.1016/j.biopsych.2009.02.013; Raffaitin C, 2009, DIABETES CARE, V32, P169, DOI 10.2337/dc08-0272; Schrijvers EMC, 2010, NEUROLOGY, V75, P1982, DOI 10.1212/WNL.0b013e3181ffe4f6; SCHWARTZ P, 1965, T NEW YORK ACAD SCI, V27, P393, DOI 10.1111/j.2164-0947.1965.tb02977.x; Seeliger J, 2012, J MOL BIOL, V421, P348, DOI 10.1016/j.jmb.2012.01.048; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Sonnen JA, 2009, ARCH NEUROL-CHICAGO, V66, P315, DOI 10.1001/archneurol.2008.579; Sponarova J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003308; Steen E, 2005, J ALZHEIMERS DIS, V7, P63, DOI 10.3233/jad-2005-7107; Sterniczuk R, 2010, BRAIN RES, V1348, P149, DOI 10.1016/j.brainres.2010.06.011; Takeda S, 2010, P NATL ACAD SCI USA, V107, P7036, DOI 10.1073/pnas.1000645107; Talbot K, 2012, J CLIN INVEST, V122, P1316, DOI 10.1172/JCI59903; Toledo JB, 2013, BRAIN, V136, P2697, DOI 10.1093/brain/awt188; Tremblay C, 2007, J ALZHEIMERS DIS, V12, P377; Upadhaya AR, 2012, NEUROBIOL AGING, V33, P2641, DOI 10.1016/j.neurobiolaging.2011.12.032; Vandal M, 2014, DIABETES, V63, P4291, DOI 10.2337/db14-0375; Walsh DM, 1997, J BIOL CHEM, V272, P22364, DOI 10.1074/jbc.272.35.22364; WESTERMARK P, 1972, UPSALA J MED SCI, V77, P91, DOI 10.1517/03009734000000014; Westermark P, 2011, PHYSIOL REV, V91, P795, DOI 10.1152/physrev.00042.2009; Whitmer RA, 2008, NEUROLOGY, V71, P1057, DOI 10.1212/01.wnl.0000306313.89165.ef; Yan LM, 2014, CURR PHARM DESIGN, V20, P1182, DOI 10.2174/13816128113199990064; Zhang S, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010386.pub2; Zhang Y, 2013, DIABETES, V62, P1159, DOI 10.2337/db12-0670	78	62	62	0	14	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2015	29	10					4273	4284		10.1096/fj.14-268482	http://dx.doi.org/10.1096/fj.14-268482			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CR5FY	26108977				2022-12-26	WOS:000361367300017
J	Pap, PL; Osvath, G; Aparicio, JM; Barbos, L; Matyjasiak, P; Rubolini, D; Saino, N; Vagasi, CI; Vincze, O; Moller, AP				Pap, Peter L.; Osvath, Gergely; Aparicio, Jose Miguel; Barbos, Lorinc; Matyjasiak, Piotr; Rubolini, Diego; Saino, Nicola; Vagasi, Csongor I.; Vincze, Orsolya; Moller, Anders Pape			Sexual Dimorphism and Population Differences in Structural Properties of Barn Swallow (Hirundo rustica) Wing and Tail Feathers	PLOS ONE			English	Article							RESOURCE-ALLOCATION; MIGRATORY BEHAVIOR; GROWTH-RATE; FLIGHT; QUALITY; PERFORMANCE; SELECTION; AERODYNAMICS; ORNAMENTS; EVOLUTION	Sexual selection and aerodynamic forces affecting structural properties of the flight feathers of birds are poorly understood. Here, we compared the structural features of the innermost primary wing feather (P1) and the sexually dimorphic outermost (Ta6) and monomorphic second outermost (Ta5) tail feathers of barn swallows (Hirundo rustica) from a Romanian population to investigate how sexual selection and resistance to aerodynamic forces affect structural differences among these feathers. Furthermore, we compared structural properties of Ta6 of barn swallows from six European populations. Finally, we determined the relationship between feather growth bars width (GBW) and the structural properties of tail feathers. The structure of P1 indicates strong resistance against aerodynamic forces, while the narrow rachis, low vane density and low bending stiffness of tail feathers suggest reduced resistance against airflow. The highly elongated Ta6 is characterized by structural modifications such as large rachis width and increased barbule density in relation to the less elongated Ta5, which can be explained by increased length and/or high aerodynamic forces acting at the leading tail edge. However, these changes in Ta6 structure do not allow for full compensation of elongation, as reflected by the reduced bending stiffness of Ta6. Ta6 elongation in males resulted in feathers with reduced resistance, as shown by the low barb density and reduced bending stiffness compared to females. The inconsistency in sexual dimorphism and in change in quality traits of Ta6 among six European populations shows that multiple factors may contribute to shaping population differences. In general, the difference in quality traits between tail feathers cannot be explained by the GBW of feathers. Our results show that the material and structural properties of wing and tail feathers of barn swallows change as a result of aerodynamic forces and sexual selection, although the result of these changes can be contrasting.	[Pap, Peter L.; Barbos, Lorinc; Vagasi, Csongor I.] Univ Babes Bolyai, Hungarian Dept Biol & Ecol, Evolutionary Ecol Grp, R-3400 Cluj Napoca, Romania; [Pap, Peter L.; Vagasi, Csongor I.; Vincze, Orsolya] Debrecen Univ Med, Dept Evolutionary Zool & Human Biol, MTA Lendlet Behav Ecol Res Grp, H-4012 Debrecen, Hungary; [Osvath, Gergely] Univ Babes Bolyai, Museum Zool, R-3400 Cluj Napoca, Romania; [Aparicio, Jose Miguel] UCLM, JCCM, CSIC, IREC,Grp Invest Biodiversidad Genet & Cultural, Ciudad Real, Spain; [Barbos, Lorinc] Milvus Grp Bird & Nat Protect Assoc, Tirgu Mure, Romania; [Matyjasiak, Piotr] Cardinal Stefan Wyszynski Univ Warsaw, Fac Biol & Environm Sci, Warsaw, Poland; [Rubolini, Diego; Saino, Nicola] Univ Milan, Dipartimento Biosci, Milan, Italy; [Moller, Anders Pape] Univ Paris 11, CNRS, Lab Ecol Systamat & Evolut, UMR 8079, F-91405 Orsay, France	Babes Bolyai University from Cluj; University of Debrecen; Babes Bolyai University from Cluj; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigacion en Recursos Cinegeticos (IREC); Universidad de Castilla-La Mancha; Cardinal Stefan Wyszynski University in Warsaw; University of Milan; AgroParisTech; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Universite Paris Saclay	Pap, PL (corresponding author), Univ Babes Bolyai, Hungarian Dept Biol & Ecol, Evolutionary Ecol Grp, R-3400 Cluj Napoca, Romania.	peterlpap@gmail.com	Vincze, Orsolya/AEQ-1159-2022; Moller, Anders/O-6665-2016; Rubolini, Diego/F-2851-2011; Aparicio, Jose M/K-8712-2014; Vágási, Csongor I./AAU-4548-2020; Matyjasiak, Piotr/AAT-8660-2021	Vincze, Orsolya/0000-0001-5789-2124; Moller, Anders/0000-0003-3739-4675; Rubolini, Diego/0000-0003-2703-5783; Aparicio, Jose M/0000-0003-4502-4746; Vágási, Csongor I./0000-0002-8736-2391; Matyjasiak, Piotr/0000-0003-0384-2935; Saino, Nicola/0000-0002-0230-3967				Andersson Malte, 1994; Aparicio JM, 2003, EVOLUTION, V57, P397, DOI 10.1111/j.0014-3820.2003.tb00273.x; Barbosa A, 2003, ARDEA, V91, P85; Barbosa A, 1999, BEHAV ECOL, V10, P112, DOI 10.1093/beheco/10.1.112; Dawson A, 2000, P ROY SOC B-BIOL SCI, V267, P2093, DOI 10.1098/rspb.2000.1254; de la Hera I, 2011, AUK, V128, P321, DOI 10.1525/auk.2011.10181; de la Hera I, 2010, AUK, V127, P647, DOI 10.1525/auk.2010.09120; de la Hera I, 2010, J AVIAN BIOL, V41, P342, DOI 10.1111/j.1600-048X.2009.04835.x; de la Hera I, 2009, BIOL J LINN SOC, V97, P98, DOI 10.1111/j.1095-8312.2008.01189.x; Dial TR, 2012, J EXP BIOL, V215, P3693, DOI 10.1242/jeb.062018; Evans MR, 1997, P ROY SOC B-BIOL SCI, V264, P211, DOI 10.1098/rspb.1997.0030; Feo TJ, 2015, P R SOC B, P282; Fox John, 2003, J STAT SOFTW, V8, P1, DOI [10.18637/jss.v008.i15, DOI 10.18637/JSS.V008.I15]; Grubb T. C., 2006, PTILOCHRONOLOGY FEAT; Heers AM, 2011, J EXP BIOL, V214, P717, DOI 10.1242/jeb.051177; Liechti F, 2015, J AVIAN BIOL; Matyjasiak P, 2004, P ROY SOC B-BIOL SCI, V271, P1831, DOI 10.1098/rspb.2004.2812; Matyjasiak P, 2013, BEHAV ECOL SOCIOBIOL, V67, P91, DOI 10.1007/s00265-012-1429-x; Maybury WJ, 2001, P ROY SOC B-BIOL SCI, V268, P1443, DOI 10.1098/rspb.2001.1666; Maybury WJ, 2001, P ROY SOC B-BIOL SCI, V268, P1405, DOI 10.1098/rspb.2001.1635; Aparicio JM, 2012, BIOL J LINN SOC, V105, P925, DOI 10.1111/j.1095-8312.2011.01830.x; Moller AP, 2006, EVOLUTION, V60, P856; MOLLER AP, 1989, NATURE, V339, P132; Moller AP., 1994, SEXUAL SELECTION BAR; Muller W, 1998, J EXP BIOL, V201, P2591; Norberg U., 1990, VERTEBRATE FLIGHT ME; Norberg UML, 2002, J MORPHOL, V252, P52, DOI 10.1002/jmor.10013; Pap PL, 2013, BIOL J LINN SOC, V108, P414, DOI 10.1111/j.1095-8312.2012.02029.x; Pap PL, 2008, CAN J ZOOL, V86, P834, DOI 10.1139/Z08-060; Pap PL, 2015, FUNCT ECOL IN PRESS; Pennycuick C.J., 1975, AVIAN BIOL, P1, DOI DOI 10.1016/B978-0-12-249405-5.50009-4; Pennycuick C.J., 1989, BIRD FLIGHT PERFORMA; Prum RO, 2002, Q REV BIOL, V77, P261, DOI 10.1086/341993; R Core Team, 2014, LANG ENV STAT COMP; Roulin A, 2013, BIOL J LINN SOC, V109, P562, DOI 10.1111/bij.12078; Saino N, 2004, ECOL LETT, V7, P21, DOI 10.1046/j.1461-0248.2003.00553.x; Saino N, 2012, J AVIAN BIOL, V43, P513, DOI 10.1111/j.1600-048X.2012.05622.x; Scheipl F., 2020, LINEAR MIXED EFFECTS, DOI 10.18637/jss.v067.i01; SMITH HG, 1991, BEHAV ECOL SOCIOBIOL, V28, P195; THOMAS ALR, 1993, PHILOS T ROY SOC B, V340, P361, DOI 10.1098/rstb.1993.0079; Tubaro PL, 2005, BIOL J LINN SOC, V86, P477, DOI 10.1111/j.1095-8312.2005.00548.x; Vagasi CI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040651; von Ronn JAC, 2015, J EVOLUTION BIOL, V28, P535, DOI 10.1111/jeb.12585; Wang X, 2012, J EVOLUTION BIOL, V25, P547, DOI 10.1111/j.1420-9101.2011.02449.x	44	3	3	1	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2015	10	6							e0130844	10.1371/journal.pone.0130844	http://dx.doi.org/10.1371/journal.pone.0130844			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4OY	26110255	Green Published, Green Submitted, gold			2022-12-26	WOS:000356933800093
J	Li, JP; Lin, JH; Luo, YL; Kuang, MH; Liu, YJ				Li, Jianpei; Lin, Jianhua; Luo, Yaoling; Kuang, Miaohuan; Liu, Yijun			Multivariate Analysis of Prognostic Biomarkers in Surgically Treated Endometrial Cancer	PLOS ONE			English	Article							CERVICAL-CANCER; CUTOFF VALUE; D-DIMER; RISK; MARKERS; INVASION; ADENOCARCINOMA; INVOLVEMENT; PREDICTION; OUTCOMES	Objective The aim of this study was to identify biomarkers with prognostic value in the setting of surgically treated endometrial cancer. Methods Medical data for 282 patients with surgically treated endometrial cancer were reviewed retrospectively. Preoperative concentrations of six serum biomarkers (CA125, CA15-3, C-reactive protein [CRP], D-dimer [D-D], platelet-to-lymphocyte ratio [PLR], and neutrophil-to-lymphocyte ratio [NLR]) were analysed to determine potential associations with clinicopathologic characteristics and to assess prognostic values separately via Kaplan-Meier method and multivariate Cox regression. Results In univariate analyses, the 5-year overall survival (OS) rate was 86.5% for a maximum follow-up period of 75 months. High concentrations of CA125, CA15-3, CRP, D-D, PLR, and NLR each proved significantly predictive of poor survival (log-rank test, P<0.01). CRP and D-D were identified as independent prognosticators, using a Cox regression model. Study patients were then stratified (based on combined independent risk factors) into three tiers (P< 0.001), marked by 5-year OS rates of 92.1%, 78.4%, and 33.3%. Conclusions All serum biomarkers assessed (CA125, CA15-3, CRP, D-D, PLR, and NLR) proved to be valid prognostic indices of surgically treated endometrial cancer. A novel prognostic grouping system, incorporating independent risk factors (CRP and D-D Concentrations), may have merit in assessing these patients preoperatively, providing a biologic basis for improved clinical staging.	[Li, Jianpei; Lin, Jianhua; Luo, Yaoling; Kuang, Miaohuan; Liu, Yijun] Sun Yat Sen Univ, Dept Clin Lab, State Key Lab Oncol South China, Ctr Canc, Guangzhou 510275, Guangdong, Peoples R China	State Key Lab Oncology South China; Sun Yat Sen University	Lin, JH (corresponding author), Sun Yat Sen Univ, Dept Clin Lab, State Key Lab Oncol South China, Ctr Canc, Guangzhou 510275, Guangdong, Peoples R China.	linjh@sysucc.org.cn						Binder PS, 2014, WOMENS HEALTH, V10, P277, DOI [10.2217/whe.14.13, 10.2217/WHE.14.13]; Black S, 2004, J BIOL CHEM, V279, P48487, DOI 10.1074/jbc.R400025200; BOKHMAN JV, 1983, GYNECOL ONCOL, V15, P10, DOI 10.1016/0090-8258(83)90111-7; Bozkurt M, 2013, EUR J GYNAECOL ONCOL, V34, P540; Brennan DJ, 2014, GYNECOL ONCOL, V132, P159, DOI 10.1016/j.ygyno.2013.10.036; Burke W.M., 2014, GYNECOL ONCOL; Case AS, 2006, OBSTET GYNECOL, V108, P1375, DOI 10.1097/01.AOG.0000245444.14015.00; Chao A, 2013, GYNECOL ONCOL, V129, P500, DOI 10.1016/j.ygyno.2013.02.032; Cushman M, 2003, BLOOD, V101, P1243, DOI 10.1182/blood-2002-05-1416; Dossus L, 2010, ENDOCR-RELAT CANCER, V17, P1007, DOI 10.1677/ERC-10-0053; Dotters DJ, 2000, AM J OBSTET GYNECOL, V182, P1328, DOI 10.1067/mob.2000.106251; Emons G, 2000, ENDOCR-RELAT CANCER, V7, P227, DOI 10.1677/erc.0.0070227; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Fotiou S, 2009, GYNECOL ONCOL, V112, P517, DOI 10.1016/j.ygyno.2008.11.009; GALLUP DG, 1984, OBSTET GYNECOL, V64, P417; Ghezzi F, 2010, GYNECOL ONCOL, V119, P309, DOI 10.1016/j.ygyno.2010.07.014; Guntupalli SR, 2012, GYNECOL ONCOL, V124, P31, DOI 10.1016/j.ygyno.2011.09.017; Haldorsen IS, 2012, GYNECOL ONCOL, V126, P413, DOI 10.1016/j.ygyno.2012.05.009; Hecht JL, 2006, J CLIN ONCOL, V24, P4783, DOI 10.1200/JCO.2006.06.7173; Ho CM, 2004, GYNECOL ONCOL, V93, P458, DOI 10.1016/j.ygyno.2004.01.026; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; KAMURA T, 1992, CANCER-AM CANCER SOC, V69, P181, DOI 10.1002/1097-0142(19920101)69:1<181::AID-CNCR2820690130>3.0.CO;2-B; Kawaguchi R, 2012, J GYNECOL ONCOL, V23, P98, DOI 10.3802/jgo.2012.23.2.98; Lee NK, 2007, OBSTET GYNECOL, V109, P655, DOI 10.1097/01.AOG.0000255980.88205.15; Liu Fu-Shing, 2007, Taiwan J Obstet Gynecol, V46, P26, DOI 10.1016/S1028-4559(08)60102-3; Lo KWK, 2001, GYNECOL ONCOL, V82, P279, DOI 10.1006/gyno.2001.6270; Lo SST, 1997, TUMOR BIOL, V18, P241, DOI 10.1159/000218037; Mantovani A, 2010, CYTOKINE GROWTH F R, V21, P27, DOI 10.1016/j.cytogfr.2009.11.007; Satoh T, 2008, BRIT J CANCER, V99, P1034, DOI 10.1038/sj.bjc.6604658; Setiawan VW, 2013, J CLIN ONCOL, V31, P2607, DOI 10.1200/JCO.2012.48.2596; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Suh DH, 2012, EUR J OBSTET GYN R B, V162, P206, DOI 10.1016/j.ejogrb.2012.02.028; Takeda N, 2002, ACTA OBSTET GYN SCAN, V81, P1144, DOI 10.1034/j.1600-0412.2002.811208.x; Toyoda Maki, 2005, Int J Clin Oncol, V10, P444, DOI 10.1007/s10147-005-0517-6; Walentowicz-Sadlecka M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084629; Wang D, 2013, ONCOTARGETS THER, V6, P211, DOI 10.2147/OTT.S41711; Wang T, 2011, CANCER EPIDEM BIOMAR, V20, P971, DOI 10.1158/1055-9965.EPI-10-1222; Yurkovetsky Z, 2007, GYNECOL ONCOL, V107, P58, DOI 10.1016/j.ygyno.2007.05.041; Zaino RJ, 1996, CANCER-AM CANCER SOC, V77, P1115, DOI 10.1002/(SICI)1097-0142(19960315)77:6<1115::AID-CNCR17>3.0.CO;2-4; Zhou X, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101119	40	24	24	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2015	10	6							e0130640	10.1371/journal.pone.0130640	http://dx.doi.org/10.1371/journal.pone.0130640			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4OM	26107255	Green Published, Green Submitted, gold			2022-12-26	WOS:000356932500114
J	Ma, SL; Vega-Warner, V; Gillies, C; Sampson, MG; Kher, V; Sethi, SK; Otto, EA				Ma, Sara L.; Vega-Warner, Virginia; Gillies, Christopher; Sampson, Matthew G.; Kher, Vijay; Sethi, Sidharth K.; Otto, Edgar A.			Whole Exome Sequencing Reveals Novel PHEX Splice Site Mutations in Patients with Hypophosphatemic Rickets	PLOS ONE			English	Article							X-LINKED HYPOPHOSPHATEMIA; PEX GENE; EXPRESSION; CLONING	Objective Hypophosphatemic rickets (HR) is a heterogeneous genetic phosphate wasting disorder. The disease is most commonly caused by mutations in the PHEX gene located on the X-chromosome or by mutations in CLCN5, DMP1, ENPP1, FGF23, and SLC34A3. The aims of this study were to perform molecular diagnostics for four patients with HR of Indian origin (two independent families) and to describe their clinical features. Methods We performed whole exome sequencing (WES) for the affected mother of two boys who also displayed the typical features of HR, including bone malformations and phosphate wasting. B-lymphoblast cell lines were established by EBV transformation and subsequent RT-PCR to investigate an uncommon splice site variant found by WES. An in silico analysis was done to obtain accurate nucleotide frequency occurrences of consensus splice positions other than the canonical sites of all human exons. Additionally, we applied direct Sanger sequencing for all exons and exon/intron boundaries of the PHEX gene for an affected girl from an independent second Indian family. Results WES revealed a novel PHEX splice acceptor mutation in intron 9 (c. 1080-3C>A) in a family with 3 affected individuals with HR. The effect on splicing of this mutation was further investigated by RT-PCR using RNA obtained from a patient's EBV-transformed lymphoblast cell line. RT-PCR revealed an aberrant splice transcript skipping exons 10-14 which was not observed in control samples, confirming the diagnosis of X-linked dominant hypophosphatemia (XLH). The in silico analysis of all human splice sites adjacent to all 327,293 exons across 81,814 transcripts among 20,345 human genes revealed that cytosine is, with 64.3%, the most frequent nucleobase at the minus 3 splice acceptor position, followed by thymidine with 28.7%, adenine with 6.3%, and guanine with 0.8%. We generated frequency tables and pictograms for the extended donor and acceptor splice consensus regions by analyzing all human exons. Direct Sanger sequencing of all PHEX exons in a sporadic case with HR from the Indian subcontinent revealed an additional novel PHEX mutation (c. 1211_1215delACAAAinsTTTACAT, p.Asp404Valfs* 5, de novo) located in exon 11. Conclusions Mutation analyses revealed two novel mutations and helped to confirm the clinical diagnoses of XLH in two families from India. WES helped to analyze all genes implicated in the underlying disease complex. Mutations at splice positions other than the canonical key sites need further functional investigation to support the assertion of pathogenicity.	[Ma, Sara L.] Univ Michigan, Coll Literature Sci & Arts, Ann Arbor, MI 48109 USA; [Vega-Warner, Virginia; Gillies, Christopher; Sampson, Matthew G.; Otto, Edgar A.] Univ Michigan, Dept Pediat & Communicable Dis, Div Nephrol, Ann Arbor, MI 48109 USA; [Kher, Vijay; Sethi, Sidharth K.] Medic Hosp, Kidney & Urol Inst, Gurgaon, India	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Otto, EA (corresponding author), Univ Michigan, Dept Pediat & Communicable Dis, Div Nephrol, Ann Arbor, MI 48109 USA.	eotto@umich.edu	Sampson, Matthew/U-4501-2017	Sampson, Matthew/0000-0001-9560-076X; Otto, Edgar/0000-0002-2387-9973	Michigan Institute for Clinical & Health Research (MICHR) [UL1TR000433]	Michigan Institute for Clinical & Health Research (MICHR)	This research was supported by a grant from "The Michigan Institute for Clinical & Health Research (MICHR)" Pilot Grant Program to E.A.O. and M.G.S. (UL1TR000433). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Auricchio A, 2008, ONLINE METABOLIC MOL; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Bergwitz C, 2006, AM J HUM GENET, V78, P179, DOI 10.1086/499409; Bolino A., 1993, European Journal of Human Genetics, V1, P269; Chandran M, 2010, NEPHRON PHYSIOL, V116, pP17, DOI 10.1159/000319318; Cheon Chong Kun, 2014, Ann Pediatr Endocrinol Metab, V19, P36, DOI 10.6065/apem.2014.19.1.36; Cho HY, 2005, PEDIATR RES, V58, P329, DOI 10.1203/01.PDR.0000169983.40758.7B; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; Dixon PH, 1998, J CLIN ENDOCR METAB, V83, P3615, DOI 10.1210/jc.83.10.3615; Drezner MK, 2000, KIDNEY INT, V57, P9, DOI 10.1046/j.1523-1755.2000.00807.x; Du L, 1996, GENOMICS, V36, P22, DOI 10.1006/geno.1996.0421; Durmaz E, 2013, BONE, V52, P286, DOI 10.1016/j.bone.2012.10.012; Feng JQ, 2006, NAT GENET, V38, P1310, DOI 10.1038/ng1905; FRANCIS F, 1995, NAT GENET, V11, P130, DOI 10.1038/ng1095-130; Gaucher C, 2009, HUM GENET, V125, P401, DOI 10.1007/s00439-009-0631-z; Guo R, 1997, J BONE MINER RES, V12, P1009, DOI 10.1359/jbmr.1997.12.7.1009; HANNA JD, 1991, AM J DIS CHILD, V145, P865, DOI 10.1001/archpedi.1991.02160080041018; Holm IA, 1997, AM J HUM GENET, V60, P790; Jagtap Varsha S, 2012, Indian J Endocrinol Metab, V16, P177, DOI 10.4103/2230-8210.93733; KELLER EB, 1984, P NATL ACAD SCI-BIOL, V81, P7417, DOI 10.1073/pnas.81.23.7417; Kircher M, 2014, NAT GENET, V46, P310, DOI 10.1038/ng.2892; Kitanaka S, 1998, NEW ENGL J MED, V338, P653, DOI 10.1056/NEJM199803053381004; Lorenz-Depiereux B, 2010, AM J HUM GENET, V86, P267, DOI 10.1016/j.ajhg.2010.01.006; Otto EA, 2008, HUM MUTAT, V29, P418, DOI 10.1002/humu.20669; PADGETT RA, 1986, ANNU REV BIOCHEM, V55, P1119, DOI 10.1146/annurev.bi.55.070186.005351; Rowe PSN, 2000, ARCH DIS CHILD, V83, P192, DOI 10.1136/adc.83.3.192; Sabbagh Y, 2003, J CLIN ENDOCR METAB, V88, P2213, DOI 10.1210/jc.2002-021809; Schwarz JM, 2010, NAT METHODS, V7, P575, DOI 10.1038/nmeth0810-575; Tenenhouse HS, 2003, J AM SOC NEPHROL, V14, P240, DOI 10.1097/01.ASN.0000045045.47494.71; Thompson DL, 2002, J BONE MINER RES, V17, P311, DOI 10.1359/jbmr.2002.17.2.311; WALTON RJ, 1975, LANCET, V2, P309, DOI 10.1016/S0140-6736(75)92736-1; White KE, 2000, NAT GENET, V26, P345, DOI 10.1038/81664; Yue H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097830	34	22	24	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2015	10	6							e0130729	10.1371/journal.pone.0130729	http://dx.doi.org/10.1371/journal.pone.0130729			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4OM	26107949	Green Published, gold, Green Submitted			2022-12-26	WOS:000356932500121
J	Wu, YH; Liao, YC; Chen, YH; Chang, MH; Lin, CH				Wu, Yu-Hsuan; Liao, Yi-Chu; Chen, Yi-Huei; Chang, Ming-Hong; Lin, Ching-Heng			Risk of Premotor Symptoms in Patients with Newly Diagnosed PD: A Nationwide, Population-Based, Case-Control Study in Taiwan	PLOS ONE			English	Article							SLEEP BEHAVIOR DISORDER; PARKINSONS-DISEASE; LIFE-STYLE; CONSTIPATION; ASSOCIATION; DEPRESSION; REGISTER; ONSET; AGE	Background To evaluate the risk of premotor symptoms, namely rapid eye movement behavior disorder (RBD), constipation, and depression among patients with newly diagnosed Parkinson disease (PD). Methods A total of 705 PD patients and 2,820 control subjects were selected from the Taiwan National Health Insurance Research Database. Patients were traced back for a maximum of 14 years to determine the diagnoses of RBD, depression, and constipation. Logistic regression analysis was used to identify risk of premotor symptoms for PD. Moreover, subgroup analyses were performed by dividing the patients into a middle-age onset group (<= 64 years) and an old-age onset group (>= 65 years). The associations between these premotor symptoms and age of PD onset were further examined. Results An association was found between a history of premotor symptoms and newly diagnosed PD in which a high occurrence of premotor symptoms was identified in PD patients as compared to selected controls (4.3% vs. 1.2% for RBD, 40.4% vs. 24.0% for constipation, and 13.0% vs. 5.1% for depression). The strength of this association remained statistically significant after adjustment for potential confounders (3.69 fold risk for RBD, 2.36 for constipation, and 2.82 for depression, all p < 0.0001). The average interval between premotor symptoms and PD ranged from 4.5 to 6.2 years. RBD and depression carried higher risks for PD in the middle-age onset group than in the old-age onset group (7.20- vs. 2.24-fold risk for RBD, 6.06 vs. 1.40 for depression). Conclusion The prevalence of premotor symptoms was higher among the PD patients than in the controls. Premotor symptoms appeared to be associated with a higher risk for PD in subjects with an earlier age of onset.	[Wu, Yu-Hsuan; Liao, Yi-Chu; Chang, Ming-Hong] Taichung Vet Gen Hosp, Neurol Sect, Taichung, Taiwan; [Liao, Yi-Chu; Chang, Ming-Hong] Natl Yang Ming Univ, Sch Med, Dept Neurol, Taipei 112, Taiwan; [Chen, Yi-Huei; Lin, Ching-Heng] Taichung Vet Gen Hosp, Dept Med Educ & Res, Taichung, Taiwan	Taichung Veterans General Hospital; National Yang Ming Chiao Tung University; Taichung Veterans General Hospital	Chang, MH (corresponding author), Taichung Vet Gen Hosp, Neurol Sect, Taichung, Taiwan.	cmh50@ms10.hinet.net; joelin99@gmail.com		Liao, Yi-Chu/0000-0002-9644-2086	Taichung Veterans General Hospital [TCVGH-1043404C]	Taichung Veterans General Hospital	Full financial support for all authors came from the Taichung Veterans General Hospital (TCVGH-1043404C). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott RD, 2003, J NEUROL, V250, P30, DOI 10.1007/s00415-003-1306-7; Abbott RD, 2001, NEUROLOGY, V57, P456, DOI 10.1212/WNL.57.3.456; Gaig C, 2009, MOVEMENT DISORD, V24, pS656, DOI 10.1002/mds.22672; Guo YJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107465; Hawkes CH, 2010, PARKINSONISM RELAT D, V16, P79, DOI 10.1016/j.parkreldis.2009.08.007; Iranzo A, 2006, LANCET NEUROL, V5, P572, DOI 10.1016/S1474-4422(06)70476-8; Lang AE, 2011, MOVEMENT DISORD, V26, P775, DOI 10.1002/mds.23609; Lavault S, 2010, J NEUROL, V257, P1154, DOI 10.1007/s00415-010-5482-y; Leentjens AFG, 2003, MOVEMENT DISORD, V18, P414, DOI 10.1002/mds.10387; Nilsson FM, 2001, ACTA PSYCHIAT SCAND, V104, P380, DOI 10.1034/j.1600-0447.2001.00372.x; Parkinson J, 2002, J NEUROPSYCH CLIN N, V14, P223, DOI 10.1176/appi.neuropsych.14.2.223; Savica R, 2009, NEUROLOGY, V73, P1752, DOI 10.1212/WNL.0b013e3181c34af5; Schenck CH, 2013, SLEEP MED, V14, P744, DOI 10.1016/j.sleep.2012.10.009; Schrag A, 2015, LANCET NEUROL, V14, P57, DOI 10.1016/S1474-4422(14)70287-X; Shannon KM, 2012, MOVEMENT DISORD, V27, P716, DOI 10.1002/mds.25020; Shen CC, 2013, NEUROLOGY, V81, P1538, DOI 10.1212/WNL.0b013e3182a956ad; Shiba M, 2000, MOVEMENT DISORD, V15, P669, DOI 10.1002/1531-8257(200007)15:4<669::AID-MDS1011>3.0.CO;2-5; Ueki A, 2004, J NEUROL, V251, P18, DOI 10.1007/s00415-004-1706-3; Van Den Eeden SK, 2003, AM J EPIDEMIOL, V157, P1015, DOI 10.1093/aje/kwg068; Zhou MZ, 2013, CLIN NEUROL NEUROSUR, V115, P2103, DOI 10.1016/j.clineuro.2013.07.027	20	14	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2015	10	6							e0130282	10.1371/journal.pone.0130282	http://dx.doi.org/10.1371/journal.pone.0130282			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4OM	26107935	Green Submitted, gold, Green Published			2022-12-26	WOS:000356932500090
J	Modi, KK; Roy, A; Brahmachari, S; Rangasamy, SB; Pahan, K				Modi, Khushbu K.; Roy, Avik; Brahmachari, Saurabh; Rangasamy, Suresh B.; Pahan, Kalipada			Cinnamon and Its Metabolite Sodium Benzoate Attenuate the Activation of p21(rac) and Protect Memory and Learning in an Animal Model of Alzheimer's Disease	PLOS ONE			English	Article							RESPONSE ELEMENT-BINDING; NADPH OXIDASE COMPLEX; OXIDATIVE STRESS; NEUTRAL SPHINGOMYELINASE; PARKINSONS-DISEASE; LIPID-PEROXIDATION; MOUSE MODEL; ACID; NEURONS; BRAIN	This study underlines the importance of cinnamon, a commonly used natural spice and flavoring material, and its metabolite sodium benzoate (NaB) in attenuating oxidative stress and protecting memory and learning in an animal model of Alzheimer's disease (AD). NaB, but not sodium formate, was found to inhibit LPS-induced production of reactive oxygen species (ROS) in mouse microglial cells. Similarly, NaB also inhibited fibrillar amyloid beta (A beta)- and 1-methyl-4-phenylpyridinium(+)-induced microglial production of ROS. Although NaB reduced the level of cholesterol in vivo in mice, reversal of the inhibitory effect of NaB on ROS production by mevalonate, and geranylgeranyl pyrophosphate, but not cholesterol, suggests that depletion of intermediates, but not end products, of the mevalonate pathway is involved in the antioxidant effect of NaB. Furthermore, we demonstrate that an inhibitor of p21(rac) geranylgeranyl protein transferase suppressed the production of ROS and that NaB suppressed the activation of p21(rac) in microglia. As expected, marked activation of p21(rac) was observed in the hippocampus of subjects with AD and 5XFAD transgenic (Tg) mouse model of AD. However, oral feeding of cinnamon (Cinnamonum verum) powder and NaB suppressed the activation of p21(rac) and attenuated oxidative stress in the hippocampus of Tg mice as evident by decreased dihydroethidium (DHE) and nitrotyrosine staining, reduced homocysteine level and increased level of reduced glutathione. This was accompanied by suppression of neuronal apoptosis, inhibition of glial activation, and reduction of A beta burden in the hippocampus and protection of memory and learning in transgenic mice. Therefore, cinnamon powder may be a promising natural supplement in halting or delaying the progression of AD.	[Modi, Khushbu K.; Roy, Avik; Brahmachari, Saurabh; Rangasamy, Suresh B.; Pahan, Kalipada] Rush Univ, Med Ctr, Dept Neurol Sci, Chicago, IL 60612 USA; [Pahan, Kalipada] Jesse Brown Vet Affairs Med Ctr, Div Res & Dev, Chicago, IL USA	Rush University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Jesse Brown VA Medical Center	Pahan, K (corresponding author), Rush Univ, Med Ctr, Dept Neurol Sci, Chicago, IL 60612 USA.	Kalipada_Pahan@rush.edu			National Institutes of Health [AT6681]; Alzheimer's Association [IIRG-12-241179]; Veterans Affairs Merit Award [1I01BX003033]; National Center for Complementary & Integrative Health [R01AT006681] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alzheimer's Association(Alzheimer's Association); Veterans Affairs Merit Award(US Department of Veterans Affairs); National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was supported by grants from the National Institutes of Health (AT6681) and the Alzheimer's Association (IIRG-12-241179) and the Veterans Affairs Merit Award (1I01BX003033). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abd El-Mawla AMA, 2001, PLANTA, V212, P288, DOI 10.1007/s004250000394; Atri Alireza, 2011, Am J Manag Care, V17 Suppl 13, pS346; Beal MF, 2002, FREE RADICAL BIO MED, V32, P797, DOI 10.1016/S0891-5849(02)00780-3; Bell RD, 2012, J ALZHEIMERS DIS, V32, P699, DOI 10.3233/JAD-2012-121060; Brahmachari S, 2007, J IMMUNOL, V179, P275, DOI 10.4049/jimmunol.179.1.275; Brahmachari S, 2009, J IMMUNOL, V183, P5917, DOI 10.4049/jimmunol.0803336; BRIDGES JW, 1970, BIOCHEM J, V118, P47, DOI 10.1042/bj1180047; Butterfield DA, 2002, FREE RADICAL BIO MED, V32, P1050, DOI 10.1016/S0891-5849(02)00794-3; Castegna A, 2003, J NEUROCHEM, V85, P1394, DOI 10.1046/j.1471-4159.2003.01786.x; Citron M, 2000, MOL MED TODAY, V6, P392, DOI 10.1016/S1357-4310(00)01759-7; Corbett GT, 2013, J BIOL CHEM, V288, P8299, DOI 10.1074/jbc.M112.426536; Corbett GT, 2012, J IMMUNOL, V189, P1002, DOI 10.4049/jimmunol.1102624; Cosmetic Ingredient Review Expert, 2001, INT J TOXICOL, V20, P23; Frydman-Marom A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016564; Ghosh A, 2007, P NATL ACAD SCI USA, V104, P18754, DOI 10.1073/pnas.0704908104; Goedert M, 2006, SCIENCE, V314, P777, DOI 10.1126/science.1132814; HENSLEY K, 1995, J NEUROCHEM, V65, P2146; Jana A, 2004, J BIOL CHEM, V279, P51451, DOI 10.1074/jbc.M404635200; Jana A, 2013, J NEUROIMMUNE PHARM, V8, P739, DOI 10.1007/s11481-013-9447-7; Jana A, 2010, J NEUROSCI, V30, P12676, DOI 10.1523/JNEUROSCI.1243-10.2010; Khasnavis S, 2014, J NEUROIMMUNE PHARM, V9, P569, DOI 10.1007/s11481-014-9552-2; Khasnavis S, 2012, J NEUROIMMUNE PHARM, V7, P424, DOI 10.1007/s11481-011-9286-3; KUBOTA K, 1991, EUR J CLIN PHARMACOL, V41, P363, DOI 10.1007/BF00314969; Leonard J V, 2002, Semin Neonatol, V7, P27, DOI 10.1053/siny.2001.0085; Lin CH, 2014, BIOL PSYCHIAT, V75, P678, DOI 10.1016/j.biopsych.2013.08.010; Lovell MA, 2001, NEUROBIOL AGING, V22, P187, DOI 10.1016/S0197-4580(00)00235-9; Mansuy IM, 1998, CELL, V92, P39, DOI 10.1016/S0092-8674(00)80897-1; Melov S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000536; Modi KK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103606; Mondal S, 2014, PLOS ONE, V10; Mondal S, 2012, J NEUROIMMUNE PHARM, V7, P544, DOI 10.1007/s11481-012-9377-9; Nunomura A, 1999, J NEUROSCI, V19, P1959; Oda A, 2010, J NEUROSCI RES, V88, P1137, DOI 10.1002/jnr.22271; Petry A, 2010, ANTIOXID REDOX SIGN, V13, P467, DOI 10.1089/ars.2009.3026; PIKE CJ, 1993, J NEUROSCI, V13, P1676; Pratico D, 2004, J ALZHEIMERS DIS, V6, P171; Pratico D, 2008, TRENDS PHARMACOL SCI, V29, P609, DOI 10.1016/j.tips.2008.09.001; Prut L, 2007, BEHAV BRAIN RES, V179, P107, DOI 10.1016/j.bbr.2007.01.017; Querfurth HW, 2010, NEW ENGL J MED, V362, P329, DOI 10.1056/NEJMra0909142; Roy A, 2008, FREE RADICAL BIO MED, V45, P686, DOI 10.1016/j.freeradbiomed.2008.05.026; Roy A, 2013, CELL REP, V4, P724, DOI 10.1016/j.celrep.2013.07.028; Saharan S, 2014, J ALZHEIMERS DIS, V40, P519, DOI 10.3233/JAD-132483; Scaglia F, 2004, MOL GENET METAB, V81, pS79, DOI 10.1016/j.ymgme.2003.11.017; SMALE G, 1995, EXP NEUROL, V133, P225, DOI 10.1006/exnr.1995.1025; Smith MA, 1997, J NEUROSCI, V17, P2653; Stanley A, 2014, ANTIOXID REDOX SIGN, V20, P2026, DOI 10.1089/ars.2013.5713; Wilkinson BL, 2006, J NEUROINFLAMM, V3, DOI 10.1186/1742-2094-3-30	47	65	67	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2015	10	6							e0130398	10.1371/journal.pone.0130398	http://dx.doi.org/10.1371/journal.pone.0130398			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4DD	26102198	gold, Green Published, Green Submitted			2022-12-26	WOS:000356901900040
J	Obianyo, O; Liang, Y; Burnham, EL; Mehta, A; Park, Y; Uppal, K; Harris, FL; Jones, DP; Brown, LAS				Obianyo, Obiamaka; Liang, Yan; Burnham, Ellen L.; Mehta, Ashish; Park, Youngja; Uppal, Karan; Harris, Frank L.; Jones, Dean P.; Brown, Lou Ann S.			Metabolic Consequences of Chronic Alcohol Abuse in Non-Smokers: A Pilot Study	PLOS ONE			English	Article							INTENSIVE-CARE-UNIT; RESPIRATORY-DISTRESS-SYNDROME; CHRONIC ETHANOL INGESTION; TANDEM MASS-SPECTROMETRY; BRONCHOALVEOLAR LAVAGE FLUID; GROUP-B-STREPTOCOCCUS; ALVEOLAR MACROPHAGE; GLUTATHIONE HOMEOSTASIS; OXIDATIVE STRESS; LUNG INJURY	An alcohol use disorder (AUD) is associated with an increased susceptibility to respiratory infection and injury and, upon hospitalization, higher mortality rates. Studies in model systems show effects of alcohol on mitochondrial function, lipid metabolism and antioxidant systems. The present study applied high-resolution metabolomics to test for these changes in bronchoalveolar lavage fluid (BALF) of subjects with an AUD. Smokers were excluded to avoid confounding effects and compliance was verified by cotinine measurements. Statistically significant metabolic features, differentially expressed by control and AUD subjects, were identified by statistical and bioinformatic methods. The results show that fatty acid and acylcarnitine concentrations were increased in AUD subjects, consistent with perturbed mitochondrial and lipid metabolism. Decreased concentrations of methyl-donor compounds suggest altered one-carbon metabolism and oxidative stress. An accumulation of peptides suggests proteolytic activity, which could reflect altered epithelial barrier function. Two metabolites of possible microbial origin suggest subclinical bacterial infection. Furthermore, increased diacetylspermine suggests additional metabolic perturbations, which could contribute to dysregulated alveolar macrophage function and vulnerability to infection. Together, the results show an extended metabolic consequence of AUD in the bronchoalveolar space.	[Obianyo, Obiamaka; Liang, Yan; Mehta, Ashish; Uppal, Karan; Jones, Dean P.] Emory Univ, Sch Med, Div Pulm Allergy & Crit Care Med, Atlanta, GA USA; [Burnham, Ellen L.] Univ Colorado, Dept Med, Div Pulm & Crit Care, Denver, CO USA; [Burnham, Ellen L.] Univ Colorado, Hlth Sci Ctr, Denver, CO USA; [Park, Youngja] Korea Univ, Coll Pharm, Sejong City, South Korea; [Mehta, Ashish] Atlanta Vet Affairs & Emory Univ, Med Ctr, Decatur, GA USA; [Harris, Frank L.; Brown, Lou Ann S.] Emory Univ, Sch Med, Dept Pediat, Div Neonatal Perinatal Med, Atlanta, GA 30322 USA; [Brown, Lou Ann S.] Childrens Healthcare Atlanta Ctr Dev Lung Biol, Atlanta, GA USA	Emory University; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; Korea University; Emory University; Children's Healthcare of Atlanta (CHOA)	Brown, LAS (corresponding author), Emory Univ, Sch Med, Dept Pediat, Div Neonatal Perinatal Med, Atlanta, GA 30322 USA.	lbrow03@emory.edu		Liang, Yan/0000-0001-6407-1607; Park, Youngja/0000-0002-1310-148X; Uppal, Karan/0000-0001-5985-1668	National Institute of Health [T32HL116271, T32AA012528, P50AA135757, R01AA12197, R24AA019661]; Career Development Award [1IK2CX000643]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001082] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL116271] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES019776, T32ES012870] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA012197, R24AA019661] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD018006] Funding Source: NIH RePORTER; Veterans Affairs [IK2CX000643] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Career Development Award; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs(US Department of Veterans Affairs)	Funding for this work was provided by National Institute of Health T32HL116271 to OO, National Institute of Health T32AA012528 to YL, National Institute of Health P50AA135757 to LAB and DPJ, National Institute of Health R01AA12197 to LAB, National Institute of Health R24AA019661 to EB and VA, and Career Development Award 1IK2CX000643 to AM.	Baughman RP, 2002, RESPIRATION, V69, P57, DOI 10.1159/000049371; Bercault N, 2001, CRIT CARE MED, V29, P2303, DOI 10.1097/00003246-200112000-00012; Bhatty M, 2011, ALCOHOL, V45, P523, DOI 10.1016/j.alcohol.2011.02.305; Bochicchio GV, 2004, J TRAUMA, V56, P296, DOI 10.1097/01.TA.0000109857.22312.DF; Brown SD, 2012, ALCOHOL CLIN EXP RES, V36, P1952, DOI 10.1111/j.1530-0277.2012.01825.x; Burnham EL, 2003, ALCOHOL CLIN EXP RES, V27, P1167, DOI 10.1097/01.ALC.0000075821.34270.98; Chace DH, 2001, CLIN CHEM, V47, P1166; Chen Chang-Wen, 1992, Journal of the Formosan Medical Association, V91, P754; Cribbs SK, 2014, AIDS RES HUM RETROV, V30, P579, DOI [10.1089/aid.2013.0198, 10.1089/AID.2013.0198]; Evans CR, 2014, J PROTEOME RES, V13, P640, DOI 10.1021/pr4007624; Fabiano A, 2011, J MATERN-FETAL NEO M, V24, P56, DOI 10.3109/14767058.2011.606977; Fine MJ, 1996, JAMA-J AM MED ASSOC, V275, P134, DOI 10.1001/jama.275.2.134; Fitzpatrick AM, 2014, J ALLERGY CLIN IMMUN, V133, P258, DOI 10.1016/j.jaci.2013.10.012; Gauthier TW, 2010, AM J PHYSIOL-LUNG C, V299, pL8, DOI 10.1152/ajplung.90609.2008; Gauthier TW, 2009, ALCOHOL CLIN EXP RES, V33, P300, DOI 10.1111/j.1530-0277.2008.00833.x; Gauthier TW, 2005, ALCOHOL CLIN EXP RES, V29, P1035, DOI 10.1097/01.ALC.0000167956.28160.5E; Gauthier TW, 2005, PEDIATR RES, V57, P76, DOI 10.1203/01.PDR.0000149108.44152.D3; Grant BF, 2004, DRUG ALCOHOL DEPEN, V74, P223, DOI 10.1016/j.drugalcdep.2004.02.004; Grobmyer S. R., 1996, Journal of Burn Care and Rehabilitation, V17, P532, DOI 10.1097/00004630-199611000-00010; Guidot DM, 2000, ALCOHOL CLIN EXP RES, V24, P1070, DOI 10.1097/00000374-200007000-00019; Holguin F, 1998, J CLIN INVEST, V101, P761, DOI 10.1172/JCI1396; Joshi PC, 2005, J IMMUNOL, V175, P6837, DOI 10.4049/jimmunol.175.10.6837; Joshi PC, 2007, AM J PHYSIOL-LUNG C, V292, pL813, DOI 10.1152/ajplung.00348.2006; Kaphalia L, 2013, TOXICOL LETT, V222, P171, DOI 10.1016/j.toxlet.2013.07.016; Kepka A, 2013, POSTEP HIG MED DOSW, V67, P548; Li SZ, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003123; Liang Y, 2013, FREE RADICAL BIO MED, V65, P1427, DOI 10.1016/j.freeradbiomed.2013.10.010; Liang Y, 2012, J ELECTR COMPUT ENG, V2012, DOI 10.1155/2012/649057; MacNee W, 2001, EUR J PHARMACOL, V429, P195, DOI 10.1016/S0014-2999(01)01320-6; Maeda Y, 2008, J CHROMATOGR B, V870, P154, DOI 10.1016/j.jchromb.2007.11.037; Mehta AJ, 2013, AM J RESP CRIT CARE, V188, P716, DOI 10.1164/rccm.201301-0061OC; Mehta AJ, 2012, AM J MED SCI, V343, P244, DOI 10.1097/MAJ.0b013e31823ede77; Merali S, 2000, J BIOL CHEM, V275, P14958, DOI 10.1074/jbc.275.20.14958; Moss M, 2003, CRIT CARE MED, V31, pS207, DOI 10.1097/01.CCM.0000057845.77458.25; Moss M, 1996, JAMA-J AM MED ASSOC, V275, P50, DOI 10.1001/jama.275.1.50; Moss M, 2000, AM J RESP CRIT CARE, V161, P414, DOI 10.1164/ajrccm.161.2.9905002; Mukinda FK, 2012, INT J TUBERC LUNG D, V16, P196, DOI 10.5588/ijtld.11.0116; Obeid R, 2013, NUTRIENTS, V5, P3481, DOI 10.3390/nu5093481; Pabst D, 2011, EUR J INTERN MED, V22, pE119, DOI 10.1016/j.ejim.2011.08.014; Park MH, 2013, BIOMOL THER, V21, P1, DOI 10.4062/biomolther.2012.097; Park YH, 2012, TOXICOLOGY, V295, P47, DOI 10.1016/j.tox.2012.02.007; Pegg AE, 2008, AM J PHYSIOL-ENDOC M, V294, pE995, DOI 10.1152/ajpendo.90217.2008; Saitz R, 1997, ARCH INTERN MED, V157, P1446, DOI 10.1001/archinte.157.13.1446; Shukla SD, 2013, ALCOHOL RES-CURR REV, V35, P1; Smith CA, 2005, THER DRUG MONIT, V27, P747, DOI 10.1097/01.ftd.0000179845.53213.39; Soltow QA, 2010, INTEGR COMP BIOL, V50, P844, DOI 10.1093/icb/icq094; Sozio M, 2008, AM J PHYSIOL-ENDOC M, V295, pE10, DOI 10.1152/ajpendo.00011.2008; Spies CD, 1996, INTENS CARE MED, V22, P286, DOI 10.1007/s001340050082; Spies CD, 1996, ACTA ANAESTH SCAND, V40, P649, DOI 10.1111/j.1399-6576.1996.tb04505.x; Tang SM, 2009, ALCOHOL CLIN EXP RES, V33, P1197, DOI 10.1111/j.1530-0277.2009.00943.x; Uppal K, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-15; Vreken P, 1999, J INHERIT METAB DIS, V22, P302, DOI 10.1023/A:1005587617745; Watanabe T, 1996, DIGEST DIS SCI, V41, P49, DOI 10.1007/BF02208583; Wattiez R, 2005, J CHROMATOGR B, V815, P169, DOI 10.1016/j.jchromb.2004.10.029; Wishart DS, 2013, NUCLEIC ACIDS RES, V41, pD801, DOI 10.1093/nar/gks1065; Wolak JE, 2009, BIOMARKERS, V14, P55, DOI 10.1080/13547500802688194; Xia JG, 2011, NAT PROTOC, V6, P743, DOI 10.1038/nprot.2011.319; Yeh MY, 2007, AM J RESP CRIT CARE, V176, P270, DOI 10.1164/rccm.200611-1722OC; Yeligar SM, 2014, AM J PHYSIOL-LUNG C, V306, pL429, DOI 10.1152/ajplung.00159.2013; Zakhari S, 2013, ALCOHOL RES-CURR REV, V35, P6; Zhang P, 2002, ALCOHOL CLIN EXP RES, V26, P65, DOI 10.1111/j.1530-0277.2002.tb02433.x	61	8	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2015	10	6							e0129570	10.1371/journal.pone.0129570	http://dx.doi.org/10.1371/journal.pone.0129570			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4DD	26102199	Green Submitted, Green Published, gold			2022-12-26	WOS:000356901900016
J	Pakhale, S; Baron, J; Armstrong, M; Tasca, G; Gaudet, E; Aaron, S; Cameron, W; Balfour, L				Pakhale, Smita; Baron, Justine; Armstrong, Michael; Tasca, Georgio; Gaudet, Ena; Aaron, Shawn; Cameron, William; Balfour, Louise			A Cross-Sectional Study of the Psychological Needs of Adults Living with Cystic Fibrosis	PLOS ONE			English	Article							QUALITY-OF-LIFE; GENERALIZED ANXIETY DISORDER; HEALTH-CARE; TREATMENT COMPLEXITY; MEDICAL-PRACTICE; MENTAL-HEALTH; YOUNG-ADULTS; UNMET NEEDS; DEPRESSION; PREVALENCE	Background Depression and anxiety are prevalent in people with cystic fibrosis (CF), yet psychological services are rarely accessible in CF clinics. This cross-sectional single center study reports on a psychological needs assessment of people with CF. Methods We asked adults attending a CF clinic, without integrated psychological services, to complete a psychological needs assessment survey that included items on: a) past access to psychological services (via a CF referral service), b) concerns relevant to discuss with a psychologist, and c) their likelihood of accessing psychological services if available at the CF clinic, and standardized measures of depression (CES-D) and anxiety (GAD-7). Results We enrolled 49 participants and 45 (91.8%) completed the survey. Forty percent reported elevated symptoms of depression and 13% had elevated anxiety. A majority of individuals (72.2% and 83.3%, respectively) indicated they would be likely to use psychological services, if available at the clinic. Concerns considered most relevant to discuss with a psychologist were: 1) worries (51.1%), 2) mood (44.4%), 3) life stress (46.6%), 4) adjustment to CF (42.2%), 5) life transitions (42.2%) and 6) quality of life (42.2%). Conclusions This study highlights the rationale for screening adults with CF for depression and anxiety, and to facilitate provision of psychological services and preventative mental health interventions as an integral component of multi-disciplinary CF care.	[Pakhale, Smita; Baron, Justine; Armstrong, Michael; Tasca, Georgio; Aaron, Shawn; Cameron, William; Balfour, Louise] Ottawa Hosp, Res Inst, Ottawa, ON K1H 8M5, Canada; [Pakhale, Smita; Tasca, Georgio; Gaudet, Ena; Aaron, Shawn; Cameron, William; Balfour, Louise] Ottawa Hosp, Ottawa, ON K1H 8M5, Canada; [Pakhale, Smita; Baron, Justine; Tasca, Georgio; Aaron, Shawn; Cameron, William; Balfour, Louise] Univ Ottawa, Ottawa, ON K1H 8M5, Canada; [Pakhale, Smita; Aaron, Shawn] Ottawa Hosp, Div Resp Med, Ottawa, ON K1H 8L6, Canada	University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; University of Ottawa; Ottawa Hospital Research Institute	Pakhale, S (corresponding author), Ottawa Hosp, Res Inst, 501 Smyth Rd, Ottawa, ON K1H 8M5, Canada.	spakhale@ohri.ca	Tasca, Giorgio A./AAG-1867-2019; Cameron, Bill/E-9180-2010	Tasca, Giorgio A./0000-0001-7596-0661; Cameron, Bill/0000-0002-0090-3539; Pakhale, Smita/0000-0002-4051-962X; Aaron, Shawn/0000-0002-4762-3542	Department of Medicine, The Ottawa Hospital; Novartis, Ltd., Canada	Department of Medicine, The Ottawa Hospital; Novartis, Ltd., Canada	SP received a grant from The Department of Medicine, The Ottawa Hospital (http://www.ottawahospital.on.ca/wps/portal/Base/TheHospitoal/ClinicalServices/DeptPgrmCS/Departments/Medicine/) and from Novartis, Ltd., Canada (http://www.novartis.ca/en/index.shtml).	Abbott J, 2015, J CYST FIBROS, V14, P533, DOI 10.1016/j.jcf.2014.12.015; Alonso J, 2004, ACTA PSYCHIAT SCAND, V109, P47; [Anonymous], 2002, REPORT MENTAL ILLNES; Balfour L, 2004, CAN J PUBLIC HEALTH, V95, P272, DOI 10.1007/BF03405130; Berge J, 2004, FAMILIES SYSTEMS HLT, V22, P74, DOI DOI 10.1037/1091-7527.22.1.74; Besier T, 2012, QUAL LIFE RES, V21, P1829, DOI 10.1007/s11136-011-0096-0; Beswick L, 2013, CYSTIC FIBROSIS OUR; Bienenfeld D, 2014, SCREENING TESTS DEPR; Bonevski B, 2000, CANCER, V88, P217, DOI 10.1002/(SICI)1097-0142(20000101)88:1<217::AID-CNCR29>3.0.CO;2-Y; Braithwaite M, 2011, J CYST FIBROS, V10, P253, DOI 10.1016/j.jcf.2011.03.002; Conway S, 2014, J CYST FIBROS, V13, pS3, DOI 10.1016/j.jcf.2014.03.009; Cruz I, 2009, SEMIN RESP CRIT CARE, V30, P569, DOI 10.1055/s-0029-1238915; Cystic Fibrosis Canada, 2014, CYST FIBR CAN 2012 A; Cystic Fibrosis Canada, 2011, THE GUIDE RESOURCES; Cystic Fibrosis Canada, 2014, CYST FIBR CAN 2013 2; Cystic Fibrosis Foundation European Cystic Fibrosis Society, 2014, CFF ECFS GU IN PRESS; Duff A J, 2001, Paediatr Respir Rev, V2, P350, DOI 10.1053/prrv.2001.0171; Eisenberg D, 2007, MED CARE, V45, P594, DOI 10.1097/MLR.0b013e31803bb4c1; Fidika A, 2014, BMC PULM MED, V14, DOI 10.1186/1471-2466-14-205; Garcia-Campayo J, 2012, HEALTH QUAL LIFE OUT, V10, DOI 10.1186/1477-7525-10-114; Goldbeck L, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003148.pub3; Havermans T, 2013, J CYST FIBROS, V12, P423, DOI 10.1016/j.jcf.2013.04.001; Havermans T, 2008, J CYST FIBROS, V7, P581, DOI 10.1016/j.jcf.2008.05.010; Johansson R, 2013, PEERJ, V1, DOI 10.7717/peerj.98; Johnson C.S., 2008, CANADIAN J COMMUNITY, V27, P79, DOI 10.7870/cjcmh-2008-0006; Kilbourne AM, 2007, CURR OPIN PSYCHIATR, V20, P626, DOI 10.1097/YCO.0b013e3282f0c4d3; Koenig HG, 1998, AM J PSYCHIAT, V155, P871, DOI 10.1176/ajp.155.7.871; Kulhan T. T., 2012, ACTA MED MARTINIANA, V12, P32, DOI [10. 2478/v10201-011-0035-3, DOI 10.2478/V10201-011-0035-3]; Nobili RM, 2011, J CYST FIBROS, V10, pS45, DOI 10.1016/S1569-1993(11)60008-8; Offord DR, 1996, CAN J PSYCHIAT, V41, P559, DOI 10.1177/070674379604100904; Oliver KN, 2014, J CYST FIBROS, V13, P737, DOI 10.1016/j.jcf.2014.04.005; Orens JB, 2006, J HEART LUNG TRANSPL, V25, P745, DOI 10.1016/j.healun.2006.03.011; Oxley H, 2005, J ROY SOC MED, V98, P37; Pakhale S, 2014, BMC PULM MED, V14, DOI 10.1186/1471-2466-14-76; Pascoe S, 2000, AUST NZ J PSYCHIAT, V34, P785, DOI 10.1046/j.1440-1614.2000.00817.x; Pfeffer P E, 2003, J Cyst Fibros, V2, P61, DOI 10.1016/S1569-1993(03)00020-1; Public Health Agency of Canada, 2002, REP MENT ILLN CAN; Quittner AL, 2008, CURR OPIN PULM MED, V14, P582, DOI 10.1097/MCP.0b013e3283121cf1; Quittner AL, 2014, THORAX, V69, P1090, DOI 10.1136/thoraxjnl-2014-205983; Quon BS, 2015, PSYCHOSOMATICS, V56, P345, DOI 10.1016/j.psym.2014.05.017; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Riekert KA, 2007, CHEST, V132, P231, DOI 10.1378/chest.06-2474; Roback PJ, 2005, CONSERV BIOL, V19, P261, DOI 10.1111/j.1523-1739.2005.00269.x; Rodgers M., 2005, EFFECTS PSYCHOSOCIAL; Sawicki GS, 2007, J CYST FIBROS, V6, P411, DOI 10.1016/j.jcf.2007.03.004; Sawicki GS, 2013, J CYST FIBROS, V12, P461, DOI 10.1016/j.jcf.2012.12.009; Sawicki GS, 2012, PEDIATR PULM, V47, P523, DOI 10.1002/ppul.22546; Sawicki GS, 2009, J CYST FIBROS, V8, P91, DOI 10.1016/j.jcf.2008.09.007; Schwartz LA, 2009, J PEDIATR PSYCHOL, V34, P954, DOI 10.1093/jpepsy/jsn144; Senate Canada, 2004, 1 SEN CAN STAND SEN; SHINAR D, 1986, STROKE, V17, P241, DOI 10.1161/01.STR.17.2.241; Smith BA, 2010, PEDIATR PULM, V45, P756, DOI 10.1002/ppul.21238; Snell C, 2014, PEDIATR PULM, V49, P1177, DOI 10.1002/ppul.22990; Spitzer RL, 2006, ARCH INTERN MED, V166, P1092, DOI 10.1001/archinte.166.10.1092; Unutzer J, 2009, J AM GERIATR SOC, V57, P506, DOI 10.1111/j.1532-5415.2008.02134.x; Wen Kuang-Yi, 2004, Health Qual Life Outcomes, V2, P11; World Health Organization, 2000, NEEDS ASSESSMENT WOR	57	4	5	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2015	10	6							e0127944	10.1371/journal.pone.0127944	http://dx.doi.org/10.1371/journal.pone.0127944			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CL4DD	26102351	Green Submitted, gold, Green Published			2022-12-26	WOS:000356901900006
J	Jin, Y; Qian, H; Yu, MJ				Jin, Yi; Qian, Hong; Yu, Mingjian			Phylogenetic Structure of Tree Species across Different Life Stages from Seedlings to Canopy Trees in a Subtropical Evergreen Broad-Leaved Forest	PLOS ONE			English	Article							COMMUNITY STRUCTURE; COMPETITIVE-EXCLUSION; SUCCESSION EVIDENCE; FUNCTIONAL TRAITS; BETA-DIVERSITY; RAIN; GAPS; ECOLOGY; COEXISTENCE; DISTURBANCE	Investigating patterns of phylogenetic structure across different life stages of tree species in forests is crucial to understanding forest community assembly, and investigating forest gap influence on the phylogenetic structure of forest regeneration is necessary for understanding forest community assembly. Here, we examine the phylogenetic structure of tree species across life stages from seedlings to canopy trees, as well as forest gap influence on the phylogenetic structure of forest regeneration in a forest of the subtropical region in China. We investigate changes in phylogenetic relatedness (measured as NRI) of tree species from seedlings, saplings, treelets to canopy trees; we compare the phylogenetic turnover (measured as beta(NRI)) between canopy trees and seedlings in forest understory with that between canopy trees and seedlings in forest gaps. We found that phylogenetic relatedness generally increases from seedlings through saplings and treelets up to canopy trees, and that phylogenetic relatedness does not differ between seedlings in forest understory and those in forest gaps, but phylogenetic turnover between canopy trees and seedlings in forest understory is lower than that between canopy trees and seedlings in forest gaps. We conclude that tree species tend to be more closely related from seedling to canopy layers, and that forest gaps alter the seedling phylogenetic turnover of the studied forest. It is likely that the increasing trend of phylogenetic clustering as tree stem size increases observed in this subtropical forest is primarily driven by abiotic filtering processes, which select a set of closely related evergreen broad-leaved tree species whose regeneration has adapted to the closed canopy environments of the subtropical forest developed under the regional monsoon climate.	[Jin, Yi; Yu, Mingjian] Zhejiang Univ, Coll Life Sci, Hangzhou 310003, Zhejiang, Peoples R China; [Qian, Hong] Illinois State Museum, Res & Collect Ctr, Springfield, IL USA	Zhejiang University	Yu, MJ (corresponding author), Zhejiang Univ, Coll Life Sci, Hangzhou 310003, Zhejiang, Peoples R China.	fishmj202@hotmail.com			National Science & Technology Pillar Program from the Ministry of Environmental Protection of China [2008BAC39B02]; National Natural Science Foundation of China [NSFC 31061160188, NSFC 31361123001]	National Science & Technology Pillar Program from the Ministry of Environmental Protection of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Science & Technology Pillar Program from the Ministry of Environmental Protection of China (2008BAC39B02). This work was also supported by National Natural Science Foundation of China (http://www.nsfc.gov.cn/) to MY (NSFC 31061160188, NSFC 31361123001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Algar AC, 2011, ECOLOGY, V92, P903, DOI 10.1890/10-0606.1; Archibold O.W., 1995, ECOLOGY WORLD VEGETA, VDordrecht; Baraloto C, 2012, J ECOL, V100, P690, DOI 10.1111/j.1365-2745.2012.01966.x; Bell G, 2001, SCIENCE, V293, P2413, DOI 10.1126/science.293.5539.2413; BROKAW NVL, 1982, BIOTROPICA, V14, P158, DOI 10.2307/2387750; BROKAW NVL, 1985, ECOLOGY, V66, P682, DOI 10.2307/1940529; Brown C, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.0502; Cavender-Bares J, 2009, ECOL LETT, V12, P693, DOI 10.1111/j.1461-0248.2009.01314.x; Chazdon R.L., 2008, INTROPICAL FORESTCOM, P384; Condit R., 1998, Tropical forest census plots: methods and results from Barro Colorado Island, Panama and a comparison with other plots.; de Romer AH, 2007, J VEG SCI, V18, P815, DOI 10.1111/j.1654-1103.2007.tb02598.x; Denslow JS, 1998, J ECOL, V86, P597, DOI 10.1046/j.1365-2745.1998.00295.x; DENSLOW JS, 1987, ANNU REV ECOL SYST, V18, P431, DOI 10.1146/annurev.es.18.110187.002243; Ding Y, 2012, OIKOS, V121, P1263, DOI 10.1111/j.1600-0706.2011.19992.x; Dobzhansky T., 1950, American Scientist, V38, P209; Du YJ, 2012, ACTA OECOL, V44, P11, DOI 10.1016/j.actao.2011.06.001; Feng G, 2014, FOREST ECOL MANAG, V313, P188, DOI 10.1016/j.foreco.2013.10.047; Fukami Tadashi, 2010, P45; Goberna M, 2014, ECOL LETT, V17, P1191, DOI 10.1111/ele.12341; HARDIN G, 1960, SCIENCE, V131, P1292, DOI 10.1126/science.131.3409.1292; Haston E, 2009, BOT J LINN SOC, V161, P128, DOI 10.1111/j.1095-8339.2009.00996.x; Helmus MR, 2010, ECOL LETT, V13, P162, DOI 10.1111/j.1461-0248.2009.01411.x; HilleRisLambers J, 2012, ANNU REV ECOL EVOL S, V43, P227, DOI 10.1146/annurev-ecolsys-110411-160411; Hothorn T, 2014, PACKAGE COIN CONDITI; Hubbell SP, 1999, SCIENCE, V283, P554, DOI 10.1126/science.283.5401.554; Hubbell SP, 2001, ECOL RES, V16, P859, DOI 10.1046/j.1440-1703.2001.00445.x; Hubbell Stephen P., 2001, V32, pi; Iida Y, 2014, J ECOL, V102, P641, DOI 10.1111/1365-2745.12221; KEDDY PA, 1992, J VEG SCI, V3, P157, DOI 10.2307/3235676; Kembel SW, 2006, ECOLOGY, V87, pS86, DOI 10.1890/0012-9658(2006)87[86:TPSOAN]2.0.CO;2; Letcher SG, 2012, PERSPECT PLANT ECOL, V14, P79, DOI 10.1016/j.ppees.2011.09.005; Letcher SG, 2010, P ROY SOC B-BIOL SCI, V277, P97, DOI 10.1098/rspb.2009.0865; Liu XJ, 2013, FUNCT ECOL, V27, P264, DOI 10.1111/1365-2435.12018; Man XingXing, 2011, Biodiversity Science, V19, P197, DOI 10.3724/SP.J.1003.2011.09220; Mayfield MM, 2010, ECOL LETT, V13, P1085, DOI 10.1111/j.1461-0248.2010.01509.x; Myers JA, 2013, ECOL LETT, V16, P151, DOI 10.1111/ele.12021; Norden N, 2012, ECOLOGY, V93, pS70, DOI 10.1890/10-2179.1; Parmentier I, 2014, J ECOL, V102, P1008, DOI 10.1111/1365-2745.12254; Prescott CE, 2002, TREE PHYSIOL, V22, P1193, DOI 10.1093/treephys/22.15-16.1193; Qian H, 2014, J PLANT ECOL, V7, P97, DOI 10.1093/jpe/rtt077; Qian H, 2013, GLOBAL ECOL BIOGEOGR, V22, P1183, DOI 10.1111/geb.12069; Qian H, 2013, GLOBAL ECOL BIOGEOGR, V22, P1152, DOI 10.1111/geb.12076; R Core Team, 2021, R LANGUAGE ENV STAT; RUNKLE JR, 1982, ECOLOGY, V63, P1533, DOI 10.2307/1938878; Schemske DW, 2009, ANNU REV ECOL EVOL S, V40, P245, DOI 10.1146/annurev.ecolsys.39.110707.173430; Schnitzer SA, 2001, ECOLOGY, V82, P913, DOI 10.1890/0012-9658(2001)082[0913:TGATMO]2.0.CO;2; Soliveres S, 2012, J VEG SCI, V23, P822, DOI 10.1111/j.1654-1103.2012.01410.x; Song Y-C., 1995, VEGETATION SCI FORES, P69; Swenson NG, 2007, ECOLOGY, V88, P1770, DOI 10.1890/06-1499.1; TILMAN D, 1994, ECOLOGY, V75, P2, DOI 10.2307/1939377; Webb CO, 2008, BIOINFORMATICS, V24, P2098, DOI 10.1093/bioinformatics/btn358; Webb CO, 2006, ECOLOGY, V87, pS123, DOI 10.1890/0012-9658(2006)87[123:PSMSSA]2.0.CO;2; Webb CO, 2002, ANNU REV ECOL SYST, V33, P475, DOI 10.1146/annurev.ecolsys.33.010802.150448; Webb CO, 2000, AM NAT, V156, P145, DOI 10.1086/303378; Weiher E, 1998, OIKOS, V81, P309, DOI 10.2307/3547051; Weiher E, 2001, ECOLOGICAL ASSEMBLY; Whitfeld TJS, 2012, ECOGRAPHY, V35, P821, DOI 10.1111/j.1600-0587.2011.07181.x; Wu, 1980, VEGETATION CHINA; Yamamoto S.I., 2000, J FORESTRY RES, V5, P223, DOI DOI 10.1007/BF02767114; Yang J, 2014, FUNCT ECOL, V28, P520, DOI 10.1111/1365-2435.12176; Yu M, 2000, J ZHEJIANG U AGR LIF, V27, P375; Zheng C., 2005, KEYS SEED PLANTS ZHE; Zhu Yan, 2008, Zhiwu Shengtai Xuebao, V32, P262, DOI 10.3773/j.issn.1005-264x.2008.02.004; Zhu Y, 2015, J ECOL, V103, P957, DOI 10.1111/1365-2745.12414	64	10	13	13	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2015	10	6							e0131162	10.1371/journal.pone.0131162	http://dx.doi.org/10.1371/journal.pone.0131162			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL3FM	26098916	Green Submitted, Green Published, gold			2022-12-26	WOS:000356835800152
J	Wei, J; Zeng, C; Gong, QY; Li, XX; Lei, GH; Yang, TB				Wei, Jie; Zeng, Chao; Gong, Qian-yi; Li, Xiao-xiao; Lei, Guang-hua; Yang, Tu-bao			Associations between Dietary Antioxidant Intake and Metabolic Syndrome	PLOS ONE			English	Article							HEALTHY-YOUNG ADULTS; SELENIUM INTAKE; CARDIOVASCULAR-DISEASE; OXIDATIVE STRESS; SERUM; RISK; PREVALENCE; POPULATION; ADIPOSITY; CHINA	Background The objective of this study was to evaluate the association between dietary antioxidant intake (carotenoid, vitamin C, E and selenium) intake and metabolic syndrome (MS). Method This cross-sectional study included 2069 subjects undergoing a regular health checkup. Biochemical test results and data on dietary intakes were collected for analysis. Adjustment for energy intake and multi-variable logistic regression were performed to determine adjusted odds ratios (ORs) and corresponding 95% confidence intervals (95% CI) for the relationship between dietary antioxidants intake and MS. The lowest quartile of antioxidant intake was regarded as the reference category. Result Dietary vitamin C intake (P values for trend were 0.02 in energy adjusted analysis and 0.08 in multivariable adjusted analysis) had a negative association with MS, as did selenium intake in the second quartile (energy adjusted OR: 0.60, 95% CI: 0.43 to 0.85; multivariable adjusted OR: 0.60, 95% CI: 0.43 to 0.86). However, there was no significant relationship between dietary carotenoid and vitamin E intake and MS. Conclusion Subjects with low intake of vitamin C might be predisposed to development of MS, while dietary selenium intake had a moderate negative association with MS. Dietary carotenoid and vitamin E intake was not associated with MS.	[Wei, Jie; Gong, Qian-yi; Li, Xiao-xiao; Yang, Tu-bao] Cent S Univ, Dept Epidemiol & Hlth Stat, Sch Publ Hlth, Changsha 410008, Hunan, Peoples R China; [Zeng, Chao; Lei, Guang-hua] Cent S Univ, Xiangya Hosp, Dept Orthopaed, Changsha 410008, Hunan, Peoples R China	Central South University; Central South University	Yang, TB (corresponding author), Cent S Univ, Dept Epidemiol & Hlth Stat, Sch Publ Hlth, Changsha 410008, Hunan, Peoples R China.	1064960669@qq.com	Wei, Jie/ACR-8087-2022	Wei, Jie/0000-0003-3510-8241	Hunan Provincial Innovation Foundation for Postgraduate [CX2014B096]; Fundamental Research Funds for the Central Universities of Central South University [2014zzts070]	Hunan Provincial Innovation Foundation for Postgraduate; Fundamental Research Funds for the Central Universities of Central South University	This work was supported by Hunan Provincial Innovation Foundation for Postgraduate (CX2014B096), the Fundamental Research Funds for the Central Universities of Central South University (2014zzts070). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Zulet MA, 2009, NUTR RES, V29, P41, DOI 10.1016/j.nutres.2008.11.003; Atli T, 2004, ARCH GERONTOL GERIAT, V39, P269, DOI 10.1016/j.archger.2004.04.065; Beydoun MA, 2012, J NUTR, V142, P1693, DOI 10.3945/jn.112.160416; Bian SS, 2013, NUTR J, V12, DOI 10.1186/1475-2891-12-106; Brenneisen Peter, 2005, Molecular Aspects of Medicine, V26, P256, DOI 10.1016/j.mam.2005.07.004; Cai H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036936; Czernichow S, 2009, AM J CLIN NUTR, V90, P329, DOI 10.3945/ajcn.2009.27635; Damms-Machado A, 2012, NUTR J, V11, DOI 10.1186/1475-2891-11-34; Ford ES, 2003, DIABETES, V52, P2346, DOI 10.2337/diabetes.52.9.2346; Ford ES, 2005, DIABETES CARE, V28, P2745, DOI 10.2337/diacare.28.11.2745; Fulop T, 2006, PATHOL BIOL, V54, P375, DOI 10.1016/j.patbio.2006.07.002; Grundy SM, 2005, CIRCULATION, V112, P2735, DOI 10.1161/CIRCULATIONAHA.105.169404; Hu SS, 2012, BIOMED ENVIRON SCI, V25, P251, DOI 10.3967/0895-3988.2012.03.001; Lao XQ, 2006, J ENDOCRINOL INVEST, V29, P989, DOI 10.1007/BF03349212; Lavie CJ, 2011, J CARDIOPULM REHABIL, V31, P211, DOI 10.1097/HCR.0b013e318211e3d8; Li YR, 2013, ASIA PAC J CLIN NUTR, V22, P60, DOI 10.6133/apjcn.2013.22.1.06; Li ZY, 2006, ATHEROSCLEROSIS, V184, P188, DOI 10.1016/j.atherosclerosis.2005.03.033; Motamed Soudabe, 2013, N Am J Med Sci, V5, P377, DOI 10.4103/1947-2714.114171; Mutakin, 2013, J TRACE ELEM MED BIO, V27, P112, DOI 10.1016/j.jtemb.2012.09.006; Neve J, 2002, CURR OPIN CLIN NUTR, V5, P659, DOI 10.1097/00075197-200211000-00008; Odum EP, 2012, NIGER J CLIN PRACT, V15, P442, DOI 10.4103/1119-3077.104522; Palmieri VO, 2006, J NUTR, V136, P3022, DOI 10.1093/jn/136.12.3022; Park K, 2009, DIABETES CARE, V32, P1302, DOI 10.2337/dc09-0259; Pendyala G, 2013, N AM J MED SCI, V5, P51, DOI 10.4103/1947-2714.106208; Pizent A, 2010, J NUTR HEALTH AGING, V14, P866, DOI 10.1007/s12603-010-0139-1; Puchau B, 2009, EUR J CLIN NUTR, V63, P858, DOI 10.1038/ejcn.2008.48; Puchau B, 2010, NUTRITION, V26, P534, DOI 10.1016/j.nut.2009.06.017; Rajpathak S, 2005, J AM COLL NUTR, V24, P250, DOI 10.1080/07315724.2005.10719472; Sharma P, 2005, INDIAN J CLIN BIOCHE, V20, P145, DOI 10.1007/BF02893061; Stoffaneller R, 2015, NUTRIENTS, V7, P1494, DOI 10.3390/nu7031494; Stranges S, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-564; Sun C, 2013, NUTR FOOD HYGIENE; Willett WC, 1998, NUTR EPIDEMIOLOGY, P101, DOI DOI 10.1093/ACPROF:OSO/9780195122978.003.06; Yang YX., 2009, CHINA FOOD COMPOSITI; Zimmet P, 2005, J ATHEROSCLER THROMB, V12, P295, DOI 10.5551/jat.12.295; Zulet MA, 2008, J NUTR SCI VITAMINOL, V54, P347, DOI 10.3177/jnsv.54.347	36	47	47	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2015	10	6							e0130876	10.1371/journal.pone.0130876	http://dx.doi.org/10.1371/journal.pone.0130876			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL3FM	26098747	Green Submitted, Green Published, gold			2022-12-26	WOS:000356835800115
J	Woodcroft, MW; Nanan, K; Thompson, P; Tyryshkin, K; Smith, SP; Slany, RK; LeBrun, DP				Woodcroft, Mark W.; Nanan, Kyster; Thompson, Patrick; Tyryshkin, Kathrin; Smith, Steven P.; Slany, Robert K.; LeBrun, David P.			Retrovirus-Mediated Expression of E2A-PBX1 Blocks Lymphoid Fate but Permits Retention of Myeloid Potential in Early Hematopoietic Progenitors	PLOS ONE			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; B-LYMPHOCYTES; STEM-CELL; CHIMERIC ONCOPROTEIN; ACTIVATION DOMAINS; DNA-BINDING; KIX DOMAIN; DIFFERENTIATION; GENES; PROLIFERATION	The oncogenic transcription factor E2A-PBX1 is expressed consequent to chromosomal translocation 1;19 and is an important oncogenic driver in cases of pre-B-cell acute lymphoblastic leukemia (ALL). Elucidating the mechanism by which E2A-PBX1 induces lymphoid leukemia would be expedited by the availability of a tractable experimental model in which enforced expression of E2A-PBX1 in hematopoietic progenitors induces pre-B-cell ALL. However, hematopoietic reconstitution of irradiated mice with bone marrow infected with E2A-PBX1-expressing retroviruses consistently gives rise to myeloid, not lymphoid, leukemia. Here, we elucidate the hematopoietic consequences of forced E2A-PBX1 expression in primary murine hematopoietic progenitors. We show that introducing E2A-PBX1 into multipotent progenitors permits the retention of myeloid potential but imposes a dense barrier to lymphoid development prior to the common lymphoid progenitor stage, thus helping to explain the eventual development of myeloid, and not lymphoid, leukemia in transplanted mice. Our findings also indicate that E2A-PBX1 enforces the aberrant, persistent expression of some genes that would normally have been down-regulated in the subsequent course of hematopoietic maturation. We show that enforced expression of one such gene, Hoxa9, a proto-oncogene associated with myeloid leukemia, partially reproduces the phenotype produced by E2A-PBX1 itself. Existing evidence suggests that the 1;19 translocation event takes place in committed B-lymphoid progenitors. However, we find that retrovirus-enforced expression of E2A-PBX1 in committed pro-B-cells results in cell cycle arrest and apoptosis. Our findings indicate that the neoplastic phenotype induced by E2A-PBX1 is determined by the developmental stage of the cell into which the oncoprotein is introduced.	[Woodcroft, Mark W.; Nanan, Kyster; Thompson, Patrick; Tyryshkin, Kathrin; LeBrun, David P.] Queens Univ, Dept Pathol & Mol Med, Kingston, ON, Canada; [Smith, Steven P.] Queens Univ, Dept Biomed & Mol Sci, Kingston, ON, Canada; [Slany, Robert K.] Univ Erlangen Nurnberg, Dept Genet, Erlangen, Germany	McMaster University; Queens University - Canada; Queens University - Canada; University of Erlangen Nuremberg	LeBrun, DP (corresponding author), Queens Univ, Dept Pathol & Mol Med, Kingston, ON, Canada.	DPL1@queensu.ca		Smith, Steven/0000-0003-2710-4400	Canadian Institutes of Health Research [MOP-81333]; Cancer Research Society; Leukemia and Lymphoma Society Canada; Canadian Institutes of Health Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Cancer Research Society; Leukemia and Lymphoma Society Canada; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This research was funded by operating grants to DPL from the Canadian Institutes of Health Research (MOP-81333), The Cancer Research Society and the Leukemia and Lymphoma Society Canada. MWW is the recipient of a Canada Graduate Scholarship from the Canadian Institutes of Health Research.	Bach C, 2010, BLOOD, V115, P2910, DOI 10.1182/blood-2009-04-216606; Bayly R, 2004, J BIOL CHEM, V279, P55362, DOI 10.1074/jbc.M408654200; Bayly R, 2006, MOL CELL BIOL, V26, P6442, DOI 10.1128/MCB.02025-05; Bhalla S, 2008, J IMMUNOL, V180, P1694, DOI 10.4049/jimmunol.180.3.1694; Bhandoola A, 2007, IMMUNITY, V26, P678, DOI 10.1016/j.immuni.2007.05.009; Bijl J, 2005, GENE DEV, V19, P224, DOI 10.1101/gad.1268505; Calvo KR, 2001, P NATL ACAD SCI USA, V98, P13120, DOI 10.1073/pnas.231115398; Calvo KR, 2000, MOL CELL BIOL, V20, P3274, DOI 10.1128/MCB.20.9.3274-3285.2000; CARROLL AJ, 1984, BLOOD, V63, P721; Chang CP, 1997, MOL CELL BIOL, V17, P5679, DOI 10.1128/MCB.17.10.5679; Cho SK, 1999, P NATL ACAD SCI USA, V96, P9797, DOI 10.1073/pnas.96.17.9797; de Pooter RF, 2010, IMMUNOL REV, V238, P93, DOI 10.1111/j.1600-065X.2010.00957.x; DEDERA DA, 1993, CELL, V74, P833, DOI 10.1016/0092-8674(93)90463-Z; Denis CM, 2014, NUCLEIC ACIDS RES, V42, P7370, DOI 10.1093/nar/gku206; Dias S, 2008, IMMUNITY, V29, P217, DOI 10.1016/j.immuni.2008.05.015; Dudoit S, 2002, STAT SINICA, V12, P111; Ficara F, 2013, J CELL SCI, V126, P3181, DOI 10.1242/jcs.125435; Gil J, 2006, NAT REV MOL CELL BIO, V7, P667, DOI 10.1038/nrm1987; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; HOAGLIN DC, 1987, J AM STAT ASSOC, V82, P1147, DOI 10.1080/01621459.1987.10478551; Hu YF, 2009, J IMMUNOL METHODS, V347, P70, DOI 10.1016/j.jim.2009.06.008; Jiao XL, 2012, BIOINFORMATICS, V28, P1805, DOI 10.1093/bioinformatics/bts251; Kamps MP, 1996, ONCOGENE, V12, P19; KAMPS MP, 1993, MOL CELL BIOL, V13, P351, DOI 10.1128/MCB.13.1.351; Kawagoe H, 1999, LEUKEMIA, V13, P687, DOI 10.1038/sj.leu.2401410; Knoepfler PS, 1997, P NATL ACAD SCI USA, V94, P14553, DOI 10.1073/pnas.94.26.14553; Kroon E, 1998, EMBO J, V17, P3714, DOI 10.1093/emboj/17.13.3714; Lawrence HJ, 1999, LEUKEMIA, V13, P1993, DOI 10.1038/sj.leu.2401578; Lopez-Romero P, 2012, BIOCONDUCTOR; Magnani L, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002368; MONICA K, 1994, MOL CELL BIOL, V14, P8304, DOI 10.1128/MCB.14.12.8304; Nakamura T, 1996, NAT GENET, V12, P149, DOI 10.1038/ng0296-149; Nelson JD, 2006, NAT PROTOC, V1, P179, DOI 10.1038/nprot.2006.27; Oguro H, 2010, CELL STEM CELL, V6, P279, DOI 10.1016/j.stem.2010.01.005; Pineault N, 2002, EXP HEMATOL, V30, P49, DOI 10.1016/S0301-472X(01)00757-3; PUI CH, 1994, J CLIN ONCOL, V12, P2601, DOI 10.1200/JCO.1994.12.12.2601; Rolink Antonius G, 2004, Methods Mol Biol, V271, P271; Rutherford MN, 2001, LEUKEMIA, V15, P362, DOI 10.1038/sj.leu.2402059; Saeed S, 2012, BLOOD, V120, P3058, DOI 10.1182/blood-2011-10-386086; Smith KS, 1997, ONCOGENE, V14, P2917, DOI 10.1038/sj.onc.1201249; Smith KS, 2003, MOL CELL, V12, P393, DOI 10.1016/S1097-2765(03)00277-6; Sulong S, 2009, BLOOD, V113, P100, DOI 10.1182/blood-2008-07-166801; Sykes DB, 2004, MOL CELL BIOL, V24, P1256, DOI 10.1128/MCB.24.3.1256-1269.2004; Sykes DB, 2001, BLOOD, V98, P2308, DOI 10.1182/blood.V98.8.2308; Thorsteinsdottir U, 2002, BLOOD, V99, P121, DOI 10.1182/blood.V99.1.121; Tukey J., 1977, BIOMETR J, V23, P413; Vieira Paulo, 2004, Methods Mol Biol, V271, P67; Wang GG, 2005, BLOOD, V106, P254, DOI 10.1182/blood-2004-12-4664; Weir EG, 2001, SEMIN HEMATOL, V38, P124, DOI 10.1053/shem.2001.21924; Wiemels JL, 2002, P NATL ACAD SCI USA, V99, P15101, DOI 10.1073/pnas.222481199; Williams RT, 2008, COLD SH Q B, V73, P461, DOI 10.1101/sqb.2008.73.039; Zhu J, 2013, CELL, V152, P642, DOI 10.1016/j.cell.2012.12.033	53	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2015	10	6							e0130495	10.1371/journal.pone.0130495	http://dx.doi.org/10.1371/journal.pone.0130495			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL3FM	26098938	Green Published, Green Submitted, gold			2022-12-26	WOS:000356835800075
J	Zhang, ZY; Hatano, H; Shaw, J; Nordkamp, MO; Jiang, GS; Li, DM; Kollnberger, S				Zhang, Zhiyong; Hatano, Hiroko; Shaw, Jacqueline; Nordkamp, Marloes Olde; Jiang, Guosheng; Li, Demin; Kollnberger, Simon			The Leukocyte Immunoglobulin-Like Receptor Family Member LILRB5 Binds to HLA-Class I Heavy Chains	PLOS ONE			English	Article							MHC CLASS-I; CELL-SURFACE EXPRESSION; FREE H CHAINS; HLA-B27 HOMODIMERS; CUTTING EDGE; ANKYLOSING-SPONDYLITIS; INHIBITORY RECEPTORS; CRYSTAL-STRUCTURE; RECOGNITION; ACTIVATION	Objective The leukocyte immunoglobulin-like receptor (LILR) family includes inhibitory and stimulatory members which bind to classical and non-classical HLA-class I. The ligands for many LILR including LILRB5 have not yet been identified. Methods We generated C-terminal eGFP and N-terminal FLAG-tagged fusion constructs for monitoring LILR expression. We screened for LILR binding to HLA-class I by tetramer staining of 293T cells transfected with LILRA1, A4, A5 A6 and LILRB2 and LILRB5. We also studied HLA class I tetramer binding to LILRB5 on peripheral monocyte cells. LILRB5 binding to HLA-class I heavy chains was confirmed by co-immunoprecipitation. Results HLA-B27 (B27) free heavy chain (FHC) dimer but not other HLA-class I stained LILRB5-transfected 293T cells. B27 dimer binding to LILRB5 was blocked with the class I heavy chain antibody HC10 and anti-LILRB5 antisera. B27 dimers also bound to LILRB5 on peripheral monocytes. HLA-B7 and B27 heavy chains co-immunoprecipitated with LILRB5 in transduced B and rat basophil RBL cell lines. Conclusions Our findings show that class I free heavy chains are ligands for LILRB5. The unique binding specificity of LILRB5 for HLA-class I heavy chains probably results from differences in the D1 and D2 immunoglobulin-like binding domains which are distinct from other LILR which bind to beta 2m-associated HLA-class I.	[Zhang, Zhiyong; Hatano, Hiroko; Shaw, Jacqueline; Kollnberger, Simon] Univ Oxford, Botnar Res Ctr, Nuffield Dept Orthopaed Rheumatol & Musculoskelet, Oxford, England; [Nordkamp, Marloes Olde; Li, Demin] Univ Oxford, John Radcliffe Hosp, RDM Clin Lab Sci, Oxford OX3 9DU, England; [Jiang, Guosheng] Shandong Acad Med Sci, Inst Basic Med, Dept Hematooncol, Jinan, Shandong, Peoples R China	University of Oxford; University of Oxford; Shandong First Medical University & Shandong Academy of Medical Sciences; University of Jinan	Kollnberger, S (corresponding author), Univ Oxford, Botnar Res Ctr, Nuffield Dept Orthopaed Rheumatol & Musculoskelet, Oxford, England.	simon.kollnberger@ndorms.ox.ac.uk	Li, Demin/O-4065-2019	Li, Demin/0000-0002-7118-3401	Natural Science Foundation of Shandong Province [ZR2010HQ034]; Natural Science Foundation of China [81101605]; Shandong Research Award Fund for Outstanding Young Scientist [BS2009YY008]; Japan Society for the Promotion of Science; Arthritis Research UK; Arthritis Research UK (AR UK); National Institute of Health Research (NIHR); Cancer Research UK	Natural Science Foundation of Shandong Province(Natural Science Foundation of Shandong Province); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shandong Research Award Fund for Outstanding Young Scientist; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Arthritis Research UK(Versus Arthritis); Arthritis Research UK (AR UK)(Versus Arthritis); National Institute of Health Research (NIHR)(National Institute for Health Research (NIHR)); Cancer Research UK(Cancer Research UK)	This work was supported by the following: Natural Science Foundation of Shandong Province (Grant No. ZR2010HQ034), Natural Science Foundation of China (Grant No. 81101605) and Shandong Research Award Fund for Outstanding Young Scientist (Grant No. BS2009YY008) (to ZZ); Japan Society for the Promotion of Science (to HH); Arthritis Research UK (to JS); Arthritis Research UK (AR UK) and the National Institute of Health Research (NIHR) (to SK); and Cancer Research UK (to DL).	Allen RL, 2001, J IMMUNOL, V167, P5543, DOI 10.4049/jimmunol.167.10.5543; Allen RL, 1999, J IMMUNOL, V162, P5045; Bird LA, 2003, EUR J IMMUNOL, V33, P748, DOI 10.1002/eji.200323678; Borges L, 1997, J IMMUNOL, V159, P5192; Brown D, 2004, TISSUE ANTIGENS, V64, P215, DOI 10.1111/j.0001-2815.2004.00290.x; Brown MA, 1996, ANN RHEUM DIS, V55, P268, DOI 10.1136/ard.55.4.268; BURLINGHAM WJ, 1989, P NATL ACAD SCI USA, V86, P8005, DOI 10.1073/pnas.86.20.8005; Cauli A, 2013, RHEUMATOLOGY, V52, P1952, DOI 10.1093/rheumatology/ket219; Chen Y, 2009, J MOL BIOL, V386, P841, DOI 10.1016/j.jmb.2009.01.006; Cheng H, 2011, J BIOL CHEM, V286, P18013, DOI 10.1074/jbc.M111.221028; Cheng H, 2011, J BIOL CHEM, V286, P43622, DOI 10.1074/jbc.M111.291583; Colonna M, 1998, J IMMUNOL, V160, P3096; Deng M, 2014, BLOOD, V124, P924, DOI 10.1182/blood-2014-01-549162; Fanger NA, 1998, EUR J IMMUNOL, V28, P3423, DOI 10.1002/(SICI)1521-4141(199811)28:11<3423::AID-IMMU3423>3.0.CO;2-2; Giles J, 2012, J IMMUNOL, V188, P6184, DOI 10.4049/jimmunol.1102711; Jones DC, 2011, J IMMUNOL, V186, P2990, DOI 10.4049/jimmunol.1003078; Jones D, 2009, AGENDA, V44, P39; Kollnberger S, 2002, ARTHRITIS RHEUM, V46, P2972, DOI 10.1002/art.10605; Kollnberger S, 2007, EUR J IMMUNOL, V37, P1313, DOI 10.1002/eji.200635997; Kollnberger S, 2009, ADV EXP MED BIOL, V649, P277; Masuda A, 2007, J EXP MED, V204, P907, DOI 10.1084/jem.20060631; Payeli SK, 2012, ARTHRITIS RHEUM-US, V64, P3139, DOI 10.1002/art.34538; Ryu M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019245; Shiroishi M, 2006, P NATL ACAD SCI USA, V103, P16412, DOI 10.1073/pnas.0605228103; Tedla N, 2008, J LEUKOCYTE BIOL, V83, P334, DOI 10.1189/jlb.0507314; Willcox BE, 2003, NAT IMMUNOL, V4, P913, DOI 10.1038/ni961; Wong-Baeza I, 2013, J IMMUNOL, V190, P3216, DOI 10.4049/jimmunol.1202926; Zheng JK, 2012, NATURE, V485, P656, DOI 10.1038/nature11095	28	22	22	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2015	10	6							e0129063	10.1371/journal.pone.0129063	http://dx.doi.org/10.1371/journal.pone.0129063			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL3FM	26098415	Green Published, Green Submitted, gold			2022-12-26	WOS:000356835800023
J	Aouali, N; Broukou, A; Bosseler, M; Keunen, O; Schlesser, V; Janji, B; Palissot, V; Stordeur, P; Berchem, G				Aouali, Nassera; Broukou, Angeliki; Bosseler, Manon; Keunen, Olivier; Schlesser, Vincent; Janji, Bassam; Palissot, Valerie; Stordeur, Philippe; Berchem, Guy			Epigenetic Activity of Peroxisome Proliferator-Activated Receptor Gamma Agonists Increases the Anticancer Effect of Histone Deacetylase Inhibitors on Multiple Myeloma Cells	PLOS ONE			English	Article							PPAR-GAMMA; TRANSCRIPTIONAL ACTIVITY; VALPROIC ACID; HDAC INHIBITORS; DIFFERENTIATION; CARCINOGENESIS; THERAPY; LIGAND; GROWTH	Epigenetic modifications play a major role in the development of multiple myeloma. We have previously reported that the PPAR. agonist pioglitazone (PIO) enhances, in-vitro, the cytotoxic effect of the Histone deacetylase inhibitor (HDACi), valproic acid (VPA), on multiple myeloma cells. Here, we described the development of a new multiple myeloma mouse model using MOLP8 cells, in order to evaluate the effect of VPA/PIO combination on the progression of myeloma cells, by analyzing the proliferation of bone marrow plasma cells. We showed that VPA/PIO delays the progression of the disease and the invasion of myeloma cells in the bone marrow. Mechanistically, we demonstrated that VPA/PIO increases the cleavage of caspase 3 and PARP, and induces the acetylation of Histone 3 (H3). Furthermore, we provided evidence that PPAR. agonist is able to enhance the action of other HDACi such as Vorinostat or Mocetinostat. Using PPAR. antagonist or siPPAR gamma, we strongly suggest that, as described during adipogenesis, PIO behaves as an epigenetic regulator by improving the activity of HDACi. This study highlights the therapeutic benefit of PIO/VPA combination, compared to VPA treatment as a single-arm therapy on multiple myeloma and further highlights that such combination may constitute a new promising treatment strategy which should be supported by clinical trials.	[Aouali, Nassera; Broukou, Angeliki; Bosseler, Manon; Janji, Bassam; Palissot, Valerie; Berchem, Guy] LIH, LHCE, Lab Expt Hematooncol, Luxembourg, Luxembourg; [Keunen, Olivier] LIH, Norlux, Lab Neurooncol, Luxembourg, Luxembourg; [Schlesser, Vincent; Berchem, Guy] CHL, Hematol Lab, Luxembourg, Luxembourg; [Stordeur, Philippe] CER Grp, Expt Infect Dis Platform, Dept Biotechnol, Marloie, Belgium	Luxembourg Institute of Health; Luxembourg Institute of Health; Luxembourg Hospital Center	Aouali, N (corresponding author), LIH, LHCE, Lab Expt Hematooncol, Luxembourg, Luxembourg.	Nassera.Aouali@lih.lu	Keunen, Olivier/AAD-1483-2022; Berchem, Guy/C-9364-2014	Keunen, Olivier/0000-0003-2203-7026; Berchem, Guy/0000-0003-0157-2257; JANJI, Bassam/0000-0002-9763-0943	Ministere de l'Enseignement Superieur et de la Recherche [20071005]; Televie [FC53996/7.4537.07F]	Ministere de l'Enseignement Superieur et de la Recherche(Estonian Research Council); Televie	This study was supported by Ministere de l'Enseignement Superieur et de la Recherche www.mesr.public.lu/ (Grant#20071005) and Televie funding http://www.fnrs.be/ (Grant#FC53996/7.4537.07F). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson KC, 2003, MAYO CLIN PROC, V78, P15, DOI 10.4065/78.1.15; Aouali N, 2009, BRIT J HAEMATOL, V147, P662, DOI 10.1111/j.1365-2141.2009.07902.x; Bataille R, 2006, HAEMATOLOGICA, V91, P1234; Biermann J, 2011, MOL VIS, V17, P395; Bolden JE, 2006, NAT REV DRUG DISCOV, V5, P769, DOI 10.1038/nrd2133; Chen XF, 2011, MOL CANCER RES, V9, P448, DOI 10.1158/1541-7786.MCR-10-0471; Chesi M, 2012, BLOOD, V120, P376, DOI 10.1182/blood-2012-02-412783; Cheung P, 2000, CELL, V103, P263, DOI 10.1016/S0092-8674(00)00118-5; Cinatl J, 1997, ANTI-CANCER DRUG, V8, P958, DOI 10.1097/00001813-199711000-00007; Davids MS, 2010, AM J HEMATOL, V85, P787, DOI 10.1002/ajh.21815; deMedeiros SRB, 1997, J BIOL CHEM, V272, P18250, DOI 10.1074/jbc.272.29.18250; Deweerdt S, 2011, NATURE, V480, pS38, DOI 10.1038/480S38a; Eeckhoute J, 2012, PPAR RES, V2012, DOI 10.1155/2012/164140; Eshaghian S, 2012, CURR OPIN SUPPORT PA, V6, P330, DOI 10.1097/SPC.0b013e3283565c56; FORMAN BM, 1995, CELL, V83, P803, DOI 10.1016/0092-8674(95)90193-0; Fuchida S, 2012, INT J HEMATOL, V96, P664, DOI 10.1007/s12185-012-1164-0; Gentile M, 2012, EXPERT OPIN EMERG DR, V17, P407, DOI 10.1517/14728214.2012.713345; Gottlicher M, 2001, EMBO J, V20, P6969, DOI 10.1093/emboj/20.24.6969; Guan HP, 2005, GENE DEV, V19, P453, DOI 10.1101/gad.1263305; Hideshima T, 2013, INT J HEMATOL, V97, P324, DOI 10.1007/s12185-013-1290-3; HORLEIN AJ, 1995, NATURE, V377, P397, DOI 10.1038/377397a0; Huang JW, 2005, MOL PHARMACOL, V67, P1342, DOI 10.1124/mol.104.007732; Kurokawa R, 1998, SCIENCE, V279, P700, DOI 10.1126/science.279.5351.700; Kyle RA, 2009, LEUKEMIA, V23, P3, DOI 10.1038/leu.2008.291; Landgren O, 2012, BLOOD, V120, P1754, DOI 10.1182/blood-2012-06-434571; Lonial S, 2012, J CLIN ONCOL, V30, P2434, DOI 10.1200/JCO.2011.40.6967; Neri P, 2008, BRIT J HAEMATOL, V143, P520, DOI 10.1111/j.1365-2141.2008.07387.x; Neri P, 2012, EXPERT OPIN INV DRUG, V21, P733, DOI 10.1517/13543784.2012.668883; Ondrey F, 2009, CLIN CANCER RES, V15, P2, DOI 10.1158/1078-0432.CCR-08-0326; Palumbo A, 2011, NEW ENGL J MED, V364, P1046, DOI 10.1056/NEJMra1011442; Peters JM, 2012, NAT REV CANCER, V12, P181, DOI 10.1038/nrc3214; Robbins GT, 2012, FRONT BIOSCI-LANDMRK, V17, P1816, DOI 10.2741/4021; Rosen ED, 2001, J BIOL CHEM, V276, P37731, DOI 10.1074/jbc.R100034200; Sharabi A, 2010, CANCER PREV RES, V3, P1265, DOI 10.1158/1940-6207.CAPR-10-0138; Sikka S, 2012, PPAR RES, V2012, DOI 10.1155/2012/968040; Sugii S, 2011, FEBS LETT, V585, P2121, DOI 10.1016/j.febslet.2011.05.007; Thiagalingam S, 2003, ANN NY ACAD SCI, V983, P84, DOI 10.1111/j.1749-6632.2003.tb05964.x; Tontonoz P, 1997, P NATL ACAD SCI USA, V94, P237, DOI 10.1073/pnas.94.1.237; Tsukahara T, 2012, PPAR RES, V2012, DOI 10.1155/2012/362361; Ullman-Cullere MH, 1999, LAB ANIM SCI, V49, P319; Wagner JM, 2010, CLIN EPIGENETICS, V1, DOI 10.1007/s13148-010-0012-4; Yin F, 2001, BIOCHEM BIOPH RES CO, V286, P916, DOI 10.1006/bbrc.2001.5491; Youssef J, 2011, BRIT J PHARMACOL, V164, P68, DOI 10.1111/j.1476-5381.2011.01383.x; Yu C, 2005, J BIOL CHEM, V280, P13600, DOI 10.1074/jbc.M409468200	44	10	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2015	10	6							e0130339	10.1371/journal.pone.0130339	http://dx.doi.org/10.1371/journal.pone.0130339			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL3FE	26091518	gold, Green Published, Green Submitted			2022-12-26	WOS:000356835000104
J	Gandasi, NR; Vesto, K; Helou, M; Yin, P; Saras, J; Barg, S				Gandasi, Nikhil R.; Vesto, Kim; Helou, Maria; Yin, Peng; Saras, Jan; Barg, Sebastian			Survey of Red Fluorescence Proteins as Markers for Secretory Granule Exocytosis	PLOS ONE			English	Article							SYNAPTIC-TRANSMISSION; VESICLE MEMBRANE; INSULIN GRANULES; PLASMA-MEMBRANE; FUSION PORE; GREEN; GRANUPHILIN; ENDOCYTOSIS; PH; SYNTAXIN	Fluorescent proteins (FPs) have proven to be valuable tools for high-resolution imaging studies of vesicle transport processes, including exo- and endocytosis. Since the pH of the vesicle lumen changes between acidic and neutral during these events, pH-sensitive FPs with near neutral pKa, such as pHluorin, are particularly useful. FPs with pKa>6 are readily available in the green spectrum, while red-emitting pH-sensitive FPs are rare and often not well characterized as reporters of exo- or endocytosis. Here we tested a panel of ten orange/red and two green FPs in fusions with neuropeptide Y (NPY) for use as secreted vesicle marker and reporter of dense core granule exocytosis and release. We report relative brightness, bleaching rate, targeting accuracy, sensitivity to vesicle pH, and their performance in detecting exocytosis in live cells. Tandem dimer (td)-mOrange2 was identified as well-targeted, bright, slowly bleaching and pH-sensitive FP that performed similar to EGFP. Single exocytosis events were readily observed, which allowed measurements of fusion pore lifetime and the dynamics of the exocytosis protein syntaxin at the release site during membrane fusion and cargo release.	[Gandasi, Nikhil R.; Vesto, Kim; Helou, Maria; Yin, Peng; Saras, Jan; Barg, Sebastian] Uppsala Univ, Inst Med Cell Biol, S-75123 Uppsala, Sweden	Uppsala University	Barg, S (corresponding author), Uppsala Univ, Inst Med Cell Biol, Box 571,Husargatan 3, S-75123 Uppsala, Sweden.	sebastian.barg@mcb.uu.se	Barg, Sebastian/F-9523-2010; Gandasi, Nikhil R/F-2164-2018	Barg, Sebastian/0000-0003-4661-5724; Gandasi, Nikhil R/0000-0001-9400-6494	Swedish Research Council; Swedish Diabetes Society; European Foundation for the Study of Diabetes; Diabetes Wellness Network Sweden; Barndiabetesfonden; NovoNordisk-foundation; Family Ernfors-foundation; OE&E Johanssons-foundation; Novo Nordisk Fonden [NNF14OC0010001, NNF15OC0016260] Funding Source: researchfish; European Foundation for the Study of Diabetes [BI 2014_5] Funding Source: researchfish	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Diabetes Society; European Foundation for the Study of Diabetes; Diabetes Wellness Network Sweden; Barndiabetesfonden; NovoNordisk-foundation(Novo Nordisk Foundation); Family Ernfors-foundation; OE&E Johanssons-foundation; Novo Nordisk Fonden(Novo Nordisk Foundation); European Foundation for the Study of Diabetes	The work was supported by the Swedish Research Council, Swedish Diabetes Society, European Foundation for the Study of Diabetes, Diabetes Wellness Network Sweden, Barndiabetesfonden, and the NovoNordisk-, Family Ernfors-, and OE&E Johanssons-foundations.	Anantharam A, 2010, J CELL BIOL, V188, P415, DOI 10.1083/jcb.200908010; Bai L, 2006, TRAFFIC, V7, P416, DOI 10.1111/j.1600-0854.2006.00394.x; Barg S, 2010, P NATL ACAD SCI USA, V107, P20804, DOI 10.1073/pnas.1014823107; Barg S, 2002, NEURON, V33, P287, DOI 10.1016/S0896-6273(02)00563-9; CHALFIE M, 1994, SCIENCE, V263, P802, DOI 10.1126/science.8303295; Coppola T, 2002, MOL BIOL CELL, V13, P1906, DOI 10.1091/mbc.02-02-0025; Davidson MW, 2009, NAT METHODS, V6, P713, DOI 10.1038/nmeth1009-713; Felmy F, 2009, PFLUG ARCH EUR J PHY, V458, P403, DOI 10.1007/s00424-008-0623-1; Galvez-Santisteban M, 2012, NAT CELL BIOL, V14, P838, DOI 10.1038/ncb2541; Gandasi NR, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4914; Gandhi SP, 2003, NATURE, V423, P607, DOI 10.1038/nature01677; Goedhart J, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1738; Gomi H, 2005, J CELL BIOL, V171, P99, DOI 10.1083/jcb.200505179; Gordon SL, 2011, J NEUROSCI, V31, P14032, DOI 10.1523/JNEUROSCI.3162-11.2011; Granseth B, 2006, NEURON, V51, P773, DOI 10.1016/j.neuron.2006.08.029; Handley MTW, 2008, BIOCHEM BIOPH RES CO, V373, P275, DOI 10.1016/j.bbrc.2008.06.043; Hartman KN, 2006, NAT NEUROSCI, V9, P642, DOI 10.1038/nn1677; Hohmeier HE, 2000, DIABETES, V49, P424, DOI 10.2337/diabetes.49.3.424; Hoppa MB, 2012, NATURE, V486, P122, DOI 10.1038/nature11033; Hua YF, 2011, NAT NEUROSCI, V14, P833, DOI 10.1038/nn.2838; Jahn R, 2003, CELL, V112, P519, DOI 10.1016/S0092-8674(03)00112-0; Johnson DE, 2009, J BIOL CHEM, V284, P20499, DOI 10.1074/jbc.M109.019042; Jordens I, 2006, PIGM CELL RES, V19, P412, DOI 10.1111/j.1600-0749.2006.00329.x; Jullie D, 2014, J NEUROSCI, V34, P11106, DOI 10.1523/JNEUROSCI.0799-14.2014; Kremers GJ, 2011, J CELL SCI, V124, P157, DOI 10.1242/jcs.072744; Lam AJ, 2012, NAT METHODS, V9, P1005, DOI [10.1038/NMETH.2171, 10.1038/nmeth.2171]; Lampe M, 2014, MOL BIOL CELL, V25, P3070, DOI 10.1091/mbc.E14-06-1112; Lang T, 1997, NEURON, V18, P857, DOI 10.1016/S0896-6273(00)80325-6; Lang T, 2007, J PHYSIOL-LONDON, V585, P693, DOI 10.1113/jphysiol.2007.134346; Li HY, 2011, FRONT MOL NEUROSCI, V4, DOI 10.3389/fnmol.2011.00034; Li YL, 2012, NAT NEUROSCI, V15, P1047, DOI 10.1038/nn.3126; Merrifield CJ, 2005, CELL, V121, P593, DOI 10.1016/j.cell.2005.03.015; Michael DJ, 2004, BIOPHYS J, V87, pL3, DOI 10.1529/biophysj.104.052175; Miesenbock G, 1998, NATURE, V394, P192, DOI 10.1038/28190; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Obermuller S, 2005, J CELL SCI, V118, P4271, DOI 10.1242/jcs.02549; Ohara-Imaizumi M, 2002, BIOCHEM J, V363, P73, DOI 10.1042/0264-6021:3630073; Ohara-Imaizumi M, 2007, J CELL BIOL, V177, P695, DOI 10.1083/jcb.200608132; Perrais D, 2005, DEV CELL, V9, P581, DOI 10.1016/j.devcel.2005.10.002; Perrais D, 2004, J PHYSIOL-LONDON, V560, P413, DOI 10.1113/jphysiol.2004.064410; PRASHER DC, 1992, GENE, V111, P229, DOI 10.1016/0378-1119(92)90691-H; Sankaranarayanan S, 2001, NAT NEUROSCI, V4, P129, DOI 10.1038/83949; Sankaranarayanan S, 2000, NAT CELL BIOL, V2, P197, DOI 10.1038/35008615; Santos MS, 2013, J NEUROSCI, V33, P10634, DOI 10.1523/JNEUROSCI.0329-13.2013; SCHWEIZER FE, 1995, NEURON, V14, P689, DOI 10.1016/0896-6273(95)90213-9; Shaner NC, 2008, NAT METHODS, V5, P545, DOI 10.1038/nmeth.1209; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Shen Y, 2014, J CELL BIOL, V207, P419, DOI 10.1083/jcb.201404107; Sieber JJ, 2007, SCIENCE, V317, P1072, DOI 10.1126/science.1141727; Snaith HA, 2010, METHOD CELL BIOL, V97, P147, DOI 10.1016/S0091-679X(10)97009-X; Sochacki KA, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2158; Spiliotis M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035407; Steyer JA, 1997, NATURE, V388, P474, DOI 10.1038/41329; Subach FV, 2010, J AM CHEM SOC, V132, P6481, DOI 10.1021/ja100906g; Tantama M, 2011, J AM CHEM SOC, V133, P10034, DOI 10.1021/ja202902d; Taraska JW, 2003, P NATL ACAD SCI USA, V100, P2070, DOI 10.1073/pnas.0337526100; Taylor MJ, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000604; Torii S, 2004, J BIOL CHEM, V279, P22532, DOI 10.1074/jbc.M400600200; Torii S, 2002, MOL CELL BIOL, V22, P5518, DOI 10.1128/MCB.22.15.5518-5526.2002; Tsuboi T, 2000, CURR BIOL, V10, P1307, DOI 10.1016/S0960-9822(00)00756-9; Tsuboi T, 2003, CURR BIOL, V13, P563, DOI 10.1016/S0960-9822(03)00176-3; Vanlandingham PA, 2009, J BIOL CHEM, V284, P12110, DOI 10.1074/jbc.M809277200; Vonderheit A, 2005, PLOS BIOL, V3, P1225, DOI 10.1371/journal.pbio.0030233; Wilhelm BG, 2010, NAT NEUROSCI, V13, P1454, DOI 10.1038/nn.2690; Xu J, 2014, J GEN PHYSIOL, V144, P79, DOI 10.1085/jgp.201411169; Xu YK, 2011, J CELL BIOL, V193, P643, DOI 10.1083/jcb.201008135; Yang TT, 1996, NUCLEIC ACIDS RES, V24, P4592, DOI 10.1093/nar/24.22.4592	67	26	26	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2015	10	6							e0127801	10.1371/journal.pone.0127801	http://dx.doi.org/10.1371/journal.pone.0127801			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL3FE	26091288	Green Submitted, Green Published, gold			2022-12-26	WOS:000356835000012
J	Huang, ZK; Luo, Q; Guo, Y; Chen, J; Xiong, GL; Peng, YP; Ye, JQ; Li, JM				Huang, Zikun; Luo, Qing; Guo, Yang; Chen, Jie; Xiong, Guoliang; Peng, Yiping; Ye, Jianqing; Li, Junming			Mycobacterium tuberculosis-Induced Polarization of Human Macrophage Orchestrates the Formation and Development of Tuberculous Granulomas In Vitro	PLOS ONE			English	Article							ACTIVATION; INFECTION; MODEL; MONOCYTES; CELLS	The tuberculous granuloma is an elaborately organized structure and one of the main histological hallmarks of tuberculosis. Macrophages, which are important immunologic effector and antigen-presenting cells, are the main cell type found in the tuberculous granuloma and have high plasticity. Macrophage polarization during bacterial infection has been elucidated in numerous recent studies; however, macrophage polarization during tuberculous granuloma formation and development has rarely been reported. It remains to be clarified whether differences in the activation status of macrophages affect granuloma formation. In this study, the variation in macrophage polarization during the formation and development of tuberculous granulomas was investigated in both sections of lung tissues from tuberculosis patients and an in vitro tuberculous granuloma model. The roles of macrophage polarization in this process were also investigated. Mycobacterium tuberculosis (M. tuberculosis) infection was found to induce monocyte-derived macrophage polarization. In the in vitro tuberculous granuloma model, macrophage transformation from M1 to M2 was observed over time following M. tuberculosis infection. M2 macrophages were found to predominate in both necrotic and non-necrotic granulomas from tuberculosis patients, while both M1 and M2 polarized macrophages were found in the non-granulomatous lung tissues. Furthermore, it was found that M1 macrophages promote granuloma formation and macrophage bactericidal activity in vitro, while M2 macrophages inhibit these effects. The findings of this study provide insights into the mechanism by which M. tuberculosis circumvents the host immune system as well as a theoretical foundation for the development of novel tuberculosis therapies based on reprogramming macrophage polarization.	[Huang, Zikun; Luo, Qing; Guo, Yang; Chen, Jie; Ye, Jianqing; Li, Junming] Nanchang Univ, Affiliated Hosp 1, Dept Clin Lab, Nanchang, Jiangxi, Peoples R China; [Xiong, Guoliang] Jiangxi Chest Hosp, Dept Clin Lab, Nanchang, Jiangxi, Peoples R China; [Peng, Yiping] Jiangxi Chest Hosp, Dept TB, Nanchang, Jiangxi, Peoples R China	Nanchang University	Li, JM (corresponding author), Nanchang Univ, Affiliated Hosp 1, Dept Clin Lab, Nanchang, Jiangxi, Peoples R China.	lisir361@163.com		Luo, Qing/0000-0001-7559-5174; Li, Junming/0000-0003-1409-3634	National Natural Science Foundation of China [81170006]; Natural Science Foundation of Jiangxi, China [20114BAB205002]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangxi, China(Natural Science Foundation of Jiangxi Province)	This work was supported by grants from the National Natural Science Foundation of China (No. 81170006 to L.J.-M.) and by the Natural Science Foundation of Jiangxi, China (No. 20114BAB205002 to L.J.-M.). The URL of the NSFC is http://www.nsfc.gov.cn. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bility MT, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004032; Birkness KA, 2007, IMMUNOL CELL BIOL, V85, P160, DOI 10.1038/sj.icb.7100019; Biswas SK, 2012, IMMUNOL RES, V53, P11, DOI 10.1007/s12026-012-8291-9; Cyktor JC, 2013, J IMMUNOL, V190, P2778, DOI 10.4049/jimmunol.1202722; Davis MJ, 2013, MBIO, V4, DOI 10.1128/mBio.00264-13; Egen JG, 2008, IMMUNITY, V28, P271, DOI 10.1016/j.immuni.2007.12.010; Eurosurveillance editorial team, 2013, EURO SURVEILL, V18, P20615; Geissmann F, 2010, SCIENCE, V327, P656, DOI 10.1126/science.1178331; Sans-Fons MG, 2013, J INFECT DIS, V207, P1684, DOI 10.1093/infdis/jit084; Gordon S, 2010, IMMUNITY, V32, P593, DOI 10.1016/j.immuni.2010.05.007; Kapoor N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053657; Labonte AC, 2014, MOL CELLS, V37, P275, DOI 10.14348/molcells.2014.2374; Leemans JC, 2005, J INFECT DIS, V191, P65, DOI 10.1086/426395; Li W, 2012, INFECT IMMUN, V80, P4426, DOI 10.1128/IAI.00912-12; Liu PT, 2008, CURR OPIN IMMUNOL, V20, P371, DOI 10.1016/j.coi.2008.05.014; Lugo-Villarino G, 2013, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00405; Lugo-Villarino G, 2011, FRONT IMMUNOL, V2, DOI 10.3389/fimmu.2011.00043; Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015; Marino S, 2015, INFECT IMMUN, V83, P324, DOI 10.1128/IAI.02494-14; Martinez FO, 2008, FRONT BIOSCI-LANDMRK, V13, P453, DOI 10.2741/2692; Mattila JT, 2013, J IMMUNOL, V191, P773, DOI 10.4049/jimmunol.1300113; Miranda MS, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/139127; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Puissegur MP, 2004, CELL MICROBIOL, V6, P423, DOI 10.1111/j.1462-5822.2004.00371.x; Redente EF, 2010, J LEUKOCYTE BIOL, V88, P159, DOI 10.1189/jlb.0609378; Russell DG, 2007, NAT REV MICROBIOL, V5, P39, DOI 10.1038/nrmicro1538; Saunders BM, 2007, IMMUNOL CELL BIOL, V85, P103, DOI 10.1038/sj.icb.7100027; Wang HS, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-279; WHO, 2014, GLOB TUB REP 2014	29	103	114	4	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2015	10	6							e0129744	10.1371/journal.pone.0129744	http://dx.doi.org/10.1371/journal.pone.0129744			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL3FE	26091535	gold, Green Submitted, Green Published			2022-12-26	WOS:000356835000055
J	Svendsen, GM; Romero, MA; Williams, GN; Gagliardini, DA; Crespo, EA; Dans, SL; Gonzalez, RA				Martin Svendsen, Guillermo; Alejandra Romero, Maria; Noemi Williams, Gabriela; Antonio Gagliardini, Domingo; Alberto Crespo, Enrique; Laura Dans, Silvana; Alberto Gonzalez, Raul			Environmental Niche Overlap between Common and Dusky Dolphins in North Patagonia, Argentina	PLOS ONE			English	Article							LAGENORHYNCHUS-OBSCURUS; HABITAT PREFERENCES; DELPHINUS; DISTRIBUTIONS; CETACEANS; ABUNDANCE; BEHAVIOR; PACIFIC; GULF	Research on the ecology of sympatric dolphins has increased worldwide in recent decades. However, many dolphin associations such as that between common dolphins (Delphinus delphis) and dusky dolphins (Lagenorhynchus obscurus) are poorly understood. The present study was conducted in the San MatIas Gulf (SMG) ecosystem (North Patagonia, Argentina) where a high diet overlap among both species was found. The main objective of the present work was to explore the niche overlap of common and dusky dolphins in the habitat and temporal dimensions. The specific aims were (a) to evaluate the habitat use strategies of both species through a comparison of their group attributes (social composition, size and activity), and (b) to evaluate their habitat preferences and habitat overlap through Environmental Niche modeling considering two oceanographic seasons. To accomplish these aims, we used a historic database of opportunistic and systematic records collected from 1983 to 2011. Common and dusky dolphins exhibited similar patterns of group size (from less than 10 to more than 100 individuals), activity (both species use the area to feed, nurse, and copulate), and composition (adults, juveniles, and mothers with calves were observed for both species). Also, both species were observed travelling and feeding in mixed-species groups. Specific overlap indices were higher for common dolphins than for dusky dolphins, but all indices were low, suggesting that they are mainly segregated in the habitat dimension. In the case of common dolphins, the best habitats were located in the northwest of the gulf far from the coast. In the warm season they prefer areas with temperate sea surface and in the cold season they prefer areas with relatively high variability of sea surface temperature. Meanwhile, dusky dolphins prefer areas with steep slopes close to the coast in the southwestern sector of the gulf in both seasons.	[Martin Svendsen, Guillermo; Alejandra Romero, Maria; Alberto Gonzalez, Raul] Univ Nacl Comahue, IBMPAS, Escuela Super Ciencias Marinas ESCiMar, San Antonio Oeste, Rio Negro, Argentina; [Martin Svendsen, Guillermo; Alejandra Romero, Maria; Alberto Gonzalez, Raul] Consejo Nacl Invest Cient & Tecn, RA-1033 Buenos Aires, DF, Argentina; [Alberto Crespo, Enrique; Laura Dans, Silvana] Consejo Nacl Invest Cient & Tecn, CENPAT, Ctr Nacl Patagon, Lab Mamiferos Marinos, Puerto Madryn, Chubut, Argentina; [Noemi Williams, Gabriela; Antonio Gagliardini, Domingo] Consejo Nacl Invest Cient & Tecn, CENPAT, Ctr Nacl Patagon, Unidad Oceanog & Meteorol, Puerto Madryn, Chubut, Argentina; [Antonio Gagliardini, Domingo] Consejo Nacl Invest Cient & Tecn, IAFE, RA-1033 Buenos Aires, DF, Argentina	Universidad Nacional del Comahue; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Centro Nacional Patagonico (CENPAT); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Centro Nacional Patagonico (CENPAT); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Instituto de Astronomia y Fisica del Espacio (IAFE)	Svendsen, GM (corresponding author), Univ Nacl Comahue, IBMPAS, Escuela Super Ciencias Marinas ESCiMar, San Antonio Oeste, Rio Negro, Argentina.	guillesen@yahoo.es	Romero, Maria Alejandra/X-3361-2019	Romero, Maria Alejandra/0000-0003-3690-8179	Global Enviromental Facility/Programa de las Naciones Unidas para el Desarrollo [ARG-02/G31, ARG-02/018]; Agencia Espanola de Cooperacion Internacional and Agencia Nacional de Promocion Cientifica y Tecnologica [04025, 371, 1575, 04]; Ministerio de Ciencia, Tecnologia e Innovacion productiva; Comision Nacional de Actividades Espaciales (SAC-D Aquarius Science Team); CONICET (Argentina)	Global Enviromental Facility/Programa de las Naciones Unidas para el Desarrollo; Agencia Espanola de Cooperacion Internacional and Agencia Nacional de Promocion Cientifica y Tecnologica; Ministerio de Ciencia, Tecnologia e Innovacion productiva; Comision Nacional de Actividades Espaciales (SAC-D Aquarius Science Team); CONICET (Argentina)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET))	Financial support was given by the Project ARG-02/G31 and ARG-02/018 (Global Enviromental Facility/Programa de las Naciones Unidas para el Desarrollo; www.thegef.org/gef/home); Agencia Espanola de Cooperacion Internacional and Agencia Nacional de Promocion Cientifica y Tecnologica (Research projects PICT-2001 No 04025, PID-2003 No 371, PICT-2006 Start Up No 1575, and PICT No-04; http://foncyt.mincyt.gov.ar); Ministerio de Ciencia, Tecnologia e Innovacion productiva (www.mincyt.gob.ar); and Comision Nacional de Actividades Espaciales (SAC-D Aquarius Science Team; www.conae.gov.ar). Guillermo Svendsen, Maria Alejandra Romero, and Gabriela Williams were supported by fellowships of CONICET (Argentina; www.conicet.gov.ar/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Romero MA, 2012, MAR MAMMAL SCI, V28, P364, DOI 10.1111/j.1748-7692.2011.00477.x; [Anonymous], P 21 INT C MACH LEAR; Ballance LT, 2006, PROG OCEANOGR, V69, P360, DOI 10.1016/j.pocean.2006.03.013; Bastida R., 2003, MAMIFEROS MARINOS PA; Bearzi M, 2005, MAR BIOL RES, V1, P165, DOI 10.1080/17451000510019132; Bearzi M., 2003, HABITAT PARTITIONING; Bearzi M, 2007, CONTRIB ZOOL, V76, P235, DOI 10.1163/18759866-07604003; Brager S, 1998, NEW ZEAL J MAR FRESH, V32, P105, DOI 10.1080/00288330.1998.9516809; Broennimann O, 2012, GLOBAL ECOL BIOGEOGR, V21, P481, DOI 10.1111/j.1466-8238.2011.00698.x; Carreto JI, 1974, FITOPLANCTON PIGMENT, P10; Cipriano F, 2010, DUSKY DOLPHIN: MASTER ACROBAT OFF DIFFERENT SHORES, P21, DOI 10.1016/B978-0-12-373723-6.00002-3; Crespo Enrique A., 1997, Journal of Northwest Atlantic Fishery Science, V22, P189; Crespo Enrique A., 2000, Journal of Cetacean Research and Management, V2, P11; Crespo Enrique Alberto, 1997, Report of the International Whaling Commission, V47, P693; Dans SL, 2010, DUSKY DOLPHIN: MASTER ACROBAT OFF DIFFERENT SHORES, P49, DOI 10.1016/B978-0-12-373723-6.00003-5; Degrati M, 2008, J MAMMAL, V89, P1241, DOI 10.1644/07-MAMM-A-110.1; Elith J, 2011, DIVERS DISTRIB, V17, P43, DOI 10.1111/j.1472-4642.2010.00725.x; Fielding AH, 2002, PREDICTING SPECIES OCCURRENCES: ISSUES OF ACCURACY AND SCALE, P271; Frantzis Alexandros, 2002, Aquatic Mammals, V28, P188; Friedlaender AS, 2011, DEEP-SEA RES PT II, V58, P1729, DOI 10.1016/j.dsr2.2010.11.018; Gagliardini Domingo A, 2004, Gayana (Concepc.), V68, P186; Garaffo GV, 2007, MAR BIOL, V152, P165, DOI 10.1007/s00227-007-0686-0; Garaffo GV, 2011, MAR ECOL PROG SER, V421, P217, DOI 10.3354/meps08912; Garaffo GV, 2010, J MAMMAL, V91, P54, DOI 10.1644/09-MAMM-A-105R1.1; GASKIN D E, 1968, New Zealand Journal of Marine and Freshwater Research, V2, P527; Gonzalez RAC, 1990, COM 4 REUN TRAB ESP; Goodall RNP, 1985, REV FOOD HABITS SMAL; Heinrich S, 2010, DUSKY DOLPHIN: MASTER ACROBAT OFF DIFFERENT SHORES, P313, DOI 10.1016/B978-0-12-373723-6.00015-1; Kiszka J, 2011, MAR ECOL PROG SER, V433, P273, DOI 10.3354/meps09165; Krausman PR., 1999, GRAZING BEHAV LIVEST, P85; Ludwig J. A., 1988, STAT ECOLOGY; MacLeod CD, 2008, HYDROBIOLOGIA, V612, P21, DOI 10.1007/s10750-008-9491-0; Macleod CD, 2010, J MAR BIOL ASSOC UK, V90, P1269, DOI 10.1017/S0025315410000408; Mann J, 1999, MAR MAMMAL SCI, V15, P102, DOI 10.1111/j.1748-7692.1999.tb00784.x; Marino L, 2004, ANAT REC PART A, V281A, P1247, DOI 10.1002/ar.a.20128; Marino L, 2004, INT J COMP PSYCHOL, V17, P1, DOI DOI 10.1017/S0140525X00052961; Mazio CA, 1983, MAREAS GOLFO SAN MAT, P13; Moura AE, 2012, ACTA OECOL, V38, P24, DOI 10.1016/j.actao.2011.08.006; Reinaldo MO, 2013, MAR BIOL RES, V9, P394, DOI 10.1080/17451000.2012.739700; Palma ED, 2008, J GEOPHYS RES-OCEANS, V113, DOI 10.1029/2007JC004720; Parra GJ, 2006, J ANIM ECOL, V75, P862, DOI 10.1111/j.1365-2656.2006.01104.x; Parra JL, 2004, ECOGRAPHY, V27, P350, DOI 10.1111/j.0906-7590.2004.03822.x; Perrin W., 2017, ENCY MARINE MAMMALS, P245; PETRAITIS PS, 1979, ECOLOGY, V60, P703, DOI 10.2307/1936607; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Piola A.R., 1988, GEOACTA, V15, P33; Piola A.R., 1997, MAR ARGENTINO SUS RE, V1, P119; Pisoni JP, 2014, REMOTE SENS ENVIRON, V152, P207; Pizarro MJ, 1975, ANALISIS RESULTADOS, P3; Praca E, 2008, OCEAN SCI, V4, P49, DOI 10.5194/os-4-49-2008; Querouil S, 2008, ETHOLOGY, V114, P1183, DOI 10.1111/j.1439-0310.2008.01570.x; Ready J, 2010, ECOL MODEL, V221, P467, DOI 10.1016/j.ecolmodel.2009.10.025; Redfern JV, 2006, MAR ECOL PROG SER, V310, P271, DOI 10.3354/meps310271; Romero MA, 2011, ROL MAMIFEROS MARINO; Scasso LM, 1988, GEOACTA, V15, P33; Schiavini A, 1999, MAR MAMMAL SCI, V15, P828, DOI 10.1111/j.1748-7692.1999.tb00845.x; Schneider C., 2009, SISTEMA COMPOSICION; Srinivasan M, 2010, DUSKY DOLPHIN: MASTER ACROBAT OFF DIFFERENT SHORES, P133, DOI 10.1016/B978-0-12-373723-6.00007-2; Stockin Karen A., 2008, Aquatic Mammals, V34, P200, DOI 10.1578/AM.34.2.2008.200; Stockwell DRB, 2002, PREDICTING SPECIES OCCURRENCES: ISSUES OF ACCURACY AND SCALE, P537; Svendsen GM, 2008, 13 REUN TRAB ESP MAM; Tavares M, 2010, MAMMAL REV, V40, P40, DOI 10.1111/j.1365-2907.2009.00154.x; Tonini MH, 2013, CONT SHELF RES, V65, P97, DOI 10.1016/j.csr.2013.06.011; Warren DL, 2008, EVOLUTION, V62, P2868, DOI 10.1111/j.1558-5646.2008.00482.x; Warren DL, 2010, ECOGRAPHY, V33, P607, DOI 10.1111/j.1600-0587.2009.06142.x; Williams G, 2010, INT J REMOTE SENS, V31, P4531, DOI 10.1080/01431161.2010.485218; Williams G., 2004, THESIS U NACL PATAGO; Wursig B, 2010, DUSKY DOLPHIN: MASTER ACROBAT OFF DIFFERENT SHORES, P1; WURSIG B, 1980, FISH B-NOAA, V77, P871	70	8	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2015	10	6							e0126182	10.1371/journal.pone.0126182	http://dx.doi.org/10.1371/journal.pone.0126182			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL3FE	26091542	Green Published, gold, Green Submitted			2022-12-26	WOS:000356835000006
J	Nakielski, P; Pawlowska, S; Pierini, F; Liwinska, W; Hejduk, P; Zembrzycki, K; Zabost, E; Kowalewski, TA				Nakielski, Pawel; Pawlowska, Sylwia; Pierini, Filippo; Liwinska, Wioletta; Hejduk, Patryk; Zembrzycki, Krzysztof; Zabost, Ewelina; Kowalewski, Tomasz A.			Hydrogel Nanofilaments via Core-Shell Electrospinning	PLOS ONE			English	Article							FLEXURAL RIGIDITY; NANOFIBERS; POLYMERIZATION; MICROTUBULES	Recent biomedical hydrogels applications require the development of nanostructures with controlled diameter and adjustable mechanical properties. Here we present a technique for the production of flexible nanofilaments to be used as drug carriers or in microfluidics, with deformability and elasticity resembling those of long DNA chains. The fabrication method is based on the core-shell electrospinning technique with core solution polymerisation post electrospinning. Produced from the nanofibers highly deformable hydrogel nanofilaments are characterised by their Brownian motion and bending dynamics. The evaluated mechanical properties are compared with AFM nanoindentation tests.	[Nakielski, Pawel; Pawlowska, Sylwia; Pierini, Filippo; Hejduk, Patryk; Zembrzycki, Krzysztof; Kowalewski, Tomasz A.] Polish Acad Sci, Inst Fundamental Technol Res, Dept Mech & Phys Fluids, Warsaw, Poland; [Liwinska, Wioletta; Zabost, Ewelina] Univ Warsaw, Fac Chem, Warsaw, Poland	Polish Academy of Sciences; Institute of Fundamental Technological Research of the Polish Academy of Sciences; University of Warsaw	Nakielski, P (corresponding author), Polish Acad Sci, Inst Fundamental Technol Res, Dept Mech & Phys Fluids, Warsaw, Poland.	pnakiel@ippt.pan.pl	Kowalewski, Tomasz Aleksander/F-2055-2011; Nakielski, Pawel/A-2077-2013; Pawłowska, Sylwia/HIK-1653-2022; Pierini, Filippo/B-5328-2019	Kowalewski, Tomasz Aleksander/0000-0002-3664-9659; Nakielski, Pawel/0000-0001-6194-701X; Pierini, Filippo/0000-0002-6526-4141; Zabost, Ewelina/0000-0003-4544-6033	National Science Centre Poland [2011/03/B/ST8/05481, 2012/05/D/ST5/03464]	National Science Centre Poland(National Science Centre, Poland)	This work was supported by 2011/03/B/ST8/05481, National Science Centre Poland (http:// www.ncn.gov.pl/?language = en) and 2012/05/D/ST5/03464, National Science Centre Poland (http://www.ncn.gov.pl/?language = en). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhaduri B, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2887883; Brandl C, 2011, MACROMOL MATER ENG, V296, P858, DOI 10.1002/mame.201100031; Chen ML, 2010, CHEM MATER, V22, P4214, DOI 10.1021/cm100753r; Doi M., 1986, INT SERIES MONOGRAPH; Evingur GA, 2014, POLYM-PLAST TECHNOL, V53, P834, DOI 10.1080/03602559.2014.886049; Fathi M, 2013, RADIAT PHYS CHEM, V86, P145, DOI 10.1016/j.radphyschem.2013.02.005; Fu GD, 2008, MACROMOLECULES, V41, P6854, DOI 10.1021/ma800499h; GITTES F, 1993, J CELL BIOL, V120, P923, DOI 10.1083/jcb.120.4.923; Graham JS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094766; Hu M, 2010, BIOMATERIALS, V31, P863, DOI 10.1016/j.biomaterials.2009.10.002; Jia WJ, 2010, J MATER CHEM, V20, P8617, DOI 10.1039/c0jm01179g; Kikumoto M, 2006, BIOPHYS J, V90, P1687, DOI 10.1529/biophysj.104.055483; Koombhongse S, 2001, J POLYM SCI POL PHYS, V39, P2598, DOI 10.1002/polb.10015; Kowalczyk T, 2008, BIOMACROMOLECULES, V9, P2087, DOI 10.1021/bm800421s; MathWorks, 2014, MATLAB; Nakielski P, 2015, IPPT REPORTS; Nakielski P, 2015, J BIOMED MATER RES B, V103, P282, DOI 10.1002/jbm.b.33197; Oh JK, 2008, PROG POLYM SCI, V33, P448, DOI 10.1016/j.progpolymsci.2008.01.002; Ortega A, 2003, J CHEM PHYS, V119, P9914, DOI 10.1063/1.1615967; OTT A, 1993, PHYS REV E, V48, pR1642, DOI 10.1103/PhysRevE.48.R1642; Ottenbrite RM, 2010, BIOMEDICAL APPLICATIONS OF HYDROGELS HANDBOOK, P1, DOI 10.1007/978-1-4419-5919-5; Reddy CS, 2009, J MATER CHEM, V19, P7198, DOI 10.1039/b916185f; Sadlej K, 2010, INT J HEAT FLUID FL, V31, P996, DOI 10.1016/j.ijheatfluidflow.2010.02.021; Slowicka AM, 2012, J CHEM PHYS, V136, DOI 10.1063/1.3678852; Sun ZC, 2003, ADV MATER, V15, P1929, DOI 10.1002/adma.200305136; Tan EPS, 2006, COMPOS SCI TECHNOL, V66, P1102, DOI 10.1016/j.compscitech.2005.10.003; Wu Q, 2013, ANAL CHEM, V85, P5924, DOI 10.1021/ac4006974; Xue RP, 2014, SENSOR ACTUAT B-CHEM, V192, P697, DOI 10.1016/j.snb.2013.10.084; Yamakawa H., 1971, HARPERS CHEM SERIES; Yan H, 2005, LANGMUIR, V21, P7076, DOI 10.1021/la0512749; Yarin A. L., 2014, FUNDAMENTALS APPL MI; Zabost E, 2014, ELECTROCHEM COMMUN, V42, P50, DOI 10.1016/j.elecom.2014.02.011; Zheng F, 2011, TALANTA, V85, P1166, DOI 10.1016/j.talanta.2011.05.039	33	16	16	5	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2015	10	6							e0129816	10.1371/journal.pone.0129816	http://dx.doi.org/10.1371/journal.pone.0129816			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL3FE	26091487	Green Published, gold			2022-12-26	WOS:000356835000061
J	Stimers, JR; Song, L; Rusch, NJ; Rhee, SW				Stimers, Joseph R.; Song, Li; Rusch, Nancy J.; Rhee, Sung W.			Overexpression of the Large-Conductance, Ca2+-Activated K+ (BK) Channel Shortens Action Potential Duration in HL-1 Cardiomyocytes	PLOS ONE			English	Article							LONG-QT SYNDROME; CA2+ CHANNELS; BETA-SUBUNITS; CELL-LINE; MEMBRANE; REPOLARIZATION; MYOCYTES; CALCIUM; BLOCK	Long QT syndrome is characterized by a prolongation of the interval between the Q wave and the T wave on the electrocardiogram. This abnormality reflects a prolongation of the ventricular action potential caused by a number of genetic mutations or a variety of drugs. Since effective treatments are unavailable, we explored the possibility of using cardiac expression of the large-conductance, Ca2+-activated K+ (BK) channel to shorten action potential duration (APD). We hypothesized that expression of the pore-forming a subunit of human BK channels (hBK alpha) in HL-1 cells would shorten action potential duration in this mouse atrial cell line. Expression of hBK alpha had minimal effects on expression levels of other ion channels with the exception of a small but significant reduction in Kv11.1. Patch-clamped hBK alpha expressing HL-1 cells exhibited an outward voltage- and Ca2+-sensitive K+ current, which was inhibited by the BK channel blocker iberiotoxin (100 nM). This BK current phenotype was not detected in untransfected HL-1 cells or in HL-1 null cells sham-transfected with an empty vector. Importantly, APD in hBK alpha-expressing HL-1 cells averaged 14.3 +/- 2.8 ms (n = 10), which represented a 53% reduction in APD compared to HL-1 null cells lacking BK alpha expression. APD in the latter cells averaged 31.0 +/- 5.1 ms (n = 13). The shortened APD in hBK alpha-expressing cells was restored to normal duration by 100 nM iberiotoxin, suggesting that a repolarizing K+ current attributed to BK channels accounted for action potential shortening. These findings provide initial proof-of-concept that the introduction of hBK alpha channels into a cardiac cell line can shorten APD, and raise the possibility that gene-based interventions to increase hBK alpha channels in cardiac cells may hold promise as a therapeutic strategy for long QT syndrome.	[Stimers, Joseph R.; Song, Li; Rusch, Nancy J.; Rhee, Sung W.] Univ Arkansas Med Sci, Dept Pharmacol & Toxicol, Little Rock, AR 72205 USA	University of Arkansas System; University of Arkansas Medical Sciences	Stimers, JR (corresponding author), Univ Arkansas Med Sci, Dept Pharmacol & Toxicol, Little Rock, AR 72205 USA.	StimersJosephR@uams.edu			American Heart Association [SDG 0830060N]; NIH [R01 HL093526]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL093526] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This was supported in part by American Heart Association (http://www.heart.org/HEARTORG/) SDG 0830060N (SWR) and NIH (http://www.nih.gov/) R01 HL093526 (NJR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brenner R, 2000, J BIOL CHEM, V275, P6453, DOI 10.1074/jbc.275.9.6453; CANDIA S, 1992, BIOPHYS J, V63, P583, DOI 10.1016/S0006-3495(92)81630-2; Claycomb WC, 1998, P NATL ACAD SCI USA, V95, P2979, DOI 10.1073/pnas.95.6.2979; Contreras GF, 2013, CHANNELS, V7, P442, DOI 10.4161/chan.26242; Guo WN, 2000, CIRC RES, V87, P73, DOI 10.1161/01.RES.87.1.73; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; Hedley PL, 2009, HUM MUTAT, V30, P1486, DOI 10.1002/humu.21106; Hohendanner F, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00035; Hu XQ, 2012, DRUG DISCOV TODAY, V17, P974, DOI 10.1016/j.drudis.2012.04.002; Imlach WL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008698; Ko JH, 2009, BIOCHEM BIOPH RES CO, V389, P74, DOI 10.1016/j.bbrc.2009.08.087; Li W, 2007, J CELL PHYSIOL, V212, P348, DOI 10.1002/jcp.21007; Liu Y, 2011, J NEUROPHYSIOL, V106, P144, DOI 10.1152/jn.01107.2010; McWhinney CD, 2000, MOL CELL BIOCHEM, V214, P111, DOI 10.1023/A:1007129723949; Michael G, 2009, CARDIOVASC RES, V81, P491, DOI 10.1093/cvr/cvn266; Mikuni I, 2015, ANESTHESIOLOGY, V122, P806, DOI 10.1097/ALN.0000000000000583; Nissen JD, 2009, J CARDIOVASC PHARM, V54, P169, DOI 10.1097/FJC.0b013e3181af6db3; Pesic A, 2004, CIRC RES, V94, pE97, DOI 10.1161/01.RES.0000131495.93500.3c; Polak S, 2012, J CARDIOVASC TRANSL, V5, P321, DOI 10.1007/s12265-012-9357-8; Rhee SW, 2005, TRAFFIC, V6, P978, DOI 10.1111/j.1600-0854.2005.00333.x; Schmitt N, 2014, PHYSIOL REV, V94, P609, DOI 10.1152/physrev.00022.2013; Schwartz PJ, 2012, CIRC-ARRHYTHMIA ELEC, V5, P868, DOI 10.1161/CIRCEP.111.962019; Schwartz PJ, 2010, CIRCULATION, V122, P1272, DOI 10.1161/CIRCULATIONAHA.110.950147; Schwartz PJ, 2009, CIRCULATION, V120, P1761, DOI 10.1161/CIRCULATIONAHA.109.863209; Shruti S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033429; So EC, 2012, EUR J PHARMACOL, V683, P1, DOI 10.1016/j.ejphar.2012.02.012; Stimers JR, 2002, BIOPHYS J, V82, p95A; Sun XH, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00063; Szeliga MA, 2010, KARDIOL POL, V68, P575; Tamargo J, 2004, CARDIOVASC RES, V62, P9, DOI 10.1016/j.cardiores.2003.12.026; Telemaque S, 2008, J PHARMACOL EXP THER, V325, P37, DOI 10.1124/jpet.107.128215; Telemaque Sabine, 2009, Expert Rev Cardiovasc Ther, V7, P939, DOI 10.1586/erc.09.76; Toyoda F, 2010, J MEMBRANE BIOL, V235, P73, DOI 10.1007/s00232-010-9257-2; Wondergem R, 2012, AM J PHYSIOL-CELL PH, V303, pC825, DOI 10.1152/ajpcell.00173.2012; Xu WH, 2002, SCIENCE, V298, P1029, DOI 10.1126/science.1074360; Yang HG, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00029; Yang T, 2001, J CARDIOVASC PHARM, V38, P737, DOI 10.1097/00005344-200111000-00010; YANG T, 1995, CIRC RES, V77, P1246, DOI 10.1161/01.RES.77.6.1246	38	4	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2015	10	6							e0130588	10.1371/journal.pone.0130588	http://dx.doi.org/10.1371/journal.pone.0130588			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL3FE	26091273	gold, Green Published			2022-12-26	WOS:000356835000131
J	Iwahori, S; Hakki, M; Chou, S; Kalejta, RF				Iwahori, Satoko; Hakki, Morgan; Chou, Sunwen; Kalejta, Robert F.			Molecular Determinants for the Inactivation of the Retinoblastoma Tumor Suppressor by the Viral Cyclin-dependent Kinase UL97	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LARGE T-ANTIGEN; CYTOMEGALOVIRUS PP71 PROTEIN; RB FAMILY; TRANSCRIPTION FACTOR; E2F TRANSACTIVATION; HISTONE DEACETYLASE; STRUCTURAL BASIS; GENE-EXPRESSION; POCKET PROTEINS; TERMINAL DOMAIN	The retinoblastoma (Rb) tumor suppressor restricts cell cycle progression by repressing E2F-responsive transcription. Cellular cyclin-dependent kinase (CDK)-mediated Rb inactivation through phosphorylation disrupts Rb-E2F complexes, stimulating transcription. The human cytomegalovirus (HCMV) UL97 protein is a viral CDK (v-CDK) that phosphorylates Rb. Here we show that UL97 phosphorylates 11 of the 16 consensus CDK sites in Rb. A cleft within Rb accommodates peptides with the amino acid sequence LXCXE. UL97 contains three such motifs. We determined that the first LXCXE motif (L1) of UL97 and the Rb cleft enhance UL97-mediated Rb phosphorylation. A UL97 mutant with a non-functional L1 motif (UL97-L1m) displayed significantly reduced Rb phosphorylation at multiple sites. Curiously, however, it efficiently disrupted Rb-E2F complexes but failed to relieve Rb-mediated repression of E2F reporter constructs. The HCMV immediate early 1 protein cooperated with UL97-L1m to inactivate Rb in transfection assays, likely indicating that cells infected with a UL97-L1m mutant virus show no defects in growth or E2F-responsive gene expression because of redundant viral mechanisms to inactivate Rb. Ourdata suggest that UL97 possesses a mechanism to elicit E2F-dependent gene expression distinct from disruption of Rb-E2F complexes and dependent upon both the L1 motif of UL97 and the cleft region of Rb.	[Iwahori, Satoko; Kalejta, Robert F.] Univ Wisconsin, Inst Mol Virol, Madison, WI 53706 USA; [Iwahori, Satoko; Kalejta, Robert F.] Univ Wisconsin, McArdle Lab Canc Res, Madison, WI 53706 USA; [Hakki, Morgan; Chou, Sunwen] Oregon Hlth & Sci Univ, Div Infect Dis, Portland, OR 97239 USA; [Chou, Sunwen] Vet Affairs Portland Hlth Care Syst, Portland, OR 97239 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Oregon Health & Science University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Portland Health Care System	Kalejta, RF (corresponding author), Univ Wisconsin, Inst Mol Virol, 1525 Linden Dr, Madison, WI 53706 USA.	rfkalejta@wisc.edu	Iwahori, Satoko/L-1948-2019; Regan, Clinton/E-6250-2012		National Institutes of Health [AI080675]; Department of Veterans Affairs [BX000925]; Japan Herpesvirus Infections Forum scholarship award in herpesvirus infection research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI080675] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000925] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs(US Department of Veterans Affairs); Japan Herpesvirus Infections Forum scholarship award in herpesvirus infection research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported, in whole or in part, by National Institutes of Health Grant AI080675 (to R. F. K.). This work was also supported by Department of Veterans Affairs Grant BX000925 (to S. C.). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by a Japan Herpesvirus Infections Forum scholarship award in herpesvirus infection research.	Adams PD, 1999, MOL CELL BIOL, V19, P1068; Adams PD, 2001, BBA-REV CANCER, V1471, pM123, DOI 10.1016/S0304-419X(01)00019-1; Albright ER, 2013, J VIROL, V87, P9802, DOI 10.1128/JVI.01436-13; Baek MC, 2004, VIROLOGY, V324, P184, DOI 10.1016/j.virol.2004.03.015; Baker GL, 2005, CELL CYCLE, V4, P330; Bellacchio E, 2013, J CELL PHYSIOL, V228, P285, DOI 10.1002/jcp.24137; Bigley TM, 2013, J VIROL, V87, P7393, DOI 10.1128/JVI.02825-12; Brehm A, 1998, NATURE, V391, P597, DOI 10.1038/35404; Britt W, 2008, CURR TOP MICROBIOL, V325, P417; Burke JR, 2012, GENE DEV, V26, P1156, DOI 10.1101/gad.189837.112; Burkhart DL, 2008, NAT REV CANCER, V8, P671, DOI 10.1038/nrc2399; Chen DN, 2009, NATURE, V462, P925, DOI 10.1038/nature08544; Chen TT, 2000, MOL CELL BIOL, V20, P5571, DOI 10.1128/MCB.20.15.5571-5580.2000; Chou S, 2008, J VIROL, V82, P246, DOI 10.1128/JVI.01787-07; Chou SW, 2013, ANTIMICROB AGENTS CH, V57, P3375, DOI 10.1128/AAC.00511-13; Chou SW, 2010, ANTIMICROB AGENTS CH, V54, P2371, DOI 10.1128/AAC.00186-10; Chou SW, 2009, ANTIMICROB AGENTS CH, V53, P81, DOI 10.1128/AAC.01177-08; Chou SW, 2006, ANTIMICROB AGENTS CH, V50, P2557, DOI 10.1128/AAC.00207-06; Di Fiore R, 2013, J CELL PHYSIOL, V228, P1676, DOI 10.1002/jcp.24329; Dick FA, 2007, CELL DIV, V2, DOI 10.1186/1747-1028-2-26; Dick FA, 2013, NAT REV MOL CELL BIO, V14, P297, DOI 10.1038/nrm3567; Dimova DK, 2005, ONCOGENE, V24, P2810, DOI 10.1038/sj.onc.1208612; DYNLACHT BD, 1994, GENE DEV, V8, P1772, DOI 10.1101/gad.8.15.1772; Dynlacht BD, 1997, MOL CELL BIOL, V17, P3867, DOI 10.1128/MCB.17.7.3867; Dziurzynski K, 2012, NEURO-ONCOLOGY, V14, P246, DOI 10.1093/neuonc/nor227; Fang F, 2010, J IMMUNOL, V184, P6084, DOI 10.4049/jimmunol.0902561; Fera D, 2012, CHEM BIOL, V19, P518, DOI 10.1016/j.chembiol.2012.03.007; FRIEND SH, 1986, NATURE, V323, P643, DOI 10.1038/323643a0; Gill RB, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-9; Hassler M, 2007, MOL CELL, V28, P371, DOI 10.1016/j.molcel.2007.08.023; He ZW, 1997, J VIROL, V71, P405, DOI 10.1128/JVI.71.1.405-411.1997; Heilmann AMF, 2012, GENE DEV, V26, P1128, DOI 10.1101/gad.195552.112; Helt AM, 2003, CARCINOGENESIS, V24, P159, DOI 10.1093/carcin/24.2.159; HENGLEIN B, 1994, P NATL ACAD SCI USA, V91, P5490, DOI 10.1073/pnas.91.12.5490; Hume AJ, 2008, SCIENCE, V320, P797, DOI 10.1126/science.1152095; Hume AJ, 2009, CELL DIV, V4, DOI 10.1186/1747-1028-4-1; Iaquinta PJ, 2007, CURR OPIN CELL BIOL, V19, P649, DOI 10.1016/j.ceb.2007.10.006; Indovina P, 2013, J CELL PHYSIOL, V228, P525, DOI 10.1002/jcp.24170; Iwahori S, 2007, J VIROL, V81, P9653, DOI 10.1128/JVI.00568-07; Jiang H, 2009, CURR GENE THER, V9, P422, DOI 10.2174/156652309789753356; JOHNSON DG, 1994, GENE DEV, V8, P1514, DOI 10.1101/gad.8.13.1514; Juckem LK, 2008, J IMMUNOL, V180, P4965, DOI 10.4049/jimmunol.180.7.4965; Kalejta RF, 2003, P NATL ACAD SCI USA, V100, P3263, DOI 10.1073/pnas.0538058100; Kalejta RF, 2003, MOL CELL BIOL, V23, P1885, DOI 10.1128/MCB.23.6.1885-1895.2003; Kim HY, 2001, EMBO J, V20, P295, DOI 10.1093/emboj/20.1.295; Kim M, 2010, ONCOGENE, V29, P3990, DOI 10.1038/onc.2010.137; KITAGAWA M, 1995, ONCOGENE, V10, P229; Kuny CV, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001092; Lee C, 2002, GENE DEV, V16, P3199, DOI 10.1101/gad.1046102; Lee C, 2002, REV MED VIROL, V12, P81, DOI 10.1002/rmv.340; Lee CP, 2008, J VIROL, V82, P11913, DOI 10.1128/JVI.01100-08; Lee JO, 1998, NATURE, V391, P859, DOI 10.1038/36038; Leng XH, 1997, CURR BIOL, V7, P709, DOI 10.1016/S0960-9822(06)00301-0; Li RF, 2011, CELL HOST MICROBE, V10, P390, DOI 10.1016/j.chom.2011.08.013; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Malumbres M, 2005, TRENDS BIOCHEM SCI, V30, P630, DOI 10.1016/j.tibs.2005.09.005; Marschall M, 2011, ADV VIRUS RES, V80, P69, DOI 10.1016/B978-0-12-385987-7.00004-X; Mitchell DA, 2015, NATURE, V519, P366, DOI 10.1038/nature14320; Moore PS, 2010, NAT REV CANCER, V10, P878, DOI 10.1038/nrc2961; Morris EJ, 2001, ADV CANCER RES, V82, P1, DOI 10.1016/S0065-230X(01)82001-7; Nicolay BN, 2013, CURR OPIN CELL BIOL, V25, P735, DOI 10.1016/j.ceb.2013.07.012; NOWAK B, 1984, VIROLOGY, V132, P325, DOI 10.1016/0042-6822(84)90039-4; Ohtani K, 1996, MOL CELL BIOL, V16, P6977; Pajovic S, 1997, MOL CELL BIOL, V17, P6459, DOI 10.1128/MCB.17.11.6459; PEEPER DS, 1995, ONCOGENE, V10, P39; Penkert RR, 2012, FUTURE VIROL, V7, P855, DOI 10.2217/FVL.12.86; Phatnani HP, 2006, GENE DEV, V20, P2922, DOI 10.1101/gad.1477006; Poma EE, 1996, J VIROL, V70, P7867, DOI 10.1128/JVI.70.11.7867-7877.1996; Prichard MN, 2008, J VIROL, V82, P5054, DOI 10.1128/JVI.02174-07; Prichard MN, 1999, J VIROL, V73, P5663, DOI 10.1128/JVI.73.7.5663-5670.1999; Prichard MN, 2005, J VIROL, V79, P15494, DOI 10.1128/JVI.79.24.15494-15502.2005; Ptacek J, 2005, NATURE, V438, P679, DOI 10.1038/nature04187; QIN XQ, 1992, GENE DEV, V6, P953, DOI 10.1101/gad.6.6.953; Ranganathan P, 2012, J VIROL, V86, P854, DOI 10.1128/JVI.06097-11; Rubin SM, 2013, TRENDS BIOCHEM SCI, V38, P12, DOI 10.1016/j.tibs.2012.10.007; Rubin SM, 2005, CELL, V123, P1093, DOI 10.1016/j.cell.2005.09.044; Russell SJ, 2012, NAT BIOTECHNOL, V30, P658, DOI 10.1038/nbt.2287; Saffert RT, 2006, J VIROL, V80, P3863, DOI 10.1128/JVI.80.8.3863-3871.2006; Satyanarayana A, 2009, ONCOGENE, V28, P2925, DOI 10.1038/onc.2009.170; Schulman BA, 1998, P NATL ACAD SCI USA, V95, P10453, DOI 10.1073/pnas.95.18.10453; Sellers WR, 1998, GENE DEV, V12, P95, DOI 10.1101/gad.12.1.95; SHEW JY, 1990, P NATL ACAD SCI USA, V87, P6, DOI 10.1073/pnas.87.1.6; Soroceanu L, 2011, VIRUS RES, V157, P193, DOI 10.1016/j.virusres.2010.10.026; Sun XP, 2013, J VIROL, V87, P10126, DOI 10.1128/JVI.01671-13; Trimarchi JM, 2002, NAT REV MOL CELL BIO, V3, P11, DOI 10.1038/nrm714; VanDeusen HR, 2015, J VIROL, V89, P5012, DOI 10.1128/JVI.00175-15; WEINBERG RA, 1995, CELL, V81, P323, DOI 10.1016/0092-8674(95)90385-2; Wolf DG, 2001, P NATL ACAD SCI USA, V98, P1895, DOI 10.1073/pnas.98.4.1895; XU M, 1994, MOL CELL BIOL, V14, P8420, DOI 10.1128/MCB.14.12.8420; Yu YJ, 2008, J VIROL, V82, P4521, DOI 10.1128/JVI.02365-07; ZHU H, 1995, J VIROL, V69, P7960, DOI 10.1128/JVI.69.12.7960-7970.1995	91	21	21	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 7	2015	290	32					19666	19680		10.1074/jbc.M115.660043	http://dx.doi.org/10.1074/jbc.M115.660043			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CO7TL	26100623	Green Published, hybrid			2022-12-26	WOS:000359364600027
J	Carvour, ML; Harms, JP; Lynch, CF; Mayer, RR; Meier, JL; Liu, D; Torner, JC				Carvour, Martha L.; Harms, Jerald P.; Lynch, Charles F.; Mayer, Randall R.; Meier, Jeffery L.; Liu, Dawei; Torner, James C.			Differential Survival for Men and Women with HIV/AIDS-Related Neurologic Diagnoses	PLOS ONE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; HIV DISEASE PROGRESSION; GENDER-DIFFERENCES; INFECTED PATIENTS; DRUG-USE; AIDS; SEX; COHORT; SEROCONVERSION; DEATH	Objectives Neurologic complications of human immunodeficiency virus (HIV) infection and acquired immune deficiency syndrome (AIDS) frequently lead to disability or death in affected patients. The aim of this study was to determine whether survival patterns differ between men and women with HIV/AIDS-related neurologic disease (neuro-AIDS). Methods Retrospective cohort data from a statewide surveillance database for HIV/AIDS were used to characterize survival following an HIV/AIDS-related neurologic diagnosis for men and women with one or more of the following conditions: cryptococcosis, toxoplasmosis, primary central nervous system lymphoma, progressive multifocal leukoencephalopathy, and HIV-associated dementia. A second, non-independent cohort was formed using university-based cases to confirm and extend the findings from the statewide data. Kaplan-Meier analysis was used to compare the survival experiences for men and women in the cohorts. Cox regression was employed to characterize survival while controlling for potential confounders in the study population. Results Women (n=27) had significantly poorer outcomes than men (n=198) in the statewide cohort (adjusted hazard ratio=2.31, 95% CI: 1.22 to 4.35), and a similar, non-significant trend was observed among university-based cases (n=17 women, 154 men). Secondary analyses suggested that this difference persisted over the course of the AIDS epidemic and was not attributable to differential antiretroviral therapy responses among men and women. Conclusions The survival disadvantage of women compared to men should be confirmed and the mechanisms underlying this disparity elucidated. If this relationship is confirmed, targeted clinical and public health efforts might be directed towards screening, treatment, and support for women affected by neuro-AIDS.	[Carvour, Martha L.; Lynch, Charles F.; Torner, James C.] Univ Iowa, Dept Epidemiol, Iowa City, IA 52242 USA; [Carvour, Martha L.; Torner, James C.] Univ Iowa, Inst Clin & Translat Sci, Iowa City, IA USA; [Carvour, Martha L.] Univ Iowa, Med Scientist Training Program, Iowa City, IA USA; [Harms, Jerald P.; Mayer, Randall R.] Iowa Dept Publ Hlth, Bur Human Immunodeficiency Virus Sexually Transmi, Des Moines, IA 50319 USA; [Meier, Jeffery L.] Univ Iowa, Dept Internal Med, Iowa City, IA USA; [Meier, Jeffery L.] Iowa City Vet Affairs Hlth Care Syst, Iowa City, IA USA; [Liu, Dawei] Univ Iowa, Dept Psychiat, Iowa City, IA USA	University of Iowa; University of Iowa; University of Iowa; University of Iowa; US Department of Veterans Affairs; Veterans Health Administration (VHA); Iowa City VA Health Care System; University of Iowa	Torner, JC (corresponding author), Univ Iowa, Dept Epidemiol, Iowa City, IA 52242 USA.	james-torner@uiowa.edu		Meier, Jeffery/0000-0001-9491-1697; Carvour, Martha/0000-0003-2295-5062	NIH [T32 GM07337, TL1 RR024981]; NATIONAL CANCER INSTITUTE [P30CA086862] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [TL1RR024981] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007337] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Training support for Martha Carvour was provided through NIH grants T32 GM07337 and TL1 RR024981. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bilgrami Mohammed, 2014, Handb Clin Neurol, V121, P1321, DOI 10.1016/B978-0-7020-4088-7.00090-0; Centers for Disease Control and Prevention, CDC HIV SURV WOM; DalPan GJ, 1996, NEUROL CLIN, V14, P359, DOI 10.1016/S0733-8619(05)70262-0; de la Hera MG, 2004, J EPIDEMIOL COMMUN H, V58, P944, DOI 10.1136/jech.2003.017475; ELLERBROCK TV, 1991, JAMA-J AM MED ASSOC, V265, P2971, DOI 10.1001/jama.265.22.2971; Fanjul F, 2013, HIV MED, V14, P321, DOI 10.1111/hiv.12008; Gutierrez F, 2014, HIV MED, V15, P213, DOI 10.1111/hiv.12104; Hessol NA, 2007, CLIN INFECT DIS, V44, P287, DOI 10.1086/510488; IATRAKIS GM, 1994, GENITOURIN MED, V70, P290; Jarrin I, 2008, AM J EPIDEMIOL, V168, P532, DOI 10.1093/aje/kwn179; Kempf MC, 2009, JAIDS-J ACQ IMM DEF, V52, P336, DOI 10.1097/QAI.0b013e3181b628be; LEMP GF, 1992, J INFECT DIS, V166, P74, DOI 10.1093/infdis/166.1.74; LEPRI AC, 1994, BRIT MED J, V309, P1537, DOI 10.1136/bmj.309.6968.1537; MELNICK SL, 1994, JAMA-J AM MED ASSOC, V272, P1915, DOI 10.1001/jama.272.24.1915; Mocroft A, 2009, CLIN INFECT DIS, V48, P1138, DOI 10.1086/597468; PHILLIPS AN, 1994, AIDS, V8, P831, DOI 10.1097/00002030-199406000-00017; Poundstone KE, 2001, AIDS, V15, P1115, DOI 10.1097/00002030-200106150-00006; Price RW, 2014, SEMIN NEUROL, V34, P7, DOI 10.1055/s-0034-1372337; Prins M, 2005, AIDS, V19, P357, DOI 10.1097/01.aids.0000161765.75663.27; Prins M, 1999, AIDS, V13, P2361, DOI 10.1097/00002030-199912030-00007; Robertson KR, 2004, JAIDS-J ACQ IMM DEF, V36, P817, DOI 10.1097/00126334-200407010-00008; Smith T, SURVIVAL ANAL USING, P5; United States Department of Agriculture, USDA ERS URB INFL CO; VELLA S, 1995, AIDS, V9, P51, DOI 10.1097/00002030-199501000-00007; Vivithanaporn P, 2010, NEUROLOGY, V75, P1150, DOI 10.1212/WNL.0b013e3181f4d5bb; VONOVERBECK J, 1994, AIDS, V8, P1307, DOI 10.1097/00002030-199409000-00014; Wilson M, 2006, J PETROL, V47, P1	27	4	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2015	10	6							e0123119	10.1371/journal.pone.0123119	http://dx.doi.org/10.1371/journal.pone.0123119			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4OM	26107253	Green Published, gold			2022-12-26	WOS:000356932500004
J	Gazmuri, RJ; Whitehouse, K; Whittinghill, K; Baetiong, A; Radhakrishnan, J				Gazmuri, Raul J.; Whitehouse, Kasen; Whittinghill, Karla; Baetiong, Alvin; Radhakrishnan, Jeejabai			Vasopressin Infusion with Small-Volume Fluid Resuscitation during Hemorrhagic Shock Promotes Hemodynamic Stability and Survival in Swine	PLOS ONE			English	Article							ARGININE-VASOPRESSIN; ABDOMINAL-SURGERY; LIVER TRAUMA; IMPLEMENTATION; NOREPINEPHRINE; STRATEGIES; MILITARY; PRESSURE; FUTURE	Introduction Current management of hemorrhagic shock (HS) in the battlefield and civilian settings favors small-volume fluid resuscitation before controlling the source of bleeding. We investigated in a swine model of HS the effects of vasopressin infusion along with small-volume fluid resuscitation; with erythropoietin (EPO) and HS severity as additional factors. Methods HS was induced in 24 male domestic pigs (36 to 41 kg) by blood withdrawal (BW) through a right atrial cannula modeling spontaneous bleeding by a mono-exponential decay function. The initial 12 pigs received no fluids; the last 12 pigs received normal saline (NS) half the BW volume. Pigs were randomized 2:1 to receive intraosseously vasopressin (0.04 U/kg.min(-1)) or vehicle control from minute 7 to minute 210. Pigs assigned to vasopressin were further randomized 1:1 to receive EPO (1,200 U/kg) or vehicle control and 1:1 to have 65% or 75% BW of their blood volume. Shed blood was reinfused at 210 minutes and the pigs recovered from anesthesia. Results Survival at 72 hours was influenced by vasopressin and NS but not by EPO or % BW. Vasopressin with NS promoted the highest survival (8/8) followed by vasopressin without NS (3/8), NS without vasopressin (1/4), and neither treatment (0/4) with overall statistical significance (log-rank test, p = 0.009) and each subset different from vasopressin with NS by Holm-Sidak test. Vasopressin increased systemic vascular resistance whereas NS increased cardiac output. Conclusion Vasopressin infusion with small-volume fluid resuscitation during severe HS was highly effective enabling critical hemodynamic stabilization and improved 72 hour survival.	[Gazmuri, Raul J.; Whitehouse, Kasen; Whittinghill, Karla; Baetiong, Alvin; Radhakrishnan, Jeejabai] Rosalind Franklin Univ Med & Sci, Dept Med, N Chicago, IL 60064 USA; [Gazmuri, Raul J.; Whitehouse, Kasen; Whittinghill, Karla; Baetiong, Alvin; Radhakrishnan, Jeejabai] Rosalind Franklin Univ Med & Sci, Resuscitat Inst, N Chicago, IL USA; [Gazmuri, Raul J.] Rosalind Franklin Univ Med & Sci, Dept Physiol, N Chicago, IL USA; [Gazmuri, Raul J.] Captain James A Lovell Fed Hlth Care Ctr, Crit Care Med, N Chicago, IL USA	Rosalind Franklin University Medical & Science; Rosalind Franklin University Medical & Science; Rosalind Franklin University Medical & Science	Gazmuri, RJ (corresponding author), Rosalind Franklin Univ Med & Sci, Dept Med, N Chicago, IL 60064 USA.	raul.gazmuri@rosalindfranklin.edu		Gazmuri, Raul J./0000-0002-3848-7227	Telemedicine and Advanced Technology Research Center (TATRC) at the U.S. Army Medical Research and Materiel Command (USAMRMC) Fort Detrick, MD [W81XWH-11-2-0019]	Telemedicine and Advanced Technology Research Center (TATRC) at the U.S. Army Medical Research and Materiel Command (USAMRMC) Fort Detrick, MD	This research was supported by the Telemedicine and Advanced Technology Research Center (TATRC) at the U.S. Army Medical Research and Materiel Command (USAMRMC) Fort Detrick, MD under contract number: W81XWH-11-2-0019 to RJG.	Anand T, 2012, J SURG RES, V178, P321, DOI 10.1016/j.jss.2012.02.062; BICKELL WH, 1994, NEW ENGL J MED, V331, P1105, DOI 10.1056/NEJM199410273311701; Borovnik-Lesjak V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110908; Campion EM, 2013, J TRAUMA ACUTE CARE, V75, pS221, DOI 10.1097/TA.0b013e318299d59b; Davenport R, 2013, TRANSFUSION, V53, p23S, DOI 10.1111/trf.12032; den Ouden DT, 2005, NETH J MED, V63, P4; Dubick Michael A, 2011, US Army Med Dep J, P18; Eastridge BJ, 2012, J TRAUMA ACUTE CARE, V73, pS431, DOI 10.1097/TA.0b013e3182755dcc; Faybik P, 2010, RESUSCITATION, V81, P1584, DOI 10.1016/j.resuscitation.2010.05.024; Gazmuri RJ, 2001, CRIT CARE MED, V29, P673, DOI 10.1097/00003246-200103000-00042; Guzman JA, 2003, J APPL PHYSIOL, V95, P803, DOI 10.1152/japplphysiol.00017.2003; Hasser EM, 1997, CLIN EXP PHARMACOL P, V24, P102, DOI 10.1111/j.1440-1681.1997.tb01791.x; Hooper TJ, 2014, SHOCK, V41, P90, DOI 10.1097/SHK.0000000000000081; KELLEY KW, 1973, J ANIM SCI, V36, P927; Madigan MC, 2008, J TRAUMA, V64, P280, DOI 10.1097/TA.0b013e3181622bb6; Moore EE, 1996, AM J SURG, V172, P405, DOI 10.1016/S0002-9610(96)00216-4; Nunez TC, 2010, J TRAUMA, V68, P1498, DOI 10.1097/TA.0b013e3181d3cc25; PANG CCY, 1986, BRIT J PHARMACOL, V89, P389, DOI 10.1111/j.1476-5381.1986.tb10272.x; Radhakrishnan J, 2013, AM J TRANSL RES, V5, P316; Raedler C, 2004, ANESTH ANALG, V98, P1759, DOI 10.1213/01.ANE.0000117150.29361.5A; Rajani RR, 2009, AM SURGEON, V75, P1207; Russell JA, 2013, AM J RESP CRIT CARE, V188, P356, DOI 10.1164/rccm.201302-0355OC; SANDERS AB, 1994, ANN EMERG MED, V23, P56, DOI 10.1016/S0196-0644(94)70009-5; Shaw AD, 2012, ANN SURG, V255, P821, DOI 10.1097/SLA.0b013e31825074f5; Voelckel WG, 2003, CRIT CARE MED, V31, P1160, DOI 10.1097/01.CCM.0000060014.75282.69; Voelckel WG, 2010, J TRAUMA, V69, pS69, DOI 10.1097/TA.0b013e3181e44937; Volta CA, 2013, J INFLAMM-LOND, V10, DOI 10.1186/1476-9255-10-29; Yoo JH, 2007, J VET MED SCI, V69, P459, DOI 10.1292/jvms.69.459	28	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2015	10	6							e0130134	10.1371/journal.pone.0130134	http://dx.doi.org/10.1371/journal.pone.0130134			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4OM	26107942	Green Submitted, Green Published, gold			2022-12-26	WOS:000356932500080
J	Donahue, MJ; Karnauskas, M; Toews, C; Paris, CB				Donahue, Megan J.; Karnauskas, Mandy; Toews, Carl; Paris, Claire B.			Location Isn't Everything: Timing of Spawning Aggregations Optimizes Larval Replenishment	PLOS ONE			English	Article							TRANSPORT; LIFE	Many species of reef fishes form large spawning aggregations that are highly predictable in space and time. Prior research has suggested that aggregating fish derive fitness benefits not just from mating at high density but, also, from oceanographic features of the spatial locations where aggregations occur. Using a probabilistic biophysical model of larval dispersal coupled to a fine resolution hydrodynamic model of the Florida Straits, we develop a stochastic landscape of larval fitness. Tracking virtual larvae from release to settlement and incorporating changes in larval behavior through ontogeny, we found that larval success was sensitive to the timing of spawning. Indeed, propagules released during the observed spawning period had higher larval success rates than those released outside the observed spawning period. In contrast, larval success rates were relatively insensitive to the spatial position of the release site. In addition, minimum (rather than mean) larval survival was maximized during the observed spawning period, indicating a reproductive strategy that minimizes the probability of recruitment failure. Given this landscape of larval fitness, we take an inverse optimization approach to define a biological objective function that reflects a tradeoff between the mean and variance of larval success in a temporally variable environment. Using this objective function, we suggest that the length of the spawning period can provide insight into the tradeoff between reproductive risk and reward.	[Donahue, Megan J.] Univ Hawaii, Hawaii Inst Marine Biol, Kaneohe, HI 96744 USA; [Karnauskas, Mandy] Southeast Fisheries Sci Ctr, Miami, FL USA; [Toews, Carl] Univ Puget Sound, Dept Math & Comp Sci, Tacoma, WA 98416 USA; [Paris, Claire B.] Univ Miami, Rosentiel Sch Marine & Atmospher Sci, Miami, FL USA	University of Hawaii System; University of Miami	Donahue, MJ (corresponding author), Univ Hawaii, Hawaii Inst Marine Biol, Kaneohe, HI 96744 USA.	donahuem@hawaii.edu	Donahue, Megan/Q-3528-2017	Donahue, Megan/0000-0002-7529-001X; Paris-Limouzy, Claire Beatrix/0000-0002-0637-1334; Karnauskas, Mandy/0000-0002-6631-0592	National Science Foundation; U.S. Department of Homeland Security; U.S. Department of Agriculture through NSF [EF-0832858]; University of Tennessee, Knoxville; Div Of Biological Infrastructure [1300426] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); U.S. Department of Homeland Security(United States Department of Homeland Security (DHS)); U.S. Department of Agriculture through NSF(National Science Foundation (NSF)); University of Tennessee, Knoxville; Div Of Biological Infrastructure(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was conducted as a part of the 'Pretty Darn Good' Control Working Group at the National Institute for Mathematical and Biological Synthesis, sponsored by the National Science Foundation (www.nsf.gov), the U.S. Department of Homeland Security (www.dhs.gov), and the U.S. Department of Agriculture (www.usda.gov) through NSF Award #EF-0832858, with additional support from The University of Tennessee, Knoxville (www.utk.edu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AndrrAndre S, 2006, GLOBAL ASSESSMENT MO; Chassignet EP, 2007, J MARINE SYST, V65, P60, DOI 10.1016/j.jmarsys.2005.09.016; Childs DZ, 2010, P ROY SOC B-BIOL SCI, V277, P3055, DOI 10.1098/rspb.2010.0707; Claro Rodolfo, 2003, Gulf and Caribbean Research, V14, P91; D'Alessandro EK, 2011, J EXP MAR BIOL ECOL, V399, P182, DOI 10.1016/j.jembe.2010.12.014; Domeier ML, 1997, B MAR SCI, V60, P698; Gladstone W, 2007, MAR BIOL, V151, P1143, DOI 10.1007/s00227-006-0555-2; Hamilton SL, 2008, P NATL ACAD SCI USA, V105; Heppell SA, 2008, P 61 GULF CARIBB FIS; Holstein DM, 2014, MAR ECOL PROG SER, V499, P1, DOI 10.3354/meps10647; JOHANNES R E, 1978, Environmental Biology of Fishes, V3, P65, DOI 10.1007/BF00006309; Karnauskas M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022067; Kourafalou VH, 2012, J GEOPHYS RES-OCEANS, V117, DOI 10.1029/2011JC007383; Lindeman KC, 1997, THESIS U MIAMI; Naud MJ, 2004, ANIM BEHAV, V67, P1043, DOI 10.1016/j.anbehav.2003.10.005; Paris CB, 2005, MAR ECOL PROG SER, V296, P93, DOI 10.3354/meps296093; Paris CB, 2013, ENVIRON MODELL SOFTW, V42, P47, DOI 10.1016/j.envsoft.2012.12.006; REAL L, 1986, ANNU REV ECOL SYST, V17, P371, DOI 10.1146/annurev.es.17.110186.002103; REAL LA, 1992, ECOLOGY, V73, P1227, DOI 10.2307/1940671; Sadovy Y, 2005, CORAL REEFS, V24, P254, DOI 10.1007/s00338-005-0474-6; SHAPIRO DY, 1988, ENVIRON BIOL FISH, V22, P3, DOI 10.1007/BF00000540; Sponaugle S, 2006, INTEGR COMP BIOL, V46, P623, DOI 10.1093/icb/icl014; Stearns SC, 2000, NATURWISSENSCHAFTEN, V87, P476, DOI 10.1007/s001140050763; Whaylen L, 2004, ENVIRON BIOL FISH, V70, P305, DOI 10.1023/B:EBFI.0000033341.57920.a8	24	26	26	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2015	10	6							e0130694	10.1371/journal.pone.0130694	http://dx.doi.org/10.1371/journal.pone.0130694			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4DD	26103162	Green Submitted, Green Published, gold			2022-12-26	WOS:000356901900058
J	Halava, H; Westerlund, H; Korhonen, MJ; Pentti, J; Kivimaki, M; Kjeldgard, L; Alexanderson, K; Vahtera, J				Halava, Heli; Westerlund, Hugo; Korhonen, Maarit Jaana; Pentti, Jaana; Kivimaeki, Mika; Kjeldgard, Linnea; Alexanderson, Kristina; Vahtera, Jussi			Influence of Retirement on Adherence to Statins in the Insurance Medicine All-Sweden Total Population Data Base	PLOS ONE			English	Article							MEDICATION ADHERENCE; NATIONWIDE REGISTER; RISK INDICATORS; THERAPY; METAANALYSIS; PREDICTORS; NONADHERENCE; HEALTH; COHORT; HYPERTENSION	Background Retirement has been suggested to reduce medication adherence, but no evidence is available for statins. We investigated changes in adherence to statins among Swedish adults after retirement. Methods A prospective cohort study was carried out on all individuals living in Sweden on 31 December 2004, alive in 2010, having purchased statins in the second half of 2005, and retired in 2008 (n=11 718). We used prescription dispensing data in 2006-2010 to determine nonadherence (defined as <80% of days covered by filled prescriptions) before and after old-age or disability retirement. Using multiple repeat measurements of filled statin prescriptions, we calculated the annual prevalence rates of nonadherence for those who continued therapy. Discontinuation was defined as no statin dispensations during a calendar year. Results After adjustment for age at retirement, the prevalence ratio (PR) of nonadherence after retirement in comparison with those before retirement was 1.23 [95% confidence interval (CI) 1.17-1.29] for the men and 1.19 (95% CI 1.13-1.26) for the women. A post-retirement increase in nonadherence was consistently observed across the strata of age at retirement, marital status, education, income, type of retirement, and participants with and without cardiovascular disease, the largest increases being observed for statin use in secondary prevention (men: PR 1.38, 95% CI 1.26-1.54; women: PR 1.43, 1.18-1.72). For primary prevention, the corresponding prevalence ratios were 1.18 (95% CI 1.13. 1.25) and 1.18 (95% CI 1.11-1.24), respectively. Interpretation Retirement appears to be associated with increased nonadherence to statin therapy among Swedish men and women.	[Halava, Heli; Vahtera, Jussi] Univ Turku, Dept Publ Hlth, Turku, Finland; [Westerlund, Hugo] Stockholm Univ, Stress Res Inst, S-10691 Stockholm, Sweden; [Westerlund, Hugo; Kjeldgard, Linnea; Alexanderson, Kristina; Vahtera, Jussi] Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden; [Korhonen, Maarit Jaana] Univ Turku, Dept Pharmacol Drug Dev & Therapeut, Turku, Finland; [Pentti, Jaana; Vahtera, Jussi] Finnish Inst Occupat Hlth, Turku, Finland; [Kivimaeki, Mika] UCL, Dept Epidemiol & Publ Hlth, London, England; [Vahtera, Jussi] Turku Univ Hosp, FIN-20520 Turku, Finland	University of Turku; Stockholm University; Karolinska Institutet; University of Turku; Finnish Institute of Occupational Health; University of London; University College London; University of Turku	Halava, H (corresponding author), Univ Turku, Dept Publ Hlth, Turku, Finland.	heli.halava@utu.fi	Westerlund, Hugo/A-3049-2012; Kivimaki, Mika/B-3607-2012	Westerlund, Hugo/0000-0002-8806-5698; Kivimaki, Mika/0000-0002-4699-5627; Vahtera, Jussi/0000-0002-6036-061X; Korhonen, Maarit/0000-0002-2953-4757; Kjeldgard, Linnea/0000-0002-4575-7483	Social Insurance Institution of Finland; Finnish Work Environment Foundation; United Kingdom Medical Research Council; Economic and Social Research Council, United Kingdom; Academy of Finland [264944, 267727]; ESRC [ES/J023299/1] Funding Source: UKRI; MRC [MR/K013351/1] Funding Source: UKRI; Economic and Social Research Council [ES/J023299/1] Funding Source: researchfish; Medical Research Council [MR/K013351/1] Funding Source: researchfish	Social Insurance Institution of Finland; Finnish Work Environment Foundation; United Kingdom Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Economic and Social Research Council, United Kingdom(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Academy of Finland(Academy of Finland); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	MJK received grants from the Social Insurance Institution of Finland. MK is supported by the Finnish Work Environment Foundation, the United Kingdom Medical Research Council, and a professorial fellowship from the Economic and Social Research Council, United Kingdom. JV was supported by Academy of Finland (grant #264944 and 267727). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chan DC, 2010, MED CARE, V48, P196, DOI 10.1097/MLR.0b013e3181c132ad; Chowdhury R, 2013, EUR HEART J, V34, P2940, DOI 10.1093/eurheartj/eht295; Godman B, 2010, EXPERT REV PHARM OUT, V10, P707, DOI [10.1586/erp.10.72, 10.1586/ERP.10.72]; Grenard JL, 2011, J GEN INTERN MED, V26, P1175, DOI 10.1007/s11606-011-1704-y; Halava H, 2014, CAN MED ASSOC J, V186, pE449, DOI 10.1503/cmaj.131807; Haukenes I, 2013, J EPIDEMIOL COMMUN H, V67, P758, DOI 10.1136/jech-2012-202182; Helin-Salmivaara A, 2008, CLIN THER, V30, P2228, DOI 10.1016/j.clinthera.2008.12.003; Karlsson Nadine, 2006, Work, V27, P173; Kildemoes HW, 2010, PHARMACOEPIDEM DR S, V19, P1276, DOI 10.1002/pds.2039; Kivimaki M, 2013, CAN MED ASSOC J, V185, pE784, DOI 10.1503/cmaj.122010; Krousel-Wood M, 2011, HYPERTENSION, V58, P804, DOI 10.1161/HYPERTENSIONAHA.111.176859; Latry P, 2010, EUR J CLIN PHARMACOL, V66, P743, DOI 10.1007/s00228-010-0819-0; Lemstra M, 2012, CAN J CARDIOL, V28, P574, DOI 10.1016/j.cjca.2012.05.007; Lemstra M, 2012, CAN J CARDIOL, V28, P567, DOI 10.1016/j.cjca.2012.03.018; Lesen E, 2011, PHARMACOEPIDEM DR S, V20, P1073, DOI 10.1002/pds.2204; Lewey J, 2013, AM HEART J, V165, P665, DOI 10.1016/j.ahj.2013.02.011; Li PX, 2012, ANN INTERN MED, V156, P776, DOI 10.7326/0003-4819-156-11-201206050-00004; Lim SS, 2012, LANCET, V380, P2224, DOI DOI 10.1016/S0140-6736(12)61766-8; LIPSITZ SR, 1994, STAT MED, V13, P1149, DOI 10.1002/sim.4780131106; Mann DM, 2010, ANN PHARMACOTHER, V44, P1410, DOI 10.1345/aph.1P150; Moran GM, 2014, EUR J NEUROL, V21, P1258, DOI 10.1111/ene.12469; Murphy GK, 2015, CAN J CARDIOL, V31, P341, DOI 10.1016/j.cjca.2014.11.024; Nichols M, 2013, EUR HEART J, V34, P3028, DOI 10.1093/eurheartj/eht356; Oksanen T, 2011, EPIDEMIOLOGY, V22, P553, DOI 10.1097/EDE.0b013e31821c41bd; Osterberg L, 2005, NEW ENGL J MED, V353, P487, DOI 10.1056/NEJMra050100; Pettersson B, 2012, HEALTH POLICY, V104, P84, DOI 10.1016/j.healthpol.2011.10.010; Pietilainen O, 2011, PLOS ONE, V20, P6; Reiner Z, 2011, EUR HEART J, V32, P1769, DOI [10.1093/eurheartj/ehr158, 10.1016/j.atherosclerosis.2011.06.012]; Simeonova E, 2013, J HEALTH ECON, V32, P33, DOI 10.1016/j.jhealeco.2012.10.010; Sjosten N, 2013, J HYPERTENS, V31, P1477, DOI 10.1097/HJH.0b013e32836098d1; Svensson E, 2015, CLIN EPIDEMIOL, V7, P213, DOI 10.2147/CLEP.S78145; Vahtera J, 2007, SLEEP, V30, P1537, DOI 10.1093/sleep/30.11.1537; von Bonsdorff ME, 2010, OCCUP MED-OXFORD, V60, P94, DOI 10.1093/occmed/kqp126; Wang M, 2014, OCCUP ENVIRON MED, V71, P12, DOI 10.1136/oemed-2013-101462; Weber MT, 2014, J STEROID BIOCHEM, V142, P90, DOI 10.1016/j.jsbmb.2013.06.001; Westerlund H, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c6149; Westerlund H, 2009, LANCET, V374, P1889, DOI 10.1016/S0140-6736(09)61570-1; WHO, 2015, US ATC DDD; World Health Organization, 2015, INT CLASS DIS ICD	39	11	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2015	10	6							e0130901	10.1371/journal.pone.0130901	http://dx.doi.org/10.1371/journal.pone.0130901			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CL4DD	26102521	gold, Green Published, Green Submitted			2022-12-26	WOS:000356901900067
J	Su, YY; Nishimoto, T; Feghali-Bostwick, C				Su, Yunyun; Nishimoto, Tetsuya; Feghali-Bostwick, Carol			IGFBP-5 Promotes Fibrosis Independently of Its Translocation to the Nucleus and Its Interaction with Nucleolin and IGF	PLOS ONE			English	Article							FACTOR-BINDING PROTEIN-5; BREAST-CANCER CELLS; FACTOR (IGF)-BINDING PROTEIN-5; SURFACE-EXPRESSED NUCLEOLIN; INHIBITS HIV-INFECTION; EXTRACELLULAR-MATRIX; PULMONARY-FIBROSIS; PLASMA PROTEIN-A2; MAMMARY-GLAND; I ACTIONS	Background Insulin-like growth factor binding protein (IGFBP)-5 levels are increased in systemic sclerosis (SSc) skin and lung. We previously reported that IGFBP-5 is a pro-fibrotic factor that induces extracellular matrix (ECM) production and deposition. Since IGFBP-5 contains a nuclear localization signal (NLS) that facilitates its nuclear translocation, we sought to examine the role of nuclear translocation on the fibrotic activity of IGFBP-5 and identify IGFBP-5 binding partners relevant for its nuclear compartmentalization. Methods We generated functional wild type IGFBP-5 and IGFBP-5 with a mutated NLS or a mutated IGF binding site. Abrogation of nuclear translocation in the NLS mutant was confirmed using immunofluorescence and immunoblotting of nuclear and cytoplasmic cellular extracts. Abrogation of IGF binding was confirmed using western ligand blot. The fibrotic activity of wild type and mutant IGFBP-5 was examined in vitro in primary human fibroblasts and ex vivo in human skin. We identified IGFBP-5 binding partners using immunoprecipitation and mass spectrometry. We examined the effect of nucleolin on IGFBP-5 localization and function via sequence-specific silencing in primary human fibroblasts. Results Our results show that IGFBP-5-induced ECM production in vitro in primary human fibroblasts is independent of its nuclear translocation. The NLS-mutant also induced fibrosis ex vivo in human skin, thus confirming and extending the in vitro findings. Similar findings were obtained with the IGF-binding mutant. Nucleolin, a nucleolar protein that can serve as a nuclear receptor, was identified as an IGFBP-5 binding partner. Silencing nucleolin reduced IGFBP-5 translocation to the nucleus but did not block the ability of IGFBP-5 to induce ECM production and a fibrotic phenotype. Conclusions IGFBP-5 transport to the nucleus requires an intact NLS and nucleolin. However, nuclear translocation is not necessary for IGFBP-5 fibrotic activity; neither is IGF binding. Our data provide further insights into the role of cellular compartmentalization in IGFBP-5- induced fibrosis.	[Su, Yunyun; Nishimoto, Tetsuya; Feghali-Bostwick, Carol] Med Univ S Carolina, Div Rheumatol & Immunol, Dept Med, Charleston, SC 29425 USA	Medical University of South Carolina	Feghali-Bostwick, C (corresponding author), Med Univ S Carolina, Div Rheumatol & Immunol, Dept Med, Charleston, SC 29425 USA.	feghalib@musc.edu			NIH/NIAMS [R01 AR050840, K24 AR060297, P60 AR049459-05]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K24AR060297, R01AR050840, P60AR049459] Funding Source: NIH RePORTER	NIH/NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by NIH/NIAMS grants R01 AR050840 (CFB), K24 AR060297 (CFB), and P60 AR049459-05 (pilot project to YYS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akkiprik M, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-103; Amaar YG, 2005, J BONE MINER RES, V20, P1430, DOI 10.1359/JBMR.050311; Amaar YG, 2002, J BIOL CHEM, V277, P12053, DOI 10.1074/jbc.M110872200; ANDREWS NC, 1991, NUCLEIC ACIDS RES, V19, P2499, DOI 10.1093/nar/19.9.2499; Barel M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014193; BOURBON H, 1983, FEBS LETT, V155, P218, DOI 10.1016/0014-5793(82)80606-6; CHEN CM, 1991, J BIOL CHEM, V266, P7754; Cobb LJ, 2004, J CELL SCI, V117, P1737, DOI 10.1242/jcs.01028; Feghali CA, 1999, ARTHRITIS RHEUM-US, V42, P1451, DOI 10.1002/1529-0131(199907)42:7<1451::AID-ANR19>3.0.CO;2-6; Flint DJ, 2000, J MAMMARY GLAND BIOL, V5, P65, DOI 10.1023/A:1009567316520; Ginisty H, 1998, EMBO J, V17, P1476, DOI 10.1093/emboj/17.5.1476; Hermani A, 2013, CELL SIGNAL, V25, P1395, DOI 10.1016/j.cellsig.2013.02.018; Hovanessian AG, 2006, CELL RES, V16, P174, DOI 10.1038/sj.cr.7310024; Imai Y, 2000, J BIOL CHEM, V275, P18188, DOI 10.1074/jbc.M000070200; JONES JI, 1993, J CELL BIOL, V121, P679, DOI 10.1083/jcb.121.3.679; LAPEYRE B, 1987, P NATL ACAD SCI USA, V84, P1472, DOI 10.1073/pnas.84.6.1472; LISCHWE MA, 1982, J BIOL CHEM, V257, P4600; LISCHWE MA, 1985, BIOCHEMISTRY-US, V24, P6025, DOI 10.1021/bi00343a001; Ma N, 2007, J CELL SCI, V120, P2091, DOI 10.1242/jcs.008771; Moralez AM, 2005, J CELL PHYSIOL, V203, P328, DOI 10.1002/jcp.20343; Nam T, 2002, ENDOCRINOLOGY, V143, P30, DOI 10.1210/en.143.1.30; Nam TJ, 2000, ENDOCRINOLOGY, V141, P1100, DOI 10.1210/en.141.3.1100; Overgaard MT, 2001, J BIOL CHEM, V276, P21849, DOI 10.1074/jbc.M102191200; Parker A, 1998, MOL BIOL CELL, V9, P2383, DOI 10.1091/mbc.9.9.2383; Perks CM, 2000, J CELL BIOCHEM, V80, P248; Pilewski JM, 2005, AM J PATHOL, V166, P399, DOI 10.1016/S0002-9440(10)62263-8; Said EA, 2005, FEBS J, V272, P4646, DOI 10.1111/j.1742-4658.2005.04870.x; Santos AM, 2009, J CLIN INVEST, V119, P3613, DOI 10.1172/JCI38988; Schedlich LJ, 1998, J BIOL CHEM, V273, P18347, DOI 10.1074/jbc.273.29.18347; Schedlich LJ, 2000, J BIOL CHEM, V275, P23462, DOI 10.1074/jbc.M002208200; Seinsoth S, 2003, EMBO REP, V4, P263, DOI 10.1038/sj.embor.embor770; Seurin D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059323; Shi HB, 2007, BLOOD, V110, P2899, DOI 10.1182/blood-2007-01-064428; Sureshbabu A, 2012, J CELL SCI, V125, P1693, DOI 10.1242/jcs.092882; Tonner E, 2000, ADV EXP MED BIOL, V480, P45; Tripathi G, 2009, FASEB J, V23, P2616, DOI 10.1096/fj.08-114124; Xu QJ, 2004, CIRC RES, V94, pE46, DOI 10.1161/01.RES.0000124761.62846.DF; Yamaguchi Y, 2011, J CELL MOL MED, V15, P957, DOI 10.1111/j.1582-4934.2010.01063.x; Yan XL, 2010, J CLIN ENDOCR METAB, V95, P1412, DOI 10.1210/jc.2009-2277; Yasuoka H, 2006, AM J PATHOL, V169, P1633, DOI 10.2353/ajpath.2006.060501; Yasuoka H, 2006, ARTHRITIS RHEUM-US, V54, P3001, DOI 10.1002/art.22084; Yasuoka H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087754; Yasuoka H, 2009, AM J RESP CELL MOL, V41, P179, DOI 10.1165/rcmb.2008-0211OC; Yasuoka Hidekata, 2008, Open Rheumatol J, V2, P17, DOI 10.2174/1874312900802010017; Yasuoka H, 2009, AM J PATHOL, V175, P605, DOI 10.2353/ajpath.2009.080991	45	15	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2015	10	6							0130546	10.1371/journal.pone.0130546	http://dx.doi.org/10.1371/journal.pone.0130546			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4DD	26103640	Green Published, gold, Green Submitted			2022-12-26	WOS:000356901900049
J	Arregi, I; Falces, J; Olazabal-Herrero, A; Alonso-Marino, M; Taneva, SG; Rodriguez, JA; Urbaneja, MA; Banuelos, S				Arregi, Igor; Falces, Jorge; Olazabal-Herrero, Anne; Alonso-Marino, Marian; Taneva, Stefka G.; Rodriguez, Jose A.; Urbaneja, Maria A.; Banuelos, Sonia			Leukemia-Associated Mutations in Nucleophosmin Alter Recognition by CRM1: Molecular Basis of Aberrant Transport	PLOS ONE			English	Article							NUCLEAR-EXPORT SIGNALS; CRYSTAL-STRUCTURE; SEQUENCE; LOCALIZATION; ACCUMULATION; STABILITY; CHAPERONE; TERMINUS; PROTEINS; INSIGHTS	Nucleophosmin (NPM) is a nucleocytoplasmic shuttling protein, normally enriched in nucleoli, that performs several activities related to cell growth. NPM mutations are characteristic of a subtype of acute myeloid leukemia (AML), where mutant NPM seems to play an oncogenic role. AML-associated NPM mutants exhibit altered subcellular traffic, being aberrantly located in the cytoplasm of leukoblasts. Exacerbated export of AML variants of NPM is mediated by the nuclear export receptor CRM1, and due, in part, to a mutationally acquired novel nuclear export signal (NES). To gain insight on the molecular basis of NPM transport in physiological and pathological conditions, we have evaluated the export efficiency of NPM in cells, and present new data indicating that, in normal conditions, wild type NPM is weakly exported by CRM1. On the other hand, we have found that AML-associated NPM mutants efficiently form complexes with CRM1(HA) (a mutant CRM1 with higher affinity for NESs), and we have quantitatively analyzed CRM1(HA) interaction with the NES motifs of these mutants, using fluorescence anisotropy and isothermal titration calorimetry. We have observed that the affinity of CRM1(HA) for these NESs is similar, which may help to explain the transport properties of the mutants. We also describe NPM recognition by the import machinery. Our combined cellular and biophysical studies shed further light on the determinants of NPM traffic, and how it is dramatically altered by AML-related mutations.	[Arregi, Igor; Falces, Jorge; Alonso-Marino, Marian; Taneva, Stefka G.; Urbaneja, Maria A.; Banuelos, Sonia] Univ Basque Country, UPV EHU, CSIC, Unidad Biofis, Leioa, Spain; [Olazabal-Herrero, Anne; Rodriguez, Jose A.] Univ Basque Country, Dept Genet Phys Anthropol & Anim Physiol, Leioa, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); University of Basque Country; CSIC - UPV EHU - Instituto Biofisika; University of Basque Country	Banuelos, S (corresponding author), Univ Basque Country, UPV EHU, CSIC, Unidad Biofis, Leioa, Spain.	sonia.banuelos@ehu.es	Rodriguez, Jose Antonio/AAA-1125-2019; Bañuelos, Sonia/N-9128-2019; LARIJANI, Professor Banafshe/H-3909-2015	Rodriguez, Jose Antonio/0000-0002-2823-3733; Bañuelos, Sonia/0000-0002-1399-381X; LARIJANI, Professor Banafshe/0000-0003-4735-1169; Alonso, Marian/0000-0003-1347-4347	Spanish Ministry of Economy [SAF2014-57743-R]; Basque Government Department of Industry [ETORTEK BioGUNE IE12-331]; University of the Basque Country [IT709-13, UFI 11/20]; Fundacion Biofisica Bizkaia	Spanish Ministry of Economy(Spanish Government); Basque Government Department of Industry(Basque Government); University of the Basque Country; Fundacion Biofisica Bizkaia	This work was supported by the Spanish Ministry of Economy (www.mineco.gob.es) (grant SAF2014-57743-R to JAR and SB), the Basque Government (www.euskadi.net) Department of Industry (grant ETORTEK BioGUNE IE12-331), and the University of the Basque Country (www.ehu.eus) (grant IT709-13). JAR thanks support from the University of the Basque Country (UFI 11/20). SGT was an IKERBASQUE (www.ikerbasque.net) visiting senior researcher. IA is funded by Fundacion Biofisica Bizkaia (www.fundacionbiofisicabizkaia.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azmi AS, 2014, SEMIN CANCER BIOL, V27, P1, DOI 10.1016/j.semcancer.2014.04.011; Banuelos S, 2013, FEBS LETT, V587, P2254, DOI 10.1016/j.febslet.2013.05.055; Bolli N, 2007, CANCER RES, V67, P6230, DOI 10.1158/0008-5472.CAN-07-0273; Bolli N, 2010, BLOOD, V115, P3329, DOI 10.1182/blood-2009-02-207225; BORER RA, 1989, CELL, V56, P379, DOI 10.1016/0092-8674(89)90241-9; Cheng K, 2010, BLOOD, V115, P3341, DOI 10.1182/blood-2009-03-208587; Chiarella S, 2013, NUCLEIC ACIDS RES, V41, P3228, DOI 10.1093/nar/gkt001; Colombo E, 2005, MOL CELL BIOL, V25, P8874, DOI 10.1128/MCB.25.20.8874-8886.2005; Colombo E, 2002, NAT CELL BIOL, V4, P529, DOI 10.1038/ncb814; Dian C, 2013, STRUCTURE, V21, P1338, DOI 10.1016/j.str.2013.06.003; Dong XH, 2009, NATURE, V458, P1136, DOI 10.1038/nature07975; Emmott E, 2009, EMBO REP, V10, P231, DOI 10.1038/embor.2009.14; Etchin J, 2013, LEUKEMIA, V27, P66, DOI 10.1038/leu.2012.219; Falces J, 2010, BIOCHEMISTRY-US, V49, P9756, DOI 10.1021/bi101179g; Falini B, 2005, NEW ENGL J MED, V352, P254, DOI 10.1056/NEJMoa041974; Falini B, 2006, BLOOD, V107, P4514, DOI 10.1182/blood-2005-11-4745; Federici L, 2013, PROTEIN SCI, V22, P545, DOI 10.1002/pro.2240; Federici L, 2010, J BIOL CHEM, V285, P37138, DOI 10.1074/jbc.M110.166736; Fox AM, 2011, J BIOL CHEM, V286, P29325, DOI 10.1074/jbc.M111.245092; Fung HYJ, 2014, SEMIN CANCER BIOL, V27, P52, DOI 10.1016/j.semcancer.2014.03.002; Grisendi S, 2006, NAT REV CANCER, V6, P493, DOI 10.1038/nrc1885; Grummitt Charles G, 2008, J Biol Chem, V283, P23326, DOI 10.1074/jbc.M801706200; Guttler T, 2010, NAT STRUCT MOL BIOL, V17, P1367, DOI 10.1038/nsmb.1931; Henderson BR, 2000, EXP CELL RES, V256, P213, DOI 10.1006/excr.2000.4825; Itahana K, 2003, MOL CELL, V12, P1151, DOI 10.1016/S1097-2765(03)00431-3; Koike A, 2010, CANCER RES, V70, P6746, DOI 10.1158/0008-5472.CAN-10-0382; Koyama M, 2010, EMBO J, V29, P2002, DOI 10.1038/emboj.2010.89; Kutay U, 2005, TRENDS CELL BIOL, V15, P121, DOI 10.1016/j.tcb.2005.01.005; Lee HH, 2007, PROTEINS, V69, P672, DOI 10.1002/prot.21504; Lindstrom MS, 2011, BIOCHEM RES INT, V2011, DOI 10.1155/2011/195209; Maggi LB, 2008, MOL CELL BIOL, V28, P7050, DOI 10.1128/MCB.01548-07; Mitrea DM, 2014, P NATL ACAD SCI USA, V111, P4466, DOI 10.1073/pnas.1321007111; Monecke T, 2009, SCIENCE, V324, P1087, DOI 10.1126/science.1173388; Namboodiri VMH, 2004, STRUCTURE, V12, P2149, DOI 10.1016/j.str.2004.09.017; Negi SS, 2006, J CELL SCI, V119, P3676, DOI 10.1242/jcs.03090; Nishimura Y, 2002, BIOSCI BIOTECH BIOCH, V66, P2239, DOI 10.1271/bbb.66.2239; Poletto M, 2014, MOL BIOL CELL, V25, P1641, DOI 10.1091/mbc.E13-12-0717; Prieto G, 2014, BIOINFORMATICS, V30, P1220, DOI 10.1093/bioinformatics/btu016; Rodriguez JA, 2006, ONCOGENE, V25, P4867, DOI 10.1038/sj.onc.1209499; Rodriguez JA, 2000, J BIOL CHEM, V275, P38589, DOI 10.1074/jbc.M003851200; WANG DR, 1994, J BIOL CHEM, V269, P30994; Wang W, 2005, NAT CELL BIOL, V7, P823, DOI 10.1038/ncb1282; Xu DR, 2012, MOL BIOL CELL, V23, P3677, DOI 10.1091/mbc.E12-01-0046; Yu Y, 2006, MOL CELL BIOL, V26, P3798, DOI 10.1128/MCB.26.10.3798-3809.2006	44	14	14	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2015	10	6							e0130610	10.1371/journal.pone.0130610	http://dx.doi.org/10.1371/journal.pone.0130610			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL3FE	26091065	Green Published, Green Submitted, gold			2022-12-26	WOS:000356835000136
J	Gustin, A; Kirchmeyer, M; Koncina, E; Felten, P; Losciuto, S; Heurtaux, T; Tardivel, A; Heuschling, P; Dostert, C				Gustin, Audrey; Kirchmeyer, Melanie; Koncina, Eric; Felten, Paul; Losciuto, Sophie; Heurtaux, Tony; Tardivel, Aubry; Heuschling, Paul; Dostert, Catherine			NLRP3 Inflammasome Is Expressed and Functional in Mouse Brain Microglia but Not in Astrocytes	PLOS ONE			English	Article							MOLECULAR PLATFORM; NALP3 INFLAMMASOME; DISTINCT PATHWAYS; ACTIVATION; IL-1-BETA; INTERLEUKIN-1; NEUROINFLAMMATION; INHIBITION; MECHANISMS; RECEPTORS	Neuroinflammation is the local reaction of the brain to infection, trauma, toxic molecules or protein aggregates. The brain resident macrophages, microglia, are able to trigger an appropriate response involving secretion of cytokines and chemokines, resulting in the activation of astrocytes and recruitment of peripheral immune cells. IL-1 beta plays an important role in this response; yet its production and mode of action in the brain are not fully understood and its precise implication in neurodegenerative diseases needs further characterization. Our results indicate that the capacity to form a functional NLRP3 inflammasome and secretion of IL-1 beta is limited to the microglial compartment in the mouse brain. We were not able to observe IL-1 beta secretion from astrocytes, nor do they express all NLRP3 inflammasome components. Microglia were able to produce IL-1 beta in response to different classical inflammasome activators, such as ATP, Nigericin or Alum. Similarly, microglia secreted IL-18 and IL-1 alpha, two other inflammasome-linked pro-inflammatory factors. Cell stimulation with alpha-synuclein, a neurodegenerative disease-related peptide, did not result in the release of active IL-1 beta by microglia, despite a weak pro-inflammatory effect. Amyloid-beta peptides were able to activate the NLRP3 inflammasome in microglia and IL-1 beta secretion occurred in a P2X7 receptor-independent manner. Thus microglia-dependent inflammasome activation can play an important role in the brain and especially in neuroinflammatory conditions.	[Gustin, Audrey; Kirchmeyer, Melanie; Koncina, Eric; Losciuto, Sophie; Heurtaux, Tony; Heuschling, Paul; Dostert, Catherine] Univ Luxembourg, Fac Sci Technol & Commun, Life Sci Res Unit, Luxembourg, Luxembourg; [Tardivel, Aubry] Univ Lausanne, Inst Biochem, CH-1066 Epalinges, Switzerland	University of Luxembourg; University of Lausanne	Dostert, C (corresponding author), Univ Luxembourg, Fac Sci Technol & Commun, Life Sci Res Unit, Luxembourg, Luxembourg.	catherine.dostert@uni.lu	Dostert, Catherine/AAJ-5473-2020	HEURTAUX, Tony/0000-0002-1709-5312	National Research Fund Luxembourg [C11/BM/1198303]; AFR grant from the National Research Fund Luxembourg [1076532]; Fondation du Pelican de Mie et Pierre Hippert-Faber under the aegis of Fondation de Luxembourg	National Research Fund Luxembourg(Luxembourg National Research Fund); AFR grant from the National Research Fund Luxembourg; Fondation du Pelican de Mie et Pierre Hippert-Faber under the aegis of Fondation de Luxembourg	This work was supported by the National Research Fund Luxembourg, Grant C11/BM/1198303 to CD (www.fnr.lu). AG was supported by an AFR grant (1076532) from the National Research Fund Luxembourg and is the recipient of a fellowship from the Fondation du Pelican de Mie et Pierre Hippert-Faber under the aegis of Fondation de Luxembourg. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abulafia DP, 2009, J CEREBR BLOOD F MET, V29, P534, DOI 10.1038/jcbfm.2008.143; Allan SM, 2001, NAT REV NEUROSCI, V2, P734, DOI 10.1038/35094583; Allan SM, 2005, NAT REV IMMUNOL, V5, P629, DOI 10.1038/nri1664; Butovsky O, 2014, NAT NEUROSCI, V17, P131, DOI 10.1038/nn.3599; Codolo G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055375; Crocker SJ, 2008, GLIA, V56, P1187, DOI 10.1002/glia.20689; El Khoury JB, 2003, J EXP MED, V197, P1657, DOI 10.1084/jem.20021546; Facci L, 2014, SCI REP-UK, V4, DOI 10.1038/srep06824; Farina C, 2007, TRENDS IMMUNOL, V28, P138, DOI 10.1016/j.it.2007.01.005; Felderhoff-Mueser U, 2005, TRENDS NEUROSCI, V28, P487, DOI 10.1016/j.tins.2005.06.008; Freeman D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062143; Glass CK, 2010, CELL, V140, P918, DOI 10.1016/j.cell.2010.02.016; Gonthier B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005099; Gross Olaf, 2012, Immunity, V36, P388, DOI 10.1016/j.immuni.2012.01.018; Guarda G, 2009, NATURE, V460, P269, DOI 10.1038/nature08100; Hafner-Bratkovic I, 2012, CELL MOL LIFE SCI, V69, P4215, DOI 10.1007/s00018-012-1140-0; Halle A, 2008, NAT IMMUNOL, V9, P857, DOI 10.1038/ni.1636; Hanamsagar R, 2012, TRENDS IMMUNOL, V33, P333, DOI 10.1016/j.it.2012.03.001; Hanamsagar R, 2011, J NEUROCHEM, V119, P736, DOI 10.1111/j.1471-4159.2011.07481.x; Heneka MT, 2014, NAT REV IMMUNOL, V14, P463, DOI 10.1038/nri3705; Heneka MT, 2013, NATURE, V493, P674, DOI 10.1038/nature11729; Henn A, 2011, J IMMUNOL, V186, P3237, DOI 10.4049/jimmunol.1002787; Inoue M, 2013, AUTOIMMUN DIS, V2013, DOI 10.1155/2013/859145; Koprich JB, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-8; Lamkanfi M, 2010, J IMMUNOL, V185, P4385, DOI 10.4049/jimmunol.1000803; Latz E, 2013, NAT REV IMMUNOL, V13, P397, DOI 10.1038/nri3452; Losciuto S, 2012, J NEUROSCI METH, V207, P59, DOI 10.1016/j.jneumeth.2012.03.010; Lu B, 2012, NATURE, V488, P670, DOI 10.1038/nature11290; Mariathasan S, 2006, NATURE, V440, P228, DOI 10.1038/nature04515; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; Masters SL, 2011, TRENDS MOL MED, V17, P276, DOI 10.1016/j.molmed.2011.01.005; Masters SL, 2010, NAT IMMUNOL, V11, P897, DOI 10.1038/ni.1935; Minkiewicz J, 2013, GLIA, V61, P1113, DOI 10.1002/glia.22499; Moynagh PN, 2005, J ANAT, V207, P265, DOI 10.1111/j.1469-7580.2005.00445.x; Parajuli B, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.503; Paranjape GS, 2012, ACS CHEM NEUROSCI, V3, P302, DOI 10.1021/cn2001238; Peng H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030344; Ratsimandresy RA, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00440; Robbins GR, 2014, MOL CELL, V54, P297, DOI 10.1016/j.molcel.2014.03.029; Rubartelli A, 2011, TRENDS IMMUNOL, V32, P559, DOI 10.1016/j.it.2011.08.005; Sanz JM, 2009, J IMMUNOL, V182, P4378, DOI 10.4049/jimmunol.0803612; Saura J, 2007, J NEUROINFLAMM, V4, DOI 10.1186/1742-2094-4-26; Sheedy FJ, 2013, NAT IMMUNOL, V14, P812, DOI 10.1038/ni.2639; Shi FS, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-73; Shie FS, 2007, CURR MED CHEM, V14, P2865, DOI 10.2174/092986707782359981; Simi A, 2007, BIOCHEM SOC T, V35, P1122, DOI 10.1042/BST0351122; Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8; Steinman L, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003898; Tarassishin L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103432; Vaccari JPDR, 2008, J NEUROSCI, V28, P3404, DOI 10.1523/JNEUROSCI.0157-08.2008; Vaccari JPD, 2014, J CEREBR BLOOD F MET, V34, P369, DOI 10.1038/jcbfm.2013.227; Walsh JG, 2014, NAT REV NEUROSCI, V15, P84, DOI 10.1038/nrn3638; Wen HT, 2013, IMMUNITY, V39, P432, DOI 10.1016/j.immuni.2013.08.037	54	222	234	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2015	10	6							e0130624	10.1371/journal.pone.0130624	http://dx.doi.org/10.1371/journal.pone.0130624			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL3FE	26091541	Green Published, gold, Green Submitted			2022-12-26	WOS:000356835000139
J	Kanni, T; Tzanetakou, V; Savva, A; Kersten, B; Pistiki, A; van de Veerdonk, FL; Netea, MG; van der Meer, JW; Giamarellos-Bourboulis, EJ				Kanni, Theodora; Tzanetakou, Vassiliki; Savva, Athina; Kersten, Brigit; Pistiki, Aikaterini; van de Veerdonk, Frank L.; Netea, Mihai G.; van der Meer, Jos W.; Giamarellos-Bourboulis, Evangelos J.			Compartmentalized Cytokine Responses in Hidradenitis Suppurativa	PLOS ONE			English	Article							OPEN-LABEL; ETANERCEPT; ADALIMUMAB; INHIBITION; INFLIXIMAB; EFFICACY; MODERATE; THERAPY; INNATE; ALPHA	Background Favorable treatment outcomes with TNF blockade led us to explore cytokine responses in hidradenitis suppurativa (HS). Methods Blood monocytes of 120 patients and 24 healthy volunteers were subtyped by flow cytometry. Isolated blood mononuclear cells (PBMCs) were stimulated for cytokine production; this was repeated in 13 severe patients during treatment with etanercept. Cytokines in pus were measured. Results CD14(bright)CD16(dim) inflammatory monocytes and patrolling monocytes were increased in Hurley III patients. Cytokine production by stimulated PBMCs was low compared to controls but the cytokine gene copies did not differ, indicating post-translational inhibition. The low production of IL-17 was restored, when cells were incubated with adalimumab. In pus, high concentrations of pro-inflammatory cytokines were detected. Based on the patterns, six different cytokine profiles were discerned, which are potentially relevant for the choice of treatment. Clinical improvement with etanercept was predicted by increased production of IL-1 beta and IL-17 by PBMCs at week 8. Conclusions Findings indicate compartmentalized cytokine expression in HS; high in pus but suppressed in PBMCs. This is modulated through blockade of TNF.	[Kanni, Theodora; Tzanetakou, Vassiliki; Savva, Athina; Pistiki, Aikaterini; Giamarellos-Bourboulis, Evangelos J.] Univ Athens, Sch Med, Dept Internal Med 4, GR-11527 Athens, Greece; [Kersten, Brigit; van de Veerdonk, Frank L.; Netea, Mihai G.; van der Meer, Jos W.; Giamarellos-Bourboulis, Evangelos J.] Radboud Univ Nijmegen, Med Ctr, Dept Internal Med, NL-6525 ED Nijmegen, Netherlands; [Kersten, Brigit; van de Veerdonk, Frank L.; Netea, Mihai G.; van der Meer, Jos W.; Giamarellos-Bourboulis, Evangelos J.] Nijmegen Inst Infect Inflammat & Immun N4i, Nijmegen, Netherlands	Athens Medical School; National & Kapodistrian University of Athens; Radboud University Nijmegen; Radboud University Nijmegen	Giamarellos-Bourboulis, EJ (corresponding author), Univ Athens, Sch Med, Dept Internal Med 4, GR-11527 Athens, Greece.	egiamarel@med.uoa.gr	van de Veerdonk, Frank L/C-7256-2008; van der Meer, Jos W.M./C-8521-2013; Giamarellos-Bourboulis, Evangelos/AAD-7155-2019; Netea, Mihai/N-5155-2014	van de Veerdonk, Frank L/0000-0002-1121-4894; van der Meer, Jos W.M./0000-0001-5120-3690; Giamarellos-Bourboulis, Evangelos/0000-0003-4713-3911	Hellenic Institute for the Study of Sepsis; Vici grant of the Netherlands Organization for Scientific Research	Hellenic Institute for the Study of Sepsis; Vici grant of the Netherlands Organization for Scientific Research	The study was funded by the Hellenic Institute for the Study of Sepsis. MGN was funded by a Vici grant of the Netherlands Organization for Scientific Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams DR, 2010, ARCH DERMATOL, V146, P501, DOI 10.1001/archdermatol.2010.72; Blanco R, 2009, ARCH DERMATOL, V145, P580, DOI 10.1001/archdermatol.2009.49; Cua DJ, 2010, NAT REV IMMUNOL, V10, P479, DOI 10.1038/nri2800; Cusack C, 2006, BRIT J DERMATOL, V154, P726, DOI 10.1111/j.1365-2133.2005.07067.x; ENDRES S, 1989, EUR J IMMUNOL, V19, P2327, DOI 10.1002/eji.1830191222; Giamarellos-Bourboulis EJ, 2008, BRIT J DERMATOL, V158, P567, DOI 10.1111/j.1365-2133.2007.08372.x; Giamarellos-Bourboulis EJ, 2007, BRIT J DERMATOL, V156, P51, DOI 10.1111/j.1365-2133.2006.07556.x; Giamarellos-Bourboulis EJ, 2009, ANN RHEUM DIS, V68, P273, DOI 10.1136/ard.2007.082222; Giamarellos-Bourboulis EJ, 2011, CRIT CARE, V15, DOI 10.1186/cc9974; Jemec GBE, 2004, EXPERT OPIN PHARMACO, V5, P1767, DOI 10.1517/14656566.5.8.1767; Karmiris K, 2009, GASTROENTEROLOGY, V137, P1628, DOI 10.1053/j.gastro.2009.07.062; Kimball AB, 2012, ANN INTERN MED, V157, P846, DOI 10.7326/0003-4819-157-12-201212180-00004; Lee RA, 2009, J AM ACAD DERMATOL, V60, P565, DOI 10.1016/j.jaad.2008.11.898; Leslie KS, 2014, J AM ACAD DERMATOL, V70, P243, DOI 10.1016/j.jaad.2013.09.044; Matusiak L, 2009, ACTA DERM-VENEREOL, V89, P601, DOI 10.2340/00015555-0749; Mekkes JR, 2008, BRIT J DERMATOL, V158, P370, DOI 10.1111/j.1365-2133.2007.08332.x; Morris MC, 2015, TRENDS IMMUNOL, V5, P680; Revuz JE, 2008, J AM ACAD DERMATOL, V59, P596, DOI 10.1016/j.jaad.2008.06.020; Sartorius K, 2003, BRIT J DERMATOL, V149, P211, DOI 10.1046/j.1365-2133.2003.05390.x; Schellevis MA, 2011, ANN RHEUM DIS, V70, P1168, DOI 10.1136/ard.2009.126185; Slade DEM, 2003, BRIT J PLAST SURG, V56, P451, DOI 10.1016/S0007-1226(03)00177-2; Sullivan TP, 2003, BRIT J DERMATOL, V149, P1046, DOI 10.1111/j.1365-2133.2003.05663.x; van der Zee HH, 2011, BRIT J DERMATOL, V164, P1292, DOI 10.1111/j.1365-2133.2011.10254.x; Von der Werth JM, 2001, BRIT J DERMATOL, V144, P809, DOI 10.1046/j.1365-2133.2001.04137.x	24	36	37	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2015	10	6							e0130522	10.1371/journal.pone.0130522	http://dx.doi.org/10.1371/journal.pone.0130522			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL3FE	26091259	gold, Green Published			2022-12-26	WOS:000356835000124
J	Popova, TG; Espina, V; Liotta, LA; Popov, SG				Popova, Taissia G.; Espina, Virginia; Liotta, Lance A.; Popov, Serguei G.			Reverse-Phase Microarray Analysis Reveals Novel Targets in Lymph Nodes of Bacillus anthracis Spore-Challenged Mice	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; EPITHELIAL-CELLS; SURFACE EXPRESSION; LETHAL TOXIN; APOPTOSIS; PHOSPHORYLATION; MACROSIALIN; NEUTROPHILS; ACTIVATION; SURVIVIN	Anthrax is a frequently fatal infection of many animal species and men. The causative agent Bacillus anthracis propagates through the lymphatic system of the infected host; however, the specific interactions of the host and microbe within the lymphatics are incompletely understood. We report the first description of the phosphoprotein signaling in the lymph nodes of DBA/2 mice using a novel technique combining the reverse-phase microarray with the laser capture microdissesction. Mice were challenged into foot pads with spores of toxinogenic, unencapsulated Sterne strain. The spores quickly migrated to the regional popliteal lymph nodes and spread to the bloodstream as early as 3 h post challenge. All mice died before 72 h post challenge from the systemic disease accompanied by a widespread LN tissue damage by bacteria, including the hemorrhagic necrotizing lymphadenitis, infiltration of CD11b+ and CD3+ cells, and massive proliferation of bacteria in lymph nodes. A macrophage scavenger receptor CD68/macrosialin was upregulated and found in association with vegetative bacteria likely as a marker of their prior interaction with macrophages. The major signaling findings among the 65 tested proteins included the reduced MAPK signaling, upregulation of STAT transcriptional factors, and altered abundance of a number of pro-and anti-apoptotic proteins with signaling properties opposing each other. Downregulation of ERK1/2 was associated with the response of CD11b+ macrophages/dendritic cells, while upregulation of the pro-apoptotic Puma indicated a targeting of CD3+ T-cells. A robust upregulation of the anti-apoptotic survivin was unexpected because generally it is not observed in adult tissues. Taken together with the activation of STATs it may reflect a new pathogenic mechanism aimed to delay the onset of apoptosis. Our data emphasize a notion that the net biological outcome of disease is determined by a cumulative impact of factors representing the microbial insult and the protective capacity of the host.	[Popova, Taissia G.; Espina, Virginia; Liotta, Lance A.] George Mason Univ, Ctr Appl Prote & Mol Med, Manassas, VA 20109 USA; [Popov, Serguei G.] George Mason Univ, Natl Ctr Biodefense & Infect Dis, Manassas, VA USA	George Mason University; George Mason University	Popov, SG (corresponding author), George Mason Univ, Ctr Appl Prote & Mol Med, Manassas, VA 20109 USA.	spopov@gmu.edu		Espina, Virginia/0000-0001-5080-5972	National Institutes of Health, USA [5R21AI099851-2]; George Mason University Libraries Open Access Publishing Fund; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI099851] Funding Source: NIH RePORTER	National Institutes of Health, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); George Mason University Libraries Open Access Publishing Fund; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institutes of Health, USA, grant 5R21AI099851-2. Publication of this article was funded in part by the George Mason University Libraries Open Access Publishing Fund.	Altieri DC, 2015, SEMIN CELL DEV BIOL, V39, P91, DOI 10.1016/j.semcdb.2014.12.007; Bachmann MF, 2010, NAT REV IMMUNOL, V10, P787, DOI 10.1038/nri2868; Barua S, 2013, INFECT IMMUN, V81, P3693, DOI 10.1128/IAI.00709-13; Battle T. E., 2002, Current Molecular Medicine (Hilversum), V2, P381, DOI 10.2174/1566524023362456; Beierlein JM, 2011, CURR MED CHEM, V18, P5083; Bok K, 2009, J VIROL, V83, P3647, DOI 10.1128/JVI.02028-08; Cai QL, 2010, J VIROL, V84, P11134, DOI 10.1128/JVI.01293-10; Nguyen C, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-2; Clybouw C, 2011, BLOOD, V118, P4120, DOI 10.1182/blood-2011-04-347096; Corre JP, 2013, J INFECT DIS, V207, P450, DOI 10.1093/infdis/jis686; Duesbery NS, 1999, J APPL MICROBIOL, V87, P289, DOI 10.1046/j.1365-2672.1999.00892.x; Espina V, 2006, NAT PROTOC, V1, P586, DOI 10.1038/nprot.2006.85; Garraud K, 2012, INFECT IMMUN, V80, P131, DOI 10.1128/IAI.05988-11; Glomski IJ, 2007, PLOS PATHOG, V3, P699, DOI 10.1371/journal.ppat.0030076; Guichard A, 2012, MICROBES INFECT, V14, P97, DOI 10.1016/j.micinf.2011.08.016; Hacker G, 2006, CELL CYCLE, V5, P2421, DOI 10.4161/cc.5.21.3397; HOLNESS CL, 1993, J BIOL CHEM, V268, P9661; Inglesby TV, 2002, JAMA-J AM MED ASSOC, V287, P2236, DOI 10.1001/jama.287.17.2236; Kehn-Hall K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034761; Kirby JE, 2004, INFECT IMMUN, V72, P430, DOI 10.1128/IAI.72.1.430-439.2004; Klichko VI, 2003, BIOCHEM BIOPH RES CO, V303, P855, DOI 10.1016/S0006-291X(03)00440-6; Kurushima H, 2000, J LEUKOCYTE BIOL, V67, P104, DOI 10.1002/jlb.67.1.104; Kyriakis JM, 2001, PHYSIOL REV, V81, P807, DOI 10.1152/physrev.2001.81.2.807; Lammermann T, 2008, IMMUNOL REV, V221, P26, DOI 10.1111/j.1600-065X.2008.00592.x; LANDRY J, 1992, J BIOL CHEM, V267, P794; Li Q, 2014, MICROBES INFECT, V16, P17, DOI 10.1016/j.micinf.2013.10.006; Long Kristin M, 2013, Methods Mol Biol, V1031, P97, DOI 10.1007/978-1-62703-481-4_12; Longo C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004763; Luchini A, 2010, CURR MOL MED, V10, P133, DOI 10.2174/156652410790963268; Luchini A, 2008, NANO LETT, V8, P350, DOI 10.1021/nl072174l; Magnuson B, 2012, BIOCHEM J, V441, P1, DOI 10.1042/BJ20110892; Mao S, 2007, CELL MICROBIOL, V9, P1997, DOI 10.1111/j.1462-5822.2007.00931.x; McCubrey JA, 2014, ONCOTARGET, V5, P2881, DOI 10.18632/oncotarget.2037; Mina B, 2002, JAMA-J AM MED ASSOC, V287, P858, DOI 10.1001/jama.287.7.858; Mobahat M, 2014, INT J MOL SCI, V15, P2494, DOI 10.3390/ijms15022494; Mock M, 2001, ANNU REV MICROBIOL, V55, P647, DOI 10.1146/annurev.micro.55.1.647; Ng HP, 2009, INT J PARASITOL, V39, P1539, DOI 10.1016/j.ijpara.2009.06.001; Pierobon M, 2014, ONCOGENE; Popov SG, 2002, BIOCHEM BIOPH RES CO, V293, P349, DOI 10.1016/S0006-291X(02)00227-9; Popova T, 2009, FEMS IMMUNOL MED MIC, V56, P129, DOI 10.1111/j.1574-695X.2009.00558.x; Popova TG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110873; Popova TG, 2011, FEMS IMMUNOL MED MIC, V61, P15, DOI 10.1111/j.1574-695X.2010.00740.x; Popova TG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013805; Ramprasad MP, 1996, P NATL ACAD SCI USA, V93, P14833, DOI 10.1073/pnas.93.25.14833; Ribet D, VIRULENCE, V1, P532; Roskoski R, 2015, PHARMACOL RES, V94, P9, DOI 10.1016/j.phrs.2015.01.003; Shin E, 2014, LIPIDS, V49, P457, DOI 10.1007/s11745-014-3893-8; SMITH RO, 1949, J EXP MED, V90, P555, DOI 10.1084/jem.90.6.555; Spurrier B, 2008, NAT PROTOC, V3, P1796, DOI 10.1038/nprot.2008.179; Strasser A, 2005, NAT REV IMMUNOL, V5, P189, DOI 10.1038/nri1568; Thomas SR, 2002, J BIOL CHEM, V277, P6017, DOI 10.1074/jbc.M109107200; Valenzuela M, 2013, J INFECT DIS, V208, P1131, DOI 10.1093/infdis/jit286; Vitale G, 1999, J APPL MICROBIOL, V87, P288, DOI 10.1046/j.1365-2672.1999.00893.x; Wang ZL, 2010, EUR J CANCER, V46, P2996, DOI 10.1016/j.ejca.2010.07.008; Weiner ZP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030201; Weiner ZP, 2012, INFECT IMMUN, V80, P1626, DOI 10.1128/IAI.06061-11; Wulfkuhle JD, 2006, NAT CLIN PRACT ONCOL, V3, P256, DOI 10.1038/ncponc0485; Zhang Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113928	58	7	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2015	10	6							e0129860	10.1371/journal.pone.0129860	http://dx.doi.org/10.1371/journal.pone.0129860			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL3FE	26091359	Green Submitted, gold, Green Published			2022-12-26	WOS:000356835000068
J	Panjehpour, M; Chai, HK; Voo, YL				Panjehpour, Mohammad; Chai, Hwa Kian; Voo, Yen Lei			Refinement of Strut-and-Tie Model for Reinforced Concrete Deep Beams	PLOS ONE			English	Article							STRENGTH	Deep beams are commonly used in tall buildings, offshore structures, and foundations. According to many codes and standards, strut-and-tie model (STM) is recommended as a rational approach for deep beam analyses. This research focuses on the STM recommended by ACI 318-11 and AASHTO LRFD and uses experimental results to modify the strut effectiveness factor in STM for reinforced concrete (RC) deep beams. This study aims to refine STM through the strut effectiveness factor and increase result accuracy. Six RC deep beams with different shear span to effective-depth ratios (a/d) of 0.75, 1.00, 1.25, 1.50, 1.75, and 2.00 were experimentally tested under a four-point bending set-up. The ultimate shear strength of deep beams obtained from non-linear finite element modeling and STM recommended by ACI 318-11 as well as AASHTO LRFD (2012) were compared with the experimental results. An empirical equation was proposed to modify the principal tensile strain value in the bottle-shaped strut of deep beams. The equation of the strut effectiveness factor from AASHTTO LRFD was then modified through the aforementioned empirical equation. An investigation on the failure mode and crack propagation in RC deep beams subjected to load was also conducted.	[Panjehpour, Mohammad] INTI Int Univ, Dept Civil Engn, Fac Sci Engn Technol & Math FOSTEM, Nilai 71800, Malaysia; [Chai, Hwa Kian] Univ Malaya, Fac Engn, Dept Civil Engn, Kuala Lumpur 50603, Malaysia; [Voo, Yen Lei] DURA Technol Sdn Bhd, Ipoh, Malaysia	INTI International University; Universiti Malaya	Panjehpour, M (corresponding author), INTI Int Univ, Dept Civil Engn, Fac Sci Engn Technol & Math FOSTEM, Nilai 71800, Malaysia.	mohammad.panjehpour@newinti.edu.my; hkchai@um.edu.my	Chai, Hwa Kian/AAW-5514-2020		High Impact Research Grant [UM.C/625/1/HIR/MOHE/ENG/54]	High Impact Research Grant	This study was supported by High Impact Research Grant UM.C/625/1/HIR/MOHE/ENG/54. DURA Technology Sdn Bhd provided experimental facilities and material. Dura Technology will not have any right regarding the findings of this research for issues of patent, copyright and etc.	AASHTO, 2012, DES SPEC CUST US UN; ACI, 2011, BUILD COD REQ STRUCT; Alam MA, 2012, ARAB J SCI ENG, V37, P905, DOI 10.1007/s13369-012-0213-6; [Anonymous], 2005, A23304 CSA; [Anonymous], 2006, CANCSAS606; [Anonymous], 2009, AS3600; [Anonymous], 1990, REINFORCED CONCRETE; [Anonymous], 2006, 3101 NZS; BELARBI A, 1995, ACI STRUCT J, V92, P562; Bruggi M, 2009, COMPUT STRUCT, V87, P1483, DOI 10.1016/j.compstruc.2009.06.003; Cheng MY, 2014, ENG APPL ARTIF INTEL, V28, P86, DOI 10.1016/j.engappai.2013.11.001; Collins MP, 1986, ACI J; DIN. Building and Civil Engineering Standards Committee, 2001, 10451 DIN; Eurocode2, 2005, 199222005 EN EUR; Farghaly AS, 2013, J COMPOS CONSTR, V17, DOI 10.1061/(ASCE)CC.1943-5614.0000385; Godat A, 2013, COMPOS STRUCT, V99, P327, DOI 10.1016/j.compstruct.2012.11.034; He ZQ, 2010, ENG STRUCT, V32, P2057, DOI 10.1016/j.engstruct.2010.03.006; Hognestad E., 1952, ACI J, V49, P117; Khalifa ES, 2012, AIN SHAMS ENG J, V3, P359, DOI 10.1016/j.asej.2012.04.004; Kim HS, 2011, J BREAST CANCER, V14, P14, DOI 10.4048/jbc.2011.14.1.14; Mohammad M, 2011, PROCEDIA ENGINEER, V14, DOI 10.1016/j.proeng.2011.07.269; Mohammadhassani M, 2012, CONSTR BUILD MATER, V30, P265, DOI 10.1016/j.conbuildmat.2011.12.004; Morsch E, 1909, EISENBETONBAU SEINE; Muttoni A., 1997, DESIGN CONCRETE STRU; Panjehpour M., 2012, CONSTRUCT 2, V2, P45; Panjehpour M, 2014, MATER CONSTRUCC, V64, DOI [10.1038/srep05988, DOI 10.1038/SREP05988]; Panjehpour M, 2014, STEEL COMPOS STRUCT, V16, P481, DOI 10.12989/scs.2014.16.5.481; Panjehpour M, 2014, COMPUT CONCRETE, V13, P135, DOI 10.12989/cac.2014.13.1.135; Panjehpour M, 2012, INT J ENG RES AFR, V8, P37, DOI 10.4028/www.scientific.net/JERA.8.37; Perera R, 2009, COMPOS PART B-ENG, V40, P714, DOI 10.1016/j.compositesb.2009.06.008; Perera R, 2009, CONSTR BUILD MATER, V23, P2914, DOI 10.1016/j.conbuildmat.2009.02.016; Ritter W, 1899, SCHWEIZERISCHE BAUZE; Schlaich J., 1982, B INFORM COMITE EURO, V150, P163; Schlaich JS, 1987, J PRESTRESSED CONCRE, V32; Smith DA., 2007, DESIGNERS GUIDE EN 1; Wang GL, 2008, ENG STRUCT, V30, P3489, DOI 10.1016/j.engstruct.2008.05.020; Zhang N, 2010, ENG STRUCT, V32, P361, DOI 10.1016/j.engstruct.2009.09.019	37	4	4	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2015	10	6							e0130734	10.1371/journal.pone.0130734	http://dx.doi.org/10.1371/journal.pone.0130734			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4OY	26110268	Green Submitted, Green Published, gold			2022-12-26	WOS:000356933800081
J	Chantarasuwan, B; Berg, CC; Kjellberg, F; Ronsted, N; Garcia, M; Baider, C; van Welzen, PC				Chantarasuwan, Bhanumas; Berg, Cornelis C.; Kjellberg, Finn; Ronsted, Nina; Garcia, Marjorie; Baider, Claudia; van Welzen, Peter C.			A New Classification of Ficus Subsection Urostigma (Moraceae) Based on Four Nuclear DNA Markers (ITS, ETS, G3pdh, and ncpGS), Morphology and Leaf Anatomy	PLOS ONE			English	Article							PHYLOGENETIC ANALYSIS; FIGS; HISTORY	Ficus subsection Urostigma as currently circumscribed contains 27 species, distributed in Africa, Asia, Australia and the Pacific, and is of key importance to understand the origin and evolution of Ficus and the fig-wasp mutualism. The species of subsection Urostigma are very variable in morphological characters and exhibit a wide range of often partly overlapping distributions, which makes identification often difficult. The systematic classification within and between this subsection and others is problematic, e.g., it is still unclear where to classify F. amplissima and F. rumphii. To clarify the circumscription of subsection Urostigma, a phylogenetic reconstruction based on four nuclear DNA markers (ITS, ETS, G3pdh, and ncpGS) combined with morphology and leaf anatomy is conducted. The phylogenetic tree based on the combined datasets shows that F. madagascariensis, a Madagascan species, is sister to the remainder of subsect. Urostigma. Ficus amplissima and F. rumphii, formerly constituting sect. Leucogyne, appear to be imbedded in subsect. Conosycea. The result of the phylogenetic analysis necessitates nomenclatural adjustments. A new classification of Ficus subsection Urostigma is presented along with the morphological and leaf anatomical apomorphies typical for the clades. Two new species are described - one in subsect. Urostigma, the other in Conosycea. One variety is raised to species level.	[Chantarasuwan, Bhanumas; Berg, Cornelis C.; van Welzen, Peter C.] Nat Biodivers Ctr, Bot, Leiden, Netherlands; [Chantarasuwan, Bhanumas] Natl Sci Museum, Thailand Nat Hist Museum, Pathum Thani, Thailand; [Chantarasuwan, Bhanumas; van Welzen, Peter C.] Leiden Univ, Inst Biol Leiden, Leiden, Netherlands; [Kjellberg, Finn; Garcia, Marjorie] Univ Paul Valery Montpellier EPHE, CEFE UMR 5175, CNRS Univ Montpellier, Montpellier, France; [Ronsted, Nina] Univ Copenhagen, Nat Hist Museum Denmark, Copenhagen, Denmark; [Baider, Claudia] Mauritius Herbarium, Reduit, Mauritius	Naturalis Biodiversity Center; Leiden University; Leiden University - Excl LUMC; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Universite de Montpellier; University of Copenhagen	Chantarasuwan, B (corresponding author), Nat Biodivers Ctr, Bot, Leiden, Netherlands.	b.chantarasuwan@gmail.com	Baider, Claudia/C-2570-2009; Rønsted, Nina/A-5065-2013; van Welzen, Peter/GYR-0640-2022; Kjellberg, Finn/S-3281-2019	Baider, Claudia/0000-0002-2203-2076; Rønsted, Nina/0000-0002-2002-5809; Kjellberg, Finn/0000-0001-6708-9538	Royal Thai Government; Thailand National Science Museum	Royal Thai Government; Thailand National Science Museum	The first author wishes to thank the Royal Thai Government for a scholarship and to acknowledge the support from the Thailand National Science Museum enabling him to study for a Ph.D. in Leiden, the Netherlands. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baldwin BG, 1998, MOL PHYLOGENET EVOL, V10, P449, DOI 10.1006/mpev.1998.0545; Berg C.C., 1992, AFRICAN FIG TREES FI; Berg CC, 2004, BLUMEA, V49, P463; Berg CC, 2011, FLORA THAILAND, P475; Berg CC., 2005, FLORA MALESIANA, V17, P1, DOI DOI 10.1663/0007-196X(2006)58[; Chantarasuwan B, 2014, BLUMEA, V59, P6, DOI 10.3767/000651914X681126; Chantarasuwan B, 2014, BOT J LINN SOC, V175, P259, DOI 10.1111/boj.12165; Chantarasuwan B, 2013, SYST BOT, V38, P653, DOI 10.1600/036364413X670241; CORNER E. J. H., 1958, REINWARDTIA, V4, P325; CORNER E. J. H., 1965, GARD BULL [SINGAPORE], V21, P1; Corner E. J. H., 1959, GARD B SINGAPORE, V17, P368; Corner E. J. H., 1960, GARDENS B SINGAPORE, V18, P83; Corner E.J.H., 1981, REVISED HDB FLORA CE, P213; Cruaud A, 2012, SYST BIOL, V61, P1029, DOI 10.1093/sysbio/sys068; Cruaud A, 2010, CLADISTICS, V26, P359, DOI 10.1111/j.1096-0031.2009.00291.x; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075; Erixon P, 2003, SYST BIOL, V52, P665, DOI 10.1080/10635150390235485; Felsenstein J., 1993, PHYLIP PHYLOGENY INF; Galtier N, 1996, COMPUT APPL BIOSCI, V12, P543; Gasparrini G., 1844, NOVA GENERA QUAE SUP; Jousselin E, 2003, EVOLUTION, V57, P1255, DOI 10.1111/j.0014-3820.2003.tb00334.x; King G., 1887, ANN ROYAL BOT GARDEN, V1, P1; Maddison D. R., 2005, MACCLADE 4 08A ANAL, DOI [DOI 10.1046/J.1420-9101.1996.9020153.X, DOI 10.1007/s13592-012-0141-1]; Maddison WP, 2011, MESQUITE MODULAR SYS; Miquel F.A.G., 1867, ANN MUSEI BOT LUGDUN, V3, P260; Rambaut A, 2013, TRACER V1 6; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Ronsted N, 2008, SYMBIOSIS, V45, P45; Ronsted N, 2005, P ROY SOC B-BIOL SCI, V272, P2593, DOI 10.1098/rspb.2005.3249; Strand AE, 1997, MOL ECOL, V6, P113, DOI 10.1046/j.1365-294X.1997.00153.x; SUN Y, 1994, THEOR APPL GENET, V89, P26, DOI 10.1007/BF00226978; Swofford D, 2002, PAUP PHYLOGENETIC AN, DOI 10.1111/J.0014-3820.2002.TB00191.X; Weiblen GD, 2000, AM J BOT, V87, P1342, DOI 10.2307/2656726; White TJ., 1990, PCR PROTOCOLS GUIDE, P315; WIEBES JT, 1992, P K NED AKAD WETENSC, V95, P109; Wiens JJ, 2004, SYST BIOL, V53, P653, DOI 10.1080/10635150490472959; Xu L, 2011, J SYST EVOL, V49, P546, DOI 10.1111/j.1759-6831.2011.00155.x	39	16	17	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2015	10	6							e0128289	10.1371/journal.pone.0128289	http://dx.doi.org/10.1371/journal.pone.0128289			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4OM	26107649	gold, Green Published, Green Submitted			2022-12-26	WOS:000356932500018
J	Fujisawa, K; Terai, S; Matsumoto, T; Takami, T; Yamamoto, N; Nishina, H; Furutani-Seiki, M; Sakaida, I				Fujisawa, Koichi; Terai, Shuji; Matsumoto, Toshihiko; Takami, Taro; Yamamoto, Naoki; Nishina, Hiroshi; Furutani-Seiki, Makoto; Sakaida, Isao			Evidence for a Role of the Transcriptional Regulator Maid in Tumorigenesis and Aging	PLOS ONE			English	Article							INTERACTING PROTEIN; LIVER-REGENERATION; JAPANESE MEDAKA; MARKER PROTEIN; HUMAN HOMOLOG; GCIP; EXPRESSION; ZEBRAFISH; GROWTH; HEPATOCARCINOGENESIS	Maid is a helix-loop-helix protein that is involved in cell proliferation. In order to further elucidate its physiological functions, we studied Maid activity in two small fish model systems. We found that Maid expression was greatest in zebrafish liver and that it increased following partial hepatectomy. Maid levels were also high in hepatic preneoplastic foci induced by treatment of zebrafish with diethylnitrosamine (DEN), but low in hepatocellular carcinomas (HCC), mixed tumors, and cholangiocarcinomas developing in these animals. In DEN-treated transgenic medaka overexpressing Maid, hepatic BrdU uptake and proliferation were reduced. After successive breedings, Maid transgenic medaka exhibited decreased movement and a higher incidence of abnormal spine curvature, possibly due to the senescence of spinal cord cells. Taken together, our results suggest that Maid levels can influence the progression of liver cancer. In conclusion, we found that Maid is important regulator of hepatocarconogenesis and aging.	[Fujisawa, Koichi; Sakaida, Isao] Yamaguchi Univ, Ctr Reparat Med, Sch Med, Ube, Yamaguchi 7558505, Japan; [Fujisawa, Koichi; Terai, Shuji; Matsumoto, Toshihiko; Takami, Taro; Yamamoto, Naoki; Sakaida, Isao] Yamaguchi Univ, Dept Gastroenterol & Hepatol, Grad Sch Med, Ube, Yamaguchi 7558505, Japan; [Terai, Shuji] Niigata Univ, Grad Sch Med & Dent Sci, Div Gastroenterol & Hepatol, Chuo Ku, Niigata 9518510, Japan; [Nishina, Hiroshi] Tokyo Med & Dent Univ, Med Res Inst, Dept Dev & Regenerat Biol, Bunkyo Ku, Tokyo 1138510, Japan; [Furutani-Seiki, Makoto] Univ Bath, Dept Biol & Biochem, Bath BA2 7AY, Avon, England	Yamaguchi University; Yamaguchi University; Niigata University; Tokyo Medical & Dental University (TMDU); University of Bath	Terai, S (corresponding author), Yamaguchi Univ, Dept Gastroenterol & Hepatol, Grad Sch Med, Minami Kogushi 1-1-1, Ube, Yamaguchi 7558505, Japan.	terais@med.niigata-u.ac.jp	fujisawa, koichi/AAC-1392-2022		Japan Society for the Promotion of Science [22390150, 22659148, 23659398, 25670370]; Ministry of Health, Labour and Welfare; Japan Science and Technology Agency (JST)	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Health, Labour and Welfare(Ministry of Health, Labour and Welfare, Japan); Japan Science and Technology Agency (JST)(Japan Science & Technology Agency (JST))	This study was supported by a Grant-in-Aid for Scientific Research (22390150), and Grants-in-Aid for Challenging Exploratory Research (22659148, 23659398, 25670370) from the Japan Society for the Promotion of Science. This study was supported by Grants-in-Aid for scientific research from the Ministry of Health, Labour and Welfare, health and labour sciences research grants and Japan Science and Technology Agency (JST), the project of realization of regenerative medicine and highway.	Albrecht JH, 1998, ONCOGENE, V16, P2141, DOI 10.1038/sj.onc.1201728; Amatruda T, 2002, GENETIC TESTING HERE; Au DWT, 2009, COMP BIOCHEM PHYS C, V149, P161, DOI 10.1016/j.cbpc.2008.08.005; BRAUN L, 1988, P NATL ACAD SCI USA, V85, P1539, DOI 10.1073/pnas.85.5.1539; Brennan LM, 2001, TOXICOL PATHOL, V29, P387, DOI 10.1080/019262301316905354; Chang MS, 2000, BIOCHEM BIOPH RES CO, V279, P732, DOI 10.1006/bbrc.2000.3992; Chang TW, 2008, ONCOGENE, V27, P332, DOI 10.1038/sj.onc.1210651; Chellas-Gery B, 2007, CELL MICROBIOL, V9, P2417, DOI 10.1111/j.1462-5822.2007.00970.x; Chen WC, 2008, HISTOPATHOLOGY, V53, P554, DOI 10.1111/j.1365-2559.2008.03154.x; Fujisawa K, 2011, BIOCHEM BIOPH RES CO, V414, P331, DOI 10.1016/j.bbrc.2011.09.067; Fujisawa K, 2009, COMP BIOCHEM PHYS B, V153, P29, DOI 10.1016/j.cbpb.2009.01.006; Goessling W, 2007, J CLIN ONCOL, V25, P2473, DOI 10.1200/JCO.2006.08.9821; Hwang SY, 1997, DEV DYNAM, V209, P217, DOI 10.1002/(SICI)1097-0177(199706)209:2<217::AID-AJA7>3.0.CO;2-L; Ikushima H, 2008, EMBO J, V27, P2955, DOI 10.1038/emboj.2008.218; Lee I, 2010, CANCER RES, V70, P4357, DOI 10.1158/0008-5472.CAN-09-3791; Ma W, 2006, ONCOGENE, V25, P4207, DOI 10.1038/sj.onc.1209450; Michishita E, 2008, NATURE, V452, P492, DOI 10.1038/nature06736; Nasevicius A, 2000, NAT GENET, V26, P216, DOI 10.1038/79951; Sadler KC, 2007, P NATL ACAD SCI USA, V104, P1570, DOI 10.1073/pnas.0610774104; Sonnenberg-Riethmacher E, 2007, HEPATOLOGY, V45, P404, DOI 10.1002/hep.21461; Takami T, 2005, GASTROENTEROLOGY, V128, P1369, DOI 10.1053/j.gastro.2005.03.014; Terai S, 2000, HEPATOLOGY, V32, P357, DOI 10.1053/jhep.2000.9092; Xia CZ, 2000, J BIOL CHEM, V275, P20942, DOI 10.1074/jbc.M002598200; Yao Y, 2000, EXP CELL RES, V257, P22, DOI 10.1006/excr.2000.4884	24	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2015	10	6							e0129950	10.1371/journal.pone.0129950	http://dx.doi.org/10.1371/journal.pone.0129950			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4OM	26107180	gold, Green Published, Green Submitted			2022-12-26	WOS:000356932500073
J	Hao, ZX; Sun, D; Zheng, JY				Hao, Zhixin; Sun, Di; Zheng, Jingyun			East Asian Monsoon Signals Reflected in Temperature and Precipitation Changes over the Past 300 Years in the Middle and Lower Reaches of the Yangtze River	PLOS ONE			English	Article							NORTH-ATLANTIC OSCILLATION; PACIFIC DECADAL OSCILLATION; WINTER MONSOON; SUMMER MONSOON; ARCTIC OSCILLATION; CHINA; RECONSTRUCTION; INDEX; VARIABILITY; RECORD	Based on observational data and Asian monsoon intensity datasets from China, the relationships between the East Asian winter monsoon index and winter temperature, the East Asian summer monsoon index and Meiyu precipitation over the middle and lower reaches of the Yangtze River, were analyzed. We found that the monsoon signals were reflected in the temperature and Meiyu precipitation variations. Thus, we used the reconstructed Meiyu precipitation and winter temperature series for the past 300 years and detected the summer/winter monsoon intensity signals using multi-taper spectral estimation method and wavelet analysis. The main periodicities of Meiyu precipitation and winter temperature, such as interannual cycle with 2-7-year, interdecadal-centennial cycles with 30-40-year and 50-100-year, were found. The good relationships between the East Asian summer and winter monsoons suggested that they were in phase at 31-year cycle, while out of phase at 100-year cycle, but with 20-year phase difference. In addition, the winter monsoon intensity may be regulated by the North Atlantic Oscillation, the Arctic Oscillation and the Atlantic Multidecadal Oscillation, and the summer monsoon is closely related to the signal intensities of the Pacific Decadal Oscillation.	[Hao, Zhixin; Sun, Di; Zheng, Jingyun] Chinese Acad Sci, Inst Geog Sci & Nat Resources Res, Beijing, Peoples R China; [Sun, Di] Univ Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Geographic Sciences & Natural Resources Research, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Hao, ZX (corresponding author), Chinese Acad Sci, Inst Geog Sci & Nat Resources Res, Beijing, Peoples R China.	haozx@igsnrr.ac.cn	Zheng, Jingyun/M-5789-2015		Chinese Academy of Sciences [XDA05080100, 2014RC101]; Jiangsu Collaborative Innovation Center for Climate Change	Chinese Academy of Sciences(Chinese Academy of Sciences); Jiangsu Collaborative Innovation Center for Climate Change	This work was supported by the Chinese Academy of Sciences (No. XDA05080100; No. 2014RC101)& Jiangsu Collaborative Innovation Center for Climate Change (No grant number). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Biondi F, 2001, J CLIMATE, V14, P5, DOI 10.1175/1520-0442(2001)014<0005:NPDCVS>2.0.CO;2; Bretherton CS, 1999, J CLIMATE, V12, P1990, DOI 10.1175/1520-0442(1999)012<1990:TENOSD>2.0.CO;2; Chen F, 2013, QUATERN INT, V283, P36, DOI 10.1016/j.quaint.2012.05.047; Chu PC, 2012, J QUATERNARY SCI, V27, P901, DOI 10.1002/jqs.2579; Cook ER, 1998, HOLOCENE, V8, P9, DOI 10.1191/095968398677793725; Cook ER, 2002, J CLIMATE, V15, P1754, DOI 10.1175/1520-0442(2002)015<1754:AWVMRO>2.0.CO;2; Cosford J, 2014, EARTH PLANET SC LETT, V275, P296; D'Arrigo R, 2001, CLIM DYNAM, V18, P219, DOI 10.1007/s003820100177; D'Arrigo RD, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL017250; D'Arrigo R, 2006, INT J CLIMATOL, V26, P1607, DOI 10.1002/joc.1326; Ding Y., 2005, ACTA METEOROL SIN, V19, P302; Ding Y., 1993, SPRINGER NETHERLANDS, DOI DOI 10.1007/978-94-015-8302-2; Ding YH, 2008, INT J CLIMATOL, V26, P1607; Fu CB, 2005, CHINESE SCI BULL, V50, P2505, DOI 10.1360/04wd0284; Ge QS, 2008, CHINESE SCI BULL, V53, P107, DOI 10.1007/s11434-007-0440-5; Glueck MF, 2001, INT J CLIMATOL, V21, P1453, DOI 10.1002/joc.684; Gong DY, 2001, GEOPHYS RES LETT, V28, P2073, DOI 10.1029/2000GL012311; Gray ST, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL019932; Guo Q.Y., 1994, Q J APPL METEOROL, V5, P218; Hao ZX, 2012, CLIM PAST, V8, P1023, DOI 10.5194/cp-8-1023-2012; Hao ZX, 2011, CLIM RES, V50, P161, DOI 10.3354/cr01052; He SP, 2013, J CLIMATE, V26, P9819, DOI 10.1175/JCLI-D-13-00174.1; Huang RH, 2004, ADV ATMOS SCI, V21, P407, DOI 10.1007/BF02915568; Jhun JG, 2004, J CLIMATE, V17, P711, DOI 10.1175/1520-0442(2004)017&lt;0711:ANEAWM&gt;2.0.CO;2; LEES JM, 1995, COMPUT GEOSCI, V21, P199, DOI 10.1016/0098-3004(94)00067-5; Li CY, 2011, CHINESE SCI BULL, V56, P70, DOI 10.1007/s11434-010-4200-6; [李茜 Li Qian], 2012, [古地理学报, Journal of Palaeogeography], V14, P253; Liu Y, 2010, J GEOPHYS RES-ATMOS, V115, DOI 10.1029/2009JD012330; [刘浴辉 Liu Yuhui], 2005, [第四纪研究, Quaternary Sciences], V25, P228; Luterbacher J, 2001, ATMOS SCI LETT, V2, P114, DOI 10.1006/asle.2001.0044; MacDonald GM, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL022478; Mantua NJ, 1997, B AM METEOROL SOC, V78, P1069, DOI 10.1175/1520-0477(1997)078<1069:APICOW>2.0.CO;2; [裴顺强 PEI ShunQiang], 2007, [气候与环境研究, Climatic and Environmental Research], V12, P124; Qian WH, 2011, CHINESE SCI BULL, V56, P3019, DOI 10.1007/s11434-011-4714-6; Shen CM, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL024804; Si D, 2012, INT J CLIMATOL, V32, P1697, DOI 10.1002/joc.2386; Steinke S, 2011, GLOBAL PLANET CHANGE, V78, P170, DOI 10.1016/j.gloplacha.2011.06.006; Torrence C, 1998, B AM METEOROL SOC, V79, P61, DOI 10.1175/1520-0477(1998)079<0061:APGTWA>2.0.CO;2; Trouet V, 2009, SCIENCE, V324, P78, DOI 10.1126/science.1166349; Wang B., 2006, ASIAN MONSOON, P1; Wang HJ, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL024562; [王会军 Wang Huijun], 2004, [第四纪研究, Quaternary Sciences], V24, P19; Wang L, 2014, CHINESE SCI BULL, V59, P430, DOI 10.1007/s11434-013-0029-0; Wang L, 2012, QUATERNARY SCI REV, V32, P131, DOI 10.1016/j.quascirev.2011.11.003; Wang PX, 2014, CLIM PAST, V10, P2007, DOI 10.5194/cp-10-2007-2014; Wang WC, 2008, J METEOROL SOC JPN, V86, P827, DOI 10.2151/jmsj.86.827; Watanabe T, 2014, GEOPHYS RES LETT, V41, P3609, DOI 10.1002/2014GL060037; Wei F Y, 2009, SCI CHINA SER D, V39, P301; 刘禹, 2003, [中国科学. D辑, 地球科学, Science in China], V33, P543; Wu BY, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2002GL015373; Yancheva G, 2007, NATURE, V445, P74, DOI 10.1038/nature05431; [杨保 Yang Bao], 2009, [第四纪研究, Quaternary Sciences], V29, P880; Zhan RF, 2008, J METEOROL SOC JPN, V86, P167, DOI 10.2151/jmsj.86.167; Zhang D, 2007, NATURE, V450, pE7, DOI 10.1038/nature06338; [张庆云 Zhang Qingyun], 2003, [气象学报, Acta Meteorologica Sinica], V61, P559; Zhou LT, 2011, INT J CLIMATOL, V31, P677, DOI 10.1002/joc.2101; Zhou XJ, 2011, CHINESE SCI BULL, V56, P28; Zhu HF, 2009, CLIM PAST, V5, P661, DOI 10.5194/cp-5-661-2009	58	6	6	2	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2015	10	6							e0131159	10.1371/journal.pone.0131159	http://dx.doi.org/10.1371/journal.pone.0131159			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4OM	26107375	Green Published, Green Submitted, gold			2022-12-26	WOS:000356932500145
J	Leow, SN; Luu, CD; Nizam, MHH; Mok, PL; Ruhaslizan, R; Wong, HS; Halim, WHWA; Ng, MH; Ruszymah, BHI; Chowdhury, SR; Bastion, MLC; Then, KY				Leow, S. N.; Luu, Chi D.; Nizam, M. H. Hairul; Mok, P. L.; Ruhaslizan, R.; Wong, H. S.; Halim, Wan Haslina Wan Abdul; Ng, M. H.; Ruszymah, B. H. I.; Chowdhury, S. R.; Bastion, M. L. C.; Then, K. Y.			Safety and Efficacy of Human Wharton's Jelly-Derived Mesenchymal Stem Cells Therapy for Retinal Degeneration	PLOS ONE			English	Article							HUMAN UMBILICAL-CORD; STROMAL CELLS; GENE-TRANSFER; RODENT MODEL; RCS RAT; FETAL; FUSION; BLOOD; NANOTECHNOLOGIES; DIFFERENTIATION	Purpose To investigate the safety and efficacy of subretinal injection of human Wharton's Jelly-derived mesenchymal stem cells (hWJ-MSCs) on retinal structure and function in Royal College of Surgeons (RCS) rats. Methods RCS rats were divided into 2 groups: hWJ-MSCs treated group (n = 8) and placebo control group (n = 8). In the treatment group, hWJ-MSCs from healthy donors were injected into the subretinal space in one eye of each rat at day 21. Control group received saline injection of the same volume. Additional 3 animals were injected with nanogold-labelled stem cells for in vivo tracking of cells localisation using a micro-computed tomography (microCT). Retinal function was assessed by electroretinography (ERG) 3 days before the injection and repeated at days 15, 30 and 70 after the injection. Eyes were collected at day 70 for histology, cellular and molecular studies. Results No retinal tumor formation was detected by histology during the study period. MicroCT scans showed that hWJ-MSCs stayed localised in the eye with no systemic migration. Transmission electron microscopy showed that nanogold-labelled cells were located within the subretinal space. Histology showed preservation of the outer nuclear layer (ONL) in the treated group but not in the control group. However, there were no significant differences in the ERG responses between the groups. Confocal microscopy showed evidence of hWJ-MSCs expressing markers for photoreceptor, Muller cells and bipol cells. Conclusions Subretinal injection of hWJ-MSCs delay the loss of the ONL in RCS rats. hWJ-MSCs appears to be safe and has potential to differentiate into retinal-like cells. The potential of this cell-based therapy for the treatment of retinal dystrophies warrants further studies.	[Leow, S. N.; Nizam, M. H. Hairul; Ruhaslizan, R.; Wong, H. S.; Halim, Wan Haslina Wan Abdul; Bastion, M. L. C.; Then, K. Y.] Univ Kebangsaan Malaysia, Dept Ophthalmol, Med Ctr, Kuala Lumpur, Malaysia; [Luu, Chi D.] Univ Melbourne, Royal Victorian Eye & Ear Hosp, Ctr Eye Res Australia, Melbourne, Vic, Australia; [Mok, P. L.] Univ Putra Malaysia, Dept Obstet & Gynaecol, Fac Med & Hlth Sci, Selangor Darul Ehsan, Malaysia; [Mok, P. L.] Univ Putra Malaysia, Genet & Regenerat Med Res Ctr, Fac Med & Hlth Sci, Selangor Darul Ehsan, Malaysia; [Ng, M. H.; Ruszymah, B. H. I.; Chowdhury, S. R.] Univ Kebangsaan Malaysia, Tissue Engn Ctr, Med Ctr, Kuala Lumpur, Malaysia	Universiti Kebangsaan Malaysia; Centre for Eye Research Australia; Royal Victorian Eye & Ear Hospital; University of Melbourne; Universiti Putra Malaysia; Universiti Putra Malaysia; Universiti Kebangsaan Malaysia	Leow, SN (corresponding author), Univ Kebangsaan Malaysia, Dept Ophthalmol, Med Ctr, Kuala Lumpur, Malaysia.	sue_ngein@yahoo.com	Chowdhury, Somnath Roy/A-9468-2013; Mok, Pooi Ling/AAJ-7480-2021; Bastion, Mae-Lynn/ABE-1237-2020; Chowdhury, Shiplu Roy/D-3039-2017; Ng, Angela Min Hwei/ABC-6726-2020; Halim, Wan Haslina Wan Abdul/AAP-6141-2020; Kumar, suresh S/J-2423-2017; HARUN, MOHD HAIRUL NIZAM/D-5351-2017	Chowdhury, Somnath Roy/0000-0001-9195-2928; Bastion, Mae-Lynn/0000-0002-6856-8052; Chowdhury, Shiplu Roy/0000-0002-8687-3587; Ng, Angela Min Hwei/0000-0002-5791-639X; Halim, Wan Haslina Wan Abdul/0000-0001-9140-4040; Kumar, suresh S/0000-0002-0505-7554; HARUN, MOHD HAIRUL NIZAM/0000-0002-2387-9834; Luu, Chi/0000-0002-7604-7097	Universiti Kebangsaan Malaysia Industry University Research Incentive Grant [Industri-2011-048]	Universiti Kebangsaan Malaysia Industry University Research Incentive Grant	Funding for this work came from Universiti Kebangsaan Malaysia Industry University Research Incentive Grant (Industri-2011-048). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The author who received funding is ML.	Anker PSI, 2003, HAEMATOLOGICA, V88, P845; Bilic G, 2008, CELL TRANSPLANT, V17, P955, DOI 10.3727/096368908786576507; Bongso A, 2013, STEM CELL REV REP, V9, P226, DOI 10.1007/s12015-012-9418-z; Breymann C, 2006, STEM CELL REV, V2, P87; Buy K, 2014, TOXICOL IN VITRO, V28, P113, DOI 10.1016/j.tiv.2013.06.014; Chang PL, 2006, CONNECT TISSUE RES, V47, P67, DOI 10.1080/03008200600584074; Ciavatta Vincent T, 2013, Mol Vis, V19, P995; Conconi MT., 2011, OPEN TISSUE ENG REGE, V4, P6, DOI [10.2174/1875043501104010006, DOI 10.2174/1875043501104010006]; D'Cruz PM, 2000, HUM MOL GENET, V9, P645, DOI 10.1093/hmg/9.4.645; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; El-Sadik AO, 2010, CLIN PHARMACOL-ADV A, V2, P9, DOI 10.2147/CPAA.S8931; Fan CG, 2005, CELL TRANSPLANT, V14, P311, DOI 10.3727/000000005783983070; Fan CG, 2011, STEM CELL REV REP, V7, P195, DOI 10.1007/s12015-010-9168-8; Fischer UM, 2009, STEM CELLS DEV, V18, P683, DOI 10.1089/scd.2008.0253; Fong CY, 2011, STEM CELL REV REP, V7, P1, DOI 10.1007/s12015-010-9166-x; Fu YS, 2004, J BIOMED SCI, V11, P652, DOI 10.1159/000079678; Furlani D, 2009, MICROVASC RES, V77, P370, DOI 10.1016/j.mvr.2009.02.001; Gauthaman K, 2012, REPROD BIOMED ONLINE, V24, P235, DOI 10.1016/j.rbmo.2011.10.007; Hess David C, 2008, Expert Rev Neurother, V8, P1193, DOI 10.1586/14737175.8.8.1193; Hill AJ, 2009, STEM CELLS DEV, V18, P399, DOI 10.1089/scd.2008.0084; Hsieh JY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072604; Hu Y, 2013, NEURAL REGEN RES, V8, P1783, DOI 10.3969/j.issn.1673-5374.2013.19.006; in't Anker PS, 2004, STEM CELLS, V22, P1338, DOI 10.1634/stemcells.2004-0058; Kim DW, 2013, INT J MOL SCI, V14, P11692, DOI 10.3390/ijms140611692; Liu SY, 2014, J BIOSCI BIOENG, V117, P229, DOI 10.1016/j.jbiosc.2013.07.001; Lu FZ, 2005, J LAB CLIN MED, V146, P271, DOI 10.1016/j.lab.2005.07.003; Lu X, 2011, ADV EXP MED BIOL, V714, P129, DOI 10.1007/978-94-007-0782-5_6; Lund RD, 2007, STEM CELLS, V25, P602, DOI 10.1634/stemcells.2006-0308; Ma L, 2005, CHINESE MED J-PEKING, V118, P1987; Mareschi K, 2009, CYTOTHERAPY, V11, P534, DOI 10.1080/14653240902974024; Messerli M, 2013, REPROD SCI; Mitchell KE, 2003, STEM CELLS, V21, P50, DOI 10.1634/stemcells.21-1-50; Nagler C, 2011, ADV EXP MED BIOL, V714, P173, DOI 10.1007/978-94-007-0782-5_9; Peng JA, 2011, BRAIN RES BULL, V84, P235, DOI 10.1016/j.brainresbull.2010.12.013; Pereira WC, 2008, J TISSUE ENG REGEN M, V2, P394, DOI 10.1002/term.107; Prasanna J., 2011, OPEN TISSUE ENG REGE, V4, DOI DOI 10.2174/1875043501104010028; Ricles LM, 2011, INT J NANOMED, V6, P407, DOI 10.2147/IJN.S16354; Sabapathy V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093726; Villa C, 2011, TISSUE ENG PART B-RE, V17, P1, DOI 10.1089/ten.TEB.2010.0362; Villa C, 2010, INT J MOL SCI, V11, P1070, DOI 10.3390/ijms11031070; Vollrath D, 2001, P NATL ACAD SCI USA, V98, P12584, DOI 10.1073/pnas.221364198; Wang SM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009200; Watson N, 2015, CYTOTHERAPY, V17, P18, DOI 10.1016/j.jcyt.2014.08.009; Weiss ML, 2006, STEM CELLS, V24, P781, DOI 10.1634/stemcells.2005-0330; Weiss ML, 2008, STEM CELLS, V26, P2865, DOI 10.1634/stemcells.2007-1028; Yang CC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003336; Yang WJ, 2012, J CELL MOL MED, V16, P3085, DOI 10.1111/j.1582-4934.2012.01600.x; Yu MJ, 2004, BRIT J HAEMATOL, V124, P666, DOI 10.1111/j.1365-2141.2004.04826.x	48	51	53	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2015	10	6							e0128973	10.1371/journal.pone.0128973	http://dx.doi.org/10.1371/journal.pone.0128973			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4OM	26107378	gold, Green Accepted, Green Published			2022-12-26	WOS:000356932500035
J	Li, B; Shin, H; Gulbekyan, G; Pustovalova, O; Nikolsky, Y; Hope, A; Bessarabova, M; Schu, M; Kolpakova-Hart, E; Merberg, D; Dorner, A; Trepicchio, WL				Li, Bin; Shin, Hyunjin; Gulbekyan, Georgy; Pustovalova, Olga; Nikolsky, Yuri; Hope, Andrew; Bessarabova, Marina; Schu, Matthew; Kolpakova-Hart, Elona; Merberg, David; Dorner, Andrew; Trepicchio, William L.			Development of a Drug-Response Modeling Framework to Identify Cell Line Derived Translational Biomarkers That Can Predict Treatment Outcome to Erlotinib or Sorafenib	PLOS ONE			English	Article							GENE-EXPRESSION DATA; OLIGONUCLEOTIDE ARRAY DATA; LEAST-SQUARES REGRESSION; MULTIARRAY ANALYSIS FRMA; NCI-60 CANCER-CELLS; MULTIPLE-MYELOMA; BREAST-CANCER; BATTLE TRIAL; SENSITIVITY; DISCOVERY	Development of drug responsive biomarkers from pre-clinical data is a critical step in drug discovery, as it enables patient stratification in clinical trial design. Such translational biomarkers can be validated in early clinical trial phases and utilized as a patient inclusion parameter in later stage trials. Here we present a study on building accurate and selective drug sensitivity models for Erlotinib or Sorafenib from pre-clinical in vitro data, followed by validation of individual models on corresponding treatment arms from patient data generated in the BATTLE clinical trial. A Partial Least Squares Regression (PLSR) based modeling framework was designed and implemented, using a special splitting strategy and canonical pathways to capture robust information for model building. Erlotinib and Sorafenib predictive models could be used to identify a sub-group of patients that respond better to the corresponding treatment, and these models are specific to the corresponding drugs. The model derived signature genes reflect each drug's known mechanism of action. Also, the models predict each drug's potential cancer indications consistent with clinical trial results from a selection of globally normalized GEO expression datasets.	[Li, Bin; Shin, Hyunjin; Schu, Matthew; Merberg, David; Dorner, Andrew; Trepicchio, William L.] Takeda Pharmaceut Int Co, Dept Translat Med, Cambridge, MA 02139 USA; [Gulbekyan, Georgy; Pustovalova, Olga; Nikolsky, Yuri; Hope, Andrew; Bessarabova, Marina; Kolpakova-Hart, Elona] Thomson Reuters, Ann Arbor, MI 48108 USA	Takeda Pharmaceutical Company Ltd; Takeda Pharmaceuticals International, Inc.; Clarivate	Trepicchio, WL (corresponding author), Takeda Pharmaceut Int Co, Dept Translat Med, 35 Landsdowne St, Cambridge, MA 02139 USA.	Bill.Trepicchio@takeda.com			Thomson Reuters; Takeda Pharmaceuticals International Co	Thomson Reuters; Takeda Pharmaceuticals International Co(Takeda Pharmaceutical Company Ltd)	The authors received no specific funding for this work. Thomson Reuters and Takeda Pharmaceuticals International Co provided support in the form of salaries for the authors, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bar J, 2012, CLIN LUNG CANCER, V13, P267, DOI 10.1016/j.cllc.2011.09.001; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Benjamini Y, 2001, ANN STAT, V29, P1165; Bessarabova M, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S16-S13; Blower PE, 2007, MOL CANCER THER, V6, P1483, DOI 10.1158/1535-7163.MCT-07-0009; Blumenschein GR, 2013, CLIN CANCER RES, V19, P6967, DOI 10.1158/1078-0432.CCR-12-1818; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Bussey KJ, 2006, MOL CANCER THER, V5, P853, DOI 10.1158/1535-7163.MCT-05-0155; Cao KAL, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-253; Carlson MW, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-117; Chun H, 2010, J R STAT SOC B, V72, P3, DOI 10.1111/j.1467-9868.2009.00723.x; Chun H, 2009, GENETICS, V182, P79, DOI 10.1534/genetics.109.100362; Costello JC, 2014, NAT BIOTECHNOL, V32, P1202, DOI 10.1038/nbt.2877; Decaux O, 2008, J CLIN ONCOL, V26, P4798, DOI 10.1200/JCO.2007.13.8545; DEMMEL J, 1990, SIAM J SCI STAT COMP, V11, P873, DOI 10.1137/0911052; Dezso Z, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-36; Fagan A, 2007, PROTEOMICS, V7, P2162, DOI 10.1002/pmic.200600898; Garnett MJ, 2012, NATURE, V483, P570, DOI 10.1038/nature11005; Ikediobi ON, 2006, MOL CANCER THER, V5, P2606, DOI 10.1158/1535-7163.MCT-06-0433; Janes KA, 2006, CELL, V124, P1225, DOI 10.1016/j.cell.2006.01.041; Katz S, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-464; Kim ES, 2011, CANCER DISCOV, V1, P44, DOI 10.1158/2159-8274.CD-10-0010; Lazar C, 2013, IEEE ACM T COMPUT BI, V10, P383, DOI 10.1109/TCBB.2013.12; Lazar C, 2013, BRIEF BIOINFORM, V14, P469, DOI 10.1093/bib/bbs037; Le Cao KA, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-34; Lee JK, 2007, P NATL ACAD SCI USA, V104, P13086, DOI 10.1073/pnas.0610292104; Lee JK, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-12-r82; LINDGREN F, 1993, J CHEMOMETR, V7, P45, DOI 10.1002/cem.1180070104; Luo J, 2010, PHARMACOGENOMICS J, V10, P278, DOI 10.1038/tpj.2010.57; McCall MN, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-369; McCall MN, 2010, BIOSTATISTICS, V11, P242, DOI 10.1093/biostatistics/kxp059; Mulligan G, 2007, BLOOD, V109, P3177, DOI 10.1182/blood-2006-09-044974; Nikolsky Y, 2009, METHODS MOL BIOL, V563, P177, DOI 10.1007/978-1-60761-175-2_10; Nishizuka S, 2003, P NATL ACAD SCI USA, V100, P14229, DOI 10.1073/pnas.2331323100; Paik S, 2004, NEW ENGL J MED, V351, P2817, DOI 10.1056/NEJMoa041588; Perakslis ED, 2010, CLIN PHARMACOL THER, V87, P614, DOI 10.1038/clpt.2010.21; Reinhold WC, 2007, MOL CANCER THER, V6, P391, DOI 10.1158/1535-7163.MCT-06-0609; Reinhold WC, 2012, CANCER RES, V72, P3499, DOI 10.1158/0008-5472.CAN-12-1370; Shaughnessy JD, 2007, BLOOD, V109, P2276, DOI 10.1182/blood-2006-07-038430; Shi LM, 2010, NAT BIOTECHNOL, V28, P827, DOI 10.1038/nbt.1665; Shoemaker R H, 1988, Prog Clin Biol Res, V276, P265; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; Vellaichamy A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010936; Virtanen C, 2002, P NATL ACAD SCI USA, V99, P12357, DOI 10.1073/pnas.192240599; Weinstein JN, 1997, SCIENCE, V275, P343, DOI 10.1126/science.275.5298.343; Wheeler DL, 2010, NAT REV CLIN ONCOL, V7, P493, DOI 10.1038/nrclinonc.2010.97; Witten DM, 2009, STAT APPL GENET MOL, V8, DOI 10.2202/1544-6115.1470; Wold S, 2001, CHEMOMETR INTELL LAB, V58, P109, DOI 10.1016/S0169-7439(01)00155-1; Zhan FH, 2008, BLOOD, V111, P968, DOI 10.1182/blood-2007-10-119321; Zhan F, 2006, BLOOD, V108, P2020, DOI 10.1182/blood-2005-11-013458	50	20	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2015	10	6							e0130700	10.1371/journal.pone.0130700	http://dx.doi.org/10.1371/journal.pone.0130700			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4OM	26107615	Green Published, Green Submitted, gold			2022-12-26	WOS:000356932500117
J	Meik, JM; Streicher, JW; Lawing, AM; Flores-Villela, O; Fujita, MK				Meik, Jesse M.; Streicher, Jeffrey W.; Lawing, A. Michelle; Flores-Villela, Oscar; Fujita, Matthew K.			Limitations of Climatic Data for Inferring Species Boundaries: Insights from Speckled Rattlesnakes	PLOS ONE			English	Article							PHYLOGEOGRAPHIC BREAKS; NICHE; DELIMITATION; CROTALUS; CALIFORNIA; EVOLUTION; CONCORDANCE; VICARIANCE; INFERENCE; REPTILES	Phenotypes, DNA, and measures of ecological differences are widely used in species delimitation. Although rarely defined in such studies, ecological divergence is almost always approximated using multivariate climatic data associated with sets of specimens (i.e., the "climatic niche"); the justification for this approach is that species-specific climatic envelopes act as surrogates for physiological tolerances. Using identical statistical procedures, we evaluated the usefulness and validity of the climate-as-proxy assumption by comparing performance of genetic (nDNA SNPs and mitochondrial DNA), phenotypic, and climatic data for objective species delimitation in the speckled rattlesnake (Crotalus mitchellii) complex. Ordination and clustering patterns were largely congruent among intrinsic (heritable) traits (nDNA, mtDNA, phenotype), and discordance is explained by biological processes (e.g., ontogeny, hybridization). In contrast, climatic data did not produce biologically meaningful clusters that were congruent with any intrinsic dataset, but rather corresponded to regional differences in atmospheric circulation and climate, indicating an absence of inherent taxonomic signal in these data. Surrogating climate for physiological tolerances adds artificial weight to evidence of species boundaries, as these data are irrelevant for that purpose. Based on the evidence from congruent clustering of intrinsic datasets, we recommend that three subspecies of C. mitchellii be recognized as species: C. angelensis, C. mitchellii, and C. Pyrrhus.	[Meik, Jesse M.] Tarleton State Univ, Dept Biol Sci, Stephenville, TX 76401 USA; [Streicher, Jeffrey W.; Fujita, Matthew K.] Univ Texas Arlington, Dept Biol, Arlington, TX 76019 USA; [Lawing, A. Michelle] Texas A&M Univ, Dept Ecosyst Sci & Management, College Stn, TX USA; [Flores-Villela, Oscar] Univ Nacl Autonoma Mexico, Fac Ciencias, Museo Zool, Mexico City 04510, DF, Mexico	Texas A&M University System; Tarleton State University; University of Texas System; University of Texas Arlington; Texas A&M University System; Texas A&M University College Station; Universidad Nacional Autonoma de Mexico	Meik, JM (corresponding author), Tarleton State Univ, Dept Biol Sci, Stephenville, TX 76401 USA.	meik@tarleton.edu	Lawing, Michelle/F-7453-2019	Lawing, Michelle/0000-0003-4041-6177; Flores-Villela, Oscar/0000-0002-2849-6912; Streicher, Jeffrey/0000-0002-3738-4162	TE Inc.; Explorer's Club Exploration Fund; H. and L. Darley (Nancy Ruth Fund); TI Foundation; National Institute for Mathematical and Biological Synthesis; National Science Foundation; U.S. Department of Homeland Security; U.S. Department of Agriculture through NSF [EF-0832858]; University of Tennessee, Knoxville; Div Of Biological Infrastructure [1300426] Funding Source: National Science Foundation	TE Inc.; Explorer's Club Exploration Fund; H. and L. Darley (Nancy Ruth Fund); TI Foundation; National Institute for Mathematical and Biological Synthesis; National Science Foundation(National Science Foundation (NSF)); U.S. Department of Homeland Security(United States Department of Homeland Security (DHS)); U.S. Department of Agriculture through NSF(National Science Foundation (NSF)); University of Tennessee, Knoxville; Div Of Biological Infrastructure(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by T&E Inc.; the Explorer's Club Exploration Fund; H. and L. Darley (Nancy Ruth Fund) and the TI Foundation (to JMM); the National Institute for Mathematical and Biological Synthesis, an institute sponsored by The National Science Foundation; the U.S. Department of Homeland Security; and the U.S. Department of Agriculture through NSF award #EF-0832858; with additional support from The University of Tennessee, Knoxville (to AML).	Altekar G, 2004, BIOINFORMATICS, V20, P407, DOI 10.1093/bioinformatics/btg427; Alvarez-Borrego Saul, 2002, P41; [Anonymous], 2014, R LANG ENV STAT COMP; Bond JE, 2008, SYST BIOL, V57, P628, DOI 10.1080/10635150802302443; Boria RA, 2014, ECOL MODEL, V275, P73, DOI 10.1016/j.ecolmodel.2013.12.012; Boucher FC, 2014, AM NAT, V183, P573, DOI 10.1086/675506; Bryant D, 2012, MOL BIOL EVOL, V29, P1917, DOI 10.1093/molbev/mss086; Campbell J. A., 2004, VENOMOUS REPTILES W; Cariou M, 2013, ECOL EVOL, V3, P846, DOI 10.1002/ece3.512; Carreno Ana Luisa, 2002, P14; Catchen J, 2013, MOL ECOL, V22, P3124, DOI 10.1111/mec.12354; Coyne J.A., 2004, SPECIATION; De Queiroz K, 2007, SYST BIOL, V56, P879, DOI 10.1080/10635150701701083; Dent R, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0036889, 10.1371/journal.pone.0037135]; Douglas ME, 2007, COPEIA, P920, DOI 10.1643/0045-8511(2007)7[920:GCBMAN]2.0.CO;2; Douglas ME, 2006, MOL ECOL, V15, P3353, DOI 10.1111/j.1365-294X.2006.03007.x; Durand EY, 2011, MOL BIOL EVOL, V28, P2239, DOI 10.1093/molbev/msr048; Earl DA, 2011, CONSERV GENET RESOUR, V4, P359, DOI DOI 10.1007/S12686-011-9548-7; Edwards DL, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.2765; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Ezard THG, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-175; Fraley C, 2012, 597 U WASH; GRIsMER L. L., 2002, TUCSON HERPETOLOGICA; Grismer LL, 1999, HERPETOLOGICA, V55, P446; Guillot G, 2012, SYST BIOL, V61, P897, DOI 10.1093/sysbio/sys038; Hausdorf B, 2011, EVOLUTION, V65, P923, DOI 10.1111/j.1558-5646.2011.01231.x; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Houle D, 2011, Q REV BIOL, V86, P3, DOI 10.1086/658408; Irwin DE, 2002, EVOLUTION, V56, P2383; Jimenez-Valverde A, 2008, DIVERS DISTRIB, V14, P885, DOI 10.1111/j.1472-4642.2008.00496.x; Jombart T, 2011, BIOINFORMATICS, V27, P3070, DOI 10.1093/bioinformatics/btr521; KLAUBER LAURENCE M, 1940, OCCAS PAPERS SAN DIEGO SOC NAT HIST, V6, P1; Klauber LM, 1936, T SAN DIEGO SOC NAT, V6, P353; Knouft JH, 2006, ECOLOGY, V87, pS29, DOI 10.1890/0012-9658(2006)87[29:PAOTEO]2.0.CO;2; Kuo CH, 2005, GENETICA, V124, P179, DOI 10.1007/s10709-005-2095-y; Leache AD, 2007, BIOL LETTERS, V3, P646, DOI 10.1098/rsbl.2007.0368; Leache AD, 2009, P NATL ACAD SCI USA, V106, P12418, DOI 10.1073/pnas.0906380106; Lozier JD, 2009, J BIOGEOGR, V36, P1623, DOI 10.1111/j.1365-2699.2009.02152.x; Mackessy SP, 2008, BIOL RATTLESNAKES, P495; MADDISON D, 2002, MACCLADE ANAL PHYLOG; Martin SH, 2015, MOL BIOL EVOL, V32, P244, DOI 10.1093/molbev/msu269; Mayden R. L., 1997, V54, P381; McCormack JE, 2010, EVOLUTION, V64, P1231, DOI 10.1111/j.1558-5646.2009.00900.x; McInerny GJ, 2012, J BIOGEOGR, V39, P2103, DOI 10.1111/jbi.12032; Meik Jesse M., 2012, PHYLLOMEDUSA, V11, P3; Meik JM, 2008, BIOL RATTLESNAKES, P39; Murphy Robert W., 2002, P69; Nix H.A., 1986, ATLAS ELAPID SNAKES, P4; Pritchard JK, 2000, GENETICS, V155, P945; Raxworthy CJ, 2007, SYST BIOL, V56, P907, DOI 10.1080/10635150701775111; Reeves PA, 2011, SYST BIOL, V60, P45, DOI 10.1093/sysbio/syq056; Reyes-Velasco J, 2013, MOL PHYLOGENET EVOL, V69, P524, DOI 10.1016/j.ympev.2013.07.025; Riddle BR, 2000, P NATL ACAD SCI USA, V97, P14438, DOI 10.1073/pnas.250413397; Rissler LJ, 2007, SYST BIOL, V56, P924, DOI 10.1080/10635150701703063; Sites JW, 2003, TRENDS ECOL EVOL, V18, P462, DOI 10.1016/S0169-5347(03)00184-8; Streicher JW, 2014, MOL ECOL, V23, P3273, DOI 10.1111/mec.12814; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; VANVALEN L, 1976, TAXON, V25, P233, DOI 10.2307/1219444; Warren DL, 2014, TRENDS ECOL EVOL, V29, P572, DOI 10.1016/j.tree.2014.08.003; Warren DL, 2010, ECOGRAPHY, V33, P607, DOI 10.1111/j.1600-0587.2009.06142.x; Wu CI, 2004, NAT REV GENET, V5, P114, DOI 10.1038/nrg1269	61	26	27	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2015	10	6							e0131435	10.1371/journal.pone.0131435	http://dx.doi.org/10.1371/journal.pone.0131435			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4OM	26107178	Green Submitted, Green Published, gold			2022-12-26	WOS:000356932500163
J	Porcal, P; Dillon, PJ; Molot, LA				Porcal, Petr; Dillon, Peter J.; Molot, Lewis A.			Temperature Dependence of Photodegradation of Dissolved Organic Matter to Dissolved Inorganic Carbon and Particulate Organic Carbon	PLOS ONE			English	Article							SOLAR-RADIATION; PHOTOCHEMICAL SOURCE; SEASONAL-CHANGES; WATER; STREAMS; LAKES; FLOCCULATION; SEDIMENTS; PHOTOREACTIONS; PHOTOOXIDATION	Photochemical transformation of dissolved organic matter (DOM) has been studied for more than two decades. Usually, laboratory or "in-situ" experiments are used to determine photodegradation variables. A common problem with these experiments is that the photodegradation experiments are done at higher than ambient temperature. Five laboratory experiments were done to determine the effect of temperature on photochemical degradation of DOM. Experimental results showed strong dependence of photodegradation on temperature. Mathematical modeling of processes revealed that two different pathways engaged in photochemical transformation of DOM to dissolved inorganic carbon (DIC) strongly depend on temperature. Direct oxidation of DOM to DIC dominated at low temperatures while conversion of DOM to intermediate particulate organic carbon (POC) prior to oxidation to DIC dominated at high temperatures. It is necessary to consider this strong dependence when the results of laboratory experiments are interpreted in regard to natural processes. Photodegradation experiments done at higher than ambient temperature will necessitate correction of rate constants.	[Porcal, Petr; Dillon, Peter J.] Trent Univ, Environm & Resource Studies, Peterborough, ON K9J 7B8, Canada; [Porcal, Petr] Acad Sci Czech Republic, Inst Hydrobiol, Ctr Biol, Vvi, Ceske Budejovice, Czech Republic; [Molot, Lewis A.] York Univ, Fac Environm Studies, Toronto, ON M3J 2R7, Canada	Trent University; Czech Academy of Sciences; Biology Centre of the Czech Academy of Sciences; York University - Canada	Porcal, P (corresponding author), Trent Univ, Environm & Resource Studies, Peterborough, ON K9J 7B8, Canada.	porcal@hbu.cas.cz	Porcal, Petr/A-7350-2014; Porcal, Petr/R-4687-2019	Porcal, Petr/0000-0002-7787-4924; 	Czech Science Foundation projects [P503/12/0781, 15-09721S]; NSERC Strategic Grant	Czech Science Foundation projects; NSERC Strategic Grant(Natural Sciences and Engineering Research Council of Canada (NSERC))	This research was made possible by an NSERC Strategic Grant and by the Czech Science Foundation projects P503/12/0781 and 15-09721S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anesio AM, 1999, ECOLOGY, V80, P1852, DOI 10.1890/0012-9658(1999)080[1852:POICFA]2.0.CO;2; Bertilsson S, 1998, LIMNOL OCEANOGR, V43, P885, DOI 10.4319/lo.1998.43.5.0885; Chin WC, 1998, NATURE, V391, P568, DOI 10.1038/35345; DILLON PJ, 1991, J ENVIRON QUAL, V20, P857, DOI 10.2134/jeq1991.00472425002000040025x; DRISCOLL CT, 1988, J ENVIRON ENG-ASCE, V114, P21, DOI 10.1061/(ASCE)0733-9372(1988)114:1(21); Eimers MC, 2008, CAN J FISH AQUAT SCI, V65, P796, DOI 10.1139/F07-194; Escobedo JF, 2011, RENEW ENERG, V36, P169, DOI 10.1016/j.renene.2010.06.018; Estapa ML, 2010, MAR CHEM, V122, P138, DOI 10.1016/j.marchem.2010.06.003; Gao HZ, 1998, ENVIRON SCI TECHNOL, V32, P2940, DOI 10.1021/es9803660; Graneli W, 1996, LIMNOL OCEANOGR, V41, P698, DOI 10.4319/lo.1996.41.4.0698; Hagreaves BR, 2003, UV EFFECTS AQUATIC O, P59; Hanson AT, 1990, J AM WATER WORKS ASS, V80, P168; KANG LS, 1995, J ENVIRON ENG, V121, P893, DOI 10.1061/(ASCE)0733-9372(1995)121:12(893); Kelton N, 2007, WATER RES, V41, P638, DOI 10.1016/j.watres.2006.11.001; KIEBER DJ, 1989, NATURE, V341, P637, DOI 10.1038/341637a0; Kieber RJ, 2006, LIMNOL OCEANOGR, V51, P2187, DOI 10.4319/lo.2006.51.5.2187; Kohler S, 2002, AQUAT SCI, V64, P269, DOI 10.1007/s00027-002-8071-z; Kopacek J, 2006, ENVIRON SCI TECHNOL, V40, P4455, DOI 10.1021/es0600532; Mayer LM, 2006, LIMNOL OCEANOGR, V51, P1064, DOI 10.4319/lo.2006.51.2.1064; Molot LA, 1997, GLOBAL BIOGEOCHEM CY, V11, P357, DOI 10.1029/97GB01198; Molot LA, 2005, AQUAT SCI, V67, P189, DOI 10.1007/s00027-005-0754-9; MOPPER K, 1991, NATURE, V353, P60, DOI 10.1038/353060a0; Moran MA, 2000, LIMNOL OCEANOGR, V45, P1254, DOI 10.4319/lo.2000.45.6.1254; Morris DP, 1995, LIMNOL OCEANOGR, V40, P1381, DOI 10.4319/lo.1995.40.8.1381; Ontario Ministry of Environment, 1983, HDB AN METH ENV SAMP; Osburn CL, 2001, BIOGEOCHEMISTRY, V54, P251, DOI 10.1023/A:1010657428418; Petty G. W., 2006, 1 COURSE ATMOSPHERIC, V2; Porcal P, 2004, AQUAT SCI, V66, P211, DOI 10.1007/s00027-004-0701-1; Porcal P, 2013, BIOGEOSCIENCES, V10, P5533, DOI 10.5194/bg-10-5533-2013; Porcal P, 2013, AQUAT SCI, V75, P469, DOI 10.1007/s00027-013-0293-8; Porcal P, 2010, ENVIRON MONIT ASSESS, V171, P71, DOI 10.1007/s10661-010-1529-x; Porcal P, 2009, J ENVIRON MONITOR, V11, P1064, DOI 10.1039/b812330f; Stumm W., 2012, AQUATIC CHEM CHEM EQ; Upadhyay S.K., 2006, CHEM KINETICS REACTI; Vahatalo A, 1998, MAR ECOL PROG SER, V170, P107, DOI 10.3354/meps170107; VANBENSCHOTEN JE, 1990, WATER RES, V24, P1519, DOI 10.1016/0043-1354(90)90086-L; von Wachenfeldt E, 2008, LIMNOL OCEANOGR, V53, P2416, DOI 10.4319/lo.2008.53.6.2416; von Wachenfeldt E, 2008, ECOSYSTEMS, V11, P803, DOI 10.1007/s10021-008-9162-z; WETZEL RG, 1992, HYDROBIOLOGIA, V229, P181, DOI 10.1007/BF00007000; Zepp R. G., 1995, AMBIO, V24, P1995	40	43	46	10	91	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2015	10	6							e0128884	10.1371/journal.pone.0128884	http://dx.doi.org/10.1371/journal.pone.0128884			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4OM	26106898	Green Submitted, gold, Green Published			2022-12-26	WOS:000356932500032
J	Naganandhini, S; Kennedy, ZJ; Uyttendaele, M; Balachandar, D				Naganandhini, S.; Kennedy, Z. John; Uyttendaele, M.; Balachandar, D.			Persistence of Pathogenic and Non-Pathogenic Escherichia coli Strains in Various Tropical Agricultural Soils of India	PLOS ONE			English	Article							MANURE-AMENDED SOIL; ENTERICA SEROVAR TYPHIMURIUM; MICROBIAL COMMUNITY; O157-H7 SURVIVAL; E.-COLI; O157/H7; FATE; O157H7; DIVERSITY; LETTUCE	The persistence of Shiga-like toxin producing Escherichia coli (STEC) strains in the agricultural soil creates serious threat to human health through fresh vegetables growing on them. However, the survival of STEC strains in Indian tropical soils is not yet understood thoroughly. Additionally how the survival of STEC strain in soil diverges with non-pathogenic and genetically modified Escherichia coli strains is also not yet assessed. Hence in the present study, the survival pattern of STEC strain (O157-TNAU) was compared with non-pathogenic (MTCC433) and genetically modified (DH5 alpha) strains on different tropical agricultural soils and on a vegetable growing medium, cocopeat under controlled condition. The survival pattern clearly discriminated DH5 alpha from MTCC433 and O157-TNAU, which had shorter life (40 days) than those compared (60 days). Similarly, among the soils assessed, the red laterite and tropical latosol supported longer survival of O157-TNAU and MTCC433 as compared to wetland and black cotton soils. In cocopeat, O157 recorded significantly longer survival than other two strains. The survival data were successfully analyzed using Double-Weibull model and the modeling parameters were correlated with soil physico-chemical and biological properties using principal component analysis (PCA). The PCA of all the three strains revealed that pH, microbial biomass carbon, dehydrogenase activity and available N and P contents of the soil decided the survival of Escherichia coli strains in those soils and cocopeat. The present research work suggests that the survival of O157 differs in tropical Indian soils due to varied physico-chemical and biological properties and the survival is much shorter than those reported in temperate soils. As the survival pattern of non-pathogenic strain, MTCC433 is similar to O157-TNAU in tropical soils, the former can be used as safe model organism for open field studies.	[Naganandhini, S.; Balachandar, D.] Tamil Nadu Agr Univ, Dept Agr Microbiol, Coimbatore 641003, Tamil Nadu, India; [Kennedy, Z. John] Tamil Nadu Agr Univ, Post Harvest Technol Ctr, Coimbatore 641003, Tamil Nadu, India; [Uyttendaele, M.] Univ Ghent, Fac Biosci Engn, Dept Food Safety & Food Qual, Lab Food Microbiol & Food Preservat, B-9000 Ghent, Belgium	Tamil Nadu Agricultural University; Tamil Nadu Agricultural University; Ghent University	Balachandar, D (corresponding author), Tamil Nadu Agr Univ, Dept Agr Microbiol, Coimbatore 641003, Tamil Nadu, India.	dbalu@tnau.ac.in	Dananjeyan, Balachandar/V-3795-2019	Balachandar, Dananjeyan/0000-0002-4434-6316	European Community's Seventh Framework Program (FP7) (project VEG-i-TRADE) [244994]; Department of Biotechnology, New Delhi [BT/PR10398/PFN/20/899/2013]	European Community's Seventh Framework Program (FP7) (project VEG-i-TRADE); Department of Biotechnology, New Delhi(Department of Biotechnology (DBT) India)	This research was supported by the European Community's Seventh Framework Program (FP7) under grant agreement 244994 (project VEG-i-TRADE) and Department of Biotechnology, New Delhi through R & D Project (Molecular detection and quantification of Shiga-like toxin producing Escherichia coli in fresh vegetables, Sanction No. BT/PR10398/PFN/20/899/2013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bolton DJ, 1999, J APPL MICROBIOL, V86, P407, DOI 10.1046/j.1365-2672.1999.00677.x; Cai P, 2013, ENVIRON SCI TECHNOL, V47, P1896, DOI 10.1021/es304686a; Castellani A, 1919, MANUAL TROPICAL MED, V3rd; CEBULA TA, 1995, J CLIN MICROBIOL, V33, P248, DOI 10.1128/JCM.33.1.248-250.1995; Chambers B, 2001, MANAGING LIVESTOCK M, P18; Chart H, 2000, J APPL MICROBIOL, V88, p12S, DOI 10.1111/j.1365-2672.2000.tb05328.x; Chinnadurai C, 2014, ARCH AGRON SOIL SCI, V60, P531, DOI 10.1080/03650340.2013.803072; Cooley M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001159; Cools D, 2001, APPL SOIL ECOL, V17, P53, DOI 10.1016/S0929-1393(00)00133-5; Coroller L, 2006, APPL ENVIRON MICROB, V72, P6493, DOI 10.1128/AEM.00876-06; Entry J. A., 2010, APPL ENV SOIL SCI, V2010, P1, DOI [10.1155/2010/973925, DOI 10.1155/2010/973925]; Franz E, 2005, APPL ENVIRON MICROB, V71, P6165, DOI 10.1128/AEM.71.10.6165-6174.2005; Franz E, 2008, ENVIRON MICROBIOL, V10, P313, DOI 10.1111/j.1462-2920.2007.01453.x; Fremaux B, 2008, VET MICROBIOL, V132, P1, DOI 10.1016/j.vetmic.2008.05.015; Fremaux B, 2008, J APPL MICROBIOL, V104, P296; Geeraerd AH, 2005, INT J FOOD MICROBIOL, V102, P95, DOI 10.1016/j.ijfoodmicro.2004.11.038; Guan TY, 2003, J ENVIRON QUAL, V32, P383, DOI 10.2134/jeq2003.0383; HAHESY T, 1992, IRISH VET J, V45, P122; Hanway J.J., 1952, IOWA AGR, V57, P1, DOI DOI 10.12691/AJWR-7-1-5; Hepburn NF, 2002, LETT APPL MICROBIOL, V35, P233, DOI 10.1046/j.1472-765X.2002.01173.x; Hilborn ED, 1999, ARCH INTERN MED, V159, P1758, DOI 10.1001/archinte.159.15.1758; Hutchison ML, 2004, APPL ENVIRON MICROB, V70, P5111, DOI 10.1128/AEM.70.9.5111-5118.2004; Ibekwe A Mark, 2011, Int J Microbiol, V2011, DOI 10.1155/2011/421379; Ibekwe AM, 2011, SCI TOTAL ENVIRON, V409, P3740, DOI 10.1016/j.scitotenv.2011.06.033; Islam M, 2005, FOOD MICROBIOL, V22, P63, DOI 10.1016/j.fm.2004.04.007; Islam M, 2004, J FOOD PROTECT, V67, P1365, DOI 10.4315/0362-028X-67.7.1365; Jenkinson D. S., 1981, Soil biochemistry. Volume 5, P415; Jiang XP, 2002, APPL ENVIRON MICROB, V68, P2605, DOI 10.1128/AEM.68.5.2605-2609.2002; KLEIN D A, 1971, Soil Biology and Biochemistry, V3, P385, DOI 10.1016/0038-0717(71)90049-6; Kudva IT, 1998, APPL ENVIRON MICROB, V64, P3166; Lang NL, 2007, J APPL MICROBIOL, V103, P2122, DOI 10.1111/j.1365-2672.2007.03490.x; Ma JC, 2014, SCI TOTAL ENVIRON, V490, P822, DOI 10.1016/j.scitotenv.2014.05.069; Ma JC, 2012, ENVIRON SCI TECHNOL, V46, P12154, DOI 10.1021/es302738z; Ma JC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023191; MAULE A, 1999, INT FOOD HYGIENE, V9, P21; Michino H, 1999, AM J EPIDEMIOL, V150, P787, DOI 10.1093/oxfordjournals.aje.a010082; Miller WG, 1997, GENE, V191, P149, DOI 10.1016/S0378-1119(97)00051-6; Moyne AL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070643; Mubiru DN, 2000, J ENVIRON QUAL, V29, P1821, DOI 10.2134/jeq2000.00472425002900060012x; Mukherjee A, 2006, J APPL MICROBIOL, V101, P429, DOI 10.1111/j.1365-2672.2006.02913.x; Nataro JP, 1998, CLIN MICROBIOL REV, V11, P403; Ngole V, 2006, EUR J SOIL BIOL, V42, P208, DOI 10.1016/j.ejsobi.2006.03.004; Nicholson FA, 2005, BIORESOURCE TECHNOL, V96, P135, DOI 10.1016/j.biortech.2004.02.030; O'Brien AD, 1998, ESCHERICHIA COLI O15, P1; Ogden ID, 2001, INT J FOOD MICROBIOL, V66, P111, DOI 10.1016/S0168-1605(00)00508-0; Olive DM, 1999, J CLIN MICROBIOL, V37, P1661, DOI 10.1128/JCM.37.6.1661-1669.1999; Oliveira M, 2012, INT J FOOD MICROBIOL, V156, P133, DOI 10.1016/j.ijfoodmicro.2012.03.014; OLSEN STERLING R., 1954, U S DEPT AGRIC CIRC, V939, P1; Ongeng D, 2011, J APPL MICROBIOL, V110, P1007, DOI 10.1111/j.1365-2672.2011.04956.x; Ongeng D, 2011, INT J FOOD MICROBIOL, V145, P301, DOI 10.1016/j.ijfoodmicro.2011.01.018; Ongeng D, 2015, CRIT REV MICROBIOL, V41, P273, DOI 10.3109/1040841X.2013.829415; Paton JC, 1998, CLIN MICROBIOL REV, V11, P450, DOI 10.1128/CMR.11.3.450; Posada-Izquierdo GD, 2013, FOOD MICROBIOL, V33, P131, DOI 10.1016/j.fm.2012.08.010; RECORBET G, 1992, FEMS MICROBIOL ECOL, V101, P251; RILEY LW, 1983, NEW ENGL J MED, V308, P681, DOI 10.1056/NEJM198303243081203; Sambrook J, 1989, MOL CLONING; Semenov AV, 2008, ENVIRON MICROBIOL, V10, P1450, DOI 10.1111/j.1462-2920.2007.01558.x; Urzi C, 2001, ENVIRON MICROBIOL, V3, P471, DOI 10.1046/j.1462-2920.2001.00217.x; van Elsas JD, 2007, ISME J, V1, P204, DOI 10.1038/ismej.2007.21; van Elsas JD, 2012, P NATL ACAD SCI USA, V109, P1159, DOI 10.1073/pnas.1109326109; Versalovic James, 1994, Methods in Molecular and Cellular Biology, V5, P25; Vidovic S, 2007, CAN J MICROBIOL, V53, P822, DOI 10.1139/W07-041; Walkley A, 1934, SOIL SCI, V37, P29, DOI 10.1097/00010694-193401000-00003; Wang GD, 1996, APPL ENVIRON MICROB, V62, P2567, DOI 10.1128/AEM.62.7.2567-2570.1996; Wang HZ, 2014, ENVIRON SCI POLLUT R, V21, P518, DOI 10.1007/s11356-013-1938-9; WARING SA, 1964, NATURE, V201, P951, DOI 10.1038/201951a0; Williams AP, 2007, J APPL MICROBIOL, V102, P319, DOI 10.1111/j.1365-2672.2006.03104.x; WOLD S, 1987, CHEMOMETR INTELL LAB, V2, P37, DOI 10.1016/0169-7439(87)80084-9; WOODCOCK DM, 1989, NUCLEIC ACIDS RES, V17, P3469, DOI 10.1093/nar/17.9.3469; XLSTAT, 2010, XLSTAT ADD SARL; Yao ZY, 2014, APPL ENVIRON MICROB, V80, P70, DOI 10.1128/AEM.03046-13; Zhang TX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081178	72	21	21	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2015	10	6							e0130038	10.1371/journal.pone.0130038	http://dx.doi.org/10.1371/journal.pone.0130038			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4DD	26101887	Green Published, gold, Green Submitted			2022-12-26	WOS:000356901900026
J	Ren, ZQ; Liu, TC; Zhuang, SH; Lin, GF; Hou, JY; Wu, YS				Ren, Zhi-Qi; Liu, Tian-Cai; Zhuang, Si-Hui; Lin, Guan-Feng; Hou, Jing-Yuan; Wu, Ying-Song			Establishment of Magnetic Microparticles-Assisted Time-Resolved Fluoroimmunoassay for Determinating Biomarker Models in Human Serum	PLOS ONE			English	Article							CHEMILUMINESCENCE ENZYME-IMMUNOASSAY; HEPATITIS-B; IMMUNOCHROMATOGRAPHIC ASSAY; FLUORESCENCE IMMUNOASSAY; ULTRASENSITIVE DETECTION; SENSITIVE DETECTION; SURFACE-ANTIGEN; FREE-THYROXINE; ANTIBODY; PROTEIN	In order to early screen and detect suspected biomarkers from pathogens and the human body itself, tracers or reaction strategies that can act as signal enhancers have been proposed forth at purpose. In this paper, we discussed the applicability of magnetic microparticles-assisted time-resolved fluoroimmunoassay (MMPs-TRFIA) for sensitive determination of potential analytes. Hepatitis B e antigen, antibody to hepatitis B surface antigen and free triiodothyronine were used as biomarker models to explore the reliability of the method. By coupling with bioprobes, MMPs were used as immunoassay carriers to capture target molecules. Under optimal condition, assay performance, including accuracy, precision and specificity, was outstanding and demonstrated satisfactory. To further evaluate the performance of the MMPs-TRFIA in patients, a total of 728 serum samples from hospital were analyzed for three biomarkers in parallel with the proposed method and chemiluminescence immunoassay kit commercially available. Fairly good agreements are obtained between the two methods via data analysis. Not only that but the reliability of MMPs-TRFIA has also been illustrated by three different reaction models. It is confirmed that the novel method modified with MMPs has been established and showed great potential applications in both biological detection and clinical diagnosis, including big molecule protein and low molecular weight haptens.	[Ren, Zhi-Qi; Liu, Tian-Cai; Zhuang, Si-Hui; Lin, Guan-Feng; Hou, Jing-Yuan; Wu, Ying-Song] Southern Med Univ, Sch Biotechnol, Inst Antibody Engn, State Key Lab Organ Failure Res, Guangzhou, Guangdong, Peoples R China	Southern Medical University - China	Wu, YS (corresponding author), Southern Med Univ, Sch Biotechnol, Inst Antibody Engn, State Key Lab Organ Failure Res, Guangzhou, Guangdong, Peoples R China.	wg@smu.edu.cn	Liu, Tiancai/C-6822-2011	lin, guan feng/0000-0002-1150-9625	National Natural Science Foundation of China [81271931]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (Grant No. 81271931).	Bottero J, 2013, J HEPATOL, V58, P473, DOI 10.1016/j.jhep.2012.11.016; Careri M, 2008, J CHROMATOGR A, V1206, P89, DOI 10.1016/j.chroma.2008.07.091; Choi Y, 2008, COMB CHEM HIGH T SCR, V11, P1; Fan F, 2014, CLIN CHIM ACTA, V431, P113, DOI 10.1016/j.cca.2014.02.003; Harma H, 2011, SENSORS-BASEL, V11, P11335, DOI 10.3390/s111211335; HEIJTINK RA, 1995, J MED VIROL, V47, P245, DOI 10.1002/jmv.1890470310; HEMMILA I, 1988, SCAND J CLIN LAB INV, V48, P389, DOI 10.3109/00365518809085747; Holubova L, 2014, MAT SCI ENG C-MATER, V44, P345, DOI 10.1016/j.msec.2014.08.039; Hu Z, 2014, APPL MICROBIOL BIOT, V98, P9073, DOI 10.1007/s00253-014-6078-8; Huang B, 2006, ANAL CHIM ACTA, V571, P74, DOI 10.1016/j.aca.2006.04.053; ITHAKISSIOS DS, 1977, CLIN CHEM, V23, P2072; ITHAKISSIOS DS, 1978, CLIN CHIM ACTA, V84, P69, DOI 10.1016/0009-8981(78)90478-3; Jin H, 2009, J PHARMACEUT BIOMED, V50, P891, DOI 10.1016/j.jpba.2009.06.011; JUNGELLNORTAMO A, 1988, MOL CELL PROBE, V2, P281, DOI 10.1016/0890-8508(88)90012-6; Lehmphul I, 2014, THYROID, V24, P1350, DOI 10.1089/thy.2013.0688; Li M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106415; Lin JY, 2011, TALANTA, V86, P200, DOI 10.1016/j.talanta.2011.08.061; Mahapatra D, 2014, J CLIN DIAGN RES, V8, pDC8, DOI 10.7860/JCDR/2014/8589.4697; McDonald SLR, 2011, J VIROL METHODS, V172, P60, DOI 10.1016/j.jviromet.2010.12.021; Meng K, 2014, BIOSENS BIOELECTRON, V55, P396, DOI 10.1016/j.bios.2013.12.048; Mitchell DR, 2003, CLIN CHIM ACTA, V332, P89, DOI 10.1016/S0009-8981(03)00127-X; Morris CJ, 2013, J VIROL METHODS, V193, P391, DOI 10.1016/j.jviromet.2013.06.036; Ren ML, 2014, ACS APPL MATER INTER, V6, P14215, DOI 10.1021/am503517s; Ren ZQ, 2014, LUMINESCENCE, V29, P591, DOI 10.1002/bio.2587; Sampedro-Martinez A, 2013, J MICROBIOL METH, V94, P133, DOI 10.1016/j.mimet.2013.05.015; Sarkar M, 2008, GEN COMP ENDOCR, V158, P240, DOI 10.1016/j.ygcen.2008.07.007; SOINI E, 1983, CLIN CHEM, V29, P65; Tan XT, 2014, BMC INFECT DIS, V14, DOI 10.1186/s12879-014-0563-7; Wadajkar AS, 2014, BIOMATERIALS, V35, P654, DOI 10.1016/j.biomaterials.2013.10.015; Wang K, 2009, TOXICOL MECH METHOD, V19, P559, DOI 10.3109/15376510903380720; Wang X, 2008, CLIN CHIM ACTA, V393, P90, DOI 10.1016/j.cca.2008.03.010; Wang Z, 2011, ANN CLIN BIOCHEM, V48, P550, DOI 10.1258/acb.2011.010242; Yu LSL, 2002, J MICROBIOL METH, V49, P63, DOI 10.1016/S0167-7012(01)00352-9; Yu XX, 2014, ANAL CHIM ACTA, V812, P236, DOI 10.1016/j.aca.2014.01.021; Zhang TT, 2015, TALANTA, V131, P379, DOI 10.1016/j.talanta.2014.08.024; Zhang YX, 2007, J CHROMATOGR B, V857, P100, DOI 10.1016/j.jchromb.2007.07.006; Zhao Shulin, 2013, Methods Mol Biol, V919, P79, DOI 10.1007/978-1-62703-029-8_8	37	7	9	3	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2015	10	6							e0130481	10.1371/journal.pone.0130481	http://dx.doi.org/10.1371/journal.pone.0130481			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4DD	26103625	Green Submitted, Green Published, gold			2022-12-26	WOS:000356901900048
J	Black, M; Moolhuijzen, P; Barrero, R; La, T; Phillips, N; Hampson, D; Herbst, W; Barth, S; Bellgard, M				Black, Michael; Moolhuijzen, Paula; Barrero, Roberto; La, Tom; Phillips, Nyree; Hampson, David; Herbst, Werner; Barth, Stefanie; Bellgard, Matthew			Analysis of Multiple Brachyspira hyodysenteriae Genomes Confirms That the Species Is Relatively Conserved but Has Potentially Important Strain Variation	PLOS ONE			English	Article							SEQUENCE ALIGNMENT; OPEN SOFTWARE	The intestinal spirochete Brachyspira hyodysenteriae is an important pathogen in swine, causing mucohemorrhagic colitis in a disease known as swine dysentery. Based on the detection of significant linkage disequilibrium in multilocus sequence data, the species is considered to be clonal. An analysis of the genome sequence of Western Australian B. hyodysenteriaestrain WA1 has been published, and in the current study 19 further strains from countries around the world were sequenced with Illumina technology. The genomes were assembled and aligned to over 97.5% of the reference WA1 genome at a percentage sequence identity better than 80%. Strain regions not aligned to the reference ranged between 0.2 and 2.5%. Clustering of the strain genes found on average 2,354 (88%) core genes, 255 (8.6%) ancillary genes and 77 (2.9%) unique genes per strain. Depending on the strain the proportion of genes with 100% sequence identity to WA1 ranged from 85% to 20%. The result is a global comparative genomic analysis of B. hyodysenteriaegenomes revealing potential differential phenotypic markers for numerous strains. Despite the differences found, the genomes were less varied than those of the related pathogenic species Brachyspira pilosicoli, and the analysis supports the clonal nature of the species. From this study, a public genome resource has been created that will serve as a repository for further genetic and phenotypic studies of these important porcine bacteria. This is the first intra-species B. hyodysenteriae comparative genomic analysis.	[Black, Michael; Moolhuijzen, Paula; Barrero, Roberto] Murdoch Univ, Ctr Comparat Genom, Murdoch, WA 6150, Australia; [La, Tom; Phillips, Nyree; Hampson, David; Bellgard, Matthew] Murdoch Univ, Sch Vet & Life Sci, Murdoch, WA 6150, Australia; [Herbst, Werner; Barth, Stefanie] Univ Giessen, Inst Hyg & Infect Dis Anim, D-35390 Giessen, Germany	Murdoch University; Murdoch University; Justus Liebig University Giessen	Bellgard, M (corresponding author), Murdoch Univ, Sch Vet & Life Sci, Murdoch, WA 6150, Australia.	mbellgard@ccg.murdoch.edu.au	Hampson, David/AAE-3666-2019; Hampson, David J/A-9464-2008; Barth, Stefanie/K-7053-2019; Black, Michael/H-7645-2016	Hampson, David J/0000-0002-7729-0427; Barth, Stefanie/0000-0003-4921-5056; Moolhuijzen, Paula/0000-0002-3502-7612; Barrero, Roberto/0000-0002-7735-665X; Bellgard, Matthew/0000-0002-6303-9469	Boehringer Ingelheim Vetmedica, Germany	Boehringer Ingelheim Vetmedica, Germany(Boehringer Ingelheim)	Funding was received from Boehringer Ingelheim Vetmedica, Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achacha M, 1996, CAN J VET RES, V60, P45; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Bellgard MI, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004641; Binnewies TT, 2005, MICROBIOL-SGM, V151, P1, DOI 10.1099/mic.0.27760-0; Burland T G, 2000, Methods Mol Biol, V132, P71; Cho NH, 2005, ANN NY ACAD SCI, V1063, P100, DOI 10.1196/annals.1355.016; Cullen PA, 2003, MICROBES INFECT, V5, P275, DOI 10.1016/S1286-4579(03)00027-3; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Hampson DJ, 2012, DIS SWINE, P680; Hess J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022783; Hsu T, 2001, INFECT IMMUN, V69, P706, DOI 10.1128/IAI.69.2.706-711.2001; Hunter AA, 2012, SOURCE CODE BIOL MED, V7, DOI 10.1186/1751-0473-7-1; JENSEN NS, 1993, VET MICROBIOL, V36, P221, DOI 10.1016/0378-1135(93)90090-T; Junier T, 2010, BIOINFORMATICS, V26, P1669, DOI 10.1093/bioinformatics/btq243; Kanehisa M, 2002, NOVART FDN SYMP, V247, P91; Kennedy MJ, 1996, VET MICROBIOL, V49, P21, DOI 10.1016/0378-1135(95)00174-3; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; La T, 2011, VET MICROBIOL, V153, P150, DOI 10.1016/j.vetmic.2011.02.053; La T, 2009, VET MICROBIOL, V138, P330, DOI 10.1016/j.vetmic.2009.03.025; Lin CY, 2013, GENOME ANNOUNCEMENTS, V1, DOI 10.1128/genomeA.00215-12; Mappley LJ, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-454; Mirajkar NS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107176; Neo E, 2013, GUT PATHOG, V5, DOI 10.1186/1757-4749-5-24; Osorio J, 2013, RES VET SCI, V95, P861, DOI 10.1016/j.rvsc.2013.07.014; Osorio J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039082; Rasback T, 2007, MICROBIOL-SGM, V153, P4074, DOI 10.1099/mic.0.2007/008540-0; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; TERHUURNE AAHM, 1994, MICROB PATHOGENESIS, V16, P269, DOI 10.1006/mpat.1994.1028; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; Wanchanthuek P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011455; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	35	20	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2015	10	6							e0131050	10.1371/journal.pone.0131050	http://dx.doi.org/10.1371/journal.pone.0131050			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL3FM	26098837	gold, Green Published, Green Submitted			2022-12-26	WOS:000356835800137
J	Sugie, K; Suzuki, K				Sugie, Koji; Suzuki, Koji			Size of Dominant Diatom Species Can Alter Their Evenness	PLOS ONE			English	Article							PHYTOPLANKTON COMMUNITIES; MARINE-PHYTOPLANKTON; CELL-SIZE; NUTRIENT ACQUISITION; CONSUMERS GUIDE; BIODIVERSITY; GROWTH; OCEAN; BACILLARIOPHYCEAE; DIVERSITY	Traditionally, biodiversity has often been estimated on the basis of abundance partly due to the need for complicated measurements of biomass. Here, we conducted robust measurements of the community composition and of the size structure of diatoms in the North Pacific to evaluate the importance of biomass on the biodiversity. We found that the two most useful evenness indices increased in most cases where small species were numerically dominant when calculations were based on biomass compared with those on abundance. Size-abundance spectra of diatoms revealed that numerically dominant small species rarely dominated in terms of biomass. On the other hand, intermediate to large diatom species generally played a dominant role in terms of biomass in diatom community. The results suggest that the size of the dominant species is a crucial factor in determining the role of diatoms in the ecosystem functioning. Because such size variability can also be observed in other organisms, we need to pay attention to the effect of size structures on biodiversity.	[Sugie, Koji; Suzuki, Koji] Hokkaido Univ, Fac Environm Earth Sci, Sapporo, Hokkaido, Japan; [Sugie, Koji; Suzuki, Koji] Japan Sci & Technol Agcy, CREST, Sapporo, Hokkaido, Japan	Hokkaido University; Japan Science & Technology Agency (JST)	Sugie, K (corresponding author), Japan Agcy Marine Earth Sci & Technol, Res & Dev Ctr Global Change, 2-15 Natsushimacho, Yokosuka, Kanagawa 2370061, Japan.	sugie@jamstec.go.jp	Suzuki, Koji/A-4349-2013; Suzuki, Koji/GVS-9807-2022; Sugie, Koji/AAG-1639-2020; Suzuki, Koji/AAD-2630-2022	Suzuki, Koji/0000-0001-5354-1044; Suzuki, Koji/0000-0001-5354-1044; Sugie, Koji/0000-0003-3316-504X; 	Japan Science and Technology Agency; Ministry of Education, Culture, Sports, Science and Technology, Japan	Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was supported by the two projects "Development of simulation techniques to nowcast the biodiversity of marine phytoplankton" from the Japan Science and Technology Agency (http://www.jst.go.jp/EN/index.html) and "The study of Kuroshio Ecosystem dynamics for sustainable management" from the Ministry of Education, Culture, Sports, Science and Technology, Japan (http://www.mext.go.jp/english/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armbrust EV, 2009, NATURE, V459, P185, DOI 10.1038/nature08057; Barton AD, 2013, LIMNOL OCEANOGR, V58, P254, DOI 10.4319/lo.2013.58.1.0254; Buesseler KO, 2007, SCIENCE, V316, P567, DOI 10.1126/science.1137959; Carpenter EJ, 1999, MAR ECOL PROG SER, V185, P273, DOI 10.3354/meps185273; Cermeno P, 2014, J PLANKTON RES, V36, P1135, DOI 10.1093/plankt/fbu033; Chapin FS, 2000, NATURE, V405, P234, DOI 10.1038/35012241; Chung Mi Hee, 2010, Algae, V25, P57, DOI 10.4490/algae.2010.25.2.057; Falkowski PG, 2004, SCIENCE, V305, P354, DOI 10.1126/science.1095964; Fawcett SE, 2011, MAR ECOL PROG SER, V428, P13, DOI 10.3354/meps09070; Finkel ZV, 2009, P ROY SOC B-BIOL SCI, V276, P1627, DOI 10.1098/rspb.2008.1610; Friedrichs L, 2013, MAR ECOL PROG SER, V481, P41, DOI 10.3354/meps10227; Gamito S, 2010, ECOL INDIC, V10, P550, DOI 10.1016/j.ecolind.2009.07.006; Giovagnetti V, 2012, EUR J PHYCOL, V47, P408, DOI 10.1080/09670262.2012.733030; Gotelli NJ, 2001, ECOL LETT, V4, P379, DOI 10.1046/j.1461-0248.2001.00230.x; Hasle G. R., 1997, IDENTIFYING MARINE P, V39, P5; HASLE GR, 1978, PHYTOPLANKTON MANUAL, P191; Hillebrand H, 1999, J PHYCOL, V35, P403, DOI 10.1046/j.1529-8817.1999.3520403.x; Hillebrand H, 2008, ECOLOGY, V89, P1510, DOI 10.1890/07-1053.1; Huete-Ortega M, 2012, P ROY SOC B-BIOL SCI, V279, P1815, DOI 10.1098/rspb.2011.2257; Irigoien X, 2005, J PLANKTON RES, V27, P313, DOI 10.1093/plankt/fbi011; Irigoien X, 2004, NATURE, V429, P863, DOI 10.1038/nature02593; Irwin AJ, 2006, J PLANKTON RES, V28, P459, DOI 10.1093/plankt/fbi148; Kobayashi F, 2002, DEEP SEA RES 2, V49, P2081, DOI DOI 10.1016/S0967-0645(02)00059-0; Leblanc K, 2012, EARTH SYST SCI DATA, V4, P149, DOI 10.5194/essd-4-149-2012; Litchman E, 2008, ANNU REV ECOL EVOL S, V39, P615, DOI 10.1146/annurev.ecolsys.39.110707.173549; Maranon E, 2015, ANNU REV MAR SCI, V7, P241, DOI 10.1146/annurev-marine-010814-015955; Maranon E, 2013, ECOL LETT, V16, P371, DOI 10.1111/ele.12052; Matthiessen B, 2010, HYDROBIOLOGIA, V653, P65, DOI 10.1007/s10750-010-0349-x; Menden-Deuer S, 2000, LIMNOL OCEANOGR, V45, P569, DOI 10.4319/lo.2000.45.3.0569; Moore CM, 2013, NAT GEOSCI, V6, P701, DOI [10.1038/ngeo1765, 10.1038/NGEO1765]; Moore JK, 1996, MAR ECOL PROG SER, V132, P203, DOI 10.3354/meps132203; Pahlow M, 1997, LIMNOL OCEANOGR, V42, P1660, DOI 10.4319/lo.1997.42.8.1660; PIELOU EC, 1966, J THEOR BIOL, V10, P370, DOI 10.1016/0022-5193(66)90133-0; Prowe AEF, 2012, PROG OCEANOGR, V101, P1, DOI 10.1016/j.pocean.2011.11.016; Ptacnik R, 2008, P NATL ACAD SCI USA, V105, P5134, DOI 10.1073/pnas.0708328105; Raven JA, 1997, ADV BOT RES, V25, P59, DOI 10.1016/S0065-2296(08)60148-2; Rodriguez-Ramos T, 2014, J PLANKTON RES, V36, P334, DOI 10.1093/plankt/fbt115; Round F. E., 1990, DIATOMS BIOL MORPHOL; Sarthou G, 2005, J SEA RES, V53, P25, DOI 10.1016/j.seares.2004.01.007; Schleuter D, 2010, ECOL MONOGR, V80, P469, DOI 10.1890/08-2225.1; SHELDON RW, 1972, LIMNOL OCEANOGR, V17, P327, DOI 10.4319/lo.1972.17.3.0327; Smayda TJ, 1978, PHYTOPLANKTON MANUAL, P273; Smith B, 1996, OIKOS, V76, P70, DOI 10.2307/3545749; Stachowicz JJ, 2007, ANNU REV ECOL EVOL S, V38, P739, DOI 10.1146/annurev.ecolsys.38.091206.095659; Strzepek RF, 2004, NATURE, V431, P689, DOI 10.1038/nature02954; Sugie K, 2008, J PLANKTON RES, V30, P1245, DOI 10.1093/plankt/fbn080; Sugie K, 2013, J PHYCOL, V49, P475, DOI 10.1111/jpy.12054; Sugie K, 2010, DEEP-SEA RES PT II, V57, P1630, DOI 10.1016/j.dsr2.2010.03.007; Sunda WG, 2010, MAR ECOL PROG SER, V401, P63, DOI 10.3354/meps08390; Suzuki K, 2011, DEEP-SEA RES PT I, V58, P575, DOI 10.1016/j.dsr.2011.03.003; Thingstad TF, 2005, ECOL LETT, V8, P675, DOI 10.1111/j.1461-0248.2005.00768.x; Tuomisto H, 2012, OIKOS, V121, P1203, DOI 10.1111/j.1600-0706.2011.19897.x	52	6	6	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2015	10	6							e0131454	10.1371/journal.pone.0131454	http://dx.doi.org/10.1371/journal.pone.0131454			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL3FM	26098838	gold, Green Published, Green Submitted			2022-12-26	WOS:000356835800180
J	Blaizot, S; Riche, B; Maman, D; Mukui, I; Kirubi, B; Etard, JF; Ecochard, R				Blaizot, Stephanie; Riche, Benjamin; Maman, David; Mukui, Irene; Kirubi, Beatrice; Etard, Jean-Francois; Ecochard, Rene			Estimation and Short-Term Prediction of the Course of the HIV Epidemic Using Demographic and Health Survey Methodology-Like Data	PLOS ONE			English	Article							SUB-SAHARAN AFRICA; ANTIRETROVIRAL THERAPY; MALE CIRCUMCISION; PREEXPOSURE PROPHYLAXIS; MATHEMATICAL-MODELS; DRUG-RESISTANCE; PREVENTION; TRANSMISSION; IMPACT; INFECTION	Background Mathematical models have played important roles in the understanding of epidemics and in the study of the impacts of various behavioral or medical measures. However, modeling accurately the future spread of an epidemic requires context-specific parameters that are difficult to estimate because of lack of data. Our objective is to propose a methodology to estimate context-specific parameters using Demographic and Health Survey (DHS)-like data that can be used in mathematical modeling of short-term HIV spreading. Methods and Findings The model splits the population according to sex, age, HIV status, and antiretroviral treatment status. To estimate context-specific parameters, we used individuals' histories included in DHS-like data and a statistical analysis that used decomposition of the Poisson likelihood. To predict the course of the HIV epidemic, sex-and age-specific differential equations were used. This approach was applied to recent data from Kenya. The approach allowed the estimation of several key epidemiological parameters. Women had a higher infection rate than men and the highest infection rate in the youngest age groups (15-24 and 25-34 years) whereas men had the highest infection rate in age group 25-34 years. The immunosuppression rates were similar between age groups. The treatment rate was the highest in age group 35-59 years in both sexes. The results showed that, within the 1524 year age group, increasing male circumcision coverage and antiretroviral therapy coverage at CD4 <= 350/mm(3) over the current 70% could have short-term impacts. Conclusions The study succeeded in estimating the model parameters using DHS-like data rather than literature data. The analysis provides a framework for using the same data for estimation and prediction, which can improve the validity of context-specific predictions and help designing HIV prevention campaigns.	[Blaizot, Stephanie; Riche, Benjamin; Ecochard, Rene] Hosp Civils Lyon, Serv Biostat, F-69003 Lyon, France; [Blaizot, Stephanie; Riche, Benjamin; Ecochard, Rene] Univ Lyon, F-69000 Lyon, France; [Blaizot, Stephanie; Riche, Benjamin; Ecochard, Rene] Univ Lyon 1, F-69100 Villeurbanne, France; [Blaizot, Stephanie; Riche, Benjamin; Ecochard, Rene] CNRS, UMR 5558, Lab Biometrie & Biol Evolut, Equipe Biostatist Sante, F-69100 Villeurbanne, France; [Maman, David; Etard, Jean-Francois] Epictr, F-75011 Paris, France; [Mukui, Irene] Natl AIDS & STDs Control Program, Nairobi, Kenya; [Kirubi, Beatrice] Med Sans Frontieres, Nairobi, Kenya; [Etard, Jean-Francois] Univ Montpellier I, Inst Rech Dev, INSERM, UMI TransVIHMI 233,U1175, F-34000 Montpellier, France	CHU Lyon; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); VetAgro Sup; Institut de Recherche pour le Developpement (IRD); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier	Blaizot, S (corresponding author), Hosp Civils Lyon, Serv Biostat, F-69003 Lyon, France.	stephanie.blaizot@chu-lyon.fr	Mukui, Irene/GYE-0151-2022; Kirubi, Beatrice/HHS-5040-2022; Etard, Jean François/A-9630-2008; Etard, Jean-Francois/V-4865-2019	Kirubi, Beatrice/0000-0002-6195-1876; Etard, Jean François/0000-0002-4873-0788; Etard, Jean-Francois/0000-0002-4873-0788; Mukui, Irene/0000-0002-3699-1841; Maman, David/0000-0002-9839-3011	Medecins Sans Frontieres (France); Agence Nationale de Recherche sur le SIDA et les hepatites virales, ANRS (France REcherche Nord & sud SIDA-HIV Hepatites: FRENSH), France; Kenyan Ministry of Medical Services; Kenyan Ministry of Public Health and Sanitation; National AIDS and STDs Control Programme (NASCOP, Nairobi, Kenya); Kenyan Medical Research Institute (KEMRI, Nairobi, Kenya); KEMRI/CDC (Kisumu, Kenya); Hospices Civils de Lyon (France)	Medecins Sans Frontieres (France); Agence Nationale de Recherche sur le SIDA et les hepatites virales, ANRS (France REcherche Nord & sud SIDA-HIV Hepatites: FRENSH), France; Kenyan Ministry of Medical Services; Kenyan Ministry of Public Health and Sanitation; National AIDS and STDs Control Programme (NASCOP, Nairobi, Kenya); Kenyan Medical Research Institute (KEMRI, Nairobi, Kenya); KEMRI/CDC (Kisumu, Kenya); Hospices Civils de Lyon (France)	The NHIPS study was funded and sponsored by Medecins Sans Frontieres (France) and conducted by Epicentre (France) in collaboration with the Kenyan Ministry of Medical Services, the Kenyan Ministry of Public Health and Sanitation, the National AIDS and STDs Control Programme (NASCOP, Nairobi, Kenya), the Kenyan Medical Research Institute (KEMRI, Nairobi, Kenya), the KEMRI/CDC (Kisumu, Kenya) and Hospices Civils de Lyon (France). Author SB was financially supported by Agence Nationale de Recherche sur le SIDA et les hepatites virales, ANRS (France REcherche Nord & sud SIDA-HIV Hepatites: FRENSH), France.	Abbas UL, 2014, J INFECT DIS, V209, P164, DOI 10.1093/infdis/jit545; Abbas UL, 2013, J INFECT DIS, V208, P224, DOI 10.1093/infdis/jit150; Alsallaq RA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054575; Amornkul PN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006470; Andersen PK, 2002, STAT METHODS MED RES, V11, P91, DOI 10.1191/0962280202SM276ra; ANDERSON R M, 1991; Anderson SJ, 2014, LANCET, V384, P249, DOI 10.1016/S0140-6736(14)61053-9; [Anonymous], MEAS DHS; Auvert B, 2005, PLOS MED, V2, P1112, DOI 10.1371/journal.pmed.0020298; Auvert B, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001509; Bacaer N, 2010, B MATH BIOL, V72, P2180, DOI 10.1007/s11538-010-9535-2; Baggaley RF, 2006, PLOS MED, V3, P493, DOI 10.1371/journal.pmed.0030124; Bailey RC, 2007, LANCET, V369, P643, DOI 10.1016/S0140-6736(07)60312-2; Bellan SE, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001801; Bellan SE, 2013, LANCET, V381, P1561, DOI 10.1016/S0140-6736(12)61960-6; Boily MC, 2007, SEX TRANSM INFECT, V83, P582, DOI 10.1136/sti.2007.027516; Boily MC, 2004, SEX TRANSM DIS, V31, P100, DOI 10.1097/01.OLQ.0000112721.21285.A2; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Couchoud C, 2013, NEPHROL DIAL TRANSPL, V28, P2372, DOI 10.1093/ndt/gft204; Crampin AC, 2002, AIDS, V16, P1545, DOI 10.1097/00002030-200207260-00012; Cremin I, 2013, AIDS, V27, P447, DOI 10.1097/QAD.0b013e32835ca2dd; Eaton JW, 2014, LANCET GLOB HEALTH, V2, pE23, DOI 10.1016/S2214-109X(13)70172-4; Eaton JW, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001245; Garnett GP, 2011, LANCET, V378, P515, DOI 10.1016/S0140-6736(10)61505-X; Granich RM, 2009, LANCET, V373, P48, DOI 10.1016/S0140-6736(08)61697-9; Gray RH, 2007, LANCET, V369, P657, DOI 10.1016/S0140-6736(07)60313-4; Jahn A, 2008, LANCET, V371, P1603, DOI 10.1016/S0140-6736(08)60693-5; Johnson LF, 2011, SEX TRANSM INFECT, V87, P629, DOI 10.1136/sti.2010.045500; Johnson LF, 2011, MODEL IMPACT HIV AID; Joint United Nations Programme on HIV/AIDS (UNAIDS), 2013, GLOB REP UNAIDS REP; Kasamba I, 2012, TROP MED INT HEALTH, V17, pe66, DOI 10.1111/j.1365-3156.2012.02841.x; KAY R, 1986, BIOMETRICS, V42, P855, DOI 10.2307/2530699; Keeling, 2008, MODELLING INFECT DIS; Kenya national Bureau of statistics (KNBS) and ICF macro, 2010, KEN DEM HLTH SURV 20; Kretzschmar ME, 2013, P NATL ACAD SCI USA, V110, P15538, DOI 10.1073/pnas.1301801110; Lodi S, 2011, CLIN INFECT DIS, V53, P817, DOI 10.1093/cid/cir494; Maman D, 2013, 17 INT C AIDS STIS A; Maman D, 2013, INT AIDS C 2013 KUAL; McCallum H, 2001, TRENDS ECOL EVOL, V16, P295, DOI 10.1016/S0169-5347(01)02144-9; McKinnon LR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049797; Nagelkerke NJD, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-16; National AIDS and STI Control Programme (NASCOP) Kenya, 2009, KEN AIDS IND SURV 20; National AIDS and STI Control Programme (NASCOP) Kenya, 2014, KEN 2014 KEN AIDS IN; Pantazis N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032369; Powers KA, 2011, LANCET, V378, P256, DOI 10.1016/S0140-6736(11)60842-8; Shisana O, 2014, S AFRICAN NATL HIV P; van Eijk AM, 2008, TROP MED INT HEALTH, V13, P1314, DOI 10.1111/j.1365-3156.2008.02136.x; Wawer MJ, 2005, J INFECT DIS, V191, P1403, DOI 10.1086/429411; Williams BG, 2010, P NATL ACAD SCI USA, V107, P19485, DOI 10.1073/pnas.1005660107; World Health Organisation, 2013, CONS GUID GEN HIV CA; Zaba B, 2007, AIDS, V21, pS87, DOI 10.1097/01.aids.0000299415.67646.26; Zwahlen M, 2008, SEX TRANSM INFECT, V84, pI31, DOI 10.1136/sti.2008.029793	52	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2015	10	6							e0130387	10.1371/journal.pone.0130387	http://dx.doi.org/10.1371/journal.pone.0130387			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL3FE	26091253	Green Published, Green Submitted, gold			2022-12-26	WOS:000356835000110
J	Okawa, S; Ansah, EK; Nanishi, K; Enuameh, Y; Shibanuma, A; Kikuchi, K; Yasuoka, J; Gyapong, M; Owusu-Agyei, S; Oduro, AR; Asare, GQ; Hodgson, A; Jimba, M				Okawa, Sumiyo; Ansah, Evelyn Korkor; Nanishi, Keiko; Enuameh, Yeetey; Shibanuma, Akira; Kikuchi, Kimiyo; Yasuoka, Junko; Gyapong, Margaret; Owusu-Agyei, Seth; Oduro, Abraham Rexford; Asare, Gloria Quansah; Hodgson, Abraham; Jimba, Masamine		Ghana EMBRACE Implementation Res P	High Incidence of Neonatal Danger Signs and Its Implications for Postnatal Care in Ghana: A Cross-Sectional Study	PLOS ONE			English	Article							FOR-GESTATIONAL-AGE; MULTILEVEL ANALYSIS; CHILD SURVIVAL; NORTHERN GHANA; MATERNAL-CARE; MORTALITY; HEALTH; DETERMINANTS; PROGRAM; SERVICES	Background Reducing neonatal mortality is a major public health priority in sub-Saharan Africa. Numerous studies have examined the determinants of neonatal mortality, but few have explored neonatal danger signs which potentially cause morbidity. This study assessed danger signs observed in neonates at birth, determined the correlations of multiple danger signs and complications between neonates and their mothers, and identified factors associated with neonatal danger signs. Methods A cross-sectional study was conducted in three sites across Ghana between July and September in 2013. Using two-stage random sampling, we recruited 1,500 pairs of neonates and their mothers who had given birth within the preceding two years. We collected data on their socio-demographic characteristics, utilization of maternal and neonatal health services, and experiences with neonatal danger signs and maternal complications. We calculated the correlations of multiple danger signs and complications between neonates and their mothers, and performed multiple logistic regression analysis to identify factors associated with neonatal danger signs. Results More than 25% of the neonates were born with danger signs. At-birth danger signs in neonates were correlated with maternal delivery complications (r = 0.20, p < 0.001), and neonatal complications within the first six weeks of life (r = 0.19, p < 0.001). However, only 29.1% of neonates with danger signs received postnatal care in the first two days, and 52.4% at two weeks of life. In addition to maternal complications during delivery, maternal age less than 20 years, maternal education level lower than secondary school, and fewer than four antenatal care visits significantly predicted neonatal danger signs. Conclusions Over a quarter of neonates are born with danger signs. Maternal factors can be used to predict neonatal health condition at birth. Management of maternal health and close medical attention to high-risk neonates are crucial to reduce neonatal morbidity in Ghana.	[Okawa, Sumiyo; Nanishi, Keiko; Shibanuma, Akira; Kikuchi, Kimiyo; Yasuoka, Junko; Jimba, Masamine] Univ Tokyo, Grad Sch Med, Dept Community & Global Hlth, Tokyo, Japan; [Ansah, Evelyn Korkor; Hodgson, Abraham] Ghana Hlth Serv, Div Res & Dev, Accra, Ghana; [Enuameh, Yeetey; Owusu-Agyei, Seth] Kintampo Hlth Res Ctr, Kintampo, Kintampo Hlth R, Ghana; [Gyapong, Margaret] Dodowa Hlth Res Ctr, Dodowa, Greater Accra, Ghana; [Oduro, Abraham Rexford] Navrongo Hlth Res Ctr, Navrongo, Upper East, Ghana; [Asare, Gloria Quansah] Ghana Hlth Serv, Accra, Ghana	University of Tokyo; Ghana Health Service; Kintampo Health Research Centre; Navrongo Health Research Center; Ghana Health Service	Jimba, M (corresponding author), Univ Tokyo, Grad Sch Med, Dept Community & Global Hlth, Tokyo, Japan.	mjimba@m.u-tokyo.ac.jp	Shibanuma, Akira/C-7652-2016; Yasuoka, Junko/GVT-8950-2022; Enuameh, Yeetey/AAO-7304-2020; Jimba, Masamine/AAF-5630-2020	Shibanuma, Akira/0000-0003-2058-1722; Enuameh, Yeetey/0000-0003-3772-7425; Gyapong, Margaret/0000-0002-4818-3497; Nanishi, Keiko/0000-0001-7067-8413; Owusu-Agyei, Seth/0000-0002-0807-1781; Ansah, Evelyn/0000-0003-0401-8606; ODURO, ABRAHAM/0000-0002-4191-7419	Japan International Cooperation Agency (JICA) Human Development Department; JICA Research Institute	Japan International Cooperation Agency (JICA) Human Development Department; JICA Research Institute	This paper was funded by the Japan International Cooperation Agency (JICA) Human Development Department, and JICA Research Institute (http://www.jica.go.jp/english/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, LANCET, V384, P1159, DOI [10.1016/S0140-6736(14)61707-4, DOI 10.1016/S0140-6736(14)61707-4]; Awoonor-Williams JK, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-S2-S3; Babalola S, 2009, BMC PREGNANCY CHILDB, V9, DOI 10.1186/1471-2393-9-43; Baiden F, 2006, TROP MED INT HEALTH, V11, P532, DOI 10.1111/j.1365-3156.2006.01582.x; Cox JE, 2008, J PEDIATR ADOL GYNEC, V21, P275, DOI 10.1016/j.jpag.2008.02.002; Debelew GT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107184; Engmann C, 2012, TROP MED INT HEALTH, V17, P272, DOI 10.1111/j.1365-3156.2011.02931.x; Ezeh OK, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-521; Ghana Health Service, 2008, GHAN NAT SAF MOTH SE; Ghana Statistical Service UNDP, 2013, 2010 POP HOUS CENS M; Katz J, 2013, LANCET, V382, P417, DOI 10.1016/S0140-6736(13)60993-9; Kayode GA, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-165; Kikuchi K, 2015, TRIALS, V16, DOI 10.1186/s13063-014-0539-3; Kozuki N, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-S3-S3; Kumar GA, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-357; Lawn JE, 2005, LANCET, V365, P891, DOI 10.1016/S0140-6736(05)71048-5; Manandhar S R, 2010, Kathmandu Univ Med J (KUMJ), V8, P62; Marchant T, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001292; Markovitz BP, 2005, BMC PUBLIC HEALTH, V5, DOI 10.1186/1471-2458-5-79; Ministry of Health Ghana, 2014, GHAN  NAT NEWB HLTH; Mosley WH, 2003, B WORLD HEALTH ORGAN, V81, P140; Naariyong S, 2012, MATERN CHILD HLTH J, V16, P1709, DOI 10.1007/s10995-011-0880-z; Nyonator FK, 2005, HEALTH POLICY PLANN, V20, P25, DOI 10.1093/heapol/czi003; Singh K, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-941; Tuncalp O, 2014, MATERN CHILD HLTH J, V18, P1648, DOI 10.1007/s10995-013-1405-8; UNICEF, 2014, COMM CHILD SURV PROM, DOI [10.1186/1742-4755-11-82, DOI 10.1186/1742-4755-11-82]; Vogel JP, 2014, BJOG-INT J OBSTET GY, V121, P76, DOI 10.1111/1471-0528.12633; Welaga P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058924; Were M, 2007, ECON HUM BIOL, V5, P322, DOI 10.1016/j.ehb.2007.03.005; Worku AG, 2013, BMC INT HEALTH HUM R, V13, DOI 10.1186/1472-698X-13-20; World Health Organization, 2014, EV WOM EV CHILD POST	31	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2015	10	6							e0130712	10.1371/journal.pone.0130712	http://dx.doi.org/10.1371/journal.pone.0130712			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL3FE	26091424	gold, Green Published, Green Submitted			2022-12-26	WOS:000356835000145
J	Shi, PH; Tang, L; Wang, LH; Sun, T; Liu, LL; Cao, WX; Zhu, Y				Shi, Peihua; Tang, Liang; Wang, Lihuan; Sun, Ting; Liu, Leilei; Cao, Weixing; Zhu, Yan			Post-Heading Heat Stress in Rice of South China during 1981-2010	PLOS ONE			English	Article							HIGH-TEMPERATURE STRESS; CLIMATE-CHANGE; SPIKELET STERILITY; GRAIN QUALITY; FIELD CROPS; YIELD; GROWTH; MAIZE; PHENOLOGY; TRENDS	Frequent extreme heat events are the serious threat to rice production, but the historical trend of heat stress associated with phenology shift and its impact on rice yield over a long period are poorly known. Based on the analysis of observed climate and phenology data from 228 stations in South China during 1981-2010, the spatio-temporal variation of post-heading heat stress was investigated among two single-season rice sub-regions in the northern Middle and Lower Reaches of Yangtze River (S-NMLYtz) and Southwest Plateau (S-SWP), and two double-season early rice sub-regions in the southern Middle and Lower Reaches of Yangtze River (DE-SMLYtz) and Southern China (DE-SC). Post-heading heat stress was more severe in DE-SMLYtz, west S-NMLYtz and east S-SWP than elsewhere, because of rice exposure to the hot season during post-heading stage. The spatial variation of post-heading heat stress was greater in single-season rice region than in double-season early rice region due to the greater spatial variation of heading and maturity dates. Post-heading heat stress increased from 1981 to 2010 in most areas, with significant increases in the east of double-season early rice region and west S-SWP. Phenology shift during 1981-2010 mitigated the increasing trends of heat stress in most areas, but not in west S-SWP. Post-heading heat stress played a dominated role in the reduction of rice yield in South China. Grain yield was more sensitive to post-heading heat stress in double-season early rice region than that in single-season rice region. Rice yield decreased by 1.5%, 6.2%, 9.7% and 4.6% in S-NMLYtz, S-SWP, DE-SMLYtz and DE-SC, respectively, because of post-heading heat stress during 1981-2010, although there were some uncertainties. Given the current level and potential increase of post-heading heat stress in South China, the specific adaptation or mitigation strategies are necessary for different sub-regions to stabilize rice production under heat stress.	[Shi, Peihua; Tang, Liang; Wang, Lihuan; Sun, Ting; Liu, Leilei; Cao, Weixing; Zhu, Yan] Nanjing Agr Univ, Jiangsu Collaborat Innovat Ctr Modern Crop Prod, Jiangsu Key Lab Informat Agr, Natl Engn & Technol Ctr Informat Agr, Nanjing 210095, Jiangsu, Peoples R China	Nanjing Agricultural University	Zhu, Y (corresponding author), Nanjing Agr Univ, Jiangsu Collaborat Innovat Ctr Modern Crop Prod, Jiangsu Key Lab Informat Agr, Natl Engn & Technol Ctr Informat Agr, Nanjing 210095, Jiangsu, Peoples R China.	yanzhu@njau.edu.cn	Tang, Liang/L-2889-2019; Zhu, Yan/AAK-6927-2020	Tang, Liang/0000-0002-3483-0462; Zhu, Yan/0000-0002-8912-3888	National High-Tech Research and Development Program of China [2013AA100404]; National Science and Technology Support Program of China [2011BAD21B03]; Priority Academic Development Program of Jiangsu Higher Education Institutions	National High-Tech Research and Development Program of China(National High Technology Research and Development Program of China); National Science and Technology Support Program of China; Priority Academic Development Program of Jiangsu Higher Education Institutions	This study was supported by the National High-Tech Research and Development Program of China (Grant number: 2013AA100404; URL: http://www.863.gov.cn/; received the funding: YZ), the National Science and Technology Support Program of China (Grant number: 2011BAD21B03; URL: http://www.973.gov.cn/Default_3.aspx; received the funding: YZ), and the Priority Academic Development Program of Jiangsu Higher Education Institutions (Grant number: PADP; URL: http://jsycw.ec.js.edu.cn/default.aspx; received the funding: YZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alderman PD., 2013, P WORKSH MOD WHEAT R; Asseng S, 2011, GLOBAL CHANGE BIOL, V17, P997, DOI 10.1111/j.1365-2486.2010.02262.x; Chmielewski FM, 2004, AGR FOREST METEOROL, V121, P69, DOI 10.1016/S0168-1923(03)00161-8; Ciais P, 2005, NATURE, V437, P529, DOI 10.1038/nature03972; Cicchino M, 2010, CROP SCI, V50, P1431, DOI 10.2135/cropsci2009.07.0400; Deryng D, 2014, ENVIRON RES LETT, V9, DOI 10.1088/1748-9326/9/3/034011; Nguyen DN, 2014, FIELD CROP RES, V156, P293, DOI 10.1016/j.fcr.2013.11.009; FAO, 2011, FOOD AGR ORG UN; Gong S, 2013, ANHUI AGR SCI B, V19, P37; Gourdji SM, 2013, ENVIRON RES LETT, V8, DOI 10.1088/1748-9326/8/2/024041; Hasegawa Toshihiro, 2011, Journal of Agricultural Meteorology, V67, P225, DOI 10.2480/agrmet.67.4.3; Hawkins E, 2013, GLOBAL CHANGE BIOL, V19, P937, DOI 10.1111/gcb.12069; Huang M., 2009, World Applied Sciences Journal, V6, P674; Iizumi T, 2013, NAT CLIM CHANGE, V3, P904, DOI [10.1038/nclimate1945, 10.1038/NCLIMATE1945]; Jagadish SVK, 2007, J EXP BOT, V58, P1627, DOI 10.1093/jxb/erm003; Jagadish SVK, 2010, J EXP BOT, V61, P143, DOI 10.1093/jxb/erp289; Kim J, 2011, FIELD CROP RES, V122, P207, DOI 10.1016/j.fcr.2011.03.014; Li J, 2013, CHINA RICE, V19, P27; Liu B, 2014, GLOBAL CHANGE BIOL, V20, P372, DOI 10.1111/gcb.12442; Liu JG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057750; Liu LL, 2013, AGR ECOSYST ENVIRON, V165, P28, DOI 10.1016/j.agee.2012.11.009; Liu LL, 2012, AGR ECOSYST ENVIRON, V149, P20, DOI 10.1016/j.agee.2011.12.008; Liu QH, 2013, AGRON J, V105, P446, DOI 10.2134/agronj2012.0164; Lloret F, 2012, GLOBAL CHANGE BIOL, V18, P797, DOI 10.1111/j.1365-2486.2011.02624.x; Lobell DB, 2007, ENVIRON RES LETT, V2, DOI 10.1088/1748-9326/2/1/014002; Lobell DB, 2007, AGR FOREST METEOROL, V145, P229, DOI 10.1016/j.agrformet.2007.05.002; Lobell DB, 2013, NAT CLIM CHANGE, V3, P497, DOI [10.1038/nclimate1832, 10.1038/NCLIMATE1832]; Lobell DB, 2011, SCIENCE, V333, P616, DOI [10.1126/science.1204531, 10.1126/science.1206376]; Lobell DB, 2011, NAT CLIM CHANGE, V1, P42, DOI [10.1038/nclimate1043, 10.1038/NCLIMATE1043]; Lu PL, 2008, CLIM RES, V36, P79, DOI 10.3354/cr00729; Madan P, 2012, J EXP BOT, V63, P3843, DOI 10.1093/jxb/ers077; Matsui T, 2002, ANN BOT-LONDON, V89, P683, DOI 10.1093/aob/mcf112; Matsui T, 2001, PLANT PROD SCI, V4, P90, DOI 10.1626/pps.4.90; Moriondo M, 2011, CLIMATIC CHANGE, V104, P679, DOI 10.1007/s10584-010-9871-0; Olesen JE, 2011, EUR J AGRON, V34, P96, DOI 10.1016/j.eja.2010.11.003; Piao SL, 2010, NATURE, V467, P43, DOI 10.1038/nature09364; Sherwood SC, 2010, P NATL ACAD SCI USA, V107, P9552, DOI 10.1073/pnas.0913352107; Shi PH, 2015, FIELD CROP RES, V177, P26, DOI 10.1016/j.fcr.2015.02.023; Sun W, 2011, AGR FOREST METEOROL, V151, P1193, DOI 10.1016/j.agrformet.2011.04.009; Tao FL, 2006, AGR FOREST METEOROL, V138, P82, DOI 10.1016/j.agrformet.2006.03.014; Tao FL, 2013, GLOBAL CHANGE BIOL, V19, P3200, DOI 10.1111/gcb.12250; Tao FL, 2013, REG ENVIRON CHANGE, V13, P743, DOI 10.1007/s10113-012-0357-7; Tao Long-xing, 2007, Zhongguo Shuidao Kexue, V21, P518; Teixeira EI, 2013, AGR FOREST METEOROL, V170, P206, DOI 10.1016/j.agrformet.2011.09.002; Vergni L, 2011, AGR FOREST METEOROL, V151, P301, DOI 10.1016/j.agrformet.2010.11.005; Wang P, 2014, CLIMATIC CHANGE, V124, P777, DOI 10.1007/s10584-014-1136-x; Wolkovich EM, 2012, NATURE, V485, P494, DOI 10.1038/nature11014; Zacharias Manju, 2010, Indian Journal of Plant Physiology, V15, P350; Zhang TY, 2013, GLOBAL CHANGE BIOL, V19, P563, DOI 10.1111/gcb.12057; Zhao HaiYan, 2006, Scientia Agricultura Sinica, V39, P1765; Zhou YQ, 2011, CLIM RES, V50, P125, DOI 10.3354/cr01053	51	30	36	0	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2015	10	6							e0130642	10.1371/journal.pone.0130642	http://dx.doi.org/10.1371/journal.pone.0130642			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4OY	26110263	gold, Green Submitted, Green Published			2022-12-26	WOS:000356933800069
J	Cases, O; Joseph, A; Obry, A; Santin, MD; Ben-Yacoub, S; Paques, M; Amsellem-Levera, S; Bribian, A; Simonutti, M; Augustin, S; Debeir, T; Sahel, JA; Christ, A; de Castro, F; Lehericy, S; Cosette, P; Kozyraki, R				Cases, Olivier; Joseph, Antoine; Obry, Antoine; Santin, Mathieu D.; Ben-Yacoub, Sirine; Paques, Michel; Amsellem-Levera, Sabine; Bribian, Ana; Simonutti, Manuel; Augustin, Sebastien; Debeir, Thomas; Sahel, Jose Alain; Christ, Annabel; de Castro, Fernando; Lehericy, Stephane; Cosette, Pascal; Kozyraki, Renata			Foxg1-Cre Mediated Lrp2 Inactivation in the Developing Mouse Neural Retina, Ciliary and Retinal Pigment Epithelia Models Congenital High Myopia	PLOS ONE			English	Article							EYE DEVELOPMENT; DONNAI-BARROW; ANIMAL-MODELS; RECEPTOR; MEGALIN; MICE; TELENCEPHALON; MACULOPATHY; MANAGEMENT; MUTATIONS	Myopia is a common ocular disorder generally due to increased axial length of the eye-globe. Its extreme form high myopia (HM) is a multifactorial disease leading to retinal and scleral damage, visual impairment or loss and is an important health issue. Mutations in the endocytic receptor LRP2 gene result in Donnai-Barrow (DBS) and Stickler syndromes, both characterized by HM. To clearly establish the link between Lrp2 and congenital HM we inactivated Lrp2 in the mouse forebrain including the neural retina and the retinal and ciliary pigment epithelia. High resolution in vivo MRI imaging and ophthalmological analyses showed that the adult Lrp2-deficient eyes were 40% longer than the control ones mainly due to an excessive elongation of the vitreal chamber. They had an apparently normal intraocular pressure and developed chorioretinal atrophy and posterior scleral staphyloma features reminiscent of human myopic retinopathy. Immunomorphological and ultrastructural analyses showed that increased eye lengthening was first observed by post-natal day 5 (P5) and that it was accompanied by a rapid decrease of the bipolar, photoreceptor and retinal ganglion cells, and eventually the optic nerve axons. It was followed by scleral thinning and collagen fiber disorganization, essentially in the posterior pole. We conclude that the function of LRP2 in the ocular tissues is necessary for normal eye growth and that the Lrp2-deficient eyes provide a unique tool to further study human HM.	[Cases, Olivier; Joseph, Antoine; Ben-Yacoub, Sirine; Paques, Michel; Amsellem-Levera, Sabine; Simonutti, Manuel; Augustin, Sebastien; Sahel, Jose Alain; Kozyraki, Renata] INSERM, U968, F-75012 Paris, France; [Cases, Olivier; Joseph, Antoine; Ben-Yacoub, Sirine; Paques, Michel; Amsellem-Levera, Sabine; Simonutti, Manuel; Augustin, Sebastien; Sahel, Jose Alain; Kozyraki, Renata] Univ Paris 06, UMR S968, Inst Vis, F-75012 Paris, France; [Cases, Olivier; Joseph, Antoine; Ben-Yacoub, Sirine; Paques, Michel; Amsellem-Levera, Sabine; Simonutti, Manuel; Augustin, Sebastien; Sahel, Jose Alain; Kozyraki, Renata] CNRS, UMR 7210, F-75012 Paris, France; [Obry, Antoine; Cosette, Pascal] Rouen Univ Hosp, Inst Res & Innovat Biomed, PISSARO Prote Platform, CNRS,UMR 6270, F-76821 Rouen, France; [Obry, Antoine] Rouen Univ Hosp, Inst Res & Innovat Biomed, PISSARO Prote Platform, INSERM,U905, F-76821 Rouen, France; [Santin, Mathieu D.; Lehericy, Stephane] Ctr NeuroImagerie Rech, F-75013 Paris, France; [Paques, Michel; Sahel, Jose Alain] Ctr Hosp Natl Ophthalmol Quinze Vingts, INSERM, DHOS CIC 503, F-75012 Paris, France; [Bribian, Ana; de Castro, Fernando] Hosp Nacl Paraplej, Grp Neurobiol Desarollo GNDe, Toledo, Spain; [Debeir, Thomas] Sanofi Ophthalmol, F-75012 Paris, France; [Christ, Annabel] Max Delbruck Ctr Mol Med, D-13125 Berlin, Germany	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); CHU de Rouen; CHU de Rouen; Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); Hospital Nacional de Paraplejicos; Helmholtz Association; Max Delbruck Center for Molecular Medicine	Kozyraki, R (corresponding author), INSERM, U968, F-75012 Paris, France.	renata.kozyraki@inserm.fr	Santin, Mathieu/AAJ-2213-2020; Kozyraki, Renata/G-5321-2017; cases, olivier/G-4882-2017; de Castro, Fernando/Q-8624-2018; Sahel, Jose-Alain/F-3172-2017	cases, olivier/0000-0002-5678-7362; de Castro, Fernando/0000-0002-7018-8032; Sahel, Jose-Alain/0000-0002-4831-1153; Cosette, Pascal/0000-0002-7588-0167; Kozyraki, Renata/0000-0001-9779-5898	RK Institut National sur la Recherche Medicale [ANR-10-LABX-65, ANR-11-IDEX-004-02]; Sanofi FDC MINECO SAF [2012-40023, R012-003212]; Sanofi	RK Institut National sur la Recherche Medicale; Sanofi FDC MINECO SAF; Sanofi	Funding provided by RK Institut National sur la Recherche Medicale ANR-10-LABX-65, ANR-11-IDEX-004-02, and Sanofi FDC MINECO SAF 2012-40023, R012-003212. Sanofi provided support in the form of a salary for author TD, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Amsellem S, 2010, J AM SOC NEPHROL, V21, P1859, DOI 10.1681/ASN.2010050492; Bansal Alok S, 2010, Retina, V30, pS15, DOI 10.1097/IAE.0b013e3181cf5c80; Bento-Abreu A, 2008, J NEUROCHEM, V106, P1149, DOI 10.1111/j.1471-4159.2008.05462.x; Cases O, 2013, J BIOL CHEM, V288, P16655, DOI 10.1074/jbc.M113.451070; Chai Y, 2000, DEVELOPMENT, V127, P1671; Chen Y, 2013, J BIOL CHEM, V288, P7506, DOI 10.1074/jbc.M112.439935; Christ A, 2012, DEV CELL, V22, P268, DOI 10.1016/j.devcel.2011.11.023; Collery RF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110699; Ortega MC, 2012, GLIA, V60, P851, DOI 10.1002/glia.22316; CURTIN BJ, 1979, ARCH OPHTHALMOL-CHIC, V97, P912, DOI 10.1001/archopht.1979.01020010470017; Flitcroft DI, 2013, EXP EYE RES, V114, P16, DOI 10.1016/j.exer.2013.02.008; Fredrick DR, 2002, BRIT MED J, V324, P1195, DOI 10.1136/bmj.324.7347.1195; Graw J, 2010, CURR TOP DEV BIOL, V90, P343, DOI 10.1016/S0070-2153(10)90010-0; Hawthorne FA, 2013, EXP EYE RES, V114, P141, DOI 10.1016/j.exer.2012.12.015; Hebert JM, 2000, DEV BIOL, V222, P296, DOI 10.1006/dbio.2000.9732; Kantarci S, 2007, NAT GENET, V39, P957, DOI 10.1038/ng2063; Kur E, 2011, DEV DYNAM, V240, P1567, DOI 10.1002/dvdy.22624; Lai TYY, 2008, EYE, V22, P209, DOI 10.1038/sj.eye.6702573; Leheste JR, 2002, FASEB J, V16, P247, DOI 10.1096/fj.02-0578fje; McBrien NA, 2013, EXP EYE RES, V114, P128, DOI 10.1016/j.exer.2013.01.014; Meng WH, 2011, OPHTHALMOLOGICA, V225, P127, DOI 10.1159/000317072; Mitry D, 2012, GRAEF ARCH CLIN EXP, V250, P3, DOI 10.1007/s00417-011-1889-0; Morgan IG, 2012, LANCET, V379, P1739, DOI 10.1016/S0140-6736(12)60272-4; Nykjaer A, 1999, CELL, V96, P507, DOI 10.1016/S0092-8674(00)80655-8; Ouyang PB, 2012, INT J OPHTHALMOL-CHI, V5, P754, DOI 10.3980/j.issn.2222-3959.2012.06.19; Paques M, 2007, INVEST OPHTH VIS SCI, V48, P2769, DOI 10.1167/iovs.06-1099; Pardue MT, 2013, EXP EYE RES, V114, P96, DOI 10.1016/j.exer.2012.12.014; Patel N, 2007, J CHILD NEUROL, V22, P462, DOI 10.1177/0883073807301933; Rada JAS, 2006, EXP EYE RES, V82, P185, DOI 10.1016/j.exer.2005.08.009; Schrauwen I, 2014, CLIN GENET, V86, P282, DOI 10.1111/cge.12265; Silva R, 2012, OPHTHALMOLOGICA, V228, P197, DOI 10.1159/000339893; Sivak JG, 2008, EXP EYE RES, V87, P3, DOI 10.1016/j.exer.2008.03.001; Spoelgen R, 2005, DEVELOPMENT, V132, P405, DOI 10.1242/dev.01580; Storm T, 2014, CELL TISSUE RES, V358, P99, DOI 10.1007/s00441-014-1919-4; Tkatchenko TV, 2010, INVEST OPHTH VIS SCI, V51, P21, DOI 10.1167/iovs.08-2767; Veth KN, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001310; Vongphanit J, 2002, OPHTHALMOLOGY, V109, P704, DOI 10.1016/S0161-6420(01)01024-7; YOUNG RW, 1984, J COMP NEUROL, V229, P362, DOI 10.1002/cne.902290307; Zejmo M, 2009, MED SCI MONITOR, V15, pRA199; ZHENG G, 1994, J HISTOCHEM CYTOCHEM, V42, P531, DOI 10.1177/42.4.7510321; Zhuo L, 2001, GENESIS, V31, P85, DOI 10.1002/gene.10008	41	22	22	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2015	10	6							e0129518	10.1371/journal.pone.0129518	http://dx.doi.org/10.1371/journal.pone.0129518			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4OM	26107939	Green Published, Green Submitted, gold, Green Accepted			2022-12-26	WOS:000356932500060
J	Poudrier, J; Soulas, C; Chagnon-Choquet, J; Burdo, T; Autissier, P; Oskar, K; Williams, KC; Roger, M				Poudrier, Johanne; Soulas, Caroline; Chagnon-Choquet, Josiane; Burdo, Tricia; Autissier, Patrick; Oskar, Kathryn; Williams, Kenneth C.; Roger, Michel			High Expression Levels of BLyS/BAFF by Blood Dendritic Cells and Granulocytes Are Associated with B-cell dysregulation in SIV-Infected Rhesus Macaques	PLOS ONE			English	Article							AIDS-LIKE DISEASE; IMMUNODEFICIENCY VIRUS-INFECTION; LYMPHOCYTE STIMULATOR BLYS; TRANSGENIC MICE; HIV-INFECTION; T-CELLS; RESPONSES; DEVELOP; BAFF; NEF	Dendritic cells (DCs) modulate B-cell survival and differentiation, mainly through production of growth factors such as B lymphocyte stimulator (BLyS/BAFF). In recent longitudinal studies involving HIV-1-infected individuals with different rates of disease progression, we have shown that DCs were altered in number and phenotype in the context of HIV-1 disease progression and B-cell dysregulations were associated with increased BLyS/BAFF expression in plasma and by blood myeloid DCs (mDCs) in rapid and classic progressors but not in HIV-1-elite controllers (EC). Suggesting that the extent to which HIV-1 disease progression is controlled may be linked to BLyS/BAFF expression status and the capacity to orchestrate B-cell responses. Herein, longitudinal analyses of simian immunodeficiency virus (SIV)-infected rhesus macaques also revealed increased expression of BLyS/BAFF by blood mDCs as soon as day 8 and throughout infection. Strikingly, granulocytes presented the highest BLyS/BAFF expression profile in the blood of SIV-infected macaques. BLyS/BAFF levels were also increased in plasma and correlated with viral loads. Consequently, these SIV-infected animals had plasma hyperglobulinemia and reduced blood B-cell numbers with altered population frequencies. These data underscore that BLyS/BAFF is associated with immune dysregulation in SIV-infected rhesus macaques and suggest that BLyS/BAFF is a key regulator of immune activation that is highly conserved among primates. These findings emphasize the potential importance of this SIV-infected primate model to test whether blocking excess BLyS/BAFF has an effect on the overall inflammatory burden and immune restoration.	[Poudrier, Johanne] Ctr Hosp Univ Montreal, Ctr Rech, Lab Immunogenet, Montreal, PQ, Canada; [Poudrier, Johanne; Chagnon-Choquet, Josiane; Roger, Michel] Ctr Hosp Univ Montreal, Ctr Rech, Lab Immunogenet, Montreal, PQ, Canada; [Poudrier, Johanne; Chagnon-Choquet, Josiane; Roger, Michel] Univ Montreal, Dept Microbiol Infectiol & Immunol, Montreal, PQ, Canada; [Soulas, Caroline; Burdo, Tricia; Autissier, Patrick; Oskar, Kathryn; Williams, Kenneth C.] Boston Coll, Boston, MA USA	Universite de Montreal; Universite de Montreal; Universite de Montreal; Boston College	Poudrier, J (corresponding author), Ctr Hosp Univ Montreal, Ctr Rech, Lab Immunogenet, Montreal, PQ, Canada.	johanne.poudrier@crchum.qc.ca; michel.roger.chum@ssss.gouv.qc.ca			Canadian Institutes of Health Research (CIHR) [CHR-126633, HBF-13180]; Reseau SIDA from the Fonds de Recherche du Quebec en Sante (FRQS); NIH [RO1NS40237]; Fondation Gabriel Marquis; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS040237, R01NS082116] Funding Source: NIH RePORTER	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Reseau SIDA from the Fonds de Recherche du Quebec en Sante (FRQS); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fondation Gabriel Marquis; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by grants #CHR-126633 and HBF-13180 from the Canadian Institutes of Health Research (CIHR) and by the Reseau SIDA from the Fonds de Recherche du Quebec en Sante (FRQS) to MR and by grant NIH RO1NS40237 to KCW. Josiane Chagnon-Choquet holds a Studentship from the Fondation Gabriel Marquis.	[Anonymous], 2010, Drugs R D, V10, P55, DOI 10.2165/11538300-000000000-00000; Autissier P, 2010, J IMMUNOL METHODS, V360, P119, DOI 10.1016/j.jim.2010.06.017; Batista FD, 2009, NAT REV IMMUNOL, V9, P15, DOI 10.1038/nri2454; Brenchley JM, 2013, MUCOSAL IMMUNOL, V6, P657, DOI 10.1038/mi.2013.15; Cancro MP, 2009, J CLIN INVEST, V119, P1066, DOI 10.1172/JCI38010; Cerutti A, 2013, J LEUKOCYTE BIOL, V94, P677, DOI 10.1189/jlb.1112596; Cerutti A, 2013, NAT REV IMMUNOL, V13, P118, DOI 10.1038/nri3383; Cerutti A, 2011, TRENDS IMMUNOL, V32, P202, DOI 10.1016/j.it.2011.02.004; Chagnon-Choquet J, 2015, J INFECT DIS, V211, P1229, DOI 10.1093/infdis/jiu611; Chagnon-Choquet J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101949; Chaoul N, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-43; Cline AN, 2005, J MED PRIMATOL, V34, P303; Das A, 2011, CLIN IMMUNOL, V140, P223, DOI 10.1016/j.clim.2011.04.018; Das A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016524; Fontaine J, 2011, BLOOD, V117, P145, DOI 10.1182/blood-2010-08-301887; Fontaine J, 2009, J INFECT DIS, V199, P1007, DOI 10.1086/597278; Fujii Y, 1996, FEBS LETT, V393, P93, DOI 10.1016/0014-5793(96)00859-9; Hanna Z, 1998, J VIROL, V72, P121, DOI 10.1128/JVI.72.1.121-132.1998; Hanna Z, 1998, CELL, V95, P163, DOI 10.1016/S0092-8674(00)81748-1; Hassler S, 2006, BLOOD, V108, P1941, DOI 10.1182/blood-2006-04-019679; Hong JJ, 2012, J IMMUNOL, V188, P3247, DOI 10.4049/jimmunol.1103138; Klatt NR, 2011, BLOOD, V118, P5803, DOI 10.1182/blood-2011-07-365874; Lanini S, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-36; Levesque MC, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000107; Lindh E, 2008, P NATL ACAD SCI USA, V105, P18466, DOI 10.1073/pnas.0808205105; Mackay F, 1999, J EXP MED, V190, P1697, DOI 10.1084/jem.190.11.1697; MacPherson G, 1999, IMMUNOL REV, V172, P325, DOI 10.1111/j.1600-065X.1999.tb01376.x; Moir S, 2008, J EXP MED, V205, P1797, DOI 10.1084/jem.20072683; Moir S, 2009, NAT REV IMMUNOL, V9, P235, DOI 10.1038/nri2524; Pillai S, 2009, NAT REV IMMUNOL, V9, P767, DOI 10.1038/nri2656; Poudrier J, 2003, J VIROL, V77, P11733, DOI 10.1128/JVI.77.21.11733-11744.2003; Poudrier J, 2001, IMMUNITY, V15, P173, DOI 10.1016/S1074-7613(01)00177-7; Poudrier J., 2012, CLIN DEV IMMUNOL, V2012, DOI [10.1155/2012/592187, DOI 10.1155/2012/592187]; Poudrier J, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/875821; Poudrier J, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002154; Pranzatelli MR, 2011, CYTOKINE, V53, P384, DOI 10.1016/j.cyto.2010.12.004; Raymond AD, 2011, AIDS RES HUM RETROV, V27, P167, DOI 10.1089/aid.2009.0170; Tangye SG, 2006, SEMIN IMMUNOL, V18, P305, DOI 10.1016/j.smim.2006.04.004; Varin MM, 2010, AUTOIMMUN REV, V9, P604, DOI 10.1016/j.autrev.2010.05.006; Vincent FB, 2013, CYTOKINE GROWTH F R, V24, P203, DOI 10.1016/j.cytogfr.2013.04.003; Wijewardana V, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001235; Wild J, 2015, LEUKEMIA, V29, P1676, DOI 10.1038/leu.2015.50; Xicoy B, 2014, LEUKEMIA LYMPHOMA, V55, P1300, DOI 10.3109/10428194.2013.834532; Xu HB, 2013, IMMUNOL REV, V254, P10, DOI 10.1111/imr.12072; Zouali M, 2011, FRONT IMMUNOL, V2, DOI 10.3389/fimmu.2011.00063	46	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2015	10	6							e0131513	10.1371/journal.pone.0131513	http://dx.doi.org/10.1371/journal.pone.0131513			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4OM	26107380	Green Submitted, Green Published, gold			2022-12-26	WOS:000356932500165
J	Moreira, EM; Gall, H; Leening, MJG; Lahousse, L; Loth, DW; Krijthe, BP; Kiefte-de Jong, JC; Brusselle, GG; Hofman, A; Stricker, BH; Ghofrani, HA; Franco, OH; Felix, JF				Moreira, Eduardo M.; Gall, Henning; Leening, Maarten J. G.; Lahousse, Lies; Loth, Daan W.; Krijthe, Bouwe P.; Kiefte-de Jong, Jessica C.; Brusselle, Guy G.; Hofman, Albert; Stricker, Bruno H.; Ghofrani, Hossein A.; Franco, Oscar H.; Felix, Janine F.			Prevalence of Pulmonary Hypertension in the General Population: The Rotterdam Study	PLOS ONE			English	Article							ARTERY SYSTOLIC PRESSURE; HEART-FAILURE; ECHOCARDIOGRAPHY; ASSOCIATION; GUIDELINES; CARDIOLOGY; ACCURACY; DEATH	Background Pulmonary hypertension is characterized by increased pulmonary artery pressure and carries an increased mortality. Population-based studies into pulmonary hypertension are scarce and little is known about its prevalence in the general population. We aimed to describe the distribution of echocardiographically-assessed pulmonary artery systolic pressure (ePASP) in the general population, to estimate the prevalence of pulmonary hypertension, and to identify associated factors. Methods Participants (n = 3381, mean age 76.4 years, 59% women) from the Rotterdam Study, a population-based cohort, underwent echocardiography. Echocardiographic pulmonary hypertension was defined as ePASP>40 mmHg. Results Mean ePASP was 26.3 mmHg (SD 7.0). Prevalence of echocardiographic pulmonary hypertension was 2.6% (95%CI: 2.0; 3.2). Prevalence was higher in older participants compared to younger ones (8.3% in those over 85 years versus 0.8% in those between 65 and 70), and in those with underlying disorders versus those without (5.9% in subjects with COPD versus 2.3%; 9.2% in those with left ventricular systolic dysfunction versus 2.3%; 23.1% in stages 3 or 4 left ventricular diastolic dysfunction versus 1.9% in normal or stage 1). Factors independently associated with higher ePASP were older age, higher BMI, left ventricular diastolic dysfunction, COPD and systemic hypertension. Conclusion In this large population-based study, we show that pulmonary hypertension as measured by echocardiography has a low prevalence in the overall general population in the Netherlands, but estimates may be higher in specific subgroups, especially in those with underlying diseases. Increased pulmonary arterial pressure is likely to gain importance in the near future due to population aging and the accompanying prevalences of underlying disorders.	[Moreira, Eduardo M.; Leening, Maarten J. G.; Lahousse, Lies; Loth, Daan W.; Krijthe, Bouwe P.; Kiefte-de Jong, Jessica C.; Brusselle, Guy G.; Hofman, Albert; Stricker, Bruno H.; Franco, Oscar H.; Felix, Janine F.] Erasmus MC, Dept Epidemiol, Rotterdam, Netherlands; [Moreira, Eduardo M.] Pontificia Univ Catolica Parana, Sch Med, Curitiba, Parana, Brazil; [Gall, Henning; Ghofrani, Hossein A.] Univ Giessen & Marburg Lung Ctr UGMLC, German Ctr Lung Res DZL, Giessen, Germany; [Leening, Maarten J. G.] Erasmus MC, Dept Cardiol, Rotterdam, Netherlands; [Lahousse, Lies; Brusselle, Guy G.] Ghent Univ Hosp, Dept Resp Med, Ghent, Belgium; [Loth, Daan W.] Amphia Hosp, Dept Resp Med, Breda, Netherlands; [Brusselle, Guy G.] Erasmus MC, Dept Resp Med, Rotterdam, Netherlands; [Stricker, Bruno H.] Dept Internal Med, Erasmus MC, Rotterdam, Netherlands; [Stricker, Bruno H.] Inspectorate Hlth Care, The Hague, Netherlands	Erasmus University Rotterdam; Erasmus MC; Pontificia Universidade Catolica do Parana; Erasmus University Rotterdam; Erasmus MC; Ghent University; Ghent University Hospital; Amphia Hospital; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC	Felix, JF (corresponding author), Erasmus MC, Dept Epidemiol, Rotterdam, Netherlands.	j.felix@erasmusmc.nl	Lahousse, Lies/O-9426-2019; Ghofrani, Ardeschir/AAD-5293-2020; Kiefte-de Jong, Jessica/GLV-3216-2022; Franco, Óscar H/ABE-2305-2020; Ghofrani, Hossein Ardeschir/AAD-2856-2022	Lahousse, Lies/0000-0002-3494-4363; Ghofrani, Ardeschir/0000-0002-2029-4419; Kiefte-de Jong, Jessica/0000-0002-8136-0918; Franco, Óscar H/0000-0002-4606-4929; Felix, Janine/0000-0002-9801-5774; Loth, Daan/0000-0003-1260-9326; Brusselle, Guy/0000-0001-7021-8505	Erasmus MC and Erasmus University Rotterdam; Netherlands Organisation for Scientific Research (NWO); Netherlands Organisation for Health Research and Development (ZonMw); Research Institute for Diseases in the Elderly (RIDE); Netherlands Genomics Initiative (NGI); Ministry of Education, Culture and Science; European Commission (DG XII); Municipality of Rotterdam; National Council for Scientific and Technological Development (CNPq), Brazilian government entity; Nestle; Metagenics Inc.; AXA; Netherlands Organisation for Health Research and Development (ZonMw, HTA grant) [80-82500-98-10208]; Prins Bernhard Cultuurfonds Fellowship [30140588]; De Drie Lichten Foundation [04/14]; Fund for Scientific Research Flanders (FWO) [G035014N]; Belgian Thoracic Society Fellowship; Nutrition (Nestec Ltd.); Ministry of Health, Welfare and Sports	Erasmus MC and Erasmus University Rotterdam; Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Netherlands Organisation for Health Research and Development (ZonMw)(Netherlands Organization for Health Research and Development); Research Institute for Diseases in the Elderly (RIDE); Netherlands Genomics Initiative (NGI); Ministry of Education, Culture and Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); European Commission (DG XII)(European CommissionEuropean Commission Joint Research Centre); Municipality of Rotterdam; National Council for Scientific and Technological Development (CNPq), Brazilian government entity(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)Fundacao de Apoio a Pesquisa do Distrito Federal (FAPDF)); Nestle(Nestle SA); Metagenics Inc.; AXA; Netherlands Organisation for Health Research and Development (ZonMw, HTA grant); Prins Bernhard Cultuurfonds Fellowship; De Drie Lichten Foundation; Fund for Scientific Research Flanders (FWO)(FWO); Belgian Thoracic Society Fellowship; Nutrition (Nestec Ltd.); Ministry of Health, Welfare and Sports	The Rotterdam Study is supported by the Erasmus MC and Erasmus University Rotterdam; the Netherlands Organisation for Scientific Research (NWO); the Netherlands Organisation for Health Research and Development (ZonMw); the Research Institute for Diseases in the Elderly (RIDE); the Netherlands Genomics Initiative (NGI); the Ministry of Education, Culture and Science, the Ministry of Health, Welfare and Sports; the European Commission (DG XII); and the Municipality of Rotterdam. EMM was granted a scholarship by the National Council for Scientific and Technological Development (CNPq), a Brazilian government entity. JCK-dJ and OHF work in ErasmusAGE, a center for aging research across the life course funded by Nestle, Nutrition (Nestec Ltd.), Metagenics Inc. and AXA. M.J.G.L. and B.H.S. are supported by the Netherlands Organisation for Health Research and Development (ZonMw, HTA grant 80-82500-98-10208). M.J.G.L. is supported by a Prins Bernhard Cultuurfonds Fellowship (30140588); and De Drie Lichten Foundation (04/14). LL is funded by the Fund for Scientific Research Flanders (FWO) [project G035014N] and has received a Belgian Thoracic Society Fellowship. All authors are independent of the funding sources. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen KH, 2012, J HEART LUNG TRANSPL, V31, P373, DOI 10.1016/j.healun.2011.11.020; Appelbaum L, 2001, CHEST, V119, P1801, DOI 10.1378/chest.119.6.1801; Bursi F, 2012, J AM COLL CARDIOL, V59, P222, DOI 10.1016/j.jacc.2011.06.076; Choudhary G, 2014, CIRC-HEART FAIL, V7, P558, DOI 10.1161/CIRCHEARTFAILURE.114.001366; Choudhary G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084264; D'Alto M, 2013, INT J CARDIOL, V168, P4058, DOI 10.1016/j.ijcard.2013.07.005; D'Andrea A, 2014, CHEST, V145, P1071, DOI 10.1378/chest.12-3079; Damy T, 2010, EUR HEART J, V31, P2280, DOI 10.1093/eurheartj/ehq245; Fayngersh V, 2011, LUNG, V189, P377, DOI 10.1007/s00408-011-9315-2; Fisher MR, 2009, AM J RESP CRIT CARE, V179, P615, DOI 10.1164/rccm.200811-1691OC; Galie N, 2009, EUR HEART J, V30, P2493, DOI 10.1093/eurheartj/ehp297; Gladwin MT, 2004, NEW ENGL J MED, V350, P886, DOI 10.1056/NEJMoa035477; Grossman A, 2014, RESP CARE, V59, P371, DOI 10.4187/respcare.02701; Hatano S, 1975, WHO M GEN WHO; Hofman A, 2013, EUR J EPIDEMIOL, V28, P889, DOI 10.1007/s10654-013-9866-z; Humbert M, 2006, AM J RESP CRIT CARE, V173, P1023, DOI 10.1164/rccm.200510-1668OC; Hyduk Alexandra, 2005, Morbidity and Mortality Weekly Report, V54, P1; Janda S, 2011, HEART, V97, P612, DOI 10.1136/hrt.2010.212084; Khouri SJ, 2004, J AM SOC ECHOCARDIOG, V17, P290, DOI 10.1016/j.echo.2003.08.012; Lam CSP, 2009, CIRCULATION, V119, P2663, DOI 10.1161/CIRCULATIONAHA.108.838698; Lam CSP, 2009, J AM COLL CARDIOL, V53, P1119, DOI 10.1016/j.jacc.2008.11.051; McLaughlin VV, 2009, J AM COLL CARDIOL, V53, P1573, DOI 10.1016/j.jacc.2009.01.004; McQuillan BM, 2001, CIRCULATION, V104, P2797, DOI 10.1161/hc4801.100076; Nagueh SF, 2009, J AM SOC ECHOCARDIOG, V22, P107, DOI 10.1016/j.echo.2008.11.023; Pengo V, 2004, NEW ENGL J MED, V350, P2257, DOI 10.1056/NEJMoa032274; Rudski LG, 2010, J AM SOC ECHOCARDIOG, V23, P685, DOI 10.1016/j.echo.2010.05.010; Schiller N B, 1989, J Am Soc Echocardiogr, V2, P358; Simonneau G, 2009, J AM COLL CARDIOL, V54, pS43, DOI [10.1016/j.jacc.2009.04.012, 10.1016/j.jacc.2013.10.029]; Strange G, 2012, HEART, V98, P1805, DOI 10.1136/heartjnl-2012-301992; Szwejkowski BR, 2012, EUR J HEART FAIL, V14, P162, DOI 10.1093/eurjhf/hfr159; van Hoek M, 2008, DIABETES, V57, P3122, DOI 10.2337/db08-0425; Vasan RS, 2002, JAMA-J AM MED ASSOC, V288, P1252, DOI 10.1001/jama.288.10.1252; WHO, 2006, DEFINITION AND DIAGN	33	42	42	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2015	10	6							e0130072	10.1371/journal.pone.0130072	http://dx.doi.org/10.1371/journal.pone.0130072			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4DD	26102085	Green Published, Green Submitted, gold			2022-12-26	WOS:000356901900027
J	Fan, DQ; Zhu, WQ; Zheng, ZT; Zhang, DH; Pan, YZ; Jiang, N; Zhou, XF				Fan, Deqin; Zhu, Wenquan; Zheng, Zhoutao; Zhang, Donghai; Pan, Yaozhong; Jiang, Nan; Zhou, Xiafei			Change in the Green-Up Dates for Quercus mongolica in Northeast China and Its Climate-Driven Mechanism from 1962 to 2012	PLOS ONE			English	Article							VEGETATION PHENOLOGY; SPRING PHENOLOGY; TEMPERATE; RESPONSES; GROWTH; BUDBURST; BOREAL; TRENDS; SEASON; MODEL	The currently available studies on the green-up date were mainly based on ground observations and/or satellite data, and few model simulations integrated with wide coverage satellite data have been reported at large scale over a long time period (i.e., > 30 years). In this study, we combined phenology mechanism model, long-term climate data and synoptic scale remote sensing data to investigate the change in the green-up dates for Quercus mongolica over 33 weather stations in Northeast China and its climate-driven mechanism during 1962-2012. The results indicated that the unified phenology model can be well parameterized with the satellite derived green-up dates. The optimal daily mean temperature for chilling effect was between -27 degrees C and 1 degrees C for Q. mongolica in Northeast China, while the optimal daily mean temperature for forcing effect was above -3 degrees C. The green-up dates for Q. mongolica across Northeast China showed a delayed latitudinal gradient of 2.699 days degree(-1), with the earliest date on the Julian day 93 (i.e., 3th April) in the south and the latest date on the Julian day 129 (i.e., 9th May) in the north. The green-up date for Q. mongolica in Northeast China has advanced 6.6 days (1.3 days decade-1) from 1962 to 2012. With the prevailing warming in autumn, winter and spring in Northeast China during the past 51 years, the chilling effect for Q. mongolica has been weakened, while the forcing effect has been enhanced. The advancing trend in the green-up dates for Q. mongolica implied that the enhanced forcing effect to accelerate green-up was stronger than the weakened chilling effect to hold back green-up while the changes of both effects were caused by the warming climate.	[Fan, Deqin; Zhu, Wenquan; Zheng, Zhoutao; Zhang, Donghai; Pan, Yaozhong; Jiang, Nan; Zhou, Xiafei] Beijing Normal Univ, State Key Lab Earth Surface Processes & Resource, Beijing 100875, Peoples R China; [Fan, Deqin; Zhu, Wenquan; Zheng, Zhoutao; Zhang, Donghai; Pan, Yaozhong; Jiang, Nan; Zhou, Xiafei] Beijing Normal Univ, Coll Resources Sci & Technol, Beijing 100875, Peoples R China	Beijing Normal University; Beijing Normal University	Zhu, WQ (corresponding author), Beijing Normal Univ, State Key Lab Earth Surface Processes & Resource, Beijing 100875, Peoples R China.	zhuwq75@bnu.edu.cn	JIANG, NAN/HHN-3354-2022; Pan, YZ/GVS-2269-2022	JIANG, NAN/0000-0001-5151-5715; 	National Natural Science Foundation of China [41371389]; State Key Laboratory of Earth Surface Processes and Resource Ecology [2013-ZY-14]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Key Laboratory of Earth Surface Processes and Resource Ecology	This work was supported by the National Natural Science Foundation of China (Grant No. 41371389), and the State Key Laboratory of Earth Surface Processes and Resource Ecology (Grant No. 2013-ZY-14). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Botta A, 2000, GLOBAL CHANGE BIOL, V6, P709, DOI 10.1046/j.1365-2486.2000.00362.x; Brohan P, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2005JD006548; Chen XQ, 2011, ACTA ECOL SIN, V31, P3559; Chuine I, 2000, J THEOR BIOL, V207, P337, DOI 10.1006/jtbi.2000.2178; Delbart N, 2008, GLOBAL CHANGE BIOL, V14, P603, DOI 10.1111/j.1365-2486.2007.01505.x; Dragoni D, 2011, GLOBAL CHANGE BIOL, V17, P886, DOI 10.1111/j.1365-2486.2010.02281.x; Flora of China academy of sciences committee, 1998, FLORA CHINA; Guo Zhi-xing, 2010, Shengtaixue Zazhi, V29, P165; HANNINEN H, 1990, Acta Forestalia Fennica, V213, P1; HUNTER AF, 1992, J APPL ECOL, V29, P597, DOI 10.2307/2404467; Jeong SJ, 2011, GLOBAL CHANGE BIOL, V17, P2385, DOI 10.1111/j.1365-2486.2011.02397.x; Jiang N, 2013, REMOTE SENS-BASEL, V5, P4031, DOI 10.3390/rs5084031; Kadiyala MDM, 2015, AGR WATER MANAGE, V149, P23, DOI 10.1016/j.agwat.2014.10.019; KIRKPATRICK S, 1983, SCIENCE, V220, P671, DOI 10.1126/science.220.4598.671; KRAMER K, 1994, J APPL ECOL, V31, P172, DOI 10.2307/2404609; Kramer K, 2000, INT J BIOMETEOROL, V44, P67, DOI 10.1007/s004840000066; LANDSBERG JJ, 1974, ANN BOT-LONDON, V38, P1013, DOI 10.1093/oxfordjournals.aob.a084891; Min L, 2008, SPECTROSC SPECT ANAL, V28, P2352, DOI 10.3964/j.issn.1000-0593(2008)10-2352-04; Li Rong-ping, 2010, Shengtaixue Zazhi, V29, P2317; Morin X, 2009, GLOBAL CHANGE BIOL, V15, P961, DOI 10.1111/j.1365-2486.2008.01735.x; MURRAY MB, 1989, J APPL ECOL, V26, P693, DOI 10.2307/2404093; Myneni RB, 1997, NATURE, V386, P698, DOI 10.1038/386698a0; Penuelas J, 2009, SCIENCE, V324, P887, DOI 10.1126/science.1173004; Piao SL, 2011, GLOBAL CHANGE BIOL, V17, P3228, DOI 10.1111/j.1365-2486.2011.02419.x; Piao SL, 2006, GLOBAL CHANGE BIOL, V12, P672, DOI 10.1111/j.1365-2486.2006.01123.x; Ruane AC, 2014, GLOBAL CHANGE BIOL, V20, P394, DOI 10.1111/gcb.12412; Song YL, 2010, INT J CLIMATOL, V30, P33, DOI 10.1002/joc.1868; Sun H., 2000, CHINA ENCY RESOURCES; Tai BingYang, 2012, Journal of Northeast Forestry University, V40, P34; Tian HQ, 2010, FOREST ECOL MANAG, V259, P1311, DOI 10.1016/j.foreco.2009.10.009; Vrieling A, 2013, REMOTE SENS-BASEL, V5, P982, DOI 10.3390/rs5020982; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; Wang HJ, 2012, SCI CHINA EARTH SCI, V55, P991, DOI 10.1007/s11430-011-4349-0; Weiss M, 2014, J CLIMATE, V27, P8563, DOI 10.1175/JCLI-D-13-00684.1; Whitcraft AK, 2015, INT J DIGIT EARTH, V8, P173, DOI 10.1080/17538947.2014.894147; White MA, 1997, GLOBAL BIOGEOCHEM CY, V11, P217, DOI 10.1029/97GB00330; Willis CG, 2008, P NATL ACAD SCI USA, V105, P17029, DOI 10.1073/pnas.0806446105; Yu HY, 2010, P NATL ACAD SCI USA, V107, P22151, DOI 10.1073/pnas.1012490107; Zhang GL, 2013, P NATL ACAD SCI USA, V110, P4309, DOI 10.1073/pnas.1210423110; Zhu WQ, 2012, GLOBAL ECOL BIOGEOGR, V21, P260, DOI 10.1111/j.1466-8238.2011.00675.x	40	2	3	2	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2015	10	6							e0130516	10.1371/journal.pone.0130516	http://dx.doi.org/10.1371/journal.pone.0130516			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL3FM	26098358	Green Published, Green Submitted, gold			2022-12-26	WOS:000356835800077
J	He, XL; Yin, W; Ding, YJ; Cui, SJ; Luan, JW; Zhao, PW; Yue, X; Yu, CH; Laing, XH; Zhao, YL				He, Xuelian; Yin, Wei; Ding, Yan; Cui, Shu-jian; Luan, Jiangwei; Zhao, Peiwei; Yue, Xin; Yu, Chunhua; Laing, Xiaohui; Zhao, YuLan			Higher Serum Angiotensinogen Is an Indicator of IgA Vasculitis with Nephritis Revealed by Comparative Proteomes Analysis	PLOS ONE			English	Article							HENOCH-SCHONLEIN PURPURA; KAWASAKI-DISEASE; RHEUMATOID-ARTHRITIS; GRANULOMATOSIS; BIOMARKER	IgA vasculitis (IgAV), previously named as Henoch-Schonlein purpura, is the most common systematic vasculitis with unknown etiology. Lack of appropriate study system and/or animal model limits the understanding of its molecular pathogenesis and hinders the identification of targets for rational therapy, especially for its long-term complication, IgAV nephritis (IgAVN). In this study, we applied comparative analysis of serum proteomes to obtain an insight about disease pathogenesis. This study has utilized high sensitivity nanoscale ultra performance liquid chromatography-mass spectrometry (nanoLC-MS/MS) to investigate the alterations in serum proteomic profiles in patients with IgAV (n=6), IgAVN (n=6) and healthy subjects (n=7). The differentially expressed proteins were subjected to functional pathway analysis by PANTHER and DAVID software. We identified 107 differentially expressed proteins among three different groups, and functional analysis suggested that, in addition to earlier reported pathways, such as acute phase response, immune response, complement and blood coagulation pathways, hemostasis and Wnt signaling pathway were probably involved in pathogenesis of IgAV. A few differentially abundant proteins identified, such as C4a, serum amyloid A, angiotensinogen, and kininogen 1, were further validated by ELISA. More importantly, we found that angiotensinogen concentration is correlated with IgAVN and could be used as a potential marker for the progression of IgAV. This is the first report of analyzing the proteomic alterations in IgAV patients and the differentially proteins identified in this study may enhance understanding of the pathology of IgAV and a few of them may be used to monitor disease progression.	[He, Xuelian; Zhao, Peiwei; Yue, Xin; Yu, Chunhua] Wuhan Childrens Hosp, Clin Res Ctr, Wuhan, Peoples R China; [Yin, Wei; Ding, Yan] Wuhan Childrens Hosp, Dept Rheumatol, Wuhan, Peoples R China; [Cui, Shu-jian] Yangzhou Univ, Coll Biosci & Biotechnol, Key Lab Crop Genet & Physiol Jiangsu Prov, Yangzhou 225009, Jiangsu, Peoples R China; [Luan, Jiangwei] Wuhan Childrens Hosp, Dept Nephrol, Wuhan, Peoples R China; [Laing, Xiaohui] Wuhan Univ, Sch Publ Hlth, Wuhan 430072, Peoples R China; [Zhao, YuLan] E China Normal Univ, Inst Adv Interdisciplinary Res, Shanghai 200062, Peoples R China	Yangzhou University; Wuhan University; East China Normal University	He, XL (corresponding author), Wuhan Childrens Hosp, Clin Res Ctr, 100 Hongkong Rd, Wuhan, Peoples R China.	hexuelian2013@hotmail.com; xhliang@whu.edu.cn; ylzhao@imet.ecnu.edu.cn			Ministry of Human Resource of China Oversea Returned scholars	Ministry of Human Resource of China Oversea Returned scholars	This study was funded by the supporting program of the Ministry of Human Resource of China Oversea Returned scholars. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABOURAGHEB HHA, 1992, NEPHRON, V62, P22, DOI 10.1159/000186989; Bogdanovic R, 2009, ACTA PAEDIATR, V98, P1882, DOI 10.1111/j.1651-2227.2009.01445.x; Gardner-Medwin JMM, 2002, LANCET, V360, P1197, DOI 10.1016/S0140-6736(02)11279-7; Haubitz M, 2009, MOL CELL PROTEOMICS, V8, P2296, DOI 10.1074/mcp.M800529-MCP200; He XL, 2012, INFLAMMATION, V35, P1251, DOI 10.1007/s10753-012-9435-8; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Kentsis A, 2013, EMBO MOL MED, V5, P210, DOI 10.1002/emmm.201201494; Lau KK, 2010, PEDIATR NEPHROL, V25, P19, DOI 10.1007/s00467-009-1230-x; Liu XY, 2012, INFLAMM BOWEL DIS, V18, P418, DOI 10.1002/ibd.21788; Mateos J, 2012, J PROTEOMICS, V75, P2869, DOI 10.1016/j.jprot.2011.12.042; Narchi H, 2005, ARCH DIS CHILD, V90, P916, DOI 10.1136/adc.2005.074641; Ozen S, 2006, ANN RHEUM DIS, V65, P936, DOI 10.1136/ard.2005.046300; Richardson J, 2006, FRONT BIOSCI-LANDMRK, V11, P1042, DOI 10.2741/1862; Saulsbury FT, 2007, LANCET, V369, P976, DOI 10.1016/S0140-6736(07)60474-7; Schirle M, 2003, MOL CELL PROTEOMICS, V2, P1297, DOI 10.1074/mcp.M300087-MCP200; Serada S, 2014, METHODS MOL BIOL, V1142, P99, DOI 10.1007/978-1-4939-0404-4_12; Smith GC, 1997, PEDIATR NEPHROL, V11, P477, DOI 10.1007/s004670050320; Smith MPW, 2013, KIDNEY INT, V84, P1214, DOI 10.1038/ki.2013.200; Stone JH, 2005, ARTHRITIS RHEUM, V52, P902, DOI 10.1002/art.20938; Thomas PD, 2006, NUCLEIC ACIDS RES, V34, pW645, DOI 10.1093/nar/gkl229; Uchida T, 2013, J PROTEOMICS, V91, P259, DOI 10.1016/j.jprot.2013.07.021; van Bon L, 2014, ANN RHEUM DIS, V73, P1585, DOI 10.1136/annrheumdis-2013-205013; WYATT RJ, 1993, CONTRIB NEPHROL, V104, P82; Yang YH, 2005, RHEUMATOLOGY, V44, P618, DOI 10.1093/rheumatology/keh544; Zhang L, 2014, BIOCHEM BIOPH RES CO, V447, P19, DOI 10.1016/j.bbrc.2014.03.108	25	6	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2015	10	6							e0130536	10.1371/journal.pone.0130536	http://dx.doi.org/10.1371/journal.pone.0130536			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL3FM	26098644	Green Submitted, gold, Green Published			2022-12-26	WOS:000356835800080
J	Newman, MM; Liles, MR; Feminella, JW				Newman, Molli M.; Liles, Mark R.; Feminella, Jack W.			Litter Breakdown and Microbial Succession on Two Submerged Leaf Species in a Small Forested Stream	PLOS ONE			English	Article							INTERGENIC SPACER ANALYSIS; CATCHMENT DISTURBANCE; COMMUNITY STRUCTURE; NUTRIENT DYNAMICS; DECOMPOSITION; BACTERIA; FUNGI; DIVERSITY; GRADIENT; LEAVES	Microbial succession during leaf breakdown was investigated in a small forested stream in west-central Georgia, USA, using multiple culture-independent techniques. Red maple (Acer rubrum) and water oak (Quercus nigra) leaf litter were incubated in situ for 128 days, and litter breakdown was quantified by ash-free dry mass (AFDM) method and microbial assemblage composition using phospholipid fatty acid analysis (PLFA), ribosomal intergenic spacer analysis (RISA), denaturing gradient gel electrophoresis (DGGE), and bar-coded next-generation sequencing of 16S rRNA gene amplicons. Leaf breakdown was faster for red maple than water oak. PLFA revealed a significant time effect on microbial lipid profiles for both leaf species. Microbial assemblages on maple contained a higher relative abundance of bacterial lipids than oak, and oak microbial assemblages contained higher relative abundance of fungal lipids than maple. RISA showed that incubation time was more important in structuring bacterial assemblages than leaf physicochemistry. DGGE profiles revealed high variability in bacterial assemblages over time, and sequencing of DGGE-resolved amplicons indicated several taxa present on degrading litter. Next-generation sequencing revealed temporal shifts in dominant taxa within the phylum Proteobacteria, whereas gamma-Proteobacteria dominated pre-immersion and alpha- and beta-Proteobacteria dominated after 1 month of instream incubation; the latter groups contain taxa that are predicted to be capable of using organic material to fuel further breakdown. Our results suggest that incubation time is more important than leaf species physicochemistry in influencing leaf litter microbial assemblage composition, and indicate the need for investigation into seasonal and temporal dynamics of leaf litter microbial assemblage succession.	[Newman, Molli M.; Liles, Mark R.; Feminella, Jack W.] Auburn Univ, Dept Biol Sci, Auburn, AL 36849 USA	Auburn University System; Auburn University	Newman, MM (corresponding author), Auburn Univ, Dept Biol Sci, Auburn, AL 36849 USA.	ramsemm@auburn.edu			Auburn University Graduate School	Auburn University Graduate School	This work was funded by the Auburn University Graduate School. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abelho M, 2001, ScientificWorldJournal, V1, P656; Agency USEP, 2002, PERMEATION AND LEACH, P24; Allan J D, 2007, STREAM ECOLOGY STRUC, V2nd; Ardon M, 2008, OECOLOGIA, V155, P311, DOI 10.1007/s00442-007-0913-x; Armon R, 2011, SOIL BIOL, V23, P67, DOI 10.1007/978-3-642-14512-4_3; Ausubel FM, 1994, CURRENT PROTOCOLS IN, V27, P23; BARLOCHER F, 1974, J ECOL, V62, P761, DOI 10.2307/2258954; Bartram AK, 2011, APPL ENVIRON MICROB, V77, P3846, DOI 10.1128/AEM.02772-10; Beattie GA, 2006, PLANT-ASSOCIATED BACTERIA, P1; Beier S, 2010, BACTERIAL DEGRADATIO; Berg B., 1980, Ecological Bulletins, V32, P373; BOBBIE RJ, 1980, APPL ENVIRON MICROB, V39, P1212, DOI 10.1128/AEM.39.6.1212-1222.1980; BOULTON AJ, 1991, AUST J MAR FRESH RES, V42, P1; BOWMAN JP, 1993, INT J SYST BACTERIOL, V43, P735, DOI 10.1099/00207713-43-4-735; BOX GEP, 1964, J ROY STAT SOC B, V26, P211, DOI 10.1111/j.2517-6161.1964.tb00553.x; BRAY JR, 1957, ECOL MONOGR, V27, P326, DOI 10.2307/1942268; Brenner D.J., 2005, BERGEYS MANUAL SYSTE, V2, P183; Briee C, 2007, RES MICROBIOL, V158, P213, DOI 10.1016/j.resmic.2006.12.012; Canhoto C, 1999, MICROBIAL ECOL, V37, P163, DOI 10.1007/s002489900140; Caporaso JG, 2012, ISME J, V6, P1621, DOI 10.1038/ismej.2012.8; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Caporaso JG, 2010, BIOINFORMATICS, V26, P266, DOI 10.1093/bioinformatics/btp636; Cardinale M, 2004, APPL ENVIRON MICROB, V70, P6147, DOI 10.1128/AEM.70.10.6147-6156.2004; Cavalcanti G, 2004, EFFECTS OF SEDIMENT; CHAO A, 1984, SCAND J STAT, V11, P265; Chapman SK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062671; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; COULSON JC, 1978, J ECOL, V66, P631, DOI 10.2307/2259155; CUMMINS KW, 1974, BIOSCIENCE, V24, P631, DOI 10.2307/1296676; Dangles O, 2004, J APPL ECOL, V41, P365, DOI 10.1111/j.0021-8901.2004.00888.x; Das M, 2007, APPL ENVIRON MICROB, V73, P756, DOI 10.1128/AEM.01170-06; de Boer W, 2005, FEMS MICROBIOL REV, V29, P795, DOI 10.1016/j.femsre.2004.11.005; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Dirr MA, 1998, MANUAL OF WOODY LAND; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Findlay S, 2010, J N AM BENTHOL SOC, V29, P170, DOI 10.1899/09-023.1; Fisher MM, 1999, APPL ENVIRON MICROB, V65, P4630; FISHER SG, 1973, ECOL MONOGR, V43, P421, DOI 10.2307/1942301; GALLARDO A, 1993, ECOLOGY, V74, P152, DOI 10.2307/1939510; Gessner MO, 2002, ECOL APPL, V12, P498, DOI 10.1890/1051-0761(2002)012[0498:ACFULB]2.0.CO;2; GESSNER MO, 1994, ECOLOGY, V75, P1807, DOI 10.2307/1939639; Graca MAS, 2001, INT REV HYDROBIOL, V86, P383, DOI 10.1002/1522-2632(200107)86:4/5<383::AID-IROH383>3.0.CO;2-D; Griffith GE, 2001, ECOREGIONS OF ALABAM; GUCKERT JB, 1985, FEMS MICROBIOL ECOL, V31, P147, DOI 10.1111/j.1574-6968.1985.tb01143.x; Gulis V, 2003, AQUAT MICROB ECOL, V30, P149, DOI 10.3354/ame030149; Haas BJ, 2011, GENOME RES, V21, P494, DOI 10.1101/gr.112730.110; Hauer FR, 2011, METHODS IN STREAM EC; HAWKINS CP, 1993, FISHERIES, V18, P3, DOI 10.1577/1548-8446(1993)018<0003:AHATCS>2.0.CO;2; Hieber M, 2002, ECOLOGY, V83, P1026, DOI 10.1890/0012-9658(2002)083[1026:COSDFA]2.0.CO;2; Hobbie SE, 2006, ECOLOGY, V87, P2288, DOI 10.1890/0012-9658(2006)87[2288:TSEODA]2.0.CO;2; Houser JN, 2005, J N AM BENTHOL SOC, V24, P538, DOI 10.1899/04-034.1; Huse SM, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000255; Kim SY, 2010, FOOD SCI BIOTECHNOL, V19, P749, DOI 10.1007/s10068-010-0105-z; Knapp AK, 1998, AM J BOT, V85, P940, DOI 10.2307/2446360; KOLATTUKUDY PE, 1980, SCIENCE, V208, P990, DOI 10.1126/science.208.4447.990; Kreutzweiser DP, 2003, CAN J FOREST RES, V33, P1444, DOI 10.1139/X03-030; KRUSKAL WH, 1952, J AM STAT ASSOC, V47, P583, DOI 10.1080/01621459.1952.10483441; Lane D.J., 1991, NUCL ACID TECH BACT, P115, DOI DOI 10.1007/S00227-012-2133-0; Lockaby BG, 2005, J ENVIRON QUAL, V34, P390, DOI 10.2134/jeq2005.0390; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Lyautey E, 2005, MICROB ECOL, V50, P589, DOI 10.1007/s00248-005-5032-9; MACKAY RJ, 1969, ECOLOGY, V50, P101, DOI 10.2307/1934667; Maloney KO, 2006, ECOL INDIC, V6, P469, DOI 10.1016/j.ecolind.2005.06.003; Maloney KO, 2005, ENVIRON MANAGE, V35, P677, DOI 10.1007/s00267-004-4212-6; MCARTHUR JV, 1994, J N AM BENTHOL SOC, V13, P57, DOI 10.2307/1467265; MEENTEMEYER V, 1978, ECOLOGY, V59, P465, DOI 10.2307/1936576; MINSHALL GW, 1967, ECOLOGY, V48, P139; MULLIS KB, 1994, ANGEW CHEM INT EDIT, V33, P1209, DOI 10.1002/anie.199412091; Muyzer G, 1998, ANTON LEEUW INT J G, V73, P127, DOI 10.1023/A:1000669317571; MUYZER G, 1993, APPL ENVIRON MICROB, V59, P695, DOI 10.1128/AEM.59.3.695-700.1993; Newman Molli M, 2010, Cold Spring Harb Protoc, V2010, DOI 10.1101/pdb.prot5383; Nikolcheva LG, 2005, MYCOL RES, V109, P246, DOI 10.1017/S0953756204001698; Nold Stephen C., 1998, Aquatic Ecology, V32, P17, DOI 10.1023/A:1009991918036; Ostrofsky ML, 1997, J N AM BENTHOL SOC, V16, P750, DOI 10.2307/1468168; Pascoal C, 2004, APPL ENVIRON MICROB, V70, P5266, DOI 10.1128/AEM.70.9.5266-5273.2004; PETERSEN RC, 1974, FRESHWATER BIOL, V4, P343, DOI 10.1111/j.1365-2427.1974.tb00103.x; PETERSON DL, 1982, FOREST SCI, V28, P667; Pope RJ, 1999, HYDROBIOLOGIA, V392, P99, DOI 10.1023/A:1003537232319; Rabeni CF, 2002, ECOL APPL, V12, P782; Redford AJ, 2010, ENVIRON MICROBIOL, V12, P2885, DOI 10.1111/j.1462-2920.2010.02258.x; Rees GN, 2006, J N AM BENTHOL SOC, V25, P370, DOI 10.1899/0887-3593(2006)25[370:VISMCI]2.0.CO;2; Romani AM, 2006, ECOLOGY, V87, P2559, DOI 10.1890/0012-9658(2006)87[2559:IOBAFO]2.0.CO;2; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sasser M., 1990, IDENTIFICATION OF BA; Schweitzer B, 2001, APPL ENVIRON MICROB, V67, P632, DOI 10.1128/AEM.67.2.632-645.2001; SHANNON CE, 1948, BELL SYST TECH J, V27, P623, DOI 10.1002/j.1538-7305.1948.tb00917.x; SOKAL ROBERT R., 1958, UNIV KANSAS SCI BULL, V38, P1409; Stoddard JL, 2006, ECOL APPL, V16, P1267, DOI 10.1890/1051-0761(2006)016[1267:SEFTEC]2.0.CO;2; SUBERKROPP K, 1976, ECOLOGY, V57, P707, DOI 10.2307/1936184; Suberkropp KF, 1974, MICROB ECOL, V1, P96, DOI 10.1007/BF02512381; Suzuki MT, 1996, APPL ENVIRON MICROB, V62, P625, DOI 10.1128/AEM.62.2.625-630.1996; VANNOTE RL, 1980, CAN J FISH AQUAT SCI, V37, P130, DOI 10.1139/f80-017; VESTAL JR, 1989, BIOSCIENCE, V39, P535, DOI 10.2307/1310976; WALLACE JB, 1982, OECOLOGIA, V53, P197, DOI 10.1007/BF00545663; Wallace JB, 1996, ANNU REV ENTOMOL, V41, P115, DOI 10.1146/annurev.en.41.010196.000555; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; WARD JH, 1963, J AM STAT ASSOC, V58, P236, DOI 10.2307/2282967; Webster J. R., 1995, RIVER STREAM ECOSYST, P117; WEBSTER JR, 1986, ANNU REV ECOL SYST, V17, P567, DOI 10.1146/annurev.es.17.110186.003031; WHITE DC, 1979, OECOLOGIA, V40, P51, DOI 10.1007/BF00388810; WITKAMP M, 1966, ECOLOGY, V47, P194, DOI 10.2307/1933765; YAMAMOTO N, 1985, J EXP MAR BIOL ECOL, V90, P209, DOI 10.1016/0022-0981(85)90167-4; Yeo IK, 2000, BIOMETRIKA, V87, P954, DOI 10.1093/biomet/87.4.954; Young IM, 2008, ADV AGRON, V100, P81, DOI 10.1016/S0065-2113(08)00604-4; Zar J. H., 1999, BIOSTATISTICAL ANALY; Zelles L, 1999, BIOL FERT SOILS, V29, P111, DOI 10.1007/s003740050533	106	18	18	3	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2015	10	6							e0130801	10.1371/journal.pone.0130801	http://dx.doi.org/10.1371/journal.pone.0130801			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL3FM	26098687	Green Submitted, Green Published, gold			2022-12-26	WOS:000356835800103
J	Wu, ZY; Lin, WX; Li, BL; Wu, LK; Fang, CX; Zhang, ZX				Wu, Zeyan; Lin, Wenxiong; Li, Bailian; Wu, Linkun; Fang, Changxun; Zhang, Zhixing			Terminal Restriction Fragment Length Polymorphism Analysis of Soil Bacterial Communities under Different Vegetation Types in Subtropical Area	PLOS ONE			English	Article							MICROBIAL COMMUNITIES; FUNGAL COMMUNITY; T-RFLP; DIVERSITY; GRADIENT; MODEL	Soil microbes are active players in energy flow and material exchange of the forest ecosystems, but the research on the relationship between the microbial diversity and the vegetation types is less conducted, especially in the subtropical area of China. In this present study, the rhizosphere soils of evergreen broad-leaf forest (EBF), coniferous forest (CF), subalpine dwarf forest (SDF) and alpine meadow (AM) were chosen as test sites. Terminalrestriction fragment length polymorphisms (T-RFLP) analysis was used to detect the composition and diversity of soil bacterial communities under different vegetation types in the National Natural Reserve of Wuyi Mountains. Our results revealed distinct differences in soil microbial composition under different vegetation types. Total 73 microbes were identified in soil samples of the four vegetation types, and 56, 49, 46 and 36 clones were obtained from the soils of EBF, CF, SDF and AM, respectively, and subsequently sequenced. The Actinobacteria, Fusobacterium, Bacteroidetes and Proteobacteria were the most predominant in all soil samples. The order of Shannon-Wiener index (H) of all soil samples was in the order of EBF>CF>SDF>AM, whereas bacterial species richness as estimated by four restriction enzymes indicated no significant difference. Principal component analysis (PCA) revealed that the soil bacterial communities' structures of EBF, CF, SDF and AM were clearly separated along the first and second principal components, which explained 62.17% and 31.58% of the total variance, respectively. The soil physical-chemical properties such as total organic carbon (TOC), total nitrogen (TN), total phosphorus (TP) and total potassium (TK) were positively correlated with the diversity of bacterial communities.	[Wu, Zeyan; Lin, Wenxiong; Wu, Linkun; Fang, Changxun; Zhang, Zhixing] Fujian Agr & Forestry Univ, Life Sci Coll, Fuzhou, Fujian, Peoples R China; [Li, Bailian] Univ Calif Riverside, Ecol Complex & Modeling Lab, Riverside, CA 92521 USA	Fujian Agriculture & Forestry University; University of California System; University of California Riverside	Lin, WX (corresponding author), Fujian Agr & Forestry Univ, Life Sci Coll, Fuzhou, Fujian, Peoples R China.	wenxiong1810@163.com	Wu, Linkun/GLN-5951-2022		National Science Foundation of China [30772729]	National Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Science Foundation of China (Grant no. 30772729 to LWX).	Aponte C, 2010, BIOGEOCHEMISTRY, V101, P77, DOI 10.1007/s10533-010-9418-5; Baath E, 2003, SOIL BIOL BIOCHEM, V35, P955, DOI 10.1016/S0038-0717(03)00154-8; Bach LH, 2010, SOIL BIOL BIOCHEM, V42, P1934, DOI 10.1016/j.soilbio.2010.07.002; Bowers RM, 2012, ATMOS ENVIRON, V50, P41, DOI 10.1016/j.atmosenv.2012.01.005; Brockett BFT, 2012, SOIL BIOL BIOCHEM, V44, P9, DOI 10.1016/j.soilbio.2011.09.003; Bu XL, 2012, APPL SOIL ECOL, V52, P42, DOI 10.1016/j.apsoil.2011.10.005; Ding T, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-1; Evans TN, 2014, ANTON LEEUW INT J G, V105, P559, DOI 10.1007/s10482-013-0108-x; Hackl E, 2005, SOIL BIOL BIOCHEM, V37, P661, DOI 10.1016/j.soilbio.2004.08.023; Huang W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078973; Innes L, 2004, BIOL FERT SOILS, V40, P7, DOI 10.1007/s00374-004-0748-0; Joo S, 2010, J MICROBIOL METH, V81, P61, DOI 10.1016/j.mimet.2010.01.025; Kirk JL, 2004, J MICROBIOL METH, V58, P169, DOI 10.1016/j.mimet.2004.04.006; Leckie SE, 2005, FOREST ECOL MANAG, V220, P88, DOI 10.1016/j.foreco.2005.08.007; Liang C, 2012, APPL SOIL ECOL, V54, P24, DOI 10.1016/j.apsoil.2011.11.015; Lin S, 2012, SUGAR TECH, V14, P275, DOI 10.1007/s12355-012-0147-z; Mendes R, 2011, SCIENCE, V332, P1097, DOI 10.1126/science.1203980; Nithya C, 2012, APPL BIOCHEM BIOTECH, V167, P1763, DOI 10.1007/s12010-012-9578-y; Park S, 2006, SOIL BIOL BIOCHEM, V38, P2344, DOI 10.1016/j.soilbio.2006.02.019; Schutte UME, 2008, APPL MICROBIOL BIOT, V80, P365, DOI 10.1007/s00253-008-1565-4; Shishido M, 2008, SOIL BIOL BIOCHEM, V40, P1460, DOI 10.1016/j.soilbio.2007.12.024; Singh BK, 2006, APPL ENVIRON MICROB, V72, P7278, DOI 10.1128/AEM.00510-06; Sun GQ, 2014, COMMUN NONLINEAR SCI, V19, P1507, DOI 10.1016/j.cnsns.2013.09.016; Sun GQ, 2012, NONLINEAR DYNAM, V69, P1631, DOI 10.1007/s11071-012-0374-6; Sun GQ, 2008, ECOL MODEL, V219, P248, DOI 10.1016/j.ecolmodel.2008.08.009; Wang GB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053914; Wang SJ, 2009, SOIL BIOL BIOCHEM, V41, P891, DOI 10.1016/j.soilbio.2008.12.016; Weand MP, 2010, SOIL BIOL BIOCHEM, V42, P2161, DOI 10.1016/j.soilbio.2010.08.012; Wu LK, 2013, APPL SOIL ECOL, V67, P1, DOI 10.1016/j.apsoil.2013.02.008; Wu YP, 2010, J SOIL SEDIMENT, V10, P223, DOI 10.1007/s11368-009-0118-5; Zhang B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066184; Zhang ZY, 2011, AGR SCI CHINA, V10, P1374, DOI 10.1016/S1671-2927(11)60130-2	32	14	14	2	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2015	10	6							e0129397	10.1371/journal.pone.0129397	http://dx.doi.org/10.1371/journal.pone.0129397			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL3FM	26098851	Green Submitted, Green Published, gold			2022-12-26	WOS:000356835800028
J	Han, SW; Cheon, KY; Kim, JY; Baik, JS				Han, Sang Won; Cheon, Kyeong Yeol; Kim, Jeong Yeon; Baik, Jong Sam			Carpal Tunnel Syndrome in Patients with Tremor Dominant Parkinson's Disease	PLOS ONE			English	Article							TRANSIENT STABILITY ASSESSMENT; DYNAMIC SECURITY ASSESSMENT; EXTREME LEARNING-MACHINE; POWER-SYSTEMS; CLASSIFICATION	Background Unilateral hand tremor is one of the cardinal symptoms of Parkinson's disease. Additionally, mechanical traumatic hand movement is one of the risk factors for carpal tunnel syndrome. Our objective in this study was to examine whether repetitive mechanical movement may be related to the development of carpal tunnel syndrome in Parkinson's disease with unilateral hand tremor using neurophysiological methods. Methods The study participants included 33 de novo Parkinson's disease patients with unilateral hand tremor, and we compared the tremor hand and non-tremor hand within the same patients. Results Seven (21.2%) of the 33 patients had carpal tunnel syndrome. All of carpal tunnel syndrome patients showed neurophysiological abnormalities in both the hand without tremor and the hand with tremor. In addition, in patients without carpal tunnel syndrome, the sensory nerve action potential was lower in the hand without tremor than in the hand with tremor, although there were no significant differences. Conclusions We concluded that hand tremor in de novo Parkinson's disease patients was not directly related to the development of carpal tunnel syndrome. In contrast, more frequent use of hand without tremor may induce mechanical loading and may be associated with CTS in the hand without tremor. Early diagnosis of Parkinson's disease and proper education in hand use may be essential for preventing carpal tunnel syndrome in Parkinson's disease tremor patients.	[Han, Sang Won; Cheon, Kyeong Yeol; Kim, Jeong Yeon; Baik, Jong Sam] Inje Univ, Coll Med, Sanggye Paik Hosp, Dept Neurol, Seoul, South Korea	Inje University	Baik, JS (corresponding author), Inje Univ, Coll Med, Sanggye Paik Hosp, Dept Neurol, Seoul, South Korea.	jsbaik@paik.ac.kr			Inje University research grant	Inje University research grant	This work was supported by the 2013 Inje University research grant.	Amjady N, 2010, IET GENER TRANSM DIS, V4, P509, DOI 10.1049/iet-gtd.2009.0255; Anderson P. M., 2003, POWER SYSTEM CONTROL; Andersson G, 2005, IEEE T POWER SYST, V20, P1922, DOI 10.1109/TPWRS.2005.857942; Frieman JH, 2008, ANN APPL STAT, V2, P916, DOI 10.1214/07-AOAS148; Gomez FR, 2011, IEEE T POWER SYST, V26, P1474, DOI 10.1109/TPWRS.2010.2082575; Gu XP, 2015, INT J ELEC POWER, V64, P664, DOI 10.1016/j.ijepes.2014.07.070; Huang GB, 2006, NEUROCOMPUTING, V70, P489, DOI 10.1016/j.neucom.2005.12.126; Huang GB, 2012, IEEE T SYST MAN CY B, V42, P513, DOI 10.1109/TSMCB.2011.2168604; Kamwa I, 2009, IEEE T POWER SYST, V24, P258, DOI 10.1109/TPWRS.2008.2009430; Kundur P, 2004, IEEE T POWER SYST, V19, P1387, DOI 10.1109/TPWRS.2004.825981; Lin YJ, 2010, INT J ELEC POWER, V32, P873, DOI 10.1016/j.ijepes.2010.01.026; LIU B, 2004, IEEE COMPUTATIONAL I, V3, P31; Martens D, 2007, IEEE T EVOLUT COMPUT, V11, P651, DOI 10.1109/TEVC.2006.890229; Mohammadi M, 2010, ENERG CONVERS MANAGE, V51, P640, DOI 10.1016/j.enconman.2009.10.021; Moulin LS, 2004, IEEE T POWER SYST, V19, P818, DOI 10.1109/TPWRS.2004.826018; Pai M.A., 1989, ENERGY FUNCTION ANAL; Parpinelli RS, 2002, IEEE T EVOLUT COMPUT, V6, P321, DOI 10.1109/TEVC.2002.802452; Phadke AG, 2008, POWER ELECTRON POWER, P3, DOI 10.1007/978-0-387-76537-2_1; Rodriguez JJ, 2006, IEEE T PATTERN ANAL, V28, P1619, DOI 10.1109/TPAMI.2006.211; Sun K, 2007, IEEE T POWER SYST, V22, P1935, DOI 10.1109/TPWRS.2007.908476; Taylor CW, 2005, P IEEE, V93, P892, DOI 10.1109/JPROC.2005.846338; Terzija V, 2011, P IEEE, V99, P80, DOI 10.1109/JPROC.2010.2060450; Wehenkel L, 1997, IEEE EXPERT, V12, P60, DOI 10.1109/64.621229; Wolpert D. H., 1997, IEEE Transactions on Evolutionary Computation, V1, P67, DOI 10.1109/4235.585893; Xu Y, 2012, IEEE T POWER SYST, V27, P1253, DOI 10.1109/TPWRS.2012.2183899; XUE Y, 1992, IEEE T POWER SYST, V7, P1012, DOI 10.1109/59.207314; Zhang R, 2007, IEEE ACM T COMPUT BI, V4, P185; Zhou ZH, 2003, AI COMMUN, V16, P3	28	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2015	10	6							e0130779	10.1371/journal.pone.0130779	http://dx.doi.org/10.1371/journal.pone.0130779			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL3FE	26091110	Green Published, gold, Green Submitted			2022-12-26	WOS:000356835000151
J	Macerollo, A; Chen, JC; Parees, I; Kassavetis, P; Kilner, JM; Edwards, MJ				Macerollo, Antonella; Chen, Jui-Cheng; Parees, Isabel; Kassavetis, Panagiotis; Kilner, James Morvan; Edwards, Mark John			Sensory Attenuation Assessed by Sensory Evoked Potentials in Functional Movement Disorders	PLOS ONE			English	Article							PERCEPTION; STIMULI	Background Functional ( psychogenic) movement disorders ( FMD) have features associated with voluntary movement (e.g. distractibility) but patients report movements to be out of their control. One explanation for this phenomenon is that sense of agency for movement is impaired. The phenomenon of reduction in the intensity of sensory experience when movement is self-generated and a reduction in sensory evoked potentials (SEPs) amplitude at the onset of self-paced movement (sensory attenuation) have been linked to sense of agency for movement. Methods We compared amplitude of SEPs from median nerve stimulation at rest and at the onset of a self-paced movement of the thumb in 17 patients with FMD and 17 healthy controls. Results Patients showed lack of attenuation of SEPs at the onset of movement compared to reduction in amplitude of SEPs in controls. FMD patients had significantly different ratios of movement onset to rest SEPs than did healthy controls at each electrode: 0.79 in healthy controls and 1.35 in patients at F3 (t = -4.22, p<0.001), 0.78 in healthy controls and 1.12 at patients C3 (t = -3.15, p = 0.004) and 0.77 in healthy controls and 1.05 at patients P3 (t = -2.88, p = 0.007). Conclusions Patients with FMD have reduced sensory attenuation as measured by SEPs at onset of self-paced movement. This finding can be plausibly linked to impairment of sense of agency for movement in these patients.	[Macerollo, Antonella; Chen, Jui-Cheng; Parees, Isabel; Kassavetis, Panagiotis; Kilner, James Morvan; Edwards, Mark John] UCL, Inst Neurol, Natl Hosp Neurol & Neurosurg, Sobell Dept Motor Neurosci & Movement Disorders, London, England; [Macerollo, Antonella] Aldo Moro Univ Bari, Dept Neurosci & Sense Organs, Bari, Italy	University of London; University College London; UCL Medical School; University College London Hospitals NHS Foundation Trust; Universita degli Studi di Bari Aldo Moro	Edwards, MJ (corresponding author), UCL, Inst Neurol, Natl Hosp Neurol & Neurosurg, Sobell Dept Motor Neurosci & Movement Disorders, London, England.	m.j.edwards@ucl.ac.uk	Edwards, Mark J/F-1052-2012	Edwards, Mark J/0000-0002-8283-9015; Martins-Filho, Olindo Assis/0000-0002-5494-4889; Sobreira Silva Araujo, Marcio/0000-0002-7532-3360; Kilner, James/0000-0002-6632-6797	Teva pharmaceuticals	Teva pharmaceuticals(Teva Pharmaceutical Industries)	M.J. Edwards received funding for conference travel from Teva pharmaceuticals and Orion. M.J. Edwards received Royalties from Oxford University Press for book: Oxford Specialist Handbook of Parkinson's Disease and Other Movement Disorders. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Blakemore SJ, 1998, NAT NEUROSCI, V1, P635, DOI 10.1038/2870; Blakemore SJ, 2000, NEUROREPORT, V11, pR11, DOI 10.1097/00001756-200008030-00002; Blakemore SJ, 1999, J COGNITIVE NEUROSCI, V11, P551, DOI 10.1162/089892999563607; CHAPMAN CE, 1987, EXP BRAIN RES, V68, P516; Fahn S, 1988, Adv Neurol, V50, P431; Hughes G, 2011, NEUROIMAGE, V56, P1632, DOI 10.1016/j.neuroimage.2011.02.057; MILNE RJ, 1988, EXP BRAIN RES, V70, P569; Parees I, 2014, BRAIN, V137, P2916, DOI 10.1093/brain/awu237; RUSHTON DN, 1981, BRAIN, V104, P465, DOI 10.1093/brain/104.3.465; Shergill SS, 2003, SCIENCE, V301, P187, DOI 10.1126/science.1085327; Shergill SS, 2005, AM J PSYCHIAT, V162, P2384, DOI 10.1176/appi.ajp.162.12.2384; Stone J, 2010, CLIN NEUROL NEUROSUR, V112, P747, DOI 10.1016/j.clineuro.2010.05.011; Voss M, 2006, NAT NEUROSCI, V9, P26, DOI 10.1038/nn1592; WEISKRANTZ L, 1971, NATURE, V230, P598, DOI 10.1038/230598a0	14	24	24	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2015	10	6							e0129507	10.1371/journal.pone.0129507	http://dx.doi.org/10.1371/journal.pone.0129507			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL3FE	26091500	Green Published, gold, Green Accepted			2022-12-26	WOS:000356835000048
J	Rocheleau, AD; Sumagin, R; Sarelius, IH; King, MR				Rocheleau, Anne D.; Sumagin, Ronen; Sarelius, Ingrid H.; King, Michael R.			Simulation and Analysis of Tethering Behavior of Neutrophils with Pseudopods	PLOS ONE			English	Article							MULTIPARTICLE ADHESIVE DYNAMICS; FLUID SHEAR RESPONSE; CELL-ADHESION; ROLLING LEUKOCYTES; HYDRODYNAMIC COLLISIONS; STATE DIAGRAM; L-SELECTIN; FLOW; DEFORMATION; INFLAMMATION	P-selectin and P-selectin glycoprotein ligand-1 (PSGL-1) play important roles in mediating the inflammatory cascade. Selectin kinetics, together with neutrophil hydrodynamics, regulate the fundamental adhesion cascade of cell tethering and rolling on the endothelium. The current study uses the Multiscale Adhesive Dynamics computational model to simulate, for the first time, the tethering and rolling behavior of pseudopod-containing neutrophils as mediated by P-selectin/PSGL-1 bonds. This paper looks at the effect of including P-selectin/ PSGL-1 adhesion kinetics. The parameters examined included the shear rate, adhesion on-rate, initial neutrophil position, and receptor number sensitivity. The outcomes analyzed included types of adhesive behavior observed, tether rolling distance and time, number of bonds formed during an adhesive event, contact area, and contact time. In contrast to the hydrodynamic model, P-selectin/PSGL-1 binding slows the neutrophil's translation in the direction of flow and causes the neutrophil to swing around perpendicular to flow. Several behaviors were observed during the simulations, including tethering without firm adhesion, tethering with downstream firm adhesion, and firm adhesion upon first contact with the endothelium. These behaviors were qualitatively consistent with in vivo data of murine neutrophils with pseudopods. In the simulations, increasing shear rate, receptor count, and bond formation rate increased the incidence of firm adhesion upon first contact with the endothelium. Tethering was conserved across a range of physiological shear rates and was resistant to fluctuations in the number of surface PSGL-1 molecules. In simulations where bonding occurred, interaction with the side of the pseudopod, rather than the tip, afforded more surface area and greater contact time with the endothelial wall.	[Rocheleau, Anne D.; King, Michael R.] Cornell Univ, Dept Biomed Engn, Ithaca, NY 14850 USA; [Sumagin, Ronen] Northwestern Univ, Dept Pathol, Feinberg Sch Med, Chicago, IL 60611 USA; [Sarelius, Ingrid H.] Univ Rochester, Med Ctr, Dept Physiol & Pharmacol, Rochester, NY 14642 USA	Cornell University; Northwestern University; Feinberg School of Medicine; University of Rochester	King, MR (corresponding author), Cornell Univ, Dept Biomed Engn, Ithaca, NY 14850 USA.	mike.king@cornell.edu			National Institutes of Health [HL018208]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL018208] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was funded by the National Institutes of Health, grant number HL018208 to MRK.	Alon R, 1997, J CELL BIOL, V138, P1169, DOI 10.1083/jcb.138.5.1169; Barreiro O, 2007, IMMUNOL REV, V218, P147, DOI 10.1111/j.1600-065X.2007.00529.x; BELL GI, 1984, BIOPHYS J, V45, P1051, DOI 10.1016/S0006-3495(84)84252-6; BELL GI, 1978, SCIENCE, V200, P618, DOI 10.1126/science.347575; Beste MT, 2008, P NATL ACAD SCI USA, V105, P20716, DOI 10.1073/pnas.0808213105; Bhatia SK, 2003, BIOPHYS J, V84, P2671, DOI 10.1016/S0006-3495(03)75073-5; Cai HQ, 2011, SEMIN CELL DEV BIOL, V22, P834, DOI 10.1016/j.semcdb.2011.07.020; Caputo KE, 2005, BIOPHYS J, V89, P187, DOI 10.1529/biophysj.104.054171; Chang KC, 2000, BIOPHYS J, V79, P1891, DOI 10.1016/S0006-3495(00)76439-3; Chang KC, 2000, P NATL ACAD SCI USA, V97, P11262, DOI 10.1073/pnas.200240897; Coughlin MF, 2004, BIOPHYS J, V87, P2035, DOI 10.1529/biophysj.104.042192; Dong C, 1999, ANN BIOMED ENG, V27, P298, DOI 10.1114/1.143; Dong C, 2000, J BIOMECH, V33, P35, DOI 10.1016/S0021-9290(99)00174-8; Evans E, 2004, P NATL ACAD SCI USA, V101, P11281, DOI 10.1073/pnas.0401870101; Fukuda S, 2004, J LEUKOCYTE BIOL, V75, P664, DOI 10.1189/jlb.1003464; Fukuda S, 2002, J LEUKOCYTE BIOL, V72, P133; Insall RH, 2010, NAT REV MOL CELL BIO, V11, P453, DOI 10.1038/nrm2905; Jadhav S, 2005, BIOPHYS J, V88, P96, DOI 10.1529/biophysj.104.051029; Khismatullin DB, 2004, MICROVASC RES, V68, P188, DOI 10.1016/j.mvr.2004.07.003; King MR, 2005, MATH BIOSCI, V194, P71, DOI 10.1016/j.mbs.2004.12.008; King MR, 2005, BIOPHYS J, V88, P1676, DOI 10.1529/biophysj.104.051805; King MR, 2001, P NATL ACAD SCI USA, V98, P14919, DOI 10.1073/pnas.261272498; King MR, 2001, LANGMUIR, V17, P4139, DOI 10.1021/la010234b; King MR, 2001, BIOPHYS J, V81, P799, DOI 10.1016/S0006-3495(01)75742-6; Kolaczkowska E, 2013, NAT REV IMMUNOL, V13, P159, DOI 10.1038/nri3399; Lei X, 1999, J BIOMECH ENG-T ASME, V121, P636, DOI 10.1115/1.2800866; Ley K, 2003, TRENDS MOL MED, V9, P263, DOI 10.1016/S1471-4914(03)00071-6; McEver RP, 2010, ANNU REV CELL DEV BI, V26, P363, DOI 10.1146/annurev.cellbio.042308.113238; Mitchell MJ, 2012, BIOPHYS J, V102, P1804, DOI 10.1016/j.bpj.2012.03.053; Mody NA, 2005, PHYS FLUIDS, V17, DOI 10.1063/1.2126937; Mody NA, 2008, BIOPHYS J, V95, P2556, DOI [10.1529/biophysj.107.128520, 10.1529/biophysj.107.12X520]; Mody NA, 2008, BIOPHYS J, V95, P2539, DOI 10.1529/biophysj.107.127670; N'Dri NA, 2003, BIOPHYS J, V85, P2273, DOI 10.1016/S0006-3495(03)74652-9; Pospieszalska MK, 2009, CELL MOL BIOENG, V2, P207, DOI 10.1007/s12195-009-0063-9; Sabri S, 2000, J CELL SCI, V113, P1589; Schmid-Schonbein GW, 2006, ANNU REV BIOMED ENG, V8, P93, DOI 10.1146/annurev.bioeng.8.061505.095708; Smith MJ, 1999, BIOPHYS J, V77, P3371, DOI 10.1016/S0006-3495(99)77169-9; Somers WS, 2000, CELL, V103, P467, DOI 10.1016/S0092-8674(00)00138-0; Sumagin R, 2010, J IMMUNOL, V185, P7057, DOI 10.4049/jimmunol.1001638; Sundd P, 2011, BIORHEOLOGY, V48, P1, DOI 10.3233/BIR-2011-0579; Wang WW, 2013, J COMPUT PHYS, V244, P223, DOI 10.1016/j.jcp.2012.08.014; Wautier JL, 1999, CLIN HEMORHEOL MICRO, V21, P7; Yumura S, 2013, BIOL OPEN, V2, P200, DOI 10.1242/bio.20122899; Zhao YH, 2001, BIOPHYS J, V80, P1124, DOI 10.1016/S0006-3495(01)76090-0	44	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2015	10	6							e0128378	10.1371/journal.pone.0128378	http://dx.doi.org/10.1371/journal.pone.0128378			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL3FE	26091091	Green Submitted, Green Published, gold			2022-12-26	WOS:000356835000018
J	Vargas, S; Kelly, M; Schnabel, K; Mills, S; Bowden, D; Worheide, G				Vargas, Sergio; Kelly, Michelle; Schnabel, Kareen; Mills, Sadie; Bowden, David; Woerheide, Gert			Diversity in a Cold Hot-Spot: DNA-Barcoding Reveals Patterns of Evolution among Antarctic Demosponges (Class Demospongiae, Phylum Porifera)	PLOS ONE			English	Article							SEROLID ISOPODS CRUSTACEA; MARINE BENTHIC DIVERSITY; SEQUENCE ALIGNMENT; PHYLOGENY; HEXACTINELLIDS; BIODIVERSITY; SPECIATION; DYNAMICS; SPONGES; WEDDELL	Background The approximately 350 demosponge species that have been described from Antarctica represent a faunistic component distinct from that of neighboring regions. Sponges provide structure to the Antarctic benthos and refuge to other invertebrates, and can be dominant in some communities. Despite the importance of sponges in the Antarctic subtidal environment, sponge DNA barcodes are scarce but can provide insight into the evolutionary relationships of this unique biogeographic province. Methodology/Principal Findings We sequenced the standard barcoding COI region for a comprehensive selection of sponges collected during expeditions to the Ross Sea region in 2004 and 2008, and produced DNA-barcodes for 53 demosponge species covering about 60% of the species collected. The Antarctic sponge communities are phylogenetically diverse, matching the diversity of well-sampled sponge communities in the Lusitanic and Mediterranean marine provinces in the Temperate Northern Atlantic for which molecular data are readily available. Additionally, DNA-barcoding revealed levels of in situ molecular evolution comparable to those present among Caribbean sponges. DNA-barcoding using the Segregating Sites Algorithm correctly assigned approximately 54% of the barcoded species to the morphologically determined species. Conclusion/Significance A barcode library for Antarctic sponges was assembled and used to advance the systematic and evolutionary research of Antarctic sponges. We provide insights on the evolutionary forces shaping Antarctica's diverse sponge communities, and a barcode library against which future sequence data from other regions or depth strata of Antarctica can be compared. The opportunity for rapid taxonomic identification of sponge collections for ecological research is now at the horizon.	[Vargas, Sergio; Woerheide, Gert] Univ Munich, Dept Earth & Environm Sci Palaeontol & Geobiol, D-80333 Munich, Germany; [Kelly, Michelle] Natl Ctr Coasts & Oceans, Natl Inst Water & Atmospher Res, Auckland 1149, New Zealand; [Schnabel, Kareen; Mills, Sadie; Bowden, David] Natl Ctr Coasts & Oceans, Natl Inst Water & Atmospher Res, Wellington, New Zealand; [Woerheide, Gert] GeoBio Ctr LMU, D-80333 Munich, Germany; [Woerheide, Gert] Bavarian State Collect Palaeontol & Geol, D-80333 Munich, Germany	University of Munich; National Institute of Water & Atmospheric Research (NIWA) - New Zealand; National Institute of Water & Atmospheric Research (NIWA) - New Zealand; University of Munich	Worheide, G (corresponding author), Univ Munich, Dept Earth & Environm Sci Palaeontol & Geobiol, Richard Wagner Str 10, D-80333 Munich, Germany.	woerheide@lmu.de	Wörheide, Gert/C-1080-2008; Vargas, Sergio/A-5678-2011	Wörheide, Gert/0000-0002-6380-7421; Schnabel, Kareen/0000-0002-9965-9010; Vargas, Sergio/0000-0001-8704-1339; Mills, Victoria/0000-0002-8122-0456	Deutsche Forschungsgemeinschaft (DFG) [Wo896/9-1,2, SPP 1158]; New Zealand Government through Ministry of Primary Industries [IPY2007-01]; Ministry of Business, Innovation Employment [CO1X1226]; Ministry of Primary Industries Science Team [IPY2007-01]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); New Zealand Government through Ministry of Primary Industries; Ministry of Business, Innovation Employment(New Zealand Ministry of Business, Innovation and Employment (MBIE)); Ministry of Primary Industries Science Team	This research was funded Deutsche Forschungsgemeinschaft (DFG) through the SPP 1158 "Antarktisforschung", grants Wo896/9-1,2 to G. Worheide and by the New Zealand Government through Ministry of Primary Industries project IPY2007-01 (The New Zealand International Polar Year-Census of Antarctic Marine Life Project; IPY-CAML), and Ministry of Business, Innovation & Employment project CO1X1226 (Ross Sea Climate and Ecosystems). The authors gratefully acknowledge project governance during IPY2007-01 by the Ministry of Primary Industries Science Team and the Ocean Survey 20/20 CAML Advisory Group. The funders had no role in study design, data compilation, analysis, decision to publish, or preparation of the manuscript.	BARTHEL D, 1992, OPHELIA, V36, P111, DOI 10.1080/00785326.1992.10430362; Barthel D, 1997, POLAR BIOL, V17, P91, DOI 10.1007/s003000050110; Barthel D, 1992, VERHANLUNGEN DTSCH Z, V85, P271; Benson DA, 2011, NUCLEIC ACIDS RES, V39, pD32, DOI [10.1093/nar/gkw1070, 10.1093/nar/gks1195, 10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkx1094, 10.1093/nar/gkn723, 10.1093/nar/gkp1024, 10.1093/nar/gkr1202]; Brandao SN, 2010, MOL PHYLOGENET EVOL, V55, P1055, DOI 10.1016/j.ympev.2010.01.014; Brandt A, 2007, PHILOS T R SOC B, V362, P39, DOI 10.1098/rstb.2006.1952; Brown JM, 2010, SYST BIOL, V59, P145, DOI 10.1093/sysbio/syp081; CLARKE A, 1992, PHILOS T ROY SOC B, V338, P299, DOI 10.1098/rstb.1992.0150; Clarke A, 2010, PHILOS T R SOC B, V365, P3655, DOI 10.1098/rstb.2010.0270; Clarke A, 2008, J EXP MAR BIOL ECOL, V366, P48, DOI 10.1016/j.jembe.2008.07.008; de Laubenfels MW, 1936, PAP TORTUGAS LAB, V30, P245; Desqueyroux-Faundez R., 2002, SYSTEMA PORIFERA GUI, V1, P893, DOI DOI 10.1007/978-1-4615-0747-5_94; DESQUEYROUXFAUN.R, 2002, SYSTEMA PORIFERA GUI, P874; Downey RV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041672; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Erpenbeck D, 2007, J MAR BIOL ASSOC UK, V87, P1; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Grant RA, 2009, POLAR BIOL, V32, P1629, DOI 10.1007/s00300-009-0662-x; Gutt J, 1998, ANTARCT SCI, V10, P398, DOI 10.1017/S0954102098000480; Gutt J, 1998, POLAR BIOL, V20, P229, DOI 10.1007/s003000050300; Gutt J, 2007, ANTARCT SCI, V19, P165, DOI 10.1017/S0954102007000247; Hanchet S, 2008, WLG200874 NIWA; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Held C, 2000, MOL PHYLOGENET EVOL, V15, P165, DOI 10.1006/mpev.1999.0739; Held C, 2001, POLAR BIOL, V24, P497, DOI 10.1007/s003000100245; Held C, 2005, SCI MAR; Ivanova NV, 2006, MOL ECOL NOTES, V6, P998, DOI 10.1111/j.1471-8286.2006.01428.x; Kress WJ, 2005, P NATL ACAD SCI USA, V102, P8369, DOI 10.1073/pnas.0503123102; Lawver LA, 2003, PALAEOGEOGR PALAEOCL, V198, P11, DOI 10.1016/S0031-0182(03)00392-4; Lewis LA, 2005, SYST BIOL, V54, P936, DOI 10.1080/10635150500354852; Linse K, 2007, POLAR BIOL, V30, P1059, DOI 10.1007/s00300-007-0265-3; Lou M, 2010, MOL PHYLOGENET EVOL, V56, P187, DOI 10.1016/j.ympev.2010.01.002; McClintock JB, 2005, INTEGR COMP BIOL, V45, P359, DOI 10.1093/icb/45.2.359; Meyer CP, 2005, EVOLUTION, V59, P113, DOI 10.1111/j.0014-3820.2005.tb00899.x; Mitchell J, 2004, WLG200419 NIWA; O'loughlin PM, 2010, DEEP SEA RES 2, P1; Page MJ, 2002, ZBD200002 NIWA MIN F; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; SANDERS HL, 1968, AM NAT, V102, P243, DOI 10.1086/282541; SARA M, 1992, POLAR BIOL, V12, P559; Schiaparelli S, 2003, POLAR BIOL, V26, P342, DOI 10.1007/s00300-003-0481-4; SIMBERLOFF D, 1972, AM NAT, V106, P414, DOI 10.1086/282781; Spalding MD, 2007, BIOSCIENCE, V57, P573, DOI 10.1641/B570707; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Szitenberg A, 2013, MOL PHYLOGENET EVOL, V67, P509, DOI 10.1016/j.ympev.2013.02.018; Van Soest RWM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035105; Vargas S, 2013, ZOOL SCR, V42, P106, DOI 10.1111/j.1463-6409.2012.00560.x; Vargas S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039345	49	17	18	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2015	10	6							e0127573	10.1371/journal.pone.0127573	http://dx.doi.org/10.1371/journal.pone.0127573			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL3FE	26091103	Green Published, Green Submitted, gold			2022-12-26	WOS:000356835000011
J	Dueholm, MS; Larsen, P; Finster, K; Stenvang, MR; Christiansen, G; Vad, BS; Boggild, A; Otzen, DE; Nielsen, PH				Dueholm, Morten S.; Larsen, Poul; Finster, Kai; Stenvang, Marcel R.; Christiansen, Gunna; Vad, Brian S.; Boggild, Andreas; Otzen, Daniel E.; Nielsen, Per Halkjaer			The Tubular Sheaths Encasing Methanosaeta thermophila Filaments Are Functional Amyloids	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							METHANOSPIRILLUM-HUNGATEI GP1; GAS VESICLES; STREPTOMYCES-COELICOLOR; SULFOLOBUS-SOLFATARICUS; SALMONELLA-ENTERITIDIS; AGGREGATIVE FIMBRIAE; RODLET LAYER; CELL-WALL; FIBRILS; PROTEIN	Archaea are renowned for their ability to thrive in extreme environments, although they can be found in virtually all habitats. Their adaptive success is linked to their unique cell envelopes that are extremely resistant to chemical and thermal denaturation and that resist proteolysis by common proteases. Here we employ amyloid-specific conformation antibodies and biophysical techniques to show that the extracellular cell wall sheaths encasing the methanogenic archaea Methanosaeta thermophila PT are functional amyloids. Depolymerization of sheaths and subsequent MS/MS analyses revealed that the sheaths are composed of a single major sheath protein (MspA). The amyloidogenic nature of MspA was confirmed by in vitro amyloid formation of recombinant MspA under a wide range of environmental conditions. This is the first report of a functional amyloid from the archaeal domain of life. The amyloid nature explains the extreme resistance of the sheath, the elastic properties that allow diffusible substrates to penetrate through expandable hoop boundaries, and how the sheaths are able to split and elongate outside the cell. The archaeal sheath amyloids do not share homology with any of the currently known functional amyloids and clearly represent a new function of the amyloid protein fold.	[Dueholm, Morten S.; Larsen, Poul; Nielsen, Per Halkjaer] Aalborg Univ, Dept Chem & Biosci, Ctr Microbial Communities, DK-9220 Aalborg, Denmark; [Finster, Kai] Aarhus Univ, Dept Biosci, DK-8000 Aarhus, Denmark; [Stenvang, Marcel R.; Vad, Brian S.; Otzen, Daniel E.] Aarhus Univ, Interdisciplinary Nanosci Ctr iNANO, DK-8000 Aarhus, Denmark; [Stenvang, Marcel R.; Vad, Brian S.; Otzen, Daniel E.] Aarhus Univ, Ctr Insoluble Prot Struct InSPIN, DK-8000 Aarhus, Denmark; [Stenvang, Marcel R.; Vad, Brian S.; Boggild, Andreas; Otzen, Daniel E.] Aarhus Univ, Dept Mol Biol & Genet, DK-8000 Aarhus, Denmark; [Christiansen, Gunna] Aarhus Univ, Dept Biomed, DK-8000 Aarhus, Denmark	Aalborg University; Aarhus University; Aarhus University; Aarhus University; Aarhus University; Aarhus University	Nielsen, PH (corresponding author), Aalborg Univ, Dept Chem & Biosci, Fredriks Bajers Vej 7H, DK-9220 Aalborg, Denmark.	phn@bio.aau.dk	Bøggild, Andreas/J-4763-2013; Nielsen, Per Halkjær/T-6796-2018; Dueholm, Morten Simonsen/T-6718-2018; Finster, Kai W/I-7475-2013	Bøggild, Andreas/0000-0003-2130-3521; Nielsen, Per Halkjær/0000-0002-6402-1877; Dueholm, Morten Simonsen/0000-0003-4135-2670; Finster, Kai W/0000-0002-9132-5542; Christiansen, Gunna/0000-0003-0540-1367	Villum Foundation; Innovation Fund Denmark; Sino-Danish Centre for Education and Research	Villum Foundation(Villum Fonden); Innovation Fund Denmark; Sino-Danish Centre for Education and Research	This work was supported in part by funds from the Villum Foundation and Innovation Fund Denmark (to M. S. D.) and is in part supported by the Sino-Danish Centre for Education and Research (to M. R. S.). The authors declare that they have no conflicts of interest with the contents of this article.	Albers SV, 2011, NAT REV MICROBIOL, V9, P414, DOI 10.1038/nrmicro2576; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Ban T, 2003, J BIOL CHEM, V278, P16462, DOI 10.1074/jbc.C300049200; Bayro MJ, 2012, J BIOL CHEM, V287, P3479, DOI 10.1074/jbc.M111.313049; Bayry J, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002700; Bemporad F, 2009, FEBS LETT, V583, P2630, DOI 10.1016/j.febslet.2009.07.013; BEVERIDGE TJ, 1985, J BACTERIOL, V162, P728, DOI 10.1128/JB.162.2.728-737.1985; BEVERIDGE TJ, 1987, CAN J MICROBIOL, V33, P725, DOI 10.1139/m87-126; Blanco LP, 2012, TRENDS MICROBIOL, V20, P66, DOI 10.1016/j.tim.2011.11.005; Cavicchioli R, 2011, NAT REV MICROBIOL, V9, P51, DOI 10.1038/nrmicro2482; Chapman MR, 2002, SCIENCE, V295, P851, DOI 10.1126/science.1067484; Chimileski S, 2014, BMC BIOL, V12, DOI 10.1186/s12915-014-0065-5; Claessen D, 2004, MOL MICROBIOL, V53, P433, DOI 10.1111/j.1365-2958.2004.04143.x; Claessen D, 2003, GENE DEV, V17, P1714, DOI 10.1101/gad.264303; COLLINSON SK, 1991, J BACTERIOL, V173, P4773, DOI 10.1128/jb.173.15.4773-4781.1991; Dueholm M. S., 2013, FUNCTIONAL AMYLOIDS, P411; Dueholm MS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076630; Dueholm MS, 2013, MICROBIOLOGYOPEN, V2, P365, DOI 10.1002/mbo3.81; Dueholm MS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051274; Dueholm MS, 2011, BIOCHEMISTRY-US, V50, P8281, DOI 10.1021/bi200967c; Dueholm MS, 2010, MOL MICROBIOL, V77, P1009, DOI 10.1111/j.1365-2958.2010.07269.x; Elliot MA, 2003, GENE DEV, V17, P1727, DOI 10.1101/gad.264403; Ezzeldin HM, 2012, J STRUCT BIOL, V179, P18, DOI 10.1016/j.jsb.2012.04.015; Fandrich M, 2007, CELL MOL LIFE SCI, V64, P2066, DOI 10.1007/s00018-007-7110-2; Fandrich M, 2003, P NATL ACAD SCI USA, V100, P15463, DOI 10.1073/pnas.0303758100; FIRTEL M, 1993, J BACTERIOL, V175, P7550, DOI 10.1128/JB.175.23.7550-7560.1993; Fowler DM, 2006, PLOS BIOL, V4, P100, DOI 10.1371/journal.pbio.0040006; Goldsbury C, 2011, J STRUCT BIOL, V173, P1, DOI 10.1016/j.jsb.2010.09.018; Hedderich R, 2013, PROKARYOTES, P635; Heger A, 2000, PROTEINS, V41, P224, DOI 10.1002/1097-0134(20001101)41:2<224::AID-PROT70>3.0.CO;2-Z; Ishihama Y, 2005, MOL CELL PROTEOMICS, V4, P1265, DOI 10.1074/mcp.M500061-MCP200; Jahn TR, 2006, NAT STRUCT MOL BIOL, V13, P195, DOI 10.1038/nsmb1058; Jordal PB, 2009, APPL ENVIRON MICROB, V75, P4101, DOI 10.1128/AEM.02107-08; KAMAGATA Y, 1992, INT J SYST BACTERIOL, V42, P463, DOI 10.1099/00207713-42-3-463; Larsen P, 2008, APPL ENVIRON MICROB, V74, P1517, DOI 10.1128/AEM.02274-07; Larsen P, 2007, ENVIRON MICROBIOL, V9, P3077, DOI 10.1111/j.1462-2920.2007.01418.x; Liu YC, 2008, ANN NY ACAD SCI, V1125, P171, DOI 10.1196/annals.1419.019; Lorenzen N, 2014, FEBS LETT, V588, P497, DOI 10.1016/j.febslet.2013.12.015; Maji SK, 2009, SCIENCE, V325, P328, DOI 10.1126/science.1173155; McGlinchey RP, 2009, P NATL ACAD SCI USA, V106, P13731, DOI 10.1073/pnas.0906509106; Miles AJ, 2006, CHEM SOC REV, V35, P39, DOI 10.1039/b316168b; O'Nuallain B, 2002, P NATL ACAD SCI USA, V99, P1485, DOI 10.1073/pnas.022662599; Pagano K, 2010, J BIOL CHEM, V285, P14689, DOI 10.1074/jbc.M109.082156; PATEL GB, 1986, CAN J MICROBIOL, V32, P623, DOI 10.1139/m86-117; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Pfeifer F, 2012, NAT REV MICROBIOL, V10, P705, DOI 10.1038/nrmicro2834; Plakoutsi G, 2004, J BIOL CHEM, V279, P14111, DOI 10.1074/jbc.M312961200; Romero D, 2010, P NATL ACAD SCI USA, V107, P2230, DOI 10.1073/pnas.0910560107; Sawyer EB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018839; SHAW PJ, 1985, J BACTERIOL, V161, P750, DOI 10.1128/JB.161.2.750-757.1985; Shewmaker F, 2009, J BIOL CHEM, V284, P25065, DOI 10.1074/jbc.M109.007054; Shokri MM, 2013, AMYLOID, V20, P226, DOI 10.3109/13506129.2013.830246; Smith KS, 2007, TRENDS MICROBIOL, V15, P150, DOI 10.1016/j.tim.2007.02.002; SOUTHAM G, 1992, J BACTERIOL, V174, P935, DOI 10.1128/jb.174.3.935-946.1992; SPROTT GD, 1986, CAN J MICROBIOL, V32, P847, DOI 10.1139/m86-156; SPROTT GD, 1980, CAN J MICROBIOL, V26, P115, DOI 10.1139/m80-017; STEWART M, 1985, J MOL BIOL, V183, P509, DOI 10.1016/0022-2836(85)90019-1; Sunde M, 1997, J MOL BIOL, V273, P729, DOI 10.1006/jmbi.1997.1348; Sunde M, 2008, MICRON, V39, P773, DOI 10.1016/j.micron.2007.08.003; Tian PF, 2015, J AM CHEM SOC, V137, P22, DOI 10.1021/ja5093634; Tsolis AC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054175; Van Melckebeke H, 2010, J AM CHEM SOC, V132, P13765, DOI [10.1021/ja104213J, 10.1021/ja104213j]; WALSBY AE, 1994, MICROBIOL REV, V58, P94, DOI 10.1128/MMBR.58.1.94-144.1994; Wasmer C, 2008, SCIENCE, V319, P1523, DOI 10.1126/science.1151839; Weiland P, 2010, APPL MICROBIOL BIOT, V85, P849, DOI 10.1007/s00253-009-2246-7; Welte C, 2011, J BACTERIOL, V193, P2868, DOI 10.1128/JB.00162-11; White AP, 2001, J MOL BIOL, V311, P735, DOI 10.1006/jmbi.2001.4876; Wickner RB, 2007, NAT REV MICROBIOL, V5, P611, DOI 10.1038/nrmicro1708; WOESE CR, 1990, P NATL ACAD SCI USA, V87, P4576, DOI 10.1073/pnas.87.12.4576; WOSTEN HAB, 1993, PLANT CELL, V5, P1567; Xu W, 1996, J BACTERIOL, V178, P3106, DOI 10.1128/jb.178.11.3106-3112.1996; Zandomeneghi G, 2004, PROTEIN SCI, V13, P3314, DOI 10.1110/ps.041024904; Zykwinska A, 2014, BBA-PROTEINS PROTEOM, V1844, P1231, DOI 10.1016/j.bbapap.2014.04.003	73	25	25	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 14	2015	290	33					20590	20600		10.1074/jbc.M115.654780	http://dx.doi.org/10.1074/jbc.M115.654780			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CP1AT	26109065	Green Published, hybrid			2022-12-26	WOS:000359608900054
J	Hiess, F; Vallmitjana, A; Wang, RW; Cheng, HQ; ter Keurs, HEDJ; Chen, J; Hove-Madsen, L; Benitez, R; Chen, SRW				Hiess, Florian; Vallmitjana, Alexander; Wang, Ruiwu; Cheng, Hongqiang; ter Keurs, Henk E. D. J.; Chen, Ju; Hove-Madsen, Leif; Benitez, Raul; Chen, S. R. Wayne			Distribution and Function of Cardiac Ryanodine Receptor Clusters in Live Ventricular Myocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CA2+ RELEASE SITES; CALCIUM TRANSIENTS; 3-DIMENSIONAL DISTRIBUTION; MITOCHONDRIAL CALCIUM; LOCAL-CONTROL; HEART; RAT; SPARKS; MODEL; ORGANIZATION	The cardiac Ca2+ release channel (ryanodine receptor, RyR2) plays an essential role in excitation-contraction coupling in cardiac muscle cells. Effective and stable excitation-contraction coupling critically depends not only on the expression of RyR2, but also on its distribution. Despite its importance, little is known about the distribution and organization of RyR2 in living cells. To study the distribution of RyR2 in living cardiomyocytes, we generated a knock-in mouse model expressing a GFP-tagged RyR2 (GFP-RyR2). Confocal imaging of live ventricular myocytes isolated from the GFP-RyR2 mouse heart revealed clusters of GFP-RyR2 organized in rows with a striated pattern. Similar organization of GFP-RyR2 clusters was observed in fixed ventricular myocytes. Immunofluorescence staining with the anti-alpha-actinin antibody (a z-line marker) showed that nearly all GFP-RyR2 clusters were localized in the z-line zone. There were small regions with dislocated GFP-RyR2 clusters. Interestingly, these same regions also displayed dislocated z-lines. Staining with di-8-ANEPPS revealed that nearly all GFP-RyR2 clusters were co-localized with transverse but not longitudinal tubules, whereas staining with MitoTracker Red showed that GFP-RyR2 clusters were not co-localized with mitochondria in live ventricular myocytes. We also found GFP-RyR2 clusters interspersed between z-lines only at the periphery of live ventricular myocytes. Simultaneous detection of GFP-RyR2 clusters and Ca2+ sparks showed that Ca2+ sparks originated exclusively from RyR2 clusters. Ca2+ sparks from RyR2 clusters induced no detectable changes in mitochondrial Ca2+ level. These results reveal, for the first time, the distribution of RyR2 clusters and its functional correlation in living ventricular myocytes.	[Hiess, Florian; Wang, Ruiwu; Chen, S. R. Wayne] Univ Calgary, Libin Cardiovasc Inst Alberta, Dept Physiol & Pharmacol, Calgary, AB T2N 1N4, Canada; [ter Keurs, Henk E. D. J.] Univ Calgary, Libin Cardiovasc Inst Alberta, Dept Cardiac Sci, Calgary, AB T2N 1N4, Canada; [Vallmitjana, Alexander; Benitez, Raul] Univ Politecn Cataluna, Dept Automat Control, ES-08034 Barcelona, Spain; [Cheng, Hongqiang; Chen, Ju] Univ Calif San Diego, Dept Med, La Jolla, CA 92161 USA; [Hove-Madsen, Leif] Hosp Santa Creu & Sant Pau, Cardiovasc Res Ctr CSIC ICCC, Barcelona 08025, Spain	Libin Cardiovascular Institute Of Alberta; University of Calgary; Libin Cardiovascular Institute Of Alberta; University of Calgary; Universitat Politecnica de Catalunya; University of California System; University of California San Diego; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Institut Catala de Ciencies Cardiovasculars (ICCC); Hospital of Santa Creu i Sant Pau	Chen, SRW (corresponding author), HRIC GAC58,3330 Hosp Dr NW, Calgary, AB T2N 1N4, Canada.	swchen@ucalgary.ca	Chen, Ju/E-5579-2011; Vallmitjana, Alexander/B-5058-2019; Benítez, Raúl/AGO-5018-2022	Vallmitjana, Alexander/0000-0002-7149-9385; Benítez, Raúl/0000-0002-8782-9406; Hove-Madsen, Leif/0000-0001-5493-3998	Natural Sciences and Engineering Research Council; Canadian Institutes of Health Research; Canada Foundation for Innovation; Heart and Stroke Foundation/Libin Professorship in Cardiovascular Research; Spanish Ministry of Science and Innovation [SAF2011-30312, CNIC-2009-08, DPI2013-44584-R]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL080101] Funding Source: NIH RePORTER	Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Heart and Stroke Foundation/Libin Professorship in Cardiovascular Research; Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by research grants from the Natural Sciences and Engineering Research Council, Canadian Institutes of Health Research, the Canada Foundation for Innovation, and the Heart and Stroke Foundation/Libin Professorship in Cardiovascular Research (to S. R. W. C.), and Spanish Ministry of Science and Innovation Grants SAF2011-30312; CNIC-2009-08 (to L. H. M.) and DPI2013-44584-R (to R. B.). The authors declare that they have no conflicts of interest with the contents of this article.	Asghari P, 2009, BIOPHYS J, V96, P4651, DOI 10.1016/j.bpj.2009.02.058; BASSANI JWM, 1995, AM J PHYSIOL-CELL PH, V268, pC1313, DOI 10.1152/ajpcell.1995.268.5.C1313; Bers DM, 2002, NATURE, V415, P198, DOI 10.1038/415198a; Bers DM, 2001, EXCITATION CONTRACTI; Cannell MB, 1997, BIOPHYS J, V73, P112, DOI 10.1016/S0006-3495(97)78052-4; CANNELL MB, 1995, SCIENCE, V268, P1045, DOI 10.1126/science.7754384; CARL SL, 1995, J CELL BIOL, V129, P673, DOI 10.1083/jcb.129.3.673; Chen-Izu Y, 2006, BIOPHYS J, V91, P1, DOI 10.1529/biophysj.105.077180; Cheng H, 1996, CELL CALCIUM, V20, P129, DOI 10.1016/S0143-4160(96)90102-5; CHENG H, 1993, SCIENCE, V262, P740, DOI 10.1126/science.8235594; Cheng HP, 2008, PHYSIOL REV, V88, P1491, DOI 10.1152/physrev.00030.2007; Cleemann L, 1998, P NATL ACAD SCI USA, V95, P10984, DOI 10.1073/pnas.95.18.10984; Cordeiro JM, 2001, J PHYSIOL-LONDON, V531, P301, DOI 10.1111/j.1469-7793.2001.0301i.x; Dan P, 2007, BIOPHYS J, V93, P2504, DOI 10.1529/biophysj.107.104943; Franzini-Armstrong C, 1999, BIOPHYS J, V77, P1528, DOI 10.1016/S0006-3495(99)77000-1; Griffiths EJ, 1999, BIOCHEM BIOPH RES CO, V263, P554, DOI 10.1006/bbrc.1999.1311; Griffiths EJ, 1997, AM J PHYSIOL-CELL PH, V273, pC37, DOI 10.1152/ajpcell.1997.273.1.C37; Hunt DJ, 2007, BIOCHEM J, V404, P431, DOI 10.1042/BJ20070135; Jayasinghe ID, 2010, J MOL CELL CARDIOL, V48, P964, DOI 10.1016/j.yjmcc.2009.12.012; Jayasinghe ID, 2009, BIOPHYS J, V97, P2664, DOI 10.1016/j.bpj.2009.08.036; Liu Z, 2004, J MOL BIOL, V338, P533, DOI 10.1016/j.jmb.2004.03.011; LOPEZLOPEZ JR, 1994, J PHYSIOL-LONDON, V480, P21, DOI 10.1113/jphysiol.1994.sp020337; LOPEZLOPEZ JR, 1995, SCIENCE, V268, P1042, DOI 10.1126/science.7754383; Lukyanenko V, 2007, J PHYSIOL-LONDON, V583, P251, DOI 10.1113/jphysiol.2007.136549; NIGGLI E, 1990, SCIENCE, V250, P565, DOI 10.1126/science.2173135; Parker I, 1996, J PHYSIOL-LONDON, V497, P31, DOI 10.1113/jphysiol.1996.sp021747; Scriven DRL, 2000, BIOPHYS J, V79, P2682, DOI 10.1016/S0006-3495(00)76506-4; Sedarat F, 2000, AM J PHYSIOL-HEART C, V279, pH202, DOI 10.1152/ajpheart.2000.279.1.H202; Smith GD, 1998, BIOPHYS J, V75, P15, DOI 10.1016/S0006-3495(98)77491-0; Sobie EA, 2002, BIOPHYS J, V83, P59, DOI 10.1016/S0006-3495(02)75149-7; Soeller C, 2007, P NATL ACAD SCI USA, V104, P14958, DOI 10.1073/pnas.0703016104; STERN MD, 1992, FASEB J, V6, P3092, DOI 10.1096/fasebj.6.12.1325933; Stern MD, 1997, J GEN PHYSIOL, V110, P415, DOI 10.1085/jgp.110.4.415; STERN MD, 1992, BIOPHYS J, V63, P497, DOI 10.1016/S0006-3495(92)81615-6; Subramanian S, 2001, BIOPHYS J, V80, P1, DOI 10.1016/S0006-3495(01)75991-7; Szalai G, 2000, J BIOL CHEM, V275, P15305, DOI 10.1074/jbc.275.20.15305; Trollinger DR, 1997, BIOCHEM BIOPH RES CO, V236, P738, DOI 10.1006/bbrc.1997.7042; WIER WG, 1994, J PHYSIOL-LONDON, V474, P463, DOI 10.1113/jphysiol.1994.sp020037	38	18	18	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 14	2015	290	33					20477	20487		10.1074/jbc.M115.650531	http://dx.doi.org/10.1074/jbc.M115.650531			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CP1AT	26109063	hybrid, Green Published			2022-12-26	WOS:000359608900045
J	Zhang, DD; Yan, HY; Li, H; Hao, SY; Zhuang, Z; Liu, M; Sun, Q; Yang, YQ; Zhou, ML; Li, KY; Hang, CH				Zhang, Dingding; Yan, Huiying; Li, Hua; Hao, Shuangying; Zhuang, Zong; Liu, Ming; Sun, Qing; Yang, Yiqing; Zhou, Mengliang; Li, Kuanyu; Hang, Chunhua			TGF beta-activated Kinase 1 (TAK1) Inhibition by 5Z-7-Oxozeaenol Attenuates Early Brain Injury after Experimental Subarachnoid Hemorrhage	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; SIGNALING PATHWAYS; LEARNING-DEFICITS; GROWTH; PHOSPHORYLATION; INFLAMMATION; MECHANISMS; EXPRESSION; VASOSPASM; PROTECTS	Accumulating evidence suggests that activation of mitogen-activated protein kinases (MAPKs) and nuclear factor NF-kappa B exacerbates early brain injury (EBI) following subarachnoid hemorrhage (SAH) by provoking proapoptotic and proinflammatory cellular signaling. Here we evaluate the role of TGF beta-activated kinase 1 (TAK1), a critical regulator of the NF-kappa B and MAPK pathways, in early brain injury following SAH. Although the expression level of TAK1 did not present significant alternation in the basal temporal lobe after SAH, the expression of phosphorylated TAK1 (Thr-187, p-TAK1) showed a substantial increase 24 h post-SAH. Intracerebroventricular injection of a selective TAK1 inhibitor (10 min post-SAH), 5Z-7-oxozeaenol (OZ), significantly reduced the levels of TAK1 and p-TAK1 at 24 h post-SAH. Involvement of MAPKs and NF-kappa B signaling pathways was revealed that OZ inhibited SAH-induced phosphorylation of p38 and JNK, the nuclear translocation of NF-kappa B p65, and degradation of I kappa B alpha. Furthermore, OZ administration diminished the SAH-induced apoptosis and EBI. As a result, neurological deficits caused by SAH were reversed. Our findings suggest that TAK1 inhibition confers marked neuroprotection against EBI following SAH. Therefore, TAK1 might be a promising new molecular target for the treatment of SAH.	[Zhang, Dingding; Yan, Huiying; Li, Hua; Zhuang, Zong; Sun, Qing; Yang, Yiqing; Zhou, Mengliang; Hang, Chunhua] Nanjing Univ, Sch Med, Jinling Hosp, Dept Neurosurg, Nanjing 210002, Jiangsu, Peoples R China; [Hao, Shuangying; Li, Kuanyu] Nanjing Univ, Jiangsu Key Lab Mol Med, Sch Med, Nanjing 210093, Jiangsu, Peoples R China; [Liu, Ming; Hang, Chunhua] Southern Med Univ Guangzhou, Sch Med, Jinling Hosp, Dept Neurosurg, Nanjing 210002, Jiangsu, Peoples R China	Nanjing University; Nanjing University; Southern Medical University - China	Li, KY (corresponding author), Nanjing Univ, Jiangsu Key Lab Mol Med, Sch Med, 22 Hankou Rd, Nanjing 210093, Jiangsu, Peoples R China.	likuanyu@nju.edu.cn; hang_neurosurgery@163.com	Li, Kuanyu/AAL-2051-2020	Zhou, Meng-liang/0000-0002-1165-5489; Li, Hua/0000-0001-5893-535X	National Natural Science Foundation [81371294, 31371060, 81400980]; Nature Science Foundation of the Jiangsu Province [BK2010459]; National Basic Research Program, China [2105CB856300]	National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Nature Science Foundation of the Jiangsu Province; National Basic Research Program, China(National Basic Research Program of China)	This work was supported by National Natural Science Foundation Grants 81371294, 31371060, and 81400980, Nature Science Foundation of the Jiangsu Province Grant BK2010459, and National Basic Research Program Grant 2105CB856300, China. The authors declare that they have no conflicts of interest with the contents of this article.	Ajibade AA, 2013, TRENDS IMMUNOL, V34, P307, DOI 10.1016/j.it.2013.03.007; Ajibade AA, 2012, IMMUNITY, V36, P43, DOI 10.1016/j.immuni.2011.12.010; Altay O, 2014, NEUROBIOL DIS, V62, P365, DOI 10.1016/j.nbd.2013.09.016; Cai PCH, 2014, ONCOTARGET, V5, P7549, DOI 10.18632/oncotarget.2273; Caner B, 2012, J NEUROCHEM, V123, P12, DOI 10.1111/j.1471-4159.2012.07939.x; Carr KR, 2013, NEUROL RES INT, V2013, DOI 10.1155/2013/506584; Chen G, 2013, NEUROSCIENCE, V231, P136, DOI 10.1016/j.neuroscience.2012.11.024; Chen S, 2013, NEUROBIOL DIS, V58, P296, DOI 10.1016/j.nbd.2013.06.011; Claassen J, 2002, STROKE, V33, P1225, DOI 10.1161/01.STR.0000015624.29071.1F; Denes A, 2010, BRAIN BEHAV IMMUN, V24, P708, DOI 10.1016/j.bbi.2009.09.010; Douglas MR, 2009, J NEUROL NEUROSUR PS, V80, P545, DOI 10.1136/jnnp.2008.155671; Flood C, 2001, J CEREBR BLOOD F MET, V21, P157, DOI 10.1097/00004647-200102000-00007; Fujii M, 2013, TRANSL STROKE RES, V4, P432, DOI 10.1007/s12975-013-0257-2; Fujii M, 2012, NEUROCHEM INT, V60, P327, DOI 10.1016/j.neuint.2011.12.014; Goldmann T, 2013, NAT NEUROSCI, V16, P1618, DOI 10.1038/nn.3531; Hasegawa Y, 2011, ACTA NEUROCHIR SUPPL, V110, P43, DOI 10.1007/978-3-7091-0353-1_8; Ireland DJ, 2015, MOL HUM REPROD, V21, P479, DOI 10.1093/molehr/gav005; Ivshina M, 2015, MOL CELL BIOL, V35, P610, DOI 10.1128/MCB.00800-14; Jeon H, 2010, NEUROSCIENCE, V169, P1805, DOI 10.1016/j.neuroscience.2010.06.039; Kooijman E, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-2; Kusaka G, 2004, J CEREBR BLOOD F MET, V24, P916, DOI 10.1097/01.WCB.0000125886.48838.7E; Napetschnig J, 2013, ANNU REV BIOPHYS, V42, P443, DOI 10.1146/annurev-biophys-083012-130338; Neubert M, 2011, CELL DEATH DIFFER, V18, P1521, DOI 10.1038/cdd.2011.29; Ninomiya-Tsuji J, 2003, J BIOL CHEM, V278, P18485, DOI 10.1074/jbc.M207453200; Provencio JJ, 2005, SEMIN NEUROL, V25, P435, DOI 10.1055/s-2005-923537; Ridder DA, 2013, EXP NEUROL, V239, P68, DOI 10.1016/j.expneurol.2012.09.010; Sabri M, 2008, BRAIN RES, V1238, P163, DOI 10.1016/j.brainres.2008.08.031; Sabri M, 2013, STROKE RES TREAT, V2013, DOI 10.1155/2013/394036; Sabri M, 2013, J CEREBR BLOOD F MET, V33, P1008, DOI 10.1038/jcbfm.2013.49; Sakurai H, 2000, FEBS LETT, V474, P141, DOI 10.1016/S0014-5793(00)01588-X; Sakurai H, 2012, TRENDS PHARMACOL SCI, V33, P522, DOI 10.1016/j.tips.2012.06.007; Sehba FA, 2012, PROG NEUROBIOL, V97, P14, DOI 10.1016/j.pneurobio.2012.02.003; Singhirunnusorn P, 2005, J BIOL CHEM, V280, P7359, DOI 10.1074/jbc.M407537200; Sozen T, 2009, STROKE, V40, P2519, DOI 10.1161/STROKEAHA.109.549592; Sun Q, 2013, BRAIN RES, V1520, P134, DOI 10.1016/j.brainres.2013.05.010; Wang Z, 2011, MEDIAT INFLAMM, V2011, DOI 10.1155/2011/848309; Wang Z, 2012, J PINEAL RES, V53, P129, DOI 10.1111/j.1600-079X.2012.00978.x; White BJ, 2012, EXP NEUROL, V237, P238, DOI 10.1016/j.expneurol.2012.05.019; Wu JQ, 2013, ACS CHEM BIOL, V8, P643, DOI 10.1021/cb3005897; Xu H, 2015, BRIT J PHARMACOL, V172, P2892, DOI 10.1111/bph.13094; YAMAGUCHI K, 1995, SCIENCE, V270, P2008, DOI 10.1126/science.270.5244.2008; Yamaguchi M, 2004, STROKE, V35, P1750, DOI 10.1161/01.STR.0000129898.68350.9f; You WC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060290; Yu Y, 2008, J BIOL CHEM, V283, P24497, DOI 10.1074/jbc.M802825200; Zhang D, 2013, NEUROSCIENCE, V238, P209, DOI 10.1016/j.neuroscience.2013.02.022	45	36	38	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 7	2015	290	32					19900	19909		10.1074/jbc.M115.636795	http://dx.doi.org/10.1074/jbc.M115.636795			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CO7TL	26100626	hybrid, Green Published			2022-12-26	WOS:000359364600045
J	Ramos-Molina, B; Lick, AN; Shirazi, AN; Oh, D; Tiwari, R; El-Sayed, NS; Parang, K; Lindberg, I				Ramos-Molina, Bruno; Lick, Adam N.; Shirazi, Amir Nasrolahi; Oh, Donghoon; Tiwari, Rakesh; El-Sayed, Naglaa Salem; Parang, Keykavous; Lindberg, Iris			Cationic Cell-Penetrating Peptides Are Potent Furin Inhibitors	PLOS ONE			English	Article							HUMAN IMMUNODEFICIENCY VIRUS; TAT-MEDIATED TRANSDUCTION; ARGININE-RICH PEPTIDES; PROPROTEIN CONVERTASES; IN-VIVO; MOLECULAR TRANSPORTERS; EFFICIENT DELIVERY; TUMOR PROGRESSION; CYCLIC-PEPTIDES; NUCLEIC-ACID	Cationic cell-penetrating peptides have been widely used to enhance the intracellular delivery of various types of cargoes, such as drugs and proteins. These reagents are chemically similar to the multi-basic peptides that are known to be potent proprotein convertase inhibitors. Here, we report that both HIV-1 TAT(47-57) peptide and the Chariot reagent are micromolar inhibitors of furin activity in vitro. In agreement, HIV-1 TAT(47-57) reduced HT1080 cell migration, thought to be mediated by proprotein convertases, by 25%. In addition, cyclic polyarginine peptides containing hydrophobic moieties which have been previously used as transfection reagents also exhibited potent furin inhibition in vitro and also inhibited intracellular convertases. Our finding that cationic cell-penetrating peptides exert potent effects on cellular convertase activity should be taken into account when biological effects are assessed.	[Ramos-Molina, Bruno; Lick, Adam N.; Lindberg, Iris] Univ Maryland, Dept Anat & Neurobiol, Sch Med, Baltimore, MD 21201 USA; [Shirazi, Amir Nasrolahi; Oh, Donghoon; Tiwari, Rakesh; El-Sayed, Naglaa Salem; Parang, Keykavous] Chapman Univ, Sch Pharm, Irvine, CA USA	University System of Maryland; University of Maryland Baltimore; Chapman University System; Chapman University	Lindberg, I (corresponding author), Univ Maryland, Dept Anat & Neurobiol, Sch Med, Baltimore, MD 21201 USA.	ilindberg@som.umaryland.edu	Parang, Keykavous/ABC-1584-2021; Lindberg, Iris/Q-3825-2019; Ramos-Molina, Bruno/L-7876-2015; Ramos-Molina, Bruno/K-8303-2019; Molina, Bruno Ramos/A-4574-2017	Parang, Keykavous/0000-0001-8600-0893; Ramos-Molina, Bruno/0000-0001-6804-5449; Molina, Bruno Ramos/0000-0001-6804-5449; aboud, naglaa/0000-0001-8687-2325	National Institutes of Health (NIH) R01 Grant [DA05084-27]; NATIONAL INSTITUTE ON DRUG ABUSE [R56DA005084, R01DA005084] Funding Source: NIH RePORTER	National Institutes of Health (NIH) R01 Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by the National Institutes of Health (NIH) R01 Grant DA05084-27 (IL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bassi DE, 2000, MOL CARCINOGEN, V28, P63, DOI 10.1002/1098-2744(200006)28:2<63::AID-MC1>3.3.CO;2-3; Becker GL, 2012, J BIOL CHEM, V287, P21992, DOI 10.1074/jbc.M111.332643; Bolhassani A, 2011, BBA-REV CANCER, V1816, P232, DOI 10.1016/j.bbcan.2011.07.006; Cameron A, 2000, J BIOL CHEM, V275, P36741, DOI 10.1074/jbc.M003848200; Coppola J, 2008, NEOPLASIA, V10, P363, DOI 10.1593/neo.08166; Coppola JM, 2007, ANAL BIOCHEM, V364, P19, DOI 10.1016/j.ab.2007.01.013; DEROSSI D, 1994, J BIOL CHEM, V269, P10444; Foerg C, 2008, J PHARM SCI-US, V97, P144, DOI 10.1002/jps.21117; FRANKEL AD, 1988, CELL, V55, P1189, DOI 10.1016/0092-8674(88)90263-2; Fugere M, 2007, MOL PHARMACOL, V71, P323, DOI 10.1124/mol.106.027946; Futaki S, 2001, BIOCONJUGATE CHEM, V12, P1005, DOI 10.1021/bc015508l; Futaki S, 2001, J BIOL CHEM, V276, P5836, DOI 10.1074/jbc.M007540200; Gagnon H, 2014, J MED CHEM, V57, P29, DOI 10.1021/jm400633d; GREEN M, 1988, CELL, V55, P1179, DOI 10.1016/0092-8674(88)90262-0; Gros E, 2006, BBA-BIOMEMBRANES, V1758, P384, DOI 10.1016/j.bbamem.2006.02.006; Joliot A, 2004, NAT CELL BIOL, V6, P189, DOI 10.1038/ncb0304-189; Kacprzak MM, 2004, J BIOL CHEM, V279, P36788, DOI 10.1074/jbc.M400484200; Khatib AM, 2002, AM J PATHOL, V160, P1921, DOI 10.1016/S0002-9440(10)61140-6; Khatib AM, 2001, J BIOL CHEM, V276, P30686, DOI 10.1074/jbc.M101725200; Levesque C, 2012, J MED CHEM, V55, P10501, DOI 10.1021/jm3011178; Liu BR, 2012, GENE, V505, P37, DOI 10.1016/j.gene.2012.05.053; Longuespee R, 2014, TRANSL ONCOL; Mandal D, 2011, ANGEW CHEM INT EDIT, V50, P9633, DOI 10.1002/anie.201102572; Mitchell DJ, 2000, J PEPT RES, V56, P318, DOI 10.1034/j.1399-3011.2000.00723.x; Moutal A, 2015, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00471; Nasrolahi Shirazi A., 2013, MOL PHARMACOL, V10, P500, DOI DOI 10.1021/MP300448K; Oh D, 2014, MOL PHARMACEUT, V11, P3528, DOI 10.1021/mp5003027; Oh D, 2014, MOL PHARMACEUT, V11, P2845, DOI 10.1021/mp500203e; Peinado JR, 2004, BIOCHEM BIOPH RES CO, V321, P601, DOI 10.1016/j.bbrc.2004.07.012; Qian ZQ, 2013, ACS CHEM BIOL, V8, P423, DOI 10.1021/cb3005275; Remacle AG, 2010, INT J BIOCHEM CELL B, V42, P987, DOI 10.1016/j.biocel.2010.02.013; Rothbard JB, 2000, NAT MED, V6, P1253, DOI 10.1038/81359; Rudolph C, 2003, J BIOL CHEM, V278, P11411, DOI 10.1074/jbc.M211891200; Sarac MS, 2004, INFECT IMMUN, V72, P602, DOI 10.1128/IAI.72.1.602-605.2004; Sarac MS, 2002, INFECT IMMUN, V70, P7136, DOI 10.1128/IAI.70.12.7136-7139.2002; Sato H, 1996, FEBS LETT, V393, P101, DOI 10.1016/0014-5793(96)00861-7; Schwarze SR, 1999, SCIENCE, V285, P1569, DOI 10.1126/science.285.5433.1569; Shen Y, 2011, MOL THER, V19, P903, DOI 10.1038/mt.2010.283; Shirazi AN, 2014, MOL PHARMACEUT, V11, P3631, DOI 10.1021/mp500364a; Shirazi AN, 2014, MOLECULES, V19, P13319, DOI 10.3390/molecules190913319; Shirazi AN, 2013, MOL PHARMACEUT, V10, P2008, DOI 10.1021/mp400046u; Shirazi AN, 2013, MOL PHARMACEUT, V10, P488, DOI 10.1021/mp3004034; Shiryaev SA, 2006, BIOCHEM J, V393, P503, DOI 10.1042/BJ20051374; Shiryaev SA, 2007, J BIOL CHEM, V282, P20847, DOI 10.1074/jbc.M703847200; Tung CH, 2003, ADV DRUG DELIVER REV, V55, P281, DOI 10.1016/S0169-409X(02)00183-7; Verdurmen WPR, 2011, TRENDS PHARMACOL SCI, V32, P116, DOI 10.1016/j.tips.2010.11.005; Vives E, 1997, J BIOL CHEM, V272, P16010, DOI 10.1074/jbc.272.25.16010; Vivoli M, 2012, MOL PHARMACOL, V81, P440, DOI 10.1124/mol.111.077040; Wadia JS, 2003, CURR PROTEIN PEPT SC, V4, P97, DOI 10.2174/1389203033487289; Wadia JS, 2005, ADV DRUG DELIVER REV, V57, P579, DOI 10.1016/j.addr.2004.10.005; Wender PA, 2000, P NATL ACAD SCI USA, V97, P13003, DOI 10.1073/pnas.97.24.13003	51	22	24	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2015	10	6							e0130417	10.1371/journal.pone.0130417	http://dx.doi.org/10.1371/journal.pone.0130417			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4OY	26110264	Green Submitted, gold, Green Published			2022-12-26	WOS:000356933800045
J	Jeong, KI; Piepenhagen, PA; Kishko, M; DiNapoli, JM; Groppo, RP; Zhang, LH; Almond, J; Kleanthous, H; Delagrave, S; Parrington, M				Jeong, Kwang-Il; Piepenhagen, Peter A.; Kishko, Michael; DiNapoli, Joshua M.; Groppo, Rachel P.; Zhang, Linong; Almond, Jeffrey; Kleanthous, Harry; Delagrave, Simon; Parrington, Mark			CX3CR1 Is Expressed in Differentiated Human Ciliated Airway Cells and Co-Localizes with Respiratory Syncytial Virus on Cilia in a G Protein-Dependent Manner	PLOS ONE			English	Article							REPLICATION IN-VITRO; EPITHELIAL-CELLS; MOLECULAR CHARACTERIZATION; CX3C-CX3CR1 BINDING; FUSION GLYCOPROTEIN; VACCINE DEVELOPMENT; RECEPTOR CX(3)CR1; INFECTION; ATTACHMENT; RSV	Respiratory syncytial virus (RSV) is the principal cause of bronchiolitis in infants and a significant healthcare problem. The RSV Glycoprotein (G) mediates attachment of the virus to the cell membrane, which facilitates interaction of the RSV Fusion (F) protein with nucleolin, thereby triggering fusion of the viral and cellular membranes. However, a host protein ligand for G has not yet been identified. Here we show that CX3CR1 is expressed in the motile cilia of differentiated human airway epithelial (HAE) cells, and that CX3CR1 co-localizes with RSV particles. Upon infection, the distribution of CX3CR1 in these cells is significantly altered. Complete or partial deletion of RSV G results in viruses binding at least 72-fold less efficiently to cells, and reduces virus replication. Moreover, an antibody targeting an epitope near the G protein's CX3CR1-binding motif significantly inhibits binding of the virus to airway cells. Given previously published evidence of the interaction of G with CX3CR1 in human lymphocytes, these findings suggest a role for G in the interaction of RSV with ciliated lung cells. This interpretation is consistent with past studies showing a protective benefit in immunizing against G in animal models of RSV infection, and would support targeting the CX3CR1-G protein interaction for prophylaxis or therapy. CX3CR1 expression in lung epithelial cells may also have implications for other respiratory diseases such as asthma.	[Jeong, Kwang-Il; Kishko, Michael; DiNapoli, Joshua M.; Groppo, Rachel P.; Zhang, Linong; Almond, Jeffrey; Kleanthous, Harry; Delagrave, Simon; Parrington, Mark] Sanofi Pasteur, Res North Amer, Cambridge, MA 02139 USA; [Piepenhagen, Peter A.] Genzyme Corp, Dept Pathol, Framingham, MA 01701 USA	Sanofi-Aventis; Sanofi-Aventis; Genzyme Corporation	Delagrave, S (corresponding author), Sanofi Pasteur, Res North Amer, 38 Sidney St, Cambridge, MA 02139 USA.	simon.delagrave@sanofipasteur.com			Sanofi Pasteur	Sanofi Pasteur	This work was funded by Sanofi Pasteur. The funder provided support in the form of salaries for authors KJ MK JD RG SD LZ MP HK JA, Genzyme provided support in the form of salaries for author PP, but neither company had any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Bourgeois C, 1998, J VIROL, V72, P7221, DOI 10.1128/JVI.72.9.7221-7227.1998; Cepika AM, 2008, PEDIAT ALLERG IMM-UK, V19, P148, DOI 10.1111/j.1399-3038.2007.00611.x; Choi Y, 2012, VIRAL IMMUNOL, V25, P193, DOI 10.1089/vim.2011.0094; COLLINS PL, 1995, P NATL ACAD SCI USA, V92, P11563, DOI 10.1073/pnas.92.25.11563; Feldman SA, 2000, J VIROL, V74, P6442, DOI 10.1128/JVI.74.14.6442-6447.2000; Feldman SA, 1999, J VIROL, V73, P6610, DOI 10.1128/JVI.73.8.6610-6617.1999; Fujimoto K, 2001, AM J RESP CELL MOL, V25, P233, DOI 10.1165/ajrcmb.25.2.4275; Gray TE, 1996, AM J RESP CELL MOL, V14, P104, DOI 10.1165/ajrcmb.14.1.8534481; Guvenel AK, 2014, EXPERT REV VACCINES, V13, P333, DOI 10.1586/14760584.2014.878653; Hall CB, 2009, NEW ENGL J MED, V360, P588, DOI 10.1056/NEJMoa0804877; HALL CB, 1991, J INFECT DIS, V163, P693, DOI 10.1093/infdis/163.4.693; Hancock GE, 2000, J INFECT DIS, V181, P1768, DOI 10.1086/315475; Harcourt JL, 2004, J INFECT DIS, V190, P1936, DOI 10.1086/425516; Harrison JK, 1998, P NATL ACAD SCI USA, V95, P10896, DOI 10.1073/pnas.95.18.10896; Haynes LM, 2009, J INFECT DIS, V200, P439, DOI 10.1086/600108; Imai T, 1997, CELL, V91, P521, DOI 10.1016/S0092-8674(00)80438-9; Jorquera PA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074905; Karron RA, 1997, P NATL ACAD SCI USA, V94, P13961, DOI 10.1073/pnas.94.25.13961; LEVINE S, 1987, J GEN VIROL, V68, P2521, DOI 10.1099/0022-1317-68-9-2521; Lopez-Souza N, 2009, J ALLERGY CLIN IMMUN, V123, P1384, DOI 10.1016/j.jaci.2009.03.010; Mastrangelo P, 2013, VIRUSES-BASEL, V5, P873, DOI 10.3390/v5030873; Matrosovich MN, 2004, P NATL ACAD SCI USA, V101, P4620, DOI 10.1073/pnas.0308001101; McLellan JS, 2013, CURR TOP MICROBIOL, V372, P83, DOI 10.1007/978-3-642-38919-1_4; McLellan JS, 2013, SCIENCE, V342, P592, DOI 10.1126/science.1243283; Meucci O, 2000, P NATL ACAD SCI USA, V97, P8075, DOI 10.1073/pnas.090017497; Mionnet C, 2010, NAT MED, V16, P1305, DOI 10.1038/nm.2253; Murawski MR, 2010, J VIROL, V84, P1110, DOI 10.1128/JVI.01709-09; Nair H, 2010, LANCET, V375, P1545, DOI 10.1016/S0140-6736(10)60206-1; Nishiyori A, 1998, FEBS LETT, V429, P167, DOI 10.1016/S0014-5793(98)00583-3; Oshansky CM, 2010, J INFECT DIS, V201, P1201, DOI 10.1086/651431; Oshansky CM, 2009, VIRAL IMMUNOL, V22, P147, DOI 10.1089/vim.2008.0098; Persson BD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102368; Quan FS, 2011, J INFECT DIS, V204, P987, DOI 10.1093/infdis/jir474; Regnier SA, 2013, VACCINE, V31, P4347, DOI 10.1016/j.vaccine.2013.07.024; Shah AS, 2009, SCIENCE, V325, P1131, DOI 10.1126/science.1173869; Tayyari F, 2011, NAT MED, V17, P1132, DOI 10.1038/nm.2444; Techaarpornkul S, 2001, J VIROL, V75, P6825, DOI 10.1128/JVI.75.15.6825-6834.2001; Teng MN, 2001, VIROLOGY, V289, P283, DOI 10.1006/viro.2001.1138; Tripp RA, 2001, NAT IMMUNOL, V2, P732, DOI 10.1038/90675; Villenave R, 2013, TRENDS MICROBIOL, V21, P238, DOI 10.1016/j.tim.2013.02.004; Villenave R, 2012, P NATL ACAD SCI USA, V109, P5040, DOI 10.1073/pnas.1110203109; Villenave R, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-43; WALSH EE, 1983, J VIROL, V47, P171, DOI 10.1128/JVI.47.1.171-177.1983; Zhang LQ, 2005, J VIROL, V79, P1113, DOI 10.1128/JVI.79.2.1113-1124.2005; Zhang LQ, 2002, J VIROL, V76, P5654, DOI 10.1128/JVI.76.11.5654-5666.2002; Zhang WL, 2010, J VIROL, V84, P1148, DOI 10.1128/JVI.01755-09	46	56	56	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2015	10	6							e0130517	10.1371/journal.pone.0130517	http://dx.doi.org/10.1371/journal.pone.0130517			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4OM	26107373	gold, Green Published, Green Submitted			2022-12-26	WOS:000356932500105
J	Maier, LJ; Wunderli, MD; Vonmoos, M; Rommelt, AT; Baumgartner, MR; Seifritz, E; Schaub, MP; Quednow, BB				Maier, Larissa J.; Wunderli, Michael D.; Vonmoos, Matthias; Roemmelt, Andreas T.; Baumgartner, Markus R.; Seifritz, Erich; Schaub, Michael P.; Quednow, Boris B.			Pharmacological Cognitive Enhancement in Healthy Individuals: A Compensation for Cognitive Deficits or a Question of Personality?	PLOS ONE			English	Article							COLLEGE-STUDENTS; COCAINE USERS; METHYLPHENIDATE; MDMA; PREDICTS; BRAIN; DRUGS	The ongoing bioethical debate on pharmacological cognitive enhancement (PCE) in healthy individuals is often legitimated by the assumption that PCE will widely spread and become desirable for the general public in the near future. This assumption was questioned as PCE is not equally save and effective in everyone. Additionally, it was supposed that the willingness to use PCE is strongly personality-dependent likely preventing a broad PCE epidemic. Thus, we investigated whether the cognitive performance and personality of healthy individuals with regular nonmedical methylphenidate (MPH) use for PCE differ from stimulant-naive controls. Twenty-five healthy individuals using MPH for PCE were compared with 39 age-, sex-, and education-matched healthy controls regarding cognitive performance and personality assessed by a comprehensive neuropsychological test battery including social cognition, prosocial behavior, decision-making, impulsivity, and personality questionnaires. Substance use was assessed through self-report in an interview and quantitative hair and urine analyses. Recently abstinent PCE users showed no cognitive impairment but superior strategic thinking and decision-making. Furthermore, PCE users displayed higher levels of trait impulsivity, novelty seeking, and Machiavellianism combined with lower levels of social reward dependence and cognitive empathy. Finally, PCE users reported a smaller social network and exhibited less prosocial behavior in social interaction tasks. In conclusion, the assumption that PCE use will soon become epidemic is not supported by the present findings as PCE users showed a highly specific personality profile that shares a number of features with illegal stimulant users. Lastly, regular MPH use for PCE is not necessarily associated with cognitive deficits.	[Maier, Larissa J.] Univ Zurich, Swiss Res Inst Publ Hlth & Addict ISGF, Associated Inst, Zurich, Switzerland; [Maier, Larissa J.] WHO Collaborating Ctr, Zurich, Switzerland; [Wunderli, Michael D.; Vonmoos, Matthias; Quednow, Boris B.] Univ Zurich, Expt & Clin Pharmacopsychol, Dept Psychiat Psychotherapy & Psychosomat, Hosp Psychiat, Zurich, Switzerland; [Roemmelt, Andreas T.; Baumgartner, Markus R.] Univ Zurich, Inst Forens Med, Ctr Forens Hairanalyt, Zurich, Switzerland; [Seifritz, Erich] Univ Zurich, Hosp Psychiat, Dept Psychiat Psychotherapy & Psychosomat, Zurich, Switzerland; [Seifritz, Erich; Quednow, Boris B.] Univ Zurich, Neurosci Ctr Zurich, Zurich, Switzerland; [Seifritz, Erich; Quednow, Boris B.] Swiss Fed Inst Technol, Zurich, Switzerland	University of Zurich; World Health Organization; University of Zurich; University of Zurich; University of Zurich; University of Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich	Quednow, BB (corresponding author), Univ Zurich, Expt & Clin Pharmacopsychol, Dept Psychiat Psychotherapy & Psychosomat, Hosp Psychiat, Zurich, Switzerland.	quednow@bli.uzh.ch	Maier, Larissa J/C-2922-2017; Schaub, Michael P./ABF-9468-2021; Quednow, Boris B./A-1666-2008; Maier, Larissa/P-8669-2014	Maier, Larissa J/0000-0002-4302-0488; Schaub, Michael P./0000-0002-8375-4005; Quednow, Boris B./0000-0001-7933-2865; Maier, Larissa/0000-0002-4302-0488; Baumgartner, Markus R./0000-0002-0979-931X	Swiss National Science Foundation, (SNSF) [PP00P1-146326/1]	Swiss National Science Foundation, (SNSF)(Swiss National Science Foundation (SNSF))	This study was funded by the Swiss National Science Foundation, (SNSF; grant No. PP00P1-146326/1). The SNSF did not influence study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bogle Kristin E, 2009, Curr Drug Abuse Rev, V2, P157; Bostrom N, 2009, SCI ENG ETHICS, V15, P311, DOI 10.1007/s11948-009-9142-5; Clatworthy PL, 2009, J NEUROSCI, V29, P4690, DOI 10.1523/JNEUROSCI.3266-08.2009; de Jongh R, 2008, NEUROSCI BIOBEHAV R, V32, P760, DOI 10.1016/j.neubiorev.2007.12.001; Farah MJ, 2004, NAT REV NEUROSCI, V5, P421, DOI 10.1038/nrn1390; Franke AG, 2011, PHARMACOPSYCHIATRY, V44, P60, DOI 10.1055/s-0030-1268417; Greely H, 2008, NATURE, V456, P702, DOI 10.1038/456702a; Hulka LM, 2014, PSYCHOL MED, V44, P1015, DOI 10.1017/S0033291713001839; Husain M, 2011, TRENDS COGN SCI, V15, P28, DOI 10.1016/j.tics.2010.11.002; Hysek CM, 2014, INT J NEUROPSYCHOPH, V17, P371, DOI 10.1017/S1461145713001132; Maier LJ, 2015, EUR PSYCHOL, V20, P155, DOI 10.1027/1016-9040/a000228; Maier LJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077967; McCabe SE, 2005, ADDICTION, V100, P96, DOI 10.1111/j.1360-0443.2005.00944.x; McCabe SE, 2014, ADDICT BEHAV, V39, P1176, DOI 10.1016/j.addbeh.2014.03.008; Morris K, 2008, LANCET NEUROL, V7, P476, DOI 10.1016/S1474-4422(08)70101-7; Nyberg F, 2014, NEUROPHARMACOLOGY, V87, P115, DOI 10.1016/j.neuropharm.2014.07.004; Preller KH, 2014, ADDICT BIOL, V19, P452, DOI 10.1111/adb.12070; Preller KH, 2014, P NATL ACAD SCI USA, V111, P2842, DOI 10.1073/pnas.1317090111; Quednow BB, 2004, NEUROPSYCHOPHARMACOL, V29, P982, DOI 10.1038/sj.npp.1300396; Quednow BB, 2010, BIOSOCIETIES, V5, P153, DOI 10.1057/biosoc.2009.13; Rabiner DL, 2009, J ATTEN DISORD, V13, P259, DOI 10.1177/1087054708320399; Rauthmann JF, 2012, PERS INDIV DIFFER, V53, P884, DOI 10.1016/j.paid.2012.06.020; Repantis D, 2013, COGNITIVE ENHANCEMEN; Reske M, 2011, J PSYCHIATR RES, V45, P361, DOI 10.1016/j.jpsychires.2010.07.005; Reske M, 2010, BIOL PSYCHIAT, V68, P762, DOI 10.1016/j.biopsych.2010.04.021; Rounsaville BJ, 2004, BIOL PSYCHIAT, V56, P803, DOI 10.1016/j.biopsych.2004.05.009; Rubia K, 2014, BIOL PSYCHIAT, V76, P616, DOI 10.1016/j.biopsych.2013.10.016; Sahakian B, 2007, NATURE, V450, P1157, DOI 10.1038/4501157a; Sattler S, 2014, SUBST ABUSE TREAT PR, V9, DOI 10.1186/1747-597X-9-8; Schleim S, RETHINKING IN PRESS; Schmid Y, 2014, J PSYCHOPHARMACOL, V28, P847, DOI 10.1177/0269881114542454; van der Schaaf ME, 2013, NEUROPSYCHOPHARMACOL, V38, P2011, DOI 10.1038/npp.2013.100; Vonmoos M, 2014, NEUROPSYCHOPHARMACOL, V39, P2200, DOI 10.1038/npp.2014.71; Vonmoos M, 2013, DRUG ALCOHOL DEPEN, V133, P61, DOI 10.1016/j.drugalcdep.2013.05.032; Vonmoos M, 2013, BRIT J PSYCHIAT, V203, P35, DOI 10.1192/bjp.bp.112.118091; Weyandt LL, 2009, J ATTEN DISORD, V13, P284, DOI 10.1177/1087054709342212; Wood S, 2014, PHARMACOL REV, V66, P193, DOI 10.1124/pr.112.007054	37	30	30	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2015	10	6							e0129805	10.1371/journal.pone.0129805	http://dx.doi.org/10.1371/journal.pone.0129805			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CL4OM	26107846	Green Accepted, Green Published, gold			2022-12-26	WOS:000356932500069
J	Meikle, PJ; Mundra, PA; Wong, G; Rahman, K; Huynh, K; Barlow, CK; Duly, AMP; Haber, PS; Whitfield, JB; Seth, D				Meikle, Peter J.; Mundra, Piyushkumar A.; Wong, Gerard; Rahman, Khairunnessa; Huynh, Kevin; Barlow, Christopher K.; Duly, Alastair M. P.; Haber, Paul S.; Whitfield, John B.; Seth, Devanshi			Circulating Lipids Are Associated with Alcoholic Liver Cirrhosis and Represent Potential Biomarkers for Risk Assessment	PLOS ONE			English	Article							HEPATIC FAT-CONTENT; METABOLISM; SERUM	Liver disease is the greatest cause of death related to alcohol and a major public health problem. While excessive alcohol intake results in hepatosteatosis in most individuals, this can progress in some to more severe forms of liver disease including fibrosis and cirrhosis. An ongoing challenge in the management of alcoholic liver disease is the identification of liver injury early in the disease process such that intervention strategies can prevent serious long term outcomes. Given that excessive alcohol consumption results in dysregulation of lipid metabolism we applied lipid profiling technology to characterise and compare serum lipid profiles from excessive chronic drinkers with no liver disease to those with advanced alcoholic cirrhosis. In a cohort of 59 excessive drinkers (31 with liver cirrhosis and 28 with no evidence of liver disease) we used electrospray ionisation tandem mass spectrometry to measure over 300 individual lipid species in serum, including species of the major phospholipid, sphingolipid, glycerolipid and sterol classes. Six of the 25 lipid classes and subclasses were significantly associated with alcoholic liver cirrhosis; these included dihexosylceramide, trihexosylceramide, alkylphosphatidylcholine, lysoalkylphosphatidylcholine, phosphatidylinositol and free cholesterol. Multivariate classification models created with only clinical characteristics gave an optimal model with an AUC of 0.847 and an accuracy of 79.7%. The addition of lipid measurements to the clinical characteristics resulted in models of improved performance with an AUC of 0.892 and accuracy of 81.8%. The gain in AUC and accuracy of the combined models highlight the potential of serum lipids as markers of liver injury in alcoholic liver disease.	[Meikle, Peter J.; Mundra, Piyushkumar A.; Wong, Gerard; Huynh, Kevin; Barlow, Christopher K.] Baker IDI Heart & Diabet Inst, Melbourne, Vic 3004, Australia; [Rahman, Khairunnessa; Haber, Paul S.; Seth, Devanshi] Univ Sydney, Fac Med, Discipline Clin Med & Addict Med, Sydney, NSW 2006, Australia; [Duly, Alastair M. P.] St Vincents Hosp, Garvan Inst Med Res, Darlinghurst, NSW 2010, Australia; [Haber, Paul S.; Seth, Devanshi] Royal Prince Alfred Hosp, Drug Hlth Serv, Camperdown, NSW 2050, Australia; [Haber, Paul S.; Seth, Devanshi] Royal Prince Alfred Hosp, Centenary Inst Canc Med & Cell Biol, Camperdown, NSW 2050, Australia; [Whitfield, John B.] QIMR Berghofer Med Res Inst, Genet Epidemiol, Herston, Qld 4029, Australia	Baker Heart and Diabetes Institute; University of Sydney; Garvan Institute of Medical Research; St Vincents Hospital Sydney; University of Sydney; University of Sydney; Centenary Institute; QIMR Berghofer Medical Research Institute	Meikle, PJ (corresponding author), Baker IDI Heart & Diabet Inst, Melbourne, Vic 3004, Australia.	peter.meikle@bakeridi.edu.au; d.seth@sydney.edu.au	Meikle, Peter J/B-4023-2009	Mundra, Piyushkumar/0000-0001-7769-2939; Barlow, Christopher/0000-0001-9309-2829; Meikle, Peter/0000-0002-2593-4665	National Institutes of Health (NIH)/National Institutes on Alcoholism and Alcohol Abuse (NIAAA) as part of the GenomALC Consortium [U01 AA018389-01A2]; National Health and Medical Research Council of Australia [APP1042095]; OIS Program of the Victorian Government, Australia; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [U01AA018389] Funding Source: NIH RePORTER	National Institutes of Health (NIH)/National Institutes on Alcoholism and Alcohol Abuse (NIAAA) as part of the GenomALC Consortium; National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); OIS Program of the Victorian Government, Australia; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	Patient sample and clinical data collection was funded by National Institutes of Health (NIH)/National Institutes on Alcoholism and Alcohol Abuse (NIAAA) as part of the GenomALC Consortium (U01 AA018389-01A2). This work was supported by the National Health and Medical Research Council of Australia [APP1042095] and the OIS Program of the Victorian Government, Australia.	Bajaj M, 2003, DIABETES, V52, P1364, DOI 10.2337/diabetes.52.6.1364; BANERJI MA, 1995, INT J OBESITY, V19, P846; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Boros LG, 2009, PANCREAS, V38, pE47, DOI 10.1097/MPA.0b013e318199fea4; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Chatterjee S, 2014, CIRCULATION; Clugston RD, 2011, J LIPID RES, V52, P2021, DOI 10.1194/jlr.M017368; Glaros EN, 2005, J BIOL CHEM, V280, P24515, DOI 10.1074/jbc.M413862200; Hart CL, 2010, INT J OBESITY, V34, P1051, DOI 10.1038/ijo.2010.20; Kononenko I, 1997, APPL INTELL, V7, P39, DOI 10.1023/A:1008280620621; Lakshman AR, 2004, ALCOHOL, V34, P45, DOI 10.1016/j.alcohol.2004.08.004; Lieber C. S., 1992, MED NUTR COMPLICATIO; Lijmer JG, 1999, JAMA-J AM MED ASSOC, V282, P1061, DOI 10.1001/jama.282.11.1061; Liu B, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c912; Mayerson AB, 2002, DIABETES, V51, P797, DOI 10.2337/diabetes.51.3.797; Meikle PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074341; Nikkila K, 2008, J HEPATOL, V49, P936, DOI 10.1016/j.jhep.2008.07.026; Rasineni K, 2012, INDIAN J PHARMACOL, V44, P299, DOI 10.4103/0253-7613.96297; Ryysy L, 2000, DIABETES, V49, P749, DOI 10.2337/diabetes.49.5.749; SAUNDERS JB, 1993, ADDICTION, V88, P791, DOI 10.1111/j.1360-0443.1993.tb02093.x; SAVOLAINEN MJ, 1984, J LIPID RES, V25, P813; Seitz HK, 2006, BIOL CHEM, V387, P349, DOI 10.1515/BC.2006.047; Siler SQ, 1999, AM J CLIN NUTR, V70, P928; Sozio MS, 2010, SEMIN LIVER DIS, V30, P378, DOI 10.1055/s-0030-1267538; Tomita K, 2014, J HEPATOL; UTHUS EO, 1976, LIPIDS, V11, P641, DOI 10.1007/BF02532880; Weir JM, 2013, J LIPID RES, V54, P2898, DOI 10.1194/jlr.P035808; Ydreborg M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093601; Zhao ZW, 2011, ALCOHOL CLIN EXP RES, V35, P229, DOI 10.1111/j.1530-0277.2010.01338.x	29	21	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2015	10	6							e0130346	10.1371/journal.pone.0130346	http://dx.doi.org/10.1371/journal.pone.0130346			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4OM	26107182	gold, Green Published			2022-12-26	WOS:000356932500093
J	Munch, J; Aydin, A; Suling, A; Voigt, C; Blankenberg, S; Patten, M				Muench, Julia; Aydin, Ali; Suling, Anna; Voigt, Christian; Blankenberg, Stefan; Patten, Monica			Orthostatic Blood Pressure Test for Risk Stratification in Patients with Hypertrophic Cardiomyopathy	PLOS ONE			English	Article							CARDIOVASCULAR MAGNETIC-RESONANCE; POSTURAL TACHYCARDIA SYNDROME; OF-CARDIOLOGY FOUNDATION; HEART RHYTHM SOCIETY; MYOCARDIAL-INFARCTION; SCIENTIFIC STATEMENT; CONSENSUS STATEMENT; CLINICAL CARDIOLOGY; SUDDEN-DEATH; QT-INTERVAL	Background Hypertrophic cardiomyopathy (HCM) is the most common cause of sudden cardiac death (SCD) in young adults, mainly ascribed to ventricular tachycardia (VT). Assuming that VT is the major cause of (pre-) syncope in HCM patients, its occurrence is essential for SCD risk stratification and primarily preventive ICD-implantation. However, evidence of VT during syncope is often missing. As the differentiation of potential lethal causes for syncope such as VT from more harmless reasons is crucial, HCM patients were screened for orthostatic dysregulation by using a simple orthostatic blood pressure test. Methods Over 15 months (IQR [9; 20]) 100 HCM patients (55.8+/-16.2 yrs, 61% male) were evaluated for (pre-) syncope and VT (24h-ECGs, device-memories) within the last five years. Eighty patients underwent an orthostatic blood pressure test. Logistic regression models were used for statistical analysis. Results In older patients (> 40 yrs) a positive orthostatic test result increased the chance of (pre-) syncope by a factor of 63 (95%-CI [8.8; 447.9], p< 0.001; 93% sensitivity, 95%-CI [76; 99]; 74% specificity, 95%-CI [58; 86]). No correlation with VT was shown. A prolonged QTc interval also increased the chance of (pre-) syncope by a factor of 6.6 (95%-CI [2.0; 21.7]; p= 0.002). Conclusions The orthostatic blood pressure test is highly valuable for evaluation of syncope and presyncope especially in older HCM patients, suggesting that orthostatic syncope might be more relevant than previously assumed. Considering the high complication rates due to ICD therapies, this test may provide useful information for the evaluation of syncope in individual risk stratification and may help to prevent unnecessary device implantations, especially in older HCM patients.	[Muench, Julia; Voigt, Christian; Blankenberg, Stefan; Patten, Monica] Univ Herzzentrum Hamburg, Klin & Poliklin Allgemeine & Intervent Kardiol, D-20246 Hamburg, Germany; [Aydin, Ali] Krankenhaus Reinbek, Abt Kardiol, D-21465 Reinbek, Germany; [Suling, Anna] Univ Klinikum Hamburg Eppendorf, Inst Med Biometrie & Epidemiol, D-20246 Hamburg, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf	Patten, M (corresponding author), Univ Herzzentrum Hamburg, Klin & Poliklin Allgemeine & Intervent Kardiol, Martinistr 52, D-20246 Hamburg, Germany.	patten@uke.de						COUNIHAN PJ, 1991, CIRCULATION, V84, P686, DOI 10.1161/01.CIR.84.2.686; Daubert JP, 2008, J AM COLL CARDIOL, V51, P1357, DOI 10.1016/j.jacc.2007.09.073; DRITSAS A, 1992, CLIN CARDIOL, V15, P739, DOI 10.1002/clc.4960151010; Efthimiadis GK, 2007, HEART VESSELS, V22, P322, DOI 10.1007/s00380-007-0976-y; Elliott PM, 2014, EUR HEART J, V35, P2733, DOI 10.1093/eurheartj/ehu284; Freeman R, 2011, AUTON NEUROSCI-BASIC, V161, P46, DOI 10.1016/j.autneu.2011.02.004; Gersh BJ, 2011, CIRCULATION, V124, P2761, DOI 10.1161/CIR.0b013e318223e230; Gray B, 2013, JACC-HEART FAIL, V1, P149, DOI 10.1016/j.jchf.2013.01.004; Grubb BP, 2006, J CARDIOVASC ELECTR, V17, P108, DOI 10.1111/j.1540-8167.2005.00318.x; Johnson JN, 2011, EUR HEART J, V32, P1114, DOI 10.1093/eurheartj/ehr021; Lim Pitt O, 2002, Cardiol Rev, V10, P15, DOI 10.1097/00045415-200201000-00005; Luukinen H, 2004, J INTERN MED, V255, P486, DOI 10.1111/j.1365-2796.2004.01313.x; Mader S, 2006, AGING HLTH, V2, P505; Mader SL, 2012, EXPERT REV CARDIOVAS, V10, P387, DOI [10.1586/erc.12.11, 10.1586/ERC.12.11]; MADER SL, 1989, MED CLIN N AM, V73, P1337, DOI 10.1016/S0025-7125(16)30602-2; Maron BJ, 2008, J CARDIOVASC ELECTR, V19, P1118, DOI 10.1111/j.1540-8167.2008.01147.x; Maron BJ, 2013, LANCET, V381, P242, DOI 10.1016/S0140-6736(12)60397-3; MARON BJ, 1987, NEW ENGL J MED, V316, P844, DOI 10.1056/NEJM198704023161405; Maron MS, 2011, CIRCULATION, V124, P40, DOI 10.1161/CIRCULATIONAHA.110.985812; Moss AJ, 2002, NEW ENGL J MED, V346, P877, DOI 10.1056/NEJMoa013474; Naschitz JE, 2007, POSTGRAD MED J, V83, DOI 10.1136/pgmj.2007.058198; Olivotto I, 2008, J AM COLL CARDIOL, V52, P559, DOI 10.1016/j.jacc.2008.04.047; Olivotto I, 2012, CIRC-HEART FAIL, V5, P535, DOI 10.1161/CIRCHEARTFAILURE.112.967026; Prasad K, 2008, HEART, V94, P1312, DOI 10.1136/hrt.2008.141507; Rose KM, 2006, CIRCULATION, V114, P630, DOI 10.1161/CIRCULATIONAHA.105.598722; RUTAN GH, 1992, HYPERTENSION, V19, P508, DOI 10.1161/01.HYP.19.6.508; Sadoul N, 1997, CIRCULATION, V96, P2987, DOI 10.1161/01.CIR.96.9.2987; Savelieva I, 1998, AM J CARDIOL, V81, P471, DOI 10.1016/S0002-9149(97)00927-2; Schatz IJ, 1996, NEUROLOGY, V46, P1470, DOI 10.1212/wnl.46.5.1470; Spirito P, 2014, AM J CARDIOL, V113, P1550, DOI 10.1016/j.amjcard.2014.01.435; Strickberger SA, 2006, J AM COLL CARDIOL, V47, P473, DOI 10.1016/j.jacc.2005.12.019; Surawicz B, 2009, J AM COLL CARDIOL, V53, P976, DOI 10.1016/j.jacc.2008.12.013; YANAGISAWAMIWA A, 1991, AM J CARDIOL, V67, P1428, DOI 10.1016/0002-9149(91)90476-2	33	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2015	10	6							e0131044	10.1371/journal.pone.0131044	http://dx.doi.org/10.1371/journal.pone.0131044			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4OM	26107635	Green Published, Green Submitted, gold			2022-12-26	WOS:000356932500137
J	Foshtomi, MY; Braeckman, U; Derycke, S; Sapp, M; Van Gansbeke, D; Sabbe, K; Willems, A; Vincx, M; Vanaverbeke, J				Foshtomi, Maryam Yazdani; Braeckman, Ulrike; Derycke, Sofie; Sapp, Melanie; Van Gansbeke, Dirk; Sabbe, Koen; Willems, Anne; Vincx, Magda; Vanaverbeke, Jan			The Link between Microbial Diversity and Nitrogen Cycling in Marine Sediments Is Modulated by Macrofaunal Bioturbation	PLOS ONE			English	Article							AMMONIA-OXIDIZING BACTERIA; NORTH-SEA; BIOGEOCHEMICAL PROCESSES; ARCHAEAL COMMUNITIES; NEREIS-DIVERSICOLOR; ECOSYSTEM FUNCTION; ORGANIC-MATTER; FRESH-WATER; IMPACT; BIODIVERSITY	Objectives The marine benthic nitrogen cycle is affected by both the presence and activity of macrofauna and the diversity of N-cycling microbes. However, integrated research simultaneously investigating macrofauna, microbes and N-cycling is lacking. We investigated spatio-temporal patterns in microbial community composition and diversity, macrofaunal abundance and their sediment reworking activity, and N-cycling in seven subtidal stations in the Southern North Sea. Spatio-Temporal Patterns of the Microbial Communities Our results indicated that bacteria (total and beta-AOB) showed more spatio-temporal variation than archaea (total and AOA) as sedimentation of organic matter and the subsequent changes in the environment had a stronger impact on their community composition and diversity indices in our study area. However, spatio-temporal patterns of total bacterial and beta-AOB communities were different and related to the availability of ammonium for the autotrophic beta-AOB. Highest bacterial richness and diversity were observed in June at the timing of the phytoplankton bloom deposition, while richness of beta-AOB as well as AOA peaked in September. Total archaeal community showed no temporal variation in diversity indices. Macrofauna, Microbes and the Benthic N-Cycle Distance based linear models revealed that, independent from the effect of grain size and the quality and quantity of sediment organic matter, nitrification and N-mineralization were affected by respectively the diversity of metabolically active beta-AOB and AOA, and the total bacteria, near the sediment-water interface. Separate models demonstrated a significant and independent effect of macrofaunal activities on community composition and richness of total bacteria, and diversity indices of metabolically active AOA. Diversity of beta-AOB was significantly affected by macrofaunal abundance. Our results support the link between microbial biodiversity and ecosystem functioning in marine sediments, and provided broad correlative support for the hypothesis that this relationship is modulated by macrofaunal activity. We hypothesized that the latter effect can be explained by their bioturbating and bio-irrigating activities, increasing the spatial complexity of the biogeochemical environment.	[Foshtomi, Maryam Yazdani; Braeckman, Ulrike; Derycke, Sofie; Van Gansbeke, Dirk; Vincx, Magda; Vanaverbeke, Jan] Univ Ghent, Dept Biol, Marine Biol Res Grp, B-9000 Ghent, Belgium; [Foshtomi, Maryam Yazdani; Willems, Anne] Univ Ghent, CeMoFE, B-9000 Ghent, Belgium; [Sapp, Melanie] Food & Environm Res Agcy, York, N Yorkshire, England; [Sabbe, Koen] Univ Ghent, Dept Biol, Lab Protistol & Aquat Ecol, B-9000 Ghent, Belgium; [Willems, Anne] Univ Ghent, Microbiol Lab, Dept Biochem & Microbiol, B-9000 Ghent, Belgium	Ghent University; Ghent University; Food & Environment Research Agency; Ghent University; Ghent University	Foshtomi, MY (corresponding author), Iranian Natl Inst Oceanog & Atmospher Sci, Tehran, Iran.	Maryam.YazdaniFoshtomi@Ugent.be	Sapp, Melanie/H-7174-2019; Sapp, Melanie/J-4941-2017; Willems, Anne/B-2872-2010; Braeckman, Ulrike/AAJ-4801-2021	Sapp, Melanie/0000-0002-0817-5425; Sapp, Melanie/0000-0002-0817-5425; Willems, Anne/0000-0002-8421-2881; Braeckman, Ulrike/0000-0002-7558-6363	Ministry of Science, Research and Technology, Iran [24-88200022]; FWO Project [G.0033.11]; Special Research Fund of Ghent University [BOF-GOA01GA1911W]	Ministry of Science, Research and Technology, Iran; FWO Project(FWO); Special Research Fund of Ghent University(Ghent University)	This work was supported by the Ministry of Science, Research and Technology, Iran (http://www.msrt.ir/fa/pages/Home.aspx#) scholarship nr 24-88200022; Recipient: MYF. UB was supported by FWO Project No. G.0033.11. This work was also supported by the Special Research Fund of Ghent University (BOF-GOA 01GA1911W). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abell GCJ, 2013, AQUAT MICROB ECOL, V70, P63, DOI 10.3354/ame01642; Abell GCJ, 2010, ISME J, V4, P286, DOI 10.1038/ismej.2009.105; Anderson M.J., 2008, PERMANOVA PRIMER GUI; Beman JM, 2006, APPL ENVIRON MICROB, V72, P7767, DOI 10.1128/AEM.00946-06; Benlloch S, 2002, ENVIRON MICROBIOL, V4, P349, DOI 10.1046/j.1462-2920.2002.00306.x; Bergamaschi BA, 1997, GEOCHIM COSMOCHIM AC, V61, P1247, DOI 10.1016/S0016-7037(96)00394-8; Bertics VJ, 2009, ISME J, V3, P1269, DOI 10.1038/ismej.2009.62; Birchenough SNR, 2012, ECOL INDIC, V12, P8, DOI 10.1016/j.ecolind.2011.03.015; Blackburn TH, 1988, NITROGEN CYCLING COA, P175; Boer SI, 2009, ISME J, V3, P780, DOI 10.1038/ismej.2009.29; Boon AR, 1998, MAR ECOL PROG SER, V162, P33, DOI 10.3354/meps162033; Braeckman U, 2014, ECOSYSTEMS, V17, P720, DOI 10.1007/s10021-014-9755-7; Braeckman U, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018078; Braeckman U, 2010, MAR ECOL PROG SER, V399, P173, DOI 10.3354/meps08336; Canfield DE, 2005, ADV MAR BIOL, V48, P1; Cardinale BJ, 2012, NATURE, V486, P59, DOI 10.1038/nature11148; Clarke KR., 2001, CHANGE MARINE COMMUN, V2; Corinaldesi C, 2005, APPL ENVIRON MICROB, V71, P46, DOI 10.1128/AEM.71.1.46-50.2005; Dai TH, 2012, FRONT MICROBIOL, V3, DOI [10.3389/fmicb.2012.00120, 10.3389/fmicb.2012.00417]; Danovaro R, 2007, ESTUAR COAST SHELF S, V75, P4, DOI 10.1016/j.ecss.2007.02.030; Duarte S, 2012, GEL ELECTROPHORESIS - PRINCIPLES AND BASICS, P173; Ehrenhauss S, 2004, MAR ECOL PROG SER, V271, P99, DOI 10.3354/meps271099; Ehrenhauss S, 2004, J SEA RES, V52, P179, DOI 10.1016/j.seares.2004.01.004; Franco MA, 2007, AQUAT MICROB ECOL, V48, P241, DOI 10.3354/ame048241; Frossard A, 2012, ISME J, V6, P680, DOI 10.1038/ismej.2011.134; Gilbertson WW, 2012, FEMS MICROBIOL ECOL, V82, P11, DOI 10.1111/j.1574-6941.2012.01400.x; Graue J, 2012, ISME J, V6, P660, DOI 10.1038/ismej.2011.120; Herbert RA, 1999, FEMS MICROBIOL REV, V23, P563, DOI 10.1016/S0168-6445(99)00022-4; Ho A, 2014, ISME J, V8, P1945, DOI 10.1038/ismej.2014.74; Howe RL, 2004, J MAR BIOL ASSOC UK, V84, P629, DOI 10.1017/S002531540400966Xh; Jiang L, 2007, ECOLOGY, V88, P1075, DOI 10.1890/06-1556; JORGENSEN BB, 1982, NATURE, V296, P643, DOI 10.1038/296643a0; Kristensen E, 2003, MAR ECOL PROG SER, V265, P141, DOI 10.3354/meps265141; Lancelot C, 2005, MAR ECOL PROG SER, V289, P63, DOI 10.3354/meps289063; Langenheder S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010834; Laverock B, 2014, ENV MICROBIOL REP, V6, P113, DOI 10.1111/1758-2229.12115; Laverock B, 2011, BIOCHEM SOC T, V39, P315, DOI 10.1042/BST0390315; Laverock B, 2010, ISME J, V4, P1531, DOI 10.1038/ismej.2010.86; Lucas FS, 2003, AQUAT MICROB ECOL, V32, P165, DOI 10.3354/ame032165; Lyons MM, 2012, HYDROBIOLOGIA, V686, P181, DOI 10.1007/s10750-012-1010-7; M'harzi A, 1998, J PLANKTON RES, V20, P2031; Magni P, 2008, MAR POLLUT BULL, V56, P549, DOI 10.1016/j.marpolbul.2007.12.004; Mermillod-Blondin F, 2004, AQUAT MICROB ECOL, V36, P271, DOI 10.3354/ame036271; Mermillod-Blondin F, 2011, J N AM BENTHOL SOC, V30, P770, DOI 10.1899/10-121.1; Mills HJ, 2008, APPL ENVIRON MICROB, V74, P4440, DOI 10.1128/AEM.02692-07; Mosier AC, 2011, THESIS STANFORD U; Mussmann M, 2011, P NATL ACAD SCI USA, V108, P16771, DOI 10.1073/pnas.1106427108; Naeem S, 2012, SCIENCE, V336, P1401, DOI 10.1126/science.1215855; Obernosterer I, 2010, MICROB ECOL, V59, P428, DOI 10.1007/s00248-009-9588-7; Papaspyrou S, 2006, MAR BIOL, V148, P541, DOI 10.1007/s00227-005-0105-3; Papaspyrou S, 2005, AQUAT MICROB ECOL, V38, P181, DOI 10.3354/ame038181; Park BJ, 2010, APPL ENVIRON MICROB, V76, P7575, DOI 10.1128/AEM.01478-10; Parsons T. R., 1984, MANUAL CHEM BIOL MET, DOI [10.1016/B978-0-08-030287-4.50004-9, DOI 10.1016/C2009-0-07774-5]; Peter H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023225; Peter H, 2011, ISME J, V5, P351, DOI 10.1038/ismej.2010.119; Philippot L, 2013, ISME J, V7, P1609, DOI 10.1038/ismej.2013.34; Plugge CM, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00081; Provoost P, 2013, ESTUAR COAST SHELF S, V120, P1, DOI 10.1016/j.ecss.2013.01.008; Qin W, 2014, P NATL ACAD SCI USA, V111, P12504, DOI 10.1073/pnas.1324115111; Queiros AM, 2013, ECOL EVOL, V3, P3958, DOI 10.1002/ece3.769; Rousseau V, 2002, MAR ECOL PROG SER, V236, P61, DOI 10.3354/meps236061; Rousseau V., 2006, CURRENT STATUS EUTRO, P122; Sapp M, 2010, FEMS MICROBIOL ECOL, V74, P410, DOI 10.1111/j.1574-6941.2010.00957.x; Satoh H, 2007, APPL ENVIRON MICROB, V73, P1341, DOI 10.1128/AEM.02073-06; Solan M, 2004, SCIENCE, V306, P1177, DOI 10.1126/science.1103960; Stauffert M, 2014, MICROB ECOL, V67, P108, DOI 10.1007/s00248-013-0288-y; Steward CC, 1996, MAR ECOL PROG SER, V133, P149, DOI 10.3354/meps133149; Stief P, 2013, BIOGEOSCIENCES, V10, P7829, DOI 10.5194/bg-10-7829-2013; Sun MY, 1999, J MAR RES, V57, P775, DOI 10.1357/002224099321560573; Szabo KE, 2007, AQUAT MICROB ECOL, V47, P1, DOI 10.3354/ame047001; Tait K, 2014, MAR ECOL PROG SER, V511, P41, DOI 10.3354/meps10933; Tang C, 2013, APPL ENVIRON MICROB, V79, P1034, DOI 10.1128/AEM.02336-12; Tiodjio RE, 2014, SCI REP-UK, V4, DOI 10.1038/srep06151; Van Hoey G, 2009, MACROBENTHOS MONITOR; van Nugteren P, 2009, LIMNOL OCEANOGR, V54, P1413, DOI 10.4319/lo.2009.54.5.1413; von Scheibner M, 2014, ENVIRON MICROBIOL, V16, P718, DOI 10.1111/1462-2920.12195; Wohl DL, 2004, ECOLOGY, V85, P1534, DOI 10.1890/03-3050; Wright S., 1997, PHYTOPLANKTON PIGMEN, P327; Yingst JY, 1980, MARINE BENTHIC DYNAM, P407; Zhang Y, 2014, BIOGEOSCIENCES, V11, P2131, DOI 10.5194/bg-11-2131-2014; Zheng YL, 2013, APPL MICROBIOL BIOT, V97, P8351, DOI 10.1007/s00253-012-4512-3	81	50	51	5	98	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2015	10	6							e0130116	10.1371/journal.pone.0130116	http://dx.doi.org/10.1371/journal.pone.0130116			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4DD	26102286	Green Published, gold			2022-12-26	WOS:000356901900029
J	Lundwall, RA; Watkins, JK				Lundwall, Rebecca A.; Watkins, Jeffrey K.			Genetic Influence on Slope Variability in a Childhood Reflexive Attention Task	PLOS ONE			English	Article							DEFICIT HYPERACTIVITY DISORDER; CONTINUOUS PERFORMANCE-TEST; DOPAMINE TRANSPORTER GENE; REACTION-TIME VARIABILITY; APOLIPOPROTEIN-E GENE; DEFICIT/HYPERACTIVITY DISORDER; CHOLINE TRANSPORTER; MOLECULAR-GENETICS; SUSTAINED ATTENTION; VISUAL-ATTENTION	Individuals are not perfectly consistent, and interindividual variability is a common feature in all varieties of human behavior. Some individuals respond more variably than others, however, and this difference may be important to understanding how the brain works. In this paper, we explore genetic contributions to response time (RT) slope variability on a reflexive attention task. We are interested in such variability because we believe it is an important part of the overall picture of attention that, if understood, has the potential to improve intervention for those with attentional deficits. Genetic association studies are valuable in discovering biological pathways of variability and several studies have found such associations with a sustained attention task. Here, we expand our knowledge to include a reflexive attention task. We ask whether specific candidate genes are associated with inter-individual variability on a childhood reflexive attention task in 9-16 year olds. The genetic makers considered are on 11 genes: APOE, BDNF, CHRNA4, COMT, DRD4, HTR4, IGF2, MAOA, SLC5A7, SLC6A3, and SNAP25. We find significant associations with variability with markers on nine and we discuss the results in terms of neurotransmitters associated with each gene and the characteristics of the associated measures from the reflexive attention task.	[Lundwall, Rebecca A.] Brigham Young Univ, Dept Psychol, Provo, UT 84602 USA; [Lundwall, Rebecca A.; Watkins, Jeffrey K.] Brigham Young Univ, Neurosci Ctr, Provo, UT 84602 USA	Brigham Young University; Brigham Young University	Lundwall, RA (corresponding author), Brigham Young Univ, Dept Psychol, Provo, UT 84602 USA.	Rebecca_Lundwall@byu.edu	Lundwall, Rebecca/K-2506-2013	Lundwall, Rebecca/0000-0003-4036-9091	Social Sciences Research Institute at Rice University; Waisman Center (University of Wisconsin-Madison) from the National Institute of Child Health and Human Development [P30 HD03352]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD003352] Funding Source: NIH RePORTER	Social Sciences Research Institute at Rice University; Waisman Center (University of Wisconsin-Madison) from the National Institute of Child Health and Human Development; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	The data analyzed in this study were collected as part of the dissertation research of RAL. Funding for the dissertation was made possible by grants from the Social Sciences Research Institute at Rice University (Dissertation Improvement Grant to RAL and Seed Money Grant to James L. Dannemiller). Infrastructure support was provided by the Waisman Center (University of Wisconsin-Madison) via a core grant from the National Institute of Child Health and Human Development (P30 HD03352; http://www.nichd.nih.gov/about/Pages/index.aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht B, 2014, J CHILD PSYCHOL PSYC, V55, P914, DOI 10.1111/jcpp.12212; Apparsundaram S, 2000, BIOCHEM BIOPH RES CO, V276, P862, DOI 10.1006/bbrc.2000.3561; Barr RS, 2008, NEUROPSYCHOPHARMACOL, V33, P480, DOI 10.1038/sj.npp.1301423; Belbin O, 2007, HUM MOL GENET, V16, P2199, DOI 10.1093/hmg/ddm171; Bellgrove MA, 2005, AM J MED GENET B, V136B, P81, DOI 10.1002/ajmg.b.30193; Bellgrove MA, 2008, ANN NY ACAD SCI, V1129, P200, DOI 10.1196/annals.1417.013; Bidwell LC, 2011, BEHAV GENET, V41, P165, DOI 10.1007/s10519-010-9437-y; Carrasco M, 2011, VISION RES, V51, P1484, DOI 10.1016/j.visres.2011.04.012; Castellanos FX, 2002, NAT REV NEUROSCI, V3, P617, DOI 10.1038/nrn896; Chu CA, 2014, OPTOMETRY VISION SCI, V91, P297, DOI 10.1097/OPX.0000000000000157; CONNERS CK, 1992, CONTINUOUS PERFORMAN; Cools R, 2011, BIOL PSYCHIAT, V69, pE113, DOI 10.1016/j.biopsych.2011.03.028; Cotter RB, 2005, EVAL PROGRAM PLANN, V28, P15, DOI 10.1016/j.evalprogplan.2004.10.002; Dannemiller JL, 2005, DEVELOPMENTAL SCI, V8, P567, DOI 10.1111/j.1467-7687.2005.00448.x; Dong Y, 2013, BIOCHEM PHARMACOL, V86, P1084, DOI 10.1016/j.bcp.2013.07.019; Doran SM, 2001, ARCH ITAL BIOL, V139, P253; Duffy VG, 2002, HUM FACTOR ERGON MAN, V12, P193, DOI 10.1002/hfm.10008; Egan MF, 2003, CELL, V112, P257, DOI 10.1016/S0092-8674(03)00035-7; English BA, 2009, J NEURODEV DISORD, V1, P252, DOI 10.1007/s11689-009-9033-8; Epstein JN, 2011, NEUROPSYCHOLOGY, V25, P427, DOI 10.1037/a0022155; Epstein JN, 1996, NAT GENET, V12, P78; Evans S, 2014, NEUROBIOL AGING, V35, P1615, DOI 10.1016/j.neurobiolaging.2014.01.145; Faraone SV, 2010, PSYCHIAT CLIN N AM, V33, P159, DOI 10.1016/j.psc.2009.12.004; Feng Y, 2005, MOL PSYCHIATR, V10, P998, DOI 10.1038/sj.mp.4001722; Fera F, 2007, BRAIN RES BULL, V74, P75, DOI 10.1016/j.brainresbull.2007.05.009; Forero DA, 2009, J PSYCHIATR NEUROSCI, V34, P361; Forssman L, 2014, J CHILD PSYCHOL PSYC, V55, P793, DOI 10.1111/jcpp.12181; Freed WJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001422; Friedel S, 2007, MOL PSYCHIATR, V12, P923, DOI 10.1038/sj.mp.4001986; Gizer IR, 2009, HUM GENET, V126, P51, DOI 10.1007/s00439-009-0694-x; Gottesman II, 2003, AM J PSYCHIAT, V160, P636, DOI 10.1176/appi.ajp.160.4.636; Greenwood PM, 2000, P NATL ACAD SCI USA, V97, P11661, DOI 10.1073/pnas.97.21.11661; Hawi Z, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060274; Huang X, 2009, TSINGHUA SCI TECHNOL, V14, P534; Karalunas SL, 2013, J CHILD PSYCHOL PSYC, V54, P536, DOI 10.1111/jcpp.12028; Kebir O, 2009, J PSYCHIATR NEUROSCI, V34, P88; Kim JW, 2007, AM J MED GENET B, V144B, P781, DOI 10.1002/ajmg.b.30522; Konrad K, 2010, AM J MED GENET B, V153B, P148, DOI 10.1002/ajmg.b.30967; Kring SII, 2010, PSYCHOSOM MED, V72, P427, DOI 10.1097/PSY.0b013e3181de30ad; Krishnan V, 2007, CELL, V131, P391, DOI 10.1016/j.cell.2007.09.018; Kristofikova Z, 2013, NEUROCHEM RES, V38, P1949, DOI 10.1007/s11064-013-1101-5; Kroener S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006507; Lasky-Su J, 2008, AM J MED GENET B, V147B, P100, DOI 10.1002/ajmg.b.30567; Lijffijt M, 2006, EUR PSYCHIAT, V21, P544, DOI 10.1016/j.eurpsy.2005.04.003; Lundwall RA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030731; Manor I, 2002, MOL PSYCHIATR, V7, P790, DOI 10.1038/sj.mp.4001078; Melendres MCS, 2004, PEDIATRICS, V114, P768, DOI 10.1542/peds.2004-0730; Monte-Silva K, 2009, J NEUROSCI, V29, P6124, DOI 10.1523/JNEUROSCI.0728-09.2009; Munafo MR, 2008, BIOL PSYCHIAT, V63, P197, DOI 10.1016/j.biopsych.2007.04.006; Nandam LS, 2011, BIOL PSYCHIAT, V69, P902, DOI 10.1016/j.biopsych.2010.11.014; Nemeth N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084207; Newman EL, 2012, FRONT BEHAV NEUROSCI, V6, DOI 10.3389/fnbeh.2012.00024; Oades RD, 2008, BEHAV BRAIN FUNCT, V4, DOI 10.1186/1744-9081-4-48; Poitou T, 2012, CONTEMPORARY TRENDS, P15; Posner M.I., 1978, CHRONOMETRIC EXPLORA; POSNER MI, 1980, Q J EXP PSYCHOL, V32, P3, DOI 10.1080/00335558008248231; Preacher KJ, 2005, PSYCHOL METHODS, V10, P178, DOI 10.1037/1082-989X.10.2.178; Ribisl KM, 1996, EVAL PROGRAM PLANN, V19, P1, DOI 10.1016/0149-7189(95)00037-2; Robertson IH, 1997, NEUROPSYCHOLOGIA, V35, P747, DOI 10.1016/S0028-3932(97)00015-8; Sagvolden T, 2005, BEHAV BRAIN SCI, V28, P397, DOI 10.1017/S0140525X05000075; Soderqvist S, 2014, J COGNITIVE NEUROSCI, V26, P54, DOI 10.1162/jocn_a_00478; Stefanis NC, 2005, AM J PSYCHIAT, V162, P1752, DOI 10.1176/appi.ajp.162.9.1752; STERN JA, 1994, HUM FACTORS, V36, P285, DOI 10.1177/001872089403600209; TEBES JK, 1992, EVALUATION REV, V16, P151, DOI 10.1177/0193841X9201600203; Thakur GA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049616; Thapar A, 2005, HUM MOL GENET, V14, pR275, DOI 10.1093/hmg/ddi263; Thomas DC, 2002, CANCER EPIDEM BIOMAR, V11, P505; Thomson CJ, 2013, SCAND J MED SCI SPOR, V23, pe108, DOI 10.1111/sms.12031; van de Giessen EM, 2009, J NUCL MED, V50, P45, DOI 10.2967/jnumed.108.053652; Vaurio RG, 2009, NEUROPSYCHOLOGIA, V47, P2389, DOI 10.1016/j.neuropsychologia.2009.01.022; Wang CA, 2014, J NEUROSCI, V34, P408, DOI 10.1523/JNEUROSCI.3550-13.2014; WhitakerAzmitia PM, 1996, BEHAV BRAIN RES, V73, P19; Witte EA, 1996, BEHAV BRAIN RES, V82, P103, DOI 10.1016/S0166-4328(97)81113-8; Wolska A, 1999, Int J Occup Saf Ergon, V5, P553	74	1	1	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2015	10	6							e0130668	10.1371/journal.pone.0130668	http://dx.doi.org/10.1371/journal.pone.0130668			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4DD	26102342	Green Published, Green Submitted, gold			2022-12-26	WOS:000356901900054
J	McMurray, RG; Butte, NF; Crouter, SE; Trost, SG; Pfeiffer, KA; Bassett, DR; Puyau, MR; Berrigan, D; Watson, KB; Fulton, JE				McMurray, Robert G.; Butte, Nancy F.; Crouter, Scott E.; Trost, Stewart G.; Pfeiffer, Karin A.; Bassett, David R.; Puyau, Maurice R.; Berrigan, David; Watson, Kathleen B.; Fulton, Janet E.		CDC NCI NCCOR Res Grp Energy Expen	Exploring Metrics to Express Energy Expenditure of Physical Activity in Youth	PLOS ONE			English	Article							BODY-SIZE; SUBSTRATE UTILIZATION; AEROBIC POWER; CHILDREN; ADOLESCENTS; EXPLANATION; COMPENDIUM; VARIABLES; EXERCISE; ECONOMY	Background Several approaches have been used to express energy expenditure in youth, but no consensus exists as to which best normalizes data for the wide range of ages and body sizes across a range of physical activities. This study examined several common metrics for expressing energy expenditure to determine whether one metric can be used for all healthy children. Such a metric could improve our ability to further advance the Compendium of Physical Activities for Youth. Methods A secondary analysis of oxygen uptake (VO2) data obtained from five sites was completed, that included 947 children ages 5 to 18 years, who engaged in 14 different activities. Resting metabolic rate (RMR) was computed based on Schofield Equations [Hum Nutr Clin Nut. 39 (Suppl 1), 1985]. Absolute oxygen uptake (ml.min(-1)), oxygen uptake per kilogram body mass (VO2 in ml. kg(-1).min(-1)), net oxygen uptake (VO2 - resting metabolic rate), allometric scaled oxygen uptake (VO2 in ml. kg(-0.75).min(-1)) and YOUTH-MET (VO2.[resting VO2](-1)) were calculated. These metrics were regressed with age, sex, height, and body mass. Results Net and allometric-scaled VO2, and YOUTH-MET were least associated with age, sex and physical characteristics. For moderate-to-vigorous intensity activities, allometric scaling was least related to age and sex. For sedentary and low-intensity activities, YOUTH-MET was least related to age and sex. Conclusions No energy expenditure metric completely eliminated the influence of age, physical characteristics, and sex. The Adult MET consistently overestimated EE. YOUTH-MET was better for expressing energy expenditure for sedentary and light activities, whereas allometric scaling was better for moderate and vigorous intensity activities. From a practical perspective, The YOUTH-MET may be the more feasible metric for improving of the Compendium of Physical Activities for Youth.	[McMurray, Robert G.] Univ N Carolina, Exercise & Sport Sci & Nutr, Chapel Hill, NC 27599 USA; [Butte, Nancy F.; Puyau, Maurice R.] Baylor Coll Med, USDA ARS, Childrens Nutr Res Ctr, Houston, TX 77030 USA; [Crouter, Scott E.; Bassett, David R.] Univ Tennessee, Dept Kinesiol Recreat & Sport Studies, Knoxville, TN USA; [Trost, Stewart G.] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Exercise & Nutr Sci, Brisbane, Qld 4001, Australia; [Pfeiffer, Karin A.] Michigan State Univ, Dept Kinesiol, E Lansing, MI 48824 USA; [Berrigan, David] NCI, Ctr Dis Control & Prevent, Natl Collaborat Childhood Obes Res, Washington, DC USA; [Watson, Kathleen B.; Fulton, Janet E.] CDC, Div Nutr Phys Act & Obes, Atlanta, GA 30333 USA	University of North Carolina; University of North Carolina Chapel Hill; Baylor College of Medicine; United States Department of Agriculture (USDA); University of Tennessee System; University of Tennessee Knoxville; Queensland University of Technology (QUT); Michigan State University; Centers for Disease Control & Prevention - USA; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Centers for Disease Control & Prevention - USA	McMurray, RG (corresponding author), Univ N Carolina, Exercise & Sport Sci & Nutr, Chapel Hill, NC 27599 USA.	exphys@live.unc.edu	Pfeiffer, Karin A/D-5252-2018; Crouter, Scott/H-4852-2011; Berrigan, David/AAF-1576-2020; Trost, Stewart G/B-5948-2012	Pfeiffer, Karin A/0000-0001-6280-9495; Crouter, Scott/0000-0003-1297-9538; Trost, Stewart G/0000-0001-9587-3944; Berrigan, David/0000-0002-5333-179X	NHLBI NIH HHS [R21 HL093407] Funding Source: Medline; NICHD NIH HHS [L30 HD066736] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL093407] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Abbott RA, 2004, ANN HUM BIOL, V31, P690, DOI 10.1080/03014460400019786; Ainsworth BE, 2011, MED SCI SPORT EXER, V43, P1575, DOI 10.1249/MSS.0b013e31821ece12; Ainsworth BE, 2000, MED SCI SPORT EXER, V32, pS498, DOI 10.1097/00005768-200009001-00009; [Anonymous], 2008, PHYS ACTIVITY GUIDEL; Brehm MA, 2012, DEV MED CHILD NEUROL, V54, P267, DOI 10.1111/j.1469-8749.2011.04164.x; Butte NE, 2010, J NUTR, V140, P1516, DOI 10.3945/jn.109.120162; Crouter SE, 2013, MED SCI SPORT EXER, V45, P1403, DOI 10.1249/MSS.0b013e318285f03b; Eisenmann JC, 2005, EUR J APPL PHYSIOL, V93, P440, DOI 10.1007/s00421-004-1227-x; Glazier DS, 2005, BIOL REV, V80, P611, DOI 10.1017/S1464793105006834; Harrell JS, 2005, MED SCI SPORT EXER, V37, P329, DOI 10.1249/01.MSS.0000153115.33762.3F; Janz KF, 1998, MED SCI SPORT EXER, V30, P1436, DOI 10.1097/00005768-199809000-00014; Malina RM, 2004, GROWTH MATURATION PH, V2nd, P235; MARTINEZ LR, 1992, MED SCI SPORT EXER, V24, P975; McMurray RG, 2011, PEDIATR EXERC SCI, V23, P411, DOI 10.1123/pes.23.3.411; McMurray RG, 2011, ANN HUM BIOL, V38, P647, DOI 10.3109/03014460.2011.598561; MENG XL, 1992, PSYCHOL BULL, V111, P172, DOI 10.1037/0033-2909.111.1.172; MORGAN DW, 1989, SPORTS MED, V7, P310, DOI 10.2165/00007256-198907050-00003; Nevill AM, 2005, YEARB PHYS ANTHROPOL, V48, P141, DOI 10.1002/ajpa.20356; NEVILL AM, 1994, J APPL PHYSIOL, V77, P2870, DOI 10.1152/jappl.1994.77.6.2870; NEVILL AM, 1992, EUR J APPL PHYSIOL, V65, P110, DOI 10.1007/BF00705066; Ondrak KS, 2007, J ADOLESCENT HEALTH, V41, P146, DOI 10.1016/j.jadohealth.2007.03.008; Peyrot N, 2012, MED SCI SPORT EXER, V44, P659, DOI 10.1249/MSS.0b013e318236edd8; Ridley K, 2008, INT J BEHAV NUTR PHY, V5, DOI 10.1186/1479-5868-5-45; ROBINSON S., 1938, ARBEITSPHYSIOL, V10, P251; Rowland T., 2005, CHILDRENS EXERCISE P, P80; Schofield W N, 1985, Hum Nutr Clin Nutr, V39 Suppl 1, P5; Snedecor GW., 1989, STAT METHODS, P177; Trost SG, 2011, MED SCI SPORT EXER, V43, P1360, DOI 10.1249/MSS.0b013e318206476e; Welsman JR, 1996, MED SCI SPORT EXER, V28, P259, DOI 10.1097/00005768-199602000-00016; WHO, 2014, CHILDH OV OB; Zakeri I, 2006, J NUTR, V136, P1371, DOI 10.1093/jn/136.5.1371; Zunquin G, 2009, BRIT J SPORT MED, V43, P869, DOI 10.1136/bjsm.2007.044529	32	35	35	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2015	10	6							e0130869	10.1371/journal.pone.0130869	http://dx.doi.org/10.1371/journal.pone.0130869			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4DD	26102204	Green Published, gold, Green Submitted			2022-12-26	WOS:000356901900064
J	Amaladoss, A; Chen, QF; Liu, M; Dummler, SK; Dao, M; Suresh, S; Chen, JZ; Preiser, PR				Amaladoss, Anburaj; Chen, Qingfeng; Liu, Min; Dummler, Sara K.; Dao, Ming; Suresh, Subra; Chen, Jianzhu; Preiser, Peter R.			De Novo Generated Human Red Blood Cells in Humanized Mice Support Plasmodium falciparum Infection	PLOS ONE			English	Article							HUMAN MALARIA PARASITES; NOD/LTSZ-SCID MICE; IN-VIVO MODEL; IMMUNOCOMPROMISED MICE; HUMAN ERYTHROCYTES; RECONSTITUTION; DEFORMABILITY; CLEARANCE; RECEPTOR; DISEASE	Immunodeficient mouse-human chimeras provide a powerful approach to study host specific pathogens like Plasmodium (P.) falciparum that causes human malaria. Existing mouse models of P. falciparum infection require repeated injections of human red blood cells (RBCs). In addition, clodronate lipsomes and anti-neutrophil antibodies are injected to suppress the clearance of human RBCs by the residual immune system of the immunodeficient mice. Engraftment of NOD-scid Il2rg(-/-) mice with human hematopoietic stem cells leads to reconstitution of human immune cells. Although human B cell reconstitution is robust and T cell reconstitution is reasonable in the recipient mice, human RBC reconstitution is generally poor or undetectable. The poor reconstitution is mainly the result of a deficiency of appropriate human cytokines that are necessary for the development and maintenance of these cell lineages. Delivery of plasmid DNA encoding human erythropoietin and interleukin-3 into humanized mice by hydrodynamic tail-vein injection resulted in significantly enhanced reconstitution of erythrocytes. With this improved humanized mouse, here we show that P. falciparum infects de novo generated human RBCs, develops into schizonts and causes successive reinvasion. We also show that different parasite strains exhibit variation in their ability to infect these humanized mice. Parasites could be detected by nested PCR in the blood samples of humanized mice infected with P. falciparum K1 and HB3 strains for 3 cycles, whereas in other strains such as 3D7, DD2, 7G8, FCR3 and W2mef parasites could only be detected for 1 cycle. In vivo adaptation of K1 strain further improves the infection efficiency and parasites can be detected by microscopy for 3 cycles. The parasitemia ranges between 0.13 and 0.25% at the first cycle of infection, falls between 0.08 and 0.15% at the second cycle, and drops to barely detectable levels at the third cycle of infection. Compared to existing mouse models, our model generates human RBCs de novo and does not require the treatment of mice with immunomodulators.	[Amaladoss, Anburaj; Chen, Qingfeng; Liu, Min; Dummler, Sara K.; Dao, Ming; Chen, Jianzhu; Preiser, Peter R.] Singapore Massachusetts Inst Technol Alliance Res, Infect Dis Interdisciplinary Res Grp, Singapore 138602, Singapore; [Chen, Qingfeng] Agcy Sci Technol & Res, Inst Mol & Cell Biol, Humanised Mouse Unit, Singapore 138673, Singapore; [Dao, Ming] MIT, Dept Mat Sci & Engn, Cambridge, MA 02139 USA; [Suresh, Subra] Carnegie Mellon Univ, Dept Biomed Engn, Pittsburgh, PA 15213 USA; [Suresh, Subra] Carnegie Mellon Univ, Dept Mat Sci & Engn, Pittsburgh, PA 15213 USA; [Chen, Jianzhu] MIT, Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA; [Chen, Jianzhu] MIT, Dept Biol, Cambridge, MA 02139 USA; [Preiser, Peter R.] Nanyang Technol Univ, Sch Biol Sci, Singapore 637551, Singapore	Massachusetts Institute of Technology (MIT); Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; National University of Singapore; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); Massachusetts Institute of Technology (MIT); Carnegie Mellon University; Carnegie Mellon University; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Dao, M (corresponding author), Singapore Massachusetts Inst Technol Alliance Res, Infect Dis Interdisciplinary Res Grp, Singapore 138602, Singapore.	mingdao@mit.edu; prpreiser@ntu.edu.sg	Dao, Ming/B-1602-2008; Preiser, Peter R/A-2201-2011; Suresh, Subra/B-8289-2008	Dao, Ming/0000-0001-5372-385X; Suresh, Subra/0000-0002-6223-6831; , Peter/0000-0003-4331-7000; Friedl, Sara Katharina/0000-0002-8566-9875	National Research Foundation Singapore through the Singapore-MIT Alliance for Research and Technology's Infectious Disease IRG research programme	National Research Foundation Singapore through the Singapore-MIT Alliance for Research and Technology's Infectious Disease IRG research programme	This research was supported by the National Research Foundation Singapore through the Singapore-MIT Alliance for Research and Technology's Infectious Disease IRG research programme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angulo-Barturen I, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002252; Arnold L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018045; Badell E, 2000, J EXP MED, V192, P1653, DOI 10.1084/jem.192.11.1653; Jimenez-Diaz MB, 2009, ANTIMICROB AGENTS CH, V53, P4533, DOI 10.1128/AAC.00519-09; Blackman M.J., 2008, METHODS MALARIA RES, P73; Chen QF, 2014, P NATL ACAD SCI USA, V111, P1479, DOI 10.1073/pnas.1323318111; Chen QF, 2009, P NATL ACAD SCI USA, V106, P21783, DOI 10.1073/pnas.0912274106; Crabb BS, 1997, CELL, V89, P287, DOI 10.1016/S0092-8674(00)80207-X; Diez-Silva M, 2010, MRS BULL, V35, P382, DOI 10.1557/mrs2010.571; Fernandez V., 2008, METHODS MALARIA RES, P25; Hu Z, 2011, BLOOD, V118, P5938, DOI 10.1182/blood-2010-11-321414; Huang S, 2014, INFECT IMMUN, V82, P2532, DOI 10.1128/IAI.01525-13; Huang S, 2013, INTEGR BIOL-UK, V5, P414, DOI 10.1039/c2ib20161e; Jarra W, 1998, INFECT IMMUN, V66, P3783, DOI 10.1128/IAI.66.8.3783-3787.1998; KLOTZ FW, 1987, J EXP MED, V165, P1713, DOI 10.1084/jem.165.6.1713; MOORE JM, 1995, J EXP MED, V181, P2265, DOI 10.1084/jem.181.6.2265; Moreno A, 2006, INT J PARASITOL, V36, P361, DOI 10.1016/j.ijpara.2005.10.012; Moreno A, 2001, ANTIMICROB AGENTS CH, V45, P1847, DOI 10.1128/AAC.45.6.1847-1853.2001; Moreno A, 2007, TRENDS PARASITOL, V23, P254, DOI 10.1016/j.pt.2007.04.004; Sabater AM, 2005, PARASITOL RES, V95, P97, DOI 10.1007/s00436-004-1249-7; Shultz LD, 2005, J IMMUNOL, V174, P6477, DOI 10.4049/jimmunol.174.10.6477; Shultz LD, 2007, ANN NY ACAD SCI, V1103, P77, DOI 10.1196/annals.1394.002; SNOUNOU G, 1993, MOL BIOCHEM PARASIT, V61, P315, DOI 10.1016/0166-6851(93)90077-B; Suresh S, 2005, ACTA BIOMATER, V1, P15, DOI 10.1016/j.actbio.2004.09.001; Thompson JK, 2001, MOL MICROBIOL, V41, P47, DOI 10.1046/j.1365-2958.2001.02484.x; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; TSUJI M, 1995, VACCINE, V13, P1389, DOI 10.1016/0264-410X(95)00081-B	27	17	19	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2015	10	6							e0129825	10.1371/journal.pone.0129825	http://dx.doi.org/10.1371/journal.pone.0129825			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL3FM	26098918	Green Submitted, Green Published, gold			2022-12-26	WOS:000356835800042
J	Andersson, C; Kvist, PH; McElhinney, K; Baylis, R; Gram, LK; Pelzer, H; Lauritzen, B; Holm, TL; Hogan, S; Wu, D; Turpin, B; Miller, W; Palumbo, JS				Andersson, Christina; Kvist, Peter H.; McElhinney, Kathryn; Baylis, Richard; Gram, Luise K.; Pelzer, Hermann; Lauritzen, Brian; Holm, Thomas L.; Hogan, Simon; Wu, David; Turpin, Brian; Miller, Whitney; Palumbo, Joseph S.			Factor XIII Transglutaminase Supports the Resolution of Mucosal Damage in Experimental Colitis	PLOS ONE			English	Article							COAGULATION-FACTOR-XIII; TISSUE FACTOR; FIBRIN; DEFICIENCY; MECHANISMS; INFECTION; MICE; SUBSTITUTION; RECRUITMENT; ACTIVATION	The thrombin-activated transglutaminase factor XIII (FXIII) that covalently crosslinks and stablizes provisional fibrin matrices is also thought to support endothelial and epithelial barrier function and to control inflammatory processes. Here, gene-targeted mice lacking the FXIII catalytic A subunit were employed to directly test the hypothesis that FXIII limits colonic pathologies associated with experimental colitis. Wildtype (WT) and FXIII-/- mice were found to be comparable in their initial development of mucosal damage following exposure to dextran sulfate sodium (DSS) challenge. However, unlike FXIII-sufficient mice, FXIII-deficient cohorts failed to efficiently resolve colonic inflammatory pathologies and mucosal damage following withdrawal of DSS. Consistent with prior evidence of ongoing coagulation factor activation and consumption in individuals with active colitis, plasma FXIII levels were markedly decreased in colitis-challenged WT mice. Treatment of colitis-challenged mice with recombinant human FXIII-A zymogen significantly mitigated weight loss, intestinal bleeding, and diarrhea, regardless of whether cohorts were FXIII-sufficient or were genetically devoid of FXIII. Similarly, both qualitative and quantitative microscopic analyses of colonic tissues revealed that exogenous FXIII improved the resolution of multiple colitis disease parameters in both FXIII-/- and WT mice. The most striking differences were seen in the resolution of mucosal ulceration, the most severe histopathological manifestation of DSS-induced colitis. These findings directly demonstrate that FXIII is a significant determinant of mucosal healing and clinical outcome following inflammatory colitis induced mucosal injury and provide a proof-of-principle that clinical interventions supporting FXIII activity may be a means to limit colitis pathology and improve resolution of mucosal damage.	[Andersson, Christina; Kvist, Peter H.; Gram, Luise K.; Pelzer, Hermann; Lauritzen, Brian; Holm, Thomas L.] Novo Nordisk AS, Biopharmaceut Res Unit, Copenhagen, Denmark; [Hogan, Simon; Wu, David] Cincinnati Childrens Hosp Med Ctr, Div Allergy & Immunol, Cincinnati, OH 45229 USA; [McElhinney, Kathryn; Baylis, Richard; Turpin, Brian; Miller, Whitney; Palumbo, Joseph S.] Cincinnati Childrens Hosp Med Ctr, Canc & Blood Dis Inst, Cincinnati, OH 45229 USA	Novo Nordisk; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center	Palumbo, JS (corresponding author), Cincinnati Childrens Hosp Med Ctr, Canc & Blood Dis Inst, Cincinnati, OH 45229 USA.	joe.palumbo@cchmc.org			National Institutes of Health [HL085545]; Novo Nordisk Corporation; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001425] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL085545] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK078392] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Novo Nordisk Corporation; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	These studies were supported by the National Institutes of Health (grant HL085545, JSP) and grant funding from Novo Nordisk Corporation (JSP). The funder provided support in the form of salaries for authors (C.A., P.H.K., L.K.G., H.P., B.L., T.L.H., W.M., J.S.P), but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	AbdAlla S, 2004, CELL, V119, P343, DOI 10.1016/j.cell.2004.10.006; Adams RA, 2007, J EXP MED, V204, P571, DOI 10.1084/jem.20061931; Aleman MM, 2014, J CLIN INVEST, V124, P3590, DOI 10.1172/JCI75386; Anthoni C, 2007, J EXP MED, V204, P1595, DOI 10.1084/jem.20062354; Anwar R, 1999, BRIT J HAEMATOL, V107, P468, DOI 10.1046/j.1365-2141.1999.01648.x; Bagoly Z, 2012, THROMB RES, V129, pS77, DOI 10.1016/j.thromres.2012.02.040; BOARD PG, 1993, BLOOD REV, V7, P229, DOI 10.1016/0268-960X(93)90010-2; Chamouard P, 1998, AM J GASTROENTEROL, V93, P610; Chiarantini E, 1996, THROMB RES, V82, P137, DOI 10.1016/0049-3848(96)00060-6; D'Argenio G, 2005, GUT, V54, P496, DOI 10.1136/gut.2004.049411; D'Argenio G, 2000, DIGEST DIS SCI, V45, P987, DOI 10.1023/A:1005541512152; D'Argenio G, 2001, DIGEST DIS SCI, V46, P649, DOI 10.1023/A:1005680022573; Dardik R, 2006, THROMB HAEMOSTASIS, V95, P546, DOI 10.1160/TH05-06-0409; Dardik R, 2005, ARTERIOSCL THROM VAS, V25, P526, DOI 10.1161/01.ATV.0000154137.21230.80; Davalos D, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2230; Degen JL, 2007, J THROMB HAEMOST, V5, P24, DOI 10.1111/j.1538-7836.2007.02519.x; Drew AF, 1998, BLOOD, V91, P1616, DOI 10.1182/blood.V91.5.1616.1616_1616_1624; Flick MJ, 2013, BLOOD, V121, P1783, DOI 10.1182/blood-2012-09-453894; Flick MJ, 2004, J CLIN INVEST, V113, P1596, DOI 10.1172/JCI200420741; Ichinose A, 2012, INT J HEMATOL, V95, P362, DOI 10.1007/s12185-012-1064-3; Inbal A, 2005, THROMB HAEMOSTASIS, V94, P432, DOI 10.1160/TH05-04-0291; Inbal A, 2006, PATHOPHYSIOL HAEMO T, V35, P162, DOI 10.1159/000093562; Ivaskevicius V, 2007, THROMB HAEMOSTASIS, V97, P914, DOI 10.1160/TH07-01-0034; Kasahara K, 2010, BLOOD, V115, P1277, DOI 10.1182/blood-2009-06-227645; Linskens RK, 2001, DIGEST DIS SCI, V46, P644, DOI 10.1023/A:1005628005734; Loof TG, 2011, BLOOD, V118, P2589, DOI 10.1182/blood-2011-02-337568; Lorand L, 2001, ANN NY ACAD SCI, V936, P291; LORENZ R, 1995, LANCET, V345, P449, DOI 10.1016/S0140-6736(95)90428-X; LORENZ R, 1991, HAEMOSTASIS, V21, P5; Lorenz Reinhard, 1996, Seminars in Thrombosis and Hemostasis, V22, P451, DOI 10.1055/s-2007-999045; Luo DY, 2011, J IMMUNOL, V187, P1866, DOI 10.4049/jimmunol.1101094; Mullarky IK, 2005, INFECT IMMUN, V73, P3888, DOI 10.1128/IAI.73.7.3888-3895.2005; Nagalingam NA, 2012, INFLAMM BOWEL DIS, V18, P968, DOI 10.1002/ibd.21866; Nahrendorf M, 2006, CIRCULATION, V113, P1196, DOI 10.1161/CIRCULATIONAHA.105.602094; Ponce R, 2005, TOXICOL PATHOL, V33, P702, DOI 10.1080/15459620500330625; Ponce RA, 2005, TOXICOL PATHOL, V33, P495, DOI 10.1080/01926230490966247; Reber SO, 2006, ENDOCRINOLOGY, V147, P4968, DOI 10.1210/en.2006-0347; Richardson VR, 2013, CLIN SCI, V124, P123, DOI 10.1042/CS20120233; Saleh M, 2011, NAT REV IMMUNOL, V11, P9, DOI 10.1038/nri2891; Sarvary A, 2004, CELL IMMUNOL, V228, P81, DOI 10.1016/j.cellimm.2004.04.007; Schroeder V, 2007, SWISS MED WKLY, V137, P272; Serrano K, 2002, THROMB HAEMOSTASIS, V88, P315; Soendergaard C, 2013, J THROMB HAEMOST, V11, P806, DOI 10.1111/jth.12169; Souri M, 2008, THROMB HAEMOSTASIS, V99, P401, DOI 10.1160/TH07-10-0599; Steinbrecher KA, 2008, J IMMUNOL, V180, P2588, DOI 10.4049/jimmunol.180.4.2588; Steinbrecher KA, 2010, CANCER RES, V70, P2634, DOI 10.1158/0008-5472.CAN-09-3465; Sun HM, 2009, BLOOD, V113, P1358, DOI 10.1182/blood-2008-07-170506; SUZUKI R, 1989, BLUT, V59, P162, DOI 10.1007/BF00320061; Tsujimoto I, 2011, AM J PATHOL, V179, P3011, DOI 10.1016/j.ajpath.2011.08.037; Turpin B, 2014, CANCER RES, V74, P3020, DOI 10.1158/0008-5472.CAN-13-3276; Vowinkel T, 2007, AM J PHYSIOL-GASTR L, V293, pG1054, DOI 10.1152/ajpgi.00350.2007; Xu YH, 2008, J NEUROIMMUNOL, V200, P53, DOI 10.1016/j.jneuroim.2008.06.008; Zaets SB, 2011, J SURG RES, V166, pE135, DOI 10.1016/j.jss.2010.12.001; Zaets SB, 2009, SHOCK, V31, P621, DOI 10.1097/SHK.0b013e31818bbe21	54	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2015	10	6							e0128113	10.1371/journal.pone.0128113	http://dx.doi.org/10.1371/journal.pone.0128113			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL3FM	26098308	Green Published, gold, Green Submitted			2022-12-26	WOS:000356835800011
J	Arvai, KJ; Hsu, YH; Lee, LA; Jones, D				Arvai, Kevin J.; Hsu, Ya-Hsuan; Lee, Lobin A.; Jones, Dan			A Transition Zone Showing Highly Discontinuous or Alternating Levels of Stem Cell and Proliferation Markers Characterizes the Development of PTEN-Haploinsufficient Colorectal Cancer	PLOS ONE			English	Article							ESC SELF-RENEWAL; SIGNALING PATHWAYS; TUMOR-SUPPRESSOR; CARCINOMA-CELLS; BETA-CATENIN; HUMAN COLON; EXPRESSION; ACTIVATION; SURVIVAL; AKT	Background Stepwise acquisition of oncogene mutations and deletion/inactivation of tumor suppressor genes characterize the development of colorectal cancer (CRC). These genetic events interact with discrete morphologic transitions from hyperplastic mucosa to adenomatous areas, followed by in situ malignant transformation and finally invasive carcinoma. The goal of this study was to identify tissue markers of the adenoma-carcinoma morphogenetic transitions in CRC. Methods and Findings We analyzed the patterns of expression of growth regulatory and stem cell markers across these distinct morphologic transition zones in 735 primary CRC tumors. In 202 cases with preserved adenoma-adenocarcinoma transition, we identified, in 37.1% of cases, a zone of adenomatous epithelium, located immediately adjacent to the invasive component, that showed rapidly alternating intraglandular stretches of PTEN+ and PTEN-epithelium. This zone exactly overlapped with similar alternating expression of Ki-67 and inversely with the transforming growth factor-beta (TGF-beta) growth regulator SMAD4. These zones also show parallel alternating levels and/or subcellular localization of multiple cancer stem/progenitor cell (CSC) markers, including beta-catenin/CTNNB1, ALDH1, and CD44. PTEN was always re-expressed in the invasive tumor in these cases, unlike those with complete loss of PTEN expression. Genomic microarray analysis of CRC with prominent CSC-like expansions demonstrated a high frequency of PTEN genomic deletion/haploinsufficiency in tumors with CSC-like transition zones (62.5%) but not in tumors with downregulated but non-alternating PTEN expression (14.3%). There were no significant differences in the levels of KRAS mutation or CTNNB1 mutation in CSC-like tumors as compared to unselected CRC cases. Conclusions In conclusion, we have identified a distinctive CSC-like pre-invasive transition zone in PTEN-haploinsufficient CRC that shows convergent on-off regulation of the PTEN/AKT, TGF-beta/SMAD and Wnt/beta-catenin pathways. This bottleneck-like zone is usually followed by the emergence of invasive tumors with intact PTEN expression but dysregulated TP53 and uniformly high proliferation rates.	[Arvai, Kevin J.; Lee, Lobin A.; Jones, Dan] Quest Diagnost Nichols Inst, Dept Pathol, Chantilly, VA USA; [Hsu, Ya-Hsuan] Quest Diagnost Nichols Inst, Dept Cytogenet, Chantilly, VA USA		Jones, D (corresponding author), Ohio State Univ, Dept Pathol, Columbus, OH 43210 USA.	dan.jones.gm@gmail.com		Arvai, Kevin/0000-0001-8751-8918	Quest Diagnostics	Quest Diagnostics	There are no current funding sources for this study. Quest Diagnostics provided support in the form of reagents/materials and salaries for all authors, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The Scientific Publications staff at Quest Diagnostics reviewed the manuscript prior to submission, with the names of these reviewers listed in the acknowledgment section, with their approval.	Byun DS, 2011, AM J PHYSIOL-GASTR L, V301, pG856, DOI 10.1152/ajpgi.00178.2011; Chang CC, 2005, J BIOL CHEM, V280, P10164, DOI 10.1074/jbc.M409161200; CHO KR, 1992, J CELL BIOCHEM, P137; Clevers H, 2013, NATURE, V495, P53, DOI 10.1038/nature11958; Djordjeyic B, 2012, MODERN PATHOL, V25, P699, DOI 10.1038/modpathol.2011.208; Du L, 2008, CLIN CANCER RES, V14, P6751, DOI 10.1158/1078-0432.CCR-08-1034; Finkielsztein A, 2009, BIOL CELL, V101, P661, DOI 10.1042/BC20090034; Freeman TJ, 2012, GASTROENTEROLOGY, V142, P562, DOI 10.1053/j.gastro.2011.11.026; GOLDBERG DM, 1993, CLIN CHEM, V39, P2360; Hammoud SS, 2013, CURR OPIN CELL BIOL, V25, P177, DOI 10.1016/j.ceb.2013.01.007; He XC, 2004, NAT GENET, V36, P1117, DOI 10.1038/ng1430; He XC, 2007, NAT GENET, V39, P189, DOI 10.1038/ng1928; Hill R, 2010, CANCER RES, V70, P7114, DOI 10.1158/0008-5472.CAN-10-1649; Hill R, 2009, J BIOL CHEM, V284, P11755, DOI 10.1074/jbc.R800071200; Jung CJ, 2012, MOL CANCER RES, V10, P979, DOI 10.1158/1541-7786.MCR-11-0421; Jung HY, 2013, MOL CELL, V52, P193, DOI 10.1016/j.molcel.2013.08.028; Kaur M, 2013, CANCER RES, V73, P695, DOI 10.1158/0008-5472.CAN-12-2522; Kharas MG, 2010, BLOOD, V115, P1406, DOI 10.1182/blood-2009-06-229443; Kobielak K, 2007, P NATL ACAD SCI USA, V104, P10063, DOI 10.1073/pnas.0703004104; Lee MY, 2009, STEM CELLS, V27, P1858, DOI 10.1002/stem.124; Lin YJ, 2012, MOL CELL, V48, P627, DOI 10.1016/j.molcel.2012.08.030; Mukherjee A, 2013, MOL CARCINOGEN, V52, P611, DOI 10.1002/mc.21903; Mutter GL, 2001, CANCER RES, V61, P4311; Mutter GL, 2000, JNCI-J NATL CANCER I, V92, P924, DOI 10.1093/jnci/92.11.924; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Naguib A, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-123; Narducci MG, 2002, P NATL ACAD SCI USA, V99, P11712, DOI 10.1073/pnas.182412399; Ning ZQ, 2001, BLOOD, V97, P3559, DOI 10.1182/blood.V97.11.3559; Nucci MR, 1997, HUM PATHOL, V28, P1396, DOI 10.1016/S0046-8177(97)90230-6; Pinto D, 2005, EXP CELL RES, V306, P357, DOI 10.1016/j.yexcr.2005.02.022; Sakr RA, 2010, APPL IMMUNOHISTO M M, V18, P371, DOI 10.1097/PAI.0b013e3181d50bd5; Seminario MC, 2003, ONCOGENE, V22, P8195, DOI 10.1038/sj.onc.1206872; Tian XX, 2009, BIOCHEM BIOPH RES CO, V380, P478, DOI 10.1016/j.bbrc.2009.01.124; Trotman LC, 2003, PLOS BIOL, V1, P385, DOI 10.1371/journal.pbio.0000059; Voutsadakis IA, 2008, BBA-MOL BASIS DIS, V1782, P800, DOI 10.1016/j.bbadis.2008.06.007; Wan M, 2002, EMBO REP, V3, P171, DOI 10.1093/embo-reports/kvf024; Wilkens L, 2005, VIRCHOWS ARCH, V447, P586, DOI 10.1007/s00428-005-1211-9; Xia DR, 2007, J BIOL CHEM, V282, P3507, DOI 10.1074/jbc.M610141200	38	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2015	10	6							e0131108	10.1371/journal.pone.0131108	http://dx.doi.org/10.1371/journal.pone.0131108			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL3FM	26098881	Green Published, gold, Green Submitted			2022-12-26	WOS:000356835800150
J	Brown, AR; Correa, E; Xu, Y; AlMasoud, N; Pimblott, SM; Goodacre, R; Lloyd, JR				Brown, Ashley R.; Correa, Elon; Xu, Yun; AlMasoud, Najla; Pimblott, Simon M.; Goodacre, Royston; Lloyd, Jonathan R.			Phenotypic Characterisation of Shewanella oneidensis MR-1 Exposed to X-Radiation	PLOS ONE			English	Article							TRANSFORM INFRARED-SPECTROSCOPY; AMINO-ACID-RESIDUES; DEINOCOCCUS-RADIODURANS; MICROBIAL REDUCTION; QUANTITATIVE DETECTION; IONIZING-RADIATION; GAMMA-RADIATION; FERRIC IRON; DNA-DAMAGE; OXIDATION	Biogeochemical processes mediated by Fe(III)-reducing bacteria such as Shewanella oneidensis have the potential to influence the post-closure evolution of a geological disposal facility for radioactive wastes and to affect the solubility of some radionuclides. Furthermore, their potential to reduce both Fe(III) and radionuclides can be harnessed for the bioremediation of radionuclide-contaminated land. As some such sites are likely to have significant radiation fluxes, there is a need to characterise the impact of radiation stress on such microorganisms. There have, however, been few global cell analyses on the impact of ionizing radiation on subsurface bacteria, so here we address the metabolic response of S. oneidensis MR-1 to acute doses of X-radiation. UV/Vis spectroscopy and CFU counts showed that although X-radiation decreased initial viability and extended the lag phase of batch cultures, final biomass yields remained unchanged. FT-IR spectroscopy of whole cells indicated an increase in lipid associated vibrations and decreases in vibrations tentatively assigned to nucleic acids, phosphate, saccharides and amines. MALDI-TOF-MS detected an increase in total protein expression in cultures exposed to 12 Gy. At 95 Gy, a decrease in total protein levels was generally observed, although an increase in a putative cold shock protein was observed, which may be related to the radiation stress response of this organism. Multivariate statistical analyses applied to these FT-IR and MALDI-TOF-MS spectral data suggested that an irradiated phenotype developed throughout subsequent generations. This study suggests that significant alteration to the metabolism of S. oneidensis MR-1 is incurred as a result of X-irradiation and that dose dependent changes to specific biomolecules characterise this response. Irradiated S. oneidensis also displayed enhanced levels of poorly crystalline Fe(III) oxide reduction, though the mechanism underpinning this phenomenon is unclear.	[Brown, Ashley R.; Lloyd, Jonathan R.] Univ Manchester, Williamson Res Ctr Mol Environm Sci, Manchester M13 9PL, Lancs, England; [Brown, Ashley R.; Lloyd, Jonathan R.] Univ Manchester, Res Ctr Radwaste & Decommissioning, Manchester M13 9PL, Lancs, England; [Brown, Ashley R.; Lloyd, Jonathan R.] Univ Manchester, Sch Earth Atmospher & Environm Sci, Manchester M13 9PL, Lancs, England; [Correa, Elon; Xu, Yun; AlMasoud, Najla; Goodacre, Royston] Univ Manchester, Manchester Inst Biotechnol, Manchester M1 7DN, Lancs, England; [Pimblott, Simon M.] Univ Manchester, Dalton Cumbrian Facil, Moor Row CA24 3HA, Cumbria, England; [Pimblott, Simon M.; Goodacre, Royston] Univ Manchester, Sch Chem, Manchester M13 9PL, Lancs, England	University of Manchester; University of Manchester; University of Manchester; University of Manchester; University of Manchester; University of Manchester	Lloyd, JR (corresponding author), Univ Manchester, Williamson Res Ctr Mol Environm Sci, Oxford Rd, Manchester M13 9PL, Lancs, England.	jon.lloyd@manchester.ac.uk	Pimblott, Simon/AAM-3434-2021; Goodacre, Roy/J-1600-2012; Goodacre, Roy/AAO-3194-2021; Xu, Yun/ABG-2114-2021; Correa, Elon/T-8686-2019; Pimblott, Simon/AAL-6818-2020	Pimblott, Simon/0000-0001-9169-3030; Goodacre, Roy/0000-0003-2230-645X; Goodacre, Roy/0000-0003-2230-645X; Xu, Yun/0000-0003-3228-5111; Lloyd, Jonathan/0000-0002-0719-0498; Correa, Elon/0000-0002-5122-4384	UK Biotechnology and Biological Sciences Research Council [BB/F017472/1]; CASE award from Radioactive Waste Management	UK Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); CASE award from Radioactive Waste Management	This work was funded by a PhD studentship from the UK Biotechnology and Biological Sciences Research Council (BB/F017472/1) awarded to ARB and a CASE award from Radioactive Waste Management. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allard T, 2009, APPL CLAY SCI, V43, P143, DOI 10.1016/j.clay.2008.07.032; [Anonymous], 2014, ICOSHIFT PUBLICLY AV; Apweiler R, 2013, NUCLEIC ACIDS RES, V41, pD43, DOI 10.1093/nar/gks1068; Artimo P, 2012, NUCLEIC ACIDS RES, V40, pW597, DOI 10.1093/nar/gks400; Berlett BS, 1997, J BIOL CHEM, V272, P20313, DOI 10.1074/jbc.272.33.20313; Brereton RG, 2003, CHEMOMETRICS DATA AN, DOI [10.1016/j.aca.2009.06.015, DOI 10.1016/J.ACA.2009.06.015]; Brim H, 2000, NAT BIOTECHNOL, V18, P85, DOI 10.1038/71986; Brim H, 2003, APPL ENVIRON MICROB, V69, P4575, DOI 10.1128/AEM.69.8.4575-4582.2003; Brown AR, 2014, ENVIRON SCI TECHNOL, V48, P10672, DOI 10.1021/es503249r; Chatfield C., 1980, INTRO MULTIVARIATE A; Choo-Smith LP, 2001, APPL ENVIRON MICROB, V67, P1461, DOI 10.1128/AEM.67.4.1461-1469.2001; Correa E, 2012, ANAL BIOANAL CHEM, V403, P2591, DOI 10.1007/s00216-012-6068-6; Daly MJ, 2007, PLOS BIOL, V5, P769, DOI 10.1371/journal.pbio.0050092; Daly MJ, 2004, SCIENCE, V306, P1025, DOI 10.1126/science.1103185; Daulton TL, 2007, GEOCHIM COSMOCHIM AC, V71, P556, DOI 10.1016/j.gca.2006.10.007; Dertinger H, 1970, MOL RAD BIOL ACTION; Du J, 2004, INT J BIOCHEM CELL B, V36, P2334, DOI 10.1016/j.biocel.2004.05.012; Ehrlich H., 2002, GEOMICROBIOLOGY; Ellis DI, 2003, METABOLIC PROFILING: ITS ROLE IN BIOMARKER DISCOVERY AND GENE FUNCTION ANALYSIS, P111; Ellis DI, 2002, APPL ENVIRON MICROB, V68, P2822, DOI 10.1128/AEM.68.6.2822-2828.2002; Fredrickson JK, 2004, APPL ENVIRON MICROB, V70, P4230, DOI 10.1128/AEM.70.7.4230-4241.2004; Fricke H, 1935, J CHEM PHYS, V3, P60, DOI 10.1063/1.1749558; Ghosal D, 2005, FEMS MICROBIOL REV, V29, P361, DOI 10.1016/j.fmrre.2004.12.007; Goodacre R, 1998, MICROBIOL-SGM, V144, P1157, DOI 10.1099/00221287-144-5-1157; Goodacre R, 2007, METABOLOMICS, V3, P231, DOI 10.1007/s11306-007-0081-3; Graumann PL, 1998, TRENDS BIOCHEM SCI, V23, P286, DOI 10.1016/S0968-0004(98)01255-9; Heidelberg JF, 2002, NAT BIOTECHNOL, V20, P1118, DOI 10.1038/nbt749; Imlay JA, 2003, ANNU REV MICROBIOL, V57, P395, DOI 10.1146/annurev.micro.57.030502.090938; Keith-Roach MJ, 2008, SCI TOTAL ENVIRON, V396, P1, DOI 10.1016/j.scitotenv.2008.02.030; Krisko A, 2010, P NATL ACAD SCI USA, V107, P14373, DOI 10.1073/pnas.1009312107; Lloyd JR, 2005, MET IONS BIOL SYST, V44, P205; Lloyd JR, 2003, FEMS MICROBIOL REV, V27, P411, DOI 10.1016/S0168-6445(03)00044-5; Lovley DR, 2003, NAT REV MICROBIOL, V1, P35, DOI 10.1038/nrmicro731; LOVLEY DR, 1986, APPL ENVIRON MICROB, V52, P751, DOI 10.1128/AEM.52.4.751-757.1986; LOVLEY DR, 1986, APPL ENVIRON MICROB, V51, P683, DOI 10.1128/AEM.51.4.683-689.1986; Lu HM, 2009, MOL CELL PROTEOMICS, V8, P481, DOI 10.1074/mcp.M800123-MCP200; MARTENS H, 1991, J PHARMACEUT BIOMED, V9, P625, DOI 10.1016/0731-7085(91)80188-F; MONTAUDON D, 1987, BIOCHIMIE, V69, P1243, DOI 10.1016/0300-9084(87)90152-0; MYERS CR, 1988, SCIENCE, V240, P1319, DOI 10.1126/science.240.4857.1319; NEALSON KH, 1994, ANNU REV MICROBIOL, V48, P311, DOI 10.1146/annurev.mi.48.100194.001523; Nicolaou N, 2008, ANALYST, V133, P1424, DOI 10.1039/b804439b; Niedree B, 2013, J ENVIRON RADIOACTIV, V115, P168, DOI 10.1016/j.jenvrad.2012.08.008; Peng JT, 2010, ANAL CHIM ACTA, V683, P63, DOI 10.1016/j.aca.2010.08.033; Perromat A, 2003, BIOPOLYMERS, V72, P207, DOI 10.1002/bip.10381; Phadtare S, 1999, CURR OPIN MICROBIOL, V2, P175, DOI 10.1016/S1369-5274(99)80031-9; Qiu XY, 2006, J BACTERIOL, V188, P1199, DOI 10.1128/JB.188.3.1199-1204.2006; Qiu XY, 2005, J BACTERIOL, V187, P3556, DOI 10.1128/JB.187.10.3556-3564.2005; Ramos JL, 2001, CURR OPIN MICROBIOL, V4, P166, DOI 10.1016/S1369-5274(00)00183-1; Riley RG, 1992, CHEM CONTAMINATION D; Savorani F, 2010, J MAGN RESON, V202, P190, DOI 10.1016/j.jmr.2009.11.012; Shadyro O, 2004, FREE RADICAL BIO MED, V36, P1612, DOI 10.1016/j.freeradbiomed.2004.03.013; Shadyro OI, 2002, INT J RADIAT BIOL, V78, P211, DOI 10.1080/09553000110104065; Spinks J.W.T., 1964, INTRO RAD CHEM; STADTMAN ER, 1993, ANNU REV BIOCHEM, V62, P797, DOI 10.1146/annurev.bi.62.070193.004053; Stadtman ER, 2003, AMINO ACIDS, V25, P207, DOI 10.1007/s00726-003-0011-2; STARK G, 1991, BIOCHIM BIOPHYS ACTA, V1071, P103, DOI 10.1016/0304-4157(91)90020-W; Stroes-Gascoyne S, 1994, MRS ONLINE P LIBR, V353; Tiedje JM, 2002, NAT BIOTECHNOL, V20, P1093, DOI 10.1038/nbt1102-1093; Timmins EM, 1998, J CLIN MICROBIOL, V36, P367, DOI 10.1128/JCM.36.2.367-374.1998; Tomasi G, 2011, J CHROMATOGR A, V1218, P7832, DOI 10.1016/j.chroma.2011.08.086; Wade R, 2000, FEMS MICROBIOL LETT, V184, P143, DOI 10.1111/j.1574-6968.2000.tb09005.x; Wang H, 2013, METABOLOMICS, V9, P642, DOI 10.1007/s11306-012-0488-3; Wang H, 2010, APPL ENVIRON MICROB, V76, P6266, DOI 10.1128/AEM.00912-10; Wang H, 2010, J BACTERIOL, V192, P1143, DOI 10.1128/JB.01277-09; WARD JF, 1994, RADIAT RES, V138, pS85, DOI 10.2307/3578769; Weiss J, 1955, P INT C PEAC US AT E, P179; West JM, 2002, INTERACTIONS MICROOR; Wildung RE, 2000, APPL ENVIRON MICROB, V66, P2451, DOI 10.1128/AEM.66.6.2451-2460.2000; Williams KH, 2011, GEOMICROBIOL J, V28, P519, DOI 10.1080/01490451.2010.520074; Winder CL, 2006, MICROBIOL-SGM, V152, P2757, DOI 10.1099/mic.0.28986-0; Wold S, 2001, CHEMOMETR INTELL LAB, V58, P109, DOI 10.1016/S0169-7439(01)00155-1	71	3	3	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2015	10	6							e0131249	10.1371/journal.pone.0131249	http://dx.doi.org/10.1371/journal.pone.0131249			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL3FM	26098880	Green Published, gold, Green Submitted			2022-12-26	WOS:000356835800161
J	Kaasalainen, U; Olsson, S; Rikkinen, J				Kaasalainen, Ulla; Olsson, Sanna; Rikkinen, Jouko			Evolution of the tRNA(Leu) (UAA) Intron and Congruence of Genetic Markers in Lichen-Symbiotic Nostoc	PLOS ONE			English	Article							GROUP-I INTRONS; BAYESIAN-INFERENCE; CYANOBACTERIAL DIVERSITY; RIBOSOMAL-RNA; TRNL INTRON; PHYLOGENY; GENUS; ALGORITHM; PATTERNS; SEQUENCE	The group I intron interrupting the tRNALeu UAA gene (trnL) is present in most cyanobacterial genomes as well as in the plastids of many eukaryotic algae and all green plants. In lichen symbiotic Nostoc, the P6b stem-loop of trnL intron always involves one of two different repeat motifs, either Class I or Class II, both with unresolved evolutionary histories. Here we attempt to resolve the complex evolution of the two different trnL P6b region types. Our analysis indicates that the Class II repeat motif most likely appeared first and that independent and unidirectional shifts to the Class I motif have since taken place repeatedly. In addition, we compare our results with those obtained with other genetic markers and find strong evidence of recombination in the 16S rRNA gene, a marker widely used in phylogenetic studies on Bacteria. The congruence of the different genetic markers is successfully evaluated with the recently published software Saguaro, which has not previously been utilized in comparable studies.	[Kaasalainen, Ulla] Univ Gottingen, Dept Geobiol, D-37073 Gottingen, Germany; [Olsson, Sanna; Rikkinen, Jouko] Univ Helsinki, Dept Biosci, Helsinki, Finland	University of Gottingen; University of Helsinki	Kaasalainen, U (corresponding author), Univ Gottingen, Dept Geobiol, D-37073 Gottingen, Germany.	ulla.kaasalainen@geo.uni-goettingen.de	Rikkinen, Jouko/AAM-8732-2021; Kaasalainen, Ulla/AAG-8713-2021; Olsson, Sanna/W-4515-2017	Kaasalainen, Ulla/0000-0001-9899-4768; Olsson, Sanna/0000-0002-1199-4499; Rikkinen, Jouko/0000-0002-4615-6639; Kaasalainen, Sanna/0000-0001-6628-418X	Suomen Akatemia [122288]; German Research Foundation (DFG); University of Gottingen; Emil Aaltonen Saatio	Suomen Akatemia; German Research Foundation (DFG)(German Research Foundation (DFG)); University of Gottingen; Emil Aaltonen Saatio	Emil Aaltonen Saatio to UK. Suomen Akatemia, project number 122288, to JR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Open Access Grant Program of the German Research Foundation (DFG) and the Open Access Publication Fund of the University of Gottingen. The financial support is for the publication fees of an open access journal.	Adams DG, 2008, J EXP BOT, V59, P1047, DOI 10.1093/jxb/ern005; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Bergman B, 2002, CYANOBACTERIA IN SYMBIOSIS, P207; Besendahl A, 2000, CURR GENET, V37, P12, DOI 10.1007/s002940050002; Bruen TC, 2006, GENETICS, V172, P2665, DOI 10.1534/genetics.105.048975; CECH TR, 1988, GENE, V73, P259, DOI 10.1016/0378-1119(88)90492-1; CECH TR, 1994, NAT STRUCT BIOL, V1, P273, DOI 10.1038/nsb0594-273; Costa JL, 2004, FEMS MICROBIOL ECOL, V49, P481, DOI 10.1016/j.femsec.2004.05.001; Costa JL, 2002, MOL BIOL EVOL, V19, P850, DOI 10.1093/oxfordjournals.molbev.a004142; Costa JL, 2001, APPL ENVIRON MICROB, V67, P4393, DOI 10.1128/AEM.67.9.4393-4396.2001; Delport W, 2010, BIOINFORMATICS, V26, P2455, DOI 10.1093/bioinformatics/btq429; Dirks RM, 2003, J COMPUT CHEM, V24, P1664, DOI 10.1002/jcc.10296; Dirks RM, 2004, J COMPUT CHEM, V25, P1295, DOI 10.1002/jcc.20057; Dirks RM, 2007, SIAM REV, V49, P65, DOI 10.1137/060651100; Elvebakk A, 2008, J PHYCOL, V44, P1049, DOI 10.1111/j.1529-8817.2008.00556.x; Fedrowitz K, 2012, ECOL EVOL, V2, P2291, DOI 10.1002/ece3.343; Fedrowitz K, 2011, BRYOLOGIST, V114, P220, DOI 10.1639/0007-2745-114.1.220; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Han D, 2009, CURR MICROBIOL, V58, P170, DOI 10.1007/s00284-008-9302-x; Huelsenbeck JP, 2002, SYST BIOL, V51, P673, DOI 10.1080/10635150290102366; Huelsenbeck JP, 2001, SCIENCE, V294, P2310, DOI 10.1126/science.1065889; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Kaasalainen U, 2012, P NATL ACAD SCI USA, V109, P5886, DOI 10.1073/pnas.1200279109; Kelchner SA, 2000, ANN MO BOT GARD, V87, P482, DOI 10.2307/2666142; KIMURA M, 1991, JPN J GENET, V66, P367, DOI 10.1266/jjg.66.367; Kitahara Kei, 2013, Mob Genet Elements, V3, pe24210; KRUGER K, 1982, CELL, V31, P147, DOI 10.1016/0092-8674(82)90414-7; Kumar S, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-357; Linke K., 2003, BIBLIOTHECA LICHENOL, V86, P113; Lucking R, 2009, AM J BOT, V96, P1409, DOI 10.3732/ajb.0800258; Lucking R, 2014, LICHENOLOGIST, V46, P261, DOI 10.1017/S0024282913000352; Magain N, 2014, PLOS ONE, V24, P9, DOI DOI 10.1371/J0URNAL.P0NE.0089876; McInerney JO, 2008, TRENDS ECOL EVOL, V23, P276, DOI 10.1016/j.tree.2008.01.008; MICHELI C, 2014, OPEN J ECOL, V4, P456, DOI DOI 10.4236/oje.2014.48039; Miller M.A., 2010, P GAT COMP ENV WORKS; Muller KF, 2005, PHYDE 0 995 PHYLOGEN; Myllys L, 2007, NEW PHYTOL, V173, P621, DOI 10.1111/j.1469-8137.2006.01944.x; Nilsson M, 2000, ARCH MICROBIOL, V173, P97, DOI 10.1007/s002039900113; O'Brien HE, 2013, NEW PHYTOL, V198, P557, DOI 10.1111/nph.12165; Oksanen I, 2004, INT J SYST EVOL MICR, V54, P765, DOI 10.1099/ijs.0.02928-0; Olsson S, 2012, CURR GENET, V58, P49, DOI 10.1007/s00294-011-0364-0; Pagel M, 2004, SYST BIOL, V53, P673, DOI 10.1080/10635150490522232; Papaefthimiou D, 2008, INT J SYST EVOL MICR, V58, P553, DOI 10.1099/ijs.0.65312-0; Paquin B, 1997, J BACTERIOL, V179, P6798, DOI 10.1128/jb.179.21.6798-6806.1997; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Pond SLK, 2006, BIOINFORMATICS, V22, P3096, DOI 10.1093/bioinformatics/btl474; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Rambaut A, 2009, TRACER V1 5; Rikkinen J, 2002, CYANOBACTERIA IN SYMBIOSIS, P31; Rikkinen J, 2003, SYMBIOSIS, V34, P99; Rikkinen J, 2002, SCIENCE, V297, P357, DOI 10.1126/science.1072961; Rikkinen J, 2004, SYMB BOT UPSAL, V34, P377; Rikkinen J, 2008, J EXP BOT, V59, P1007, DOI 10.1093/jxb/ern004; Rikkinen J, 2013, MYCOKEYS, P3, DOI 10.3897/mycokeys.6.3869; Rikkinen J, 2015, BIODIVERS CONSERV, V24, P973, DOI 10.1007/s10531-015-0906-8; Rudi K, 1998, J BACTERIOL, V180, P3453, DOI 10.1128/JB.180.13.3453-3461.1998; Schirrmeister BE, 2013, P NATL ACAD SCI USA, V110, P1791, DOI 10.1073/pnas.1209927110; Shishido TK, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-86; Simon D, 2003, J MOL EVOL, V57, P710, DOI 10.1007/s00239-003-2533-3; Stover BC, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-7; Sukumaran J, 2010, BIOINFORMATICS, V26, P1569, DOI 10.1093/bioinformatics/btq228; Svenning MM, 2005, ARCH MICROBIOL, V183, P19, DOI 10.1007/s00203-004-0740-y; Tanabe Y, 2004, J MOL EVOL, V58, P633, DOI 10.1007/s00239-004-2583-1; Tavare S., 1986, LECT MATH LIFE SCI, V17, P57; Thajuddin N, 2010, J BASIC MICROB, V50, P254, DOI 10.1002/jobm.200900343; TRFfS Computing, 2011, R LANG ENV STAT COMP, DOI [10.1016/j.neuroimage.2011.01.013, DOI 10.1016/J.NEUROIMAGE.2011.01.013]; Zadeh JN, 2011, J COMPUT CHEM, V32, P170, DOI 10.1002/jcc.21596; Zamani N, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-347; Zwickl DJ., 2006, THESIS	70	7	7	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2015	10	6							e0131223	10.1371/journal.pone.0131223	http://dx.doi.org/10.1371/journal.pone.0131223			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL3FM	26098760	Green Published, Green Submitted, gold			2022-12-26	WOS:000356835800159
J	Krumins, JA; Krumins, V; Forgoston, E; Billings, L; van der Putten, WH				Krumins, Jennifer Adams; Krumins, Valdis; Forgoston, Eric; Billings, Lora; van der Putten, Wim H.			Herbivory and Stoichiometric Feedbacks to Primary Production	PLOS ONE			English	Article							BELOW-GROUND HERBIVORY; MICROBIAL LOOP; FRESH-WATER; SOIL; NUTRIENT; PLANT; NITROGEN; TERRESTRIAL; DEFOLIATION; LINKAGES	Established theory addresses the idea that herbivory can have positive feedbacks on nutrient flow to plants. Positive feedbacks likely emerge from a greater availability of organic carbon that primes the soil by supporting nutrient turnover through consumer and especially microbially-mediated metabolism in the detrital pool. We developed an entirely novel stoichiometric model that demonstrates the mechanism of a positive feedback. In particular, we show that sloppy or partial feeding by herbivores increases detrital carbon and nitrogen allowing for greater nitrogen mineralization and nutritive feedback to plants. The model consists of differential equations coupling flows among pools of: plants, herbivores, detrital carbon and nitrogen, and inorganic nitrogen. We test the effects of different levels of herbivore grazing completion and of the stoichiometric quality (carbon to nitrogen ratio, C:N) of the host plant. Our model analyses show that partial feeding and plant C:N interact because when herbivores are sloppy and plant biomass is diverted to the detrital pool, more mineral nitrogen is available to plants because of the stoichiometric difference between the organisms in the detrital pool and the herbivore. This model helps to identify how herbivory may feedback positively on primary production, and it mechanistically connects direct and indirect feedbacks from soil to plant production.	[Krumins, Jennifer Adams] Montclair State Univ, Dept Biol & Mol Biol, Montclair, NJ 07043 USA; [Krumins, Valdis] Rutgers State Univ, Dept Environm Sci, New Brunswick, NJ 08903 USA; [Forgoston, Eric; Billings, Lora] Montclair State Univ, Dept Math Sci, Montclair, NJ USA; [Krumins, Jennifer Adams; van der Putten, Wim H.] Netherlands Inst Ecol, Dept Terr Ecol, Wageningen, Netherlands; [van der Putten, Wim H.] Wageningen Univ, Nematol Lab, NL-6700 AP Wageningen, Netherlands	Montclair State University; Rutgers State University New Brunswick; Montclair State University; Royal Netherlands Academy of Arts & Sciences; Netherlands Institute of Ecology (NIOO-KNAW); Wageningen University & Research	Krumins, JA (corresponding author), Montclair State Univ, Dept Biol & Mol Biol, Montclair, NJ 07043 USA.	kruminsj@mail.montclair.edu	van der Putten, Wim H/C-3707-2011; KNAW, NIOO-KNAW/A-4320-2012	van der Putten, Wim H/0000-0002-9341-4442; KNAW, NIOO-KNAW/0000-0002-3835-159X; Krumins, Valdis/0000-0002-4358-2253; Krumins, Jennifer/0000-0002-1231-2453	National Science Foundation in grant OISE [0758674]; National Science Foundation in grant CMMI [1233397]	National Science Foundation in grant OISE; National Science Foundation in grant CMMI	JAK was supported for this work by the National Science Foundation in grant OISE# 0758674. LB and EF were supported by the National Science Foundation in grant CMMI# 1233397.	Agrawal AA, 2000, TRENDS PLANT SCI, V5, P309, DOI 10.1016/S1360-1385(00)01679-4; Ahn MY, 2009, ECOSYSTEMS, V12, P672, DOI 10.1007/s10021-009-9250-8; Anderson TR, 2005, AM NAT, V165, P1, DOI 10.1086/426598; Ayres E, 2007, FUNCT ECOL, V21, P256, DOI 10.1111/j.1365-2435.2006.01227.x; Bardgett R.D., 2010, ABOVEGROUND BELOWGRO; Bardgett RD, 2003, ECOLOGY, V84, P2258, DOI 10.1890/02-0274; Bardgett RD, 1999, ECOL LETT, V2, P357; Bonkowski M, 2004, NEW PHYTOL, V162, P617, DOI 10.1111/j.1469-8137.2004.01066.x; Cebrian J, 1999, AM NAT, V154, P449, DOI 10.1086/303244; Chase JM, 2000, TRENDS ECOL EVOL, V15, P408, DOI 10.1016/S0169-5347(00)01942-X; Cherif M, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2453; CYR H, 1993, NATURE, V361, P148, DOI 10.1038/361148a0; Daufresne T, 2005, P NATL ACAD SCI USA, V102, P9212, DOI 10.1073/pnas.0406427102; Daufresne T, 2001, ECOL LETT, V4, P196, DOI 10.1046/j.1461-0248.2001.00210.x; DERUITER PC, 1995, SCIENCE, V269, P1257, DOI 10.1126/science.269.5228.1257; Elser JJ, 2000, NATURE, V408, P578, DOI 10.1038/35046058; EVANS JR, 1989, OECOLOGIA, V78, P9, DOI 10.1007/BF00377192; Frost PC, 2006, ECOL LETT, V9, P774, DOI 10.1111/j.1461-0248.2006.00919.x; Guenet B, 2010, ECOLOGY, V91, P2850, DOI 10.1890/09-1968.1; Hamilton EW, 2008, SOIL BIOL BIOCHEM, V40, P2865, DOI 10.1016/j.soilbio.2008.08.007; Hamilton EW, 2001, ECOLOGY, V82, P2397, DOI 10.1890/0012-9658(2001)082[2397:CPSSMA]2.0.CO;2; Hillebrand H, 2009, ECOL LETT, V12, P516, DOI 10.1111/j.1461-0248.2009.01304.x; HOAGLAND D. R., 1950, Circular. California Agricultural Experiment Station, V347; HUNT HW, 1987, BIOL FERT SOILS, V3, P57, DOI 10.1007/BF00260580; Knoll LB, 2009, OIKOS, V118, P1732, DOI 10.1111/j.1600-0706.2009.17367.x; Krumins JA, 2013, BIOSCIENCE, V63, P35, DOI 10.1525/bio.2013.63.1.8; Kuzyakov Y, 2000, SOIL BIOL BIOCHEM, V32, P1485, DOI 10.1016/S0038-0717(00)00084-5; Liebig J., 1840, CHEM ITS APPL AGR PH; Lindeman RL, 1942, ECOLOGY, V23, P399, DOI 10.2307/1930126; MCNAUGHTON SJ, 1976, SCIENCE, V191, P92, DOI 10.1126/science.191.4222.92; Mikola J, 2009, ECOL MONOGR, V79, P221, DOI 10.1890/08-1846.1; Moore JC, 1996, ECOLOGY, V77, P694, DOI 10.2307/2265494; Moore JC, 2005, PEDOBIOLOGIA, V49, P499, DOI 10.1016/j.pedobi.2005.05.008; Osler GHR, 2007, ECOLOGY, V88, P1611, DOI 10.1890/06-1357.1; Raynaud X, 2006, PLANT SOIL, V287, P95, DOI 10.1007/s11104-006-9003-9; RUESS RW, 1987, OIKOS, V49, P101, DOI 10.2307/3565559; SIH A, 1980, AM NAT, V116, P281, DOI 10.1086/283626; Sterner R.W, 2002, ECOLOGICAL STOICHIOM, DOI DOI 10.1086/382444; STERNER RW, 1990, AM NAT, V136, P209, DOI 10.1086/285092; Tu C, 2003, MICROB ECOL, V46, P134, DOI 10.1007/s00248-002-1068-2; VANDERPUTTEN WH, 1988, OECOLOGIA, V76, P313, DOI 10.1007/BF00379970; VANVEEN JA, 1984, PLANT SOIL, V76, P257, DOI 10.1007/BF02205585; VITOUSEK PM, 1991, BIOGEOCHEMISTRY, V13, P87; Wardle DA, 2004, SCIENCE, V304, P1629, DOI 10.1126/science.1094875	44	14	14	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2015	10	6							e0129775	10.1371/journal.pone.0129775	http://dx.doi.org/10.1371/journal.pone.0129775			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL3FM	26098841	Green Published, gold, Green Submitted			2022-12-26	WOS:000356835800039
J	Morimoto-Kobayashi, Y; Ohara, K; Takahashi, C; Kitao, S; Wang, GY; Taniguchi, Y; Katayama, M; Nagai, K				Morimoto-Kobayashi, Yumie; Ohara, Kazuaki; Takahashi, Chika; Kitao, Sayoko; Wang, Guanying; Taniguchi, Yoshimasa; Katayama, Mikio; Nagai, Katsuya			Matured Hop Bittering Components Induce Thermogenesis in Brown Adipose Tissue via Sympathetic Nerve Activity	PLOS ONE			English	Article							DIET-INDUCED OBESITY; FAT; ISOHUMULONES; BEER; ANTIOBESITY; ALPHA; ACIDS; XANTHOHUMOL; RESISTANCE; PRODUCTS	Obesity is the principal symptom of metabolic syndrome, which refers to a group of risk factors that increase the likelihood of atherosclerosis. In recent decades there has been a sharp rise in the incidence of obesity throughout the developed world. Iso-alpha-acids, the bitter compounds derived from hops in beer, have been shown to prevent diet-induced obesity by increasing lipid oxidation in the liver and inhibition of lipid absorption from the intestine. Whereas the sharp bitterness induced by effective dose of iso-alpha-acids precludes their acceptance as a nutrient, matured hop bittering components (MHB) appear to be more agreeable. Therefore, we tested MHB for an effect on ameliorating diet-induced body fat accumulation in rodents. MHB ingestion had a beneficial effect but, compared to iso-alpha-acids and despite containing structurally similar compounds, acted via different mechanisms to reduce body fat accumulation. MHB supplementation significantly reduced body weight gain, epididymal white adipose tissue weight, and plasma non-esterified free fatty acid levels in diet-induced obese mice. We also found that uncoupling protein 1 (UCP1) expression in brown adipose tissue (BAT) was significantly increased in MHB-fed mice at both the mRNA and protein levels. In addition, MHB administration in rats induced the beta-adrenergic signaling cascade, which is related to cAMP accumulation in BAT, suggesting that MHB could modulate sympathetic nerve activity innervating BAT (BAT-SNA). Indeed, single oral administration of MHB elevated BAT-SNA in rats, and this elevation was dissipated by subdiaphragmatic vagotomy. Single oral administration of MHB maintained BAT temperature at a significantly higher level than in control rats. Taken together, these findings indicate that MHB ameliorates diet-induced body fat accumulation, at least partly, by enhancing thermogenesis in BAT via BAT-SNA activation. Our data suggests that MHB is a useful tool for developing functional foods or beverages to counteract the accumulation of body fat.	[Morimoto-Kobayashi, Yumie; Ohara, Kazuaki; Takahashi, Chika; Kitao, Sayoko; Wang, Guanying; Taniguchi, Yoshimasa; Katayama, Mikio] KIRIN Co Ltd, Res Labs Hlth Sci & Food Technol, Yokohama, Kanagawa, Japan; [Nagai, Katsuya] ANBAS Corp, Osaka, Japan		Morimoto-Kobayashi, Y (corresponding author), KIRIN Co Ltd, Res Labs Hlth Sci & Food Technol, Yokohama, Kanagawa, Japan.	Yumie_Kobayashi@kirin.co.jp		Taniguchi, Yoshimasa/0000-0003-4588-4877	Kirin Company, Ltd.; ANBAS Corporation	Kirin Company, Ltd.; ANBAS Corporation	Kirin Company, Ltd. and ANBAS Corporation provided support in the form of salaries for authors YMK, KO, CT, SK, GW, YT, MK and KN, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Almaguer C, 2012, BREW SCI, V65, P118; Azzu V, 2010, TRENDS BIOCHEM SCI, V35, P298, DOI 10.1016/j.tibs.2009.11.001; Bachman ES, 2002, SCIENCE, V297, P843, DOI 10.1126/science.1073160; Bordicchia M, 2012, J CLIN INVEST, V122, P1022, DOI 10.1172/JCI59701; Boss Olivier, 2012, Front Endocrinol (Lausanne), V3, P14, DOI 10.3389/fendo.2012.00014; Bullen JW, 2007, AM J PHYSIOL-ENDOC M, V292, pE1079, DOI 10.1152/ajpendo.00245.2006; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Chen HY, 2013, PPAR RES, V2013, DOI 10.1155/2013/476049; Fisher FM, 2012, GENE DEV, V26, P271, DOI 10.1101/gad.177857.111; FOLCH J, 1957, J BIOL CHEM, V226, P497; Hemmeryckx B, 2011, OBESITY, V19, P659, DOI 10.1038/oby.2010.266; Inokuma K, 2006, AM J PHYSIOL-ENDOC M, V290, pE1014, DOI 10.1152/ajpendo.00105.2005; Janssen S, 2013, TRENDS ENDOCRIN MET, V24, P92, DOI 10.1016/j.tem.2012.11.006; Kahn BB, 2000, J CLIN INVEST, V106, P473, DOI 10.1172/JCI10842; Kajimura S, 2010, CELL METAB, V11, P257, DOI 10.1016/j.cmet.2010.03.005; Kim SY, 2013, CHEM-BIOL INTERACT, V203, P565, DOI 10.1016/j.cbi.2013.03.012; Lee YH, 2014, BBA-MOL BASIS DIS, V1842, P358, DOI 10.1016/j.bbadis.2013.05.011; Li B, 2000, NAT MED, V6, P1115, DOI 10.1038/80450; Lowell BB, 2000, NATURE, V404, P652, DOI 10.1038/35007527; Mathieu P, 2006, VASC HEALTH RISK MAN, V2, P285, DOI 10.2147/vhrm.2006.2.3.285; Milligan S, 2002, REPRODUCTION, V123, P235, DOI 10.1530/rep.0.1230235; Miura Y, 2005, BRIT J NUTR, V93, P559, DOI 10.1079/BJN20041384; Nozawa H, 2005, MOL NUTR FOOD RES, V49, P772, DOI 10.1002/mnfr.200500027; Ono E, 2011, BIOCHEM BIOPH RES CO, V410, P677, DOI 10.1016/j.bbrc.2011.06.055; ONO M, 1987, Journal of the American Society of Brewing Chemists, V45, P61; Puigserver P, 2005, INT J OBESITY, V29, pS5, DOI 10.1038/sj.ijo.0802905; Saito M, 2014, ENDOCR J, V61, P409, DOI 10.1507/endocrj.EJ13-0527; Saito M, 2013, DIABETES METAB J, V37, P22, DOI 10.4093/dmj.2013.37.1.22; Saito M, 2009, DIABETES, V58, P1526, DOI 10.2337/db09-0530; Schoonjans K, 1996, J LIPID RES, V37, P907; Shen J, 2005, NEUROSCI LETT, V383, P188, DOI 10.1016/j.neulet.2005.04.010; Shen J, 2009, NEUROSCI LETT, V461, P30, DOI 10.1016/j.neulet.2009.05.067; Shimamura M, 2001, BIOCHEM BIOPH RES CO, V289, P220, DOI 10.1006/bbrc.2001.5934; Smith SJ, 2000, NAT GENET, V25, P87, DOI 10.1038/75651; Spiegelman BM, 2001, CELL, V104, P531, DOI 10.1016/S0092-8674(01)00240-9; Stevens JF, 2004, PHYTOCHEMISTRY, V65, P1317, DOI 10.1016/j.phytochem.2004.04.025; Taniguchi Y, 2015, BIOSCI BIOT IN PRESS; Taniguchi Y, 2014, J NAT PROD, V77, P1252, DOI 10.1021/np4008427; Taniguchi Y, 2013, J AGR FOOD CHEM, V61, P3121, DOI 10.1021/jf3047187; Yajima H, 2005, INT J OBESITY, V29, P991, DOI 10.1038/sj.ijo.0802965; Yajima H, 2004, J BIOL CHEM, V279, P33456, DOI 10.1074/jbc.M403456200; Zanoli P, 2008, J ETHNOPHARMACOL, V116, P383, DOI 10.1016/j.jep.2008.01.011	42	21	21	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2015	10	6							e0131042	10.1371/journal.pone.0131042	http://dx.doi.org/10.1371/journal.pone.0131042			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL3FM	26098641	Green Published, Green Submitted, gold			2022-12-26	WOS:000356835800135
J	Zhdanov, A; Nurminen, J; Baess, P; Hirvenkari, L; Jousmaki, V; Makela, JP; Mandel, A; Meronen, L; Hari, R; Parkkonen, L				Zhdanov, Andrey; Nurminen, Jussi; Baess, Pamela; Hirvenkari, Lotta; Jousmaki, Veikko; Makela, Jyrki P.; Mandel, Anne; Meronen, Lassi; Hari, Riitta; Parkkonen, Lauri			An Internet-Based Real-Time Audiovisual Link for Dual MEG Recordings	PLOS ONE			English	Article							EEG; SYNCHRONIZATION; SPEECH; CORTEX; FMRI	Hyperscanning Most neuroimaging studies of human social cognition have focused on brain activity of single subjects. More recently, "two-person neuroimaging" has been introduced, with simultaneous recordings of brain signals from two subjects involved in social interaction. These simultaneous "hyperscanning" recordings have already been carried out with a spectrum of neuroimaging modalities, such as functional magnetic resonance imaging (fMRI), electroencephalography (EEG), and functional near-infrared spectroscopy (fNIRS). Dual MEG Setup We have recently developed a setup for simultaneous magnetoencephalographic (MEG) recordings of two subjects that communicate in real time over an audio link between two geographically separated MEG laboratories. Here we present an extended version of the setup, where we have added a video connection and replaced the telephone-landline-based link with an Internet connection. Our setup enabled transmission of video and audio streams between the sites with a one-way communication latency of about 130 ms. Our software that allows reproducing the setup is publicly available. Validation We demonstrate that the audiovisual Internet-based link can mediate real-time interaction between two subjects who try to mirror each others' hand movements that they can see via the video link. All the nine pairs were able to synchronize their behavior. In addition to the video, we captured the subjects' movements with accelerometers attached to their index fingers; we determined from these signals that the average synchronization accuracy was 215 ms. In one subject pair we demonstrate inter-subject coherence patterns of the MEG signals that peak over the sensorimotor areas contralateral to the hand used in the task.	[Zhdanov, Andrey; Nurminen, Jussi; Baess, Pamela; Hirvenkari, Lotta; Jousmaki, Veikko; Mandel, Anne; Meronen, Lassi; Hari, Riitta; Parkkonen, Lauri] Aalto Univ, Sch Sci, Dept Neurosci & Biomed Engn, Espoo, Finland; [Zhdanov, Andrey] Aalto Univ, Aalto Neuroimaging, MEG Core, Espoo, Finland; [Zhdanov, Andrey; Makela, Jyrki P.] Univ Helsinki, HUS Med Imaging Ctr, BioMag Lab, Helsinki, Finland; [Zhdanov, Andrey; Makela, Jyrki P.] Helsinki Univ Hosp, Helsinki, Finland	Aalto University; Aalto University; Hyvinkaan Sairaala; University of Helsinki; University of Helsinki; Helsinki University Central Hospital	Zhdanov, A (corresponding author), Aalto Univ, Sch Sci, Dept Neurosci & Biomed Engn, Espoo, Finland.	andrey.zhdanov@aalto.fi	Jousmäki, Veikko/H-6008-2012; Parkkonen, Lauri/G-6755-2012; Mäkelä, Jyrki/M-1215-2019; Hari, Riitta K/J-1880-2012; Zhdanov, Andrey/I-7136-2012	Jousmäki, Veikko/0000-0003-1963-5834; Parkkonen, Lauri/0000-0002-0130-0801; Hari, Riitta K/0000-0002-3142-2703; Zhadnov, Andrey/0000-0002-3379-0251	European Research Council [232946]; European Union [604102]; Academy of Finland [129678, 218072, 131483, 263800, 135198]; aivoAALTO research project of Aalto University; Finnish Graduate School of Neuroscience / Doctoral Program Brain Mind; Jenny and Antti Wihuri Foundation; Academy of Finland Computational Program [135198]; SalWe Research Program for Mind and Body (Tekes-the Finnish Funding Agency for Innovation grant) [1104/10]	European Research Council(European Research Council (ERC)European Commission); European Union(European Commission); Academy of Finland(Academy of Finland); aivoAALTO research project of Aalto University; Finnish Graduate School of Neuroscience / Doctoral Program Brain Mind; Jenny and Antti Wihuri Foundation; Academy of Finland Computational Program; SalWe Research Program for Mind and Body (Tekes-the Finnish Funding Agency for Innovation grant)	This study was financially supported by the European Research Council (Advanced Grant #232946 "Brain2Brain"), the European Union Seventh Framework Programme (FP7/2007-2013) under grant agreement no. 604102 (Human Brain Project), the Academy of Finland (grants #129678, #218072, #131483 and #263800, and grant LASTU #135198), the aivoAALTO research project of Aalto University (http://www.aivoaalto.fi), the Finnish Graduate School of Neuroscience / Doctoral Program Brain & Mind, the Jenny and Antti Wihuri Foundation, the Academy of Finland Computational Program (grant #135198), and the SalWe Research Program for Mind and Body (Tekes-the Finnish Funding Agency for Innovation grant 1104/10). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Astolfi L, 2010, IEEE ENG MED BIO, P1734, DOI 10.1109/IEMBS.2010.5626708; Astolfi L, 2010, BRAIN TOPOGR, V23, P243, DOI 10.1007/s10548-010-0147-9; Babiloni Fabio, 2006, Conf Proc IEEE Eng Med Biol Soc, V2006, P3666; Baess P, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00083; Baldi M, 2000, IEEE ACM T NETWORK, V8, P479, DOI 10.1109/90.865076; Bourguignon M, 2011, NEUROIMAGE, V55, P1475, DOI 10.1016/j.neuroimage.2011.01.031; Cui X, 2012, NEUROIMAGE, V59, P2430, DOI 10.1016/j.neuroimage.2011.09.003; Dumas G, 2011, IRBM, V32, P48, DOI 10.1016/j.irbm.2011.01.002; Dumas G, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00128; Dumas Guillaume, 2011, Commun Integr Biol, V4, P349, DOI 10.4161/cib.4.3.15110; Free Software Foundation, 2007, GNU GEN PUBL LIC VER; Gramfort A, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00267; Gramfort A, 2014, NEUROIMAGE, V86, P446, DOI 10.1016/j.neuroimage.2013.10.027; HAMALAINEN M, 1993, REV MOD PHYS, V65, P413, DOI 10.1103/RevModPhys.65.413; Hari R, 2009, PHYSIOL REV, V89, P453, DOI 10.1152/physrev.00041.2007; Hirata M, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00118; Hunter JD, 2007, COMPUT SCI ENG, V9, P90, DOI 10.1109/MCSE.2007.55; Jansen J, 2013, P 23 ACM WORKSH NETW, P37; Jiang J, 2012, J NEUROSCI, V32, P16064, DOI 10.1523/JNEUROSCI.2926-12.2012; Lindenberger U, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-22; Montague PR, 2002, NEUROIMAGE, V16, P1159, DOI 10.1006/nimg.2002.1150; Sanger J, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00312; Sharon D, 2007, NEUROIMAGE, V36, P1225, DOI 10.1016/j.neuroimage.2007.03.066; SUMMERFIELD Q, 1992, PHILOS T ROY SOC B, V335, P71, DOI 10.1098/rstb.1992.0009; Taulu S, 2004, BRAIN TOPOGR, V16, P269, DOI 10.1023/b:brat.0000032864.93890.f9; Vroomen J, 2011, COGNITION, V118, P75, DOI 10.1016/j.cognition.2010.10.002; Zhdanov A, HELSINKI VIDEOMEG PR; Zhdanov A, AALTO MEG2MEG PROJEC; Zhdanov A, 2013, EPILEPSY RES, V105, P405, DOI 10.1016/j.eplepsyres.2013.02.017	29	21	23	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2015	10	6							e0128485	10.1371/journal.pone.0128485	http://dx.doi.org/10.1371/journal.pone.0128485			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL3FM	26098628	Green Submitted, Green Accepted, Green Published, gold			2022-12-26	WOS:000356835800014
J	da Silva, NR; Florindo, JB; Gomez, MC; Rossatto, DR; Kolb, RM; Bruno, OM				da Silva, Nubia Rosa; Florindo, Joao Batista; Gomez, Maria Cecilia; Rossatto, Davi Rodrigo; Kolb, Rosana Marta; Bruno, Odemir Martinez			Plant Identification Based on Leaf Midrib Cross-Section Images Using Fractal Descriptors	PLOS ONE			English	Article							ANGIOSPERM PHYLOGENY; DIMENSION; SYSTEMATICS; FEATURES; TOOL	The correct identification of plants is a common necessity not only to researchers but also to the lay public. Recently, computational methods have been employed to facilitate this task, however, there are few studies front of the wide diversity of plants occurring in the world. This study proposes to analyse images obtained from cross-sections of leaf midrib using fractal descriptors. These descriptors are obtained from the fractal dimension of the object computed at a range of scales. In this way, they provide rich information regarding the spatial distribution of the analysed structure and, as a consequence, they measure the multiscale morphology of the object of interest. In Biology, such morphology is of great importance because it is related to evolutionary aspects and is successfully employed to characterize and discriminate among different biological structures. Here, the fractal descriptors are used to identify the species of plants based on the image of their leaves. A large number of samples are examined, being 606 leaf samples of 50 species from Brazilian flora. The results are compared to other imaging methods in the literature and demonstrate that fractal descriptors are precise and reliable in the taxonomic process of plant species identification.	[da Silva, Nubia Rosa; Florindo, Joao Batista; Gomez, Maria Cecilia; Bruno, Odemir Martinez] Univ Sao Paulo, Sao Carlos Inst Phys, BR-13560970 Sao Carlos, SP, Brazil; [da Silva, Nubia Rosa; Bruno, Odemir Martinez] Univ Sao Paulo, Inst Math & Comp Sci, BR-13560970 Sao Carlos, SP, Brazil; [Gomez, Maria Cecilia] Natl Univ Littoral, Fac Biochem & Biol Sci, Dept Phys, Santa Fe, Argentina; [Rossatto, Davi Rodrigo] Univ Estadual Paulista, UNESP, Fac Agr & Vet Sci, Dept Appl Biol, Jaboticabal, SP, Brazil; [Kolb, Rosana Marta] Univ Estadual Paulista, UNESP, Fac Sci & Letters, Dept Biol Sci, Assis, SP, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo; National University of the Littoral; Universidade Estadual Paulista; Universidade Estadual Paulista	Bruno, OM (corresponding author), Univ Sao Paulo, Sao Carlos Inst Phys, POB 369, BR-13560970 Sao Carlos, SP, Brazil.	bruno@ifsc.usp.br	Florindo, Joao/S-5823-2019; Rossatto, Davi/A-3521-2011; Bruno, Odemir M/A-5279-2009; Kolb, Rosana M./D-3592-2012; Bruno, Odemir/AAU-7209-2020; Florindo, Joao/H-4580-2012; da Silva, Núbia/E-5856-2015; da Silva, Núbia/R-4889-2019	Florindo, Joao/0000-0002-0071-0227; Rossatto, Davi/0000-0001-9510-8345; Bruno, Odemir M/0000-0002-2945-1556; Kolb, Rosana M./0000-0003-3841-5597; Bruno, Odemir/0000-0002-2945-1556; da Silva, Núbia/0000-0003-1982-5144; da Silva, Núbia/0000-0003-1982-5144	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [2011/21467-9, 2012/19143-3, 2011/23112-3, 2011/01523-1]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [307797/2014-7, 484312/2013-8]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	NRS was supported by grant number 2011/21467-9, Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (http://www.bv.fapesp.br/pt/bolsas/133991/reconhecimento-de-padroes-heterogeneos-e-suas-aplicacoes-em-biologia-e-nanotecnologia/). JBF was supported by grant number 2012/19143-3, Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (http://www.bv.fapesp.br/pt/bolsas/140250/geometria-fractal-e-analise-de-imagens-aplicadas-a-biologia-vegetal/). RMK was supported by grant number 2011/23112-3, Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (http://www.bv.fapesp.br/pt/auxilios/46845/anatomia-foliar-de-plantas-de-diferentes-formacoes-vegetacionais/). OMB was supported by grant number 2011/01523-1, Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (http://www.bv.fapesp.br/pt/auxilios/30465/metodos-de-visao-computacional-aplicados-a-identificacao-e-analise-de-plantas/); grant number 307797/2014-7, Conselho Nacional de Desenvolvimento Cientifico e Tecnologico; and grant number 484312/2013-8, Conselho Nacional de Desenvolvimento Cientifico e Tecnologico.	Araujo JS, 2010, PLANT SYST EVOL, V286, P117, DOI 10.1007/s00606-010-0268-3; Backes AR, 2009, INT J PATTERN RECOGN, V23, P1145, DOI 10.1142/S0218001409007508; Bruno OM, 2008, INFORM SCIENCES, V178, P2722, DOI 10.1016/j.ins.2008.01.023; Casanova D, 2009, INT J IMAG SYST TECH, V19, P236, DOI 10.1002/ima.20201; Cronquist A., 1981, INTEGRATED SYSTEM CL; DAHLGREN R, 1983, Nordic Journal of Botany, V3, P119, DOI 10.1111/j.1756-1051.1983.tb01448.x; Dalvi VC, 2014, PLANT SYST EVOL, V300, P99, DOI 10.1007/s00606-013-0863-1; Davis PH, 1963, PRINCIPLES ANGIOSPER; Sa JJD, 2013, ECOL INFORM, V15, P34, DOI 10.1016/j.ecoinf.2013.02.007; Dickison W.C., 2000, INTEGRATIVE PLANT AN; Donoghue M. J., 1992, MOL SYSTEMATICS PLAN, P340, DOI DOI 10.1007/978-1-4615-3276-715; Du JX, 2013, NEUROCOMPUTING, V116, P150, DOI 10.1016/j.neucom.2012.03.028; Duda R. O., 1973, PATTERN CLASSIFICATI; Endress PK, 2002, BOT REV, V68, P545, DOI 10.1663/0006-8101(2002)068[0545:MAASIT]2.0.CO;2; Evert RF., 2006, ESAUS PLANT ANATOMY, DOI [10.1002/0470047380, DOI 10.1002/0470047380]; EYDE RH, 1975, ANN MO BOT GARD, V62, P521, DOI 10.2307/2395266; Florindo JB, 2012, PATTERN RECOGN LETT, V33, P798, DOI 10.1016/j.patrec.2011.12.016; Florindo JB, 2013, EXPERT SYST APPL, V40, P4022, DOI 10.1016/j.eswa.2013.01.007; Florindo JB, 2012, PHYSICA A, V391, P4909, DOI 10.1016/j.physa.2012.03.039; Foroughbakhch R, 2008, PHYTON-INT J EXP BOT, V77, P113; Ghimire B, 2015, PLANT SYST EVOL, V301, P531, DOI 10.1007/s00606-014-1090-0; Greene EL, 1983, LANDMARKS BOT HIST 2; GUREVITCH J, 2006, ECOLOGY PLANTS; HARTE D, 2001, MULTIFRACTALS THEORY; Hennig W., 1999, PHYLOGENETIC SYSTEMA; HICKEY LJ, 1975, ANN MO BOT GARD, V62, P538, DOI 10.2307/2395267; JOHANSEN D.A., 1940, PLANT MICROTECHNIQUE; Judd WS, 2008, PLANT SYSTEMATICS PH; KEATING RC, 1984, ANN MO BOT GARD, V71, P801, DOI 10.2307/2399163; Lopes R, 2009, MED IMAGE ANAL, V13, P634, DOI 10.1016/j.media.2009.05.003; Manoel ETM, 2002, SIBGRAPI 2002: XV BRAZILIAN SYMPOSIUM ON COMPUTER GRAPHICS AND IMAGE PROCESSING, PROCEEDINGS, P269, DOI 10.1109/SIBGRA.2002.1167154; Mantovani André, 2009, Hoehnea, V36, P269; Mayr E., 1985, GROWTH BIOL THOUGHT; Metcalfe C.R., 1950, ANATOMY DICOTYLEDONS, V2; Metcalfe CR, 1979, ANATOMY DICOTYLEDONS; Mugnai S, 2008, PLANT SYST EVOL, V270, P95, DOI 10.1007/s00606-007-0601-7; Niinemets U, 2007, TREE PHYSIOL, V27, P1137, DOI 10.1093/treephys/27.8.1137; Pietikainen M, 2011, COMPUT IMAGING VIS, V40, P1; Plotze RD, 2005, CAN J BOT, V83, P287, DOI [10.1139/b05-002, 10.1139/B05-002]; RATHCKE B, 1985, ANNU REV ECOL SYST, V16, P179, DOI 10.1146/annurev.es.16.110185.001143; Rossatto DR, 2011, PLANT SYST EVOL, V291, P103, DOI 10.1007/s00606-010-0366-2; Sa JJD, 2011, BOTANY, V89, P467, DOI [10.1139/b11-038, 10.1139/B11-038]; Silva NR, 2014, J PHYS CONF SER, V490, DOI 10.1088/1742-6596/490/1/012085; Sneath P.H.A., 1973, SERIES BOOKS BIOL; Stevens P. F., 1994, DEV BIOL SYSTEMATICS; STRECKEISEN A, 1979, GEOLOGY, V7, P331, DOI 10.1130/0091-7613(1979)7<331:CANOVR>2.0.CO;2; Streckeisen A., 1980, GEOL RUNDSCH, V69, P194, DOI [DOI 10.1007/BF01869032, 10.1007/BF01869032]; Stuessy TF, 2003, DEEP MORPHOLOGY RENA; Tian-Gang L, 2007, COMPUT MED IMAG GRAP, V31, P665, DOI 10.1016/j.compmedimag.2007.08.002; Wang H, 2009, ENVIRON EXP BOT, V65, P338, DOI 10.1016/j.envexpbot.2008.10.002; Wang XF, 2005, LECT NOTES COMPUT SC, V3644, P87	52	19	19	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2015	10	6							e0130014	10.1371/journal.pone.0130014	http://dx.doi.org/10.1371/journal.pone.0130014			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL3FE	26091501	Green Published, Green Submitted, gold			2022-12-26	WOS:000356835000083
J	Klanderud, K; Vandvik, V; Goldberg, D				Klanderud, Kari; Vandvik, Vigdis; Goldberg, Deborah			The Importance of Biotic vs. Abiotic Drivers of Local Plant Community Composition Along Regional Bioclimatic Gradients	PLOS ONE			English	Article							CLIMATE-CHANGE; SPECIES RICHNESS; POSITIVE INTERACTIONS; ARCTIC TUNDRA; RESPONSES; FACILITATION; ENVIRONMENT; DIVERSITY; PATTERNS; SCALE	We assessed if the relative importance of biotic and abiotic factors for plant community composition differs along environmental gradients and between functional groups, and asked which implications this may have in a warmer and wetter future. The study location is a unique grid of sites spanning regional-scale temperature and precipitation gradients in boreal and alpine grasslands in southern Norway. Within each site we sampled vegetation and associated biotic and abiotic factors, and combined broad- and fine-scale ordination analyses to assess the relative explanatory power of these factors for species composition. Although the community responses to biotic and abiotic factors did not consistently change as predicted along the bioclimatic gradients, abiotic variables tended to explain a larger proportion of the variation in species composition towards colder sites, whereas biotic variables explained more towards warmer sites, supporting the stress gradient hypothesis. Significant interactions with precipitation suggest that biotic variables explained more towards wetter climates in the sub alpine and boreal sites, but more towards drier climates in the colder alpine. Thus, we predict that biotic interactions may become more important in alpine and boreal grasslands in a warmer future, although more winter precipitation may counteract this trend in oceanic alpine climates. Our results show that both local and regional scales analyses are needed to disentangle the local vegetation-environment relationships and their regional-scale drivers, and biotic interactions and precipitation must be included when predicting future species assemblages.	[Klanderud, Kari] Norwegian Univ Life Sci, Dept Ecol & Nat Resource Management, As, Norway; [Klanderud, Kari; Vandvik, Vigdis] Univ Bergen, Dept Biol, Bergen, Norway; [Goldberg, Deborah] Univ Michigan, Dept Ecol & Evolutionary Biol, Ann Arbor, MI 48109 USA	Norwegian University of Life Sciences; University of Bergen; University of Michigan System; University of Michigan	Klanderud, K (corresponding author), Norwegian Univ Life Sci, Dept Ecol & Nat Resource Management, As, Norway.	kari.klanderud@nmbu.no	Vandvik, Vigdis/C-1924-2008	Vandvik, Vigdis/0000-0003-4651-4798; , Kari/0000-0003-1049-7025	Norwegian Research Council through the programme NORKLIMA; SeedClim project [184912/S30]	Norwegian Research Council through the programme NORKLIMA; SeedClim project	This study was funded by the Norwegian Research Council (http://www.forskningsradet.no/) through the programme NORKLIMA and the SeedClim project, grant number 184912/S30 to VV. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MJ, 2006, ECOL LETT, V9, P683, DOI 10.1111/j.1461-0248.2006.00926.x; [Anonymous], 2001, PLANT STRATEGIES VEG; Banks-Leite C, 2013, ECOL INDIC, V31, P82, DOI 10.1016/j.ecolind.2012.04.015; Berge A, 2010, THESIS; BERTNESS MD, 1994, TRENDS ECOL EVOL, V9, P191, DOI 10.1016/0169-5347(94)90088-4; BILLINGS WD, 1968, BIOL REV, V43, P481, DOI 10.1111/j.1469-185X.1968.tb00968.x; Blundo C, 2012, J TROP ECOL, V28, P83, DOI 10.1017/S0266467411000617; Bret-Harte MS, 2004, J ECOL, V92, P635, DOI 10.1111/j.0022-0477.2004.00902.x; Brooker RW, 2008, J ECOL, V96, P18, DOI 10.1111/j.1365-2745.2007.01295.x; Brooker RW, 2006, NEW PHYTOL, V171, P271, DOI 10.1111/j.1469-8137.2006.01752.x; Brooker RW, 1998, OIKOS, V81, P196, DOI 10.2307/3546481; Callaway RM, 2002, NATURE, V417, P844, DOI 10.1038/nature00812; Cavieres LA, 2014, ECOL LETT, V17, P193, DOI 10.1111/ele.12217; Cavieres LA, 2009, J ECOL, V97, P1181, DOI 10.1111/j.1365-2745.2009.01579.x; CHAPIN FS, 1995, ECOLOGY, V76, P694, DOI 10.2307/1939337; Cushman SA, 2002, LANDSCAPE ECOL, V17, P637, DOI 10.1023/A:1021571603605; de Dios VR, 2014, J VEG SCI, V25, P937, DOI 10.1111/jvs.12164; Dorrepaal E, 2006, FUNCT ECOL, V20, P31, DOI 10.1111/j.1365-2435.2006.01076.x; Dray S, 2012, ECOL MONOGR, V82, P257, DOI 10.1890/11-1183.1; Elmendorf SC, 2012, NAT CLIM CHANGE, V2, P453, DOI 10.1038/NCLIMATE1465; Elmendorf SC, 2012, ECOL LETT, V15, P164, DOI 10.1111/j.1461-0248.2011.01716.x; Eskelinen A, 2005, OIKOS, V110, P360, DOI 10.1111/j.0030-1299.2005.13579.x; FACELLI JM, 1991, BOT REV, V57, P1, DOI 10.1007/BF02858763; Farinas A. S., 2011, THESIS; Fox J., 2019, R COMPANION APPL REG, V.; Fremstad E, 1997, NINA TEMAHEFTE, V12, P1; Gleason H.A., 1926, B TORREY BOT CLUB, V53, P7, DOI DOI 10.2307/2479933; GOLDBERG DE, 1995, FOLIA GEOBOT PHYTOTX, V30, P231, DOI 10.1007/BF02812101; Goldberg DE, 1999, ECOLOGY, V80, P1118, DOI 10.2307/177059; Gough L, 2006, ECOGRAPHY, V29, P44, DOI 10.1111/j.2005.0906-7590.04096.x; GRIME JP, 1973, NATURE, V242, P344, DOI 10.1038/242344a0; Hanssen-Bauer I, 2009, KLIMA NORGE 2100 BAK; He Q, 2013, ECOL LETT, V16, P695, DOI 10.1111/ele.12080; Hobbie SE, 1999, OIKOS, V84, P417, DOI 10.2307/3546421; Keuper F, 2011, GLOBAL CHANGE BIOL, V17, P2162, DOI 10.1111/j.1365-2486.2010.02377.x; Kikvidze Z, 2005, ECOLOGY, V86, P1395, DOI 10.1890/04-1926; Klanderud K, 2005, ECOLOGY, V86, P2047, DOI 10.1890/04-1563; Klanderud K, 2007, OIKOS, V116, P1279, DOI 10.1111/j.2007.0030-1299.15906.x; Klanderud K, 2010, J ECOL, V98, P1128, DOI 10.1111/j.1365-2745.2010.01703.x; Knick ST, 2008, ECOGRAPHY, V31, P389, DOI 10.1111/j.0906-7590.2008.05391.x; Lavergne S, 2010, ANNU REV ECOL EVOL S, V41, P321, DOI 10.1146/annurev-ecolsys-102209-144628; Lenoir J, 2013, GLOBAL CHANGE BIOL, V19, P1470, DOI 10.1111/gcb.12129; Mamayev, 1972, PINACEAE URALE TYPES; Meineri E, 2013, PLANT ECOL, V214, P607, DOI 10.1007/s11258-013-0193-y; Michalet R, 2006, ECOL LETT, V9, P767, DOI 10.1111/j.1461-0248.2006.00935.x; Michel P, 2013, NEW ZEAL J ECOL, V37, P114; Michel P, 2011, OIKOS, V120, P1272, DOI 10.1111/j.1600-0706.2010.19148.x; Moya-Larano J., 2010, OPEN ECOL J; Norwegian Meteorological Institute, 2010, NORM PER 1961 1990; Okland RH, 1999, J VEG SCI, V10, P131, DOI 10.2307/3237168; Olofsson J, 1999, OIKOS, V86, P539, DOI 10.2307/3546658; Olofsson J, 2007, J ECOL, V95, P916, DOI 10.1111/j.1365-2745.2007.01284.x; Olsen SL, 2014, OIKOS, V123, P71, DOI 10.1111/j.1600-0706.2013.00336.x; R Development Core Team, 2012, R LANG ENV STAT COMP; Richardson PJ, 2012, ECOLOGY, V93, P1431, DOI 10.1890/11-1290.1; Ross LC, 2012, J VEG SCI, V23, P755, DOI 10.1111/j.1654-1103.2012.01390.x; Shaver GR, 1999, POLAR RES, V18, P245, DOI 10.1111/j.1751-8369.1999.tb00300.x; Siefert A, 2012, J VEG SCI, V23, P942, DOI 10.1111/j.1654-1103.2012.01401.x; ter Braak C. J. F., 2012, CANOCO WINDOWS VERSI; ter Braak CJF, 1994, ECOSCIENCE, V1, P127, DOI 10.1080/11956860.1994.11682237; TERBRAAK CJF, 1986, ECOLOGY, V67, P1167; Tilman D., 1982, Monographs in Population Biology, pi; TILMAN D, 1988; Tveito OE, 2005, METEOROL APPL, V12, P57, DOI 10.1017/S1350482705001490; Vandvik V, 2002, PLANT ECOL, V162, P233, DOI 10.1023/A:1020322205469; Walker MD, 2006, P NATL ACAD SCI USA, V103, P1342, DOI 10.1073/pnas.0503198103; Wisz MS, 2013, BIOL REV, V88, P15, DOI 10.1111/j.1469-185X.2012.00235.x	67	55	60	5	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2015	10	6							e0130205	10.1371/journal.pone.0130205	http://dx.doi.org/10.1371/journal.pone.0130205			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL3FE	26091266	Green Published, gold			2022-12-26	WOS:000356835000096
J	Najafi, E; Darooneh, AH				Najafi, Elham; Darooneh, Amir H.			The Fractal Patterns of Words in a Text: A Method for Automatic Keyword Extraction	PLOS ONE			English	Article								A text can be considered as a one dimensional array of words. The locations of each word type in this array form a fractal pattern with certain fractal dimension. We observe that important words responsible for conveying the meaning of a text have dimensions considerably different from one, while the fractal dimensions of unimportant words are close to one. We introduce an index quantifying the importance of the words in a given text using their fractal dimensions and then ranking them according to their importance. This index measures the difference between the fractal pattern of a word in the original text relative to a shuffled version. Because the shuffled text is meaningless (i.e., words have no importance), the difference between the original and shuffled text can be used to ascertain degree of fractality. The degree of fractality may be used for automatic keyword detection. Words with the degree of fractality higher than a threshold value are assumed to be the retrieved keywords of the text. We measure the efficiency of our method for keywords extraction, making a comparison between our proposed method and two other well-known methods of automatic keyword extraction.	[Najafi, Elham; Darooneh, Amir H.] Univ Zanjan, Dept Phys, Zanjan, Iran	University Zanjan	Najafi, E (corresponding author), Univ Zanjan, Dept Phys, Zanjan, Iran.	e.najafi@znu.ac.ir	Najafi, Elham/O-3815-2019	Najafi, Elham/0000-0001-9593-1593				Altmann G., 1980, GLOTTOMETRIKA, V2, P110; Andres J, 2012, J QUANT LINGUIST, V19, P1, DOI 10.1080/09296174.2011.608604; Andres J, 2010, J QUANT LINGUIST, V17, P101, DOI 10.1080/09296171003643189; Ausloos M, 2012, PHYS REV E, V86, DOI 10.1103/PhysRevE.86.031108; Ausloos M., 2012, CHAOS SOLITON FRACT, V45; Carpena P, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.035102; Darwin C., 1859, NATURE; Eftekhari A., 2006, J QUANT LINGUIST, V13, P177, DOI [10.1080/09296170600850106, DOI 10.1080/09296170600850106]; Gouyet J. F., 1996, PHYS FRACTAL STRUCTU; HAWKING SW, 1988, BRIEF HIST TIME; Heaps Harold Stanley, 1978, INFORM RETRIEVAL COM; Herrera JP, 2008, EUR PHYS J B, V63, P135, DOI 10.1140/epjb/e2008-00206-x; Hrebiek L.K., 1994, J QUANT LINGUIST, V1, P82, DOI 10.1080/09296179408590001; Kord Delsame K., 2012, THESIS U ZANJAN; Larsen-Freeman D., 2008, COMPLEX SYSTEMS APPL; LUHN HP, 1958, IBM J RES DEV, V2, P159, DOI 10.1147/rd.22.0159; Mehri A, 2011, PHYSICA A, V390, P3157, DOI 10.1016/j.physa.2011.04.013; Mehri A, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.056106; Mihalcea R, 2004, C EMP METH NAT LANG, V4, P404; Ortuno M, 2002, EUROPHYS LETT, V57, P759, DOI 10.1209/epl/i2002-00528-3; Sano Y, 2012, PROG THEOR PHYS SUPP, P202; Weinberg S., 1949, 1 3 MINUTES; Zhou HD, 2003, PHYSICA A, V329, P309, DOI [10.1016/S0378-4371(03)00625-3, 10.1016/0378-4371(03)00625-3]; Zipf G. K., 1949, HUMAN BEHAV PRINCIPL	24	18	18	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2015	10	6							e0130617	10.1371/journal.pone.0130617	http://dx.doi.org/10.1371/journal.pone.0130617			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL3FE	26091207	gold, Green Submitted, Green Published			2022-12-26	WOS:000356835000137
J	Singh, D; Trivedi, AK; Rani, S; Panda, S; Kumar, V				Singh, Devraj; Trivedi, Amit Kumar; Rani, Sangeeta; Panda, Satchidananda; Kumar, Vinod			Circadian timing in central and peripheral tissues in a migratory songbird: dependence on annual life-history states	FASEB JOURNAL			English	Article						black-headed bunting; Bmal1; circadian genes; Clock; cryptochrome	GENE-EXPRESSION; CLOCK GENES; SUPRACHIASMATIC NUCLEUS; EMBERIZA-MELANOCEPHALA; SEASONAL REPRODUCTION; RESPONSE ELEMENT; PARS TUBERALIS; RESTLESSNESS; BIRDS; TRANSCRIPTION	Predictable seasonal change in photoperiod triggers a sequential change in the daily activity-rest pattern, adaptive for migration in several bird species. The night-migratory black-headed bunting (Emberiza melanocephala) is day active under short photoperiods (8 h light: 16 h dark, short day sensitive). Under long photoperiods (16 h light: 8 h dark), the buntings are initially day active (long day premigratory) but subsequently become intensely night active (long day migratory) and after few weeks again return to a day active pattern (long day refractory). However, it is unclear how the daily expression of circadian genes changes during photoperiod-induced seasonal life-history states (LHSs). We measured period 2 (Per2), cryptochrome 1 (Cry1), brain and muscle arnt-like protein 1 (Bmal1), and circadian locomotor output cycles kaput (Clock) mRNA expressions in various neural and peripheral tissues of buntings in different LHSs and discovered differences of similar to 2 to 6 h in the phase and 2- to 4-fold in amplitude of circadian oscillations of Per2, Cry1, and Bmal1 between photoperiod-induced LHSs. Phase relationship in mRNA oscillations was altered between oscillator components in the circadian pacemaker system (retina, pineal, hypothalamus) as well as in the peripheral (liver, muscle) tissues. These results show for the first time altered waveforms of clock gene expressions in all tissues in parallel with behavioral shifts and suggest the involvement of circadian system in photoperiod induction of seasonal LHSs in a migratory species.	[Singh, Devraj; Trivedi, Amit Kumar; Rani, Sangeeta; Kumar, Vinod] Univ Delhi, Ctr Excellence Biol Rhythms Res, Intensificat Res High Prior Areas, Dept Sci & Technol, Delhi 110007, India; [Singh, Devraj; Trivedi, Amit Kumar; Rani, Sangeeta; Kumar, Vinod] Univ Delhi, Indo US Ctr Biol Timing, Delhi 110007, India; [Singh, Devraj; Trivedi, Amit Kumar; Kumar, Vinod] Univ Delhi, Dept Zool, Delhi 110007, India; [Rani, Sangeeta] Univ Lucknow, Dept Zool, Lucknow 226007, Uttar Pradesh, India; [Panda, Satchidananda] Salk Inst Biol Studies, Regulatory Biol Lab, La Jolla, CA 92037 USA	University of Delhi; University of Delhi; University of Delhi; Lucknow University; Salk Institute	Kumar, V (corresponding author), Univ Delhi, Dept Zool, Delhi 110007, India.	drvkumar11@yahoo.com	Trivedi, Amit/AAF-4018-2021	Trivedi, Amit/0000-0003-0985-3088	Department of Biotechnology [New Delhi, India] [BT/PR4984/MED/30/752/2012]; Science and Engineering Research Board [New Delhi, India] [IR/SO/LU-02/2005, SR/SO/AS-50/2010]; Indo-U.S. Joint Center on Biological Timing; University of Delhi-Department of Science and Technology Promotion of University Research and Scientific Excellence (DU-DST PURSE); NATIONAL CANCER INSTITUTE [P30CA014195] Funding Source: NIH RePORTER	Department of Biotechnology [New Delhi, India](Department of Biotechnology (DBT) India); Science and Engineering Research Board [New Delhi, India]; Indo-U.S. Joint Center on Biological Timing; University of Delhi-Department of Science and Technology Promotion of University Research and Scientific Excellence (DU-DST PURSE); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The authors are grateful to M. Gorman (University of California, San Diego, CA, USA) who helped to analyze the present results. Generous funding from the Department of Biotechnology [New Delhi, India (BT/PR4984/MED/30/752/2012)], Science and Engineering Research Board [New Delhi, India (IR/SO/LU-02/2005, SR/SO/AS-50/2010)], Indo-U.S. Joint Center on Biological Timing, and University of Delhi-Department of Science and Technology Promotion of University Research and Scientific Excellence (DU-DST PURSE) funding is acknowledged.	Bartell PA, 2005, J BIOL RHYTHM, V20, P538, DOI 10.1177/0748730405281826; Caprioli M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035140; Cermakian N, 2002, CURR OPIN NEUROBIOL, V12, P359, DOI 10.1016/S0959-4388(02)00347-1; Chen RM, 2009, MOL CELL, V36, P417, DOI 10.1016/j.molcel.2009.10.012; Falvey E, 1996, BIOL CHEM, V377, P797; Gekakis N, 1998, SCIENCE, V280, P1564, DOI 10.1126/science.280.5369.1564; GWINNER E, 1978, OIKOS, V30, P364, DOI 10.2307/3543485; Gwinner E., 1986, CIRCANNUAL RHYTHMS, Vfirst; HARDING HP, 1993, MOL CELL BIOL, V13, P3113, DOI 10.1128/MCB.13.5.3113; Helm B, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.0016; Kiessling S, 2010, J CLIN INVEST, V120, P2600, DOI 10.1172/JCI41192; Kumar V, 2004, BIOL RHYTHM RES, V35, P121, DOI 10.1080/09291010412331313287; Kumar V, 2010, PHYSIOL BIOCHEM ZOOL, V83, P827, DOI 10.1086/652243; Liedvogel M, 2009, MOL ECOL, V18, P2444, DOI 10.1111/j.1365-294X.2009.04204.x; Lincoln G, 2002, P NATL ACAD SCI USA, V99, P13890, DOI 10.1073/pnas.212517599; Lincoln GA, 2003, J ENDOCRINOL, V179, P1, DOI 10.1677/joe.0.1790001; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Misra M, 2004, REPROD NUTR DEV, V44, P341, DOI 10.1051/rnd:2004039; Peirson SN, 2006, BIOCHEM BIOPH RES CO, V351, P800, DOI 10.1016/j.bbrc.2006.10.118; Ramenofsky M, 2014, HORM BEHAV, V66, P148, DOI 10.1016/j.yhbeh.2014.04.012; Rani S, 2006, CURR SCI INDIA, V91, P1093; Singh D, 2013, CHRONOBIOL INT, V30, P1208, DOI 10.3109/07420528.2013.810632; Stevenson TJ, 2011, P ROY SOC B-BIOL SCI, V278, P2477, DOI 10.1098/rspb.2010.2181; Trivedi AK, 2014, J BIOL RHYTHM, V29, P332, DOI 10.1177/0748730414549766; Ueda HR, 2002, NATURE, V418, P534, DOI 10.1038/nature00906; Ukai-Tadenuma M, 2011, CELL, V144, P268, DOI 10.1016/j.cell.2010.12.019; WELSH DK, 1995, NEURON, V14, P697, DOI 10.1016/0896-6273(95)90214-7; Yasuo S, 2004, ENDOCRINOLOGY, V145, P1612, DOI 10.1210/en.2003-1285	28	38	40	1	29	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2015	29	10					4248	4255		10.1096/fj.15-275339	http://dx.doi.org/10.1096/fj.15-275339			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CR5FY	26103987	Green Published			2022-12-26	WOS:000361367300014
J	Jacquez, P; Avila, G; Boone, K; Altiyev, A; Puschhof, J; Sauter, R; Arigi, E; Ruiz, B; Peng, XL; Almeida, I; Sherman, M; Xiao, C; Sun, JJ				Jacquez, Pedro; Avila, Gustavo; Boone, Kyle; Altiyev, Agamyrat; Puschhof, Jens; Sauter, Roland; Arigi, Emma; Ruiz, Blanca; Peng, Xiuli; Almeida, Igor; Sherman, Michael; Xiao, Chuan; Sun, Jianjun			The Disulfide Bond Cys255-Cys279 in the Immunoglobulin-Like Domain of Anthrax Toxin Receptor 2 Is Required for Membrane Insertion of Anthrax Protective Antigen Pore	PLOS ONE			English	Article							CAPILLARY MORPHOGENESIS PROTEIN-2; DIPHTHERIA-TOXIN; CRYSTAL-STRUCTURE; CHOLERA-TOXIN; MEDIATED REDUCTION; MAMMALIAN-CELLS; LIPID NANODISCS; LETHAL-FACTOR; PH THRESHOLD; HIV-1 ENTRY	Anthrax toxin receptors act as molecular clamps or switches that control anthrax toxin entry, pH-dependent pore formation, and translocation of enzymatic moieties across the endosomal membranes. We previously reported that reduction of the disulfide bonds in the immunoglobulin-like (Ig) domain of the anthrax toxin receptor 2 (ANTXR2) inhibited the function of the protective antigen (PA) pore. In the present study, the disulfide linkage in the Ig domain was identified as Cys255-Cys279 and Cys230-Cys315. Specific disulfide bond deletion mutants were achieved by replacing Cys residues with Ala residues. Deletion of the disulfide bond C255-C279, but not C230-C315, inhibited the PA pore-induced release of the fluorescence dyes from the liposomes, suggesting that C255-C279 is essential for PA pore function. Furthermore, we found that deletion of C255-C279 did not affect PA prepore-to-pore conversion, but inhibited PA pore membrane insertion by trapping the PA membrane-inserting loops in proteinaceous hydrophobic pockets. Fluorescence spectra of Trp59, a residue adjacent to the PA-binding motif in vonWillebrand factor A (VWA) domain of ANTXR2, showed that deletion of C255-C279 resulted in a significant conformational change on the receptor ectodomain. The disulfide deletion-induced conformational change on the VWA domain was further confirmed by single-particle 3D reconstruction of the negatively stained PA-receptor heptameric complexes. Together, the biochemical and structural data obtained in this study provides a mechanistic insight into the role of the receptor disulfide bond C255-C279 in anthrax toxin action. Manipulation of the redox states of the receptor, specifically targeting to C255-C279, may become a novel strategy to treat anthrax.	[Jacquez, Pedro; Puschhof, Jens; Sauter, Roland; Arigi, Emma; Ruiz, Blanca; Almeida, Igor; Sun, Jianjun] Univ Texas El Paso, Dept Biol Sci, El Paso, TX 79968 USA; [Jacquez, Pedro; Puschhof, Jens; Sauter, Roland; Arigi, Emma; Ruiz, Blanca; Almeida, Igor; Sun, Jianjun] Univ Texas El Paso, Border Biomed Res Ctr, El Paso, TX 79968 USA; [Avila, Gustavo; Xiao, Chuan] Univ Texas El Paso, Dept Chem, El Paso, TX 79968 USA; [Boone, Kyle; Altiyev, Agamyrat] Univ Texas El Paso, Bioinformat Program, El Paso, TX 79968 USA; [Sherman, Michael] Univ Texas Med Branch, Sealy Ctr Struct Biol & Mol Biophys, Dept Biochem & Mol Biol, Galveston, TX 77555 USA; [Peng, Xiuli] Huazhong Agr Univ, China Natl Key Lab Agr Microbiol, Wuhan 430070, Peoples R China	University of Texas System; University of Texas El Paso; University of Texas System; University of Texas El Paso; University of Texas System; University of Texas El Paso; University of Texas System; University of Texas El Paso; University of Texas System; University of Texas Medical Branch Galveston; Huazhong Agricultural University	Xiao, C (corresponding author), Univ Texas El Paso, Dept Chem, 500 West Univ Ave, El Paso, TX 79968 USA.	cxiao@utep.edu; jsun@utep.edu	Almeida, Igor C./AAF-9409-2019; Xiao, Chuan/B-2130-2010	Almeida, Igor C./0000-0002-2443-8213; Xiao, Chuan/0000-0001-6599-8762; Ruiz-Medina, Blanca E./0000-0003-1947-4014; Boone, Kyle/0000-0001-6383-6479	National Institute of General Medical Sciences [SC1GM095475]; UTEP new faculty startup fund; National Center for Research Resources [5G12RR008124]; National Institute on Minority Health and Health Disparities [G12MD007592]; NSF [DUE-0926721]; DAAD RISE program; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [SC1GM095475] Funding Source: NIH RePORTER; Division Of Undergraduate Education [1153832] Funding Source: National Science Foundation	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); UTEP new faculty startup fund; National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); NSF(National Science Foundation (NSF)); DAAD RISE program; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Division Of Undergraduate Education(National Science Foundation (NSF)NSF- Directorate for Education & Human Resources (EHR))	This study is supported by a grant from National Institute of General Medical Sciences SC1GM095475 (to J. Sun), UTEP new faculty startup fund (to J. Sun) and UTEP new faculty startup fund (to C. Xiao), the grants from National Center for Research Resources (5G12RR008124), and the National Institute on Minority Health and Health Disparities (G12MD007592). The negatively stained EM images were taken using a JEOL 3200FS electron microscope acquired by NSF MRI 0923437. AA was supported by a NSF grant DUE-0926721 (to Ming-Ying Leung, UTEP bioinformatics). JP and RS were supported by DAAD RISE program.	Abrami L, 2006, J CELL BIOL, V172, P309, DOI 10.1083/jcb.200507067; Abrami L, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000792; Abromaitis S, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000357; Akkaladevi N, 2013, PROTEIN SCI, V22, P492, DOI 10.1002/pro.2231; Auwerx J, 2009, INT J BIOCHEM CELL B, V41, P1269, DOI 10.1016/j.biocel.2008.10.031; Bordoli L, 2009, NAT PROTOC, V4, P1, DOI 10.1038/nprot.2008.197; Bradley KA, 2001, NATURE, V414, P225, DOI 10.1038/n35101999; Collier RJ, 2003, ANNU REV CELL DEV BI, V19, P45, DOI 10.1146/annurev.cellbio.19.111301.140655; Conant CG, 2007, CELL MICROBIOL, V9, P222, DOI 10.1111/j.1462-5822.2006.00783.x; De Leon J, 2012, J BIOL CHEM, V287, P44184, DOI 10.1074/jbc.M112.420869; Dennis MK, 2014, BIOCHEMISTRY-US, V53, P2166, DOI 10.1021/bi5000756; Deuquet J, 2011, EMBO MOL MED, V3, P208, DOI 10.1002/emmm.201100124; Duesbery NS, 1998, SCIENCE, V280, P734, DOI 10.1126/science.280.5364.734; FALNES PO, 1995, J BIOL CHEM, V270, P20787, DOI 10.1074/jbc.270.35.20787; Grigorieff N, 2007, J STRUCT BIOL, V157, P117, DOI 10.1016/j.jsb.2006.05.004; Hogg PJ, 2003, TRENDS BIOCHEM SCI, V28, P210, DOI 10.1016/S0968-0004(03)00057-4; Jacquez P, 2014, PROTEIN EXPRES PURIF, V95, P149, DOI 10.1016/j.pep.2013.12.010; Katayama H, 2010, P NATL ACAD SCI USA, V107, P3453, DOI 10.1073/pnas.1000100107; Katayama H, 2008, NAT STRUCT MOL BIOL, V15, P754, DOI 10.1038/nsmb.1442; Kintzer AF, 2009, J MOL BIOL, V392, P614, DOI 10.1016/j.jmb.2009.07.037; Lacy DB, 2004, P NATL ACAD SCI USA, V101, P6367, DOI 10.1073/pnas.0401506101; Lacy DB, 2002, CURR TOP MICROBIOL, V271, P61; Lacy DB, 2004, P NATL ACAD SCI USA, V101, P13147, DOI 10.1073/pnas.0405405101; LEPPLA SH, 1982, P NATL ACAD SCI-BIOL, V79, P3162, DOI 10.1073/pnas.79.10.3162; Lin AEJ, 2010, PROTOPLASMA, V244, P75, DOI 10.1007/s00709-010-0164-2; Liu SL, 2009, P NATL ACAD SCI USA, V106, P12424, DOI 10.1073/pnas.0905409106; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Majoul I, 1997, FEBS LETT, V401, P104, DOI 10.1016/S0014-5793(96)01447-0; Matthias LJ, 2003, ANTIOXID REDOX SIGN, V5, P133, DOI 10.1089/152308603321223621; Matthias LJ, 2002, NAT IMMUNOL, V3, P727, DOI 10.1038/ni815; Miller CJ, 1999, BIOCHEMISTRY-US, V38, P10432, DOI 10.1021/bi990792d; MILNE JC, 1994, J BIOL CHEM, V269, P20607; Mogridge J, 2002, P NATL ACAD SCI USA, V99, P7045, DOI 10.1073/pnas.052160199; MOLLOY SS, 1992, J BIOL CHEM, V267, P16396; Mullangi V, 2014, BIOCHEMISTRY-US, V53, P6084, DOI 10.1021/bi500718g; Naik S, 2013, BIOCHEMISTRY-US, V52, P6335, DOI 10.1021/bi400705n; Orlandi PA, 1997, J BIOL CHEM, V272, P4591; PAPINI E, 1993, J BIOL CHEM, V268, P1567; Petosa C, 1997, NATURE, V385, P833, DOI 10.1038/385833a0; Pilpa RM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002354; Rainey GJA, 2005, P NATL ACAD SCI USA, V102, P13278, DOI 10.1073/pnas.0505865102; Rajapaksha M, 2009, PROTEIN SCI, V18, P17, DOI 10.1002/pro.26; Ratts R, 2003, J CELL BIOL, V160, P1139, DOI 10.1083/jcb.200210028; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Ryser HJP, 2005, DRUG DISCOV TODAY, V10, P1085, DOI 10.1016/S1359-6446(05)03550-6; RYSER HJP, 1991, J BIOL CHEM, V266, P18439; Santelli E, 2004, NATURE, V430, P905, DOI 10.1038/nature02763; Scobie HM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000329; Scobie HM, 2003, P NATL ACAD SCI USA, V100, P5170, DOI 10.1073/pnas.0431098100; Sun J, 2008, P NATL ACAD SCI USA, V105, P4346, DOI 10.1073/pnas.0800701105; Sun JJ, 2007, J BIOL CHEM, V282, P1059, DOI 10.1074/jbc.M609869200; Sun JJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010553; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; Tsai B, 2001, CELL, V104, P937, DOI 10.1016/S0092-8674(01)00289-6; Tsai M, 2002, J CELL BIOL, V159, P207, DOI 10.1083/jcb.200207120; Wigelsworth DJ, 2004, J BIOL CHEM, V279, P23349, DOI 10.1074/jbc.M401292200; Williams AS, 2009, PROTEIN SCI, V18, P2277, DOI 10.1002/pro.238; Wolfe JT, 2005, J BIOL CHEM, V280, P39417, DOI 10.1074/jbc.M509049200; Yang Z, 2012, J STRUCT BIOL, V179, P269, DOI 10.1016/j.jsb.2011.09.006; Young JAT, 2007, ANNU REV BIOCHEM, V76, P243, DOI 10.1146/annurev.biochem.75.103004.142728	60	5	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2015	10	6							e0130832	10.1371/journal.pone.0130832	http://dx.doi.org/10.1371/journal.pone.0130832			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4OM	26107617	gold, Green Published, Green Submitted			2022-12-26	WOS:000356932500127
J	Vigani, G; Faoro, F; Ferretti, AM; Cantele, F; Maffi, D; Marelli, M; Maver, M; Murgia, I; Zocchi, G				Vigani, Gianpiero; Faoro, Franco; Ferretti, Anna Maria; Cantele, Francesca; Maffi, Dario; Marelli, Marcello; Maver, Mauro; Murgia, Irene; Zocchi, Graziano			Three-Dimensional Reconstruction, by TEM Tomography, of the Ultrastructural Modifications Occurring in Cucumis sativus L. Mitochondria under Fe Deficiency	PLOS ONE			English	Article							IRON-DEFICIENCY; BIOFORTIFICATION; CHLOROPLASTS; HOMEOSTASIS; TRANSPORT; RESPONSES; STRESS	Background Mitochondria, as recently suggested, might be involved in iron sensing and signalling pathways in plant cells. For a better understanding of the role of these organelles in mediating the Fe deficiency responses in plant cells, it is crucial to provide a full overview of their modifications occurring under Fe-limited conditions. The aim of this work is to characterize the ultrastructural as well as the biochemical changes occurring in leaf mitochondria of cucumber (Cucumis sativus L.) plants grown under Fe deficiency. Methodology/Results Mitochondrial ultrastructure was investigated by transmission electron microscopy (TEM) and electron tomography techniques, which allowed a three-dimensional (3D) reconstruction of cellular structures. These analyses reveal that mitochondria isolated from cucumber leaves appear in the cristae junction model conformation and that Fe deficiency strongly alters both the number and the volume of cristae. The ultrastructural changes observed in mitochondria isolated from Fe-deficient leaves reflect a metabolic status characterized by a respiratory chain operating at a lower rate (orthodox-like conformation) with respect to mitochondria from control leaves. Conclusions To our knowledge, this is the first report showing a 3D reconstruction of plant mitochondria. Furthermore, these results suggest that a detailed characterization of the link between changes in the ultrastructure and functionality of mitochondria during different nutritional conditions, can provide a successful approach to understand the role of these organelles in the plant response to Fe deficiency.	[Vigani, Gianpiero; Faoro, Franco; Maffi, Dario; Maver, Mauro; Zocchi, Graziano] Univ Milan, Dipartimento Sci Agr Ambientali Pro, Terr, Agr, Milan, Italy; [Ferretti, Anna Maria; Marelli, Marcello] CNR, Ist Sci Tecnol Mol, I-20133 Milan, Italy; [Cantele, Francesca] Univ Milan, Dipartimento Chim, Milan, Italy; [Murgia, Irene] Univ Milan, Dipartimento Biosci, Milan, Italy	University of Milan; Consiglio Nazionale delle Ricerche (CNR); Istituto di Scienze e Tecnologie Molecolari (ISTM-CNR); University of Milan; University of Milan	Vigani, G (corresponding author), Univ Milan, Dipartimento Sci Agr Ambientali Pro, Terr, Agr, Milan, Italy.	gianpiero.vigani@unimi.it	Marelli, Marcello/L-5423-2019; Maver, Mauro/GLT-8406-2022; Vigani, Gianpiero/R-5539-2019; Murgia, Irene/ABD-7070-2020; Ferretti, Anna Maria/E-6861-2010; Faoro, Franco/O-6631-2017; marelli, marcello/B-7547-2015	Marelli, Marcello/0000-0003-3662-7326; Maver, Mauro/0000-0002-8162-3618; Murgia, Irene/0000-0002-3193-6325; Ferretti, Anna Maria/0000-0002-7373-7965; Faoro, Franco/0000-0003-2620-9171; marelli, marcello/0000-0003-3662-7326; Vigani, Gianpiero/0000-0001-8852-3866; CANTELE, FRANCESCA ORTENSIA/0000-0003-1373-0793	Fondo per gli Investimenti della Ricerca di Base (FIRB) project, Futuro in Ricerca [RBFR127WJ9]	Fondo per gli Investimenti della Ricerca di Base (FIRB) project, Futuro in Ricerca	This work was financially supported by the Fondo per gli Investimenti della Ricerca di Base (FIRB) project, Futuro in Ricerca 2012 No RBFR127WJ9, "Rhizosphere management for sustainable crop production: processes and mechanisms involved in soil nutrient availability, plant uptake and translocation-RHIZOCROP" founded by the Italian Ministry of University and Research (MIUR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abadia J, 2011, PLANT PHYSIOL BIOCH, V49, P471, DOI 10.1016/j.plaphy.2011.01.026; Balk J, 2001, PLANT CELL, V13, P1803, DOI 10.1105/tpc.13.8.1803; Barcena M, 2009, SEMIN CELL DEV BIOL, V20, P920, DOI 10.1016/j.semcdb.2009.07.008; Cantele F, 2010, J STRUCT BIOL, V169, P192, DOI 10.1016/j.jsb.2009.10.003; Cogliati S, 2013, CELL, V155, P160, DOI 10.1016/j.cell.2013.08.032; Curie C, 2003, ANNU REV PLANT BIOL, V54, P183, DOI 10.1146/annurev.arplant.54.031902.135018; DAEMS WT, 1966, J ULTRA MOL STRUCT R, V16, P123, DOI 10.1016/S0022-5320(66)80027-8; Daum B, 2011, J EXP BOT, V62, P2393, DOI 10.1093/jxb/err034; Glaesener AG, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00337; HACKENBR.CR, 1968, P NATL ACAD SCI USA, V61, P598, DOI 10.1073/pnas.61.2.598; Higa A, 2010, J PLANT PHYSIOL, V167, P870, DOI 10.1016/j.jplph.2010.01.011; Jacoby RP, 2012, J INTEGR PLANT BIOL, V54, P887, DOI 10.1111/j.1744-7909.2012.01177.x; Jain A, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00348; Kispal G, 1997, FEBS LETT, V418, P346, DOI 10.1016/S0014-5793(97)01414-2; Kobayashi T, 2013, NAT COMMUN, V4, P2742, DOI [10.1038/ncomms3742, DOI 10.1038/NCOMMS3742]; Kremer JR, 1996, J STRUCT BIOL, V116, P71, DOI 10.1006/jsbi.1996.0013; Logan DC, 2006, J EXP BOT, V57, P1225, DOI 10.1093/jxb/erj151; Logan DC, 2001, PLANT PHYSIOL, V125, P662, DOI 10.1104/pp.125.2.662; Lopez-Millan AF, 2000, PLANT PHYSIOL, V124, P885, DOI 10.1104/pp.124.2.885; Mannella CA, 2006, BBA-MOL BASIS DIS, V1762, P140, DOI 10.1016/j.bbadis.2005.07.001; MANNELLA CA, 1994, MICROSC RES TECHNIQ, V27, P278, DOI 10.1002/jemt.1070270403; Mannella CA, 1997, TRENDS BIOCHEM SCI, V22, P37, DOI 10.1016/S0968-0004(96)30050-9; Mondini S, 2012, NANOSCALE, V4, P5356, DOI 10.1039/c2nr31276j; Murgia I, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00429; Murgia I, 2012, TRENDS PLANT SCI, V17, P47, DOI 10.1016/j.tplants.2011.10.003; PALADE GE, 1952, ANAT RECORD, V114, P427, DOI 10.1002/ar.1091140304; PASCAL N, 1993, PLANT PHYSIOL, V103, P1329, DOI 10.1104/pp.103.4.1329; PENCZEK P, 1995, ULTRAMICROSCOPY, V60, P393, DOI 10.1016/0304-3991(95)00078-X; Rodiger A, 2010, J PLANT PHYSIOL, V167, P620, DOI 10.1016/j.jplph.2009.11.013; Salvi E, 2008, J STRUCT BIOL, V161, P287, DOI 10.1016/j.jsb.2007.06.011; SJOSTRAND FS, 1953, NATURE, V171, P30, DOI 10.1038/171030a0; Tarantino D, 2005, PLANTA, V221, P757, DOI 10.1007/s00425-005-1485-9; Tarantino D, 2010, J PLANT PHYSIOL, V167, P453, DOI 10.1016/j.jplph.2009.10.015; Vigani G, 2013, TRENDS PLANT SCI, V18, P305, DOI 10.1016/j.tplants.2013.01.006; Vigani G, 2012, J PLANT PHYSIOL, V169, P1, DOI 10.1016/j.jplph.2011.09.008; Vigani G, 2010, J PLANT PHYSIOL, V167, P666, DOI 10.1016/j.jplph.2009.12.006; Vigani G, 2009, NEW PHYTOL, V182, P127, DOI 10.1111/j.1469-8137.2008.02747.x; Zick M, 2009, BBA-MOL CELL RES, V1793, P5, DOI 10.1016/j.bbamcr.2008.06.013	38	20	20	2	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2015	10	6							e0129141	10.1371/journal.pone.0129141	http://dx.doi.org/10.1371/journal.pone.0129141			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4OM	26107946	Green Submitted, Green Published, gold			2022-12-26	WOS:000356932500041
J	Wu, S; Xiong, J; Yu, YH				Wu, Shu; Xiong, Jie; Yu, Yuhe			Taxonomic Resolutions Based on 18S rRNA Genes: A Case Study of Subclass Copepoda	PLOS ONE			English	Article							INTERNAL TRANSCRIBED SPACER; SPECIES DELIMITATION; PHYLOGENETIC-RELATIONSHIPS; MOLECULAR-DATA; BIODIVERSITY ASSESSMENT; EUKARYOTIC DIVERSITY; BAYESIAN-INFERENCE; MITOCHONDRIAL COI; DNA; CRUSTACEA	Biodiversity studies are commonly conducted using 18S rRNA genes. In this study, we compared the inter-species divergence of variable regions (V1-9) within the copepod 18S rRNA gene, and tested their taxonomic resolutions at different taxonomic levels. Our results indicate that the 18S rRNA gene is a good molecular marker for the study of copepod biodiversity, and our conclusions are as follows: 1) 18S rRNA genes are highly conserved intraspecies (intra-species similarities are close to 100%); and could aid in species-level analyses, but with some limitations; 2) nearly-whole-length sequences and some partial regions (around V2, V4, and V9) of the 18S rRNA gene can be used to discriminate between samples at both the family and order levels (with a success rate of about 80%); 3) compared with other regions, V9 has a higher resolution at the genus level (with an identification success rate of about 80%); and 4) V7 is most divergent in length, and would be a good candidate marker for the phylogenetic study of Acartia species. This study also evaluated the correlation between similarity thresholds and the accuracy of using nuclear 18S rRNA genes for the classification of organisms in the subclass Copepoda. We suggest that sample identification accuracy should be considered when a molecular sequence divergence threshold is used for taxonomic identification, and that the lowest similarity threshold should be determined based on a pre-designated level of acceptable accuracy.	[Wu, Shu; Xiong, Jie; Yu, Yuhe] Chinese Acad Sci, Inst Hydrobiol, Key Lab Aquat Biodivers & Conservat, Wuhan, Peoples R China; [Wu, Shu] Univ Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Hydrobiology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Yu, YH (corresponding author), Chinese Acad Sci, Inst Hydrobiol, Key Lab Aquat Biodivers & Conservat, Wuhan, Peoples R China.	yhyu@ihb.ac.cn			National Natural Science Foundation of China [31172084]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (Grant No. 31172084). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alekseev V, 2006, ZOOL SCR, V35, P123, DOI 10.1111/j.1463-6409.2006.00223.x; [Anonymous], 2008, BLAST COMM LIN APPL; Barthelemy RM, 1999, J MAR BIOL ASSOC UK, V79, P857, DOI 10.1017/S0025315499001022; Bergsten J, 2012, SYST BIOL, V61, P851, DOI 10.1093/sysbio/sys037; Bernasconi MV, 2000, INSECT MOL BIOL, V9, P67, DOI 10.1046/j.1365-2583.2000.00158.x; Birky CW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010609; Blanco-Bercial L, 2011, MOL PHYLOGENET EVOL, V59, P103, DOI 10.1016/j.ympev.2011.01.008; Bucklin A, 2003, MAR BIOL, V142, P333, DOI 10.1007/s00227-002-0943-1; Buse HY, 2013, ENVIRON SCI POLLUT R, V20, P6351, DOI 10.1007/s11356-013-1646-5; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Chantangsi C, 2010, INT J SYST EVOL MICR, V60, P1962, DOI 10.1099/ijs.0.013888-0; Chen J, 2014, MAR BIODIVERS, V44, P55, DOI 10.1007/s12526-013-0184-1; Chullasorn S, 2011, ZOOL STUD, V50, P103; Collins RA, 2013, MOL ECOL RESOUR, V13, P969, DOI 10.1111/1755-0998.12046; Collins RA, 2012, METHODS ECOL EVOL, V3, P457, DOI 10.1111/j.2041-210X.2011.00176.x; Cornils A, 2013, MOL PHYLOGENET EVOL, V69, P861, DOI 10.1016/j.ympev.2013.06.018; Diez B, 2001, APPL ENVIRON MICROB, V67, P2942, DOI 10.1128/AEM.67.7.2942-2951.2001; Dupuis JR, 2012, MOL ECOL, V21, P4422, DOI 10.1111/j.1365-294X.2012.05642.x; FITCH DHA, 1995, MOL BIOL EVOL, V12, P346; Fonseca VG, 2014, GLOBAL ECOL BIOGEOGR, V23, P1293, DOI 10.1111/geb.12223; Fonseca VG, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1095; Fontaneto D, 2015, MAR BIODIVERS, V45, P433, DOI 10.1007/s12526-015-0319-7; Francis CM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012575; Frost DR, 2006, B AM MUS NAT HIST, P8, DOI 10.1206/0003-0090(2006)297[0001:TATOL]2.0.CO;2; Fujisawa T, 2013, SYST BIOL, V62, P707, DOI 10.1093/sysbio/syt033; Gattolliat JL, 2010, J N AM BENTHOL SOC, V29, P1042, DOI 10.1899/09-119.1; Gazis R, 2011, MOL ECOL, V20, P3001, DOI 10.1111/j.1365-294X.2011.05110.x; Hadziavdic K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087624; Hajibabaei M, 2007, TRENDS GENET, V23, P167, DOI 10.1016/j.tig.2007.02.001; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hanelt B, 2015, MOL PHYLOGENET EVOL, V82, P211, DOI 10.1016/j.ympev.2014.09.010; Harris DJ, 2003, TRENDS ECOL EVOL, V18, P317, DOI 10.1016/S0169-5347(03)00150-2; Harvey ML, 2003, MED VET ENTOMOL, V17, P363, DOI 10.1111/j.1365-2915.2003.00452.x; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Huang DW, 2008, J MOL EVOL, V66, P167, DOI 10.1007/s00239-008-9069-5; Huang JH, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0082400, 10.1371/journal.pone.0068688]; Huys R, 2006, BIOL J LINN SOC, V87, P403, DOI 10.1111/j.1095-8312.2005.00579.x; Huys R, 2007, MOL PHYLOGENET EVOL, V43, P368, DOI 10.1016/j.ympev.2007.02.004; Huys R, 2012, INT J PARASITOL, V42, P71, DOI 10.1016/j.ijpara.2011.10.009; Huys R, 2009, MOL PHYLOGENET EVOL, V51, P143, DOI 10.1016/j.ympev.2008.12.007; Johnsen A, 2010, J ORNITHOL, V151, P565, DOI 10.1007/s10336-009-0490-3; Karanovic T, 2012, CRUSTACEANA, V85, P1549, DOI 10.1163/156854012X651709; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; Ki J-S, 2012, J APPL PHYCOL, V24, P1; Koski LB, 2001, J MOL EVOL, V52, P540, DOI 10.1007/s002390010184; Kruger M, 2012, NEW PHYTOL, V193, P970, DOI 10.1111/j.1469-8137.2011.03962.x; Laakmann S, 2013, MOL ECOL RESOUR, V13, P862, DOI 10.1111/1755-0998.12139; Lefebure T, 2006, MOL PHYLOGENET EVOL, V40, P435, DOI 10.1016/j.ympev.2006.03.014; Leray M, 2013, FRONT ZOOL, V10, DOI 10.1186/1742-9994-10-34; Lie AAY, 2014, APPL ENVIRON MICROB, V80, P4363, DOI 10.1128/AEM.00057-14; Lin XZ, 2004, ACTA OCEANOL SIN, V23, P699; Lindeque PK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081327; Luo AR, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-84; Machida RJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046180; Mallatt JM, 2004, MOL PHYLOGENET EVOL, V31, P178, DOI 10.1016/j.ympev.2003.07.013; Marrone F, 2013, MOL PHYLOGENET EVOL, V66, P190, DOI 10.1016/j.ympev.2012.09.016; Meier R, 2006, SYST BIOL, V55, P715, DOI 10.1080/10635150600969864; Meyer CP, 2005, PLOS BIOL, V3, P2229, DOI 10.1371/journal.pbio.0030422; Miralles A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068242; Ogedengbe JD, 2011, INT J PARASITOL, V41, P843, DOI 10.1016/j.ijpara.2011.03.007; Oines O, 2008, ACTA PARASITOL, V53, P93, DOI 10.2478/s11686-008-0002-2; Orlandi PA, 2003, APPL ENVIRON MICROB, V69, P4806, DOI 10.1128/AEM.69.8.4806-4813.2003; Penn O, 2010, MOL BIOL EVOL, V27, P1759, DOI 10.1093/molbev/msq066; Pertsemlidis A, 2001, GENOME BIOL, V2; Petrov AS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088222; Phuong M, 2014, J CLIN MICROBIOL, V52, P1068, DOI 10.1128/JCM.03477-13; Pons J, 2006, SYST BIOL, V55, P595, DOI 10.1080/10635150600852011; Porras-Alfaro A, 2014, APPL ENVIRON MICROB, V80, P829, DOI 10.1128/AEM.02894-13; Porter TM, 2011, NEW PHYTOL, V192, P775, DOI 10.1111/j.1469-8137.2011.03838.x; Puillandre N, 2012, MOL ECOL, V21, P1864, DOI 10.1111/j.1365-294X.2011.05239.x; Regier JC, 2005, P ROY SOC B-BIOL SCI, V272, P395, DOI 10.1098/rspb.2004.2917; Robertson JA, 2013, SYST ENTOMOL, V38, P209, DOI 10.1111/j.1365-3113.2012.00655.x; Ruiz-Lopez F, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-44; Salim B, 2010, PARASITOL RES, V106, P493, DOI 10.1007/s00436-009-1691-7; Slapeta J, 2005, P ROY SOC B-BIOL SCI, V272, P2073, DOI 10.1098/rspb.2005.3195; Song H, 2008, P NATL ACAD SCI USA, V105, P13486, DOI 10.1073/pnas.0803076105; Song Y, 2008, PARASITOL RES, V102, P299, DOI 10.1007/s00436-007-0764-8; Stern RF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042780; Stoeck T, 2003, APPL ENVIRON MICROB, V69, P2657, DOI 10.1128/AEM.69.5.2657-2663.2003; Stoeck T, 2010, MOL ECOL, V19, P21, DOI 10.1111/j.1365-294X.2009.04480.x; Taberlet P, 2012, MOL ECOL, V21, P2045, DOI 10.1111/j.1365-294X.2012.05470.x; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tang CQ, 2012, P NATL ACAD SCI USA, V109, P16208, DOI 10.1073/pnas.1209160109; Taniguchi M, 2004, J PLANKTON RES, V26, P1249, DOI 10.1093/plankt/fbh115; Thum RA, 2004, HYDROBIOLOGIA, V519, P135, DOI 10.1023/B:HYDR.0000026500.27949.e9; van Hannen EJ, 1998, J PHYCOL, V34, P206, DOI 10.1046/j.1529-8817.1998.340206.x; Vences M, 2005, PHILOS T R SOC B, V360, P1859, DOI 10.1098/rstb.2005.1717; Virgilio M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031581; Voigt O, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-69; von Reumont BM, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-119; Wang M, 2010, THESIS CHINESE ACAD; Ward RD, 2009, MOL ECOL RESOUR, V9, P1077, DOI 10.1111/j.1755-0998.2009.02541.x; Wiemers M, 2007, FRONT ZOOL, V4, DOI 10.1186/1742-9994-4-8; Wilke T, 2013, MOL PHYLOGENET EVOL, V66, P715, DOI 10.1016/j.ympev.2012.10.025; Wu DY, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002566; Wyngaard GA, 2010, MOL PHYLOGENET EVOL, V55, P753, DOI 10.1016/j.ympev.2010.02.029; Zhan AB, 2014, METHODS ECOL EVOL, V5, P881, DOI 10.1111/2041-210X.12230; Zhang AB, 2012, MOL ECOL, V21, P1848, DOI 10.1111/j.1365-294X.2011.05235.x; Zhang JJ, 2013, BIOINFORMATICS, V29, P2869, DOI 10.1093/bioinformatics/btt499; Zhang QQ, 2012, P ROY SOC B-BIOL SCI, V279, P2625, DOI 10.1098/rspb.2011.2688; Zheng XD, 2004, J SHELLFISH RES, V23, P881	101	63	65	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2015	10	6							e0131498	10.1371/journal.pone.0131498	http://dx.doi.org/10.1371/journal.pone.0131498			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4OM	26107258	Green Published, gold, Green Submitted			2022-12-26	WOS:000356932500164
J	Zhang, XL; Zhang, JY; Yang, F; Wu, WR; Sun, HQ; Xie, QH; Si, WK; Zou, QM; Yang, Z				Zhang, Xiaoli; Zhang, Jinyong; Yang, Feng; Wu, Weiru; Sun, Heqiang; Xie, Qinghua; Si, Weike; Zou, Quanming; Yang, Zhong			Immunization with Heat Shock Protein A and gamma-Glutamyl Transpeptidase Induces Reduction on the Helicobacter pylori Colonization in Mice	PLOS ONE			English	Article							ORAL IMMUNIZATION; IMMUNE-RESPONSE; INFECTION; VACCINE; ANTIGEN; ABSENCE; ERADICATION; PROTECTION; ANTIBODIES; CONTRIBUTE	The human gastric pathogen Helicobacter pylori (H. pylori) is a successful colonizer of the stomach. H. pylori infection strongly correlates with the development and progression of chronic gastritis, peptic ulcer disease, and gastric malignances. Vaccination is a promising strategy for preventing H. pylori infection. In this study, we evaluated the candidate antigens heat shock protein A (HspA) and H. pylori gamma-glutamyl transpeptidase (GGT) for their effectiveness in development of subunit vaccines against H. pylori infection. rHspA, rGGT, and rHspA-GGT, a fusion protein based on HspA and GGT, were constructed and separately expressed in Escherichia coli and purified. Mice were then immunized intranasally with these proteins, with or without adjuvant. Immunized mice exhibited reduced bacterial colonization in stomach. The highest reduction in bacterial colonization was seen in mice immunized with the fusion protein rHspA-GGT when paired with the mucosal adjuvant LTB. Protection against H. pylori colonization was mediated by a strong systemic and localized humoral immune response, as well as a balanced Th1/Th2 cytokine response. In addition, immunofluorescence microscopy confirmed that rHspA-GGT specific rabbit antibodies were able to directly bind H. pylori in vitro. These results suggest antibodies are essential to the protective immunity associated with rHspA-GGT immunization. In summary, our results suggest HspA and GGT are promising vaccine candidates for protection against H. pylori infection.	[Zhang, Xiaoli; Wu, Weiru; Si, Weike; Yang, Zhong] Third Mil Med Univ, Southwest Hosp, Dept Clin Hematol, Chongqing 400038, Peoples R China; [Zhang, Jinyong; Yang, Feng; Sun, Heqiang; Xie, Qinghua; Zou, Quanming] Third Mil Med Univ, Coll Pharm, Natl Engn Res Ctr Immunol Prod, Dept Microbiol & Biochem Pharm, Chongqing 400038, Peoples R China	Army Medical University; Army Medical University	Zou, QM (corresponding author), Third Mil Med Univ, Coll Pharm, Natl Engn Res Ctr Immunol Prod, Dept Microbiol & Biochem Pharm, Chongqing 400038, Peoples R China.	qmzou2007@163.com; zyang@tmmu.edu.cn		Zhang, Jinyong/0000-0001-9622-5834	Chinese National Natural Science Foundation Project [31300043]; Chongqing Natural Science Foundation [cstc2013jcyjA10096]	Chinese National Natural Science Foundation Project(National Natural Science Foundation of China (NSFC)); Chongqing Natural Science Foundation(Natural Science Foundation of Chongqing)	This work was supported by Chinese National Natural Science Foundation Project (No. 31300043) and Chongqing Natural Science Foundation (cstc2013jcyjA10096). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal K, 2008, MAYO CLIN PROC, V83, P169, DOI 10.4065/83.2.169; [Anonymous], 1983, LANCET, V1, P1273; Baldwin SL, 2012, J IMMUNOL, V188, P2189, DOI 10.4049/jimmunol.1102696; Berry LJ, 2004, INFECT IMMUN, V72, P1019, DOI 10.1128/IAI.72.2.1019-1028.2004; Cameron EAB, 2005, ALIMENT PHARM THERAP, V22, P76, DOI 10.1111/j.1365-2036.2005.02521.x; Chevalier C, 1999, MOL MICROBIOL, V31, P1359, DOI 10.1046/j.1365-2958.1999.01271.x; CORTHESYTHEULAZ I, 1995, GASTROENTEROLOGY, V109, P115, DOI 10.1016/0016-5085(95)90275-9; Cun SJ, 2008, J BIOL CHEM, V283, P15142, DOI 10.1074/jbc.M800591200; Ding H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069384; Ernst PB, 2001, ACTA ODONTOL SCAND, V59, P216, DOI 10.1080/00016350152509238; Ferrero RL, 1997, GASTROENTEROLOGY, V113, P185, DOI 10.1016/S0016-5085(97)70094-5; FERRERO RL, 1995, P NATL ACAD SCI USA, V92, P6499, DOI 10.1073/pnas.92.14.6499; Gomez-Duarte OG, 1998, VACCINE, V16, P460, DOI 10.1016/S0264-410X(97)00247-8; Gong M, 2010, GASTROENTEROLOGY, V139, P564, DOI 10.1053/j.gastro.2010.03.050; Hu DL, 2003, J INFECT DIS, V188, P743, DOI 10.1086/377308; Keenan J, 2000, INFECT IMMUN, V68, P3337, DOI 10.1128/IAI.68.6.3337-3343.2000; Kusters JG, 2006, CLIN MICROBIOL REV, V19, P449, DOI 10.1128/CMR.00054-05; Liu KY, 2011, VACCINE, V29, P6679, DOI 10.1016/j.vaccine.2011.06.099; Loguercio S, 2008, FEBS LETT, V582, P3537, DOI 10.1016/j.febslet.2008.09.025; Maier RJ, 2007, BIOMETALS, V20, P655, DOI 10.1007/s10534-006-9061-8; Malfertheiner P, 2007, GUT, V56, P772, DOI 10.1136/gut.2006.101634; McCluskie MJ, 2001, VACCINE, V19, P3759, DOI 10.1016/S0264-410X(01)00088-3; Mohammadi M, 1997, GASTROENTEROLOGY, V113, P1848, DOI 10.1016/S0016-5085(97)70004-0; Muller A, 2011, HELICOBACTER, V16, P26, DOI 10.1111/j.1523-5378.2011.00877.x; Nystrom J, 2006, MICROBES INFECT, V8, P442, DOI 10.1016/j.micinf.2005.07.010; Radcliff FJ, 1997, INFECT IMMUN, V65, P4668, DOI 10.1128/IAI.65.11.4668-4674.1997; RamirezRamos A, 1997, CLIN INFECT DIS, V25, P1027, DOI 10.1086/516083; Ricci V, 2014, WORLD J GASTROENTERO, V20, P630, DOI 10.3748/wjg.v20.i3.630; Satin B, 2000, J EXP MED, V191, P1467, DOI 10.1084/jem.191.9.1467; Schmees C, 2007, GASTROENTEROLOGY, V132, P1820, DOI 10.1053/j.gastro.2007.02.031; Shi Y, 2010, J IMMUNOL, V184, P5121, DOI 10.4049/jimmunol.0901115; Srivastava R, 2013, INDIAN J CLIN BIOCHE, V28, P19, DOI 10.1007/s12291-012-0262-3; Sutton P, 2000, IMMUNOL CELL BIOL, V78, P28, DOI 10.1046/j.1440-1711.2000.00881.x; Sutton P, 2013, EXPERT REV VACCINES, V12, P433, DOI [10.1586/erv.13.20, 10.1586/ERV.13.20]; Tan MP, 2008, INFECT IMMUN, V76, P1289, DOI 10.1128/IAI.00779-07; Taylor JM, 2008, MICROB PATHOGENESIS, V44, P20, DOI 10.1016/j.micpath.2007.06.006; Valenzuela M, 2013, J INFECT DIS, V208, P1131, DOI 10.1093/infdis/jit286; Vermoote M, 2013, VACCINE, V31, P3250, DOI 10.1016/j.vaccine.2013.05.047; Zhang JY, 2011, MOL BIOL REP, V38, P1957, DOI 10.1007/s11033-010-0317-6	39	8	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2015	10	6							e0130391	10.1371/journal.pone.0130391	http://dx.doi.org/10.1371/journal.pone.0130391			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4DD	26102080	Green Published, Green Submitted, gold			2022-12-26	WOS:000356901900039
J	Du, YD; Feng, JH; Wang, RQ; Zhang, HJ; Liu, J				Du, Yuanda; Feng, Jinhong; Wang, Renqing; Zhang, Haijie; Liu, Jian			Effects of Flavonoids from Potamogeton crispus L. on Proliferation, Migration, and Invasion of Human Ovarian Cancer Cells	PLOS ONE			English	Article							MATRIX METALLOPROTEINASES; SUPPRESSES MIGRATION; NATURAL-PRODUCTS; CYCLE ARREST; CONSTITUENTS; APOPTOSIS; PATHWAY; IDENTIFICATION; ANGIOGENESIS; POLYPHENOLS	In order to explore the efficient utilization of plant resources from constructed wetlands, the potential anti-metastatic effects of flavonoids from Potamogeton crispusL. were investigated in human ovarian cancer cells (ES-2). Two major flavonoids, luteolin-3'-O-beta-D-glucopyranoside and flavone-6-C-beta-D-glucopyranoside, were isolated from P. crispus and identified. The effects of these flavonoids on cell proliferation, cell morphology, cell cycle, apoptosis, and cell migration and invasion were then investigated. Furthermore, reverse transcriptase polymerase chain reaction assays and western blotting analysis were conducted to examine the expression level of mRNA and protein. Results indicated that Luteolin-3'-O-beta-D-glucopyranoside inhibited ES-2 cell migration and invasion and suppressed the expression of two matrix metalloproteinases (MMPs), MMP-2 and MMP-9, and Flavone-6-C-beta-D-glucopyranoside had no significant inhibitory effects on ES-2 cells. Thus, this study demonstrated the potential anti-metastatic properties of a P. crispus flavonoid, and provided a scientific approach for the screening of promising natural resources from constructed wetlands to identify useful products for use in the pharmaceutical and health-care industries.	[Du, Yuanda; Wang, Renqing; Zhang, Haijie; Liu, Jian] Shandong Univ, Inst Environm Res, Jinan 250100, Peoples R China; [Feng, Jinhong] Shandong Acad Sci, Shandong Anal & Test Ctr, Jinan 250014, Peoples R China; [Wang, Renqing] Shandong Univ, Sch Life Sci, Jinan 250100, Peoples R China; [Wang, Renqing] Shandong Univ, Ctr Vegetat Ecol, Shandong Prov Engn & Technol Res, Jinan 250100, Peoples R China	Shandong University; Qilu University of Technology; Shandong University; Shandong University	Liu, J (corresponding author), Shandong Univ, Inst Environm Res, Jinan 250100, Peoples R China.	ecology@sdu.edu.cn	Liu, Jian/T-1760-2017; Liu, Jian/AAG-9184-2019	Liu, Jian/0000-0003-1920-2641; Liu, Jian/0000-0003-1920-2641	National Natural Science Foundation of China [31200426]; National Water Special Project [2012ZX07203-004]; Science and Technology Planning Project of Shandong Province [2011GGH21605]; Natural Science Foundation of Shandong Province of China [ZR2014YL001]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Water Special Project; Science and Technology Planning Project of Shandong Province; Natural Science Foundation of Shandong Province of China(Natural Science Foundation of Shandong Province)	This study was financially supported by National Natural Science Foundation of China (No. 31200426), National Water Special Project (No. 2012ZX07203-004), Science and Technology Planning Project of Shandong Province (No. 2011GGH21605), and Natural Science Foundation of Shandong Province of China (No. ZR2014YL001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrae-Marobela K, 2013, CURR DRUG METAB, V14, P392, DOI 10.2174/13892002113149990095; Attoub S, 2011, EUR J PHARMACOL, V651, P18, DOI 10.1016/j.ejphar.2010.10.063; Cai XT, 2011, TOXICOL IN VITRO, V25, P1385, DOI 10.1016/j.tiv.2011.05.009; Chakraborti S, 2003, MOL CELL BIOCHEM, V253, P269, DOI 10.1023/A:1026028303196; Chen KL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072927; Chen YJ, 2013, GYNECOL ONCOL, V131, P734, DOI 10.1016/j.ygyno.2013.10.012; Choi AY, 2011, EUR J PHARMACOL, V668, P115, DOI 10.1016/j.ejphar.2011.06.047; Cordell GA, 2012, J NAT PROD, V75, P514, DOI 10.1021/np200803m; Coticchia CM, 2011, GYNECOL ONCOL, V123, P295, DOI 10.1016/j.ygyno.2011.07.034; Delassus GS, 2008, J CELL PHYSIOL, V217, P739, DOI 10.1002/jcp.21548; Delmas D, 2012, ANTI-CANCER AGENT ME, V12, P835, DOI 10.2174/187152012802650093; Deng GF, 2013, CRIT REV FOOD SCI, V53, P296, DOI 10.1080/10408398.2010.529624; Deryugina EI, 2006, CANCER METAST REV, V25, P9, DOI 10.1007/s10555-006-7886-9; Du YD, 2014, BIOL ENVIRON, V114B, P79, DOI 10.3318/BIOE.2014.19; Gialeli C, 2011, FEBS J, V278, P16, DOI 10.1111/j.1742-4658.2010.07919.x; Harborne JB, 2000, PHYTOCHEMISTRY, V55, P481, DOI 10.1016/S0031-9422(00)00235-1; Havsteen BH, 2002, PHARMACOL THERAPEUT, V96, P67, DOI 10.1016/S0163-7258(02)00298-X; Hsieh CY, 2013, CHEM-BIOL INTERACT, V204, P105, DOI 10.1016/j.cbi.2013.05.005; Hsieh CY, 2013, TOXICOL IN VITRO, V27, P1, DOI 10.1016/j.tiv.2012.10.001; Jian YX, 2003, AQUAT BOT, V75, P59, DOI 10.1016/S0304-3770(02)00165-1; Khan MK, 2014, J FOOD COMPOS ANAL, V33, P85, DOI 10.1016/j.jfca.2013.11.004; Kim JH, 2012, J PHARMACOL SCI, V118, P198, DOI 10.1254/jphs.11196FP; Kobayashi T, 2002, CANCER LETT, V176, P17, DOI 10.1016/S0304-3835(01)00738-8; Krafczyk N, 2008, J AGR FOOD CHEM, V56, P3368, DOI 10.1021/jf703701n; Lee EJ, 2012, FOOD CHEM TOXICOL, V50, P4136, DOI 10.1016/j.fct.2012.08.025; Li X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060338; LIOTTA LA, 1991, CELL, V64, P327, DOI 10.1016/0092-8674(91)90642-C; MARKHAM KR, 1978, TETRAHEDRON, V34, P1389, DOI 10.1016/0040-4020(78)88336-7; NAWWAR MAM, 1994, PHYTOCHEMISTRY, V37, P1175, DOI 10.1016/S0031-9422(00)89552-7; PARK SJ, 2013, ASIAN WOMEN, V29, P1, DOI DOI 10.1016/J.BI0CHI.2013.07.021; Ren D, 2008, FOOD CHEM, V106, P410, DOI 10.1016/j.foodchem.2007.05.074; Ren DD, 2006, TOXICOL IN VITRO, V20, P1411, DOI 10.1016/j.tiv.2006.06.011; Steeg PS, 2006, NAT MED, V12, P895, DOI 10.1038/nm1469; Stetler-Stevenson W G, 2001, Surg Oncol Clin N Am, V10, P383; Tsai YD, 2013, J TAIWAN INST CHEM E, V44, P837, DOI 10.1016/j.jtice.2013.03.005; Verma AK, 2012, TETRAHEDRON, V68, P8523, DOI 10.1016/j.tet.2012.06.097; Walle T, 2005, J NUTR, V135, P48, DOI 10.1093/jn/135.1.48; Wang L, 2010, CANCER LETT, V297, P42, DOI 10.1016/j.canlet.2010.04.022; Waridel P, 2004, PHYTOCHEMISTRY, V65, P945, DOI 10.1016/j.phytochem.2004.01.018; Waridel P, 2004, PHYTOCHEMISTRY, V65, P2401, DOI 10.1016/j.phytochem.2004.06.031; Xiao Jianbo, 2014, Biotechnol Adv, DOI 10.1016/j.biotechadv.2014.05.004; Xiao JB, 2014, BIOTECHNOL ADV, V32, P1145, DOI 10.1016/j.biotechadv.2014.04.006; Xiao J, 2013, J PHARM PHARMACOL, V65, P1679, DOI 10.1111/jphp.12186; Yamazaki S, 2014, ARCH BIOCHEM BIOPHYS, V557, P18, DOI 10.1016/j.abb.2014.05.030; Ye M, 2012, CHINESE CHEM LETT, V23, P1157, DOI 10.1016/j.cclet.2012.07.018; Yodkeeree S, 2010, EUR J PHARMACOL, V627, P8, DOI 10.1016/j.ejphar.2009.09.052	46	15	15	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2015	10	6							e0130685	10.1371/journal.pone.0130685	http://dx.doi.org/10.1371/journal.pone.0130685			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL3FM	26098839	Green Submitted, Green Published, gold			2022-12-26	WOS:000356835800094
J	Yang, JQ; Tian, LX; Xu, BY; Xie, W; Wang, SL; Zhang, YJ; Wang, XJ; Wu, QJ				Yang, Jiaqiang; Tian, Lixia; Xu, Baoyun; Xie, Wen; Wang, Shaoli; Zhang, Youjun; Wang, Xiangjing; Wu, Qingjun			Insight into the Migration Routes of Plutella xylostella in China Using mtCOI and ISSR Markers	PLOS ONE			English	Article							DIAMONDBACK MOTH LEPIDOPTERA; MITOCHONDRIAL COI GENE; STATISTICAL TESTS; HIGH-ALTITUDE; DNA; POPULATIONS; RESISTANCE; MANAGEMENT; DISPERSAL; FLOW	The larvae of the diamondback moth, Plutella xylostella, cause major economic losses to cruciferous crops, including cabbage, which is an important vegetable crop in China. In this study, we used the mitochondrial COI gene and 11 ISSR markers to characterize the genetic structure and seasonal migration routes of 23 P. xylostella populations in China. Both the mitochondrial and nuclear markers revealed high haplotype diversity and gene flow among the populations, although some degree of genetic isolation was evident between the populations of Hainan Island and other sampling sites. The dominant haplotypes, LX1 and LX2, differed significantly from all other haplotypes both in terms of the number of individuals with those haplotypes and their distributions. Haplotypes that were shared among populations revealed that P. xylostella migrates from the lower reaches of the Yangtze River to northern China and then to northeastern China. Our results also revealed another potential migration route for P. xylostella, i.e., from southwestern China to both northwestern and southern China.	[Yang, Jiaqiang; Wang, Xiangjing] Northeast Agr Univ, Key Lab Agr Biol Funct Gene, Heilongjiang Prov Educ Comm, Harbin, Peoples R China; [Yang, Jiaqiang; Tian, Lixia; Xu, Baoyun; Xie, Wen; Wang, Shaoli; Zhang, Youjun; Wu, Qingjun] Chinese Acad Agr Sci, Inst Vegetables & Flowers, Beijing 100193, Peoples R China	Northeast Agricultural University - China; Chinese Academy of Agricultural Sciences; Institute of Vegetables & Flowers, CAAS	Wang, XJ (corresponding author), Northeast Agr Univ, Key Lab Agr Biol Funct Gene, Heilongjiang Prov Educ Comm, Harbin, Peoples R China.	wangneau2013@163.com; wuqingjun@caas.cn	Zhang, Youjun/AAY-7948-2020	Zhang, Youjun/0000-0003-3508-6695	Special Fund for Agro-scientific Research in the Public Interest [201103021]; National Science and Technology Support Task [2012BAD19B06]; Beijing Key Laboratory for Pest Control and Sustainable Cultivation of Vegetables; Science and Technology Innovation Program of the Chinese Academy of Agricultural Sciences	Special Fund for Agro-scientific Research in the Public Interest; National Science and Technology Support Task; Beijing Key Laboratory for Pest Control and Sustainable Cultivation of Vegetables; Science and Technology Innovation Program of the Chinese Academy of Agricultural Sciences	This research was supported by grants from the Special Fund for Agro-scientific Research in the Public Interest (201103021), the National Science and Technology Support Task (2012BAD19B06), the Beijing Key Laboratory for Pest Control and Sustainable Cultivation of Vegetables, and the Science and Technology Innovation Program of the Chinese Academy of Agricultural Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BROWN WM, 1982, J MOL EVOL, V18, P225, DOI 10.1007/BF01734101; CAPRIO MA, 1992, ENVIRON ENTOMOL, V21, P808, DOI 10.1093/ee/21.4.808; Chapman JW, 2004, B ENTOMOL RES, V94, P123, DOI 10.1079/BER2004287; Chapman JW, 2002, ECOL ENTOMOL, V27, P641, DOI 10.1046/j.1365-2311.2002.00472.x; Chu Y.-I., 1986, P77; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Dick CW, 2004, MOL ECOL, V13, P3775, DOI 10.1111/j.1365-294X.2004.02374.x; Dosdall LM, 2001, CANOLA W CANADA, V15, P26; Endersby NM, 2006, MOL ECOL, V15, P107, DOI 10.1111/j.1365-294X.2005.02789.x; Fu YX, 1996, GENETICS, V143, P557; Fu YX, 1997, GENETICS, V147, P915; Furlong MJ, 2013, ANNU REV ENTOMOL, V58, P517, DOI 10.1146/annurev-ento-120811-153605; HARCOURT D. G., 1963, Proc. eat. Soc. Ont., 1962, V93, P61; HARRISON RG, 1989, TRENDS ECOL EVOL, V4, P6, DOI 10.1016/0169-5347(89)90006-2; Henniges-Janssen K, 2011, HEREDITY, V107, P421, DOI 10.1038/hdy.2011.27; Honda K, 1992, DIAM MOTH OTH CRUC P, V168, P43; Jensen JL, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-13; Kfir R, 1998, ANN ENTOMOL SOC AM, V91, P164, DOI 10.1093/aesa/91.2.164; Kim I, 2003, KOREAN J GENETIC, V25, P155; Kim Yonggyun, 1999, Journal of Asia-Pacific Entomology, V2, P1; Lee Seung-Chan, 1993, Korean Journal of Applied Entomology, V32, P323; Li JH, 2006, EUR J ENTOMOL, V103, P605, DOI 10.14411/eje.2006.081; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Liu YB, 1996, J ECON ENTOMOL, V89, P798, DOI 10.1093/jee/89.4.798; Ma C, 2012, MOL ECOL, V21, P4344, DOI 10.1111/j.1365-294X.2012.05684.x; [马春森 Ma Chunsen], 2010, [生态学报, Acta Ecologica Sinica], V21, P3628; Ma CS, 1991, P 1 NAT PLANT PROT C, P294; MENKEN SBJ, 1992, ANNU REV ENTOMOL, V37, P41, DOI 10.1146/annurev.en.37.010192.000353; Mo JH, 2003, ENVIRON ENTOMOL, V32, P71, DOI 10.1603/0046-225X-32.1.71; Niu YQ, 2014, J APPL ENTOMOL, V138, P692, DOI 10.1111/jen.12130; Raymond M, 1995, EVOLUTION, V49, P1280, DOI 10.1111/j.1558-5646.1995.tb04456.x; Roderick GK, 1996, ANNU REV ENTOMOL, V41, P325, DOI 10.1146/annurev.en.41.010196.001545; Roderick GK, 2003, NAT REV GENET, V4, P889, DOI 10.1038/nrg1201; Roux O, 2007, MOL PHYLOGENET EVOL, V43, P240, DOI 10.1016/j.ympev.2006.09.017; Saw Jesslyn, 2006, Insect Science, V13, P365, DOI 10.1111/j.1744-7917.2006.00105.x; Sayyed AH, 2004, PEST MANAG SCI, V60, P827, DOI 10.1002/ps.869; Schaefer H, 2008, MOL PHYLOGENET EVOL, V47, P799, DOI 10.1016/j.ympev.2008.01.030; SIMON C, 1994, ANN ENTOMOL SOC AM, V87, P651, DOI 10.1093/aesa/87.6.651; TABASHNIK BE, 1987, J ECON ENTOMOL, V80, P1091, DOI 10.1093/jee/80.6.1091; Tajima F, 1996, GENETICS, V143, P1457; TAJIMA F, 1989, GENETICS, V123, P585; TALEKAR NS, 1993, ANNU REV ENTOMOL, V38, P275, DOI 10.1146/annurev.en.38.010193.001423; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; TEMPLETON AR, 1992, GENETICS, V132, P619; Vastrad A. S., 2002, Karnataka Journal of Agricultural Sciences, V15, P379; Verkerk RHJ, 1996, B ENTOMOL RES, V86, P205, DOI 10.1017/S0007485300052482; Wei SJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059654; Wei SJ, 2013, DNA CELL BIOL, V32, P173, DOI 10.1089/dna.2012.1942; WILSON AC, 1985, BIOL J LINN SOC, V26, P375, DOI 10.1111/j.1095-8312.1985.tb02048.x; [杨家强 Yang Jiaqiang], 2012, [植物保护, Plant Protection], V38, P90; Yeh FC, 1997, POPGENE USER FRIENDL; You MS, 2013, NAT GENET, V45, P220, DOI 10.1038/ng.2524; Zalucki MP, 2012, J ECON ENTOMOL, V105, P1115, DOI 10.1603/EC12107; Zhao Feng, 2006, Kunchong Zhishi, V43, P640; Zhao JZ, 2006, J ECON ENTOMOL, V99, P176, DOI 10.1603/0022-0493(2006)099[0176:MODMLP]2.0.CO;2; Zhao JZ, 2002, J ECON ENTOMOL, V95, P430, DOI 10.1603/0022-0493-95.2.430; Zhou Li-juan, 2011, Journal of South China Agricultural University, V32, P45; Zhou LJ, 2011, CROP PROT, V30, P272, DOI 10.1016/j.cropro.2010.10.006	58	18	22	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2015	10	6							e0130905	10.1371/journal.pone.0130905	http://dx.doi.org/10.1371/journal.pone.0130905			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL3FM	26098353	Green Submitted, Green Published, gold			2022-12-26	WOS:000356835800121
J	Backstedt, BT; Buyuktanir, O; Lindow, J; Wunder, EA; Reis, MG; Usmani-Brown, S; Ledizet, M; Ko, A; Pal, U				Backstedt, Brian T.; Buyuktanir, Ozlem; Lindow, Janet; Wunder, Elsio A., Jr.; Reis, Mitermayer G.; Usmani-Brown, Sahar; Ledizet, Michel; Ko, Albert; Pal, Utpal			Efficient Detection of Pathogenic Leptospires Using 16S Ribosomal RNA	PLOS ONE			English	Article							MEDIATED ISOTHERMAL AMPLIFICATION; REAL-TIME PCR; APTIMA COMBO-2 ASSAY; GENE-EXPRESSION; CHLAMYDIA-TRACHOMATIS; RAPID DETECTION; DIAGNOSIS; OUTBREAK; IDENTIFICATION; INFECTION	Pathogenic Leptospira species cause a prevalent yet neglected zoonotic disease with mild to life-threatening complications in a variety of susceptible animals and humans. Diagnosis of leptospirosis, which primarily relies on antiquated serotyping methods, is particularly challenging due to presentation of non-specific symptoms shared by other febrile illnesses, often leading to misdiagnosis. Initiation of antimicrobial therapy during early infection to prevent more serious complications of disseminated infection is often not performed because of a lack of efficient diagnostic tests. Here we report that specific regions of leptospiral 16S ribosomal RNA molecules constitute a novel and efficient diagnostic target for PCR-based detection of pathogenic Leptospira serovars. Our diagnostic test using spiked human blood was at least 100-fold more sensitive than corresponding leptospiral DNA-based quantitative PCR assays, targeting the same 16S nucleotide sequence in the RNA and DNA molecules. The sensitivity and specificity of our RNA assay against laboratory-confirmed human leptospirosis clinical samples were 64% and 100%, respectively, which was superior then an established parallel DNA detection assay. Remarkably, we discovered that 16S transcripts remain appreciably stable ex vivo, including untreated and stored human blood samples, further highlighting their use for clinical detection of L. interrogans. Together, these studies underscore a novel utility of RNA targets, specifically 16S rRNA, for development of PCR-based modalities for diagnosis of human leptospirosis, and also may serve as paradigm for detection of additional bacterial pathogens for which early diagnosis is warranted.	[Backstedt, Brian T.; Buyuktanir, Ozlem; Pal, Utpal] Univ Maryland, Dept Vet Med, College Pk, MD 20742 USA; [Backstedt, Brian T.; Buyuktanir, Ozlem; Pal, Utpal] Univ Maryland, Virginia Maryland Reg Coll Vet Med, College Pk, MD 20742 USA; [Lindow, Janet; Wunder, Elsio A., Jr.; Ko, Albert] Yale Univ, Sch Publ Hlth, Dept Epidemiol Microbial Dis, New Haven, CT USA; [Lindow, Janet; Reis, Mitermayer G.; Ko, Albert] Fundacao Oswaldo Cruz, Ctr Pesquisas Goncalo Moniz, Salvador, BA, Brazil; [Usmani-Brown, Sahar; Ledizet, Michel] L2 Diagnost, New Haven, CT USA	University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park; Yale University; Fundacao Oswaldo Cruz	Pal, U (corresponding author), Univ Maryland, Dept Vet Med, College Pk, MD 20742 USA.	upal@umd.edu	Pal, Utpal/I-5265-2015; Reis, Mitermayer/AAO-9742-2020; Büyüktanir Yaş, Özlem/AAP-2720-2020; Ko, Albert/P-2343-2015; Wunder, Elsio Augusto/C-2733-2013	Reis, Mitermayer/0000-0002-3051-9060; Büyüktanir Yaş, Özlem/0000-0002-7641-7350; Ko, Albert/0000-0001-9023-2339; Wunder, Elsio Augusto/0000-0002-5239-8511; Lindow, Janet/0000-0003-3235-3698	National Institute of Allergy and Infectious Diseases [AI114064-01, AI052473, TW009504, AI088752, 1R43AI114064-01]; ASTMH Gorgas Memorial Institute Research Award; Fiocruz-CNPq Ciencias Sem Fronteiras; FOGARTY INTERNATIONAL CENTER [R01TW009504, R25TW009338] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R41AI114064, U01AI088752, R01AI052473] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); ASTMH Gorgas Memorial Institute Research Award; Fiocruz-CNPq Ciencias Sem Fronteiras; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by funding from the National Institute of Allergy and Infectious Diseases (Award Number AI114064-01 to AK, ML, and UP as well as AI052473, TW009504, and AI088752 to AK, and 1R43AI114064-01 to L2 Diagnostics (AK, ML, UP co-PIs). JL is supported by 2014 ASTMH Gorgas Memorial Institute Research Award, 2014 Global Health Equity Scholars Fellowship and Fiocruz-CNPq Ciencias Sem Fronteiras. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. L2 Diagnostics provided support in the form of salaries for authors SUB and ML as well as AK and UP through subcontracts with Yale University and the University of Maryland, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler B, 2010, VET MICROBIOL, V140, P287, DOI 10.1016/j.vetmic.2009.03.012; Agampodi SB, 2012, CLIN INFECT DIS, V54, P1249, DOI 10.1093/cid/cis035; Ahmed A, 2014, INT J ENV RES PUB HE, V11, P4953, DOI 10.3390/ijerph110504953; Ahmed A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007093; Arikawa E, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-328; Beissner M, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001756; Bharti AR, 2003, LANCET INFECT DIS, V3, P757, DOI 10.1016/S1473-3099(03)00830-2; Biggs HM, 2013, VECTOR-BORNE ZOONOT, V13, P572, DOI 10.1089/vbz.2012.1205; Biggs HM, 2011, AM J TROP MED HYG, V85, P275, DOI 10.4269/ajtmh.2011.11-0176; BOLIN CA, 1991, AM J VET RES, V52, P1639; Boonsilp S, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-338; Bourhy P, 2011, J CLIN MICROBIOL, V49, P2154, DOI 10.1128/JCM.02452-10; Bruce MG, 2005, ACTA TROP, V96, P36, DOI 10.1016/j.actatropica.2005.07.001; Bugrysheva JV, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-17; Cao YG, 2011, VACCINE, V29, P7379, DOI 10.1016/j.vaccine.2011.07.070; Cheng A, 2014, AM J CLIN PATHOL, V141, P397, DOI 10.1309/AJCPFQ25SQVZAWHZ; Chong S, 2003, J CLIN MICROBIOL, V41, P778, DOI 10.1128/JCM.41.2.778-782.2003; Clarridge JE, 2004, CLIN MICROBIOL REV, V17, P840, DOI 10.1128/CMR.17.4.840-862.2004; CORWIN A, 1990, INT J EPIDEMIOL, V19, P743, DOI 10.1093/ije/19.3.743; Coutinho ML, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003307; Curtis KA, 2014, J CLIN MICROBIOL, V52, P2674, DOI 10.1128/JCM.00935-14; Dufour B, 2008, REV SCI TECH OIE, V27, P529, DOI 10.20506/rst.27.2.1817; Elias AF, 2002, INFECT IMMUN, V70, P2139, DOI 10.1128/IAI.70.4.2139-2150.2002; ELLINGHAUSEN HC, 1965, AM J VET RES, V26, P45; Ferreira AS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112312; Flannery B, 2001, J CLIN MICROBIOL, V39, P3303, DOI 10.1128/JCM.39.9.3303-3310.2001; GALE NB, 1966, AM J TROP MED HYG, V15, P64, DOI 10.4269/ajtmh.1966.15.64; Goarant C, 2009, TROP MED INT HEALTH, V14, P926, DOI 10.1111/j.1365-3156.2009.02310.x; Goarant C, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002289; Gouvela EL, 2008, EMERG INFECT DIS, V14, P505, DOI 10.3201/eid1403.071064; HELLSTROM JS, 1978, RES VET SCI, V25, P29, DOI 10.1016/S0034-5288(18)33003-0; Imai M, 2007, J VIROL METHODS, V141, P173, DOI 10.1016/j.jviromet.2006.12.004; JACKSON LA, 1993, PEDIATR INFECT DIS J, V12, P48, DOI 10.1097/00006454-199301000-00011; Jayawardena S, 2007, EMERG INFECT DIS, V13, P899, DOI 10.3201/eid1306.061572; Jiang LJ, 2012, J MICROBIOL BIOTECHN, V22, P1301, DOI 10.4014/jmb.1202.02032; Jiang W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081525; Johnson MAS, 2004, EMERG INFECT DIS, V10, P1016, DOI 10.3201/eid1006.030660; Karande S, 2005, J TROP PEDIATRICS, V51, P174, DOI 10.1093/tropej/fmh100; Ko AI, 1999, LANCET, V354, P820, DOI 10.1016/S0140-6736(99)80012-9; Ko AI, 2009, NAT REV MICROBIOL, V7, P736, DOI 10.1038/nrmicro2208; Koizumi N, 2005, J Postgrad Med, V51, P210; Lacerda HG, 2008, T ROY SOC TROP MED H, V102, P1233, DOI 10.1016/j.trstmh.2008.05.010; Lau CL, 2010, T ROY SOC TROP MED H, V104, P631, DOI 10.1016/j.trstmh.2010.07.002; Leshem E, 2010, AM J TROP MED HYG, V82, P459, DOI 10.4269/ajtmh.2010.09-0239; Lessa-Aquino C, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002499; Lettieri C, 2004, MIL MED, V169, P687, DOI 10.7205/MILMED.169.9.687; Levett PN, 2001, CLIN MICROBIOL REV, V14, P296, DOI 10.1128/CMR.14.2.296-326.2001; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lourdault K, 2014, INFECT IMMUN, V82, P893, DOI 10.1128/IAI.01533-13; Lowe P, 2006, J CLIN MICROBIOL, V44, P2619, DOI 10.1128/JCM.00476-06; Lucchi NW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013733; Maquart M, 2014, J VIROL METHODS, V195, P92, DOI 10.1016/j.jviromet.2013.10.001; Matsui M, 2012, APPL ENVIRON MICROB, V78, P6372, DOI 10.1128/AEM.00911-12; McBride AJA, 2005, CURR OPIN INFECT DIS, V18, P376, DOI 10.1097/01.qco.0000178824.05715.2c; Morgan J, 2002, CLIN INFECT DIS, V34, P1593, DOI 10.1086/340615; Musso D, 2013, J MICROBIOL IMMUNOL, V46, P245, DOI 10.1016/j.jmii.2013.03.001; Nascimento ALTO, 2004, J BACTERIOL, V186, P2164, DOI 10.1128/JB.186.7.2164-2172.2004; Natarajaseenivasan K, 2012, SAUDI J BIOL SCI, V19, P151, DOI 10.1016/j.sjbs.2011.11.005; Noubade R, 2002, Indian J Med Microbiol, V20, P33; Pan L, 2011, J CLIN MICROBIOL, V49, P4117, DOI 10.1128/JCM.01085-11; Parida M, 2004, J CLIN MICROBIOL, V42, P257, DOI 10.1128/JCM.42.1.257-263.2004; Patel JC, 2014, J INFECT DIS, V210, P1180, DOI 10.1093/infdis/jiu252; Paulino LC, 2002, ELECTROPHORESIS, V23, P520, DOI 10.1002/1522-2683(200202)23:4<520::AID-ELPS520>3.0.CO;2-R; Perez J, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-325; Picardeau M, 2014, DIAGN MICR INFEC DIS, V78, P1, DOI 10.1016/j.diagmicrobio.2013.09.012; Promnares K, 2009, MOL MICROBIOL, V74, P112, DOI 10.1111/j.1365-2958.2009.06853.x; Raz A, 2012, MOL MICROBIOL, V84, P631, DOI 10.1111/j.1365-2958.2012.08047.x; Reis RB, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000228; Reller ME, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002941; Ren SX, 2003, NATURE, V422, P888, DOI 10.1038/nature01597; Ricaldi JN, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001853; Sethi S, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000579; Slack AT, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-95; Smythe LD, 2002, BMC INFECT DIS, V2, DOI 10.1186/1471-2334-2-13; Sonthayanon P, 2011, AM J TROP MED HYG, V84, P614, DOI 10.4269/ajtmh.2011.10-0473; Stern EJ, 2010, CLIN INFECT DIS, V50, P843, DOI 10.1086/650578; Stoddard RA, 2009, DIAGN MICR INFEC DIS, V64, P247, DOI 10.1016/j.diagmicrobio.2009.03.014; Storck CH, 2008, EPIDEMIOL INFECT, V136, P1407, DOI 10.1017/S0950268807000052; THIERMANN AB, 1980, INT J ZOONOSES, V7, P62; Trueba G, 2004, INT MICROBIOL, V7, P35; Tucunduva de Faria M, 2007, J COMP PATHOL, V137, P231, DOI 10.1016/j.jcpa.2007.08.001; VANCREVEL R, 1994, CLIN INFECT DIS, V19, P132, DOI 10.1093/clinids/19.1.132; Vinetz JM, 1996, ANN INTERN MED, V125, P794, DOI 10.7326/0003-4819-125-10-199611150-00002; Waggoner JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112356; Yang XL, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000326; Zhang GD, 2011, APPL ENVIRON MICROB, V77, P6495, DOI 10.1128/AEM.00520-11; Zhu ZW, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0056662, 10.1371/journal.pone.0080028]; Zuerner RL, 2011, CLIN VACCINE IMMUNOL, V18, P684, DOI 10.1128/CVI.00288-10	88	26	27	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2015	10	6							e0128913	10.1371/journal.pone.0128913	http://dx.doi.org/10.1371/journal.pone.0128913			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL3FE	26091292	gold, Green Published, Green Submitted			2022-12-26	WOS:000356835000033
J	Gasanov, SE; Shrivastava, IH; Israilov, FS; Kim, AA; Rylova, KA; Zhang, B; Dagda, RK				Gasanov, Sardar E.; Shrivastava, Indira H.; Israilov, Firuz S.; Kim, Aleksandr A.; Rylova, Kamila A.; Zhang, Boris; Dagda, Ruben K.			Naja naja oxiana Cobra Venom Cytotoxins CTI and CTII Disrupt Mitochondrial Membrane Integrity: Implications for Basic Three-Fingered Cytotoxins	PLOS ONE			English	Article							DEUTERIUM MAGNETIC-RESONANCE; OXYGEN SPECIES GENERATION; N-SH CELLS; PHOSPHOLIPID-MEMBRANES; PLANT-MITOCHONDRIA; LIPID-COMPOSITION; APOPTOTIC DEATH; CARDIOTOXIN; LIPOSOMES; DYNAMICS	Cobra venom cytotoxins are basic three-fingered, amphipathic, non-enzymatic proteins that constitute a major fraction of cobra venom. While cytotoxins cause mitochondrial dysfunction in different cell types, the mechanisms by which cytotoxins bind to mitochondria remain unknown. We analyzed the abilities of CTI and CTII, S-type and P-type cytotoxins from Naja naja oxiana respectively, to associate with isolated mitochondrial fractions or with model membranes that simulate the mitochondrial lipid environment by using a myriad of biophysical techniques. Phosphorus-31 nuclear magnetic resonance (P-31-NMR) spectroscopy data suggest that both cytotoxins bind to isolated mitochondrial fractions and promote the formation of aberrant non-bilayer structures. We then hypothesized that CTI and CTII bind to cardiolipin (CL) to disrupt mitochondrial membranes. Collectively, P-31-NMR, electron paramagnetic resonance (EPR), proton NMR (H-1-NMR), deuterium NMR (H-2-NMR) spectroscopy, differential scanning calorimetry, and erythrosine phosphorescence assays suggest that CTI and CTII bind to CL to generate non-bilayer structures and promote the permeabilization, dehydration and fusion of large unilamellar phosphatidylcholine (PC) liposomes enriched with CL. On the other hand, CTII but not CTI caused biophysical alterations of large unilamellar PC liposomes enriched with phosphatidylserine (PS). Mechanistically, single molecule docking simulations identified putative CL, PS and PC binding sites in CTI and CTII. While the predicted binding sites for PS and PC share a high number of interactive amino acid residues in CTI and CTII, the CL biding sites in CTII and CTI are more divergent as it contains additional interactive amino acid residues. Overall, our data suggest that cytotoxins physically associate with mitochondrial membranes by binding to CL to disrupt mitochondrial structural integrity.	[Gasanov, Sardar E.; Israilov, Firuz S.; Kim, Aleksandr A.; Rylova, Kamila A.] Moscow State Univ Branch, Appl Math & Informat Dept, Tashkent, Uzbekistan; [Gasanov, Sardar E.] Tashkent Ulugbek Int Sch, Dept Sci, Tashkent, Uzbekistan; [Shrivastava, Indira H.] Univ Pittsburgh, Dept Computat & Syst Biol, Pittsburgh, PA USA; [Zhang, Boris; Dagda, Ruben K.] Univ Nevada, Sch Med, Dept Pharmacol, Reno, NV 89557 USA	Lomonosov Moscow State University; Lomonosov Moscow State University, Tashkent Branch; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Nevada System of Higher Education (NSHE); University of Nevada Reno	Dagda, RK (corresponding author), Univ Nevada, Sch Med, Dept Pharmacol, Reno, NV 89557 USA.	rdagda@medicine.nevada.edu	Gasanov, Sardar/R-1123-2019	Dagda, Ruben/0000-0002-9946-9591; Gasanov, Sardar/0000-0001-6199-3112; Zhang, Boris/0000-0001-9365-3868	National Institute of Health (NIH) grants [GM103554]; internal International Activities Grant Award (University of Nevada, Reno); Extreme Science and Engineering Discovery Environment (XSEDE) Start-up Computer Resource Allocation Award [MCB140186]; NIH [U19-AI068021, P20GM103440]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI068021] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103440, P20GM103554] Funding Source: NIH RePORTER	National Institute of Health (NIH) grants; internal International Activities Grant Award (University of Nevada, Reno); Extreme Science and Engineering Discovery Environment (XSEDE) Start-up Computer Resource Allocation Award; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The data collection, analyses and design of experiments were supported by National Institute of Health (NIH) grants GM103554 (to RKD), NIH P20GM103440 (to BZ), and by an internal International Activities Grant Award (University of Nevada, Reno to RKD). The molecular dynamics and modeling endeavors were supported by an Extreme Science and Engineering Discovery Environment (XSEDE) Start-up Computer Resource Allocation Award #MCB140186 (RKD) and by a NIH grant U19-AI068021 (IHS).	ARIPOV TF, 1989, GEN PHYSIOL BIOPHYS, V8, P459; ARIPOV TF, 1986, DOKL AKAD NAUK SSSR+, V288, P728; Berliner LJ, 1979, METHODS OF SPIN LABE; Chen KC, 2008, TOXICON, V52, P361, DOI 10.1016/j.toxicon.2008.06.013; Chen KC, 2008, TOXICON, V51, P624, DOI 10.1016/j.toxicon.2007.11.024; CHIEN KY, 1994, J BIOL CHEM, V269, P14473; Chu CT, 2013, NAT CELL BIOL, V15, P1197, DOI 10.1038/ncb2837; Cowdry NH, 1917, BIOL BULL-US, V33, P196, DOI 10.2307/1536370; CULLIS PR, 1980, BIOCHIM BIOPHYS ACTA, V600, P625, DOI 10.1016/0005-2736(80)90466-6; DAUM G, 1985, BIOCHIM BIOPHYS ACTA, V822, P1, DOI 10.1016/0304-4157(85)90002-4; De Kruijff B, 1985, MODULATION OF LIPID; DEAMER D, 1976, BIOCHIM BIOPHYS ACTA, V443, P629, DOI 10.1016/0005-2787(76)90527-X; Dementieva DV, 1999, EUR J BIOCHEM, V263, P152, DOI 10.1046/j.1432-1327.1999.00478.x; DEVAUX PF, 1985, BIOCHIM BIOPHYS ACTA, V822, P63, DOI 10.1016/0304-4157(85)90004-8; Dubovskii PV, 2005, BIOCHEM J, V387, P807, DOI 10.1042/BJ20041814; Dubovskii PV, 2003, EUR J BIOCHEM, V270, P2038, DOI 10.1046/j.1432-1033.2003.03580.x; Dubovskii PV, 2013, CURR MED CHEM; Feofanov AV, 2005, BIOCHEM J, V390, P11, DOI 10.1042/BJ20041892; Feofanov AV, 2004, BIOCHEMISTRY-MOSCOW+, V69, P1148, DOI 10.1023/B:BIRY.0000046890.46901.7e; FLEISCHER S, 1967, J LIPID RES, V8, P170; Forouhar F, 2003, J BIOL CHEM, V278, P21980, DOI 10.1074/jbc.M208650200; Gasanov S, 1989, DOKL AKAD NAUK SSSR, P51; Gasanov S E, 1990, Nauchnye Doki Vyss Shkoly Biol Nauki, P42; Gasanov S.E., 1994, J BIOL PHYS, V19, P235, DOI [10.1007/BF00700663, DOI 10.1007/BF00700663]; GASANOV SE, 1994, GEN PHYSIOL BIOPHYS, V13, P275; GASANOV SE, 1995, GEN PHYSIOL BIOPHYS, V14, P107; GASANOV SE, 1993, ARCH BIOCHEM BIOPHYS, V301, P367, DOI 10.1006/abbi.1993.1157; GASANOV SE, 1990, BIOFIZIKA+, V35, P958; Gasanov SE, 1997, J MEMBRANE BIOL, V155, P133, DOI 10.1007/s002329900165; GASANOV SE, 1990, BIOL MEMBRANY, V7, P1045; Gasanov SE, 1989, DOKL AKAD NAUK, P53; Gasanov SE, 1988, MECHANISMS OF FUSOGE; Gebert N, 2009, CURR BIOL, V19, P2133, DOI 10.1016/j.cub.2009.10.074; GRISHIN EV, 1974, FEBS LETT, V48, P179, DOI 10.1016/0014-5793(74)80462-X; Hanwell MD, 2012, J CHEMINFORMATICS, V4, DOI 10.1186/1758-2946-4-17; Horvath SE, 2013, PROG LIPID RES, V52, P590, DOI 10.1016/j.plipres.2013.07.002; Ivanov I., 1988, MODERN METHODS BIOPH, P203, DOI [10.1002/bip.22253, DOI 10.1002/BIP.22253]; Konshina AG, 2010, ACTA NATURAE, V2, P88, DOI 10.32607/20758251-2010-2-3-88-95; Konshina AG, 2012, CURR PROTEIN PEPT SC, V13, P570; Konshina AG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019064; Levtsova OV, 2009, COMPUT BIOL CHEM, V33, P29, DOI 10.1016/j.compbiolchem.2008.07.018; MANTSCH HH, 1977, PROG NUCL MAG RES SP, V11, P211, DOI 10.1016/0079-6565(77)80010-1; MARKIN VS, 1984, GEN PHYSIOL BIOPHYS, V3, P361; OIMATOV M, 1986, STUD BIOPHYS, V112, P237; Papahadjopoulos D, 1979, METHODS IN MEMBRANE; Rael E.D., 2014, J CLIN TOXICOL, V4; SCHWERTNER HA, 1973, J LIPID RES, V14, P235; SEELIG J, 1977, Q REV BIOPHYS, V10, P353, DOI 10.1017/S0033583500002948; Segal' N. K., 1993, Biokhimiya, V58, P1812; Siegel D.P., 1984, J BIOPHYS SOC, V45, P399; Smith I, 1984, PHOSPHORUS 31 NMR OF; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; Wang CH, 2005, FEBS LETT, V579, P3169, DOI 10.1016/j.febslet.2005.05.006; WHITEHOUSE DG, 1989, PLANT PHYSIOL, V91, P487, DOI 10.1104/pp.91.2.487; Wi S, 2008, J PHYS CHEM B, V112, P11402, DOI 10.1021/jp801825k; Wu MY, 2013, AM J CHINESE MED, V41, P643, DOI 10.1142/S0192415X13500456; Yang SH, 2006, EXP MOL MED, V38, P435, DOI 10.1038/emm.2006.51	58	25	28	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2015	10	6							e0129248	10.1371/journal.pone.0129248	http://dx.doi.org/10.1371/journal.pone.0129248			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL3FE	26091109	Green Published, Green Accepted, gold, Green Submitted			2022-12-26	WOS:000356835000039
J	Imai, H; Kano, K; Fujii, W; Takasawa, K; Wakitani, S; Hiyama, M; Nishino, K; Kusakabe, KT; Kiso, Y				Imai, Hiroyuki; Kano, Kiyoshi; Fujii, Wataru; Takasawa, Ken; Wakitani, Shoichi; Hiyama, Masato; Nishino, Koichiro; Kusakabe, Ken Takeshi; Kiso, Yasuo			Tetraploid Embryonic Stem Cells Maintain Pluripotency and Differentiation Potency into Three Germ Layers	PLOS ONE			English	Article							MOUSE EMBRYOS; CYTOCHALASIN-B; PREIMPLANTATION DEVELOPMENT; TRANSGENIC MICE; ELECTROFUSION; DERIVATION; BLASTOMERES; CULTURE; BLASTOCYSTS; EXPRESSION	Polyploid amphibians and fishes occur naturally in nature, while polyploid mammals do not. For example, tetraploid mouse embryos normally develop into blastocysts, but exhibit abnormalities and die soon after implantation. Thus, polyploidization is thought to be harmful during early mammalian development. However, the mechanisms through which polyploidization disrupts development are still poorly understood. In this study, we aimed to elucidate how genome duplication affects early mammalian development. To this end, we established tetraploid embryonic stem cells (TESCs) produced from the inner cell masses of tetraploid blastocysts using electrofusion of two-cell embryos in mice and studied the developmental potential of TESCs. We demonstrated that TESCs possessed essential pluripotency and differentiation potency to form teratomas, which differentiated into the three germ layers, including diploid embryonic stem cells. TESCs also contributed to the inner cell masses in aggregated chimeric blastocysts, despite the observation that tetraploid embryos fail in normal development soon after implantation in mice. In TESCs, stability after several passages, colony morphology, and alkaline phosphatase activity were similar to those of diploid ESCs. TESCs also exhibited sufficient expression and localization of pluripotent markers and retained the normal epigenetic status of relevant reprogramming factors. TESCs proliferated at a slower rate than ESCs, indicating that the difference in genomic dosage was responsible for the different growth rates. Thus, our findings suggested that mouse ESCs maintained intrinsic pluripotency and differentiation potential despite tetraploidization, providing insights into our understanding of developmental elimination in polyploid mammals.	[Imai, Hiroyuki; Kano, Kiyoshi; Hiyama, Masato; Kusakabe, Ken Takeshi; Kiso, Yasuo] Yamaguchi Univ, Lab Vet Anat, Joint Fac Vet Med, Yamaguchi, Japan; [Imai, Hiroyuki; Kano, Kiyoshi] Yamaguchi Univ, Dev Biol Lab, Joint Fac Vet Med, Yamaguchi, Japan; [Kano, Kiyoshi] Yamaguchi Univ, United Grad Sch Vet Sci, BSCTR, Yamaguchi, Japan; [Fujii, Wataru] Univ Tokyo, Grad Sch Agr & Life Sci, Lab Appl Genet, Tokyo, Japan; [Takasawa, Ken; Wakitani, Shoichi; Nishino, Koichiro] Miyazaki Univ, Lab Vet Biochem & Mol Biol, Miyazaki, Japan	Yamaguchi University; Yamaguchi University; Yamaguchi University; University of Tokyo; University of Miyazaki	Kano, K (corresponding author), Yamaguchi Univ, Lab Vet Anat, Joint Fac Vet Med, Yamaguchi, Japan.	kanokiyo@yamaguchi-u.ac.jp	Takasawa, Ken/AAY-6755-2020	Takasawa, Ken/0000-0001-8699-0858; Fujii, Wataru/0000-0002-6438-7350	JSPS [24658237, 26712025, 25292187, 24380159]; Foundation for Growth Science	JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Foundation for Growth Science	This study was supported in part by Grants-in-aid for Scientific Research (Grant-in-Aid for challenging Exploratory Research) (24658237) from JSPS to KK, a Grant-in-Aid for Young Scientists (A) (26712025) from JSPS to WF, Grants-in-aid for Scientific Research (B) (25292187) from JSPS to KN, Grants-in-aid for Scientific Research (B) (24380159) from JSPS to YK, and Grants-in-Aid from the Foundation for Growth Science for KK.	Bacquet C, 2008, MAMM GENOME, V19, P439, DOI 10.1007/s00335-008-9131-z; BERG H, 1982, BIOELECTROCH BIOENER, V9, P223, DOI 10.1016/0302-4598(82)80178-5; Brodsky VYa., 1985, GENOME MULTIPLICATIO; Brons IGM, 2007, NATURE, V448, P191, DOI 10.1038/nature05950; Cleveland BM, 2014, MOL CELL ENDOCRINOL, V382, P139, DOI 10.1016/j.mce.2013.09.024; Dietrich JE, 2007, DEVELOPMENT, V134, P4219, DOI 10.1242/dev.003798; Dyban A.P., 1987, CYTOGENETICS MAMMALI; Eakin GS, 2003, DEV DYNAM, V228, P751, DOI 10.1002/dvdy.10363; Eakin GS, 2005, DEV BIOL, V288, P150, DOI 10.1016/j.ydbio.2005.09.028; Elling U, 2011, CELL STEM CELL, V9, P563, DOI 10.1016/j.stem.2011.10.012; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; Hayashi K, 2012, SCIENCE, V338, P971, DOI 10.1126/science.1226889; Hayashi K, 2011, CELL, V146, P519, DOI 10.1016/j.cell.2011.06.052; Horii T, 2015, SCI REP-UK, V5, DOI 10.1038/srep08907; Ishiguro N, 2005, J REPROD DEVELOP, V51, P567, DOI 10.1262/jrd.17004; Jaillon O, 2004, NATURE, V431, P946, DOI 10.1038/nature03025; JAMES RM, 1992, GENET RES, V60, P185, DOI 10.1017/S0016672300030937; KAUFMAN MH, 1991, J ANAT, V179, P169; KAUFMAN MH, 1992, J ANAT, V180, P521; KAUFMAN MH, 1990, DEVELOPMENT, V110, P1121; Kawaguchi J, 2009, J REPROD DEVELOP, V55, P670, DOI 10.1262/jrd.09-127A; KOIZUMI N, 1995, EXP ANIM TOKYO, V44, P105, DOI 10.1538/expanim.44.105; KUBIAK JZ, 1985, EXP CELL RES, V157, P561, DOI 10.1016/0014-4827(85)90143-0; KURISCHKO A, 1986, BIOELECTROCH BIOENER, V15, P513, DOI 10.1016/0302-4598(86)85039-5; Leeb M, 2011, NATURE, V479, P131, DOI 10.1038/nature10448; Li W, 2012, NATURE, V490, P407, DOI 10.1038/nature11435; Lin CJ, 2010, BIOL REPROD, V83, P177, DOI 10.1095/biolreprod.110.084707; LIN M, 1995, J ANAT, V186, P563; Liu L, 2004, GENE EXPR PATTERNS, V4, P433, DOI 10.1016/j.modgep.2004.01.004; McFeely R. A, 1969, COMP MAMMALIAN CYTOG, P434; NAGY A, 1993, P NATL ACAD SCI USA, V90, P8424, DOI 10.1073/pnas.90.18.8424; Nagy A., 1993, Gene targeting: a practical approach., P147; Nichols J, 2009, CELL STEM CELL, V4, P487, DOI 10.1016/j.stem.2009.05.015; Park MR, 2011, DEV DYNAM, V240, P1660, DOI 10.1002/dvdy.22653; Pfeiffer MJ, 2013, STEM CELLS, V31, P2343, DOI 10.1002/stem.1497; Piferrer F, 2009, AQUACULTURE, V293, P125, DOI 10.1016/j.aquaculture.2009.04.036; Pralong D, 2005, CLONING STEM CELLS, V7, P272, DOI 10.1089/clo.2005.7.272; SNOW MHL, 1975, J EMBRYOL EXP MORPH, V34, P707; SNOW MHL, 1973, NATURE, V244, P513, DOI 10.1038/244513a0; TARKOWSKI AK, 1977, J EMBRYOL EXP MORPH, V41, P47; Wang ZQ, 1997, MECH DEVELOP, V62, P137, DOI 10.1016/S0925-4773(97)00655-2; Wen DC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094730; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Zhang KJ, 2010, DEVELOPMENT, V137, P2095, DOI 10.1242/dev.049494	44	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2015	10	6							e0130585	10.1371/journal.pone.0130585	http://dx.doi.org/10.1371/journal.pone.0130585			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL3FE	26091100	Green Submitted, gold, Green Published			2022-12-26	WOS:000356835000130
J	Jeffrey, M; Piccardo, P; Ritchie, DL; Ironside, JW; Green, AJE; McGovern, G				Jeffrey, Martin; Piccardo, Pedro; Ritchie, Diane L.; Ironside, James W.; Green, Alison J. E.; McGovern, Gillian			A Naturally Occurring Bovine Tauopathy Is Geographically Widespread in the UK	PLOS ONE			English	Article							STEM NEURONAL CHROMATOLYSIS; PRION PROTEIN; SPONGIFORM ENCEPHALOPATHY; NEUROFIBRILLARY TANGLES; PARKINSONS-DISEASE; PESTICIDE EXPOSURE; CEREBRAL-CORTEX; TAU; BRAIN; SHEEP	Many human neurodegenerative diseases are associated with hyperphosphorylation and widespread intra-neuronal and glial associated aggregation of the microtubule associated protein tau. In contrast, animal tauopathies are not reported with only senescent animals showing inconspicuous tau labelling of fine processes albeit significant tau aggregation may occur in some experimental animal disease. Since 1986, an idiopathic neurological condition of adult cattle has been recognised in the UK as a sub-set of cattle slaughtered as suspect bovine spongiform encephalopathy cases. This disorder is characterised by brainstem neuronal chromatolysis and degeneration with variable hippocampal sclerosis and spongiform change. Selected cases of idiopathic brainstem neuronal chromatolysis (IBNC) were identified from archive material and characterised using antibodies specific to several tau hyperphosphorylation sites or different isoforms of the tau microtubule binding region. Labelling was also carried out for alpha synuclein, ubiquitin, TDP43, A beta(1-42), A beta(1-40). Widespread tau labelling was identified in all IBNC brains examined and with each of seven tau antibodies recognising different hyperphosphorylated sites. Labelling with each antibody was associated with dendrites, neuronal perikarya and glia. Thus IBNC is a sporadic, progressive neurological disease predominantly affecting aged cattle that occurs throughout the UK and is associated with hyperphosphorylation of tau, a rare example of a naturally-occurring tauopathy in a non-primate species. Secondary accumulation of alpha synuclein and ubiquitin was also present. The neuropathology does not precisely correspond with any human tauopathy. The cause of IBNC remains undetermined but environmental factors and exposure to agrochemicals needs to be considered in future aetiological investigations.	[Jeffrey, Martin; McGovern, Gillian] Anim & Plant Hlth Agcy, Lasswade Vet Lab, Penicuik, Midlothian, Scotland; [Piccardo, Pedro] Food & Drug Adm, Lab Bacterial & TSE Agents, Rockville, MD USA; [Ritchie, Diane L.; Ironside, James W.; Green, Alison J. E.] Univ Edinburgh, Western Gen Hosp, Natl CJD Res & Surveillance Unit, Ctr Clin Brain Sci,Sch Clin Sci, Edinburgh, Midlothian, Scotland	US Food & Drug Administration (FDA); University of Edinburgh	McGovern, G (corresponding author), Anim & Plant Hlth Agcy, Lasswade Vet Lab, Pentlands Sci Pk, Penicuik, Midlothian, Scotland.	gillian.mcgovern@apha.gsi.gov.uk	Green, Alison/O-7356-2019	Ironside, James/0000-0001-5869-2108	UK Department of farming and rural affairs grant [Se1957]; NIH-NIAID Agreement [Y1-AI-4893-02]; FDA Agreement [224-05-1307]; BBSRC [BBS/E/D/20251967, BBS/E/D/20251968] Funding Source: UKRI; MRC [G0900580, G0600953] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/D/20251968, BBS/E/D/20251967] Funding Source: researchfish; Medical Research Council [G0600953, G0900580] Funding Source: researchfish	UK Department of farming and rural affairs grant; NIH-NIAID Agreement; FDA Agreement; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	These studies were partly funded by UK Department of farming and rural affairs grant Se1957 and NIH-NIAID Agreement No. Y1-AI-4893-02 and FDA Agreement No. 224-05-1307. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1998, BOVINE SPONGIFORM EN; Ascherio A, 2006, ANN NEUROL, V60, P197, DOI 10.1002/ana.20904; Asuni AA, 2010, BIOCHEM SOC T, V38, P545, DOI 10.1042/BST0380545; Augustinack JC, 2002, ACTA NEUROPATHOL, V103, P26, DOI 10.1007/s004010100423; Betarbet R, 2000, NAT NEUROSCI, V3, P1301, DOI 10.1038/81834; BRAAK H, 1994, NEUROSCI LETT, V171, P1, DOI 10.1016/0304-3940(94)90589-4; Capucchio MT, 2010, J COMP PATHOL, V142, P61, DOI 10.1016/j.jcpa.2009.07.007; Costello S, 2009, AM J EPIDEMIOL, V169, P919, DOI 10.1093/aje/kwp006; Crary JF, 2014, ACTA NEUROPATHOL, V128, P755, DOI 10.1007/s00401-014-1349-0; Delacourte A, 2005, FOLIA NEUROPATHOL, V43, P244; Di Monte DA, 2003, LANCET NEUROL, V2, P531, DOI 10.1016/S1474-4422(03)00501-5; Dick FD, 2006, BRIT MED BULL, V79-80, P219, DOI 10.1093/bmb/ldl018; Frank S, 2008, ACTA NEUROPATHOL, V115, P39, DOI 10.1007/s00401-007-0291-9; Goerdert M, 2012, COLD SPRING HARB PER, V4, DOI [10.1101/cshperspect.a006254, DOI 10.1101/CSHPERSPECT.A006254]; Gonzalez L, 2002, J COMP PATHOL, V126, P17, DOI 10.1053/jcpa.2001.0516; GRUNDKEIQBAL I, 1986, P NATL ACAD SCI USA, V83, P4913, DOI 10.1073/pnas.83.13.4913; Hartig W, 2000, ACTA NEUROPATHOL, V100, P305, DOI 10.1007/s004010000183; Janke C, 1999, MOL BRAIN RES, V68, P119, DOI 10.1016/S0169-328X(99)00079-0; JEFFREY M, 1992, VET REC, V131, P332, DOI 10.1136/vr.131.15.332; JEFFREY M, 1992, VET REC, V131, P359, DOI 10.1136/vr.131.16.359; Jeffrey M, 2012, J COMP PATHOL, V147, P46, DOI 10.1016/j.jcpa.2011.08.011; Jeffrey M, 2008, BMC VET RES, V4, DOI 10.1186/1746-6148-4-38; Kovacs GG, 2015, NEUROPATH APPL NEURO, V41, P3, DOI 10.1111/nan.12208; Kovacs GG, 2011, ACTA NEUROPATHOL, V122, P205, DOI 10.1007/s00401-011-0819-x; Lee VMY, 1999, METHOD ENZYMOL, V309, P81; Nelson PT, 1996, J NEUROCHEM, V67, P1622; NELSON PT, 1994, NEUROSCI LETT, V170, P187, DOI 10.1016/0304-3940(94)90270-4; Oikawa N, 2010, BRAIN RES, V1315, P137, DOI 10.1016/j.brainres.2009.12.005; Piccardo P, 2014, J GEN VIROL, V95, P1612, DOI 10.1099/vir.0.062083-0; Reiniger L, 2011, ACTA NEUROPATHOL, V121, P5, DOI 10.1007/s00401-010-0691-0; Stewart WB, 1997, VET REC, V140, P260; Uchihara T, 2011, BRAIN PATHOL, V21, P180, DOI 10.1111/j.1750-3639.2010.00433.x	32	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2015	10	6							e0129499	10.1371/journal.pone.0129499	http://dx.doi.org/10.1371/journal.pone.0129499			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL3FE	26091261	Green Submitted, Green Published, gold			2022-12-26	WOS:000356835000047
J	Lopez-Vinyallonga, S; Soriano, I; Susanna, A; Montserra, JM; Roquet, C; Garcia-Jacas, N				Lopez-Vinyallonga, Sara; Soriano, Ignasi; Susanna, Alfonso; Maria Montserra, Josep; Roquet, Cristina; Garcia-Jacas, Nuria			The Polyploid Series of the Achillea millefolium Aggregate in the Iberian Peninsula Investigated Using Microsatellites	PLOS ONE			English	Article							POPULATION GENETIC-STRUCTURE; MULTIPLE INTRODUCTIONS; ANTIMICROBIAL ACTIVITY; ALLELIC CONFIGURATION; INVASIVE POPULATIONS; L. ASTERACEAE; DIVERSITY; EVOLUTION; COMPLEX; HYBRIDIZATION	The Achillea millefolium aggregate is one of the most diverse polyploid complexes of the Northern hemisphere and has its western Eurasian boundary in the Iberian Peninsula. Four ploidy levels have been detected in A. millefolium, three of which have already been found in Iberia (diploid, hexaploid and octoploid), and a fourth (tetraploid) reported during the preparation of this paper. We collected a sample from 26 Iberian populations comprising all ploidy levels, and we used microsatellite markers analyzed as dominant in view of the high ploidy levels. Our goals were to quantify the genetic diversity of A. millefolium in the Iberian Peninsula, to elucidate its genetic structure, to investigate the differences in ploidy levels, and to analyse the dispersal of the species. The lack of spatial genetic structure recovered is linked to both high levels of gene flow between populations and to the fact that most genetic variability occurs within populations. This in turn suggests the existence of a huge panmictic yarrow population in the Iberian Peninsula. This is consistent with the assumption that recent colonization and rapid expansion occurred throughout this area. Likewise, the low levels of genetic variability recovered suggest that bottlenecks and/or founder events may have been involved in this process, and clonal reproduction may have played an important role in maintaining this genetic impoverishment. Indeed, the ecological and phenologic uniformity present in the A. millefolium agg. in Iberia compared to Eurasia and North America may be responsible for the low number of representatives of this complex of species present in the Iberian Peninsula. The low levels of genetic differentiation between ploidy levels recovered in our work suggest the absence of barriers between them.	[Lopez-Vinyallonga, Sara; Susanna, Alfonso; Garcia-Jacas, Nuria] ICUB, CSIC, IBB, Barcelona, Spain; [Soriano, Ignasi] Univ Barcelona, Dept Plant Biol, Barcelona, Spain; [Maria Montserra, Josep] Consortium Museum Nat Hist Barcelona, Barcelona Bot Garden, Barcelona, Spain; [Roquet, Cristina] Univ Grenoble Alpes, CNRS, Lab Ecol Alpine, UMR 5553, Grenoble, France	Autonomous University of Barcelona; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Institut Botanic de Barcelona (ICUB); University of Barcelona; Museu de Ciencies Naturals de Barcelona; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Universite de Savoie	Susanna, A (corresponding author), ICUB, CSIC, IBB, Barcelona, Spain.	asusanna@ibb.csic.es	Soriano, Ignasi/AAD-1676-2019; Susanna, Alfonso/C-1683-2013; Roquet, Cristina/AAB-4031-2019; Garcia-Jacas, Núria/K-8910-2014; Soriano, Ignasi/F-4657-2016	Soriano, Ignasi/0000-0003-3875-7511; Susanna, Alfonso/0000-0003-4717-9063; Soriano, Ignasi/0000-0003-3875-7511; Garcia-Jacas, Nuria/0000-0003-1893-5122; Roquet, Cristina/0000-0001-8748-3743	"Ajuts a Grups de Recerca Consolidats" [2009SGR/00439, 2014/SGR/514]	"Ajuts a Grups de Recerca Consolidats"	Dr Joan Uriach Marsal privately funded this research (grant assigned to AS and NGJ). Generalitat de Catalunya partly contributed financial support by grants "Ajuts a Grups de Recerca Consolidats" number 2009SGR/00439 and 2014/SGR/514 to all the authors.	Akram M, 2013, J MEMBRANE BIOL, V246, P661, DOI 10.1007/s00232-013-9588-x; Amsellem L, 2000, MOL ECOL, V9, P443, DOI 10.1046/j.1365-294x.2000.00876.x; Andreakis N, 2009, MOL ECOL, V18, P212, DOI 10.1111/j.1365-294X.2008.04022.x; [Anonymous], VERGLEICHENDE CHOROL; [Anonymous], COMPOSITAE 2 S1; [Anonymous], BOT JEN 17 22 SEPT 2; [Anonymous], 10 C BOT PYR CANT BA; [Anonymous], MODERN ASPECTS SPECI; [Anonymous], 2006, MOL ECOL NOTES, DOI [DOI 10.1111/J.1471-8286.2005.01155.X, DOI doi:10.1111/j.1471-8286.2005.01155.x]; [Anonymous], 1975, EVOLUTION, DOI DOI 10.1111/j.1558-5646.1975.tb00807.x; Arrigo N, 2010, NEW PHYTOL, V187, P1170, DOI 10.1111/j.1469-8137.2010.03328.x; Babaei A, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-12; Barrett S.C.H., 1986, P21; Becher SA, 2000, THEOR APPL GENET, V101, P643, DOI 10.1007/s001220051526; Bruvo R, 2004, MOL ECOL, V13, P2101, DOI 10.1111/j.1365-294X.2004.02209.x; Candan F, 2003, J ETHNOPHARMACOL, V87, P215, DOI 10.1016/S0378-8741(03)00149-1; Cullings KW, 1992, MOL ECOL, V1, P233, DOI 10.1111/j.1365-294X.1992.tb00182.x; Dall'Acqua S, 2011, PHYTOMEDICINE, V18, P1031, DOI 10.1016/j.phymed.2011.05.005; de Souza P, 2011, PHYTOMEDICINE, V18, P819, DOI 10.1016/j.phymed.2011.02.005; Doyle J. J., 1987, PHYTOCHEM B, P11; Durka W, 2005, MOL ECOL, V14, P1697, DOI 10.1111/j.1365-294X.2005.02521.x; Ehrendorfer Friedrich, 2006, Willdenowia, V36, P69, DOI 10.3372/wi.36.36105; Ellstrand NC, 2000, P NATL ACAD SCI USA, V97, P7043, DOI 10.1073/pnas.97.13.7043; Espinoza NR, 2002, J HERED, V93, P81, DOI 10.1093/jhered/93.2.81; Esselink GD, 2004, THEOR APPL GENET, V109, P402, DOI 10.1007/s00122-004-1645-5; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Facon B, 2008, CURR BIOL, V18, P363, DOI 10.1016/j.cub.2008.01.063; Gaskin JF, 2005, MOL ECOL, V14, P2331, DOI 10.1111/j.1365-294X.2005.02589.x; Genton BJ, 2005, MOL ECOL, V14, P4275, DOI 10.1111/j.1365-294X.2005.02750.x; Guo YP, 2008, TAXON, V57, P153, DOI 10.2307/25065957; Guo YP, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-2; Guo YP, 2005, NEW PHYTOL, V166, P273, DOI 10.1111/j.1469-8137.2005.01315.x; Guo YP, 2004, TAXON, V53, P657, DOI 10.2307/4135441; Harbaugh DT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004698; Hartigan J. A., 1979, Applied Statistics, V28, P100, DOI 10.2307/2346830; Huang Y, 2009, CONSERV GENET, V10, P515, DOI 10.1007/s10592-008-9553-x; HUSBAND BC, 1991, HEREDITY, V66, P287, DOI 10.1038/hdy.1991.36; Jiao YN, 2011, NATURE, V473, P97, DOI 10.1038/nature09916; Landergott U, 2006, THEOR APPL GENET, V113, P453, DOI 10.1007/s00122-006-0310-6; Legendre P., 2012, NUMERICAL ECOLOGY; Lehane Adele M, 2008, BMC Res Notes, V1, P26, DOI 10.1186/1756-0500-1-26; Lepais O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075029; Lopez-Vinyallonga S, 2010, AM J BOT, V97, pE4, DOI 10.3732/ajb.0900376; Markwith SH, 2006, MOL ECOL NOTES, V6, P586, DOI 10.1111/j.1471-8286.2006.01345.x; Marrs RA, 2008, MOL ECOL, V17, P4197, DOI 10.1111/j.1365-294X.2008.03903.x; Marrs RA, 2008, BIOL INVASIONS, V10, P561, DOI 10.1007/s10530-007-9153-6; MASTERSON J, 1994, SCIENCE, V264, P421, DOI 10.1126/science.264.5157.421; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Poulin J, 2005, DIVERS DISTRIB, V11, P241, DOI 10.1111/j.1366-9516.2005.00136.x; Pritchard JK, 2000, GENETICS, V155, P945; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; Rahimmalek M, 2011, GENES GENOM, V33, P475, DOI 10.1007/s13258-011-0045-x; Ramsey J, 2008, EVOLUTION, V62, P639, DOI 10.1111/j.1558-5646.2007.00264.x; ROOSE ML, 1976, EVOLUTION, V30, P818, DOI 10.1111/j.1558-5646.1976.tb00963.x; Saltonstall K, 2003, MOL ECOL, V12, P1689, DOI 10.1046/j.1365-294X.2003.01849.x; Samadi S, 1999, MOL ECOL, V8, P1141, DOI 10.1046/j.1365-294x.1999.00671.x; SCHWEIZER D, 1983, BIOL ZBL, V102, P637; Soltis DE, 1999, TRENDS ECOL EVOL, V14, P348, DOI 10.1016/S0169-5347(99)01638-9; SOLTIS DE, 1993, CRIT REV PLANT SCI, V12, P243, DOI 10.1080/713608048; Soltis DE, 2009, AM J BOT, V96, P336, DOI 10.3732/ajb.0800079; Stojanovic G, 2005, J ETHNOPHARMACOL, V101, P185, DOI 10.1016/j.jep.2005.04.026; Tel-Zur N, 1999, PLANT MOL BIOL REP, V17, P249, DOI 10.1023/A:1007656315275; Vetter S, 1996, CARYOLOGIA, V49, P227, DOI 10.1080/00087114.1996.10797367; Yaeesh S, 2006, PHYTOTHER RES, V20, P546, DOI 10.1002/ptr.1897; Zhang DX, 2003, MOL ECOL, V12, P563, DOI 10.1046/j.1365-294X.2003.01773.x	65	9	12	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2015	10	6							e0129861	10.1371/journal.pone.0129861	http://dx.doi.org/10.1371/journal.pone.0129861			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL3FE	26091537	Green Published, gold, Green Submitted			2022-12-26	WOS:000356835000069
J	Gonzalez, SM; Taborda, NA; Feria, MG; Arcia, D; Aguilar-Jimenez, W; Zapata, W; Rugeles, MT				Milena Gonzalez, Sandra; Andrea Taborda, Natalia; Geronimo Feria, Manuel; Arcia, David; Aguilar-Jimenez, Wbeimar; Zapata, Wildeman; Teresa Rugeles, Maria			High Expression of Antiviral Proteins in Mucosa from Individuals Exhibiting Resistance to Human Immunodeficiency Virus	PLOS ONE			English	Article							HIV-1 INFECTION; MESSENGER-RNA; SERONEGATIVE INDIVIDUALS; SERPIN A1; ALPHA-1-ANTITRYPSIN; RESTRICTION; PLASMA; SAMHD1; TRACT; CELLS	Background Several soluble factors have been reported to have the capacity of inhibiting HIV replication at different steps of the virus life cycle, without eliminating infected cells and through enhancement of specific cellular mechanisms. Yet, it is unclear if these antiviral factors play a role in the protection from HIV infection or in the control of viral replication. Here we evaluated two cohorts: i) one of 58 HIV-exposed seronegative individuals (HESNs) who were compared with 59 healthy controls (HCs), and ii) another of 13 HIV-controllers who were compared with 20 HIV-progressors. Peripheral blood, oral and genital mucosa and gut-associated lymphoid tissue (GALT) samples were obtained to analyze the mRNA expression of ELAFIN, APOBEC3G, SAMHD1, TRIM5 alpha, RNase 7 and SerpinA1 using real-time PCR. Results HESNs exhibited higher expression of all antiviral factors in peripheral blood mononuclear cells (PBMCs), oral or genital mucosa when compared with HCs. Furthermore, HIV-controllers exhibited higher levels of SerpinA1 in GALT. Conclusions These findings suggest that the activity of these factors is compartmentalized and that these proteins have a predominant role depending on the tissue to avoid the infection, reduce the viral load and modulate the susceptibility to HIV infection.	[Milena Gonzalez, Sandra; Andrea Taborda, Natalia; Geronimo Feria, Manuel; Arcia, David; Aguilar-Jimenez, Wbeimar; Zapata, Wildeman; Teresa Rugeles, Maria] Univ Antioquia UdeA, Fac Med, Grp Inmunovirol, Medellin, Colombia; [Zapata, Wildeman] Univ Cooperat Colombia, Fac Med, Grp Infettare, Medellin, Colombia	Universidad de Antioquia; Universidad Cooperativa de Colombia	Rugeles, MT (corresponding author), Univ Antioquia UdeA, Fac Med, Grp Inmunovirol, Medellin, Colombia.	maria.rugeles@udea.edu.co	Zapata, Wildeman/ABE-5082-2020; Zapata, Wildeman/C-1622-2018	Zapata, Wildeman/0000-0002-7351-8738; Zapata, Wildeman/0000-0002-7351-8738; Rugeles, Maria T./0000-0001-7855-1409; Aguilar Jimenez, Wbeimar/0000-0002-0790-055X; Arcia Anaya, David/0000-0002-9902-5819; Taborda, Natalia/0000-0002-6169-0119; Taborda Vanegas, Natalia Andrea/0000-0001-6085-855X	comite para el desarrollo de la investigacion (CODI) de la Universidad de Antioquia: convocatoria mediana cuantia CODI [235]; Convocatoria publica programatica CODI [255, 259]; Estrategia de Sostenibilidad de la Universidad de Antioquia; Banco de la Republica (Universidad Cooperativa de Colombia) [Proyecto 3377, convenio 201414]; Colciencias	comite para el desarrollo de la investigacion (CODI) de la Universidad de Antioquia: convocatoria mediana cuantia CODI; Convocatoria publica programatica CODI; Estrategia de Sostenibilidad de la Universidad de Antioquia; Banco de la Republica (Universidad Cooperativa de Colombia); Colciencias(Departamento Administrativo de Ciencia, Tecnologia e Innovacion Colciencias)	This investigation was supported by the following programs from comite para el desarrollo de la investigacion (CODI) de la Universidad de Antioquia: convocatoria mediana cuantia CODI 2011 (grant 235); Convocatoria publica programatica CODI 2012-2013 (grants 255 and 259); Estrategia de Sostenibilidad 2014-2015 de la Universidad de Antioquia; Banco de la Republica (convenio 201414 Universidad Cooperativa de Colombia - Proyecto 3377); NT and WAJ received a scholarship from Colciencias. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar-Jimenez W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082717; Baldauf HM, 2012, NAT MED, V18, P1682, DOI 10.1038/nm.2964; Biasin M, 2007, J INFECT DIS, V195, P960, DOI 10.1086/511988; BUCURENCI N, 1992, FEBS LETT, V300, P21, DOI 10.1016/0014-5793(92)80156-B; Campo J, 2006, ORAL DIS, V12, P219, DOI 10.1111/j.1601-0825.2005.01187.x; Congote LF, 2007, VIRUS RES, V125, P119, DOI 10.1016/j.virusres.2006.12.018; Drannik AG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052738; Drannik AG, 2012, J VIROL, V86, P4599, DOI 10.1128/JVI.06561-11; Ghosh M, 2010, IMMUNOLOGY, V129, P207, DOI 10.1111/j.1365-2567.2009.03165.x; Herzberg M C, 2006, Adv Dent Res, V19, P158; Javanbakht H, 2006, VIROLOGY, V354, P15, DOI 10.1016/j.virol.2006.06.031; Kourteva Y, 2012, VIROLOGY, V430, P1, DOI 10.1016/j.virol.2012.03.018; Mantri CK, 2014, J DENT RES, V93, P794, DOI 10.1177/0022034514537647; Rueda CM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030307; Mbisa JL, 2010, J VIROL, V84, P5250, DOI 10.1128/JVI.02358-09; Piacentini L, 2008, VACCINE, V26, P3002, DOI 10.1016/j.vaccine.2007.11.062; Pott GB, 2009, J LEUKOCYTE BIOL, V85, P886, DOI 10.1189/jlb.0208145; Potthoff AV, 2007, AIDS, V21, P2115, DOI 10.1097/QAD.0b013e3282f08b97; Rahman S, 2013, AM J REPROD IMMUNOL, V69, P64, DOI 10.1111/aji.12014; Ryoo J, 2014, NAT MED, V20, P936, DOI 10.1038/nm.3626; Spencer JD, 2013, KIDNEY INT, V83, P615, DOI 10.1038/ki.2012.410; Stremlau M, 2006, P NATL ACAD SCI USA, V103, P5514, DOI 10.1073/pnas.0509996103; Surasombatpattana P, 2011, INFECT GENET EVOL, V11, P1664, DOI 10.1016/j.meegid.2011.06.009; Tugizov SM, 2011, VIROLOGY, V409, P211, DOI 10.1016/j.virol.2010.10.004; Vazquez-Perez JA, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-23; Walker BD, 2007, TOP HIV MED, V15, P134; Walker NJ, 2002, SCIENCE, V296, P557, DOI 10.1126/science.296.5567.557; Wang YW, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0094548, 10.1371/journal.pone.0091307, 10.1371/journal.pone.0095143]; Yap MW, 2005, CURR BIOL, V15, P73, DOI 10.1016/j.cub.2004.12.042; Young JM, 2011, AIDS RES HUM RETROV, V27, P737, DOI [10.1089/aid.2010.0313, 10.1089/AID.2010.0313]; Zapata W, 2008, CURR HIV RES, V6, P531, DOI 10.2174/157016208786501463; Zapata Wildeman, 2006, Biomed., V26, P451; Zhang LJ, 2010, ELECTROPHORESIS, V31, P3437, DOI 10.1002/elps.201000153	33	12	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2015	10	6							e0131139	10.1371/journal.pone.0131139	http://dx.doi.org/10.1371/journal.pone.0131139			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL3FE	26091527	Green Submitted, Green Published, gold			2022-12-26	WOS:000356835000172
J	Perez-Delgado, CM; Garcia-Calderon, M; Marquez, AJ; Betti, M				Perez-Delgado, Carmen M.; Garcia-Calderon, Margarita; Marquez, Antonio J.; Betti, Marco			Reassimilation of Photorespiratory Ammonium in Lotus japonicus lePlants Deficient in Plastidic Glutamine Synthetase	PLOS ONE			English	Article							GENE FAMILY; ASPARAGINE SYNTHETASE; MEDICAGO-TRUNCATULA; FUNCTIONAL GENOMICS; COLORIMETRIC ASSAY; PLANT-GROWTH; NITROGEN; ARABIDOPSIS; DEHYDROGENASE; ASSIMILATION	It is well established that the plastidic isoform of glutamine synthetase (GS(2)) is the enzyme in charge of photorespiratory ammonium reassimilation in plants. The metabolic events associated to photorespiratory NH4+ accumulation were analyzed in a Lotus japonicus photorespiratory mutant lacking GS(2). The mutant plants accumulated high levels of NH4+ when photorespiration was active, followed by a sudden drop in the levels of this compound. In this paper it was examined the possible existence of enzymatic pathways alternative to GS(2) that could account for this decline in the photorespiratory ammonium. Induction of genes encoding for cytosolic glutamine synthetase (GS(1)), glutamate dehydrogenase (GDH) and asparagine synthetase (ASN) was observed in the mutant in correspondence with the diminishment of NH4+. Measurements of gene expression, polypeptide levels, enzyme activity and metabolite levels were carried out in leaf samples from WT and mutant plants after different periods of time under active photorespiratory conditions. In the case of asparagine synthetase it was not possible to determine enzyme activity and polypeptide content; however, an increased asparagine content in parallel with the induction of ASN gene expression was detected in the mutant plants. This increase in asparagine levels took place concomitantly with an increase in glutamine due to the induction of cytosolic GS(1) in the mutant, thus revealing a major role of cytosolic GS(1) in the reassimilation and detoxification of photorespiratory NH4+ when the plastidic GS(2) isoform is lacking. Moreover, a diminishment in glutamate levels was observed, that may be explained by the induction of NAD (H)-dependent GDH activity.	[Perez-Delgado, Carmen M.; Garcia-Calderon, Margarita; Marquez, Antonio J.; Betti, Marco] Univ Seville, Fac Quim, Dept Bioquim Vegetal & Biol Mol, E-41071 Seville, Spain	University of Sevilla	Betti, M (corresponding author), Univ Seville, Fac Quim, Dept Bioquim Vegetal & Biol Mol, Calle Prof Garcia Gonzalez, E-41071 Seville, Spain.	mbetti@us.es	García-Calderón, Margarita/G-9395-2018; Marquez, Antonio/L-6570-2014; Betti, Marco/E-6304-2010	García-Calderón, Margarita/0000-0003-3595-3963; Marquez, Antonio/0000-0001-7254-1496; Betti, Marco/0000-0002-7334-5734; Perez-Delgado, Carmen M/0000-0002-2445-4547	Consejeria de Economia, Innovacion y Ciencia, Junta de Andalucia [P1O-CVI-6368, BIO-163]; Spanish Ministerio de Economia y Competitividad [AGL2014-54413-R]; University of Seville	Consejeria de Economia, Innovacion y Ciencia, Junta de Andalucia(Junta de Andalucia); Spanish Ministerio de Economia y Competitividad(Spanish Government); University of Seville	This work was supported by project P1O-CVI-6368 and BIO-163 support from Consejeria de Economia, Innovacion y Ciencia, Junta de Andalucia (http://www.juntadeandalucia.es/organismos/economiainnovacioncienciayempleo.htmThis work was supported by project P1O-CVI-6368 and BIO-163 support from Consejeria de Economia, Innovacion y Ciencia, Junta de Andalucia (http://www.juntadeandalucia.es/organismos/economiainnovacioncienciayempleo.html) and by the project AGL2014-54413-R from Spanish Ministerio de Economia y Competitividad (http://www.mineco.gob.es/). CMP acknowledges the support of PIF and V Plan Propio fellowships from the University of Seville (www.us.es). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews M, 2013, ANN APPL BIOL, V163, P174, DOI 10.1111/aab.12045; Araujo WL, 2010, PLANT CELL, V22, P1549, DOI 10.1105/tpc.110.075630; Araujo WL, 2014, PLANT SCI, V15, P552; Azevedo RA, 2006, AMINO ACIDS, V30, P143, DOI 10.1007/s00726-005-0245-2; Bernard SM, 2009, NEW PHYTOL, V182, P608, DOI 10.1111/j.1469-8137.2009.02823.x; Betti M, 2002, THERMOCHIM ACTA, V394, P63, DOI 10.1016/S0040-6031(02)00239-3; Betti M, 2006, PLANTA, V224, P1068, DOI 10.1007/s00425-006-0279-z; Betti M, 2014, J EXP BOT, V65, P5557, DOI 10.1093/jxb/eru260; Betti M, 2012, INT J MOL SCI, V13, P7994, DOI 10.3390/ijms13077994; BLACKWELL RD, 1987, J EXP BOT, V38, P1799, DOI 10.1093/jxb/38.11.1799; Britto DT, 2002, J PLANT PHYSIOL, V159, P567, DOI 10.1078/0176-1617-0774; Canas RA, 2006, PLANTA, V224, P83, DOI 10.1007/s00425-005-0196-6; Castro-Rodriguez V, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-014-0365-5; Castro-Rodriguez V, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-119; Credali A, 2013, PLANT CELL PHYSIOL, V54, P107, DOI 10.1093/pcp/pcs156; Czechowski T, 2004, PLANT J, V38, P366, DOI 10.1111/j.1365-313X.2004.02051.x; DOREMUS HD, 1986, ARCH BIOCHEM BIOPHYS, V250, P112, DOI 10.1016/0003-9861(86)90707-1; Fernie AR, 2013, PLANT BIOLOGY, V15, P748, DOI 10.1111/j.1438-8677.2012.00693.x; Fontaine JX, 2013, PLANT SIGNAL BEHAV, V8, DOI 10.4161/psb.23329; Fontaine JX, 2012, PLANT CELL, V24, P4044, DOI 10.1105/tpc.112.103689; Forde BG, 2007, J EXP BOT, V58, P2339, DOI 10.1093/jxb/erm121; Gutierrez RA, 2012, SCIENCE, V336, P1673, DOI 10.1126/science.1217620; HANDBERG K, 1992, PLANT J, V2, P487, DOI 10.1111/j.1365-313X.1992.00487.x; Hodges M, 2002, J EXP BOT, V53, P905, DOI 10.1093/jexbot/53.370.905; Husted S, 2002, PLANT PHYSIOL, V130, P989, DOI 10.1104/pp.006759; Krapp A, 2014, J EXP BOT, V65, P789, DOI 10.1093/jxb/eru001; Labboun S, 2009, PLANT CELL PHYSIOL, V50, P1761, DOI 10.1093/pcp/pcp118; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lea PJ, 2007, ANN APPL BIOL, V150, P1, DOI 10.1111/j.1744-7348.2006.00104.x; Li BH, 2014, TRENDS PLANT SCI, V19, P107, DOI 10.1016/j.tplants.2013.09.004; Lothier J, 2011, J EXP BOT, V62, P1375, DOI 10.1093/jxb/erq299; LOULAKAKIS CA, 1990, PLANT PHYSIOL, V94, P109, DOI 10.1104/pp.94.1.109; LOULAKAKIS KA, 1991, PLANT PHYSIOL, V97, P104, DOI 10.1104/pp.97.1.104; Marquez AJ, 2005, LOTUS JAPONICUS HANDBOOK, P315, DOI 10.1007/1-4020-3735-X_31; Masclaux-Daubresse C, 2006, PLANT PHYSIOL, V140, P444, DOI 10.1104/pp.105.071910; Masclaux-Daubresse C, 2010, ANN BOT-LONDON, V105, P1141, DOI 10.1093/aob/mcq028; Molla-Morales A, 2011, PLANT J, V65, P335, DOI 10.1111/j.1365-313X.2010.04425.x; Oliveira IC, 2002, PLANT PHYSIOL, V129, P1170, DOI 10.1104/pp.020013; Orea A, 2001, PHYSIOL PLANTARUM, V113, P193, DOI 10.1034/j.1399-3054.2001.1130206.x; Perez-Delgado CM, 2013, PLANT PHYSIOL, V162, P1834, DOI 10.1104/pp.113.217216; Perez-Garcia A, 1998, PLANTA, V206, P426, DOI 10.1007/s004250050418; PIERSON DL, 1980, J BIOCHEM BIOPH METH, V3, P31, DOI 10.1016/0165-022X(80)90004-4; Potel F, 2009, FEBS J, V276, P4061, DOI 10.1111/j.1742-4658.2009.07114.x; Saeed AI, 2006, METHOD ENZYMOL, V411, P134, DOI 10.1016/S0076-6879(06)11009-5; Sanchez DH, 2008, PLANT J, V53, P973, DOI 10.1111/j.1365-313X.2007.03381.x; Sarasketa A, 2014, J EXP BOT, V65, P6023, DOI 10.1093/jxb/eru342; Seabra AR, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-137; Seabra AR, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-183; Setien I, 2013, J PLANT PHYSIOL, V170, P758, DOI 10.1016/j.jplph.2012.12.015; SHENG SJ, 1993, ANAL BIOCHEM, V211, P242, DOI 10.1006/abio.1993.1264; Skopelitis DS, 2006, PLANT CELL, V18, P2767, DOI 10.1105/tpc.105.038323; Slocum RD, 2005, PLANT PHYSIOL BIOCH, V43, P729, DOI 10.1016/j.plaphy.2005.06.007; Solorzano L., 1969, OCEAN LIMNO OCEANOGR, V14, P799, DOI DOI 10.4319/LO.1969.14.5.0799; Terce-Laforgue T, 2013, PLANT CELL PHYSIOL, V54, P1635, DOI 10.1093/pcp/pct108; Thomsen HC, 2014, TRENDS PLANT SCI, V19, P656, DOI 10.1016/j.tplants.2014.06.002; Udvardi M, 2013, ANNU REV PLANT BIOL, V64, P781, DOI 10.1146/annurev-arplant-050312-120235; WALLSGROVE RM, 1987, PLANT PHYSIOL, V83, P155, DOI 10.1104/pp.83.1.155; Waterhouse RN, 1996, PLANT MOL BIOL, V30, P883, DOI 10.1007/BF00020801; Yamaya T, 2014, J EXP BOT, V65, P5519, DOI 10.1093/jxb/eru103	59	23	23	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2015	10	6							e0130438	10.1371/journal.pone.0130438	http://dx.doi.org/10.1371/journal.pone.0130438			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL3FE	26091523	Green Published, gold			2022-12-26	WOS:000356835000118
J	Shimayoshi, T; Cha, CY; Amano, A				Shimayoshi, Takao; Cha, Chae Young; Amano, Akira			Quantitative Decomposition of Dynamics of Mathematical Cell Models: Method and Application to Ventricular Myocyte Models	PLOS ONE			English	Article							SINOATRIAL NODE PACEMAKING; PANCREATIC BETA-CELLS; CURRENT I-F; BIFURCATION ANALYSES; INTRACELLULAR NA+; IONIC MECHANISMS; INSIGHTS; CA2+; ROLES; SIMULATION	Mathematical cell models are effective tools to understand cellular physiological functions precisely. For detailed analysis of model dynamics in order to investigate how much each component affects cellular behaviour, mathematical approaches are essential. This article presents a numerical analysis technique, which is applicable to any complicated cell model formulated as a system of ordinary differential equations, to quantitatively evaluate contributions of respective model components to the model dynamics in the intact situation. The present technique employs a novel mathematical index for decomposed dynamics with respect to each differential variable, along with a concept named instantaneous equilibrium point, which represents the trend of a model variable at some instant. This article also illustrates applications of the method to comprehensive myocardial cell models for analysing insights into the mechanisms of action potential generation and calcium transient. The analysis results exhibit quantitative contributions of individual channel gating mechanisms and ion exchanger activities to membrane repolarization and of calcium fluxes and buffers to raising and descending of the cytosolic calcium level. These analyses quantitatively explicate principle of the model, which leads to a better understanding of cellular dynamics.	[Shimayoshi, Takao] Kyoto Univ, Grad Sch Informat, Kyoto, Japan; [Cha, Chae Young] Univ Oxford, Oxford Ctr Diabet Endocrinol & Metab, Oxford, England; [Amano, Akira] Ritsumeikan Univ, Coll Life Sci, Kusatsu, Shiga, Japan	Kyoto University; University of Oxford; Ritsumeikan University	Shimayoshi, T (corresponding author), Kyoto Univ, Grad Sch Informat, Kyoto, Japan.	simayosi@i.kyoto-u.ac.jp	Shimayoshi, Takao/R-1106-2019; Fontes, Marcos Roberto/B-1941-2009	Shimayoshi, Takao/0000-0001-8187-9915; Fontes, Marcos Roberto/0000-0002-4634-6221	Biomedical Cluster Kansai project of the Ministry of Education, Culture, Sports, Science, and Technology of Japan; Grants-in-Aid for Scientific Research [26540028, 26350520] Funding Source: KAKEN	Biomedical Cluster Kansai project of the Ministry of Education, Culture, Sports, Science, and Technology of Japan; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Biomedical Cluster Kansai project of the Ministry of Education, Culture, Sports, Science, and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Biktashev VN, 2008, B MATH BIOL, V70, P517, DOI 10.1007/s11538-007-9267-0; Biktashev VN, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.168103; Biltasheva I, 2006, PHILOS T R SOC A, V364, P1283, DOI 10.1098/rsta.2006.1770; Cha CY, 2011, PROG BIOPHYS MOL BIO, V107, P265, DOI 10.1016/j.pbiomolbio.2011.08.001; Cha CY, 2011, J GEN PHYSIOL, V138, P21, DOI 10.1085/jgp.201110611; Cha CY, 2009, BIOPHYS J, V97, P3086, DOI 10.1016/j.bpj.2009.08.060; Clewley R, 2005, MULTISCALE MODEL SIM, V4, P732, DOI 10.1137/040615535; Clewley R, 2011, J COMPUT NEUROSCI, V30, P391, DOI 10.1007/s10827-010-0267-y; Grandi E, 2010, J MOL CELL CARDIOL, V48, P112, DOI 10.1016/j.yjmcc.2009.09.019; Himeno Y, 2011, AM J PHYSIOL-HEART C, V300, pH251, DOI 10.1152/ajpheart.00764.2010; Kurata Y, 2005, BIOPHYS J, V89, P2865, DOI 10.1529/biophysj.105.060830; Kurata Y, 2003, AM J PHYSIOL-HEART C, V285, pH2804, DOI 10.1152/ajpheart.01050.2002; Kurata Y, 2008, BIOPHYS J, V95, P951, DOI 10.1529/biophysj.107.112854; Kurata Y, 2007, AM J PHYSIOL-HEART C, V292, pH701, DOI 10.1152/ajpheart.00426.2006; Kurata Y, 2013, AM J PHYSIOL-HEART C, V304, pH1337, DOI 10.1152/ajpheart.00777.2012; Kurata Y, 2012, AM J PHYSIOL-HEART C, V302, pH2285, DOI 10.1152/ajpheart.00221.2011; Kurata Y, 2010, AM J PHYSIOL-HEART C, V298, pH1748, DOI 10.1152/ajpheart.00729.2009; Kuzumoto M, 2008, PROG BIOPHYS MOL BIO, V96, P171, DOI 10.1016/j.pbiomolbio.2007.07.005; Niederer SA, 2007, BIOPHYS J, V92, P4030, DOI 10.1529/biophysj.106.095463; O'Hara T, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002061; Priebe L, 1998, CIRC RES, V82, P1206, DOI 10.1161/01.RES.82.11.1206; Suckley R, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.011902; Takeuchi A, 2006, J GEN PHYSIOL, V128, P495, DOI 10.1085/jgp.200609646; ten Tusscher KHWJ, 2004, AM J PHYSIOL-HEART C, V286, pH1573, DOI 10.1152/ajpheart.00794.2003	24	3	3	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2015	10	6							e0124970	10.1371/journal.pone.0124970	http://dx.doi.org/10.1371/journal.pone.0124970			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL3FE	26091413	Green Published, gold, Green Submitted			2022-12-26	WOS:000356835000005
J	Wethmar, K; Schulz, J; Muro, EM; Talyan, S; Andrade-Navarro, MA; Leutz, A				Wethmar, K.; Schulz, J.; Muro, E. M.; Talyan, S.; Andrade-Navarro, M. A.; Leutz, A.			Comprehensive translational control of tyrosine kinase expression by upstream open reading frames	ONCOGENE			English	Article							INITIATION; DATABASE; GENE; CENSUS	Post-transcriptional control has emerged as a major regulatory event in gene expression and often occurs at the level of translation initiation. Although overexpression or constitutive activation of tyrosine kinases (TKs) through gene amplification, translocation or mutation are well-characterized oncogenic events, current knowledge about translational mechanisms of TK activation is scarce. Here, we report the presence of translational cis-regulatory upstream open reading frames (uORFs) in the majority of transcript leader sequences of human TK mRNAs. Genetic ablation of uORF initiation codons in TK transcripts resulted in enhanced translation of the associated downstream main protein-coding sequences (CDSs) in all cases studied. Similarly, experimental removal of uORF start codons in additional non-TK proto-oncogenes, and naturally occurring loss-of-uORF alleles of the c-met proto-oncogene (MET) and the kinase insert domain receptor (KDR), was associated with increased CDS translation. Based on genome-wide sequence analyses we identified polymorphisms in 15.9% of all human genes affecting uORF initiation codons, associated Kozak consensus sequences or uORF-related termination codons. Together, these data suggest a comprehensive role of uORF-mediated translational control and delineate how aberrant induction of proto-oncogenes through loss-of-function mutations at uORF initiation codons may be involved in the etiology of cancer. We provide a detailed map of uORFs across the human genome to stimulate future research on the pathogenic role of uORFs.	[Wethmar, K.; Schulz, J.; Leutz, A.] Max Delbrueck Ctr Mol Med, Dept Cell Differentiat & Tumorigenesis, Berlin, Germany; [Wethmar, K.] Univ Hosp Muenster, Dept Hematol Oncol & Pneumol, Albert Schweitzer Campus 1, D-48149 Munster, Germany; [Muro, E. M.; Andrade-Navarro, M. A.] Max Delbrueck Ctr Mol Med, Dept Computat Biol & Data Min, Berlin, Germany; [Muro, E. M.; Talyan, S.; Andrade-Navarro, M. A.] Johannes Gutenberg Univ Mainz, Dept Biol, Inst Mol Biol, D-55122 Mainz, Germany; [Leutz, A.] Humboldt Univ, Dept Biol, Berlin, Germany	Helmholtz Association; Max Delbruck Center for Molecular Medicine; University of Munster; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Institute of Molecular Biology (IMB); Johannes Gutenberg University of Mainz; Humboldt University of Berlin	Wethmar, K (corresponding author), Univ Hosp Muenster, Dept Hematol Oncol & Pneumol, Albert Schweitzer Campus 1, D-48149 Munster, Germany.	klaus.wethmar@ukmuenster.de	Wethmar, Klaus/AAQ-7085-2021; Leutz, Achim/K-9643-2013; Talyan, Sweta/AAR-1436-2021; Muro, Enrique M./AAX-3698-2021	Leutz, Achim/0000-0001-8259-927X; Talyan, Sweta/0000-0002-7160-6742; 	Deutsche Krebshilfe e.V., Bonn, Germany [110525]	Deutsche Krebshilfe e.V., Bonn, Germany(Deutsche Krebshilfe)	This work was supported by the Deutsche Krebshilfe e.V., Bonn, Germany (grant 110525 to KW and AL).	Barbosa C, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003529; Calkhoven CF, 2000, GENE DEV, V14, P1920; Calvo SE, 2009, P NATL ACAD SCI USA, V106, P7507, DOI 10.1073/pnas.0810916106; Chen HY, 2012, J MOL NEUROSCI, V47, P448, DOI 10.1007/s12031-012-9705-9; Churbanov A, 2005, NUCLEIC ACIDS RES, V33, P5512, DOI 10.1093/nar/gki847; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Glubb DM, 2011, CLIN CANCER RES, V17, P5257, DOI 10.1158/1078-0432.CCR-11-0379; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Hampf M, 2006, ANAL BIOCHEM, V356, P94, DOI 10.1016/j.ab.2006.04.046; Iacono M, 2005, GENE, V349, P97, DOI 10.1016/j.gene.2004.11.041; Ingolia NT, 2009, SCIENCE, V324, P218, DOI 10.1126/science.1168978; Ivanov IP, 2010, P NATL ACAD SCI USA, V107, P18056, DOI 10.1073/pnas.1009269107; Jackson RJ, 2012, ADV PROTEIN CHEM STR, V86, P45, DOI [10.1016/B978-0-12-386497-0.00002-5, 10.1016/B978-0-12.386497.000002-5]; Jin XP, 2003, J BIOL CHEM, V278, P25716, DOI 10.1074/jbc.M300316200; Kozak M, 2002, GENE, V299, P1, DOI 10.1016/S0378-1119(02)01056-9; Krause DS, 2005, NEW ENGL J MED, V353, P172, DOI 10.1056/NEJMra044389; Lee S, 2012, P NATL ACAD SCI USA, V109, pE2424, DOI 10.1073/pnas.1207846109; Liu L, 1999, NAT GENET, V21, P128, DOI 10.1038/5082; Mendell JT, 2004, NAT GENET, V36, P1073, DOI 10.1038/ng1429; Michel AM, 2014, NUCLEIC ACIDS RES, V42, pD859, DOI 10.1093/nar/gkt1035; Occhi G, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003350; Pabst S, 2010, CHEST, V137, P156, DOI 10.1378/chest.09-1003; Pruitt KD, 2014, NUCLEIC ACIDS RES, V42, pD756, DOI 10.1093/nar/gkt1114; Rosenbloom KR, 2015, NUCLEIC ACIDS RES, V43, pD670, DOI 10.1093/nar/gku1177; Santarius T, 2010, NAT REV CANCER, V10, P59, DOI 10.1038/nrc2771; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Somers J, 2013, INT J BIOCHEM CELL B, V45, P1690, DOI 10.1016/j.biocel.2013.04.020; Spevak CC, 2006, BIOCHEM BIOPH RES CO, V350, P834, DOI 10.1016/j.bbrc.2006.09.128; Uzunoglu FG, 2013, ANN ONCOL, V24, P1282, DOI 10.1093/annonc/mds634; Wethmar K, 2014, WIRES RNA, V5, P765, DOI 10.1002/wrna.1245; Wethmar K, 2014, NUCLEIC ACIDS RES, V42, pD60, DOI 10.1093/nar/gkt952; Wethmar K, 2010, BIOESSAYS, V32, P885, DOI 10.1002/bies.201000037	32	22	22	1	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 31	2016	35	13					1736	1742		10.1038/onc.2015.233	http://dx.doi.org/10.1038/onc.2015.233			7	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DH8RP	26096937	hybrid, Green Published, Green Accepted			2022-12-26	WOS:000373064200012
J	Montes, J; Pena, JM; DeFelipe, J; Herreras, O; Merchan-Perez, A				Montes, Jesus; Pena, Jose M.; DeFelipe, Javier; Herreras, Oscar; Merchan-Perez, Angel			The Influence of Synaptic Size on AMPA Receptor Activation: A Monte Carlo Model	PLOS ONE			English	Article							DENDRITIC SPINES; NMDA RECEPTORS; GLUTAMATERGIC SYNAPSES; PYRAMIDAL NEURON; DIFFUSION; SPIKES; VARIABILITY; MODULATION; EXPRESSION; MICROSCOPY	Physiological and electron microscope studies have shown that synapses are functionally and morphologically heterogeneous and that variations in size of synaptic junctions are related to characteristics such as release probability and density of postsynaptic AMPA receptors. The present article focuses on how these morphological variations impact synaptic transmission. We based our study on Monte Carlo computational simulations of simplified model synapses whose morphological features have been extracted from hundreds of actual synaptic junctions reconstructed by three-dimensional electron microscopy. We have examined the effects that parameters such as synaptic size or density of AMPA receptors have on the number of receptors that open after release of a single synaptic vesicle. Our results indicate that the maximum number of receptors that will open after the release of a single synaptic vesicle may show a ten-fold variation in the whole population of synapses. When individual synapses are considered, there is also a stochastical variability that is maximal in small synapses with low numbers of receptors. The number of postsynaptic receptors and the size of the synaptic junction are the most influential parameters, while the packing density of receptors or the concentration of extrasynaptic transporters have little or no influence on the opening of AMPA receptors.	[Montes, Jesus; Pena, Jose M.; Merchan-Perez, Angel] Univ Politecn Madrid, Fac Informat, Dept Arquitectura & Tecnol Sistemas Informat, Madrid, Spain; [DeFelipe, Javier; Merchan-Perez, Angel] Univ Politecn Madrid, Ctr Tecnol Biomed, Lab Cajal Circuitos Corticales, Madrid, Spain; [DeFelipe, Javier; Herreras, Oscar] CSIC, Inst Cajal, Madrid, Spain	Universidad Politecnica de Madrid; Universidad Politecnica de Madrid; Centro de Tecnologia Biomedica (CTB); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Cajal (IC)	Montes, J (corresponding author), Univ Politecn Madrid, Fac Informat, Dept Arquitectura & Tecnol Sistemas Informat, Madrid, Spain.	jmontes@fi.upm.es	Merchan-Perez, Angel/AAY-8947-2020; DEFELIPE, JAVIER/D-1195-2014; Montes, Jesus/AAF-2479-2021; Herreras, Oscar/O-1711-2019; Merchan-Perez, Angel/D-7417-2014; herreras, oscar/D-5256-2016	Merchan-Perez, Angel/0000-0002-7228-5821; DEFELIPE, JAVIER/0000-0001-5484-0660; Montes, Jesus/0000-0002-1454-4784; Herreras, Oscar/0000-0002-8210-3710; Merchan-Perez, Angel/0000-0002-7228-5821; herreras, oscar/0000-0002-8210-3710; Pena, Jose Maria/0000-0002-3303-0455	Spanish Ministry of Economy and Competitiveness (NAVAN project); Spanish Ministry of Economy and Competitiveness [BFU2012-34963]; Centro de Investigacion Biomedica en Red (CIBERNED) [CB06/05/0066]; Cajal Blue Brain Project, Spanish partner of the Blue Brain Project initiative from EPFL; European Union [604102]	Spanish Ministry of Economy and Competitiveness (NAVAN project); Spanish Ministry of Economy and Competitiveness(Spanish Government); Centro de Investigacion Biomedica en Red (CIBERNED); Cajal Blue Brain Project, Spanish partner of the Blue Brain Project initiative from EPFL; European Union(European Commission)	This work was supported by Spanish Ministry of Economy and Competitiveness (NAVAN project and BFU2012-34963, http://www.mineco.gob.es/(JM JMP JDF)); Centro de Investigacion Biomedica en Red (CIBERNED) (CB06/05/0066, http://ciberned.es/(JDF)); Cajal Blue Brain Project, Spanish partner of the Blue Brain Project initiative from EPFL (http://cajalbbp.cesvima.upm.es/(JM)); and the European Union Seventh Framework Programme (FP7/2007-2013) under grant agreement no. 604102, Human Brain Project (JMP JDF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews SS, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000705; Anton-Sanchez L, 2014, FRONT NEUROANAT, V8, DOI 10.3389/fnana.2014.00085; Araya R, 2014, FRONT NEUROANAT, V8, DOI 10.3389/fnana.2014.00141; Arellano JI, 2007, FRONT NEUROSCI-SWITZ, V1, P131, DOI 10.3389/neuro.01.1.1.010.2007; Bates D., 1988, NONLINEAR REGRESSION; Bates D.M., 1992, STAT MODELS S; Bergles DE, 2002, J NEUROSCI, V22, P10153; Bouteiller Jean-Marie C., 2008, Journal of Integrative Neuroscience, V7, P185, DOI 10.1142/S0219635208001770; Canals S, 2005, J NEUROPHYSIOL, V93, P909, DOI 10.1152/jn.00686.2004; Chen WR, 1997, SCIENCE, V278, P463, DOI 10.1126/science.278.5337.463; ELKAREH AW, 1993, BIOPHYS J, V64, P1638, DOI 10.1016/S0006-3495(93)81532-7; Eyal G, 2014, J NEUROSCI, V34, P8063, DOI 10.1523/JNEUROSCI.5431-13.2014; Franks KM, 2002, BIOPHYS J, V83, P2333, DOI 10.1016/S0006-3495(02)75248-X; Fukazawa Y, 2012, CURR OPIN NEUROBIOL, V22, P446, DOI 10.1016/j.conb.2012.01.006; Ganeshina O, 2004, NEUROSCIENCE, V125, P615, DOI 10.1016/j.neuroscience.2004.02.025; Ganeshina O, 2004, J COMP NEUROL, V468, P86, DOI 10.1002/cne.10950; Granger AJ, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0136; Gulledge AT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036007; Harris Kristen M, 2012, Cold Spring Harb Perspect Biol, V4, DOI 10.1101/cshperspect.a005587; Hausser M, 1997, J PHYSIOL-LONDON, V501, P77; Herreras O, 2009, ADV ARTIFICIAL INTEL, P42; Ibarz JM, 2006, EUR J NEUROSCI, V23, P1219, DOI 10.1111/j.1460-9568.2006.04615.x; Kamondi A, 1998, J NEUROSCI, V18, P3919; Kasai H, 2010, TRENDS NEUROSCI, V33, P121, DOI 10.1016/j.tins.2010.01.001; Kessler JP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070791; Kharazia VN, 1999, J COMP NEUROL, V412, P292, DOI 10.1002/(SICI)1096-9861(19990920)412:2<292::AID-CNE8>3.0.CO;2-G; Lehre KP, 1998, J NEUROSCI, V18, P8751, DOI 10.1523/jneurosci.18-21-08751.1998; Lisman JE, 2007, NAT REV NEUROSCI, V8, P597, DOI 10.1038/nrn2191; Major G, 2013, ANNU REV NEUROSCI, V36, P1, DOI 10.1146/annurev-neuro-062111-150343; Marder E, 2011, NAT NEUROSCI, V14, P133, DOI 10.1038/nn.2735; Matsuzaki M, 2004, NATURE, V429, P761, DOI 10.1038/nature02617; Matz J, 2010, P NATL ACAD SCI USA, V107, P8836, DOI 10.1073/pnas.0906087107; Merchan-Perez A, 2014, CEREB CORTEX, V24, P1579, DOI 10.1093/cercor/bht018; Merchan-Perez A, 2009, FRONT NEUROANAT, V3, DOI 10.3389/neuro.05.018.2009; Momiyama A, 2003, J PHYSIOL-LONDON, V549, P75, DOI 10.1113/jphysiol.2002.033472; Montes J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068888; Morales J, 2013, FRONT NEUROANAT, V7, DOI 10.3389/fnana.2013.00020; Morales J, 2011, FRONT NEUROANAT, V5, DOI 10.3389/fnana.2011.00018; Murthy VN, 2001, NEURON, V32, P673, DOI 10.1016/S0896-6273(01)00500-1; Nielsen TA, 2004, NEURON, V42, P757, DOI 10.1016/j.neuron.2004.04.003; Noguchi J, 2011, J PHYSIOL-LONDON, V589, P2447, DOI 10.1113/jphysiol.2011.207100; Nusser Z, 1998, NEURON, V21, P545, DOI 10.1016/S0896-6273(00)80565-6; Peters A., 1991, FINE STRUCTURE NERVO; Plimpton SJ, 2005, J PHYS CONF SER, V16, P305, DOI 10.1088/1742-6596/16/1/042; Poirazi P, 2003, NEURON, V37, P989, DOI 10.1016/S0896-6273(03)00149-1; Rollenhagen A, 2015, BRAIN STRUCT FUNCT, V220, P3185, DOI 10.1007/s00429-014-0850-5; Rusakov DA, 1998, J NEUROSCI, V18, P3158; Rusakov DA, 2011, TRENDS NEUROSCI, V34, P359, DOI 10.1016/j.tins.2011.03.002; Santuy A, 2014, 1 HUM BRAIN PROJ SCH; Savtchenko LP, 2007, P NATL ACAD SCI USA, V104, P1823, DOI 10.1073/pnas.0606636104; Schikorski T, 1997, J NEUROSCI, V17, P5858; Shinohara Y, 2009, FRONT NEUROANAT, V3, DOI 10.3389/neuro.05.010.2009; Stiles Bartol, 2013, MCELL MONTECARLO SIM; Stiles JR, 2001, METH NE FRO NEUROSCI, P87; Sykova E, 2008, PHYSIOL REV, V88, P1277, DOI 10.1152/physrev.00027.2007; Takamori S, 2006, CELL, V127, P831, DOI 10.1016/j.cell.2006.10.030; Takumi Y, 1999, NAT NEUROSCI, V2, P618, DOI 10.1038/10172; Tarusawa E, 2009, J NEUROSCI, V29, P12896, DOI 10.1523/JNEUROSCI.6160-08.2009; Thorne RG, 2006, P NATL ACAD SCI USA, V103, P5567, DOI 10.1073/pnas.0509425103; Wei DS, 2001, SCIENCE, V293, P2272, DOI 10.1126/science.1061198; Zheng KY, 2008, BIOPHYS J, V95, P4584, DOI 10.1529/biophysj.108.129874	61	19	19	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2015	10	6							e0130924	10.1371/journal.pone.0130924	http://dx.doi.org/10.1371/journal.pone.0130924			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4OM	26107874	Green Published, Green Submitted, gold			2022-12-26	WOS:000356932500130
J	Chen, XQ; Zhu, L; Xin, L; Du, KX; Ran, XH; Cui, XY; Xiang, QJ; Zhang, HY; Xu, PZ; Wu, XJ				Chen, Xiaoqiong; Zhu, Ling; Xin, Long; Du, Kangxi; Ran, Xiuhua; Cui, Xiaoyun; Xiang, Quanju; Zhang, Hongyu; Xu, Peizhou; Wu, Xianjun			Rice stripe1-2 and stripe1-3 Mutants Encoding the Small Subunit of Ribonucleotide Reductase Are Temperature Sensitive and Are Required for Chlorophyll Biosynthesis	PLOS ONE			English	Article							EARLY LEAF DEVELOPMENT; CHLOROPLAST DEVELOPMENT; SUBCELLULAR-LOCALIZATION; VARIEGATION MUTANTS; GENETIC SYSTEM; NUCLEAR GENE; BIOGENESIS; PROTEIN; VIRESCENT-2; EXPRESSION	We induced mutants, stripe1-2 (st1-2) and stripe1-3(st1-3), from rice (Oryza sativa L.) Indica 9311 using Ethyl methanesulfonate (EMS). Both st1-2 and st1-3 mutants encoded the small subunit of ribonucleotide reductase 1 (RNRS1), differed in the location of the mutated base, and displayed white-stripe from the L2 stage through maturity. The mutants were sensitive to temperature, and their chlorophyll content increased with the increase in temperature; however, they did not revert to normal green leaf phenotype under field conditions. The mutant st1-2 showed loosely arranged thylakoid lamellar structure as compared with wild-type (WT) plants. Contrastingly, st1-3 displayed normal thylakoid lamellar structure, good agronomic traits, and higher yield than st1-2 but lower yield than WT. Three-dimensional structure prediction for RNRS1 indicated that the mutation in Val-171 residue in st1-2 influenced the connection of RNRS1 to iron, causing abnormal development of chloroplasts. Real-time PCR analysis showed that the expression levels associated with chlorophyll biosynthetic pathway and photosynthesis were affected in st1-2 and st1-3 at different temperatures and different developmental stages.	[Chen, Xiaoqiong; Zhu, Ling; Xin, Long; Du, Kangxi; Ran, Xiuhua; Cui, Xiaoyun; Zhang, Hongyu; Xu, Peizhou; Wu, Xianjun] Sichuan Agr Univ, Rice Res Inst, Key Lab Southwest Crop Genet Resources & Improvem, Minist Educ, Wenjiang 611130, Sichuan, Peoples R China; [Xiang, Quanju] Sichuan Agr Univ, Coll Resources, Wenjiang 611130, Sichuan, Peoples R China	Sichuan Agricultural University; Sichuan Agricultural University	Wu, XJ (corresponding author), Sichuan Agr Univ, Rice Res Inst, Key Lab Southwest Crop Genet Resources & Improvem, Minist Educ, 211 Huimin Rd, Wenjiang 611130, Sichuan, Peoples R China.	wuxjsau@126.com						Aluru MR, 2006, J EXP BOT, V57, P1871, DOI 10.1093/jxb/erj008; ARCHER EK, 1987, PLANT PHYSIOL, V83, P920, DOI 10.1104/pp.83.4.920; Carol P, 2001, TRENDS PLANT SCI, V6, P31, DOI 10.1016/S1360-1385(00)01811-2; Chi YH, 2008, PLANT PHYSIOL, V148, P808, DOI 10.1104/pp.108.123547; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; Fiser A, 2000, PROTEIN SCI, V9, P1753, DOI 10.1110/ps.9.9.1753; Gothandam KM, 2005, PLANT MOL BIOL, V58, P421, DOI 10.1007/s11103-005-5702-5; HAN CD, 1992, EMBO J, V11, P4037, DOI 10.1002/j.1460-2075.1992.tb05497.x; IBA K, 1991, DEV GENET, V12, P342, DOI 10.1002/dvg.1020120503; Jung KH, 2003, PLANT CELL PHYSIOL, V44, P463, DOI 10.1093/pcp/pcg064; Koussevitzky S, 2007, SCIENCE, V316, P715, DOI 10.1126/science. 1140516; Kusumi K, 2004, PLANT CELL PHYSIOL, V45, P1194, DOI 10.1093/pcp/pch133; Kusumi K, 1997, PLANT J, V12, P1241, DOI 10.1046/j.1365-313x.1997.12061241.x; Kusumi K, 2000, PLANT CELL PHYSIOL, V41, P158, DOI 10.1093/pcp/41.2.158; Kusumi K, 2011, PLANT J, V68, P1039, DOI 10.1111/j.1365-313X.2011.04755.x; LICHTENTHALER HK, 1987, METHOD ENZYMOL, V148, P350; Mandel MA, 1996, PLANT J, V9, P649, DOI 10.1046/j.1365-313X.1996.9050649.x; Miyoshi K, 2003, PLANT J, V36, P532, DOI 10.1046/j.1365-313X.2003.01897.x; Park SY, 2007, PLANT CELL, V19, P1649, DOI 10.1105/tpc.106.044891; Smith P, 2009, BIOCHEMISTRY-US, V48, P11134, DOI 10.1021/bi9001425; Sugimoto H, 2004, PLANT CELL PHYSIOL, V45, P985, DOI 10.1093/pcp/pch111; Sugimoto H, 2007, PLANT J, V52, P512, DOI 10.1111/j.1365-313X.2007.03251.x; Yao RJ, 2003, P NATL ACAD SCI USA, V100, P6628, DOI 10.1073/pnas.1131932100; Yu F, 2007, PLANT CELL ENVIRON, V30, P350, DOI 10.1111/j.1365-3040.2006.01630.x; Zhou KN, 2013, PLANTA, V237, P279, DOI 10.1007/s00425-012-1756-1	25	2	3	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2015	10	6							e0130172	10.1371/journal.pone.0130172	http://dx.doi.org/10.1371/journal.pone.0130172			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4DD	26102588	gold, Green Published, Green Submitted			2022-12-26	WOS:000356901900032
J	Kim, SJ; Myong, JP; Suh, H; Lee, KE; Youn, YK				Kim, Su-jin; Myong, Jun Pyo; Suh, Hyunsuk; Lee, Kyu Eun; Youn, Yeo-Kyu			Optimal Cutoff Age for Predicting Mortality Associated with Differentiated Thyroid Cancer	PLOS ONE			English	Article							PROGNOSTIC SCORING SYSTEM; RISK-GROUP; CARCINOMA; PAPILLARY; EPIDEMIOLOGY; SURVEILLANCE; MENOPAUSE; SURVIVAL; INDEX	Patient's age at the time of diagnosis is an important prognostic factor for differentiated thyroid cancer (DTC) as reflected in various staging and risk stratification systems. However, discrepancies exist among the different staging systems on an optimal cut-off age for predicting the clinical outcome of patients with DTC. To determine the age at diagnosis most predictive of clinical outcomes of DTC, a population-based cohort study was performed composed of 35,323 patients with DTC between 1988 and 2010 using the Surveillance, Epidemiology, and End Results (SEER) database. The Youden index J was used to determine the most predictive age-at-diagnosis for thyroid-cancer-specific death. The multivariate Cox proportional hazards model was used to determine the hazard ratios (HRs) for each age group. With a median follow-up of 5.4 years (range, 0-22.9 years), DTC-associated mortality was 1.5% (n = 533) and the rate of death from overall cause was 7.0% (n = 2482). The optimal cutoff age at diagnosis for thyroid-cancer-specific death was 57. Multivariate analysis found that the age-at-diagnosis is the most prognostic factor for thyroid-cancer-specific death (HR 10.02, 95% CI 8.18-12.28). Age at diagnosis is the most important prognostic factor for DTC patients. Based on our analysis, age at diagnosis of 57 might be the optimal predictor of thyroid-cancer-specific death. This finding might be used as consideration in revision of the risk stratification system for treatment of DTC patients.	[Kim, Su-jin; Lee, Kyu Eun; Youn, Yeo-Kyu] Seoul Natl Univ Hosp & Coll Med, Dept Surg, Seoul, South Korea; [Kim, Su-jin; Lee, Kyu Eun; Youn, Yeo-Kyu] Seoul Natl Univ, Coll Med, Canc Res Inst, Seoul, South Korea; [Kim, Su-jin; Lee, Kyu Eun; Youn, Yeo-Kyu] Seoul Natl Univ, Canc Hosp, Thyroid Ctr, Div Surg, Seoul, South Korea; [Myong, Jun Pyo] Catholic Univ, Seoul St Marys Hosp, Coll Med, Dept Occupat & Environm Med, Seoul, South Korea; [Suh, Hyunsuk] Mt Sinai Beth Israel Hosp, Icahn Sch Med Mt Sinai, Dept Surg, New York, NY USA	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Catholic University of Korea; Seoul St. Mary's Hospital; Icahn School of Medicine at Mount Sinai	Myong, JP (corresponding author), Catholic Univ, Seoul St Marys Hosp, Coll Med, Dept Occupat & Environm Med, Seoul, South Korea.	medical001@catholic.ac.kr; kyueunlee@snu.ac.kr	Kim, Su-jin/AAR-5059-2020; Myong, Jun-Pyo/M-7351-2019	Kim, Su-jin/0000-0001-5511-3596; Myong, Jun-Pyo/0000-0001-8674-1034				Bischoff LA, 2013, ENDOCR PRACT, V19, P995, DOI 10.4158/EP13029.OR; BYAR DP, 1979, EUR J CANCER, V15, P1033, DOI 10.1016/0014-2964(79)90291-3; CADY B, 1988, SURGERY, V104, P947; Cao HST, 2012, SURGERY, V152, P145, DOI 10.1016/j.surg.2012.02.015; Edge S, 2010, AJCC CANC STAGING HD; Eustatia-Rutten CFA, 2006, J CLIN ENDOCR METAB, V91, P313, DOI 10.1210/jc.2005-1322; Gilliland FD, 1997, CANCER-AM CANCER SOC, V79, P564, DOI 10.1002/(SICI)1097-0142(19970201)79:3<564::AID-CNCR20>3.0.CO;2-0; HAY ID, 1993, SURGERY, V114, P1050; HAY ID, 1987, SURGERY, V102, P1088; Hundahl SA, 1998, CANCER-AM CANCER SOC, V83, P2638, DOI 10.1002/(SICI)1097-0142(19981215)83:12<2638::AID-CNCR31>3.0.CO;2-1; In H, 2014, ANN SURG ONCOL, V21, P1520, DOI 10.1245/s10434-014-3516-x; Ito Y, 2014, ENDOCR J, V61, P491, DOI 10.1507/endocrj.EJ13-0529; Jonklaas J, 2012, J CLIN ENDOCR METAB, V97, pE878, DOI 10.1210/jc.2011-2864; Mazurat A, 2013, ENDOCR CONNECT, V2, DOI 10.1530/EC-13-0056; Mazzaferri EL, 2001, J CLIN ENDOCR METAB, V86, P1447, DOI 10.1210/jc.86.4.1447; MCKINLAY SM, 1992, MATURITAS, V14, P103, DOI 10.1016/0378-5122(92)90003-M; NOGUCHI S, 1994, WORLD J SURG, V18, P552, DOI 10.1007/BF00353763; Pellegriti G, 2013, J CANCER EPIDEMIOL, V2013, DOI 10.1155/2013/965212; Schisterman EF, 2005, EPIDEMIOLOGY, V16, P73, DOI 10.1097/01.ede.0000147512.81966.ba; SEER, SEER SURV EP END RES; SHAHA AR, 1994, SURGERY, V116, P1036; Sherman SI, 2003, LANCET, V361, P501, DOI 10.1016/S0140-6736(03)12488-9; Sherman SI, 1998, CANCER-AM CANCER SOC, V83, P1012; Weinstein M, 2003, AM J EPIDEMIOL, V158, P782, DOI 10.1093/aje/kwg223; Yang LM, 2013, J CLIN ONCOL, V31, P468, DOI 10.1200/JCO.2012.42.4457	25	22	25	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2015	10	6							e0130848	10.1371/journal.pone.0130848	http://dx.doi.org/10.1371/journal.pone.0130848			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4DD	26102084	Green Published, gold, Green Submitted			2022-12-26	WOS:000356901900063
J	Li, Z; Wu, N; Liu, T; Chen, H; Tang, M				Li, Zhen; Wu, Na; Liu, Ting; Chen, Hui; Tang, Ming			Sex-Related Responses of Populus cathayana Shoots and Roots to AM Fungi and Drought Stress	PLOS ONE			English	Article							ARBUSCULAR MYCORRHIZAL FUNGI; UV-B RADIATION; OXIDATIVE STRESS; OSMOTIC-STRESS; WATER-STRESS; SALT STRESS; FRUIT YIELD; GROWTH; METABOLISM; TOLERANCE	We investigated the impact of drought and arbuscular mycorrhizal (AM) fungi on the morphological structure and physiological function of shoots and roots of male and female seedlings of the dioecious plant Populus cathayana Rehder. Pot-grown seedlings were subjected to well watered or water-limiting conditions (drought) and were grown in soil that was either inoculated or not inoculated with the AM fungus Rhizophagus intraradices. No significant differences were found in the infection rates between the two sexes. Drought decreased root and shoot growth, biomass and root morphological characteristics, whereas superoxide radical (O-2-) and hydrogen peroxide content, peroxidase (POD) activity, malondialdehyde (MDA) concentration and proline content were significantly enhanced in both sexes. Male plants that formed an AM fungal symbiosis showed a significant increase in shoot and root morphological growth, increased proline content of leaves and roots, and increased POD activity in roots under both watering regimes; however, MDA concentration in the roots decreased. By contrast, AM fungi either had no effect or a slight negative effect on the shoot and root growth of female plants, with lower root biomass, total biomass and root/ shoot ration under drought. In females, MDA concentration increased in leaves and roots under both watering regimes, and the proline content and POD activity of roots increased under drought conditions; however, POD activity significantly decreased under well-watered conditions. These findings suggest that AM fungi enhanced the tolerance of male plants to drought by improving shoot and root growth, biomass and the antioxidant system. Further investigation is needed to unravel the complex effects of AM fungi on the growth and antioxidant system of female plants.	[Li, Zhen; Liu, Ting] Northwest A&F Univ, Coll Life Sci, Yangling, Peoples R China; [Wu, Na; Chen, Hui; Tang, Ming] Northwest A&F Univ, Coll Forestry, Yangling, Peoples R China	Northwest A&F University - China; Northwest A&F University - China	Tang, M (corresponding author), Northwest A&F Univ, Coll Forestry, Yangling, Peoples R China.	15109241277@163.com; tangm@nwsuaf.edu.cn		Tang, Ming/0000-0002-8158-6300	Special Fund for Forest Scientific Research in the Public Welfare [201404217]; National Natural Science Foundation of China [31270639, 31170567]; Program for Changjiang Scholars and Innovative Research Team in University of China [IRT1035]	Special Fund for Forest Scientific Research in the Public Welfare; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for Changjiang Scholars and Innovative Research Team in University of China(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT))	This research was supported by Special Fund for Forest Scientific Research in the Public Welfare (201404217, http://www.forestry.gov.cn/, MT), the National Natural Science Foundation of China (31270639 and 31170567, http://www.nsfc.gov.cn/, MT), the Program for Changjiang Scholars and Innovative Research Team in University of China (IRT1035, http://www.moe.gov.cn/, HC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Karaki G, 2004, MYCORRHIZA, V14, P263, DOI 10.1007/s00572-003-0265-2; Al-Karaki GN, 2001, J PLANT NUTR, V24, P1311, DOI 10.1081/PLN-100106983; Allen MF, 2007, VADOSE ZONE J, V6, P291, DOI 10.2136/vzj2006.0068; Aroca R, 2008, J EXP BOT, V59, P2029, DOI 10.1093/jxb/ern057; Ashraf M, 2007, ENVIRON EXP BOT, V59, P206, DOI 10.1016/j.envexpbot.2005.12.006; Auge RM, 2001, MYCORRHIZA, V11, P3, DOI 10.1007/s005720100097; Baslam M, 2012, MYCORRHIZA, V22, P347, DOI 10.1007/s00572-011-0408-9; BATES LS, 1973, PLANT SOIL, V39, P205, DOI 10.1007/BF00018060; Bearden BN, 2000, PLANT SOIL, V218, P173, DOI 10.1023/A:1014923911324; Bhargava S, 2004, J PLANT PHYSIOL, V161, P125, DOI 10.1078/0176-1617-01126; Chen J, 2014, FUNCT ECOL, V28, P124, DOI 10.1111/1365-2435.12180; Chen LH, 2014, TREES-STRUCT FUNCT, V28, P793, DOI 10.1007/s00468-014-0992-3; Fan QJ, 2011, ACTA PHYSIOL PLANT, V33, P1533, DOI 10.1007/s11738-011-0789-6; Flavel RJ, 2012, J EXP BOT, V63, P2503, DOI 10.1093/jxb/err421; Fujii H, 2011, P NATL ACAD SCI USA, V108, P1717, DOI 10.1073/pnas.1018367108; FUKAI S, 1995, FIELD CROP RES, V40, P67, DOI 10.1016/0378-4290(94)00096-U; GIOVANNETTI M, 1980, NEW PHYTOL, V84, P489, DOI 10.1111/j.1469-8137.1980.tb04556.x; Gong MG, 2013, NEW FOREST, V44, P399, DOI 10.1007/s11056-012-9349-1; Han Y, 2013, PLANT CELL ENVIRON, V36, P356, DOI 10.1111/j.1365-3040.2012.02578.x; Kanazawa S, 2000, PHYSIOL PLANTARUM, V109, P211, DOI 10.1034/j.1399-3054.2000.100214.x; Kapoor R., 2013, PLANT ACCLIMATION EN, P359, DOI [10.1007/978-1-4614-5001-6_14, DOI 10.1007/978-1-4614-5001-6_14]; Kishor PBK, 2005, CURR SCI INDIA, V88, P424; KRAMER GF, 1991, PHYTOCHEMISTRY, V30, P2101, DOI 10.1016/0031-9422(91)83595-C; Latef AAHA, 2011, SCI HORTIC-AMSTERDAM, V127, P228, DOI 10.1016/j.scienta.2010.09.020; Li Z, 2015, PHYSIOL PLANTARUM, V155, P192, DOI 10.1111/ppl.12336; Lin CC, 2000, PLANT GROWTH REGUL, V30, P151, DOI 10.1023/A:1006345126589; Liu T, 2014, ACTA PHYSIOL PLANT, V36, P871, DOI 10.1007/s11738-013-1465-9; Lu YW, 2014, CAN J FOREST RES, V44, P1020, DOI 10.1139/cjfr-2014-0009; Mittler R, 2002, TRENDS PLANT SCI, V7, P405, DOI 10.1016/S1360-1385(02)02312-9; Norman JR, 1996, PLANT SOIL, V185, P191, DOI 10.1007/BF02257524; Orlowska E, 2012, ENVIRON POLLUT, V168, P121, DOI 10.1016/j.envpol.2012.04.026; Passioura JB, 1996, PLANT GROWTH REGUL, V20, P79, DOI 10.1007/BF00024003; PHILLIPS JM, 1970, T BRIT MYCOL SOC, V55, P158, DOI 10.1016/S0007-1536(70)80110-3; Redecker D, 2000, MYCORRHIZA, V10, P73, DOI 10.1007/s005720000061; Regier N, 2009, PLANT CELL ENVIRON, V32, P1724, DOI 10.1111/j.1365-3040.2009.02030.x; Ruiz-Lozano JM, 2003, MYCORRHIZA, V13, P309, DOI 10.1007/s00572-003-0237-6; Ruiz-Lozano JM, 2006, NEW PHYTOL, V171, P693, DOI 10.1111/j.1469-8137.2006.01841.x; Verelst W, 2013, MOL PLANT, V6, P311, DOI 10.1093/mp/sss098; Wu QS, 2006, EUR J SOIL BIOL, V42, P166, DOI 10.1016/j.ejsobi.2005.12.006; Wu QS, 2006, J PLANT PHYSIOL, V163, P417, DOI 10.1016/j.jplph.2005.04.024; Xu X, 2008, PLANT CELL ENVIRON, V31, P850, DOI 10.1111/j.1365-3040.2008.01799.x; Xu XA, 2010, TREE PHYSIOL, V30, P1489, DOI 10.1093/treephys/tpq094; Yadav R, 1997, THEOR APPL GENET, V94, P619, DOI 10.1007/s001220050459; Yang F, 2009, PLANT SCI, V176, P669, DOI 10.1016/j.plantsci.2009.02.008; Yoshida S., 1982, Drought resistance in crops with emphasis on rice, P97; [张玲玲 ZHANG LingLing], 2006, [生态学报, Acta Ecologica Sinica], V26, P1330, DOI 10.1016/S1872-2032(06)60025-5; Zhang S, 2010, TREE PHYSIOL, V30, P116, DOI 10.1093/treephys/tpp094	47	15	16	3	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2015	10	6							e0128841	10.1371/journal.pone.0128841	http://dx.doi.org/10.1371/journal.pone.0128841			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4DD	26102587	Green Submitted, Green Published, gold			2022-12-26	WOS:000356901900008
J	Kosono, S; Tamura, M; Suzuki, S; Kawamura, Y; Yoshida, A; Nishiyama, M; Yoshida, M				Kosono, Saori; Tamura, Masaru; Suzuki, Shota; Kawamura, Yumi; Yoshida, Ayako; Nishiyama, Makoto; Yoshida, Minoru			Changes in the Acetylome and Succinylome of Bacillus subtilis in Response to Carbon Source	PLOS ONE			English	Article							A SYNTHETASE ACSA; LYSINE ACETYLATION; PROTEIN ACETYLATION; ESCHERICHIA-COLI; ACETATE KINASE; POSTTRANSLATIONAL MODIFICATION; METABOLIC ENZYMES; CRYSTAL-STRUCTURE; PYRUVATE OXIDASE; GENE POXB	Lysine residues can be post-translationally modified by various acyl modifications in bacteria and eukarya. Here, we showed that two major acyl modifications, acetylation and succinylation, were changed in response to the carbon source in the Gram-positive model bacterium Bacillus subtilis. Acetylation was more common when the cells were grown on glucose, glycerol, or pyruvate, whereas succinylation was upregulated when the cells were grown on citrate, reflecting the metabolic states that preferentially produce acetyl-CoA and succinyl-CoA, respectively. To identify and quantify changes in acetylation and succinylation in response to the carbon source, we performed a stable isotope labeling by amino acids in cell culture (SILAC)-based quantitative proteomic analysis of cells grown on glucose or citrate. We identified 629 acetylated proteins with 1355 unique acetylation sites and 204 succinylated proteins with 327 unique succinylation sites. Acetylation targeted different metabolic pathways under the two growth conditions: branched-chain amino acid biosynthesis and purine metabolism in glucose and the citrate cycle in citrate. Succinylation preferentially targeted the citrate cycle in citrate. Acetylation and succinylation mostly targeted different lysine residues and showed a preference for different residues surrounding the modification sites, suggesting that the two modifications may depend on different factors such as characteristics of acyl-group donors, molecular environment of the lysine substrate, and/or the modifying enzymes. Changes in acetylation and succinylation were observed in proteins involved in central carbon metabolism and in components of the transcription and translation machineries, such as RNA polymerase and the ribosome. Mutations that modulate protein acylation affected B. subtilis growth. A mutation in acetate kinase (ackA) increased the global acetylation level, suggesting that acetyl phosphate-dependent acetylation is common in B. subtilis, just as it is in Escherichia coli. Our results suggest that acyl modifications play a role in the physiological adaptations to changes in carbon nutrient availability of B. subtilis.	[Kosono, Saori; Tamura, Masaru; Suzuki, Shota; Yoshida, Ayako; Nishiyama, Makoto] Univ Tokyo, Biotechnol Res Ctr, Bunkyo Ku, Tokyo, Japan; [Kosono, Saori; Kawamura, Yumi; Yoshida, Minoru] RIKEN Ctr Sustainable Resource Sci, Wako, Saitama, Japan	University of Tokyo; RIKEN	Kosono, S (corresponding author), Univ Tokyo, Biotechnol Res Ctr, Bunkyo Ku, Tokyo, Japan.	uskos@mail.ecc.u-tokyo.ac.jp	Yoshida, Minoru/C-8049-2014	Yoshida, Minoru/0000-0002-4376-5674; Yoshida, Ayako/0000-0002-3668-9001; Nishiyama, Makoto/0000-0001-8143-8052	Kyowa Hakko Kirin Co., Ltd; Japan Society for the Promotion of Science, KAKENHI [21580105, 24580133]; Grants-in-Aid for Scientific Research [15K14685] Funding Source: KAKEN	Kyowa Hakko Kirin Co., Ltd(Kyowa Kirin Ltd); Japan Society for the Promotion of Science, KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Kyowa Hakko Kirin Co., Ltd (http://www.kyowa-kirin.com/index.html) to SK; and Japan Society for the Promotion of Science (http://www.jsps.go.jp/english/index.html), KAKENHI no. 21580105 and 24580133 to SK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AbouElfetouh A, 2015, MICROBIOLOGYOPEN, V4, P66, DOI 10.1002/mbo3.223; Buescher JM, 2012, SCIENCE, V335, P1099, DOI 10.1126/science.1206871; Caron C, 2005, BIOESSAYS, V27, P408, DOI 10.1002/bies.20210; Castano-Cerezo S, 2014, MOL SYST BIOL, V10, DOI 10.15252/msb.20145227; CHANG YY, 1983, J BACTERIOL, V154, P756, DOI 10.1128/JB.154.2.756-762.1983; Chen Y, 2007, MOL CELL PROTEOMICS, V6, P812, DOI 10.1074/mcp.M700021-MCP200; Chubukov V, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.66; Colaert N, 2009, NAT METHODS, V6, P786, DOI 10.1038/nmeth1109-786; Colak G, 2013, MOL CELL PROTEOMICS, V12, P3509, DOI 10.1074/mcp.M113.031567; Gardner JG, 2008, J BACTERIOL, V190, P5132, DOI 10.1128/JB.00340-08; Gardner JG, 2006, J BACTERIOL, V188, P5460, DOI 10.1128/JB.00215-06; Gardner JG, 2009, J BACTERIOL, V191, P1749, DOI 10.1128/JB.01674-08; Garrity J, 2007, J BIOL CHEM, V282, P30239, DOI 10.1074/jbc.M704409200; GRABAU C, 1984, J BACTERIOL, V160, P1088, DOI 10.1128/JB.160.3.1088-1092.1984; GRUNDY FJ, 1993, J BACTERIOL, V175, P7348, DOI 10.1128/JB.175.22.7348-7355.1993; Guan KL, 2011, TRENDS BIOCHEM SCI, V36, P108, DOI 10.1016/j.tibs.2010.09.003; Guan KL, 2010, NAT PROTOC, V5, P1583, DOI 10.1038/nprot.2010.117; Hirschey MD, 2015, MOL CELL PROTEOMICS, V14, P2308, DOI 10.1074/mcp.R114.046664; Hu LI, 2010, MOL MICROBIOL, V77, P15, DOI 10.1111/j.1365-2958.2010.07204.x; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Imamura D, 2004, J BACTERIOL, V186, P5450, DOI 10.1128/JB.186.16.5450-5459.2004; ITAYA M, 1989, NUCLEIC ACIDS RES, V17, P4410, DOI 10.1093/nar/17.11.4410; Jones JD, 2011, PROTEOMICS, V11, P3012, DOI 10.1002/pmic.201000812; Kim D, 2013, PROTEOMICS, V13, P1726, DOI 10.1002/pmic.201200001; Kim GW, 2011, TRENDS BIOCHEM SCI, V36, P211, DOI 10.1016/j.tibs.2010.10.001; Kuhn ML, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094816; Lee DW, 2013, PROTEOMICS, V13, P2278, DOI 10.1002/pmic.201200072; Liao GJ, 2014, J PROTEOMICS, V106, P260, DOI 10.1016/j.jprot.2014.04.017; Lima BP, 2012, J BIOL CHEM, V287, P32147, DOI 10.1074/jbc.M112.365502; Lima BP, 2011, MOL MICROBIOL, V81, P1190, DOI 10.1111/j.1365-2958.2011.07742.x; Liu FY, 2014, MOL CELL PROTEOMICS, V13, P3352, DOI 10.1074/mcp.M114.041962; Murakami KS, 2013, J BIOL CHEM, V288, P9126, DOI 10.1074/jbc.M112.430900; Nicolas P, 2012, SCIENCE, V335, P1103, DOI 10.1126/science.1206848; Okanishi H, 2014, MOL CELL PROTEOMICS, V13, P2382, DOI 10.1074/mcp.M113.035659; Okanishi H, 2013, J PROTEOME RES, V12, P3952, DOI 10.1021/pr400245k; Pan JY, 2014, J PROTEOME RES, V13, P3294, DOI 10.1021/pr500133t; Peng C, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.012658; Pericone CD, 2003, J BACTERIOL, V185, P6815, DOI 10.1128/JB.185.23.6815-6825.2003; Presecan-Siedel E, 1999, J BACTERIOL, V181, P6889, DOI 10.1128/JB.181.22.6889-6897.1999; Ramakrishnan R, 1998, P NATL ACAD SCI USA, V95, P4918, DOI 10.1073/pnas.95.9.4918; Ramos-Montanez S, 2010, J BACTERIOL, V192, P6390, DOI 10.1128/JB.00995-10; Rardin MJ, 2013, P NATL ACAD SCI USA, V110, P6601, DOI 10.1073/pnas.1302961110; Sadoul K, 2008, BIOCHIMIE, V90, P306, DOI 10.1016/j.biochi.2007.06.009; Sadoul K, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/970382; Schroder S, 2013, MOL CELL, V52, P314, DOI 10.1016/j.molcel.2013.10.009; Schwartz D, 2005, NAT BIOTECHNOL, V23, P1391, DOI 10.1038/nbt1146; Silva JC, 2006, MOL CELL PROTEOMICS, V5, P144, DOI 10.1074/mcp.M500230-MCP200; Starai VJ, 2002, SCIENCE, V298, P2390, DOI 10.1126/science.1077650; Tagami K, 2012, MICROBIOLOGYOPEN, V1, P115, DOI 10.1002/mbo3.16; Tan MJ, 2014, CELL METAB, V19, P605, DOI 10.1016/j.cmet.2014.03.014; Tan MJ, 2011, CELL, V146, P1015, DOI 10.1016/j.cell.2011.08.008; Thao S, 2011, CURR OPIN MICROBIOL, V14, P200, DOI 10.1016/j.mib.2010.12.013; Toda T, 1996, BIOSCI BIOTECH BIOCH, V60, P773, DOI 10.1271/bbb.60.773; VALLARI DS, 1987, J BIOL CHEM, V262, P2468; Vassylyev DG, 2002, NATURE, V417, P712, DOI 10.1038/nature752; Vizcaino JA, 2013, NUCLEIC ACIDS RES, V41, pD1063, DOI 10.1093/nar/gks1262; Wagner GR, 2013, J BIOL CHEM, V288, P29036, DOI 10.1074/jbc.M113.486753; Wang QJ, 2010, SCIENCE, V327, P1004, DOI 10.1126/science.1179687; WANNER BL, 1992, J BACTERIOL, V174, P2124, DOI 10.1128/JB.174.7.2124-2130.1992; Weinert BT, 2013, CELL REP, V4, P842, DOI 10.1016/j.celrep.2013.07.024; Weinert BT, 2013, MOL CELL, V51, P265, DOI 10.1016/j.molcel.2013.06.003; Wu X, 2013, J PROTEOMICS, V79, P60, DOI 10.1016/j.jprot.2012.12.001; Xiong Y, 2012, J CELL BIOL, V198, P155, DOI 10.1083/jcb.201202056; Yang XJ, 2008, MOL CELL, V31, P449, DOI 10.1016/j.molcel.2008.07.002; Yano K, 2013, MICROBIOL-SGM, V159, P2225, DOI 10.1099/mic.0.067025-0; Yu BJ, 2008, J MICROBIOL BIOTECHN, V18, P1529; Zhang JM, 2009, MOL CELL PROTEOMICS, V8, P215, DOI 10.1074/mcp.M800187-MCP200; Zhang K, 2013, J PROTEOME RES, V12, P844, DOI 10.1021/pr300912q; Zhang ZH, 2011, NAT CHEM BIOL, V7, P58, DOI [10.1038/nchembio.495, 10.1038/NCHEMBIO.495]; Zhao SM, 2010, SCIENCE, V327, P1000, DOI 10.1126/science.1179689	70	94	98	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2015	10	6							e0131169	10.1371/journal.pone.0131169	http://dx.doi.org/10.1371/journal.pone.0131169			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL3FM	26098117	Green Published, gold, Green Submitted			2022-12-26	WOS:000356835800153
J	Ma, X; Wang, EP; Lu, YY; Wang, Y; Ou, SY; Yan, R				Ma, Xiang; Wang, Erpei; Lu, Yuyun; Wang, Yong; Ou, Shiyi; Yan, Rian			Acylation of Antioxidant of Bamboo Leaves with Fatty Acids by Lipase and the Acylated Derivatives' Efficiency in the Inhibition of Acrylamide Formation in Fried Potato Crisps	PLOS ONE			English	Article							ENZYMATIC ACYLATION; FLAVONOID GLYCOSIDES; ANTIRADICAL ACTIVITY; MAILLARD REACTION; MODEL REACTIONS; ISOORIENTIN; EXTRACTS; SYSTEMS; EMULSION; HEALTH	This study selectively acylated the primary hydroxyl groups on flavonoids in antioxidant of bamboo leaves (AOB) using lauric acid with Candida antarctica lipase B in tert-amy-alcohol. The separation and isolation of acylated derivatives were performed using silica gel column chromatography with a mixture of dichloromethane/diethylether/methanol as eluents. Both thin layer chromatography and high-performance liquid chromatography analyses confirmed the high efficiency of the isolation process with the purified orientin-6 ''-laurate, isoorientin-6 ''-laurate, vitexin-6 ''-laurate, and isovitexin-6 ''-laurate that were obtained. The addition of AOB and acylated AOB reduced acrylamide formation in fried potato crisps. Results showed that 0.05% AOB and 0.05% and 0.1% acylated AOB groups significantly (p < 0.05) reduced the content of acrylamide in potato crisps by 30.7%, 44.5%, and 46.9%, respectively.	[Ma, Xiang; Wang, Erpei; Lu, Yuyun; Wang, Yong; Ou, Shiyi; Yan, Rian] Jinan Univ, Coll Sci & Engn, Dept Food Sci & Engn, Guangzhou 510632, Guangdong, Peoples R China	Jinan University	Yan, R (corresponding author), Jinan Univ, Coll Sci & Engn, Dept Food Sci & Engn, Guangzhou 510632, Guangdong, Peoples R China.	yanrian813@gmail.com	Lu, Yuyun/AAK-3548-2020; WANG, YONG/K-5715-2019	Lu, Yuyun/0000-0003-3977-0603	Guangdong Natural Science Foundation [S2013010012931]	Guangdong Natural Science Foundation(National Natural Science Foundation of Guangdong Province)	This work was supported by grant no. S2013010012931 from the Guangdong Natural Science Foundation, http://gdsf.gdstc.gov.cn.	Afifi FU, 1999, J ETHNOPHARMACOL, V65, P173, DOI 10.1016/S0378-8741(98)00147-0; Ardhaoui M, 2004, J MOL CATAL B-ENZYM, V29, P63, DOI 10.1016/j.molcatb.2004.02.013; Cazarolli LH, 2008, MINI-REV MED CHEM, V8, P1429, DOI 10.2174/138955708786369564; Chebil L, 2007, J AGR FOOD CHEM, V55, P9496, DOI 10.1021/jf071943j; Chebil L, 2006, PROCESS BIOCHEM, V41, P2237, DOI 10.1016/j.procbio.2006.05.027; Cheng KW, 2010, J AGR FOOD CHEM, V58, P309, DOI 10.1021/jf902529v; Engler MB, 2006, NUTR REV, V64, P109, DOI [10.1301/nr.2006.mar.109-118, 10.1111/j.1753-4887.2006.tb00194.x]; Figueroa-Espinoza MC, 2005, J AGR FOOD CHEM, V53, P2779, DOI 10.1021/jf0484273; Gao CL, 2001, BIOTECHNOL BIOENG, V71, P235, DOI 10.1002/1097-0290(2000)71:3<235::AID-BIT1013>3.0.CO;2-M; Gayot S, 2003, J BIOTECHNOL, V101, P29, DOI 10.1016/S0168-1656(02)00286-9; Ishihara K, 2003, J MOL CATAL B-ENZYM, V23, P411, DOI 10.1016/S1381-1177(03)00106-1; Kontogianni A, 2003, J MOL CATAL B-ENZYM, V21, P59, DOI 10.1016/S1381-1177(02)00139-X; Kontogianni A, 2001, EUR J LIPID SCI TECH, V103, P655, DOI 10.1002/1438-9312(200110)103:10<655::AID-EJLT655>3.0.CO;2-X; Kosmider B, 2004, DRUG DEVELOP RES, V63, P200, DOI 10.1002/ddr.10421; Kotsiou K, 2011, FOOD CHEM, V124, P242, DOI 10.1016/j.foodchem.2010.06.025; Laane C, 2009, BIOTECHNOL BIOENG, V102, P2, DOI 10.1002/bit.22209; Lamuela-Raventos RM, 2005, FOOD SCI TECHNOL INT, V11, P159, DOI 10.1177/1082013205054498; Lue BM, 2010, PROCESS BIOCHEM, V45, P1375, DOI 10.1016/j.procbio.2010.05.024; Lue BM, 2010, J AM OIL CHEM SOC, V87, P55, DOI 10.1007/s11746-009-1471-7; Ma X, 2012, J AGR FOOD CHEM, V60, P10844, DOI 10.1021/jf303595e; Mellou F, 2005, J BIOTECHNOL, V116, P295, DOI 10.1016/j.jbiotec.2004.12.002; Mottram DS, 2002, NATURE, V419, P448, DOI 10.1038/419448a; PORTER WL, 1989, J AGR FOOD CHEM, V37, P615, DOI 10.1021/jf00087a009; Salem JH, 2011, FOOD CHEM, V124, P486, DOI 10.1016/j.foodchem.2010.06.059; Stadler RH, 2002, NATURE, V419, P449, DOI 10.1038/419449a; Tan ZL, 2013, FOOD CHEM, V138, P1220, DOI 10.1016/j.foodchem.2012.10.130; Tareke E, 2002, J AGR FOOD CHEM, V50, P4998, DOI 10.1021/jf020302f; Tommasini S, 2004, J PHARMACEUT BIOMED, V35, P379, DOI 10.1016/S0731-7085(03)00647-2; Tripoli E, 2007, FOOD CHEM, V104, P466, DOI 10.1016/j.foodchem.2006.11.054; Xu J, 2014, EUR FOOD RES TECHNOL, V239, P661, DOI 10.1007/s00217-014-2262-4; Zeng XH, 2009, FOOD CHEM, V116, P34, DOI 10.1016/j.foodchem.2009.01.093; Zhang Y, 2008, FOOD CHEM, V107, P1326, DOI 10.1016/j.foodchem.2007.09.037; Zhang Y, 2008, J FOOD ENG, V85, P105, DOI 10.1016/j.jfoodeng.2007.07.013; Zhang Y, 2007, J AGR FOOD CHEM, V55, P523, DOI 10.1021/jf062568i; Zhong Y, 2012, FOOD CHEM, V131, P22, DOI 10.1016/j.foodchem.2011.07.089; Zou L, 2015, FOOD CHEM, V168, P504, DOI 10.1016/j.foodchem.2014.07.098	36	10	11	0	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2015	10	6							e0130680	10.1371/journal.pone.0130680	http://dx.doi.org/10.1371/journal.pone.0130680			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL3FM	26098744	Green Submitted, gold, Green Published			2022-12-26	WOS:000356835800093
J	Bonnyaud, C; Pradon, D; Vuillerme, N; Bensmail, D; Roche, N				Bonnyaud, Celine; Pradon, Didier; Vuillerme, Nicolas; Bensmail, Djamel; Roche, Nicolas			Spatiotemporal and Kinematic Parameters Relating to Oriented Gait and Turn Performance in Patients with Chronic Stroke	PLOS ONE			English	Article							SIT-TO-STAND; LOWER-LIMB IMPAIRMENTS; GO TEST; LOCOMOTOR CAPACITIES; PARKINSONS-DISEASE; HEALTHY CONTROLS; ELDERLY PERSONS; FOOT PLACEMENT; WALKING SPEED; STEP WIDTH	Background The timed up and go test (TUG) is a functional test which is increasingly used to evaluate patients with stroke. The outcome measured is usually global TUG performance-time. Assessment of spatiotemporal and kinematic parameters during the Oriented gait and Turn sub-tasks of the TUG would provide a better understanding of the mechanisms underlying patients' performance and therefore may help to guide rehabilitation. The aim of this study was thus to determine the spatiotemporal and kinematic parameters which were most related to the walking and turning sub-tasks of TUG performance in stroke patients. Methods 29 stroke patients carried out the TUG test which was recorded using an optoelectronic system in two conditions: spontaneous and standardized condition (standardized foot position and instructed to turn towards the paretic side). They also underwent a clinical assessment. Stepwise regression was used to determine the parameters most related to Oriented gait and Turn sub-tasks. Relationships between explanatory parameters of Oriented gait and Turn performance and clinical scales were evaluated using Spearman correlations. Results Step length and cadence explained 82% to 95% of the variance for the walking sub-tasks in both conditions. Percentage single support phase and contralateral swing phase (depending on the condition) respectively explained 27% and 56% of the variance during the turning sub-task in the spontaneous and standardized conditions. Discussion and Conclusion Step length, cadence, percentage of paretic single support phase and non-paretic swing phase, as well as dynamic stability were the main parameters related to TUG performance and they should be targeted in rehabilitation.	[Bonnyaud, Celine; Pradon, Didier; Roche, Nicolas] Hop Raymond Poincare, AP HP, Inserm Unit 1179, UVSQ CIC 805,Serv Physiol & Explorat Fonct,Team T, F-92380 Garches, France; [Bensmail, Djamel] Hop Raymond Poincare, AP HP, Inserm Unit 1179, UVSQ CIC 805,Serv Med Phys & Readaptat,Team Techn, F-92380 Garches, France; [Vuillerme, Nicolas] Univ Grenoble Alpes, Lab AGIM, La Tronche, France; [Vuillerme, Nicolas] Inst Univ France, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Raymond-Poincare - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Raymond-Poincare - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Institut Universitaire de France	Bonnyaud, C (corresponding author), Hop Raymond Poincare, AP HP, Inserm Unit 1179, UVSQ CIC 805,Serv Physiol & Explorat Fonct,Team T, F-92380 Garches, France.	celine.bonnyaud@rpc.aphp.fr	roche, nicolas/R-6080-2018; Bonnyaud, Celine/AGK-7246-2022; Bensmail, Djamel/R-6035-2018; VUILLERME, Nicolas/U-5767-2019	Bensmail, Djamel/0000-0001-9360-9330; VUILLERME, Nicolas/0000-0003-3773-393X				Arnadottir SA, 2000, PHYS THER, V80, P17, DOI 10.1093/ptj/80.1.17; Barre A, 2014, COMPUT METH PROG BIO, V114, DOI 10.1016/j.cmpb.2014.01.012; BERG KO, 1992, CAN J PUBLIC HEALTH, V83, pS7; Blum L, 2008, PHYS THER, V88, P559, DOI 10.2522/ptj.20070205; BOHANNON RW, 1987, ARCH PHYS MED REHAB, V68, P777; BOHANNON RW, 1987, PHYS THER, V67, P206, DOI 10.1093/ptj/67.2.206; Bonnyaud C, 2014, NEUROREHABILITATION, P29, DOI [10.3233/NRE-131007, DOI 10.3233/NRE-131007]; Bonnyaud C, 2013, GAIT POSTURE, V38, P466, DOI 10.1016/j.gaitpost.2013.01.015; Botolfsen P, 2008, PHYSIOTHER RES INT, V13, P94, DOI 10.1002/pri.394; Brunt D, 2002, ARCH PHYS MED REHAB, V83, P924, DOI 10.1053/apmr.2002.3324; Chamberlin ME, 2005, J GERONTOL A-BIOL, V60, P1163, DOI 10.1093/gerona/60.9.1163; Cheng PT, 1998, ARCH PHYS MED REHAB, V79, P1043, DOI 10.1016/S0003-9993(98)90168-X; De Bujanda E, 2003, J REHABIL MED, V35, P259, DOI 10.1080/16501970310012428; Dion L, 2003, NEUROREHAB NEURAL RE, V17, P83, DOI 10.1177/0888439003017002002; Donelan JM, 2001, P ROY SOC B-BIOL SCI, V268, P1985, DOI 10.1098/rspb.2001.1761; Donoghue OA, 2013, GAIT POSTURE, V38, P120, DOI 10.1016/j.gaitpost.2012.10.023; Faria CD, 2012, ARCH PHYS MED REHAB, V93, P1034, DOI 10.1016/j.apmr.2011.11.025; Faria CDCM, 2013, J REHABIL MED, V45, P232, DOI 10.2340/16501977-1107; Frykberg GE, 2009, ARCH PHYS MED REHAB, V90, P1009, DOI 10.1016/j.apmr.2008.12.023; Galli M, 2008, GAIT POSTURE, V28, P80, DOI 10.1016/j.gaitpost.2007.10.003; Gilleard W, 2008, GAIT POSTURE, V27, P8, DOI 10.1016/j.gaitpost.2006.11.002; Hall AL, 2012, CLIN BIOMECH, V27, P1017, DOI 10.1016/j.clinbiomech.2012.07.006; Hase K, 1999, J NEUROPHYSIOL, V81, P2914, DOI 10.1152/jn.1999.81.6.2914; HEITMANN DK, 1989, PHYS THER, V69, P923, DOI 10.1093/ptj/69.11.923; Herman T, 2014, EXP BRAIN RES, V232, P713, DOI 10.1007/s00221-013-3778-8; Heung THM, 2009, J REHABIL MED, V41, P719, DOI 10.2340/16501977-0411; Hyndman D, 2002, ARCH PHYS MED REHAB, V83, P165, DOI 10.1053/apmr.2002.28030; Janssen WGM, 2002, PHYS THER, V82, P866, DOI 10.1093/ptj/82.9.866; KADABA MP, 1990, J ORTHOP RES, V8, P383, DOI 10.1002/jor.1100080310; Kao PC, 2014, GAIT POSTURE, V40, P457, DOI 10.1016/j.gaitpost.2014.05.014; Lamontagne A, 2004, STROKE, V35, P2543, DOI 10.1161/01.STR.0000144685.88760.d7; Lecours J, 2008, J REHABIL MED, V40, P200, DOI 10.2340/16501977-0155; Lincoln N., 1991, CLIN REHABIL, V5, P273, DOI [DOI 10.1177/026921559100500403, 10.1177/026921559100500403]; Maki BE, 1997, J AM GERIATR SOC, V45, P313, DOI 10.1111/j.1532-5415.1997.tb00946.x; Mao HF, 2002, STROKE, V33, P1022, DOI 10.1161/01.STR.0000012516.63191.C5; McGinley JL, 2009, GAIT POSTURE, V29, P360, DOI 10.1016/j.gaitpost.2008.09.003; Medical Research Council MR, 1976, AID EX PER NERV SYST; Ng SS, 2005, ARCH PHYS MED REHAB, V86, P1641, DOI 10.1016/j.apmr.2005.01.011; OLNEY SJ, 1994, PHYS THER, V74, P872, DOI 10.1093/ptj/74.9.872; Park J, 2014, J PHYS THER SCI, V26, P1883, DOI 10.1589/jpts.26.1883; Patterson KK, 2008, ARCH PHYS MED REHAB, V89, P304, DOI 10.1016/j.apmr.2007.08.142; Perry J, 1992, GAIT ANAL NORMAL PAT, P9; PODSIADLO D, 1991, J AM GERIATR SOC, V39, P142, DOI 10.1111/j.1532-5415.1991.tb01616.x; POWELL LE, 1995, J GERONTOL A-BIOL, V50, pM28, DOI 10.1093/gerona/50A.1.M28; Richards CL, 1999, CLIN GERIATR MED, V15, P833; Roche N, 2015, CLIN BIOMEC IN PRESS; Roth EJ, 1997, AM J PHYS MED REHAB, V76, P128, DOI 10.1097/00002060-199703000-00008; Roy G, 2006, CLIN BIOMECH, V21, P585, DOI 10.1016/j.clinbiomech.2006.01.007; Suzuki K, 1999, ARCH PHYS MED REHAB, V80, P179, DOI 10.1016/S0003-9993(99)90117-X; Tabachnick B.G., 2007, USING MULTIVARIATE S, VVolume 5, P481; Thigpen MT, 2000, PHYS THER, V80, P1174, DOI 10.1093/ptj/80.12.1174; Wall JC, 2000, J REHABIL RES DEV, V37, P109; Weiss A, 2010, MED ENG PHYS, V32, P119, DOI 10.1016/j.medengphy.2009.10.015; WINTER DA, 1974, J BIOMECH, V7, P157, DOI 10.1016/0021-9290(74)90056-6; Zampieri C, 2010, J NEUROL NEUROSUR PS, V81, P171, DOI 10.1136/jnnp.2009.173740	56	22	22	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2015	10	6							e0129821	10.1371/journal.pone.0129821	http://dx.doi.org/10.1371/journal.pone.0129821			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL3FE	26091555	Green Published, Green Submitted, gold			2022-12-26	WOS:000356835000062
J	Navidian, A; Yaghoubinia, F; Ganjali, A; Khoshsimaee, S				Navidian, Ali; Yaghoubinia, Fariba; Ganjali, Alireza; Khoshsimaee, Sadegh			The Effect of Self-Care Education on the Awareness, Attitude, and Adherence to Self-Care Behaviors in Hospitalized Patients Due to Heart Failure with and without Depression	PLOS ONE			English	Article							QUALITY-OF-LIFE; MEDICATION ADHERENCE; COLLABORATIVE CARE; RISK-FACTOR; SYMPTOMS; ANXIETY; MORTALITY; MANAGEMENT; DISEASE; INTERVENTION	Background Cardiovascular diseases are among somatic disorders and psychological factors affect their onset, exacerbation, and treatment. This study was conducted on the hospitalized patients who had heart failure with and without depression. The study criteria was to evaluate the effect of self-care education on awareness, attitude, and adherence to self-care behaviors on these patients. Materials and Methods In this quasi-experimental study, seventy patients with heart failure that met the inclusion criteria were recruited through purposive sampling method. They were assigned in to two equal size groups regarding their depression status. First, the eligible patients were selected; then Beck Depression Inventory was done on the patients followed by examination by the clinical psychologist. Patients with average and higher scores were classified in the depressed group and others who got lower than average scores were classified as the non -depressed group. A questionnaire containing items related to awareness, attitude, and adherence to self-care behaviors was used to collect the data. First, self-care behavior was determined and then a four-sessions of educational intervention were held individually for both groups. The second round of questionnaires were completed at patients' home twelve weeks after the discharge. The Collected data was analyzed using independent-samples and paired-sample t tests, Chi square, and statistical analysis of covariance (ANCOVA) tests through SPSS (version 21, SPSS Inc., Chicago, IL, USA). Results After the educational sessions, the statistical analysis showed significant differences in the mean scores of awareness, attitude, and adherence to self-care behaviors between the two groups (P<0.0001). Conclusion Self-care behavior education had lower effects on the depressed patients with heart failure. Therefore, before providing education for these patients, it is necessary to consider their psychological problems such as depression.	[Navidian, Ali; Yaghoubinia, Fariba] Zahedan Univ Med Sci, Pregnancy Hlth Res Ctr, Zahedan, Iran; [Ganjali, Alireza] Zahedan Univ Med Sci, Fac Med, Zahedan, Iran; [Khoshsimaee, Sadegh] Zahedan Univ Med Sci, Fac Nursing & Midwifery, Zahedan, Iran	Zahedan University of Medical Sciences; Zahedan University of Medical Sciences; Zahedan University of Medical Sciences	Yaghoubinia, F (corresponding author), Zahedan Univ Med Sci, Pregnancy Hlth Res Ctr, Zahedan, Iran.	yaghoubinia@gmail.com	Ganjali, Alireza/P-9916-2017; navidian, ali/H-1469-2017	Ganjali, Alireza/0000-0003-1577-1548; 	Islamic Azad University of Zahedan, Iran	Islamic Azad University of Zahedan, Iran	The current study was issued and financially supported by Islamic Azad University of Zahedan, Iran. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert NM, 2008, J CARDIOVASC NURS, V23, P277, DOI 10.1097/01.JCN.0000305095.27635.4f; Annema C, 2009, HEART LUNG, V38, P427, DOI 10.1016/j.hrtlng.2008.12.002; [Anonymous], 2006, Harv Mens Health Watch, V11, P6; Association AP DSM-IV APA on, 2000, DIAGN STAT MAN MENT; Bagheri saveh MI, 2012, J NURS MIDWIFERY S B, V22, P17; Binafar N., 1999, CARDIOVASCULAR DIS; Blumenthal JA, 2003, LANCET, V362, P604, DOI 10.1016/S0140-6736(03)14190-6; BRIODY ME, 1984, NURS CLIN N AM, V19, P387; Cameron J, 2010, EUR J CARDIOVASC NUR, V9, P92, DOI 10.1016/j.ejcnurse.2009.10.004; Casey E, 2008, J BEHAV MED, V31, P421, DOI 10.1007/s10865-008-9168-1; Chew-Graham CA, 2007, BRIT J GEN PRACT, V57, P364; Ciechanowski P, 2011, CLIN DIABETES, V29, P43, DOI DOI 10.2337/DIACLIN.29.2.43; Coyle MK, 2012, ARCH PSYCHIAT NURS, V26, P127, DOI 10.1016/j.apnu.2011.06.004; Dempe C, 2013, J PSYCHOSOM RES, V74, P122, DOI 10.1016/j.jpsychores.2012.12.003; DiMatteo MR, 2000, ARCH INTERN MED, V160, P2101, DOI 10.1001/archinte.160.14.2101; Gehi A, 2005, ARCH INTERN MED, V165, P2508, DOI 10.1001/archinte.165.21.2508; Gehi AK, 2007, ARCH INTERN MED, V167, P1798, DOI 10.1001/archinte.167.16.1798; Gharib M, 2001, 12 CARD C TEHR; Ghassemzadeh H, 2005, DEPRESS ANXIETY, V21, P185, DOI 10.1002/da.20070; Gonzalez Beatriz, 2005, Eur J Cardiovasc Nurs, V4, P107, DOI 10.1016/j.ejcnurse.2005.03.006; Grenard JL, 2011, J GEN INTERN MED, V26, P1175, DOI 10.1007/s11606-011-1704-y; Halvorsen M, 2011, PSYCHIAT RES, V188, P350, DOI 10.1016/j.psychres.2011.02.022; Hassani M., 2010, IRANIAN J CARE NURS, V3, P87; Heo S, 2008, INT J NURS STUD, V45, P1807, DOI 10.1016/j.ijnurstu.2008.05.008; Hertel PT, 2008, ACTA PSYCHOL, V127, P636, DOI 10.1016/j.actpsy.2007.11.004; Huffman JC, 2006, AM J CARDIOL, V98, P319, DOI 10.1016/j.amjcard.2006.02.033; Jaarsma T, 2000, HEART LUNG, V29, P319, DOI 10.1067/mhl.2000.108323; Jiang W, 2001, ARCH INTERN MED, V161, P1849, DOI 10.1001/archinte.161.15.1849; Kronish IM, 2006, J GEN INTERN MED, V21, P1178, DOI 10.1111/j.1525-1497.2006.00586.x; Krumholz HM, 2002, J AM COLL CARDIOL, V39, P83, DOI 10.1016/S0735-1097(01)01699-0; Lane D, 2002, BRIT J HEALTH PSYCH, V7, P11, DOI 10.1348/135910702169321; Lesperance F, 2002, CIRCULATION, V105, P1049, DOI 10.1161/hc0902.104707; Lloyd-Jones D, 2009, CIRCULATION, V119, pE21, DOI 10.1161/CIRCULATIONAHA.108.191261; Mangulian Shahrbabaki P, 2012, SHAHREKORD J NURS, V31, P918; Mast C., 2008, THESIS BALL STATE U; Moser DK, 2007, AM J CRIT CARE, V16, P361; Nakao M, 2001, BEHAV MED, V26, P177, DOI 10.1080/08964280109595765; Pattenden J F, 2007, Eur J Cardiovasc Nurs, V6, P273, DOI 10.1016/j.ejcnurse.2007.01.097; Paul S, 2008, CRIT CARE NURSE, V28, P66; Pozuelo L, 2009, CLEV CLIN J MED, V76, P59, DOI 10.3949/ccjm.75a.08011; Rasmussen JN, 2007, JAMA-J AM MED ASSOC, V297, P177, DOI 10.1001/jama.297.2.177; Rieckmann N, 2006, AM HEART J, V152, P922, DOI 10.1016/j.ahj.2006.05.014; Ruo B, 2003, JAMA-J AM MED ASSOC, V290, P215, DOI 10.1001/jama.290.2.215; Scotto Carrie J, 2005, J Cardiopulm Rehabil, V25, P158, DOI 10.1097/00008483-200505000-00006; Seraji M, 2013, HEALTH SCOPE, V2, P104, DOI 10.17795/jhealthscope-11414; Shojaee F, 2009, PAYESH FASLNAMEH, V8, P361; Shojafard J, 2009, PAYAVARD SALAMAT, V2, P43; Sullivan G, 2007, GEN HOSP PSYCHIAT, V29, P379, DOI 10.1016/j.genhosppsych.2007.04.005; Tang H-YJ, 2013, CLIN NURS RES; Timmerman IGH, 1998, BEHAV RES THER, V36, P863, DOI 10.1016/S0005-7967(98)00053-9; van der Wal MHL, 2006, EUR HEART J, V27, P434, DOI 10.1093/eurheartj/ehi603; Venner G H, 1996, J Cardiovasc Nurs, V10, P71; Wang SP, 2011, J NURS RES, V19, P257, DOI 10.1097/JNR.0b013e318237f08d; Zipfel S, 2002, PSYCHOSOM MED, V64, P740, DOI 10.1097/01.PSY.0000031575.42041.6A	54	18	18	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2015	10	6							e0130973	10.1371/journal.pone.0130973	http://dx.doi.org/10.1371/journal.pone.0130973			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CL3FE	26091101	Green Published, gold, Green Submitted			2022-12-26	WOS:000356835000163
J	Zhang, WD; Chu, SY; Ding, WH; Wang, F				Zhang, Wenduo; Chu, Songyun; Ding, Wenhui; Wang, Fang			Serum Level of Fibroblast Growth Factor 21 Is Independently Associated with Acute Myocardial Infarction	PLOS ONE			English	Article							REGULATOR; FGF-21; LIVER	Background Fibroblast growth factor 21 (FGF21) has been described as a metabolic hormone critical for glucose and lipid metabolism. Previously, high levels of FGF21 were observed in patients with coronary heart disease and non-acute myocardial infarction (non-AMI). In this study, we investigated the changes in FGF21 levels in Chinese patients with AMI. Methodology/Principal Findings We used ELISA to measure circulating FGF21 levels in 55 AMI patients and 45 non-AMI control patients on the 1st day after syndrome onset. All patients were followed-up within 30 days. FGF21 levels in AMI patients were significantly higher than those in non-AMI controls (0.25 (0.16-0.34) vs. 0.14 (0.11-0.20) ng/mL, P < 0.001). FGF21 levels reached the maximum within approximately 24 h after the onset of AMI and remained at high for 7 days, and the FGF21 level (OR: 16.93; 95% confidence interval (CI): 2.65-108.05; P = 0.003) was identified as an independent factor associated with the presence of AMI. On the 7th day, FGF21 levels were significantly higher in the patients who subsequently developed re-infarction within 30 days than in the patients who did not develop re-infarction (with vs. without re-infarction: 0.45 (0.22-0.64) vs. 0.21 (0.15-0.29) ng/mL, P = 0.014). Conclusions/Significance The level of serum FGF21 is independently associated with the presence of AMI in Chinese patients. High FGF21 levels might be related to the incidence of re-infarction within 30 days after onset.	[Zhang, Wenduo; Wang, Fang] China Minist Hlth, Beijing Hosp, Dept Cardiol, Beijing, Peoples R China; [Chu, Songyun; Ding, Wenhui] Peking Univ, Hosp 1, Dept Cardiol, Beijing 100871, Peoples R China	Beijing Hospital; Peking University	Ding, WH (corresponding author), Peking Univ, Hosp 1, Dept Cardiol, Beijing 100871, Peoples R China.	dwh_rd@126.com; 13911015388@163.com	Chu, Song-Yun/ABD-8292-2021	Chu, Song-Yun/0000-0003-4042-4054				Amer Diabet Assoc, 2012, DIABETES CARE, V35, pS64, DOI [10.2337/dc12-S064, 10.2337/dc09-S062, 10.2337/dc11-S011]; [Anonymous], 2012, CIRCULATION, V126, P875, DOI [10.1161/CIR.0b013e318256f1e0, DOI 10.1161/CIR.0B013E318256F1E0]; [Anonymous], 2004, 045230 NAT HEART LUN; Chow WS, 2013, ARTERIOSCL THROM VAS, V33, P2454, DOI 10.1161/ATVBAHA.113.301599; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Fukuyama H, 2011, INTERNAL MED, V50, P1917, DOI 10.2169/internalmedicine.50.5279; Hong YJ, 2009, CORONARY ARTERY DIS, V20, P518, DOI 10.1097/MCA.0b013e32832a196e; Jensen JK, 2009, AM J CARDIOL, V104, P287, DOI 10.1016/j.amjcard.2009.03.029; Lenart-Lipinska M, 2013, DIABETES RES CLIN PR, V101, P194, DOI 10.1016/j.diabres.2013.04.010; Li HT, 2013, FRONT MED-PRC, V7, P25, DOI 10.1007/s11684-013-0244-8; Li HT, 2009, J CLIN ENDOCR METAB, V94, P2151, DOI 10.1210/jc.2008-2331; Lin ZF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015534; Liu SQ, 2012, AM J PHYSIOL-HEART C, V303, pH1446, DOI 10.1152/ajpheart.00362.2012; Lu Y, 2010, CHINESE MED J-PEKING, V123, P3417, DOI 10.3760/cma.j.issn.0366-6999.2010.23.008; Mayr A, 2011, INT J CARDIOL, V147, P118, DOI 10.1016/j.ijcard.2009.09.537; Mraz M, 2009, CLIN ENDOCRINOL, V71, P369, DOI 10.1111/j.1365-2265.2008.03502.x; Nishimura T, 2000, BBA-GENE STRUCT EXPR, V1492, P203, DOI 10.1016/S0167-4781(00)00067-1; O'Gara PT, 2013, J AM COLL CARDIOL, V61, pE78, DOI [10.1016/j.jacc.2012.11.019, 10.1161/CIR.0b013e3182742cf6]; Ong KL, 2015, DIABETOLOGIA, V58, P464, DOI 10.1007/s00125-014-3458-7; Patel V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087102; Planavila A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3019; Reinehr T, 2012, J CLIN ENDOCR METAB, V97, P2143, DOI 10.1210/jc.2012-1221; Semba RD, 2013, J HUM HYPERTENS, V27, P397, DOI 10.1038/jhh.2012.52; Semba RD, 2012, J CLIN ENDOCR METAB, V97, P1375, DOI 10.1210/jc.2011-2823; Shen Y, 2013, CARDIOVASC DIABETOL, V12, DOI 10.1186/1475-2840-12-124; Thygesen K, 2012, CIRCULATION, V126, P2020, DOI 10.1161/CIR.0b013e31826e1058	26	36	37	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2015	10	6							e0129791	10.1371/journal.pone.0129791	http://dx.doi.org/10.1371/journal.pone.0129791			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL3FE	26091256	Green Submitted, Green Published, gold			2022-12-26	WOS:000356835000060
J	Chakraborty, M; Walloe, S; Nedergaard, S; Fridel, EE; Dabelsteen, T; Pakkenberg, B; Bertelsen, MF; Dorrestein, GM; Brauth, SE; Durand, SE; Jarvis, ED				Chakraborty, Mukta; Walloe, Solveig; Nedergaard, Signe; Fridel, Emma E.; Dabelsteen, Torben; Pakkenberg, Bente; Bertelsen, Mads F.; Dorrestein, Gerry M.; Brauth, Steven E.; Durand, Sarah E.; Jarvis, Erich D.			Core and Shell Song Systems Unique to the Parrot Brain	PLOS ONE			English	Article							BUDGERIGAR MELOPSITTACUS-UNDULATUS; DRIVEN GENE-EXPRESSION; VOCAL CONTROL PATHWAYS; HUMAN SPEECH; REVISED NOMENCLATURE; AVIAN TELENCEPHALON; AUDITORY PATHWAYS; CONTROL NUCLEUS; HUMAN LANGUAGE; BASAL GANGLIA	The ability to imitate complex sounds is rare, and among birds has been found only in parrots, songbirds, and hummingbirds. Parrots exhibit the most advanced vocal mimicry among non-human animals. A few studies have noted differences in connectivity, brain position and shape in the vocal learning systems of parrots relative to songbirds and hummingbirds. However, only one parrot species, the budgerigar, has been examined and no differences in the presence of song system structures were found with other avian vocal learners. Motivated by questions of whether there are important differences in the vocal systems of parrots relative to other vocal learners, we used specialized constitutive gene expression, singing-driven gene expression, and neural connectivity tracing experiments to further characterize the song system of budgerigars and/or other parrots. We found that the parrot brain uniquely contains a song system within a song system. The parrot "core" song system is similar to the song systems of songbirds and hummingbirds, whereas the "shell" song system is unique to parrots. The core with only rudimentary shell regions were found in the New Zealand kea, representing one of the only living species at a basal divergence with all other parrots, implying that parrots evolved vocal learning systems at least 29 million years ago. Relative size differences in the core and shell regions occur among species, which we suggest could be related to species differences in vocal and cognitive abilities.	[Chakraborty, Mukta; Fridel, Emma E.; Jarvis, Erich D.] Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27708 USA; [Chakraborty, Mukta; Jarvis, Erich D.] Howard Hughes Med Inst, Chevy Chase, MD USA; [Walloe, Solveig; Dabelsteen, Torben] Univ Copenhagen, Dept Biol, Copenhagen, Denmark; [Nedergaard, Signe] Natl Ctr Forens Serv, Danish Natl Police, Vanloese, Denmark; [Walloe, Solveig; Pakkenberg, Bente] Bispebjerg Hosp, Res Lab Stereol & Neurosci, Copenhagen, Denmark; [Bertelsen, Mads F.] Copenhagen Zoo, Frederiksberg, Denmark; [Dorrestein, Gerry M.] Dutch Res Inst Avian & Exot Anim, Veldhoven, Netherlands; [Brauth, Steven E.] Univ Maryland, College Pk, MA USA; [Durand, Sarah E.] LaGuardia Community Coll, New York, NY USA	Duke University; Howard Hughes Medical Institute; University of Copenhagen; University of Copenhagen; Bispebjerg Hospital; University System of Maryland; University of Maryland College Park	Chakraborty, M (corresponding author), Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27708 USA.	chakraborty@neuro.duke.edu; jarvis@neuro.duke.edu	Jarvis, Erich D/A-2319-2008; Dorrestein, Gerry/AAX-5652-2020; Bertelsen, Mads/AAA-5746-2022	Jarvis, Erich D/0000-0001-8931-5049; Dorrestein, Gerry/0000-0003-1667-1477; Bertelsen, Mads/0000-0001-9201-7499; pakkenberg, bente/0000-0003-3851-6494	NIH Director's Pioneer Award; Howard Hughes Medical Institute; University of Copenhagen (Faculty of Science); Danish Council for Independent Research	NIH Director's Pioneer Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); University of Copenhagen (Faculty of Science); Danish Council for Independent Research(Det Frie Forskningsrad (DFF))	This study was funded by grants provided by the NIH Director's Pioneer Award and the Howard Hughes Medical Institute to E.D.J., a Doctoral scholarship from the University of Copenhagen (Faculty of Science) to S.W., and the Frame work Grant from the Danish Council for Independent Research to T.D. (HHMI: http://www.hhmi.org/; NIH: http://commonfund.nih.gov/pioneer/index). The funders had no role in study design, data collection, and analysis, decision to publish, or preparation of the manuscript.	Arriaga G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046610; BALL GF, 1994, BRAIN BEHAV EVOLUT, V44, P234, DOI 10.1159/000113579; Bond AB, 2005, BEHAVIOUR, V142, P1, DOI 10.1163/1568539053627721; Bottjer SW, 2010, NAT NEUROSCI, V13, P153, DOI 10.1038/nn.2472; Bottjer SW, 2004, ANN NY ACAD SCI, V1016, P395, DOI 10.1196/annals.1298.037; BRAUN K, 1988, BRAIN RES, V475, P205, DOI 10.1016/0006-8993(88)90609-9; Brauth SE, 2005, J COMP NEUROL, V484, P15, DOI 10.1002/cne.20458; Brauth SE, 2001, J COMP NEUROL, V432, P481; CELIO MR, 1986, SCIENCE, V231, P995, DOI 10.1126/science.3945815; Chen CC, 2013, J COMP NEUROL, V521, P3666, DOI 10.1002/cne.23406; Chen CC, 2012, JOVE-J VIS EXP, DOI 10.3791/3764; Colbert-White EN, 2011, J COMP PSYCHOL, V125, P175, DOI 10.1037/a0022097; Cook P, 2013, J COMP PSYCHOL, V127, P412, DOI 10.1037/a0032345; CRUICKSHANK AJ, 1993, IBIS, V135, P293, DOI 10.1111/j.1474-919X.1993.tb02846.x; Durand SE, 2001, BRAIN BEHAV EVOLUT, V58, P61, DOI 10.1159/000047262; Durand SE, 1998, J COMP NEUROL, V393, P145, DOI 10.1002/(SICI)1096-9861(19980406)393:2<145::AID-CNE2>3.0.CO;2-2; Durand SE, 1997, J COMP NEUROL, V377, P179, DOI 10.1002/(SICI)1096-9861(19970113)377:2<179::AID-CNE3>3.0.CO;2-0; Farabaugh SM, 1997, BRAIN RES, V747, P18, DOI 10.1016/S0006-8993(96)01143-2; Feenders G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001768; Fisher SE, 2009, TRENDS GENET, V25, P166, DOI 10.1016/j.tig.2009.03.002; Fitch WT, 2013, STRUNGMANN FORUM REP, P499; Fitch WT, 2012, EVOL BIOL, V39, P613, DOI 10.1007/s11692-012-9162-y; Fitch WT, 2010, NEURON, V65, P795, DOI 10.1016/j.neuron.2010.03.011; Fitch WT, 2000, TRENDS COGN SCI, V4, P258, DOI 10.1016/S1364-6613(00)01494-7; Fitch WT, 2012, EVOLUTION LANGUAGE; Gahr M, 2000, J COMP NEUROL, V426, P182; GRAMZA A F, 1970, Zeitschrift fuer Tierpsychologie, V27, P971; Haesler S, 2004, J NEUROSCI, V24, P3164, DOI 10.1523/JNEUROSCI.4369-03.2004; Hannula-Jouppi K, 2005, PLOS GENET, V1, P467, DOI 10.1371/journal.pgen.0010050; Hara E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029457; Harpoth SW, 2013, THESIS U COPENHAGEN; Horita H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042173; Horita H, 2010, J COMP NEUROL, V518, P2873, DOI 10.1002/cne.22370; Janik VM, 1997, ADV STUD BEHAV, V26, P59, DOI 10.1016/S0065-3454(08)60377-0; Jarvis ED, 1998, NEURON, V21, P775, DOI 10.1016/S0896-6273(00)80594-2; Jarvis ED, 2004, ANN NY ACAD SCI, V1016, P749, DOI 10.1196/annals.1298.038; Jarvis ED, 1997, P NATL ACAD SCI USA, V94, P4097, DOI 10.1073/pnas.94.8.4097; Jarvis ED, 2000, NATURE, V406, P628, DOI 10.1038/35020570; Jarvis ED, 2000, J COMP NEUROL, V419, P1, DOI 10.1002/(SICI)1096-9861(20000327)419:1<1::AID-CNE1>3.0.CO;2-M; Jarvis ED, 2005, NAT REV NEUROSCI, V6, P151, DOI 10.1038/nrn1606; Jarvis ED, 2004, NATURES MUSIC SCI BI; Jarvis ED, 2007, J ORNITHOL, V148, pS35, DOI 10.1007/s10336-007-0243-0; Jarvis ED, 2014, SCIENCE, V346, P1320, DOI 10.1126/science.1253451; Jarvis ED, 2013, J COMP NEUROL, V521, P3614, DOI 10.1002/cne.23404; Joseph L, 2012, ZOOTAXA, P26, DOI 10.11646/zootaxa.3205.1.2; KATZ LC, 1981, BRAIN RES, V221, P192, DOI 10.1016/0006-8993(81)91073-8; Kelley LA, 2008, ANIM BEHAV, V76, P521, DOI 10.1016/j.anbehav.2008.04.012; Kelley LA, 2011, CURR BIOL, V21, pR9, DOI 10.1016/j.cub.2010.11.026; Kelley LA, 2010, BIOL LETTERS, V6, P626, DOI 10.1098/rsbl.2010.0093; Kim M, 2011, DEV BIOL, V358, P181, DOI 10.1016/j.ydbio.2011.07.025; KLATT DH, 1974, J ACOUST SOC AM, V55, P822, DOI 10.1121/1.1914607; Konopka G, 2009, NATURE, V462, P213, DOI 10.1038/nature08549; Kroodsma D, 2013, WILSON J ORNITHOL, V125, P1; Lavenex PB, 2000, J COMP NEUROL, V421, P437, DOI 10.1002/(SICI)1096-9861(20000612)421:4<437::AID-CNE1>3.0.CO;2-A; Liu WC, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3082; Mandelblat-Cerf Y, 2014, ELIFE, V3, DOI 10.7554/eLife.02152; Matsunaga E, 2008, BRAIN RES, V1208, P87, DOI 10.1016/j.brainres.2008.02.076; MCCASLAND JS, 1981, P NATL ACAD SCI-BIOL, V78, P7815, DOI 10.1073/pnas.78.12.7815; MELLO CV, 1994, J NEUROSCI, V14, P6652; Mello CV, 1998, J COMP NEUROL, V395, P137; NOTTEBOHM F, 1972, AM NAT, V106, P116, DOI 10.1086/282756; Patel AD, 2009, CURR BIOL, V19, P827, DOI 10.1016/j.cub.2009.03.038; PATON JA, 1981, J NEUROSCI, V1, P1279; Pepperberg IM., 1999, ALEX STUDIES COGNITI; Pepperberg IM, 2010, BRAIN LANG, V115, P81, DOI 10.1016/j.bandl.2009.11.002; Petkov Christopher I, 2012, Front Evol Neurosci, V4, P12, DOI 10.3389/fnevo.2012.00012; Pfenning AR, 2014, SCIENCE, V346, P1333, DOI 10.1126/science.1256846; Poole JH, 2005, NATURE, V434, P455, DOI 10.1038/434455a; RALLS K, 1985, CAN J ZOOL, V63, P1050, DOI 10.1139/z85-157; Reiner A, 2004, J COMP NEUROL, V473, P377, DOI 10.1002/cne.20118; RICHARDS DG, 1984, J COMP PSYCHOL, V98, P10, DOI 10.1037/0735-7036.98.1.10; Ridgway S, 2012, CURR BIOL, V22, pR860, DOI 10.1016/j.cub.2012.08.044; Roberts TF, 2001, J COMP NEUROL, V429, P436, DOI 10.1002/1096-9861(20010115)429:3<436::AID-CNE6>3.0.CO;2-H; Schachner Adena, 2010, Communicative & Integrative Biology, V3, P290; Schachner A, 2009, CURR BIOL, V19, P831, DOI 10.1016/j.cub.2009.03.061; Stoeger AS, 2012, CURR BIOL, V22, P2144, DOI 10.1016/j.cub.2012.09.022; STRIEDTER GF, 1994, J COMP NEUROL, V343, P35, DOI 10.1002/cne.903430104; Striedter GF, 2006, VOCAL PERFORMANCE PL; Suh A, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1448; Touchton JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095746; Wada K, 2004, J COMP NEUROL, V476, P44, DOI 10.1002/cne.20201; Wada K, 2006, P NATL ACAD SCI USA, V103, P15212, DOI 10.1073/pnas.0607098103; Wang R, 2015, J COMP NEUROL, V523, P892, DOI 10.1002/cne.23719; Whitney O, 2015, DEV NEUROBIOL, V75, P778, DOI 10.1002/dneu.22247; Wong K, 2002, CURR OPIN GENET DEV, V12, P583, DOI 10.1016/S0959-437X(02)00343-X	85	41	42	0	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2015	10	6							e0118496	10.1371/journal.pone.0118496	http://dx.doi.org/10.1371/journal.pone.0118496			37	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CL4OM	26107173	Green Submitted, Green Published, gold			2022-12-26	WOS:000356932500003
J	Kilale, AM; Ngadaya, E; Kagaruki, GB; Lema, YL; Muhumuza, J; Ngowi, BJ; Mfinanga, SG; Hinderaker, SG				Kilale, Andrew Martin; Ngadaya, Esther; Kagaruki, Gibson Benard; Lema, Yakobo Leonard; Muhumuza, Julius; Ngowi, Bernard James; Mfinanga, Sayoki Godfrey; Hinderaker, Sven Gudmund			Experienced and Perceived Risks of Mycobacterial Diseases: A Cross Sectional Study among Agropastoral Communities in Northern Tanzania	PLOS ONE			English	Article							NONTUBERCULOUS MYCOBACTERIA; TUBERCULOSIS INFECTION; PASTORAL COMMUNITIES; UGANDA; PERCEPTION; INTERFACE; KNOWLEDGE; ETHIOPIA; REGION	Objective The current study was conducted to assess experienced risk factors and perceptions of mycobacterial diseases in communities in northern Tanzania. Methods We conducted a cross-sectional study in Arusha and Manyara regions in Northern Tanzania. We enrolled tuberculosis (TB) patients attending Mount Meru Hospital, Enduleni Hospital and Haydom Lutheran Hospitals in Arusha municipality, Ngorongoro and Mbulu districts, respectively. Patient addresses were recorded during their first visit to the hospitals. Patients with confirmed diagnosis of TB by sputum smear microscopy and/or culture at central laboratory were followed up and interviewed using pre-tested questionnaires, and selected relatives and neighbors were also interviewed. The study was conducted between June 2011 and May 2013. Results The study involved 164 respondents: 41(25%) were TB patients, 68(41.5%) were their relatives and 55(33.5%) their neighbors. Sixty four (39%) knew a risk factor for mycobacterial disease. Overall, 64(39%) perceived to be at risk of mycobacterial diseases. Exposure to potential risks of mycobacterial diseases were: keeping livestock, not boiling drinking water, large family, smoking and sharing dwelling with TB patients. Rural dwellers were more often livestock keepers (p<0.01), more often shared dwelling with livestock (p<0.01) than urban dwellers. More primary school leavers reported sharing dwelling with TB patients than participants with secondary and higher education (p = 0.01). Conclusion Livestock keeping, sharing dwelling with livestock, sharing household with a TB patient were perceived risk factors for mycobacterial diseases and the participants were exposed to some of these risk factors. Improving knowledge about the risk factors may protect them from these serious diseases.	[Kilale, Andrew Martin; Ngadaya, Esther; Lema, Yakobo Leonard; Muhumuza, Julius; Mfinanga, Sayoki Godfrey] Natl Inst Med Res, Muhimbili Ctr, Dar Es Salaam, Tanzania; [Kagaruki, Gibson Benard; Ngowi, Bernard James] Natl Inst Med Res, Tukuyu Ctr, Tukuyu, Mbeya, Tanzania; [Kilale, Andrew Martin; Hinderaker, Sven Gudmund] Univ Bergen, Ctr Int Hlth, Bergen, Norway	National Institute of Medical Research; University of Bergen	Kilale, AM (corresponding author), Natl Inst Med Res, Muhimbili Ctr, Dar Es Salaam, Tanzania.	kilale@yahoo.com		Ngadaya, Esther/0000-0003-4540-5637	Welcome Trust, through Afrique One Consortium	Welcome Trust, through Afrique One Consortium	This work was supported in the form of funds for data collection from Welcome Trust, through Afrique One Consortium. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ameni G, 2003, INT J APPL RES VET M, V1, P1; Ameni G, 2011, VET J, V188, P359, DOI 10.1016/j.tvjl.2010.05.005; Bryan C., 2011, MICROBIOLOGY IMMUNOL; Corti M, 2009, CURR OPIN PULM MED, V15, P209, DOI 10.1097/MCP.0b013e328329bd2c; den Boon S, 2005, THORAX, V60, P555, DOI 10.1136/thx.2004.030924; Eltholth MM, 2009, J APPL MICROBIOL, V107, P1061, DOI 10.1111/j.1365-2672.2009.04286.x; Joseph HA, 2008, J IMMIGR MINOR HEALT, V10, P177, DOI 10.1007/s10903-007-9067-5; Kankya C, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-320; Kankya C, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-471; Legesse M, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-187; Malama S, 2013, INFECT DIS POVERTY, V2, DOI 10.1186/2049-9957-2-13; Mawak Jd, 2006, Ghana Med J, V40, P132; Mfinanga S G M, 2004, East Afr Med J, V81, P171; Mfinanga SG, 2003, INT J TUBERC LUNG D, V7, P933; Munyeme M, 2010, BMC VET RES, V6, DOI 10.1186/1746-6148-6-21; National Bureau of Statistics (Tanzania), TANZ POP HOUS CENS 2; National TB, NAT TUB LEPR 2013 AN; National TB, NAT TUB LEPR 2011 AN; Oloya J, 2008, EPIDEMIOL INFECT, V136, P636, DOI 10.1017/S0950268807009004; Primm TP, 2004, CLIN MICROBIOL REV, V17, P98, DOI 10.1128/CMR.17.1.98-106.2004; Shitaye JE, 2007, VET MED-CZECH, V52, P317, DOI 10.17221/1872-VETMED; Shrestha-Kuwahara R, 2006, PERCEPTIONS TUBERCUL; Siddiqui MS, 2011, J PAK MED STUD, V1; van Ingen J, 2009, CLIN MICROBIOL INFEC, V15, P888, DOI 10.1111/j.1469-0691.2009.03013.x; Wanyeki I, 2006, SOC SCI MED, V63, P501, DOI 10.1016/j.socscimed.2005.12.015; WHO, WHOHTMTB201315; Young D., 2012, Journal of Public Health and Epidemiology, V4, P24	27	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2015	10	6							e0130180	10.1371/journal.pone.0130180	http://dx.doi.org/10.1371/journal.pone.0130180			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4OM	26107266	Green Published, gold, Green Submitted			2022-12-26	WOS:000356932500084
J	Liu, KE; Frazier, WA				Liu, Katherine E.; Frazier, William A.			Phosphorylation of the BNIP3 C-Terminus Inhibits Mitochondrial Damage and Cell Death without Blocking Autophagy	PLOS ONE			English	Article							PROTEIN-KINASE-A; HYPOXIA-INDUCED AUTOPHAGY; DNA COPY NUMBER; CYTOCHROME-C; ISCHEMIA/REPERFUSION INJURY; PERMEABILITY TRANSITION; INDUCED APOPTOSIS; CARDIAC MYOCYTES; UP-REGULATION; EXPRESSION	BNIP3 is a dual function protein, able to activate autophagy and induce cell death. Upon expression of BNIP3, which is upregulated by hypoxia, the protein induces mitochondrial dysfunction, often leading to cell death. However, some highly respiring cells and cancer cells tolerate BNIP3 expression, suggesting that a yet unknown mechanism exists to restrain the lethal effects of BNIP3 on mitochondria. Here we present evidence that BNIP3 undergoes several phosphorylation events at its C-terminus, adjacent to the transmembrane domain. Phosphorylation at these residues inhibits BNIP3-induced mitochondrial damage, preventing a loss of mitochondrial mass and mitochondrial membrane potential, as well as preventing an increase in reactive oxygen species. This decrease in mitochondrial damage, as well as the reduction of cell death upon C-terminal BNIP3 phosphorylation, can be explained by a diminished interaction between BNIP3 and OPA1, a key regulator of mitochondrial fusion and mitochondrial inner membrane structure. Importantly, phosphorylation of these C-terminal BNIP3 residues blocks cell death without preventing autophagy, providing evidence that the two functional roles of BNIP3 can be regulated independently. These findings establish phosphorylation as a switch to determine the pro-survival and pro-death effects of the protein. Our findings also suggest a novel target for the regulation of these activities in transformed cells where BNIP3 is often highly expressed.	[Liu, Katherine E.; Frazier, William A.] Washington Univ, Sch Med, Dept Biochem & Mol Biophys, St Louis, MO 63110 USA	Washington University (WUSTL)	Frazier, WA (corresponding author), Washington Univ, Sch Med, Dept Biochem & Mol Biophys, St Louis, MO 63110 USA.	frazier@wustl.edu	Liu, Katherine/GQA-3751-2022		National Institutes of Health [HL-54390, UL1-TR000448]; Washington University Siteman Cancer Center; National Cancer Institute Cancer Center Support Grant [P30 CA91842]; National Science Foundation Graduate Research Fellowship Program [DGE-1143954]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000448] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020579] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Washington University Siteman Cancer Center; National Cancer Institute Cancer Center Support Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Science Foundation Graduate Research Fellowship Program(National Science Foundation (NSF)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was supported by National Institutes of Health grants HL-54390 and UL1-TR000448 (WAF) (www.nih.gov), a pilot grant from the Washington University Siteman Cancer Center, supported by the National Cancer Institute Cancer Center Support Grant P30 CA91842 (WAF) (www.cancer.gov), and the National Science Foundation Graduate Research Fellowship Program under Grant No. DGE-1143954 (KEL) (www.nsfgrfp.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnoult D, 2005, J BIOL CHEM, V280, P35742, DOI 10.1074/jbc.M505970200; Azad MB, 2008, AUTOPHAGY, V4, P195, DOI 10.4161/auto.5278; Azad MB, 2010, ANN NY ACAD SCI, V1210, P8, DOI 10.1111/j.1749-6632.2010.05778.x; Bellot G, 2009, MOL CELL BIOL, V29, P2570, DOI 10.1128/MCB.00166-09; Bristow N, 2011, BBA-MOL BASIS DIS, V1812, P302, DOI 10.1016/j.bbadis.2010.11.013; Burton TR, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.100; Cipolat S, 2006, CELL, V126, P163, DOI 10.1016/j.cell.2006.06.021; Dalby KN, 2010, AUTOPHAGY, V6, P322, DOI 10.4161/auto.6.3.11625; Decuypere Jean-Paul, 2012, Cells, V1, P284, DOI 10.3390/cells1030284; Fentress SJ, 2010, CELL HOST MICROBE, V8, P484, DOI 10.1016/j.chom.2010.11.005; Ferecatu I, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-50; Frezza C, 2006, CELL, V126, P177, DOI 10.1016/j.cell.2006.06.025; Funderburk SF, 2010, TRENDS CELL BIOL, V20, P355, DOI 10.1016/j.tcb.2010.03.002; Ghavami S, 2010, CELL RES, V20, P314, DOI 10.1038/cr.2009.129; Ghavami S, 2009, BBA-MOL CELL RES, V1793, P546, DOI 10.1016/j.bbamcr.2009.01.002; Giatromanolaki A, 2008, J CLIN PATHOL, V61, P217, DOI 10.1136/jcp.2007.046680; Giatromanolaki A, 2004, CLIN CANCER RES, V10, P5566, DOI 10.1158/1078-0432.CCR-04-0076; Gordge PC, 1996, EUR J CANCER, V32A, P2120, DOI 10.1016/S0959-8049(96)00255-9; Graham RM, 2007, ANTIOXID REDOX SIGN, V9, P1309, DOI 10.1089/ars.2007.1726; Gu L, 2009, CLIN CANCER RES, V15, P7196, DOI 10.1158/1078-0432.CCR-09-0585; Guo K, 2001, CELL DEATH DIFFER, V8, P367, DOI 10.1038/sj.cdd.4400810; Gustafsson AB, 2011, PEDIATR CARDIOL, V32, P267, DOI 10.1007/s00246-010-9876-5; Hamacher-Brady A, 2007, CELL DEATH DIFFER, V14, P146, DOI 10.1038/sj.cdd.4401936; Hamacher-Brady A, 2006, J BIOL CHEM, V281, P29776, DOI 10.1074/jbc.M603783200; Hanna RA, 2012, J BIOL CHEM; He CY, 2013, DIABETES, V62, P1270, DOI 10.2337/db12-0533; Kaaman M, 2007, DIABETOLOGIA, V50, P2526, DOI 10.1007/s00125-007-0818-6; Kim JY, 2002, ARCH BIOCHEM BIOPHYS, V398, P147, DOI 10.1006/abbi.2001.2673; Kothari S, 2003, ONCOGENE, V22, P4734, DOI 10.1038/sj.onc.1206666; Kubasiak LA, 2002, P NATL ACAD SCI USA, V99, P12825, DOI 10.1073/pnas.202474099; Lamy L, 2003, J BIOL CHEM, V278, P23915, DOI 10.1074/jbc.M301869200; Landes T, 2010, EMBO REP, V11, P459, DOI 10.1038/embor.2010.50; Lee Y, 2011, AM J PHYSIOL-HEART C, V301, pH1924, DOI 10.1152/ajpheart.00368.2011; Lefkimmiatis K, 2013, J CELL BIOL, V202, P453, DOI 10.1083/jcb.201303159; Liu J, 2012, JOINT BONE SPINE, V79, P186, DOI 10.1016/j.jbspin.2011.04.011; Ma X, 2012, AUTOPHAGY, V8; Maes H, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.94; Mellor HR, 2010, BIOCHEM PHARMACOL, V79, P1562, DOI 10.1016/j.bcp.2010.01.019; Merrill RA, 2014, INT J BIOCHEM CELL B, V48, P92, DOI 10.1016/j.biocel.2013.12.012; Mizushima N, 2007, AUTOPHAGY, V3, P542, DOI 10.4161/auto.4600; Murai M, 2005, CLIN CANCER RES, V11, P1021; Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125; Okami J, 2004, CANCER RES, V64, P5338, DOI 10.1158/0008-5472.CAN-04-0089; Olichon A, 2003, J BIOL CHEM, V278, P7743, DOI 10.1074/jbc.C200677200; Pattingre S, 2005, CELL, V122, P927, DOI 10.1016/j.cell.2005.07.002; Perry SW, 2011, BIOTECHNIQUES, V50, P98, DOI 10.2144/000113610; Pidoux G, 2010, J MOL ENDOCRINOL, V44, P271, DOI 10.1677/JME-10-0010; Prabhakaran K, 2007, NEUROSCIENCE, V150, P159, DOI 10.1016/j.neuroscience.2007.07.033; Quinsay MN, 2010, AUTOPHAGY, V6, P855, DOI 10.4161/auto.6.7.13005; Ray R, 2000, J BIOL CHEM, V275, P1439, DOI 10.1074/jbc.275.2.1439; Regula KM, 2002, CIRC RES, V91, P226, DOI 10.1161/01.RES.0000029232.42227.16; Rikka S, 2011, CELL DEATH DIFFER, V18, P721, DOI 10.1038/cdd.2010.146; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Scorrano L, 2002, DEV CELL, V2, P55, DOI 10.1016/S1534-5807(01)00116-2; Shaikh D, 2012, CELL SIGNAL, V24, P2396, DOI 10.1016/j.cellsig.2012.08.007; Sowter HM, 2003, J PATHOL, V201, P573, DOI 10.1002/path.1486; Tsigginou A, 2012, ENDOCR-RELAT CANCER, V19, P457, DOI 10.1530/ERC-11-0328; Twig G, 2008, EMBO J, V27, P433, DOI 10.1038/sj.emboj.7601963; Vande Velde C, 2000, MOL CELL BIOL, V20, P5454, DOI 10.1128/MCB.20.15.5454-5468.2000; Venegas V, 2012, METHODS MOL BIOL, V837, P327, DOI 10.1007/978-1-61779-504-6_22; Vijayalingam S, 2010, Genes Cancer, V1, P964, DOI 10.1177/1947601910386110; Wang Y, 2013, HEPATOLOGY, V58, P995, DOI 10.1002/hep.26394; Wojtkowiak JW, 2012, CANCER RES, V72, P3938, DOI 10.1158/0008-5472.CAN-11-3881; Yamamoto K, 1999, MOL CELL BIOL, V19, P8469; Yang ZF, 2010, CURR OPIN CELL BIOL, V22, P124, DOI 10.1016/j.ceb.2009.11.014; Zhang HF, 2008, J BIOL CHEM, V283, P10892, DOI 10.1074/jbc.M800102200; Zhang J, 2009, CELL DEATH DIFFER, V16, P939, DOI 10.1038/cdd.2009.16; Zhu YY, 2013, J BIOL CHEM, V288, P1099, DOI 10.1074/jbc.M112.399345	68	26	26	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2015	10	6							e0129667	10.1371/journal.pone.0129667	http://dx.doi.org/10.1371/journal.pone.0129667			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4DD	26102349	Green Published, gold, Green Submitted			2022-12-26	WOS:000356901900018
J	Bindels, LB; Neyrinck, AM; Salazar, N; Taminiau, B; Druart, C; Muccioli, GG; Francois, E; Blecker, C; Richel, A; Daube, G; Mahillon, J; de los Reyes-Gavilan, CG; Cani, PD; Delzenne, NM				Bindels, Laure B.; Neyrinck, Audrey M.; Salazar, Nuria; Taminiau, Bernard; Druart, Celine; Muccioli, Giulio G.; Francois, Emmanuelle; Blecker, Christophe; Richel, Aurore; Daube, Georges; Mahillon, Jacques; de los Reyes-Gavilan, Clara G.; Cani, Patrice D.; Delzenne, Nathalie M.			Non Digestible Oligosaccharides Modulate the Gut Microbiota to Control the Development of Leukemia and Associated Cachexia in Mice	PLOS ONE			English	Article							CANCER-ASSOCIATED CACHEXIA; DIETARY FIBER; METABOLISM; PECTIN; CELLS; CHEMOTHERAPY; LIPOLYSIS; CHILDREN; HEALTHY; DISEASE	We tested the hypothesis that changing the gut microbiota using pectic oligosaccharides (POS) or inulin (INU) differently modulates the progression of leukemia and related metabolic disorders. Mice were transplanted with Bcr-Abl-transfected proB lymphocytes mimicking leukemia and received either POS or INU in their diet (5%) for 2 weeks. Combination of pyrosequencing, PCR-DGGE and qPCR analyses of the 16S rRNA gene revealed that POS decreased microbial diversity and richness of caecal microbiota whereas it increased Bifidobacterium spp., Roseburia spp. and Bacteroides spp. (affecting specifically B. dorei) to a higher extent than INU. INU supplementation increased the portal SCFA propionate and butyrate, and decreased cancer cell invasion in the liver. POS treatment did not affect hepatic cancer cell invasion, but was more efficient than INU to decrease the metabolic alterations. Indeed, POS better than INU delayed anorexia linked to cancer progression. In addition, POS treatment increased acetate in the caecal content, changed the fatty acid profile inside adipose tissue and counteracted the induction of markers controlling beta-oxidation, thereby hampering fat mass loss. Non digestible carbohydrates with prebiotic properties may constitute a new nutritional strategy to modulate gut microbiota with positive consequences on cancer progression and associated cachexia.	[Bindels, Laure B.; Neyrinck, Audrey M.; Salazar, Nuria; Druart, Celine; Cani, Patrice D.; Delzenne, Nathalie M.] Catholic Univ Louvain, Metab & Nutr Res Grp, Louvain Drug Res Inst, B-1200 Brussels, Belgium; [Taminiau, Bernard; Daube, Georges] Univ Liege, FARAH, Fac Vet Med, Liege, Belgium; [Muccioli, Giulio G.] Catholic Univ Louvain, Bioanal & Pharmacol Bioact Lipids Lab, Louvain Drug Res Inst, B-1200 Brussels, Belgium; [Francois, Emmanuelle; Blecker, Christophe; Richel, Aurore] Univ Liege, Gembloux Agrobio Tech, Dept Chem & Bioind, Gembloux, Belgium; [Mahillon, Jacques] Catholic Univ Louvain, Lab Food & Environm Microbiol, Earth & Life Inst, Louvain La Neuve, Belgium; [de los Reyes-Gavilan, Clara G.] IPLA CSIC, Dept Microbiol & Biochem Dairy Prod, Inst Prod Lacteos Asturias, Villaviciosa, Asturias, Spain; [Cani, Patrice D.] Louvain Drug Res Inst, Walloon Excellence Life Sci & BIOtechnol WELBIO, B-1200 Brussels, Belgium	Universite Catholique Louvain; University of Liege; Universite Catholique Louvain; University of Liege; Universite Catholique Louvain; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Productos Lacteos de Asturias (IPLA); WELBIO	Delzenne, NM (corresponding author), Catholic Univ Louvain, Metab & Nutr Res Grp, Louvain Drug Res Inst, B-1200 Brussels, Belgium.	nathalie.delzenne@uclouvain.be	Taminiau, Bernard/E-8008-2017; Salazar, Nuria/D-2189-2015; Neyrinck, Audrey/AAE-7929-2019; D., Cani Patrice/M-8055-2016; Delzenne, Nathalie/AAC-4628-2019; Bindels, Laure/T-7846-2019; de los Reyes-Gavilan, Clara G./E-5443-2011	Taminiau, Bernard/0000-0001-6456-329X; Salazar, Nuria/0000-0003-1435-7628; Neyrinck, Audrey/0000-0002-9435-3338; D., Cani Patrice/0000-0003-2040-2448; Delzenne, Nathalie/0000-0003-2115-6082; Bindels, Laure/0000-0003-3747-3234; de los Reyes-Gavilan, Clara G./0000-0001-9396-6311; Druart, Celine/0000-0002-7786-9172; Daube, Georges/0000-0002-9282-8408; Muccioli, Giulio/0000-0002-1600-9259; Richel, Aurore/0000-0002-4352-6542	F.R.S.-FNRS (Fond National de la Recherche Scientifique, Belgium); Spanish Ministry of Education, Culture and Sports; FRS-FNRS; FSR (UCL, Belgium); Walloon Region (Hydrasante Project) [816875]; Spanish Ministry of Economy and Competitiveness [AGL2010-16525]; FNRS; ERC (European Research Council) [336452-ENIGMO]	F.R.S.-FNRS (Fond National de la Recherche Scientifique, Belgium)(Fonds de la Recherche Scientifique - FNRS); Spanish Ministry of Education, Culture and Sports(Spanish Government); FRS-FNRS(Fonds de la Recherche Scientifique - FNRS); FSR (UCL, Belgium); Walloon Region (Hydrasante Project); Spanish Ministry of Economy and Competitiveness(Spanish Government); FNRS(Fonds de la Recherche Scientifique - FNRS); ERC (European Research Council)(European Research Council (ERC))	LBB is a Postdoctoral Researcher from the F.R.S.-FNRS (Fond National de la Recherche Scientifique, Belgium). NS is the recipient of a postdoctoral fellowship from the Spanish Ministry of Education, Culture and Sports. CD benefits from a Danone Institute grant. PDC is a research associate at FRS-FNRS (Fonds de la Recherche Scientifique, Belgium). GGM is a recipient of grants from FRS-FNRS and from FSR (UCL, Belgium). Financial support has been provided by a grant from the Walloon Region (Hydrasante Project, convention 816875) and by a grant from the Spanish Ministry of Economy and Competitiveness (AGL2010-16525). NMD and PDC are recipients of grants from FNRS, and PDC is a recipient of ERC Starting Grant 2013 (European Research Council, Starting Grant 336452-ENIGMO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agustsson T, 2007, CANCER RES, V67, P5531, DOI 10.1158/0008-5472.CAN-06-4585; Argiles JM, 2014, NAT REV CANCER, V14, P754, DOI 10.1038/nrc3829; Bakir MA, 2006, INT J SYST EVOL MICR, V56, P1639, DOI 10.1099/ijs.0.64257-0; Baracos VE, 2012, CURR OPIN CLIN NUTR, V15, P211, DOI 10.1097/MCO.0b013e328352dc41; Bindels LB, 2012, BRIT J CANCER, V107, P1337, DOI 10.1038/bjc.2012.409; Bindels LB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037971; Bindels LB, 2015, NAT REV GASTROENTERO; Cabassi A, 2013, CURR OPIN CLIN NUTR, V16, P267, DOI 10.1097/MCO.0b013e32835f816c; Claesson MJ, 2012, NATURE, V488, P178, DOI 10.1038/nature11319; Das SK, 2013, TRENDS MOL MED, V19, P292, DOI 10.1016/j.molmed.2013.02.006; Das SK, 2011, SCIENCE, V333, P233, DOI 10.1126/science.1198973; Dewulf EM, 2013, GUT, V62, P1112, DOI 10.1136/gutjnl-2012-303304; DEWYS WD, 1980, AM J MED, V69, P491, DOI 10.1016/S0149-2918(05)80001-3; Druart C, 2013, BR J NUTR, V18, P1, DOI DOI 10.1017/S000711451300278X; Druart C, 2014, ADV NUTR, V5, p624S, DOI 10.3945/an.114.005835; Druart C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087560; Everard A, 2014, ISME J; Everard A, 2011, DIABETES, V60, P2775, DOI 10.2337/db11-0227; Fearon K, 2013, NAT REV CLIN ONCOL, V10, P90, DOI 10.1038/nrclinonc.2012.209; Fiskus W, 2006, CLIN CANCER RES, V12, P5869, DOI 10.1158/1078-0432.CCR-06-0980; Fiskus W, 2006, BLOOD, V108, P645, DOI 10.1182/blood-2005-11-4639; Ge HF, 2008, ENDOCRINOLOGY, V149, P4519, DOI 10.1210/en.2008-0059; Inoue Y, 2007, EXP HEMATOL, V35, P407, DOI 10.1016/j.exphem.2006.11.006; Koren O, 2012, CELL, V150, P470, DOI 10.1016/j.cell.2012.07.008; Leijdekkers AGM, 2014, J AGR FOOD CHEM, V62, P1079, DOI 10.1021/jf4049676; Louis P, 2007, J APPL MICROBIOL, V102, P1197, DOI 10.1111/j.1365-2672.2007.03322.x; Monira S, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00228; Moschovi M, 2008, J PEDIAT HEMATOL ONC, V30, P733, DOI 10.1097/MPH.0b013e318179a1d8; Neyrinck AM, 2012, J NUTR BIOCHEM, V23, P51, DOI 10.1016/j.jnutbio.2010.10.008; Neyrinck AM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020944; Olano-Martin E, 2002, J APPL MICROBIOL, V93, P505, DOI 10.1046/j.1365-2672.2002.01719.x; Onumpai C, 2011, APPL ENVIRON MICROB, V77, P5747, DOI 10.1128/AEM.00179-11; Peters DG, 2001, BLOOD, V97, P1404, DOI 10.1182/blood.V97.5.1404; Roberfroid M, 2010, BRIT J NUTR, V104, pS1, DOI 10.1017/S0007114510003363; Ryan KK, 2014, NATURE, V509, P183, DOI 10.1038/nature13135; Salazar N, 2011, INT J FOOD MICROBIOL, V144, P342, DOI 10.1016/j.ijfoodmicro.2010.10.016; Sanaka M, 2007, CLIN EXP PHARMACOL P, V34, P1151, DOI 10.1111/j.1440-1681.2007.04706.x; Sessions J, 2007, J MANAGE CARE PHARM, V13, pS4, DOI 10.18553/jmcp.2007.13.s8-a.4; Sheridan PO, 2014, GUT MICROBES, V5, P74, DOI 10.4161/gmic.27252; Smith MI, 2013, SCIENCE, V339, P548, DOI 10.1126/science.1229000; Trompette A, 2014, NAT MED, V20, P159, DOI 10.1038/nm.3444; Wanders AJ, 2014, PHYSIOL BEHAV, V128, P212, DOI 10.1016/j.physbeh.2014.02.007	42	74	79	0	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2015	10	6							e0131009	10.1371/journal.pone.0131009	http://dx.doi.org/10.1371/journal.pone.0131009			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL3FM	26098097	gold, Green Published			2022-12-26	WOS:000356835800131
J	Jiang, LF; Song, MK; Luo, CL; Zhang, DY; Zhang, G				Jiang, Longfei; Song, Mengke; Luo, Chunling; Zhang, Dayi; Zhang, Gan			Novel Phenanthrene-Degrading Bacteria Identified by DNA-Stable Isotope Probing	PLOS ONE			English	Article							POLYCYCLIC AROMATIC-HYDROCARBONS; PAH-CONTAMINATED SOIL; 16S RIBOSOMAL-RNA; MICROBIAL COMMUNITY STRUCTURE; TIME PCR QUANTIFICATION; IN-SITU; DIOXYGENASE GENES; DIVERSITY; BIODEGRADATION; DEGRADATION	Microorganisms responsible for the degradation of phenanthrene in a clean forest soil sample were identified by DNA-based stable isotope probing (SIP). The soil was artificially amended with either C-12- or C-13-labeled phenanthrene, and soil DNA was extracted on days 3, 6 and 9. Terminal restriction fragment length polymorphism (TRFLP) results revealed that the fragments of 219- and 241-bp in HaeIII digests were distributed throughout the gradient profile at three different sampling time points, and both fragments were more dominant in the heavy fractions of the samples exposed to the C-13-labeled contaminant. 16S rRNA sequencing of the C-13-enriched fraction suggested that Acidobacterium spp. within the class Acidobacteria, and Collimonas spp. within the class Betaproteobacteria, were directly involved in the uptake and degradation of phenanthrene at different times. To our knowledge, this is the first report that the genus Collimonas has the ability to degrade PAHs. Two PAH-RHD alpha genes were identified in C-13-labeled DNA. However, isolation of pure cultures indicated that strains of Staphylococcus sp. PHE-3, Pseudomonas sp. PHE-1, and Pseudomonas sp. PHE-2 in the soil had high phenanthrene-degrading ability. This emphasizes the role of a culture-independent method in the functional understanding of microbial communities in situ.	[Jiang, Longfei; Song, Mengke; Luo, Chunling; Zhang, Gan] Chinese Acad Sci, Guangzhou Inst Geochem, State Key Lab Organ Geochem, Guangzhou 510640, Guangdong, Peoples R China; [Zhang, Dayi] Univ Lancaster, Lancaster Environm Ctr, Lancaster LA1 4YQ, England; [Song, Mengke] Chinese Acad Sci, Grad Univ, Beijing 100039, Peoples R China	Chinese Academy of Sciences; Guangzhou Institute of Geochemistry, CAS; Lancaster University; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Luo, CL (corresponding author), Chinese Acad Sci, Guangzhou Inst Geochem, State Key Lab Organ Geochem, Guangzhou 510640, Guangdong, Peoples R China.	clluo@gig.ac.cn	Zhang, Dayi/Y-2956-2019; Song, Mengke/F-2101-2019; Zhang, Gan/C-3528-2012; ZHANG, DAYI/F-7858-2010	Song, Mengke/0000-0001-7360-7821; ZHANG, DAYI/0000-0002-4175-5982; Zhang, Dayi/0000-0002-1647-0408	National Natural Science Foundation of China [41173082, 41322008, U1133004]; Natural Science Foundation of Guangdong Province, China [U1133004]; Natural Environment Research Council [ceh010010] Funding Source: researchfish	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Guangdong Province, China(National Natural Science Foundation of Guangdong Province); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This study was supported by the Joint Funds of the National Natural Science Foundation of China and the Natural Science Foundation of Guangdong Province, China (No. U1133004), and the National Natural Science Foundation of China (Nos. 41173082 and 41322008). This is contribution No. IS-2082 from GIGCAS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abed RMM, 2002, APPL ENVIRON MICROB, V68, P1674, DOI 10.1128/AEM.68.4.1674-1683.2002; Andreoni V, 2007, APPL MICROBIOL BIOT, V76, P287, DOI 10.1007/s00253-007-1018-5; Borodina E, 2005, ENVIRON MICROBIOL, V7, P1318, DOI 10.1111/j.1462-5822.2005.00819.x; Bosch R, 1999, GENE, V236, P149, DOI 10.1016/S0378-1119(99)00241-3; Cebron A, 2008, J MICROBIOL METH, V73, P148, DOI 10.1016/j.mimet.2008.01.009; Cebron A, 2011, ENVIRON MICROBIOL, V13, P722, DOI 10.1111/j.1462-2920.2010.02376.x; Chang CH, 2011, INT BIODETER BIODEGR, V65, P198, DOI 10.1016/j.ibiod.2010.11.003; Clement BG, 1998, J MICROBIOL METH, V31, P135, DOI 10.1016/S0167-7012(97)00105-X; Correa PA, 2010, ENVIRON INT, V36, P901, DOI 10.1016/j.envint.2009.07.015; Cupples AM, 2007, SOIL BIOL BIOCHEM, V39, P232, DOI 10.1016/j.soilbio.2006.07.011; de Boer W, 2004, INT J SYST EVOL MICR, V54, P857, DOI 10.1099/ijs.0.02920-0; DeRito CM, 2005, APPL ENVIRON MICROB, V71, P7858, DOI 10.1128/AEM.71.12.7858-7865.2005; Di Gregorio S, 2013, ENVIRON SCI POLLUT R, V20, P3989, DOI 10.1007/s11356-012-1350-x; Dunbar J, 1999, APPL ENVIRON MICROB, V65, P1662; Eisler R., 1987, POLYCYCLIC AROMATIC; Gan YL, 2012, APPL ENVIRON MICROB, V78, P4923, DOI 10.1128/AEM.00688-12; Gutierrez T, 2011, APPL ENVIRON MICROB, V77, P7856, DOI 10.1128/AEM.06200-11; Hamamura N, 2006, APPL ENVIRON MICROB, V72, P6316, DOI 10.1128/AEM.01015-06; Haritash AK, 2009, J HAZARD MATER, V169, P1, DOI 10.1016/j.jhazmat.2009.03.137; Hoppener-Ogawa S, 2007, APPL ENVIRON MICROB, V73, P4191, DOI 10.1128/AEM.00387-07; Jakobs-Schonwandt D, 2010, APPL ENVIRON MICROB, V76, P8076, DOI 10.1128/AEM.01092-10; Janssen PH, 2006, APPL ENVIRON MICROB, V72, P1719, DOI 10.1128/AEM.72.3.1719-1728.2006; Jeon CO, 2003, P NATL ACAD SCI USA, V100, P13591, DOI 10.1073/pnas.1735529100; Jones MD, 2008, MICROB ECOL, V56, P341, DOI 10.1007/s00248-007-9352-9; Jones MD, 2011, ENVIRON MICROBIOL, V13, P2623, DOI 10.1111/j.1462-2920.2011.02501.x; KEITH LH, 1979, ENVIRON SCI TECHNOL, V13, P416, DOI 10.1021/es60152a601; Kleinsteuber S, 2008, FEMS MICROBIOL ECOL, V63, P107, DOI 10.1111/j.1574-6941.2007.00402.x; Kumar M, 2010, J APPL MICROBIOL, V108, P1252, DOI 10.1111/j.1365-2672.2009.04523.x; Liu YJ, 2011, ENVIRON MICROBIOL, V13, P991, DOI 10.1111/j.1462-2920.2010.02405.x; Ludwig W, 1997, FEMS MICROBIOL LETT, V153, P181, DOI 10.1016/S0378-1097(97)00256-5; Lueders T, 2004, APPL ENVIRON MICROB, V70, P5778, DOI 10.1128/AEM.70.10.5778-5786.2004; Luo CL, 2009, APPL ENVIRON MICROB, V75, P4644, DOI 10.1128/AEM.00283-09; Mahmood S, 2005, ENVIRON MICROBIOL, V7, P1349, DOI 10.1111/j.1462-2920.2005.00822.x; Mallick S, 2007, MICROBIOL-SGM, V153, P2104, DOI 10.1099/mic.0.2006/004218-0; Martin F, 2012, ENVIRON POLLUT, V162, P345, DOI 10.1016/j.envpol.2011.11.032; Moscoso F, 2012, IND ENG CHEM RES, V51, P15895, DOI 10.1021/ie3021736; Moser R, 2001, APPL MICROBIOL BIOT, V55, P609, DOI 10.1007/s002530000489; MU DY, 1994, APPL ENVIRON MICROB, V60, P2661, DOI 10.1128/AEM.60.7.2661-2665.1994; Oren A, 2004, PHILOS T R SOC B, V359, P623, DOI 10.1098/rstb.2003.1458; Osborn AM, 2000, ENVIRON MICROBIOL, V2, P39, DOI 10.1046/j.1462-2920.2000.00081.x; Peng RH, 2008, FEMS MICROBIOL REV, V32, P927, DOI 10.1111/j.1574-6976.2008.00127.x; Perez-Leblic MI, 2012, J ENVIRON MANAGE, V95, pS285, DOI 10.1016/j.jenvman.2010.07.017; Powell SN, 2008, ENVIRON SCI TECHNOL, V42, P4099, DOI 10.1021/es703007n; Quaiser A, 2008, ENVIRON MICROBIOL, V10, P2704, DOI 10.1111/j.1462-2920.2008.01691.x; Radajewski S, 2000, NATURE, V403, P646, DOI 10.1038/35001054; Regonne RK, 2013, ENVIRON POLLUT, V180, P145, DOI 10.1016/j.envpol.2013.04.038; Rentz JA, 2004, ENVIRON MICROBIOL, V6, P574, DOI 10.1111/j.1462-2920.2004.00589.x; Rosano-Hernandez MC, 2012, J ENVIRON MANAGE, V95, pS325, DOI 10.1016/j.jenvman.2011.06.046; Sawulski P, 2014, BIODEGRADATION, V25, P835, DOI 10.1007/s10532-014-9703-4; Singleton DR, 2006, ENVIRON MICROBIOL, V8, P1736, DOI 10.1111/j.1462-2920.2006.01112.x; Singleton DR, 2005, APPL ENVIRON MICROB, V71, P1202, DOI 10.1128/AEM.71.3.1202-1209.2005; Sul WJ, 2009, APPL ENVIRON MICROB, V75, P5501, DOI 10.1128/AEM.00121-09; Sun WM, 2010, APPL ENVIRON MICROB, V76, P956, DOI 10.1128/AEM.01364-09; Tejeda-Agredano MC, 2013, SOIL BIOL BIOCHEM, V57, P830, DOI 10.1016/j.soilbio.2012.08.008; Tian WJ, 2014, ECOL ENG, V70, P275, DOI 10.1016/j.ecoleng.2014.06.003; Uhlik O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040653; Uroz S, 2007, APPL ENVIRON MICROB, V73, P3019, DOI 10.1128/AEM.00121-07; Uroz S, 2009, SOIL BIOL BIOCHEM, V41, P2178, DOI 10.1016/j.soilbio.2009.07.031; Whiteley AS, 2006, CURR OPIN BIOTECH, V17, P67, DOI 10.1016/j.copbio.2005.11.002; Xie SG, 2011, BIODEGRADATION, V22, P71, DOI 10.1007/s10532-010-9377-5; Zhang XZ, 2014, CURR MICROBIOL, V68, P756, DOI 10.1007/s00284-014-0535-6	61	27	27	2	129	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2015	10	6							e0130846	10.1371/journal.pone.0130846	http://dx.doi.org/10.1371/journal.pone.0130846			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL3FM	26098417	Green Submitted, gold, Green Published, Green Accepted			2022-12-26	WOS:000356835800111
J	Zhang, Y; Huang, Q; Tang, M; Zhang, JJ; Fan, W				Zhang, Yi; Huang, Qing; Tang, Min; Zhang, Junjun; Fan, Wei			Complement Factor H Expressed by Retinal Pigment Epithelium Cells Can Suppress Neovascularization of Human Umbilical Vein Endothelial Cells: An in vitro Study	PLOS ONE			English	Article							MACULAR DEGENERATION; OXIDATIVE STRESS; GROWTH-FACTOR; CHOROIDAL NEOVASCULARIZATION; ACTIVATION; DRUSEN; PROTEINS; PATHOGENESIS; INFLAMMATION; POLYMORPHISM	Complement factor H (CFH) is one of the most important soluble complement regulatory proteins and is closely associated with age-related macular degeneration (AMD), the leading cause of irreversible central vision loss in the elderly population in developed countries. Our study searches to investigate whether CFH expression is changed in oxidative damaged retinal pigment epithelium (RPE) cells and the role of CFH in the in vitro neovascularization. First, it was confirmed by immunofluorescence staining that CFH was expressed by ARPE-19 cells. CFH mRNA and protein in oxidative (H2O2) damaged ARPE-19 cells were both reduced, as determined by Real-time PCR and Western blotting analysis. Enzyme-linked immunosorbent assay (ELISA) also showed that ARPE-19 cells treated with H2O2 caused an increase in C3a content, which indicates complement activation. Then, wound assays were performed to show that CFH expression suppression promoted human umbilical vein endothelial cell (HUVECs) migration. Thereafter, ARPE-19 cells were transfected with CFH-specific siRNA and CFH knockdown was confirmed with the aid of Real-time PCR, immunofluorescence staining and Western blotting. The ELISA results showed that specific CFH knockdown in ARPE-19 cells activated the complement system. Finally, in vitro matrigel tube formation assay was performed to determine whether change of CFH expression in RPE would affect tube formation by HUVECs. More tubes were formed by HUVECs co-cultured with ARPE-19 cells transfected with CFH specific-siRNA when compared with controls. Our results suggested that RPE cells might be the local CFH source, and RPE cell injuries (such as oxidative stress) may cause CFH expression suppression, which in turn may lead to complement activation and promotion of tube formation by HUVECs. This finding is of importance in elucidating the role of complement in the pathogenesis of ocular neovascularization including choroidal neovascularization.	[Zhang, Yi; Huang, Qing; Tang, Min; Zhang, Junjun; Fan, Wei] Sichuan Univ, West China Hosp, Dept Ophthalmol, Chengdu, Sichuan, Peoples R China	Sichuan University	Fan, W (corresponding author), Sichuan Univ, West China Hosp, Dept Ophthalmol, Chengdu, Sichuan, Peoples R China.	fanwei55@yahoo.com			National Natural Science Foundation of China [8107042]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	WF is supported by the National Natural Science Foundation of China (No. 8107042). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen RG, 2000, FREE RADICAL BIO MED, V28, P463, DOI 10.1016/S0891-5849(99)00242-7; An E, 2006, J PROTEOME RES, V5, P2599, DOI 10.1021/pr060121j; Anderson DH, 2002, AM J OPHTHALMOL, V134, P411, DOI 10.1016/S0002-9394(02)01624-0; Bailey TA, 2004, INVEST OPHTH VIS SCI, V45, P675, DOI 10.1167/iovs.03-0351; Beatty S, 2000, SURV OPHTHALMOL, V45, P115, DOI 10.1016/S0039-6257(00)00140-5; BENZAQUEN LR, 1994, J EXP MED, V179, P985, DOI 10.1084/jem.179.3.985; Bhutto IA, 2011, BRIT J OPHTHALMOL, V95, P1323, DOI 10.1136/bjo.2010.199216; Bora NS, 2006, J IMMUNOL, V177, P1872, DOI 10.4049/jimmunol.177.3.1872; Bradley DT, 2011, EYE, V25, P683, DOI 10.1038/eye.2011.37; Brantley MA, 2007, OPHTHALMOLOGY, V114, P2168, DOI 10.1016/j.ophtha.2007.09.008; BROOIMANS RA, 1992, EUR J IMMUNOL, V22, P791, DOI 10.1002/eji.1830220324; Chen M, 2007, EXP EYE RES, V84, P635, DOI 10.1016/j.exer.2006.11.015; Dawson DW, 1999, SCIENCE, V285, P245, DOI 10.1126/science.285.5425.245; Denker SP, 2002, J CELL BIOL, V159, P1087, DOI 10.1083/jcb.200208050; Ding XY, 2009, PROG RETIN EYE RES, V28, P1, DOI 10.1016/j.preteyeres.2008.10.001; Donoso LA, 2006, SURV OPHTHALMOL, V51, P137, DOI 10.1016/j.survophthal.2005.12.001; Duvvari MR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094165; Edwards AO, 2005, SCIENCE, V308, P421, DOI 10.1126/science.1110189; Fan W, 2002, INVEST OPHTH VIS SCI, V43, pU656; Fan W, 2002, IN VITRO CELL DEV-AN, V38, P228; Ferrara N, 2004, ENDOCR REV, V25, P581, DOI 10.1210/er.2003-0027; Flierman R, 2007, IMMUNOBIOLOGY, V212, P363, DOI 10.1016/j.imbio.2006.11.005; Fosbrink M, 2006, J BIOL CHEM, V281, P19009, DOI 10.1074/jbc.M602055200; Goverdhan SV, 2008, EYE, V22, P849, DOI 10.1038/sj.eye.6702830; Haines JL, 2005, SCIENCE, V308, P419, DOI 10.1126/science.1110359; Honda S, 2001, MOL VIS, V7, P63; Johnson LV, 2001, EXP EYE RES, V73, P887, DOI 10.1006/exer.2001.1094; Kaczara P, 2010, FREE RADICAL BIO MED, V48, P1064, DOI 10.1016/j.freeradbiomed.2010.01.022; Kim Min-Ho, 2003, Korean J Ophthalmol, V17, P19; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; Kurihara R, 2010, INFLAMM RES, V59, P659, DOI 10.1007/s00011-010-0178-4; Kuroki M, 1996, J CLIN INVEST, V98, P1667, DOI 10.1172/JCI118962; Lambooij AC, 2003, INVEST OPHTH VIS SCI, V44, P2192, DOI 10.1167/iovs.02-0410; Mandal NA, 2006, INVEST OPHTH VIS SCI, V47, P4091, DOI 10.1167/iovs.05-1655; McLaughlin BJ, 2003, INVEST OPHTH VIS SCI, V44, P3669, DOI 10.1167/iovs.02-0813; Mullins RF, 2000, FASEB J, V14, P835, DOI 10.1096/fasebj.14.7.835; Nozaki M, 2006, P NATL ACAD SCI USA, V103, P2328, DOI 10.1073/pnas.0408835103; Ogata N, 1997, CURR EYE RES, V16, P9, DOI 10.1076/ceyr.16.1.9.5121; Salvador-Morales C, 2006, MOL IMMUNOL, V43, P193, DOI 10.1016/j.molimm.2005.02.006; Scholl HPN, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002593; Sivaprasad S, 2006, EYE, V20, P867, DOI 10.1038/sj.eye.6702176; Skeie JM, 2010, INVEST OPHTH VIS SCI, V51, P5336, DOI 10.1167/iovs.10-5322; Smailhodzic D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112682; Sparrow JR, 2010, ADV EXP MED BIOL, V703, P63, DOI 10.1007/978-1-4419-5635-4_5; Umeda S, 2005, FASEB J, V19, P1683, DOI 10.1096/fj.04-3525fje; Vogt SD, 2011, EXP EYE RES, V93, P413, DOI 10.1016/j.exer.2011.06.002; von Leithner PL, 2009, AM J PATHOL, V175, P412, DOI 10.2353/ajpath.2009.080927; Wu ZH, 2007, J BIOL CHEM, V282, P22414, DOI 10.1074/jbc.M702321200; Yang P, 2009, INVEST OPHTH VIS SCI, V50, P3473, DOI 10.1167/iovs.08-3202; Zhou JL, 2006, P NATL ACAD SCI USA, V103, P16182, DOI 10.1073/pnas.0604255103	50	9	9	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2015	10	6							e0129945	10.1371/journal.pone.0129945	http://dx.doi.org/10.1371/journal.pone.0129945			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL3FE	26091360	Green Published, Green Submitted, gold			2022-12-26	WOS:000356835000075
J	Marshall, J; Wong, KY; Rupasinghe, CN; Tiwari, R; Zhao, XW; Berberoglu, ED; Sinkler, C; Liu, J; Lee, I; Parang, K; Spaller, MR; Huttemann, M; Goebel, DJ				Marshall, John; Wong, Kwoon Y.; Rupasinghe, Chamila N.; Tiwari, Rakesh; Zhao, Xiwu; Berberoglu, Eren D.; Sinkler, Christopher; Liu, Jenney; Lee, Icksoo; Parang, Keykavous; Spaller, Mark R.; Huettemann, Maik; Goebel, Dennis J.			Inhibition of N-Methyl-D-aspartate-induced Retinal Neuronal Death by Polyarginine Peptides Is Linked to the Attenuation of Stress-induced Hyperpolarization of the Inner Mitochondrial Membrane Potential	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NMDA RECEPTOR SUBUNITS; CELL-DEATH; OXIDATIVE STRESS; PERMEABILITY TRANSITION; SYNAPTIC-TRANSMISSION; INDUCED NEUROTOXICITY; SIGNALING PATHWAYS; DIFFERENT ROLES; CYTOCHROME-C; PDZ DOMAIN	It is widely accepted that overactivation of NMDA receptors, resulting in calcium overload and consequent mitochondrial dysfunction in retinal ganglion neurons, plays a significant role in promoting neurodegenerative disorders such as glaucoma. Calcium has been shown to initiate a transient hyperpolarization of the mitochondrial membrane potential triggering a burst of reactive oxygen species leading to apoptosis. Strategies that enhance cell survival signaling pathways aimed at preventing this adverse hyperpolarization of the mitochondrial membrane potential may provide a novel therapeutic intervention in retinal disease. In the retina, brain-derived neurotrophic factor has been shown to be neuroprotective, and our group previously reported a PSD-95/PDZ-binding cyclic peptide (CN2097) that augments brain-derived neurotrophic factor-induced pro-survival signaling. Here, we examined the neuroprotective properties of CN2097 using an established retinal in vivo NMDA toxicity model. CN2097 completely attenuated NMDA-induced caspase 3-dependent and -independent cell death and PARP-1 activation pathways, blocked necrosis, and fully prevented the loss of long term ganglion cell viability. Although neuroprotection was partially dependent upon CN2097 binding to the PDZ domain of PSD-95, our results show that the polyarginine-rich transport moiety C-R(7), linked to the PDZ-PSD-95-binding cyclic peptide, was sufficient to mediate short and long term protection via a mitochondrial targeting mechanism. C-R(7) localized to mitochondria and was found to reduce mitochondrial respiration, mitochondrial membrane hyperpolarization, and the generation of reactive oxygen species, promoting survival of retinal neurons.	[Marshall, John] Brown Univ, Dept Mol Pharmacol Physiol & Biotechnol, Providence, RI 02912 USA; [Wong, Kwoon Y.; Zhao, Xiwu] Univ Michigan, Dept Ophthalmol & Visual Sci, Ann Arbor, MI 48105 USA; [Rupasinghe, Chamila N.; Spaller, Mark R.] Geisel Sch Med Dartmouth, Dept Pharmacol & Toxicol, Lebanon, NH 03756 USA; [Rupasinghe, Chamila N.; Spaller, Mark R.] Norris Cotton Canc Ctr, Lebanon, NH 03756 USA; [Tiwari, Rakesh; Parang, Keykavous] Chapman Univ, Sch Pharm, Irvine, CA 92618 USA; [Berberoglu, Eren D.; Goebel, Dennis J.] Wayne State Univ, Sch Med, Dept Anat & Cell Biol, Detroit, MI 48201 USA; [Sinkler, Christopher; Liu, Jenney; Huettemann, Maik] Wayne State Univ, Sch Med, Ctr Mol Med & Genet, Detroit, MI 48201 USA; [Lee, Icksoo] Dankook Univ, Coll Med, Cheonan Si 330714, Chungcheongnam, South Korea	Brown University; University of Michigan System; University of Michigan; Dartmouth College; Norris Cotton Cancer Center; Chapman University System; Chapman University; Wayne State University; Wayne State University; Dankook University	Goebel, DJ (corresponding author), Wayne State Univ, Dept Anat & Cell Biol, 540 E Canfield, Detroit, MI 48202 USA.	dgoebel@med.wayne.edu	Parang, Keykavous/ABC-1584-2021	Parang, Keykavous/0000-0001-8600-0893; Wong, Kwoon/0000-0001-9279-7827; Huttemann, Maik/0000-0001-6310-7081	National Institutes of Health from NINDS [R21 NS061176]; NEI [R01 EY014430, GM63021, P30EY0468, P20-EY00700]; NHLBI [T32HL120822]; NATIONAL EYE INSTITUTE [P30EY007003, R01EY014430] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL120822] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063021] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS061176] Funding Source: NIH RePORTER	National Institutes of Health from NINDS; NEI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants R21 NS061176 (to D. J. G., M. R. S., and J. M.) from NINDS, Grants R01 EY014430 (to D. J. G.) and GM63021 (to M. R. S.) from NEI, NEI Core Grants P30EY0468 (Wayne State University) and P20-EY00700 (University of Michigan), and NHLBI Training Grant T32HL120822 (to C. S.). J. M. owns shares in Angelus Therapeutics. No materials or support were received from this company. United States patent application entitled "Neuroprotective Composition and Method of Use" (United States Patent Application WO2013158739) has been filed by Brown University, with D. J. G. and J. M. listed as inventors.	Aarts M, 2002, SCIENCE, V298, P846, DOI 10.1126/science.1072873; Abeti R, 2015, PHARMACOL RES, V99, P377, DOI 10.1016/j.phrs.2015.05.007; Abramov AY, 2008, BBA-BIOENERGETICS, V1777, P953, DOI 10.1016/j.bbabio.2008.04.017; Almeida RD, 2005, CELL DEATH DIFFER, V12, P1329, DOI 10.1038/sj.cdd.4401662; Bai N, 2013, MOL BRAIN, V6, DOI 10.1186/1756-6606-6-34; Bartlett TE, 2013, NEUROPHARMACOLOGY, V74, P59, DOI 10.1016/j.neuropharm.2013.01.012; Bell KFS, 2013, J NEUROCHEM, V126, P274, DOI 10.1111/jnc.12176; Brustovetsky T, 2014, J BIOL CHEM, V289, P7470, DOI 10.1074/jbc.M113.518472; Buckingham BP, 2008, J NEUROSCI, V28, P2735, DOI 10.1523/JNEUROSCI.4443-07.2008; Calkins DJ, 2012, PROG RETIN EYE RES, V31, P702, DOI 10.1016/j.preteyeres.2012.07.001; Cao C, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001478; Costantini P, 1996, J BIOL CHEM, V271, P6746, DOI 10.1074/jbc.271.12.6746; Eriksson O, 1998, J BIOL CHEM, V273, P12669, DOI 10.1074/jbc.273.20.12669; Figurov A, 1996, NATURE, V381, P706, DOI 10.1038/381706a0; Gajavelli S, 2015, J BIOENERG BIOMEMBR, V47, P133, DOI 10.1007/s10863-014-9589-1; Goebel DJ, 2006, J NEUROCHEM, V98, P1732, DOI 10.1111/j.1471-4159.2006.04065.x; Goebel DJ, 2009, BRAIN RES, V1256, P190, DOI 10.1016/j.brainres.2008.12.051; Goebel DJ, 1998, BRAIN RES, V808, P141, DOI 10.1016/S0006-8993(98)00749-5; Grover GJ, 2004, AM J PHYSIOL-HEART C, V287, pH1747, DOI 10.1152/ajpheart.01019.2003; Guigas B, 2004, BIOCHEM J, V382, P877, DOI 10.1042/BJ20040885; Guo X, 2014, BIOCHEM J, V461, P137, DOI 10.1042/BJ20131438; Hardingham GE, 2002, NAT NEUROSCI, V5, P405, DOI 10.1038/nn835; Hernandez C, 2012, CURR DIABETES REP, V12, P329, DOI 10.1007/s11892-012-0284-5; Huttemann M, 2011, MITOCHONDRION, V11, P369, DOI 10.1016/j.mito.2011.01.010; Ji YY, 2010, NAT NEUROSCI, V13, P302, DOI 10.1038/nn.2505; Jonas EA, 2009, EXP NEUROL, V218, P203, DOI 10.1016/j.expneurol.2009.03.025; Kadenbach B, 2004, BBA-BIOENERGETICS, V1655, P400, DOI 10.1016/j.bbabio.2003.06.005; KANG HJ, 1995, SCIENCE, V267, P1658, DOI 10.1126/science.7886457; Kang HJ, 1997, NEURON, V19, P653, DOI 10.1016/S0896-6273(00)80378-5; Kolarow R, 2007, J NEUROSCI, V27, P10350, DOI 10.1523/JNEUROSCI.0692-07.2007; KORNAU HC, 1995, SCIENCE, V269, P1737, DOI 10.1126/science.7569905; LeBlanc BW, 2010, NEUROSCIENCE, V167, P490, DOI 10.1016/j.neuroscience.2010.02.031; Lee D, 2014, APOPTOSIS, V19, P603, DOI 10.1007/s10495-013-0956-x; Lee I, 2010, BBA-MOL BASIS DIS, V1802, P275, DOI 10.1016/j.bbadis.2009.10.005; LEVY DI, 1990, NEUROLOGY, V40, P852, DOI 10.1212/WNL.40.5.852; Li T, 2004, BIOORG MED CHEM LETT, V14, P1385, DOI 10.1016/j.bmcl.2003.09.103; Liu SS, 1999, J BIOENERG BIOMEMBR, V31, P367; Martel MA, 2012, NEURON, V74, P543, DOI 10.1016/j.neuron.2012.03.021; Meloni BP, 2015, J CEREBR BLOOD F MET, V35, P993, DOI 10.1038/jcbfm.2015.11; Meloni BP, 2014, CELL MOL NEUROBIOL, V34, P173, DOI 10.1007/s10571-013-9999-3; Messaoudi E, 1998, J NEUROPHYSIOL, V79, P496, DOI 10.1152/jn.1998.79.1.496; Minichiello L, 2009, NAT REV NEUROSCI, V10, P850, DOI 10.1038/nrn2738; Mittag TW, 2000, INVEST OPHTH VIS SCI, V41, P3451; Nguyen D, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.117; Osborne NN, 2010, EXP EYE RES, V90, P750, DOI 10.1016/j.exer.2010.03.008; Owen MR, 2000, BIOCHEM J, V348, P607, DOI 10.1042/0264-6021:3480607; Parsons MP, 2014, NEURON, V82, P279, DOI 10.1016/j.neuron.2014.03.030; Patra CR, 2012, ACS CHEM BIOL, V7, P770, DOI 10.1021/cb200536r; Piserchio A, 2004, CHEM BIOL, V11, P469, DOI 10.1016/j.chembiol.2004.03.013; Pourcho RG, 2001, J COMP NEUROL, V433, P75, DOI 10.1002/cne.1126; Qiu J, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3034; Reichardt LF, 2006, PHILOS T R SOC B, V361, P1545, DOI 10.1098/rstb.2006.1894; RIGOBELLO MP, 1995, BIOCHEM BIOPH RES CO, V217, P144, DOI 10.1006/bbrc.1995.2756; Sagdullaev BT, 2006, NEURON, V50, P923, DOI 10.1016/j.neuron.2006.05.015; Sanderson TH, 2013, MOL NEUROBIOL, V47, P9, DOI 10.1007/s12035-012-8344-z; Saro D, 2004, ORG LETT, V6, P3429, DOI 10.1021/ol049181q; Saro D, 2007, BIOCHEMISTRY-US, V46, P6340, DOI 10.1021/bi062088k; Schmidt N, 2010, FEBS LETT, V584, P1806, DOI 10.1016/j.febslet.2009.11.046; Seki M, 2008, PROG BRAIN RES, V173, P495, DOI 10.1016/S0079-6123(08)01134-5; SILIPRANDI R, 1992, VISUAL NEUROSCI, V8, P567, DOI 10.1017/S0952523800005666; Soriano FX, 2008, J NEUROSCI, V28, P10696, DOI 10.1523/JNEUROSCI.1207-08.2008; Stafford BK, 2014, J NEUROSCI, V34, P1942, DOI 10.1523/JNEUROSCI.4461-13.2014; Stout AK, 1998, NAT NEUROSCI, V1, P366, DOI 10.1038/1577; Szeto HH, 2006, AAPS J, V8, pE277, DOI 10.1007/BF02854898; Tezel G, 2006, PROG RETIN EYE RES, V25, P490, DOI 10.1016/j.preteyeres.2006.07.003; Vaslin A, 2009, NEUROTOX RES, V15, P123, DOI 10.1007/s12640-009-9012-6; Zhang J, 2009, J NEUROSCI, V29, P4274, DOI 10.1523/JNEUROSCI.5602-08.2009; Zhou X, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.82	68	42	45	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 4	2015	290	36					22030	22048		10.1074/jbc.M115.662791	http://dx.doi.org/10.1074/jbc.M115.662791			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CQ9XI	26100636	Green Published, hybrid			2022-12-26	WOS:000360968500023
J	Osman, D; Piergentili, C; Chen, JJ; Chakrabarti, B; Foster, AW; Lurie-Luke, E; Huggins, TG; Robinson, NJ				Osman, Deenah; Piergentili, Cecilia; Chen, Junjun; Chakrabarti, Buddhapriya; Foster, Andrew W.; Lurie-Luke, Elena; Huggins, Thomas G.; Robinson, Nigel J.			Generating a Metal-responsive Transcriptional Regulator to Test What Confers Metal Sensing in Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI RCNR; BACILLUS-SUBTILIS; REPRESSOR CSOR; MYCOBACTERIUM-TUBERCULOSIS; STAPHYLOCOCCUS-AUREUS; COPPER EFFLUX; BINDING SITES; HIGH-AFFINITY; TRANSFER-RNA; CODON USAGE	FrmR from Salmonella enterica serovar typhimurium (a CsoR/RcnR-like transcriptional de-repressor) is shown to repress the frmRA operator-promoter, and repression is alleviated by formaldehyde but not manganese, iron, cobalt, nickel, copper, or Zn(II) within cells. In contrast, repression by a mutant FrmRE64H (which gains an RcnR metal ligand) is alleviated by cobalt and Zn(II). Unexpectedly, FrmR was found to already bind Co(II), Zn(II), and Cu(I), and moreover metals, as well as formaldehyde, trigger an allosteric response that weakens DNA affinity. However, the sensory metal sites of the cells' endogenous metal sensors (RcnR, ZntR, Zur, and CueR) are all tighter than FrmR for their cognate metals. Furthermore, the endogenous metal sensors are shown to out-compete FrmR. The metal-sensing FrmRE64H mutant has tighter metal affinities than FrmR by approximately 1 order of magnitude. Gain of cobalt sensing by FrmRE64H remains enigmatic because the cobalt affinity of FrmRE64H is substantially weaker than that of the endogenous cobalt sensor. Cobalt sensing requires glutathione, which may assist cobalt access, conferring a kinetic advantage. For Zn(II), the metal affinity of FrmRE64H approaches the metal affinities of cognate Zn(II) sensors. Counter-intuitively, the allosteric coupling free energy for Zn(II) is smaller in metal-sensing FrmRE64H compared with nonsensing FrmR. By determining the copies of FrmR and FrmRE64H tetramers per cell, then estimating promoter occupancy as a function of intracellular Zn(II) concentration, we show how a modest tightening of Zn(II) affinity, plus weakened DNA affinity of the apoprotein, conspires to make the relative properties of FrmRE64H (compared with ZntR and Zur) sufficient to sense Zn(II) inside cells.	[Osman, Deenah; Piergentili, Cecilia; Chakrabarti, Buddhapriya; Foster, Andrew W.; Robinson, Nigel J.] Univ Durham, Sch Biol & Biomed Sci, Durham DH1 3LE, England; [Osman, Deenah; Piergentili, Cecilia; Chakrabarti, Buddhapriya; Foster, Andrew W.; Robinson, Nigel J.] Univ Durham, Dept Chem, Durham DH1 3LE, England; [Chen, Junjun; Huggins, Thomas G.] Procter & Gamble Co, Mason Business Ctr, Cincinnati, OH 45040 USA; [Lurie-Luke, Elena] Procter & Gamble Tech Ctr Ltd, London Innovat Ctr, Life Sci Open Innovat, Egham TW20 9NW, Surrey, England	Durham University; Durham University; Procter & Gamble; Procter & Gamble	Robinson, NJ (corresponding author), Univ Durham, Sch Biol & Biomed Sci, Durham DH1 3LE, England.	nigel.robinson@durham.ac.uk	Chakrabarti, Buddhapriya/AAC-8351-2020; Osman, Deenah/AAB-4516-2020; Robinson, Nigel J/J-6363-2012	Chakrabarti, Buddhapriya/0000-0003-2699-4157; Osman, Deenah/0000-0002-0251-9231; Robinson, Nigel J/0000-0001-5586-1092	Biotechnology and Biological Sciences Research Council [BB/J017787/1]; Procter and Gamble; BBSRC [BB/J017787/1, BB/L013711/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/L013711/1] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Procter and Gamble(Procter & Gamble); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by a Biotechnology and Biological Sciences Research Council Industrial Partnership Award BB/J017787/1 in conjunction with a financial contribution from Procter and Gamble.	Ammendola S, 2014, BIOMETALS, V27, P703, DOI 10.1007/s10534-014-9763-2; Baker J, 2011, ENVIRON MICROBIOL, V13, P2495, DOI 10.1111/j.1462-2920.2011.02522.x; Cave JS, 2002, J BIOL CHEM, V277, P38441, DOI 10.1074/jbc.M207677200; Chang FMJ, 2014, J BIOL CHEM, V289, P19204, DOI 10.1074/jbc.M114.556704; Changela A, 2003, SCIENCE, V301, P1383, DOI 10.1126/science.1085950; Cobine PA, 2002, BIOCHEMISTRY-US, V41, P5822, DOI 10.1021/bi025515c; Corbett D, 2011, MOL MICROBIOL, V81, P457, DOI 10.1111/j.1365-2958.2011.07705.x; Dainty SJ, 2010, J BIOL INORG CHEM, V15, P77, DOI 10.1007/s00775-009-0555-z; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Denby KJ, 2015, ENVIRON MICROBIOL, V17, P2477, DOI 10.1111/1462-2920.12726; Dong HJ, 1996, J MOL BIOL, V260, P649, DOI 10.1006/jmbi.1996.0428; Dwarakanath S, 2012, J BIOL CHEM, V287, P17833, DOI 10.1074/jbc.M112.352740; Espariz M, 2007, MICROBIOL-SGM, V153, P2989, DOI 10.1099/mic.0.2007/006536-0; Festa RA, 2011, MOL MICROBIOL, V79, P133, DOI 10.1111/j.1365-2958.2010.07431.x; Finney LA, 2003, SCIENCE, V300, P931, DOI 10.1126/science.1085049; Foster AW, 2014, J BIOL CHEM, V289, P28095, DOI 10.1074/jbc.R114.588145; Foster AW, 2014, MOL MICROBIOL, V92, P797, DOI 10.1111/mmi.12594; Foster AW, 2012, J BIOL CHEM, V287, P12142, DOI 10.1074/jbc.M111.338301; Gilston BA, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001987; Golynskiy MV, 2006, BIOCHEMISTRY-US, V45, P15359, DOI 10.1021/bi0607406; Grossoehme N, 2011, J BIOL CHEM, V286, P13522, DOI 10.1074/jbc.M111.220012; Grossoehme Nicholas E, 2012, Methods Mol Biol, V875, P165, DOI 10.1007/978-1-61779-806-1_8; Guerra AJ, 2012, ARCH BIOCHEM BIOPHYS, V519, P210, DOI 10.1016/j.abb.2011.11.021; GUTHEIL WG, 1992, BIOCHEMISTRY-US, V31, P475, DOI 10.1021/bi00117a025; Helbig K, 2008, J BACTERIOL, V190, P5431, DOI 10.1128/JB.00271-08; Helmann JD, 2014, J BIOL CHEM, V289, P28112, DOI 10.1074/jbc.R114.587071; Herring CD, 2004, J BACTERIOL, V186, P6714, DOI 10.1128/JB.186.20.6714-6720.2004; Higgins KA, 2014, CHEM LETT, V43, P20, DOI 10.1246/cl.130965; Higgins KA, 2013, BIOCHEMISTRY-US, V52, P84, DOI 10.1021/bi300886q; Higgins KA, 2012, J AM CHEM SOC, V134, P7081, DOI 10.1021/ja300834b; IRVING H, 1948, NATURE, V162, P746, DOI 10.1038/162746a0; Iwig JS, 2008, J AM CHEM SOC, V130, P7592, DOI 10.1021/ja710067d; Iwig JS, 2006, MOL MICROBIOL, V62, P252, DOI 10.1111/j.1365-2958.2006.05369.x; JEFFERSON JR, 1990, ANAL BIOCHEM, V187, P328, DOI 10.1016/0003-2697(90)90465-L; Kuzmic P, 1996, ANAL BIOCHEM, V237, P260, DOI 10.1006/abio.1996.0238; KWAN CY, 1990, J BIOL CHEM, V265, P678; Lisher JP, 2013, BIOCHEMISTRY-US, V52, P7689, DOI 10.1021/bi401132w; Liu LM, 2001, NATURE, V410, P490, DOI 10.1038/35068596; Liu T, 2007, NAT CHEM BIOL, V3, P60, DOI 10.1038/nchembio844; Lucarelli D, 2007, J BIOL CHEM, V282, P9914, DOI 10.1074/jbc.M609974200; Luebke JL, 2014, MOL MICROBIOL, V94, P1343, DOI 10.1111/mmi.12835; Ma Z, 2014, MOL MICROBIOL, V94, P756, DOI 10.1111/mmi.12794; Ma Z, 2012, MOL MICROBIOL, V86, P1144, DOI 10.1111/mmi.12049; Ma Z, 2011, NUCLEIC ACIDS RES, V39, P9130, DOI 10.1093/nar/gkr625; Ma Z, 2009, J AM CHEM SOC, V131, P18044, DOI 10.1021/ja908372b; Ma Z, 2009, CHEM REV, V109, P4644, DOI 10.1021/cr900077w; Ma Z, 2009, BIOCHEMISTRY-US, V48, P3325, DOI 10.1021/bi900115w; McGuire AM, 2013, BIOCHEMISTRY-US, V52, P701, DOI 10.1021/bi301550t; Nakamura Y, 2000, NUCLEIC ACIDS RES, V28, P292, DOI 10.1093/nar/28.1.292; Nobre LS, 2009, MICROBIOL-SGM, V155, P813, DOI 10.1099/mic.0.023911-0; Osman D, 2013, MOL MICROBIOL, V87, P466, DOI 10.1111/mmi.12107; Osman D, 2010, J BIOL CHEM, V285, P25259, DOI 10.1074/jbc.M110.145953; Patterson CJ, 2013, METALLOMICS, V5, P352, DOI 10.1039/c3mt20241k; Pennella MA, 2006, J MOL BIOL, V356, P1124, DOI 10.1016/j.jmb.2005.12.019; Petrarca P, 2010, J BACTERIOL, V192, P1553, DOI 10.1128/JB.01310-09; Reyes-Caballero H, 2011, BIOPHYS CHEM, V156, P103, DOI 10.1016/j.bpc.2011.03.010; Rubio-Sanz L, 2013, APPL ENVIRON MICROB, V79, P6414, DOI 10.1128/AEM.01954-13; Sakamoto K, 2010, MICROBIOL-SGM, V156, P1993, DOI 10.1099/mic.0.037382-0; Sambrook J., 2001, MOL CLONING LAB MANU; SCHELLER KH, 1980, EUR J BIOCHEM, V107, P455; Shin JH, 2011, P NATL ACAD SCI USA, V108, P5045, DOI 10.1073/pnas.1017744108; SIMONS RW, 1987, GENE, V53, P85, DOI 10.1016/0378-1119(87)90095-3; SIMONS TJB, 1993, J BIOCHEM BIOPH METH, V27, P25, DOI 10.1016/0165-022X(93)90065-V; Smaldone GT, 2007, MICROBIOL-SGM, V153, P4123, DOI 10.1099/mic.0.2007/011742-0; Teramoto H, 2015, APPL MICROBIOL BIOT, V99, P3505, DOI 10.1007/s00253-015-6373-z; VanZile ML, 2000, BIOCHEMISTRY-US, V39, P11818, DOI 10.1021/bi001140o; VanZile ML, 2002, BIOCHEMISTRY-US, V41, P9765, DOI 10.1021/bi0201771; Waldron KJ, 2009, NATURE, V460, P823, DOI 10.1038/nature08300; Waldron KJ, 2009, NAT REV MICROBIOL, V7, P25, DOI 10.1038/nrmicro2057; Wang D, 2012, J INORG BIOCHEM, V111, P173, DOI 10.1016/j.jinorgbio.2012.02.008; Wang SY, 2009, APPL ENVIRON MICROB, V75, P6110, DOI 10.1128/AEM.00914-09; Xiao ZG, 2010, NAT PROD REP, V27, P768, DOI 10.1039/b906690j; Zhu T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017367	73	17	17	1	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 7	2015	290	32					19806	19822		10.1074/jbc.M115.663427	http://dx.doi.org/10.1074/jbc.M115.663427			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CO7TL	26109070	Green Published, hybrid, Green Accepted			2022-12-26	WOS:000359364600037
J	Teder, T; Lohelaid, H; Boeglin, WE; Calcutt, WM; Brash, AR; Samel, N				Teder, Tarvi; Lohelaid, Helike; Boeglin, William E.; Calcutt, Wade M.; Brash, Alan R.; Samel, Nigulas			A Catalase-related Hemoprotein in Coral Is Specialized for Synthesis of Short-chain Aldehydes DISCOVERY OF P450-TYPE HYDROPEROXIDE LYASE ACTIVITY IN A CATALASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALLENE OXIDE SYNTHASE; FATTY-ACID HYDROPEROXIDES; MAGNETIC CIRCULAR-DICHROISM; LIPOXYGENASE FUSION PROTEIN; SOYBEAN LIPOXYGENASE; ANAEROBIC REACTION; MOLECULAR-CLONING; LINOLEIC-ACID; ACTIVE-SITE; LYASE	In corals a catalase-lipoxygenase fusion protein transforms arachidonic acid to the allene oxide 8R,9-epoxy-5,9,11,14-eico-satetraenoic acid from which arise cyclopentenones such as the prostanoid-related clavulones. Recently we cloned two catalase-lipoxygenase fusion protein genes (a and b) from the coral Capnella imbricata, form a being an allene oxide synthase and form b giving uncharacterized polar products (Lohelaid, H., Teder, T., Toldsepp, K., Ekins, M., and Samel, N. (2014) PloS ONE 9, e89215). Here, using HPLC-UV, LC-MS, andNMRmethods, we identify a novel activity of fusion protein b, establishing its role in cleaving the lipoxygenase product 8R-hydroperoxy-eicosatetraenoic acid into the short-chain aldehydes (5Z)-8-oxo-octenoic acid and (3Z,6Z)-dodecadienal; these primary products readily isomerize in an aqueous medium to the corresponding 6E- and 2E, 6Z derivatives. This type of enzymatic cleavage, splitting the carbon chain within the conjugated diene of the hydroperoxide substrate, is known only in plant cytochrome P450 hydroperoxide lyases. In mechanistic studies using O-18-labeled substrate and incubations in (H2O)-O-18, we established synthesis of the C8-oxo acid and C12 aldehyde with the retention of the hydroperoxy oxygens, consistent with synthesis of a short-lived hemiacetal intermediate that breaks down spontaneously into the two aldehydes. Taken together with our initial studies indicating differing gene regulation of the allene oxide synthase and the newly identified catalase-related hydroperoxide lyase and given the role of aldehydes in plant defense, this work uncovers a potential pathway in coral stress signaling and a novel enzymatic activity in the animal kingdom.	[Teder, Tarvi; Lohelaid, Helike; Samel, Nigulas] Tallinn Univ Technol, Dept Chem, EE-12618 Tallinn, Estonia; [Teder, Tarvi; Boeglin, William E.; Brash, Alan R.] Vanderbilt Univ, Dept Pharmacol, Nashville, TN 37232 USA; [Teder, Tarvi; Boeglin, William E.; Brash, Alan R.] Vanderbilt Univ, Vanderbilt Inst Chem Biol, Nashville, TN 37232 USA; [Calcutt, Wade M.] Vanderbilt Univ, Dept Biochem, Nashville, TN 37232 USA	Tallinn University of Technology; Vanderbilt University; Vanderbilt University; Vanderbilt University	Samel, N (corresponding author), Tallinn Univ Technol, Dept Chem, EE-12618 Tallinn, Estonia.	nigulas.samel@ttu.ee	Teder, Tarvi/M-6893-2018; Samel, Nigulas/A-1420-2019; Regan, Clinton/E-6250-2012; Lõhelaid, Helike/G-5425-2013	Teder, Tarvi/0000-0002-8489-3955; Lõhelaid, Helike/0000-0002-6885-8666	National Institutes of Health [GM-074888]; Estonian Ministry of Education and Research [IUT19-9]; Estonian Science Foundation [9410]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074888] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Estonian Ministry of Education and Research(Ministry of Education and Research, Estonia); Estonian Science Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM-074888 (to A. R. B.). This work was also supported by the Institutional Research Funding IUT19-9 of the Estonian Ministry of Education and Research and the Estonian Science Foundation Grant 9410 (both to N. S.). The authors declare that they have no conflicts of interest with the contents of this article.	Abraham BD, 2001, BIOCHEMISTRY-US, V40, P2251, DOI 10.1021/bi002121h; Bandara DMI, 2011, J INORG BIOCHEM, V105, P1786, DOI 10.1016/j.jinorgbio.2011.09.026; Bate NJ, 1998, PLANT J, V16, P561, DOI 10.1046/j.1365-313x.1998.00324.x; Bate NJ, 1998, PLANT PHYSIOL, V117, P1393, DOI 10.1104/pp.117.4.1393; Boutaud O, 1999, J BIOL CHEM, V274, P33764, DOI 10.1074/jbc.274.47.33764; Brash AR, 2014, J BIOL CHEM, V289, P13101, DOI 10.1074/jbc.M114.555904; Brash AR, 2009, PHYTOCHEMISTRY, V70, P1522, DOI 10.1016/j.phytochem.2009.08.005; Brash AR, 1996, J BIOL CHEM, V271, P20949, DOI 10.1074/jbc.271.34.20949; BRASH AR, 1991, J BIOL CHEM, V266, P22926; Brodhun F, 2011, FEBS J, V278, P1047, DOI 10.1111/j.1742-4658.2011.08027.x; D'Auria JC, 2007, PLANT J, V49, P194, DOI 10.1111/j.1365-313X.2006.02946.x; Eek P, 2012, J BIOL CHEM, V287, P22377, DOI 10.1074/jbc.M112.343285; Farmer EE, 2007, CURR OPIN PLANT BIOL, V10, P380, DOI 10.1016/j.pbi.2007.04.019; Feussner I, 2002, ANNU REV PLANT BIOL, V53, P275, DOI 10.1146/annurev.arplant.53.100301.135248; GARDNER HW, 1989, FREE RADICAL BIO MED, V7, P65, DOI 10.1016/0891-5849(89)90102-0; Garscha U, 2007, J BIOL CHEM, V282, P34707, DOI 10.1074/jbc.M705366200; GARSSEN GJ, 1971, BIOCHEM J, V122, P327, DOI 10.1042/bj1220327; GARSSEN GJ, 1972, BIOCHEM J, V130, P435, DOI 10.1042/bj1300435; Gilbert NC, 2008, BIOCHEMISTRY-US, V47, P10665, DOI 10.1021/bi800751p; GLASGOW WC, 1986, J BIOL CHEM, V261, P200; Glauser G, 2009, J BIOL CHEM, V284, P34506, DOI 10.1074/jbc.M109.061432; Gomi K, 2003, J PLANT PHYSIOL, V160, P1219, DOI 10.1078/0176-1617-01177; Grechkin AN, 2006, BBA-MOL CELL BIOL L, V1761, P1419, DOI 10.1016/j.bbalip.2006.09.002; Grechkin AN, 2004, BBA-MOL CELL BIOL L, V1636, P47, DOI 10.1016/j.bbalip.2003.12.003; Grechkin AN, 2002, PROSTAG OTH LIPID M, V68-9, P457, DOI 10.1016/S0090-6980(02)00048-5; HAMBERG M, 1989, J AM OIL CHEM SOC, V66, P1445, DOI 10.1007/BF02661968; Havrilla CM, 2000, J AM CHEM SOC, V122, P8042, DOI 10.1021/ja001180f; Hoffmann I, 2013, J BIOL CHEM, V288, P11459, DOI 10.1074/jbc.M113.458257; Hughes RK, 2008, PROTEINS, V72, P1199, DOI 10.1002/prot.22012; Jarving R, 2012, BIOCHEMISTRY-US, V51, P3310, DOI 10.1021/bi201690z; Kishimoto K, 2005, PLANT CELL PHYSIOL, V46, P1093, DOI 10.1093/pcp/pci122; Koljak R, 1997, SCIENCE, V277, P1994, DOI 10.1126/science.277.5334.1994; LABEQUE R, 1988, BIOCHEMISTRY-US, V27, P7060, DOI 10.1021/bi00418a059; LAM BK, 1987, BIOCHEM BIOPH RES CO, V149, P1111, DOI 10.1016/0006-291X(87)90523-7; Lee DS, 2008, NATURE, V455, P363, DOI 10.1038/nature07307; Li LO, 2008, P NATL ACAD SCI USA, V105, P13883, DOI 10.1073/pnas.0804099105; Lohelaid H, 2015, CORAL REEFS, V34, P143, DOI 10.1007/s00338-014-1238-y; Lohelaid H, 2008, BBA-GEN SUBJECTS, V1780, P315, DOI 10.1016/j.bbagen.2007.10.010; Lohelaid H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089215; Matsui K, 2000, FEBS LETT, V481, P183, DOI 10.1016/S0014-5793(00)01997-9; Matsui K, 2000, BIOSCI BIOTECH BIOCH, V64, P1189, DOI 10.1271/bbb.64.1189; Matsui K, 2006, CURR OPIN PLANT BIOL, V9, P274, DOI 10.1016/j.pbi.2006.03.002; Mortimer M, 2006, ARCH BIOCHEM BIOPHYS, V445, P147, DOI 10.1016/j.abb.2005.10.023; Mueller MJ, 2009, PHYTOCHEMISTRY, V70, P1511, DOI 10.1016/j.phytochem.2009.05.018; Noordermeer MA, 2000, EUR J BIOCHEM, V267, P2473, DOI 10.1046/j.1432-1327.2000.01283.x; Noordermeer MA, 1999, FEBS LETT, V443, P201, DOI 10.1016/S0014-5793(98)01706-2; Noordermeer MA, 2002, J AGR FOOD CHEM, V50, P4270, DOI 10.1021/jf0202685; Oldham ML, 2005, P NATL ACAD SCI USA, V102, P297, DOI 10.1073/pnas.0406352102; Prost I, 2005, PLANT PHYSIOL, V139, P1902, DOI 10.1104/pp.105.066274; Takamura H, 1996, BBA-LIPID LIPID MET, V1303, P83, DOI 10.1016/0005-2760(96)00076-8; TANABE T, 1995, J LIPID MEDIAT CELL, V12, P243, DOI 10.1016/0929-7855(95)00031-K; Tijet N, 2001, ARCH BIOCHEM BIOPHYS, V386, P281, DOI 10.1006/abbi.2000.2218; Tosha T, 2006, J BIOL CHEM, V281, P12610, DOI 10.1074/jbc.M600061200; Tsitsigiannis DI, 2007, TRENDS MICROBIOL, V15, P109, DOI 10.1016/j.tim.2007.01.005; Wichard T, 2005, ANGEW CHEM INT EDIT, V44, P158, DOI 10.1002/anie.200460686; ZIMMERMAN DC, 1979, PLANT PHYSIOL, V63, P536, DOI 10.1104/pp.63.3.536	56	17	17	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 7	2015	290	32					19823	19832		10.1074/jbc.M115.660282	http://dx.doi.org/10.1074/jbc.M115.660282			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CO7TL	26100625	Green Published, hybrid			2022-12-26	WOS:000359364600038
J	Kobayashi, Y; Takahashi, T; Shibata, T; Ikeda, S; Koshiba, T; Mizumura, H; Oda, T; Kawabata, S				Kobayashi, Yuki; Takahashi, Toshiaki; Shibata, Toshio; Ikeda, Shunsuke; Koshiba, Takumi; Mizumura, Hikaru; Oda, Toshio; Kawabata, Shun-ichiro			Factor B Is the Second Lipopolysaccharide-binding Protease Zymogen in the Horseshoe Crab Coagulation Cascade	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR-C; SERINE PROTEASES; HEMOCYTES; RECOGNITION; ACTIVATION; EXPRESSION	Factor B is a serine-protease zymogen in the horseshoe crab coagulation cascade, and it is the primary substrate for activated factor C, the LPS-responsive initiator of the cascade. Factor C is autocatalytically activated to alpha-factor C on LPS and is artificially converted to beta-factor C, another activated form, by chymotrypsin. It is not known, however, whether LPS is required for the activation of factor B. Here we found that wild-type factor B expressed in HEK293S cells is activated by alpha-factor C, but not by beta-factor C, in an LPS-dependent manner and that beta-factor C loses the LPS binding activity of factor C through additional cleavage by chymotrypsin within the N-terminal LPS-binding region. Surface plasmon resonance and quartz crystal microbalance analyses revealed that wild-type factor B binds to LPS with high affinity comparable with that of factor C, demonstrating that factor B is the second LPS-binding zymogen in the cascade. An LPS-binding site of wild-type factor B was found in the N-terminal clip domain, and the activation rate of a clip domain deletion mutant was considerably slower than that of wild-type factor B. Moreover, in the presence of LPS, Triton X-100 inhibited the activation of wild-type factor B by alpha-factor C. We conclude that the clip domain of factor B has an important role in localizing factor B to the surface of Gram-negative bacteria or LPS released from bacteria to initiate effective proteolytic activation by alpha-factor C.	[Kobayashi, Yuki; Shibata, Toshio; Koshiba, Takumi; Kawabata, Shun-ichiro] Kyushu Univ, Fac Sci, Dept Biol, Fukuoka 8128581, Japan; [Takahashi, Toshiaki; Ikeda, Shunsuke; Koshiba, Takumi; Kawabata, Shun-ichiro] Kyushu Univ, Grad Sch Syst Life Sci, Fukuoka 8128581, Japan; [Shibata, Toshio] Kyushu Univ, Inst Adv Study, Fukuoka 8128581, Japan; [Mizumura, Hikaru; Oda, Toshio] Seikagaku Corp, LAL Res & Dev Grp, Higashiyamato, Tokyo 2070021, Japan	Kyushu University; Kyushu University; Kyushu University; Seikagaku Corporation	Kawabata, S (corresponding author), Kyushu Univ, Fac Sci, Dept Biol, Higashi Ku, 6-10-1 Hakozaki, Fukuoka 8128581, Japan.	skawascb@kyudai.jp	Shibata, Toshio/AAE-1694-2020	Shibata, Toshio/0000-0003-0211-5525; Koshiba, Takumi/0000-0001-8535-5043	Seikagaku Corporation	Seikagaku Corporation	This work was supported by the joint research fund of the Seikagaku Corporation. The authors declare that they have no conflicts of interest with the contents of this article.	Aachoui Y, 2013, SCIENCE, V339, P975, DOI 10.1126/science.1230751; Aricescu AR, 2006, ACTA CRYSTALLOGR D, V62, P1243, DOI 10.1107/S0907444906029799; Armstrong Peter B., 2003, P288; BODE W, 1976, FEBS LETT, V68, P231, DOI 10.1016/0014-5793(76)80443-7; Cao XL, 2015, INSECT BIOCHEM MOLEC, V62, P51, DOI 10.1016/j.ibmb.2014.10.006; DAVIE EW, 1991, BIOCHEMISTRY-US, V30, P10363, DOI 10.1021/bi00107a001; Hashiguchi T, 2007, P NATL ACAD SCI USA, V104, P19535, DOI 10.1073/pnas.0707830104; Jang IH, 2008, BMB REP, V41, P102, DOI 10.5483/BMBRep.2008.41.2.102; Jiang HB, 2000, INSECT BIOCHEM MOLEC, V30, P95, DOI 10.1016/S0965-1748(99)00113-7; Kawabata S, 2010, ADV EXP MED BIOL, V708, P122; Kawabata S, 2010, J BIOCHEM, V147, P611, DOI 10.1093/jb/mvq026; Kobayashi Y, 2014, J BIOL CHEM, V289, P25987, DOI 10.1074/jbc.M114.586933; Koshiba T, 2007, J BIOL CHEM, V282, P3962, DOI 10.1074/jbc.M609198200; LeMosy EK, 1999, TRENDS CELL BIOL, V9, P102, DOI 10.1016/S0962-8924(98)01494-9; Levin Jack, 2003, P310; MIURA Y, 1992, J BIOCHEM-TOKYO, V112, P476, DOI 10.1093/oxfordjournals.jbchem.a123924; MUTA T, 1991, J BIOL CHEM, V266, P6554; Muta T, 1996, CURR OPIN IMMUNOL, V8, P41, DOI 10.1016/S0952-7915(96)80103-8; MUTA T, 1993, J BIOL CHEM, V268, P21384; MUTA T, 1990, J BIOL CHEM, V265, P22426; NAKAMURA T, 1988, J BIOCHEM, V103, P370, DOI 10.1093/oxfordjournals.jbchem.a122276; NAKAMURA T, 1986, EUR J BIOCHEM, V154, P511, DOI 10.1111/j.1432-1033.1986.tb09427.x; NAKAMURA T, 1986, J BIOCHEM, V99, P847, DOI 10.1093/oxfordjournals.jbchem.a135545; Rathinam VAK, 2012, CELL, V150, P606, DOI 10.1016/j.cell.2012.07.007; Reeves PJ, 2002, P NATL ACAD SCI USA, V99, P13419, DOI 10.1073/pnas.212519299; Sarma JV, 2011, CELL TISSUE RES, V343, P227, DOI 10.1007/s00441-010-1034-0; SATO T, 1994, BIOCHEM BIOPH RES CO, V204, P551, DOI 10.1006/bbrc.1994.2494; Shi JJ, 2014, NATURE, V514, P187, DOI 10.1038/nature13683; TOKUNAGA F, 1991, J BIOCHEM, V109, P150, DOI 10.1093/oxfordjournals.jbchem.a123337	29	12	13	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 31	2015	290	31					19379	19386		10.1074/jbc.M115.653196	http://dx.doi.org/10.1074/jbc.M115.653196			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CN9PK	26109069	hybrid, Green Published			2022-12-26	WOS:000358781100048
J	Llibre, JM; Bravo, I; Ornelas, A; Santos, JR; Puig, J; Martin-Iguacel, R; Paredes, R; Clotet, B				Llibre, Josep M.; Bravo, Isabel; Ornelas, Arelly; Santos, Jose R.; Puig, Jordi; Martin-Iguacel, Raquel; Paredes, Roger; Clotet, Bonaventura			Effectiveness of a Treatment Switch to Nevirapine plus Tenofovir and Emtricitabine (or Lamivudine) in Adults with HIV-1 Suppressed Viremia	PLOS ONE			English	Article							REVERSE-TRANSCRIPTASE INHIBITOR; BOOSTED PROTEASE INHIBITOR; HIV-1-INFECTED PATIENTS; INFECTED PATIENTS; ANTIRETROVIRAL THERAPY; VIROLOGICAL FAILURE; COFORMULATED ELVITEGRAVIR; GENOTYPIC RESISTANCE; CONTAINING REGIMENS; OPEN-LABEL	Background Switching subjects with persistently undetectable HIV-1 viremia under antiretroviral treatment (ART) to once-daily tenofovir/emtricitabine (or lamivudine) + nevirapine is a cost-effective and well-tolerated strategy. However, the effectiveness of this approach has not been established. Methods We performed a retrospective study evaluating the rates of treatment failure, virological failure (VF), and variables associated, in all subjects initiating this switch combination in our clinic since 2001. Analyses were performed by a modified intention to treat, where switch due to toxicity equalled failure. The main endpoint was plasma HIV-RNA < 50 copies/mL. Results 341 patients were treated for a median of 176 (57; 308) weeks. At week 48, 306 (89.7%) subjects had HIV-1 RNA < 50 copies/mL, 10 (2.9%) experienced VF, and 25 (7.4%) discontinued the treatment due to toxicity. During the whole follow-up 23 (6.7%) individuals (17 on lamivudine, 6 on emtricitabine; p = 0.034) developed VF and treatment modification due to toxicity occurred in 36 (10.7%). Factors independently associated with VF in a multivariate analysis were: intravenous drug use (HR 1.51; 95% CI 1.12, 2.04), time with undetectable viral load before the switch (HR 0.98; 0.97, 0.99), number of prior NRTIs (HR 1.49; 1.15, 1.93) or NNRTIs (HR 3.22; 1.64, 6.25), and previous NVP (HR 1.54; 1.10, 2.17) or efavirenz (HR 5.76; 1.11, 29.87) unscheduled interruptions. VF was associated with emergence of usual nevirapine mutations (Y181C/I/D, K103N and V106A/I), M184V (n = 16; 12 with lamivudine vs. 4 with emtricitabine, p = 0.04), and K65R (n = 7). Conclusions The rates of treatment failure at 48 weeks, or long-term toxicity or VF with this switch regimen are low and no unexpected mutations or patterns of mutations were selected in subjects with treatment failure.	[Llibre, Josep M.; Bravo, Isabel; Santos, Jose R.; Puig, Jordi; Paredes, Roger; Clotet, Bonaventura] Univ Hosp Germans Trias i Pujol, HIV Unit, Badalona, Spain; [Llibre, Josep M.; Bravo, Isabel; Santos, Jose R.; Puig, Jordi; Paredes, Roger; Clotet, Bonaventura] Univ Hosp Germans Trias i Pujol, Lluita SIDA Fdn, Badalona, Spain; [Llibre, Josep M.; Santos, Jose R.; Paredes, Roger; Clotet, Bonaventura] Univ Autonoma Barcelona, E-08193 Barcelona, Spain; [Ornelas, Arelly] Univ Barcelona, Dept Econometr Stat & Econ, Barcelona, Spain; [Martin-Iguacel, Raquel] Odense Univ Hosp, Dept Infect Dis, DK-5000 Odense, Denmark; [Paredes, Roger; Clotet, Bonaventura] Univ Vic UVic Vic, Catalonia, Spain	Autonomous University of Barcelona; University of Barcelona; University of Southern Denmark; Odense University Hospital; Universitat de Vic - Universitat Central de Catalunya (UVic-UCC)	Llibre, JM (corresponding author), Univ Hosp Germans Trias i Pujol, HIV Unit, Badalona, Spain.	jmllibre@flsida.org			CHAIN, Collaborative HIV and Anti-HIV Drug Resistance Network - European Commission [223131]; Gala contra la Sida Barcelona	CHAIN, Collaborative HIV and Anti-HIV Drug Resistance Network - European Commission(European CommissionEuropean Commission Joint Research Centre); Gala contra la Sida Barcelona	This work was supported by "CHAIN, Collaborative HIV and Anti-HIV Drug Resistance Network" (Integrated Project no. 223131, funded by the European Commission Framework 7 Program) and by "Gala contra la Sida Barcelona 2011". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors had full access to the data, and the corresponding author had the final responsibility for submitting the manuscript for publication.	Abgrall S, 2006, AIDS, V20, P2099, DOI 10.1097/01.aids.0000247581.93201.79; Annan NT, 2009, JAIDS-J ACQ IMM DEF, V51, P140, DOI 10.1097/QAI.0b013e3181a56e81; Arribas JR, 2014, LANCET INFECT DIS, V14, P581, DOI 10.1016/S1473-3099(14)70782-0; Berenguerl J, 2014, ENFERM INFEC MICR CL, V32, P447, DOI 10.1016/j.eimc.2014.02.018; Bommenel T, 2011, J ANTIMICROB CHEMOTH, V66, P1869, DOI 10.1093/jac/dkr208; Bonjoch A, 2006, AIDS RES HUM RETROV, V22, P321, DOI 10.1089/aid.2006.22.321; Calmy A, 2009, ANTIVIR THER, V14, P931, DOI 10.3851/IMP1418; Chiesa E, 2003, ANTIVIR THER, V8, P27; Cohen CJ, 2011, LANCET, V378, P229, DOI 10.1016/S0140-6736(11)60983-5; Darque A, 1999, ANTIMICROB AGENTS CH, V43, P2245, DOI 10.1128/AAC.43.9.2245; de Echaguen AO, 2005, AIDS, V19, P1385, DOI 10.1097/01.aids.0000181010.85255.3c; Deforche K, 2008, AIDS, V22, P2107, DOI 10.1097/QAD.0b013e32830fe940; Dieleman JP, 2002, J INFECT DIS, V185, P1261, DOI 10.1086/340131; Ena J, 2008, HIV MED, V9, P747, DOI 10.1111/j.1468-1293.2008.00627.x; Eron JJ, 2010, LANCET, V375, P396, DOI 10.1016/S0140-6736(09)62041-9; Fisac C, 2005, AIDS, V19, P917, DOI 10.1097/01.aids.0000171405.46113.bf; Fox Z, 2008, AIDS, V22, P2279, DOI 10.1097/QAD.0b013e328311d16f; Franssen R, 2009, ARTERIOSCL THROM VAS, V29, P1336, DOI 10.1161/ATVBAHA.109.192088; Gathe J, 2011, ANTIVIR THER, V16, P759, DOI 10.3851/IMP1803; Graham SM, 2012, JAIDS-J ACQ IMM DEF, V60, P511, DOI 10.1097/QAI.0b013e31825bd703; Gunthard HF, 2014, JAMA-J AM MED ASSOC, V312, P410, DOI 10.1001/jama.2014.8722; Haim-Boukobza S, 2011, AIDS, V25, P341, DOI 10.1097/QAD.0b013e3283427de3; Hare CB, 2008, CLIN INFECT DIS, V47, P421, DOI 10.1086/589867; Hazen R, 2003, JAIDS-J ACQ IMM DEF, V32, P255, DOI 10.1097/00126334-200303010-00003; Blasco AJ, 2013, ENFERM INFEC MICR CL, V31, P568, DOI 10.1016/j.eimc.2013.06.002; Kesselring AM, 2009, AIDS, V23, P1689, DOI 10.1097/QAD.0b013e32832d3b54; Labarga P, 2010, AIDS, V24, P777, DOI 10.1097/QAD.0b013e3283322895; Llibre J, 2014, HIV DRUG THER 2014 G; Llibre JM, 2008, J ANTIMICROB CHEMOTH, V62, P909, DOI 10.1093/jac/dkn297; Llibre JM, 2010, CLIN INFECT DIS, V50, P872, DOI 10.1086/650732; Marcelin AG, 2012, J ANTIMICROB CHEMOTH, V67, P1475, DOI 10.1093/jac/dks047; Martinez E, 2003, NEW ENGL J MED, V349, P1036, DOI 10.1056/NEJMoa021589; Martinez E, 2007, AIDS, V21, P1829, DOI 10.1097/QAD.0b013e328133f081; Martinez E, 2007, AIDS, V21, P367, DOI 10.1097/QAD.0b013e3280121ab1; Martinez E, 2010, AIDS, V24, P1697, DOI 10.1097/QAD.0b013e32833a608a; Martinez E, 2009, JAIDS-J ACQ IMM DEF, V51, P290, DOI 10.1097/QAI.0b013e3181aa12d5; Miller M, 2010, INT HIV HEP DRUG RES; Molina JM, 2011, LANCET, V378, P238, DOI 10.1016/S0140-6736(11)60936-7; Palella FJ, 2014, AIDS, V28, P335, DOI 10.1097/QAD.0000000000000087; Parienti JJ, 2007, CLIN INFECT DIS, V45, P263, DOI 10.1086/518973; Parienti JJ, 2004, CLIN INFECT DIS, V38, P1311, DOI 10.1086/383572; Pavie J, 2011, J ANTIMICROB CHEMOTH, V66, P2372, DOI 10.1093/jac/dkr316; Pillay P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068995; Podzamczer D, 2011, HIV MED, V12, P374, DOI 10.1111/j.1468-1293.2011.00917.x; Podzomczer D, 2005, ANTIVIR THER, V10, P171; Porter D, 2013, 11 EUR M HIV HEP TRE; Porter DP, 2014, JAIDS-J ACQ IMM DEF, V65, P318, DOI 10.1097/QAI.0000000000000017; Pozniak A, 2014, LANCET INFECT DIS, V14, P590, DOI 10.1016/S1473-3099(14)70796-0; Riddler SA, 2008, NEW ENGL J MED, V358, P2095, DOI 10.1056/NEJMoa074609; Rokx C, 2015, CLIN INFECT DIS, V60, P143, DOI 10.1093/cid/ciu763; Schouten JT, 2010, CLIN INFECT DIS, V50, P787, DOI 10.1086/650539; Soriano V, 2011, ANTIVIR THER, V16, P339, DOI 10.3851/IMP1745; Squires KE, 2012, HIV CLIN TRIALS, V13, P233, DOI 10.1310/hct1305-233; Svicher V, 2010, JAIDS-J ACQ IMM DEF, V55, P336, DOI 10.1097/QAI.0b013e3181e6763f; Tang MW, 2012, CLIN INFECT DIS, V54, P862, DOI 10.1093/cid/cir1034; van Leth F, 2004, LANCET, V363, P1253, DOI 10.1016/S0140-6736(04)15997-7	56	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2015	10	6							e0128131	10.1371/journal.pone.0128131	http://dx.doi.org/10.1371/journal.pone.0128131			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4OM	26107265	Green Published, Green Submitted, gold			2022-12-26	WOS:000356932500014
J	Pfafferott, K; Deshpande, P; McKinnon, E; Merani, S; Lucas, A; Heckerman, D; Mallal, S; John, M; Gaudieri, S; Lucas, M				Pfafferott, Katja; Deshpande, Pooja; McKinnon, Elizabeth; Merani, Shahzma; Lucas, Andrew; Heckerman, David; Mallal, Simon; John, Mina; Gaudieri, Silvana; Lucas, Michaela			Anti-Hepatitis C Virus T-Cell Immunity in the Context of Multiple Exposures to the Virus	PLOS ONE			English	Article							MHC CLASS-I; DOMINANT INFLUENCE; POPULATION-LEVEL; SINGLE-SOURCE; CD8 EPITOPE; INFECTION; RESPONSES; HLA; ESCAPE; FITNESS	Characterisation of Hepatitis C virus (HCV)-specific CD8(+) T-cell responses in the context of multiple HCV exposures is critical to identify broadly protective immune responses necessary for an effective HCV vaccine against the different HCV genotypes. However, host and viral genetic diversity complicates vaccine development. To compensate for the observed variation in circulating autologous viruses and host molecules that restrict antigen presentation (human leucocyte antigens; HLA), this study used a reverse genomics approach that identified sites of viral adaptation to HLA-restricted T-cell immune pressure to predict genotype-specific HCV CD8+ T-cell targets. Peptides representing these putative HCV CD8(+) T-cell targets, and their adapted form, were used in individualised IFN-gamma ELISpot assays to screen for HCV-specific T-cell responses in 133 HCV-seropositive subjects with high-risk of multiple HCV exposures. The data obtained from this study i) confirmed that genetic studies of viral evolution is an effective approach to detect novel in vivo HCV T-cell targets, ii) showed that HCV-specific T-cell epitopes can be recognised in their adapted form and would not have been detected using wild-type peptides and iii) showed that HCV-specific T-cell (but not antibody) responses against alternate genotypes in chronic HCV-infected subjects are readily found, implying clearance of previous alternate genotype infection. In summary, HCV adaptation to HLA Class I-restricted T-cell responses plays a central role in anti-HCV immunity and multiple HCV genotype exposure is highly prevalent in at-risk exposure populations, which are important considerations for future vaccine design.	[Pfafferott, Katja; McKinnon, Elizabeth; Lucas, Andrew; Mallal, Simon; John, Mina; Gaudieri, Silvana; Lucas, Michaela] Murdoch Univ, Inst Immunol & Infect Dis, Murdoch, WA 6150, Australia; [Deshpande, Pooja; Gaudieri, Silvana] Univ Western Australia, Sch Anat Physiol & Human Biol, Crawley, WA, Australia; [Merani, Shahzma] Univ Western Australia, Ctr Forens Sci, Crawley, WA, Australia; [Heckerman, David] Microsoft Corp, Microsoft Res, Redmond, WA 98052 USA; [Mallal, Simon] Vanderbilt Univ, Dept Med, Div Infect Dis, Nashville, TN USA; [Mallal, Simon] Vanderbilt Univ, Dept Pathol Microbiol & Immunol, Nashville, TN 37235 USA; [Lucas, Michaela] Univ Western Australia, Harry Perkins Inst, Sch Med & Pharmacol, Crawley, WA, Australia; [Lucas, Michaela] Univ Western Australia, Sch Pathol & Lab Med, Crawley, WA, Australia	Murdoch University; University of Western Australia; University of Western Australia; Microsoft; Vanderbilt University; Vanderbilt University; Harry Perkins Institute of Medical Research; University of Western Australia; University of Western Australia	Gaudieri, S (corresponding author), Murdoch Univ, Inst Immunol & Infect Dis, Murdoch, WA 6150, Australia.	silvana.gaudieri@uwa.edu.au	Mallal, Simon Alexander/HDM-9561-2022	Mallal, Simon Alexander/0000-0002-7036-1309; , Silvana/0000-0001-6873-0198; Lucas, Michaela/0000-0001-8881-9990; Lucas, Andrew Douglas/0000-0003-2899-1806	Haemophilia Foundation of Australia; McCusker Research Foundation; Raine Medical Research Foundation; Microsoft Research, Microsoft, Redmond, Washington, USA	Haemophilia Foundation of Australia; McCusker Research Foundation; Raine Medical Research Foundation; Microsoft Research, Microsoft, Redmond, Washington, USA	The work presented in this manuscript was supported by the Haemophilia Foundation of Australia, the McCusker Research Foundation and the Raine Medical Research Foundation. Microsoft Research, Microsoft, Redmond, Washington, USA provided support in the form of salaries for author DH, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Aitken CK, 2008, HEPATOLOGY, V48, P1746, DOI 10.1002/hep.22534; Almeida CAM, 2009, J IMMUNOL METHODS, V344, P1, DOI 10.1016/j.jim.2009.02.007; Apps R, 2013, SCIENCE, V340, P87, DOI 10.1126/science.1232685; Aspinall EJ, 2013, CLIN INFECT DIS, V57, pS80, DOI 10.1093/cid/cit306; Baker RI, 1996, AUST NZ J MED, V26, P789, DOI 10.1111/j.1445-5994.1996.tb00626.x; Bowen DG, 2005, NATURE, V436, P946, DOI 10.1038/nature04079; Carrington M, 2012, ANNU REV MED, V63, P131, DOI 10.1146/annurev-med-062909-130018; Cohen GB, 1999, IMMUNITY, V10, P661, DOI 10.1016/S1074-7613(00)80065-5; Crawford H, 2007, J VIROL, V81, P8346, DOI 10.1128/JVI.00465-07; Dazert E, 2009, J CLIN INVEST, V119, P376, DOI 10.1172/JCI36587; Fitzmaurice K, 2011, GUT, V60, P1563, DOI 10.1136/gut.2010.228403; Gaudieri S, 2006, J VIROL, V80, P11094, DOI 10.1128/JVI.00912-06; Harcourt GC, 2004, J VIRAL HEPATITIS, V11, P324, DOI 10.1111/j.1365-2893.2004.00516.x; Hertz T, 2011, J VIROL, V85, P1310, DOI 10.1128/JVI.01966-10; Herzer K, 2003, J VIROL, V77, P8299, DOI 10.1128/JVI.77.15.8299-8309.2003; Hraber P, 2007, HEPATOLOGY, V46, P1713, DOI 10.1002/hep.21889; John M, 2010, J IMMUNOL, V184, P4368, DOI 10.4049/jimmunol.0903745; Keane NM, 2012, IMMUNOL CELL BIOL, V90, P224, DOI 10.1038/icb.2011.34; Kiepiela P, 2004, NATURE, V432, P769, DOI 10.1038/nature03113; Lauer GM, 2002, J VIROL, V76, P6104, DOI 10.1128/JVI.76.12.6104-6113.2002; Listgarten J, 2007, PLOS COMPUT BIOL, V3, P1879, DOI 10.1371/journal.pcbi.0030188; Lundegaard C, 2008, NUCLEIC ACIDS RES, V36, pW509, DOI 10.1093/nar/gkn202; Martinez-Picado J, 2006, J VIROL, V80, P3617, DOI 10.1128/JVI.80.7.3617-3623.2006; McKiernan SM, 2004, HEPATOLOGY, V40, P108, DOI 10.1002/hep.20261; Merani S, 2011, HEPATOLOGY, V53, P396, DOI 10.1002/hep.24076; Moore CB, 2002, SCIENCE, V296, P1439, DOI 10.1126/science.1069660; Neumann-Haefelin C, 2006, HEPATOLOGY, V43, P563, DOI 10.1002/hep.21049; Neumann-Haefelin C, 2008, J VIROL, V82, P3438, DOI 10.1128/JVI.01700-07; PARKER KC, 1994, J IMMUNOL, V152, P163; RAMMENSEE HG, 1995, IMMUNOGENETICS, V41, P178, DOI 10.1007/BF00172063; Rauch A, 2009, HEPATOLOGY, V50, P1017, DOI 10.1002/hep.23101; Ruhl M, 2011, GASTROENTEROLOGY, V140, P2064, DOI 10.1053/j.gastro.2011.02.060; Salloum S, 2008, J VIROL, V82, P11803, DOI 10.1128/JVI.00997-08; Schneidewind A, 2007, J VIROL, V81, P12382, DOI 10.1128/JVI.01543-07; Soderholm J, 2006, GUT, V55, P266, DOI 10.1136/gut.2005.072231; Takaki A, 2000, NAT MED, V6, P578, DOI 10.1038/75063; Timm J, 2004, J EXP MED, V200, P1593, DOI 10.1084/jem.20041006; Timm J, 2007, HEPATOLOGY, V46, P339, DOI 10.1002/hep.21702; Ward S, 2002, CLIN EXP IMMUNOL, V128, P195, DOI 10.1046/j.1365-2249.2002.01840.x; Wiegand J, 2004, HEPATOLOGY, V40, P98, DOI 10.1002/hep.20291; zur Wiesch JS, 2007, BLOOD, V110, P1559, DOI 10.1182/blood-2007-01-069583	41	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2015	10	6							e0130420	10.1371/journal.pone.0130420	http://dx.doi.org/10.1371/journal.pone.0130420			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4OM	26107956	Green Published, gold, Green Submitted			2022-12-26	WOS:000356932500101
J	Salez, N; Vabret, A; Leruez-Ville, M; Andreoletti, L; Carrat, F; Renois, F; de Lamballerie, X				Salez, Nicolas; Vabret, Astrid; Leruez-Ville, Marianne; Andreoletti, Laurent; Carrat, Fabrice; Renois, Fanny; de lamballerie, Xavier			Evaluation of Four Commercial Multiplex Molecular Tests for the Diagnosis of Acute Respiratory Infections	PLOS ONE			English	Article							ACID AMPLIFICATION TESTS; VIRAL PANEL FAST; REAL-TIME PCR; FILMARRAY RP; FAST ASSAY; VIRUSES; PERFORMANCE; RVP; PATHOGENS	Acute Respiratory Infections (ARIs) are responsible for considerable morbidity and mortality worldwide. Documentation of respiratory specimens can help for an appropriate clinical management with a significant effect on the disease progress in patient, the antimicrobial therapy used and the risk of secondary spread of infection. Here, we compared the performances of four commercial multiplex kits used in French University Hospital diagnostic microbiology laboratories for the detection of ARI pathogens (i.e., the xTAG Respiratory Viral Panel Fast, RespiFinder SMART 22, CLART PneumoVir and Fast Track Diagnostics Respiratory Pathogen 33 kits). We used a standardised nucleic acids extraction protocol and a comprehensive comparative approach that mixed reference to well established real-time PCR detection techniques and analysis of convergent positive results. We tested 166 respiratory clinical samples and identified a global high degree of correlation for at least three of the techniques (xTAG, RespiFinder and FTD33). For these techniques, the highest Youden's index (YI), positive predictive (PPV) and specificity (Sp) values were observed for Core tests (e.g., influenza A [YI:0.86-1.00; PPV:78.95-100.00; Sp:97.32-100.00] & B [YI:0.44-1.00; PPV:100.00; Sp:100.00], hRSV [YI:0.50-0.99; PPV:85.71-100.00; Sp:99.38-100.00], hMPV [YI:0.71-1.00; PPV:83.33-100.00; Sp:99.37-100.00], EV/hRV [YI:0.62-0.82; PPV:93.33-100.00; Sp:94.48-100.00], AdV [YI:1.00; PPV:100.00; Sp:100.00] and hBoV [YI:0.20-0.80; PPV:57.14-100.00; Sp:98.14-100.00]). The present study completed an overview of the multiplex techniques available for the diagnosis of acute respiratory infections.	[Salez, Nicolas; de lamballerie, Xavier] Aix Marseille Univ, IRD French Inst Res Dev, EHESP French Sch Publ Hlth, EPV UMR D Emergence Pathol Virales 190, Marseille, France; [Vabret, Astrid] Univ Hosp, Lab Human & Mol Virol, IFR ICORE 146, Caen, France; [Leruez-Ville, Marianne] Univ Paris 05, Hop Necker Enfants Malad, APHP, Sorbonne Paris Cite,Virol Lab,EA 36 20, Paris, France; [Andreoletti, Laurent] Ctr Hosp Univ, Unit Virol Med & Mol, Reims, France; [Andreoletti, Laurent] Fac Med, IFR EA DAT PPCIDH 53 4303, Reims, France; [Carrat, Fabrice] Univ Paris 06, INSERM, UMR S 707, Paris, France; [Carrat, Fabrice] Hop St Antoine, AP HP, Dept Internal Med, Unit St Publ, Paris, France; [de lamballerie, Xavier] IHU Inst Hosp Univ Med Infect, APHM Publ Hosp Marseille, Marseille, France	Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Aix-Marseille Universite; CHU de Caen NORMANDIE; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; CHU de Reims; Universite de Reims Champagne-Ardenne; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille	Salez, N (corresponding author), Aix Marseille Univ, IRD French Inst Res Dev, EHESP French Sch Publ Hlth, EPV UMR D Emergence Pathol Virales 190, Marseille, France.	salez.umr190@yahoo.fr	Carrat, Fabrice/AAU-8480-2020; Andreoletti, Laurent/AAQ-2756-2020	Carrat, Fabrice/0000-0002-8672-7918; ANDREOLETTI, LAURENT/0000-0002-7440-8880; VABRET, Astrid/0000-0002-8940-7645				Anderson TP, 2013, J VIROL METHODS, V191, P118, DOI 10.1016/j.jviromet.2013.04.005; Babady NE, 2012, J CLIN MICROBIOL, V50, P2282, DOI 10.1128/JCM.06186-11; Balada-Llasat JM, 2011, J CLIN VIROL, V50, P42, DOI 10.1016/j.jcv.2010.09.022; BULLA A, 1978, B WORLD HEALTH ORGAN, V56, P481; Dabisch-Ruthe M, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-163; Fox JD, 2007, J CLIN VIROL, V40, pS15, DOI 10.1016/S1386-6532(07)70005-7; Fox JD, 2007, J CLIN VIROL, V40, pS24, DOI 10.1016/S1386-6532(07)70006-9; Gadsby NJ, 2010, J CLIN MICROBIOL, V48, P2213, DOI 10.1128/JCM.02446-09; Gharabaghi F, 2011, CLIN MICROBIOL INFEC, V17, P1900, DOI 10.1111/j.1469-0691.2011.03529.x; Gonzales R, 2001, CLIN INFECT DIS, V33, P757, DOI 10.1086/322627; Huguenin A, 2012, J MED VIROL, V84, P979, DOI 10.1002/jmv.23272; Jokela P, 2012, J VIROL METHODS, V182, P82, DOI 10.1016/j.jviromet.2012.03.015; Lapidus N, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-417; Loeffelholz MJ, 2011, J CLIN MICROBIOL, V49, P4083, DOI 10.1128/JCM.05010-11; Loens K, 2012, J CLIN MICROBIOL, V50, P977, DOI 10.1128/JCM.00200-11; Merante F, 2007, J CLIN VIROL, V40, pS31, DOI 10.1016/S1386-6532(07)70007-0; Pabbaraju K, 2011, J CLIN MICROBIOL, V49, P1738, DOI 10.1128/JCM.02090-10; Perez-Ruiz Mercedes, 2012, Open Virol J, V6, P151, DOI 10.2174/1874357901206010151; Pillet S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072174; Popowitch EB, 2013, J CLIN MICROBIOL, V51, P1528, DOI 10.1128/JCM.03368-12; Rand KH, 2011, J CLIN MICROBIOL, V49, P2449, DOI 10.1128/JCM.02582-10; Raymaekers M, 2011, J CLIN VIROL, V52, P314, DOI 10.1016/j.jcv.2011.08.017; Renaud C, 2012, DIAGN MICR INFEC DIS, V74, P379, DOI 10.1016/j.diagmicrobio.2012.08.003; Sakthivel SK, 2012, J VIROL METHODS, V185, P259, DOI 10.1016/j.jviromet.2012.07.010; van Coppenraet LESB, 2010, J VIROL METHODS, V169, P188, DOI 10.1016/j.jviromet.2010.07.032; van Elden LJR, 2001, J CLIN MICROBIOL, V39, P196, DOI 10.1128/JCM.39.1.196-200.2001; Verani JR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083600; Welch DF, 2010, J CLIN MICROBIOL, V48, P22, DOI 10.1128/JCM.02268-09	28	47	48	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2015	10	6							e0130378	10.1371/journal.pone.0130378	http://dx.doi.org/10.1371/journal.pone.0130378			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4OM	26107509	Green Submitted, Green Published, gold			2022-12-26	WOS:000356932500096
J	Gagne-Bourque, F; Mayer, BF; Charron, JB; Vali, H; Bertrand, A; Jabaji, S				Gagne-Bourque, Francois; Mayer, Boris F.; Charron, Jean-Benoit; Vali, Hojatollah; Bertrand, Annick; Jabaji, Suha			Accelerated Growth Rate and Increased Drought Stress Resilience of the Model Grass Brachypodium distachyon Colonized by Bacillus subtilis B26	PLOS ONE			English	Article							PROMOTING RHIZOBACTERIA PGPR; PLANT-GROWTH; GENE-EXPRESSION; BACTERIAL ENDOPHYTES; BIOLOGICAL-CONTROL; PAENIBACILLUS-POLYMYXA; ACC DEAMINASE; TOLERANCE; NITROGEN; SEEDS	Plant growth-promoting bacteria (PGB) induce positive effects in plants, for instance, increased growth and reduced abiotic stresses susceptibility. The mechanisms by which these bacteria impact the host plant are numerous, diverse and often specific. Here, we studied the agronomical, molecular and biochemical effects of the endophytic PGB Bacillus subtilis B26 on the full life cycle of Brachypodium distachyon Bd21, an established model species for functional genomics in cereal crops and temperate grasses. Inoculation of Brachypodium with B. subtilis strain B26 increased root and shoot weights, accelerated growth rate and seed yield as compared to control plants. B. subtilis strain B26 efficiently colonized the plant and was recovered fromroots, stems and blades as well as seeds of Brachypodium, indicating that the bacterium is able to migrate, spread systemically inside the plant, establish itself in the aerial plant tissues and organs, and is vertically transmitted to seeds. The presence of B. subtilis strain B26 in the seed led to systemic colonization of the next generation of Brachypodium plants. Inoculated Brachypodium seedlings and mature plants exposed to acute and chronic drought stress minimized the phenotypic effect of drought compared to plants not harbouring the bacterium. Protection from the inhibitory effects of drought by the bacterium was linked to upregulation of the drought-response genes, DREB2B-like, DHN3-like and LEA-14-A-like and modulation of the DNA methylation genes, MET1B-like, CMT3-like and DRM2-like, that regulate the process. Additionally, total soluble sugars and starch contents increased in stressed inoculated plants, a biochemical indication of drought tolerance. In conclusion, we show a single inoculation of Brachypodium with a PGB affected the whole growth cycle of the plant, accelerating its growth rates, shortening its vegetative period, and alleviating drought stress effects. These effects are relevant to grasses and cereal crops.	[Gagne-Bourque, Francois; Mayer, Boris F.; Charron, Jean-Benoit; Jabaji, Suha] McGill Univ, Dept Plant Sci, Quebec City, PQ H9X 3V9, Canada; [Vali, Hojatollah] McGill Univ, FEMR, Montreal, PQ H3A 0C7, Canada; [Bertrand, Annick] Agr & Agri Food Canada, Soils & Crops Res Dev Ctr, Quebec City, PQ G1V 2J3, Canada	McGill University; McGill University; Agriculture & Agri Food Canada	Charron, JB (corresponding author), McGill Univ, Dept Plant Sci, Macdonald Campus,21,111 Lakeshore Rd, Quebec City, PQ H9X 3V9, Canada.	jean-benoit.charron@mcgill.ca; suha.jabaji@mcgill.ca	Jabaji, Suha/D-2479-2016	Jabaji, Suha/0000-0002-7232-9994; Mayer, Boris/0000-0002-4845-9668	natural Sciences and Engineering Council of Canada (NSERC) [137135, 386537]; FRQNT-Regroupment Strategique-Centre SEVE Grant [RS-144]	natural Sciences and Engineering Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); FRQNT-Regroupment Strategique-Centre SEVE Grant	This work was supported by The natural Sciences and Engineering Council of Canada (NSERC) grants 137135 and 386537 to SJ and JBC. The authors also acknowledge the support of FRQNT-Regroupment Strategique-Centre SEVE Grant RS-144 to both SJ and JBC.	Arkhipova TN, 2007, PLANT SOIL, V292, P305, DOI 10.1007/s11104-007-9233-5; Bertrand A, 2008, GRASS FORAGE SCI, V63, P421, DOI 10.1111/j.1365-2494.2008.00649.x; BLAKENEY AB, 1980, J SCI FOOD AGR, V31, P889, DOI 10.1002/jsfa.2740310905; Brkljacic J, 2011, PLANT PHYSIOL, V157, P3, DOI 10.1104/pp.111.179531; Cankar K, 2005, FEMS MICROBIOL LETT, V244, P341, DOI 10.1016/j.femsle.2005.02.008; Chaves MM, 2004, J EXP BOT, V55, P2365, DOI 10.1093/jxb/erh269; Choudhary DK, 2009, MICROBIOL RES, V164, P493, DOI 10.1016/j.micres.2008.08.007; Colton-Gagnon K, 2014, ANN BOT-LONDON, V113, P681, DOI 10.1093/aob/mct283; Compant S, 2005, APPL ENVIRON MICROB, V71, P4951, DOI 10.1128/AEM.71.9.4951-4959.2005; Compant S, 2010, SOIL BIOL BIOCHEM, V42, P669, DOI 10.1016/j.soilbio.2009.11.024; Da KD, 2012, PLANT PHYSIOL BIOCH, V50, P24, DOI 10.1016/j.plaphy.2011.09.013; Dimkpa C, 2009, PLANT CELL ENVIRON, V32, P1682, DOI 10.1111/j.1365-3040.2009.02028.x; Dordas C, 2009, EUR J AGRON, V30, P129, DOI 10.1016/j.eja.2008.09.001; Draper J, 2001, PLANT PHYSIOL, V127, P1539, DOI 10.1104/pp.010196; Elbeltagy A, 2001, APPL ENVIRON MICROB, V67, P5285, DOI 10.1128/AEM.67.11.5285-5293.2001; Farag MA, 2006, PHYTOCHEMISTRY, V67, P2262, DOI 10.1016/j.phytochem.2006.07.021; Ferreira A, 2008, FEMS MICROBIOL LETT, V287, P8, DOI 10.1111/j.1574-6968.2008.01258.x; Figueiredo MVB, 2008, APPL SOIL ECOL, V40, P182, DOI 10.1016/j.apsoil.2008.04.005; Gagne-Bourgue F, 2013, J APPL MICROBIOL, V114, P836, DOI 10.1111/jam.12088; Gontia-Mishra I, 2014, BIOTECHNOL LETT, V36, P889, DOI 10.1007/s10529-014-1458-9; Gregory PJ, 2006, EUR J SOIL SCI, V57, P2, DOI 10.1111/j.1365-2389.2005.00778.x; Hallmann J, 2006, MICROBIAL ROOT ENDOP, V9, P15, DOI DOI 10.1007/3-540-33526-9_2; Hardoim PR, 2008, TRENDS MICROBIOL, V16, P463, DOI 10.1016/j.tim.2008.07.008; Hong SY, 2011, WEED RES, V51, P612, DOI 10.1111/j.1365-3180.2011.00877.x; Hong SY, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-112; Huang B, 2011, PLANT BIOLOGY, V13, P925, DOI 10.1111/j.1438-8677.2011.00456.x; James EK, 2002, MOL PLANT MICROBE IN, V15, P894, DOI 10.1094/MPMI.2002.15.9.894; Ji XL, 2008, FEMS MICROBIOL ECOL, V65, P565, DOI 10.1111/j.1574-6941.2008.00543.x; Poupin MJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069435; Liu B, 2009, BIOL CONTROL, V49, P277, DOI 10.1016/j.biocontrol.2009.02.007; Liu Q, 1998, PLANT CELL, V10, P1391, DOI 10.1105/tpc.10.8.1391; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Livingston DP, 2009, CELL MOL LIFE SCI, V66, P2007, DOI 10.1007/s00018-009-0002-x; Lugtenberg B, 2009, ANNU REV MICROBIOL, V63, P541, DOI 10.1146/annurev.micro.62.081307.162918; Mena-Violante HG, 2007, SCI HORTIC-AMSTERDAM, V113, P103, DOI 10.1016/j.scienta.2007.01.031; Muurinen S, 2007, AGRON J, V99, P441, DOI 10.2134/agronj2006.0107; Nadeem SM, 2014, BIOTECHNOL ADV, V32, P429, DOI 10.1016/j.biotechadv.2013.12.005; Niu DD, 2011, MOL PLANT MICROBE IN, V24, P533, DOI 10.1094/MPMI-09-10-0213; Ongena M, 2008, TRENDS MICROBIOL, V16, P115, DOI 10.1016/j.tim.2007.12.009; Orhan E, 2006, SCI HORTIC-AMSTERDAM, V111, P38, DOI 10.1016/j.scienta.2006.09.002; Ortiz-Castro R, 2008, PLANT SIGNAL BEHAV, V3, P263, DOI 10.4161/psb.3.4.5204; Parker D, 2008, NAT PROTOC, V3, P435, DOI 10.1038/nprot.2007.499; PARKINSON JA, 1975, COMMUN SOIL SCI PLAN, V6, P1, DOI 10.1080/00103627509366539; Perez-Garcia A, 2011, CURR OPIN BIOTECH, V22, P187, DOI 10.1016/j.copbio.2010.12.003; Porebski S, 1997, PLANT MOL BIOL REP, V15, P8, DOI 10.1007/BF02772108; Reinhold-Hurek B, 2011, CURR OPIN PLANT BIOL, V14, P435, DOI 10.1016/j.pbi.2011.04.004; Reva ON, 2004, FEMS MICROBIOL ECOL, V48, P249, DOI 10.1016/j.femsec.2004.02.003; Rocha FR, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-71; Rodriguez H, 1999, BIOTECHNOL ADV, V17, P319, DOI 10.1016/S0734-9750(99)00014-2; Rosenblueth M, 2006, MOL PLANT MICROBE IN, V19, P827, DOI 10.1094/MPMI-19-0827; Sakuma Y, 2006, PLANT CELL, V18, P1292, DOI 10.1105/tpc.105.035881; Sandhya V, 2010, PLANT GROWTH REGUL, V62, P21, DOI 10.1007/s10725-010-9479-4; Sarma RK, 2014, PLANT SOIL, V377, P111, DOI 10.1007/s11104-013-1981-9; SKINNER FA, 1952, J GEN MICROBIOL, V6, P261, DOI 10.1099/00221287-6-3-4-261; Timmusk S, 1999, MOL PLANT MICROBE IN, V12, P951, DOI 10.1094/MPMI.1999.12.11.951; Truyens S, 2015, ENV MICROBIOL REP, V7, P40, DOI 10.1111/1758-2229.12181; Vain P, 2008, PLANT BIOTECHNOL J, V6, P236, DOI 10.1111/j.1467-7652.2007.00308.x; Valliyodan B, 2006, CURR OPIN PLANT BIOL, V9, P189, DOI 10.1016/j.pbi.2006.01.019; van Loon LC, 2007, EUR J PLANT PATHOL, V119, P243, DOI 10.1007/s10658-007-9165-1; VANELSAS JD, 1986, FEMS MICROBIOL ECOL, V38, P151, DOI 10.1016/0378-1097(86)90046-7; Vogel JP, 2010, NATURE, V463, P763, DOI 10.1038/nature08747; Wahyudi AT, 2011, J MICROBIOL ANTIMICR, V2, P406; Wang WS, 2011, J EXP BOT, V62, P1951, DOI 10.1093/jxb/erq391; Wilson SM, 2012, NAT PROTOC, V7, P1716, DOI 10.1038/nprot.2012.096; Wolter A, 2012, INT S SOILL CULT, P107; Woodman ME, 2008, CURR PROTOC MICROBIO; Wulff EG, 2003, PLANT SOIL, V255, P463, DOI 10.1023/A:1026026917355; Xu MS, 2014, WORLD J MICROB BIOT, V30, P835, DOI 10.1007/s11274-013-1486-y; Yang J, 2009, TRENDS PLANT SCI, V14, P1, DOI 10.1016/j.tplants.2008.10.004	69	70	71	0	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2015	10	6							e0130456	10.1371/journal.pone.0130456	http://dx.doi.org/10.1371/journal.pone.0130456			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4DD	26103151	Green Published, gold, Green Submitted			2022-12-26	WOS:000356901900045
J	Simonini, I; Pandolfi, A				Simonini, Irene; Pandolfi, Anna			Customized Finite Element Modelling of the Human Cornea	PLOS ONE			English	Article							COLLAGEN ORGANIZATION; IDENTIFICATION; SIMULATIONS	Aim To construct patient-specific solid models of human cornea from ocular topographer data, to increase the accuracy of the biomechanical and optical estimate of the changes in refractive power and stress caused by photorefractive keratectomy (PRK). Method Corneal elevation maps of five human eyes were taken with a rotating Scheimpflug camera combined with a Placido disk before and after refractive surgery. Patient-specific solid models were created and discretized in finite elements to estimate the corneal strain and stress fields in preoperative and postoperative configurations and derive the refractive parameters of the cornea. Results Patient-specific geometrical models of the cornea allow for the creation of personalized refractive maps at different levels of IOP. Thinned postoperative corneas show a higher stress gradient across the thickness and higher sensitivity of all geometrical and refractive parameters to the fluctuation of the IOP. Conclusion Patient-specific numerical models of the cornea can provide accurate quantitative information on the refractive properties of the cornea under different levels of IOP and describe the change of the stress state of the cornea due to refractive surgery (PRK). Patient-specific models can be used as indicators of feasibility before performing the surgery.	[Simonini, Irene] Politecn Milan, Dipartimento Matemat, I-20133 Milan, Italy; [Pandolfi, Anna] Politecn Milan, Dipartimento Ingn Civile & Ambientale, I-20133 Milan, Italy	Polytechnic University of Milan; Polytechnic University of Milan	Pandolfi, A (corresponding author), Politecn Milan, Dipartimento Ingn Civile & Ambientale, I-20133 Milan, Italy.	anna.pandolfi@polimi.it	Pandolfi, Anna/E-1481-2013	Pandolfi, Anna/0000-0002-7084-7456				Aghamohammadzadeh H, 2004, STRUCTURE, V12, P249, DOI 10.1016/j.str.2004.01.002; Alastrue V, 2006, J BIOMECH ENG-T ASME, V128, P150, DOI 10.1115/1.2132368; Anderson K, 2004, J R SOC INTERFACE, V1, P3, DOI 10.1098/rsif.2004.0002; Asejczyk-Widlicka M, 2007, BRIT J OPHTHALMOL, V91, P1054, DOI 10.1136/bjo.2006.109793; Boote C, 2006, INVEST OPHTH VIS SCI, V47, P901, DOI 10.1167/iovs.05-0893; Boschetti F, 2012, J BIOMECH ENG-T ASME, V134, DOI 10.1115/1.4006089; Bryant MR, 1996, J BIOMECH ENG-T ASME, V118, P473, DOI 10.1115/1.2796033; Buzard K A, 1992, Refract Corneal Surg, V8, P127; Cano D, 2004, J OPT SOC AM A, V21, P926, DOI 10.1364/JOSAA.21.000926; Cavas-Martinez F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110249; Djotyan GP, 2006, OPHTHALMIC RES, V38, P329, DOI 10.1159/000096227; Elsheikh A, 2010, BIOMECH THEOR APPL, P57; Elsheikh A, 2010, J REFRACT SURG, V26, P289, DOI 10.3928/1081597X-20090710-01; Evans S, 2012, COMPUT METHOD BIOMEC, V15, P1, DOI 10.1080/10255842.2012.650321; Gonzalez-Perez J, 2011, EYE CONTACT LENS, V37, P66, DOI 10.1097/ICL.0b013e31820c6ffc; Grytz R, 2010, BIOMECH MODEL MECHAN, V9, P225, DOI 10.1007/s10237-009-0173-2; Han ZL, 2014, J REFRACT SURG, V30, P208, DOI 10.3928/1081597X-20140212-02; Hanna K D, 1992, Refract Corneal Surg, V8, P152; Kling S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104904; Kling S, 2013, INVEST OPHTH VIS SCI, V54, P5078, DOI 10.1167/iovs.13-12509; Lanchares E, 2008, J BIOMECH, V41, P797, DOI 10.1016/j.jbiomech.2007.11.010; Luce DA, 2005, J CATARACT REFR SURG, V31, P156, DOI 10.1016/j.jcrs.2004.10.044; Pandolfi A, 2006, BIOMECH MODEL MECHAN, V5, P237, DOI 10.1007/s10237-005-0014-x; Pandolfi A, 2012, MECH MATER, V44, P151, DOI 10.1016/j.mechmat.2011.06.004; Pandolfi A, 2008, J BIOMECH ENG-T ASME, V130, DOI 10.1115/1.2982251; Pandolfi A, 2009, ENG COMPUT-GERMANY, V25, P15, DOI 10.1007/s00366-008-0102-5; Petsche SJ, 2013, BIOMECH MODEL MECHAN, V12, P1101, DOI 10.1007/s10237-012-0466-8; Pinero DP, 2014, J CATARACT REFR SURG, V40, P870, DOI 10.1016/j.jcrs.2014.03.021; Pinero DP, 2010, CLIN EXP OPHTHALMOL, V38, P154, DOI 10.1111/j.1442-9071.2010.02197.x; Pinsky P M, 1992, Refract Corneal Surg, V8, P164; Pinsky PM, 2005, J CATARACT REFR SURG, V31, P136, DOI 10.1016/j.jcrs.2004.10.048; Roy AS, 2010, J BIOMECHANICAL ENG, V133; Ruberti JW, 2011, ANNU REV BIOMED ENG, V13, P269, DOI 10.1146/annurev-bioeng-070909-105243; Sanchez P, 2014, J CATARACT REFR SURG, V40, P905, DOI 10.1016/j.jcrs.2014.03.020; SANDWELL DT, 1987, GEOPHYS RES LETT, V14, P139, DOI 10.1029/GL014i002p00139; Srodka W, 2006, PRACE NAUKOWE INSTYT, V91, P1; Studer H, 2012, COMPUT METHOD BIOMEC, V15, P93, DOI 10.1080/10255842.2011.552184; Studer HP, 2013, J BIOMECH, V46, P751, DOI 10.1016/j.jbiomech.2012.11.018; Swartz TS, 2012, CORNEAL TOPOGRAPHY: A GUIDE FOR CLINICAL APPLICATION IN THE WAVEFRONT ERA, SECOND EDITION, P167; Swartz TS, 2012, CORNEAL TOPOGRAPHY: A GUIDE FOR CLINICAL APPLICATION IN THE WAVEFRONT ERA, SECOND EDITION, P35; Velinsky S A, 1992, Refract Corneal Surg, V8, P173; Vito R P, 1989, Refract Corneal Surg, V5, P82; Vito R P, 1992, Refract Corneal Surg, V8, P146; Winkler M, 2013, INVEST OPHTH VIS SCI, V54, P7293, DOI 10.1167/iovs.13-13150; Zhang K, 2014, BIOMEDICAL ENG ONLIN, V13, DOI [10.1186/1475-925X-13-162, DOI 10.1186/1475-925X-13-162]	45	55	57	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2015	10	6							e0130426	10.1371/journal.pone.0130426	http://dx.doi.org/10.1371/journal.pone.0130426			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL3FM	26098104	gold, Green Published, Green Submitted			2022-12-26	WOS:000356835800065
J	Wang, JJ; Chen, P; Xu, JZ; Zou, JX; Wang, HB; Chen, HW				Wang, Junjian; Chen, Peng; Xu, Jianzhen; Zou, June. X.; Wang, Haibin; Chen, Hong-Wu			Transporting Cells in Semi-Solid Gel Condition and at Ambient Temperature	PLOS ONE			English	Article							MATRIGEL	Mammalian cells including human cancer cells are usually transported in cryovials on dry ice or in a liquid nitrogen vapor shipping vessel between different places at long distance. The hazardous nature of dry ice and liquid nitrogen, and the associated high shipping cost strongly limit their routine use. In this study, we tested the viability and properties of cells after being preserved or shipped over long distance in Matrigel mixture for different days. Our results showed that cells mixed with Matrigel at suitable ratios maintained excellent viability (>90%) for one week at room temperature and preserved the properties such as morphology, drug sensitivity and metabolism well, which was comparable to cells cryopreserved in liquid nitrogen. We also sent cells in the Matrigel mixture via FedEx service to different places at ambient temperature. Upon arrival, it was found that over 90% of the cells were viable and grew well after replating. These data collectively suggested that our Matrigel-based method was highly convenient for shipping live cells for long distances in semi-solid gel condition and at ambient temperature.	[Wang, Junjian; Chen, Peng; Zou, June. X.; Chen, Hong-Wu] Univ Calif Davis, Ctr Comprehens Canc, Sacramento, CA 95817 USA; [Wang, Junjian; Zou, June. X.; Chen, Hong-Wu] Univ Calif Davis, Sch Med, Dept Biochem & Mol Med, Sacramento, CA 95817 USA; [Chen, Peng] Guangzhou Univ Chinese Med, Sch Clin Med 1, Guangzhou 510405, Guangdong, Peoples R China; [Xu, Jianzhen] Shantou Univ, Coll Med, Shantou 515041, Peoples R China; [Wang, Haibin] Guangzhou Univ Chinese Med, Affiliated Hosp 1, Guangzhou 510405, Guangdong, Peoples R China	University of California System; University of California Davis; University of California System; University of California Davis; Guangzhou University of Chinese Medicine; Shantou University; Guangzhou University of Chinese Medicine	Wang, HB (corresponding author), Guangzhou Univ Chinese Med, Affiliated Hosp 1, Guangzhou 510405, Guangdong, Peoples R China.	hipknee@163.com; hwzchen@ucdavis.edu	Wang, Junjian/S-5574-2019; Xu, Jianzhen/G-2456-2011	Xu, Jianzhen/0000-0002-0697-9075; Wang, Junjian/0000-0002-5328-2908; Chen, Peng/0000-0002-3069-9997				Albeck JG, 2013, MOL CELL, V49, P249, DOI 10.1016/j.molcel.2012.11.002; Betensky RA, 2000, CLIN DIAGN LAB IMMUN, V7, P759, DOI 10.1128/CDLI.7.5.759-763.2000; Coriell L L, 1979, Methods Enzymol, V58, P29; Gupta RA, 2010, NATURE, V464, P1071, DOI 10.1038/nature08975; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hanna J, 2009, ORGANOGENESIS, V5, P134, DOI 10.4161/org.5.3.9585; Hughes CS, 2010, PROTEOMICS, V10, P1886, DOI 10.1002/pmic.200900758; Lee YA, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0063255, 10.1371/journal.pone.0054889]; Maria OM, 2011, INT J BIOCHEM CELL B, V43, P622, DOI 10.1016/j.biocel.2011.01.001; Molina-Jimenez F, 2012, VIROLOGY, V425, P31, DOI 10.1016/j.virol.2011.12.021; Ohyabu Y, 2014, J BIOSCI BIOENG, V118, P112, DOI 10.1016/j.jbiosc.2013.12.005; Saunders DE, 1997, INT J CANCER, V70, P214, DOI 10.1002/(SICI)1097-0215(19970117)70:2<214::AID-IJC13>3.0.CO;2-I; Stevens VL, 2007, CANCER EPIDEM BIOMAR, V16, P2160, DOI 10.1158/1055-9965.EPI-07-0604; Wright B, 2012, REGEN MED, V7, P295, DOI [10.2217/RME.12.7, 10.2217/rme.12.7]; Yang Lingzhi, 2009, Curr Chem Genomics, V3, P50, DOI 10.2174/1875397300903010050; Yeh PY, 2004, ONCOGENE, V23, P3580, DOI 10.1038/sj.onc.1207426	16	5	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2015	10	6							e0128229	10.1371/journal.pone.0128229	http://dx.doi.org/10.1371/journal.pone.0128229			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL3FM	26098554	gold, Green Published, Green Submitted			2022-12-26	WOS:000356835800013
J	Dittmar, MS; Petermichl, W; Lindner, R; Sinner, B; Graf, BM; Schlachetzki, F; Gruber, M				Dittmar, Michael S.; Petermichl, Walter; Lindner, Regina; Sinner, Barbara; Graf, Bernhard M.; Schlachetzki, Felix; Gruber, Michael			In Vitro Induction of Endothelial Apoptosis of the Post-Hypoxic Blood-Brain Barrier by Isoflurane but Not by Sevoflurane and Midazolam	PLOS ONE			English	Article							ISCHEMIA-REPERFUSION INJURY; DEVELOPING RAT-BRAIN; CEREBRAL-ISCHEMIA; PROVIDES NEUROPROTECTION; ANESTHESIA; EXPOSURE; NEURODEGENERATION; POSTTREATMENT; DYSFUNCTION; INHIBITION	Background The effects of anesthetics on the injured brain continue to be the subject of controversial discussion. Since isoflurane has recently been shown to induce apoptosis of cerebral endothelial cells, this study compared different anesthetic compounds regarding their potential to induce cerebro-vascular apoptosis. Methods The in vitro model of the blood-brain barrier used in this study consisted of astrocyte-conditioned human umbilical vein endothelial cells (AC-HUVEC) has been used. After 24 h of deep hypoxia and reoxygenation or control treatment, AC-HUVEC were exposed to 0, 0.5, 1.0, or 2.0 times the minimum alveolar concentration of isoflurane or sevoflurane, or 0, 75, 150, or 300 nM of midazolam for 2 h. After 24 h, AC-HUVEC were harvested, and the degree of apoptosis was assessed by means of Western blots for the Bax and Bcl-2 ratio and, for controls and the highest concentration groups, terminal deoxynucleotidyl-mediated dUTP-biotin nick end labeling (TUNEL). Results Without hypoxic pretreatment, 2.0 MAC of isoflurane slightly increased TUNEL intensity compared to control and sevoflurane, but without any significant changes in the Bax and Bcl-2 ratio. After hypoxic pretreatment, exposure to isoflurane led to a multifold increase in the Bax and Bcl-2 ratio in a dose dependent manner, which was also significantly higher than the ratio observed in the 2 MAC sevoflurane group. TUNEL intensity in the post-hypoxic 2 MAC isoflurane group was increased by a factor of 11 vs. control and by 40 vs. sevoflurane. Sevoflurane and midazolam did not significantly alter these markers of apoptosis, when compared to the control group. Conclusions Isoflurane administered after hypoxia elevates markers of apoptosis in endothelial cells transdifferentiated to the cerebro-vascular endothelium. Endothelial apoptosis may be a previously underestimated mechanism of anesthetic neurotoxicity. Administration of high concentrations of isoflurane in experimental settings may have negative effects on the blood-brain barrier.	[Dittmar, Michael S.; Petermichl, Walter; Lindner, Regina; Sinner, Barbara; Graf, Bernhard M.; Gruber, Michael] Univ Regensburg, Med Ctr, Dept Anesthesiol, D-93053 Regensburg, Germany; [Schlachetzki, Felix] Univ Regensburg, Dept Neurol, Bezirksklinikum Regensburg, D-93053 Regensburg, Germany	University of Regensburg; University of Regensburg	Dittmar, MS (corresponding author), Univ Regensburg, Med Ctr, Dept Anesthesiol, D-93053 Regensburg, Germany.	michael.dittmar@ukr.de		Dittmar, Michael S./0000-0002-8687-5830	Department of Anesthesiology, Regensburg University Medical Center	Department of Anesthesiology, Regensburg University Medical Center	The study was financed by the Department of Anesthesiology, Regensburg University Medical Center. The publication costs were covered by the German Research Foundation (DFG) within the funding program Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altay O, 2012, STROKE, V43, P2513, DOI 10.1161/STROKEAHA.112.661728; Bedirli N, 2012, J NEUROSURG ANESTH, V24, P336, DOI 10.1097/ANA.0b013e318266791e; Bezerra FJ, 2014, NEUROL RES, V36, P847, DOI 10.1179/1743132814Y.0000000341; Chi OZ, 2010, ANESTH ANALG, V110, P1412, DOI 10.1213/ANE.0b013e3181d6c0ae; Dittmar MS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038260; Engelhard K, 1999, BRIT J ANAESTH, V83, P415, DOI 10.1093/bja/83.3.415; Gwak MS, 2011, ENVIRON TOXICOL PHAR, V31, P262, DOI 10.1016/j.etap.2010.10.009; He HJ, 2012, CNS NEUROSCI THER, V18, P994, DOI 10.1111/cns.12018; Hertle Daniel, 2012, Acta Neurochir Suppl, V114, P383, DOI 10.1007/978-3-7091-0956-4_74; Hu N, 2014, BRAIN RES, V1551, P13, DOI 10.1016/j.brainres.2014.01.015; Hu Q, 2011, STROKE, V42, P1750, DOI 10.1161/STROKEAHA.110.603142; Jacobs V R, 2005, Zentralbl Gynakol, V127, P368; Jevtovic-Todorovic V, 2003, J NEUROSCI, V23, P876, DOI 10.1523/jneurosci.23-03-00876.2003; Krueger M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056419; Kuntz M, 2014, J CEREBR BLOOD F MET, V34, P95, DOI 10.1038/jcbfm.2013.169; KUROIWA T, 1985, ACTA NEUROPATHOL, V68, P122, DOI 10.1007/BF00688633; Lee JH, 2013, NEUROCHEM RES, V38, P2276, DOI 10.1007/s11064-013-1136-7; Liang G, 2010, ANESTHESIOLOGY, V112, P1325, DOI 10.1097/ALN.0b013e3181d94da5; Liu J, 2012, J NEUROSCI, V32, P3044, DOI 10.1523/JNEUROSCI.6409-11.2012; Loepke AW, 2009, ANESTH ANALG, V108, P90, DOI 10.1213/ane.0b013e31818cdb29; Maud P, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/802539; Murphy KM, 2000, CELL DEATH DIFFER, V7, P102, DOI 10.1038/sj.cdd.4400597; Pillai DR, 2009, J CEREBR BLOOD F MET, V29, P1846, DOI 10.1038/jcbfm.2009.106; Ren XY, 2014, NEUROL SCI, V35, P1401, DOI 10.1007/s10072-014-1726-4; Schwamm LH, 1998, STROKE, V29, P2268, DOI 10.1161/01.STR.29.11.2268; Sinner B, 2011, TOXICOLOGY, V290, P96, DOI 10.1016/j.tox.2011.08.022; Sosunov SA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120456; Strbian D, 2008, NEUROSCIENCE, V153, P175, DOI 10.1016/j.neuroscience.2008.02.012; Taheri S, 2014, BRAIN RES, V1586, P173, DOI 10.1016/j.brainres.2014.08.003; Terrando N, 2011, ANN NEUROL, V70, P986, DOI 10.1002/ana.22664; Tetrault S, 2008, EUR J NEUROSCI, V28, P1330, DOI 10.1111/j.1460-9568.2008.06443.x; Thal SC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050752; Wang JK, 2010, BRAIN RES, V1357, P142, DOI 10.1016/j.brainres.2010.08.009; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Yon JH, 2005, NEUROSCIENCE, V135, P815, DOI 10.1016/j.neuroscience.2005.03.064; Zhang Y, 2012, MOLECULES, V17, P341, DOI 10.3390/molecules17010341; Zhang YY, 2012, ANN NEUROL, V71, P687, DOI 10.1002/ana.23536; Zhang YY, 2010, J BIOL CHEM, V285, P4025, DOI 10.1074/jbc.M109.065664; Zheng H, 2013, ANESTHESIOLOGY, V118, P516, DOI 10.1097/ALN.0b013e3182834d5d; Zhou YL, 2010, STROKE, V41, P1521, DOI 10.1161/STROKEAHA.110.583757	40	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2015	10	6							e0130408	10.1371/journal.pone.0130408	http://dx.doi.org/10.1371/journal.pone.0130408			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL3FE	26091107	Green Published, gold, Green Submitted			2022-12-26	WOS:000356835000116
J	Moore, R; Call, J; Tomasello, M				Moore, Richard; Call, Josep; Tomasello, Michael			Production and Comprehension of Gestures between Orang-Utans (Pongo pygmaeus) in a Referential Communication Game	PLOS ONE			English	Article							BONOBOS PAN-PANISCUS; SOCIAL CUES; CHIMPANZEES; POINT; APES; TROGLODYTES; ATTENTION; BEHAVIOR; MOTIVES; SIGNS	Orang-utans played a communication game in two studies testing their ability to produce and comprehend requestive pointing. While the 'communicator' could see but not obtain hidden food, the 'donor' could release the food to the communicator, but could not see its location for herself. They could coordinate successfully if the communicator pointed to the food, and if the donor comprehended his communicative goal and responded pro-socially. In Study 1, one orang-utan pointed regularly and accurately for peers. However, they responded only rarely. In Study 2, a human experimenter played the communicator's role in three conditions, testing the apes' comprehension of points of different heights and different degrees of ostension. There was no effect of condition. However, across conditions one donor performed well individually, and as a group orang-utans' comprehension performance tended towards significance. We explain this on the grounds that comprehension required inferences that they found difficult - but not impossible. The finding has valuable implications for our thinking about the development of pointing in phylogeny.	[Moore, Richard; Call, Josep; Tomasello, Michael] Max Planck Inst Evolutionary Anthropol, Dept Dev & Comparat Psychol, Leipzig, Germany; [Moore, Richard] Humboldt Univ, Berlin Sch Mind & Brain, D-10099 Berlin, Germany; [Call, Josep] Univ St Andrews, Sch Psychol & Neurosci, St Andrews, Fife, Scotland	Max Planck Society; Humboldt University of Berlin; University of St Andrews	Moore, R (corresponding author), Max Planck Inst Evolutionary Anthropol, Dept Dev & Comparat Psychol, Leipzig, Germany.	r.t.moore@gmail.com	Moore, Richard/Q-9371-2019	Moore, Richard/0000-0003-4649-7676; Call Balaguer, Josep/0000-0002-8597-8336	German Max Planck Society for the Advancement of Science	German Max Planck Society for the Advancement of Science	All funding for this research came from the German Max Planck Society for the Advancement of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIELLO LC, 1995, CURR ANTHROPOL, V36, P199, DOI 10.1086/204350; Behne T, 2012, BRIT J DEV PSYCHOL, V30, P359, DOI 10.1111/j.2044-835X.2011.02043.x; Bullinger AF, 2011, DEVELOPMENTAL SCI, V14, P58, DOI 10.1111/j.1467-7687.2010.00952.x; CALL J, 1994, J COMP PSYCHOL, V108, P307, DOI 10.1037/0735-7036.108.4.307; Call J., 2007, GESTURAL COMMUNICATI; DEWAAL FBM, 1981, BEHAVIOUR, V77, P164, DOI 10.1163/156853981X00211; Forstmeier W, 2011, BEHAV ECOL SOCIOBIOL, V65, P47, DOI 10.1007/s00265-010-1038-5; Franco F, 2009, SOC DEV, V18, P51, DOI 10.1111/j.1467-9507.2008.00464.x; Gergely C, 2010, MIND LANG, V25, P141; Gomez Juan Carlos, 1996, P131; Hare B, 2004, ANIM BEHAV, V68, P571, DOI 10.1016/j.anbehav.2003.11.011; Hare B, 1999, J COMP PSYCHOL, V113, P173, DOI 10.1037/0735-7036.113.2.173; HEMELRIJK CK, 1991, BEHAVIOUR, V118, P89, DOI 10.1163/156853991X00210; Herrmann E, 2006, DEVELOPMENTAL SCI, V9, P518, DOI 10.1111/j.1467-7687.2006.00519.x; Hobaiter Catherine, 2013, J COMP PSYCHOL; Jaeger TF, 2008, J MEM LANG, V59, P434, DOI 10.1016/j.jml.2007.11.007; Kirchhofer KC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030913; Leavens DA, 2005, CURR DIR PSYCHOL SCI, V14, P185, DOI 10.1111/j.0963-7214.2005.00361.x; Leavens DA, 2004, J COMP PSYCHOL, V118, P48, DOI 10.1037/0735-7036.118.1.48; Leekam SR, 2010, DEVELOPMENTAL SCI, V13, P108, DOI 10.1111/j.1467-7687.2009.00862.x; Liszkowski U, 2004, DEVELOPMENTAL SCI, V7, P297, DOI 10.1111/j.1467-7687.2004.00349.x; Liszkowski U, 2006, J COGN DEV, V7, P173, DOI 10.1207/s15327647jcd0702_2; Lyn H, 2010, PSYCHOL SCI, V21, P360, DOI 10.1177/0956797610362218; Moore R., 2014, DEV SCI; Moore R, 2013, HUMANA MENTE, P27; Moore R, 2013, INTERACT STUD, V14, P62, DOI 10.1075/is.14.1.05moo; Mulcahy NJ, 2009, J COMP PSYCHOL, V123, P304, DOI 10.1037/a0016222; Pele M, 2009, J COMP PSYCHOL, V123, P375, DOI 10.1037/a0017253; Pika S, 2006, CURR BIOL, V16, pR191, DOI 10.1016/j.cub.2006.02.037; Senju A, 2008, CURR BIOL, V18, P668, DOI 10.1016/j.cub.2008.03.059; Teglas E, 2012, CURR BIOL, V22, P209, DOI 10.1016/j.cub.2011.12.018; Tempelmann S, 2013, INTERACTION STUDIES; Tomasello M, 1997, CHILD DEV, V68, P1067, DOI 10.2307/1132292; TOMASELLO M, 1985, J HUM EVOL, V14, P175, DOI 10.1016/S0047-2484(85)80005-1; Tomasello M., 2006, ROOTS HUMAN SOCIALIT; Tomasello M, 2008, JEAN NICOD LECT, P1; van der Goot M, 2013, CHILD DEV; Vea JJ, 1998, FOLIA PRIMATOL, V69, P289, DOI 10.1159/000021640; Yamamoto S, 2012, P NATL ACAD SCI USA, V109, P3588, DOI 10.1073/pnas.1108517109; Yamamoto S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007416; Zimmermann F, 2009, ANIM COGN, V12, P347, DOI 10.1007/s10071-008-0194-8	41	15	15	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2015	10	6							e0129726	10.1371/journal.pone.0129726	http://dx.doi.org/10.1371/journal.pone.0129726			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL3FE	26091358	gold, Green Published, Green Submitted			2022-12-26	WOS:000356835000054
J	Attur, M; Yang, Q; Shimada, K; Tachida, Y; Nagase, H; Mignatti, P; Statman, L; Palmer, G; Kirsch, T; Beier, F; Abramson, SB				Attur, Mukundan; Yang, Qing; Shimada, Kohei; Tachida, Yuki; Nagase, Hiroyuki; Mignatti, Paolo; Statman, Lauren; Palmer, Glyn; Kirsch, Thorsten; Beier, Frank; Abramson, Steven B.			Elevated expression of periostin in human osteoarthritic cartilage and its potential role in matrix degradation via matrix metalloproteinase-13	FASEB JOURNAL			English	Article						posttraumatic osteoarthritis; chondrocytes; Wnt signaling; ADAMTS	ARTICULAR-CARTILAGE; GENE-EXPRESSION; INFLAMMATORY MEDIATORS; BONE; CHONDROCYTES; REVEALS; DESTRUCTION; PROGRESSION; MECHANISMS; PATHWAYS	We investigated the role of periostin, an extracellular matrix protein, in the pathophysiology of osteoarthritis (OA). In OA, dysregulated gene expression and phenotypic changes in articular chondrocytes culminate in progressive loss of cartilage fromthe joint surface. The molecular mechanisms underlying this process are poorly understood. We examined periostin expression by immunohistochemical analysis of lesional and nonlesional cartilage from human and rodent OA knee cartilage. In addition, we used small interfering (si) RNA and adenovirus transduction of chondrocytes to knock down and up-regulate periostin levels, respectively, and analyzed its effect on matrix metalloproteinase (MMP)-13, a disintegrin and MMP with thrombospondin motifs (ADAMTS)-4, and type II collagen expression. We found high periostin levels in human and rodent OA cartilage. Periostin increased MMP-13 expression dose [1-10 mu g/ml (EC50 0.5-1 mu g/ml)] and time (24-72 h) dependently, significantly enhanced expression of ADAMTS4 mRNA, and promoted cartilage degeneration through collagen and proteoglycan degradation. Periostin induction of MMP-13 expression was inhibited by CCT031374 hydrobromide, an inhibitor of the canonical Wnt/beta-catenin signaling pathway. In addition, siRNA-mediated knockdown of endogenous periostin blocked constitutive MMP-13 expression. These findings implicate periostin as a catabolic protein that promotes cartilage degeneration in OA by up-regulating MMP-13 through canonical Wnt signaling.	[Attur, Mukundan; Yang, Qing; Mignatti, Paolo; Statman, Lauren; Palmer, Glyn; Abramson, Steven B.] NYU, Sch Med, Dept Med, Div Rheumatol, New York, NY USA; [Mignatti, Paolo] NYU, Sch Med, Dept Cell Biol, New York, NY 10016 USA; [Kirsch, Thorsten] NYU, Sch Med, Dept Orthopaed Surg, New York, NY 10016 USA; [Kirsch, Thorsten] NYU, Langone Med Ctr, New York, NY USA; [Shimada, Kohei; Tachida, Yuki; Nagase, Hiroyuki] Daiichi Sankyo Co Ltd, Frontier Res Labs, Tokyo, Japan; [Palmer, Glyn] Univ Florida, Dept Orthopaed & Rehabil, Gainesville, FL USA; [Beier, Frank] Univ Western Ontario, Schulich Sch Med & Dent, Dept Physiol & Pharmacol, London, ON, Canada	New York University; New York University; New York University; New York University; NYU Langone Medical Center; Daiichi Sankyo Company Limited; State University System of Florida; University of Florida; Western University (University of Western Ontario)	Attur, M (corresponding author), NYU, Hosp Joint Dis, Div Rheumatol, 301 East 17th St,Suite 1410, New York, NY 10003 USA.	mukundan.attur@nyumc.org	Beier, Frank/G-4595-2013; Kirsch, Thorsten/GQP-1157-2022; Attur, Mukundan/O-1578-2019; Beier, Frank/T-4734-2019	Beier, Frank/0000-0002-8505-7537; Attur, Mukundan/0000-0001-7080-8118; Beier, Frank/0000-0002-8505-7537; Abramson, Steven/0000-0002-0668-6344; Mignatti, Paolo/0000-0002-8157-457X	U.S. National Institutes of Health (NIH) National Institute of Arthritis and Musculoskeletal and Skin Diseases [R01-AR054817]; U.S. NIH National Cancer Institute [R01-CA136715]; Daiichi Sankyo Co., Ltd. (Tokyo, Japan); NATIONAL CANCER INSTITUTE [R01CA136715] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001427] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR054817] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); U.S. NIH National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Daiichi Sankyo Co., Ltd. (Tokyo, Japan)(Daiichi Sankyo Company Limited); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported in part by U.S. National Institutes of Health (NIH) National Institute of Arthritis and Musculoskeletal and Skin Diseases Grant R01-AR054817 (to S.B.A.) and U.S. NIH National Cancer Institute Grant R01-CA136715 (to P.M.); and by a research grant from Daiichi Sankyo Co., Ltd. (Tokyo, Japan). K.S., Y.T., and H.N. are employees of Daiichi Sankyo Co., Ltd. The authors declare no conflicts of interests.	Abramson SB, 2006, NAT CLIN PRACT RHEUM, V2, P304, DOI 10.1038/ncprheum0193; Amin AR, 1997, J CLIN INVEST, V99, P1231, DOI 10.1172/JCI119280; AMIN AR, 1995, J EXP MED, V182, P2097, DOI 10.1084/jem.182.6.2097; Appleton CTG, 2007, ARTHRITIS RHEUM-US, V56, P1854, DOI 10.1002/art.22711; Attur M, 2011, OSTEOARTHR CARTILAGE, V19, P1158, DOI 10.1016/j.joca.2011.06.006; Attur M. G., 2002, Current Issues in Molecular Biology, V4, P129; Attur MG, 2001, ARTHRITIS RHEUM-US, V44, P578, DOI 10.1002/1529-0131(200103)44:3<578::AID-ANR106>3.3.CO;2-Z; Attur M, 2013, CURR OPIN RHEUMATOL, V25, P136, DOI 10.1097/BOR.0b013e32835a9381; Attur M, 2012, ARTHRITIS RHEUM-US, V64, P1940, DOI 10.1002/art.34360; Attur MG, 2009, FASEB J, V23, P79, DOI 10.1096/fj.08-114363; Bendele A. M., 2001, Journal of Musculoskeletal & Neuronal Interactions, V1, P363; Blom AB, 2010, CURR DRUG TARGETS, V11, P620; Bonnet N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078347; Bonnet N, 2012, P NATL ACAD SCI USA, V109, P15048, DOI 10.1073/pnas.1203085109; Bove SE, 2006, OSTEOARTHR CARTILAGE, V14, P1041, DOI 10.1016/j.joca.2006.05.001; Campbell KA, 2013, ARTHRITIS RHEUM-US, V65, P3120, DOI 10.1002/art.38182; Chou CH, 2013, OSTEOARTHR CARTILAGE, V21, P450, DOI 10.1016/j.joca.2012.11.016; Conway SJ, 2014, CELL MOL LIFE SCI, V71, P1279, DOI 10.1007/s00018-013-1494-y; Ewan K, 2010, CANCER RES, V70, P5963, DOI 10.1158/0008-5472.CAN-10-1028; Fosang AJ, 2011, BEST PRACT RES CL RH, V25, P751, DOI 10.1016/j.berh.2011.11.010; Gardiner MD, 2015, OSTEOARTHR CARTILAGE, V23, P616, DOI 10.1016/j.joca.2014.12.014; Goldring MB, 2007, J CELL PHYSIOL, V213, P626, DOI 10.1002/jcp.21258; Hakuno D, 2010, J CLIN INVEST, V120, P2292, DOI 10.1172/JCI40973; HANDLEY CJ, 1995, METHOD ENZYMOL, V248, P47; Houard X, 2013, CURR RHEUMATOL REP, V15, DOI 10.1007/s11926-013-0375-6; Kamekura S, 2006, ARTHRITIS RHEUM, V54, P2462, DOI 10.1002/art.22041; Karlsson C, 2010, OSTEOARTHR CARTILAGE, V18, P581, DOI 10.1016/j.joca.2009.12.002; Kikuchi Y, 2014, AM J PATHOL, V184, P859, DOI 10.1016/j.ajpath.2013.11.012; Li YP, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/916530; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loeser RF, 2006, ARTHRITIS RHEUM-US, V54, P1357, DOI 10.1002/art.21813; Loeser RF, 2014, MATRIX BIOL, V39, P11, DOI 10.1016/j.matbio.2014.08.007; Loeser RF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054633; Loeser RF, 2013, CURR OPIN RHEUMATOL, V25, P108, DOI 10.1097/BOR.0b013e32835a9428; Loeser RF, 2012, ARTHRITIS RHEUM-US, V64, P705, DOI 10.1002/art.33388; Lotz M, 2012, OSTEOARTHR CARTILAGE, V20, P192, DOI 10.1016/j.joca.2011.11.015; Lotz M, 2012, BONE, V51, P241, DOI 10.1016/j.bone.2012.03.023; Lourido L, 2014, J PROTEOME RES, V13, P6096, DOI 10.1021/pr501024p; Maldonado M, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/284873; Mariani E, 2014, INT J MOL SCI, V15, P8667, DOI 10.3390/ijms15058667; Marie PJ, 2014, TRENDS ENDOCRIN MET, V25, P567, DOI 10.1016/j.tem.2014.06.009; McCann JC, 2009, AM J CLIN NUTR, V90, P889, DOI 10.3945/ajcn.2009.27930; Merle B, 2012, OSTEOPOROSIS INT, V23, P1199, DOI 10.1007/s00198-011-1892-7; Minashima T, 2014, ARTHRITIS RHEUMATOL, V66, P1228, DOI 10.1002/art.38373; Misra D, 2013, AM J MED, V126, P243, DOI 10.1016/j.amjmed.2012.10.011; Nagase H, 2013, OSTEOARTHR CARTILAGE, V21, P514, DOI 10.1016/j.joca.2012.12.013; Olex AL, 2014, GENE, V542, P38, DOI 10.1016/j.gene.2014.03.022; Orecchia P, 2011, EUR J CANCER, V47, P2221, DOI 10.1016/j.ejca.2011.04.026; Sandell LJ, 2007, ARTHRITIS RHEUM, V56, P2474, DOI 10.1002/art.22760; Shen J, 2013, ARTHRITIS RHEUM-US, V65, P3107, DOI 10.1002/art.38122; Shih CH, 2014, J NEUROSCI, V34, P2438, DOI 10.1523/JNEUROSCI.2947-13.2014; van der Kraan PM, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar2896; Wang MN, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4133; Watanabe T, 2012, ARCH ORAL BIOL, V57, P52, DOI 10.1016/j.archoralbio.2011.07.010; Wen W, 2010, J DENT RES, V89, P1439, DOI 10.1177/0022034510378684; Yang LL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041994; Yuasa T, 2008, LAB INVEST, V88, P264, DOI 10.1038/labinvest.3700747; Zhang RK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032356; Zhen GH, 2013, NAT MED, V19, P704, DOI 10.1038/nm.3143	59	38	42	1	15	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2015	29	10					4107	4121		10.1096/fj.15-272427	http://dx.doi.org/10.1096/fj.15-272427			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CR5FY	26092928	Green Published			2022-12-26	WOS:000361367300003
J	Joo, Y; Schumacher, B; Landrieu, I; Bartel, M; Smet-Nocca, C; Jang, A; Choi, HS; Jeon, NL; Chang, KA; Kim, HS; Ottmann, C; Suh, YH				Joo, Yuyoung; Schumacher, Benjamin; Landrieu, Isabelle; Bartel, Maria; Smet-Nocca, Caroline; Jang, Ahram; Choi, Hee Soon; Jeon, Noo Li; Chang, Keun-A; Kim, Hye-Sun; Ottmann, Christian; Suh, Yoo-Hun			Involvement of 14-3-3 in tubulin instability and impaired axon development is mediated by Tau	FASEB JOURNAL			English	Article						protein-protein interactions; Alzheimer's disease; phosphorylation; X-ray crystallography; NMR spectroscopy	PROTEIN-PROTEIN INTERACTIONS; NEUROFIBRILLARY TANGLES; ALZHEIMERS-DISEASE; TRANSCRIPTIONAL ACTIVATION; PHOSPHORYLATION SITES; NMR ASSIGNMENT; IDENTIFICATION; 14-3-3-PROTEINS; MICROTUBULES; BINDING	14-3-3 proteins act as adapters that exert their function by interacting with their various protein partners. 14-3-3 proteins have been implicated in a variety of human diseases including neurodegenerative diseases. 14-3-3 proteins have recently been reported to be abundant in the neurofibrillary tangles (NFTs) observed inside the neurons of brains affected by Alzheimer's disease (AD). These NFTs are mainly constituted of phosphorylated Tau protein, a microtubule-associated protein known to bind 14-3-3. Despite this indication of 14-3-3 protein involvement in the AD pathogenesis, the role of 14-3-3 in the Tauopathy remains to be clarified. In the present study, we shed light on the role of 14-3-3 proteins in the molecular pathways leading to Tauopathies. Overexpression of the 14-3-3s isoform resulted in a disruption of the tubulin cytoskeleton and prevented neuritic outgrowth in neurons. NMR studies validated the phosphorylated residues pSer214 and pSer324 in Tau as the 2 primary sites for 14-3-3binding, with the crystal structure of 14-3-3 sigma in complex with Tau-pSer214 and Tau-pSer324 revealing the molecular details of the interaction. These data suggest a rationale for a possible pharmacologic intervention of the Tau/14-3-3 interaction.	[Joo, Yuyoung; Jang, Ahram; Choi, Hee Soon; Kim, Hye-Sun; Suh, Yoo-Hun] Seoul Natl Univ, Coll Med, Dept Pharmacol, Seoul, South Korea; [Joo, Yuyoung; Jang, Ahram; Choi, Hee Soon; Kim, Hye-Sun; Suh, Yoo-Hun] Seoul Natl Univ, Med Res Council, Neurosci Res Inst, Seoul, South Korea; [Jeon, Noo Li] Seoul Natl Univ, Sch Mech & Aerosp Engn, Seoul, South Korea; [Joo, Yuyoung; Chang, Keun-A] Gachon Univ, Coll Med, Dept Pharmacol, Inchon, South Korea; [Schumacher, Benjamin; Bartel, Maria; Ottmann, Christian] Max Planck Gesell, Chem Genom Ctr, D-44227 Dortmund, Germany; [Landrieu, Isabelle; Smet-Nocca, Caroline] Univ Lille, Ctr Natl Rech Sci, Unit Mixte Rech 8576, Villeneuve Dascq, France; [Ottmann, Christian] Eindhoven Univ Technol, Biol Chem Lab, Dept Biomed Engn, NL-5600 MB Eindhoven, Netherlands; [Ottmann, Christian] Eindhoven Univ Technol, Inst Complex Mol Syst, NL-5600 MB Eindhoven, Netherlands; [Choi, Hee Soon; Suh, Yoo-Hun] Korea Brain Res Inst, Daegu, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Gachon University; Max Planck Society; Centre National de la Recherche Scientifique (CNRS); Universite de Lille - ISITE; Universite de Lille; Eindhoven University of Technology; Eindhoven University of Technology; Korea Brain Research Institute (KBRI)	Ottmann, C (corresponding author), Max Planck Gesell, Chem Genom Ctr, D-44227 Dortmund, Germany.	c.ottmann@tue.nl; yhsuh@kbri.re.kr	Landrieu, Isabelle/AAF-8495-2019; Smet-Nocca, Caroline/U-3427-2019; Smet-Nocca, Caroline/G-2868-2012	Landrieu, Isabelle/0000-0002-4883-2637; Smet-Nocca, Caroline/0000-0002-9793-0882; Smet-Nocca, Caroline/0000-0002-9793-0882; Bartel, Maria/0000-0001-8131-1078	AstraZeneca; BayerCrop Science; Bayer Healthcare; Boehringer Ingelheim; Merck KGaA; Conversing Research Center Program through the National Research Foundation of Korea - Ministry of Education, Science and Technology [2009-0082268]; Korea Research Foundation - Korean government [KRF-2008-621-H00002]; National Research Foundation of Korea - Korean Government (Ministry of Education, Science and Technology) [NRF-2011-355-E00089]; Establishment and Operation of Korea Brain Research Institute basic research program of the Ministry of Science, Internal Cooperation and Future Planning [2231-415]; 14-3-3STABS European Union [286418]; French Laboratory of Excellency Distalz; Region Nord; Centre national de la recherche scientifique; Pasteur Institute of Lille; European Community (Fonds Europeen de Developpement Regional; FEDER); French Research Ministry; University of Sciences and Technologies of Lille 1; Tres Grand Equipement Resonance Magnetique Nucleaire Tres Hauts Champs, France [FR-3050]	AstraZeneca(AstraZeneca); BayerCrop Science; Bayer Healthcare(Bayer AGBayer Healthcare Pharmaceuticals); Boehringer Ingelheim(Boehringer Ingelheim); Merck KGaA(Merck & Company); Conversing Research Center Program through the National Research Foundation of Korea - Ministry of Education, Science and Technology; Korea Research Foundation - Korean government(National Research Foundation of KoreaKorean Government); National Research Foundation of Korea - Korean Government (Ministry of Education, Science and Technology); Establishment and Operation of Korea Brain Research Institute basic research program of the Ministry of Science, Internal Cooperation and Future Planning; 14-3-3STABS European Union; French Laboratory of Excellency Distalz; Region Nord(Region Hauts-de-France); Centre national de la recherche scientifique(Centre National de la Recherche Scientifique (CNRS)); Pasteur Institute of Lille; European Community (Fonds Europeen de Developpement Regional; FEDER); French Research Ministry(Ministry of Research, France); University of Sciences and Technologies of Lille 1; Tres Grand Equipement Resonance Magnetique Nucleaire Tres Hauts Champs, France	C.O. thanks AstraZeneca, BayerCrop Science, Bayer Healthcare, Boehringer Ingelheim, and Merck KGaA for support. This functional research was additionally supported by the Conversing Research Center Program through the National Research Foundation of Korea funded by the Ministry of Education, Science and Technology (2009-0082268), the Korea Research Foundation grant funded by the Korean government (KRF-2008-621-H00002), National Research Foundation of Korea grant funded by the Korean Government (Ministry of Education, Science and Technology; NRF-2011-355-E00089), the Establishment and Operation of Korea Brain Research Institute basic research program of the Ministry of Science, Internal Cooperation and Future Planning (2231-415), the 14-3-3STABS European Union Project 286418, and the French Laboratory of Excellency Distalz. The nuclear magnetic resonance facilities were funded by the Region Nord, Centre national de la recherche scientifique, Pasteur Institute of Lille, European Community (Fonds Europeen de Developpement Regional; FEDER), French Research Ministry, and the University of Sciences and Technologies of Lille 1. The authors acknowledge support from the Tres Grand Equipement Resonance Magnetique Nucleaire Tres Hauts Champs (FR-3050, France). I.L., Y.-H.S., and C.O. conceived the project and wrote the manuscript. Y.J. and B.S. performed most of the experimental work. M.B. performed biophysical experiments. C.S.-N. performed nuclear magnetic resonance experiments. The authors declare no conflicts of interest.	Aitken A, 2006, SEMIN CANCER BIOL, V16, P162, DOI 10.1016/j.semcancer.2006.03.005; Amniai L, 2009, FASEB J, V23, P1146, DOI 10.1096/fj.08-121590; Anders C, 2013, CHEM BIOL, V20, P583, DOI 10.1016/j.chembiol.2013.03.015; Berg D, 2003, NAT REV NEUROSCI, V4, P752, DOI 10.1038/nrn1197; BIERNAT J, 1993, NEURON, V11, P153, DOI 10.1016/0896-6273(93)90279-Z; BOSTON PF, 1982, J NEUROCHEM, V38, P1475, DOI 10.1111/j.1471-4159.1982.tb07928.x; Camoni L, 2011, BIOCHEM J, V436, P429, DOI 10.1042/BJ20102037; Campenot RB, 1996, J CELL BIOL, V135, P701, DOI 10.1083/jcb.135.3.701; Chun J, 2004, MOL CELLS, V18, P360; Corradi V, 2010, BIOORG MED CHEM LETT, V20, P6133, DOI 10.1016/j.bmcl.2010.08.019; de Vries-van Leeuwen IJ, 2010, CANCER LETT, V293, P198, DOI 10.1016/j.canlet.2010.01.009; Dehmelt L, 2004, J NEUROBIOL, V58, P18, DOI 10.1002/neu.10284; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FU H, 1993, P NATL ACAD SCI USA, V90, P2320, DOI 10.1073/pnas.90.6.2320; Gordon-Weeks PR, 2004, NAT CELL BIOL, V6, P390, DOI 10.1038/ncb0504-390; Hashiguchi M, 2000, J BIOL CHEM, V275, P25247, DOI 10.1074/jbc.M003738200; Hermeking H, 2003, NAT REV CANCER, V3, P931, DOI 10.1038/nrc1230; Hermeking H, 2006, SEMIN CANCER BIOL, V16, P183, DOI 10.1016/j.semcancer.2006.03.002; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kim YS, 2005, ENDOCRINOLOGY, V146, P3133, DOI 10.1210/en.2004-1455; KOPKE E, 1993, J BIOL CHEM, V268, P24374; Landrieu I, 2006, J AM CHEM SOC, V128, P3575, DOI 10.1021/ja054656+; Layfield R, 1996, NEUROSCI LETT, V209, P57, DOI 10.1016/0304-3940(96)12598-2; De Vries-van Leeuwen IJ, 2013, P NATL ACAD SCI USA, V110, P8894, DOI 10.1073/pnas.1220809110; LINDWALL G, 1984, J BIOL CHEM, V259, P5301; Lippens G, 2004, CHEMBIOCHEM, V5, P73, DOI 10.1002/cbic.200300763; Matthews TA, 2005, NEUROSCI LETT, V384, P211, DOI 10.1016/j.neulet.2005.04.101; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Molzan M, 2013, ACS CHEM BIOL, V8, P1869, DOI 10.1021/cb4003464; Molzan M, 2010, MOL CELL BIOL, V30, P4698, DOI 10.1128/MCB.01636-09; Mukrasch MD, 2009, PLOS BIOL, V7, P399, DOI 10.1371/journal.pbio.1000034; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nichols RJ, 2010, BIOCHEM J, V430, P393, DOI 10.1042/BJ20100483; Ottmann C, 2007, MOL CELL, V25, P427, DOI 10.1016/j.molcel.2006.12.017; Ottmann C, 2009, J MOL BIOL, V386, P913, DOI 10.1016/j.jmb.2009.01.005; Park JW, 2006, NAT PROTOC, V1, P2128, DOI 10.1038/nprot.2006.316; Qureshi HY, 2013, BIOCHEMISTRY-US, V52, P6445, DOI 10.1021/bi400442d; Rajagopalan S, 2010, NUCLEIC ACIDS RES, V38, P893, DOI 10.1093/nar/gkp1041; Rose R, 2010, ANGEW CHEM INT EDIT, V49, P4129, DOI 10.1002/anie.200907203; Sadik G, 2009, J NEUROCHEM, V108, P33, DOI 10.1111/j.1471-4159.2008.05716.x; Schumacher B, 2010, FEBS LETT, V584, P1443, DOI 10.1016/j.febslet.2010.02.065; SCOTT CW, 1993, J BIOL CHEM, V268, P1166; Sillen A, 2007, BIOCHEMISTRY-US, V46, P3055, DOI 10.1021/bi061920i; Sluchanko NN, 2009, FEBS LETT, V583, P2739, DOI 10.1016/j.febslet.2009.07.043; Smet C, 2004, CHEMBIOCHEM, V5, P1639, DOI 10.1002/cbic.200400145; Umahara T, 2004, ACTA NEUROPATHOL, V108, P279, DOI 10.1007/s00401-004-0885-4; Wu H, 2010, ANGEW CHEM INT EDIT, V49, P6528, DOI 10.1002/anie.201003257; Wurtele M, 2003, EMBO J, V22, P987, DOI 10.1093/emboj/cdg104; Yang HY, 2003, MOL CELL BIOL, V23, P7096, DOI 10.1128/MCB.23.20.7096-7107.2003; Yano M, 2006, MOL BIOL CELL, V17, P4769, DOI 10.1091/mbc.E06-03-0229; Zeidler M, 2000, ANN NEUROL, V47, P683, DOI 10.1002/1531-8249(200005)47:5<683::AID-ANA25>3.0.CO;2-V; Zhao J, 2011, P NATL ACAD SCI USA, V108, P16212, DOI 10.1073/pnas.1100012108	53	49	49	1	20	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2015	29	10					4133	4144		10.1096/fj.14-265009	http://dx.doi.org/10.1096/fj.14-265009			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CR5FY	26103986				2022-12-26	WOS:000361367300005
J	Chen, XS; Xu, HX; Ding, LL; Lou, GY; Liu, Y; Yao, YL; Chen, LW; Huang, WD; Fu, XH				Chen, Xiaosong; Xu, Haixia; Ding, Lili; Lou, Guiyu; Liu, Yan; Yao, Yalan; Chen, Liangwan; Huang, Wendong; Fu, Xianghui			Identification of miR-26a as a Target Gene of Bile Acid Receptor GPBAR-1/TGR5	PLOS ONE			English	Article							TGR5; METABOLISM; MICRORNAS; PROTECTS; GLUCOSE; CELLS; LIVER	GPBAR1/TGR5 is a G protein-coupled receptor of bile acids. TGR5 is known to regulate the BA homeostasis and energy metabolism. Recent studies highlight an important role of TGR5 in alleviating obesity and improving glucose regulation, however, the mechanism of which is still unclear. Here we report that TGR5 is involved in mediating the anti-obesity and anti-hyperglycemia effect of a natural compound, oleanolic acid. By comparing the miRNA profiles between wild type and TGR5(-/-) livers after OA treatment, we identified miR-26a as a novel downstream target gene of TGR5 activation. The expression of miR-26a in the liver was induced in a TGR5-dependent manner after feeding the mice with a bile acid diet. TGR5 activation strongly increased the expression of miR-26a in macrophages, including the Kupffer cells in the liver. We further demonstrated that JNK pathway was required for miR-26a induction by TGR5 activation. Interestingly, we located the TGR5-responsive DNA element to a proximal region of miR-26's promoter, which was independent of the transcription of its host genes. These results unravel a new mechanism by which bile acid receptor TGR5 activates a miRNA gene expression.	[Chen, Xiaosong; Liu, Yan; Chen, Liangwan] Fujian Med Univ, Dept Plast Surg, Union Hosp, Fuzhou 350001, Fujian, Peoples R China; [Xu, Haixia; Yao, Yalan; Fu, Xianghui] Sichuan Univ, West China Hosp, Div Endocrinol & Metab, State Key Lab Biotherapy, Chengdu 610041, Sichuan, Peoples R China; [Xu, Haixia; Yao, Yalan; Fu, Xianghui] Collaborat Innovat Ctr Biotherapy, Chengdu 610041, Sichuan, Peoples R China; [Ding, Lili; Lou, Guiyu; Huang, Wendong] City Hope Natl Med Ctr, Diabet & Metab Res Inst, Beckman Res Inst, Dept Diabet Complicat & Metab, Duarte, CA 91010 USA; [Lou, Guiyu] Henan Peoples Hosp, Cent Lab, Zhengzhou 450003, Henan, Peoples R China; [Lou, Guiyu] Zhengzhou Univ, Peoples Hosp, Zhengzhou 450003, Henan, Peoples R China	Fujian Medical University; Sichuan University; City of Hope; Beckman Research Institute of City of Hope; Zhengzhou University	Chen, XS (corresponding author), Fujian Med Univ, Dept Plast Surg, Union Hosp, 29 Xinquan Rd, Fuzhou 350001, Fujian, Peoples R China.	chenxiaosong74@163.com; whuang@coh.org; xfu@scu.edu.cn		Fu, Xianghui/0000-0001-9808-3892; Chen, Xiaosong/0000-0002-3780-5510	National Natural Science Foundation of China [81372092, 81441121]; Fujian Natural Science Foundation [2011J01173]; Fujian Municipal Natural Science Foundation [2011Y0029]; Foundation of Fujian Educational Committee National [JA11122]; National Cancer Institute [R01-139158]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fujian Natural Science Foundation(Natural Science Foundation of Fujian Province); Fujian Municipal Natural Science Foundation; Foundation of Fujian Educational Committee National; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work is supported partially by the National Natural Science Foundation of China-Grant No. 81372092, Fujian Natural Science Foundation-Grant No. 2011J01173, Fujian Municipal Natural Science Foundation-Grant No. 2011Y0029, Foundation of Fujian Educational Committee National-Grant No. JA11122 to X.C., National Natural Science Foundation of China-Grant No. 81441121 to X.F., and National Cancer Institute-Grant No. R01-139158 to W.H. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baskerville S, 2005, RNA, V11, P241, DOI 10.1261/rna.7240905; Chen XS, 2011, EXP DIABETES RES, DOI 10.1155/2011/853501; Davies John Q, 2005, Methods Mol Biol, V290, P91; Dill H, 2012, GENE DEV, V26, P25, DOI 10.1101/gad.177774.111; Fan M, 2014, BIOCH BIOPHYS ACTA; Fu X, 2014, ONCOGENE, V33, P4296, DOI 10.1038/onc.2013.385; Fu XH, 2015, J CLIN INVEST, V125, P2497, DOI 10.1172/JCI75438; Fu XH, 2013, P NATL ACAD SCI USA, V110, P17892, DOI 10.1073/pnas.1317397110; Harach T, 2012, SCI REP-UK, V2, DOI 10.1038/srep00430; Kawamata Y, 2003, J BIOL CHEM, V278, P9435, DOI 10.1074/jbc.M209706200; Keitel V, 2007, HEPATOLOGY, V45, P695, DOI 10.1002/hep.21458; Kuipers F, 2014, NAT REV ENDOCRINOL, V10, P488, DOI 10.1038/nrendo.2014.60; Li TT, 2011, MOL ENDOCRINOL, V25, P1066, DOI 10.1210/me.2010-0460; Liu WM, 2010, PHYTOTHER RES, V24, P369, DOI 10.1002/ptr.2948; Lou GY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093567; Maruyama T, 2006, J ENDOCRINOL, V191, P197, DOI 10.1677/joe.1.06546; Meng ZP, 2010, HEPATOLOGY, V52, P2148, DOI 10.1002/hep.23915; Monteys AM, 2010, RNA, V16, P495, DOI 10.1261/rna.1731910; Pean N, 2013, HEPATOLOGY, V58, P1451, DOI 10.1002/hep.26463; Perino A, 2014, J CLIN INVEST, V124, P5424, DOI 10.1172/JCI76289; Pols TWH, 2011, CELL METAB, V14, P747, DOI 10.1016/j.cmet.2011.11.006; Rottiers V, 2012, NAT REV MOL CELL BIO, V13, P239, DOI 10.1038/nrm3313; Sato H, 2007, BIOCHEM BIOPH RES CO, V362, P793, DOI 10.1016/j.bbrc.2007.06.130; Tahrani AA, 2011, LANCET, V378, P182, DOI 10.1016/S0140-6736(11)60207-9; Thomas C, 2009, CELL METAB, V10, P167, DOI 10.1016/j.cmet.2009.08.001; Vallim TQD, 2013, CELL METAB, V17, P657, DOI 10.1016/j.cmet.2013.03.013; van Rooij E, 2012, NAT REV DRUG DISCOV, V11, P860, DOI 10.1038/nrd3864; Vassileva G, 2006, BIOCHEM J, V398, P423, DOI 10.1042/BJ20060537; Wang YD, 2011, HEPATOLOGY, V54, P1421, DOI 10.1002/hep.24525; Watanabe M, 2006, NATURE, V439, P484, DOI 10.1038/nature04330; Yu DD, 2015, BIOORGAN MED CHEM, V23, P1613, DOI 10.1016/j.bmc.2015.01.048	31	11	16	4	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2015	10	6							e0131294	10.1371/journal.pone.0131294	http://dx.doi.org/10.1371/journal.pone.0131294			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4OM	26107166	Green Submitted, Green Published, gold			2022-12-26	WOS:000356932500153
J	Martins, JA; Rodrigues, JMF; du Buf, H				Martins, Jaime A.; Rodrigues, Joao M. F.; du Buf, Hans			Luminance, Colour, Viewpoint and Border Enhanced Disparity Energy Model	PLOS ONE			English	Article								The visual cortex is able to extract disparity information through the use of binocular cells. This process is reflected by the Disparity Energy Model, which describes the role and functioning of simple and complex binocular neuron populations, and how they are able to extract disparity. This model uses explicit cell parameters to mathematically determine preferred cell disparities, like spatial frequencies, orientations, binocular phases and receptive field positions. However, the brain cannot access such explicit cell parameters; it must rely on cell responses. In this article, we implemented a trained binocular neuronal population, which encodes disparity information implicitly. This allows the population to learn how to decode disparities, in a similar way to how our visual system could have developed this ability during evolution. At the same time, responses of monocular simple and complex cells can also encode line and edge information, which is useful for refining disparities at object borders. The brain should then be able, starting from a low-level disparity draft, to integrate all information, including colour and viewpoint perspective, in order to propagate better estimates to higher cortical areas.	[Martins, Jaime A.; du Buf, Hans] Univ Algarve, Vis Lab FCT, ISR LARSyS, Faro, Portugal; [Rodrigues, Joao M. F.] Univ Algarve, Vis Lab ISE, ISR LARSyS, Faro, Portugal	Universidade do Algarve; Universidade do Algarve	Martins, JA (corresponding author), Univ Algarve, Vis Lab FCT, ISR LARSyS, Faro, Portugal.	jamartins@ualg.pt	Rodrigues, João/GVU-7735-2022; Martins, Jaime/HHC-7281-2022; RODRIGUES, JOÃO/AAC-6993-2019; Rodrigues, João/D-1617-2010	Rodrigues, João/0000-0002-3562-6025; Martins, Jaime Afonso/0000-0001-9360-0221	Portuguese Foundation for Science and Technology (FCT); LARSyS FCT [UID/EEA/50009/2013]; EU project NeuroDynamics [FP7-ICT-2009-6, PN: 270247]; FCT project SparseCoding [EXPL/EEI-SII/1982/2013]; FCT PhD grant [SFRH-BD-44941-2008]; Fundação para a Ciência e a Tecnologia [EXPL/EEI-SII/1982/2013] Funding Source: FCT	Portuguese Foundation for Science and Technology (FCT)(Portuguese Foundation for Science and Technology); LARSyS FCT(Portuguese Foundation for Science and Technology); EU project NeuroDynamics; FCT project SparseCoding; FCT PhD grant(Portuguese Foundation for Science and Technology); Fundação para a Ciência e a Tecnologia	This work was partly supported by the Portuguese Foundation for Science and Technology (FCT), LARSyS FCT (UID/EEA/50009/2013), EU project NeuroDynamics (FP7-ICT-2009-6, PN: 270247), FCT project SparseCoding (EXPL/EEI-SII/1982/2013) and FCT PhD grant to author JAM (SFRH-BD-44941-2008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.		0	11	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2015	10	6							e0129908	10.1371/journal.pone.0129908	http://dx.doi.org/10.1371/journal.pone.0129908			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4OM	26107954	Green Published, gold, Green Submitted			2022-12-26	WOS:000356932500071
J	Ning, B; Wei, JL; Zhang, AJ; Gong, WM; Fu, JQ; Jia, TH; Yang, SY				Ning, Bin; Wei, Jianlu; Zhang, Aijun; Gong, Weiming; Fu, Jinqiu; Jia, Tanghong; Yang, Shang-You			Antigen-Specific Tolerogenic Dendritic Cells Ameliorate the Severity of Murine Collagen-Induced Arthritis	PLOS ONE			English	Article							REGULATORY T-CELLS; RHEUMATOID-ARTHRITIS; IMMUNE THROMBOCYTOPENIA; TOLERANCE; THERAPY; MICE; METHOTREXATE; CYTOKINES; TARGETS; ANERGY	Dendritic cells (DCs) play important roles in initiation of the pathogenic processes of autoimmune disorders, such as rheumatoid arthritis (RA). Tolerogenic dendritic cells (tolDCs) are generated from naive DCs and induce T cell tolerance; thus, they represent a promising strategy for specific cellular therapy for autoimmune diseases. In this study, we generated green fluorescent protein (GFP)-labeled tolDCs and confirmed their phenotypes and biological functions. We found that tolDCs suppressed the memory lymphocyte response and exhibited strong tolerogenic potential; thus, these cells show promise for the treatment of autoimmune diseases. Additionally, a collagen-induced arthritis (CIA) mouse model was used to test the role of tolDCs in vivo. The results of a further mechanistic experiment revealed that tolDCs suppressed inflammatory arthritis at least partially by up-regulating regulatory T (Treg) cells. Collectively, our data suggest that tolDCs may be used as a promising alternative therapy for inflammatory arthritis.	[Ning, Bin; Wei, Jianlu; Gong, Weiming; Jia, Tanghong; Yang, Shang-You] Shandong Univ, Jinan Cent Hosp, Dept Orthoped Surg, Jinan, Shandong, Peoples R China; [Zhang, Aijun; Fu, Jinqiu] Shandong Univ, Qilu Hosp, Dept Pediat, Jinan, Shandong, Peoples R China; [Ning, Bin; Yang, Shang-You] Wichita State Univ, Dept Biol Sci, Wichita, KS 67208 USA	Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University; Shandong University; Wichita State University	Jia, TH (corresponding author), Shandong Univ, Jinan Cent Hosp, Dept Orthoped Surg, Jinan, Shandong, Peoples R China.	jiatanghong@hotmail.com; shang-you.yang@wichita.edu	Yang, Shang-You/ADX-1056-2022; Yang, Shang-You/AAR-2933-2021; Fu, Jinqiu/AAY-2242-2021	Yang, Shang-You/0000-0002-8835-5302; 	National Natural Science Foundation of China [81401014]; Star of Jinan Youth Science and Technology Project [20100114]; Young Scientists Awards Foundation of Shandong Province [BS2013YY049]; China Postdoctoral Science Foundation [2012M511036, 2014M561935]; International Cooperation Projects of Jinan City [201305053]; Arthritis Foundation Michigan Chapter	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Star of Jinan Youth Science and Technology Project; Young Scientists Awards Foundation of Shandong Province; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); International Cooperation Projects of Jinan City; Arthritis Foundation Michigan Chapter	This work was supported in part by research grants from the National Natural Science Foundation of China (No. 81401014), the Star of Jinan Youth Science and Technology Project (No. 20100114), the Young Scientists Awards Foundation of Shandong Province (No. BS2013YY049), the China Postdoctoral Science Foundation (Nos. 2012M511036 and 2014M561935), the International Cooperation Projects of Jinan City (No. 201305053), and the Arthritis Foundation Michigan Chapter (to SYY). None of the authors declare any conflicts of interest in association with this study.	Aghdami N, 2008, EXP ANIM TOKYO, V57, P45, DOI 10.1538/expanim.57.45; Alghasham A, 2014, AUTOIMMUNITY, V47, P77, DOI 10.3109/08916934.2013.873413; Anderson AE, 2009, J LEUKOCYTE BIOL, V85, P243, DOI 10.1189/jlb.0608374; Bruder D, 2005, DIABETES, V54, P3395, DOI 10.2337/diabetes.54.12.3395; Chen M, 2006, SCIENCE, V311, P1160, DOI 10.1126/science.1122545; Flores-Borja F, 2008, EUR J IMMUNOL, V38, P934, DOI 10.1002/eji.200738107; Fu JQ, 2012, CLIN APPL THROMB-HEM, V18, P469, DOI 10.1177/1076029612438612; Greenberg JD, 2010, ANN RHEUM DIS, V69, P380, DOI 10.1136/ard.2008.089276; Guyot P, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3537; Harris HE, 1997, CLIN EXP IMMUNOL, V107, P480, DOI 10.1046/j.1365-2249.1997.3311221.x; Jorgensen KT, 2008, ANN RHEUM DIS, V67, P860, DOI 10.1136/ard.2007.073825; Khan S, 2009, NAT REV RHEUMATOL, V5, P566, DOI 10.1038/nrrheum.2009.185; Kim SH, 2000, ARTHRITIS RES, V2, P293, DOI 10.1186/ar104; Ko HJ, 2010, J AUTOIMMUN, V34, P111, DOI 10.1016/j.jaut.2009.07.006; Lim DS, 2009, EUR J IMMUNOL, V39, P1334, DOI 10.1002/eji.200838987; Morelli AE, 2007, NAT REV IMMUNOL, V7, P610, DOI 10.1038/nri2132; Oriss TB, 2005, J IMMUNOL, V174, P854, DOI 10.4049/jimmunol.174.2.854; Piccioli D, 2007, BLOOD, V109, P5371, DOI 10.1182/blood-2006-08-038422; Schinnerling K, 2015, AUTOIMMUN REV, V14, P517, DOI 10.1016/j.autrev.2015.01.014; Tang QZ, 2004, J EXP MED, V199, P1455, DOI 10.1084/jem.20040139; Tang W, 2011, SCIENCE, V332, P478, DOI 10.1126/science.1199214; Torres-Aguilar H, 2010, J IMMUNOL, V184, P1765, DOI 10.4049/jimmunol.0902133; Tuettenberg A, 2009, J IMMUNOL, V182, P3349, DOI 10.4049/jimmunol.0802733; Wang L, 2008, P NATL ACAD SCI USA, V105, P9331, DOI 10.1073/pnas.0710441105; Yin DZ, 2008, INT J ONCOL, V33, P253, DOI 10.3892/ijo_00000004; Zhang AJ, 2013, THROMB RES, V132, P63, DOI 10.1016/j.thromres.2013.04.001; Zhang LL, 2015, INT IMMUNOPHARMACOL, V25, P96, DOI 10.1016/j.intimp.2015.01.014; Zhang MH, 2004, NAT IMMUNOL, V5, P1124, DOI 10.1038/ni1130; Zhang QG, 2013, SCI WORLD J, DOI 10.1155/2013/718061; Zhao YP, 2012, RHEUMATOL INT, V32, P837, DOI 10.1007/s00296-011-2133-2	30	14	17	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2015	10	6							e0131152	10.1371/journal.pone.0131152	http://dx.doi.org/10.1371/journal.pone.0131152			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4OM	26107250	Green Published, gold, Green Submitted			2022-12-26	WOS:000356932500144
J	Pant, I; Kumar, N; Khan, I; Rao, SG; Kondaiah, P				Pant, Ila; Kumar, Neeraj; Khan, Imran; Rao, Somanahalli Girish; Kondaiah, Paturu			Role of Areca Nut Induced TGF-beta and Epithelial-Mesenchymal Interaction in the Pathogenesis of Oral Submucous Fibrosis	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; IN-VITRO; FIBROBLASTS; CONTRACTION; GENES; QUID	Areca nut consumption has been implicated in the progression of Oral Submucous fibrosis (OSF); an inflammatory precancerous fibrotic condition. Our previous studies have demonstrated the activation of TGF-beta signaling in epithelial cells by areca nut components and also propose a role for epithelial expressed TGF-beta in the pathogenesis of OSF. Although the importance of epithelial cells in the manifestation of OSF has been proposed, the actual effectors are fibroblast cells. However, the role of areca nut and TGF-beta in the context of fibroblast response has not been elucidated. Therefore, to understand their role in the context of fibroblast response in OSF pathogenesis, human gingival fibroblasts (hGF) were treated with areca nut and/or TGF-beta followed by transcriptome profiling. The gene expression profile obtained was compared with the previously published transcriptome profiles of OSF tissues and areca nut treated epithelial cells. The analysis revealed regulation of 4666 and 1214 genes by areca nut and TGF-beta treatment respectively. The expression of 413 genes in hGF cells was potentiated by areca nut and TGF-beta together. Further, the differentially expressed genes of OSF tissues compared to normal tissues overlapped significantly with areca nut and TGF-beta induced genes in epithelial and hGF cells. Several positively enriched pathways were found to be common between OSF tissues and areca nut + TGF-beta treated hGF cells. In concordance, areca nut along with TGF-beta enhanced fibroblast activation as demonstrated by potentiation of alpha SMA, gamma SMA and collagen gel contraction by hGF cells. Furthermore, TGF-beta secreted by areca nut treated epithelial cells influenced fibroblast activation and other genes implicated in fibrosis. These data establish a role for areca nut influenced epithelial cells in OSF progression by activation of fibroblasts and emphasizes the importance of epithelial-mesenchymal interaction in OSF.	[Pant, Ila; Kumar, Neeraj; Khan, Imran; Kondaiah, Paturu] Indian Inst Sci, Dept Mol Reprod, Dev & Genet, Bangalore 560012, Karnataka, India; [Rao, Somanahalli Girish] DA Pandu Mem RV Dent Coll & Hosp, Dept Oral & Maxillofacial Surg, Bangalore, Karnataka, India	Indian Institute of Science (IISC) - Bangalore	Kondaiah, P (corresponding author), Indian Inst Sci, Dept Mol Reprod, Dev & Genet, Bangalore 560012, Karnataka, India.	paturu@mrdg.iisc.ernet.in	khan, imran/K-9921-2013; Pant, Ila/AAG-9501-2020	khan, imran/0000-0001-6888-7347; Pant, Ila/0000-0003-0517-6542	Department of Science and Technology, Government of India; Department of Biotechnolgy, Government of India; Council of Scientific and Industrial Research, New Delhi	Department of Science and Technology, Government of India(Department of Science & Technology (India)); Department of Biotechnolgy, Government of India(Department of Biotechnology (DBT) India); Council of Scientific and Industrial Research, New Delhi(Council of Scientific & Industrial Research (CSIR) - India)	The authors would like to acknowledge University Grants Commission; DST-FIST and Department of Biotechnology, Government of India for providing infrastructural support to the department. This research is funded by the Departments of Science and Technology and Biotechnolgy, Government of India. IP is a recipient of a fellowship from the Council of Scientific and Industrial Research, New Delhi. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; Chang MC, 2013, CARCINOGENESIS, V34, P1096, DOI 10.1093/carcin/bgt012; Cox SC, 1996, AUST DENT J, V41, P294, DOI 10.1111/j.1834-7819.1996.tb03136.x; Fang F, 2011, AM J PATHOL, V178, P2077, DOI 10.1016/j.ajpath.2011.01.035; Haque MF, 2000, J ORAL PATHOL MED, V29, P123, DOI 10.1034/j.1600-0714.2000.290304.x; HARVEY W, 1986, ARCH ORAL BIOL, V31, P45, DOI 10.1016/0003-9969(86)90112-3; IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, 2004, IARC Monogr Eval Carcinog Risks Hum, V85, P1; Inman GJ, 2002, MOL PHARMACOL, V62, P65, DOI 10.1124/mol.62.1.65; Jacob BJ, 2004, ORAL ONCOL, V40, P697, DOI 10.1016/j.oraloncology.2004.01.005; JENG JH, 1994, J DENT RES, V73, P1043, DOI 10.1177/00220345940730050501; Khan I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051806; Khan I, 2011, GROWTH FACTORS, V29, P119, DOI 10.3109/08977194.2011.582839; MEGHJI S, 1987, ARCH ORAL BIOL, V32, P213, DOI 10.1016/0003-9969(87)90138-5; Ngo P, 2006, METH MOL B, V341, P103; Nigam M, 2008, LIFE SCI, V82, P577, DOI 10.1016/j.lfs.2007.11.028; Novo E, 2014, ARCH BIOCHEM BIOPHYS, V548, P20, DOI 10.1016/j.abb.2014.02.015; Perera MWS, 2007, J ORAL PATHOL MED, V36, P273, DOI 10.1111/j.1600-0714.2007.00523.x; PINDBORG JJ, 1984, SCAND J DENT RES, V92, P224; PINDBORG JJ, 1966, ORAL SURG ORAL MED O, V22, P764, DOI 10.1016/0030-4220(66)90367-7; Ranganathan P, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-98; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Sakai N, 2013, BBA-MOL BASIS DIS, V1832, P911, DOI 10.1016/j.bbadis.2013.03.001; Sehgal P, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-63; SINOR PN, 1990, J ORAL PATHOL MED, V19, P94, DOI 10.1111/j.1600-0714.1990.tb00804.x; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Thangjam GS, 2009, J PERIODONTAL RES, V44, P673, DOI 10.1111/j.1600-0765.2008.01176.x; Tullberg-Reinert H, 1999, HISTOCHEM CELL BIOL, V112, P271, DOI 10.1007/s004180050447; Untergasser G, 2005, MECH AGEING DEV, V126, P59, DOI 10.1016/j.mad.2004.09.023; Utsunomiya H, 2005, J ORAL PATHOL MED, V34, P498, DOI 10.1111/j.1600-0714.2005.00339.x; Xu C, 2000, Hua Xi Kou Qiang Yi Xue Za Zhi, V18, P394; YOUNG L, 1993, ENVIRON HEALTH PERSP, V101, P56, DOI 10.2307/3431572	32	29	29	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2015	10	6							e0129252	10.1371/journal.pone.0129252	http://dx.doi.org/10.1371/journal.pone.0129252			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4OM	26107172	Green Published, Green Submitted, gold			2022-12-26	WOS:000356932500043
J	Sahdra, BK; Ciarrochi, J; Parker, PD				Sahdra, Baljinder K.; Ciarrochi, Joseph; Parker, Philip D.			High-Frequency Heart Rate Variability Linked to Affiliation with a New Group	PLOS ONE			English	Article							RESPIRATORY SINUS ARRHYTHMIA; POWER SPECTRUM ANALYSIS; CARDIAC VAGAL TONE; CONFIDENCE-INTERVALS; EMOTIONS; PSYCHOPHYSIOLOGY; ATTACHMENT; BOOTSTRAP; ORIGINS; INDEXES	This study tests the hypothesis that high levels of high-frequency heart rate variability (HF-HRV) predisposes individuals to affiliate with new groups. Resting cardiac physiological recordings were taken before and after experimental sessions to measure trait high-frequency heart rate variability as an index of dispositional autonomic influence on heart rate. Following an experimental manipulation of priming of caring-related words, participants engaged in a minimal group paradigm, in which they imagined being a member of one of two arbitrary groups, allocated money to members of the two groups, and rated their affiliation with the groups. High levels of HF-HRV were associated with ingroup favouritism while allocating money, an effect largely attributable to a positive relationship between HF-HRV and allocation of money to the ingroup, and less due to a negative relationship between HF-HRV and money allocation to the outgroup. HF-HRV was also associated with increased self-reported affiliation feelings for the ingroup but was unrelated to feelings towards the outgroup. These effects remained substantial even after controlling for age, gender, BMI, mood, caffeine consumption, time of day of data collection, smoking and alcohol behaviour, and respiration rate. Further, the effects were observed regardless of whether participants were primed with caring-related words or not. This study is the first to bridge a long history of research on ingroup favouritism to the relatively recent body of research on cardiac vagal tone by uncovering a positive association between HF-HRV and affiliation with a novel group.	[Sahdra, Baljinder K.; Ciarrochi, Joseph; Parker, Philip D.] Australian Catholic Univ, Inst Posit Psychol & Educ, Strathfield, NSW 2059, Australia	Australian Catholic University	Sahdra, BK (corresponding author), Australian Catholic Univ, Inst Posit Psychol & Educ, Strathfield, NSW 2059, Australia.	baljinder.sahdra@acu.edu.au	Ciarrochi, Joseph/HHS-0346-2022; Parker, Philip/K-2896-2018; Ciarrochi, Joseph/F-5823-2016; Sahdra, Baljinder K./AAG-1559-2019	Parker, Philip/0000-0002-4604-8566; Ciarrochi, Joseph/0000-0003-0471-8100; Sahdra, Baljinder K./0000-0001-5064-7783	Mind and Life Contemplative Studies Fellowship [2012-01-005]; Australian Research Council [FT100100656]	Mind and Life Contemplative Studies Fellowship; Australian Research Council(Australian Research Council)	This research was facilitated by the Mind and Life Contemplative Studies Fellowship (2012-01-005) to BKS, and Australian Research Council grant (FT100100656) to JC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKSELROD S, 1981, SCIENCE, V213, P220, DOI 10.1126/science.6166045; Allen JJB, 2007, BIOL PSYCHOL, V74, P243, DOI 10.1016/j.biopsycho.2006.08.005; Allen MT, 2000, INT J PSYCHOPHYSIOL, V37, P185, DOI 10.1016/S0167-8760(00)00089-1; Appelhans BM, 2006, REV GEN PSYCHOL, V10, P229, DOI 10.1037/1089-2680.10.3.229; BERNTSON GG, 1993, PSYCHOL BULL, V114, P296, DOI 10.1037/0033-2909.114.2.296; Berntson GG, 1997, PSYCHOPHYSIOLOGY, V34, P623, DOI 10.1111/j.1469-8986.1997.tb02140.x; BERNTSON GG, 1993, PSYCHOPHYSIOLOGY, V30, P183, DOI 10.1111/j.1469-8986.1993.tb01731.x; Bertsch K, 2012, PSYCHOPHYSIOLOGY, V49, P672, DOI 10.1111/j.1469-8986.2011.01341.x; Bourhis RY., 2001, INTERGROUP PROCESSES, VVol. 4, P89; Bourhis RY, 1994, INTERGROUP RES TAJFE; Camm AJ, 1996, CIRCULATION, V93, P1043; Diamond LM, 2010, J SOC PERS RELAT, V27, P218, DOI 10.1177/0265407509360906; Diamond LM, 2005, J SOC PERS RELAT, V22, P499, DOI 10.1177/0265407505054520; Diamond LM, 2001, PERS SOC PSYCHOL REV, V5, P276, DOI 10.1207/S15327957PSPR0504_1; Diehl M., 1990, EUROPEAN REV SOCIAL, V1, P263, DOI [https://doi.org/10.1080/14792779108401864, DOI 10.1080/14792779108401864]; Fabes RA, 1997, J PERS SOC PSYCHOL, V73, P1107, DOI 10.1037/0022-3514.73.5.1107; Fairclough SH, 2004, BIOL PSYCHOL, V66, P177, DOI 10.1016/j.biopsycho.2003.10.001; Geisler FCM, 2013, BIOL PSYCHOL, V93, P279, DOI 10.1016/j.biopsycho.2013.02.013; Grossman P, 2007, BIOL PSYCHOL, V74, P263, DOI 10.1016/j.biopsycho.2005.11.014; Hansen AL, 2004, EUR J APPL PHYSIOL, V93, P263, DOI 10.1007/s00421-004-1208-0; Hertel G, 2001, J EXP SOC PSYCHOL, V37, P316, DOI 10.1006/jesp.2000.1447; Hewstone M, 2002, ANNU REV PSYCHOL, V53, P575, DOI 10.1146/annurev.psych.53.100901.135109; Holt-Lunstad J, 2007, ANN BEHAV MED, V33, P278, DOI 10.1007/BF02879910; Hutcherson CA, 2008, EMOTION, V8, P720, DOI 10.1037/a0013237; James G., 2014, INTRO STAT LEARNING; Johnsen BH, 2003, J ANXIETY DISORD, V17, P75, DOI 10.1016/S0887-6185(02)00178-0; Kelley K, 2005, EDUC PSYCHOL MEAS, V65, P51, DOI 10.1177/0013164404264850; Kirby KN, 2013, BEHAV RES METHODS, V45, P905, DOI 10.3758/s13428-013-0330-5; Kok BE, 2010, BIOL PSYCHOL, V85, P432, DOI 10.1016/j.biopsycho.2010.09.005; Koval P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081536; MCCRATY R, 1995, AM J CARDIOL, V76, P1089, DOI 10.1016/S0002-9149(99)80309-9; Oveis C, 2009, EMOTION, V9, P265, DOI 10.1037/a0015383; Pinter B, 2011, GROUP PROCESS INTERG, V14, P81, DOI 10.1177/1368430210375251; Porges SW, 2001, INT J PSYCHOPHYSIOL, V42, P123, DOI 10.1016/S0167-8760(01)00162-3; R Core Team, 2012, R LANG ENV STAT COMP; RABBIE JM, 1969, J PERS SOC PSYCHOL, V13, P269, DOI 10.1037/h0028284; Ritz T, 2009, BIOL PSYCHOL, V80, P158, DOI 10.1016/j.biopsycho.2008.08.003; Sahdra B, 2007, PERS SOC PSYCHOL B, V33, P384, DOI 10.1177/0146167206296103; Schwerdtfeger AR, 2011, ANN BEHAV MED, V42, P64, DOI 10.1007/s12160-011-9272-2; Segerstrom SC, 2007, PSYCHOL SCI, V18, P275, DOI 10.1111/j.1467-9280.2007.01888.x; Smith TW, 2011, J PERS SOC PSYCHOL, V100, P103, DOI 10.1037/a0021136; TAJFEL H, 1971, EUR J SOC PSYCHOL, V1, P149, DOI 10.1002/ejsp.2420010202; Tajfel H., 2010, SOCIAL IDENTITY INTE; Tajfel H., 1979, SOCIAL PSYCHOL INTER, P33, DOI DOI 10.1016/S0065-2601(05)37005-5; Tarvainen MP, 2014, COMPUT METH PROG BIO, V113, P210, DOI 10.1016/j.cmpb.2013.07.024; Thayer JF, 2009, ANN BEHAV MED, V37, P141, DOI 10.1007/s12160-009-9101-z; Thayer JF, 2009, NEUROSCI BIOBEHAV R, V33, P81, DOI 10.1016/j.neubiorev.2008.08.004; Widjaja D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101713	48	5	5	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2015	10	6							e0129583	10.1371/journal.pone.0129583	http://dx.doi.org/10.1371/journal.pone.0129583			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CL4OM	26106891	Green Submitted, gold, Green Published			2022-12-26	WOS:000356932500062
J	Sommer, A; Fabri, M				Sommer, Andrea; Fabri, Mario			Vitamin D Regulates Cytokine Patterns Secreted by Dendritic Cells to Promote Differentiation of IL-22-Producing T Cells	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; RECEPTOR-DEFICIENT PATIENTS; HUMAN-SKIN; 1-ALPHA,25-DIHYDROXYVITAMIN D-3; HUMAN KERATINOCYTES; IN-VITRO; 1,25-DIHYDROXYVITAMIN D-3; ANTIMICROBIAL RESPONSE; DIHYDROXYVITAMIN D-3; TISSUE HOMEOSTASIS	One central mechanism, by which vitamin D regulates human immune responses, is the direct modulation of dendritic cells (DCs). However, the effect of vitamin D on several key DC functions, such as the secretion of central inflammatory cytokines, remains controversial. Moreover, whether vitamin D treatment of DCs regulates their ability to promote differentiation of IL-17-/IL-22-producing T cell subsets, such as Th17 and Th22 cell, is not known. Here, we report that vitamin D treatment during differentiation of monocytes into DCs markedly enhanced their ability to secrete TNF-alpha, IL-6, IL-1 beta and IL-23. Cytokines secreted by vitamin D-treated DC were significantly more potent in driving differentiation of IL-22-producing T cells, but not IL-17-producing T cells, as compared to secreted cytokines of not-vitamin D-treated DCs. Finally, we found that the differentiation of IL-22-producing T cells mediated by supernatants of vitamin D-treated DCs was dependent on TNF-alpha IL-6 and IL-23. In summary, our study suggests a novel role of vitamin D in regulating DC-mediated immune responses in humans.	[Sommer, Andrea; Fabri, Mario] Univ Cologne, Dept Dermatol, Cologne, Germany; [Sommer, Andrea; Fabri, Mario] Univ Cologne, Ctr Mol Med Cologne, D-50931 Cologne, Germany	University of Cologne; University of Cologne	Fabri, M (corresponding author), Univ Cologne, Dept Dermatol, Cologne, Germany.	mario.fabri@uk-koeln.de			Ministry of Innovation, Science, Research and Technology of the German State of North Rhine-Westphalia [NRW Ruckkehrerprogramm]; Center for Molecular Medicine [GB4]; Deutsche Forschungsgemeinschaft [SFB829 - B13]	Ministry of Innovation, Science, Research and Technology of the German State of North Rhine-Westphalia; Center for Molecular Medicine; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was funded by the Ministry of Innovation, Science, Research and Technology of the German State of North Rhine-Westphalia (Grant No. NRW Ruckkehrerprogramm, http://www.wissenschaft.nrw.de/), the Center for Molecular Medicine (Grant No. GB4, http://www.zmmk.uni-koeln.de/), and the Deutsche Forschungsgemeinschaft (Grant No. SFB829 - B13; http://www.dfg.de/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta-Rodriguez EV, 2007, NAT IMMUNOL, V8, P942, DOI 10.1038/ni1496; Altare F, 1998, SCIENCE, V280, P1432, DOI 10.1126/science.280.5368.1432; Aujla SJ, 2008, NAT MED, V14, P275, DOI 10.1038/nm1710; Basu R, 2012, IMMUNITY, V37, P1061, DOI 10.1016/j.immuni.2012.08.024; Berer A, 2000, EXP HEMATOL, V28, P575, DOI 10.1016/S0301-472X(00)00143-0; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; BEUTLER B, 1986, NATURE, V320, P584, DOI 10.1038/320584a0; Bikle DD, 2010, TRENDS ENDOCRIN MET, V21, P375, DOI 10.1016/j.tem.2010.01.003; Boniface K, 2005, J IMMUNOL, V174, P3695, DOI 10.4049/jimmunol.174.6.3695; Campbell GR, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002689; Chamorro S, 2009, J IMMUNOL, V183, P2984, DOI 10.4049/jimmunol.0801155; Chen Z, 2007, ARTHRITIS RHEUM-US, V56, P2936, DOI 10.1002/art.22866; Chu CC, 2012, J EXP MED, V209, P935, DOI 10.1084/jem.20112583; de Jong R, 1998, SCIENCE, V280, P1435; Duhen T, 2009, NAT IMMUNOL, V10, P857, DOI 10.1038/ni.1767; Engelhardt KR, 2013, J ALLERGY CLIN IMMUN, V131, P825, DOI 10.1016/j.jaci.2012.09.025; Evans HG, 2007, P NATL ACAD SCI USA, V104, P17034, DOI 10.1073/pnas.0708426104; Eyerich S, 2011, EUR J IMMUNOL, V41, P1894, DOI 10.1002/eji.201041197; Eyerich S, 2009, J CLIN INVEST, V119, P3573, DOI 10.1172/JCI40202; Fabri M, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3003045; Fritsche J, 2003, BLOOD, V102, P3314, DOI 10.1182/blood-2002-11-3521; Fujita H, 2009, P NATL ACAD SCI USA, V106, P21795, DOI 10.1073/pnas.0911472106; Gordon JR, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00007; Griffin MD, 2001, P NATL ACAD SCI USA, V98, P6800, DOI 10.1073/pnas.121172198; Hewison M, 2003, J IMMUNOL, V170, P5382, DOI 10.4049/jimmunol.170.11.5382; Hewison M, 2011, VITAM HORM, V86, P23, DOI 10.1016/B978-0-12-386960-9.00002-2; Hijnen D, 2013, J INVEST DERMATOL, V133, P973, DOI 10.1038/jid.2012.456; HOLICK MF, 1980, SCIENCE, V210, P203, DOI 10.1126/science.6251551; HSIEH CS, 1993, SCIENCE, V260, P547, DOI 10.1126/science.8097338; Imazeki I, 2006, BIOMED RES-TOKYO, V27, P1, DOI 10.2220/biomedres.27.1; Jeffery LE, 2012, J IMMUNOL, V189, P5155, DOI 10.4049/jimmunol.1200786; Jin W, IL 17 CYTOKINES IMMU; Kleijwegt FS, 2010, J IMMUNOL, V185, P1412, DOI 10.4049/jimmunol.1000560; Klug-Micu GM, 2013, IMMUNOLOGY, V139, P121, DOI 10.1111/imm.12062; Krutzik SR, 2005, NAT MED, V11, P653, DOI 10.1038/nm1246; Kuang DM, 2014, J CLIN INVEST, V124, P4657, DOI 10.1172/JCI74381; Lehmann B, 2000, EXP DERMATOL, V9, P97, DOI 10.1034/j.1600-0625.2000.009002097.x; Lehmann B, 2001, J INVEST DERMATOL, V117, P1179, DOI 10.1046/j.0022-202x.2001.01538.x; Leung JM, 2014, MUCOSAL IMMUNOL, V7, P124, DOI 10.1038/mi.2013.31; Liang SC, 2006, J EXP MED, V203, P2271, DOI 10.1084/jem.20061308; Liu PT, 2006, SCIENCE, V311, P1770, DOI 10.1126/science.1123933; MACLAUGHLIN JA, 1991, FEBS LETT, V282, P409, DOI 10.1016/0014-5793(91)80525-8; Manel N, 2008, NAT IMMUNOL, V9, P641, DOI 10.1038/ni.1610; MANETTI R, 1993, J EXP MED, V177, P1199, DOI 10.1084/jem.177.4.1199; McGeachy MJ, 2007, NAT IMMUNOL, V8, P1390, DOI 10.1038/ni1539; Mercer F, 2014, J IMMUNOL, V193, P1047, DOI 10.4049/jimmunol.1302936; Miossec P, 2009, NEW ENGL J MED, V361, P888, DOI 10.1056/NEJMra0707449; Murphey K, 2008, INNATE IMMUN-LONDON, P39; Nikolic T, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00113; Nograles KE, 2008, BRIT J DERMATOL, V159, P1092, DOI 10.1111/j.1365-2133.2008.08769.x; Nurieva R, 2007, NATURE, V448, P480, DOI 10.1038/nature05969; Ouyang WJ, 2008, IMMUNITY, V28, P454, DOI 10.1016/j.immuni.2008.03.004; Pedersen AW, 2009, CLIN EXP IMMUNOL, V157, P48, DOI 10.1111/j.1365-2249.2009.03961.x; Peelen E, 2011, AUTOIMMUN REV, V10, P733, DOI 10.1016/j.autrev.2011.05.002; Penna G, 2000, J IMMUNOL, V164, P2405, DOI 10.4049/jimmunol.164.5.2405; Piemonti L, 2000, J IMMUNOL, V164, P4443, DOI 10.4049/jimmunol.164.9.4443; PILLAI S, 1988, J BIOL CHEM, V263, P5390; Pludowski P, 2013, AUTOIMMUN REV, V12, P976, DOI 10.1016/j.autrev.2013.02.004; Rutz S, 2014, NAT REV IMMUNOL, V14, P783, DOI 10.1038/nri3766; Sabat R, 2014, NAT REV DRUG DISCOV, V13, P21, DOI 10.1038/nrd4176; Schenk M, 2012, NAT MED, V18, P555, DOI 10.1038/nm.2650; Schuessler M, 2001, STEROIDS, V66, P399, DOI 10.1016/S0039-128X(00)00229-4; Sigmundsdottir H, 2007, NAT IMMUNOL, V8, P285, DOI 10.1038/ni1433; Silverberg MS, 2009, NAT GENET, V41, P216, DOI 10.1038/ng.275; Sonnenberg GF, 2011, NAT IMMUNOL, V12, P383, DOI 10.1038/ni.2025; Szeles L, 2009, J IMMUNOL, V182, P2074, DOI 10.4049/jimmunol.0803345; Trifari S, 2009, NAT IMMUNOL, V10, P864, DOI 10.1038/ni.1770; Unger WWJ, 2009, EUR J IMMUNOL, V39, P3147, DOI 10.1002/eji.200839103; van Beelen AJ, 2007, IMMUNITY, V27, P660, DOI 10.1016/j.immuni.2007.08.013; van der Aar AMG, 2011, J ALLERGY CLIN IMMUN, V127, P1532, DOI 10.1016/j.jaci.2011.01.068; van Halteren AGS, 2002, DIABETES, V51, P2119, DOI 10.2337/diabetes.51.7.2119; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; Verway M, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003407; Volpe E, 2008, NAT IMMUNOL, V9, P650, DOI 10.1038/ni.1613; Vyas JM, 2008, NAT REV IMMUNOL, V8, P607, DOI 10.1038/nri2368; Watts C, 2010, CURR OPIN IMMUNOL, V22, P124, DOI 10.1016/j.coi.2009.12.005; Wilson NJ, 2007, NAT IMMUNOL, V8, P950, DOI 10.1038/ni1497; Wobke TK, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00244; Wolk K, 2004, IMMUNITY, V21, P241, DOI 10.1016/j.immuni.2004.07.007; Wolk K, 2006, EUR J IMMUNOL, V36, P1309, DOI 10.1002/eji.200535503; Zenewicz LA, 2011, INT IMMUNOL, V23, P159, DOI 10.1093/intimm/dxr001; Zheng Y, 2007, NATURE, V445, P648, DOI 10.1038/nature05505; Zielinski CE, 2012, NATURE, V484, P514, DOI 10.1038/nature10957	84	34	40	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2015	10	6							e0130395	10.1371/journal.pone.0130395	http://dx.doi.org/10.1371/journal.pone.0130395			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4OM	26107738	gold, Green Submitted, Green Published			2022-12-26	WOS:000356932500099
J	Camacho-Vallejo, JF; Mar-Ortiz, J; Lopez-Ramos, F; Rodriguez, RP				Camacho-Vallejo, Jose-Fernando; Mar-Ortiz, Julio; Lopez-Ramos, Francisco; Pedraza Rodriguez, Ricardo			A Genetic Algorithm for the Bi-Level Topological Design of Local Area Networks	PLOS ONE			English	Article							BILEVEL PROGRAMMING-PROBLEMS; OPTIMIZATION; OPTIMALITY; MODEL	Local access networks (LAN) are commonly used as communication infrastructures which meet the demand of a set of users in the local environment. Usually these networks consist of several LAN segments connected by bridges. The topological LAN design bi-level problem consists on assigning users to clusters and the union of clusters by bridges in order to obtain a minimum response time network with minimum connection cost. Therefore, the decision of optimally assigning users to clusters will be made by the leader and the follower will make the decision of connecting all the clusters while forming a spanning tree. In this paper, we propose a genetic algorithm for solving the bi-level topological design of a Local Access Network. Our solution method considers the Stackelberg equilibrium to solve the bi-level problem. The Stackelberg-Genetic algorithm procedure deals with the fact that the follower's problem cannot be optimally solved in a straightforward manner. The computational results obtained from two different sets of instances show that the performance of the developed algorithm is efficient and that it is more suitable for solving the bi-level problem than a previous Nash-Genetic approach.	[Camacho-Vallejo, Jose-Fernando; Pedraza Rodriguez, Ricardo] Univ Autonoma Nuevo Leon, Fac Ciencias Fis Matemat, San Nicolas De Los Garza, Nuevo Leon, Mexico; [Mar-Ortiz, Julio] Univ Autonoma Tamaulipas, Fac Ingn, Tampico, Tamaulipas, Mexico; [Lopez-Ramos, Francisco] Pontificia Univ Catolica Valparaiso, Sch Transport Engn, Valparaiso, Chile	Universidad Autonoma de Nuevo Leon; Universidad Autonoma de Tamaulipas; Pontificia Universidad Catolica de Valparaiso	Camacho-Vallejo, JF (corresponding author), Univ Autonoma Nuevo Leon, Fac Ciencias Fis Matemat, San Nicolas De Los Garza, Nuevo Leon, Mexico.	jose.camachovl@uanl.edu.mx	Lopez-Ramos, Francisco/GMJ-1258-2022; López-Ramos, Francisco/P-8695-2016	Lopez-Ramos, Francisco/0000-0002-2680-618X; López-Ramos, Francisco/0000-0002-2680-618X; Camacho-Vallejo, Jose-Fernando/0000-0001-6519-7690	SEP-CONACYT [CB-2014-O1-240814]	SEP-CONACYT(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	The work done by Camacho-Vallejo J. F. and Pedraza R., was supported by the SEP-CONACYT grant CB-2014-O1-240814.	Alekseeva E, 2009, 13 IFAC S INF CONTR, P1516; Alumur S, 2008, EUR J OPER RES, V190, P1, DOI 10.1016/j.ejor.2007.06.008; Brotcorne L, 2012, COMPUT OPER RES, V39, P2603, DOI 10.1016/j.cor.2012.01.005; Calvete HI, 2010, LECT NOTES ECON MATH, V634, P155, DOI 10.1007/978-3-642-04045-0_13; Calvete HI, 2011, COMPUT OPER RES, V38, P320, DOI 10.1016/j.cor.2010.05.007; Camacho-Vallejo JF, 2014, MATH PROBL ENG, V2014, P14; CANDLER W, 1988, COMPUT OPER RES, V15, P297, DOI 10.1016/0305-0548(88)90043-3; Chu CH, 2000, EUR J OPER RES, V127, P140, DOI 10.1016/S0377-2217(99)00329-X; CLARK DD, 1978, P IEEE, V66, P1497, DOI 10.1109/PROC.1978.11152; CLARK PA, 1988, NAV RES LOG, V35, P413, DOI 10.1002/1520-6750(198810)35:5<413::AID-NAV3220350505>3.0.CO;2-6; Eiselt H., 1996, EUR J OPER RES, V96, P217; Elbaum R, 1996, IEEE ACM T NETWORK, V4, P766, DOI 10.1109/90.541324; ERSOY C, 1993, IEEE J SEL AREA COMM, V11, P1172, DOI 10.1109/49.245906; Estepa R, 2011, COMPUT NETW, V55, P2303, DOI 10.1016/j.comnet.2011.03.011; Feng CM, 2005, PROC E ASIA SOC TRAN, V5, P1408; FISK CS, 1984, TRANSPORT RES B-METH, V18, P301, DOI 10.1016/0191-2615(84)90013-4; Friesz TL, ANAL STUDIES TRANSPO; Gallo M, 2010, EUR J OPER RES, V201, P144, DOI 10.1016/j.ejor.2009.02.026; Gavish B., 1991, Annals of Operations Research, V33, P17, DOI 10.1007/BF02061657; Hansen P, 2004, G200424 GERADHEC; HAURIE A, 1990, OPER RES, V38, P553, DOI 10.1287/opre.38.3.553; JAN RH, 1993, IEEE T RELIAB, V42, P63, DOI 10.1109/24.210272; Jaramillo JH, 2002, COMPUT OPER RES, V29, P761, DOI 10.1016/S0305-0548(01)00021-1; Kalashnikov V, 2010, INT J INNOV COMPUT I, V6, P3529; Kara B, 2004, TRANSPORT SCI, V44, P1595; Khan SA, 2012, APPL INTELL, V36, P161, DOI 10.1007/s10489-010-0251-2; Kim JR, 2007, LECT NOTES COMPUT SC, V4413, P269; Kim JR, 2009, COMPUT IND ENG, V56, P1040, DOI 10.1016/j.cie.2008.09.030; Kucukaydin H, 2010, LECT NOTES COMPUT SC, V6373, P31; Labbe M, 1998, MANAGE SCI, V44, P1608, DOI 10.1287/mnsc.44.12.1608; Leblanc L. J., 1973, MATH PROGRAMMING ALG; Lee M., 1991, ANN OPER RES, V33, P351; Legillon F, 2012, IEEE C EV COMP CEC 2; MARCOTTE P, 1991, COMPUT OPER RES, V18, P355, DOI 10.1016/0305-0548(91)90096-A; Marcotte P, 2009, TRANSPORT SCI, V43, P228, DOI 10.1287/trsc.1080.0236; Mateus GR, 2001, ANN OPER RES, V106, P331, DOI 10.1023/A:1014526112244; MATHIEU R, 1994, RAIRO-RECH OPER, V28, P1; NASH J, 1951, ANN MATH, V54, P286, DOI 10.2307/1969529; Oduguwa V, 2002, 2002 IEEE INTERNATIONAL CONFERENCE ON ARTIFICIAL INTELLIGENCE SYSTEMS, PROCEEDINGS, P322, DOI 10.1109/ICAIS.2002.1048121; Pieume CO, 2009, OPSEARCH, V46, P169, DOI 10.1007/s12597-009-0011-4; Rothlauf F, 2009, OPER RES, V57, P413, DOI 10.1287/opre.1080.0592; Stackelberg H., 1952, THEORY MARKET EC; Vasilyev IL, 2009, J APPL IND MATH, V4, P441; VICENTE LN, 1994, J GLOBAL OPTIM, V5, P291, DOI 10.1007/BF01096458; Wang JF, 2001, IEEE C EVOL COMPUTAT, P552, DOI 10.1109/CEC.2001.934440; Wang Jing, 2010, Proceedings of the 2010 IEEE International Conference on Emergency Management and Management Sciences (ICEMMS), P202, DOI 10.1109/ICEMMS.2010.5563466; Yang H, 2001, TRANSPORT RES B-METH, V35, P1, DOI 10.1016/S0191-2615(00)00025-4; Yang J, COMPUTERS MATH APPL, V57, P1985	49	15	15	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2015	10	6							e0128067	10.1371/journal.pone.0128067	http://dx.doi.org/10.1371/journal.pone.0128067			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4DD	26102502	Green Accepted, gold, Green Published, Green Submitted			2022-12-26	WOS:000356901900007
J	Sepetiene, R; Patamsyte, V; Zukovas, G; Jariene, G; Stanioniene, Z; Benetis, R; Lesauskaite, V				Sepetiene, Ramune; Patamsyte, Vaiva; Zukovas, Giedrius; Jariene, Giedre; Stanioniene, Zita; Benetis, Rimantas; Lesauskaite, Vaiva			Blood Plasma TGF-beta 1 Concentration in Sporadic Dilatative Pathology of Ascending Aorta: More Questions than Answers	PLOS ONE			English	Article							TRANSFORMING-GROWTH-FACTOR; FACTOR-BETA; RELEASE	Transforming growth factor beta 1 (TGF-beta 1) is a cytokine that participates in a broad range of cellular regulatory processes and is associated with various diseases including aortic aneurysm. Increased TGF-beta 1 levels are associated with Marfan syndrome (MFS) caused by FBN1 mutations and subsequent defects in signaling system. We studied TGF-beta 1 levels in 62 patients with sporadic, non syndromic, dilatative pathology of ascending aorta (DPAA) and in reference group subjects (n = 212). An initial screening of 212 reference individuals identified TGF-beta 1 gender discrepancies and age-dependent cytokine increase in women. Patients with DPAA had increased levels of TGF-beta 1 in comparison to reference group subjects (median 7.7 ng/ml, range 2.1-25.3, and median 6.2 ng/ml, range 1.0-33.1, respectively). There is a significant association between TGF-beta 1 concentration and DPAA (OR 1.084, CI 1.027-1.144, p = 0.004) but the mechanisms of cause and effect have not been established yet. Slightly increased TGF-beta 1 concentrations in patients with sporadic DPAA in comparison to the reference subjects show a potential use of TGF-beta 1 as a biomarker for the disease. However, cytokine dependence on age, gender, and other unknown factors among individuals with no cardiovascular complains reduces its specificity for DPAA. We would also like to raise awareness regarding the choice of methods when measuring TGF-beta 1 levels with an emphasis on preanalytical phase and the choice of sample.	[Sepetiene, Ramune; Patamsyte, Vaiva; Jariene, Giedre; Stanioniene, Zita; Benetis, Rimantas; Lesauskaite, Vaiva] Lithuanian Univ Hlth Sci, Med Acad, Inst Cardiol, Kaunas, Lithuania; [Zukovas, Giedrius; Benetis, Rimantas] Lithuanian Univ Hlth Sci, Dept Cardiac Thorac & Vasc Surg, Kaunas, Lithuania	Lithuanian University of Health Sciences; Lithuanian University of Health Sciences	Sepetiene, R (corresponding author), Lithuanian Univ Hlth Sci, Med Acad, Inst Cardiol, Sukileliu 17, Kaunas, Lithuania.	sepetiene@yahoo.co.uk	Sepetiene, Ramune/GYA-5351-2022	Patamsyte, Vaiva/0000-0002-2270-1276; Lesauskaite, Vaiva/0000-0003-2736-3111	Research Council of Lithuania for National Research Programme "Chronic Noncommunicable Diseases" [LIG 05/2012]	Research Council of Lithuania for National Research Programme "Chronic Noncommunicable Diseases"	Funding was provided by the Research Council of Lithuania for National Research Programme "Chronic Noncommunicable Diseases" (Agreement No LIG 05/2012).	Agg B, 2014, BMC CARDIOVASC DISOR, V14, DOI 10.1186/1471-2261-14-47; ASSOIAN RK, 1986, J CELL BIOL, V102, P1217, DOI 10.1083/jcb.102.4.1217; Barrett PM, 2013, HEART, V99, P83, DOI 10.1136/heartjnl-2012-301840; Bierie B, 2010, CYTOKINE GROWTH F R, V21, P49, DOI 10.1016/j.cytogfr.2009.11.008; Chaudhry SS, 2007, J CELL BIOL, V176, P355, DOI 10.1083/jcb.200608167; Franken R, 2013, INT J CARDIOL, V168, P2441, DOI 10.1016/j.ijcard.2013.03.033; Gueripel X, 2004, BIOL REPROD, V70, P640, DOI 10.1095/biolreprod.103.021162; Hillebrand M, 2014, CLIN CARDIOL, V37, P672, DOI 10.1002/clc.22320; Holm TM, 2011, SCIENCE, V332, P358, DOI 10.1126/science.1192149; Kropf J, 1997, CLIN CHEM, V43, P1965; LeMaire SA, 2011, NAT GENET, V43, P996, DOI 10.1038/ng.934; Lesauskaite V, 2014, URJ CARDIOTHORAC SUR; LUDLAM CA, 1975, THROMB RES, V6, P543, DOI 10.1016/0049-3848(75)90066-3; Matt P, 2009, CIRCULATION, V120, P526, DOI 10.1161/CIRCULATIONAHA.108.841981; Meyer A, 2012, BLOOD, V119, P1064, DOI 10.1182/blood-2011-09-377648; Ogawa N, 2013, INT HEART J, V54, P23, DOI 10.1536/ihj.54.23; Vaninetti S, 2000, EUR J ENDOCRINOL, V142, P144, DOI 10.1530/eje.0.1420144; Zhang D, 2014, AGING CELL	18	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2015	10	6							e0129353	10.1371/journal.pone.0129353	http://dx.doi.org/10.1371/journal.pone.0129353			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4DD	26103587	Green Published, Green Submitted, gold			2022-12-26	WOS:000356901900012
J	Chen, XP; Song, FY; Jhamb, D; Li, JL; Bottino, MC; Palakal, MJ; Stocum, DL				Chen, Xiaoping; Song, Fengyu; Jhamb, Deepali; Li, Jiliang; Bottino, Marco C.; Palakal, Mathew J.; Stocum, David L.			The Axolotl Fibula as a Model for the Induction of Regeneration across Large Segment Defects in Long Bones of the Extremities	PLOS ONE			English	Article							HEPATOCYTE GROWTH-FACTOR; SKELETAL REGENERATION; LIMB REGENERATION; FRACTURE REPAIR; XENOPUS-LAEVIS; BIOLOGY; EXPRESSION; BMP; PROTEINS; HEAL	We tested the ability of the axolotl (Ambystoma mexicanum) fibula to regenerate across segment defects of different size in the absence of intervention or after implant of a unique 8-braid pig small intestine submucosa (SIS) scaffold, with or without incorporated growth factor combinations or tissue protein extract. Fractures and defects of 10% and 20% of the total limb length regenerated well without any intervention, but 40% and 50% defects failed to regenerate after either simple removal of bone or implanting SIS scaffold alone. By contrast, scaffold soaked in the growth factor combination BMP-4/HGF or in protein extract of intact limb tissue promoted partial or extensive induction of cartilage and bone across 50% segment defects in 30%-33% of cases. These results show that BMP-4/HGF and intact tissue protein extract can promote the events required to induce cartilage and bone formation across a segment defect larger than critical size and that the long bones of axolotl limbs are an inexpensive model to screen soluble factors and natural and synthetic scaffolds for their efficacy in stimulating this process.	[Chen, Xiaoping; Li, Jiliang; Stocum, David L.] Indiana Univ Purdue Univ, Dept Biol, Sch Sci, Indianapolis, IN 46205 USA; [Song, Fengyu] Indiana Univ Purdue Univ, Dept Oral Biol, Sch Dent, Indianapolis, IN 46202 USA; [Bottino, Marco C.] Indiana Univ Purdue Univ, Sch Dent, Dept Restorat Dent, Div Dent Biomat, Indianapolis, IN 46202 USA; [Jhamb, Deepali; Palakal, Mathew J.] Indiana Univ Purdue Univ, Sch Informat & Comp, Indianapolis, IN 46202 USA	Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis	Stocum, DL (corresponding author), Indiana Univ Purdue Univ, Dept Biol, Sch Sci, Indianapolis, IN 46205 USA.	dstocum@iupui.edu		Bottino, Marco C./0000-0001-8740-2464	Telemedicine & Advanced Technology Research Center, United States Army Medical Research and Materiel Command [W81XWH-11-1-0743]	Telemedicine & Advanced Technology Research Center, United States Army Medical Research and Materiel Command	This research was supported by grant W81XWH-11-1-0743 from the Telemedicine & Advanced Technology Research Center, United States Army Medical Research and Materiel Command to DLS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bostrom MPG, 1998, CLIN ORTHOP RELAT R, pS116, DOI 10.1097/00003086-199810001-00013; Brockes JR, 2008, ANNU REV CELL DEV BI, V24, P525, DOI 10.1146/annurev.cellbio.24.110707.175336; Brown-Etris M, 2002, WOUNDS, V14, P150; Cameron JA, 2013, NEW PERSPECTIVES REG; Cameron JA, 2013, CURR TOP MICROBIOL, V367, P113, DOI 10.1007/82_2012_291; Cancedda R, 2007, BIOMATERIALS, V28, P4240, DOI 10.1016/j.biomaterials.2007.06.023; Chin CH, 2014, BMC SYST BIOL, V8, DOI 10.1186/1752-0509-8-S4-S11; Einhorn TA, 1998, CLIN ORTHOP RELAT R, pS7; Feng LA, 2011, TISSUE ENG PT A, V17, P691, DOI [10.1089/ten.tea.2010.0123, 10.1089/ten.TEA.2010.0123]; Fisher MB, 2013, TISSUE ENG PART B-RE, V19, P1, DOI [10.1089/ten.TEB.2012.0723, 10.1089/ten.teb.2012.0723]; Garbuz DS, 1998, ORTHOP CLIN N AM, V29, P199, DOI 10.1016/S0030-5898(05)70318-7; Gilbert S.F., 2010, DEV BIOL; GOSS RJ, 1958, J EMBRYOL EXP MORPH, V6, P638; Goss RJ, 1956, J MORPHOL, V98, P8; Harris JS, 2013, BONE, V55, P241, DOI 10.1016/j.bone.2013.02.002; Hutchison C, 2007, BONE, V40, P45, DOI 10.1016/j.bone.2006.07.005; Imai Y, 2005, J BONE MINER RES, V20, P1723, DOI 10.1359/JBMR.050607; Jhamb D, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-80; Kanczler JM, 2008, EUR CELLS MATER, V15, P100, DOI 10.22203/eCM.v015a08; KORNELUK RG, 1984, J EMBRYOL EXP MORPH, V82, P9; Kragl M, 2009, NATURE, V460, P60, DOI 10.1038/nature08152; Kumar A, 2007, SCIENCE, V318, P772, DOI 10.1126/science.1147710; LEPISTO J, 1992, J SURG RES, V53, P596, DOI 10.1016/0022-4804(92)90260-7; Li J, 2014, BASIC APPL BONE BIOL; Li RH, 2001, TRENDS BIOTECHNOL, V19, P255, DOI 10.1016/S0167-7799(01)01665-1; Martin JF, 2000, GENESIS, V26, P225, DOI 10.1002/(SICI)1526-968X(200004)26:4<225::AID-GENE10>3.0.CO;2-F; Masini BD, 2009, J ORTHOP TRAUMA, V23, P261, DOI 10.1097/BOT.0b013e31819dfa04; McKean DM, 2003, J CELL BIOL, V161, P393, DOI 10.1083/jcb.jcb.200302126; MCKIBBIN B, 1978, J BONE JOINT SURG BR, V60, P150, DOI 10.1302/0301-620X.60B2.350882; Monaghan JR, 2012, BIOL OPEN, V1, P937, DOI 10.1242/bio.20121594; Nguyen LH, 2012, TISSUE ENG PART B-RE, V18, P363, DOI 10.1089/ten.teb.2012.0012; Niklaou VS, 2007, CURR ORTHOPAED, V21, P245; Nikolaou VS, 2007, CURR ORTHOPAED, V21, P249, DOI 10.1016/j.cuor.2007.08.001; Opperman LA, 2000, DEV DYNAM, V219, P237, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1044>3.0.CO;2-F; Patterson TE, 2008, J BONE JOINT SURG AM, V90A, P111, DOI 10.2106/JBJS.G.01572; Pautke C, 2005, BONE, V37, P441, DOI 10.1016/j.bone.2005.05.008; Pekkarinen T, 2006, ACTA ORTHOP, V77, P952, DOI 10.1080/17453670610013286; Rao N, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-83; Reddi AH, 1998, CLIN ORTHOPAED REL S, V355S, pS665; ROSEN V, 1992, TRENDS GENET, V8, P97, DOI 10.1016/0168-9525(92)90063-A; Rosen V, 2006, ANN NY ACAD SCI, V1068, P19, DOI 10.1196/annals.1346.005; Satoh A, 2010, DEV BIOL, V337, P444, DOI 10.1016/j.ydbio.2009.11.023; Seeherman H, 2002, SPINE, V27, pS16, DOI 10.1097/00007632-200208151-00005; SHAH M, 1995, J CELL SCI, V108, P985; Shi SL, 2013, J CELL BIOCHEM, V114, P908, DOI 10.1002/jcb.24430; Shi SL, 2013, GROWTH FACTORS, V31, P32, DOI 10.3109/08977194.2012.750652; Shi SL, 2012, J ORTHOP RES, V30, P1026, DOI 10.1002/jor.22036; Song FY, 2010, ORGANOGENESIS, V6, P141, DOI 10.4161/org.6.3.12039; Spicer PP, 2012, NAT PROTOC, V7, P1918, DOI 10.1038/nprot.2012.113; Standal T, 2007, BLOOD, V109, P3024, DOI 10.1182/blood-2006-07-034884; Stevenson S, 1999, ORTHOP CLIN N AM, V30, P543, DOI 10.1016/S0030-5898(05)70107-3; Stocum DL, 2011, EUR J NEUROSCI, V34, P908, DOI 10.1111/j.1460-9568.2011.07827.x; Stocum DL, 2011, DEV DYNAM, V240, P943, DOI 10.1002/dvdy.22553; Stocum DL, 2012, BIOL MED; Stoick-Cooper CL, 2002, GENE DEV, V21, P1292; Suckow MA, 1999, J INVEST SURG, V12, P277, DOI 10.1080/089419399272395; Tabin CJ, 2006, CELL, V127, P27, DOI 10.1016/j.cell.2006.09.018; Tatsumi R, 1998, DEV BIOL, V194, P114, DOI 10.1006/dbio.1997.8803; Tolli H, 2011, INT ORTHOP, V35, P615, DOI 10.1007/s00264-010-1034-4; Weiss P, 1925, W ROUX ARCH ENTWICKL, V104, P359; Xu CC, 2010, J BIOMED MATER RES A, V93A, P1335, DOI 10.1002/jbm.a.32632; Yokoyama H, 2008, DEV GROWTH DIFFER, V50, P13, DOI 10.1111/j.1440-169x.2007.00973.x; Yun YR, 2010, J TISSUE ENG, V1, DOI 10.4061/2010/218142	63	4	4	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2015	10	6							e0130819	10.1371/journal.pone.0130819	http://dx.doi.org/10.1371/journal.pone.0130819			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL3FM	26098852	gold, Green Published, Green Submitted			2022-12-26	WOS:000356835800105
J	Degnan, AJ; Wisnowski, JL; Choi, S; Ceschin, R; Bhushan, C; Leahy, RM; Corby, P; Schmithorst, VJ; Panigrahy, A				Degnan, Andrew J.; Wisnowski, Jessica L.; Choi, SoYoung; Ceschin, Rafael; Bhushan, Chitresh; Leahy, Richard M.; Corby, Patricia; Schmithorst, Vincent J.; Panigrahy, Ashok			Altered Structural and Functional Connectivity in Late Preterm Preadolescence: An Anatomic Seed-Based Study of Resting State Networks Related to the Posteromedial and Lateral Parietal Cortex	PLOS ONE			English	Article							INFERIOR LONGITUDINAL FASCICULUS; CEREBRAL WHITE-MATTER; HUMAN BRAIN; ADOLESCENTS BORN; CORPUS-CALLOSUM; BIRTH; CHILDREN; INFANTS; AUTISM; ATTENTION	Objective Late preterm birth confers increased risk of developmental delay, academic difficulties and social deficits. The late third trimester may represent a critical period of development of neural networks including the default mode network (DMN), which is essential to normal cognition. Our objective is to identify functional and structural connectivity differences in the posteromedial cortex related to late preterm birth. Methods Thirty-eight preadolescents (ages 9-13; 19 born in the late preterm period (>= 32 weeks gestational age) and 19 at term) without access to advanced neonatal care were recruited from a low socioeconomic status community in Brazil. Participants underwent neurocognitive testing, 3-dimensional T1-weighted imaging, diffusion-weighted imaging and resting state functional MRI (RS-fMRI). Seed-based probabilistic diffusion tractography and RS-fMRI analyses were performed using unilateral seeds within the posterior DMN (posterior cingulate cortex, precuneus) and lateral parietal DMN (superior marginal and angular gyri). Results Late preterm children demonstrated increased functional connectivity within the posterior default mode networks and increased anti-correlation with the central-executive network when seeded from the posteromedial cortex (PMC). Key differences were demonstrated between PMC components with increased anti-correlation with the salience network seen only with posterior cingulate cortex seeding but not with precuneus seeding. Probabilistic tractography showed increased streamlines within the right inferior longitudinal fasciculus and inferior fronto-occipital fasciculus within late preterm children while decreased intrahemispheric streamlines were also observed. No significant differences in neurocognitive testing were demonstrated between groups. Conclusion Late preterm preadolescence is associated with altered functional connectivity from the PMC and lateral parietal cortex to known distributed functional cortical networks despite no significant executive neurocognitive differences. Selective increased structural connectivity was observed in the setting of decreased posterior interhemispheric connections. Future work is needed to determine if these findings represent a compensatory adaptation employing alternate neural circuitry or could reflect subtle pathology resulting in emotional processing deficits not seen with neurocognitive testing.	[Degnan, Andrew J.; Wisnowski, Jessica L.; Ceschin, Rafael; Schmithorst, Vincent J.; Panigrahy, Ashok] UPMC, Childrens Hosp Pittsburgh, Dept Pediat Radiol, Pittsburgh, PA 15224 USA; [Degnan, Andrew J.] UPMC, Dept Radiol, Pittsburgh, PA 15213 USA; [Wisnowski, Jessica L.; Choi, SoYoung; Panigrahy, Ashok] Univ So Calif, Brain & Creat Inst, Los Angeles, CA 90089 USA; [Bhushan, Chitresh; Leahy, Richard M.] Univ So Calif, Signal & Image Proc Inst, Los Angeles, CA 90089 USA; [Wisnowski, Jessica L.; Panigrahy, Ashok] Childrens Hosp Los Angeles, Dept Radiol, Los Angeles, CA 90027 USA; [Ceschin, Rafael; Panigrahy, Ashok] Univ Pittsburgh, Dept Biomed Informat, Pittsburgh, PA USA; [Corby, Patricia] Twins Inst Genet Res, BR-39400115 Montes Claros, Minas Gerais, Brazil; [Corby, Patricia] New York Univ Bluestone, Clin Res Ctr, New York, NY 10010 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Southern California; University of Southern California; Children's Hospital Los Angeles; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Panigrahy, A (corresponding author), UPMC, Childrens Hosp Pittsburgh, Dept Pediat Radiol, 4401 Penn Ave,Floor 2, Pittsburgh, PA 15224 USA.	Ashok.Panigrahy@chp.edu	Bhushan, Chitresh/AAG-3305-2020	Bhushan, Chitresh/0000-0002-2935-2515; Choi, So Young/0000-0001-7165-4691; Degnan, Andrew/0000-0002-7373-0990; Ceschin, Rafael/0000-0002-3715-9627	National Institute of Neurological Disorders and Stroke Research Career Development grant [K23NS063371-02]; American Society of Pediatric Neuroradiology (ASPNR); National Library of Medicine Training grant [5T15LM007059-27]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K23NS063371] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [T15LM007059] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke Research Career Development grant; American Society of Pediatric Neuroradiology (ASPNR); National Library of Medicine Training grant; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This study was supported in part by National Institute of Neurological Disorders and Stroke Research Career Development grant (K23NS063371-02) to AP, American Society of Pediatric Neuroradiology (ASPNR) 2013 Annual Award in Pediatric Neuroradiology Research grant to AJD, and National Library of Medicine Training grant 5T15LM007059-27 to RC.	Aarnoudse-Moens CSH, 2009, PEDIATRICS, V124, P717, DOI 10.1542/peds.2008-2816; Achard S, 2006, J NEUROSCI, V26, P63, DOI 10.1523/JNEUROSCI.3874-05.2006; Allin MPG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024525; Ashtari M, 2007, ARCH GEN PSYCHIAT, V64, P1270, DOI 10.1001/archpsyc.64.11.1270; Ashtari M, 2012, DEV MED CHILD NEUROL, V54, P6, DOI 10.1111/j.1469-8749.2011.04122.x; Ball G, 2014, P NATL ACAD SCI USA, V111, P7456, DOI 10.1073/pnas.1324118111; Baron IS, 2012, NEUROPSYCHOL REV, V22, P438, DOI 10.1007/s11065-012-9210-5; Behrens TEJ, 2007, NEUROIMAGE, V34, P144, DOI 10.1016/j.neuroimage.2006.09.018; Belmonte MK, 2003, COGNITIVE BRAIN RES, V17, P651, DOI 10.1016/S0926-6410(03)00189-7; Bhushan C, 2014, MAGN RESON MED, V72, P1218, DOI 10.1002/mrm.25026; Bhushan C, 2012, ASIAPAC SIGN INFO PR; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Bretz WA, 2005, J DENT RES, V84, P1047, DOI 10.1177/154405910508401115; Cameron AC, 2008, REV ECON STAT, V90, P414, DOI 10.1162/rest.90.3.414; Catani M, 2003, BRAIN, V126, P2093, DOI 10.1093/brain/awg203; Chanraud S, 2010, NEUROPSYCHOL REV, V20, P209, DOI 10.1007/s11065-010-9129-7; Cherkassky VL, 2006, NEUROREPORT, V17, P1687, DOI 10.1097/01.wnr.0000239956.45448.4c; CHI JG, 1977, ARCH NEUROL-CHICAGO, V34, P346, DOI 10.1001/archneur.1977.00500180040008; Coben R., 2008, J NEUROTHER INVEST N, V12, P161, DOI DOI 10.1080/10874200802398824; Corby PM, 2005, J CLIN MICROBIOL, V43, P5753, DOI 10.1128/JCM.43.11.5753-5759.2005; Cordes D, 2000, AM J NEURORADIOL, V21, P1636; Cordes D, 2001, AM J NEURORADIOL, V22, P1326; Courchesne E, 2005, CURR OPIN NEUROBIOL, V15, P225, DOI 10.1016/j.conb.2005.03.001; Courchesne E, 2004, MENT RETARD DEV D R, V10, P106, DOI 10.1002/mrdd.20020; Dahl LB, 2006, PEDIATRICS, V118, pE449, DOI 10.1542/peds.2005-3024; Doria V, 2010, P NATL ACAD SCI USA, V107, P20015, DOI 10.1073/pnas.1007921107; Engle WA, 2007, PEDIATRICS, V120, P1390, DOI 10.1542/peds.2007-2952; Fair DA, 2008, P NATL ACAD SCI USA, V105, P4028, DOI 10.1073/pnas.0800376105; Feldman HM, 2012, DEV MED CHILD NEUROL, V54, P809, DOI 10.1111/j.1469-8749.2012.04378.x; Fiala JC, 2002, BRAIN RES REV, V39, P29, DOI 10.1016/S0165-0173(02)00158-3; Fischer J.S., 2012, NEUROPSYCHOLOGICAL A, V5th; Fransson P, 2007, P NATL ACAD SCI USA, V104, P15531, DOI 10.1073/pnas.0704380104; Fransson P, 2011, CEREB CORTEX, V21, P145, DOI 10.1093/cercor/bhq071; Frith C, 2003, NOVART FDN SYMP, V251, P149; Gao W, 2009, P NATL ACAD SCI USA, V106, P6790, DOI 10.1073/pnas.0811221106; Gimenez M, 2008, NEUROIMAGE, V41, P728, DOI 10.1016/j.neuroimage.2008.02.029; Gimenez M, 2006, NEUROIMAGE, V32, P1485, DOI 10.1016/j.neuroimage.2006.05.013; Gozzo Y, 2009, NEUROIMAGE, V48, P458, DOI 10.1016/j.neuroimage.2009.06.046; Gruner P, 2014, HUM BRAIN MAPP, V35, P5306, DOI 10.1002/hbm.22551; Guinchat V, 2012, ACTA OBSTET GYN SCAN, V91, P287, DOI 10.1111/j.1600-0412.2011.01325.x; Haas BW, 2013, CEREB CORTEX; Hart AR, 2008, DEV MED CHILD NEUROL, V50, P655, DOI 10.1111/j.1469-8749.2008.03050.x; Healy E, 2013, J PEDIATR-US, V163, P1596, DOI 10.1016/j.jpeds.2013.08.011; Hutsler JJ, 2010, BRAIN RES, V1309, P83, DOI 10.1016/j.brainres.2009.09.120; Jaekel J, 2013, PSYCHOL MED, V43, P183, DOI 10.1017/S0033291712001031; Jaekel J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065219; Jellison BJ, 2004, AM J NEURORADIOL, V25, P356; Johnson S, 2011, PEDIATR RES, V69, p11R, DOI 10.1203/PDR.0b013e318212faa0; Joshi Anand A, 2012, Biomed Image Regist Proc, V7359, P180, DOI 10.1007/978-3-642-31340-0_19; Joshi AA, 2010, NEUROIMAGE, V50, P950, DOI 10.1016/j.neuroimage.2009.12.064; Kesler SR, 2008, J PEDIATR-US, V152, P513, DOI 10.1016/j.jpeds.2007.08.009; Kinney HC, 2006, SEMIN PERINATOL, V30, P81, DOI 10.1053/j.semperi.2006.02.006; Kostovic I, 2006, SEMIN FETAL NEONAT M, V11, P415, DOI 10.1016/j.siny.2006.07.001; Kuzniewicz MW, 2014, J PEDIATR-US, V164, P20, DOI 10.1016/j.jpeds.2013.09.021; LAMANTIA AS, 1994, J COMP NEUROL, V340, P328, DOI 10.1002/cne.903400304; Ledberg A, 1998, NEUROIMAGE, V8, P113, DOI 10.1006/nimg.1998.0336; Lindstrom K, 2011, PEDIATRICS, V127, P858, DOI 10.1542/peds.2010-1279; Lowe MJ, 1998, NEUROIMAGE, V7, P119, DOI 10.1006/nimg.1997.0315; Lubsen J, 2011, SEMIN PERINATOL, V35, P34, DOI 10.1053/j.semperi.2010.10.006; Mandonnet E, 2007, BRAIN, V130, P623, DOI 10.1093/brain/awl361; McGowan JE, 2011, PEDIATRICS, V127, P1111, DOI 10.1542/peds.2010-2257; Morse SB, 2009, PEDIATRICS, V123, pE622, DOI 10.1542/peds.2008-1405; Moster D, 2008, NEW ENGL J MED, V359, P262, DOI 10.1056/NEJMoa0706475; Mullen KM, 2011, NEUROIMAGE, V54, P2563, DOI 10.1016/j.neuroimage.2010.11.019; Myers EH, 2010, NEUROIMAGE, V51, P1445, DOI 10.1016/j.neuroimage.2010.03.049; Narberhaus A, 2007, J CHILD NEUROL, V22, P761, DOI 10.1177/0883073807304006; Ortibus E, 2012, DEV MED CHILD NEUROL, V54, P38, DOI 10.1111/j.1469-8749.2011.04147.x; Paolicelli RC, 2011, SCIENCE, V333, P1456, DOI 10.1126/science.1202529; Petrini JR, 2009, J PEDIATR-US, V154, P169, DOI 10.1016/j.jpeds.2008.08.020; Pfefferbaum A, 2011, CEREB CORTEX, V21, P233, DOI 10.1093/cercor/bhq090; Power JD, 2014, NEUROIMAGE, V84, P320, DOI 10.1016/j.neuroimage.2013.08.048; PRICE DJ, 1993, EUR J NEUROSCI, V5, P223, DOI 10.1111/j.1460-9568.1993.tb00488.x; Rinaldi T, 2008, CEREB CORTEX, V18, P763, DOI 10.1093/cercor/bhm117; Rykhlevskaia E, 2009, FRONT HUM NEUROSCI, V3, DOI 10.3389/neuro.09.051.2009; Selip DB, 2012, NEUROL RES INT, V2012, DOI 10.1155/2012/725184; SIDMAN RL, 1973, BRAIN RES, V62, P1, DOI 10.1016/0006-8993(73)90617-3; Skranes J, 2007, BRAIN, V130, P654, DOI 10.1093/brain/awm001; Smyser CD, 2010, CEREB CORTEX, V20, P2852, DOI 10.1093/cercor/bhq035; Supekar K, 2013, CELL REP, V5, P738, DOI 10.1016/j.celrep.2013.10.001; Teune MJ, 2011, AM J OBSTET GYNECOL, V205, DOI 10.1016/j.ajog.2011.07.015; Thevenaz P, 1998, IEEE T IMAGE PROCESS, V7, P27, DOI 10.1109/83.650848; Thomason ME, 2008, NEUROIMAGE, V41, P1493, DOI 10.1016/j.neuroimage.2008.03.029; Thompson DK, 2012, NEUROIMAGE, V59, P3571, DOI 10.1016/j.neuroimage.2011.11.057; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; van den Heuvel MP, 2015, CEREB CORTEX, V25, P3000, DOI 10.1093/cercor/bhu095; Wakana S, 2004, RADIOLOGY, V230, P77, DOI 10.1148/radiol.2301021640; Wycoco V, 2013, NEUROIMAG CLIN N AM, V23, P197, DOI 10.1016/j.nic.2012.12.002; Zielinski BA, 2010, P NATL ACAD SCI USA, V107, P18191, DOI 10.1073/pnas.1003109107	88	20	20	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2015	10	6							e0130686	10.1371/journal.pone.0130686	http://dx.doi.org/10.1371/journal.pone.0130686			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL3FM	26098888	Green Submitted, Green Published, gold, Green Accepted			2022-12-26	WOS:000356835800095
J	Forbes, L; Ebsworth-Mojica, K; DiDone, L; Li, SG; Freundlich, JS; Connell, N; Dunman, PM; Krysan, DJ				Forbes, Lauren; Ebsworth-Mojica, Katherine; DiDone, Louis; Li, Shao-Gang; Freundlich, Joel S.; Connell, Nancy; Dunman, Paul M.; Krysan, Damian J.			A High Throughput Screening Assay for Anti-Mycobacterial Small Molecules Based on Adenylate Kinase Release as a Reporter of Cell Lysis	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; DRUG DISCOVERY; IDENTIFICATION; RESISTANCE; INHIBITORS; SMEGMATIS	Mycobacterium tuberculosis (Mtb) is well-established to be one of the most important bacterial pathogens for which new antimicrobial therapies are needed. Herein, we describe the development of a high throughput screening assay for the identification of molecules that are bactericidal against Mycobacteria. The assay utilizes the release of the intracellular enzyme adenylate kinase into the culture medium as a reporter of mycobacterial cell death. We demonstrate that the assay is selective for mycobactericidal molecules and detects anti-mycobacterial activity at concentrations below the minimum inhibitory concentration of many molecules. Thus, the AK assay is more sensitive than traditional growth assays. We have validated the AK assay in the HTS setting using the Mtb surrogate organism M. smegmatis and libraries of FDA approved drugs as well as a commercially available Diversity set. The screen of the FDA-approved library demonstrated that the AK assay is able to identify the vast majority of drugs with known mycobactericidal activity. Importantly, our screen of the Diversity set revealed that the increased sensitivity of the AK assay increases the ability of M. smegmatis-based screens to detect molecules with relatively poor activity against M. smegmatis but good to excellent activity against Mtb.	[Forbes, Lauren; Dunman, Paul M.; Krysan, Damian J.] Univ Rochester, Sch Med & Dent, Dept Microbiol Immunol, Rochester, NY 14642 USA; [Ebsworth-Mojica, Katherine; DiDone, Louis; Krysan, Damian J.] Univ Rochester, Sch Med & Dent, Dept Pediat, Rochester, NY 14642 USA; [Li, Shao-Gang; Freundlich, Joel S.] Rutgers State Univ, Dept Pharmacol, Newark, NJ 07103 USA; [Freundlich, Joel S.; Connell, Nancy] Rutgers State Univ, Dept Physiol, Newark, NJ 07103 USA; [Freundlich, Joel S.; Connell, Nancy] Rutgers State Univ, Dept Med, Ctr Emerging & Re Emerging Pathogens, Newark, NJ 07103 USA	University of Rochester; University of Rochester; Rutgers State University Newark; Rutgers State University New Brunswick; Rutgers State University Newark; Rutgers State University New Brunswick; Rutgers State University Newark; Rutgers State University New Brunswick	Dunman, PM (corresponding author), Univ Rochester, Sch Med & Dent, Dept Microbiol Immunol, Rochester, NY 14642 USA.	paul_dunman@urmc.rochester.edu; damian_krysan@urmc.rochester.edu	Li, Shao-Gang/O-4223-2019; Connell, Nancy/AFN-1305-2022	Krysan, Damian/0000-0001-6330-3365	National Institute of Allergy and Infectious Diseases [5R01 AI103507]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI103507] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	National Institute of Allergy and Infectious Diseases, http://www.niaid.nih.gov; 5R01 AI103507. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altaf M, 2010, TUBERCULOSIS, V90, P333, DOI 10.1016/j.tube.2010.09.002; Ananthan S, 2009, TUBERCULOSIS, V89, P334, DOI 10.1016/j.tube.2009.05.008; Berisio R, 2006, ANTIMICROB AGENTS CH, V50, P3816, DOI 10.1128/AAC.00767-06; Cooper CB, 2013, J MED CHEM, V56, P7755, DOI 10.1021/jm400381v; Diacon AH, 2009, NEW ENGL J MED, V360, P2397, DOI 10.1056/NEJMoa0808427; DiDone L, 2010, NAT PROTOC, V5, P1107, DOI 10.1038/nprot.2010.47; Donald PR, 2008, TUBERCULOSIS, V88, pS75, DOI 10.1016/S1472-9792(08)70038-6; Gajadeera C, 2015, J ANTIBIOT, V68, P153, DOI 10.1038/ja.2014.131; Golchin SA, 2012, TUBERCULOSIS, V92, P489, DOI 10.1016/j.tube.2012.06.006; Greenstein RJ, 2014, INT J INFECT DIS, V26, P37, DOI 10.1016/j.ijid.2014.01.026; Jacobs AC, 2013, ANTIMICROB AGENTS CH, V57, P26, DOI 10.1128/AAC.01640-12; Koul A, 2011, NATURE, V469, P483, DOI 10.1038/nature09657; Lechartier B, 2014, EMBO MOL MED, V6, P158, DOI 10.1002/emmm.201201772; Lougheed KEA, 2009, TUBERCULOSIS, V89, P364, DOI 10.1016/j.tube.2009.07.002; Meissner A, 2013, BIOORGAN MED CHEM, V21, P6385, DOI 10.1016/j.bmc.2013.08.048; Nash KA, 2003, ANTIMICROB AGENTS CH, V47, P3053, DOI 10.1128/AAC.47.10.3053-3060.2003; Payne DJ, 2007, NAT REV DRUG DISCOV, V6, P29, DOI 10.1038/nrd2201; Pieroni M, 2014, EUR J MED CHEM, V72, P26, DOI 10.1016/j.ejmech.2013.11.007; Shin SJ, 2008, ANTIMICROB AGENTS CH, V52, P418, DOI 10.1128/AAC.00678-07; Stanley SA, 2012, ACS CHEM BIOL, V7, P1377, DOI 10.1021/cb300151m; Wakamoto Y, 2013, SCIENCE, V339, P91, DOI 10.1126/science.1229858; World Health Organisation, 2011, WHOHTMTB201116; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206; Zumla A, 2013, NAT REV DRUG DISCOV, V12, P388, DOI 10.1038/nrd4001	24	17	17	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2015	10	6							e0129234	10.1371/journal.pone.0129234	http://dx.doi.org/10.1371/journal.pone.0129234			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL3FM	26098625	Green Published, gold, Green Submitted			2022-12-26	WOS:000356835800025
J	Wang, H; Dong, XL; Gu, X; Qin, R; Jia, HP; Gao, JP				Wang, Hui; Dong, Xiaolin; Gu, Xin; Qin, Rong; Jia, Hongping; Gao, Jianpeng			The MicroRNA-217 Functions as a Potential Tumor Suppressor in Gastric Cancer by Targeting GPC5	PLOS ONE			English	Article							LUNG-CANCER; ADENOCARCINOMA; GENE; IDENTIFICATION; AMPLIFICATION; OSTEOSARCOMA; METASTASIS; GLYPICAN-5; EXPRESSION; CARCINOMA	Gastric cancer (GC) is one of the most common malignancies worldwide. Emerging evidence has shown that aberrant expression of microRNAs (miRNAs) plays important roles in cancer progression. However, little is known about the potential role of miR-217 in GC. In this study, we investigated the role of miR-217 on GC cell proliferation and invasion. The expression of miR-217 was down-regulated in GC cells and human GC tissues. Enforced expression of miR-217 inhibited GC cells proliferation and invasion. Moreover, Glypican-5 (GPC5), a new ocncogene, was identified as the potential target of miR-217. In addition, overexpression of miR-217 impaired GPC5-induced promotion of proliferation and invasion in GC cells. In conclusion, these findings revealed that miR-217 functioned as a tumor suppressor and inhibited the proliferation and invasion of GC cells by targeting GPC5, which might consequently serve as a therapeutic target for GC patients.	[Wang, Hui; Qin, Rong; Jia, Hongping; Gao, Jianpeng] Kunming Med Univ, Affiliated YanAn Hosp, Dept Gastroenterol, Kunming 650051, Yunnan, Peoples R China; [Dong, Xiaolin] Kunming Med Univ, Affiliated YanAn Hosp, Dept Neurol, Kunming 650051, Yunnan, Peoples R China; [Gu, Xin] Kunming Med Univ, Affiliated YanAn Hosp, Dept Gen Surg, Kunming 650051, Yunnan, Peoples R China	Kunming Medical University; Kunming Medical University; Kunming Medical University	Gao, JP (corresponding author), Kunming Med Univ, Affiliated YanAn Hosp, Dept Gastroenterol, Kunming 650051, Yunnan, Peoples R China.	ggq4fv@163.com						Fei BJ, 2012, ONCOL RES, V20, P557, DOI 10.3727/096504013X13775486749254; Han G, 2012, ONCOL RES, V20, P149, DOI 10.3727/096504012X13522227232237; Jiang LL, 2010, AM J PATHOL, V177, P29, DOI 10.2353/ajpath.2010.090812; Joslyn G, 2011, G3-GENES GENOM GENET, V1, P627, DOI 10.1534/g3.111.000976; Katada T, 2009, INT J ONCOL, V34, P537, DOI 10.3892/ijo_00000179; Lee H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083471; Li H, 2013, NEOPLASMA, V60, P511, DOI 10.4149/neo_2013_066; Li YF, 2011, J THORAC ONCOL, V6, P2, DOI 10.1097/JTO.0b013e3181fd6b04; Li Z, 2014, GASTRIC CANC OFFICIA; Li Z, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109595; Shen JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104510; Shende VR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022586; Song LB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025454; Thiel A, 2012, HELICOBACTER, V17, P26, DOI 10.1111/j.1523-5378.2012.00979.x; Wang ZG, 2013, ONCOL RES, V21, P145, DOI 10.3727/096504013X13841340689573; Williams KJ, 2008, BRIT J RADIOL, V81, pS21, DOI 10.1259/bjr/59853976; Williamson D, 2007, CANCER RES, V67, P57, DOI 10.1158/0008-5472.CAN-06-1650; Xiao XC, 2012, ONCOL RES, V20, P537, DOI 10.3727/096504013X13775486749335; Yamashita S, 2012, ONCOLOGY-BASEL, V82, P205, DOI 10.1159/000336809; Yan K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033778; Yang J, 2014, GENE, V548, P285, DOI 10.1016/j.gene.2014.07.048; Yang L, 2006, WORLD J GASTROENTERO, V12, P17, DOI 10.3748/wjg.v12.i1.17; Yang X, 2013, CANCER LETT, V341, P265, DOI 10.1016/j.canlet.2013.08.020; Yasui W, 2011, PATHOL RES PRACT, V207, P608, DOI 10.1016/j.prp.2011.09.006; Yin HQ, 2012, J BIOL CHEM, V287, P9817, DOI 10.1074/jbc.M111.333534; Yu W, 2003, J HUM GENET, V48, P331, DOI 10.1007/s10038-003-0026-2; Yu X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083080; Zhang CW, 2011, MOL GENET METAB, V103, P104, DOI 10.1016/j.ymgme.2011.02.005; Zhang H, 2010, ONCOL REP, V24, P1363, DOI 10.3892/or_00000994; Zhang WH, 2012, ONCOL RES, V20, P139, DOI 10.3727/096504012X13522227232156; Zhang XY, 2012, TUMOR BIOL, V33, P1589, DOI 10.1007/s13277-012-0414-3; Zhang YN, 2014, ARCH ORAL BIOL, V59, P1172, DOI 10.1016/j.archoralbio.2014.07.009; Zhang Y, 2014, ONCOL RES, V21, P201, DOI 10.3727/096504014X13890370410203; Zhao GY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053906; Zhao WG, 2010, CARCINOGENESIS, V31, P1726, DOI 10.1093/carcin/bgq160; Zhao ZY, 2014, MOL MED REP, V9, P2540, DOI 10.3892/mmr.2014.2092; Zhu ED, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106049	37	35	36	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2015	10	6							e0125474	10.1371/journal.pone.0125474	http://dx.doi.org/10.1371/journal.pone.0125474			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL3FM	26098560	Green Published, Green Submitted, gold			2022-12-26	WOS:000356835800002
J	De Gracia, M; Cascales, M; Expert, P; Bellanger, MN; Le Cam, B; Lemaire, C				De Gracia, Marie; Cascales, Mathilde; Expert, Pascale; Bellanger, Marie-Noelle; Le Cam, Bruno; Lemaire, Christophe			How Did Host Domestication Modify Life History Traits of Its Pathogens?	PLOS ONE			English	Article							VENTURIA-INAEQUALIS ASCOSPORES; NUCLEOTIDE DIVERSITY; EVOLUTION; WILD; GENOME; FUNGUS; QUANTIFICATION; SELECTION; PATTERNS; ORIGINS	Understanding evolutionary dynamics of pathogens during domestication of their hosts and rise of agro-ecosystems is essential for durable disease management. Here, we investigated changes in life-history traits of the fungal pathogen Venturia inaequalis during domestication of the apple. Life traits linked to fungal dispersal were compared between 60 strains that were sampled in domestic and wild habitats in Kazakhstan, the center of origin of both host and pathogen. Our two main findings are that transition from wild to agro-ecosystems was associated with an increase of both spore size and sporulation capacity; and that distribution of quantitative traits of the domestic population mostly overlapped with those of the wild population. Our results suggest that apple domestication had a considerable impact on fungal characters linked to its dispersal through selection from standing phenotypic diversity. We showed that pestification of V. inaequalis in orchards led to an enhanced allocation in colonization ability from standing variation in the wild area. This study emphasizes the potential threat that pathogenic fungal populations living in wild environments represent for durability of resistance in agro-ecosystems.	[De Gracia, Marie; Cascales, Mathilde; Expert, Pascale; Bellanger, Marie-Noelle; Le Cam, Bruno; Lemaire, Christophe] INRA, IRHS, SFR QUASAV, F-49071 Beaucouze, France; [De Gracia, Marie; Cascales, Mathilde; Expert, Pascale; Bellanger, Marie-Noelle; Le Cam, Bruno; Lemaire, Christophe] Univ Angers, IRHS, PRES UNAM, SFR QUASAV, F-49045 Angers, France; [De Gracia, Marie; Cascales, Mathilde; Expert, Pascale; Bellanger, Marie-Noelle; Le Cam, Bruno; Lemaire, Christophe] Agrocampus Ouest, SFR QUASAV, IRHS, F-49045 Angers, France	INRAE; Universite d'Angers; Institut Agro; Agrocampus Ouest; Universite d'Angers	Le Cam, B (corresponding author), INRA, IRHS, SFR QUASAV, F-49071 Beaucouze, France.	bruno.lecam@angers.inra.fr; christophe.lemaire@univ-angers.fr			Departement Sante des Plantes et Environnement de l'Institut National de Recherche Agronomique (INRA); Region Pays de Loire; Agence Nationale Pour la Recherche (ANR): Projet Bioadapt ANR Gandalf [ANR-12-ADAP-0009]	Departement Sante des Plantes et Environnement de l'Institut National de Recherche Agronomique (INRA); Region Pays de Loire(Region Pays de la Loire); Agence Nationale Pour la Recherche (ANR): Projet Bioadapt ANR Gandalf(French National Research Agency (ANR))	The PhD thesis of Marie De Gracia was funded by both the Departement Sante des Plantes et Environnement de l'Institut National de Recherche Agronomique (INRA) (http://www.spe.inra.fr/) and the Region Pays de Loire (http://www.paysdelaloire.fr/). The project was granted by Agence Nationale Pour la Recherche (ANR): Projet Bioadapt ANR Gandalf ANR-12-ADAP-0009 (http://www.agence-nationale-recherche.fr/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson PK, 2004, TRENDS ECOL EVOL, V19, P535, DOI 10.1016/j.tree.2004.07.021; AYLOR DE, 1992, PHYTOPATHOLOGY, V82, P532, DOI 10.1094/Phyto-82-532; Aylor DE, 1998, PLANT DIS, V82, P838, DOI 10.1094/PDIS.1998.82.8.838; AYLOR DE, 1995, AGR FOREST METEOROL, V76, P59, DOI 10.1016/0168-1923(94)02211-2; Belin E, 2013, COMPUT ELECTRON AGR, V90, P159, DOI 10.1016/j.compag.2012.09.014; Brasier CM, 1999, GEN RES, V77, P213; Buckler ES, 2001, GENET RES, V77, P213, DOI 10.1017/S0016672301005158; Clement CR, 1999, ECON BOT, V53, P188, DOI 10.1007/BF02866498; Cornille A, 2013, MOL ECOL, V22, P2249, DOI 10.1111/mec.12231; Cornille A, 2014, TRENDS GENET, V30, P57, DOI 10.1016/j.tig.2013.10.002; Cornille A, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002703; deVisser JAGM, 1997, EVOLUTION, V51, P1499, DOI 10.1111/j.1558-5646.1997.tb01473.x; Giraud T, 2010, TRENDS ECOL EVOL, V25, P387, DOI 10.1016/j.tree.2010.03.006; Gladieux P, 2010, MOL ECOL, V19, P658, DOI 10.1111/j.1365-294X.2009.04498.x; Gladieux P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001455; Glemin S, 2009, NEW PHYTOL, V183, P273, DOI 10.1111/j.1469-8137.2009.02884.x; Hammer K., 1984, KULTURPFLANZE, V32, P11, DOI [DOI 10.1007/BF02098682, 10.1007/BF02098682]; HARLAN JR, 1973, EVOLUTION, V27, P311, DOI [10.2307/2406971, 10.1111/j.1558-5646.1973.tb00676.x]; Harris SA, 2002, TRENDS GENET, V18, P426, DOI 10.1016/S0168-9525(02)02689-6; Haudry A, 2007, MOL BIOL EVOL, V24, P1506, DOI 10.1093/molbev/msm077; Hittinger CT, 2013, TRENDS GENET, V29, P309, DOI 10.1016/j.tig.2013.01.002; Holb IJ, 2004, J PHYTOPATHOL, V152, P639, DOI 10.1111/j.1439-0434.2004.00910.x; Hyten DL, 2006, P NATL ACAD SCI USA, V103, P16666, DOI 10.1073/pnas.0604379103; Ingold C., 1971, MYCOLOGIA; Le Van A, 2012, EVOL APPL, V5, P694, DOI 10.1111/j.1752-4571.2012.00246.x; Leroy T, 2014, INFECT GENET EVOL, V27, P521, DOI 10.1016/j.meegid.2013.12.022; Leroy T, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-64; Li CB, 2006, NEW PHYTOL, V170, P185, DOI 10.1111/j.1469-8137.2005.01647.x; Liti G, 2009, NATURE, V458, P337, DOI 10.1038/nature07743; Liu AZ, 2006, GENETICS, V173, P321, DOI 10.1534/genetics.105.051110; MacHardy WE, 2001, PLANT DIS, V85, P1036, DOI 10.1094/PDIS.2001.85.10.1036; McDonald BA, 2002, ANNU REV PHYTOPATHOL, V40, P349, DOI 10.1146/annurev.phyto.40.120501.101443; MCHARDY WE, 1996, APPLE SCAB BIOL EPID; Meerts P, 1999, J EVOLUTION BIOL, V12, P161, DOI 10.1046/j.1420-9101.1999.00020.x; Monteil CL, 2013, NEW PHYTOL, V199, P800, DOI 10.1111/nph.12316; Morgan J., 1993, THE BOOK OF APPLES; Norros V, 2014, ECOLOGY, V95, P1612, DOI 10.1890/13-0877.1; OBERT M, 1990, J BACTERIOL, V172, P1180, DOI 10.1128/jb.172.3.1180-1185.1990; Papagianni M, 2006, MICROB CELL FACT, V5, DOI 10.1186/1475-2859-5-5; Pinheiro J., 2014, R PACKAGE VERSION, V3, P1; Pringle A, 2002, TRENDS MICROBIOL, V10, P474, DOI 10.1016/S0966-842X(02)02447-2; R Development Core Team, 2013, R LANG ENV STAT COMP, DOI [10.3758/s13428-013-0330-5, DOI 10.3758/S13428-013-0330-5]; Ropars J, 2014, EVOL APPL, V7, P433, DOI 10.1111/eva.12140; Rubin CJ, 2010, NATURE, V464, P587, DOI 10.1038/nature08832; Saleh D, 2014, NEW PHYTOL, V201, P1440, DOI 10.1111/nph.12627; Stukenbrock EH, 2008, ANNU REV PHYTOPATHOL, V46, P75, DOI 10.1146/annurev.phyto.010708.154114; Tenaillon MI, 2004, MOL BIOL EVOL, V21, P1214, DOI 10.1093/molbev/msh102; Velasco R, 2010, NAT GENET, V42, P833, DOI 10.1038/ng.654; Webster J.W., 1995, FUNGAL ECOL; WHITEHEAD DR, 1969, EVOLUTION, V23, P28, DOI [10.2307/2406479, 10.1111/j.1558-5646.1969.tb03490.x]; Wirth T, 2005, MOL ECOL, V14, P3289, DOI 10.1111/j.1365-294X.2005.02687.x; Wright K, 2013, CORRGRAM CALCULATES	52	3	3	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2015	10	6							e0122909	10.1371/journal.pone.0122909	http://dx.doi.org/10.1371/journal.pone.0122909			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL3FE	26091067	Green Published, gold, Green Submitted			2022-12-26	WOS:000356835000003
J	Iyer, PM; Egan, C; Pinto-Grau, M; Burke, T; Elamin, M; Nasseroleslami, B; Pender, N; Lalor, EC; Hardiman, O				Iyer, Parameswaran Mahadeva; Egan, Catriona; Pinto-Grau, Marta; Burke, Tom; Elamin, Marwa; Nasseroleslami, Bahman; Pender, Niall; Lalor, Edmund C.; Hardiman, Orla			Functional Connectivity Changes in RestingState EEG as Potential Biomarker for Amyotrophic Lateral Sclerosis	PLOS ONE			English	Article							GRAPH-THEORETICAL ANALYSIS; ALS	Background Amyotrophic Lateral Sclerosis (ALS) is heterogeneous and overlaps with frontotemporal dementia. Spectral EEG can predict damage in structural and functional networks in frontotemporal dementia but has never been applied to ALS. Methods 18 incident ALS patients with normal cognition and 17 age matched controls underwent 128 channel EEG and neuropsychology assessment. The EEG data was analyzed using Field-Trip software in MATLAB to calculate simple connectivity measures and scalp network measures. sLORETA was used in nodal analysis for source localization and same methods were applied as above to calculate nodal network measures. Graph theory measures were used to assess network integrity. Results Cross spectral density in alpha band was higher in patients. In ALS patients, increased degree values of the network nodes was noted in the central and frontal regions in the theta band across seven of the different connectivity maps (p<0.0005). Among patients, clustering coefficient in alpha and gamma bands was increased in all regions of the scalp and connectivity were significantly increased (p=0.02). Nodal network showed increased assortativity in alpha band in the patients group. The Clustering Coefficient in Partial Directed Connectivity (PDC) showed significantly higher values for patients in alpha, beta, gamma, theta and delta frequencies (p=0.05). Discussion There is increased connectivity in the fronto-central regions of the scalp and areas corresponding to Salience and Default Mode network in ALS, suggesting a pathologic disruption of neuronal networking in early disease states. Spectral EEG has potential utility as a biomarker in ALS.	[Iyer, Parameswaran Mahadeva; Elamin, Marwa] Univ Dublin Trinity Coll, Sch Med, Dublin 2, Ireland; [Egan, Catriona; Lalor, Edmund C.] Univ Dublin Trinity Coll, Sch Engn, Dublin 2, Ireland; [Egan, Catriona; Lalor, Edmund C.] Univ Dublin Trinity Coll, Trin Ctr Bioengn, Dublin 2, Ireland; [Iyer, Parameswaran Mahadeva; Pinto-Grau, Marta; Burke, Tom; Elamin, Marwa; Nasseroleslami, Bahman; Pender, Niall; Hardiman, Orla] Univ Dublin Trinity Coll, Trin Biomed Sci Inst, Acad Unit Neurol, Dublin 2, Ireland	Trinity College Dublin; Trinity College Dublin; Trinity College Dublin; Trinity College Dublin	Iyer, PM (corresponding author), Univ Dublin Trinity Coll, Sch Med, Dublin 2, Ireland.	parames68@gmail.com	Nasseroleslami, Bahman/D-3546-2012; Burke, Tom/AAH-8963-2020; Hardiman, Orla/Y-3441-2019	Nasseroleslami, Bahman/0000-0002-2227-2176; Burke, Tom/0000-0002-6563-1597; Hardiman, Orla/0000-0003-2610-1291; Pender, Niall/0000-0002-4172-0704; Lalor, Edmund/0000-0002-2498-6631	Health Research Board (HRB Ireland) grant [HPF/2009/17]; Research Motor Neuron (RMN) Foundation; European Community [259867]; Joint Programme for Neurodegeneration (JPND) SOPHIA project	Health Research Board (HRB Ireland) grant; Research Motor Neuron (RMN) Foundation; European Community(European Commission); Joint Programme for Neurodegeneration (JPND) SOPHIA project	This work was supported by the Health Research Board (HRB Ireland) grant HPF/2009/17 and the Research Motor Neuron (RMN) Foundation. The research leading to these results received funding from the European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreement no. 259867 (EUROMOTOR) and by the Joint Programme for Neurodegeneration (JPND) SOPHIA project. The sponsors of the study had no role in study design, data acquisition, data analysis, data interpretation, or writing of the manuscript.	Agosta F, 2007, HUM BRAIN MAPP, V28, P1430, DOI 10.1002/hbm.20364; Brettschneider J, 2013, ANN NEUROL, V74, P20, DOI 10.1002/ana.23937; Bullmore ET, 2012, NAT REV NEUROSCI, V13, P336, DOI 10.1038/nrn3214; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Byrne S, 2012, LANCET NEUROL, V11, P232, DOI 10.1016/S1474-4422(12)70014-5; de Haan W, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-101; Elamin M, 2011, NEUROLOGY, V76, P1263, DOI 10.1212/WNL.0b013e318214359f; EVANS AC, 1993, NUCLEAR SCIENCE SYMPOSIUM & MEDICAL IMAGING CONFERENCE, VOLS 1-3, P1813, DOI 10.1109/NSSMIC.1993.373602; Fawcett T., 2004, MACH LEARN, V31, P1, DOI DOI 10.1016/J.PATREC.2005.10.010; Furtula J, 2013, CLIN NEUROPHYSIOL, V124, P610, DOI 10.1016/j.clinph.2012.08.023; Harris CM, 1998, J NEUROSCI METH, V83, P15, DOI 10.1016/S0165-0270(98)00080-6; Kerr A, DATA DRIVEN CONNECTI; Kiernan MC, 2011, LANCET, V377, P942, DOI 10.1016/S0140-6736(10)61156-7; Knyazeva MG, 2010, NEUROBIOL AGING, V31, P1132, DOI 10.1016/j.neurobiolaging.2008.07.019; Kollewe K, 2012, NEUROL RES INT, V2012, DOI 10.1155/2012/608501; Lo CYZ, 2011, REV NEUROSCIENCE, V22, P551, DOI 10.1515/RNS.2011.039; Menon Vinod, 2010, Brain Struct Funct, V214, P655, DOI 10.1007/s00429-010-0262-0; Nolan H, 2010, J NEUROSCI METH, V192, P152, DOI 10.1016/j.jneumeth.2010.07.015; Oostenveld R, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/156869; PASCUALMARQUI RD, 1994, INT J PSYCHOPHYSIOL, V18, P49, DOI 10.1016/0167-8760(84)90014-X; Phukan J, 2012, J NEUROL NEUROSUR PS, V83, P102, DOI 10.1136/jnnp-2011-300188; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003	22	33	33	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2015	10	6							e0128682	10.1371/journal.pone.0128682	http://dx.doi.org/10.1371/journal.pone.0128682			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL3FE	26091258	gold, Green Published, Green Submitted			2022-12-26	WOS:000356835000026
J	Silveira, CM; Quintas, PO; Moura, I; Moura, JJG; Hildebrandt, P; Almeida, MG; Todorovic, S				Silveira, Celia M.; Quintas, Pedro O.; Moura, Isabel; Moura, Jose J. G.; Hildebrandt, Peter; Gabriela Almeida, M.; Todorovic, Smilja			SERR Spectroelectrochemical Study of Cytochrome cd(1) Nitrite Reductase Co-Immobilized with Physiological Redox Partner Cytochrome c(552) on Biocompatible Metal Electrodes	PLOS ONE			English	Article							RESONANCE RAMAN-SPECTROSCOPY; PSEUDOMONAS-AERUGINOSA; METHYLOPHILUS-METHYLOTROPHUS; HEME; NO; BINDING; OXIDE; PROTEINS; KINETICS; ENZYMES	Cytochrome cd1 nitrite reductases (cd(1)NiRs) catalyze the one-electron reduction of nitrite to nitric oxide. Due to their catalytic reaction, cd(1)NiRs are regarded as promising components for biosensing, bioremediation and biotechnological applications. Motivated by earlier findings that catalytic activity of cd(1)NiR from Marinobacter hydrocarbonoclasticus (Mhcd(1)) depends on the presence of its physiological redox partner, cytochrome c(552) (cyt c(552)), we show here a detailed surface enhanced resonance Raman characterization of Mhcd(1) and cyt c(552) attached to biocompatible electrodes in conditions which allow direct electron transfer between the conducting support and immobilized proteins. Mhcd(1) and cyt c(552) are co-immobilized on silver electrodes coated with self-assembled monolayers (SAMs) and the electrocatalytic activity of Ag // SAM // Mhcd(1) // cyt c(552) and Ag // SAM // cyt c(552) // Mhcd(1) constructs is tested in the presence of nitrite. Simultaneous evaluation of structural and thermodynamic properties of the immobilized proteins reveals that cyt c(552) retains its native properties, while the redox potential of apparently intact Mhcd(1) undergoes a similar to 150 mV negative shift upon adsorption. Neither of the immobilization strategies results in an active Mhcd(1), reinforcing the idea that subtle and very specific interactions between Mhcd(1) and cyt c(552) govern efficient intermolecular electron transfer and catalytic activity of Mhcd(1).	[Silveira, Celia M.; Quintas, Pedro O.; Todorovic, Smilja] Univ Nova Lisboa, Inst Tecnol Quim & Biol, P-2780156 Oeiras, Portugal; [Silveira, Celia M.; Moura, Isabel; Moura, Jose J. G.; Gabriela Almeida, M.] Univ Nova Lisboa, UCIBIO, REQUIMTE, Fac Ciencias & Tecnol,Dept Quim, Caparica, Portugal; [Hildebrandt, Peter] Tech Univ Berlin, Inst Chem, Berlin, Germany; [Gabriela Almeida, M.] Inst Super Ciencias Saude Egas Moniz, CiiEM, Caparica, Portugal	Universidade Nova de Lisboa; Universidade Nova de Lisboa; Technical University of Berlin; Instituto Superior de Ciencias da Saude Egas Moniz	Silveira, CM (corresponding author), Univ Nova Lisboa, Inst Tecnol Quim & Biol, P-2780156 Oeiras, Portugal.	c.silveira@fct.unl.pt; smilja@itqb.unl.pt	Quintas, Pedro/O-7477-2019; FCT/UNL, REQUIMTE Biological Chemistry at/V-8183-2017; Hildebrandt, Peter/J-5658-2014; Silveira, Célia/D-8348-2013; Almeida, Maria Gabriela/D-8265-2013; Moura, Isabel/D-6339-2013; Moura, José J G/D-6426-2013; Todorovic, Smilja M/F-7612-2010; Almeida, Gabriela/GXV-3687-2022	Hildebrandt, Peter/0000-0003-1030-5900; Silveira, Célia/0000-0002-4821-2358; Almeida, Maria Gabriela/0000-0002-4508-7379; Moura, Isabel/0000-0003-0971-4977; Moura, José J G/0000-0002-4726-2388; Todorovic, Smilja M/0000-0002-0219-6743; 	Fundacao para a Ciencia e Tecnologia [SFRH/BPD/79566/2011]; Deutsche Forschungsgemeinschaft; DAAD-CRUP [A43/12]; UniCat	Fundacao para a Ciencia e Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); DAAD-CRUP; UniCat	Funding provided by Fundacao para a Ciencia e Tecnologia, SFRH/BPD/79566/2011 (CMS), Deutsche Forschungsgemeinschaft, UniCat (PH), and DAAD-CRUP, A43/12 (PH and ST). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aigrain L, 2009, EMBO REP, V10, P742, DOI 10.1038/embor.2009.82; Almeida MG, 2010, SENSORS-BASEL, V10, P11530, DOI 10.3390/s101211530; Andrew CR, 2002, BIOCHEMISTRY-US, V41, P2353, DOI 10.1021/bi011419k; Andrew CR, 2001, BIOCHEMISTRY-US, V40, P4115, DOI 10.1021/bi0023652; Ash PA, 2012, CHEM COMMUN, V48, P1400, DOI 10.1039/c1cc15871f; BESSON S, 1995, ANAEROBE, V1, P219, DOI 10.1006/anae.1995.1021; Brown K, 1999, J MOL BIOL, V289, P1017, DOI 10.1006/jmbi.1999.2838; CHING Y, 1982, FEBS LETT, V138, P239, DOI 10.1016/0014-5793(82)80451-1; Cutruzzola F, 1999, BBA-BIOENERGETICS, V1411, P231, DOI 10.1016/S0005-2728(99)00017-1; Cutruzzola F, 2009, BIOESSAYS, V31, P885, DOI 10.1002/bies.200800235; Das TK, 2001, BIOCHEMISTRY-US, V40, P10774, DOI 10.1021/bi002327i; Dopner S, 1996, SPECTROCHIM ACTA A, V52, P573, DOI 10.1016/0584-8539(95)01647-3; Farver O, 2009, BIOPHYS J, V96, P2849, DOI 10.1016/j.bpj.2008.12.3937; FAUQUE G, 1992, OCEANIS S D, V18, P211; George SJ, 2000, J BIOL CHEM, V275, P33231, DOI 10.1074/jbc.M005033200; KASSNER RJ, 1973, J AM CHEM SOC, V95, P2674, DOI 10.1021/ja00789a044; Koppenhofer A, 2000, BIOCHEMISTRY-US, V39, P4243, DOI 10.1021/bi000192a; Latypov RF, 2008, J MOL BIOL, V383, P437, DOI 10.1016/j.jmb.2008.08.025; Lojou E, 2003, ELECTROCHIM ACTA, V48, P1055, DOI 10.1016/S0013-4686(02)00843-5; Lopes H, 2001, J BIOL INORG CHEM, V6, P55, DOI 10.1007/s007750000159; Murgida DH, 2004, ACCOUNTS CHEM RES, V37, P854, DOI 10.1021/ar0400443; Murgida DH, 2001, J PHYS CHEM B, V105, P1578, DOI 10.1021/jp003742n; Noll T, 2011, CHEM SOC REV, V40, P3564, DOI 10.1039/c1cs15030h; Nurizzo D, 1999, J BIOL CHEM, V274, P14997, DOI 10.1074/jbc.274.21.14997; Nurizzo D, 1997, STRUCTURE, V5, P1157, DOI 10.1016/S0969-2126(97)00267-0; Nurizzo D, 1998, BIOCHEMISTRY-US, V37, P13987, DOI 10.1021/bi981348y; Quintas PO, 2011, BIOCHEMISTRY-US, V50, P5624, DOI 10.1021/bi200480a; Reynolds MF, 2000, BIOCHEMISTRY-US, V39, P388, DOI 10.1021/bi991378g; Rinaldo S, 2007, BIOCHEM BIOPH RES CO, V363, P662, DOI 10.1016/j.bbrc.2007.09.036; Rinaldo S, 2007, J BIOL CHEM, V282, P14761, DOI 10.1074/jbc.M700933200; Rinaldo S, 2011, BIOCHEM J, V435, P217, DOI 10.1042/BJ20101615; Rosa CC, 2002, BIOSENS BIOELECTRON, V17, P45, DOI 10.1016/S0956-5663(01)00263-9; SANTOS H, 1988, BIOCHIM BIOPHYS ACTA, V954, P277, DOI 10.1016/0167-4838(88)90083-0; SARAIVA LM, 1994, EUR J BIOCHEM, V224, P1011, DOI 10.1111/j.1432-1033.1994.01011.x; Serra A., 2012, THESIS U NOVA LISBOA; Serra AS, 2011, ANAL CHIM ACTA, V693, P41, DOI 10.1016/j.aca.2011.03.029; Sezer M, 2012, IUBMB LIFE, V64, P455, DOI 10.1002/iub.1020; SHIMADA H, 1975, FEBS LETT, V54, P237, DOI 10.1016/0014-5793(75)80082-2; SILVESTRINI MC, 1982, BIOCHEM J, V203, P445, DOI 10.1042/bj2030445; SILVESTRINI MC, 1979, BIOCHEM J, V183, P701, DOI 10.1042/bj1830701; Soldatova AV, 2010, J AM CHEM SOC, V132, P4614, DOI 10.1021/ja906233m; Sun YH, 2014, P NATL ACAD SCI USA, V111, P6570, DOI 10.1073/pnas.1322274111; Todorovic S, 2006, J BIOL INORG CHEM, V11, P119, DOI 10.1007/s00775-005-0054-9; Todorovic S, 2008, J PHYS CHEM B, V112, P16952, DOI 10.1021/jp807862m; Wang YN, 1996, J AM CHEM SOC, V118, P3972, DOI 10.1021/ja9538647; Wherland S, 2005, CHEMPHYSCHEM, V6, P805, DOI 10.1002/cphc.200400353; Williams PA, 1997, NATURE, V389, P406, DOI 10.1038/38775; Willner B, 2006, CURR OPIN BIOTECH, V17, P589, DOI 10.1016/j.copbio.2006.10.008	48	11	11	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2015	10	6							e0129940	10.1371/journal.pone.0129940	http://dx.doi.org/10.1371/journal.pone.0129940			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL3FE	26091174	Green Published, Green Submitted, gold			2022-12-26	WOS:000356835000074
J	Kaur, G; Pinggera, A; Ortner, NJ; Lieb, A; Sinnegger-Brauns, MJ; Yarov-Yarovoy, V; Obermair, GJ; Flucher, BE; Striessnig, J				Kaur, Gurjot; Pinggera, Alexandra; Ortner, Nadine J.; Lieb, Andreas; Sinnegger-Brauns, Martina J.; Yarov-Yarovoy, Vladimir; Obermair, Gerald J.; Flucher, Bernhard E.; Striessnig, Jorg			A Polybasic Plasma Membrane Binding Motif in the I-II Linker Stabilizes Voltage-gated Ca(V)1.2 Calcium Channel Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-TERMINAL DOMAIN; PHOSPHOLIPASE-C; CA2+ CHANNELS; BETA-SUBUNIT; STRUCTURAL DETERMINANTS; INTRACELLULAR LINKER; STRUCTURE PREDICTION; FLUORESCENT-PROTEIN; POTASSIUM CHANNELS; CRYSTAL-STRUCTURE	L-type voltage-gated Ca2+ channels (LTCCs) regulate many physiological functions like muscle contraction, hormone secretion, gene expression, and neuronal excitability. Their activity is strictly controlled by various molecular mechanisms. The pore-forming alpha(1)-subunit comprises four repeated domains (I-IV), each connected via an intracellular linker. Here we identified a polybasic plasma membrane binding motif, consisting of four arginines, within the I-II linker of all LTCCs. The primary structure of this motif is similar to polybasic clusters known to interact with polyphosphoinositides identified in other ion channels. We used de novo molecular modeling to predict the conformation of this polybasic motif, immunofluorescence microscopy and live cell imaging to investigate the interaction with the plasma membrane, and electrophysiology to study its role for Ca(v)1.2 channel function. According to our models, this polybasic motif of the I-II linker forms a straight alpha-helix, with the positive charges facing the lipid phosphates of the inner leaflet of the plasma membrane. Membrane binding of the I-II linker could be reversed after phospholipase C activation, causing polyphosphoinositide breakdown, and was accelerated by elevated intracellular Ca2+ levels. This indicates the involvement of negatively charged phospholipids in the plasma membrane targeting of the linker. Neutralization of four arginine residues eliminated plasma membrane binding. Patch clamp recordings revealed facilitated opening of Cav1.2 channels containing these mutations, weaker inhibition by phospholipase C activation, and reduced expression of channels (as quantified by ON-gating charge) at the plasma membrane. Our data provide new evidence for a membrane binding motif within the I-II linker of LTCC alpha(1)-subunits essential for stabilizing normal Ca2+ channel function.	[Kaur, Gurjot; Pinggera, Alexandra; Ortner, Nadine J.; Lieb, Andreas; Sinnegger-Brauns, Martina J.; Striessnig, Jorg] Univ Innsbruck, Inst Pharm, Dept Pharmacol & Toxicol, A-6020 Innsbruck, Austria; [Kaur, Gurjot; Pinggera, Alexandra; Ortner, Nadine J.; Lieb, Andreas; Sinnegger-Brauns, Martina J.; Striessnig, Jorg] Univ Innsbruck, Inst Pharm, Ctr Mol Biosci, A-6020 Innsbruck, Austria; [Yarov-Yarovoy, Vladimir] Univ Calif Davis, Sch Med, Dept Physiol & Membrane Biol, Davis, CA 95616 USA; [Obermair, Gerald J.; Flucher, Bernhard E.] Med Univ Innsbruck, Div Physiol, A-6020 Innsbruck, Austria	University of Innsbruck; University of Innsbruck; University of California System; University of California Davis; Medical University of Innsbruck	Striessnig, J (corresponding author), Univ Innsbruck, Inst Pharm, Dept Pharmacol & Toxicol, Ctr Chem & Biomed, Innrain 80-82-3, A-6020 Innsbruck, Austria.	joerg.striessnig@uibk.ac.at	Yarov-Yarovoy, Vladimir/ABE-5454-2020; , Gerald/AAD-3183-2020; Kaur, Gurjot/AAB-7988-2022; Striessnig, Joerg/S-9334-2017	Yarov-Yarovoy, Vladimir/0000-0002-2325-4834; Striessnig, Joerg/0000-0002-9406-7120; Ortner, Nadine Jasmin/0000-0003-3882-3283; Lieb, Andreas/0000-0001-9567-649X; Kaur, Gurjot/0000-0002-2894-4009; Flucher, Bernhard/0000-0002-5255-4705; Brauns, Martina/0000-0002-0547-2731	Austrian Science Fund [F44020, F44060, W1101]; University of Innsbruck	Austrian Science Fund(Austrian Science Fund (FWF)); University of Innsbruck	This work was supported by Austrian Science Fund Grants F44020, F44060, and W1101 and the University of Innsbruck. The authors declare that they have no conflicts of interest with the contents of this article.	Almagor L, 2012, J NEUROSCI, V32, P7602, DOI 10.1523/JNEUROSCI.5727-11.2012; Altier C, 2011, NAT NEUROSCI, V14, P173, DOI 10.1038/nn.2712; Bae YS, 2003, MOL PHARMACOL, V63, P1043, DOI 10.1124/mol.63.5.1043; Balasubramanian K, 2007, J BIOL CHEM, V282, P18357, DOI 10.1074/jbc.M700202200; Barth P, 2007, P NATL ACAD SCI USA, V104, P15682, DOI 10.1073/pnas.0702515104; Baumgart JP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002976; Bonneau R, 2002, J MOL BIOL, V322, P65, DOI 10.1016/S0022-2836(02)00698-8; Buchan DWA, 2010, NUCLEIC ACIDS RES, V38, pW563, DOI 10.1093/nar/gkq427; Campiglio M, 2013, J CELL SCI, V126, P2092, DOI 10.1242/jcs.jcs124537; Cao YM, 2015, P NATL ACAD SCI USA, V112, P2239, DOI 10.1073/pnas.1405748112; Catterall WA, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a003947; Dayal A, 2013, P NATL ACAD SCI USA, V110, P7488, DOI 10.1073/pnas.1301087110; DeWaard M, 1997, NATURE, V385, P446, DOI 10.1038/385446a0; Doering CJ, 2007, NEUROSCIENCE, V146, P1032, DOI 10.1016/j.neuroscience.2007.02.049; Findeisen F, 2009, J GEN PHYSIOL, V133, P327, DOI 10.1085/jgp.200810143; Fu Y, 2014, P NATL ACAD SCI USA, V111, P16598, DOI 10.1073/pnas.1419129111; Fuller MD, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001152; Gamper N, 2004, J NEUROSCI, V24, P10980, DOI 10.1523/JNEUROSCI.3869-04.2004; Gebhart M, 2010, MOL CELL NEUROSCI, V44, P246, DOI 10.1016/j.mcn.2010.03.011; Gonzalez-Gutierrez G, 2010, CHANNELS, V4, P42, DOI 10.4161/chan.4.1.10562; Goo Rhee Sue, 1992, Advances in Second Messenger and Phosphoprotein Research, V26, P35; Grabner M, 1998, P NATL ACAD SCI USA, V95, P1903, DOI 10.1073/pnas.95.4.1903; Grueter CE, 2006, MOL CELL, V23, P641, DOI 10.1016/j.molcel.2006.07.006; Hall DD, 2013, NEURON, V78, P483, DOI 10.1016/j.neuron.2013.02.032; Hammond GRV, 2012, SCIENCE, V337, P727, DOI 10.1126/science.1222483; Hansen SB, 2011, NATURE, V477, P495, DOI 10.1038/nature10370; Heo WD, 2006, SCIENCE, V314, P1458, DOI 10.1126/science.1134389; Hermosilla T, 2011, CHANNELS, V5, P280, DOI 10.4161/chan.5.3.15833; Hildebrand A, 2009, PROTEINS, V77, P128, DOI 10.1002/prot.22499; Hilgemann DW, 2012, J GEN PHYSIOL, V140, P245, DOI 10.1085/jgp.201210874; Hille B, 2015, BBA-MOL CELL BIOL L, V1851, P844, DOI 10.1016/j.bbalip.2014.09.010; Horowitz LF, 2005, J GEN PHYSIOL, V126, P243, DOI 10.1085/jgp.200509309; HORTON RM, 1989, GENE, V77, P61, DOI 10.1016/0378-1119(89)90359-4; Hulme JT, 2006, P NATL ACAD SCI USA, V103, P16574, DOI 10.1073/pnas.0607294103; Hulme JT, 2006, J PHYSIOL-LONDON, V576, P87, DOI 10.1113/jphysiol.2006.111799; Hulme JT, 2005, P NATL ACAD SCI USA, V102, P5274, DOI 10.1073/pnas.0409885102; Kadamur G, 2013, ANNU REV PHYSIOL, V75, P127, DOI 10.1146/annurev-physiol-030212-183750; Leroy J, 2005, J NEUROSCI, V25, P6984, DOI 10.1523/JNEUROSCI.1137-05.2005; Liao P, 2005, CARDIOVASC RES, V68, P197, DOI 10.1016/j.cardiores.2005.06.024; Lieb A, 2012, CHANNELS, V6, P197, DOI 10.4161/chan.21002; Lindner M, 2011, J PHYSIOL-LONDON, V589, P3149, DOI 10.1113/jphysiol.2011.208983; Lipscombe D, 2005, CURR OPIN NEUROBIOL, V15, P358, DOI 10.1016/j.conb.2005.04.002; Lipscombe D, 2002, MOL NEUROBIOL, V26, P21, DOI 10.1385/MN:26:1:021; Long JZ, 2005, BMC BIOTECHNOL, V5, DOI 10.1186/1472-6750-5-20; Michailidis IE, 2007, PFLUG ARCH EUR J PHY, V455, P147, DOI 10.1007/s00424-007-0272-9; Miranda-Laferte E, 2014, J BIOL CHEM, V289, P10387, DOI 10.1074/jbc.M113.507244; Neely A, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00209; Obermair GJ, 2010, J BIOL CHEM, V285, P5776, DOI 10.1074/jbc.M109.044271; Obermair GJ, 2004, J MUSCLE RES CELL M, V25, P239, DOI 10.1023/B:JURE.0000038361.47060.fe; Ortner NJ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4897; Payandeh J, 2011, NATURE, V475, P353, DOI 10.1038/nature10238; Peterson BZ, 1999, NEURON, V22, P549, DOI 10.1016/S0896-6273(00)80709-6; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pinggera A, 2015, BIOL PSYCHIAT, V77, P816, DOI 10.1016/j.biopsych.2014.11.020; Rhee SG, 1997, J BIOL CHEM, V272, P15045, DOI 10.1074/jbc.272.24.15045; Roberts-Crowley ML, 2009, CELL CALCIUM, V45, P589, DOI 10.1016/j.ceca.2009.03.015; Roberts-Crowley ML, 2009, J GEN PHYSIOL, V133, P387, DOI 10.1085/jgp.200810047; Rousset M, 2004, J BIOL CHEM, V279, P14619, DOI 10.1074/jbc.M313284200; Singh A, 2008, J BIOL CHEM, V283, P20733, DOI 10.1074/jbc.M802254200; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Striessnig Jorg, 2014, Wiley Interdiscip Rev Membr Transp Signal, V3, P15; Suh BC, 2002, NEURON, V35, P507, DOI 10.1016/S0896-6273(02)00790-0; Suh BC, 2008, ANNU REV BIOPHYS, V37, P175, DOI 10.1146/annurev.biophys.37.032807.125859; Suh BC, 2012, P NATL ACAD SCI USA, V109, P3161, DOI 10.1073/pnas.1121434109; Suh BC, 2010, NEURON, V67, P224, DOI 10.1016/j.neuron.2010.07.001; Takahashi SX, 2005, J GEN PHYSIOL, V126, P365, DOI 10.1085/jgp.200509354; Tedford HW, 2010, MOL BRAIN, V3, DOI 10.1186/1756-6606-3-6; van der Wal J, 2001, J BIOL CHEM, V276, P15337, DOI 10.1074/jbc.M007194200; Van Petegem F, 2004, NATURE, V429, P671, DOI 10.1038/nature02588; Varnai P, 1998, J CELL BIOL, V143, P501, DOI 10.1083/jcb.143.2.501; Wang C, 2007, J MOL BIOL, V373, P503, DOI 10.1016/j.jmb.2007.07.050; Whorton MR, 2011, CELL, V147, P199, DOI 10.1016/j.cell.2011.07.046; Wu L, 2002, NATURE, V419, P947, DOI 10.1038/nature01118; Yang Yong Ryoul, 2013, Advances in Biological Regulation, V53, P232, DOI 10.1016/j.jbior.2013.08.003; Yarov-Yarovoy V, 2006, PROTEINS, V62, P1010, DOI 10.1002/prot.20817; Yarov-Yarovoy V, 2006, P NATL ACAD SCI USA, V103, P7292, DOI 10.1073/pnas.0602350103; Yarov-Yarovoy V, 2012, P NATL ACAD SCI USA, V109, pE93, DOI 10.1073/pnas.1118434109; Yeung T, 2008, SCIENCE, V319, P210, DOI 10.1126/science.1152066; Zahedi B, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.189605; Zhen XG, 2006, FEBS LETT, V580, P5733, DOI 10.1016/j.febslet.2006.09.027	80	15	15	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 21	2015	290	34					21086	21100		10.1074/jbc.M115.645671	http://dx.doi.org/10.1074/jbc.M115.645671			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CP6QC	26100638	Green Published, hybrid			2022-12-26	WOS:000360011800041
J	Condomines, M; Arnason, J; Benjamin, R; Gunset, G; Plotkin, J; Sadelain, M				Condomines, Maud; Arnason, Jon; Benjamin, Reuben; Gunset, Gertrude; Plotkin, Jason; Sadelain, Michel			Tumor-Targeted Human T Cells Expressing CD28-Based Chimeric Antigen Receptors Circumvent CTLA-4 Inhibition	PLOS ONE			English	Article							LYMPHOCYTE ANTIGEN-4; NEGATIVE REGULATION; CD28; COSTIMULATION; SIGNAL; CD80; SPECIFICITY; PERSISTENCE; ACTIVATION; EXPANSION	Adoptive T cell therapy represents a promising treatment for cancer. Human T cells engineered to express a chimeric antigen receptor (CAR) recognize and kill tumor cells in a MHC-unrestricted manner and persist in vivo when the CAR includes a CD28 costimulatory domain. However, the intensity of the CAR-mediated CD28 activation signal and its regulation by the CTLA-4 checkpoint are unknown. We investigated whether T cells expressing an anti-CD19, CD3 zeta and CD28-based CAR (19-28z) displayed the same proliferation and anti-tumor abilities than T cells expressing a CD3 zeta-based CAR (19z1) costimulated through the CD80/CD28, ligand/receptor pathway. Repeated in vitro antigen-specific stimulations indicated that 19-28z(+) T cells secreted higher levels of Th1 cytokines and showed enhanced proliferation compared to those of 19z1(+) or 19z1-CD80(+) T cells. In an aggressive pre-B cell leukemia model, mice treated with 19-28z(+) T cells had 10-fold reduced tumor progression compared to those treated with 19z1(+) or 19z1-CD80(+) T cells. shRNA-mediated CTLA-4 down-regulation in 19z1-CD80(+) T cells significantly increased their in vivo expansion and anti-tumor properties, but had no effect in 19-28z(+) T cells. Our results establish that CTLA-4 down-regulation may benefit human adoptive T cell therapy and demonstrate that CAR design can elude negative checkpoints to better sustain T cell function.	[Condomines, Maud] Mem Sloan Kettering Canc Ctr, Ctr Cell Engn & Mol Pharmacol, New York, NY 10065 USA; Mem Sloan Kettering Canc Ctr, Chem Program, New York, NY 10065 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Condomines, M (corresponding author), Mem Sloan Kettering Canc Ctr, Ctr Cell Engn & Mol Pharmacol, New York, NY 10065 USA.	condominesm@gmail.com; m-sadelain@ski.mskcc.org		Benjamin, Reuben/0000-0003-1434-0594	ARC (Association pour la Recherche contre le Cancer) [PPG-PO1-CA059350]; NATIONAL CANCER INSTITUTE [P30CA008748, P01CA059350] Funding Source: NIH RePORTER	ARC (Association pour la Recherche contre le Cancer)(Fondation ARC pour la Recherche sur le Cancer); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was support by grant PPG-PO1-CA059350 from the ARC (Association pour la Recherche contre le Cancer) in the form of a fellowship for MC. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brentjens RJ, 2007, CLIN CANCER RES, V13, P5426, DOI 10.1158/1078-0432.CCR-07-0674; Brentjens RJ, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005930; Brentjens RJ, 2003, NAT MED, V9, P279, DOI 10.1038/nm827; Brocker T, 2000, BLOOD, V96, P1999, DOI 10.1182/blood.V96.5.1999.h8001999_1999_2001; Butler MO, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002207; Carpenito C, 2009, P NATL ACAD SCI USA, V106, P3360, DOI 10.1073/pnas.0813101106; Chikuma S, 2003, J EXP MED, V197, P129, DOI 10.1084/jem.20021646; Corse E, 2012, J IMMUNOL, V189, P1123, DOI 10.4049/jimmunol.1200695; Darlington PJ, 2005, J IMMUNOL, V175, P996, DOI 10.4049/jimmunol.175.2.996; Davila ML, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008226; Egen JG, 2002, IMMUNITY, V16, P23, DOI 10.1016/S1074-7613(01)00259-X; Finney HM, 2004, J IMMUNOL, V172, P104, DOI 10.4049/jimmunol.172.1.104; Gade TPF, 2005, CANCER RES, V65, P9080, DOI 10.1158/0008-5472.CAN-05-0436; Gallardo HF, 1997, BLOOD, V90, P952, DOI 10.1182/blood.V90.3.952.952_952_957; Gao JF, 2011, EUR J IMMUNOL, V41, P2699, DOI 10.1002/eji.201141428; Ghani K, 2009, HUM GENE THER, V20, P966, DOI 10.1089/hum.2009.001; Gong Michael C., 1999, Neoplasia (New York), V1, P123, DOI 10.1038/sj.neo.7900018; GROSS G, 1992, FASEB J, V6, P3370, DOI 10.1096/fasebj.6.15.1464371; Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; Kochenderfer JN, 2012, BLOOD, V119, P2709, DOI 10.1182/blood-2011-10-384388; Kohn DB, 2011, MOL THER, V19, P432, DOI 10.1038/mt.2011.1; Kong KF, 2014, NAT IMMUNOL, V15, P465, DOI 10.1038/ni.2866; Kowalczyk A, 2014, EUR J IMMUNOL, V44, P1143, DOI 10.1002/eji.201343601; Kowolik CM, 2006, CANCER RES, V66, P10995, DOI 10.1158/0008-5472.CAN-06-0160; Kvistborg P, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008918; Maher J, 2002, NAT BIOTECHNOL, V20, P70, DOI 10.1038/nbt0102-70; Markley JC, 2010, BLOOD, V115, P3508, DOI 10.1182/blood-2009-09-241398; Martin M, 2001, J EXP MED, V194, P1675, DOI 10.1084/jem.194.11.1675; Masteller EL, 2000, J IMMUNOL, V164, P5319, DOI 10.4049/jimmunol.164.10.5319; Porter DL, 2011, NEW ENGL J MED, V365, P725, DOI 10.1056/NEJMoa1103849; Provasi E, 2012, NAT MED, V18, P807, DOI 10.1038/nm.2700; Quezada SA, 2010, J EXP MED, V207, P637, DOI 10.1084/jem.20091918; Qureshi OS, 2011, SCIENCE, V332, P600, DOI 10.1126/science.1202947; Robbins PF, 2011, J CLIN ONCOL, V29, P917, DOI 10.1200/JCO.2010.32.2537; Rudd CE, 2009, IMMUNOL REV, V229, P12, DOI 10.1111/j.1600-065X.2009.00770.x; Sadelain M, 2003, NAT REV CANCER, V3, P35, DOI 10.1038/nrc971; Savoldo B, 2011, J CLIN INVEST, V121, P1822, DOI 10.1172/JCI46110; Schneider H, 2006, SCIENCE, V313, P1972, DOI 10.1126/science.1131078; Snyder A, 2014, NEW ENGL J MED, V371, P2189, DOI 10.1056/NEJMoa1406498; Stamper CC, 2001, NATURE, V410, P608, DOI 10.1038/35069118; Stephan MT, 2007, NAT MED, V13, P1440, DOI 10.1038/nm1676; Stumpf M, 2014, EUR J IMMUNOL, V44, P1737, DOI 10.1002/eji.201343891; Teft WA, 2006, ANNU REV IMMUNOL, V24, P65, DOI 10.1146/annurev.immunol.24.021605.090535; Walker LSK, 2015, TRENDS IMMUNOL, V36, P63, DOI 10.1016/j.it.2014.12.001; Wang CJ, 2012, J IMMUNOL, V189, P1118, DOI 10.4049/jimmunol.1200972; Weber JS, 2012, J CLIN ONCOL, V30, P2691, DOI 10.1200/JCO.2012.41.6750; Wing JB, 2014, IMMUNITY, V41, P1013, DOI 10.1016/j.immuni.2014.12.006; Wolchok JD, 2010, LANCET ONCOL, V11, P155, DOI 10.1016/S1470-2045(09)70334-1; Yokosuka T, 2010, IMMUNITY, V33, P326, DOI 10.1016/j.immuni.2010.09.006; Yuan JD, 2008, P NATL ACAD SCI USA, V105, P20410, DOI 10.1073/pnas.0810114105; Zhong XS, 2010, MOL THER, V18, P413, DOI 10.1038/mt.2009.210	51	42	53	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2015	10	6							e0130518	10.1371/journal.pone.0130518	http://dx.doi.org/10.1371/journal.pone.0130518			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4OY	26110267	Green Submitted, Green Published, gold			2022-12-26	WOS:000356933800057
J	Chang, CH; Chen, SJ; Liu, CY				Chang, Chun-Hung; Chen, Shaw-Ji; Liu, Chieh-Yu			Fracture Risk and Adjuvant Therapies in Young Breast Cancer Patients: A Population-Based Study	PLOS ONE			English	Article							BONE-MINERAL DENSITY; POSTMENOPAUSAL WOMEN; AROMATASE INHIBITORS; TAMOXIFEN; ANASTROZOLE; TRIAL	Background Breast cancer survivors have an increased risk of bone fracture. But the risk among young patients with adjuvant therapies remains unknown. This population-based study is aimed to assess the incidence and risk of fracture among young (age of 20 to 39 years) breast cancer patients who received adjuvant therapies. Methods From January 2001 to December 2007, 5,146 newly diagnosed breast cancer patients were enrolled from the National Health Insurance Research Database (NHIRD) in Taiwan. Patients were observed for a maximum of 6 years to determine the incidence of newly onset fracture. Kaplan Meier and Cox regression analyses were used to evaluate the risk of fracture in young breast cancer patients who received adjuvant treatments. Results Of the total 5,146 young (age of 20 to 39 years) breast cancer patients, the Cox multivariate proportional hazards analysis showed that AIs, radiotherapy, and monoclonal antibodies were significantly associated with a high risk of fracture. Moreover, patients who received AIs for more than 180 days had a high hazard ratio (HR) of 1.77 (95% CI = 0.68-4.57), and patients who received more than four radiotherapy visits had a high HR of 2.54 (95% CI = 1.07-6.06). Under the site-specific analysis, young breast cancer patients who received AIs had the highest risk of hip fracture (HR = 8.520, 95% CI = 1.711-42.432, p < 0.04), whereas patients who received radiotherapy had the highest risk of vertebral fracture (HR = 5.512, 95% CI = 1.847-16.451, p < 0.01). Conclusion Young breast cancer patients who are receiving AIs, radiotherapy or monoclonal antibody need to be more careful for preventing fracture events. Breast cancer treatment plans are suggested to incorporate fracture prevention interventions.	[Chang, Chun-Hung] China Med Univ Hosp, Taichung, Taiwan; [Chang, Chun-Hung] China Med Univ, Inst Clin Med, Taichung, Taiwan; [Chen, Shaw-Ji] Mackay Mem Hosp, Dept Psychiat, Taitung Branch, Taitung, Taiwan; [Chen, Shaw-Ji] Tzu Chi Univ, Inst Med Sci, Hualien, Taiwan; [Liu, Chieh-Yu] Natl Taipei Univ Nursing & Hlth Sci, Inst Nursing Midwifery, Biostat Consulting Lab, Taipei, Taiwan	China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; Mackay Memorial Hospital; Tzu Chi University; National Taipei University of Nursing & Health Science (NTUNHS)	Liu, CY (corresponding author), Natl Taipei Univ Nursing & Hlth Sci, Inst Nursing Midwifery, Biostat Consulting Lab, Taipei, Taiwan.	b89401068@ntu.edu.tw	Liu, Chieh-Yu/AAR-9654-2021; Chang, Chun-Hung/AAT-1641-2021; Liu, Chieh-Yu/J-3789-2019	Liu, Chieh-Yu/0000-0003-3283-028X; 				Ademuyiwa FO, 2015, CANCER-AM CANCER SOC, V121, P1469, DOI 10.1002/cncr.29178; Anders CK, 2009, SEMIN ONCOL, V36, P237, DOI 10.1053/j.seminoncol.2009.03.001; Benson JR, 2009, LANCET, V373, P1463, DOI 10.1016/S0140-6736(09)60316-0; Berry DA, 2005, NEW ENGL J MED, V353, P1784, DOI 10.1056/NEJMoa050518; Bleyer A, 2006, NIH PUBLICATION, V06-5767, DOI [10.1634/theoncologist.11-6-590, DOI 10.1634/THEONCOLOGIST.11-6-590]; Buchholz TA, 2009, NEW ENGL J MED, V360, P63, DOI 10.1056/NEJMct0803525; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Chen Z, 2005, ARCH INTERN MED, V165, P552, DOI 10.1001/archinte.165.5.552; Cheng CL, 2011, PHARMACOEPIDEM DR S, V20, P236, DOI 10.1002/pds.2087; Coleman RE, 2001, CANCER TREAT REV, V27, P165, DOI 10.1053/ctrv.2000.0210; Coleman RE, 2007, LANCET ONCOL, V8, P119, DOI 10.1016/S1470-2045(07)70003-7; Coombes RC, 2007, LANCET, V369, P559, DOI 10.1016/S0140-6736(07)60200-1; Court-Brown CM, 2006, INJURY, V37, P691, DOI 10.1016/j.injury.2006.04.130; Davies C, 2011, LANCET, V378, P771, DOI 10.1016/S0140-6736(11)60993-8; DeSantis C, 2014, CA-CANCER J CLIN, V64, P52, DOI 10.3322/caac.21203; Eastell R, 2008, J CLIN ONCOL, V26, P1051, DOI 10.1200/JCO.2007.11.0726; Eastell R, 2006, J BONE MINER RES, V21, P1215, DOI 10.1359/JBMR.060508; Geisler J, 2005, J STEROID BIOCHEM, V95, P75, DOI 10.1016/j.jsbmb.2005.04.015; Goss PE, 2003, NEW ENGL J MED, V349, P1793, DOI 10.1056/NEJMoa032312; Hudis CA, 2007, NEW ENGL J MED, V357, P39, DOI 10.1056/NEJMra043186; Jakesz R, 2005, LANCET, V366, P455, DOI 10.1016/S0140-6736(05)67059-6; Kanis JA, 1999, BRIT J CANCER, V79, P1179, DOI 10.1038/sj.bjc.6690188; KRISTENSEN B, 1994, J CLIN ONCOL, V12, P992, DOI 10.1200/JCO.1994.12.5.992; Kristensen B, 1996, BREAST CANCER RES TR, V39, P321, DOI 10.1007/BF01806160; LOVE RR, 1992, NEW ENGL J MED, V326, P852, DOI 10.1056/NEJM199203263261302; Neuner JM, 2011, OSTEOPOROSIS INT, V22, P2847, DOI 10.1007/s00198-010-1493-x; Newcomb PA, 2001, AM J EPIDEMIOL, V153, P1071, DOI 10.1093/aje/153.11.1071; Powles T, 1996, J CLIN ONCOL, V14, P78, DOI 10.1200/JCO.1996.14.1.78; Simpson ER, 2002, RECENT PROG HORM RES, V57, P317, DOI 10.1210/rp.57.1.317; Tsa CH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075109; Vestergaard P, 2008, CALCIFIED TISSUE INT, V82, P334, DOI 10.1007/s00223-008-9132-7; Warner E, 2011, NEW ENGL J MED, V365, P1025, DOI 10.1056/NEJMcp1101540; Xu L, 2014, MED ONCOL, V31, DOI 10.1007/s12032-014-0128-z	33	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2015	10	6							e0130725	10.1371/journal.pone.0130725	http://dx.doi.org/10.1371/journal.pone.0130725			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4OM	26107848	Green Published, gold, Green Submitted			2022-12-26	WOS:000356932500120
J	Chu, HJ; Lee, CW; Yeh, SJ; Tsai, LK; Tang, SC; Jeng, JS				Chu, Hai-Jui; Lee, Chung-Wei; Yeh, Shin-Joe; Tsai, Li-Kai; Tang, Sung-Chun; Jeng, Jiann-Shing			Cerebral Lipiodol Embolism in Hepatocellular Carcinoma Patients Treated with Transarterial Embolization/Chemoembolization	PLOS ONE			English	Article							TRANSCATHETER ARTERIAL CHEMOEMBOLIZATION; LIPID EMBOLIZATION; PULMONARY; COMPLICATION; LYMPHOGRAPHY; LYMPHOMA	Background and Purpose Liver cancer is the third leading cause of cancer mortality worldwide. The aim of this study was to investigate the frequency and characteristics of cerebral lipiodol embolism (CLE) in patients with hepatocellular carcinoma (HCC) receiving transarterial embolization/chemoembolization (TAE/TACE). Methods We reviewed all HCC patients who received TAE/TACE during the period of 2007 and 2013 at a university medical center. The frequency of CLE per procedure and the clinical manifestations of CLE, including the review of previous reported cases (n = 24), were analyzed. Results During the study period, a total of 7855 TAE/TACE procedures were conducted on 3277 patients. There were 8 patients (mean age 59 +/- 11 years; 5 males and 3 females) who developed CLE. The frequency of TAE/TACE-related CLE was 1.02 (95% CI, 0.44-2.01) per 1000 procedures. Acute disturbance of consciousness and respiratory distress after TAE/TACE were the most common presentations of CLE. All patients had disseminated infarcts involving both the anterior and posterior cerebral circulations. For 3 patients with shunting between the tumor feeding artery and the pulmonary vein, a specific imaging pattern of coexisting scattered hyperdense spots was found. Furthermore, combined with our 8 cases, the total of 32 cases indicated that old age and female sex were the two risk factors for poor outcome after CLE. Conclusions CLE is a rare but potentially serious complication in HCC patients receiving TAE/TACE. The clinical characteristics of CLE summarized in our study would help facilitate the ability of clinicians to provide timely diagnosis and management.	[Chu, Hai-Jui; Yeh, Shin-Joe; Tsai, Li-Kai; Tang, Sung-Chun; Jeng, Jiann-Shing] Natl Taiwan Univ Hosp, Stroke Ctr, Taipei, Taiwan; [Chu, Hai-Jui; Yeh, Shin-Joe; Tsai, Li-Kai; Tang, Sung-Chun; Jeng, Jiann-Shing] Natl Taiwan Univ Hosp, Dept Neurol, Taipei, Taiwan; [Lee, Chung-Wei] Natl Taiwan Univ Hosp, Dept Med Imaging & Radiol, Taipei, Taiwan	National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital	Tang, SC (corresponding author), Natl Taiwan Univ Hosp, Stroke Ctr, Taipei, Taiwan.	tangneuro@gmail.com	yeh, shin-joe/HGV-0244-2022	Tang, Sung-Chun/0000-0003-3731-5973; Tsai, Li-Kai/0000-0001-8420-6951; LEE, CHUNG-WEI/0000-0002-3573-2506; JENG, JIANN-SHING/0000-0002-1456-3686; Yeh, Shin-Joe/0000-0003-1511-6295				Bansaghi Z, 2013, WORLD J SURG ONCOL, V11, DOI 10.1186/1477-7819-11-122; Barthel HR, 2005, J GASTROEN HEPATOL, V20, P1464, DOI 10.1111/j.1440-1746.2005.03848.x; Chang YC, 2010, CHINESE J INTERVENTI, V7; Choi CS, 2008, WORLD J GASTROENTERO, V14, P4834, DOI 10.3748/wjg.14.4834; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Forner A, 2012, LANCET, V379, P1245, DOI 10.1016/S0140-6736(11)61347-0; Ishikawa T, 2013, HEPATOL RES, V43, P1251, DOI 10.1111/hepr.12074; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jia ZZ, 2012, WORLD J GASTROENTERO, V18, P4069, DOI 10.3748/wjg.v18.i30.4069; Karapanayiotides T, 2009, J NEUROL, V256, P1171, DOI 10.1007/s00415-009-5066-x; Kim JT, 2009, J NEUROIMAGING, V19, P394, DOI 10.1111/j.1552-6569.2009.00380.x; Kritzinger J, 2013, CLIN RADIOL, V68, P1, DOI 10.1016/j.crad.2012.06.112; KUSUMOTO S, 1991, CLIN RADIOL, V44, P279, DOI 10.1016/S0009-9260(05)80199-0; Lee CS, 2010, J COMPUT ASSIST TOMO, V34, P105, DOI 10.1097/RCT.0b013e3181b382f8; Lencioni R, 2012, SEMIN ONCOL, V39, P503, DOI 10.1053/j.seminoncol.2012.05.004; Li Z, 2011, CHINESE MED J-PEKING, V124, P4355, DOI 10.3760/cma.j.issn.0366-6999.2011.24.040; Llovet JM, 1999, SEMIN LIVER DIS, V19, P329, DOI 10.1055/s-2007-1007122; Matsumoto K, 2007, CARDIOVASC INTER RAD, V30, P512, DOI 10.1007/s00270-006-0092-x; OKEN MM, 1982, AM J CLIN ONCOL-CANC, V5, P649, DOI 10.1097/00000421-198212000-00014; Sakamoto I, 1998, RADIOGRAPHICS, V18, P605, DOI 10.1148/radiographics.18.3.9599386; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Takao H, 2005, J COMPUT ASSIST TOMO, V29, P680, DOI 10.1097/01.rct.0000165906.83160.7d; Wan CC, 2015, LIVER INT, V35, P673, DOI 10.1111/liv.12511; Winterer JT, 1999, RADIOLOGY, V210, P381, DOI 10.1148/radiology.210.2.r99fe09381; Wu JJ, 2009, WORLD J GASTROENTERO, V15, P633, DOI 10.3748/wjg.15.633; Wu JJ, 2009, CHINESE MED J-PEKING, V122, P878, DOI 10.3760/cma.j.issn.0366-6999.2009.07.022; Wu L, 2010, WORLD J GASTROENTERO, V16, P398, DOI 10.3748/wjg.v16.i3.398; Yoo KM, 2004, NEUROLOGY, V63, P181, DOI 10.1212/01.WNL.0000132645.23611.2D; Zach V, 2012, J STROKE CEREBROVASC, V21, P217, DOI 10.1016/j.jstrokecerebrovasdis.2010.08.001	29	5	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2015	10	6							e0129367	10.1371/journal.pone.0129367	http://dx.doi.org/10.1371/journal.pone.0129367			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4OM	26107693	Green Submitted, gold, Green Published			2022-12-26	WOS:000356932500049
J	Sonoda, N; Morimoto, A; Ugi, S; Morino, K; Sekine, O; Nemoto, K; Godai, K; Maegawa, H; Miyamatsu, N				Sonoda, Nao; Morimoto, Akiko; Ugi, Satoshi; Morino, Katsutaro; Sekine, Osamu; Nemoto, Ken-ichi; Godai, Kayo; Maegawa, Hiroshi; Miyamatsu, Naomi			Predictors for Mild and Severe Hypoglycemia in Insulin-Treated Japanese Diabetic Patients	PLOS ONE			English	Article							HOSPITALIZED-PATIENTS; GLYCATED HEMOGLOBIN; RISK-FACTORS; FREQUENCY; SUPPORT; TYPE-1; IMPACT	The objective of this study was to explore predictors, including social factors, lifestyle factors, and factors relevant to glycemic control and treatment, for mild and severe hypoglycemia in insulin-treated Japanese diabetic patients. This study included 123 insulin-treated diabetic patients who were referred to the diabetes clinic between January and July 2013 at Shiga University of Medical Science Hospital. After a survey examining the various factors, patients were followed for 6 months. During the follow-up period, blood glucose was self-monitored. Mild hypoglycemia was defined as blood glucose level 50-69 mg/dl, and severe hypoglycemia was defined as blood glucose level <= 49 mg/dl. Multinomial logistic regression was used to estimate the adjusted odds ratio (OR) and 95% confidence interval (CI) of each factor for mild and severe hypoglycemia. During the 6-month follow-up period, 41 (33.3%) patients experienced mild hypoglycemia, and 20 (16.3%) experienced severe hypoglycemia. In multivariable-adjusted analyses, assistance from family members at the time of the insulin injection [presence/absence, OR (95% CI): 0.39 (0.16-0.97)] and drinking [current drinker/non- and ex-drinker, OR (95% CI): 4.89 (1.68-14.25)] affected mild hypoglycemia. Assistance from family members at the time of insulin injection [presence/absence, OR (95% CI): 0.19 (0.05-0.75)] and intensive insulin therapy [yes/no, OR (95% CI): 3.61 (1.06-12.26)] affected severe hypoglycemia. In conclusion, our findings suggest that not only a factor relevant to glycemic control and treatment (intensive insulin therapy) but also a social factor (assistance from family members) and a lifestyle factor (current drinking) were predictors for mild or severe hypoglycemia in Japanese insulin-treated diabetic patients.	[Sonoda, Nao; Morimoto, Akiko; Godai, Kayo; Miyamatsu, Naomi] Shiga Univ Med Sci, Dept Clin Nursing, Otsu, Shiga 52021, Japan; [Ugi, Satoshi; Morino, Katsutaro; Sekine, Osamu; Nemoto, Ken-ichi; Maegawa, Hiroshi] Shiga Univ Med Sci, Dept Med, Otsu, Shiga 52021, Japan	Shiga University of Medical Science; Shiga University of Medical Science	Sonoda, N (corresponding author), Shiga Univ Med Sci, Dept Clin Nursing, Otsu, Shiga 52021, Japan.	nao14531@belle.shiga-med.ac.jp	MORINO, KATSUTARO/I-3207-2019	MORINO, KATSUTARO/0000-0003-2420-3817; Maegawa, Hiroshi/0000-0002-4611-8149	Japan Society for the Promotion of Science (JSPS) [15K20762, 25862144]; Fund for Care Prevention from NPO Biwako Health and Welfare Consortium; Shiga Prefecture	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Fund for Care Prevention from NPO Biwako Health and Welfare Consortium; Shiga Prefecture	This work was supported by the Japan Society for the Promotion of Science (JSPS) Grant-in-Aid for Young Scientists (B) (grant number: 15K20762, 25862144). This work was supported by the Fund for Care Prevention from NPO Biwako Health and Welfare Consortium and Shiga Prefecture. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akram K, 2006, DIABETIC MED, V23, P750, DOI 10.1111/j.1464-5491.2006.01880.x; Barendse S, 2012, DIABETIC MED, V29, P293, DOI 10.1111/j.1464-5491.2011.03416.x; Boyle PJ, 1995, NEW ENGL J MED, V333, P1726, DOI 10.1056/NEJM199512283332602; Bramlage P, 2012, CARDIOVASC DIABETOL, V11, DOI 10.1186/1475-2840-11-122; Childs BP, 2005, DIABETES CARE, V28, P1245; Cryer PE, 2003, DIABETES CARE, V26, P1902, DOI 10.2337/diacare.26.6.1902; Davis WA, 2011, J CLIN ENDOCR METAB, V96, pE696, DOI 10.1210/jc.2010-2087; Donnelly LA, 2005, DIABETIC MED, V22, P749, DOI 10.1111/j.1464-5491.2005.01501.x; Frier BM, 1993, BAILLIERE CLIN ENDOC, V7, P567; GAMBA G, 1991, REV INVEST CLIN, V43, P234; Ginde AA, 2008, DIABETES CARE, V31, P511, DOI 10.2337/dc07-1790; Goto A, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f4533; Hashimoto T, 2013, INTERNAL MED, V52, P2721, DOI 10.2169/internalmedicine.52.0495; Henderson JN, 2003, DIABETIC MED, V20, P1016, DOI 10.1046/j.1464-5491.2003.01072.x; Kashiwagi A, 2012, J DIABETES INVEST, V3, P39, DOI 10.1111/j.2040-1124.2012.00207.x; Miller ME, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.b5444; Miller TA, 2013, DIABET METAB SYND OB, V6, P421, DOI 10.2147/DMSO.S36368; PRAMMING S, 1991, DIABETIC MED, V8, P217, DOI 10.1111/j.1464-5491.1991.tb01575.x; Quilliam BJ, 2011, CLIN THER, V33, P1781, DOI 10.1016/j.clinthera.2011.09.020; Rubin DJ, 2011, DIABETES CARE, V34, P1723, DOI 10.2337/dc10-2434; Seaquist ER, 2013, DIABETES CARE, V36, P1384, DOI 10.2337/dc12-2480; Tsujimoto T, 2014, DIABETES CARE, V37, P217, DOI 10.2337/dc13-0701; Turner RC, 1998, LANCET, V352, P854, DOI 10.1016/s0140-6736(98)07037-8; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; Wen LK, 2004, DIABETES EDUCATOR, V30, P980, DOI 10.1177/014572170403000619; Whitmer RA, 2009, JAMA-J AM MED ASSOC, V301, P1565, DOI 10.1001/jama.2009.460	26	7	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2015	10	6							e0130584	10.1371/journal.pone.0130584	http://dx.doi.org/10.1371/journal.pone.0130584			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4DD	26102197	Green Submitted, Green Published, gold			2022-12-26	WOS:000356901900052
J	Aldonza, MBD; Hong, JY; Bae, SY; Song, J; Kim, WK; Oh, J; Shin, Y; Lee, SH; Lee, SK				Aldonza, Mark Borris Docdoc; Hong, Ji-Young; Bae, Song Yi; Song, Jayoung; Kim, Won Kyung; Oh, Jedo; Shin, Yoonho; Lee, Seung Ho; Lee, Sang Kook			Suppression of MAPK Signaling and Reversal of mTOR-Dependent MDR1-Associated Multidrug Resistance by 21 alpha-Methylmelianodiol in Lung Cancer Cells	PLOS ONE			English	Article							PONCIRUS-TRIFOLIATA FRUIT; P-GLYCOPROTEIN EXPRESSION; CISPLATIN RESISTANCE; GENE-EXPRESSION; FLOW-CYTOMETRY; DRUG-TREATMENT; BREAST-CANCER; ACTIVATION; INHIBITION; SURVIVAL	Lung cancer is the leading cause of cancer-related deaths worldwide and remains the most prevalent. Interplay between PI3K/AMPK/AKT and MAPK pathways is a crucial effector in lung cancer growth and progression. These signals transduction protein kinases serve as good therapeutic targets for non-small cell lung cancer (NSCLC) which comprises up to 90% of lung cancers. Here, we described whether 21 alpha-Methylmelianodiol (21 alpha-MMD), an active triterpenoid derivative of Poncirus trifoliate, can display anticancer properties by regulating these signals and modulate the occurrence of multidrug resistance in NSCLC cells. We found that 21 alpha-MMD inhibited the growth and colony formation of lung cancer cells without affecting the normal lung cell phenotype. 21 alpha-MMD also abrogated the metastatic activity of lung cancer cells through the inhibition of cell migration and invasion, and induced G(0)/G(1) cell cycle arrest with increased intracellular ROS generation and loss of mitochondrial membrane integrity. 21 alpha-MMD regulated the expressions of PI3K/AKT/AMPK and MAPK signaling which drove us to further evaluate its activity on multidrug resistance (MDR) in lung cancer cells by specifying on P-glycoprotein (P-gp)/MDR1-association. Employing the established paclitaxel-resistant A549 cells (A549-PacR), we further found that 21 alpha-MMD induced a MDR reversal activity through the inhibition of P-gp/MDR1 expressions, function, and transcription with regained paclitaxel sensitivity which might dependently correlate to the regulation of PI3K/mTOR signaling pathway. Taken together, these findings demonstrate, for the first time, the mechanistic evaluation in vitro of 21 alpha-MMD displaying growth-inhibiting potential with influence on MDR reversal in human lung cancer cells.	[Aldonza, Mark Borris Docdoc; Hong, Ji-Young; Bae, Song Yi; Song, Jayoung; Kim, Won Kyung; Oh, Jedo; Shin, Yoonho; Lee, Sang Kook] Seoul Natl Univ, Coll Pharm, Seoul, South Korea; [Lee, Seung Ho] Yeungnam Univ, Coll Pharm, Gyeongbuk, South Korea	Seoul National University (SNU); Yeungnam University	Lee, SK (corresponding author), Seoul Natl Univ, Coll Pharm, Seoul, South Korea.	sklee61@snu.ac.kr	Aldonza, Mark Borris/A-3851-2017	Aldonza, Mark Borris/0000-0002-0771-129X	Ministry of Food and Drug Safety [12172MFDS989]; National Research Foundation of Korea (NRF) - Korean Government (MEST) [2009-0083533]	Ministry of Food and Drug Safety(Ministry of Food & Drug Safety (MFDS), Republic of Korea); National Research Foundation of Korea (NRF) - Korean Government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaNational Research Foundation of KoreaKorean Government)	This research was supported by a grant (2005 and 12172MFDS989) from Ministry of Food and Drug Safety and the National Research Foundation of Korea (NRF) grant funded by the Korean Government (MEST) (No. 2009-0083533).	Ambudkar SV, 2003, ONCOGENE, V22, P7468, DOI 10.1038/sj.onc.1206948; Amer J, 2003, EUR J HAEMATOL, V70, P84, DOI 10.1034/j.1600-0609.2003.00011.x; Arany I, 2004, KIDNEY INT, V65, P1231, DOI 10.1111/j.1523-1755.2004.00500.x; Arumugam S, 2012, EXP MOL PATHOL, V93, P183, DOI 10.1016/j.yexmp.2012.04.012; Bansal T, 2009, J PHARM PHARM SCI, V12, P46, DOI 10.18433/J3RC77; Barancik M, 2006, EUR J PHARM SCI, V29, P426, DOI 10.1016/j.ejps.2006.08.006; Bellamy WT, 1996, ANNU REV PHARMACOL, V36, P161, DOI 10.1146/annurev.pa.36.040196.001113; Bishayee A, 2011, FRONT BIOSCI-LANDMRK, V16, P980, DOI 10.2741/3730; Borst P, 2000, JNCI-J NATL CANCER I, V92, P1295, DOI 10.1093/jnci/92.16.1295; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chetram MA, 2013, MOL CELL BIOCHEM, V376, P63, DOI 10.1007/s11010-012-1549-7; Choi JS, 2004, INT J PHARMACEUT, V275, P165, DOI 10.1016/j.ijpharm.2004.01.032; Chung HJ, 2011, FOOD CHEM TOXICOL, V49, P2942, DOI 10.1016/j.fct.2011.07.001; Dhillon AS, 2007, ONCOGENE, V26, P3279, DOI 10.1038/sj.onc.1210421; Ding S, 2001, BRIT J CANCER, V85, P1175, DOI 10.1054/bjoc.2001.2044; Fumarola C, 2014, BIOCHEM PHARMACOL, V90, P197, DOI 10.1016/j.bcp.2014.05.011; Gutierrez-Uzquiza A, 2012, J BIOL CHEM, V287, P2632, DOI 10.1074/jbc.M111.323709; Han Z, 2007, J EXP CLIN CANC RES, V26, P261; Heavey S, 2014, CANCER TREAT REV, V40, P445, DOI 10.1016/j.ctrv.2013.08.006; Ho GT, 2003, GUT, V52, P759, DOI 10.1136/gut.52.5.759; Houston Michele A, 2011, Int J Cell Biol, V2011, P978583, DOI 10.1155/2011/978583; Jayaprakasha G.K., 2012, PLANTA MED, V78; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Ji MJ, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-147; Jiang BH, 2008, DRUG RESIST UPDATE, V11, P63, DOI 10.1016/j.drup.2008.03.001; Jorissen RN, 2003, EXP CELL RES, V284, P31, DOI 10.1016/S0014-4827(02)00098-8; Jung CH, 2010, FEBS LETT, V584, P1287, DOI 10.1016/j.febslet.2010.01.017; Kim EH, 2012, FOOD CHEM TOXICOL, V50, P1060, DOI 10.1016/j.fct.2011.11.008; Koldehoff M, 2014, CANCER GENE THER, V21, P275, DOI 10.1038/cgt.2014.27; Kondratov RV, 2001, P NATL ACAD SCI USA, V98, P14078, DOI 10.1073/pnas.241314798; Kumar Priyank, 2012, Cells, V1, P558, DOI 10.3390/cells1030558; Kuo TC, 2011, BIOCHEM PHARMACOL, V81, P1136, DOI 10.1016/j.bcp.2011.02.013; Kurmasheva RT, 2006, BRIT J CANCER, V95, P955, DOI 10.1038/sj.bjc.6603353; Lee IJ, 2008, PLANTA MED, V74, P396, DOI 10.1055/s-2008-1034329; Lee YM, 1996, J ETHNOPHARMACOL, V54, P77, DOI 10.1016/S0378-8741(96)01451-1; Liang JY, 2013, CANCER RES, V73, P2929, DOI 10.1158/0008-5472.CAN-12-3876; Lin JH, 2003, CLIN PHARMACOKINET, V42, P59, DOI 10.2165/00003088-200342010-00003; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LUDESCHER C, 1992, BRIT J HAEMATOL, V82, P161, DOI 10.1111/j.1365-2141.1992.tb04608.x; [马强 Ma Qiang], 2012, [肿瘤, Tumor], V32, P782; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Najar IA, 2010, PHYTOTHER RES, V24, P454, DOI 10.1002/ptr.2951; Newman DJ, 2003, J NAT PROD, V66, P1022, DOI 10.1021/np030096l; Nogueira V, 2008, CANCER CELL, V14, P458, DOI 10.1016/j.ccr.2008.11.003; Patlolla JMR, 2012, CURR PHARM BIOTECHNO, V13, P147; Peng DJ, 2010, BIOCHEM BIOPH RES CO, V394, P600, DOI 10.1016/j.bbrc.2010.03.029; Perez-Tomas R, 2006, CURR MED CHEM, V13, P1859, DOI 10.2174/092986706777585077; Persons DL, 1999, CLIN CANCER RES, V5, P1007; Pokharel YR, 2006, PHARMAZIE, V61, P796; Pop IV, 2009, LEUKEMIA LYMPHOMA, V50, P1155, DOI 10.1080/10428190903046722; Pozarowski Piotr, 2004, Methods Mol Biol, V281, P301; Randle RA, 2007, BIOCHEM J, V406, P445, DOI 10.1042/BJ20070235; Shin TY, 2006, TOXICOL IN VITRO, V20, P1071, DOI 10.1016/j.tiv.2006.02.003; Son Yong, 2011, J Signal Transduct, V2011, P792639, DOI 10.1155/2011/792639; Spengler G, 2009, ANTICANCER RES, V29, P3989; Trachootham D, 2008, ANTIOXID REDOX SIGN, V10, P1343, DOI 10.1089/ars.2007.1957; Wang SF, 2013, BIOCHEM PHARMACOL, V86, P548, DOI 10.1016/j.bcp.2013.06.006; Wang XT, 2000, J BIOL CHEM, V275, P39435, DOI 10.1074/jbc.M004583200; Wartenberg M, 2001, J BIOL CHEM, V276, P17420, DOI 10.1074/jbc.M100141200; Wojtalla A, 2011, CRIT REV ONCOL HEMAT, V80, P278, DOI 10.1016/j.critrevonc.2011.01.007; Wu CJ, 2005, MOL CANCER, V4, DOI 10.1186/1476-4598-4-25; Yu R, 2000, J BIOL CHEM, V275, P39907, DOI 10.1074/jbc.M004037200; Zhou HY, 2007, EUR J PHARMACOL, V572, P239, DOI 10.1016/j.ejphar.2007.07.005	63	23	25	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2015	10	6							e0127841	10.1371/journal.pone.0127841	http://dx.doi.org/10.1371/journal.pone.0127841			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL3FM	26098947	Green Submitted, Green Published, gold			2022-12-26	WOS:000356835800009
J	Varella, AC; Menezes-Netto, AC; Alonso, JDD; Caixeta, DF; Peterson, RKD; Fernandes, OA				Varella, Andrea Correa; Menezes-Netto, Alexandre Carlos; de Souza Alonso, Juliana Duarte; Caixeta, Daniel Ferreira; Peterson, Robert K. D.; Fernandes, Odair Aparecido			Mortality Dynamics of Spodoptera frugiperda (Lepidoptera: Noctuidae) Immatures in Maize	PLOS ONE			English	Article							FALL ARMYWORM LEPIDOPTERA; TELENOMUS-REMUS NIXON; THERMAL REQUIREMENTS; BIOLOGICAL-CONTROL; SMITH LEPIDOPTERA; NATURAL ENEMIES; INTRAGUILD PREDATION; GENERALIST PREDATORS; SUBSISTENCE MAIZE; PARASITISM	We characterized the dynamics of mortality factors affecting immature developmental stages of the fall armyworm, Spodoptera frugiperda (J.E. Smith) (Lepidoptera: Noctuidae). Multiple decrement life tables for egg and early larval stages of S. frugiperda in maize (Zea maysL.) fields were developed with and without augmentative releases of Telenomus remus Nixon (Hymenoptera: Platygastridae) from 2009 to 2011. Total egg mortality ranged from 73 to 81% and the greatest egg mortality was due to inviability, dislodgement, and predation. Parasitoids did not cause significant mortality in egg or early larval stages and the releases of T. remusdid not increase egg mortality. Greater than 95% of early larvae died from predation, drowning, and dislodgment by rainfall. Total mortality due to these factors was largely irreplaceable. Results indicate that a greater effect in reducing generational survival may be achieved by adding mortality to the early larval stage of S. frugiperda.	[Varella, Andrea Correa] Montana State Univ, Dept Plant Sci & Plant Pathol, Bozeman, MT 59717 USA; [Menezes-Netto, Alexandre Carlos; Caixeta, Daniel Ferreira; Fernandes, Odair Aparecido] UNESP Univ Estadual Paulista, Dept Fitossanidade, BR-14884900 Jaboticabal, SP, Brazil; [de Souza Alonso, Juliana Duarte] Embrapa Arroz & Feijao, BR-75375000 Santo Antonio de Goias, Go, Brazil; [Peterson, Robert K. D.] Montana State Univ, Dept Land Resources & Environm Sci, Bozeman, MT 59717 USA	Montana State University System; Montana State University Bozeman; Universidade Estadual Paulista; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Montana State University System; Montana State University Bozeman	Fernandes, OA (corresponding author), UNESP Univ Estadual Paulista, Dept Fitossanidade, BR-14884900 Jaboticabal, SP, Brazil.	oafernandes@fcav.unesp.br	Menezes-Netto, Alexandre C./ABC-6444-2020; Fernandes, Odair A/C-1345-2013	Menezes-Netto, Alexandre C./0000-0002-8696-3881; Fernandes, Odair A/0000-0003-3489-4754	National Council for Scientific and Technological Development, CNPq, Brazil	National Council for Scientific and Technological Development, CNPq, Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	Funding provided by the National Council for Scientific and Technological Development, CNPq, Brazil (assistantship to ACV and research grant).	[Anonymous], 1936, HDB KLIMATOLOGIE C; BEIRNE B P, 1970, Canadian Entomologist, V102, P1360; BELLOWS TS, 1992, ANNU REV ENTOMOL, V37, P587, DOI 10.1146/annurev.en.37.010192.003103; Beserra EB, 2002, FLA ENTOMOL, V85, P588, DOI 10.1653/0015-4040(2002)085[0588:DANPOS]2.0.CO;2; Buck Nick, 1999, Ecological Bulletins, V47, P68; Busato GR, 2005, PESQUI AGROPECU BRAS, V40, P329, DOI 10.1590/S0100-204X2005000400003; Capinera JL, 1999, EENY098 U FLOR IFAS; Carey JR, 1995, EXP GERONTOL, V30, P605, DOI 10.1016/0531-5565(95)00013-5; Carey JR., 1993, APPL DEMOGRAPHY BIOL; Chapman JW, 1999, ECOL ENTOMOL, V24, P268, DOI 10.1046/j.1365-2311.1999.00224.x; Figueiredo MDC, 2006, PESQUI AGROPECU BRAS, V41, P1693, DOI 10.1590/S0100-204X2006001200002; Cruz I, 2008, TECNOLOGIAS PRODUCAO, P311; Davis RS, 2011, COMPUT ELECTRON AGR, V75, P363, DOI 10.1016/j.compag.2010.12.009; Diez-Rodriguez Gabriela I., 2001, Neotropical Entomology, V30, P311, DOI 10.1590/S1519-566X2001000200016; Fatouros NE, 2008, BEHAV ECOL, V19, P677, DOI 10.1093/beheco/arn011; Fenoglio MS, 2007, ENVIRON ENTOMOL, V36, P1159, DOI 10.1603/0046-225X(2007)36[1159:IOWCAD]2.0.CO;2; Ferrer F., 2001, BIOCONTROL NEWS INFO, V22, P67; Figueiredo M. L. C., 2005, COMUNICADO TECNICO, V130; Figueiredo MDC, 1999, PESQUI AGROPECU BRAS, V34, P1975, DOI 10.1590/S0100-204X1999001100001; FIGUEIREDO MLC, 2002, REVISTA BRASILEIRA D, V1, P1; Fornasieri-Filho D., 2007, MANUAL CULTURA MILHO; Garcia R. F., 2002, Revista Colombiana de Entomologia, V28, P53; Garcia-Roa F, 1999, CONTROL BIOL MICROBI; Harvey JA, 2013, ANNU REV ENTOMOL, V58, P333, DOI 10.1146/annurev-ento-120811-153622; Institute SAS, 2004, SAS STAT US GUID REL; Kasten P. Jr., 1978, Revista de Agricultura, V53, P68; King EG, 1985, SOUTHWEST ENTOMOL S, V8, P1; LEUCK DB, 1972, J ECON ENTOMOL, V65, P482, DOI 10.1093/jee/65.2.482; Meirelles AP, 2009, REV BRAS ENTOMOL, V53, P457, DOI 10.1590/S0085-56262009000300022; Menezes-Netto AC, 2012, BRAZ ARCH BIOL TECHN, V55, P97, DOI 10.1590/S1516-89132012000100012; Molina-Ochoa J, 2003, FLA ENTOMOL, V86, P254, DOI 10.1653/0015-4040(2003)086[0254:PAPOSF]2.0.CO;2; Murua MG, 2008, ANN ENTOMOL SOC AM, V101, P639, DOI 10.1603/0013-8746(2008)101[639:FAMCOS]2.0.CO;2; Naranjo SE, 2007, BIOCONTROL SCI TECHN, V17, P605, DOI 10.1080/09583150701408816; Bueno RCOD, 2008, CIENC RURAL, V38, P1, DOI 10.1590/S0103-84782008000100001; Oliveira RC, 2006, AGENTES CONTROLE BIO, P151; Pell JK, 2008, BIOCONTROL, V53, P147, DOI 10.1007/s10526-007-9125-x; Peterson RKD, 2011, BIOCONTROL, V56, P831, DOI 10.1007/s10526-011-9357-7; Peterson RKD, 2009, ENVIRON ENTOMOL, V38, P2, DOI 10.1603/022.038.0102; Pomari AF, 2012, ANN ENTOMOL SOC AM, V105, P73, DOI 10.1603/AN11115; Razze JM, 2012, J ECON ENTOMOL, V105, P1214, DOI 10.1603/EC11288; Roger C, 2001, ECOL ENTOMOL, V26, P163, DOI 10.1046/j.1365-2311.2001.00305.x; Sa LAN, 1994, FLA ENTOMOL, V77, P185; Snyder WE, 2001, ECOLOGY, V82, P705, DOI 10.1890/0012-9658(2001)082[0705:GPDBCB]2.0.CO;2; Southwood TRE., 1978, ECOLOGICAL METHODS P; SPARKS AN, 1979, FLA ENTOMOL, V62, P82, DOI 10.2307/3494083; Wyckhuys KAG, 2007, INT J PEST MANAGE, V53, P89, DOI 10.1080/09670870701245207; Wyckhuys KAG, 2006, CROP PROT, V25, P1180, DOI 10.1016/j.cropro.2006.03.003; Zalucki MP, 2002, ANNU REV ENTOMOL, V47, P361, DOI 10.1146/annurev.ento.47.091201.145220	48	27	28	2	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2015	10	6							e0130437	10.1371/journal.pone.0130437	http://dx.doi.org/10.1371/journal.pone.0130437			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL3FM	26098422	Green Published, Green Submitted, gold			2022-12-26	WOS:000356835800067
